,Word,T,P
0,Anesthesia,0,1
1,for,0,0
2,in,0,0
3,vitro,0,0
4,fertilization,0,0
5,:,0,0
6,the,0,0
7,addition,0,0
8,of,0,0
9,fentanyl,0,0
10,to,0,0
11,1.5,0,0
12,%,0,0
13,lidocaine,0,0
14,.,0,0
15,UNLABELLED,0,0
16,Ultrasonically,0,0
17,guided,0,0
18,transvaginal,0,0
19,oocyte,0,0
20,retrieval,0,1
21,is,0,0
22,relatively,0,0
23,short,0,0
24,procedure,0,0
25,that,0,0
26,is,0,0
27,performed,0,0
28,on,0,0
29,an,0,0
30,out-patient,0,0
31,basis,0,0
32,.,0,0
33,The,0,0
34,optimal,0,0
35,anesthetic,0,0
36,technique,0,0
37,should,0,0
38,allow,0,0
39,good,0,0
40,surgical,0,0
41,anesthesia,0,0
42,with,0,0
43,minimal,0,1
44,side,0,1
45,effects,0,1
46,",",0,0
47,a,0,0
48,short,0,1
49,recovery,0,1
50,time,0,1
51,",",0,1
52,and,0,1
53,",",0,1
54,if,0,0
55,possible,0,0
56,",",0,0
57,a,0,0
58,high,0,0
59,rate,0,1
60,of,0,0
61,successful,0,0
62,pregnancy,0,0
63,.,0,0
64,Spinal,0,0
65,anesthesia,0,0
66,is,0,0
67,often,0,0
68,used,0,0
69,in,0,0
70,this,0,0
71,institution,0,0
72,",",0,0
73,as,0,0
74,well,0,0
75,as,0,0
76,many,0,0
77,others,0,0
78,",",0,0
79,for,0,0
80,this,0,0
81,procedure,0,0
82,.,0,0
83,The,0,0
84,addition,0,0
85,of,0,0
86,fentanyl,0,0
87,may,0,0
88,be,0,0
89,effective,0,0
90,for,0,0
91,both,0,0
92,intraoperative,0,0
93,and,0,0
94,postoperative,0,1
95,pain,0,1
96,relief,0,1
97,.,0,0
98,We,0,0
99,assessed,0,0
100,the,0,0
101,effect,0,0
102,of,0,0
103,adding,0,0
104,fentanyl,0,0
105,to,0,0
106,1.5,0,0
107,%,0,0
108,lidocaine,0,0
109,in,0,0
110,women,0,0
111,undergoing,0,0
112,ultrasonically,0,0
113,guided,0,0
114,oocyte,0,0
115,retrieval,0,1
116,.,0,0
117,Seventy-eight,0,0
118,women,0,0
119,were,0,0
120,randomized,0,0
121,to,0,0
122,receive,0,0
123,45,0,0
124,mg,0,0
125,of,0,0
126,hyperbaric,0,0
127,1.5,0,0
128,%,0,0
129,lidocaine,0,0
130,with,0,0
131,or,0,0
132,without,0,0
133,10,0,0
134,microg,0,0
135,of,0,0
136,fentanyl,0,0
137,.,0,0
138,Visual,1,1
139,analog,1,1
140,scale,1,1
141,(,1,0
142,VAS,1,1
143,),1,0
144,pain,1,1
145,scores,1,1
146,were,0,0
147,lower,0,0
148,in,0,0
149,the,0,0
150,operating,0,1
151,room,0,0
152,(,0,0
153,OR,0,1
154,),0,0
155,(,0,0
156,P,0,0
157,<,0,0
158,0.05,0,0
159,),0,0
160,and,0,0
161,postanesthesia,0,1
162,care,0,0
163,unit,0,0
164,(,0,0
165,PACU,0,1
166,),0,0
167,(,0,0
168,P,0,0
169,<,0,0
170,0.0005,0,0
171,),0,0
172,for,0,0
173,the,0,0
174,group,0,0
175,that,0,0
176,received,0,0
177,fentanyl,0,0
178,.,0,0
179,In,0,0
180,addition,0,0
181,",",0,0
182,the,0,0
183,amount,1,1
184,of,1,0
185,narcotic,1,1
186,required,1,0
187,in,0,0
188,the,0,0
189,PACU,0,1
190,was,0,0
191,less,0,0
192,in,0,0
193,the,0,0
194,fentanyl,0,0
195,group,0,0
196,(,0,0
197,P,0,0
198,<,0,0
199,0.005,0,0
200,),0,0
201,.,0,0
202,There,0,0
203,was,0,0
204,no,0,0
205,difference,0,0
206,in,0,0
207,VAS,1,0
208,scores,1,1
209,the,0,0
210,evening,0,0
211,of,0,0
212,or,0,0
213,24,0,0
214,h,0,0
215,after,0,0
216,the,0,0
217,procedure,0,0
218,.,0,0
219,The,0,0
220,amount,1,0
221,of,1,0
222,analgesics,1,1
223,and,1,0
224,narcotics,1,0
225,required,1,0
226,after,1,0
227,discharge,1,0
228,was,0,0
229,the,0,0
230,same,0,0
231,for,0,0
232,both,0,0
233,groups,0,0
234,.,0,0
235,Timed,1,0
236,variables,1,1
237,",",1,0
238,such,1,0
239,as,1,0
240,time,1,1
241,to,1,0
242,urination,1,1
243,",",1,0
244,ambulation,1,1
245,",",1,1
246,and,1,1
247,discharge,1,1
248,",",0,0
249,were,0,0
250,the,0,0
251,same,0,0
252,for,0,0
253,both,0,0
254,groups,0,0
255,of,0,0
256,women,0,0
257,.,0,0
258,The,0,0
259,addition,0,0
260,of,0,0
261,fentanyl,0,0
262,to,0,0
263,lidocaine,0,0
264,for,0,0
265,transvaginal,0,0
266,oocyte,0,1
267,retrieval,0,1
268,results,0,0
269,in,0,0
270,a,0,0
271,more,0,0
272,comfortable,0,1
273,patient,0,0
274,in,0,0
275,the,0,0
276,OR,0,0
277,and,0,0
278,PACU,0,1
279,.,0,0
280,IMPLICATIONS,0,0
281,This,0,0
282,study,0,0
283,demonstrates,0,0
284,that,0,0
285,when,0,0
286,fentanyl,0,0
287,is,0,0
288,added,0,0
289,to,0,0
290,a,0,0
291,local,0,0
292,anesthetic,0,0
293,",",0,0
294,lidocaine,0,0
295,",",0,0
296,with,0,0
297,spinal,0,1
298,anesthesia,0,0
299,for,0,0
300,egg,0,0
301,retrieval,0,1
302,procedures,0,0
303,",",0,0
304,patients,0,0
305,are,0,0
306,more,0,0
307,comfortable,0,1
308,during,0,0
309,the,0,0
310,procedure,0,0
311,compared,0,0
312,with,0,0
313,those,0,0
314,who,0,0
315,receive,0,0
316,lidocaine,0,0
317,alone,0,0
318,.,0,0
319,In,0,0
320,addition,0,0
321,",",0,0
322,the,0,0
323,narcotic,0,1
324,requirements,0,0
325,of,0,0
326,patients,0,0
327,are,0,0
328,less,0,0
329,in,0,0
330,the,0,0
331,postanesthesia,0,1
332,care,0,0
333,unit,0,0
334,.,0,0
335,Behavioral,1,1
336,and,1,0
337,physiological,1,1
338,effects,1,1
339,of,0,0
340,remifentanil,0,0
341,and,0,1
342,alfentanil,0,0
343,in,0,0
344,healthy,0,0
345,volunteers,0,0
346,.,0,0
347,BACKGROUND,0,0
348,The,1,0
349,subjective,1,1
350,and,1,0
351,psychomotor,1,1
352,effects,1,1
353,of,0,0
354,remifentanil,0,0
355,have,0,0
356,not,0,0
357,been,0,0
358,evaluated,0,0
359,.,0,0
360,Accordingly,0,0
361,",",0,0
362,the,0,0
363,authors,0,0
364,used,0,0
365,mood,0,1
366,inventories,0,1
367,and,0,1
368,psychomotor,0,1
369,tests,0,0
370,to,0,0
371,characterize,0,0
372,the,0,0
373,effects,0,0
374,of,0,0
375,remifentanil,0,0
376,in,0,0
377,healthy,0,0
378,",",0,0
379,non-drug-abusing,0,0
380,volunteers,0,0
381,.,0,0
382,Alfentanil,0,0
383,was,0,0
384,used,0,0
385,as,0,0
386,a,0,0
387,comparator,0,0
388,drug,0,0
389,.,0,0
390,METHODS,0,0
391,Ten,0,0
392,healthy,0,0
393,volunteers,0,0
394,were,0,0
395,enrolled,0,0
396,in,0,0
397,a,0,0
398,randomized,0,0
399,",",0,0
400,double-blinded,0,0
401,",",0,0
402,placebo-controlled,0,0
403,",",0,0
404,crossover,0,0
405,trial,0,0
406,in,0,0
407,which,0,0
408,they,0,0
409,received,0,0
410,an,0,0
411,infusion,0,0
412,of,0,0
413,saline,0,0
414,",",0,0
415,remifentanil,0,0
416,",",0,1
417,or,0,1
418,alfentanil,0,0
419,for,0,0
420,120,0,0
421,min,0,0
422,.,0,0
423,The,0,0
424,age-,0,0
425,and,0,0
426,weight-adjusted,0,0
427,infusions,0,0
428,(,0,0
429,determined,0,0
430,with,0,0
431,STANPUMP,0,0
432,",",0,0
433,a,0,0
434,computer,0,0
435,modeling,0,0
436,software,0,0
437,package,0,0
438,),0,0
439,were,0,0
440,given,0,0
441,to,0,0
442,achieve,0,0
443,three,0,0
444,predicted,0,0
445,constant,0,0
446,plasma,0,1
447,levels,0,1
448,for,0,0
449,40,0,0
450,min,0,0
451,each,0,0
452,of,0,0
453,remifentanil,0,0
454,(,0,0
455,0.75,0,0
456,",",0,0
457,1.5,0,0
458,",",0,0
459,and,0,0
460,3,0,0
461,ng/ml,0,0
462,),0,0
463,and,0,1
464,alfentanil,0,0
465,(,0,0
466,16,0,0
467,",",0,0
468,32,0,0
469,",",0,0
470,and,0,0
471,64,0,0
472,ng/ml,0,0
473,),0,0
474,.,0,0
475,Mood,0,1
476,forms,0,0
477,and,0,1
478,psychomotor,0,1
479,tests,0,1
480,were,0,0
481,completed,0,0
482,",",0,0
483,and,0,1
484,miosis,0,1
485,was,0,0
486,assessed,0,0
487,",",0,0
488,during,0,0
489,and,0,0
490,after,0,0
491,the,0,0
492,infusions,0,0
493,.,0,0
494,In,0,0
495,addition,0,0
496,",",0,0
497,analgesia,0,1
498,was,0,0
499,tested,0,0
500,at,0,0
501,each,0,0
502,dose,0,0
503,level,0,0
504,using,0,0
505,a,0,0
506,cold-pressor,0,0
507,test,0,0
508,.,0,0
509,RESULTS,0,0
510,Remifentanil,0,0
511,had,0,0
512,prototypic,1,0
513,micro-like,1,0
514,opioid,1,0
515,subjective,1,1
516,effects,1,1
517,",",1,0
518,impaired,1,1
519,psychomotor,1,1
520,performance,1,1
521,",",1,1
522,and,1,1
523,produced,1,0
524,analgesia,1,1
525,.,1,0
526,Alfentanil,0,0
527,at,0,0
528,the,0,0
529,dose,0,0
530,range,0,0
531,tested,0,0
532,had,0,0
533,more,0,0
534,mild,0,1
535,effects,0,0
536,on,0,0
537,these,0,0
538,measures,0,1
539,",",0,0
540,and,0,0
541,the,0,0
542,analgesia,1,1
543,data,0,0
544,indicated,0,0
545,that,0,0
546,a,0,0
547,40:1,0,0
548,potency,0,1
549,ratio,0,0
550,",",0,0
551,rather,0,0
552,than,0,0
553,the,0,0
554,20:1,0,0
555,ratio,0,0
556,we,0,0
557,used,0,0
558,",",0,0
559,may,0,0
560,exist,0,0
561,between,0,0
562,remifentanil,0,0
563,and,0,0
564,alfentanil,0,0
565,.,0,0
566,A,0,0
567,psychomotor,0,1
568,test,0,0
569,administered,0,0
570,60,0,0
571,min,0,0
572,after,0,0
573,the,0,0
574,remifentanil,0,0
575,infusion,0,0
576,was,0,0
577,discontinued,0,0
578,showed,0,0
579,that,0,0
580,the,0,0
581,volunteers,0,0
582,were,0,0
583,still,0,0
584,impaired,0,0
585,",",0,0
586,although,0,0
587,they,0,0
588,reported,0,0
589,feeling,0,1
590,no,0,0
591,drug,0,0
592,effects,0,0
593,.,0,0
594,CONCLUSIONS,0,0
595,The,0,0
596,notion,0,0
597,that,0,0
598,the,0,0
599,pharmacodynamic,1,1
600,effects,1,0
601,of,0,0
602,remifentanil,0,0
603,are,0,0
604,extremely,0,0
605,short-lived,0,0
606,after,0,0
607,the,0,0
608,drug,0,0
609,is,0,0
610,no,0,0
611,longer,0,0
612,administered,0,0
613,must,0,0
614,be,0,0
615,questioned,0,0
616,given,0,0
617,our,0,0
618,findings,0,0
619,that,0,0
620,psychomotor,1,1
621,effects,1,1
622,were,0,0
623,still,0,0
624,apparent,0,0
625,1,0,0
626,h,0,0
627,after,0,0
628,the,0,0
629,infusion,0,0
630,was,0,0
631,discontinued,0,0
632,.,0,0
633,Comparison,0,0
634,of,0,0
635,three,0,0
636,solutions,0,0
637,of,0,0
638,ropivacaine/fentanyl,0,0
639,for,0,0
640,postoperative,0,1
641,patient-controlled,0,0
642,epidural,0,0
643,analgesia,0,0
644,.,0,0
645,BACKGROUND,0,0
646,Ropivacaine,0,0
647,",",0,0
648,0.2,0,0
649,%,0,0
650,",",0,0
651,is,0,0
652,a,0,0
653,new,0,0
654,local,0,0
655,anesthetic,0,0
656,approved,0,0
657,for,0,0
658,epidural,0,0
659,analgesia,0,0
660,.,0,0
661,The,0,0
662,addition,0,0
663,of,0,0
664,4,0,0
665,microg/ml,0,0
666,fentanyl,0,0
667,improves,0,0
668,analgesia,0,0
669,from,0,0
670,epidural,0,0
671,ropivacaine,0,0
672,.,0,0
673,Use,0,0
674,of,0,0
675,a,0,0
676,lower,0,0
677,concentration,0,1
678,of,0,0
679,ropivacaine-fentanyl,0,0
680,may,0,0
681,further,0,0
682,improve,0,0
683,analgesia,1,1
684,or,0,0
685,decrease,0,1
686,side,1,1
687,effects,1,0
688,.,1,0
689,METHODS,0,0
690,Thirty,0,0
691,patients,0,0
692,undergoing,0,0
693,lower,0,0
694,abdominal,0,1
695,surgery,0,0
696,were,0,0
697,randomized,0,0
698,in,0,0
699,a,0,0
700,double-blinded,0,0
701,manner,0,0
702,to,0,0
703,receive,0,0
704,one,0,0
705,of,0,0
706,three,0,0
707,solutions,0,0
708,:,0,0
709,0.2,0,0
710,%,0,0
711,ropivacaine-4,0,0
712,microg,0,0
713,fentanyl,0,0
714,0.1,0,0
715,%,0,0
716,ropivacaine-2,0,0
717,microg,0,0
718,fentanyl,0,0
719,",",0,0
720,or,0,0
721,0.05,0,0
722,%,0,0
723,ropivacaine-1,0,0
724,microg,0,0
725,fentanyl,0,0
726,for,0,0
727,patient-controlled,0,0
728,epidural,0,0
729,analgesia,0,1
730,after,0,0
731,standardized,0,0
732,combined,0,0
733,epidural,0,0
734,and,0,0
735,general,0,0
736,anesthesia,0,0
737,.,0,0
738,Patient-controlled,0,0
739,epidural,0,0
740,analgesia,0,1
741,settings,0,0
742,and,0,0
743,adjustments,0,0
744,for,0,0
745,the,0,0
746,three,0,0
747,solutions,0,0
748,were,0,0
749,standardized,0,0
750,to,0,0
751,deliver,0,0
752,equivalent,0,0
753,drug,0,0
754,doses,0,0
755,.,0,0
756,Pain,1,1
757,scores,1,1
758,(,1,0
759,rest,1,0
760,",",1,1
761,cough,1,1
762,",",1,1
763,and,1,1
764,ambulation,1,1
765,),1,1
766,",",1,0
767,side,1,1
768,effects,1,1
769,(,1,0
770,nausea,1,1
771,",",1,1
772,pruritus,1,1
773,",",1,1
774,sedation,1,1
775,",",1,1
776,motor,1,1
777,block,1,1
778,",",1,1
779,hypotension,1,1
780,",",1,1
781,and,1,1
782,orthostasis,1,1
783,),1,1
784,",",1,0
785,and,1,1
786,patient-controlled,1,0
787,epidural,1,0
788,analgesia,1,1
789,consumption,1,1
790,were,0,0
791,measured,0,0
792,for,0,0
793,48,0,0
794,h.,0,0
795,RESULTS,0,0
796,All,0,0
797,three,0,0
798,solutions,0,0
799,produced,0,0
800,equivalent,0,0
801,analgesia,0,1
802,.,0,0
803,Motor,1,0
804,block,1,0
805,was,0,0
806,significantly,0,0
807,more,0,0
808,common,0,0
809,(,0,0
810,30,0,0
811,vs.,0,0
812,0,0,0
813,%,0,0
814,),0,0
815,and,0,0
816,more,0,0
817,intense,0,0
818,with,0,0
819,the,0,0
820,0.2,0,0
821,%,0,0
822,ropivacaine-4,0,0
823,microg,0,0
824,fentanyl,0,0
825,solution,0,0
826,.,0,0
827,Other,0,0
828,side,0,1
829,effects,0,1
830,were,0,0
831,equivalent,0,0
832,between,0,0
833,solutions,0,0
834,and,0,0
835,mild,0,1
836,in,0,0
837,severity,1,1
838,.,1,0
839,A,0,0
840,significantly,0,0
841,smaller,0,0
842,volume,0,1
843,of,0,0
844,0.2,0,0
845,%,0,0
846,ropivacaine-4,1,0
847,microg,1,0
848,fentanyl,1,0
849,solution,1,0
850,was,0,0
851,used,0,0
852,",",0,0
853,whereas,0,0
854,the,0,0
855,0.1,0,0
856,%,0,0
857,ropivacaine-2,0,0
858,microg,0,0
859,fentanyl,0,0
860,group,0,0
861,used,0,0
862,a,0,0
863,significantly,0,0
864,greater,0,0
865,amount,0,1
866,of,0,1
867,ropivacaine,1,0
868,and,1,0
869,fentanyl,1,0
870,.,1,0
871,CONCLUSIONS,0,0
872,Lesser,0,1
873,concentrations,0,1
874,of,0,0
875,ropivacaine,0,0
876,and,0,0
877,fentanyl,0,0
878,provide,0,0
879,comparable,0,0
880,analgesia,1,1
881,with,0,0
882,less,0,0
883,motor,1,1
884,block,1,0
885,despite,0,0
886,the,0,0
887,use,0,0
888,of,0,0
889,similar,0,0
890,amounts,0,1
891,of,0,0
892,ropivacaine,0,0
893,and,0,0
894,fentanyl,0,0
895,.,0,0
896,This,0,0
897,finding,0,0
898,suggests,0,0
899,that,0,0
900,concentration,0,1
901,of,0,0
902,local,0,0
903,anesthetic,0,0
904,solution,0,0
905,at,0,0
906,low,0,0
907,doses,0,0
908,is,0,0
909,a,0,0
910,primary,0,0
911,determinant,1,1
912,of,1,0
913,motor,1,1
914,block,1,0
915,with,0,0
916,patient-controlled,0,0
917,epidural,0,0
918,analgesia,0,1
919,after,0,0
920,lower,0,0
921,abdominal,0,1
922,surgery,0,0
923,.,0,0
924,Independent,0,0
925,prognostic,0,1
926,information,0,0
927,provided,0,0
928,by,0,0
929,sphygmomanometrically,0,0
930,determined,0,0
931,pulse,1,0
932,pressure,1,1
933,and,0,0
934,mean,0,1
935,arterial,1,1
936,pressure,1,1
937,in,0,0
938,patients,0,0
939,with,0,0
940,left,0,0
941,ventricular,0,1
942,dysfunction,0,0
943,.,0,0
944,OBJECTIVES,0,0
945,The,0,0
946,purpose,0,0
947,of,0,0
948,this,0,0
949,study,0,0
950,was,0,0
951,to,0,0
952,evaluate,0,0
953,the,0,0
954,relationship,0,0
955,of,0,0
956,baseline,0,0
957,pulse,0,1
958,pressure,0,1
959,and,0,0
960,mean,0,1
961,arterial,0,1
962,pressure,0,1
963,to,0,0
964,mortality,0,1
965,in,0,0
966,patients,0,0
967,with,0,0
968,left,0,0
969,ventricular,0,1
970,dysfunction,0,0
971,.,0,0
972,BACKGROUND,0,0
973,Increased,0,0
974,conduit,0,1
975,vessel,0,1
976,stiffness,0,1
977,increases,0,1
978,pulse,0,1
979,pressure,0,1
980,and,0,1
981,pulsatile,0,1
982,load,0,1
983,",",0,0
984,potentially,0,0
985,contributing,0,0
986,to,0,0
987,adverse,0,1
988,outcomes,0,0
989,in,0,0
990,patients,0,0
991,with,0,0
992,left,0,0
993,ventricular,0,1
994,dysfunction,0,0
995,.,0,0
996,METHODS,0,0
997,Pulse,0,0
998,and,0,0
999,mean,0,1
1000,arterial,0,1
1001,pressure,0,1
1002,were,0,0
1003,analyzed,0,0
1004,for,0,0
1005,their,0,0
1006,effect,0,0
1007,on,0,0
1008,mortality,1,1
1009,",",0,0
1010,adjusting,0,0
1011,for,0,0
1012,other,0,0
1013,modifiers,0,0
1014,of,0,0
1015,risk,0,1
1016,",",0,0
1017,using,0,0
1018,Cox,0,0
1019,proportional,0,0
1020,hazards,0,1
1021,regression,0,0
1022,analysis,0,0
1023,of,0,0
1024,data,0,0
1025,collected,0,0
1026,from,0,0
1027,"6,781",0,0
1028,patients,0,0
1029,randomized,0,0
1030,into,0,0
1031,the,0,0
1032,Studies,0,0
1033,of,0,0
1034,Left,0,0
1035,Ventricular,0,1
1036,Dysfunction,0,1
1037,trials,0,0
1038,.,0,0
1039,RESULTS,0,0
1040,Pulse,1,0
1041,and,1,0
1042,mean,1,1
1043,arterial,1,1
1044,pressure,1,1
1045,were,0,0
1046,related,0,0
1047,positively,0,0
1048,to,0,0
1049,each,0,0
1050,other,0,0
1051,",",0,0
1052,age,0,0
1053,",",0,1
1054,ejection,0,1
1055,fraction,0,1
1056,and,0,1
1057,prevalence,0,1
1058,of,0,1
1059,diabetes,0,0
1060,and,0,1
1061,hypertension,0,1
1062,and,0,0
1063,inversely,0,0
1064,to,0,0
1065,prior,0,0
1066,myocardial,0,1
1067,infarction,0,1
1068,and,0,0
1069,beta-adrenergic,0,1
1070,blocking,0,1
1071,agent,0,0
1072,use,0,0
1073,.,0,0
1074,Higher,1,0
1075,pulse,1,1
1076,pressure,1,1
1077,was,0,0
1078,associated,0,0
1079,with,0,0
1080,increased,0,0
1081,prevalence,0,0
1082,of,0,0
1083,female,0,0
1084,gender,0,0
1085,",",0,0
1086,greater,0,1
1087,calcium,0,1
1088,channel,0,0
1089,blocking,0,0
1090,agent,0,0
1091,",",0,0
1092,digoxin,0,0
1093,and,0,1
1094,diuretic,0,1
1095,use,0,1
1096,",",0,0
1097,lower,0,1
1098,heart,0,1
1099,rate,0,1
1100,and,0,0
1101,a,0,0
1102,higher,0,0
1103,rate,0,1
1104,of,0,1
1105,reported,0,0
1106,smoking,0,0
1107,history,0,0
1108,.,0,0
1109,Higher,1,0
1110,mean,1,1
1111,arterial,1,1
1112,pressure,1,1
1113,was,0,0
1114,associated,0,0
1115,with,0,0
1116,higher,0,0
1117,heart,0,1
1118,rate,0,1
1119,",",0,0
1120,lower,0,1
1121,calcium,0,1
1122,channel,0,1
1123,blocker,0,0
1124,and,0,1
1125,digoxin,0,1
1126,use,0,1
1127,and,0,0
1128,lower,0,0
1129,New,0,1
1130,York,0,0
1131,Heart,0,0
1132,Association,0,0
1133,functional,0,0
1134,class,0,0
1135,.,0,0
1136,Over,0,0
1137,a,0,0
1138,61-month,0,0
1139,follow-up,0,0
1140,"1,582",0,0
1141,deaths,1,0
1142,(,0,0
1143,"1,397",0,0
1144,cardiovascular,0,1
1145,),0,0
1146,occurred,0,0
1147,.,0,0
1148,In,0,0
1149,a,0,0
1150,multivariate,0,0
1151,analysis,0,0
1152,adjusting,0,0
1153,for,0,0
1154,the,0,0
1155,above,0,0
1156,covariates,0,0
1157,and,0,1
1158,treatment,0,0
1159,assignment,0,0
1160,",",0,0
1161,higher,0,1
1162,pulse,1,1
1163,pressure,1,1
1164,remained,0,0
1165,an,0,0
1166,independent,0,0
1167,predictor,0,0
1168,of,0,0
1169,total,1,1
1170,and,1,0
1171,cardiovascular,1,1
1172,mortality,1,1
1173,(,0,0
1174,total,0,1
1175,mortality,0,1
1176,relative,0,1
1177,risk,0,1
1178,",",0,0
1179,1.05,0,0
1180,per,0,0
1181,10,0,0
1182,mm,0,0
1183,Hg,0,0
1184,increment,0,1
1185,;,0,0
1186,95,0,0
1187,%,0,0
1188,confidence,0,0
1189,interval,0,0
1190,",",0,0
1191,1.01,0,0
1192,to,0,0
1193,1.10,0,0
1194,;,0,0
1195,p,0,0
1196,=,0,0
1197,0.02,0,0
1198,),0,0
1199,.,0,0
1200,Mean,1,0
1201,arterial,1,1
1202,pressure,1,1
1203,was,0,0
1204,inversely,0,0
1205,related,0,0
1206,to,0,0
1207,total,1,1
1208,and,1,0
1209,cardiovascular,1,1
1210,mortality,1,1
1211,(,0,0
1212,total,0,1
1213,mortality,0,1
1214,relative,0,1
1215,risk,0,1
1216,",",0,0
1217,0.89,0,0
1218,;,0,0
1219,95,0,0
1220,%,0,0
1221,confidence,0,0
1222,interval,0,0
1223,",",0,0
1224,0.85,0,0
1225,to,0,0
1226,0.94,0,0
1227,;,0,0
1228,p,0,0
1229,<,0,0
1230,0.0001,0,0
1231,),0,0
1232,.,0,0
1233,CONCLUSIONS,0,0
1234,One,0,0
1235,noninvasive,0,0
1236,blood,0,1
1237,pressure,0,1
1238,measurement,0,0
1239,provides,0,0
1240,two,0,0
1241,independent,0,0
1242,prognostic,0,0
1243,factors,0,0
1244,for,0,0
1245,survival,1,1
1246,.,1,0
1247,Increased,1,0
1248,conduit,1,1
1249,vessel,1,1
1250,stiffness,1,1
1251,",",0,0
1252,as,0,0
1253,assessed,0,0
1254,by,0,0
1255,pulse,0,1
1256,pressure,0,1
1257,",",0,0
1258,may,0,0
1259,contribute,0,0
1260,to,0,0
1261,increased,0,0
1262,mortality,1,1
1263,in,0,0
1264,patients,0,0
1265,with,0,0
1266,left,0,0
1267,ventricular,0,1
1268,dysfunction,0,1
1269,",",0,0
1270,independent,0,0
1271,of,0,0
1272,mean,0,1
1273,arterial,0,1
1274,pressure,0,1
1275,.,0,0
1276,Protocol,0,0
1277,for,0,0
1278,the,0,0
1279,Multicenter,0,0
1280,Acute,0,0
1281,Stroke,0,0
1282,Trial,0,0
1283,--,0,0
1284,thrombolysis,0,0
1285,study,0,0
1286,.,0,0
1287,The,0,0
1288,rationale,0,0
1289,for,0,0
1290,the,0,0
1291,Multicenter,0,0
1292,Acute,0,0
1293,Stroke,0,0
1294,Trial,0,0
1295,(,0,0
1296,MAST,0,0
1297,),0,0
1298,is,0,0
1299,presented,0,0
1300,in,0,0
1301,a,0,0
1302,companion,0,0
1303,article,0,0
1304,appearing,0,0
1305,in,0,0
1306,this,0,0
1307,issue,0,0
1308,.,0,0
1309,Acute,0,0
1310,ischaemic,0,0
1311,stroke,0,0
1312,is,0,0
1313,the,0,0
1314,third,0,0
1315,major,0,0
1316,cause,0,0
1317,of,0,0
1318,death,1,1
1319,in,0,0
1320,developed,0,1
1321,countries,0,0
1322,",",0,0
1323,and,0,0
1324,a,0,0
1325,major,0,0
1326,cause,0,0
1327,of,0,0
1328,disability,1,1
1329,.,1,0
1330,Despite,0,0
1331,a,0,0
1332,very,0,0
1333,poor,0,1
1334,prognosis,0,0
1335,",",0,0
1336,no,0,0
1337,treatment,0,0
1338,has,0,0
1339,demonstrated,0,0
1340,an,0,0
1341,efficacy,0,1
1342,in,0,0
1343,lowering,0,0
1344,the,0,0
1345,mortality,1,1
1346,and,1,0
1347,disability,1,1
1348,resulting,0,0
1349,from,0,0
1350,stroke,0,0
1351,events,0,1
1352,.,0,0
1353,Thrombolysis,0,0
1354,has,0,0
1355,been,0,0
1356,proven,0,0
1357,to,0,0
1358,reduce,0,0
1359,mortality,1,1
1360,in,1,0
1361,myocardial,1,1
1362,infarction,1,1
1363,",",0,0
1364,and,0,0
1365,it,0,0
1366,has,0,0
1367,been,0,0
1368,shown,0,0
1369,able,0,0
1370,to,0,0
1371,induce,0,0
1372,recanalisation,1,1
1373,when,0,0
1374,administered,0,0
1375,to,0,0
1376,acute,0,0
1377,stroke,0,0
1378,patients,0,0
1379,.,0,0
1380,A,0,0
1381,recent,0,0
1382,meta,0,0
1383,analysis,0,0
1384,of,0,0
1385,small-sized,0,0
1386,studies,0,0
1387,suggests,0,0
1388,that,0,0
1389,thrombolysis,0,0
1390,could,0,0
1391,offer,0,0
1392,some,0,0
1393,benefit,0,0
1394,to,0,0
1395,stroke,0,1
1396,patients,0,0
1397,",",0,0
1398,by,0,0
1399,reducing,0,0
1400,the,0,0
1401,mortality,1,1
1402,and,1,0
1403,severe,1,1
1404,invalidity,1,1
1405,by,0,0
1406,56,0,0
1407,%,0,0
1408,;,0,0
1409,these,0,0
1410,results,0,0
1411,need,0,0
1412,to,0,0
1413,be,0,0
1414,confirmed,0,0
1415,in,0,0
1416,adequately,0,0
1417,designed,0,0
1418,and,0,0
1419,sized,0,0
1420,studies,0,0
1421,.,0,0
1422,Behavioral,0,1
1423,and,0,0
1424,physiological,0,1
1425,effects,0,1
1426,of,0,0
1427,deep,0,0
1428,pressure,0,1
1429,on,0,0
1430,children,0,0
1431,with,0,0
1432,autism,0,0
1433,:,0,0
1434,a,0,0
1435,pilot,0,0
1436,study,0,0
1437,evaluating,0,0
1438,the,0,0
1439,efficacy,0,1
1440,of,0,0
1441,Grandin,0,0
1442,'s,0,0
1443,Hug,0,0
1444,Machine,0,0
1445,.,0,0
1446,OBJECTIVE,0,0
1447,One,0,0
1448,symptom,0,1
1449,common,0,0
1450,to,0,0
1451,many,0,0
1452,persons,0,0
1453,with,0,0
1454,autism,0,0
1455,is,0,0
1456,a,0,0
1457,high,0,0
1458,arousal,0,1
1459,or,0,0
1460,anxiety,0,1
1461,level,0,1
1462,.,0,0
1463,This,0,0
1464,study,0,0
1465,investigated,0,0
1466,the,0,0
1467,effects,0,0
1468,of,0,0
1469,deep,0,0
1470,pressure,0,1
1471,on,0,0
1472,arousal,0,1
1473,and,0,1
1474,anxiety,0,1
1475,reduction,0,1
1476,in,0,0
1477,autism,0,0
1478,with,0,0
1479,Grandin,0,0
1480,'s,0,0
1481,Hug,0,1
1482,Machine,0,0
1483,",",0,0
1484,a,0,0
1485,device,0,0
1486,that,0,0
1487,allows,0,0
1488,self-administration,0,0
1489,of,0,0
1490,lateral,0,0
1491,body,0,1
1492,pressure,0,1
1493,.,0,0
1494,METHOD,0,0
1495,Twelve,0,0
1496,children,0,0
1497,with,0,0
1498,autism,0,0
1499,were,0,0
1500,randomly,0,0
1501,assigned,0,0
1502,to,0,0
1503,either,0,0
1504,an,0,0
1505,experimental,0,0
1506,group,0,0
1507,(,0,0
1508,receiving,0,0
1509,deep,0,1
1510,pressure,0,1
1511,),0,0
1512,or,0,0
1513,a,0,0
1514,placebo,0,0
1515,group,0,0
1516,(,0,0
1517,not,0,0
1518,receiving,0,0
1519,deep,0,0
1520,pressure,0,1
1521,but,0,0
1522,in,0,0
1523,the,0,0
1524,disengaged,0,0
1525,Hug,0,0
1526,Machine,0,0
1527,),0,0
1528,.,0,0
1529,All,0,0
1530,children,0,0
1531,received,0,0
1532,two,0,0
1533,20-min,0,0
1534,sessions,0,0
1535,a,0,0
1536,week,0,0
1537,over,0,0
1538,a,0,0
1539,6-week,0,0
1540,period,0,0
1541,.,0,0
1542,Arousal,1,1
1543,was,0,0
1544,measured,0,0
1545,behaviorally,0,0
1546,with,0,0
1547,the,0,0
1548,Conners,1,0
1549,Parent,1,0
1550,Rating,1,1
1551,Scale,1,1
1552,and,1,0
1553,physiologically,1,0
1554,with,1,0
1555,galvanic,1,0
1556,skin,1,1
1557,response,1,1
1558,(,1,0
1559,GSR,1,0
1560,),1,0
1561,readings,1,0
1562,.,1,0
1563,RESULTS,0,0
1564,Behavioral,0,0
1565,results,0,0
1566,indicated,0,0
1567,a,0,0
1568,significant,1,0
1569,reduction,1,1
1570,in,1,0
1571,tension,1,0
1572,and,1,0
1573,a,1,0
1574,marginally,1,0
1575,significant,1,0
1576,reduction,1,1
1577,in,1,0
1578,anxiety,1,1
1579,for,0,0
1580,children,0,0
1581,who,0,0
1582,received,0,0
1583,the,0,0
1584,deep,0,0
1585,pressure,0,1
1586,compared,0,0
1587,with,0,0
1588,the,0,0
1589,children,0,0
1590,who,0,0
1591,did,0,0
1592,not,0,0
1593,.,0,0
1594,Additionally,0,0
1595,",",0,0
1596,children,0,0
1597,in,0,0
1598,the,0,0
1599,experimental,0,0
1600,group,0,0
1601,",",0,0
1602,whose,0,0
1603,GSR,1,0
1604,measures,1,1
1605,decreased,0,0
1606,",",0,0
1607,on,0,0
1608,average,0,1
1609,",",0,0
1610,after,0,0
1611,deep,0,1
1612,pressure,0,1
1613,",",0,0
1614,were,0,0
1615,somewhat,0,0
1616,more,0,0
1617,likely,0,0
1618,to,0,0
1619,have,0,0
1620,higher,0,0
1621,GSR,1,0
1622,arousal,1,1
1623,a,0,0
1624,priori,0,0
1625,.,0,0
1626,CONCLUSION,0,0
1627,These,0,0
1628,preliminary,0,0
1629,findings,0,0
1630,support,0,0
1631,the,0,0
1632,hypothesis,0,0
1633,that,0,0
1634,deep,0,0
1635,pressure,0,0
1636,may,0,0
1637,have,0,0
1638,a,0,0
1639,calming,0,0
1640,effect,0,0
1641,for,0,0
1642,persons,0,0
1643,with,0,0
1644,autism,0,0
1645,",",0,0
1646,especially,0,0
1647,those,0,0
1648,with,0,0
1649,high,0,0
1650,levels,0,1
1651,of,0,0
1652,arousal,0,1
1653,or,0,0
1654,anxiety,0,1
1655,.,0,0
1656,Reduction,0,0
1657,of,0,0
1658,stimulus,1,1
1659,overselectivity,1,1
1660,with,0,0
1661,nonverbal,0,1
1662,differential,0,0
1663,observing,0,0
1664,responses,0,1
1665,.,0,0
1666,Three,0,0
1667,individuals,0,0
1668,with,0,0
1669,mental,0,1
1670,retardation,0,0
1671,exhibited,0,0
1672,stimulus,1,1
1673,overselectivity,1,1
1674,in,0,0
1675,a,0,0
1676,delayed,0,0
1677,matching-to-sample,0,0
1678,task,0,0
1679,in,0,0
1680,which,0,0
1681,two,0,0
1682,sample,0,0
1683,stimuli,0,0
1684,were,0,0
1685,displayed,0,0
1686,on,0,0
1687,each,0,0
1688,trial,0,0
1689,.,0,0
1690,Intermediate,0,1
1691,accuracy,1,1
1692,scores,1,1
1693,indicated,0,0
1694,that,0,0
1695,participants,0,0
1696,could,0,0
1697,match,0,0
1698,one,0,0
1699,of,0,0
1700,the,0,0
1701,samples,0,0
1702,but,0,0
1703,not,0,0
1704,both,0,0
1705,of,0,0
1706,them,0,0
1707,.,0,0
1708,Accuracy,1,0
1709,in,0,0
1710,a,0,0
1711,baseline,0,0
1712,condition,0,0
1713,was,0,0
1714,compared,0,0
1715,to,0,0
1716,accuracy,1,0
1717,with,0,0
1718,a,0,0
1719,differential,0,0
1720,observing,0,0
1721,response,0,1
1722,procedure,0,0
1723,.,0,0
1724,This,0,0
1725,procedure,0,0
1726,prompted,0,0
1727,participants,0,0
1728,to,0,0
1729,make,0,0
1730,simultaneous,0,0
1731,identity-matching,0,0
1732,responses,0,1
1733,that,0,0
1734,required,0,0
1735,observation,0,0
1736,and,0,1
1737,discrimination,0,1
1738,of,0,0
1739,both,0,0
1740,sample,0,0
1741,stimuli,0,0
1742,.,0,0
1743,These,0,0
1744,observing,0,0
1745,responses,0,1
1746,were,0,0
1747,never,0,0
1748,followed,0,0
1749,by,0,0
1750,differential,0,0
1751,consequences,0,0
1752,.,0,0
1753,When,0,0
1754,observing,0,0
1755,responses,0,1
1756,were,0,0
1757,prompted,0,0
1758,",",0,0
1759,participants,0,0
1760,',0,1
1761,accuracy,1,1
1762,scores,1,1
1763,improved,0,0
1764,.,0,0
1765,In,0,0
1766,a,0,0
1767,return,0,0
1768,to,0,0
1769,the,0,0
1770,baseline,0,0
1771,condition,0,0
1772,",",0,0
1773,when,0,0
1774,differential,0,0
1775,observing,0,0
1776,responses,0,1
1777,were,0,0
1778,no,0,0
1779,longer,0,0
1780,prompted,0,0
1781,",",0,0
1782,accuracy,1,1
1783,returned,0,0
1784,to,0,0
1785,intermediate,0,0
1786,levels,0,1
1787,.,0,0
1788,The,0,0
1789,results,0,0
1790,show,0,0
1791,that,0,0
1792,stimulus,1,0
1793,overselectivity,1,0
1794,can,0,0
1795,be,0,0
1796,greatly,0,0
1797,reduced,0,0
1798,by,0,0
1799,a,0,0
1800,behavioral,0,1
1801,intervention,0,0
1802,that,0,0
1803,controls,0,0
1804,observing,0,0
1805,behavior,0,1
1806,and,0,1
1807,verifies,0,0
1808,discrimination,0,1
1809,",",0,0
1810,but,0,0
1811,that,0,0
1812,exposure,0,0
1813,to,0,0
1814,such,0,0
1815,procedures,0,0
1816,alone,0,0
1817,may,0,0
1818,be,0,0
1819,insufficient,0,0
1820,for,0,0
1821,lasting,1,0
1822,benefits,1,0
1823,.,1,0
1824,Clinical,0,1
1825,hypnosis,0,0
1826,versus,0,0
1827,cognitive,0,1
1828,behavioral,0,1
1829,training,0,0
1830,for,0,0
1831,pain,1,1
1832,management,1,0
1833,with,0,0
1834,pediatric,0,0
1835,cancer,0,0
1836,patients,0,0
1837,undergoing,0,0
1838,bone,0,1
1839,marrow,0,0
1840,aspirations,0,0
1841,.,0,0
1842,A,0,0
1843,randomized,0,0
1844,controlled,0,0
1845,trial,0,0
1846,was,0,0
1847,conducted,0,0
1848,to,0,0
1849,compare,0,0
1850,the,0,0
1851,efficacy,0,1
1852,of,0,0
1853,clinical,0,0
1854,hypnosis,0,0
1855,versus,0,0
1856,cognitive,0,1
1857,behavioral,0,1
1858,(,0,0
1859,CB,0,1
1860,),0,0
1861,coping,0,1
1862,skills,0,1
1863,training,0,0
1864,in,0,0
1865,alleviating,0,0
1866,the,0,0
1867,pain,1,1
1868,and,1,0
1869,distress,1,1
1870,of,0,0
1871,30,0,0
1872,pediatric,0,0
1873,cancer,0,0
1874,patients,0,0
1875,(,0,0
1876,age,0,0
1877,5,0,0
1878,to,0,0
1879,15,0,0
1880,years,0,0
1881,),0,0
1882,undergoing,0,0
1883,bone,0,1
1884,marrow,0,0
1885,aspirations,0,0
1886,.,0,0
1887,Patients,0,0
1888,were,0,0
1889,randomized,0,0
1890,to,0,0
1891,one,0,0
1892,of,0,0
1893,three,0,0
1894,groups,0,0
1895,:,0,0
1896,hypnosis,0,0
1897,",",0,0
1898,a,0,0
1899,package,0,0
1900,of,0,0
1901,CB,0,1
1902,coping,0,1
1903,skills,0,1
1904,",",0,0
1905,and,0,0
1906,no,0,0
1907,intervention,0,0
1908,.,0,0
1909,Patients,0,0
1910,who,0,0
1911,received,0,0
1912,either,0,0
1913,hypnosis,0,1
1914,or,0,1
1915,CB,0,1
1916,reported,0,0
1917,less,0,0
1918,pain,1,1
1919,and,1,1
1920,pain-related,1,1
1921,anxiety,1,1
1922,than,0,0
1923,did,0,0
1924,control,0,0
1925,patients,0,0
1926,and,0,0
1927,less,0,0
1928,pain,1,1
1929,and,1,1
1930,anxiety,1,1
1931,than,0,0
1932,at,0,0
1933,their,0,0
1934,own,0,0
1935,baseline,0,0
1936,.,0,0
1937,Hypnosis,0,1
1938,and,0,0
1939,CB,0,1
1940,were,0,0
1941,similarly,0,0
1942,effective,0,0
1943,in,0,0
1944,the,0,0
1945,relief,1,1
1946,of,1,0
1947,pain,1,1
1948,.,1,0
1949,Results,0,0
1950,also,0,0
1951,indicated,0,0
1952,that,0,0
1953,children,0,0
1954,reported,0,0
1955,more,0,0
1956,anxiety,1,1
1957,and,0,0
1958,exhibited,0,0
1959,more,0,0
1960,behavioral,1,1
1961,distress,1,1
1962,in,0,0
1963,the,0,0
1964,CB,0,1
1965,group,0,0
1966,than,0,0
1967,in,0,0
1968,the,0,0
1969,hypnosis,0,0
1970,group,0,0
1971,.,0,0
1972,It,0,0
1973,is,0,0
1974,concluded,0,0
1975,that,0,0
1976,hypnosis,0,0
1977,and,0,0
1978,CB,0,1
1979,coping,0,1
1980,skills,0,1
1981,are,0,0
1982,effective,1,0
1983,in,0,0
1984,preparing,1,0
1985,pediatric,0,0
1986,oncology,0,0
1987,patients,0,0
1988,for,0,0
1989,bone,0,1
1990,marrow,0,0
1991,aspiration,0,0
1992,.,0,0
1993,Local,0,0
1994,injection,0,0
1995,of,0,0
1996,bupivacaine,0,0
1997,after,0,0
1998,rubber,0,0
1999,band,0,1
2000,ligation,0,1
2001,of,0,0
2002,hemorrhoids,0,0
2003,:,0,0
2004,prospective,0,0
2005,",",0,0
2006,randomized,0,0
2007,study,0,0
2008,.,0,0
2009,PURPOSE,0,0
2010,The,0,0
2011,aim,0,0
2012,of,0,0
2013,this,0,0
2014,study,0,0
2015,was,0,0
2016,to,0,0
2017,determine,0,0
2018,if,0,0
2019,local,0,0
2020,injection,0,0
2021,of,0,0
2022,bupivacaine,0,0
2023,after,0,0
2024,hemorrhoidal,0,0
2025,banding,0,0
2026,causes,0,0
2027,a,0,0
2028,decrease,1,0
2029,in,1,0
2030,pain,1,1
2031,and,1,0
2032,in,1,0
2033,the,1,0
2034,incidence,1,1
2035,of,1,0
2036,associated,1,0
2037,symptoms,1,1
2038,.,1,0
2039,METHODS,0,0
2040,After,0,0
2041,hemorrhoidal,0,1
2042,banding,0,1
2043,",",0,0
2044,patients,0,0
2045,were,0,0
2046,randomly,0,0
2047,assigned,0,0
2048,to,0,0
2049,receive,0,0
2050,a,0,0
2051,local,0,0
2052,injection,0,0
2053,of,0,0
2054,bupivacaine,0,0
2055,with,0,0
2056,"1:200,000",0,0
2057,epinephrine,0,0
2058,",",0,0
2059,an,0,0
2060,injection,0,0
2061,of,0,0
2062,normal,0,0
2063,saline,0,0
2064,",",0,0
2065,or,0,0
2066,no,0,0
2067,injection,0,0
2068,",",0,0
2069,just,0,0
2070,superior,0,0
2071,to,0,0
2072,each,0,0
2073,band,0,0
2074,.,0,0
2075,Pain,1,1
2076,was,0,0
2077,graded,0,0
2078,by,0,0
2079,the,0,0
2080,patient,0,0
2081,and,0,0
2082,by,0,0
2083,the,0,0
2084,study,0,0
2085,nurse,0,0
2086,within,0,0
2087,30,0,0
2088,minutes,0,0
2089,",",0,0
2090,and,0,0
2091,any,0,0
2092,associated,1,0
2093,symptoms,1,1
2094,were,0,0
2095,recorded,0,0
2096,.,0,0
2097,At,0,0
2098,intervals,0,0
2099,6,0,0
2100,",",0,0
2101,24,0,0
2102,",",0,0
2103,and,0,0
2104,48,0,0
2105,hours,0,0
2106,postbanding,0,0
2107,",",0,0
2108,the,0,0
2109,patient,0,1
2110,recorded,0,0
2111,pain,1,1
2112,",",1,0
2113,limitation,1,1
2114,of,1,1
2115,activities,1,1
2116,",",1,0
2117,and,1,1
2118,analgesic,1,1
2119,requirements,1,1
2120,.,1,0
2121,Associated,1,0
2122,symptoms,1,1
2123,while,0,0
2124,at,0,0
2125,home,0,0
2126,were,0,0
2127,recorded,0,0
2128,.,0,0
2129,RESULTS,0,0
2130,Of,0,0
2131,115,0,0
2132,patients,0,0
2133,studied,0,0
2134,",",0,0
2135,42,0,0
2136,received,0,0
2137,bupivacaine,0,0
2138,injection,0,0
2139,",",0,0
2140,42,0,0
2141,received,0,0
2142,normal,0,0
2143,saline,0,0
2144,injection,0,0
2145,",",0,0
2146,and,0,0
2147,31,0,0
2148,received,0,0
2149,no,0,0
2150,injection,0,0
2151,.,0,0
2152,In,0,0
2153,patients,0,0
2154,receiving,0,0
2155,bupivacaine,0,0
2156,compared,0,0
2157,with,0,0
2158,no,0,0
2159,injection,0,0
2160,",",0,0
2161,within,0,0
2162,30,0,0
2163,minutes,0,0
2164,postbanding,0,0
2165,there,0,0
2166,was,0,0
2167,a,0,0
2168,significant,0,0
2169,reduction,1,1
2170,in,1,0
2171,pain,1,1
2172,graded,0,0
2173,by,0,0
2174,the,0,0
2175,patient,0,0
2176,(,0,0
2177,P,0,0
2178,=,0,0
2179,0.000002,0,0
2180,),0,0
2181,and,0,0
2182,by,0,0
2183,the,0,0
2184,nurse,0,0
2185,(,0,0
2186,P,0,0
2187,=,0,0
2188,0.000005,0,0
2189,),0,0
2190,and,0,0
2191,a,0,0
2192,significant,0,0
2193,reduction,0,1
2194,in,0,0
2195,incidence,1,1
2196,of,1,0
2197,nausea,1,1
2198,(,0,0
2199,P,0,0
2200,=,0,0
2201,0.01,0,0
2202,),0,0
2203,and,0,0
2204,shaking,0,0
2205,(,0,0
2206,P,0,0
2207,=,0,0
2208,0.008,0,0
2209,),0,0
2210,.,0,0
2211,However,0,0
2212,",",0,0
2213,in,0,0
2214,the,0,0
2215,bupivacaine,0,0
2216,group,0,0
2217,compared,0,0
2218,with,0,0
2219,the,0,0
2220,other,0,0
2221,two,0,0
2222,groups,0,0
2223,",",0,0
2224,at,0,0
2225,the,0,0
2226,intervals,0,0
2227,of,0,0
2228,6,0,0
2229,",",0,0
2230,24,0,0
2231,",",0,0
2232,and,0,0
2233,48,0,0
2234,hours,0,0
2235,postbanding,0,0
2236,there,0,0
2237,was,0,0
2238,no,0,0
2239,sustained,0,0
2240,reduction,0,0
2241,in,0,0
2242,the,0,0
2243,severity,1,1
2244,of,1,0
2245,pain,1,1
2246,and,0,0
2247,no,0,0
2248,reduction,0,1
2249,in,0,0
2250,analgesic,1,1
2251,requirements,1,1
2252,or,1,0
2253,limitation,1,0
2254,of,1,1
2255,normal,1,0
2256,activities,1,1
2257,.,1,0
2258,In,0,0
2259,the,0,0
2260,week,0,0
2261,after,0,0
2262,banding,0,0
2263,",",0,0
2264,there,0,0
2265,was,0,0
2266,no,0,0
2267,difference,0,0
2268,between,0,0
2269,groups,0,0
2270,in,0,0
2271,symptoms,0,1
2272,of,0,0
2273,nausea,1,1
2274,",",1,0
2275,shaking,1,1
2276,",",1,1
2277,lightheadedness,1,1
2278,",",1,1
2279,urinary,1,1
2280,retention,1,1
2281,",",1,0
2282,or,1,0
2283,bleeding,1,1
2284,.,1,0
2285,CONCLUSIONS,0,0
2286,Bupivacaine,0,0
2287,injection,0,0
2288,may,0,0
2289,be,0,0
2290,useful,0,0
2291,for,0,0
2292,reducing,0,0
2293,pain,0,1
2294,and,0,1
2295,associated,0,0
2296,symptoms,0,1
2297,long,0,0
2298,enough,0,0
2299,to,0,0
2300,tolerate,0,0
2301,a,0,0
2302,trip,0,0
2303,home,0,0
2304,from,0,0
2305,the,0,0
2306,outpatient,0,0
2307,department,0,0
2308,but,0,0
2309,does,0,0
2310,not,0,0
2311,show,0,0
2312,a,0,0
2313,sustained,0,0
2314,effect,0,0
2315,.,0,0
2316,Allelic,1,1
2317,imbalance,1,0
2318,in,0,0
2319,the,0,0
2320,clonal,0,1
2321,evolution,0,1
2322,of,0,0
2323,prostate,0,0
2324,carcinoma,0,0
2325,.,0,0
2326,BACKGROUND,0,0
2327,To,0,0
2328,understand,0,0
2329,better,0,0
2330,the,0,0
2331,genetic,0,0
2332,basis,0,0
2333,of,0,0
2334,the,0,0
2335,clonal,0,1
2336,evolution,0,1
2337,of,0,0
2338,prostate,0,0
2339,carcinoma,0,0
2340,",",0,0
2341,the,0,0
2342,authors,0,0
2343,analyzed,0,0
2344,the,0,0
2345,pattern,0,0
2346,of,0,0
2347,allelic,1,1
2348,loss,1,1
2349,in,0,0
2350,25,0,0
2351,matched,0,0
2352,primary,0,0
2353,and,0,0
2354,metastatic,0,0
2355,prostate,0,0
2356,tumors,0,0
2357,.,0,0
2358,METHODS,0,0
2359,Twenty-five,0,0
2360,cases,0,0
2361,were,0,0
2362,selected,0,0
2363,from,0,0
2364,the,0,0
2365,surgical,0,0
2366,pathology,0,0
2367,files,0,0
2368,of,0,0
2369,the,0,0
2370,Mayo,0,0
2371,Clinic,0,0
2372,from,0,0
2373,patients,0,0
2374,who,0,0
2375,had,0,0
2376,undergone,0,0
2377,radical,0,0
2378,retropubic,0,0
2379,prostatectomy,0,0
2380,and,0,1
2381,bilateral,0,0
2382,lymphadenectomy,0,0
2383,between,0,0
2384,1987-1991,0,0
2385,.,0,0
2386,All,0,0
2387,patients,0,0
2388,had,0,0
2389,regional,0,0
2390,lymph,0,1
2391,node,0,1
2392,metastases,0,0
2393,at,0,0
2394,the,0,0
2395,time,0,1
2396,of,0,0
2397,surgery,0,0
2398,.,0,0
2399,DNA,0,1
2400,samples,0,0
2401,for,0,0
2402,the,0,0
2403,analysis,0,0
2404,of,0,0
2405,allelic,1,1
2406,loss,1,1
2407,pattern,0,0
2408,were,0,0
2409,prepared,0,0
2410,from,0,0
2411,primary,0,0
2412,tumors,0,1
2413,and,0,0
2414,matched,0,0
2415,synchronous,0,0
2416,lymph,0,1
2417,node,0,1
2418,metastases,0,0
2419,by,0,0
2420,tissue,0,0
2421,microdissection,0,0
2422,.,0,0
2423,The,0,0
2424,oligonucleotide,0,0
2425,primer,0,0
2426,pairs,0,0
2427,for,0,0
2428,the,0,0
2429,microsatellite,0,1
2430,DNA,0,1
2431,markers,0,1
2432,were,0,0
2433,D8S133,0,0
2434,",",0,0
2435,D8S136,0,1
2436,",",0,1
2437,D8S137,0,0
2438,",",0,0
2439,ANK1,0,0
2440,on,0,0
2441,chromosome,0,0
2442,8p12-21,0,0
2443,",",0,0
2444,LPLTET,0,0
2445,on,0,0
2446,chromosome,0,0
2447,8p22,0,0
2448,",",0,0
2449,and,0,0
2450,D17S855,0,1
2451,(,0,0
2452,intragenic,0,0
2453,to,0,0
2454,the,0,0
2455,BRCA1,0,0
2456,gene,0,1
2457,),0,0
2458,on,0,0
2459,chromosome,0,0
2460,17q21,0,0
2461,.,0,0
2462,One,0,0
2463,case,0,0
2464,was,0,0
2465,not,0,0
2466,informative,0,0
2467,at,0,0
2468,any,0,0
2469,of,0,0
2470,the,0,0
2471,loci,0,1
2472,tested,0,0
2473,and,0,0
2474,was,0,0
2475,excluded,0,0
2476,from,0,0
2477,further,0,0
2478,analysis,0,0
2479,.,0,0
2480,RESULTS,0,0
2481,The,0,0
2482,overall,1,1
2483,frequency,1,1
2484,of,1,0
2485,allelic,1,1
2486,imbalance,1,0
2487,was,0,0
2488,79,0,0
2489,%,0,0
2490,in,0,0
2491,primary,0,0
2492,tumors,0,0
2493,and,0,0
2494,88,0,0
2495,%,0,0
2496,in,0,0
2497,paired,0,0
2498,metastases,0,0
2499,.,0,0
2500,Of,0,0
2501,24,0,0
2502,informative,0,0
2503,cases,0,0
2504,",",0,0
2505,14,0,0
2506,patients,0,0
2507,(,0,0
2508,58,0,0
2509,%,0,0
2510,),0,0
2511,showed,0,0
2512,the,0,0
2513,same,0,0
2514,pattern,0,0
2515,of,0,0
2516,allelic,1,1
2517,loss,1,1
2518,or,1,0
2519,retention,1,1
2520,in,0,0
2521,matched,0,0
2522,primary,0,0
2523,and,0,0
2524,metastatic,0,0
2525,tumors,0,0
2526,at,0,0
2527,all,0,0
2528,marker,0,1
2529,locus,0,1
2530,;,0,0
2531,discordant,0,0
2532,allelic,1,1
2533,loss,1,1
2534,was,0,0
2535,observed,0,0
2536,in,0,0
2537,the,0,0
2538,remaining,0,0
2539,10,0,0
2540,patients,0,0
2541,(,0,0
2542,42,0,0
2543,%,0,0
2544,),0,0
2545,.,0,0
2546,Four,0,0
2547,patients,0,0
2548,showed,0,0
2549,loss,0,1
2550,of,0,0
2551,the,0,0
2552,same,0,0
2553,allele,1,0
2554,at,0,0
2555,one,0,0
2556,or,0,0
2557,more,0,0
2558,marker,0,1
2559,loci,0,1
2560,in,0,0
2561,both,0,0
2562,primary,0,0
2563,and,0,0
2564,metastatic,0,0
2565,tumors,0,1
2566,",",0,0
2567,but,0,0
2568,discordant,0,1
2569,allelic,1,1
2570,loss,1,1
2571,was,0,0
2572,observed,0,0
2573,at,0,0
2574,other,0,0
2575,marker,0,1
2576,loci,0,0
2577,.,0,0
2578,Five,0,0
2579,patients,0,0
2580,showed,0,0
2581,allelic,1,1
2582,loss,1,1
2583,in,0,0
2584,at,0,0
2585,least,0,0
2586,one,0,0
2587,genetic,0,0
2588,marker,0,0
2589,in,0,0
2590,the,0,0
2591,metastatic,0,0
2592,tumor,0,1
2593,but,0,0
2594,not,0,0
2595,in,0,0
2596,its,0,0
2597,matched,0,0
2598,primary,0,0
2599,tumor,0,0
2600,.,0,0
2601,Five,0,0
2602,patients,0,0
2603,displayed,0,0
2604,loss,1,1
2605,of,1,0
2606,one,1,0
2607,allele,1,0
2608,at,1,0
2609,one,1,0
2610,or,0,0
2611,more,0,0
2612,marker,0,1
2613,loci,0,1
2614,in,0,0
2615,a,0,0
2616,primary,0,0
2617,tumor,0,1
2618,but,0,0
2619,not,0,0
2620,in,0,0
2621,the,0,0
2622,matched,0,0
2623,metastases,0,0
2624,.,0,0
2625,There,0,0
2626,was,0,0
2627,no,0,0
2628,significant,0,0
2629,difference,0,0
2630,in,0,0
2631,the,0,0
2632,frequency,1,1
2633,of,1,0
2634,allelic,1,1
2635,imbalance,1,0
2636,between,0,0
2637,primary,0,0
2638,and,0,0
2639,metastatic,0,0
2640,tumors,0,0
2641,at,0,0
2642,any,0,0
2643,marker,0,1
2644,analyzed,0,0
2645,(,0,0
2646,P,0,0
2647,>,0,0
2648,0.05,0,0
2649,),0,0
2650,.,0,0
2651,CONCLUSIONS,0,0
2652,These,0,0
2653,data,0,0
2654,suggest,0,0
2655,that,0,0
2656,different,0,0
2657,patterns,0,0
2658,of,0,0
2659,allelic,1,1
2660,deletion,1,0
2661,may,0,0
2662,be,0,0
2663,acquired,0,0
2664,during,0,0
2665,cancer,0,0
2666,progression,0,1
2667,to,0,0
2668,metastases,0,0
2669,.,0,0
2670,The,0,0
2671,differences,0,0
2672,in,0,0
2673,genetic,0,0
2674,composition,0,0
2675,between,0,0
2676,primary,0,0
2677,prostate,0,0
2678,carcinoma,0,0
2679,and,0,0
2680,its,0,0
2681,metastases,0,0
2682,may,0,0
2683,be,0,0
2684,related,0,0
2685,to,0,0
2686,intrinsic,0,0
2687,cancer,0,0
2688,heterogeneity,0,0
2689,",",0,0
2690,overall,0,1
2691,genetic,0,1
2692,instability,0,1
2693,",",0,0
2694,and,0,1
2695,clonal,0,1
2696,divergence,0,1
2697,.,0,0
2698,Thrombolysis,0,0
2699,is,0,0
2700,superior,0,0
2701,to,0,0
2702,heparin,0,0
2703,for,0,0
2704,non-obstructive,0,0
2705,mitral,0,1
2706,mechanical,0,0
2707,valve,0,0
2708,thrombosis,0,1
2709,.,0,0
2710,BACKGROUND,0,0
2711,AND,0,0
2712,AIM,0,0
2713,OF,0,0
2714,THE,0,0
2715,STUDY,0,1
2716,Non-obstructive,0,1
2717,prosthetic,0,1
2718,valve,0,1
2719,thrombosis,0,1
2720,(,0,0
2721,PVT,0,0
2722,),0,0
2723,is,0,0
2724,a,0,0
2725,unique,0,0
2726,subset,0,0
2727,that,0,0
2728,features,0,0
2729,clinical,0,0
2730,presentation,0,1
2731,without,0,0
2732,heart,0,1
2733,failure,0,1
2734,",",0,0
2735,and,0,0
2736,may,0,0
2737,be,0,0
2738,asymptomatic,0,0
2739,.,0,0
2740,Thrombolysis,0,0
2741,has,0,0
2742,been,0,0
2743,accepted,0,0
2744,for,0,0
2745,obstructive,0,0
2746,PVT,0,1
2747,",",0,0
2748,but,0,0
2749,treatment,0,0
2750,strategies,0,0
2751,of,0,0
2752,non-obstructive,0,0
2753,PVT,0,0
2754,are,0,0
2755,controversial,0,0
2756,.,0,0
2757,This,0,0
2758,study,0,0
2759,compared,0,0
2760,the,0,0
2761,efficacy,1,1
2762,and,1,0
2763,safety,1,1
2764,of,0,1
2765,thrombolysis,0,0
2766,and,0,1
2767,heparin,0,0
2768,treatment,0,0
2769,in,0,0
2770,these,0,0
2771,patients,0,0
2772,.,0,0
2773,METHODS,0,0
2774,Between,0,0
2775,1993,0,0
2776,and,0,0
2777,1998,0,0
2778,",",0,0
2779,20,0,0
2780,consecutive,0,0
2781,patients,0,0
2782,were,0,0
2783,found,0,0
2784,by,0,0
2785,multiplane,0,0
2786,transesophageal,0,1
2787,echocardiography,0,1
2788,(,0,0
2789,TEE,0,1
2790,),0,0
2791,to,0,0
2792,have,0,0
2793,non-obstructive,0,0
2794,PVT,0,0
2795,.,0,0
2796,TEE,0,1
2797,was,0,0
2798,performed,0,0
2799,for,0,0
2800,peripheral,0,1
2801,embolism,0,1
2802,in,0,0
2803,two,0,0
2804,patients,0,0
2805,",",0,0
2806,stroke,0,1
2807,or,0,0
2808,transient,0,1
2809,ischemic,0,1
2810,attack,0,0
2811,in,0,0
2812,six,0,0
2813,",",0,0
2814,stroke,0,0
2815,and,0,1
2816,fever,0,1
2817,in,0,0
2818,two,0,0
2819,",",0,0
2820,fever,0,0
2821,in,0,0
2822,one,0,0
2823,patient,0,0
2824,",",0,0
2825,as,0,0
2826,a,0,0
2827,routine,0,0
2828,postoperative,0,1
2829,examination,0,0
2830,in,0,0
2831,two,0,0
2832,patients,0,0
2833,",",0,0
2834,and,0,0
2835,for,0,0
2836,other,0,0
2837,reasons,0,0
2838,in,0,0
2839,seven,0,0
2840,.,0,0
2841,Patients,0,0
2842,were,0,0
2843,allocated,0,0
2844,to,0,0
2845,two,0,0
2846,groups,0,0
2847,:,0,0
2848,group,0,0
2849,I,0,0
2850,(,0,0
2851,n,0,0
2852,=,0,0
2853,8,0,0
2854,),0,0
2855,received,0,0
2856,streptokinase-mediated,0,0
2857,fibrinolysis,0,1
2858,;,0,0
2859,group,0,0
2860,II,0,0
2861,(,0,0
2862,n,0,0
2863,=,0,0
2864,12,0,0
2865,),0,0
2866,received,0,0
2867,intravenous,0,0
2868,heparin,0,0
2869,by,0,0
2870,infusion,0,0
2871,.,0,0
2872,Treatment,0,0
2873,was,0,0
2874,monitored,0,0
2875,using,0,0
2876,TEE,0,0
2877,.,0,0
2878,RESULTS,0,0
2879,There,0,0
2880,was,0,0
2881,no,0,0
2882,difference,0,0
2883,between,0,0
2884,patient,0,0
2885,groups,0,0
2886,with,0,0
2887,regard,0,0
2888,to,0,0
2889,sex,0,0
2890,",",0,0
2891,age,0,0
2892,",",0,1
2893,type,0,0
2894,of,0,1
2895,prosthesis,0,0
2896,and,0,1
2897,time,0,1
2898,since,0,0
2899,operation,0,0
2900,",",0,0
2901,though,0,0
2902,anticoagulant,0,1
2903,status,0,1
2904,was,0,0
2905,more,0,0
2906,often,0,0
2907,inadequate,0,0
2908,in,0,0
2909,group,0,0
2910,II,0,0
2911,.,0,0
2912,By,0,0
2913,TEE,0,1
2914,",",0,0
2915,valve,1,1
2916,motion,1,1
2917,was,0,0
2918,normal,0,0
2919,in,0,0
2920,all,0,0
2921,patients,0,0
2922,.,0,0
2923,In,0,0
2924,group,0,0
2925,I,0,0
2926,",",0,0
2927,all,0,0
2928,thrombi,1,0
2929,were,0,0
2930,mobile,1,0
2931,and,0,0
2932,5-13,0,0
2933,mm,0,0
2934,in,0,0
2935,diameter,0,1
2936,;,0,0
2937,in,0,0
2938,group,0,0
2939,II,0,0
2940,",",0,0
2941,all,0,0
2942,thrombi,0,0
2943,but,0,0
2944,three,0,0
2945,were,0,0
2946,mobile,1,0
2947,and,0,0
2948,3-18,0,0
2949,mm,0,0
2950,in,0,0
2951,diameter,0,1
2952,.,0,0
2953,In,0,0
2954,group,0,0
2955,I,0,0
2956,",",0,0
2957,thrombolysis,0,0
2958,was,0,0
2959,successful,0,0
2960,in,0,0
2961,all,0,0
2962,patients,0,0
2963,",",0,0
2964,without,0,0
2965,complications,1,1
2966,",",0,0
2967,within,0,0
2968,6-72,0,0
2969,h.,0,0
2970,In,0,0
2971,group,0,0
2972,II,0,0
2973,",",0,0
2974,heparin,0,0
2975,treatment,0,0
2976,was,0,0
2977,successful,0,0
2978,in,0,0
2979,six,0,0
2980,patients,0,0
2981,in,0,0
2982,3-32,0,0
2983,days,0,0
2984,.,0,0
2985,In,0,0
2986,one,0,0
2987,patient,0,0
2988,",",0,0
2989,seven,0,0
2990,days,0,0
2991,',0,0
2992,of,0,0
2993,unsuccessful,0,0
2994,heparin,0,0
2995,was,0,0
2996,followed,0,0
2997,by,0,0
2998,two,0,0
2999,months,0,0
3000,',0,0
3001,successful,0,0
3002,coumarin,0,0
3003,therapy,0,0
3004,.,0,0
3005,Among,0,0
3006,five,0,0
3007,unsuccessful,0,0
3008,cases,0,0
3009,",",0,0
3010,the,0,0
3011,thrombus,1,1
3012,size,1,1
3013,increased,0,0
3014,in,0,0
3015,four,0,0
3016,(,0,0
3017,three,0,0
3018,became,0,0
3019,obstructive,0,0
3020,in,0,0
3021,7-35,0,1
3022,days,0,0
3023,),0,0
3024,;,0,0
3025,all,0,0
3026,four,0,0
3027,patients,0,0
3028,were,0,0
3029,switched,0,0
3030,to,0,0
3031,fibrinolysis,0,1
3032,",",0,0
3033,which,0,0
3034,was,0,0
3035,successful,0,0
3036,without,0,0
3037,complications,0,1
3038,in,0,0
3039,12-60,0,0
3040,h.,0,0
3041,The,0,0
3042,fifth,0,0
3043,patient,0,0
3044,developed,0,0
3045,a,0,0
3046,stroke,1,0
3047,after,0,0
3048,nine,0,0
3049,days,0,0
3050,of,0,0
3051,heparin,0,0
3052,treatment,0,0
3053,and,0,0
3054,was,0,0
3055,subsequently,0,0
3056,operated,0,0
3057,on,0,0
3058,.,0,0
3059,CONCLUSIONS,0,0
3060,Non-obstructive,0,0
3061,PVT,0,0
3062,may,0,0
3063,be,0,0
3064,asymptomatic,0,0
3065,in,0,0
3066,one-third,0,0
3067,of,0,0
3068,patients,0,0
3069,.,0,0
3070,Thrombolysis,0,0
3071,is,0,0
3072,an,0,0
3073,efficient,1,0
3074,and,1,0
3075,safe,1,1
3076,treatment,0,0
3077,",",0,0
3078,and,0,0
3079,may,0,0
3080,be,0,0
3081,first-line,0,0
3082,therapy,0,0
3083,if,0,0
3084,there,0,0
3085,is,0,0
3086,no,0,0
3087,contraindication,0,0
3088,.,0,0
3089,Heparin,0,0
3090,treatment,0,0
3091,was,0,0
3092,successful,0,0
3093,in,0,0
3094,about,0,0
3095,one-half,0,0
3096,of,0,0
3097,our,0,0
3098,cases,0,0
3099,in,0,0
3100,the,0,0
3101,presence,0,0
3102,of,0,0
3103,sessile,0,0
3104,or,0,0
3105,small,0,1
3106,thrombi,0,1
3107,and,0,0
3108,inadequate,0,1
3109,anticoagulant,0,1
3110,status,0,1
3111,.,0,0
3112,In,0,0
3113,unsuccessful,0,0
3114,cases,0,0
3115,",",0,0
3116,thrombi,0,1
3117,became,0,0
3118,obstructive,0,0
3119,or,0,0
3120,caused,0,0
3121,stroke,1,1
3122,during,0,0
3123,heparin,0,0
3124,therapy,0,0
3125,",",0,0
3126,the,0,0
3127,adequate,0,0
3128,duration,0,1
3129,of,0,0
3130,which,0,0
3131,remains,0,0
3132,unclear,0,0
3133,.,0,0
3134,Comparative,0,0
3135,evaluation,0,0
3136,of,0,0
3137,olopatadine,0,0
3138,ophthalmic,0,0
3139,solution,0,0
3140,(,0,0
3141,0.1,0,0
3142,%,0,0
3143,),0,0
3144,versus,0,0
3145,ketorolac,0,0
3146,ophthalmic,0,0
3147,solution,0,0
3148,(,0,0
3149,0.5,0,0
3150,%,0,0
3151,),0,0
3152,using,0,0
3153,the,0,0
3154,provocative,0,0
3155,antigen,0,1
3156,challenge,0,0
3157,model,0,0
3158,.,0,0
3159,OBJECTIVE,0,0
3160,This,0,0
3161,study,0,0
3162,was,0,0
3163,conducted,0,0
3164,to,0,0
3165,compare,0,0
3166,the,0,0
3167,efficacy,1,1
3168,and,1,0
3169,safety,1,1
3170,of,0,1
3171,olopatadine,0,0
3172,ophthalmic,0,0
3173,solution,0,0
3174,(,0,0
3175,0.1,0,0
3176,%,0,0
3177,),0,0
3178,with,0,0
3179,ketorolac,0,0
3180,ophthalmic,0,0
3181,solution,0,0
3182,(,0,0
3183,0.5,0,0
3184,%,0,0
3185,),0,0
3186,in,0,0
3187,a,0,0
3188,clinical,0,0
3189,model,0,0
3190,of,0,0
3191,acute,0,0
3192,allergic,0,0
3193,conjunctivitis,0,0
3194,.,0,0
3195,Olopatadine,0,0
3196,is,0,0
3197,a,0,0
3198,dual,0,0
3199,acting,0,0
3200,H1,0,1
3201,histamine,0,1
3202,receptor,0,1
3203,antagonist,0,0
3204,and,0,0
3205,a,0,0
3206,mast,0,1
3207,cell,0,1
3208,stabilizer,0,0
3209,",",0,0
3210,shown,0,0
3211,to,0,0
3212,be,0,0
3213,effective,0,0
3214,in,0,0
3215,treating,0,0
3216,allergic,0,0
3217,conjunctivitis,0,0
3218,.,0,0
3219,Ketorolac,0,0
3220,is,0,0
3221,a,0,0
3222,non-steroidal,0,0
3223,anti-inflammatory,0,0
3224,drug,0,0
3225,approved,0,0
3226,in,0,0
3227,the,0,0
3228,United,0,0
3229,States,0,0
3230,for,0,0
3231,the,0,0
3232,relief,0,1
3233,of,0,0
3234,ocular,0,1
3235,itching,0,1
3236,associated,0,0
3237,with,0,0
3238,seasonal,0,0
3239,allergic,0,0
3240,conjunctivitis,0,0
3241,.,0,0
3242,METHODS,0,0
3243,The,0,0
3244,provocative,0,0
3245,antigen,0,1
3246,challenge,0,0
3247,model,0,0
3248,was,0,0
3249,used,0,0
3250,in,0,0
3251,this,0,0
3252,randomized,0,0
3253,",",0,0
3254,double-blind,0,0
3255,",",0,0
3256,single-center,0,0
3257,",",0,0
3258,crossover,0,0
3259,study,0,0
3260,.,0,0
3261,The,0,0
3262,allergen,0,0
3263,and,0,0
3264,concentration,0,1
3265,that,0,0
3266,consistently,0,0
3267,elicited,0,0
3268,a,0,0
3269,positive,0,0
3270,allergic,0,0
3271,reaction,0,1
3272,was,0,0
3273,used,0,0
3274,for,0,0
3275,challenge,0,0
3276,.,0,0
3277,After,0,0
3278,at,0,0
3279,least,0,0
3280,14,0,0
3281,days,0,0
3282,",",0,0
3283,subjects,0,0
3284,were,0,0
3285,randomized,0,0
3286,to,0,0
3287,receive,0,0
3288,either,0,0
3289,olopatadine,0,0
3290,in,0,0
3291,one,0,0
3292,eye,0,0
3293,and,0,0
3294,placebo,0,0
3295,in,0,0
3296,the,0,0
3297,contralateral,0,0
3298,eye,0,0
3299,",",0,0
3300,or,0,1
3301,ketorolac,0,0
3302,in,0,0
3303,one,0,0
3304,eye,0,0
3305,and,0,0
3306,placebo,0,0
3307,in,0,0
3308,the,0,0
3309,contralateral,0,0
3310,eye,0,0
3311,.,0,0
3312,Twenty-seven,0,0
3313,minutes,0,0
3314,after,0,0
3315,drug,0,0
3316,instillation,0,0
3317,subjects,0,0
3318,were,0,0
3319,challenged,0,0
3320,with,0,0
3321,allergen,0,0
3322,.,0,0
3323,At,0,0
3324,3,0,0
3325,",",0,0
3326,10,0,0
3327,",",0,0
3328,and,0,0
3329,20,0,0
3330,minutes,0,0
3331,following,0,0
3332,allergen,0,0
3333,challenge,0,0
3334,",",0,0
3335,subjects,0,0
3336,graded,1,1
3337,ocular,1,1
3338,itching,1,1
3339,and,0,0
3340,were,0,0
3341,assessed,0,0
3342,for,0,0
3343,hyperemia,1,1
3344,in,1,0
3345,conjunctival,1,1
3346,",",1,0
3347,ciliary,1,1
3348,",",1,0
3349,and,1,1
3350,episcleral,1,1
3351,vessel,1,1
3352,beds,1,0
3353,.,1,0
3354,Approximately,0,0
3355,14,0,0
3356,days,0,0
3357,later,0,0
3358,",",0,0
3359,subjects,0,0
3360,received,0,0
3361,the,0,0
3362,alternate,0,0
3363,treatment,0,0
3364,in,0,0
3365,one,0,0
3366,eye,0,0
3367,and,0,0
3368,placebo,0,0
3369,in,0,0
3370,the,0,0
3371,contralateral,0,0
3372,eye,0,0
3373,.,0,0
3374,They,0,0
3375,were,0,0
3376,again,0,0
3377,challenged,0,0
3378,with,0,0
3379,allergen,0,0
3380,and,0,0
3381,their,0,0
3382,responses,0,1
3383,were,0,0
3384,rated,0,0
3385,in,0,0
3386,the,0,0
3387,same,0,0
3388,manner,0,0
3389,.,0,0
3390,RESULTS,0,0
3391,Olopatadine,0,0
3392,significantly,0,0
3393,(,0,0
3394,p,0,0
3395,<,0,0
3396,0.0001,0,0
3397,),0,0
3398,reduced,0,0
3399,both,0,0
3400,ocular,1,1
3401,itching,1,1
3402,and,1,1
3403,hyperemia,1,1
3404,in,0,0
3405,all,0,0
3406,three,0,0
3407,vessel,0,0
3408,beds,0,0
3409,compared,0,0
3410,to,0,0
3411,placebo,0,0
3412,at,0,0
3413,all,0,0
3414,time,0,1
3415,points,0,0
3416,tested,0,0
3417,following,0,0
3418,allergen,0,0
3419,challenge,0,0
3420,.,0,0
3421,Ketorolac,0,0
3422,did,0,0
3423,not,0,0
3424,significantly,0,0
3425,reduce,0,0
3426,itching,1,1
3427,and,0,0
3428,showed,0,0
3429,a,0,0
3430,trend,0,0
3431,of,0,0
3432,increased,0,0
3433,hyperemia,1,1
3434,compared,0,0
3435,to,0,0
3436,placebo,0,0
3437,.,0,0
3438,Olopatadine,0,0
3439,was,0,0
3440,significantly,0,0
3441,(,0,0
3442,p,0,0
3443,<,0,0
3444,0.001,0,0
3445,),0,0
3446,more,0,0
3447,effective,1,1
3448,than,0,0
3449,ketorolac,0,0
3450,in,0,0
3451,reducing,0,0
3452,hyperemia,1,1
3453,and,1,0
3454,ocular,1,1
3455,itching,1,1
3456,at,0,0
3457,all,0,0
3458,time,0,1
3459,points,0,0
3460,and,0,1
3461,was,0,0
3462,also,0,0
3463,significantly,0,0
3464,(,0,0
3465,p,0,0
3466,<,0,0
3467,0.05,0,0
3468,),0,0
3469,more,0,0
3470,comfortable,1,1
3471,than,0,0
3472,ketorolac,0,0
3473,as,0,0
3474,reported,0,0
3475,by,0,0
3476,subjects,0,0
3477,immediately,0,0
3478,following,0,0
3479,drug,0,0
3480,instillation,0,0
3481,.,0,0
3482,CONCLUSION,0,0
3483,The,0,0
3484,study,0,0
3485,demonstrated,0,0
3486,that,0,0
3487,olopatadine,0,0
3488,is,0,0
3489,effective,0,1
3490,and,0,0
3491,safe,0,1
3492,in,0,0
3493,preventing,0,0
3494,and,0,0
3495,treating,0,0
3496,ocular,1,1
3497,itching,1,1
3498,and,1,1
3499,hyperemia,1,1
3500,associated,0,0
3501,with,0,0
3502,acute,0,0
3503,allergic,0,0
3504,conjunctivitis,0,0
3505,and,0,0
3506,is,0,0
3507,more,0,0
3508,effective,0,1
3509,and,0,0
3510,more,0,0
3511,comfortable,0,1
3512,than,0,0
3513,ketorolac,0,0
3514,.,0,0
3515,Oral,0,1
3516,and,0,0
3517,parenteral,0,0
3518,glutamine,0,0
3519,in,0,0
3520,bone,0,1
3521,marrow,0,0
3522,transplantation,0,0
3523,:,0,0
3524,a,0,0
3525,randomized,0,0
3526,",",0,0
3527,double-blind,0,0
3528,study,0,0
3529,.,0,0
3530,BACKGROUND,0,0
3531,Total,0,1
3532,parenteral,0,0
3533,nutrition,0,1
3534,(,0,0
3535,TPN,0,0
3536,),0,0
3537,supplemented,0,0
3538,with,0,0
3539,glutamine,0,0
3540,(,0,0
3541,GLN,0,0
3542,),0,0
3543,has,0,0
3544,been,0,0
3545,reported,0,0
3546,to,0,0
3547,be,0,0
3548,effective,0,0
3549,for,0,0
3550,patients,0,0
3551,with,0,0
3552,bone,0,1
3553,marrow,0,1
3554,transplantation,0,0
3555,(,0,0
3556,BMT,0,1
3557,),0,0
3558,.,0,0
3559,Our,0,0
3560,aim,0,0
3561,was,0,0
3562,to,0,0
3563,evaluate,0,0
3564,enteral,0,0
3565,and,0,0
3566,parenteral,0,0
3567,glutamine,0,0
3568,in,0,0
3569,patients,0,0
3570,undergoing,0,0
3571,BMT,0,1
3572,.,0,0
3573,METHODS,0,0
3574,For,0,0
3575,evaluation,0,0
3576,of,0,0
3577,GLN,0,0
3578,in,0,0
3579,BMT,0,1
3580,",",0,0
3581,66,0,0
3582,patients,0,0
3583,with,0,0
3584,43,0,0
3585,hematologic,0,0
3586,and,0,0
3587,23,0,0
3588,solid,0,0
3589,malignancies,0,0
3590,(,0,0
3591,21,0,0
3592,breast,0,0
3593,carcinomas,0,0
3594,),0,1
3595,",",0,0
3596,were,0,0
3597,randomized,0,0
3598,",",0,0
3599,double-blinded,0,0
3600,",",0,0
3601,to,0,0
3602,either,0,0
3603,oral,0,0
3604,GLN,0,0
3605,(,0,0
3606,n,0,0
3607,=,0,0
3608,35,0,0
3609,),0,0
3610,or,0,0
3611,glycine-control,0,0
3612,(,0,1
3613,GLY,0,1
3614,),0,0
3615,(,0,0
3616,n,0,0
3617,=,0,0
3618,31,0,0
3619,),0,0
3620,",",0,0
3621,10,0,0
3622,g,0,0
3623,three,0,0
3624,times,0,0
3625,daily,0,0
3626,.,0,0
3627,When,0,0
3628,TPN,0,0
3629,became,0,0
3630,necessary,0,0
3631,",",0,0
3632,patients,0,0
3633,who,0,0
3634,received,0,0
3635,GLN,0,0
3636,orally,0,0
3637,were,0,0
3638,given,0,0
3639,TPN,0,0
3640,with,0,0
3641,GLN,0,0
3642,(,0,0
3643,0.57,0,0
3644,g/kg,0,0
3645,),0,0
3646,.,0,0
3647,Those,0,0
3648,who,0,0
3649,received,0,0
3650,GLY,0,1
3651,received,0,0
3652,standard,0,0
3653,TPN,0,0
3654,",",0,0
3655,isocaloric,0,0
3656,and,0,0
3657,isonitrogenous,0,0
3658,.,0,0
3659,Patients,0,0
3660,with,0,0
3661,hematologic,0,1
3662,malignancies,0,0
3663,received,0,0
3664,high-dose,0,0
3665,chemotherapy,0,0
3666,",",0,0
3667,total,0,1
3668,body,0,1
3669,irradiation,0,0
3670,",",0,0
3671,and,0,0
3672,either,0,0
3673,allogeneic,0,0
3674,(,0,0
3675,ALLO,0,0
3676,),0,1
3677,BMT,0,1
3678,(,0,0
3679,n,0,0
3680,=,0,0
3681,18,0,0
3682,),0,0
3683,or,0,0
3684,autologous,0,0
3685,(,0,0
3686,AUTO,0,1
3687,),0,1
3688,stem,0,1
3689,cell,0,1
3690,transplantation,0,0
3691,(,0,0
3692,n,0,0
3693,=,0,0
3694,25,0,0
3695,),0,0
3696,.,0,0
3697,Patients,0,0
3698,with,0,0
3699,solid,0,0
3700,malignancies,0,0
3701,(,0,0
3702,n,0,0
3703,=,0,0
3704,23,0,0
3705,),0,0
3706,received,0,0
3707,AUTO,0,0
3708,.,0,0
3709,RESULTS,0,0
3710,There,0,0
3711,were,0,0
3712,14,0,0
3713,in-hospital,0,1
3714,deaths,0,0
3715,without,0,0
3716,relationship,0,0
3717,to,0,0
3718,GLN,0,0
3719,administration,0,0
3720,.,0,0
3721,For,0,0
3722,respective,0,0
3723,comparisons,0,0
3724,of,0,0
3725,ALLO,0,0
3726,and,0,0
3727,AUTO,0,1
3728,transplants,0,0
3729,in,0,0
3730,the,0,0
3731,GLN,0,0
3732,and,0,0
3733,GLY,0,0
3734,hematologic,0,1
3735,groups,0,0
3736,and,0,0
3737,AUTO,0,1
3738,in,0,0
3739,the,0,0
3740,solid,0,0
3741,tumor,0,1
3742,groups,0,0
3743,",",0,0
3744,there,0,0
3745,were,0,0
3746,no,0,0
3747,significant,0,0
3748,differences,0,0
3749,in,0,0
3750,hospital,1,1
3751,stay,1,1
3752,",",1,0
3753,duration,1,1
3754,of,1,1
3755,stay,1,1
3756,after,1,0
3757,BMT,1,1
3758,",",1,0
3759,TPN,1,0
3760,days,1,0
3761,",",1,0
3762,neutrophil,1,1
3763,recovery,1,1
3764,>,1,0
3765,500/mm3,1,0
3766,",",1,0
3767,incidence,1,1
3768,of,1,1
3769,positive,1,1
3770,blood,1,1
3771,cultures,1,1
3772,",",1,1
3773,sepsis,1,1
3774,",",1,1
3775,mucositis,1,1
3776,",",1,1
3777,and,1,1
3778,diarrhea,1,1
3779,.,1,1
3780,Acute,1,0
3781,graft,1,0
3782,us,1,0
3783,host,1,0
3784,disease,1,0
3785,occurred,0,0
3786,in,0,0
3787,1,0,0
3788,of,0,0
3789,10,0,0
3790,hematologic,0,0
3791,patients,0,0
3792,receiving,0,0
3793,GLN,0,0
3794,and,0,0
3795,in,0,0
3796,3,0,0
3797,of,0,0
3798,8,0,0
3799,patients,0,0
3800,receiving,0,0
3801,GLY,0,1
3802,placebo,0,0
3803,(,0,0
3804,p,0,0
3805,>,0,0
3806,.05,0,0
3807,),0,0
3808,.,0,0
3809,Possible,0,0
3810,reduction,1,1
3811,in,1,0
3812,need,1,0
3813,for,1,0
3814,TPN,1,0
3815,and,0,0
3816,a,0,0
3817,suggestion,0,0
3818,of,0,0
3819,improved,1,1
3820,long-term,1,0
3821,survival,1,1
3822,were,0,0
3823,associated,0,0
3824,with,0,0
3825,GLN,0,0
3826,.,0,0
3827,CONCLUSIONS,0,0
3828,Oral,0,1
3829,and,0,0
3830,parenteral,0,0
3831,GLN,0,0
3832,seemed,0,0
3833,to,0,0
3834,be,0,0
3835,of,0,0
3836,limited,0,0
3837,benefit,0,0
3838,for,0,0
3839,patients,0,0
3840,having,0,0
3841,AUTO,0,1
3842,or,0,0
3843,ALLO,0,0
3844,BMT,0,1
3845,for,0,0
3846,hematologic,0,1
3847,or,0,0
3848,solid,0,0
3849,malignancies,0,0
3850,.,0,0
3851,Further,0,0
3852,study,0,0
3853,of,0,0
3854,long-term,0,0
3855,effects,0,0
3856,of,0,0
3857,GLN,0,0
3858,in,0,0
3859,BMT,0,0
3860,seems,0,0
3861,warranted,0,0
3862,.,0,0
3863,Effects,0,0
3864,of,0,0
3865,a,0,0
3866,videotape,0,0
3867,information,0,1
3868,intervention,0,0
3869,at,0,0
3870,discharge,0,1
3871,on,0,0
3872,diet,0,0
3873,and,0,0
3874,exercise,0,0
3875,compliance,0,1
3876,after,0,0
3877,coronary,0,0
3878,bypass,0,0
3879,surgery,0,0
3880,.,0,0
3881,BACKGROUND,0,0
3882,This,0,0
3883,study,0,0
3884,evaluated,0,0
3885,the,0,0
3886,relative,0,0
3887,effects,0,0
3888,on,0,0
3889,compliance,0,1
3890,with,0,0
3891,recommended,0,0
3892,lifestyle,0,0
3893,changes,0,0
3894,of,0,0
3895,two,0,0
3896,experimental,0,0
3897,videotapes,0,0
3898,that,0,0
3899,involved,0,0
3900,different,0,0
3901,approaches,0,0
3902,for,0,0
3903,preparing,0,0
3904,coronary,0,0
3905,artery,0,1
3906,bypass,0,0
3907,graft,0,1
3908,(,0,0
3909,CABG,0,1
3910,),0,0
3911,patients,0,0
3912,for,0,0
3913,the,0,0
3914,posthospital,0,1
3915,recovery,0,1
3916,period,0,0
3917,.,0,0
3918,The,0,0
3919,tapes,0,0
3920,differed,0,0
3921,in,0,0
3922,the,0,0
3923,extent,0,0
3924,to,0,0
3925,which,0,0
3926,they,0,0
3927,portrayed,0,0
3928,the,0,0
3929,recovery,0,1
3930,period,0,0
3931,as,0,0
3932,a,0,0
3933,steady,0,0
3934,",",0,0
3935,forward,0,0
3936,progression,0,1
3937,versus,0,0
3938,a,0,0
3939,series,0,0
3940,of,0,0
3941,ups,0,1
3942,and,0,0
3943,downs,0,0
3944,.,0,0
3945,METHODS,0,0
3946,Two,0,0
3947,hundred,0,0
3948,sixteen,0,0
3949,male,0,0
3950,and,0,0
3951,female,0,0
3952,CABG,0,1
3953,patients,0,0
3954,were,0,0
3955,assigned,0,0
3956,randomly,0,0
3957,either,0,0
3958,to,0,0
3959,view,0,0
3960,one,0,0
3961,of,0,0
3962,the,0,0
3963,two,0,0
3964,videotapes,0,0
3965,before,0,0
3966,discharge,0,0
3967,from,0,0
3968,the,0,0
3969,hospital,0,0
3970,or,0,0
3971,to,0,0
3972,receive,0,0
3973,only,0,0
3974,the,0,0
3975,standard,0,0
3976,discharge,0,1
3977,preparation,0,0
3978,provided,0,0
3979,by,0,0
3980,the,0,0
3981,hospital,0,0
3982,.,0,0
3983,All,0,0
3984,patients,0,0
3985,completed,0,0
3986,measures,1,0
3987,of,1,0
3988,anxiety,1,1
3989,and,1,1
3990,self-efficacy,1,1
3991,at,0,0
3992,discharge,0,1
3993,",",0,0
3994,1,0,0
3995,month,0,0
3996,and,0,0
3997,3,0,0
3998,months,0,0
3999,after,0,0
4000,discharge,0,0
4001,from,0,0
4002,the,0,0
4003,hospital,0,0
4004,.,0,0
4005,Patients,0,0
4006,also,0,0
4007,completed,0,0
4008,measures,0,1
4009,of,0,0
4010,dietary,1,0
4011,fat,1,1
4012,consumption,1,1
4013,and,0,1
4014,activity,1,1
4015,level,1,1
4016,1,1,0
4017,and,1,0
4018,3,1,0
4019,months,0,0
4020,after,0,0
4021,discharge,0,0
4022,.,0,0
4023,RESULTS,0,0
4024,Relative,0,0
4025,to,0,0
4026,controls,0,0
4027,",",0,0
4028,patients,0,0
4029,who,0,0
4030,viewed,0,0
4031,either,0,0
4032,of,0,0
4033,the,0,0
4034,videotapes,0,0
4035,before,0,0
4036,hospital,0,1
4037,release,0,1
4038,reported,0,0
4039,higher,0,0
4040,self-efficacy,1,1
4041,for,1,0
4042,adhering,1,0
4043,to,1,0
4044,the,1,0
4045,recommended,1,0
4046,low-fat,1,0
4047,diet,1,0
4048,both,0,0
4049,at,0,0
4050,discharge,0,0
4051,and,0,0
4052,1,0,0
4053,month,0,0
4054,after,0,0
4055,surgery,0,0
4056,.,0,0
4057,Viewing,0,0
4058,either,0,0
4059,of,0,0
4060,the,0,0
4061,videotapes,0,0
4062,also,0,0
4063,resulted,0,0
4064,in,0,0
4065,significantly,1,0
4066,less,1,0
4067,dietary,1,0
4068,fat,1,1
4069,intake,1,0
4070,1,1,0
4071,month,1,0
4072,after,1,0
4073,hospital,1,1
4074,release,1,1
4075,compared,0,0
4076,with,0,0
4077,controls,0,0
4078,.,0,0
4079,Patients,0,0
4080,who,0,0
4081,viewed,0,0
4082,the,0,0
4083,tape,0,1
4084,that,0,0
4085,portrayed,0,0
4086,the,0,0
4087,recovery,0,1
4088,period,0,0
4089,as,0,0
4090,consisting,0,0
4091,of,0,0
4092,ups,0,1
4093,and,0,0
4094,downs,0,0
4095,also,0,0
4096,reported,0,0
4097,significantly,0,0
4098,more,0,0
4099,frequent,0,1
4100,moderate,1,0
4101,exercise,1,0
4102,at,1,0
4103,1,1,0
4104,month,1,0
4105,and,0,0
4106,more,0,0
4107,frequent,0,1
4108,strenuous,1,0
4109,exercise,1,0
4110,3,0,0
4111,months,0,0
4112,after,0,0
4113,discharge,0,0
4114,.,0,0
4115,CONCLUSIONS,0,0
4116,The,0,0
4117,experimental,0,0
4118,videotapes,0,0
4119,proved,0,0
4120,to,0,0
4121,be,0,0
4122,an,0,0
4123,effective,0,0
4124,method,0,0
4125,for,0,0
4126,increasing,0,0
4127,dietary,1,0
4128,and,1,0
4129,exercise,1,0
4130,compliance,1,1
4131,during,0,0
4132,the,0,0
4133,first,0,0
4134,3,0,0
4135,months,0,0
4136,after,0,0
4137,CABG,0,0
4138,.,0,0
4139,Primary,0,0
4140,capsulectomy,0,0
4141,",",0,0
4142,anterior,0,1
4143,vitrectomy,0,0
4144,",",0,0
4145,lensectomy,0,0
4146,",",0,1
4147,and,0,1
4148,posterior,0,1
4149,chamber,0,0
4150,lens,0,0
4151,implantation,0,0
4152,in,0,0
4153,children,0,0
4154,:,0,0
4155,limbal,0,1
4156,versus,0,0
4157,pars,0,0
4158,plana,0,0
4159,.,0,0
4160,PURPOSE,0,0
4161,To,0,0
4162,compare,0,0
4163,the,0,0
4164,results,0,0
4165,of,0,0
4166,a,0,0
4167,limbal,0,0
4168,versus,0,0
4169,a,0,0
4170,pars,0,0
4171,plana,0,0
4172,approach,0,0
4173,for,0,0
4174,primary,0,0
4175,posterior,0,0
4176,capsulectomy,0,0
4177,and,0,0
4178,anterior,0,1
4179,vitrectomy,0,0
4180,in,0,0
4181,the,0,0
4182,management,0,0
4183,of,0,0
4184,childhood,1,0
4185,cataract,1,0
4186,.,1,0
4187,SETTING,0,0
4188,Department,0,0
4189,of,0,0
4190,Ophthalmology,0,0
4191,",",0,0
4192,Labbafinejad,0,0
4193,Medical,0,0
4194,Center,0,0
4195,",",0,0
4196,Tehran,0,0
4197,",",0,0
4198,Iran,0,0
4199,.,0,0
4200,METHODS,0,0
4201,A,0,0
4202,randomized,0,0
4203,",",0,0
4204,controlled,0,0
4205,",",0,0
4206,double-masked,0,0
4207,clinical,0,0
4208,trial,0,0
4209,of,0,0
4210,45,0,0
4211,eyes,0,0
4212,was,0,0
4213,conducted,0,0
4214,.,0,0
4215,After,0,0
4216,being,0,0
4217,matched,0,0
4218,",",0,0
4219,38,0,0
4220,eyes,0,0
4221,were,0,0
4222,included,0,0
4223,in,0,0
4224,the,0,0
4225,study,0,0
4226,and,0,0
4227,were,0,0
4228,divided,0,0
4229,into,0,0
4230,2,0,0
4231,equal,0,0
4232,groups,0,0
4233,for,0,0
4234,data,0,0
4235,analysis,0,0
4236,.,0,0
4237,All,0,0
4238,eyes,0,0
4239,had,0,0
4240,lensectomy,0,0
4241,and,0,1
4242,posterior,0,0
4243,chamber,0,0
4244,intraocular,0,1
4245,lens,0,0
4246,(,0,0
4247,PC,0,0
4248,IOL,0,0
4249,),0,0
4250,implantation,0,0
4251,.,0,0
4252,Primary,0,0
4253,posterior,0,0
4254,capsulectomy,0,0
4255,and,0,0
4256,anterior,0,1
4257,vitrectomy,0,0
4258,were,0,0
4259,performed,0,0
4260,through,0,0
4261,the,0,0
4262,limbus,0,1
4263,in,0,0
4264,half,0,0
4265,of,0,0
4266,the,0,0
4267,eyes,0,0
4268,and,0,0
4269,the,0,0
4270,pars,0,0
4271,plana,0,0
4272,in,0,0
4273,the,0,0
4274,other,0,0
4275,half,0,0
4276,.,0,0
4277,Main,0,0
4278,outcome,0,1
4279,measures,0,1
4280,included,0,0
4281,visual,1,1
4282,acuity,1,1
4283,",",1,0
4284,estimated,1,0
4285,red,1,1
4286,reflex,1,1
4287,",",1,0
4288,postsurgical,1,1
4289,inflammatory,1,1
4290,reaction,1,1
4291,",",1,0
4292,corneal,1,1
4293,clarity,1,1
4294,",",1,0
4295,posterior,1,0
4296,synechias,1,0
4297,",",1,0
4298,iris,1,1
4299,capture,1,1
4300,",",1,0
4301,IOL,1,1
4302,position,1,1
4303,",",1,0
4304,capsulectomy,1,0
4305,size,1,1
4306,",",1,0
4307,glaucoma,1,0
4308,",",1,1
4309,cystoid,1,1
4310,macular,1,1
4311,edema,1,1
4312,",",1,0
4313,retinal,1,1
4314,tear,1,1
4315,",",1,0
4316,and,1,1
4317,postoperative,1,1
4318,refraction,1,1
4319,.,1,0
4320,RESULTS,0,0
4321,No,0,0
4322,statistically,0,0
4323,significant,0,0
4324,differences,0,0
4325,were,0,0
4326,found,0,0
4327,between,0,0
4328,the,0,0
4329,2,0,0
4330,approaches,0,0
4331,in,0,0
4332,the,0,0
4333,outcome,0,0
4334,measures,0,0
4335,.,0,0
4336,CONCLUSION,0,0
4337,The,0,0
4338,anatomic,0,0
4339,and,0,0
4340,visual,0,1
4341,results,0,0
4342,were,0,0
4343,encouraging,0,0
4344,when,0,0
4345,posterior,0,0
4346,capsulectomy,0,0
4347,and,0,0
4348,anterior,0,1
4349,vitrectomy,0,0
4350,",",0,0
4351,using,0,0
4352,a,0,0
4353,limbal,0,1
4354,or,0,0
4355,pars,0,0
4356,plana,0,0
4357,approach,0,0
4358,",",0,0
4359,were,0,0
4360,combined,0,0
4361,with,0,0
4362,lensectomy,0,0
4363,and,0,1
4364,PC,0,0
4365,IOL,0,1
4366,implantation,0,0
4367,in,0,0
4368,children,0,0
4369,.,0,0
4370,The,0,0
4371,application,0,0
4372,of,0,0
4373,these,0,0
4374,techniques,0,0
4375,depends,0,0
4376,on,0,0
4377,surgeon,0,0
4378,experience,0,0
4379,and,0,0
4380,skill,0,1
4381,.,0,0
4382,Phenobarbital,0,0
4383,compared,0,0
4384,with,0,0
4385,phenytoin,0,0
4386,for,0,0
4387,the,0,0
4388,treatment,0,0
4389,of,0,0
4390,neonatal,0,1
4391,seizures,0,0
4392,.,0,0
4393,BACKGROUND,0,0
4394,Seizures,0,0
4395,occur,0,0
4396,in,0,0
4397,1,0,0
4398,to,0,0
4399,2,0,0
4400,percent,0,0
4401,of,0,0
4402,neonates,0,0
4403,admitted,0,0
4404,to,0,0
4405,an,0,0
4406,intensive,0,0
4407,care,0,0
4408,unit,0,0
4409,.,0,0
4410,The,0,0
4411,treatment,0,0
4412,is,0,0
4413,usually,0,0
4414,with,0,0
4415,either,0,0
4416,phenobarbital,0,0
4417,or,0,0
4418,phenytoin,0,1
4419,",",0,0
4420,but,0,0
4421,the,0,0
4422,efficacy,1,1
4423,of,0,0
4424,the,0,0
4425,two,0,0
4426,drugs,0,0
4427,has,0,0
4428,not,0,0
4429,been,0,0
4430,compared,0,0
4431,directly,0,0
4432,.,0,0
4433,METHODS,0,0
4434,From,0,0
4435,1990,0,0
4436,to,0,0
4437,1995,0,0
4438,",",0,0
4439,we,0,0
4440,studied,0,0
4441,59,0,0
4442,neonates,0,0
4443,with,0,0
4444,seizures,0,0
4445,that,0,0
4446,were,0,0
4447,confirmed,0,0
4448,by,0,0
4449,electroencephalography,0,0
4450,.,0,0
4451,The,0,0
4452,neonates,0,0
4453,were,0,0
4454,randomly,0,0
4455,assigned,0,0
4456,to,0,0
4457,receive,0,0
4458,either,0,0
4459,phenobarbital,0,0
4460,or,0,0
4461,phenytoin,0,0
4462,intravenously,0,0
4463,",",0,0
4464,at,0,0
4465,doses,0,0
4466,sufficient,0,0
4467,to,0,0
4468,achieve,0,0
4469,free,0,1
4470,plasma,0,1
4471,concentrations,0,1
4472,of,0,0
4473,25,0,0
4474,microg,0,0
4475,per,0,0
4476,milliliter,0,0
4477,for,0,0
4478,phenobarbital,0,0
4479,and,0,0
4480,3,0,0
4481,microg,0,0
4482,per,0,0
4483,milliliter,0,0
4484,for,0,0
4485,phenytoin,0,0
4486,.,0,0
4487,Neonates,0,0
4488,whose,0,0
4489,seizures,0,0
4490,were,0,0
4491,not,0,0
4492,controlled,0,0
4493,by,0,0
4494,the,0,0
4495,assigned,0,0
4496,drug,0,0
4497,were,0,0
4498,then,0,0
4499,treated,0,0
4500,with,0,0
4501,both,0,0
4502,drugs,0,0
4503,.,0,0
4504,Seizure,1,1
4505,control,1,0
4506,was,0,0
4507,assessed,0,0
4508,by,0,0
4509,electroencephalographic,0,0
4510,criteria,0,0
4511,.,0,0
4512,RESULTS,0,0
4513,Seizures,1,0
4514,were,0,0
4515,controlled,0,0
4516,in,0,0
4517,13,0,0
4518,of,0,0
4519,the,0,0
4520,30,0,0
4521,neonates,0,0
4522,assigned,0,0
4523,to,0,0
4524,receive,0,0
4525,phenobarbital,0,0
4526,(,0,0
4527,43,0,0
4528,percent,0,0
4529,),0,0
4530,and,0,0
4531,13,0,0
4532,of,0,0
4533,the,0,0
4534,29,0,0
4535,neonates,0,0
4536,assigned,0,0
4537,to,0,0
4538,receive,0,0
4539,phenytoin,0,0
4540,(,0,0
4541,45,0,0
4542,percent,0,0
4543,;,0,0
4544,P=1.00,0,0
4545,),0,0
4546,.,0,0
4547,When,0,0
4548,combined,0,0
4549,treatment,0,0
4550,is,0,0
4551,considered,0,0
4552,",",0,0
4553,seizure,1,1
4554,control,1,0
4555,was,0,0
4556,achieved,0,0
4557,in,0,0
4558,17,0,0
4559,(,0,0
4560,57,0,0
4561,percent,0,0
4562,),0,0
4563,of,0,0
4564,the,0,0
4565,neonates,0,0
4566,assigned,0,0
4567,to,0,0
4568,receive,0,0
4569,phenobarbital,0,0
4570,first,0,0
4571,and,0,0
4572,18,0,0
4573,(,0,0
4574,62,0,0
4575,percent,0,0
4576,),0,0
4577,of,0,0
4578,those,0,0
4579,assigned,0,0
4580,to,0,0
4581,receive,0,0
4582,phenytoin,0,0
4583,first,0,0
4584,(,0,0
4585,P=0.67,0,0
4586,),0,0
4587,.,0,0
4588,The,0,0
4589,severity,1,1
4590,of,1,0
4591,the,1,0
4592,seizures,1,0
4593,was,0,0
4594,a,0,0
4595,stronger,0,0
4596,predictor,0,0
4597,of,0,0
4598,the,0,0
4599,success,0,1
4600,of,0,0
4601,treatment,0,0
4602,than,0,0
4603,was,0,0
4604,the,0,0
4605,assigned,0,0
4606,agent,0,0
4607,.,0,0
4608,Neonates,0,0
4609,with,0,0
4610,mild,1,1
4611,seizures,1,1
4612,or,0,0
4613,with,0,0
4614,seizures,1,1
4615,that,0,0
4616,were,0,0
4617,decreasing,0,0
4618,in,0,0
4619,severity,1,1
4620,before,0,0
4621,treatment,0,0
4622,were,0,0
4623,more,0,0
4624,likely,0,0
4625,to,0,0
4626,have,0,0
4627,their,0,0
4628,seizures,1,0
4629,end,1,0
4630,",",0,0
4631,regardless,0,0
4632,of,0,0
4633,the,0,0
4634,treatment,0,0
4635,assignment,0,0
4636,.,0,0
4637,CONCLUSIONS,0,0
4638,Phenobarbital,0,0
4639,and,0,0
4640,phenytoin,0,0
4641,are,0,0
4642,equally,0,0
4643,but,0,0
4644,incompletely,0,0
4645,effective,0,0
4646,as,0,0
4647,anticonvulsants,1,0
4648,in,0,0
4649,neonates,0,0
4650,.,0,0
4651,With,0,0
4652,either,0,0
4653,drug,0,0
4654,given,0,0
4655,alone,0,0
4656,",",0,0
4657,the,0,0
4658,seizures,1,1
4659,were,0,0
4660,controlled,1,0
4661,in,0,0
4662,fewer,0,0
4663,than,0,0
4664,half,0,0
4665,of,0,0
4666,the,0,0
4667,neonates,0,0
4668,.,0,0
4669,Inhibition,1,0
4670,of,1,0
4671,the,1,0
4672,seasonal,1,0
4673,IgE,1,0
4674,increase,0,0
4675,to,0,0
4676,Dactylis,0,0
4677,glomerata,0,0
4678,by,0,0
4679,daily,0,0
4680,sodium,0,0
4681,chloride,0,0
4682,nasal-sinus,0,1
4683,irrigation,0,0
4684,during,0,0
4685,the,0,0
4686,grass,0,0
4687,pollen,0,0
4688,season,0,0
4689,.,0,0
4690,Chemotherapy,0,0
4691,for,0,0
4692,operable,0,0
4693,gastric,0,0
4694,cancer,0,0
4695,:,0,0
4696,results,0,0
4697,of,0,0
4698,the,0,0
4699,Dutch,0,0
4700,randomised,0,0
4701,FAMTX,0,0
4702,trial,0,0
4703,.,0,0
4704,The,0,0
4705,Dutch,0,0
4706,Gastric,0,0
4707,Cancer,0,1
4708,Group,0,0
4709,(,0,0
4710,DGCG,0,0
4711,),0,0
4712,.,0,0
4713,The,0,0
4714,aim,0,0
4715,of,0,0
4716,this,0,0
4717,trial,0,0
4718,was,0,0
4719,to,0,0
4720,investigate,0,0
4721,whether,0,0
4722,pre-operative,0,0
4723,chemotherapy,0,0
4724,leads,0,0
4725,to,0,0
4726,a,0,0
4727,15,0,0
4728,%,0,0
4729,higher,0,0
4730,curative,1,1
4731,resectability,1,1
4732,rate,1,1
4733,in,0,0
4734,patients,0,0
4735,with,0,0
4736,operable,0,0
4737,gastric,0,1
4738,cancer,0,0
4739,.,0,0
4740,In,0,0
4741,this,0,0
4742,randomised,0,0
4743,trial,0,0
4744,",",0,0
4745,patients,0,0
4746,were,0,0
4747,allocated,0,0
4748,to,0,0
4749,receive,0,0
4750,either,0,0
4751,four,0,0
4752,courses,0,0
4753,of,0,0
4754,chemotherapy,0,0
4755,using,0,0
4756,5-fluorouracil,0,0
4757,",",0,0
4758,doxorubicin,0,0
4759,and,0,1
4760,methotrexate,0,0
4761,(,0,1
4762,FAMTX,0,0
4763,),0,0
4764,prior,0,0
4765,to,0,0
4766,surgery,0,0
4767,or,0,0
4768,to,0,0
4769,undergo,0,0
4770,surgery,0,0
4771,only,0,0
4772,.,0,0
4773,Patients,0,0
4774,younger,0,0
4775,than,0,0
4776,75,0,0
4777,years,0,0
4778,of,0,0
4779,age,0,0
4780,with,0,0
4781,a,0,0
4782,good,0,0
4783,physical,0,1
4784,and,0,0
4785,mental,0,1
4786,condition,0,0
4787,and,0,0
4788,a,0,0
4789,histologically,0,0
4790,proven,0,0
4791,adenocarcinoma,0,0
4792,of,0,0
4793,the,0,0
4794,stomach,0,0
4795,without,0,0
4796,clinical,0,0
4797,or,0,0
4798,radiographic,0,1
4799,(,0,0
4800,computed,0,0
4801,tomography,0,0
4802,scan,0,0
4803,),0,0
4804,evidence,0,0
4805,of,0,0
4806,distant,0,1
4807,metastases,0,0
4808,were,0,0
4809,eligible,0,0
4810,for,0,0
4811,this,0,0
4812,trial,0,0
4813,.,0,0
4814,Early,0,0
4815,gastric,0,1
4816,cancer,0,0
4817,or,0,0
4818,cardia,0,0
4819,carcinoma,0,0
4820,were,0,0
4821,excluded,0,0
4822,.,0,0
4823,The,0,0
4824,response,0,1
4825,to,0,0
4826,chemotherapy,0,0
4827,was,0,0
4828,evaluated,0,0
4829,after,0,0
4830,two,0,0
4831,and,0,0
4832,four,0,0
4833,courses,0,0
4834,.,0,0
4835,In,0,0
4836,case,0,0
4837,of,0,0
4838,progressive,0,1
4839,disease,0,1
4840,(,0,0
4841,PD,0,1
4842,),0,0
4843,after,0,0
4844,two,0,0
4845,courses,0,0
4846,",",0,0
4847,patients,0,0
4848,were,0,0
4849,operated,0,0
4850,upon,0,0
4851,as,0,0
4852,soon,0,0
4853,as,0,0
4854,possible,0,0
4855,.,0,0
4856,Otherwise,0,0
4857,complete,0,1
4858,response,0,1
4859,(,0,0
4860,CR,0,1
4861,),0,0
4862,partial,0,0
4863,response,0,1
4864,(,0,0
4865,PR,0,1
4866,),0,0
4867,or,0,0
4868,stable,0,1
4869,disease,0,1
4870,(,0,0
4871,SD,0,0
4872,),0,0
4873,",",0,0
4874,two,0,0
4875,more,0,0
4876,courses,0,0
4877,were,0,0
4878,scheduled,0,0
4879,.,0,0
4880,The,0,0
4881,standard,0,0
4882,surgical,0,0
4883,procedure,0,0
4884,was,0,0
4885,a,0,0
4886,limited,0,0
4887,lymphadenectomy,0,0
4888,(,0,0
4889,D1,0,0
4890,),0,0
4891,with,0,0
4892,staging,0,0
4893,biopsy,0,0
4894,of,0,0
4895,the,0,0
4896,para-aortic,0,0
4897,lymph,0,0
4898,nodes,0,0
4899,.,0,0
4900,Between,0,0
4901,September,0,0
4902,1993,0,0
4903,and,0,0
4904,February,0,0
4905,1996,0,0
4906,",",0,0
4907,56,0,0
4908,eligible,0,0
4909,and,0,0
4910,evaluable,0,0
4911,patients,0,0
4912,were,0,0
4913,entered,0,0
4914,:,0,0
4915,27,0,0
4916,were,0,0
4917,randomised,0,0
4918,to,0,0
4919,receive,0,0
4920,FAMTX,0,0
4921,before,0,0
4922,surgery,0,0
4923,and,0,0
4924,29,0,0
4925,to,0,0
4926,undergo,0,0
4927,surgery,0,0
4928,only,0,0
4929,.,0,0
4930,In,0,0
4931,the,0,0
4932,FAMTX,0,0
4933,+,0,0
4934,surgery,0,0
4935,treatment,0,0
4936,group,0,0
4937,",",0,0
4938,15/27,0,0
4939,(,0,0
4940,56,0,0
4941,%,0,0
4942,),0,0
4943,had,0,0
4944,curative,1,0
4945,resections,1,0
4946,versus,0,0
4947,18/29,0,0
4948,(,0,0
4949,62,0,0
4950,%,0,0
4951,),0,0
4952,in,0,0
4953,the,0,0
4954,surgery,0,0
4955,only,0,0
4956,arm,0,0
4957,.,0,0
4958,There,0,0
4959,was,0,0
4960,no,0,0
4961,difference,0,0
4962,in,0,0
4963,the,0,0
4964,frequency,1,1
4965,of,1,0
4966,TNM,1,1
4967,stages,1,0
4968,I,1,0
4969,+,1,0
4970,II,1,0
4971,in,0,0
4972,both,0,0
4973,treatment,0,0
4974,arms,0,0
4975,:,0,0
4976,15/27,0,0
4977,versus,0,0
4978,15/29,0,0
4979,.,0,0
4980,Due,0,0
4981,to,0,0
4982,PD,0,1
4983,and/or,0,0
4984,toxicity,1,1
4985,",",0,0
4986,12,0,0
4987,patients,0,0
4988,(,0,0
4989,44,0,0
4990,%,0,0
4991,),0,0
4992,could,0,0
4993,not,0,0
4994,complete,0,0
4995,the,0,0
4996,planned,0,0
4997,four,0,0
4998,courses,0,0
4999,of,0,0
5000,FAMTX,0,0
5001,.,0,0
5002,Response,0,1
5003,evaluation,0,0
5004,after,0,0
5005,chemotherapy,0,0
5006,was,0,0
5007,possible,0,0
5008,in,0,0
5009,25,0,0
5010,patients,0,0
5011,:,0,0
5012,2,0,0
5013,CR,0,0
5014,",",0,0
5015,6,0,0
5016,PR,0,0
5017,",",0,0
5018,8,0,0
5019,SD,0,0
5020,and,0,0
5021,9,0,0
5022,PD,0,0
5023,.,0,0
5024,The,0,0
5025,difference,0,0
5026,in,0,0
5027,curative,1,0
5028,resectability,1,1
5029,rate,0,1
5030,was,0,0
5031,6.5,0,0
5032,%,0,0
5033,(,0,0
5034,95,0,0
5035,%,0,0
5036,confidence,0,0
5037,interval,0,0
5038,-32,0,0
5039,to,0,0
5040,+19,0,0
5041,%,0,0
5042,),0,0
5043,in,0,0
5044,favour,0,0
5045,of,0,0
5046,surgery,0,0
5047,only,0,0
5048,.,0,0
5049,Downstaging,0,0
5050,for,0,0
5051,stages,0,0
5052,I,0,0
5053,+,0,0
5054,II,0,0
5055,did,0,0
5056,not,0,0
5057,occur,0,0
5058,.,0,0
5059,PD,0,1
5060,was,0,0
5061,more,0,0
5062,often,0,0
5063,the,0,0
5064,reason,0,0
5065,for,0,0
5066,not,0,0
5067,completing,0,0
5068,the,0,0
5069,planned,0,0
5070,four,0,0
5071,courses,0,0
5072,than,0,0
5073,toxicity,0,1
5074,.,0,0
5075,More,0,0
5076,active,0,0
5077,regimens,0,0
5078,than,0,0
5079,FAMTX,0,0
5080,are,0,0
5081,required,0,0
5082,for,0,0
5083,future,0,0
5084,randomised,0,0
5085,trials,0,0
5086,.,0,0
5087,Barriers,0,1
5088,to,0,0
5089,hypertension,0,1
5090,care,0,0
5091,and,0,1
5092,control,0,0
5093,in,0,0
5094,young,0,0
5095,urban,0,0
5096,black,0,0
5097,men,0,0
5098,.,0,0
5099,Barriers,0,0
5100,to,0,0
5101,high,1,0
5102,blood,1,1
5103,pressure,1,1
5104,(,0,0
5105,HBP,0,1
5106,),0,1
5107,care,0,0
5108,and,0,0
5109,control,0,0
5110,have,0,0
5111,been,0,0
5112,reported,0,0
5113,in,0,0
5114,the,0,0
5115,literature,0,0
5116,for,0,0
5117,>,0,0
5118,30,0,0
5119,years,0,0
5120,.,0,0
5121,Few,0,0
5122,reports,0,0
5123,on,0,0
5124,barriers,0,0
5125,",",0,0
5126,however,0,0
5127,",",0,0
5128,have,0,0
5129,focused,0,0
5130,on,0,0
5131,the,0,0
5132,young,0,0
5133,black,0,0
5134,man,0,0
5135,with,0,0
5136,HBP,0,0
5137,",",0,0
5138,the,0,0
5139,age/sex/race,0,0
5140,group,0,0
5141,with,0,0
5142,the,0,0
5143,highest,0,0
5144,rates,0,1
5145,of,0,0
5146,early,0,0
5147,severe,0,1
5148,and,0,0
5149,complicated,0,0
5150,HBP,0,0
5151,and,0,0
5152,the,0,0
5153,lowest,0,0
5154,rates,0,1
5155,of,0,0
5156,awareness,0,1
5157,",",0,0
5158,treatment,0,0
5159,",",0,1
5160,and,0,1
5161,control,0,0
5162,.,0,0
5163,In,0,0
5164,a,0,0
5165,randomized,0,0
5166,clinical,0,0
5167,trial,0,0
5168,of,0,0
5169,comprehensive,0,0
5170,care,0,0
5171,for,0,0
5172,hypertensive,0,0
5173,young,0,0
5174,urban,0,0
5175,black,0,0
5176,men,0,0
5177,",",0,0
5178,factors,0,0
5179,potentially,0,0
5180,associated,0,0
5181,with,0,0
5182,care,0,0
5183,and,0,1
5184,control,0,0
5185,were,0,0
5186,assessed,0,0
5187,at,0,0
5188,baseline,0,0
5189,for,0,0
5190,the,0,0
5191,309,0,0
5192,enrolled,0,0
5193,men,0,0
5194,.,0,0
5195,A,0,0
5196,majority,0,0
5197,of,0,0
5198,the,0,0
5199,men,0,0
5200,encountered,0,0
5201,a,0,0
5202,variety,0,0
5203,of,0,0
5204,barriers,0,0
5205,including,0,0
5206,economic,0,0
5207,",",0,0
5208,social,0,1
5209,",",0,0
5210,and,0,1
5211,lifestyle,0,1
5212,obstacles,0,0
5213,to,0,0
5214,adequate,0,0
5215,BP,0,1
5216,care,0,0
5217,and,0,1
5218,control,0,0
5219,",",0,0
5220,including,0,0
5221,no,1,0
5222,current,1,0
5223,HBP,1,0
5224,care,1,0
5225,(,0,0
5226,49,0,0
5227,%,0,0
5228,),0,0
5229,",",0,0
5230,risk,1,1
5231,of,1,1
5232,alcoholism,1,0
5233,(,0,0
5234,62,0,0
5235,%,0,0
5236,),0,0
5237,",",0,0
5238,use,1,0
5239,of,1,1
5240,illicit,1,1
5241,drugs,1,0
5242,(,0,0
5243,45,0,0
5244,%,0,0
5245,),0,0
5246,",",0,0
5247,social,1,1
5248,isolation,1,0
5249,(,0,0
5250,47,0,0
5251,%,0,0
5252,),0,0
5253,",",0,0
5254,unemployment,1,1
5255,(,0,0
5256,40,0,0
5257,%,0,0
5258,),0,0
5259,",",0,0
5260,and,0,1
5261,lack,1,0
5262,of,1,1
5263,health,1,1
5264,insurance,1,1
5265,(,0,0
5266,51,0,0
5267,%,0,0
5268,),0,0
5269,.,0,0
5270,Having,1,1
5271,health,1,1
5272,insurance,1,1
5273,(,0,0
5274,odds,0,0
5275,ratio,0,1
5276,=,0,0
5277,7.20,0,0
5278,",",0,0
5279,P,0,0
5280,=,0,0
5281,.00,0,0
5282,),0,0
5283,and,0,0
5284,a,0,0
5285,negative,1,1
5286,urine,1,1
5287,drug,1,0
5288,screen,1,1
5289,(,0,0
5290,odds,0,0
5291,ratio,0,1
5292,=,0,0
5293,.56,0,0
5294,",",0,0
5295,P,0,0
5296,=,0,0
5297,.04,0,0
5298,),0,0
5299,were,0,0
5300,significant,0,0
5301,predictors,0,0
5302,of,0,0
5303,being,0,0
5304,in,0,0
5305,HBP,0,0
5306,care,0,0
5307,.,0,0
5308,Low,1,0
5309,alcoholism,1,0
5310,risk,1,1
5311,and,1,1
5312,employment,1,1
5313,were,0,0
5314,identified,0,0
5315,as,0,0
5316,significant,0,0
5317,predictors,0,0
5318,of,0,0
5319,compliance,0,1
5320,with,0,0
5321,HBP,0,0
5322,medication-taking,0,1
5323,behavior,0,1
5324,.,0,0
5325,Men,0,0
5326,currently,0,0
5327,using,1,0
5328,illicit,1,0
5329,drugs,1,0
5330,were,0,0
5331,2.64,0,0
5332,times,0,0
5333,less,0,0
5334,likely,0,0
5335,to,0,0
5336,have,0,0
5337,controlled,1,0
5338,BP,1,1
5339,compared,0,0
5340,with,0,0
5341,their,0,0
5342,counterparts,0,0
5343,who,0,0
5344,did,0,0
5345,not,0,0
5346,use,0,0
5347,illicit,0,0
5348,drugs,0,0
5349,",",0,0
5350,and,0,1
5351,men,0,0
5352,currently,0,0
5353,taking,1,0
5354,HBP,1,0
5355,medication,1,1
5356,were,0,0
5357,63,0,0
5358,times,0,0
5359,more,0,0
5360,likely,0,0
5361,have,0,0
5362,controlled,1,0
5363,BP,1,1
5364,compared,0,0
5365,with,0,0
5366,men,0,0
5367,not,0,0
5368,taking,0,0
5369,HBP,0,0
5370,medication,0,0
5371,.,0,0
5372,Comprehensive,0,0
5373,interventions,0,0
5374,are,0,0
5375,needed,0,0
5376,to,0,0
5377,address,0,0
5378,socioeconomic,0,0
5379,and,0,0
5380,lifestyle,0,1
5381,issues,0,0
5382,as,0,0
5383,well,0,0
5384,as,0,0
5385,other,0,0
5386,barriers,0,0
5387,to,0,0
5388,care,0,0
5389,and,0,0
5390,treatment,0,0
5391,",",0,0
5392,if,0,0
5393,HBP,0,0
5394,care,0,0
5395,is,0,0
5396,to,0,0
5397,be,0,0
5398,salient,0,1
5399,and,0,0
5400,effective,0,0
5401,in,0,0
5402,this,0,0
5403,high,0,0
5404,risk,0,0
5405,group,0,0
5406,.,0,0
5407,Comparison,0,0
5408,of,0,0
5409,antiresorptive,0,0
5410,activities,0,1
5411,of,0,0
5412,ipriflavone,0,0
5413,",",0,0
5414,an,0,0
5415,isoflavone,0,0
5416,derivative,0,0
5417,",",0,1
5418,and,0,1
5419,elcatonin,0,0
5420,",",0,0
5421,an,0,0
5422,eel,0,0
5423,carbocalcitonin,0,0
5424,.,0,0
5425,Thirty,0,0
5426,postmenopausal,0,0
5427,women,0,0
5428,with,0,0
5429,reduced,0,0
5430,bone,0,1
5431,mineral,0,1
5432,density,0,1
5433,were,0,0
5434,divided,0,0
5435,randomly,0,0
5436,into,0,0
5437,two,0,0
5438,groups,0,0
5439,based,0,0
5440,on,0,0
5441,the,0,0
5442,chronological,0,0
5443,sequence,0,0
5444,of,0,0
5445,their,0,0
5446,first,0,0
5447,visit,0,1
5448,to,0,0
5449,the,0,0
5450,Osteoporosis,0,0
5451,Clinic,0,0
5452,of,0,0
5453,Katsuragi,0,0
5454,Hospital,0,1
5455,.,0,0
5456,Group,0,0
5457,I,0,0
5458,was,0,0
5459,given,0,0
5460,600,0,0
5461,mg,0,0
5462,ipriflavone,0,0
5463,orally,0,0
5464,daily,0,0
5465,and,0,0
5466,group,0,0
5467,II,0,0
5468,was,0,0
5469,weekly,0,0
5470,injected,0,0
5471,intramuscularly,0,0
5472,with,0,0
5473,20,0,0
5474,units,0,0
5475,elcatonin,0,0
5476,",",0,0
5477,Asu1-7,0,0
5478,eel,0,0
5479,calcitonin,0,1
5480,(,0,0
5481,carbocalcitonin,0,0
5482,),0,0
5483,.,0,0
5484,Lumbar,1,1
5485,spine,1,0
5486,BMD,1,1
5487,was,0,0
5488,measured,0,0
5489,by,0,0
5490,dual-energy,0,0
5491,X-ray,0,1
5492,absorptiometry,0,1
5493,",",0,0
5494,and,0,1
5495,trabecular,1,1
5496,bone,1,1
5497,mineral,1,1
5498,density,1,1
5499,at,0,0
5500,the,0,0
5501,distal,0,0
5502,radius,0,0
5503,",",0,0
5504,cortical,1,1
5505,bone,1,1
5506,density,1,1
5507,",",0,0
5508,and,0,1
5509,relative,1,1
5510,cortical,1,1
5511,volume,1,1
5512,at,0,0
5513,the,0,0
5514,radial,0,1
5515,diaphysis,0,1
5516,by,0,0
5517,peripheral,0,1
5518,computed,0,0
5519,tomography,0,0
5520,before,0,0
5521,the,0,0
5522,beginning,0,0
5523,of,0,0
5524,the,0,0
5525,study,0,0
5526,and,0,0
5527,at,0,0
5528,the,0,0
5529,4th,0,0
5530,",",0,0
5531,8th,0,0
5532,",",0,0
5533,and,0,0
5534,12th,0,0
5535,month,0,0
5536,.,0,0
5537,Markers,1,1
5538,of,1,0
5539,bone,1,1
5540,metabolism,1,0
5541,--,1,0
5542,serum,1,1
5543,total,1,1
5544,alkaline,1,1
5545,phosphatase,1,1
5546,",",1,0
5547,bone-specific,1,1
5548,alkaline,1,1
5549,phosphatase,1,1
5550,",",1,0
5551,tartrate-resistant,1,1
5552,acid,1,1
5553,phosphatase,1,1
5554,",",1,1
5555,osteocalcin,1,1
5556,",",1,1
5557,intact,1,1
5558,osteocalcin,1,1
5559,",",1,0
5560,PICP,1,1
5561,and,1,1
5562,ICTP,1,1
5563,",",1,1
5564,and,1,1
5565,urinary,1,1
5566,pyridinoline,1,1
5567,",",1,0
5568,deoxypyridinoline,1,1
5569,",",1,1
5570,and,1,1
5571,calcium/creatinine,1,1
5572,(,1,1
5573,Ca/Cr,1,0
5574,),1,0
5575,--,1,0
5576,were,1,0
5577,also,0,0
5578,measured,0,0
5579,at,0,0
5580,the,0,0
5581,same,0,0
5582,interval,0,0
5583,.,0,0
5584,Plasma,1,1
5585,parathyroid,1,1
5586,hormone,1,1
5587,(,1,0
5588,PTH,1,1
5589,),1,1
5590,and,1,1
5591,calcitonin,1,1
5592,(,1,1
5593,CT,1,1
5594,),1,0
5595,were,0,0
5596,measured,0,0
5597,at,0,0
5598,the,0,0
5599,same,0,0
5600,time,0,1
5601,.,0,0
5602,Radial,1,1
5603,trabecular,1,1
5604,bone,1,1
5605,density,1,1
5606,showed,0,0
5607,a,0,0
5608,significantly,0,0
5609,higher,0,0
5610,rate,0,1
5611,of,0,1
5612,increase,0,0
5613,in,0,0
5614,group,0,0
5615,I,0,0
5616,(,0,0
5617,ipriflavone,0,0
5618,group,0,0
5619,),0,0
5620,than,0,0
5621,in,0,0
5622,group,0,0
5623,II,0,0
5624,(,0,0
5625,elcatonin,0,0
5626,group,0,0
5627,),0,0
5628,at,0,0
5629,the,0,0
5630,4th,0,0
5631,month,0,0
5632,",",0,0
5633,whereas,0,0
5634,lumbar,1,0
5635,spine,1,0
5636,BMD,1,1
5637,showed,0,0
5638,more,0,0
5639,pronounced,0,0
5640,increase,0,0
5641,in,0,0
5642,the,0,0
5643,elcatonin,0,0
5644,group,0,0
5645,than,0,0
5646,in,0,0
5647,the,0,0
5648,ipriflavone,0,0
5649,group,0,0
5650,throughout,0,0
5651,the,0,0
5652,study,0,0
5653,period,0,0
5654,.,0,0
5655,Bone,1,0
5656,metabolism,1,1
5657,markers,1,1
5658,tended,0,0
5659,to,0,0
5660,decline,0,0
5661,in,0,0
5662,both,0,0
5663,groups,0,0
5664,.,0,0
5665,Total,1,0
5666,and,1,0
5667,intact,1,1
5668,osteocalcin,1,1
5669,showed,0,0
5670,a,0,0
5671,significant,0,0
5672,fall,0,0
5673,from,0,0
5674,the,0,0
5675,baseline,0,0
5676,throughout,0,0
5677,the,0,0
5678,study,0,0
5679,period,0,0
5680,only,0,0
5681,in,0,0
5682,the,0,0
5683,ipriflavone,0,0
5684,group,0,0
5685,.,0,0
5686,Urine,1,1
5687,pyridinoline,1,1
5688,and,1,1
5689,deoxypyridinoline,1,1
5690,showed,0,0
5691,a,0,0
5692,significant,0,0
5693,fall,0,0
5694,from,0,0
5695,the,0,0
5696,baseline,0,0
5697,at,0,0
5698,the,0,0
5699,12th,0,0
5700,month,0,0
5701,only,0,0
5702,in,0,0
5703,the,0,0
5704,ipriflavone,0,0
5705,group,0,0
5706,.,0,0
5707,On,0,0
5708,comparing,0,0
5709,bone,0,1
5710,gainers,0,0
5711,with,0,0
5712,increase,0,0
5713,of,0,0
5714,lumbar,1,0
5715,spine,1,0
5716,BMD,1,1
5717,by,0,0
5718,2,0,0
5719,%,0,0
5720,or,0,0
5721,more,0,0
5722,with,0,0
5723,bone,0,1
5724,losers,0,0
5725,with,0,0
5726,a,0,0
5727,decrease,0,0
5728,by,0,0
5729,2,0,0
5730,%,0,0
5731,or,0,0
5732,more,0,0
5733,",",0,0
5734,only,0,0
5735,urine,1,1
5736,Ca/Cr,1,0
5737,was,0,0
5738,significantly,0,0
5739,different,0,0
5740,",",0,0
5741,lower,0,0
5742,in,0,0
5743,the,0,0
5744,former,0,0
5745,than,0,0
5746,in,0,0
5747,the,0,0
5748,latter,0,0
5749,",",0,0
5750,despite,0,0
5751,the,0,0
5752,general,0,0
5753,tendency,0,0
5754,for,0,0
5755,bone,0,1
5756,resorption,0,1
5757,markers,0,1
5758,to,0,0
5759,decrease,0,0
5760,in,0,0
5761,bone,0,1
5762,gainers,0,0
5763,and,0,0
5764,to,0,0
5765,increase,0,0
5766,in,0,0
5767,bone,0,0
5768,losers,0,0
5769,.,0,0
5770,Comparison,0,0
5771,of,0,0
5772,chemotherapy,0,0
5773,with,0,0
5774,chemohormonal,0,0
5775,therapy,0,0
5776,as,0,0
5777,first-line,0,0
5778,therapy,0,0
5779,for,0,0
5780,metastatic,0,0
5781,",",0,0
5782,hormone-sensitive,0,1
5783,breast,0,0
5784,cancer,0,0
5785,:,0,0
5786,An,0,0
5787,Eastern,0,0
5788,Cooperative,0,0
5789,Oncology,0,0
5790,Group,0,0
5791,study,0,0
5792,.,0,0
5793,PURPOSE,0,0
5794,Although,0,0
5795,hormonal,0,0
5796,therapy,0,0
5797,represents,0,0
5798,standard,0,0
5799,therapy,0,0
5800,for,0,0
5801,metastatic,0,0
5802,hormone-sensitive,0,0
5803,disease,0,0
5804,",",0,0
5805,many,0,0
5806,patients,0,0
5807,receive,0,0
5808,initial,0,0
5809,chemotherapy,0,0
5810,because,0,0
5811,of,0,0
5812,the,0,0
5813,location,0,0
5814,",",0,0
5815,bulk,0,1
5816,",",0,1
5817,or,0,1
5818,aggressiveness,0,1
5819,of,0,0
5820,their,0,0
5821,disease,0,0
5822,.,0,0
5823,It,0,0
5824,is,0,0
5825,uncertain,0,0
5826,whether,0,0
5827,simultaneous,0,0
5828,hormonal,0,0
5829,therapy,0,0
5830,provides,0,0
5831,additional,0,0
5832,benefit,0,0
5833,compared,0,0
5834,with,0,0
5835,chemotherapy,0,0
5836,alone,0,0
5837,.,0,0
5838,Eastern,0,0
5839,Cooperative,0,0
5840,Oncology,0,0
5841,Group,0,0
5842,trial,0,0
5843,E3186,0,0
5844,was,0,0
5845,initiated,0,0
5846,to,0,0
5847,explore,0,0
5848,this,0,0
5849,question,0,0
5850,.,0,0
5851,PATIENTS,0,0
5852,AND,0,0
5853,METHODS,0,0
5854,Between,0,0
5855,January,0,0
5856,1988,0,0
5857,and,0,0
5858,December,0,0
5859,1992,0,0
5860,",",0,0
5861,231,0,0
5862,patients,0,0
5863,with,0,0
5864,estrogen,0,1
5865,receptor,0,1
5866,(,0,0
5867,ER,0,0
5868,),0,0
5869,-positive,0,0
5870,or,0,0
5871,ER-unknown,0,0
5872,metastatic,0,0
5873,breast,0,0
5874,cancer,0,0
5875,were,0,0
5876,randomized,0,0
5877,to,0,0
5878,receive,0,0
5879,either,0,0
5880,chemotherapy,0,0
5881,(,0,0
5882,cyclophosphamide,0,0
5883,",",0,1
5884,doxorubicin,0,0
5885,",",0,1
5886,and,0,0
5887,fluorouracil,0,0
5888,?CAF,0,0
5889,),0,0
5890,or,0,0
5891,chemohormonal,0,1
5892,therapy,0,0
5893,(,0,0
5894,CAF,0,1
5895,plus,0,0
5896,tamoxifen,0,0
5897,and,0,1
5898,Halotestin,0,1
5899,?fluoxymesterone,0,0
5900,;,0,0
5901,Pharmacia-Upjohn,0,0
5902,",",0,0
5903,Kalamazoo,0,0
5904,",",0,0
5905,MI,0,1
5906,?CAFTH,0,0
5907,),0,0
5908,as,0,0
5909,front-line,0,0
5910,therapy,0,0
5911,for,0,0
5912,metastatic,0,0
5913,breast,0,0
5914,cancer,0,0
5915,.,0,0
5916,Patients,0,0
5917,who,0,0
5918,experienced,0,0
5919,a,0,0
5920,complete,0,0
5921,response,0,1
5922,to,0,0
5923,induction,0,1
5924,therapy,0,0
5925,either,0,0
5926,received,0,0
5927,or,0,0
5928,did,0,0
5929,not,0,0
5930,receive,0,0
5931,maintenance,0,0
5932,cyclophosphamide,0,0
5933,",",0,1
5934,methotrexate,0,0
5935,",",0,1
5936,fluorouracil,0,0
5937,",",0,1
5938,prednisone,0,0
5939,",",0,1
5940,and,0,1
5941,TH,0,1
5942,as,0,0
5943,a,0,0
5944,secondary,0,0
5945,randomization,0,0
5946,.,0,0
5947,RESULTS,0,0
5948,The,0,0
5949,response,1,1
5950,rates,1,1
5951,(,1,0
5952,complete,1,1
5953,response,1,1
5954,and,1,0
5955,partial,1,1
5956,response,1,1
5957,),1,0
5958,of,1,0
5959,patients,0,0
5960,who,0,0
5961,received,0,0
5962,CAF,0,1
5963,and,0,1
5964,CAFTH,0,1
5965,were,0,0
5966,similar,0,0
5967,(,0,0
5968,69.2,0,0
5969,%,0,0
5970,v,0,0
5971,68.9,0,0
5972,%,0,0
5973,",",0,0
5974,respectively,0,0
5975,;,0,0
5976,P,0,0
5977,=.99,1,0
5978,),1,0
5979,.,1,0
5980,Time,1,0
5981,to,1,0
5982,treatment,1,0
5983,failure,1,1
5984,(,1,0
5985,TTF,1,1
5986,),1,0
5987,was,1,0
5988,slightly,0,0
5989,longer,0,0
5990,for,0,0
5991,patients,0,0
5992,who,0,0
5993,received,0,0
5994,chemohormonal,0,0
5995,therapy,0,0
5996,compared,0,0
5997,with,0,0
5998,chemotherapy,0,0
5999,alone,0,0
6000,patients,0,0
6001,(,0,0
6002,13.4,0,0
6003,months,0,0
6004,v,0,0
6005,10.3,0,0
6006,months,0,0
6007,",",0,0
6008,respectively,0,0
6009,;,0,0
6010,P,0,0
6011,=.087,0,0
6012,),0,0
6013,",",0,0
6014,and,0,1
6015,TTF,1,1
6016,was,1,0
6017,significantly,0,0
6018,longer,0,0
6019,in,0,0
6020,ER-positive,0,1
6021,compared,0,0
6022,with,0,0
6023,ER-negative,0,0
6024,patients,0,0
6025,(,0,0
6026,17.4,0,0
6027,months,0,0
6028,v,0,0
6029,10.3,0,0
6030,months,0,0
6031,",",0,0
6032,respectively,0,0
6033,;,0,0
6034,P,0,0
6035,=.048,0,0
6036,),0,0
6037,.,0,0
6038,However,0,0
6039,",",0,0
6040,ER,0,0
6041,status,0,1
6042,had,0,0
6043,no,0,0
6044,effect,0,0
6045,on,0,0
6046,overall,1,1
6047,survival,1,1
6048,(,1,0
6049,30.0,1,0
6050,months,0,0
6051,for,0,0
6052,CAF,0,0
6053,v,0,0
6054,29.3,0,0
6055,months,0,0
6056,for,0,0
6057,CAFTH,0,0
6058,),0,0
6059,.,0,0
6060,CONCLUSION,0,0
6061,In,0,0
6062,patients,0,0
6063,with,0,0
6064,potentially,0,0
6065,hormone-sensitive,0,0
6066,metastatic,0,0
6067,breast,0,0
6068,cancer,0,0
6069,",",0,0
6070,chemohormonal,0,1
6071,therapy,0,0
6072,prolongs,0,1
6073,TTF,0,1
6074,for,0,0
6075,ER-positive,0,1
6076,patients,0,0
6077,without,0,0
6078,improving,0,1
6079,overall,0,1
6080,survival,0,1
6081,.,0,0
6082,Effectiveness,0,1
6083,of,0,0
6084,manual,0,0
6085,physical,0,1
6086,therapy,0,0
6087,and,0,1
6088,exercise,0,0
6089,in,0,0
6090,osteoarthritis,0,0
6091,of,0,0
6092,the,0,0
6093,knee,0,0
6094,.,0,0
6095,A,0,0
6096,randomized,0,0
6097,",",0,0
6098,controlled,0,0
6099,trial,0,0
6100,.,0,0
6101,BACKGROUND,0,0
6102,Few,0,0
6103,investigations,0,0
6104,include,0,0
6105,both,0,0
6106,subjective,0,1
6107,and,0,0
6108,objective,0,0
6109,measurements,0,0
6110,of,0,0
6111,the,0,0
6112,effectiveness,0,1
6113,of,0,0
6114,treatments,0,0
6115,for,0,0
6116,osteoarthritis,0,0
6117,of,0,0
6118,the,0,0
6119,knee,0,0
6120,.,0,0
6121,Beneficial,0,0
6122,interventions,0,0
6123,may,0,0
6124,decrease,0,0
6125,the,0,0
6126,disability,1,0
6127,associated,0,0
6128,with,0,0
6129,osteoarthritis,0,0
6130,and,0,0
6131,the,0,0
6132,need,0,0
6133,for,0,0
6134,more,0,0
6135,invasive,0,0
6136,treatments,0,0
6137,.,0,0
6138,OBJECTIVE,0,0
6139,To,0,0
6140,evaluate,0,0
6141,the,0,0
6142,effectiveness,0,0
6143,of,0,0
6144,physical,0,1
6145,therapy,0,0
6146,for,0,0
6147,osteoarthritis,0,0
6148,of,0,0
6149,the,0,0
6150,knee,0,1
6151,",",0,0
6152,applied,0,0
6153,by,0,0
6154,experienced,0,0
6155,physical,0,1
6156,therapists,0,0
6157,with,0,0
6158,formal,0,0
6159,training,0,0
6160,in,0,0
6161,manual,0,0
6162,therapy,0,0
6163,.,0,0
6164,DESIGN,0,0
6165,Randomized,0,0
6166,",",0,0
6167,controlled,0,0
6168,clinical,0,0
6169,trial,0,0
6170,.,0,0
6171,SETTING,0,0
6172,Outpatient,0,0
6173,physical,0,1
6174,therapy,0,0
6175,department,0,0
6176,of,0,0
6177,a,0,0
6178,large,0,0
6179,military,0,0
6180,medical,0,0
6181,center,0,0
6182,.,0,0
6183,PATIENTS,0,0
6184,83,0,0
6185,patients,0,0
6186,with,0,0
6187,osteoarthritis,0,0
6188,of,0,0
6189,the,0,0
6190,knee,0,1
6191,who,0,0
6192,were,0,0
6193,randomly,0,0
6194,assigned,0,0
6195,to,0,0
6196,receive,0,0
6197,treatment,0,0
6198,(,0,0
6199,n,0,0
6200,=,0,0
6201,42,0,0
6202,;,0,0
6203,15,0,0
6204,men,0,0
6205,and,0,0
6206,27,0,0
6207,women,0,0
6208,[,0,0
6209,mean,0,1
6210,age,0,0
6211,",",0,0
6212,60,0,0
6213,+/-,0,0
6214,11,0,0
6215,years,0,0
6216,],0,0
6217,),0,0
6218,or,0,0
6219,placebo,0,0
6220,(,0,0
6221,n,0,0
6222,=,0,0
6223,41,0,0
6224,;,0,0
6225,19,0,0
6226,men,0,0
6227,and,0,0
6228,22,0,0
6229,women,0,0
6230,[,0,0
6231,mean,0,1
6232,age,0,0
6233,",",0,0
6234,62,0,0
6235,+/-,0,0
6236,10,0,0
6237,years,0,0
6238,],0,0
6239,),0,0
6240,.,0,0
6241,INTERVENTION,0,0
6242,The,0,0
6243,treatment,0,0
6244,group,0,0
6245,received,0,0
6246,manual,0,1
6247,therapy,0,0
6248,",",0,0
6249,applied,0,0
6250,to,0,0
6251,the,0,0
6252,knee,0,0
6253,as,0,0
6254,well,0,0
6255,as,0,0
6256,to,0,0
6257,the,0,0
6258,lumbar,0,0
6259,spine,0,0
6260,",",0,1
6261,hip,0,1
6262,",",0,1
6263,and,0,0
6264,ankle,0,1
6265,as,0,0
6266,required,0,0
6267,",",0,0
6268,and,0,0
6269,performed,0,0
6270,a,0,0
6271,standardized,0,0
6272,knee,0,1
6273,exercise,0,0
6274,program,0,0
6275,in,0,0
6276,the,0,0
6277,clinic,0,0
6278,and,0,0
6279,at,0,0
6280,home,0,0
6281,.,0,0
6282,The,0,0
6283,placebo,0,0
6284,group,0,0
6285,had,0,0
6286,subtherapeutic,0,0
6287,ultrasound,0,1
6288,to,0,0
6289,the,0,0
6290,knee,0,0
6291,at,0,0
6292,an,0,0
6293,intensity,0,0
6294,of,0,0
6295,0.1,0,0
6296,W/cm2,0,0
6297,with,0,0
6298,a,0,0
6299,10,0,0
6300,%,0,0
6301,pulsed,0,0
6302,mode,0,0
6303,.,0,0
6304,Both,0,0
6305,groups,0,0
6306,were,0,0
6307,treated,0,0
6308,at,0,0
6309,the,0,0
6310,clinic,0,0
6311,twice,0,0
6312,weekly,0,0
6313,for,0,0
6314,4,0,0
6315,weeks,0,0
6316,.,0,0
6317,MEASUREMENTS,0,0
6318,Distance,1,1
6319,walked,1,0
6320,in,1,0
6321,6,1,0
6322,minutes,1,0
6323,and,1,0
6324,sum,1,1
6325,of,1,0
6326,the,1,0
6327,function,1,1
6328,",",1,0
6329,pain,1,1
6330,",",1,1
6331,and,1,1
6332,stiffness,1,1
6333,subscores,1,1
6334,of,1,0
6335,the,1,0
6336,Western,1,0
6337,Ontario,1,0
6338,and,1,0
6339,McMaster,1,1
6340,Universities,1,0
6341,Osteoarthritis,1,0
6342,Index,1,0
6343,(,1,0
6344,WOMAC,1,0
6345,),1,0
6346,.,1,0
6347,A,0,0
6348,tester,0,0
6349,who,0,0
6350,was,0,0
6351,blinded,0,0
6352,to,0,0
6353,group,0,0
6354,assignment,0,0
6355,made,0,0
6356,group,0,0
6357,comparisons,0,0
6358,at,0,0
6359,the,0,0
6360,initial,0,0
6361,visit,0,1
6362,(,0,0
6363,before,0,0
6364,initiation,0,0
6365,of,0,0
6366,treatment,0,0
6367,),0,0
6368,",",0,0
6369,4,0,0
6370,weeks,0,0
6371,",",0,0
6372,8,0,0
6373,weeks,0,0
6374,",",0,0
6375,and,0,0
6376,1,0,0
6377,year,0,0
6378,.,0,0
6379,RESULTS,0,0
6380,Clinically,0,1
6381,and,0,0
6382,statistically,0,0
6383,significant,0,0
6384,improvements,0,1
6385,in,0,0
6386,6-minute,1,1
6387,walk,1,1
6388,distance,1,1
6389,and,1,1
6390,WOMAC,1,1
6391,score,1,1
6392,at,0,0
6393,4,0,0
6394,weeks,0,0
6395,and,0,0
6396,8,0,0
6397,weeks,0,0
6398,were,0,0
6399,seen,0,0
6400,in,0,0
6401,the,0,0
6402,treatment,0,0
6403,group,0,0
6404,but,0,0
6405,not,0,0
6406,the,0,0
6407,placebo,0,0
6408,group,0,0
6409,.,0,0
6410,By,0,0
6411,8,0,0
6412,weeks,0,0
6413,",",0,0
6414,average,0,1
6415,6-minute,1,1
6416,walk,1,1
6417,distances,1,1
6418,had,0,0
6419,improved,0,0
6420,by,0,0
6421,13.1,0,0
6422,%,0,0
6423,and,0,0
6424,WOMAC,1,1
6425,scores,1,1
6426,had,0,0
6427,improved,0,0
6428,by,0,0
6429,55.8,0,0
6430,%,0,0
6431,over,0,0
6432,baseline,0,0
6433,values,0,1
6434,in,0,0
6435,the,0,0
6436,treatment,0,0
6437,group,0,0
6438,(,0,0
6439,P,0,0
6440,<,0,0
6441,0.05,0,0
6442,),0,0
6443,.,0,0
6444,After,0,0
6445,controlling,0,0
6446,for,0,0
6447,potential,0,0
6448,confounding,0,0
6449,variables,0,0
6450,",",0,0
6451,the,0,0
6452,average,0,1
6453,distance,1,1
6454,walked,1,0
6455,in,1,0
6456,6,1,0
6457,minutes,1,0
6458,at,0,0
6459,8,0,0
6460,weeks,0,0
6461,among,0,0
6462,patients,0,0
6463,in,0,0
6464,the,0,0
6465,treatment,0,0
6466,group,0,0
6467,was,0,0
6468,170,0,0
6469,m,0,0
6470,(,0,0
6471,95,0,0
6472,%,0,0
6473,CI,0,0
6474,",",0,0
6475,71,0,0
6476,to,0,0
6477,270,0,0
6478,m,0,0
6479,),0,0
6480,more,0,0
6481,than,0,0
6482,that,0,0
6483,in,0,0
6484,the,0,0
6485,placebo,0,0
6486,group,0,0
6487,and,0,0
6488,the,0,0
6489,average,0,1
6490,WOMAC,1,0
6491,scores,1,1
6492,were,0,0
6493,599,0,0
6494,mm,0,0
6495,higher,0,0
6496,(,0,0
6497,95,0,0
6498,%,0,0
6499,CI,0,0
6500,",",0,0
6501,197,0,0
6502,to,0,0
6503,1002,0,0
6504,mm,0,0
6505,),0,0
6506,.,0,0
6507,At,0,0
6508,1,0,0
6509,year,0,0
6510,",",0,0
6511,patients,0,0
6512,in,0,0
6513,the,0,0
6514,treatment,0,0
6515,group,0,0
6516,had,0,0
6517,clinically,0,0
6518,and,0,0
6519,statistically,0,0
6520,significant,0,0
6521,gains,0,1
6522,over,0,0
6523,baseline,1,0
6524,WOMAC,1,1
6525,scores,1,1
6526,and,1,0
6527,walking,1,1
6528,distance,1,1
6529,;,1,0
6530,20,0,0
6531,%,0,0
6532,of,0,0
6533,patients,0,0
6534,in,0,0
6535,the,0,0
6536,placebo,0,0
6537,group,0,0
6538,and,0,0
6539,5,0,0
6540,%,0,0
6541,of,0,0
6542,patients,0,0
6543,in,0,0
6544,the,0,0
6545,treatment,0,0
6546,group,0,0
6547,had,0,0
6548,undergone,0,0
6549,knee,1,1
6550,arthroplasty,1,0
6551,.,1,0
6552,CONCLUSIONS,0,0
6553,A,0,0
6554,combination,0,0
6555,of,0,0
6556,manual,0,0
6557,physical,0,1
6558,therapy,0,0
6559,and,0,1
6560,supervised,0,0
6561,exercise,0,0
6562,yields,0,1
6563,functional,1,0
6564,benefits,1,0
6565,for,0,0
6566,patients,0,0
6567,with,0,0
6568,osteoarthritis,0,0
6569,of,0,0
6570,the,0,0
6571,knee,0,0
6572,and,0,0
6573,may,0,0
6574,delay,0,1
6575,or,0,0
6576,prevent,0,0
6577,the,0,0
6578,need,0,0
6579,for,0,0
6580,surgical,1,0
6581,intervention,1,0
6582,.,1,0
6583,Effect,0,0
6584,of,0,0
6585,topical,0,0
6586,rh-TGF-beta,0,0
6587,1,0,0
6588,on,0,0
6589,second,1,0
6590,intention,1,1
6591,wound,1,0
6592,healing,1,1
6593,in,0,0
6594,horses,0,0
6595,.,0,0
6596,OBJECTIVE,0,0
6597,To,0,0
6598,investigate,0,0
6599,the,0,0
6600,effects,0,0
6601,on,0,0
6602,wound,0,0
6603,healing,0,1
6604,of,0,0
6605,transforming,0,0
6606,growth,0,0
6607,factor-beta,0,0
6608,1,0,0
6609,as,0,0
6610,a,0,0
6611,topical,0,0
6612,treatment,0,0
6613,to,0,0
6614,full-thickness,0,1
6615,",",0,0
6616,excisional,0,0
6617,wounds,0,1
6618,of,0,0
6619,the,0,0
6620,distal,0,0
6621,limb,0,1
6622,of,0,0
6623,horses,0,0
6624,.,0,0
6625,DESIGN,0,0
6626,A,0,0
6627,randomised,0,0
6628,block,0,0
6629,study,0,0
6630,using,0,0
6631,four,0,0
6632,horses,0,0
6633,",",0,0
6634,each,0,0
6635,with,0,0
6636,wounds,0,0
6637,assigned,0,0
6638,to,0,0
6639,four,0,0
6640,treatment,0,0
6641,groups,0,0
6642,.,0,0
6643,ANIMALS,0,0
6644,Four,0,0
6645,adult,0,0
6646,Standardbred,0,0
6647,geldings,0,0
6648,.,0,0
6649,PROCEDURE,0,0
6650,Four,0,1
6651,",",0,0
6652,4,0,0
6653,cm2,0,0
6654,",",0,0
6655,full-thickness,0,1
6656,wounds,0,1
6657,were,0,0
6658,created,0,0
6659,on,0,0
6660,the,0,0
6661,dorsomedial,0,0
6662,and,0,0
6663,dorsolateral,0,1
6664,aspect,0,1
6665,of,0,0
6666,the,0,0
6667,metacarpus,0,0
6668,or,0,0
6669,metatarsus,0,1
6670,of,0,0
6671,each,0,0
6672,limb,0,0
6673,of,0,0
6674,four,0,0
6675,horses,0,0
6676,",",0,0
6677,giving,0,0
6678,a,0,0
6679,total,0,0
6680,of,0,0
6681,64,0,0
6682,wounds,0,0
6683,.,0,0
6684,For,0,0
6685,each,0,0
6686,limb,0,1
6687,",",0,0
6688,wounds,0,1
6689,were,0,0
6690,randomly,0,0
6691,assigned,0,0
6692,to,0,0
6693,four,0,0
6694,treatment,0,0
6695,groups,0,0
6696,:,0,0
6697,no,0,0
6698,treatment,0,0
6699,(,0,0
6700,control,0,0
6701,),0,1
6702,",",0,0
6703,carrier,0,1
6704,(,0,0
6705,Methyl,0,0
6706,Cellulose,0,0
6707,gel,0,0
6708,),0,0
6709,",",0,0
6710,50,0,0
6711,ng/wound,0,0
6712,rhTGF-beta,0,0
6713,1,0,0
6714,in,0,0
6715,carrier,0,0
6716,",",0,0
6717,and,0,0
6718,500,0,0
6719,ng/wound,0,0
6720,rhTGF-beta,0,0
6721,1,0,0
6722,in,0,0
6723,carrier,0,0
6724,.,0,0
6725,Wounds,0,0
6726,were,0,0
6727,treated,0,0
6728,on,0,0
6729,day,0,0
6730,0,0,0
6731,and,0,0
6732,day,0,0
6733,8,0,0
6734,.,0,0
6735,Effects,0,0
6736,of,0,0
6737,treatment,0,0
6738,were,0,0
6739,evaluated,0,0
6740,on,0,0
6741,the,0,0
6742,basis,0,0
6743,of,0,0
6744,the,0,0
6745,presence,1,0
6746,of,1,0
6747,exuberant,1,0
6748,granulation,1,1
6749,tissue,1,1
6750,requiring,1,0
6751,excision,1,0
6752,",",1,0
6753,number,1,1
6754,of,1,1
6755,times,1,1
6756,excision,1,0
6757,was,1,0
6758,required,1,0
6759,",",1,0
6760,total,1,1
6761,wound,1,1
6762,area,1,1
6763,",",1,0
6764,area,1,1
6765,of,1,1
6766,epithelialisation,1,1
6767,",",1,0
6768,area,1,1
6769,of,1,1
6770,granulation,1,1
6771,",",1,0
6772,and,1,1
6773,histological,1,1
6774,evaluation,1,0
6775,of,1,0
6776,biopsy,1,0
6777,samples,1,0
6778,of,1,0
6779,wounds,1,1
6780,on,0,0
6781,day,0,0
6782,8,0,0
6783,and,0,0
6784,excised,0,0
6785,wounds,0,1
6786,on,0,0
6787,day,0,0
6788,21,0,0
6789,.,0,0
6790,RESULTS,0,0
6791,Topical,0,1
6792,application,0,0
6793,of,0,0
6794,TGF-beta,0,0
6795,1,0,0
6796,at,0,0
6797,the,0,0
6798,two,0,0
6799,concentrations,0,1
6800,studied,0,0
6801,had,0,0
6802,no,0,0
6803,significant,0,0
6804,effect,0,0
6805,on,0,0
6806,the,0,0
6807,total,1,1
6808,area,1,1
6809,of,1,0
6810,wounds,1,1
6811,(,0,0
6812,P,0,0
6813,=,0,0
6814,0.7,0,0
6815,),0,0
6816,",",0,0
6817,the,1,0
6818,area,1,1
6819,of,1,0
6820,granulation,1,1
6821,tissue,1,1
6822,(,0,0
6823,P,0,0
6824,=,0,0
6825,0.78,0,0
6826,),0,0
6827,",",0,0
6828,the,1,0
6829,area,1,1
6830,of,1,0
6831,epithelialisation,1,1
6832,(,0,0
6833,P,0,0
6834,=,0,0
6835,0.92,0,0
6836,),0,0
6837,",",0,0
6838,histological,0,1
6839,assessment,0,1
6840,or,0,0
6841,subjective,1,1
6842,clinical,1,0
6843,assessment,1,0
6844,of,1,0
6845,wounds,1,1
6846,.,1,0
6847,CONCLUSION,0,0
6848,TGF-beta,0,0
6849,1,0,0
6850,had,0,0
6851,no,0,0
6852,beneficial,0,0
6853,effects,0,0
6854,on,0,0
6855,wound,1,0
6856,healing,1,1
6857,.,1,0
6858,Additional,0,0
6859,trials,0,0
6860,are,0,0
6861,needed,0,0
6862,to,0,0
6863,test,0,0
6864,if,0,0
6865,it,0,0
6866,has,0,0
6867,value,0,0
6868,for,0,0
6869,wound,0,1
6870,treatment,0,0
6871,in,0,0
6872,horses,0,0
6873,.,0,0
6874,Comparison,0,0
6875,of,0,0
6876,0.25,0,0
6877,%,0,0
6878,S,0,0
6879,(,0,0
6880,-,0,0
6881,),0,0
6882,-bupivacaine,0,0
6883,with,0,0
6884,0.25,0,0
6885,%,0,0
6886,RS-bupivacaine,0,0
6887,for,0,0
6888,epidural,0,0
6889,analgesia,1,1
6890,in,0,0
6891,labour,0,0
6892,.,0,0
6893,We,0,0
6894,have,0,0
6895,compared,0,0
6896,the,0,0
6897,efficacy,0,0
6898,of,0,0
6899,0.25,0,0
6900,%,0,0
6901,S,0,0
6902,(,0,0
6903,-,0,0
6904,),0,0
6905,-bupivacaine,0,0
6906,with,0,0
6907,0.25,0,0
6908,%,0,0
6909,RS-bupivacaine,0,0
6910,in,0,0
6911,providing,0,0
6912,epidural,1,0
6913,analgesia,1,1
6914,for,0,0
6915,labour,0,0
6916,in,0,0
6917,a,0,0
6918,randomized,0,0
6919,",",0,0
6920,multicentre,0,0
6921,",",0,0
6922,double-blind,0,0
6923,study,0,0
6924,.,0,0
6925,Analgesia,0,1
6926,was,0,0
6927,initiated,0,0
6928,with,0,0
6929,10,0,0
6930,ml,0,0
6931,of,0,0
6932,the,0,0
6933,study,0,0
6934,solution,0,0
6935,and,0,0
6936,maintained,0,0
6937,with,0,0
6938,10-ml,0,0
6939,top-ups,0,0
6940,.,0,0
6941,We,0,0
6942,studied,0,0
6943,137,0,0
6944,women,0,0
6945,and,0,0
6946,treatments,0,0
6947,were,0,0
6948,found,0,0
6949,to,0,0
6950,be,0,0
6951,equivalent,0,0
6952,for,0,0
6953,onset,0,1
6954,",",0,0
6955,duration,0,1
6956,and,0,1
6957,quality,0,1
6958,of,0,0
6959,block,0,0
6960,.,0,0
6961,Median,1,1
6962,onset,1,1
6963,of,1,0
6964,pain,1,1
6965,relief,1,1
6966,was,0,0
6967,12,0,0
6968,min,0,0
6969,for,0,0
6970,both,0,0
6971,drugs,0,0
6972,and,0,0
6973,median,0,1
6974,duration,0,1
6975,was,0,0
6976,49,0,0
6977,(,0,0
6978,range,0,0
6979,3-129,0,0
6980,),0,0
6981,min,0,0
6982,and,0,0
6983,51,0,0
6984,(,0,0
6985,7-157,0,0
6986,),0,0
6987,min,0,0
6988,for,0,0
6989,S,0,0
6990,(,0,0
6991,-,0,0
6992,),0,0
6993,-bupivacaine,0,0
6994,and,0,1
6995,RS,0,1
6996,bupivacaine,0,0
6997,",",0,0
6998,respectively,0,0
6999,.,0,0
7000,The,0,0
7001,estimated,0,0
7002,treatment,0,0
7003,difference,0,0
7004,for,0,0
7005,duration,1,1
7006,of,1,0
7007,pain,1,1
7008,relief,1,1
7009,was,0,0
7010,-4,0,0
7011,(,0,0
7012,90,0,0
7013,%,0,0
7014,CI,0,0
7015,-13,0,0
7016,",",0,0
7017,6,0,0
7018,),0,0
7019,min,0,0
7020,.,0,0
7021,Thirty,0,0
7022,patients,0,0
7023,failed,0,0
7024,to,0,0
7025,achieve,1,0
7026,pain,1,1
7027,relief,1,1
7028,after,0,0
7029,the,0,0
7030,first,0,0
7031,injection,0,0
7032,(,0,0
7033,20,0,0
7034,patients,0,0
7035,after,0,0
7036,S,0,0
7037,(,0,0
7038,-,0,0
7039,),0,0
7040,-bupivacaine,0,0
7041,and,0,0
7042,10,0,0
7043,after,0,0
7044,RS-bupivacaine,0,0
7045,;,0,0
7046,P,0,0
7047,=,0,0
7048,0.039,0,0
7049,),0,0
7050,.,0,0
7051,However,0,0
7052,",",0,0
7053,median,1,1
7054,duration,1,1
7055,of,1,0
7056,pain,1,1
7057,relief,1,1
7058,from,0,0
7059,the,0,0
7060,first,0,0
7061,top-up,0,0
7062,was,0,0
7063,82,0,0
7064,(,0,0
7065,range,0,0
7066,3-164,0,0
7067,),0,0
7068,min,0,0
7069,for,0,0
7070,S,0,0
7071,(,0,0
7072,-,0,0
7073,),0,0
7074,-bupivacaine,0,0
7075,and,0,0
7076,76,0,0
7077,(,0,0
7078,22-221,0,0
7079,),0,0
7080,min,0,0
7081,for,0,0
7082,RS-bupivacaine,0,0
7083,.,0,0
7084,There,0,0
7085,were,0,0
7086,no,0,0
7087,significant,0,0
7088,differences,0,0
7089,in,0,0
7090,the,0,0
7091,quality,1,1
7092,of,1,0
7093,analgesia,1,1
7094,",",0,0
7095,as,0,0
7096,assessed,0,0
7097,by,0,0
7098,the,0,0
7099,investigators,0,0
7100,.,0,0
7101,There,0,0
7102,were,0,0
7103,no,0,0
7104,significant,0,0
7105,differences,0,0
7106,in,0,0
7107,the,0,0
7108,extent,0,0
7109,of,0,0
7110,sensory,1,1
7111,block,1,0
7112,",",1,0
7113,percentage,1,1
7114,of,1,0
7115,patients,1,0
7116,with,1,0
7117,motor,1,1
7118,block,1,0
7119,or,1,0
7120,incidence,1,1
7121,of,1,1
7122,adverse,1,1
7123,events,1,1
7124,.,1,0
7125,Growth,1,1
7126,hormone,1,1
7127,(,1,0
7128,GH,1,0
7129,),1,0
7130,responses,1,1
7131,to,0,0
7132,GH-releasing,0,0
7133,hormone,0,1
7134,alone,0,0
7135,or,0,0
7136,combined,0,0
7137,with,0,0
7138,arginine,0,0
7139,in,0,0
7140,patients,0,0
7141,with,0,0
7142,adrenal,0,0
7143,incidentaloma,0,0
7144,:,0,0
7145,evidence,0,0
7146,for,0,0
7147,enhanced,0,0
7148,somatostatinergic,0,1
7149,tone,0,1
7150,.,0,0
7151,Spontaneous,0,1
7152,and,0,0
7153,stimulated,0,1
7154,GH,0,0
7155,secretion,0,1
7156,is,0,0
7157,blunted,0,0
7158,in,0,0
7159,hypercortisolemic,0,0
7160,states,0,0
7161,due,0,0
7162,to,0,0
7163,increased,0,0
7164,hypothalamic,0,1
7165,somatostatinergic,0,1
7166,tone,0,1
7167,.,0,0
7168,However,0,0
7169,",",0,0
7170,no,0,0
7171,data,0,0
7172,are,0,0
7173,available,0,0
7174,on,0,0
7175,the,0,0
7176,characteristics,0,0
7177,of,0,0
7178,GH,0,0
7179,secretion,0,1
7180,in,0,0
7181,patients,0,0
7182,with,0,0
7183,incidentally,0,0
7184,discovered,0,0
7185,adrenal,0,0
7186,adenomas,0,0
7187,.,0,0
7188,They,0,0
7189,represent,0,0
7190,an,0,0
7191,interesting,0,0
7192,model,0,0
7193,for,0,0
7194,studying,0,0
7195,GH,0,0
7196,secretion,0,1
7197,",",0,0
7198,as,0,0
7199,a,0,0
7200,slight,0,1
7201,degree,0,1
7202,of,0,0
7203,cortisol,0,1
7204,excess,0,0
7205,may,0,0
7206,frequently,0,0
7207,be,0,0
7208,observed,0,0
7209,in,0,0
7210,such,0,0
7211,patients,0,0
7212,who,0,0
7213,do,0,0
7214,not,0,0
7215,present,0,0
7216,with,0,0
7217,any,0,0
7218,clear,0,0
7219,Cushingoid,0,1
7220,sign,0,1
7221,.,0,0
7222,In,0,0
7223,the,0,0
7224,present,0,0
7225,study,0,0
7226,",",0,0
7227,10,0,0
7228,patients,0,0
7229,(,0,0
7230,3,0,0
7231,men,0,0
7232,and,0,0
7233,7,0,0
7234,women,0,0
7235,",",0,0
7236,aged,0,0
7237,48-63,0,0
7238,yr,0,0
7239,),0,0
7240,with,0,0
7241,an,0,0
7242,adrenal,0,1
7243,mass,0,1
7244,discovered,0,0
7245,serendipitously,0,0
7246,underwent,0,0
7247,",",0,0
7248,on,0,0
7249,separate,0,0
7250,occasions,0,0
7251,",",0,0
7252,a,0,0
7253,GHRH,0,0
7254,injection,0,0
7255,alone,0,0
7256,or,0,0
7257,combined,0,0
7258,with,0,0
7259,an,0,0
7260,infusion,0,0
7261,of,0,0
7262,the,0,0
7263,functional,0,0
7264,somatostatin,0,1
7265,antagonist,0,0
7266,",",0,0
7267,arginine,0,0
7268,.,0,0
7269,Thirteen,0,0
7270,age-matched,0,0
7271,healthy,0,0
7272,volunteers,0,0
7273,served,0,0
7274,as,0,0
7275,controls,0,0
7276,.,0,0
7277,Briefly,0,0
7278,",",0,0
7279,arginine,0,0
7280,(,0,0
7281,30,0,0
7282,g,0,0
7283,),0,0
7284,was,0,0
7285,infused,0,0
7286,from,0,0
7287,-30,0,0
7288,to,0,0
7289,0,0,0
7290,min,0,0
7291,",",0,0
7292,and,0,1
7293,GHRH,0,1
7294,(,0,0
7295,100,0,0
7296,microg,0,0
7297,),0,0
7298,was,0,0
7299,injected,0,0
7300,as,0,0
7301,a,0,0
7302,bolus,0,0
7303,at,0,0
7304,0,0,0
7305,min,0,0
7306,",",0,0
7307,with,0,0
7308,measurement,0,1
7309,of,0,0
7310,serum,0,1
7311,GH,0,0
7312,[,0,0
7313,immunoradiometric,0,1
7314,assay,0,0
7315,(,0,0
7316,IRMA,0,0
7317,),0,0
7318,],0,0
7319,every,0,0
7320,15,0,0
7321,min,0,0
7322,for,0,0
7323,150,0,0
7324,min,0,0
7325,.,0,0
7326,Plasma,0,1
7327,IGF-I,0,1
7328,(,0,0
7329,RIA,0,0
7330,after,0,0
7331,acid-ethanol,0,0
7332,extraction,0,0
7333,),0,0
7334,was,0,0
7335,measured,0,0
7336,in,0,0
7337,a,0,0
7338,morning,0,0
7339,sample,0,0
7340,.,0,0
7341,The,0,0
7342,diagnosis,0,0
7343,of,0,0
7344,cortical,0,1
7345,adenoma,0,1
7346,was,0,0
7347,based,0,0
7348,on,0,0
7349,computed,0,0
7350,tomography,0,0
7351,features,0,0
7352,and,0,1
7353,pattern,0,0
7354,of,0,1
7355,uptake,0,1
7356,on,0,0
7357,adrenal,0,0
7358,scintigraphy,0,0
7359,.,0,0
7360,Patients,0,0
7361,with,0,0
7362,obesity,0,1
7363,and/or,0,0
7364,diabetes,0,0
7365,were,0,0
7366,excluded,0,0
7367,.,0,0
7368,The,0,0
7369,study,0,0
7370,design,0,0
7371,included,0,0
7372,also,0,0
7373,an,0,0
7374,endocrine,0,0
7375,work-up,0,0
7376,aimed,0,0
7377,to,0,0
7378,study,0,0
7379,the,0,0
7380,hypothalamic-pituitary-adrenal,1,1
7381,axis,1,0
7382,[,1,0
7383,urinary,1,1
7384,free,1,1
7385,cortisol,1,1
7386,(,1,0
7387,UFC,1,1
7388,),1,1
7389,excretion,1,1
7390,",",1,0
7391,serum,1,1
7392,cortisol,1,1
7393,at,1,0
7394,0800,1,0
7395,h,1,0
7396,",",1,0
7397,plasma,1,1
7398,ACTH,1,0
7399,at,1,0
7400,0800,1,0
7401,h,1,0
7402,",",1,0
7403,morning,1,1
7404,cortisol,1,1
7405,after,1,0
7406,overnight,1,0
7407,1,1,0
7408,mg,1,0
7409,dexamethasone,1,0
7410,],1,0
7411,.,1,0
7412,Five,0,0
7413,of,0,0
7414,10,0,0
7415,patients,0,0
7416,showed,0,0
7417,abnormalities,1,0
7418,of,1,0
7419,the,1,0
7420,hypothalamic-pituitary-adrenal,1,1
7421,axis,1,0
7422,",",0,0
7423,including,0,0
7424,borderline,1,1
7425,or,1,0
7426,increased,1,0
7427,UFC,1,0
7428,excretion,1,1
7429,in,0,0
7430,4,0,0
7431,of,0,0
7432,them,0,0
7433,accompanied,0,0
7434,by,0,0
7435,blunted,0,0
7436,ACTH,0,0
7437,in,0,0
7438,2,0,0
7439,cases,0,0
7440,and,0,0
7441,failure,0,1
7442,of,0,0
7443,cortisol,0,1
7444,to,0,0
7445,suppress,0,0
7446,after,0,0
7447,dexamethasone,0,0
7448,in,0,0
7449,1,0,0
7450,;,0,0
7451,the,0,0
7452,fifth,0,0
7453,patient,0,0
7454,displayed,0,0
7455,low,0,0
7456,ACTH,0,1
7457,and,0,0
7458,resistance,0,1
7459,to,0,0
7460,dexamethasone,0,0
7461,suppression,0,1
7462,.,0,0
7463,However,0,0
7464,",",0,0
7465,all,0,0
7466,patients,0,0
7467,had,0,0
7468,a,0,0
7469,unilateral,0,0
7470,uptake,0,1
7471,of,0,0
7472,the,0,0
7473,tracer,0,0
7474,on,0,0
7475,the,0,0
7476,side,0,0
7477,of,0,0
7478,the,0,0
7479,mass,0,1
7480,with,0,0
7481,suppression,0,1
7482,of,0,0
7483,the,0,0
7484,contralateral,0,0
7485,normal,0,0
7486,adrenal,0,0
7487,gland,0,0
7488,.,0,0
7489,As,0,0
7490,a,0,0
7491,group,0,0
7492,",",0,0
7493,the,0,0
7494,patients,0,0
7495,displayed,0,0
7496,greater,0,0
7497,UFC,1,1
7498,excretion,1,1
7499,and,1,0
7500,lower,1,0
7501,ACTH,1,1
7502,concentrations,1,1
7503,than,0,0
7504,the,0,0
7505,controls,0,0
7506,.,0,0
7507,GH,1,0
7508,release,1,1
7509,after,1,0
7510,GHRH,1,0
7511,treatment,1,0
7512,was,0,0
7513,blunted,0,0
7514,in,0,0
7515,patients,0,0
7516,bearing,0,0
7517,adrenal,0,1
7518,incidentaloma,0,0
7519,compared,0,0
7520,with,0,0
7521,controls,0,0
7522,(,0,0
7523,GH,0,1
7524,peak,0,1
7525,",",0,0
7526,5.7,0,0
7527,+/-,0,0
7528,5.2,0,0
7529,vs.,0,0
7530,18.0,0,0
7531,+/-,0,0
7532,7.0,0,0
7533,microg/L,0,0
7534,;,0,0
7535,P,0,0
7536,<,0,0
7537,0.0001,0,0
7538,),0,0
7539,",",0,0
7540,whereas,0,0
7541,GHRH,0,1
7542,plus,0,0
7543,arginine,0,0
7544,was,0,0
7545,able,0,0
7546,to,0,0
7547,elicit,0,0
7548,a,0,0
7549,comparable,0,0
7550,response,0,1
7551,in,0,0
7552,the,0,0
7553,2,0,0
7554,groups,0,0
7555,(,0,0
7556,GH,0,1
7557,peak,0,1
7558,",",0,0
7559,33.5,0,0
7560,+/-,0,0
7561,20.3,0,0
7562,vs.,0,0
7563,33.7,0,0
7564,+/-,0,0
7565,17.5,0,0
7566,microg/L,0,0
7567,;,0,0
7568,P,0,0
7569,=,0,0
7570,NS,0,1
7571,),0,0
7572,.,0,0
7573,The,0,0
7574,ratio,0,1
7575,between,0,0
7576,GH,1,0
7577,peaks,1,1
7578,after,1,0
7579,GHRH,1,0
7580,plus,1,0
7581,arginine,1,1
7582,and,1,1
7583,after,1,0
7584,GHRH,1,1
7585,plus,1,0
7586,saline,1,0
7587,was,0,0
7588,significantly,0,0
7589,greater,0,0
7590,in,0,0
7591,patients,0,0
7592,than,0,0
7593,in,0,0
7594,controls,0,0
7595,(,0,0
7596,751,0,0
7597,+/-,0,0
7598,531,0,0
7599,%,0,0
7600,vs.,0,0
7601,81,0,0
7602,+/-,0,0
7603,45,0,0
7604,%,0,0
7605,;,0,0
7606,P,0,0
7607,=,0,0
7608,0.0001,0,0
7609,),0,0
7610,.,0,0
7611,Similar,0,0
7612,data,0,0
7613,were,0,0
7614,obtained,0,0
7615,when,0,0
7616,comparing,0,0
7617,GH,0,0
7618,area,0,1
7619,under,0,0
7620,the,0,0
7621,curve,0,1
7622,after,0,0
7623,GHRH,0,0
7624,plus,0,0
7625,saline,0,0
7626,or,0,1
7627,GHRH,0,1
7628,plus,0,0
7629,arginine,0,0
7630,between,0,0
7631,the,0,0
7632,2,0,0
7633,groups,0,0
7634,.,0,0
7635,In,0,0
7636,summary,0,0
7637,",",0,0
7638,the,0,0
7639,present,0,0
7640,data,0,0
7641,suggest,0,0
7642,that,0,0
7643,in,0,0
7644,patients,0,0
7645,with,0,0
7646,incidental,0,0
7647,adrenal,0,0
7648,adenomas,0,0
7649,the,0,0
7650,GH,1,0
7651,response,1,1
7652,to,0,0
7653,GHRH,0,0
7654,is,0,0
7655,blunted,0,0
7656,due,0,0
7657,to,0,0
7658,increased,0,0
7659,somatostatinergic,1,1
7660,tone,1,1
7661,",",0,0
7662,as,0,0
7663,it,0,0
7664,can,0,0
7665,be,0,0
7666,restored,0,0
7667,to,0,0
7668,normal,0,0
7669,by,0,0
7670,pretreatment,0,0
7671,with,0,0
7672,the,0,0
7673,functional,0,0
7674,somatostatin,0,1
7675,antagonist,0,0
7676,arginine,0,0
7677,.,0,0
7678,The,0,0
7679,blunted,0,0
7680,GH,0,0
7681,release,0,1
7682,to,0,0
7683,GHRH,0,0
7684,may,0,0
7685,be,0,0
7686,an,0,0
7687,early,0,0
7688,and,0,0
7689,long,0,0
7690,lasting,0,1
7691,sign,0,1
7692,of,0,0
7693,autonomous,0,0
7694,cortisol,0,1
7695,secretion,0,1
7696,by,0,0
7697,the,0,0
7698,adrenal,0,0
7699,adenoma,0,0
7700,.,0,0
7701,A,0,0
7702,comparison,0,0
7703,of,0,0
7704,local,0,0
7705,anaesthetics,0,0
7706,for,0,0
7707,venepuncture,0,0
7708,.,0,0
7709,AIM,0,0
7710,To,0,0
7711,compare,0,0
7712,the,0,0
7713,effectiveness,0,0
7714,of,0,0
7715,EMLA,0,0
7716,cream,0,0
7717,and,0,1
7718,Ametop,0,0
7719,gel,0,0
7720,in,0,0
7721,providing,0,0
7722,analgesia,0,1
7723,for,0,0
7724,venous,0,1
7725,cannulation,0,0
7726,.,0,0
7727,METHODS,0,0
7728,Single,0,0
7729,blind,0,0
7730,study,0,0
7731,in,0,0
7732,120,0,0
7733,children,0,0
7734,.,0,0
7735,RESULTS,0,0
7736,Both,0,0
7737,anaesthetic,0,0
7738,agents,0,0
7739,produced,0,0
7740,adequate,1,0
7741,analgesia,1,0
7742,.,1,0
7743,However,0,0
7744,",",0,0
7745,Ametop,0,0
7746,gel,0,0
7747,was,0,0
7748,more,0,0
7749,effective,0,1
7750,",",0,0
7751,with,0,0
7752,a,0,0
7753,statistically,0,0
7754,significant,0,0
7755,difference,0,0
7756,in,0,0
7757,the,0,0
7758,pain,1,1
7759,scores,1,1
7760,of,0,0
7761,the,0,0
7762,two,0,0
7763,groups,0,0
7764,(,0,0
7765,p,0,0
7766,<,0,0
7767,0.05,0,0
7768,),0,0
7769,.,0,0
7770,Comparison,0,0
7771,of,0,0
7772,different,0,0
7773,long-term,0,0
7774,asthma,0,0
7775,treatments,0,0
7776,in,0,0
7777,subjects,0,0
7778,with,0,0
7779,mild-to-moderate,0,0
7780,asthma,0,0
7781,.,0,0
7782,In,0,0
7783,order,0,0
7784,to,0,0
7785,compare,0,0
7786,the,0,0
7787,efficacy,0,1
7788,of,0,0
7789,different,0,0
7790,asthma,0,0
7791,treatment,0,0
7792,in,0,0
7793,subjects,0,0
7794,with,0,0
7795,mild-to-moderate,0,0
7796,asthma,0,0
7797,",",0,0
7798,three,0,0
7799,groups,0,0
7800,of,0,0
7801,11,0,0
7802,patients,0,0
7803,were,0,0
7804,treated,0,0
7805,with,0,0
7806,nedocromil,0,0
7807,sodium,0,0
7808,(,0,0
7809,NS,0,1
7810,),0,0
7811,",",0,0
7812,beclomethasone,0,0
7813,dipropionate,0,0
7814,(,0,0
7815,BDP,0,1
7816,),0,1
7817,and,0,0
7818,beclomethasone,0,0
7819,dipropionate,0,0
7820,plus,0,0
7821,salmeterol,0,0
7822,(,0,0
7823,BDP,0,1
7824,+,0,0
7825,S,0,0
7826,),0,0
7827,in,0,0
7828,an,0,0
7829,open,0,0
7830,",",0,0
7831,randomized,0,0
7832,study,0,0
7833,.,0,0
7834,Symptom,0,1
7835,score,0,1
7836,",",0,0
7837,peak,0,1
7838,expiratory,0,1
7839,flow,0,1
7840,(,0,0
7841,PEF,0,1
7842,),0,0
7843,maximal,0,1
7844,amplitude,0,1
7845,",",0,0
7846,forced,0,0
7847,expiratory,0,1
7848,volume,0,1
7849,in,0,0
7850,one,0,0
7851,second,0,0
7852,(,0,0
7853,FEV1,0,1
7854,),0,1
7855,",",0,0
7856,and,0,1
7857,methacholine,0,1
7858,reactivity,0,1
7859,were,0,0
7860,measured,0,0
7861,at,0,0
7862,the,0,0
7863,baseline,0,0
7864,and,0,0
7865,at,0,0
7866,intervals,0,0
7867,of,0,0
7868,3,0,0
7869,months,0,0
7870,up,0,0
7871,to,0,0
7872,12,0,0
7873,months,0,0
7874,.,0,0
7875,After,0,0
7876,3,0,0
7877,months,0,0
7878,",",0,0
7879,symptoms,0,1
7880,reduced,0,0
7881,significantly,0,0
7882,in,0,0
7883,all,0,0
7884,treatment,0,0
7885,groups,0,0
7886,",",0,0
7887,while,0,0
7888,PEF,0,1
7889,variability,0,1
7890,improved,0,0
7891,in,0,0
7892,BDP,0,0
7893,and,0,0
7894,BDP,0,1
7895,+,0,0
7896,S,0,0
7897,groups,0,0
7898,;,0,0
7899,FEV1,0,1
7900,and,0,0
7901,bronchial,0,0
7902,responsiveness,0,1
7903,to,0,0
7904,methacholine,0,0
7905,were,0,0
7906,significantly,0,0
7907,improved,0,0
7908,in,0,0
7909,comparison,0,0
7910,with,0,0
7911,baseline,0,0
7912,value,0,0
7913,in,0,0
7914,the,0,0
7915,BDP,0,0
7916,+,0,0
7917,S,0,0
7918,group,0,0
7919,only,0,0
7920,.,0,0
7921,No,1,0
7922,significant,1,0
7923,difference,1,0
7924,was,1,0
7925,observed,1,0
7926,after,1,0
7927,6,1,0
7928,and,1,0
7929,12,1,0
7930,months,1,0
7931,of,1,0
7932,treatment,1,0
7933,in,1,0
7934,PEF,1,1
7935,variability,1,1
7936,",",1,0
7937,FEV1,1,1
7938,or,1,1
7939,bronchial,1,1
7940,hyperreactivity,1,1
7941,in,1,0
7942,the,1,0
7943,NS,1,1
7944,group,1,0
7945,compared,1,0
7946,with,1,0
7947,baseline,1,0
7948,values,1,1
7949,",",1,0
7950,while,1,0
7951,a,1,0
7952,significant,1,0
7953,difference,1,0
7954,was,1,0
7955,observed,1,0
7956,in,1,0
7957,symptom,1,1
7958,score,1,1
7959,.,1,0
7960,BDP,1,1
7961,group,1,0
7962,showed,1,0
7963,a,1,0
7964,significant,1,0
7965,improvement,1,1
7966,in,1,0
7967,FEV1,1,1
7968,and,1,0
7969,bronchial,1,0
7970,reactivity,1,1
7971,to,1,0
7972,methacholine,1,0
7973,after,1,0
7974,6,1,0
7975,and,1,0
7976,12,1,0
7977,months,1,0
7978,of,1,0
7979,treatment,1,0
7980,.,1,0
7981,In,1,0
7982,the,1,0
7983,BDP,1,0
7984,+,1,0
7985,S,1,0
7986,group,1,0
7987,",",1,0
7988,the,1,0
7989,improvement,1,1
7990,in,1,0
7991,symptoms,1,1
7992,and,1,0
7993,pulmonary,1,1
7994,function,1,1
7995,persisted,1,0
7996,until,1,0
7997,the,1,0
7998,end,1,0
7999,of,1,0
8000,the,1,0
8001,study,1,0
8002,.,1,0
8003,In,0,0
8004,conclusion,0,0
8005,",",0,0
8006,the,1,0
8007,combination,1,0
8008,of,1,0
8009,beclomethasone,1,0
8010,dipropionate,1,0
8011,and,1,1
8012,salmeterol,1,0
8013,improved,1,1
8014,pulmonary,1,1
8015,function,1,1
8016,and,1,0
8017,bronchial,1,1
8018,reactivity,1,1
8019,earlier,1,0
8020,than,1,0
8021,beclomethasone,1,0
8022,dipropionate,1,0
8023,alone,1,0
8024,",",1,0
8025,while,1,0
8026,nedocromil,1,0
8027,sodium,1,0
8028,improved,1,1
8029,symptoms,1,1
8030,but,1,0
8031,not,1,0
8032,pulmonary,1,0
8033,function,1,1
8034,.,1,0
8035,Assuming,0,0
8036,that,0,0
8037,bronchial,1,0
8038,reactivity,1,1
8039,could,0,0
8040,be,0,0
8041,an,0,0
8042,indirect,0,0
8043,measurement,0,0
8044,of,0,0
8045,airway,0,1
8046,inflammation,0,1
8047,",",0,0
8048,overtreatment,1,1
8049,of,1,1
8050,asthma,1,0
8051,in,1,0
8052,relationship,1,0
8053,with,1,0
8054,the,1,0
8055,classification,1,1
8056,of,1,0
8057,asthma,1,0
8058,severity,1,1
8059,of,1,0
8060,the,1,0
8061,International,1,0
8062,Guidelines,1,0
8063,could,1,0
8064,improve,1,0
8065,both,1,0
8066,airway,1,1
8067,inflammation,1,1
8068,and,1,0
8069,the,1,0
8070,prognosis,1,1
8071,of,1,0
8072,airway,1,1
8073,obstruction,1,0
8074,.,1,0
8075,[,0,0
8076,Improving,0,1
8077,wound,1,0
8078,healing,1,1
8079,after,0,0
8080,nose,0,1
8081,surgery,0,0
8082,by,0,0
8083,combined,0,0
8084,administration,0,0
8085,of,0,0
8086,xylometazoline,0,0
8087,and,0,0
8088,dexpanthenol,0,0
8089,],0,0
8090,.,0,0
8091,BACKGROUND,0,0
8092,The,0,0
8093,aim,0,0
8094,of,0,0
8095,this,0,0
8096,study,0,0
8097,was,0,0
8098,the,0,0
8099,examination,0,0
8100,of,0,0
8101,efficacy,1,1
8102,and,1,1
8103,tolerability,1,1
8104,of,0,0
8105,an,0,0
8106,application-form,0,0
8107,of,0,0
8108,the,0,0
8109,new,0,0
8110,combination,0,0
8111,of,0,0
8112,Xylometazoline,0,0
8113,with,0,0
8114,Dexpanthenol,0,0
8115,(,0,0
8116,Nasic,0,0
8117,),0,0
8118,versus,0,0
8119,Xylometazoline,0,0
8120,alone,0,0
8121,.,0,0
8122,PATIENTS,0,0
8123,AND,0,0
8124,METHODS,0,0
8125,Randomized,0,0
8126,verum,0,0
8127,controlled,0,0
8128,parallel-group-comparison,0,0
8129,of,0,0
8130,two,0,0
8131,weeks,0,0
8132,treatment,0,0
8133,of,0,0
8134,a,0,0
8135,nasal-spray,0,0
8136,.,0,0
8137,61,0,0
8138,inpatients,0,0
8139,with,0,0
8140,the,0,0
8141,diagnosis,0,0
8142,Rhinitis,0,0
8143,following,0,0
8144,nasal,0,1
8145,operation,0,0
8146,were,0,0
8147,included,0,0
8148,in,0,0
8149,this,0,0
8150,study,0,0
8151,and,0,0
8152,30,0,0
8153,patients,0,0
8154,were,0,0
8155,treated,0,0
8156,with,0,0
8157,verum,0,0
8158,and,0,0
8159,placebo,0,0
8160,each,0,0
8161,.,0,0
8162,The,0,0
8163,assessment,0,0
8164,of,0,0
8165,nasal-breathing-resistance,1,1
8166,according,1,0
8167,to,1,0
8168,scores,1,1
8169,was,0,0
8170,defined,0,0
8171,as,0,0
8172,target-parameter,0,0
8173,.,0,0
8174,Confirmatory,0,0
8175,statistical,0,1
8176,analysis,0,0
8177,was,0,0
8178,carried,0,0
8179,out,0,0
8180,according,0,0
8181,to,0,0
8182,Wilcoxon-Mann-Whitney-U,0,1
8183,two-sided,0,0
8184,at,0,0
8185,alpha,0,1
8186,<,0,0
8187,or,0,0
8188,=,0,0
8189,0.05,0,0
8190,.,0,0
8191,MAIN,0,0
8192,OUTCOME,0,0
8193,MEASURE,0,0
8194,The,0,0
8195,superiority,0,0
8196,of,0,0
8197,the,0,0
8198,combination,0,0
8199,of,0,0
8200,Xylometazoline-Dexpanthenol,0,0
8201,nasal-spray,0,0
8202,versus,0,0
8203,Xylometazoline,0,0
8204,nasal,0,1
8205,spray,0,0
8206,could,0,0
8207,be,0,0
8208,proven,0,0
8209,for,0,0
8210,the,0,0
8211,target-parameter,0,0
8212,as,0,0
8213,clinically,0,0
8214,relevant,0,0
8215,and,0,0
8216,statistically,0,0
8217,significant,0,0
8218,.,0,0
8219,The,0,0
8220,clinically,1,0
8221,proven,1,0
8222,efficacy,1,1
8223,is,0,0
8224,emphasized,0,0
8225,by,0,0
8226,good,0,0
8227,tolerability,1,0
8228,of,0,0
8229,both,0,0
8230,treatments,0,0
8231,.,0,0
8232,Due,0,0
8233,to,0,0
8234,easy,0,0
8235,handling,0,0
8236,of,0,0
8237,the,0,0
8238,nasal-spray,0,0
8239,a,0,0
8240,good,0,0
8241,compliance,1,1
8242,was,0,0
8243,confirmed,0,0
8244,.,0,0
8245,CONCLUSION,0,0
8246,Distinct,0,0
8247,improvement,1,1
8248,of,1,0
8249,symptoms,1,1
8250,in,0,0
8251,patients,0,0
8252,following,0,0
8253,nasal,0,0
8254,operations,0,0
8255,underlines,0,0
8256,the,0,0
8257,efficacy,1,1
8258,of,0,0
8259,both,0,0
8260,medications,0,0
8261,.,0,0
8262,With,0,0
8263,respect,0,0
8264,to,0,0
8265,the,0,0
8266,tolerability,1,1
8267,therapy,0,0
8268,with,0,0
8269,the,0,0
8270,combination,0,0
8271,is,0,0
8272,more,0,0
8273,beneficial,0,0
8274,in,0,0
8275,comparison,0,0
8276,to,0,0
8277,the,0,0
8278,alternative,0,0
8279,therapy,0,0
8280,.,0,0
8281,The,0,0
8282,result,0,0
8283,of,0,0
8284,this,0,0
8285,controlled,0,0
8286,clinical,0,0
8287,study,0,0
8288,confirms,0,0
8289,that,0,0
8290,the,0,0
8291,combination,0,0
8292,Xylometazoline-Dexpanthenol,0,0
8293,is,0,0
8294,an,0,0
8295,enlargement,1,1
8296,and,1,0
8297,improvement,1,1
8298,of,1,1
8299,effective,1,1
8300,medicinal,0,0
8301,treatment,0,0
8302,of,0,0
8303,rhinitis,0,0
8304,following,0,0
8305,nasal,0,1
8306,operation,0,0
8307,in,0,0
8308,comparison,0,0
8309,to,0,0
8310,therapy,0,0
8311,with,0,0
8312,Xylometazoline,0,0
8313,alone,0,0
8314,.,0,0
8315,Comments,0,0
8316,on,0,0
8317,Secretin,1,1
8318,and,0,0
8319,autism,1,0
8320,:,1,0
8321,a,0,0
8322,two-part,0,0
8323,clinical,0,0
8324,investigation,0,0
8325,by,0,0
8326,M.G,0,0
8327,.,0,0
8328,Chez,0,1
8329,et,0,0
8330,al,0,0
8331,.,0,0
8332,Response,0,1
8333,of,0,0
8334,pre-core,0,0
8335,mutant,0,0
8336,chronic,0,0
8337,hepatitis,0,0
8338,B,0,0
8339,infection,0,1
8340,to,0,0
8341,lamivudine,0,0
8342,.,0,0
8343,The,0,0
8344,proportion,0,0
8345,of,0,0
8346,chronic,0,0
8347,liver,0,0
8348,disease,0,1
8349,associated,0,0
8350,with,0,0
8351,the,0,0
8352,pre-core,0,0
8353,mutant,0,0
8354,of,0,0
8355,hepatitis,0,0
8356,B,0,0
8357,virus,0,0
8358,(,0,0
8359,HBV,0,1
8360,),0,0
8361,infection,0,1
8362,is,0,0
8363,increasing,0,0
8364,",",0,0
8365,particularly,0,0
8366,in,0,0
8367,Mediterranean,0,1
8368,Europe,0,0
8369,and,0,0
8370,in,0,0
8371,Asia,0,0
8372,.,0,0
8373,The,0,0
8374,pre-core,0,0
8375,mutant,0,0
8376,HBV,0,0
8377,is,0,0
8378,unable,0,0
8379,to,0,0
8380,produce,0,0
8381,hepatitis,0,0
8382,B,0,0
8383,e,0,1
8384,antigen,0,1
8385,(,0,0
8386,HBeAg,0,0
8387,),0,0
8388,",",0,0
8389,so,0,0
8390,that,0,0
8391,patients,0,0
8392,with,0,0
8393,this,0,0
8394,variant,0,0
8395,do,0,0
8396,not,0,0
8397,present,0,0
8398,with,0,0
8399,HBV,0,0
8400,characterised,0,0
8401,by,0,0
8402,HBeAg,1,0
8403,in,1,0
8404,the,1,0
8405,serum,1,1
8406,.,1,0
8407,Pre-core,0,1
8408,mutant,0,0
8409,chronic,0,0
8410,hepatitis,0,0
8411,B,0,0
8412,infection,0,1
8413,usually,0,0
8414,proceeds,0,0
8415,to,0,0
8416,serious,0,1
8417,liver,0,0
8418,disease,0,0
8419,.,0,0
8420,Wild-type,0,0
8421,HBV,0,0
8422,infection,0,0
8423,may,0,0
8424,be,0,0
8425,mild,0,1
8426,and,0,0
8427,respond,0,0
8428,relatively,0,0
8429,well,0,0
8430,to,0,0
8431,interferon,0,0
8432,(,0,0
8433,IFN,0,1
8434,),0,1
8435,alpha,0,1
8436,therapy,0,0
8437,",",0,0
8438,but,0,0
8439,IFN,0,1
8440,alpha,0,0
8441,is,0,0
8442,not,0,0
8443,an,0,0
8444,effective,0,0
8445,therapeutic,0,0
8446,option,0,0
8447,in,0,0
8448,pre-core,0,1
8449,mutant,0,1
8450,hepatitis,0,0
8451,B,0,0
8452,infection,0,1
8453,and,0,0
8454,new,0,0
8455,therapeutic,0,0
8456,options,0,0
8457,are,0,0
8458,needed,0,0
8459,.,0,0
8460,Clinical,0,0
8461,data,0,0
8462,show,0,0
8463,that,0,0
8464,lamivudine,0,0
8465,is,0,0
8466,an,0,0
8467,effective,1,0
8468,treatment,0,0
8469,for,0,0
8470,patients,0,0
8471,with,0,0
8472,pre-core,0,0
8473,mutant,0,0
8474,hepatitis,0,0
8475,B,0,0
8476,.,0,0
8477,There,0,0
8478,is,0,0
8479,profound,0,0
8480,suppression,0,1
8481,of,0,0
8482,HBV,1,1
8483,replication,1,0
8484,and,0,1
8485,improvement,0,1
8486,in,0,0
8487,indicators,1,1
8488,of,1,0
8489,liver,1,0
8490,disease,1,0
8491,in,0,0
8492,most,0,0
8493,patients,0,0
8494,.,0,0
8495,In,0,0
8496,conclusion,0,0
8497,",",0,0
8498,lamivudine,0,0
8499,is,0,0
8500,suitable,0,0
8501,for,0,0
8502,treatment,0,0
8503,of,0,0
8504,a,0,0
8505,wide,0,0
8506,range,0,0
8507,of,0,0
8508,patients,0,0
8509,with,0,0
8510,chronic,0,0
8511,hepatitis,0,0
8512,B,0,0
8513,",",0,0
8514,including,0,0
8515,those,0,0
8516,with,0,0
8517,pre-core,0,0
8518,mutant,0,0
8519,HBV,0,0
8520,infection,0,1
8521,.,0,0
8522,The,0,0
8523,effect,0,0
8524,of,0,0
8525,case,0,0
8526,management,0,0
8527,on,0,0
8528,the,0,0
8529,costs,1,1
8530,of,1,0
8531,health,1,1
8532,care,1,0
8533,for,0,0
8534,enrollees,0,0
8535,in,0,0
8536,Medicare,0,0
8537,Plus,0,0
8538,Choice,0,0
8539,plans,0,0
8540,:,0,0
8541,a,0,0
8542,randomized,0,0
8543,trial,0,0
8544,.,0,0
8545,OBJECTIVE,0,0
8546,To,0,0
8547,measure,0,0
8548,the,0,0
8549,effects,0,0
8550,of,0,0
8551,case,0,0
8552,management,0,0
8553,on,0,0
8554,an,0,0
8555,older,0,0
8556,population,0,1
8557,'s,0,1
8558,costs,1,1
8559,of,1,0
8560,health,1,0
8561,care,1,0
8562,.,1,0
8563,DESIGN,0,0
8564,A,0,0
8565,1-year,0,0
8566,randomized,0,0
8567,controlled,0,0
8568,trial,0,0
8569,.,0,0
8570,SETTING,0,0
8571,Multiple,0,0
8572,sites,0,0
8573,of,0,0
8574,care,0,0
8575,in,0,0
8576,San,0,0
8577,Francisco,0,0
8578,",",0,0
8579,California,0,0
8580,.,0,0
8581,PARTICIPANTS,0,0
8582,Patients,0,0
8583,aged,0,0
8584,65,0,0
8585,or,0,0
8586,older,0,0
8587,of,0,1
8588,primary,0,0
8589,care,0,0
8590,physicians,0,0
8591,in,0,0
8592,a,0,0
8593,large,0,0
8594,provider,0,0
8595,organization,0,1
8596,bearing,0,0
8597,financial,0,1
8598,risk,0,1
8599,for,0,0
8600,their,0,0
8601,care,0,0
8602,(,0,0
8603,n,0,0
8604,=,0,0
8605,6409,0,0
8606,),0,0
8607,.,0,0
8608,INTERVENTION,0,0
8609,Screening,0,0
8610,for,0,0
8611,high,0,0
8612,risk,0,1
8613,and,0,1
8614,provision,0,0
8615,of,0,1
8616,social,0,1
8617,work-based,0,0
8618,case,0,0
8619,management,0,0
8620,.,0,0
8621,OUTCOME,0,0
8622,MEASURES,0,0
8623,Volume,1,1
8624,and,1,1
8625,cost,1,1
8626,of,1,1
8627,hospital,1,1
8628,",",1,0
8629,physician,1,0
8630,",",1,1
8631,case,1,0
8632,management,1,0
8633,",",1,0
8634,and,1,1
8635,other,1,0
8636,health-related,1,1
8637,services,1,0
8638,.,1,0
8639,RESULTS,0,0
8640,The,0,0
8641,experimental,0,0
8642,group,0,0
8643,used,0,0
8644,more,0,0
8645,case,1,0
8646,management,1,0
8647,services,1,0
8648,than,0,0
8649,the,0,0
8650,control,0,0
8651,group,0,0
8652,(,0,0
8653,0.09,0,0
8654,vs.,0,0
8655,0.02,0,0
8656,months,0,0
8657,per,0,0
8658,person,0,0
8659,",",0,0
8660,P,0,0
8661,<,0,0
8662,.001,0,0
8663,),0,0
8664,.,0,0
8665,The,0,0
8666,experimental,0,0
8667,group,0,0
8668,'s,0,0
8669,average,0,1
8670,total,1,1
8671,payments,1,0
8672,for,1,0
8673,health,1,1
8674,care,1,0
8675,were,0,0
8676,slightly,0,0
8677,lower,0,0
8678,(,0,0
8679,$,0,0
8680,3148,0,0
8681,vs,0,0
8682,$,0,0
8683,3277,0,0
8684,",",0,0
8685,P,0,0
8686,=,0,0
8687,.40,0,0
8688,),0,0
8689,.,0,0
8690,CONCLUSIONS,0,0
8691,This,0,0
8692,study,0,0
8693,provides,0,0
8694,no,0,0
8695,statistically,0,0
8696,significant,0,0
8697,evidence,0,0
8698,that,0,0
8699,social,0,1
8700,work-oriented,0,0
8701,case,0,0
8702,management,0,0
8703,reduces,0,0
8704,the,0,0
8705,use,0,0
8706,or,0,0
8707,the,0,0
8708,cost,1,1
8709,of,1,0
8710,health,1,1
8711,care,1,0
8712,for,0,0
8713,high-risk,0,0
8714,older,0,0
8715,people,0,0
8716,.,0,0
8717,Other,0,0
8718,potentially,0,0
8719,favorable,0,0
8720,effects,0,0
8721,of,0,0
8722,this,0,0
8723,type,0,0
8724,of,0,0
8725,case,0,0
8726,management,0,0
8727,need,0,0
8728,to,0,0
8729,be,0,0
8730,evaluated,0,0
8731,",",0,0
8732,as,0,0
8733,do,0,0
8734,the,0,0
8735,effects,0,0
8736,of,0,0
8737,other,0,0
8738,types,0,0
8739,of,0,0
8740,case,0,0
8741,management,0,0
8742,.,0,0
8743,Physostigmine,0,0
8744,reverses,0,0
8745,propofol-induced,0,1
8746,unconsciousness,0,1
8747,and,0,1
8748,attenuation,0,1
8749,of,0,0
8750,the,0,0
8751,auditory,0,1
8752,steady,0,1
8753,state,0,1
8754,response,0,1
8755,and,0,1
8756,bispectral,0,1
8757,index,0,1
8758,in,0,0
8759,human,0,0
8760,volunteers,0,0
8761,.,0,0
8762,BACKGROUND,0,0
8763,It,0,0
8764,is,0,0
8765,postulated,0,0
8766,that,0,0
8767,alteration,0,0
8768,of,0,0
8769,central,0,0
8770,cholinergic,0,1
8771,transmission,0,0
8772,plays,0,0
8773,an,0,0
8774,important,0,0
8775,role,0,0
8776,in,0,0
8777,the,0,0
8778,mechanism,0,0
8779,by,0,0
8780,which,0,0
8781,anesthetics,0,0
8782,produce,0,0
8783,unconsciousness,0,1
8784,.,0,0
8785,The,0,0
8786,authors,0,0
8787,investigated,0,0
8788,the,0,0
8789,effect,0,0
8790,of,0,0
8791,altering,0,0
8792,central,0,0
8793,cholinergic,0,1
8794,transmission,0,1
8795,",",0,0
8796,by,0,0
8797,physostigmine,0,0
8798,and,0,1
8799,scopolamine,0,0
8800,",",0,1
8801,on,0,0
8802,unconsciousness,0,1
8803,produced,0,0
8804,by,0,0
8805,propofol,0,0
8806,.,0,0
8807,METHODS,0,0
8808,Propofol,0,0
8809,was,0,0
8810,administered,0,0
8811,to,0,0
8812,American,0,0
8813,Society,0,0
8814,of,0,0
8815,Anesthesiologists,0,0
8816,physical,0,1
8817,status,0,0
8818,1,0,0
8819,(,0,0
8820,n,0,0
8821,=,0,0
8822,17,0,0
8823,),0,0
8824,volunteers,0,0
8825,with,0,0
8826,use,0,0
8827,of,0,0
8828,a,0,0
8829,computer-controlled,0,0
8830,infusion,0,0
8831,pump,0,0
8832,at,0,0
8833,increasing,0,0
8834,concentrations,0,1
8835,until,0,0
8836,unconsciousness,0,1
8837,resulted,0,0
8838,(,0,0
8839,inability,0,0
8840,to,0,0
8841,respond,0,0
8842,to,0,0
8843,verbal,0,1
8844,commands,0,0
8845,",",0,0
8846,abolition,0,0
8847,of,0,1
8848,spontaneous,0,1
8849,movement,0,1
8850,),0,0
8851,.,0,0
8852,Central,1,1
8853,nervous,1,1
8854,system,1,0
8855,function,1,1
8856,was,0,0
8857,assessed,0,0
8858,by,0,0
8859,use,0,0
8860,of,0,0
8861,the,0,0
8862,Auditory,1,0
8863,Steady,1,1
8864,State,1,1
8865,Response,1,1
8866,(,1,0
8867,ASSR,1,0
8868,),1,0
8869,and,1,0
8870,Bispectral,1,1
8871,Index,1,1
8872,(,1,0
8873,BIS,1,1
8874,),1,0
8875,analysis,1,0
8876,of,1,0
8877,electrooculogram,1,1
8878,.,1,0
8879,During,0,0
8880,continuous,0,0
8881,administration,0,0
8882,of,0,0
8883,propofol,0,0
8884,",",0,0
8885,reversal,1,1
8886,of,1,1
8887,unconsciousness,1,1
8888,produced,0,0
8889,by,0,0
8890,physostigmine,0,0
8891,(,0,0
8892,28,0,0
8893,microgram/kg,0,0
8894,),0,0
8895,and,0,0
8896,block,1,0
8897,of,1,0
8898,this,1,0
8899,reversal,1,0
8900,by,0,0
8901,scopolamine,0,0
8902,(,0,0
8903,8.6,0,0
8904,microgram/kg,0,0
8905,),0,0
8906,were,0,0
8907,evaluated,0,0
8908,.,0,0
8909,RESULTS,0,0
8910,Propofol,0,0
8911,produced,0,0
8912,unconsciousness,1,1
8913,at,0,0
8914,a,0,0
8915,plasma,1,1
8916,concentration,1,1
8917,of,0,0
8918,3.2,0,0
8919,+/-,0,0
8920,0.8,0,0
8921,(,0,0
8922,+/-,0,0
8923,SD,0,0
8924,),0,0
8925,microgram/ml,0,0
8926,(,0,0
8927,n,0,0
8928,=,0,0
8929,17,0,0
8930,),0,0
8931,.,0,0
8932,Unconsciousness,1,1
8933,was,0,0
8934,associated,0,0
8935,with,0,0
8936,reductions,1,0
8937,in,0,0
8938,ASSR,1,0
8939,(,0,0
8940,0.10,0,0
8941,+/-,0,0
8942,0.08,0,0
8943,microV,0,0
8944,[,0,0
8945,awake,0,0
8946,baseline,0,0
8947,0.32,0,0
8948,+/-,0,0
8949,0.18,0,0
8950,microV,0,0
8951,],0,0
8952,",",0,0
8953,P,0,0
8954,<,0,0
8955,0.001,0,0
8956,),0,0
8957,and,0,0
8958,BIS,1,1
8959,(,0,0
8960,55.7,0,0
8961,+/-,0,0
8962,8.8,0,0
8963,[,0,0
8964,awake,0,0
8965,baseline,0,0
8966,92.4,0,0
8967,+/-,0,0
8968,3.9,0,0
8969,],0,0
8970,",",0,0
8971,P,0,0
8972,<,0,0
8973,0.001,0,0
8974,),0,0
8975,.,0,0
8976,Physostigmine,0,0
8977,restored,1,0
8978,consciousness,1,1
8979,in,0,0
8980,9,0,0
8981,of,0,0
8982,11,0,0
8983,subjects,0,0
8984,",",0,0
8985,with,0,0
8986,concomitant,0,0
8987,increases,1,1
8988,in,0,0
8989,ASSR,1,0
8990,(,0,0
8991,0.38,0,0
8992,+/-,0,0
8993,0.17,0,0
8994,microV,0,0
8995,",",0,0
8996,P,0,0
8997,<,0,0
8998,0.01,0,0
8999,),0,0
9000,and,0,0
9001,BIS,1,1
9002,(,0,0
9003,75.3,0,0
9004,+/-,0,0
9005,8.3,0,0
9006,",",0,0
9007,P,0,0
9008,<,0,0
9009,0.001,0,0
9010,),0,0
9011,.,0,0
9012,In,0,0
9013,all,0,0
9014,subjects,0,0
9015,(,0,0
9016,n,0,0
9017,=,0,0
9018,6,0,0
9019,),0,0
9020,scopolamine,0,0
9021,blocked,0,0
9022,the,0,0
9023,physostigmine-induced,1,1
9024,reversal,1,0
9025,of,1,0
9026,unconsciousness,1,1
9027,and,0,0
9028,the,0,0
9029,increase,1,0
9030,of,1,0
9031,the,1,0
9032,ASSR,1,0
9033,and,1,0
9034,BIS,1,1
9035,(,1,0
9036,ASSR,1,0
9037,and,1,1
9038,BIS,1,1
9039,during,0,0
9040,propofol-induced,0,0
9041,unconsciousness,0,1
9042,:,0,0
9043,0.09,0,0
9044,+/-,0,0
9045,0.09,0,0
9046,microV,0,0
9047,and,0,0
9048,58.2,0,0
9049,+/-,0,0
9050,7.5,0,0
9051,",",0,0
9052,respectively,0,0
9053,;,0,0
9054,ASSR,1,0
9055,and,1,0
9056,BIS,1,1
9057,after,0,0
9058,physostigmine,0,0
9059,administration,0,0
9060,:,0,0
9061,0.08,0,0
9062,+/-,0,0
9063,0.06,0,0
9064,microV,0,0
9065,and,0,0
9066,56.8,0,0
9067,+/-,0,0
9068,6.7,0,0
9069,",",0,0
9070,respectively,0,0
9071,",",0,0
9072,NS,0,1
9073,),0,0
9074,.,0,0
9075,CONCLUSIONS,0,0
9076,These,0,0
9077,findings,0,0
9078,suggest,0,0
9079,that,0,0
9080,the,0,0
9081,unconsciousness,0,1
9082,produced,0,0
9083,by,0,0
9084,propofol,0,0
9085,is,0,0
9086,mediated,0,0
9087,at,0,0
9088,least,0,0
9089,in,0,0
9090,part,0,0
9091,via,0,0
9092,interruption,0,0
9093,of,0,0
9094,central,0,1
9095,cholinergic,0,1
9096,muscarinic,0,0
9097,transmission,0,0
9098,.,0,0
9099,Onset/offset,1,1
9100,characteristics,1,1
9101,and,1,1
9102,intubating,1,0
9103,conditions,1,0
9104,of,0,0
9105,rapacuronium,0,0
9106,:,0,0
9107,a,0,0
9108,comparison,0,0
9109,with,0,0
9110,rocuronium,0,0
9111,.,0,0
9112,We,0,0
9113,compared,0,0
9114,onset,1,0
9115,and,1,0
9116,offset,1,0
9117,of,1,1
9118,action,1,1
9119,and,1,0
9120,tracheal,1,1
9121,intubating,1,0
9122,conditions,1,0
9123,after,0,0
9124,rapacuronium,0,0
9125,and,0,1
9126,rocuronium,0,0
9127,in,0,0
9128,60,0,0
9129,patients,0,0
9130,in,0,0
9131,a,0,0
9132,randomized,0,0
9133,",",0,0
9134,assessor-blinded,0,0
9135,study,0,0
9136,.,0,0
9137,Following,0,0
9138,induction,0,0
9139,of,0,0
9140,anaesthesia,0,0
9141,with,0,0
9142,propofol,0,0
9143,2.5,0,0
9144,mg,0,0
9145,kg-1,0,0
9146,",",0,0
9147,either,0,0
9148,rapacuronium,0,0
9149,1.5,0,0
9150,mg,0,0
9151,kg-1,0,0
9152,(,0,0
9153,n,0,0
9154,=,0,0
9155,30,0,0
9156,),0,0
9157,or,0,0
9158,rocuronium,0,0
9159,0.6,0,0
9160,mg,0,0
9161,kg-1,0,0
9162,(,0,0
9163,n,0,0
9164,=,0,0
9165,30,0,0
9166,),0,0
9167,was,0,0
9168,administered,0,0
9169,to,0,0
9170,facilitate,0,0
9171,tracheal,0,0
9172,intubation,0,0
9173,.,0,0
9174,Anaesthesia,0,1
9175,was,0,0
9176,maintained,0,0
9177,with,0,0
9178,either,0,0
9179,a,0,0
9180,propofol,0,0
9181,infusion,0,0
9182,(,0,0
9183,100,0,0
9184,micrograms,0,0
9185,kg-1,0,0
9186,min-1,0,0
9187,),0,0
9188,or,0,0
9189,sevoflurane,0,0
9190,(,0,0
9191,1,0,0
9192,%,0,0
9193,end-tidal,0,0
9194,),0,0
9195,with,0,0
9196,66,0,0
9197,%,0,0
9198,nitrous,0,0
9199,oxide,0,0
9200,(,0,0
9201,N2O,0,0
9202,),0,0
9203,",",0,0
9204,n,0,0
9205,=,0,0
9206,15,0,0
9207,in,0,0
9208,each,0,0
9209,subgroup,0,0
9210,.,0,0
9211,Neuromuscular,1,1
9212,monitoring,1,0
9213,was,0,0
9214,performed,0,0
9215,using,0,0
9216,an,0,0
9217,electromyographic,0,0
9218,(,0,0
9219,EMG,0,1
9220,),0,1
9221,device,0,0
9222,(,0,0
9223,Datex,0,0
9224,Relaxograph,0,0
9225,),0,0
9226,.,0,0
9227,The,0,0
9228,lag,1,1
9229,times,1,1
9230,(,0,0
9231,mean,0,0
9232,42,0,0
9233,(,0,0
9234,SD,0,0
9235,11,0,0
9236,),0,0
9237,s,0,0
9238,and,0,0
9239,44,0,0
9240,(,0,0
9241,16,0,0
9242,),0,0
9243,s,0,0
9244,),0,0
9245,",",0,0
9246,maximum,1,1
9247,block,1,0
9248,(,0,0
9249,99,0,0
9250,(,0,0
9251,2,0,0
9252,),0,0
9253,%,0,0
9254,and,0,0
9255,98,0,0
9256,(,0,0
9257,3,0,0
9258,),0,0
9259,%,0,0
9260,),0,0
9261,and,0,0
9262,intubating,1,0
9263,conditions,1,0
9264,at,1,0
9265,60,1,0
9266,s,1,0
9267,(,0,0
9268,good-to-excellent,0,1
9269,in,0,0
9270,86,0,0
9271,%,0,0
9272,and,0,0
9273,84,0,0
9274,%,0,0
9275,of,0,0
9276,patients,0,0
9277,),0,0
9278,were,0,0
9279,similar,0,0
9280,for,0,0
9281,rapacuronium,0,0
9282,and,0,1
9283,rocuronium,0,0
9284,",",0,0
9285,respectively,0,0
9286,.,0,0
9287,The,0,0
9288,onset,1,1
9289,time,1,1
9290,of,0,0
9291,rapacuronium,0,0
9292,was,0,0
9293,shorter,0,0
9294,than,0,0
9295,rocuronium,0,0
9296,(,0,0
9297,87,0,0
9298,(,0,0
9299,20,0,0
9300,),0,0
9301,vs,0,0
9302,141,0,0
9303,(,0,0
9304,65,0,0
9305,),0,0
9306,s,0,0
9307,",",0,0
9308,P,0,0
9309,<,0,0
9310,0.001,0,0
9311,),0,0
9312,",",0,0
9313,and,0,0
9314,the,0,0
9315,degree,1,1
9316,of,1,0
9317,block,1,0
9318,at,1,0
9319,60,1,0
9320,s,1,0
9321,was,0,0
9322,greater,0,0
9323,(,0,0
9324,69,0,0
9325,(,0,0
9326,26,0,0
9327,),0,0
9328,vs,0,0
9329,50,0,0
9330,(,0,0
9331,27,0,0
9332,),0,0
9333,%,0,0
9334,",",0,0
9335,P,0,0
9336,<,0,0
9337,0.05,0,0
9338,),0,0
9339,.,0,0
9340,Twenty-five,0,0
9341,per,0,0
9342,cent,0,0
9343,recovery,1,1
9344,was,0,0
9345,shorter,0,0
9346,with,0,0
9347,rapacuronium,0,0
9348,than,0,0
9349,rocuronium,0,0
9350,during,0,0
9351,propofol,0,0
9352,(,0,0
9353,15.0,0,0
9354,(,0,0
9355,3.2,0,0
9356,),0,0
9357,vs,0,0
9358,39.1,0,0
9359,(,0,0
9360,14.2,0,0
9361,),0,0
9362,min,0,0
9363,",",0,0
9364,P,0,0
9365,<,0,0
9366,0.001,0,0
9367,),0,0
9368,and,0,0
9369,sevoflurane,0,0
9370,(,0,0
9371,15.1,0,0
9372,(,0,0
9373,4.2,0,0
9374,),0,0
9375,vs,0,0
9376,47.8,0,0
9377,(,0,0
9378,19.0,0,0
9379,),0,0
9380,min,0,0
9381,",",0,0
9382,P,0,0
9383,<,0,0
9384,0.001,0,0
9385,),0,0
9386,anaesthesia,0,0
9387,.,0,0
9388,We,0,0
9389,conclude,0,0
9390,that,0,0
9391,rapacuronium,0,0
9392,1.5,0,0
9393,mg,0,0
9394,kg-1,0,0
9395,had,0,0
9396,a,0,0
9397,more,0,0
9398,rapid,0,1
9399,onset,1,1
9400,",",0,0
9401,similar,0,0
9402,intubating,1,0
9403,conditions,1,0
9404,",",0,0
9405,and,0,1
9406,shorter,0,1
9407,recovery,1,1
9408,times,1,1
9409,than,0,0
9410,rocuronium,0,0
9411,0.6,0,0
9412,mg,0,0
9413,kg-1,0,0
9414,.,0,0
9415,Paclitaxel,0,0
9416,(,0,0
9417,175,0,0
9418,mg/m2,0,0
9419,),0,0
9420,plus,0,0
9421,carboplatin,0,0
9422,(,0,0
9423,6,0,0
9424,AUC,0,0
9425,),0,0
9426,versus,0,0
9427,paclitaxel,0,0
9428,(,0,0
9429,225,0,0
9430,mg/m2,0,0
9431,),0,0
9432,plus,0,0
9433,carboplatin,0,0
9434,(,0,0
9435,6,0,0
9436,AUC,0,0
9437,),0,0
9438,in,0,0
9439,advanced,0,0
9440,non-small-cell,0,0
9441,lung,0,1
9442,cancer,0,0
9443,(,0,0
9444,NSCLC,0,1
9445,),0,0
9446,:,0,0
9447,a,0,0
9448,multicenter,0,0
9449,randomized,0,0
9450,trial,0,0
9451,.,0,0
9452,Hellenic,0,0
9453,Cooperative,0,0
9454,Oncology,0,0
9455,Group,0,0
9456,(,0,0
9457,HeCOG,0,0
9458,),0,0
9459,.,0,0
9460,PURPOSE,0,0
9461,The,0,0
9462,combination,0,0
9463,of,0,0
9464,paclitaxel,0,0
9465,and,0,0
9466,carboplatin,0,0
9467,has,0,0
9468,become,0,0
9469,a,0,0
9470,widely,0,0
9471,used,0,0
9472,regimen,0,0
9473,in,0,0
9474,NSCLC,0,1
9475,due,0,0
9476,to,0,0
9477,phase,0,0
9478,II,0,0
9479,reports,0,0
9480,of,0,0
9481,moderate,0,0
9482,toxicity,0,1
9483,",",0,0
9484,reasonable,0,0
9485,activity,0,1
9486,and,0,0
9487,easy,0,0
9488,outpatient,0,0
9489,administration,0,0
9490,.,0,0
9491,Purpose,0,0
9492,of,0,0
9493,our,0,0
9494,present,0,0
9495,prospective,0,0
9496,study,0,0
9497,was,0,0
9498,to,0,0
9499,evaluate,0,0
9500,the,0,0
9501,dose,1,0
9502,response,1,1
9503,relationship,0,0
9504,of,0,0
9505,paclitaxel,0,0
9506,.,0,0
9507,PATIENTS,0,0
9508,AND,0,0
9509,METHODS,0,0
9510,Since,0,0
9511,July,0,0
9512,1996,0,0
9513,",",0,0
9514,198,0,0
9515,patients,0,0
9516,with,0,0
9517,non-operable,0,0
9518,NSCLC,0,1
9519,and,0,0
9520,measurable,0,1
9521,disease,0,1
9522,without,0,0
9523,previous,0,0
9524,chemotherapy,0,0
9525,entered,0,0
9526,the,0,0
9527,trial,0,0
9528,.,0,0
9529,Ninety,0,0
9530,nine,0,0
9531,patients,0,0
9532,(,0,0
9533,group,0,0
9534,A,0,0
9535,),0,0
9536,were,0,0
9537,randomized,0,0
9538,to,0,0
9539,receive,0,0
9540,paclitaxel,0,0
9541,175,0,0
9542,mg/m2,0,0
9543,in,0,0
9544,three-hour,0,0
9545,infusion,0,0
9546,plus,0,0
9547,carboplatin,0,0
9548,dosed,0,0
9549,to,0,0
9550,an,0,0
9551,area,0,0
9552,under,0,0
9553,the,0,0
9554,concentration-time,0,1
9555,curve,0,1
9556,of,0,0
9557,6,0,0
9558,every,0,0
9559,3,0,0
9560,weeks,0,0
9561,and,0,0
9562,99,0,0
9563,(,0,0
9564,group,0,0
9565,B,0,0
9566,),0,0
9567,to,0,0
9568,receive,0,0
9569,the,0,0
9570,same,0,0
9571,regimen,0,0
9572,with,0,0
9573,paclitaxel,0,0
9574,increased,0,0
9575,to,0,0
9576,225,0,0
9577,mg/m2,0,0
9578,.,0,0
9579,Eligibility,0,1
9580,criteria,0,0
9581,included,0,0
9582,WHO,0,0
9583,performance,0,1
9584,status,0,1
9585,0-2,0,0
9586,",",0,0
9587,documented,0,0
9588,inoperable,0,0
9589,stage,0,0
9590,IIIA,0,1
9591,and,0,1
9592,IIIB,0,1
9593,",",0,1
9594,IV,0,1
9595,",",0,0
9596,no,0,0
9597,brain,0,1
9598,metastasis,0,1
9599,",",0,0
9600,no,0,0
9601,prior,0,0
9602,chemotherapy,0,0
9603,and,0,0
9604,adequate,0,1
9605,renal,0,1
9606,and,0,0
9607,hepatic,0,1
9608,function,0,1
9609,.,0,0
9610,Patients,0,0
9611,in,0,0
9612,both,0,0
9613,groups,0,0
9614,were,0,0
9615,well-matched,0,0
9616,with,0,0
9617,baseline,0,0
9618,disease,0,0
9619,characteristics,0,0
9620,.,0,0
9621,RESULTS,0,0
9622,In,0,0
9623,group,0,0
9624,A,0,0
9625,with,0,0
9626,90,0,0
9627,evaluable,0,0
9628,patients,0,0
9629,",",0,0
9630,the,0,0
9631,response,1,1
9632,rate,1,1
9633,was,0,0
9634,25.6,0,0
9635,%,0,0
9636,(,0,0
9637,6,0,0
9638,CR,0,0
9639,",",0,0
9640,17,0,0
9641,PR,0,0
9642,),0,0
9643,whereas,0,0
9644,in,0,0
9645,group,0,0
9646,B,0,0
9647,with,0,0
9648,88,0,0
9649,evaluable,0,0
9650,patients,0,0
9651,",",0,0
9652,the,0,0
9653,response,1,1
9654,rate,1,1
9655,was,0,0
9656,31.8,0,0
9657,%,0,0
9658,(,0,0
9659,3,0,0
9660,CR,0,0
9661,",",0,0
9662,25,0,0
9663,PR,0,0
9664,),0,0
9665,",",0,0
9666,P,0,0
9667,=,0,0
9668,0.733,0,0
9669,.,0,0
9670,Median,1,0
9671,time,1,1
9672,to,1,0
9673,progression,1,1
9674,favored,0,0
9675,the,0,0
9676,high-dose,0,0
9677,paclitaxel,0,0
9678,(,0,0
9679,4.3,0,0
9680,vs.,0,0
9681,6.4,0,0
9682,months,0,0
9683,",",0,0
9684,P,0,0
9685,=,0,0
9686,0.044,0,0
9687,),0,0
9688,.,0,0
9689,The,0,0
9690,median,1,0
9691,survival,1,1
9692,was,0,0
9693,9.5,0,0
9694,months,0,0
9695,for,0,0
9696,group,0,0
9697,A,0,0
9698,versus,0,0
9699,11.4,0,0
9700,months,0,0
9701,for,0,0
9702,group,0,0
9703,B,0,0
9704,(,0,0
9705,P,0,0
9706,=,0,0
9707,0.16,0,0
9708,),0,0
9709,.,0,0
9710,The,0,0
9711,one-year,1,1
9712,survival,1,1
9713,was,0,0
9714,37,0,0
9715,%,0,0
9716,for,0,0
9717,group,0,0
9718,A,0,0
9719,and,0,0
9720,44,0,0
9721,%,0,0
9722,for,0,0
9723,group,0,0
9724,B,0,0
9725,(,0,0
9726,P,0,0
9727,=,0,0
9728,0.35,0,0
9729,),0,0
9730,.,0,0
9731,The,0,0
9732,best,0,0
9733,prognostic,0,1
9734,factor,0,0
9735,for,0,0
9736,one-year,1,1
9737,survival,1,1
9738,was,0,0
9739,the,0,0
9740,response,1,1
9741,rate,1,1
9742,(,0,0
9743,P,0,0
9744,<,0,0
9745,0.0001,0,0
9746,),0,0
9747,.,0,0
9748,With,0,0
9749,a,0,0
9750,relative,0,0
9751,dose,0,0
9752,intensity,0,1
9753,of,0,0
9754,paclitaxel,0,0
9755,0.94,0,0
9756,in,0,0
9757,both,0,0
9758,groups,0,0
9759,",",0,0
9760,neurotoxicity,1,1
9761,(,0,0
9762,P,0,0
9763,=,0,0
9764,0.025,0,0
9765,),0,0
9766,and,0,0
9767,leucopenia,1,1
9768,(,0,0
9769,P,0,0
9770,=,0,0
9771,0.038,0,0
9772,),0,0
9773,were,0,0
9774,more,0,0
9775,pronounced,0,0
9776,in,0,0
9777,group,0,0
9778,B,0,0
9779,patients,0,0
9780,.,0,0
9781,No,0,0
9782,toxic,1,1
9783,death,1,1
9784,was,0,0
9785,observed,0,0
9786,.,0,0
9787,CONCLUSIONS,0,0
9788,Higher,0,0
9789,dose,0,0
9790,paclitaxel,0,0
9791,prolongs,0,0
9792,the,0,0
9793,median,0,0
9794,time,0,1
9795,to,0,0
9796,progression,0,1
9797,but,0,0
9798,causes,0,0
9799,more,0,0
9800,neurotoxicity,0,1
9801,and,0,1
9802,leucopenia,0,1
9803,.,0,0
9804,The,0,0
9805,better,0,0
9806,response,0,1
9807,rate,0,1
9808,",",0,0
9809,the,0,0
9810,longer,0,0
9811,overall,0,1
9812,and,0,0
9813,better,0,0
9814,one-year,0,1
9815,survival,0,1
9816,seen,0,0
9817,with,0,0
9818,the,0,0
9819,higher,0,0
9820,dose,0,0
9821,of,0,0
9822,paclitaxel,0,0
9823,are,0,0
9824,not,0,0
9825,statistically,0,0
9826,significant,0,0
9827,.,0,0
9828,[,0,0
9829,Effectiveness,0,1
9830,of,0,0
9831,morphine,0,0
9832,by,0,0
9833,periarticular,0,1
9834,injections,0,0
9835,after,0,0
9836,shoulder,0,0
9837,arthroscopy,0,0
9838,],0,0
9839,.,0,0
9840,Peripheral,0,0
9841,opioid,0,0
9842,receptors,0,0
9843,have,0,0
9844,been,0,0
9845,found,0,0
9846,in,0,0
9847,inflamed,0,0
9848,synovia,0,1
9849,and,0,0
9850,the,0,0
9851,analgesic,0,1
9852,effect,0,0
9853,of,0,0
9854,intra-articularly,0,0
9855,administered,0,0
9856,morphine,0,0
9857,after,0,0
9858,arthroscopic,0,0
9859,knee,0,1
9860,surgery,0,0
9861,has,0,0
9862,been,0,0
9863,proven,0,0
9864,.,0,0
9865,There,0,0
9866,is,0,0
9867,controversy,0,0
9868,about,0,0
9869,efficacy,0,1
9870,of,0,0
9871,intraarticular,0,1
9872,morphine,0,0
9873,after,0,0
9874,shoulder,0,0
9875,arthroscopy,0,0
9876,.,0,0
9877,Thirty-two,0,0
9878,patients,0,0
9879,with,0,0
9880,impingement,0,0
9881,syndrome,0,0
9882,underwent,0,0
9883,subacromial,0,0
9884,decompression,0,0
9885,in,0,0
9886,the,0,0
9887,course,0,0
9888,of,0,0
9889,arthroscopic,0,0
9890,shoulder,0,0
9891,surgery,0,0
9892,.,0,0
9893,At,0,0
9894,the,0,0
9895,end,0,0
9896,of,0,0
9897,the,0,0
9898,operation,0,0
9899,morphine,0,0
9900,(,0,0
9901,5,0,0
9902,mg,0,0
9903,),0,0
9904,or,0,0
9905,saline,0,0
9906,was,0,0
9907,injected,0,0
9908,periarticularly,0,0
9909,.,0,0
9910,Pain,1,1
9911,intensity,1,1
9912,(,1,0
9913,rest,1,0
9914,and,1,1
9915,passive,1,1
9916,mobilisation,1,1
9917,),1,0
9918,was,0,0
9919,recorded,0,0
9920,after,0,0
9921,recovery,0,1
9922,and,0,0
9923,after,0,0
9924,"1,2,4",0,0
9925,",",0,0
9926,and,0,0
9927,24,0,0
9928,hours,0,0
9929,(,0,0
9930,Numeric,0,1
9931,Rating,0,1
9932,Scale,0,1
9933,),0,0
9934,;,0,0
9935,the,0,0
9936,use,1,0
9937,of,1,0
9938,rescue,1,1
9939,medication,1,1
9940,(,1,0
9941,piritramide,1,0
9942,by,1,0
9943,patient,1,0
9944,controlled,1,0
9945,analgesia,1,1
9946,),1,0
9947,was,0,0
9948,noted,0,0
9949,.,0,0
9950,No,0,0
9951,relevant,0,0
9952,pain,1,1
9953,reduction,1,1
9954,was,0,0
9955,apparent,0,0
9956,in,0,0
9957,the,0,0
9958,morphine,0,0
9959,group,0,0
9960,.,0,0
9961,Piritramide,1,0
9962,consumption,1,1
9963,was,0,0
9964,identical,0,0
9965,in,0,0
9966,both,0,0
9967,groups,0,0
9968,(,0,0
9969,19.7,0,0
9970,+/-,0,0
9971,16,0,0
9972,mg,0,0
9973,vs.,0,0
9974,19.8,0,0
9975,+/-,0,0
9976,19,0,0
9977,mg,0,0
9978,),0,0
9979,.,0,0
9980,We,0,0
9981,conclude,0,0
9982,that,0,0
9983,periarticularly,0,0
9984,administered,0,0
9985,morphine,0,0
9986,in,0,0
9987,arthroscopic,0,0
9988,subacromial,0,0
9989,decompression,0,0
9990,in,0,0
9991,the,0,0
9992,dosage,0,0
9993,applied,0,0
9994,in,0,0
9995,this,0,0
9996,study,0,0
9997,does,0,0
9998,exert,0,0
9999,no,0,0
10000,relevant,0,0
10001,analgesic,1,1
10002,effect,1,0
10003,.,1,0
10004,This,0,0
10005,is,0,0
10006,possibly,0,0
10007,due,0,0
10008,to,0,0
10009,the,0,0
10010,fact,0,0
10011,that,0,0
10012,either,0,0
10013,subacromial,0,0
10014,tissue,0,1
10015,",",0,0
10016,despite,0,0
10017,of,0,0
10018,chronic,0,0
10019,inflammation,0,0
10020,",",0,0
10021,does,0,0
10022,not,0,0
10023,show,0,0
10024,the,0,0
10025,same,0,0
10026,reagibility,0,1
10027,as,0,0
10028,synovia,0,1
10029,or,0,0
10030,it,0,0
10031,is,0,0
10032,a,0,0
10033,problem,0,0
10034,of,0,0
10035,the,0,0
10036,nearly,0,0
10037,complete,0,0
10038,resection,0,0
10039,of,0,0
10040,the,0,0
10041,subacromial,0,0
10042,bursa,0,0
10043,.,0,0
10044,Cost-effectiveness,0,1
10045,of,0,0
10046,clozapine,0,0
10047,compared,0,0
10048,with,0,0
10049,conventional,0,0
10050,antipsychotic,0,0
10051,medication,0,1
10052,for,0,0
10053,patients,0,0
10054,in,0,0
10055,state,0,0
10056,hospitals,0,0
10057,.,0,0
10058,BACKGROUND,0,0
10059,An,0,0
10060,open-label,0,0
10061,",",0,0
10062,randomized,0,0
10063,controlled,0,0
10064,trial,0,0
10065,compared,0,0
10066,clozapine,0,0
10067,with,0,0
10068,physicians'-choice,0,0
10069,medications,0,0
10070,among,0,0
10071,long-term,0,0
10072,state,0,0
10073,hospital,0,1
10074,inpatients,0,0
10075,in,0,0
10076,Connecticut,0,0
10077,.,0,0
10078,The,0,0
10079,goal,0,0
10080,was,0,0
10081,to,0,0
10082,examine,0,0
10083,clozapine,0,1
10084,'s,0,0
10085,cost-effectiveness,1,0
10086,in,0,0
10087,routine,0,0
10088,practice,0,0
10089,for,0,0
10090,people,0,0
10091,experiencing,0,1
10092,lengthy,0,0
10093,hospitalizations,0,1
10094,.,0,0
10095,METHODS,0,0
10096,Long-stay,0,0
10097,patients,0,0
10098,with,0,0
10099,schizophrenia,0,0
10100,in,0,0
10101,a,0,0
10102,state,0,0
10103,hospital,0,1
10104,were,0,0
10105,randomly,0,0
10106,assigned,0,0
10107,to,0,0
10108,begin,0,0
10109,open-label,0,0
10110,clozapine,0,0
10111,(,0,0
10112,n,0,0
10113,=,0,0
10114,138,0,0
10115,),0,0
10116,or,0,0
10117,to,0,0
10118,continue,0,0
10119,receiving,0,0
10120,conventional,0,0
10121,antipsychotic,0,0
10122,medications,0,0
10123,(,0,0
10124,n,0,0
10125,=,0,0
10126,89,0,0
10127,),0,0
10128,.,0,0
10129,We,0,0
10130,interviewed,0,0
10131,study,0,0
10132,participants,0,0
10133,every,0,0
10134,4,0,0
10135,months,0,0
10136,for,0,0
10137,2,0,0
10138,years,0,0
10139,to,0,0
10140,assess,1,0
10141,psychiatric,1,0
10142,symptoms,1,1
10143,and,1,0
10144,functional,1,1
10145,status,1,1
10146,",",0,0
10147,and,0,0
10148,we,0,0
10149,collected,0,0
10150,continuous,0,0
10151,measures,0,1
10152,of,0,0
10153,prescribed,0,0
10154,medications,0,0
10155,",",0,0
10156,service,0,1
10157,utilization,0,1
10158,",",0,0
10159,and,0,1
10160,other,0,0
10161,costs,0,1
10162,.,0,0
10163,We,0,0
10164,used,0,0
10165,both,0,0
10166,parametric,0,0
10167,and,0,0
10168,nonparametric,0,0
10169,techniques,0,0
10170,to,0,0
10171,examine,0,0
10172,changes,1,1
10173,in,1,0
10174,cost,1,1
10175,and,1,0
10176,parametric,1,1
10177,analyses,1,0
10178,to,0,0
10179,examine,0,0
10180,changes,1,1
10181,in,1,0
10182,effectiveness,1,0
10183,.,1,0
10184,We,0,0
10185,used,0,0
10186,bootstrap,1,0
10187,techniques,1,0
10188,to,0,0
10189,estimate,1,0
10190,incremental,1,0
10191,cost-effectiveness,1,0
10192,ratios,1,1
10193,and,0,0
10194,create,0,0
10195,cost-effectiveness,1,0
10196,acceptability,1,1
10197,curves,1,1
10198,.,1,0
10199,RESULTS,0,0
10200,Both,0,0
10201,groups,0,0
10202,incurred,0,0
10203,similar,0,0
10204,costs,0,1
10205,during,0,0
10206,the,0,0
10207,2-year,0,0
10208,study,0,0
10209,period,0,0
10210,",",0,0
10211,with,0,0
10212,a,0,0
10213,trend,0,0
10214,for,0,0
10215,clozapine,0,0
10216,to,0,0
10217,be,0,0
10218,less,1,0
10219,costly,1,0
10220,than,0,0
10221,usual,0,0
10222,care,0,0
10223,in,0,0
10224,the,0,0
10225,second,0,0
10226,study,0,0
10227,year,0,0
10228,.,0,0
10229,Clozapine,0,1
10230,was,0,0
10231,more,0,0
10232,effective,1,1
10233,than,0,0
10234,usual,0,0
10235,care,0,0
10236,on,0,0
10237,many,0,0
10238,but,0,0
10239,not,0,0
10240,all,0,0
10241,measures,0,0
10242,.,0,0
10243,With,0,0
10244,the,0,0
10245,use,0,0
10246,of,0,0
10247,effectiveness,1,1
10248,measures,1,1
10249,that,0,0
10250,favored,0,0
10251,clozapine,0,0
10252,(,0,0
10253,extrapyramidal,0,1
10254,side,0,1
10255,effects,0,1
10256,",",0,1
10257,disruptiveness,0,1
10258,),0,1
10259,",",0,0
10260,bootstrap,0,1
10261,techniques,0,0
10262,indicated,0,0
10263,that,0,0
10264,",",0,0
10265,even,0,0
10266,when,0,0
10267,a,0,0
10268,payer,0,0
10269,is,0,0
10270,unwilling,0,0
10271,to,0,0
10272,incur,0,0
10273,any,0,0
10274,additional,0,0
10275,cost,0,1
10276,for,0,0
10277,gains,0,1
10278,in,0,0
10279,effectiveness,0,1
10280,",",0,0
10281,the,0,0
10282,probability,0,1
10283,that,0,0
10284,clozapine,0,0
10285,is,0,0
10286,more,1,0
10287,cost-effective,1,0
10288,than,0,0
10289,usual,0,0
10290,care,0,0
10291,is,0,0
10292,at,0,0
10293,least,0,0
10294,0.80,0,0
10295,.,0,0
10296,These,0,0
10297,findings,0,0
10298,were,0,0
10299,not,0,0
10300,as,0,0
10301,evident,0,0
10302,when,0,0
10303,outcomes,0,1
10304,where,0,0
10305,clozapine,0,0
10306,was,0,0
10307,not,0,0
10308,clearly,0,0
10309,superior,0,0
10310,(,1,0
10311,psychotic,1,1
10312,symptoms,1,1
10313,",",1,0
10314,weight,1,1
10315,gain,1,1
10316,),1,0
10317,were,0,0
10318,examined,0,0
10319,.,0,0
10320,CONCLUSION,0,0
10321,Clozapine,0,1
10322,demonstrated,0,0
10323,cost-effectiveness,1,0
10324,on,0,0
10325,some,0,0
10326,but,0,0
10327,not,0,0
10328,all,0,0
10329,measures,0,0
10330,of,0,0
10331,effectiveness,0,0
10332,when,0,0
10333,the,0,0
10334,alternative,0,0
10335,was,0,0
10336,a,0,0
10337,range,0,0
10338,of,0,0
10339,conventional,0,0
10340,antipsychotic,0,0
10341,medications,0,0
10342,.,0,0
10343,Beta,0,1
10344,radiation,0,0
10345,as,0,0
10346,an,0,0
10347,adjunct,0,0
10348,to,0,0
10349,low-risk,0,0
10350,trabeculectomy,0,0
10351,.,0,0
10352,PURPOSE,0,0
10353,To,0,0
10354,assess,0,0
10355,a,0,0
10356,single,0,0
10357,dose,0,0
10358,of,0,0
10359,intraoperative,0,1
10360,beta,0,1
10361,radiation,0,0
10362,used,0,0
10363,to,0,0
10364,enhance,0,0
10365,the,0,0
10366,success,0,1
10367,rate,0,1
10368,of,0,0
10369,trabeculectomy,0,0
10370,in,0,0
10371,a,0,0
10372,population,0,0
10373,of,0,0
10374,low-risk,0,0
10375,glaucoma,0,0
10376,patients,0,0
10377,in,0,0
10378,whom,0,0
10379,antimetabolites,0,0
10380,might,0,0
10381,not,0,0
10382,be,0,0
10383,indicated,0,0
10384,.,0,0
10385,METHODS,0,0
10386,A,0,0
10387,prospective,0,0
10388,randomized,0,0
10389,trial,0,0
10390,of,0,0
10391,65,0,0
10392,eyes,0,0
10393,was,0,0
10394,designed,0,0
10395,",",0,0
10396,with,0,0
10397,31,0,0
10398,eyes,0,0
10399,receiving,0,0
10400,750,0,0
10401,rads,0,0
10402,of,0,0
10403,intraoperative,0,0
10404,beta,0,1
10405,radiation,0,0
10406,(,0,0
10407,group,0,0
10408,1,0,0
10409,),0,0
10410,",",0,0
10411,and,0,0
10412,34,0,0
10413,eyes,0,0
10414,receiving,0,0
10415,no,0,0
10416,supplementation,0,0
10417,(,0,0
10418,group,0,0
10419,2,0,0
10420,),0,0
10421,.,0,0
10422,RESULTS,0,0
10423,Mean,0,0
10424,follow-up,0,0
10425,time,0,1
10426,was,0,0
10427,24,0,0
10428,months,0,0
10429,.,0,0
10430,Mean,1,0
10431,postoperative,1,1
10432,intraocular,1,1
10433,pressure,1,1
10434,was,0,0
10435,12.2,0,0
10436,mmHg,0,0
10437,in,0,0
10438,group,0,0
10439,1,0,0
10440,",",0,0
10441,and,0,0
10442,13.7,0,0
10443,mmHg,0,0
10444,in,0,0
10445,group,0,0
10446,2,0,0
10447,(,0,0
10448,P,0,0
10449,=,0,0
10450,0.16,0,0
10451,),0,0
10452,.,0,0
10453,Mean,0,0
10454,decrease,0,0
10455,in,0,0
10456,intraocular,1,1
10457,pressure,1,1
10458,was,0,0
10459,10.3,0,0
10460,mmHg,0,0
10461,in,0,0
10462,group,0,0
10463,1,0,0
10464,",",0,0
10465,and,0,0
10466,9.3,0,0
10467,mmHg,0,0
10468,in,0,0
10469,group,0,0
10470,2,0,0
10471,(,0,0
10472,P,0,0
10473,=,0,0
10474,0.49,0,0
10475,),0,0
10476,.,0,0
10477,The,0,0
10478,two,0,0
10479,groups,0,0
10480,were,0,0
10481,not,0,0
10482,significantly,0,0
10483,different,0,0
10484,in,0,0
10485,terms,0,0
10486,of,0,0
10487,surgical,1,0
10488,complications,1,1
10489,.,1,0
10490,CONCLUSION,0,0
10491,For,0,0
10492,this,0,0
10493,population,0,0
10494,of,0,0
10495,low-risk,0,0
10496,patients,0,0
10497,",",0,0
10498,there,0,0
10499,was,0,0
10500,no,0,0
10501,significant,0,0
10502,difference,0,0
10503,in,0,0
10504,outcome,0,1
10505,after,0,0
10506,applications,0,0
10507,of,0,0
10508,a,0,0
10509,single,0,0
10510,intraoperative,0,0
10511,dose,0,0
10512,of,0,0
10513,beta,0,0
10514,radiation,0,0
10515,.,0,0
10516,Short-,0,0
10517,and,0,0
10518,long-term,0,0
10519,results,0,0
10520,after,0,0
10521,thrombolytic,0,0
10522,treatment,0,0
10523,of,0,0
10524,deep,0,0
10525,venous,0,1
10526,thrombosis,0,1
10527,.,0,0
10528,OBJECTIVES,0,0
10529,The,0,0
10530,goal,0,0
10531,of,0,0
10532,this,0,0
10533,study,0,0
10534,was,0,0
10535,to,0,0
10536,assess,0,0
10537,the,0,0
10538,short-,0,0
10539,and,0,0
10540,long-term,0,1
10541,efficacy,0,1
10542,of,0,0
10543,different,0,0
10544,thrombolytic,0,0
10545,therapy,0,0
10546,regimens,0,0
10547,in,0,0
10548,patients,0,0
10549,with,0,0
10550,leg,0,1
10551,or,0,0
10552,pelvic,0,0
10553,deep,0,0
10554,venous,0,1
10555,thrombosis,0,1
10556,(,0,0
10557,DVT,0,0
10558,),0,0
10559,.,0,0
10560,BACKGROUND,0,0
10561,It,0,0
10562,is,0,0
10563,unclear,0,0
10564,whether,0,0
10565,locoregional,0,0
10566,or,0,0
10567,systemic,0,0
10568,thrombolysis,0,0
10569,is,0,0
10570,superior,0,0
10571,in,0,0
10572,treating,0,0
10573,acute,0,0
10574,leg,0,1
10575,DVT,0,1
10576,or,0,0
10577,even,0,0
10578,whether,0,0
10579,lysis,0,1
10580,is,0,0
10581,more,0,0
10582,effective,0,1
10583,than,0,0
10584,anticoagulation,0,0
10585,therapy,0,0
10586,in,0,0
10587,preventing,0,0
10588,postthrombotic,0,0
10589,syndrome,0,0
10590,.,0,0
10591,METHODS,0,0
10592,A,0,0
10593,total,0,1
10594,of,0,0
10595,250,0,0
10596,patients,0,0
10597,averaging,0,0
10598,40,0,0
10599,years,0,0
10600,of,0,0
10601,age,0,0
10602,with,0,0
10603,acute,0,0
10604,DVT,0,0
10605,were,0,0
10606,randomized,0,0
10607,into,0,0
10608,five,0,0
10609,groups,0,0
10610,to,0,0
10611,receive,0,0
10612,full,0,0
10613,heparinization,0,0
10614,(,0,0
10615,"1,000",0,0
10616,IU/h,0,1
10617,),0,0
10618,and,0,0
10619,compression,0,1
10620,treatment,0,0
10621,",",0,0
10622,with,0,0
10623,four,0,0
10624,groups,0,0
10625,also,0,0
10626,administered,0,0
10627,locoregional,0,1
10628,tissue,0,1
10629,plasminogen,0,1
10630,activator,0,0
10631,(,0,0
10632,20,0,0
10633,mg/day,0,0
10634,),0,0
10635,or,0,0
10636,urokinase,0,0
10637,(,0,0
10638,"100,000",0,0
10639,IU/day,0,0
10640,),0,0
10641,or,0,0
10642,systemic,0,1
10643,streptokinase,0,0
10644,(,0,0
10645,"3,000,000",0,0
10646,IU,0,0
10647,daily,0,0
10648,),0,0
10649,or,0,0
10650,urokinase,0,0
10651,(,0,0
10652,"5,000,000",0,0
10653,IU,0,0
10654,daily,0,0
10655,),0,0
10656,.,0,0
10657,All,0,0
10658,groups,0,0
10659,then,0,0
10660,received,0,0
10661,anticoagulation,0,0
10662,and,0,1
10663,compression,0,1
10664,treatment,0,0
10665,for,0,0
10666,one,0,0
10667,year,0,0
10668,.,0,0
10669,Primary,0,1
10670,efficacy,0,1
10671,criteria,0,0
10672,included,0,0
10673,the,0,0
10674,change,0,0
10675,after,0,0
10676,one,0,0
10677,year,0,0
10678,in,0,0
10679,the,0,0
10680,number,0,1
10681,of,0,0
10682,closed,1,0
10683,vein,1,0
10684,segments,1,0
10685,and,0,0
10686,the,0,0
10687,occurrence,0,1
10688,of,0,0
10689,postthrombotic,0,0
10690,syndrome,0,0
10691,.,0,0
10692,RESULTS,0,0
10693,Systemic,0,0
10694,thrombolytic,0,0
10695,therapy,0,0
10696,significantly,0,0
10697,reduced,0,0
10698,the,0,0
10699,number,0,1
10700,of,0,0
10701,closed,1,0
10702,vein,1,0
10703,segments,1,0
10704,after,0,0
10705,12,0,0
10706,months,0,0
10707,in,0,0
10708,patients,0,0
10709,with,0,0
10710,acute,0,0
10711,DVT,0,0
10712,compared,0,0
10713,with,0,0
10714,conventional,0,0
10715,treatment,0,0
10716,(,0,0
10717,p,0,0
10718,<,0,0
10719,0.05,0,0
10720,),0,0
10721,.,0,0
10722,Postthrombotic,1,0
10723,syndrome,1,0
10724,also,0,0
10725,occurred,0,0
10726,with,0,0
10727,less,0,0
10728,frequency,0,1
10729,in,0,0
10730,systemically,0,0
10731,treated,0,0
10732,patients,0,0
10733,versus,0,0
10734,controls,0,0
10735,(,0,0
10736,p,0,0
10737,<,0,0
10738,0.001,0,0
10739,),0,0
10740,.,0,0
10741,High-dose,0,0
10742,thrombolysis,0,0
10743,led,0,0
10744,to,0,0
10745,better,0,0
10746,rates,0,1
10747,of,0,0
10748,complete,1,1
10749,recanalization,1,1
10750,after,0,0
10751,seven,0,0
10752,days,0,0
10753,(,0,0
10754,p,0,0
10755,<,0,0
10756,0.01,0,0
10757,),0,0
10758,than,0,0
10759,locoregional,0,0
10760,lysis,0,1
10761,.,0,0
10762,However,0,0
10763,",",0,0
10764,12,0,0
10765,patients,0,0
10766,receiving,0,0
10767,thrombolysis,0,0
10768,(,0,0
10769,9,0,0
10770,systemic,0,0
10771,",",0,0
10772,3,0,0
10773,local,0,0
10774,),0,0
10775,suffered,0,0
10776,major,1,0
10777,bleeding,1,1
10778,complications,1,1
10779,;,1,0
10780,9,0,0
10781,patients,0,0
10782,on,0,0
10783,systemic,0,1
10784,treatment,0,0
10785,developed,0,0
10786,pulmonary,1,1
10787,emboli,1,0
10788,.,1,0
10789,CONCLUSIONS,0,0
10790,Systemic,0,0
10791,thrombolytic,0,0
10792,treatment,0,0
10793,for,0,0
10794,acute,0,0
10795,DVT,0,0
10796,achieved,0,0
10797,a,0,0
10798,significantly,0,0
10799,better,0,0
10800,short-,0,1
10801,and,0,1
10802,long-term,0,1
10803,clinical,0,0
10804,outcome,0,0
10805,than,0,0
10806,conventional,0,0
10807,heparin/anticoagulation,0,0
10808,therapy,0,0
10809,but,0,0
10810,at,0,0
10811,the,0,0
10812,expense,0,0
10813,of,0,0
10814,a,0,0
10815,serious,0,1
10816,increase,0,0
10817,in,0,0
10818,major,0,1
10819,bleeding,0,1
10820,and,0,0
10821,pulmonary,0,1
10822,emboli,0,1
10823,.,0,0
10824,Given,0,0
10825,the,0,0
10826,inherent,0,0
10827,risks,0,1
10828,for,0,0
10829,such,0,0
10830,serious,0,1
10831,complications,0,1
10832,",",0,0
10833,systemic,0,1
10834,thrombolysis,0,0
10835,",",0,0
10836,although,0,0
10837,effective,0,0
10838,",",0,0
10839,should,0,0
10840,be,0,0
10841,used,0,0
10842,selectively,0,0
10843,in,0,0
10844,limb-threatening,0,0
10845,thrombotic,0,1
10846,situations,0,0
10847,.,0,0
10848,Epidural,0,0
10849,fentanyl-bupivacaine,0,0
10850,compared,0,0
10851,with,0,0
10852,clonidine-bupivacaine,0,0
10853,for,0,0
10854,analgesia,0,1
10855,in,0,0
10856,labour,0,0
10857,.,0,0
10858,Alpha-adrenergic,0,0
10859,agonists,0,0
10860,produce,0,0
10861,pain,1,1
10862,relief,1,1
10863,through,0,0
10864,an,0,0
10865,opioid,0,0
10866,independent,0,0
10867,mechanism,0,0
10868,and,0,0
10869,may,0,0
10870,be,0,0
10871,alternatives,0,0
10872,to,0,0
10873,opioids,0,0
10874,for,0,0
10875,combination,0,0
10876,with,0,0
10877,local,0,0
10878,anaesthetics,0,0
10879,for,0,0
10880,analgesia,0,1
10881,during,0,0
10882,labour,0,0
10883,.,0,0
10884,We,0,0
10885,studied,0,0
10886,41,0,0
10887,pregnant,0,0
10888,women,0,0
10889,.,0,0
10890,Epidural,0,0
10891,block,0,0
10892,was,0,0
10893,performed,0,0
10894,with,0,0
10895,75,0,0
10896,microg,0,0
10897,clonidine,0,0
10898,(,0,0
10899,n,0,0
10900,=,0,0
10901,20,0,0
10902,),0,0
10903,or,0,0
10904,50,0,0
10905,microg,0,0
10906,fentanyl,0,0
10907,(,0,0
10908,n,0,0
10909,=,0,0
10910,21,0,0
10911,),0,0
10912,combined,0,0
10913,with,0,0
10914,0.125,0,0
10915,%,0,0
10916,bupivacaine,0,0
10917,(,0,0
10918,10,0,0
10919,mL,0,0
10920,),0,0
10921,.,0,0
10922,Maternal,1,0
10923,vital,1,1
10924,parameters,1,1
10925,were,0,0
10926,measured,0,0
10927,.,0,0
10928,Analgesia,1,0
10929,was,0,0
10930,evaluated,0,0
10931,using,0,0
10932,a,0,0
10933,visual,0,1
10934,analogue,0,1
10935,scale,0,1
10936,(,0,0
10937,VAS,0,0
10938,),0,0
10939,;,0,0
10940,sedation,1,1
10941,was,0,0
10942,scored,0,0
10943,using,0,0
10944,a,0,0
10945,five-point,0,0
10946,scale,0,1
10947,.,0,0
10948,There,0,0
10949,were,0,0
10950,no,0,0
10951,differences,0,0
10952,in,0,0
10953,maternal,1,1
10954,vital,1,1
10955,parameters,1,1
10956,",",1,0
10957,fetal,1,1
10958,heart,1,1
10959,rate,1,1
10960,(,1,0
10961,FHR,1,0
10962,),1,0
10963,or,1,0
10964,Apgar,1,1
10965,scores,1,1
10966,between,0,0
10967,the,0,0
10968,groups,0,0
10969,.,0,0
10970,Analgesia,1,1
10971,lasted,0,0
10972,longer,0,0
10973,in,0,0
10974,the,0,0
10975,bupivacaine-clonidine,0,0
10976,group,0,0
10977,(,0,0
10978,139.4,0,0
10979,+/-,0,0
10980,31,0,0
10981,min,0,0
10982,),0,0
10983,compared,0,0
10984,with,0,0
10985,the,0,0
10986,bupivacaine-fentanyl,0,0
10987,group,0,0
10988,(,0,0
10989,127.9,0,0
10990,+/-,0,0
10991,48,0,0
10992,min,0,0
10993,),0,0
10994,(,0,0
10995,P,0,0
10996,=,0,0
10997,0.42,0,0
10998,),0,0
10999,.,0,0
11000,Additional,1,0
11001,analgesic,1,1
11002,requirement,1,1
11003,was,0,0
11004,more,0,0
11005,often,0,0
11006,in,0,0
11007,the,0,0
11008,fentanyl-bupivacaine,0,0
11009,group,0,0
11010,and,0,0
11011,total,0,1
11012,bupivacaine,0,0
11013,requirement,0,1
11014,was,0,0
11015,less,0,0
11016,in,0,0
11017,the,0,0
11018,clonidine-bupivacaine,0,0
11019,group,0,0
11020,(,0,0
11021,22.5,0,0
11022,+/-,0,0
11023,12.5,0,0
11024,mg,0,0
11025,vs.,0,0
11026,30.9,0,0
11027,+/-,0,0
11028,12.8,0,0
11029,mg,0,0
11030,),0,0
11031,(,0,0
11032,P,0,0
11033,=,0,0
11034,0.04,0,0
11035,),0,0
11036,.,0,0
11037,This,0,0
11038,small,0,0
11039,study,0,0
11040,confirms,0,0
11041,that,0,0
11042,this,0,0
11043,combination,0,0
11044,of,0,0
11045,bupivacaine,0,0
11046,and,0,0
11047,clonidine,0,0
11048,provides,0,0
11049,satisfactory,1,1
11050,analgesia,1,1
11051,for,0,0
11052,first-stage,0,0
11053,labour,0,1
11054,",",0,0
11055,and,0,1
11056,of,0,1
11057,longer,0,0
11058,duration,1,1
11059,than,0,0
11060,bupivacaine-fentanyl,0,0
11061,.,0,0
11062,Effect,0,0
11063,of,0,0
11064,systemic,0,0
11065,nitric,0,1
11066,oxide,0,0
11067,synthase,0,0
11068,inhibition,0,1
11069,on,0,0
11070,postexercise,0,0
11071,hypotension,0,1
11072,in,0,0
11073,humans,0,0
11074,.,0,0
11075,An,0,0
11076,acute,0,0
11077,bout,0,1
11078,of,0,0
11079,aerobic,0,0
11080,exercise,0,0
11081,results,0,0
11082,in,0,0
11083,a,0,0
11084,reduced,0,0
11085,blood,1,1
11086,pressure,1,1
11087,that,0,0
11088,lasts,0,0
11089,several,0,0
11090,hours,0,0
11091,.,0,0
11092,Animal,0,0
11093,studies,0,0
11094,suggest,0,0
11095,this,0,0
11096,response,0,0
11097,is,0,0
11098,mediated,0,0
11099,by,0,0
11100,increased,0,0
11101,production,0,1
11102,of,0,0
11103,nitric,0,1
11104,oxide,0,0
11105,.,0,0
11106,We,0,0
11107,tested,0,0
11108,the,0,0
11109,extent,0,0
11110,to,0,0
11111,which,0,0
11112,systemic,0,0
11113,nitric,0,1
11114,oxide,0,0
11115,synthase,0,0
11116,inhibition,0,1
11117,[,0,0
11118,N,0,0
11119,(,0,0
11120,G,0,0
11121,),0,1
11122,-monomethyl-L-arginine,0,0
11123,(,0,0
11124,L-NMMA,0,0
11125,),0,0
11126,],0,0
11127,can,0,0
11128,reverse,0,0
11129,the,0,0
11130,drop,0,0
11131,in,0,0
11132,blood,1,1
11133,pressure,1,1
11134,that,0,0
11135,occurs,0,0
11136,after,0,0
11137,exercise,0,0
11138,in,0,0
11139,humans,0,0
11140,.,0,0
11141,Eight,0,0
11142,healthy,0,0
11143,subjects,0,0
11144,underwent,0,0
11145,parallel,0,0
11146,experiments,0,0
11147,on,0,0
11148,2,0,0
11149,separate,0,0
11150,days,0,0
11151,.,0,0
11152,The,0,0
11153,order,0,0
11154,of,0,0
11155,the,0,0
11156,experiments,0,0
11157,was,0,0
11158,randomized,0,0
11159,between,0,0
11160,sham,0,0
11161,(,0,0
11162,60,0,0
11163,min,0,0
11164,of,0,0
11165,seated,0,0
11166,upright,0,0
11167,rest,0,0
11168,),0,0
11169,and,0,1
11170,exercise,0,0
11171,(,0,0
11172,60,0,0
11173,min,0,0
11174,of,0,0
11175,upright,0,0
11176,cycling,0,0
11177,at,0,0
11178,60,0,0
11179,%,0,0
11180,peak,0,1
11181,aerobic,0,1
11182,capacity,0,1
11183,),0,0
11184,.,0,0
11185,After,0,0
11186,both,0,0
11187,sham,0,0
11188,and,0,1
11189,exercise,0,0
11190,",",0,0
11191,subjects,0,0
11192,received,0,0
11193,",",0,0
11194,in,0,0
11195,sequence,0,1
11196,",",0,0
11197,systemic,0,1
11198,alpha-adrenergic,0,1
11199,blockade,0,0
11200,(,0,0
11201,phentolamine,0,0
11202,),0,1
11203,and,0,0
11204,L-NMMA,0,0
11205,.,0,1
11206,Phentolamine,0,0
11207,was,0,0
11208,given,0,0
11209,first,0,0
11210,to,0,0
11211,isolate,0,0
11212,the,0,0
11213,contribution,0,0
11214,of,0,0
11215,nitric,0,1
11216,oxide,0,0
11217,to,0,0
11218,postexercise,0,0
11219,hypotension,0,1
11220,by,0,0
11221,preventing,0,0
11222,reflex,0,1
11223,changes,0,1
11224,in,0,0
11225,sympathetic,0,1
11226,tone,0,1
11227,that,0,0
11228,result,0,0
11229,from,0,0
11230,systemic,0,0
11231,nitric,0,1
11232,oxide,0,0
11233,synthase,0,0
11234,inhibition,0,1
11235,and,0,0
11236,to,0,0
11237,control,0,0
11238,for,0,0
11239,alterations,0,0
11240,in,0,0
11241,resting,0,0
11242,sympathetic,0,1
11243,activity,0,1
11244,after,0,0
11245,exercise,0,0
11246,.,0,0
11247,During,0,0
11248,each,0,0
11249,condition,0,0
11250,",",0,0
11251,systemic,1,1
11252,and,1,1
11253,regional,1,0
11254,hemodynamics,1,1
11255,were,0,0
11256,measured,0,0
11257,.,0,0
11258,Throughout,0,0
11259,the,0,0
11260,study,0,0
11261,",",0,0
11262,arterial,1,1
11263,pressure,1,1
11264,and,1,0
11265,vascular,1,1
11266,resistances,1,1
11267,remained,0,0
11268,lower,0,0
11269,postexercise,0,0
11270,vs.,0,0
11271,postsham,0,0
11272,despite,0,0
11273,nitric,1,1
11274,oxide,1,0
11275,synthase,1,1
11276,inhibition,0,1
11277,(,0,0
11278,e.g.,0,0
11279,",",0,0
11280,mean,1,1
11281,arterial,1,1
11282,pressure,1,1
11283,after,1,0
11284,L-NMMA,1,0
11285,was,0,0
11286,108.0+/-2.4,0,0
11287,mmHg,0,0
11288,postsham,0,0
11289,vs.,0,0
11290,102.1+/-3.3,0,0
11291,mmHg,0,0
11292,postexercise,0,0
11293,;,0,0
11294,P,0,0
11295,<,0,0
11296,0.05,0,0
11297,),0,0
11298,.,0,0
11299,Thus,0,0
11300,it,0,0
11301,does,0,0
11302,not,0,0
11303,appear,0,0
11304,that,0,0
11305,postexercise,1,0
11306,hypotension,1,1
11307,is,0,0
11308,dependent,0,0
11309,on,0,0
11310,increased,0,0
11311,production,1,1
11312,of,1,0
11313,nitric,1,1
11314,oxide,1,0
11315,in,0,0
11316,humans,0,0
11317,.,0,0
11318,Magnetic,0,0
11319,resonance,0,0
11320,angiography,0,0
11321,for,0,0
11322,monitoring,0,0
11323,prophylactic,0,0
11324,endoscopic,0,1
11325,treatment,0,0
11326,of,0,0
11327,high,0,0
11328,risk,0,1
11329,esophageal,0,0
11330,varices,0,1
11331,.,0,0
11332,BACKGROUND,0,0
11333,AND,0,0
11334,STUDY,0,1
11335,AIMS,0,1
11336,Endoscopic,0,1
11337,injection,0,0
11338,sclerotherapy,0,0
11339,(,0,0
11340,EIS,0,1
11341,),0,0
11342,and,0,0
11343,endoscopic,0,1
11344,variceal,0,1
11345,ligation,0,0
11346,(,0,0
11347,EVL,0,0
11348,),0,0
11349,are,0,0
11350,used,0,0
11351,worldwide,0,0
11352,as,0,0
11353,the,0,0
11354,treatment,0,0
11355,for,0,0
11356,esophageal,0,0
11357,varices,0,0
11358,.,0,0
11359,We,0,0
11360,evaluated,0,0
11361,portal,0,1
11362,hemodynamics,0,1
11363,using,0,0
11364,magnetic,0,0
11365,resonance,0,0
11366,angiography,0,0
11367,(,0,0
11368,MRA,0,0
11369,),0,0
11370,in,0,0
11371,these,0,0
11372,two,0,0
11373,forms,0,0
11374,of,0,0
11375,treatment,0,0
11376,.,0,0
11377,PATIENTS,0,0
11378,AND,0,0
11379,METHODS,0,0
11380,The,0,0
11381,study,0,0
11382,was,0,0
11383,carried,0,0
11384,out,0,0
11385,in,0,0
11386,50,0,0
11387,cirrhotic,0,0
11388,patients,0,0
11389,.,0,0
11390,MRA,0,0
11391,was,0,0
11392,performed,0,0
11393,to,0,0
11394,identify,0,0
11395,the,0,0
11396,hepatofugal,0,0
11397,supply,0,0
11398,vein,0,0
11399,selectively,0,0
11400,for,0,0
11401,esophageal,0,0
11402,varices,0,0
11403,.,0,0
11404,Those,0,0
11405,who,0,0
11406,showed,0,0
11407,a,0,0
11408,positive,0,0
11409,MR,0,0
11410,angiogram,0,0
11411,for,0,0
11412,the,0,0
11413,supply,0,0
11414,vein,0,1
11415,were,0,0
11416,randomly,0,0
11417,allocated,0,0
11418,to,0,0
11419,one,0,0
11420,of,0,0
11421,two,0,0
11422,groups,0,0
11423,",",0,0
11424,using,0,0
11425,the,0,0
11426,sealed,0,0
11427,envelope,0,0
11428,method,0,0
11429,",",0,0
11430,and,0,1
11431,underwent,0,0
11432,either,0,0
11433,EIS,0,1
11434,or,0,0
11435,EVL,0,0
11436,.,0,0
11437,On,0,0
11438,the,0,0
11439,other,0,0
11440,hand,0,0
11441,",",0,0
11442,those,0,0
11443,with,0,0
11444,a,0,0
11445,negative,0,1
11446,angiogram,0,0
11447,received,0,0
11448,only,0,0
11449,EVL,0,0
11450,.,0,0
11451,EIS,0,1
11452,was,0,0
11453,done,0,0
11454,to,0,0
11455,embolize,0,1
11456,esophageal,0,0
11457,varices,0,1
11458,as,0,0
11459,well,0,0
11460,as,0,0
11461,their,0,0
11462,feeders,0,0
11463,by,0,0
11464,intravariceal,0,1
11465,injection,0,0
11466,of,0,0
11467,sclerosant,0,0
11468,under,0,0
11469,fluoroscopic,0,0
11470,guidance,0,0
11471,.,0,0
11472,RESULTS,0,0
11473,A,0,0
11474,positive,0,1
11475,MR,0,0
11476,angiogram,0,0
11477,of,0,0
11478,the,0,0
11479,hepatofugal,0,0
11480,left,0,0
11481,gastric,0,1
11482,vein,0,0
11483,as,0,0
11484,the,0,0
11485,supply,0,0
11486,vein,0,1
11487,was,0,0
11488,observed,0,0
11489,in,0,0
11490,41,0,0
11491,patients,0,0
11492,.,0,0
11493,Nine,0,0
11494,patients,0,0
11495,showed,0,0
11496,negative,0,1
11497,MRA,0,0
11498,results,0,0
11499,.,0,0
11500,Among,0,0
11501,those,0,0
11502,with,0,0
11503,positive,0,0
11504,angiograms,0,0
11505,",",0,0
11506,the,0,0
11507,rate,1,1
11508,of,1,0
11509,eradication,1,1
11510,of,1,0
11511,the,1,0
11512,left,1,0
11513,gastric,1,1
11514,vein,1,0
11515,was,0,0
11516,higher,0,0
11517,in,0,0
11518,the,0,0
11519,EIS-treated,0,0
11520,group,0,0
11521,than,0,0
11522,in,0,0
11523,the,0,0
11524,EVL,0,0
11525,treated,0,0
11526,group,0,0
11527,(,0,0
11528,50,0,0
11529,%,0,0
11530,vs.,0,0
11531,8.6,0,0
11532,%,0,0
11533,),0,0
11534,.,0,0
11535,After,0,0
11536,either,0,0
11537,treatment,0,0
11538,",",0,0
11539,the,0,0
11540,recurrence-free,1,1
11541,rate,1,1
11542,for,1,0
11543,high,1,0
11544,risk,1,1
11545,esophageal,1,1
11546,varices,1,1
11547,was,0,0
11548,higher,0,0
11549,in,0,0
11550,patients,0,0
11551,with,0,0
11552,complete,0,1
11553,eradication,0,1
11554,of,0,0
11555,the,0,0
11556,left,0,0
11557,gastric,0,1
11558,vein,0,1
11559,than,0,0
11560,in,0,0
11561,those,0,0
11562,without,0,0
11563,(,0,0
11564,88,0,0
11565,%,0,0
11566,vs.,0,0
11567,35,0,0
11568,%,0,0
11569,),0,0
11570,.,0,0
11571,In,0,0
11572,patients,0,0
11573,with,0,0
11574,negative,0,1
11575,angiogram,0,1
11576,results,0,0
11577,",",0,0
11578,who,0,0
11579,only,0,0
11580,underwent,0,0
11581,EVL,0,0
11582,",",0,0
11583,high,0,1
11584,risk,1,1
11585,esophageal,1,1
11586,varices,1,1
11587,did,0,0
11588,not,0,0
11589,reappear,0,0
11590,over,0,0
11591,a,0,0
11592,long,0,0
11593,period,0,0
11594,.,0,0
11595,CONCLUSION,0,0
11596,MRA,0,0
11597,is,0,0
11598,useful,0,0
11599,for,0,0
11600,evaluating,0,0
11601,portal,0,0
11602,hemodynamics,0,1
11603,.,0,0
11604,With,0,0
11605,the,0,0
11606,aim,0,0
11607,of,0,0
11608,avoiding,0,0
11609,recurrence,0,1
11610,of,0,0
11611,esophageal,0,0
11612,varices,0,1
11613,",",0,0
11614,EIS,0,1
11615,was,0,0
11616,suitable,0,0
11617,for,0,0
11618,patients,0,0
11619,who,0,0
11620,had,0,0
11621,a,0,0
11622,hepatofugal,0,1
11623,supply,0,0
11624,vein,0,0
11625,for,0,0
11626,the,0,0
11627,varices,0,1
11628,because,0,0
11629,recurrence,0,1
11630,could,0,0
11631,be,0,0
11632,prevented,0,0
11633,by,0,0
11634,embolization,0,1
11635,of,0,0
11636,the,0,0
11637,supply,0,0
11638,vein,0,0
11639,.,0,0
11640,EVL,0,0
11641,may,0,0
11642,be,0,0
11643,expected,0,0
11644,to,0,0
11645,be,0,0
11646,efficacious,0,0
11647,in,0,0
11648,patients,0,0
11649,where,0,0
11650,no,0,0
11651,image,0,0
11652,of,0,0
11653,a,0,0
11654,hepatofugal,0,0
11655,supply,0,0
11656,vein,0,0
11657,is,0,0
11658,found,0,0
11659,on,0,0
11660,MRA,0,0
11661,.,0,0
11662,Effects,0,0
11663,of,0,0
11664,nicotine,1,0
11665,on,0,0
11666,regional,1,0
11667,cerebral,1,1
11668,glucose,1,1
11669,metabolism,1,0
11670,in,0,0
11671,awake,0,0
11672,resting,0,1
11673,tobacco,0,0
11674,smokers,0,0
11675,.,0,0
11676,Eleven,0,0
11677,healthy,0,0
11678,tobacco,0,0
11679,smoking,0,0
11680,adult,0,0
11681,male,0,0
11682,volunteers,0,0
11683,of,0,0
11684,mixed,0,0
11685,race,0,0
11686,were,0,0
11687,tobacco,0,0
11688,abstinent,0,0
11689,overnight,0,0
11690,for,0,0
11691,this,0,0
11692,study,0,0
11693,.,0,0
11694,In,0,0
11695,each,0,0
11696,subject,0,0
11697,",",0,0
11698,positron,1,0
11699,emission,1,1
11700,tomographic,1,0
11701,images,1,0
11702,of,0,0
11703,regional,0,0
11704,cerebral,1,1
11705,metabolism,1,0
11706,of,1,0
11707,glucose,1,1
11708,with,0,0
11709,[,1,0
11710,18F,1,0
11711,],1,0
11712,fluorodeoxyglucose,1,0
11713,were,0,0
11714,obtained,0,0
11715,in,0,0
11716,two,0,0
11717,conditions,0,0
11718,in,0,0
11719,the,0,0
11720,morning,0,0
11721,on,0,0
11722,different,0,0
11723,days,0,0
11724,:,0,0
11725,about,0,0
11726,3min,0,0
11727,after,0,0
11728,approximately,0,0
11729,1-2mg,0,0
11730,of,0,0
11731,nasal,0,1
11732,nicotine,0,0
11733,spray,0,0
11734,and,0,0
11735,after,0,0
11736,an,0,0
11737,equivalent,0,0
11738,volume,0,1
11739,of,0,0
11740,an,0,0
11741,active,0,0
11742,placebo,0,0
11743,spray,0,0
11744,of,0,0
11745,oleoresin,0,0
11746,of,0,0
11747,pepper,0,0
11748,in,0,0
11749,a,0,0
11750,random,0,0
11751,counterbalanced,0,0
11752,design,0,0
11753,.,0,0
11754,A,0,0
11755,Siemens/CTI,0,1
11756,931/08-12,0,0
11757,scanner,0,0
11758,with,0,0
11759,the,0,0
11760,capability,0,0
11761,of,0,0
11762,15,0,0
11763,horizontal,0,0
11764,brain,0,0
11765,slices,0,0
11766,was,0,0
11767,used,0,0
11768,.,0,0
11769,The,0,0
11770,images,0,0
11771,were,0,0
11772,further,0,0
11773,converted,0,0
11774,into,0,0
11775,a,0,0
11776,standard,0,0
11777,uniform,0,0
11778,brain,0,1
11779,format,0,0
11780,in,0,0
11781,which,0,0
11782,the,0,0
11783,mean,0,1
11784,data,0,0
11785,of,0,0
11786,all,0,0
11787,11,0,0
11788,subjects,0,0
11789,were,0,0
11790,obtained,0,0
11791,.,0,0
11792,Images,0,0
11793,were,0,0
11794,analysed,0,0
11795,in,0,0
11796,stereotactic,0,0
11797,coordinates,0,0
11798,using,0,0
11799,pixel-wise,0,0
11800,t,0,0
11801,statistics,0,0
11802,and,0,0
11803,a,0,0
11804,smoothed,0,0
11805,Gaussian,0,0
11806,model,0,0
11807,.,0,0
11808,Peak,1,1
11809,plasma,1,1
11810,nicotine,1,0
11811,levels,1,1
11812,varied,0,0
11813,three-fold,0,0
11814,and,0,0
11815,the,0,0
11816,areas,0,0
11817,under,0,0
11818,the,0,0
11819,curve,0,1
11820,(,0,0
11821,0-30min,0,1
11822,),0,0
11823,varied,0,0
11824,seven-fold,0,0
11825,among,0,0
11826,the,0,0
11827,individual,0,0
11828,subjects,0,0
11829,.,0,0
11830,Nicotine,0,0
11831,caused,0,0
11832,a,0,0
11833,small,0,0
11834,overall,0,1
11835,reduction,0,1
11836,in,0,0
11837,global,1,1
11838,cerebral,1,1
11839,metabolism,1,1
11840,of,1,0
11841,glucose,1,1
11842,but,0,0
11843,",",0,0
11844,when,0,0
11845,the,0,0
11846,data,0,0
11847,were,0,0
11848,normalized,0,0
11849,",",0,0
11850,several,0,0
11851,brain,0,1
11852,regions,0,0
11853,showed,0,0
11854,relative,0,0
11855,increases,1,1
11856,in,1,0
11857,activity,1,1
11858,.,1,0
11859,Cerebral,0,1
11860,structures,0,0
11861,specifically,0,0
11862,activated,0,0
11863,by,0,0
11864,nicotine,0,0
11865,(,0,0
11866,nicotine,0,0
11867,minus,0,0
11868,pepper,0,0
11869,",",0,0
11870,Z,0,1
11871,score,0,1
11872,>,0,0
11873,4.0,0,0
11874,),0,0
11875,included,0,0
11876,:,0,0
11877,left,0,0
11878,inferior,0,0
11879,frontal,0,1
11880,gyrus,0,1
11881,",",0,0
11882,left,0,1
11883,posterior,0,0
11884,cingulate,0,1
11885,gyrus,0,1
11886,and,0,1
11887,right,0,0
11888,thalamus,0,1
11889,.,0,0
11890,The,0,0
11891,visual,0,1
11892,cortex,0,0
11893,",",0,0
11894,including,0,0
11895,the,0,0
11896,right,0,0
11897,and,0,0
11898,left,0,1
11899,cuneus,0,1
11900,and,0,1
11901,left,0,1
11902,lateral,0,0
11903,occipito-temporal,0,1
11904,gyrus,0,1
11905,fusiformis,0,0
11906,",",0,0
11907,also,0,0
11908,showed,0,0
11909,an,0,0
11910,increase,0,0
11911,in,0,0
11912,regional,1,0
11913,cerebral,1,1
11914,metabolism,1,1
11915,of,1,0
11916,glucose,1,1
11917,with,0,0
11918,Z,0,0
11919,scores,0,1
11920,>,0,0
11921,3,0,0
11922,.,0,0
11923,6,0,0
11924,.,0,0
11925,Structures,0,0
11926,with,0,0
11927,a,0,0
11928,decrease,1,0
11929,in,1,0
11930,regional,1,0
11931,cerebral,1,1
11932,metabolism,1,1
11933,of,1,0
11934,glucose,1,1
11935,(,1,0
11936,pepper,1,0
11937,minus,0,0
11938,nicotine,1,0
11939,),1,0
11940,were,0,0
11941,the,0,0
11942,left,0,1
11943,insula,0,1
11944,and,0,0
11945,right,0,0
11946,inferior,0,1
11947,occipital,0,1
11948,gyrus,0,1
11949,",",0,0
11950,with,0,0
11951,Z,0,1
11952,scores,0,1
11953,>,0,0
11954,3.5,0,0
11955,.,0,0
11956,Especially,0,0
11957,important,0,0
11958,is,0,0
11959,the,0,0
11960,fact,0,0
11961,that,0,0
11962,the,0,0
11963,thalamus,0,0
11964,is,0,0
11965,activated,0,0
11966,by,0,0
11967,nicotine,0,0
11968,.,0,0
11969,This,0,0
11970,is,0,0
11971,consistent,0,0
11972,with,0,0
11973,the,0,0
11974,high,0,0
11975,density,0,1
11976,of,0,0
11977,nicotinic,0,0
11978,cholinoceptors,0,0
11979,in,0,0
11980,that,0,0
11981,brain,0,0
11982,region,0,0
11983,.,0,0
11984,However,0,0
11985,",",0,0
11986,not,0,0
11987,all,0,0
11988,brain,0,0
11989,regions,0,0
11990,affected,0,0
11991,by,0,0
11992,nicotine,0,0
11993,are,0,0
11994,known,0,0
11995,to,0,0
11996,have,0,0
11997,many,0,0
11998,nicotinic,0,0
11999,cholinoceptors,0,0
12000,.,0,0
12001,The,0,0
12002,results,0,0
12003,are,0,0
12004,discussed,0,0
12005,in,0,0
12006,relation,0,0
12007,to,0,0
12008,the,0,0
12009,cognitive,1,0
12010,effects,1,0
12011,of,1,0
12012,nicotine,1,0
12013,.,1,0
12014,Perioperative,0,0
12015,blood,0,1
12016,transfusions,0,1
12017,",",0,0
12018,with,0,0
12019,or,0,0
12020,without,0,0
12021,allogeneic,0,0
12022,leucocytes,0,1
12023,",",0,0
12024,relate,0,0
12025,to,0,0
12026,survival,1,1
12027,",",0,0
12028,not,0,0
12029,to,0,0
12030,cancer,1,0
12031,recurrence,1,1
12032,.,1,0
12033,BACKGROUND,0,0
12034,Perioperative,0,0
12035,blood,0,1
12036,transfusions,0,1
12037,are,0,0
12038,reported,0,0
12039,to,0,0
12040,be,0,0
12041,related,0,0
12042,to,0,0
12043,cancer,1,0
12044,recurrence,1,1
12045,and,0,1
12046,reduced,1,1
12047,survival,1,1
12048,.,1,0
12049,Different,0,0
12050,underlying,0,0
12051,mechanisms,0,0
12052,have,0,0
12053,been,0,0
12054,proposed,0,0
12055,",",0,0
12056,and,0,0
12057,allogeneic,0,0
12058,leucocytes,0,1
12059,in,0,0
12060,transfused,0,1
12061,blood,0,1
12062,have,0,0
12063,been,0,0
12064,suggested,0,0
12065,to,0,0
12066,contribute,0,0
12067,to,0,0
12068,this,0,0
12069,phenomenon,0,0
12070,.,0,0
12071,METHODS,0,0
12072,Packed,0,0
12073,red,0,1
12074,cells,0,1
12075,without,0,0
12076,buffy,0,0
12077,coat,0,1
12078,(,0,0
12079,PC,0,1
12080,group,0,0
12081,),0,0
12082,were,0,0
12083,compared,0,0
12084,with,0,0
12085,filtered,0,0
12086,",",0,0
12087,leucoreduced,0,0
12088,",",0,0
12089,red,0,1
12090,cells,0,1
12091,(,0,0
12092,LD,0,0
12093,group,0,0
12094,),0,0
12095,in,0,0
12096,a,0,0
12097,randomized,0,0
12098,trial,0,0
12099,of,0,0
12100,697,0,0
12101,patients,0,0
12102,with,0,0
12103,colorectal,0,0
12104,carcinoma,0,0
12105,.,0,0
12106,Five-year,1,0
12107,survival,1,1
12108,and,1,1
12109,cancer,1,1
12110,recurrence,1,1
12111,rates,1,1
12112,were,0,0
12113,determined,0,0
12114,",",0,0
12115,with,0,0
12116,special,0,0
12117,emphasis,0,0
12118,on,0,0
12119,the,0,0
12120,location,1,0
12121,of,1,0
12122,recurrence,1,1
12123,.,1,0
12124,RESULTS,0,0
12125,The,0,0
12126,intention-to-treat,0,0
12127,analysis,0,0
12128,showed,0,0
12129,a,0,0
12130,survival,1,1
12131,rate,1,1
12132,of,0,0
12133,63.6,0,0
12134,per,0,0
12135,cent,0,0
12136,in,0,0
12137,the,0,0
12138,PC,0,0
12139,group,0,0
12140,and,0,0
12141,65.3,0,0
12142,per,0,0
12143,cent,0,0
12144,in,0,0
12145,the,0,0
12146,LD,0,0
12147,group,0,0
12148,(,0,0
12149,P,0,0
12150,=,0,0
12151,0.69,0,0
12152,),0,0
12153,",",0,0
12154,with,0,0
12155,recurrence,1,1
12156,rates,1,1
12157,of,0,0
12158,27.8,0,0
12159,and,0,0
12160,27.9,0,0
12161,per,0,0
12162,cent,0,0
12163,respectively,0,0
12164,.,0,0
12165,The,0,0
12166,observational,0,0
12167,analysis,0,0
12168,showed,0,0
12169,a,0,0
12170,significant,0,0
12171,difference,1,0
12172,in,1,0
12173,survival,1,1
12174,between,0,0
12175,transfused,0,1
12176,and,0,0
12177,non-transfused,0,0
12178,patients,0,0
12179,(,0,0
12180,59.6,0,0
12181,versus,0,0
12182,72.9,0,0
12183,per,0,0
12184,cent,0,0
12185,;,0,0
12186,P,0,0
12187,<,0,0
12188,0.001,0,0
12189,),0,0
12190,.,0,0
12191,The,0,0
12192,difference,1,0
12193,in,1,0
12194,cancer,1,0
12195,recurrence,1,1
12196,rate,1,1
12197,between,0,0
12198,transfused,0,1
12199,and,0,0
12200,non-transfused,0,0
12201,patients,0,0
12202,was,0,0
12203,not,0,0
12204,statistically,0,0
12205,significant,0,0
12206,(,0,0
12207,29.8,0,0
12208,versus,0,0
12209,24.3,0,0
12210,per,0,0
12211,cent,0,0
12212,;,0,0
12213,P,0,0
12214,=,0,0
12215,0.13,0,0
12216,),0,0
12217,.,0,0
12218,Local,1,0
12219,recurrences,1,1
12220,were,0,0
12221,more,0,0
12222,frequent,0,1
12223,in,0,0
12224,transfused,0,1
12225,than,0,0
12226,non-transfused,0,0
12227,patients,0,0
12228,(,0,0
12229,11.9,0,0
12230,versus,0,0
12231,7.6,0,0
12232,per,0,0
12233,cent,0,0
12234,;,0,0
12235,P,0,0
12236,=,0,0
12237,0.09,0,0
12238,),0,0
12239,.,0,0
12240,CONCLUSION,0,0
12241,Leucocyte,0,1
12242,depletion,0,0
12243,of,0,0
12244,perioperative,0,0
12245,transfused,0,1
12246,blood,0,0
12247,has,0,0
12248,no,0,0
12249,effect,0,0
12250,on,0,0
12251,long-term,1,0
12252,survival,1,1
12253,and/or,1,0
12254,cancer,1,0
12255,recurrence,1,1
12256,.,1,0
12257,Perioperative,0,0
12258,blood,0,1
12259,transfusions,0,1
12260,are,0,0
12261,associated,0,0
12262,with,0,0
12263,impaired,0,0
12264,survival,0,1
12265,",",0,0
12266,but,0,0
12267,not,0,0
12268,with,0,0
12269,cancer,0,0
12270,recurrence,0,1
12271,.,0,0
12272,The,0,0
12273,slight,0,1
12274,increase,0,0
12275,in,0,0
12276,local,0,0
12277,recurrence,1,1
12278,rate,1,1
12279,in,0,0
12280,transfused,0,1
12281,patients,0,0
12282,appears,0,0
12283,to,0,0
12284,be,0,0
12285,related,0,0
12286,to,0,0
12287,complicated,0,0
12288,",",0,0
12289,in,0,0
12290,particular,0,0
12291,rectal,0,1
12292,",",0,0
12293,surgery,0,0
12294,.,0,0
12295,[,0,0
12296,Diphtheria,0,0
12297,antitoxin,0,1
12298,level,0,0
12299,2,0,0
12300,years,0,0
12301,after,0,0
12302,booster,0,0
12303,vaccination,0,0
12304,],0,0
12305,.,0,0
12306,In,0,0
12307,a,0,0
12308,prospective,0,0
12309,",",0,0
12310,controlled,0,0
12311,",",0,0
12312,randomized,0,0
12313,",",0,0
12314,multicenter,0,0
12315,study,0,0
12316,the,0,0
12317,immunogenicity,0,1
12318,of,0,0
12319,a,0,0
12320,single,0,0
12321,(,0,0
12322,day,0,0
12323,0,0,0
12324,),0,0
12325,and,0,0
12326,two,0,0
12327,(,0,0
12328,day,0,0
12329,0,0,0
12330,",",0,0
12331,28,0,0
12332,),0,0
12333,booster,0,0
12334,vaccination,0,0
12335,against,0,1
12336,diphtheria,0,0
12337,were,0,0
12338,compared,0,0
12339,in,0,0
12340,subjects,0,0
12341,who,0,0
12342,had,0,0
12343,received,0,0
12344,their,0,0
12345,last,0,0
12346,diphtheria,0,0
12347,vaccination,0,0
12348,more,0,0
12349,than,0,0
12350,10,0,0
12351,years,0,0
12352,ago,0,0
12353,.,0,0
12354,Both,0,0
12355,short-term,0,0
12356,and,0,0
12357,long-term,0,1
12358,immunogenicity,0,1
12359,was,0,0
12360,assessed,0,0
12361,by,0,0
12362,determining,0,0
12363,diphtheria,1,0
12364,antitoxin,1,1
12365,levels,1,1
12366,four,0,0
12367,weeks,0,0
12368,after,0,0
12369,vaccination,0,0
12370,and,0,0
12371,after,0,0
12372,one,0,0
12373,and,0,0
12374,two,0,0
12375,years,0,0
12376,.,0,0
12377,102,0,0
12378,subjects,0,0
12379,received,0,0
12380,the,0,0
12381,first,0,0
12382,booster,0,0
12383,vaccination,0,1
12384,",",0,0
12385,and,0,0
12386,83,0,0
12387,were,0,0
12388,vaccinated,0,0
12389,twice,0,0
12390,.,0,0
12391,Prior,0,0
12392,to,0,0
12393,the,0,0
12394,first,0,0
12395,vaccination,0,0
12396,27,0,0
12397,%,0,0
12398,of,0,0
12399,the,0,0
12400,subjects,0,0
12401,had,0,0
12402,a,0,0
12403,diphtheria,1,0
12404,antitoxin,1,1
12405,level,1,1
12406,below,0,0
12407,0.01,0,0
12408,I.U./ml,0,0
12409,;,0,0
12410,after,0,0
12411,the,0,0
12412,first,0,0
12413,booster,0,0
12414,only,0,0
12415,5,0,0
12416,%,0,0
12417,were,0,0
12418,unprotected,0,0
12419,.,0,0
12420,The,0,0
12421,second,0,0
12422,booster,0,0
12423,did,0,0
12424,not,0,0
12425,show,0,0
12426,a,0,0
12427,significant,0,0
12428,effect,0,0
12429,",",0,0
12430,however,0,0
12431,",",0,0
12432,in,0,0
12433,1,0,0
12434,of,0,0
12435,the,0,0
12436,5,0,0
12437,subjects,0,0
12438,who,0,0
12439,were,0,0
12440,still,0,0
12441,unprotected,0,0
12442,after,0,0
12443,the,0,0
12444,first,0,0
12445,booster,0,0
12446,the,0,0
12447,second,0,0
12448,elicited,0,0
12449,an,0,0
12450,antitoxin,1,1
12451,level,1,1
12452,of,0,0
12453,more,0,0
12454,than,0,0
12455,0.01,0,0
12456,I.U./ml,0,0
12457,.,0,0
12458,After,0,0
12459,one,0,0
12460,and,0,0
12461,two,0,0
12462,years,0,0
12463,7,0,0
12464,%,0,0
12465,and,0,0
12466,8,0,0
12467,%,0,0
12468,of,0,0
12469,the,0,0
12470,subjects,0,0
12471,had,0,0
12472,diphtheria,1,0
12473,antitoxin,1,1
12474,level,1,0
12475,below,0,0
12476,0.01,0,0
12477,I.U./ml,0,0
12478,.,0,0
12479,A,0,0
12480,serological,0,0
12481,effect,0,0
12482,of,0,0
12483,a,0,0
12484,second,0,0
12485,booster,0,0
12486,vaccination,0,0
12487,four,0,0
12488,weeks,0,0
12489,after,0,0
12490,the,0,0
12491,first,0,0
12492,one,0,0
12493,could,0,0
12494,not,0,0
12495,be,0,0
12496,demonstrated,0,0
12497,neither,0,0
12498,after,0,0
12499,one,0,0
12500,nor,0,0
12501,after,0,0
12502,two,0,0
12503,years,0,0
12504,.,0,0
12505,Increasing,0,0
12506,the,0,0
12507,reach,0,0
12508,of,0,0
12509,health,1,1
12510,sponsorship,0,0
12511,:,0,0
12512,using,0,0
12513,a,0,0
12514,sponsorship,0,0
12515,kit,0,0
12516,to,0,0
12517,promote,0,0
12518,health,0,0
12519,.,0,0
12520,In,0,0
12521,Australia,0,0
12522,",",0,0
12523,a,0,0
12524,tobacco,0,0
12525,tax,0,0
12526,provides,0,0
12527,funding,0,0
12528,for,0,0
12529,Healthway,0,0
12530,",",0,0
12531,the,0,0
12532,Western,0,0
12533,Australian,0,0
12534,Health,0,1
12535,Promotion,0,1
12536,Foundation,0,0
12537,.,0,0
12538,Healthway,0,0
12539,provides,0,0
12540,sponsorships,0,0
12541,for,0,0
12542,the,0,0
12543,arts,0,0
12544,and,0,1
12545,racing,0,1
12546,and,0,1
12547,sporting,0,0
12548,events,0,1
12549,to,0,0
12550,replace,0,0
12551,funds,0,0
12552,previously,0,0
12553,provided,0,0
12554,by,0,0
12555,tobacco,0,0
12556,companies,0,0
12557,.,0,0
12558,These,0,0
12559,sponsorships,0,0
12560,provide,0,0
12561,visibility,0,1
12562,for,0,0
12563,Healthway,0,0
12564,and,0,0
12565,positive,0,1
12566,health,0,1
12567,messages,0,0
12568,.,0,0
12569,Normally,0,0
12570,",",0,0
12571,Healthway,0,0
12572,staff,0,0
12573,attends,0,0
12574,these,0,0
12575,events,0,1
12576,to,0,0
12577,help,0,0
12578,promote,0,0
12579,health,0,0
12580,messages,0,0
12581,.,0,0
12582,To,0,0
12583,reduce,0,0
12584,Healthway,0,0
12585,staff,0,0
12586,time,0,1
12587,spent,0,1
12588,helping,0,0
12589,event,0,0
12590,organizers,0,0
12591,promote,0,0
12592,health,0,1
12593,messages,0,0
12594,",",0,0
12595,Healthway,0,0
12596,developed,0,0
12597,a,0,0
12598,sponsor,0,0
12599,kit,0,1
12600,of,0,0
12601,promotional,0,0
12602,materials,0,0
12603,which,0,0
12604,communicate,0,0
12605,health,0,1
12606,messages,0,0
12607,without,0,0
12608,requiring,0,0
12609,Healthway,0,0
12610,staff,0,0
12611,to,0,0
12612,attend,0,0
12613,events,0,1
12614,.,0,0
12615,Recognition,1,0
12616,",",1,0
12617,awareness,1,1
12618,",",1,1
12619,comprehension,1,1
12620,",",1,1
12621,and,1,1
12622,acceptance,1,1
12623,of,1,1
12624,health,1,1
12625,messages,1,0
12626,was,0,0
12627,comparable,0,0
12628,at,0,0
12629,events,0,1
12630,that,0,0
12631,featured,0,0
12632,Healthway,0,0
12633,staff,0,0
12634,versus,0,0
12635,the,0,0
12636,sponsor,0,0
12637,kits,0,0
12638,",",0,0
12639,but,0,0
12640,the,0,0
12641,average,0,1
12642,cost,0,1
12643,of,0,0
12644,the,0,0
12645,sponsorship,0,0
12646,kits,0,0
12647,was,0,0
12648,only,0,0
12649,40,0,0
12650,%,0,0
12651,of,0,0
12652,the,0,0
12653,cost,0,1
12654,when,0,0
12655,Healthway,0,0
12656,staff,0,0
12657,was,0,0
12658,featured,0,0
12659,.,0,0
12660,Comparison,0,0
12661,of,0,0
12662,the,0,0
12663,efficacy,0,1
12664,of,0,0
12665,fluoxetine,0,0
12666,alone,0,0
12667,vs.,0,0
12668,fluoxetine,0,0
12669,plus,0,0
12670,local,0,1
12671,lidocaine,0,0
12672,ointment,0,0
12673,in,0,0
12674,the,0,0
12675,treatment,0,0
12676,of,0,0
12677,premature,0,0
12678,ejaculation,0,0
12679,.,0,0
12680,OBJECTIVE,0,0
12681,The,0,0
12682,present,0,0
12683,study,0,0
12684,compares,0,0
12685,the,0,0
12686,efficacy,0,1
12687,and,0,0
12688,side,0,1
12689,effects,0,1
12690,of,0,0
12691,fluoxetine,0,0
12692,alone,0,0
12693,vs.,0,0
12694,fluoxetine,0,0
12695,plus,0,0
12696,local,0,1
12697,lidocaine,0,0
12698,ointment,0,0
12699,in,0,0
12700,the,0,0
12701,treatment,0,0
12702,of,0,0
12703,premature,0,0
12704,ejaculation,0,0
12705,.,0,0
12706,METHODS,0,0
12707,Forty-three,0,0
12708,patients,0,0
12709,suffering,0,0
12710,from,0,0
12711,premature,0,0
12712,ejaculation,0,0
12713,were,0,0
12714,studied,0,0
12715,.,0,0
12716,The,0,0
12717,exclusion,0,0
12718,criteria,0,0
12719,were,0,0
12720,erectile,0,1
12721,dysfunction,0,1
12722,",",0,0
12723,loss,0,1
12724,of,0,1
12725,libido,0,1
12726,",",0,0
12727,alcohol,0,1
12728,and,0,1
12729,substance,0,1
12730,abuse,0,1
12731,",",0,0
12732,mental,0,1
12733,retardation,0,0
12734,",",0,0
12735,diabetes,0,1
12736,mellitus,0,0
12737,",",0,0
12738,thyroid,0,1
12739,disease,0,1
12740,",",0,0
12741,hypotension,0,1
12742,",",0,1
12743,previous,0,0
12744,use,0,0
12745,of,0,0
12746,these,0,0
12747,drugs,0,0
12748,and,0,0
12749,urogenital,0,1
12750,infections,0,0
12751,.,0,0
12752,The,0,0
12753,patients,0,0
12754,',0,0
12755,ages,0,0
12756,ranged,0,0
12757,from,0,0
12758,19,0,0
12759,to,0,0
12760,48,0,0
12761,years,0,0
12762,(,0,0
12763,mean,0,1
12764,age,0,0
12765,28,0,0
12766,+/-,0,0
12767,1.6,0,0
12768,),0,0
12769,.,0,0
12770,They,0,0
12771,had,0,0
12772,regular,0,0
12773,sexual,0,1
12774,lives,0,0
12775,.,0,0
12776,They,0,0
12777,had,0,0
12778,normal,0,0
12779,psychiatric,0,0
12780,consultation,0,0
12781,and,0,0
12782,the,0,0
12783,Glombock,1,1
12784,Rast,1,0
12785,Sexual,1,1
12786,Satisfactory,1,1
12787,Test,1,1
12788,(,1,0
12789,GRISS,1,0
12790,),1,0
12791,psychiatric,1,0
12792,test,1,0
12793,were,0,0
12794,in,0,0
12795,accordance,0,0
12796,with,0,0
12797,premature,0,0
12798,ejaculation,0,0
12799,.,0,0
12800,RESULTS,0,0
12801,The,0,0
12802,patients,0,0
12803,were,0,0
12804,assigned,0,0
12805,to,0,0
12806,two,0,0
12807,groups,0,0
12808,.,0,0
12809,Twenty-six,0,0
12810,patients,0,0
12811,",",0,0
12812,aged,0,0
12813,21,0,0
12814,to,0,0
12815,36,0,0
12816,years,0,0
12817,(,0,0
12818,mean,0,1
12819,age,0,0
12820,27,0,0
12821,),0,0
12822,",",0,0
12823,received,0,0
12824,only,0,0
12825,fluoxetine,0,0
12826,20,0,0
12827,mg/day,0,0
12828,(,0,0
12829,1,0,0
12830,capsule,0,0
12831,),0,0
12832,for,0,0
12833,a,0,0
12834,week,0,0
12835,which,0,0
12836,was,0,0
12837,later,0,0
12838,increased,0,0
12839,to,0,0
12840,40,0,0
12841,mg/day,0,0
12842,(,0,0
12843,2,0,0
12844,capsules,0,0
12845,),0,0
12846,.,0,0
12847,Seventeen,0,0
12848,patients,0,0
12849,",",0,0
12850,aged,0,0
12851,19,0,0
12852,to,0,0
12853,48,0,0
12854,years,0,0
12855,(,0,0
12856,mean,0,1
12857,age,0,0
12858,31,0,0
12859,),0,0
12860,",",0,0
12861,were,0,0
12862,given,0,0
12863,fluoxetine,0,0
12864,20,0,0
12865,mg/day,0,0
12866,plus,0,0
12867,local,0,1
12868,application,0,0
12869,of,0,0
12870,lidocaine,0,0
12871,ointment,0,0
12872,.,0,0
12873,The,0,0
12874,patients,0,0
12875,and,0,0
12876,partners,0,1
12877,were,0,0
12878,re-evaluated,0,0
12879,8,0,0
12880,weeks,0,0
12881,after,0,0
12882,the,0,0
12883,treatment,0,0
12884,.,0,0
12885,The,0,0
12886,results,0,0
12887,were,0,0
12888,classified,0,0
12889,as,0,0
12890,unsuccessful,1,0
12891,",",1,0
12892,improvement,1,1
12893,and,1,1
12894,cure,1,1
12895,.,1,0
12896,The,0,0
12897,chi-square,1,0
12898,test,1,0
12899,was,0,0
12900,used,0,0
12901,for,0,0
12902,statistical,0,0
12903,analysis,0,0
12904,.,0,0
12905,In,0,0
12906,the,0,0
12907,fluoxetine,0,0
12908,group,0,0
12909,",",0,0
12910,8,0,0
12911,(,0,0
12912,30.8,0,0
12913,%,0,0
12914,),0,0
12915,patients,0,0
12916,cured,1,0
12917,",",0,0
12918,11,0,0
12919,(,0,0
12920,42.2,0,0
12921,%,0,0
12922,),0,0
12923,showed,0,0
12924,improvement,1,1
12925,and,0,1
12926,there,0,0
12927,were,0,0
12928,7,0,0
12929,failures,1,0
12930,(,0,0
12931,26.9,0,0
12932,%,0,0
12933,),0,0
12934,.,0,0
12935,In,0,0
12936,the,0,0
12937,combination,0,0
12938,treatment,0,0
12939,group,0,0
12940,",",0,0
12941,9,0,0
12942,(,0,0
12943,52.9,0,0
12944,%,0,0
12945,),0,0
12946,patients,0,0
12947,cured,0,0
12948,",",0,0
12949,improvement,1,1
12950,was,0,0
12951,observed,0,0
12952,in,0,0
12953,5,0,0
12954,(,0,0
12955,29.4,0,0
12956,%,0,0
12957,),0,0
12958,and,0,0
12959,failure,0,1
12960,in,0,0
12961,3,0,0
12962,(,0,0
12963,17.6,0,0
12964,%,0,0
12965,),0,0
12966,.,0,0
12967,Side,0,0
12968,effects,0,1
12969,in,0,0
12970,group,0,0
12971,I,0,0
12972,were,0,0
12973,observed,0,0
12974,in,0,0
12975,6,0,0
12976,patients,0,0
12977,(,0,0
12978,23,0,0
12979,%,0,0
12980,),0,0
12981,and,0,0
12982,in,0,0
12983,5,0,0
12984,(,0,0
12985,29.4,0,0
12986,%,0,0
12987,),0,0
12988,in,0,0
12989,group,0,0
12990,II,0,0
12991,.,0,0
12992,There,0,0
12993,were,0,0
12994,no,0,0
12995,statistical,0,0
12996,differences,0,0
12997,between,0,0
12998,the,0,0
12999,two,0,0
13000,groups,0,0
13001,according,0,0
13002,to,0,0
13003,the,0,0
13004,side,0,1
13005,effects,0,1
13006,(,0,0
13007,p,0,0
13008,>,0,0
13009,0.01,0,0
13010,),0,0
13011,.,0,0
13012,No,0,0
13013,patients,0,0
13014,were,0,0
13015,excluded,0,0
13016,from,0,0
13017,the,0,0
13018,study,0,0
13019,due,0,0
13020,to,0,0
13021,side,0,0
13022,effects,0,0
13023,.,0,0
13024,CONCLUSION,0,0
13025,The,0,0
13026,combination,0,0
13027,of,0,0
13028,fluoxetine,0,0
13029,plus,0,0
13030,local,0,1
13031,application,0,0
13032,of,0,0
13033,lidocaine,0,0
13034,ointment,0,0
13035,was,0,0
13036,found,0,0
13037,to,0,0
13038,be,0,0
13039,more,0,0
13040,effective,0,0
13041,than,0,0
13042,fluoxetine,0,0
13043,alone,0,0
13044,in,0,0
13045,the,0,0
13046,treatment,0,0
13047,of,0,0
13048,premature,0,0
13049,ejaculation,0,0
13050,.,0,0
13051,However,0,0
13052,",",0,0
13053,the,0,0
13054,results,0,0
13055,should,0,0
13056,be,0,0
13057,confirmed,0,0
13058,in,0,0
13059,further,0,0
13060,studies,0,0
13061,with,0,0
13062,a,0,0
13063,placebo,0,0
13064,group,0,0
13065,to,0,0
13066,rule,0,0
13067,out,0,0
13068,the,0,0
13069,placebo,0,0
13070,effect,0,0
13071,.,0,0
13072,Cognitive,1,1
13073,performance,1,1
13074,and,0,0
13075,serotonergic,1,1
13076,function,1,1
13077,in,0,0
13078,users,0,0
13079,of,0,0
13080,ecstasy,0,0
13081,.,0,0
13082,RATIONALE,0,0
13083,(,0,0
13084,+/-,0,0
13085,),0,0
13086,"3,4-Methylenedioxymethamphetamine",0,0
13087,(,0,0
13088,MDMA,0,0
13089,or,0,1
13090,ecstasy,0,0
13091,),0,0
13092,has,0,0
13093,been,0,0
13094,shown,0,0
13095,to,0,0
13096,cause,0,0
13097,long,0,0
13098,term,0,0
13099,damage,0,1
13100,to,0,0
13101,serotonergic,0,0
13102,cerebral,0,1
13103,neurons,0,1
13104,in,0,0
13105,animals,0,0
13106,.,0,0
13107,The,0,0
13108,neurotoxic,1,0
13109,effects,1,0
13110,in,0,0
13111,humans,0,0
13112,are,0,0
13113,less,0,0
13114,clear,0,0
13115,and,0,0
13116,little,0,0
13117,is,0,0
13118,known,0,0
13119,about,0,0
13120,the,0,0
13121,functional,0,0
13122,consequences,0,0
13123,",",0,0
13124,although,0,0
13125,some,0,0
13126,studies,0,0
13127,suggest,0,0
13128,memory,0,1
13129,impairment,0,1
13130,.,0,0
13131,Given,0,0
13132,the,0,0
13133,widespread,0,0
13134,use,0,0
13135,of,0,0
13136,MDMA,0,0
13137,",",0,0
13138,our,0,0
13139,lack,0,0
13140,of,0,0
13141,knowledge,0,1
13142,raises,0,0
13143,concerns,0,1
13144,.,0,0
13145,OBJECTIVE,0,0
13146,We,0,0
13147,investigated,0,0
13148,",",0,0
13149,in,0,0
13150,humans,0,0
13151,",",0,0
13152,the,0,0
13153,relation,0,0
13154,between,0,0
13155,past,0,0
13156,use,0,0
13157,of,0,0
13158,ecstasy,0,0
13159,and,0,0
13160,cognitive,0,1
13161,performance,0,1
13162,as,0,0
13163,well,0,0
13164,as,0,0
13165,serotonergic,0,0
13166,function,0,1
13167,.,0,0
13168,METHODS,0,0
13169,Two,0,0
13170,groups,0,0
13171,of,0,0
13172,21,0,0
13173,males,0,0
13174,with,0,0
13175,moderate,0,0
13176,and,0,0
13177,heavy,0,0
13178,recreational,0,0
13179,use,0,0
13180,of,0,0
13181,MDMA,0,0
13182,",",0,0
13183,respectively,0,0
13184,",",0,0
13185,and,0,0
13186,a,0,0
13187,control,0,0
13188,group,0,0
13189,of,0,0
13190,20,0,0
13191,males,0,0
13192,without,0,0
13193,use,0,0
13194,of,0,0
13195,MDMA,0,0
13196,were,0,0
13197,compared,0,0
13198,.,0,0
13199,All,0,0
13200,were,0,0
13201,from,0,0
13202,the,0,0
13203,same,0,0
13204,subculture,0,0
13205,.,0,0
13206,Reaction,1,1
13207,time,1,1
13208,",",1,0
13209,direct,1,1
13210,recall,1,1
13211,",",0,0
13212,and,0,1
13213,recognition,1,1
13214,were,0,0
13215,assessed,0,0
13216,.,0,0
13217,Serotonergic,1,1
13218,function,1,1
13219,was,0,0
13220,measured,0,0
13221,by,0,0
13222,the,0,0
13223,neuro-endocrine,0,1
13224,response,0,1
13225,to,0,0
13226,a,0,0
13227,placebo-controlled,0,0
13228,",",0,0
13229,crossover,0,0
13230,challenge,0,0
13231,with,0,0
13232,dexfenfluramine,0,0
13233,.,0,0
13234,RESULTS,0,0
13235,Ecstasy,0,1
13236,users,0,0
13237,showed,0,0
13238,a,0,0
13239,broad,0,0
13240,pattern,0,0
13241,of,0,0
13242,statistically,0,0
13243,significant,0,0
13244,",",0,0
13245,but,0,0
13246,clinically,0,1
13247,small,1,0
13248,",",1,0
13249,impairment,1,1
13250,of,1,1
13251,memory,1,1
13252,and,1,0
13253,prolonged,1,1
13254,reaction,1,1
13255,times,1,1
13256,.,1,0
13257,Heavy,0,0
13258,users,0,0
13259,were,0,0
13260,affected,0,0
13261,stronger,0,0
13262,than,0,0
13263,moderate,0,0
13264,users,0,0
13265,.,0,0
13266,Release,1,0
13267,of,1,0
13268,cortisol,1,1
13269,but,0,0
13270,not,0,0
13271,of,0,0
13272,prolactin,1,1
13273,after,0,0
13274,dexfenfluramine,0,0
13275,administration,0,0
13276,was,0,0
13277,significantly,0,0
13278,reduced,0,0
13279,in,0,0
13280,both,0,0
13281,groups,0,0
13282,of,0,0
13283,ecstasy,0,0
13284,users,0,0
13285,compared,0,0
13286,with,0,0
13287,the,0,0
13288,controls,0,0
13289,.,0,0
13290,Analyses,0,0
13291,of,0,0
13292,covariance,0,1
13293,showed,0,0
13294,that,0,0
13295,likely,0,0
13296,confounding,0,0
13297,variables,0,0
13298,including,0,0
13299,recent,0,0
13300,exposure,0,0
13301,to,0,0
13302,ecstasy,0,0
13303,",",0,0
13304,psychosocial,0,1
13305,profiles,0,1
13306,and,0,0
13307,use,0,0
13308,of,0,1
13309,other,0,0
13310,drugs,0,0
13311,did,0,0
13312,not,0,0
13313,explain,0,0
13314,the,0,0
13315,differences,0,0
13316,found,0,0
13317,between,0,0
13318,the,0,0
13319,groups,0,0
13320,.,0,0
13321,CONCLUSIONS,0,0
13322,These,0,0
13323,results,0,0
13324,provide,0,0
13325,further,0,0
13326,evidence,0,0
13327,that,0,0
13328,use,0,0
13329,of,0,0
13330,ecstasy,0,0
13331,may,0,0
13332,be,0,0
13333,associated,0,0
13334,with,0,0
13335,impairment,1,1
13336,of,1,0
13337,memory,1,1
13338,and,1,0
13339,of,1,1
13340,serotonergic,1,0
13341,function,1,1
13342,.,1,0
13343,These,0,0
13344,findings,0,0
13345,are,0,0
13346,compatible,0,0
13347,with,0,0
13348,neurotoxicity,1,1
13349,of,0,0
13350,ecstasy,0,0
13351,as,0,0
13352,shown,0,0
13353,in,0,0
13354,animals,0,0
13355,.,0,0
13356,Comparison,0,0
13357,of,0,0
13358,provocative,0,0
13359,tests,0,0
13360,for,0,0
13361,unexplained,0,0
13362,syncope,0,0
13363,:,0,0
13364,isoprenaline,0,0
13365,and,0,1
13366,glyceryl,0,0
13367,trinitrate,0,0
13368,for,0,0
13369,diagnosing,0,0
13370,vasovagal,1,1
13371,syncope,1,0
13372,.,1,0
13373,AIMS,0,0
13374,To,0,0
13375,compare,0,0
13376,the,0,0
13377,sensitivity,0,1
13378,",",0,0
13379,specificity,0,1
13380,and,0,1
13381,adverse,0,1
13382,event,0,1
13383,profile,0,1
13384,of,0,0
13385,glyceryl,0,0
13386,trinitrate,0,0
13387,head-up,0,0
13388,tilt,0,1
13389,with,0,0
13390,isoprenaline,0,0
13391,head-up,0,0
13392,tilt,0,1
13393,in,0,0
13394,the,0,0
13395,diagnosis,0,0
13396,of,0,0
13397,vasovagal,0,1
13398,syncope,0,0
13399,in,0,0
13400,patients,0,0
13401,with,0,0
13402,unexplained,0,0
13403,syncope,0,0
13404,and,0,0
13405,healthy,0,0
13406,controls,0,0
13407,.,0,0
13408,METHODS,0,0
13409,AND,0,0
13410,RESULTS,0,0
13411,Forty-eight,0,0
13412,patients,0,0
13413,with,0,0
13414,unexplained,0,0
13415,syncope,0,0
13416,and,0,0
13417,negative,0,1
13418,passive,0,1
13419,head-up,0,0
13420,tilt,0,1
13421,at,0,0
13422,70,0,0
13423,degrees,0,0
13424,for,0,0
13425,40,0,0
13426,min,0,0
13427,",",0,0
13428,and,0,0
13429,14,0,0
13430,healthy,0,0
13431,controls,0,0
13432,underwent,0,0
13433,glyceryl,0,0
13434,trinitrate,0,0
13435,head-up,0,0
13436,tilt,0,1
13437,and,0,1
13438,isoprenaline,0,0
13439,head-up,0,1
13440,tilt,0,1
13441,(,0,0
13442,maximum,0,1
13443,dose,0,0
13444,5,0,0
13445,microg,0,0
13446,x,0,0
13447,min,0,0
13448,(,0,0
13449,-1,0,0
13450,),0,0
13451,),0,0
13452,one,0,0
13453,week,0,0
13454,apart,0,0
13455,in,0,0
13456,random,0,0
13457,order,0,0
13458,.,0,0
13459,Outcome,0,1
13460,measures,0,1
13461,were,0,0
13462,production,1,1
13463,of,1,1
13464,symptoms,1,1
13465,(,1,0
13466,syncope,1,1
13467,",",1,1
13468,pre-syncope,1,1
13469,),1,0
13470,with,1,0
13471,development,1,1
13472,of,1,0
13473,hypotension,1,1
13474,.,1,0
13475,In,0,0
13476,those,0,0
13477,with,0,0
13478,negative,0,0
13479,passive,0,1
13480,head-up,0,0
13481,tilt,0,1
13482,",",0,0
13483,the,0,0
13484,sensitivity,1,1
13485,of,1,0
13486,glyceryl,1,0
13487,trinitrate,1,0
13488,for,0,0
13489,diagnosing,0,0
13490,vasovagal,1,1
13491,syncope,1,0
13492,was,0,0
13493,48,0,0
13494,%,0,0
13495,and,0,0
13496,the,0,0
13497,specificity,0,0
13498,was,0,0
13499,71,0,0
13500,%,0,0
13501,.,0,0
13502,Glyceryl,0,0
13503,trinitrate,0,0
13504,was,0,0
13505,well,0,0
13506,tolerated,1,1
13507,.,1,0
13508,Isoprenaline,1,0
13509,sensitivity,1,1
13510,was,0,0
13511,21,0,0
13512,%,0,0
13513,with,0,0
13514,specificity,1,0
13515,64,0,0
13516,%,0,0
13517,.,0,0
13518,Side-effects,1,1
13519,prevented,0,0
13520,completion,0,0
13521,of,0,0
13522,the,0,0
13523,test,0,0
13524,in,0,0
13525,68,0,0
13526,%,0,0
13527,.,0,0
13528,Commonest,0,1
13529,adverse,0,1
13530,events,0,1
13531,were,0,0
13532,the,0,0
13533,development,1,1
13534,of,1,0
13535,hypertension,1,1
13536,or,1,0
13537,tachycardia,1,1
13538,and,1,1
13539,intolerable,1,1
13540,flushing,1,1
13541,or,1,0
13542,nausea,1,1
13543,.,1,0
13544,CONCLUSIONS,0,0
13545,Glyceryl,0,0
13546,trinitrate,0,0
13547,head-up,0,0
13548,tilt,0,1
13549,is,0,0
13550,as,0,0
13551,effective,1,0
13552,as,0,0
13553,isoprenaline,0,0
13554,head-up,0,0
13555,tilt,0,1
13556,as,0,0
13557,a,0,0
13558,provocative,0,0
13559,agent,0,0
13560,for,0,0
13561,vasovagal,1,1
13562,syncope,1,0
13563,and,1,0
13564,has,1,0
13565,a,1,0
13566,lower,1,0
13567,incidence,1,1
13568,of,1,1
13569,adverse,1,1
13570,events,1,1
13571,.,1,0
13572,Effectiveness,1,1
13573,of,0,0
13574,the,0,0
13575,school,0,0
13576,dental,0,0
13577,screening,0,0
13578,programme,0,0
13579,in,0,0
13580,stimulating,1,0
13581,dental,1,0
13582,attendance,1,1
13583,for,0,0
13584,children,0,0
13585,in,0,0
13586,need,0,0
13587,of,0,0
13588,treatment,0,0
13589,in,0,0
13590,Northern,0,0
13591,Ireland,0,0
13592,.,0,0
13593,UNLABELLED,0,0
13594,The,0,0
13595,school,0,0
13596,dental,0,0
13597,screening,0,0
13598,programme,0,0
13599,has,0,0
13600,been,0,0
13601,in,0,0
13602,existence,0,0
13603,from,0,0
13604,the,0,0
13605,beginning,0,0
13606,of,0,0
13607,the,0,0
13608,20th,0,0
13609,century,0,0
13610,yet,0,0
13611,its,0,0
13612,value,0,0
13613,in,0,0
13614,encouraging,0,0
13615,attendance,0,1
13616,among,0,0
13617,children,0,0
13618,with,0,0
13619,a,0,0
13620,dental,0,0
13621,health,0,0
13622,need,0,0
13623,is,0,0
13624,not,0,0
13625,fully,0,0
13626,established,0,0
13627,.,0,0
13628,OBJECTIVE,0,0
13629,To,0,0
13630,evaluate,0,0
13631,the,0,0
13632,effectiveness,0,1
13633,of,0,0
13634,school,0,0
13635,dental,0,0
13636,screening,0,0
13637,in,0,0
13638,promoting,0,0
13639,dental,1,0
13640,attendance,1,1
13641,among,0,0
13642,children,0,0
13643,with,0,0
13644,a,0,0
13645,treatment,0,0
13646,need,0,0
13647,and,0,0
13648,to,0,0
13649,examine,0,0
13650,the,0,0
13651,relative,0,0
13652,importance,0,0
13653,of,0,0
13654,screening,0,0
13655,",",0,0
13656,social,0,1
13657,class,0,0
13658,and,0,0
13659,other,0,0
13660,factors,0,0
13661,in,0,0
13662,dental,1,0
13663,attendance,1,1
13664,.,1,0
13665,METHODS,0,0
13666,Sixty-four,0,0
13667,participating,0,0
13668,schools,0,0
13669,were,0,0
13670,assigned,0,0
13671,to,0,0
13672,study,0,0
13673,and,0,0
13674,control,0,0
13675,groups,0,0
13676,using,0,0
13677,a,0,0
13678,stratified,0,0
13679,",",0,0
13680,blocked,0,1
13681,randomisation,0,0
13682,technique,0,0
13683,.,0,0
13684,The,0,0
13685,study,0,0
13686,group,0,0
13687,children,0,0
13688,received,0,0
13689,the,0,0
13690,standard,0,0
13691,school,0,0
13692,dental,0,0
13693,screening,0,0
13694,and,0,0
13695,the,0,0
13696,dental,1,0
13697,attendance,1,0
13698,of,0,0
13699,those,0,0
13700,with,0,0
13701,a,0,0
13702,positive,0,0
13703,screening,1,0
13704,result,1,0
13705,was,0,0
13706,assessed,0,0
13707,after,0,0
13708,2,0,0
13709,months,0,0
13710,by,0,0
13711,means,0,0
13712,of,0,0
13713,a,0,0
13714,questionnaire,0,0
13715,issued,0,0
13716,to,0,0
13717,the,0,0
13718,children,0,0
13719,'s,0,0
13720,parents,0,0
13721,.,0,0
13722,The,0,0
13723,control,0,0
13724,group,0,0
13725,children,0,0
13726,were,0,0
13727,not,0,0
13728,",",0,0
13729,at,0,0
13730,this,0,0
13731,stage,0,0
13732,",",0,0
13733,screened,0,1
13734,",",0,0
13735,yet,0,0
13736,their,0,0
13737,parents,0,0
13738,received,0,0
13739,the,0,0
13740,same,0,0
13741,questionnaire,0,1
13742,assessing,0,0
13743,dental,1,0
13744,attendance,1,0
13745,over,0,0
13746,the,0,0
13747,2-month,0,0
13748,period,0,0
13749,.,0,0
13750,However,0,0
13751,",",0,0
13752,only,0,0
13753,questionnaires,0,0
13754,from,0,0
13755,control,0,0
13756,group,0,0
13757,children,0,0
13758,who,0,0
13759,had,0,0
13760,a,0,0
13761,positive,0,0
13762,result,0,0
13763,at,0,0
13764,a,0,0
13765,subsequent,0,0
13766,screening,0,0
13767,were,0,0
13768,retained,0,0
13769,for,0,0
13770,analysis,0,0
13771,.,0,0
13772,RESULTS,0,0
13773,A,0,0
13774,total,0,0
13775,of,0,0
13776,"2,321",0,0
13777,children,0,0
13778,were,0,0
13779,screened,0,0
13780,",",0,0
13781,with,0,0
13782,980,0,0
13783,having,0,0
13784,a,0,0
13785,positive,0,0
13786,result,0,0
13787,.,0,0
13788,The,0,0
13789,mean,0,1
13790,dmft,0,0
13791,of,0,0
13792,those,0,0
13793,screening,0,0
13794,positive,0,0
13795,was,0,0
13796,4.85,0,0
13797,.,0,0
13798,In,0,0
13799,all,0,0
13800,",",0,0
13801,664,0,0
13802,completed,0,0
13803,questionnaires,0,0
13804,were,0,0
13805,returned,0,0
13806,",",0,0
13807,giving,0,0
13808,a,0,0
13809,response,0,1
13810,rate,0,1
13811,of,0,0
13812,67.8,0,0
13813,%,0,0
13814,.,0,0
13815,Dental,1,0
13816,attendance,1,1
13817,was,0,0
13818,reported,0,0
13819,among,0,0
13820,45.5,0,0
13821,%,0,0
13822,of,0,0
13823,the,0,0
13824,study,0,0
13825,group,0,0
13826,(,0,0
13827,n=352,0,0
13828,),0,0
13829,in,0,0
13830,the,0,0
13831,2,0,0
13832,months,0,0
13833,following,0,0
13834,screening,0,0
13835,.,0,0
13836,In,0,0
13837,the,0,0
13838,same,0,0
13839,period,0,0
13840,",",0,0
13841,27.6,0,0
13842,%,0,0
13843,of,0,0
13844,the,0,0
13845,control,0,0
13846,group,0,0
13847,(,0,0
13848,n=312,0,0
13849,),0,0
13850,claimed,0,0
13851,attendance,0,0
13852,.,0,0
13853,The,0,0
13854,effect,0,0
13855,was,0,0
13856,found,0,0
13857,to,0,0
13858,be,0,0
13859,significant,0,0
13860,among,0,0
13861,the,0,0
13862,high,0,0
13863,employed,0,0
13864,group,0,0
13865,(,0,0
13866,P,0,0
13867,<,0,0
13868,0.01,0,0
13869,),0,0
13870,and,0,0
13871,the,0,0
13872,unemployed,0,0
13873,group,0,0
13874,(,0,0
13875,P,0,0
13876,<,0,0
13877,0.05,0,0
13878,),0,0
13879,.,0,0
13880,CONCLUSION,0,0
13881,School,0,0
13882,dental,0,0
13883,screening,0,0
13884,was,0,0
13885,capable,0,1
13886,of,0,0
13887,stimulating,0,0
13888,dental,1,0
13889,attendance,1,0
13890,.,1,0
13891,The,0,0
13892,strong,0,0
13893,effect,0,0
13894,among,0,0
13895,the,0,0
13896,lowest,0,0
13897,socio-economic,0,0
13898,group,0,0
13899,shows,0,0
13900,that,0,0
13901,school,0,0
13902,dental,0,0
13903,screening,0,0
13904,may,0,0
13905,be,0,0
13906,used,0,0
13907,to,0,0
13908,decrease,0,0
13909,dental,1,0
13910,health,1,0
13911,inequalities,1,0
13912,.,1,0
13913,Effect,0,0
13914,of,0,0
13915,the,0,0
13916,essential,0,0
13917,oils,0,0
13918,of,0,0
13919,garlic,0,0
13920,and,0,1
13921,onion,0,0
13922,on,0,0
13923,alimentary,0,0
13924,hyperlipemia,0,0
13925,.,0,0
13926,SUMMARY,0,0
13927,The,0,0
13928,effect,0,0
13929,of,0,0
13930,garlic,0,0
13931,and,0,1
13932,onion,0,0
13933,on,0,0
13934,alimentary,0,0
13935,hyperlipemia,0,0
13936,",",0,0
13937,induced,0,0
13938,by,0,0
13939,feeding,0,0
13940,100,0,0
13941,g,0,0
13942,butter,0,0
13943,",",0,0
13944,has,0,0
13945,been,0,0
13946,studied,0,0
13947,in,0,0
13948,10,0,0
13949,healthy,0,0
13950,subjects,0,0
13951,.,0,0
13952,The,0,0
13953,freshly,0,0
13954,extracted,0,0
13955,juice,0,0
13956,of,0,0
13957,50,0,0
13958,g,0,0
13959,of,0,0
13960,garlic,0,0
13961,or,0,0
13962,onion,0,0
13963,",",0,0
13964,as,0,0
13965,well,0,0
13966,as,0,0
13967,an,0,0
13968,equivalent,0,0
13969,amount,0,0
13970,of,0,0
13971,their,0,0
13972,ether-extracted,0,0
13973,essential,0,0
13974,oils,0,0
13975,",",0,0
13976,was,0,0
13977,administered,0,0
13978,randomly,0,0
13979,on,0,0
13980,four,0,0
13981,different,0,0
13982,days,0,0
13983,during,0,0
13984,a,0,0
13985,one-week,0,0
13986,period,0,0
13987,.,0,0
13988,Garlic,0,0
13989,and,0,0
13990,onion,0,0
13991,have,0,0
13992,a,0,0
13993,significant,0,0
13994,protective,0,0
13995,action,0,1
13996,against,0,1
13997,fat-induced,1,0
13998,increases,1,1
13999,in,1,0
14000,serum,1,1
14001,cholesterol,1,1
14002,and,1,1
14003,plasma,1,1
14004,fibrinogen,1,1
14005,and,1,1
14006,decreases,1,1
14007,in,1,0
14008,coagulation,1,1
14009,time,1,1
14010,and,1,1
14011,fibrinolytic,1,0
14012,activity,1,1
14013,.,1,0
14014,The,0,0
14015,essential,0,0
14016,oil,0,0
14017,fraction,0,1
14018,",",0,0
14019,which,0,0
14020,contains,0,0
14021,all,0,0
14022,the,0,0
14023,taste,0,1
14024,and,0,1
14025,odour,0,1
14026,",",0,0
14027,exactly,0,0
14028,duplicated,0,0
14029,the,0,0
14030,beneficial,1,0
14031,effects,1,0
14032,of,0,0
14033,whole,0,0
14034,garlic,0,0
14035,and,0,0
14036,onion,0,0
14037,.,0,0
14038,It,0,0
14039,is,0,0
14040,",",0,0
14041,therefore,0,0
14042,",",0,0
14043,concluded,0,0
14044,that,0,0
14045,the,0,0
14046,active,0,0
14047,principle,0,0
14048,of,0,0
14049,garlic,0,0
14050,and,0,0
14051,onion,0,0
14052,is,0,0
14053,the,0,0
14054,essential,0,0
14055,oil,0,0
14056,",",0,0
14057,which,0,0
14058,chemically,0,0
14059,is,0,0
14060,a,0,0
14061,combination,0,0
14062,of,0,0
14063,sulphur-containing,0,0
14064,compounds,0,0
14065,",",0,0
14066,mainly,0,0
14067,allyl,0,0
14068,propyl,0,0
14069,disulphide,0,1
14070,and,0,0
14071,diallyl,0,0
14072,disulphide,0,0
14073,.,0,0
14074,Peptide,1,1
14075,T,1,0
14076,:,1,0
14077,negative,1,1
14078,trial,1,0
14079,result,1,0
14080,.,1,0
14081,Effects,0,0
14082,of,0,0
14083,irrigation,0,0
14084,fluid,0,1
14085,temperature,0,1
14086,on,0,0
14087,core,0,1
14088,body,0,1
14089,temperature,0,1
14090,during,0,0
14091,transurethral,0,0
14092,resection,0,0
14093,of,0,0
14094,the,0,0
14095,prostate,0,0
14096,.,0,0
14097,OBJECTIVES,0,0
14098,To,0,0
14099,determine,0,0
14100,the,0,0
14101,effect,0,0
14102,irrigation,0,0
14103,fluid,0,1
14104,temperature,0,1
14105,has,0,0
14106,on,0,0
14107,core,0,0
14108,body,0,1
14109,temperature,0,1
14110,changes,0,1
14111,in,0,0
14112,patients,0,0
14113,undergoing,0,0
14114,transurethral,0,0
14115,resection,0,0
14116,of,0,0
14117,the,0,0
14118,prostate,0,0
14119,(,0,0
14120,TURP,0,0
14121,),0,0
14122,.,0,0
14123,METHODS,0,0
14124,Fifty-six,0,0
14125,male,0,0
14126,patients,0,0
14127,(,0,0
14128,mean,0,1
14129,age,0,0
14130,71.2,0,0
14131,+/-,0,0
14132,8.2,0,0
14133,years,0,0
14134,),0,0
14135,scheduled,0,0
14136,for,0,0
14137,TURP,0,1
14138,were,0,0
14139,enrolled,0,0
14140,in,0,0
14141,the,0,0
14142,study,0,0
14143,.,0,0
14144,Patients,0,0
14145,were,0,0
14146,randomized,0,0
14147,to,0,0
14148,one,0,0
14149,of,0,0
14150,two,0,0
14151,groups,0,0
14152,.,0,0
14153,Group,0,0
14154,1,0,0
14155,consisted,0,0
14156,of,0,0
14157,27,0,0
14158,patients,0,0
14159,who,0,0
14160,received,0,0
14161,room,0,0
14162,temperature,0,1
14163,irrigation,0,1
14164,fluid,0,1
14165,(,0,0
14166,70,0,0
14167,degrees,0,0
14168,F,0,0
14169,),0,0
14170,throughout,0,0
14171,TURP,0,0
14172,;,0,0
14173,group,0,0
14174,2,0,0
14175,consisted,0,0
14176,of,0,0
14177,29,0,0
14178,patients,0,0
14179,whose,0,0
14180,procedure,0,0
14181,was,0,0
14182,performed,0,0
14183,with,0,0
14184,warmed,0,0
14185,irrigation,0,0
14186,fluid,0,1
14187,(,0,0
14188,91.5,0,0
14189,degrees,0,0
14190,F,0,0
14191,),0,0
14192,.,0,0
14193,The,0,0
14194,irrigation,0,0
14195,fluid,0,1
14196,used,0,0
14197,for,0,0
14198,both,0,0
14199,groups,0,0
14200,was,0,0
14201,glycine,0,0
14202,.,0,0
14203,The,0,0
14204,baseline,0,0
14205,temperature,0,1
14206,",",0,0
14207,final,0,1
14208,temperature,0,1
14209,",",0,0
14210,total,0,1
14211,time,0,1
14212,in,0,0
14213,the,0,0
14214,operating,0,1
14215,room,0,0
14216,",",0,1
14217,and,0,1
14218,amount,0,1
14219,of,0,1
14220,irrigation,0,0
14221,fluid,0,1
14222,used,0,0
14223,during,0,0
14224,the,0,0
14225,procedure,0,0
14226,were,0,0
14227,recorded,0,0
14228,for,0,0
14229,each,0,0
14230,patient,0,0
14231,.,0,0
14232,RESULTS,0,0
14233,No,0,0
14234,significant,0,0
14235,difference,0,0
14236,in,0,0
14237,the,0,0
14238,average,1,0
14239,time,1,1
14240,spent,1,0
14241,in,1,0
14242,the,1,0
14243,operating,1,1
14244,room,1,0
14245,or,1,0
14246,in,1,0
14247,the,1,0
14248,total,1,1
14249,irrigation,1,0
14250,fluid,1,1
14251,used,0,0
14252,between,0,0
14253,the,0,0
14254,two,0,0
14255,groups,0,0
14256,was,0,0
14257,observed,0,0
14258,.,0,0
14259,Of,0,0
14260,the,0,0
14261,27,0,0
14262,patients,0,0
14263,who,0,0
14264,received,0,0
14265,room,1,0
14266,temperature,1,1
14267,irrigation,1,1
14268,fluid,1,1
14269,",",0,0
14270,15,0,0
14271,(,0,0
14272,55.6,0,0
14273,%,0,0
14274,),0,0
14275,had,0,0
14276,a,0,0
14277,decrease,0,0
14278,in,0,0
14279,body,1,1
14280,temperature,1,1
14281,.,1,0
14282,A,0,0
14283,decrease,0,0
14284,in,0,0
14285,temperature,1,1
14286,was,0,0
14287,observed,0,0
14288,in,0,0
14289,21,0,0
14290,(,0,0
14291,72.4,0,0
14292,%,0,0
14293,),0,0
14294,of,0,0
14295,the,0,0
14296,29,0,0
14297,patients,0,0
14298,who,0,0
14299,received,0,0
14300,warm,0,0
14301,irrigation,1,0
14302,fluid,1,1
14303,.,1,0
14304,Groups,0,0
14305,1,0,0
14306,and,0,0
14307,2,0,0
14308,had,0,0
14309,12,0,0
14310,(,0,0
14311,44.4,0,0
14312,%,0,0
14313,),0,0
14314,of,0,0
14315,27,0,0
14316,and,0,0
14317,8,0,0
14318,(,0,0
14319,27.6,0,0
14320,%,0,0
14321,),0,0
14322,of,0,0
14323,29,0,0
14324,patients,0,0
14325,",",0,0
14326,respectively,0,0
14327,",",0,0
14328,who,0,0
14329,demonstrated,0,0
14330,an,0,0
14331,elevation,1,1
14332,in,0,0
14333,their,0,0
14334,core,1,0
14335,body,1,1
14336,temperature,1,1
14337,.,1,0
14338,CONCLUSIONS,0,0
14339,The,0,0
14340,results,0,0
14341,of,0,0
14342,our,0,0
14343,study,0,0
14344,suggest,0,0
14345,that,0,0
14346,irrigation,0,0
14347,fluid,0,1
14348,temperature,0,1
14349,is,0,0
14350,not,0,0
14351,a,0,0
14352,factor,0,0
14353,responsible,0,0
14354,for,0,0
14355,altering,0,0
14356,the,0,0
14357,core,0,0
14358,body,1,1
14359,temperature,1,1
14360,in,0,0
14361,patients,0,0
14362,undergoing,0,0
14363,TURP,0,0
14364,.,0,0
14365,Dose,0,1
14366,response,0,1
14367,effect,0,0
14368,of,0,0
14369,cyclical,0,1
14370,medroxyprogesterone,0,0
14371,on,0,0
14372,blood,1,1
14373,pressure,1,1
14374,in,0,0
14375,postmenopausal,0,0
14376,women,0,0
14377,.,0,0
14378,OBJECTIVE,0,0
14379,This,0,0
14380,study,0,0
14381,was,0,0
14382,designed,0,0
14383,to,0,0
14384,compare,0,0
14385,with,0,0
14386,placebo,0,0
14387,the,0,0
14388,dose-response,0,0
14389,effect,0,0
14390,of,0,0
14391,cyclical,0,1
14392,doses,0,0
14393,of,0,0
14394,the,0,0
14395,C21,0,1
14396,progestogen,0,0
14397,",",0,0
14398,medroxyprogesterone,0,0
14399,acetate,0,0
14400,(,0,0
14401,MPA,0,1
14402,),0,0
14403,on,0,0
14404,blood,0,1
14405,pressure,0,1
14406,(,0,0
14407,BP,0,1
14408,),0,0
14409,when,0,0
14410,administered,0,0
14411,to,0,0
14412,normotensive,0,0
14413,postmenopausal,0,0
14414,women,0,0
14415,receiving,0,0
14416,a,0,0
14417,fixed,0,0
14418,mid-range,0,0
14419,daily,0,0
14420,dose,0,0
14421,of,0,0
14422,conjugated,0,0
14423,equine,0,0
14424,oestrogen,0,1
14425,(,0,0
14426,CEE,0,0
14427,),0,0
14428,.,0,0
14429,MATERIALS,0,0
14430,AND,0,0
14431,METHODS,0,0
14432,Twenty,0,0
14433,normotensive,0,0
14434,postmenopausal,0,0
14435,women,0,0
14436,(,0,0
14437,median,0,0
14438,age,0,0
14439,53,0,0
14440,years,0,0
14441,),0,0
14442,participated,0,0
14443,in,0,0
14444,the,0,0
14445,study,0,0
14446,which,0,0
14447,used,0,0
14448,a,0,0
14449,double-blind,0,0
14450,crossover,0,0
14451,design,0,0
14452,.,0,0
14453,There,0,0
14454,were,0,0
14455,four,0,0
14456,randomised,0,0
14457,treatment,0,0
14458,phases,0,0
14459,",",0,0
14460,each,0,0
14461,of,0,0
14462,4,0,0
14463,weeks,0,0
14464,duration,0,0
14465,.,0,0
14466,The,0,0
14467,four,0,0
14468,blinded,0,0
14469,treatments,0,0
14470,were,0,0
14471,MPA,0,0
14472,2.5,0,0
14473,mg,0,0
14474,",",0,0
14475,MPA,0,0
14476,5,0,0
14477,mg,0,0
14478,",",0,0
14479,MPA,0,0
14480,10,0,0
14481,mg,0,0
14482,and,0,0
14483,matching,0,0
14484,placebo,0,0
14485,",",0,0
14486,taken,0,0
14487,for,0,0
14488,the,0,0
14489,last,0,0
14490,14,0,0
14491,days,0,0
14492,of,0,0
14493,each,0,0
14494,28,0,0
14495,day,0,0
14496,treatment,0,0
14497,cycle,0,1
14498,.,0,0
14499,CEE,0,0
14500,0.625,0,0
14501,mg,0,0
14502,was,0,0
14503,also,0,0
14504,administered,0,0
14505,once,0,0
14506,daily,0,0
14507,as,0,0
14508,open,0,0
14509,labelled,0,0
14510,tablets,0,0
14511,to,0,0
14512,all,0,0
14513,subjects,0,0
14514,throughout,0,0
14515,the,0,0
14516,study,0,0
14517,.,0,0
14518,Clinic,1,0
14519,BP,1,1
14520,was,0,0
14521,measured,0,0
14522,weekly,0,0
14523,with,0,0
14524,the,0,0
14525,mean,0,1
14526,values,0,1
14527,of,0,0
14528,weeks,0,0
14529,3,0,0
14530,and,0,0
14531,4,0,0
14532,of,0,0
14533,each,0,0
14534,phase,0,0
14535,used,0,0
14536,for,0,0
14537,analysis,0,0
14538,.,0,0
14539,Ambulatory,1,1
14540,BP,1,1
14541,was,0,0
14542,performed,0,0
14543,in,0,0
14544,the,0,0
14545,final,0,1
14546,week,0,0
14547,of,0,0
14548,each,0,0
14549,phase,0,0
14550,.,0,0
14551,RESULTS,0,0
14552,Compared,0,0
14553,with,0,0
14554,the,0,0
14555,placebo,0,0
14556,phase,0,0
14557,",",0,0
14558,end,0,0
14559,of,0,1
14560,phase,0,0
14561,clinic,1,0
14562,BP,1,1
14563,was,0,0
14564,unchanged,0,0
14565,by,0,0
14566,any,0,0
14567,of,0,0
14568,the,0,0
14569,progestogen,0,0
14570,treatments,0,0
14571,.,0,0
14572,There,0,0
14573,was,0,0
14574,a,0,0
14575,dose-dependent,0,0
14576,decrease,1,0
14577,in,1,0
14578,ambulatory,1,0
14579,daytime,1,1
14580,diastolic,1,1
14581,and,1,0
14582,mean,1,1
14583,arterial,1,1
14584,BP,1,1
14585,with,0,0
14586,the,0,0
14587,progestogen,0,0
14588,treatments,0,0
14589,compared,0,0
14590,with,0,0
14591,placebo,0,0
14592,(,0,0
14593,P,0,0
14594,<,0,0
14595,0.05,0,0
14596,),0,0
14597,.,0,0
14598,CONCLUSION,0,0
14599,In,0,0
14600,a,0,0
14601,regimen,0,0
14602,of,0,0
14603,postmenopausal,0,0
14604,hormone,0,1
14605,replacement,0,0
14606,therapy,0,0
14607,with,0,0
14608,a,0,0
14609,fixed,0,0
14610,mid-range,0,0
14611,daily,0,0
14612,dose,0,0
14613,of,0,0
14614,CEE,0,0
14615,combined,0,0
14616,with,0,0
14617,a,0,0
14618,cyclical,0,1
14619,regimen,0,0
14620,of,0,0
14621,a,0,0
14622,C21,0,1
14623,progestogen,0,0
14624,spanning,0,0
14625,the,0,0
14626,current,0,0
14627,clinical,0,0
14628,dose,0,0
14629,range,0,0
14630,",",0,0
14631,the,0,0
14632,progestogen,0,0
14633,has,0,0
14634,either,0,0
14635,no,0,0
14636,effect,0,0
14637,or,0,0
14638,a,0,0
14639,small,0,0
14640,dose-dependent,0,0
14641,reduction,0,1
14642,in,0,0
14643,clinic,1,0
14644,and,1,0
14645,ambulatory,1,0
14646,BPs,1,1
14647,over,0,0
14648,one,0,0
14649,treatment,0,0
14650,cycle,0,0
14651,.,0,0
14652,Rehabilitation,1,0
14653,outcomes,1,1
14654,following,0,0
14655,percutaneous,0,0
14656,coronary,0,0
14657,interventions,0,0
14658,(,0,0
14659,PCI,0,1
14660,),0,0
14661,.,0,0
14662,This,0,0
14663,prospective,0,0
14664,study,0,0
14665,evaluated,0,0
14666,the,0,0
14667,effect,0,0
14668,of,0,0
14669,an,0,0
14670,individualized,0,0
14671,",",0,0
14672,comprehensive,0,0
14673,",",0,0
14674,home-based,0,0
14675,cardiac,0,1
14676,rehabilitation,0,0
14677,program,0,0
14678,combining,0,0
14679,exercise,0,0
14680,training,0,0
14681,with,0,0
14682,risk,0,1
14683,factor,0,1
14684,modification,0,0
14685,and,0,1
14686,psychosocial,0,1
14687,counseling,0,0
14688,on,0,0
14689,risk,1,1
14690,factors,1,0
14691,",",1,0
14692,psychological,1,1
14693,well-being,1,1
14694,",",1,0
14695,functional,1,1
14696,capacity,1,1
14697,",",1,0
14698,and,1,1
14699,work,1,1
14700,resumption,1,1
14701,in,0,0
14702,99,0,0
14703,post-percutaneous,0,0
14704,coronary,0,0
14705,interventions,0,0
14706,(,0,0
14707,PCI,0,1
14708,),0,0
14709,patients,0,0
14710,randomized,0,0
14711,to,0,0
14712,control,0,0
14713,(,0,0
14714,standard,0,0
14715,care,0,0
14716,plus,0,0
14717,telephone,0,1
14718,follow-up,0,1
14719,",",0,1
14720,n=49,0,0
14721,),0,1
14722,or,0,0
14723,intervention,0,0
14724,(,0,0
14725,individualized,0,0
14726,",",0,0
14727,comprehensive,0,0
14728,",",0,0
14729,home-based,0,0
14730,cardiac,0,1
14731,rehabilitation,0,0
14732,",",0,0
14733,n=50,0,0
14734,),0,0
14735,groups,0,0
14736,.,0,0
14737,Data,0,0
14738,were,0,0
14739,collected,0,0
14740,at,0,0
14741,time,0,0
14742,1,0,0
14743,(,0,0
14744,T,0,0
14745,(,0,0
14746,1,0,0
14747,),0,0
14748,),0,0
14749,during,0,0
14750,hospital,0,1
14751,admission,0,1
14752,",",0,0
14753,time,0,1
14754,2,0,0
14755,(,0,0
14756,T,0,0
14757,(,0,0
14758,2,0,0
14759,),0,0
14760,),0,0
14761,approximately,0,0
14762,2,0,0
14763,months,0,0
14764,post-PCI,0,0
14765,",",0,0
14766,and,0,0
14767,time,0,1
14768,3,0,0
14769,(,0,0
14770,T,0,0
14771,(,0,0
14772,3,0,0
14773,),0,0
14774,),0,0
14775,approximately,0,0
14776,12,0,0
14777,months,0,0
14778,post-PCI,0,0
14779,.,0,0
14780,Results,0,0
14781,suggest,0,0
14782,that,0,0
14783,the,0,0
14784,allocation,0,0
14785,to,0,0
14786,an,0,0
14787,individualized,0,0
14788,",",0,0
14789,comprehensive,0,0
14790,",",0,0
14791,home-based,0,0
14792,cardiac,0,1
14793,rehabilitation,0,0
14794,program,0,0
14795,provided,0,0
14796,more,0,0
14797,advantageous,0,0
14798,outcomes,0,0
14799,.,0,0
14800,At,0,0
14801,both,0,0
14802,follow-ups,0,0
14803,",",0,0
14804,the,0,0
14805,intervention,0,0
14806,group,0,0
14807,showed,0,0
14808,within-group,0,0
14809,improvement,0,1
14810,in,0,0
14811,serum,1,1
14812,cholesterol,1,1
14813,levels,1,1
14814,(,0,0
14815,P,0,0
14816,<,0,0
14817,0.02,0,0
14818,;,0,0
14819,P,0,0
14820,<,0,0
14821,0.01,0,0
14822,),0,0
14823,and,0,0
14824,exercise,1,0
14825,participation,1,1
14826,(,0,0
14827,P,0,0
14828,<,0,0
14829,0.001,0,0
14830,;,0,0
14831,P,0,0
14832,<,0,0
14833,0.001,0,0
14834,),0,0
14835,with,0,0
14836,differences,0,0
14837,in,0,0
14838,exercise,1,0
14839,participation,1,0
14840,favoring,0,0
14841,the,0,0
14842,intervention,0,0
14843,group,0,0
14844,(,0,0
14845,P,0,0
14846,<,0,0
14847,0.01,0,0
14848,),0,0
14849,at,0,0
14850,T,0,0
14851,(,0,0
14852,2,0,0
14853,),0,0
14854,.,0,0
14855,Repeated,0,0
14856,measures,0,1
14857,ANOVA,0,0
14858,showed,0,0
14859,significant,0,0
14860,improvements,0,1
14861,over,0,0
14862,time,0,1
14863,in,0,0
14864,body,1,1
14865,mass,1,1
14866,index,1,1
14867,(,1,0
14868,BMI,1,1
14869,),1,0
14870,(,0,0
14871,P,0,0
14872,<,0,0
14873,0.01,0,0
14874,),0,0
14875,",",0,0
14876,psychological,1,1
14877,well-being,1,1
14878,(,0,0
14879,P,0,0
14880,<,0,0
14881,0.001,0,0
14882,),0,0
14883,",",0,0
14884,and,0,1
14885,functional,1,1
14886,capacity,1,1
14887,(,0,0
14888,P,0,0
14889,<,0,0
14890,0.001,0,0
14891,),0,0
14892,for,0,0
14893,both,0,0
14894,groups,0,0
14895,.,0,0
14896,More,0,0
14897,patients,0,0
14898,in,0,0
14899,the,0,0
14900,intervention,0,0
14901,group,0,0
14902,had,0,0
14903,returned,1,0
14904,to,1,0
14905,work,1,0
14906,at,0,0
14907,T,0,0
14908,(,0,0
14909,2,0,0
14910,),0,0
14911,(,0,0
14912,P,0,0
14913,<,0,0
14914,0.001,0,0
14915,),0,0
14916,and,0,0
14917,did,0,0
14918,so,0,0
14919,more,0,0
14920,quickly,0,0
14921,(,0,0
14922,P,0,0
14923,<,0,0
14924,0.01,0,0
14925,),0,0
14926,.,0,0
14927,These,0,0
14928,findings,0,0
14929,suggest,0,0
14930,that,0,0
14931,an,0,0
14932,individualized,0,0
14933,",",0,0
14934,comprehensive,0,0
14935,",",0,0
14936,home-based,0,0
14937,cardiac,0,1
14938,rehabilitation,0,0
14939,program,0,0
14940,improves,0,1
14941,risk,1,1
14942,factor,1,1
14943,profiles,1,1
14944,and,1,1
14945,work,1,0
14946,resumption,1,1
14947,patterns,1,1
14948,for,0,0
14949,patients,0,0
14950,following,0,0
14951,PCI,0,0
14952,.,0,0
14953,Double-blind,0,0
14954,",",0,0
14955,placebo-controlled,0,0
14956,study,0,0
14957,of,0,0
14958,amantadine,0,0
14959,hydrochloride,0,0
14960,in,0,0
14961,the,0,0
14962,treatment,0,0
14963,of,0,0
14964,children,0,0
14965,with,0,0
14966,autistic,0,0
14967,disorder,0,0
14968,.,0,0
14969,OBJECTIVE,0,0
14970,To,0,0
14971,test,0,0
14972,the,0,0
14973,hypothesis,0,0
14974,that,0,0
14975,amantadine,0,0
14976,hydrochloride,0,0
14977,is,0,0
14978,a,0,0
14979,safe,0,0
14980,and,0,0
14981,effective,0,1
14982,treatment,0,0
14983,for,0,0
14984,behavioral,1,1
14985,disturbances,1,1
14986,--,1,0
14987,for,1,0
14988,example,0,0
14989,",",0,0
14990,hyperactivity,1,1
14991,and,1,0
14992,irritability,1,1
14993,--,1,0
14994,in,1,0
14995,children,0,0
14996,with,0,0
14997,autism,0,0
14998,.,0,0
14999,METHOD,0,0
15000,Thirty-nine,0,0
15001,subjects,0,0
15002,(,0,0
15003,intent,0,0
15004,to,0,0
15005,treat,0,0
15006,;,0,0
15007,5-19,0,0
15008,years,0,0
15009,old,0,0
15010,;,0,0
15011,IQ,0,0
15012,>,0,0
15013,35,0,0
15014,),0,0
15015,had,0,0
15016,autism,0,0
15017,diagnosed,0,0
15018,according,0,0
15019,to,0,0
15020,DSM-IV,0,1
15021,and,0,0
15022,ICD-10,0,0
15023,criteria,0,0
15024,using,0,0
15025,the,0,0
15026,Autism,0,1
15027,Diagnostic,0,0
15028,Interview-Revised,0,0
15029,and,0,0
15030,the,0,0
15031,Autism,0,1
15032,Diagnostic,0,0
15033,Observation,0,0
15034,Schedule-Generic,0,0
15035,.,0,0
15036,The,0,0
15037,Aberrant,1,0
15038,Behavior,1,1
15039,Checklist-Community,1,1
15040,Version,1,1
15041,(,1,0
15042,ABC-CV,1,0
15043,),1,0
15044,and,1,0
15045,Clinical,1,1
15046,Global,1,1
15047,Impressions,1,1
15048,(,1,0
15049,CGI,1,1
15050,),1,1
15051,scale,0,1
15052,were,0,0
15053,used,0,0
15054,as,0,0
15055,outcome,0,0
15056,variables,0,0
15057,.,0,0
15058,After,0,0
15059,a,0,0
15060,1-week,0,0
15061,",",0,0
15062,single-blind,0,0
15063,placebo,0,0
15064,run-in,0,0
15065,",",0,0
15066,patients,0,0
15067,received,0,0
15068,a,0,0
15069,single,0,0
15070,daily,0,0
15071,dose,0,0
15072,of,0,0
15073,amantadine,0,0
15074,(,0,0
15075,2.5,0,0
15076,mg/kg,0,0
15077,per,0,0
15078,day,0,0
15079,),0,0
15080,or,0,0
15081,placebo,0,0
15082,for,0,0
15083,the,0,0
15084,next,0,0
15085,week,0,0
15086,",",0,0
15087,and,0,0
15088,then,0,0
15089,bid,0,0
15090,dosing,0,0
15091,(,0,0
15092,5.0,0,0
15093,mg/kg,0,0
15094,per,0,0
15095,day,0,0
15096,),0,0
15097,for,0,0
15098,the,0,0
15099,subsequent,0,0
15100,3,0,0
15101,weeks,0,0
15102,.,0,0
15103,RESULTS,0,0
15104,When,0,0
15105,assessed,0,0
15106,on,0,0
15107,the,0,0
15108,basis,0,0
15109,of,0,0
15110,parent-rated,1,1
15111,ABC-CV,1,0
15112,ratings,1,1
15113,of,1,0
15114,irritability,1,1
15115,and,1,1
15116,hyperactivity,1,1
15117,",",0,0
15118,the,0,0
15119,mean,0,1
15120,placebo,0,0
15121,response,0,1
15122,rate,0,1
15123,was,0,0
15124,37,0,0
15125,%,0,0
15126,versus,0,0
15127,amantadine,0,0
15128,at,0,0
15129,47,0,0
15130,%,0,0
15131,(,0,0
15132,not,0,0
15133,significant,0,0
15134,),0,0
15135,.,0,0
15136,However,0,0
15137,",",0,0
15138,in,0,0
15139,the,0,0
15140,amantadine-treated,0,0
15141,group,0,0
15142,there,0,0
15143,were,0,0
15144,statistically,0,0
15145,significant,0,0
15146,improvements,0,1
15147,in,0,0
15148,absolute,0,1
15149,changes,0,1
15150,in,0,0
15151,clinician-rated,0,1
15152,ABC-CVs,1,0
15153,for,1,0
15154,hyperactivity,1,1
15155,(,0,0
15156,amantadine,0,0
15157,-6.4,0,0
15158,versus,0,0
15159,placebo,0,0
15160,-2.1,0,0
15161,;,0,0
15162,p,0,0
15163,=,0,0
15164,.046,0,0
15165,),0,0
15166,and,0,0
15167,inappropriate,1,1
15168,speech,1,1
15169,(,0,0
15170,-1.9,0,0
15171,versus,0,0
15172,0.4,0,0
15173,;,0,0
15174,p,0,0
15175,=,0,0
15176,.008,0,0
15177,),0,0
15178,.,0,0
15179,CGI,1,1
15180,scale,1,1
15181,ratings,1,1
15182,were,0,0
15183,higher,0,0
15184,in,0,0
15185,the,0,0
15186,amantadine,0,0
15187,group,0,0
15188,:,0,0
15189,53,0,0
15190,%,0,0
15191,improved,0,0
15192,versus,0,0
15193,25,0,0
15194,%,0,0
15195,(,0,0
15196,p,0,0
15197,=,0,0
15198,.076,0,0
15199,),0,0
15200,.,0,0
15201,Amantadine,0,0
15202,was,0,0
15203,well,0,0
15204,tolerated,0,1
15205,.,0,0
15206,CONCLUSIONS,0,0
15207,Parents,0,0
15208,did,0,0
15209,not,0,0
15210,report,0,0
15211,statistically,0,0
15212,significant,0,0
15213,behavioral,1,1
15214,change,1,0
15215,with,0,0
15216,amantadine,0,0
15217,.,0,0
15218,However,0,0
15219,",",0,0
15220,clinician-rated,1,1
15221,improvements,1,1
15222,in,1,0
15223,behavioral,1,1
15224,ratings,1,1
15225,following,0,0
15226,treatment,0,0
15227,with,0,0
15228,amantadine,0,0
15229,suggest,0,0
15230,that,0,0
15231,further,0,0
15232,studies,0,0
15233,with,0,0
15234,this,0,0
15235,or,0,0
15236,other,0,0
15237,drugs,0,0
15238,acting,0,0
15239,on,0,0
15240,the,0,0
15241,glutamatergic,0,0
15242,system,0,0
15243,are,0,0
15244,warranted,0,0
15245,.,0,0
15246,The,0,0
15247,design,0,0
15248,of,0,0
15249,these,0,0
15250,and,0,0
15251,similar,0,0
15252,drug,0,0
15253,trials,0,0
15254,in,0,0
15255,children,0,0
15256,with,0,0
15257,autistic,0,0
15258,disorder,0,0
15259,must,0,0
15260,take,0,0
15261,into,0,0
15262,account,0,0
15263,the,0,0
15264,possibility,0,0
15265,of,0,0
15266,a,0,0
15267,large,0,0
15268,placebo,0,0
15269,response,0,1
15270,.,0,0
15271,Four-year,0,0
15272,outcomes,0,0
15273,from,0,0
15274,adolescent,0,0
15275,alcohol,0,0
15276,and,0,1
15277,drug,0,0
15278,treatment,0,0
15279,.,0,0
15280,OBJECTIVE,0,0
15281,Knowledge,0,1
15282,of,0,0
15283,treatment,0,0
15284,response,0,1
15285,for,0,0
15286,alcohol,0,0
15287,and,0,1
15288,drug,0,0
15289,problems,0,1
15290,among,0,0
15291,adults,0,0
15292,is,0,0
15293,mounting,0,0
15294,;,0,0
15295,less,0,0
15296,is,0,0
15297,known,0,0
15298,about,0,0
15299,long-term,0,0
15300,outcome,0,1
15301,for,0,0
15302,adolescents,0,0
15303,who,0,0
15304,receive,0,0
15305,treatment,0,0
15306,for,0,0
15307,alcohol,0,0
15308,and,0,1
15309,drug,0,0
15310,problems,0,1
15311,.,0,0
15312,The,0,0
15313,current,0,0
15314,study,0,0
15315,examined,0,0
15316,youth,0,0
15317,substance,0,0
15318,involvement,0,1
15319,over,0,0
15320,4,0,0
15321,years,0,0
15322,(,0,0
15323,using,0,0
15324,five,0,0
15325,waves,0,0
15326,of,0,0
15327,data,0,0
15328,collection,0,0
15329,),0,0
15330,following,0,0
15331,treatment,0,0
15332,for,0,0
15333,alcohol,0,0
15334,and,0,1
15335,drug,0,0
15336,abuse,0,0
15337,.,0,0
15338,METHOD,0,0
15339,A,0,0
15340,cohort,0,0
15341,of,0,1
15342,youth,0,0
15343,(,0,0
15344,N,0,0
15345,=,0,0
15346,162,0,0
15347,",",0,0
15348,60,0,0
15349,%,0,0
15350,male,0,0
15351,),0,0
15352,treated,0,0
15353,during,0,0
15354,adolescence,0,1
15355,(,0,0
15356,mean,0,1
15357,age,0,0
15358,=,0,0
15359,16,0,0
15360,years,0,0
15361,),0,0
15362,was,0,0
15363,followed,0,0
15364,into,0,0
15365,young,0,0
15366,adulthood,0,0
15367,",",0,0
15368,a,0,0
15369,period,0,0
15370,associated,0,0
15371,with,0,0
15372,stabilization,0,0
15373,of,0,0
15374,alcohol,0,0
15375,use,0,1
15376,patterns,0,1
15377,and,0,0
15378,elevated,0,1
15379,risk,0,1
15380,for,0,0
15381,life,0,1
15382,problems,0,1
15383,secondary,0,0
15384,to,0,0
15385,both,0,0
15386,alcohol,0,0
15387,and,0,1
15388,drug,0,0
15389,use,0,0
15390,.,0,0
15391,Participants,0,0
15392,(,0,0
15393,14-18,0,0
15394,years,0,0
15395,old,0,0
15396,),0,0
15397,were,0,0
15398,consecutive,0,0
15399,admissions,0,0
15400,to,0,0
15401,inpatient,0,0
15402,adolescent,0,0
15403,alcohol,0,0
15404,and,0,1
15405,drug,0,1
15406,treatment,0,0
15407,centers,0,0
15408,in,0,0
15409,San,0,0
15410,Diego,0,0
15411,that,0,0
15412,were,0,0
15413,abstinence,0,1
15414,focused,0,0
15415,and,0,0
15416,based,0,0
15417,on,0,0
15418,the,0,0
15419,12-step,0,0
15420,approach,0,0
15421,.,0,0
15422,RESULTS,0,0
15423,Alcohol,1,0
15424,and,1,0
15425,other,1,0
15426,drug,1,1
15427,use,1,0
15428,were,0,0
15429,reduced,0,0
15430,during,0,0
15431,the,0,0
15432,4,0,0
15433,years,0,0
15434,posttreatment,0,0
15435,",",0,0
15436,with,0,0
15437,the,0,0
15438,exception,0,0
15439,of,0,0
15440,nicotine,0,0
15441,.,0,0
15442,The,0,0
15443,greatest,0,0
15444,prevalence,1,1
15445,reduction,1,1
15446,occurred,0,0
15447,for,0,0
15448,stimulants,0,0
15449,;,0,0
15450,modest,0,0
15451,changes,0,1
15452,were,0,0
15453,evident,0,0
15454,in,0,0
15455,alcohol,0,0
15456,and,0,1
15457,marijuana,0,1
15458,use,0,1
15459,.,0,0
15460,Nicotine,0,0
15461,was,0,0
15462,the,0,0
15463,most,0,0
15464,commonly,0,0
15465,used,0,0
15466,substance,0,0
15467,throughout,0,0
15468,the,0,0
15469,4,0,0
15470,years,0,0
15471,after,0,0
15472,treatment,0,0
15473,.,0,0
15474,Several,0,0
15475,distinct,0,0
15476,substance,0,0
15477,involvement,0,1
15478,trajectories,0,1
15479,were,0,0
15480,evident,0,0
15481,during,0,0
15482,the,0,0
15483,4,0,0
15484,years,0,0
15485,following,0,0
15486,treatment,0,0
15487,.,0,0
15488,CONCLUSIONS,0,0
15489,Alcohol,0,0
15490,and,0,1
15491,drug,0,1
15492,use,0,1
15493,patterns,0,0
15494,during,0,0
15495,the,0,0
15496,4,0,0
15497,years,0,0
15498,following,0,0
15499,treatment,0,0
15500,highlight,0,0
15501,both,0,0
15502,changes,0,1
15503,and,0,0
15504,diversity,0,1
15505,in,0,0
15506,substance,0,0
15507,involvement,0,1
15508,as,0,0
15509,youth,0,0
15510,make,0,0
15511,the,0,0
15512,transitions,0,0
15513,from,0,0
15514,middle,0,0
15515,to,0,0
15516,late,0,1
15517,adolescence,0,1
15518,and,0,0
15519,into,0,0
15520,young,0,0
15521,adulthood,0,0
15522,.,0,0
15523,Findings,0,0
15524,demonstrate,0,0
15525,the,0,0
15526,importance,0,0
15527,of,0,0
15528,identifying,0,0
15529,transitional,0,0
15530,periods,0,0
15531,and,0,0
15532,the,0,0
15533,need,0,0
15534,for,0,0
15535,alternative,0,0
15536,intervention,0,0
15537,strategies,0,0
15538,that,0,0
15539,may,0,0
15540,help,0,0
15541,the,0,0
15542,progression,0,1
15543,of,0,0
15544,this,0,0
15545,population,0,0
15546,into,0,0
15547,young,0,0
15548,adulthood,0,0
15549,.,0,0
15550,Risk,0,0
15551,factors,0,0
15552,for,0,0
15553,malnutrition,0,1
15554,in,0,0
15555,patients,0,0
15556,undergoing,0,0
15557,gastroenterological,0,0
15558,and,0,0
15559,hernia,0,0
15560,surgery,0,0
15561,:,0,0
15562,an,0,0
15563,analysis,0,0
15564,of,0,0
15565,374,0,0
15566,patients,0,0
15567,.,0,0
15568,OBJECTIVE,0,0
15569,The,0,0
15570,aim,0,0
15571,of,0,0
15572,this,0,0
15573,study,0,0
15574,was,0,0
15575,to,0,0
15576,assess,0,0
15577,the,0,0
15578,nutritional,0,0
15579,status,0,0
15580,of,0,0
15581,374,0,0
15582,surgical,0,0
15583,patients,0,0
15584,with,0,0
15585,gastrointestinal,0,1
15586,disease,0,1
15587,and,0,1
15588,hernias,0,0
15589,of,0,0
15590,the,0,0
15591,abdominal,0,0
15592,wall,0,0
15593,;,0,0
15594,to,0,0
15595,identify,0,0
15596,risk,0,1
15597,factors,0,0
15598,associated,0,0
15599,with,0,0
15600,a,0,0
15601,poorer,0,0
15602,nutritional,0,1
15603,status,0,1
15604,in,0,0
15605,this,0,0
15606,group,0,0
15607,of,0,0
15608,patients,0,0
15609,and,0,0
15610,to,0,0
15611,assess,0,0
15612,awareness,0,0
15613,of,0,0
15614,the,0,0
15615,patient,0,1
15616,'s,0,0
15617,nutritional,0,1
15618,status,0,1
15619,by,0,0
15620,medical,0,0
15621,teams,0,0
15622,.,0,0
15623,SUMMARY,0,0
15624,BACKGROUND,0,0
15625,DATA,0,0
15626,Malnutrition,0,0
15627,is,0,0
15628,prevalent,0,0
15629,among,0,0
15630,surgical,0,0
15631,patients,0,0
15632,and,0,0
15633,is,0,0
15634,associated,0,0
15635,with,0,0
15636,higher,0,0
15637,surgical,0,0
15638,complication,0,1
15639,rates,0,1
15640,and,0,0
15641,mortality,0,1
15642,.,0,0
15643,The,0,0
15644,major,0,0
15645,causes,0,0
15646,of,0,0
15647,poor,0,1
15648,nutritional,0,0
15649,status,0,0
15650,are,0,0
15651,related,0,0
15652,to,0,0
15653,the,0,0
15654,underlying,0,0
15655,disease,0,0
15656,",",0,0
15657,socio-economic,0,1
15658,factors,0,0
15659,",",0,0
15660,age,0,0
15661,",",0,1
15662,and,0,1
15663,length,0,1
15664,of,0,0
15665,hospitalization,0,1
15666,.,0,0
15667,Despite,0,0
15668,its,0,0
15669,high,0,0
15670,prevalence,0,1
15671,",",0,0
15672,medical,0,0
15673,teams,0,0
15674,often,0,0
15675,overlook,0,0
15676,malnutrition,0,1
15677,",",0,0
15678,and,0,1
15679,screening,0,0
15680,of,0,0
15681,these,0,0
15682,patients,0,0
15683,is,0,0
15684,not,0,0
15685,routine,0,0
15686,.,0,0
15687,It,0,0
15688,is,0,0
15689,of,0,0
15690,utmost,0,0
15691,importance,0,0
15692,to,0,0
15693,identify,0,0
15694,patients,0,0
15695,at,0,0
15696,risk,0,1
15697,for,0,0
15698,malnutrition,0,1
15699,in,0,0
15700,order,0,0
15701,to,0,0
15702,prevent,0,0
15703,related,0,0
15704,complications,0,1
15705,.,0,0
15706,METHODS,0,0
15707,The,0,0
15708,374,0,0
15709,patients,0,0
15710,evaluated,0,0
15711,in,0,0
15712,this,0,0
15713,study,0,0
15714,were,0,0
15715,a,0,0
15716,subgroup,0,0
15717,of,0,0
15718,a,0,0
15719,larger,0,0
15720,multicenter,0,0
15721,",",0,1
15722,cross-sectional,0,0
15723,",",0,0
15724,randomized,0,0
15725,study,0,0
15726,that,0,0
15727,was,0,0
15728,carried,0,0
15729,out,0,0
15730,in,0,0
15731,1996,0,0
15732,.,0,0
15733,Nutritional,0,0
15734,status,0,1
15735,was,0,0
15736,assessed,0,0
15737,by,0,0
15738,using,0,0
15739,Subjective,0,1
15740,Global,0,1
15741,Assessment,0,0
15742,.,0,0
15743,RESULTS,0,0
15744,Malnutrition,1,1
15745,was,0,0
15746,present,0,0
15747,in,0,0
15748,55,0,0
15749,%,0,0
15750,of,0,0
15751,the,0,0
15752,patients,0,0
15753,",",0,0
15754,with,0,0
15755,19,0,0
15756,%,0,0
15757,of,0,0
15758,the,0,0
15759,patients,0,0
15760,severely,0,0
15761,malnourished,0,0
15762,.,0,0
15763,The,0,0
15764,presence,0,0
15765,of,0,0
15766,cancer,0,0
15767,",",0,0
15768,infection,0,1
15769,",",0,1
15770,age,0,0
15771,over,0,0
15772,60,0,0
15773,years,0,0
15774,",",0,0
15775,upper,0,0
15776,gastrointestinal,0,1
15777,disease,0,1
15778,",",0,0
15779,and,0,1
15780,longer,0,1
15781,length,0,1
15782,of,0,1
15783,hospital,0,1
15784,stay,0,1
15785,all,0,0
15786,negatively,0,0
15787,influenced,0,0
15788,nutritional,1,0
15789,status,1,0
15790,.,1,0
15791,Despite,0,0
15792,the,0,0
15793,high,0,0
15794,prevalence,0,0
15795,of,0,0
15796,malnutrition,1,1
15797,",",0,0
15798,the,0,0
15799,medical,0,0
15800,teams,0,0
15801,only,0,0
15802,assessed,0,0
15803,the,0,0
15804,nutritional,1,1
15805,status,0,0
15806,of,0,0
15807,a,0,0
15808,few,0,0
15809,patients,0,0
15810,.,0,0
15811,CONCLUSION,0,0
15812,Malnutrition,1,1
15813,was,0,0
15814,highly,0,0
15815,prevalent,0,0
15816,in,0,0
15817,this,0,0
15818,setting,0,0
15819,of,0,0
15820,patients,0,0
15821,.,0,0
15822,Therefore,0,0
15823,",",0,0
15824,patients,0,0
15825,with,0,0
15826,the,0,0
15827,risk,0,0
15828,factors,0,0
15829,above,0,0
15830,presented,0,0
15831,should,0,0
15832,routinely,0,0
15833,undergo,0,0
15834,nutritional,0,1
15835,screening,0,0
15836,and/or,0,0
15837,assessment,0,0
15838,in,0,0
15839,order,0,0
15840,to,0,0
15841,be,0,0
15842,able,0,0
15843,to,0,0
15844,early,0,0
15845,diagnose,0,0
15846,or,0,0
15847,prevent,0,0
15848,malnutrition,0,1
15849,and,0,0
15850,its,0,0
15851,correlated,0,1
15852,morbidity,0,1
15853,and,0,0
15854,mortality,0,1
15855,.,0,0
15856,Uncomplicated,0,0
15857,moderate,0,0
15858,coronary,0,0
15859,artery,0,0
15860,dissections,0,0
15861,after,0,0
15862,balloon,0,0
15863,angioplasty,0,0
15864,:,0,0
15865,good,0,0
15866,outcome,0,0
15867,without,0,0
15868,stenting,0,0
15869,.,0,0
15870,OBJECTIVE,0,0
15871,To,0,0
15872,study,0,0
15873,the,0,0
15874,relation,0,0
15875,between,0,0
15876,moderate,0,0
15877,coronary,0,0
15878,dissections,0,0
15879,",",0,0
15880,coronary,0,1
15881,flow,0,1
15882,velocity,0,1
15883,reserve,0,1
15884,(,0,0
15885,CFVR,0,1
15886,),0,1
15887,",",0,0
15888,and,0,1
15889,long,0,1
15890,term,0,1
15891,outcome,0,1
15892,.,0,0
15893,METHODS,0,0
15894,523,0,0
15895,patients,0,0
15896,undergoing,0,0
15897,balloon,0,0
15898,angioplasty,0,0
15899,and,0,1
15900,sequential,0,0
15901,intracoronary,0,1
15902,Doppler,0,1
15903,measurements,0,0
15904,were,0,0
15905,examined,0,0
15906,as,0,0
15907,part,0,0
15908,of,0,0
15909,the,0,0
15910,DEBATE,0,0
15911,II,0,0
15912,trial,0,0
15913,(,0,0
15914,Doppler,0,0
15915,endpoints,0,1
15916,balloon,0,0
15917,angioplasty,0,0
15918,trial,0,0
15919,Europe,0,0
15920,),0,0
15921,.,0,0
15922,After,0,0
15923,successful,0,0
15924,balloon,0,0
15925,angioplasty,0,0
15926,",",0,0
15927,patients,0,0
15928,were,0,0
15929,randomised,0,0
15930,to,0,0
15931,stenting,0,0
15932,or,0,0
15933,no,0,0
15934,further,0,0
15935,treatment,0,0
15936,.,0,0
15937,Dissections,0,0
15938,were,0,0
15939,graded,0,0
15940,at,0,0
15941,the,0,0
15942,core,0,0
15943,laboratory,0,0
15944,by,0,0
15945,two,0,0
15946,observers,0,0
15947,and,0,0
15948,divided,0,0
15949,into,0,0
15950,four,0,0
15951,categories,0,0
15952,:,0,0
15953,none,0,0
15954,",",0,1
15955,mild,0,1
15956,(,0,0
15957,type,0,0
15958,A-B,0,1
15959,),0,0
15960,",",0,0
15961,moderate,0,0
15962,(,0,0
15963,type,0,0
15964,C,0,0
15965,),0,0
15966,",",0,0
15967,severe,0,1
15968,(,0,0
15969,types,0,0
15970,D,0,1
15971,to,0,0
15972,F,0,0
15973,),0,0
15974,.,0,0
15975,Patients,0,0
15976,with,0,0
15977,severe,0,1
15978,dissections,0,0
15979,(,0,0
15980,n,0,0
15981,=,0,0
15982,128,0,0
15983,),0,0
15984,or,0,0
15985,without,0,0
15986,available,0,0
15987,reference,0,0
15988,vessel,0,1
15989,CFVR,0,1
15990,(,0,0
15991,n,0,0
15992,=,0,0
15993,139,0,0
15994,),0,0
15995,were,0,0
15996,excluded,0,0
15997,.,0,0
15998,The,0,0
15999,remaining,0,0
16000,256,0,0
16001,patients,0,0
16002,were,0,0
16003,divided,0,0
16004,into,0,0
16005,two,0,0
16006,groups,0,0
16007,according,0,0
16008,to,0,0
16009,the,0,0
16010,presence,0,0
16011,(,0,0
16012,group,0,0
16013,A,0,0
16014,",",0,0
16015,n,0,0
16016,=,0,0
16017,45,0,0
16018,),0,0
16019,or,0,0
16020,absence,0,0
16021,(,0,0
16022,group,0,0
16023,B,0,0
16024,",",0,0
16025,n,0,0
16026,=,0,0
16027,211,0,0
16028,),0,0
16029,of,0,0
16030,moderate,0,0
16031,dissection,0,0
16032,.,0,0
16033,RESULTS,0,0
16034,Following,0,0
16035,balloon,0,0
16036,angioplasty,0,0
16037,",",0,0
16038,there,0,0
16039,was,0,0
16040,no,0,0
16041,difference,0,0
16042,in,0,0
16043,CFVR,1,0
16044,between,0,0
16045,the,0,0
16046,two,0,0
16047,groups,0,0
16048,.,0,0
16049,At,0,0
16050,12,0,0
16051,months,0,0
16052,follow,0,0
16053,up,0,0
16054,",",0,0
16055,a,0,0
16056,higher,0,0
16057,rate,0,1
16058,of,0,1
16059,major,1,0
16060,adverse,1,1
16061,cardiac,1,1
16062,events,1,1
16063,was,0,0
16064,observed,0,0
16065,overall,0,1
16066,in,0,0
16067,group,0,0
16068,A,0,0
16069,than,0,0
16070,in,0,0
16071,group,0,0
16072,B,0,0
16073,(,0,0
16074,10,0,0
16075,(,0,0
16076,22,0,0
16077,%,0,0
16078,),0,0
16079,v,0,0
16080,23,0,0
16081,(,0,0
16082,11,0,0
16083,%,0,0
16084,),0,0
16085,",",0,0
16086,p,0,0
16087,=,0,0
16088,0.041,0,0
16089,),0,0
16090,.,0,0
16091,However,0,0
16092,",",0,0
16093,the,0,0
16094,risk,1,1
16095,of,1,0
16096,major,1,0
16097,adverse,1,1
16098,events,1,1
16099,was,0,0
16100,similar,0,0
16101,in,0,0
16102,the,0,0
16103,subgroups,0,0
16104,receiving,0,0
16105,balloon,0,0
16106,angioplasty,0,1
16107,(,0,0
16108,group,0,0
16109,A,0,0
16110,",",0,0
16111,6,0,0
16112,(,0,0
16113,19,0,0
16114,%,0,0
16115,),0,0
16116,v,0,0
16117,group,0,0
16118,B,0,0
16119,",",0,0
16120,16,0,0
16121,(,0,0
16122,16,0,0
16123,%,0,0
16124,),0,0
16125,",",0,0
16126,NS,0,1
16127,),0,0
16128,.,0,0
16129,Among,0,0
16130,group,0,0
16131,A,0,0
16132,patients,0,0
16133,",",0,0
16134,the,0,0
16135,adverse,1,1
16136,events,1,1
16137,risk,1,1
16138,was,0,0
16139,greater,0,0
16140,in,0,0
16141,those,0,0
16142,randomised,0,0
16143,to,0,0
16144,stenting,0,0
16145,(,0,0
16146,odds,0,0
16147,ratios,0,0
16148,6.603,0,0
16149,v,0,0
16150,1.197,0,0
16151,",",0,0
16152,p,0,0
16153,=,0,0
16154,0.046,0,0
16155,),0,0
16156,",",0,0
16157,whereas,0,0
16158,there,0,0
16159,was,0,0
16160,no,0,0
16161,difference,0,0
16162,in,0,0
16163,risk,0,0
16164,if,0,0
16165,the,0,0
16166,group,0,0
16167,was,0,0
16168,analysed,0,0
16169,according,0,0
16170,to,0,0
16171,whether,0,0
16172,the,0,0
16173,CFVR,0,0
16174,was,0,0
16175,<,0,0
16176,2.5,0,0
16177,or,0,0
16178,>,0,0
16179,/=,0,0
16180,2.5,0,0
16181,after,0,0
16182,balloon,0,0
16183,angioplasty,0,0
16184,.,0,0
16185,CONCLUSIONS,0,0
16186,Moderate,0,0
16187,dissections,0,0
16188,left,0,1
16189,untreated,0,0
16190,result,0,0
16191,in,0,0
16192,no,0,0
16193,increased,0,0
16194,risk,1,0
16195,of,1,0
16196,major,1,0
16197,adverse,1,1
16198,cardiac,1,0
16199,events,1,1
16200,.,1,0
16201,Additional,0,0
16202,stenting,0,0
16203,does,0,0
16204,not,0,0
16205,improve,0,0
16206,the,0,0
16207,long,0,0
16208,term,0,0
16209,outcome,0,0
16210,.,0,0
16211,There,0,0
16212,are,0,0
16213,some,0,0
16214,benefits,0,0
16215,for,0,0
16216,eradicating,0,0
16217,Helicobacter,0,0
16218,pylori,0,0
16219,in,0,0
16220,patients,0,0
16221,with,0,0
16222,non-ulcer,0,0
16223,dyspepsia,0,1
16224,.,0,0
16225,BACKGROUND,0,0
16226,The,0,0
16227,relationship,0,0
16228,between,0,0
16229,Helicobacter,0,0
16230,pylori,0,0
16231,infection,0,1
16232,and,0,1
16233,non-ulcer,0,0
16234,dyspepsia,0,1
16235,is,0,0
16236,not,0,0
16237,established,0,0
16238,.,0,0
16239,AIM,0,0
16240,To,0,0
16241,determine,0,0
16242,whether,0,0
16243,eradication,0,1
16244,of,0,0
16245,H.,0,0
16246,pylori,0,0
16247,might,0,0
16248,be,0,0
16249,of,0,0
16250,benefit,0,0
16251,in,0,0
16252,non-ulcer,0,0
16253,dyspepsia,0,1
16254,patients,0,0
16255,.,0,0
16256,METHODS,0,0
16257,We,0,0
16258,randomly,0,0
16259,assigned,0,0
16260,129,0,0
16261,H.,0,0
16262,pylori,0,0
16263,infected,0,0
16264,patients,0,0
16265,with,0,0
16266,severe,0,1
16267,epigastric,0,1
16268,pain,0,1
16269,",",0,0
16270,without,0,0
16271,gastro-oesophageal,0,1
16272,reflux,0,1
16273,symptoms,0,1
16274,",",0,0
16275,to,0,0
16276,receive,0,0
16277,twice,0,0
16278,daily,0,0
16279,treatment,0,0
16280,with,0,0
16281,300,0,0
16282,mg,0,0
16283,of,0,0
16284,ranitidine,0,0
16285,",",0,0
16286,1000,0,0
16287,mg,0,0
16288,of,0,0
16289,amoxicillin,0,0
16290,",",0,0
16291,and,0,0
16292,500,0,0
16293,mg,0,0
16294,of,0,0
16295,clarithromycin,0,0
16296,for,0,0
16297,7,0,0
16298,days,0,0
16299,and,0,0
16300,124,0,0
16301,such,0,0
16302,patients,0,0
16303,to,0,0
16304,receive,0,0
16305,identical-appearing,0,0
16306,placebos,0,0
16307,.,0,0
16308,RESULTS,0,0
16309,Treatment,0,0
16310,was,0,0
16311,successful,0,0
16312,(,0,0
16313,decrease,0,1
16314,of,0,0
16315,symptoms,0,1
16316,at,0,0
16317,12,0,0
16318,months,0,0
16319,),0,0
16320,in,0,0
16321,62,0,0
16322,%,0,0
16323,of,0,0
16324,patients,0,0
16325,in,0,0
16326,the,0,0
16327,active-treatment,0,0
16328,group,0,0
16329,and,0,0
16330,in,0,0
16331,60,0,0
16332,%,0,0
16333,of,0,0
16334,the,0,0
16335,placebo,0,0
16336,group,0,0
16337,(,0,0
16338,N.S.,0,0
16339,),0,0
16340,.,0,0
16341,At,0,0
16342,12,0,0
16343,months,0,0
16344,",",0,0
16345,the,0,0
16346,rate,1,1
16347,of,1,0
16348,eradication,1,1
16349,of,1,0
16350,H.,1,1
16351,pylori,1,0
16352,was,0,0
16353,69,0,0
16354,%,0,0
16355,in,0,0
16356,the,0,0
16357,active-treatment,0,0
16358,group,0,0
16359,and,0,0
16360,18,0,0
16361,%,0,0
16362,in,0,0
16363,the,0,0
16364,placebo,0,0
16365,group,0,0
16366,(,0,0
16367,P,0,0
16368,<,0,0
16369,0.001,0,0
16370,),0,0
16371,.,0,0
16372,Complete,1,0
16373,relief,1,1
16374,of,1,0
16375,symptoms,1,1
16376,occurred,0,0
16377,significantly,0,0
16378,more,0,0
16379,frequently,0,0
16380,in,0,0
16381,patients,0,0
16382,on,0,0
16383,the,0,0
16384,active,0,0
16385,treatment,0,0
16386,(,0,0
16387,43,0,0
16388,%,0,0
16389,),0,0
16390,than,0,0
16391,in,0,0
16392,placebo-treated,0,0
16393,patients,0,0
16394,(,0,0
16395,31,0,0
16396,%,0,0
16397,",",0,0
16398,P=0.048,0,0
16399,),0,0
16400,.,0,0
16401,Within,0,0
16402,the,0,0
16403,active-treatment,0,0
16404,group,0,0
16405,",",0,0
16406,therapeutic,1,1
16407,success,1,1
16408,was,0,0
16409,significantly,0,0
16410,more,0,0
16411,frequent,0,0
16412,in,0,0
16413,the,0,0
16414,non-infected,0,0
16415,patients,0,0
16416,(,0,0
16417,84,0,0
16418,%,0,0
16419,vs.,0,0
16420,64,0,0
16421,%,0,0
16422,",",0,0
16423,P=0.04,0,0
16424,),0,0
16425,.,0,0
16426,CONCLUSIONS,0,0
16427,Although,0,0
16428,eradicating,0,0
16429,H.,0,0
16430,pylori,0,0
16431,is,0,0
16432,not,0,0
16433,likely,0,0
16434,to,0,0
16435,relieve,0,0
16436,symptoms,0,1
16437,in,0,0
16438,the,0,0
16439,majority,0,0
16440,of,0,0
16441,patients,0,0
16442,with,0,0
16443,non-ulcer,0,0
16444,dyspepsia,0,1
16445,",",0,0
16446,a,0,0
16447,small,0,0
16448,proportion,0,0
16449,of,0,0
16450,H.,0,0
16451,pylori-infected,0,0
16452,patients,0,0
16453,may,0,0
16454,benefit,0,0
16455,from,0,0
16456,eradication,0,1
16457,treatment,0,0
16458,.,0,0
16459,Dipyridamole,0,0
16460,in,0,0
16461,chronic,0,0
16462,stable,0,1
16463,angina,0,0
16464,pectoris,0,0
16465,;,0,0
16466,a,0,0
16467,randomized,0,0
16468,",",0,0
16469,double,0,0
16470,blind,0,0
16471,",",0,0
16472,placebo-controlled,0,0
16473,",",0,0
16474,parallel,0,0
16475,group,0,0
16476,study,0,0
16477,.,0,0
16478,BACKGROUND,0,0
16479,Oral,0,1
16480,dipyridamole,0,0
16481,induces,0,0
16482,accumulation,0,1
16483,of,0,0
16484,endogenous,0,1
16485,adenosine,0,0
16486,",",0,0
16487,which,0,0
16488,in,0,0
16489,a,0,0
16490,hypoxic,0,0
16491,milieu,0,0
16492,exerts,0,0
16493,experimentally,0,0
16494,an,0,0
16495,angiogenic,0,1
16496,effect,0,0
16497,on,0,0
16498,coronary,0,0
16499,collateral,0,1
16500,circulation,0,1
16501,.,0,0
16502,A,0,0
16503,meta-analysis,0,0
16504,of,0,0
16505,13,0,0
16506,randomized,0,0
16507,placebo-controlled,0,0
16508,trials,0,0
16509,published,0,0
16510,between,0,0
16511,1960,0,0
16512,and,0,0
16513,1992,0,0
16514,showed,0,0
16515,evidence,0,0
16516,of,0,0
16517,benefit,0,0
16518,for,0,0
16519,dipyridamole,0,0
16520,in,0,0
16521,the,0,0
16522,treatment,0,0
16523,of,0,0
16524,angina,0,1
16525,pectoris,0,0
16526,",",0,0
16527,especially,0,0
16528,with,0,0
16529,longer,0,0
16530,duration,0,1
16531,of,0,0
16532,treatment,0,0
16533,.,0,0
16534,Aim,0,0
16535,To,0,0
16536,assess,0,0
16537,the,0,0
16538,efficacy,1,1
16539,and,1,0
16540,safety,1,1
16541,of,0,1
16542,dipyridamole,0,0
16543,in,0,0
16544,the,0,0
16545,treatment,0,0
16546,of,0,0
16547,patients,0,0
16548,with,0,0
16549,chronic,0,0
16550,stable,0,0
16551,angina,0,0
16552,in,0,0
16553,a,0,0
16554,large,0,0
16555,scale,0,1
16556,",",0,0
16557,international,0,0
16558,",",0,0
16559,randomized,0,0
16560,",",0,0
16561,placebo-controlled,0,0
16562,",",0,0
16563,parallel,0,0
16564,group,0,0
16565,study,0,0
16566,.,0,0
16567,METHODS,0,0
16568,Four,0,0
16569,hundred,0,0
16570,patients,0,0
16571,with,0,0
16572,chronic,0,0
16573,stable,0,1
16574,angina,0,1
16575,pectoris,0,0
16576,and,0,0
16577,a,0,0
16578,positive,0,1
16579,treadmill,0,0
16580,exercise,0,0
16581,test,0,1
16582,were,0,0
16583,randomized,0,0
16584,to,0,0
16585,receive,0,0
16586,either,0,0
16587,modified,0,0
16588,release,0,1
16589,dipyridamole,0,0
16590,(,0,0
16591,200,0,0
16592,mg,0,0
16593,b.i.d,0,0
16594,.,0,1
16595,p.o.,0,0
16596,",",0,0
16597,n=198,0,0
16598,),0,1
16599,or,0,0
16600,corresponding,0,1
16601,placebo,0,0
16602,(,0,0
16603,n=202,0,0
16604,),0,0
16605,",",0,0
16606,for,0,0
16607,24,0,0
16608,weeks,0,0
16609,as,0,0
16610,an,0,0
16611,add-on,0,0
16612,to,0,0
16613,conventional,0,0
16614,antianginal,0,0
16615,therapy,0,0
16616,and,0,0
16617,for,0,0
16618,4,0,0
16619,additional,0,0
16620,weeks,0,0
16621,as,0,0
16622,monotherapy,0,0
16623,--,0,0
16624,the,0,0
16625,latter,0,0
16626,after,0,0
16627,withdrawal,0,0
16628,of,0,0
16629,standard,0,0
16630,treatment,0,0
16631,with,0,0
16632,calcium,0,0
16633,antagonists,0,0
16634,and/or,0,0
16635,beta-blockers,0,0
16636,and/or,0,0
16637,long-acting,0,0
16638,(,0,0
16639,prophylactic,0,0
16640,),0,0
16641,nitrates,0,0
16642,.,0,0
16643,RESULTS,0,0
16644,Of,0,0
16645,the,0,0
16646,198,0,0
16647,patients,0,0
16648,randomized,0,0
16649,to,0,0
16650,dipyridamole,0,0
16651,",",0,0
16652,134,0,0
16653,completed,0,0
16654,the,0,0
16655,add-on,0,0
16656,and,0,0
16657,only,0,0
16658,12,0,0
16659,the,0,0
16660,monotherapy,0,0
16661,phase,0,0
16662,.,0,0
16663,Of,0,0
16664,the,0,0
16665,202,0,0
16666,patients,0,0
16667,randomized,0,0
16668,to,0,0
16669,placebo,0,0
16670,",",0,0
16671,162,0,0
16672,reached,0,0
16673,the,0,0
16674,add-on,0,0
16675,and,0,0
16676,only,0,0
16677,12,0,0
16678,the,0,0
16679,monotherapy,0,0
16680,phase,0,0
16681,.,0,0
16682,Serious,1,0
16683,adverse,1,1
16684,events,1,1
16685,occurred,0,0
16686,in,0,0
16687,15,0,0
16688,patients,0,0
16689,with,0,0
16690,dipyridamole,0,0
16691,and,0,0
16692,in,0,0
16693,12,0,0
16694,with,0,0
16695,placebo,0,0
16696,(,0,0
16697,7.6,0,0
16698,%,0,0
16699,vs,0,0
16700,6.0,0,0
16701,",",0,0
16702,P=0.52,0,0
16703,),0,0
16704,.,0,0
16705,Increase,1,0
16706,over,1,0
16707,the,1,0
16708,baseline,1,0
16709,treadmill,1,0
16710,exercise,1,0
16711,test,1,1
16712,was,0,0
16713,similar,0,0
16714,in,0,0
16715,the,0,0
16716,treatment,0,0
16717,groups,0,0
16718,at,0,0
16719,each,0,0
16720,stage,0,0
16721,of,0,0
16722,the,0,0
16723,trial,0,0
16724,for,0,0
16725,all,0,0
16726,the,0,0
16727,main,0,0
16728,efficacy,0,1
16729,parameters,0,1
16730,:,0,0
16731,total,1,1
16732,treadmill,1,0
16733,exercise,1,0
16734,test,1,0
16735,duration,1,1
16736,;,1,0
16737,time,1,1
16738,to,1,0
16739,first,1,0
16740,anginal,1,0
16741,pain,1,1
16742,(,0,0
16743,except,0,0
16744,for,0,0
16745,a,0,0
16746,-13,0,0
16747,s,0,0
16748,difference,0,1
16749,in,0,0
16750,favour,0,0
16751,of,0,0
16752,placebo,0,0
16753,at,0,0
16754,week,0,0
16755,24,0,0
16756,;,0,0
16757,P=0.040,0,0
16758,),0,0
16759,;,0,0
16760,time,1,1
16761,to,1,0
16762,ST,1,1
16763,segment,1,1
16764,depression,1,1
16765,>,0,0
16766,0.1,0,0
16767,mVolt,1,0
16768,(,0,0
16769,except,0,0
16770,for,0,0
16771,a,0,0
16772,+21,0,0
16773,s,0,0
16774,difference,0,0
16775,in,0,0
16776,favour,0,0
16777,of,0,0
16778,dipyridamole,0,0
16779,at,0,0
16780,week,0,0
16781,8,0,0
16782,;,0,0
16783,P=0.024,0,0
16784,;,0,0
16785,this,0,0
16786,latter,0,0
16787,difference,0,0
16788,was,0,0
16789,totally,0,0
16790,attributable,0,0
16791,to,0,0
16792,patients,0,0
16793,with,0,0
16794,lower,0,0
16795,exercise,0,0
16796,tolerance,0,1
16797,--,0,0
16798,Bruce,0,0
16799,stage,0,0
16800,II,0,0
16801,at,0,0
16802,study,0,0
16803,entry,0,0
16804,),0,0
16805,.,0,0
16806,CONCLUSION,0,0
16807,In,0,0
16808,patients,0,0
16809,with,0,0
16810,chronic,0,0
16811,stable,0,0
16812,angina,0,0
16813,treated,0,0
16814,with,0,0
16815,regular,0,0
16816,antianginal,0,0
16817,background,0,0
16818,medication,0,1
16819,",",0,0
16820,the,0,0
16821,use,0,0
16822,of,0,0
16823,oral,0,0
16824,dipyridamole,0,0
16825,is,0,0
16826,safe,1,1
16827,and,0,0
16828,well,0,0
16829,tolerated,1,1
16830,.,1,0
16831,Antianginal,0,0
16832,and,0,0
16833,antiischaemic,0,1
16834,efficacy,0,1
16835,",",0,0
16836,as,0,0
16837,assessed,0,0
16838,by,0,0
16839,exercise,0,0
16840,testing,0,0
16841,",",0,0
16842,is,0,0
16843,comparable,0,0
16844,to,0,0
16845,placebo,0,0
16846,",",0,0
16847,except,0,0
16848,for,0,0
16849,a,0,0
16850,beneficial,0,0
16851,effect,0,0
16852,on,0,0
16853,time,0,1
16854,to,0,0
16855,ischaemia,0,0
16856,after,0,0
16857,2,0,0
16858,months,0,0
16859,",",0,0
16860,totally,0,0
16861,attributable,0,0
16862,to,0,0
16863,patients,0,0
16864,with,0,0
16865,lower,0,0
16866,exercise,0,0
16867,tolerance,0,1
16868,at,0,0
16869,study,0,0
16870,entry,0,0
16871,.,0,0
16872,Effect,0,0
16873,of,0,0
16874,antioxidant,0,1
16875,supplementation,0,0
16876,on,0,0
16877,ozone-induced,0,0
16878,lung,0,0
16879,injury,0,1
16880,in,0,0
16881,human,0,0
16882,subjects,0,0
16883,.,0,0
16884,To,0,0
16885,determine,0,0
16886,whether,0,0
16887,antioxidants,0,0
16888,can,0,0
16889,influence,0,0
16890,human,0,0
16891,susceptibility,0,1
16892,to,0,0
16893,ozone,0,0
16894,(,0,0
16895,O,0,1
16896,(,0,0
16897,3,0,0
16898,),0,0
16899,),0,0
16900,-induced,0,0
16901,changes,0,1
16902,in,0,0
16903,lung,1,0
16904,function,1,1
16905,and,1,1
16906,airway,1,1
16907,inflammation,1,1
16908,",",0,0
16909,we,0,0
16910,placed,0,0
16911,31,0,0
16912,healthy,0,0
16913,nonsmoking,0,0
16914,adults,0,0
16915,(,0,0
16916,18,0,0
16917,to,0,0
16918,35,0,0
16919,yr,0,0
16920,old,0,0
16921,),0,0
16922,on,0,0
16923,a,0,0
16924,diet,0,0
16925,low,0,0
16926,in,0,0
16927,ascorbate,0,0
16928,for,0,0
16929,3,0,0
16930,wk,0,0
16931,.,0,0
16932,At,0,0
16933,1,0,0
16934,wk,0,0
16935,",",0,0
16936,subjects,0,0
16937,were,0,0
16938,exposed,0,0
16939,to,0,0
16940,filtered,0,0
16941,air,0,0
16942,for,0,0
16943,2,0,0
16944,h,0,0
16945,while,0,0
16946,exercising,0,0
16947,(,0,0
16948,20,0,0
16949,L/min/m,0,0
16950,(,0,0
16951,2,0,0
16952,),0,0
16953,),0,0
16954,",",0,0
16955,and,0,0
16956,then,0,0
16957,underwent,0,0
16958,bronchoalveolar,0,1
16959,lavage,0,0
16960,(,0,0
16961,BAL,0,1
16962,),0,1
16963,and,0,0
16964,were,0,0
16965,randomly,0,0
16966,assigned,0,0
16967,to,0,0
16968,receive,0,0
16969,either,0,0
16970,a,0,0
16971,placebo,0,0
16972,or,0,0
16973,250,0,0
16974,mg,0,0
16975,of,0,0
16976,vitamin,0,0
16977,C,0,0
16978,",",0,0
16979,50,0,0
16980,IU,0,0
16981,of,0,0
16982,alpha-tocopherol,0,0
16983,",",0,0
16984,and,0,0
16985,12,0,0
16986,oz,0,0
16987,of,0,0
16988,vegetable,0,0
16989,cocktail,0,0
16990,daily,0,0
16991,for,0,0
16992,2,0,0
16993,wk,0,0
16994,.,0,0
16995,Subjects,0,0
16996,were,0,0
16997,then,0,0
16998,exposed,0,0
16999,to,0,0
17000,0.4,0,0
17001,ppm,0,0
17002,O,0,0
17003,(,0,0
17004,3,0,0
17005,),0,0
17006,for,0,0
17007,2,0,0
17008,h,0,0
17009,and,0,0
17010,underwent,0,0
17011,a,0,0
17012,second,0,0
17013,BAL,0,0
17014,.,0,0
17015,On,0,0
17016,the,0,0
17017,day,0,0
17018,of,0,0
17019,the,0,0
17020,O,0,0
17021,(,0,0
17022,3,0,0
17023,),0,0
17024,exposure,0,0
17025,",",0,0
17026,supplemented,0,0
17027,subjects,0,0
17028,were,0,0
17029,found,0,0
17030,to,0,0
17031,have,0,0
17032,significantly,0,0
17033,increased,0,0
17034,levels,1,1
17035,of,1,0
17036,plasma,1,1
17037,ascorbate,1,0
17038,",",1,0
17039,tocopherols,1,1
17040,",",1,1
17041,and,1,1
17042,carotenoids,1,1
17043,as,0,0
17044,compared,0,0
17045,with,0,0
17046,those,0,0
17047,of,0,0
17048,the,0,0
17049,placebo,0,0
17050,group,0,0
17051,.,0,0
17052,Pulmonary,0,1
17053,function,0,1
17054,testing,0,0
17055,showed,0,0
17056,that,0,0
17057,O,1,1
17058,(,1,0
17059,3,1,0
17060,),1,0
17061,-induced,1,0
17062,reductions,1,1
17063,in,1,0
17064,FEV,1,0
17065,(,1,0
17066,1,1,0
17067,),1,0
17068,and,1,0
17069,FVC,1,0
17070,were,0,0
17071,30,0,0
17072,%,0,0
17073,and,0,0
17074,24,0,0
17075,%,0,0
17076,smaller,0,0
17077,",",0,0
17078,respectively,0,0
17079,",",0,0
17080,in,0,0
17081,the,0,0
17082,supplemented,0,0
17083,cohort,0,0
17084,.,0,0
17085,In,0,0
17086,contrast,0,0
17087,",",0,0
17088,the,0,0
17089,inflammatory,1,1
17090,response,1,1
17091,to,1,0
17092,O,1,1
17093,(,1,0
17094,3,1,0
17095,),1,0
17096,inhalation,0,0
17097,",",0,0
17098,as,0,0
17099,represented,0,0
17100,by,0,0
17101,the,0,0
17102,percent,1,0
17103,neutrophils,1,1
17104,and,1,0
17105,the,1,0
17106,concentration,1,1
17107,of,1,0
17108,interleukin-6,1,1
17109,recovered,0,0
17110,in,0,0
17111,the,0,0
17112,BAL,0,0
17113,fluid,0,0
17114,at,0,0
17115,1,0,0
17116,h,0,0
17117,after,0,0
17118,O,0,1
17119,(,0,0
17120,3,0,0
17121,),0,0
17122,exposure,0,0
17123,was,0,0
17124,not,0,0
17125,different,0,0
17126,for,0,0
17127,the,0,0
17128,two,0,0
17129,groups,0,0
17130,.,0,0
17131,These,0,0
17132,data,0,0
17133,suggest,0,0
17134,that,0,0
17135,dietary,0,0
17136,antioxidants,0,0
17137,protect,0,0
17138,against,0,0
17139,O,1,1
17140,(,1,0
17141,3,1,0
17142,),1,0
17143,-induced,1,0
17144,pulmonary,1,1
17145,function,1,1
17146,decrements,0,1
17147,in,0,0
17148,humans,0,0
17149,.,0,0
17150,Comparison,0,0
17151,of,0,0
17152,tropisetron,0,0
17153,and,0,1
17154,granisetron,0,0
17155,in,0,0
17156,the,0,0
17157,control,0,0
17158,of,0,0
17159,nausea,1,1
17160,and,1,1
17161,vomiting,1,1
17162,in,0,0
17163,children,0,0
17164,receiving,0,0
17165,combined,0,0
17166,cancer,0,0
17167,chemotherapy,0,0
17168,.,0,0
17169,Tropisetron,0,0
17170,and,0,0
17171,granisetron,0,0
17172,are,0,0
17173,selective,0,0
17174,serotonin,0,0
17175,(,0,0
17176,5-HT3,0,0
17177,),0,0
17178,antagonists,0,0
17179,that,0,0
17180,have,0,0
17181,been,0,0
17182,proven,0,0
17183,effective,0,0
17184,in,0,0
17185,the,0,0
17186,prevention,0,0
17187,of,0,0
17188,nausea,1,1
17189,and,1,1
17190,vomiting,1,1
17191,in,0,0
17192,adults,0,0
17193,and,0,0
17194,children,0,0
17195,receiving,0,0
17196,cancer,0,0
17197,chemotherapy,0,0
17198,.,0,0
17199,This,0,0
17200,prospective,0,0
17201,",",0,0
17202,randomised,0,0
17203,study,0,0
17204,was,0,0
17205,designed,0,0
17206,to,0,0
17207,compare,0,0
17208,the,0,0
17209,efficacy,0,1
17210,of,0,0
17211,the,0,0
17212,two,0,0
17213,agents,0,0
17214,in,0,0
17215,the,0,0
17216,prevention,0,0
17217,of,0,0
17218,vomiting,1,1
17219,and,1,0
17220,nausea,1,1
17221,in,0,0
17222,children,0,0
17223,receiving,0,0
17224,highly,0,0
17225,emetogenic,0,0
17226,chemotherapy,0,0
17227,for,0,0
17228,various,0,0
17229,malignancies,0,0
17230,.,0,0
17231,A,0,0
17232,total,0,0
17233,of,0,0
17234,51,0,0
17235,children,0,0
17236,(,0,0
17237,mean,0,1
17238,age,0,0
17239,:,0,0
17240,7.7,0,0
17241,+/-,0,0
17242,4.8,0,0
17243,year,0,0
17244,),0,0
17245,were,0,0
17246,studied,0,0
17247,in,0,0
17248,133,0,0
17249,chemotherapy,0,0
17250,cycles,0,0
17251,.,0,0
17252,In,0,0
17253,66,0,0
17254,chemotherapy,0,0
17255,cycles,0,0
17256,",",0,0
17257,the,0,0
17258,children,0,0
17259,received,0,0
17260,tropisetron,0,0
17261,as,0,0
17262,an,0,0
17263,antiemetic,0,0
17264,agent,0,0
17265,in,0,0
17266,a,0,0
17267,dose,0,0
17268,of,0,0
17269,0.2,0,0
17270,mg/kg/24,0,0
17271,h,0,0
17272,intravenously,0,0
17273,and,0,0
17274,",",0,0
17275,in,0,0
17276,67,0,0
17277,cycles,0,0
17278,",",0,0
17279,they,0,0
17280,received,0,0
17281,granisetron,0,0
17282,40,0,0
17283,micrograms/kg/24,0,0
17284,h,0,0
17285,intravenously,0,0
17286,before,0,0
17287,cytotoxic,0,1
17288,drug,0,0
17289,administration,0,0
17290,during,0,0
17291,the,0,0
17292,days,0,0
17293,they,0,0
17294,received,0,0
17295,chemotherapy,0,0
17296,.,0,0
17297,The,0,0
17298,response,0,0
17299,per,0,0
17300,24,0,0
17301,h,0,0
17302,of,0,0
17303,chemotherapy,0,0
17304,was,0,0
17305,defined,0,0
17306,as,0,0
17307,complete,0,0
17308,(,0,0
17309,no,0,0
17310,nausea,0,1
17311,and,0,1
17312,vomiting,0,1
17313,),0,1
17314,",",0,0
17315,partial,0,1
17316,(,0,0
17317,1-4,0,0
17318,events,0,1
17319,of,0,0
17320,vomiting,0,1
17321,and/or,0,0
17322,nausea,0,1
17323,),0,0
17324,",",0,0
17325,and,0,1
17326,failure,0,1
17327,(,0,0
17328,more,0,0
17329,than,0,0
17330,4,0,0
17331,events,0,1
17332,of,0,0
17333,vomiting,0,1
17334,and/or,0,0
17335,nausea,0,1
17336,),0,0
17337,.,0,0
17338,Efficacy,0,0
17339,of,0,0
17340,antiemetic,0,0
17341,therapy,0,0
17342,was,0,0
17343,evaluated,0,0
17344,as,0,0
17345,acute,0,0
17346,(,0,0
17347,Day,0,0
17348,1,0,0
17349,),0,0
17350,and,0,0
17351,overall,0,1
17352,was,0,0
17353,based,0,0
17354,on,0,0
17355,the,0,0
17356,worst,0,1
17357,day,0,0
17358,during,0,0
17359,the,0,0
17360,chemotherapy,0,0
17361,.,0,0
17362,Complete,1,0
17363,control,1,0
17364,of,1,0
17365,acute,1,0
17366,vomiting,1,1
17367,was,0,0
17368,achieved,0,0
17369,in,0,0
17370,74,0,0
17371,%,0,0
17372,of,0,0
17373,tropisetron,0,0
17374,and,0,0
17375,88,0,0
17376,%,0,0
17377,of,0,0
17378,granisetron,0,0
17379,patients,0,0
17380,(,0,0
17381,P,0,0
17382,=,0,0
17383,0.04,0,0
17384,),0,0
17385,",",0,0
17386,and,0,1
17387,complete,0,1
17388,control,0,0
17389,of,0,0
17390,acute,1,0
17391,nausea,1,1
17392,in,0,0
17393,56,0,0
17394,%,0,0
17395,and,0,0
17396,82,0,0
17397,%,0,0
17398,respectively,0,0
17399,(,0,0
17400,p,0,0
17401,=,0,0
17402,0.002,0,0
17403,),0,0
17404,.,0,0
17405,Overall,1,0
17406,response,1,1
17407,by,0,0
17408,means,0,0
17409,of,0,0
17410,complete,0,1
17411,control,0,0
17412,of,0,0
17413,both,0,0
17414,vomiting,1,1
17415,and,1,0
17416,nausea,1,1
17417,during,0,0
17418,the,0,0
17419,whole,0,0
17420,therapy,0,0
17421,period,0,0
17422,was,0,0
17423,29,0,0
17424,%,0,0
17425,of,0,0
17426,tropisetron,0,0
17427,group,0,0
17428,and,0,0
17429,55,0,0
17430,%,0,0
17431,of,0,0
17432,granisetron,0,0
17433,group,0,0
17434,(,0,0
17435,p,0,0
17436,=,0,0
17437,0.007,0,0
17438,),0,0
17439,.,0,0
17440,The,0,0
17441,statistical,0,0
17442,analysis,0,0
17443,(,0,0
17444,depending,0,0
17445,on,0,0
17446,the,0,0
17447,emetogenicity,0,1
17448,of,0,0
17449,the,0,0
17450,chemotherapy,0,0
17451,cycles,0,0
17452,),0,0
17453,showed,0,0
17454,increased,0,0
17455,efficacy,0,1
17456,of,0,0
17457,granisetron,0,0
17458,in,0,0
17459,highly,0,0
17460,(,0,0
17461,grade,0,0
17462,3,0,0
17463,),0,0
17464,emetogenic,0,0
17465,chemotherapy,0,0
17466,cycles,0,0
17467,(,0,0
17468,p,0,0
17469,=,0,0
17470,0.002,0,0
17471,),0,0
17472,",",0,0
17473,whereas,0,0
17474,there,0,0
17475,was,0,0
17476,no,0,0
17477,difference,0,0
17478,in,0,0
17479,the,0,0
17480,very,0,0
17481,highly,0,0
17482,emetogenic,0,0
17483,cycles,0,0
17484,(,0,0
17485,p,0,0
17486,=,0,0
17487,0.7,0,0
17488,),0,0
17489,.,0,0
17490,Also,0,0
17491,",",0,0
17492,granisetron,0,0
17493,was,0,0
17494,found,0,0
17495,to,0,0
17496,be,0,0
17497,more,1,0
17498,effective,1,1
17499,than,0,0
17500,tropisetron,0,0
17501,",",0,0
17502,especially,0,0
17503,in,0,0
17504,patients,0,0
17505,heavier,0,0
17506,than,0,0
17507,25,0,0
17508,kg,0,0
17509,(,0,0
17510,p,0,0
17511,=,0,0
17512,0.02,0,0
17513,),0,0
17514,.,0,0
17515,The,1,0
17516,adverse,1,1
17517,reactions,1,1
17518,were,0,0
17519,few,0,0
17520,and,0,0
17521,mild,0,1
17522,.,0,0
17523,There,0,0
17524,were,0,0
17525,no,0,0
17526,differences,0,0
17527,in,0,0
17528,the,0,0
17529,tolerability,1,0
17530,of,0,0
17531,the,0,0
17532,two,0,0
17533,antiemetic,1,0
17534,therapy,1,0
17535,modalities,1,0
17536,.,1,0
17537,In,0,0
17538,conclusion,0,0
17539,",",0,0
17540,granisetron,0,0
17541,was,0,0
17542,found,0,0
17543,to,0,0
17544,be,0,0
17545,more,0,0
17546,effective,0,1
17547,than,0,0
17548,tropisetron,0,0
17549,in,0,0
17550,controlling,0,0
17551,nausea,1,1
17552,and,1,1
17553,vomiting,1,1
17554,in,0,0
17555,children,0,0
17556,receiving,0,0
17557,highly,0,0
17558,emetogenic,0,0
17559,chemotherapy,0,0
17560,.,0,0
17561,This,1,0
17562,increased,1,0
17563,antiemetic,1,0
17564,efficacy,1,1
17565,of,0,0
17566,ganisetron,0,0
17567,might,0,0
17568,have,0,0
17569,been,0,0
17570,related,0,0
17571,to,0,0
17572,maximal,0,0
17573,dose,0,0
17574,differences,0,0
17575,according,0,0
17576,to,0,0
17577,body,1,1
17578,weight,1,1
17579,.,1,0
17580,Induction,0,1
17581,versus,0,0
17582,noninduction,0,0
17583,in,0,0
17584,renal,0,1
17585,transplant,0,0
17586,recipients,0,0
17587,with,0,0
17588,tacrolimus-based,0,0
17589,immunosuppression,0,0
17590,.,0,0
17591,BACKGROUND,0,0
17592,The,0,0
17593,aim,0,0
17594,of,0,0
17595,this,0,0
17596,study,0,0
17597,was,0,0
17598,to,0,0
17599,compare,0,0
17600,the,0,0
17601,efficacy,1,1
17602,and,1,0
17603,safety,1,1
17604,of,0,1
17605,induction,0,1
17606,treatment,0,0
17607,with,0,0
17608,antithymocyte,0,0
17609,globulins,0,1
17610,(,0,0
17611,ATG,0,1
17612,),0,0
17613,followed,0,0
17614,by,0,0
17615,tacrolimus,0,0
17616,therapy,0,0
17617,with,0,0
17618,immediate,0,1
17619,tacrolimus,0,0
17620,therapy,0,0
17621,in,0,0
17622,renal,0,1
17623,transplant,0,0
17624,recipients,0,0
17625,.,0,0
17626,METHODS,0,0
17627,This,0,0
17628,12-month,0,0
17629,",",0,0
17630,open,0,0
17631,",",0,0
17632,prospective,0,0
17633,study,0,0
17634,was,0,0
17635,conducted,0,0
17636,in,0,0
17637,15,0,0
17638,centers,0,0
17639,in,0,0
17640,France,0,1
17641,and,0,0
17642,1,0,0
17643,center,0,0
17644,in,0,0
17645,Belgium,0,0
17646,;,0,0
17647,309,0,0
17648,patients,0,0
17649,were,0,0
17650,randomized,0,0
17651,to,0,0
17652,receive,0,0
17653,either,0,0
17654,induction,0,0
17655,therapy,0,0
17656,with,0,0
17657,ATG,0,1
17658,(,0,0
17659,n=151,0,0
17660,),0,0
17661,followed,0,0
17662,by,0,0
17663,initiation,0,0
17664,of,0,0
17665,tacrolimus,0,0
17666,on,0,0
17667,day,0,0
17668,9,0,0
17669,or,0,0
17670,immediate,0,0
17671,tacrolimus-based,0,0
17672,triple,0,0
17673,therapy,0,0
17674,(,0,0
17675,n=158,0,0
17676,),0,0
17677,.,0,0
17678,In,0,0
17679,both,0,0
17680,study,0,0
17681,arms,0,0
17682,",",0,0
17683,the,0,0
17684,initial,0,0
17685,daily,0,0
17686,tacrolimus,0,0
17687,dose,0,0
17688,was,0,0
17689,0.2,0,0
17690,mg/kg,0,0
17691,.,0,0
17692,Steroid,0,0
17693,boluses,0,0
17694,were,0,0
17695,given,0,0
17696,in,0,0
17697,the,0,0
17698,first,0,0
17699,2,0,0
17700,days,0,0
17701,and,0,0
17702,tapered,0,0
17703,thereafter,0,0
17704,from,0,0
17705,20,0,0
17706,mg/day,0,0
17707,to,0,0
17708,5,0,0
17709,mg/day,0,0
17710,.,0,0
17711,Azathioprine,0,0
17712,was,0,0
17713,administered,0,0
17714,at,0,0
17715,1-2,0,0
17716,mg/kg,0,0
17717,per,0,0
17718,day,0,0
17719,.,0,0
17720,RESULTS,0,0
17721,At,0,0
17722,month,0,0
17723,12,0,0
17724,",",0,0
17725,biopsy-confirmed,1,0
17726,acute,1,1
17727,rejections,1,1
17728,were,0,0
17729,reported,0,0
17730,for,0,0
17731,15.2,0,0
17732,%,0,0
17733,(,0,0
17734,induction,0,1
17735,),0,0
17736,and,0,0
17737,30.4,0,0
17738,%,0,0
17739,(,0,0
17740,noninduction,0,0
17741,),0,0
17742,of,0,0
17743,patients,0,0
17744,(,0,0
17745,P=0.001,0,0
17746,),0,0
17747,.,0,0
17748,The,0,0
17749,incidence,1,1
17750,of,1,0
17751,steroid-sensitive,1,0
17752,acute,1,0
17753,rejections,1,0
17754,was,0,0
17755,7.9,0,0
17756,%,0,0
17757,(,0,0
17758,induction,0,1
17759,),0,0
17760,and,0,0
17761,22.2,0,0
17762,%,0,0
17763,(,0,0
17764,noninduction,0,0
17765,),0,1
17766,(,0,0
17767,P=0.001,0,0
17768,),0,0
17769,.,0,0
17770,Steroid-resistant,1,1
17771,acute,1,0
17772,rejections,1,0
17773,were,0,0
17774,reported,0,0
17775,for,0,0
17776,8.6,0,0
17777,%,0,0
17778,(,0,0
17779,induction,0,1
17780,),0,0
17781,and,0,0
17782,8.9,0,0
17783,%,0,0
17784,(,0,0
17785,noninduction,0,0
17786,),0,0
17787,of,0,0
17788,patients,0,0
17789,.,0,0
17790,A,0,0
17791,total,0,0
17792,of,0,0
17793,nine,0,0
17794,patients,0,0
17795,died,1,0
17796,.,1,0
17797,Patient,1,1
17798,survival,1,1
17799,and,1,1
17800,graft,1,1
17801,survival,1,1
17802,at,0,0
17803,month,0,0
17804,12,0,0
17805,was,0,0
17806,similar,0,0
17807,in,0,0
17808,both,0,0
17809,treatment,0,0
17810,groups,0,0
17811,(,0,0
17812,97.4,0,0
17813,%,0,0
17814,vs.,0,0
17815,96.8,0,0
17816,%,0,0
17817,and,0,0
17818,92.1,0,0
17819,%,0,0
17820,vs.,0,0
17821,91.1,0,0
17822,%,0,0
17823,",",0,0
17824,respectively,0,0
17825,),0,0
17826,.,0,0
17827,Statistically,0,0
17828,significant,0,0
17829,differences,0,0
17830,in,0,0
17831,the,0,0
17832,incidence,1,1
17833,of,1,0
17834,adverse,1,1
17835,events,1,1
17836,were,0,0
17837,found,0,0
17838,for,0,0
17839,cytomegalovirus,1,1
17840,(,1,0
17841,CMV,1,0
17842,),1,1
17843,infection,1,1
17844,(,0,0
17845,induction,0,1
17846,",",0,0
17847,32.5,0,0
17848,%,0,0
17849,vs.,0,0
17850,noninduction,0,0
17851,",",0,0
17852,19.0,0,0
17853,%,0,0
17854,",",0,0
17855,P=0.009,0,0
17856,),0,1
17857,",",0,0
17858,leukopenia,1,1
17859,(,0,0
17860,37.3,0,0
17861,%,0,0
17862,vs.,0,0
17863,9.5,0,0
17864,%,0,0
17865,",",0,0
17866,P,0,0
17867,<,0,0
17868,0.001,0,0
17869,),0,0
17870,",",0,0
17871,fever,1,1
17872,(,0,0
17873,25.2,0,0
17874,%,0,0
17875,vs.,0,0
17876,10.1,0,0
17877,%,0,0
17878,",",0,0
17879,P=0.001,0,0
17880,),0,0
17881,",",0,0
17882,herpes,1,0
17883,simplex,1,0
17884,(,0,0
17885,17.9,0,0
17886,%,0,0
17887,vs.,0,0
17888,5.7,0,0
17889,%,0,0
17890,",",0,0
17891,P=0.001,0,0
17892,),0,1
17893,",",0,0
17894,and,0,1
17895,thrombocytopenia,1,1
17896,(,0,0
17897,11.3,0,0
17898,%,0,0
17899,vs.,0,0
17900,3.2,0,0
17901,%,0,0
17902,",",0,0
17903,P=0.007,0,0
17904,),0,0
17905,.,0,0
17906,In,0,0
17907,the,0,0
17908,induction,0,1
17909,group,0,0
17910,",",0,1
17911,serum,1,1
17912,sickness,1,1
17913,was,0,0
17914,observed,0,0
17915,in,0,0
17916,10.6,0,0
17917,%,0,0
17918,of,0,0
17919,patients,0,0
17920,.,0,0
17921,The,0,0
17922,incidence,0,1
17923,of,0,0
17924,new,1,0
17925,onset,1,1
17926,diabetes,1,0
17927,mellitus,1,0
17928,was,0,0
17929,3.4,0,0
17930,%,0,0
17931,(,0,0
17932,induction,0,1
17933,),0,0
17934,and,0,0
17935,4.5,0,0
17936,%,0,0
17937,(,0,0
17938,noninduction,0,0
17939,),0,0
17940,.,0,0
17941,CONCLUSION,0,0
17942,Low,0,0
17943,incidences,0,1
17944,of,0,0
17945,acute,1,0
17946,rejection,1,1
17947,were,0,0
17948,found,0,0
17949,in,0,0
17950,both,0,0
17951,treatment,0,0
17952,arms,0,0
17953,.,0,0
17954,Induction,0,1
17955,treatment,0,0
17956,with,0,0
17957,ATG,0,0
17958,has,0,0
17959,the,0,0
17960,advantage,0,0
17961,of,0,0
17962,a,0,0
17963,lower,0,0
17964,incidence,0,1
17965,of,0,1
17966,acute,0,0
17967,rejection,0,1
17968,",",0,0
17969,but,0,0
17970,it,0,0
17971,significantly,0,0
17972,increases,0,0
17973,adverse,1,1
17974,events,1,1
17975,",",0,0
17976,particularly,0,0
17977,CMV,1,0
17978,infection,1,1
17979,.,1,0
17980,Effect,0,0
17981,of,0,0
17982,a,0,0
17983,specific,0,0
17984,preparation,0,0
17985,of,0,0
17986,Chinese,0,0
17987,herbs,0,0
17988,(,0,0
17989,clear,0,0
17990,the,0,0
17991,way,0,0
17992,),0,0
17993,on,0,0
17994,duration,1,1
17995,and,1,1
17996,severity,1,1
17997,of,1,0
17998,the,1,0
17999,common,1,0
18000,cold,1,0
18001,.,1,0
18002,Relationship,0,0
18003,between,0,0
18004,endogenous,0,1
18005,estrogen,0,1
18006,concentrations,0,1
18007,and,0,1
18008,serum,0,1
18009,cholesteryl,0,1
18010,ester,0,1
18011,transfer,0,1
18012,protein,0,1
18013,concentrations,0,1
18014,in,0,0
18015,Chinese,0,0
18016,women,0,0
18017,.,0,0
18018,BACKGROUND,0,0
18019,CETP,0,0
18020,plays,0,0
18021,an,0,0
18022,important,0,0
18023,role,0,0
18024,in,0,0
18025,HDL,0,1
18026,metabolism,0,1
18027,and,0,0
18028,in,0,0
18029,the,0,0
18030,reverse,0,0
18031,cholesterol,0,1
18032,transport,0,1
18033,pathway,0,0
18034,.,0,0
18035,METHODS,0,0
18036,The,0,0
18037,relationship,0,0
18038,between,0,0
18039,the,0,0
18040,changes,0,0
18041,of,0,0
18042,endogenous,0,1
18043,estrogen,0,0
18044,and,0,0
18045,the,0,0
18046,concentration,0,1
18047,of,0,0
18048,cholesteryl,0,1
18049,ester,0,1
18050,transfer,0,1
18051,protein,0,1
18052,(,0,0
18053,CETP,0,0
18054,),0,0
18055,in,0,0
18056,the,0,0
18057,serum,0,1
18058,of,0,0
18059,Chinese,0,0
18060,women,0,0
18061,was,0,0
18062,investigated,0,0
18063,.,0,0
18064,Serum,1,0
18065,concentrations,1,1
18066,of,1,0
18067,estradiol,1,0
18068,(,1,0
18069,E,1,0
18070,(,1,0
18071,2,1,0
18072,),1,0
18073,),1,0
18074,",",1,0
18075,follicle-stimulating,1,1
18076,hormone,1,1
18077,(,1,0
18078,FSH,1,1
18079,),1,0
18080,",",1,0
18081,CETP,1,0
18082,and,1,1
18083,lipid,1,1
18084,profile,1,1
18085,were,0,0
18086,determined,0,0
18087,in,0,0
18088,196,0,0
18089,Chinese,0,0
18090,women,0,0
18091,(,0,0
18092,52,0,0
18093,premenopausal,0,0
18094,with,0,0
18095,ages,0,0
18096,ranging,0,0
18097,from,0,0
18098,18,0,0
18099,to,0,0
18100,40,0,0
18101,years,0,0
18102,",",0,0
18103,57,0,0
18104,perimenopausal,0,0
18105,from,0,0
18106,41,0,0
18107,to,0,0
18108,60,0,0
18109,years,0,0
18110,",",0,0
18111,and,0,0
18112,87,0,0
18113,postmenopausal,0,0
18114,from,0,0
18115,61,0,0
18116,to,0,0
18117,81,0,0
18118,years,0,0
18119,),0,0
18120,.,0,0
18121,RESULTS,0,0
18122,Serum,1,1
18123,CETP,1,0
18124,concentration,1,1
18125,was,0,0
18126,significantly,0,0
18127,lower,0,0
18128,in,0,0
18129,postmenopausal,0,0
18130,women,0,0
18131,compared,0,0
18132,with,0,0
18133,those,0,0
18134,in,0,0
18135,perimenopausal,0,0
18136,and,0,0
18137,premenopausal,0,0
18138,women,0,0
18139,(,0,0
18140,1.39+/-1.06,0,0
18141,",",0,0
18142,2.36+/-1.50,0,0
18143,and,0,1
18144,2.31+/-1.25,0,0
18145,mg/l,0,0
18146,",",0,0
18147,respectively,0,0
18148,",",0,0
18149,P,0,0
18150,<,0,0
18151,0.0001,0,0
18152,),0,0
18153,.,0,0
18154,Even,0,0
18155,in,0,0
18156,the,0,0
18157,women,0,0
18158,around,0,0
18159,the,0,0
18160,menopausal,0,0
18161,",",0,0
18162,CETP,1,1
18163,concentration,1,1
18164,in,0,0
18165,postmenopause,0,1
18166,was,0,0
18167,significantly,0,0
18168,lower,0,0
18169,than,0,0
18170,that,0,0
18171,in,0,0
18172,premenopause,0,1
18173,(,0,0
18174,1.93+/-1.33,0,0
18175,vs.,0,0
18176,3.42+/-1.35,0,0
18177,mg/l,0,0
18178,",",0,0
18179,P,0,0
18180,<,0,0
18181,0.01,0,0
18182,),0,0
18183,.,0,0
18184,In,0,0
18185,addition,0,0
18186,",",0,0
18187,CETP,0,1
18188,concentration,0,1
18189,had,0,0
18190,a,0,0
18191,highly,0,0
18192,positive,0,0
18193,correlation,0,0
18194,with,0,0
18195,serum,1,1
18196,concentration,1,1
18197,of,0,0
18198,E,0,0
18199,(,0,0
18200,2,0,0
18201,),0,0
18202,(,0,0
18203,r=0.243,0,1
18204,",",0,0
18205,P,0,0
18206,<,0,0
18207,0.001,0,0
18208,),0,0
18209,",",0,0
18210,while,0,0
18211,negative,0,1
18212,correlation,0,0
18213,of,0,0
18214,CETP,1,0
18215,concentration,1,1
18216,with,0,0
18217,serum,1,1
18218,concentration,1,1
18219,of,1,0
18220,FSH,1,1
18221,was,0,0
18222,found,0,0
18223,(,0,0
18224,r=-0.273,0,0
18225,",",0,0
18226,P,0,0
18227,<,0,0
18228,0.001,0,0
18229,),0,0
18230,.,0,0
18231,CONCLUSIONS,0,0
18232,Estrogen,0,0
18233,may,0,0
18234,affect,0,0
18235,the,0,0
18236,concentration,1,1
18237,of,1,0
18238,CETP,1,0
18239,.,1,0
18240,Physical,0,1
18241,activity,0,1
18242,in,0,0
18243,first-degree,0,0
18244,relatives,0,1
18245,of,0,0
18246,breast,0,0
18247,cancer,0,0
18248,patients,0,0
18249,.,0,0
18250,This,0,0
18251,study,0,0
18252,sought,0,0
18253,to,0,0
18254,evaluate,0,0
18255,physical,0,1
18256,activity,0,1
18257,in,0,0
18258,women,0,0
18259,at,0,0
18260,moderate,0,0
18261,risk,0,1
18262,for,0,0
18263,breast,0,0
18264,cancer,0,0
18265,",",0,0
18266,the,0,0
18267,correlates,0,0
18268,of,0,0
18269,engaging,0,0
18270,in,0,0
18271,regular,0,0
18272,physical,0,1
18273,activity,0,1
18274,",",0,0
18275,and,0,1
18276,whether,0,0
18277,physical,0,0
18278,activity,0,1
18279,relates,0,0
18280,to,0,0
18281,psychological,1,1
18282,well-being,1,1
18283,.,1,0
18284,The,0,0
18285,results,0,0
18286,revealed,0,0
18287,that,0,0
18288,55,0,0
18289,%,0,0
18290,of,0,0
18291,women,0,0
18292,were,0,0
18293,regularly,0,0
18294,active,0,0
18295,.,0,0
18296,Logistic,0,0
18297,regression,0,0
18298,models,0,0
18299,indicated,0,0
18300,that,0,0
18301,positive,0,1
18302,affect,0,0
18303,was,0,0
18304,associated,0,0
18305,with,0,0
18306,increased,0,0
18307,and,0,0
18308,negative,0,1
18309,affect,0,0
18310,was,0,0
18311,associated,0,0
18312,with,0,0
18313,decreased,0,0
18314,overall,0,1
18315,and,0,0
18316,leisure,1,1
18317,activity,1,1
18318,.,1,0
18319,Older,0,0
18320,",",0,0
18321,married,0,0
18322,",",0,0
18323,and,0,0
18324,employed,0,0
18325,women,0,0
18326,were,0,0
18327,more,0,0
18328,likely,0,0
18329,to,0,0
18330,engage,0,0
18331,in,0,0
18332,household/occupational,1,1
18333,activity,1,1
18334,",",0,0
18335,whereas,0,0
18336,women,0,0
18337,who,0,0
18338,perceived,0,0
18339,their,0,0
18340,risk,0,0
18341,for,0,0
18342,breast,0,0
18343,cancer,0,0
18344,as,0,0
18345,high,0,0
18346,were,0,0
18347,less,0,0
18348,likely,0,0
18349,.,0,0
18350,More,0,0
18351,educated,0,0
18352,women,0,0
18353,and,0,0
18354,those,0,0
18355,with,0,0
18356,higher,0,0
18357,perceived,0,1
18358,risk,0,1
18359,were,0,0
18360,more,0,0
18361,likely,0,0
18362,to,0,0
18363,engage,0,0
18364,in,0,0
18365,leisure,1,1
18366,activity,1,1
18367,",",0,0
18368,and,0,1
18369,married,0,0
18370,women,0,0
18371,were,0,0
18372,less,0,0
18373,likely,0,0
18374,.,0,0
18375,These,0,0
18376,results,0,0
18377,suggest,0,0
18378,a,0,0
18379,need,0,0
18380,to,0,0
18381,increase,0,0
18382,activity,0,1
18383,levels,0,1
18384,in,0,0
18385,women,0,0
18386,at,0,0
18387,moderate,0,0
18388,risk,0,1
18389,for,0,0
18390,breast,0,0
18391,cancer,0,0
18392,",",0,0
18393,provide,0,0
18394,variables,0,1
18395,upon,0,0
18396,which,0,0
18397,interventions,0,0
18398,can,0,0
18399,be,0,0
18400,tailored,0,0
18401,to,0,0
18402,promote,0,0
18403,activity,0,1
18404,",",0,0
18405,and,0,1
18406,point,0,1
18407,to,0,0
18408,psychological,0,1
18409,benefits,0,0
18410,of,0,0
18411,activity,0,1
18412,in,0,0
18413,this,0,0
18414,population,0,0
18415,.,0,0
18416,Quantitative,0,0
18417,angiographic,0,1
18418,methods,0,0
18419,for,0,0
18420,appropriate,0,0
18421,end-point,1,1
18422,analysis,1,0
18423,",",1,0
18424,edge-effect,1,1
18425,evaluation,1,0
18426,",",0,0
18427,and,0,1
18428,prediction,1,1
18429,of,1,1
18430,recurrent,1,1
18431,restenosis,1,1
18432,after,0,0
18433,coronary,0,0
18434,brachytherapy,0,0
18435,with,0,0
18436,gamma,0,0
18437,irradiation,0,0
18438,.,0,0
18439,OBJECTIVES,0,0
18440,The,0,0
18441,study,0,0
18442,was,0,0
18443,done,0,0
18444,to,0,0
18445,investigate,0,0
18446,the,0,0
18447,relationship,0,0
18448,between,0,0
18449,clinical,0,0
18450,restenosis,0,1
18451,and,0,0
18452,the,0,0
18453,relative,0,0
18454,angiographic,0,1
18455,location,0,0
18456,of,0,0
18457,the,0,0
18458,recurrent,0,0
18459,restenotic,0,1
18460,lesion,0,1
18461,",",0,0
18462,after,0,0
18463,treatment,0,0
18464,of,0,0
18465,in-stent,0,1
18466,restenosis,0,1
18467,with,0,0
18468,vascular,0,1
18469,brachytherapy,0,0
18470,in,0,0
18471,the,0,0
18472,Washington,0,0
18473,Radiation,0,0
18474,for,0,0
18475,In-Stent,0,0
18476,Restenosis,0,1
18477,Trial,0,0
18478,(,0,0
18479,WRIST,0,0
18480,),0,0
18481,.,0,0
18482,BACKGROUND,0,0
18483,Intracoronary,0,1
18484,radiation,0,0
18485,therapy,0,0
18486,reduces,0,0
18487,recurrence,0,1
18488,of,0,0
18489,in-stent,0,1
18490,restenosis,0,1
18491,.,0,0
18492,We,0,0
18493,investigated,0,0
18494,the,0,0
18495,above,0,0
18496,objective,0,0
18497,in,0,0
18498,patients,0,0
18499,enrolled,0,0
18500,in,0,0
18501,WRIST,0,0
18502,.,0,0
18503,METHODS,0,0
18504,The,0,0
18505,WRIST,0,1
18506,study,0,0
18507,randomized,0,0
18508,130,0,0
18509,patients,0,0
18510,to,0,0
18511,double-blinded,0,0
18512,therapy,0,0
18513,with,0,0
18514,gamma,0,1
18515,irradiation,0,0
18516,(,0,0
18517,iridium-192,0,0
18518,[,0,0
18519,(,0,0
18520,192,0,0
18521,),0,0
18522,Ir,0,0
18523,],0,0
18524,),0,0
18525,versus,0,0
18526,placebo,0,0
18527,after,0,0
18528,interventional,0,0
18529,treatment,0,0
18530,of,0,0
18531,diffuse,0,0
18532,in-stent,0,1
18533,restenosis,0,1
18534,.,0,0
18535,After,0,0
18536,the,0,0
18537,intervention,0,0
18538,and,0,0
18539,at,0,0
18540,follow-up,0,0
18541,",",0,0
18542,three,0,0
18543,vessel,0,0
18544,segments,0,0
18545,were,0,0
18546,individually,0,0
18547,analyzed,0,0
18548,with,0,0
18549,quantitative,0,0
18550,coronary,0,0
18551,angiography,0,0
18552,:,0,0
18553,1,0,0
18554,),0,0
18555,the,0,0
18556,stent,0,0
18557,",",0,0
18558,2,0,0
18559,),0,0
18560,the,0,0
18561,radiation,0,0
18562,ribbon,0,1
18563,",",0,0
18564,and,0,0
18565,3,0,0
18566,),0,0
18567,the,0,0
18568,ribbon+margin,0,0
18569,segment,0,0
18570,(,0,0
18571,including,0,0
18572,5,0,0
18573,mm,0,0
18574,on,0,0
18575,either,0,0
18576,end,0,0
18577,of,0,0
18578,the,0,0
18579,injured,0,0
18580,or,0,0
18581,radiation-ribbon,0,0
18582,segment,0,0
18583,),0,0
18584,.,0,0
18585,Receiver,0,0
18586,operator,0,1
18587,curves,0,1
18588,(,0,0
18589,ROC,0,1
18590,),0,0
18591,were,0,0
18592,used,0,0
18593,to,0,0
18594,assess,0,0
18595,the,0,0
18596,value,0,0
18597,of,0,0
18598,the,0,0
18599,follow-up,0,0
18600,percent,0,0
18601,diameter,0,1
18602,stenosis,0,1
18603,(,0,0
18604,DS,0,1
18605,),0,0
18606,for,0,0
18607,each,0,0
18608,of,0,0
18609,the,0,0
18610,three,0,0
18611,analyzed,0,0
18612,segments,0,0
18613,in,0,0
18614,predicting,0,1
18615,target,0,0
18616,vessel,0,1
18617,revascularization,0,1
18618,(,0,0
18619,TVR,0,0
18620,),0,0
18621,.,0,0
18622,RESULTS,0,0
18623,(,0,0
18624,192,0,0
18625,),0,0
18626,Ir,0,0
18627,reduced,0,0
18628,recurrent,1,1
18629,restenosis,1,1
18630,(,0,0
18631,23.7,0,0
18632,%,0,0
18633,vs.,0,0
18634,60.7,0,0
18635,%,0,0
18636,",",0,0
18637,p,0,0
18638,<,0,0
18639,0.001,0,0
18640,),0,0
18641,and,0,0
18642,the,0,0
18643,length,1,1
18644,of,1,0
18645,recurrent,1,1
18646,restenosis,1,1
18647,(,0,0
18648,8.99,0,0
18649,+/-,0,0
18650,4.34,0,0
18651,mm,0,0
18652,vs.,0,0
18653,17.54,0,0
18654,+/-,0,0
18655,10.48,0,0
18656,mm,0,0
18657,",",0,0
18658,p,0,0
18659,<,0,0
18660,0.001,0,0
18661,),0,0
18662,at,0,0
18663,follow-up,0,0
18664,compared,0,0
18665,to,0,0
18666,placebo,0,0
18667,.,0,0
18668,Isolated,1,0
18669,stent,1,1
18670,edge,1,1
18671,(,0,0
18672,3.4,0,0
18673,%,0,0
18674,),0,0
18675,and,0,0
18676,ribbon,1,1
18677,edge,1,1
18678,(,0,0
18679,1.7,0,0
18680,%,0,0
18681,),0,0
18682,restenoses,1,1
18683,were,0,0
18684,infrequent,0,0
18685,in,0,0
18686,both,0,0
18687,groups,0,0
18688,.,0,0
18689,The,0,0
18690,best,0,0
18691,angiographic,0,1
18692,surrogate,0,0
18693,of,0,0
18694,TVR,0,0
18695,was,0,0
18696,the,0,0
18697,50,0,0
18698,%,0,0
18699,follow-up,0,0
18700,DS,0,1
18701,obtained,0,0
18702,from,0,0
18703,the,0,0
18704,ribbon+margin,0,0
18705,analysis,0,0
18706,(,0,0
18707,ROC,0,0
18708,area,0,0
18709,0.806,0,0
18710,),0,0
18711,.,0,0
18712,CONCLUSIONS,0,0
18713,In,0,0
18714,WRIST,0,1
18715,",",0,0
18716,not,0,0
18717,only,0,0
18718,was,0,0
18719,(,0,0
18720,192,0,0
18721,),0,0
18722,Ir,0,0
18723,therapy,0,0
18724,effective,0,1
18725,in,0,0
18726,reducing,0,0
18727,restenosis,0,1
18728,",",0,0
18729,but,0,0
18730,it,0,0
18731,also,0,0
18732,reduced,0,0
18733,the,0,0
18734,lesion,0,1
18735,length,0,1
18736,of,0,0
18737,treatment,0,0
18738,failures,0,1
18739,by,0,0
18740,50,0,0
18741,%,0,0
18742,",",0,0
18743,and,0,0
18744,it,0,0
18745,was,0,0
18746,not,0,0
18747,associated,0,0
18748,with,0,0
18749,edge,0,1
18750,proliferation,0,1
18751,.,0,0
18752,The,0,0
18753,restenosis,0,1
18754,rate,0,1
18755,obtained,0,0
18756,from,0,0
18757,the,0,0
18758,vessel,0,1
18759,segment,0,0
18760,inclusive,0,0
18761,of,0,0
18762,the,0,0
18763,dose,0,0
18764,fall-off,0,1
18765,zones,0,1
18766,was,0,0
18767,the,0,0
18768,best,0,0
18769,correlate,0,0
18770,of,0,0
18771,TVR,0,0
18772,and,0,0
18773,should,0,0
18774,become,0,0
18775,a,0,0
18776,standard,0,0
18777,analysis,0,0
18778,site,0,0
18779,in,0,0
18780,all,0,0
18781,vascular,0,1
18782,brachytherapy,0,0
18783,trials,0,0
18784,.,0,0
18785,Marginal,0,1
18786,biotin,0,0
18787,deficiency,0,0
18788,during,0,0
18789,normal,0,0
18790,pregnancy,0,0
18791,.,0,0
18792,BACKGROUND,0,0
18793,Biotin,0,0
18794,deficiency,0,0
18795,is,0,0
18796,teratogenic,0,0
18797,in,0,0
18798,several,0,0
18799,mammalian,0,0
18800,species,0,0
18801,.,0,0
18802,Approximately,0,0
18803,50,0,0
18804,%,0,0
18805,of,0,0
18806,pregnant,0,0
18807,women,0,0
18808,have,0,0
18809,an,0,0
18810,abnormally,0,0
18811,increased,0,0
18812,urinary,0,1
18813,excretion,0,1
18814,of,0,0
18815,3-hydroxyisovaleric,1,1
18816,acid,1,0
18817,(,1,0
18818,3-HIA,1,0
18819,),1,0
18820,",",0,0
18821,which,0,0
18822,probably,0,0
18823,reflects,0,0
18824,decreased,0,0
18825,activity,0,1
18826,of,0,0
18827,the,0,0
18828,biotin-dependent,0,0
18829,enzyme,0,0
18830,methylcrotonyl-CoA,0,0
18831,carboxylase,0,0
18832,.,0,0
18833,However,0,0
18834,",",0,0
18835,increased,0,0
18836,3-HIA,0,0
18837,excretion,0,1
18838,could,0,0
18839,result,0,0
18840,from,0,0
18841,pregnancy,0,1
18842,per,0,0
18843,se,0,1
18844,(,0,0
18845,eg,0,0
18846,",",0,0
18847,from,0,0
18848,an,0,0
18849,effect,0,0
18850,of,0,0
18851,pregnancy,0,1
18852,on,0,0
18853,renal,0,1
18854,handling,0,0
18855,of,0,0
18856,organic,0,0
18857,acids,0,0
18858,),0,0
18859,.,0,0
18860,OBJECTIVE,0,0
18861,We,0,0
18862,tested,0,0
18863,the,0,0
18864,hypothesis,0,0
18865,that,0,0
18866,biotin,0,0
18867,supplementation,0,0
18868,significantly,0,0
18869,decreases,0,0
18870,3-HIA,0,0
18871,excretion,0,1
18872,in,0,0
18873,pregnant,0,0
18874,women,0,0
18875,with,0,0
18876,abnormally,0,0
18877,increased,0,0
18878,3-HIA,0,0
18879,excretion,0,1
18880,.,0,0
18881,DESIGN,0,0
18882,Twenty-six,0,0
18883,pregnant,0,0
18884,women,0,0
18885,with,0,0
18886,increased,0,0
18887,3-HIA,0,0
18888,excretion,0,1
18889,were,0,0
18890,studied,0,0
18891,in,0,0
18892,a,0,0
18893,randomized,0,0
18894,",",0,0
18895,placebo-controlled,0,0
18896,trial,0,0
18897,;,0,0
18898,10,0,0
18899,women,0,0
18900,were,0,0
18901,studied,0,0
18902,during,0,0
18903,early,0,0
18904,pregnancy,0,1
18905,(,0,0
18906,6-17,0,0
18907,wk,0,0
18908,gestation,0,0
18909,),0,0
18910,and,0,0
18911,16,0,0
18912,women,0,0
18913,during,0,0
18914,late,0,1
18915,pregnancy,0,1
18916,(,0,0
18917,21-37,0,0
18918,wk,0,0
18919,gestation,0,0
18920,),0,0
18921,.,0,0
18922,Urine,1,0
18923,samples,1,0
18924,were,0,0
18925,collected,0,0
18926,before,0,0
18927,and,0,0
18928,after,0,0
18929,14,0,0
18930,d,0,0
18931,of,0,0
18932,supplementation,0,0
18933,with,0,0
18934,300,0,0
18935,microg,0,0
18936,(,0,0
18937,1.2,0,0
18938,micromol,0,0
18939,),0,0
18940,biotin/d,0,0
18941,or,0,0
18942,placebo,0,0
18943,.,0,0
18944,RESULTS,0,0
18945,In,0,0
18946,the,0,0
18947,early-pregnancy,0,1
18948,group,0,0
18949,",",0,0
18950,3-HIA,1,0
18951,excretion,1,1
18952,decreased,0,0
18953,(,0,0
18954,P,0,0
18955,<,0,0
18956,0.006,0,0
18957,),0,0
18958,by,0,0
18959,11.7,0,0
18960,+/-,0,0
18961,3.6,0,0
18962,mmol/mol,0,0
18963,creatinine,0,1
18964,(,0,0
18965,mean,0,1
18966,+/-,0,0
18967,SEM,0,0
18968,),0,0
18969,in,0,0
18970,the,0,0
18971,5,0,0
18972,women,0,0
18973,who,0,0
18974,received,0,0
18975,biotin,0,0
18976,supplements,0,0
18977,",",0,0
18978,whereas,0,0
18979,3-HIA,1,0
18980,excretion,1,1
18981,increased,0,0
18982,by,0,0
18983,1.6,0,0
18984,+/-,0,0
18985,0.6,0,0
18986,mmol/mol,0,0
18987,creatinine,0,0
18988,in,0,0
18989,the,0,0
18990,5,0,0
18991,women,0,0
18992,who,0,0
18993,received,0,0
18994,placebo,0,0
18995,.,0,0
18996,In,0,0
18997,the,0,0
18998,late-pregnancy,0,1
18999,group,0,0
19000,",",0,0
19001,3-HIA,1,0
19002,excretion,1,1
19003,decreased,0,0
19004,(,0,0
19005,P,0,0
19006,<,0,0
19007,0.002,0,0
19008,),0,0
19009,by,0,0
19010,7.1,0,0
19011,+/-,0,0
19012,1.2,0,0
19013,mmol/mol,0,0
19014,creatinine,0,0
19015,in,0,0
19016,the,0,0
19017,8,0,0
19018,women,0,0
19019,who,0,0
19020,received,0,0
19021,biotin,0,0
19022,supplements,0,0
19023,",",0,0
19024,whereas,0,0
19025,3-HIA,1,0
19026,excretion,1,1
19027,increased,0,0
19028,by,0,0
19029,0.9,0,0
19030,+/-,0,0
19031,1.8,0,0
19032,mmol/mol,0,0
19033,creatinine,0,0
19034,in,0,0
19035,the,0,0
19036,8,0,0
19037,women,0,0
19038,who,0,0
19039,received,0,0
19040,placebo,0,0
19041,.,0,0
19042,CONCLUSIONS,0,0
19043,This,0,0
19044,study,0,0
19045,provides,0,0
19046,evidence,0,0
19047,that,0,0
19048,the,0,0
19049,increased,0,0
19050,excretion,1,1
19051,of,1,0
19052,3-HIA,1,0
19053,seen,0,0
19054,frequently,0,0
19055,in,0,0
19056,normal,0,0
19057,pregnancy,0,0
19058,reflects,0,0
19059,reduced,0,0
19060,biotin,1,0
19061,status,1,0
19062,.,1,0
19063,The,0,0
19064,conclusion,0,0
19065,that,0,0
19066,marginal,0,1
19067,biotin,0,0
19068,deficiency,0,0
19069,occurs,0,0
19070,frequently,0,0
19071,in,0,0
19072,the,0,0
19073,first,0,0
19074,trimester,0,0
19075,further,0,0
19076,raises,0,0
19077,concern,0,0
19078,about,0,0
19079,potential,0,0
19080,human,0,0
19081,teratogenicity,0,0
19082,.,0,0
19083,Multicenter,0,0
19084,randomized,0,0
19085,controlled,0,0
19086,trial,0,0
19087,of,0,0
19088,the,0,0
19089,management,0,0
19090,of,0,0
19091,unresectable,0,0
19092,malignant,0,0
19093,mesothelioma,0,0
19094,proposed,0,0
19095,by,0,0
19096,the,0,0
19097,British,0,0
19098,Thoracic,0,0
19099,Society,0,0
19100,and,0,0
19101,the,0,0
19102,British,0,0
19103,Medical,0,0
19104,Research,0,0
19105,Council,0,0
19106,.,0,0
19107,Malignant,0,0
19108,mesothelioma,0,0
19109,is,0,0
19110,almost,0,0
19111,invariably,0,0
19112,fatal,0,0
19113,.,0,0
19114,The,0,0
19115,incidence,0,1
19116,of,0,0
19117,the,0,0
19118,disease,0,0
19119,is,0,0
19120,rising,0,0
19121,rapidly,0,0
19122,in,0,0
19123,many,0,0
19124,countries,0,0
19125,",",0,0
19126,and,0,0
19127,there,0,0
19128,is,0,0
19129,no,0,0
19130,generally,0,0
19131,accepted,0,0
19132,standard,0,0
19133,treatment,0,0
19134,for,0,0
19135,patients,0,0
19136,with,0,0
19137,unresectable,0,0
19138,disease,0,0
19139,.,0,0
19140,According,0,0
19141,to,0,0
19142,current,0,0
19143,British,0,0
19144,Thoracic,0,0
19145,Society,0,0
19146,(,0,0
19147,BTS,0,1
19148,),0,0
19149,guidelines,0,0
19150,",",0,0
19151,patients,0,0
19152,should,0,0
19153,be,0,0
19154,treated,0,0
19155,with,0,0
19156,active,0,0
19157,symptom,0,1
19158,control,0,0
19159,(,0,0
19160,ASC,0,1
19161,),0,0
19162,",",0,0
19163,involving,0,0
19164,(,0,0
19165,1,0,0
19166,),0,0
19167,regular,0,0
19168,follow-up,0,0
19169,in,0,0
19170,a,0,0
19171,specialist,0,0
19172,clinic,0,0
19173,;,0,0
19174,(,0,0
19175,2,0,0
19176,),0,0
19177,structured,0,0
19178,assessments,0,0
19179,of,0,0
19180,physical,0,1
19181,",",0,0
19182,psychological,0,1
19183,and,0,1
19184,social,0,1
19185,problems,0,1
19186,with,0,0
19187,appropriate,0,0
19188,action,0,1
19189,;,0,0
19190,(,0,0
19191,3,0,0
19192,),0,0
19193,rapid,0,0
19194,involvement,0,1
19195,of,0,0
19196,additional,0,0
19197,specialists,0,0
19198,;,0,0
19199,and,0,0
19200,(,0,0
19201,4,0,0
19202,),0,0
19203,parallel,0,0
19204,nursing,0,0
19205,support,0,0
19206,.,0,0
19207,Although,0,0
19208,many,0,0
19209,nonrandomized,0,0
19210,studies,0,0
19211,have,0,0
19212,reported,0,0
19213,tumor,0,0
19214,responses,0,1
19215,to,0,0
19216,anticancer,0,0
19217,chemotherapy,0,0
19218,",",0,0
19219,few,0,0
19220,have,0,0
19221,studied,0,0
19222,palliation,0,0
19223,and,0,0
19224,it,0,0
19225,is,0,0
19226,not,0,0
19227,known,0,0
19228,whether,0,0
19229,chemotherapy,0,0
19230,prolongs,0,1
19231,survival,0,1
19232,or,0,0
19233,provides,0,0
19234,clinically,0,1
19235,worthwhile,0,0
19236,palliation,0,0
19237,with,0,0
19238,acceptable,0,0
19239,toxicity,0,1
19240,when,0,0
19241,given,0,0
19242,in,0,0
19243,addition,0,0
19244,to,0,0
19245,ASC,0,0
19246,.,0,0
19247,We,0,0
19248,therefore,0,0
19249,plan,0,0
19250,to,0,0
19251,conduct,0,0
19252,a,0,0
19253,multicenter,0,0
19254,randomized,0,0
19255,controlled,0,0
19256,trial,0,0
19257,comparing,0,0
19258,(,0,0
19259,1,0,0
19260,),0,0
19261,ASC,0,0
19262,alone,0,0
19263,",",0,0
19264,(,0,0
19265,2,0,0
19266,),0,0
19267,ASC,0,0
19268,plus,0,0
19269,mitomycin,0,0
19270,vinblastine,0,0
19271,and,0,1
19272,cisplatin,0,0
19273,(,0,1
19274,MVP,0,1
19275,),0,1
19276,",",0,0
19277,and,0,0
19278,(,0,0
19279,3,0,0
19280,),0,0
19281,ASC,0,0
19282,plus,0,0
19283,vinorelbine,0,0
19284,(,0,0
19285,N,0,0
19286,;,0,0
19287,Navelbine,0,0
19288,",",0,0
19289,Pierre,0,0
19290,Fabre,0,0
19291,Oncology,0,0
19292,",",0,0
19293,Winchester,0,1
19294,",",0,1
19295,UK,0,0
19296,),0,0
19297,.,0,0
19298,We,0,0
19299,chose,0,0
19300,these,0,0
19301,chemotherapy,0,0
19302,regimens,0,0
19303,because,0,0
19304,they,0,0
19305,have,0,0
19306,been,0,0
19307,shown,0,0
19308,in,0,0
19309,nonrandomized,0,0
19310,studies,0,0
19311,to,0,0
19312,provide,0,0
19313,good,0,0
19314,symptom,0,1
19315,control,0,0
19316,as,0,0
19317,recorded,0,0
19318,by,0,0
19319,patients,0,0
19320,.,0,0
19321,The,0,0
19322,outcome,0,0
19323,measures,0,0
19324,are,0,0
19325,overall,1,1
19326,survival,1,1
19327,",",1,0
19328,palliation,1,0
19329,of,1,1
19330,symptoms,1,1
19331,",",1,0
19332,performance,1,1
19333,status,1,1
19334,",",1,0
19335,analgesic,1,1
19336,usage,1,0
19337,",",1,0
19338,toxicity,1,1
19339,",",1,1
19340,quality,1,1
19341,of,1,1
19342,life,1,1
19343,",",1,0
19344,tumor,1,1
19345,response,1,1
19346,",",1,0
19347,and,1,1
19348,recurrence/progression-free,1,1
19349,survival,1,1
19350,.,1,0
19351,In,0,0
19352,a,0,0
19353,preliminary,0,0
19354,feasibility,0,0
19355,study,0,0
19356,",",0,0
19357,we,0,0
19358,are,0,0
19359,assessing,0,0
19360,the,0,0
19361,acceptability,0,0
19362,of,0,0
19363,the,0,0
19364,trial,0,0
19365,design,0,0
19366,to,0,0
19367,patients,0,0
19368,and,0,0
19369,the,0,0
19370,suitability,0,0
19371,of,0,0
19372,two,0,0
19373,standard,0,0
19374,quality-of-life,1,0
19375,instruments,0,0
19376,in,0,0
19377,mesothelioma,0,0
19378,.,0,0
19379,Data,0,0
19380,will,0,0
19381,help,0,0
19382,us,0,0
19383,to,0,0
19384,decide,0,0
19385,the,0,0
19386,final,0,0
19387,details,0,0
19388,of,0,0
19389,the,0,0
19390,large,0,0
19391,multicenter,0,0
19392,trial,0,0
19393,.,0,0
19394,Laparoscopically,0,0
19395,assisted,0,0
19396,vaginal,0,0
19397,hysterectomy,0,0
19398,versus,0,0
19399,abdominal,0,1
19400,hysterectomy,0,0
19401,in,0,0
19402,stage,0,0
19403,I,0,0
19404,endometrial,0,0
19405,cancer,0,0
19406,.,0,0
19407,The,0,0
19408,purpose,0,0
19409,of,0,0
19410,this,0,0
19411,study,0,0
19412,was,0,0
19413,to,0,0
19414,evaluate,0,0
19415,and,0,0
19416,compare,0,0
19417,laparoscopic,0,0
19418,treatment,0,0
19419,for,0,0
19420,stage,0,0
19421,I,0,0
19422,endometrial,0,1
19423,cancer,0,0
19424,with,0,0
19425,the,0,0
19426,traditional,0,0
19427,transabdominal,0,0
19428,approach,0,0
19429,.,0,0
19430,From,0,0
19431,July,0,0
19432,1996,0,0
19433,to,0,0
19434,July,0,0
19435,1998,0,0
19436,",",0,0
19437,61,0,0
19438,patients,0,0
19439,with,0,0
19440,clinical,0,0
19441,stage,0,0
19442,I,0,0
19443,endometrial,0,1
19444,cancer,0,0
19445,were,0,0
19446,treated,0,0
19447,at,0,0
19448,the,0,0
19449,Gynaecology,0,0
19450,Oncology,0,0
19451,Unit,0,0
19452,at,0,0
19453,the,0,0
19454,Royal,0,0
19455,North,0,0
19456,Shore,0,1
19457,of,0,0
19458,Sydney,0,0
19459,",",0,0
19460,Australia,0,0
19461,.,0,0
19462,Twenty-nine,0,0
19463,patients,0,0
19464,were,0,0
19465,treated,0,0
19466,with,0,0
19467,laparoscopic,0,0
19468,assisted,0,0
19469,vaginal,0,0
19470,hysterectomy,0,0
19471,(,0,0
19472,LAVH,0,0
19473,),0,0
19474,and,0,0
19475,bilateral,0,0
19476,salpingo-oophrectomy,0,0
19477,(,0,0
19478,BSO,0,1
19479,),0,1
19480,plus,0,0
19481,minus,0,0
19482,laparoscopic,0,0
19483,pelvic,0,0
19484,lymphadenectomy,0,0
19485,(,0,0
19486,LPLA,0,1
19487,),0,0
19488,",",0,0
19489,while,0,0
19490,32,0,0
19491,patients,0,0
19492,were,0,0
19493,treated,0,0
19494,with,0,0
19495,the,0,0
19496,traditional,0,0
19497,laparotomy,0,0
19498,and,0,0
19499,underwent,0,0
19500,total,0,1
19501,abdominal,0,1
19502,hysterectomy,0,0
19503,(,0,0
19504,TAH,0,1
19505,),0,0
19506,and,0,0
19507,BSO,0,1
19508,plus,0,0
19509,minus,0,0
19510,pelvic,0,1
19511,lymphadenectomy,0,0
19512,(,0,0
19513,PLA,0,0
19514,),0,0
19515,.,0,0
19516,The,0,0
19517,main,0,0
19518,outcomes,0,0
19519,studied,0,0
19520,were,0,0
19521,operative,1,1
19522,time,1,1
19523,",",1,0
19524,blood,1,1
19525,loss,1,1
19526,",",1,1
19527,blood,1,1
19528,transfusion,1,1
19529,",",1,0
19530,intraoperative,1,1
19531,complications,1,1
19532,",",1,0
19533,postoperative,1,1
19534,complications,1,1
19535,",",1,0
19536,duration,1,1
19537,of,1,1
19538,hospital,1,1
19539,stay,1,1
19540,",",1,1
19541,and,1,1
19542,number,1,1
19543,of,1,1
19544,lymph,1,1
19545,nodes,1,0
19546,obtained,0,0
19547,.,0,0
19548,In,0,0
19549,conclusion,0,0
19550,",",0,0
19551,laparoscopic,0,0
19552,treatment,0,0
19553,of,0,0
19554,endometrial,0,0
19555,cancer,0,0
19556,is,0,0
19557,safe,1,0
19558,in,0,0
19559,the,0,0
19560,hands,0,0
19561,of,0,0
19562,experienced,0,0
19563,operators,0,0
19564,with,0,0
19565,minimal,0,1
19566,intraoperative,0,0
19567,and,0,0
19568,postoperative,0,1
19569,complications,0,1
19570,.,0,0
19571,This,0,0
19572,procedure,0,0
19573,is,0,0
19574,associated,0,0
19575,with,0,0
19576,significantly,0,0
19577,less,0,0
19578,blood,1,1
19579,loss,1,1
19580,and,0,0
19581,shorter,0,1
19582,hospitalization,1,1
19583,;,1,0
19584,however,0,0
19585,",",0,0
19586,it,0,0
19587,is,0,0
19588,associated,0,0
19589,with,0,0
19590,significantly,0,0
19591,longer,0,0
19592,operating,1,0
19593,time,1,1
19594,.,1,0
19595,Proper,0,0
19596,selection,0,0
19597,of,0,0
19598,patients,0,0
19599,for,0,0
19600,the,0,0
19601,laparoscopic,0,0
19602,procedure,0,0
19603,is,0,0
19604,the,0,0
19605,vital,0,1
19606,step,0,0
19607,in,0,0
19608,achieving,0,0
19609,the,0,0
19610,major,0,0
19611,goals,0,0
19612,of,0,0
19613,this,0,0
19614,approach,0,0
19615,.,0,0
19616,Effect,0,0
19617,of,0,0
19618,delayed,0,0
19619,cord,0,1
19620,clamping,0,0
19621,on,0,0
19622,iron,1,0
19623,stores,1,0
19624,in,0,0
19625,infants,0,0
19626,born,0,0
19627,to,0,0
19628,anemic,0,0
19629,mothers,0,0
19630,:,0,0
19631,a,0,0
19632,randomized,0,0
19633,controlled,0,0
19634,trial,0,0
19635,.,0,0
19636,OBJECTIVE,0,0
19637,To,0,0
19638,study,0,0
19639,the,0,0
19640,effects,0,0
19641,of,0,0
19642,cord,0,0
19643,clamping,0,0
19644,on,0,0
19645,iron,0,0
19646,stores,0,0
19647,of,0,0
19648,infants,0,0
19649,born,0,0
19650,to,0,0
19651,anemic,0,0
19652,mothers,0,0
19653,at,0,0
19654,3,0,0
19655,months,0,0
19656,of,0,0
19657,age,0,0
19658,.,0,0
19659,DESIGN,0,0
19660,Randomized,0,0
19661,controlled,0,0
19662,trial,0,0
19663,.,0,0
19664,SETTING,0,0
19665,Teaching,0,0
19666,hospital,0,1
19667,.,0,0
19668,METHODS,0,0
19669,Infants,0,0
19670,born,0,0
19671,to,0,0
19672,mothers,0,0
19673,with,0,0
19674,hemoglobin,0,1
19675,(,0,0
19676,Hb,0,1
19677,),0,0
19678,<,0,0
19679,100,0,0
19680,g/L,0,0
19681,were,0,0
19682,randomized,0,0
19683,at,0,0
19684,delivery,0,0
19685,to,0,0
19686,either,0,0
19687,immediate,0,0
19688,cord,0,1
19689,clamping,0,1
19690,(,0,0
19691,early,0,0
19692,group,0,0
19693,),0,0
19694,or,0,0
19695,cord,0,1
19696,clamping,0,0
19697,delayed,0,0
19698,till,0,0
19699,descent,0,0
19700,of,0,0
19701,placenta,0,1
19702,into,0,0
19703,vagina,0,0
19704,(,0,0
19705,delayed,0,1
19706,group,0,0
19707,),0,0
19708,.,0,0
19709,The,0,0
19710,outcome,0,1
19711,measures,0,1
19712,were,0,0
19713,infant,1,1
19714,'s,1,1
19715,hemoglobin,1,1
19716,and,1,0
19717,serum,1,1
19718,ferritin,1,0
19719,3,1,0
19720,months,1,0
19721,after,1,0
19722,delivery,1,0
19723,.,1,0
19724,RESULTS,0,0
19725,There,0,0
19726,were,0,0
19727,102,0,0
19728,neonates,0,0
19729,randomized,0,0
19730,to,0,0
19731,early,0,0
19732,(,0,0
19733,n,0,0
19734,=,0,0
19735,43,0,0
19736,),0,0
19737,or,0,0
19738,delayed,0,1
19739,cord,0,1
19740,clamping,0,0
19741,(,0,0
19742,n,0,0
19743,=,0,0
19744,59,0,0
19745,),0,0
19746,.,0,0
19747,The,0,0
19748,groups,0,0
19749,were,0,0
19750,comparable,0,0
19751,for,0,0
19752,maternal,0,1
19753,age,0,0
19754,",",0,0
19755,parity,0,1
19756,",",0,1
19757,weight,0,1
19758,and,0,1
19759,supplemental,0,0
19760,iron,0,0
19761,intake,0,1
19762,",",0,0
19763,infant,0,1
19764,s,0,1
19765,birth,0,1
19766,weight,0,1
19767,",",0,1
19768,gestation,0,1
19769,and,0,1
19770,sex,0,0
19771,.,0,0
19772,The,0,0
19773,mean,1,1
19774,infant,1,1
19775,ferritin,1,1
19776,and,1,1
19777,Hb,1,1
19778,at,1,0
19779,3,1,0
19780,months,1,0
19781,were,0,0
19782,significantly,0,0
19783,higher,0,0
19784,in,0,0
19785,the,0,0
19786,delayed,0,0
19787,clamping,0,0
19788,group,0,0
19789,(,0,0
19790,118.4,0,0
19791,microg/L,0,0
19792,and,0,0
19793,99,0,0
19794,g/L,0,0
19795,),0,0
19796,than,0,0
19797,in,0,0
19798,the,0,0
19799,early,0,0
19800,clamping,0,0
19801,group,0,0
19802,(,0,0
19803,73,0,0
19804,microg/L,0,0
19805,and,0,0
19806,88,0,0
19807,g/L,0,0
19808,),0,0
19809,.,0,0
19810,The,0,0
19811,mean,0,1
19812,decrease,0,0
19813,in,0,0
19814,Hb,1,1
19815,(,0,0
19816,g/L,0,0
19817,),0,0
19818,at,0,0
19819,3,0,0
19820,months,0,0
19821,adjusted,0,0
19822,for,0,0
19823,co-variates,0,1
19824,was,0,0
19825,significantly,0,0
19826,less,0,0
19827,in,0,0
19828,the,0,0
19829,delayed,0,0
19830,clamping,0,0
19831,group,0,0
19832,compared,0,0
19833,to,0,0
19834,the,0,0
19835,early,0,0
19836,clamping,0,0
19837,group,0,0
19838,(,0,0
19839,-1.09,0,0
19840,",",0,0
19841,95,0,0
19842,%,0,0
19843,CI-1.58,0,0
19844,to,0,0
19845,-0.62,0,0
19846,",",0,0
19847,p,0,0
19848,>,0,0
19849,0.001,0,0
19850,),0,0
19851,.,0,0
19852,The,0,0
19853,odds,0,0
19854,for,0,0
19855,anemia,1,1
19856,(,0,0
19857,<,0,0
19858,100,0,0
19859,g/L,0,0
19860,),0,0
19861,at,0,0
19862,3,0,0
19863,months,0,0
19864,was,0,0
19865,7.7,0,0
19866,(,0,0
19867,95,0,0
19868,%,0,0
19869,CI,0,0
19870,1.84-34.9,0,0
19871,),0,0
19872,times,0,0
19873,higher,0,0
19874,in,0,0
19875,the,0,0
19876,early,0,0
19877,compared,0,0
19878,to,0,0
19879,the,0,0
19880,delayed,0,0
19881,clamping,0,0
19882,group,0,0
19883,.,0,0
19884,CONCLUSION,0,0
19885,Iron,1,0
19886,stores,1,1
19887,and,1,0
19888,Hb,1,1
19889,in,0,0
19890,infancy,0,0
19891,can,0,0
19892,be,0,0
19893,improved,0,0
19894,in,0,0
19895,neonates,0,0
19896,born,0,0
19897,to,0,0
19898,anemic,0,0
19899,mothers,0,0
19900,by,0,0
19901,delaying,0,0
19902,cord,0,1
19903,clamping,0,0
19904,at,0,0
19905,birth,0,0
19906,.,0,0
19907,Benefits,1,1
19908,",",1,0
19909,morbidity,1,1
19910,",",1,1
19911,and,1,1
19912,mortality,1,1
19913,associated,0,0
19914,with,0,0
19915,long-term,0,0
19916,administration,0,0
19917,of,0,0
19918,oral,0,0
19919,anticoagulant,0,0
19920,therapy,0,0
19921,to,0,0
19922,patients,0,0
19923,with,0,0
19924,peripheral,0,1
19925,arterial,0,1
19926,bypass,0,0
19927,procedures,0,0
19928,:,0,0
19929,a,0,0
19930,prospective,0,0
19931,randomized,0,0
19932,study,0,0
19933,.,0,0
19934,BACKGROUND,0,0
19935,The,0,0
19936,benefits,0,0
19937,of,0,0
19938,the,0,0
19939,long-term,0,0
19940,administration,0,0
19941,of,0,0
19942,oral,0,0
19943,anticoagulant,0,0
19944,therapy,0,0
19945,remain,0,0
19946,unclear,0,0
19947,in,0,0
19948,patients,0,0
19949,with,0,0
19950,lower,0,0
19951,extremity,0,1
19952,arterial,0,1
19953,bypass,0,0
19954,surgery,0,0
19955,.,0,0
19956,We,0,0
19957,studied,0,0
19958,the,0,0
19959,effect,0,0
19960,of,0,0
19961,warfarin,0,0
19962,plus,0,0
19963,aspirin,0,0
19964,therapy,0,0
19965,(,0,0
19966,WASA,0,1
19967,),0,0
19968,versus,0,0
19969,aspirin,0,0
19970,therapy,0,0
19971,alone,0,0
19972,(,0,0
19973,ASA,0,0
19974,),0,0
19975,on,0,0
19976,patient,1,1
19977,mortality,1,1
19978,",",1,1
19979,morbidity,1,1
19980,and,1,1
19981,bypass,1,1
19982,patency,1,1
19983,rates,1,1
19984,in,0,0
19985,a,0,0
19986,randomized,0,0
19987,clinical,0,0
19988,trial,0,0
19989,.,0,0
19990,METHODS,0,0
19991,In,0,0
19992,a,0,0
19993,multicenter,0,0
19994,",",0,0
19995,prospective,0,0
19996,",",0,0
19997,nonmasked,0,0
19998,clinical,0,1
19999,trial,0,0
20000,",",0,0
20001,831,0,0
20002,patients,0,0
20003,who,0,0
20004,underwent,0,0
20005,peripheral,0,1
20006,arterial,0,1
20007,bypass,0,0
20008,surgery,0,0
20009,were,0,0
20010,compared,0,0
20011,in,0,0
20012,a,0,0
20013,long-term,0,0
20014,treatment,0,0
20015,program,0,0
20016,of,0,1
20017,WASA,0,0
20018,(,0,0
20019,target,0,0
20020,international,0,0
20021,normalized,0,0
20022,ratio,0,1
20023,of,0,0
20024,1.4,0,0
20025,to,0,0
20026,2.8,0,0
20027,;,0,0
20028,325,0,0
20029,mg/day,0,0
20030,),0,0
20031,with,0,0
20032,ASA,0,0
20033,(,0,0
20034,325,0,0
20035,mg/day,0,0
20036,),0,0
20037,.,0,0
20038,The,0,0
20039,primary,0,0
20040,end,0,0
20041,point,0,0
20042,was,0,0
20043,bypass,1,0
20044,patency,1,1
20045,",",1,0
20046,and,1,1
20047,mortality,1,1
20048,and,1,1
20049,morbidity,1,1
20050,were,0,0
20051,the,0,0
20052,secondary,0,0
20053,endpoints,0,0
20054,.,0,0
20055,RESULTS,0,0
20056,There,0,0
20057,were,0,0
20058,133,0,0
20059,deaths,1,0
20060,in,0,0
20061,the,0,0
20062,WASA,0,1
20063,group,0,0
20064,(,0,0
20065,31.8,0,0
20066,%,0,0
20067,),0,0
20068,and,0,0
20069,95,0,0
20070,deaths,1,1
20071,in,0,0
20072,the,0,0
20073,ASA,0,0
20074,group,0,0
20075,(,0,0
20076,23.0,0,0
20077,%,0,0
20078,;,0,0
20079,risk,0,1
20080,ratio,0,1
20081,",",0,0
20082,1.41,0,0
20083,;,0,0
20084,95,0,0
20085,%,0,0
20086,confidence,0,0
20087,interval,0,0
20088,",",0,0
20089,1.09,0,0
20090,to,0,0
20091,1.84,0,0
20092,;,0,0
20093,P,0,0
20094,=.0001,0,0
20095,),0,0
20096,.,0,0
20097,Major,1,0
20098,hemorrhagic,1,1
20099,events,1,1
20100,occurred,0,0
20101,more,0,0
20102,frequently,0,0
20103,in,0,0
20104,the,0,0
20105,WASA,0,1
20106,group,0,0
20107,(,0,0
20108,WASA,0,1
20109,",",0,0
20110,n,0,0
20111,=,0,0
20112,35,0,0
20113,;,0,0
20114,ASA,0,0
20115,",",0,0
20116,n,0,0
20117,=,0,0
20118,15,0,0
20119,;,0,0
20120,P,0,0
20121,=.02,0,0
20122,),0,0
20123,.,0,0
20124,In,0,0
20125,the,0,0
20126,prosthetic,0,0
20127,bypass,0,0
20128,group,0,0
20129,",",0,0
20130,there,0,0
20131,was,0,0
20132,no,0,0
20133,significant,0,0
20134,difference,0,0
20135,in,0,0
20136,patency,1,1
20137,rate,1,1
20138,in,0,0
20139,the,0,0
20140,8-mm,0,0
20141,bypass,0,0
20142,subgroup,0,0
20143,",",0,0
20144,but,0,0
20145,there,0,0
20146,was,0,0
20147,a,0,0
20148,significant,0,0
20149,difference,0,0
20150,in,0,0
20151,patency,1,1
20152,rate,1,1
20153,in,0,0
20154,the,0,0
20155,6-mm,0,0
20156,bypass,0,0
20157,subgroup,0,0
20158,(,0,0
20159,femoral-popliteal,0,0
20160,;,0,0
20161,71.4,0,0
20162,%,0,0
20163,in,0,0
20164,the,0,0
20165,WASA,0,1
20166,group,0,0
20167,versus,0,0
20168,57.9,0,0
20169,%,0,0
20170,in,0,0
20171,the,0,0
20172,ASA,0,0
20173,group,0,0
20174,;,0,0
20175,P,0,0
20176,=.02,0,0
20177,),0,0
20178,.,0,0
20179,In,0,0
20180,the,0,0
20181,vein,0,0
20182,bypass,0,0
20183,group,0,0
20184,",",0,1
20185,patency,1,1
20186,rate,1,1
20187,was,0,0
20188,unaffected,0,0
20189,(,0,0
20190,75.3,0,0
20191,%,0,0
20192,in,0,0
20193,the,0,0
20194,WASA,0,1
20195,group,0,0
20196,versus,0,0
20197,74.9,0,0
20198,%,0,0
20199,in,0,0
20200,the,0,0
20201,ASA,0,0
20202,group,0,0
20203,),0,0
20204,.,0,0
20205,CONCLUSION,0,0
20206,The,0,0
20207,long-term,0,0
20208,administration,0,0
20209,of,0,0
20210,warfarin,0,0
20211,therapy,0,0
20212,when,0,0
20213,combined,0,0
20214,with,0,0
20215,aspirin,0,0
20216,therapy,0,0
20217,has,0,0
20218,only,0,0
20219,a,0,0
20220,few,0,0
20221,selected,0,0
20222,indications,0,0
20223,for,0,0
20224,improvement,0,1
20225,of,0,0
20226,bypass,1,0
20227,patency,1,1
20228,and,0,0
20229,is,0,0
20230,associated,0,0
20231,with,0,0
20232,an,0,0
20233,increased,0,0
20234,risk,1,0
20235,of,1,0
20236,morbidity,1,1
20237,and,1,0
20238,mortality,1,1
20239,.,1,0
20240,Comparison,0,0
20241,of,0,0
20242,comfort,1,1
20243,and,1,0
20244,local,1,1
20245,complications,1,1
20246,after,0,0
20247,cardiac,0,0
20248,catheterization,0,0
20249,.,0,0
20250,The,0,0
20251,purpose,0,0
20252,of,0,0
20253,this,0,0
20254,study,0,0
20255,was,0,0
20256,to,0,0
20257,compare,0,0
20258,the,0,0
20259,effects,0,0
20260,of,0,0
20261,4,0,0
20262,hours,0,0
20263,of,0,0
20264,bed,0,1
20265,rest,0,0
20266,versus,0,0
20267,6,0,0
20268,hours,0,0
20269,of,0,0
20270,bed,0,1
20271,rest,0,0
20272,on,0,0
20273,patients,0,0
20274,',0,0
20275,safety,1,1
20276,",",1,0
20277,comfort,1,1
20278,",",1,1
20279,and,1,1
20280,satisfaction,1,1
20281,levels,1,1
20282,.,1,0
20283,Using,0,0
20284,a,0,0
20285,quasi-experimental,0,0
20286,design,0,0
20287,",",0,0
20288,the,0,0
20289,authors,0,0
20290,studied,0,0
20291,118,0,0
20292,left-heart,0,0
20293,catheterization,0,0
20294,patients,0,0
20295,who,0,0
20296,were,0,0
20297,randomly,0,0
20298,assigned,0,0
20299,to,0,0
20300,4,0,0
20301,hours,0,0
20302,or,0,0
20303,6,0,0
20304,hours,0,0
20305,of,0,0
20306,bed,0,1
20307,rest,0,0
20308,.,0,0
20309,Among,0,0
20310,the,0,0
20311,study,0,0
20312,participants,0,0
20313,",",0,0
20314,only,0,0
20315,1,0,0
20316,in,0,0
20317,the,0,0
20318,6-hour,0,0
20319,group,0,0
20320,had,0,0
20321,significant,1,0
20322,bleeding,1,1
20323,.,1,0
20324,There,0,0
20325,were,0,0
20326,no,0,0
20327,complications,1,1
20328,in,0,0
20329,the,0,0
20330,4-hour,0,0
20331,group,0,0
20332,.,0,0
20333,There,0,0
20334,were,0,0
20335,no,0,0
20336,statistically,0,0
20337,significant,0,0
20338,differences,0,0
20339,between,0,0
20340,the,0,0
20341,two,0,0
20342,groups,0,0
20343,on,0,0
20344,any,0,0
20345,of,0,0
20346,the,0,0
20347,other,0,0
20348,study,0,0
20349,variables,0,0
20350,.,0,0
20351,Given,0,0
20352,the,0,0
20353,lack,0,0
20354,of,0,0
20355,significant,0,0
20356,complications,0,1
20357,for,0,0
20358,the,0,0
20359,4-hour,0,0
20360,group,0,0
20361,and,0,0
20362,similar,0,0
20363,comfort,1,1
20364,levels,1,1
20365,for,0,0
20366,both,0,0
20367,study,0,0
20368,groups,0,0
20369,",",0,0
20370,these,0,0
20371,findings,0,0
20372,suggest,0,0
20373,the,0,0
20374,feasibility,0,0
20375,of,0,0
20376,reducing,0,0
20377,the,0,0
20378,standard,0,0
20379,period,0,0
20380,of,0,0
20381,postcatheterization,0,0
20382,bed,0,1
20383,rest,0,0
20384,from,0,0
20385,6,0,0
20386,hours,0,0
20387,to,0,0
20388,4,0,0
20389,hours,0,0
20390,",",0,0
20391,thereby,0,0
20392,possibly,0,0
20393,lowering,0,0
20394,the,0,0
20395,cost,1,1
20396,of,1,0
20397,the,1,0
20398,outpatient,1,0
20399,procedure,1,0
20400,.,1,0
20401,Mediastinal,0,1
20402,lymphadenectomy,0,0
20403,in,0,0
20404,non-small,0,0
20405,cell,0,1
20406,lung,0,0
20407,cancer,0,0
20408,:,0,0
20409,effectiveness,0,1
20410,in,0,0
20411,patients,0,0
20412,with,0,0
20413,or,0,0
20414,without,0,0
20415,nodal,0,0
20416,micrometastases,0,1
20417,-,0,0
20418,results,0,0
20419,of,0,0
20420,a,0,0
20421,preliminary,0,0
20422,study,0,0
20423,.,0,0
20424,OBJECTIVES,0,0
20425,So,0,0
20426,far,0,0
20427,it,0,0
20428,has,0,0
20429,not,0,0
20430,clearly,0,0
20431,been,0,0
20432,demonstrated,0,0
20433,that,0,0
20434,systematic,0,0
20435,mediastinal,0,0
20436,lymphadenectomy,0,0
20437,improves,0,1
20438,survival,1,1
20439,in,0,0
20440,patients,0,0
20441,with,0,0
20442,non-small,0,0
20443,cell,0,1
20444,lung,0,0
20445,cancer,0,0
20446,.,0,0
20447,One,0,0
20448,explanation,0,0
20449,might,0,0
20450,be,0,0
20451,that,0,0
20452,in,0,0
20453,some,0,0
20454,patients,0,0
20455,an,0,0
20456,early,0,0
20457,spread,0,0
20458,of,0,0
20459,tumor,0,0
20460,cells,0,1
20461,has,0,0
20462,occurred,0,0
20463,which,0,0
20464,might,0,0
20465,not,0,0
20466,be,0,0
20467,curable,0,0
20468,by,0,0
20469,surgical,0,0
20470,means,0,0
20471,.,0,0
20472,To,0,0
20473,test,0,0
20474,this,0,0
20475,hypothesis,0,0
20476,lymph,0,0
20477,nodes,0,1
20478,of,0,0
20479,patients,0,0
20480,which,0,0
20481,were,0,0
20482,treated,0,0
20483,either,0,0
20484,by,0,0
20485,lymph,0,1
20486,node,0,1
20487,sampling,0,0
20488,or,0,0
20489,systematic,0,0
20490,lymphadenectomy,0,0
20491,were,0,0
20492,screened,0,0
20493,for,0,0
20494,micrometastatic,0,0
20495,spread,0,0
20496,of,0,0
20497,tumor,0,1
20498,cells,0,1
20499,and,0,0
20500,the,0,0
20501,influence,0,0
20502,of,0,0
20503,nodal,0,0
20504,micrometastases,0,1
20505,on,0,0
20506,the,0,0
20507,efficacy,0,1
20508,of,0,0
20509,lymphadenectomy,0,0
20510,was,0,0
20511,analyzed,0,0
20512,.,0,0
20513,METHODS,0,0
20514,Lymph,0,1
20515,nodes,0,1
20516,from,0,0
20517,patients,0,0
20518,(,0,0
20519,n=94,0,0
20520,),0,0
20521,which,0,0
20522,were,0,0
20523,included,0,0
20524,in,0,0
20525,a,0,0
20526,randomized,0,0
20527,trial,0,0
20528,of,0,0
20529,lymph,0,1
20530,node,0,1
20531,sampling,0,0
20532,(,0,0
20533,LS,0,0
20534,",",0,1
20535,n=41,0,0
20536,),0,1
20537,versus,0,0
20538,radical,0,0
20539,systematic,0,0
20540,lymphadenectomy,0,0
20541,(,0,0
20542,LA,0,1
20543,",",0,0
20544,n=53,0,0
20545,),0,0
20546,were,0,0
20547,screened,0,0
20548,by,0,0
20549,immunohistochemistry,0,0
20550,for,0,0
20551,disseminated,0,0
20552,tumor,0,1
20553,cells,0,1
20554,using,0,0
20555,the,0,0
20556,antibody,0,0
20557,Ber-Ep4,0,0
20558,.,0,0
20559,The,0,0
20560,median,1,0
20561,observation,1,0
20562,time,1,1
20563,was,0,0
20564,longer,0,0
20565,than,0,0
20566,5,0,0
20567,years,0,0
20568,and,0,0
20569,follow-up,0,0
20570,data,0,0
20571,were,0,0
20572,available,0,0
20573,from,0,0
20574,all,0,0
20575,94,0,0
20576,patients,0,0
20577,.,0,0
20578,Kaplan-Meier,1,0
20579,curves,1,1
20580,were,0,0
20581,calculated,0,0
20582,and,0,0
20583,tested,0,0
20584,for,0,0
20585,statistical,0,0
20586,significance,0,0
20587,using,0,0
20588,the,0,0
20589,log-rank,0,0
20590,test,0,0
20591,.,0,0
20592,RESULTS,0,0
20593,Standard,0,0
20594,histopathological,0,1
20595,analysis,0,0
20596,revealed,0,0
20597,no,1,0
20598,lymph,1,0
20599,node,1,1
20600,involvement,1,1
20601,(,0,0
20602,pN0,0,1
20603,),0,0
20604,in,0,0
20605,61,0,0
20606,patients,0,0
20607,",",0,0
20608,pN1,0,0
20609,disease,0,0
20610,in,0,0
20611,13,0,0
20612,patients,0,0
20613,and,0,0
20614,pN2,0,1
20615,disease,0,0
20616,in,0,0
20617,20,0,0
20618,patients,0,0
20619,without,0,0
20620,significant,0,0
20621,differences,0,0
20622,between,0,0
20623,LA,0,1
20624,and,0,0
20625,LS,0,0
20626,with,0,0
20627,respect,0,0
20628,to,0,0
20629,T-stage,0,1
20630,",",0,0
20631,N-stage,0,1
20632,or,0,1
20633,age,0,0
20634,and,0,1
20635,sex,0,0
20636,of,0,0
20637,the,0,0
20638,patients,0,0
20639,.,0,0
20640,By,0,0
20641,immunohistochemistry,0,0
20642,a,0,0
20643,minimal,0,1
20644,nodal,1,0
20645,spread,1,0
20646,of,1,0
20647,tumor,1,1
20648,cells,1,1
20649,was,0,0
20650,detected,0,0
20651,in,0,0
20652,21,0,0
20653,out,0,0
20654,of,0,0
20655,94,0,0
20656,patients,0,0
20657,(,0,0
20658,LS,0,0
20659,",",0,1
20660,n=10,0,0
20661,(,0,0
20662,24,0,0
20663,%,0,0
20664,),0,0
20665,;,0,0
20666,LA,0,1
20667,",",0,0
20668,n=11,0,0
20669,(,0,0
20670,21,0,0
20671,%,0,0
20672,),0,0
20673,),0,0
20674,.,0,0
20675,Similar,0,0
20676,to,0,0
20677,the,0,0
20678,entire,0,0
20679,group,0,0
20680,of,0,0
20681,patients,0,0
20682,also,0,0
20683,in,0,0
20684,the,0,0
20685,subset,0,0
20686,of,0,0
20687,patients,0,0
20688,with,0,0
20689,nodal,0,0
20690,micrometastases,0,1
20691,the,0,0
20692,type,0,0
20693,of,0,0
20694,lymphadenectomy,0,0
20695,did,0,0
20696,not,0,0
20697,significantly,0,0
20698,influence,0,0
20699,the,0,0
20700,long-term,1,0
20701,survival,1,1
20702,(,0,0
20703,P=0.27,0,0
20704,and,0,1
20705,P=0.39,0,0
20706,",",0,0
20707,respectively,0,0
20708,),0,0
20709,.,0,0
20710,In,0,0
20711,contrast,0,0
20712,",",0,0
20713,in,0,0
20714,patients,0,0
20715,with,0,0
20716,a,0,0
20717,negative,0,0
20718,immunohistochemical,0,0
20719,analysis,0,0
20720,systematic,0,0
20721,lymphadenectomy,0,0
20722,resulted,0,0
20723,in,0,0
20724,an,0,0
20725,improved,1,0
20726,overall,1,1
20727,survival,1,1
20728,(,0,0
20729,P=0.044,0,0
20730,),0,0
20731,.,0,0
20732,CONCLUSIONS,0,0
20733,Our,0,0
20734,data,0,0
20735,provide,0,0
20736,some,0,0
20737,evidence,0,0
20738,that,0,0
20739,systematic,0,0
20740,lymphadenectomy,0,0
20741,improves,0,1
20742,survival,1,1
20743,in,0,0
20744,patients,0,0
20745,without,0,0
20746,an,0,0
20747,early,0,0
20748,locoregional,1,0
20749,spread,1,0
20750,of,1,0
20751,cancer,1,0
20752,cells,1,1
20753,.,1,0
20754,As,0,0
20755,long,0,0
20756,as,0,0
20757,these,0,0
20758,patients,0,0
20759,can,0,0
20760,not,0,0
20761,be,0,0
20762,identified,0,0
20763,preoperatively,0,0
20764,all,0,0
20765,patients,0,0
20766,should,0,0
20767,undergo,0,0
20768,a,0,0
20769,systematic,0,0
20770,mediastinal,0,1
20771,lymphadenectomy,0,0
20772,.,0,0
20773,A,0,0
20774,role,0,0
20775,for,0,0
20776,error,0,1
20777,training,0,0
20778,in,0,0
20779,surgical,0,0
20780,technical,0,1
20781,skill,0,1
20782,instruction,0,0
20783,and,0,0
20784,evaluation,0,0
20785,.,0,0
20786,BACKGROUND,0,0
20787,During,0,0
20788,the,0,0
20789,evaluation,0,0
20790,of,0,0
20791,many,0,0
20792,instances,0,0
20793,of,0,0
20794,the,0,0
20795,same,0,0
20796,basic,0,0
20797,surgical,0,0
20798,skill,0,1
20799,",",0,0
20800,we,0,0
20801,observed,0,0
20802,that,0,0
20803,there,0,0
20804,were,0,0
20805,several,0,0
20806,errors,0,1
20807,that,0,0
20808,occurred,0,0
20809,frequently,0,0
20810,.,0,0
20811,Two,0,0
20812,studies,0,0
20813,were,0,0
20814,undertaken,0,0
20815,to,0,0
20816,examine,0,0
20817,the,0,0
20818,use,0,0
20819,of,0,0
20820,these,0,0
20821,errors,0,0
20822,for,0,0
20823,improving,0,0
20824,the,0,0
20825,instruction,0,0
20826,and,0,0
20827,evaluation,0,0
20828,of,0,0
20829,the,0,0
20830,skill,0,1
20831,.,0,0
20832,MATERIALS,0,0
20833,AND,0,0
20834,METHODS,0,0
20835,For,0,0
20836,both,0,0
20837,studies,0,0
20838,",",0,0
20839,two,0,0
20840,types,0,0
20841,of,0,0
20842,rater,0,0
20843,training,0,0
20844,videotapes,0,0
20845,were,0,0
20846,developed,0,0
20847,.,0,0
20848,One,0,0
20849,involved,0,0
20850,the,0,0
20851,use,0,0
20852,of,0,0
20853,examples,0,0
20854,of,0,0
20855,common,0,0
20856,errors,0,1
20857,(,0,0
20858,error,0,1
20859,),0,0
20860,and,0,0
20861,the,0,0
20862,other,0,0
20863,demonstrated,0,0
20864,the,0,0
20865,skill,0,1
20866,being,0,0
20867,performed,0,0
20868,correctly,0,0
20869,(,0,0
20870,correct,0,0
20871,),0,0
20872,.,0,0
20873,A,0,0
20874,testing,0,0
20875,videotape,0,0
20876,was,0,0
20877,created,0,0
20878,consisting,0,0
20879,of,0,0
20880,24,0,0
20881,performances,0,0
20882,of,0,0
20883,the,0,0
20884,skill,0,1
20885,that,0,0
20886,ranged,0,0
20887,in,0,0
20888,quality,0,1
20889,of,0,0
20890,the,0,0
20891,performance,0,0
20892,.,0,0
20893,The,0,0
20894,first,0,0
20895,study,0,0
20896,was,0,0
20897,designed,0,0
20898,to,0,0
20899,assess,0,0
20900,the,0,0
20901,impact,0,0
20902,of,0,0
20903,error,0,1
20904,instruction,0,0
20905,on,0,0
20906,skill,1,1
20907,acquisition,1,0
20908,.,1,0
20909,In,0,0
20910,this,0,0
20911,study,0,0
20912,",",0,0
20913,a,0,0
20914,group,0,0
20915,of,0,0
20916,30,0,0
20917,senior,0,0
20918,medical,0,0
20919,students,0,0
20920,were,0,0
20921,randomly,0,0
20922,assigned,0,0
20923,to,0,0
20924,one,0,0
20925,of,0,0
20926,four,0,0
20927,different,0,0
20928,training,0,0
20929,groups,0,0
20930,:,0,0
20931,none,0,0
20932,",",0,0
20933,error,0,1
20934,only,0,0
20935,",",0,0
20936,correct,0,0
20937,only,0,0
20938,",",0,0
20939,and,0,0
20940,error+correct,0,0
20941,.,0,1
20942,Subjects,0,0
20943,were,0,0
20944,videotaped,0,0
20945,performing,0,0
20946,the,0,0
20947,skill,0,1
20948,before,0,0
20949,and,0,0
20950,after,0,0
20951,the,0,0
20952,training,0,0
20953,and,0,0
20954,three,0,0
20955,experts,0,0
20956,evaluated,0,0
20957,these,0,0
20958,performances,1,1
20959,independently,0,0
20960,using,0,0
20961,a,0,0
20962,7-point,0,1
20963,rating,0,1
20964,scale,0,1
20965,.,0,0
20966,The,0,0
20967,second,0,0
20968,study,0,0
20969,was,0,0
20970,designed,0,0
20971,to,0,0
20972,assess,0,0
20973,the,0,0
20974,impact,0,0
20975,of,0,0
20976,error,0,1
20977,training,0,0
20978,on,0,0
20979,skill,0,1
20980,evaluation,0,0
20981,and,0,0
20982,was,0,0
20983,done,0,0
20984,using,0,0
20985,both,0,0
20986,novice,0,0
20987,and,0,0
20988,expert,0,0
20989,raters,0,0
20990,.,0,0
20991,The,0,0
20992,same,0,0
20993,group,0,0
20994,of,0,0
20995,30,0,0
20996,senior,0,0
20997,medical,0,0
20998,students,0,0
20999,used,0,0
21000,in,0,0
21001,the,0,0
21002,first,0,0
21003,study,0,0
21004,was,0,0
21005,used,0,0
21006,as,0,0
21007,novice,0,0
21008,raters,0,0
21009,.,0,0
21010,Following,0,0
21011,training,0,0
21012,in,0,0
21013,one,0,0
21014,of,0,0
21015,the,0,0
21016,four,0,0
21017,training,0,0
21018,groups,0,0
21019,",",0,0
21020,each,0,0
21021,subject,0,0
21022,rated,0,0
21023,the,0,0
21024,24,0,0
21025,performances,0,0
21026,on,0,0
21027,the,0,0
21028,testing,0,0
21029,videotape,0,0
21030,and,0,1
21031,interrater,0,1
21032,reliability,0,1
21033,was,0,0
21034,assessed,0,0
21035,for,0,0
21036,each,0,0
21037,group,0,0
21038,.,0,0
21039,Surgical,0,1
21040,faculty,0,0
21041,served,0,0
21042,as,0,0
21043,expert,0,0
21044,raters,0,0
21045,in,0,0
21046,this,0,0
21047,study,0,0
21048,and,0,0
21049,were,0,0
21050,randomly,0,0
21051,assigned,0,0
21052,to,0,0
21053,receive,0,0
21054,either,0,0
21055,error,0,1
21056,training,0,0
21057,or,0,0
21058,no,0,0
21059,training,0,0
21060,.,0,0
21061,Each,0,0
21062,subject,0,0
21063,viewed,0,0
21064,the,0,0
21065,testing,0,0
21066,videotape,0,0
21067,",",0,0
21068,rating,0,1
21069,the,0,0
21070,performances,0,1
21071,and,0,0
21072,giving,0,0
21073,feedback,0,0
21074,commentary,0,0
21075,.,0,0
21076,Interrater,1,1
21077,reliability,1,1
21078,was,0,0
21079,calculated,0,0
21080,for,0,0
21081,the,0,0
21082,two,0,0
21083,groups,0,0
21084,and,0,0
21085,the,0,0
21086,precision,0,0
21087,of,0,0
21088,the,0,0
21089,feedback,0,0
21090,was,0,0
21091,assessed,0,0
21092,.,0,0
21093,RESULTS,0,0
21094,Significant,0,0
21095,improvement,0,1
21096,in,0,0
21097,posttest,1,0
21098,performance,1,1
21099,scores,1,1
21100,was,0,0
21101,seen,0,0
21102,only,0,0
21103,in,0,0
21104,the,0,0
21105,error+correct,0,0
21106,training,0,0
21107,group,0,0
21108,.,0,0
21109,Interrater,1,1
21110,reliability,1,1
21111,was,0,0
21112,somewhat,0,0
21113,lower,0,0
21114,for,0,0
21115,the,0,0
21116,correct,0,0
21117,only,0,0
21118,and,0,0
21119,error,0,0
21120,only,0,0
21121,training,0,0
21122,groups,0,0
21123,in,0,0
21124,both,0,0
21125,the,0,0
21126,student,0,0
21127,and,0,0
21128,faculty,0,0
21129,studies,0,0
21130,.,0,0
21131,Faculty,0,1
21132,raters,0,0
21133,receiving,0,0
21134,error,0,1
21135,training,0,0
21136,had,0,0
21137,a,0,0
21138,higher,0,0
21139,proportion,0,0
21140,of,0,1
21141,specific,0,0
21142,comments,0,0
21143,than,0,0
21144,the,0,0
21145,group,0,0
21146,that,0,0
21147,received,0,0
21148,no,0,0
21149,training,0,0
21150,although,0,0
21151,this,0,0
21152,difference,0,0
21153,was,0,0
21154,not,0,0
21155,statistically,0,0
21156,significant,0,0
21157,.,0,0
21158,CONCLUSIONS,0,0
21159,Instruction,0,0
21160,about,0,0
21161,common,0,0
21162,errors,0,0
21163,",",0,0
21164,when,0,0
21165,combined,0,0
21166,with,0,0
21167,instruction,0,0
21168,about,0,0
21169,the,0,0
21170,correct,0,0
21171,performance,0,1
21172,enhanced,0,0
21173,the,0,0
21174,acquisition,0,0
21175,of,0,0
21176,this,0,0
21177,surgical,0,0
21178,skill,0,1
21179,.,0,0
21180,This,0,0
21181,suggests,0,0
21182,a,0,0
21183,role,0,0
21184,for,0,0
21185,the,0,0
21186,use,0,0
21187,of,0,0
21188,errors,0,0
21189,in,0,0
21190,surgical,0,0
21191,technical,0,1
21192,skill,0,1
21193,instruction,0,0
21194,.,0,0
21195,Our,0,0
21196,study,0,0
21197,provides,0,0
21198,no,0,0
21199,support,0,0
21200,for,0,0
21201,a,0,0
21202,role,0,0
21203,for,0,0
21204,error,0,1
21205,training,0,0
21206,in,0,0
21207,improving,0,1
21208,skill,0,1
21209,evaluation,0,0
21210,.,0,0
21211,Diet,0,0
21212,and,0,1
21213,tobacco,0,0
21214,use,0,0
21215,:,0,0
21216,analysis,0,0
21217,of,0,0
21218,data,0,0
21219,from,0,0
21220,the,0,0
21221,diabetic,0,0
21222,control,0,0
21223,and,0,1
21224,complications,0,1
21225,trial,0,0
21226,",",0,0
21227,a,0,0
21228,randomized,0,0
21229,study,0,0
21230,.,0,0
21231,CONTEXT,0,0
21232,The,0,0
21233,Diabetic,0,0
21234,Control,0,0
21235,and,0,0
21236,Complications,0,1
21237,Trial,0,1
21238,(,0,0
21239,DCCT,0,1
21240,),0,0
21241,researchers,0,0
21242,kept,0,0
21243,careful,0,0
21244,records,0,0
21245,of,0,0
21246,the,0,0
21247,food,0,0
21248,consumption,0,1
21249,and,0,1
21250,tobacco,0,0
21251,using,0,0
21252,habits,0,1
21253,of,0,0
21254,type,0,0
21255,1,0,0
21256,diabetic,0,0
21257,subjects,0,0
21258,.,0,0
21259,However,0,0
21260,",",0,0
21261,they,0,0
21262,did,0,0
21263,not,0,0
21264,report,0,0
21265,the,0,0
21266,relationship,0,0
21267,of,0,0
21268,tobacco,1,0
21269,using,1,0
21270,habits,1,1
21271,with,0,0
21272,dietary,1,0
21273,intake,1,1
21274,.,1,0
21275,OBJECTIVE,0,0
21276,Analyze,0,0
21277,the,0,0
21278,relationship,1,0
21279,between,1,0
21280,tobacco,1,0
21281,smoking,1,1
21282,and,1,1
21283,intake,1,1
21284,of,1,1
21285,macro,1,0
21286,and,1,0
21287,micronutrients,1,1
21288,.,1,0
21289,DESIGN,0,0
21290,Randomized,0,0
21291,controlled,0,0
21292,trial,0,0
21293,.,0,0
21294,SETTING,0,0
21295,Referral,0,0
21296,clinics,0,0
21297,in,0,0
21298,27,0,0
21299,academic,0,0
21300,centers,0,0
21301,.,0,0
21302,PATIENTS,0,0
21303,Type,0,0
21304,1,0,0
21305,diabetics,0,0
21306,.,0,0
21307,INTERVENTION,0,0
21308,Using,0,0
21309,the,0,0
21310,data,0,0
21311,sets,0,0
21312,of,0,0
21313,the,0,0
21314,DCCT,0,0
21315,",",0,0
21316,this,0,0
21317,study,0,0
21318,analyzed,0,0
21319,the,0,0
21320,strengths,0,0
21321,of,0,0
21322,the,0,0
21323,associations,1,0
21324,between,1,0
21325,smoking,1,0
21326,and,1,1
21327,macronutrient,1,1
21328,consumption,1,1
21329,",",1,0
21330,hemoglobin,1,1
21331,A1c,1,1
21332,(,1,0
21333,HbA1c,1,0
21334,),1,0
21335,",",1,0
21336,body,1,1
21337,mass,1,1
21338,index,1,1
21339,(,1,0
21340,BMI,1,1
21341,),1,1
21342,",",1,0
21343,and,1,0
21344,serum,1,1
21345,lipid,1,1
21346,levels,1,1
21347,at,0,0
21348,the,0,0
21349,study,0,0
21350,baseline,0,0
21351,",",0,0
21352,2,0,0
21353,years,0,0
21354,",",0,0
21355,and,0,0
21356,4,0,0
21357,years,0,0
21358,.,0,0
21359,MAIN,0,0
21360,OUTCOME,0,0
21361,MEASURES,0,0
21362,Statistically,1,0
21363,significant,1,0
21364,correlations,1,0
21365,between,1,0
21366,smoking,1,0
21367,and,1,0
21368,nutrient,1,1
21369,intake,1,1
21370,",",1,0
21371,HbA1c,1,1
21372,",",1,0
21373,and,1,0
21374,serum,1,1
21375,lipid,1,1
21376,levels,1,1
21377,.,1,0
21378,RESULTS,0,0
21379,Cigarette,1,0
21380,",",1,0
21381,cigar,1,1
21382,",",1,1
21383,or,1,1
21384,pipe,1,1
21385,use,1,0
21386,at,0,0
21387,each,0,0
21388,time,0,1
21389,interval,0,0
21390,correlated,0,0
21391,with,0,0
21392,significantly,0,0
21393,increased,0,0
21394,caloric,1,0
21395,intake,1,1
21396,in,0,0
21397,males,0,0
21398,but,0,0
21399,not,0,0
21400,in,0,0
21401,females,0,0
21402,.,0,0
21403,In,0,0
21404,both,0,0
21405,males,0,0
21406,and,0,0
21407,females,0,0
21408,",",0,1
21409,tobacco,1,0
21410,users,1,0
21411,consumed,1,0
21412,more,1,0
21413,fat,1,1
21414,",",1,0
21415,cholesterol,1,1
21416,",",1,1
21417,and,1,1
21418,alcohol,1,0
21419,.,1,1
21420,Female,0,0
21421,smokers,0,0
21422,had,0,0
21423,higher,0,0
21424,serum,1,1
21425,low-density,1,1
21426,lipoprotein,1,1
21427,(,1,0
21428,LDL,1,1
21429,),1,1
21430,/high-density,1,0
21431,lipoprotein,1,1
21432,(,1,0
21433,HDL,1,1
21434,),1,0
21435,ratios,1,1
21436,and,1,0
21437,triglycerides,1,1
21438,.,1,0
21439,Serum,1,1
21440,cholesterols,1,1
21441,",",1,0
21442,LDL/HDL,1,1
21443,ratios,1,1
21444,",",1,0
21445,LDL,1,1
21446,cholesterols,1,1
21447,",",1,0
21448,and,1,1
21449,triglyceride,1,1
21450,determinations,1,0
21451,in,0,0
21452,male,0,0
21453,tobacco,0,0
21454,users,0,0
21455,significantly,0,0
21456,exceeded,0,0
21457,those,0,0
21458,in,0,0
21459,nonsmoking,0,0
21460,males,0,0
21461,.,0,0
21462,HDL,1,1
21463,cholesterols,1,1
21464,were,0,0
21465,lower,0,0
21466,in,0,0
21467,both,0,0
21468,female,0,0
21469,and,0,0
21470,male,0,0
21471,tobacco,0,0
21472,users,0,0
21473,.,0,0
21474,Nutrient,1,0
21475,intake,1,1
21476,of,0,0
21477,former,0,0
21478,tobacco,0,0
21479,users,0,0
21480,resembled,0,0
21481,that,0,0
21482,of,0,0
21483,nonusers,0,0
21484,rather,0,0
21485,than,0,0
21486,current,0,0
21487,users,0,0
21488,.,0,0
21489,CONCLUSIONS,0,0
21490,A,0,0
21491,significant,0,0
21492,association,0,0
21493,exists,0,0
21494,between,0,0
21495,smoking,0,0
21496,and,0,0
21497,a,0,0
21498,diet,1,0
21499,with,1,0
21500,higher,1,0
21501,risks,1,1
21502,of,1,1
21503,atherosclerosis,1,1
21504,",",1,0
21505,cancer,1,1
21506,",",1,1
21507,and,1,1
21508,other,1,0
21509,degenerative,1,0
21510,diseases,1,0
21511,.,1,0
21512,The,0,0
21513,strong,0,0
21514,association,0,0
21515,of,0,0
21516,tobacco,0,0
21517,with,0,0
21518,heart,0,1
21519,disease,0,1
21520,",",0,1
21521,stroke,0,1
21522,",",0,1
21523,vasculopathies,0,1
21524,",",0,1
21525,and,0,1
21526,various,0,0
21527,malignancies,0,0
21528,may,0,0
21529,be,0,0
21530,in,0,0
21531,part,0,0
21532,due,0,0
21533,to,0,0
21534,its,0,0
21535,association,0,0
21536,with,0,0
21537,a,0,0
21538,higher,0,0
21539,fat,1,1
21540,diet,0,0
21541,.,0,0
21542,The,0,0
21543,higher,0,0
21544,fat,0,1
21545,diet,0,0
21546,of,0,0
21547,tobacco,0,0
21548,users,0,0
21549,probably,0,0
21550,accounts,0,0
21551,in,0,0
21552,part,0,0
21553,for,0,0
21554,their,0,0
21555,higher,0,0
21556,risk,0,1
21557,of,0,0
21558,developing,0,0
21559,type,0,0
21560,2,0,0
21561,diabetes,0,0
21562,and,0,0
21563,hyperlipidemia,0,0
21564,.,0,1
21565,Tobacco,0,0
21566,users,0,0
21567,should,0,0
21568,be,0,0
21569,informed,0,0
21570,about,0,0
21571,the,0,0
21572,diet,1,0
21573,and,1,0
21574,tobacco,1,0
21575,use,1,1
21576,association,0,0
21577,.,0,0
21578,Rizatriptan,0,0
21579,5,0,0
21580,mg,0,0
21581,for,0,0
21582,the,0,0
21583,acute,0,0
21584,treatment,0,0
21585,of,0,0
21586,migraine,1,0
21587,in,0,0
21588,adolescents,0,0
21589,:,0,0
21590,a,0,0
21591,randomized,0,0
21592,",",0,0
21593,double-blind,0,0
21594,",",0,0
21595,placebo-controlled,0,0
21596,study,0,0
21597,.,0,0
21598,OBJECTIVE,0,0
21599,To,0,0
21600,investigate,0,0
21601,the,0,0
21602,tolerability,1,1
21603,and,1,0
21604,efficacy,1,1
21605,of,0,0
21606,rizatriptan,0,0
21607,5,0,0
21608,mg,0,0
21609,in,0,0
21610,adolescent,0,0
21611,migraineurs,0,0
21612,.,0,0
21613,METHODS,0,0
21614,Randomized,0,0
21615,",",0,0
21616,double-blind,0,0
21617,",",0,1
21618,placebo-controlled,0,0
21619,study,0,0
21620,.,0,0
21621,Patients,0,0
21622,aged,0,0
21623,12,0,0
21624,to,0,0
21625,17,0,0
21626,years,0,0
21627,received,0,0
21628,rizatriptan,0,0
21629,5,0,0
21630,mg,0,0
21631,(,0,0
21632,n,0,0
21633,=,0,0
21634,149,0,0
21635,),0,0
21636,or,0,0
21637,placebo,0,0
21638,(,0,0
21639,n,0,0
21640,=,0,0
21641,147,0,0
21642,),0,0
21643,for,0,0
21644,a,0,0
21645,moderate,0,0
21646,or,0,0
21647,severe,0,1
21648,headache,0,1
21649,and,0,0
21650,for,0,0
21651,up,0,0
21652,to,0,0
21653,two,0,0
21654,recurrences,0,0
21655,.,0,0
21656,Headache,1,1
21657,severity,1,1
21658,",",1,1
21659,presence,1,1
21660,or,1,1
21661,absence,1,0
21662,of,1,0
21663,associated,1,0
21664,symptoms,1,1
21665,",",1,0
21666,and,1,1
21667,functional,1,1
21668,disability,1,1
21669,were,1,0
21670,assessed,1,0
21671,over,1,0
21672,a,1,0
21673,4-hour,1,0
21674,postdose,1,0
21675,period,1,0
21676,",",0,0
21677,and,0,0
21678,any,0,1
21679,adverse,1,1
21680,events,1,1
21681,were,0,0
21682,recorded,0,0
21683,.,0,0
21684,The,0,0
21685,primary,0,0
21686,efficacy,0,1
21687,measure,0,0
21688,was,0,0
21689,pain-free,1,0
21690,status,1,1
21691,at,1,0
21692,2,1,0
21693,hours,1,0
21694,postdose,1,0
21695,.,1,0
21696,RESULTS,0,0
21697,Rizatriptan,0,0
21698,5,0,0
21699,mg,0,0
21700,was,0,0
21701,well,0,0
21702,tolerated,0,1
21703,.,0,0
21704,The,0,0
21705,most,0,0
21706,commonly,0,0
21707,reported,0,0
21708,adverse,1,1
21709,events,1,1
21710,(,0,0
21711,all,0,0
21712,with,0,0
21713,incidence,0,1
21714,of,0,0
21715,5,0,0
21716,%,0,0
21717,or,0,0
21718,less,0,0
21719,),0,1
21720,among,0,0
21721,patients,0,0
21722,receiving,0,0
21723,rizatriptan,0,0
21724,were,0,0
21725,dry,1,0
21726,mouth,1,1
21727,",",1,0
21728,dizziness,1,1
21729,",",1,1
21730,asthenia/fatigue,1,1
21731,",",1,1
21732,nausea,1,1
21733,",",1,1
21734,and,1,1
21735,somnolence,1,1
21736,.,1,0
21737,The,0,0
21738,percentage,0,1
21739,of,0,0
21740,patients,0,0
21741,pain-free,1,0
21742,at,0,0
21743,2,0,0
21744,hours,0,0
21745,was,0,0
21746,32,0,0
21747,%,0,0
21748,for,0,0
21749,rizatriptan,0,0
21750,5,0,0
21751,mg,0,0
21752,versus,0,0
21753,28,0,0
21754,%,0,0
21755,for,0,0
21756,placebo,0,0
21757,(,0,0
21758,P=.474,0,0
21759,),0,0
21760,.,0,0
21761,The,0,0
21762,percentage,1,1
21763,of,1,0
21764,patients,1,0
21765,with,1,0
21766,pain,1,1
21767,relief,1,1
21768,(,0,0
21769,reduction,0,1
21770,of,0,0
21771,predose,1,0
21772,pain,1,1
21773,intensity,1,0
21774,to,0,0
21775,mild,0,1
21776,or,0,0
21777,none,0,0
21778,),0,0
21779,at,0,0
21780,2,0,0
21781,hours,0,0
21782,was,0,0
21783,66,0,0
21784,%,0,0
21785,for,0,0
21786,rizatriptan,0,0
21787,versus,0,0
21788,56,0,0
21789,%,0,0
21790,for,0,0
21791,placebo,0,0
21792,(,0,0
21793,P=.079,0,0
21794,),0,0
21795,.,0,0
21796,Placebo,1,0
21797,response,1,1
21798,rates,1,1
21799,were,0,0
21800,higher,0,0
21801,than,0,0
21802,those,0,0
21803,typically,0,0
21804,observed,0,0
21805,in,0,0
21806,previous,0,0
21807,studies,0,0
21808,of,0,0
21809,rizatriptan,0,0
21810,in,0,0
21811,adults,0,0
21812,.,0,0
21813,Compared,0,0
21814,with,0,0
21815,placebo,0,0
21816,",",0,0
21817,rizatriptan,0,0
21818,significantly,0,0
21819,improved,0,0
21820,functional,1,0
21821,disability,1,0
21822,at,0,0
21823,1.5,0,0
21824,and,0,0
21825,2,0,0
21826,hours,0,0
21827,",",0,0
21828,and,0,1
21829,nausea,1,1
21830,at,0,0
21831,1,0,0
21832,and,0,0
21833,1.5,0,0
21834,hours,0,0
21835,.,0,0
21836,Post,0,0
21837,hoc,0,0
21838,analysis,0,0
21839,showed,0,0
21840,a,0,0
21841,significant,0,0
21842,benefit,0,0
21843,of,0,0
21844,rizatriptan,0,0
21845,versus,0,0
21846,placebo,0,0
21847,in,0,0
21848,the,0,0
21849,percentage,0,1
21850,of,0,0
21851,patients,0,0
21852,who,0,0
21853,had,0,0
21854,pain,1,1
21855,relief,1,1
21856,when,0,0
21857,their,0,0
21858,migraine,0,0
21859,attacks,0,1
21860,were,0,0
21861,treated,0,0
21862,on,0,0
21863,weekends,0,0
21864,(,0,0
21865,65,0,0
21866,%,0,0
21867,versus,0,0
21868,36,0,0
21869,%,0,0
21870,",",0,0
21871,P=.046,0,0
21872,),0,0
21873,compared,0,0
21874,with,0,0
21875,weekdays,0,0
21876,(,0,0
21877,66,0,0
21878,%,0,0
21879,versus,0,0
21880,61,0,0
21881,%,0,0
21882,",",0,0
21883,P=.365,0,0
21884,),0,1
21885,",",0,0
21886,and,0,0
21887,the,0,0
21888,weekend,0,0
21889,placebo,0,0
21890,response,1,1
21891,rate,1,1
21892,was,0,0
21893,similar,0,0
21894,to,0,0
21895,that,0,0
21896,seen,0,0
21897,in,0,0
21898,adults,0,0
21899,.,0,0
21900,CONCLUSIONS,0,0
21901,Rizatriptan,0,0
21902,5,0,0
21903,mg,0,0
21904,was,0,0
21905,well,0,0
21906,tolerated,1,1
21907,and,1,0
21908,effective,1,0
21909,on,0,0
21910,some,0,0
21911,measures,0,0
21912,when,0,0
21913,used,0,0
21914,in,0,0
21915,adolescents,0,0
21916,for,0,0
21917,the,0,0
21918,treatment,0,0
21919,of,0,0
21920,a,0,0
21921,migraine,0,0
21922,attack,0,0
21923,.,0,0
21924,N-butyl,0,0
21925,cyanoacrylate,0,0
21926,embolization,0,1
21927,of,0,0
21928,cerebral,0,1
21929,arteriovenous,0,1
21930,malformations,0,0
21931,:,0,0
21932,results,0,0
21933,of,0,0
21934,a,0,0
21935,prospective,0,0
21936,",",0,0
21937,randomized,0,0
21938,",",0,0
21939,multi-center,0,0
21940,trial,0,0
21941,.,0,0
21942,BACKGROUND,0,0
21943,AND,0,0
21944,PURPOSE,0,0
21945,Liquid,0,0
21946,N-butyl,0,0
21947,cyanoacrylate,0,0
21948,(,0,0
21949,n-BCA,0,0
21950,),0,0
21951,use,0,0
21952,for,0,0
21953,the,0,0
21954,treatment,0,0
21955,of,0,0
21956,arteriovenous,0,1
21957,malformations,0,0
21958,(,0,0
21959,AVM,0,1
21960,),0,0
21961,in,0,0
21962,the,0,0
21963,brain,0,0
21964,has,0,0
21965,become,0,0
21966,part,0,0
21967,of,0,0
21968,medical,0,0
21969,practice,0,0
21970,.,0,0
21971,However,0,0
21972,",",0,0
21973,no,0,0
21974,study,0,0
21975,has,0,0
21976,led,0,0
21977,to,0,0
21978,the,0,0
21979,Food,0,1
21980,and,0,0
21981,Drug,0,0
21982,Administration,0,1
21983,'s,0,0
21984,approval,0,0
21985,of,0,0
21986,n-BCA,0,0
21987,for,0,0
21988,intravascular,0,0
21989,use,0,0
21990,.,0,0
21991,The,0,0
21992,purpose,0,0
21993,of,0,0
21994,this,0,0
21995,study,0,0
21996,was,0,0
21997,to,0,0
21998,verify,0,0
21999,the,0,0
22000,effectiveness,0,1
22001,and,0,0
22002,safety,0,1
22003,of,0,0
22004,an,0,0
22005,n-BCA/Tantalum,0,0
22006,Powder/Ethiodized,0,0
22007,Oil,0,0
22008,mixture,0,0
22009,",",0,0
22010,compared,0,0
22011,with,0,0
22012,conventional,0,0
22013,treatment,0,0
22014,(,0,0
22015,Trufill,0,0
22016,polyvinyl,0,0
22017,alcohol,0,0
22018,[,0,0
22019,PVA,0,1
22020,],0,0
22021,),0,0
22022,for,0,0
22023,preoperative,0,0
22024,embolization,0,1
22025,of,0,0
22026,cerebral,0,0
22027,AVM,0,1
22028,.,0,0
22029,METHODS,0,0
22030,Between,0,0
22031,October,0,0
22032,15,0,0
22033,",",0,0
22034,1996,0,0
22035,",",0,0
22036,and,0,0
22037,March,0,0
22038,24,0,0
22039,",",0,0
22040,1999,0,0
22041,",",0,0
22042,104,0,0
22043,patients,0,0
22044,at,0,0
22045,13,0,0
22046,centers,0,0
22047,were,0,0
22048,prospectively,0,0
22049,randomized,0,0
22050,to,0,0
22051,undergo,0,0
22052,embolization,0,1
22053,using,0,0
22054,an,0,0
22055,n-BCA/Tantalum,0,0
22056,Powder/Ethiodol,0,0
22057,mixture,0,0
22058,or,0,0
22059,Trufill,0,0
22060,PVA,0,0
22061,.,0,0
22062,The,0,0
22063,pre-embolization,0,0
22064,therapy,0,0
22065,goals,0,1
22066,were,0,0
22067,determined,0,0
22068,in,0,0
22069,terms,0,0
22070,of,0,0
22071,the,0,0
22072,number,0,1
22073,of,0,0
22074,pedicles,0,0
22075,to,0,0
22076,be,0,0
22077,embolized,0,0
22078,and,0,0
22079,the,0,0
22080,percent,0,0
22081,of,0,0
22082,nidus,0,0
22083,reduction,0,0
22084,expected,0,0
22085,.,0,0
22086,Embolization,0,0
22087,results,0,0
22088,were,0,0
22089,evaluated,0,0
22090,by,0,0
22091,a,0,0
22092,central,0,0
22093,laboratory,0,0
22094,.,0,0
22095,Subsequent,0,0
22096,surgical,0,0
22097,resection,0,0
22098,data,0,0
22099,were,0,0
22100,recorded,0,0
22101,.,0,0
22102,Safety,0,1
22103,evaluation,0,0
22104,data,0,0
22105,included,0,0
22106,recording,0,0
22107,device,1,0
22108,complications,1,1
22109,",",1,0
22110,procedure,1,0
22111,complications,1,1
22112,",",1,0
22113,and,1,1
22114,intracranial,1,1
22115,events/overall,1,1
22116,neurologic,1,1
22117,outcomes,1,1
22118,",",0,0
22119,which,0,0
22120,could,0,0
22121,be,0,0
22122,either,0,0
22123,device-related,0,1
22124,",",0,0
22125,procedure-related,0,1
22126,",",0,0
22127,or,0,0
22128,both,0,0
22129,.,0,0
22130,RESULTS,0,0
22131,The,0,0
22132,reduction,0,0
22133,of,0,0
22134,AVM,1,1
22135,dimensions,1,1
22136,(,0,0
22137,79.4,0,0
22138,%,0,0
22139,in,0,0
22140,the,0,0
22141,n-BCA,0,0
22142,group,0,0
22143,and,0,0
22144,86.9,0,0
22145,%,0,0
22146,in,0,0
22147,the,0,0
22148,PVA,0,0
22149,group,0,0
22150,),0,0
22151,and,0,0
22152,the,0,0
22153,mean,1,1
22154,number,1,1
22155,of,1,0
22156,vessels,1,1
22157,embolized,1,0
22158,(,0,0
22159,2.2,0,0
22160,in,0,0
22161,the,0,0
22162,n-BCA,0,0
22163,group,0,0
22164,and,0,0
22165,2.1,0,0
22166,in,0,0
22167,the,0,0
22168,PVA,0,0
22169,group,0,0
22170,),0,0
22171,was,0,0
22172,similar,0,0
22173,in,0,0
22174,the,0,0
22175,two,0,0
22176,groups,0,0
22177,.,0,0
22178,Coils,0,0
22179,were,0,0
22180,used,0,0
22181,more,0,0
22182,commonly,0,0
22183,with,0,0
22184,PVA,0,1
22185,embolization,0,1
22186,(,0,0
22187,P,0,0
22188,<,0,0
22189,.0001,0,0
22190,),0,0
22191,.,0,0
22192,No,0,0
22193,differences,0,0
22194,were,0,0
22195,detected,0,0
22196,in,0,0
22197,surgical,1,0
22198,resection,1,0
22199,time,1,1
22200,",",1,0
22201,number,1,1
22202,of,1,0
22203,patients,1,0
22204,who,1,0
22205,required,1,0
22206,transfusion,1,1
22207,",",1,1
22208,volume,1,1
22209,and,1,1
22210,number,1,1
22211,of,1,1
22212,transfusion,1,1
22213,units,1,0
22214,",",1,0
22215,or,1,1
22216,type,1,1
22217,and,1,1
22218,volume,1,1
22219,of,1,1
22220,fluid,1,1
22221,replacement,1,0
22222,.,1,0
22223,Glasgow,1,0
22224,Outcome,1,1
22225,Scale,1,1
22226,scores,1,1
22227,were,0,0
22228,not,0,0
22229,significantly,0,0
22230,different,0,0
22231,between,0,0
22232,the,0,0
22233,two,0,0
22234,groups,0,0
22235,before,0,0
22236,treatment,0,0
22237,",",0,0
22238,after,0,0
22239,embolization,0,1
22240,",",0,0
22241,or,0,0
22242,after,0,0
22243,resection,0,0
22244,.,0,0
22245,Two,0,0
22246,of,0,0
22247,42,0,0
22248,patients,0,0
22249,who,0,0
22250,underwent,0,0
22251,resection,0,0
22252,and,0,0
22253,had,0,0
22254,been,0,0
22255,treated,0,0
22256,with,0,0
22257,n-BCA,0,0
22258,experienced,0,0
22259,post-resection,1,0
22260,hematoma,1,1
22261,",",0,0
22262,compared,0,0
22263,with,0,0
22264,eight,0,0
22265,of,0,0
22266,45,0,0
22267,patients,0,0
22268,who,0,0
22269,underwent,0,0
22270,resection,0,0
22271,and,0,0
22272,had,0,0
22273,been,0,0
22274,treated,0,0
22275,with,0,0
22276,PVA,0,0
22277,(,0,0
22278,P,0,0
22279,<,0,0
22280,.05,0,0
22281,),0,0
22282,.,0,0
22283,CONCLUSION,0,0
22284,This,0,0
22285,prospective,0,0
22286,",",0,0
22287,randomized,0,0
22288,trial,0,0
22289,showed,0,0
22290,that,0,0
22291,n-BCA,0,0
22292,is,0,0
22293,equivalent,0,0
22294,to,0,0
22295,PVA,0,0
22296,as,0,0
22297,a,0,0
22298,preoperative,0,0
22299,embolic,0,1
22300,agent,0,0
22301,for,0,0
22302,treatment,0,0
22303,of,0,0
22304,cerebral,0,1
22305,AVM,0,1
22306,as,0,0
22307,determined,0,0
22308,by,0,0
22309,percent,0,0
22310,of,0,0
22311,nidus,0,0
22312,reduction,0,1
22313,and,0,1
22314,number,0,1
22315,of,0,0
22316,feeding,0,0
22317,pedicles,0,0
22318,embolized,0,0
22319,.,0,0
22320,The,0,0
22321,influence,0,0
22322,of,0,0
22323,placebo,0,0
22324,awareness,0,1
22325,on,0,0
22326,stimulant,0,0
22327,drug,0,0
22328,response,0,1
22329,in,0,0
22330,a,0,0
22331,double-blind,0,0
22332,trial,0,0
22333,.,0,0
22334,RATIONALE,0,0
22335,Critics,0,0
22336,have,0,0
22337,called,0,0
22338,into,0,0
22339,question,0,0
22340,findings,0,0
22341,from,0,0
22342,double-blind,0,0
22343,placebo-controlled,0,0
22344,studies,0,0
22345,because,0,0
22346,subjects,0,0
22347,are,0,0
22348,given,0,0
22349,drug,0,0
22350,administration,0,0
22351,instructions,0,0
22352,informing,0,0
22353,them,0,0
22354,of,0,0
22355,a,0,0
22356,placebo,0,0
22357,condition,0,0
22358,.,0,0
22359,The,0,0
22360,assertion,0,0
22361,that,0,0
22362,these,0,0
22363,drug,0,0
22364,administration,0,0
22365,instructions,0,0
22366,bias,0,0
22367,estimates,0,0
22368,of,0,0
22369,effectiveness,0,0
22370,has,0,0
22371,undergone,0,0
22372,surprisingly,0,0
22373,little,0,0
22374,empirical,0,0
22375,investigation,0,0
22376,.,0,0
22377,OBJECTIVES,0,0
22378,The,0,0
22379,primary,0,0
22380,objective,0,0
22381,of,0,0
22382,this,0,0
22383,study,0,0
22384,was,0,0
22385,to,0,0
22386,determine,0,0
22387,whether,0,0
22388,drug,0,0
22389,administration,0,0
22390,instructions,0,1
22391,informing,0,0
22392,subjects,0,0
22393,of,0,0
22394,a,0,0
22395,placebo,0,0
22396,condition,0,0
22397,affect,0,0
22398,the,0,0
22399,drug,0,0
22400,response,0,1
22401,and,0,0
22402,affect,0,0
22403,the,0,0
22404,saliva,1,0
22405,concentration,1,1
22406,of,0,0
22407,the,0,0
22408,stimulant,0,0
22409,.,0,0
22410,METHODS,0,0
22411,We,0,0
22412,assessed,0,0
22413,caffeine,1,0
22414,responses,1,1
22415,and,1,0
22416,levels,1,1
22417,of,1,1
22418,saliva,1,0
22419,concentration,1,1
22420,of,1,0
22421,caffeine,1,0
22422,in,0,0
22423,52,0,0
22424,subjects,0,0
22425,who,0,0
22426,were,0,0
22427,randomly,0,0
22428,assigned,0,0
22429,to,0,0
22430,receive,0,0
22431,one,0,0
22432,of,0,0
22433,two,0,0
22434,drug,0,0
22435,administration,0,0
22436,instructions,0,1
22437,:,0,0
22438,(,0,0
22439,a,0,0
22440,),0,0
22441,placebo-informed,0,0
22442,instructions,0,1
22443,(,0,0
22444,i.e.,0,0
22445,",",0,1
22446,individuals,0,0
22447,informed,0,0
22448,of,0,0
22449,the,0,0
22450,placebo,0,0
22451,),0,0
22452,analogous,0,0
22453,to,0,0
22454,those,0,0
22455,used,0,0
22456,in,0,0
22457,double-blind,0,0
22458,studies,0,0
22459,and,0,1
22460,(,0,0
22461,b,0,0
22462,),0,0
22463,placebo-uninformed,0,0
22464,instructions,0,1
22465,(,0,0
22466,i.e.,0,0
22467,",",0,1
22468,individuals,0,0
22469,informed,0,0
22470,they,0,0
22471,are,0,0
22472,taking,0,0
22473,an,0,0
22474,active,0,0
22475,stimulant,0,0
22476,),0,0
22477,.,0,0
22478,RESULTS,0,0
22479,On,0,0
22480,most,0,0
22481,measures,0,1
22482,(,1,0
22483,systolic,1,1
22484,blood,1,1
22485,pressure,1,1
22486,",",1,1
22487,heart,1,1
22488,rate,1,1
22489,",",1,1
22490,hand,1,1
22491,steadiness,1,1
22492,",",1,1
22493,reaction,1,1
22494,time,1,1
22495,",",1,1
22496,fatigue,1,1
22497,",",1,1
22498,and,1,1
22499,tension,1,1
22500,),1,1
22501,",",0,0
22502,drug,0,0
22503,administration,0,0
22504,instructions,0,1
22505,did,0,0
22506,not,0,0
22507,significantly,0,0
22508,influence,0,0
22509,caffeine,1,0
22510,response,1,1
22511,.,1,0
22512,Instructions,0,0
22513,also,0,0
22514,had,0,0
22515,no,0,0
22516,significant,0,0
22517,effect,0,0
22518,on,0,0
22519,saliva,1,0
22520,concentration,1,1
22521,of,0,0
22522,caffeine,0,0
22523,.,0,0
22524,However,0,0
22525,",",0,0
22526,only,0,0
22527,individuals,0,0
22528,who,0,0
22529,were,0,0
22530,uninformed,0,0
22531,of,0,0
22532,the,0,0
22533,placebo,0,0
22534,condition,0,0
22535,showed,0,0
22536,significant,0,0
22537,diastolic,1,1
22538,blood,1,1
22539,pressure,1,1
22540,and,1,1
22541,vigor,1,1
22542,increases,0,1
22543,with,0,0
22544,125,0,0
22545,mg,0,0
22546,caffeine,0,0
22547,",",0,0
22548,and,0,1
22549,significant,0,1
22550,hand,1,1
22551,steadiness,1,1
22552,impairment,1,1
22553,and,1,1
22554,vigor,1,1
22555,increases,0,1
22556,with,0,0
22557,325,0,0
22558,mg,0,0
22559,caffeine,0,0
22560,compared,0,0
22561,to,0,0
22562,placebo,0,0
22563,.,0,0
22564,CONCLUSIONS,0,0
22565,These,0,0
22566,overall,0,1
22567,findings,0,0
22568,suggest,0,0
22569,that,0,0
22570,a,0,0
22571,limited,0,0
22572,bias,0,0
22573,is,0,0
22574,introduced,0,0
22575,by,0,0
22576,drug,0,0
22577,administration,0,0
22578,instructions,0,0
22579,.,0,0
22580,The,0,0
22581,results,0,0
22582,do,0,0
22583,not,0,0
22584,support,0,0
22585,any,0,0
22586,suggestion,0,0
22587,that,0,0
22588,information,0,0
22589,about,0,0
22590,the,0,0
22591,existence,0,0
22592,of,0,0
22593,a,0,0
22594,placebo,0,0
22595,condition,0,0
22596,dramatically,0,0
22597,influences,0,0
22598,conclusions,0,0
22599,drawn,0,0
22600,about,0,0
22601,drug,0,0
22602,responses,0,1
22603,in,0,0
22604,placebo-controlled,0,0
22605,trials,0,0
22606,.,0,0
22607,The,0,0
22608,impact,0,0
22609,of,0,0
22610,angiotensin,0,0
22611,II,0,0
22612,receptor,0,1
22613,blockade,0,0
22614,and,0,0
22615,the,0,0
22616,DASH,0,0
22617,diet,0,0
22618,on,0,0
22619,markers,1,1
22620,of,0,0
22621,endogenous,0,0
22622,fibrinolysis,0,1
22623,.,0,0
22624,Hypertension,0,0
22625,is,0,0
22626,associated,0,0
22627,with,0,0
22628,impaired,0,0
22629,fibrinolysis,0,1
22630,.,0,0
22631,Both,0,0
22632,angiotensin,0,0
22633,receptor,0,1
22634,blockers,0,0
22635,(,0,0
22636,ARB,0,0
22637,),0,0
22638,and,0,0
22639,the,0,0
22640,DASH,0,0
22641,(,0,0
22642,Dietary,0,0
22643,Approaches,0,0
22644,to,0,0
22645,Stop,0,0
22646,Hypertension,0,0
22647,),0,0
22648,diet,0,0
22649,effectively,0,0
22650,lower,0,0
22651,blood,1,1
22652,pressure,1,1
22653,in,0,0
22654,hypertensive,0,0
22655,patients,0,0
22656,.,0,0
22657,Some,0,0
22658,evidence,0,0
22659,suggests,0,0
22660,that,0,0
22661,treatment,0,0
22662,with,0,0
22663,ARBs,0,0
22664,could,0,0
22665,increase,0,0
22666,fibrinolysis,0,1
22667,",",0,0
22668,however,0,0
22669,",",0,0
22670,data,0,0
22671,is,0,0
22672,conflicting,0,0
22673,.,0,0
22674,The,0,0
22675,impact,0,0
22676,of,0,0
22677,the,0,0
22678,DASH,0,0
22679,diet,0,0
22680,on,0,0
22681,fibrinolytic,1,0
22682,parameters,1,0
22683,is,0,0
22684,not,0,0
22685,known,0,0
22686,.,0,0
22687,Fifty-five,0,0
22688,hypertensive,0,0
22689,participants,0,0
22690,(,0,0
22691,35,0,0
22692,African-American,0,0
22693,",",0,0
22694,20,0,0
22695,white,0,0
22696,),0,0
22697,were,0,0
22698,randomly,0,0
22699,assigned,0,0
22700,to,0,0
22701,receive,0,0
22702,8,0,0
22703,weeks,0,0
22704,of,0,0
22705,either,0,0
22706,a,0,0
22707,control,0,0
22708,diet,0,0
22709,or,0,0
22710,the,0,0
22711,DASH,0,0
22712,diet,0,0
22713,.,0,0
22714,The,0,0
22715,diets,0,0
22716,did,0,0
22717,not,0,0
22718,differ,0,0
22719,in,0,0
22720,sodium,0,0
22721,content,0,1
22722,(,0,0
22723,approximately,0,0
22724,3,0,0
22725,g/day,0,0
22726,),0,0
22727,.,0,0
22728,Within,0,0
22729,each,0,0
22730,diet,0,0
22731,",",0,0
22732,individuals,0,0
22733,were,0,0
22734,randomly,0,0
22735,assigned,0,0
22736,to,0,0
22737,receive,0,0
22738,losartan,0,0
22739,or,0,0
22740,placebo,0,0
22741,for,0,0
22742,4,0,0
22743,weeks,0,0
22744,in,0,0
22745,double-blind,0,0
22746,",",0,0
22747,cross-over,0,0
22748,fashion,0,0
22749,.,0,0
22750,Tissue,1,0
22751,plasminogen,1,1
22752,activator,1,0
22753,(,1,0
22754,t-PA,1,0
22755,),1,0
22756,antigen,1,1
22757,",",1,0
22758,t-PA,1,1
22759,activity,1,1
22760,",",1,0
22761,plasminogen,1,1
22762,activator,1,1
22763,inhibitor-1,1,1
22764,(,1,0
22765,PAI-1,1,0
22766,),1,1
22767,activity,1,1
22768,and,1,1
22769,plasma,1,1
22770,renin,1,1
22771,activity,1,1
22772,(,1,0
22773,PRA,1,1
22774,),1,0
22775,were,0,0
22776,measured,0,0
22777,at,0,0
22778,the,0,0
22779,end,0,0
22780,of,0,0
22781,a,0,0
22782,2-week,0,0
22783,run-in,0,0
22784,period,0,0
22785,on,0,0
22786,the,0,0
22787,control,0,0
22788,diet,0,0
22789,and,0,0
22790,after,0,0
22791,each,0,0
22792,treatment,0,0
22793,period,0,0
22794,.,0,0
22795,The,0,0
22796,DASH,0,0
22797,diet,0,0
22798,did,0,0
22799,not,0,0
22800,affect,0,0
22801,markers,0,1
22802,of,0,0
22803,fibrinolysis,0,1
22804,.,0,0
22805,Losartan,0,0
22806,significantly,0,0
22807,lowered,0,0
22808,t-PA,1,0
22809,antigen,1,1
22810,levels,1,1
22811,(,0,0
22812,-1.8,0,0
22813,ng/mL,0,0
22814,",",0,0
22815,P,0,0
22816,=,0,0
22817,0.045,0,0
22818,),0,0
22819,",",0,0
22820,but,0,0
22821,had,0,0
22822,no,0,0
22823,effect,0,0
22824,on,0,0
22825,t-PA,1,0
22826,or,1,0
22827,PAI-1,1,0
22828,activities,1,1
22829,.,1,0
22830,This,0,0
22831,effect,0,0
22832,was,0,0
22833,more,0,0
22834,pronounced,0,0
22835,in,0,0
22836,whites,0,0
22837,(,0,0
22838,-4.1,0,0
22839,ng/mL,0,0
22840,(,0,0
22841,P,0,0
22842,=,0,0
22843,0.003,0,0
22844,),0,0
22845,),0,0
22846,compared,0,0
22847,with,0,0
22848,African-Americans,0,0
22849,(,0,0
22850,-0.3,0,0
22851,ng/mL,0,0
22852,(,0,0
22853,P,0,0
22854,=,0,0
22855,0.7,0,0
22856,),0,0
22857,",",0,0
22858,P-interaction,0,0
22859,=,0,0
22860,0.03,0,0
22861,),0,0
22862,.,0,0
22863,Results,0,0
22864,were,0,0
22865,not,0,0
22866,materially,0,0
22867,affected,0,0
22868,by,0,0
22869,adjustment,0,0
22870,for,0,0
22871,basline,0,1
22872,values,0,1
22873,or,0,0
22874,changes,0,1
22875,in,0,0
22876,blood,1,1
22877,pressure,1,1
22878,.,1,0
22879,This,0,0
22880,study,0,0
22881,demonstrates,0,0
22882,that,0,0
22883,losartan,0,0
22884,reduces,0,0
22885,t-PA,1,0
22886,antigen,1,1
22887,levels,1,1
22888,in,0,0
22889,white,0,0
22890,",",0,0
22891,but,0,0
22892,not,0,0
22893,African-American,0,0
22894,hypertensive,0,0
22895,individuals,0,0
22896,.,0,0
22897,In,0,0
22898,contrast,0,0
22899,",",0,0
22900,the,0,0
22901,DASH,0,0
22902,diet,0,0
22903,had,0,0
22904,no,0,0
22905,significant,0,0
22906,effect,0,0
22907,on,0,0
22908,markers,1,1
22909,of,1,0
22910,fibrinolysis,1,1
22911,in,0,0
22912,whites,0,0
22913,or,0,0
22914,African-Americans,0,0
22915,.,0,0
22916,Effectiveness,0,1
22917,of,0,0
22918,a,0,0
22919,brief,0,0
22920,cognitive-behavioural,0,0
22921,therapy,0,0
22922,intervention,0,0
22923,in,0,0
22924,the,0,0
22925,treatment,0,0
22926,of,0,0
22927,schizophrenia,1,0
22928,.,1,0
22929,BACKGROUND,0,0
22930,Little,0,0
22931,evidence,0,0
22932,exists,0,0
22933,to,0,0
22934,indicate,0,0
22935,whether,0,0
22936,community,0,0
22937,psychiatric,0,0
22938,nurses,0,0
22939,can,0,0
22940,achieve,0,0
22941,the,0,0
22942,results,0,0
22943,reported,0,0
22944,by,0,0
22945,expert,0,0
22946,cognitive-behavioural,0,0
22947,therapists,0,0
22948,in,0,0
22949,patients,0,0
22950,with,0,0
22951,schizophrenia,0,0
22952,.,0,0
22953,AIMS,0,0
22954,To,0,0
22955,assess,0,0
22956,the,0,0
22957,effectiveness,0,1
22958,and,0,0
22959,safety,0,1
22960,of,0,0
22961,a,0,0
22962,brief,0,0
22963,cognitive-behavioural,0,0
22964,therapy,0,0
22965,(,0,0
22966,CBT,0,0
22967,),0,0
22968,intervention,0,0
22969,in,0,0
22970,a,0,0
22971,representative,0,0
22972,community,0,0
22973,sample,0,0
22974,of,0,0
22975,patients,0,0
22976,with,0,0
22977,schizophrenia,0,0
22978,in,0,0
22979,secondary,0,0
22980,care,0,0
22981,settings,0,0
22982,.,0,0
22983,METHOD,0,0
22984,A,0,0
22985,pragmatic,0,0
22986,randomised,0,0
22987,trial,0,0
22988,was,0,0
22989,performed,0,0
22990,involving,0,0
22991,422,0,0
22992,patients,0,0
22993,and,0,0
22994,carers,0,0
22995,to,0,0
22996,compare,0,0
22997,a,0,0
22998,brief,0,0
22999,CBT,0,0
23000,intervention,0,0
23001,against,0,1
23002,treatment,0,0
23003,as,0,0
23004,usual,0,0
23005,.,0,0
23006,RESULTS,0,0
23007,Patients,0,0
23008,who,0,0
23009,received,0,0
23010,CBT,0,0
23011,(,0,0
23012,n=257,0,0
23013,),0,0
23014,improved,0,0
23015,in,0,0
23016,overall,1,1
23017,symptomatology,1,1
23018,(,0,0
23019,P=0.015,0,0
23020,;,0,0
23021,number,1,1
23022,needed,1,0
23023,to,1,0
23024,treat,1,0
23025,[,0,0
23026,NNT,0,0
23027,],0,0
23028,=13,0,0
23029,),0,0
23030,",",0,0
23031,insight,1,0
23032,(,0,0
23033,P,0,0
23034,<,0,0
23035,0.001,0,0
23036,;,0,0
23037,NNT=10,0,0
23038,),0,0
23039,and,0,1
23040,depression,1,1
23041,(,0,0
23042,P=0.003,0,0
23043,;,0,0
23044,NNT=9,0,0
23045,),0,0
23046,compared,0,0
23047,with,0,0
23048,the,0,0
23049,control,0,0
23050,group,0,0
23051,(,0,0
23052,n=165,0,0
23053,),0,0
23054,.,0,0
23055,Insight,1,0
23056,was,0,0
23057,clinically,0,0
23058,significantly,0,0
23059,improved,0,0
23060,(,0,0
23061,risk,0,1
23062,ratio=1.15,0,0
23063,",",0,0
23064,95,0,0
23065,%,0,0
23066,CI,0,0
23067,1.01-1.31,0,0
23068,),0,0
23069,.,0,0
23070,There,0,0
23071,was,0,0
23072,no,0,0
23073,increase,0,0
23074,in,0,0
23075,suicidal,1,1
23076,ideation,1,1
23077,.,1,0
23078,CONCLUSIONS,0,0
23079,Community,0,1
23080,psychiatric,0,0
23081,nurses,0,0
23082,can,0,0
23083,safely,1,0
23084,and,1,0
23085,effectively,1,0
23086,deliver,0,0
23087,a,0,0
23088,brief,0,0
23089,CBT,0,0
23090,intervention,0,0
23091,to,0,0
23092,patients,0,0
23093,with,0,0
23094,schizophrenia,0,0
23095,and,0,0
23096,their,0,0
23097,carers,0,0
23098,.,0,0
23099,Impact,0,0
23100,of,0,0
23101,interviewer,0,0
23102,'s,0,1
23103,body,0,1
23104,mass,0,1
23105,index,0,1
23106,on,0,0
23107,underreporting,0,1
23108,energy,0,1
23109,intake,0,1
23110,in,0,0
23111,overweight,0,1
23112,and,0,0
23113,obese,0,0
23114,women,0,0
23115,.,0,0
23116,OBJECTIVE,0,0
23117,To,0,0
23118,determine,0,0
23119,if,0,0
23120,overweight,0,1
23121,and,0,0
23122,obese,0,0
23123,women,0,0
23124,provide,0,0
23125,more,0,0
23126,accurate,0,0
23127,reports,0,0
23128,of,0,0
23129,their,0,0
23130,energy,0,1
23131,intake,0,1
23132,by,0,0
23133,1,0,0
23134,),0,0
23135,in-person,0,0
23136,recall,0,1
23137,with,0,0
23138,an,0,0
23139,obese,0,0
23140,interviewer,0,0
23141,",",0,0
23142,2,0,0
23143,),0,0
23144,in-person,0,0
23145,recall,0,1
23146,with,0,0
23147,a,0,0
23148,lean,0,1
23149,interviewer,0,0
23150,",",0,0
23151,or,0,0
23152,3,0,0
23153,),0,0
23154,telephone,0,0
23155,recall,0,1
23156,with,0,0
23157,an,0,0
23158,unknown,0,0
23159,interviewer,0,0
23160,.,0,0
23161,RESEARCH,0,0
23162,METHODS,0,0
23163,AND,0,0
23164,PROCEDURES,0,1
23165,Eighty-eight,0,0
23166,overweight,0,1
23167,and,0,1
23168,obese,0,0
23169,women,0,0
23170,participated,0,0
23171,in,0,0
23172,this,0,0
23173,study,0,0
23174,.,0,0
23175,Subjects,0,0
23176,completed,0,0
23177,one,0,0
23178,telephone-administered,0,0
23179,multiple-pass,0,0
23180,24-hour,0,1
23181,recall,0,1
23182,(,0,0
23183,MP24R,0,1
23184,),0,0
23185,with,0,0
23186,an,0,0
23187,unknown,0,0
23188,interviewer,0,0
23189,and,0,0
23190,were,0,0
23191,then,0,0
23192,randomly,0,0
23193,assigned,0,0
23194,to,0,0
23195,an,0,0
23196,in-person,0,0
23197,MP24R,0,1
23198,with,0,0
23199,either,0,0
23200,a,0,0
23201,lean,0,1
23202,or,0,0
23203,obese,0,0
23204,interviewer,0,0
23205,to,0,0
23206,gather,0,0
23207,reported,1,0
23208,energy,1,1
23209,intake,1,1
23210,(,1,0
23211,rEI,1,0
23212,),1,0
23213,.,0,0
23214,Basal,1,0
23215,metabolic,1,1
23216,rate,1,1
23217,(,1,0
23218,BMR,1,0
23219,),1,0
23220,was,0,0
23221,measured,0,0
23222,using,0,0
23223,a,0,0
23224,Deltrac,0,0
23225,monitor,0,0
23226,",",0,0
23227,and,0,1
23228,physical,1,1
23229,activity,1,1
23230,(,1,0
23231,EEPA,1,1
23232,),1,0
23233,was,0,0
23234,estimated,0,0
23235,using,0,0
23236,a,0,0
23237,Caltrac,0,0
23238,accelerometer,0,0
23239,.,0,0
23240,Therefore,0,0
23241,",",0,0
23242,estimated,0,0
23243,energy,0,1
23244,expenditure,0,1
23245,was,0,0
23246,determined,0,0
23247,by,0,0
23248,:,0,0
23249,estTEE,0,0
23250,=,0,0
23251,(,0,0
23252,BMR,0,0
23253,+,0,0
23254,EEPA,0,1
23255,),0,0
23256,x,0,0
23257,1.10,0,0
23258,.,0,0
23259,RESULTS,0,0
23260,No,0,0
23261,significant,0,0
23262,differences,0,0
23263,were,0,0
23264,found,0,0
23265,between,0,0
23266,the,0,0
23267,two,0,0
23268,in-person,0,0
23269,interview,0,0
23270,modes,0,0
23271,for,0,0
23272,subject,0,0
23273,age,0,0
23274,",",0,0
23275,weight,0,1
23276,",",0,1
23277,body,0,1
23278,mass,0,1
23279,index,0,1
23280,",",0,0
23281,percentage,0,1
23282,of,0,1
23283,body,0,1
23284,fat,0,1
23285,",",0,0
23286,total,0,1
23287,energy,0,1
23288,expenditure,0,1
23289,",",0,1
23290,rEI,0,1
23291,",",0,1
23292,and,0,1
23293,misreporting,0,1
23294,of,0,1
23295,energy,0,1
23296,intake,0,1
23297,.,0,0
23298,In-person,0,0
23299,recall,0,1
23300,data,0,0
23301,were,0,0
23302,combined,0,0
23303,for,0,0
23304,comparison,0,0
23305,with,0,0
23306,the,0,0
23307,telephone,0,0
23308,recalls,0,1
23309,.,0,0
23310,No,0,0
23311,significant,0,0
23312,difference,0,0
23313,was,0,0
23314,found,0,0
23315,between,0,0
23316,the,0,0
23317,in-person,0,0
23318,and,0,0
23319,telephone,0,0
23320,recalls,0,1
23321,for,0,0
23322,rEI,1,0
23323,and,1,0
23324,misreporting,1,1
23325,.,1,1
23326,Mean,1,0
23327,reported,1,0
23328,energy,1,1
23329,intake,1,1
23330,was,0,0
23331,significantly,0,0
23332,lower,0,0
23333,than,0,0
23334,estimated,0,0
23335,total,1,1
23336,energy,1,1
23337,expenditure,1,1
23338,for,0,0
23339,the,0,0
23340,telephone,0,0
23341,recalls,0,1
23342,and,0,1
23343,combined,0,0
23344,(,0,0
23345,lean,0,1
23346,and,0,0
23347,obese,0,0
23348,modes,0,0
23349,),0,0
23350,in-person,0,0
23351,recalls,0,1
23352,.,0,0
23353,CONCLUSIONS,0,0
23354,This,0,0
23355,study,0,0
23356,found,0,0
23357,that,0,0
23358,interviewer,0,0
23359,body,0,1
23360,mass,0,1
23361,index,0,1
23362,had,0,0
23363,no,0,0
23364,impact,0,0
23365,on,0,0
23366,self-reported,0,1
23367,energy,0,1
23368,intake,0,1
23369,during,0,0
23370,an,0,0
23371,in-person,0,0
23372,MP24R,0,1
23373,",",0,0
23374,and,0,1
23375,that,0,0
23376,telephone,0,0
23377,recall,0,1
23378,data,0,0
23379,were,0,0
23380,comparable,0,0
23381,with,0,0
23382,in-person,0,0
23383,recalls,0,1
23384,.,0,0
23385,Underreporting,0,0
23386,was,0,0
23387,a,0,0
23388,widespread,0,0
23389,problem,0,0
23390,(,0,0
23391,approximately,0,0
23392,26,0,0
23393,%,0,0
23394,),0,0
23395,for,0,0
23396,all,0,0
23397,modes,0,0
23398,in,0,0
23399,this,0,0
23400,sample,0,0
23401,.,0,0
23402,Onset,0,0
23403,of,0,0
23404,action,0,1
23405,following,0,0
23406,formoterol,0,0
23407,Turbuhaler,0,0
23408,and,0,1
23409,salbutamol,0,0
23410,pMDI,0,0
23411,in,0,0
23412,reversible,0,0
23413,chronic,0,0
23414,airway,0,1
23415,obstruction,0,0
23416,.,0,0
23417,Short-acting,0,0
23418,beta,0,0
23419,(,0,0
23420,2,0,0
23421,),0,0
23422,-agonists,0,0
23423,are,0,0
23424,currently,0,0
23425,recommended,0,0
23426,for,0,0
23427,symptom,0,1
23428,relief,0,1
23429,in,0,0
23430,asthma,0,0
23431,and,0,0
23432,the,0,0
23433,treatment,0,0
23434,of,0,0
23435,mild,0,1
23436,",",0,0
23437,acute,0,0
23438,exacerbations,0,1
23439,in,0,0
23440,COPD,0,0
23441,.,0,0
23442,However,0,0
23443,",",0,0
23444,formoterol,0,0
23445,has,0,0
23446,as,0,0
23447,fast,0,0
23448,an,0,0
23449,onset,0,1
23450,of,0,0
23451,action,0,1
23452,as,0,0
23453,salbutamol,0,0
23454,with,0,0
23455,the,0,0
23456,additional,0,0
23457,benefit,0,0
23458,of,0,0
23459,longer-lasting,0,1
23460,bronchodilation,0,1
23461,(,0,0
23462,approximately,0,0
23463,12,0,0
23464,h,0,0
23465,),0,0
23466,.,0,0
23467,Furthermore,0,0
23468,",",0,0
23469,systemic,0,1
23470,side,0,1
23471,effects,0,1
23472,observed,0,0
23473,with,0,0
23474,formoterol,0,0
23475,are,0,0
23476,of,0,0
23477,a,0,0
23478,similar,0,0
23479,duration,0,1
23480,but,0,0
23481,less,0,0
23482,pronounced,0,0
23483,than,0,0
23484,with,0,0
23485,short-acting,0,0
23486,beta,0,0
23487,(,0,0
23488,2,0,0
23489,),0,0
23490,-agonists,0,0
23491,.,0,0
23492,In,0,0
23493,this,0,0
23494,double-blind,0,0
23495,",",0,0
23496,randomized,0,0
23497,",",0,0
23498,cross-over,0,0
23499,study,0,0
23500,",",0,0
23501,20,0,0
23502,adult,0,0
23503,patients,0,0
23504,with,0,0
23505,reversible,0,0
23506,chronic,0,0
23507,airway,0,1
23508,obstruction,0,1
23509,(,0,0
23510,intrinsic,0,1
23511,asthma,0,0
23512,or,0,0
23513,COPD,0,0
23514,),0,1
23515,inhaled,0,0
23516,single,0,0
23517,doses,0,0
23518,of,0,0
23519,formoterol,0,0
23520,9,0,0
23521,microg,0,0
23522,or,0,0
23523,salbutamol,0,0
23524,100,0,0
23525,microg,0,0
23526,(,0,0
23527,group,0,0
23528,A,0,0
23529,),0,0
23530,or,0,0
23531,formoterol,0,0
23532,18,0,0
23533,microg,0,0
23534,or,0,0
23535,salbutamol,0,0
23536,200,0,0
23537,microg,0,0
23538,(,0,0
23539,group,0,0
23540,B,0,0
23541,),0,0
23542,.,0,0
23543,FEV,1,0
23544,(,1,0
23545,1,1,0
23546,),1,0
23547,was,0,0
23548,measured,0,0
23549,prior,0,0
23550,to,0,0
23551,and,0,0
23552,5,0,0
23553,",",0,0
23554,10,0,0
23555,",",0,0
23556,15,0,0
23557,",",0,0
23558,20,0,0
23559,",",0,0
23560,25,0,0
23561,and,0,0
23562,30,0,0
23563,min,0,0
23564,following,0,0
23565,inhalation,0,0
23566,of,0,0
23567,study,0,0
23568,drug,0,0
23569,.,0,0
23570,No,0,0
23571,significant,0,0
23572,differences,0,0
23573,in,0,0
23574,FEV,1,0
23575,(,1,0
23576,1,1,0
23577,),1,0
23578,values,1,0
23579,were,0,0
23580,observed,0,0
23581,between,0,0
23582,group,0,0
23583,A,0,0
23584,(,0,0
23585,P=0.704,0,0
23586,),0,1
23587,or,0,0
23588,group,0,0
23589,B,0,0
23590,(,0,0
23591,P=0.270,0,0
23592,),0,0
23593,at,0,0
23594,baseline,0,0
23595,",",0,0
23596,or,0,0
23597,at,0,0
23598,5,0,0
23599,(,0,0
23600,Group,0,0
23601,A,0,0
23602,:,0,0
23603,P=0.340,0,0
23604,;,0,0
23605,Group,0,0
23606,B,0,0
23607,:,0,0
23608,P=0.559,0,0
23609,),0,0
23610,and,0,0
23611,15,0,0
23612,min,0,0
23613,(,0,0
23614,Group,0,0
23615,A,0,0
23616,:,0,0
23617,P=0.526,0,0
23618,;,0,0
23619,Group,0,0
23620,B,0,0
23621,:,0,0
23622,P=0.818,0,0
23623,),0,0
23624,post,0,0
23625,dose,0,0
23626,.,0,0
23627,No,0,0
23628,adverse,1,1
23629,events,1,1
23630,were,0,0
23631,reported,0,0
23632,during,0,0
23633,the,0,0
23634,study,0,0
23635,.,0,0
23636,Formoterol,0,0
23637,Turbuhaler,0,0
23638,has,0,0
23639,as,0,0
23640,rapid,0,0
23641,an,0,0
23642,onset,0,1
23643,of,0,0
23644,action,0,1
23645,as,0,0
23646,salbutamol,0,0
23647,pMDI,0,0
23648,when,0,0
23649,given,0,0
23650,at,0,0
23651,the,0,0
23652,recommended,0,0
23653,doses,0,0
23654,.,0,0
23655,A,0,0
23656,pilot,0,0
23657,study,0,0
23658,of,0,0
23659,the,0,0
23660,safety,0,1
23661,and,0,0
23662,efficacy,0,1
23663,of,0,1
23664,supplemental,0,0
23665,arginine,0,0
23666,to,0,0
23667,enhance,0,0
23668,immune,0,1
23669,function,0,1
23670,in,0,0
23671,persons,0,0
23672,with,0,0
23673,HIV/AIDS,0,0
23674,.,0,0
23675,OBJECTIVE,0,0
23676,We,0,0
23677,collected,0,0
23678,preliminary,0,0
23679,data,0,0
23680,on,0,0
23681,the,0,0
23682,safety,0,1
23683,and,0,0
23684,efficacy,0,1
23685,of,0,1
23686,supplemental,0,0
23687,arginine,0,0
23688,to,0,0
23689,improve,0,0
23690,natural,0,0
23691,killer,0,1
23692,cell,0,1
23693,cytotoxicity,0,1
23694,in,0,0
23695,a,0,0
23696,sample,0,0
23697,of,0,0
23698,persons,0,0
23699,with,0,0
23700,human,0,0
23701,immunodeficiency,0,0
23702,virus,0,0
23703,(,0,0
23704,HIV,0,1
23705,),0,1
23706,and,0,0
23707,acquired,0,0
23708,immunodeficiency,0,0
23709,syndrome,0,0
23710,(,0,0
23711,AIDS,0,0
23712,),0,0
23713,.,0,0
23714,METHODS,0,0
23715,In,0,0
23716,a,0,0
23717,randomized,0,0
23718,",",0,0
23719,double-blind,0,0
23720,",",0,0
23721,placebo-controlled,0,0
23722,pilot,0,0
23723,study,0,0
23724,in,0,0
23725,an,0,0
23726,academic,0,0
23727,medical,0,0
23728,center-based,0,0
23729,infectious,0,1
23730,disease,0,1
23731,clinic,0,0
23732,",",0,0
23733,11,0,0
23734,clinically,0,0
23735,stable,0,0
23736,",",0,0
23737,HIV-infected,0,0
23738,adults,0,0
23739,had,0,0
23740,been,0,0
23741,treated,0,0
23742,with,0,0
23743,highly,0,0
23744,active,0,0
23745,",",0,0
23746,antiretroviral,0,0
23747,therapy,0,0
23748,and,0,0
23749,had,0,0
23750,HIV,0,1
23751,plasma,0,1
23752,RNA,0,0
23753,levels,0,1
23754,of,0,0
23755,less,0,0
23756,than,0,0
23757,10,0,0
23758,000,0,0
23759,copies/mL,0,0
23760,.,0,0
23761,Participants,0,0
23762,were,0,0
23763,randomly,0,0
23764,assigned,0,0
23765,to,0,0
23766,receive,0,0
23767,19.6,0,0
23768,g,0,0
23769,of,0,0
23770,arginine/d,0,0
23771,(,0,0
23772,n,0,0
23773,=,0,0
23774,6,0,0
23775,),0,0
23776,or,0,0
23777,placebo,0,0
23778,(,0,0
23779,n,0,0
23780,=,0,0
23781,5,0,0
23782,),0,0
23783,for,0,0
23784,14,0,0
23785,d.,0,0
23786,Plasma,1,0
23787,HIV,1,1
23788,RNA,1,0
23789,levels,1,1
23790,",",1,0
23791,neuropsychologic,1,1
23792,functioning,1,1
23793,",",1,0
23794,and,1,1
23795,self-reported,1,1
23796,adverse,1,1
23797,events,1,1
23798,were,0,0
23799,analyzed,0,0
23800,for,0,0
23801,safety,0,1
23802,of,0,0
23803,treatment,0,0
23804,.,0,0
23805,Efficacy,1,1
23806,was,0,0
23807,measured,0,0
23808,by,0,0
23809,natural,0,0
23810,killer,0,1
23811,cell,0,0
23812,cytotoxicity,0,1
23813,.,0,0
23814,RESULTS,0,0
23815,None,0,0
23816,of,0,0
23817,the,0,0
23818,participants,0,0
23819,experienced,0,0
23820,any,0,0
23821,adverse,1,1
23822,clinical,1,0
23823,",",1,0
23824,virologic,1,1
23825,",",1,1
23826,or,1,0
23827,neuropsychologic,1,1
23828,events,1,1
23829,that,0,0
23830,necessitated,0,0
23831,withdrawal,0,0
23832,from,0,0
23833,the,0,0
23834,study,0,0
23835,.,0,0
23836,The,0,0
23837,arginine-supplemented,0,0
23838,group,0,0
23839,showed,0,0
23840,a,0,0
23841,mean,1,1
23842,natural,1,0
23843,killer,1,1
23844,cell,1,1
23845,cytotoxicity,1,1
23846,increase,0,0
23847,of,0,0
23848,18.9,0,0
23849,lytic,0,1
23850,units,0,0
23851,",",0,0
23852,whereas,0,0
23853,the,0,0
23854,placebo,0,0
23855,group,0,0
23856,showed,0,0
23857,an,0,0
23858,increase,0,0
23859,of,0,0
23860,0.3,0,0
23861,lytic,0,0
23862,units,0,0
23863,.,0,0
23864,This,0,0
23865,difference,0,0
23866,was,0,0
23867,not,0,0
23868,statistically,0,0
23869,significant,0,0
23870,(,0,0
23871,P,0,0
23872,=,0,0
23873,0.79,0,0
23874,),0,0
23875,.,0,0
23876,CONCLUSIONS,0,0
23877,Short-term,0,0
23878,arginine,0,0
23879,supplementation,0,0
23880,is,0,0
23881,safe,0,0
23882,for,0,0
23883,persons,0,0
23884,with,0,0
23885,HIV/AIDS,0,0
23886,.,0,0
23887,Additional,0,0
23888,studies,0,0
23889,with,0,0
23890,larger,0,0
23891,samples,0,0
23892,and,0,1
23893,longer,0,0
23894,periods,0,0
23895,are,0,0
23896,warranted,0,0
23897,to,0,0
23898,determine,0,0
23899,the,0,0
23900,effects,0,0
23901,of,0,0
23902,arginine,0,0
23903,supplementation,0,0
23904,on,0,0
23905,other,0,0
23906,indices,0,1
23907,of,0,0
23908,immune,0,1
23909,function,0,1
23910,and,0,0
23911,on,0,0
23912,clinical,0,0
23913,outcomes,0,1
23914,such,0,0
23915,as,0,0
23916,intercurrent,0,0
23917,illnesses,0,0
23918,.,0,0
23919,Overexpression,0,1
23920,of,0,0
23921,vascular,0,1
23922,endothelial,0,1
23923,growth,0,1
23924,factor,0,1
23925,(,0,0
23926,VEGF,0,1
23927,),0,0
23928,and,0,0
23929,its,0,0
23930,cellular,0,1
23931,receptor,0,1
23932,KDR,0,1
23933,(,0,0
23934,VEGFR-2,0,0
23935,),0,0
23936,in,0,0
23937,the,0,0
23938,bone,0,1
23939,marrow,0,0
23940,of,0,0
23941,patients,0,0
23942,with,0,0
23943,acute,0,0
23944,myeloid,0,0
23945,leukemia,0,0
23946,.,0,0
23947,Vascular,0,1
23948,endothelial,0,1
23949,growth,0,1
23950,factor,0,1
23951,(,0,0
23952,VEGF,0,1
23953,),0,0
23954,and,0,0
23955,its,0,0
23956,cellular,0,1
23957,receptor,0,0
23958,VEGFR-2,0,0
23959,have,0,0
23960,been,0,0
23961,implicated,0,0
23962,as,0,0
23963,the,0,0
23964,main,0,0
23965,endothelial,0,1
23966,pathway,0,0
23967,required,0,0
23968,for,0,0
23969,tumor,0,0
23970,neovascularization,0,0
23971,.,0,0
23972,However,0,0
23973,",",0,0
23974,the,0,0
23975,importance,0,0
23976,of,0,0
23977,the,0,0
23978,VEGF/VEGFR-2,0,0
23979,system,0,0
23980,for,0,0
23981,angiogenesis,0,1
23982,in,0,0
23983,hematologic,0,1
23984,malignancies,0,0
23985,such,0,0
23986,as,0,0
23987,AML,0,0
23988,remains,0,0
23989,to,0,0
23990,be,0,0
23991,elucidated,0,0
23992,.,0,0
23993,In,0,0
23994,32,0,0
23995,patients,0,0
23996,with,0,0
23997,newly,0,0
23998,diagnosed,0,0
23999,untreated,0,0
24000,AML,0,0
24001,",",0,0
24002,we,0,0
24003,observed,0,0
24004,by,0,0
24005,immunohistochemical,0,1
24006,analysis,0,0
24007,of,0,0
24008,bone,0,1
24009,marrow,0,0
24010,biopsies,0,0
24011,significantly,0,0
24012,higher,0,0
24013,levels,0,1
24014,of,0,1
24015,VEGF,0,0
24016,and,0,0
24017,VEGFR-2,0,1
24018,expression,0,1
24019,than,0,0
24020,in,0,0
24021,10,0,0
24022,control,0,0
24023,patients,0,0
24024,(,0,0
24025,P,0,0
24026,<,0,0
24027,0.001,0,0
24028,),0,0
24029,.,0,0
24030,In,0,0
24031,contrast,0,0
24032,",",0,0
24033,VEGFR-1,0,1
24034,staining,0,1
24035,levels,0,1
24036,in,0,0
24037,AML,0,0
24038,patients,0,0
24039,were,0,0
24040,in,0,0
24041,the,0,0
24042,same,0,0
24043,range,0,0
24044,as,0,0
24045,in,0,0
24046,the,0,0
24047,controls,0,0
24048,.,0,0
24049,Expression,1,1
24050,of,1,0
24051,VEGF,1,1
24052,and,1,0
24053,VEGFR-2,1,1
24054,was,0,0
24055,significantly,0,0
24056,higher,0,0
24057,in,0,0
24058,patients,0,0
24059,with,0,0
24060,a,0,0
24061,high,0,0
24062,degree,0,1
24063,of,0,0
24064,microvessel,0,1
24065,density,0,1
24066,compared,0,0
24067,to,0,0
24068,those,0,0
24069,with,0,0
24070,a,0,0
24071,low,0,0
24072,degree,0,1
24073,(,0,0
24074,VEGF,0,0
24075,:,0,0
24076,P,0,0
24077,=0.024,0,0
24078,;,0,0
24079,VEGFR-2,0,0
24080,:,0,0
24081,P,0,0
24082,=0.040,0,0
24083,),0,0
24084,and,0,0
24085,correlated,0,0
24086,well,0,0
24087,with,0,0
24088,bone,0,1
24089,marrow,0,1
24090,microvessel,0,1
24091,density,0,1
24092,(,0,0
24093,r,0,0
24094,(,0,0
24095,s,0,0
24096,),0,0
24097,=0.566,0,0
24098,and,0,0
24099,0.609,0,0
24100,",",0,0
24101,respectively,0,0
24102,;,0,0
24103,P,0,0
24104,<,0,0
24105,0.001,0,0
24106,),0,0
24107,.,0,0
24108,Furthermore,0,0
24109,",",0,0
24110,in,0,0
24111,patients,0,0
24112,who,0,0
24113,achieved,0,0
24114,a,0,0
24115,complete,0,1
24116,remission,1,1
24117,following,0,0
24118,induction,0,1
24119,chemotherapy,0,0
24120,VEGFR-2,1,0
24121,staining,1,1
24122,levels,1,1
24123,decreased,0,0
24124,into,0,0
24125,the,0,0
24126,normal,0,0
24127,range,0,0
24128,.,0,0
24129,In,0,0
24130,conclusion,0,0
24131,",",0,0
24132,our,0,0
24133,results,0,0
24134,provide,0,0
24135,evidence,0,0
24136,for,0,0
24137,increased,0,0
24138,expression,0,1
24139,of,0,0
24140,VEGF/VEGFR-2,1,0
24141,of,1,0
24142,leukemic,1,1
24143,blasts,1,1
24144,and,0,0
24145,correlation,0,0
24146,with,0,0
24147,angiogenesis,0,0
24148,in,0,0
24149,the,0,0
24150,bone,0,1
24151,marrow,0,0
24152,of,0,0
24153,AML,0,0
24154,patients,0,0
24155,.,0,0
24156,Thus,0,0
24157,",",0,0
24158,VEGF/VEGFR-2,0,0
24159,might,0,0
24160,constitute,0,0
24161,promising,0,0
24162,targets,0,0
24163,for,0,0
24164,antiangiogenic,0,0
24165,and,0,0
24166,antileukemic,0,1
24167,treatment,0,0
24168,strategies,0,0
24169,in,0,0
24170,AML,0,0
24171,.,0,0
24172,Pain,1,1
24173,and,1,0
24174,fatigue,1,1
24175,management,1,0
24176,:,1,0
24177,results,0,0
24178,of,0,0
24179,a,0,0
24180,nursing,0,0
24181,randomized,0,0
24182,clinical,0,0
24183,trial,0,0
24184,.,0,0
24185,PURPOSE/OBJECTIVES,0,0
24186,Through,0,0
24187,a,0,0
24188,randomized,0,0
24189,clinical,0,0
24190,trial,0,0
24191,",",0,0
24192,to,0,0
24193,compare,0,0
24194,patients,0,0
24195,undergoing,0,0
24196,an,0,0
24197,initial,0,0
24198,course,0,0
24199,of,0,0
24200,chemotherapy,0,0
24201,who,0,0
24202,report,0,0
24203,pain,1,1
24204,and,1,1
24205,fatigue,1,1
24206,at,0,0
24207,baseline,0,0
24208,and,0,0
24209,who,0,0
24210,are,0,0
24211,receiving,0,0
24212,conventional,0,0
24213,care,0,0
24214,alone,0,0
24215,with,0,0
24216,those,0,0
24217,receiving,0,0
24218,conventional,0,0
24219,care,0,0
24220,plus,0,0
24221,a,0,0
24222,nursing,0,0
24223,intervention,0,0
24224,on,0,0
24225,outcomes,0,1
24226,reported,0,0
24227,at,0,0
24228,20,0,0
24229,weeks,0,0
24230,.,0,0
24231,SETTING,0,0
24232,Chemotherapy,0,0
24233,clinics,0,0
24234,of,0,0
24235,two,0,0
24236,comprehensive,0,0
24237,and,0,0
24238,two,0,0
24239,community,0,0
24240,cancer,0,0
24241,centers,0,0
24242,.,0,0
24243,METHODS,0,0
24244,Interviews,0,0
24245,were,0,0
24246,conducted,0,0
24247,at,0,0
24248,baseline,0,0
24249,and,0,0
24250,10,0,0
24251,and,0,0
24252,20,0,0
24253,weeks,0,0
24254,.,0,0
24255,An,0,0
24256,18-week,0,0
24257,",",0,0
24258,10-contact,0,0
24259,nursing,0,0
24260,intervention,0,0
24261,utilizing,0,0
24262,problem-solving,0,1
24263,approaches,0,0
24264,to,0,0
24265,symptom,0,1
24266,management,0,0
24267,and,0,0
24268,improving,0,1
24269,physical,1,1
24270,functioning,1,1
24271,and,1,0
24272,emotional,1,1
24273,health,1,1
24274,was,0,0
24275,implemented,0,0
24276,.,0,0
24277,SAMPLE,0,0
24278,The,0,0
24279,sample,0,0
24280,consisted,0,0
24281,of,0,0
24282,53,0,0
24283,patients,0,0
24284,in,0,0
24285,the,0,0
24286,experimental,0,0
24287,arm,0,0
24288,and,0,0
24289,60,0,0
24290,in,0,0
24291,the,0,0
24292,control,0,0
24293,arm,0,0
24294,who,0,0
24295,reported,0,0
24296,pain,1,1
24297,and,1,1
24298,fatigue,1,1
24299,at,0,0
24300,baseline,0,0
24301,.,0,0
24302,VARIABLES,0,0
24303,Pain,1,1
24304,and,1,1
24305,fatigue,1,1
24306,",",1,1
24307,numbers,1,1
24308,of,1,0
24309,other,1,0
24310,symptoms,1,1
24311,",",1,0
24312,and,1,1
24313,physical,1,1
24314,role,1,0
24315,impact,1,0
24316,and,1,1
24317,social-functioning,1,1
24318,subscales,1,1
24319,from,0,0
24320,the,0,0
24321,Medical,0,0
24322,Outcomes,0,0
24323,Study,0,0
24324,36,0,0
24325,Short,0,0
24326,Form,0,0
24327,.,0,0
24328,FINDINGS,0,0
24329,Patients,0,0
24330,who,0,0
24331,received,0,0
24332,the,0,0
24333,intervention,0,0
24334,reported,0,0
24335,a,0,0
24336,significant,0,0
24337,reduction,0,0
24338,in,0,0
24339,the,0,0
24340,number,1,1
24341,of,1,0
24342,symptoms,1,1
24343,experienced,1,0
24344,and,0,0
24345,improved,0,1
24346,physical,1,1
24347,and,1,0
24348,social,1,1
24349,functioning,1,1
24350,.,1,0
24351,Fewer,0,0
24352,patients,0,0
24353,in,0,0
24354,the,0,0
24355,experimental,0,0
24356,arm,0,0
24357,reported,0,0
24358,both,0,0
24359,pain,1,1
24360,and,1,0
24361,fatigue,1,1
24362,at,0,0
24363,20,0,0
24364,weeks,0,0
24365,.,0,0
24366,CONCLUSIONS,0,0
24367,Behavioral,0,0
24368,interventions,0,0
24369,targeted,0,0
24370,to,0,0
24371,patients,0,0
24372,with,0,0
24373,pain,1,1
24374,and,1,0
24375,fatigue,1,1
24376,can,0,0
24377,reduce,0,0
24378,symptom,1,1
24379,burden,1,1
24380,",",0,0
24381,improve,0,0
24382,the,0,0
24383,quality,1,1
24384,of,1,0
24385,the,1,0
24386,daily,1,0
24387,life,1,1
24388,of,0,0
24389,patients,0,0
24390,",",0,0
24391,and,0,0
24392,demonstrate,0,0
24393,the,0,0
24394,value-added,0,1
24395,role,0,0
24396,of,0,0
24397,nursing,0,0
24398,care,0,0
24399,for,0,0
24400,patients,0,0
24401,undergoing,0,0
24402,chemotherapy,0,0
24403,.,0,0
24404,IMPLICATIONS,0,0
24405,FOR,0,0
24406,NURSING,0,0
24407,These,0,0
24408,data,0,0
24409,support,0,0
24410,the,0,0
24411,value-added,0,1
24412,role,0,0
24413,of,0,0
24414,nursing,0,0
24415,interventions,0,0
24416,for,0,0
24417,symptom,0,1
24418,management,0,0
24419,and,0,0
24420,improved,1,1
24421,quality,1,1
24422,of,1,0
24423,life,1,1
24424,during,0,0
24425,the,0,0
24426,course,0,0
24427,of,0,0
24428,cancer,0,0
24429,treatment,0,0
24430,.,0,0
24431,Double-blind,0,0
24432,placebo-controlled,0,0
24433,trial,0,0
24434,of,0,0
24435,secretin,0,1
24436,:,0,0
24437,effects,0,1
24438,on,0,0
24439,aberrant,1,0
24440,behavior,1,1
24441,in,1,0
24442,children,1,0
24443,with,1,0
24444,autism,1,0
24445,.,1,0
24446,Secretin,0,0
24447,has,0,0
24448,been,0,0
24449,proposed,0,0
24450,as,0,0
24451,a,0,0
24452,treatment,0,0
24453,alternative,0,0
24454,for,0,0
24455,autistic,1,0
24456,spectrum,1,0
24457,disorders,1,0
24458,",",0,0
24459,but,0,0
24460,empirical,0,0
24461,support,0,0
24462,is,0,0
24463,lacking,0,0
24464,.,0,0
24465,A,0,0
24466,double-blind,0,0
24467,placebo-controlled,0,0
24468,study,0,0
24469,examined,0,0
24470,the,0,0
24471,effect,0,0
24472,of,0,0
24473,a,0,0
24474,single,0,0
24475,dose,0,0
24476,of,0,0
24477,synthetic,0,0
24478,human,0,0
24479,secretin,0,1
24480,on,0,0
24481,aberrant,1,0
24482,behavior,1,1
24483,.,1,0
24484,Parent,0,1
24485,and,0,1
24486,teacher,0,1
24487,data,0,0
24488,from,0,0
24489,the,0,0
24490,Aberrant,1,0
24491,Behavior,1,1
24492,Checklist,1,1
24493,for,0,0
24494,eight,0,0
24495,male,0,0
24496,children,0,0
24497,were,0,0
24498,analyzed,0,0
24499,for,0,0
24500,reliable,0,0
24501,change,0,0
24502,in,0,0
24503,a,0,0
24504,clinical,0,0
24505,replication,0,0
24506,series,0,0
24507,.,0,0
24508,By,0,1
24509,parent,0,1
24510,and,0,1
24511,teacher,0,1
24512,report,0,0
24513,",",0,0
24514,the,0,0
24515,majority,0,0
24516,of,0,0
24517,change,0,1
24518,occurred,0,0
24519,either,0,0
24520,on,0,0
24521,the,0,0
24522,placebo,0,0
24523,trial,0,0
24524,or,0,0
24525,reflected,0,0
24526,deterioration,0,1
24527,subsequent,0,0
24528,to,0,0
24529,secretin,0,0
24530,infusion,0,0
24531,.,0,0
24532,Repeated-measures,0,0
24533,multivariate,0,0
24534,analysis,0,0
24535,of,0,0
24536,variance,0,1
24537,results,0,0
24538,were,0,0
24539,similar,0,0
24540,.,0,0
24541,Results,0,0
24542,are,0,0
24543,consistent,0,0
24544,with,0,0
24545,other,0,0
24546,studies,0,0
24547,",",0,0
24548,suggesting,0,0
24549,that,0,0
24550,secretin,0,0
24551,may,0,0
24552,not,0,0
24553,be,0,0
24554,an,0,0
24555,effective,0,0
24556,treatment,0,0
24557,option,0,0
24558,.,0,0
24559,Walking,0,1
24560,trials,0,0
24561,in,0,0
24562,postmenopausal,0,0
24563,women,0,0
24564,:,0,0
24565,effect,0,0
24566,of,0,0
24567,one,0,0
24568,vs,0,0
24569,two,0,0
24570,daily,0,0
24571,bouts,0,0
24572,on,0,0
24573,aerobic,1,0
24574,fitness,1,1
24575,.,1,0
24576,We,0,0
24577,compared,0,0
24578,the,0,0
24579,effects,0,0
24580,of,0,0
24581,one,0,0
24582,vs,0,0
24583,two,0,0
24584,daily,0,0
24585,bouts,0,0
24586,of,0,0
24587,walking,0,0
24588,on,0,0
24589,aerobic,1,0
24590,fitness,1,1
24591,and,1,1
24592,body,1,1
24593,composition,1,1
24594,in,0,0
24595,postmenopausal,0,0
24596,women,0,0
24597,.,0,0
24598,One,0,0
24599,hundred,0,0
24600,and,0,0
24601,thirty-four,0,0
24602,subjects,0,0
24603,were,0,0
24604,randomized,0,0
24605,into,0,0
24606,exercise,0,0
24607,groups,0,0
24608,or,0,0
24609,a,0,0
24610,control,0,0
24611,group,0,0
24612,and,0,0
24613,130,0,0
24614,completed,0,0
24615,the,0,0
24616,study,0,0
24617,.,0,0
24618,The,0,0
24619,subjects,0,0
24620,walked,0,0
24621,5,0,0
24622,d/week,0,0
24623,for,0,0
24624,15,0,0
24625,weeks,0,0
24626,at,0,0
24627,65,0,0
24628,%,0,0
24629,of,0,0
24630,their,0,0
24631,maximal,0,1
24632,aerobic,0,0
24633,power,0,0
24634,expending,0,0
24635,300,0,0
24636,kcal,0,0
24637,(,0,0
24638,1255,0,0
24639,kJ,0,0
24640,),0,0
24641,in,0,0
24642,exercise,0,0
24643,in,0,0
24644,one,0,0
24645,(,0,0
24646,Group,0,0
24647,S1,0,1
24648,),0,0
24649,or,0,0
24650,two,0,0
24651,daily,0,0
24652,sessions,0,0
24653,(,0,0
24654,Group,0,0
24655,S2,0,0
24656,),0,0
24657,.,0,0
24658,VO,1,1
24659,(,1,0
24660,2max,1,0
24661,),1,0
24662,was,0,0
24663,measured,0,0
24664,in,0,0
24665,a,0,0
24666,direct,0,0
24667,maximal,0,1
24668,treadmill,0,0
24669,test,0,0
24670,.,0,0
24671,Body,1,0
24672,mass,1,1
24673,index,1,1
24674,(,1,0
24675,BMI,1,1
24676,),1,0
24677,was,0,0
24678,calculated,0,0
24679,and,0,0
24680,the,0,0
24681,percentage,0,1
24682,of,0,0
24683,body,0,1
24684,fat,0,1
24685,(,0,0
24686,fat,0,1
24687,%,0,0
24688,),0,0
24689,estimated,0,0
24690,using,0,0
24691,skinfold,0,0
24692,measurements,0,0
24693,.,0,0
24694,The,0,0
24695,net,0,0
24696,change,0,0
24697,in,0,0
24698,the,0,0
24699,VO,1,0
24700,(,1,0
24701,2max,1,0
24702,),1,0
24703,was,0,0
24704,2.5,0,0
24705,mL,0,0
24706,min/kg,0,0
24707,(,0,0
24708,95,0,0
24709,%,0,0
24710,CI,0,0
24711,1.5,0,0
24712,",",0,0
24713,3.5,0,0
24714,),0,0
24715,(,0,0
24716,8.7,0,0
24717,%,0,0
24718,),0,0
24719,in,0,0
24720,Group,0,0
24721,S1,0,1
24722,and,0,0
24723,2.5,0,0
24724,mL,0,0
24725,min/kg,0,0
24726,(,0,0
24727,95,0,0
24728,%,0,0
24729,CI,0,0
24730,1.5,0,0
24731,",",0,0
24732,3.5,0,0
24733,),0,0
24734,(,0,0
24735,8.8,0,0
24736,%,0,0
24737,),0,0
24738,in,0,0
24739,Group,0,0
24740,S2,0,0
24741,.,0,0
24742,The,0,0
24743,net,1,0
24744,change,1,0
24745,in,1,0
24746,body,1,1
24747,mass,1,1
24748,was,0,0
24749,-1.2,0,0
24750,kg,0,0
24751,(,0,0
24752,95,0,0
24753,%,0,0
24754,CI-1.9,0,0
24755,",",0,0
24756,-0.5,0,0
24757,),0,0
24758,in,0,0
24759,Group,0,0
24760,S1,0,1
24761,and,0,0
24762,-1.1,0,0
24763,kg,0,0
24764,(,0,0
24765,95,0,0
24766,%,0,0
24767,CI,0,0
24768,-1.8,0,0
24769,",",0,0
24770,-0.4,0,0
24771,),0,0
24772,in,0,0
24773,Group,0,0
24774,S2,0,0
24775,.,0,0
24776,The,0,0
24777,net,1,1
24778,fat,1,1
24779,%,1,0
24780,change,1,1
24781,was,0,0
24782,-2.1,0,0
24783,%,0,0
24784,(,0,0
24785,95,0,0
24786,%,0,0
24787,CI-2.7,0,0
24788,",",0,0
24789,-1.4,0,0
24790,),0,0
24791,in,0,0
24792,Group,0,0
24793,S1,0,1
24794,and,0,1
24795,-1.7,0,0
24796,%,0,0
24797,(,0,0
24798,95,0,0
24799,%,0,0
24800,CI-2.3,0,0
24801,",",0,0
24802,-1.0,0,0
24803,),0,0
24804,in,0,0
24805,Group,0,0
24806,S2,0,0
24807,.,0,0
24808,Exercise,0,0
24809,improved,0,0
24810,the,0,0
24811,maximal,0,1
24812,aerobic,0,0
24813,power,0,1
24814,and,0,1
24815,body,0,1
24816,composition,0,0
24817,equally,0,0
24818,when,0,0
24819,walking,0,1
24820,was,0,0
24821,performed,0,0
24822,in,0,0
24823,one,0,0
24824,or,0,0
24825,two,0,0
24826,daily,0,0
24827,bouts,0,0
24828,.,0,0
24829,Effect,0,0
24830,of,0,0
24831,clinical,0,0
24832,pharmacy,0,0
24833,services,0,0
24834,on,0,0
24835,the,0,0
24836,blood,1,1
24837,pressure,1,1
24838,of,0,0
24839,African-American,0,0
24840,renal,0,1
24841,transplant,0,0
24842,patients,0,0
24843,.,0,0
24844,OBJECTIVE,0,0
24845,The,0,0
24846,objective,0,0
24847,of,0,0
24848,this,0,0
24849,study,0,0
24850,was,0,0
24851,to,0,0
24852,determine,0,0
24853,if,0,0
24854,African-American,0,0
24855,renal,0,1
24856,transplant,0,0
24857,patients,0,0
24858,who,0,0
24859,received,0,0
24860,direct,0,0
24861,patient,0,1
24862,care,0,0
24863,from,0,0
24864,a,0,0
24865,clinical,0,0
24866,pharmacist,0,0
24867,had,0,0
24868,better,0,0
24869,blood,1,1
24870,pressure,1,1
24871,control,1,0
24872,compared,0,0
24873,to,0,0
24874,African-American,0,0
24875,renal,0,1
24876,transplant,0,0
24877,patients,0,0
24878,who,0,0
24879,did,0,0
24880,not,0,0
24881,have,0,0
24882,clinical,0,0
24883,pharmacy,0,0
24884,services,0,0
24885,.,0,0
24886,METHODS,0,0
24887,Renal,0,1
24888,transplant,0,0
24889,patients,0,0
24890,were,0,0
24891,prospectively,0,0
24892,randomized,0,0
24893,into,0,0
24894,an,0,0
24895,intervention,0,0
24896,group,0,0
24897,or,0,0
24898,a,0,0
24899,control,0,0
24900,group,0,0
24901,.,0,0
24902,Patients,0,0
24903,in,0,0
24904,the,0,0
24905,intervention,0,0
24906,group,0,0
24907,received,0,0
24908,clinical,0,0
24909,pharmacy,0,0
24910,services,0,1
24911,that,0,0
24912,included,0,0
24913,a,0,0
24914,clinical,0,0
24915,pharmacist,0,0
24916,performing,0,0
24917,patient,0,1
24918,medication,0,1
24919,reviews,0,0
24920,",",0,0
24921,with,0,0
24922,emphasis,0,0
24923,on,0,0
24924,preventing,0,0
24925,or,0,0
24926,resolving,0,1
24927,medication-related,0,0
24928,problems,0,1
24929,and,0,0
24930,providing,0,0
24931,medication,0,1
24932,recommendations,0,0
24933,.,0,0
24934,Patients,0,0
24935,in,0,0
24936,the,0,0
24937,control,0,0
24938,group,0,0
24939,received,0,0
24940,routine,0,0
24941,clinic,0,0
24942,services,0,1
24943,",",0,1
24944,but,0,0
24945,had,0,0
24946,no,0,0
24947,clinical,0,0
24948,pharmacist,0,0
24949,interaction,0,1
24950,.,0,0
24951,Analysis,0,1
24952,was,0,0
24953,performed,0,0
24954,to,0,0
24955,detect,0,0
24956,differences,0,0
24957,between,0,0
24958,the,0,0
24959,intervention,0,0
24960,and,0,0
24961,control,0,0
24962,groups,0,0
24963,in,0,0
24964,baseline,1,0
24965,and,1,0
24966,quarterly,1,0
24967,systolic,1,1
24968,blood,1,1
24969,pressure,1,1
24970,(,1,0
24971,SBP,1,1
24972,),1,0
24973,and,1,0
24974,diastolic,1,1
24975,blood,1,1
24976,pressure,1,1
24977,(,1,0
24978,DBP,1,1
24979,),1,0
24980,for,0,0
24981,one,0,0
24982,year,0,0
24983,post-study,0,0
24984,enrollment,0,0
24985,.,0,0
24986,RESULTS,0,0
24987,There,0,0
24988,were,0,0
24989,no,0,0
24990,differences,0,0
24991,between,0,0
24992,the,0,0
24993,intervention,0,0
24994,(,0,0
24995,N,0,0
24996,=,0,0
24997,13,0,0
24998,),0,0
24999,and,0,0
25000,control,0,0
25001,(,0,0
25002,N,0,0
25003,=,0,0
25004,10,0,0
25005,),0,0
25006,groups,0,0
25007,in,0,0
25008,baseline,0,0
25009,blood,1,1
25010,pressures,1,1
25011,or,0,0
25012,in,0,0
25013,the,0,0
25014,percentage,0,1
25015,of,0,0
25016,hypertensive,0,0
25017,patients,0,0
25018,.,0,0
25019,Significant,0,0
25020,differences,0,0
25021,in,0,0
25022,the,0,0
25023,change,0,0
25024,in,0,0
25025,SBP,1,1
25026,and,1,0
25027,DBP,1,1
25028,from,0,0
25029,baseline,0,0
25030,between,0,0
25031,the,0,0
25032,intervention,0,0
25033,and,0,0
25034,control,0,0
25035,groups,0,0
25036,were,0,0
25037,observed,0,0
25038,at,0,0
25039,the,0,0
25040,second,0,0
25041,",",0,0
25042,third,0,1
25043,",",0,0
25044,and,0,1
25045,fourth,0,0
25046,quarters,0,0
25047,of,0,0
25048,the,0,0
25049,study,0,0
25050,",",0,0
25051,favoring,0,0
25052,the,0,0
25053,intervention,0,0
25054,group,0,0
25055,(,0,0
25056,P,0,0
25057,<,0,0
25058,.01,0,0
25059,),0,0
25060,.,0,0
25061,Mean,1,0
25062,SBP,1,1
25063,was,0,0
25064,significantly,0,0
25065,lower,0,0
25066,in,0,0
25067,the,0,0
25068,intervention,0,0
25069,group,0,0
25070,at,0,0
25071,the,0,0
25072,second,0,0
25073,(,0,0
25074,137.8,0,0
25075,+/-,0,0
25076,15.0,0,0
25077,vs,0,0
25078,168.9,0,0
25079,+/-,0,0
25080,15.3,0,0
25081,),0,0
25082,",",0,0
25083,third,0,0
25084,(,0,0
25085,135.9,0,0
25086,+/-,0,0
25087,11.7,0,0
25088,vs,0,0
25089,164.6,0,0
25090,+/-,0,0
25091,20.1,0,0
25092,),0,0
25093,",",0,0
25094,and,0,1
25095,fourth,0,0
25096,(,0,0
25097,145.3,0,0
25098,+/-,0,0
25099,16.8,0,0
25100,vs,0,0
25101,175.8,0,0
25102,+/-,0,0
25103,33.9,0,0
25104,),0,0
25105,quarters,0,0
25106,of,0,0
25107,the,0,0
25108,study,0,0
25109,(,0,0
25110,P,0,0
25111,<,0,0
25112,.05,0,0
25113,),0,0
25114,.,0,0
25115,Mean,1,0
25116,DBP,1,1
25117,was,0,0
25118,significantly,0,0
25119,lower,0,0
25120,in,0,0
25121,the,0,0
25122,intervention,0,0
25123,group,0,0
25124,at,0,0
25125,the,0,0
25126,second,0,0
25127,(,0,0
25128,76.0,0,0
25129,+/-,0,0
25130,11.8,0,0
25131,vs,0,0
25132,84.9,0,0
25133,+/-,0,0
25134,6.1,0,0
25135,),0,0
25136,and,0,0
25137,fourth,0,0
25138,(,0,0
25139,77.0,0,0
25140,+/-,0,0
25141,10.2,0,0
25142,vs,0,0
25143,91.8,0,0
25144,+/-,0,0
25145,12.0,0,0
25146,),0,0
25147,quarters,0,0
25148,(,0,0
25149,P,0,0
25150,<,0,0
25151,.05,0,0
25152,),0,0
25153,.,0,0
25154,CONCLUSION,0,0
25155,Direct,0,1
25156,patient,0,1
25157,care,0,0
25158,services,0,0
25159,provided,0,0
25160,by,0,0
25161,a,0,0
25162,clinical,0,0
25163,pharmacist,0,0
25164,",",0,0
25165,in,0,0
25166,addition,0,0
25167,to,0,0
25168,routine,0,0
25169,clinical,0,0
25170,services,0,0
25171,",",0,0
25172,have,0,0
25173,a,0,0
25174,positive,0,0
25175,effect,0,0
25176,on,0,0
25177,the,0,0
25178,blood,1,1
25179,pressure,1,1
25180,of,0,0
25181,African-American,0,0
25182,renal,0,1
25183,transplant,0,0
25184,patients,0,0
25185,.,0,0
25186,A,0,0
25187,multidisciplinary,0,0
25188,team,0,0
25189,that,0,0
25190,includes,0,0
25191,a,0,0
25192,clinical,0,0
25193,pharmacist,0,0
25194,is,0,0
25195,beneficial,0,0
25196,to,0,0
25197,patient,0,0
25198,care,0,0
25199,.,0,0
25200,Risperidone,0,0
25201,in,0,0
25202,children,0,0
25203,with,0,0
25204,autism,0,0
25205,and,0,0
25206,serious,0,1
25207,behavioral,0,1
25208,problems,0,0
25209,.,0,0
25210,BACKGROUND,0,0
25211,Atypical,0,0
25212,antipsychotic,0,0
25213,agents,0,0
25214,",",0,0
25215,which,0,0
25216,block,0,0
25217,postsynaptic,0,0
25218,dopamine,0,0
25219,and,0,1
25220,serotonin,0,1
25221,receptors,0,0
25222,",",0,0
25223,have,0,0
25224,advantages,0,0
25225,over,0,0
25226,traditional,0,0
25227,antipsychotic,0,0
25228,medications,0,0
25229,in,0,0
25230,the,0,0
25231,treatment,0,0
25232,of,0,0
25233,adults,0,0
25234,with,0,0
25235,schizophrenia,0,0
25236,and,0,0
25237,may,0,0
25238,be,0,0
25239,beneficial,0,0
25240,in,0,0
25241,children,0,0
25242,with,0,0
25243,autistic,0,0
25244,disorder,0,0
25245,who,0,0
25246,have,0,0
25247,serious,0,1
25248,behavioral,0,1
25249,disturbances,0,1
25250,.,0,0
25251,However,0,0
25252,",",0,0
25253,data,0,0
25254,on,0,0
25255,the,0,0
25256,safety,0,1
25257,and,0,0
25258,efficacy,0,1
25259,of,0,1
25260,atypical,0,0
25261,antipsychotic,0,0
25262,agents,0,0
25263,in,0,0
25264,children,0,0
25265,are,0,0
25266,limited,0,0
25267,.,0,0
25268,METHODS,0,0
25269,We,0,0
25270,conducted,0,0
25271,a,0,0
25272,multisite,0,0
25273,",",0,0
25274,randomized,0,0
25275,",",0,0
25276,double-blind,0,0
25277,trial,0,0
25278,of,0,0
25279,risperidone,0,0
25280,as,0,0
25281,compared,0,0
25282,with,0,0
25283,placebo,0,0
25284,for,0,0
25285,the,0,0
25286,treatment,0,0
25287,of,0,0
25288,autistic,0,0
25289,disorder,0,0
25290,accompanied,0,0
25291,by,0,0
25292,severe,0,1
25293,tantrums,0,1
25294,",",0,0
25295,aggression,0,1
25296,",",0,1
25297,or,0,1
25298,self-injurious,0,1
25299,behavior,0,1
25300,in,0,0
25301,children,0,0
25302,5,0,0
25303,to,0,0
25304,17,0,0
25305,years,0,0
25306,old,0,0
25307,.,0,0
25308,The,0,0
25309,primary,0,0
25310,outcome,0,1
25311,measures,0,1
25312,were,0,0
25313,the,0,0
25314,score,0,1
25315,on,0,0
25316,the,0,0
25317,Irritability,0,1
25318,subscale,0,1
25319,of,0,0
25320,the,0,0
25321,Aberrant,0,0
25322,Behavior,0,1
25323,Checklist,0,1
25324,and,0,0
25325,the,0,0
25326,rating,0,1
25327,on,0,0
25328,the,0,0
25329,Clinical,0,0
25330,Global,0,1
25331,Impressions,0,1
25332,-,0,0
25333,Improvement,0,1
25334,(,0,0
25335,CGI-I,0,1
25336,),0,0
25337,scale,0,1
25338,at,0,0
25339,eight,0,0
25340,weeks,0,0
25341,.,0,0
25342,RESULTS,0,0
25343,A,0,0
25344,total,0,0
25345,of,0,0
25346,101,0,0
25347,children,0,0
25348,(,0,0
25349,82,0,0
25350,boys,0,0
25351,and,0,0
25352,19,0,0
25353,girls,0,0
25354,;,0,0
25355,mean,0,0
25356,[,0,0
25357,+/-SD,0,0
25358,],0,0
25359,age,0,0
25360,",",0,0
25361,8.8+/-2.7,0,0
25362,years,0,0
25363,),0,0
25364,were,0,0
25365,randomly,0,0
25366,assigned,0,0
25367,to,0,0
25368,receive,0,0
25369,risperidone,0,0
25370,(,0,0
25371,49,0,0
25372,children,0,0
25373,),0,0
25374,or,0,0
25375,placebo,0,0
25376,(,0,0
25377,52,0,0
25378,),0,0
25379,.,0,0
25380,Treatment,0,0
25381,with,0,0
25382,risperidone,0,0
25383,for,0,0
25384,eight,0,0
25385,weeks,0,0
25386,(,0,0
25387,dose,0,0
25388,range,0,0
25389,",",0,0
25390,0.5,0,0
25391,to,0,0
25392,3.5,0,0
25393,mg,0,0
25394,per,0,0
25395,day,0,0
25396,),0,0
25397,resulted,0,0
25398,in,0,0
25399,a,0,0
25400,56.9,0,0
25401,percent,0,0
25402,reduction,0,0
25403,in,0,0
25404,the,0,0
25405,Irritability,1,1
25406,score,1,1
25407,",",0,0
25408,as,0,0
25409,compared,0,0
25410,with,0,0
25411,a,0,0
25412,14.1,0,0
25413,percent,0,0
25414,decrease,0,0
25415,in,0,0
25416,the,0,0
25417,placebo,0,0
25418,group,0,0
25419,(,0,0
25420,P,0,0
25421,<,0,0
25422,0.001,0,0
25423,),0,0
25424,.,0,0
25425,The,0,0
25426,rate,0,1
25427,of,0,0
25428,a,0,0
25429,positive,0,0
25430,response,0,1
25431,",",0,0
25432,defined,0,1
25433,as,0,0
25434,at,0,0
25435,least,0,0
25436,a,0,0
25437,25,0,0
25438,percent,0,0
25439,decrease,0,0
25440,in,0,0
25441,the,0,0
25442,Irritability,1,1
25443,score,1,1
25444,and,0,0
25445,a,0,0
25446,rating,0,1
25447,of,0,0
25448,much,0,0
25449,improved,0,0
25450,or,0,0
25451,very,0,0
25452,much,0,0
25453,improved,0,0
25454,on,0,0
25455,the,0,0
25456,CGI-I,1,0
25457,scale,1,1
25458,",",0,0
25459,was,0,0
25460,69,0,0
25461,percent,0,0
25462,in,0,0
25463,the,0,0
25464,risperidone,0,0
25465,group,0,0
25466,(,0,0
25467,34,0,0
25468,of,0,0
25469,49,0,0
25470,children,0,0
25471,had,0,0
25472,a,0,0
25473,positive,0,1
25474,response,0,1
25475,),0,0
25476,and,0,0
25477,12,0,0
25478,percent,0,0
25479,in,0,0
25480,the,0,0
25481,placebo,0,0
25482,group,0,0
25483,(,0,0
25484,6,0,0
25485,of,0,0
25486,52,0,0
25487,",",0,0
25488,P,0,0
25489,<,0,0
25490,0.001,0,0
25491,),0,0
25492,.,0,0
25493,Risperidone,0,0
25494,therapy,0,0
25495,was,0,0
25496,associated,0,0
25497,with,0,0
25498,an,0,0
25499,average,1,0
25500,weight,1,1
25501,gain,1,1
25502,of,0,0
25503,2.7+/-2.9,0,0
25504,kg,0,0
25505,",",0,0
25506,as,0,0
25507,compared,0,0
25508,with,0,0
25509,0.8+/-2.2,0,0
25510,kg,0,0
25511,with,0,0
25512,placebo,0,0
25513,(,0,0
25514,P,0,0
25515,<,0,0
25516,0.001,0,0
25517,),0,0
25518,.,0,0
25519,Increased,0,0
25520,appetite,1,1
25521,",",1,0
25522,fatigue,1,1
25523,",",1,1
25524,drowsiness,1,1
25525,",",1,1
25526,dizziness,1,1
25527,",",1,1
25528,and,1,1
25529,drooling,1,1
25530,were,0,0
25531,more,0,0
25532,common,0,0
25533,in,0,0
25534,the,0,0
25535,risperidone,0,0
25536,group,0,0
25537,than,0,0
25538,in,0,0
25539,the,0,0
25540,placebo,0,0
25541,group,0,0
25542,(,0,0
25543,P,0,0
25544,<,0,0
25545,0.05,0,0
25546,for,0,0
25547,each,0,0
25548,comparison,0,0
25549,),0,0
25550,.,0,0
25551,In,0,0
25552,two,0,0
25553,thirds,0,0
25554,of,0,0
25555,the,0,0
25556,children,0,0
25557,with,0,0
25558,a,0,0
25559,positive,0,0
25560,response,0,0
25561,to,0,0
25562,risperidone,0,0
25563,at,0,0
25564,eight,0,0
25565,weeks,0,0
25566,(,0,0
25567,23,0,0
25568,of,0,0
25569,34,0,0
25570,),0,0
25571,",",0,0
25572,the,0,0
25573,benefit,0,0
25574,was,0,0
25575,maintained,0,0
25576,at,0,0
25577,six,0,0
25578,months,0,0
25579,.,0,0
25580,CONCLUSIONS,0,0
25581,Risperidone,0,0
25582,was,0,0
25583,effective,0,1
25584,and,0,0
25585,well,0,0
25586,tolerated,0,1
25587,for,0,0
25588,the,0,0
25589,treatment,0,0
25590,of,0,0
25591,tantrums,0,1
25592,",",0,0
25593,aggression,0,1
25594,",",0,1
25595,or,0,1
25596,self-injurious,0,1
25597,behavior,0,1
25598,in,0,0
25599,children,0,0
25600,with,0,0
25601,autistic,0,0
25602,disorder,0,0
25603,.,0,0
25604,The,0,0
25605,short,0,0
25606,period,0,0
25607,of,0,0
25608,this,0,0
25609,trial,0,0
25610,limits,0,0
25611,inferences,0,0
25612,about,0,0
25613,adverse,0,1
25614,effects,0,1
25615,such,0,0
25616,as,0,0
25617,tardive,0,0
25618,dyskinesia,0,0
25619,.,0,0
25620,Multimodal,0,0
25621,evaluation,0,0
25622,of,0,0
25623,risperidone,0,0
25624,for,0,0
25625,destructive,0,0
25626,behavior,0,1
25627,:,0,0
25628,functional,1,0
25629,analysis,1,0
25630,",",1,0
25631,direct,1,1
25632,observations,1,0
25633,",",1,0
25634,rating,1,1
25635,scales,1,1
25636,",",1,0
25637,and,1,1
25638,psychiatric,1,0
25639,impressions,1,0
25640,.,1,0
25641,Risperidone,0,0
25642,",",0,0
25643,an,0,0
25644,atypical,0,0
25645,neuroleptic,0,0
25646,",",0,0
25647,has,0,0
25648,become,0,0
25649,a,0,0
25650,popular,0,0
25651,option,0,0
25652,for,0,0
25653,treating,0,0
25654,destructive,0,0
25655,behaviors,0,1
25656,of,0,0
25657,persons,0,0
25658,with,0,0
25659,developmental,0,0
25660,disabilities,0,0
25661,.,0,0
25662,A,0,0
25663,few,0,0
25664,studies,0,0
25665,have,0,0
25666,been,0,0
25667,conducted,0,0
25668,that,0,0
25669,evaluate,0,0
25670,the,0,0
25671,effects,0,0
25672,of,0,0
25673,risperidone,0,0
25674,on,0,0
25675,destructive,0,0
25676,behavior,0,1
25677,;,0,0
25678,however,0,0
25679,",",0,0
25680,none,0,0
25681,of,0,0
25682,these,0,0
25683,studies,0,0
25684,have,0,0
25685,combined,0,0
25686,objective,0,0
25687,measures,0,0
25688,with,0,0
25689,rating,0,1
25690,scales,0,1
25691,to,0,0
25692,evaluate,0,0
25693,the,0,0
25694,effects,0,0
25695,of,0,0
25696,risperidone,0,0
25697,on,0,0
25698,destructive,0,1
25699,behavior,0,1
25700,across,0,0
25701,home,0,0
25702,and,0,0
25703,clinical,0,0
25704,settings,0,0
25705,.,0,0
25706,This,0,0
25707,study,0,0
25708,evaluated,0,0
25709,the,0,0
25710,wide,0,0
25711,range,0,0
25712,of,0,0
25713,effects,0,1
25714,of,0,0
25715,risperidone,0,0
25716,on,0,0
25717,destructive,0,1
25718,behavior,0,1
25719,of,0,0
25720,2,0,0
25721,persons,0,0
25722,with,0,0
25723,developmental,0,0
25724,disabilities,0,0
25725,using,0,0
25726,weekly,0,0
25727,functional,1,0
25728,analysis,1,0
25729,sessions,1,0
25730,",",1,0
25731,daily,1,0
25732,observations,1,0
25733,",",1,0
25734,hourly,1,1
25735,home,1,0
25736,data,1,0
25737,",",1,0
25738,weekly,1,0
25739,rating,1,1
25740,scales,1,1
25741,",",1,0
25742,and,1,1
25743,monthly,1,1
25744,psychiatric,1,0
25745,impressions,1,0
25746,.,1,0
25747,Results,0,0
25748,indicate,0,0
25749,that,0,0
25750,risperidone,0,0
25751,does,0,0
25752,decrease,0,0
25753,destructive,1,1
25754,behavior,1,1
25755,and,0,0
25756,that,0,0
25757,",",0,0
25758,for,0,0
25759,the,0,0
25760,most,0,0
25761,part,0,0
25762,",",0,0
25763,all,0,0
25764,of,0,0
25765,the,0,0
25766,various,0,0
25767,measures,0,1
25768,yielded,0,0
25769,similar,0,0
25770,results,0,0
25771,.,0,0
25772,Examining,0,0
25773,possible,0,0
25774,gender,0,0
25775,differences,0,0
25776,among,0,0
25777,cocaine-dependent,0,0
25778,outpatients,0,0
25779,.,0,0
25780,Potential,0,0
25781,differences,0,0
25782,in,0,0
25783,sociodemographics,0,0
25784,",",0,0
25785,drug,0,1
25786,use,0,1
25787,",",0,1
25788,and,0,1
25789,measures,0,1
25790,of,0,1
25791,treatment,0,0
25792,outcome,0,1
25793,were,0,0
25794,examined,0,0
25795,among,0,0
25796,137,0,0
25797,male,0,0
25798,and,0,0
25799,51,0,0
25800,female,0,0
25801,cocaine-dependent,0,0
25802,outpatients,0,0
25803,.,0,0
25804,More,0,0
25805,women,0,0
25806,than,0,0
25807,men,0,0
25808,were,0,0
25809,unemployed,0,0
25810,",",0,0
25811,received,0,0
25812,public,0,0
25813,assistance,0,1
25814,",",0,0
25815,and,0,1
25816,were,0,0
25817,living,0,0
25818,with,0,0
25819,their,0,0
25820,children,0,0
25821,.,0,0
25822,Women,0,0
25823,reported,0,0
25824,fewer,0,0
25825,years,0,0
25826,of,0,1
25827,regular,0,0
25828,cocaine,0,0
25829,use,0,1
25830,",",0,0
25831,spending,0,1
25832,less,0,0
25833,money,0,1
25834,per,0,1
25835,week,0,0
25836,on,0,0
25837,cocaine,0,0
25838,",",0,0
25839,less,0,0
25840,prior,0,0
25841,treatment,0,0
25842,for,0,0
25843,cocaine,0,0
25844,abuse,0,1
25845,",",0,1
25846,and,0,1
25847,were,0,0
25848,more,0,0
25849,likely,0,0
25850,than,0,0
25851,men,0,0
25852,to,0,0
25853,test,0,0
25854,positive,0,0
25855,for,0,0
25856,cocaine,0,0
25857,at,0,0
25858,intake,0,1
25859,.,0,0
25860,With,0,0
25861,respect,0,0
25862,to,0,0
25863,other,0,0
25864,drug,0,0
25865,use,0,0
25866,",",0,0
25867,fewer,0,1
25868,women,0,0
25869,than,0,0
25870,men,0,0
25871,reported,0,0
25872,using,1,0
25873,sedatives,1,0
25874,and,0,0
25875,tested,0,0
25876,positive,0,1
25877,for,0,0
25878,sedatives,1,0
25879,at,1,0
25880,intake,1,1
25881,.,1,0
25882,Women,0,0
25883,reported,0,0
25884,a,0,0
25885,lower,0,0
25886,frequency,1,1
25887,of,1,1
25888,alcohol,1,0
25889,use,1,0
25890,before,1,0
25891,intake,1,1
25892,",",0,0
25893,and,0,1
25894,fewer,0,1
25895,women,0,0
25896,than,0,0
25897,men,0,0
25898,met,0,0
25899,criteria,0,0
25900,for,0,0
25901,cannabis,0,0
25902,dependence,0,0
25903,.,0,0
25904,Men,0,0
25905,and,0,0
25906,women,0,0
25907,experienced,0,0
25908,comparable,0,0
25909,improvement,0,1
25910,during,0,0
25911,the,0,0
25912,course,0,0
25913,of,0,0
25914,treatment,0,0
25915,and,0,0
25916,follow-up,0,0
25917,.,0,0
25918,Therapeutic,1,0
25919,angiogenesis,1,1
25920,for,0,0
25921,patients,0,0
25922,with,0,0
25923,limb,0,1
25924,ischaemia,0,1
25925,by,0,0
25926,autologous,0,0
25927,transplantation,0,0
25928,of,0,0
25929,bone-marrow,0,0
25930,cells,0,1
25931,:,0,0
25932,a,0,0
25933,pilot,0,0
25934,study,0,0
25935,and,0,0
25936,a,0,0
25937,randomised,0,0
25938,controlled,0,0
25939,trial,0,0
25940,.,0,0
25941,BACKGROUND,0,0
25942,Preclinical,0,0
25943,studies,0,0
25944,have,0,0
25945,established,0,0
25946,that,0,0
25947,implantation,0,0
25948,of,0,0
25949,bone,0,1
25950,marrow-mononuclear,0,0
25951,cells,0,1
25952,",",0,0
25953,including,0,0
25954,endothelial,0,1
25955,progenitor,0,1
25956,cells,0,1
25957,",",0,0
25958,into,0,0
25959,ischaemic,0,0
25960,limbs,0,0
25961,increases,0,1
25962,collateral,1,1
25963,vessel,1,1
25964,formation,1,1
25965,.,1,0
25966,We,0,0
25967,investigated,0,0
25968,efficacy,1,1
25969,and,1,1
25970,safety,1,1
25971,of,0,1
25972,autologous,0,0
25973,implantation,0,0
25974,of,0,0
25975,bone,0,1
25976,marrow-mononuclear,0,0
25977,cells,0,1
25978,in,0,0
25979,patients,0,0
25980,with,0,0
25981,ischaemic,0,0
25982,limbs,0,0
25983,because,0,0
25984,of,0,0
25985,peripheral,0,1
25986,arterial,0,1
25987,disease,0,0
25988,.,0,0
25989,METHODS,0,0
25990,We,0,0
25991,first,0,0
25992,did,0,0
25993,a,0,0
25994,pilot,0,0
25995,study,0,0
25996,",",0,0
25997,in,0,0
25998,which,0,0
25999,25,0,0
26000,patients,0,0
26001,(,0,0
26002,group,0,0
26003,A,0,0
26004,),0,0
26005,with,0,0
26006,unilateral,0,0
26007,ischaemia,0,0
26008,of,0,0
26009,the,0,0
26010,leg,0,1
26011,were,0,0
26012,injected,0,0
26013,with,0,0
26014,bone,0,1
26015,marrow-mononuclear,0,0
26016,cells,0,1
26017,into,0,0
26018,the,0,0
26019,gastrocnemius,0,0
26020,of,0,0
26021,the,0,0
26022,ischaemic,0,0
26023,limb,0,1
26024,and,0,0
26025,with,0,0
26026,saline,0,0
26027,into,0,0
26028,the,0,0
26029,less,0,0
26030,ischaemic,0,0
26031,limb,0,1
26032,.,0,0
26033,We,0,0
26034,then,0,0
26035,recruited,0,0
26036,22,0,0
26037,patients,0,0
26038,(,0,0
26039,group,0,0
26040,B,0,0
26041,),0,0
26042,with,0,0
26043,bilateral,0,0
26044,leg,0,1
26045,ischaemia,0,0
26046,",",0,0
26047,who,0,0
26048,were,0,0
26049,randomly,0,0
26050,injected,0,0
26051,with,0,0
26052,bone,0,1
26053,marrow-mononuclear,0,0
26054,cells,0,1
26055,in,0,0
26056,one,0,0
26057,leg,0,1
26058,and,0,0
26059,peripheral,0,1
26060,blood-mononuclear,0,1
26061,cells,0,1
26062,in,0,0
26063,the,0,0
26064,other,0,0
26065,as,0,0
26066,a,0,0
26067,control,0,0
26068,.,0,0
26069,Primary,0,0
26070,outcomes,0,1
26071,were,0,0
26072,safety,1,1
26073,and,1,1
26074,feasibility,1,1
26075,of,1,1
26076,treatment,1,0
26077,",",0,0
26078,based,0,0
26079,on,0,0
26080,ankle-brachial,1,1
26081,index,1,1
26082,(,1,0
26083,ABI,1,1
26084,),1,1
26085,and,0,0
26086,rest,1,0
26087,pain,1,1
26088,",",0,1
26089,and,0,1
26090,analysis,0,0
26091,was,0,0
26092,per,0,0
26093,protocol,0,0
26094,.,0,0
26095,FINDINGS,0,0
26096,Two,0,0
26097,patients,0,0
26098,were,0,0
26099,excluded,0,0
26100,from,0,0
26101,group,0,0
26102,B,0,0
26103,after,0,0
26104,randomisation,0,0
26105,.,0,0
26106,At,0,0
26107,4,0,0
26108,weeks,0,0
26109,in,0,0
26110,group,0,0
26111,B,0,0
26112,patients,0,0
26113,",",0,0
26114,ABI,1,1
26115,was,0,0
26116,significantly,0,0
26117,improved,0,0
26118,in,0,0
26119,legs,0,1
26120,injected,0,0
26121,with,0,0
26122,bone,0,1
26123,marrow-mononuclear,0,0
26124,cells,0,1
26125,compared,0,0
26126,with,0,0
26127,those,0,0
26128,injected,0,0
26129,with,0,0
26130,peripheral,0,1
26131,blood-mononuclear,0,1
26132,cells,0,1
26133,(,0,0
26134,difference,0,0
26135,0.09,0,0
26136,[,0,0
26137,95,0,0
26138,%,0,0
26139,CI,0,0
26140,0.06-0.11,0,0
26141,],0,0
26142,;,0,0
26143,p,0,0
26144,<,0,0
26145,0.0001,0,0
26146,),0,0
26147,.,0,0
26148,Similar,0,0
26149,improvements,0,1
26150,were,0,0
26151,seen,0,0
26152,for,0,0
26153,transcutaneous,1,0
26154,oxygen,1,1
26155,pressure,1,1
26156,(,0,0
26157,13,0,0
26158,[,0,0
26159,9-17,0,0
26160,],0,0
26161,;,0,0
26162,p,0,0
26163,<,0,0
26164,0.0001,0,0
26165,),0,0
26166,",",0,0
26167,rest,1,0
26168,pain,1,1
26169,(,0,0
26170,-0.85,0,0
26171,[,0,0
26172,-1.6,0,0
26173,to,0,0
26174,-0.12,0,0
26175,],0,0
26176,;,0,0
26177,p=0.025,0,0
26178,),0,0
26179,",",0,0
26180,and,0,1
26181,pain-free,1,1
26182,walking,1,1
26183,time,1,1
26184,(,0,0
26185,1.2,0,0
26186,[,0,0
26187,0.7-1.7,0,0
26188,],0,0
26189,;,0,0
26190,p=0.0001,0,0
26191,),0,0
26192,.,0,0
26193,These,0,0
26194,improvements,1,1
26195,were,0,0
26196,sustained,0,0
26197,at,0,0
26198,24,0,0
26199,weeks,0,0
26200,.,0,0
26201,Similar,0,0
26202,improvements,1,1
26203,were,0,0
26204,seen,0,0
26205,in,0,0
26206,group,0,0
26207,A,0,0
26208,patients,0,0
26209,.,0,0
26210,Two,0,0
26211,patients,0,0
26212,in,0,0
26213,group,0,0
26214,A,0,0
26215,died,1,0
26216,after,1,0
26217,myocardial,1,1
26218,infarction,1,0
26219,unrelated,0,0
26220,to,0,0
26221,treatment,0,0
26222,.,0,0
26223,INTERPRETATION,0,0
26224,Autologous,0,0
26225,implantation,0,0
26226,of,0,0
26227,bone,0,1
26228,marrow-mononuclear,0,0
26229,cells,0,1
26230,could,0,0
26231,be,0,0
26232,safe,1,0
26233,and,1,0
26234,effective,1,1
26235,for,0,0
26236,achievement,0,1
26237,of,0,0
26238,therapeutic,1,0
26239,angiogenesis,1,1
26240,",",0,0
26241,because,0,0
26242,of,0,0
26243,the,0,0
26244,natural,0,0
26245,ability,0,1
26246,of,0,0
26247,marrow,0,0
26248,cells,0,1
26249,to,0,0
26250,supply,0,0
26251,endothelial,0,1
26252,progenitor,0,1
26253,cells,0,1
26254,and,0,0
26255,to,0,0
26256,secrete,0,1
26257,various,0,0
26258,angiogenic,0,1
26259,factors,0,0
26260,or,0,0
26261,cytokines,0,1
26262,.,0,0
26263,Efficacy,1,1
26264,of,0,0
26265,erbium,0,0
26266,:,0,0
26267,yttrium-aluminum-garnet,0,0
26268,laser-assisted,0,0
26269,delivery,0,0
26270,of,0,0
26271,topical,0,0
26272,anesthetic,0,0
26273,.,0,0
26274,BACKGROUND,0,0
26275,Penetration,0,1
26276,through,0,0
26277,the,0,0
26278,stratum,0,1
26279,corneum,0,1
26280,limits,0,0
26281,effectiveness,0,1
26282,of,0,0
26283,topical,0,0
26284,anesthetics,0,0
26285,.,0,0
26286,OBJECTIVE,0,0
26287,Our,0,0
26288,aim,0,0
26289,was,0,0
26290,to,0,0
26291,evaluate,0,0
26292,the,0,0
26293,effectiveness,0,0
26294,of,0,0
26295,5,0,0
26296,%,0,0
26297,lidocaine,0,0
26298,(,0,0
26299,ELA-Max,0,0
26300,),0,0
26301,cream,0,0
26302,applied,0,0
26303,after,0,0
26304,erbium,0,0
26305,:,0,0
26306,yttrium-aluminum-garnet,0,0
26307,(,0,0
26308,Er,0,0
26309,:,0,0
26310,YAG,0,0
26311,),0,0
26312,laser,0,0
26313,ablation,0,0
26314,of,0,0
26315,the,0,0
26316,stratum,0,1
26317,corneum,0,1
26318,.,0,0
26319,METHODS,0,0
26320,Randomized,0,0
26321,",",0,0
26322,controlled,0,0
26323,",",0,0
26324,split-face,0,0
26325,comparison,0,0
26326,of,0,0
26327,anesthesia,0,0
26328,was,0,0
26329,performed,0,0
26330,on,0,0
26331,12,0,0
26332,volunteers,0,0
26333,.,0,0
26334,The,0,0
26335,stratum,0,1
26336,corneum,0,1
26337,was,0,0
26338,painlessly,0,0
26339,ablated,0,0
26340,with,0,0
26341,a,0,0
26342,low-fluence,0,0
26343,Er,0,0
26344,:,0,0
26345,YAG,0,0
26346,laser,0,0
26347,on,0,0
26348,half,0,0
26349,of,0,0
26350,the,0,0
26351,face,0,0
26352,",",0,0
26353,then,0,0
26354,the,0,0
26355,whole,0,0
26356,face,0,0
26357,was,0,0
26358,covered,0,0
26359,with,0,0
26360,ELA-Max,0,0
26361,cream,0,0
26362,for,0,0
26363,60,0,0
26364,minutes,0,0
26365,.,0,0
26366,Full-face,0,0
26367,laser,0,0
26368,resurfacing,0,0
26369,was,0,0
26370,performed,0,0
26371,",",0,0
26372,and,0,0
26373,visual,1,1
26374,analog,1,1
26375,pain,1,1
26376,scores,1,1
26377,(,1,0
26378,0,1,0
26379,to,1,0
26380,10,1,0
26381,),1,0
26382,were,0,0
26383,recorded,0,0
26384,during,0,0
26385,each,0,0
26386,of,0,0
26387,2,0,0
26388,passes,0,0
26389,.,0,0
26390,RESULTS,0,0
26391,Laser-assisted,0,0
26392,topical,0,0
26393,anesthesia,0,0
26394,demonstrated,0,0
26395,significantly,0,0
26396,lower,0,0
26397,mean,1,1
26398,pain,1,1
26399,scores,1,1
26400,than,0,0
26401,topical,0,0
26402,anesthesia,0,0
26403,alone,0,0
26404,.,0,0
26405,This,0,0
26406,was,0,0
26407,more,0,0
26408,pronounced,0,0
26409,during,0,0
26410,the,0,0
26411,more,0,0
26412,painful,0,1
26413,second,0,0
26414,pass,0,0
26415,.,0,0
26416,Resurfacing,0,0
26417,after,0,0
26418,laser-assisted,0,0
26419,topical,0,0
26420,anesthesia,0,0
26421,was,0,0
26422,well,0,0
26423,tolerated,1,1
26424,by,0,0
26425,72,0,0
26426,%,0,0
26427,of,0,0
26428,subjects,0,0
26429,in,0,0
26430,pass,0,0
26431,1,0,0
26432,and,0,0
26433,58,0,0
26434,%,0,0
26435,in,0,0
26436,pass,0,0
26437,2,0,0
26438,.,0,0
26439,CONCLUSION,0,0
26440,Laser-assisted,0,0
26441,topical,0,0
26442,anesthesia,0,0
26443,is,0,0
26444,fast,0,0
26445,",",0,0
26446,painless,0,1
26447,",",0,1
26448,and,0,0
26449,substantially,0,0
26450,more,0,0
26451,effective,0,1
26452,than,0,0
26453,conventional,0,0
26454,topical,0,0
26455,anesthesia,0,0
26456,but,0,0
26457,does,0,0
26458,not,0,0
26459,provide,0,0
26460,adequate,0,0
26461,anesthesia,0,0
26462,for,0,0
26463,full-face,0,0
26464,resurfacing,0,0
26465,in,0,0
26466,all,0,0
26467,subjects,0,0
26468,.,0,0
26469,7-hexanoyltaxol-eluting,0,0
26470,stent,0,0
26471,for,0,0
26472,prevention,0,0
26473,of,0,0
26474,neointimal,0,1
26475,growth,0,0
26476,:,0,0
26477,an,0,0
26478,intravascular,0,0
26479,ultrasound,0,1
26480,analysis,0,0
26481,from,0,0
26482,the,0,0
26483,Study,0,0
26484,to,0,0
26485,COmpare,0,0
26486,REstenosis,0,1
26487,rate,0,1
26488,between,0,0
26489,QueST,0,1
26490,and,0,1
26491,QuaDS-QP2,0,1
26492,(,0,0
26493,SCORE,0,0
26494,),0,0
26495,.,0,0
26496,BACKGROUND,0,0
26497,Inhibition,0,0
26498,of,0,0
26499,neointimal,0,1
26500,tissue,0,0
26501,growth,0,0
26502,has,0,0
26503,been,0,0
26504,demonstrated,0,0
26505,in,0,0
26506,preliminary,0,0
26507,human,0,0
26508,feasibility,0,0
26509,studies,0,0
26510,with,0,0
26511,a,0,0
26512,stent-based,0,0
26513,polymer,0,0
26514,sleeve,0,0
26515,delivering,0,0
26516,7-hexanoyltaxol,0,0
26517,.,0,0
26518,The,0,0
26519,Study,0,0
26520,to,0,0
26521,COmpare,0,0
26522,REstenosis,0,1
26523,rate,0,1
26524,between,0,0
26525,QueST,0,1
26526,and,0,1
26527,QuaDS-QP2,0,1
26528,(,0,0
26529,SCORE,0,1
26530,),0,0
26531,trial,0,0
26532,is,0,0
26533,a,0,0
26534,human,0,0
26535,",",0,0
26536,randomized,0,0
26537,",",0,0
26538,multicenter,0,0
26539,trial,0,0
26540,comparing,0,0
26541,7-hexanoyltaxol,0,0
26542,(,0,0
26543,QP2,0,1
26544,),0,0
26545,-eluting,0,0
26546,stents,0,0
26547,(,0,0
26548,qDES,0,0
26549,),0,0
26550,with,0,0
26551,bare,0,0
26552,metal,0,0
26553,stents,0,0
26554,(,0,0
26555,BMS,0,1
26556,),0,0
26557,in,0,0
26558,the,0,0
26559,treatment,0,0
26560,of,0,0
26561,de,0,0
26562,novo,0,0
26563,coronary,0,0
26564,lesions,0,1
26565,.,0,0
26566,The,0,0
26567,purpose,0,0
26568,of,0,0
26569,this,0,0
26570,substudy,0,0
26571,was,0,0
26572,to,0,0
26573,evaluate,0,0
26574,the,0,0
26575,acute,1,0
26576,expansion,1,0
26577,property,1,1
26578,and,1,1
26579,long-term,1,1
26580,neointimal,1,1
26581,responses,1,1
26582,of,0,0
26583,qDES,0,0
26584,compared,0,0
26585,with,0,0
26586,BMS,0,0
26587,as,0,0
26588,assessed,0,0
26589,by,0,0
26590,intravascular,0,0
26591,ultrasound,0,1
26592,(,0,0
26593,IVUS,0,1
26594,),0,0
26595,.,0,0
26596,METHODS,0,0
26597,AND,0,0
26598,RESULTS,0,0
26599,A,0,0
26600,total,0,1
26601,of,0,0
26602,122,0,0
26603,(,0,0
26604,qDES,0,0
26605,66,0,0
26606,",",0,0
26607,BMS,0,0
26608,56,0,0
26609,),0,0
26610,patients,0,0
26611,were,0,0
26612,enrolled,0,0
26613,into,0,0
26614,the,0,0
26615,IVUS,0,0
26616,substudy,0,0
26617,.,0,0
26618,All,0,0
26619,IVUS,0,1
26620,images,0,0
26621,(,0,0
26622,immediately,0,0
26623,after,0,0
26624,the,0,0
26625,procedure,0,0
26626,and,0,0
26627,at,0,0
26628,6-month,0,0
26629,follow-up,0,0
26630,),0,0
26631,were,0,0
26632,analyzed,0,0
26633,at,0,0
26634,an,0,0
26635,independent,0,0
26636,core,0,0
26637,laboratory,0,0
26638,in,0,0
26639,a,0,0
26640,blind,0,0
26641,manner,0,0
26642,.,0,0
26643,At,0,0
26644,baseline,0,0
26645,",",0,0
26646,qDES,0,0
26647,achieved,0,0
26648,stent,1,0
26649,expansion,1,0
26650,similar,0,0
26651,to,0,0
26652,BMS,0,0
26653,.,0,0
26654,At,0,0
26655,follow-up,0,0
26656,",",0,0
26657,qDES,0,1
26658,showed,0,0
26659,reduced,0,0
26660,neointimal,1,1
26661,growth,1,0
26662,by,0,0
26663,70,0,0
26664,%,0,0
26665,at,0,0
26666,the,0,0
26667,tightest,0,0
26668,cross,0,0
26669,section,0,0
26670,and,0,0
26671,by,0,0
26672,68,0,0
26673,%,0,0
26674,over,0,0
26675,the,0,0
26676,stented,0,0
26677,segment,0,0
26678,(,0,0
26679,P,0,0
26680,<,0,0
26681,0.0001,0,0
26682,for,0,0
26683,both,0,0
26684,),0,0
26685,",",0,0
26686,resulting,0,0
26687,in,0,0
26688,a,0,0
26689,significantly,0,0
26690,larger,0,0
26691,lumen,0,0
26692,in,0,0
26693,qDES,0,0
26694,than,0,0
26695,in,0,0
26696,BMS,0,0
26697,.,0,0
26698,Unlike,0,1
26699,intracoronary,0,1
26700,brachytherapy,0,0
26701,",",0,0
26702,there,0,0
26703,was,0,0
26704,no,0,0
26705,evidence,0,0
26706,of,0,0
26707,negative,1,1
26708,edge,1,1
26709,effects,1,1
26710,",",1,0
26711,unhealed,1,1
26712,dissections,1,0
26713,",",1,0
26714,or,1,0
26715,late,1,1
26716,stent-vessel,1,1
26717,wall,1,1
26718,malapposition,1,1
26719,over,0,0
26720,the,0,0
26721,stented,0,0
26722,and,0,0
26723,adjacent,0,0
26724,references,0,0
26725,segments,0,0
26726,in,0,0
26727,either,0,0
26728,group,0,0
26729,.,0,0
26730,CONCLUSIONS,0,0
26731,Detailed,0,0
26732,IVUS,0,1
26733,analysis,0,0
26734,revealed,0,0
26735,that,0,0
26736,qDES,0,0
26737,had,0,0
26738,comparable,0,0
26739,acute,0,0
26740,mechanical,0,0
26741,and,0,0
26742,superior,0,1
26743,long-term,0,0
26744,biological,0,0
26745,effects,0,0
26746,to,0,0
26747,BMS,0,0
26748,.,0,0
26749,Although,0,0
26750,the,0,0
26751,long-term,0,0
26752,benefits,0,0
26753,and,0,0
26754,limitations,0,0
26755,of,0,0
26756,this,0,0
26757,technology,0,0
26758,require,0,0
26759,further,0,0
26760,investigation,0,0
26761,",",0,0
26762,the,0,0
26763,reduction,0,1
26764,in,0,0
26765,neointimal,0,1
26766,thickenings,0,0
26767,demonstrated,0,0
26768,that,0,0
26769,local,0,0
26770,delivery,0,0
26771,of,0,0
26772,7-hexanoyltaxol,0,0
26773,through,0,0
26774,polymer,0,0
26775,sleeves,0,1
26776,augments,0,1
26777,conventional,0,0
26778,mechanical,0,0
26779,treatment,0,0
26780,of,0,0
26781,atherosclerotic,0,1
26782,disease,0,0
26783,.,0,0
26784,Randomized,0,0
26785,trial,0,0
26786,of,0,0
26787,adoptive,0,0
26788,transfer,0,0
26789,of,0,0
26790,melanoma,0,0
26791,tumor-infiltrating,0,1
26792,lymphocytes,0,1
26793,as,0,0
26794,adjuvant,0,0
26795,therapy,0,0
26796,for,0,0
26797,stage,0,0
26798,III,0,0
26799,melanoma,0,0
26800,.,0,0
26801,The,0,0
26802,aim,0,0
26803,of,0,0
26804,this,0,0
26805,study,0,0
26806,was,0,0
26807,to,0,0
26808,demonstrate,0,0
26809,the,0,0
26810,interest,0,0
26811,of,0,0
26812,using,0,0
26813,tumor-infiltrating,0,1
26814,lymphocytes,0,1
26815,(,0,0
26816,TIL,0,0
26817,),0,0
26818,as,0,0
26819,adjuvant,0,0
26820,therapy,0,0
26821,for,0,0
26822,stage,0,0
26823,III,0,0
26824,(,0,0
26825,regional,0,0
26826,lymph,0,1
26827,nodes,0,1
26828,),0,0
26829,melanoma,0,0
26830,.,0,0
26831,After,0,0
26832,lymph,0,1
26833,node,0,1
26834,excision,0,0
26835,",",0,0
26836,patients,0,0
26837,without,0,0
26838,any,0,0
26839,detectable,0,1
26840,metastases,0,0
26841,were,0,0
26842,randomly,0,0
26843,assigned,0,0
26844,to,0,0
26845,receive,0,0
26846,either,0,0
26847,TIL,0,0
26848,plus,0,0
26849,interleukin-2,0,1
26850,(,0,0
26851,IL-2,0,0
26852,),0,0
26853,for,0,0
26854,2,0,0
26855,months,0,0
26856,",",0,0
26857,or,0,0
26858,IL-2,0,0
26859,only,0,0
26860,.,0,0
26861,The,0,0
26862,primary,0,0
26863,endpoint,0,1
26864,was,0,0
26865,determination,1,0
26866,of,1,0
26867,the,1,0
26868,duration,1,1
26869,of,1,0
26870,the,1,0
26871,relapse-free,1,1
26872,interval,1,0
26873,.,1,0
26874,Eighty-eight,0,0
26875,patients,0,0
26876,determined,0,0
26877,as,0,0
26878,eligible,0,0
26879,for,0,0
26880,treatment,0,0
26881,were,0,0
26882,enrolled,0,0
26883,in,0,0
26884,the,0,0
26885,study,0,0
26886,.,0,0
26887,After,0,0
26888,a,0,0
26889,median,0,0
26890,follow-up,0,0
26891,of,0,0
26892,46.9,0,0
26893,months,0,0
26894,",",0,0
26895,for,0,0
26896,the,0,0
26897,study,0,0
26898,population,0,0
26899,the,0,0
26900,analysis,0,0
26901,did,0,0
26902,not,0,0
26903,show,0,0
26904,a,0,0
26905,significant,0,0
26906,extension,0,0
26907,of,0,0
26908,the,0,0
26909,relapse-free,1,1
26910,interval,1,0
26911,or,1,0
26912,overall,1,1
26913,survival,1,1
26914,.,1,0
26915,However,0,0
26916,",",0,0
26917,a,0,0
26918,significant,0,0
26919,interaction,0,1
26920,(,0,0
26921,P,0,0
26922,<,0,0
26923,0.001,0,0
26924,),0,0
26925,was,0,0
26926,found,0,0
26927,between,0,0
26928,the,0,0
26929,treatment,0,0
26930,and,0,0
26931,the,0,0
26932,number,1,1
26933,of,1,0
26934,invaded,1,0
26935,lymph,1,0
26936,nodes,1,0
26937,.,1,0
26938,In,0,0
26939,the,0,0
26940,group,0,0
26941,with,0,0
26942,only,0,0
26943,one,0,0
26944,invaded,0,0
26945,lymph,0,0
26946,node,0,1
26947,",",0,0
26948,the,0,0
26949,estimated,1,0
26950,relapse,1,1
26951,rate,1,1
26952,was,0,0
26953,significantly,0,0
26954,lower,0,0
26955,(,0,0
26956,P,0,0
26957,(,0,0
26958,adjusted,0,0
26959,),0,0
26960,=0.0285,0,0
26961,),0,0
26962,and,0,0
26963,the,0,0
26964,overall,1,1
26965,survival,1,1
26966,was,0,0
26967,increased,0,0
26968,(,0,0
26969,P,0,0
26970,(,0,0
26971,adjusted,0,0
26972,),0,0
26973,=0.039,0,0
26974,),0,0
26975,in,0,0
26976,the,0,0
26977,TIL+IL-2,0,0
26978,arm,0,0
26979,compared,0,0
26980,with,0,0
26981,the,0,0
26982,IL-2,0,0
26983,only,0,0
26984,arm,0,0
26985,.,0,0
26986,No,0,0
26987,differences,0,0
26988,between,0,0
26989,the,0,0
26990,two,0,0
26991,arms,0,0
26992,",",0,0
26993,either,0,0
26994,as,0,0
26995,regards,0,0
26996,the,0,0
26997,duration,1,1
26998,of,1,0
26999,disease-free,1,1
27000,survival,1,1
27001,or,1,0
27002,overall,1,1
27003,survival,1,1
27004,",",0,0
27005,were,0,0
27006,noted,0,0
27007,in,0,0
27008,the,0,0
27009,group,0,0
27010,with,0,0
27011,more,0,0
27012,than,0,0
27013,one,0,0
27014,invaded,0,0
27015,lymph,0,0
27016,node,0,0
27017,whatever,0,0
27018,the,0,0
27019,number,0,1
27020,of,0,0
27021,invaded,0,0
27022,lymph,0,0
27023,nodes,0,1
27024,.,0,0
27025,Treatment,0,0
27026,was,0,0
27027,compatible,0,0
27028,with,0,0
27029,normal,0,0
27030,daily,0,0
27031,activity,0,1
27032,.,0,0
27033,This,0,0
27034,study,0,0
27035,demonstrates,0,0
27036,for,0,0
27037,the,0,0
27038,first,0,0
27039,time,0,1
27040,that,0,0
27041,the,0,0
27042,efficiency,0,1
27043,of,0,0
27044,TIL,0,0
27045,in,0,0
27046,stage,0,0
27047,III,0,1
27048,melanoma,0,0
27049,(,0,0
27050,AJCC,0,0
27051,),0,0
27052,is,0,0
27053,directly,0,0
27054,related,0,0
27055,to,0,0
27056,the,0,0
27057,number,0,1
27058,of,0,0
27059,invaded,0,0
27060,lymph,0,1
27061,nodes,0,1
27062,",",0,0
27063,indicating,0,0
27064,that,0,0
27065,tumor,0,0
27066,burden,0,0
27067,might,0,0
27068,be,0,0
27069,a,0,0
27070,crucial,0,0
27071,factor,0,0
27072,in,0,0
27073,the,0,0
27074,efficacy,0,1
27075,and/or,0,0
27076,in,0,0
27077,vitro,0,1
27078,expansion,0,0
27079,of,0,0
27080,T,0,0
27081,cells,0,1
27082,specific,0,0
27083,for,0,0
27084,autologous,0,0
27085,tumor,0,1
27086,antigen,0,1
27087,",",0,0
27088,a,0,0
27089,finding,0,0
27090,which,0,0
27091,could,0,0
27092,be,0,0
27093,of,0,0
27094,value,0,0
27095,in,0,0
27096,future,0,0
27097,vaccine,0,0
27098,development,0,0
27099,for,0,0
27100,the,0,0
27101,treatment,0,0
27102,of,0,0
27103,melanoma,0,0
27104,.,0,0
27105,Adherence,0,1
27106,to,0,0
27107,moderate-intensity,0,0
27108,exercise,0,0
27109,during,0,0
27110,breast,0,0
27111,cancer,0,0
27112,therapy,0,0
27113,.,0,0
27114,PURPOSE,0,0
27115,The,0,0
27116,aims,0,0
27117,of,0,0
27118,this,0,0
27119,pilot,0,0
27120,study,0,0
27121,were,0,0
27122,the,0,0
27123,following,0,0
27124,:,0,0
27125,1,0,0
27126,),0,0
27127,to,0,0
27128,examine,0,0
27129,patterns,0,0
27130,of,0,0
27131,adherence,0,0
27132,to,0,0
27133,a,0,0
27134,brisk,0,0
27135,walking,0,0
27136,program,0,0
27137,in,0,0
27138,women,0,0
27139,receiving,0,0
27140,adjuvant,0,0
27141,chemotherapy,0,0
27142,or,0,0
27143,radiation,0,1
27144,therapy,0,0
27145,for,0,0
27146,newly,0,0
27147,diagnosed,0,0
27148,breast,0,0
27149,cancer,0,0
27150,using,0,0
27151,a,0,0
27152,prospective,0,0
27153,",",0,0
27154,randomized,0,0
27155,",",0,0
27156,controlled,0,0
27157,experimental,0,0
27158,design,0,0
27159,;,0,0
27160,2,0,0
27161,),0,0
27162,to,0,0
27163,examine,0,0
27164,the,0,0
27165,influence,0,0
27166,of,0,0
27167,disease,0,1
27168,symptoms,0,1
27169,and,0,1
27170,treatment,0,0
27171,side,0,1
27172,effects,0,1
27173,on,0,0
27174,exercise,0,0
27175,levels,0,1
27176,;,0,0
27177,and,0,0
27178,3,0,0
27179,),0,0
27180,to,0,0
27181,suggest,0,0
27182,methods,0,0
27183,that,0,0
27184,may,0,0
27185,improve,0,0
27186,future,0,0
27187,clinical,0,0
27188,trials,0,0
27189,of,0,0
27190,moderate-intensity,0,0
27191,exercise,0,0
27192,in,0,0
27193,similar,0,0
27194,populations,0,0
27195,.,0,0
27196,DESCRIPTION,0,0
27197,OF,0,0
27198,STUDY,0,1
27199,Fifty-two,0,0
27200,patients,0,0
27201,with,0,0
27202,newly,0,0
27203,diagnosed,0,0
27204,breast,0,0
27205,cancer,0,0
27206,were,0,0
27207,randomly,0,0
27208,assigned,0,0
27209,to,0,0
27210,one,0,0
27211,of,0,0
27212,two,0,0
27213,treatment,0,0
27214,arms,0,0
27215,:,0,0
27216,usual,0,0
27217,care,0,0
27218,or,0,0
27219,usual,0,0
27220,care,0,0
27221,plus,0,0
27222,exercise,0,0
27223,.,0,0
27224,Those,0,0
27225,assigned,0,0
27226,to,0,0
27227,the,0,0
27228,exercise,0,0
27229,group,0,0
27230,received,0,0
27231,a,0,0
27232,standardized,0,0
27233,",",0,0
27234,self-administered,0,0
27235,",",0,0
27236,home-based,0,0
27237,brisk,0,1
27238,walking,0,1
27239,intervention,0,0
27240,in,0,0
27241,addition,0,0
27242,to,0,0
27243,usual,0,0
27244,care,0,0
27245,.,0,0
27246,Each,0,0
27247,day,0,0
27248,subjects,0,0
27249,completed,0,0
27250,self-report,0,0
27251,diary,0,0
27252,forms,0,0
27253,that,0,0
27254,elicited,0,0
27255,information,0,0
27256,about,0,0
27257,activity,0,1
27258,levels,0,1
27259,",",0,0
27260,and,0,0
27261,the,0,0
27262,occurrence,0,1
27263,of,0,0
27264,symptoms,0,1
27265,and,0,0
27266,side,0,1
27267,effects,0,1
27268,during,0,0
27269,cancer,0,0
27270,treatment,0,0
27271,.,0,0
27272,RESULTS,0,0
27273,Analyses,0,0
27274,of,0,0
27275,self-reported,0,1
27276,daily,0,0
27277,activity,0,1
27278,levels,0,1
27279,revealed,0,0
27280,a,0,0
27281,diffusion,0,0
27282,of,0,0
27283,treatment,0,0
27284,effect,0,0
27285,.,0,0
27286,Fifty,0,0
27287,percent,0,0
27288,of,0,0
27289,the,0,0
27290,usual-care,0,0
27291,group,0,0
27292,reported,0,0
27293,maintaining,1,1
27294,or,1,0
27295,increasing,1,0
27296,their,1,0
27297,physical,1,0
27298,activity,1,1
27299,to,1,0
27300,a,1,0
27301,moderate-intensity,1,0
27302,level,1,1
27303,",",0,0
27304,while,0,0
27305,33,0,0
27306,%,0,0
27307,of,0,0
27308,the,0,0
27309,exercise,0,0
27310,group,0,0
27311,did,0,0
27312,not,0,0
27313,exercise,0,0
27314,at,0,0
27315,the,0,0
27316,prescribed,0,0
27317,levels,0,1
27318,.,0,0
27319,Analyses,0,0
27320,of,0,0
27321,self-reported,1,1
27322,disease,1,1
27323,symptoms,1,1
27324,and,1,1
27325,treatment,1,0
27326,side,1,1
27327,effects,1,1
27328,did,0,0
27329,not,0,0
27330,reveal,0,0
27331,clinically,0,0
27332,meaningful,0,0
27333,differences,0,0
27334,between,0,0
27335,the,0,0
27336,two,0,0
27337,groups,0,0
27338,.,0,0
27339,CLINICAL,0,0
27340,IMPLICATIONS,0,0
27341,The,0,0
27342,results,0,0
27343,of,0,0
27344,this,0,0
27345,study,0,0
27346,suggest,0,0
27347,that,0,0
27348,women,0,0
27349,who,0,0
27350,exercised,0,0
27351,regularly,0,0
27352,before,0,0
27353,receiving,0,0
27354,a,0,0
27355,breast,0,0
27356,cancer,0,0
27357,diagnosis,0,0
27358,attempted,0,0
27359,to,0,0
27360,maintain,0,0
27361,their,0,0
27362,exercise,0,0
27363,programs,0,0
27364,.,0,0
27365,Women,0,0
27366,who,0,0
27367,lead,0,0
27368,sedentary,0,0
27369,lifestyles,0,0
27370,may,0,0
27371,benefit,0,0
27372,from,0,0
27373,a,0,0
27374,structured,0,0
27375,exercise,0,0
27376,program,0,0
27377,that,0,0
27378,includes,0,0
27379,information,0,1
27380,and,0,1
27381,support,0,0
27382,related,0,0
27383,to,0,0
27384,exercise,0,0
27385,adherence,0,1
27386,strategies,0,0
27387,.,0,0
27388,A,0,0
27389,randomized,0,0
27390,",",0,0
27391,double-blind,0,0
27392,",",0,0
27393,placebo-controlled,0,0
27394,trial,0,0
27395,of,0,0
27396,porcine,0,0
27397,versus,0,0
27398,synthetic,0,0
27399,secretin,0,1
27400,for,0,0
27401,reducing,0,0
27402,symptoms,1,1
27403,of,1,0
27404,autism,1,0
27405,.,1,0
27406,OBJECTIVE,0,0
27407,To,0,0
27408,compare,0,0
27409,the,0,0
27410,effects,0,0
27411,of,0,0
27412,a,0,0
27413,single,0,0
27414,dose,0,0
27415,of,0,0
27416,biologic,0,0
27417,and,0,0
27418,synthetic,0,1
27419,porcine,0,0
27420,secretin,0,0
27421,to,0,0
27422,placebo,0,0
27423,on,0,0
27424,a,0,0
27425,variety,0,0
27426,of,0,0
27427,autism,0,0
27428,symptoms,0,1
27429,.,0,0
27430,METHOD,0,0
27431,Eighty-five,0,0
27432,children,0,0
27433,with,0,0
27434,autism,0,0
27435,without,0,0
27436,other,0,0
27437,medical,0,0
27438,conditions,0,0
27439,and,0,0
27440,not,0,0
27441,taking,0,0
27442,other,0,0
27443,psychotropic,0,1
27444,medications,0,0
27445,participated,0,0
27446,(,0,0
27447,ages,0,0
27448,between,0,0
27449,3,0,0
27450,and,0,0
27451,12,0,0
27452,years,0,0
27453,",",0,0
27454,mean,0,1
27455,IQ,0,1
27456,=,0,0
27457,55,0,0
27458,),0,0
27459,.,0,0
27460,Children,0,0
27461,were,0,0
27462,grouped,0,0
27463,into,0,0
27464,trios,0,0
27465,matched,0,0
27466,by,0,0
27467,age,0,0
27468,and,0,1
27469,communication,0,1
27470,level,0,1
27471,and,0,0
27472,then,0,0
27473,randomly,0,0
27474,assigned,0,0
27475,to,0,0
27476,one,0,0
27477,of,0,0
27478,three,0,0
27479,treatment,0,0
27480,groups,0,0
27481,:,0,0
27482,biologic,0,0
27483,secretin,0,1
27484,(,0,0
27485,2,0,0
27486,CU/kg,0,0
27487,),0,0
27488,",",0,0
27489,synthetic,0,1
27490,secretin,0,1
27491,(,0,0
27492,0.4,0,0
27493,microg/kg,0,0
27494,),0,0
27495,",",0,0
27496,and,0,0
27497,placebo,0,0
27498,.,0,1
27499,Measures,0,1
27500,collected,0,0
27501,1,0,0
27502,week,0,0
27503,before,0,0
27504,and,0,0
27505,4,0,0
27506,weeks,0,0
27507,after,0,0
27508,infusion,0,0
27509,included,0,0
27510,autism,1,0
27511,symptoms,1,1
27512,",",1,0
27513,language,1,1
27514,skills,1,1
27515,",",1,0
27516,and,1,1
27517,problem,1,1
27518,behaviors,1,1
27519,",",1,0
27520,gathered,1,0
27521,from,1,0
27522,parents,1,0
27523,",",1,0
27524,teachers,1,0
27525,",",1,1
27526,and,1,1
27527,investigators,1,0
27528,",",0,1
27529,who,0,0
27530,were,0,0
27531,all,0,0
27532,blind,0,0
27533,to,0,0
27534,treatment,0,0
27535,.,0,0
27536,Two-factor,0,0
27537,",",0,0
27538,repeated-measures,0,0
27539,analyses,0,0
27540,of,0,0
27541,variance,0,0
27542,(,0,0
27543,3,0,0
27544,treatment,0,0
27545,levels,0,0
27546,by,0,0
27547,2,0,0
27548,repeated,0,0
27549,measures,0,0
27550,",",0,0
27551,pre-,0,0
27552,and,0,1
27553,postinfusion,0,1
27554,),0,1
27555,were,0,0
27556,used,0,0
27557,to,0,0
27558,examine,0,0
27559,efficacy,0,1
27560,.,0,0
27561,RESULTS,0,0
27562,Direct,0,1
27563,observation,0,0
27564,measures,0,1
27565,did,0,0
27566,not,0,0
27567,show,0,0
27568,change,0,0
27569,over,0,0
27570,time,0,1
27571,related,0,0
27572,to,0,0
27573,secretin,0,0
27574,.,0,0
27575,Parent,0,1
27576,reports,0,0
27577,showed,0,0
27578,an,0,0
27579,overall,0,1
27580,reduction,0,1
27581,of,0,0
27582,symptom,1,1
27583,severity,1,1
27584,for,0,0
27585,all,0,0
27586,treatment,0,0
27587,groups,0,0
27588,",",0,0
27589,including,0,0
27590,the,0,0
27591,placebo,0,0
27592,group,0,0
27593,.,0,0
27594,One,0,0
27595,teacher-report,0,0
27596,measure,0,0
27597,showed,0,0
27598,decreases,0,0
27599,in,0,0
27600,autism,0,0
27601,symptoms,0,1
27602,in,0,0
27603,the,0,0
27604,placebo,0,0
27605,and,0,0
27606,synthetic,0,1
27607,secretin,0,1
27608,groups,0,0
27609,.,0,0
27610,CONCLUSIONS,0,0
27611,No,0,0
27612,evidence,0,0
27613,that,0,0
27614,either,0,0
27615,biologic,0,0
27616,or,0,0
27617,synthetic,0,1
27618,secretin,0,1
27619,provided,0,0
27620,amelioration,0,1
27621,of,0,0
27622,symptoms,0,1
27623,beyond,0,0
27624,placebo,0,0
27625,was,0,0
27626,observed,0,0
27627,.,0,0
27628,This,0,0
27629,held,0,0
27630,true,0,0
27631,when,0,0
27632,children,0,0
27633,with,0,0
27634,and,0,0
27635,without,0,0
27636,gastrointestinal,0,1
27637,problems,0,1
27638,were,0,0
27639,examined,0,0
27640,separately,0,0
27641,.,0,0
27642,Effects,0,0
27643,of,0,0
27644,two,0,0
27645,types,0,0
27646,of,0,0
27647,social,0,1
27648,support,0,0
27649,and,0,1
27650,education,0,0
27651,on,0,0
27652,adaptation,0,0
27653,to,0,0
27654,early-stage,0,0
27655,breast,0,0
27656,cancer,0,0
27657,.,0,0
27658,A,0,0
27659,Roy,0,0
27660,adaptation,0,1
27661,model-based,0,0
27662,support,0,0
27663,and,0,1
27664,education,0,0
27665,intervention,0,0
27666,for,0,0
27667,women,0,0
27668,with,0,0
27669,early-stage,0,0
27670,breast,0,0
27671,cancer,0,0
27672,was,0,0
27673,tested,0,0
27674,in,0,0
27675,a,0,0
27676,three-group,0,0
27677,",",0,0
27678,three-phase,0,0
27679,randomized,0,0
27680,clinical,0,0
27681,trial,0,0
27682,of,0,0
27683,a,0,0
27684,sample,0,0
27685,of,0,0
27686,125,0,0
27687,women,0,0
27688,.,0,0
27689,The,0,0
27690,experimental,0,0
27691,group,0,0
27692,received,0,0
27693,13,0,0
27694,months,0,0
27695,of,0,0
27696,combined,0,0
27697,individual,0,0
27698,telephone,0,0
27699,and,0,1
27700,in-person,0,0
27701,group,0,0
27702,support,0,0
27703,and,0,1
27704,education,0,0
27705,",",0,1
27706,Control,0,0
27707,Group,0,0
27708,1,0,0
27709,received,0,0
27710,13,0,0
27711,months,0,0
27712,of,0,0
27713,telephone-only,0,0
27714,individual,0,0
27715,support,0,0
27716,and,0,1
27717,education,0,0
27718,",",0,1
27719,and,0,1
27720,Control,0,0
27721,Group,0,0
27722,2,0,0
27723,received,0,0
27724,one-time,0,0
27725,mailed,0,0
27726,educational,0,0
27727,information,0,0
27728,.,0,0
27729,The,0,0
27730,experimental,0,0
27731,group,0,0
27732,and,0,0
27733,Control,0,0
27734,Group,0,0
27735,1,0,0
27736,reported,0,0
27737,less,0,0
27738,mood,1,1
27739,disturbance,1,1
27740,at,0,0
27741,the,0,0
27742,end,0,0
27743,of,0,0
27744,all,0,0
27745,three,0,0
27746,phases,0,0
27747,",",0,0
27748,less,1,0
27749,loneliness,1,1
27750,at,0,0
27751,the,0,0
27752,end,0,0
27753,of,0,0
27754,Phases,0,0
27755,II,0,0
27756,and,0,1
27757,III,0,1
27758,",",0,0
27759,and,0,0
27760,a,0,0
27761,higher-quality,1,1
27762,relationship,1,0
27763,with,1,0
27764,a,1,0
27765,significant,1,0
27766,other,1,0
27767,at,0,0
27768,the,0,0
27769,end,0,0
27770,of,0,0
27771,Phase,0,0
27772,II,0,0
27773,than,0,0
27774,did,0,0
27775,Control,0,0
27776,Group,0,0
27777,2,0,0
27778,.,0,0
27779,No,0,0
27780,group,0,0
27781,differences,0,0
27782,were,0,0
27783,found,0,0
27784,for,0,0
27785,cancer-related,1,0
27786,worry,1,1
27787,or,1,0
27788,well-being,1,1
27789,.,1,0
27790,The,0,0
27791,findings,0,0
27792,suggest,0,0
27793,that,0,0
27794,individual,0,0
27795,telephone,0,0
27796,support,0,0
27797,may,0,0
27798,provide,0,0
27799,an,0,0
27800,effective,0,0
27801,alternative,0,0
27802,to,0,0
27803,in-person,0,0
27804,support,0,0
27805,groups,0,0
27806,.,0,0
27807,Further,0,0
27808,study,0,0
27809,of,0,0
27810,telephone,0,0
27811,interventions,0,0
27812,is,0,0
27813,recommended,0,0
27814,using,0,0
27815,ethnically,0,0
27816,and,0,0
27817,economically,0,0
27818,heterogeneous,0,0
27819,samples,0,0
27820,.,0,0
27821,Determinants,0,0
27822,of,0,0
27823,serum,0,1
27824,creatinine,0,1
27825,trajectory,0,1
27826,in,0,0
27827,acute,0,0
27828,contrast,0,0
27829,nephropathy,0,0
27830,.,0,0
27831,The,0,0
27832,aim,0,0
27833,of,0,0
27834,this,0,0
27835,study,0,0
27836,was,0,0
27837,to,0,0
27838,describe,0,0
27839,the,0,0
27840,trajectory,0,1
27841,of,0,0
27842,creatinine,1,1
27843,(,1,0
27844,Cr,1,0
27845,),1,1
27846,rise,1,0
27847,and,0,0
27848,its,0,0
27849,determinants,0,0
27850,after,0,0
27851,exposure,0,0
27852,to,0,0
27853,radiocontrast,0,0
27854,media,0,0
27855,.,0,0
27856,Included,0,0
27857,were,0,0
27858,98,0,0
27859,subjects,0,0
27860,who,0,0
27861,underwent,0,0
27862,cardiac,0,1
27863,catheterization,0,1
27864,and,0,0
27865,were,0,0
27866,randomized,0,0
27867,to,0,0
27868,forced,0,0
27869,diuresis,0,1
27870,with,0,0
27871,i.v,0,0
27872,.,0,0
27873,crystalloid,0,0
27874,",",0,0
27875,furosemide,0,0
27876,",",0,0
27877,mannitol,0,0
27878,(,0,0
27879,if,0,0
27880,pulmonary,0,1
27881,capillary,0,1
27882,wedge,0,0
27883,pressure,0,1
27884,was,0,0
27885,<,0,0
27886,20,0,0
27887,mmHg,0,0
27888,),0,0
27889,",",0,0
27890,and,0,1
27891,low,0,0
27892,dose,0,0
27893,dopamine,0,0
27894,versus,0,0
27895,intravenous,0,0
27896,crystalloid,0,1
27897,and,0,0
27898,matching,0,0
27899,placebos,0,0
27900,.,0,0
27901,Baseline,0,0
27902,and,0,1
27903,postcatheterization,0,1
27904,serum,1,1
27905,Cr,1,0
27906,levels,1,1
27907,were,0,0
27908,analyzed,0,0
27909,in,0,0
27910,a,0,0
27911,longitudinal,0,0
27912,fashion,0,0
27913,",",0,0
27914,allowing,0,0
27915,for,0,0
27916,differences,0,0
27917,in,0,0
27918,the,0,0
27919,time,0,1
27920,between,0,0
27921,blood,0,1
27922,draws,0,0
27923,",",0,0
27924,to,0,0
27925,determine,0,0
27926,the,0,0
27927,different,0,0
27928,critical,0,0
27929,trajectories,0,1
27930,of,0,0
27931,serum,0,1
27932,Cr,0,0
27933,.,0,0
27934,The,0,0
27935,mean,1,1
27936,age,1,0
27937,",",1,0
27938,baseline,1,1
27939,serum,1,1
27940,Cr,1,1
27941,",",1,0
27942,and,1,1
27943,Cr,1,1
27944,clearance,1,1
27945,(,1,0
27946,CrCl,1,0
27947,),1,0
27948,were,0,0
27949,69.3,0,0
27950,+/-,0,0
27951,10.8,0,0
27952,years,0,0
27953,",",0,0
27954,2.5,0,0
27955,+/-,0,0
27956,0.9,0,0
27957,mg/dL,0,0
27958,",",0,0
27959,and,0,0
27960,31.4,0,0
27961,+/-,0,0
27962,12.1,0,0
27963,mL/min,0,0
27964,",",0,0
27965,respectively,0,0
27966,.,0,0
27967,The,0,0
27968,clinically,1,0
27969,driven,1,0
27970,postprocedural,1,1
27971,observation,1,0
27972,time,1,1
27973,was,0,0
27974,5.5,0,0
27975,+/-,0,0
27976,5.1,0,0
27977,days,0,0
27978,(,0,0
27979,range,0,0
27980,19,0,0
27981,hours,0,0
27982,and,0,0
27983,one,0,0
27984,Cr,0,0
27985,value,0,0
27986,to,0,0
27987,25.7,0,0
27988,days,0,0
27989,and,0,0
27990,18,0,0
27991,values,0,0
27992,),0,0
27993,.,0,0
27994,The,0,0
27995,mean,1,1
27996,maximum,1,1
27997,Cr,1,0
27998,was,0,0
27999,3.3,0,0
28000,+/-,0,0
28001,1.4,0,0
28002,",",0,0
28003,range,0,0
28004,1.7-8.7,0,0
28005,mg/dL,0,0
28006,),0,0
28007,.,0,0
28008,Longitudinal,0,0
28009,models,0,0
28010,support,0,0
28011,baseline,0,0
28012,Cr,1,0
28013,clearance,1,1
28014,predictions,0,0
28015,for,0,0
28016,the,0,0
28017,change,0,0
28018,in,0,0
28019,Cr,0,0
28020,at,0,0
28021,24,0,0
28022,hours,0,0
28023,",",0,0
28024,time,0,1
28025,as,0,0
28026,the,0,0
28027,determinant,0,0
28028,of,0,0
28029,Cr,0,0
28030,trajectory,0,1
28031,",",0,0
28032,and,0,1
28033,requisite,0,0
28034,monitoring,0,0
28035,.,0,0
28036,For,0,0
28037,any,0,0
28038,given,0,0
28039,individual,0,0
28040,",",0,0
28041,a,0,0
28042,rise,0,0
28043,in,0,0
28044,Cr,1,0
28045,of,0,0
28046,<,0,0
28047,or,0,0
28048,=,0,0
28049,0.5,0,0
28050,mg/dL,0,0
28051,in,0,0
28052,the,0,0
28053,first,0,0
28054,24,0,0
28055,hours,0,0
28056,after,0,0
28057,contrast,0,0
28058,exposure,0,0
28059,predicted,0,0
28060,a,0,0
28061,favorable,0,0
28062,outcome,0,0
28063,.,0,0
28064,Baseline,1,0
28065,renal,1,0
28066,function,1,0
28067,is,0,0
28068,the,0,0
28069,major,0,0
28070,determinant,0,0
28071,of,0,0
28072,the,0,0
28073,rate,0,1
28074,of,0,0
28075,rise,0,0
28076,",",0,0
28077,height,0,1
28078,",",0,1
28079,and,0,1
28080,duration,0,1
28081,of,0,1
28082,Cr,0,0
28083,trajectory,0,1
28084,after,0,0
28085,contrast,0,0
28086,exposure,0,0
28087,.,0,0
28088,Length,0,1
28089,of,0,0
28090,observation,0,0
28091,and,0,1
28092,frequency,0,1
28093,of,0,1
28094,laboratory,0,0
28095,measures,0,0
28096,can,0,0
28097,be,0,0
28098,anticipated,0,0
28099,from,0,0
28100,these,0,0
28101,models,0,0
28102,.,0,0
28103,Galantamine,0,0
28104,may,0,0
28105,be,0,0
28106,effective,0,0
28107,in,0,0
28108,treating,0,0
28109,autistic,0,0
28110,disorder,0,0
28111,.,0,0
28112,Ankle,0,0
28113,cryotherapy,0,0
28114,facilitates,0,0
28115,soleus,1,0
28116,function,1,1
28117,.,1,0
28118,STUDY,0,1
28119,DESIGN,0,0
28120,A,0,0
28121,2-factor,0,0
28122,(,0,0
28123,group,0,0
28124,and,0,1
28125,time,0,1
28126,),0,1
28127,experimental,0,0
28128,design,0,0
28129,with,0,0
28130,repeated,0,0
28131,measures,0,1
28132,on,0,0
28133,time,0,1
28134,.,0,0
28135,OBJECTIVES,0,0
28136,To,0,0
28137,determine,0,0
28138,the,0,0
28139,effects,0,0
28140,of,0,0
28141,ankle,0,1
28142,cryotherapy,0,0
28143,on,0,0
28144,voluntary,1,0
28145,and,1,0
28146,resting,1,1
28147,motor,1,1
28148,function,1,1
28149,of,1,0
28150,the,1,0
28151,soleus,1,0
28152,over,0,0
28153,a,0,0
28154,60-minute,0,0
28155,period,0,0
28156,.,0,0
28157,To,0,0
28158,determine,0,0
28159,if,0,0
28160,a,0,0
28161,relationship,0,0
28162,exists,0,0
28163,between,0,0
28164,changes,0,1
28165,in,0,0
28166,torque,1,1
28167,production,1,1
28168,and,0,1
28169,Hoffmann,1,0
28170,reflex,1,1
28171,(,1,0
28172,H-reflex,1,1
28173,),1,0
28174,following,0,0
28175,ankle,0,1
28176,joint,0,1
28177,cryotherapy,0,0
28178,treatment,0,0
28179,.,0,0
28180,BACKGROUND,0,0
28181,Controversy,0,0
28182,surrounds,0,0
28183,the,0,0
28184,use,0,0
28185,of,0,0
28186,cryotherapy,0,0
28187,prior,0,0
28188,to,0,0
28189,activity,0,1
28190,and,0,0
28191,rehabilitation,0,0
28192,.,0,0
28193,While,0,0
28194,cooling,0,0
28195,muscle,0,0
28196,may,0,0
28197,have,0,0
28198,a,0,0
28199,deleterious,0,0
28200,effect,0,0
28201,on,0,0
28202,motor,1,1
28203,function,1,1
28204,",",0,0
28205,cooling,0,0
28206,the,0,0
28207,joint,0,0
28208,may,0,0
28209,enhance,0,0
28210,motor,1,1
28211,function,1,1
28212,around,0,0
28213,the,0,0
28214,joint,0,0
28215,.,0,0
28216,The,0,0
28217,H-reflex,1,0
28218,is,0,0
28219,a,0,0
28220,good,0,0
28221,resting,0,1
28222,measure,0,0
28223,of,0,0
28224,motoneuronal,0,1
28225,activity,0,1
28226,.,0,0
28227,However,0,0
28228,",",0,0
28229,its,0,0
28230,relationship,0,0
28231,to,0,0
28232,voluntary,0,0
28233,activity,0,1
28234,is,0,0
28235,unknown,0,0
28236,.,0,0
28237,METHODS,0,0
28238,AND,0,0
28239,MEASURES,0,1
28240,Thirty,0,0
28241,subjects,0,0
28242,were,0,0
28243,pretested,0,0
28244,(,0,0
28245,baseline,0,0
28246,),0,0
28247,for,0,0
28248,normalized,0,0
28249,H-reflex,1,1
28250,(,0,0
28251,defined,0,0
28252,as,0,0
28253,the,0,0
28254,ratio,0,1
28255,of,0,0
28256,maximum,0,1
28257,H-reflex,0,1
28258,[,0,0
28259,Hmax,0,1
28260,],0,0
28261,to,0,0
28262,maximum,0,1
28263,direct,0,0
28264,motor,0,1
28265,response,0,1
28266,[,0,0
28267,Mmax,0,1
28268,],0,0
28269,),0,0
28270,and,0,0
28271,peak,1,1
28272,plantar,1,1
28273,flexion,1,1
28274,torque,1,1
28275,.,1,0
28276,A,0,0
28277,crushed,0,0
28278,ice,0,0
28279,bag,0,0
28280,was,0,0
28281,placed,0,0
28282,over,0,0
28283,the,0,0
28284,ankle,0,0
28285,of,0,0
28286,15,0,0
28287,subjects,0,0
28288,for,0,0
28289,30,0,0
28290,minutes,0,0
28291,.,0,0
28292,H-reflex,1,1
28293,and,1,0
28294,torque,1,1
28295,measurements,1,0
28296,were,0,0
28297,collected,0,0
28298,immediately,0,0
28299,following,0,0
28300,the,0,0
28301,cryotherapy,0,0
28302,treatment,0,0
28303,at,0,0
28304,30,0,0
28305,",",0,0
28306,60,0,0
28307,",",0,0
28308,and,0,0
28309,90,0,0
28310,minutes,0,0
28311,.,0,0
28312,Surface,1,1
28313,temperatures,1,1
28314,were,0,0
28315,recorded,0,0
28316,from,0,0
28317,the,0,0
28318,ankle,0,0
28319,and,0,0
28320,electrode,0,0
28321,site,0,0
28322,with,0,0
28323,each,0,0
28324,measurement,0,0
28325,interval,0,0
28326,.,0,0
28327,RESULTS,0,0
28328,Both,0,0
28329,peak,1,1
28330,H-reflex,1,1
28331,and,1,0
28332,plantar,1,1
28333,flexion,1,1
28334,torque,1,1
28335,at,0,0
28336,30,0,0
28337,",",0,0
28338,60,0,0
28339,",",0,0
28340,and,0,0
28341,90,0,0
28342,minutes,0,0
28343,increased,0,0
28344,relative,0,0
28345,to,0,0
28346,baseline,0,0
28347,measurements,0,0
28348,.,0,0
28349,Each,0,0
28350,measurement,0,0
28351,was,0,0
28352,also,0,0
28353,greater,0,0
28354,than,0,0
28355,the,0,0
28356,corresponding,0,0
28357,control,0,0
28358,at,0,0
28359,30,0,0
28360,",",0,0
28361,60,0,0
28362,",",0,0
28363,and,0,0
28364,90,0,0
28365,minutes,0,0
28366,.,0,0
28367,A,0,0
28368,weak,0,0
28369,correlation,0,0
28370,(,0,0
28371,r,0,0
28372,=,0,0
28373,0.38,0,0
28374,;,0,0
28375,P,0,0
28376,=,0,0
28377,0.036,0,0
28378,),0,0
28379,existed,0,0
28380,between,0,0
28381,changes,0,1
28382,in,0,0
28383,H-reflex,1,1
28384,and,1,0
28385,plantar,1,1
28386,flexion,1,1
28387,torque,1,1
28388,at,0,0
28389,30,0,0
28390,minutes,0,0
28391,.,0,0
28392,CONCLUSIONS,0,0
28393,The,0,0
28394,soleus,0,0
28395,motoneuron,0,0
28396,pool,0,0
28397,is,0,0
28398,facilitated,0,0
28399,following,0,0
28400,a,0,0
28401,30-minute,0,0
28402,crushed,0,0
28403,ice,0,0
28404,application,0,0
28405,to,0,0
28406,the,0,0
28407,ankle,0,1
28408,and,0,0
28409,over,0,0
28410,a,0,0
28411,60-minute,0,0
28412,postcooling,0,0
28413,period,0,0
28414,.,0,0
28415,These,0,0
28416,data,0,0
28417,support,0,0
28418,the,0,0
28419,use,0,0
28420,of,0,0
28421,joint,0,1
28422,cooling,0,0
28423,prior,0,0
28424,to,0,0
28425,activity,0,1
28426,and,0,0
28427,rehabilitation,0,0
28428,.,0,0
28429,Treatment,0,0
28430,effects,0,1
28431,of,0,0
28432,eptifibatide,0,0
28433,in,0,0
28434,planned,0,0
28435,coronary,0,0
28436,stent,0,0
28437,implantation,0,0
28438,in,0,0
28439,patients,0,0
28440,with,0,0
28441,chronic,0,0
28442,kidney,0,1
28443,disease,0,1
28444,(,0,0
28445,ESPRIT,0,0
28446,Trial,0,0
28447,),0,0
28448,.,0,0
28449,The,0,0
28450,role,0,0
28451,of,0,0
28452,platelet,0,1
28453,glycoprotein,0,1
28454,IIb/IIIa,0,1
28455,inhibitor,0,0
28456,therapy,0,0
28457,in,0,0
28458,patients,0,0
28459,with,0,0
28460,mild,0,1
28461,renal,0,0
28462,impairment,0,0
28463,is,0,0
28464,not,0,0
28465,well,0,0
28466,characterized,0,0
28467,.,0,0
28468,Our,0,0
28469,objective,0,0
28470,was,0,0
28471,to,0,0
28472,explore,0,0
28473,the,0,0
28474,associations,1,0
28475,of,1,0
28476,creatinine,1,1
28477,clearance,1,1
28478,(,1,0
28479,CrCl,1,0
28480,),1,0
28481,with,0,0
28482,outcomes,1,0
28483,in,0,0
28484,a,0,0
28485,trial,0,0
28486,of,0,0
28487,eptifibatide,0,1
28488,therapy,0,0
28489,in,0,0
28490,patients,0,0
28491,who,0,0
28492,underwent,0,0
28493,percutaneous,0,0
28494,coronary,0,0
28495,intervention,0,0
28496,(,0,0
28497,PCI,0,1
28498,),0,0
28499,.,0,0
28500,We,0,0
28501,analyzed,0,0
28502,48-hour,0,0
28503,and,0,0
28504,30-day,0,1
28505,outcomes,0,1
28506,of,0,0
28507,patients,0,0
28508,enrolled,0,0
28509,in,0,0
28510,the,0,0
28511,Enhanced,0,0
28512,Suppression,0,1
28513,of,0,0
28514,the,0,0
28515,Platelet,0,1
28516,IIb/IIIa,0,0
28517,Receptor,0,0
28518,with,0,0
28519,Integrilin,0,0
28520,Therapy,0,0
28521,(,0,0
28522,ESPRIT,0,0
28523,),0,0
28524,trial,0,0
28525,.,0,0
28526,Patients,0,0
28527,were,0,0
28528,randomly,0,0
28529,assigned,0,0
28530,to,0,0
28531,placebo,0,0
28532,or,0,0
28533,eptifibatide,0,0
28534,as,0,0
28535,an,0,0
28536,adjunct,0,0
28537,to,0,0
28538,stent,0,0
28539,implantation,0,0
28540,(,0,0
28541,"1,755",0,0
28542,with,0,0
28543,CrCl,0,0
28544,>,0,0
28545,or,0,0
28546,=60,0,0
28547,ml/min,0,0
28548,and,0,0
28549,289,0,0
28550,with,0,0
28551,CrCl,0,0
28552,<,0,0
28553,60,0,0
28554,ml/min,0,0
28555,),0,0
28556,.,0,0
28557,CrCl,1,0
28558,was,0,0
28559,calculated,0,0
28560,using,0,0
28561,the,1,0
28562,Cockcroft,1,0
28563,and,1,0
28564,Gault,1,1
28565,formula,1,0
28566,",",0,0
28567,and,0,0
28568,the,0,0
28569,associations,0,0
28570,of,0,0
28571,CrCl,1,0
28572,with,0,0
28573,outcomes,0,1
28574,were,0,0
28575,evaluated,0,0
28576,using,0,0
28577,logistic,1,0
28578,regression,1,0
28579,models,1,0
28580,.,1,0
28581,Patients,0,0
28582,with,0,0
28583,CrCl,0,0
28584,<,0,0
28585,60,0,0
28586,ml/min,0,0
28587,were,0,0
28588,more,0,0
28589,likely,0,0
28590,to,0,0
28591,be,0,0
28592,older,0,0
28593,",",0,0
28594,women,0,0
28595,",",0,1
28596,hypertensive,0,1
28597,",",0,0
28598,and,0,0
28599,have,0,0
28600,a,0,0
28601,history,0,0
28602,of,0,0
28603,coronary,0,0
28604,artery,0,1
28605,bypass,0,0
28606,surgery,0,0
28607,",",0,1
28608,stroke,0,1
28609,",",0,1
28610,or,0,0
28611,peripheral,0,1
28612,vascular,0,1
28613,disease,0,0
28614,.,0,0
28615,The,0,0
28616,interaction,0,1
28617,of,0,0
28618,eptifibatide,0,0
28619,with,0,0
28620,CrCl,0,0
28621,had,0,0
28622,borderline,0,0
28623,significance,0,1
28624,for,0,0
28625,the,0,0
28626,30-day,0,1
28627,outcome,0,1
28628,(,0,0
28629,p,0,0
28630,=,0,0
28631,0.109,0,0
28632,),0,0
28633,.,0,0
28634,Treatment,0,0
28635,effect,0,0
28636,trended,0,0
28637,toward,0,0
28638,a,0,0
28639,greater,0,0
28640,magnitude,0,1
28641,in,0,0
28642,patients,0,0
28643,with,0,0
28644,lower,0,0
28645,CrCl,0,0
28646,(,0,0
28647,60,0,0
28648,ml/min,0,0
28649,),0,0
28650,(,0,0
28651,odds,0,0
28652,ratio,0,0
28653,0.53,0,0
28654,",",0,0
28655,confidence,0,0
28656,interval,0,0
28657,0.34,0,0
28658,to,0,0
28659,0.83,0,0
28660,),0,0
28661,compared,0,0
28662,with,0,0
28663,those,0,0
28664,with,0,0
28665,higher,0,0
28666,CrCl,0,0
28667,(,0,0
28668,90,0,0
28669,ml/min,0,0
28670,),0,0
28671,(,0,0
28672,odds,0,0
28673,ratio,0,0
28674,0.68,0,0
28675,",",0,0
28676,confidence,0,0
28677,interval,0,0
28678,0.49,0,0
28679,to,0,0
28680,0.94,0,0
28681,),0,0
28682,.,0,0
28683,An,0,0
28684,accompanying,0,0
28685,increase,0,0
28686,in,0,0
28687,bleeding,1,1
28688,risk,1,1
28689,also,0,0
28690,was,0,0
28691,not,0,0
28692,apparent,0,0
28693,with,0,0
28694,lower,0,0
28695,CrCl,0,0
28696,.,0,0
28697,The,0,0
28698,treatment,0,0
28699,effect,0,0
28700,of,0,0
28701,eptifibatide,0,0
28702,is,0,0
28703,realized,0,0
28704,regardless,0,0
28705,of,0,0
28706,renal,0,1
28707,function,0,1
28708,and,0,0
28709,trends,0,1
28710,toward,0,0
28711,being,0,0
28712,greater,0,0
28713,in,0,0
28714,patients,0,0
28715,with,0,0
28716,mild,0,1
28717,renal,1,0
28718,impairment,1,0
28719,.,1,0
28720,Is,0,0
28721,the,0,0
28722,orientation,0,0
28723,of,0,0
28724,the,0,0
28725,apical,0,0
28726,defibrillation,0,0
28727,paddle,0,1
28728,of,0,0
28729,importance,0,0
28730,during,0,0
28731,manual,0,0
28732,external,0,0
28733,defibrillation,0,0
28734,?,0,0
28735,OBJECTIVE,0,0
28736,Transthoracic,1,1
28737,impedance,1,1
28738,(,1,0
28739,TTI,1,1
28740,),1,0
28741,is,0,0
28742,a,0,0
28743,factor,0,0
28744,determining,0,0
28745,the,0,0
28746,magnitude,0,1
28747,of,0,0
28748,the,0,0
28749,transmyocardial,0,0
28750,current,0,0
28751,during,0,0
28752,external,0,0
28753,defibrillation,0,0
28754,.,0,0
28755,Minimising,0,0
28756,TTI,0,1
28757,increases,0,0
28758,the,0,0
28759,chances,0,0
28760,of,0,0
28761,successful,0,0
28762,defibrillation,0,0
28763,.,0,0
28764,Most,0,0
28765,external,0,0
28766,defibrillation,0,0
28767,paddles,0,0
28768,are,0,0
28769,rectangular,0,0
28770,in,0,0
28771,shape,0,0
28772,and,0,0
28773,can,0,0
28774,",",0,0
28775,therefore,0,0
28776,",",0,0
28777,be,0,0
28778,placed,0,0
28779,in,0,0
28780,a,0,0
28781,transverse,0,1
28782,or,0,0
28783,longitudinal,0,0
28784,orientation,0,0
28785,.,0,0
28786,The,0,0
28787,apical,0,0
28788,paddle,0,0
28789,is,0,0
28790,often,0,0
28791,placed,0,0
28792,in,0,0
28793,a,0,0
28794,transverse,0,0
28795,orientation,0,0
28796,.,0,0
28797,This,0,0
28798,may,0,0
28799,theoretically,0,0
28800,result,0,0
28801,in,0,0
28802,a,0,0
28803,higher,0,0
28804,TTI,0,1
28805,than,0,0
28806,a,0,0
28807,longitudinal,0,0
28808,orientation,0,0
28809,because,0,0
28810,of,0,0
28811,poorer,0,0
28812,contact,0,1
28813,at,0,0
28814,the,0,0
28815,lateral,0,0
28816,paddle,0,0
28817,edges,0,0
28818,.,0,0
28819,We,0,0
28820,compared,0,0
28821,TTI,0,1
28822,with,0,0
28823,the,0,0
28824,apical,0,0
28825,paddle,0,0
28826,in,0,0
28827,both,0,0
28828,a,0,0
28829,transverse,0,1
28830,and,0,0
28831,longitudinal,0,0
28832,orientation,0,1
28833,.,0,0
28834,MATERIALS,0,0
28835,AND,0,0
28836,METHODS,0,0
28837,Twenty,0,0
28838,sequential,0,0
28839,anaesthetised,0,0
28840,patients,0,0
28841,were,0,0
28842,studied,0,0
28843,.,0,0
28844,A,0,0
28845,pair,0,0
28846,of,0,0
28847,defibrillator,0,0
28848,paddles,0,1
28849,were,0,0
28850,instrumented,0,0
28851,to,0,0
28852,measure,0,0
28853,paddle,1,1
28854,force,1,1
28855,.,1,0
28856,TTI,1,1
28857,was,0,0
28858,recorded,0,0
28859,pre-operatively,0,0
28860,at,0,0
28861,end-expiration,0,0
28862,with,0,0
28863,the,0,0
28864,apical,0,0
28865,paddle,0,0
28866,in,0,0
28867,both,0,0
28868,longitudinal,0,0
28869,and,0,0
28870,transverse,0,1
28871,orientations,0,0
28872,.,0,0
28873,The,0,0
28874,sternal,0,1
28875,paddle,0,1
28876,was,0,0
28877,placed,0,0
28878,in,0,0
28879,a,0,0
28880,longitudinal,0,0
28881,orientation,0,0
28882,for,0,0
28883,all,0,0
28884,measurements,0,0
28885,.,0,0
28886,RESULTS,0,0
28887,TTI,1,1
28888,decreased,0,0
28889,in,0,0
28890,both,0,0
28891,transverse,0,1
28892,and,0,0
28893,longitudinal,0,0
28894,orientations,0,1
28895,as,0,0
28896,paddle,0,1
28897,force,0,1
28898,increased,0,0
28899,.,0,0
28900,Transverse,0,1
28901,paddle,0,1
28902,orientation,0,1
28903,resulted,0,0
28904,in,0,0
28905,a,0,0
28906,significantly,0,0
28907,(,0,0
28908,P,0,0
28909,<,0,0
28910,0.01,0,0
28911,),0,0
28912,higher,0,0
28913,TTI,1,1
28914,than,0,0
28915,longitudinal,0,0
28916,orientation,0,0
28917,at,0,0
28918,all,0,0
28919,paddle,0,0
28920,forces,0,0
28921,below,0,0
28922,12,0,0
28923,kg,0,0
28924,force,0,0
28925,.,0,0
28926,CONCLUSION,0,0
28927,The,0,0
28928,longitudinal,0,0
28929,orientation,0,0
28930,of,0,0
28931,a,0,0
28932,rectangular,0,0
28933,defibrillation,0,0
28934,paddle,0,0
28935,provides,0,0
28936,a,0,0
28937,lower,0,0
28938,TTI,1,1
28939,than,0,0
28940,orientation,0,0
28941,horizontally,0,0
28942,.,0,0
28943,Direct,0,1
28944,aortic,0,1
28945,cannulation,0,0
28946,in,0,0
28947,minimally,0,0
28948,invasive,0,0
28949,mitral-valve,0,0
28950,operations,0,0
28951,.,0,0
28952,The,0,0
28953,minimally,0,0
28954,invasive,0,0
28955,Port-Access,0,0
28956,(,0,0
28957,Heartport,0,0
28958,",",0,0
28959,Redwood,0,1
28960,City,0,1
28961,",",0,0
28962,CA,0,0
28963,),0,1
28964,approach,0,0
28965,in,0,0
28966,mitral-valve,0,0
28967,operations,0,0
28968,originally,0,0
28969,required,0,0
28970,femoral,0,1
28971,arterial,0,1
28972,cannulation,0,0
28973,",",0,0
28974,which,0,0
28975,is,0,0
28976,considered,0,0
28977,a,0,0
28978,disadvantage,0,0
28979,",",0,0
28980,especially,0,0
28981,in,0,0
28982,patients,0,0
28983,with,0,0
28984,peripheral,0,1
28985,vessel,0,1
28986,disease,0,0
28987,.,0,0
28988,In,0,0
28989,this,0,0
28990,study,0,0
28991,20,0,0
28992,patients,0,0
28993,were,0,0
28994,prospectively,0,0
28995,randomized,0,0
28996,into,0,0
28997,2,0,0
28998,groups,0,0
28999,",",0,0
29000,to,0,0
29001,undergo,0,0
29002,either,0,0
29003,standard,0,0
29004,femoral,0,1
29005,(,0,0
29006,group,0,0
29007,A,0,0
29008,),0,0
29009,or,0,0
29010,direct,0,0
29011,aortic,0,1
29012,cannulation,0,0
29013,(,0,0
29014,group,0,0
29015,B,0,0
29016,),0,0
29017,.,0,0
29018,Pre-,0,0
29019,and,0,0
29020,postoperative,0,1
29021,data,0,0
29022,as,0,0
29023,well,0,0
29024,as,0,0
29025,markers,0,1
29026,for,0,0
29027,myocardial,0,1
29028,damage,0,1
29029,were,0,0
29030,assessed,0,0
29031,.,0,0
29032,Postoperatively,0,0
29033,",",0,0
29034,patients,0,0
29035,of,0,1
29036,group,0,0
29037,B,0,0
29038,showed,0,0
29039,lower,0,0
29040,levels,1,1
29041,of,1,1
29042,damage,1,1
29043,",",0,0
29044,indicating,0,0
29045,that,0,0
29046,direct,0,0
29047,aortic,0,0
29048,cannulation,0,0
29049,might,0,0
29050,provide,0,0
29051,better,0,0
29052,myocardial,0,1
29053,protection,0,1
29054,.,0,0
29055,Furthermore,0,0
29056,",",0,0
29057,the,0,0
29058,direct,0,0
29059,aortic,0,1
29060,cannulation,0,0
29061,technique,0,0
29062,may,0,0
29063,eliminate,0,0
29064,complications,1,1
29065,associated,0,0
29066,with,0,0
29067,the,0,0
29068,standard,0,0
29069,femoral,0,1
29070,artery,0,0
29071,cannulation,0,0
29072,.,0,0
29073,The,0,0
29074,development,0,1
29075,and,0,0
29076,evaluation,0,0
29077,of,0,0
29078,a,0,0
29079,computer-based,0,0
29080,program,0,0
29081,to,0,0
29082,test,0,0
29083,and,0,0
29084,to,0,0
29085,teach,0,0
29086,the,0,0
29087,recognition,0,0
29088,of,0,0
29089,facial,1,0
29090,affect,1,0
29091,.,1,0
29092,Autism,0,0
29093,is,0,0
29094,a,0,0
29095,chronic,0,0
29096,pervasive,0,0
29097,neurodevelopmental,0,0
29098,disorder,0,0
29099,characterized,0,0
29100,by,0,0
29101,the,0,0
29102,early,0,0
29103,onset,0,1
29104,of,0,0
29105,social,0,1
29106,and,0,0
29107,communicative,0,1
29108,impairments,0,0
29109,as,0,0
29110,well,0,0
29111,as,0,0
29112,restricted,0,0
29113,",",0,0
29114,ritualized,0,0
29115,",",0,0
29116,stereotypic,0,0
29117,behavior,0,1
29118,.,0,0
29119,The,0,0
29120,endophenotype,0,0
29121,of,0,0
29122,autism,0,0
29123,includes,0,0
29124,neuropsychological,0,0
29125,deficits,0,0
29126,",",0,0
29127,for,0,0
29128,instance,0,0
29129,a,0,0
29130,lack,0,0
29131,of,0,0
29132,Theory,0,0
29133,of,0,0
29134,Mind,0,1
29135,and,0,0
29136,problems,0,1
29137,recognizing,0,0
29138,facial,0,0
29139,affect,0,0
29140,.,0,0
29141,In,0,0
29142,this,0,0
29143,study,0,0
29144,",",0,0
29145,we,0,0
29146,report,0,0
29147,the,0,0
29148,development,0,1
29149,and,0,0
29150,evaluation,0,0
29151,of,0,0
29152,a,0,0
29153,computer-based,0,0
29154,program,0,0
29155,to,0,0
29156,teach,0,0
29157,and,0,0
29158,test,0,0
29159,the,0,0
29160,ability,0,0
29161,to,0,0
29162,identify,0,0
29163,basic,1,0
29164,facially,1,0
29165,expressed,1,0
29166,emotions,1,0
29167,.,1,0
29168,10,0,0
29169,adolescent,0,0
29170,or,0,0
29171,adult,0,0
29172,subjects,0,0
29173,with,0,0
29174,high-functioning,0,0
29175,autism,0,0
29176,or,0,0
29177,Asperger-syndrome,0,0
29178,were,0,0
29179,included,0,0
29180,in,0,0
29181,the,0,0
29182,investigation,0,0
29183,.,0,0
29184,A,0,0
29185,priori,0,0
29186,the,0,0
29187,facial,0,0
29188,affect,0,0
29189,recognition,0,1
29190,test,0,1
29191,had,0,0
29192,shown,0,0
29193,good,0,0
29194,psychometric,0,1
29195,properties,0,1
29196,in,0,0
29197,a,0,0
29198,normative,0,0
29199,sample,0,0
29200,(,0,0
29201,internal,0,0
29202,consistency,0,1
29203,:,0,0
29204,rtt=.91-.95,0,0
29205,;,0,0
29206,retest,0,0
29207,reliability,0,1
29208,:,0,0
29209,rtt=.89-.92,0,0
29210,),0,0
29211,.,0,0
29212,In,0,0
29213,a,0,0
29214,prepost,0,0
29215,design,0,0
29216,",",0,0
29217,one,0,0
29218,half,0,0
29219,of,0,0
29220,the,0,0
29221,sample,0,0
29222,was,0,0
29223,randomly,0,0
29224,assigned,0,0
29225,to,0,0
29226,receive,0,0
29227,computer,0,0
29228,treatment,0,0
29229,while,0,0
29230,the,0,0
29231,other,0,0
29232,half,0,0
29233,of,0,0
29234,the,0,0
29235,sample,0,0
29236,served,0,0
29237,as,0,0
29238,control,0,0
29239,group,0,0
29240,.,0,0
29241,The,0,0
29242,training,0,0
29243,was,0,0
29244,conducted,0,0
29245,for,0,0
29246,five,0,0
29247,weeks,0,0
29248,",",0,0
29249,consisting,0,0
29250,of,0,0
29251,two,0,0
29252,hours,0,0
29253,training,0,0
29254,a,0,0
29255,week,0,0
29256,.,0,0
29257,The,0,0
29258,trained,0,0
29259,individuals,0,0
29260,improved,0,0
29261,significantly,0,0
29262,on,0,0
29263,the,0,0
29264,affect,1,0
29265,recognition,1,1
29266,task,1,1
29267,",",0,0
29268,but,0,0
29269,not,0,0
29270,on,0,0
29271,any,0,0
29272,other,0,0
29273,measure,0,0
29274,.,0,0
29275,Results,0,0
29276,support,0,0
29277,the,0,0
29278,usefulness,0,0
29279,of,0,0
29280,the,0,0
29281,program,0,0
29282,to,0,0
29283,teach,1,0
29284,the,1,0
29285,detection,1,0
29286,of,1,0
29287,facial,1,0
29288,affect,1,0
29289,.,1,0
29290,However,0,0
29291,",",0,0
29292,the,0,0
29293,improvement,0,0
29294,found,0,0
29295,is,0,0
29296,limited,0,0
29297,to,0,0
29298,a,0,0
29299,circumscribed,0,0
29300,area,0,1
29301,of,0,0
29302,social-communicative,0,1
29303,function,0,1
29304,and,0,0
29305,generalization,0,0
29306,is,0,0
29307,not,0,0
29308,ensured,0,0
29309,.,0,0
29310,Effects,0,0
29311,of,0,0
29312,oral,0,0
29313,Lactobacillus,0,0
29314,GG,0,0
29315,on,0,0
29316,enteric,1,0
29317,microflora,1,0
29318,in,0,0
29319,low-birth-weight,0,0
29320,neonates,0,0
29321,.,0,0
29322,BACKGROUND,0,0
29323,Colonization,0,1
29324,patterns,0,1
29325,",",0,0
29326,especially,0,0
29327,by,0,0
29328,anaerobic,0,0
29329,flora,0,0
29330,",",0,0
29331,may,0,0
29332,play,0,0
29333,an,0,0
29334,important,0,0
29335,role,0,0
29336,in,0,0
29337,neonatal,0,1
29338,gut,0,1
29339,function,0,1
29340,.,0,0
29341,Probiotics,0,0
29342,could,0,0
29343,affect,0,0
29344,disease,1,0
29345,risk,1,0
29346,either,0,0
29347,directly,0,0
29348,through,0,0
29349,colonization,0,1
29350,or,0,0
29351,indirectly,0,0
29352,by,0,0
29353,promoting,0,0
29354,changes,0,1
29355,in,0,0
29356,gut,0,1
29357,microbial,0,0
29358,ecology,0,0
29359,.,0,0
29360,METHODS,0,0
29361,To,0,0
29362,study,0,0
29363,the,0,0
29364,ability,0,0
29365,of,0,0
29366,Lactobacillus,0,1
29367,GG,0,0
29368,(,0,0
29369,LGG,0,0
29370,),0,0
29371,to,0,0
29372,colonize,1,0
29373,the,1,0
29374,neonatal,1,1
29375,gut,1,0
29376,and,1,0
29377,modify,1,0
29378,its,1,0
29379,microbial,1,0
29380,ecology,1,0
29381,",",0,0
29382,a,0,0
29383,prospective,0,0
29384,",",0,0
29385,randomized,0,0
29386,study,0,0
29387,was,0,0
29388,performed,0,0
29389,in,0,0
29390,71,0,0
29391,preterm,0,0
29392,infants,0,0
29393,of,0,0
29394,less,0,0
29395,than,0,0
29396,2000,0,0
29397,g,0,0
29398,birth,0,0
29399,weight,0,0
29400,.,0,0
29401,Infants,0,0
29402,less,0,0
29403,than,0,0
29404,1500,0,0
29405,g,0,0
29406,(,0,0
29407,24,0,0
29408,treated,0,0
29409,",",0,0
29410,15,0,0
29411,control,0,0
29412,),0,0
29413,received,0,0
29414,10,0,0
29415,(,0,0
29416,9,0,0
29417,),0,0
29418,LGG,0,0
29419,orally,0,0
29420,twice,0,0
29421,daily,0,0
29422,for,0,0
29423,21,0,0
29424,days,0,0
29425,.,0,0
29426,Those,0,0
29427,infants,0,0
29428,weighing,0,0
29429,1500,0,0
29430,to,0,0
29431,1999,0,0
29432,g,0,0
29433,(,0,0
29434,23,0,0
29435,treated,0,0
29436,",",0,0
29437,9,0,0
29438,control,0,0
29439,),0,0
29440,were,0,0
29441,treated,0,0
29442,for,0,0
29443,8,0,0
29444,days,0,0
29445,.,0,0
29446,Stools,0,1
29447,were,0,0
29448,collected,0,0
29449,before,0,0
29450,treatment,0,0
29451,and,0,0
29452,on,0,0
29453,day,0,0
29454,7,0,0
29455,to,0,0
29456,8,0,0
29457,(,0,0
29458,and,0,0
29459,day,0,0
29460,14,0,0
29461,and,0,0
29462,21,0,0
29463,",",0,0
29464,in,0,0
29465,the,0,0
29466,infants,0,0
29467,weighing,0,0
29468,less,0,0
29469,than,0,0
29470,1500,0,0
29471,g,0,0
29472,),0,0
29473,for,0,0
29474,quantitative,1,0
29475,aerobic,1,0
29476,and,1,0
29477,anaerobic,1,0
29478,cultures,1,0
29479,.,1,0
29480,RESULTS,0,0
29481,Colonization,1,1
29482,with,1,0
29483,LGG,1,0
29484,occurred,1,0
29485,in,0,0
29486,5,0,0
29487,of,0,0
29488,24,0,0
29489,(,0,0
29490,21,0,0
29491,%,0,0
29492,),0,0
29493,infants,0,0
29494,who,0,0
29495,weighed,0,0
29496,less,0,0
29497,than,0,0
29498,1500,0,0
29499,g,0,0
29500,versus,0,0
29501,11,0,0
29502,of,0,0
29503,23,0,0
29504,(,0,0
29505,47,0,0
29506,%,0,0
29507,),0,0
29508,in,0,0
29509,larger,0,0
29510,infants,0,0
29511,.,0,1
29512,Colonization,1,1
29513,was,0,0
29514,limited,0,0
29515,to,0,0
29516,infants,0,0
29517,who,0,0
29518,were,0,0
29519,not,0,0
29520,on,0,0
29521,antibiotics,0,0
29522,within,0,0
29523,7,0,0
29524,days,0,0
29525,of,0,0
29526,treatment,0,0
29527,with,0,0
29528,LGG,0,0
29529,.,0,0
29530,There,0,0
29531,was,0,0
29532,a,0,0
29533,paucity,0,0
29534,of,0,0
29535,bacterial,0,1
29536,species,0,0
29537,at,0,0
29538,baseline,0,0
29539,",",0,0
29540,although,0,0
29541,larger,0,0
29542,infants,0,0
29543,had,0,0
29544,more,0,0
29545,bacterial,1,1
29546,species,1,0
29547,(,0,0
29548,1.59,0,0
29549,+/-,0,0
29550,0.13,0,0
29551,(,0,0
29552,SEM,0,0
29553,),0,0
29554,vs,0,0
29555,1.11,0,0
29556,+/-,0,0
29557,0.12,0,0
29558,;,0,0
29559,P,0,0
29560,<,0,0
29561,0.03,0,0
29562,),0,0
29563,and,0,0
29564,higher,0,1
29565,mean,1,1
29566,log,1,1
29567,colony,1,1
29568,forming,1,0
29569,units,1,0
29570,(,1,0
29571,CFU,1,0
29572,),1,0
29573,(,0,0
29574,8.79,0,0
29575,+/-,0,0
29576,0.43,0,0
29577,vs,0,0
29578,7.22,0,0
29579,+/-,0,0
29580,0.63,0,0
29581,;,0,0
29582,P,0,0
29583,<,0,0
29584,0.05,0,0
29585,),0,0
29586,compared,0,0
29587,with,0,0
29588,infants,0,0
29589,weighing,0,0
29590,less,0,0
29591,than,0,0
29592,1500,0,0
29593,g,0,0
29594,LGG,0,0
29595,.,0,0
29596,Treatment,0,0
29597,in,0,0
29598,infants,0,0
29599,weighing,0,0
29600,less,0,0
29601,than,0,0
29602,1500,0,0
29603,g,0,0
29604,resulted,0,0
29605,in,0,0
29606,a,0,0
29607,significant,0,0
29608,increase,1,0
29609,in,1,0
29610,species,1,0
29611,number,1,1
29612,by,1,0
29613,day,1,0
29614,7,1,0
29615,",",1,0
29616,with,1,0
29617,further,1,0
29618,increases,1,1
29619,by,1,0
29620,day,1,0
29621,21,1,0
29622,.,1,0
29623,This,0,0
29624,increase,0,0
29625,was,0,0
29626,mainly,0,0
29627,the,0,0
29628,result,0,0
29629,of,0,0
29630,increased,1,0
29631,Gram,1,0
29632,(,1,0
29633,+,1,0
29634,),1,0
29635,and,1,0
29636,anaerobic,1,0
29637,species,1,0
29638,.,1,0
29639,No,0,0
29640,difference,0,0
29641,in,0,0
29642,species,1,1
29643,number,1,1
29644,was,0,0
29645,noted,0,0
29646,in,0,0
29647,controls,0,0
29648,.,0,0
29649,Mean,1,0
29650,log,1,1
29651,CFU,1,0
29652,of,1,0
29653,Gram,1,0
29654,(,1,0
29655,-,1,0
29656,),1,0
29657,bacteria,1,1
29658,did,0,0
29659,not,0,0
29660,change,0,0
29661,in,0,0
29662,treated,0,0
29663,infants,0,0
29664,weighing,0,0
29665,less,0,0
29666,than,0,0
29667,1500,0,0
29668,g.,0,0
29669,However,0,0
29670,",",0,0
29671,Gram,1,0
29672,(,1,0
29673,+,1,0
29674,),1,0
29675,mean,1,1
29676,log,1,1
29677,CFU,1,0
29678,showed,0,0
29679,a,0,0
29680,significant,0,0
29681,increase,0,0
29682,on,0,0
29683,day,0,0
29684,21,0,0
29685,(,0,0
29686,6.1,0,0
29687,+/-,0,0
29688,0.9,0,0
29689,),0,0
29690,compared,0,0
29691,with,0,0
29692,day,0,0
29693,0,0,0
29694,(,0,0
29695,3.5,0,0
29696,+/-,0,0
29697,0.9,0,0
29698,),0,0
29699,(,0,0
29700,P,0,0
29701,<,0,0
29702,0.05,0,0
29703,),0,0
29704,.,0,0
29705,No,0,0
29706,significant,0,0
29707,changes,0,1
29708,in,0,0
29709,species,1,1
29710,number,1,1
29711,or,1,0
29712,quantitative,1,0
29713,counts,1,1
29714,were,0,0
29715,noted,0,0
29716,after,0,0
29717,LGG,0,0
29718,treatment,0,0
29719,in,0,0
29720,the,0,0
29721,infants,0,0
29722,weighing,0,0
29723,1500,0,0
29724,to,0,0
29725,1999,0,0
29726,g,0,0
29727,LGG,1,0
29728,was,1,0
29729,well,1,0
29730,tolerated,1,1
29731,in,0,0
29732,all,0,0
29733,infants,0,0
29734,.,0,0
29735,CONCLUSION,0,0
29736,The,0,0
29737,neonatal,1,1
29738,response,1,1
29739,to,1,0
29740,a,1,0
29741,probiotic,1,0
29742,preparation,1,0
29743,is,0,0
29744,dependent,0,0
29745,on,0,0
29746,gestational,0,1
29747,and,0,0
29748,post-natal,0,1
29749,age,0,0
29750,and,0,0
29751,prior,0,0
29752,antibiotic,0,0
29753,exposure,0,0
29754,.,0,0
29755,Although,0,0
29756,LGG,0,0
29757,is,0,0
29758,a,0,0
29759,relatively,0,0
29760,poor,0,0
29761,colonizer,0,0
29762,in,0,0
29763,infants,0,0
29764,",",0,0
29765,especially,0,0
29766,those,0,0
29767,infants,0,0
29768,weighing,0,0
29769,less,0,0
29770,than,0,0
29771,1500,0,0
29772,g,0,0
29773,at,0,0
29774,birth,0,0
29775,",",0,0
29776,it,0,0
29777,does,0,0
29778,appear,0,0
29779,to,0,0
29780,affect,0,0
29781,neonatal,1,1
29782,intestinal,1,1
29783,colonization,1,1
29784,patterns,1,0
29785,.,1,0
29786,Optimal,0,1
29787,therapy,0,0
29788,for,0,0
29789,advanced,0,0
29790,chronic,0,0
29791,venous,0,1
29792,insufficiency,0,1
29793,.,0,0
29794,INTRODUCTION,0,0
29795,While,0,0
29796,definitive,0,0
29797,therapy,0,0
29798,awaits,0,0
29799,level,0,1
29800,I,0,0
29801,evidence,0,0
29802,",",0,0
29803,controversy,0,0
29804,persists,0,0
29805,regarding,0,0
29806,the,0,0
29807,optimal,0,0
29808,operation,0,0
29809,for,0,0
29810,treatment,0,0
29811,of,0,0
29812,advanced,0,0
29813,chronic,0,0
29814,venous,0,1
29815,insufficiency,0,1
29816,(,0,0
29817,CVI,0,0
29818,),0,0
29819,.,0,0
29820,We,0,0
29821,propose,0,0
29822,a,0,0
29823,pragmatic,0,0
29824,approach,0,0
29825,to,0,0
29826,the,0,0
29827,correction,0,0
29828,or,0,0
29829,amelioration,0,1
29830,of,0,1
29831,venous,0,1
29832,hypertension,0,1
29833,resulting,0,0
29834,from,0,0
29835,hydrodynamic,0,0
29836,and,0,0
29837,hydrostatic,0,1
29838,venous,0,1
29839,reflux,0,1
29840,.,0,0
29841,We,0,0
29842,evaluated,0,0
29843,a,0,0
29844,strategy,0,0
29845,of,0,0
29846,balloon,0,0
29847,dissection,0,0
29848,",",0,0
29849,subfascial,0,1
29850,endoscopic,0,1
29851,perforating,0,1
29852,vein,0,1
29853,surgery,0,0
29854,(,0,0
29855,SEPS,0,0
29856,),0,0
29857,with,0,0
29858,routine,0,0
29859,posterior,0,0
29860,deep,0,0
29861,compartment,0,0
29862,fasciotomy,0,0
29863,",",0,0
29864,including,0,0
29865,ligation,0,1
29866,and,0,1
29867,stripping,0,0
29868,of,0,0
29869,the,0,0
29870,superficial,0,0
29871,system,0,0
29872,",",0,0
29873,for,0,0
29874,use,0,0
29875,when,0,0
29876,reflux,0,1
29877,is,0,0
29878,documented,0,0
29879,at,0,0
29880,duplex,0,1
29881,ultrasound,0,1
29882,(,0,0
29883,US,0,1
29884,),0,0
29885,scanning,0,0
29886,.,0,0
29887,METHODS,0,0
29888,This,0,0
29889,is,0,0
29890,a,0,0
29891,cooperative,0,0
29892,",",0,0
29893,multicenter,0,0
29894,",",0,1
29895,retrospective,0,0
29896,review,0,0
29897,of,0,0
29898,832,0,0
29899,patients,0,0
29900,stratified,0,0
29901,by,0,0
29902,CEAP,0,0
29903,classification,0,1
29904,.,0,0
29905,The,0,0
29906,series,0,0
29907,consisted,0,0
29908,of,0,0
29909,300,0,0
29910,patients,0,0
29911,with,0,0
29912,C4,0,0
29913,CVI,0,0
29914,",",0,0
29915,119,0,0
29916,patients,0,0
29917,with,0,0
29918,C5,0,0
29919,CVI,0,0
29920,",",0,0
29921,and,0,0
29922,413,0,0
29923,patients,0,0
29924,with,0,0
29925,C6,0,0
29926,CVI,0,0
29927,.,0,0
29928,A,0,0
29929,subset,0,0
29930,of,0,0
29931,92,0,0
29932,patients,0,0
29933,with,0,0
29934,C4,0,0
29935,disease,0,1
29936,were,0,0
29937,prospectively,0,0
29938,randomized,0,0
29939,",",0,0
29940,and,0,0
29941,ambulatory,0,0
29942,venous,0,1
29943,pressure,0,1
29944,(,0,0
29945,AVP,0,1
29946,),0,0
29947,was,0,0
29948,determined,0,0
29949,preoperatively,0,0
29950,and,0,0
29951,postoperatively,0,0
29952,.,0,0
29953,All,0,0
29954,patients,0,0
29955,underwent,0,0
29956,duplex,0,1
29957,US,0,0
29958,scanning,0,0
29959,to,0,0
29960,document,0,0
29961,reflux,0,1
29962,in,0,0
29963,the,0,0
29964,deep,0,0
29965,",",0,0
29966,superficial,0,1
29967,",",0,0
29968,and,0,0
29969,perforating,0,1
29970,venous,0,1
29971,systems,0,0
29972,.,0,0
29973,Efficacy,1,1
29974,",",1,0
29975,safety,1,1
29976,",",1,1
29977,and,1,1
29978,durability,1,1
29979,were,0,0
29980,evaluated,0,0
29981,over,0,0
29982,follow-up,0,0
29983,of,0,0
29984,1,0,0
29985,to,0,0
29986,9,0,0
29987,years,0,0
29988,(,0,0
29989,mean,0,1
29990,",",0,0
29991,31/2,0,0
29992,years,0,0
29993,),0,0
29994,.,0,0
29995,Uniformity,0,1
29996,was,0,0
29997,attempted,0,0
29998,by,0,0
29999,adoption,0,0
30000,of,0,0
30001,the,0,0
30002,senior,0,0
30003,author,0,0
30004,'s,0,1
30005,protocol,0,0
30006,and,0,1
30007,technique,0,0
30008,through,0,0
30009,on-site,0,0
30010,preceptorship,0,0
30011,in,0,0
30012,each,0,0
30013,surgeon,0,0
30014,'s,0,0
30015,operative,0,1
30016,theater,0,0
30017,.,0,0
30018,RESULTS,0,0
30019,This,0,0
30020,technique,0,0
30021,interrupted,0,0
30022,3,0,0
30023,to,0,0
30024,14,0,0
30025,(,0,0
30026,mean,0,0
30027,",",0,0
30028,7,0,0
30029,),0,0
30030,incompetent,0,0
30031,perforating,0,0
30032,veins,0,0
30033,per,0,0
30034,patient,0,0
30035,.,0,0
30036,Of,0,0
30037,the,0,0
30038,832,0,0
30039,patients,0,0
30040,undergoing,0,0
30041,SEPS,0,0
30042,",",0,0
30043,460,0,0
30044,(,0,0
30045,55,0,0
30046,%,0,0
30047,),0,0
30048,underwent,0,0
30049,saphenous,0,1
30050,vein,0,1
30051,ligation,0,1
30052,and,0,1
30053,stripping,0,0
30054,at,0,0
30055,the,0,0
30056,same,0,0
30057,operation,0,0
30058,.,0,0
30059,In,0,0
30060,92,0,0
30061,%,0,0
30062,ulcers,1,0
30063,healed,1,1
30064,or,1,0
30065,were,1,0
30066,significantly,1,0
30067,improved,1,0
30068,within,0,0
30069,4,0,0
30070,to,0,0
30071,14,0,0
30072,weeks,0,0
30073,.,0,0
30074,In,0,0
30075,64,0,0
30076,(,0,0
30077,8,0,0
30078,%,0,0
30079,),0,0
30080,patients,0,0
30081,",",0,0
30082,ulcers,1,1
30083,failed,1,0
30084,to,1,0
30085,heal,1,0
30086,or,0,0
30087,there,0,0
30088,was,0,0
30089,no,0,0
30090,benefit,0,0
30091,from,0,0
30092,the,0,0
30093,operation,1,0
30094,.,1,0
30095,Thirty-two,0,0
30096,patients,0,0
30097,(,0,0
30098,4,0,0
30099,%,0,0
30100,),0,0
30101,experienced,0,0
30102,recurrent,1,1
30103,ulceration,1,1
30104,or,1,0
30105,skin,1,1
30106,deterioration,1,1
30107,at,0,0
30108,6,0,0
30109,months-2,0,0
30110,years,0,0
30111,(,0,0
30112,mean,0,1
30113,",",0,0
30114,15,0,0
30115,mo,0,0
30116,),0,0
30117,.,0,0
30118,Repeat,0,0
30119,SEPS,0,0
30120,was,0,0
30121,successful,0,0
30122,in,0,0
30123,25,0,0
30124,of,0,0
30125,these,0,0
30126,96,0,0
30127,patients,0,0
30128,",",0,0
30129,and,0,1
30130,deep,0,1
30131,valve,0,1
30132,repair,0,0
30133,was,0,0
30134,successful,0,0
30135,in,0,0
30136,4,0,0
30137,patients,0,0
30138,.,0,0
30139,In,0,0
30140,the,0,0
30141,92,0,0
30142,randomized,0,0
30143,patients,0,0
30144,with,0,0
30145,C4,0,0
30146,disease,0,0
30147,",",0,0
30148,41,0,0
30149,refused,0,0
30150,postoperative,0,0
30151,AVP,0,0
30152,",",0,0
30153,leaving,0,0
30154,51,0,0
30155,compliant,0,0
30156,patients,0,0
30157,.,0,0
30158,The,0,0
30159,SEPS,0,0
30160,group,0,0
30161,(,0,0
30162,n,0,0
30163,=,0,0
30164,25,0,0
30165,),0,0
30166,had,0,0
30167,significantly,0,0
30168,reduced,0,0
30169,AVP,1,0
30170,(,0,0
30171,P,0,0
30172,<,0,0
30173,.01,0,0
30174,),0,0
30175,compared,0,0
30176,with,0,0
30177,the,0,0
30178,control,0,0
30179,group,0,0
30180,(,0,0
30181,n,0,0
30182,=,0,0
30183,26,0,0
30184,),0,0
30185,.,0,0
30186,Complications,0,0
30187,in,0,0
30188,825,0,0
30189,patients,0,0
30190,were,0,0
30191,less,0,0
30192,than,0,0
30193,3,0,0
30194,%,0,0
30195,and,0,0
30196,consisted,0,0
30197,mostly,0,0
30198,of,0,0
30199,transient,1,1
30200,neurologic,1,1
30201,disorders,1,0
30202,(,0,0
30203,eg,0,0
30204,",",0,1
30205,paradysthesia,1,1
30206,),1,1
30207,",",1,0
30208,but,1,0
30209,deep,1,1
30210,venous,1,1
30211,thrombosis,1,1
30212,occurred,0,0
30213,in,0,0
30214,2,0,0
30215,patients,0,0
30216,",",0,0
30217,with,0,0
30218,pulmonary,0,1
30219,embolus,0,0
30220,in,0,0
30221,1,0,0
30222,.,0,0
30223,No,0,0
30224,operative,0,1
30225,deaths,1,1
30226,occurred,0,0
30227,.,0,0
30228,Follow-up,0,0
30229,for,0,0
30230,1,0,0
30231,to,0,0
30232,9,0,0
30233,years,0,0
30234,(,0,0
30235,mean,0,1
30236,",",0,0
30237,31/2,0,0
30238,years,0,0
30239,),0,0
30240,demonstrated,0,0
30241,durability,1,0
30242,.,1,0
30243,CONCLUSION,0,0
30244,The,0,0
30245,efficacy,0,1
30246,",",0,0
30247,safety,0,1
30248,",",0,1
30249,and,0,1
30250,durability,0,1
30251,of,0,0
30252,this,0,0
30253,operative,0,1
30254,protocol,0,0
30255,proved,0,0
30256,beneficial,0,0
30257,in,0,0
30258,our,0,0
30259,clinical,0,0
30260,experience,0,0
30261,with,0,0
30262,832,0,0
30263,patients,0,0
30264,during,0,0
30265,9,0,0
30266,years,0,0
30267,of,0,0
30268,follow-up,0,0
30269,.,0,0
30270,The,0,0
30271,SEPS,0,0
30272,subset,0,0
30273,of,0,0
30274,randomized,0,0
30275,patients,0,0
30276,with,0,0
30277,C4,0,0
30278,disease,0,1
30279,experienced,0,0
30280,significant,0,0
30281,decrease,0,0
30282,in,0,0
30283,AVP,0,0
30284,",",0,0
30285,objectively,0,0
30286,supporting,0,0
30287,the,0,0
30288,effectiveness,0,1
30289,of,0,0
30290,reflux,0,1
30291,surgery,0,0
30292,in,0,0
30293,advanced,0,0
30294,CVI,0,0
30295,.,0,0
30296,Until,0,0
30297,definitive,0,0
30298,level,0,1
30299,I,0,0
30300,evidence,0,0
30301,is,0,0
30302,available,0,0
30303,",",0,0
30304,this,0,0
30305,operative,0,0
30306,technique,0,0
30307,is,0,0
30308,advocated,0,0
30309,as,0,0
30310,optimal,0,0
30311,therapy,0,0
30312,for,0,0
30313,CVI,0,0
30314,.,0,0
30315,The,0,0
30316,effects,0,0
30317,of,0,0
30318,peer,0,0
30319,counseling,0,0
30320,on,0,0
30321,smoking,0,0
30322,cessation,1,0
30323,and,0,0
30324,reduction,0,1
30325,.,0,0
30326,OBJECTIVE,0,0
30327,To,0,0
30328,evaluate,0,0
30329,a,0,0
30330,peer,0,0
30331,counseling,0,0
30332,intervention,0,0
30333,for,0,0
30334,pregnant,0,0
30335,smokers,0,0
30336,.,0,0
30337,METHODS,0,0
30338,One,0,0
30339,hundred,0,0
30340,forty-two,0,0
30341,pregnant,0,0
30342,",",0,0
30343,predominantly,0,0
30344,Hispanic,0,0
30345,women,0,0
30346,were,0,0
30347,assigned,0,0
30348,to,0,0
30349,a,0,0
30350,peer-led,0,0
30351,smoking,0,0
30352,cessation,0,1
30353,program,0,0
30354,or,0,0
30355,to,0,0
30356,usual,0,0
30357,care,0,0
30358,.,0,0
30359,RESULTS,0,0
30360,Compared,0,0
30361,with,0,0
30362,usual,0,0
30363,care,0,0
30364,",",0,0
30365,peer,0,0
30366,counseling,0,0
30367,reduced,0,1
30368,smoking,0,0
30369,(,0,0
30370,-9.1,0,0
30371,versus,0,0
30372,-4.5,0,0
30373,cigarettes,0,0
30374,daily,0,0
30375,",",0,0
30376,P,0,0
30377,=.03,0,0
30378,),0,0
30379,",",0,0
30380,but,0,0
30381,did,0,0
30382,not,0,0
30383,affect,0,0
30384,absolute,0,1
30385,quit,1,1
30386,rates,1,1
30387,(,0,0
30388,24,0,0
30389,%,0,0
30390,versus,0,0
30391,21,0,0
30392,%,0,0
30393,),0,0
30394,at,0,0
30395,36,0,0
30396,weeks,0,0
30397,',0,0
30398,gestation,0,0
30399,.,0,0
30400,Infant,1,1
30401,birth,1,1
30402,weight,1,1
30403,negatively,0,0
30404,correlated,0,0
30405,with,0,0
30406,cigarettes,0,0
30407,smoked,0,0
30408,per,0,0
30409,day,0,0
30410,(,0,0
30411,r,0,0
30412,=,0,0
30413,-0.29,0,0
30414,",",0,0
30415,P,0,0
30416,<,0,0
30417,.01,0,0
30418,),0,0
30419,and,0,0
30420,expired,0,1
30421,carbon,0,1
30422,monoxide,0,1
30423,(,0,0
30424,r,0,1
30425,=,0,0
30426,-0.39,0,0
30427,",",0,0
30428,(,0,0
30429,P,0,0
30430,<,0,0
30431,.001,0,0
30432,),0,0
30433,at,0,0
30434,delivery,0,0
30435,.,0,0
30436,Birth,1,1
30437,weight,1,1
30438,for,1,0
30439,infants,1,0
30440,born,1,0
30441,to,1,0
30442,women,1,0
30443,who,1,0
30444,quit,1,0
30445,smoking,1,0
30446,averaged,0,0
30447,7.2,0,0
30448,lb,0,0
30449,versus,0,0
30450,6.8,0,0
30451,and,0,0
30452,6.3,0,0
30453,lb,0,0
30454,for,0,0
30455,mothers,0,0
30456,smoking,0,0
30457,one,0,0
30458,to,0,0
30459,six,0,0
30460,and,0,0
30461,more,0,0
30462,than,0,0
30463,six,0,0
30464,cigarettes,0,0
30465,per,0,0
30466,day,0,0
30467,at,0,0
30468,delivery,0,1
30469,(,0,0
30470,P,0,0
30471,<,0,0
30472,.01,0,0
30473,),0,0
30474,.,0,0
30475,CONCLUSION,0,0
30476,Peer,1,0
30477,counseling,1,0
30478,reduced,0,0
30479,the,0,0
30480,number,1,1
30481,of,1,0
30482,cigarettes,1,0
30483,smoked,1,0
30484,daily,1,0
30485,but,0,0
30486,did,0,0
30487,not,0,0
30488,increase,0,0
30489,cigarette,1,0
30490,abstinence,1,1
30491,rates,1,1
30492,.,1,0
30493,Infant,1,1
30494,birth,1,1
30495,weight,1,1
30496,increases,0,1
30497,with,0,0
30498,both,0,0
30499,smoking,0,0
30500,cessation,0,0
30501,and,0,1
30502,smoking,0,1
30503,reduction,0,1
30504,",",0,0
30505,suggesting,0,0
30506,that,0,0
30507,peer,0,0
30508,counseling,0,0
30509,intervention,0,0
30510,programs,0,0
30511,may,0,0
30512,improve,0,0
30513,newborn,1,0
30514,health,1,1
30515,despite,0,0
30516,their,0,0
30517,failure,0,0
30518,to,0,0
30519,affect,0,0
30520,smoking,0,0
30521,cessation,0,0
30522,.,0,0
30523,Evaluation,0,0
30524,of,0,0
30525,25-gauge,0,0
30526,Quincke,0,0
30527,and,0,0
30528,24-gauge,0,0
30529,Gertie,0,1
30530,Marx,0,0
30531,needles,0,0
30532,for,0,0
30533,spinal,0,0
30534,anaesthesia,0,0
30535,for,0,0
30536,caesarean,0,0
30537,section,0,0
30538,.,0,0
30539,OBJECTIVE,0,0
30540,To,0,0
30541,compare,0,0
30542,the,0,0
30543,insertion,0,0
30544,characteristics,0,1
30545,and,0,1
30546,rate,0,1
30547,of,0,1
30548,complications,0,1
30549,between,0,0
30550,25-gauge,0,0
30551,Quincke,0,0
30552,and,0,0
30553,24-gauge,0,0
30554,Gertie,0,1
30555,Marx,0,0
30556,needles,0,0
30557,.,0,0
30558,DESIGN,0,0
30559,Prospective,0,0
30560,",",0,0
30561,randomized,0,0
30562,study,0,0
30563,.,0,0
30564,SETTING,0,0
30565,University,0,0
30566,of,0,0
30567,Benin,0,0
30568,Teaching,0,0
30569,Hospital,0,0
30570,;,0,0
30571,a,0,0
30572,university-affiliated,0,0
30573,tertiary,0,0
30574,centre,0,0
30575,.,0,0
30576,SUBJECTS,0,0
30577,Parturients,0,0
30578,(,0,0
30579,ASA,0,0
30580,1,0,0
30581,and,0,0
30582,2,0,0
30583,),0,0
30584,scheduled,0,0
30585,for,0,0
30586,elective,0,0
30587,caesarean,0,0
30588,section,0,0
30589,.,0,0
30590,They,0,0
30591,were,0,0
30592,randomly,0,0
30593,assigned,0,0
30594,to,0,0
30595,receive,0,0
30596,spinal,0,0
30597,anaesthesia,0,0
30598,with,0,0
30599,either,0,0
30600,25-gauge,0,0
30601,Quincke,0,0
30602,needle,0,0
30603,or,0,0
30604,24-gauge,0,0
30605,Gertie,0,1
30606,Marx,0,0
30607,needle,0,0
30608,.,0,0
30609,The,0,0
30610,patients,0,0
30611,with,0,0
30612,abnormal,0,1
30613,spaces,0,1
30614,",",0,0
30615,coagulopathy,0,1
30616,",",0,1
30617,infection,0,1
30618,",",0,1
30619,pre-eclampsia/eclampsia,0,1
30620,or,0,1
30621,obesity,0,1
30622,were,0,0
30623,excluded,0,0
30624,.,0,0
30625,MAIN,0,0
30626,OUTCOME,0,0
30627,MEASURES,0,0
30628,The,0,0
30629,number,1,1
30630,of,1,0
30631,attempts,1,0
30632,at,1,0
30633,successful,1,0
30634,identification,1,0
30635,of,1,0
30636,the,1,0
30637,spinal,1,0
30638,space,1,0
30639,",",1,0
30640,intraoperative,1,1
30641,complications,1,1
30642,",",1,0
30643,incidence,1,1
30644,of,1,1
30645,postdural,1,1
30646,puncture,1,0
30647,headache,1,1
30648,(,1,0
30649,PDPH,1,1
30650,),1,0
30651,",",1,0
30652,non-postdural,1,0
30653,puncture,1,1
30654,headache,1,1
30655,(,1,0
30656,NPDPH,1,0
30657,),1,1
30658,and,1,0
30659,backache,1,1
30660,.,1,0
30661,RESULTS,0,0
30662,Sixty,0,0
30663,women,0,0
30664,were,0,0
30665,studied,0,0
30666,.,0,0
30667,The,0,0
30668,24-gauge,0,0
30669,Gertie,0,0
30670,Marx,0,0
30671,needle,0,0
30672,resulted,0,0
30673,in,0,0
30674,more,0,0
30675,successful,1,0
30676,location,1,0
30677,of,1,0
30678,the,1,0
30679,spinal,1,0
30680,space,1,0
30681,on,0,0
30682,the,0,0
30683,second,0,0
30684,attempt,0,0
30685,(,0,0
30686,P,0,0
30687,<,0,0
30688,0.05,0,0
30689,),0,0
30690,.,0,0
30691,Non-postdural,1,1
30692,puncture,1,0
30693,headache,1,1
30694,was,0,0
30695,seen,0,0
30696,in,0,0
30697,43,0,0
30698,%,0,0
30699,of,0,0
30700,the,0,0
30701,study,0,0
30702,population,0,0
30703,.,0,0
30704,PDPH,1,0
30705,was,0,0
30706,seen,0,0
30707,in,0,0
30708,10,0,0
30709,%,0,0
30710,of,0,0
30711,the,0,0
30712,Quincke,0,0
30713,group,0,0
30714,and,0,1
30715,none,0,0
30716,in,0,0
30717,the,0,0
30718,Gertie,0,0
30719,Marx,0,0
30720,group,0,0
30721,.,0,0
30722,There,0,0
30723,was,0,0
30724,no,0,0
30725,difference,0,0
30726,in,0,0
30727,the,0,0
30728,incidence,0,1
30729,of,0,0
30730,backache,1,1
30731,in,0,0
30732,both,0,0
30733,groups,0,0
30734,.,0,0
30735,CONCLUSION,0,0
30736,The,0,0
30737,ease,0,1
30738,of,0,0
30739,insertion,0,1
30740,and,0,0
30741,low,0,0
30742,incidence,0,1
30743,of,0,0
30744,PDPH,1,0
30745,with,0,0
30746,the,0,0
30747,Gertie,0,0
30748,Marx,0,0
30749,needle,0,0
30750,may,0,0
30751,encourage,0,0
30752,trainee,0,0
30753,anaesthetists,0,0
30754,to,0,0
30755,use,0,0
30756,this,0,0
30757,needle,0,0
30758,for,0,0
30759,caesarean,0,0
30760,section,0,0
30761,.,0,0
30762,Effect,0,0
30763,of,0,0
30764,postural,0,1
30765,supports,0,0
30766,on,0,0
30767,neuromotor,1,1
30768,function,1,1
30769,in,0,0
30770,very,0,0
30771,preterm,0,0
30772,infants,0,0
30773,to,0,0
30774,term,0,1
30775,equivalent,0,0
30776,age,0,0
30777,.,0,0
30778,OBJECTIVE,0,0
30779,To,0,0
30780,determine,0,0
30781,the,0,0
30782,effect,0,0
30783,of,0,0
30784,a,0,0
30785,postural,0,0
30786,support,0,0
30787,nappy,0,1
30788,and/or,0,0
30789,a,0,0
30790,postural,0,0
30791,support,0,0
30792,roll,0,0
30793,on,0,0
30794,neuromotor,1,1
30795,function,1,1
30796,in,0,0
30797,very,0,0
30798,preterm,0,0
30799,infants,0,0
30800,when,0,0
30801,nursed,0,0
30802,prone,0,0
30803,to,0,0
30804,term,0,1
30805,equivalent,0,0
30806,age,0,0
30807,.,0,0
30808,METHODS,0,0
30809,A,0,0
30810,randomized,0,0
30811,observer,0,1
30812,blind,0,0
30813,controlled,0,0
30814,trial,0,0
30815,of,0,0
30816,123,0,0
30817,very,0,0
30818,preterm,0,0
30819,infants,0,0
30820,was,0,0
30821,conducted,0,0
30822,in,0,0
30823,the,0,0
30824,neonatal,0,1
30825,intensive,0,0
30826,care,0,0
30827,unit,0,0
30828,of,0,0
30829,the,0,0
30830,sole,0,0
30831,tertiary,0,0
30832,referral,0,0
30833,centre,0,0
30834,in,0,0
30835,Western,0,0
30836,Australia,0,0
30837,.,0,0
30838,Infants,0,0
30839,were,0,0
30840,stratified,0,0
30841,by,0,0
30842,gestational,0,1
30843,age,0,0
30844,(,0,0
30845,<,0,0
30846,29,0,0
30847,weeks,0,0
30848,or,0,0
30849,29-30,0,0
30850,weeks,0,0
30851,),0,0
30852,",",0,0
30853,then,0,0
30854,randomized,0,0
30855,into,0,0
30856,one,0,0
30857,of,0,0
30858,three,0,0
30859,intervention,0,0
30860,groups,0,0
30861,:,0,0
30862,postural,0,1
30863,support,0,0
30864,nappy,0,1
30865,",",0,0
30866,postural,0,1
30867,support,0,0
30868,nappy,0,1
30869,and,0,0
30870,postural,0,1
30871,support,0,0
30872,roll,0,0
30873,",",0,0
30874,or,0,0
30875,disposable,0,1
30876,nappy,0,1
30877,and,0,0
30878,postural,0,1
30879,support,0,0
30880,roll,0,0
30881,.,0,0
30882,Interventions,0,0
30883,started,0,0
30884,when,0,0
30885,infants,0,0
30886,were,0,0
30887,stable,0,1
30888,and,0,0
30889,ceased,0,0
30890,when,0,0
30891,routine,0,0
30892,side-lying,0,0
30893,commenced,0,0
30894,.,0,0
30895,Measurements,0,0
30896,of,0,0
30897,shoulder,1,0
30898,and,1,1
30899,hip,1,1
30900,posture,1,1
30901,were,0,0
30902,performed,0,0
30903,pre-intervention,0,0
30904,",",0,0
30905,5,0,0
30906,weeks,0,0
30907,post-intervention,0,0
30908,and,0,1
30909,term,0,1
30910,postmenstrual,0,0
30911,age,0,0
30912,.,0,0
30913,RESULTS,0,0
30914,Infants,0,0
30915,nursed,0,0
30916,with,0,0
30917,a,0,0
30918,postural,0,0
30919,support,0,0
30920,roll,0,0
30921,and,0,0
30922,a,0,0
30923,postural,0,1
30924,support,0,0
30925,nappy,0,1
30926,demonstrated,0,0
30927,improved,0,1
30928,hip,1,1
30929,posture,1,1
30930,to,0,0
30931,term,0,1
30932,equivalent,0,0
30933,age,0,0
30934,compared,0,0
30935,with,0,0
30936,infants,0,0
30937,nursed,0,0
30938,with,0,0
30939,either,0,0
30940,a,0,0
30941,postural,0,1
30942,support,0,0
30943,roll,0,0
30944,only,0,0
30945,",",0,0
30946,or,0,0
30947,a,0,0
30948,postural,0,1
30949,support,0,0
30950,nappy,0,1
30951,only,0,0
30952,.,0,0
30953,Infants,0,0
30954,nursed,0,0
30955,with,0,0
30956,a,0,0
30957,postural,0,0
30958,support,0,0
30959,roll,0,0
30960,either,0,0
30961,with,0,0
30962,or,0,0
30963,without,0,0
30964,a,0,0
30965,postural,0,0
30966,support,0,0
30967,nappy,0,1
30968,demonstrated,0,0
30969,improved,0,1
30970,shoulder,1,0
30971,posture,1,1
30972,to,0,0
30973,term,0,1
30974,equivalent,0,0
30975,age,0,0
30976,.,0,0
30977,CONCLUSIONS,0,0
30978,Combined,0,0
30979,use,0,0
30980,of,0,0
30981,a,0,0
30982,postural,0,0
30983,support,0,0
30984,roll,0,0
30985,and,0,0
30986,a,0,0
30987,postural,0,1
30988,support,0,0
30989,nappy,0,1
30990,while,0,0
30991,very,0,0
30992,preterm,0,0
30993,infants,0,0
30994,are,0,0
30995,nursed,0,0
30996,prone,0,0
30997,improves,0,0
30998,hip,1,1
30999,posture,1,1
31000,up,0,0
31001,to,0,0
31002,term,0,1
31003,postmenstrual,0,0
31004,age,0,0
31005,.,0,0
31006,Use,0,0
31007,of,0,0
31008,a,0,0
31009,postural,0,0
31010,support,0,0
31011,roll,0,0
31012,improves,0,1
31013,shoulder,1,0
31014,posture,1,1
31015,up,0,1
31016,to,0,0
31017,term,0,1
31018,equivalent,0,0
31019,age,0,0
31020,.,0,0
31021,Enhanced,0,0
31022,pitch,0,0
31023,sensitivity,0,1
31024,in,0,0
31025,individuals,0,0
31026,with,0,0
31027,autism,0,0
31028,:,0,0
31029,a,0,0
31030,signal,0,1
31031,detection,0,0
31032,analysis,0,0
31033,.,0,0
31034,Past,0,0
31035,research,0,0
31036,has,0,0
31037,shown,0,0
31038,a,0,0
31039,superiority,0,0
31040,of,0,0
31041,participants,0,0
31042,with,0,0
31043,high-functioning,0,0
31044,autism,0,0
31045,over,0,0
31046,comparison,0,0
31047,groups,0,0
31048,in,0,0
31049,memorizing,0,1
31050,picture-pitch,0,1
31051,associations,0,0
31052,and,0,0
31053,in,0,0
31054,detecting,0,0
31055,pitch,0,0
31056,changes,0,1
31057,in,0,0
31058,melodies,0,0
31059,.,0,0
31060,A,0,0
31061,subset,0,0
31062,of,0,0
31063,individuals,0,0
31064,with,0,0
31065,autism,0,0
31066,",",0,0
31067,known,0,0
31068,as,0,0
31069,musical,0,0
31070,savants,0,0
31071,",",0,0
31072,is,0,0
31073,also,0,0
31074,known,0,0
31075,to,0,0
31076,possess,0,0
31077,absolute,0,1
31078,pitch,0,0
31079,.,0,0
31080,This,0,0
31081,superiority,0,0
31082,might,0,0
31083,be,0,0
31084,due,0,0
31085,to,0,0
31086,an,0,0
31087,abnormally,0,0
31088,high,0,0
31089,sensitivity,0,1
31090,to,0,0
31091,fine-grained,0,0
31092,pitch,0,0
31093,differences,0,0
31094,in,0,0
31095,sounds,0,0
31096,.,0,0
31097,To,0,0
31098,test,0,0
31099,this,0,0
31100,hypothesis,0,0
31101,",",0,0
31102,psychoacoustic,0,1
31103,tasks,0,1
31104,were,0,0
31105,devised,0,0
31106,so,0,0
31107,as,0,0
31108,to,0,0
31109,use,0,0
31110,a,0,0
31111,signal,0,1
31112,detection,0,0
31113,methodology,0,0
31114,.,0,0
31115,Participants,0,0
31116,were,0,0
31117,all,0,0
31118,musically,0,0
31119,untrained,0,0
31120,and,0,0
31121,were,0,0
31122,divided,0,0
31123,into,0,0
31124,a,0,0
31125,group,0,0
31126,of,0,0
31127,12,0,0
31128,high-functioning,0,0
31129,individuals,0,0
31130,with,0,0
31131,autism,0,0
31132,and,0,0
31133,a,0,0
31134,group,0,0
31135,of,0,0
31136,12,0,0
31137,normally,0,0
31138,developing,0,0
31139,individuals,0,0
31140,.,0,0
31141,Their,0,0
31142,task,0,0
31143,was,0,0
31144,to,0,0
31145,judge,0,0
31146,the,0,0
31147,pitch,0,0
31148,of,0,0
31149,pure,0,0
31150,tones,0,0
31151,in,0,0
31152,a,0,0
31153,same-different,0,0
31154,discrimination,0,1
31155,task,0,1
31156,and,0,0
31157,in,0,0
31158,a,0,0
31159,high-low,0,0
31160,categorization,0,0
31161,task,0,0
31162,.,0,0
31163,In,0,0
31164,both,0,0
31165,tasks,0,0
31166,",",0,0
31167,the,0,0
31168,obtained,0,0
31169,psychometric,0,0
31170,functions,0,0
31171,revealed,0,0
31172,higher,1,0
31173,pitch,1,1
31174,sensitivity,1,1
31175,for,0,0
31176,subjects,0,0
31177,with,0,0
31178,autism,0,0
31179,",",0,0
31180,with,0,0
31181,a,0,0
31182,more,0,0
31183,pronounced,0,0
31184,advantage,0,0
31185,over,0,0
31186,control,0,0
31187,participants,0,0
31188,in,0,0
31189,the,0,0
31190,categorization,1,0
31191,task,1,0
31192,.,1,0
31193,These,0,0
31194,findings,0,0
31195,confirm,0,0
31196,that,0,0
31197,pitch,1,0
31198,processing,1,0
31199,is,0,0
31200,enhanced,0,0
31201,in,0,0
31202,high-functioning,0,0
31203,autism,0,0
31204,.,0,0
31205,Superior,0,0
31206,performance,0,1
31207,in,0,0
31208,pitch,1,1
31209,discrimination,1,1
31210,and,1,0
31211,categorization,1,0
31212,extends,0,0
31213,previous,0,0
31214,findings,0,0
31215,of,0,0
31216,enhanced,0,0
31217,visual,1,1
31218,performance,1,1
31219,to,0,0
31220,the,0,0
31221,auditory,0,1
31222,domain,0,0
31223,.,0,0
31224,Thus,0,1
31225,",",0,0
31226,and,0,0
31227,as,0,0
31228,predicted,0,0
31229,by,0,0
31230,the,0,0
31231,enhanced,0,0
31232,perceptual,0,1
31233,functioning,0,1
31234,model,0,0
31235,for,0,0
31236,peaks,0,1
31237,of,0,0
31238,ability,0,1
31239,in,0,0
31240,autism,0,0
31241,(,0,0
31242,Mottron,0,1
31243,&,0,0
31244,Burack,0,0
31245,",",0,0
31246,2001,0,0
31247,),0,0
31248,",",0,0
31249,autistic,0,0
31250,individuals,0,0
31251,outperform,0,0
31252,typically,0,0
31253,developing,0,0
31254,population,0,0
31255,in,0,0
31256,a,0,0
31257,variety,0,0
31258,of,0,0
31259,low-level,0,0
31260,perceptual,0,1
31261,tasks,0,0
31262,.,0,0
31263,Changing,0,0
31264,Childbirth,0,0
31265,:,0,0
31266,a,0,0
31267,pilot,0,0
31268,project,0,0
31269,.,0,0
31270,OBJECTIVE,0,0
31271,To,0,0
31272,compare,0,0
31273,the,0,0
31274,outcomes,0,0
31275,of,0,0
31276,an,0,0
31277,adapted,0,0
31278,pilot,0,0
31279,Changing,0,0
31280,Childbirth,0,1
31281,initiative,0,0
31282,providing,0,0
31283,continuity,0,1
31284,of,0,0
31285,care,0,0
31286,by,0,0
31287,a,0,0
31288,group,0,0
31289,of,0,0
31290,known,0,0
31291,midwives,0,0
31292,with,0,0
31293,traditional,0,0
31294,maternity,0,0
31295,care,0,0
31296,.,0,0
31297,DESIGN,0,0
31298,Between-groups,0,0
31299,trial,0,0
31300,to,0,0
31301,compare,0,0
31302,levels,0,1
31303,of,0,0
31304,satisfaction,0,1
31305,and,0,0
31306,clinical,0,0
31307,outcomes,0,0
31308,for,0,0
31309,two,0,0
31310,groups,0,0
31311,of,0,0
31312,women,0,0
31313,",",0,0
31314,cared,0,0
31315,for,0,0
31316,either,0,0
31317,under,0,0
31318,this,0,0
31319,Changing,0,0
31320,Childbirth,0,1
31321,scheme,0,0
31322,or,0,0
31323,the,0,0
31324,traditional,0,0
31325,model,0,0
31326,of,0,0
31327,care,0,0
31328,.,0,0
31329,METHOD,0,0
31330,Of,0,0
31331,the,0,0
31332,200,0,0
31333,women,0,0
31334,who,0,0
31335,agreed,0,0
31336,to,0,0
31337,participate,0,0
31338,in,0,0
31339,the,0,0
31340,project,0,0
31341,",",0,0
31342,100,0,0
31343,were,0,0
31344,randomly,0,0
31345,allocated,0,0
31346,to,0,0
31347,the,0,0
31348,pilot,0,0
31349,scheme,0,0
31350,and,0,0
31351,100,0,0
31352,to,0,0
31353,the,0,0
31354,traditional,0,0
31355,care,0,0
31356,package,0,0
31357,.,0,0
31358,During,0,0
31359,the,0,0
31360,postpartum,0,1
31361,period,0,0
31362,",",0,0
31363,information,0,1
31364,was,0,0
31365,collected,0,0
31366,via,0,0
31367,a,0,0
31368,questionnaire,0,1
31369,about,0,0
31370,participants,0,0
31371,',0,0
31372,levels,0,1
31373,of,0,0
31374,satisfaction,0,1
31375,with,0,0
31376,a,0,0
31377,variety,0,0
31378,of,0,0
31379,aspects,0,0
31380,of,0,0
31381,care,0,0
31382,provided,0,0
31383,during,0,0
31384,the,0,0
31385,antenatal,0,0
31386,",",0,0
31387,delivery,0,1
31388,and,0,1
31389,postpartum,0,1
31390,periods,0,1
31391,.,0,0
31392,Data,0,0
31393,about,0,0
31394,clinical,0,0
31395,outcomes,0,0
31396,for,0,0
31397,the,0,0
31398,two,0,0
31399,groups,0,0
31400,were,0,0
31401,also,0,0
31402,obtained,0,0
31403,.,0,0
31404,RESULTS,0,0
31405,Women,0,0
31406,in,0,0
31407,the,0,0
31408,pilot,0,0
31409,group,0,0
31410,had,0,0
31411,significantly,0,0
31412,more,0,0
31413,continuity,1,1
31414,of,1,0
31415,care,1,0
31416,throughout,0,0
31417,each,0,0
31418,of,0,0
31419,the,0,0
31420,three,0,0
31421,periods,0,0
31422,",",0,0
31423,were,0,0
31424,generally,0,0
31425,more,0,0
31426,satisfied,1,0
31427,with,0,0
31428,their,0,0
31429,care,0,0
31430,",",0,0
31431,felt,0,0
31432,that,0,0
31433,they,0,0
31434,had,0,0
31435,more,1,0
31436,choice,1,0
31437,over,0,0
31438,a,0,0
31439,variety,1,0
31440,of,1,0
31441,aspects,1,0
31442,of,1,0
31443,care,1,0
31444,and,0,0
31445,experienced,0,0
31446,no,0,0
31447,compromise,1,0
31448,in,0,0
31449,clinical,0,0
31450,outcomes,0,1
31451,(,0,0
31452,P,0,0
31453,=,0,0
31454,0.05,0,0
31455,or,0,0
31456,less,0,0
31457,in,0,0
31458,each,0,0
31459,case,0,0
31460,),0,0
31461,.,0,0
31462,IMPLICATIONS,0,0
31463,FOR,0,0
31464,PRACTICE,0,0
31465,Many,0,1
31466,previous,0,0
31467,attempts,0,0
31468,to,0,0
31469,introduce,0,0
31470,the,0,0
31471,Changing,0,0
31472,Childbirth,0,1
31473,initiative,0,0
31474,have,0,0
31475,revealed,0,0
31476,significant,0,0
31477,problems,0,0
31478,",",0,0
31479,particularly,0,0
31480,with,0,0
31481,regard,0,0
31482,to,0,0
31483,the,0,0
31484,continuity,0,0
31485,of,0,0
31486,carer,0,1
31487,requirement,0,1
31488,.,0,0
31489,Taking,0,1
31490,account,0,0
31491,of,0,0
31492,local,0,0
31493,health,0,1
31494,care,0,0
31495,needs,0,0
31496,and,0,0
31497,existing,0,0
31498,provision,0,0
31499,",",0,0
31500,the,0,0
31501,present,0,0
31502,study,0,0
31503,adapted,0,0
31504,this,0,0
31505,concept,0,0
31506,to,0,0
31507,continuity,0,1
31508,of,0,0
31509,care,0,0
31510,.,0,0
31511,This,0,0
31512,did,0,0
31513,not,0,0
31514,apparently,0,0
31515,affect,0,0
31516,any,0,0
31517,of,0,0
31518,the,0,0
31519,guiding,0,0
31520,principles,0,0
31521,contained,0,0
31522,in,0,0
31523,the,0,0
31524,original,0,0
31525,document,0,0
31526,",",0,0
31527,and,0,0
31528,yet,0,0
31529,enhanced,0,0
31530,satisfaction,0,0
31531,.,0,0
31532,It,0,0
31533,would,0,0
31534,appear,0,0
31535,that,0,0
31536,the,0,0
31537,Changing,0,0
31538,Childbirth,0,1
31539,agenda,0,0
31540,can,0,0
31541,be,0,0
31542,adapted,0,0
31543,and,0,0
31544,integrated,0,0
31545,with,0,0
31546,local,0,0
31547,health,0,1
31548,care,0,0
31549,situations,0,0
31550,without,0,0
31551,sacrificing,0,0
31552,any,0,0
31553,of,0,0
31554,the,0,0
31555,overarching,0,0
31556,principles,0,0
31557,.,0,0
31558,Stapled,0,0
31559,mucosectomy,0,0
31560,for,0,0
31561,acute,0,0
31562,thrombosed,0,0
31563,circumferentially,0,0
31564,prolapsed,0,0
31565,piles,0,0
31566,:,0,0
31567,a,0,0
31568,prospective,0,0
31569,randomized,0,0
31570,comparison,0,0
31571,with,0,0
31572,conventional,0,0
31573,haemorrhoidectomy,0,0
31574,.,0,0
31575,OBJECTIVE,0,0
31576,Stapled,0,0
31577,mucosectomy,0,0
31578,has,0,0
31579,been,0,0
31580,developed,0,0
31581,as,0,0
31582,an,0,0
31583,alternative,0,0
31584,to,0,0
31585,conventional,0,0
31586,haemorrhoidectomy,0,0
31587,for,0,0
31588,the,0,0
31589,elective,0,0
31590,treatment,0,0
31591,of,0,0
31592,haemorrhoids,0,0
31593,",",0,0
31594,but,0,0
31595,has,0,0
31596,not,0,0
31597,been,0,0
31598,assessed,0,0
31599,in,0,0
31600,the,0,0
31601,emergency,0,0
31602,setting,0,0
31603,.,0,0
31604,The,0,0
31605,aim,0,0
31606,of,0,0
31607,this,0,0
31608,study,0,0
31609,was,0,0
31610,to,0,0
31611,compare,0,0
31612,this,0,0
31613,technique,0,0
31614,with,0,0
31615,a,0,0
31616,conventional,0,0
31617,procedure,0,0
31618,for,0,0
31619,acute,0,0
31620,thrombosed,0,0
31621,circumferential,0,1
31622,prolapsed,0,0
31623,haemorrhoids,0,0
31624,.,0,0
31625,PATIENTS,0,0
31626,AND,0,0
31627,METHODS,0,0
31628,A,0,0
31629,prospective,0,0
31630,randomized,0,0
31631,comparison,0,0
31632,of,0,0
31633,conventional,0,0
31634,Milligan-Morgan,0,0
31635,haemorrhoidectomy,0,0
31636,and,0,1
31637,stapled,0,1
31638,mucosectomy,0,0
31639,was,0,0
31640,carried,0,0
31641,out,0,0
31642,on,0,0
31643,35,0,0
31644,consecutive,0,0
31645,patients,0,0
31646,presenting,0,0
31647,with,0,0
31648,acute,0,0
31649,thrombosed,0,0
31650,circumferential,0,1
31651,prolapsed,0,0
31652,haemorrhoids,0,0
31653,.,0,0
31654,Operative,1,1
31655,data,1,0
31656,",",1,0
31657,postoperative,1,1
31658,stay,1,1
31659,",",1,0
31660,pain,1,1
31661,assessment,1,1
31662,and,1,1
31663,persistent,1,1
31664,symptoms,1,1
31665,were,0,0
31666,compared,0,0
31667,at,0,0
31668,discharge,0,1
31669,and,0,0
31670,at,0,0
31671,2,0,0
31672,week,0,0
31673,and,0,0
31674,6,0,0
31675,week,0,0
31676,review,0,0
31677,.,0,0
31678,Additionally,0,0
31679,at,0,0
31680,6,0,0
31681,week,0,0
31682,review,0,0
31683,the,0,0
31684,time,0,0
31685,to,0,0
31686,return,0,0
31687,to,0,0
31688,work,0,0
31689,was,0,0
31690,recorded,0,0
31691,and,0,0
31692,an,0,0
31693,endoanal,1,0
31694,ultrasound,1,1
31695,was,0,0
31696,carried,0,0
31697,out,0,0
31698,.,0,0
31699,RESULTS,0,0
31700,Thirty,0,0
31701,patients,0,0
31702,were,0,0
31703,randomized,0,0
31704,and,0,0
31705,followed,0,0
31706,up,0,0
31707,for,0,0
31708,six,0,0
31709,weeks,0,0
31710,.,0,0
31711,Although,0,0
31712,postoperative,1,1
31713,stay,1,1
31714,and,1,0
31715,in-hospital,1,1
31716,analgesia,1,1
31717,were,0,0
31718,the,0,0
31719,same,0,0
31720,",",0,0
31721,patients,0,0
31722,from,0,0
31723,the,0,0
31724,stapled,0,0
31725,group,0,0
31726,reported,0,0
31727,significantly,0,0
31728,more,0,0
31729,pain,0,1
31730,at,0,0
31731,discharge,0,1
31732,.,0,0
31733,However,0,0
31734,",",0,0
31735,by,0,0
31736,2,0,0
31737,weeks,0,0
31738,the,0,0
31739,conventional,0,0
31740,group,0,0
31741,reported,0,0
31742,significantly,0,0
31743,higher,1,0
31744,pain,1,1
31745,scores,1,1
31746,particularly,0,0
31747,on,0,0
31748,passing,0,0
31749,stool,0,0
31750,.,0,0
31751,By,0,0
31752,this,0,0
31753,stage,0,0
31754,over,0,0
31755,half,0,0
31756,the,0,0
31757,stapled,0,0
31758,group,0,0
31759,patients,0,0
31760,reported,0,0
31761,no,1,0
31762,pain,1,1
31763,at,0,0
31764,all,0,0
31765,.,0,0
31766,More,0,0
31767,patients,0,0
31768,in,0,0
31769,the,0,0
31770,conventional,0,0
31771,group,0,0
31772,complained,0,0
31773,of,0,0
31774,persistent,1,0
31775,symptoms,1,1
31776,of,1,0
31777,pain,1,1
31778,",",1,0
31779,bleeding,1,1
31780,and,1,1
31781,discharge,1,1
31782,at,0,0
31783,2,0,0
31784,week,0,0
31785,and,0,0
31786,6,0,0
31787,week,0,0
31788,review,0,0
31789,with,0,0
31790,20,0,0
31791,%,0,0
31792,requiring,0,0
31793,readmission,0,1
31794,compared,0,0
31795,with,0,0
31796,none,0,0
31797,in,0,0
31798,the,0,0
31799,stapled,0,0
31800,group,0,0
31801,.,0,0
31802,The,0,0
31803,median,1,0
31804,return,1,0
31805,to,1,0
31806,work,1,0
31807,was,1,0
31808,significantly,1,0
31809,shorter,1,0
31810,for,0,0
31811,the,0,0
31812,stapled,0,0
31813,group,0,0
31814,(,0,0
31815,14,0,0
31816,days,0,0
31817,vs,0,0
31818,28,0,0
31819,days,0,0
31820,",",0,0
31821,P,0,0
31822,<,0,0
31823,0.05,0,0
31824,),0,0
31825,.,0,0
31826,Although,0,0
31827,all,0,0
31828,patients,0,0
31829,claimed,0,0
31830,to,0,0
31831,be,0,0
31832,continent,0,0
31833,",",0,0
31834,two,0,0
31835,patients,0,0
31836,from,0,0
31837,each,0,0
31838,group,0,0
31839,had,0,0
31840,ultrasonic,0,0
31841,evidence,0,0
31842,of,0,0
31843,internal,1,0
31844,sphincter,1,0
31845,damage,1,1
31846,.,1,0
31847,CONCLUSION,0,0
31848,Stapled,0,0
31849,mucosectomy,0,0
31850,for,0,0
31851,acute,0,0
31852,thrombosed,0,0
31853,circumferential,0,1
31854,piles,0,0
31855,is,0,0
31856,feasible,0,0
31857,and,0,0
31858,may,0,0
31859,result,0,0
31860,in,0,0
31861,less,1,0
31862,pain,1,1
31863,",",0,0
31864,a,0,0
31865,more,0,0
31866,rapid,0,1
31867,resolution,0,1
31868,of,0,0
31869,symptoms,0,1
31870,and,0,0
31871,an,0,0
31872,earlier,0,0
31873,return,0,1
31874,to,0,0
31875,work,0,0
31876,compared,0,0
31877,with,0,0
31878,a,0,0
31879,conventional,0,0
31880,procedure,0,0
31881,.,0,0
31882,Prevention,0,0
31883,of,0,0
31884,coronary,0,0
31885,spasm,0,1
31886,by,0,0
31887,nicorandil,0,0
31888,:,0,0
31889,comparison,0,0
31890,with,0,0
31891,nifedipine,0,0
31892,.,0,0
31893,The,0,0
31894,efficacy,0,1
31895,of,0,0
31896,nicorandil,0,0
31897,was,0,0
31898,compared,0,0
31899,with,0,0
31900,that,0,0
31901,of,0,0
31902,nifedipine,0,0
31903,in,0,0
31904,13,0,0
31905,patients,0,0
31906,with,0,0
31907,vasospastic,0,1
31908,angina,0,0
31909,enrolled,0,0
31910,in,0,0
31911,a,0,0
31912,randomized,0,0
31913,",",0,0
31914,placebo-controlled,0,0
31915,",",0,0
31916,crossover,0,0
31917,study,0,0
31918,.,0,0
31919,All,0,0
31920,patients,0,0
31921,had,0,0
31922,a,0,0
31923,coronary,0,0
31924,spasm,0,1
31925,during,0,0
31926,coronary,0,0
31927,arteriography,0,0
31928,",",0,0
31929,either,0,0
31930,spontaneously,0,0
31931,or,0,0
31932,ergometrine-induced,0,0
31933,.,0,0
31934,During,0,0
31935,two,0,0
31936,consecutive,0,0
31937,periods,0,0
31938,of,0,0
31939,2,0,0
31940,days,0,0
31941,",",0,0
31942,patients,0,0
31943,received,0,0
31944,active,0,0
31945,drugs,0,0
31946,or,0,0
31947,placebo,0,0
31948,in,0,0
31949,a,0,0
31950,randomized,0,0
31951,order,0,0
31952,.,0,0
31953,Each,0,0
31954,patient,0,0
31955,received,0,0
31956,single,0,0
31957,oral,0,0
31958,doses,0,0
31959,of,0,0
31960,30,0,0
31961,mg,0,0
31962,nicorandil,0,0
31963,",",0,0
31964,10,0,0
31965,mg,0,0
31966,nifedipine,0,0
31967,",",0,1
31968,and,0,1
31969,",",0,0
31970,on,0,0
31971,2,0,0
31972,days,0,0
31973,",",0,0
31974,a,0,0
31975,placebo,0,0
31976,.,0,0
31977,One,0,0
31978,hour,0,0
31979,after,0,0
31980,drug,0,0
31981,intake,0,1
31982,",",0,0
31983,patients,0,0
31984,underwent,0,0
31985,an,0,0
31986,ergometrine,0,0
31987,test,0,0
31988,with,0,0
31989,increasing,0,0
31990,doses,0,0
31991,of,0,0
31992,Methergin,0,0
31993,(,0,0
31994,ergometrine,0,0
31995,),0,0
31996,(,0,0
31997,0.05,0,0
31998,",",0,0
31999,0.10,0,0
32000,",",0,0
32001,0.20,0,0
32002,",",0,0
32003,and,0,0
32004,0.40,0,0
32005,mg,0,0
32006,every,0,0
32007,5,0,0
32008,min,0,0
32009,),0,0
32010,.,0,0
32011,After,0,0
32012,placebo,0,0
32013,",",0,0
32014,the,0,0
32015,tests,0,0
32016,always,0,0
32017,were,0,0
32018,positive,0,1
32019,",",0,0
32020,and,0,0
32021,the,0,0
32022,ECG,1,1
32023,changes,1,1
32024,occurred,0,0
32025,at,0,0
32026,the,0,0
32027,same,0,0
32028,+/-,0,0
32029,1,0,0
32030,dose,0,0
32031,of,0,0
32032,ergometrine,0,0
32033,in,0,0
32034,10,0,0
32035,cases,0,0
32036,",",0,0
32037,showing,0,0
32038,good,1,0
32039,reproducibility,1,1
32040,.,1,0
32041,After,0,0
32042,nicorandil,0,0
32043,",",0,0
32044,the,0,0
32045,tests,0,1
32046,were,0,0
32047,negative,0,0
32048,in,0,0
32049,nine,0,0
32050,patients,0,0
32051,and,0,0
32052,positive,0,0
32053,for,0,0
32054,a,0,0
32055,higher,0,0
32056,or,0,0
32057,lower,0,1
32058,dose,0,0
32059,of,0,1
32060,ergometrine,0,0
32061,in,0,0
32062,three,0,0
32063,and,0,0
32064,one,0,0
32065,patient,0,0
32066,",",0,0
32067,respectively,0,0
32068,(,0,0
32069,p,0,0
32070,=,0,0
32071,0.0034,0,0
32072,vs.,0,0
32073,placebo,0,0
32074,),0,0
32075,.,0,0
32076,After,0,0
32077,nifedipine,0,0
32078,",",0,0
32079,the,0,0
32080,tests,0,1
32081,were,0,0
32082,negative,0,0
32083,in,0,0
32084,five,0,0
32085,patients,0,0
32086,and,0,0
32087,positive,0,0
32088,for,0,0
32089,a,0,0
32090,higher,0,0
32091,or,0,0
32092,the,0,0
32093,same,0,0
32094,dose,0,0
32095,of,0,0
32096,ergometrine,0,0
32097,in,0,0
32098,four,0,0
32099,and,0,0
32100,four,0,0
32101,patients,0,0
32102,",",0,0
32103,respectively,0,0
32104,(,0,0
32105,p,0,0
32106,=,0,0
32107,0.0039,0,0
32108,vs.,0,0
32109,placebo,0,0
32110,),0,0
32111,.,0,0
32112,Nifedipine,0,0
32113,(,0,0
32114,10,0,0
32115,mg,0,0
32116,),0,0
32117,and,0,0
32118,nicorandil,0,0
32119,(,0,0
32120,30,0,0
32121,mg,0,0
32122,),0,0
32123,were,0,0
32124,equally,0,0
32125,effective,0,0
32126,in,0,0
32127,eight,0,0
32128,patients,0,0
32129,;,0,0
32130,in,0,0
32131,the,0,0
32132,remaining,0,0
32133,five,0,0
32134,patients,0,0
32135,",",0,0
32136,nicorandil,0,0
32137,had,0,0
32138,better,0,0
32139,results,0,0
32140,(,0,0
32141,p,0,0
32142,=,0,0
32143,0.06,0,0
32144,),0,0
32145,.,0,0
32146,Nicorandil,0,0
32147,(,0,0
32148,30,0,0
32149,mg,0,0
32150,),0,0
32151,prevents,0,0
32152,ergometrine-induced,1,0
32153,coronary,1,0
32154,spasm,1,0
32155,.,1,0
32156,This,0,0
32157,compound,0,0
32158,may,0,0
32159,be,0,0
32160,beneficial,0,0
32161,in,0,0
32162,patients,0,0
32163,with,0,0
32164,vasospastic,1,1
32165,angina,1,0
32166,.,1,0
32167,The,0,0
32168,prevalence,0,0
32169,of,0,0
32170,IgE,0,0
32171,sensitization,0,0
32172,to,0,0
32173,formaldehyde,0,0
32174,in,0,0
32175,asthmatic,0,0
32176,children,0,0
32177,.,0,0
32178,BACKGROUND,0,0
32179,Formaldehyde,0,0
32180,(,0,0
32181,FA,0,0
32182,),0,0
32183,is,0,0
32184,well,0,0
32185,documented,0,0
32186,as,0,0
32187,a,0,0
32188,cause,0,0
32189,of,0,0
32190,occupational,1,0
32191,asthma,1,0
32192,.,1,0
32193,Recently,0,0
32194,",",0,0
32195,attention,0,0
32196,has,0,0
32197,been,0,0
32198,paid,0,0
32199,to,0,0
32200,FA,0,0
32201,as,0,0
32202,an,0,0
32203,allergen,0,0
32204,and,0,0
32205,a,0,0
32206,pollutant,0,0
32207,that,0,0
32208,enhances,1,0
32209,allergic,1,0
32210,sensitization,1,0
32211,.,1,0
32212,We,0,0
32213,have,0,0
32214,investigated,0,0
32215,the,0,0
32216,prevalence,0,0
32217,of,0,0
32218,FA-specific,0,0
32219,IgE,0,0
32220,in,0,0
32221,asthmatic,0,0
32222,children,0,0
32223,and,0,0
32224,the,0,0
32225,correlation,0,0
32226,between,0,0
32227,IgE,0,0
32228,sensitization,0,1
32229,to,0,0
32230,FA,0,0
32231,and,0,0
32232,the,0,0
32233,severity,1,1
32234,of,1,0
32235,asthma,1,0
32236,.,1,0
32237,METHODS,0,0
32238,One,0,0
32239,hundred,0,0
32240,and,0,0
32241,fifty-five,0,0
32242,children,0,0
32243,were,0,0
32244,investigated,0,0
32245,",",0,0
32246,122,0,0
32247,of,0,0
32248,them,0,0
32249,asthmatic,0,0
32250,and,0,0
32251,33,0,0
32252,nonallergic,0,0
32253,.,0,0
32254,Specific,1,0
32255,IgE,1,0
32256,against,1,1
32257,FA,1,0
32258,was,0,0
32259,measured,0,0
32260,by,0,0
32261,CAP,0,0
32262,RAST,0,0
32263,.,0,0
32264,In,0,0
32265,addition,0,0
32266,",",0,0
32267,the,0,0
32268,patients,0,0
32269,answered,0,0
32270,a,0,0
32271,questionnaire,1,1
32272,",",0,0
32273,containing,0,0
32274,questions,0,1
32275,on,0,0
32276,clinical,1,0
32277,features,1,0
32278,of,1,0
32279,their,1,0
32280,asthma,1,0
32281,",",1,0
32282,their,1,0
32283,living,1,0
32284,conditions,1,0
32285,",",1,0
32286,and,1,1
32287,symptoms,1,1
32288,of,1,1
32289,mucosal,1,1
32290,irritation,1,1
32291,.,1,0
32292,RESULTS,0,0
32293,Of,0,0
32294,all,0,0
32295,the,0,0
32296,subjects,0,0
32297,assessed,0,0
32298,",",0,0
32299,FA-specific,1,0
32300,IgE,1,1
32301,was,0,0
32302,detected,0,0
32303,in,0,0
32304,only,0,0
32305,two,0,0
32306,asthmatics,0,0
32307,",",0,0
32308,and,0,0
32309,their,0,0
32310,IgE,0,0
32311,levels,0,1
32312,of,0,0
32313,FA,0,0
32314,were,0,0
32315,low,0,0
32316,(,0,0
32317,0.42,0,0
32318,and,0,0
32319,0.46,0,0
32320,UA/ml,0,0
32321,),0,0
32322,.,0,0
32323,One,0,0
32324,of,0,0
32325,the,0,0
32326,two,0,0
32327,patients,0,0
32328,with,0,0
32329,FA-specific,0,0
32330,IgE,0,1
32331,had,0,0
32332,severe,1,1
32333,asthma,1,0
32334,and,1,0
32335,frequent,1,1
32336,symptoms,1,1
32337,of,1,0
32338,mucosal,1,1
32339,irritation,1,1
32340,",",0,0
32341,but,0,0
32342,the,0,0
32343,other,0,0
32344,had,0,0
32345,mild,1,1
32346,asthma,1,0
32347,and,1,0
32348,only,1,0
32349,rare,1,0
32350,symptoms,1,1
32351,of,1,0
32352,mucosal,1,1
32353,irritation,1,1
32354,.,1,0
32355,CONCLUSIONS,0,0
32356,The,0,0
32357,prevalence,0,0
32358,of,0,0
32359,IgE,1,0
32360,sensitization,1,1
32361,to,0,0
32362,FA,0,0
32363,appears,0,0
32364,very,0,0
32365,low,0,0
32366,in,0,0
32367,Japanese,0,0
32368,children,0,0
32369,",",0,0
32370,whether,0,0
32371,or,0,0
32372,not,0,0
32373,they,0,0
32374,have,0,0
32375,asthma,0,0
32376,.,0,0
32377,Therefore,0,0
32378,",",0,0
32379,it,0,0
32380,appears,0,0
32381,likely,0,0
32382,that,0,0
32383,FA,0,0
32384,is,0,0
32385,not,0,0
32386,one,0,0
32387,of,0,0
32388,the,0,0
32389,major,0,0
32390,allergens,0,0
32391,causing,0,0
32392,childhood,0,0
32393,asthma,0,0
32394,.,0,0
32395,Alendronate,0,0
32396,daily,0,0
32397,",",0,0
32398,weekly,0,0
32399,in,0,0
32400,conventional,0,0
32401,tablets,0,0
32402,and,0,0
32403,weekly,0,0
32404,in,0,0
32405,enteric,0,0
32406,tablets,0,0
32407,:,0,0
32408,preliminary,0,0
32409,study,0,0
32410,on,0,0
32411,the,0,0
32412,effects,0,0
32413,in,0,0
32414,bone,1,1
32415,turnover,1,1
32416,markers,1,1
32417,and,0,1
32418,incidence,1,1
32419,of,1,1
32420,side,1,1
32421,effects,1,1
32422,.,1,0
32423,Bisphosphonates,0,0
32424,are,0,0
32425,now,0,0
32426,in,0,0
32427,the,0,0
32428,vanguard,0,0
32429,of,0,0
32430,osteoporosis,0,0
32431,treatment,0,0
32432,.,0,0
32433,Frequently,0,0
32434,",",0,0
32435,gastro-oesophageal,0,1
32436,symptoms,0,1
32437,are,0,0
32438,associated,0,0
32439,with,0,0
32440,these,0,0
32441,drugs,0,0
32442,.,0,0
32443,The,0,0
32444,objective,0,0
32445,of,0,0
32446,this,0,0
32447,study,0,0
32448,was,0,0
32449,to,0,0
32450,compare,0,0
32451,side,0,1
32452,effects,0,1
32453,and,0,1
32454,bone,0,1
32455,turnover,0,1
32456,markers,0,1
32457,in,0,0
32458,postmenopausal,0,0
32459,women,0,0
32460,who,0,0
32461,had,0,0
32462,received,0,0
32463,alendronate,0,0
32464,daily,0,0
32465,or,0,0
32466,weekly,0,0
32467,in,0,0
32468,tablets,0,0
32469,with,0,0
32470,or,0,0
32471,without,0,0
32472,enteric,0,0
32473,coating,0,0
32474,.,0,0
32475,We,0,0
32476,conducted,0,0
32477,a,0,0
32478,randomised,0,0
32479,",",0,0
32480,double-blind,0,0
32481,",",0,0
32482,3-month,0,0
32483,trial,0,0
32484,.,0,0
32485,The,0,0
32486,trial,0,0
32487,involved,0,0
32488,75,0,0
32489,volunteers,0,0
32490,",",0,0
32491,aged,0,0
32492,45-58,0,0
32493,with,0,0
32494,moderate,0,0
32495,to,0,0
32496,severe,0,1
32497,osteopenia,0,1
32498,(,0,0
32499,T-score,0,1
32500,lower,0,0
32501,than,0,0
32502,-2,0,0
32503,SD,0,0
32504,),0,0
32505,assessed,0,0
32506,by,0,0
32507,quantitative,0,0
32508,ultrasound,0,0
32509,.,0,0
32510,Women,0,0
32511,were,0,0
32512,assigned,0,0
32513,randomly,0,0
32514,to,0,0
32515,receive,0,0
32516,:,0,0
32517,(,0,0
32518,a,0,0
32519,),0,0
32520,alendronate,0,0
32521,10mg/day,0,0
32522,:,0,0
32523,(,0,0
32524,b,0,0
32525,),0,0
32526,alendronate,0,0
32527,70,0,0
32528,mg,0,0
32529,once,0,0
32530,a,0,0
32531,week,0,0
32532,:,0,0
32533,or,0,0
32534,(,0,0
32535,c,0,0
32536,),0,0
32537,enteric,0,0
32538,alendronate,0,0
32539,70,0,0
32540,mg,0,0
32541,per,0,0
32542,week,0,0
32543,.,0,0
32544,We,0,0
32545,recorded,0,0
32546,side,1,1
32547,effects,1,1
32548,",",1,0
32549,C-telopeptide,1,1
32550,",",1,1
32551,osteocalcin,1,1
32552,and,1,1
32553,urine,1,1
32554,hydroxyproline,1,1
32555,at,0,0
32556,the,0,0
32557,start,0,0
32558,of,0,0
32559,the,0,0
32560,study,0,0
32561,and,0,0
32562,at,0,0
32563,3,0,0
32564,months,0,0
32565,.,0,0
32566,After,0,0
32567,3,0,0
32568,months,0,0
32569,",",0,0
32570,pyrosis,1,1
32571,(,1,1
32572,heartburn,1,1
32573,),1,0
32574,was,0,0
32575,noted,0,0
32576,by,0,0
32577,seven,0,0
32578,women,0,0
32579,in,0,0
32580,group,0,0
32581,A,0,0
32582,(,0,0
32583,28,0,0
32584,%,0,0
32585,),0,0
32586,",",0,0
32587,three,0,0
32588,in,0,0
32589,group,0,0
32590,B,0,0
32591,(,0,0
32592,12,0,0
32593,%,0,0
32594,),0,0
32595,and,0,0
32596,two,0,0
32597,in,0,0
32598,group,0,0
32599,C,0,0
32600,(,0,0
32601,8,0,0
32602,%,0,0
32603,),0,0
32604,;,0,0
32605,nausea,1,1
32606,:,1,0
32607,by,0,0
32608,one,0,0
32609,woman,0,0
32610,in,0,0
32611,group,0,0
32612,B,0,0
32613,;,0,0
32614,and,0,0
32615,headache,1,1
32616,by,0,0
32617,one,0,0
32618,patient,0,0
32619,in,0,0
32620,each,0,0
32621,group,0,0
32622,.,0,0
32623,C-telopeptide,1,1
32624,(,0,0
32625,A,0,0
32626,:,0,0
32627,40.7,0,0
32628,%,0,0
32629,;,0,0
32630,B,0,0
32631,:,0,0
32632,34.1,0,0
32633,%,0,0
32634,and,0,0
32635,C,0,0
32636,:,0,0
32637,38.5,0,0
32638,%,0,0
32639,),0,0
32640,;,0,0
32641,hydroxyproline,1,1
32642,(,0,0
32643,A,0,0
32644,:,0,0
32645,31.1,0,0
32646,%,0,0
32647,;,0,0
32648,B,0,0
32649,:,0,0
32650,25.3,0,0
32651,%,0,0
32652,and,0,0
32653,C,0,0
32654,:,0,0
32655,31.5,0,0
32656,%,0,0
32657,),0,0
32658,and,0,0
32659,osteocalcin,1,1
32660,(,0,0
32661,A,0,0
32662,:,0,0
32663,27.0,0,0
32664,%,0,0
32665,;,0,0
32666,B,0,0
32667,:,0,0
32668,25.4,0,0
32669,%,0,0
32670,and,0,0
32671,C,0,0
32672,:,0,0
32673,25.1,0,0
32674,%,0,0
32675,),0,0
32676,decreased,0,0
32677,similarly,0,0
32678,in,0,0
32679,the,0,0
32680,three,0,0
32681,groups,0,0
32682,.,0,0
32683,Weekly,0,0
32684,intake,0,1
32685,of,0,0
32686,alendronate,0,0
32687,",",0,0
32688,whether,0,0
32689,conventional,0,0
32690,or,0,0
32691,enteric-coated,0,0
32692,;,0,0
32693,is,0,0
32694,associated,0,0
32695,with,0,0
32696,less,0,0
32697,heartburn,1,1
32698,and,1,1
32699,nausea,1,1
32700,.,1,1
32701,Enteric,0,0
32702,alendronate,0,0
32703,has,0,0
32704,a,0,0
32705,similar,0,0
32706,action,0,0
32707,to,0,0
32708,the,0,0
32709,conventional,0,0
32710,tablets,0,0
32711,on,0,0
32712,biochemical,1,0
32713,markers,1,0
32714,.,1,0
32715,Virtual,0,0
32716,reality,0,0
32717,intervention,0,0
32718,for,0,0
32719,older,0,0
32720,women,0,0
32721,with,0,0
32722,breast,0,0
32723,cancer,0,0
32724,.,0,0
32725,This,0,0
32726,study,0,0
32727,examined,0,0
32728,the,0,0
32729,effects,0,0
32730,of,0,0
32731,a,0,0
32732,virtual,0,0
32733,reality,0,0
32734,distraction,0,0
32735,intervention,0,0
32736,on,0,0
32737,chemotherapy-related,0,1
32738,symptom,1,1
32739,distress,1,1
32740,levels,0,1
32741,in,0,0
32742,16,0,0
32743,women,0,0
32744,aged,0,0
32745,50,0,0
32746,and,0,0
32747,older,0,0
32748,.,0,0
32749,A,0,0
32750,cross-over,0,0
32751,design,0,0
32752,was,0,0
32753,used,0,0
32754,to,0,0
32755,answer,0,0
32756,the,0,0
32757,following,0,0
32758,research,0,0
32759,questions,0,1
32760,:,0,0
32761,(,0,0
32762,1,0,0
32763,),0,0
32764,Is,0,0
32765,virtual,0,0
32766,reality,0,0
32767,an,0,0
32768,effective,0,1
32769,distraction,0,0
32770,intervention,0,0
32771,for,0,0
32772,reducing,0,0
32773,chemotherapy-related,0,1
32774,symptom,0,1
32775,distress,0,1
32776,levels,0,1
32777,in,0,0
32778,older,0,0
32779,women,0,0
32780,with,0,0
32781,breast,0,0
32782,cancer,0,0
32783,?,0,0
32784,(,0,0
32785,2,0,0
32786,),0,0
32787,Does,0,0
32788,virtual,0,0
32789,reality,0,0
32790,have,0,0
32791,a,0,0
32792,lasting,0,0
32793,effect,0,0
32794,?,0,0
32795,Chemotherapy,0,0
32796,treatments,0,0
32797,are,0,0
32798,intensive,0,0
32799,and,0,0
32800,difficult,0,0
32801,to,0,0
32802,endure,0,0
32803,.,0,0
32804,One,0,0
32805,way,0,0
32806,to,0,0
32807,cope,0,1
32808,with,0,0
32809,chemotherapy-related,0,1
32810,symptom,0,1
32811,distress,0,1
32812,is,0,0
32813,through,0,0
32814,the,0,0
32815,use,0,0
32816,of,0,0
32817,distraction,0,0
32818,.,0,0
32819,For,0,0
32820,this,0,0
32821,study,0,0
32822,",",0,0
32823,a,0,0
32824,head-mounted,0,0
32825,display,0,0
32826,(,0,0
32827,Sony,0,1
32828,PC,0,0
32829,Glasstron,0,0
32830,PLM,0,0
32831,-,0,0
32832,S700,0,0
32833,),0,0
32834,was,0,0
32835,used,0,0
32836,to,0,0
32837,display,0,0
32838,encompassing,0,0
32839,images,0,0
32840,and,0,0
32841,block,0,0
32842,competing,0,0
32843,stimuli,0,1
32844,during,0,0
32845,chemotherapy,0,0
32846,infusions,0,0
32847,.,0,0
32848,The,0,0
32849,Symptom,1,1
32850,Distress,1,1
32851,Scale,1,1
32852,(,1,0
32853,SDS,1,0
32854,),1,0
32855,",",1,0
32856,Revised,1,0
32857,Piper,1,0
32858,Fatigue,1,1
32859,Scale,1,1
32860,(,1,0
32861,PFS,1,1
32862,),1,1
32863,",",1,0
32864,and,1,0
32865,the,1,0
32866,State,1,1
32867,Anxiety,1,1
32868,Inventory,1,1
32869,(,1,0
32870,SAI,1,0
32871,),1,0
32872,were,0,0
32873,used,0,0
32874,to,0,0
32875,measure,0,0
32876,symptom,0,1
32877,distress,0,1
32878,.,0,0
32879,For,0,0
32880,two,0,0
32881,matched,0,0
32882,chemotherapy,0,0
32883,treatments,0,0
32884,",",0,0
32885,one,0,0
32886,pre-test,0,0
32887,and,0,0
32888,two,0,0
32889,post-test,0,0
32890,measures,0,0
32891,were,0,0
32892,employed,0,0
32893,.,0,0
32894,Participants,0,0
32895,were,0,0
32896,randomly,0,0
32897,assigned,0,0
32898,to,0,0
32899,receive,0,0
32900,the,0,0
32901,VR,0,1
32902,distraction,0,0
32903,intervention,0,0
32904,during,0,0
32905,one,0,0
32906,chemotherapy,0,0
32907,treatment,0,0
32908,and,0,0
32909,received,0,0
32910,no,0,0
32911,distraction,0,0
32912,intervention,0,0
32913,(,0,0
32914,control,0,0
32915,condition,0,0
32916,),0,0
32917,during,0,0
32918,an,0,0
32919,alternate,0,0
32920,chemotherapy,0,0
32921,treatment,0,0
32922,.,0,0
32923,Analysis,0,0
32924,using,0,0
32925,paired,0,0
32926,t-tests,0,0
32927,demonstrated,0,0
32928,a,0,0
32929,significant,0,0
32930,decrease,1,0
32931,in,0,0
32932,the,0,0
32933,SAI,1,0
32934,(,0,0
32935,p,0,0
32936,=,0,0
32937,0.10,0,0
32938,),0,0
32939,scores,0,0
32940,immediately,0,0
32941,following,0,0
32942,chemotherapy,0,0
32943,treatments,0,0
32944,when,0,0
32945,participants,0,0
32946,used,0,0
32947,VR,0,1
32948,.,0,0
32949,No,0,0
32950,significant,0,0
32951,changes,0,1
32952,were,0,0
32953,found,0,0
32954,in,0,0
32955,SDS,1,0
32956,or,1,0
32957,PFS,1,1
32958,values,1,1
32959,.,1,0
32960,There,0,0
32961,was,0,0
32962,a,0,0
32963,consistent,0,0
32964,trend,0,0
32965,toward,0,0
32966,improved,1,0
32967,symptoms,1,1
32968,on,0,0
32969,all,0,0
32970,measures,0,0
32971,48,0,0
32972,h,0,0
32973,following,0,0
32974,completion,0,1
32975,of,0,0
32976,chemotherapy,0,0
32977,.,0,0
32978,Evaluation,0,0
32979,of,0,0
32980,the,0,0
32981,intervention,0,0
32982,indicated,0,0
32983,that,0,0
32984,women,0,0
32985,thought,0,0
32986,the,0,0
32987,head,0,0
32988,mounted,0,0
32989,device,0,0
32990,was,0,0
32991,easy,0,0
32992,to,0,0
32993,use,0,0
32994,",",0,0
32995,they,0,0
32996,experienced,0,0
32997,no,0,0
32998,cybersickness,1,1
32999,",",0,0
33000,and,0,0
33001,100,0,0
33002,%,0,0
33003,would,0,0
33004,use,0,0
33005,VR,0,1
33006,again,0,0
33007,.,0,0
33008,Reduced,0,0
33009,platelet,1,1
33010,thromboxane,1,1
33011,formation,1,1
33012,after,0,0
33013,long-term,0,0
33014,administration,0,0
33015,of,0,0
33016,a,0,0
33017,dihydropyridine,0,0
33018,calcium,0,0
33019,channel,0,0
33020,blocker,0,0
33021,:,0,0
33022,a,0,0
33023,prospective,0,0
33024,",",0,0
33025,double-blind,0,0
33026,",",0,0
33027,placebo-controlled,0,0
33028,study,0,0
33029,with,0,0
33030,nitrendipine,0,0
33031,in,0,0
33032,borderline,0,0
33033,hypertensive,0,0
33034,patients,0,0
33035,with,0,0
33036,IDDM-type,0,0
33037,diabetes,0,0
33038,mellitus,0,0
33039,.,0,0
33040,Twenty-nine,0,0
33041,IDDM,0,0
33042,patients,0,0
33043,with,0,0
33044,borderline,0,0
33045,hypertension,0,1
33046,were,0,0
33047,randomly,0,0
33048,allocated,0,0
33049,to,0,0
33050,placebo,0,0
33051,or,0,0
33052,nitrendipine,0,0
33053,treatment,0,0
33054,.,0,0
33055,Nitrendipine,0,0
33056,was,0,0
33057,given,0,0
33058,orally,0,0
33059,at,0,0
33060,a,0,0
33061,dosage,0,0
33062,of,0,0
33063,20,0,0
33064,mg,0,0
33065,once,0,0
33066,daily,0,0
33067,over,0,0
33068,4,0,0
33069,weeks,0,0
33070,.,0,0
33071,Stimulated,1,0
33072,platelet,1,1
33073,thromboxane,1,1
33074,formation,1,1
33075,at,0,0
33076,rest,0,0
33077,and,0,0
33078,after,0,0
33079,standardized,0,0
33080,",",0,0
33081,non,0,0
33082,exhausting,0,1
33083,exercise,0,0
33084,was,0,0
33085,measured,0,0
33086,by,0,0
33087,standard,0,0
33088,methods,0,0
33089,.,0,0
33090,In,0,0
33091,addition,0,0
33092,",",0,0
33093,plasma,1,1
33094,levels,1,1
33095,of,1,0
33096,platelet,1,1
33097,factor,1,0
33098,4,1,0
33099,and,1,0
33100,aggregation,1,1
33101,responses,1,1
33102,to,1,0
33103,collagen,1,0
33104,and,1,0
33105,ADP,1,1
33106,were,0,0
33107,determined,0,0
33108,.,0,0
33109,In,0,0
33110,the,0,0
33111,treatment,0,0
33112,group,0,0
33113,thromboxane,1,1
33114,formation,1,1
33115,after,0,0
33116,stimulation,0,0
33117,with,0,0
33118,collagen,0,0
33119,(,0,0
33120,0.3,0,0
33121,and,0,0
33122,1.0,0,0
33123,micrograms/ml,0,0
33124,),0,0
33125,and,0,0
33126,1,0,0
33127,mM,0,0
33128,arachidonic,0,1
33129,acid,0,0
33130,(,0,0
33131,AA,0,0
33132,),0,0
33133,was,0,0
33134,reduced,0,0
33135,in,0,0
33136,the,0,0
33137,resting,0,0
33138,state,0,0
33139,.,0,0
33140,Exercise,1,0
33141,induced,1,0
33142,change,1,1
33143,of,1,0
33144,thromboxane,1,1
33145,synthesis,1,1
33146,in,0,0
33147,response,0,1
33148,to,0,0
33149,1.0,0,0
33150,micrograms/ml,0,0
33151,collagen,0,0
33152,was,0,0
33153,significantly,0,0
33154,lower,0,0
33155,as,0,0
33156,compared,0,0
33157,to,0,0
33158,placebo,0,0
33159,(,0,0
33160,p,0,0
33161,<,0,0
33162,0.05,0,0
33163,),0,0
33164,.,0,0
33165,In,0,0
33166,parallel,0,0
33167,",",0,0
33168,PF4,1,0
33169,plasma,1,1
33170,levels,1,1
33171,were,0,0
33172,significantly,0,0
33173,lowered,0,0
33174,(,0,0
33175,p,0,0
33176,<,0,0
33177,0.05,0,0
33178,),0,0
33179,.,0,0
33180,Whole,1,0
33181,blood,1,1
33182,aggregation,1,1
33183,after,1,0
33184,collagen,1,0
33185,stimulation,1,0
33186,(,0,0
33187,1.0,0,0
33188,micrograms/ml,0,0
33189,),0,0
33190,was,0,0
33191,reduced,0,0
33192,after,0,0
33193,4,0,0
33194,weeks,0,0
33195,of,0,0
33196,nitrendipine,0,0
33197,treatment,0,0
33198,",",0,0
33199,but,0,0
33200,ADP,1,1
33201,(,1,0
33202,5,1,0
33203,microM,1,0
33204,),1,0
33205,induced,1,0
33206,aggregation,1,1
33207,was,0,0
33208,not,0,0
33209,.,0,0
33210,These,0,0
33211,effects,0,0
33212,of,0,0
33213,nitrendipine,0,0
33214,were,0,0
33215,not,0,0
33216,seen,0,0
33217,in,0,0
33218,platelet,0,1
33219,rich,0,0
33220,plasma,0,1
33221,.,0,0
33222,In,0,0
33223,conclusion,0,0
33224,long-term,0,0
33225,nitrendipine,0,0
33226,treatment,0,0
33227,may,0,0
33228,inhibit,0,0
33229,collagen,1,0
33230,dependent,1,0
33231,platelet,1,1
33232,activation,1,1
33233,in,0,0
33234,the,0,0
33235,blood,0,1
33236,of,0,0
33237,diabetic,0,0
33238,patients,0,0
33239,with,0,0
33240,borderline,0,0
33241,hypertension,0,0
33242,.,0,0
33243,Cisplatin,0,0
33244,",",0,0
33245,epirubicin,0,0
33246,",",0,1
33247,leucovorin,0,0
33248,and,0,1
33249,5-fluorouracil,0,0
33250,(,0,0
33251,PELF,0,0
33252,),0,0
33253,is,0,0
33254,more,0,0
33255,active,0,0
33256,than,0,0
33257,5-fluorouracil,0,0
33258,",",0,0
33259,doxorubicin,0,0
33260,and,0,1
33261,methotrexate,0,0
33262,(,0,1
33263,FAMTX,0,0
33264,),0,0
33265,in,0,0
33266,advanced,0,0
33267,gastric,0,1
33268,carcinoma,0,0
33269,.,0,0
33270,BACKGROUND,0,0
33271,5-Fluorouracil,0,0
33272,(,0,0
33273,5-FU,0,1
33274,),0,0
33275,",",0,0
33276,doxorubicin,0,0
33277,and,0,1
33278,methotrexate,0,0
33279,(,0,1
33280,FAMTX,0,1
33281,),0,1
33282,and,0,1
33283,cisplatin,0,0
33284,",",0,1
33285,epirubicin,0,0
33286,",",0,1
33287,leucovorin,0,0
33288,and,0,1
33289,5-FU,0,1
33290,(,0,0
33291,PELF,0,0
33292,),0,0
33293,have,0,0
33294,both,0,0
33295,been,0,0
33296,reported,0,0
33297,to,0,0
33298,be,0,0
33299,superior,0,0
33300,to,0,0
33301,the,0,0
33302,combination,0,0
33303,5-FU,0,0
33304,",",0,0
33305,doxorubicin,0,0
33306,and,0,0
33307,mitomycin,0,0
33308,C,0,0
33309,(,0,0
33310,FAM,0,0
33311,),0,0
33312,in,0,0
33313,advanced,0,0
33314,gastric,0,1
33315,carcinoma,0,0
33316,.,0,0
33317,On,0,0
33318,the,0,0
33319,basis,0,0
33320,of,0,0
33321,the,0,0
33322,presence,0,0
33323,and,0,0
33324,dose,0,0
33325,intensity,0,1
33326,of,0,0
33327,the,0,0
33328,included,0,0
33329,agents,0,0
33330,",",0,0
33331,we,0,0
33332,hypothesised,0,0
33333,that,0,0
33334,PELF,0,0
33335,would,0,0
33336,be,0,0
33337,superior,0,0
33338,to,0,0
33339,FAMTX,0,0
33340,.,0,0
33341,PATIENTS,0,0
33342,AND,0,0
33343,METHODS,0,0
33344,Two,0,0
33345,hundred,0,0
33346,patients,0,0
33347,with,0,0
33348,untreated,0,0
33349,advanced,0,0
33350,gastric,0,1
33351,carcinoma,0,0
33352,were,0,0
33353,randomised,0,0
33354,to,0,0
33355,receive,0,0
33356,PELF,0,1
33357,or,0,0
33358,FAMTX,0,0
33359,for,0,0
33360,a,0,0
33361,maximum,0,0
33362,of,0,0
33363,six,0,0
33364,cycles,0,0
33365,or,0,0
33366,until,0,0
33367,disease,0,0
33368,progression,0,0
33369,.,0,0
33370,RESULTS,0,0
33371,The,0,0
33372,complete,1,1
33373,response,1,1
33374,(,1,0
33375,CR,1,1
33376,),1,0
33377,rates,1,1
33378,to,0,0
33379,PELF,0,1
33380,and,0,0
33381,FAMTX,0,1
33382,were,0,0
33383,",",0,0
33384,respectively,0,0
33385,",",0,0
33386,13,0,0
33387,%,0,0
33388,[,0,0
33389,95,0,0
33390,%,0,0
33391,confidence,0,0
33392,intervals,0,0
33393,(,0,0
33394,CI,0,0
33395,),0,0
33396,6,0,0
33397,%,0,0
33398,to,0,0
33399,20,0,0
33400,%,0,0
33401,],0,0
33402,and,0,0
33403,2,0,0
33404,%,0,0
33405,(,0,0
33406,95,0,0
33407,%,0,0
33408,CI,0,0
33409,0,0,0
33410,%,0,0
33411,to,0,0
33412,5,0,0
33413,%,0,0
33414,;,0,0
33415,P,0,0
33416,=,0,0
33417,0.003,0,0
33418,),0,0
33419,",",0,0
33420,and,0,0
33421,the,0,0
33422,objective,1,0
33423,response,1,1
33424,rates,1,1
33425,[,0,0
33426,CR,0,0
33427,plus,0,0
33428,partial,1,1
33429,response,1,1
33430,(,0,0
33431,PR,0,1
33432,),0,0
33433,rates,0,1
33434,],0,0
33435,39,0,0
33436,%,0,0
33437,(,0,0
33438,95,0,0
33439,%,0,0
33440,CI,0,0
33441,29,0,0
33442,%,0,0
33443,to,0,0
33444,49,0,0
33445,%,0,0
33446,),0,0
33447,and,0,0
33448,22,0,0
33449,%,0,0
33450,(,0,0
33451,95,0,0
33452,%,0,0
33453,CI,0,0
33454,13,0,0
33455,%,0,0
33456,to,0,0
33457,30,0,0
33458,%,0,0
33459,;,0,0
33460,P,0,0
33461,=,0,0
33462,0.009,0,0
33463,),0,0
33464,",",0,0
33465,thus,0,0
33466,significantly,0,0
33467,favouring,0,0
33468,the,0,0
33469,PELF,0,0
33470,combination,0,0
33471,.,0,0
33472,The,0,0
33473,survival,1,1
33474,rates,1,1
33475,after,0,0
33476,12,0,0
33477,months,0,0
33478,(,0,0
33479,30.8,0,0
33480,%,0,0
33481,versus,0,0
33482,22.4,0,0
33483,%,0,0
33484,),0,0
33485,and,0,0
33486,24,0,0
33487,months,0,0
33488,(,0,0
33489,15.7,0,0
33490,%,0,0
33491,versus,0,0
33492,9.5,0,0
33493,%,0,0
33494,),0,0
33495,were,0,0
33496,also,0,0
33497,higher,0,0
33498,among,0,0
33499,patients,0,0
33500,receiving,0,0
33501,PELF,0,1
33502,",",0,0
33503,but,0,0
33504,these,0,0
33505,differences,0,0
33506,were,0,0
33507,not,0,0
33508,statistically,0,0
33509,significant,0,0
33510,.,0,0
33511,The,0,0
33512,toxicities,1,1
33513,were,0,0
33514,qualitatively,0,0
33515,different,0,0
33516,but,0,0
33517,quantitatively,0,0
33518,similar,0,0
33519,.,0,0
33520,Both,0,0
33521,regimens,0,0
33522,seem,0,0
33523,to,0,0
33524,be,0,0
33525,feasible,0,0
33526,provided,0,0
33527,that,0,0
33528,careful,0,0
33529,patient,0,0
33530,monitoring,0,0
33531,is,0,0
33532,assured,0,0
33533,.,0,0
33534,CONCLUSIONS,0,0
33535,PELF,0,0
33536,is,0,0
33537,significantly,0,0
33538,more,0,0
33539,active,0,0
33540,than,0,0
33541,FAMTX,0,0
33542,and,0,0
33543,deserves,0,0
33544,further,0,0
33545,research,0,0
33546,in,0,0
33547,the,0,0
33548,adjuvant,0,0
33549,setting,0,0
33550,.,0,0
33551,Effects,0,0
33552,of,0,0
33553,pentoxifylline,0,0
33554,administration,0,0
33555,on,0,0
33556,urinary,0,1
33557,N-acetyl-beta-glucosaminidase,0,1
33558,excretion,0,1
33559,in,0,0
33560,type,0,0
33561,2,0,0
33562,diabetic,0,0
33563,patients,0,0
33564,:,0,0
33565,a,0,0
33566,short-term,0,0
33567,",",0,0
33568,prospective,0,0
33569,",",0,0
33570,randomized,0,0
33571,study,0,0
33572,.,0,0
33573,BACKGROUND,0,0
33574,Tubulointerstitial,0,1
33575,injury,0,0
33576,is,0,0
33577,a,0,0
33578,major,0,0
33579,feature,0,0
33580,of,0,0
33581,diabetic,0,0
33582,nephropathy,0,0
33583,and,0,0
33584,an,0,0
33585,important,0,0
33586,predictor,0,0
33587,of,0,0
33588,renal,0,1
33589,dysfunction,0,0
33590,.,0,0
33591,In,0,0
33592,45,0,0
33593,patients,0,0
33594,with,0,0
33595,type,0,0
33596,2,0,0
33597,diabetes,0,0
33598,mellitus,0,0
33599,(,0,0
33600,DM,0,0
33601,),0,0
33602,",",0,0
33603,we,0,0
33604,prospectively,0,0
33605,analyzed,0,0
33606,urinary,0,1
33607,excretion,0,1
33608,of,0,0
33609,N-acetyl-beta-glucosaminidase,0,1
33610,(,0,0
33611,NAG,0,0
33612,),0,0
33613,",",0,0
33614,a,0,0
33615,marker,0,1
33616,of,0,0
33617,tubular,0,0
33618,renal,0,0
33619,damage,0,1
33620,;,0,0
33621,the,0,0
33622,potential,0,0
33623,relationship,0,0
33624,with,0,0
33625,urinary,0,1
33626,protein,0,0
33627,excretion,0,1
33628,;,0,0
33629,and,0,0
33630,effects,0,1
33631,of,0,1
33632,pentoxifylline,0,0
33633,(,0,0
33634,PTF,0,0
33635,),0,0
33636,administration,0,0
33637,.,0,0
33638,METHODS,0,0
33639,Forty-five,0,0
33640,patients,0,0
33641,with,0,0
33642,type,0,0
33643,2,0,0
33644,DM,0,0
33645,initially,0,0
33646,were,0,0
33647,compared,0,0
33648,with,0,0
33649,15,0,0
33650,healthy,0,0
33651,controls,0,0
33652,matched,0,0
33653,for,0,0
33654,age,0,0
33655,and,0,0
33656,sex,0,0
33657,.,0,0
33658,After,0,0
33659,randomization,0,0
33660,",",0,0
33661,PTF,0,0
33662,(,0,0
33663,"1,200",0,0
33664,mg/d,0,0
33665,),0,0
33666,was,0,0
33667,administered,0,0
33668,for,0,0
33669,4,0,0
33670,months,0,0
33671,to,0,0
33672,30,0,0
33673,patients,0,0
33674,and,0,0
33675,results,0,0
33676,were,0,0
33677,compared,0,0
33678,with,0,0
33679,data,0,0
33680,from,0,0
33681,a,0,0
33682,control,0,0
33683,group,0,0
33684,(,0,0
33685,n,0,0
33686,=,0,0
33687,15,0,0
33688,),0,0
33689,.,0,0
33690,RESULTS,0,0
33691,Proteinuria,1,1
33692,and,1,0
33693,urinary,1,1
33694,NAG,1,1
33695,excretion,1,1
33696,were,0,0
33697,significantly,0,0
33698,greater,0,0
33699,in,0,0
33700,patients,0,0
33701,with,0,0
33702,DM,0,0
33703,with,0,0
33704,respect,0,0
33705,to,0,0
33706,healthy,0,0
33707,controls,0,0
33708,.,0,0
33709,Before,0,0
33710,PTF,0,0
33711,administration,0,0
33712,",",0,0
33713,baseline,0,0
33714,parameters,0,1
33715,were,0,0
33716,similar,0,0
33717,in,0,0
33718,both,0,0
33719,groups,0,0
33720,of,0,0
33721,patients,0,0
33722,with,0,0
33723,DM,0,0
33724,.,0,0
33725,At,0,0
33726,the,0,0
33727,end,0,0
33728,of,0,0
33729,the,0,0
33730,study,0,0
33731,",",0,0
33732,urinary,1,1
33733,protein,1,1
33734,excretion,1,1
33735,and,1,1
33736,NAG-creatinine,1,1
33737,ratios,1,1
33738,decreased,0,0
33739,in,0,0
33740,the,0,0
33741,active,0,0
33742,group,0,0
33743,from,0,0
33744,920,0,0
33745,+/-,0,0
33746,522,0,0
33747,mg/d,0,0
33748,and,0,0
33749,14.3,0,0
33750,+/-,0,0
33751,16.9,0,0
33752,U/g,0,0
33753,to,0,0
33754,803,0,0
33755,+/-,0,0
33756,523,0,0
33757,mg/d,0,0
33758,(,0,0
33759,P,0,0
33760,<,0,0
33761,0.001,0,0
33762,),0,0
33763,and,0,0
33764,10.5,0,0
33765,+/-,0,0
33766,9.3,0,0
33767,U/g,0,0
33768,(,0,0
33769,P,0,0
33770,<,0,0
33771,0.05,0,0
33772,),0,0
33773,",",0,0
33774,respectively,0,0
33775,.,0,0
33776,Conversely,0,0
33777,",",0,0
33778,proteinuria,1,1
33779,and,1,1
33780,urinary,1,1
33781,NAG,1,1
33782,excretion,1,1
33783,did,0,0
33784,not,0,0
33785,change,0,0
33786,in,0,0
33787,the,0,0
33788,control,0,0
33789,group,0,0
33790,.,0,0
33791,Regression,0,1
33792,analysis,0,0
33793,showed,0,0
33794,that,0,0
33795,urinary,1,1
33796,NAG,1,0
33797,excretion,1,1
33798,was,0,0
33799,significantly,0,0
33800,associated,0,0
33801,with,0,0
33802,duration,1,1
33803,of,1,0
33804,DM,1,0
33805,(,0,0
33806,r,0,0
33807,=,0,0
33808,0.61,0,0
33809,;,0,0
33810,P,0,0
33811,<,0,0
33812,0.001,0,0
33813,),0,0
33814,and,0,0
33815,proteinuria,1,1
33816,(,0,0
33817,r,0,0
33818,=,0,0
33819,0.51,0,0
33820,;,0,0
33821,P,0,0
33822,<,0,0
33823,0.001,0,0
33824,),0,0
33825,.,0,0
33826,CONCLUSION,0,0
33827,Urinary,1,1
33828,NAG,1,0
33829,excretion,1,1
33830,is,0,0
33831,elevated,0,0
33832,in,0,0
33833,patients,0,0
33834,with,0,0
33835,type,0,0
33836,2,0,0
33837,DM,0,0
33838,compared,0,0
33839,with,0,0
33840,healthy,0,0
33841,individuals,0,0
33842,and,0,0
33843,increases,0,1
33844,as,0,0
33845,nephropathy,0,0
33846,progresses,0,0
33847,.,0,0
33848,PTF,0,0
33849,administration,0,0
33850,is,0,0
33851,effective,0,0
33852,in,0,0
33853,reducing,0,0
33854,proteinuria,1,1
33855,and,1,0
33856,urinary,1,1
33857,NAG,1,0
33858,excretion,1,1
33859,in,0,0
33860,these,0,0
33861,patients,0,0
33862,.,0,0
33863,These,0,0
33864,findings,0,0
33865,suggest,0,0
33866,that,0,0
33867,PTF,0,0
33868,may,0,0
33869,have,0,0
33870,beneficial,0,0
33871,effects,0,0
33872,on,0,0
33873,tubulointerstitial,0,1
33874,damage,0,1
33875,in,0,0
33876,diabetic,0,0
33877,kidney,0,0
33878,disease,0,0
33879,.,0,0
33880,Evaluation,0,0
33881,of,0,0
33882,the,0,0
33883,effect,0,0
33884,of,0,0
33885,acetazolamide,0,0
33886,on,0,0
33887,cystoid,0,1
33888,macular,0,0
33889,oedema,0,1
33890,in,0,0
33891,patients,0,0
33892,with,0,0
33893,Behcet,0,0
33894,'s,0,0
33895,disease,0,0
33896,.,0,0
33897,AIM,0,0
33898,To,0,0
33899,study,0,0
33900,the,0,0
33901,effect,0,0
33902,of,0,0
33903,acetazolamide,0,0
33904,on,0,0
33905,cystoid,0,1
33906,macular,0,1
33907,oedema,0,1
33908,(,0,0
33909,CMO,0,1
33910,),0,0
33911,in,0,0
33912,patients,0,0
33913,with,0,0
33914,Behcet,0,0
33915,'s,0,0
33916,disease,0,0
33917,.,0,0
33918,PATIENTS,0,0
33919,AND,0,0
33920,METHODS,0,0
33921,A,0,0
33922,total,0,1
33923,of,0,0
33924,67,0,0
33925,eyes,0,0
33926,of,0,0
33927,35,0,0
33928,Behcet,0,0
33929,'s,0,0
33930,patients,0,0
33931,with,0,0
33932,chronic,0,0
33933,",",0,0
33934,but,0,0
33935,well-controlled,0,1
33936,uveitis,0,1
33937,",",0,0
33938,and,0,1
33939,CMO,0,1
33940,were,0,0
33941,randomised,0,0
33942,into,0,0
33943,a,0,0
33944,double-masked,0,0
33945,",",0,0
33946,crossover,0,0
33947,trial,0,0
33948,comparing,0,0
33949,the,0,0
33950,effect,0,0
33951,of,0,0
33952,acetazolamide,0,0
33953,vs,0,0
33954,placebo,0,0
33955,.,0,0
33956,The,0,0
33957,patients,0,0
33958,received,0,0
33959,an,0,0
33960,initial,0,0
33961,4-week,0,0
33962,course,0,0
33963,of,0,0
33964,either,0,0
33965,250,0,0
33966,mg,0,0
33967,acetazolamide,0,0
33968,twice,0,0
33969,daily,0,0
33970,(,0,0
33971,b.i.d,0,0
33972,.,0,0
33973,),0,0
33974,or,0,0
33975,placebo,0,0
33976,",",0,0
33977,followed,0,0
33978,by,0,0
33979,a,0,0
33980,4-week,0,0
33981,washout,0,0
33982,period,0,0
33983,.,0,0
33984,They,0,0
33985,then,0,0
33986,received,0,0
33987,a,0,0
33988,4-week,0,0
33989,course,0,0
33990,of,0,0
33991,the,0,0
33992,reverse,0,0
33993,study,0,0
33994,medication,0,0
33995,.,0,0
33996,An,0,0
33997,improvement,0,0
33998,in,0,0
33999,visual,1,1
34000,acuity,1,1
34001,and,1,0
34002,fundus,1,0
34003,fluorescein,1,0
34004,angiographic,1,1
34005,findings,1,0
34006,was,0,0
34007,assessed,0,0
34008,.,0,0
34009,RESULTS,0,0
34010,In,0,0
34011,total,0,1
34012,",",0,0
34013,29,0,0
34014,patients,0,0
34015,(,0,0
34016,55,0,0
34017,eyes,0,0
34018,),0,0
34019,completed,0,0
34020,the,0,0
34021,trial,0,0
34022,and,0,0
34023,were,0,0
34024,available,0,0
34025,for,0,0
34026,analysis,0,0
34027,.,0,0
34028,Of,0,0
34029,the,0,0
34030,29,0,0
34031,",",0,0
34032,16,0,0
34033,men,0,0
34034,and,0,0
34035,13,0,0
34036,were,0,0
34037,women,0,0
34038,.,0,0
34039,The,0,0
34040,age,0,0
34041,range,0,0
34042,was,0,0
34043,13-50,0,0
34044,years,0,0
34045,(,0,0
34046,mean,0,0
34047,33.6,0,0
34048,years,0,0
34049,),0,0
34050,.,0,0
34051,Patients,0,0
34052,on,0,0
34053,acetazolamide,0,0
34054,showed,0,0
34055,a,0,0
34056,slightly,0,0
34057,better,0,0
34058,improvement,0,1
34059,of,0,0
34060,angiographic,1,1
34061,signs,1,1
34062,(,0,0
34063,at,0,0
34064,least,0,0
34065,by,0,0
34066,one,0,0
34067,grade,0,0
34068,improvement,0,0
34069,),0,0
34070,over,0,0
34071,that,0,0
34072,of,0,0
34073,placebo,0,0
34074,(,0,0
34075,12,0,0
34076,vs,0,0
34077,five,0,0
34078,eyes,0,0
34079,),0,0
34080,.,0,0
34081,They,0,0
34082,also,0,0
34083,had,0,0
34084,less,0,0
34085,deterioration,1,1
34086,of,1,1
34087,angiographic,1,1
34088,signs,1,0
34089,over,0,0
34090,that,0,0
34091,of,0,0
34092,placebo,0,0
34093,(,0,0
34094,three,0,0
34095,vs,0,0
34096,seven,0,0
34097,eyes,0,0
34098,),0,0
34099,.,0,0
34100,However,0,0
34101,",",0,0
34102,these,0,0
34103,findings,0,0
34104,were,0,0
34105,not,0,0
34106,statistically,0,0
34107,significant,0,0
34108,(,0,0
34109,P=0.99,0,0
34110,),0,0
34111,.,0,0
34112,Acetazolamide,0,0
34113,had,0,0
34114,no,0,0
34115,statistically,0,0
34116,significant,0,0
34117,effect,0,0
34118,(,0,0
34119,P=0.53,0,0
34120,),0,0
34121,on,0,0
34122,the,0,0
34123,improvement,0,0
34124,of,0,0
34125,visual,1,1
34126,acuity,1,1
34127,of,0,0
34128,patients,0,0
34129,over,0,0
34130,that,0,0
34131,of,0,0
34132,placebo,0,0
34133,(,0,0
34134,13,0,0
34135,vs,0,0
34136,eight,0,0
34137,eyes,0,0
34138,),0,0
34139,",",0,0
34140,nor,0,0
34141,on,0,0
34142,the,0,0
34143,deterioration,0,1
34144,of,0,0
34145,visual,1,1
34146,acuity,1,1
34147,(,0,0
34148,three,0,0
34149,vs,0,0
34150,11,0,0
34151,eyes,0,0
34152,),0,0
34153,.,0,0
34154,CONCLUSION,0,0
34155,Despite,0,0
34156,seemingly,0,0
34157,favourable,0,0
34158,results,0,0
34159,",",0,0
34160,the,0,0
34161,4-week,0,0
34162,course,0,0
34163,of,0,0
34164,acetazolamide,0,0
34165,(,0,0
34166,250,0,0
34167,mg,0,0
34168,b.i.d,0,0
34169,.,0,0
34170,),0,0
34171,has,0,0
34172,no,0,0
34173,statistically,0,0
34174,significant,0,0
34175,effect,0,0
34176,on,0,0
34177,the,0,0
34178,improvement,0,0
34179,of,0,0
34180,the,0,0
34181,visual,1,1
34182,acuity,1,1
34183,and,0,0
34184,the,0,0
34185,fluorescein,1,0
34186,angiographic,1,1
34187,findings,1,0
34188,in,0,0
34189,Behcet,0,0
34190,'s,0,0
34191,patients,0,0
34192,with,0,0
34193,CMO,0,0
34194,.,0,0
34195,Advice,0,1
34196,or,0,0
34197,exercise,0,0
34198,for,0,0
34199,chronic,0,0
34200,whiplash,0,0
34201,disorders,0,0
34202,?,0,0
34203,Design,0,0
34204,of,0,0
34205,a,0,0
34206,randomized,0,0
34207,controlled,0,0
34208,trial,0,0
34209,.,0,0
34210,BACKGROUND,0,0
34211,Whiplash-associated,0,0
34212,disorder,0,0
34213,(,0,0
34214,or,0,1
34215,whiplash,0,0
34216,),0,0
34217,is,0,0
34218,a,0,0
34219,common,0,0
34220,condition,0,0
34221,incurring,0,1
34222,considerable,0,0
34223,expense,0,0
34224,in,0,0
34225,social,0,1
34226,and,0,0
34227,economic,0,0
34228,terms,0,0
34229,.,0,0
34230,A,0,0
34231,lack,0,0
34232,of,0,0
34233,research,0,0
34234,on,0,0
34235,effective,0,1
34236,therapy,0,0
34237,for,0,0
34238,patients,0,0
34239,with,0,0
34240,chronic,0,0
34241,whiplash,0,0
34242,associated,0,0
34243,disorders,0,0
34244,prompted,0,0
34245,the,0,0
34246,design,0,0
34247,of,0,0
34248,the,0,0
34249,current,0,0
34250,study,0,0
34251,.,0,0
34252,The,0,0
34253,primary,0,0
34254,aim,0,0
34255,of,0,0
34256,this,0,0
34257,randomised,0,0
34258,controlled,0,0
34259,trial,0,0
34260,is,0,0
34261,to,0,0
34262,determine,0,0
34263,the,0,0
34264,effects,1,0
34265,of,1,0
34266,a,1,0
34267,physical,1,1
34268,activity,1,1
34269,program,1,0
34270,for,1,0
34271,people,1,0
34272,with,1,0
34273,chronic,1,0
34274,(,1,0
34275,symptoms,1,1
34276,of,1,0
34277,>,1,0
34278,3,1,0
34279,months,1,0
34280,duration,1,0
34281,),1,0
34282,whiplash,1,0
34283,.,1,0
34284,A,0,0
34285,secondary,0,0
34286,aim,0,0
34287,is,0,0
34288,to,0,0
34289,determine,0,0
34290,if,0,0
34291,pain,1,1
34292,severity,1,1
34293,",",1,0
34294,level,1,1
34295,of,1,1
34296,disability,1,1
34297,and,1,1
34298,fear,1,1
34299,of,1,1
34300,movement/,1,1
34301,(,1,0
34302,re,1,0
34303,),1,0
34304,injury,1,0
34305,predict,0,0
34306,response,1,1
34307,to,0,0
34308,a,0,0
34309,physical,0,1
34310,activity,0,1
34311,program,0,0
34312,.,0,0
34313,METHODS/DESIGN,0,0
34314,This,0,0
34315,paper,0,0
34316,presents,0,0
34317,the,0,0
34318,rationale,0,0
34319,and,0,0
34320,design,0,0
34321,of,0,0
34322,a,0,0
34323,randomised,0,0
34324,controlled,0,0
34325,trial,0,0
34326,examining,0,0
34327,the,0,0
34328,effects,1,0
34329,of,1,0
34330,advice,1,0
34331,and,1,0
34332,individualized,1,0
34333,sub-maximal,1,1
34334,exercise,1,0
34335,programs,1,0
34336,in,0,0
34337,the,0,0
34338,treatment,0,0
34339,of,0,0
34340,whiplash,0,0
34341,associated,0,0
34342,disorders,0,0
34343,.,0,0
34344,DISCUSSION,0,0
34345,This,0,0
34346,paper,0,0
34347,highlights,0,0
34348,the,0,0
34349,design,0,0
34350,",",0,0
34351,methods,0,0
34352,and,0,1
34353,operational,0,1
34354,aspects,0,0
34355,of,0,0
34356,a,0,0
34357,significant,0,0
34358,clinical,0,0
34359,trial,0,0
34360,in,0,0
34361,the,0,0
34362,area,0,1
34363,of,0,0
34364,whiplash,0,0
34365,and,0,0
34366,chronic,0,0
34367,pain,0,1
34368,.,0,0
34369,Cirrhosis,0,0
34370,and,0,0
34371,bleeding,0,1
34372,:,0,0
34373,the,0,0
34374,need,0,0
34375,for,0,0
34376,very,0,0
34377,early,0,0
34378,management,0,0
34379,.,0,0
34380,BACKGROUND/AIMS,0,0
34381,Retrospective,0,0
34382,studies,0,0
34383,suggest,0,0
34384,that,0,0
34385,the,0,0
34386,prognosis,0,0
34387,of,0,0
34388,patients,0,0
34389,with,0,0
34390,cirrhosis,0,0
34391,and,0,1
34392,variceal,0,1
34393,hemorrhage,0,1
34394,has,0,0
34395,improved,0,0
34396,in,0,0
34397,more,0,0
34398,recent,0,0
34399,decades,0,0
34400,.,0,0
34401,In,0,0
34402,a,0,0
34403,prospective,0,0
34404,cohort,0,0
34405,study,0,0
34406,in,0,0
34407,which,0,0
34408,the,0,0
34409,choice,0,0
34410,of,0,0
34411,prophylactic,0,0
34412,therapy,0,0
34413,was,0,0
34414,left,0,0
34415,to,0,0
34416,each,0,0
34417,practitioner,0,0
34418,",",0,0
34419,we,0,0
34420,followed,0,0
34421,cirrhotic,0,0
34422,patients,0,0
34423,with,0,0
34424,medium/large,0,0
34425,varices,0,1
34426,to,0,0
34427,determine,0,0
34428,factors,0,0
34429,predictive,0,0
34430,of,0,0
34431,bleeding,0,0
34432,and,0,0
34433,death,0,1
34434,.,0,0
34435,METHODS,0,0
34436,Three,0,0
34437,hundred,0,0
34438,fourteen,0,0
34439,patients,0,0
34440,with,0,0
34441,grades,0,0
34442,2,0,0
34443,or,0,0
34444,3,0,0
34445,esophageal,0,0
34446,varices,0,0
34447,(,0,0
34448,Child,0,0
34449,A,0,0
34450,and,0,0
34451,B/C,0,0
34452,:,0,0
34453,218,0,0
34454,and,0,0
34455,96,0,0
34456,),0,0
34457,were,0,0
34458,enrolled,0,0
34459,.,0,0
34460,One,0,0
34461,hundred,0,0
34462,seventy-three,0,0
34463,patients,0,0
34464,had,0,0
34465,no,0,0
34466,previous,0,0
34467,history,0,0
34468,of,0,0
34469,variceal,0,1
34470,bleeding,0,1
34471,.,0,0
34472,Only,0,0
34473,245,0,0
34474,patients,0,0
34475,(,0,0
34476,100,0,0
34477,%,0,0
34478,of,0,0
34479,patients,0,0
34480,with,0,0
34481,prior,0,0
34482,variceal,0,1
34483,hemorrhage,0,1
34484,",",0,0
34485,61,0,0
34486,%,0,0
34487,of,0,0
34488,patients,0,0
34489,without,0,0
34490,prior,0,0
34491,hemorrhage,0,1
34492,),0,0
34493,were,0,0
34494,receiving,0,0
34495,some,0,0
34496,form,0,0
34497,of,0,0
34498,prophylactic,0,0
34499,therapy,0,0
34500,.,0,0
34501,The,0,0
34502,median,0,0
34503,follow-up,0,0
34504,was,0,0
34505,18,0,0
34506,months,0,0
34507,.,0,0
34508,RESULTS,0,0
34509,There,0,0
34510,were,0,0
34511,76,0,0
34512,bleeding,1,1
34513,events,1,1
34514,and,0,0
34515,14,0,0
34516,related,1,0
34517,deaths,1,0
34518,(,0,0
34519,18,0,0
34520,%,0,0
34521,),0,0
34522,;,0,0
34523,nine,0,0
34524,of,0,0
34525,these,0,0
34526,deaths,0,1
34527,occurred,0,0
34528,within,0,0
34529,24,0,0
34530,h,0,0
34531,of,0,0
34532,bleeding,1,1
34533,onset,0,0
34534,(,0,0
34535,two,0,0
34536,at,0,0
34537,home,0,0
34538,",",0,0
34539,two,0,0
34540,during,0,0
34541,hospital,0,0
34542,transfer,0,1
34543,",",0,0
34544,and,0,0
34545,five,0,0
34546,in,0,0
34547,hospital,0,0
34548,",",0,0
34549,a,0,0
34550,mean,0,1
34551,of,0,0
34552,2.5,0,0
34553,h,0,0
34554,after,0,0
34555,onset,0,0
34556,;,0,0
34557,six,0,0
34558,involved,0,0
34559,Child,0,0
34560,C,0,0
34561,patients,0,0
34562,),0,0
34563,.,0,0
34564,Twenty-five,0,0
34565,deaths,1,1
34566,were,0,0
34567,not,0,0
34568,due,0,0
34569,to,0,0
34570,bleeding,0,1
34571,but,0,0
34572,were,0,0
34573,closely,0,0
34574,related,0,0
34575,to,0,0
34576,cirrhosis,0,0
34577,.,0,0
34578,In,0,0
34579,a,0,0
34580,Cox,0,0
34581,model,0,0
34582,",",0,0
34583,the,0,0
34584,presence,0,0
34585,of,0,0
34586,tense,0,0
34587,ascites,0,1
34588,(,0,0
34589,relative,0,0
34590,risk,0,0
34591,3.4,0,0
34592,",",0,0
34593,95,0,0
34594,%,0,0
34595,confidence,0,0
34596,interval,0,0
34597,",",0,0
34598,CI,0,0
34599,2.5-5.9,0,0
34600,),0,0
34601,and,0,0
34602,a,0,0
34603,prior,0,0
34604,history,0,0
34605,of,0,0
34606,hemorrhage,0,1
34607,(,0,0
34608,relative,0,0
34609,risk,0,0
34610,4.4,0,0
34611,",",0,0
34612,95,0,0
34613,%,0,0
34614,CI,0,0
34615,2.6-7.5,0,0
34616,),0,0
34617,were,0,0
34618,independent,0,0
34619,predictors,0,0
34620,of,0,0
34621,variceal,1,1
34622,hemorrhage,1,1
34623,.,1,0
34624,In,0,0
34625,patients,0,0
34626,without,0,0
34627,a,0,0
34628,prior,0,0
34629,history,0,0
34630,of,0,0
34631,bleeding,1,1
34632,",",1,0
34633,bleeding,1,1
34634,risk,1,1
34635,was,0,0
34636,higher,0,0
34637,with,0,0
34638,more,0,0
34639,prolonged,0,1
34640,prothrombin,0,1
34641,time,0,1
34642,and,0,0
34643,lower,0,0
34644,when,0,0
34645,patients,0,0
34646,were,0,0
34647,receiving,0,0
34648,propranolol,0,0
34649,.,0,0
34650,CONCLUSIONS,0,0
34651,Despite,0,0
34652,the,0,0
34653,advent,0,0
34654,of,0,0
34655,effective,0,1
34656,drugs,0,0
34657,and,0,1
34658,endoscopic,0,1
34659,therapy,0,0
34660,for,0,0
34661,variceal,0,1
34662,bleeding,0,1
34663,",",0,0
34664,about,0,0
34665,a,0,0
34666,quarter,0,0
34667,of,0,0
34668,deaths,1,1
34669,occur,0,0
34670,very,0,0
34671,early,0,0
34672,after,0,0
34673,bleeding,0,1
34674,onset,0,1
34675,",",0,0
34676,confirming,0,0
34677,the,0,0
34678,need,0,0
34679,for,0,0
34680,rapid,0,0
34681,specific,0,0
34682,management,0,0
34683,.,0,0
34684,Outcome,1,1
34685,of,0,0
34686,children,0,0
34687,with,0,0
34688,centrally,0,0
34689,reviewed,0,0
34690,low-grade,0,0
34691,gliomas,0,0
34692,treated,0,0
34693,with,0,0
34694,chemotherapy,0,0
34695,with,0,0
34696,or,0,0
34697,without,0,0
34698,radiotherapy,0,0
34699,on,0,0
34700,Children,0,0
34701,'s,0,0
34702,Cancer,0,0
34703,Group,0,0
34704,high-grade,0,0
34705,glioma,0,0
34706,study,0,0
34707,CCG-945,0,0
34708,.,0,0
34709,BACKGROUND,0,0
34710,The,0,0
34711,objectives,0,0
34712,of,0,0
34713,the,0,0
34714,current,0,0
34715,study,0,0
34716,were,0,0
34717,to,0,0
34718,determine,0,0
34719,the,0,0
34720,outcome,1,0
34721,of,0,0
34722,children,0,0
34723,who,0,0
34724,were,0,0
34725,treated,0,0
34726,with,0,0
34727,chemotherapy,0,0
34728,and,0,1
34729,radiotherapy,0,0
34730,on,0,0
34731,the,0,0
34732,Children,0,0
34733,'s,0,0
34734,Cancer,0,0
34735,Group,0,0
34736,(,0,0
34737,CCG,0,0
34738,),0,1
34739,high-grade,0,0
34740,glioma,0,1
34741,protocol,0,0
34742,(,0,0
34743,CCG-945,0,0
34744,),0,0
34745,who,0,0
34746,were,0,0
34747,diagnosed,0,0
34748,with,0,0
34749,low-grade,0,0
34750,gliomas,0,0
34751,on,0,0
34752,post,0,0
34753,hoc,0,0
34754,central,0,1
34755,pathologic,0,1
34756,review,0,0
34757,and,0,0
34758,to,0,0
34759,identify,0,0
34760,clinical,1,0
34761,and,1,0
34762,biologic,1,0
34763,features,1,0
34764,associated,0,0
34765,with,0,0
34766,prognosis,0,0
34767,.,0,0
34768,METHODS,0,0
34769,Between,0,0
34770,1985,0,0
34771,and,0,0
34772,1991,0,0
34773,",",0,0
34774,250,0,0
34775,children,0,0
34776,with,0,0
34777,institutionally,0,0
34778,classified,0,0
34779,high-grade,0,0
34780,gliomas,0,0
34781,were,0,0
34782,enrolled,0,0
34783,on,0,0
34784,CCG-945,0,0
34785,.,0,0
34786,Patients,0,0
34787,older,0,0
34788,than,0,0
34789,24,0,0
34790,months,0,0
34791,with,0,0
34792,intracranial,0,1
34793,lesions,0,1
34794,were,0,0
34795,assigned,0,0
34796,randomly,0,0
34797,to,0,0
34798,receive,0,0
34799,either,0,0
34800,lomustine,0,0
34801,",",0,0
34802,vincristine,0,0
34803,",",0,1
34804,and,0,1
34805,prednisone,0,0
34806,(,0,0
34807,control,0,0
34808,regimen,0,0
34809,),0,0
34810,or,0,0
34811,the,0,0
34812,8-drugs-in-1-day,0,0
34813,regimen,0,0
34814,(,0,0
34815,experimental,0,0
34816,regimen,0,0
34817,),0,0
34818,;,0,0
34819,younger,0,0
34820,patients,0,0
34821,and,0,0
34822,those,0,0
34823,with,0,0
34824,primary,0,0
34825,spinal,0,0
34826,cord,0,1
34827,tumors,0,1
34828,were,0,0
34829,assigned,0,0
34830,nonrandomly,0,0
34831,to,0,0
34832,the,0,0
34833,experimental,0,0
34834,regimen,0,0
34835,.,0,0
34836,Central,0,1
34837,independent,0,0
34838,review,0,0
34839,by,0,0
34840,5,0,0
34841,neuropathologists,0,0
34842,led,0,0
34843,to,0,0
34844,a,0,0
34845,reclassification,0,0
34846,of,0,0
34847,low-grade,0,0
34848,glioma,0,0
34849,in,0,0
34850,70,0,0
34851,patients,0,0
34852,",",0,0
34853,who,0,0
34854,were,0,0
34855,the,0,0
34856,focus,0,0
34857,of,0,0
34858,the,0,0
34859,current,0,0
34860,study,0,0
34861,.,0,0
34862,RESULTS,0,0
34863,The,0,0
34864,study,0,0
34865,involved,0,0
34866,42,0,0
34867,males,0,0
34868,and,0,0
34869,28,0,0
34870,females,0,0
34871,(,0,0
34872,median,0,1
34873,age,0,0
34874,",",0,0
34875,7.7,0,0
34876,years,0,0
34877,),0,0
34878,with,0,0
34879,a,0,0
34880,median,0,0
34881,follow-up,0,0
34882,of,0,0
34883,10.4,0,0
34884,years,0,0
34885,.,0,0
34886,At,0,0
34887,5,0,0
34888,years,0,0
34889,",",0,0
34890,the,0,0
34891,progression-free,1,1
34892,survival,1,1
34893,(,1,0
34894,PFS,1,1
34895,),1,1
34896,rate,1,1
34897,was,0,0
34898,63,0,0
34899,%,0,0
34900,+/-,0,0
34901,6,0,0
34902,%,0,0
34903,",",0,0
34904,and,0,0
34905,the,0,0
34906,overall,1,1
34907,survival,1,1
34908,(,1,0
34909,OS,1,1
34910,),1,1
34911,rate,1,1
34912,was,0,0
34913,79,0,0
34914,%,0,0
34915,+/-,0,0
34916,5,0,0
34917,%,0,0
34918,",",0,0
34919,compared,0,0
34920,with,0,0
34921,a,0,0
34922,PFS,1,0
34923,rate,1,1
34924,of,0,0
34925,19,0,0
34926,%,0,0
34927,+/-,0,0
34928,3,0,0
34929,%,0,0
34930,(,0,0
34931,P,0,0
34932,<,0,0
34933,0.0001,0,0
34934,),0,0
34935,and,0,0
34936,an,0,0
34937,OS,1,1
34938,rate,1,1
34939,of,0,0
34940,22,0,0
34941,%,0,0
34942,+/-,0,0
34943,3,0,0
34944,%,0,0
34945,(,0,0
34946,P,0,0
34947,<,0,0
34948,0.0001,0,0
34949,),0,0
34950,in,0,0
34951,the,0,0
34952,remainder,0,0
34953,of,0,0
34954,the,0,0
34955,cohort,0,0
34956,.,0,0
34957,Significantly,0,0
34958,poorer,0,0
34959,5-year,1,1
34960,PFS,1,1
34961,was,0,0
34962,seen,0,0
34963,in,0,0
34964,children,0,0
34965,younger,0,0
34966,than,0,0
34967,24,0,0
34968,months,0,0
34969,",",0,0
34970,those,0,0
34971,with,0,0
34972,fibrillary,0,0
34973,astrocytoma,0,1
34974,",",0,0
34975,and,0,0
34976,those,0,0
34977,with,0,0
34978,posterior,0,0
34979,fossa,0,0
34980,tumors,0,0
34981,.,0,0
34982,Patients,0,0
34983,demonstrated,0,0
34984,a,0,0
34985,modest,0,0
34986,improvement,0,1
34987,in,0,0
34988,PFS,1,0
34989,but,0,0
34990,no,0,0
34991,improvement,0,1
34992,in,0,0
34993,OS,1,1
34994,compared,0,0
34995,with,0,0
34996,children,0,0
34997,with,0,0
34998,low-grade,0,0
34999,gliomas,0,0
35000,who,0,0
35001,were,0,0
35002,treated,0,0
35003,with,0,0
35004,contemporary,0,0
35005,chemotherapy-alone,0,0
35006,approaches,0,0
35007,.,0,0
35008,CONCLUSIONS,0,0
35009,The,0,0
35010,current,0,0
35011,report,0,0
35012,calls,0,1
35013,attention,0,0
35014,to,0,0
35015,the,0,0
35016,importance,0,0
35017,of,0,0
35018,central,0,0
35019,pathologic,0,1
35020,review,0,0
35021,in,0,0
35022,large,0,0
35023,multiinstitutional,0,0
35024,trials,0,0
35025,of,0,0
35026,children,0,0
35027,with,0,0
35028,gliomas,0,0
35029,and,0,0
35030,suggests,0,0
35031,that,0,0
35032,aggressive,0,1
35033,front-line,0,0
35034,combined,0,0
35035,chemoradiotherapy,0,0
35036,does,0,0
35037,not,0,0
35038,confer,0,0
35039,a,0,0
35040,survival,1,1
35041,advantage,1,0
35042,in,0,0
35043,this,0,0
35044,highly,0,0
35045,selected,0,0
35046,population,0,0
35047,of,0,0
35048,patients,0,0
35049,.,0,0
35050,Abrasive,1,0
35051,wear,1,1
35052,on,0,0
35053,eroded,0,0
35054,root,0,0
35055,dentine,0,0
35056,after,0,0
35057,different,0,0
35058,periods,0,0
35059,of,0,0
35060,exposure,0,0
35061,to,0,0
35062,saliva,0,0
35063,in,0,0
35064,situ,0,0
35065,.,0,0
35066,The,0,0
35067,effect,0,0
35068,of,0,0
35069,salivary,0,1
35070,exposure,0,0
35071,time,0,1
35072,on,0,0
35073,the,0,0
35074,abrasive,1,0
35075,wear,1,1
35076,of,0,0
35077,acid-eroded,0,0
35078,dentine,0,0
35079,was,0,0
35080,evaluated,0,0
35081,in,0,0
35082,situ,0,0
35083,.,0,0
35084,One-hundred,0,0
35085,and,0,0
35086,twenty,0,0
35087,bovine,0,0
35088,root,0,0
35089,dentine,0,1
35090,slabs,0,1
35091,were,0,0
35092,randomly,0,0
35093,assigned,0,0
35094,into,0,0
35095,six,0,0
35096,groups,0,0
35097,(,0,0
35098,A-F,0,1
35099,),0,0
35100,and,0,0
35101,placed,0,0
35102,in,0,0
35103,intraoral,0,0
35104,palatal,0,1
35105,devices,0,0
35106,",",0,0
35107,which,0,0
35108,were,0,0
35109,worn,0,0
35110,by,0,0
35111,10,0,0
35112,volunteers,0,0
35113,for,0,0
35114,4,0,0
35115,d.,0,0
35116,On,0,0
35117,the,0,0
35118,first,0,0
35119,day,0,0
35120,",",0,0
35121,no,0,0
35122,erosive/abrasive,0,1
35123,procedures,0,0
35124,were,0,0
35125,carried,0,0
35126,out,0,0
35127,.,0,0
35128,On,0,0
35129,the,0,0
35130,following,0,0
35131,3,0,0
35132,d,0,0
35133,",",0,0
35134,erosive,0,1
35135,challenges,0,0
35136,were,0,0
35137,performed,0,0
35138,extraorally,0,0
35139,",",0,0
35140,two,0,0
35141,times,0,0
35142,per,0,0
35143,day,0,0
35144,",",0,0
35145,by,0,0
35146,immersing,0,0
35147,the,0,0
35148,device,0,0
35149,for,0,0
35150,90,0,0
35151,s,0,0
35152,in,0,0
35153,a,0,0
35154,soft,0,0
35155,drink,0,0
35156,.,0,0
35157,Subsequently,0,0
35158,",",0,0
35159,the,0,0
35160,group,0,0
35161,A,0,0
35162,specimens,0,0
35163,were,0,0
35164,immediately,0,0
35165,brushed,0,0
35166,(,0,0
35167,40,0,0
35168,strokes,0,0
35169,),0,0
35170,",",0,0
35171,and,0,0
35172,the,0,0
35173,others,0,0
35174,were,0,0
35175,brushed,0,0
35176,after,0,0
35177,the,0,0
35178,following,0,0
35179,times,0,0
35180,:,0,0
35181,B,0,0
35182,",",0,0
35183,20,0,0
35184,min,0,0
35185,;,0,0
35186,C,0,0
35187,",",0,0
35188,40,0,0
35189,min,0,0
35190,;,0,0
35191,and,0,0
35192,D,0,1
35193,",",0,0
35194,60,0,0
35195,min,0,0
35196,.,0,0
35197,Group,0,0
35198,E,0,1
35199,specimens,0,0
35200,were,0,0
35201,only,0,0
35202,acid-eroded,0,0
35203,and,0,0
35204,those,0,0
35205,of,0,0
35206,group,0,0
35207,F,0,0
35208,were,0,0
35209,only,0,0
35210,brushed,0,0
35211,.,0,0
35212,Dentine,1,0
35213,wear,1,1
35214,was,0,0
35215,measured,0,0
35216,with,0,0
35217,a,0,0
35218,profilometer,0,0
35219,.,0,0
35220,anova,0,0
35221,and,0,0
35222,Dunnett,0,1
35223,'s,0,1
35224,test,0,0
35225,showed,0,0
35226,that,0,0
35227,groups,0,0
35228,A-D,0,1
35229,did,0,0
35230,not,0,0
35231,differ,0,0
35232,statistically,0,0
35233,from,0,0
35234,the,0,0
35235,control,0,0
35236,group,0,0
35237,E,0,1
35238,but,0,0
35239,differed,0,0
35240,from,0,0
35241,the,0,0
35242,control,0,0
35243,group,0,0
35244,F.,0,0
35245,The,0,0
35246,lowest,0,0
35247,mean,0,1
35248,value,0,0
35249,was,0,0
35250,found,0,0
35251,for,0,0
35252,group,0,0
35253,F.,0,1
35254,Regression,0,1
35255,analysis,0,0
35256,was,0,0
35257,unable,0,0
35258,to,0,0
35259,show,0,0
35260,salivary,0,1
35261,effect,0,0
35262,on,0,0
35263,dentine,1,1
35264,wear,1,1
35265,reduction,1,1
35266,.,1,0
35267,The,0,0
35268,data,0,0
35269,suggest,0,0
35270,that,0,0
35271,the,0,0
35272,exposure,0,0
35273,time,0,1
35274,of,0,0
35275,saliva,0,0
35276,of,0,0
35277,up,0,0
35278,to,0,0
35279,60,0,0
35280,min,0,0
35281,has,0,0
35282,no,0,0
35283,effect,0,0
35284,on,0,0
35285,reducing,0,0
35286,the,0,0
35287,eroded,1,0
35288,dentine,1,0
35289,wear,1,1
35290,by,0,0
35291,toothbrushing,0,0
35292,.,0,0
35293,Randomized,0,0
35294,phase,0,0
35295,II,0,0
35296,trial,0,0
35297,of,0,0
35298,high-dose,0,0
35299,4'-epi-doxorubicin,0,0
35300,+,0,0
35301,cyclophosphamide,0,0
35302,versus,0,0
35303,high-dose,0,0
35304,4'-epi-doxorubicin,0,0
35305,+,0,0
35306,cisplatin,0,0
35307,in,0,0
35308,previously,0,0
35309,untreated,0,0
35310,patients,0,0
35311,with,0,0
35312,extensive,0,0
35313,small,0,0
35314,cell,0,1
35315,lung,0,0
35316,cancer,0,0
35317,.,0,0
35318,One,0,0
35319,hundred,0,0
35320,and,0,0
35321,eleven,0,0
35322,previously,0,0
35323,untreated,0,0
35324,patients,0,0
35325,with,0,0
35326,extensive,0,0
35327,small,0,0
35328,cell,0,1
35329,lung,0,1
35330,cancer,0,0
35331,were,0,0
35332,included,0,0
35333,in,0,0
35334,a,0,0
35335,prospective,0,0
35336,randomized,0,0
35337,study,0,0
35338,with,0,0
35339,the,0,0
35340,aim,0,0
35341,to,0,0
35342,assess,0,0
35343,the,0,0
35344,efficacy,1,1
35345,and,0,0
35346,tolerance,1,1
35347,of,0,1
35348,high-dose,0,0
35349,epirubicin,0,0
35350,(,0,0
35351,120,0,0
35352,mg/m2,0,0
35353,),0,0
35354,in,0,0
35355,combination,0,0
35356,with,0,0
35357,either,0,0
35358,cyclophosphamide,0,0
35359,(,0,0
35360,800,0,0
35361,mg/m2,0,0
35362,;,0,0
35363,arm,0,0
35364,1,0,0
35365,),0,0
35366,or,0,0
35367,cisplatin,0,0
35368,(,0,0
35369,60,0,0
35370,mg/m2,0,0
35371,;,0,0
35372,arm,0,0
35373,2,0,0
35374,),0,0
35375,.,0,0
35376,Ninety-six,0,0
35377,patients,0,0
35378,were,0,0
35379,evaluable,0,0
35380,for,0,0
35381,response,1,1
35382,and,1,1
35383,toxicity,1,1
35384,and,0,0
35385,additional,0,0
35386,12,0,0
35387,patients,0,0
35388,for,0,0
35389,toxicity,1,1
35390,only,0,0
35391,.,0,0
35392,The,0,0
35393,overall,1,1
35394,response,1,1
35395,rate,1,1
35396,(,1,0
35397,CR+PR,1,0
35398,),1,0
35399,in,0,0
35400,arm,0,0
35401,1,0,0
35402,and,0,0
35403,2,0,0
35404,were,0,0
35405,61.4,0,0
35406,(,0,0
35407,27/44,0,0
35408,),0,0
35409,and,0,0
35410,67.3,0,0
35411,%,0,0
35412,(,0,0
35413,35/52,0,0
35414,),0,0
35415,",",0,0
35416,respectively,0,0
35417,.,0,0
35418,The,0,0
35419,mean,1,1
35420,duration,1,1
35421,of,1,0
35422,remission,1,1
35423,was,0,0
35424,4.4,0,0
35425,months,0,0
35426,(,0,0
35427,arm,0,0
35428,1,0,0
35429,),0,0
35430,and,0,0
35431,4.9,0,0
35432,months,0,0
35433,(,0,0
35434,arm,0,0
35435,2,0,0
35436,),0,0
35437,.,0,0
35438,The,0,0
35439,mean,1,1
35440,survival,1,1
35441,time,1,1
35442,was,0,0
35443,6.6,0,0
35444,months,0,0
35445,in,0,0
35446,arm,0,0
35447,1,0,0
35448,and,0,0
35449,7.7,0,0
35450,months,0,0
35451,in,0,0
35452,arm,0,0
35453,2.,0,0
35454,WHO,1,0
35455,grade,1,0
35456,4,1,0
35457,toxicity,1,1
35458,was,0,0
35459,encountered,0,0
35460,in,0,0
35461,25.5,0,0
35462,and,0,0
35463,15.8,0,0
35464,%,0,0
35465,of,0,0
35466,patients,0,0
35467,in,0,0
35468,arm,0,0
35469,1,0,0
35470,and,0,0
35471,2,0,0
35472,",",0,0
35473,respectively,0,0
35474,.,0,0
35475,One,0,0
35476,case,0,0
35477,of,0,0
35478,cardiotoxicity,1,1
35479,resulting,0,0
35480,in,0,0
35481,the,0,0
35482,patient,0,1
35483,'s,0,0
35484,death,1,1
35485,was,0,0
35486,observed,0,0
35487,in,0,0
35488,arm,0,0
35489,1,0,0
35490,.,0,0
35491,Both,0,0
35492,combinations,0,0
35493,showed,0,0
35494,considerable,0,0
35495,antitumor,1,1
35496,activity,1,1
35497,.,1,0
35498,Toxicity,1,1
35499,was,0,0
35500,acceptable,0,0
35501,.,0,0
35502,Long-term,0,0
35503,anticoagulant,0,1
35504,treatment,0,0
35505,after,0,0
35506,acute,0,0
35507,myocardial,0,1
35508,infarction,0,0
35509,.,0,0
35510,The,0,0
35511,Warfarin,0,0
35512,Re-Infarction,0,0
35513,Study,0,0
35514,.,0,0
35515,High,0,0
35516,levels,0,1
35517,of,0,0
35518,fibrinogen,0,1
35519,and,0,0
35520,clotting,0,1
35521,factor,0,0
35522,VII,0,0
35523,are,0,0
35524,associated,0,0
35525,with,0,0
35526,an,0,0
35527,increased,1,0
35528,risk,1,0
35529,for,0,0
35530,subsequent,1,0
35531,death,1,1
35532,and,0,0
35533,cardiovascular,1,1
35534,disease,1,1
35535,in,0,0
35536,apparently,0,0
35537,healthy,0,0
35538,individuals,0,0
35539,.,0,0
35540,Furthermore,0,0
35541,",",0,0
35542,pathoanatomic,0,1
35543,studies,0,0
35544,and,0,0
35545,coronary,0,0
35546,angiography,0,0
35547,have,0,0
35548,confirmed,0,0
35549,a,0,0
35550,relationship,1,0
35551,between,1,0
35552,coronary,1,0
35553,thrombus,1,1
35554,formation,1,1
35555,and,1,1
35556,acute,1,1
35557,Q-wave,1,1
35558,infarction,1,0
35559,.,1,0
35560,Effective,0,0
35561,antithrombotic,0,0
35562,agents,0,0
35563,may,0,0
35564,prevent,0,0
35565,or,0,0
35566,limit,0,0
35567,thrombus,1,1
35568,formation,1,1
35569,and,0,0
35570,events,1,1
35571,related,1,0
35572,to,1,0
35573,thrombosis,1,0
35574,.,1,0
35575,The,0,0
35576,Warfarin,0,0
35577,Re-Infarction,0,1
35578,Study,0,0
35579,(,0,0
35580,WARIS,0,0
35581,),0,0
35582,studied,0,0
35583,the,0,0
35584,effect,0,0
35585,of,0,0
35586,warfarin,0,0
35587,in,0,0
35588,survivors,0,0
35589,of,0,0
35590,acute,0,0
35591,myocardial,0,1
35592,infarction,0,0
35593,.,0,0
35594,Patients,0,0
35595,aged,0,0
35596,75,0,0
35597,years,0,0
35598,or,0,0
35599,less,0,0
35600,were,0,0
35601,randomized,0,0
35602,in,0,0
35603,a,0,0
35604,double-blind,0,0
35605,",",0,0
35606,placebo-controlled,0,0
35607,study,0,0
35608,to,0,0
35609,test,0,0
35610,whether,0,0
35611,long-term,0,0
35612,treatment,0,0
35613,with,0,0
35614,warfarin,0,0
35615,reduces,0,0
35616,the,0,0
35617,risk,1,0
35618,of,0,0
35619,death,1,1
35620,",",1,0
35621,reinfarction,1,1
35622,",",0,1
35623,and,0,1
35624,thromboembolic,1,1
35625,morbidity,1,1
35626,.,1,0
35627,A,0,0
35628,total,0,0
35629,of,0,0
35630,1918,0,0
35631,patients,0,0
35632,were,0,0
35633,screened,0,0
35634,for,0,0
35635,participation,0,0
35636,;,0,0
35637,1214,0,0
35638,were,0,0
35639,recruited,0,0
35640,.,0,0
35641,The,0,0
35642,mean,0,1
35643,follow-up,0,0
35644,was,0,0
35645,37,0,0
35646,months,0,0
35647,.,0,0
35648,Analyzed,0,0
35649,on,0,0
35650,an,0,0
35651,intention-to-treat,0,0
35652,basis,0,0
35653,",",0,0
35654,123,0,0
35655,(,0,0
35656,20,0,0
35657,%,0,0
35658,),0,0
35659,in,0,0
35660,the,0,0
35661,placebo,0,0
35662,group,0,0
35663,died,1,1
35664,",",0,0
35665,versus,0,0
35666,94,0,0
35667,(,0,0
35668,15,0,0
35669,%,0,0
35670,),0,0
35671,in,0,0
35672,the,0,0
35673,warfarin,0,0
35674,group,0,0
35675,",",0,0
35676,a,0,0
35677,risk,1,1
35678,reduction,1,0
35679,of,0,0
35680,24,0,0
35681,%,0,0
35682,(,0,0
35683,P,0,0
35684,=,0,0
35685,0.026,0,0
35686,),0,0
35687,.,0,0
35688,Considering,0,0
35689,patients,0,0
35690,on,0,0
35691,treatment,0,0
35692,or,0,0
35693,within,0,0
35694,28,0,0
35695,days,0,0
35696,after,0,0
35697,discontinuing,0,0
35698,the,0,0
35699,test,0,0
35700,medication,0,0
35701,",",0,0
35702,92,0,0
35703,in,0,0
35704,the,0,0
35705,placebo,0,0
35706,group,0,0
35707,died,1,1
35708,",",0,0
35709,as,0,0
35710,compared,0,0
35711,with,0,0
35712,60,0,0
35713,of,0,0
35714,the,0,0
35715,warfarin-treated,0,0
35716,patients,0,0
35717,",",0,0
35718,a,0,0
35719,risk,1,1
35720,reduction,1,0
35721,of,0,0
35722,35,0,0
35723,%,0,0
35724,(,0,0
35725,P,0,0
35726,=,0,0
35727,0.005,0,0
35728,),0,0
35729,.,0,0
35730,Relapsing,1,0
35731,myocardial,1,1
35732,infarction,1,1
35733,(,1,0
35734,fatal,1,1
35735,and,1,1
35736,nonfatal,1,1
35737,),1,0
35738,was,0,0
35739,reduced,0,0
35740,by,0,0
35741,43,0,0
35742,%,0,0
35743,(,0,0
35744,P,0,0
35745,=,0,0
35746,0.0001,0,0
35747,),0,0
35748,.,0,0
35749,The,0,0
35750,incidence,1,1
35751,of,1,0
35752,cerebrovascular,1,1
35753,attacks,1,1
35754,was,0,0
35755,lower,0,0
35756,in,0,0
35757,the,0,0
35758,warfarin,0,0
35759,group,0,0
35760,(,0,0
35761,16,0,0
35762,patients,0,0
35763,),0,0
35764,than,0,0
35765,the,0,0
35766,placebo,0,0
35767,group,0,0
35768,(,0,0
35769,41,0,0
35770,patients,0,0
35771,),0,0
35772,",",0,0
35773,a,0,0
35774,highly,0,0
35775,significant,0,0
35776,reduction,0,0
35777,of,0,0
35778,61,0,0
35779,%,0,0
35780,(,0,0
35781,P,0,0
35782,=,0,0
35783,0.0003,0,0
35784,),0,0
35785,.,0,0
35786,Serious,1,0
35787,bleeding,1,1
35788,occurred,0,0
35789,in,0,0
35790,11,0,0
35791,patients,0,0
35792,taking,0,0
35793,warfarin,0,0
35794,",",0,0
35795,an,0,0
35796,incidence,0,1
35797,of,0,0
35798,0.6,0,0
35799,%,0,0
35800,per,0,0
35801,year,0,0
35802,.,0,0
35803,In,0,0
35804,conclusion,0,0
35805,",",0,0
35806,long-term,0,1
35807,anticoagulant,0,0
35808,therapy,0,0
35809,may,0,0
35810,be,0,0
35811,recommended,0,0
35812,after,0,0
35813,acute,0,0
35814,myocardial,0,1
35815,infarction,0,0
35816,.,0,0
35817,Effect,0,0
35818,of,0,0
35819,enalapril,0,0
35820,on,0,0
35821,myocardial,0,1
35822,infarction,0,1
35823,and,0,0
35824,unstable,0,1
35825,angina,0,1
35826,in,0,0
35827,patients,0,0
35828,with,0,0
35829,low,0,0
35830,ejection,0,0
35831,fractions,0,0
35832,.,0,0
35833,An,0,0
35834,association,0,0
35835,between,0,0
35836,raised,0,1
35837,renin,0,0
35838,levels,0,1
35839,and,0,1
35840,myocardial,0,1
35841,infarction,0,0
35842,has,0,0
35843,been,0,0
35844,reported,0,0
35845,.,0,0
35846,We,0,0
35847,studied,0,0
35848,the,0,0
35849,effects,0,1
35850,of,0,0
35851,enalapril,0,0
35852,",",0,0
35853,an,0,0
35854,angiotensin-converting,0,0
35855,enzyme,0,0
35856,(,0,0
35857,ACE,0,1
35858,),0,1
35859,inhibitor,0,0
35860,",",0,0
35861,on,0,0
35862,the,0,0
35863,development,0,0
35864,of,0,0
35865,myocardial,0,1
35866,infarction,0,1
35867,and,0,0
35868,unstable,0,1
35869,angina,0,0
35870,in,0,0
35871,6797,0,0
35872,patients,0,0
35873,with,0,0
35874,ejection,0,0
35875,fractions,0,0
35876,<,0,0
35877,or,0,0
35878,=,0,0
35879,0.35,0,0
35880,enrolled,0,0
35881,into,0,0
35882,the,0,0
35883,two,0,0
35884,Studies,0,0
35885,of,0,0
35886,Left,0,0
35887,Ventricular,0,1
35888,Dysfunction,0,1
35889,(,0,0
35890,SOLVD,0,1
35891,),0,0
35892,trials,0,0
35893,.,0,0
35894,Patients,0,0
35895,were,0,0
35896,randomly,0,0
35897,assigned,0,0
35898,to,0,0
35899,placebo,0,0
35900,(,0,0
35901,n,0,0
35902,=,0,0
35903,3401,0,0
35904,),0,0
35905,or,0,0
35906,enalapril,0,0
35907,(,0,0
35908,n,0,0
35909,=,0,0
35910,3396,0,0
35911,),0,0
35912,at,0,0
35913,doses,0,0
35914,of,0,0
35915,2.5-20,0,0
35916,mg,0,0
35917,per,0,0
35918,day,0,0
35919,in,0,0
35920,two,0,0
35921,concurrent,0,0
35922,double-blind,0,0
35923,trials,0,0
35924,with,0,0
35925,the,0,0
35926,same,0,0
35927,protocol,0,0
35928,.,0,0
35929,Patients,0,0
35930,with,0,0
35931,heart,0,1
35932,failure,0,1
35933,entered,0,0
35934,the,0,0
35935,treatment,0,0
35936,trial,0,0
35937,(,0,0
35938,n,0,0
35939,=,0,0
35940,2569,0,0
35941,),0,0
35942,and,0,0
35943,those,0,0
35944,without,0,0
35945,heart,0,1
35946,failure,0,1
35947,entered,0,0
35948,the,0,0
35949,prevention,0,0
35950,trial,0,0
35951,(,0,0
35952,n,0,0
35953,=,0,0
35954,4228,0,0
35955,),0,0
35956,.,0,0
35957,Follow-up,0,0
35958,averaged,0,0
35959,40,0,0
35960,months,0,0
35961,.,0,0
35962,In,0,0
35963,each,0,0
35964,trial,0,0
35965,there,0,0
35966,were,0,0
35967,significant,0,0
35968,reductions,0,1
35969,in,0,0
35970,the,0,0
35971,number,0,1
35972,of,0,0
35973,patients,0,0
35974,developing,0,0
35975,myocardial,0,1
35976,infarction,0,1
35977,(,0,0
35978,treatment,0,0
35979,trial,0,0
35980,:,0,0
35981,158,0,0
35982,placebo,0,0
35983,vs,0,0
35984,127,0,0
35985,enalapril,0,0
35986,",",0,0
35987,p,0,0
35988,<,0,0
35989,0.02,0,0
35990,;,0,0
35991,prevention,0,0
35992,trial,0,0
35993,:,0,0
35994,204,0,0
35995,vs,0,0
35996,161,0,0
35997,p,0,0
35998,<,0,0
35999,0.01,0,0
36000,),0,0
36001,or,0,0
36002,unstable,0,1
36003,angina,0,1
36004,(,0,0
36005,240,0,0
36006,vs,0,0
36007,187,0,0
36008,p,0,0
36009,<,0,0
36010,0.001,0,0
36011,;,0,0
36012,355,0,0
36013,vs,0,0
36014,312,0,0
36015,",",0,0
36016,p,0,0
36017,<,0,0
36018,0.05,0,0
36019,),0,0
36020,.,0,0
36021,Combined,0,0
36022,",",0,0
36023,there,0,0
36024,were,0,0
36025,362,0,0
36026,placebo,0,0
36027,group,0,0
36028,patients,0,0
36029,with,0,0
36030,myocardial,0,1
36031,infarction,0,1
36032,compared,0,0
36033,with,0,0
36034,288,0,0
36035,in,0,0
36036,the,0,0
36037,enalapril,0,0
36038,group,0,0
36039,(,0,0
36040,risk,0,1
36041,reduction,0,0
36042,23,0,0
36043,%,0,0
36044,",",0,0
36045,95,0,0
36046,%,0,0
36047,CI,0,0
36048,11-34,0,0
36049,%,0,0
36050,;,0,0
36051,p,0,0
36052,<,0,0
36053,0.001,0,0
36054,),0,0
36055,.,0,0
36056,595,0,0
36057,placebo,0,0
36058,group,0,0
36059,patients,0,0
36060,developed,0,0
36061,unstable,1,0
36062,angina,1,0
36063,compared,0,0
36064,with,0,0
36065,499,0,0
36066,in,0,0
36067,the,0,0
36068,enalapril,0,0
36069,group,0,0
36070,(,0,0
36071,risk,0,1
36072,reduction,0,0
36073,20,0,0
36074,%,0,0
36075,",",0,0
36076,95,0,0
36077,%,0,0
36078,CI,0,0
36079,9-29,0,0
36080,%,0,0
36081,",",0,0
36082,p,0,0
36083,<,0,0
36084,0.001,0,0
36085,),0,0
36086,.,0,0
36087,There,0,0
36088,was,0,0
36089,also,0,0
36090,a,0,0
36091,reduction,1,0
36092,in,1,0
36093,cardiac,1,1
36094,deaths,1,1
36095,(,0,0
36096,711,0,0
36097,placebo,0,0
36098,",",0,0
36099,615,0,0
36100,enalapril,0,0
36101,;,0,0
36102,p,0,0
36103,<,0,0
36104,0.003,0,0
36105,),0,0
36106,",",0,0
36107,so,0,0
36108,that,0,0
36109,the,0,0
36110,reduction,0,0
36111,in,0,0
36112,the,0,0
36113,combined,1,0
36114,endpoint,1,0
36115,of,1,0
36116,deaths,1,1
36117,",",1,0
36118,myocardial,1,1
36119,infarction,1,1
36120,",",1,0
36121,and,1,1
36122,unstable,1,1
36123,angina,1,1
36124,was,0,0
36125,highly,0,0
36126,significant,0,0
36127,(,0,0
36128,20,0,0
36129,%,0,0
36130,risk,0,0
36131,reduction,0,1
36132,",",0,0
36133,95,0,0
36134,%,0,0
36135,CI,0,0
36136,14-26,0,0
36137,%,0,0
36138,;,0,0
36139,p,0,0
36140,<,0,0
36141,0.0001,0,0
36142,),0,0
36143,.,0,0
36144,Enalapril,0,0
36145,treatment,0,0
36146,significantly,0,0
36147,reduced,0,0
36148,myocardial,1,1
36149,infarction,1,0
36150,",",1,0
36151,unstable,1,1
36152,angina,1,1
36153,",",1,0
36154,and,1,1
36155,cardiac,1,1
36156,mortality,1,1
36157,in,0,0
36158,patients,0,0
36159,with,0,0
36160,low,0,0
36161,ejection,0,0
36162,fractions,0,0
36163,.,0,0
36164,Iloprost,0,0
36165,in,0,0
36166,cardiopulmonary,0,1
36167,bypass,0,0
36168,procedures,0,0
36169,.,0,0
36170,The,0,0
36171,inhibition,0,1
36172,of,0,0
36173,platelet,0,1
36174,aggregation,0,1
36175,during,0,0
36176,cardiopulmonary,0,1
36177,bypass,0,0
36178,and,0,0
36179,effects,0,1
36180,on,0,0
36181,post-operative,0,1
36182,placebo-controlled,0,0
36183,study,0,0
36184,of,0,0
36185,145,0,0
36186,patients,0,0
36187,.,0,0
36188,Significant,0,0
36189,preservation,0,0
36190,of,0,0
36191,platelet,0,1
36192,numbers,0,1
36193,and,0,1
36194,function,0,1
36195,were,0,0
36196,shown,0,0
36197,without,0,0
36198,significant,0,0
36199,haemodynamic,0,1
36200,problems,0,1
36201,",",0,0
36202,but,0,0
36203,no,0,0
36204,effect,0,0
36205,on,0,0
36206,cerebral,0,0
36207,deficits,0,0
36208,could,0,0
36209,be,0,0
36210,found,0,0
36211,.,0,0
36212,The,0,0
36213,use,0,0
36214,of,0,0
36215,iloprost,0,0
36216,in,0,0
36217,patients,0,0
36218,with,0,0
36219,severe,0,0
36220,thrombocytopenia,0,0
36221,seems,0,0
36222,justified,0,0
36223,",",0,0
36224,but,0,0
36225,the,0,0
36226,clinical,0,0
36227,benefits,0,0
36228,from,0,0
36229,its,0,0
36230,use,0,0
36231,in,0,0
36232,routine,0,0
36233,cardiopulmonary,0,1
36234,bypass,0,0
36235,remain,0,0
36236,to,0,0
36237,be,0,0
36238,shown,0,0
36239,.,0,0
36240,Treatment,0,0
36241,of,0,0
36242,peptic,1,0
36243,ulcer,1,1
36244,disease,1,0
36245,with,0,0
36246,furazolidone,0,0
36247,.,0,0
36248,Furazolidone,0,0
36249,(,0,0
36250,FZ,0,1
36251,),0,0
36252,has,0,0
36253,been,0,0
36254,used,0,0
36255,in,0,0
36256,China,0,0
36257,as,0,0
36258,a,0,0
36259,treatment,0,0
36260,of,0,0
36261,peptic,1,0
36262,ulcer,0,1
36263,disease,0,0
36264,for,0,0
36265,about,0,0
36266,20,0,0
36267,years,0,0
36268,.,0,0
36269,Clinical,0,1
36270,and,0,0
36271,experimental,0,0
36272,studies,0,0
36273,suggest,0,0
36274,that,0,0
36275,it,0,0
36276,has,0,0
36277,good,0,0
36278,short-term,0,0
36279,and,0,0
36280,long-term,0,0
36281,effects,0,1
36282,on,0,0
36283,both,0,0
36284,human,0,0
36285,and,0,0
36286,animal,1,0
36287,ulcers,1,0
36288,.,1,0
36289,The,0,0
36290,ulcer,1,1
36291,healing,1,1
36292,rate,0,1
36293,is,0,0
36294,related,0,0
36295,to,0,0
36296,the,0,0
36297,dosage,0,0
36298,and,0,0
36299,course,0,1
36300,of,0,0
36301,treatment,0,0
36302,.,0,0
36303,The,0,0
36304,healing,0,1
36305,rate,0,1
36306,of,0,0
36307,a,0,0
36308,high,0,0
36309,dose,0,0
36310,",",0,0
36311,2,0,0
36312,week,0,0
36313,course,0,0
36314,is,0,0
36315,about,0,0
36316,70-75,0,0
36317,%,0,0
36318,and,0,0
36319,the,0,0
36320,relapse,0,1
36321,rate,0,1
36322,after,0,0
36323,3,0,0
36324,years,0,0
36325,is,0,0
36326,9.5,0,0
36327,%,0,0
36328,.,0,0
36329,The,0,0
36330,adverse,0,1
36331,reactions,0,1
36332,to,0,0
36333,FZ,0,1
36334,are,0,0
36335,not,0,0
36336,severe,0,1
36337,",",0,0
36338,and,0,0
36339,are,0,0
36340,well,0,0
36341,tolerated,1,1
36342,in,0,0
36343,most,0,0
36344,patients,0,0
36345,.,0,0
36346,However,0,0
36347,the,0,0
36348,mutagenic,0,1
36349,studies,0,0
36350,of,0,0
36351,several,0,0
36352,biological,0,0
36353,systems,0,0
36354,indicate,0,0
36355,that,0,0
36356,it,0,0
36357,has,0,0
36358,a,0,0
36359,mutagenic,1,1
36360,effect,0,0
36361,",",0,0
36362,but,0,0
36363,the,0,0
36364,mutagenic,0,1
36365,and,0,0
36366,carcinogenic,1,1
36367,effects,0,1
36368,on,0,0
36369,humans,0,0
36370,and,0,0
36371,animals,0,0
36372,remain,0,0
36373,questionable,0,0
36374,",",0,0
36375,because,0,0
36376,FZ,0,1
36377,has,0,0
36378,been,0,0
36379,biotransformed,0,0
36380,into,0,0
36381,other,0,0
36382,metabolites,0,0
36383,.,0,0
36384,The,0,0
36385,mechanisms,0,0
36386,of,0,0
36387,FZ,0,1
36388,in,0,0
36389,the,0,0
36390,treatment,0,0
36391,of,0,0
36392,peptic,0,0
36393,ulcer,0,0
36394,disease,0,0
36395,are,0,0
36396,not,0,0
36397,fully,0,0
36398,understood,0,0
36399,",",0,0
36400,perhaps,0,0
36401,partly,0,0
36402,due,0,0
36403,to,0,0
36404,the,0,0
36405,monoamine,1,1
36406,oxidase,1,1
36407,(,1,0
36408,MAO,1,0
36409,),1,1
36410,inhibitory,1,1
36411,reaction,1,1
36412,and,0,0
36413,partly,0,0
36414,to,0,0
36415,the,0,0
36416,antibacterial,1,0
36417,activity,1,1
36418,to,1,0
36419,Helicobacter,1,1
36420,pylori,1,0
36421,(,0,0
36422,HP,0,1
36423,),0,0
36424,.,0,0
36425,The,0,0
36426,long-term,0,0
36427,effects,0,0
36428,of,0,0
36429,FZ,0,1
36430,are,0,0
36431,still,0,0
36432,not,0,0
36433,clear,0,0
36434,.,0,0
36435,Buprenorphine,0,0
36436,alone,0,0
36437,and,0,0
36438,in,0,0
36439,combination,0,0
36440,with,0,0
36441,naloxone,0,0
36442,in,0,0
36443,non-dependent,0,0
36444,humans,0,0
36445,.,0,0
36446,This,0,0
36447,study,0,0
36448,evaluated,0,0
36449,the,0,0
36450,effects,0,1
36451,of,0,0
36452,concurrent,0,0
36453,naloxone,0,0
36454,on,0,0
36455,the,0,0
36456,opioid,1,0
36457,agonist,1,0
36458,effects,1,1
36459,of,0,0
36460,buprenorphine,0,0
36461,",",0,0
36462,a,0,0
36463,mixed,0,0
36464,agonist-antagonist,0,0
36465,marketed,0,0
36466,as,0,0
36467,an,0,0
36468,analgesic,0,1
36469,and,0,0
36470,under,0,0
36471,development,0,1
36472,as,0,0
36473,a,0,0
36474,treatment,0,0
36475,for,0,0
36476,drug,0,0
36477,abuse,0,0
36478,.,0,0
36479,In,0,0
36480,a,0,0
36481,residential,0,0
36482,laboratory,0,0
36483,seven,0,0
36484,non-physically-dependent,0,0
36485,opioid,0,0
36486,abuser,0,0
36487,volunteers,0,0
36488,received,0,0
36489,intramuscular,0,0
36490,buprenorphine,0,0
36491,(,0,0
36492,0.4,0,0
36493,mg,0,0
36494,or,0,0
36495,0.8,0,0
36496,mg/70,0,0
36497,kg,0,0
36498,),0,0
36499,alone,0,0
36500,and,0,0
36501,in,0,0
36502,combination,0,0
36503,with,0,0
36504,naloxone,0,0
36505,(,0,0
36506,0.4,0,0
36507,mg,0,0
36508,or,0,0
36509,0.8,0,0
36510,mg/70,0,0
36511,kg,0,0
36512,),0,0
36513,versus,0,0
36514,placebo,0,0
36515,.,0,0
36516,Buprenorphine,0,0
36517,produced,0,0
36518,dose-related,0,1
36519,opioid,0,1
36520,agonist,0,0
36521,effects,0,1
36522,on,0,0
36523,physiological,1,0
36524,and,1,0
36525,subjective,1,1
36526,measures,1,1
36527,.,1,0
36528,Concurrent,0,0
36529,naloxone,0,0
36530,attenuated,0,0
36531,the,1,0
36532,opioid,1,0
36533,agonist,1,0
36534,effects,1,1
36535,of,0,0
36536,buprenorphine,0,0
36537,.,0,0
36538,Thus,0,0
36539,",",0,0
36540,a,0,0
36541,combination,0,0
36542,product,0,1
36543,of,0,1
36544,buprenorphine,0,0
36545,and,0,0
36546,naloxone,0,0
36547,may,0,0
36548,have,0,0
36549,lower,0,0
36550,abuse,1,1
36551,liability,1,0
36552,than,0,0
36553,buprenorphine,0,0
36554,alone,0,0
36555,.,0,0
36556,Prevention,0,0
36557,of,0,0
36558,acute,1,0
36559,postoperative,1,0
36560,pressure,1,1
36561,rises,0,1
36562,in,0,0
36563,glaucoma,0,0
36564,patients,0,0
36565,undergoing,0,0
36566,cataract,0,0
36567,extraction,0,0
36568,with,0,0
36569,posterior,0,0
36570,chamber,0,0
36571,lens,0,0
36572,implant,0,0
36573,.,0,0
36574,Acute,0,0
36575,elevations,0,1
36576,in,0,0
36577,intraocular,1,1
36578,pressure,1,1
36579,(,1,0
36580,IOP,1,1
36581,),1,0
36582,commonly,0,0
36583,follow,0,0
36584,extracapsular,0,0
36585,cataract,0,0
36586,extraction,0,0
36587,and,0,0
36588,lens,0,0
36589,implant,0,0
36590,in,0,0
36591,glaucoma,0,0
36592,patients,0,0
36593,.,0,0
36594,Thirty,0,0
36595,six,0,0
36596,patients,0,0
36597,with,0,0
36598,glaucoma,0,0
36599,undergoing,0,0
36600,cataract,0,0
36601,extraction,0,0
36602,and,0,1
36603,posterior,0,0
36604,chamber,0,0
36605,lens,0,0
36606,implantation,0,0
36607,received,0,0
36608,one,0,0
36609,of,0,0
36610,three,0,0
36611,treatments,0,0
36612,.,0,0
36613,Group,0,0
36614,1,0,0
36615,:,0,0
36616,500,0,0
36617,mg,0,0
36618,of,0,0
36619,Diamox,0,0
36620,Sustets,0,0
36621,(,0,0
36622,acetazolamide,0,0
36623,),0,0
36624,1,0,0
36625,hour,0,0
36626,preoperatively,0,0
36627,(,0,0
36628,10,0,0
36629,patients,0,0
36630,),0,0
36631,;,0,0
36632,Group,0,0
36633,2,0,0
36634,:,0,0
36635,peroperative,0,0
36636,intracameral,0,0
36637,Miochol,0,1
36638,(,0,0
36639,acetylcholine,0,1
36640,),0,0
36641,(,0,0
36642,11,0,0
36643,patients,0,0
36644,),0,0
36645,;,0,0
36646,Group,0,0
36647,3,0,0
36648,:,0,0
36649,the,0,0
36650,above,0,0
36651,treatments,0,0
36652,combined,0,0
36653,(,0,0
36654,15,0,0
36655,patients,0,0
36656,),0,0
36657,.,0,0
36658,IOPs,1,1
36659,were,0,0
36660,measured,0,0
36661,at,0,0
36662,3,0,0
36663,",",0,0
36664,6,0,0
36665,",",0,0
36666,9,0,0
36667,",",0,0
36668,and,0,0
36669,24,0,0
36670,hours,0,0
36671,postoperatively,0,0
36672,.,0,0
36673,The,0,0
36674,average,1,0
36675,of,1,0
36676,the,1,0
36677,maximum,1,0
36678,pressure,1,1
36679,rises,1,1
36680,above,0,0
36681,the,0,0
36682,preoperative,0,0
36683,level,0,0
36684,over,0,0
36685,the,0,0
36686,24,0,0
36687,hour,0,0
36688,period,0,0
36689,was,0,0
36690,greatest,0,0
36691,for,0,0
36692,the,0,0
36693,group,0,0
36694,receiving,0,0
36695,acetazolamide,0,0
36696,only,0,0
36697,at,0,0
36698,8.9,0,0
36699,mm,0,0
36700,Hg,0,0
36701,;,0,0
36702,for,0,0
36703,the,0,0
36704,acetylcholine,0,1
36705,group,0,0
36706,the,0,0
36707,average,0,1
36708,maximum,0,1
36709,rise,0,0
36710,was,0,0
36711,6.3,0,0
36712,mm,0,0
36713,Hg,0,0
36714,;,0,0
36715,while,0,0
36716,the,0,0
36717,combined,0,0
36718,treatment,0,0
36719,group,0,0
36720,showed,0,0
36721,a,0,0
36722,decrease,0,0
36723,of,0,0
36724,0.7,0,0
36725,mm,0,0
36726,Hg,0,0
36727,.,0,0
36728,IOP,1,0
36729,rises,1,1
36730,of,0,0
36731,>,0,0
36732,6,0,0
36733,mm,0,0
36734,Hg,0,0
36735,were,0,0
36736,seen,0,0
36737,in,0,0
36738,7,0,0
36739,%,0,0
36740,of,0,0
36741,patients,0,0
36742,(,0,0
36743,one,0,0
36744,of,0,0
36745,15,0,0
36746,),0,0
36747,in,0,0
36748,the,0,0
36749,combined,0,0
36750,treatment,0,0
36751,group,0,0
36752,",",0,0
36753,45,0,0
36754,%,0,0
36755,(,0,0
36756,five,0,0
36757,of,0,0
36758,11,0,0
36759,),0,0
36760,of,0,0
36761,the,0,0
36762,acetylcholine,0,1
36763,group,0,0
36764,",",0,0
36765,and,0,0
36766,70,0,0
36767,%,0,0
36768,(,0,0
36769,seven,0,0
36770,of,0,0
36771,10,0,0
36772,),0,0
36773,of,0,0
36774,the,0,0
36775,acetazolamide,0,0
36776,group,0,0
36777,.,0,0
36778,IOP,1,0
36779,rises,1,1
36780,of,0,0
36781,>,0,0
36782,10,0,0
36783,mm,0,0
36784,Hg,0,0
36785,were,0,0
36786,seen,0,0
36787,in,0,0
36788,7,0,0
36789,%,0,0
36790,of,0,0
36791,the,0,0
36792,combined,0,0
36793,treatment,0,0
36794,group,0,0
36795,",",0,0
36796,in,0,0
36797,18,0,0
36798,%,0,0
36799,of,0,0
36800,the,0,0
36801,acetylcholine,0,1
36802,only,0,0
36803,group,0,0
36804,",",0,0
36805,and,0,0
36806,in,0,0
36807,50,0,0
36808,%,0,0
36809,of,0,0
36810,the,0,0
36811,acetazolamide,0,0
36812,only,0,0
36813,group,0,0
36814,.,0,0
36815,A,0,0
36816,pressure,1,1
36817,rise,1,0
36818,>,1,0
36819,20,1,0
36820,mm,1,0
36821,Hg,1,0
36822,was,0,0
36823,seen,0,0
36824,in,0,0
36825,one,0,0
36826,patient,0,0
36827,receiving,0,0
36828,acetazolamide,0,0
36829,only,0,0
36830,and,0,0
36831,one,0,0
36832,patient,0,0
36833,receiving,0,0
36834,acetylcholine,0,1
36835,only,0,0
36836,.,0,0
36837,The,0,0
36838,difference,0,0
36839,between,0,0
36840,the,0,0
36841,acetylcholine,0,1
36842,group,0,0
36843,and,0,0
36844,the,0,0
36845,combined,0,0
36846,group,0,0
36847,for,0,0
36848,rises,1,0
36849,>,1,0
36850,6,1,0
36851,mm,1,0
36852,Hg,1,0
36853,was,0,0
36854,significant,0,0
36855,using,0,0
36856,the,0,0
36857,chi,0,0
36858,2,0,0
36859,test,0,0
36860,while,0,0
36861,the,0,0
36862,acetazolamide,0,0
36863,group,0,0
36864,showed,0,0
36865,a,0,0
36866,significant,0,0
36867,difference,0,0
36868,for,0,0
36869,rises,1,0
36870,>,1,0
36871,6,1,0
36872,and,0,0
36873,10,0,0
36874,mm,0,0
36875,Hg,0,0
36876,compared,0,0
36877,with,0,0
36878,the,0,0
36879,combined,0,0
36880,group,0,0
36881,.,0,0
36882,All,0,0
36883,acute,1,0
36884,pressure,1,1
36885,rises,1,1
36886,were,0,0
36887,recorded,0,0
36888,before,0,0
36889,or,0,0
36890,at,0,0
36891,9,0,0
36892,hours,0,0
36893,following,0,0
36894,operation,0,0
36895,except,0,0
36896,in,0,0
36897,the,0,0
36898,combined,0,0
36899,treatment,0,0
36900,patient,0,0
36901,where,0,0
36902,the,0,0
36903,rise,0,0
36904,occurred,0,0
36905,at,0,0
36906,24,0,0
36907,hours,0,0
36908,.,0,0
36909,To,0,0
36910,prevent,0,0
36911,the,0,0
36912,acute,1,0
36913,IOP,1,0
36914,rises,0,1
36915,seen,0,0
36916,following,0,0
36917,cataract,0,0
36918,surgery,0,0
36919,with,0,0
36920,lens,0,0
36921,implant,0,0
36922,in,0,0
36923,glaucoma,0,0
36924,patients,0,0
36925,we,0,0
36926,recommend,0,0
36927,combined,0,0
36928,ocular,0,0
36929,hypotensive,0,1
36930,therapy,0,0
36931,.,0,0
36932,Pharmacokinetics,0,1
36933,and,0,0
36934,pharmacodynamics,0,0
36935,of,0,1
36936,intravenous,0,0
36937,diltiazem,0,0
36938,in,0,0
36939,patients,0,0
36940,with,0,0
36941,atrial,0,1
36942,fibrillation,0,1
36943,or,0,0
36944,atrial,0,1
36945,flutter,0,0
36946,.,0,0
36947,BACKGROUND,0,0
36948,Diltiazem,0,0
36949,",",0,0
36950,a,0,0
36951,calcium,0,0
36952,channel,0,0
36953,blocker,0,0
36954,",",0,0
36955,has,0,0
36956,been,0,0
36957,shown,0,0
36958,to,0,0
36959,be,0,0
36960,safe,0,0
36961,and,0,0
36962,effective,0,0
36963,in,0,0
36964,the,0,0
36965,treatment,0,0
36966,of,0,0
36967,patients,0,0
36968,in,0,0
36969,atrial,0,1
36970,fibrillation,0,1
36971,and/or,0,0
36972,atrial,0,1
36973,flutter,0,0
36974,.,0,0
36975,However,0,0
36976,",",0,0
36977,there,0,0
36978,have,0,0
36979,been,0,0
36980,no,0,0
36981,pharmacokinetic/pharmacodynamic,0,0
36982,studies,0,0
36983,of,0,0
36984,diltiazem,0,0
36985,in,0,0
36986,these,0,0
36987,patients,0,0
36988,.,0,0
36989,METHODS,0,0
36990,AND,0,0
36991,RESULTS,0,0
36992,The,0,0
36993,pharmacokinetics,0,1
36994,and,0,0
36995,pharmacodynamics,0,0
36996,of,0,1
36997,intravenous,0,0
36998,diltiazem,0,0
36999,were,0,0
37000,determined,0,0
37001,in,0,0
37002,32,0,0
37003,patients,0,0
37004,with,0,0
37005,atrial,0,1
37006,fibrillation,0,1
37007,or,0,0
37008,atrial,0,1
37009,flutter,0,1
37010,(,0,0
37011,mean,0,1
37012,+/-,0,0
37013,SD,0,0
37014,age,0,0
37015,",",0,0
37016,66,0,0
37017,+/-,0,0
37018,7,0,0
37019,years,0,0
37020,;,0,0
37021,mean,0,1
37022,baseline,0,0
37023,heart,0,1
37024,rate,0,1
37025,",",0,0
37026,131,0,0
37027,+/-,0,0
37028,10,0,0
37029,beats,0,1
37030,per,0,0
37031,minute,0,0
37032,),0,0
37033,after,0,0
37034,20,0,0
37035,mg,0,0
37036,or,0,0
37037,20,0,0
37038,mg,0,0
37039,followed,0,0
37040,by,0,0
37041,25-mg,0,0
37042,bolus,0,0
37043,doses,0,0
37044,and,0,0
37045,a,0,0
37046,10,0,0
37047,and,0,0
37048,15,0,0
37049,mg/hr,0,0
37050,infusion,0,0
37051,for,0,0
37052,24,0,0
37053,hours,0,0
37054,.,0,0
37055,After,0,0
37056,the,0,0
37057,10,0,0
37058,and,0,0
37059,15,0,0
37060,mg/hr,0,0
37061,infusions,0,0
37062,of,0,0
37063,diltiazem,0,0
37064,",",0,0
37065,mean,0,1
37066,+/-,0,0
37067,SD,0,0
37068,elimination,0,1
37069,half-life,0,1
37070,was,0,0
37071,6.8,0,0
37072,+/-,0,0
37073,1.8,0,0
37074,and,0,0
37075,6.9,0,0
37076,+/-,0,0
37077,1.5,0,0
37078,hours,0,0
37079,",",0,0
37080,volume,0,1
37081,of,0,1
37082,distribution,0,0
37083,was,0,0
37084,411,0,0
37085,+/-,0,0
37086,151.8,0,0
37087,and,0,0
37088,299,0,0
37089,+/-,0,0
37090,70.8,0,0
37091,I,0,0
37092,",",0,0
37093,and,0,1
37094,systemic,0,1
37095,clearance,0,1
37096,was,0,0
37097,42,0,0
37098,+/-,0,0
37099,12.4,0,0
37100,and,0,0
37101,31,0,0
37102,+/-,0,0
37103,8.3,0,0
37104,l/hr,0,0
37105,",",0,0
37106,respectively,0,0
37107,.,0,0
37108,Percentages,1,1
37109,of,1,0
37110,the,1,0
37111,plasma,1,1
37112,concentrations,1,1
37113,of,1,0
37114,the,1,0
37115,principal,1,0
37116,metabolites,1,1
37117,desacetyldiltiazem,1,0
37118,and,1,0
37119,N-desmethyldiltiazem,1,0
37120,to,1,0
37121,diltiazem,1,0
37122,were,0,0
37123,<,0,0
37124,15,0,0
37125,%,0,0
37126,and,0,0
37127,<,0,0
37128,10,0,0
37129,%,0,0
37130,",",0,0
37131,respectively,0,0
37132,.,0,0
37133,Thirty,0,0
37134,of,0,0
37135,32,0,0
37136,patients,0,0
37137,maintained,0,0
37138,response,0,1
37139,throughout,0,0
37140,the,0,0
37141,24-hour,0,1
37142,infusion,0,0
37143,of,0,0
37144,diltiazem,0,0
37145,.,0,0
37146,Using,0,0
37147,a,0,0
37148,sigmoidal,0,0
37149,Emax,0,1
37150,pharmacodynamic,0,1
37151,model,0,0
37152,",",0,0
37153,a,0,0
37154,strong,0,0
37155,relation,0,0
37156,(,0,0
37157,mean,0,1
37158,+/-,0,0
37159,SD,0,0
37160,r2,0,1
37161,",",0,0
37162,0.78,0,0
37163,+/-,0,0
37164,0.2,0,0
37165,),0,0
37166,was,0,0
37167,observed,0,0
37168,between,0,0
37169,plasma,1,1
37170,diltiazem,1,0
37171,concentration,1,1
37172,and,1,1
37173,percent,1,1
37174,heart,1,1
37175,rate,1,1
37176,reduction,1,1
37177,.,1,0
37178,Mean,1,0
37179,+/-,1,0
37180,SD,1,0
37181,Emax,1,1
37182,(,0,0
37183,maximum,0,1
37184,percent,0,1
37185,reduction,0,1
37186,in,0,0
37187,heart,0,1
37188,rate,0,1
37189,from,0,0
37190,baseline,0,0
37191,),0,0
37192,and,0,1
37193,EC50,1,1
37194,(,0,0
37195,plasma,0,1
37196,diltiazem,0,0
37197,concentration,0,1
37198,that,0,0
37199,achieves,0,0
37200,half,0,0
37201,Emax,0,1
37202,),0,0
37203,were,0,0
37204,52,0,0
37205,+/-,0,0
37206,17,0,0
37207,%,0,0
37208,and,0,0
37209,110,0,0
37210,+/-,0,0
37211,84,0,0
37212,ng/ml,0,0
37213,",",0,0
37214,respectively,0,0
37215,.,0,0
37216,The,0,0
37217,model,0,0
37218,predicts,0,0
37219,that,0,0
37220,mean,0,1
37221,plasma,1,1
37222,diltiazem,1,0
37223,concentration,1,1
37224,of,0,0
37225,79,0,0
37226,",",0,0
37227,172,0,0
37228,",",0,0
37229,and,0,0
37230,294,0,0
37231,ng/ml,0,0
37232,are,0,0
37233,required,0,0
37234,to,0,0
37235,produce,0,0
37236,a,0,0
37237,20,0,0
37238,%,0,0
37239,",",0,0
37240,30,0,0
37241,%,0,0
37242,",",0,0
37243,and,0,0
37244,40,0,0
37245,%,0,0
37246,reduction,0,0
37247,in,0,0
37248,heart,1,1
37249,rate,1,1
37250,",",0,0
37251,respectively,0,0
37252,.,0,0
37253,A,0,0
37254,relation,0,0
37255,between,0,0
37256,plasma,0,1
37257,diltiazem,0,0
37258,concentration,0,1
37259,and,0,1
37260,percent,0,1
37261,change,0,1
37262,in,0,0
37263,systolic,1,1
37264,blood,1,1
37265,pressure,1,1
37266,(,1,0
37267,SBP,1,1
37268,),1,0
37269,or,1,0
37270,diastolic,1,1
37271,blood,1,1
37272,pressure,1,1
37273,(,1,0
37274,DBP,1,1
37275,),1,0
37276,from,0,0
37277,baseline,0,0
37278,was,0,0
37279,not,0,0
37280,observed,0,0
37281,(,0,0
37282,mean,0,1
37283,+/-,0,0
37284,SD,0,0
37285,r2,0,1
37286,",",0,0
37287,SBP/DBP,0,0
37288,:,0,0
37289,0.35,0,0
37290,+/-,0,0
37291,0.24/0.36,0,0
37292,+/-,0,0
37293,0.2,0,0
37294,),0,0
37295,.,0,0
37296,There,0,0
37297,were,0,0
37298,no,0,0
37299,untoward,0,1
37300,side,0,1
37301,effects,0,0
37302,observed,0,0
37303,.,0,0
37304,CONCLUSIONS,0,0
37305,First,0,1
37306,",",0,0
37307,the,0,0
37308,pharmacokinetics,0,1
37309,of,0,0
37310,diltiazem,0,0
37311,in,0,0
37312,patients,0,0
37313,with,0,0
37314,atrial,0,1
37315,fibrillation,0,1
37316,or,0,0
37317,atrial,0,1
37318,flutter,0,0
37319,is,0,0
37320,nonlinear,0,0
37321,with,0,0
37322,an,0,0
37323,apparent,0,0
37324,dose-dependent,0,0
37325,decrease,0,0
37326,in,0,0
37327,systemic,0,1
37328,clearance,0,1
37329,with,0,0
37330,increasing,0,0
37331,infusion,0,0
37332,rate,0,1
37333,.,0,0
37334,Second,0,1
37335,",",0,0
37336,using,0,0
37337,a,0,0
37338,sigmoidal,0,0
37339,Emax,0,1
37340,model,0,0
37341,",",0,0
37342,there,0,0
37343,is,0,0
37344,a,0,0
37345,strong,0,0
37346,relation,0,0
37347,between,0,0
37348,plasma,0,1
37349,diltiazem,0,0
37350,concentration,0,1
37351,and,0,1
37352,percent,0,1
37353,heart,0,1
37354,rate,0,1
37355,reduction,0,1
37356,.,0,0
37357,Third,0,0
37358,",",0,0
37359,the,0,0
37360,plasma,0,1
37361,concentrations,0,1
37362,of,0,0
37363,the,0,0
37364,principal,0,0
37365,metabolites,0,1
37366,desacetyldiltiazem,0,0
37367,and,0,0
37368,N-desmethyldiltiazem,0,0
37369,are,0,0
37370,low,0,0
37371,and,0,0
37372,are,0,0
37373,not,0,0
37374,expected,0,0
37375,to,0,0
37376,contribute,0,0
37377,significantly,0,0
37378,to,0,0
37379,the,0,0
37380,pharmacodynamics,0,0
37381,of,0,0
37382,intravenous,0,0
37383,diltiazem,0,0
37384,in,0,0
37385,these,0,0
37386,patients,0,0
37387,.,0,0
37388,[,0,0
37389,Mitoxantrone,0,0
37390,(,0,0
37391,MTX,0,0
37392,),0,1
37393,versus,0,0
37394,mitomycin,0,0
37395,C,0,0
37396,(,0,0
37397,MMC,0,0
37398,),0,0
37399,in,0,0
37400,the,0,0
37401,ablative,0,0
37402,treatment,0,0
37403,of,0,0
37404,Ta,0,0
37405,",",0,0
37406,T1,0,1
37407,superficial,0,1
37408,bladder,0,0
37409,tumors,0,0
37410,.,0,0
37411,Phase,0,0
37412,III,0,0
37413,",",0,0
37414,randomized,0,0
37415,prospective,0,0
37416,study,0,0
37417,],0,0
37418,.,0,0
37419,A,0,0
37420,prospective,0,0
37421,randomized,0,0
37422,study,0,0
37423,was,0,0
37424,conducted,0,0
37425,to,0,0
37426,determine,0,0
37427,the,0,0
37428,ablation,1,0
37429,capacity,1,1
37430,of,0,0
37431,mitoxantrone,0,0
37432,in,0,0
37433,Ta-T1,0,1
37434,superficial,0,1
37435,bladder,0,0
37436,tumors,0,0
37437,versus,0,0
37438,mitomycin,0,0
37439,C,0,0
37440,",",0,0
37441,a,0,0
37442,drug,0,0
37443,whose,0,0
37444,intravesical,0,0
37445,ablation,0,0
37446,properties,0,0
37447,are,0,0
37448,well-known,0,0
37449,.,0,0
37450,Fifty-seven,0,0
37451,patients,0,0
37452,comprised,0,0
37453,the,0,0
37454,study,0,0
37455,.,0,0
37456,The,0,0
37457,tumor,0,1
37458,was,0,0
37459,not,0,0
37460,completely,0,0
37461,resected,0,0
37462,when,0,0
37463,the,0,0
37464,patient,0,0
37465,underwent,0,0
37466,TUR,0,0
37467,.,0,0
37468,This,0,0
37469,residual,0,1
37470,tumor,0,1
37471,was,0,0
37472,used,0,0
37473,as,0,0
37474,control,0,0
37475,.,0,0
37476,The,0,0
37477,patients,0,0
37478,were,0,0
37479,treated,0,0
37480,with,0,0
37481,either,0,0
37482,20,0,0
37483,mg,0,0
37484,Mitoxantrone,0,0
37485,or,0,0
37486,40,0,0
37487,mg,0,0
37488,mitomycin,0,0
37489,C,0,0
37490,weekly,0,0
37491,for,0,0
37492,8,0,0
37493,weeks,0,0
37494,and,0,0
37495,two,0,0
37496,other,0,0
37497,instillations,0,0
37498,every,0,0
37499,15,0,0
37500,days,0,0
37501,in,0,0
37502,50,0,0
37503,ml,0,0
37504,saline,0,0
37505,solution,0,0
37506,.,0,0
37507,Response,1,1
37508,to,1,0
37509,therapy,1,0
37510,was,0,0
37511,evaluated,0,0
37512,between,0,0
37513,the,0,0
37514,4th,0,0
37515,and,0,0
37516,8th,0,0
37517,week,0,0
37518,and,0,0
37519,classified,0,0
37520,as,0,0
37521,complete,1,1
37522,response,1,1
37523,(,1,0
37524,CR,1,1
37525,),1,1
37526,",",0,0
37527,defined,0,0
37528,as,0,0
37529,no,0,0
37530,gross,1,1
37531,and,1,0
37532,microscopic,1,1
37533,evidence,1,0
37534,of,1,0
37535,residual,1,1
37536,tumor,1,1
37537,",",0,0
37538,or,0,0
37539,no,1,0
37540,response,1,1
37541,(,1,0
37542,NR,1,0
37543,),1,0
37544,or,1,0
37545,therapeutic,1,0
37546,failure,1,1
37547,.,1,0
37548,CR,0,0
37549,was,0,0
37550,observed,0,0
37551,in,0,0
37552,77.7,0,0
37553,%,0,0
37554,of,0,0
37555,the,0,0
37556,patients,0,0
37557,treated,0,0
37558,with,0,0
37559,mitomycin,0,0
37560,C,0,0
37561,and,0,0
37562,in,0,0
37563,50,0,0
37564,%,0,0
37565,in,0,0
37566,those,0,0
37567,that,0,0
37568,had,0,0
37569,been,0,0
37570,treated,0,0
37571,with,0,0
37572,Mitoxantrone,0,0
37573,.,0,0
37574,Treatment,0,0
37575,was,0,0
37576,discontinued,0,0
37577,because,0,0
37578,of,0,0
37579,side,1,1
37580,effects,1,0
37581,in,0,0
37582,15,0,0
37583,%,0,0
37584,of,0,0
37585,the,0,0
37586,patients,0,0
37587,treated,0,0
37588,with,0,0
37589,mitomycin,0,0
37590,C,0,0
37591,and,0,0
37592,in,0,0
37593,63.4,0,0
37594,%,0,0
37595,of,0,0
37596,those,0,0
37597,who,0,0
37598,received,0,0
37599,Mitoxantrone,0,0
37600,.,0,0
37601,We,0,0
37602,can,0,0
37603,conclude,0,0
37604,from,0,0
37605,the,0,0
37606,results,0,0
37607,of,0,0
37608,the,0,0
37609,present,0,0
37610,study,0,0
37611,that,0,0
37612,Mitoxantrone,0,0
37613,is,0,0
37614,a,0,0
37615,useful,0,0
37616,agent,0,0
37617,for,0,0
37618,ablation,0,0
37619,therapy,0,0
37620,of,0,0
37621,superficial,0,1
37622,bladder,0,0
37623,tumors,0,1
37624,",",0,0
37625,although,0,0
37626,the,0,0
37627,high,0,0
37628,incidence,0,1
37629,of,0,0
37630,severe,0,1
37631,side,1,1
37632,effects,1,1
37633,warrants,0,0
37634,its,0,0
37635,limited,0,0
37636,use,0,0
37637,and,0,0
37638,at,0,0
37639,high,0,0
37640,dilutions,0,1
37641,.,0,0
37642,Controlled,0,0
37643,study,0,0
37644,on,0,0
37645,the,0,0
37646,therapeutic,1,0
37647,efficacy,1,1
37648,of,0,0
37649,propionyl-L-carnitine,0,0
37650,in,0,0
37651,patients,0,0
37652,with,0,0
37653,congestive,0,1
37654,heart,0,0
37655,failure,0,0
37656,.,0,0
37657,A,0,0
37658,double-blind,0,0
37659,phase,0,0
37660,II,0,0
37661,study,0,0
37662,of,0,1
37663,propionyl-L-carnitine,0,0
37664,(,0,0
37665,CAS,0,0
37666,17298-37-2,0,0
37667,),0,0
37668,versus,0,0
37669,placebo,0,0
37670,was,0,0
37671,carried,0,0
37672,out,0,0
37673,on,0,0
37674,a,0,0
37675,group,0,0
37676,of,0,0
37677,60,0,0
37678,patients,0,0
37679,with,0,0
37680,mild,0,0
37681,to,0,0
37682,moderate,0,0
37683,(,0,0
37684,II,0,0
37685,and,0,1
37686,III,0,1
37687,NYHA,0,1
37688,class,0,0
37689,),0,0
37690,congestive,0,1
37691,heart,0,0
37692,failure,0,0
37693,.,0,0
37694,The,0,0
37695,group,0,0
37696,was,0,0
37697,made,0,0
37698,up,0,0
37699,of,0,0
37700,men,0,0
37701,and,0,0
37702,women,0,0
37703,aged,0,0
37704,between,0,0
37705,48,0,0
37706,and,0,0
37707,73,0,0
37708,years,0,0
37709,in,0,0
37710,chronic,0,0
37711,treatment,0,0
37712,with,0,0
37713,digitalis,0,0
37714,and,0,0
37715,diuretics,0,0
37716,for,0,0
37717,at,0,0
37718,least,0,0
37719,3,0,0
37720,months,0,0
37721,and,0,0
37722,who,0,0
37723,still,0,0
37724,displayed,0,0
37725,symptoms,0,1
37726,.,0,0
37727,Thirty,0,0
37728,of,0,0
37729,these,0,0
37730,patients,0,0
37731,were,0,0
37732,chosen,0,0
37733,randomly,0,0
37734,and,0,0
37735,for,0,0
37736,180,0,0
37737,days,0,0
37738,",",0,0
37739,500,0,0
37740,mg,0,0
37741,of,0,0
37742,propionyl-L-carnitine,0,0
37743,was,0,0
37744,orally,0,0
37745,administered,0,0
37746,",",0,0
37747,3,0,0
37748,times,0,0
37749,a,0,0
37750,day,0,0
37751,in,0,0
37752,addition,0,0
37753,to,0,0
37754,their,0,0
37755,usual,0,0
37756,treatment,0,0
37757,.,0,0
37758,At,0,0
37759,basal,0,1
37760,conditions,0,0
37761,and,0,0
37762,after,0,0
37763,30,0,0
37764,",",0,0
37765,90,0,0
37766,and,0,0
37767,180,0,0
37768,days,0,0
37769,the,0,0
37770,maximum,1,1
37771,exercise,1,0
37772,time,1,1
37773,was,1,0
37774,evaluated,1,0
37775,using,1,0
37776,an,1,0
37777,exercise,1,0
37778,tolerance,1,1
37779,test,1,1
37780,performed,0,0
37781,on,0,0
37782,an,0,0
37783,ergometer,0,0
37784,bicycle,0,0
37785,and,0,0
37786,the,0,0
37787,left,1,1
37788,ventricular,1,1
37789,ejection,1,1
37790,fraction,1,1
37791,was,0,0
37792,tested,0,0
37793,by,0,0
37794,means,0,0
37795,of,0,0
37796,bidimensional,1,1
37797,echocardiography,1,0
37798,.,1,0
37799,After,0,0
37800,one,0,0
37801,month,0,0
37802,of,0,0
37803,treatment,0,0
37804,",",0,0
37805,the,0,0
37806,patients,0,0
37807,treated,0,0
37808,with,0,0
37809,propionyl-L-carnitine,0,0
37810,",",0,0
37811,compared,0,0
37812,to,0,0
37813,the,0,0
37814,control,0,0
37815,group,0,0
37816,",",0,0
37817,showed,0,0
37818,significant,0,0
37819,increases,0,1
37820,in,0,0
37821,the,0,0
37822,values,1,0
37823,of,1,0
37824,both,1,0
37825,tests,1,0
37826,",",0,0
37827,increases,0,1
37828,which,0,0
37829,became,0,0
37830,even,0,0
37831,more,0,0
37832,evident,0,0
37833,after,0,0
37834,90,0,0
37835,and,0,0
37836,180,0,0
37837,days,0,0
37838,.,0,0
37839,At,0,0
37840,the,0,0
37841,stated,0,0
37842,times,0,0
37843,the,0,0
37844,increases,0,0
37845,in,0,0
37846,the,0,0
37847,maximum,1,1
37848,exercise,1,0
37849,time,1,1
37850,were,0,0
37851,16.4,0,0
37852,%,0,0
37853,",",0,0
37854,22.9,0,0
37855,%,0,0
37856,",",0,0
37857,and,0,0
37858,25.9,0,0
37859,%,0,0
37860,",",0,0
37861,respectively,0,0
37862,.,0,0
37863,The,0,0
37864,ventricular,1,1
37865,ejection,1,0
37866,fraction,1,1
37867,increased,0,0
37868,by,0,0
37869,8.4,0,0
37870,%,0,0
37871,",",0,0
37872,11.6,0,0
37873,%,0,0
37874,and,0,0
37875,13.6,0,0
37876,%,0,0
37877,",",0,0
37878,respectively,0,0
37879,.,0,0
37880,On,0,0
37881,the,0,0
37882,basis,0,0
37883,of,0,0
37884,these,0,0
37885,results,0,0
37886,",",0,0
37887,having,0,0
37888,studied,0,0
37889,the,0,0
37890,particular,0,0
37891,mechanism,0,0
37892,of,0,0
37893,action,0,1
37894,of,0,0
37895,propionyl-L-carnitine,0,0
37896,the,0,0
37897,authors,0,0
37898,conclude,0,0
37899,that,0,0
37900,it,0,0
37901,represents,0,0
37902,a,0,0
37903,drug,0,0
37904,of,0,0
37905,undoubted,0,0
37906,therapeutic,0,0
37907,interest,0,0
37908,in,0,0
37909,patients,0,0
37910,with,0,0
37911,congestive,0,1
37912,heart,0,1
37913,failure,0,1
37914,",",0,0
37915,in,0,0
37916,whom,0,0
37917,it,0,0
37918,could,0,0
37919,be,0,0
37920,efficaciously,1,0
37921,administered,0,0
37922,along,0,0
37923,with,0,0
37924,a,0,0
37925,standard,0,0
37926,pharmacological,0,0
37927,therapy,0,0
37928,.,0,0
37929,Leukocyte-depleted,0,0
37930,reperfusion,0,1
37931,of,0,0
37932,transplanted,0,0
37933,human,0,0
37934,hearts,0,0
37935,:,0,0
37936,a,0,0
37937,randomized,0,0
37938,",",0,0
37939,double-blind,0,0
37940,clinical,0,0
37941,trial,0,0
37942,.,0,0
37943,Standard,0,0
37944,methods,0,0
37945,of,0,0
37946,myocardial,0,1
37947,preservation,0,0
37948,for,0,0
37949,heart,0,0
37950,transplantation,0,0
37951,have,0,0
37952,generally,0,0
37953,provided,0,0
37954,good,0,0
37955,results,1,0
37956,.,1,0
37957,Preservation,0,0
37958,times,0,0
37959,beyond,0,0
37960,3,0,0
37961,hours,0,0
37962,",",0,0
37963,however,0,0
37964,",",0,0
37965,have,0,0
37966,been,0,0
37967,associated,0,0
37968,with,0,0
37969,decreased,0,0
37970,survival,1,1
37971,.,1,0
37972,Leukocyte-mediated,0,1
37973,reperfusion,0,1
37974,injury,0,0
37975,is,0,0
37976,partly,0,0
37977,responsible,0,0
37978,for,0,0
37979,decreased,0,0
37980,graft,1,1
37981,function,1,1
37982,after,0,0
37983,prolonged,0,1
37984,graft,0,1
37985,ischemia,0,1
37986,.,0,0
37987,Leukocyte-depleted,0,0
37988,reperfusion,0,0
37989,has,0,0
37990,been,0,0
37991,shown,0,0
37992,experimentally,0,0
37993,to,0,0
37994,improve,0,0
37995,cardiac,1,1
37996,function,1,1
37997,after,0,0
37998,cold,0,0
37999,ischemic,0,0
38000,arrest,0,1
38001,.,0,0
38002,To,0,0
38003,determine,0,0
38004,the,0,0
38005,efficacy,1,1
38006,and,1,0
38007,safety,1,1
38008,of,0,1
38009,leukocyte-depleted,0,0
38010,reperfusion,0,1
38011,",",0,0
38012,20,0,0
38013,patients,0,0
38014,were,0,0
38015,enrolled,0,0
38016,in,0,0
38017,a,0,0
38018,randomized,0,0
38019,",",0,0
38020,double-blind,0,0
38021,clinical,0,0
38022,trial,0,0
38023,to,0,0
38024,be,0,0
38025,treated,0,0
38026,with,0,0
38027,either,0,0
38028,warm,0,0
38029,whole,0,0
38030,blood,0,1
38031,reperfusion,0,1
38032,(,0,0
38033,group,0,0
38034,I,0,0
38035,;,0,0
38036,n,0,0
38037,=,0,0
38038,9,0,0
38039,),0,0
38040,or,0,0
38041,warm,0,0
38042,leukocyte-depleted,0,0
38043,blood,0,1
38044,reperfusion,0,1
38045,(,0,0
38046,group,0,0
38047,II,0,0
38048,;,0,0
38049,n,0,0
38050,=,0,0
38051,11,0,0
38052,),0,0
38053,.,0,0
38054,Reperfusion,0,0
38055,with,0,0
38056,leukocyte-depleted,0,0
38057,blood,0,1
38058,or,0,0
38059,whole,0,1
38060,blood,0,1
38061,was,0,0
38062,carried,0,0
38063,out,0,0
38064,for,0,0
38065,10,0,0
38066,minutes,0,0
38067,",",0,0
38068,with,0,0
38069,enriched,0,0
38070,cardioplegic,0,0
38071,solution,0,0
38072,added,0,0
38073,for,0,0
38074,the,0,0
38075,first,0,0
38076,3,0,0
38077,minutes,0,0
38078,of,0,0
38079,reperfusion,0,0
38080,.,0,0
38081,The,0,0
38082,mean,1,1
38083,donor,1,0
38084,and,1,0
38085,recipient,1,1
38086,age,1,0
38087,and,1,0
38088,the,1,0
38089,ischemic,1,1
38090,time,1,1
38091,(,0,0
38092,142,0,0
38093,versus,0,0
38094,153,0,0
38095,minutes,0,0
38096,),0,0
38097,were,0,0
38098,not,0,0
38099,significantly,0,0
38100,different,0,0
38101,between,0,0
38102,the,0,0
38103,two,0,0
38104,groups,0,0
38105,.,0,0
38106,Coronary,1,0
38107,sinus,1,0
38108,release,1,1
38109,of,1,0
38110,creatinine,1,1
38111,phosphokinase-MB,1,0
38112,5,1,0
38113,minutes,1,0
38114,after,1,0
38115,reperfusion,1,1
38116,was,0,0
38117,significantly,0,0
38118,less,0,0
38119,in,0,0
38120,group,0,0
38121,II,0,0
38122,(,0,0
38123,1.65,0,0
38124,EU/min,0,0
38125,),0,0
38126,than,0,0
38127,in,0,0
38128,group,0,0
38129,I,0,0
38130,(,0,0
38131,3.83,0,0
38132,units/min,0,0
38133,;,0,0
38134,p,0,0
38135,=,0,0
38136,0.05,0,0
38137,),0,0
38138,.,0,0
38139,Thromboxane,1,1
38140,B2,1,1
38141,release,1,1
38142,was,0,0
38143,also,0,0
38144,significantly,0,0
38145,less,0,0
38146,(,0,0
38147,p,0,0
38148,=,0,0
38149,0.05,0,0
38150,),0,0
38151,in,0,0
38152,group,0,0
38153,II,0,0
38154,(,0,0
38155,33.6,0,0
38156,pg/min,0,0
38157,),0,0
38158,than,0,0
38159,in,0,0
38160,group,0,0
38161,I,0,0
38162,(,0,0
38163,67.0,0,0
38164,pg/min,0,0
38165,),0,0
38166,.,0,0
38167,All,0,0
38168,hearts,1,0
38169,functioned,1,0
38170,adequately,0,0
38171,in,0,0
38172,both,0,0
38173,groups,0,0
38174,.,0,0
38175,The,0,0
38176,duration,1,1
38177,of,1,0
38178,inotropic,1,1
38179,support,1,0
38180,was,0,0
38181,shorter,0,0
38182,in,0,0
38183,group,0,0
38184,II,0,0
38185,than,0,0
38186,in,0,0
38187,group,0,0
38188,I,0,0
38189,",",0,0
38190,but,0,0
38191,the,0,0
38192,difference,0,0
38193,was,0,0
38194,not,0,0
38195,statistically,0,0
38196,significant,0,0
38197,.,0,0
38198,Postoperative,1,0
38199,hemodynamics,1,1
38200,",",1,0
38201,rejection,1,1
38202,episodes,1,1
38203,",",1,0
38204,and,1,1
38205,infectious,1,1
38206,complications,1,1
38207,were,0,0
38208,also,0,0
38209,not,0,0
38210,significantly,0,0
38211,different,0,0
38212,between,0,0
38213,groups,0,0
38214,in,0,0
38215,a,0,0
38216,mean,0,1
38217,follow-up,0,0
38218,of,0,0
38219,9,0,0
38220,months,0,0
38221,.,0,0
38222,Mean,1,0
38223,ejection,1,0
38224,fraction,1,1
38225,1,1,0
38226,month,1,0
38227,after,1,0
38228,operation,1,0
38229,was,0,0
38230,65,0,0
38231,%,0,0
38232,in,0,0
38233,both,0,0
38234,groups,0,0
38235,.,0,0
38236,One,0,0
38237,early,0,0
38238,death,1,1
38239,occurred,0,0
38240,at,0,0
38241,66,0,0
38242,days,0,0
38243,secondary,0,0
38244,to,0,0
38245,infection,0,0
38246,;,0,0
38247,two,0,0
38248,late,0,0
38249,deaths,1,0
38250,occurred,0,0
38251,in,0,0
38252,group,0,0
38253,II,0,0
38254,",",0,0
38255,both,0,0
38256,from,0,0
38257,rejection,0,1
38258,.,0,0
38259,Leukocyte-depleted,0,0
38260,reperfusion,0,0
38261,is,0,0
38262,safe,1,1
38263,and,0,0
38264,easily,0,0
38265,applied,0,0
38266,in,0,0
38267,the,0,0
38268,operating,0,0
38269,room,0,0
38270,.,0,0
38271,Furthermore,0,0
38272,",",0,0
38273,leukocyte-depleted,0,0
38274,reperfusion,0,1
38275,decreases,0,1
38276,biochemical,1,1
38277,evidence,1,0
38278,of,0,0
38279,reperfusion,0,1
38280,injury,0,0
38281,.,0,0
38282,Although,0,0
38283,not,0,0
38284,influencing,0,0
38285,postoperative,0,1
38286,cardiac,1,1
38287,function,1,1
38288,when,0,0
38289,the,0,0
38290,ischemic,0,0
38291,time,0,1
38292,is,0,0
38293,short,0,1
38294,",",0,0
38295,less,0,0
38296,than,0,0
38297,3,0,0
38298,hours,0,0
38299,",",0,0
38300,leukocyte-depleted,0,0
38301,reperfusion,0,0
38302,may,0,0
38303,prevent,0,0
38304,significant,0,0
38305,reperfusion,1,1
38306,injury,1,0
38307,and,0,1
38308,improve,0,0
38309,posttransplantation,1,0
38310,graft,1,1
38311,function,1,1
38312,when,0,0
38313,ischemic,1,0
38314,times,1,0
38315,are,0,0
38316,long,0,0
38317,.,0,0
38318,Safe,0,0
38319,extension,0,0
38320,of,0,0
38321,the,0,0
38322,ischemic,0,0
38323,time,0,0
38324,would,0,0
38325,expand,0,0
38326,the,0,0
38327,donor,0,0
38328,pool,0,0
38329,and,0,0
38330,allow,0,0
38331,for,0,0
38332,better,0,0
38333,crossmatching,0,1
38334,.,0,0
38335,Evaluation,0,0
38336,of,0,0
38337,umbilical,0,1
38338,cord,0,1
38339,serum,0,1
38340,therapy,0,0
38341,for,0,0
38342,persistent,0,0
38343,corneal,0,1
38344,epithelial,0,0
38345,defects,0,0
38346,.,0,0
38347,AIMS,0,0
38348,To,0,0
38349,evaluate,0,0
38350,umbilical,0,1
38351,cord,0,1
38352,serum,0,1
38353,therapy,0,0
38354,as,0,0
38355,a,0,0
38356,means,0,0
38357,of,0,0
38358,promoting,0,0
38359,the,0,0
38360,healing,0,1
38361,of,0,0
38362,persistent,1,0
38363,corneal,1,1
38364,epithelial,1,0
38365,defects,1,0
38366,.,1,0
38367,METHODS,0,0
38368,Umbilical,0,1
38369,cord,0,1
38370,serum,0,1
38371,or,0,0
38372,autologous,0,0
38373,serum,0,1
38374,drops,0,0
38375,were,0,0
38376,used,0,0
38377,to,0,0
38378,promote,0,0
38379,the,0,0
38380,healing,0,1
38381,of,0,0
38382,persistent,1,0
38383,epithelial,1,0
38384,defects,1,0
38385,.,1,0
38386,The,0,0
38387,study,0,0
38388,design,0,0
38389,was,0,0
38390,a,0,0
38391,prospective,0,0
38392,randomised,0,0
38393,controlled,0,0
38394,clinical,0,0
38395,trial,0,0
38396,.,0,0
38397,60,0,0
38398,eyes,0,0
38399,of,0,0
38400,59,0,0
38401,patients,0,0
38402,were,0,0
38403,divided,0,0
38404,into,0,0
38405,two,0,0
38406,groups,0,0
38407,",",0,0
38408,31,0,0
38409,in,0,0
38410,the,0,0
38411,cord,0,1
38412,serum,0,1
38413,group,0,0
38414,and,0,0
38415,29,0,0
38416,in,0,0
38417,the,0,0
38418,autologous,0,0
38419,serum,0,1
38420,control,0,0
38421,group,0,0
38422,.,0,0
38423,Epithelial,0,1
38424,defects,0,0
38425,measuring,0,0
38426,at,0,0
38427,least,0,0
38428,2,0,0
38429,mm,0,0
38430,in,0,0
38431,linear,0,0
38432,dimension,0,1
38433,resistant,0,0
38434,to,0,0
38435,conventional,0,0
38436,medical,0,0
38437,management,0,0
38438,were,0,0
38439,included,0,0
38440,.,0,0
38441,Serial,0,0
38442,measurements,0,0
38443,of,0,0
38444,the,0,0
38445,size,0,0
38446,of,0,0
38447,the,0,0
38448,epithelial,0,0
38449,defects-namely,0,0
38450,",",0,0
38451,two,0,0
38452,maximum,0,0
38453,linear,0,0
38454,dimensions,0,1
38455,perpendicular,0,1
38456,to,0,0
38457,each,0,0
38458,other,0,0
38459,",",0,0
38460,and,0,0
38461,the,0,0
38462,area,0,1
38463,and,0,1
38464,perimeter,0,1
38465,was,0,0
38466,done,0,0
38467,at,0,0
38468,start,0,0
38469,of,0,0
38470,therapy,0,0
38471,and,0,0
38472,follow,0,0
38473,up,0,0
38474,days,0,0
38475,3,0,0
38476,",",0,0
38477,7,0,0
38478,",",0,0
38479,14,0,0
38480,",",0,0
38481,21,0,0
38482,.,0,0
38483,Rate,1,0
38484,of,1,0
38485,healing,1,1
38486,of,1,0
38487,the,1,0
38488,epithelial,1,1
38489,defects,1,0
38490,were,0,0
38491,measured,0,0
38492,as,0,0
38493,percentage,0,1
38494,decrease,0,0
38495,from,0,0
38496,the,0,0
38497,baseline,0,0
38498,parameter,0,0
38499,at,0,0
38500,each,0,0
38501,subsequent,0,0
38502,follow,0,0
38503,up,0,0
38504,.,0,0
38505,The,0,0
38506,data,0,0
38507,were,0,0
38508,analysed,0,0
38509,by,0,0
38510,the,0,0
38511,non-parametric,0,0
38512,Wilcoxon,0,1
38513,rank,0,1
38514,sum,0,1
38515,test,0,1
38516,using,0,0
38517,STATA,0,0
38518,7.0,0,0
38519,.,0,0
38520,RESULTS,0,0
38521,The,0,0
38522,median,0,0
38523,percentage,0,1
38524,decrease,1,0
38525,in,1,0
38526,the,1,0
38527,size,1,0
38528,of,1,0
38529,the,1,0
38530,epithelial,1,1
38531,defect,1,0
38532,was,0,0
38533,significantly,0,0
38534,greater,0,0
38535,in,0,0
38536,the,0,0
38537,cord,0,1
38538,serum,0,1
38539,group,0,0
38540,at,0,0
38541,days,0,0
38542,7,0,0
38543,",",0,0
38544,14,0,0
38545,and,0,0
38546,21,0,0
38547,(,0,0
38548,p,0,0
38549,<,0,0
38550,0.05,0,0
38551,),0,0
38552,when,0,0
38553,measured,0,0
38554,in,0,0
38555,terms,0,0
38556,of,0,0
38557,the,0,0
38558,area,0,1
38559,and,0,0
38560,perimeter,0,1
38561,.,0,0
38562,A,0,0
38563,greater,0,0
38564,number,0,1
38565,of,0,1
38566,patients,0,0
38567,showed,0,0
38568,complete,1,1
38569,re-epithelialisation,1,1
38570,with,0,0
38571,umbilical,0,1
38572,cord,0,1
38573,serum,0,1
38574,(,0,0
38575,n,0,0
38576,=,0,0
38577,18,0,0
38578,),0,0
38579,than,0,0
38580,with,0,0
38581,autologous,0,0
38582,serum,0,1
38583,(,0,0
38584,n,0,0
38585,=,0,0
38586,11,0,0
38587,),0,0
38588,(,0,0
38589,Pearson,0,0
38590,chi,0,0
38591,=,0,0
38592,0.19,0,0
38593,),0,0
38594,.,0,0
38595,None,0,0
38596,of,0,0
38597,the,0,0
38598,patients,0,0
38599,reported,0,0
38600,any,0,0
38601,side,0,1
38602,effects,0,1
38603,or,0,0
38604,discomfort,0,1
38605,with,0,0
38606,either,0,0
38607,treatment,0,0
38608,.,0,0
38609,CONCLUSIONS,0,0
38610,Umbilical,0,1
38611,cord,0,0
38612,serum,0,1
38613,leads,0,0
38614,to,0,0
38615,faster,1,0
38616,healing,1,1
38617,of,1,0
38618,the,1,0
38619,persistent,1,0
38620,corneal,1,1
38621,epithelial,1,1
38622,defects,1,0
38623,refractory,0,0
38624,to,0,0
38625,all,0,0
38626,medical,0,0
38627,management,0,0
38628,compared,0,0
38629,to,0,0
38630,autologous,0,0
38631,serum,0,1
38632,.,0,0
38633,Presentation,0,0
38634,of,0,0
38635,allergen,0,0
38636,in,0,0
38637,different,0,0
38638,food,0,0
38639,preparations,0,0
38640,affects,0,0
38641,the,0,0
38642,nature,0,0
38643,of,0,0
38644,the,0,0
38645,allergic,0,0
38646,reaction,0,0
38647,--,0,0
38648,a,0,0
38649,case,0,0
38650,series,0,0
38651,.,0,0
38652,BACKGROUND,0,0
38653,Characterization,0,0
38654,of,0,0
38655,fatal,0,1
38656,and,0,0
38657,non-fatal,0,1
38658,reactions,0,1
38659,to,0,0
38660,food,0,0
38661,indicates,0,0
38662,that,0,0
38663,the,0,0
38664,majority,0,0
38665,of,0,0
38666,reactions,0,1
38667,are,0,0
38668,due,0,0
38669,to,0,0
38670,the,0,0
38671,ingestion,0,0
38672,of,0,0
38673,prepared,0,0
38674,foods,0,0
38675,rather,0,0
38676,than,0,0
38677,the,0,0
38678,non-processed,0,0
38679,allergen,0,0
38680,.,0,0
38681,In,0,0
38682,an,0,0
38683,ongoing,0,0
38684,study,0,0
38685,that,0,0
38686,used,0,0
38687,a,0,0
38688,double-blind,0,0
38689,placebo-controlled,0,0
38690,food,0,0
38691,challenge,0,0
38692,to,0,0
38693,investigate,0,0
38694,peanut,0,0
38695,allergy,0,1
38696,and,0,1
38697,clinical,0,1
38698,symptoms,0,1
38699,",",0,0
38700,the,0,0
38701,observed,0,0
38702,reaction,0,1
38703,severity,0,1
38704,in,0,0
38705,four,0,0
38706,of,0,0
38707,the,0,0
38708,first,0,0
38709,six,0,0
38710,subjects,0,0
38711,was,0,0
38712,greater,0,0
38713,than,0,0
38714,anticipated,0,0
38715,.,0,0
38716,We,0,0
38717,hypothesized,0,0
38718,that,0,0
38719,this,0,0
38720,was,0,0
38721,due,0,0
38722,to,0,0
38723,differences,0,0
38724,in,0,0
38725,the,0,0
38726,composition,0,0
38727,of,0,0
38728,the,0,0
38729,challenge,0,0
38730,vehicle,0,0
38731,.,0,0
38732,OBJECTIVE,0,0
38733,The,0,0
38734,aim,0,0
38735,was,0,0
38736,to,0,0
38737,investigate,0,0
38738,whether,0,0
38739,the,0,0
38740,severity,0,1
38741,of,0,0
38742,observed,0,0
38743,challenge,0,0
38744,reactions,0,0
38745,would,0,0
38746,be,0,0
38747,repeated,0,0
38748,on,0,0
38749,re-challenge,0,0
38750,with,0,0
38751,a,0,0
38752,lower,0,0
38753,fat,0,1
38754,challenge,0,0
38755,vehicle,0,0
38756,.,0,0
38757,METHODS,0,0
38758,Peanut-allergic,0,0
38759,subjects,0,0
38760,were,0,0
38761,re-challenged,0,0
38762,with,0,0
38763,a,0,0
38764,lower,0,0
38765,fat,0,1
38766,recipe,0,0
38767,after,0,0
38768,reacting,0,0
38769,more,0,0
38770,severely,0,0
38771,than,0,0
38772,was,0,0
38773,anticipated,0,0
38774,to,0,0
38775,an,0,0
38776,initial,0,0
38777,peanut,0,0
38778,challenge,0,0
38779,.,0,0
38780,Similar,0,0
38781,challenge,0,0
38782,vehicle,0,0
38783,recipes,0,0
38784,were,0,0
38785,used,0,0
38786,",",0,0
38787,the,0,0
38788,only,0,0
38789,difference,0,0
38790,being,0,0
38791,the,0,0
38792,lower,0,0
38793,fat,0,1
38794,content,0,1
38795,(,0,0
38796,22.9,0,0
38797,%,0,0
38798,compared,0,0
38799,with,0,0
38800,31.5,0,0
38801,%,0,0
38802,),0,0
38803,.,0,0
38804,The,0,0
38805,peanut,0,0
38806,content,0,1
38807,of,0,0
38808,the,0,0
38809,two,0,0
38810,recipes,0,0
38811,was,0,0
38812,analysed,0,0
38813,using,0,0
38814,RAST,0,0
38815,inhibition,0,1
38816,studies,0,0
38817,and,0,1
38818,ELISA,0,0
38819,tests,0,1
38820,.,0,0
38821,RESULTS,0,0
38822,Three,0,0
38823,of,0,0
38824,four,0,0
38825,subjects,0,0
38826,reacted,0,0
38827,to,0,0
38828,much,0,0
38829,smaller,0,0
38830,doses,1,0
38831,of,1,1
38832,peanut,1,0
38833,protein,1,1
38834,on,1,0
38835,re-challenge,1,0
38836,(,0,0
38837,mean,0,1
38838,dose,0,0
38839,equivalence,0,0
38840,-,0,0
38841,23,0,0
38842,times,0,0
38843,less,0,0
38844,peanut,0,0
38845,),0,0
38846,with,0,0
38847,the,0,0
38848,lower,0,0
38849,fat,0,1
38850,recipe,0,0
38851,.,0,0
38852,RAST,1,1
38853,inhibition,1,1
38854,showed,0,0
38855,that,0,0
38856,neither,0,0
38857,recipe,0,0
38858,altered,0,0
38859,epitope,1,0
38860,recognition,1,0
38861,.,1,0
38862,The,0,0
38863,higher,0,0
38864,fat,0,1
38865,recipe,0,0
38866,required,0,0
38867,twice,0,0
38868,as,0,0
38869,much,0,0
38870,peanut,0,0
38871,to,0,0
38872,cause,0,0
38873,50,1,0
38874,%,1,0
38875,inhibition,1,0
38876,.,1,0
38877,ELISA,0,0
38878,detected,0,0
38879,far,0,0
38880,lower,0,0
38881,levels,0,1
38882,of,0,1
38883,peanut,0,0
38884,in,0,0
38885,the,0,0
38886,higher,0,0
38887,fat,0,1
38888,recipe,0,0
38889,(,0,0
38890,220,0,0
38891,000,0,0
38892,parts,0,0
38893,per,0,0
38894,million,0,0
38895,(,0,0
38896,p.p.m,0,0
38897,.,0,0
38898,),0,0
38899,),0,0
38900,than,0,0
38901,in,0,0
38902,the,0,0
38903,lower,0,0
38904,fat,0,1
38905,recipe,0,0
38906,(,0,0
38907,990,0,0
38908,000,0,0
38909,p.p.m.,0,0
38910,),0,0
38911,.,0,0
38912,CONCLUSION,0,0
38913,The,0,0
38914,fat,0,1
38915,content,0,1
38916,of,0,0
38917,a,0,0
38918,challenge,0,0
38919,vehicle,0,0
38920,has,0,0
38921,a,0,0
38922,profound,0,0
38923,effect,0,0
38924,on,0,0
38925,the,0,0
38926,reaction,0,1
38927,experienced,0,0
38928,after,0,0
38929,allergen,0,0
38930,ingestion,0,0
38931,.,0,0
38932,This,0,0
38933,is,0,0
38934,another,0,0
38935,factor,0,0
38936,to,0,0
38937,be,0,0
38938,considered,0,0
38939,in,0,0
38940,assessing,0,0
38941,the,0,0
38942,risk,0,0
38943,of,0,0
38944,certain,0,0
38945,foods,0,0
38946,to,0,0
38947,food-allergic,0,0
38948,consumers,0,0
38949,and,0,0
38950,adds,0,0
38951,another,0,0
38952,dimension,0,1
38953,to,0,0
38954,clinical,0,0
38955,",",0,0
38956,research,0,0
38957,and,0,1
38958,regulatory,0,0
38959,practice,0,0
38960,.,0,0
38961,Effects,0,0
38962,of,0,0
38963,weight,0,1
38964,reduction,0,1
38965,interventions,0,0
38966,by,0,0
38967,community,0,0
38968,pharmacists,0,0
38969,.,0,0
38970,OBJECTIVE,0,0
38971,To,0,0
38972,compare,0,0
38973,a,0,0
38974,meal,0,0
38975,replacement,0,0
38976,(,0,0
38977,MR,0,1
38978,),0,0
38979,program,0,0
38980,with,0,0
38981,a,0,0
38982,conventional,0,0
38983,reduced-calorie,0,0
38984,diet,0,0
38985,(,0,0
38986,RCD,0,0
38987,),0,0
38988,for,0,0
38989,weight,1,1
38990,management,1,0
38991,using,0,0
38992,the,0,0
38993,pharmacy,0,0
38994,as,0,0
38995,the,0,0
38996,setting,0,0
38997,and,0,0
38998,the,0,0
38999,pharmacist,0,0
39000,as,0,0
39001,the,0,0
39002,point,0,0
39003,of,0,0
39004,contact,0,1
39005,for,0,0
39006,dietary,0,0
39007,advice,0,0
39008,.,0,0
39009,DESIGN,0,0
39010,Randomized,0,0
39011,",",0,0
39012,controlled,0,0
39013,",",0,0
39014,open-label,0,0
39015,trial,0,0
39016,.,0,0
39017,SETTING,0,0
39018,Travis,0,0
39019,Pharmacy,0,0
39020,in,0,0
39021,Shenandoah,0,0
39022,",",0,0
39023,Iowa,0,0
39024,.,0,0
39025,PATIENTS,0,0
39026,Ninety-five,0,0
39027,patients,0,0
39028,from,0,0
39029,southwestern,0,0
39030,iowa,0,0
39031,and,0,0
39032,southeastern,0,0
39033,Nebraska,0,0
39034,were,0,0
39035,enrolled,0,0
39036,",",0,0
39037,of,0,0
39038,whom,0,0
39039,88,0,0
39040,were,0,0
39041,considered,0,0
39042,eligible,0,0
39043,for,0,0
39044,comparison,0,0
39045,(,0,0
39046,by,0,0
39047,continuing,0,0
39048,through,0,0
39049,week,0,0
39050,2,0,0
39051,of,0,0
39052,the,0,0
39053,study,0,0
39054,),0,0
39055,.,0,0
39056,INTERVENTION,0,0
39057,Patients,0,0
39058,were,0,0
39059,randomized,0,0
39060,to,0,0
39061,an,0,0
39062,MR,0,0
39063,plan,0,0
39064,or,0,0
39065,a,0,0
39066,traditional,0,0
39067,RCD,0,0
39068,plan,0,0
39069,.,0,0
39070,Patients,0,0
39071,were,0,0
39072,followed,0,0
39073,for,0,0
39074,a,0,0
39075,3-month,0,0
39076,period,0,0
39077,of,0,0
39078,active,0,0
39079,weight,0,1
39080,loss,0,1
39081,and,0,0
39082,a,0,0
39083,10-week,0,0
39084,period,0,0
39085,of,0,0
39086,weight,0,1
39087,maintenance,0,0
39088,.,0,0
39089,Patients,0,0
39090,returned,0,0
39091,every,0,0
39092,3,0,0
39093,weeks,0,0
39094,for,0,0
39095,follow-up,0,0
39096,with,0,0
39097,the,0,0
39098,pharmacist,0,0
39099,",",0,0
39100,for,0,0
39101,a,0,0
39102,total,0,0
39103,of,0,0
39104,13,0,0
39105,visits,0,0
39106,.,0,0
39107,MAIN,0,0
39108,OUTCOME,0,0
39109,MEASURE,0,0
39110,Weight,1,0
39111,changes,1,1
39112,.,1,0
39113,RESULTS,0,0
39114,During,0,0
39115,the,0,0
39116,active,0,0
39117,weight,0,1
39118,loss,0,1
39119,phase,0,0
39120,",",0,0
39121,the,0,0
39122,MR,0,1
39123,(,0,0
39124,n,0,0
39125,=,0,0
39126,45,0,0
39127,),0,0
39128,and,0,0
39129,RCD,0,0
39130,(,0,0
39131,n,0,0
39132,=,0,0
39133,43,0,0
39134,),0,0
39135,groups,0,0
39136,lost,0,0
39137,a,0,0
39138,significant,1,0
39139,amount,1,1
39140,of,1,0
39141,weight,1,1
39142,",",0,0
39143,although,0,0
39144,no,0,0
39145,significant,0,0
39146,difference,0,0
39147,was,0,0
39148,found,0,0
39149,between,0,0
39150,the,0,0
39151,groups,0,0
39152,(,0,0
39153,mean,0,1
39154,+/-,0,0
39155,standard,0,0
39156,error,0,0
39157,=,0,0
39158,4.90,0,0
39159,+/-,0,0
39160,0.30,0,0
39161,kg,0,0
39162,MR,0,0
39163,versus,0,0
39164,4.30,0,0
39165,+/-,0,0
39166,0.30,0,0
39167,kg,0,0
39168,RCD,0,0
39169,;,0,0
39170,P,0,0
39171,=,0,0
39172,.16,0,0
39173,),0,0
39174,.,0,0
39175,In,0,0
39176,the,0,0
39177,weight,0,1
39178,maintenance,0,0
39179,phase,0,0
39180,",",0,0
39181,the,0,0
39182,MR,0,1
39183,group,0,0
39184,lost,0,0
39185,0.70,0,0
39186,+/-,0,0
39187,0.40,0,0
39188,kg,0,0
39189,and,0,0
39190,the,0,0
39191,RCD,0,0
39192,group,0,0
39193,lost,0,0
39194,0.90,0,0
39195,+/-,0,0
39196,0.40,0,0
39197,kg,0,0
39198,(,0,0
39199,P,0,0
39200,=,0,0
39201,.60,0,0
39202,),0,0
39203,.,0,0
39204,Significant,0,0
39205,improvements,0,1
39206,were,0,0
39207,observed,0,0
39208,in,0,0
39209,waist,1,1
39210,circumference,1,1
39211,",",1,0
39212,systolic,1,1
39213,and,1,1
39214,diastolic,1,1
39215,blood,1,1
39216,pressure,1,1
39217,",",1,1
39218,and,1,1
39219,triglyceride,1,1
39220,levels,1,1
39221,.,1,0
39222,No,0,0
39223,significant,0,0
39224,changes,0,1
39225,were,0,0
39226,seen,0,0
39227,in,0,0
39228,high-density,1,1
39229,lipoprotein,1,1
39230,cholesterol,1,1
39231,or,1,0
39232,low-density,1,1
39233,lipoprotein,1,1
39234,cholesterol,1,1
39235,levels,1,1
39236,in,0,0
39237,either,0,0
39238,group,0,0
39239,.,0,0
39240,CONCLUSION,0,0
39241,Successful,0,0
39242,weight,1,1
39243,management,1,0
39244,can,0,0
39245,be,0,0
39246,achieved,0,0
39247,in,0,0
39248,a,0,0
39249,pharmacy,0,0
39250,setting,0,0
39251,.,0,0
39252,Both,0,0
39253,MR,0,0
39254,and,0,0
39255,RCD,0,0
39256,programs,0,0
39257,were,0,0
39258,effective,0,0
39259,.,0,0
39260,Extracorporeal,0,0
39261,shock,0,0
39262,wave,0,1
39263,therapy,0,0
39264,(,0,0
39265,ESWT,0,0
39266,),0,0
39267,in,0,0
39268,patients,0,0
39269,with,0,0
39270,chronic,0,0
39271,proximal,0,0
39272,plantar,0,0
39273,fasciitis,0,0
39274,:,0,0
39275,a,0,0
39276,2-year,0,0
39277,follow-up,0,0
39278,.,0,0
39279,The,0,0
39280,aim,0,0
39281,of,0,0
39282,this,0,0
39283,study,0,0
39284,was,0,0
39285,to,0,0
39286,compare,0,0
39287,the,0,0
39288,effect,0,0
39289,of,0,0
39290,extracorporeal,0,0
39291,shock,0,0
39292,wave,0,1
39293,therapy,0,0
39294,(,0,0
39295,ESWT,0,0
39296,),0,0
39297,in,0,0
39298,patients,0,0
39299,with,0,0
39300,chronically,0,0
39301,painful,0,0
39302,proximal,0,0
39303,plantar,0,1
39304,fasciitis,0,0
39305,with,0,0
39306,a,0,0
39307,further,0,0
39308,conventional,0,0
39309,conservative,0,0
39310,treatment,0,0
39311,.,0,0
39312,Forty-seven,0,0
39313,patients,0,0
39314,(,0,0
39315,49,0,0
39316,feet,0,0
39317,),0,0
39318,with,0,0
39319,a,0,0
39320,previously,0,0
39321,unsuccessful,0,0
39322,nonsurgical,0,0
39323,treatment,0,0
39324,of,0,0
39325,at,0,0
39326,least,0,0
39327,6,0,0
39328,months,0,0
39329,were,0,0
39330,randomized,0,0
39331,to,0,0
39332,two,0,0
39333,groups,0,0
39334,.,0,0
39335,Heel,0,0
39336,cups,0,0
39337,had,0,0
39338,to,0,0
39339,be,0,0
39340,worn,0,0
39341,throughout,0,0
39342,the,0,0
39343,study,0,0
39344,.,0,0
39345,Group,0,0
39346,1,0,0
39347,(,0,0
39348,25,0,0
39349,heels,0,1
39350,),0,0
39351,was,0,0
39352,treated,0,0
39353,immediately,0,0
39354,with,0,0
39355,three,0,0
39356,sessions,0,0
39357,of,0,0
39358,ESWT,0,0
39359,(,0,0
39360,3000,0,0
39361,shock,0,0
39362,waves/session,0,0
39363,of,0,0
39364,0.2,0,0
39365,mJ/mm2,0,0
39366,),0,0
39367,at,0,0
39368,weekly,0,0
39369,intervals,0,0
39370,.,0,0
39371,The,0,0
39372,patients,0,0
39373,of,0,0
39374,group,0,0
39375,2,0,0
39376,(,0,0
39377,24,0,0
39378,heels,0,1
39379,),0,0
39380,continued,0,0
39381,nonsurgical,0,0
39382,treatment,0,0
39383,(,0,0
39384,iontophoresis,0,0
39385,with,0,0
39386,diclofenac,0,0
39387,and,0,0
39388,an,0,0
39389,oral,0,0
39390,nonsteroidal,0,0
39391,anti-inflammatory,0,0
39392,drug,0,0
39393,),0,0
39394,for,0,0
39395,12,0,0
39396,weeks,0,0
39397,.,0,0
39398,After,0,0
39399,this,0,0
39400,period,0,0
39401,they,0,0
39402,were,0,0
39403,treated,0,0
39404,using,0,0
39405,the,0,0
39406,protocol,0,0
39407,of,0,0
39408,group,0,0
39409,1,0,0
39410,.,0,0
39411,No,0,0
39412,significant,0,0
39413,difference,0,0
39414,of,0,0
39415,pain,1,1
39416,and,1,1
39417,walking,1,1
39418,time,1,1
39419,after,0,0
39420,further,0,0
39421,nonsurgical,0,0
39422,treatment,0,0
39423,(,0,0
39424,3,0,0
39425,months,0,0
39426,),0,0
39427,was,0,0
39428,seen,0,0
39429,in,0,0
39430,group,0,0
39431,2,0,0
39432,.,0,0
39433,At,0,0
39434,12,0,0
39435,weeks,0,0
39436,after,0,0
39437,ESWT,0,0
39438,",",0,0
39439,the,0,0
39440,pain,1,1
39441,estimation,1,0
39442,on,1,0
39443,the,1,0
39444,visual,1,1
39445,analogue,1,1
39446,scale,1,1
39447,(,1,0
39448,VAS,1,1
39449,),1,0
39450,for,1,0
39451,activities,1,1
39452,of,1,0
39453,daily,1,0
39454,living,1,0
39455,diminished,0,1
39456,significantly,0,0
39457,by,0,0
39458,62.9,0,0
39459,%,0,0
39460,in,0,0
39461,group,0,0
39462,1,0,0
39463,and,0,0
39464,by,0,0
39465,63.0,0,0
39466,%,0,0
39467,in,0,0
39468,group,0,0
39469,2,0,0
39470,.,0,0
39471,The,0,0
39472,comfortable,1,1
39473,walking,1,1
39474,time,1,1
39475,had,0,0
39476,increased,0,0
39477,significantly,0,0
39478,in,0,0
39479,both,0,0
39480,groups,0,0
39481,.,0,0
39482,Two,0,0
39483,years,0,0
39484,after,0,0
39485,ESWT,0,0
39486,",",0,0
39487,pain,1,1
39488,during,1,0
39489,activities,1,1
39490,of,1,0
39491,daily,1,0
39492,living,1,0
39493,decreased,0,0
39494,by,0,0
39495,94,0,0
39496,%,0,0
39497,in,0,0
39498,group,0,0
39499,1,0,0
39500,and,0,0
39501,by,0,0
39502,90,0,0
39503,%,0,0
39504,in,0,0
39505,group,0,0
39506,2,0,0
39507,on,0,0
39508,the,0,0
39509,VAS,0,0
39510,and,0,0
39511,the,0,0
39512,comfortable,1,1
39513,walking,1,1
39514,time,1,1
39515,had,0,0
39516,increased,0,0
39517,significantly,0,0
39518,in,0,0
39519,both,0,0
39520,groups,0,0
39521,.,0,0
39522,Nonnucleoside,0,1
39523,reverse,0,0
39524,transcriptase,0,0
39525,inhibitor-containing,0,0
39526,regimens,0,0
39527,are,0,0
39528,associated,0,0
39529,with,0,0
39530,increased,0,0
39531,satisfaction,1,1
39532,with,1,0
39533,sexual,1,1
39534,life,1,1
39535,.,1,0
39536,Effect,0,0
39537,of,0,0
39538,a,0,0
39539,carbohydrate-protein,0,0
39540,supplement,0,0
39541,on,0,0
39542,endurance,1,1
39543,performance,1,1
39544,during,0,0
39545,exercise,0,0
39546,of,0,0
39547,varying,0,0
39548,intensity,0,0
39549,.,0,0
39550,Increasing,0,0
39551,the,0,0
39552,plasma,0,1
39553,glucose,0,1
39554,and,0,1
39555,insulin,0,1
39556,concentrations,0,1
39557,during,0,0
39558,prolonged,0,1
39559,variable,0,0
39560,intensity,0,1
39561,exercise,0,0
39562,by,0,0
39563,supplementing,0,0
39564,with,0,0
39565,carbohydrate,0,0
39566,has,0,0
39567,been,0,0
39568,found,0,0
39569,to,0,0
39570,spare,0,0
39571,muscle,0,1
39572,glycogen,0,1
39573,and,0,0
39574,increase,0,1
39575,aerobic,1,0
39576,endurance,1,0
39577,.,1,0
39578,Furthermore,0,0
39579,",",0,0
39580,the,0,0
39581,addition,0,0
39582,of,0,0
39583,protein,0,0
39584,to,0,0
39585,a,0,0
39586,carbohydrate,0,0
39587,supplement,0,0
39588,will,0,0
39589,enhance,0,0
39590,the,0,0
39591,insulin,0,1
39592,response,0,1
39593,of,0,0
39594,a,0,0
39595,carbohydrate,0,0
39596,supplement,0,0
39597,.,0,0
39598,The,0,0
39599,purpose,0,0
39600,of,0,0
39601,the,0,0
39602,present,0,0
39603,study,0,0
39604,was,0,0
39605,to,0,0
39606,compare,0,0
39607,the,0,0
39608,effects,0,0
39609,of,0,0
39610,a,0,0
39611,carbohydrate,0,0
39612,and,0,0
39613,a,0,0
39614,carbohydrate-protein,0,0
39615,supplement,0,0
39616,on,0,0
39617,aerobic,1,0
39618,endurance,1,0
39619,performance,1,1
39620,.,1,0
39621,Nine,0,1
39622,trained,0,0
39623,cyclists,0,0
39624,exercised,0,0
39625,on,0,0
39626,3,0,0
39627,separate,0,0
39628,occasions,0,0
39629,at,0,0
39630,intensities,0,0
39631,that,0,0
39632,varied,0,0
39633,between,0,0
39634,45,0,0
39635,%,0,0
39636,and,0,0
39637,75,0,0
39638,%,0,0
39639,VO2max,0,0
39640,for,0,0
39641,3,0,0
39642,h,0,0
39643,and,0,0
39644,then,0,0
39645,at,0,0
39646,85,0,0
39647,%,0,0
39648,VO2max,0,0
39649,until,0,0
39650,fatigued,0,0
39651,.,0,0
39652,Supplements,0,0
39653,(,0,0
39654,200,0,0
39655,ml,0,0
39656,),0,0
39657,were,0,0
39658,provided,0,0
39659,every,0,0
39660,20,0,0
39661,min,0,0
39662,and,0,0
39663,consisted,0,0
39664,of,0,0
39665,placebo,0,0
39666,",",0,0
39667,a,0,0
39668,7.75,0,0
39669,%,0,0
39670,carbohydrate,0,0
39671,solution,0,0
39672,",",0,0
39673,and,0,0
39674,a,0,0
39675,7.75,0,0
39676,%,0,0
39677,carbohydrate/1.94,0,0
39678,%,0,0
39679,protein,0,1
39680,solution,0,0
39681,.,0,0
39682,Treatments,0,0
39683,were,0,0
39684,administered,0,0
39685,using,0,0
39686,a,0,0
39687,double-blind,0,0
39688,randomized,0,0
39689,design,0,0
39690,.,0,0
39691,Carbohydrate,0,0
39692,supplementation,0,0
39693,significantly,0,0
39694,increased,0,0
39695,time,1,1
39696,to,1,0
39697,exhaustion,1,1
39698,(,0,0
39699,carbohydrate,0,0
39700,19.7,0,0
39701,+/-,0,0
39702,4.6,0,0
39703,min,0,0
39704,vs.,0,0
39705,placebo,0,0
39706,12.7,0,0
39707,+/-,0,0
39708,3.1,0,0
39709,min,0,0
39710,),0,0
39711,",",0,0
39712,while,0,0
39713,the,0,0
39714,addition,0,0
39715,of,0,0
39716,protein,0,0
39717,enhanced,0,0
39718,the,0,0
39719,effect,0,0
39720,of,0,0
39721,the,0,0
39722,carbohydrate,0,0
39723,supplement,0,0
39724,(,0,0
39725,carbohydrate-protein,0,0
39726,26.9,0,0
39727,+/-,0,0
39728,4.5,0,0
39729,min,0,0
39730,",",0,0
39731,p,0,0
39732,<,0,0
39733,.05,0,0
39734,),0,0
39735,.,0,0
39736,Blood,1,1
39737,glucose,1,1
39738,and,1,1
39739,plasma,1,1
39740,insulin,1,1
39741,levels,1,1
39742,were,0,0
39743,elevated,0,0
39744,above,0,0
39745,placebo,0,0
39746,during,0,0
39747,carbohydrate,0,0
39748,and,0,0
39749,carbohydrate-protein,0,1
39750,supplementation,0,0
39751,",",0,0
39752,but,0,0
39753,no,0,0
39754,differences,0,0
39755,were,0,0
39756,found,0,0
39757,between,0,0
39758,the,0,0
39759,carbohydrate,0,0
39760,and,0,0
39761,carbohydrate-protein,0,0
39762,treatments,0,0
39763,.,0,0
39764,In,0,0
39765,summary,0,0
39766,",",0,0
39767,we,0,0
39768,found,0,0
39769,that,0,0
39770,the,0,0
39771,addition,0,0
39772,of,0,0
39773,protein,0,0
39774,to,0,0
39775,a,0,0
39776,carbohydrate,0,0
39777,supplement,0,0
39778,enhanced,0,0
39779,aerobic,1,0
39780,endurance,1,1
39781,performance,1,1
39782,above,0,0
39783,that,0,0
39784,which,0,0
39785,occurred,0,0
39786,with,0,0
39787,carbohydrate,0,0
39788,alone,0,0
39789,",",0,0
39790,but,0,0
39791,the,0,0
39792,reason,0,0
39793,for,0,0
39794,this,0,0
39795,improvement,0,1
39796,in,0,0
39797,performance,0,1
39798,was,0,0
39799,not,0,0
39800,evident,0,0
39801,.,0,0
39802,The,0,0
39803,long-term,0,0
39804,effect,0,0
39805,of,0,0
39806,oxandrolone,0,0
39807,on,0,0
39808,hepatic,0,1
39809,acute,0,0
39810,phase,0,0
39811,proteins,0,0
39812,in,0,0
39813,severely,0,0
39814,burned,0,0
39815,children,0,0
39816,.,0,0
39817,BACKGROUND,0,0
39818,Acute,0,0
39819,phase,0,0
39820,protein,0,0
39821,production,0,1
39822,is,0,0
39823,a,0,0
39824,hallmark,0,0
39825,of,0,0
39826,severe,0,1
39827,burns,0,0
39828,.,0,0
39829,We,0,0
39830,wondered,0,0
39831,whether,0,0
39832,anabolic,0,1
39833,treatment,0,0
39834,with,0,0
39835,oxandrolone,0,0
39836,would,0,0
39837,affect,0,0
39838,these,0,0
39839,proteins,0,0
39840,.,0,0
39841,METHODS,0,0
39842,Thirty-five,0,0
39843,children,0,0
39844,with,0,0
39845,>,0,0
39846,or,0,0
39847,=40,0,0
39848,%,0,0
39849,total,0,0
39850,body,0,1
39851,surface,0,0
39852,area,0,1
39853,burns,0,1
39854,were,0,0
39855,randomized,0,0
39856,to,0,0
39857,receive,0,0
39858,either,0,0
39859,placebo,0,0
39860,or,0,0
39861,oxandrolone,0,0
39862,(,0,0
39863,0.1,0,0
39864,mg/kg,0,0
39865,by,0,0
39866,mouth,0,0
39867,twice,0,0
39868,daily,0,0
39869,),0,0
39870,from,0,0
39871,postoperative,0,0
39872,day,0,0
39873,5,0,0
39874,to,0,0
39875,1,0,0
39876,year,0,0
39877,postburn,0,0
39878,.,0,0
39879,Levels,0,1
39880,of,0,0
39881,constitutive,0,1
39882,proteins,0,0
39883,and,0,0
39884,acute,0,1
39885,phase,0,0
39886,proteins,0,0
39887,were,0,0
39888,measured,0,0
39889,at,0,0
39890,admission,0,0
39891,;,0,0
39892,at,0,0
39893,discharge,0,0
39894,;,0,0
39895,and,0,0
39896,at,0,0
39897,6,0,0
39898,",",0,0
39899,9,0,0
39900,",",0,0
39901,and,0,0
39902,12,0,0
39903,months,0,0
39904,after,0,0
39905,burn,0,0
39906,.,0,0
39907,Total,1,0
39908,albumin,1,1
39909,supplementation,1,0
39910,and,1,0
39911,hepatic,1,1
39912,transaminases,1,1
39913,were,0,0
39914,also,0,0
39915,assessed,0,0
39916,.,0,0
39917,RESULTS,0,0
39918,Constitutive,1,1
39919,proteins,1,0
39920,such,1,0
39921,as,1,0
39922,albumin,1,1
39923,",",1,0
39924,prealbumin,1,1
39925,",",1,1
39926,and,1,1
39927,retinol-binding,1,1
39928,protein,1,1
39929,levels,1,1
39930,increased,0,0
39931,(,0,0
39932,p,0,0
39933,<,0,0
39934,0.05,0,0
39935,),0,0
39936,",",0,0
39937,and,0,1
39938,acute,1,1
39939,phase,1,0
39940,proteins,1,0
39941,such,1,0
39942,as,1,0
39943,alpha,1,0
39944,1-acid,1,1
39945,glycoprotein,1,0
39946,",",1,0
39947,C3,1,1
39948,complement,1,1
39949,",",1,0
39950,alpha,1,1
39951,2-macroglobulin,1,0
39952,",",1,0
39953,and,1,1
39954,fibrinogen,1,1
39955,levels,1,1
39956,significantly,0,0
39957,decreased,0,0
39958,in,0,0
39959,the,0,0
39960,oxandrolone,0,0
39961,group,0,0
39962,compared,0,0
39963,with,0,0
39964,placebo,0,0
39965,(,0,0
39966,p,0,0
39967,<,0,0
39968,0.05,0,0
39969,),0,0
39970,.,0,0
39971,Albumin,1,1
39972,supplementation,1,0
39973,during,1,0
39974,the,1,0
39975,acute,1,0
39976,hospitalization,1,1
39977,was,0,0
39978,reduced,0,0
39979,in,0,0
39980,the,0,0
39981,oxandrolone,0,0
39982,group,0,0
39983,.,0,0
39984,Hepatic,1,0
39985,transaminases,1,1
39986,remained,0,0
39987,within,0,0
39988,normal,1,0
39989,levels,1,1
39990,.,1,0
39991,CONCLUSION,0,0
39992,Treatment,0,0
39993,with,0,0
39994,oxandrolone,0,0
39995,in,0,0
39996,severe,0,1
39997,burns,0,0
39998,significantly,0,0
39999,increases,0,1
40000,constitutive,1,1
40001,protein,1,1
40002,and,0,0
40003,reduces,0,0
40004,acute,1,1
40005,phase,1,0
40006,protein,1,0
40007,levels,1,1
40008,.,1,0
40009,Left,0,1
40010,internal,0,0
40011,thoracic,0,0
40012,artery-radial,0,0
40013,artery,0,1
40014,composite,0,1
40015,grafts,0,0
40016,as,0,0
40017,the,0,0
40018,technique,0,0
40019,of,0,0
40020,choice,0,0
40021,for,0,0
40022,myocardial,0,1
40023,revascularization,0,0
40024,in,0,0
40025,elderly,0,0
40026,patients,0,0
40027,:,0,0
40028,a,0,0
40029,prospective,0,0
40030,randomized,0,0
40031,evaluation,0,0
40032,.,0,0
40033,OBJECTIVES,0,0
40034,The,0,0
40035,technique,0,0
40036,of,0,0
40037,choice,0,0
40038,for,0,0
40039,myocardial,0,1
40040,revascularization,0,0
40041,in,0,0
40042,elderly,0,0
40043,patients,0,0
40044,remains,0,0
40045,a,0,0
40046,debated,0,0
40047,issue,0,0
40048,.,0,0
40049,We,0,0
40050,evaluated,0,0
40051,the,0,0
40052,potential,0,0
40053,advantages,0,0
40054,of,0,0
40055,the,0,0
40056,use,0,0
40057,of,0,0
40058,left,0,1
40059,internal,0,0
40060,thoracic,0,0
40061,artery-radial,0,0
40062,artery,0,1
40063,composite,0,1
40064,grafts,0,0
40065,compared,0,0
40066,with,0,0
40067,conventional,0,0
40068,coronary,0,0
40069,artery,0,1
40070,bypass,0,0
40071,grafts,0,1
40072,in,0,0
40073,elderly,0,0
40074,patients,0,0
40075,.,0,0
40076,METHODS,0,0
40077,We,0,0
40078,prospectively,0,0
40079,enrolled,0,0
40080,160,0,0
40081,patients,0,0
40082,aged,0,0
40083,more,0,0
40084,than,0,0
40085,70,0,0
40086,years,0,0
40087,scheduled,0,0
40088,to,0,0
40089,undergo,0,0
40090,isolated,0,0
40091,myocardial,0,1
40092,revascularization,0,0
40093,.,0,0
40094,Patients,0,0
40095,were,0,0
40096,assigned,0,0
40097,at,0,0
40098,random,0,0
40099,to,0,0
40100,group,0,0
40101,1,0,0
40102,",",0,0
40103,80,0,0
40104,patients,0,0
40105,undergoing,0,0
40106,total,0,1
40107,arterial,0,1
40108,revascularization,0,1
40109,(,0,0
40110,left,0,1
40111,internal,0,0
40112,thoracic,0,0
40113,artery,0,1
40114,on,0,0
40115,left,0,1
40116,anterior,0,0
40117,descending,0,1
40118,coronary,0,0
40119,artery,0,1
40120,plus,0,0
40121,radial,0,1
40122,artery,0,1
40123,),0,0
40124,",",0,0
40125,or,0,0
40126,group,0,0
40127,2,0,0
40128,",",0,0
40129,80,0,0
40130,patients,0,0
40131,undergoing,0,0
40132,standard,0,0
40133,coronary,0,0
40134,artery,0,1
40135,bypass,0,0
40136,graft,0,1
40137,surgery,0,0
40138,(,0,0
40139,left,0,1
40140,internal,0,0
40141,thoracic,0,0
40142,artery,0,1
40143,on,0,0
40144,left,0,1
40145,anterior,0,0
40146,descending,0,1
40147,coronary,0,0
40148,artery,0,1
40149,plus,0,0
40150,saphenous,0,1
40151,veins,0,0
40152,),0,0
40153,.,0,0
40154,The,0,0
40155,radial,0,1
40156,artery,0,0
40157,was,0,0
40158,used,0,0
40159,in,0,0
40160,all,0,0
40161,cases,0,0
40162,as,0,0
40163,a,0,0
40164,composite,0,1
40165,Y-graft,0,0
40166,.,0,0
40167,RESULTS,0,0
40168,Preoperative,0,1
40169,characteristics,0,1
40170,and,0,1
40171,risk,0,1
40172,factors,0,1
40173,(,0,0
40174,EuroSCORE,0,0
40175,:,0,0
40176,group,0,0
40177,1,0,0
40178,=,0,0
40179,7.9,0,0
40180,vs,0,0
40181,group,0,0
40182,2,0,0
40183,=,0,0
40184,8.1,0,0
40185,),0,0
40186,",",0,0
40187,number,1,1
40188,of,1,0
40189,grafted,1,0
40190,coronary,1,0
40191,vessels,1,1
40192,(,0,0
40193,group,0,0
40194,1,0,0
40195,=,0,0
40196,2.4,0,0
40197,vs,0,0
40198,group,0,0
40199,2,0,0
40200,=,0,0
40201,2.5,0,0
40202,),0,0
40203,",",0,0
40204,aortic,1,1
40205,crossclamping,1,1
40206,time,1,1
40207,(,0,0
40208,group,0,0
40209,1,0,0
40210,=,0,0
40211,37,0,0
40212,+/-,0,0
40213,7,0,0
40214,minutes,0,0
40215,vs,0,0
40216,group,0,0
40217,2,0,0
40218,=,0,0
40219,38,0,0
40220,+/-,0,0
40221,7,0,0
40222,minutes,0,0
40223,),0,0
40224,",",0,0
40225,ventilation,1,1
40226,time,1,1
40227,(,0,0
40228,group,0,0
40229,1,0,0
40230,=,0,0
40231,22,0,0
40232,+/-,0,0
40233,12,0,0
40234,hours,0,0
40235,vs,0,0
40236,group,0,0
40237,2,0,0
40238,=,0,0
40239,23,0,0
40240,+/-,0,0
40241,11,0,0
40242,hours,0,0
40243,),0,0
40244,",",0,0
40245,intensive,1,0
40246,care,1,0
40247,unit,1,1
40248,stay,1,1
40249,(,0,0
40250,group,0,0
40251,1,0,0
40252,=,0,0
40253,39,0,0
40254,+/-,0,0
40255,10,0,0
40256,hours,0,0
40257,vs,0,0
40258,group,0,0
40259,2,0,0
40260,=,0,0
40261,40,0,0
40262,+/-,0,0
40263,9,0,0
40264,hours,0,0
40265,),0,0
40266,",",0,0
40267,and,0,1
40268,hospital,1,1
40269,mortality,1,1
40270,(,0,0
40271,group,0,0
40272,1,0,0
40273,=,0,0
40274,3.8,0,0
40275,%,0,0
40276,vs,0,0
40277,group,0,0
40278,2,0,0
40279,=,0,0
40280,5,0,0
40281,%,0,0
40282,),0,0
40283,were,0,0
40284,comparable,0,0
40285,between,0,0
40286,the,0,0
40287,groups,0,0
40288,.,0,0
40289,Comparison,0,0
40290,between,0,0
40291,the,0,0
40292,2,0,0
40293,groups,0,0
40294,in,0,0
40295,terms,0,0
40296,of,0,0
40297,early,1,0
40298,postoperative,1,1
40299,complications,1,1
40300,showed,0,0
40301,a,0,0
40302,higher,0,0
40303,incidence,0,1
40304,of,0,1
40305,cerebrovascular,1,1
40306,accidents,1,0
40307,in,0,0
40308,group,0,0
40309,2,0,0
40310,(,0,0
40311,group,0,0
40312,1,0,0
40313,=,0,0
40314,0,0,0
40315,patients,0,0
40316,vs,0,0
40317,group,0,0
40318,2,0,0
40319,=,0,0
40320,4,0,0
40321,patients,0,0
40322,",",0,0
40323,5,0,0
40324,%,0,0
40325,),0,0
40326,.,0,0
40327,At,0,0
40328,a,0,0
40329,mean,0,1
40330,follow-up,0,0
40331,of,0,0
40332,16,0,0
40333,+/-,0,0
40334,3,0,0
40335,months,0,0
40336,",",0,0
40337,patients,0,0
40338,in,0,0
40339,group,0,0
40340,1,0,0
40341,showed,0,0
40342,superior,0,0
40343,clinical,0,0
40344,results,0,0
40345,with,0,0
40346,a,0,0
40347,lower,0,0
40348,incidence,0,1
40349,of,0,1
40350,graft,1,1
40351,occlusion,1,1
40352,(,0,0
40353,group,0,0
40354,1,0,0
40355,=,0,0
40356,2,0,0
40357,vs,0,0
40358,group,0,0
40359,2,0,0
40360,=,0,0
40361,11,0,0
40362,;,0,0
40363,P,0,0
40364,=.06,0,0
40365,),0,0
40366,and,0,0
40367,angina,1,1
40368,recurrence,1,1
40369,(,0,0
40370,group,0,0
40371,1,0,0
40372,=,0,0
40373,2,0,0
40374,patients,0,0
40375,vs,0,0
40376,group,0,0
40377,2,0,0
40378,=,0,0
40379,12,0,0
40380,patients,0,0
40381,;,0,0
40382,P,0,0
40383,=.03,0,0
40384,),0,0
40385,.,0,0
40386,Multivariate,0,0
40387,analysis,0,0
40388,identified,0,0
40389,saphenous,0,1
40390,vein,0,0
40391,grafts,0,0
40392,as,0,0
40393,independent,0,0
40394,predictors,0,0
40395,for,0,0
40396,graft,1,1
40397,occlusion,1,1
40398,and,1,1
40399,angina,1,1
40400,recurrence,1,1
40401,.,1,0
40402,CONCLUSIONS,0,0
40403,Left,0,1
40404,internal,0,0
40405,thoracic,0,0
40406,artery-radial,0,0
40407,artery,0,1
40408,composite,0,1
40409,grafts,0,0
40410,proved,0,0
40411,to,0,0
40412,be,0,0
40413,a,0,0
40414,safe,0,0
40415,procedure,0,0
40416,in,0,0
40417,elderly,0,0
40418,patients,0,0
40419,.,0,0
40420,It,0,0
40421,improved,0,0
40422,the,0,0
40423,clinical,0,0
40424,outcome,0,1
40425,",",0,0
40426,providing,0,0
40427,a,0,0
40428,significantly,0,0
40429,higher,0,0
40430,graft,0,1
40431,patency,0,1
40432,rate,0,1
40433,and,0,0
40434,a,0,0
40435,lower,0,0
40436,incidence,0,1
40437,of,0,1
40438,late,0,0
40439,cardiac,0,0
40440,events,0,1
40441,.,0,0
40442,Body,0,0
40443,asymmetry,0,1
40444,affects,0,0
40445,conjugate,1,0
40446,lateral,1,0
40447,eye,1,0
40448,movement,1,1
40449,.,1,0
40450,A.,0,1
40451,H.,0,1
40452,Baker,0,0
40453,(,0,0
40454,1989,0,0
40455,),0,0
40456,and,0,0
40457,A.,0,1
40458,H.,0,1
40459,Baker,0,0
40460,and,0,0
40461,A.,0,1
40462,I.,0,0
40463,Ledner,0,0
40464,(,0,0
40465,1990,0,0
40466,),0,0
40467,reported,0,0
40468,that,0,0
40469,asymmetrical,0,0
40470,visual,0,1
40471,stimulation,0,0
40472,affects,0,0
40473,conjugate,1,0
40474,lateral,1,0
40475,eye,1,0
40476,movement,1,1
40477,(,1,0
40478,CLEM,1,1
40479,),1,0
40480,.,1,0
40481,In,0,0
40482,the,0,0
40483,present,0,0
40484,article,0,0
40485,",",0,0
40486,the,0,0
40487,authors,0,0
40488,explored,0,0
40489,whether,0,0
40490,asymmetrical,0,0
40491,body,0,1
40492,position,0,0
40493,similarly,0,0
40494,affects,0,0
40495,CLEM,0,0
40496,.,0,0
40497,The,0,0
40498,authors,0,0
40499,assessed,0,0
40500,CLEMs,0,0
40501,twice,0,0
40502,in,0,0
40503,a,0,0
40504,counterbalanced,0,0
40505,design,0,0
40506,.,0,0
40507,In,0,0
40508,the,0,0
40509,control,0,0
40510,(,0,0
40511,symmetric,0,0
40512,),0,0
40513,condition,0,0
40514,",",0,0
40515,each,0,0
40516,participant,0,0
40517,sat,0,1
40518,in,0,0
40519,a,0,0
40520,completely,0,0
40521,symmetrical,0,0
40522,position,0,0
40523,facing,0,0
40524,a,0,0
40525,wall,0,0
40526,devoid,0,0
40527,of,0,0
40528,any,0,0
40529,asymmetrical,0,0
40530,features,0,0
40531,.,0,0
40532,In,0,0
40533,the,0,0
40534,experimental,0,0
40535,(,0,0
40536,asymmetrical,0,0
40537,),0,0
40538,condition,0,0
40539,",",0,0
40540,half,0,0
40541,the,0,0
40542,participants,0,0
40543,rotated,0,0
40544,their,0,0
40545,heads,0,0
40546,68,0,0
40547,degrees,0,0
40548,clockwise,0,0
40549,relative,0,0
40550,to,0,0
40551,their,0,0
40552,bodies,0,0
40553,to,0,0
40554,face,0,0
40555,the,0,0
40556,experimenter,0,0
40557,",",0,0
40558,and,0,0
40559,the,0,0
40560,other,0,0
40561,half,0,0
40562,rotated,0,0
40563,their,0,0
40564,heads,0,0
40565,68,0,0
40566,degrees,0,0
40567,counterclockwise,0,0
40568,",",0,0
40569,also,0,0
40570,to,0,0
40571,face,0,0
40572,the,0,0
40573,experimenter,0,0
40574,.,0,0
40575,CLEM,0,1
40576,was,0,0
40577,predominantly,0,0
40578,toward,0,0
40579,the,0,0
40580,body,0,1
40581,'s,0,0
40582,position,0,0
40583,in,0,0
40584,the,0,0
40585,asymmetrical,0,0
40586,condition,0,0
40587,rather,0,0
40588,than,0,0
40589,toward,0,0
40590,the,0,0
40591,body,0,1
40592,'s,0,0
40593,position,0,0
40594,in,0,0
40595,the,0,0
40596,symmetrical,0,0
40597,condition,0,0
40598,.,0,0
40599,Strength,0,1
40600,of,0,0
40601,vital,0,1
40602,force,0,1
40603,in,0,0
40604,classical,0,0
40605,homeopathy,0,0
40606,:,0,0
40607,bio-psycho-social-spiritual,0,1
40608,correlates,0,0
40609,within,0,0
40610,a,0,0
40611,complex,0,0
40612,systems,0,0
40613,context,0,0
40614,.,0,0
40615,OBJECTIVE,0,0
40616,To,0,0
40617,explore,0,0
40618,associations,0,0
40619,between,0,0
40620,a,0,0
40621,global,0,1
40622,rating,0,1
40623,for,0,0
40624,the,0,0
40625,classical,0,0
40626,homeopathic,0,0
40627,construct,0,0
40628,of,0,0
40629,vital,0,1
40630,force,0,1
40631,and,0,1
40632,clinician,0,1
40633,and,0,1
40634,patient,0,1
40635,ratings,0,1
40636,on,0,0
40637,previously,0,0
40638,validated,0,0
40639,bio-psycho-social-spiritual,0,0
40640,questionnaires,0,0
40641,.,0,0
40642,METHODS,0,0
40643,Sixty-two,0,0
40644,(,0,0
40645,62,0,0
40646,),0,0
40647,community-recruited,0,0
40648,patients,0,0
40649,with,0,0
40650,fibromyalgia,0,0
40651,(,0,0
40652,FM,0,1
40653,),0,0
40654,were,0,0
40655,assessed,0,0
40656,at,0,0
40657,baseline,0,0
40658,prior,0,0
40659,to,0,0
40660,a,0,0
40661,clinical,0,0
40662,trial,0,0
40663,of,0,0
40664,individualized,0,0
40665,homeopathy,0,0
40666,.,0,0
40667,Two,0,0
40668,homeopaths,0,0
40669,jointly,0,0
40670,performed,0,0
40671,case-taking,0,0
40672,interviews,0,0
40673,.,0,0
40674,A,0,0
40675,conventional,0,0
40676,medical,0,0
40677,provider,0,0
40678,independently,0,0
40679,evaluated,0,0
40680,patients,0,0
40681,with,0,0
40682,a,0,0
40683,standardized,0,0
40684,history,0,0
40685,and,0,0
40686,physical,0,1
40687,examination,0,0
40688,.,0,0
40689,Homeopaths,0,0
40690,rated,0,0
40691,each,0,0
40692,patient,0,1
40693,'s,0,0
40694,vital,0,1
40695,force,0,1
40696,(,0,0
40697,five-point,0,1
40698,Likert,0,1
40699,scale,0,1
40700,",",0,0
40701,with,0,0
40702,1,0,0
40703,=,0,0
40704,very,0,0
40705,weak,0,0
40706,to,0,0
40707,5,0,0
40708,=,0,0
40709,very,0,0
40710,strong,0,0
40711,),0,0
40712,.,0,0
40713,Homeopaths,0,0
40714,and,0,0
40715,the,0,0
40716,conventional,0,0
40717,medical,0,0
40718,provider,0,0
40719,rated,0,0
40720,their,0,0
40721,Clinical,1,0
40722,Global,1,1
40723,Impression,1,1
40724,(,1,0
40725,CGI,1,1
40726,),1,0
40727,of,1,0
40728,the,1,0
40729,severity,1,1
40730,of,1,0
40731,illness,1,1
40732,(,0,0
40733,1,0,0
40734,=,0,0
40735,normal,0,0
40736,;,0,0
40737,7,0,0
40738,=,0,0
40739,among,0,0
40740,the,0,0
40741,most,0,0
40742,extremely,0,0
40743,ill,0,0
40744,),0,0
40745,.,0,0
40746,Patients,0,0
40747,completed,0,0
40748,self-rating,1,1
40749,scales,1,1
40750,on,1,0
40751,pain,1,1
40752,",",1,0
40753,global,1,1
40754,health,1,1
40755,",",1,0
40756,mood,1,1
40757,",",1,1
40758,quality,1,1
40759,of,1,1
40760,life,1,1
40761,",",1,0
40762,coping,1,1
40763,style,1,1
40764,",",1,0
40765,health,1,1
40766,locus,1,1
40767,of,1,1
40768,control,1,0
40769,",",1,0
40770,multidimensional,1,1
40771,well-being,1,1
40772,",",1,0
40773,spirituality,1,1
40774,",",1,1
40775,sense,1,1
40776,of,1,1
40777,coherence,1,0
40778,",",1,0
40779,positive,1,1
40780,states,1,0
40781,of,1,0
40782,mind,1,0
40783,",",1,0
40784,and,1,1
40785,social,1,1
40786,desirability,1,1
40787,.,1,0
40788,RESULTS,0,0
40789,Greater,0,0
40790,vital,1,1
40791,force,1,1
40792,ratings,1,1
40793,(,0,0
40794,mean,0,0
40795,2.9,0,0
40796,standard,0,0
40797,deviation,0,0
40798,[,0,0
40799,SD,0,0
40800,],0,0
40801,0.6,0,0
40802,),0,0
40803,correlated,0,0
40804,moderately,0,0
40805,(,0,0
40806,p,0,0
40807,<,0,0
40808,or,0,0
40809,=,0,0
40810,0.005,0,0
40811,),0,0
40812,with,0,0
40813,less,0,0
40814,severe,0,1
40815,CGI,1,1
40816,illness,1,1
40817,ratings,0,1
40818,by,0,0
40819,the,0,0
40820,homeopaths,0,0
40821,(,0,0
40822,r,0,0
40823,=-0.59,0,0
40824,),0,0
40825,",",0,0
40826,decreased,0,0
40827,patient-rated,1,1
40828,mental,1,1
40829,confusion,1,1
40830,(,0,0
40831,r,0,0
40832,=-0.43,0,0
40833,),0,0
40834,",",0,0
40835,higher,0,1
40836,vigor,1,1
40837,(,0,0
40838,r,0,0
40839,=,0,0
40840,0.38,0,0
40841,),0,0
40842,",",0,0
40843,and,0,0
40844,greater,0,1
40845,positive,1,1
40846,states,1,0
40847,of,1,0
40848,mind,1,0
40849,(,0,0
40850,r,0,0
40851,=,0,0
40852,0.36,0,0
40853,),0,0
40854,.,0,0
40855,Vital,0,0
40856,force,0,1
40857,also,0,0
40858,showed,0,0
40859,correlations,0,0
40860,(,0,0
40861,p,0,0
40862,<,0,0
40863,0.05,0,0
40864,),0,0
40865,with,0,0
40866,lower,0,0
40867,CGI,1,1
40868,ratings,1,1
40869,by,0,0
40870,the,0,0
40871,conventional,0,0
40872,medical,0,0
40873,provider,0,0
40874,(,0,0
40875,r,0,0
40876,=-0.32,0,0
40877,),0,0
40878,",",0,0
40879,better,0,0
40880,selfrated,0,0
40881,quality,1,1
40882,of,1,0
40883,life,1,1
40884,(,0,0
40885,r,0,0
40886,=,0,0
40887,0.33,0,0
40888,),0,0
40889,",",0,0
40890,lesser,0,0
40891,fatigue,1,1
40892,(,0,0
40893,r,0,0
40894,=-0.31,0,0
40895,),0,0
40896,",",0,0
40897,better,1,0
40898,global,1,1
40899,health,1,1
40900,(,0,0
40901,r,0,0
40902,=,0,0
40903,0.29,0,0
40904,),0,0
40905,",",0,0
40906,greater,1,0
40907,sense,1,1
40908,of,1,1
40909,coherence,1,0
40910,(,0,0
40911,r,0,0
40912,=,0,0
40913,0.28,0,0
40914,),0,0
40915,",",0,0
40916,powerful-others,1,1
40917,health,1,1
40918,locus,1,1
40919,of,1,1
40920,control,1,0
40921,(,0,0
40922,r,0,0
40923,=,0,0
40924,0.27,0,0
40925,),0,0
40926,",",0,0
40927,increased,1,0
40928,emotional,1,1
40929,well-being,1,1
40930,(,0,0
40931,r,0,0
40932,=,0,0
40933,0.27,0,0
40934,),0,0
40935,",",0,0
40936,and,0,0
40937,higher,1,1
40938,social,1,1
40939,desirability,1,1
40940,(,0,0
40941,r,0,0
40942,=,0,0
40943,0.27,0,0
40944,),0,0
40945,",",0,0
40946,but,0,0
40947,not,0,0
40948,with,0,0
40949,age,0,0
40950,",",0,0
40951,pain,0,1
40952,",",0,1
40953,or,0,1
40954,illness,0,1
40955,duration,0,1
40956,.,0,0
40957,CONCLUSION,0,0
40958,Homeopathic,0,0
40959,vital,0,1
40960,force,0,1
40961,ratings,0,1
40962,reflect,0,0
40963,better,0,0
40964,perceived,0,1
40965,mental,0,1
40966,function,0,1
40967,",",0,0
40968,energy,0,1
40969,",",0,1
40970,and,0,1
40971,positive,0,1
40972,dimensions,0,1
40973,of,0,0
40974,the,0,0
40975,individual,0,0
40976,",",0,0
40977,beyond,0,0
40978,absence,0,0
40979,of,0,0
40980,disease,0,0
40981,.,0,0
40982,Brain,1,0
40983,activity,1,1
40984,correlates,0,0
40985,differentially,0,0
40986,with,0,0
40987,increasing,0,0
40988,temporal,0,0
40989,complexity,0,1
40990,of,0,0
40991,rhythms,0,1
40992,during,0,0
40993,initialisation,0,1
40994,",",0,0
40995,synchronisation,0,1
40996,",",0,1
40997,and,0,1
40998,continuation,0,1
40999,phases,0,0
41000,of,0,0
41001,paced,0,1
41002,finger,0,0
41003,tapping,0,1
41004,.,0,0
41005,Activity,1,1
41006,in,1,0
41007,parts,1,0
41008,of,1,0
41009,the,1,0
41010,human,1,0
41011,motor,1,1
41012,system,1,0
41013,has,0,0
41014,been,0,0
41015,shown,0,0
41016,to,0,0
41017,correlate,0,0
41018,with,0,0
41019,the,0,0
41020,complexity,0,0
41021,of,0,0
41022,performed,0,0
41023,motor,0,1
41024,sequences,0,0
41025,in,0,0
41026,terms,0,0
41027,of,0,0
41028,the,0,0
41029,number,0,1
41030,of,0,0
41031,limbs,0,0
41032,moved,0,0
41033,",",0,0
41034,number,0,1
41035,of,0,1
41036,movements,0,1
41037,",",0,0
41038,and,0,1
41039,number,0,1
41040,of,0,0
41041,trajectories,0,1
41042,.,0,0
41043,Here,0,0
41044,",",0,0
41045,we,0,0
41046,searched,0,0
41047,for,0,0
41048,activity,0,1
41049,correlating,0,0
41050,with,0,0
41051,temporal,0,0
41052,complexity,0,1
41053,",",0,0
41054,in,0,0
41055,terms,0,0
41056,of,0,0
41057,the,0,0
41058,number,0,1
41059,of,0,0
41060,different,0,0
41061,intervals,0,0
41062,produced,0,0
41063,in,0,0
41064,the,0,0
41065,sequence,0,0
41066,",",0,0
41067,using,0,0
41068,an,0,0
41069,overlearned,0,0
41070,tapping,0,1
41071,task,0,0
41072,.,0,0
41073,Our,0,0
41074,task,0,0
41075,was,0,0
41076,divided,0,0
41077,into,0,0
41078,three,0,0
41079,phases,0,0
41080,:,0,0
41081,movement,0,1
41082,selection,0,1
41083,and,0,1
41084,initiation,0,1
41085,(,0,1
41086,initiate,0,0
41087,),0,1
41088,",",0,0
41089,synchronisation,0,1
41090,of,0,1
41091,finger,0,0
41092,tapping,0,1
41093,with,0,0
41094,an,0,0
41095,external,0,0
41096,auditory,0,1
41097,cue,0,0
41098,(,0,0
41099,synchronise,0,0
41100,),0,1
41101,",",0,0
41102,and,0,1
41103,continued,0,0
41104,tapping,0,1
41105,in,0,0
41106,absence,0,0
41107,of,0,0
41108,the,0,0
41109,auditory,0,1
41110,pacer,0,0
41111,(,0,0
41112,continue,0,0
41113,),0,0
41114,.,0,0
41115,Comparisons,0,0
41116,between,0,0
41117,synchronisation,0,1
41118,and,0,1
41119,continuation,0,0
41120,showed,0,0
41121,a,0,0
41122,pattern,0,0
41123,in,0,0
41124,keeping,0,0
41125,with,0,0
41126,prior,0,0
41127,neuroimaging,0,0
41128,studies,0,0
41129,of,0,0
41130,paced,0,1
41131,finger,0,0
41132,tapping,0,1
41133,.,0,0
41134,Thus,0,0
41135,",",0,0
41136,activation,1,1
41137,of,1,0
41138,bilateral,1,0
41139,SMA,1,0
41140,and,1,1
41141,basal,1,1
41142,ganglia,1,1
41143,was,0,0
41144,greater,0,0
41145,in,0,0
41146,continuation,0,0
41147,tapping,0,1
41148,than,0,0
41149,in,0,0
41150,synchronisation,0,0
41151,tapping,0,1
41152,.,0,0
41153,Parametric,0,1
41154,analysis,0,0
41155,revealed,0,0
41156,activity,1,1
41157,correlating,1,0
41158,with,1,0
41159,temporal,1,0
41160,complexity,1,1
41161,during,1,0
41162,initiate,1,0
41163,in,1,0
41164,bilateral,1,0
41165,supplementary,1,0
41166,and,1,0
41167,pre-supplementary,1,0
41168,motor,1,1
41169,cortex,1,1
41170,(,1,0
41171,SMA,1,0
41172,and,1,1
41173,preSMA,1,0
41174,),1,1
41175,",",1,0
41176,rostral,1,0
41177,dorsal,1,0
41178,premotor,1,1
41179,cortex,1,1
41180,(,1,0
41181,PMC,1,0
41182,),1,0
41183,",",1,0
41184,basal,1,1
41185,ganglia,1,1
41186,",",1,0
41187,and,1,1
41188,dorsolateral,1,1
41189,prefrontal,1,1
41190,cortex,1,1
41191,(,1,0
41192,DLPFC,1,1
41193,),1,0
41194,",",1,0
41195,among,1,0
41196,other,1,0
41197,areas,1,0
41198,.,1,0
41199,During,0,0
41200,synchronise,0,0
41201,",",0,0
41202,correlated,1,1
41203,activity,1,1
41204,was,0,0
41205,observed,0,0
41206,in,0,0
41207,bilateral,0,0
41208,SMA,0,0
41209,",",0,0
41210,more,0,0
41211,caudal,0,1
41212,dorsal,0,0
41213,and,0,0
41214,ventral,0,1
41215,PMC,0,0
41216,",",0,0
41217,right,0,0
41218,DLPFC,0,1
41219,and,0,0
41220,right,0,0
41221,primary,0,0
41222,motor,0,1
41223,cortex,0,0
41224,.,0,0
41225,No,0,0
41226,correlated,0,0
41227,activity,0,1
41228,was,0,0
41229,observed,0,0
41230,during,0,0
41231,continue,0,0
41232,at,0,0
41233,P,0,0
41234,<,0,0
41235,0.01,0,0
41236,(,0,0
41237,corrected,0,0
41238,",",0,0
41239,cluster,0,0
41240,level,0,1
41241,),0,1
41242,",",0,0
41243,though,0,0
41244,left,0,0
41245,angular,0,1
41246,gyrus,0,1
41247,was,0,0
41248,active,0,0
41249,at,0,0
41250,P,0,0
41251,<,0,0
41252,0.05,0,0
41253,.,0,0
41254,We,0,0
41255,suggest,0,0
41256,that,0,0
41257,the,0,0
41258,preSMA,1,0
41259,and,1,0
41260,rostral,1,0
41261,dorsal,1,0
41262,PMC,1,0
41263,activities,1,1
41264,during,0,0
41265,initiate,0,0
41266,may,0,0
41267,be,0,0
41268,associated,0,0
41269,with,0,0
41270,selection,1,0
41271,of,1,0
41272,timing,1,1
41273,parameters,1,1
41274,",",0,0
41275,while,0,0
41276,activation,0,1
41277,in,0,0
41278,centromedial,0,1
41279,prefrontal,0,0
41280,cortex,0,0
41281,during,0,0
41282,both,0,0
41283,initiate,0,0
41284,and,0,0
41285,synchronise,0,0
41286,may,0,0
41287,be,0,0
41288,associated,0,0
41289,with,0,0
41290,temporal,1,0
41291,error,1,1
41292,monitoring,1,0
41293,or,1,0
41294,correction,1,0
41295,.,1,0
41296,The,0,0
41297,absence,0,0
41298,of,0,0
41299,activity,1,1
41300,significantly,1,0
41301,correlated,1,0
41302,with,1,0
41303,temporal,1,0
41304,complexity,1,1
41305,during,0,0
41306,continue,0,0
41307,suggests,0,0
41308,that,0,0
41309,",",0,0
41310,once,0,0
41311,an,0,0
41312,overlearned,0,0
41313,timed,0,0
41314,movement,0,0
41315,sequence,0,0
41316,has,0,0
41317,been,0,0
41318,selected,0,0
41319,and,0,0
41320,initiated,0,0
41321,",",0,0
41322,there,0,0
41323,is,0,0
41324,no,0,0
41325,further,0,0
41326,adjustment,0,0
41327,of,0,0
41328,the,0,0
41329,timing,0,0
41330,control,0,0
41331,processes,0,1
41332,related,0,0
41333,to,0,0
41334,its,0,0
41335,continued,0,0
41336,production,0,1
41337,in,0,0
41338,absence,0,0
41339,of,0,0
41340,external,0,0
41341,cues,0,0
41342,.,0,0
41343,Needle,0,1
41344,versus,0,0
41345,loop,0,0
41346,diathermy,0,0
41347,excision,0,0
41348,of,0,0
41349,the,0,0
41350,transformation,0,0
41351,zone,0,0
41352,for,0,0
41353,the,0,0
41354,treatment,0,0
41355,of,0,0
41356,cervical,0,0
41357,intraepithelial,0,0
41358,neoplasia,0,0
41359,:,0,0
41360,a,0,0
41361,randomised,0,0
41362,controlled,0,0
41363,trial,0,0
41364,.,0,0
41365,OBJECTIVE,0,0
41366,To,0,0
41367,determine,0,0
41368,whether,0,0
41369,lower,0,0
41370,rates,0,1
41371,or,0,1
41372,incomplete,0,0
41373,resection,0,0
41374,of,0,0
41375,cervical,0,0
41376,intraepithelial,0,1
41377,neoplasia,0,0
41378,(,0,0
41379,CIN,0,0
41380,),0,0
41381,may,0,0
41382,be,0,0
41383,achieved,0,0
41384,by,0,0
41385,needle,0,0
41386,excision,0,0
41387,of,0,0
41388,the,0,0
41389,transformation,0,0
41390,zone,0,1
41391,(,0,0
41392,NETZ,0,1
41393,),0,0
41394,than,0,0
41395,with,0,0
41396,loop,0,0
41397,excision,0,0
41398,(,0,0
41399,LLETZ,0,0
41400,),0,0
41401,.,0,0
41402,DESIGN,0,0
41403,A,0,0
41404,prospective,0,0
41405,randomised,0,0
41406,controlled,0,0
41407,trial,0,0
41408,.,0,0
41409,SETTING,0,0
41410,A,0,0
41411,gynaecological,0,0
41412,oncology,0,0
41413,centre,0,0
41414,and,0,0
41415,a,0,0
41416,teaching,0,0
41417,hospital,0,0
41418,in,0,0
41419,West,0,1
41420,London,0,0
41421,.,0,0
41422,POPULATION,0,0
41423,Four,0,0
41424,hundred,0,0
41425,and,0,0
41426,four,0,0
41427,women,0,0
41428,due,0,0
41429,to,0,0
41430,receive,0,0
41431,treatment,0,0
41432,for,0,0
41433,suspected,0,0
41434,CIN,0,0
41435,.,0,0
41436,METHODS,0,0
41437,Women,0,0
41438,were,0,0
41439,randomised,0,0
41440,to,0,0
41441,receive,0,0
41442,either,0,0
41443,LLETZ,0,0
41444,or,0,0
41445,NETZ,0,1
41446,.,0,0
41447,MAIN,0,0
41448,OUTCOME,0,0
41449,MEASURES,0,0
41450,The,0,0
41451,study,0,0
41452,was,0,0
41453,designed,0,0
41454,to,0,0
41455,demostrate,0,0
41456,a,0,0
41457,difference,0,0
41458,in,0,0
41459,the,0,0
41460,proportion,1,0
41461,of,1,0
41462,women,1,0
41463,with,1,0
41464,clear,1,0
41465,histological,1,1
41466,margins,1,0
41467,of,0,0
41468,82,0,0
41469,%,0,0
41470,for,0,0
41471,LLETZ,0,0
41472,compared,0,0
41473,to,0,0
41474,94,0,0
41475,%,0,0
41476,for,0,0
41477,NETZ,0,0
41478,with,0,0
41479,90,0,0
41480,%,0,0
41481,power,0,0
41482,at,0,0
41483,a,0,0
41484,5,0,0
41485,%,0,0
41486,significance,0,0
41487,level,0,1
41488,",",0,0
41489,allowing,0,0
41490,for,0,0
41491,absence,0,0
41492,of,0,0
41493,CIN,0,0
41494,in,0,0
41495,the,0,0
41496,treatment,1,0
41497,specimen,1,0
41498,in,0,0
41499,15,0,0
41500,%,0,0
41501,.,0,0
41502,RESULTS,0,0
41503,Four,0,1
41504,randomised,0,0
41505,women,0,0
41506,were,0,0
41507,excluded,0,0
41508,from,0,0
41509,the,0,0
41510,analysis,0,0
41511,",",0,0
41512,as,0,0
41513,they,0,0
41514,were,0,0
41515,ineligible,0,0
41516,for,0,0
41517,the,0,0
41518,study,0,0
41519,.,0,0
41520,Three,0,0
41521,hundred,0,0
41522,and,0,0
41523,forty-seven,0,0
41524,(,0,0
41525,87,0,0
41526,%,0,0
41527,),0,0
41528,had,0,0
41529,CIN,0,0
41530,in,0,0
41531,the,0,0
41532,treatment,0,0
41533,specimen,0,0
41534,and,0,0
41535,could,0,0
41536,be,0,0
41537,included,0,0
41538,in,0,0
41539,the,0,0
41540,analysis,0,0
41541,of,0,0
41542,excision,0,0
41543,margins,0,1
41544,.,0,0
41545,More,0,0
41546,women,0,0
41547,in,0,0
41548,the,0,0
41549,NETZ,0,1
41550,arm,0,0
41551,had,0,0
41552,clear,1,0
41553,histological,1,1
41554,margins,1,1
41555,(,0,0
41556,84.8,0,0
41557,%,0,0
41558,vs,0,0
41559,75,0,0
41560,%,0,0
41561,",",0,0
41562,(,0,0
41563,P=,0,1
41564,0.03,0,0
41565,),0,0
41566,.,0,0
41567,The,0,0
41568,median,1,0
41569,volume,1,1
41570,of,1,0
41571,specimens,1,0
41572,in,0,0
41573,the,0,0
41574,NETZ,0,1
41575,arm,0,0
41576,was,0,0
41577,739,0,0
41578,mm,0,0
41579,(,0,0
41580,3,0,0
41581,),0,0
41582,larger,0,0
41583,(,0,0
41584,P=,0,1
41585,0.33,0,0
41586,),0,0
41587,and,0,0
41588,they,0,0
41589,were,0,0
41590,less,1,0
41591,likely,1,0
41592,to,1,0
41593,be,1,0
41594,removed,1,0
41595,in,0,0
41596,multiple,0,0
41597,pieces,0,0
41598,(,0,0
41599,2.5,0,0
41600,%,0,0
41601,vs,0,0
41602,29.5,0,0
41603,%,0,0
41604,",",0,0
41605,RR,0,0
41606,0.09,0,0
41607,",",0,0
41608,95,0,0
41609,%,0,0
41610,CI,0,0
41611,0.04,0,0
41612,to,0,0
41613,0.20,0,0
41614,),0,0
41615,.,0,0
41616,Needle,0,1
41617,excision,0,0
41618,took,0,0
41619,longer,1,0
41620,to,1,0
41621,perform,1,0
41622,(,1,0
41623,median,1,1
41624,treatment,1,0
41625,time,1,1
41626,210,0,0
41627,vs,0,0
41628,90,0,0
41629,seconds,0,0
41630,",",0,0
41631,P,0,0
41632,<,0,0
41633,0.0001,0,0
41634,),0,0
41635,and,0,0
41636,surgeons,0,0
41637,more,0,0
41638,often,0,0
41639,reported,1,0
41640,the,1,0
41641,procedure,1,0
41642,as,1,0
41643,'difficult,1,1
41644,',1,0
41645,(,0,0
41646,9.5,0,0
41647,%,0,0
41648,vs,0,0
41649,3.0,0,0
41650,%,0,0
41651,",",0,0
41652,RR,0,0
41653,=,0,0
41654,3.17,0,0
41655,%,0,0
41656,",",0,0
41657,95,0,0
41658,%,0,0
41659,CI,0,0
41660,1.33,0,0
41661,to,0,0
41662,7.58,0,0
41663,),0,0
41664,.,0,0
41665,No,0,0
41666,difference,0,0
41667,in,0,0
41668,peri-operative,1,1
41669,or,1,0
41670,post-operative,1,1
41671,complication,1,1
41672,rates,1,1
41673,could,0,0
41674,be,0,0
41675,demonstrated,0,0
41676,between,0,0
41677,the,0,0
41678,two,0,0
41679,groups,0,0
41680,.,0,0
41681,CONCLUSION,0,0
41682,NETZ,0,0
41683,is,0,0
41684,more,0,0
41685,likely,0,0
41686,to,0,0
41687,produce,0,0
41688,a,0,0
41689,specimen,0,0
41690,in,0,0
41691,one,0,0
41692,piece,0,0
41693,and,0,0
41694,with,0,0
41695,clear,0,0
41696,margins,0,0
41697,compared,0,0
41698,to,0,0
41699,LLETZ,0,0
41700,.,0,0
41701,Untreated,0,0
41702,silicone,0,0
41703,breast,0,0
41704,implant,0,0
41705,rupture,0,1
41706,.,0,0
41707,Implant,0,0
41708,rupture,0,0
41709,is,0,0
41710,a,0,0
41711,well-known,0,0
41712,complication,0,1
41713,of,0,0
41714,breast,0,0
41715,implant,0,0
41716,surgery,0,0
41717,that,0,0
41718,can,0,0
41719,pass,0,0
41720,unnoticed,0,0
41721,by,0,0
41722,both,0,0
41723,patient,0,0
41724,and,0,0
41725,physician,0,0
41726,.,0,0
41727,To,0,0
41728,date,0,0
41729,",",0,0
41730,no,0,0
41731,prospective,0,0
41732,study,0,0
41733,has,0,0
41734,addressed,0,0
41735,the,0,0
41736,possible,0,0
41737,health,0,1
41738,implications,0,0
41739,of,0,0
41740,silicone,0,0
41741,breast,0,0
41742,implant,0,0
41743,rupture,0,1
41744,.,0,0
41745,The,0,0
41746,aim,0,0
41747,of,0,0
41748,the,0,0
41749,present,0,0
41750,study,0,0
41751,was,0,0
41752,to,0,0
41753,evaluate,0,0
41754,whether,0,0
41755,untreated,0,0
41756,ruptures,0,0
41757,are,0,0
41758,associated,0,0
41759,with,0,0
41760,changes,0,0
41761,over,0,0
41762,time,0,1
41763,in,0,0
41764,magnetic,0,0
41765,resonance,0,0
41766,imaging,0,1
41767,findings,0,0
41768,",",0,0
41769,serologic,0,1
41770,markers,0,1
41771,",",0,0
41772,or,0,0
41773,self-reported,0,1
41774,breast,0,0
41775,symptoms,0,1
41776,.,0,0
41777,A,0,0
41778,baseline,0,0
41779,magnetic,0,0
41780,resonance,0,0
41781,imaging,0,1
41782,examination,0,0
41783,was,0,0
41784,performed,0,0
41785,in,0,0
41786,1999,0,0
41787,on,0,0
41788,271,0,0
41789,women,0,0
41790,who,0,0
41791,were,0,0
41792,randomly,0,0
41793,chosen,0,0
41794,from,0,0
41795,a,0,0
41796,larger,0,0
41797,cohort,0,0
41798,of,0,1
41799,women,0,0
41800,having,0,0
41801,cosmetic,0,0
41802,breast,0,0
41803,implants,0,0
41804,for,0,0
41805,a,0,0
41806,median,0,0
41807,period,0,0
41808,of,0,0
41809,12,0,0
41810,years,0,0
41811,(,0,0
41812,range,0,0
41813,",",0,0
41814,3,0,0
41815,to,0,0
41816,25,0,0
41817,years,0,0
41818,),0,0
41819,.,0,0
41820,A,0,0
41821,follow-up,0,0
41822,magnetic,0,0
41823,resonance,0,0
41824,imaging,0,1
41825,examination,0,0
41826,was,0,0
41827,carried,0,0
41828,out,0,0
41829,in,0,0
41830,2001,0,0
41831,",",0,0
41832,excluding,0,0
41833,women,0,0
41834,who,0,0
41835,underwent,0,0
41836,explantation,0,0
41837,in,0,0
41838,the,0,0
41839,period,0,0
41840,between,0,0
41841,the,0,0
41842,two,0,0
41843,magnetic,0,0
41844,resonance,0,0
41845,imaging,0,1
41846,examinations,0,0
41847,(,0,0
41848,n,0,0
41849,=,0,0
41850,44,0,0
41851,),0,0
41852,.,0,0
41853,On,0,0
41854,the,0,0
41855,basis,0,0
41856,of,0,0
41857,these,0,0
41858,examinations,0,0
41859,",",0,0
41860,the,0,0
41861,authors,0,0
41862,identified,0,0
41863,64,0,0
41864,women,0,0
41865,who,0,0
41866,had,0,0
41867,at,0,0
41868,least,0,0
41869,one,0,0
41870,ruptured,0,0
41871,implant,0,0
41872,at,0,0
41873,the,0,0
41874,first,0,0
41875,magnetic,0,0
41876,resonance,0,0
41877,imaging,0,1
41878,examination,0,0
41879,and,0,0
41880,",",0,0
41881,for,0,0
41882,comparison,0,0
41883,",",0,0
41884,all,0,0
41885,women,0,0
41886,who,0,0
41887,had,0,0
41888,intact,0,0
41889,implants,0,0
41890,at,0,0
41891,both,0,0
41892,examinations,0,0
41893,(,0,0
41894,n,0,0
41895,=,0,0
41896,98,0,0
41897,),0,0
41898,.,0,0
41899,Magnetic,0,0
41900,resonance,0,0
41901,images,0,0
41902,from,0,0
41903,the,0,0
41904,two,0,0
41905,examinations,0,0
41906,were,0,0
41907,compared,0,0
41908,and,0,0
41909,changes,0,1
41910,in,0,0
41911,rupture,0,1
41912,configuration,0,0
41913,were,0,0
41914,evaluated,0,0
41915,.,0,0
41916,Comparisons,0,0
41917,were,0,0
41918,also,0,0
41919,made,0,0
41920,for,0,0
41921,self-reported,0,1
41922,breast,0,0
41923,symptoms,0,1
41924,occurring,0,0
41925,during,0,0
41926,the,0,0
41927,study,0,0
41928,period,0,0
41929,and,0,0
41930,for,0,0
41931,changes,0,1
41932,in,0,0
41933,serum,0,1
41934,values,0,1
41935,of,0,0
41936,antinuclear,0,1
41937,antibodies,0,0
41938,",",0,0
41939,rheumatoid,0,1
41940,factor,0,1
41941,",",0,0
41942,and,0,1
41943,cardiolipin,0,1
41944,antibodies,0,0
41945,immunoglobulin,0,0
41946,G,0,0
41947,and,0,0
41948,immunoglobulin,0,0
41949,M.,0,0
41950,The,0,0
41951,majority,0,0
41952,of,0,0
41953,the,0,0
41954,women,0,0
41955,with,0,0
41956,implant,0,0
41957,rupture,0,1
41958,had,0,0
41959,no,0,0
41960,visible,0,1
41961,magnetic,1,0
41962,resonance,1,0
41963,imaging,1,1
41964,changes,1,1
41965,of,0,0
41966,their,0,0
41967,ruptured,0,0
41968,implants,0,0
41969,.,0,0
41970,For,0,0
41971,11,0,0
41972,implants,0,0
41973,(,0,0
41974,11,0,0
41975,percent,0,0
41976,),0,0
41977,in,0,0
41978,10,0,0
41979,women,0,0
41980,",",0,0
41981,the,0,0
41982,authors,0,0
41983,observed,0,0
41984,progression,0,1
41985,of,0,1
41986,silicone,1,0
41987,seepage,1,1
41988,",",0,0
41989,either,0,0
41990,as,0,0
41991,a,0,0
41992,conversion,0,0
41993,from,0,0
41994,intracapsular,0,0
41995,into,0,0
41996,extracapsular,0,0
41997,rupture,0,1
41998,(,0,0
41999,n,0,0
42000,=,0,0
42001,7,0,0
42002,),0,0
42003,",",0,0
42004,as,0,0
42005,progression,0,1
42006,of,0,0
42007,extra-capsular,0,0
42008,silicone,0,0
42009,(,0,0
42010,n,0,0
42011,=,0,0
42012,3,0,0
42013,),0,0
42014,",",0,0
42015,or,0,0
42016,as,0,0
42017,increasing,0,0
42018,herniation,1,0
42019,of,1,0
42020,the,1,0
42021,silicone,1,0
42022,within,1,0
42023,the,1,0
42024,fibrous,1,1
42025,capsule,1,0
42026,(,0,0
42027,n,0,0
42028,=,0,0
42029,1,0,0
42030,),0,0
42031,;,0,0
42032,however,0,0
42033,",",0,0
42034,in,0,0
42035,most,0,0
42036,cases,0,0
42037,",",0,0
42038,these,0,0
42039,changes,0,1
42040,were,0,0
42041,minor,0,0
42042,.,0,0
42043,Some,0,0
42044,changes,0,0
42045,could,0,0
42046,be,0,0
42047,ascribed,0,0
42048,to,0,0
42049,trauma,0,0
42050,",",0,0
42051,but,0,0
42052,others,0,1
42053,seemed,0,0
42054,spontaneous,0,0
42055,.,0,0
42056,There,0,0
42057,was,0,0
42058,no,0,0
42059,increase,0,0
42060,in,0,0
42061,levels,1,1
42062,of,1,0
42063,autoantibodies,1,1
42064,during,0,0
42065,the,0,0
42066,study,0,0
42067,period,0,0
42068,in,0,0
42069,either,0,0
42070,study,0,0
42071,group,0,0
42072,.,0,0
42073,Women,0,0
42074,with,0,0
42075,untreated,0,0
42076,implant,0,0
42077,ruptures,0,0
42078,reported,0,0
42079,a,0,0
42080,significant,0,0
42081,increase,0,0
42082,in,0,0
42083,nonspecific,1,0
42084,breast,1,0
42085,changes,1,1
42086,(,0,0
42087,odds,0,1
42088,ratio,0,1
42089,",",0,0
42090,2.1,0,0
42091,;,0,0
42092,95,0,0
42093,percent,0,0
42094,confidence,0,0
42095,interval,0,0
42096,",",0,0
42097,1.2,0,0
42098,to,0,0
42099,3.8,0,0
42100,),0,0
42101,compared,0,0
42102,with,0,0
42103,women,0,0
42104,without,0,0
42105,ruptures,0,0
42106,.,0,0
42107,On,0,0
42108,the,0,0
42109,basis,0,0
42110,of,0,0
42111,this,0,0
42112,first,0,0
42113,study,0,0
42114,of,0,0
42115,women,0,0
42116,with,0,0
42117,untreated,0,0
42118,silicone,0,0
42119,breast,0,0
42120,implant,0,0
42121,rupture,0,1
42122,",",0,0
42123,the,0,0
42124,authors,0,0
42125,conclude,0,0
42126,that,0,0
42127,implant,0,0
42128,rupture,0,0
42129,is,0,0
42130,a,0,0
42131,relatively,0,0
42132,harmless,0,0
42133,condition,0,0
42134,",",0,0
42135,which,0,0
42136,only,0,0
42137,rarely,0,0
42138,progresses,0,0
42139,and,0,0
42140,gives,0,0
42141,rise,0,0
42142,to,0,0
42143,notable,0,0
42144,symptoms,0,1
42145,.,0,0
42146,Even,0,0
42147,so,0,0
42148,",",0,0
42149,because,0,0
42150,of,0,0
42151,a,0,0
42152,small,0,0
42153,risk,0,1
42154,of,0,0
42155,silicone,0,0
42156,spread,0,0
42157,",",0,0
42158,the,0,0
42159,authors,0,0
42160,suggest,0,0
42161,that,0,0
42162,women,0,0
42163,with,0,0
42164,implant,0,0
42165,ruptures,0,0
42166,be,0,0
42167,followed,0,0
42168,clinically,0,0
42169,",",0,0
42170,if,0,0
42171,not,0,0
42172,operated,0,0
42173,on,0,0
42174,.,0,0
42175,Because,0,0
42176,implant,0,0
42177,ruptures,0,0
42178,often,0,0
42179,occur,0,0
42180,asymptomatically,0,0
42181,",",0,0
42182,any,0,0
42183,woman,0,0
42184,with,0,0
42185,silicone,0,0
42186,implants,0,0
42187,",",0,0
42188,regardless,0,0
42189,of,0,0
42190,rupture,0,1
42191,status,0,1
42192,",",0,0
42193,should,0,0
42194,be,0,0
42195,evaluated,0,0
42196,at,0,0
42197,regular,0,0
42198,intervals,0,0
42199,.,0,0
42200,Evaluation,0,0
42201,of,0,0
42202,an,0,0
42203,aquatics,0,0
42204,programme,0,0
42205,on,0,0
42206,fitness,1,1
42207,parameters,1,1
42208,of,0,0
42209,individuals,0,0
42210,with,0,0
42211,a,0,0
42212,brain,0,0
42213,injury,0,0
42214,.,0,0
42215,The,0,0
42216,primary,0,0
42217,objective,0,0
42218,was,0,0
42219,to,0,0
42220,determine,0,0
42221,the,0,0
42222,effect,0,0
42223,of,0,0
42224,an,0,0
42225,aquatic,0,0
42226,exercise,0,0
42227,programme,0,0
42228,on,0,0
42229,the,0,0
42230,physical,1,0
42231,fitness,1,1
42232,of,0,0
42233,people,0,0
42234,with,0,0
42235,a,0,0
42236,brain,0,0
42237,injury,0,0
42238,.,0,0
42239,A,0,0
42240,pre-test-post-test,0,0
42241,randomized-groups,0,0
42242,design,0,0
42243,was,0,0
42244,conducted,0,0
42245,.,0,0
42246,Sixteen,0,0
42247,outpatients,0,0
42248,with,0,0
42249,a,0,0
42250,brain,0,1
42251,injury,0,1
42252,were,0,0
42253,included,0,0
42254,in,0,0
42255,the,0,0
42256,study,0,0
42257,.,0,0
42258,Eight,0,0
42259,participants,0,0
42260,were,0,0
42261,assigned,0,0
42262,to,0,0
42263,an,0,0
42264,aquatic,0,0
42265,exercise,0,0
42266,group,0,0
42267,and,0,0
42268,eight,0,0
42269,to,0,0
42270,a,0,0
42271,control,0,0
42272,group,0,0
42273,.,0,0
42274,The,0,0
42275,components,0,0
42276,of,0,0
42277,physical,0,1
42278,fitness,0,1
42279,measured,0,0
42280,included,0,0
42281,cardiovascular,1,1
42282,endurance,1,1
42283,",",1,0
42284,body,1,1
42285,composition,1,1
42286,",",1,0
42287,muscular,1,1
42288,strength,1,1
42289,and,1,1
42290,endurance,1,1
42291,and,1,1
42292,flexibility,1,1
42293,.,1,1
42294,Measurements,0,0
42295,were,0,0
42296,taken,0,0
42297,pre-,0,0
42298,and,0,0
42299,post-programme,0,0
42300,.,0,0
42301,Results,0,0
42302,indicated,0,0
42303,an,0,0
42304,increase,0,0
42305,in,0,0
42306,components,1,0
42307,of,1,0
42308,physical,1,1
42309,fitness,1,1
42310,for,0,0
42311,the,0,0
42312,experimental,0,0
42313,group,0,0
42314,but,0,0
42315,not,0,0
42316,the,0,0
42317,control,0,0
42318,group,0,0
42319,.,0,0
42320,Increases,0,0
42321,in,0,0
42322,fitness,0,1
42323,were,0,0
42324,reported,0,0
42325,as,0,0
42326,having,0,0
42327,a,0,0
42328,positive,0,0
42329,impact,0,0
42330,on,0,0
42331,the,0,0
42332,functional,1,0
42333,capacity,1,1
42334,of,0,0
42335,individuals,0,0
42336,in,0,0
42337,the,0,0
42338,exercise,0,0
42339,group,0,0
42340,as,0,0
42341,well,0,0
42342,as,0,0
42343,enhancing,0,0
42344,the,0,0
42345,individual,0,0
42346,'s,0,0
42347,ability,1,0
42348,to,1,0
42349,complete,1,1
42350,activities,1,1
42351,of,1,0
42352,daily,1,0
42353,living,1,0
42354,successfully,0,0
42355,.,0,0
42356,Results,0,0
42357,indicate,0,0
42358,that,0,0
42359,aquatic,0,0
42360,exercise,0,0
42361,may,0,0
42362,positively,0,0
42363,impact,0,0
42364,the,0,0
42365,primary,1,0
42366,and,1,0
42367,secondary,1,0
42368,physical,1,1
42369,injuries,1,0
42370,caused,0,0
42371,by,0,0
42372,a,0,0
42373,brain,0,0
42374,injury,0,0
42375,.,0,0
42376,Predicting,0,0
42377,the,0,0
42378,costs,1,1
42379,of,0,0
42380,allogeneic,0,0
42381,sibling,0,0
42382,stem-cell,0,0
42383,transplantation,0,0
42384,:,0,0
42385,results,0,0
42386,from,0,0
42387,a,0,0
42388,prospective,0,0
42389,",",0,0
42390,multicenter,0,0
42391,",",0,1
42392,French,0,0
42393,study,0,0
42394,.,0,0
42395,BACKGROUND,0,0
42396,Allogeneic,0,0
42397,hematopoietic,0,0
42398,stem-cell,0,0
42399,transplantation,0,0
42400,is,0,0
42401,a,0,0
42402,widely,0,0
42403,used,0,0
42404,",",0,0
42405,cost-intensive,0,0
42406,procedure,0,0
42407,.,0,0
42408,Our,0,0
42409,purpose,0,0
42410,was,0,0
42411,to,0,0
42412,estimate,0,0
42413,costs,1,1
42414,and,0,0
42415,determine,0,0
42416,cost,1,1
42417,predictors,1,0
42418,.,1,0
42419,METHODS,0,0
42420,We,0,0
42421,used,0,0
42422,data,0,0
42423,from,0,0
42424,a,0,0
42425,prospective,0,0
42426,French,0,0
42427,study,0,0
42428,comparing,0,0
42429,four,0,0
42430,doses,0,0
42431,of,0,0
42432,immunoglobulins,0,0
42433,.,0,0
42434,Resource,0,0
42435,use,0,0
42436,of,0,0
42437,hematopoietic,0,0
42438,stem-cell,0,0
42439,transplant,0,0
42440,recipients,0,0
42441,during,0,0
42442,the,0,0
42443,first,0,0
42444,6,0,0
42445,months,0,0
42446,posttransplant,0,0
42447,",",0,0
42448,both,0,0
42449,inpatient,0,0
42450,and,0,0
42451,ambulatory,0,1
42452,costs,0,1
42453,",",0,0
42454,in,0,0
42455,85,0,0
42456,patients,0,0
42457,from,0,0
42458,five,0,0
42459,centers,0,0
42460,were,0,0
42461,collected,0,0
42462,prospectively,0,0
42463,and,0,0
42464,costed,0,0
42465,.,0,0
42466,Baseline,0,0
42467,data,0,0
42468,and,0,1
42469,clinical,0,1
42470,events,0,1
42471,were,0,0
42472,retrieved,0,0
42473,.,0,0
42474,Protocol-driven,0,0
42475,costs,0,1
42476,were,0,0
42477,excluded,0,0
42478,.,0,0
42479,Multivariable,1,0
42480,analysis,1,0
42481,evaluated,0,0
42482,the,0,0
42483,association,0,0
42484,between,0,0
42485,costs,1,1
42486,and,1,0
42487,patient,1,1
42488,'s,1,1
42489,pretransplant,1,0
42490,status,1,1
42491,and,1,0
42492,transplant-related,1,1
42493,complications,1,1
42494,.,1,0
42495,Because,0,0
42496,of,0,0
42497,the,0,0
42498,absence,0,0
42499,of,0,0
42500,differences,0,0
42501,in,0,0
42502,outcome,0,0
42503,among,0,0
42504,the,0,0
42505,four,0,0
42506,randomization,0,0
42507,groups,0,0
42508,",",0,0
42509,cost,1,1
42510,data,1,0
42511,for,0,0
42512,all,0,0
42513,patients,0,0
42514,were,0,0
42515,pooled,0,0
42516,.,0,0
42517,RESULTS,0,0
42518,Total,1,0
42519,costs,1,1
42520,per,0,0
42521,patient,0,0
42522,were,0,0
42523,the,0,0
42524,following,0,0
42525,:,0,0
42526,mean,0,0
42527,"76,237",0,0
42528,Euros,0,0
42529,;,0,0
42530,standard,0,0
42531,deviation,0,0
42532,"32,565",0,0
42533,Euros,0,0
42534,;,0,0
42535,median,0,0
42536,"69,516",0,0
42537,Euros,0,0
42538,;,0,0
42539,range,0,0
42540,"183,758",0,0
42541,to,0,0
42542,"14,761Euros",0,0
42543,.,0,0
42544,The,0,0
42545,major,0,0
42546,cost,0,1
42547,driver,0,0
42548,was,0,0
42549,hospital,0,0
42550,days,0,0
42551,.,0,0
42552,No,0,0
42553,association,0,0
42554,was,0,0
42555,found,0,0
42556,between,0,0
42557,costs,1,1
42558,and,1,1
42559,baseline,1,0
42560,status,1,1
42561,.,1,0
42562,The,0,0
42563,predictors,0,0
42564,of,0,0
42565,higher,0,0
42566,costs,0,1
42567,(,0,0
42568,adding,0,0
42569,an,0,0
42570,average,0,0
42571,"20,000",0,0
42572,Euros/patient,0,0
42573,),0,0
42574,were,0,0
42575,the,0,0
42576,occurrence,0,1
42577,of,0,0
42578,transplant-related,1,1
42579,complications,1,1
42580,:,1,0
42581,graft-versus-host,0,1
42582,disease,0,1
42583,and,0,1
42584,repeated,1,0
42585,infections,1,1
42586,that,0,0
42587,were,0,0
42588,unpredictable,0,0
42589,before,0,0
42590,transplant,0,0
42591,in,0,0
42592,this,0,0
42593,homogeneous,0,0
42594,group,0,0
42595,of,0,0
42596,patients,0,0
42597,.,0,0
42598,CONCLUSION,0,0
42599,Our,0,0
42600,data,0,0
42601,highlight,0,0
42602,the,0,0
42603,discrepancy,0,0
42604,between,0,0
42605,the,0,0
42606,Diagnosis,0,0
42607,Related,0,1
42608,Group,0,0
42609,prospective,0,0
42610,payment,0,0
42611,system,0,0
42612,and,0,1
42613,actual,1,1
42614,costs,1,1
42615,.,1,0
42616,The,0,0
42617,actual,1,0
42618,cost,1,1
42619,of,0,0
42620,geno-identical,0,0
42621,stem-cell,0,0
42622,transplantation,0,0
42623,results,0,0
42624,from,0,0
42625,posttransplant,0,0
42626,complications,0,1
42627,that,0,0
42628,can,0,0
42629,not,0,0
42630,be,0,0
42631,predicted,0,0
42632,prospectively,0,0
42633,and,0,0
42634,require,0,0
42635,ex,0,1
42636,post,0,0
42637,cost,0,1
42638,adjustment,0,0
42639,.,0,0
42640,Registration,0,0
42641,accuracy,0,1
42642,of,0,0
42643,153Gd,0,0
42644,transmission,0,0
42645,images,0,0
42646,of,0,0
42647,the,0,0
42648,brain,0,0
42649,.,0,0
42650,PURPOSE,0,0
42651,The,0,0
42652,aim,0,0
42653,of,0,0
42654,the,0,0
42655,study,0,0
42656,was,0,0
42657,to,0,0
42658,determine,0,0
42659,the,0,0
42660,accuracy,0,0
42661,of,0,0
42662,non-rigid,0,0
42663,nine-parameter,0,0
42664,image,0,0
42665,registrations,0,0
42666,based,0,0
42667,on,0,0
42668,153Gd,0,0
42669,transmission,0,0
42670,computed,0,0
42671,tomography,0,0
42672,(,0,0
42673,TCT,0,1
42674,),0,0
42675,images,0,0
42676,as,0,0
42677,compared,0,0
42678,with,0,0
42679,those,0,0
42680,based,0,0
42681,on,0,0
42682,99mTc-ethyl,0,0
42683,cysteinate,0,0
42684,dimer,0,1
42685,(,0,0
42686,ECD,0,0
42687,),0,0
42688,images,0,0
42689,and,0,0
42690,to,0,0
42691,assess,0,0
42692,whether,0,0
42693,normalised,0,0
42694,mutual,0,1
42695,information,0,0
42696,(,0,0
42697,NMI,0,1
42698,),0,1
42699,or,0,0
42700,count,0,1
42701,difference,0,1
42702,(,0,0
42703,CD,0,0
42704,),0,0
42705,should,0,0
42706,be,0,0
42707,used,0,0
42708,.,0,0
42709,METHODS,0,0
42710,TCT,0,1
42711,and,0,0
42712,ECD,0,1
42713,data,0,0
42714,were,0,0
42715,acquired,0,0
42716,in,0,0
42717,25,0,0
42718,randomly,0,0
42719,selected,0,0
42720,patients,0,0
42721,.,0,0
42722,Emission,0,1
42723,images,0,0
42724,were,0,0
42725,registered,0,0
42726,to,0,0
42727,an,0,0
42728,ECD,0,0
42729,template,0,0
42730,with,0,0
42731,a,0,0
42732,CD,0,0
42733,cost,0,1
42734,function,0,1
42735,.,0,0
42736,The,0,0
42737,same,0,0
42738,registration,0,0
42739,parameters,0,1
42740,were,0,0
42741,applied,0,0
42742,to,0,0
42743,the,0,0
42744,transmission,0,0
42745,images,0,0
42746,to,0,0
42747,create,0,0
42748,a,0,0
42749,TCT,0,1
42750,template,0,0
42751,.,0,0
42752,All,0,0
42753,TCT,0,1
42754,images,0,0
42755,were,0,0
42756,registered,0,0
42757,to,0,0
42758,the,0,0
42759,TCT,0,1
42760,template,0,0
42761,and,0,0
42762,the,0,0
42763,same,0,0
42764,registration,0,0
42765,parameters,0,1
42766,were,0,0
42767,applied,0,0
42768,to,0,0
42769,the,0,0
42770,ECD,0,0
42771,images,0,0
42772,.,0,0
42773,The,0,0
42774,procedure,0,0
42775,was,0,0
42776,repeated,0,0
42777,with,0,0
42778,NMI,0,1
42779,as,0,0
42780,cost,0,1
42781,function,0,1
42782,.,0,0
42783,Accuracy,0,0
42784,of,0,0
42785,both,0,0
42786,ECD-based,0,0
42787,and,0,0
42788,TCT-based,0,0
42789,registrations,0,0
42790,was,0,0
42791,assessed,0,0
42792,by,0,0
42793,comparing,0,0
42794,the,0,0
42795,normalisation,0,0
42796,parameter,0,1
42797,values,0,1
42798,and,0,1
42799,regional,0,0
42800,activities,0,1
42801,in,0,0
42802,the,0,0
42803,spatially,0,0
42804,normalised,0,0
42805,ECD,0,0
42806,images,0,0
42807,",",0,0
42808,using,0,0
42809,a,0,0
42810,mixed-model,0,0
42811,analysis,0,0
42812,of,0,0
42813,variance,0,1
42814,(,0,0
42815,ANOVA,0,0
42816,),0,0
42817,.,0,0
42818,Scheffe,0,0
42819,post,0,0
42820,hoc,0,0
42821,tests,0,1
42822,were,0,0
42823,performed,0,0
42824,.,0,0
42825,RESULTS,0,0
42826,No,1,0
42827,significant,1,0
42828,differences,1,0
42829,were,0,0
42830,found,0,0
42831,between,0,0
42832,ECD/CD,0,0
42833,",",0,0
42834,ECD/NMI,0,1
42835,and,0,1
42836,TCT/CD,0,0
42837,",",0,0
42838,suggesting,0,0
42839,that,0,0
42840,ECD,0,0
42841,registration,0,0
42842,can,0,0
42843,be,0,0
42844,done,0,0
42845,with,0,0
42846,either,0,0
42847,CD,0,0
42848,or,0,0
42849,NMI,0,1
42850,",",0,1
42851,and,0,0
42852,that,0,0
42853,TCT,0,1
42854,registration,0,0
42855,using,0,0
42856,CD,0,0
42857,is,0,0
42858,equally,0,0
42859,as,0,0
42860,accurate,0,0
42861,as,0,0
42862,ECD,0,0
42863,registration,0,0
42864,.,0,0
42865,The,0,0
42866,accuracy,1,0
42867,of,1,0
42868,TCT,1,1
42869,registration,1,0
42870,with,0,0
42871,NMI,0,1
42872,was,0,0
42873,lower,1,0
42874,",",0,0
42875,with,0,0
42876,discrepancies,0,0
42877,occurring,0,0
42878,in,0,0
42879,the,0,0
42880,frontal,0,1
42881,inferior,0,0
42882,region,0,0
42883,and,0,0
42884,the,0,0
42885,cerebellum,0,0
42886,.,0,0
42887,The,0,0
42888,analysis,0,0
42889,of,0,0
42890,normalisation,0,1
42891,parameters,0,1
42892,indicated,0,0
42893,that,0,0
42894,z-scaling,0,0
42895,is,0,0
42896,underestimated,0,0
42897,and,0,0
42898,yz-rotation,0,1
42899,overestimated,0,0
42900,with,0,0
42901,TCT/NMI,0,0
42902,registration,0,0
42903,.,0,0
42904,CONCLUSION,0,0
42905,We,0,0
42906,conclude,0,0
42907,that,0,0
42908,ECD,0,0
42909,registrations,0,0
42910,with,0,0
42911,CD,0,0
42912,or,0,0
42913,NMI,0,1
42914,are,0,0
42915,as,0,0
42916,accurate,0,0
42917,as,0,0
42918,TCT,0,1
42919,registrations,0,0
42920,with,0,0
42921,CD,0,0
42922,and,0,0
42923,that,0,0
42924,TCT,0,1
42925,registrations,0,0
42926,with,0,0
42927,NMI,0,0
42928,should,0,0
42929,be,0,0
42930,avoided,0,0
42931,.,0,0
42932,Caudal,0,1
42933,neostigmine,0,0
42934,with,0,0
42935,bupivacaine,0,0
42936,produces,0,0
42937,a,0,0
42938,dose-independent,0,0
42939,analgesic,0,1
42940,effect,0,0
42941,in,0,0
42942,children,0,0
42943,.,0,0
42944,PURPOSE,0,0
42945,To,0,0
42946,evaluate,1,0
42947,the,0,0
42948,analgesic,1,1
42949,efficacy,1,1
42950,and,1,1
42951,duration,1,1
42952,of,0,0
42953,varying,0,0
42954,doses,0,0
42955,of,0,0
42956,caudal,0,0
42957,neostigmine,0,0
42958,with,0,0
42959,plain,0,0
42960,bupivacaine,0,0
42961,and,0,0
42962,its,0,0
42963,side,0,1
42964,effects,0,1
42965,in,0,0
42966,children,0,0
42967,undergoing,0,0
42968,genito-urinary,0,0
42969,surgery,0,0
42970,.,0,0
42971,METHODS,0,0
42972,In,0,0
42973,a,0,0
42974,randomized,0,0
42975,double-blind,0,0
42976,prospective,0,0
42977,study,0,0
42978,80,0,0
42979,boys,0,0
42980,aged,0,0
42981,two,0,0
42982,to,0,0
42983,eight,0,0
42984,years,0,0
42985,scheduled,0,0
42986,for,0,0
42987,surgical,0,0
42988,repair,0,0
42989,of,0,0
42990,hypospadias,0,0
42991,were,0,0
42992,allocated,0,0
42993,randomly,0,0
42994,to,0,0
42995,one,0,0
42996,of,0,0
42997,four,0,0
42998,groups,0,0
42999,(,0,0
43000,n,0,0
43001,=,0,0
43002,20,0,0
43003,each,0,0
43004,),0,0
43005,and,0,0
43006,received,0,0
43007,either,0,0
43008,only,0,0
43009,caudal,0,0
43010,0.25,0,0
43011,%,0,0
43012,plain,0,0
43013,bupivacaine,0,0
43014,0.5,0,0
43015,mL.kg,0,0
43016,(,0,0
43017,-1,0,0
43018,),0,1
43019,(,0,0
43020,Group,0,0
43021,I,0,0
43022,),0,0
43023,or,0,0
43024,0.25,0,0
43025,%,0,0
43026,plain,0,0
43027,bupivacaine,0,0
43028,0.5,0,0
43029,mL.kg,0,0
43030,(,0,0
43031,-1,0,0
43032,),0,0
43033,with,0,0
43034,neostigmine,0,0
43035,(,0,0
43036,Groups,0,1
43037,II-IV,0,1
43038,),0,0
43039,in,0,0
43040,doses,0,0
43041,of,0,0
43042,2,0,0
43043,",",0,0
43044,3,0,0
43045,and,0,0
43046,4,0,0
43047,microg.kg,0,0
43048,(,0,0
43049,-1,0,0
43050,),0,0
43051,respectively,0,0
43052,.,0,0
43053,Postoperative,1,0
43054,pain,1,1
43055,was,0,0
43056,assessed,0,0
43057,for,0,0
43058,24,0,0
43059,hr,0,0
43060,using,0,0
43061,an,0,0
43062,objective,1,0
43063,pain,1,1
43064,score,1,1
43065,.,1,0
43066,Blood,1,1
43067,pressure,1,1
43068,",",1,0
43069,heart,1,1
43070,rate,1,1
43071,",",1,1
43072,oxygen,1,1
43073,saturation,1,1
43074,",",1,0
43075,total,1,1
43076,amount,1,1
43077,of,1,0
43078,analgesic,1,1
43079,consumed,1,0
43080,and,1,0
43081,adverse,1,1
43082,effects,1,1
43083,were,0,0
43084,also,0,0
43085,recorded,0,0
43086,.,0,0
43087,RESULTS,0,0
43088,The,0,0
43089,duration,1,1
43090,of,1,0
43091,postoperative,1,1
43092,analgesia,1,1
43093,in,0,0
43094,Group,0,0
43095,I,0,0
43096,(,0,0
43097,5.1,0,0
43098,+/-,0,0
43099,2.3,0,0
43100,hr,0,0
43101,),0,0
43102,was,0,0
43103,significantly,0,0
43104,shorter,0,0
43105,than,0,0
43106,in,0,0
43107,the,0,0
43108,other,0,0
43109,three,0,0
43110,groups,0,0
43111,(,0,0
43112,II,0,0
43113,-16.6,0,0
43114,+/-,0,0
43115,4.9,0,0
43116,hr,0,0
43117,;,0,0
43118,III,0,0
43119,-,0,0
43120,17.2,0,0
43121,+/-,0,0
43122,5.5,0,0
43123,hr,0,0
43124,;,0,0
43125,IV,0,0
43126,-,0,0
43127,17.0,0,0
43128,+/-,0,0
43129,5.8,0,0
43130,hr,0,0
43131,;,0,0
43132,P,0,0
43133,<,0,0
43134,0.05,0,0
43135,),0,0
43136,.,0,0
43137,Total,1,0
43138,analgesic,1,1
43139,(,1,0
43140,paracetamol,1,0
43141,),1,1
43142,consumption,1,1
43143,was,0,0
43144,significantly,0,0
43145,more,0,0
43146,in,0,0
43147,Group,0,0
43148,I,0,0
43149,(,0,0
43150,697.6,0,0
43151,+/-,0,0
43152,240.7,0,0
43153,mg,0,0
43154,),0,0
43155,than,0,0
43156,in,0,0
43157,the,0,0
43158,groups,0,0
43159,receiving,0,0
43160,caudal,0,0
43161,neostigmine,0,0
43162,(,0,0
43163,II,0,0
43164,-,0,0
43165,248.0,0,0
43166,+/-,0,0
43167,178.4,0,0
43168,;,0,0
43169,III,0,0
43170,-,0,0
43171,270.2,0,0
43172,+/-,0,0
43173,180.8,0,0
43174,and,0,0
43175,IV,0,0
43176,-230.6,0,0
43177,+/-,0,0
43178,166.9,0,0
43179,mg,0,0
43180,;,0,0
43181,P,0,0
43182,<,0,0
43183,0.05,0,0
43184,),0,0
43185,.,0,0
43186,Groups,0,0
43187,II,0,0
43188,",",0,0
43189,III,0,1
43190,and,0,1
43191,IV,0,1
43192,were,0,0
43193,comparable,0,0
43194,with,0,0
43195,regards,0,0
43196,to,0,0
43197,duration,1,1
43198,of,1,0
43199,postoperative,1,1
43200,analgesia,1,1
43201,and,1,0
43202,total,1,1
43203,analgesic,1,1
43204,consumption,1,1
43205,(,0,0
43206,P,0,0
43207,>,0,0
43208,0.05,0,0
43209,),0,0
43210,.,0,0
43211,Incidence,0,1
43212,of,0,0
43213,nausea,1,1
43214,and,1,1
43215,vomiting,1,1
43216,were,0,0
43217,comparable,0,0
43218,in,0,0
43219,all,0,0
43220,four,0,0
43221,groups,0,0
43222,.,0,0
43223,No,0,0
43224,significant,0,0
43225,alteration,0,0
43226,in,0,0
43227,vital,1,1
43228,signs,1,1
43229,or,0,0
43230,any,0,0
43231,other,0,0
43232,adverse,0,1
43233,effects,0,1
43234,were,0,0
43235,observed,0,0
43236,.,0,0
43237,CONCLUSIONS,0,0
43238,Caudal,0,1
43239,neostigmine,0,0
43240,(,0,0
43241,2,0,0
43242,",",0,0
43243,3,0,0
43244,and,0,0
43245,4,0,0
43246,microg.kg,0,0
43247,(,0,0
43248,-1,0,0
43249,),0,0
43250,),0,0
43251,with,0,0
43252,bupivacaine,0,0
43253,produces,0,0
43254,a,0,0
43255,dose-independent,0,0
43256,analgesic,1,1
43257,effect,1,0
43258,(,0,0
43259,approximately,0,0
43260,16-17,0,0
43261,hr,0,0
43262,),0,0
43263,in,0,0
43264,children,0,0
43265,as,0,0
43266,compared,0,0
43267,to,0,0
43268,those,0,0
43269,receiving,0,0
43270,caudal,0,0
43271,bupivacaine,0,0
43272,alone,0,0
43273,(,0,0
43274,approximately,0,0
43275,five,0,0
43276,hours,0,0
43277,),0,0
43278,and,0,0
43279,a,0,0
43280,reduction,0,1
43281,in,0,0
43282,postoperative,1,1
43283,rescue,1,0
43284,analgesic,1,1
43285,consumption,1,1
43286,without,0,0
43287,increasing,0,0
43288,the,0,0
43289,incidence,0,1
43290,of,0,0
43291,adverse,1,1
43292,effects,1,0
43293,.,1,0
43294,Ropinirole,0,0
43295,as,0,0
43296,a,0,0
43297,treatment,0,0
43298,of,0,0
43299,restless,0,0
43300,legs,0,1
43301,syndrome,0,0
43302,in,0,0
43303,patients,0,0
43304,on,0,0
43305,chronic,0,0
43306,hemodialysis,0,0
43307,:,0,0
43308,an,0,0
43309,open,0,0
43310,randomized,0,0
43311,crossover,0,0
43312,trial,0,0
43313,versus,0,0
43314,levodopa,0,0
43315,sustained,0,0
43316,release,0,1
43317,.,0,0
43318,OBJECTIVE,0,0
43319,Restless,0,0
43320,legs,0,1
43321,syndrome,0,0
43322,(,0,0
43323,RLS,0,0
43324,),0,0
43325,is,0,0
43326,a,0,0
43327,common,0,0
43328,neurologic,0,1
43329,condition,0,0
43330,characterized,0,0
43331,by,0,0
43332,uncomfortable,0,0
43333,and,0,0
43334,unpleasant,0,1
43335,sensations,0,1
43336,in,0,0
43337,the,0,0
43338,legs,0,1
43339,",",0,0
43340,occurring,0,0
43341,primarily,0,0
43342,at,0,0
43343,rest,0,0
43344,",",0,0
43345,which,0,0
43346,are,0,0
43347,usually,0,0
43348,worse,0,0
43349,in,0,0
43350,the,0,0
43351,evening,0,0
43352,and,0,0
43353,are,0,0
43354,alleviated,0,0
43355,by,0,0
43356,movement,0,0
43357,.,0,0
43358,RLS,0,0
43359,is,0,0
43360,present,0,0
43361,in,0,0
43362,20-40,0,0
43363,%,0,0
43364,of,0,0
43365,patients,0,0
43366,with,0,0
43367,renal,0,0
43368,failure,0,0
43369,.,0,0
43370,This,0,0
43371,study,0,0
43372,was,0,0
43373,a,0,0
43374,14-week,0,0
43375,open,0,0
43376,",",0,0
43377,randomized,0,0
43378,",",0,0
43379,crossover,0,0
43380,trial,0,0
43381,of,0,0
43382,ropinirole,0,0
43383,vs.,0,0
43384,levodopa,0,0
43385,sustained,0,1
43386,release,0,1
43387,(,0,0
43388,SR,0,0
43389,),0,0
43390,in,0,0
43391,11,0,0
43392,patients,0,0
43393,with,0,0
43394,RLS,0,0
43395,on,0,0
43396,chronic,0,0
43397,hemodialysis,0,0
43398,.,0,0
43399,METHODS,0,0
43400,Eleven,0,0
43401,patients,0,0
43402,(,0,0
43403,7,0,0
43404,men,0,0
43405,",",0,0
43406,4,0,0
43407,women,0,0
43408,),0,0
43409,were,0,0
43410,enrolled,0,0
43411,in,0,0
43412,the,0,0
43413,study,0,0
43414,.,0,0
43415,They,0,0
43416,received,0,0
43417,either,0,0
43418,levodopa,0,0
43419,SR,0,0
43420,or,0,0
43421,ropinirole,0,0
43422,for,0,0
43423,6,0,0
43424,weeks,0,0
43425,",",0,0
43426,followed,0,0
43427,by,0,0
43428,a,0,0
43429,washout,0,0
43430,week,0,0
43431,",",0,0
43432,then,0,0
43433,the,0,0
43434,alternate,0,0
43435,treatment,0,0
43436,for,0,0
43437,6,0,0
43438,weeks,0,0
43439,.,0,0
43440,Patients,0,0
43441,rated,0,0
43442,the,0,0
43443,severity,1,1
43444,of,1,0
43445,RLS,1,1
43446,by,0,0
43447,means,0,0
43448,of,0,0
43449,a,0,0
43450,6-item,0,0
43451,questionnaire,0,1
43452,developed,0,0
43453,by,0,0
43454,the,0,0
43455,International,0,0
43456,Restless,0,0
43457,Legs,0,1
43458,Study,0,0
43459,Group,0,0
43460,(,0,0
43461,6-item,0,1
43462,IRLS,0,0
43463,),0,0
43464,",",0,0
43465,by,0,0
43466,the,0,0
43467,Clinical,0,0
43468,Global,0,1
43469,Impression,0,1
43470,(,0,0
43471,CGI,0,1
43472,),0,1
43473,scale,0,1
43474,",",0,0
43475,and,0,1
43476,by,0,0
43477,sleep,0,1
43478,diaries,0,0
43479,.,0,0
43480,RESULTS,0,0
43481,Under,0,0
43482,treatment,0,0
43483,with,0,0
43484,levodopa,0,0
43485,SR,0,0
43486,",",0,0
43487,1,0,0
43488,patient,0,0
43489,presented,0,0
43490,severe,1,1
43491,vomiting,1,1
43492,",",0,0
43493,leading,0,0
43494,to,0,0
43495,study,0,0
43496,discontinuation,0,0
43497,.,0,0
43498,The,0,0
43499,10,0,0
43500,patients,0,0
43501,who,0,0
43502,completed,0,0
43503,the,0,0
43504,study,0,0
43505,reported,0,0
43506,a,0,0
43507,33.5,0,0
43508,%,0,0
43509,improvement,0,0
43510,(,0,0
43511,from,0,0
43512,16.7,0,0
43513,+/-,0,0
43514,3.2,0,0
43515,to,0,0
43516,11.1,0,0
43517,+/-,0,0
43518,4,0,0
43519,;,0,0
43520,P,0,0
43521,<,0,0
43522,0.001,0,0
43523,),0,0
43524,of,0,0
43525,the,0,0
43526,6-item,0,0
43527,IRLS,0,0
43528,scores,0,1
43529,during,0,0
43530,levodopa,0,0
43531,SR,0,0
43532,treatment,0,0
43533,and,0,0
43534,a,0,0
43535,73.5,0,0
43536,%,0,0
43537,improvement,0,0
43538,(,0,0
43539,from,0,0
43540,16.6,0,0
43541,+/-,0,0
43542,2.8,0,0
43543,to,0,0
43544,4.4,0,0
43545,+/-,0,0
43546,3.8,0,0
43547,;,0,0
43548,P,0,0
43549,<,0,0
43550,0.001,0,0
43551,),0,0
43552,during,0,0
43553,ropinirole,0,0
43554,treatment,0,0
43555,.,0,0
43556,By,0,0
43557,the,0,0
43558,end,0,0
43559,of,0,0
43560,the,0,0
43561,study,0,0
43562,the,0,0
43563,mean,0,1
43564,levodopa,0,0
43565,SR,0,1
43566,dosage,0,0
43567,was,0,0
43568,190,0,0
43569,mg/d,0,0
43570,and,0,0
43571,the,0,0
43572,mean,0,1
43573,ropinirole,0,0
43574,dosage,0,0
43575,was,0,0
43576,1.45,0,0
43577,mg/d,0,0
43578,.,0,0
43579,Ropinirole,0,0
43580,was,0,0
43581,superior,0,0
43582,to,0,0
43583,levodopa,0,0
43584,SR,0,0
43585,in,0,0
43586,reducing,0,0
43587,6-item,0,0
43588,IRLS,0,0
43589,scores,0,1
43590,(,0,0
43591,P,0,0
43592,<,0,0
43593,0.001,0,0
43594,),0,0
43595,and,0,0
43596,in,0,0
43597,increasing,0,0
43598,sleep,1,1
43599,time,1,1
43600,(,0,0
43601,P,0,0
43602,<,0,0
43603,0.001,0,0
43604,),0,0
43605,.,0,0
43606,The,0,0
43607,patient,0,0
43608,CGI,1,1
43609,scale,1,1
43610,showed,0,0
43611,a,0,0
43612,significant,0,0
43613,difference,0,0
43614,favoring,0,0
43615,ropinirole,0,0
43616,(,0,0
43617,P,0,0
43618,<,0,0
43619,0.01,0,0
43620,),0,0
43621,.,0,0
43622,There,0,0
43623,was,0,0
43624,no,0,0
43625,significant,0,0
43626,carryover,1,0
43627,or,1,0
43628,period,1,0
43629,effect,1,0
43630,for,0,0
43631,any,0,0
43632,outcome,0,0
43633,measure,0,0
43634,.,0,0
43635,Four,0,0
43636,patients,0,0
43637,reported,0,0
43638,a,0,0
43639,complete,0,1
43640,reversion,0,1
43641,of,0,0
43642,RLS,1,1
43643,symptoms,1,1
43644,during,0,0
43645,ropinirole,0,0
43646,treatment,0,0
43647,at,0,0
43648,doses,0,0
43649,ranging,0,0
43650,from,0,0
43651,0.25-2,0,0
43652,mg/d,0,0
43653,.,0,0
43654,CONCLUSIONS,0,0
43655,These,0,0
43656,results,0,0
43657,suggest,0,0
43658,that,0,0
43659,ropinirole,0,0
43660,is,0,0
43661,more,0,0
43662,effective,0,1
43663,than,0,0
43664,levodopa,0,0
43665,SR,0,0
43666,in,0,0
43667,the,0,0
43668,treatment,0,0
43669,of,0,0
43670,RLS,0,1
43671,in,0,0
43672,patients,0,0
43673,on,0,0
43674,chronic,0,0
43675,hemodialysis,0,0
43676,.,0,0
43677,Absorption,1,1
43678,of,1,0
43679,intramuscular,1,0
43680,phenobarbitone,1,0
43681,in,0,0
43682,children,0,0
43683,with,0,0
43684,severe,0,1
43685,falciparum,0,0
43686,malaria,0,0
43687,.,0,0
43688,The,0,0
43689,absorption,1,0
43690,of,1,0
43691,intramuscular,1,0
43692,phenobarbitone,1,0
43693,7,0,0
43694,mg.kg-1,0,0
43695,was,0,0
43696,studied,0,0
43697,in,0,0
43698,11,0,0
43699,Karen,0,0
43700,children,0,0
43701,aged,0,0
43702,between,0,0
43703,1.7,0,0
43704,and,0,0
43705,11,0,0
43706,y,0,0
43707,with,0,0
43708,severe,0,1
43709,falciparum,0,0
43710,malaria,0,0
43711,.,0,0
43712,Eight,0,0
43713,of,0,0
43714,the,0,0
43715,children,0,0
43716,were,0,0
43717,comatose,0,0
43718,.,0,0
43719,Clinical,0,1
43720,findings,0,0
43721,were,0,0
43722,compared,0,0
43723,with,0,0
43724,those,0,0
43725,in,0,0
43726,9,0,0
43727,further,0,0
43728,children,0,0
43729,with,0,0
43730,severe,0,1
43731,malaria,0,0
43732,of,0,0
43733,similar,0,0
43734,age,0,0
43735,range,0,0
43736,(,0,0
43737,four,0,0
43738,of,0,0
43739,whom,0,0
43740,were,0,0
43741,unconscious,0,1
43742,),0,0
43743,",",0,0
43744,who,0,0
43745,received,0,0
43746,an,0,0
43747,identical,0,0
43748,placebo,0,0
43749,.,0,0
43750,One,0,0
43751,child,0,0
43752,",",0,0
43753,who,0,0
43754,had,0,0
43755,received,0,0
43756,placebo,0,0
43757,",",0,0
43758,had,0,0
43759,repeated,1,0
43760,convulsions,1,1
43761,and,0,0
43762,died,0,0
43763,1,0,0
43764,h,0,0
43765,after,0,0
43766,admission,0,1
43767,to,0,0
43768,hospital,0,0
43769,.,0,0
43770,The,0,0
43771,remainder,0,0
43772,made,0,0
43773,an,0,0
43774,uncomplicated,1,0
43775,recovery,1,1
43776,.,1,0
43777,There,0,0
43778,were,0,0
43779,no,0,0
43780,convulsions,1,0
43781,subsequent,0,0
43782,to,0,0
43783,treatment,0,0
43784,",",0,0
43785,although,0,0
43786,the,0,0
43787,study,0,0
43788,was,0,0
43789,too,0,0
43790,small,0,0
43791,to,0,0
43792,assess,0,0
43793,anticonvulsant,0,1
43794,efficacy,0,1
43795,.,0,0
43796,There,0,0
43797,was,0,0
43798,no,0,0
43799,observable,0,1
43800,toxicity,1,1
43801,",",0,0
43802,but,0,0
43803,phenobarbitone,0,0
43804,recipients,0,0
43805,had,0,0
43806,a,0,0
43807,significant,0,0
43808,tendency,0,0
43809,to,0,0
43810,deepen,0,0
43811,in,0,0
43812,their,0,0
43813,level,1,1
43814,of,1,0
43815,coma,1,1
43816,or,0,0
43817,to,0,0
43818,become,1,0
43819,sleepy,1,0
43820,within,0,0
43821,the,0,0
43822,4,0,0
43823,h,0,0
43824,after,0,0
43825,drug,0,0
43826,administration,0,0
43827,.,0,0
43828,Phenobarbitone,0,0
43829,was,0,0
43830,rapidly,0,0
43831,absorbed,0,0
43832,",",0,0
43833,reaching,0,0
43834,a,0,0
43835,mean,0,1
43836,(,0,0
43837,range,0,0
43838,),0,1
43839,peak,0,1
43840,concentration,0,1
43841,of,0,0
43842,34.2,0,0
43843,[,0,0
43844,29.3-42.6,0,0
43845,],0,0
43846,mumol.l-1,0,0
43847,in,0,0
43848,a,0,0
43849,median,0,1
43850,(,0,0
43851,range,0,0
43852,),0,0
43853,of,0,0
43854,4,0,0
43855,(,0,0
43856,2.5-12,0,0
43857,),0,0
43858,h.,0,0
43859,These,0,0
43860,values,0,0
43861,are,0,0
43862,comparable,0,0
43863,to,0,0
43864,those,0,0
43865,previously,0,0
43866,reported,0,0
43867,in,0,0
43868,healthy,0,0
43869,children,0,0
43870,and,0,0
43871,in,0,0
43872,children,0,0
43873,with,0,0
43874,febrile,1,0
43875,convulsions,1,0
43876,.,1,0
43877,Intramuscular,0,0
43878,phenobarbitone,0,0
43879,is,0,0
43880,well,0,0
43881,absorbed,0,0
43882,in,0,0
43883,children,0,0
43884,with,0,0
43885,severe,0,0
43886,malaria,0,0
43887,;,0,0
43888,the,0,0
43889,optimum,0,1
43890,prophylactic,0,0
43891,anticonvulsant,0,0
43892,dose,0,0
43893,remains,0,0
43894,to,0,0
43895,be,0,0
43896,determined,0,0
43897,.,0,0
43898,Creon,0,0
43899,"10,000",0,0
43900,Minimicrospheres,0,0
43901,vs.,0,0
43902,Creon,0,0
43903,"8,000",0,0
43904,microspheres,0,0
43905,--,0,0
43906,an,0,0
43907,open,0,0
43908,randomised,0,0
43909,crossover,0,0
43910,preference,0,0
43911,study,0,0
43912,.,0,0
43913,Creon,0,0
43914,"10,000",0,0
43915,Minimicrospherestrade,0,0
43916,mark,0,0
43917,(,0,0
43918,Creon,0,0
43919,),0,0
43920,"10,000",0,0
43921,MMS,0,0
43922,),0,0
43923,is,0,0
43924,a,0,0
43925,pancreatic,0,1
43926,enzyme,0,0
43927,formulation,0,0
43928,that,0,0
43929,contains,0,0
43930,smaller,0,0
43931,spheres,0,0
43932,of,0,1
43933,pancreatin,0,0
43934,in,0,0
43935,a,0,0
43936,50,0,0
43937,%,0,0
43938,smaller,0,0
43939,capsule,0,0
43940,than,0,0
43941,conventional,0,0
43942,microspheres,0,0
43943,(,0,0
43944,Creon,0,0
43945,),0,0
43946,"8,000",0,0
43947,),0,0
43948,.,0,0
43949,This,0,0
43950,three-centre,0,0
43951,study,0,0
43952,investigated,0,0
43953,the,0,0
43954,preference,1,0
43955,of,0,0
43956,cystic,0,0
43957,fibrosis,0,1
43958,(,0,0
43959,CF,0,1
43960,),0,0
43961,patients,0,0
43962,for,0,0
43963,these,0,0
43964,products,0,0
43965,.,0,0
43966,In,0,0
43967,one,0,0
43968,centre,0,0
43969,",",0,0
43970,72,0,0
43971,h,0,0
43972,stool,1,0
43973,fat,1,1
43974,excretion,1,1
43975,and,1,1
43976,coefficient,1,1
43977,of,1,1
43978,fat,1,1
43979,absorption,1,1
43980,(,1,0
43981,CFA,1,0
43982,),1,0
43983,were,0,0
43984,also,0,0
43985,compared,0,0
43986,.,0,0
43987,Fifty-nine,0,0
43988,patients,0,0
43989,with,0,0
43990,a,0,0
43991,mean,0,0
43992,age,0,0
43993,10,0,0
43994,years,0,0
43995,(,0,0
43996,range,0,0
43997,3-17,0,0
43998,),0,0
43999,took,0,0
44000,Creon,0,0
44001,"8,000",0,0
44002,ms,0,0
44003,for,0,0
44004,14,0,0
44005,days,0,0
44006,and,0,0
44007,were,0,0
44008,then,0,0
44009,randomised,0,0
44010,to,0,0
44011,28,0,0
44012,days,0,0
44013,of,0,0
44014,Creon,0,0
44015,"8,000",0,0
44016,ms,0,0
44017,followed,0,0
44018,by,0,0
44019,28,0,0
44020,days,0,0
44021,of,0,0
44022,Creon,0,0
44023,"10,000",0,0
44024,MMS,0,0
44025,",",0,0
44026,or,0,1
44027,vice,0,0
44028,versa,0,0
44029,.,0,0
44030,Dosing,0,0
44031,was,0,0
44032,lipase,0,1
44033,for,0,0
44034,lipase,0,0
44035,according,0,0
44036,to,0,0
44037,the,0,0
44038,labelled,0,0
44039,declaration,0,0
44040,.,0,0
44041,At,0,0
44042,the,0,0
44043,end,0,0
44044,of,0,0
44045,the,0,0
44046,second,0,0
44047,treatment,0,0
44048,period,0,0
44049,",",0,0
44050,51,0,0
44051,of,0,0
44052,54,0,0
44053,patients,0,0
44054,who,0,0
44055,completed,0,0
44056,the,0,0
44057,study,0,0
44058,expressed,0,0
44059,a,0,0
44060,preference,0,0
44061,",",0,0
44062,with,0,0
44063,a,0,0
44064,statistically,1,0
44065,significant,1,0
44066,preference,1,0
44067,in,0,0
44068,favour,0,0
44069,of,0,0
44070,Creon,0,0
44071,"10,000",0,0
44072,MMS,0,0
44073,(,0,0
44074,47/51,0,0
44075,;,0,0
44076,87,0,0
44077,%,0,0
44078,),0,0
44079,vs.,0,0
44080,Creon,0,0
44081,"8,000",0,0
44082,ms,0,0
44083,(,0,0
44084,4/51,0,0
44085,;,0,0
44086,7.4,0,0
44087,%,0,0
44088,;,0,0
44089,P,0,0
44090,<,0,0
44091,0.0001,0,0
44092,),0,0
44093,.,0,0
44094,Stool,1,0
44095,fat,1,1
44096,(,1,0
44097,g/day,1,0
44098,),1,1
44099,and,1,1
44100,CFA,1,1
44101,(,1,1
44102,%,1,0
44103,),1,0
44104,were,0,0
44105,measured,0,0
44106,in,0,0
44107,24,0,0
44108,patients,0,0
44109,at,0,0
44110,the,0,0
44111,end,0,0
44112,of,0,0
44113,each,0,0
44114,treatment,0,0
44115,period,0,0
44116,:,0,0
44117,the,0,0
44118,products,0,0
44119,were,0,0
44120,therapeutically,0,0
44121,equivalent,0,0
44122,(,0,0
44123,Creon,0,0
44124,"10,000",0,0
44125,:,0,0
44126,8.4,0,0
44127,g/day,0,0
44128,",",0,0
44129,91.3,0,0
44130,%,0,0
44131,CFA,0,0
44132,;,0,0
44133,Creon,0,0
44134,"8,000",0,0
44135,:,0,0
44136,6.7,0,0
44137,g/day,0,0
44138,",",0,0
44139,93.5,0,0
44140,%,0,0
44141,CFA,0,0
44142,),0,0
44143,.,0,0
44144,Both,0,0
44145,products,0,0
44146,were,0,0
44147,well,0,0
44148,tolerated,0,1
44149,.,0,0
44150,In,0,0
44151,conclusion,0,0
44152,",",0,0
44153,in,0,0
44154,CF,0,0
44155,children,0,0
44156,we,0,0
44157,found,0,0
44158,a,0,0
44159,clear,0,0
44160,preference,0,0
44161,for,0,0
44162,Creon,0,0
44163,"10,000",0,0
44164,MMS,0,0
44165,compared,0,0
44166,with,0,0
44167,Creon,0,0
44168,"8,000",0,0
44169,ms,0,0
44170,with,0,0
44171,no,0,0
44172,difference,0,0
44173,in,0,0
44174,fat,1,1
44175,absorption,1,0
44176,between,0,0
44177,the,0,0
44178,two,0,0
44179,products,0,0
44180,.,0,0
44181,Creon,0,0
44182,"10,000s",0,0
44183,smaller,0,0
44184,capsules,0,0
44185,are,0,0
44186,easier,0,0
44187,to,0,0
44188,take,0,0
44189,and,0,0
44190,should,0,0
44191,aid,0,0
44192,patient,0,0
44193,compliance,0,1
44194,.,0,0
44195,Effects,0,0
44196,of,0,0
44197,finasteride,0,0
44198,on,0,0
44199,the,0,0
44200,morphology,1,0
44201,of,1,0
44202,polycystic,1,0
44203,ovaries,1,0
44204,.,1,0
44205,The,0,0
44206,effect,0,0
44207,of,0,0
44208,calcium,0,0
44209,supplementation,0,0
44210,on,0,0
44211,bone,0,1
44212,density,0,1
44213,in,0,0
44214,premenarcheal,0,0
44215,females,0,0
44216,:,0,0
44217,a,0,0
44218,co-twin,0,0
44219,approach,0,0
44220,.,0,0
44221,The,0,0
44222,age,0,0
44223,and,0,0
44224,developmental,0,0
44225,stage,0,0
44226,at,0,0
44227,which,0,0
44228,calcium,0,0
44229,supplementation,0,0
44230,produces,0,0
44231,the,0,0
44232,greatest,0,0
44233,bone,0,0
44234,effects,0,0
44235,remain,0,0
44236,controversial,0,0
44237,.,0,0
44238,We,0,0
44239,tested,0,0
44240,the,0,0
44241,hypothesis,0,0
44242,that,0,0
44243,calcium,0,0
44244,supplementation,0,0
44245,may,0,0
44246,improve,0,0
44247,bone,1,1
44248,accrual,1,0
44249,in,0,0
44250,premenarcheal,0,0
44251,females,0,0
44252,.,0,0
44253,Fifty-one,0,0
44254,pairs,0,0
44255,of,0,0
44256,premenarcheal,0,0
44257,female,0,0
44258,twins,0,1
44259,(,0,0
44260,27,0,0
44261,monozygotic,0,0
44262,and,0,0
44263,24,0,0
44264,dizygotic,0,0
44265,;,0,0
44266,mean,0,1
44267,+/-,0,0
44268,sd,0,0
44269,age,0,0
44270,",",0,0
44271,10.3,0,0
44272,+/-,0,0
44273,1.5,0,0
44274,yr,0,0
44275,),0,0
44276,participated,0,0
44277,in,0,0
44278,a,0,0
44279,randomized,0,0
44280,",",0,0
44281,single-blind,0,0
44282,",",0,0
44283,placebo-controlled,0,0
44284,trial,0,0
44285,with,0,0
44286,one,0,0
44287,twin,0,0
44288,of,0,0
44289,each,0,0
44290,pair,0,0
44291,receiving,0,0
44292,a,0,0
44293,1200-mg,0,0
44294,calcium,0,0
44295,carbonate,0,0
44296,(,0,0
44297,Caltrate,0,0
44298,),0,0
44299,supplement,0,0
44300,.,0,0
44301,Areal,1,1
44302,bone,1,1
44303,mineral,1,1
44304,density,1,1
44305,(,1,0
44306,aBMD,1,1
44307,),1,0
44308,was,0,0
44309,measured,0,0
44310,at,0,0
44311,baseline,0,0
44312,and,0,0
44313,6,0,0
44314,",",0,0
44315,12,0,0
44316,",",0,0
44317,18,0,0
44318,and,0,0
44319,24,0,0
44320,months,0,0
44321,.,0,0
44322,There,0,0
44323,were,0,0
44324,no,0,0
44325,within-pair,0,0
44326,differences,0,0
44327,in,0,0
44328,height,0,1
44329,",",0,0
44330,weight,0,1
44331,",",0,1
44332,or,0,1
44333,calcium,0,1
44334,intake,0,1
44335,at,0,0
44336,baseline,0,0
44337,.,0,0
44338,Calcium,0,0
44339,supplementation,0,0
44340,was,0,0
44341,associated,0,0
44342,(,0,0
44343,P,0,0
44344,<,0,0
44345,0.05,0,0
44346,),0,0
44347,with,0,0
44348,increased,0,0
44349,aBMD,1,0
44350,compared,0,0
44351,with,0,0
44352,placebo,0,0
44353,",",0,0
44354,adjusted,0,0
44355,for,0,0
44356,age,0,0
44357,",",0,0
44358,height,0,1
44359,",",0,1
44360,and,0,1
44361,weight,0,1
44362,at,0,0
44363,the,0,0
44364,following,0,0
44365,time,0,1
44366,points,0,0
44367,from,0,0
44368,baseline,0,0
44369,:,0,0
44370,total,0,1
44371,hip,0,1
44372,",",0,0
44373,6,0,0
44374,months,0,0
44375,(,0,0
44376,1.9,0,0
44377,%,0,0
44378,),0,0
44379,",",0,0
44380,12,0,0
44381,months,0,0
44382,(,0,0
44383,1.6,0,0
44384,%,0,0
44385,),0,0
44386,",",0,0
44387,and,0,0
44388,18,0,0
44389,months,0,0
44390,(,0,0
44391,2.4,0,0
44392,%,0,0
44393,),0,0
44394,;,0,0
44395,lumbar,0,0
44396,spine,0,0
44397,",",0,0
44398,12,0,0
44399,months,0,0
44400,(,0,0
44401,1.0,0,0
44402,%,0,0
44403,),0,0
44404,;,0,0
44405,femoral,0,1
44406,neck,0,0
44407,",",0,0
44408,6,0,0
44409,months,0,0
44410,(,0,0
44411,1.9,0,0
44412,%,0,0
44413,),0,0
44414,.,0,0
44415,Adjusted,1,1
44416,total,1,1
44417,body,1,1
44418,bone,1,1
44419,mineral,1,1
44420,content,1,1
44421,was,0,0
44422,higher,0,0
44423,in,0,0
44424,the,0,0
44425,calcium,0,0
44426,group,0,0
44427,at,0,0
44428,6,0,0
44429,months,0,0
44430,(,0,0
44431,2.0,0,0
44432,%,0,0
44433,),0,0
44434,",",0,0
44435,12,0,0
44436,months,0,0
44437,(,0,0
44438,2.5,0,0
44439,%,0,0
44440,),0,0
44441,",",0,0
44442,18,0,0
44443,months,0,0
44444,(,0,0
44445,4.6,0,0
44446,%,0,0
44447,),0,0
44448,",",0,0
44449,and,0,0
44450,24,0,0
44451,months,0,0
44452,(,0,0
44453,3.7,0,0
44454,%,0,0
44455,),0,0
44456,",",0,0
44457,respectively,0,0
44458,(,0,0
44459,all,0,0
44460,P,0,0
44461,<,0,0
44462,0.001,0,0
44463,),0,0
44464,.,0,0
44465,Calcium,0,0
44466,supplementation,0,0
44467,was,0,0
44468,effective,0,0
44469,in,0,0
44470,increasing,0,0
44471,aBMD,1,1
44472,at,0,0
44473,regional,0,0
44474,sites,0,0
44475,over,0,0
44476,the,0,0
44477,first,0,0
44478,12-18,0,0
44479,months,0,0
44480,",",0,0
44481,but,0,0
44482,these,0,0
44483,gains,0,1
44484,were,0,0
44485,not,0,0
44486,maintained,0,0
44487,to,0,0
44488,24,0,0
44489,months,0,0
44490,.,0,0
44491,Endoscopic,0,1
44492,sphincterotomy,0,0
44493,by,0,0
44494,using,0,0
44495,pure-cut,0,0
44496,electrosurgical,0,0
44497,current,0,0
44498,and,0,0
44499,the,0,0
44500,risk,0,1
44501,of,0,0
44502,post-ERCP,0,0
44503,pancreatitis,0,0
44504,:,0,0
44505,a,0,0
44506,prospective,0,0
44507,randomized,0,0
44508,trial,0,0
44509,.,0,0
44510,BACKGROUND,0,0
44511,It,0,0
44512,has,0,0
44513,been,0,0
44514,suggested,0,0
44515,that,0,0
44516,the,0,0
44517,use,0,0
44518,of,0,0
44519,pure-cut,0,0
44520,electrosurgical,0,0
44521,current,0,0
44522,for,0,0
44523,endoscopic,0,0
44524,sphincterotomy,0,0
44525,may,0,0
44526,reduce,0,0
44527,the,0,0
44528,risk,0,0
44529,of,0,0
44530,post-ERCP,0,0
44531,pancreatitis,0,0
44532,.,0,0
44533,The,0,0
44534,aim,0,0
44535,of,0,0
44536,this,0,0
44537,study,0,0
44538,was,0,0
44539,to,0,0
44540,determine,0,0
44541,whether,0,0
44542,pure-cut,0,0
44543,current,0,0
44544,reduces,0,0
44545,the,0,0
44546,risk,0,0
44547,of,0,0
44548,pancreatitis,1,1
44549,compared,0,0
44550,with,0,0
44551,blend,0,0
44552,current,0,0
44553,.,0,0
44554,METHODS,0,0
44555,Patients,0,0
44556,were,0,0
44557,randomly,0,0
44558,assigned,0,0
44559,to,0,0
44560,undergo,0,0
44561,sphincterotomy,0,0
44562,over,0,0
44563,a,0,0
44564,non-conductive,0,0
44565,guidewire,0,0
44566,with,0,0
44567,30,0,0
44568,W/sec,0,0
44569,pure-cut,0,0
44570,current,0,0
44571,or,0,0
44572,30,0,0
44573,W/sec,0,0
44574,blend-2,0,0
44575,current,0,0
44576,by,0,0
44577,a,0,0
44578,blinded,0,0
44579,endoscopist,0,0
44580,.,0,0
44581,Serum,0,1
44582,amylase,0,1
44583,and,0,1
44584,lipase,0,1
44585,levels,0,1
44586,were,0,0
44587,determined,0,0
44588,1,0,0
44589,day,0,0
44590,before,0,0
44591,and,0,0
44592,within,0,0
44593,24,0,0
44594,hours,0,0
44595,after,0,0
44596,ERCP,0,0
44597,.,0,0
44598,Post-ERCP,1,1
44599,pancreatitis,1,1
44600,was,0,0
44601,the,0,0
44602,primary,0,0
44603,outcome,0,0
44604,of,0,0
44605,interest,0,0
44606,.,0,0
44607,Secondary,0,0
44608,outcomes,0,1
44609,were,0,0
44610,as,0,0
44611,follows,0,0
44612,:,0,0
44613,severity,1,1
44614,of,1,0
44615,immediate,1,1
44616,bleeding,1,1
44617,",",1,0
44618,as,1,0
44619,graded,1,0
44620,by,1,0
44621,a,1,0
44622,3-point,1,1
44623,scale,1,1
44624,from,1,0
44625,1,1,0
44626,(,1,0
44627,no,1,0
44628,bleeding,1,1
44629,),1,0
44630,to,1,0
44631,3,1,0
44632,(,1,0
44633,injection,1,0
44634,or,1,0
44635,balloon,1,0
44636,tamponade,1,1
44637,therapy,1,0
44638,required,1,0
44639,to,1,0
44640,stop,1,0
44641,bleeding,1,1
44642,),1,0
44643,and,1,0
44644,evidence,1,0
44645,of,1,1
44646,delayed,1,0
44647,bleeding,1,0
44648,24,1,0
44649,hours,1,0
44650,after,1,0
44651,ERCP,1,0
44652,.,1,0
44653,Analyses,0,0
44654,were,0,0
44655,performed,0,0
44656,in,0,0
44657,intention-to-treat,0,0
44658,fashion,0,0
44659,.,0,0
44660,RESULTS,0,0
44661,A,0,0
44662,total,0,0
44663,of,0,0
44664,246,0,0
44665,patients,0,0
44666,were,0,0
44667,randomized,0,0
44668,(,0,0
44669,116,0,0
44670,pure-cut,0,0
44671,current,0,0
44672,",",0,0
44673,130,0,0
44674,blend,0,0
44675,current,0,0
44676,),0,0
44677,.,0,0
44678,There,0,0
44679,were,0,0
44680,no,0,0
44681,differences,0,0
44682,in,0,0
44683,baseline,0,0
44684,characteristics,0,0
44685,between,0,0
44686,the,0,0
44687,groups,0,0
44688,.,0,0
44689,The,0,0
44690,overall,0,1
44691,frequency,0,1
44692,of,0,0
44693,post-ERCP,1,1
44694,pancreatitis,1,0
44695,was,0,0
44696,6.9,0,0
44697,%,0,0
44698,",",0,0
44699,with,0,0
44700,no,0,0
44701,significant,0,0
44702,difference,0,0
44703,in,0,0
44704,frequency,0,1
44705,between,0,0
44706,treatment,0,0
44707,arms,0,0
44708,(,0,0
44709,pure,0,0
44710,cut,0,0
44711,",",0,0
44712,7.8,0,0
44713,%,0,0
44714,vs.,0,0
44715,blend,0,0
44716,",",0,0
44717,6.1,0,0
44718,%,0,0
44719,;,0,0
44720,p,0,0
44721,=,0,0
44722,0.62,0,0
44723,),0,0
44724,.,0,0
44725,The,0,0
44726,difference,0,0
44727,in,0,0
44728,rates,0,1
44729,of,0,0
44730,pancreatitis,1,0
44731,between,0,0
44732,the,0,0
44733,two,0,0
44734,groups,0,0
44735,was,0,0
44736,1.7,0,0
44737,%,0,0
44738,:,0,0
44739,95,0,0
44740,%,0,0
44741,CI,0,0
44742,[,0,0
44743,-4.8,0,0
44744,%,0,0
44745,",",0,0
44746,8.2,0,0
44747,%,0,0
44748,],0,0
44749,.,0,0
44750,Six,0,0
44751,patients,0,0
44752,(,0,0
44753,2.4,0,0
44754,%,0,0
44755,),0,0
44756,had,0,0
44757,delayed,1,0
44758,bleeding,1,1
44759,after,0,0
44760,ERCP,0,0
44761,",",0,0
44762,of,0,0
44763,which,0,0
44764,two,0,0
44765,required,0,0
44766,transfusion,0,0
44767,.,0,0
44768,There,0,0
44769,was,0,0
44770,a,0,0
44771,significant,0,0
44772,increase,0,0
44773,in,0,0
44774,minor,1,0
44775,bleeding,1,1
44776,episodes,1,1
44777,(,0,0
44778,grade,0,0
44779,2,0,0
44780,),0,0
44781,in,0,0
44782,the,0,0
44783,pure-cut,0,0
44784,group,0,0
44785,(,0,0
44786,p,0,0
44787,<,0,0
44788,0.0001,0,0
44789,),0,0
44790,.,0,0
44791,Delayed,1,0
44792,episodes,1,1
44793,of,1,0
44794,bleeding,1,1
44795,were,0,0
44796,equal,0,0
44797,(,0,0
44798,n,0,0
44799,=,0,0
44800,3,0,0
44801,),0,0
44802,in,0,0
44803,each,0,0
44804,arm,0,0
44805,.,0,0
44806,CONCLUSIONS,0,0
44807,The,0,0
44808,type,0,0
44809,of,0,0
44810,current,0,0
44811,used,0,0
44812,when,0,0
44813,performing,0,0
44814,endoscopic,0,0
44815,sphincterotomy,0,0
44816,does,0,0
44817,not,0,0
44818,appear,0,0
44819,to,0,0
44820,alter,0,0
44821,the,0,0
44822,risk,0,0
44823,of,0,0
44824,post-ERCP,0,0
44825,pancreatitis,0,0
44826,.,0,0
44827,The,0,0
44828,selection,0,0
44829,of,0,0
44830,electrosurgical,0,0
44831,current,0,0
44832,for,0,0
44833,biliary,0,1
44834,endoscopic,0,0
44835,sphincterotomy,0,0
44836,should,0,0
44837,be,0,0
44838,based,0,0
44839,on,0,0
44840,endoscopist,0,0
44841,preference,0,0
44842,.,0,0
44843,[,0,0
44844,Long-term,0,0
44845,effects,0,0
44846,of,0,0
44847,7-year,0,0
44848,growth,0,0
44849,hormone,0,0
44850,substitution,0,0
44851,on,0,0
44852,bone,1,1
44853,metabolism,1,1
44854,",",1,1
44855,bone,1,1
44856,density,1,1
44857,",",1,1
44858,and,1,1
44859,bone,1,1
44860,quality,1,1
44861,in,0,0
44862,growth,0,1
44863,hormone-deficient,0,0
44864,adults,0,0
44865,],0,0
44866,.,0,0
44867,BACKGROUND,0,0
44868,AND,0,0
44869,PURPOSE,0,0
44870,Subnormal,1,1
44871,bone,1,1
44872,mineral,1,1
44873,density,1,1
44874,(,1,0
44875,BMD,1,1
44876,),1,0
44877,and,1,0
44878,increased,1,1
44879,fracture,1,1
44880,risk,1,0
44881,are,0,0
44882,described,0,0
44883,in,0,0
44884,patients,0,0
44885,with,0,0
44886,growth,0,1
44887,hormone,0,1
44888,deficiency,0,0
44889,(,0,0
44890,GHD,0,0
44891,),0,0
44892,.,0,0
44893,Growth,0,1
44894,hormone,0,1
44895,(,0,0
44896,GH,0,0
44897,),0,0
44898,has,0,0
44899,been,0,0
44900,reported,0,0
44901,to,0,0
44902,have,0,0
44903,beneficial,0,0
44904,effects,1,1
44905,on,1,0
44906,bone,1,1
44907,in,0,0
44908,GHD,0,0
44909,.,0,0
44910,The,0,0
44911,aim,0,0
44912,of,0,0
44913,this,0,0
44914,study,0,0
44915,was,0,0
44916,to,0,0
44917,investigate,0,0
44918,the,0,0
44919,long-term,0,0
44920,effects,0,0
44921,of,0,0
44922,GH,0,0
44923,replacement,0,0
44924,therapy,0,0
44925,on,0,0
44926,bone,1,1
44927,metabolism,1,1
44928,",",1,1
44929,BMD,1,1
44930,",",1,1
44931,and,1,1
44932,bone,1,1
44933,quality,1,1
44934,in,0,0
44935,patients,0,0
44936,with,0,0
44937,GHD,0,0
44938,.,0,0
44939,PATIENTS,0,0
44940,AND,0,0
44941,METHODS,0,0
44942,20,0,0
44943,adult,0,0
44944,patients,0,0
44945,with,0,0
44946,GHD,0,1
44947,(,0,0
44948,eleven,0,0
44949,male,0,0
44950,",",0,0
44951,nine,0,0
44952,female,0,0
44953,",",0,0
44954,mean,0,1
44955,age,0,0
44956,42.5,0,0
44957,years,0,0
44958,),0,0
44959,were,0,0
44960,included,0,0
44961,in,0,0
44962,the,0,0
44963,study,0,0
44964,and,0,0
44965,randomized,0,0
44966,to,0,0
44967,either,0,0
44968,GH,0,0
44969,or,0,0
44970,placebo,0,0
44971,in,0,0
44972,a,0,0
44973,dose,0,0
44974,of,0,0
44975,0.25,0,0
44976,U/kg,0,0
44977,body,0,0
44978,weight/week,0,0
44979,.,0,0
44980,After,0,0
44981,6,0,0
44982,months,0,0
44983,all,0,0
44984,patients,0,0
44985,received,0,0
44986,GH,0,0
44987,.,0,0
44988,After,0,0
44989,a,0,0
44990,1-year,0,0
44991,double-blind,0,0
44992,",",0,0
44993,placebo-controlled,0,0
44994,study,0,0
44995,the,0,0
44996,patients,0,0
44997,were,0,0
44998,followed,0,0
44999,for,0,0
45000,another,0,0
45001,72,0,0
45002,months,0,0
45003,in,0,0
45004,an,0,0
45005,open,0,0
45006,study,0,0
45007,.,0,0
45008,The,0,0
45009,patients,0,0
45010,were,0,0
45011,compared,0,0
45012,to,0,0
45013,20,0,0
45014,age-,0,0
45015,und,0,0
45016,sex-matched,0,0
45017,healthy,0,0
45018,controls,0,0
45019,.,0,0
45020,Bone,1,0
45021,turnover,1,1
45022,was,0,0
45023,determined,0,0
45024,by,0,0
45025,ICTP,0,0
45026,(,0,0
45027,type,0,0
45028,I,0,0
45029,collagen,0,0
45030,carboxyterminal,0,1
45031,cross-linked,0,0
45032,telopeptide,0,1
45033,),0,0
45034,as,0,0
45035,parameter,0,1
45036,of,0,0
45037,bone,0,1
45038,resorption,0,1
45039,and,0,1
45040,PICP,0,1
45041,(,0,0
45042,carboxyterminal,0,1
45043,propeptide,0,1
45044,of,0,0
45045,type,0,0
45046,I,0,0
45047,procollagen,0,1
45048,),0,0
45049,as,0,0
45050,marker,0,1
45051,of,0,0
45052,bone,0,1
45053,formation,0,1
45054,.,0,0
45055,BMD,1,1
45056,was,0,0
45057,measured,0,0
45058,at,0,0
45059,the,0,0
45060,lumbar,0,0
45061,spine,0,0
45062,by,0,0
45063,dual-photon,0,0
45064,absorptiometry,0,1
45065,(,0,0
45066,DPA,0,1
45067,),0,0
45068,and,0,0
45069,at,0,0
45070,the,0,0
45071,forearm,0,0
45072,by,0,0
45073,single-photon,0,0
45074,absorptiometry,0,1
45075,(,0,0
45076,SPA,0,0
45077,),0,0
45078,.,0,0
45079,Apparent,1,0
45080,phalangeal,1,1
45081,ultrasound,1,1
45082,transmission,1,1
45083,velocity,1,1
45084,(,1,0
45085,APU,1,1
45086,),1,0
45087,was,0,0
45088,assessed,0,0
45089,as,0,0
45090,parameter,0,0
45091,of,0,0
45092,bone,0,1
45093,quality,0,1
45094,independent,0,0
45095,of,0,0
45096,BMD,0,1
45097,.,0,0
45098,RESULTS,0,0
45099,At,0,0
45100,the,0,0
45101,beginning,0,0
45102,of,0,0
45103,the,0,0
45104,study,0,0
45105,BMD,1,1
45106,at,0,0
45107,both,0,0
45108,measuring,0,0
45109,sites,0,0
45110,was,0,0
45111,lower,0,0
45112,in,0,0
45113,patients,0,0
45114,with,0,0
45115,GHD,0,0
45116,than,0,0
45117,in,0,0
45118,healthy,0,0
45119,controls,0,0
45120,.,0,0
45121,During,0,0
45122,the,0,0
45123,1st,0,0
45124,year,0,0
45125,of,0,0
45126,GH,0,0
45127,replacement,0,0
45128,therapy,0,0
45129,BMD,1,1
45130,decreased,0,0
45131,",",0,0
45132,followed,0,0
45133,by,0,0
45134,a,0,0
45135,continuous,0,0
45136,increase,0,0
45137,in,0,0
45138,BMD,1,1
45139,(,0,0
45140,about,0,0
45141,12,0,0
45142,%,0,0
45143,),0,0
45144,up,0,0
45145,to,0,0
45146,60,0,0
45147,months,0,0
45148,which,0,0
45149,remained,0,0
45150,unchanged,0,0
45151,thereafter,0,0
45152,",",0,0
45153,building,0,0
45154,up,0,0
45155,a,0,0
45156,plateau,0,0
45157,.,0,0
45158,After,0,0
45159,72,0,0
45160,months,0,0
45161,no,0,0
45162,significant,0,0
45163,difference,0,0
45164,between,0,0
45165,the,0,0
45166,patients,0,0
45167,and,0,0
45168,the,0,0
45169,healthy,0,0
45170,controls,0,0
45171,could,0,0
45172,be,0,0
45173,detected,0,0
45174,.,0,0
45175,Concerning,0,0
45176,parameters,0,1
45177,of,0,0
45178,bone,1,1
45179,turnover,1,1
45180,",",1,0
45181,first,1,0
45182,ICTP,1,0
45183,as,0,0
45184,marker,1,1
45185,of,1,0
45186,bone,1,1
45187,resorption,1,1
45188,showed,0,0
45189,a,0,0
45190,significant,0,0
45191,increase,0,0
45192,",",0,0
45193,later,0,0
45194,on,0,0
45195,the,0,0
45196,marker,1,1
45197,of,1,0
45198,bone,1,1
45199,formation,1,1
45200,increased,0,0
45201,as,0,0
45202,well,0,0
45203,.,0,0
45204,APU,1,1
45205,decreased,0,0
45206,during,0,0
45207,the,0,0
45208,first,0,0
45209,6,0,0
45210,months,0,0
45211,of,0,0
45212,treatment,0,0
45213,",",0,0
45214,but,0,0
45215,had,0,0
45216,returned,0,0
45217,to,0,0
45218,its,0,0
45219,baseline,0,0
45220,value,0,0
45221,after,0,0
45222,24,0,0
45223,months,0,0
45224,and,0,0
45225,remained,0,0
45226,unchanged,0,0
45227,throughout,0,0
45228,the,0,0
45229,rest,0,0
45230,of,0,0
45231,the,0,0
45232,study,0,0
45233,.,0,0
45234,CONCLUSION,0,0
45235,BMD,1,1
45236,is,0,0
45237,subnormal,0,1
45238,in,0,0
45239,adults,0,0
45240,with,0,0
45241,GHD,0,0
45242,.,0,0
45243,GH,0,0
45244,replacement,0,0
45245,therapy,0,0
45246,stimulates,0,0
45247,bone,1,0
45248,turnover,1,0
45249,in,0,0
45250,patients,0,0
45251,with,0,0
45252,GHD,0,1
45253,and,0,0
45254,in,0,0
45255,the,0,0
45256,long,0,0
45257,term,0,1
45258,such,0,0
45259,stimulation,0,0
45260,results,0,0
45261,in,0,0
45262,an,0,0
45263,increased,0,0
45264,BMD,1,1
45265,.,1,0
45266,Thereby,0,0
45267,",",0,0
45268,GH,0,0
45269,shows,0,0
45270,a,0,0
45271,triphasic,0,0
45272,action,0,1
45273,on,0,0
45274,BMD,1,1
45275,:,1,0
45276,an,0,0
45277,initial,0,0
45278,decrease,0,0
45279,in,0,0
45280,BMD,1,1
45281,during,0,0
45282,the,0,0
45283,1st,0,0
45284,year,0,0
45285,",",0,0
45286,followed,0,0
45287,by,0,0
45288,a,0,0
45289,continuous,0,0
45290,increase,0,0
45291,in,0,0
45292,BMD,1,1
45293,with,0,0
45294,buildup,0,0
45295,of,0,0
45296,a,0,0
45297,stable,0,0
45298,plateau,0,0
45299,after,0,0
45300,60,0,0
45301,months,0,0
45302,.,0,0
45303,The,0,0
45304,newly,0,0
45305,formed,0,0
45306,bone,0,0
45307,seems,0,0
45308,to,0,0
45309,have,0,0
45310,normal,1,0
45311,bone,1,1
45312,elasticity,1,1
45313,.,1,0
45314,A,0,0
45315,randomized,0,0
45316,multicenter,0,0
45317,trial,0,0
45318,comparing,0,0
45319,resection,0,0
45320,and,0,1
45321,radiochemotherapy,0,0
45322,for,0,0
45323,resectable,0,0
45324,locally,0,0
45325,invasive,0,0
45326,pancreatic,0,0
45327,cancer,0,0
45328,.,0,0
45329,BACKGROUND,0,0
45330,Though,0,0
45331,the,0,0
45332,outcome,0,0
45333,of,0,0
45334,resection,0,0
45335,for,0,0
45336,locally,0,0
45337,invasive,0,0
45338,pancreatic,0,0
45339,cancer,0,0
45340,is,0,0
45341,still,0,0
45342,poor,0,0
45343,",",0,0
45344,it,0,0
45345,has,0,0
45346,gradually,0,0
45347,improved,0,0
45348,in,0,0
45349,Japan,0,0
45350,",",0,0
45351,and,0,0
45352,the,0,0
45353,5-year,1,0
45354,survival,1,1
45355,is,0,0
45356,now,0,0
45357,about,0,0
45358,10,0,0
45359,%,0,0
45360,.,0,0
45361,However,0,0
45362,",",0,0
45363,the,0,0
45364,advantage,0,0
45365,of,0,0
45366,resection,0,0
45367,over,0,0
45368,radiochemotherapy,0,0
45369,has,0,0
45370,not,0,0
45371,yet,0,0
45372,been,0,0
45373,confirmed,0,0
45374,by,0,0
45375,a,0,0
45376,randomized,0,0
45377,trial,0,0
45378,.,0,0
45379,We,0,0
45380,conducted,0,0
45381,this,0,0
45382,study,0,0
45383,to,0,0
45384,compare,0,0
45385,surgical,0,0
45386,resection,0,0
45387,alone,0,0
45388,versus,0,0
45389,radiochemotherapy,0,0
45390,without,0,0
45391,resection,0,0
45392,for,0,0
45393,locally,0,0
45394,invasive,0,0
45395,pancreatic,0,1
45396,cancer,0,0
45397,using,0,0
45398,a,0,0
45399,multicenter,0,0
45400,randomized,0,0
45401,design,0,0
45402,.,0,0
45403,METHODS,0,0
45404,Patients,0,0
45405,with,0,0
45406,pancreatic,0,0
45407,cancer,0,0
45408,who,0,0
45409,met,0,0
45410,our,0,0
45411,preoperative,0,0
45412,criteria,0,0
45413,for,0,0
45414,inclusion,0,0
45415,(,0,0
45416,pancreatic,0,1
45417,cancer,0,0
45418,invading,0,0
45419,the,0,0
45420,pancreatic,0,1
45421,capsule,0,0
45422,without,0,0
45423,involvement,0,0
45424,of,0,0
45425,the,0,0
45426,superior,0,0
45427,mesenteric,0,1
45428,artery,0,0
45429,or,0,0
45430,the,0,0
45431,common,0,0
45432,hepatic,0,0
45433,artery,0,1
45434,",",0,0
45435,or,0,0
45436,without,0,0
45437,distant,0,1
45438,metastasis,0,1
45439,),0,0
45440,underwent,0,0
45441,laparotomy,0,0
45442,.,0,0
45443,Patients,0,0
45444,with,0,0
45445,operative,0,1
45446,findings,0,0
45447,consistent,0,0
45448,with,0,0
45449,our,0,0
45450,criteria,0,0
45451,were,0,0
45452,randomized,0,0
45453,into,0,0
45454,a,0,0
45455,radical,0,0
45456,resection,0,0
45457,group,0,0
45458,and,0,0
45459,a,0,0
45460,radiochemotherapy,0,0
45461,group,0,0
45462,(,0,0
45463,200,0,0
45464,mg/m,0,0
45465,(,0,0
45466,2,0,0
45467,),0,0
45468,/day,0,0
45469,of,0,0
45470,intravenous,0,0
45471,5-fluorouracil,0,0
45472,and,0,0
45473,5040,0,0
45474,cGy,0,0
45475,of,0,0
45476,radiotherapy,0,0
45477,),0,0
45478,without,0,0
45479,resection,0,0
45480,.,0,0
45481,The,0,0
45482,2,0,0
45483,groups,0,0
45484,were,0,0
45485,compared,0,0
45486,for,0,0
45487,mean,1,1
45488,survival,1,1
45489,",",1,0
45490,hazard,1,1
45491,ratio,1,1
45492,",",1,0
45493,1-year,1,1
45494,survival,1,1
45495,",",1,0
45496,quality,1,1
45497,of,1,1
45498,life,1,1
45499,scores,1,1
45500,",",1,0
45501,and,1,1
45502,hematologic,1,1
45503,and,1,1
45504,blood,1,1
45505,chemical,1,1
45506,data,1,0
45507,.,1,0
45508,RESULTS,0,0
45509,Twenty,0,0
45510,patients,0,0
45511,were,0,0
45512,assigned,0,0
45513,to,0,0
45514,the,0,0
45515,resection,0,0
45516,group,0,0
45517,and,0,0
45518,22,0,0
45519,to,0,0
45520,the,0,0
45521,radiochemotherapy,0,0
45522,group,0,0
45523,.,0,0
45524,There,0,0
45525,was,0,0
45526,1,0,0
45527,operative,1,0
45528,death,1,0
45529,.,1,0
45530,The,0,0
45531,surgical,0,0
45532,resection,0,0
45533,group,0,0
45534,had,0,0
45535,better,0,0
45536,results,0,0
45537,than,0,0
45538,the,0,0
45539,radiochemotherapy,0,0
45540,group,0,0
45541,as,0,0
45542,measured,0,0
45543,by,0,0
45544,1-year,1,0
45545,survival,1,1
45546,(,0,0
45547,62,0,0
45548,%,0,0
45549,vs,0,0
45550,32,0,0
45551,%,0,0
45552,",",0,0
45553,P=.05,0,1
45554,),0,0
45555,",",0,0
45556,mean,1,1
45557,survival,1,1
45558,time,1,1
45559,(,0,0
45560,>,0,0
45561,17,0,0
45562,vs,0,0
45563,11,0,0
45564,months,0,0
45565,",",0,0
45566,P,0,0
45567,<,0,0
45568,.03,0,0
45569,),0,0
45570,",",0,0
45571,and,0,0
45572,hazard,1,1
45573,ratio,1,1
45574,(,0,0
45575,0.46,0,0
45576,",",0,0
45577,P=.04,0,0
45578,),0,0
45579,.,0,0
45580,There,0,0
45581,were,0,0
45582,no,0,0
45583,differences,0,0
45584,in,0,0
45585,the,0,0
45586,quality,1,1
45587,of,1,0
45588,life,1,1
45589,score,1,1
45590,or,0,0
45591,laboratory,1,1
45592,data,1,0
45593,apart,0,0
45594,from,0,0
45595,increased,0,0
45596,diarrhea,1,1
45597,after,0,0
45598,surgical,0,0
45599,resection,0,0
45600,.,0,0
45601,CONCLUSIONS,0,0
45602,Locally,0,0
45603,invasive,0,0
45604,pancreatic,0,1
45605,cancer,0,0
45606,without,0,0
45607,distant,0,1
45608,metastases,0,0
45609,and,0,0
45610,major,0,1
45611,arterial,0,1
45612,invasion,0,1
45613,appears,0,0
45614,to,0,0
45615,be,0,0
45616,best,0,0
45617,treated,0,0
45618,by,0,0
45619,surgical,0,0
45620,resection,0,0
45621,.,0,0
45622,A,0,0
45623,randomized,0,0
45624,crossover,0,0
45625,study,0,0
45626,investigating,0,0
45627,the,0,0
45628,influence,0,0
45629,of,0,0
45630,ranitidine,0,0
45631,or,0,0
45632,omeprazole,0,0
45633,on,0,0
45634,the,0,0
45635,pharmacokinetics,1,0
45636,of,1,0
45637,cephalexin,1,0
45638,monohydrate,1,0
45639,.,1,0
45640,Limited,0,0
45641,data,0,0
45642,characterize,0,0
45643,pharmacokinetic,0,1
45644,interactions,0,0
45645,between,0,0
45646,cephalexin,0,0
45647,and,0,1
45648,ranitidine,0,0
45649,",",0,0
45650,and,0,0
45651,no,0,0
45652,data,0,0
45653,exist,0,0
45654,for,0,0
45655,an,0,0
45656,interaction,0,1
45657,with,0,0
45658,proton,0,0
45659,pump,0,0
45660,inhibitors,0,0
45661,.,0,0
45662,The,0,0
45663,purpose,0,0
45664,of,0,0
45665,this,0,0
45666,study,0,0
45667,was,0,0
45668,to,0,0
45669,investigate,0,0
45670,the,0,0
45671,effects,0,0
45672,of,0,0
45673,ranitidine,0,0
45674,or,0,0
45675,omeprazole,0,0
45676,administration,0,0
45677,on,0,0
45678,the,0,0
45679,pharmacokinetics,1,1
45680,and,1,0
45681,pharmacodynamics,1,0
45682,of,1,0
45683,cephalexin,1,0
45684,.,1,0
45685,A,0,0
45686,randomized,0,0
45687,single-,0,0
45688,and,0,0
45689,multiple-dose,0,0
45690,crossover,0,0
45691,study,0,0
45692,was,0,0
45693,conducted,0,0
45694,in,0,0
45695,healthy,0,0
45696,subjects,0,0
45697,ingesting,0,0
45698,cephalexin,0,0
45699,before,0,0
45700,and,0,0
45701,after,0,0
45702,steady-state,0,1
45703,administration,0,0
45704,of,0,0
45705,ranitidine,0,0
45706,or,0,0
45707,omeprazole,0,0
45708,.,0,1
45709,Time-concentration,1,1
45710,profiles,0,1
45711,were,0,0
45712,determined,0,0
45713,and,0,0
45714,pharmacokinetic,1,1
45715,parameters,1,1
45716,were,0,0
45717,characterized,0,0
45718,using,0,0
45719,noncompartmental,0,0
45720,methods,0,0
45721,.,0,0
45722,Pharmacokinetic,0,1
45723,data,0,0
45724,were,0,0
45725,analyzed,0,0
45726,in,0,0
45727,accordance,0,0
45728,with,0,0
45729,the,0,0
45730,two,0,0
45731,1-sided,0,0
45732,test,0,0
45733,for,0,0
45734,bioequivalence,0,0
45735,.,0,0
45736,The,0,0
45737,percentage,1,1
45738,of,1,0
45739,time,1,1
45740,that,1,0
45741,serum,1,1
45742,concentrations,1,1
45743,remain,1,0
45744,above,1,0
45745,the,1,0
45746,MIC,1,0
45747,(,1,0
45748,90,1,0
45749,),1,0
45750,during,1,0
45751,the,1,0
45752,dosing,1,0
45753,interval,1,0
45754,(,1,0
45755,T,1,1
45756,>,1,0
45757,MIC,1,0
45758,(,1,0
45759,90,1,0
45760,),1,0
45761,),1,0
45762,for,1,0
45763,Streptococcus,1,0
45764,pyogenes,1,0
45765,and,1,0
45766,Staphylococcus,1,1
45767,aureus,1,0
45768,associated,1,0
45769,with,1,0
45770,the,1,0
45771,pharmacokinetic,1,0
45772,profiles,1,0
45773,was,1,0
45774,calculated,1,0
45775,.,1,0
45776,The,0,0
45777,coadministration,0,0
45778,of,0,0
45779,cephalexin,0,0
45780,with,0,0
45781,ranitidine,0,0
45782,or,0,0
45783,omeprazole,0,0
45784,resulted,0,0
45785,in,0,0
45786,relatively,0,0
45787,minor,0,0
45788,changes,0,1
45789,in,0,0
45790,C,1,0
45791,(,1,0
45792,max,1,1
45793,),1,0
45794,",",1,0
45795,AUC,1,0
45796,(,1,1
45797,infinity,1,1
45798,),1,0
45799,",",1,0
45800,t,1,0
45801,(,1,0
45802,1/2,1,0
45803,),1,0
45804,",",1,0
45805,or,1,0
45806,CL/F,1,1
45807,.,1,1
45808,t,1,0
45809,(,1,0
45810,max,1,1
45811,),1,0
45812,was,0,0
45813,significantly,0,0
45814,prolonged,0,0
45815,when,0,0
45816,cephalexin,0,0
45817,was,0,0
45818,administered,0,0
45819,with,0,0
45820,ranitidine,0,0
45821,or,0,0
45822,omeprazole,0,0
45823,.,0,0
45824,Suboptimal,1,0
45825,T,1,0
45826,>,1,0
45827,MIC,1,0
45828,(,1,0
45829,90,1,0
45830,),1,0
45831,was,0,0
45832,observed,0,0
45833,for,0,0
45834,cephalexin,0,0
45835,irrespective,0,0
45836,of,0,0
45837,acid,0,0
45838,suppression,0,1
45839,.,0,0
45840,Delay,0,0
45841,in,0,0
45842,absorption,0,1
45843,of,0,0
45844,cephalexin,0,0
45845,resulted,0,0
45846,in,0,0
45847,a,0,0
45848,decrease,0,0
45849,in,0,0
45850,the,0,0
45851,percentage,0,1
45852,of,0,0
45853,T,1,0
45854,>,1,0
45855,MIC,1,0
45856,(,1,0
45857,90,1,0
45858,),1,0
45859,for,0,0
45860,certain,0,0
45861,acid-suppressive,0,0
45862,regimens,0,0
45863,and,0,1
45864,pathogen,0,1
45865,combinations,0,0
45866,.,0,0
45867,With,0,0
45868,the,0,0
45869,exception,0,0
45870,of,0,0
45871,an,0,0
45872,increase,0,0
45873,in,0,0
45874,t,1,0
45875,(,1,0
45876,max,1,1
45877,),1,0
45878,",",0,0
45879,there,0,0
45880,were,0,0
45881,no,0,0
45882,significant,0,0
45883,pharmacokinetic,0,0
45884,interactions,0,0
45885,between,0,0
45886,cephalexin,0,0
45887,and,0,1
45888,ranitidine,0,0
45889,or,0,0
45890,omeprazole,0,0
45891,.,0,0
45892,Delayed,0,0
45893,t,1,0
45894,(,1,0
45895,max,1,1
45896,),1,0
45897,associated,0,0
45898,with,0,0
45899,acid,0,0
45900,suppression,0,0
45901,may,0,0
45902,result,0,0
45903,in,0,0
45904,a,0,0
45905,diminished,0,1
45906,T,0,0
45907,>,0,0
45908,MIC,0,0
45909,(,0,0
45910,90,0,0
45911,),0,0
45912,.,0,0
45913,[,0,0
45914,Study,0,0
45915,on,0,0
45916,treatment,0,0
45917,of,0,0
45918,iron-deficiency,0,0
45919,anemia,0,1
45920,by,0,0
45921,shengxuening,0,0
45922,],0,0
45923,.,0,0
45924,OBJECTIVE,0,0
45925,To,0,0
45926,observe,0,0
45927,the,0,0
45928,therapeutic,0,0
45929,effect,0,0
45930,of,0,0
45931,shengxuening,0,0
45932,(,0,0
45933,SXN,0,0
45934,),0,0
45935,in,0,0
45936,treating,0,0
45937,iron-deficiency,0,0
45938,anemia,0,1
45939,(,0,0
45940,IDA,0,1
45941,),0,0
45942,and,0,0
45943,to,0,0
45944,explore,0,0
45945,its,0,0
45946,molecular,0,0
45947,mechanism,0,0
45948,on,0,0
45949,iron,0,0
45950,metabolism,0,1
45951,balance,0,1
45952,regulation,0,0
45953,.,0,0
45954,METHODS,0,0
45955,Patients,0,0
45956,with,0,0
45957,IDA,0,0
45958,were,0,0
45959,randomly,0,0
45960,divided,0,0
45961,into,0,0
45962,the,0,0
45963,treated,0,0
45964,group,0,0
45965,and,0,0
45966,the,0,0
45967,control,0,0
45968,group,0,0
45969,",",0,0
45970,50,0,0
45971,in,0,0
45972,each,0,0
45973,group,0,0
45974,.,0,0
45975,They,0,0
45976,were,0,0
45977,treated,0,0
45978,with,0,0
45979,SXN,0,0
45980,(,0,0
45981,0.1,0,0
45982,g,0,0
45983,",",0,0
45984,three,0,0
45985,times,0,0
45986,per,0,0
45987,day,0,0
45988,),0,0
45989,and,0,0
45990,ferrous,0,0
45991,gluconate,0,0
45992,(,0,0
45993,0.1,0,0
45994,g,0,0
45995,",",0,0
45996,three,0,0
45997,times,0,0
45998,per,0,0
45999,day,0,0
46000,),0,0
46001,respectively,0,0
46002,",",0,0
46003,for,0,0
46004,30,0,0
46005,days,0,0
46006,.,0,0
46007,Levels,1,0
46008,of,1,0
46009,serum,1,1
46010,iron,1,0
46011,(,1,0
46012,Fe,1,0
46013,),1,0
46014,",",1,0
46015,total,1,1
46016,iron,1,0
46017,binding,1,1
46018,capacity,1,1
46019,(,1,0
46020,TIBC,1,1
46021,),1,0
46022,",",1,0
46023,transferrin,1,1
46024,saturation,1,1
46025,(,1,0
46026,TS,1,0
46027,),1,0
46028,",",1,0
46029,serum,1,1
46030,ferritin,1,1
46031,(,1,0
46032,SF,1,0
46033,),1,0
46034,",",1,0
46035,transferrin,1,1
46036,(,1,1
46037,Tf,1,0
46038,),1,0
46039,",",1,0
46040,soluble,1,1
46041,transferrin,1,1
46042,receptor,1,1
46043,(,1,0
46044,sTfR,1,1
46045,),1,1
46046,and,1,0
46047,blood,1,1
46048,routine,1,0
46049,test,1,1
46050,",",1,0
46051,as,1,0
46052,well,1,0
46053,as,1,0
46054,scoring,1,1
46055,of,1,0
46056,TCM,1,0
46057,qi-blood,1,0
46058,deficiency,1,0
46059,Syndrome,1,1
46060,were,0,0
46061,conducted,0,0
46062,before,0,0
46063,and,0,0
46064,after,0,0
46065,treatment,0,0
46066,.,0,0
46067,RESULTS,0,0
46068,The,0,0
46069,total,0,1
46070,effective,0,0
46071,rate,0,1
46072,in,0,0
46073,the,0,0
46074,treated,0,0
46075,group,0,0
46076,reached,0,0
46077,92,0,0
46078,%,0,0
46079,",",0,0
46080,it,0,0
46081,was,0,0
46082,shown,0,0
46083,that,0,0
46084,SXN,0,0
46085,could,0,0
46086,improve,0,0
46087,the,0,0
46088,iron,1,0
46089,metabolism,1,1
46090,",",1,0
46091,increase,1,1
46092,levels,1,1
46093,of,1,0
46094,Fe,1,0
46095,",",1,0
46096,TS,1,0
46097,",",1,1
46098,SF,1,0
46099,and,1,1
46100,reduce,1,0
46101,levels,1,1
46102,of,1,0
46103,TIBC,1,1
46104,",",1,0
46105,Tf,1,0
46106,",",1,1
46107,sTfR,1,1
46108,",",0,0
46109,it,0,0
46110,has,0,0
46111,obvious,0,1
46112,effect,0,0
46113,in,0,0
46114,promoting,0,0
46115,erythrocyte,0,1
46116,generation,0,0
46117,and,0,0
46118,could,0,0
46119,promote,0,0
46120,formation,0,1
46121,of,0,0
46122,leucocytes,0,1
46123,and,0,0
46124,platelets,0,1
46125,.,0,0
46126,The,0,0
46127,total,1,1
46128,effective,1,0
46129,rate,1,1
46130,in,0,0
46131,the,0,0
46132,control,0,0
46133,group,0,0
46134,was,0,0
46135,32,0,0
46136,%,0,0
46137,",",0,0
46138,which,0,0
46139,was,0,0
46140,significantly,0,0
46141,lower,0,0
46142,than,0,0
46143,that,0,0
46144,in,0,0
46145,the,0,0
46146,treated,0,0
46147,group,0,0
46148,(,0,0
46149,P,0,0
46150,<,0,0
46151,0.01,0,0
46152,),0,0
46153,.,0,0
46154,CONCLUSION,0,0
46155,The,0,0
46156,effect,0,0
46157,of,0,0
46158,SXN,0,0
46159,in,0,0
46160,treating,0,0
46161,IDA,0,1
46162,and,0,0
46163,qi-blood,0,1
46164,deficiency,0,0
46165,Syndrome,0,0
46166,is,0,0
46167,evident,0,0
46168,",",0,0
46169,it,0,0
46170,could,0,0
46171,improve,0,0
46172,the,0,0
46173,iron,0,0
46174,metabolism,0,1
46175,",",0,0
46176,increase,0,1
46177,levels,0,1
46178,of,0,0
46179,Fe,0,0
46180,",",0,0
46181,TS,0,0
46182,",",0,1
46183,SF,0,0
46184,and,0,1
46185,lower,0,0
46186,levels,0,1
46187,of,0,1
46188,TIBC,0,1
46189,",",0,0
46190,Tf,0,0
46191,",",0,0
46192,sTfR,0,1
46193,.,0,0
46194,5,0,0
46195,%,0,0
46196,imiquimod,0,0
46197,cream,0,0
46198,and,0,0
46199,reflectance-mode,0,0
46200,confocal,0,0
46201,microscopy,0,0
46202,as,0,0
46203,adjunct,0,0
46204,modalities,0,0
46205,to,0,0
46206,Mohs,0,1
46207,micrographic,0,0
46208,surgery,0,0
46209,for,0,0
46210,treatment,0,0
46211,of,0,0
46212,basal,0,1
46213,cell,0,0
46214,carcinoma,0,0
46215,.,0,0
46216,BACKGROUND,0,0
46217,Imiquimod,0,0
46218,is,0,0
46219,an,0,0
46220,immune,0,0
46221,response,0,1
46222,modifier,0,0
46223,that,0,0
46224,up-regulates,0,1
46225,cytokines,0,1
46226,and,0,0
46227,has,0,0
46228,been,0,0
46229,shown,0,0
46230,in,0,0
46231,clinical,0,0
46232,studies,0,0
46233,to,0,0
46234,reduce,0,0
46235,or,0,0
46236,clear,0,0
46237,basal,0,1
46238,cell,0,1
46239,carcinoma,0,0
46240,tumors,0,1
46241,when,0,0
46242,applied,0,0
46243,topically,0,0
46244,.,0,0
46245,OBJECTIVE,0,0
46246,The,0,0
46247,objectives,0,0
46248,were,0,0
46249,to,0,0
46250,evaluate,0,0
46251,the,0,0
46252,efficacy,0,0
46253,of,0,0
46254,5,0,0
46255,%,0,0
46256,imiquimod,0,0
46257,cream,0,0
46258,in,0,0
46259,treating,0,0
46260,basal,0,1
46261,cell,0,1
46262,carcinoma,0,0
46263,preceding,0,0
46264,excision,0,0
46265,by,0,0
46266,Mohs,0,1
46267,micrographic,0,0
46268,surgery,0,0
46269,and,0,0
46270,to,0,0
46271,determine,0,0
46272,if,0,0
46273,reflectance-mode,0,0
46274,confocal,0,0
46275,microscopy,0,0
46276,is,0,0
46277,useful,0,0
46278,to,0,0
46279,establish,0,0
46280,the,0,0
46281,need,0,0
46282,for,0,0
46283,surgical,0,0
46284,intervention,0,0
46285,after,0,0
46286,imiquimod,0,0
46287,treatment,0,0
46288,.,0,0
46289,METHODS,0,0
46290,Subjects,0,0
46291,applied,0,0
46292,study,0,0
46293,cream,0,0
46294,to,0,0
46295,one,0,0
46296,biopsy-confirmed,0,0
46297,basal,0,0
46298,cell,0,1
46299,carcinoma,0,0
46300,tumor,0,0
46301,5,0,0
46302,x/week,0,0
46303,for,0,0
46304,2,0,0
46305,",",0,0
46306,4,0,0
46307,",",0,0
46308,or,0,0
46309,6,0,0
46310,weeks,0,0
46311,in,0,0
46312,this,0,0
46313,vehicle-controlled,0,0
46314,",",0,0
46315,double-blind,0,0
46316,study,0,0
46317,.,0,0
46318,Confocal,0,1
46319,microscopy,0,0
46320,was,0,0
46321,used,0,0
46322,for,0,0
46323,the,0,0
46324,6-week,0,0
46325,treatment,0,0
46326,group,0,0
46327,to,0,0
46328,examine,0,0
46329,the,0,0
46330,target,0,0
46331,tumor,0,1
46332,area,0,1
46333,at,0,0
46334,each,0,0
46335,interval,0,0
46336,visit,0,1
46337,and,0,0
46338,immediately,0,0
46339,before,0,0
46340,Mohs,0,1
46341,micrographic,0,0
46342,surgery,0,0
46343,.,0,0
46344,After,0,0
46345,the,0,0
46346,Mohs,0,1
46347,micrographic,0,0
46348,surgery,0,0
46349,excision,0,0
46350,",",0,0
46351,the,0,0
46352,tissue,0,1
46353,was,0,0
46354,evaluated,0,0
46355,histologically,0,0
46356,",",0,0
46357,and,0,0
46358,the,0,0
46359,excision,0,0
46360,area,0,1
46361,was,0,0
46362,measured,0,0
46363,.,0,0
46364,Confocal,0,0
46365,microscopy,0,0
46366,readings,0,0
46367,were,0,0
46368,correlated,0,0
46369,to,0,0
46370,the,0,0
46371,histologic,0,0
46372,diagnosis,0,0
46373,.,0,0
46374,RESULTS,0,0
46375,Tumors,1,1
46376,cleared,1,0
46377,or,1,0
46378,the,1,0
46379,target,1,0
46380,tumor,1,1
46381,area,1,1
46382,was,0,0
46383,reduced,0,0
46384,in,0,0
46385,subjects,0,0
46386,in,0,0
46387,the,0,0
46388,4-,0,0
46389,and,0,0
46390,6-week,0,0
46391,dosing,0,0
46392,regimens,0,0
46393,.,0,0
46394,Confocal,1,1
46395,microscopy,1,0
46396,assessments,1,0
46397,correlated,0,0
46398,well,0,0
46399,with,0,0
46400,the,0,0
46401,histologic,0,0
46402,diagnosis,0,0
46403,.,0,0
46404,CONCLUSION,0,0
46405,Imiquimod,0,0
46406,improved,0,1
46407,excision,1,0
46408,results,1,0
46409,relative,0,0
46410,to,0,0
46411,vehicle,0,0
46412,when,0,0
46413,used,0,0
46414,for,0,0
46415,treating,0,0
46416,basal,0,1
46417,cell,0,1
46418,carcinoma,0,0
46419,before,0,0
46420,Mohs,0,1
46421,micrographic,0,0
46422,surgery,0,0
46423,.,0,0
46424,Confocal,0,1
46425,microscopy,0,0
46426,assessments,0,0
46427,correlated,0,0
46428,well,0,0
46429,with,0,0
46430,tumor,0,1
46431,response,0,1
46432,to,0,0
46433,therapy,0,0
46434,",",0,0
46435,suggesting,0,0
46436,that,0,0
46437,confocal,0,0
46438,microscopy,0,0
46439,may,0,0
46440,help,0,0
46441,determine,0,0
46442,the,0,0
46443,need,0,0
46444,for,0,0
46445,surgery,0,0
46446,.,0,0
46447,Efficiency,1,1
46448,of,0,0
46449,adjuvant,0,0
46450,immunochemotherapy,0,0
46451,following,0,0
46452,curative,0,0
46453,resection,0,0
46454,in,0,0
46455,patients,0,0
46456,with,0,0
46457,locally,0,0
46458,advanced,0,0
46459,gastric,0,1
46460,cancer,0,0
46461,.,0,0
46462,BACKGROUND,0,0
46463,Despite,0,0
46464,curative,0,0
46465,resection,0,0
46466,",",0,0
46467,50,0,0
46468,%,0,0
46469,-90,0,0
46470,%,0,0
46471,of,0,0
46472,gastric,0,1
46473,cancer,0,0
46474,patients,0,0
46475,die,0,0
46476,of,0,0
46477,disease,1,0
46478,relapse,1,1
46479,.,1,0
46480,Although,0,0
46481,some,0,0
46482,clinical,0,0
46483,trials,0,0
46484,have,0,0
46485,indicated,0,0
46486,that,0,0
46487,chemotherapy,0,0
46488,and,0,0
46489,immunochemotherapy,0,0
46490,may,0,0
46491,be,0,0
46492,effective,0,1
46493,modalities,0,0
46494,",",0,0
46495,more,0,0
46496,recent,0,0
46497,studies,0,0
46498,have,0,0
46499,not,0,0
46500,been,0,0
46501,able,0,0
46502,to,0,0
46503,define,0,0
46504,the,0,0
46505,standard,0,0
46506,treatment,0,0
46507,for,0,0
46508,advanced,0,0
46509,gastric,0,1
46510,cancer,0,0
46511,.,0,0
46512,The,0,0
46513,present,0,0
46514,study,0,0
46515,evaluated,0,0
46516,the,0,0
46517,effect,0,0
46518,of,0,0
46519,adjuvant,0,0
46520,immunochemotherapy,0,0
46521,with,0,0
46522,the,0,0
46523,use,0,0
46524,of,0,0
46525,BCG,0,0
46526,(,0,0
46527,bacille,0,0
46528,Calmette-Guerin,0,0
46529,),0,0
46530,and,0,0
46531,FAM,0,0
46532,(,0,0
46533,5-fluorouracil,0,0
46534,",",0,0
46535,adriamycin,0,0
46536,",",0,0
46537,mitomycin,0,0
46538,C,0,0
46539,),0,0
46540,chemotherapy,0,0
46541,on,0,0
46542,the,0,0
46543,survival,1,1
46544,of,1,0
46545,patients,1,0
46546,with,0,0
46547,locally,0,0
46548,advanced,0,0
46549,resectable,0,0
46550,gastric,0,0
46551,cancer,0,0
46552,.,0,0
46553,METHODS,0,0
46554,A,0,0
46555,total,0,1
46556,of,0,0
46557,156,0,0
46558,patients,0,0
46559,with,0,0
46560,stage,0,0
46561,III,0,0
46562,or,0,0
46563,IV,0,1
46564,gastric,0,1
46565,cancer,0,0
46566,who,0,0
46567,had,0,0
46568,undergone,0,0
46569,curative,0,0
46570,resection,0,0
46571,were,0,0
46572,randomly,0,0
46573,assigned,0,0
46574,to,0,0
46575,three,0,0
46576,treatment,0,0
46577,groups,0,0
46578,:,0,0
46579,BCG,0,0
46580,+,0,0
46581,FAM,0,0
46582,(,0,0
46583,immunochemotherapy,0,0
46584,),0,0
46585,",",0,0
46586,FAM,0,1
46587,(,0,1
46588,chemotherapy,0,0
46589,),0,1
46590,",",0,0
46591,and,0,1
46592,control,0,1
46593,(,0,0
46594,surgery,0,0
46595,only,0,0
46596,),0,0
46597,.,0,0
46598,Treatment,0,0
46599,was,0,0
46600,continued,0,0
46601,for,0,0
46602,2,0,0
46603,years,0,0
46604,or,0,0
46605,until,0,0
46606,death,0,1
46607,.,0,0
46608,Further,0,0
46609,postsurgical,0,0
46610,follow,0,0
46611,up,0,0
46612,was,0,0
46613,carried,0,0
46614,on,0,0
46615,for,0,0
46616,up,0,0
46617,to,0,0
46618,10,0,0
46619,years,0,0
46620,.,0,0
46621,RESULTS,0,0
46622,Overall,0,0
46623,10-year,1,1
46624,survival,1,1
46625,was,0,0
46626,47.1,0,0
46627,%,0,0
46628,for,0,0
46629,the,0,0
46630,immunochemotherapy,0,0
46631,group,0,0
46632,(,0,0
46633,P,0,0
46634,<,0,0
46635,0.037,0,0
46636,vs,0,0
46637,FAM,0,0
46638,and,0,0
46639,P,0,0
46640,<,0,0
46641,0.0006,0,0
46642,vs,0,0
46643,control,0,0
46644,),0,0
46645,",",0,0
46646,30,0,0
46647,%,0,0
46648,for,0,0
46649,the,0,0
46650,chemotherapy,0,0
46651,group,0,0
46652,(,0,0
46653,vs,0,0
46654,control,0,0
46655,",",0,0
46656,NS,0,1
46657,),0,1
46658,",",0,0
46659,and,0,0
46660,15.2,0,0
46661,%,0,0
46662,for,0,0
46663,the,0,0
46664,control,0,0
46665,group,0,0
46666,.,0,0
46667,In,0,0
46668,patients,0,0
46669,with,0,0
46670,pT2/T3,0,0
46671,primary,0,0
46672,tumors,0,0
46673,",",0,0
46674,10-year,1,1
46675,survival,1,1
46676,was,0,0
46677,55.3,0,0
46678,%,0,0
46679,for,0,0
46680,BCG,0,0
46681,+,0,0
46682,FAM,0,0
46683,vs,0,0
46684,28.2,0,0
46685,%,0,0
46686,for,0,0
46687,FAM,0,0
46688,(,0,0
46689,P,0,0
46690,<,0,0
46691,0.01,0,0
46692,),0,0
46693,and,0,0
46694,14.6,0,0
46695,%,0,0
46696,for,0,0
46697,the,0,0
46698,control,0,0
46699,group,0,0
46700,(,0,0
46701,P,0,0
46702,<,0,0
46703,0.00018,0,0
46704,),0,0
46705,.,0,0
46706,BCG,0,0
46707,+,0,0
46708,FAM,0,0
46709,significantly,0,0
46710,improved,0,0
46711,the,0,0
46712,survival,1,1
46713,of,1,0
46714,patients,1,0
46715,with,0,0
46716,intestinal-type,0,0
46717,but,0,0
46718,not,0,0
46719,diffuse-type,0,0
46720,cancer,0,0
46721,.,0,0
46722,Immunochemotherapy,0,0
46723,was,0,0
46724,well,0,0
46725,tolerated,0,1
46726,.,0,0
46727,CONCLUSION,0,0
46728,This,0,0
46729,study,0,0
46730,",",0,0
46731,based,0,0
46732,on,0,0
46733,a,0,0
46734,limited,0,0
46735,number,0,1
46736,of,0,0
46737,patients,0,0
46738,",",0,0
46739,indicates,0,0
46740,that,0,0
46741,adjuvant,0,0
46742,immunochemotherapy,0,0
46743,(,0,0
46744,BCG,0,0
46745,+,0,0
46746,FAM,0,0
46747,),0,0
46748,may,0,0
46749,prolong,0,0
46750,the,0,0
46751,survival,1,1
46752,of,0,0
46753,gastric,0,1
46754,cancer,0,0
46755,patients,0,0
46756,after,0,0
46757,curative,0,0
46758,gastrectomy,0,0
46759,;,0,0
46760,in,0,0
46761,particular,0,0
46762,",",0,0
46763,in,0,0
46764,patients,0,0
46765,with,0,0
46766,pT2/T3,0,0
46767,tumors,0,0
46768,and,0,0
46769,intestinal-type,0,1
46770,primary,0,0
46771,tumors,0,0
46772,.,0,0
46773,There,0,0
46774,was,0,0
46775,no,0,0
46776,survival,1,1
46777,benefit,1,0
46778,from,0,0
46779,FAM,0,0
46780,adjuvant,0,0
46781,chemotherapy,0,0
46782,.,0,0
46783,Slotted,0,0
46784,versus,0,0
46785,non-slotted,0,0
46786,locked,0,0
46787,intramedullary,0,0
46788,nailing,0,0
46789,for,0,0
46790,femoral,0,1
46791,shaft,0,1
46792,fractures,0,0
46793,.,0,0
46794,Experimentally,0,0
46795,",",0,0
46796,two,0,0
46797,slotted,0,0
46798,nails,0,0
46799,",",0,0
46800,the,0,0
46801,Grosse-Kempf,0,0
46802,nail,0,1
46803,and,0,0
46804,the,0,0
46805,AO/ASIF,0,1
46806,universal,0,0
46807,femoral,0,1
46808,nail,0,1
46809,",",0,0
46810,were,0,0
46811,compared,0,0
46812,to,0,0
46813,the,0,0
46814,non-slotted,0,0
46815,Grosse-Kempf,0,0
46816,nail,0,1
46817,and,0,1
46818,control,0,0
46819,bone,0,1
46820,using,0,0
46821,a,0,0
46822,cadaver,0,0
46823,femoral,0,1
46824,osteotomy,0,0
46825,.,0,0
46826,The,0,0
46827,stiffnesses,1,0
46828,and,1,0
46829,strengths,1,0
46830,of,1,0
46831,the,1,0
46832,osteotomies,1,0
46833,fixed,1,0
46834,with,0,0
46835,slotted,0,0
46836,nails,0,1
46837,in,0,0
46838,10-30,0,0
46839,degrees,0,0
46840,torsion,0,1
46841,were,0,0
46842,6-8,0,0
46843,%,0,0
46844,and,0,0
46845,the,0,0
46846,values,0,1
46847,of,0,0
46848,non-slotted,0,0
46849,nails,0,0
46850,40,0,0
46851,%,0,0
46852,of,0,0
46853,control,0,0
46854,bone,0,0
46855,.,0,0
46856,The,0,0
46857,maximal,1,1
46858,moments,1,0
46859,were,0,0
46860,14-18,0,0
46861,%,0,0
46862,and,0,0
46863,48,0,0
46864,%,0,0
46865,",",0,0
46866,respectively,0,0
46867,.,0,0
46868,In,0,0
46869,the,0,0
46870,clinical,0,0
46871,range,0,0
46872,of,0,0
46873,torsion,0,1
46874,",",0,0
46875,the,0,0
46876,implant-bone,1,1
46877,construct,1,0
46878,never,0,0
46879,failed,0,0
46880,or,0,0
46881,was,0,0
46882,deformed,0,1
46883,.,0,0
46884,Clinically,0,0
46885,",",0,0
46886,46,0,0
46887,femoral,0,1
46888,shaft,0,0
46889,fractures,0,1
46890,were,0,0
46891,randomized,0,0
46892,to,0,0
46893,treatment,0,0
46894,with,0,0
46895,Gross-Kempf,0,0
46896,nails,0,1
46897,",",0,0
46898,24,0,0
46899,with,0,0
46900,slotted,0,0
46901,nails,0,0
46902,and,0,0
46903,22,0,0
46904,with,0,0
46905,non-slotted,0,0
46906,nails,0,0
46907,.,0,0
46908,Four,0,0
46909,complications,1,0
46910,in,0,0
46911,the,0,0
46912,slotted,0,0
46913,nail,0,1
46914,group,0,0
46915,and,0,0
46916,three,0,0
46917,in,0,0
46918,the,0,0
46919,non-slotted,0,0
46920,nail,0,1
46921,group,0,0
46922,were,0,0
46923,considered,0,0
46924,to,0,0
46925,be,0,0
46926,independent,0,0
46927,of,0,0
46928,the,0,0
46929,choice,0,0
46930,of,0,0
46931,nail,0,1
46932,and,0,0
46933,did,0,0
46934,not,0,0
46935,affect,0,0
46936,the,0,0
46937,end,0,0
46938,result,0,0
46939,.,0,0
46940,Three,0,0
46941,splinterings,1,0
46942,of,1,0
46943,the,1,0
46944,distal,1,0
46945,fragment,1,1
46946,",",0,0
46947,one,0,0
46948,resulting,0,0
46949,in,0,0
46950,a,0,0
46951,change,1,0
46952,of,1,0
46953,the,1,0
46954,osteosynthesis,1,0
46955,implant,1,0
46956,to,0,0
46957,a,0,0
46958,condylar,0,1
46959,plate,0,0
46960,",",0,0
46961,were,0,0
46962,considered,0,0
46963,to,0,0
46964,result,0,0
46965,from,0,0
46966,the,0,0
46967,high,0,0
46968,stiffness,0,1
46969,of,0,0
46970,the,0,0
46971,non-slotted,0,0
46972,nail,0,1
46973,.,0,0
46974,Osteosynthesis,0,0
46975,of,0,0
46976,femoral,0,1
46977,shaft,0,1
46978,fractures,0,1
46979,using,0,0
46980,slotted,0,0
46981,nails,0,0
46982,has,0,0
46983,not,0,0
46984,resulted,0,0
46985,in,0,0
46986,healing,0,1
46987,disturbances,0,1
46988,",",0,0
46989,which,0,0
46990,could,0,0
46991,be,0,0
46992,accounted,0,0
46993,for,0,0
46994,by,0,0
46995,the,0,0
46996,high,0,0
46997,torsional,0,1
46998,elasticity,0,1
46999,of,0,0
47000,the,0,0
47001,nail,0,1
47002,;,0,0
47003,there,0,0
47004,seems,0,0
47005,to,0,0
47006,be,0,0
47007,no,0,0
47008,indication,0,0
47009,for,0,0
47010,high-stiffness,0,1
47011,nails,0,1
47012,in,0,0
47013,femoral,0,1
47014,fractures,0,0
47015,.,0,0
47016,[,0,0
47017,Relationship,0,1
47018,between,0,0
47019,sCD44v6,1,0
47020,expression,1,1
47021,and,0,1
47022,TCM,0,0
47023,differentiation,0,1
47024,type,0,0
47025,of,0,0
47026,gastric,0,1
47027,carcinoma,0,0
47028,patients,0,0
47029,and,0,1
47030,influence,0,0
47031,of,0,1
47032,weitai,0,0
47033,capsule,0,0
47034,on,0,0
47035,the,0,0
47036,expression,1,1
47037,],1,0
47038,.,0,0
47039,OBJECTIVE,0,0
47040,To,0,0
47041,explore,0,0
47042,the,0,0
47043,relationship,0,0
47044,of,0,0
47045,TCM,0,0
47046,type,0,0
47047,with,0,0
47048,serum,1,1
47049,level,1,1
47050,of,1,0
47051,soluble,1,1
47052,CD44v6,1,0
47053,(,1,0
47054,sCD44v6,1,1
47055,),1,1
47056,and,0,0
47057,different,0,0
47058,histologic,1,1
47059,parameters,1,1
47060,in,0,0
47061,gastric,0,1
47062,carcinoma,0,0
47063,patients,0,0
47064,and,0,0
47065,to,0,0
47066,observe,0,0
47067,the,0,0
47068,influence,0,0
47069,of,0,0
47070,Weitai,0,0
47071,capsule,0,0
47072,(,0,0
47073,WTC,0,1
47074,),0,0
47075,on,0,0
47076,the,0,0
47077,sCD44v6,1,0
47078,expression,1,1
47079,.,1,0
47080,METHODS,0,0
47081,TCM,1,0
47082,typing,1,1
47083,and,0,1
47084,sCD44v6,1,1
47085,expression,1,1
47086,were,0,0
47087,determined,0,0
47088,in,0,0
47089,all,0,0
47090,the,0,0
47091,enrolled,0,0
47092,patients,0,0
47093,(,0,0
47094,30,0,0
47095,in,0,0
47096,the,0,0
47097,control,0,0
47098,and,0,0
47099,32,0,0
47100,in,0,0
47101,the,0,0
47102,trial,0,0
47103,group,0,0
47104,),0,0
47105,before,0,0
47106,operation,0,0
47107,",",0,0
47108,and,0,1
47109,3-4,0,1
47110,courses,0,0
47111,of,0,0
47112,chemotherapy,0,0
47113,was,0,0
47114,applied,0,0
47115,to,0,0
47116,them,0,0
47117,from,0,0
47118,3-4,0,0
47119,weeks,0,0
47120,after,0,0
47121,operation,0,0
47122,.,0,0
47123,To,0,0
47124,the,0,0
47125,patients,0,0
47126,of,0,0
47127,trial,0,0
47128,group,0,0
47129,",",0,0
47130,oral,0,0
47131,administration,0,0
47132,of,0,0
47133,WTC,0,1
47134,was,0,0
47135,given,0,0
47136,additionally,0,0
47137,with,0,0
47138,4,0,0
47139,capsules,0,0
47140,",",0,0
47141,3,0,0
47142,times,0,0
47143,a,0,0
47144,day,0,0
47145,for,0,0
47146,consecutive,0,0
47147,3,0,0
47148,months,0,0
47149,.,0,0
47150,RESULTS,0,0
47151,sCD44v6,1,0
47152,was,0,0
47153,significantly,0,0
47154,positive,0,0
47155,correlated,0,0
47156,with,0,0
47157,the,0,0
47158,degree,1,1
47159,of,1,0
47160,cancer,1,0
47161,cell,1,1
47162,differentiation,1,1
47163,",",1,1
47164,infiltration,1,1
47165,and,1,1
47166,lymph,1,1
47167,node,1,1
47168,metastasis,1,1
47169,;,1,0
47170,(,0,0
47171,2,0,0
47172,),0,0
47173,Level,1,0
47174,of,1,0
47175,sCD44v6,1,0
47176,was,0,0
47177,the,0,0
47178,highest,0,0
47179,in,0,0
47180,patients,0,0
47181,of,0,0
47182,blood,0,1
47183,stasis,0,1
47184,type,0,0
47185,",",0,0
47186,as,0,0
47187,compared,0,0
47188,with,0,0
47189,that,0,0
47190,in,0,0
47191,the,0,0
47192,patients,0,0
47193,of,0,0
47194,Pi-deficiency,0,1
47195,type,0,0
47196,or,0,0
47197,of,0,1
47198,damp-heat,0,1
47199,type,0,0
47200,",",0,0
47201,the,0,0
47202,difference,0,0
47203,was,0,0
47204,significant,0,0
47205,;,0,0
47206,(,0,0
47207,3,0,0
47208,),0,0
47209,After,0,0
47210,ending,0,0
47211,treatment,0,0
47212,",",0,0
47213,level,1,1
47214,of,1,1
47215,sCD44v6,1,0
47216,in,0,0
47217,the,0,0
47218,trial,0,0
47219,group,0,0
47220,was,0,0
47221,significantly,0,0
47222,lower,0,0
47223,than,0,0
47224,that,0,0
47225,in,0,0
47226,the,0,0
47227,control,0,0
47228,group,0,0
47229,.,0,0
47230,CONCLUSION,0,0
47231,(,0,0
47232,1,0,0
47233,),0,0
47234,Serum,1,0
47235,level,1,1
47236,of,1,0
47237,sCD44v6,1,0
47238,could,0,0
47239,be,0,0
47240,taken,0,0
47241,as,0,0
47242,the,0,0
47243,criterion,0,0
47244,for,0,0
47245,evaluating,0,0
47246,the,0,0
47247,development,1,1
47248,and,1,0
47249,prognosis,1,1
47250,of,1,1
47251,gastric,1,1
47252,cancer,1,0
47253,",",0,0
47254,as,0,0
47255,well,0,0
47256,as,0,0
47257,the,0,0
47258,therapeutic,0,0
47259,target,0,0
47260,for,0,0
47261,anti-metastasis,0,0
47262,treatment,0,0
47263,;,0,0
47264,(,0,0
47265,2,0,0
47266,),0,0
47267,Serum,1,0
47268,level,1,1
47269,of,1,0
47270,sCD44v6,1,0
47271,is,0,0
47272,related,0,0
47273,to,0,0
47274,some,0,0
47275,extent,0,0
47276,with,0,0
47277,TCM,1,0
47278,type,1,0
47279,of,1,0
47280,blood,1,1
47281,stasis,1,1
47282,and,1,0
47283,Pi-deficiency,1,0
47284,;,1,0
47285,(,0,0
47286,3,0,0
47287,),0,0
47288,WTC,0,0
47289,combined,0,0
47290,with,0,0
47291,chemotherapy,0,0
47292,could,0,0
47293,further,0,0
47294,inhibit,0,0
47295,the,0,0
47296,expression,1,1
47297,of,1,0
47298,serum,1,1
47299,sCD44v6,1,0
47300,in,0,0
47301,gastric,0,1
47302,carcinoma,0,0
47303,patients,0,0
47304,.,0,0
47305,Effectiveness,1,1
47306,of,0,0
47307,once-daily,0,0
47308,monotherapy,0,0
47309,with,0,0
47310,a,0,0
47311,new,0,0
47312,nifedipine,0,0
47313,sustained,0,1
47314,release,0,1
47315,calcium,0,0
47316,antagonist,0,0
47317,.,0,0
47318,Data,0,0
47319,from,0,0
47320,2,0,0
47321,separate,0,0
47322,multicenter,0,0
47323,",",0,0
47324,double-blind,0,0
47325,clinical,0,0
47326,studies,0,0
47327,following,0,0
47328,the,0,0
47329,same,0,0
47330,protocol,0,0
47331,",",0,0
47332,except,0,0
47333,for,0,0
47334,the,0,0
47335,selection,0,0
47336,of,0,0
47337,doses,0,0
47338,",",0,0
47339,were,0,0
47340,pooled,0,0
47341,to,0,0
47342,evaluate,0,0
47343,the,0,0
47344,efficacy,1,1
47345,and,1,0
47346,tolerability,1,1
47347,of,0,1
47348,fixed,0,0
47349,doses,0,0
47350,of,0,0
47351,a,0,0
47352,new,0,0
47353,sustained-release,0,0
47354,(,0,0
47355,SR,0,0
47356,),0,0
47357,formulation,0,0
47358,of,0,0
47359,nifedipine,0,0
47360,compared,0,0
47361,with,0,0
47362,placebo,0,0
47363,in,0,0
47364,388,0,0
47365,patients,0,0
47366,with,0,0
47367,mild,0,0
47368,to,0,0
47369,moderate,0,0
47370,uncomplicated,0,0
47371,essential,0,0
47372,hypertension,0,0
47373,.,0,0
47374,After,0,0
47375,a,0,0
47376,3-6,0,0
47377,week,0,0
47378,placebo,0,0
47379,washout,0,0
47380,period,0,0
47381,",",0,0
47382,the,0,0
47383,patients,0,0
47384,were,0,0
47385,randomized,0,0
47386,to,0,0
47387,receive,0,0
47388,either,0,0
47389,placebo,0,0
47390,or,0,0
47391,nifedipine,0,0
47392,SR-20,0,1
47393,mg,0,0
47394,(,0,0
47395,study,0,0
47396,I,0,0
47397,only,0,0
47398,),0,0
47399,",",0,0
47400,50,0,0
47401,mg,0,0
47402,",",0,0
47403,100,0,0
47404,mg,0,0
47405,",",0,0
47406,or,0,0
47407,150,0,0
47408,mg,0,0
47409,(,0,0
47410,study,0,0
47411,II,0,0
47412,only,0,0
47413,),0,0
47414,.,0,0
47415,Among,0,0
47416,the,0,0
47417,278,0,0
47418,patients,0,0
47419,who,0,0
47420,completed,0,0
47421,6,0,0
47422,weeks,0,0
47423,of,0,0
47424,active,0,0
47425,therapy,0,0
47426,",",0,0
47427,mean,1,1
47428,supine,1,0
47429,diastolic,1,1
47430,blood,1,1
47431,pressure,1,1
47432,reductions,1,1
47433,from,0,0
47434,pretreatment,0,0
47435,baseline,0,0
47436,were,0,0
47437,5.9,0,0
47438,",",0,0
47439,9.3,0,0
47440,",",0,0
47441,9.2,0,0
47442,",",0,0
47443,11.1,0,0
47444,",",0,0
47445,and,0,0
47446,13.2,0,0
47447,mm,0,0
47448,Hg,0,0
47449,in,0,0
47450,the,0,0
47451,placebo,0,0
47452,",",0,0
47453,20-,0,0
47454,",",0,0
47455,50-,0,0
47456,",",0,0
47457,100-,0,0
47458,",",0,0
47459,and,0,1
47460,150-mg,0,0
47461,groups,0,0
47462,",",0,0
47463,respectively,0,0
47464,.,0,0
47465,The,0,0
47466,reductions,0,0
47467,achieved,0,0
47468,in,0,0
47469,each,0,0
47470,of,0,0
47471,the,0,0
47472,nifedipine,0,0
47473,SR,0,0
47474,groups,0,0
47475,were,0,0
47476,statistically,0,0
47477,significant,0,0
47478,versus,0,0
47479,baseline,0,0
47480,values,0,1
47481,(,0,0
47482,p,0,0
47483,less,0,0
47484,than,0,0
47485,0.001,0,0
47486,),0,0
47487,.,0,0
47488,All,0,0
47489,nifedipine-SR,0,0
47490,doses,0,0
47491,reduced,1,0
47492,supine,1,0
47493,systolic,1,1
47494,blood,1,1
47495,pressure,1,1
47496,significantly,0,0
47497,more,0,0
47498,than,0,0
47499,placebo,0,0
47500,(,0,0
47501,p,0,0
47502,less,0,0
47503,than,0,0
47504,0.001,0,0
47505,),0,0
47506,.,0,0
47507,In,0,0
47508,addition,0,0
47509,",",0,0
47510,there,0,0
47511,was,0,0
47512,a,0,0
47513,significant,0,0
47514,linear,0,0
47515,relationship,0,0
47516,between,0,0
47517,the,0,0
47518,log,1,1
47519,of,1,0
47520,the,1,0
47521,dose,1,0
47522,and,0,0
47523,the,0,0
47524,blood,1,1
47525,pressure,1,1
47526,reduction,1,1
47527,(,0,0
47528,p,0,0
47529,less,0,0
47530,than,0,0
47531,0.05,0,0
47532,),0,0
47533,.,0,0
47534,Automated,1,0
47535,ambulatory,1,0
47536,blood,1,1
47537,pressure,1,1
47538,recordings,1,1
47539,performed,0,0
47540,in,0,0
47541,221,0,0
47542,of,0,0
47543,the,0,0
47544,patients,0,0
47545,showed,0,0
47546,that,0,0
47547,the,0,0
47548,blood,1,1
47549,pressure,1,1
47550,was,1,0
47551,lowered,1,0
47552,evenly,0,0
47553,through,0,0
47554,the,0,0
47555,entire,0,0
47556,24-hour,0,1
47557,dosing,0,0
47558,period,0,0
47559,.,0,0
47560,The,0,0
47561,doses,0,0
47562,that,0,0
47563,were,0,0
47564,effective,0,1
47565,and,0,0
47566,associated,0,0
47567,with,0,0
47568,the,0,0
47569,fewest,0,0
47570,adverse,0,1
47571,reactions,0,1
47572,were,0,0
47573,20,0,0
47574,mg,0,0
47575,and,0,0
47576,50,0,0
47577,mg,0,0
47578,once,0,0
47579,daily,0,0
47580,.,0,0
47581,Effect,0,0
47582,of,0,0
47583,a,0,0
47584,nutritional,0,0
47585,supplement,0,0
47586,containing,0,0
47587,vitamin,0,0
47588,E,0,1
47589,",",0,1
47590,selenium,0,0
47591,",",0,0
47592,vitamin,0,0
47593,c,0,0
47594,and,0,0
47595,coenzyme,0,0
47596,Q10,0,0
47597,on,0,0
47598,serum,1,1
47599,PSA,1,0
47600,in,0,0
47601,patients,0,0
47602,with,0,0
47603,hormonally,0,0
47604,untreated,0,0
47605,carcinoma,0,0
47606,of,0,0
47607,the,0,0
47608,prostate,0,0
47609,:,0,0
47610,a,0,0
47611,randomised,0,0
47612,placebo-controlled,0,0
47613,study,0,0
47614,.,0,0
47615,OBJECTIVE,0,0
47616,To,0,0
47617,assess,0,0
47618,the,0,0
47619,effect,0,0
47620,of,0,0
47621,a,0,0
47622,nutritional,0,0
47623,supplement,0,0
47624,containing,0,0
47625,vitamin,0,0
47626,E,0,1
47627,",",0,1
47628,selenium,0,0
47629,",",0,0
47630,vitamin,0,0
47631,C,0,0
47632,and,0,0
47633,coenzyme,0,0
47634,Q10,0,0
47635,on,0,0
47636,changes,0,1
47637,in,0,0
47638,serum,1,1
47639,levels,1,1
47640,of,1,0
47641,PSA,1,0
47642,in,0,0
47643,patients,0,0
47644,with,0,0
47645,hormonally,0,0
47646,untreated,0,0
47647,carcinoma,0,0
47648,of,0,0
47649,the,0,0
47650,prostate,0,0
47651,and,0,0
47652,rising,0,0
47653,serum,1,1
47654,PSA,1,0
47655,levels,1,1
47656,.,1,0
47657,METHODS,0,0
47658,Eighty,0,1
47659,patients,0,0
47660,were,0,0
47661,randomised,0,0
47662,to,0,0
47663,receive,0,0
47664,a,0,0
47665,daily,0,0
47666,supplement,0,0
47667,with,0,0
47668,either,0,0
47669,vitamin,0,0
47670,E,0,1
47671,",",0,1
47672,selenium,0,0
47673,",",0,0
47674,vitamin,0,0
47675,C,0,0
47676,",",0,0
47677,coenzyme,0,1
47678,Q10,0,1
47679,(,0,0
47680,intervention,0,0
47681,group,0,0
47682,),0,1
47683,or,0,0
47684,placebo,0,0
47685,over,0,0
47686,21,0,0
47687,weeks,0,0
47688,.,0,0
47689,Serum,1,0
47690,levels,1,1
47691,of,1,0
47692,PSA,1,0
47693,were,0,0
47694,assessed,0,0
47695,at,0,0
47696,baseline,0,0
47697,(,0,0
47698,-2,0,0
47699,",",0,0
47700,-1,0,0
47701,",",0,0
47702,0,0,0
47703,weeks,0,0
47704,),0,0
47705,and,0,0
47706,after,0,0
47707,6,0,0
47708,",",0,0
47709,13,0,0
47710,",",0,0
47711,19,0,0
47712,",",0,0
47713,20,0,0
47714,and,0,0
47715,21,0,0
47716,weeks,0,0
47717,.,0,0
47718,Mean,0,0
47719,changes,0,1
47720,in,0,0
47721,log,0,1
47722,serum,1,1
47723,level,1,1
47724,of,1,0
47725,PSA,1,1
47726,",",1,0
47727,testosterone,1,1
47728,",",1,1
47729,dihydrotestosterone,1,1
47730,",",1,0
47731,luteinizing,1,1
47732,hormone,1,1
47733,and,1,1
47734,sex,1,0
47735,hormone,1,1
47736,binding,1,0
47737,globulin,1,0
47738,over,0,0
47739,21,0,0
47740,weeks,0,0
47741,between,0,0
47742,the,0,0
47743,verum,0,0
47744,and,0,0
47745,the,0,0
47746,placebo,0,0
47747,group,0,0
47748,were,0,0
47749,compared,0,0
47750,by,0,0
47751,analysis,0,0
47752,of,0,0
47753,covariance,0,0
47754,.,0,0
47755,RESULTS,0,0
47756,Seventy,0,0
47757,patients,0,0
47758,completed,0,0
47759,the,0,0
47760,study,0,0
47761,(,0,0
47762,36,0,0
47763,verum,0,0
47764,;,0,0
47765,34,0,0
47766,placebo,0,0
47767,),0,0
47768,.,0,0
47769,Compliance,0,1
47770,was,0,0
47771,>,0,0
47772,90,0,0
47773,%,0,0
47774,in,0,0
47775,all,0,0
47776,patients,0,0
47777,.,0,0
47778,In,0,0
47779,the,0,0
47780,intervention,0,0
47781,group,0,0
47782,",",0,0
47783,plasma,1,1
47784,levels,1,1
47785,of,1,0
47786,vitamin,1,0
47787,E,1,1
47788,",",1,1
47789,selenium,1,1
47790,and,1,1
47791,coenzyme,1,1
47792,Q10,1,0
47793,increased,0,0
47794,significantly,0,0
47795,over,0,0
47796,the,0,0
47797,21,0,0
47798,weeks,0,0
47799,study,0,0
47800,period,0,0
47801,.,0,0
47802,No,0,0
47803,significant,0,0
47804,differences,0,0
47805,in,0,0
47806,serum,1,1
47807,levels,1,1
47808,of,1,0
47809,PSA,1,0
47810,",",1,0
47811,testosterone,1,1
47812,",",1,1
47813,dihydrotestosterone,1,1
47814,",",1,0
47815,luteinizing,1,1
47816,hormone,1,1
47817,or,1,0
47818,sex,1,0
47819,hormone,1,1
47820,binding,1,1
47821,globulin,1,1
47822,(,0,0
47823,p,0,0
47824,>,0,0
47825,0.2,0,0
47826,),0,0
47827,were,0,0
47828,observed,0,0
47829,between,0,0
47830,the,0,0
47831,intervention,0,0
47832,and,0,1
47833,control,0,0
47834,group,0,0
47835,.,0,0
47836,CONCLUSION,0,0
47837,Our,0,0
47838,results,0,0
47839,indicate,0,0
47840,that,0,0
47841,supplementation,0,0
47842,of,0,0
47843,a,0,0
47844,combination,0,0
47845,of,0,0
47846,vitamin,0,0
47847,E,0,1
47848,",",0,1
47849,selenium,0,0
47850,",",0,0
47851,vitamin,0,0
47852,C,0,0
47853,and,0,0
47854,coenzyme-Q10,0,0
47855,does,0,0
47856,not,0,0
47857,affect,0,0
47858,serum,1,1
47859,level,1,1
47860,of,1,0
47861,PSA,1,1
47862,or,1,0
47863,hormone,1,1
47864,levels,1,1
47865,in,0,0
47866,patients,0,0
47867,with,0,0
47868,hormonally,0,0
47869,untreated,0,0
47870,carcinoma,0,0
47871,of,0,0
47872,the,0,0
47873,prostate,0,0
47874,.,0,0
47875,Prospective,0,0
47876,randomised,0,0
47877,trial,0,0
47878,of,0,0
47879,amifostine,0,0
47880,cytoprotection,0,1
47881,in,0,0
47882,myeloma,0,0
47883,patients,0,0
47884,undergoing,0,0
47885,high-dose,0,0
47886,melphalan,0,0
47887,conditioned,0,1
47888,autologous,0,0
47889,stem,0,0
47890,cell,0,0
47891,transplantation,0,0
47892,.,0,0
47893,In,0,0
47894,this,0,0
47895,prospective,0,0
47896,multicentre,0,0
47897,trial,0,0
47898,",",0,0
47899,90,0,0
47900,patients,0,0
47901,undergoing,0,0
47902,autologous,0,0
47903,stem,0,1
47904,cell,0,1
47905,transplantation,0,0
47906,(,0,0
47907,ASCT,0,0
47908,),0,0
47909,were,0,0
47910,randomised,0,0
47911,to,0,0
47912,receive,0,0
47913,(,0,0
47914,n=43,0,0
47915,),0,1
47916,or,0,0
47917,not,0,0
47918,receive,0,0
47919,(,0,0
47920,n=47,0,0
47921,),0,0
47922,amifostine,0,0
47923,910,0,0
47924,mg/m,0,0
47925,(,0,0
47926,2,0,0
47927,),0,0
47928,prior,0,0
47929,to,0,0
47930,melphalan,0,0
47931,200,0,0
47932,mg/m,0,0
47933,(,0,0
47934,2,0,0
47935,),0,0
47936,.,0,0
47937,Patients,0,0
47938,were,0,0
47939,monitored,0,0
47940,for,0,0
47941,regimen-related,1,1
47942,toxicity,1,1
47943,",",1,0
47944,engraftment,1,1
47945,",",1,1
47946,supportive,1,0
47947,care,1,0
47948,",",1,0
47949,response,1,1
47950,and,1,1
47951,survival,1,1
47952,.,1,0
47953,Both,0,0
47954,groups,0,0
47955,underwent,0,0
47956,ASCT,0,0
47957,at,0,0
47958,a,0,0
47959,median,0,0
47960,of,0,0
47961,8,0,0
47962,months,0,0
47963,from,0,0
47964,diagnosis,0,0
47965,and,0,0
47966,were,0,0
47967,matched,0,0
47968,for,0,0
47969,disease,0,0
47970,characteristics,0,1
47971,",",0,0
47972,prior,0,0
47973,therapy,0,0
47974,and,0,0
47975,pre-ASCT,0,1
47976,disease,0,1
47977,responsiveness,0,1
47978,.,0,0
47979,Amifostine,0,0
47980,infusional,0,0
47981,side-effects,0,1
47982,were,0,0
47983,frequent,0,0
47984,",",0,0
47985,occurring,0,0
47986,in,0,0
47987,65,0,0
47988,%,0,0
47989,of,0,0
47990,patients,0,0
47991,",",0,0
47992,but,0,0
47993,of,0,1
47994,mild,0,1
47995,severity,0,1
47996,.,0,0
47997,Amifostine,0,0
47998,use,0,0
47999,was,0,0
48000,associated,0,0
48001,with,0,0
48002,a,0,0
48003,reduction,1,0
48004,in,0,0
48005,the,0,0
48006,median,1,0
48007,grade,1,1
48008,of,1,0
48009,oral,1,0
48010,mucositis,1,1
48011,(,0,0
48012,1,0,0
48013,vs,0,0
48014,2,0,0
48015,",",0,0
48016,P=0.01,0,0
48017,),0,0
48018,and,0,0
48019,the,0,0
48020,frequency,1,1
48021,of,1,0
48022,severe,1,1
48023,(,1,0
48024,WHO,1,0
48025,grades,1,0
48026,3,1,0
48027,or,1,0
48028,4,1,0
48029,),1,0
48030,mucositis,1,1
48031,(,0,0
48032,12,0,0
48033,vs,0,0
48034,33,0,0
48035,%,0,0
48036,",",0,0
48037,P=0.02,0,0
48038,),0,1
48039,",",0,0
48040,but,0,0
48041,no,0,0
48042,reduction,0,1
48043,in,0,0
48044,the,0,0
48045,requirement,0,1
48046,for,0,0
48047,parenteral,0,0
48048,nutrition,0,1
48049,or,0,0
48050,analgesic,0,1
48051,use,0,0
48052,.,0,0
48053,Conversion,0,0
48054,to,0,0
48055,complete,0,1
48056,remission,0,1
48057,post-ASCT,1,0
48058,occurred,0,0
48059,in,0,0
48060,30,0,0
48061,and,0,0
48062,14,0,0
48063,%,0,0
48064,of,0,0
48065,the,0,0
48066,amifostine,0,0
48067,and,0,0
48068,control,0,0
48069,groups,0,0
48070,",",0,0
48071,respectively,0,0
48072,(,0,0
48073,P=0.09,0,0
48074,),0,0
48075,.,0,0
48076,With,0,0
48077,a,0,0
48078,median,0,0
48079,follow-up,0,0
48080,of,0,0
48081,35,0,0
48082,months,0,0
48083,",",0,0
48084,there,0,0
48085,was,0,0
48086,no,0,0
48087,statistically,0,0
48088,significant,0,0
48089,difference,0,0
48090,between,0,0
48091,the,0,0
48092,median,1,0
48093,progression-free,1,1
48094,or,1,0
48095,overall,1,1
48096,survival,1,1
48097,times,1,1
48098,for,0,0
48099,the,0,0
48100,two,0,0
48101,groups,0,0
48102,.,0,0
48103,We,0,0
48104,conclude,0,0
48105,that,0,0
48106,amifostine,0,0
48107,can,0,0
48108,be,0,0
48109,safely,0,0
48110,administered,0,0
48111,prior,0,0
48112,to,0,0
48113,high-dose,0,0
48114,melphalan,0,0
48115,and,0,0
48116,significantly,0,0
48117,reduces,0,0
48118,the,0,0
48119,frequency,1,1
48120,and,1,0
48121,severity,1,1
48122,of,1,1
48123,therapy-induced,1,0
48124,oral,1,0
48125,mucositis,1,1
48126,.,1,0
48127,Comparison,0,0
48128,of,0,0
48129,intravenous,0,0
48130,and,0,0
48131,intra-arterial,0,0
48132,urokinase,0,0
48133,thrombolysis,0,0
48134,for,0,0
48135,acute,0,0
48136,ischaemic,0,0
48137,stroke,0,0
48138,.,0,0
48139,Intravenous,0,0
48140,fibrinolysis,0,1
48141,(,0,0
48142,IVF,0,1
48143,),0,0
48144,with,0,0
48145,rt-PA,0,0
48146,(,0,0
48147,alteplase,0,0
48148,),0,0
48149,provides,0,0
48150,significant,0,0
48151,benefits,0,0
48152,in,0,0
48153,acute,0,0
48154,ischaemic,0,0
48155,stroke,0,0
48156,when,0,0
48157,it,0,0
48158,is,0,0
48159,given,0,0
48160,within,0,0
48161,the,0,0
48162,first,0,0
48163,three,0,0
48164,hours,0,0
48165,following,0,0
48166,stroke,0,0
48167,onset,0,0
48168,.,0,0
48169,Intra-arterial,0,0
48170,fibrinolysis,0,1
48171,(,0,0
48172,IAF,0,1
48173,),0,0
48174,with,0,0
48175,pro-urokinase,0,0
48176,in,0,0
48177,PROACT,0,0
48178,II,0,0
48179,study,0,0
48180,provides,0,0
48181,quite,0,0
48182,the,0,0
48183,same,0,0
48184,benefit,0,0
48185,in,0,0
48186,the,0,0
48187,first,0,0
48188,6,0,0
48189,hours,0,0
48190,.,0,0
48191,IVF,0,1
48192,and,0,0
48193,IAF,0,0
48194,have,0,0
48195,never,0,0
48196,been,0,0
48197,compared,0,0
48198,.,0,0
48199,To,0,0
48200,compare,0,0
48201,the,0,0
48202,efficacy,1,1
48203,and,1,0
48204,safety,1,1
48205,of,0,1
48206,IVF,0,1
48207,and,0,0
48208,IAF,0,1
48209,with,0,0
48210,urokinase,0,0
48211,given,0,0
48212,within,0,0
48213,the,0,0
48214,first,0,0
48215,6,0,0
48216,hours,0,0
48217,of,0,0
48218,acute,0,0
48219,ischaemic,0,0
48220,stroke,0,0
48221,.,0,0
48222,Patients,0,0
48223,fulfilling,0,0
48224,the,0,0
48225,selection,0,0
48226,criteria,0,0
48227,were,0,0
48228,randomly,0,0
48229,assigned,0,0
48230,to,0,0
48231,receive,0,0
48232,urokinase,0,0
48233,"900,000",0,0
48234,units,0,0
48235,via,0,0
48236,intravenous,0,0
48237,or,0,0
48238,intra-arterial,0,0
48239,routes,0,0
48240,.,0,0
48241,This,0,0
48242,randomised,0,0
48243,monocentre,0,0
48244,study,0,0
48245,was,0,0
48246,done,0,0
48247,between,0,0
48248,December,0,0
48249,1995,0,0
48250,and,0,0
48251,August,0,0
48252,1997,0,0
48253,.,0,0
48254,The,0,0
48255,primary,0,0
48256,outcome,0,1
48257,was,0,0
48258,defined,0,0
48259,as,0,0
48260,the,0,0
48261,number,1,1
48262,of,1,0
48263,patients,1,0
48264,with,1,0
48265,a,1,0
48266,modified,1,0
48267,Rankin,1,1
48268,score,1,1
48269,of,1,0
48270,2,1,0
48271,or,1,0
48272,less,1,0
48273,.,1,1
48274,Secondary,0,0
48275,outcomes,0,1
48276,included,0,0
48277,mortality,1,1
48278,",",1,0
48279,frequency,1,1
48280,of,1,0
48281,symptomatic,1,1
48282,intracranial,1,1
48283,haemorrhage,1,1
48284,(,1,0
48285,SIH,1,1
48286,),1,0
48287,",",1,0
48288,neurological,1,1
48289,and,1,1
48290,functional,1,0
48291,scores,1,1
48292,.,1,0
48293,Fourteen,0,0
48294,patients,0,0
48295,were,0,0
48296,given,0,0
48297,IVF,0,0
48298,and,0,0
48299,13,0,0
48300,IAF,0,0
48301,.,0,0
48302,The,0,0
48303,study,0,0
48304,was,0,0
48305,terminated,0,0
48306,by,0,0
48307,the,0,0
48308,National,0,0
48309,Health,0,1
48310,Authorities,0,0
48311,when,0,0
48312,27,0,0
48313,patients,0,0
48314,had,0,0
48315,been,0,0
48316,included,0,0
48317,because,0,0
48318,of,0,0
48319,the,0,0
48320,mortality,0,1
48321,rate,0,1
48322,.,0,0
48323,Seven,0,0
48324,patients,0,0
48325,(,0,0
48326,26,0,0
48327,%,0,0
48328,),0,0
48329,died,0,0
48330,",",0,0
48331,4,0,0
48332,in,0,0
48333,the,0,0
48334,IV,0,1
48335,group,0,0
48336,(,0,0
48337,oedematous,0,1
48338,infarct,0,1
48339,in,0,0
48340,3,0,0
48341,and,0,0
48342,recurrence,0,1
48343,in,0,0
48344,1,0,0
48345,),0,0
48346,",",0,0
48347,3,0,0
48348,in,0,0
48349,the,0,0
48350,IA,0,0
48351,group,0,0
48352,(,0,0
48353,SIH,0,0
48354,in,0,0
48355,2,0,0
48356,",",0,0
48357,and,0,0
48358,oedematous,0,1
48359,infarct,0,1
48360,in,0,0
48361,1,0,0
48362,),0,0
48363,.,0,0
48364,Patients,0,0
48365,given,0,0
48366,IVF,0,0
48367,were,0,0
48368,treated,0,0
48369,significantly,0,0
48370,earlier,0,0
48371,(,0,0
48372,4:16,0,0
48373,h,0,0
48374,vs,0,0
48375,5:24,0,0
48376,h,0,0
48377,;,0,0
48378,p=.007,0,0
48379,),0,0
48380,.,0,0
48381,Although,0,0
48382,IA,0,0
48383,patients,0,0
48384,showed,0,0
48385,greater,0,0
48386,and,0,1
48387,earlier,0,0
48388,improvement,0,1
48389,there,0,0
48390,was,0,0
48391,no,0,0
48392,significant,0,0
48393,difference,0,0
48394,in,0,0
48395,primary,0,0
48396,and,0,0
48397,secondary,0,0
48398,outcomes,0,1
48399,.,0,0
48400,Because,0,0
48401,of,0,0
48402,premature,0,0
48403,termination,0,0
48404,",",0,0
48405,the,0,0
48406,trial,0,0
48407,was,0,0
48408,too,0,0
48409,small,0,0
48410,to,0,0
48411,provide,0,0
48412,any,0,0
48413,reliable,0,0
48414,and,0,0
48415,conclusive,0,0
48416,results,0,0
48417,.,0,0
48418,Intra-arterial,0,0
48419,fibrinolysis,0,1
48420,began,0,0
48421,significantly,0,0
48422,later,0,0
48423,than,0,0
48424,IV,0,1
48425,fibrinolysis,0,1
48426,but,0,0
48427,it,0,0
48428,gave,0,0
48429,non-significantly,0,0
48430,better,0,0
48431,results,0,0
48432,in,0,0
48433,this,0,0
48434,prematurely,0,0
48435,terminated,0,0
48436,study,0,0
48437,.,0,0
48438,Evidence,0,1
48439,of,0,0
48440,radiographic,1,1
48441,benefit,1,0
48442,of,0,0
48443,treatment,0,0
48444,with,0,0
48445,infliximab,0,0
48446,plus,0,0
48447,methotrexate,0,0
48448,in,0,0
48449,rheumatoid,0,1
48450,arthritis,0,0
48451,patients,0,0
48452,who,0,0
48453,had,0,0
48454,no,0,0
48455,clinical,0,0
48456,improvement,0,0
48457,:,0,0
48458,a,0,0
48459,detailed,0,0
48460,subanalysis,0,0
48461,of,0,0
48462,data,0,0
48463,from,0,0
48464,the,0,0
48465,anti-tumor,0,1
48466,necrosis,0,1
48467,factor,0,1
48468,trial,0,0
48469,in,0,0
48470,rheumatoid,0,0
48471,arthritis,0,0
48472,with,0,0
48473,concomitant,0,0
48474,therapy,0,0
48475,study,0,0
48476,.,0,0
48477,OBJECTIVE,0,0
48478,To,0,0
48479,assess,1,0
48480,the,1,0
48481,relationship,1,0
48482,between,0,0
48483,inflammation,0,1
48484,and,0,0
48485,joint,0,1
48486,destruction,0,1
48487,in,0,0
48488,rheumatoid,0,1
48489,arthritis,0,0
48490,(,0,0
48491,RA,0,0
48492,),0,0
48493,patients,0,0
48494,who,0,0
48495,have,0,0
48496,not,0,0
48497,responded,0,0
48498,clinically,0,0
48499,to,0,0
48500,treatment,0,0
48501,.,0,0
48502,METHODS,0,0
48503,Changes,0,1
48504,from,0,0
48505,baseline,0,0
48506,to,0,0
48507,week,0,0
48508,54,0,0
48509,in,0,0
48510,clinical,1,0
48511,variables,1,1
48512,and,1,0
48513,measures,1,1
48514,of,1,1
48515,radiographic,1,1
48516,progression,1,1
48517,were,0,0
48518,compared,0,0
48519,between,0,0
48520,patients,0,0
48521,who,0,0
48522,received,0,0
48523,infliximab,0,0
48524,(,0,0
48525,3,0,0
48526,mg/kg,0,0
48527,or,0,0
48528,10,0,0
48529,mg/kg,0,0
48530,every,0,0
48531,4,0,0
48532,or,0,0
48533,8,0,0
48534,weeks,0,0
48535,),0,0
48536,plus,0,0
48537,methotrexate,0,0
48538,(,0,1
48539,MTX,0,0
48540,),0,0
48541,and,0,0
48542,those,0,0
48543,who,0,0
48544,received,0,0
48545,MTX,0,0
48546,plus,0,0
48547,placebo,0,0
48548,in,0,0
48549,the,0,0
48550,Anti-Tumor,0,0
48551,Necrosis,0,1
48552,Factor,0,0
48553,Trial,0,0
48554,in,0,0
48555,RA,0,0
48556,with,0,0
48557,Concomitant,0,0
48558,Therapy,0,0
48559,trial,0,0
48560,.,0,0
48561,RESULTS,0,0
48562,At,0,0
48563,week,0,0
48564,54,0,0
48565,",",0,0
48566,patients,0,0
48567,who,0,0
48568,did,0,0
48569,not,0,0
48570,show,0,0
48571,20,0,0
48572,%,0,0
48573,improvement,1,0
48574,by,1,0
48575,American,1,0
48576,College,1,0
48577,of,1,0
48578,Rheumatology,1,0
48579,criteria,1,0
48580,(,0,0
48581,ACR20,0,0
48582,nonresponders,0,0
48583,),0,0
48584,while,0,0
48585,receiving,0,0
48586,infliximab,0,0
48587,plus,0,0
48588,MTX,0,0
48589,exhibited,0,0
48590,mild,0,1
48591,but,0,0
48592,statistically,0,0
48593,significant,0,0
48594,improvement,0,1
48595,in,0,0
48596,clinical,0,0
48597,variables,0,0
48598,",",0,0
48599,including,0,0
48600,the,0,0
48601,28-joint,1,1
48602,Disease,1,1
48603,Activity,1,1
48604,Score,1,0
48605,(,1,0
48606,DAS28,1,1
48607,),1,0
48608,(,0,0
48609,P,0,0
48610,<,0,0
48611,0.001,0,0
48612,),0,0
48613,",",0,0
48614,tender,1,1
48615,joint,1,1
48616,count,1,1
48617,(,0,0
48618,P,0,0
48619,=,0,0
48620,0.014,0,0
48621,),0,0
48622,",",0,0
48623,swollen,1,1
48624,joint,1,1
48625,count,1,1
48626,(,0,0
48627,P,0,0
48628,<,0,0
48629,0.001,0,0
48630,),0,0
48631,",",0,0
48632,and,0,1
48633,C-reactive,1,1
48634,protein,1,1
48635,(,1,0
48636,CRP,1,1
48637,),1,1
48638,level,1,1
48639,(,0,0
48640,P,0,0
48641,<,0,0
48642,0.001,0,0
48643,),0,0
48644,.,0,0
48645,Whereas,0,0
48646,the,0,0
48647,clinical,0,0
48648,and,0,0
48649,CRP,0,1
48650,changes,0,1
48651,among,0,0
48652,ACR20,0,0
48653,nonresponders,0,0
48654,to,0,0
48655,infliximab,0,0
48656,plus,0,0
48657,MTX,0,0
48658,were,0,0
48659,small,0,0
48660,and,0,0
48661,much,0,0
48662,lower,0,0
48663,than,0,0
48664,among,0,0
48665,ACR20,0,0
48666,responders,0,0
48667,to,0,0
48668,this,0,0
48669,treatment,0,0
48670,",",0,0
48671,radiographic,1,1
48672,progression,1,1
48673,among,0,0
48674,ACR20,0,0
48675,nonresponders,0,0
48676,to,0,0
48677,infliximab,0,0
48678,plus,0,0
48679,MTX,0,0
48680,was,0,0
48681,significantly,0,0
48682,inhibited,0,0
48683,(,0,0
48684,P,0,0
48685,<,0,0
48686,0.001,0,0
48687,),0,0
48688,compared,0,0
48689,with,0,0
48690,ACR20,0,0
48691,nonresponders,0,0
48692,to,0,0
48693,MTX,0,0
48694,plus,0,0
48695,placebo,0,0
48696,.,0,1
48697,Radiographic,0,1
48698,progression,0,1
48699,was,0,0
48700,much,0,0
48701,greater,0,0
48702,in,0,0
48703,patients,0,0
48704,receiving,0,0
48705,MTX,0,0
48706,plus,0,0
48707,placebo,0,0
48708,than,0,0
48709,in,0,0
48710,patients,0,0
48711,receiving,0,0
48712,infliximab,0,0
48713,plus,0,0
48714,MTX,0,0
48715,",",0,1
48716,irrespective,0,0
48717,of,0,1
48718,ACR,1,0
48719,response,1,1
48720,status,1,1
48721,(,1,0
48722,mean,1,1
48723,change,1,1
48724,in,1,0
48725,modified,1,0
48726,Sharp/van,1,1
48727,der,1,1
48728,Heijde,1,0
48729,score,1,1
48730,6.0,0,0
48731,in,0,0
48732,ACR20,0,0
48733,responders,0,0
48734,and,0,0
48735,7.2,0,0
48736,in,0,0
48737,ACR20,0,0
48738,nonresponders,0,0
48739,in,0,0
48740,the,0,0
48741,MTX,0,0
48742,plus,0,0
48743,placebo-treated,0,0
48744,group,0,0
48745,",",0,0
48746,versus,0,0
48747,0.1,0,0
48748,in,0,0
48749,ACR20,0,0
48750,responders,0,0
48751,and,0,0
48752,1.2,0,0
48753,in,0,0
48754,ACR20,0,0
48755,nonresponders,0,0
48756,in,0,0
48757,the,0,0
48758,infliximab,0,0
48759,plus,0,0
48760,MTX-treated,0,1
48761,group,0,0
48762,),0,0
48763,.,0,0
48764,Furthermore,0,0
48765,",",0,0
48766,among,0,0
48767,patients,0,0
48768,who,0,0
48769,were,0,0
48770,ACR20,0,0
48771,nonresponders,0,0
48772,through,0,0
48773,week,0,0
48774,54,0,0
48775,",",0,0
48776,patients,0,0
48777,who,0,0
48778,were,0,0
48779,DAS,0,0
48780,nonresponders,0,0
48781,at,0,0
48782,weeks,0,0
48783,30,0,0
48784,and,0,0
48785,54,0,0
48786,",",0,0
48787,and,0,0
48788,patients,0,0
48789,without,0,0
48790,any,0,0
48791,improvement,0,0
48792,in,0,0
48793,individual,0,0
48794,clinical,0,0
48795,variables,0,0
48796,",",0,0
48797,those,0,0
48798,receiving,0,0
48799,infliximab,0,0
48800,plus,0,0
48801,MTX,0,0
48802,still,0,0
48803,demonstrated,0,0
48804,inhibition,0,1
48805,of,0,0
48806,structural,0,0
48807,damage,0,1
48808,that,0,0
48809,was,0,0
48810,statistically,0,0
48811,significant,0,0
48812,compared,0,0
48813,with,0,0
48814,inhibition,0,1
48815,in,0,0
48816,patients,0,0
48817,who,0,0
48818,received,0,0
48819,MTX,0,0
48820,plus,0,0
48821,placebo,0,0
48822,(,0,0
48823,P,0,0
48824,<,0,0
48825,0.05,0,0
48826,to,0,0
48827,P,0,0
48828,<,0,0
48829,0.001,0,0
48830,),0,0
48831,.,0,0
48832,CONCLUSION,0,0
48833,Even,0,0
48834,in,0,0
48835,patients,0,0
48836,without,0,0
48837,clinical,1,0
48838,improvement,1,1
48839,",",0,0
48840,treatment,0,0
48841,with,0,0
48842,infliximab,0,0
48843,plus,0,0
48844,MTX,0,0
48845,provided,0,0
48846,significant,0,0
48847,benefit,0,0
48848,with,0,0
48849,regard,0,0
48850,to,0,0
48851,the,0,0
48852,destructive,0,0
48853,process,0,0
48854,",",0,0
48855,suggesting,0,0
48856,that,0,0
48857,in,0,0
48858,such,0,0
48859,patients,0,0
48860,these,0,0
48861,2,0,0
48862,measures,0,0
48863,of,0,0
48864,disease,0,0
48865,are,0,0
48866,dissociated,0,0
48867,.,0,0
48868,Disc,0,0
48869,coablation,0,0
48870,and,0,1
48871,epidural,0,0
48872,injection,0,0
48873,of,0,0
48874,steroids,0,0
48875,:,0,0
48876,a,0,0
48877,comparison,0,0
48878,of,0,0
48879,strategies,0,0
48880,in,0,0
48881,the,0,0
48882,treatment,0,0
48883,of,0,0
48884,mechanical,0,0
48885,spinal,0,0
48886,discogenic,0,0
48887,pain,0,1
48888,.,0,0
48889,In,0,0
48890,this,0,0
48891,study,0,0
48892,two,0,0
48893,strategies,0,0
48894,in,0,0
48895,the,0,0
48896,treatment,0,0
48897,of,0,0
48898,Mechanical,0,0
48899,Spinal,0,1
48900,Discogenic,0,0
48901,Pain,0,1
48902,have,0,0
48903,been,0,0
48904,compared,0,0
48905,:,0,0
48906,Disc,0,0
48907,Coablation,0,0
48908,and,0,0
48909,Epidural,0,1
48910,Injection,0,0
48911,of,0,0
48912,Steroids,0,0
48913,.,0,0
48914,In,0,0
48915,2003,0,0
48916,50,0,0
48917,patients,0,0
48918,treated,0,0
48919,with,0,0
48920,one,0,0
48921,or,0,0
48922,two,0,0
48923,epidural,0,0
48924,injections,0,0
48925,have,0,0
48926,been,0,0
48927,selected,0,0
48928,ad,0,0
48929,random,0,0
48930,and,0,0
48931,50,0,0
48932,patients,0,0
48933,treated,0,0
48934,with,0,0
48935,disc,0,0
48936,coablation,0,0
48937,.,0,0
48938,Comparison,0,0
48939,of,0,0
48940,the,0,0
48941,data,0,0
48942,indicated,0,0
48943,an,0,0
48944,improvement,0,1
48945,of,0,0
48946,average,1,1
48947,VAS,1,0
48948,when,0,0
48949,relaxed,0,0
48950,for,0,0
48951,both,0,0
48952,groups,0,0
48953,(,0,0
48954,p,0,0
48955,<,0,0
48956,0.01,0,0
48957,),0,0
48958,",",0,0
48959,while,0,0
48960,after,0,0
48961,slight-moderate,0,1
48962,strain,0,0
48963,",",0,0
48964,this,0,0
48965,value,0,1
48966,was,0,0
48967,significant,0,0
48968,only,0,0
48969,after,0,0
48970,coablation,0,0
48971,(,0,0
48972,p,0,0
48973,<,0,0
48974,0.001,0,0
48975,),0,0
48976,.,0,0
48977,Finally,0,0
48978,",",0,0
48979,average,1,1
48980,VAS,1,1
48981,was,0,0
48982,clearly,0,0
48983,lower,0,0
48984,(,0,0
48985,p,0,0
48986,<,0,0
48987,0.01,0,0
48988,),0,0
48989,after,0,0
48990,coablation,0,0
48991,as,0,0
48992,compared,0,0
48993,to,0,0
48994,epidural,0,0
48995,injections,0,0
48996,.,0,0
48997,[,0,0
48998,Postural,0,1
48999,biofeedback,0,0
49000,and,0,1
49001,locomotion,0,1
49002,reeducation,0,1
49003,in,0,0
49004,stroke,0,0
49005,patients,0,0
49006,],0,0
49007,.,0,0
49008,AIMS,0,0
49009,To,0,0
49010,compare,0,0
49011,",",0,0
49012,in,0,0
49013,post-acute,0,0
49014,hemiparetic,0,0
49015,patients,0,0
49016,",",0,0
49017,gait,1,1
49018,improvement,1,1
49019,after,0,0
49020,conventional,0,0
49021,physical,0,1
49022,therapy,0,0
49023,alone,0,0
49024,or,0,0
49025,with,0,0
49026,a,0,0
49027,specialised,0,0
49028,balance,0,1
49029,retraining,0,0
49030,program,0,0
49031,.,0,0
49032,PATIENTS,0,0
49033,Twenty-six,0,0
49034,patients,0,0
49035,within,0,0
49036,3,0,0
49037,months,0,0
49038,of,0,0
49039,onset,0,1
49040,of,0,0
49041,stroke,0,1
49042,were,0,0
49043,randomised,0,0
49044,to,0,0
49045,receive,0,0
49046,physical,0,1
49047,therapy,0,0
49048,(,0,0
49049,control,0,0
49050,group,0,0
49051,),0,0
49052,or,0,0
49053,therapy,0,0
49054,and,0,1
49055,retraining,0,0
49056,(,0,0
49057,experimental,0,0
49058,group,0,0
49059,),0,0
49060,",",0,0
49061,most,0,0
49062,of,0,0
49063,the,0,0
49064,patients,0,0
49065,in,0,0
49066,both,0,0
49067,groups,0,0
49068,with,0,0
49069,left,0,0
49070,hemiplegia,0,0
49071,.,0,0
49072,The,0,0
49073,experimental,0,0
49074,group,0,0
49075,was,0,0
49076,significantly,0,0
49077,older,0,0
49078,than,0,0
49079,the,0,0
49080,control,0,0
49081,group,0,0
49082,.,0,0
49083,METHOD,0,0
49084,Thirteen,0,0
49085,patients,0,0
49086,received,0,0
49087,early,0,0
49088,conventional,0,0
49089,therapy,0,0
49090,",",0,0
49091,and,0,0
49092,13,0,0
49093,received,0,0
49094,therapy,0,0
49095,combined,0,0
49096,with,0,0
49097,standing,0,0
49098,balance,0,1
49099,training,0,0
49100,by,0,0
49101,biofeedback,0,0
49102,(,0,0
49103,BPM,0,1
49104,Monitor,0,0
49105,),0,0
49106,.,0,0
49107,Clinical,0,1
49108,measures,0,1
49109,were,0,0
49110,collected,0,0
49111,at,0,0
49112,entry,0,0
49113,(,0,0
49114,J0,0,0
49115,),0,0
49116,",",0,0
49117,once,0,0
49118,when,0,0
49119,subjects,0,0
49120,began,0,0
49121,to,0,0
49122,walk,1,1
49123,(,0,0
49124,JM,0,0
49125,),0,0
49126,and,0,0
49127,30,0,0
49128,days,0,0
49129,later,0,0
49130,(,0,0
49131,JM,0,0
49132,+,0,0
49133,30,0,0
49134,),0,0
49135,.,0,0
49136,Gait,1,0
49137,spatiotemporal,1,1
49138,parameters,1,1
49139,were,0,0
49140,collected,0,0
49141,by,0,0
49142,use,0,0
49143,of,0,0
49144,the,0,0
49145,Vicon,1,0
49146,system,1,0
49147,at,0,0
49148,JM,0,0
49149,and,0,0
49150,JM,0,0
49151,+,0,0
49152,30,0,0
49153,.,0,0
49154,RESULTS,0,0
49155,Whatever,0,0
49156,the,0,0
49157,method,0,0
49158,of,0,0
49159,rehabilitation,0,0
49160,",",0,0
49161,the,0,0
49162,clinical,1,0
49163,scores,1,1
49164,improved,0,0
49165,significantly,0,0
49166,between,0,0
49167,J0,0,0
49168,and,0,0
49169,JM,0,0
49170,+,0,0
49171,30,0,0
49172,",",0,0
49173,except,0,0
49174,for,0,0
49175,spasticity,0,0
49176,.,0,0
49177,The,0,0
49178,time,1,1
49179,between,1,0
49180,stroke,1,1
49181,and,1,0
49182,the,1,0
49183,beginning,1,0
49184,of,1,0
49185,walking,1,1
49186,was,0,0
49187,not,0,0
49188,significantly,0,0
49189,different,0,0
49190,between,0,0
49191,both,0,0
49192,groups,0,0
49193,.,0,0
49194,Gait,1,0
49195,velocity,1,1
49196,increased,0,0
49197,significantly,0,0
49198,between,0,0
49199,JM,0,0
49200,and,0,0
49201,JM,0,0
49202,+,0,0
49203,30,0,0
49204,in,0,0
49205,both,0,0
49206,groups,0,0
49207,",",0,0
49208,with,0,0
49209,no,0,0
49210,difference,0,0
49211,between,0,0
49212,groups,0,0
49213,.,0,0
49214,The,1,0
49215,walking,1,1
49216,pattern,1,0
49217,was,0,0
49218,improved,0,0
49219,for,0,0
49220,both,0,0
49221,groups,0,0
49222,",",0,0
49223,with,0,0
49224,a,0,0
49225,significant,0,0
49226,increase,0,0
49227,of,0,0
49228,the,0,0
49229,duration,1,1
49230,of,1,0
49231,the,1,0
49232,paretic,1,0
49233,limb,1,1
49234,single,1,0
49235,stance,1,0
49236,.,1,0
49237,The,0,0
49238,experimental,0,0
49239,group,0,0
49240,significantly,0,0
49241,improved,0,0
49242,the,0,0
49243,duration,1,1
49244,of,1,0
49245,the,1,0
49246,reception,1,1
49247,double,1,0
49248,stance,1,0
49249,on,1,0
49250,the,1,0
49251,paretic,1,0
49252,limb,1,1
49253,between,0,0
49254,JM,0,0
49255,and,0,0
49256,JM,0,0
49257,+,0,0
49258,30,0,0
49259,compared,0,0
49260,with,0,0
49261,the,0,0
49262,control,0,0
49263,group,0,0
49264,(,0,0
49265,P,0,0
49266,=,0,0
49267,0.03,0,0
49268,),0,0
49269,.,0,0
49270,CONCLUSION,0,0
49271,Both,0,0
49272,groups,0,0
49273,demonstrated,0,0
49274,improvement,0,0
49275,in,0,0
49276,the,0,0
49277,rehabilitation,0,0
49278,unit,0,0
49279,.,0,0
49280,The,0,0
49281,benefits,0,0
49282,of,0,0
49283,visual,0,1
49284,biofeedback,0,0
49285,by,0,0
49286,forceplate,0,0
49287,system,0,0
49288,training,0,0
49289,suggest,0,0
49290,particular,0,0
49291,improvement,0,1
49292,of,0,0
49293,anticipation,0,1
49294,equilibrium,0,1
49295,with,0,0
49296,conventional,0,0
49297,therapy,0,0
49298,.,0,0
49299,Treatment,0,0
49300,outcome,0,1
49301,of,0,0
49302,appliance,0,0
49303,therapy,0,0
49304,in,0,0
49305,temporomandibular,0,0
49306,disorder,0,0
49307,patients,0,0
49308,with,0,0
49309,myofascial,1,0
49310,pain,1,1
49311,after,0,0
49312,6,0,0
49313,and,0,0
49314,12,0,0
49315,months,0,0
49316,.,0,0
49317,AIM,0,0
49318,To,0,0
49319,compare,0,0
49320,the,0,0
49321,long-term,0,0
49322,effect,0,0
49323,of,0,0
49324,treatment,0,0
49325,with,0,0
49326,a,0,0
49327,stabilization,0,0
49328,appliance,0,0
49329,(,0,0
49330,group,0,0
49331,T,0,1
49332,),0,0
49333,and,0,0
49334,treatment,0,0
49335,with,0,0
49336,a,0,0
49337,control,0,0
49338,appliance,0,0
49339,(,0,0
49340,group,0,0
49341,C,0,0
49342,),0,0
49343,in,0,0
49344,temporomandibular,0,0
49345,disorder,0,0
49346,(,0,0
49347,TMD,0,1
49348,),0,0
49349,patients,0,0
49350,with,0,0
49351,myofascial,0,0
49352,pain,0,1
49353,.,0,0
49354,METHODS,0,0
49355,In,0,0
49356,this,0,0
49357,controlled,0,0
49358,trial,0,0
49359,",",0,0
49360,60,0,0
49361,patients,0,0
49362,(,0,0
49363,mean,0,1
49364,age,0,0
49365,29,0,0
49366,years,0,0
49367,),0,0
49368,with,0,0
49369,myofascial,0,0
49370,pain,0,1
49371,were,0,0
49372,evaluated,0,0
49373,after,0,0
49374,10,0,0
49375,weeks,0,0
49376,of,0,0
49377,treatment,0,0
49378,with,0,0
49379,either,0,0
49380,a,0,0
49381,stabilization,0,1
49382,appliance,0,0
49383,or,0,0
49384,a,0,0
49385,control,0,0
49386,appliance,0,0
49387,.,0,0
49388,All,0,0
49389,60,0,0
49390,patients,0,0
49391,were,0,0
49392,then,0,0
49393,assigned,0,0
49394,to,0,0
49395,1,0,0
49396,of,0,0
49397,3,0,0
49398,groups,0,0
49399,according,0,0
49400,to,0,0
49401,demand,0,1
49402,for,0,0
49403,treatment,0,0
49404,.,0,0
49405,Seventeen,0,0
49406,patients,0,0
49407,from,0,0
49408,group,0,0
49409,C,0,0
49410,requested,0,0
49411,another,0,0
49412,appliance,0,0
49413,and,0,0
49414,were,0,0
49415,given,0,0
49416,a,0,0
49417,stabilization,0,0
49418,appliance,0,0
49419,",",0,0
49420,thus,0,0
49421,creating,0,0
49422,a,0,0
49423,mixed,0,0
49424,group,0,0
49425,(,0,0
49426,group,0,0
49427,M,0,0
49428,),0,0
49429,.,0,0
49430,RESULTS,0,0
49431,A,0,0
49432,significant,0,0
49433,difference,0,0
49434,in,0,0
49435,improvement,1,1
49436,of,1,0
49437,overall,1,1
49438,subjective,1,1
49439,symptoms,1,1
49440,in,0,0
49441,an,0,0
49442,intent-to-treat,0,0
49443,analysis,0,0
49444,between,0,0
49445,groups,0,0
49446,T,0,0
49447,and,0,0
49448,C,0,0
49449,was,0,0
49450,found,0,0
49451,at,0,0
49452,the,0,0
49453,follow-ups,0,0
49454,.,0,0
49455,In,0,0
49456,a,0,0
49457,survival,0,1
49458,analysis,0,0
49459,of,0,0
49460,treatment,0,0
49461,compliance,0,1
49462,",",0,0
49463,a,0,0
49464,significant,0,0
49465,difference,0,0
49466,was,0,0
49467,found,0,0
49468,between,0,0
49469,groups,0,0
49470,T,0,0
49471,and,0,0
49472,C.,0,1
49473,At,0,0
49474,the,0,0
49475,6-,0,0
49476,and,0,0
49477,12-month,0,0
49478,follow-ups,0,0
49479,",",0,0
49480,a,0,0
49481,significant,0,0
49482,reduction,0,1
49483,in,0,0
49484,myofascial,1,1
49485,pain,0,1
49486,",",0,0
49487,as,0,0
49488,measured,0,0
49489,on,0,0
49490,a,0,0
49491,visual,1,1
49492,analog,1,1
49493,scale,1,1
49494,",",0,0
49495,was,0,0
49496,found,0,0
49497,in,0,0
49498,all,0,0
49499,three,0,0
49500,groups,0,0
49501,.,0,0
49502,A,0,0
49503,significant,0,0
49504,decrease,0,0
49505,in,0,0
49506,frequency,1,1
49507,and,1,1
49508,intensity,1,1
49509,of,1,1
49510,myofascial,1,1
49511,pain,1,1
49512,was,0,0
49513,found,0,0
49514,in,0,0
49515,group,0,0
49516,T,0,0
49517,at,0,0
49518,the,0,0
49519,follow-ups,0,0
49520,.,0,0
49521,A,0,0
49522,significant,0,0
49523,decrease,0,0
49524,in,0,0
49525,number,1,1
49526,of,1,0
49527,tender,1,1
49528,sites,1,0
49529,on,1,0
49530,the,1,0
49531,masticatory,1,1
49532,muscles,1,0
49533,was,0,0
49534,found,0,0
49535,in,0,0
49536,group,0,0
49537,T,0,0
49538,at,0,0
49539,the,0,0
49540,follow-ups,0,0
49541,.,0,0
49542,CONCLUSION,0,0
49543,The,0,0
49544,results,0,0
49545,support,0,0
49546,the,0,0
49547,conclusion,0,0
49548,that,0,0
49549,the,0,0
49550,positive,0,0
49551,treatment,0,0
49552,outcome,0,1
49553,obtained,0,0
49554,by,0,0
49555,use,0,0
49556,of,0,0
49557,a,0,0
49558,stabilization,0,0
49559,appliance,0,0
49560,to,0,0
49561,alleviate,0,0
49562,the,0,0
49563,signs,0,1
49564,and,0,0
49565,symptoms,0,1
49566,in,0,0
49567,patients,0,0
49568,with,0,0
49569,myofascial,0,0
49570,pain,0,1
49571,persisted,0,0
49572,after,0,0
49573,6,0,0
49574,and,0,0
49575,12,0,0
49576,months,0,0
49577,.,0,0
49578,Most,0,0
49579,patients,0,0
49580,in,0,0
49581,groups,0,0
49582,T,0,0
49583,and,0,0
49584,M,0,0
49585,reported,0,0
49586,positive,0,0
49587,changes,0,1
49588,in,0,0
49589,overall,1,1
49590,subjective,1,1
49591,symptoms,1,1
49592,in,0,0
49593,this,0,0
49594,trial,0,0
49595,.,0,0
49596,We,0,0
49597,therefore,0,0
49598,recommend,0,0
49599,use,0,0
49600,of,0,0
49601,the,0,0
49602,stabilization,0,0
49603,appliance,0,0
49604,in,0,0
49605,the,0,0
49606,treatment,0,0
49607,of,0,0
49608,TMD,0,0
49609,patients,0,0
49610,with,0,0
49611,myofascial,1,0
49612,pain,1,1
49613,.,1,0
49614,Cophenylcaine,0,0
49615,spray,0,0
49616,vs.,0,0
49617,placebo,0,0
49618,in,0,0
49619,flexible,0,0
49620,nasendoscopy,0,0
49621,:,0,0
49622,a,0,0
49623,prospective,0,0
49624,double-blind,0,0
49625,randomised,0,0
49626,controlled,0,0
49627,trial,0,0
49628,.,0,0
49629,Practices,0,0
49630,vary,0,0
49631,across,0,0
49632,the,0,0
49633,UK,0,0
49634,on,0,0
49635,the,0,0
49636,use,0,0
49637,of,0,0
49638,topical,0,0
49639,preparation,0,0
49640,prior,0,0
49641,to,0,0
49642,flexible,0,0
49643,fibreoptic,0,0
49644,nasendoscopy,0,0
49645,.,0,0
49646,In,0,0
49647,this,0,0
49648,double-blind,0,0
49649,study,0,0
49650,",",0,0
49651,we,0,0
49652,randomised,0,0
49653,98,0,0
49654,patients,0,0
49655,to,0,0
49656,receive,0,0
49657,cophenylcaine,0,0
49658,or,0,0
49659,placebo,0,0
49660,nasal,0,1
49661,spray,0,0
49662,before,0,0
49663,flexible,0,0
49664,nasendoscopy,0,0
49665,.,0,0
49666,A,0,0
49667,visual,0,1
49668,analogue,0,1
49669,scale,0,1
49670,(,0,0
49671,1-100,0,0
49672,),0,0
49673,was,0,0
49674,used,0,0
49675,to,0,0
49676,record,0,0
49677,pain,1,1
49678,",",1,0
49679,unpleasantness,1,1
49680,of,1,1
49681,taste,1,1
49682,and,1,0
49683,overall,1,1
49684,discomfort,1,1
49685,experienced,1,0
49686,.,1,0
49687,Overall,0,0
49688,",",0,0
49689,the,0,0
49690,procedure,0,0
49691,was,0,0
49692,associated,0,0
49693,with,0,0
49694,minimal,0,1
49695,pain,1,1
49696,and,1,1
49697,discomfort,1,1
49698,in,0,0
49699,both,0,0
49700,groups,0,0
49701,.,0,0
49702,There,0,0
49703,was,0,0
49704,no,0,0
49705,significant,0,0
49706,difference,0,0
49707,in,0,0
49708,pain,1,1
49709,or,1,0
49710,overall,1,1
49711,discomfort,1,1
49712,experienced,0,0
49713,between,0,0
49714,the,0,0
49715,two,0,0
49716,groups,0,0
49717,;,0,0
49718,however,0,0
49719,",",0,0
49720,the,0,0
49721,sensation,1,1
49722,of,1,0
49723,bad,1,1
49724,taste,1,1
49725,was,0,0
49726,significantly,0,0
49727,worse,0,0
49728,in,0,0
49729,the,0,0
49730,cophenylcaine,0,0
49731,group,0,0
49732,.,0,0
49733,In,0,0
49734,linear,0,0
49735,regression,0,0
49736,",",0,0
49737,factors,0,1
49738,that,0,0
49739,predicted,0,0
49740,the,0,0
49741,overall,1,1
49742,unpleasantness,1,1
49743,of,0,0
49744,the,0,0
49745,experience,0,0
49746,were,0,0
49747,primarily,0,0
49748,pain,1,1
49749,experienced,1,0
49750,and,0,0
49751,secondarily,0,0
49752,unpleasantness,1,1
49753,of,1,0
49754,taste,1,0
49755,.,1,0
49756,We,0,0
49757,conclude,0,0
49758,that,0,0
49759,the,0,0
49760,routine,0,0
49761,use,0,0
49762,of,0,0
49763,cophenylcaine,0,0
49764,for,0,0
49765,nasal,0,0
49766,preparation,0,0
49767,is,0,0
49768,not,0,0
49769,justified,0,0
49770,before,0,0
49771,flexible,0,0
49772,nasendoscopy,0,0
49773,.,0,0
49774,Results,0,0
49775,of,0,0
49776,a,0,0
49777,multicenter,0,0
49778,",",0,0
49779,8-week,0,0
49780,",",0,0
49781,parallel-group,0,0
49782,",",0,0
49783,randomized,0,0
49784,",",0,0
49785,double-blind,0,0
49786,",",0,0
49787,double-dummy,0,0
49788,",",0,0
49789,Phase,0,0
49790,III,0,1
49791,clinical,0,0
49792,trial,0,0
49793,to,0,0
49794,evaluate,0,0
49795,the,0,0
49796,efficacy,0,1
49797,and,0,0
49798,tolerability,0,1
49799,of,0,1
49800,amlodipine,0,0
49801,maleate,0,0
49802,versus,0,0
49803,amlodipine,0,0
49804,besylate,0,0
49805,in,0,0
49806,Korean,0,0
49807,patients,0,0
49808,with,0,0
49809,mild,0,0
49810,to,0,0
49811,moderate,0,0
49812,hypertension,0,0
49813,.,0,0
49814,BACKGROUND,0,0
49815,Recently,0,0
49816,",",0,0
49817,amlodipine,0,0
49818,maleate,0,0
49819,was,0,0
49820,developed,0,0
49821,and,0,0
49822,tested,0,0
49823,in,0,0
49824,preclinical,0,0
49825,and,0,0
49826,Phase,0,0
49827,I,0,0
49828,clinical,0,0
49829,trials,0,0
49830,in,0,0
49831,Korea,0,0
49832,.,0,0
49833,The,0,0
49834,studies,0,0
49835,found,0,0
49836,pharmacokinetics,0,1
49837,and,0,1
49838,pharmacodynamics,0,0
49839,similar,0,0
49840,to,0,0
49841,those,0,0
49842,of,0,0
49843,amlodipine,0,0
49844,besylate,0,0
49845,.,0,0
49846,OBJECTIVE,0,0
49847,The,0,0
49848,aim,0,0
49849,of,0,0
49850,this,0,0
49851,study,0,0
49852,was,0,0
49853,to,0,0
49854,compare,0,0
49855,the,0,0
49856,efficacy,0,1
49857,and,0,0
49858,tolerability,0,1
49859,of,0,1
49860,amlodipine,0,0
49861,maleate,0,0
49862,with,0,0
49863,those,0,0
49864,of,0,0
49865,amlodipine,0,0
49866,besylate,0,0
49867,in,0,0
49868,Korean,0,0
49869,patients,0,0
49870,with,0,0
49871,mild,0,0
49872,to,0,0
49873,moderate,0,0
49874,hypertension,0,0
49875,.,0,0
49876,METHODS,0,0
49877,This,0,0
49878,was,0,0
49879,a,0,0
49880,multicenter,0,0
49881,",",0,0
49882,8-week,0,0
49883,",",0,0
49884,parallel-group,0,0
49885,",",0,0
49886,randomized,0,0
49887,",",0,0
49888,double-blind,0,0
49889,",",0,0
49890,double-dummy,0,0
49891,",",0,0
49892,Phase,0,0
49893,III,0,1
49894,clinical,0,0
49895,trial,0,0
49896,.,0,0
49897,Eligible,0,0
49898,patients,0,0
49899,were,0,0
49900,Korean,0,0
49901,",",0,0
49902,aged,0,0
49903,18,0,0
49904,to,0,0
49905,75,0,0
49906,years,0,0
49907,",",0,0
49908,had,0,0
49909,hypertension,0,1
49910,",",0,1
49911,and,0,1
49912,were,0,0
49913,either,0,0
49914,taking,0,0
49915,antihypertensive,0,0
49916,medications,0,0
49917,or,0,0
49918,had,0,0
49919,a,0,0
49920,documented,0,0
49921,sitting,0,1
49922,diastolic,0,1
49923,blood,0,1
49924,pressure,0,1
49925,of,0,0
49926,90,0,0
49927,to,0,0
49928,109,0,0
49929,mm,0,0
49930,Hg,0,0
49931,.,0,0
49932,After,0,0
49933,a,0,0
49934,washout,0,0
49935,period,0,0
49936,of,0,0
49937,2,0,0
49938,weeks,0,0
49939,",",0,0
49940,patients,0,0
49941,were,0,0
49942,randomized,0,0
49943,to,0,0
49944,amlodipine,0,0
49945,maleate,0,0
49946,or,0,0
49947,amlodipine,0,0
49948,besylate,0,0
49949,for,0,0
49950,8,0,0
49951,weeks,0,0
49952,.,0,0
49953,In,0,0
49954,both,0,0
49955,groups,0,0
49956,",",0,0
49957,the,0,0
49958,medications,0,0
49959,were,0,0
49960,initiated,0,0
49961,at,0,0
49962,5,0,0
49963,mg,0,0
49964,QD,0,0
49965,.,0,0
49966,At,0,0
49967,day,0,0
49968,29,0,0
49969,",",0,0
49970,the,0,0
49971,medication,0,1
49972,dose,0,0
49973,was,0,0
49974,increased,0,0
49975,to,0,0
49976,10,0,0
49977,mg,0,0
49978,QD,0,0
49979,if,0,0
49980,sitting,0,1
49981,diastolic,0,1
49982,blood,0,1
49983,pressure,0,1
49984,(,0,0
49985,SiDBP,0,1
49986,),0,0
49987,was,0,0
49988,>,0,0
49989,or,0,0
49990,=,0,0
49991,90,0,0
49992,mm,0,0
49993,Hg,0,0
49994,.,0,0
49995,RESULTS,0,0
49996,One,0,0
49997,hundred,0,0
49998,eighteen,0,0
49999,patients,0,0
50000,were,0,0
50001,enrolled,0,0
50002,.,0,0
50003,Fifty-seven,0,0
50004,patients,0,0
50005,received,0,0
50006,amlodipine,0,0
50007,maleate,0,0
50008,(,0,0
50009,29,0,0
50010,men,0,0
50011,",",0,0
50012,28,0,0
50013,women,0,0
50014,;,0,0
50015,mean,0,1
50016,[,0,0
50017,SD,0,0
50018,],0,0
50019,age,0,0
50020,",",0,0
50021,49.0,0,0
50022,[,0,0
50023,11.4,0,0
50024,],0,0
50025,years,0,0
50026,),0,0
50027,and,0,0
50028,61,0,0
50029,received,0,0
50030,amlodipine,0,0
50031,besylate,0,0
50032,(,0,0
50033,35,0,0
50034,men,0,0
50035,",",0,0
50036,26,0,0
50037,women,0,0
50038,;,0,0
50039,mean,0,1
50040,[,0,0
50041,SD,0,0
50042,],0,0
50043,age,0,0
50044,",",0,0
50045,51.6,0,0
50046,[,0,0
50047,9.4,0,0
50048,],0,0
50049,years,0,0
50050,),0,0
50051,.,0,0
50052,Baseline,1,0
50053,mean,1,1
50054,(,1,0
50055,SD,1,0
50056,),1,0
50057,values,1,1
50058,for,0,0
50059,sitting,1,1
50060,systolic,1,1
50061,blood,1,1
50062,pressure,1,1
50063,and,1,1
50064,SiDBP,1,1
50065,were,0,0
50066,152.0,0,0
50067,(,0,0
50068,12.2,0,0
50069,),0,0
50070,mm,0,0
50071,Hg,0,0
50072,and,0,0
50073,98.1,0,0
50074,(,0,0
50075,5.6,0,0
50076,),0,0
50077,mm,0,0
50078,Hg,0,0
50079,",",0,0
50080,respectively,0,0
50081,",",0,0
50082,for,0,0
50083,the,0,0
50084,amlodipine,0,0
50085,maleate,0,0
50086,group,0,0
50087,and,0,0
50088,153.4,0,0
50089,(,0,0
50090,14.0,0,0
50091,),0,0
50092,mm,0,0
50093,Hg,0,0
50094,and,0,0
50095,98.1,0,0
50096,(,0,0
50097,5.5,0,0
50098,),0,0
50099,mm,0,0
50100,Hg,0,0
50101,",",0,0
50102,respectively,0,0
50103,",",0,0
50104,for,0,0
50105,the,0,0
50106,amlodipine,0,0
50107,besylate,0,0
50108,group,0,0
50109,.,0,0
50110,In,0,0
50111,this,0,0
50112,population,0,0
50113,",",0,0
50114,amlodipine,0,0
50115,maleate,0,0
50116,was,0,0
50117,not,0,0
50118,inferior,0,0
50119,to,0,0
50120,amlodipine,0,0
50121,besylate,0,0
50122,:,0,0
50123,the,0,0
50124,lower,0,0
50125,limit,0,0
50126,of,0,0
50127,the,0,0
50128,2-sided,0,0
50129,95,0,0
50130,%,0,0
50131,CI,0,0
50132,for,0,0
50133,the,0,0
50134,treatment,0,0
50135,difference,0,0
50136,in,0,0
50137,SiDBP,1,0
50138,was,0,0
50139,greater,0,0
50140,than,0,0
50141,-4,0,0
50142,mm,0,0
50143,Hg,0,0
50144,.,0,0
50145,The,0,0
50146,between-group,0,0
50147,difference,0,0
50148,in,0,0
50149,SiDBP,1,1
50150,response,1,1
50151,rate,1,1
50152,(,0,0
50153,the,0,0
50154,proportion,0,0
50155,of,0,0
50156,patients,0,0
50157,who,0,0
50158,experienced,0,0
50159,adequate,0,0
50160,SiDBP,0,1
50161,reductions,0,1
50162,),0,0
50163,did,0,0
50164,not,0,0
50165,reach,0,0
50166,statistical,0,0
50167,significance,0,0
50168,:,0,0
50169,85.7,0,0
50170,%,0,0
50171,(,0,0
50172,42/49,0,0
50173,),0,0
50174,for,0,0
50175,the,0,0
50176,amlodipine,0,0
50177,maleate,0,0
50178,group,0,0
50179,and,0,0
50180,91.8,0,0
50181,%,0,0
50182,(,0,0
50183,45/49,0,0
50184,),0,0
50185,for,0,0
50186,the,0,0
50187,amlodipine,0,0
50188,besylate,0,0
50189,group,0,0
50190,.,0,0
50191,Compliance,0,1
50192,rates,0,1
50193,were,0,0
50194,similar,0,0
50195,between,0,0
50196,groups,0,0
50197,",",0,0
50198,with,0,0
50199,mean,1,1
50200,(,1,0
50201,SD,1,0
50202,),1,0
50203,compliance,1,1
50204,rates,1,1
50205,of,0,0
50206,97.4,0,0
50207,%,0,0
50208,(,0,0
50209,2.8,0,0
50210,%,0,0
50211,),0,0
50212,and,0,0
50213,97.1,0,0
50214,%,0,0
50215,(,0,0
50216,3.6,0,0
50217,%,0,0
50218,),0,0
50219,in,0,0
50220,the,0,0
50221,amlodipine,0,0
50222,maleate,0,0
50223,and,0,1
50224,amlodipine,0,0
50225,besylate,0,0
50226,groups,0,0
50227,",",0,0
50228,respectively,0,0
50229,.,0,0
50230,Also,0,0
50231,",",0,0
50232,there,0,0
50233,were,0,0
50234,no,0,0
50235,significant,0,0
50236,differences,0,0
50237,in,0,0
50238,the,0,0
50239,incidences,0,1
50240,of,0,0
50241,drug-related,0,1
50242,clinical,0,0
50243,and,0,0
50244,laboratory,0,0
50245,adverse,0,1
50246,events,0,1
50247,;,0,0
50248,the,0,0
50249,most,0,0
50250,common,0,0
50251,were,0,0
50252,headache,1,1
50253,",",1,1
50254,flushing,1,1
50255,",",1,1
50256,facial,1,1
50257,edema,1,1
50258,",",1,0
50259,and,1,1
50260,paresthesia,1,1
50261,.,1,1
50262,CONCLUSION,0,0
50263,In,0,0
50264,this,0,0
50265,population,0,0
50266,",",0,0
50267,the,0,0
50268,efficacy,0,1
50269,and,0,0
50270,tolerability,0,1
50271,observed,0,0
50272,with,0,0
50273,amlodipine,0,0
50274,maleate,0,0
50275,were,0,0
50276,similar,0,0
50277,to,0,0
50278,those,0,0
50279,seen,0,0
50280,with,0,0
50281,amlodipine,0,0
50282,besylate,0,0
50283,.,0,0
50284,Just-in-time,0,0
50285,evidence-based,0,0
50286,e-mail,0,0
50287,reminders,0,0
50288,in,0,0
50289,home,0,0
50290,health,0,1
50291,care,0,0
50292,:,0,0
50293,impact,0,0
50294,on,0,0
50295,nurse,0,0
50296,practices,0,0
50297,.,0,0
50298,OBJECTIVE,0,0
50299,To,0,0
50300,test,0,0
50301,the,0,0
50302,effectiveness,0,0
50303,of,0,0
50304,two,0,0
50305,interventions,0,0
50306,designed,0,0
50307,to,0,0
50308,improve,0,0
50309,the,0,0
50310,adoption,0,0
50311,of,0,0
50312,evidence-based,0,0
50313,practices,0,0
50314,by,0,0
50315,home,0,0
50316,health,0,1
50317,nurses,0,0
50318,caring,0,1
50319,for,0,0
50320,heart,0,1
50321,failure,0,1
50322,(,0,0
50323,HF,0,0
50324,),0,0
50325,patients,0,0
50326,.,0,0
50327,DATA,0,0
50328,SOURCES/STUDY,0,0
50329,SETTING,0,0
50330,Information,0,0
50331,on,0,0
50332,nurse,0,0
50333,practices,0,0
50334,was,0,0
50335,abstracted,0,0
50336,from,0,0
50337,the,0,0
50338,clinical,0,0
50339,records,0,0
50340,of,0,0
50341,patients,0,0
50342,admitted,0,0
50343,between,0,0
50344,June,0,0
50345,2000,0,0
50346,and,0,0
50347,November,0,0
50348,2001,0,0
50349,to,0,0
50350,the,0,0
50351,care,0,0
50352,of,0,0
50353,354,0,0
50354,study,0,0
50355,nurses,0,0
50356,at,0,0
50357,a,0,0
50358,large,0,0
50359,",",0,0
50360,urban,0,0
50361,",",0,0
50362,nonprofit,0,0
50363,home,0,0
50364,care,0,0
50365,agency,0,0
50366,.,0,0
50367,STUDY,0,0
50368,DESIGN,0,0
50369,The,0,0
50370,study,0,0
50371,employed,0,0
50372,a,0,0
50373,randomized,0,0
50374,design,0,0
50375,with,0,0
50376,nurses,0,0
50377,assigned,0,0
50378,to,0,0
50379,usual,0,0
50380,care,0,0
50381,or,0,0
50382,one,0,0
50383,of,0,0
50384,two,0,0
50385,intervention,0,0
50386,groups,0,0
50387,upon,0,0
50388,identification,0,0
50389,of,0,0
50390,an,0,0
50391,eligible,0,0
50392,patient,0,0
50393,.,0,0
50394,The,0,0
50395,basic,0,0
50396,intervention,0,0
50397,was,0,0
50398,a,0,0
50399,one-time,0,0
50400,e-mail,0,0
50401,reminder,0,0
50402,highlighting,0,0
50403,six,0,0
50404,HF-specific,0,0
50405,clinical,0,0
50406,recommendations,0,0
50407,.,0,0
50408,The,0,0
50409,augmented,0,1
50410,intervention,0,0
50411,consisted,0,0
50412,of,0,0
50413,the,0,0
50414,initial,0,0
50415,e-mail,0,0
50416,reminder,0,0
50417,supplemented,0,0
50418,by,0,0
50419,provider,0,0
50420,prompts,0,0
50421,",",0,0
50422,patient,0,1
50423,education,0,0
50424,material,0,1
50425,",",0,0
50426,and,0,1
50427,clinical,0,1
50428,nurse,0,1
50429,specialist,0,0
50430,outreach,0,0
50431,.,0,0
50432,DATA,0,0
50433,COLLECTION,0,0
50434,At,0,0
50435,each,0,0
50436,home,0,0
50437,health,0,1
50438,visit,0,1
50439,provided,0,0
50440,by,0,0
50441,a,0,0
50442,study,0,0
50443,nurse,0,0
50444,to,0,0
50445,an,0,0
50446,eligible,0,0
50447,HF,0,0
50448,patient,0,0
50449,during,0,0
50450,the,0,0
50451,45-day,0,0
50452,follow-up,0,0
50453,period,0,0
50454,",",0,0
50455,a,0,0
50456,structured,0,0
50457,chart,0,0
50458,abstraction,0,1
50459,tool,0,1
50460,was,0,0
50461,used,0,0
50462,to,0,0
50463,collect,0,0
50464,information,0,0
50465,on,0,0
50466,whether,0,0
50467,the,0,0
50468,nurse,0,0
50469,provided,0,0
50470,the,0,0
50471,care,0,0
50472,practices,0,0
50473,highlighted,0,0
50474,in,0,0
50475,the,0,0
50476,e-mail,0,0
50477,reminder,0,0
50478,.,0,0
50479,PRINCIPAL,0,1
50480,FINDINGS,0,0
50481,Both,0,0
50482,the,0,0
50483,basic,0,0
50484,and,0,0
50485,the,0,0
50486,augmented,0,1
50487,interventions,0,0
50488,greatly,0,0
50489,increased,0,0
50490,the,0,0
50491,practice,1,0
50492,of,1,0
50493,evidence-based,1,0
50494,care,1,0
50495,",",0,0
50496,according,0,0
50497,to,0,0
50498,patient,0,1
50499,records,0,0
50500,",",0,0
50501,in,0,0
50502,the,0,0
50503,areas,0,0
50504,of,0,0
50505,patient,0,1
50506,assessment,0,0
50507,and,0,0
50508,instructions,0,1
50509,about,0,0
50510,HF,0,0
50511,disease,0,0
50512,management,0,0
50513,.,0,0
50514,While,0,0
50515,not,0,0
50516,all,0,0
50517,results,0,0
50518,were,0,0
50519,statistically,0,0
50520,significant,0,0
50521,at,0,0
50522,conventional,0,0
50523,levels,0,1
50524,",",0,0
50525,intervention,1,0
50526,effects,1,1
50527,were,0,0
50528,positive,0,0
50529,in,0,0
50530,virtually,0,0
50531,all,0,0
50532,cases,0,0
50533,and,0,0
50534,effect,1,1
50535,magnitudes,1,1
50536,frequently,1,0
50537,were,0,0
50538,large,0,0
50539,.,0,0
50540,CONCLUSIONS,0,0
50541,The,0,0
50542,results,0,0
50543,of,0,0
50544,this,0,0
50545,randomized,0,0
50546,trial,0,0
50547,strongly,0,0
50548,support,0,0
50549,the,0,0
50550,efficacy,1,1
50551,of,0,0
50552,just-in-time,1,1
50553,evidence-based,1,0
50554,reminders,1,0
50555,as,0,0
50556,a,0,0
50557,means,0,0
50558,of,0,0
50559,changing,0,0
50560,clinical,0,0
50561,practice,0,0
50562,among,0,0
50563,home,0,0
50564,health,0,0
50565,nurses,0,0
50566,who,0,0
50567,are,0,0
50568,geographically,0,0
50569,dispersed,0,0
50570,and,0,0
50571,spend,0,0
50572,much,0,0
50573,of,0,0
50574,their,0,0
50575,time,0,1
50576,in,0,0
50577,the,0,0
50578,field,0,0
50579,.,0,0
50580,The,0,0
50581,effect,0,0
50582,of,0,0
50583,venlafaxine,0,0
50584,on,0,0
50585,ongoing,0,0
50586,and,0,0
50587,experimentally,0,0
50588,induced,0,0
50589,pain,0,1
50590,in,0,0
50591,neuropathic,0,0
50592,pain,0,1
50593,patients,0,0
50594,:,0,0
50595,a,0,0
50596,double,0,0
50597,blind,0,0
50598,",",0,0
50599,placebo,0,0
50600,controlled,0,0
50601,study,0,0
50602,.,0,0
50603,BACKGROUND,0,0
50604,AND,0,0
50605,AIM,0,0
50606,The,0,0
50607,aim,0,0
50608,of,0,0
50609,this,0,0
50610,randomized,0,0
50611,double,0,0
50612,blind,0,0
50613,placebo,0,0
50614,controlled,0,0
50615,study,0,0
50616,was,0,0
50617,to,0,0
50618,investigate,0,0
50619,the,0,0
50620,effectiveness,0,0
50621,and,0,0
50622,the,0,0
50623,safety,0,1
50624,of,0,0
50625,venlafaxine,0,0
50626,XR,0,0
50627,75,0,0
50628,and,0,0
50629,150,0,0
50630,mg,0,0
50631,on,0,0
50632,ongoing,0,0
50633,pain,0,1
50634,and,0,0
50635,on,0,0
50636,quantitative,0,0
50637,sensory,0,1
50638,tests,0,0
50639,in,0,0
50640,60,0,0
50641,patients,0,0
50642,with,0,0
50643,neuropathic,0,0
50644,pain,0,1
50645,for,0,0
50646,8,0,0
50647,weeks,0,0
50648,.,0,0
50649,METHODS,0,0
50650,Evaluation,0,0
50651,parameters,0,1
50652,consisted,0,0
50653,of,0,0
50654,ongoing,0,0
50655,pain,0,1
50656,intensity,0,1
50657,(,0,0
50658,VAS,0,1
50659,),0,0
50660,",",0,0
50661,patient,0,1
50662,satisfaction,0,1
50663,",",0,0
50664,side,0,1
50665,effects,0,1
50666,",",0,0
50667,global,0,1
50668,efficacy,0,1
50669,and,0,0
50670,tolerance,0,1
50671,.,0,1
50672,Quantitative,0,0
50673,sensory,0,1
50674,measurements,0,0
50675,taken,0,0
50676,from,0,0
50677,the,0,0
50678,affected,0,0
50679,area,0,1
50680,before,0,0
50681,and,0,0
50682,after,0,0
50683,the,0,0
50684,drug,0,0
50685,treatment,0,0
50686,included,0,0
50687,pin-prick,0,1
50688,hyperalgesia,0,1
50689,",",0,0
50690,allodynia,0,1
50691,",",0,1
50692,detection,0,1
50693,and,0,1
50694,pain,0,1
50695,thresholds,0,1
50696,to,0,0
50697,electrical,0,1
50698,and,0,0
50699,heat,0,0
50700,stimuli,0,1
50701,",",0,0
50702,temporal,0,1
50703,summation,0,1
50704,of,0,0
50705,repetitive,0,1
50706,electrical,0,1
50707,and,0,0
50708,heat,0,0
50709,stimuli,0,0
50710,.,0,0
50711,RESULTS,0,0
50712,A,0,0
50713,total,0,0
50714,of,0,0
50715,55,0,0
50716,patients,0,0
50717,completed,0,0
50718,the,0,0
50719,study,0,0
50720,.,0,0
50721,VAS,1,1
50722,scores,1,1
50723,decreased,0,0
50724,significantly,0,0
50725,compared,0,0
50726,to,0,0
50727,the,0,0
50728,baseline,0,0
50729,measurements,0,0
50730,in,0,0
50731,all,0,0
50732,groups,0,0
50733,.,0,0
50734,There,0,0
50735,was,0,0
50736,no,0,0
50737,significant,0,0
50738,difference,0,0
50739,between,0,0
50740,the,0,0
50741,groups,0,0
50742,regarding,0,0
50743,pain,1,1
50744,intensity,1,1
50745,and,1,1
50746,escape,1,1
50747,medication,1,1
50748,.,1,0
50749,The,0,0
50750,areas,1,0
50751,of,1,0
50752,allodynia,1,1
50753,and,1,0
50754,pin-prick,1,1
50755,hyperalgesia,1,1
50756,decreased,0,0
50757,significantly,0,0
50758,in,0,0
50759,venlafaxine,0,0
50760,groups,0,0
50761,compared,0,0
50762,to,0,0
50763,the,0,0
50764,placebo,0,0
50765,.,0,0
50766,There,0,0
50767,was,0,0
50768,no,0,0
50769,significant,0,0
50770,difference,0,0
50771,between,0,0
50772,the,0,0
50773,groups,0,0
50774,regarding,0,0
50775,the,0,0
50776,detection,0,1
50777,thresholds,0,1
50778,(,0,0
50779,electrical,0,1
50780,and,0,1
50781,heat,0,0
50782,),0,0
50783,.,0,0
50784,The,0,0
50785,pain,1,1
50786,threshold,1,1
50787,and,1,0
50788,the,1,0
50789,summation,1,1
50790,threshold,1,1
50791,to,1,0
50792,electrical,1,1
50793,stimuli,1,1
50794,and,1,0
50795,the,1,0
50796,summation,1,1
50797,threshold,1,1
50798,to,1,0
50799,heat,1,0
50800,stimuli,1,1
50801,increased,0,0
50802,significantly,0,0
50803,following,0,0
50804,treatment,0,0
50805,in,0,0
50806,both,0,0
50807,venlafaxine,0,0
50808,groups,0,0
50809,.,0,0
50810,In,0,0
50811,addition,0,0
50812,",",0,0
50813,the,0,0
50814,degree,1,1
50815,of,1,0
50816,the,1,0
50817,temporal,1,0
50818,summation,1,1
50819,to,1,0
50820,electrical,1,1
50821,and,1,0
50822,heat,1,0
50823,stimuli,1,1
50824,decreased,0,0
50825,significantly,0,0
50826,following,0,0
50827,treatment,0,0
50828,in,0,0
50829,both,0,0
50830,venlafaxine,0,0
50831,groups,0,0
50832,compared,0,0
50833,to,0,0
50834,the,0,0
50835,placebo,0,0
50836,.,0,0
50837,CONCLUSION,0,0
50838,The,0,0
50839,study,0,0
50840,showed,0,0
50841,significant,0,0
50842,effect,0,0
50843,of,0,0
50844,venlafaxine,0,0
50845,in,0,0
50846,the,0,0
50847,manifestations,0,0
50848,of,0,0
50849,hyperalgesia,0,1
50850,and,0,0
50851,temporal,0,1
50852,summation,0,1
50853,",",0,0
50854,but,0,0
50855,not,0,0
50856,on,0,0
50857,the,0,0
50858,ongoing,0,0
50859,pain,0,1
50860,intensity,0,1
50861,.,0,0
50862,Furthermore,0,0
50863,",",0,0
50864,the,0,0
50865,quantitative,0,0
50866,sensory,0,1
50867,tests,0,1
50868,provided,0,0
50869,complementing,0,0
50870,information,0,0
50871,to,0,0
50872,the,0,0
50873,clinical,0,0
50874,measures,0,0
50875,.,0,0
50876,Tolerance,1,1
50877,and,1,1
50878,efficacy,1,1
50879,of,0,1
50880,combined,0,0
50881,diethylcarbamazine,0,0
50882,and,0,1
50883,albendazole,0,0
50884,for,0,0
50885,treatment,0,0
50886,of,0,0
50887,Wuchereria,0,0
50888,bancrofti,0,0
50889,and,0,1
50890,intestinal,0,1
50891,helminth,0,1
50892,infections,0,1
50893,in,0,0
50894,Haitian,0,0
50895,children,0,0
50896,.,0,0
50897,This,0,0
50898,randomized,0,0
50899,",",0,0
50900,placebo-controlled,0,0
50901,trial,0,0
50902,investigated,0,0
50903,the,0,0
50904,tolerance,0,1
50905,",",0,0
50906,efficacy,0,1
50907,",",0,1
50908,and,0,1
50909,nutritional,0,1
50910,benefit,0,0
50911,of,0,0
50912,combining,0,0
50913,chemotherapeutic,0,0
50914,treatment,0,0
50915,of,0,0
50916,intestinal,0,1
50917,helminths,0,0
50918,and,0,0
50919,lymphatic,0,0
50920,filariasis,0,0
50921,.,0,0
50922,Children,0,0
50923,were,0,0
50924,infected,0,0
50925,with,0,0
50926,Ascaris,0,0
50927,(,0,0
50928,30.7,0,0
50929,%,0,0
50930,),0,0
50931,",",0,0
50932,Trichuris,0,0
50933,(,0,0
50934,53.4,0,0
50935,%,0,0
50936,),0,0
50937,",",0,0
50938,and,0,1
50939,hookworm,0,1
50940,(,0,0
50941,9.7,0,0
50942,%,0,0
50943,),0,0
50944,with,0,0
50945,69.9,0,0
50946,%,0,0
50947,having,0,0
50948,more,0,0
50949,than,0,0
50950,one,0,0
50951,of,0,0
50952,these,0,0
50953,parasites,0,0
50954,.,0,0
50955,A,0,0
50956,total,0,0
50957,of,0,0
50958,15.8,0,0
50959,%,0,0
50960,of,0,0
50961,the,0,0
50962,children,0,0
50963,had,0,0
50964,Wuchereria,0,0
50965,bancrofti,0,0
50966,microfilariae,0,1
50967,.,0,0
50968,Children,0,0
50969,were,0,0
50970,randomly,0,0
50971,assigned,0,0
50972,treatment,0,0
50973,with,0,0
50974,placebo,0,0
50975,",",0,1
50976,albendazole,0,0
50977,(,0,1
50978,ALB,0,1
50979,),0,0
50980,",",0,0
50981,diethylcarbamazine,0,0
50982,(,0,1
50983,DEC,0,1
50984,),0,1
50985,",",0,0
50986,or,0,0
50987,combined,0,0
50988,therapy,0,0
50989,.,0,0
50990,The,1,0
50991,combination,1,0
50992,of,1,0
50993,DEC/ALB,1,0
50994,reduced,1,0
50995,microfilarial,1,1
50996,density,1,1
50997,compared,1,0
50998,with,1,0
50999,placebo,1,0
51000,",",1,0
51001,ALB,1,1
51002,",",1,1
51003,or,1,1
51004,DEC,1,1
51005,(,1,0
51006,P,1,0
51007,<,1,0
51008,or,1,0
51009,=,1,0
51010,0.03,1,0
51011,),1,0
51012,.,1,0
51013,Albendazole,1,0
51014,and,1,0
51015,DEC/ALB,1,0
51016,reduced,1,0
51017,the,1,0
51018,prevalence,1,0
51019,of,1,0
51020,Ascaris,1,0
51021,",",1,0
51022,Trichuris,1,0
51023,",",1,1
51024,and,1,0
51025,hookworm,1,0
51026,more,1,0
51027,than,1,0
51028,placebo,1,0
51029,or,1,0
51030,DEC,1,1
51031,(,1,0
51032,P,1,0
51033,<,1,0
51034,or,1,0
51035,=,1,0
51036,0.03,1,0
51037,),1,0
51038,.,1,0
51039,Among,1,0
51040,Trichuris-infected,1,1
51041,children,1,0
51042,",",1,0
51043,those,1,0
51044,receiving,1,0
51045,ALB,1,0
51046,and,1,0
51047,DEC/ALB,1,1
51048,demonstrated,1,0
51049,greater,1,0
51050,gains,1,1
51051,in,1,0
51052,weight,1,1
51053,compared,1,0
51054,with,1,0
51055,placebo,1,0
51056,(,1,0
51057,P,1,0
51058,<,1,0
51059,or,1,0
51060,=,1,0
51061,0.05,1,0
51062,),1,0
51063,.,1,0
51064,Albendazole,1,0
51065,and,1,0
51066,DEC/ALB,1,1
51067,were,1,0
51068,equally,1,0
51069,efficacious,1,0
51070,in,1,0
51071,treating,1,0
51072,intestinal,1,1
51073,helminths,1,0
51074,and,1,0
51075,for,1,0
51076,children,1,0
51077,with,1,0
51078,W.,1,1
51079,bancrofti,1,0
51080,microfilaremia,1,1
51081,",",1,0
51082,DEC/ALB,1,1
51083,was,1,0
51084,more,1,0
51085,effective,1,1
51086,than,1,0
51087,DEC,1,1
51088,",",1,0
51089,with,1,0
51090,no,1,0
51091,increase,1,0
51092,in,1,0
51093,severity,1,1
51094,of,1,0
51095,adverse,1,1
51096,reactions,1,0
51097,.,1,0
51098,Simvastatin,0,0
51099,and,0,0
51100,preparation,0,0
51101,of,0,1
51102,polyunsaturated,0,0
51103,phospholipids,0,0
51104,produce,0,0
51105,similar,0,0
51106,changes,0,0
51107,in,0,0
51108,the,0,0
51109,phospholipid,0,1
51110,composition,0,0
51111,of,0,0
51112,high-density,0,1
51113,lipoproteins,0,1
51114,during,0,0
51115,hypercholesterolemia,0,0
51116,.,0,0
51117,We,0,0
51118,studied,0,0
51119,the,0,0
51120,phospholipid,0,1
51121,composition,0,0
51122,of,0,0
51123,high-density,0,1
51124,lipoproteins,0,1
51125,in,0,0
51126,patients,0,0
51127,with,0,0
51128,coronary,0,0
51129,heart,0,1
51130,disease,0,1
51131,and,0,1
51132,hypercholesterolemia,0,0
51133,treated,0,0
51134,with,0,0
51135,simvastatin,0,0
51136,(,0,0
51137,Zocor,0,0
51138,",",0,0
51139,inhibitor,0,0
51140,of,0,0
51141,the,0,0
51142,key,0,0
51143,enzyme,0,0
51144,of,0,0
51145,cholesterol,0,1
51146,synthesis,0,1
51147,),0,1
51148,and,0,0
51149,preparation,0,0
51150,of,0,1
51151,polyunsaturated,0,0
51152,phospholipids,0,1
51153,(,0,0
51154,lipostabil,0,0
51155,forte,0,0
51156,),0,0
51157,.,0,0
51158,Simvastatin,0,0
51159,produced,0,0
51160,a,0,0
51161,hypolipidemic,1,0
51162,effect,1,0
51163,and,1,0
51164,modulates,1,0
51165,the,1,0
51166,phospholipid,1,1
51167,composition,1,0
51168,of,1,0
51169,high-density,1,1
51170,lipoproteins,1,1
51171,(,1,0
51172,similarly,1,0
51173,to,1,0
51174,lipostabil,1,0
51175,forte,1,0
51176,),1,0
51177,.,1,0
51178,These,0,0
51179,changes,0,0
51180,contribute,0,0
51181,to,0,0
51182,functional,1,0
51183,activity,1,1
51184,of,0,0
51185,high-density,1,1
51186,lipoproteins,1,1
51187,in,0,0
51188,the,0,0
51189,reverse,0,0
51190,cholesterol,0,1
51191,transport,0,1
51192,.,0,0
51193,Investigation,0,0
51194,of,0,0
51195,maxillary,1,0
51196,tooth,1,1
51197,sizes,1,1
51198,in,0,0
51199,patients,0,0
51200,with,0,0
51201,palatal,0,1
51202,canine,0,0
51203,displacement,0,1
51204,.,0,0
51205,AIM,0,0
51206,The,0,0
51207,aim,0,0
51208,of,0,0
51209,this,0,0
51210,retrospective,0,0
51211,trial,0,0
51212,was,0,0
51213,to,0,0
51214,investigate,0,0
51215,differences,0,0
51216,in,0,0
51217,mesiodistal,0,1
51218,and,0,0
51219,vestibulo-oral,0,0
51220,crown,0,1
51221,sizes,0,1
51222,of,0,0
51223,naturally,0,0
51224,",",0,0
51225,fully-erupted,0,0
51226,permanent,0,0
51227,maxillary,0,0
51228,teeth,0,0
51229,between,0,0
51230,patients,0,0
51231,with,0,0
51232,and,0,0
51233,without,0,0
51234,palatal,0,1
51235,canine,0,0
51236,displacement,0,1
51237,.,0,0
51238,PATIENTS,0,0
51239,AND,0,0
51240,METHOD,0,0
51241,115,0,0
51242,patients,0,0
51243,(,0,0
51244,mean,0,1
51245,age,0,0
51246,:,0,0
51247,14,0,0
51248,years,0,0
51249,10,0,0
51250,months,0,0
51251,;,0,0
51252,females,0,0
51253,:,0,0
51254,77,0,0
51255,males,0,0
51256,:,0,0
51257,38,0,0
51258,),0,0
51259,treated,0,0
51260,in,0,0
51261,the,0,0
51262,Department,0,0
51263,of,0,0
51264,Orthodontics,0,0
51265,",",0,0
51266,University,0,0
51267,of,0,1
51268,Munich,0,0
51269,were,0,0
51270,included,0,0
51271,in,0,0
51272,the,0,0
51273,study,0,0
51274,.,0,0
51275,65,0,0
51276,of,0,0
51277,the,0,0
51278,patients,0,0
51279,showed,0,0
51280,at,0,0
51281,least,0,0
51282,one,0,0
51283,palatally-displaced,0,0
51284,canine,0,0
51285,.,0,0
51286,Diagnosis,0,0
51287,and,0,0
51288,the,0,0
51289,location,0,0
51290,of,0,0
51291,the,0,0
51292,displacement,0,1
51293,were,0,0
51294,determined,0,0
51295,on,0,0
51296,the,0,0
51297,basis,0,0
51298,of,0,0
51299,standardized,0,0
51300,radiographs,0,1
51301,and,0,0
51302,confirmed,0,0
51303,by,0,0
51304,surgical,0,0
51305,documentation,0,0
51306,.,0,0
51307,Each,0,0
51308,maxillary,0,0
51309,tooth,0,1
51310,'s,0,0
51311,mesiodistal,0,1
51312,and,0,0
51313,vestibulo-oral,0,1
51314,width,0,1
51315,was,0,0
51316,measured,0,0
51317,using,0,0
51318,a,0,0
51319,dial,0,0
51320,caliper,0,0
51321,on,0,0
51322,each,0,0
51323,dental,0,0
51324,cast,0,0
51325,.,0,0
51326,Excluded,0,0
51327,were,0,0
51328,partially-erupted,0,0
51329,teeth,0,0
51330,and,0,0
51331,surfaces,0,0
51332,with,0,0
51333,caries,0,0
51334,or,0,0
51335,restorations,0,0
51336,that,0,0
51337,had,0,0
51338,to,0,0
51339,be,0,0
51340,measured,0,0
51341,.,0,0
51342,An,0,0
51343,analysis,0,0
51344,of,0,0
51345,available,0,0
51346,space,0,0
51347,was,0,0
51348,made,0,0
51349,by,0,0
51350,evaluating,0,0
51351,the,0,0
51352,pre-treatment,0,0
51353,dental,0,0
51354,casts,0,0
51355,of,0,0
51356,all,0,0
51357,patients,0,0
51358,included,0,0
51359,in,0,0
51360,the,0,0
51361,study,0,0
51362,.,0,0
51363,RESULTS,0,0
51364,Comparing,0,0
51365,the,0,0
51366,tooth,1,0
51367,widths,1,1
51368,of,0,0
51369,patients,0,0
51370,with,0,0
51371,unilateral,0,0
51372,canine,0,0
51373,displacement,0,1
51374,with,0,0
51375,the,0,0
51376,corresponding,0,0
51377,contralateral,0,0
51378,quadrants,0,0
51379,",",0,0
51380,we,0,0
51381,noted,0,0
51382,a,0,0
51383,statistically,0,0
51384,significant,0,0
51385,difference,0,0
51386,",",0,0
51387,namely,0,0
51388,that,0,0
51389,the,0,0
51390,central,0,0
51391,and,0,0
51392,lateral,0,0
51393,incisors,0,0
51394,and,0,0
51395,the,0,0
51396,canines,0,0
51397,of,0,0
51398,the,0,0
51399,affected,0,0
51400,side,0,1
51401,were,0,0
51402,narrower,0,0
51403,than,0,0
51404,those,0,0
51405,of,0,0
51406,the,0,0
51407,non-affected,0,0
51408,side,0,0
51409,in,0,0
51410,the,0,0
51411,same,0,0
51412,patient,0,0
51413,.,0,0
51414,Moreover,0,0
51415,",",0,0
51416,the,0,0
51417,displaced,0,0
51418,upper,0,0
51419,canines,0,0
51420,showed,0,0
51421,an,0,0
51422,increase,0,0
51423,in,0,0
51424,vestibulo-oral,1,0
51425,dimension,1,1
51426,.,1,0
51427,Overall,1,0
51428,tooth,1,1
51429,width,1,1
51430,(,0,0
51431,including,0,0
51432,all,0,0
51433,tooth,0,0
51434,groups,0,0
51435,),0,0
51436,in,0,0
51437,patients,0,0
51438,with,0,0
51439,palatally-displaced,0,0
51440,canines,0,0
51441,was,0,0
51442,significantly,0,0
51443,less,0,0
51444,than,0,0
51445,that,0,0
51446,in,0,0
51447,the,0,0
51448,control,0,0
51449,group,0,0
51450,.,0,0
51451,However,0,0
51452,",",0,0
51453,when,0,0
51454,comparing,0,0
51455,the,0,0
51456,crown,1,0
51457,diameters,1,1
51458,of,0,0
51459,unilaterally-,0,0
51460,and,0,0
51461,bilaterally-affected,0,0
51462,patients,0,0
51463,",",0,0
51464,no,0,0
51465,differences,0,0
51466,in,0,0
51467,tooth-size,1,1
51468,were,0,0
51469,observed,0,0
51470,.,0,0
51471,The,0,0
51472,space-analysis,0,0
51473,showed,0,0
51474,excessive,0,1
51475,dental-arch,1,0
51476,space,1,0
51477,in,0,0
51478,patients,0,0
51479,with,0,0
51480,a,0,0
51481,palatally-displaced,0,0
51482,canine,0,0
51483,.,0,0
51484,CONCLUSION,0,0
51485,Patients,0,0
51486,affected,0,0
51487,by,0,0
51488,palatal,0,1
51489,canine,0,0
51490,displacement,0,1
51491,showed,0,0
51492,significantly,0,0
51493,smaller,0,0
51494,maxillary,0,0
51495,tooth,0,0
51496,size,0,0
51497,.,0,0
51498,A,0,0
51499,single,0,0
51500,dose,0,0
51501,of,0,0
51502,gabapentin,0,0
51503,reduces,0,0
51504,acute,1,0
51505,pain,1,1
51506,and,0,1
51507,allodynia,1,1
51508,in,0,0
51509,patients,0,0
51510,with,0,0
51511,herpes,0,0
51512,zoster,0,0
51513,.,0,0
51514,This,0,0
51515,randomized,0,0
51516,",",0,0
51517,double-blind,0,0
51518,",",0,0
51519,placebo-controlled,0,0
51520,crossover,0,0
51521,study,0,0
51522,measured,0,0
51523,the,0,0
51524,effect,0,0
51525,of,0,0
51526,a,0,0
51527,single,0,0
51528,dose,0,0
51529,of,0,0
51530,oral,0,0
51531,gabapentin,0,0
51532,(,0,0
51533,900,0,0
51534,mg,0,0
51535,),0,0
51536,on,0,0
51537,pain,1,1
51538,and,1,1
51539,allodynia,1,1
51540,associated,1,0
51541,with,1,0
51542,herpes,1,0
51543,zoster,1,1
51544,.,1,0
51545,Pain,1,1
51546,severity,1,1
51547,decreased,0,0
51548,by,0,0
51549,66,0,0
51550,%,0,0
51551,with,0,0
51552,gabapentin,0,0
51553,compared,0,0
51554,to,0,0
51555,33,0,0
51556,%,0,0
51557,with,0,0
51558,placebo,0,0
51559,.,0,0
51560,Reductions,0,0
51561,in,0,0
51562,allodynia,1,1
51563,area,1,1
51564,and,1,1
51565,severity,1,1
51566,",",1,1
51567,and,1,1
51568,overall,1,1
51569,pain,1,1
51570,relief,1,1
51571,",",0,0
51572,were,0,0
51573,also,0,0
51574,greater,0,0
51575,with,0,0
51576,gabapentin,0,0
51577,.,0,0
51578,Hydrogen,0,0
51579,peroxide,0,1
51580,mouth,0,0
51581,rinse,0,0
51582,:,0,0
51583,an,0,0
51584,analgesic,0,1
51585,post-tonsillectomy,0,0
51586,.,0,0
51587,OBJECTIVE,0,0
51588,To,0,0
51589,compare,0,0
51590,the,0,0
51591,analgesic,1,1
51592,efficacy,1,1
51593,of,0,0
51594,hydrogen,0,1
51595,peroxide,0,1
51596,(,0,0
51597,H2O2,0,0
51598,),0,1
51599,mouth,0,1
51600,rinse,0,0
51601,with,0,0
51602,control,0,0
51603,for,0,0
51604,post-tonsillectomy,1,0
51605,pain,1,1
51606,management,1,0
51607,.,1,0
51608,DESIGN,0,0
51609,Double-blinded,0,0
51610,",",0,0
51611,prospective,0,0
51612,",",0,0
51613,randomized,0,0
51614,",",0,0
51615,controlled,0,0
51616,clinical,0,0
51617,trial,0,0
51618,.,0,0
51619,PATIENTS,0,0
51620,AND,0,0
51621,METHODS,0,0
51622,Thirty-seven,0,0
51623,patients,0,0
51624,from,0,0
51625,5,0,0
51626,to,0,0
51627,14,0,0
51628,years,0,0
51629,old,0,0
51630,undergoing,0,0
51631,electrocautery,0,0
51632,tonsillectomy,0,0
51633,were,0,0
51634,randomized,0,0
51635,to,0,0
51636,either,0,0
51637,the,0,0
51638,H2O2,0,0
51639,mouth,0,1
51640,rinse,0,0
51641,or,0,0
51642,the,0,0
51643,water,0,1
51644,rinse,0,0
51645,(,0,0
51646,control,0,0
51647,),0,0
51648,group,0,0
51649,.,0,0
51650,For,0,0
51651,14,0,0
51652,days,0,0
51653,",",0,0
51654,patients,0,0
51655,recorded,0,1
51656,pain,1,1
51657,levels,1,1
51658,twice,1,0
51659,daily,1,0
51660,using,0,0
51661,a,0,0
51662,visual,1,1
51663,analogue,1,1
51664,scale,1,1
51665,.,1,0
51666,Analgesic,0,0
51667,uses,0,0
51668,",",0,0
51669,as,0,0
51670,well,0,0
51671,as,0,0
51672,any,0,0
51673,complications,0,1
51674,",",0,0
51675,were,0,0
51676,also,0,0
51677,noted,0,0
51678,by,0,0
51679,the,0,0
51680,patients,0,0
51681,.,0,0
51682,RESULTS,0,0
51683,Thirty-seven,0,0
51684,patients,0,0
51685,completed,0,0
51686,the,0,0
51687,study,0,0
51688,",",0,0
51689,21,0,0
51690,in,0,0
51691,the,0,0
51692,treatment,0,0
51693,group,0,0
51694,and,0,0
51695,16,0,0
51696,in,0,0
51697,the,0,0
51698,control,0,0
51699,group,0,0
51700,.,0,0
51701,Mean,1,0
51702,postoperative,1,1
51703,days,1,0
51704,of,1,0
51705,pain,1,1
51706,were,0,0
51707,10.3,0,0
51708,and,0,0
51709,8.3,0,0
51710,",",0,0
51711,respectively,0,0
51712,",",0,0
51713,and,0,1
51714,differed,0,0
51715,significantly,0,0
51716,(,0,0
51717,p,0,0
51718,=,0,0
51719,.008,0,0
51720,),0,0
51721,.,0,0
51722,Mean,1,0
51723,postoperative,1,1
51724,days,1,0
51725,of,1,0
51726,analgesic,1,1
51727,use,0,0
51728,were,0,0
51729,9.0,0,0
51730,and,0,0
51731,6.7,0,0
51732,",",0,0
51733,respectively,0,0
51734,",",0,0
51735,and,0,1
51736,differed,0,0
51737,significantly,0,0
51738,(,0,0
51739,p,0,0
51740,=,0,0
51741,.005,0,0
51742,),0,0
51743,.,0,0
51744,Only,0,0
51745,one,0,0
51746,incidence,0,1
51747,of,0,0
51748,postoperative,1,1
51749,hemorrhage,1,1
51750,occurred,0,0
51751,in,0,0
51752,the,0,0
51753,study,0,0
51754,group,0,0
51755,.,0,0
51756,CONCLUSION,0,0
51757,In,0,0
51758,our,0,0
51759,study,0,0
51760,",",0,0
51761,the,0,0
51762,H2O2,0,0
51763,mouth,0,0
51764,rinse,0,0
51765,does,0,0
51766,not,0,0
51767,provide,0,0
51768,a,0,0
51769,better,0,0
51770,analgesic,1,1
51771,effect,1,0
51772,than,0,0
51773,the,0,0
51774,water,0,0
51775,rinse,0,0
51776,for,0,0
51777,post-tonsillectomy,1,0
51778,pain,1,1
51779,relief,1,1
51780,.,0,0
51781,Analgesic,1,0
51782,efficacy,1,1
51783,of,0,0
51784,caudal,0,0
51785,block,0,0
51786,versus,0,0
51787,diclofenac,0,0
51788,suppository,0,0
51789,and,0,1
51790,local,0,1
51791,anesthetic,0,0
51792,infiltration,0,1
51793,following,0,0
51794,pediatric,0,0
51795,laparoscopy,0,0
51796,.,0,0
51797,AIM,0,0
51798,To,0,0
51799,compare,0,0
51800,the,0,0
51801,analgesic,1,1
51802,efficacy,0,1
51803,of,0,0
51804,caudal,0,0
51805,block,0,0
51806,with,0,0
51807,diclofenac,0,0
51808,suppository,0,0
51809,and,0,0
51810,local,0,1
51811,anesthetic,0,0
51812,infiltration,0,1
51813,in,0,0
51814,children,0,0
51815,undergoing,0,0
51816,laparoscopy,0,0
51817,.,0,0
51818,METHODS,0,0
51819,We,0,0
51820,studied,0,0
51821,50,0,0
51822,children,0,0
51823,undergoing,0,0
51824,laparoscopy,0,0
51825,for,0,0
51826,diagnostic,0,0
51827,and,0,0
51828,therapeutic,0,0
51829,purposes,0,0
51830,.,0,0
51831,Their,0,0
51832,ages,0,0
51833,ranged,0,0
51834,from,0,0
51835,3,0,0
51836,to,0,0
51837,13,0,0
51838,years,0,0
51839,",",0,0
51840,and,0,0
51841,all,0,0
51842,belonged,0,0
51843,to,0,0
51844,American,0,0
51845,Society,0,0
51846,of,0,0
51847,Anesthesiologists,0,0
51848,(,0,0
51849,ASA,0,0
51850,),0,0
51851,class,0,0
51852,I,0,0
51853,or,0,0
51854,II,0,0
51855,.,0,1
51856,Anesthesia,0,1
51857,was,0,0
51858,carried,0,0
51859,out,0,0
51860,using,0,0
51861,the,0,0
51862,standard,0,0
51863,procedure,0,0
51864,.,0,0
51865,Patients,0,0
51866,were,0,0
51867,randomly,0,0
51868,assigned,0,0
51869,to,0,0
51870,one,0,0
51871,of,0,0
51872,two,0,0
51873,groups,0,0
51874,.,0,0
51875,Group,0,0
51876,1,0,0
51877,received,0,0
51878,caudal,0,0
51879,block,0,0
51880,with,0,0
51881,bupivacaine,0,0
51882,1,0,0
51883,mL/kg,0,0
51884,after,0,0
51885,anesthetic,0,0
51886,induction,0,0
51887,.,0,0
51888,Group,0,0
51889,2,0,0
51890,received,0,0
51891,diclofenac,0,0
51892,suppository,0,0
51893,3,0,0
51894,mg/kg,0,0
51895,postinduction,0,0
51896,and,0,0
51897,local,0,1
51898,anesthetic,0,0
51899,infiltration,0,1
51900,at,0,0
51901,the,0,0
51902,port,0,0
51903,sites,0,0
51904,at,0,0
51905,the,0,0
51906,end,0,0
51907,of,0,0
51908,the,0,0
51909,procedure,0,0
51910,.,0,0
51911,Pain,1,1
51912,was,1,0
51913,assessed,1,0
51914,using,0,0
51915,the,0,0
51916,Hannallah,1,0
51917,objective,1,0
51918,pain,1,1
51919,scale,1,1
51920,at,0,0
51921,15,0,0
51922,",",0,0
51923,30,0,0
51924,",",0,0
51925,60,0,0
51926,",",0,0
51927,120,0,0
51928,",",0,0
51929,and,0,0
51930,360,0,0
51931,minutes,0,0
51932,postextubation,0,0
51933,.,0,0
51934,RESULTS,0,0
51935,The,0,0
51936,pain,1,1
51937,scores,1,1
51938,were,0,0
51939,comparable,0,0
51940,in,0,0
51941,both,0,0
51942,groups,0,0
51943,at,0,0
51944,all,0,0
51945,times,0,0
51946,.,0,0
51947,Twelve,0,0
51948,percent,0,0
51949,of,0,0
51950,caudal,0,0
51951,block,0,0
51952,patients,0,0
51953,and,0,0
51954,20,0,0
51955,%,0,0
51956,of,0,0
51957,diclofenac,0,0
51958,patients,0,0
51959,needed,0,0
51960,rescue,1,0
51961,analgesic,1,1
51962,",",0,0
51963,a,0,0
51964,statistically,0,0
51965,insignificant,0,0
51966,difference,0,0
51967,.,0,0
51968,In,0,0
51969,2,0,0
51970,patients,0,0
51971,",",0,0
51972,caudal,0,1
51973,block,0,0
51974,was,0,0
51975,technically,0,0
51976,difficult,0,0
51977,and,0,0
51978,they,0,0
51979,were,0,0
51980,excluded,0,0
51981,from,0,0
51982,the,0,0
51983,study,0,0
51984,.,0,0
51985,The,0,0
51986,incidence,0,1
51987,of,0,0
51988,side,0,1
51989,effects,0,1
51990,was,0,0
51991,low,0,0
51992,in,0,0
51993,our,0,0
51994,study,0,0
51995,.,0,0
51996,CONCLUSION,0,0
51997,We,0,0
51998,find,0,0
51999,the,0,0
52000,analgesic,1,1
52001,efficacy,0,1
52002,of,0,0
52003,diclofenac,0,0
52004,suppository,0,0
52005,combined,0,0
52006,with,0,0
52007,local,0,0
52008,anesthetic,0,0
52009,infiltration,0,1
52010,at,0,0
52011,port,0,0
52012,sites,0,0
52013,comparable,0,0
52014,to,0,0
52015,caudal,0,0
52016,block,0,0
52017,.,0,0
52018,Given,0,0
52019,the,0,0
52020,necessarily,0,0
52021,invasive,0,0
52022,nature,0,0
52023,of,0,0
52024,caudal,0,0
52025,block,0,0
52026,",",0,0
52027,we,0,0
52028,suggest,0,0
52029,the,0,0
52030,combined,0,0
52031,use,0,0
52032,of,0,0
52033,diclofenac,0,0
52034,suppository,0,0
52035,with,0,0
52036,local,0,0
52037,anesthetic,0,0
52038,infiltration,0,1
52039,at,0,0
52040,port,0,0
52041,sites,0,0
52042,as,0,0
52043,a,0,0
52044,useful,0,0
52045,and,0,0
52046,more,0,0
52047,economical,0,0
52048,alternative,0,0
52049,for,0,0
52050,analgesia,0,1
52051,following,0,0
52052,pediatric,0,0
52053,laparoscopy,0,0
52054,.,0,0
52055,Effects,0,0
52056,of,0,0
52057,halothane,0,0
52058,and,0,1
52059,isoflurane,0,0
52060,on,0,0
52061,transient,1,1
52062,renal,1,1
52063,dysfunction,1,1
52064,associated,0,0
52065,with,0,0
52066,infrarenal,0,0
52067,aortic,0,1
52068,cross-clamping,0,0
52069,.,0,0
52070,Aortic,0,0
52071,cross-clamping,0,0
52072,for,0,0
52073,reconstructive,0,0
52074,aortic,0,0
52075,surgery,0,0
52076,is,0,0
52077,associated,0,0
52078,with,0,0
52079,impairment,0,0
52080,of,0,0
52081,renal,1,1
52082,function,1,1
52083,.,1,0
52084,Halothane,0,0
52085,or,0,0
52086,isoflurane,0,0
52087,was,0,0
52088,used,0,0
52089,to,0,0
52090,assess,0,0
52091,the,0,0
52092,influence,0,0
52093,of,0,0
52094,volatile,0,0
52095,anesthesia,0,0
52096,on,0,0
52097,renal,1,1
52098,hemodynamics,1,1
52099,during,0,0
52100,aortic,0,1
52101,surgery,0,0
52102,.,0,0
52103,Nineteen,0,0
52104,patients,0,0
52105,with,0,0
52106,normal,0,0
52107,preoperative,0,0
52108,creatinine,0,1
52109,clearances,0,1
52110,who,0,0
52111,were,0,0
52112,scheduled,0,0
52113,for,0,0
52114,reconstructive,0,0
52115,aortic,0,1
52116,surgery,0,0
52117,were,0,0
52118,randomly,0,0
52119,divided,0,0
52120,into,0,0
52121,two,0,0
52122,groups,0,0
52123,:,0,0
52124,halothane,0,0
52125,group,0,0
52126,(,0,0
52127,n,0,0
52128,=,0,0
52129,9,0,0
52130,),0,0
52131,and,0,0
52132,isoflurane,0,0
52133,group,0,0
52134,(,0,0
52135,n,0,0
52136,=,0,0
52137,10,0,0
52138,),0,0
52139,.,0,0
52140,Induction,0,1
52141,of,0,0
52142,anesthesia,0,0
52143,consisted,0,0
52144,of,0,0
52145,midazolam,0,0
52146,",",0,0
52147,fentanyl,0,0
52148,",",0,1
52149,and,0,1
52150,pancuronium,0,0
52151,.,0,1
52152,Anesthesia,0,1
52153,was,0,0
52154,maintained,0,0
52155,with,0,0
52156,fentanyl,0,0
52157,and,0,1
52158,halothane,0,1
52159,or,0,1
52160,isoflurane,0,0
52161,in,0,0
52162,nitrous,0,0
52163,oxide,0,0
52164,and,0,1
52165,oxygen,0,1
52166,(,0,0
52167,50/50,0,0
52168,),0,0
52169,.,0,0
52170,Systemic,1,0
52171,hemodynamics,1,1
52172,were,0,0
52173,similar,0,0
52174,in,0,0
52175,both,0,0
52176,groups,0,0
52177,throughout,0,0
52178,surgery,0,0
52179,.,0,0
52180,Before,0,0
52181,aortic,0,1
52182,cross-clamping,0,0
52183,",",0,0
52184,effective,1,1
52185,renal,1,1
52186,plasma,1,1
52187,flow,1,1
52188,(,1,0
52189,ERPF,1,1
52190,),1,0
52191,(,1,0
52192,131I-hippuran,1,1
52193,clearance,1,1
52194,),1,0
52195,and,1,0
52196,glomerular,1,1
52197,filtration,1,1
52198,rate,1,1
52199,(,1,0
52200,GFR,1,0
52201,),1,0
52202,(,1,0
52203,99Tc-DTPA,1,1
52204,clearance,1,1
52205,),1,0
52206,were,0,0
52207,significantly,0,0
52208,lower,0,0
52209,in,0,0
52210,the,0,0
52211,halothane,0,0
52212,group,0,0
52213,(,0,0
52214,118.4,0,0
52215,+/-,0,0
52216,25.6,0,0
52217,and,0,0
52218,19.7,0,0
52219,+/-,0,0
52220,5.2,0,0
52221,mL/min,0,0
52222,",",0,0
52223,respectively,0,0
52224,),0,0
52225,than,0,0
52226,in,0,0
52227,the,0,0
52228,isoflurane,0,0
52229,group,0,0
52230,(,0,0
52231,253.4,0,0
52232,+/-,0,0
52233,51.5,0,0
52234,and,0,0
52235,44.9,0,0
52236,+/-,0,0
52237,8.4,0,0
52238,mL/min,0,0
52239,),0,0
52240,(,0,0
52241,P,0,0
52242,less,0,0
52243,than,0,0
52244,0.05,0,0
52245,for,0,0
52246,both,0,0
52247,),0,0
52248,.,0,0
52249,During,0,0
52250,cross-clamping,0,0
52251,",",0,0
52252,the,0,0
52253,renal,1,1
52254,variables,1,0
52255,were,0,0
52256,not,0,0
52257,markedly,0,0
52258,affected,0,0
52259,in,0,0
52260,either,0,0
52261,group,0,0
52262,and,0,0
52263,remained,0,0
52264,higher,0,0
52265,in,0,0
52266,the,0,0
52267,isoflurane-anesthetized,0,0
52268,patients,0,0
52269,(,0,0
52270,232.9,0,0
52271,+/-,0,0
52272,47.1,0,0
52273,and,0,0
52274,49.5,0,0
52275,+/-,0,0
52276,1.2,0,0
52277,mL/min,0,0
52278,for,0,0
52279,ERPF,0,1
52280,and,0,1
52281,GFR,0,1
52282,",",0,0
52283,respectively,0,0
52284,),0,0
52285,than,0,0
52286,in,0,0
52287,the,0,0
52288,halothane-anesthetized,0,0
52289,patients,0,0
52290,(,0,0
52291,132.4,0,0
52292,+/-,0,0
52293,31.6,0,0
52294,and,0,0
52295,14.8,0,0
52296,+/-,0,0
52297,3.7,0,0
52298,mL/min,0,0
52299,",",0,0
52300,respectively,0,0
52301,),0,0
52302,(,0,0
52303,P,0,0
52304,less,0,0
52305,than,0,0
52306,0.05,0,0
52307,),0,0
52308,.,0,0
52309,After,0,0
52310,aortic,0,1
52311,unclamping,0,0
52312,",",0,0
52313,ERPF,1,1
52314,increased,0,0
52315,markedly,0,0
52316,in,0,0
52317,both,0,0
52318,groups,0,0
52319,(,0,0
52320,467.8,0,0
52321,+/-,0,0
52322,122,0,0
52323,and,0,0
52324,362.5,0,0
52325,+/-,0,0
52326,57.7,0,0
52327,mL/min,0,0
52328,in,0,0
52329,the,0,0
52330,halothane,0,0
52331,and,0,0
52332,isoflurane,0,0
52333,groups,0,0
52334,",",0,0
52335,respectively,0,0
52336,),0,0
52337,",",0,0
52338,as,0,0
52339,did,0,0
52340,GFR,1,0
52341,(,0,0
52342,74.8,0,0
52343,+/-,0,0
52344,22,0,0
52345,and,0,0
52346,71.8,0,0
52347,+/-,0,0
52348,13.1,0,0
52349,mL/min,0,0
52350,",",0,0
52351,respectively,0,0
52352,),0,0
52353,.,0,0
52354,These,0,0
52355,results,0,0
52356,suggest,0,0
52357,that,0,0
52358,anesthesia,0,0
52359,with,0,0
52360,halothane,0,0
52361,is,0,0
52362,associated,0,0
52363,with,0,0
52364,transient,1,1
52365,renal,1,1
52366,vasoconstriction,1,1
52367,during,0,0
52368,abdominal,0,1
52369,surgery,0,0
52370,.,0,0
52371,In,0,0
52372,contrast,0,0
52373,",",0,0
52374,aortic,0,1
52375,cross-clamping,0,0
52376,during,0,0
52377,isoflurane,0,0
52378,anesthesia,0,0
52379,was,0,0
52380,not,0,0
52381,associated,0,0
52382,with,0,0
52383,renal,1,0
52384,hemodynamic,1,1
52385,impairment,1,0
52386,.,1,0
52387,Efficacy,1,1
52388,and,0,0
52389,safety,1,1
52390,of,0,1
52391,zidovudine,0,0
52392,and,0,1
52393,zalcitabine,0,0
52394,combined,0,0
52395,with,0,0
52396,a,0,0
52397,combination,0,0
52398,of,0,0
52399,herbs,0,0
52400,in,0,0
52401,the,0,0
52402,treatment,0,0
52403,of,0,0
52404,HIV-infected,0,0
52405,Thai,0,0
52406,patients,0,0
52407,.,0,0
52408,A,0,0
52409,randomized,0,0
52410,double,0,0
52411,blind,0,0
52412,placebo,0,0
52413,controlled,0,0
52414,trial,0,0
52415,to,0,0
52416,determine,0,0
52417,the,0,0
52418,efficacy,1,1
52419,and,0,0
52420,safety,1,1
52421,of,0,1
52422,combined-herbs,0,0
52423,(,0,0
52424,SH,0,0
52425,),0,0
52426,given,0,0
52427,with,0,0
52428,zidovudine,0,0
52429,(,0,0
52430,ZDV,0,1
52431,),0,1
52432,and,0,1
52433,zalcitabine,0,0
52434,(,0,1
52435,ddC,0,1
52436,),0,0
52437,for,0,0
52438,the,0,0
52439,treatment,0,0
52440,of,0,0
52441,HIV,0,1
52442,infection,0,1
52443,in,0,0
52444,Thai,0,0
52445,adults,0,0
52446,was,0,0
52447,conducted,0,0
52448,in,0,0
52449,3,0,0
52450,hospitals,0,0
52451,in,0,0
52452,northern,0,0
52453,Thailand,0,0
52454,during,0,0
52455,2002,0,0
52456,to,0,0
52457,2003,0,0
52458,.,0,0
52459,The,0,0
52460,eligible,0,0
52461,subjects,0,0
52462,were,0,0
52463,HIV-infected,0,0
52464,Thai,0,0
52465,adults,0,0
52466,who,0,0
52467,had,0,0
52468,never,0,0
52469,received,0,0
52470,anti-retrovirals,0,0
52471,",",0,0
52472,had,0,0
52473,a,0,0
52474,Karnofski,0,0
52475,Performance,0,1
52476,Score,0,0
52477,(,0,0
52478,KPS,0,0
52479,),0,0
52480,of,0,0
52481,>,0,0
52482,or,0,0
52483,=,0,0
52484,70,0,0
52485,",",0,0
52486,and,0,0
52487,had,0,0
52488,no,0,0
52489,opportunistic,0,0
52490,infections,0,0
52491,.,0,0
52492,The,0,0
52493,subjects,0,0
52494,were,0,0
52495,randomized,0,0
52496,to,0,0
52497,receive,0,0
52498,either,0,0
52499,a,0,0
52500,combination,0,0
52501,of,0,0
52502,ZDV,0,0
52503,200,0,0
52504,mg,0,0
52505,three,0,0
52506,times,0,0
52507,per,0,0
52508,day,0,0
52509,",",0,0
52510,ddC,0,0
52511,0.75,0,0
52512,mg,0,0
52513,three,0,0
52514,times,0,0
52515,per,0,0
52516,day,0,0
52517,",",0,0
52518,and,0,0
52519,SH,0,0
52520,2.5,0,0
52521,g,0,0
52522,three,0,0
52523,times,0,0
52524,per,0,0
52525,day,0,0
52526,or,0,0
52527,a,0,0
52528,combination,0,0
52529,of,0,0
52530,ZDV,0,0
52531,200,0,0
52532,mg,0,0
52533,three,0,0
52534,times,0,0
52535,per,0,0
52536,day,0,0
52537,",",0,0
52538,ddC,0,0
52539,0.75,0,0
52540,mg,0,0
52541,three,0,0
52542,times,0,0
52543,per,0,0
52544,day,0,0
52545,",",0,0
52546,and,0,0
52547,placebo,0,0
52548,2.5,0,0
52549,g,0,0
52550,three,0,0
52551,times,0,0
52552,per,0,0
52553,day,0,0
52554,for,0,0
52555,24,0,0
52556,weeks,0,0
52557,.,0,0
52558,The,0,0
52559,main,0,0
52560,outcome,0,1
52561,measures,0,1
52562,were,0,0
52563,HIV-RNA,1,0
52564,",",1,0
52565,CD4,1,1
52566,cells,1,1
52567,",",1,0
52568,and,1,1
52569,blood,1,1
52570,chemistry,1,1
52571,profiles,1,0
52572,prior,0,0
52573,to,0,0
52574,the,0,0
52575,treatment,0,0
52576,and,0,0
52577,then,0,0
52578,every,0,0
52579,4,0,0
52580,weeks,0,0
52581,for,0,0
52582,24,0,0
52583,weeks,0,0
52584,.,0,0
52585,The,0,0
52586,baseline,0,0
52587,characteristics,0,0
52588,of,0,0
52589,60,0,0
52590,evaluable,0,0
52591,subjects,0,0
52592,",",0,0
52593,40,0,0
52594,in,0,0
52595,the,0,0
52596,SH,0,0
52597,group,0,0
52598,and,0,0
52599,20,0,0
52600,in,0,0
52601,the,0,0
52602,placebo,0,0
52603,group,0,0
52604,",",0,0
52605,were,0,0
52606,not,0,0
52607,significantly,0,0
52608,different,0,0
52609,.,0,0
52610,HIV,1,1
52611,RNA,1,0
52612,at,0,0
52613,week,0,0
52614,4,0,0
52615,and,0,0
52616,thereafter,0,0
52617,was,0,0
52618,significantly,0,0
52619,decreased,0,0
52620,from,0,0
52621,the,0,0
52622,baseline,0,0
52623,value,0,0
52624,in,0,0
52625,both,0,0
52626,groups,0,0
52627,(,0,0
52628,p,0,0
52629,<,0,0
52630,0.001,0,0
52631,),0,0
52632,.,0,0
52633,However,0,0
52634,",",0,0
52635,the,0,0
52636,decline,0,0
52637,in,0,0
52638,HIV,1,1
52639,RNA,1,0
52640,in,0,0
52641,the,0,0
52642,SH,0,0
52643,group,0,0
52644,was,0,0
52645,significantly,0,0
52646,more,0,0
52647,than,0,0
52648,that,0,0
52649,in,0,0
52650,the,0,0
52651,placebo,0,0
52652,group,0,0
52653,.,0,0
52654,The,0,0
52655,CD4,1,1
52656,cells,1,1
52657,in,0,0
52658,the,0,0
52659,SH,0,0
52660,group,0,0
52661,at,0,0
52662,week,0,0
52663,12,0,0
52664,and,0,0
52665,thereafter,0,0
52666,were,0,0
52667,significantly,0,0
52668,increased,0,0
52669,from,0,0
52670,the,0,0
52671,baseline,0,0
52672,value,0,0
52673,.,0,0
52674,Serious,1,0
52675,adverse,1,1
52676,events,1,1
52677,in,0,0
52678,the,0,0
52679,two,0,0
52680,groups,0,0
52681,were,0,0
52682,not,0,0
52683,observed,0,0
52684,.,0,0
52685,It,0,0
52686,is,0,0
52687,concluded,0,0
52688,that,0,0
52689,an,0,0
52690,addition,0,0
52691,of,0,0
52692,SH,0,0
52693,herbs,0,0
52694,to,0,0
52695,two,0,0
52696,nucleoside,0,0
52697,reverse,0,0
52698,transcriptase,0,0
52699,inhibitors,0,0
52700,has,0,0
52701,greater,0,0
52702,antiviral,1,0
52703,activity,1,1
52704,than,0,0
52705,antiretrovirals,0,0
52706,only,0,0
52707,.,0,0
52708,The,0,0
52709,SH,0,0
52710,herbs,0,0
52711,may,0,0
52712,be,0,0
52713,an,0,0
52714,alternative,0,0
52715,for,0,0
52716,the,0,0
52717,third,0,0
52718,anti-retroviral,0,0
52719,agent,0,0
52720,in,0,0
52721,the,0,0
52722,triple,0,0
52723,drug,0,0
52724,regimen,0,0
52725,for,0,0
52726,the,0,0
52727,treatment,0,0
52728,of,0,0
52729,HIV,0,1
52730,infected,0,0
52731,patients,0,0
52732,in,0,0
52733,countries,0,0
52734,with,0,0
52735,limited,0,0
52736,resources,0,0
52737,.,0,0
52738,Tetrahydrobiopterin,0,1
52739,in,0,0
52740,the,0,0
52741,treatment,0,0
52742,of,0,0
52743,children,0,0
52744,with,0,0
52745,autistic,0,0
52746,disorder,0,0
52747,:,0,0
52748,a,0,0
52749,double-blind,0,0
52750,placebo-controlled,0,0
52751,crossover,0,0
52752,study,0,0
52753,.,0,0
52754,Twelve,0,0
52755,children,0,0
52756,",",0,0
52757,all,0,0
52758,boys,0,0
52759,",",0,0
52760,aged,0,0
52761,4,0,0
52762,to,0,0
52763,7,0,0
52764,years,0,0
52765,",",0,0
52766,with,0,0
52767,a,0,0
52768,diagnosis,0,0
52769,of,0,0
52770,autistic,0,0
52771,disorder,0,0
52772,and,0,0
52773,low,0,0
52774,concentrations,0,1
52775,of,0,0
52776,spinal,0,0
52777,"6R-l-erythro-5,6,7,8-tetrahydrobiopterin",0,1
52778,(,0,0
52779,tetrahydrobiopterin,0,0
52780,),0,0
52781,were,0,0
52782,selected,0,0
52783,to,0,0
52784,participate,0,0
52785,in,0,0
52786,a,0,0
52787,double-blind,0,0
52788,",",0,0
52789,randomized,0,0
52790,",",0,0
52791,placebo-controlled,0,0
52792,",",0,0
52793,crossover,0,0
52794,study,0,0
52795,.,0,0
52796,The,0,0
52797,children,0,0
52798,received,0,0
52799,a,0,0
52800,daily,0,0
52801,dose,0,0
52802,of,0,0
52803,3,0,0
52804,mg,0,0
52805,tetrahydrobiopterin,0,0
52806,per,0,0
52807,kilogram,0,0
52808,during,0,0
52809,6,0,0
52810,months,0,0
52811,alternating,0,0
52812,with,0,0
52813,placebo,0,0
52814,.,0,0
52815,Treatment-induced,1,1
52816,effects,1,1
52817,were,0,0
52818,assessed,0,0
52819,with,0,0
52820,the,0,0
52821,Childhood,1,0
52822,Autism,1,1
52823,Rating,1,0
52824,Scale,1,1
52825,every,0,0
52826,third,0,0
52827,month,0,0
52828,.,0,0
52829,The,0,0
52830,results,0,0
52831,showed,0,0
52832,small,0,0
52833,nonsignificant,0,0
52834,changes,0,0
52835,in,0,0
52836,the,0,0
52837,total,1,1
52838,scores,1,1
52839,of,1,0
52840,Childhood,1,0
52841,Autism,1,1
52842,Rating,1,1
52843,Scale,1,1
52844,after,0,0
52845,3-,0,0
52846,and,0,0
52847,6-month,0,0
52848,treatment,0,0
52849,.,0,0
52850,Post,0,0
52851,hoc,0,0
52852,analysis,0,0
52853,looking,0,0
52854,at,0,0
52855,the,0,0
52856,3,0,0
52857,core,0,0
52858,symptoms,0,1
52859,of,0,1
52860,autism,0,0
52861,",",0,0
52862,that,0,0
52863,is,0,0
52864,",",0,0
52865,social,1,1
52866,interaction,1,1
52867,",",1,0
52868,communication,1,1
52869,",",1,1
52870,and,1,1
52871,stereotyped,1,1
52872,behaviors,1,1
52873,",",0,0
52874,revealed,0,0
52875,a,0,0
52876,significant,0,0
52877,improvement,0,0
52878,of,0,0
52879,the,0,0
52880,social,1,1
52881,interaction,1,1
52882,score,1,1
52883,after,0,0
52884,6,0,0
52885,months,0,0
52886,of,0,0
52887,active,0,0
52888,treatment,0,0
52889,.,0,0
52890,In,0,0
52891,addition,0,0
52892,",",0,0
52893,a,0,0
52894,high,0,0
52895,positive,0,1
52896,correlation,0,0
52897,was,0,0
52898,found,0,0
52899,between,0,0
52900,response,1,0
52901,of,1,0
52902,the,1,0
52903,social,1,1
52904,interaction,1,1
52905,score,1,1
52906,and,1,0
52907,IQ,1,1
52908,.,1,0
52909,The,0,0
52910,results,0,0
52911,indicate,0,0
52912,a,0,0
52913,possible,0,0
52914,effect,0,0
52915,of,0,0
52916,tetrahydrobiopterin,0,0
52917,treatment,0,0
52918,.,0,0
52919,[,0,0
52920,Effect,0,0
52921,of,0,0
52922,branch,0,1
52923,chain,0,1
52924,amino,0,0
52925,acid,0,1
52926,enriched,0,0
52927,formula,0,0
52928,on,0,0
52929,postoperative,1,1
52930,fatigue,1,1
52931,and,0,0
52932,nutritional,1,1
52933,status,1,1
52934,after,0,0
52935,digestive,0,1
52936,surgery,0,0
52937,],0,0
52938,.,0,0
52939,OBJECTIVE,0,0
52940,To,0,0
52941,evaluate,0,0
52942,the,0,0
52943,effect,0,0
52944,of,0,0
52945,branch,0,1
52946,chain,0,1
52947,amino,0,0
52948,acid,0,1
52949,(,0,0
52950,BCAA,0,1
52951,),0,0
52952,enriched,0,0
52953,formula,0,0
52954,on,0,0
52955,nutritional,1,1
52956,status,1,1
52957,and,0,0
52958,postoperative,1,1
52959,fatigue,1,1
52960,for,0,0
52961,digestive,0,1
52962,surgery,0,0
52963,patients,0,0
52964,.,0,0
52965,METHODS,0,0
52966,Forty,0,0
52967,patients,0,0
52968,who,0,0
52969,underwent,0,0
52970,digestive,0,0
52971,surgery,0,0
52972,were,0,0
52973,randomly,0,0
52974,received,0,0
52975,parenteral,0,0
52976,nutrition,0,0
52977,with,0,0
52978,either,0,0
52979,BCAA,0,0
52980,enriched,0,0
52981,(,0,0
52982,study,0,0
52983,group,0,0
52984,",",0,0
52985,n=20,0,0
52986,),0,0
52987,or,0,0
52988,routine,0,0
52989,amino,0,0
52990,acid,0,1
52991,(,0,0
52992,control,0,0
52993,group,0,0
52994,",",0,0
52995,n=20,0,0
52996,),0,0
52997,for,0,0
52998,seven,0,0
52999,consecutive,0,0
53000,days,0,0
53001,.,0,0
53002,Nitrogen,1,0
53003,balance,1,1
53004,",",1,0
53005,serum,1,1
53006,total,1,1
53007,protein,1,1
53008,",",1,1
53009,albumin,1,1
53010,",",1,1
53011,prealbumin,1,1
53012,",",1,1
53013,transferrin,1,1
53014,",",1,1
53015,retinol,1,1
53016,binding,1,1
53017,protein,1,1
53018,and,1,1
53019,postoperative,1,1
53020,fatigue,1,1
53021,score,1,1
53022,were,0,0
53023,monitored,0,0
53024,during,0,0
53025,the,0,0
53026,postoperative,0,0
53027,period,0,0
53028,.,0,0
53029,RESULTS,0,0
53030,The,0,0
53031,cumulative,1,1
53032,postoperative,1,1
53033,fatigue,1,1
53034,scores,1,1
53035,were,0,0
53036,lower,0,0
53037,in,0,0
53038,BCAA,0,1
53039,group,0,0
53040,than,0,0
53041,that,0,0
53042,in,0,0
53043,the,0,0
53044,control,0,0
53045,group,0,0
53046,at,0,0
53047,the,0,0
53048,4th,0,0
53049,",",0,0
53050,5th,0,0
53051,and,0,0
53052,7th,0,0
53053,day,0,0
53054,after,0,0
53055,operation,0,0
53056,(,0,0
53057,P,0,0
53058,<,0,0
53059,0.05,0,0
53060,),0,0
53061,.,0,0
53062,Patients,0,0
53063,achieved,0,0
53064,positive,1,1
53065,nitrogen,1,0
53066,balance,1,1
53067,2,0,0
53068,days,0,0
53069,earlier,0,0
53070,in,0,0
53071,the,0,0
53072,study,0,0
53073,group,0,0
53074,than,0,0
53075,that,0,0
53076,in,0,0
53077,the,0,0
53078,control,0,0
53079,group,0,0
53080,",",0,0
53081,but,0,0
53082,there,0,0
53083,was,0,0
53084,no,0,0
53085,significant,0,0
53086,difference,0,0
53087,in,0,0
53088,cumulative,1,1
53089,nitrogen,1,0
53090,balance,1,1
53091,between,0,0
53092,the,0,0
53093,two,0,0
53094,groups,0,0
53095,.,0,0
53096,There,0,0
53097,was,0,0
53098,no,0,0
53099,significant,0,0
53100,difference,0,0
53101,in,0,0
53102,elevation,1,1
53103,of,1,0
53104,serum,1,1
53105,total,1,1
53106,protein,1,1
53107,",",1,0
53108,albumin,1,1
53109,",",1,1
53110,prealbumin,1,1
53111,",",1,1
53112,transferrin,1,1
53113,at,0,0
53114,the,0,0
53115,7th,0,0
53116,day,0,0
53117,after,0,0
53118,operation,0,0
53119,between,0,0
53120,the,0,0
53121,two,0,0
53122,groups,0,0
53123,(,0,0
53124,P,0,0
53125,>,0,0
53126,0.05,0,0
53127,),0,0
53128,",",0,0
53129,compared,0,0
53130,with,0,0
53131,those,0,0
53132,at,0,0
53133,the,0,0
53134,first,0,0
53135,day,0,0
53136,after,0,0
53137,operation,0,0
53138,.,0,0
53139,The,0,0
53140,serum,1,1
53141,level,1,1
53142,of,1,0
53143,retinol,1,1
53144,binding,1,1
53145,protein,1,1
53146,was,0,0
53147,higher,0,0
53148,in,0,0
53149,BCAA-enriched,0,0
53150,group,0,0
53151,than,0,0
53152,that,0,0
53153,in,0,0
53154,the,0,0
53155,control,0,0
53156,group,0,0
53157,(,0,0
53158,P=0.004,0,0
53159,),0,0
53160,.,0,0
53161,CONCLUSION,0,0
53162,TPN,0,0
53163,with,0,0
53164,BCAA,0,1
53165,enriched,0,0
53166,formula,0,0
53167,can,0,0
53168,reduce,0,0
53169,postoperative,1,1
53170,fatigue,1,1
53171,score,1,1
53172,and,0,0
53173,improve,0,0
53174,the,0,0
53175,nutritional,1,0
53176,status,1,1
53177,for,0,0
53178,digestive,0,1
53179,surgery,0,0
53180,patients,0,0
53181,.,0,0
53182,[,0,0
53183,Effect,0,0
53184,of,0,0
53185,Yufeining,0,0
53186,on,0,0
53187,induced,0,0
53188,sputum,1,0
53189,interleukin-8,1,1
53190,in,0,0
53191,patients,0,0
53192,with,0,0
53193,chronic,0,0
53194,obstructive,0,0
53195,pulmonary,0,1
53196,disease,0,0
53197,at,0,0
53198,the,0,0
53199,stable,0,0
53200,phase,0,0
53201,],0,0
53202,.,0,0
53203,OBJECTIVE,0,0
53204,To,0,0
53205,evaluate,0,0
53206,the,0,0
53207,effect,0,0
53208,of,0,0
53209,Yufeining,0,1
53210,",",0,0
53211,a,0,0
53212,traditional,0,0
53213,Chinese,0,0
53214,medicine,0,0
53215,",",0,0
53216,on,0,0
53217,induced,1,0
53218,sputum,1,0
53219,interleukin-8,1,1
53220,(,1,0
53221,IL-8,1,1
53222,),1,0
53223,in,0,0
53224,patients,0,0
53225,with,0,0
53226,chronic,0,0
53227,obstructive,0,0
53228,pulmonary,0,1
53229,disease,0,1
53230,(,0,0
53231,COPD,0,0
53232,),0,0
53233,at,0,0
53234,the,0,0
53235,stable,0,0
53236,phase,0,0
53237,.,0,0
53238,METHODS,0,0
53239,Thirty-six,0,0
53240,patients,0,0
53241,with,0,0
53242,COPD,0,0
53243,were,0,0
53244,divided,0,0
53245,into,0,0
53246,trial,0,0
53247,group,0,0
53248,(,0,0
53249,18,0,0
53250,cases,0,0
53251,),0,0
53252,and,0,0
53253,control,0,0
53254,group,0,0
53255,(,0,0
53256,18,0,0
53257,cases,0,0
53258,),0,0
53259,randomly,0,0
53260,.,0,0
53261,The,0,0
53262,trial,0,0
53263,group,0,0
53264,was,0,0
53265,treated,0,0
53266,with,0,0
53267,Yufeining,0,0
53268,pills,0,0
53269,taken,0,0
53270,orally,0,0
53271,for,0,0
53272,half,0,0
53273,a,0,0
53274,year,0,0
53275,;,0,0
53276,the,0,0
53277,control,0,0
53278,group,0,0
53279,was,0,0
53280,not,0,0
53281,given,0,0
53282,any,0,0
53283,medicine,0,0
53284,.,0,0
53285,Routine,0,1
53286,lung,1,1
53287,function,1,1
53288,was,0,0
53289,recorded,0,0
53290,before,0,0
53291,and,0,0
53292,after,0,0
53293,treatment,0,0
53294,.,0,0
53295,Total,1,0
53296,cell,1,1
53297,count,1,1
53298,(,1,0
53299,TCC,1,0
53300,),1,0
53301,",",1,0
53302,differential,1,1
53303,cell,1,1
53304,counts,1,1
53305,(,1,0
53306,DCCs,1,0
53307,),1,0
53308,and,1,0
53309,IL-8,1,1
53310,in,1,0
53311,induced,1,0
53312,sputum,1,0
53313,were,0,0
53314,determined,0,0
53315,at,0,0
53316,the,0,0
53317,baseline,0,0
53318,and,0,0
53319,6,0,0
53320,months,0,0
53321,later,0,0
53322,.,0,0
53323,RESULTS,0,0
53324,The,0,0
53325,indices,1,1
53326,of,1,0
53327,lung,1,0
53328,function,1,1
53329,improved,0,0
53330,significantly,0,0
53331,after,0,0
53332,6,0,0
53333,months,0,0
53334,',0,0
53335,treatment,0,0
53336,in,0,0
53337,trial,0,0
53338,group,0,0
53339,(,0,0
53340,P,0,0
53341,<,0,0
53342,0.05,0,0
53343,),0,0
53344,;,0,0
53345,TCC,1,0
53346,and,1,0
53347,absolute,1,1
53348,neutrophil,1,1
53349,count,1,1
53350,decreased,0,0
53351,significantly,0,0
53352,compared,0,0
53353,with,0,0
53354,baseline,0,0
53355,in,0,0
53356,the,0,0
53357,trial,0,0
53358,group,0,0
53359,(,0,0
53360,P,0,0
53361,<,0,0
53362,0.05,0,0
53363,),0,0
53364,;,0,0
53365,Sputum,1,1
53366,IL-8,1,1
53367,concentration,1,1
53368,dropped,0,0
53369,significantly,0,0
53370,after,0,0
53371,6,0,0
53372,months,0,0
53373,',0,0
53374,treatment,0,0
53375,",",0,0
53376,from,0,0
53377,a,0,0
53378,mean,0,0
53379,of,0,0
53380,5.216,0,0
53381,+/-,0,0
53382,2.914,0,0
53383,microg/L,0,0
53384,to,0,0
53385,4.222,0,0
53386,+/-,0,0
53387,2.140,0,0
53388,microg/L,0,0
53389,(,0,0
53390,P,0,0
53391,<,0,0
53392,0.05,0,0
53393,),0,0
53394,.,0,0
53395,There,0,0
53396,were,0,0
53397,insignificant,0,0
53398,changes,0,1
53399,in,0,0
53400,the,0,0
53401,parameters,1,0
53402,in,0,0
53403,the,0,0
53404,control,0,0
53405,group,0,0
53406,between,0,0
53407,baseline,0,0
53408,and,0,0
53409,6,0,0
53410,months,0,0
53411,later,0,0
53412,.,0,0
53413,CONCLUSION,0,0
53414,Yufeining,0,0
53415,could,0,0
53416,improve,0,0
53417,lung,1,0
53418,function,1,1
53419,",",0,1
53420,decrease,0,1
53421,sputum,1,1
53422,TCC,1,0
53423,",",1,0
53424,absolute,1,1
53425,neutrophil,1,1
53426,count,1,1
53427,and,1,1
53428,IL-8,1,1
53429,concentration,1,1
53430,",",0,0
53431,and,0,1
53432,relieve,0,1
53433,airway,1,1
53434,inflammation,1,1
53435,in,0,0
53436,patients,0,0
53437,with,0,0
53438,COPD,0,0
53439,in,0,0
53440,the,0,0
53441,stable,0,0
53442,phase,0,0
53443,.,0,0
53444,Pulse,0,1
53445,versus,0,0
53446,continuous,0,0
53447,terbinafine,0,0
53448,for,0,0
53449,onychomycosis,0,0
53450,:,0,0
53451,a,0,0
53452,randomized,0,0
53453,",",0,0
53454,double-blind,0,0
53455,",",0,0
53456,controlled,0,0
53457,trial,0,0
53458,.,0,0
53459,BACKGROUND,0,0
53460,Effective,0,0
53461,treatments,0,0
53462,for,0,0
53463,onychomycosis,0,0
53464,are,0,0
53465,expensive,0,0
53466,.,0,0
53467,Previous,0,0
53468,studies,0,0
53469,suggest,0,0
53470,that,0,0
53471,less,0,0
53472,costly,0,1
53473,",",0,0
53474,pulsed,0,0
53475,doses,0,0
53476,of,0,0
53477,antifungal,0,0
53478,medications,0,0
53479,may,0,0
53480,be,0,0
53481,as,0,0
53482,effective,0,0
53483,as,0,0
53484,standard,0,0
53485,",",0,0
53486,continuous,0,0
53487,doses,0,0
53488,.,0,0
53489,Terbinafine,0,0
53490,is,0,0
53491,the,0,0
53492,current,0,0
53493,treatment,0,0
53494,of,0,0
53495,choice,0,0
53496,for,0,0
53497,toenail,0,0
53498,onychomycosis,0,0
53499,.,0,0
53500,OBJECTIVE,0,0
53501,Our,0,0
53502,purpose,0,0
53503,was,0,0
53504,to,0,0
53505,determine,0,0
53506,whether,0,0
53507,pulse-dose,0,0
53508,terbinafine,0,0
53509,is,0,0
53510,as,0,0
53511,effective,0,0
53512,as,0,0
53513,standard,0,0
53514,continuous-dose,0,0
53515,terbinafine,0,0
53516,for,0,0
53517,treatment,0,0
53518,of,0,0
53519,toenail,0,0
53520,onychomycosis,0,0
53521,.,0,0
53522,METHODS,0,0
53523,We,0,0
53524,conducted,0,0
53525,a,0,0
53526,double-blind,0,0
53527,",",0,0
53528,randomized,0,0
53529,",",0,0
53530,noninferiority,0,0
53531,",",0,1
53532,clinical,0,1
53533,intervention,0,0
53534,trial,0,0
53535,in,0,0
53536,the,0,0
53537,Minneapolis,0,0
53538,Veterans,0,0
53539,Affairs,0,0
53540,Medical,0,0
53541,Center,0,0
53542,.,0,0
53543,The,0,0
53544,main,0,0
53545,inclusion,0,0
53546,criteria,0,0
53547,for,0,0
53548,participants,0,0
53549,were,0,0
53550,a,0,0
53551,positive,0,1
53552,dermatophyte,0,1
53553,culture,0,1
53554,and,0,0
53555,at,0,0
53556,least,0,0
53557,25,0,0
53558,%,0,0
53559,distal,0,0
53560,subungual,0,1
53561,clinical,0,0
53562,involvement,0,0
53563,.,0,0
53564,Six,0,0
53565,hundred,0,0
53566,eighteen,0,0
53567,volunteers,0,0
53568,were,0,0
53569,screened,0,0
53570,;,0,0
53571,306,0,0
53572,were,0,0
53573,randomized,0,0
53574,.,0,0
53575,Terbinafine,0,0
53576,",",0,0
53577,250,0,0
53578,mg,0,0
53579,daily,0,0
53580,for,0,0
53581,3,0,0
53582,months,0,0
53583,(,0,0
53584,continuous,0,0
53585,),0,0
53586,or,0,0
53587,terbinafine,0,0
53588,",",0,0
53589,500,0,0
53590,mg,0,0
53591,daily,0,0
53592,for,0,0
53593,1,0,0
53594,week,0,0
53595,per,0,0
53596,month,0,0
53597,for,0,0
53598,3,0,0
53599,months,0,0
53600,(,0,0
53601,pulse,0,1
53602,),0,0
53603,was,0,0
53604,administered,0,0
53605,.,0,0
53606,The,0,0
53607,primary,0,0
53608,outcome,0,1
53609,measure,0,0
53610,was,0,0
53611,mycological,1,1
53612,cure,1,1
53613,of,1,0
53614,the,1,0
53615,target,1,0
53616,toenail,1,0
53617,at,1,0
53618,18,1,0
53619,months,1,0
53620,.,1,0
53621,Secondary,0,0
53622,outcome,0,1
53623,measures,0,1
53624,included,0,0
53625,clinical,1,0
53626,cure,1,1
53627,and,1,1
53628,complete,1,1
53629,(,1,0
53630,clinical,1,0
53631,plus,1,0
53632,mycological,1,1
53633,),1,0
53634,cure,1,1
53635,of,1,0
53636,the,1,0
53637,target,1,0
53638,toenail,1,0
53639,and,1,1
53640,complete,1,1
53641,cure,1,1
53642,of,1,0
53643,all,1,0
53644,10,1,0
53645,toenails,1,0
53646,.,1,0
53647,RESULTS,0,0
53648,Results,0,0
53649,of,0,0
53650,an,0,0
53651,intent-to-treat,0,0
53652,analysis,0,0
53653,did,0,0
53654,not,0,0
53655,meet,0,0
53656,the,0,0
53657,prespecified,0,0
53658,criterion,0,0
53659,for,0,0
53660,noninferiority,0,1
53661,but,0,0
53662,did,0,0
53663,demonstrate,0,0
53664,the,0,0
53665,superiority,0,0
53666,of,0,0
53667,continuous-dose,0,0
53668,terbinafine,0,0
53669,for,0,0
53670,:,0,0
53671,mycological,1,0
53672,cure,1,1
53673,of,0,0
53674,the,0,0
53675,target,0,0
53676,toenail,0,0
53677,(,0,0
53678,70.9,0,0
53679,%,0,0
53680,[,0,0
53681,105/148,0,0
53682,],0,0
53683,vs,0,0
53684,58.7,0,0
53685,%,0,0
53686,[,0,0
53687,84/143,0,0
53688,],0,0
53689,;,0,0
53690,P,0,0
53691,=.03,0,0
53692,",",0,0
53693,relative,1,1
53694,risk,1,1
53695,[,0,0
53696,RR,0,0
53697,],0,0
53698,of,0,0
53699,1.21,0,0
53700,[,0,0
53701,95,0,0
53702,%,0,0
53703,confidence,0,0
53704,interval,0,0
53705,(,0,0
53706,CI,0,0
53707,),0,0
53708,",",0,0
53709,1.02-1.43,0,0
53710,],0,0
53711,),0,0
53712,;,0,0
53713,clinical,1,0
53714,cure,1,1
53715,of,0,0
53716,the,0,0
53717,target,0,0
53718,toenail,0,0
53719,(,0,0
53720,44.6,0,0
53721,%,0,0
53722,[,0,0
53723,66/148,0,0
53724,],0,0
53725,vs,0,0
53726,29.3,0,0
53727,%,0,0
53728,[,0,0
53729,42/143,0,0
53730,],0,0
53731,;,0,0
53732,P,0,0
53733,=.007,0,0
53734,",",0,0
53735,RR,0,1
53736,=1.52,0,0
53737,[,0,0
53738,95,0,0
53739,%,0,0
53740,CI,0,0
53741,",",0,0
53742,1.11-2.07,0,0
53743,),0,0
53744,;,0,0
53745,complete,1,1
53746,cure,1,1
53747,of,0,0
53748,the,0,0
53749,target,0,0
53750,toenail,0,0
53751,(,0,0
53752,40.5,0,0
53753,%,0,0
53754,[,0,0
53755,60/148,0,0
53756,],0,0
53757,vs,0,0
53758,28.0,0,0
53759,%,0,0
53760,[,0,0
53761,40/143,0,0
53762,],0,0
53763,;,0,0
53764,P,0,0
53765,=.02,0,0
53766,",",0,0
53767,RR=1.45,0,1
53768,[,0,0
53769,95,0,0
53770,%,0,0
53771,CI,0,0
53772,",",0,0
53773,1.04-2.01,0,0
53774,),0,0
53775,;,0,0
53776,and,0,0
53777,complete,1,1
53778,cure,1,1
53779,of,0,0
53780,all,0,0
53781,10,0,0
53782,toenails,0,0
53783,(,0,0
53784,25.2,0,0
53785,%,0,0
53786,[,0,0
53787,36/143,0,0
53788,],0,0
53789,vs,0,0
53790,14.7,0,0
53791,%,0,0
53792,[,0,0
53793,21/143,0,0
53794,],0,0
53795,;,0,0
53796,P,0,0
53797,=.03,0,0
53798,",",0,0
53799,RR,0,1
53800,=1.71,0,0
53801,[,0,0
53802,95,0,0
53803,%,0,0
53804,CI,0,0
53805,",",0,0
53806,1.05-2.79,0,0
53807,),0,0
53808,.,0,0
53809,Tolerability,1,0
53810,of,0,0
53811,the,0,0
53812,regimens,0,0
53813,did,0,0
53814,not,0,0
53815,differ,0,0
53816,significantly,0,0
53817,between,0,0
53818,the,0,0
53819,groups,0,0
53820,(,0,0
53821,chi2,0,0
53822,=1.63,0,0
53823,;,0,0
53824,P,0,0
53825,=.65,0,0
53826,),0,0
53827,.,0,0
53828,LIMITATIONS,0,0
53829,The,0,0
53830,study,0,0
53831,population,0,0
53832,primarily,0,0
53833,consisted,0,0
53834,of,0,0
53835,older,0,0
53836,men,0,0
53837,with,0,0
53838,severe,0,1
53839,onychomycosis,0,0
53840,.,0,0
53841,CONCLUSIONS,0,0
53842,This,0,0
53843,study,0,0
53844,demonstrated,0,0
53845,the,0,0
53846,superiority,0,0
53847,of,0,0
53848,continuous-,0,0
53849,over,0,0
53850,pulse-dose,0,0
53851,terbinafine,0,0
53852,.,0,0
53853,We,0,0
53854,also,0,0
53855,found,0,0
53856,this,0,0
53857,expensive,0,0
53858,therapy,0,0
53859,to,0,0
53860,be,0,0
53861,much,0,0
53862,less,0,0
53863,effective,1,1
53864,than,0,0
53865,previously,0,0
53866,believed,0,0
53867,",",0,0
53868,particularly,0,0
53869,for,0,0
53870,achieving,0,0
53871,complete,0,1
53872,cure,0,1
53873,of,0,0
53874,all,0,0
53875,10,0,0
53876,toenails,0,0
53877,.,0,0
53878,Intensive,0,0
53879,behavioral,0,1
53880,treatment,0,0
53881,for,0,0
53882,children,0,0
53883,with,0,0
53884,autism,1,0
53885,:,1,0
53886,four-year,0,0
53887,outcome,0,1
53888,and,0,0
53889,predictors,0,0
53890,.,0,0
53891,Twenty-four,0,0
53892,children,0,0
53893,with,0,0
53894,autism,0,0
53895,were,0,0
53896,randomly,0,0
53897,assigned,0,0
53898,to,0,0
53899,a,0,0
53900,clinic-directed,0,0
53901,group,0,0
53902,",",0,0
53903,replicating,0,0
53904,the,0,0
53905,parameters,0,0
53906,of,0,0
53907,the,0,0
53908,early,0,0
53909,intensive,0,0
53910,behavioral,0,1
53911,treatment,0,0
53912,developed,0,0
53913,at,0,0
53914,UCLA,0,1
53915,",",0,0
53916,or,0,0
53917,to,0,0
53918,a,0,0
53919,parent-directed,0,0
53920,group,0,0
53921,that,0,0
53922,received,0,0
53923,intensive,0,0
53924,hours,0,0
53925,but,0,0
53926,less,0,0
53927,supervision,0,0
53928,by,0,0
53929,equally,0,0
53930,well-trained,0,0
53931,supervisors,0,0
53932,.,0,0
53933,Outcome,0,1
53934,after,0,0
53935,4,0,0
53936,years,0,0
53937,of,0,0
53938,treatment,0,0
53939,",",0,0
53940,including,0,0
53941,cognitive,1,1
53942,",",1,0
53943,language,1,1
53944,",",1,1
53945,adaptive,1,1
53946,",",1,0
53947,social,1,1
53948,",",1,0
53949,and,1,1
53950,academic,1,1
53951,measures,1,1
53952,",",0,0
53953,was,0,0
53954,similar,0,0
53955,for,0,0
53956,both,0,0
53957,groups,0,0
53958,.,0,0
53959,After,0,0
53960,combining,0,0
53961,groups,0,0
53962,",",0,0
53963,we,0,0
53964,found,0,0
53965,that,0,0
53966,48,0,0
53967,%,0,0
53968,of,0,0
53969,all,0,0
53970,children,0,0
53971,showed,0,0
53972,rapid,1,1
53973,learning,1,1
53974,",",0,0
53975,achieved,0,0
53976,average,1,1
53977,posttreatment,1,0
53978,scores,1,1
53979,",",0,0
53980,and,0,1
53981,at,0,0
53982,age,0,0
53983,7,0,0
53984,",",0,0
53985,were,0,0
53986,succeeding,0,0
53987,in,0,0
53988,regular,0,0
53989,education,0,0
53990,classrooms,0,0
53991,.,0,0
53992,Treatment,0,0
53993,outcome,0,1
53994,was,0,0
53995,best,0,0
53996,predicted,0,0
53997,by,0,0
53998,pretreatment,1,0
53999,imitation,1,0
54000,",",1,0
54001,language,1,1
54002,",",1,1
54003,and,1,1
54004,social,1,1
54005,responsiveness,1,1
54006,.,1,0
54007,These,0,0
54008,results,0,0
54009,are,0,0
54010,consistent,0,0
54011,with,0,0
54012,those,0,0
54013,reported,0,0
54014,by,0,0
54015,Lovaas,0,0
54016,and,0,1
54017,colleagues,0,0
54018,(,0,0
54019,Lovaas,0,0
54020,",",0,0
54021,1987,0,0
54022,;,0,0
54023,McEachin,0,0
54024,",",0,0
54025,Smith,0,1
54026,",",0,1
54027,&,0,0
54028,Lovaas,0,0
54029,",",0,0
54030,1993,0,0
54031,),0,0
54032,.,0,0
54033,A,0,0
54034,comparison,0,0
54035,of,0,0
54036,two,0,0
54037,double-injection,0,0
54038,techniques,0,0
54039,for,0,0
54040,peribulbar,0,0
54041,block,0,0
54042,analgesia,0,1
54043,:,0,0
54044,infero-temporal,0,1
54045,plus,0,0
54046,supero-medial,0,1
54047,vs.,0,0
54048,infero-temporal,0,1
54049,plus,0,0
54050,medial-percaruncular,0,0
54051,.,0,0
54052,BACKGROUND,0,0
54053,Combinations,0,0
54054,of,0,0
54055,infero-temporal,0,1
54056,and,0,0
54057,either,0,0
54058,supero-nasal,0,1
54059,(,0,0
54060,'inferior-superior,0,0
54061,',0,0
54062,),0,0
54063,or,0,0
54064,medial,0,1
54065,percaruncular,0,1
54066,(,0,0
54067,'inferior-medial,0,1
54068,',0,0
54069,),0,0
54070,injections,0,0
54071,are,0,0
54072,popular,0,0
54073,double-injection,0,0
54074,techniques,0,0
54075,for,0,0
54076,establishing,0,0
54077,peribulbar,0,0
54078,block,0,0
54079,analgesia,0,1
54080,.,0,0
54081,This,0,0
54082,study,0,0
54083,compared,0,0
54084,the,0,0
54085,efficacy,0,0
54086,of,0,0
54087,these,0,0
54088,two,0,0
54089,techniques,0,0
54090,in,0,0
54091,achieving,0,0
54092,ocular,0,1
54093,and,0,0
54094,lid,0,0
54095,akinesia,0,1
54096,.,0,0
54097,METHODS,0,0
54098,One,0,0
54099,hundred,0,0
54100,patients,0,0
54101,were,0,0
54102,randomized,0,0
54103,to,0,0
54104,receive,0,0
54105,inferior-superior,0,0
54106,or,0,0
54107,inferior-medial,0,1
54108,injections,0,0
54109,in,0,0
54110,a,0,0
54111,study,0,0
54112,in,0,0
54113,which,0,0
54114,injectate,0,0
54115,",",0,0
54116,injectate,0,0
54117,volumes,0,1
54118,",",0,0
54119,5-min,0,0
54120,ocular,0,1
54121,akinesia,0,1
54122,scoring,0,1
54123,(,0,0
54124,0-8,0,0
54125,),0,0
54126,",",0,0
54127,lid,0,1
54128,scoring,0,1
54129,(,0,0
54130,0-2,0,0
54131,),0,0
54132,and,0,0
54133,supplemental,0,0
54134,injection,0,0
54135,protocols,0,0
54136,were,0,0
54137,standardized,0,0
54138,.,0,0
54139,The,0,0
54140,numbers,0,0
54141,of,0,0
54142,supplemental,0,0
54143,injections,0,0
54144,required,0,0
54145,at,0,0
54146,each,0,0
54147,observation,0,0
54148,period,0,0
54149,and,0,0
54150,the,0,0
54151,total,0,1
54152,volume,0,1
54153,of,0,0
54154,injectate,0,0
54155,required,0,0
54156,to,0,0
54157,produce,0,0
54158,ocular,0,1
54159,and,0,0
54160,lid,0,1
54161,akinesia,0,1
54162,were,0,0
54163,compared,0,0
54164,.,0,0
54165,RESULTS,0,0
54166,The,0,0
54167,two,0,0
54168,test,0,0
54169,groups,0,0
54170,were,0,0
54171,demographically,0,0
54172,similar,0,0
54173,.,0,0
54174,The,0,0
54175,inferior-medial,0,0
54176,combination,0,0
54177,achieved,0,0
54178,greater,0,0
54179,ocular,1,1
54180,akinesia,1,1
54181,than,0,0
54182,the,0,0
54183,inferior-superior,0,0
54184,combination,0,0
54185,5,0,0
54186,min,0,0
54187,after,0,0
54188,the,0,0
54189,initial,0,0
54190,injections,0,0
54191,(,0,0
54192,mean,0,1
54193,score,0,1
54194,+/-,0,0
54195,standard,0,0
54196,deviation,0,0
54197,of,0,0
54198,1.74,0,0
54199,+/-,0,0
54200,1.86,0,0
54201,vs.,0,0
54202,2.66,0,0
54203,+/-,0,0
54204,2.39,0,0
54205,;,0,0
54206,P,0,0
54207,<,0,0
54208,0.05,0,0
54209,),0,0
54210,",",0,0
54211,with,0,0
54212,a,0,0
54213,reduced,0,0
54214,requirement,0,1
54215,for,0,0
54216,supplementary,0,0
54217,injections,0,0
54218,(,0,0
54219,3,0,0
54220,vs.,0,0
54221,23,0,0
54222,supplementary,0,0
54223,injections,0,0
54224,;,0,0
54225,P,0,0
54226,<,0,0
54227,0.025,0,0
54228,),0,0
54229,.,0,0
54230,The,0,0
54231,inferior-superior,0,0
54232,technique,0,0
54233,achieved,0,0
54234,greater,0,0
54235,lid,1,0
54236,akinesia,1,1
54237,at,0,0
54238,5,0,0
54239,min,0,0
54240,than,0,0
54241,the,0,0
54242,inferior-medial,0,1
54243,technique,0,0
54244,(,0,0
54245,mean,0,1
54246,score,0,1
54247,+/-,0,0
54248,standard,0,0
54249,deviation,0,0
54250,of,0,0
54251,0.7,0,0
54252,+/-,0,0
54253,0.9,0,0
54254,vs.,0,0
54255,0.3,0,0
54256,+/-,0,0
54257,0.58,0,0
54258,;,0,0
54259,P,0,0
54260,<,0,0
54261,0.005,0,0
54262,),0,0
54263,.,0,0
54264,A,0,0
54265,medial,1,1
54266,subconjunctival,1,0
54267,hemorrhage,1,1
54268,occurred,0,0
54269,in,0,0
54270,one,0,0
54271,patient,0,0
54272,in,0,0
54273,the,0,0
54274,inferior-medial,0,0
54275,group,0,0
54276,.,0,0
54277,CONCLUSION,0,0
54278,Compared,0,0
54279,with,0,0
54280,the,0,0
54281,inferior-superior,0,0
54282,technique,0,0
54283,",",0,0
54284,the,0,0
54285,inferior-medial,0,1
54286,combination,0,0
54287,achieved,0,0
54288,more,0,0
54289,rapid,1,1
54290,ocular,1,0
54291,akinesia,1,0
54292,with,0,0
54293,less,0,0
54294,need,0,0
54295,for,0,0
54296,supplementation,0,0
54297,",",0,0
54298,but,0,0
54299,induced,0,0
54300,less,0,0
54301,efficient,0,1
54302,lid,0,0
54303,akinesia,0,1
54304,and,0,0
54305,had,0,0
54306,a,0,0
54307,propensity,0,0
54308,to,0,0
54309,cause,0,0
54310,iatrogenic,1,0
54311,subconjunctival,1,0
54312,hemorrhage,1,0
54313,.,1,0
54314,The,0,0
54315,latter,0,0
54316,complication,0,0
54317,is,0,0
54318,considered,0,0
54319,by,0,0
54320,our,0,0
54321,surgeons,0,0
54322,to,0,0
54323,be,0,0
54324,a,0,0
54325,contraindication,0,0
54326,to,0,0
54327,the,0,0
54328,inferior-medial,0,0
54329,technique,0,0
54330,in,0,0
54331,patients,0,0
54332,undergoing,0,0
54333,trabeculectomy,0,0
54334,.,0,0
54335,Comparison,0,0
54336,of,0,0
54337,methods,0,0
54338,for,0,0
54339,intravenous,0,0
54340,infusion,0,0
54341,of,0,0
54342,fat,0,1
54343,emulsion,0,0
54344,during,0,0
54345,extracorporeal,0,0
54346,membrane,0,0
54347,oxygenation,0,1
54348,.,0,0
54349,STUDY,0,0
54350,OBJECTIVES,0,0
54351,To,0,0
54352,characterize,0,0
54353,the,0,0
54354,effects,0,0
54355,of,0,0
54356,infusing,0,0
54357,fat,0,1
54358,emulsion,0,0
54359,during,0,0
54360,neonatal,0,1
54361,extracorporeal,0,0
54362,membrane,0,1
54363,oxygenation,0,1
54364,(,0,0
54365,ECMO,0,1
54366,),0,0
54367,by,0,0
54368,comparing,0,0
54369,results,0,0
54370,from,0,0
54371,patients,0,0
54372,receiving,0,0
54373,fat,0,1
54374,emulsion,0,0
54375,through,0,0
54376,the,0,0
54377,ECMO,0,1
54378,circuit,0,0
54379,with,0,0
54380,those,0,0
54381,receiving,0,0
54382,fat,0,1
54383,emulsion,0,0
54384,through,0,0
54385,separate,0,0
54386,intravenous,0,0
54387,access,0,0
54388,.,0,0
54389,A,0,0
54390,second,0,0
54391,goal,0,0
54392,was,0,0
54393,to,0,0
54394,identify,0,0
54395,the,0,0
54396,optimal,0,0
54397,route,0,0
54398,for,0,0
54399,administration,0,0
54400,.,0,0
54401,DESIGN,0,0
54402,Prospective,0,0
54403,",",0,0
54404,randomized,0,0
54405,",",0,0
54406,open-label,0,0
54407,trial,0,0
54408,.,0,0
54409,SETTING,0,0
54410,Neonatal,0,1
54411,intensive,0,0
54412,care,0,0
54413,unit,0,0
54414,in,0,0
54415,a,0,0
54416,106-bed,0,0
54417,quaternary,0,1
54418,care,0,0
54419,pediatric,0,0
54420,hospital,0,1
54421,.,0,0
54422,SUBJECTS,0,0
54423,Nine,0,0
54424,neonates,0,0
54425,receiving,0,0
54426,ECMO,0,1
54427,who,0,0
54428,required,0,0
54429,intravenous,0,0
54430,nutrition,0,0
54431,.,0,0
54432,Intervention,0,0
54433,.,0,0
54434,Patients,0,0
54435,received,0,0
54436,1-3,0,0
54437,g/kg/day,0,0
54438,of,0,0
54439,fat,0,1
54440,emulsion,0,0
54441,into,0,0
54442,either,0,0
54443,the,0,0
54444,ecmo,0,0
54445,circuit,0,1
54446,or,0,0
54447,separate,0,0
54448,intravenous,0,0
54449,access,0,0
54450,.,0,0
54451,MEASUREMENTS,0,0
54452,AND,0,0
54453,MAIN,0,0
54454,RESULTS,0,0
54455,The,0,0
54456,ECMO,0,1
54457,circuit,0,1
54458,and,0,0
54459,samples,0,0
54460,of,0,1
54461,blood,0,1
54462,were,0,0
54463,evaluated,0,0
54464,hourly,0,0
54465,for,0,0
54466,phase,0,0
54467,separation,0,0
54468,",",0,0
54469,layering,0,0
54470,out,0,0
54471,of,0,0
54472,the,0,0
54473,emulsion,0,0
54474,from,0,0
54475,blood,0,1
54476,",",0,0
54477,agglutination,0,1
54478,",",0,1
54479,and,0,1
54480,blood,0,1
54481,clots,0,1
54482,.,0,0
54483,After,0,0
54484,completion,0,0
54485,",",0,0
54486,the,0,0
54487,oxygenators,0,0
54488,were,0,0
54489,dissected,0,0
54490,and,0,0
54491,examined,0,0
54492,.,0,0
54493,Data,0,0
54494,were,0,0
54495,compared,0,0
54496,with,0,0
54497,an,0,0
54498,unpaired,0,0
54499,t,0,0
54500,test,0,0
54501,.,0,0
54502,The,0,0
54503,characteristics,0,0
54504,of,0,0
54505,the,0,0
54506,groups,0,0
54507,were,0,0
54508,similar,0,0
54509,",",0,0
54510,except,0,0
54511,for,0,0
54512,a,0,0
54513,higher,0,0
54514,mean,0,1
54515,weight,1,1
54516,in,0,0
54517,the,0,0
54518,ECMO,0,1
54519,circuit,0,1
54520,group,0,0
54521,(,0,0
54522,3.6,0,0
54523,+/-,0,0
54524,0.3,0,0
54525,kg,0,0
54526,vs,0,0
54527,2.8,0,0
54528,+/-,0,0
54529,0.4,0,0
54530,kg,0,0
54531,",",0,0
54532,p=0.03,0,0
54533,),0,0
54534,.,0,0
54535,The,0,0
54536,mean,1,1
54537,+/-,1,0
54538,SD,1,0
54539,triglyceride,1,1
54540,level,1,1
54541,during,0,0
54542,the,0,0
54543,study,0,0
54544,was,0,0
54545,87,0,0
54546,+/-,0,0
54547,79,0,0
54548,mg/dl,0,0
54549,",",0,0
54550,with,0,0
54551,no,0,0
54552,significant,0,0
54553,difference,0,0
54554,between,0,0
54555,the,0,0
54556,two,0,0
54557,groups,0,0
54558,.,0,0
54559,Two,0,0
54560,patients,0,0
54561,in,0,0
54562,each,0,0
54563,group,0,0
54564,had,0,0
54565,elevated,0,0
54566,triglyceride,1,0
54567,levels,1,1
54568,.,1,0
54569,No,0,0
54570,cases,0,0
54571,of,0,0
54572,phase,1,0
54573,separation,1,0
54574,occurred,0,0
54575,.,0,0
54576,In,0,0
54577,the,0,0
54578,five,0,0
54579,patients,0,0
54580,who,0,0
54581,received,0,0
54582,fat,0,1
54583,emulsion,0,0
54584,into,0,0
54585,the,0,0
54586,ECMO,0,1
54587,circuit,0,0
54588,",",0,0
54589,three,0,0
54590,had,0,0
54591,layering,1,0
54592,out,1,0
54593,of,1,0
54594,the,1,0
54595,emulsion,1,0
54596,and,0,1
54597,agglutination,1,1
54598,",",0,0
54599,and,0,0
54600,all,0,0
54601,developed,0,0
54602,clots,1,0
54603,in,0,0
54604,the,0,0
54605,circuit,0,0
54606,despite,0,0
54607,adequate,0,0
54608,anticoagulation,0,0
54609,.,0,0
54610,Of,0,0
54611,the,0,0
54612,four,0,0
54613,patients,0,0
54614,in,0,0
54615,the,0,0
54616,intravenous-access,0,0
54617,group,0,0
54618,",",0,0
54619,one,0,0
54620,had,0,0
54621,layering,0,0
54622,and,0,1
54623,agglutination,0,1
54624,",",0,0
54625,and,0,0
54626,two,0,0
54627,had,0,0
54628,blood,0,0
54629,clots,0,1
54630,.,0,0
54631,CONCLUSIONS,0,0
54632,Although,0,0
54633,both,0,0
54634,methods,0,0
54635,were,0,0
54636,associated,0,0
54637,with,0,0
54638,layering,1,0
54639,out,1,0
54640,",",1,0
54641,agglutination,1,1
54642,",",1,1
54643,and,1,1
54644,clot,1,1
54645,formation,1,1
54646,",",0,0
54647,these,0,0
54648,effects,0,1
54649,occurred,0,0
54650,more,0,0
54651,frequently,0,0
54652,with,0,0
54653,administration,0,0
54654,into,0,0
54655,the,0,0
54656,ECMO,0,1
54657,circuit,0,1
54658,",",0,0
54659,particularly,0,0
54660,in,0,0
54661,areas,0,0
54662,of,0,0
54663,stasis,0,1
54664,.,0,0
54665,This,0,0
54666,may,0,0
54667,result,0,0
54668,in,0,0
54669,disruption,0,0
54670,of,0,0
54671,normal,0,0
54672,ECMO,0,1
54673,blood,0,1
54674,flow,0,1
54675,and,0,1
54676,impaired,0,1
54677,delivery,0,1
54678,of,0,0
54679,calories,0,1
54680,.,0,0
54681,Fat,0,0
54682,emulsion,0,0
54683,should,0,0
54684,therefore,0,0
54685,be,0,0
54686,administered,0,0
54687,through,0,0
54688,separate,0,0
54689,intravenous,0,0
54690,access,0,0
54691,during,0,0
54692,ECMO,0,1
54693,whenever,0,0
54694,possible,0,0
54695,.,0,0
54696,Ultrasound,0,0
54697,therapy,0,0
54698,for,0,0
54699,recalcitrant,1,0
54700,diabetic,1,0
54701,foot,1,1
54702,ulcers,1,1
54703,:,1,0
54704,results,0,0
54705,of,0,0
54706,a,0,0
54707,randomized,0,0
54708,",",0,0
54709,double-blind,0,0
54710,",",0,0
54711,controlled,0,0
54712,",",0,0
54713,multicenter,0,0
54714,study,0,0
54715,.,0,0
54716,An,0,0
54717,estimated,0,0
54718,15,0,0
54719,%,0,0
54720,of,0,0
54721,patients,0,0
54722,with,0,0
54723,diabetes,0,0
54724,will,0,0
54725,develop,0,0
54726,a,0,0
54727,foot,1,1
54728,ulcer,1,1
54729,sometime,0,0
54730,in,0,0
54731,their,0,0
54732,life,0,1
54733,",",0,0
54734,making,0,0
54735,them,0,0
54736,30,0,0
54737,to,0,0
54738,40,0,0
54739,times,0,0
54740,more,0,0
54741,likely,0,0
54742,to,0,0
54743,undergo,0,0
54744,amputation,0,0
54745,due,0,0
54746,to,0,0
54747,a,0,0
54748,non-healing,0,0
54749,foot,0,1
54750,ulcer,0,1
54751,than,0,0
54752,the,0,0
54753,non-diabetic,0,0
54754,population,0,0
54755,.,0,0
54756,To,0,0
54757,determine,0,0
54758,the,0,0
54759,safety,0,1
54760,and,0,0
54761,efficacy,0,1
54762,of,0,0
54763,a,0,0
54764,new,0,0
54765,",",0,0
54766,non-contact,0,0
54767,",",0,0
54768,kilohertz,0,0
54769,ultrasound,0,1
54770,therapy,0,0
54771,for,0,0
54772,the,0,0
54773,healing,0,1
54774,of,0,0
54775,recalcitrant,1,0
54776,diabetic,1,0
54777,foot,1,1
54778,ulcers,1,1
54779,-,0,0
54780,as,0,0
54781,well,0,0
54782,as,0,0
54783,to,0,0
54784,evaluate,0,0
54785,the,0,0
54786,impact,0,0
54787,on,0,0
54788,total,0,1
54789,closure,0,0
54790,and,0,0
54791,quantitative,0,0
54792,bacterial,0,1
54793,cultures,0,0
54794,and,0,0
54795,the,0,0
54796,effect,0,0
54797,on,0,0
54798,healing,0,1
54799,of,0,0
54800,various,0,0
54801,levels,0,1
54802,of,0,0
54803,sharp/surgical,0,0
54804,debridement,0,0
54805,-,0,0
54806,a,0,0
54807,randomized,0,0
54808,",",0,0
54809,double-blinded,0,0
54810,",",0,0
54811,sham-controlled,0,0
54812,",",0,0
54813,multicenter,0,0
54814,study,0,0
54815,was,0,0
54816,conducted,0,0
54817,in,0,0
54818,hospital-based,0,0
54819,and,0,0
54820,private,0,0
54821,wound,0,1
54822,care,0,0
54823,clinics,0,0
54824,.,0,0
54825,Patients,0,0
54826,(,0,0
54827,55,0,0
54828,met,0,0
54829,criteria,0,0
54830,for,0,0
54831,efficacy,0,1
54832,analysis,0,0
54833,),0,0
54834,received,0,0
54835,standard,0,0
54836,of,0,1
54837,care,0,0
54838,",",0,0
54839,which,0,0
54840,included,0,0
54841,products,0,0
54842,that,0,0
54843,provide,0,0
54844,a,0,0
54845,moist,0,0
54846,environment,0,0
54847,",",0,0
54848,offloading,0,0
54849,diabetic,0,0
54850,shoes,0,0
54851,and,0,1
54852,socks,0,1
54853,",",0,1
54854,debridement,0,0
54855,",",0,1
54856,wound,0,1
54857,evaluation,0,0
54858,",",0,0
54859,and,0,1
54860,measurement,0,1
54861,.,0,0
54862,The,0,0
54863,therapy,0,0
54864,was,0,0
54865,either,0,0
54866,active,0,0
54867,40,0,0
54868,KHz,0,0
54869,ultrasound,0,0
54870,delivered,0,0
54871,by,0,0
54872,a,0,0
54873,saline,0,0
54874,mist,0,0
54875,or,0,0
54876,a,0,0
54877,sham,0,0
54878,device,0,0
54879,which,0,0
54880,delivered,0,0
54881,a,0,0
54882,saline,0,0
54883,mist,0,0
54884,without,0,0
54885,the,0,0
54886,use,0,0
54887,of,0,0
54888,ultrasound,0,1
54889,.,0,0
54890,After,0,0
54891,12,0,0
54892,weeks,0,0
54893,of,0,0
54894,care,0,0
54895,",",0,0
54896,the,0,0
54897,proportion,1,0
54898,of,1,0
54899,wounds,1,1
54900,healed,1,1
54901,(,0,0
54902,defined,0,0
54903,as,0,0
54904,complete,0,1
54905,epithelialization,0,1
54906,without,0,0
54907,drainage,0,0
54908,),0,0
54909,in,0,0
54910,the,0,0
54911,active,0,0
54912,ultrasound,0,1
54913,therapy,0,0
54914,device,0,0
54915,group,0,0
54916,was,0,0
54917,significantly,0,0
54918,higher,0,0
54919,than,0,0
54920,that,0,0
54921,in,0,0
54922,the,0,0
54923,sham,0,0
54924,control,0,0
54925,group,0,0
54926,(,0,0
54927,40.7,0,0
54928,%,0,0
54929,versus,0,0
54930,14.3,0,0
54931,%,0,0
54932,",",0,0
54933,P,0,0
54934,=,0,0
54935,0.0366,0,0
54936,",",0,0
54937,Fisher,0,0
54938,'s,0,1
54939,exact,0,1
54940,test,0,0
54941,),0,0
54942,.,0,0
54943,The,0,0
54944,ultrasound,0,1
54945,treatment,0,0
54946,was,0,0
54947,easy,0,0
54948,to,0,0
54949,use,0,0
54950,and,0,0
54951,no,0,0
54952,difference,0,0
54953,in,0,0
54954,the,0,0
54955,number,0,1
54956,and,0,0
54957,type,0,0
54958,of,0,1
54959,adverse,1,1
54960,events,1,1
54961,between,0,0
54962,the,0,0
54963,two,0,0
54964,treatment,0,0
54965,groups,0,0
54966,was,0,0
54967,noted,0,0
54968,.,0,0
54969,Of,0,0
54970,interest,0,0
54971,",",0,0
54972,wounds,0,1
54973,were,0,0
54974,debrided,0,0
54975,at,0,0
54976,baseline,0,0
54977,followed,0,0
54978,by,0,0
54979,a,0,0
54980,quantitative,0,0
54981,culture,0,0
54982,biopsy,0,0
54983,.,0,0
54984,The,0,0
54985,results,0,0
54986,of,0,0
54987,these,0,0
54988,cultures,0,0
54989,demonstrated,0,0
54990,a,0,0
54991,significant,0,0
54992,bioburden,1,1
54993,(,0,0
54994,greater,0,0
54995,than,0,0
54996,10,0,0
54997,(,0,0
54998,5,0,0
54999,),0,0
55000,),0,0
55001,in,0,0
55002,the,0,0
55003,majority,0,0
55004,of,0,0
55005,cases,0,0
55006,",",0,0
55007,despite,0,0
55008,a,0,0
55009,lack,0,0
55010,of,0,0
55011,clinical,0,0
55012,signs,0,1
55013,of,0,0
55014,infection,0,1
55015,.,0,0
55016,Compared,0,0
55017,to,0,0
55018,control,0,0
55019,",",0,0
55020,this,0,0
55021,therapeutic,0,0
55022,modality,0,0
55023,was,0,0
55024,found,0,0
55025,to,0,0
55026,increase,0,0
55027,the,0,0
55028,healing,1,1
55029,rate,1,1
55030,of,0,0
55031,recalcitrant,0,0
55032,",",0,0
55033,diabetic,0,0
55034,foot,0,1
55035,ulcers,0,0
55036,.,0,0
55037,Mending,0,0
55038,the,0,0
55039,rhythm,0,0
55040,does,0,0
55041,not,0,0
55042,improve,0,0
55043,prognosis,0,0
55044,in,0,0
55045,patients,0,0
55046,with,0,0
55047,persistent,0,0
55048,atrial,0,0
55049,fibrillation,0,0
55050,:,0,0
55051,a,0,0
55052,subanalysis,0,0
55053,of,0,0
55054,the,0,0
55055,RACE,0,0
55056,study,0,0
55057,.,0,0
55058,AIMS,0,0
55059,To,0,0
55060,compare,0,0
55061,outcome,0,0
55062,of,0,0
55063,AF,0,0
55064,patients,0,0
55065,with,0,0
55066,effective,0,1
55067,rhythm,0,1
55068,control,0,0
55069,with,0,0
55070,patients,0,0
55071,treated,0,0
55072,with,0,0
55073,rate,0,1
55074,control,0,0
55075,.,0,0
55076,METHODS,0,0
55077,AND,0,0
55078,RESULTS,0,0
55079,Out,0,0
55080,of,0,0
55081,the,0,0
55082,266,0,0
55083,AF,0,0
55084,patients,0,0
55085,randomized,0,0
55086,to,0,0
55087,rhythm,0,1
55088,control,0,0
55089,in,0,0
55090,the,0,0
55091,RACE,0,1
55092,study,0,0
55093,",",0,0
55094,49,0,0
55095,patients,0,0
55096,turned,0,0
55097,to,0,0
55098,long-term,0,0
55099,sinus,0,0
55100,rhythm,0,1
55101,and,0,1
55102,were,0,0
55103,continuously,0,0
55104,treated,0,0
55105,with,0,0
55106,oral,0,0
55107,anticoagulation,0,0
55108,.,0,0
55109,The,0,0
55110,incidence,0,1
55111,of,0,0
55112,the,0,0
55113,primary,0,0
55114,endpoint,0,0
55115,in,0,0
55116,these,0,0
55117,patients,0,0
55118,was,0,0
55119,compared,0,0
55120,to,0,0
55121,that,0,0
55122,in,0,0
55123,178,0,0
55124,patients,0,0
55125,out,0,0
55126,of,0,0
55127,the,0,0
55128,initial,0,0
55129,256,0,0
55130,rate-control,0,0
55131,patients,0,0
55132,of,0,0
55133,RACE,0,1
55134,who,0,0
55135,were,0,0
55136,in,0,0
55137,AF,0,1
55138,and,0,0
55139,using,0,0
55140,oral,0,0
55141,anticoagulation,0,0
55142,continuously,0,0
55143,.,0,0
55144,Baseline,0,0
55145,characteristics,0,0
55146,of,0,0
55147,both,0,0
55148,groups,0,0
55149,were,0,0
55150,not,0,0
55151,different,0,0
55152,.,0,0
55153,After,0,0
55154,a,0,0
55155,mean,0,1
55156,follow-up,0,0
55157,of,0,0
55158,2.3+/-0.6,0,0
55159,years,0,0
55160,",",0,0
55161,the,0,0
55162,primary,0,0
55163,endpoint,0,0
55164,(,0,0
55165,a,0,0
55166,composite,1,1
55167,of,1,0
55168,cardiovascular,1,1
55169,mortality,1,1
55170,",",1,0
55171,heart,1,1
55172,failure,1,1
55173,",",1,0
55174,thrombo-embolic,1,1
55175,complications,1,1
55176,(,1,0
55177,TECs,1,0
55178,),1,0
55179,",",1,0
55180,bleeding,1,1
55181,",",1,0
55182,serious,1,1
55183,adverse,1,1
55184,effects,1,0
55185,of,1,0
55186,antiarrhythmic,1,1
55187,drugs,1,0
55188,and,1,1
55189,pacemaker,1,0
55190,implants,1,0
55191,),1,0
55192,was,0,0
55193,22.4,0,0
55194,%,0,0
55195,in,0,0
55196,the,0,0
55197,rhythm-control,0,0
55198,group,0,0
55199,vs.,0,0
55200,15.2,0,0
55201,%,0,0
55202,in,0,0
55203,the,0,0
55204,rate-control,0,0
55205,group,0,0
55206,.,0,0
55207,Multivariable,0,0
55208,regression,0,0
55209,analysis,0,0
55210,indicated,0,0
55211,coronary,1,0
55212,artery,1,1
55213,disease,1,1
55214,",",1,1
55215,heart,1,1
55216,failure,1,1
55217,",",1,0
55218,and,1,0
55219,digitalis,1,0
55220,as,0,0
55221,independent,0,0
55222,risk,0,1
55223,indicators,0,1
55224,of,0,0
55225,cardiovascular,0,1
55226,morbidity,0,1
55227,and,0,0
55228,mortality,0,1
55229,.,0,1
55230,Chronic,1,0
55231,sinus,1,0
55232,rhythm,1,1
55233,did,0,0
55234,not,0,0
55235,matter,0,0
55236,.,0,0
55237,CONCLUSION,0,0
55238,Among,0,0
55239,patients,0,0
55240,who,0,0
55241,remained,0,0
55242,on,0,0
55243,warfarin,0,0
55244,",",0,0
55245,those,0,0
55246,who,0,0
55247,mostly,0,0
55248,were,0,0
55249,maintained,0,0
55250,in,0,0
55251,sinus,0,0
55252,rhythm,0,1
55253,under,0,0
55254,a,0,0
55255,rhythm-control,0,0
55256,strategy,0,0
55257,did,0,0
55258,not,0,0
55259,have,0,0
55260,a,0,0
55261,superior,0,0
55262,prognosis,0,0
55263,compared,0,0
55264,to,0,0
55265,those,0,0
55266,who,0,0
55267,remained,0,0
55268,in,0,0
55269,AF,0,0
55270,under,0,0
55271,a,0,0
55272,rate-control,0,0
55273,strategy,0,0
55274,.,0,0
55275,Intervention,0,0
55276,pilot,0,0
55277,for,0,0
55278,parents,0,0
55279,of,0,0
55280,children,0,0
55281,with,0,0
55282,autistic,0,0
55283,spectrum,0,0
55284,disorder,0,0
55285,.,0,0
55286,Parents,0,0
55287,of,0,0
55288,children,0,0
55289,who,0,0
55290,receive,0,0
55291,the,0,0
55292,diagnosis,0,0
55293,of,0,0
55294,autistic,0,0
55295,spectrum,0,0
55296,disorder,0,0
55297,(,0,0
55298,ASD,0,0
55299,),0,0
55300,experience,0,0
55301,a,0,0
55302,situational,0,1
55303,crisis,0,0
55304,related,0,0
55305,to,0,0
55306,receiving,0,0
55307,the,0,0
55308,diagnosis,0,0
55309,",",0,0
55310,which,0,0
55311,causes,0,0
55312,feelings,0,1
55313,of,0,0
55314,distress,0,1
55315,and,0,0
55316,urgency,0,1
55317,to,0,0
55318,access,0,0
55319,services,0,0
55320,for,0,0
55321,the,0,0
55322,affected,0,0
55323,child,0,0
55324,.,0,0
55325,This,0,0
55326,paper,0,0
55327,describes,0,0
55328,a,0,0
55329,randomized,0,0
55330,trial,0,0
55331,(,0,0
55332,n,0,0
55333,=,0,0
55334,31,0,0
55335,),0,0
55336,that,0,0
55337,was,0,0
55338,conducted,0,0
55339,at,0,0
55340,a,0,0
55341,regional,0,0
55342,diagnostic,0,0
55343,center,0,0
55344,of,0,0
55345,a,0,0
55346,large,0,0
55347,metropolitan,0,0
55348,children,0,0
55349,'s,0,0
55350,hospital,0,1
55351,to,0,0
55352,(,0,0
55353,a,0,0
55354,),0,0
55355,refine,0,0
55356,a,0,0
55357,nursing,0,0
55358,intervention,0,0
55359,designed,0,0
55360,for,0,0
55361,parents,0,0
55362,of,0,0
55363,children,0,0
55364,with,0,0
55365,ASD,0,0
55366,and,0,1
55367,(,0,1
55368,b,0,0
55369,),0,0
55370,to,0,0
55371,identify,0,0
55372,methodological,0,0
55373,revisions,0,0
55374,for,0,0
55375,a,0,0
55376,larger,0,0
55377,study,0,0
55378,.,0,0
55379,A,0,0
55380,secondary,0,0
55381,purpose,0,0
55382,was,0,0
55383,to,0,0
55384,test,0,0
55385,the,0,0
55386,effects,0,0
55387,of,0,0
55388,a,0,0
55389,post-diagnosis,0,0
55390,nursing,0,0
55391,intervention,0,0
55392,on,0,0
55393,parents,1,1
55394,',1,0
55395,reports,1,0
55396,of,1,0
55397,stress,1,1
55398,",",1,0
55399,impact,1,0
55400,of,1,1
55401,event,1,1
55402,(,1,0
55403,diagnosis,1,0
55404,),1,1
55405,",",0,0
55406,and,0,1
55407,use,1,1
55408,of,1,1
55409,services,1,0
55410,after,0,0
55411,a,0,0
55412,child,0,0
55413,is,0,0
55414,newly,0,0
55415,diagnosed,0,0
55416,with,0,0
55417,ASD,0,0
55418,.,0,0
55419,The,0,0
55420,intervention,0,0
55421,consisted,0,0
55422,of,0,0
55423,usual,0,0
55424,care,0,0
55425,plus,0,0
55426,3,0,0
55427,hours,0,0
55428,contact,0,0
55429,with,0,0
55430,a,0,0
55431,pediatric,0,0
55432,nurse,0,0
55433,practitioner,0,0
55434,(,0,0
55435,PNP,0,0
55436,),0,0
55437,for,0,0
55438,counseling,0,0
55439,",",0,0
55440,instruction,0,0
55441,",",0,1
55442,and,0,1
55443,assistance,0,1
55444,with,0,0
55445,implementation,0,0
55446,of,0,0
55447,the,0,0
55448,recommended,0,0
55449,treatment,0,0
55450,plan,0,0
55451,.,0,0
55452,The,0,0
55453,control,0,0
55454,group,0,0
55455,received,0,0
55456,only,0,0
55457,the,0,0
55458,usual,0,0
55459,care,0,0
55460,post-diagnosis,0,0
55461,",",0,0
55462,which,0,0
55463,consisted,0,0
55464,of,0,0
55465,a,0,0
55466,1-hour,0,0
55467,consultation,0,0
55468,session,0,0
55469,to,0,0
55470,receive,0,0
55471,the,0,0
55472,results,0,0
55473,of,0,0
55474,diagnostic,0,0
55475,tests,0,0
55476,and,0,0
55477,a,0,0
55478,written,0,0
55479,copy,0,0
55480,of,0,0
55481,the,0,0
55482,recommended,0,0
55483,treatment,0,0
55484,plan,0,0
55485,provided,0,0
55486,by,0,0
55487,a,0,0
55488,developmental,0,0
55489,pediatrician,0,0
55490,and/or,0,0
55491,PNP,0,0
55492,.,0,0
55493,Between,0,0
55494,group,0,0
55495,differences,0,0
55496,in,0,0
55497,measures,0,1
55498,of,0,0
55499,impact,1,0
55500,of,1,0
55501,event,1,1
55502,and,1,1
55503,perceived,1,1
55504,stress,1,1
55505,were,0,0
55506,not,0,0
55507,statistically,0,0
55508,significant,0,0
55509,.,0,0
55510,This,0,0
55511,was,0,0
55512,attributed,0,0
55513,to,0,0
55514,a,0,0
55515,small,0,0
55516,sample,0,0
55517,size,0,1
55518,.,0,0
55519,A,0,0
55520,larger,0,0
55521,study,0,0
55522,is,0,0
55523,feasible,0,0
55524,and,0,0
55525,recommended,0,0
55526,with,0,0
55527,an,0,0
55528,expanded,0,0
55529,nursing,0,0
55530,intervention,0,0
55531,and,0,0
55532,a,0,0
55533,significantly,0,0
55534,larger,0,0
55535,sample,0,0
55536,recruited,0,0
55537,from,0,0
55538,an,0,0
55539,additional,0,0
55540,recruitment,0,0
55541,site,0,0
55542,.,0,0
55543,Nurses,0,0
55544,working,0,0
55545,with,0,0
55546,this,0,0
55547,special,0,0
55548,population,0,0
55549,must,0,0
55550,recognize,0,0
55551,that,0,0
55552,parents,0,0
55553,have,0,0
55554,information,0,1
55555,and,0,1
55556,counseling,0,0
55557,needs,0,0
55558,that,0,0
55559,begin,0,0
55560,after,0,0
55561,they,0,0
55562,receive,0,0
55563,the,0,0
55564,diagnosis,0,0
55565,of,0,0
55566,ASD,0,0
55567,for,0,0
55568,their,0,0
55569,child,0,0
55570,and,0,0
55571,can,0,0
55572,address,0,0
55573,these,0,0
55574,needs,0,0
55575,with,0,0
55576,a,0,0
55577,standardized,0,0
55578,nursing,0,0
55579,intervention,0,0
55580,.,0,0
55581,Using,0,0
55582,dietetic,0,0
55583,assistants,0,0
55584,to,0,0
55585,improve,0,0
55586,the,0,0
55587,outcome,0,0
55588,of,0,0
55589,hip,0,1
55590,fracture,0,0
55591,:,0,0
55592,a,0,0
55593,randomised,0,0
55594,controlled,0,0
55595,trial,0,0
55596,of,0,0
55597,nutritional,0,1
55598,support,0,0
55599,in,0,0
55600,an,0,0
55601,acute,0,0
55602,trauma,0,0
55603,ward,0,0
55604,.,0,0
55605,OBJECTIVE,0,0
55606,To,0,0
55607,examine,0,0
55608,how,0,0
55609,improved,0,0
55610,attention,0,0
55611,to,0,0
55612,nutritional,1,1
55613,status,1,1
55614,and,1,0
55615,dietary,1,1
55616,intake,1,1
55617,",",0,0
55618,achieved,0,0
55619,through,0,0
55620,the,0,0
55621,employment,0,0
55622,of,0,0
55623,dietetic,0,0
55624,assistants,0,0
55625,(,0,0
55626,DAs,0,0
55627,),0,0
55628,",",0,0
55629,will,0,0
55630,affect,0,0
55631,postoperative,1,1
55632,clinical,1,0
55633,outcome,1,0
55634,among,0,0
55635,elderly,0,0
55636,women,0,0
55637,with,0,0
55638,hip,0,1
55639,fracture,0,0
55640,.,0,0
55641,DESIGN,0,0
55642,Open,0,0
55643,prospective,0,0
55644,randomised,0,0
55645,controlled,0,0
55646,trial,0,0
55647,",",0,0
55648,comparing,0,0
55649,conventional,0,0
55650,nursing,0,0
55651,care,0,0
55652,with,0,0
55653,the,0,0
55654,additional,0,0
55655,nutritional,0,1
55656,support,0,0
55657,provided,0,0
55658,by,0,0
55659,DA,0,0
55660,.,0,0
55661,SETTING,0,0
55662,Thirty-eight,0,0
55663,bedded,0,0
55664,acute,0,0
55665,trauma,0,0
55666,ward,0,0
55667,in,0,0
55668,a,0,0
55669,teaching,0,0
55670,hospital,0,0
55671,.,0,0
55672,PARTICIPANTS,0,0
55673,All,0,0
55674,but,0,0
55675,11,0,0
55676,of,0,0
55677,344,0,0
55678,consecutive,0,0
55679,admissions,0,0
55680,with,0,0
55681,acute,0,0
55682,nonpathological,0,0
55683,hip,0,1
55684,fracture,0,1
55685,were,0,0
55686,approached,0,0
55687,.,0,0
55688,Three,0,0
55689,hundred,0,0
55690,and,0,0
55691,eighteen,0,0
55692,(,0,0
55693,93,0,0
55694,%,0,0
55695,),0,0
55696,agreed,0,0
55697,to,0,0
55698,inclusion,0,0
55699,.,0,0
55700,Sixteen,0,0
55701,were,0,0
55702,ineligible,0,0
55703,as,0,0
55704,they,0,0
55705,were,0,0
55706,immediately,0,0
55707,transferred,0,0
55708,to,0,0
55709,another,0,0
55710,acute,0,0
55711,ward,0,0
55712,",",0,0
55713,were,0,0
55714,managed,0,0
55715,conservatively,0,0
55716,or,0,0
55717,died,0,0
55718,preoperatively,0,0
55719,.,0,0
55720,PRIMARY,0,0
55721,OUTCOME,0,0
55722,MEASURE,0,0
55723,Postoperative,1,1
55724,mortality,1,1
55725,in,0,0
55726,the,0,0
55727,acute,0,0
55728,trauma,0,0
55729,unit,0,0
55730,.,0,0
55731,SECONDARY,0,0
55732,OUTCOME,0,0
55733,MEASURES,0,0
55734,Postoperative,1,1
55735,mortality,1,1
55736,at,1,0
55737,4,1,0
55738,months,1,0
55739,after,1,0
55740,fracture,1,1
55741,",",1,0
55742,length,1,1
55743,of,1,1
55744,stay,1,1
55745,",",1,0
55746,energy,1,1
55747,intake,1,1
55748,and,0,1
55749,nutritional,1,1
55750,status,1,1
55751,.,1,0
55752,RESULTS,0,0
55753,DA-supported,0,0
55754,participants,0,0
55755,were,0,0
55756,less,0,0
55757,likely,1,0
55758,to,1,0
55759,die,1,0
55760,in,0,0
55761,the,0,0
55762,acute,0,0
55763,ward,0,0
55764,(,0,0
55765,4.1,0,0
55766,versus,0,0
55767,10.1,0,0
55768,%,0,0
55769,",",0,0
55770,P,0,0
55771,=,0,0
55772,0.048,0,0
55773,),0,0
55774,.,0,0
55775,This,0,0
55776,effect,0,0
55777,was,0,0
55778,still,0,0
55779,apparent,0,0
55780,at,0,0
55781,4,0,0
55782,month,0,0
55783,follow-up,0,0
55784,(,0,0
55785,13.1,0,0
55786,versus,0,0
55787,22.9,0,0
55788,%,0,0
55789,",",0,0
55790,P,0,0
55791,=,0,0
55792,0.036,0,0
55793,),0,0
55794,.,0,0
55795,DA-supported,0,0
55796,subjects,0,0
55797,had,0,0
55798,significantly,0,0
55799,better,0,0
55800,mean,1,1
55801,daily,1,0
55802,energy,1,1
55803,intake,1,1
55804,(,0,0
55805,"1,105",0,0
55806,kcal,0,0
55807,versus,0,0
55808,756,0,0
55809,kcal/24,0,0
55810,h,0,0
55811,",",0,0
55812,95,0,0
55813,%,0,0
55814,CI,0,0
55815,259-440,0,0
55816,kcal/24,0,0
55817,h,0,0
55818,",",0,0
55819,P,0,0
55820,<,0,0
55821,0.001,0,0
55822,),0,0
55823,",",0,0
55824,significantly,0,0
55825,smaller,0,0
55826,reduction,0,1
55827,in,0,0
55828,mid-arm,0,1
55829,circumference,0,1
55830,during,0,0
55831,their,0,0
55832,inpatient,0,0
55833,stay,0,1
55834,(,0,0
55835,0.39,0,0
55836,cm,0,0
55837,",",0,0
55838,P,0,0
55839,=,0,0
55840,0.002,0,0
55841,),0,0
55842,and,0,0
55843,nonsignificantly,0,0
55844,favourable,0,0
55845,results,0,0
55846,for,0,0
55847,other,0,0
55848,anthropometric,1,1
55849,and,1,0
55850,laboratory,1,0
55851,measurements,1,0
55852,.,1,0
55853,CONCLUSION,0,0
55854,Dietetic,0,0
55855,or,0,0
55856,nutrition,0,0
55857,assistants,0,0
55858,are,0,0
55859,being,0,0
55860,introduced,0,0
55861,in,0,0
55862,units,0,0
55863,across,0,0
55864,the,0,0
55865,UK,0,0
55866,.,0,0
55867,This,0,0
55868,",",0,0
55869,the,0,0
55870,largest,0,0
55871,ever,0,0
55872,study,0,0
55873,of,0,0
55874,nutritional,0,1
55875,support,0,0
55876,after,0,0
55877,hip,0,1
55878,fracture,0,1
55879,",",0,0
55880,shows,0,0
55881,that,0,0
55882,their,0,0
55883,employment,0,0
55884,significantly,0,0
55885,reduced,0,0
55886,patients,1,0
55887,',1,0
55888,risk,1,1
55889,of,1,0
55890,dying,1,0
55891,in,0,0
55892,the,0,0
55893,acute,0,0
55894,trauma,0,0
55895,unit,0,0
55896,;,0,0
55897,an,0,0
55898,effect,0,0
55899,that,0,0
55900,persisted,0,0
55901,at,0,0
55902,4,0,0
55903,month,0,0
55904,follow-up,0,0
55905,.,0,0
55906,Pre-treatment,0,0
55907,proliferation,0,1
55908,and,0,0
55909,the,0,0
55910,outcome,0,1
55911,of,0,0
55912,conventional,0,0
55913,and,0,0
55914,accelerated,0,1
55915,radiotherapy,0,0
55916,.,0,0
55917,This,0,0
55918,study,0,0
55919,investigated,0,0
55920,the,0,0
55921,influence,0,0
55922,of,0,0
55923,pre-treatment,0,0
55924,proliferation,0,1
55925,characteristics,0,1
55926,",",0,0
55927,assessed,0,0
55928,by,0,0
55929,Ki-67,0,0
55930,staining,0,1
55931,",",0,0
55932,in,0,0
55933,patients,0,0
55934,treated,0,0
55935,in,0,0
55936,the,0,0
55937,CHART,0,0
55938,trial,0,0
55939,of,0,0
55940,accelerated,0,1
55941,radiotherapy,0,0
55942,in,0,0
55943,head,0,0
55944,and,0,1
55945,neck,0,1
55946,cancer,0,0
55947,.,0,0
55948,Histological,0,0
55949,material,0,0
55950,from,0,0
55951,402,0,0
55952,patients,0,0
55953,was,0,0
55954,collected,0,0
55955,and,0,0
55956,stained,0,0
55957,for,0,0
55958,the,0,0
55959,presence,0,0
55960,and,0,0
55961,pattern,0,0
55962,of,0,1
55963,Ki-67,0,0
55964,staining,0,1
55965,.,0,0
55966,Locoregional,1,0
55967,control,1,0
55968,and,0,1
55969,overall,0,1
55970,survival,0,1
55971,were,0,0
55972,the,0,0
55973,main,0,0
55974,clinical,0,0
55975,endpoints,0,1
55976,.,0,0
55977,Increasing,0,0
55978,Ki-67,0,0
55979,positivity,0,1
55980,was,0,0
55981,associated,0,0
55982,with,0,0
55983,decreasing,0,0
55984,differentiation,0,1
55985,(,0,0
55986,P,0,0
55987,<,0,0
55988,0.001,0,0
55989,),0,0
55990,and,0,0
55991,increasing,0,1
55992,N-stage,0,0
55993,(,0,0
55994,P,0,0
55995,<,0,0
55996,0.004,0,0
55997,),0,0
55998,.,0,0
55999,Increasing,0,0
56000,N-stage,0,0
56001,was,0,0
56002,also,0,0
56003,associated,0,0
56004,with,0,0
56005,the,0,0
56006,progression,0,1
56007,of,0,0
56008,proliferation,0,1
56009,pattern,0,0
56010,from,0,0
56011,marginal,0,0
56012,to,0,0
56013,random,0,0
56014,(,0,0
56015,P,0,0
56016,<,0,0
56017,0.001,0,0
56018,),0,0
56019,.,0,0
56020,Using,0,0
56021,a,0,0
56022,multivariate,0,0
56023,model,0,0
56024,",",0,0
56025,a,0,0
56026,trend,0,0
56027,was,0,0
56028,seen,0,0
56029,towards,0,0
56030,a,0,0
56031,greater,0,0
56032,benefit,0,0
56033,from,0,0
56034,CHART,0,0
56035,in,0,0
56036,the,0,0
56037,lower,0,0
56038,Ki-67,0,0
56039,tumours,0,1
56040,(,0,0
56041,P,0,0
56042,=,0,0
56043,0.08,0,0
56044,),0,0
56045,;,0,0
56046,this,0,0
56047,became,0,0
56048,significant,0,0
56049,by,0,0
56050,pooling,0,0
56051,the,0,0
56052,low,0,0
56053,and,0,0
56054,intermediate,0,0
56055,Ki-67,0,0
56056,groups,0,0
56057,in,0,0
56058,comparison,0,0
56059,with,0,0
56060,the,0,0
56061,high,0,0
56062,Ki-67,0,0
56063,group,0,0
56064,(,0,0
56065,P,0,0
56066,=,0,0
56067,0.032,0,0
56068,),0,0
56069,.,0,0
56070,Tumours,0,0
56071,with,0,0
56072,marginal,0,1
56073,proliferation,0,1
56074,pattern,0,0
56075,showed,0,0
56076,a,0,0
56077,lower,0,0
56078,hazard,0,1
56079,ratio,0,1
56080,with,0,0
56081,CHART,0,0
56082,versus,0,0
56083,conventional,0,0
56084,for,0,0
56085,locoregional,0,1
56086,control,0,0
56087,(,0,0
56088,P,0,0
56089,=,0,0
56090,0.005,0,0
56091,),0,0
56092,.,0,0
56093,The,0,0
56094,data,0,0
56095,presented,0,0
56096,in,0,0
56097,this,0,0
56098,study,0,0
56099,do,0,0
56100,not,0,0
56101,support,0,0
56102,that,0,0
56103,a,0,0
56104,high,0,0
56105,pre-treatment,0,0
56106,Ki-67,0,0
56107,is,0,0
56108,associated,0,0
56109,with,0,0
56110,a,0,0
56111,therapeutic,1,0
56112,benefit,1,0
56113,from,0,0
56114,accelerated,0,0
56115,radiotherapy,0,0
56116,.,0,0
56117,Does,0,0
56118,an,0,0
56119,educational,0,0
56120,leaflet,0,1
56121,improve,0,0
56122,self-reported,0,1
56123,adherence,1,0
56124,to,0,0
56125,therapy,0,0
56126,in,0,0
56127,osteoporosis,0,0
56128,?,0,0
56129,The,0,0
56130,OPTIMA,0,0
56131,study,0,0
56132,.,0,0
56133,INTRODUCTION,0,0
56134,Adherence,1,1
56135,to,0,0
56136,treatment,0,0
56137,in,0,0
56138,osteoporosis,0,0
56139,remains,0,0
56140,poor,0,0
56141,.,0,0
56142,The,0,0
56143,aim,0,0
56144,of,0,0
56145,this,0,0
56146,study,0,0
56147,was,0,0
56148,to,0,0
56149,evaluate,0,0
56150,the,0,0
56151,effects,0,0
56152,of,0,0
56153,an,0,0
56154,educational,0,0
56155,leaflet,0,1
56156,on,0,0
56157,adherence,1,1
56158,to,0,0
56159,medication,0,1
56160,and,0,0
56161,to,0,0
56162,assess,0,0
56163,the,0,0
56164,association,0,0
56165,between,0,0
56166,adherence,1,1
56167,and,0,0
56168,health-related,1,1
56169,quality,1,1
56170,of,1,0
56171,life,1,1
56172,(,1,0
56173,HRQOL,1,1
56174,),1,0
56175,.,0,0
56176,METHODS,0,0
56177,A,0,0
56178,naturalistic,0,0
56179,",",0,0
56180,observational,0,0
56181,",",0,0
56182,multi-center,0,0
56183,",",0,0
56184,prospective,0,0
56185,study,0,0
56186,of,0,0
56187,12,0,0
56188,months,0,0
56189,',0,0
56190,follow-up,0,0
56191,was,0,0
56192,performed,0,0
56193,.,0,0
56194,Consecutive,0,0
56195,post-menopausal,0,0
56196,women,0,0
56197,aged,0,0
56198,50,0,0
56199,years,0,0
56200,to,0,0
56201,86,0,0
56202,years,0,0
56203,starting,0,0
56204,treatment,0,0
56205,with,0,0
56206,raloxifene,0,0
56207,according,0,0
56208,to,0,0
56209,daily,0,0
56210,practice,0,0
56211,were,0,0
56212,enrolled,0,0
56213,from,0,0
56214,126,0,0
56215,primary,0,0
56216,care,0,0
56217,offices,0,0
56218,in,0,0
56219,Spain,0,0
56220,.,0,0
56221,The,0,0
56222,women,0,0
56223,were,0,0
56224,assigned,0,0
56225,to,0,0
56226,two,0,0
56227,study,0,0
56228,groups,0,0
56229,.,0,0
56230,Group,0,0
56231,A,0,0
56232,received,0,0
56233,an,0,0
56234,educational,0,0
56235,leaflet,0,1
56236,with,0,0
56237,general,0,0
56238,information,0,0
56239,about,0,0
56240,osteoporosis,0,0
56241,;,0,0
56242,group,0,0
56243,B,0,0
56244,followed,0,0
56245,current,0,0
56246,practice,0,0
56247,.,0,0
56248,To,0,0
56249,assess,0,0
56250,adherence,1,1
56251,to,1,0
56252,medication,1,1
56253,and,1,1
56254,HRQOL,1,1
56255,",",1,0
56256,the,1,0
56257,Morisky,1,1
56258,test,1,0
56259,and,1,0
56260,the,1,0
56261,EuroQoL,1,1
56262,questionnaire,1,1
56263,were,0,0
56264,administered,0,0
56265,.,0,0
56266,A,0,0
56267,total,0,0
56268,of,0,0
56269,745,0,0
56270,post-menopausal,0,0
56271,women,0,0
56272,(,0,0
56273,group,0,0
56274,A,0,0
56275,",",0,0
56276,n=366,0,0
56277,;,0,0
56278,group,0,0
56279,B,0,0
56280,n=379,0,0
56281,),0,0
56282,",",0,0
56283,with,0,0
56284,a,0,0
56285,mean,0,1
56286,age,0,0
56287,of,0,0
56288,62,0,0
56289,years,0,0
56290,",",0,0
56291,were,0,0
56292,included,0,0
56293,.,0,0
56294,RESULTS,0,0
56295,Most,0,0
56296,patients,0,0
56297,in,0,0
56298,both,0,0
56299,study,0,0
56300,groups,0,0
56301,showed,0,0
56302,high,0,0
56303,adherence,1,0
56304,to,0,0
56305,raloxifene,0,0
56306,at,0,0
56307,the,0,0
56308,3-month,0,0
56309,visit,0,0
56310,:,0,0
56311,56.3,0,0
56312,%,0,0
56313,vs,0,0
56314,62.7,0,0
56315,%,0,0
56316,for,0,0
56317,groups,0,0
56318,A,0,0
56319,and,0,1
56320,B,0,0
56321,",",0,0
56322,respectively,0,0
56323,;,0,0
56324,this,0,0
56325,proportion,0,0
56326,at,0,0
56327,the,0,0
56328,12-month,0,0
56329,visit,0,1
56330,was,0,0
56331,47.4,0,0
56332,%,0,0
56333,(,0,0
56334,P=0.15,0,0
56335,),0,0
56336,and,0,0
56337,52.5,0,0
56338,%,0,0
56339,(,0,0
56340,P=0.02,0,0
56341,),0,0
56342,",",0,0
56343,respectively,0,0
56344,.,0,0
56345,At,0,0
56346,baseline,0,0
56347,",",0,0
56348,pain/discomfort,1,1
56349,was,0,0
56350,the,0,0
56351,dimension,0,1
56352,showing,0,0
56353,the,0,0
56354,highest,0,0
56355,percentage,0,1
56356,of,0,0
56357,women,0,0
56358,reporting,0,0
56359,problems,0,0
56360,:,0,0
56361,86.4,0,0
56362,%,0,0
56363,vs,0,0
56364,83.2,0,0
56365,%,0,0
56366,in,0,0
56367,groups,0,0
56368,A,0,0
56369,and,0,1
56370,B,0,0
56371,",",0,0
56372,respectively,0,0
56373,(,0,0
56374,P=0.22,0,0
56375,),0,0
56376,.,0,0
56377,HRQOL,1,1
56378,improved,0,0
56379,in,0,0
56380,both,0,0
56381,groups,0,0
56382,throughout,0,0
56383,the,0,0
56384,study,0,0
56385,",",0,0
56386,with,0,0
56387,an,0,0
56388,overall,0,1
56389,mean,0,1
56390,increment,0,1
56391,in,0,0
56392,the,0,0
56393,EuroQoL,1,0
56394,visual,1,1
56395,analog,1,1
56396,scale,1,1
56397,(,1,0
56398,EQ,1,0
56399,VAS,1,1
56400,),1,0
56401,of,0,0
56402,9.2,0,0
56403,at,0,0
56404,12,0,0
56405,months,0,0
56406,(,0,0
56407,P,0,0
56408,<,0,0
56409,0.01,0,0
56410,),0,0
56411,.,0,0
56412,Correlations,0,0
56413,between,0,0
56414,adherence,1,1
56415,and,1,1
56416,HRQOL,1,1
56417,were,0,0
56418,weak,0,0
56419,.,0,0
56420,After,0,0
56421,receiving,0,0
56422,an,0,0
56423,educational,0,0
56424,leaflet,0,1
56425,",",0,0
56426,young,0,0
56427,post-menopausal,0,0
56428,women,0,0
56429,suffering,0,0
56430,osteoporosis,0,0
56431,did,0,0
56432,not,0,0
56433,show,0,0
56434,improvement,0,1
56435,in,0,0
56436,adherence,1,0
56437,to,1,0
56438,therapy,1,0
56439,.,1,0
56440,HRQOL,1,1
56441,improved,0,0
56442,at,0,0
56443,12-month,0,0
56444,follow-up,0,0
56445,under,0,0
56446,treatment,0,0
56447,.,0,0
56448,CONCLUSION,0,0
56449,No,0,0
56450,consistent,0,0
56451,correlation,0,0
56452,between,0,0
56453,adherence,1,1
56454,and,1,1
56455,HRQOL,1,1
56456,was,0,0
56457,found,0,0
56458,.,0,0
56459,Sham,0,0
56460,device,0,0
56461,v,0,0
56462,inert,0,0
56463,pill,0,0
56464,:,0,0
56465,randomised,0,0
56466,controlled,0,0
56467,trial,0,0
56468,of,0,0
56469,two,0,0
56470,placebo,0,0
56471,treatments,0,0
56472,.,0,0
56473,OBJECTIVE,0,0
56474,To,0,0
56475,investigate,0,0
56476,whether,0,0
56477,a,0,0
56478,sham,0,0
56479,device,0,0
56480,(,0,0
56481,a,0,0
56482,validated,0,0
56483,sham,0,0
56484,acupuncture,0,0
56485,needle,0,0
56486,),0,0
56487,has,0,0
56488,a,0,0
56489,greater,0,0
56490,placebo,0,0
56491,effect,0,1
56492,than,0,0
56493,an,0,0
56494,inert,0,0
56495,pill,0,0
56496,in,0,0
56497,patients,0,0
56498,with,0,0
56499,persistent,0,0
56500,arm,0,0
56501,pain,0,1
56502,.,0,0
56503,DESIGN,0,0
56504,A,0,0
56505,single,0,0
56506,blind,0,0
56507,randomised,0,0
56508,controlled,0,0
56509,trial,0,0
56510,created,0,0
56511,from,0,0
56512,the,0,0
56513,two,0,0
56514,week,0,0
56515,placebo,0,0
56516,run-in,0,0
56517,periods,0,0
56518,for,0,0
56519,two,0,0
56520,nested,0,0
56521,trials,0,0
56522,that,0,0
56523,compared,0,0
56524,acupuncture,0,0
56525,and,0,0
56526,amitriptyline,0,0
56527,with,0,0
56528,their,0,0
56529,respective,0,0
56530,placebo,0,0
56531,controls,0,0
56532,.,0,0
56533,Comparison,0,0
56534,of,0,0
56535,participants,0,0
56536,who,0,0
56537,remained,0,0
56538,on,0,0
56539,placebo,0,0
56540,continued,0,0
56541,beyond,0,0
56542,the,0,0
56543,run-in,0,0
56544,period,0,0
56545,to,0,0
56546,the,0,0
56547,end,0,0
56548,of,0,0
56549,the,0,0
56550,study,0,0
56551,.,0,0
56552,SETTING,0,0
56553,Academic,0,1
56554,medical,0,0
56555,centre,0,0
56556,.,0,0
56557,PARTICIPANTS,0,0
56558,270,0,0
56559,adults,0,0
56560,with,0,0
56561,arm,0,0
56562,pain,0,1
56563,due,0,0
56564,to,0,0
56565,repetitive,0,0
56566,use,0,0
56567,that,0,0
56568,had,0,0
56569,lasted,0,0
56570,at,0,0
56571,least,0,0
56572,three,0,0
56573,months,0,0
56574,despite,0,0
56575,treatment,0,0
56576,and,0,0
56577,who,0,0
56578,scored,0,1
56579,>,0,0
56580,or,0,0
56581,=3,0,0
56582,on,0,0
56583,a,0,0
56584,10,0,0
56585,point,0,0
56586,pain,0,1
56587,scale,0,1
56588,.,0,0
56589,INTERVENTIONS,0,1
56590,Acupuncture,0,0
56591,with,0,0
56592,sham,0,0
56593,device,0,0
56594,twice,0,0
56595,a,0,0
56596,week,0,0
56597,for,0,0
56598,six,0,0
56599,weeks,0,0
56600,or,0,0
56601,placebo,0,0
56602,pill,0,0
56603,once,0,0
56604,a,0,0
56605,day,0,0
56606,for,0,0
56607,eight,0,0
56608,weeks,0,0
56609,.,0,0
56610,MAIN,0,0
56611,OUTCOME,0,0
56612,MEASURES,0,0
56613,Arm,1,1
56614,pain,1,1
56615,measured,0,0
56616,on,0,0
56617,a,0,0
56618,10,1,0
56619,point,1,0
56620,pain,1,1
56621,scale,1,1
56622,.,1,0
56623,Secondary,1,0
56624,outcomes,1,1
56625,were,1,0
56626,symptoms,1,1
56627,measured,1,0
56628,by,1,0
56629,the,1,0
56630,Levine,1,0
56631,symptom,1,1
56632,severity,1,1
56633,scale,1,1
56634,",",1,0
56635,function,1,1
56636,measured,1,1
56637,by,1,0
56638,Pransky,1,0
56639,'s,1,0
56640,upper,1,0
56641,extremity,1,0
56642,function,1,1
56643,scale,1,1
56644,",",1,0
56645,and,1,1
56646,grip,1,1
56647,strength,1,1
56648,.,1,0
56649,RESULTS,0,0
56650,Pain,1,1
56651,decreased,0,0
56652,during,0,0
56653,the,0,0
56654,two,0,0
56655,week,0,0
56656,placebo,0,0
56657,run-in,0,0
56658,period,0,0
56659,in,0,0
56660,both,0,0
56661,the,0,0
56662,sham,0,0
56663,device,0,0
56664,and,0,1
56665,placebo,0,0
56666,pill,0,0
56667,groups,0,0
56668,",",0,0
56669,but,0,0
56670,changes,0,1
56671,were,0,0
56672,not,0,0
56673,different,0,0
56674,between,0,0
56675,the,0,0
56676,groups,0,0
56677,(,0,0
56678,-0.14,0,0
56679,",",0,0
56680,95,0,0
56681,%,0,0
56682,confidence,0,0
56683,interval,0,0
56684,-0.52,0,0
56685,to,0,0
56686,0.25,0,0
56687,",",0,0
56688,P,0,0
56689,=,0,0
56690,0.49,0,0
56691,),0,0
56692,.,0,0
56693,Changes,0,1
56694,in,0,0
56695,severity,1,1
56696,scores,1,1
56697,for,1,0
56698,arm,1,0
56699,symptoms,1,1
56700,and,1,1
56701,grip,1,1
56702,strength,1,1
56703,were,0,0
56704,similar,0,0
56705,between,0,0
56706,groups,0,0
56707,",",0,0
56708,but,0,0
56709,arm,0,0
56710,function,0,1
56711,improved,0,0
56712,more,0,0
56713,in,0,0
56714,the,0,0
56715,placebo,0,0
56716,pill,0,0
56717,group,0,0
56718,(,0,0
56719,2.0,0,0
56720,",",0,0
56721,0.06,0,0
56722,to,0,0
56723,3.92,0,0
56724,",",0,0
56725,P,0,0
56726,=,0,0
56727,0.04,0,0
56728,),0,0
56729,.,0,0
56730,Longitudinal,0,0
56731,regression,0,0
56732,analyses,0,0
56733,that,0,0
56734,followed,0,0
56735,participants,0,0
56736,throughout,0,0
56737,the,0,0
56738,treatment,0,0
56739,period,0,0
56740,showed,0,0
56741,significantly,0,0
56742,greater,0,0
56743,downward,0,1
56744,slopes,0,1
56745,per,0,0
56746,week,0,0
56747,on,0,0
56748,the,0,0
56749,10,1,0
56750,point,1,0
56751,arm,1,0
56752,pain,1,1
56753,scale,1,1
56754,in,0,0
56755,the,0,0
56756,sham,0,0
56757,device,0,0
56758,group,0,0
56759,than,0,0
56760,in,0,0
56761,the,0,0
56762,placebo,0,0
56763,pill,0,0
56764,group,0,0
56765,(,0,0
56766,-0.33,0,0
56767,(,0,0
56768,-0.40,0,0
56769,to,0,0
56770,-0.26,0,0
56771,),0,0
56772,v,0,0
56773,-0.15,0,0
56774,(,0,0
56775,-0.21,0,0
56776,to,0,0
56777,-0.09,0,0
56778,),0,0
56779,",",0,0
56780,P,0,0
56781,=,0,0
56782,0.0001,0,0
56783,),0,0
56784,and,0,0
56785,on,0,0
56786,the,0,0
56787,symptom,0,1
56788,severity,0,1
56789,scale,0,1
56790,(,0,0
56791,-0.07,0,0
56792,(,0,0
56793,-0.09,0,0
56794,to,0,0
56795,-0.05,0,0
56796,),0,0
56797,v,0,0
56798,-0.05,0,0
56799,(,0,0
56800,-0.06,0,0
56801,to,0,0
56802,-0.03,0,0
56803,),0,0
56804,",",0,0
56805,P,0,0
56806,=,0,0
56807,0.02,0,0
56808,),0,0
56809,.,0,0
56810,Differences,0,0
56811,were,0,0
56812,not,0,0
56813,significant,0,0
56814,",",0,0
56815,however,0,0
56816,",",0,0
56817,on,0,0
56818,the,0,0
56819,function,0,1
56820,scale,0,1
56821,or,0,0
56822,for,0,0
56823,grip,0,1
56824,strength,0,1
56825,.,0,0
56826,Reported,0,0
56827,adverse,0,1
56828,effects,0,0
56829,were,0,0
56830,different,0,0
56831,in,0,0
56832,the,0,0
56833,two,0,0
56834,groups,0,0
56835,.,0,0
56836,CONCLUSIONS,0,0
56837,The,0,0
56838,sham,0,0
56839,device,0,0
56840,had,0,0
56841,greater,0,0
56842,effects,0,1
56843,than,0,0
56844,the,0,0
56845,placebo,0,0
56846,pill,0,0
56847,on,0,0
56848,self,0,1
56849,reported,0,0
56850,pain,0,1
56851,and,0,0
56852,severity,0,1
56853,of,0,1
56854,symptoms,0,1
56855,over,0,0
56856,the,0,0
56857,entire,0,0
56858,course,0,0
56859,of,0,0
56860,treatment,0,0
56861,but,0,0
56862,not,0,0
56863,during,0,0
56864,the,0,0
56865,two,0,0
56866,week,0,0
56867,placebo,0,0
56868,run,0,0
56869,in,0,0
56870,.,0,0
56871,Placebo,0,0
56872,effects,0,0
56873,seem,0,0
56874,to,0,0
56875,be,0,0
56876,malleable,0,0
56877,and,0,0
56878,depend,0,0
56879,on,0,0
56880,the,0,0
56881,behaviours,0,1
56882,embedded,0,0
56883,in,0,0
56884,medical,0,0
56885,rituals,0,0
56886,.,0,0
56887,Efficacy,1,1
56888,and,1,0
56889,safety,1,1
56890,of,0,1
56891,oral,0,0
56892,conivaptan,0,0
56893,:,0,0
56894,a,0,0
56895,V1A/V2,0,0
56896,vasopressin,0,0
56897,receptor,0,1
56898,antagonist,0,0
56899,",",0,0
56900,assessed,0,0
56901,in,0,0
56902,a,0,0
56903,randomized,0,0
56904,",",0,0
56905,placebo-controlled,0,0
56906,trial,0,0
56907,in,0,0
56908,patients,0,0
56909,with,0,0
56910,euvolemic,0,1
56911,or,0,0
56912,hypervolemic,0,0
56913,hyponatremia,0,1
56914,.,0,0
56915,CONTEXT,0,0
56916,Hyponatremia,0,1
56917,[,0,0
56918,serum,0,1
56919,sodium,0,0
56920,concentration,0,1
56921,(,0,0
56922,[,0,0
56923,Na,0,1
56924,(,0,0
56925,+,0,0
56926,),0,1
56927,],0,0
56928,),0,0
56929,",",0,0
56930,<,0,0
56931,135,0,0
56932,mEq/liter,0,0
56933,],0,0
56934,is,0,0
56935,the,0,0
56936,most,0,0
56937,common,0,0
56938,fluid,0,1
56939,and,0,0
56940,electrolyte,0,1
56941,abnormality,0,0
56942,among,0,0
56943,hospitalized,0,0
56944,patients,0,0
56945,.,0,0
56946,It,0,0
56947,is,0,0
56948,frequently,0,0
56949,caused,0,0
56950,by,0,0
56951,the,0,0
56952,inappropriate,0,0
56953,release,0,1
56954,of,0,0
56955,arginine,0,0
56956,vasopressin,0,0
56957,.,0,0
56958,OBJECTIVE,0,0
56959,The,0,0
56960,objective,0,0
56961,of,0,0
56962,this,0,0
56963,study,0,0
56964,was,0,0
56965,to,0,0
56966,evaluate,0,0
56967,the,0,0
56968,efficacy,1,1
56969,and,1,0
56970,safety,1,1
56971,of,0,1
56972,oral,0,0
56973,conivaptan,0,0
56974,",",0,0
56975,a,0,0
56976,vasopressin,0,0
56977,V,0,0
56978,(,0,0
56979,1A,0,0
56980,),0,0
56981,/V,0,0
56982,(,0,0
56983,2,0,0
56984,),0,0
56985,receptor,0,0
56986,antagonist,0,0
56987,",",0,0
56988,in,0,0
56989,patients,0,0
56990,with,0,0
56991,euvolemic,0,1
56992,or,0,0
56993,hypervolemic,0,0
56994,hyponatremia,0,0
56995,.,0,0
56996,DESIGN,0,0
56997,The,0,0
56998,study,0,0
56999,design,0,0
57000,was,0,0
57001,a,0,0
57002,5-d,0,0
57003,placebo-controlled,0,0
57004,",",0,0
57005,randomized,0,0
57006,",",0,0
57007,double-blind,0,0
57008,study,0,0
57009,.,0,0
57010,SETTING,0,0
57011,The,0,0
57012,study,0,0
57013,was,0,0
57014,performed,0,0
57015,at,0,0
57016,a,0,0
57017,hospital,0,0
57018,.,0,0
57019,INTERVENTION,0,1
57020,Oral,0,1
57021,conivaptan,0,0
57022,(,0,0
57023,40,0,0
57024,or,0,0
57025,80,0,0
57026,mg/d,0,0
57027,),0,0
57028,or,0,0
57029,placebo,0,0
57030,was,0,0
57031,given,0,0
57032,in,0,0
57033,two,0,0
57034,divided,0,0
57035,doses,0,0
57036,.,0,0
57037,PATIENTS,0,0
57038,Seventy-four,0,0
57039,patients,0,0
57040,(,0,0
57041,average,0,1
57042,baseline,0,0
57043,serum,0,1
57044,[,0,0
57045,Na,0,1
57046,(,0,0
57047,+,0,0
57048,),0,1
57049,],0,0
57050,",",0,0
57051,115,0,0
57052,to,0,0
57053,<,0,0
57054,130,0,0
57055,mEq/liter,0,0
57056,),0,0
57057,were,0,0
57058,studied,0,0
57059,.,0,0
57060,MAIN,0,0
57061,OUTCOME,0,0
57062,MEASURE,0,0
57063,The,0,0
57064,main,0,0
57065,outcome,0,1
57066,measure,0,0
57067,was,1,0
57068,the,1,0
57069,change,1,0
57070,from,1,0
57071,baseline,1,0
57072,in,1,0
57073,serum,1,1
57074,[,1,0
57075,Na,1,1
57076,(,1,0
57077,+,1,0
57078,),1,0
57079,],1,0
57080,area,1,0
57081,under,1,0
57082,the,1,0
57083,curve,1,1
57084,.,1,0
57085,RESULTS,0,0
57086,The,0,0
57087,least-squares,0,0
57088,mean,1,1
57089,change,0,0
57090,from,0,0
57091,baseline,0,0
57092,in,0,0
57093,the,0,0
57094,serum,0,1
57095,[,0,0
57096,Na,0,1
57097,(,0,0
57098,+,0,0
57099,),0,0
57100,],0,0
57101,area,0,0
57102,under,0,0
57103,the,0,0
57104,curve,0,1
57105,with,0,0
57106,conivaptan,0,0
57107,(,0,0
57108,40,0,0
57109,and,0,0
57110,80,0,0
57111,mg/d,0,0
57112,),0,0
57113,was,0,0
57114,2.0-fold,0,0
57115,(,0,0
57116,P,0,0
57117,=,0,0
57118,0.03,0,0
57119,),0,0
57120,and,0,0
57121,2.5-fold,0,1
57122,(,0,0
57123,P,0,0
57124,<,0,0
57125,0.001,0,0
57126,),0,0
57127,greater,0,0
57128,",",0,0
57129,respectively,0,0
57130,",",0,0
57131,than,0,0
57132,that,0,0
57133,with,0,0
57134,placebo,0,0
57135,.,0,0
57136,The,0,0
57137,median,0,0
57138,time,0,1
57139,to,0,0
57140,achieve,0,0
57141,a,0,0
57142,confirmed,0,0
57143,increase,0,0
57144,in,0,0
57145,serum,1,1
57146,[,0,0
57147,Na,0,1
57148,(,0,0
57149,+,0,0
57150,),0,0
57151,],0,0
57152,of,0,0
57153,4,0,0
57154,mEq/liter,0,0
57155,or,0,0
57156,more,0,0
57157,from,0,0
57158,baseline,0,0
57159,was,0,0
57160,71.7,0,0
57161,h,0,0
57162,for,0,0
57163,placebo,0,0
57164,",",0,0
57165,27.5,0,0
57166,h,0,0
57167,for,0,0
57168,40,0,0
57169,mg/d,0,0
57170,conivaptan,0,0
57171,(,0,0
57172,P,0,0
57173,=,0,0
57174,0.044,0,0
57175,),0,0
57176,",",0,0
57177,and,0,0
57178,12.1,0,0
57179,h,0,0
57180,for,0,0
57181,80,0,0
57182,mg/d,0,0
57183,conivaptan,0,0
57184,(,0,0
57185,P,0,0
57186,=,0,0
57187,0.002,0,0
57188,),0,0
57189,.,0,0
57190,The,0,0
57191,mean,0,1
57192,total,0,1
57193,times,0,1
57194,during,0,0
57195,which,0,0
57196,patients,0,0
57197,had,0,0
57198,a,0,0
57199,serum,1,1
57200,[,1,0
57201,Na,1,1
57202,(,1,0
57203,+,1,0
57204,),1,0
57205,],1,0
57206,level,0,1
57207,of,0,0
57208,4,0,0
57209,mEq/liter,0,0
57210,or,0,0
57211,more,0,0
57212,above,0,1
57213,baseline,0,0
57214,were,0,0
57215,46.5,0,0
57216,",",0,0
57217,69.8,0,0
57218,",",0,0
57219,and,0,0
57220,88.8,0,0
57221,h,0,0
57222,(,0,0
57223,P,0,0
57224,=,0,0
57225,0.001,0,0
57226,),0,0
57227,",",0,0
57228,respectively,0,0
57229,.,0,0
57230,The,0,0
57231,least-squares,0,0
57232,mean,1,1
57233,change,1,1
57234,in,1,0
57235,serum,1,1
57236,[,1,0
57237,Na,1,1
57238,(,1,0
57239,+,1,0
57240,),1,0
57241,],1,0
57242,from,0,0
57243,baseline,0,0
57244,to,0,0
57245,end,0,0
57246,of,0,0
57247,treatment,0,0
57248,was,0,0
57249,3.4,0,0
57250,mEq/liter,0,0
57251,for,0,0
57252,placebo,0,0
57253,",",0,0
57254,6.4,0,0
57255,mEq/liter,0,0
57256,for,0,0
57257,40,0,0
57258,mg/d,0,0
57259,conivaptan,0,0
57260,",",0,0
57261,and,0,0
57262,8.2,0,0
57263,mEq/liter,0,0
57264,for,0,0
57265,80,0,0
57266,mg/d,0,0
57267,conivaptan,0,0
57268,(,0,0
57269,P,0,0
57270,=,0,0
57271,0.002,0,0
57272,),0,0
57273,.,0,0
57274,A,0,0
57275,confirmed,0,0
57276,normal,1,0
57277,serum,1,1
57278,[,1,0
57279,Na,1,1
57280,(,1,0
57281,+,1,0
57282,),1,1
57283,],1,0
57284,(,0,0
57285,>,0,0
57286,/=135,0,0
57287,mEq/liter,0,1
57288,),0,0
57289,or,0,0
57290,increase,0,0
57291,of,0,0
57292,6,0,0
57293,mEq/liter,0,0
57294,or,0,0
57295,more,0,0
57296,was,0,0
57297,observed,0,0
57298,in,0,0
57299,48,0,0
57300,%,0,0
57301,of,0,0
57302,patients,0,0
57303,given,0,0
57304,placebo,0,0
57305,",",0,0
57306,71,0,0
57307,%,0,0
57308,given,0,0
57309,40,0,0
57310,mg/d,0,0
57311,conivaptan,0,0
57312,",",0,0
57313,and,0,0
57314,82,0,0
57315,%,0,0
57316,given,0,0
57317,80,0,0
57318,mg/d,0,0
57319,conivaptan,0,0
57320,(,0,0
57321,P,0,0
57322,=,0,0
57323,0.014,0,0
57324,),0,0
57325,.,0,0
57326,Headache,1,1
57327,",",1,0
57328,hypotension,1,1
57329,",",1,1
57330,nausea,1,1
57331,",",1,1
57332,constipation,1,1
57333,",",1,1
57334,and,1,1
57335,postural,1,1
57336,hypotension,1,1
57337,were,0,0
57338,the,0,0
57339,most,0,0
57340,common,0,0
57341,adverse,0,1
57342,events,0,1
57343,.,0,0
57344,CONCLUSION,0,0
57345,Oral,0,1
57346,conivaptan,0,0
57347,(,0,0
57348,40,0,0
57349,and,0,0
57350,80,0,0
57351,mg/d,0,0
57352,),0,0
57353,was,0,0
57354,well,0,0
57355,tolerated,0,1
57356,and,0,0
57357,efficacious,0,0
57358,in,0,0
57359,correcting,0,0
57360,serum,0,1
57361,[,0,0
57362,Na,0,1
57363,(,0,0
57364,+,0,0
57365,),0,0
57366,],0,0
57367,in,0,0
57368,hyponatremia,0,0
57369,.,0,0
57370,Etanercept,0,0
57371,treatment,0,0
57372,in,0,0
57373,adults,0,0
57374,with,0,0
57375,established,0,0
57376,rheumatoid,0,0
57377,arthritis,0,0
57378,:,0,0
57379,7,0,0
57380,years,0,0
57381,of,0,0
57382,clinical,0,0
57383,experience,0,0
57384,.,0,0
57385,OBJECTIVE,0,0
57386,To,0,0
57387,evaluate,0,0
57388,safety,1,1
57389,and,1,1
57390,efficacy,1,1
57391,of,0,1
57392,longterm,0,0
57393,etanercept,0,0
57394,treatment,0,0
57395,in,0,0
57396,patients,0,0
57397,with,0,0
57398,disease,0,0
57399,modifying,0,0
57400,antirheumatic,0,0
57401,drug,0,0
57402,(,0,0
57403,DMARD,0,0
57404,),0,0
57405,refractory,0,0
57406,rheumatoid,0,1
57407,arthritis,0,0
57408,(,0,0
57409,RA,0,0
57410,),0,0
57411,.,0,0
57412,METHODS,0,0
57413,Safety,0,1
57414,results,0,0
57415,are,0,0
57416,reported,0,0
57417,for,0,0
57418,714,0,0
57419,patients,0,0
57420,who,0,0
57421,received,0,0
57422,etanercept,0,0
57423,in,0,0
57424,one,0,0
57425,of,0,0
57426,7,0,0
57427,initial,0,0
57428,trials,0,0
57429,or,0,0
57430,a,0,0
57431,longterm,0,0
57432,extension,0,0
57433,.,0,0
57434,Efficacy,0,0
57435,results,0,0
57436,are,0,0
57437,reported,0,0
57438,for,0,0
57439,581,0,0
57440,patients,0,0
57441,who,0,0
57442,enrolled,0,0
57443,in,0,0
57444,the,0,0
57445,extension,0,0
57446,.,0,0
57447,RESULTS,0,0
57448,Of,0,0
57449,the,0,0
57450,714,0,0
57451,patients,0,0
57452,enrolled,0,0
57453,in,0,0
57454,the,0,0
57455,initial,0,0
57456,trials,0,0
57457,",",0,0
57458,581,0,0
57459,(,0,0
57460,81,0,0
57461,%,0,0
57462,),0,0
57463,enrolled,0,0
57464,in,0,0
57465,the,0,0
57466,extension,0,0
57467,",",0,0
57468,and,0,0
57469,388,0,0
57470,(,0,0
57471,54,0,0
57472,%,0,0
57473,),0,0
57474,patients,0,0
57475,are,0,0
57476,continuing,0,0
57477,to,0,0
57478,receive,0,0
57479,etanercept,0,0
57480,therapy,0,0
57481,.,0,0
57482,The,0,0
57483,longest,0,0
57484,individual,0,0
57485,treatment,0,0
57486,was,0,0
57487,8.2,0,0
57488,years,0,0
57489,",",0,0
57490,with,0,0
57491,3139,0,0
57492,total,0,0
57493,patient-years,0,0
57494,of,0,0
57495,etanercept,0,0
57496,exposure,0,0
57497,.,0,0
57498,Rates,1,0
57499,of,1,0
57500,serious,1,1
57501,adverse,1,1
57502,events,1,1
57503,(,0,0
57504,overall,0,1
57505,rate=14.8,0,0
57506,events/100,0,0
57507,patient-yrs,0,0
57508,),0,0
57509,",",0,0
57510,serious,1,1
57511,infections,1,1
57512,(,0,0
57513,overall,0,1
57514,rate=4.2,0,0
57515,events/100,0,0
57516,patient-yrs,0,0
57517,),0,0
57518,",",0,0
57519,cancer,1,0
57520,(,0,0
57521,overall,0,1
57522,rate=1.0,0,1
57523,events/100,0,0
57524,patient-yrs,0,0
57525,),0,0
57526,",",0,0
57527,and,1,1
57528,deaths,1,1
57529,(,0,0
57530,overall,0,1
57531,rate=0.7,0,0
57532,events/100,0,0
57533,patient-yrs,0,0
57534,),0,0
57535,were,0,0
57536,stable,0,0
57537,each,0,0
57538,year,0,0
57539,",",0,0
57540,through,0,0
57541,8,0,0
57542,years,0,0
57543,of,0,0
57544,etanercept,0,0
57545,exposure,0,0
57546,.,0,0
57547,For,0,0
57548,356,0,0
57549,patients,0,0
57550,who,0,0
57551,completed,0,0
57552,6,0,0
57553,years,0,0
57554,of,0,0
57555,etanercept,0,0
57556,treatment,0,0
57557,",",0,0
57558,response,1,1
57559,rates,1,1
57560,were,0,0
57561,ACR20=73,0,0
57562,%,0,0
57563,",",0,0
57564,ACR50=52,0,1
57565,%,0,0
57566,",",0,0
57567,ACR70=27,0,1
57568,%,0,0
57569,",",0,0
57570,DAS28,0,1
57571,CRP,0,1
57572,good,0,0
57573,response=52,0,1
57574,%,0,0
57575,",",0,0
57576,and,0,1
57577,DAS28,0,1
57578,CRP,0,1
57579,remission=37,0,0
57580,%,0,0
57581,of,0,0
57582,patients,0,0
57583,.,0,0
57584,Similar,0,0
57585,responses,0,1
57586,occurred,0,0
57587,in,0,0
57588,167,0,0
57589,patients,0,0
57590,who,0,0
57591,completed,0,0
57592,Year,0,0
57593,7,0,0
57594,.,0,0
57595,Doses,1,0
57596,of,0,0
57597,concomitant,0,0
57598,methotrexate,0,0
57599,or,0,0
57600,corticosteroids,0,0
57601,were,0,0
57602,reduced,0,0
57603,in,0,0
57604,many,0,0
57605,patients,0,0
57606,who,0,0
57607,maintained,0,0
57608,clinical,0,0
57609,responses,0,1
57610,.,0,0
57611,CONCLUSION,0,0
57612,The,0,0
57613,safety,1,1
57614,profile,1,1
57615,of,0,1
57616,etanercept,0,0
57617,was,0,0
57618,consistent,0,0
57619,over,0,0
57620,time,0,1
57621,",",0,0
57622,with,0,0
57623,rates,1,1
57624,of,1,0
57625,adverse,1,1
57626,events,1,1
57627,similar,0,0
57628,to,0,0
57629,those,0,0
57630,reported,0,0
57631,for,0,0
57632,patients,0,0
57633,with,0,0
57634,RA,0,0
57635,in,0,0
57636,general,0,0
57637,.,0,0
57638,Durable,0,0
57639,clinical,0,0
57640,responses,0,1
57641,were,0,0
57642,observed,0,0
57643,in,0,0
57644,some,0,0
57645,patients,0,0
57646,for,0,0
57647,7,0,0
57648,years,0,0
57649,or,0,0
57650,more,0,0
57651,.,0,0
57652,The,0,0
57653,benefit-to-risk,0,0
57654,ratio,0,1
57655,for,0,0
57656,longterm,0,0
57657,etanercept,0,0
57658,treatment,0,0
57659,remains,0,0
57660,highly,0,0
57661,favorable,0,0
57662,.,0,0
57663,Evaluation,0,0
57664,of,0,0
57665,nonpharmacologic,0,0
57666,methods,0,0
57667,of,0,0
57668,pain,0,1
57669,and,0,1
57670,anxiety,0,1
57671,management,0,0
57672,for,0,0
57673,laceration,0,1
57674,repair,0,0
57675,in,0,0
57676,the,0,0
57677,pediatric,0,0
57678,emergency,0,0
57679,department,0,0
57680,.,0,0
57681,BACKGROUND,0,0
57682,Nonpharmacologic,0,0
57683,interventions,0,0
57684,",",0,0
57685,such,0,0
57686,as,0,0
57687,distraction,0,0
57688,",",0,0
57689,have,0,0
57690,been,0,0
57691,shown,0,0
57692,to,0,0
57693,be,0,0
57694,powerful,0,0
57695,adjuncts,0,0
57696,in,0,0
57697,reducing,0,0
57698,pain,0,1
57699,and,0,1
57700,anxiety,0,1
57701,in,0,0
57702,children,0,0
57703,with,0,0
57704,both,0,0
57705,acute,0,0
57706,and,0,0
57707,chronic,0,0
57708,painful,0,0
57709,conditions,0,0
57710,.,0,0
57711,There,0,0
57712,are,0,0
57713,no,0,0
57714,controlled,0,0
57715,studies,0,0
57716,evaluating,0,0
57717,these,0,0
57718,interventions,0,0
57719,as,0,0
57720,adjuncts,0,0
57721,to,0,0
57722,facilitate,0,0
57723,completion,0,0
57724,of,0,0
57725,painful,0,1
57726,procedures,0,0
57727,in,0,0
57728,the,0,0
57729,pediatric,0,0
57730,emergency,0,1
57731,department,0,0
57732,(,0,0
57733,ED,0,0
57734,),0,0
57735,.,0,0
57736,OBJECTIVE,0,0
57737,We,0,0
57738,assessed,0,0
57739,the,0,0
57740,effectiveness,0,1
57741,of,0,0
57742,distraction,0,0
57743,techniques,0,0
57744,in,0,0
57745,reducing,0,0
57746,the,0,0
57747,sensory,0,1
57748,and,0,0
57749,affective,0,1
57750,components,0,1
57751,of,0,0
57752,pain,0,1
57753,among,0,0
57754,pediatric,0,0
57755,patients,0,0
57756,undergoing,0,0
57757,laceration,0,1
57758,repair,0,0
57759,in,0,0
57760,the,0,0
57761,ED,0,0
57762,.,0,0
57763,METHODS,0,0
57764,Eligible,0,0
57765,children,0,0
57766,between,0,0
57767,6,0,0
57768,and,0,0
57769,18,0,0
57770,years,0,0
57771,of,0,0
57772,age,0,0
57773,(,0,0
57774,N,0,0
57775,=,0,0
57776,240,0,0
57777,),0,0
57778,presenting,0,0
57779,to,0,0
57780,the,0,0
57781,ED,0,0
57782,for,0,0
57783,laceration,0,1
57784,repair,0,0
57785,were,0,0
57786,randomly,0,0
57787,assigned,0,0
57788,to,0,0
57789,an,0,0
57790,intervention,0,0
57791,or,0,0
57792,control,0,0
57793,arm,0,0
57794,.,0,0
57795,Those,0,0
57796,assigned,0,0
57797,to,0,0
57798,the,0,0
57799,intervention,0,0
57800,arm,0,0
57801,were,0,0
57802,given,0,0
57803,a,0,0
57804,choice,0,0
57805,of,0,0
57806,age-appropriate,0,0
57807,distracters,0,1
57808,during,0,0
57809,laceration,0,1
57810,repair,0,0
57811,.,0,0
57812,Quantitative,0,0
57813,measures,0,1
57814,of,0,0
57815,pain,1,1
57816,intensity,1,1
57817,",",1,0
57818,situational,1,1
57819,anxiety,1,1
57820,",",1,0
57821,and,1,1
57822,pain,1,1
57823,distress,1,1
57824,(,1,0
57825,as,1,0
57826,perceived,1,0
57827,by,1,0
57828,the,1,0
57829,parent,1,0
57830,),1,0
57831,were,0,0
57832,assessed,0,0
57833,by,0,0
57834,using,0,0
57835,the,0,0
57836,7-point,1,1
57837,Facial,1,0
57838,Pain,1,1
57839,Scale,1,1
57840,",",1,0
57841,State,1,1
57842,Trait,1,1
57843,Anxiety,1,1
57844,Inventory,1,1
57845,for,0,0
57846,Children,0,0
57847,",",0,0
57848,and,0,0
57849,a,0,0
57850,visual,1,1
57851,analog,1,1
57852,scale,1,1
57853,",",0,0
57854,respectively,0,0
57855,",",0,0
57856,before,0,0
57857,and,0,0
57858,after,0,0
57859,laceration,0,1
57860,repair,0,0
57861,.,0,0
57862,The,0,0
57863,State,1,1
57864,Trait,1,1
57865,Anxiety,1,1
57866,Inventory,1,1
57867,for,0,0
57868,Children,0,0
57869,was,0,0
57870,performed,0,0
57871,in,0,0
57872,children,0,0
57873,>,0,0
57874,or,0,0
57875,=,0,0
57876,10,0,0
57877,years,0,0
57878,of,0,0
57879,age,0,0
57880,.,0,0
57881,RESULTS,0,0
57882,There,0,0
57883,was,0,0
57884,no,0,0
57885,difference,0,0
57886,in,0,0
57887,mean,1,1
57888,change,1,0
57889,in,1,0
57890,Facial,1,0
57891,Pain,1,1
57892,Scale,1,1
57893,scores,0,1
57894,between,0,0
57895,the,0,0
57896,control,0,0
57897,and,0,0
57898,the,0,0
57899,intervention,0,0
57900,groups,0,0
57901,in,0,0
57902,children,0,0
57903,<,0,0
57904,10,0,0
57905,years,0,0
57906,of,0,0
57907,age,0,0
57908,.,0,0
57909,Multivariate,0,0
57910,analysis,0,0
57911,in,0,0
57912,this,0,0
57913,same,0,0
57914,age,0,0
57915,group,0,0
57916,showed,0,0
57917,that,0,0
57918,the,0,0
57919,intervention,0,0
57920,was,0,0
57921,independently,0,0
57922,associated,0,0
57923,with,0,0
57924,a,0,0
57925,reduction,1,1
57926,in,1,0
57927,pain,1,1
57928,distress,1,1
57929,as,0,0
57930,perceived,0,0
57931,by,0,0
57932,parents,0,0
57933,based,0,0
57934,on,0,0
57935,the,0,0
57936,mean,0,1
57937,change,0,0
57938,in,0,0
57939,visual,0,1
57940,analog,0,1
57941,scale,0,1
57942,scores,0,1
57943,.,0,0
57944,In,0,0
57945,older,0,0
57946,children,0,0
57947,",",0,0
57948,the,0,0
57949,intervention,0,0
57950,was,0,0
57951,independently,0,0
57952,associated,0,0
57953,with,0,0
57954,reduction,0,0
57955,in,0,0
57956,situational,1,1
57957,anxiety,1,1
57958,but,0,0
57959,not,0,0
57960,in,0,0
57961,pain,1,1
57962,intensity,1,1
57963,or,1,0
57964,in,1,0
57965,parental,1,1
57966,perception,1,1
57967,of,0,0
57968,pain,0,1
57969,distress,0,1
57970,.,0,0
57971,CONCLUSIONS,0,0
57972,The,0,0
57973,use,0,0
57974,of,0,0
57975,distraction,0,0
57976,techniques,0,0
57977,is,0,0
57978,effective,0,0
57979,in,0,0
57980,reducing,0,0
57981,situational,0,1
57982,anxiety,0,1
57983,in,0,0
57984,older,0,0
57985,children,0,0
57986,and,0,1
57987,lowering,0,1
57988,parental,0,1
57989,perception,0,1
57990,of,0,0
57991,pain,0,1
57992,distress,0,1
57993,in,0,0
57994,younger,0,0
57995,children,0,0
57996,.,0,0
57997,This,0,0
57998,technique,0,0
57999,may,0,0
58000,have,0,0
58001,a,0,0
58002,role,0,0
58003,in,0,0
58004,improving,0,0
58005,the,0,0
58006,quality,0,1
58007,of,0,0
58008,management,0,0
58009,of,0,0
58010,procedural,0,1
58011,pain,0,1
58012,in,0,0
58013,a,0,0
58014,pediatric,0,0
58015,ED,0,0
58016,setting,0,0
58017,.,0,0
58018,A,0,0
58019,randomized,0,0
58020,trial,0,0
58021,of,0,0
58022,an,0,0
58023,interim,0,0
58024,methadone,0,0
58025,maintenance,0,0
58026,clinic,0,0
58027,.,0,0
58028,BACKGROUND,0,0
58029,Interim,0,0
58030,methadone,0,0
58031,maintenance,0,0
58032,has,0,0
58033,been,0,0
58034,proposed,0,0
58035,as,0,0
58036,a,0,0
58037,method,0,0
58038,of,0,0
58039,providing,0,0
58040,clinically,1,0
58041,effective,1,0
58042,services,0,0
58043,to,0,0
58044,heroin,0,0
58045,addicts,0,0
58046,waiting,0,0
58047,for,0,0
58048,treatment,0,0
58049,in,0,0
58050,standard,0,0
58051,comprehensive,0,0
58052,methadone,0,0
58053,maintenance,0,0
58054,programs,0,0
58055,.,0,0
58056,METHODS,0,0
58057,A,0,0
58058,clinic,0,0
58059,that,0,0
58060,provided,0,0
58061,initial,0,0
58062,medical,0,0
58063,evaluation,0,0
58064,",",0,0
58065,methadone,0,0
58066,medication,0,1
58067,",",0,0
58068,and,0,1
58069,AIDS,0,0
58070,education,0,0
58071,",",0,1
58072,but,0,0
58073,did,0,0
58074,not,0,0
58075,include,0,0
58076,formal,0,0
58077,drug,0,0
58078,abuse,0,1
58079,counseling,0,0
58080,or,0,0
58081,other,0,0
58082,social,0,1
58083,support,0,0
58084,services,0,1
58085,was,0,0
58086,established,0,0
58087,in,0,0
58088,New,0,0
58089,York,0,0
58090,City,0,1
58091,.,0,0
58092,A,0,0
58093,sample,0,0
58094,of,0,0
58095,301,0,0
58096,volunteer,0,0
58097,subjects,0,0
58098,recruited,0,0
58099,from,0,0
58100,the,0,0
58101,waiting,0,0
58102,list,0,0
58103,for,0,0
58104,treatment,0,0
58105,in,0,0
58106,the,0,0
58107,Beth,0,0
58108,Israel,0,1
58109,methadone,0,0
58110,program,0,0
58111,were,0,0
58112,randomly,0,0
58113,assigned,0,0
58114,to,0,0
58115,immediate,0,0
58116,entry,0,0
58117,into,0,0
58118,the,0,0
58119,interim,0,0
58120,clinic,0,0
58121,or,0,0
58122,a,0,0
58123,control,0,0
58124,group,0,0
58125,.,0,0
58126,RESULTS,0,0
58127,There,0,0
58128,were,0,0
58129,no,0,0
58130,differences,0,0
58131,in,0,0
58132,initial,0,0
58133,levels,1,1
58134,of,1,0
58135,illicit,1,0
58136,drug,1,0
58137,use,1,0
58138,across,0,0
58139,the,0,0
58140,experimental,0,0
58141,and,0,0
58142,control,0,0
58143,groups,0,0
58144,.,0,0
58145,One-month,0,0
58146,urinalysis,0,1
58147,follow-up,0,0
58148,data,0,0
58149,showed,0,0
58150,a,0,0
58151,significant,0,0
58152,reduction,1,1
58153,in,1,0
58154,heroin,1,0
58155,use,1,0
58156,in,0,0
58157,the,0,0
58158,experimental,0,0
58159,group,0,0
58160,(,0,0
58161,from,0,0
58162,63,0,0
58163,%,0,0
58164,positive,0,0
58165,at,0,0
58166,intake,0,0
58167,to,0,0
58168,29,0,0
58169,%,0,0
58170,positive,0,0
58171,),0,0
58172,with,0,0
58173,no,0,0
58174,change,0,0
58175,in,0,0
58176,the,0,0
58177,control,0,0
58178,group,0,0
58179,(,0,0
58180,62,0,0
58181,%,0,0
58182,to,0,0
58183,60,0,0
58184,%,0,0
58185,positive,0,0
58186,),0,0
58187,.,0,0
58188,No,0,0
58189,significant,0,0
58190,change,0,0
58191,was,0,0
58192,observed,0,0
58193,in,0,0
58194,cocaine,1,0
58195,urinalyses,1,1
58196,(,0,0
58197,approximately,0,0
58198,70,0,0
58199,%,0,0
58200,positive,0,0
58201,for,0,0
58202,both,0,0
58203,groups,0,0
58204,at,0,0
58205,intake,0,1
58206,and,0,1
58207,follow-up,0,0
58208,),0,0
58209,.,0,0
58210,A,0,0
58211,higher,0,0
58212,percentage,0,1
58213,of,0,0
58214,the,0,0
58215,experimental,0,0
58216,group,0,0
58217,were,0,0
58218,in,0,0
58219,treatment,0,0
58220,at,0,0
58221,16-month,0,0
58222,follow-up,0,0
58223,(,0,0
58224,72,0,0
58225,%,0,0
58226,vs,0,0
58227,56,0,0
58228,%,0,0
58229,),0,0
58230,.,0,0
58231,CONCLUSIONS,0,0
58232,Limited,0,0
58233,services,0,0
58234,interim,0,0
58235,methadone,0,0
58236,maintenance,0,0
58237,can,0,0
58238,reduce,0,0
58239,heroin,1,0
58240,use,1,0
58241,among,0,0
58242,persons,0,0
58243,awaiting,0,0
58244,entry,0,0
58245,into,0,0
58246,comprehensive,0,0
58247,treatment,0,0
58248,and,0,0
58249,increase,0,0
58250,the,0,0
58251,percentage,0,1
58252,entering,0,0
58253,treatment,0,0
58254,.,0,0
58255,The,0,0
58256,double-blind,0,0
58257,sham-controlled,0,0
58258,study,0,0
58259,of,0,0
58260,high-frequency,0,0
58261,rTMS,0,0
58262,(,0,0
58263,20,0,0
58264,Hz,0,0
58265,),0,0
58266,for,0,0
58267,negative,0,0
58268,symptoms,0,1
58269,in,0,0
58270,schizophrenia,0,0
58271,:,0,0
58272,negative,0,0
58273,results,0,0
58274,.,0,0
58275,The,0,0
58276,high-frequency,0,0
58277,repetitive,0,1
58278,transcranial,0,0
58279,magnetic,0,0
58280,stimulation,0,0
58281,(,0,0
58282,HF-rTMS,0,0
58283,),0,0
58284,over,0,0
58285,the,0,0
58286,prefrontal,0,0
58287,cortex,0,0
58288,is,0,0
58289,a,0,0
58290,promising,0,0
58291,method,0,0
58292,for,0,0
58293,the,0,0
58294,treatment,0,0
58295,of,0,0
58296,negative,0,1
58297,symptoms,0,1
58298,of,0,0
58299,schizophrenia,0,0
58300,.,0,0
58301,Using,0,0
58302,double-blind,0,0
58303,sham-controlled,0,0
58304,parallel,0,0
58305,design,0,0
58306,",",0,0
58307,we,0,0
58308,evaluated,0,0
58309,the,0,0
58310,effect,0,0
58311,of,0,0
58312,HF-rTMS,0,0
58313,over,0,0
58314,the,0,0
58315,left,0,0
58316,dorsolateral,0,0
58317,prefrontal,0,1
58318,cortex,0,1
58319,(,0,0
58320,DLPFC,0,1
58321,),0,0
58322,on,0,0
58323,negative,0,0
58324,symptoms,0,1
58325,in,0,0
58326,patients,0,0
58327,with,0,0
58328,schizophrenia,0,0
58329,.,0,0
58330,Sixteen,0,0
58331,schizophrenia,0,0
58332,patients,0,0
58333,with,0,0
58334,predominantly,0,0
58335,negative,0,0
58336,symptoms,0,1
58337,on,0,0
58338,stable,0,0
58339,antipsychotic,0,0
58340,medication,0,1
58341,were,0,0
58342,treated,0,0
58343,with,0,0
58344,20,0,0
58345,Hz,0,0
58346,rTMS,0,0
58347,(,0,0
58348,90,0,0
58349,%,0,0
58350,of,0,0
58351,motor,0,1
58352,threshold,0,1
58353,",",0,0
58354,2000,0,0
58355,stimuli,0,0
58356,per,0,0
58357,session,0,0
58358,),0,0
58359,over,0,0
58360,ten,0,0
58361,days,0,0
58362,within,0,0
58363,2,0,0
58364,weeks,0,0
58365,with,0,0
58366,six,0,0
58367,weeks,0,0
58368,follow-up,0,0
58369,.,0,0
58370,The,0,0
58371,effect,0,0
58372,was,0,0
58373,assessed,0,0
58374,using,0,0
58375,PANSS,1,0
58376,",",1,0
58377,CGI,1,1
58378,",",1,1
58379,MADRS,1,1
58380,and,1,1
58381,neuropsychological,1,0
58382,tests,1,0
58383,.,1,0
58384,We,0,0
58385,failed,0,0
58386,to,0,0
58387,find,0,0
58388,any,0,0
58389,significant,0,0
58390,effect,0,0
58391,of,0,0
58392,active,1,0
58393,rTMS,1,0
58394,.,1,0
58395,Sham,1,0
58396,rTMS,1,0
58397,showed,0,0
58398,a,0,0
58399,trend,0,0
58400,for,0,0
58401,improvement,1,1
58402,over,1,0
58403,time,1,1
58404,on,0,0
58405,positive,1,1
58406,and,1,0
58407,negative,1,1
58408,subscales,1,1
58409,of,1,0
58410,PANSS,1,0
58411,and,1,0
58412,MADRS,1,0
58413,.,1,0
58414,Between-group,0,0
58415,comparisons,0,0
58416,failed,0,0
58417,to,0,0
58418,reveal,0,0
58419,any,0,0
58420,significant,0,0
58421,differences,0,0
58422,on,0,0
58423,any,0,0
58424,rating,1,1
58425,scales,1,1
58426,except,0,0
58427,a,0,0
58428,positive,1,0
58429,subscale,1,1
58430,of,1,0
58431,PANSS,1,0
58432,after,0,0
58433,8,0,0
58434,weeks,0,0
58435,.,0,0
58436,Results,0,0
58437,from,0,0
58438,our,0,0
58439,study,0,0
58440,did,0,0
58441,not,0,0
58442,confirm,0,0
58443,that,0,0
58444,HF-rTMS,1,0
58445,over,0,0
58446,the,0,0
58447,left,0,0
58448,DLPCF,1,0
58449,affects,1,0
58450,the,1,0
58451,negative,1,0
58452,symptoms,1,1
58453,of,1,0
58454,schizophrenia,1,0
58455,and,0,0
58456,alternative,0,0
58457,rTMS,0,0
58458,approaches,0,0
58459,are,0,0
58460,discussed,0,0
58461,.,0,0
58462,Safety,0,1
58463,and,0,0
58464,acceptability,0,1
58465,of,0,1
58466,cellulose,0,0
58467,sulfate,0,0
58468,as,0,0
58469,a,0,0
58470,vaginal,0,0
58471,microbicide,0,0
58472,in,0,0
58473,HIV-infected,0,0
58474,women,0,0
58475,.,0,0
58476,OBJECTIVES,0,0
58477,Few,0,1
58478,studies,0,0
58479,of,0,0
58480,topical,0,0
58481,microbicides,0,0
58482,have,0,0
58483,assessed,0,0
58484,their,0,0
58485,safety,1,1
58486,in,1,0
58487,HIV-infected,1,0
58488,women,1,0
58489,.,1,0
58490,We,0,0
58491,conducted,0,0
58492,this,0,0
58493,study,0,0
58494,to,0,0
58495,evaluate,0,0
58496,the,0,0
58497,safety,1,1
58498,and,1,0
58499,acceptability,1,1
58500,of,0,0
58501,6,0,0
58502,%,0,0
58503,cellulose,0,0
58504,sulfate,0,1
58505,(,0,0
58506,CS,0,1
58507,),0,0
58508,gel,0,0
58509,as,0,0
58510,a,0,0
58511,vaginal,0,0
58512,microbicide,0,0
58513,in,0,0
58514,sexually,0,0
58515,abstinent,0,0
58516,and,0,0
58517,active,0,0
58518,HIV-infected,0,0
58519,women,0,0
58520,.,0,0
58521,METHODS,0,0
58522,Fifty-nine,0,0
58523,HIV-infected,0,0
58524,women,0,0
58525,were,0,0
58526,enrolled,0,0
58527,in,0,0
58528,a,0,0
58529,randomized,0,0
58530,double-blind,0,0
58531,placebo-controlled,0,0
58532,study,0,0
58533,comparing,0,0
58534,6,0,0
58535,%,0,0
58536,CS,0,0
58537,to,0,0
58538,placebo,0,0
58539,gel,0,0
58540,used,0,0
58541,for,0,0
58542,14,0,0
58543,days,0,0
58544,.,0,0
58545,Sexually,0,0
58546,abstinent,0,0
58547,women,0,0
58548,applied,0,0
58549,gel,0,0
58550,once,0,0
58551,or,0,0
58552,twice,0,0
58553,daily,0,0
58554,and,0,0
58555,sexually,0,0
58556,active,0,0
58557,women,0,0
58558,used,0,0
58559,gel,0,0
58560,once,0,0
58561,daily,0,0
58562,.,0,0
58563,RESULTS,0,0
58564,CS,0,1
58565,gel,0,0
58566,was,0,0
58567,safe,0,0
58568,with,0,0
58569,no,0,0
58570,reported,0,0
58571,severe,1,0
58572,or,1,0
58573,life-threatening,1,1
58574,adverse,1,1
58575,events,1,1
58576,(,1,0
58577,AE,1,0
58578,),1,0
58579,.,1,0
58580,Thirty-nine,0,0
58581,(,0,0
58582,66,0,0
58583,%,0,0
58584,),0,0
58585,of,0,0
58586,the,0,0
58587,participants,0,0
58588,experienced,0,0
58589,urogenital,1,1
58590,AE,1,1
58591,judged,0,0
58592,as,0,0
58593,probably,0,0
58594,or,0,0
58595,possibly,0,0
58596,related,0,0
58597,to,0,0
58598,gel,0,0
58599,.,0,0
58600,The,0,0
58601,majority,0,0
58602,(,0,0
58603,51,0,0
58604,%,0,0
58605,),0,0
58606,of,0,0
58607,these,0,0
58608,participants,0,0
58609,reported,0,0
58610,only,0,0
58611,mild,1,0
58612,events,1,1
58613,.,1,0
58614,Fewer,0,0
58615,women,0,0
58616,(,0,0
58617,62,0,0
58618,%,0,0
58619,),0,0
58620,who,0,0
58621,used,0,0
58622,CS,0,1
58623,experienced,0,0
58624,urogenital,1,1
58625,AE,1,0
58626,than,0,0
58627,those,0,0
58628,assigned,0,0
58629,to,0,0
58630,placebo,0,0
58631,gel,0,0
58632,(,0,0
58633,70,0,0
58634,%,0,0
58635,),0,0
58636,(,0,0
58637,P,0,0
58638,=,0,0
58639,0.59,0,0
58640,),0,0
58641,.,0,0
58642,Eleven,0,0
58643,(,0,0
58644,19,0,0
58645,%,0,0
58646,),0,0
58647,women,0,0
58648,experienced,0,0
58649,intermenstrual,1,1
58650,bleeding,1,1
58651,judged,0,0
58652,to,0,0
58653,be,0,0
58654,probably,0,0
58655,or,0,0
58656,possibly,0,0
58657,related,0,0
58658,to,0,0
58659,gel,0,0
58660,use,0,0
58661,(,0,0
58662,four,0,0
58663,in,0,0
58664,the,0,0
58665,CS,0,0
58666,and,0,0
58667,seven,0,0
58668,in,0,0
58669,the,0,0
58670,placebo,0,0
58671,gel,0,0
58672,group,0,0
58673,),0,0
58674,.,0,0
58675,There,0,0
58676,was,0,0
58677,no,0,0
58678,increase,0,0
58679,in,0,0
58680,AE,1,0
58681,by,0,0
58682,frequency,0,1
58683,of,0,0
58684,gel,0,0
58685,use,0,1
58686,or,0,0
58687,sexual,0,1
58688,activity,0,1
58689,with,0,0
58690,the,0,0
58691,exception,0,0
58692,of,0,0
58693,abdominal/pelvic,1,0
58694,pain,1,1
58695,which,0,0
58696,was,0,0
58697,noted,0,0
58698,more,0,0
58699,frequently,0,0
58700,with,0,0
58701,twice,0,0
58702,daily,0,0
58703,use,0,0
58704,among,0,0
58705,sexually,0,0
58706,abstinent,0,0
58707,women,0,0
58708,.,0,0
58709,Women,0,0
58710,and,0,0
58711,men,0,0
58712,found,0,0
58713,the,0,0
58714,gel,0,0
58715,highly,0,0
58716,acceptable,0,0
58717,.,0,0
58718,CONCLUSIONS,0,0
58719,This,0,0
58720,Phase,0,0
58721,I,0,0
58722,study,0,0
58723,demonstrated,0,0
58724,that,0,0
58725,CS,0,1
58726,vaginal,0,1
58727,gel,0,0
58728,was,0,0
58729,safe,1,0
58730,",",1,0
58731,well,1,0
58732,tolerated,1,1
58733,and,1,0
58734,acceptable,1,0
58735,by,0,0
58736,HIV-infected,0,0
58737,women,0,0
58738,and,0,0
58739,their,0,0
58740,male,0,0
58741,partners,0,0
58742,.,0,0
58743,Thus,0,0
58744,",",0,0
58745,further,0,0
58746,development,0,1
58747,of,0,0
58748,CS,0,0
58749,is,0,0
58750,warranted,0,0
58751,as,0,0
58752,a,0,0
58753,potential,0,0
58754,method,0,0
58755,to,0,0
58756,prevent,0,0
58757,HIV,1,1
58758,transmission,1,1
58759,and,1,0
58760,acquisition,1,0
58761,.,1,0
58762,Eberconazole,0,0
58763,1,0,0
58764,%,0,0
58765,cream,0,0
58766,is,0,0
58767,an,0,0
58768,effective,1,0
58769,and,1,0
58770,safe,1,1
58771,alternative,0,0
58772,for,0,0
58773,dermatophytosis,0,1
58774,treatment,0,0
58775,:,0,0
58776,multicenter,0,0
58777,",",0,0
58778,randomized,0,0
58779,",",0,0
58780,double-blind,0,0
58781,",",0,0
58782,comparative,0,0
58783,trial,0,0
58784,with,0,0
58785,miconazole,0,0
58786,2,0,0
58787,%,0,0
58788,cream,0,0
58789,.,0,0
58790,BACKGROUND,0,0
58791,Eberconazole,0,0
58792,is,0,0
58793,a,0,0
58794,topical,0,0
58795,",",0,0
58796,broad-spectrum,0,1
58797,imidazole,0,0
58798,derivative,0,0
58799,",",0,0
58800,effective,0,1
58801,in,0,0
58802,dermatophytoses,0,0
58803,",",0,0
58804,candidiasis,0,1
58805,",",0,1
58806,and,0,1
58807,pityriasis,0,1
58808,treatment,0,0
58809,.,0,0
58810,In,0,0
58811,previous,0,0
58812,trials,0,0
58813,",",0,0
58814,it,0,0
58815,showed,0,0
58816,a,0,0
58817,higher,0,0
58818,efficacy,0,1
58819,than,0,0
58820,clotrimazole,0,0
58821,in,0,0
58822,the,0,0
58823,treatment,0,0
58824,of,0,0
58825,dermatophytoses,0,0
58826,.,0,0
58827,The,0,0
58828,purpose,0,0
58829,of,0,0
58830,this,0,0
58831,trial,0,0
58832,was,0,0
58833,to,0,0
58834,evaluate,0,0
58835,the,0,0
58836,efficacy,0,1
58837,of,0,0
58838,eberconazole,0,0
58839,1,0,0
58840,%,0,0
58841,cream,0,0
58842,compared,0,0
58843,with,0,0
58844,miconazole,0,0
58845,2,0,0
58846,%,0,0
58847,cream,0,0
58848,in,0,0
58849,the,0,0
58850,treatment,0,0
58851,of,0,0
58852,dermatophytoses,0,0
58853,.,0,0
58854,METHODS,0,0
58855,A,0,0
58856,multicenter,0,0
58857,",",0,1
58858,double-blind,0,0
58859,",",0,0
58860,randomized,0,0
58861,trial,0,0
58862,was,0,0
58863,performed,0,0
58864,in,0,0
58865,653,0,0
58866,patients,0,0
58867,with,0,0
58868,dermatophytoses,0,0
58869,",",0,0
58870,randomized,0,0
58871,to,0,0
58872,eberconazole,0,0
58873,1,0,0
58874,%,0,0
58875,cream,0,0
58876,every,0,0
58877,12,0,0
58878,h,0,0
58879,or,0,0
58880,miconazole,0,0
58881,2,0,0
58882,%,0,0
58883,cream,0,0
58884,every,0,0
58885,12,0,0
58886,h,0,0
58887,for,0,0
58888,4,0,0
58889,weeks,0,0
58890,.,0,0
58891,Treatment,1,0
58892,efficacy,1,1
58893,was,0,0
58894,assessed,0,0
58895,on,0,0
58896,the,0,0
58897,basis,0,0
58898,of,0,0
58899,the,0,0
58900,percentage,0,1
58901,of,0,0
58902,effective,0,1
58903,response,0,1
58904,after,0,0
58905,4,0,0
58906,weeks,0,0
58907,through,0,0
58908,mycologic,0,0
58909,and,0,0
58910,clinical,0,0
58911,assessment,0,0
58912,.,0,0
58913,RESULTS,0,0
58914,Of,0,0
58915,the,0,0
58916,653,0,0
58917,patients,0,0
58918,included,0,0
58919,in,0,0
58920,the,0,0
58921,trial,0,0
58922,",",0,0
58923,360,0,0
58924,produced,0,0
58925,positive,0,0
58926,baseline,0,0
58927,mycologic,0,1
58928,cultures,0,1
58929,and,0,1
58930,were,0,0
58931,included,0,0
58932,in,0,0
58933,the,0,0
58934,efficacy,0,1
58935,assessment,0,0
58936,.,0,0
58937,Clinical,0,1
58938,efficacy,0,1
58939,was,0,0
58940,shown,0,0
58941,in,0,0
58942,76.1,0,0
58943,%,0,0
58944,of,0,0
58945,patients,0,0
58946,receiving,0,0
58947,eberconazole,0,0
58948,and,0,0
58949,in,0,0
58950,75.0,0,0
58951,%,0,0
58952,of,0,0
58953,patients,0,0
58954,receiving,0,0
58955,miconazole,0,0
58956,.,0,0
58957,The,0,0
58958,incidence,0,1
58959,of,0,0
58960,adverse,1,1
58961,events,1,1
58962,related,0,0
58963,to,0,0
58964,treatment,0,0
58965,was,0,0
58966,0.91,0,0
58967,%,0,0
58968,for,0,0
58969,eberconazole,0,0
58970,and,0,0
58971,0.92,0,0
58972,%,0,0
58973,for,0,0
58974,miconazole,0,0
58975,",",0,0
58976,none,0,0
58977,being,0,0
58978,serious,0,1
58979,",",0,0
58980,and,0,0
58981,all,0,0
58982,being,0,0
58983,local,0,0
58984,and,0,0
58985,transient,0,1
58986,.,0,0
58987,CONCLUSIONS,0,0
58988,Eberconazole,0,0
58989,1,0,0
58990,%,0,0
58991,cream,0,0
58992,is,0,0
58993,an,0,0
58994,effective,0,0
58995,treatment,0,0
58996,for,0,0
58997,fungal,0,0
58998,infections,0,0
58999,produced,0,0
59000,by,0,0
59001,dermatophytes,0,0
59002,",",0,0
59003,with,0,0
59004,a,0,0
59005,good,0,0
59006,safety,1,1
59007,and,1,1
59008,tolerability,1,1
59009,profile,0,1
59010,",",0,0
59011,and,0,0
59012,can,0,0
59013,be,0,0
59014,considered,0,0
59015,a,0,0
59016,good,0,0
59017,alternative,0,0
59018,for,0,0
59019,the,0,0
59020,treatment,0,0
59021,of,0,0
59022,dermatophytoses,0,0
59023,.,0,0
59024,Confidential,0,0
59025,registration,0,0
59026,in,0,0
59027,health,0,0
59028,services,0,0
59029,:,0,0
59030,randomised,0,0
59031,controlled,0,0
59032,trial,0,0
59033,.,0,0
59034,BACKGROUND,0,0
59035,Human,0,0
59036,rights,0,0
59037,legislation,0,0
59038,safeguards,0,0
59039,the,0,0
59040,privacy,0,1
59041,and,0,0
59042,dignity,0,1
59043,of,0,0
59044,patients,0,0
59045,.,0,0
59046,OBJECTIVE,0,0
59047,To,0,0
59048,assess,0,0
59049,the,0,0
59050,effectiveness,0,1
59051,in,0,0
59052,terms,0,0
59053,of,0,0
59054,patient,0,0
59055,assessed,0,0
59056,privacy,0,1
59057,of,0,0
59058,confidential,0,0
59059,registration,0,0
59060,.,0,0
59061,DESIGN,0,0
59062,Randomised,0,0
59063,controlled,0,0
59064,trial,0,0
59065,.,0,0
59066,SETTING,0,0
59067,Emergency,0,1
59068,Department,0,0
59069,",",0,0
59070,University,0,0
59071,Hospital,0,1
59072,of,0,0
59073,Wales,0,1
59074,.,0,0
59075,PARTICIPANTS,0,0
59076,A,0,0
59077,total,0,0
59078,of,0,0
59079,302,0,0
59080,patients,0,0
59081,aged,0,0
59082,over,0,0
59083,15,0,0
59084,years,0,0
59085,.,0,0
59086,MAIN,0,0
59087,OUTCOME,0,0
59088,MEASURES,0,0
59089,Binary,0,0
59090,choices,0,0
59091,and,0,0
59092,ordinal,0,1
59093,visual,0,1
59094,analogue,0,1
59095,scores,0,1
59096,from,0,0
59097,a,0,0
59098,validated,0,0
59099,questionnaire,0,1
59100,on,0,0
59101,self,0,1
59102,reported,0,0
59103,measures,0,0
59104,:,0,0
59105,patient,1,1
59106,ability,1,1
59107,and,1,0
59108,preference,1,0
59109,to,1,0
59110,speak,1,0
59111,to,1,0
59112,receptionists,1,0
59113,and,1,0
59114,disclose,1,0
59115,confidential,1,0
59116,information,1,0
59117,without,1,0
59118,being,1,0
59119,overhead,1,1
59120,and,1,0
59121,concern,1,0
59122,about,1,0
59123,disclosure,1,1
59124,of,1,0
59125,items,1,0
59126,of,1,0
59127,confidential,1,0
59128,personal,1,0
59129,information,1,0
59130,.,1,0
59131,RESULTS,0,0
59132,Patients,0,0
59133,who,0,0
59134,registered,0,0
59135,in,0,0
59136,a,0,0
59137,screened,0,0
59138,area,0,1
59139,felt,0,0
59140,significantly,0,0
59141,more,0,0
59142,able,0,0
59143,to,0,0
59144,tell,1,0
59145,receptionists,1,0
59146,things,1,1
59147,they,1,0
59148,did,1,0
59149,not,1,0
59150,want,1,0
59151,others,1,0
59152,to,1,0
59153,hear,1,0
59154,.,1,0
59155,Control,0,0
59156,patients,0,0
59157,were,0,0
59158,significantly,0,0
59159,more,0,0
59160,concerned,0,1
59161,than,0,0
59162,intervention,0,0
59163,patients,0,0
59164,that,0,0
59165,others,1,0
59166,heard,1,0
59167,their,1,0
59168,name,1,0
59169,",",1,0
59170,address,1,0
59171,",",1,1
59172,date,1,1
59173,of,1,1
59174,birth,1,1
59175,",",1,0
59176,reason,1,0
59177,for,1,0
59178,emergency,1,1
59179,department,1,0
59180,attendance,1,1
59181,",",1,1
59182,and,1,1
59183,telephone,1,1
59184,number,1,1
59185,",",1,0
59186,but,1,0
59187,not,1,0
59188,their,1,0
59189,marital,1,0
59190,status,1,1
59191,.,1,0
59192,Overall,0,1
59193,",",0,0
59194,intervention,0,0
59195,patients,0,0
59196,were,0,0
59197,less,0,0
59198,concerned,0,1
59199,about,0,0
59200,disclosure,1,0
59201,of,1,0
59202,information,1,1
59203,and,0,0
59204,that,0,0
59205,they,0,0
59206,had,0,0
59207,been,0,0
59208,overheard,0,0
59209,.,0,0
59210,CONCLUSIONS,0,0
59211,Patients,0,0
59212,value,0,1
59213,privacy,0,1
59214,when,0,0
59215,they,0,0
59216,register,0,0
59217,and,0,0
59218,are,0,0
59219,concerned,0,1
59220,if,0,0
59221,others,0,0
59222,can,0,0
59223,hear,0,0
59224,them,0,0
59225,tell,0,0
59226,receptionists,0,0
59227,who,0,0
59228,they,0,0
59229,are,0,0
59230,",",0,0
59231,how,0,0
59232,to,0,0
59233,contact,0,0
59234,them,0,0
59235,",",0,0
59236,and,0,0
59237,why,0,0
59238,they,0,0
59239,are,0,0
59240,there,0,0
59241,.,0,0
59242,Confidential,0,0
59243,registration,0,0
59244,should,0,0
59245,be,0,0
59246,instituted,0,0
59247,in,0,0
59248,health,0,0
59249,services,0,0
59250,.,0,0
59251,Confidential,0,1
59252,registration,0,0
59253,increased,0,0
59254,patient,0,1
59255,privacy,0,1
59256,and,0,0
59257,should,0,0
59258,be,0,0
59259,instituted,0,0
59260,in,0,0
59261,health,0,0
59262,services,0,0
59263,.,0,0
59264,[,0,0
59265,Profiles,0,0
59266,of,0,0
59267,irregular,1,0
59268,bleeding,1,1
59269,induced,0,0
59270,by,0,0
59271,low-dose,0,0
59272,hormone,0,1
59273,therapy,0,0
59274,and,0,1
59275,Chinese,0,0
59276,formulated,0,0
59277,herbs,0,0
59278,products,0,0
59279,],0,0
59280,.,0,0
59281,OBJECTIVE,0,0
59282,To,0,0
59283,compare,0,0
59284,profiles,0,0
59285,and,0,0
59286,related,0,0
59287,factors,0,0
59288,of,0,0
59289,irregular,1,0
59290,bleeding,1,1
59291,induced,0,0
59292,by,0,0
59293,different,0,0
59294,types,0,0
59295,of,0,0
59296,low-dose,0,0
59297,hormone,0,1
59298,therapy,0,0
59299,(,0,0
59300,HT,0,0
59301,),0,0
59302,and,0,0
59303,a,0,0
59304,Chinese,0,0
59305,formulated,0,0
59306,herbs,0,0
59307,products,0,0
59308,.,0,0
59309,METHODS,0,0
59310,Applied,0,0
59311,with,0,0
59312,open-labeled,0,0
59313,",",0,0
59314,randomized,0,0
59315,",",0,0
59316,and,0,0
59317,clinical,0,1
59318,trial,0,0
59319,design,0,0
59320,",",0,0
59321,136,0,0
59322,postmenopausal,0,0
59323,women,0,0
59324,were,0,0
59325,assigned,0,0
59326,into,0,0
59327,four,0,0
59328,groups,0,0
59329,:,0,0
59330,group,0,0
59331,A,0,0
59332,:,0,0
59333,estradiol,0,0
59334,valerate,0,0
59335,(,0,0
59336,E2,0,1
59337,V,0,0
59338,),0,0
59339,1,0,0
59340,mg/d,0,0
59341,+,0,0
59342,medroxyprogesterone,0,0
59343,acetate,0,0
59344,(,0,0
59345,MPA,0,0
59346,),0,0
59347,2,0,0
59348,mg/d,0,0
59349,;,0,0
59350,group,0,0
59351,B,0,0
59352,:,0,0
59353,conjugated,0,0
59354,equine,0,0
59355,estrogen,0,0
59356,0.45,0,0
59357,mg/d,0,0
59358,+,0,0
59359,MPA,0,0
59360,2,0,0
59361,mg/d,0,0
59362,;,0,0
59363,group,0,0
59364,C,0,0
59365,:,0,0
59366,tibolone,0,0
59367,1.25,0,0
59368,mg/d,0,0
59369,;,0,0
59370,group,0,0
59371,D,0,0
59372,:,0,0
59373,a,0,0
59374,Chinese,0,0
59375,formulated,0,0
59376,herbs,0,0
59377,product,0,0
59378,(,0,0
59379,Kuntai,0,0
59380,),0,0
59381,4,0,0
59382,#,0,0
59383,tid,0,0
59384,.,0,0
59385,Each,0,0
59386,subject,0,0
59387,took,0,0
59388,element,0,0
59389,calcium,0,0
59390,400,0,0
59391,mg/d,0,0
59392,and,0,0
59393,vitamin,0,0
59394,D,0,0
59395,200,0,0
59396,IU/d,0,0
59397,concomitantly,0,0
59398,.,0,0
59399,Modified,0,1
59400,Kupperman,1,1
59401,scores,1,1
59402,were,0,0
59403,assessed,0,0
59404,on,0,0
59405,baseline,0,0
59406,and,0,0
59407,every,0,0
59408,3,0,0
59409,months,0,0
59410,thereafter,0,0
59411,and,0,0
59412,irregular,1,1
59413,bleeding,1,1
59414,was,0,0
59415,recorded,0,0
59416,on,0,0
59417,menopausal,0,0
59418,diary,0,0
59419,every,0,0
59420,day,0,0
59421,.,0,0
59422,The,0,0
59423,duration,0,1
59424,of,0,0
59425,this,0,0
59426,study,0,0
59427,was,0,0
59428,1,0,0
59429,year,0,0
59430,.,0,0
59431,Results,0,0
59432,The,0,0
59433,efficacies,1,1
59434,were,0,0
59435,similar,0,0
59436,in,0,0
59437,three,0,0
59438,HT-managed,0,0
59439,groups,0,0
59440,",",0,0
59441,but,0,0
59442,was,0,0
59443,better,0,0
59444,than,0,0
59445,in,0,0
59446,group,0,0
59447,D,0,1
59448,",",0,0
59449,although,0,0
59450,the,0,0
59451,latter,0,0
59452,was,0,0
59453,also,0,0
59454,effective,1,0
59455,in,0,0
59456,alleviating,0,0
59457,menopausal,0,0
59458,symptoms,0,1
59459,.,0,0
59460,Hazard,1,1
59461,ratio,1,1
59462,(,1,0
59463,HR,1,1
59464,),1,0
59465,of,1,0
59466,irregular,1,0
59467,bleeding,1,1
59468,was,0,0
59469,1.00,0,0
59470,in,0,0
59471,group,0,0
59472,C,0,0
59473,",",0,0
59474,2.43,0,0
59475,in,0,0
59476,group,0,0
59477,A,0,0
59478,(,0,0
59479,95,0,0
59480,%,0,0
59481,CI,0,0
59482,:,0,0
59483,1.08-5.46,0,0
59484,),0,0
59485,",",0,0
59486,3.12,0,0
59487,in,0,0
59488,group,0,0
59489,B,0,0
59490,(,0,0
59491,95,0,0
59492,%,0,0
59493,CI,0,0
59494,:,0,0
59495,1.42-6.88,0,0
59496,),0,0
59497,",",0,0
59498,and,0,0
59499,0.73,0,0
59500,in,0,0
59501,group,0,0
59502,D,0,1
59503,(,0,0
59504,95,0,0
59505,%,0,0
59506,CI,0,0
59507,:,0,0
59508,0.26-2.04,0,0
59509,),0,0
59510,.,0,0
59511,Most,0,0
59512,cases,0,0
59513,initially,0,0
59514,experienced,0,0
59515,bleeding,1,1
59516,in,0,0
59517,the,0,0
59518,first,0,0
59519,3,0,0
59520,months,0,0
59521,but,0,0
59522,such,0,0
59523,initiation,1,0
59524,was,0,0
59525,a,0,0
59526,bit,0,0
59527,later,0,0
59528,in,0,0
59529,group,0,0
59530,C.,0,1
59531,Endometrium,1,1
59532,",",0,0
59533,as,0,0
59534,detected,0,0
59535,by,0,0
59536,B-mode,0,0
59537,ultrasound,0,1
59538,",",0,0
59539,increased,0,0
59540,approximately,0,0
59541,1,0,0
59542,mm,0,0
59543,in,0,0
59544,HT,0,0
59545,groups,0,0
59546,",",0,0
59547,while,0,0
59548,it,0,0
59549,was,0,0
59550,a,0,0
59551,bit,0,0
59552,thicker,0,0
59553,in,0,0
59554,group,0,0
59555,C.,0,1
59556,Long,0,0
59557,periods,0,0
59558,in,0,0
59559,reproductive,0,0
59560,age,0,0
59561,and,0,0
59562,short,0,1
59563,time,0,1
59564,since,0,0
59565,menopause,0,0
59566,were,0,0
59567,high,0,0
59568,risk,0,1
59569,factors,0,0
59570,for,0,0
59571,irregular,1,0
59572,bleeding,1,1
59573,.,1,0
59574,CONCLUSION,0,0
59575,Profiles,0,0
59576,of,0,0
59577,irregular,1,0
59578,bleeding,1,1
59579,in,0,0
59580,3,0,0
59581,commonly,0,0
59582,used,0,0
59583,types,0,0
59584,of,0,0
59585,low-dose,0,0
59586,HT,0,0
59587,are,0,0
59588,different,0,0
59589,and,0,0
59590,some,0,0
59591,factors,0,0
59592,such,0,0
59593,as,0,0
59594,long,0,0
59595,period,0,0
59596,in,0,0
59597,reproductive,0,1
59598,age,0,0
59599,and,0,0
59600,short,0,1
59601,time,0,1
59602,since,0,0
59603,menopause,0,0
59604,may,0,0
59605,contribute,0,0
59606,to,0,0
59607,bleeding,0,1
59608,initiation,0,0
59609,.,0,0
59610,Milk,1,1
59611,production,1,1
59612,of,0,0
59613,dairy,0,0
59614,cows,0,0
59615,fed,0,0
59616,wet,0,0
59617,corn,0,0
59618,gluten,0,0
59619,feed,0,0
59620,during,0,0
59621,the,0,0
59622,dry,0,0
59623,period,0,0
59624,and,0,0
59625,lactation,0,1
59626,.,0,0
59627,An,0,0
59628,experiment,0,0
59629,was,0,0
59630,conducted,0,0
59631,with,0,0
59632,36,0,0
59633,primiparous,0,0
59634,and,0,0
59635,40,0,0
59636,multiparous,0,0
59637,Holstein,0,0
59638,cows,0,0
59639,to,0,0
59640,examine,0,0
59641,the,0,0
59642,effects,0,0
59643,of,0,0
59644,feeding,0,0
59645,wet,0,0
59646,corn,0,0
59647,gluten,0,0
59648,feed,0,1
59649,(,0,0
59650,WCGF,0,0
59651,),0,0
59652,on,0,0
59653,305-d,0,1
59654,milk,1,1
59655,production,1,1
59656,",",1,0
59657,dry,1,1
59658,matter,1,1
59659,(,1,0
59660,DM,1,0
59661,),1,1
59662,intake,1,1
59663,",",1,0
59664,body,1,1
59665,condition,1,1
59666,score,1,1
59667,(,1,0
59668,BCS,1,1
59669,),1,1
59670,",",1,0
59671,and,1,0
59672,health,1,1
59673,.,1,0
59674,The,0,0
59675,experimental,0,0
59676,treatments,0,0
59677,included,0,0
59678,:,0,0
59679,1,0,0
59680,),0,0
59681,control,0,0
59682,--,0,0
59683,WCGF,0,0
59684,not,0,0
59685,fed,0,0
59686,(,0,0
59687,n,0,0
59688,=,0,0
59689,27,0,0
59690,),0,0
59691,;,0,0
59692,2,0,0
59693,),0,0
59694,WCGF-L-cows,0,0
59695,received,0,0
59696,diets,0,0
59697,containing,0,0
59698,WCGF,0,0
59699,(,0,0
59700,38,0,0
59701,%,0,0
59702,DM,0,0
59703,basis,0,0
59704,),0,0
59705,during,0,0
59706,lactation,0,1
59707,(,0,0
59708,n,0,0
59709,=,0,0
59710,23,0,0
59711,),0,0
59712,;,0,0
59713,and,0,0
59714,3,0,0
59715,),0,0
59716,WCGF-DL,0,0
59717,--,0,0
59718,cows,0,0
59719,received,0,0
59720,diets,0,0
59721,containing,0,0
59722,WCGF,0,0
59723,(,0,0
59724,38,0,0
59725,%,0,0
59726,DM,0,0
59727,basis,0,0
59728,),0,0
59729,during,0,0
59730,the,0,0
59731,dry,0,0
59732,period,0,0
59733,and,0,1
59734,lactation,0,1
59735,(,0,0
59736,n,0,0
59737,=,0,0
59738,26,0,0
59739,),0,0
59740,.,0,0
59741,During,0,0
59742,the,0,0
59743,dry,0,0
59744,period,0,0
59745,",",0,0
59746,cows,0,0
59747,consuming,0,0
59748,WCGF,0,0
59749,were,0,0
59750,observed,0,0
59751,to,0,0
59752,have,0,0
59753,a,0,0
59754,significant,0,0
59755,gain,0,1
59756,in,0,0
59757,BCS,0,1
59758,(,0,0
59759,0.07,0,0
59760,+/-,0,0
59761,0.06,0,0
59762,),0,0
59763,compared,0,0
59764,with,0,0
59765,a,0,0
59766,loss,0,1
59767,in,0,0
59768,BCS,0,1
59769,in,0,0
59770,cows,0,0
59771,fed,0,0
59772,the,0,0
59773,control,0,0
59774,diet,0,0
59775,(,0,0
59776,control,0,0
59777,=,0,0
59778,-0.11,0,0
59779,+/-,0,0
59780,0.06,0,0
59781,and,0,0
59782,WCGF-L,0,0
59783,=,0,0
59784,-0.04,0,0
59785,+/-,0,0
59786,0.06,0,0
59787,),0,0
59788,.,0,0
59789,During,0,0
59790,lactation,0,1
59791,",",0,0
59792,there,0,0
59793,were,0,0
59794,no,0,0
59795,differences,0,0
59796,by,0,0
59797,treatment,0,0
59798,on,0,0
59799,BCS,0,1
59800,.,0,0
59801,Cows,0,0
59802,consuming,0,0
59803,WCGF,0,0
59804,during,0,0
59805,lactation,0,1
59806,consumed,0,0
59807,more,0,0
59808,feed,1,0
59809,compared,0,0
59810,with,0,0
59811,the,0,0
59812,control,0,0
59813,:,0,0
59814,25.4,0,0
59815,",",0,0
59816,23.8,0,0
59817,",",0,0
59818,and,0,0
59819,21.2,0,0
59820,+/-,0,0
59821,0.76,0,0
59822,kg/d,0,0
59823,for,0,0
59824,WCGF-L,0,0
59825,",",0,0
59826,WCGF-DL,0,1
59827,",",0,0
59828,and,0,0
59829,the,0,0
59830,control,0,0
59831,",",0,0
59832,respectively,0,0
59833,.,0,0
59834,Milk,1,1
59835,production,1,1
59836,was,0,0
59837,higher,0,0
59838,for,0,0
59839,cows,0,0
59840,consuming,0,0
59841,WCGF,0,0
59842,:,0,0
59843,35.0,0,0
59844,",",0,0
59845,34.7,0,0
59846,",",0,0
59847,and,0,0
59848,31.1,0,0
59849,+/-,0,0
59850,2.1,0,0
59851,kg/d,0,0
59852,for,0,0
59853,WCGF-L,0,0
59854,",",0,0
59855,WCGF-DL,0,1
59856,",",0,0
59857,and,0,0
59858,the,0,0
59859,control,0,0
59860,",",0,0
59861,respectively,0,0
59862,.,0,0
59863,No,0,0
59864,differences,0,0
59865,were,0,0
59866,found,0,0
59867,in,0,0
59868,either,0,0
59869,DM,1,0
59870,intake,1,1
59871,or,1,0
59872,actual,1,1
59873,milk,1,1
59874,yield,1,0
59875,between,0,0
59876,the,0,0
59877,WCGF-L,0,0
59878,and,0,0
59879,WCGF-DL,0,0
59880,treatments,0,0
59881,",",0,0
59882,indicating,0,0
59883,that,0,0
59884,prepartum,0,1
59885,diets,0,0
59886,did,0,0
59887,not,0,0
59888,influence,0,0
59889,lactational,0,0
59890,performance,0,1
59891,.,0,0
59892,The,0,0
59893,WCGF,0,0
59894,diets,0,0
59895,resulted,0,0
59896,in,0,0
59897,significant,0,0
59898,reductions,0,0
59899,in,0,0
59900,the,0,0
59901,concentration,1,1
59902,of,1,0
59903,milk,1,1
59904,fat,1,1
59905,(,0,0
59906,3.94,0,0
59907,",",0,0
59908,3.74,0,0
59909,",",0,0
59910,and,0,0
59911,4.15,0,0
59912,+/-,0,0
59913,0.08,0,0
59914,%,0,0
59915,for,0,0
59916,WCGF-L,0,0
59917,",",0,0
59918,WCGF-DL,0,1
59919,",",0,0
59920,and,0,0
59921,the,0,0
59922,control,0,0
59923,",",0,0
59924,respectively,0,0
59925,),0,0
59926,",",0,0
59927,but,0,0
59928,because,0,0
59929,total,1,1
59930,milk,1,1
59931,yield,1,1
59932,was,0,0
59933,increased,0,0
59934,",",0,0
59935,there,0,0
59936,were,0,0
59937,no,0,0
59938,differences,0,0
59939,in,0,0
59940,total,0,1
59941,milk,0,0
59942,fat,0,1
59943,yield,0,0
59944,.,0,0
59945,In,0,0
59946,addition,0,0
59947,",",0,0
59948,3.5,0,0
59949,%,0,0
59950,of,0,0
59951,fat-corrected,0,0
59952,milk,0,0
59953,tended,0,0
59954,to,0,0
59955,be,0,0
59956,affected,0,0
59957,by,0,0
59958,diet,0,0
59959,:,0,0
59960,38.9,0,0
59961,",",0,0
59962,36.3,0,0
59963,",",0,0
59964,and,0,0
59965,34.7,0,0
59966,+/-,0,0
59967,1.93,0,0
59968,kg/d,0,0
59969,for,0,0
59970,WCGF-L,0,0
59971,",",0,0
59972,WCGF-DL,0,1
59973,",",0,0
59974,and,0,0
59975,the,0,0
59976,control,0,0
59977,",",0,0
59978,respectively,0,0
59979,.,0,0
59980,The,0,0
59981,increasing,0,0
59982,effect,0,0
59983,of,0,0
59984,DM,1,0
59985,intake,1,1
59986,and,1,1
59987,milk,1,1
59988,yield,1,1
59989,in,0,0
59990,cows,0,0
59991,consuming,0,0
59992,WCGF,0,0
59993,resulted,0,0
59994,in,0,0
59995,a,0,0
59996,similar,0,0
59997,efficiency,0,0
59998,of,0,0
59999,3.5,0,0
60000,%,0,0
60001,fat-corrected,0,0
60002,milk,1,1
60003,production,1,1
60004,for,0,0
60005,all,0,0
60006,treatments,0,0
60007,",",0,0
60008,averaging,0,0
60009,1.5,0,0
60010,+/-,0,0
60011,0.09,0,0
60012,.,0,0
60013,Total,1,0
60014,protein,1,0
60015,yields,1,1
60016,were,0,0
60017,significantly,0,0
60018,higher,0,0
60019,for,0,0
60020,cows,0,0
60021,consuming,0,0
60022,WCGF,0,0
60023,diets,0,0
60024,during,0,0
60025,lactation,0,0
60026,:,0,0
60027,1.15,0,0
60028,",",0,0
60029,1.10,0,0
60030,",",0,0
60031,1.00,0,0
60032,+/-,0,0
60033,0.06,0,0
60034,kg/d,0,0
60035,for,0,0
60036,WCGF-L,0,0
60037,",",0,0
60038,WCGF-DL,0,1
60039,",",0,0
60040,and,0,0
60041,the,0,0
60042,control,0,0
60043,",",0,0
60044,respectively,0,0
60045,.,0,0
60046,These,0,0
60047,results,0,0
60048,indicate,0,0
60049,that,0,0
60050,diets,0,0
60051,may,0,0
60052,be,0,0
60053,formulated,0,0
60054,to,0,0
60055,contain,0,0
60056,as,0,0
60057,much,0,0
60058,as,0,0
60059,37.5,0,0
60060,%,0,0
60061,WCGF,0,0
60062,(,0,0
60063,DM,0,0
60064,basis,0,0
60065,),0,0
60066,.,0,0
60067,The,0,0
60068,safety,0,1
60069,and,0,0
60070,efficacy,0,1
60071,of,0,1
60072,terazosin,0,0
60073,in,0,0
60074,the,0,0
60075,treatment,0,0
60076,of,0,0
60077,essential,0,0
60078,hypertension,0,1
60079,in,0,0
60080,blacks,0,0
60081,.,0,0
60082,Terazosin,0,0
60083,",",0,0
60084,a,0,0
60085,new,0,0
60086,selective,0,0
60087,alpha,0,1
60088,1-adrenergic,0,0
60089,receptor,0,1
60090,antagonist,0,0
60091,",",0,0
60092,has,0,0
60093,been,0,0
60094,found,0,0
60095,to,0,0
60096,be,0,0
60097,an,0,0
60098,effective,0,0
60099,antihypertensive,0,0
60100,agent,0,0
60101,.,0,0
60102,In,0,0
60103,a,0,0
60104,series,0,0
60105,of,0,0
60106,studies,0,0
60107,",",0,0
60108,the,0,0
60109,safety,0,1
60110,and,0,0
60111,efficacy,0,1
60112,of,0,1
60113,terazosin,0,0
60114,",",0,0
60115,alone,0,0
60116,and,0,0
60117,in,0,0
60118,combination,0,0
60119,with,0,0
60120,other,0,0
60121,antihypertensive,0,0
60122,agents,0,0
60123,",",0,0
60124,were,0,0
60125,evaluated,0,0
60126,in,0,0
60127,1180,0,0
60128,black,0,0
60129,patients,0,0
60130,with,0,0
60131,mild,0,0
60132,to,0,0
60133,moderate,0,0
60134,essential,0,0
60135,hypertension,0,0
60136,.,0,0
60137,Terazosin,0,0
60138,was,0,0
60139,effective,0,0
60140,in,0,0
60141,lowering,0,0
60142,blood,0,1
60143,pressure,0,1
60144,when,0,0
60145,administered,0,0
60146,alone,0,0
60147,(,0,0
60148,in,0,0
60149,dosages,0,0
60150,of,0,0
60151,1,0,0
60152,to,0,0
60153,80,0,0
60154,mg/day,0,0
60155,),0,0
60156,and,0,0
60157,when,0,0
60158,prescribed,0,0
60159,(,0,0
60160,in,0,0
60161,dosages,0,0
60162,of,0,0
60163,1,0,0
60164,to,0,0
60165,20,0,0
60166,mg/day,0,0
60167,),0,0
60168,in,0,0
60169,combination,0,0
60170,with,0,0
60171,other,0,0
60172,antihypertensive,0,0
60173,agents,0,0
60174,.,0,0
60175,In,0,0
60176,elderly,0,0
60177,black,0,0
60178,patients,0,0
60179,",",0,0
60180,terazosin,0,0
60181,",",0,0
60182,1,0,0
60183,to,0,0
60184,10,0,0
60185,mg,0,0
60186,daily,0,0
60187,",",0,0
60188,was,0,0
60189,as,0,0
60190,effective,0,1
60191,in,0,0
60192,lowering,0,0
60193,blood,1,1
60194,pressure,1,1
60195,as,0,0
60196,propranolol,0,0
60197,(,0,0
60198,40,0,0
60199,to,0,0
60200,120,0,0
60201,mg,0,0
60202,twice,0,0
60203,daily,0,0
60204,),0,0
60205,.,0,0
60206,Changes,0,1
60207,(,0,0
60208,mean,0,1
60209,+/-,0,0
60210,SE,0,0
60211,),0,0
60212,in,0,0
60213,sitting,1,1
60214,diastolic,1,1
60215,blood,1,1
60216,pressure,1,1
60217,from,1,0
60218,baseline,1,0
60219,were,0,0
60220,-8.1,0,0
60221,+/-,0,0
60222,1.4,0,0
60223,mm,0,0
60224,Hg,0,0
60225,for,0,0
60226,terazosin,0,0
60227,and,0,0
60228,-5.0,0,0
60229,+/-,0,0
60230,1.5,0,0
60231,mm,0,0
60232,Hg,0,0
60233,for,0,0
60234,propranolol,0,0
60235,.,0,0
60236,Terazosin,0,0
60237,(,0,0
60238,5,0,0
60239,mg,0,0
60240,),0,0
60241,combined,0,0
60242,with,0,0
60243,methyclothiazide,0,0
60244,(,0,0
60245,2.5,0,0
60246,to,0,0
60247,5,0,0
60248,mg,0,0
60249,),0,0
60250,produced,0,0
60251,a,0,0
60252,significantly,0,0
60253,greater,0,0
60254,(,0,0
60255,p,0,0
60256,less,0,0
60257,than,0,0
60258,0.01,0,0
60259,),0,0
60260,antihypertensive,1,0
60261,effect,1,0
60262,than,0,0
60263,that,0,0
60264,of,0,0
60265,terazosin,0,0
60266,alone,0,0
60267,.,0,0
60268,Changes,0,1
60269,(,0,0
60270,mean,0,1
60271,+/-,0,0
60272,SE,0,0
60273,),0,0
60274,in,0,0
60275,standing,1,0
60276,diastolic,1,1
60277,blood,1,1
60278,pressure,1,1
60279,from,1,0
60280,baseline,1,0
60281,were,0,0
60282,-7.9,0,0
60283,+/-,0,0
60284,2.0,0,0
60285,mm,0,0
60286,Hg,0,0
60287,for,0,0
60288,terazosin,0,0
60289,alone,0,0
60290,",",0,0
60291,-15.1,0,0
60292,+/-,0,0
60293,2.1,0,0
60294,mm,0,0
60295,Hg,0,0
60296,for,0,0
60297,terazosin,0,0
60298,plus,0,0
60299,2.5,0,0
60300,mg,0,0
60301,of,0,0
60302,methyclothiazide,0,0
60303,",",0,0
60304,and,0,1
60305,-15.0,0,0
60306,+/-,0,0
60307,2.0,0,0
60308,mm,0,0
60309,Hg,0,0
60310,for,0,0
60311,terazosin,0,0
60312,plus,0,0
60313,5,0,0
60314,mg,0,0
60315,of,0,0
60316,methyclothiazide,0,0
60317,.,0,0
60318,Terazosin,0,0
60319,had,0,0
60320,a,0,0
60321,favorable,0,0
60322,effect,0,0
60323,on,0,0
60324,serum,1,1
60325,lipid,1,1
60326,levels,1,1
60327,and,0,0
60328,appeared,0,0
60329,to,0,0
60330,compensate,0,0
60331,for,0,0
60332,the,0,0
60333,negative,0,0
60334,lipid,0,0
60335,effects,0,0
60336,associated,0,0
60337,with,0,0
60338,diuretics,0,0
60339,and,0,0
60340,beta-blockers,0,0
60341,when,0,0
60342,used,0,0
60343,in,0,0
60344,combination,0,0
60345,with,0,0
60346,these,0,0
60347,agents,0,0
60348,.,0,0
60349,Terazosin,0,0
60350,",",0,0
60351,alone,0,0
60352,and,0,0
60353,combined,0,0
60354,with,0,0
60355,other,0,0
60356,antihypertensive,0,0
60357,agents,0,0
60358,",",0,0
60359,was,0,0
60360,well,0,0
60361,tolerated,1,1
60362,with,0,0
60363,minimal,0,0
60364,side,0,1
60365,effects,0,1
60366,in,0,0
60367,black,0,0
60368,hypertensive,0,0
60369,patients,0,0
60370,.,0,0
60371,International,0,1
60372,Czech,0,0
60373,and,0,1
60374,Slovak,0,0
60375,cooperation,0,0
60376,in,0,0
60377,the,0,0
60378,treatment,0,0
60379,of,0,0
60380,patients,0,0
60381,with,0,0
60382,differentiated,0,1
60383,thyroid,0,0
60384,cancer,0,0
60385,.,0,0
60386,BACKGROUND,0,0
60387,The,0,0
60388,aim,0,0
60389,of,0,0
60390,this,0,0
60391,paper,0,0
60392,is,0,0
60393,to,0,0
60394,present,0,0
60395,our,0,0
60396,experience,0,0
60397,concerning,0,0
60398,cooperation,0,0
60399,in,0,0
60400,the,0,0
60401,treatment,0,0
60402,of,0,0
60403,Slovak,0,0
60404,patients,0,0
60405,with,0,0
60406,differentiated,0,1
60407,thyroid,0,0
60408,cancer,0,0
60409,in,0,0
60410,Slovak,0,0
60411,and,0,0
60412,Czech,0,0
60413,hospitals,0,0
60414,.,0,0
60415,The,0,0
60416,objectives,0,0
60417,of,0,0
60418,this,0,0
60419,study,0,0
60420,were,0,0
60421,to,0,0
60422,demonstrate,0,0
60423,the,0,0
60424,means,1,0
60425,of,1,0
60426,this,1,0
60427,cooperation,1,0
60428,and,0,0
60429,the,0,0
60430,results,1,0
60431,of,0,0
60432,therapy,0,0
60433,.,0,0
60434,MATERIAL,0,0
60435,AND,0,0
60436,METHODS,0,0
60437,From,0,0
60438,September,0,0
60439,1991,0,0
60440,to,0,0
60441,October,0,0
60442,2005,0,0
60443,in,0,0
60444,the,0,0
60445,Department,0,0
60446,of,0,0
60447,Nuclear,0,0
60448,Medicine,0,0
60449,in,0,0
60450,Ostrava,0,0
60451,357,0,0
60452,patients,0,0
60453,from,0,0
60454,the,0,0
60455,Slovak,0,0
60456,Republic,0,0
60457,with,0,0
60458,differentiated,0,1
60459,thyroid,0,0
60460,cancers,0,0
60461,(,0,0
60462,follicular,0,1
60463,and,0,1
60464,papillary,0,0
60465,),0,0
60466,underwent,0,0
60467,complex,0,0
60468,therapy,0,0
60469,.,0,0
60470,They,0,0
60471,were,0,0
60472,diagnosed,0,0
60473,and,0,0
60474,operated,0,0
60475,due,0,0
60476,to,0,0
60477,the,0,0
60478,cancer,0,0
60479,(,0,0
60480,near-total,0,0
60481,thyroidectomy,0,0
60482,and,0,1
60483,removal,0,1
60484,of,0,1
60485,lymph,0,1
60486,node,0,1
60487,metastases,0,0
60488,),0,0
60489,in,0,0
60490,Slovak,0,0
60491,hospitals,0,0
60492,.,0,0
60493,Then,0,0
60494,they,0,0
60495,were,0,0
60496,sent,0,0
60497,to,0,0
60498,the,0,0
60499,Department,0,0
60500,of,0,0
60501,Nuclear,0,0
60502,Medicine,0,0
60503,in,0,0
60504,Ostrava,0,0
60505,in,0,0
60506,the,0,0
60507,Czech,0,0
60508,Republic,0,0
60509,.,0,0
60510,In,0,0
60511,this,0,0
60512,department,0,0
60513,a,0,0
60514,radioiodine,0,0
60515,ablation,0,0
60516,of,0,0
60517,thyroid,0,0
60518,remnants,0,0
60519,",",0,0
60520,by,0,0
60521,means,0,0
60522,of,0,0
60523,the,0,0
60524,treatment,0,0
60525,amount,0,1
60526,of,0,0
60527,radioiodine,0,0
60528,of,0,0
60529,a,0,0
60530,standard,0,0
60531,activity,0,1
60532,of,0,0
60533,3.7,0,0
60534,GBq,0,0
60535,",",0,0
60536,was,0,0
60537,performed,0,0
60538,",",0,0
60539,and,0,0
60540,then,0,0
60541,a,0,0
60542,suppression,0,1
60543,and,0,1
60544,substitution,0,1
60545,therapy,0,0
60546,of,0,0
60547,thyroid,0,0
60548,hormones,0,1
60549,was,0,0
60550,started,0,0
60551,.,0,0
60552,After,0,0
60553,3-6,0,0
60554,months,0,0
60555,some,0,0
60556,patients,0,0
60557,were,0,0
60558,examined,0,0
60559,by,0,0
60560,means,0,0
60561,of,0,0
60562,diagnostic,1,0
60563,whole,1,0
60564,body,1,1
60565,scintigraphy,1,1
60566,after,0,0
60567,application,0,0
60568,of,0,0
60569,300,0,0
60570,MBq,0,0
60571,131I,0,0
60572,.,0,0
60573,Some,0,0
60574,patients,0,0
60575,were,0,0
60576,treated,0,0
60577,by,0,0
60578,means,0,0
60579,of,0,0
60580,a,0,0
60581,standard,0,0
60582,activity,0,1
60583,of,0,0
60584,7.4,0,0
60585,GBq,0,0
60586,131I,0,0
60587,and,0,0
60588,after,0,0
60589,5,0,0
60590,days,0,0
60591,whole,0,0
60592,body,0,1
60593,scintigraphy,0,1
60594,(,0,0
60595,WBS,0,0
60596,),0,0
60597,was,0,0
60598,performed,0,0
60599,.,0,0
60600,In,0,0
60601,both,0,0
60602,of,0,0
60603,these,0,0
60604,groups,0,0
60605,of,0,0
60606,patients,0,0
60607,the,0,0
60608,diagnostic,0,0
60609,or,0,0
60610,therapeutic,0,0
60611,radioiodine,0,0
60612,application,0,0
60613,was,0,0
60614,done,0,0
60615,after,0,0
60616,withdrawal,0,0
60617,of,0,0
60618,thyroid,0,0
60619,hormone,0,0
60620,treatment,0,0
60621,.,0,0
60622,If,0,0
60623,thyroglobulin,1,1
60624,levels,1,1
60625,were,0,0
60626,low,0,0
60627,and,0,1
60628,WBSs,1,0
60629,were,0,0
60630,negative,0,1
60631,",",0,0
60632,patients,0,0
60633,were,0,0
60634,followed,0,0
60635,up,0,0
60636,in,0,0
60637,the,0,0
60638,Department,0,0
60639,of,0,0
60640,Nuclear,0,0
60641,Medicine,0,0
60642,in,0,0
60643,Martin,0,0
60644,.,0,0
60645,Patients,0,0
60646,with,0,0
60647,radioiodine,0,0
60648,accumulated,0,1
60649,metastases,0,0
60650,were,0,0
60651,again,0,0
60652,treated,0,0
60653,with,0,0
60654,radioiodine,0,0
60655,in,0,0
60656,Ostrava,0,0
60657,.,0,0
60658,If,0,0
60659,indicated,0,0
60660,",",0,0
60661,external,0,0
60662,radiation,0,0
60663,therapy,0,0
60664,targeted,0,0
60665,on,0,0
60666,the,0,0
60667,neck,0,1
60668,and,0,0
60669,upper,0,1
60670,mediastinum,0,1
60671,was,0,0
60672,performed,0,0
60673,in,0,0
60674,the,0,0
60675,Slovak,0,0
60676,Republic,0,0
60677,",",0,0
60678,in,0,0
60679,the,0,0
60680,University,0,0
60681,Hospital,0,1
60682,in,0,0
60683,Martin,0,0
60684,.,0,0
60685,Newly,0,0
60686,formed,0,0
60687,lymph,0,0
60688,node,0,0
60689,metastases,0,0
60690,were,0,0
60691,surgically,0,0
60692,treated,0,0
60693,in,0,0
60694,Slovakia,0,0
60695,",",0,0
60696,too,0,0
60697,.,0,0
60698,Generally,0,0
60699,we,0,0
60700,have,0,0
60701,very,0,0
60702,good,1,0
60703,treatment,1,0
60704,results,1,0
60705,.,1,0
60706,Also,0,0
60707,",",0,0
60708,economically,0,0
60709,our,0,0
60710,partnership,0,0
60711,is,0,0
60712,cost,1,1
60713,effective,1,0
60714,.,1,0
60715,Our,0,0
60716,collaboration,0,0
60717,also,0,0
60718,successfully,0,0
60719,continues,0,0
60720,after,0,0
60721,entrance,0,1
60722,of,0,0
60723,the,0,0
60724,Slovak,0,0
60725,Republic,0,0
60726,and,0,0
60727,the,0,0
60728,Czech,0,0
60729,Republic,0,0
60730,to,0,0
60731,the,0,0
60732,European,0,0
60733,Union,0,0
60734,in,0,0
60735,2004,0,0
60736,.,0,0
60737,CONCLUSIONS,0,0
60738,The,0,0
60739,results,0,0
60740,of,0,0
60741,this,0,0
60742,multi-centre,0,0
60743,study,0,0
60744,show,0,0
60745,that,0,0
60746,international,0,0
60747,Czech,0,0
60748,and,0,0
60749,Slovak,0,0
60750,cooperation,0,0
60751,in,0,0
60752,the,0,0
60753,complex,0,0
60754,therapy,0,0
60755,of,0,0
60756,patients,0,0
60757,with,0,0
60758,differentiated,0,1
60759,thyroid,0,0
60760,cancers,0,0
60761,is,0,0
60762,successful,0,0
60763,",",0,0
60764,with,0,0
60765,high,0,0
60766,efficacy,0,1
60767,.,0,0
60768,The,0,0
60769,treatment,0,0
60770,results,0,0
60771,were,0,0
60772,very,0,0
60773,similar,0,0
60774,to,0,0
60775,therapeutic,0,0
60776,results,0,0
60777,in,0,0
60778,our,0,0
60779,patients,0,0
60780,from,0,0
60781,the,0,0
60782,Czech,0,0
60783,Republic,0,0
60784,.,0,0
60785,POG,0,0
60786,8625,0,0
60787,:,0,0
60788,a,0,0
60789,randomized,0,0
60790,trial,0,0
60791,comparing,0,0
60792,chemotherapy,0,0
60793,with,0,0
60794,chemoradiotherapy,0,0
60795,for,0,0
60796,children,0,0
60797,and,0,0
60798,adolescents,0,0
60799,with,0,0
60800,Stages,0,0
60801,I,0,0
60802,",",0,0
60803,IIA,0,0
60804,",",0,0
60805,IIIA1,0,1
60806,Hodgkin,0,1
60807,Disease,0,0
60808,:,0,0
60809,a,0,0
60810,report,0,0
60811,from,0,0
60812,the,0,0
60813,Children,0,0
60814,'s,0,0
60815,Oncology,0,0
60816,Group,0,0
60817,.,0,0
60818,To,0,0
60819,determine,0,0
60820,if,0,0
60821,6,0,0
60822,courses,0,0
60823,of,0,0
60824,chemotherapy,0,0
60825,alone,0,0
60826,could,0,0
60827,achieve,0,0
60828,the,0,0
60829,same,0,0
60830,or,0,0
60831,better,0,0
60832,outcome,0,1
60833,than,0,0
60834,4,0,0
60835,courses,0,0
60836,of,0,0
60837,chemotherapy,0,0
60838,followed,0,0
60839,by,0,0
60840,radiation,0,0
60841,therapy,0,0
60842,(,0,0
60843,chemoradiotherapy,0,0
60844,),0,0
60845,in,0,0
60846,pediatric,0,0
60847,and,0,0
60848,adolescent,0,0
60849,patients,0,0
60850,with,0,0
60851,Hodgkin,0,1
60852,disease,0,0
60853,.,0,0
60854,Children,0,0
60855,<,0,0
60856,or,0,0
60857,=21,0,0
60858,years,0,0
60859,old,0,0
60860,with,0,0
60861,biopsy-proven,0,0
60862,",",0,0
60863,pathologically,0,0
60864,staged,0,0
60865,I,0,0
60866,",",0,0
60867,IIA,0,0
60868,",",0,1
60869,or,0,0
60870,IIIA1,0,1
60871,Hodgkin,0,1
60872,disease,0,1
60873,were,0,0
60874,randomly,0,0
60875,assigned,0,0
60876,6,0,0
60877,courses,0,0
60878,of,0,0
60879,alternating,0,0
60880,nitrogen,0,0
60881,mustard,0,0
60882,",",0,0
60883,oncovin,0,0
60884,",",0,1
60885,prednisone,0,0
60886,",",0,1
60887,and,0,1
60888,procarbazine/doxorubicin,0,0
60889,",",0,1
60890,bleomycin,0,0
60891,",",0,1
60892,vinblastine,0,0
60893,",",0,1
60894,and,0,1
60895,dacarbazine,0,0
60896,(,0,0
60897,treatment,0,0
60898,1,0,0
60899,),0,0
60900,or,0,0
60901,4,0,0
60902,courses,0,0
60903,of,0,0
60904,alternating,0,0
60905,nitrogen,0,0
60906,mustard,0,0
60907,",",0,0
60908,oncovin,0,0
60909,",",0,1
60910,prednisone,0,0
60911,",",0,1
60912,and,0,1
60913,procarbazine/doxorubicin,0,0
60914,",",0,1
60915,bleomycin,0,0
60916,",",0,1
60917,vinblastine,0,0
60918,",",0,0
60919,and,0,1
60920,dacarbazine,0,0
60921,+2550,0,0
60922,cGy,0,0
60923,involved-field,0,0
60924,radiotherapy,0,0
60925,(,0,0
60926,treatment,0,0
60927,2,0,0
60928,),0,0
60929,.,0,0
60930,The,0,0
60931,complete,0,1
60932,response,0,1
60933,rate,0,1
60934,was,0,0
60935,89,0,0
60936,%,0,0
60937,",",0,0
60938,with,0,0
60939,a,0,0
60940,complete,0,1
60941,response,0,1
60942,and,0,0
60943,partial,0,1
60944,response,0,1
60945,rate,0,1
60946,of,0,0
60947,99.4,0,0
60948,%,0,0
60949,.,0,0
60950,There,0,0
60951,was,0,0
60952,no,0,0
60953,statistically,0,0
60954,significant,0,0
60955,difference,0,0
60956,in,0,0
60957,event-free,1,1
60958,survival,1,1
60959,(,1,0
60960,EFS,1,1
60961,),1,0
60962,or,1,0
60963,overall,1,1
60964,survival,1,1
60965,between,0,0
60966,arms,0,0
60967,.,0,0
60968,The,0,0
60969,EFS,1,0
60970,for,0,0
60971,those,0,0
60972,who,0,0
60973,achieved,0,0
60974,an,0,0
60975,early,0,0
60976,complete,1,1
60977,response,1,1
60978,was,0,0
60979,significantly,0,0
60980,higher,0,0
60981,than,0,0
60982,for,0,0
60983,those,0,0
60984,who,0,0
60985,did,0,0
60986,not,0,0
60987,.,0,0
60988,For,0,0
60989,pediatric,0,0
60990,patients,0,0
60991,with,0,0
60992,asymptomatic,0,0
60993,low-stage,0,0
60994,and,0,1
60995,intermediate-stage,0,0
60996,Hodgkin,0,1
60997,disease,0,1
60998,",",0,1
60999,chemotherapy,0,0
61000,and,0,0
61001,chemoradiotherapy,0,0
61002,both,0,0
61003,resulted,0,0
61004,in,0,0
61005,3-year,1,0
61006,EFS,1,1
61007,of,0,0
61008,approximately,0,0
61009,90,0,0
61010,%,0,0
61011,and,0,0
61012,statistically,0,0
61013,indistinguishable,0,0
61014,8-year,1,0
61015,EFS,1,1
61016,and,0,0
61017,overall,1,1
61018,survival,1,1
61019,",",0,0
61020,without,0,0
61021,significant,0,0
61022,long-term,1,0
61023,toxicity,1,1
61024,.,1,0
61025,Early,0,0
61026,response,1,1
61027,to,1,0
61028,therapy,1,0
61029,was,0,0
61030,associated,0,0
61031,with,0,0
61032,higher,0,0
61033,EFS,1,1
61034,",",0,0
61035,a,0,0
61036,concept,0,0
61037,that,0,0
61038,has,0,0
61039,led,0,0
61040,to,0,0
61041,the,0,0
61042,Children,0,0
61043,'s,0,0
61044,Oncology,0,0
61045,Group,0,0
61046,paradigm,0,0
61047,of,0,0
61048,response-based,0,0
61049,risk-adapted,0,0
61050,therapy,0,0
61051,for,0,0
61052,pediatric,0,0
61053,Hodgkin,0,1
61054,disease,0,0
61055,.,0,0
61056,Psychological,0,0
61057,well-being,0,1
61058,correlates,0,0
61059,with,0,0
61060,free,0,1
61061,thyroxine,0,0
61062,but,0,0
61063,not,0,0
61064,free,0,1
61065,"3,5,3'-triiodothyronine",0,1
61066,levels,0,1
61067,in,0,0
61068,patients,0,0
61069,on,0,0
61070,thyroid,0,0
61071,hormone,0,0
61072,replacement,0,0
61073,.,0,0
61074,CONTEXT,0,0
61075,AND,0,0
61076,OBJECTIVE,0,0
61077,An,0,0
61078,association,0,0
61079,between,0,0
61080,mood,0,1
61081,disorders,0,0
61082,and,0,0
61083,overt,0,1
61084,thyroid,0,0
61085,dysfunction,0,0
61086,is,0,0
61087,well,0,0
61088,established,0,0
61089,",",0,0
61090,but,0,0
61091,there,0,0
61092,are,0,0
61093,few,0,0
61094,data,0,0
61095,on,0,0
61096,the,0,0
61097,potential,0,0
61098,for,0,0
61099,thyroid,0,0
61100,hormone,0,1
61101,levels,0,1
61102,closer,0,0
61103,to,0,0
61104,the,0,0
61105,reference,0,0
61106,range,0,0
61107,to,0,0
61108,correlate,0,0
61109,with,0,0
61110,psychological,0,1
61111,well-being,0,1
61112,.,0,0
61113,DESIGN,0,0
61114,",",0,0
61115,SETTING,0,0
61116,",",0,0
61117,AND,0,0
61118,PATIENTS,0,0
61119,We,0,0
61120,analyzed,0,0
61121,the,0,0
61122,relationship,0,0
61123,between,0,0
61124,psychological,0,1
61125,well-being,0,1
61126,and,0,0
61127,free,0,1
61128,T,0,0
61129,(,0,0
61130,4,0,0
61131,),0,0
61132,(,0,0
61133,fT4,0,0
61134,),0,0
61135,",",0,0
61136,free,0,1
61137,T,0,0
61138,(,0,0
61139,3,0,0
61140,),0,0
61141,(,0,0
61142,fT3,0,0
61143,),0,0
61144,",",0,0
61145,TSH,0,1
61146,",",0,1
61147,and,0,1
61148,total,0,1
61149,rT,0,0
61150,(,0,0
61151,3,0,0
61152,),0,0
61153,in,0,0
61154,697,0,0
61155,patients,0,0
61156,on,0,0
61157,thyroid,0,0
61158,hormone,0,1
61159,replacement,0,0
61160,therapy,0,0
61161,at,0,0
61162,entry,0,0
61163,to,0,0
61164,a,0,0
61165,randomized,0,0
61166,",",0,0
61167,controlled,0,0
61168,trial,0,0
61169,of,0,0
61170,combined,0,0
61171,T,0,0
61172,(,0,0
61173,4,0,0
61174,),0,0
61175,and,0,0
61176,T,0,0
61177,(,0,0
61178,3,0,0
61179,),0,0
61180,replacement,0,0
61181,therapy,0,0
61182,.,0,0
61183,All,0,0
61184,patients,0,0
61185,were,0,0
61186,on,0,0
61187,100,0,0
61188,mug,0,0
61189,or,0,0
61190,more,0,0
61191,T,0,1
61192,(,0,0
61193,4,0,0
61194,),0,0
61195,.,0,0
61196,INTERVENTIONS,0,1
61197,AND,0,0
61198,MAIN,0,0
61199,OUTCOME,0,1
61200,MEASURES,0,0
61201,Psychological,1,1
61202,well-being,1,1
61203,was,1,0
61204,assessed,1,0
61205,with,1,0
61206,General,1,0
61207,Health,1,1
61208,Questionnaire-12,1,1
61209,(,1,0
61210,GHQ-12,1,0
61211,),1,0
61212,",",1,0
61213,Thyroid,1,0
61214,Symptom,1,1
61215,Questionnaire,1,1
61216,",",1,0
61217,and,1,1
61218,Hospital,1,1
61219,Anxiety,1,1
61220,and,1,0
61221,Depression,1,1
61222,Scale,1,1
61223,.,1,0
61224,RESULTS,0,0
61225,fT,0,0
61226,(,0,0
61227,4,0,0
61228,),0,0
61229,and,0,0
61230,TSH,0,0
61231,showed,0,0
61232,a,0,0
61233,strong,0,0
61234,correlation,0,0
61235,with,0,0
61236,GHQ-12,1,0
61237,scores,1,1
61238,(,0,0
61239,fT4,0,0
61240,-,0,0
61241,b,0,0
61242,:,0,0
61243,-0.16,0,0
61244,",",0,0
61245,P,0,0
61246,=,0,0
61247,0.005,0,0
61248,;,0,0
61249,TSH,0,0
61250,-,0,0
61251,b,0,0
61252,:,0,0
61253,0.663,0,0
61254,",",0,0
61255,P,0,0
61256,=,0,0
61257,0.04,0,0
61258,),0,0
61259,.,0,0
61260,No,0,0
61261,correlations,0,0
61262,were,0,0
61263,seen,0,0
61264,between,0,0
61265,the,0,0
61266,GHQ,1,1
61267,scores,1,1
61268,and,1,1
61269,fT3,1,1
61270,(,0,0
61271,b,0,0
61272,:,0,0
61273,0.318,0,0
61274,",",0,0
61275,P,0,0
61276,=,0,0
61277,0.275,0,0
61278,),0,0
61279,",",0,0
61280,rT,0,0
61281,(,0,0
61282,3,0,0
61283,),0,0
61284,(,0,0
61285,b,0,0
61286,:,0,0
61287,0.095,0,0
61288,",",0,0
61289,P,0,0
61290,=,0,0
61291,0.95,0,0
61292,),0,0
61293,",",0,0
61294,rT,0,0
61295,(,0,0
61296,3,0,0
61297,),0,0
61298,to,0,0
61299,fT4,0,0
61300,ratio,0,1
61301,(,0,0
61302,b,0,0
61303,:,0,0
61304,71.83,0,0
61305,",",0,0
61306,P,0,0
61307,=,0,0
61308,0.09,0,0
61309,),0,0
61310,or,0,0
61311,fT3,0,0
61312,to,0,0
61313,rT,0,0
61314,(,0,0
61315,3,0,0
61316,),0,0
61317,ratio,0,0
61318,(,0,0
61319,b,0,0
61320,:,0,0
61321,0.05,0,0
61322,",",0,0
61323,P,0,0
61324,=,0,0
61325,0.32,0,0
61326,),0,0
61327,.,0,0
61328,The,0,0
61329,correlations,0,0
61330,remained,0,0
61331,when,0,0
61332,the,0,0
61333,data,0,0
61334,set,0,0
61335,was,0,0
61336,limited,0,0
61337,to,0,0
61338,patients,0,0
61339,with,0,0
61340,TSH,0,0
61341,in,0,0
61342,the,0,0
61343,range,0,0
61344,0.3-4.0,0,0
61345,mIU/liter,0,0
61346,.,0,0
61347,Similar,0,0
61348,correlations,0,0
61349,were,0,0
61350,seen,0,0
61351,with,0,0
61352,the,0,0
61353,Thyroid,1,0
61354,Symptom,1,1
61355,Questionnaire,1,1
61356,",",0,0
61357,although,0,0
61358,not,0,0
61359,with,0,0
61360,the,0,0
61361,Hospital,1,1
61362,Anxiety,1,1
61363,and,1,0
61364,Depression,1,1
61365,Scale,1,1
61366,scores,1,1
61367,.,1,0
61368,CONCLUSIONS,0,0
61369,Differences,0,0
61370,in,0,0
61371,fT4,0,0
61372,and,0,1
61373,TSH,0,1
61374,concentration,0,1
61375,",",0,0
61376,even,0,0
61377,within,0,0
61378,the,0,0
61379,reference,0,0
61380,range,0,0
61381,",",0,0
61382,may,0,0
61383,be,0,0
61384,a,0,0
61385,determinant,0,0
61386,of,0,0
61387,psychological,0,1
61388,well-being,0,1
61389,in,0,0
61390,treated,0,0
61391,hypothyroid,0,0
61392,patients,0,0
61393,although,0,0
61394,not,0,0
61395,necessarily,0,0
61396,with,0,0
61397,symptoms,0,1
61398,typical,0,0
61399,of,0,0
61400,anxiety,0,1
61401,or,0,0
61402,depression,0,1
61403,.,0,0
61404,Pelvic,0,0
61405,lymphadenectomy,0,0
61406,for,0,0
61407,cervical,0,0
61408,carcinoma,0,0
61409,:,0,0
61410,laparotomy,0,0
61411,extraperitoneal,0,0
61412,",",0,0
61413,transperitoneal,0,0
61414,or,0,1
61415,laparoscopic,0,0
61416,approach,0,0
61417,?,0,0
61418,A,0,0
61419,randomized,0,0
61420,study,0,0
61421,.,0,0
61422,OBJECTIVE,0,0
61423,To,0,0
61424,compare,0,0
61425,transperitoneal,0,0
61426,",",0,0
61427,extraperitoneal,0,0
61428,and,0,1
61429,laparoscopic,0,0
61430,pelvic,0,0
61431,lymphadenectomy,0,0
61432,in,0,0
61433,terms,0,0
61434,of,0,0
61435,feasibility,1,0
61436,and,1,1
61437,morbidity,1,1
61438,in,0,0
61439,patients,0,0
61440,affected,0,0
61441,by,0,0
61442,cervical,0,0
61443,cancer,0,0
61444,undergoing,0,0
61445,radical,0,0
61446,hysterectomy,0,0
61447,.,0,0
61448,METHODS,0,0
61449,Consecutive,0,0
61450,patients,0,0
61451,affected,0,0
61452,by,0,0
61453,stage,0,0
61454,IB-IIB,0,0
61455,cervical,0,0
61456,carcinoma,0,0
61457,scheduled,0,0
61458,for,0,0
61459,radical,0,0
61460,surgery,0,0
61461,entered,0,0
61462,the,0,0
61463,study,0,0
61464,.,0,0
61465,Patients,0,0
61466,were,0,0
61467,randomly,0,0
61468,assigned,0,0
61469,to,0,0
61470,transperitoneal,0,0
61471,(,0,0
61472,TPL,0,1
61473,),0,0
61474,",",0,0
61475,extraperitoneal,0,0
61476,(,0,0
61477,EPL,0,0
61478,),0,0
61479,or,0,0
61480,laparoscopic,0,0
61481,pelvic,0,0
61482,lymphadenectomy,0,0
61483,(,0,0
61484,LPL,0,0
61485,),0,0
61486,.,0,0
61487,All,0,0
61488,patients,0,0
61489,underwent,0,0
61490,classical,0,0
61491,radical,0,0
61492,hysterectomy,0,0
61493,.,0,0
61494,Perioperative,0,0
61495,data,0,0
61496,were,0,0
61497,recorded,0,0
61498,.,0,0
61499,Follow,0,0
61500,up,0,0
61501,examinations,1,0
61502,were,0,0
61503,performed,0,0
61504,at,0,0
61505,the,0,0
61506,15th,0,0
61507,",",0,0
61508,30th,0,0
61509,and,0,0
61510,60th,0,0
61511,day,0,0
61512,after,0,0
61513,surgery,0,0
61514,.,0,0
61515,RESULTS,0,0
61516,168,0,0
61517,patients,0,0
61518,entered,0,0
61519,the,0,0
61520,study,0,0
61521,.,0,0
61522,The,0,0
61523,mean,1,1
61524,operative,1,1
61525,times,1,0
61526,were,0,0
61527,:,0,0
61528,63+/-7.6,0,0
61529,",",0,0
61530,54+/-6.7,0,0
61531,and,0,1
61532,75+/-8.4,0,0
61533,min,0,0
61534,(,0,0
61535,TPL,0,1
61536,vs,0,0
61537,EPL,0,0
61538,P,0,0
61539,<,0,0
61540,0.001,0,0
61541,;,0,0
61542,EPL,0,0
61543,vs,0,0
61544,LPL,0,0
61545,P,0,0
61546,<,0,0
61547,0.001,0,0
61548,;,0,0
61549,TPL,0,0
61550,vs,0,0
61551,LPL,0,0
61552,P,0,0
61553,<,0,0
61554,0.001,0,0
61555,),0,0
61556,for,0,0
61557,TPL,0,1
61558,",",0,0
61559,EPL,0,0
61560,and,0,1
61561,LPL,0,0
61562,respectively,0,0
61563,.,0,0
61564,The,0,0
61565,feasibility,1,0
61566,of,1,0
61567,the,1,0
61568,procedures,1,0
61569,",",0,0
61570,analyzed,0,0
61571,on,0,0
61572,an,0,0
61573,intention-to-treat,0,0
61574,basis,0,0
61575,",",0,0
61576,was,0,0
61577,96,0,0
61578,%,0,0
61579,",",0,0
61580,93,0,0
61581,%,0,0
61582,and,0,0
61583,95,0,0
61584,%,0,0
61585,for,0,0
61586,TPL,0,1
61587,",",0,0
61588,EPL,0,0
61589,and,0,1
61590,LPL,0,1
61591,group,0,0
61592,respectively,0,0
61593,(,0,0
61594,P=ns,0,0
61595,),0,0
61596,.,0,0
61597,The,0,0
61598,average,1,0
61599,hospitalizations,1,1
61600,were,0,0
61601,:,0,0
61602,5.6+/-0.9,0,0
61603,",",0,0
61604,3.2+/-0.4,0,0
61605,and,0,1
61606,3.1+/-0.3,0,0
61607,days,0,0
61608,(,0,0
61609,TPL,0,0
61610,vs,0,0
61611,EPL,0,0
61612,P,0,0
61613,<,0,0
61614,0.001,0,0
61615,;,0,0
61616,TPL,0,0
61617,vs,0,0
61618,LPL,0,0
61619,P,0,0
61620,<,0,0
61621,0.001,0,0
61622,),0,0
61623,for,0,0
61624,TPL,0,1
61625,",",0,0
61626,EPL,0,0
61627,and,0,1
61628,LPL,0,0
61629,respectively,0,0
61630,.,0,0
61631,CONCLUSIONS,0,0
61632,EPL,0,0
61633,and,0,0
61634,LPL,0,0
61635,are,0,0
61636,as,0,0
61637,feasible,1,0
61638,and,0,0
61639,effective,1,1
61640,as,0,0
61641,TPL,0,0
61642,and,0,0
61643,can,0,0
61644,be,0,0
61645,adequately,0,0
61646,performed,0,0
61647,with,0,0
61648,a,0,0
61649,reasonable,0,0
61650,complication,0,1
61651,rate,0,1
61652,.,0,0
61653,LPL,0,0
61654,showed,0,0
61655,a,0,0
61656,statistically,0,0
61657,significant,0,0
61658,longer,0,0
61659,operative,1,1
61660,time,1,1
61661,.,1,0
61662,However,0,0
61663,",",0,0
61664,both,0,0
61665,EPL,0,0
61666,and,0,0
61667,LPL,0,0
61668,can,0,0
61669,minimize,0,0
61670,some,0,0
61671,postoperative,0,0
61672,complications,0,1
61673,reducing,0,0
61674,length,1,1
61675,of,1,0
61676,stay,1,1
61677,.,1,0
61678,Randomized,0,0
61679,comparison,0,0
61680,of,0,0
61681,two,0,0
61682,communication,0,0
61683,interventions,0,0
61684,for,0,0
61685,preschoolers,0,0
61686,with,0,0
61687,autism,0,0
61688,spectrum,0,0
61689,disorders,0,0
61690,.,0,0
61691,This,0,0
61692,randomized,0,0
61693,group,0,0
61694,experiment,0,0
61695,compared,0,0
61696,the,0,0
61697,efficacy,0,0
61698,of,0,0
61699,2,0,0
61700,communication,0,0
61701,interventions,0,0
61702,(,0,0
61703,Responsive,0,0
61704,Education,0,1
61705,and,0,0
61706,Prelinguistic,0,0
61707,Milieu,0,1
61708,Teaching,0,0
61709,[,0,0
61710,RPMT,0,0
61711,],0,0
61712,and,0,0
61713,the,0,0
61714,Picture,0,1
61715,Exchange,0,0
61716,Communication,0,1
61717,System,0,0
61718,[,0,0
61719,PECS,0,0
61720,],0,0
61721,),0,0
61722,in,0,0
61723,36,0,0
61724,preschoolers,0,0
61725,with,0,0
61726,autism,0,0
61727,spectrum,0,0
61728,disorders,0,0
61729,.,0,0
61730,Each,0,0
61731,treatment,0,0
61732,was,0,0
61733,delivered,0,0
61734,3,0,0
61735,times,0,0
61736,per,0,0
61737,week,0,0
61738,",",0,0
61739,in,0,0
61740,20-min,0,0
61741,sessions,0,0
61742,",",0,0
61743,for,0,0
61744,6,0,0
61745,months,0,0
61746,.,0,0
61747,The,0,0
61748,results,0,0
61749,revealed,0,0
61750,that,0,0
61751,the,0,0
61752,RPMT,0,0
61753,facilitated,0,0
61754,the,0,0
61755,frequency,1,1
61756,of,1,0
61757,generalized,1,1
61758,turn,1,1
61759,taking,1,0
61760,and,1,0
61761,generalized,1,1
61762,initiating,1,0
61763,joint,1,1
61764,attention,1,0
61765,more,0,0
61766,than,0,0
61767,did,0,0
61768,the,0,0
61769,PECS,0,0
61770,.,0,0
61771,The,0,0
61772,latter,0,0
61773,effect,0,0
61774,occurred,0,0
61775,only,0,0
61776,for,0,0
61777,children,0,0
61778,who,0,0
61779,began,0,0
61780,treatment,0,0
61781,with,0,0
61782,at,0,0
61783,least,0,0
61784,some,0,0
61785,initiating,1,0
61786,joint,1,1
61787,attention,1,0
61788,.,1,0
61789,In,0,0
61790,contrast,0,0
61791,",",0,0
61792,the,0,0
61793,PECS,0,0
61794,facilitated,0,0
61795,generalized,1,1
61796,requests,1,1
61797,more,0,0
61798,than,0,0
61799,the,0,0
61800,RPMT,0,0
61801,in,0,0
61802,children,0,0
61803,with,0,0
61804,very,0,0
61805,little,0,0
61806,initiating,1,0
61807,joint,1,1
61808,attention,1,0
61809,prior,0,0
61810,to,0,0
61811,treatment,0,0
61812,.,0,0
61813,These,0,0
61814,effect,1,0
61815,sizes,1,1
61816,were,0,0
61817,large,1,0
61818,.,1,0
61819,Specific,0,0
61820,immunoglobulin,0,0
61821,for,0,0
61822,treatment,0,0
61823,of,0,0
61824,whooping,0,0
61825,cough,0,1
61826,.,0,0
61827,Immunoglobulin,0,0
61828,treatment,0,0
61829,for,0,0
61830,whooping,0,1
61831,cough,0,1
61832,(,0,0
61833,pertussis,0,0
61834,),0,0
61835,is,0,0
61836,widely,0,0
61837,believed,0,0
61838,to,0,0
61839,be,0,0
61840,ineffective,1,0
61841,although,0,0
61842,there,0,0
61843,are,0,0
61844,sound,0,0
61845,reasons,0,0
61846,for,0,0
61847,regarding,0,0
61848,the,0,0
61849,condition,0,0
61850,as,0,0
61851,a,0,0
61852,toxin-induced,0,0
61853,disease,0,0
61854,.,0,0
61855,We,0,0
61856,wondered,0,0
61857,whether,0,0
61858,the,0,0
61859,lack,1,0
61860,of,1,0
61861,success,1,1
61862,with,0,0
61863,pertussis,0,0
61864,immunoglobulins,0,0
61865,might,0,0
61866,be,0,0
61867,attributable,0,0
61868,to,0,0
61869,inadequate,0,0
61870,dose,0,0
61871,",",0,0
61872,so,0,0
61873,we,0,0
61874,designed,0,0
61875,a,0,0
61876,randomised,0,0
61877,",",0,0
61878,double-blind,0,0
61879,",",0,0
61880,placebo-controlled,0,0
61881,trial,0,0
61882,of,0,0
61883,two,0,0
61884,immunoglobulin,0,0
61885,preparations,0,0
61886,.,0,0
61887,The,0,0
61888,study,0,0
61889,was,0,0
61890,conducted,0,0
61891,at,0,0
61892,three,0,0
61893,Swedish,0,0
61894,hospitals,0,0
61895,.,0,0
61896,We,0,0
61897,enrolled,0,0
61898,73,0,0
61899,children,0,0
61900,aged,0,0
61901,less,0,0
61902,than,0,0
61903,36,0,0
61904,months,0,0
61905,who,0,0
61906,were,0,0
61907,admitted,0,0
61908,with,0,0
61909,a,0,0
61910,clinical,0,0
61911,diagnosis,0,0
61912,of,0,0
61913,whooping,0,0
61914,cough,0,1
61915,.,0,0
61916,On,0,0
61917,admission,0,1
61918,they,0,0
61919,were,0,0
61920,assigned,0,0
61921,to,0,0
61922,one,0,0
61923,of,0,0
61924,three,0,0
61925,groups,0,0
61926,:,0,0
61927,(,0,0
61928,a,0,0
61929,),0,0
61930,monocomponent,0,0
61931,pertussis,0,0
61932,toxoid,0,0
61933,vaccine,0,0
61934,;,0,0
61935,(,0,0
61936,b,0,0
61937,),0,0
61938,two-component,0,0
61939,acellular,0,0
61940,vaccine,0,0
61941,also,0,0
61942,containing,0,0
61943,filamentous,0,0
61944,haemagglutinin,0,1
61945,;,0,0
61946,or,0,0
61947,(,0,0
61948,c,0,0
61949,),0,0
61950,20,0,0
61951,%,0,0
61952,albumin,0,1
61953,solution,0,0
61954,(,0,0
61955,placebo,0,0
61956,),0,0
61957,.,0,0
61958,The,0,0
61959,immunoglobulins,0,0
61960,had,0,0
61961,a,0,0
61962,high,0,0
61963,antitoxin,0,1
61964,content,0,1
61965,and,0,1
61966,had,0,0
61967,been,0,0
61968,raised,0,0
61969,with,0,0
61970,acellular,0,0
61971,pertussis,0,0
61972,vaccines,0,0
61973,.,0,0
61974,Diagnosis,0,0
61975,of,0,0
61976,pertussis,0,0
61977,was,0,0
61978,confirmed,0,0
61979,by,0,0
61980,laboratory,0,0
61981,tests,0,1
61982,and,0,0
61983,the,0,0
61984,follow-up,0,0
61985,was,0,0
61986,completed,0,0
61987,in,0,0
61988,67,0,0
61989,children,0,0
61990,.,0,0
61991,The,0,0
61992,main,0,0
61993,study,0,0
61994,group,0,0
61995,consisted,0,0
61996,of,0,0
61997,47,0,0
61998,children,0,0
61999,with,0,0
62000,less,0,0
62001,than,0,0
62002,or,0,0
62003,equal,0,0
62004,to,0,0
62005,14,0,0
62006,days,0,0
62007,of,0,0
62008,disease,0,0
62009,before,0,0
62010,therapy,0,0
62011,.,0,0
62012,Duration,1,1
62013,of,1,0
62014,whoops,1,1
62015,post-treatment,1,0
62016,was,0,0
62017,8.7,0,0
62018,days,0,0
62019,(,0,0
62020,95,0,0
62021,%,0,0
62022,Cl,0,0
62023,4.8,0,0
62024,",",0,0
62025,12.6,0,0
62026,),0,0
62027,in,0,0
62028,the,0,0
62029,33,0,0
62030,children,0,0
62031,receiving,0,0
62032,immunoglobulin,0,0
62033,vs,0,0
62034,20.6,0,0
62035,(,0,0
62036,95,0,0
62037,%,0,0
62038,Cl,0,0
62039,11.9,0,0
62040,",",0,0
62041,29.3,0,0
62042,),0,0
62043,in,0,0
62044,the,0,0
62045,14,0,0
62046,receiving,0,0
62047,placebo,0,0
62048,(,0,0
62049,p,0,0
62050,=,0,0
62051,0.0041,0,0
62052,),0,0
62053,.,0,0
62054,Mean,1,0
62055,number,1,1
62056,of,1,0
62057,whoops,1,0
62058,during,0,0
62059,the,0,0
62060,first,0,0
62061,week,0,0
62062,of,0,0
62063,follow-up,0,0
62064,was,0,0
62065,also,0,0
62066,significantly,0,0
62067,reduced,0,0
62068,(,0,0
62069,p,0,0
62070,=,0,0
62071,0.0196,0,0
62072,),0,0
62073,.,0,0
62074,We,0,0
62075,found,0,0
62076,that,0,0
62077,early,0,0
62078,treatment,0,0
62079,was,0,0
62080,important,0,0
62081,",",0,0
62082,since,0,0
62083,the,0,0
62084,effect,0,0
62085,on,0,0
62086,duration,1,1
62087,of,1,0
62088,whoops,1,0
62089,was,0,0
62090,most,0,0
62091,pronounced,0,0
62092,when,0,0
62093,disease,0,1
62094,duration,0,1
62095,before,0,0
62096,treatment,0,0
62097,was,0,0
62098,less,0,0
62099,than,0,0
62100,or,0,0
62101,equal,0,0
62102,to,0,0
62103,7,0,0
62104,days,0,0
62105,.,0,0
62106,There,0,0
62107,were,0,0
62108,no,0,0
62109,significant,0,0
62110,differences,1,0
62111,between,0,0
62112,the,0,0
62113,two,0,0
62114,immunoglobulin,0,0
62115,preparations,0,0
62116,.,0,0
62117,High-dose,0,0
62118,specific,0,0
62119,pertussis,0,0
62120,immunoglobulin,0,0
62121,with,0,0
62122,a,0,0
62123,high,0,0
62124,antitoxin,0,1
62125,concentration,0,1
62126,has,0,0
62127,a,0,0
62128,beneficial,1,0
62129,effect,1,0
62130,in,0,0
62131,the,0,0
62132,treatment,0,0
62133,of,0,0
62134,whooping,0,0
62135,cough,0,0
62136,.,0,0
62137,Gemcitabine,0,0
62138,and,0,0
62139,split-dose,0,0
62140,paclitaxel,0,0
62141,or,0,0
62142,docetaxel,0,0
62143,in,0,0
62144,metastatic,0,0
62145,breast,0,0
62146,cancer,0,0
62147,:,0,0
62148,a,0,0
62149,randomised,0,0
62150,phase,0,0
62151,II,0,0
62152,study,0,0
62153,.,0,0
62154,PURPOSE,0,0
62155,The,0,0
62156,purpose,0,0
62157,was,0,0
62158,to,0,0
62159,evaluate,0,0
62160,the,0,0
62161,activity,1,1
62162,and,1,0
62163,toxicity,1,1
62164,of,0,1
62165,split-dose,0,0
62166,paclitaxel,0,0
62167,or,0,0
62168,docetaxel,0,0
62169,in,0,0
62170,combination,0,0
62171,with,0,0
62172,gemcitabine,0,0
62173,in,0,0
62174,patients,0,0
62175,with,0,0
62176,metastatic,0,0
62177,breast,0,0
62178,cancer,0,0
62179,(,0,0
62180,MBC,0,1
62181,),0,0
62182,who,0,0
62183,had,0,0
62184,previously,0,0
62185,received,0,0
62186,anthracyclines,0,0
62187,.,0,0
62188,PATIENTS,0,0
62189,AND,0,0
62190,METHODS,0,0
62191,A,0,0
62192,total,0,1
62193,of,0,0
62194,210,0,0
62195,patients,0,0
62196,were,0,0
62197,randomly,0,0
62198,assigned,0,0
62199,to,0,0
62200,one,0,0
62201,of,0,0
62202,three,0,0
62203,treatment,0,0
62204,arms,0,0
62205,:,0,0
62206,gemcitabine,0,0
62207,"1,250",0,0
62208,mg/m,0,0
62209,(,0,0
62210,2,0,0
62211,),0,0
62212,Days,0,0
62213,1,0,0
62214,and,0,0
62215,8,0,0
62216,and,0,0
62217,paclitaxel,0,0
62218,175,0,0
62219,mg/m,0,0
62220,(,0,0
62221,2,0,0
62222,),0,0
62223,as,0,0
62224,a,0,0
62225,3-h,0,0
62226,infusion,0,0
62227,on,0,0
62228,Day,0,0
62229,1,0,0
62230,(,0,0
62231,GP1,0,0
62232,),0,0
62233,;,0,0
62234,gemcitabine,0,0
62235,"1,000",0,0
62236,mg/m,0,0
62237,(,0,0
62238,2,0,0
62239,),0,0
62240,Days,0,0
62241,1,0,0
62242,and,0,0
62243,8,0,0
62244,and,0,0
62245,paclitaxel,0,0
62246,100,0,0
62247,mg/m,0,0
62248,(,0,0
62249,2,0,0
62250,),0,0
62251,as,0,0
62252,a,0,0
62253,1-h,0,0
62254,infusion,0,0
62255,on,0,0
62256,Days,0,0
62257,1,0,0
62258,and,0,0
62259,8,0,0
62260,(,0,0
62261,GP2,0,0
62262,),0,0
62263,;,0,0
62264,gemcitabine,0,0
62265,"1,000",0,0
62266,mg/m,0,0
62267,(,0,0
62268,2,0,0
62269,),0,0
62270,Days,0,0
62271,1,0,0
62272,and,0,0
62273,8,0,0
62274,and,0,0
62275,docetaxel,0,0
62276,40,0,0
62277,mg/m,0,0
62278,(,0,0
62279,2,0,0
62280,),0,0
62281,as,0,0
62282,a,0,0
62283,1-h,0,0
62284,infusion,0,0
62285,on,0,0
62286,Days,0,0
62287,1,0,0
62288,and,0,0
62289,8,0,0
62290,(,0,0
62291,GD,0,0
62292,),0,0
62293,.,0,0
62294,Cycles,0,0
62295,were,0,0
62296,repeated,0,0
62297,every,0,0
62298,3,0,0
62299,weeks,0,0
62300,.,0,0
62301,RESULTS,0,0
62302,For,0,0
62303,the,0,0
62304,204,0,0
62305,patients,0,0
62306,evaluable,0,0
62307,for,0,0
62308,response,0,1
62309,assessment,0,0
62310,",",0,0
62311,the,0,0
62312,response,1,1
62313,rates,1,1
62314,were,0,0
62315,48.6,0,0
62316,%,0,0
62317,for,0,0
62318,GP1,0,0
62319,",",0,0
62320,52.2,0,0
62321,%,0,0
62322,for,0,0
62323,GP2,0,1
62324,",",0,0
62325,and,0,0
62326,52.3,0,0
62327,%,0,0
62328,for,0,0
62329,GD,0,0
62330,.,0,0
62331,Median,1,1
62332,response,1,1
62333,duration,1,1
62334,",",1,0
62335,time,1,1
62336,to,1,0
62337,treatment,1,0
62338,failure,1,1
62339,",",1,1
62340,and,1,1
62341,time,1,1
62342,to,1,0
62343,progression,1,1
62344,(,1,0
62345,TTP,1,0
62346,),1,0
62347,were,0,0
62348,similar,0,0
62349,in,0,0
62350,each,0,0
62351,arm,0,0
62352,.,0,0
62353,Median,1,1
62354,TTP,1,0
62355,for,0,0
62356,GP1,0,0
62357,",",0,0
62358,GP2,0,1
62359,and,0,1
62360,GD,0,0
62361,was,0,0
62362,7.5,0,0
62363,",",0,0
62364,7.0,0,0
62365,and,0,0
62366,7.4,0,0
62367,months,0,0
62368,",",0,0
62369,respectively,0,0
62370,.,0,0
62371,For,0,0
62372,the,0,0
62373,208,0,0
62374,patients,0,0
62375,evaluable,0,0
62376,for,0,0
62377,safety,1,1
62378,",",0,0
62379,the,0,0
62380,most,0,0
62381,common,0,0
62382,grade,0,0
62383,3/4,0,0
62384,toxicity,1,1
62385,for,0,0
62386,each,0,0
62387,regimen,0,0
62388,was,0,0
62389,neutropaenia,1,1
62390,",",0,0
62391,with,0,0
62392,64,0,0
62393,%,0,0
62394,",",0,0
62395,57,0,0
62396,%,0,0
62397,",",0,0
62398,and,0,0
62399,68,0,0
62400,%,0,0
62401,for,0,0
62402,GP1,0,0
62403,",",0,0
62404,GP2,0,1
62405,",",0,1
62406,and,0,1
62407,GD,0,1
62408,",",0,0
62409,respectively,0,0
62410,.,0,0
62411,Grade,0,0
62412,4,0,0
62413,neutropaenia,1,1
62414,",",0,0
62415,grade,0,0
62416,3/4,0,1
62417,anaemia,1,0
62418,",",1,0
62419,febrile,1,1
62420,neutropaenia,1,1
62421,",",1,0
62422,and,1,1
62423,diarrhoea,1,1
62424,were,0,0
62425,more,0,0
62426,common,0,0
62427,in,0,0
62428,the,0,0
62429,docetaxel,0,0
62430,arm,0,0
62431,",",0,0
62432,as,0,0
62433,was,0,0
62434,the,0,0
62435,use,0,0
62436,of,0,0
62437,intravenous,0,0
62438,antibiotics,0,0
62439,and,0,1
62440,blood,0,1
62441,transfusions,0,1
62442,.,0,0
62443,CONCLUSION,0,0
62444,The,0,0
62445,study,0,0
62446,confirmed,0,0
62447,the,0,0
62448,high,0,0
62449,activity,0,1
62450,of,0,0
62451,gemcitabine-taxane,0,0
62452,combinations,0,0
62453,in,0,0
62454,MBC,0,1
62455,.,0,0
62456,Split-dose,0,0
62457,paclitaxel,0,0
62458,had,0,0
62459,similar,0,0
62460,activity,1,1
62461,and,0,0
62462,toxicity,1,1
62463,to,0,0
62464,the,0,0
62465,3-weekly,0,0
62466,administration,0,0
62467,.,0,0
62468,The,0,0
62469,split-dose,0,0
62470,docetaxel,0,0
62471,regimen,0,0
62472,had,0,0
62473,similar,0,0
62474,activity,1,1
62475,to,0,0
62476,the,0,0
62477,paclitaxel,0,0
62478,combinations,0,0
62479,though,0,0
62480,associated,0,0
62481,with,0,0
62482,higher,0,0
62483,toxicity,1,1
62484,.,1,0
62485,Nuclear,0,0
62486,fragments,0,1
62487,and,0,0
62488,holes,0,1
62489,in,0,0
62490,grading,0,1
62491,of,0,0
62492,breast,0,0
62493,cancer,0,0
62494,aspirates,0,0
62495,.,0,0
62496,Effectiveness,0,1
62497,of,0,0
62498,a,0,0
62499,clinical,0,0
62500,intervention,0,0
62501,in,0,0
62502,improving,0,1
62503,pain,0,1
62504,control,0,0
62505,in,0,0
62506,outpatients,0,0
62507,with,0,0
62508,cancer,0,0
62509,treated,0,0
62510,by,0,0
62511,radiation,0,0
62512,therapy,0,0
62513,.,0,0
62514,PURPOSE,0,0
62515,To,0,0
62516,determine,0,0
62517,the,0,0
62518,effectiveness,0,0
62519,of,0,0
62520,a,0,0
62521,multicomponent,0,0
62522,clinical,0,0
62523,intervention,0,0
62524,to,0,0
62525,reduce,0,0
62526,pain,0,1
62527,in,0,0
62528,outpatients,0,0
62529,with,0,0
62530,cancer,0,0
62531,.,0,0
62532,METHODS,0,0
62533,AND,0,0
62534,MATERIALS,0,0
62535,Sixty-four,0,0
62536,patients,0,0
62537,were,0,0
62538,randomly,0,0
62539,assigned,0,0
62540,to,0,0
62541,receive,0,0
62542,either,0,0
62543,a,0,0
62544,clinical,0,0
62545,intervention,0,0
62546,including,0,0
62547,an,0,0
62548,information,0,0
62549,session,0,0
62550,",",0,0
62551,the,0,0
62552,use,0,0
62553,of,0,0
62554,a,0,0
62555,pain,0,1
62556,diary,0,1
62557,",",0,0
62558,and,0,0
62559,the,0,0
62560,possibility,0,0
62561,to,0,0
62562,contact,0,0
62563,a,0,0
62564,physician,0,0
62565,to,0,0
62566,adjust,0,0
62567,the,0,0
62568,pain,0,1
62569,medication,0,1
62570,",",0,0
62571,or,0,0
62572,the,0,0
62573,usual,0,0
62574,treatment,0,0
62575,of,0,0
62576,pain,0,1
62577,by,0,0
62578,the,0,0
62579,staff,0,0
62580,radiation,0,0
62581,oncologist,0,0
62582,.,0,0
62583,All,0,0
62584,patients,0,0
62585,reported,0,0
62586,their,0,0
62587,average,0,1
62588,and,0,0
62589,worst,0,1
62590,pain,1,1
62591,levels,1,1
62592,at,0,0
62593,baseline,0,0
62594,and,0,0
62595,2,0,0
62596,and,0,0
62597,3,0,0
62598,weeks,0,0
62599,after,0,0
62600,the,0,0
62601,start,0,0
62602,of,0,0
62603,the,0,0
62604,intervention,0,0
62605,.,0,0
62606,RESULTS,0,0
62607,The,0,0
62608,study,0,0
62609,groups,0,0
62610,were,0,0
62611,similar,0,0
62612,with,0,0
62613,respect,0,0
62614,to,0,0
62615,their,0,0
62616,baseline,0,0
62617,characteristics,0,1
62618,and,0,1
62619,pain,0,1
62620,levels,0,1
62621,at,0,0
62622,randomization,0,0
62623,.,0,0
62624,After,0,0
62625,3,0,0
62626,weeks,0,0
62627,",",0,0
62628,the,0,0
62629,average,0,1
62630,and,0,0
62631,worst,0,1
62632,pain,0,1
62633,experienced,0,0
62634,by,0,0
62635,patients,0,0
62636,randomized,0,0
62637,to,0,0
62638,the,0,0
62639,clinical,0,0
62640,intervention,0,0
62641,group,0,0
62642,was,0,0
62643,significantly,0,0
62644,inferior,0,0
62645,to,0,0
62646,the,0,0
62647,average,0,0
62648,pain,0,1
62649,experienced,0,0
62650,by,0,0
62651,patients,0,0
62652,in,0,0
62653,the,0,0
62654,control,0,0
62655,group,0,0
62656,(,0,0
62657,2.9/10,0,0
62658,vs.,0,0
62659,4.4/10,0,0
62660,and,0,0
62661,4.2/10,0,0
62662,vs.,0,0
62663,5.5/10,0,0
62664,",",0,0
62665,respectively,0,0
62666,),0,0
62667,.,0,0
62668,Results,0,0
62669,showed,0,0
62670,that,0,0
62671,the,0,0
62672,experimental,0,0
62673,group,0,0
62674,patients,0,0
62675,decreased,0,0
62676,their,0,0
62677,pain,0,1
62678,levels,0,1
62679,more,0,0
62680,than,0,0
62681,the,0,0
62682,control,0,0
62683,group,0,0
62684,patients,0,0
62685,did,0,0
62686,over,0,0
62687,time,0,1
62688,.,0,0
62689,CONCLUSION,0,0
62690,An,1,0
62691,intervention,1,0
62692,including,1,0
62693,patient,1,1
62694,education,1,0
62695,",",1,0
62696,a,1,0
62697,pain,1,1
62698,diary,1,1
62699,",",1,0
62700,and,1,0
62701,defining,1,0
62702,a,1,0
62703,procedure,1,0
62704,for,1,0
62705,therapeutic,1,0
62706,adjustments,1,0
62707,can,1,0
62708,be,1,0
62709,effective,1,0
62710,to,1,0
62711,improve,1,0
62712,pain,1,1
62713,relief,1,1
62714,in,1,0
62715,outpatients,1,0
62716,with,1,0
62717,cancer,1,0
62718,.,1,0
62719,Patient-reported,0,1
62720,outcomes,1,0
62721,after,0,0
62722,inguinal,0,0
62723,herniorrhaphy,0,0
62724,.,0,0
62725,BACKGROUND,0,0
62726,Patient-reported,0,1
62727,outcomes,1,1
62728,(,0,0
62729,PRO,0,0
62730,),0,0
62731,reflect,0,0
62732,the,0,0
62733,functional,0,0
62734,outcomes,0,0
62735,of,0,0
62736,inguinal,0,0
62737,herniorrhaphy,0,0
62738,.,0,0
62739,We,0,0
62740,studied,0,0
62741,the,0,0
62742,effect,0,0
62743,of,0,0
62744,hernia,0,0
62745,recurrence,0,1
62746,and,0,1
62747,complications,0,1
62748,on,0,0
62749,PRO,0,0
62750,for,0,0
62751,participants,0,0
62752,in,0,0
62753,the,0,0
62754,Veterans,0,0
62755,Affairs,0,0
62756,trial,0,0
62757,of,0,0
62758,Open,0,0
62759,or,0,0
62760,Laparoscopic,0,0
62761,Repair,0,0
62762,of,0,0
62763,Inguinal,0,0
62764,Hernia,0,0
62765,.,0,0
62766,METHODS,0,0
62767,Analyzed,0,0
62768,PRO,0,1
62769,included,0,0
62770,(,0,0
62771,1,0,0
62772,),0,0
62773,the,0,0
62774,Medical,0,0
62775,Outcomes,0,1
62776,Study,0,0
62777,Short,0,0
62778,Form,0,0
62779,36,0,0
62780,",",0,0
62781,version,0,0
62782,2,0,0
62783,",",0,0
62784,(,0,0
62785,2,0,0
62786,),0,0
62787,the,0,0
62788,Surgical,0,0
62789,Pain,0,1
62790,Scale,0,1
62791,",",0,0
62792,(,0,0
62793,3,0,0
62794,),0,0
62795,the,0,0
62796,Activities,0,1
62797,Assessment,0,0
62798,Scale,0,1
62799,",",0,1
62800,and,0,0
62801,(,0,0
62802,4,0,0
62803,),0,0
62804,patient,0,0
62805,satisfaction,0,1
62806,.,0,0
62807,Recurrences,0,1
62808,and,0,0
62809,complications,0,1
62810,were,0,0
62811,recorded,0,0
62812,at,0,0
62813,follow-up,0,0
62814,visits,0,0
62815,.,0,0
62816,Complications,0,1
62817,were,0,0
62818,categorized,0,0
62819,by,0,0
62820,(,0,0
62821,1,0,0
62822,),0,0
62823,hematoma/seroma,1,0
62824,",",0,0
62825,(,0,0
62826,2,0,0
62827,),0,0
62828,orchitis,1,0
62829,",",0,0
62830,(,0,0
62831,3,0,0
62832,),0,0
62833,neuralgia,1,0
62834,",",0,1
62835,and,0,0
62836,(,0,0
62837,4,0,0
62838,),0,0
62839,other,0,0
62840,.,0,0
62841,Univariate,0,0
62842,and,0,0
62843,multivariable,0,0
62844,regression,0,1
62845,analyses,0,0
62846,identified,0,0
62847,variables,0,0
62848,significantly,0,0
62849,associated,0,0
62850,with,0,0
62851,postoperative,0,0
62852,PRO,0,0
62853,.,0,0
62854,RESULTS,0,0
62855,Of,0,0
62856,the,0,0
62857,1603,0,0
62858,patients,0,0
62859,with,0,0
62860,PRO,0,1
62861,data,0,0
62862,",",0,0
62863,105,0,0
62864,had,0,0
62865,a,0,0
62866,recurrence,1,1
62867,and,0,0
62868,342,0,0
62869,had,0,0
62870,a,0,0
62871,complication,0,0
62872,at,0,0
62873,2,0,0
62874,years,0,0
62875,.,0,0
62876,Multivariable,0,0
62877,analyses,0,0
62878,showed,0,0
62879,neuralgia,1,1
62880,(,0,0
62881,P,0,0
62882,<,0,0
62883,.0005,0,0
62884,),0,0
62885,adversely,0,0
62886,affected,0,0
62887,all,0,0
62888,PRO,0,1
62889,",",0,0
62890,and,0,1
62891,recurrence,0,1
62892,(,0,0
62893,P,0,0
62894,<,0,0
62895,.05,0,0
62896,),0,0
62897,affected,0,0
62898,patient-reported,1,1
62899,pain,1,1
62900,",",1,0
62901,activity,1,1
62902,",",1,1
62903,and,1,1
62904,satisfaction,1,1
62905,",",0,1
62906,but,0,0
62907,not,0,0
62908,the,0,0
62909,score,0,1
62910,for,0,0
62911,the,0,0
62912,Medical,1,0
62913,Outcomes,1,1
62914,Study,1,0
62915,Short,1,0
62916,Form,1,0
62917,3,1,0
62918,.,1,0
62919,Patients,0,0
62920,with,0,0
62921,a,0,0
62922,recurrence,0,1
62923,after,0,0
62924,open,0,0
62925,repair,0,0
62926,had,0,0
62927,more,0,0
62928,pain,1,1
62929,than,0,0
62930,those,0,0
62931,with,0,0
62932,a,0,0
62933,recurrence,0,1
62934,after,0,0
62935,laparoscopic,0,0
62936,repair,0,0
62937,(,0,0
62938,P,0,0
62939,=,0,0
62940,.0001,0,0
62941,),0,0
62942,.,0,0
62943,Patients,0,0
62944,with,0,0
62945,other,0,0
62946,complications,0,1
62947,after,0,0
62948,laparoscopic,0,0
62949,repair,0,0
62950,reported,0,0
62951,more,0,0
62952,pain,1,1
62953,and,1,1
62954,less,1,0
62955,activity,1,1
62956,than,0,0
62957,those,0,0
62958,with,0,0
62959,other,0,0
62960,complications,0,1
62961,after,0,0
62962,open,0,0
62963,repair,0,0
62964,(,0,0
62965,P,0,0
62966,=,0,0
62967,.003,0,0
62968,and,0,0
62969,P,0,0
62970,=,0,0
62971,.009,0,0
62972,",",0,0
62973,respectively,0,0
62974,),0,0
62975,.,0,0
62976,CONCLUSIONS,0,0
62977,The,0,0
62978,effectiveness,0,0
62979,of,0,0
62980,inguinal,0,0
62981,herniorrhaphy,0,0
62982,should,0,0
62983,be,0,0
62984,measured,0,0
62985,by,0,0
62986,the,0,0
62987,rate,0,1
62988,of,0,0
62989,recurrence,1,1
62990,and,1,0
62991,neuralgia,1,1
62992,.,1,1
62993,Postoperative,0,0
62994,neuralgias,0,0
62995,have,0,0
62996,a,0,0
62997,deleterious,0,0
62998,effect,0,0
62999,on,0,0
63000,all,0,0
63001,patient-reported,0,0
63002,outcomes,0,0
63003,.,0,0
63004,A,0,0
63005,randomized,0,0
63006,comparison,0,0
63007,of,0,0
63008,the,0,0
63009,effect,0,0
63010,of,0,0
63011,two,0,0
63012,prelinguistic,0,0
63013,communication,0,0
63014,interventions,0,0
63015,on,0,0
63016,the,0,0
63017,acquisition,0,0
63018,of,0,0
63019,spoken,0,1
63020,communication,0,1
63021,in,0,0
63022,preschoolers,0,0
63023,with,0,0
63024,ASD,0,0
63025,.,0,0
63026,PURPOSE,0,0
63027,This,0,0
63028,randomized,0,0
63029,group,0,0
63030,experiment,0,0
63031,compared,0,0
63032,the,0,0
63033,efficacy,0,0
63034,of,0,0
63035,2,0,0
63036,communication,0,0
63037,interventions,0,0
63038,(,0,0
63039,Responsive,0,0
63040,Education,0,1
63041,and,0,0
63042,Prelinguistic,0,0
63043,Milieu,0,1
63044,Teaching,0,0
63045,[,0,0
63046,RPMT,0,0
63047,],0,0
63048,and,0,0
63049,the,0,0
63050,Picture,0,1
63051,Exchange,0,0
63052,Communication,0,1
63053,System,0,0
63054,[,0,0
63055,PECS,0,0
63056,],0,0
63057,),0,0
63058,on,0,0
63059,spoken,0,0
63060,communication,0,0
63061,in,0,0
63062,36,0,0
63063,preschoolers,0,0
63064,with,0,0
63065,autism,0,0
63066,spectrum,0,0
63067,disorders,0,0
63068,(,0,0
63069,ASD,0,0
63070,),0,0
63071,.,0,0
63072,METHOD,0,0
63073,Each,0,0
63074,treatment,0,0
63075,was,0,0
63076,delivered,0,0
63077,to,0,0
63078,children,0,0
63079,for,0,0
63080,a,0,0
63081,maximum,0,1
63082,total,0,0
63083,of,0,0
63084,24,0,0
63085,hr,0,0
63086,over,0,0
63087,a,0,0
63088,6-month,0,0
63089,period,0,0
63090,.,0,0
63091,Spoken,0,0
63092,communication,0,1
63093,was,0,0
63094,assessed,0,0
63095,in,0,0
63096,a,0,0
63097,rigorous,0,0
63098,test,0,0
63099,of,0,0
63100,generalization,0,0
63101,at,0,0
63102,pretreatment,0,0
63103,",",0,0
63104,posttreatment,0,1
63105,",",0,1
63106,and,0,1
63107,6-month,0,1
63108,follow-up,0,0
63109,periods,0,0
63110,.,0,0
63111,RESULTS,0,0
63112,PECS,1,0
63113,was,1,0
63114,more,1,0
63115,successful,1,0
63116,than,1,0
63117,RPMT,1,0
63118,in,1,0
63119,increasing,1,0
63120,the,1,0
63121,number,1,1
63122,of,1,0
63123,nonimitative,1,0
63124,spoken,1,0
63125,communication,1,1
63126,acts,1,0
63127,and,1,0
63128,the,1,0
63129,number,1,1
63130,of,1,0
63131,different,1,0
63132,nonimitative,1,0
63133,words,1,0
63134,used,1,0
63135,at,1,0
63136,the,1,0
63137,posttreatment,1,0
63138,period,1,0
63139,.,1,0
63140,Considering,0,0
63141,growth,0,0
63142,over,0,0
63143,all,0,0
63144,3,0,0
63145,measurement,0,0
63146,periods,0,0
63147,",",0,0
63148,an,0,0
63149,exploratory,0,0
63150,analysis,0,0
63151,showed,0,0
63152,that,0,0
63153,growth,1,1
63154,rate,1,1
63155,of,1,0
63156,the,1,0
63157,number,1,1
63158,of,1,0
63159,different,1,0
63160,nonimitative,1,0
63161,words,1,1
63162,was,1,0
63163,faster,1,0
63164,in,1,0
63165,the,1,0
63166,PECS,1,0
63167,group,0,0
63168,than,0,0
63169,in,0,0
63170,the,0,0
63171,RPMT,0,0
63172,group,0,0
63173,for,0,0
63174,children,0,0
63175,who,0,0
63176,began,0,0
63177,treatment,0,0
63178,with,0,0
63179,relatively,0,0
63180,high,0,0
63181,object,0,1
63182,exploration,0,0
63183,.,0,0
63184,In,0,0
63185,contrast,0,0
63186,",",0,0
63187,analogous,1,0
63188,slopes,1,1
63189,were,0,0
63190,steeper,0,0
63191,in,0,0
63192,the,0,0
63193,RPMT,0,0
63194,group,0,0
63195,than,0,0
63196,in,0,0
63197,the,0,0
63198,PECS,0,0
63199,group,0,0
63200,for,0,0
63201,children,0,0
63202,who,0,0
63203,began,0,0
63204,treatment,0,0
63205,with,0,0
63206,relatively,0,0
63207,low,0,0
63208,object,0,1
63209,exploration,0,0
63210,.,0,0
63211,Preventing,0,0
63212,paclitaxel-induced,1,0
63213,peripheral,1,1
63214,neuropathy,1,0
63215,:,1,0
63216,a,0,0
63217,phase,0,0
63218,II,0,0
63219,trial,0,0
63220,of,0,0
63221,vitamin,0,0
63222,E,0,0
63223,supplementation,0,0
63224,.,0,0
63225,A,0,0
63226,randomized,0,0
63227,",",0,0
63228,controlled,0,0
63229,trial,0,0
63230,was,0,0
63231,performed,0,0
63232,to,0,0
63233,assess,0,0
63234,the,0,0
63235,efficacy,1,1
63236,and,1,0
63237,safety,1,1
63238,of,0,1
63239,vitamin,0,0
63240,E,0,1
63241,supplementation,0,0
63242,for,0,0
63243,prophylaxis,0,0
63244,against,0,0
63245,paclitaxel-induced,1,0
63246,peripheral,1,1
63247,neuropathy,1,1
63248,(,1,0
63249,PIPN,1,0
63250,),1,0
63251,.,1,0
63252,Thirty-two,0,0
63253,patients,0,0
63254,undergoing,0,0
63255,six,0,0
63256,courses,0,0
63257,of,0,0
63258,paclitaxel-based,0,0
63259,chemotherapy,0,0
63260,were,0,0
63261,randomly,0,0
63262,assigned,0,0
63263,to,0,0
63264,receive,0,0
63265,either,0,0
63266,chemotherapy,0,0
63267,with,0,0
63268,vitamin,0,0
63269,E,0,0
63270,(,0,0
63271,300,0,0
63272,mg,0,0
63273,twice,0,0
63274,a,0,0
63275,day,0,0
63276,",",0,0
63277,Group,0,0
63278,I,0,0
63279,),0,0
63280,or,0,0
63281,chemotherapy,0,0
63282,without,0,0
63283,vitamin,0,0
63284,E,0,1
63285,supplementation,0,0
63286,(,0,0
63287,Group,0,0
63288,II,0,0
63289,),0,0
63290,.,0,0
63291,A,0,0
63292,detailed,1,0
63293,neurological,1,1
63294,examination,1,0
63295,and,1,0
63296,electrophysiological,1,1
63297,study,1,0
63298,was,0,0
63299,performed,0,0
63300,during,0,0
63301,and,0,0
63302,3,0,0
63303,months,0,0
63304,after,0,0
63305,chemotherapy,0,0
63306,.,0,0
63307,The,0,0
63308,severity,1,1
63309,of,1,0
63310,PIPN,1,0
63311,was,1,0
63312,summarized,1,0
63313,by,1,0
63314,means,1,0
63315,of,1,0
63316,a,1,0
63317,modified,1,0
63318,Peripheral,1,0
63319,Neuropathy,1,0
63320,(,1,0
63321,PNP,1,0
63322,),1,0
63323,score,1,1
63324,.,1,0
63325,The,0,0
63326,incidence,1,1
63327,of,1,0
63328,neurotoxicity,1,1
63329,differed,0,0
63330,significantly,0,0
63331,between,0,0
63332,groups,0,0
63333,",",0,0
63334,occurring,0,0
63335,in,0,0
63336,3/16,0,0
63337,(,0,0
63338,18.7,0,0
63339,%,0,0
63340,),0,0
63341,patients,0,0
63342,assigned,0,0
63343,to,0,0
63344,the,0,0
63345,vitamin,0,0
63346,E,0,1
63347,supplementation,0,0
63348,group,0,0
63349,and,0,0
63350,in,0,0
63351,10/16,0,0
63352,(,0,0
63353,62.5,0,0
63354,%,0,0
63355,),0,0
63356,controls,0,0
63357,(,0,0
63358,P=0.03,0,0
63359,),0,0
63360,.,0,0
63361,The,0,0
63362,relative,1,0
63363,risk,1,1
63364,(,1,0
63365,RR,1,0
63366,),1,0
63367,of,1,0
63368,developing,1,0
63369,PIPN,1,0
63370,was,0,0
63371,significantly,0,0
63372,higher,0,0
63373,in,0,0
63374,controls,0,0
63375,than,0,0
63376,in,0,0
63377,vitamin,0,0
63378,E,0,0
63379,group,0,0
63380,patients,0,0
63381,(,0,0
63382,RR=0.3,0,1
63383,",",0,0
63384,95,0,0
63385,%,0,0
63386,confidence,0,0
63387,interval,0,0
63388,(,0,0
63389,CI,0,0
63390,),0,1
63391,=0.1-0.9,0,0
63392,),0,0
63393,.,0,0
63394,Mean,1,0
63395,PNP,1,0
63396,scores,1,1
63397,were,0,0
63398,2.25+/-5.1,0,0
63399,(,0,0
63400,range,0,0
63401,0-15,0,0
63402,),0,0
63403,for,0,0
63404,patients,0,0
63405,in,0,0
63406,Group,0,0
63407,I,0,0
63408,and,0,0
63409,11+/-11.63,0,0
63410,(,0,0
63411,range,0,0
63412,0-32,0,0
63413,),0,0
63414,for,0,0
63415,those,0,0
63416,in,0,0
63417,Group,0,0
63418,II,0,0
63419,(,0,0
63420,P=0.01,0,0
63421,),0,0
63422,.,0,0
63423,Vitamin,0,0
63424,E,0,1
63425,supplementation,0,0
63426,was,0,0
63427,well,0,0
63428,tolerated,1,1
63429,and,0,0
63430,showed,0,0
63431,an,0,0
63432,excellent,0,0
63433,safety,1,1
63434,profile,1,0
63435,.,1,0
63436,This,0,0
63437,study,0,0
63438,shows,0,0
63439,that,0,0
63440,vitamin,0,0
63441,E,0,0
63442,effectively,0,0
63443,and,0,0
63444,safely,0,0
63445,protects,0,0
63446,patients,0,0
63447,with,0,0
63448,cancer,0,0
63449,from,0,0
63450,the,0,0
63451,occurrence,1,0
63452,of,1,0
63453,paclitaxel-induced,1,0
63454,peripheral,1,1
63455,nerve,1,0
63456,damage,1,1
63457,.,1,0
63458,A,0,0
63459,double-blind,0,0
63460,",",0,0
63461,placebo-controlled,0,0
63462,trial,0,0
63463,is,0,0
63464,needed,0,0
63465,to,0,0
63466,confirm,0,0
63467,these,0,0
63468,results,0,0
63469,.,0,0
63470,A,0,0
63471,double-blind,0,0
63472,randomized,0,0
63473,controlled,0,0
63474,trial,0,0
63475,of,0,0
63476,oral,0,0
63477,misoprostol,0,0
63478,and,0,0
63479,intramuscular,0,0
63480,syntometrine,0,0
63481,in,0,0
63482,the,0,0
63483,management,0,0
63484,of,0,0
63485,the,0,0
63486,third,0,0
63487,stage,0,0
63488,of,0,0
63489,labor,0,1
63490,.,0,0
63491,BACKGROUND,0,0
63492,The,0,0
63493,aim,0,0
63494,of,0,0
63495,this,0,0
63496,study,0,0
63497,was,0,0
63498,to,0,0
63499,compare,0,0
63500,the,0,0
63501,efficacy,0,1
63502,and,0,0
63503,safety,0,1
63504,of,0,1
63505,oral,0,0
63506,misoprostol,0,0
63507,400,0,0
63508,mug,0,0
63509,with,0,0
63510,intramuscular,0,0
63511,syntometrine,0,0
63512,in,0,0
63513,the,0,0
63514,management,0,0
63515,of,0,0
63516,the,0,0
63517,third,0,0
63518,stage,0,0
63519,of,0,0
63520,labor,0,1
63521,.,0,0
63522,MATERIAL,0,0
63523,AND,0,0
63524,METHODS,0,0
63525,This,0,0
63526,was,0,0
63527,a,0,0
63528,double-blind,0,0
63529,randomized,0,0
63530,controlled,0,0
63531,trial,0,0
63532,conducted,0,0
63533,in,0,0
63534,a,0,0
63535,tertiary,0,0
63536,care,0,0
63537,hospital,0,0
63538,.,0,0
63539,Three,0,0
63540,hundred,0,0
63541,and,0,0
63542,fifty-five,0,0
63543,women,0,0
63544,randomized,0,0
63545,to,0,0
63546,receive,0,0
63547,either,0,0
63548,oral,0,0
63549,misoprostol,0,0
63550,400,0,0
63551,mug,0,0
63552,or,0,0
63553,intramuscular,0,0
63554,syntometrine,0,0
63555,in,0,0
63556,the,0,0
63557,third,0,0
63558,stage,0,0
63559,of,0,0
63560,labor,0,1
63561,were,0,0
63562,studied,0,0
63563,.,0,0
63564,The,0,0
63565,change,0,0
63566,in,0,0
63567,hemoglobin,1,1
63568,level,1,1
63569,from,0,0
63570,before,0,0
63571,to,0,0
63572,48,0,0
63573,h,0,0
63574,after,0,0
63575,delivery,0,1
63576,",",0,0
63577,use,0,1
63578,of,0,1
63579,additional,0,0
63580,oxytocics,0,0
63581,and,0,0
63582,treatment,0,0
63583,related,0,1
63584,side,0,1
63585,effects,0,1
63586,were,0,0
63587,the,0,0
63588,main,0,0
63589,outcome,0,0
63590,measures,0,1
63591,.,0,0
63592,RESULTS,0,0
63593,There,0,0
63594,were,0,0
63595,no,0,0
63596,significant,0,0
63597,differences,0,0
63598,between,0,0
63599,the,0,0
63600,two,0,0
63601,groups,0,0
63602,in,0,0
63603,terms,0,0
63604,of,0,0
63605,the,0,0
63606,change,0,0
63607,in,0,0
63608,hemoglobin,1,1
63609,level,1,1
63610,and,1,0
63611,mean,1,1
63612,blood,1,1
63613,loss,1,1
63614,.,1,0
63615,The,0,0
63616,incidence,0,1
63617,of,0,0
63618,shivering,1,1
63619,was,0,0
63620,significantly,0,0
63621,higher,0,0
63622,in,0,0
63623,the,0,0
63624,misoprostol,0,0
63625,group,0,0
63626,whilst,0,0
63627,that,0,0
63628,of,0,0
63629,vomiting,0,1
63630,was,0,0
63631,significantly,0,0
63632,higher,0,0
63633,in,0,0
63634,the,0,0
63635,syntometrine,0,0
63636,group,0,0
63637,.,0,0
63638,There,0,0
63639,were,0,0
63640,no,0,0
63641,differences,0,0
63642,in,0,0
63643,the,0,0
63644,incidence,0,1
63645,of,0,0
63646,nausea,1,1
63647,",",1,0
63648,headache,1,1
63649,",",1,1
63650,diarrhea,1,1
63651,and,1,1
63652,pyrexia,1,1
63653,between,0,0
63654,the,0,0
63655,two,0,0
63656,groups,0,0
63657,.,0,0
63658,CONCLUSION,0,0
63659,Orally,0,0
63660,administered,0,0
63661,misoprostol,0,0
63662,at,0,0
63663,a,0,0
63664,dose,0,0
63665,of,0,0
63666,400,0,0
63667,mug,0,0
63668,is,0,0
63669,an,0,0
63670,acceptable,0,0
63671,alternative,0,0
63672,in,0,0
63673,preventing,0,0
63674,post-partum,0,1
63675,blood,1,1
63676,loss,1,1
63677,",",0,0
63678,as,0,0
63679,measured,0,0
63680,by,0,0
63681,the,0,0
63682,peri-partum,0,1
63683,change,0,0
63684,in,0,0
63685,hemoglobin,1,1
63686,level,1,1
63687,and,0,0
63688,was,0,0
63689,not,0,0
63690,associated,0,0
63691,with,0,0
63692,an,0,0
63693,increased,0,0
63694,incidence,0,1
63695,of,0,0
63696,side,0,1
63697,effects,0,0
63698,.,0,0
63699,Risperidone,0,0
63700,in,0,0
63701,children,0,0
63702,with,0,0
63703,autism,0,0
63704,:,0,0
63705,randomized,0,0
63706,",",0,0
63707,placebo-controlled,0,0
63708,",",0,0
63709,double-blind,0,0
63710,study,0,0
63711,.,0,0
63712,Some,0,0
63713,open-label,0,0
63714,studies,0,0
63715,suggest,0,0
63716,that,0,0
63717,risperidone,0,0
63718,can,0,0
63719,be,0,0
63720,useful,0,0
63721,in,0,0
63722,the,0,0
63723,treatment,0,0
63724,of,0,0
63725,certain,0,0
63726,target,0,0
63727,symptoms,0,1
63728,in,0,0
63729,children,0,0
63730,with,0,0
63731,autism,0,0
63732,.,0,0
63733,We,0,0
63734,aimed,0,0
63735,to,0,0
63736,study,0,0
63737,whether,0,0
63738,the,0,0
63739,use,0,0
63740,of,0,0
63741,risperidone,0,0
63742,in,0,0
63743,comparison,0,0
63744,with,0,0
63745,placebo,0,0
63746,improved,0,1
63747,functioning,0,1
63748,in,0,0
63749,children,0,0
63750,with,0,0
63751,autism,0,0
63752,with,0,0
63753,regard,0,0
63754,to,0,0
63755,behavior,0,1
63756,(,0,0
63757,aggressiveness,0,1
63758,",",0,1
63759,hyperactivity,0,1
63760,",",0,1
63761,irritability,0,1
63762,),0,1
63763,",",0,0
63764,social,0,1
63765,and,0,1
63766,emotional,0,1
63767,responsiveness,0,1
63768,",",0,0
63769,and,0,1
63770,communication,0,1
63771,skills,0,1
63772,.,0,0
63773,We,0,0
63774,conducted,0,0
63775,a,0,0
63776,randomized,0,0
63777,",",0,0
63778,double-blind,0,0
63779,",",0,0
63780,placebo-controlled,0,0
63781,trial,0,0
63782,with,0,0
63783,40,0,0
63784,consecutive,0,0
63785,children,0,0
63786,with,0,0
63787,autism,0,0
63788,",",0,0
63789,whose,0,0
63790,ages,0,0
63791,ranged,0,0
63792,from,0,0
63793,2,0,0
63794,to,0,0
63795,9,0,0
63796,years,0,0
63797,",",0,0
63798,who,0,0
63799,were,0,0
63800,receiving,0,0
63801,either,0,0
63802,risperidone,0,0
63803,or,0,0
63804,placebo,0,0
63805,given,0,0
63806,orally,0,0
63807,at,0,0
63808,a,0,0
63809,dose,0,0
63810,of,0,0
63811,1,0,0
63812,mg/day,0,0
63813,for,0,0
63814,6,0,0
63815,months,0,0
63816,.,0,0
63817,Autism,0,1
63818,symptoms,0,1
63819,were,0,0
63820,monitored,0,0
63821,periodically,0,0
63822,.,0,0
63823,The,0,0
63824,outcome,0,1
63825,variables,0,1
63826,were,0,0
63827,total,0,1
63828,scores,0,1
63829,on,0,0
63830,the,0,0
63831,Childhood,0,0
63832,Autism,0,1
63833,Rating,0,1
63834,Scale,0,1
63835,(,0,0
63836,CARS,0,0
63837,),0,0
63838,and,0,0
63839,the,0,0
63840,Children,0,0
63841,'s,0,0
63842,Global,0,1
63843,Assessment,0,0
63844,Scale,0,1
63845,(,0,0
63846,CGAS,0,0
63847,),0,0
63848,after,0,0
63849,6,0,0
63850,months,0,0
63851,.,0,0
63852,Of,0,0
63853,the,0,0
63854,40,0,0
63855,children,0,0
63856,enrolled,0,0
63857,",",0,0
63858,39,0,0
63859,completed,0,0
63860,the,0,0
63861,trial,0,0
63862,over,0,0
63863,a,0,0
63864,period,0,0
63865,of,0,0
63866,18,0,0
63867,months,0,0
63868,;,0,0
63869,19,0,0
63870,received,0,0
63871,risperidone,0,0
63872,",",0,0
63873,and,0,0
63874,20,0,0
63875,received,0,0
63876,placebo,0,0
63877,.,0,0
63878,In,0,0
63879,the,0,0
63880,risperidone,0,0
63881,group,0,0
63882,",",0,0
63883,12,0,0
63884,of,0,0
63885,19,0,0
63886,children,0,0
63887,showed,0,0
63888,improvement,0,0
63889,in,0,0
63890,the,0,0
63891,total,1,1
63892,Childhood,1,0
63893,Autism,1,1
63894,Rating,1,1
63895,Scale,1,1
63896,score,1,1
63897,and,0,0
63898,17,0,0
63899,of,0,0
63900,19,0,0
63901,children,0,0
63902,in,0,0
63903,the,0,0
63904,Children,1,0
63905,'s,1,0
63906,Global,1,1
63907,Assessment,1,0
63908,Scale,1,1
63909,score,1,1
63910,compared,0,0
63911,with,0,0
63912,0,0,0
63913,of,0,0
63914,20,0,0
63915,children,0,0
63916,for,0,0
63917,the,0,0
63918,Childhood,1,0
63919,Autism,1,1
63920,Rating,1,1
63921,Scale,1,1
63922,score,1,1
63923,and,0,0
63924,2,0,0
63925,of,0,0
63926,20,0,0
63927,children,0,0
63928,for,0,0
63929,the,0,0
63930,Children,1,0
63931,'s,1,0
63932,Global,1,1
63933,Assessment,1,0
63934,Scale,1,1
63935,score,1,1
63936,in,0,0
63937,the,0,0
63938,placebo,0,0
63939,group,0,0
63940,(,0,0
63941,P,0,0
63942,<,0,0
63943,.001,0,0
63944,and,0,0
63945,P,0,0
63946,=,0,0
63947,.035,0,0
63948,",",0,0
63949,respectively,0,0
63950,),0,0
63951,.,0,0
63952,Risperidone,0,0
63953,also,0,0
63954,improved,0,0
63955,social,1,1
63956,responsiveness,1,1
63957,and,1,0
63958,nonverbal,1,1
63959,communication,1,1
63960,and,0,0
63961,reduced,0,0
63962,the,0,0
63963,symptoms,1,1
63964,of,1,0
63965,hyperactivity,1,1
63966,and,1,0
63967,aggression,1,1
63968,.,1,1
63969,Risperidone,0,0
63970,was,0,0
63971,associated,0,0
63972,with,0,0
63973,increased,0,0
63974,appetite,1,1
63975,and,1,0
63976,a,1,0
63977,mild,1,1
63978,weight,1,1
63979,gain,1,1
63980,",",1,0
63981,mild,1,1
63982,sedation,1,1
63983,in,1,0
63984,20,1,0
63985,%,1,0
63986,",",1,0
63987,and,1,1
63988,transient,1,1
63989,dyskinesias,1,1
63990,in,0,0
63991,three,0,0
63992,children,0,0
63993,.,0,0
63994,Risperidone,0,0
63995,improved,0,1
63996,global,1,1
63997,functioning,1,1
63998,and,1,0
63999,social,1,1
64000,responsiveness,1,1
64001,while,0,0
64002,reducing,1,0
64003,hyperactivity,1,1
64004,and,1,1
64005,aggression,1,1
64006,in,0,0
64007,children,0,0
64008,with,0,0
64009,autism,0,0
64010,and,0,0
64011,was,0,0
64012,well,0,0
64013,tolerated,0,1
64014,.,0,0
64015,Effects,0,0
64016,of,0,0
64017,monotherapy,0,0
64018,and,0,1
64019,combination,0,0
64020,therapy,0,0
64021,on,0,0
64022,blood,0,1
64023,pressure,0,1
64024,control,0,0
64025,and,0,1
64026,target,0,1
64027,organ,0,1
64028,damage,0,1
64029,:,0,0
64030,a,0,0
64031,randomized,0,0
64032,prospective,0,0
64033,intervention,0,0
64034,study,0,0
64035,in,0,0
64036,a,0,0
64037,large,0,0
64038,population,0,0
64039,of,0,0
64040,hypertensive,0,0
64041,patients,0,0
64042,.,0,0
64043,This,0,0
64044,prospective,0,0
64045,",",0,0
64046,randomized,0,0
64047,trial,0,0
64048,evaluated,0,0
64049,the,0,0
64050,effect,0,0
64051,of,0,0
64052,monotherapy,0,0
64053,and,0,0
64054,different,0,0
64055,combination,0,0
64056,therapies,0,0
64057,on,0,0
64058,cardiovascular,0,1
64059,target,0,0
64060,organ,0,1
64061,damage,0,1
64062,and,0,0
64063,metabolic,0,1
64064,profile,0,1
64065,in,0,0
64066,520,0,0
64067,hypertensive,0,0
64068,patients,0,0
64069,.,0,0
64070,Patients,0,0
64071,were,0,0
64072,allocated,0,0
64073,to,0,0
64074,a,0,0
64075,single,0,0
64076,agent,0,0
64077,:,0,0
64078,carvedilol,0,0
64079,25,0,0
64080,mg,0,0
64081,",",0,0
64082,amlodipine,0,0
64083,10,0,0
64084,mg,0,0
64085,",",0,0
64086,enalapril,0,0
64087,20,0,0
64088,mg,0,0
64089,",",0,0
64090,or,0,0
64091,losartan,0,0
64092,50,0,0
64093,mg,0,0
64094,(,0,0
64095,groups,0,0
64096,C,0,0
64097,",",0,0
64098,A,0,0
64099,",",0,1
64100,E,0,1
64101,",",0,1
64102,and,0,1
64103,L,0,1
64104,",",0,0
64105,respectively,0,0
64106,),0,0
64107,.,0,0
64108,After,0,0
64109,2,0,0
64110,months,0,0
64111,(,0,0
64112,level,0,0
64113,2,0,0
64114,),0,0
64115,",",0,0
64116,nonresponders,0,0
64117,received,0,0
64118,a,0,0
64119,low-dose,0,0
64120,thiazide,0,0
64121,diuretic,0,1
64122,",",0,0
64123,and,0,0
64124,after,0,0
64125,4,0,0
64126,months,0,0
64127,(,0,0
64128,level,0,0
64129,3,0,0
64130,),0,0
64131,",",0,0
64132,amlodipine,0,0
64133,(,0,0
64134,groups,0,0
64135,E,0,1
64136,",",0,0
64137,C,0,0
64138,",",0,1
64139,and,0,1
64140,L,0,1
64141,),0,1
64142,and,0,1
64143,carvedilol,0,0
64144,(,0,0
64145,group,0,0
64146,A,0,0
64147,),0,0
64148,.,0,0
64149,Twenty-four-hour,1,0
64150,blood,1,1
64151,pressure,1,1
64152,was,0,0
64153,significantly,0,0
64154,lowered,0,0
64155,in,0,0
64156,all,0,0
64157,treatment,0,0
64158,groups,0,0
64159,.,0,0
64160,Blood,1,1
64161,pressure,1,1
64162,control,1,0
64163,was,0,0
64164,more,0,0
64165,pronounced,0,0
64166,in,0,0
64167,patients,0,0
64168,receiving,0,0
64169,two,0,0
64170,or,0,0
64171,three,0,0
64172,drugs,0,0
64173,.,0,0
64174,At,0,0
64175,the,0,0
64176,end,0,0
64177,of,0,0
64178,the,0,0
64179,study,0,0
64180,",",0,0
64181,the,0,0
64182,carotid,1,1
64183,intima-media,1,0
64184,thickness,1,1
64185,decreased,0,0
64186,in,0,0
64187,group,0,0
64188,L,0,1
64189,(,0,0
64190,P,0,0
64191,<,0,0
64192,.01,0,0
64193,),0,0
64194,",",0,0
64195,left,1,1
64196,ventricular,1,1
64197,mass,1,1
64198,index,1,1
64199,in,0,0
64200,groups,0,0
64201,E,0,1
64202,and,0,1
64203,L,0,1
64204,(,0,0
64205,P,0,0
64206,<,0,0
64207,.05,0,0
64208,and,0,0
64209,P,0,0
64210,<,0,0
64211,.001,0,0
64212,",",0,0
64213,respectively,0,0
64214,),0,0
64215,",",0,0
64216,with,0,0
64217,a,0,0
64218,concomitant,0,0
64219,reduction,0,1
64220,in,0,0
64221,cholesterol,1,1
64222,in,0,0
64223,group,0,0
64224,L,0,1
64225,(,0,0
64226,P,0,0
64227,<,0,0
64228,.03,0,0
64229,),0,0
64230,.,0,0
64231,Diastolic,1,1
64232,function,1,1
64233,improved,0,0
64234,significantly,0,0
64235,in,0,0
64236,group,0,0
64237,L,0,1
64238,(,0,0
64239,P,0,0
64240,<,0,0
64241,.05,0,0
64242,),0,0
64243,.,0,0
64244,This,0,0
64245,study,0,0
64246,describes,0,0
64247,the,0,0
64248,need,0,0
64249,to,0,0
64250,control,0,0
64251,blood,1,1
64252,pressure,1,1
64253,with,0,0
64254,two,0,0
64255,or,0,0
64256,more,0,0
64257,drugs,0,0
64258,in,0,0
64259,most,0,0
64260,hypertensive,0,0
64261,patients,0,0
64262,and,0,0
64263,illustrates,0,0
64264,good,0,0
64265,clinical,0,0
64266,outcomes,0,1
64267,",",0,0
64268,independent,0,0
64269,of,0,0
64270,blood,0,1
64271,pressure,0,1
64272,lowering,0,1
64273,",",0,0
64274,using,0,0
64275,combination,0,0
64276,therapy,0,0
64277,with,0,0
64278,losartan,0,0
64279,",",0,0
64280,low-dose,0,0
64281,thiazide,0,0
64282,",",0,0
64283,and,0,1
64284,amlodipine,0,0
64285,.,0,0
64286,Lack,0,0
64287,of,0,0
64288,a,0,0
64289,pharmacokinetic,1,0
64290,interaction,1,1
64291,between,0,0
64292,steady-state,0,1
64293,roflumilast,0,0
64294,and,0,0
64295,single-dose,0,0
64296,midazolam,0,0
64297,in,0,0
64298,healthy,0,0
64299,subjects,0,0
64300,.,0,0
64301,AIMS,0,0
64302,The,0,0
64303,aim,0,0
64304,of,0,0
64305,this,0,0
64306,study,0,0
64307,was,0,0
64308,to,0,0
64309,investigate,0,0
64310,the,0,0
64311,effects,0,0
64312,of,0,0
64313,roflumilast,0,0
64314,",",0,0
64315,an,0,0
64316,investigational,0,0
64317,PDE4,0,0
64318,inhibitor,0,0
64319,for,0,0
64320,the,0,0
64321,treatment,0,0
64322,of,0,0
64323,COPD,0,0
64324,and,0,0
64325,asthma,0,0
64326,",",0,0
64327,on,0,0
64328,the,0,0
64329,pharmacokinetics,1,0
64330,of,1,0
64331,the,1,0
64332,CYP3A,1,0
64333,probe,1,0
64334,drug,0,1
64335,midazolam,0,0
64336,and,0,0
64337,its,0,0
64338,major,0,0
64339,metabolites,0,0
64340,.,0,0
64341,METHODS,0,0
64342,In,0,0
64343,an,0,0
64344,open,0,0
64345,",",0,0
64346,randomized,0,0
64347,(,0,0
64348,for,0,0
64349,midazolam,0,0
64350,treatment,0,0
64351,sequence,0,1
64352,),0,1
64353,study,0,0
64354,",",0,0
64355,18,0,0
64356,healthy,0,0
64357,male,0,0
64358,subjects,0,0
64359,received,0,0
64360,single,0,0
64361,doses,0,0
64362,of,0,0
64363,midazolam,0,0
64364,(,0,0
64365,2,0,0
64366,mg,0,0
64367,oral,0,0
64368,and,0,0
64369,1,0,0
64370,mg,0,0
64371,i.v.,0,0
64372,",",0,0
64373,1,0,0
64374,day,0,0
64375,apart,0,0
64376,),0,0
64377,alone,0,0
64378,",",0,0
64379,repeated,0,0
64380,doses,0,0
64381,of,0,1
64382,roflumilast,0,0
64383,(,0,0
64384,500,0,0
64385,microg,0,0
64386,once,0,0
64387,daily,0,0
64388,for,0,0
64389,14,0,0
64390,days,0,0
64391,),0,0
64392,alone,0,0
64393,",",0,0
64394,and,0,1
64395,repeated,0,0
64396,doses,0,0
64397,of,0,0
64398,roflumilast,0,0
64399,together,0,0
64400,with,0,0
64401,single,0,0
64402,doses,0,0
64403,of,0,0
64404,midazolam,0,0
64405,(,0,0
64406,2,0,0
64407,mg,0,0
64408,oral,0,0
64409,and,0,0
64410,1,0,0
64411,mg,0,0
64412,i.v.,0,0
64413,",",0,0
64414,1,0,0
64415,day,0,0
64416,apart,0,0
64417,),0,0
64418,.,0,0
64419,RESULTS,0,0
64420,A,0,0
64421,comparison,0,0
64422,of,0,0
64423,clearance,1,1
64424,and,1,1
64425,peak,1,1
64426,and,1,1
64427,systemic,1,1
64428,exposure,1,0
64429,to,0,0
64430,midazolam,0,0
64431,following,0,0
64432,administration,0,0
64433,of,0,0
64434,roflumilast,0,0
64435,indicated,0,0
64436,no,0,0
64437,effect,0,0
64438,of,0,0
64439,roflumilast,0,0
64440,dosed,0,0
64441,to,0,0
64442,steady,0,0
64443,state,0,0
64444,on,0,0
64445,the,0,0
64446,pharmacokinetics,1,0
64447,of,1,0
64448,midazolam,1,0
64449,.,1,0
64450,Point,0,1
64451,estimates,0,0
64452,(,0,0
64453,90,0,0
64454,%,0,0
64455,CI,0,0
64456,),0,0
64457,were,0,0
64458,0.97,0,0
64459,(,0,0
64460,0.84,0,0
64461,",",0,0
64462,1.13,0,0
64463,),0,0
64464,for,0,0
64465,the,0,0
64466,AUC,0,0
64467,of,0,0
64468,i.v,0,0
64469,.,0,0
64470,midazolam,0,0
64471,and,0,0
64472,0.98,0,0
64473,(,0,0
64474,0.82,0,0
64475,",",0,0
64476,1.17,0,0
64477,),0,0
64478,for,0,0
64479,that,0,0
64480,of,0,0
64481,oral,0,0
64482,midazolam,0,0
64483,with,0,0
64484,and,0,0
64485,without,0,0
64486,roflumilast,0,0
64487,.,0,0
64488,CONCLUSIONS,0,0
64489,Therapeutic,0,0
64490,steady,0,1
64491,state,0,0
64492,concentrations,0,1
64493,of,0,1
64494,roflumilast,0,0
64495,and,0,0
64496,its,0,0
64497,N-oxide,0,0
64498,do,0,0
64499,not,0,0
64500,alter,0,0
64501,the,0,0
64502,disposition,1,0
64503,of,1,0
64504,the,1,0
64505,CYP3A,1,0
64506,substrate,1,1
64507,midazolam,1,0
64508,in,0,0
64509,healthy,0,0
64510,subjects,0,0
64511,.,0,0
64512,This,0,0
64513,finding,0,0
64514,suggests,0,0
64515,that,0,0
64516,roflumilast,0,0
64517,is,0,0
64518,unlikely,0,0
64519,to,0,0
64520,alter,0,0
64521,the,0,0
64522,clearance,0,1
64523,of,0,0
64524,drugs,0,0
64525,that,0,0
64526,are,0,0
64527,metabolized,0,0
64528,by,0,0
64529,CYP3A4,0,0
64530,.,0,0
64531,Atomoxetine,0,0
64532,for,0,0
64533,hyperactivity,0,0
64534,in,0,0
64535,autism,0,0
64536,spectrum,0,0
64537,disorders,0,0
64538,:,0,0
64539,placebo-controlled,0,0
64540,crossover,0,0
64541,pilot,0,0
64542,trial,0,0
64543,.,0,0
64544,OBJECTIVE,0,0
64545,To,0,0
64546,explore,0,0
64547,placebo-controlled,0,0
64548,efficacy,0,1
64549,and,0,1
64550,safety,0,1
64551,of,0,1
64552,atomoxetine,0,0
64553,(,0,0
64554,ATX,0,0
64555,),0,0
64556,for,0,0
64557,attention-deficit/hyperactivity,0,0
64558,disorder,0,0
64559,(,0,0
64560,ADHD,0,0
64561,),0,0
64562,symptoms,0,1
64563,in,0,0
64564,children,0,0
64565,with,0,0
64566,autism,0,0
64567,spectrum,0,0
64568,disorders,0,0
64569,(,0,0
64570,ASD,0,0
64571,),0,0
64572,.,0,0
64573,METHOD,0,0
64574,Children,0,0
64575,ages,0,0
64576,5,0,0
64577,to,0,0
64578,15,0,0
64579,with,0,0
64580,ASD,0,0
64581,and,0,0
64582,prominent,0,0
64583,ADHD,0,0
64584,symptoms,0,1
64585,were,0,0
64586,randomly,0,0
64587,assigned,0,0
64588,to,0,0
64589,order,0,0
64590,in,0,0
64591,a,0,0
64592,crossover,0,0
64593,of,0,0
64594,clinically,0,0
64595,titrated,0,0
64596,ATX,0,0
64597,and,0,0
64598,placebo,0,0
64599,",",0,0
64600,6,0,0
64601,weeks,0,0
64602,each,0,0
64603,",",0,0
64604,separated,0,0
64605,by,0,0
64606,1-week,0,0
64607,washout,0,0
64608,.,0,0
64609,Slopes,0,0
64610,for,0,0
64611,each,0,0
64612,condition,0,0
64613,were,0,0
64614,compared,0,0
64615,by,0,0
64616,paired,0,0
64617,t,0,0
64618,test,0,0
64619,.,0,0
64620,RESULTS,0,0
64621,In,0,0
64622,2004-2005,0,0
64623,",",0,0
64624,12,0,0
64625,boys,0,0
64626,and,0,0
64627,4,0,0
64628,girls,0,0
64629,(,0,0
64630,7,0,0
64631,with,0,0
64632,autistic,0,0
64633,disorder,0,0
64634,",",0,0
64635,1,0,0
64636,Asperger,0,0
64637,'s,0,0
64638,",",0,0
64639,8,0,0
64640,pervasive,0,0
64641,developmental,0,0
64642,disorder,0,0
64643,not,0,0
64644,otherwise,0,0
64645,specified,0,0
64646,),0,0
64647,all,0,0
64648,completed,0,0
64649,at,0,0
64650,least,0,0
64651,3,0,0
64652,weeks,0,0
64653,of,0,0
64654,each,0,0
64655,condition,0,0
64656,.,0,0
64657,On,0,0
64658,the,0,0
64659,primary,0,0
64660,outcome,0,0
64661,",",0,0
64662,the,0,0
64663,Hyperactivity,1,1
64664,subscale,1,1
64665,of,1,0
64666,the,1,0
64667,Aberrant,1,0
64668,Behavior,1,1
64669,Checklist,1,1
64670,",",1,0
64671,ATX,1,1
64672,was,0,0
64673,superior,0,0
64674,to,0,0
64675,placebo,0,0
64676,(,0,0
64677,p,0,0
64678,=.043,0,0
64679,",",0,0
64680,effect,0,1
64681,size,0,1
64682,d,0,0
64683,=,0,0
64684,0.90,0,0
64685,),0,0
64686,.,0,0
64687,It,0,0
64688,was,0,0
64689,also,0,0
64690,superior,0,0
64691,on,0,0
64692,a,0,0
64693,0,0,0
64694,to,0,0
64695,3,0,0
64696,rating,0,0
64697,of,0,0
64698,nine,0,0
64699,DSM-IV,1,0
64700,ADHD,1,0
64701,hyperactive/impulsive,1,1
64702,symptoms,1,1
64703,(,0,0
64704,p,0,0
64705,=.005,0,0
64706,",",0,0
64707,d,0,0
64708,=,0,0
64709,1.27,0,0
64710,),0,0
64711,",",0,0
64712,but,0,0
64713,missed,0,1
64714,significance,0,1
64715,on,0,0
64716,nine,0,0
64717,inattentive,0,0
64718,symptoms,0,0
64719,(,0,0
64720,p,0,0
64721,=.053,0,0
64722,",",0,0
64723,d=,0,0
64724,0.89,0,0
64725,),0,0
64726,.,0,0
64727,Nine,0,0
64728,subjects,0,0
64729,responded,0,0
64730,to,0,0
64731,ATX,0,0
64732,",",0,0
64733,four,0,0
64734,to,0,0
64735,placebo,0,0
64736,(,0,0
64737,25,0,0
64738,%,0,0
64739,improvement,0,0
64740,on,0,0
64741,the,0,0
64742,Hyperactivity,1,1
64743,subscale,1,1
64744,plus,1,0
64745,Clinical,1,1
64746,Global,1,1
64747,Impressions-Improvement,1,1
64748,of,0,0
64749,1-2,0,0
64750,.,0,0
64751,One,0,0
64752,was,0,0
64753,rehospitalized,1,0
64754,for,0,0
64755,recurrent,0,0
64756,violence,0,1
64757,on,0,0
64758,ATX,0,0
64759,.,0,0
64760,Adverse,1,1
64761,events,1,1
64762,were,0,0
64763,otherwise,0,0
64764,tolerable,0,1
64765,",",0,0
64766,with,0,0
64767,no,0,0
64768,tendency,0,0
64769,to,0,0
64770,stereotypy,0,0
64771,.,0,0
64772,CONCLUSIONS,0,0
64773,ATX,0,0
64774,appears,0,0
64775,safe,0,0
64776,and,0,0
64777,effective,0,1
64778,for,0,0
64779,treating,0,0
64780,hyperactivity,0,0
64781,in,0,0
64782,some,0,0
64783,children,0,0
64784,with,0,0
64785,autism,0,0
64786,spectrum,0,0
64787,disorders,0,0
64788,.,0,0
64789,The,0,0
64790,effect,0,0
64791,appears,0,0
64792,as,0,0
64793,large,0,0
64794,as,0,0
64795,in,0,0
64796,a,0,0
64797,multisite,0,0
64798,methylphenidate,0,0
64799,trial,0,0
64800,in,0,0
64801,the,0,0
64802,same,0,0
64803,population,0,0
64804,",",0,0
64805,with,0,0
64806,fewer,0,0
64807,intolerable,0,1
64808,side,0,1
64809,effects,0,0
64810,.,0,0
64811,Further,0,0
64812,study,0,0
64813,in,0,0
64814,autism,0,0
64815,spectrum,0,0
64816,disorders,0,0
64817,is,0,0
64818,indicated,0,0
64819,.,0,0
64820,Effect,0,0
64821,of,0,1
64822,hormone,0,1
64823,therapy,0,0
64824,on,0,0
64825,risk,0,1
64826,of,0,0
64827,hip,0,1
64828,and,0,0
64829,knee,0,1
64830,joint,0,1
64831,replacement,0,0
64832,in,0,0
64833,the,0,0
64834,Women,0,0
64835,'s,0,0
64836,Health,0,0
64837,Initiative,0,1
64838,.,0,0
64839,OBJECTIVE,0,0
64840,To,0,0
64841,determine,0,0
64842,the,0,0
64843,effect,0,0
64844,of,0,0
64845,hormone,0,1
64846,therapy,0,0
64847,on,0,0
64848,arthroplasty,1,0
64849,rates,1,1
64850,.,1,0
64851,METHODS,0,0
64852,We,0,0
64853,examined,0,0
64854,data,0,0
64855,from,0,0
64856,the,0,0
64857,Women,0,0
64858,'s,0,0
64859,Health,0,1
64860,Initiative,0,1
64861,placebo-controlled,0,0
64862,",",0,0
64863,double-blind,0,0
64864,",",0,0
64865,randomized,0,0
64866,trials,0,0
64867,.,0,0
64868,Community-dwelling,0,0
64869,women,0,0
64870,ages,0,0
64871,50-79,0,0
64872,years,0,0
64873,were,0,0
64874,enrolled,0,0
64875,at,0,0
64876,40,0,0
64877,US,0,0
64878,clinics,0,0
64879,.,0,0
64880,Women,0,0
64881,with,0,0
64882,prior,0,0
64883,arthroplasty,0,0
64884,were,0,0
64885,excluded,0,0
64886,",",0,0
64887,yielding,0,0
64888,a,0,0
64889,sample,0,0
64890,size,0,0
64891,of,0,0
64892,"26,321",0,0
64893,subjects,0,0
64894,.,0,0
64895,Women,0,0
64896,who,0,0
64897,had,0,0
64898,had,0,0
64899,hysterectomies,0,0
64900,(,0,0
64901,n,0,0
64902,=,0,0
64903,"10,272",0,0
64904,),0,0
64905,were,0,0
64906,randomly,0,0
64907,assigned,0,0
64908,to,0,0
64909,receive,0,0
64910,0.625,0,0
64911,mg/day,0,0
64912,conjugated,0,0
64913,equine,0,0
64914,estrogens,0,0
64915,(,0,0
64916,n,0,0
64917,=,0,0
64918,"5,076",0,0
64919,),0,0
64920,",",0,0
64921,or,0,1
64922,placebo,0,0
64923,(,0,0
64924,n,0,0
64925,=,0,0
64926,"5,196",0,0
64927,),0,0
64928,",",0,0
64929,with,0,0
64930,a,0,0
64931,mean,0,1
64932,followup,0,0
64933,of,0,0
64934,7.1,0,0
64935,years,0,0
64936,.,0,0
64937,Those,0,0
64938,who,0,0
64939,had,0,0
64940,not,0,0
64941,had,0,0
64942,hysterectomies,0,0
64943,(,0,0
64944,n,0,0
64945,=,0,0
64946,"16,049",0,0
64947,),0,0
64948,were,0,0
64949,randomly,0,0
64950,assigned,0,0
64951,to,0,0
64952,receive,0,0
64953,estrogen,0,1
64954,plus,0,0
64955,progestin,0,0
64956,(,0,0
64957,n,0,0
64958,=,0,0
64959,"8,240",0,0
64960,),0,0
64961,",",0,0
64962,given,0,0
64963,as,0,0
64964,0.625,0,0
64965,mg/day,0,0
64966,conjugated,0,0
64967,equine,0,0
64968,estrogens,0,0
64969,plus,0,0
64970,2.5,0,0
64971,mg/day,0,0
64972,medroxyprogesterone,0,0
64973,acetate,0,0
64974,",",0,1
64975,or,0,1
64976,placebo,0,0
64977,(,0,0
64978,n,0,0
64979,=,0,0
64980,"7,809",0,0
64981,),0,0
64982,",",0,0
64983,with,0,0
64984,a,0,0
64985,mean,0,1
64986,followup,0,0
64987,of,0,0
64988,5.6,0,0
64989,years,0,0
64990,.,0,0
64991,Participants,0,0
64992,reported,0,0
64993,hospitalizations,1,1
64994,",",1,1
64995,and,1,1
64996,arthroplasties,1,1
64997,were,0,0
64998,identified,0,0
64999,by,0,0
65000,procedure,1,0
65001,codes,1,0
65002,.,1,0
65003,Arthroplasties,1,0
65004,due,0,0
65005,to,0,0
65006,hip,0,1
65007,fracture,0,1
65008,were,0,0
65009,censored,0,0
65010,.,0,0
65011,Cox,0,0
65012,proportional,0,0
65013,hazards,0,1
65014,regression,0,0
65015,was,0,0
65016,used,0,0
65017,to,0,0
65018,assess,0,0
65019,hazard,0,1
65020,ratios,0,1
65021,(,0,0
65022,HRs,0,0
65023,),0,0
65024,and,0,0
65025,95,0,0
65026,%,0,0
65027,confidence,0,0
65028,intervals,0,0
65029,(,0,0
65030,95,0,0
65031,%,0,0
65032,CIs,0,0
65033,),0,0
65034,using,0,0
65035,intent-to-treat,0,0
65036,methods,0,0
65037,and,0,0
65038,outcome,0,1
65039,of,0,0
65040,time,0,1
65041,to,0,0
65042,first,0,0
65043,procedure,0,0
65044,.,0,0
65045,RESULTS,0,0
65046,In,0,0
65047,the,0,0
65048,estrogen-alone,0,0
65049,trial,0,0
65050,",",0,0
65051,women,0,0
65052,receiving,0,0
65053,hormone,0,1
65054,therapy,0,0
65055,had,0,0
65056,significantly,0,0
65057,lower,0,0
65058,rates,1,1
65059,of,1,0
65060,any,1,0
65061,arthroplasty,1,0
65062,(,0,0
65063,HR,0,0
65064,0.84,0,0
65065,[,0,0
65066,95,0,0
65067,%,0,0
65068,CI,0,0
65069,0.70-1.00,0,0
65070,],0,0
65071,",",0,0
65072,P,0,0
65073,=,0,0
65074,0.05,0,0
65075,),0,0
65076,.,0,0
65077,However,0,0
65078,",",0,0
65079,this,0,0
65080,effect,0,0
65081,was,0,0
65082,borderline,0,0
65083,statistically,0,0
65084,significant,0,0
65085,for,0,0
65086,hip,0,1
65087,arthroplasty,0,1
65088,(,0,0
65089,HR,0,0
65090,0.73,0,0
65091,[,0,0
65092,95,0,0
65093,%,0,0
65094,CI,0,0
65095,0.52-1.03,0,0
65096,],0,0
65097,",",0,0
65098,P,0,0
65099,=,0,0
65100,0.07,0,0
65101,),0,0
65102,",",0,0
65103,and,0,0
65104,not,0,0
65105,significant,0,0
65106,for,0,0
65107,knee,0,1
65108,arthroplasty,0,1
65109,(,0,0
65110,HR,0,0
65111,0.87,0,0
65112,[,0,0
65113,95,0,0
65114,%,0,0
65115,CI,0,0
65116,0.71-1.07,0,0
65117,],0,0
65118,",",0,0
65119,P,0,0
65120,=,0,0
65121,0.19,0,0
65122,),0,0
65123,.,0,0
65124,In,0,0
65125,the,0,0
65126,estrogen-plus-progestin,0,0
65127,trial,0,0
65128,",",0,0
65129,there,0,0
65130,was,0,0
65131,no,0,0
65132,association,0,0
65133,for,0,0
65134,total,1,1
65135,arthroplasty,1,0
65136,(,0,0
65137,HR,0,0
65138,0.99,0,0
65139,[,0,0
65140,95,0,0
65141,%,0,0
65142,CI,0,0
65143,0.82-1.20,0,0
65144,],0,0
65145,",",0,0
65146,P,0,0
65147,=,0,0
65148,0.92,0,0
65149,),0,0
65150,or,0,0
65151,for,0,0
65152,individual,1,0
65153,hip,1,1
65154,(,0,0
65155,HR,0,0
65156,1.14,0,0
65157,[,0,0
65158,95,0,0
65159,%,0,0
65160,CI,0,0
65161,0.83-1.57,0,0
65162,],0,0
65163,",",0,0
65164,P,0,0
65165,=,0,0
65166,0.41,0,0
65167,),0,0
65168,or,0,0
65169,knee,1,1
65170,(,0,0
65171,HR,0,0
65172,0.91,0,0
65173,[,0,0
65174,95,0,0
65175,%,0,0
65176,CI,0,0
65177,0.72-1.15,0,0
65178,],0,0
65179,",",0,0
65180,P,0,0
65181,=,0,0
65182,0.41,0,0
65183,),0,0
65184,arthroplasties,1,0
65185,.,1,0
65186,CONCLUSION,0,0
65187,These,0,0
65188,data,0,0
65189,suggest,0,0
65190,that,0,0
65191,hormone,0,0
65192,therapy,0,0
65193,may,0,0
65194,influence,0,0
65195,joint,0,1
65196,health,0,1
65197,",",0,0
65198,but,0,0
65199,this,0,0
65200,observed,0,0
65201,decrease,0,0
65202,in,0,0
65203,risk,0,0
65204,may,0,0
65205,be,0,0
65206,limited,0,0
65207,to,0,0
65208,unopposed,0,0
65209,estrogen,0,0
65210,and,0,0
65211,may,0,0
65212,possibly,0,0
65213,be,0,0
65214,more,0,0
65215,important,0,0
65216,in,0,0
65217,hip,0,1
65218,than,0,0
65219,in,0,0
65220,knee,0,1
65221,osteoarthritis,0,0
65222,.,0,0
65223,Thrombus,0,1
65224,aspiration,0,0
65225,reduces,0,0
65226,microvascular,1,1
65227,obstruction,1,0
65228,after,0,0
65229,primary,0,0
65230,coronary,0,0
65231,intervention,0,0
65232,:,0,0
65233,a,0,0
65234,myocardial,0,1
65235,contrast,0,0
65236,echocardiography,0,1
65237,substudy,0,0
65238,of,0,0
65239,the,0,0
65240,REMEDIA,0,0
65241,Trial,0,0
65242,.,0,0
65243,OBJECTIVES,0,0
65244,The,0,0
65245,aim,0,0
65246,of,0,0
65247,this,0,0
65248,study,0,0
65249,was,0,0
65250,to,0,0
65251,clarify,0,0
65252,the,0,0
65253,role,0,0
65254,of,0,0
65255,microembolization,0,0
65256,in,0,0
65257,the,0,0
65258,genesis,0,0
65259,of,0,0
65260,microvascular,1,1
65261,obstruction,1,1
65262,(,1,0
65263,MO,1,0
65264,),1,0
65265,after,0,0
65266,percutaneous,0,0
65267,coronary,0,0
65268,intervention,0,0
65269,(,0,0
65270,PCI,0,1
65271,),0,0
65272,.,0,0
65273,BACKGROUND,0,0
65274,Fifty,0,0
65275,consecutive,0,0
65276,patients,0,0
65277,entered,0,0
65278,the,0,0
65279,myocardial,0,1
65280,contrast,0,0
65281,echocardiography,0,1
65282,(,0,0
65283,MCE,0,1
65284,),0,0
65285,substudy,0,0
65286,of,0,0
65287,the,0,0
65288,REMEDIA,0,0
65289,(,0,0
65290,Randomized,0,0
65291,Evaluation,0,0
65292,of,0,0
65293,the,0,0
65294,Effect,0,0
65295,of,0,0
65296,Mechanical,0,0
65297,Reduction,0,0
65298,of,0,0
65299,Distal,0,0
65300,Embolization,0,0
65301,by,0,0
65302,Thrombus,0,1
65303,Aspiration,0,1
65304,in,0,0
65305,Primary,0,0
65306,and,0,0
65307,Rescue,0,1
65308,Angioplasty,0,0
65309,),0,0
65310,trial,0,0
65311,",",0,0
65312,which,0,0
65313,defined,0,0
65314,the,0,0
65315,role,0,0
65316,of,0,0
65317,a,0,0
65318,new,0,0
65319,thrombus-aspirating,0,0
65320,device,0,0
65321,in,0,0
65322,preventing,0,0
65323,distal,0,0
65324,microembolization,1,0
65325,after,0,0
65326,PCI,0,1
65327,.,0,0
65328,METHODS,0,0
65329,A,0,0
65330,total,0,1
65331,of,0,0
65332,25,0,0
65333,patients,0,0
65334,were,0,0
65335,randomized,0,0
65336,to,0,0
65337,be,0,0
65338,pretreated,0,0
65339,with,0,0
65340,thrombus,0,1
65341,aspiration,0,0
65342,before,0,0
65343,PCI,0,1
65344,of,0,0
65345,the,0,0
65346,culprit,0,1
65347,lesion,0,1
65348,and,0,0
65349,25,0,0
65350,received,0,0
65351,standard,0,0
65352,PCI,0,0
65353,.,0,0
65354,At,0,0
65355,24,0,0
65356,h,0,0
65357,",",0,0
65358,1,0,0
65359,week,0,0
65360,",",0,0
65361,and,0,0
65362,6,0,0
65363,months,0,0
65364,after,0,0
65365,PCI,0,1
65366,",",0,0
65367,MCE,0,1
65368,was,0,0
65369,performed,0,0
65370,by,0,0
65371,Sonovue,0,0
65372,",",0,0
65373,and,0,1
65374,real-time,0,0
65375,imaging,0,1
65376,was,0,0
65377,performed,0,0
65378,by,0,0
65379,contrast,0,0
65380,pulse,0,1
65381,sequencing,0,0
65382,technology,0,0
65383,.,0,0
65384,Regional,1,1
65385,wall,1,1
65386,motion,1,1
65387,score,1,1
65388,index,1,1
65389,(,1,0
65390,WMSI,1,0
65391,),1,0
65392,",",1,0
65393,contrast,1,0
65394,score,1,1
65395,index,1,1
65396,(,1,0
65397,CSI,1,0
65398,),1,0
65399,",",1,0
65400,endocardial,1,0
65401,length,1,1
65402,of,1,0
65403,wall,1,1
65404,motion,1,1
65405,abnormality,1,0
65406,(,1,0
65407,WML,1,0
65408,),1,1
65409,and,1,0
65410,contrast,1,0
65411,defect,1,1
65412,(,1,0
65413,CDL,1,1
65414,),1,0
65415,",",1,0
65416,end-diastolic,1,1
65417,and,1,1
65418,end-systolic,1,1
65419,left,1,1
65420,ventricular,1,1
65421,(,1,0
65422,LV,1,1
65423,),1,0
65424,volumes,1,1
65425,",",1,0
65426,and,1,1
65427,ejection,1,1
65428,fraction,1,1
65429,were,0,0
65430,calculated,0,0
65431,.,0,0
65432,RESULTS,0,0
65433,At,0,0
65434,each,0,0
65435,time,0,1
65436,point,0,0
65437,",",0,0
65438,in,0,0
65439,patients,0,0
65440,treated,0,0
65441,with,0,0
65442,a,0,0
65443,thrombus-aspiration,0,0
65444,filter,0,0
65445,device,0,0
65446,",",0,1
65447,WMSI,1,0
65448,",",1,1
65449,CSI,1,0
65450,",",1,1
65451,WML,1,0
65452,",",1,1
65453,and,1,1
65454,CDL,1,1
65455,were,0,0
65456,significantly,0,0
65457,lower,0,0
65458,and,0,1
65459,ejection,1,1
65460,fraction,1,1
65461,higher,0,0
65462,(,0,0
65463,p,0,0
65464,<,0,0
65465,0.05,0,0
65466,vs.,0,0
65467,control,0,0
65468,patients,0,0
65469,),0,0
65470,",",0,0
65471,whereas,0,0
65472,LV,1,1
65473,volumes,1,1
65474,were,0,0
65475,slightly,0,0
65476,but,0,0
65477,not,0,0
65478,significantly,0,0
65479,smaller,0,0
65480,compared,0,0
65481,with,0,0
65482,control,0,0
65483,patients,0,0
65484,.,0,0
65485,In,0,0
65486,the,0,0
65487,overall,0,1
65488,study,0,0
65489,population,0,0
65490,",",0,0
65491,the,0,0
65492,extent,1,0
65493,of,1,0
65494,MO,1,0
65495,significantly,0,0
65496,correlated,0,0
65497,with,0,0
65498,temporal,0,0
65499,changes,0,1
65500,in,0,0
65501,LV,1,0
65502,volumes,1,1
65503,.,1,0
65504,CONCLUSIONS,0,0
65505,Thrombus,0,1
65506,aspiration,0,0
65507,used,0,0
65508,at,0,0
65509,the,0,0
65510,time,0,1
65511,of,0,0
65512,PCI,0,0
65513,significantly,0,0
65514,reduces,0,0
65515,the,0,0
65516,extent,1,0
65517,of,1,0
65518,MO,1,0
65519,and,0,0
65520,myocardial,1,1
65521,dysfunction,1,1
65522,",",0,0
65523,although,0,0
65524,it,0,0
65525,does,0,0
65526,not,0,0
65527,have,0,0
65528,a,0,0
65529,significant,0,0
65530,favorable,0,0
65531,effect,0,0
65532,in,0,0
65533,preventing,0,0
65534,LV,1,0
65535,remodeling,1,0
65536,.,1,0
65537,Thus,0,0
65538,",",0,0
65539,the,0,0
65540,beneficial,0,0
65541,effect,0,0
65542,of,0,0
65543,thrombus,0,1
65544,aspiration,0,0
65545,occurs,0,0
65546,at,0,0
65547,the,0,0
65548,microvascular,0,0
65549,level,0,1
65550,",",0,0
65551,but,0,0
65552,additional,0,0
65553,mechanisms,0,0
65554,may,0,0
65555,play,0,0
65556,a,0,0
65557,role,0,0
65558,in,0,0
65559,influencing,0,0
65560,the,0,0
65561,final,0,1
65562,extent,0,0
65563,of,0,0
65564,MO,1,0
65565,",",0,0
65566,which,0,0
65567,strictly,0,0
65568,correlates,0,0
65569,with,0,0
65570,post-infarct,0,1
65571,LV,1,0
65572,remodeling,1,0
65573,.,1,0
65574,Treatment,0,0
65575,of,0,1
65576,psoriasis,0,1
65577,vulgaris,0,0
65578,by,0,0
65579,oral,0,0
65580,administration,0,0
65581,of,0,0
65582,yin,0,0
65583,xie,0,0
65584,ping,0,0
65585,granules,0,0
65586,--,0,0
65587,a,0,0
65588,clinical,0,0
65589,report,0,0
65590,of,0,0
65591,60,0,0
65592,cases,0,0
65593,.,0,0
65594,Folate,0,0
65595,and,0,0
65596,arsenic,0,0
65597,metabolism,0,0
65598,:,0,0
65599,a,0,0
65600,double-blind,0,0
65601,",",0,0
65602,placebo-controlled,0,0
65603,folic,0,0
65604,acid-supplementation,0,0
65605,trial,0,0
65606,in,0,0
65607,Bangladesh,0,0
65608,.,0,0
65609,BACKGROUND,0,0
65610,Populations,0,0
65611,in,0,0
65612,South,0,0
65613,and,0,0
65614,East,0,0
65615,Asia,0,1
65616,and,0,0
65617,many,0,0
65618,other,0,0
65619,regions,0,0
65620,of,0,0
65621,the,0,0
65622,world,0,0
65623,are,0,0
65624,chronically,0,0
65625,exposed,0,0
65626,to,0,0
65627,arsenic-contaminated,0,0
65628,drinking,0,0
65629,water,0,0
65630,.,0,0
65631,To,0,0
65632,various,0,0
65633,degrees,0,0
65634,",",0,0
65635,ingested,0,0
65636,inorganic,0,0
65637,arsenic,0,0
65638,(,0,0
65639,InAs,0,0
65640,),0,0
65641,is,0,0
65642,methylated,0,0
65643,to,0,0
65644,monomethylarsonic,0,0
65645,acid,0,0
65646,(,0,0
65647,MMA,0,0
65648,),0,0
65649,and,0,0
65650,dimethylarsinic,0,0
65651,acid,0,1
65652,(,0,0
65653,DMA,0,1
65654,),0,0
65655,via,0,0
65656,folate-dependent,0,0
65657,one-carbon,0,0
65658,metabolism,0,0
65659,;,0,0
65660,impaired,0,0
65661,methylation,0,0
65662,is,0,0
65663,associated,0,0
65664,with,0,0
65665,adverse,0,1
65666,health,0,0
65667,outcomes,0,0
65668,.,0,0
65669,Consequently,0,0
65670,",",0,0
65671,folate,0,1
65672,nutritional,0,0
65673,status,0,0
65674,may,0,0
65675,influence,0,0
65676,arsenic,1,0
65677,methylation,1,0
65678,and,0,0
65679,toxicity,0,1
65680,.,0,0
65681,OBJECTIVE,0,0
65682,The,0,0
65683,objective,0,0
65684,of,0,0
65685,this,0,0
65686,study,0,0
65687,was,0,0
65688,to,0,0
65689,test,0,0
65690,the,0,0
65691,hypothesis,0,0
65692,that,0,0
65693,folic,0,0
65694,acid,0,0
65695,supplementation,0,0
65696,of,0,0
65697,arsenic-exposed,0,0
65698,adults,0,0
65699,would,0,0
65700,increase,0,0
65701,arsenic,0,0
65702,methylation,0,0
65703,.,0,0
65704,DESIGN,0,0
65705,Two,0,0
65706,hundred,0,0
65707,adults,0,0
65708,in,0,0
65709,a,0,0
65710,rural,0,0
65711,region,0,0
65712,of,0,0
65713,Bangladesh,0,0
65714,",",0,0
65715,previously,0,0
65716,found,0,0
65717,to,0,0
65718,have,0,0
65719,low,0,0
65720,plasma,0,1
65721,concentrations,0,1
65722,of,0,0
65723,folate,0,1
65724,(,0,0
65725,<,0,0
65726,/=9,0,1
65727,nmol/L,0,0
65728,),0,0
65729,were,0,0
65730,enrolled,0,0
65731,in,0,0
65732,a,0,0
65733,randomized,0,0
65734,",",0,0
65735,double-blind,0,0
65736,",",0,0
65737,placebo-controlled,0,0
65738,folic,0,0
65739,acid-supplementation,0,0
65740,trial,0,0
65741,.,0,0
65742,Plasma,1,1
65743,concentrations,1,1
65744,of,1,0
65745,folate,1,1
65746,and,1,1
65747,homocysteine,1,1
65748,and,1,1
65749,urinary,1,1
65750,concentrations,1,1
65751,of,1,0
65752,arsenic,1,0
65753,metabolites,1,1
65754,were,0,0
65755,analyzed,0,0
65756,at,0,0
65757,baseline,0,0
65758,and,0,0
65759,after,0,0
65760,12,0,0
65761,wk,0,0
65762,of,0,0
65763,supplementation,0,0
65764,with,0,0
65765,folic,0,0
65766,acid,0,0
65767,at,0,0
65768,a,0,0
65769,dose,0,0
65770,of,0,0
65771,400,0,0
65772,microg/d,0,0
65773,or,0,0
65774,placebo,0,0
65775,.,0,0
65776,RESULTS,0,0
65777,The,0,0
65778,increase,0,0
65779,in,0,0
65780,the,0,0
65781,proportion,1,0
65782,of,1,0
65783,total,1,1
65784,urinary,1,1
65785,arsenic,1,0
65786,excreted,0,0
65787,as,0,0
65788,DMA,0,0
65789,in,0,0
65790,the,0,0
65791,folic,0,0
65792,acid,0,0
65793,group,0,0
65794,(,0,0
65795,72,0,0
65796,%,0,0
65797,before,0,0
65798,and,0,0
65799,79,0,0
65800,%,0,0
65801,after,0,0
65802,supplementation,0,0
65803,),0,0
65804,was,0,0
65805,significantly,0,0
65806,(,0,0
65807,P,0,0
65808,<,0,0
65809,0.0001,0,0
65810,),0,0
65811,greater,0,0
65812,than,0,0
65813,that,0,0
65814,in,0,0
65815,the,0,0
65816,placebo,0,0
65817,group,0,0
65818,",",0,0
65819,as,0,0
65820,was,0,0
65821,the,0,0
65822,reduction,0,0
65823,in,0,0
65824,the,0,0
65825,proportions,0,0
65826,of,0,0
65827,total,1,1
65828,urinary,1,1
65829,arsenic,1,0
65830,excreted,1,0
65831,as,0,0
65832,MMA,0,0
65833,(,0,0
65834,13,0,0
65835,%,0,0
65836,and,0,0
65837,10,0,0
65838,%,0,0
65839,",",0,0
65840,respectively,0,0
65841,;,0,0
65842,P,0,0
65843,<,0,0
65844,0.0001,0,0
65845,),0,0
65846,and,0,0
65847,as,0,0
65848,InAs,0,1
65849,(,0,0
65850,15,0,0
65851,%,0,0
65852,and,0,0
65853,11,0,0
65854,%,0,0
65855,",",0,0
65856,respectively,0,0
65857,;,0,0
65858,P,0,0
65859,<,0,0
65860,0.001,0,0
65861,),0,0
65862,.,0,0
65863,CONCLUSIONS,0,0
65864,These,0,0
65865,data,0,0
65866,indicate,0,0
65867,that,0,0
65868,folic,0,0
65869,acid,0,0
65870,supplementation,0,0
65871,to,0,0
65872,participants,0,0
65873,with,0,0
65874,low,0,0
65875,plasma,0,1
65876,folate,0,1
65877,enhances,0,0
65878,arsenic,0,0
65879,methylation,0,0
65880,.,0,0
65881,Because,0,0
65882,persons,0,0
65883,whose,0,0
65884,urine,0,1
65885,contains,0,0
65886,low,0,0
65887,proportions,0,1
65888,of,0,0
65889,DMA,0,1
65890,and,0,0
65891,high,0,0
65892,proportions,0,1
65893,of,0,0
65894,MMA,0,0
65895,and,0,0
65896,InAs,0,1
65897,have,0,0
65898,been,0,0
65899,reported,0,0
65900,to,0,0
65901,be,0,0
65902,at,0,0
65903,greater,0,0
65904,risk,0,1
65905,of,0,1
65906,skin,0,1
65907,and,0,1
65908,bladder,0,1
65909,cancers,0,1
65910,and,0,0
65911,peripheral,0,1
65912,vascular,0,1
65913,disease,0,0
65914,",",0,0
65915,these,0,0
65916,results,0,0
65917,suggest,0,0
65918,that,0,0
65919,folic,0,0
65920,acid,0,0
65921,supplementation,0,0
65922,may,0,0
65923,reduce,0,0
65924,the,0,0
65925,risk,0,0
65926,of,0,0
65927,arsenic-related,0,1
65928,health,0,0
65929,outcomes,0,0
65930,.,0,0
65931,B-vitamins,0,0
65932,reduce,0,0
65933,plasma,1,1
65934,levels,1,1
65935,of,0,0
65936,beta,0,0
65937,amyloid,0,1
65938,.,0,0
65939,Elevated,0,1
65940,plasma,0,1
65941,homocysteine,0,1
65942,(,0,0
65943,tHcy,0,0
65944,),0,0
65945,is,0,0
65946,a,0,0
65947,risk,0,1
65948,factor,0,0
65949,for,0,0
65950,Alzheimer,0,1
65951,'s,0,1
65952,disease,0,1
65953,(,0,0
65954,AD,0,0
65955,),0,1
65956,",",0,0
65957,and,0,0
65958,thus,0,0
65959,B,0,0
65960,vitamins,0,0
65961,may,0,0
65962,have,0,0
65963,a,0,0
65964,role,0,0
65965,in,0,0
65966,the,0,0
65967,prevention,0,0
65968,of,0,0
65969,AD,0,0
65970,.,0,0
65971,The,0,0
65972,objective,0,0
65973,of,0,0
65974,this,0,0
65975,study,0,0
65976,was,0,0
65977,to,0,0
65978,determine,0,0
65979,if,0,0
65980,tHcy,0,1
65981,lowering,0,0
65982,vitamins,0,0
65983,decrease,0,0
65984,the,0,0
65985,circulating,1,1
65986,levels,1,1
65987,of,1,0
65988,A-beta,1,1
65989,protein,1,1
65990,1-40,1,0
65991,(,1,0
65992,A,1,0
65993,beta,1,0
65994,40,1,0
65995,),1,0
65996,.,1,0
65997,We,0,0
65998,randomized,0,0
65999,299,0,0
66000,older,0,0
66001,men,0,0
66002,to,0,0
66003,treatment,0,0
66004,with,0,0
66005,2mg,0,0
66006,of,0,0
66007,folate,0,0
66008,",",0,0
66009,plus,0,0
66010,25mg,0,0
66011,of,0,0
66012,B6,0,0
66013,and,0,0
66014,400,0,0
66015,microg,0,0
66016,of,0,0
66017,B12,0,1
66018,",",0,0
66019,or,0,0
66020,placebo,0,0
66021,.,0,0
66022,After,0,0
66023,2,0,0
66024,years,0,0
66025,of,0,0
66026,treatment,0,0
66027,the,0,0
66028,mean,1,1
66029,(,1,0
66030,S.E,1,0
66031,.,1,0
66032,),1,0
66033,increase,1,0
66034,of,1,0
66035,A,1,0
66036,beta,1,0
66037,40,1,0
66038,was,0,0
66039,7.0,0,0
66040,pg/ml,0,0
66041,(,0,0
66042,8.4,0,0
66043,),0,0
66044,in,0,0
66045,the,0,0
66046,vitamin,0,0
66047,group,0,0
66048,(,0,0
66049,4.9,0,0
66050,%,0,0
66051,),0,0
66052,",",0,0
66053,and,0,0
66054,26.8,0,0
66055,pg/ml,0,0
66056,(,0,0
66057,7.7,0,0
66058,),0,0
66059,(,0,0
66060,18.5,0,0
66061,%,0,0
66062,),0,0
66063,in,0,0
66064,the,0,0
66065,placebo,0,0
66066,group,0,0
66067,.,0,0
66068,We,0,0
66069,conclude,0,0
66070,that,0,0
66071,B,0,0
66072,vitamins,0,0
66073,may,0,0
66074,decrease,0,0
66075,the,1,0
66076,plasma,1,1
66077,level,1,1
66078,of,1,0
66079,A,1,0
66080,beta,1,0
66081,40,1,0
66082,and,0,0
66083,have,0,0
66084,a,0,0
66085,role,0,0
66086,in,0,0
66087,the,0,0
66088,prevention,0,0
66089,of,0,0
66090,AD,0,0
66091,.,0,0
66092,A,0,0
66093,randomized,0,0
66094,controlled,0,0
66095,trial,0,0
66096,to,0,0
66097,evaluate,0,0
66098,the,0,0
66099,efficacy,1,1
66100,of,0,0
66101,ultrasound-guided,0,0
66102,laser,0,0
66103,photocoagulation,0,0
66104,for,0,0
66105,treatment,0,0
66106,of,0,0
66107,benign,0,0
66108,thyroid,1,0
66109,nodules,1,0
66110,.,1,0
66111,This,0,0
66112,randomized,0,0
66113,controlled,0,0
66114,study,0,0
66115,was,0,0
66116,designed,0,0
66117,to,0,0
66118,test,0,0
66119,the,0,0
66120,efficacy,1,1
66121,and,1,0
66122,safety,1,1
66123,of,0,1
66124,percutaneous,0,0
66125,ultrasound,0,1
66126,(,0,0
66127,US,0,1
66128,),0,0
66129,-guided,0,0
66130,laser,0,0
66131,photocoagulation,0,1
66132,(,0,0
66133,PLP,0,1
66134,),0,0
66135,for,0,0
66136,treatment,0,0
66137,of,0,0
66138,subjects,0,0
66139,with,0,0
66140,compressive,0,0
66141,symptoms,0,1
66142,due,0,0
66143,to,0,0
66144,benign,1,0
66145,thyroid,1,0
66146,nodules,1,0
66147,and/or,0,0
66148,at,0,0
66149,high,0,0
66150,surgical,0,0
66151,risk,0,0
66152,.,0,0
66153,Twenty,0,0
66154,six,0,0
66155,subjects,0,0
66156,were,0,0
66157,randomized,0,0
66158,to,0,0
66159,the,0,0
66160,intervention,0,0
66161,(,0,0
66162,no,0,0
66163,.,0,0
66164,13,0,0
66165,",",0,0
66166,age,0,0
66167,68+/-3,0,0
66168,yr,0,0
66169,",",0,0
66170,mean+/-SEM,0,0
66171,),0,1
66172,or,0,0
66173,observation,0,0
66174,(,0,0
66175,no,0,0
66176,.,0,0
66177,13,0,0
66178,",",0,0
66179,age,0,0
66180,71+/-2,0,0
66181,yr,0,0
66182,),0,0
66183,groups,0,0
66184,.,0,0
66185,In,0,0
66186,the,0,0
66187,control,0,0
66188,group,0,0
66189,",",0,0
66190,the,0,0
66191,volume,1,1
66192,of,1,0
66193,nodules,1,0
66194,did,0,0
66195,not,0,0
66196,significantly,0,0
66197,change,0,0
66198,over,0,0
66199,the,0,0
66200,30,0,0
66201,week,0,0
66202,period,0,0
66203,of,0,0
66204,observation,0,0
66205,.,0,0
66206,In,0,0
66207,the,0,0
66208,intervention,0,0
66209,group,0,0
66210,",",0,0
66211,median,1,1
66212,nodule,1,1
66213,volume,1,1
66214,at,0,0
66215,baseline,0,0
66216,was,0,0
66217,8.2,0,0
66218,ml,0,0
66219,(,0,0
66220,range,0,0
66221,2.8-26.9,0,0
66222,),0,0
66223,and,0,0
66224,was,0,0
66225,not,0,0
66226,significantly,0,0
66227,different,0,0
66228,from,0,0
66229,that,0,0
66230,of,0,0
66231,the,0,0
66232,control,0,0
66233,group,0,0
66234,.,0,0
66235,Nodules,1,0
66236,decreased,0,0
66237,significantly,0,0
66238,(,0,0
66239,p,0,0
66240,<,0,0
66241,0.0001,0,0
66242,),0,0
66243,by,0,0
66244,22,0,0
66245,%,0,0
66246,after,0,0
66247,2,0,0
66248,weeks,0,0
66249,(,0,0
66250,6.5,0,0
66251,ml,0,0
66252,;,0,0
66253,range,0,0
66254,2.4-16.7,0,0
66255,),0,0
66256,and,0,0
66257,by,0,0
66258,44,0,0
66259,%,0,0
66260,after,0,0
66261,30,0,0
66262,weeks,0,0
66263,(,0,0
66264,4.6,0,0
66265,ml,0,0
66266,;,0,0
66267,range,0,0
66268,0.69-14.2,0,0
66269,),0,0
66270,.,0,0
66271,Energy,0,1
66272,given,0,0
66273,was,0,0
66274,correlated,0,0
66275,(,0,0
66276,p,0,0
66277,<,0,0
66278,0.05,0,0
66279,),0,0
66280,with,0,0
66281,the,0,0
66282,reduction,0,0
66283,of,0,0
66284,thyroid,1,0
66285,nodule,1,0
66286,volume,1,1
66287,.,1,0
66288,All,0,0
66289,patients,0,0
66290,tolerated,0,1
66291,the,0,0
66292,treatment,1,0
66293,well,0,0
66294,and,0,0
66295,reported,0,0
66296,relief,1,1
66297,from,0,0
66298,compressive,1,0
66299,and,1,0
66300,cosmetic,1,1
66301,complaints,1,1
66302,(,0,0
66303,p,0,0
66304,<,0,0
66305,0.05,0,0
66306,),0,0
66307,.,0,0
66308,At,0,0
66309,the,0,0
66310,time,0,1
66311,of,0,0
66312,enrolment,0,0
66313,7/13,0,0
66314,(,0,0
66315,54,0,0
66316,%,0,0
66317,),0,0
66318,and,0,0
66319,6/13,0,0
66320,(,0,0
66321,46,0,0
66322,%,0,0
66323,),0,0
66324,of,0,0
66325,patients,0,0
66326,in,0,0
66327,the,0,0
66328,intervention,0,0
66329,and,0,0
66330,control,0,0
66331,groups,0,0
66332,",",0,0
66333,respectively,0,0
66334,",",0,0
66335,had,0,0
66336,sub,1,0
66337,clinical,1,0
66338,hyperthyroidism,1,0
66339,.,1,0
66340,PLP,1,1
66341,normalized,1,0
66342,thyroid,1,0
66343,function,1,1
66344,at,0,0
66345,6,0,0
66346,and,0,0
66347,30,0,0
66348,weeks,0,0
66349,after,0,0
66350,treatment,0,0
66351,.,0,0
66352,In,0,0
66353,conclusion,0,0
66354,",",0,0
66355,PLP,0,0
66356,is,0,0
66357,a,0,0
66358,promising,0,0
66359,safe,1,0
66360,and,1,0
66361,effective,1,1
66362,procedure,0,0
66363,for,0,0
66364,treatment,0,0
66365,of,0,0
66366,benign,0,0
66367,thyroid,0,0
66368,nodules,0,0
66369,in,0,0
66370,patients,0,0
66371,at,0,0
66372,high,0,0
66373,surgical,0,0
66374,risk,0,0
66375,.,0,0
66376,Effect,0,0
66377,of,0,1
66378,age,0,0
66379,and,0,1
66380,radiation,0,1
66381,dose,0,0
66382,on,0,0
66383,local,1,0
66384,control,1,0
66385,after,0,0
66386,breast,0,0
66387,conserving,0,0
66388,treatment,0,0
66389,:,0,0
66390,EORTC,0,0
66391,trial,0,0
66392,22881-10882,0,0
66393,.,0,0
66394,PURPOSE,0,0
66395,To,0,0
66396,determine,0,0
66397,whether,0,0
66398,the,0,0
66399,effect,0,0
66400,of,0,0
66401,an,0,0
66402,additional,0,0
66403,boost,0,0
66404,radiation,0,0
66405,after,0,0
66406,breast,0,0
66407,conservative,0,0
66408,therapy,0,0
66409,(,0,0
66410,BCT,0,0
66411,),0,0
66412,on,0,0
66413,local,0,0
66414,control,0,0
66415,depends,0,0
66416,on,0,0
66417,age,0,0
66418,and,0,0
66419,evaluate,0,0
66420,the,0,0
66421,impact,0,0
66422,of,0,0
66423,a,0,0
66424,treatment,0,0
66425,policy,0,0
66426,with,0,0
66427,a,0,0
66428,threshold,0,1
66429,for,0,0
66430,age,0,0
66431,.,0,0
66432,PATIENTS,0,0
66433,AND,0,0
66434,METHODS,0,0
66435,We,0,0
66436,used,0,0
66437,data,0,0
66438,from,0,0
66439,EORTC,0,0
66440,22881-10882,0,0
66441,trial,0,0
66442,",",0,0
66443,with,0,0
66444,median,0,1
66445,follow-up,0,0
66446,of,0,0
66447,77.4,0,0
66448,months,0,0
66449,.,0,0
66450,Patients,0,0
66451,receiving,0,0
66452,BCT,0,0
66453,and,0,0
66454,50Gy,0,0
66455,whole,0,0
66456,breast,0,0
66457,irradiation,0,0
66458,were,0,0
66459,randomized,0,0
66460,to,0,0
66461,no,0,0
66462,boost,0,0
66463,and,0,0
66464,16Gy,0,0
66465,boost,0,0
66466,(,0,0
66467,N=5318,0,0
66468,),0,0
66469,.,0,0
66470,RESULTS,0,0
66471,In,0,0
66472,univariate,0,0
66473,analysis,0,0
66474,",",0,0
66475,a,0,0
66476,boost,0,0
66477,reduced,0,0
66478,local,1,0
66479,failure,1,0
66480,by,0,0
66481,a,0,0
66482,factor,0,0
66483,of,0,0
66484,2,0,0
66485,(,0,0
66486,P,0,0
66487,<,0,0
66488,0.0001,0,0
66489,),0,0
66490,.,0,0
66491,Multivariate,0,0
66492,analysis,0,0
66493,showed,0,0
66494,local,1,1
66495,control,1,0
66496,increased,0,0
66497,with,0,0
66498,age,0,0
66499,(,0,0
66500,P=0.0003,0,0
66501,),0,0
66502,.,0,0
66503,There,0,0
66504,was,0,0
66505,no,0,0
66506,evidence,0,0
66507,that,0,0
66508,the,0,0
66509,relative,0,0
66510,effect,0,0
66511,of,0,0
66512,a,0,0
66513,boost,0,0
66514,on,0,0
66515,local,1,0
66516,control,1,0
66517,depends,0,0
66518,on,0,0
66519,age,0,0
66520,(,0,0
66521,P=0.97,0,0
66522,),0,0
66523,However,0,0
66524,in,0,0
66525,younger,0,0
66526,patients,0,0
66527,the,0,0
66528,5-year,0,0
66529,local,1,0
66530,failure,1,1
66531,was,0,0
66532,higher,0,0
66533,",",0,0
66534,therefore,0,0
66535,the,0,0
66536,absolute,0,1
66537,reduction,0,1
66538,was,0,0
66539,greater,0,0
66540,.,0,0
66541,If,0,0
66542,the,0,0
66543,threshold-age,0,0
66544,for,0,0
66545,boost,0,0
66546,treatment,0,0
66547,were,0,0
66548,set,0,0
66549,at,0,0
66550,40,0,0
66551,years,0,0
66552,",",0,0
66553,8.4,0,0
66554,%,0,0
66555,of,0,0
66556,the,0,0
66557,study,0,0
66558,population,0,0
66559,would,0,0
66560,receive,0,0
66561,a,0,0
66562,boost,0,0
66563,",",0,0
66564,resulting,0,0
66565,in,0,0
66566,a,0,0
66567,5-year,0,0
66568,local,1,0
66569,failure,1,0
66570,of,0,0
66571,6.1,0,0
66572,%,0,0
66573,in,0,0
66574,the,0,0
66575,study,0,0
66576,population,0,0
66577,.,0,0
66578,Changing,0,0
66579,the,0,0
66580,threshold-age,0,0
66581,to,0,0
66582,60,0,0
66583,years,0,0
66584,",",0,0
66585,67,0,0
66586,%,0,0
66587,of,0,0
66588,the,0,0
66589,study,0,0
66590,population,0,0
66591,would,0,0
66592,receive,0,0
66593,a,0,0
66594,boost,0,0
66595,and,0,0
66596,the,0,0
66597,5-year,0,0
66598,local,1,0
66599,failure,1,0
66600,would,0,0
66601,be,0,0
66602,reduced,0,0
66603,to,0,0
66604,4.4,0,0
66605,%,0,0
66606,.,0,0
66607,CONCLUSIONS,0,0
66608,In,0,0
66609,younger,0,0
66610,patients,0,0
66611,a,0,0
66612,boost,0,0
66613,dose,0,0
66614,resulted,0,0
66615,in,0,0
66616,a,0,0
66617,greater,0,0
66618,absolute,0,1
66619,reduction,0,1
66620,of,0,0
66621,local,1,0
66622,failure,1,0
66623,.,1,0
66624,The,0,0
66625,relative,1,0
66626,risk,1,1
66627,reduction,1,1
66628,was,0,0
66629,however,0,0
66630,similar,0,0
66631,for,0,0
66632,all,0,0
66633,ages,0,0
66634,.,0,0
66635,Applying,0,0
66636,a,0,0
66637,treatment,0,0
66638,policy,0,0
66639,with,0,0
66640,a,0,0
66641,threshold-age,0,0
66642,of,0,0
66643,60,0,0
66644,would,0,0
66645,result,0,0
66646,in,0,0
66647,0.6,0,0
66648,%,0,0
66649,increase,0,0
66650,in,0,0
66651,local,1,0
66652,failure,1,0
66653,in,0,0
66654,the,0,0
66655,total,0,1
66656,study,0,0
66657,population,0,0
66658,",",0,0
66659,while,0,0
66660,sparing,0,0
66661,the,0,0
66662,boost,0,0
66663,to,0,0
66664,1/3,0,0
66665,of,0,0
66666,the,0,0
66667,patients,0,0
66668,.,0,0
66669,[,1,0
66670,Efficacy,1,1
66671,and,1,1
66672,safety,1,1
66673,of,0,1
66674,extended-release,0,0
66675,niacin,0,0
66676,alone,0,0
66677,or,0,0
66678,with,0,0
66679,atorvastatin,0,0
66680,for,0,0
66681,lipid,0,1
66682,profile,0,1
66683,modification,0,0
66684,],0,0
66685,.,0,0
66686,OBJECTIVE,0,0
66687,To,0,0
66688,evaluate,0,0
66689,the,0,0
66690,efficacy,1,1
66691,and,1,0
66692,safety,1,1
66693,of,0,1
66694,extended-release,0,0
66695,niacin,0,0
66696,(,0,0
66697,niacin,0,0
66698,ER,0,0
66699,),0,0
66700,either,0,0
66701,alone,0,0
66702,or,0,0
66703,in,0,0
66704,combination,0,0
66705,with,0,0
66706,atorvastatin,0,0
66707,for,0,0
66708,the,0,0
66709,lipid,0,1
66710,profile,0,1
66711,modification,0,0
66712,in,0,0
66713,the,0,0
66714,patients,0,0
66715,with,0,0
66716,coronary,0,0
66717,heart,0,1
66718,disease,0,1
66719,(,0,0
66720,CHD,0,0
66721,),0,0
66722,and,0,0
66723,its,0,0
66724,equivalents,0,0
66725,.,0,0
66726,METHODS,0,0
66727,One,0,0
66728,hundred,0,0
66729,and,0,0
66730,ten,0,0
66731,patients,0,0
66732,with,0,0
66733,CHD,0,0
66734,and,0,0
66735,its,0,0
66736,equivalents,0,0
66737,with,0,0
66738,serum,0,1
66739,total,0,1
66740,cholesterol,0,1
66741,(,0,0
66742,TC,0,1
66743,),0,1
66744,>,0,0
66745,or,0,0
66746,=,0,0
66747,3.5,0,0
66748,mmol/L,0,0
66749,were,0,0
66750,randomly,0,0
66751,assigned,0,0
66752,into,0,0
66753,three,0,0
66754,treatment,0,0
66755,groups,0,0
66756,:,0,0
66757,(,0,0
66758,1,0,0
66759,),0,0
66760,atorvastatin,0,0
66761,group,0,0
66762,(,0,0
66763,n,0,0
66764,=,0,0
66765,38,0,0
66766,),0,0
66767,",",0,0
66768,receiving,0,0
66769,atorvastatin,0,0
66770,10,0,0
66771,mg/d,0,0
66772,for,0,0
66773,8,0,0
66774,weeks,0,0
66775,;,0,0
66776,(,0,0
66777,2,0,0
66778,),0,0
66779,niacin,0,0
66780,ER,0,0
66781,group,0,0
66782,(,0,0
66783,n,0,0
66784,=,0,0
66785,38,0,0
66786,),0,0
66787,",",0,0
66788,given,0,0
66789,niacin,0,0
66790,ER,0,0
66791,500,0,0
66792,mg/d,0,0
66793,for,0,0
66794,4,0,0
66795,weeks,0,0
66796,and,0,0
66797,then,0,0
66798,1000,0,0
66799,mg/d,0,0
66800,for,0,0
66801,4,0,0
66802,weeks,0,0
66803,;,0,0
66804,(,0,0
66805,3,0,0
66806,),0,0
66807,combination,0,0
66808,treatment,0,0
66809,group,0,0
66810,(,0,0
66811,n,0,0
66812,=,0,0
66813,34,0,0
66814,),0,0
66815,",",0,0
66816,treated,0,0
66817,with,0,0
66818,atorvastatin,0,0
66819,(,0,0
66820,10,0,0
66821,mg/d,0,0
66822,),0,0
66823,plus,0,0
66824,niacin,0,0
66825,ER,0,0
66826,",",0,0
66827,with,0,0
66828,the,0,0
66829,dose,0,0
66830,initiating,0,0
66831,from,0,0
66832,500,0,0
66833,mg/d,0,0
66834,",",0,0
66835,and,0,0
66836,increasing,0,0
66837,to,0,0
66838,1000,0,0
66839,mg/d,0,0
66840,after,0,0
66841,4,0,0
66842,weeks,0,0
66843,",",0,0
66844,for,0,0
66845,8,0,0
66846,weeks,0,0
66847,.,0,0
66848,The,0,0
66849,serums,1,0
66850,lipid,1,1
66851,profiles,1,0
66852,and,1,0
66853,adverse,1,1
66854,effects,1,1
66855,were,0,0
66856,assessed,0,0
66857,in,0,0
66858,all,0,0
66859,the,0,0
66860,patients,0,0
66861,before,0,0
66862,treatment,0,0
66863,",",0,0
66864,and,0,0
66865,4,0,0
66866,and,0,0
66867,8,0,0
66868,weeks,0,0
66869,after,0,0
66870,treatment,0,0
66871,.,0,0
66872,RESULTS,0,0
66873,(,0,0
66874,1,0,0
66875,),0,0
66876,After,0,0
66877,8,0,0
66878,weeks,0,0
66879,of,0,0
66880,treatment,0,0
66881,",",0,0
66882,the,0,0
66883,serum,1,1
66884,level,1,1
66885,of,1,0
66886,triglyceride,1,1
66887,(,1,0
66888,TG,1,1
66889,),1,0
66890,and,1,0
66891,high-density,1,1
66892,lipoprotein,1,1
66893,cholesterol,1,1
66894,(,1,0
66895,HDL-C,1,1
66896,),1,0
66897,were,0,0
66898,reduced,0,0
66899,by,0,0
66900,30,0,0
66901,%,0,0
66902,and,0,0
66903,16,0,0
66904,%,0,0
66905,respectively,0,0
66906,in,0,0
66907,the,0,0
66908,niacin,0,0
66909,ER,0,0
66910,group,0,0
66911,compared,0,0
66912,with,0,0
66913,the,0,0
66914,baseline,0,0
66915,values,0,1
66916,(,0,0
66917,both,0,0
66918,P,0,0
66919,<,0,0
66920,0.05,0,0
66921,),0,0
66922,.,0,0
66923,After,0,0
66924,8,0,0
66925,weeks,0,0
66926,",",0,0
66927,the,0,0
66928,TC,1,1
66929,",",1,0
66930,low-density,1,1
66931,lipoprotein,1,1
66932,cholesterol,1,1
66933,(,1,0
66934,LDL-C,1,1
66935,),1,1
66936,",",1,0
66937,and,1,1
66938,TG,1,1
66939,in,1,0
66940,the,1,0
66941,atorvastatin,1,0
66942,group,1,0
66943,decreased,0,0
66944,by,0,0
66945,19,0,0
66946,%,0,0
66947,",",0,0
66948,26,0,0
66949,%,0,0
66950,",",0,0
66951,and,0,0
66952,17,0,0
66953,%,0,0
66954,respectively,0,0
66955,compared,0,0
66956,with,0,0
66957,the,0,0
66958,baseline,0,0
66959,values,0,1
66960,(,0,0
66961,all,0,0
66962,P,0,0
66963,<,0,0
66964,0.05,0,0
66965,),0,0
66966,.,0,0
66967,Combination,0,0
66968,treatment,0,0
66969,decreased,0,0
66970,the,0,0
66971,TC,1,0
66972,",",1,0
66973,LDL-C,1,1
66974,",",1,1
66975,and,1,1
66976,TG,1,1
66977,levels,1,1
66978,by,0,0
66979,28,0,0
66980,%,0,0
66981,",",0,0
66982,38,0,0
66983,%,0,0
66984,",",0,0
66985,and,0,0
66986,39,0,0
66987,%,0,0
66988,respectively,0,0
66989,",",0,0
66990,and,0,0
66991,increased,0,0
66992,the,0,0
66993,HDL-C,1,0
66994,level,1,1
66995,by,0,0
66996,23,0,0
66997,%,0,0
66998,(,0,0
66999,all,0,0
67000,P,0,0
67001,<,0,0
67002,0.05,0,0
67003,),0,0
67004,.,0,0
67005,The,0,0
67006,improvement,0,0
67007,in,0,0
67008,TC,1,1
67009,and,1,0
67010,LDL-C,1,1
67011,achieved,0,0
67012,by,0,0
67013,combination,0,0
67014,treatment,0,0
67015,was,0,0
67016,superior,0,0
67017,to,0,0
67018,treatment,0,0
67019,of,0,0
67020,atorvastatin,0,0
67021,alone,0,0
67022,and,0,0
67023,treatment,0,0
67024,of,0,1
67025,niacin,0,0
67026,ER,0,0
67027,alone,0,0
67028,(,0,0
67029,all,0,0
67030,P,0,0
67031,<,0,0
67032,0.05,0,0
67033,),0,0
67034,.,0,0
67035,(,0,0
67036,2,0,0
67037,),0,0
67038,The,0,0
67039,rate,0,1
67040,of,0,0
67041,achieving,0,0
67042,the,0,0
67043,LDL-C,1,0
67044,goal,0,0
67045,of,0,0
67046,The,0,0
67047,National,0,0
67048,Cholesterol,0,0
67049,Education,0,1
67050,Program,0,0
67051,(,0,0
67052,NCEP,0,0
67053,),0,0
67054,in,0,0
67055,Adult,0,0
67056,Treatment,0,0
67057,Panel,0,1
67058,III,0,0
67059,(,0,0
67060,ATP,0,0
67061,III,0,0
67062,),0,0
67063,in,0,0
67064,the,0,0
67065,combination,0,0
67066,therapy,0,0
67067,group,0,0
67068,was,0,0
67069,73.5,0,0
67070,%,0,0
67071,",",0,0
67072,significantly,0,0
67073,higher,0,0
67074,than,0,0
67075,those,0,0
67076,of,0,0
67077,the,0,0
67078,atorvastatin,0,0
67079,and,0,0
67080,niacin,0,0
67081,groups,0,0
67082,(,0,0
67083,47.7,0,0
67084,%,0,0
67085,and,0,0
67086,42.1,0,0
67087,%,0,0
67088,respectively,0,0
67089,",",0,0
67090,both,0,0
67091,P,0,0
67092,<,0,0
67093,0.05,0,0
67094,),0,0
67095,.,0,0
67096,(,0,0
67097,3,0,0
67098,),0,0
67099,Adverse,0,0
67100,effect,0,0
67101,",",0,0
67102,such,0,0
67103,as,0,0
67104,flushing,1,0
67105,(,0,0
67106,15.8,0,0
67107,%,0,0
67108,),0,0
67109,and,0,0
67110,gastrointestinal,1,1
67111,symptoms,1,1
67112,(,0,0
67113,23.7,0,0
67114,%,0,0
67115,),0,0
67116,were,0,0
67117,found,0,0
67118,in,0,0
67119,the,0,0
67120,niacin,0,0
67121,ER,0,0
67122,group,0,0
67123,",",0,0
67124,however,0,0
67125,",",0,0
67126,no,0,0
67127,more,0,0
67128,adverse,0,1
67129,effects,0,1
67130,were,0,0
67131,found,0,0
67132,in,0,0
67133,the,0,0
67134,combination,0,0
67135,therapy,0,0
67136,group,0,0
67137,.,0,0
67138,There,0,0
67139,were,0,0
67140,no,0,0
67141,serious,0,1
67142,adverse,0,1
67143,events,0,1
67144,in,0,0
67145,all,0,0
67146,groups,0,0
67147,.,0,0
67148,CONCLUSION,0,0
67149,Niacin,0,0
67150,ER,0,0
67151,has,0,0
67152,a,0,0
67153,favorable,0,0
67154,effect,1,0
67155,in,1,0
67156,modulating,1,0
67157,the,1,0
67158,blood,1,1
67159,lipid,1,1
67160,profile,1,1
67161,",",0,0
67162,especially,0,0
67163,in,0,0
67164,reducing,1,0
67165,TG,1,0
67166,and,1,0
67167,elevating,1,0
67168,HDL-C,1,0
67169,.,1,0
67170,Combined,0,0
67171,statin,0,0
67172,with,0,0
67173,niacin,0,0
67174,may,0,0
67175,produce,0,0
67176,a,0,0
67177,more,0,0
67178,global,1,1
67179,and,1,1
67180,effective,1,1
67181,improvement,1,1
67182,in,1,0
67183,lipid,1,1
67184,blood,1,1
67185,levels,1,1
67186,than,0,0
67187,monotherapy,0,0
67188,and,0,0
67189,is,0,0
67190,generally,0,0
67191,safe,1,0
67192,and,1,0
67193,well,1,0
67194,tolerable,1,1
67195,.,1,0
67196,A,0,0
67197,comparison,0,0
67198,of,0,0
67199,three,0,0
67200,highly,0,0
67201,active,0,0
67202,antiretroviral,0,0
67203,treatment,0,0
67204,strategies,0,0
67205,consisting,0,0
67206,of,0,0
67207,non-nucleoside,0,0
67208,reverse,0,0
67209,transcriptase,0,0
67210,inhibitors,0,0
67211,",",0,0
67212,protease,0,1
67213,inhibitors,0,1
67214,",",0,0
67215,or,0,0
67216,both,0,0
67217,in,0,0
67218,the,0,0
67219,presence,0,0
67220,of,0,0
67221,nucleoside,0,1
67222,reverse,0,0
67223,transcriptase,0,0
67224,inhibitors,0,0
67225,as,0,0
67226,initial,0,0
67227,therapy,0,0
67228,(,0,0
67229,CPCRA,0,0
67230,058,0,0
67231,FIRST,0,0
67232,Study,0,0
67233,),0,0
67234,:,0,0
67235,a,0,0
67236,long-term,0,0
67237,randomised,0,0
67238,trial,0,0
67239,.,0,0
67240,BACKGROUND,0,0
67241,Long-term,0,1
67242,data,0,0
67243,from,0,0
67244,randomised,0,0
67245,trials,0,0
67246,on,0,0
67247,the,0,0
67248,consequences,0,0
67249,of,0,0
67250,treatment,0,0
67251,with,0,0
67252,a,0,0
67253,protease,0,0
67254,inhibitor,0,0
67255,(,0,0
67256,PI,0,0
67257,),0,0
67258,",",0,0
67259,non-nucleoside,0,0
67260,reverse,0,1
67261,transcriptase,0,0
67262,inhibitor,0,0
67263,(,0,0
67264,NNRTI,0,0
67265,),0,1
67266,",",0,0
67267,or,0,0
67268,both,0,0
67269,are,0,0
67270,lacking,0,0
67271,.,0,0
67272,Here,0,0
67273,",",0,0
67274,we,0,0
67275,report,0,0
67276,results,0,0
67277,from,0,0
67278,the,0,0
67279,FIRST,0,0
67280,trial,0,0
67281,",",0,0
67282,which,0,0
67283,compared,0,0
67284,initial,0,0
67285,treatment,0,0
67286,strategies,0,0
67287,for,0,0
67288,clinical,0,0
67289,",",0,0
67290,immunological,0,1
67291,",",0,0
67292,and,0,1
67293,virological,0,1
67294,outcomes,0,1
67295,.,0,0
67296,METHODS,0,0
67297,Between,0,0
67298,1999,0,0
67299,and,0,0
67300,2002,0,0
67301,",",0,0
67302,1397,0,0
67303,antiretroviral-treatment-naive,0,0
67304,patients,0,0
67305,",",0,0
67306,presenting,0,0
67307,at,0,0
67308,18,0,0
67309,clinical,0,0
67310,trial,0,0
67311,units,0,0
67312,with,0,0
67313,80,0,0
67314,research,0,0
67315,sites,0,0
67316,in,0,0
67317,the,0,0
67318,USA,0,0
67319,",",0,0
67320,were,0,0
67321,randomly,0,0
67322,assigned,0,0
67323,in,0,0
67324,a,0,0
67325,ratio,0,0
67326,of,0,0
67327,1:1:1,0,0
67328,to,0,0
67329,a,0,0
67330,protease,0,0
67331,inhibitor,0,0
67332,(,0,0
67333,PI,0,0
67334,),0,1
67335,strategy,0,0
67336,(,0,0
67337,PI,0,0
67338,plus,0,0
67339,nucleoside,0,1
67340,reverse,0,1
67341,transcriptase,0,0
67342,inhibitor,0,0
67343,[,0,0
67344,NRTI,0,0
67345,],0,0
67346,;,0,0
67347,n=470,0,0
67348,),0,0
67349,",",0,0
67350,a,0,0
67351,non-nucleoside,0,0
67352,reverse,0,0
67353,transcriptase,0,0
67354,inhibitor,0,0
67355,(,0,0
67356,NNRTI,0,0
67357,),0,1
67358,strategy,0,0
67359,(,0,0
67360,NNRTI,0,0
67361,plus,0,0
67362,NRTI,0,0
67363,;,0,0
67364,n=463,0,0
67365,),0,0
67366,",",0,0
67367,or,0,0
67368,a,0,0
67369,three-class,0,0
67370,strategy,0,0
67371,(,0,0
67372,PI,0,0
67373,plus,0,0
67374,NNRTI,0,0
67375,plus,0,0
67376,NRTI,0,0
67377,;,0,0
67378,n=464,0,0
67379,),0,0
67380,.,0,0
67381,Primary,0,0
67382,endpoints,0,1
67383,were,0,0
67384,a,0,0
67385,composite,0,1
67386,of,0,0
67387,an,0,0
67388,AIDS-defining,1,0
67389,event,1,1
67390,",",1,0
67391,death,1,1
67392,",",1,1
67393,or,1,0
67394,CD4,1,1
67395,cell,1,1
67396,count,1,1
67397,decline,1,0
67398,to,0,0
67399,less,0,0
67400,than,0,0
67401,200,0,0
67402,cells,0,1
67403,per,0,0
67404,mm3,0,0
67405,for,0,0
67406,the,0,0
67407,PI,0,0
67408,versus,0,0
67409,NNRTI,0,0
67410,comparison,0,0
67411,",",0,0
67412,and,0,1
67413,average,0,1
67414,change,1,1
67415,in,1,0
67416,CD4,1,1
67417,cell,1,1
67418,count,1,1
67419,at,0,0
67420,or,0,0
67421,after,0,0
67422,32,0,0
67423,months,0,0
67424,for,0,0
67425,the,0,0
67426,three-class,0,0
67427,versus,0,0
67428,combined,0,0
67429,two-class,0,0
67430,comparison,0,0
67431,.,0,0
67432,Analyses,0,0
67433,were,0,0
67434,by,0,0
67435,intention-to-treat,0,0
67436,.,0,0
67437,This,0,0
67438,study,0,0
67439,is,0,0
67440,registered,0,0
67441,ClinicalTrials.gov,0,0
67442,",",0,0
67443,number,0,1
67444,NCT00000922,0,0
67445,.,0,0
67446,FINDINGS,0,0
67447,1397,0,0
67448,patients,0,0
67449,were,0,0
67450,assessed,0,0
67451,for,0,0
67452,the,0,0
67453,composite,0,1
67454,endpoint,0,0
67455,.,0,0
67456,A,0,0
67457,total,0,0
67458,of,0,0
67459,388,0,0
67460,participants,0,0
67461,developed,0,0
67462,the,0,0
67463,composite,1,1
67464,endpoint,1,0
67465,",",0,0
67466,302,0,0
67467,developed,0,0
67468,AIDS,0,0
67469,or,0,0
67470,died,0,1
67471,",",0,0
67472,and,0,0
67473,188,0,0
67474,died,0,0
67475,.,0,0
67476,NNRTI,0,0
67477,versus,0,0
67478,PI,0,0
67479,hazard,1,1
67480,ratios,1,1
67481,(,1,0
67482,HRs,1,0
67483,),1,0
67484,for,0,0
67485,the,0,0
67486,composite,0,1
67487,endpoint,0,1
67488,",",0,0
67489,for,0,0
67490,AIDS,1,0
67491,or,1,0
67492,death,1,1
67493,",",1,1
67494,for,1,0
67495,death,1,1
67496,",",1,0
67497,and,1,1
67498,for,1,0
67499,virological,1,1
67500,failure,1,0
67501,were,0,0
67502,1.02,0,0
67503,(,0,0
67504,95,0,0
67505,%,0,0
67506,CI,0,0
67507,0.79-1.31,0,0
67508,),0,0
67509,",",0,0
67510,1.07,0,0
67511,(,0,0
67512,0.80-1.41,0,0
67513,),0,0
67514,",",0,0
67515,0.95,0,0
67516,(,0,0
67517,0.66-1.37,0,0
67518,),0,1
67519,",",0,0
67520,and,0,0
67521,0.66,0,0
67522,(,0,0
67523,0.56-0.78,0,0
67524,),0,0
67525,",",0,0
67526,respectively,0,0
67527,.,0,0
67528,1196,0,0
67529,patients,0,0
67530,were,0,0
67531,assessed,0,0
67532,for,0,0
67533,the,0,0
67534,three-class,0,0
67535,versus,0,0
67536,combined,0,0
67537,two-class,0,0
67538,primary,0,0
67539,endpoint,0,0
67540,.,0,0
67541,Mean,1,0
67542,change,1,0
67543,in,1,0
67544,CD4,1,1
67545,cell,1,1
67546,count,1,1
67547,at,0,0
67548,or,0,0
67549,after,0,0
67550,32,0,0
67551,months,0,0
67552,was,0,0
67553,+234,0,0
67554,cells,0,1
67555,per,0,0
67556,mm3,0,0
67557,and,0,0
67558,+227,0,0
67559,cells,0,1
67560,per,0,0
67561,mm3,0,0
67562,for,0,0
67563,the,0,0
67564,three-class,0,0
67565,and,0,0
67566,the,0,0
67567,combined,0,0
67568,two-class,0,0
67569,strategies,0,0
67570,(,0,0
67571,p=0.62,0,0
67572,),0,0
67573,",",0,0
67574,respectively,0,0
67575,.,0,0
67576,HRs,1,0
67577,(,0,0
67578,three-class,0,0
67579,vs,0,0
67580,combined,0,0
67581,two-class,0,0
67582,),0,0
67583,for,0,0
67584,AIDS,1,0
67585,or,1,0
67586,death,1,1
67587,and,1,1
67588,virological,1,1
67589,failure,1,1
67590,were,0,0
67591,1.15,0,0
67592,(,0,0
67593,0.91-1.45,0,0
67594,),0,0
67595,and,0,0
67596,0.87,0,0
67597,(,0,0
67598,0.75-1.00,0,0
67599,),0,0
67600,",",0,0
67601,respectively,0,0
67602,.,0,0
67603,HRs,1,0
67604,(,0,0
67605,three-class,0,0
67606,vs,0,0
67607,combined,0,0
67608,two-class,0,0
67609,),0,0
67610,for,0,0
67611,AIDS,1,0
67612,or,1,0
67613,death,1,1
67614,were,0,0
67615,similar,0,0
67616,for,0,0
67617,participants,0,0
67618,with,0,0
67619,baseline,0,0
67620,CD4,0,1
67621,cell,0,1
67622,counts,0,1
67623,of,0,0
67624,200,0,0
67625,cells,0,1
67626,per,0,0
67627,mm3,0,0
67628,or,0,0
67629,less,0,0
67630,and,0,1
67631,of,0,1
67632,more,0,0
67633,than,0,0
67634,200,0,0
67635,cells,0,1
67636,per,0,0
67637,mm3,0,0
67638,(,0,0
67639,p=0.38,0,0
67640,for,0,0
67641,interaction,0,1
67642,),0,0
67643,",",0,0
67644,and,0,0
67645,for,0,0
67646,participants,0,0
67647,with,0,0
67648,baseline,0,0
67649,HIV,0,1
67650,RNA,0,0
67651,concentrations,0,1
67652,less,0,0
67653,than,0,0
67654,100,0,0
67655,000,0,0
67656,copies,0,0
67657,per,0,0
67658,mL,0,0
67659,and,0,0
67660,"100,000",0,0
67661,copies,0,0
67662,per,0,0
67663,mL,0,0
67664,or,0,0
67665,more,0,0
67666,(,0,1
67667,p=0.26,0,0
67668,for,0,0
67669,interaction,0,0
67670,),0,0
67671,.,0,0
67672,Participants,0,0
67673,assigned,0,0
67674,the,0,0
67675,three-class,0,0
67676,strategy,0,0
67677,were,0,0
67678,significantly,0,0
67679,more,0,0
67680,likely,0,0
67681,to,0,0
67682,discontinue,1,0
67683,treatment,1,0
67684,because,0,0
67685,of,0,0
67686,toxic,1,1
67687,effects,1,1
67688,than,0,0
67689,were,0,0
67690,those,0,0
67691,assigned,0,0
67692,to,0,0
67693,the,0,0
67694,two-class,0,0
67695,strategies,0,0
67696,(,0,0
67697,HR,0,0
67698,1.58,0,0
67699,;,0,0
67700,p,0,0
67701,<,0,0
67702,0.0001,0,0
67703,),0,0
67704,.,0,0
67705,INTERPRETATION,0,0
67706,Initial,0,1
67707,treatment,0,0
67708,with,0,0
67709,either,0,0
67710,an,0,0
67711,NNRTI-based,0,0
67712,regimen,0,0
67713,or,0,0
67714,a,0,0
67715,PI-based,0,0
67716,regimen,0,0
67717,",",0,0
67718,but,0,0
67719,not,0,0
67720,both,0,0
67721,together,0,0
67722,",",0,0
67723,is,0,0
67724,a,0,0
67725,good,0,0
67726,strategy,0,0
67727,for,0,0
67728,long-term,0,0
67729,antiretroviral,0,0
67730,management,0,0
67731,in,0,0
67732,treatment-naive,0,0
67733,patients,0,0
67734,with,0,0
67735,HIV,0,0
67736,.,0,0
67737,Dofequidar,0,0
67738,fumarate,0,0
67739,(,0,0
67740,MS-209,0,0
67741,),0,0
67742,in,0,0
67743,combination,0,0
67744,with,0,0
67745,cyclophosphamide,0,0
67746,",",0,0
67747,doxorubicin,0,0
67748,",",0,1
67749,and,0,1
67750,fluorouracil,0,0
67751,for,0,0
67752,patients,0,0
67753,with,0,0
67754,advanced,0,0
67755,or,0,0
67756,recurrent,0,1
67757,breast,0,0
67758,cancer,0,0
67759,.,0,0
67760,PURPOSE,0,0
67761,To,0,0
67762,evaluate,0,0
67763,the,0,0
67764,efficacy,1,1
67765,and,1,0
67766,tolerability,1,1
67767,of,0,1
67768,dofequidar,0,0
67769,plus,0,0
67770,cyclophosphamide,0,0
67771,",",0,1
67772,doxorubicin,0,0
67773,",",0,1
67774,and,0,1
67775,fluorouracil,0,0
67776,(,0,1
67777,CAF,0,1
67778,),0,0
67779,therapy,0,0
67780,in,0,0
67781,comparison,0,0
67782,with,0,0
67783,CAF,0,0
67784,alone,0,0
67785,",",0,0
67786,in,0,0
67787,patients,0,0
67788,with,0,0
67789,advanced,0,0
67790,or,0,0
67791,recurrent,0,1
67792,breast,0,0
67793,cancer,0,0
67794,.,0,0
67795,Dofequidar,0,0
67796,is,0,0
67797,a,0,0
67798,novel,0,0
67799,",",0,0
67800,orally,0,0
67801,active,0,0
67802,quinoline,0,1
67803,derivative,0,0
67804,that,0,0
67805,reverses,0,0
67806,multidrug,0,0
67807,resistance,0,1
67808,.,0,0
67809,PATIENTS,0,0
67810,AND,0,0
67811,METHODS,0,0
67812,In,0,0
67813,this,0,0
67814,randomized,0,0
67815,",",0,0
67816,double-blind,0,0
67817,",",0,0
67818,placebo-controlled,0,0
67819,trial,0,0
67820,",",0,0
67821,patients,0,0
67822,were,0,0
67823,treated,0,0
67824,with,0,0
67825,six,0,0
67826,cycles,0,0
67827,of,0,0
67828,CAF,0,0
67829,therapy,0,0
67830,:,0,0
67831,28,0,0
67832,days/cycle,0,0
67833,",",0,0
67834,with,0,0
67835,doxorubicin,0,0
67836,(,0,0
67837,25,0,0
67838,mg/m2,0,0
67839,),0,0
67840,and,0,1
67841,fluorouracil,0,0
67842,(,0,0
67843,500,0,0
67844,mg/m2,0,0
67845,),0,0
67846,administered,0,0
67847,on,0,0
67848,days,0,0
67849,1,0,0
67850,and,0,0
67851,8,0,0
67852,and,0,0
67853,cyclophosphamide,0,0
67854,(,0,0
67855,100,0,0
67856,mg,0,0
67857,orally,0,0
67858,[,0,0
67859,PO,0,1
67860,],0,0
67861,),0,0
67862,administered,0,0
67863,on,0,0
67864,day,0,0
67865,1,0,0
67866,through,0,0
67867,14,0,0
67868,.,0,0
67869,Patients,0,0
67870,received,0,0
67871,dofequidar,0,0
67872,(,0,0
67873,900,0,0
67874,mg,0,0
67875,PO,0,0
67876,),0,0
67877,30,0,0
67878,minutes,0,0
67879,before,0,0
67880,each,0,0
67881,dose,0,0
67882,of,0,0
67883,doxorubicin,0,0
67884,.,0,0
67885,Primary,0,0
67886,end,0,0
67887,point,0,0
67888,was,0,0
67889,overall,1,1
67890,response,1,1
67891,rate,1,1
67892,(,1,0
67893,ORR,1,0
67894,;,1,0
67895,partial,1,0
67896,or,1,0
67897,complete,1,1
67898,response,1,1
67899,),1,0
67900,.,1,0
67901,In,0,0
67902,total,0,1
67903,",",0,0
67904,221,0,0
67905,patients,0,0
67906,were,0,0
67907,assessable,0,0
67908,.,0,0
67909,RESULTS,0,0
67910,ORR,1,0
67911,was,0,0
67912,42.6,0,0
67913,%,0,0
67914,for,0,0
67915,CAF,0,0
67916,compared,0,0
67917,with,0,0
67918,53.1,0,0
67919,%,0,0
67920,for,0,0
67921,dofequidar,0,0
67922,+,0,0
67923,CAF,0,1
67924,",",0,0
67925,a,0,0
67926,24.6,0,0
67927,%,0,0
67928,relative,0,0
67929,improvement,0,1
67930,and,0,0
67931,10.5,0,0
67932,%,0,0
67933,absolute,0,0
67934,increase,0,1
67935,(,0,0
67936,P,0,0
67937,=,0,0
67938,.077,0,0
67939,),0,0
67940,.,0,0
67941,There,0,0
67942,was,0,0
67943,a,0,0
67944,trend,0,0
67945,for,0,0
67946,prolonged,1,1
67947,progression-free,1,1
67948,survival,1,1
67949,(,1,0
67950,PFS,1,0
67951,;,1,0
67952,median,0,0
67953,241,0,0
67954,days,0,0
67955,for,0,0
67956,CAF,0,0
67957,v,0,0
67958,366,0,0
67959,days,0,0
67960,for,0,0
67961,dofequidar,0,0
67962,+,0,0
67963,CAF,0,0
67964,;,0,0
67965,P,0,0
67966,=,0,0
67967,.145,0,0
67968,),0,0
67969,.,0,0
67970,In,0,0
67971,retrospectively,0,0
67972,defined,0,0
67973,subgroups,0,0
67974,",",0,0
67975,significant,0,0
67976,improvement,0,1
67977,in,0,0
67978,PFS,1,1
67979,in,0,0
67980,favor,0,0
67981,of,0,0
67982,dofequidar,0,0
67983,was,0,0
67984,observed,0,0
67985,in,0,0
67986,patients,0,0
67987,who,0,0
67988,were,0,0
67989,premenopausal,0,0
67990,",",0,0
67991,had,0,0
67992,no,0,0
67993,prior,0,0
67994,therapy,0,0
67995,",",0,0
67996,and,0,1
67997,were,0,0
67998,stage,0,0
67999,IV,0,1
68000,at,0,0
68001,diagnosis,0,0
68002,with,0,0
68003,an,0,0
68004,intact,0,0
68005,primary,0,0
68006,tumor,0,0
68007,.,0,0
68008,Except,0,0
68009,for,0,0
68010,neutropenia,1,1
68011,and,1,1
68012,leukopenia,1,1
68013,",",0,1
68014,there,0,0
68015,was,0,0
68016,no,0,0
68017,statistically,0,0
68018,significant,0,0
68019,excess,0,0
68020,of,0,0
68021,grade,0,0
68022,3/4,0,0
68023,adverse,0,1
68024,events,0,1
68025,compared,0,0
68026,with,0,0
68027,CAF,0,0
68028,.,0,0
68029,Treatment,0,0
68030,with,0,0
68031,dofequidar,0,0
68032,did,0,0
68033,not,0,0
68034,affect,0,0
68035,the,0,0
68036,plasma,1,1
68037,concentration,1,1
68038,of,1,0
68039,doxorubicin,1,0
68040,.,1,0
68041,CONCLUSION,0,0
68042,Dofequidar,0,0
68043,+,0,0
68044,CAF,0,1
68045,was,0,0
68046,well,0,0
68047,tolerated,0,1
68048,and,0,0
68049,is,0,0
68050,suggested,0,0
68051,to,0,0
68052,have,0,0
68053,efficacy,0,1
68054,in,0,0
68055,patients,0,0
68056,who,0,0
68057,had,0,0
68058,not,0,0
68059,received,0,0
68060,prior,0,0
68061,therapy,0,0
68062,.,0,0
68063,Xuezhikang,0,0
68064,",",0,0
68065,an,0,0
68066,extract,0,0
68067,of,0,0
68068,cholestin,0,1
68069,",",0,0
68070,decreases,0,1
68071,plasma,0,1
68072,inflammatory,0,1
68073,markers,0,1
68074,and,0,1
68075,endothelin-1,0,1
68076,",",0,0
68077,improve,0,0
68078,exercise-induced,0,1
68079,ischemia,0,1
68080,and,0,0
68081,subjective,0,1
68082,feelings,0,1
68083,in,0,0
68084,patients,0,0
68085,with,0,0
68086,cardiac,0,1
68087,syndrome,0,0
68088,X,0,0
68089,.,0,0
68090,Previous,0,0
68091,studies,0,0
68092,have,0,0
68093,demonstrated,0,0
68094,that,0,0
68095,Xuezhikang,0,0
68096,",",0,0
68097,an,0,0
68098,extract,0,0
68099,of,0,0
68100,cholestin,0,1
68101,",",0,0
68102,available,0,0
68103,from,0,0
68104,Chinese,0,0
68105,red,0,1
68106,yeast,0,0
68107,rice,0,0
68108,",",0,0
68109,could,0,0
68110,effectively,0,0
68111,modify,0,0
68112,lipid,0,0
68113,profile,0,0
68114,.,0,0
68115,The,0,0
68116,present,0,0
68117,study,0,0
68118,was,0,0
68119,undertaken,0,0
68120,to,0,0
68121,investigate,0,0
68122,whether,0,0
68123,Xuezhikang,0,0
68124,could,0,0
68125,modify,0,0
68126,endothelin-1,0,1
68127,(,0,0
68128,ET-1,0,0
68129,),0,0
68130,",",0,0
68131,interleukin-6,0,1
68132,(,0,0
68133,IL-6,0,0
68134,),0,0
68135,",",0,0
68136,high-sensitivity,0,1
68137,C-reactive,0,1
68138,protein,0,1
68139,(,0,0
68140,CRP,0,1
68141,),0,0
68142,and,0,0
68143,exercise-induced,0,1
68144,ischemia,0,1
68145,in,0,0
68146,patients,0,0
68147,with,0,0
68148,cardiac,0,1
68149,syndrome,0,0
68150,X,0,0
68151,(,0,0
68152,CSX,0,0
68153,),0,0
68154,.,0,0
68155,Thirty-six,0,0
68156,patients,0,0
68157,with,0,0
68158,CSX,0,0
68159,were,0,0
68160,randomly,0,0
68161,assigned,0,0
68162,to,0,0
68163,1200,0,0
68164,mg/d,0,0
68165,of,0,0
68166,Xuezhikang,0,0
68167,or,0,0
68168,placebo,0,0
68169,group,0,0
68170,(,0,0
68171,n=18,0,0
68172,respectively,0,0
68173,),0,0
68174,.,0,0
68175,Blood,0,1
68176,samples,0,0
68177,were,0,0
68178,drawn,0,0
68179,at,0,0
68180,day,0,0
68181,0,0,0
68182,and,0,0
68183,day,0,0
68184,90,0,0
68185,for,0,0
68186,measuring,0,0
68187,above,0,0
68188,parameters,0,0
68189,.,0,0
68190,The,0,0
68191,treadmill,0,0
68192,exercise,0,0
68193,tests,0,1
68194,and,0,1
68195,subjective,0,1
68196,feelings,0,1
68197,were,0,0
68198,also,0,0
68199,assessed,0,0
68200,at,0,0
68201,day,0,0
68202,0,0,0
68203,and,0,0
68204,day,0,0
68205,90,0,0
68206,.,0,0
68207,The,0,0
68208,data,0,0
68209,showed,0,0
68210,that,0,0
68211,Xuezhikang,0,0
68212,therapy,0,0
68213,resulted,0,0
68214,in,0,0
68215,significant,0,0
68216,reductions,0,1
68217,in,0,0
68218,total,1,1
68219,cholesterol,1,1
68220,(,1,0
68221,TC,1,0
68222,",",1,0
68223,19,1,0
68224,%,1,0
68225,),1,0
68226,",",1,0
68227,low-density,1,1
68228,lipoprotein,1,1
68229,cholesterol,1,1
68230,(,1,0
68231,LDL-C,1,1
68232,),1,0
68233,(,1,0
68234,26,1,0
68235,%,1,0
68236,),1,0
68237,",",1,0
68238,and,1,1
68239,triglycerides,1,1
68240,(,1,0
68241,TG,1,0
68242,),1,0
68243,compared,0,0
68244,with,0,0
68245,baseline,0,0
68246,(,0,0
68247,16,0,0
68248,%,0,0
68249,",",0,0
68250,p,0,0
68251,<,0,0
68252,0.01,0,0
68253,respectively,0,0
68254,),0,0
68255,.,0,0
68256,The,0,0
68257,data,0,0
68258,also,0,0
68259,showed,0,0
68260,that,0,0
68261,Xuezhikang,0,0
68262,led,0,0
68263,significantly,0,0
68264,to,0,0
68265,reductions,1,1
68266,in,1,0
68267,median,1,1
68268,and,1,0
68269,log-CRP,1,1
68270,levels,1,1
68271,(,1,0
68272,38,1,0
68273,%,1,0
68274,and,1,0
68275,44,1,0
68276,%,1,0
68277,",",1,0
68278,p,1,0
68279,<,1,0
68280,0.01,1,0
68281,respectively,1,0
68282,),1,0
68283,",",1,0
68284,IL-6,1,0
68285,(,1,0
68286,20,1,0
68287,%,1,0
68288,",",1,0
68289,p,1,0
68290,<,1,0
68291,0.01,1,0
68292,),1,0
68293,",",1,0
68294,and,1,1
68295,ET-1,1,0
68296,(,1,0
68297,47,1,0
68298,%,1,0
68299,",",1,0
68300,p,1,0
68301,<,1,0
68302,0.01,1,0
68303,),1,0
68304,compared,0,0
68305,with,0,0
68306,baseline,0,0
68307,.,0,0
68308,The,0,0
68309,exercise,0,0
68310,duration,0,1
68311,",",0,1
68312,and,0,1
68313,time,1,1
68314,to,1,0
68315,1,1,0
68316,mm,1,0
68317,ST-segment,1,0
68318,depression,1,1
68319,was,0,0
68320,significantly,0,0
68321,prolonged,0,0
68322,after,0,0
68323,Xuezhikang,0,0
68324,therapy,0,0
68325,(,0,0
68326,9,0,0
68327,%,0,0
68328,and,0,0
68329,6,0,0
68330,%,0,0
68331,",",0,0
68332,p,0,0
68333,<,0,0
68334,0.05,0,0
68335,respectively,0,0
68336,),0,0
68337,accompanied,0,0
68338,by,0,0
68339,improvement,1,0
68340,of,1,0
68341,subjective,1,1
68342,feelings,1,1
68343,.,1,0
68344,Data,0,0
68345,suggested,0,0
68346,that,0,0
68347,the,0,0
68348,benefit,0,0
68349,of,0,0
68350,Xuezhikang,0,0
68351,resulted,0,0
68352,in,0,0
68353,significant,0,0
68354,modification,0,0
68355,vascular,1,1
68356,function,1,1
68357,by,0,0
68358,reduction,0,1
68359,of,0,0
68360,ET-1,1,0
68361,",",1,0
68362,inflammatory,1,1
68363,markers,1,1
68364,and,1,0
68365,LDL,1,1
68366,cholesterol,1,1
68367,",",0,0
68368,which,0,0
68369,may,0,0
68370,be,0,0
68371,clinically,0,0
68372,important,0,0
68373,for,0,0
68374,patients,0,0
68375,with,0,0
68376,CSX,0,0
68377,.,0,0
68378,Bradykinin-induced,0,0
68379,cough,0,1
68380,reflex,0,0
68381,markedly,0,0
68382,increases,0,0
68383,in,0,0
68384,patients,0,0
68385,with,0,0
68386,cough,0,1
68387,associated,0,0
68388,with,0,0
68389,captopril,0,0
68390,and,0,0
68391,enalapril,0,0
68392,.,0,0
68393,We,0,0
68394,studied,0,0
68395,the,0,0
68396,effects,0,1
68397,of,0,0
68398,angiotensin,0,0
68399,converting,0,0
68400,enzyme,0,1
68401,(,0,0
68402,ACE,0,1
68403,),0,0
68404,inhibitors,0,0
68405,on,0,0
68406,cough,1,1
68407,responses,1,1
68408,to,0,0
68409,bradykinin,0,0
68410,(,0,0
68411,BK,0,0
68412,),0,0
68413,",",0,0
68414,substance,0,0
68415,P,0,0
68416,(,0,0
68417,SP,0,0
68418,),0,0
68419,and,0,0
68420,citric,0,0
68421,acid,0,0
68422,in,0,0
68423,a,0,0
68424,double,0,0
68425,blind,0,0
68426,",",0,0
68427,random,0,0
68428,study,0,0
68429,on,0,0
68430,10,0,0
68431,hypertensive,0,0
68432,patients,0,0
68433,receiving,0,0
68434,ACE,0,0
68435,inhibitors,0,0
68436,.,0,0
68437,Of,0,0
68438,these,0,0
68439,patients,0,0
68440,",",0,0
68441,five,0,0
68442,had,0,0
68443,reported,0,0
68444,cough,0,1
68445,with,0,0
68446,ACE,0,0
68447,inhibitors,0,0
68448,.,0,0
68449,Cough,0,0
68450,responses,0,1
68451,to,0,0
68452,citric,0,0
68453,acid,0,0
68454,were,0,0
68455,similar,0,0
68456,between,0,0
68457,patients,0,0
68458,with,0,0
68459,and,0,0
68460,without,0,0
68461,cough,0,1
68462,",",0,0
68463,and,0,1
68464,SP,0,0
68465,up,0,0
68466,to,0,0
68467,10,0,0
68468,(,0,0
68469,-5,0,0
68470,),0,1
68471,M,0,0
68472,did,0,0
68473,not,0,0
68474,cause,0,0
68475,cough,0,1
68476,in,0,0
68477,any,0,0
68478,of,0,0
68479,the,0,0
68480,subjects,0,0
68481,.,0,0
68482,BK,0,0
68483,caused,0,0
68484,cough,1,1
68485,at,0,0
68486,13.4,0,0
68487,+/-,0,0
68488,1.2,0,0
68489,(,0,0
68490,-log,0,0
68491,M,0,0
68492,),0,0
68493,in,0,0
68494,5,0,0
68495,patients,0,0
68496,with,0,0
68497,cough,0,1
68498,associated,0,0
68499,with,0,0
68500,ACE,0,0
68501,inhibitors,0,0
68502,",",0,0
68503,but,0,0
68504,it,0,0
68505,did,0,0
68506,not,0,0
68507,cause,0,0
68508,cough,1,1
68509,at,0,0
68510,concentrations,0,1
68511,up,0,0
68512,to,0,0
68513,10,0,0
68514,(,0,0
68515,-5,0,0
68516,),0,0
68517,M,0,0
68518,in,0,0
68519,other,0,0
68520,5,0,0
68521,patients,0,0
68522,.,0,0
68523,One,0,0
68524,month,0,0
68525,after,0,0
68526,the,0,0
68527,withdrawal,0,0
68528,of,0,0
68529,ACE,0,1
68530,inhibitors,0,0
68531,",",0,0
68532,5,0,0
68533,patients,0,0
68534,were,0,0
68535,free,0,1
68536,from,0,0
68537,cough,1,1
68538,symptoms,1,1
68539,",",0,0
68540,and,0,1
68541,BK,0,0
68542,did,0,0
68543,not,0,0
68544,cause,0,0
68545,cough,1,0
68546,up,0,0
68547,to,0,0
68548,10,0,0
68549,(,0,0
68550,-5,0,0
68551,),0,0
68552,M,0,0
68553,in,0,0
68554,these,0,0
68555,patients,0,0
68556,",",0,0
68557,except,0,0
68558,for,0,0
68559,one,0,0
68560,who,0,0
68561,coughed,0,0
68562,at,0,0
68563,10,0,0
68564,(,0,0
68565,-9,0,0
68566,),0,1
68567,M,0,0
68568,",",0,0
68569,without,0,0
68570,changes,0,1
68571,in,0,0
68572,responses,0,1
68573,to,0,0
68574,citric,0,0
68575,acid,0,0
68576,.,0,0
68577,BK,0,0
68578,caused,0,0
68579,cough,1,1
68580,at,0,0
68581,14.3,0,0
68582,+/-,0,0
68583,0.7,0,0
68584,(,0,0
68585,-log,0,0
68586,M,0,0
68587,),0,0
68588,although,0,0
68589,BK1-7,0,0
68590,",",0,0
68591,a,0,0
68592,major,0,0
68593,metabolite,0,0
68594,of,0,0
68595,BK,0,0
68596,by,0,0
68597,ACE,0,1
68598,",",0,0
68599,caused,0,0
68600,cough,1,1
68601,at,0,0
68602,5.7,0,0
68603,+/-,0,0
68604,0.7,0,0
68605,(,0,0
68606,-log,0,0
68607,M,0,0
68608,),0,0
68609,in,0,0
68610,another,0,0
68611,3,0,0
68612,patients,0,0
68613,with,0,0
68614,cough,0,1
68615,associated,0,0
68616,with,0,0
68617,ACE,0,0
68618,inhibitor,0,0
68619,.,0,0
68620,These,0,0
68621,results,0,0
68622,suggest,0,0
68623,that,0,0
68624,impaired,0,0
68625,metabolism,0,0
68626,of,0,0
68627,BK,0,0
68628,induced,0,0
68629,by,0,0
68630,ACE,0,0
68631,inhibitors,0,0
68632,may,0,0
68633,relate,0,0
68634,to,0,0
68635,the,0,0
68636,manifestation,0,0
68637,of,0,0
68638,cough,0,1
68639,in,0,0
68640,hypertensive,0,0
68641,patients,0,0
68642,receiving,0,0
68643,ACE,0,0
68644,inhibitors,0,0
68645,.,0,0
68646,5,0,0
68647,alpha-metabolism,0,0
68648,in,0,0
68649,finasteride-treated,0,0
68650,subjects,0,0
68651,and,0,0
68652,male,0,0
68653,pseudohermaphrodites,0,0
68654,with,0,0
68655,inherited,0,0
68656,5,0,0
68657,alpha-reductase,0,0
68658,deficiency,0,0
68659,.,0,0
68660,A,0,0
68661,review,0,0
68662,.,0,0
68663,Male,0,0
68664,pseudohermaphrodites,0,0
68665,(,0,0
68666,MPHs,0,0
68667,),0,0
68668,with,0,0
68669,inherited,0,0
68670,5,0,0
68671,alpha-reductase,0,0
68672,deficiency,0,0
68673,and,0,1
68674,decreased,0,1
68675,dihydrotestosterone,0,1
68676,production,0,1
68677,have,0,0
68678,a,0,0
68679,global,0,1
68680,defect,0,0
68681,in,0,0
68682,5,0,0
68683,alpha-metabolism,0,0
68684,affecting,0,0
68685,both,0,0
68686,C19,0,0
68687,androgen,0,1
68688,metabolism,0,1
68689,and,0,0
68690,C21,0,1
68691,steroid,0,0
68692,metabolism,0,0
68693,.,0,0
68694,However,0,0
68695,",",0,0
68696,the,0,0
68697,decreased,0,0
68698,5,0,0
68699,alpha-reduction,0,0
68700,of,0,0
68701,testosterone,0,1
68702,to,0,0
68703,dihydrotestosterone,0,0
68704,is,0,0
68705,the,0,0
68706,only,0,0
68707,impaired,0,0
68708,steroid,0,0
68709,conversion,0,0
68710,to,0,0
68711,have,0,0
68712,clinical,0,0
68713,consequences,0,0
68714,",",0,0
68715,e.g.,0,0
68716,",",0,1
68717,ambiguous,1,1
68718,genitalia,1,1
68719,",",1,0
68720,impaired,1,1
68721,prostate,1,0
68722,differentiation,1,1
68723,and,1,1
68724,development,1,1
68725,",",0,1
68726,and,0,1
68727,decreased,1,1
68728,facial,1,1
68729,and,1,0
68730,body,1,1
68731,hair,1,1
68732,.,1,0
68733,The,0,0
68734,5,1,0
68735,alpha-steroid,1,0
68736,metabolite,1,0
68737,profile,1,1
68738,in,0,0
68739,the,0,0
68740,MPHs,0,0
68741,was,0,0
68742,compared,0,0
68743,with,0,0
68744,that,0,0
68745,of,0,0
68746,men,0,0
68747,with,0,0
68748,benign,0,0
68749,prostatic,0,0
68750,hyperplasia,0,1
68751,who,0,0
68752,were,0,0
68753,administered,0,0
68754,varying,0,0
68755,doses,0,0
68756,of,0,0
68757,the,0,0
68758,5,0,0
68759,alpha-reductase,0,0
68760,inhibitor,0,0
68761,finasteride,0,0
68762,.,0,0
68763,Finasteride,0,0
68764,was,0,0
68765,found,0,0
68766,to,0,0
68767,be,0,0
68768,a,0,0
68769,potent,0,0
68770,inhibitor,0,0
68771,of,0,0
68772,both,0,0
68773,C19,1,0
68774,androgen,1,1
68775,and,1,0
68776,C21,1,0
68777,5,1,0
68778,alpha-steroid,1,0
68779,metabolism,1,0
68780,affecting,0,0
68781,both,0,0
68782,hepatic,1,0
68783,and,1,0
68784,peripheral,1,0
68785,5,1,0
68786,alpha-metabolism,1,0
68787,.,1,0
68788,The,0,0
68789,5,0,0
68790,alpha-steroid,1,0
68791,metabolite,1,0
68792,profile,1,1
68793,was,0,0
68794,strikingly,0,0
68795,similar,0,0
68796,to,0,0
68797,that,0,0
68798,of,0,0
68799,MPHs,0,0
68800,with,0,0
68801,inherited,0,0
68802,5,0,0
68803,alpha-reductase,0,0
68804,deficiency,0,0
68805,.,0,0
68806,The,0,0
68807,data,0,0
68808,suggest,0,0
68809,that,0,0
68810,a,0,0
68811,5,0,0
68812,alpha-reductase,0,0
68813,gene,0,0
68814,codes,0,0
68815,for,0,0
68816,an,0,0
68817,enzyme,0,0
68818,with,0,0
68819,affinity,1,1
68820,for,1,0
68821,multiple,1,0
68822,steroid,1,0
68823,substrates,1,0
68824,.,1,0
68825,Role,0,1
68826,of,0,0
68827,diltiazem,0,0
68828,in,0,0
68829,the,0,0
68830,treatment,0,0
68831,of,0,0
68832,silent,0,1
68833,myocardial,0,1
68834,ischemia,0,1
68835,.,0,0
68836,Silent,0,1
68837,myocardial,0,0
68838,ischemia,0,0
68839,is,0,0
68840,a,0,0
68841,frequent,0,0
68842,finding,0,0
68843,when,0,0
68844,Holter,0,0
68845,monitoring,0,0
68846,is,0,0
68847,done,0,0
68848,in,0,0
68849,patients,0,0
68850,with,0,0
68851,advanced,0,0
68852,coronary,0,0
68853,disease,0,0
68854,.,0,0
68855,Silent,0,0
68856,ischemia,0,0
68857,is,0,0
68858,associated,0,0
68859,with,0,0
68860,a,0,0
68861,worse,0,0
68862,prognosis,0,1
68863,in,0,0
68864,patients,0,0
68865,with,0,0
68866,stable,0,1
68867,or,0,0
68868,unstable,0,1
68869,angina,0,1
68870,",",0,0
68871,survivors,0,1
68872,of,0,1
68873,myocardial,0,1
68874,infarction,0,1
68875,",",0,0
68876,and,0,1
68877,populations,0,1
68878,at,0,0
68879,risk,0,1
68880,for,0,0
68881,coronary,0,0
68882,disease,0,0
68883,.,0,0
68884,Whether,0,0
68885,medical,0,0
68886,therapy,0,0
68887,for,0,0
68888,silent,0,0
68889,ischemia,0,0
68890,improves,0,0
68891,prognosis,0,0
68892,is,0,0
68893,not,0,0
68894,known,0,0
68895,.,0,0
68896,In,0,0
68897,a,0,0
68898,randomized,0,0
68899,",",0,0
68900,placebo-controlled,0,0
68901,",",0,0
68902,multicenter,0,0
68903,trial,0,0
68904,of,0,0
68905,60,0,0
68906,patients,0,0
68907,with,0,0
68908,documented,0,0
68909,coronary,0,0
68910,disease,0,0
68911,",",0,0
68912,positive,0,1
68913,exercise,0,0
68914,tests,0,1
68915,",",0,0
68916,and,0,1
68917,ischemic,0,1
68918,episodes,0,1
68919,on,0,0
68920,Holter,0,0
68921,monitoring,0,0
68922,",",0,0
68923,long-acting,0,0
68924,diltiazem,0,0
68925,reduced,0,0
68926,ischemic,1,0
68927,episodes,1,1
68928,by,0,0
68929,50,0,0
68930,%,0,0
68931,compared,0,0
68932,to,0,0
68933,placebo,0,0
68934,",",0,0
68935,from,0,0
68936,a,0,0
68937,mean,0,0
68938,of,0,0
68939,5.6,0,0
68940,to,0,0
68941,2.8,0,0
68942,(,0,0
68943,p,0,0
68944,less,0,0
68945,than,0,0
68946,0.0001,0,0
68947,),0,0
68948,.,0,0
68949,Efficacy,1,0
68950,was,0,0
68951,maintained,0,0
68952,over,0,0
68953,24,0,0
68954,h,0,0
68955,and,0,0
68956,diltiazem,0,0
68957,also,0,0
68958,significantly,0,0
68959,improved,0,0
68960,exercise,1,0
68961,test,1,0
68962,parameters,1,1
68963,.,1,0
68964,Three,0,0
68965,smaller,0,0
68966,studies,0,0
68967,also,0,0
68968,demonstrated,0,0
68969,that,0,0
68970,diltiazem,0,0
68971,effectively,0,0
68972,reduces,0,0
68973,ambulatory,1,0
68974,ischemia,1,0
68975,;,1,0
68976,however,0,0
68977,",",0,0
68978,results,0,0
68979,with,0,0
68980,nifedipine,0,0
68981,are,0,0
68982,conflicting,0,0
68983,",",0,0
68984,with,0,0
68985,several,0,0
68986,studies,0,0
68987,showing,0,0
68988,no,0,0
68989,benefit,0,0
68990,.,0,0
68991,In,0,0
68992,contrast,0,0
68993,",",0,0
68994,beta-blockers,0,0
68995,reliably,0,0
68996,reduce,0,0
68997,ischemic,1,0
68998,episodes,1,0
68999,.,1,0
69000,The,0,0
69001,role,0,0
69002,of,0,0
69003,medical,0,0
69004,therapy,0,0
69005,for,0,0
69006,silent,0,0
69007,ischemia,0,0
69008,will,0,0
69009,be,0,0
69010,clarified,0,0
69011,only,0,0
69012,when,0,0
69013,its,0,0
69014,effect,0,0
69015,upon,0,0
69016,morbidity,0,1
69017,and,0,0
69018,mortality,0,1
69019,are,0,0
69020,determined,0,0
69021,.,0,0
69022,The,0,0
69023,safety,0,1
69024,of,0,0
69025,whey,0,0
69026,protein,0,1
69027,concentrate,0,0
69028,derived,0,0
69029,from,0,0
69030,the,0,0
69031,milk,0,0
69032,of,0,0
69033,cows,0,0
69034,immunized,0,0
69035,against,0,0
69036,Clostridium,0,0
69037,difficile,0,0
69038,.,0,0
69039,A,0,0
69040,whey,0,0
69041,protein,0,0
69042,concentrate,0,0
69043,prepared,0,0
69044,from,0,0
69045,the,0,0
69046,milk,0,0
69047,of,0,0
69048,cows,0,0
69049,that,0,0
69050,have,0,0
69051,been,0,0
69052,immunized,0,0
69053,against,0,0
69054,Clostridium,0,1
69055,difficile,0,1
69056,(,0,0
69057,C.,0,1
69058,difficile,0,1
69059,),0,0
69060,and,0,0
69061,its,0,0
69062,toxins,0,1
69063,",",0,0
69064,toxin,0,1
69065,A,0,0
69066,and,0,1
69067,toxin,0,1
69068,B,0,0
69069,",",0,0
69070,is,0,0
69071,produced,0,0
69072,for,0,0
69073,use,0,0
69074,as,0,0
69075,a,0,0
69076,medical,0,0
69077,food,0,0
69078,for,0,0
69079,the,0,0
69080,dietary,0,0
69081,management,0,0
69082,of,0,0
69083,patients,0,0
69084,with,0,0
69085,C.,0,1
69086,difficile-associated,0,1
69087,diarrhea,0,1
69088,(,0,0
69089,CDAD,0,0
69090,),0,0
69091,to,0,0
69092,prevent,0,0
69093,a,0,0
69094,relapse,0,1
69095,of,0,0
69096,the,0,0
69097,infection,0,0
69098,.,0,0
69099,The,0,0
69100,safety,0,1
69101,of,0,0
69102,anti-C.,0,1
69103,difficile,0,0
69104,whey,0,0
69105,protein,0,1
69106,concentrate,0,0
69107,(,0,0
69108,anti-CD,0,1
69109,WPC,0,1
69110,),0,0
69111,is,0,0
69112,supported,0,0
69113,by,0,0
69114,analytical,0,0
69115,data,0,0
69116,comparing,0,0
69117,the,0,0
69118,composition,0,0
69119,of,0,0
69120,raw,0,0
69121,milk,0,0
69122,from,0,0
69123,immunized,0,0
69124,cows,0,0
69125,versus,0,0
69126,that,0,0
69127,from,0,0
69128,non-immunized,0,0
69129,cows,0,0
69130,",",0,0
69131,and,0,0
69132,the,0,0
69133,composition,0,0
69134,of,0,0
69135,anti-CD,0,0
69136,WPC,0,1
69137,versus,0,0
69138,that,0,0
69139,of,0,0
69140,regular,0,0
69141,whey,0,0
69142,protein,0,0
69143,concentrate,0,0
69144,.,0,0
69145,Additionally,0,0
69146,",",0,0
69147,a,0,0
69148,prospective,0,0
69149,clinical,0,0
69150,study,0,0
69151,was,0,0
69152,conducted,0,0
69153,in,0,0
69154,77,0,0
69155,patients,0,0
69156,with,0,0
69157,CDAD,0,0
69158,to,0,0
69159,demonstrate,0,0
69160,the,0,0
69161,safety,0,1
69162,of,0,0
69163,consuming,0,0
69164,anti-CD,0,0
69165,WPC,0,0
69166,to,0,0
69167,prevent,0,0
69168,relapse,0,1
69169,of,0,0
69170,the,0,0
69171,infection,0,0
69172,.,0,0
69173,This,0,0
69174,study,0,0
69175,",",0,0
69176,which,0,0
69177,included,0,0
69178,adverse,0,1
69179,event,0,1
69180,monitoring,0,0
69181,",",0,0
69182,physical,0,1
69183,examinations,0,0
69184,",",0,0
69185,and,0,1
69186,extensive,0,1
69187,hematological,0,1
69188,and,0,0
69189,biochemical,0,1
69190,assessments,0,1
69191,",",0,0
69192,showed,0,0
69193,that,0,0
69194,anti-CD,0,0
69195,WPC,0,0
69196,is,0,0
69197,safe,1,0
69198,to,0,0
69199,consume,0,0
69200,by,0,0
69201,patients,0,0
69202,with,0,0
69203,CDAD,0,0
69204,.,0,0
69205,The,0,0
69206,available,0,0
69207,analytical,0,0
69208,and,0,0
69209,clinical,0,1
69210,evidence,0,0
69211,demonstrate,0,0
69212,that,0,0
69213,anti-CD,0,0
69214,WPC,0,0
69215,is,0,0
69216,safe,1,0
69217,for,0,0
69218,use,0,0
69219,by,0,0
69220,individuals,0,0
69221,with,0,0
69222,CDAD,0,0
69223,",",0,0
69224,under,0,0
69225,the,0,0
69226,described,0,0
69227,conditions,0,0
69228,of,0,0
69229,use,0,0
69230,.,0,0
69231,Cost-effectiveness,1,1
69232,of,0,0
69233,collaborative,0,0
69234,care,0,0
69235,including,0,0
69236,PST,0,0
69237,and,0,0
69238,an,0,0
69239,antidepressant,0,0
69240,treatment,0,0
69241,algorithm,0,0
69242,for,0,0
69243,the,0,0
69244,treatment,0,0
69245,of,0,0
69246,major,0,0
69247,depressive,0,1
69248,disorder,0,0
69249,in,0,0
69250,primary,0,0
69251,care,0,0
69252,;,0,0
69253,a,0,0
69254,randomised,0,0
69255,clinical,0,0
69256,trial,0,0
69257,.,0,0
69258,BACKGROUND,0,0
69259,Depressive,0,0
69260,disorder,0,0
69261,is,0,0
69262,currently,0,0
69263,one,0,0
69264,of,0,0
69265,the,0,0
69266,most,0,0
69267,burdensome,0,0
69268,disorders,0,0
69269,worldwide,0,0
69270,.,0,0
69271,Evidence-based,0,0
69272,treatments,0,0
69273,for,0,0
69274,depressive,0,1
69275,disorder,0,0
69276,are,0,0
69277,already,0,0
69278,available,0,0
69279,",",0,0
69280,but,0,0
69281,these,0,0
69282,are,0,0
69283,used,0,0
69284,insufficiently,0,0
69285,",",0,0
69286,and,0,0
69287,with,0,0
69288,less,0,0
69289,positive,0,1
69290,results,0,0
69291,than,0,0
69292,possible,0,0
69293,.,0,0
69294,Earlier,0,0
69295,research,0,0
69296,in,0,0
69297,the,0,0
69298,USA,0,0
69299,has,0,0
69300,shown,0,0
69301,good,0,0
69302,results,0,0
69303,in,0,0
69304,the,0,0
69305,treatment,0,0
69306,of,0,0
69307,depressive,0,1
69308,disorder,0,0
69309,based,0,0
69310,on,0,0
69311,a,0,0
69312,collaborative,0,0
69313,care,0,0
69314,approach,0,0
69315,with,0,0
69316,Problem,1,1
69317,Solving,1,0
69318,Treatment,1,0
69319,and,0,0
69320,an,0,0
69321,antidepressant,0,0
69322,treatment,0,0
69323,algorithm,0,0
69324,",",0,1
69325,and,0,1
69326,research,0,0
69327,in,0,0
69328,the,0,0
69329,UK,0,0
69330,has,0,0
69331,also,0,0
69332,shown,0,0
69333,good,0,0
69334,results,0,0
69335,with,0,0
69336,Problem,0,1
69337,Solving,0,0
69338,Treatment,0,0
69339,.,0,0
69340,These,0,0
69341,treatment,0,0
69342,strategies,0,0
69343,may,0,0
69344,also,0,0
69345,work,0,0
69346,very,0,0
69347,well,0,0
69348,in,0,0
69349,the,0,0
69350,Netherlands,0,0
69351,too,0,0
69352,",",0,0
69353,even,0,0
69354,though,0,0
69355,health,0,1
69356,care,0,0
69357,systems,0,0
69358,differ,0,0
69359,between,0,0
69360,countries,0,0
69361,.,0,0
69362,METHODS/DESIGN,0,0
69363,This,0,0
69364,study,0,0
69365,is,0,0
69366,a,0,0
69367,two-armed,0,0
69368,randomised,0,0
69369,clinical,0,0
69370,trial,0,0
69371,",",0,0
69372,with,0,0
69373,randomization,0,0
69374,on,0,0
69375,patient-level,0,0
69376,.,0,0
69377,The,0,0
69378,aim,0,0
69379,of,0,0
69380,the,0,0
69381,trial,0,0
69382,is,0,0
69383,to,0,0
69384,evaluate,0,0
69385,the,0,0
69386,treatment,1,0
69387,of,0,0
69388,depressive,0,1
69389,disorder,0,0
69390,in,0,0
69391,primary,0,0
69392,care,0,0
69393,in,0,0
69394,the,0,0
69395,Netherlands,0,0
69396,by,0,0
69397,means,0,0
69398,of,0,0
69399,an,0,0
69400,adapted,0,0
69401,collaborative,0,0
69402,care,0,0
69403,framework,0,0
69404,",",0,0
69405,including,0,0
69406,contracting,0,1
69407,and,0,0
69408,adherence-improving,0,1
69409,strategies,0,0
69410,",",0,0
69411,combined,0,0
69412,with,0,0
69413,Problem,0,1
69414,Solving,0,0
69415,Treatment,0,0
69416,and,0,0
69417,antidepressant,0,0
69418,medication,0,1
69419,according,0,0
69420,to,0,0
69421,a,0,0
69422,treatment,0,0
69423,algorithm,0,0
69424,.,0,0
69425,Forty,0,0
69426,general,0,0
69427,practices,0,0
69428,will,0,0
69429,be,0,0
69430,randomised,0,0
69431,to,0,0
69432,either,0,0
69433,the,0,0
69434,intervention,0,0
69435,group,0,0
69436,or,0,0
69437,the,0,0
69438,control,0,0
69439,group,0,0
69440,.,0,0
69441,Included,0,0
69442,will,0,0
69443,be,0,0
69444,patients,0,0
69445,who,0,0
69446,are,0,0
69447,diagnosed,0,0
69448,with,0,0
69449,moderate,0,0
69450,to,0,0
69451,severe,0,1
69452,depression,0,1
69453,",",0,0
69454,based,0,0
69455,on,0,0
69456,DSM-IV,0,1
69457,criteria,0,0
69458,",",0,0
69459,and,0,1
69460,stratified,0,0
69461,according,0,0
69462,to,0,0
69463,comorbid,0,0
69464,chronic,0,0
69465,physical,0,0
69466,illness,0,1
69467,.,0,0
69468,Patients,0,0
69469,in,0,0
69470,the,0,0
69471,intervention,0,0
69472,group,0,0
69473,will,0,0
69474,receive,0,0
69475,treatment,0,0
69476,based,0,0
69477,on,0,0
69478,the,0,0
69479,collaborative,0,0
69480,care,0,0
69481,approach,0,0
69482,",",0,1
69483,and,0,1
69484,patients,0,0
69485,in,0,0
69486,the,0,0
69487,control,0,0
69488,group,0,0
69489,will,0,0
69490,receive,0,0
69491,care,0,0
69492,as,0,0
69493,usual,0,0
69494,.,0,0
69495,Baseline,0,0
69496,measurements,0,0
69497,and,0,0
69498,follow,0,0
69499,up,0,0
69500,measures,0,0
69501,(,0,0
69502,3,0,0
69503,",",0,0
69504,6,0,0
69505,",",0,0
69506,9,0,0
69507,and,0,0
69508,12,0,0
69509,months,0,0
69510,),0,0
69511,are,0,0
69512,assessed,0,0
69513,using,0,0
69514,questionnaires,0,0
69515,and,0,0
69516,an,0,0
69517,interview,0,0
69518,.,0,0
69519,The,0,0
69520,primary,0,0
69521,outcome,0,0
69522,measure,0,0
69523,is,0,0
69524,severity,1,1
69525,of,1,0
69526,depressive,1,1
69527,symptoms,1,1
69528,",",1,0
69529,according,1,0
69530,to,1,0
69531,the,1,0
69532,PHQ9,1,0
69533,.,1,0
69534,Secondary,0,0
69535,outcome,0,0
69536,measures,0,1
69537,are,0,0
69538,remission,1,1
69539,as,1,0
69540,measured,1,0
69541,with,1,0
69542,the,1,0
69543,PHQ9,1,0
69544,and,1,0
69545,the,1,0
69546,IDS-SR,1,0
69547,",",1,0
69548,and,1,1
69549,cost-effectiveness,1,1
69550,measured,1,0
69551,with,1,0
69552,the,1,0
69553,TiC-P,1,0
69554,",",1,0
69555,the,1,0
69556,EQ-5D,1,0
69557,and,1,0
69558,the,1,0
69559,SF-36,1,0
69560,.,1,0
69561,DISCUSSION,0,0
69562,In,0,0
69563,this,0,0
69564,study,0,0
69565,",",0,0
69566,an,0,0
69567,American,0,0
69568,model,0,0
69569,to,0,0
69570,enhance,0,0
69571,care,0,0
69572,for,0,0
69573,patients,0,0
69574,with,0,0
69575,a,0,0
69576,depressive,0,1
69577,disorder,0,0
69578,",",0,0
69579,the,0,0
69580,collaborative,0,0
69581,care,0,0
69582,model,0,0
69583,",",0,0
69584,will,0,0
69585,be,0,0
69586,evaluated,0,0
69587,for,0,0
69588,effectiveness,0,0
69589,in,0,0
69590,the,0,0
69591,primary,0,0
69592,care,0,0
69593,setting,0,0
69594,.,0,0
69595,If,0,0
69596,effective,0,0
69597,across,0,0
69598,the,0,0
69599,Atlantic,0,0
69600,and,0,0
69601,across,0,0
69602,different,0,0
69603,health,0,1
69604,care,0,0
69605,systems,0,0
69606,",",0,0
69607,it,0,0
69608,is,0,0
69609,also,0,0
69610,likely,0,0
69611,to,0,0
69612,be,0,0
69613,an,0,0
69614,effective,0,0
69615,strategy,0,0
69616,to,0,0
69617,implement,0,0
69618,in,0,0
69619,the,0,0
69620,treatment,0,0
69621,of,0,0
69622,major,0,0
69623,depressive,0,1
69624,disorder,0,0
69625,in,0,0
69626,the,0,0
69627,Netherlands,0,0
69628,.,0,0
69629,Comparison,0,0
69630,of,0,0
69631,increasing,0,0
69632,doses,0,0
69633,of,0,0
69634,olmesartan,0,0
69635,medoxomil,0,0
69636,",",0,0
69637,losartan,0,0
69638,potassium,0,1
69639,",",0,0
69640,and,0,1
69641,valsartan,0,0
69642,in,0,0
69643,patients,0,0
69644,with,0,0
69645,essential,0,0
69646,hypertension,0,0
69647,.,0,0
69648,This,0,0
69649,12-week,0,0
69650,",",0,0
69651,randomized,0,0
69652,",",0,0
69653,double-blind,0,0
69654,",",0,0
69655,forced-titration,0,0
69656,study,0,0
69657,compared,0,0
69658,the,0,0
69659,efficacy,0,0
69660,of,0,0
69661,3,0,0
69662,angiotensin,0,0
69663,receptor,0,0
69664,blockers,0,0
69665,.,0,0
69666,Patients,0,0
69667,received,0,0
69668,olmesartan,0,0
69669,medoxomil,0,0
69670,20,0,0
69671,mg,0,0
69672,",",0,0
69673,losartan,0,0
69674,potassium,0,0
69675,50,0,0
69676,mg,0,0
69677,",",0,0
69678,valsartan,0,0
69679,80,0,0
69680,mg,0,0
69681,",",0,0
69682,or,0,1
69683,placebo,0,0
69684,once,0,0
69685,daily,0,0
69686,.,0,0
69687,At,0,0
69688,week,0,0
69689,4,0,0
69690,",",0,0
69691,doses,0,0
69692,were,0,0
69693,titrated,0,0
69694,to,0,0
69695,40,0,0
69696,",",0,0
69697,100,0,0
69698,",",0,0
69699,and,0,0
69700,160,0,0
69701,mg,0,0
69702,once,0,0
69703,daily,0,0
69704,for,0,0
69705,olmesartan,0,0
69706,",",0,0
69707,losartan,0,0
69708,",",0,1
69709,and,0,1
69710,valsartan,0,0
69711,",",0,0
69712,respectively,0,0
69713,.,0,0
69714,At,0,0
69715,week,0,0
69716,8,0,0
69717,",",0,0
69718,losartan,0,0
69719,was,0,0
69720,increased,0,0
69721,to,0,0
69722,50,0,0
69723,mg,0,0
69724,twice,0,0
69725,daily,0,0
69726,and,0,0
69727,valsartan,0,0
69728,increased,0,0
69729,to,0,0
69730,320,0,0
69731,mg,0,0
69732,once,0,0
69733,daily,0,0
69734,(,0,0
69735,olmesartan,0,0
69736,remained,0,0
69737,at,0,0
69738,40,0,0
69739,mg,0,0
69740,once,0,0
69741,daily,0,0
69742,),0,0
69743,.,0,0
69744,The,0,0
69745,primary,0,0
69746,end,0,0
69747,point,0,0
69748,was,0,0
69749,mean,0,1
69750,change,0,1
69751,from,0,0
69752,baseline,0,0
69753,in,0,0
69754,seated,1,0
69755,diastolic,1,1
69756,blood,1,1
69757,pressure,1,1
69758,(,1,0
69759,SeDBP,1,0
69760,),1,0
69761,at,0,0
69762,week,0,0
69763,8,0,0
69764,.,0,0
69765,All,0,0
69766,3,0,0
69767,medications,0,0
69768,significantly,0,0
69769,reduced,0,0
69770,mean,1,1
69771,SeDBP,1,0
69772,from,0,0
69773,baseline,0,0
69774,compared,0,0
69775,with,0,0
69776,placebo,0,0
69777,at,0,0
69778,weeks,0,0
69779,4,0,0
69780,",",0,0
69781,8,0,0
69782,",",0,0
69783,and,0,0
69784,12,0,0
69785,(,0,0
69786,P,0,0
69787,<,0,0
69788,.001,0,0
69789,),0,0
69790,.,0,0
69791,At,0,0
69792,week,0,0
69793,8,0,0
69794,",",0,0
69795,olmesartan,0,0
69796,reduced,0,0
69797,mean,0,1
69798,SeDBP,1,0
69799,more,0,0
69800,than,0,0
69801,losartan,0,0
69802,(,0,0
69803,P,0,0
69804,<,0,0
69805,.001,0,0
69806,),0,0
69807,;,0,0
69808,more,0,0
69809,patients,0,0
69810,in,0,0
69811,the,0,0
69812,olmesartan,0,0
69813,medoxomil,0,0
69814,group,0,0
69815,achieved,0,0
69816,a,0,0
69817,blood,1,1
69818,pressure,1,1
69819,goal,0,0
69820,of,0,0
69821,<,0,0
69822,140/90,0,0
69823,mm,0,0
69824,Hg,0,0
69825,(,0,0
69826,P,0,0
69827,<,0,0
69828,.001,0,0
69829,),0,0
69830,.,0,0
69831,Olmesartan,0,0
69832,did,0,0
69833,not,0,0
69834,reduce,0,0
69835,mean,1,1
69836,SeDBP,1,0
69837,significantly,0,0
69838,compared,0,0
69839,with,0,0
69840,valsartan,0,0
69841,",",0,0
69842,although,0,0
69843,more,0,0
69844,patients,0,0
69845,attained,0,0
69846,blood,1,1
69847,pressure,1,1
69848,goal,0,0
69849,with,0,0
69850,olmesartan,0,0
69851,(,0,0
69852,P=.031,0,0
69853,),0,0
69854,.,0,0
69855,At,0,0
69856,week,0,0
69857,12,0,0
69858,",",0,0
69859,all,0,0
69860,agents,0,0
69861,lowered,0,0
69862,blood,1,1
69863,pressure,1,1
69864,equivalently,0,0
69865,.,0,0
69866,Pathological,0,1
69867,features,0,0
69868,and,0,0
69869,inhaled,0,0
69870,corticosteroid,0,0
69871,response,0,1
69872,of,0,0
69873,eosinophilic,0,1
69874,and,0,0
69875,non-eosinophilic,0,1
69876,asthma,0,0
69877,.,0,0
69878,BACKGROUND,0,0
69879,Non-eosinophilic,0,1
69880,asthma,0,0
69881,is,0,0
69882,a,0,0
69883,potentially,0,0
69884,important,0,0
69885,clinicopathological,0,0
69886,phenotype,0,1
69887,since,0,0
69888,there,0,0
69889,is,0,0
69890,evidence,0,0
69891,that,0,0
69892,it,0,0
69893,responds,0,0
69894,poorly,0,0
69895,to,0,0
69896,inhaled,0,0
69897,corticosteroid,0,0
69898,therapy,0,0
69899,.,0,0
69900,However,0,0
69901,",",0,0
69902,little,0,0
69903,is,0,0
69904,known,0,0
69905,about,0,0
69906,the,0,0
69907,underlying,0,0
69908,airway,0,1
69909,immunopathology,0,1
69910,and,0,0
69911,there,0,0
69912,are,0,0
69913,no,0,0
69914,data,0,0
69915,from,0,0
69916,placebo-controlled,0,0
69917,studies,0,0
69918,examining,0,0
69919,the,0,0
69920,effect,0,0
69921,of,0,0
69922,inhaled,0,0
69923,corticosteroids,0,0
69924,.,0,0
69925,METHODS,0,0
69926,Airway,0,1
69927,immunopathology,0,1
69928,was,0,0
69929,investigated,0,0
69930,using,0,0
69931,induced,1,0
69932,sputum,1,0
69933,",",1,0
69934,bronchial,1,1
69935,biopsies,1,0
69936,",",1,0
69937,bronchial,1,1
69938,wash,1,0
69939,and,0,0
69940,bronchoalveolar,1,1
69941,lavage,1,0
69942,in,0,0
69943,12,0,0
69944,patients,0,0
69945,with,0,0
69946,symptomatic,0,0
69947,eosinophilic,0,1
69948,asthma,0,0
69949,",",0,0
69950,11,0,0
69951,patients,0,0
69952,with,0,0
69953,non-eosinophilic,0,1
69954,asthma,0,0
69955,and,0,0
69956,10,0,0
69957,healthy,0,0
69958,controls,0,0
69959,.,0,0
69960,The,0,0
69961,patients,0,0
69962,with,0,0
69963,non-eosinophilic,0,1
69964,asthma,0,0
69965,and,0,0
69966,6,0,0
69967,different,0,0
69968,patients,0,0
69969,with,0,0
69970,eosinophilic,0,1
69971,asthma,0,0
69972,entered,0,0
69973,a,0,0
69974,randomised,0,0
69975,",",0,0
69976,double-blind,0,0
69977,",",0,0
69978,placebo-controlled,0,0
69979,crossover,0,0
69980,study,0,0
69981,in,0,0
69982,which,0,0
69983,the,0,0
69984,effects,0,0
69985,of,0,0
69986,inhaled,0,0
69987,mometasone,0,0
69988,400,0,0
69989,microg,0,0
69990,once,0,0
69991,daily,0,0
69992,for,0,0
69993,8,0,0
69994,weeks,0,0
69995,on,0,0
69996,airway,1,1
69997,responsiveness,1,1
69998,and,0,1
69999,asthma,1,0
70000,quality,1,1
70001,of,1,0
70002,life,1,1
70003,were,0,0
70004,investigated,0,0
70005,.,0,0
70006,RESULTS,0,0
70007,Patients,0,0
70008,with,0,0
70009,non-eosinophilic,0,1
70010,asthma,0,0
70011,had,0,0
70012,absence,1,0
70013,of,1,0
70014,eosinophils,1,1
70015,in,1,0
70016,the,1,0
70017,mucosa,1,1
70018,(,0,0
70019,median,0,0
70020,4.4,0,0
70021,cells/mm,0,0
70022,(,0,0
70023,2,0,0
70024,),0,0
70025,vs,0,0
70026,23,0,0
70027,cells/mm,0,0
70028,(,0,0
70029,2,0,0
70030,),0,0
70031,in,0,0
70032,eosinophilic,0,1
70033,asthma,0,0
70034,and,0,0
70035,0,0,0
70036,cells/mm,0,0
70037,(,0,0
70038,2,0,0
70039,),0,0
70040,in,0,0
70041,normal,0,0
70042,controls,0,0
70043,;,0,0
70044,p,0,0
70045,=,0,0
70046,0.03,0,0
70047,),0,0
70048,and,0,0
70049,normal,0,0
70050,subepithelial,1,1
70051,layer,1,1
70052,thickness,1,1
70053,(,0,0
70054,5.8,0,0
70055,microm,0,0
70056,vs,0,0
70057,10.3,0,0
70058,microm,0,0
70059,in,0,0
70060,eosinophilic,0,1
70061,asthma,0,0
70062,and,0,0
70063,5.1,0,0
70064,microm,0,0
70065,in,0,0
70066,controls,0,0
70067,",",0,0
70068,p,0,0
70069,=,0,0
70070,0.002,0,0
70071,),0,0
70072,.,0,0
70073,Non-eosinophilic,0,1
70074,and,0,0
70075,eosinophilic,0,1
70076,asthma,0,0
70077,groups,0,0
70078,had,0,0
70079,increased,0,0
70080,mast,1,1
70081,cell,1,0
70082,numbers,1,1
70083,in,0,0
70084,the,0,0
70085,airway,0,1
70086,smooth,0,1
70087,muscle,0,0
70088,compared,0,0
70089,with,0,0
70090,normal,0,0
70091,controls,0,0
70092,(,0,0
70093,9,0,0
70094,vs,0,0
70095,8,0,0
70096,vs,0,0
70097,0,0,0
70098,cells/mm,0,0
70099,(,0,0
70100,2,0,0
70101,),0,0
70102,",",0,0
70103,p,0,0
70104,=,0,0
70105,0.016,0,0
70106,),0,0
70107,.,0,0
70108,Compared,0,0
70109,with,0,0
70110,placebo,0,0
70111,",",0,0
70112,8,0,0
70113,weeks,0,0
70114,of,0,0
70115,treatment,0,0
70116,with,0,0
70117,inhaled,0,0
70118,mometasone,0,0
70119,led,0,0
70120,to,0,0
70121,less,0,0
70122,improvement,1,1
70123,in,0,0
70124,methacholine,1,0
70125,PC,1,0
70126,(,1,0
70127,20,1,0
70128,),1,0
70129,(,0,0
70130,0.5,0,0
70131,vs,0,0
70132,5.5,0,0
70133,doubling,0,0
70134,concentrations,0,1
70135,",",0,0
70136,95,0,0
70137,%,0,0
70138,CI,0,0
70139,of,0,0
70140,difference,0,0
70141,1.1,0,0
70142,to,0,0
70143,9.1,0,0
70144,;,0,0
70145,p,0,0
70146,=,0,0
70147,0.018,0,0
70148,),0,0
70149,and,0,0
70150,asthma,1,0
70151,quality,1,1
70152,of,1,0
70153,life,1,1
70154,(,0,0
70155,0.2,0,0
70156,vs,0,0
70157,1.0,0,0
70158,points,0,0
70159,",",0,0
70160,95,0,0
70161,%,0,0
70162,CI,0,0
70163,of,0,0
70164,difference,0,0
70165,0.27,0,0
70166,to,0,0
70167,1.43,0,0
70168,;,0,0
70169,p,0,0
70170,=,0,0
70171,0.008,0,0
70172,),0,0
70173,.,0,0
70174,CONCLUSIONS,0,0
70175,Non-eosinophilic,0,1
70176,asthma,0,0
70177,represents,0,0
70178,a,0,0
70179,pathologically,0,0
70180,distinct,0,0
70181,disease,0,1
70182,phenotype,0,0
70183,which,0,0
70184,is,0,0
70185,characterised,0,0
70186,by,0,0
70187,the,0,0
70188,absence,0,0
70189,of,0,0
70190,airway,1,1
70191,eosinophilia,1,1
70192,",",0,0
70193,normal,0,0
70194,subepithelial,1,1
70195,layer,1,1
70196,thickness,1,1
70197,and,0,0
70198,a,0,0
70199,poor,0,1
70200,short-term,1,0
70201,response,1,1
70202,to,1,0
70203,treatment,1,0
70204,with,0,0
70205,inhaled,0,0
70206,corticosteroids,0,0
70207,.,0,0
70208,[,0,0
70209,Effect,0,0
70210,of,0,0
70211,alpha,0,1
70212,dihydroergocryptine,0,0
70213,in,0,0
70214,patients,0,0
70215,with,0,0
70216,fibrocystic,0,0
70217,breast,0,0
70218,disease,0,0
70219,],0,0
70220,.,0,0
70221,OBJECTIVE,0,0
70222,To,0,0
70223,evaluate,0,0
70224,the,0,0
70225,effectiveness,0,0
70226,of,0,0
70227,alpha,0,1
70228,dihidroergocriptine,0,0
70229,in,0,0
70230,patients,0,0
70231,with,0,0
70232,fibrocystic,0,0
70233,mastopathy,0,0
70234,.,0,0
70235,PATIENTS,0,0
70236,AND,0,0
70237,METHODS,0,0
70238,Patients,0,0
70239,with,0,0
70240,diagnosis,0,0
70241,of,0,0
70242,fibrocystic,0,0
70243,breast,0,0
70244,disease,0,1
70245,were,0,0
70246,included,0,0
70247,in,0,0
70248,a,0,0
70249,prospective,0,0
70250,longitudinal,0,0
70251,blind,0,0
70252,double,0,0
70253,",",0,0
70254,controlled,0,0
70255,with,0,0
70256,placebo,0,0
70257,study,0,0
70258,.,0,0
70259,Patients,0,0
70260,were,0,0
70261,randomly,0,0
70262,assigned,0,0
70263,to,0,0
70264,one,0,0
70265,of,0,0
70266,two,0,0
70267,treatment,0,0
70268,groups,0,0
70269,:,0,0
70270,of,0,0
70271,treatment,0,0
70272,group,0,0
70273,A,0,0
70274,:,0,0
70275,Alpha,0,0
70276,dihidroergocriptine,0,0
70277,tablets,0,0
70278,of,0,0
70279,10,0,0
70280,mg,0,0
70281,",",0,0
70282,group,0,0
70283,B,0,0
70284,:,0,0
70285,Placebo,0,0
70286,",",0,0
70287,during,0,0
70288,6,0,0
70289,months,0,0
70290,.,0,0
70291,After,0,0
70292,to,0,0
70293,basal,0,0
70294,evaluation,0,0
70295,",",0,0
70296,the,0,0
70297,patients,0,0
70298,were,0,0
70299,revised,0,0
70300,in,0,0
70301,a,0,0
70302,monthly,0,0
70303,way,0,0
70304,evaluating,0,0
70305,the,0,0
70306,following,0,0
70307,symptoms,0,1
70308,and,0,0
70309,signs,0,1
70310,:,0,0
70311,mastalgia,1,1
70312,",",1,0
70313,mammary,1,1
70314,tension,1,1
70315,",",1,0
70316,presence,1,0
70317,of,1,1
70318,nodules,1,0
70319,",",1,0
70320,nipple,1,1
70321,secretion,1,1
70322,",",1,0
70323,and,1,0
70324,the,1,0
70325,presence,1,0
70326,of,1,0
70327,adverse,1,1
70328,events,1,1
70329,.,1,0
70330,RESULTS,0,0
70331,39,0,0
70332,patients,0,0
70333,with,0,0
70334,alpha,0,1
70335,dihidroergocriptine,0,0
70336,and,0,0
70337,38,0,0
70338,with,0,0
70339,placebo,0,0
70340,.,0,0
70341,Mastodinia,1,0
70342,",",0,0
70343,a,0,0
70344,satisfactory,0,1
70345,response,0,1
70346,was,0,0
70347,observed,0,0
70348,in,0,0
70349,100,0,0
70350,%,0,0
70351,of,0,0
70352,alpha,0,1
70353,dihidroergocriptine,0,0
70354,group,0,0
70355,vs,0,0
70356,61.11,0,0
70357,%,0,0
70358,of,0,0
70359,placebo,0,0
70360,group,0,0
70361,(,0,0
70362,p,0,0
70363,=,0,0
70364,0.0002,0,0
70365,),0,0
70366,.,0,0
70367,Mastalgia,1,1
70368,responded,0,0
70369,in,0,0
70370,100,0,0
70371,%,0,0
70372,of,0,0
70373,alpha,0,1
70374,dihidroergocriptine,0,0
70375,group,0,0
70376,vs,0,0
70377,64.86,0,0
70378,%,0,0
70379,of,0,0
70380,placebo,0,0
70381,group,0,0
70382,(,0,0
70383,p,0,0
70384,=,0,0
70385,0.0003,0,0
70386,),0,0
70387,.,0,0
70388,Galactorrea,1,1
70389,responded,0,0
70390,100,0,0
70391,%,0,0
70392,of,0,0
70393,alpha,0,1
70394,dihidroergocriptine,0,0
70395,group,0,0
70396,vs,0,0
70397,93.33,0,0
70398,%,0,0
70399,of,0,0
70400,the,0,0
70401,placebo,0,0
70402,.,0,0
70403,The,0,0
70404,nodules,1,0
70405,in,0,0
70406,the,0,0
70407,group,0,0
70408,alpha,0,1
70409,dihidroergocriptine,0,0
70410,disappeared,0,0
70411,in,0,0
70412,23.1,0,0
70413,%,0,0
70414,and,0,0
70415,in,0,0
70416,21.1,0,0
70417,%,0,0
70418,of,0,0
70419,the,0,0
70420,placebo,0,0
70421,group,0,0
70422,.,0,0
70423,Ultrasound,1,0
70424,evaluation,1,0
70425,of,1,0
70426,the,1,0
70427,nodules,1,0
70428,did,0,0
70429,not,0,0
70430,show,0,0
70431,significant,0,0
70432,differences,0,0
70433,between,0,0
70434,both,0,0
70435,groups,0,0
70436,.,0,0
70437,Prolactin,1,1
70438,levels,1,1
70439,showed,0,0
70440,a,0,0
70441,decrease,0,0
70442,in,0,0
70443,the,0,0
70444,group,0,0
70445,treated,0,0
70446,with,0,0
70447,alpha,0,1
70448,dihidroergocriptine,0,0
70449,with,0,0
70450,an,0,0
70451,important,0,0
70452,difference,0,0
70453,between,0,0
70454,both,0,0
70455,groups,0,0
70456,at,0,0
70457,the,0,0
70458,end,0,0
70459,of,0,0
70460,the,0,0
70461,6,0,0
70462,months,0,0
70463,study,0,0
70464,period,0,0
70465,.,0,0
70466,There,0,0
70467,were,0,0
70468,not,0,0
70469,differences,0,0
70470,in,0,0
70471,the,0,0
70472,presence,1,0
70473,of,1,0
70474,adverse,1,1
70475,events,1,1
70476,between,0,0
70477,groups,0,0
70478,.,0,0
70479,CONCLUSIONS,0,0
70480,Alpha,0,0
70481,dihidroergocriptine,0,0
70482,is,0,0
70483,effective,0,0
70484,in,0,0
70485,the,0,0
70486,treatment,0,0
70487,of,0,0
70488,fribrocystic,1,0
70489,breast,1,0
70490,disease,1,1
70491,with,0,0
70492,minimum,0,1
70493,adverse,0,1
70494,events,0,1
70495,when,0,0
70496,compared,0,0
70497,with,0,0
70498,similar,0,0
70499,drugs,0,0
70500,.,0,0
70501,Middle,1,1
70502,cerebral,1,1
70503,arterial,1,1
70504,blood,1,1
70505,flow,1,1
70506,velocity,1,1
70507,and,1,1
70508,hemodynamics,1,1
70509,in,0,0
70510,heart,0,0
70511,surgery,0,0
70512,.,0,0
70513,The,0,0
70514,aim,0,0
70515,of,0,0
70516,this,0,0
70517,study,0,0
70518,was,0,0
70519,to,0,0
70520,evaluate,0,0
70521,the,0,0
70522,effects,0,0
70523,of,0,0
70524,propofol,0,0
70525,",",0,0
70526,isoflurane,0,0
70527,",",0,1
70528,and,0,1
70529,sevoflurane,0,0
70530,on,0,0
70531,middle,1,0
70532,cerebral,1,1
70533,arterial,1,1
70534,blood,1,1
70535,flow,1,1
70536,velocity,1,1
70537,during,0,0
70538,open,0,0
70539,heart,0,1
70540,surgery,0,0
70541,",",0,0
70542,and,0,0
70543,the,0,0
70544,relationship,0,0
70545,between,0,0
70546,these,0,0
70547,effects,0,0
70548,and,0,0
70549,hemodynamic,0,1
70550,parameters,0,1
70551,.,0,0
70552,Fifty-two,0,0
70553,patients,0,0
70554,undergoing,0,0
70555,coronary,0,0
70556,artery,0,0
70557,bypass,0,0
70558,on,0,0
70559,cardiopulmonary,0,1
70560,bypass,0,0
70561,were,0,0
70562,divided,0,0
70563,randomly,0,0
70564,into,0,0
70565,3,0,0
70566,groups,0,0
70567,:,0,0
70568,the,0,0
70569,first,0,0
70570,group,0,0
70571,received,0,0
70572,100,0,0
70573,microg,0,0
70574,x,0,0
70575,kg,0,0
70576,(,0,0
70577,-1,0,0
70578,),0,0
70579,x,0,0
70580,min,0,0
70581,(,0,0
70582,-1,0,0
70583,),0,1
70584,propofol,0,0
70585,",",0,0
70586,the,0,0
70587,other,0,0
70588,groups,0,0
70589,received,0,0
70590,one,0,0
70591,minimum,0,0
70592,alveolar,0,0
70593,concentration,0,1
70594,of,0,0
70595,sevoflurane,0,0
70596,or,0,0
70597,isoflurane,0,0
70598,for,0,0
70599,anesthesia,0,0
70600,maintenance,0,0
70601,.,0,0
70602,Middle,1,1
70603,cerebral,1,1
70604,arterial,1,1
70605,blood,1,1
70606,flow,1,1
70607,velocities,1,1
70608,were,0,0
70609,measured,0,0
70610,by,0,0
70611,transcranial,0,0
70612,Doppler,0,1
70613,",",0,0
70614,and,0,1
70615,hemodynamics,1,1
70616,were,0,0
70617,measured,0,0
70618,by,0,0
70619,the,0,0
70620,thermodilution,0,1
70621,technique,0,0
70622,.,0,0
70623,Middle,1,1
70624,cerebral,1,1
70625,arterial,1,1
70626,blood,1,1
70627,flow,1,1
70628,velocities,1,1
70629,decreased,0,0
70630,significantly,0,0
70631,after,0,0
70632,administration,0,0
70633,of,0,0
70634,isoflurane,0,0
70635,and,0,1
70636,propofol,0,0
70637,",",0,1
70638,but,0,0
70639,there,0,0
70640,was,0,0
70641,no,0,0
70642,significant,0,0
70643,difference,0,0
70644,between,0,0
70645,the,0,0
70646,groups,0,0
70647,.,0,0
70648,After,0,0
70649,weaning,0,0
70650,from,0,0
70651,cardiopulmonary,0,1
70652,bypass,0,0
70653,",",0,0
70654,cerebral,1,1
70655,blood,1,1
70656,flow,1,1
70657,increased,1,1
70658,and,0,0
70659,came,0,0
70660,close,0,0
70661,to,0,0
70662,the,0,0
70663,value,0,0
70664,after,0,0
70665,induction,0,0
70666,in,0,0
70667,all,0,0
70668,groups,0,0
70669,.,0,0
70670,The,0,0
70671,pulsatility,1,1
70672,index,1,1
70673,and,1,1
70674,resistivity,1,1
70675,index,1,1
70676,increased,0,0
70677,significantly,0,0
70678,only,0,0
70679,after,0,0
70680,the,0,0
70681,propofol,0,0
70682,infusion,0,0
70683,",",0,0
70684,but,0,0
70685,there,0,0
70686,was,0,0
70687,no,0,0
70688,significant,0,0
70689,difference,0,0
70690,between,0,0
70691,the,0,0
70692,groups,0,0
70693,.,0,0
70694,Information,0,0
70695,source,0,0
70696,affects,0,0
70697,peers,0,0
70698,',0,0
70699,initial,0,0
70700,attitudes,0,1
70701,toward,0,0
70702,autism,1,0
70703,.,1,0
70704,Authors,0,0
70705,examined,0,0
70706,the,0,0
70707,effects,0,1
70708,of,0,0
70709,information,0,0
70710,source,0,0
70711,on,0,0
70712,peers,0,0
70713,',0,0
70714,cognitive,1,1
70715,and,1,0
70716,behavioral,1,1
70717,attitudes,1,1
70718,toward,0,0
70719,an,0,0
70720,unfamiliar,0,0
70721,child,0,0
70722,with,0,0
70723,autism,0,0
70724,.,0,0
70725,Children,0,0
70726,(,0,0
70727,N=296,0,0
70728,;,0,0
70729,M,0,0
70730,age=10.21,0,0
70731,years,0,0
70732,),0,0
70733,received,0,0
70734,information,0,0
70735,about,0,0
70736,an,0,0
70737,unfamiliar,0,0
70738,child,0,0
70739,with,0,0
70740,autism,0,0
70741,from,0,0
70742,one,0,0
70743,of,0,0
70744,the,0,0
70745,following,0,0
70746,sources,0,0
70747,:,0,0
70748,(,0,0
70749,a,0,0
70750,),0,0
70751,videotape,0,0
70752,",",0,0
70753,(,0,1
70754,b,0,0
70755,),0,1
70756,teacher,0,0
70757,",",0,0
70758,(,0,1
70759,c,0,0
70760,),0,0
70761,hypothetical,0,0
70762,mother,0,1
70763,",",0,0
70764,(,0,1
70765,d,0,0
70766,),0,0
70767,hypothetical,0,0
70768,father,0,1
70769,",",0,1
70770,or,0,1
70771,(,0,1
70772,e,0,0
70773,),0,0
70774,hypothetical,0,0
70775,doctor,0,0
70776,.,0,0
70777,Interactive,0,0
70778,effects,0,1
70779,between,0,0
70780,source,0,0
70781,",",0,0
70782,and,0,1
70783,sex,0,1
70784,and,0,1
70785,grade,0,1
70786,were,0,0
70787,found,0,0
70788,for,0,0
70789,cognitive,0,1
70790,and,0,0
70791,behavioral,0,1
70792,attitudes,0,1
70793,.,0,0
70794,Fifth-graders,0,0
70795,reported,0,0
70796,more,0,0
70797,favorable,0,1
70798,cognitive,1,1
70799,and,1,0
70800,behavioral,1,1
70801,attitudes,1,1
70802,when,0,0
70803,information,0,0
70804,was,0,0
70805,provided,0,0
70806,by,0,0
70807,extra-familial,0,0
70808,sources,0,0
70809,(,0,0
70810,i.e.,0,0
70811,",",0,1
70812,doctor,0,1
70813,),0,1
70814,versus,0,0
70815,parent,0,0
70816,sources,0,0
70817,.,0,0
70818,Mother,0,0
70819,yielded,0,0
70820,more,1,0
70821,persuasive,1,1
70822,effects,1,0
70823,on,1,0
70824,behavioral,1,1
70825,attitudes,1,1
70826,for,0,0
70827,third-graders,0,0
70828,versus,0,0
70829,fifth-graders,0,0
70830,.,0,0
70831,Attitudes,0,1
70832,toward,0,0
70833,autism,0,0
70834,differ,0,0
70835,depending,0,0
70836,on,0,0
70837,who,0,0
70838,provides,0,0
70839,information,0,0
70840,about,0,0
70841,the,0,0
70842,disability,0,0
70843,.,0,0
70844,Persuasion,0,1
70845,theory,0,0
70846,appears,0,0
70847,useful,0,0
70848,to,0,0
70849,guide,0,0
70850,evaluation,0,0
70851,of,0,0
70852,educational,0,0
70853,interventions,0,0
70854,to,0,0
70855,improve,0,0
70856,attitudes,1,1
70857,towards,1,0
70858,autism,1,0
70859,.,1,0
70860,Implications,0,0
70861,of,0,0
70862,the,0,0
70863,findings,0,0
70864,",",0,0
70865,study,0,0
70866,limitations,0,1
70867,",",0,0
70868,and,0,1
70869,recommendations,0,0
70870,for,0,0
70871,future,0,0
70872,research,0,0
70873,are,0,0
70874,discussed,0,0
70875,.,0,0
70876,[,0,0
70877,Evaluation,0,0
70878,on,0,0
70879,the,0,0
70880,effect,0,0
70881,of,0,0
70882,intervention,0,0
70883,regarding,0,0
70884,breast,0,0
70885,self-examination,0,1
70886,for,0,0
70887,decreasing,0,0
70888,breast,0,0
70889,cancer,0,0
70890,mortality,0,1
70891,],0,0
70892,.,0,0
70893,OBJECTIVE,0,0
70894,A,0,0
70895,randomized,0,0
70896,trial,0,0
70897,of,0,0
70898,breast,0,0
70899,self-examination,0,1
70900,(,0,0
70901,BSE,0,1
70902,),0,0
70903,Program,0,0
70904,was,0,0
70905,carried,0,0
70906,out,0,0
70907,to,0,0
70908,evaluate,0,0
70909,whether,0,0
70910,the,0,0
70911,intensive,0,0
70912,BSE,0,0
70913,could,0,0
70914,reduce,0,0
70915,the,0,0
70916,number,0,1
70917,of,0,0
70918,deaths,0,1
70919,among,0,0
70920,women,0,0
70921,from,0,0
70922,breast,0,0
70923,cancer,0,0
70924,.,0,0
70925,METHODS,0,0
70926,This,0,0
70927,study,0,0
70928,was,0,0
70929,a,0,0
70930,randomized,0,0
70931,controlled,0,0
70932,trial,0,0
70933,(,0,0
70934,RCT,0,0
70935,),0,0
70936,.,0,0
70937,A,0,0
70938,total,0,0
70939,of,0,0
70940,266,0,0
70941,064,0,0
70942,women,0,0
70943,(,0,0
70944,age,0,0
70945,of,0,0
70946,30,0,0
70947,to,0,0
70948,64,0,0
70949,years,0,0
70950,),0,0
70951,associated,0,0
70952,with,0,0
70953,519,0,0
70954,textile,0,0
70955,factories,0,0
70956,in,0,0
70957,Shanghai,0,0
70958,had,0,0
70959,been,0,0
70960,randomly,0,0
70961,assigned,0,0
70962,to,0,0
70963,a,0,0
70964,BSE,0,0
70965,group,0,0
70966,(,0,0
70967,132,0,0
70968,979,0,0
70969,women,0,0
70970,),0,0
70971,or,0,0
70972,a,0,0
70973,control,0,0
70974,group,0,0
70975,(,0,0
70976,133,0,0
70977,085,0,0
70978,women,0,0
70979,),0,0
70980,since,0,0
70981,1989,0,0
70982,.,0,0
70983,Initial,0,0
70984,instruction,0,0
70985,in,0,0
70986,BSE,0,0
70987,group,0,0
70988,would,0,0
70989,include,0,0
70990,demonstration,0,0
70991,of,0,0
70992,proper,0,0
70993,palpation,0,1
70994,techniques,0,0
70995,and,0,1
70996,was,0,0
70997,followed,0,0
70998,by,0,0
70999,2,0,0
71000,reinforcement,0,0
71001,sessions,0,0
71002,during,0,0
71003,the,0,0
71004,subsequent,0,0
71005,4,0,0
71006,years,0,0
71007,including,0,0
71008,video,0,0
71009,shows,0,0
71010,",",0,0
71011,BSE,0,1
71012,instruction,0,0
71013,sessions,0,0
71014,and,0,1
71015,BSE,0,1
71016,practice,0,0
71017,under,0,0
71018,medical,0,0
71019,supervision,0,0
71020,.,0,0
71021,These,0,0
71022,activities,0,1
71023,were,0,0
71024,continued,0,0
71025,for,0,0
71026,5,0,0
71027,years,0,0
71028,.,0,0
71029,Attendance,0,1
71030,at,0,0
71031,all,0,0
71032,events,0,1
71033,was,0,0
71034,recorded,0,0
71035,.,0,0
71036,The,0,0
71037,cohort,0,0
71038,was,0,0
71039,followed,0,0
71040,through,0,0
71041,July,0,0
71042,2000,0,0
71043,for,0,0
71044,development,0,0
71045,of,0,0
71046,breast,0,0
71047,diseases,0,0
71048,",",0,0
71049,and,0,0
71050,the,0,0
71051,breast,0,0
71052,cancer,0,0
71053,cases,0,0
71054,were,0,0
71055,followed,0,0
71056,through,0,0
71057,2001,0,0
71058,for,0,0
71059,vital,0,0
71060,status,0,1
71061,.,0,0
71062,Data,0,1
71063,analysis,0,0
71064,methods,0,0
71065,used,0,0
71066,would,0,0
71067,include,0,0
71068,Kaplan-Meier,0,0
71069,plots,0,0
71070,",",0,0
71071,log-rank,0,0
71072,test,0,1
71073,and,0,1
71074,Cox,0,0
71075,modeling,0,0
71076,.,0,0
71077,RESULTS,0,0
71078,Among,0,0
71079,women,0,0
71080,under,0,0
71081,instruction,0,0
71082,",",0,0
71083,864,0,0
71084,breast,0,0
71085,cancers,0,0
71086,detected,0,0
71087,and,0,0
71088,133,0,0
71089,breast,0,0
71090,cancer,0,0
71091,deaths,0,1
71092,occurred,0,0
71093,while,0,0
71094,896,0,0
71095,breast,0,0
71096,cancers,0,0
71097,were,0,0
71098,detected,0,0
71099,and,0,0
71100,130,0,0
71101,deaths,0,1
71102,recorded,0,0
71103,in,0,0
71104,the,0,0
71105,control,0,0
71106,group,0,0
71107,.,0,0
71108,The,0,0
71109,tumor,0,1
71110,size,0,1
71111,(,0,0
71112,P,0,0
71113,=,0,0
71114,0.07,0,0
71115,),0,0
71116,",",0,0
71117,TNM,0,1
71118,stage,0,1
71119,(,0,0
71120,P,0,0
71121,=,0,0
71122,0.39,0,0
71123,),0,0
71124,and,0,0
71125,cumulative,0,1
71126,breast,1,0
71127,cancer,1,0
71128,mortality,1,1
71129,rate,1,1
71130,(,0,0
71131,P,0,0
71132,=,0,0
71133,0.72,0,0
71134,),0,0
71135,were,0,0
71136,not,0,0
71137,significantly,0,0
71138,different,0,0
71139,between,0,0
71140,the,0,0
71141,2,0,0
71142,groups,0,0
71143,.,0,0
71144,However,0,0
71145,",",0,0
71146,more,0,0
71147,and,0,1
71148,smaller,0,1
71149,fibroadenomas,0,1
71150,were,0,0
71151,detected,0,0
71152,in,0,0
71153,the,0,0
71154,instruction,0,0
71155,group,0,0
71156,than,0,0
71157,in,0,0
71158,the,0,0
71159,control,0,0
71160,group,0,0
71161,(,0,0
71162,P,0,0
71163,<,0,0
71164,0.01,0,0
71165,),0,0
71166,.,0,0
71167,CONCLUSION,0,0
71168,Intensive,1,0
71169,instruction,1,0
71170,in,1,0
71171,BSE,1,0
71172,did,1,0
71173,not,1,0
71174,seem,1,0
71175,to,1,0
71176,have,1,0
71177,reduced,1,0
71178,the,1,0
71179,mortality,1,1
71180,rate,1,1
71181,of,1,1
71182,breast,1,0
71183,cancer,1,0
71184,",",1,0
71185,but,1,0
71186,more,1,0
71187,and,1,1
71188,smaller,1,1
71189,benign,1,1
71190,breast,1,0
71191,lumps,1,0
71192,could,1,0
71193,be,1,0
71194,detected,1,0
71195,.,1,0
71196,Comparison,0,0
71197,of,0,0
71198,indicators,0,1
71199,for,0,0
71200,a,0,0
71201,primary,0,0
71202,care,0,0
71203,medical,0,0
71204,home,0,0
71205,between,0,0
71206,children,0,0
71207,with,0,0
71208,autism,0,0
71209,or,0,0
71210,asthma,0,1
71211,and,0,1
71212,other,0,0
71213,special,0,0
71214,health,0,1
71215,care,0,0
71216,needs,0,0
71217,:,0,0
71218,National,0,0
71219,Survey,0,0
71220,of,0,0
71221,Children,0,0
71222,'s,0,0
71223,Health,0,0
71224,.,0,0
71225,OBJECTIVE,0,0
71226,To,0,0
71227,assess,0,0
71228,the,0,0
71229,extent,0,0
71230,to,0,0
71231,which,0,0
71232,parents,0,0
71233,of,0,0
71234,children,0,0
71235,with,0,0
71236,autism,0,0
71237,compared,0,0
71238,with,0,0
71239,parents,0,0
71240,of,0,0
71241,children,0,0
71242,with,0,0
71243,asthma,0,0
71244,or,0,0
71245,other,0,0
71246,special,0,0
71247,health,0,0
71248,care,0,0
71249,needs,0,0
71250,report,0,0
71251,receiving,0,0
71252,primary,0,0
71253,care,0,0
71254,for,0,0
71255,their,0,0
71256,child,0,0
71257,consistent,0,0
71258,with,0,0
71259,the,0,0
71260,American,0,0
71261,Academy,0,0
71262,of,0,0
71263,Pediatrics,0,0
71264,medical,0,0
71265,home,0,0
71266,model,0,0
71267,.,0,0
71268,DESIGN,0,0
71269,Population-based,0,0
71270,cross-sectional,0,0
71271,study,0,0
71272,.,0,0
71273,SETTING,0,0
71274,National,0,1
71275,Survey,0,0
71276,for,0,0
71277,Children,0,0
71278,'s,0,0
71279,Health,0,0
71280,2003-2004,0,0
71281,telephone,0,0
71282,interview,0,0
71283,.,0,0
71284,PARTICIPANTS,0,0
71285,Parents,0,0
71286,of,0,0
71287,495,0,0
71288,children,0,0
71289,with,0,0
71290,autism,0,0
71291,",",0,0
71292,parents,0,0
71293,of,0,0
71294,6716,0,0
71295,children,0,0
71296,with,0,0
71297,asthma,0,0
71298,",",0,0
71299,and,0,1
71300,parents,0,0
71301,of,0,0
71302,"11,403",0,0
71303,children,0,0
71304,with,0,0
71305,other,0,0
71306,special,0,0
71307,health,0,0
71308,care,0,0
71309,needs,0,0
71310,without,0,0
71311,asthma,0,0
71312,.,0,0
71313,Main,0,0
71314,Exposures,0,1
71315,Autism,0,1
71316,and,0,0
71317,other,0,0
71318,special,0,0
71319,health,0,0
71320,care,0,0
71321,needs,0,0
71322,including,0,0
71323,asthma,0,0
71324,.,0,0
71325,MAIN,0,0
71326,OUTCOME,0,0
71327,MEASURES,0,0
71328,Medical,0,0
71329,home,0,0
71330,score,0,1
71331,and,0,1
71332,components,0,1
71333,of,0,1
71334,care,0,0
71335,",",0,0
71336,as,0,0
71337,follows,0,0
71338,:,0,0
71339,personal,0,1
71340,provider,0,0
71341,and,0,0
71342,preventive,0,1
71343,;,0,0
71344,family-centered,0,0
71345,",",0,0
71346,compassionate,0,0
71347,",",0,1
71348,and,0,0
71349,culturally,0,0
71350,appropriate,0,0
71351,;,0,0
71352,accessible,0,0
71353,;,0,0
71354,comprehensive,0,0
71355,;,0,0
71356,and,0,0
71357,coordinated,0,0
71358,.,0,0
71359,RESULTS,0,0
71360,The,0,0
71361,odds,1,0
71362,of,1,0
71363,parents,1,0
71364,reporting,1,0
71365,care,1,0
71366,consistent,1,0
71367,with,1,0
71368,that,1,0
71369,in,1,0
71370,a,1,0
71371,medical,1,0
71372,home,1,0
71373,were,0,0
71374,less,1,0
71375,likely,1,0
71376,for,1,0
71377,children,1,0
71378,with,1,0
71379,autism,1,0
71380,(,0,0
71381,odds,0,1
71382,ratio,0,1
71383,",",0,0
71384,0.45,0,0
71385,;,0,0
71386,95,0,0
71387,%,0,0
71388,confidence,0,0
71389,interval,0,0
71390,",",0,0
71391,0.30-0.66,0,0
71392,),0,0
71393,and,0,0
71394,more,0,0
71395,likely,0,1
71396,for,0,0
71397,children,0,0
71398,with,0,0
71399,asthma,0,0
71400,(,0,0
71401,odds,0,1
71402,ratio,0,1
71403,",",0,0
71404,1.17,0,0
71405,;,0,0
71406,95,0,0
71407,%,0,0
71408,confidence,0,0
71409,interval,0,0
71410,",",0,0
71411,1.06-1.30,0,0
71412,),0,0
71413,compared,0,0
71414,with,0,0
71415,children,0,0
71416,with,0,0
71417,other,0,0
71418,special,0,0
71419,health,0,1
71420,care,0,0
71421,needs,0,0
71422,(,0,0
71423,1,0,0
71424,[,0,0
71425,reference,0,0
71426,],0,0
71427,),0,0
71428,.,0,0
71429,These,0,0
71430,differences,0,0
71431,persisted,0,0
71432,even,0,0
71433,after,0,0
71434,controlling,0,0
71435,for,0,0
71436,condition,0,0
71437,severity,0,1
71438,",",0,0
71439,personal,0,1
71440,characteristics,0,1
71441,",",0,0
71442,and,0,1
71443,insurance,0,1
71444,status,0,1
71445,.,0,0
71446,Specific,0,0
71447,components,0,0
71448,of,0,0
71449,a,0,0
71450,medical,0,0
71451,home,0,0
71452,less,0,0
71453,prevalent,0,0
71454,among,0,0
71455,children,0,0
71456,with,0,0
71457,autism,0,0
71458,than,0,0
71459,among,0,0
71460,children,0,0
71461,with,0,0
71462,other,0,0
71463,special,0,0
71464,health,0,0
71465,care,0,0
71466,needs,0,0
71467,included,0,0
71468,family-centered,0,0
71469,",",0,0
71470,comprehensive,0,0
71471,",",0,1
71472,and,0,1
71473,coordinated,0,0
71474,care,0,0
71475,.,0,0
71476,CONCLUSION,0,0
71477,Although,0,0
71478,we,0,0
71479,could,0,0
71480,not,0,0
71481,evaluate,0,0
71482,the,0,0
71483,reasons,0,0
71484,why,0,0
71485,",",0,0
71486,a,0,0
71487,large,0,0
71488,percentage,0,1
71489,of,0,0
71490,children,0,0
71491,with,0,0
71492,autism,0,0
71493,do,0,0
71494,not,0,0
71495,receive,0,0
71496,primary,1,0
71497,care,1,0
71498,consistent,1,0
71499,with,1,0
71500,that,1,0
71501,in,1,0
71502,a,1,0
71503,medical,1,0
71504,home,1,0
71505,.,1,0
71506,Recombinant,0,0
71507,human,0,0
71508,granulocyte-macrophage,0,1
71509,colony-stimulating,0,0
71510,factor,0,0
71511,ameliorates,0,0
71512,zidovudine-induced,0,0
71513,neutropenia,0,1
71514,in,0,0
71515,patients,0,0
71516,with,0,0
71517,acquired,0,0
71518,immunodeficiency,0,0
71519,syndrome,0,0
71520,(,0,0
71521,AIDS,0,0
71522,),0,0
71523,/AIDS-related,0,0
71524,complex,0,0
71525,.,0,0
71526,To,0,0
71527,evaluate,0,0
71528,the,0,0
71529,effect,1,0
71530,of,0,0
71531,recombinant,0,0
71532,granulocyte-macrophage,0,0
71533,colony-stimulating,0,1
71534,factor,0,0
71535,(,0,0
71536,GM-CSF,0,0
71537,),0,0
71538,on,0,0
71539,patients,0,0
71540,with,0,0
71541,acquired,0,0
71542,immunodeficiency,0,0
71543,syndrome,0,0
71544,(,0,0
71545,AIDS,0,0
71546,),0,0
71547,or,0,0
71548,AIDS-related,0,1
71549,complex,0,0
71550,(,0,0
71551,ARC,0,0
71552,),0,0
71553,who,0,0
71554,were,0,0
71555,intolerant,0,0
71556,to,0,0
71557,zidovudine,0,0
71558,because,0,0
71559,of,0,0
71560,neutropenia,0,1
71561,",",0,0
71562,we,0,0
71563,performed,0,0
71564,a,0,0
71565,randomized,0,0
71566,",",0,0
71567,open-label,0,0
71568,study,0,0
71569,in,0,0
71570,which,0,0
71571,patients,0,0
71572,were,0,0
71573,assigned,0,0
71574,to,0,0
71575,one,0,0
71576,of,0,0
71577,two,0,0
71578,groups,0,0
71579,.,0,0
71580,Zidovudine,0,0
71581,was,0,0
71582,discontinued,0,0
71583,in,0,0
71584,group,0,0
71585,A,0,0
71586,patients,0,0
71587,before,0,0
71588,instituting,0,0
71589,GM-CSF,0,0
71590,treatment,0,0
71591,and,0,1
71592,was,0,0
71593,restarted,0,0
71594,in,0,0
71595,a,0,0
71596,graduated,0,0
71597,fashion,0,0
71598,over,0,0
71599,4,0,0
71600,weeks,0,0
71601,.,0,0
71602,Group,0,0
71603,B,0,0
71604,patients,0,0
71605,continued,0,0
71606,on,0,0
71607,full-dose,0,0
71608,(,0,0
71609,"1,200",0,0
71610,mg/d,0,0
71611,),0,0
71612,zidovudine,0,0
71613,therapy,0,0
71614,while,0,0
71615,beginning,0,0
71616,GM-CSF,0,0
71617,therapy,0,0
71618,.,0,0
71619,A,0,0
71620,total,0,0
71621,of,0,0
71622,17,0,0
71623,patients,0,0
71624,were,0,0
71625,entered,0,0
71626,",",0,0
71627,eight,0,0
71628,in,0,0
71629,group,0,0
71630,A,0,0
71631,and,0,0
71632,nine,0,0
71633,in,0,0
71634,group,0,0
71635,B,0,0
71636,.,0,0
71637,Five,0,0
71638,of,0,0
71639,eight,0,0
71640,patients,0,0
71641,in,0,0
71642,group,0,0
71643,A,0,0
71644,and,0,0
71645,seven,0,0
71646,of,0,0
71647,nine,0,0
71648,in,0,0
71649,group,0,0
71650,B,0,0
71651,had,0,0
71652,a,0,0
71653,history,0,0
71654,of,0,0
71655,Pneumocystis,0,0
71656,carinii,0,0
71657,pneumonia,0,0
71658,(,0,0
71659,PCP,0,0
71660,),0,0
71661,.,0,0
71662,All,0,0
71663,were,0,0
71664,homosexual,0,0
71665,males,0,0
71666,",",0,0
71667,except,0,0
71668,one,0,0
71669,female,0,0
71670,in,0,0
71671,group,0,0
71672,A,0,0
71673,who,0,0
71674,was,0,0
71675,the,0,0
71676,sex,0,0
71677,partner,0,0
71678,of,0,0
71679,a,0,0
71680,bisexual,0,0
71681,male,0,0
71682,with,0,0
71683,AIDS,0,0
71684,.,0,0
71685,All,0,0
71686,patients,0,0
71687,had,0,0
71688,neutropenia,1,1
71689,(,0,0
71690,absolute,0,1
71691,neutrophil,0,1
71692,count,0,1
71693,[,0,0
71694,ANC,0,0
71695,],0,0
71696,less,0,0
71697,than,0,0
71698,"1,000/microL",0,0
71699,),0,0
71700,while,0,0
71701,taking,0,0
71702,full-dose,0,0
71703,zidovudine,0,0
71704,.,0,0
71705,The,0,0
71706,mean,0,1
71707,CD4,0,1
71708,(,0,0
71709,+/-,0,0
71710,SD,0,0
71711,),0,0
71712,lymphocyte,0,1
71713,level,0,1
71714,was,0,0
71715,37,0,0
71716,(,0,0
71717,+/-,0,0
71718,29,0,0
71719,),0,0
71720,/microL,0,1
71721,and,0,0
71722,39,0,0
71723,(,0,0
71724,+/-,0,0
71725,44,0,0
71726,),0,0
71727,/microL,0,1
71728,in,0,0
71729,groups,0,0
71730,A,0,0
71731,and,0,1
71732,B,0,0
71733,",",0,0
71734,respectively,0,0
71735,.,0,0
71736,After,0,0
71737,randomization,0,0
71738,",",0,0
71739,patients,0,0
71740,were,0,0
71741,begun,0,0
71742,on,0,0
71743,subcutaneous,0,0
71744,GM-CSF,0,0
71745,at,0,0
71746,a,0,0
71747,dose,0,0
71748,of,0,0
71749,1.0,0,0
71750,microgram/kg/d,0,0
71751,.,0,0
71752,Patients,0,0
71753,in,0,0
71754,group,0,0
71755,A,0,0
71756,received,0,0
71757,2,0,0
71758,weeks,0,0
71759,of,0,0
71760,daily,0,0
71761,GM-CSF,0,0
71762,",",0,0
71763,at,0,0
71764,which,0,0
71765,time,0,1
71766,zidovudine,0,0
71767,was,0,0
71768,restarted,0,0
71769,if,0,0
71770,the,0,0
71771,ANC,0,0
71772,was,0,0
71773,greater,0,0
71774,than,0,0
71775,"1,000/microL",0,0
71776,;,0,0
71777,if,0,0
71778,the,0,0
71779,ANC,0,0
71780,was,0,0
71781,less,0,0
71782,than,0,0
71783,"1,000/microL",0,0
71784,",",0,0
71785,the,0,0
71786,dose,0,0
71787,of,0,0
71788,GM-CSF,0,0
71789,was,0,0
71790,increased,0,0
71791,to,0,0
71792,3.0,0,0
71793,micrograms/kg,0,0
71794,",",0,0
71795,and,0,1
71796,at,0,0
71797,2-week,0,0
71798,intervals,0,0
71799,either,0,0
71800,zidovudine,0,0
71801,was,0,0
71802,restarted,0,0
71803,or,0,0
71804,the,0,0
71805,dose,0,0
71806,of,0,0
71807,GM-CSF,0,0
71808,was,0,0
71809,increased,0,0
71810,to,0,0
71811,5,0,0
71812,micrograms/kg,0,0
71813,and,0,0
71814,then,0,0
71815,10,0,0
71816,micrograms/kg,0,0
71817,",",0,0
71818,to,0,0
71819,maintain,0,0
71820,the,0,0
71821,ANC,0,0
71822,greater,0,0
71823,than,0,0
71824,"1,000/microL",0,0
71825,.,0,0
71826,Group,0,0
71827,B,0,0
71828,patients,0,0
71829,received,0,0
71830,full-dose,0,0
71831,zidovudine,0,0
71832,concurrently,0,0
71833,with,0,0
71834,GM-CSF,0,0
71835,administration,0,0
71836,.,0,0
71837,The,0,0
71838,dose,0,0
71839,of,0,0
71840,GM-CSF,0,0
71841,was,0,0
71842,increased,0,0
71843,every,0,0
71844,2,0,0
71845,weeks,0,0
71846,if,0,0
71847,necessary,0,0
71848,to,0,0
71849,keep,0,0
71850,the,0,0
71851,ANC,1,0
71852,greater,0,0
71853,than,0,0
71854,"1,000/microL",0,0
71855,while,0,0
71856,maintaining,0,0
71857,full-dose,0,0
71858,zidovudine,0,0
71859,therapy,0,0
71860,.,0,0
71861,Patients,0,0
71862,in,0,0
71863,each,0,0
71864,group,0,0
71865,showed,0,0
71866,an,0,0
71867,increase,0,0
71868,in,0,0
71869,total,1,1
71870,white,1,0
71871,blood,1,1
71872,cell,1,1
71873,(,1,0
71874,WBC,1,1
71875,),1,0
71876,count,1,1
71877,.,1,0
71878,Neutrophils,1,1
71879,and,1,0
71880,eosinophils,1,1
71881,were,0,0
71882,responsible,0,0
71883,for,0,0
71884,the,0,0
71885,majority,0,0
71886,of,0,0
71887,this,0,0
71888,increase,0,0
71889,.,0,0
71890,Patients,0,0
71891,in,0,0
71892,group,0,0
71893,A,0,0
71894,had,0,0
71895,a,0,0
71896,more,0,0
71897,rapid,0,1
71898,increase,1,0
71899,in,1,0
71900,WBC,1,0
71901,than,0,0
71902,those,0,0
71903,in,0,0
71904,group,0,0
71905,B,0,0
71906,;,0,0
71907,however,0,0
71908,",",0,0
71909,by,0,0
71910,week,0,0
71911,8,0,0
71912,",",0,0
71913,the,0,0
71914,WBC,1,0
71915,in,0,0
71916,each,0,0
71917,group,0,0
71918,was,0,0
71919,essentially,0,0
71920,equal,0,0
71921,.,0,0
71922,Viral,1,0
71923,replication,1,0
71924,as,0,0
71925,measured,0,0
71926,by,0,0
71927,human,1,0
71928,immunodeficiency,1,0
71929,virus,1,0
71930,(,1,0
71931,HIV,1,1
71932,),1,1
71933,p24,1,0
71934,antigen,1,1
71935,(,1,0
71936,Ag,1,1
71937,),1,0
71938,was,0,0
71939,decreased,0,0
71940,in,0,0
71941,four,0,0
71942,patients,0,0
71943,in,0,0
71944,each,0,0
71945,group,0,0
71946,",",0,0
71947,increased,0,0
71948,in,0,0
71949,one,0,0
71950,patient,0,0
71951,in,0,0
71952,each,0,0
71953,group,0,0
71954,",",0,0
71955,and,0,1
71956,remained,0,1
71957,unchanged,0,0
71958,in,0,0
71959,the,0,0
71960,remainder,0,0
71961,.,0,0
71962,The,0,0
71963,ability,1,1
71964,to,1,0
71965,culture,1,1
71966,virus,1,0
71967,from,0,0
71968,peripheral,0,1
71969,blood,0,1
71970,mononuclear,0,1
71971,cells,0,1
71972,was,0,0
71973,not,0,0
71974,changed,0,0
71975,by,0,0
71976,the,0,0
71977,regimen,0,0
71978,.,0,0
71979,The,0,0
71980,major,0,0
71981,toxicities,0,1
71982,of,0,0
71983,the,0,0
71984,regimen,0,0
71985,were,0,0
71986,fever,0,0
71987,and,0,0
71988,malaise,0,1
71989,.,0,0
71990,(,0,0
71991,ABSTRACT,0,1
71992,TRUNCATED,0,0
71993,AT,0,0
71994,400,0,0
71995,WORDS,0,0
71996,),0,0
71997,[,0,0
71998,Comparison,0,0
71999,of,0,0
72000,three,0,0
72001,analgesic,0,0
72002,methods,0,0
72003,for,0,0
72004,postoperative,0,1
72005,pain,0,1
72006,relief,0,1
72007,and,0,0
72008,their,0,0
72009,effects,0,0
72010,on,0,0
72011,plasma,1,1
72012,interleukin-6,1,1
72013,concentration,1,1
72014,following,0,0
72015,radical,0,0
72016,surgery,0,0
72017,for,0,0
72018,gastric,0,1
72019,carcinoma,0,0
72020,],0,0
72021,.,0,0
72022,OBJECTIVE,0,0
72023,To,0,0
72024,compare,0,0
72025,the,0,0
72026,efficacy,0,1
72027,of,0,0
72028,preemptive,0,0
72029,epidural,0,0
72030,analgesia,0,1
72031,combined,0,0
72032,with,0,0
72033,postoperative,0,1
72034,epidural,0,0
72035,analgesia,0,1
72036,",",0,0
72037,postoperative,0,1
72038,epidural,0,0
72039,analgesia,0,1
72040,alone,0,0
72041,and,0,0
72042,intravenous,0,0
72043,analgesia,0,1
72044,for,0,0
72045,postoperative,1,1
72046,pain,1,1
72047,relief,1,1
72048,and,0,0
72049,their,0,0
72050,effects,0,0
72051,on,0,0
72052,plasma,1,1
72053,interleukin-6,1,1
72054,(,1,0
72055,IL-6,1,0
72056,),1,0
72057,concentration,1,1
72058,following,0,0
72059,radical,0,0
72060,surgery,0,0
72061,for,0,0
72062,gastric,0,1
72063,carcinoma,0,0
72064,.,0,0
72065,METHODS,0,0
72066,Sixty-six,0,0
72067,patients,0,0
72068,with,0,0
72069,gastric,0,1
72070,carcinoma,0,0
72071,scheduled,0,0
72072,for,0,0
72073,gastrectomy,0,0
72074,were,0,0
72075,randomly,0,0
72076,divided,0,0
72077,into,0,0
72078,3,0,0
72079,groups,0,0
72080,",",0,0
72081,namely,0,0
72082,group,0,0
72083,P,0,0
72084,(,0,0
72085,n=22,0,0
72086,),0,1
72087,",",0,0
72088,group,0,0
72089,E,0,1
72090,(,0,0
72091,n=22,0,0
72092,),0,1
72093,and,0,0
72094,group,0,0
72095,V,0,1
72096,(,0,0
72097,n=22,0,0
72098,),0,0
72099,",",0,0
72100,to,0,0
72101,receive,0,0
72102,preemptive,0,0
72103,epidural,0,0
72104,analgesia,0,1
72105,combined,0,0
72106,with,0,0
72107,postoperative,0,1
72108,epidural,0,0
72109,analgesia,0,1
72110,",",0,0
72111,exclusive,0,0
72112,postoperative,0,1
72113,epidural,0,0
72114,analgesia,0,1
72115,",",0,0
72116,and,0,1
72117,exclusive,0,0
72118,postoperative,0,1
72119,intravenous,0,0
72120,analgesia,0,1
72121,",",0,0
72122,respectively,0,0
72123,.,0,0
72124,Hemodynamic,1,1
72125,data,1,0
72126,were,0,0
72127,recorded,0,0
72128,for,0,0
72129,all,0,0
72130,the,0,0
72131,patients,0,0
72132,during,0,0
72133,the,0,0
72134,operation,0,0
72135,",",0,0
72136,and,0,1
72137,visual,1,1
72138,analogue,1,1
72139,scale,1,1
72140,(,1,0
72141,VAS,1,1
72142,),1,0
72143,was,0,0
72144,used,0,0
72145,to,0,0
72146,assess,0,0
72147,the,0,0
72148,pain,1,1
72149,intensity,1,0
72150,at,0,0
72151,4,0,0
72152,",",0,0
72153,8,0,0
72154,",",0,0
72155,16,0,0
72156,",",0,0
72157,24,0,0
72158,",",0,0
72159,48,0,0
72160,and,0,0
72161,72,0,0
72162,h,0,0
72163,after,0,0
72164,surgery,0,0
72165,.,0,0
72166,Plasma,1,1
72167,IL-6,1,0
72168,concentration,1,1
72169,was,0,0
72170,determined,0,0
72171,before,0,0
72172,surgery,0,0
72173,and,0,0
72174,at,0,0
72175,24,0,0
72176,",",0,0
72177,48,0,0
72178,",",0,0
72179,72,0,0
72180,h,0,0
72181,after,0,0
72182,surgery,0,0
72183,.,0,0
72184,RESULTS,0,0
72185,No,0,0
72186,significant,0,0
72187,changes,0,1
72188,occurred,0,0
72189,in,0,0
72190,the,0,0
72191,hemodynamics,0,1
72192,during,0,0
72193,the,0,0
72194,preoperative,0,0
72195,periods,0,0
72196,.,0,0
72197,VAS,1,1
72198,and,1,0
72199,IL-6,1,1
72200,were,0,0
72201,lower,0,0
72202,in,0,0
72203,group,0,0
72204,P,0,0
72205,than,0,0
72206,in,0,0
72207,group,0,0
72208,E,0,1
72209,and,0,1
72210,V,0,1
72211,",",0,1
72212,and,0,1
72213,group,0,0
72214,E,0,1
72215,had,0,0
72216,lower,0,0
72217,measurement,0,1
72218,than,0,0
72219,group,0,0
72220,V,0,1
72221,(,0,0
72222,P,0,0
72223,<,0,0
72224,0.05,0,0
72225,),0,0
72226,.,0,0
72227,CONCLUSION,0,0
72228,Preemptive,0,0
72229,epidural,0,0
72230,analgesia,0,1
72231,combined,0,0
72232,with,0,0
72233,postoperative,0,1
72234,epidural,0,0
72235,analgesia,0,0
72236,provides,0,0
72237,more,0,0
72238,satisfactory,0,1
72239,pain,1,1
72240,relief,1,1
72241,and,0,0
72242,more,0,0
72243,effectively,0,0
72244,prevents,0,0
72245,IL-6,1,0
72246,increment,1,1
72247,than,0,0
72248,exclusive,0,0
72249,epidural,0,0
72250,analgesia,0,1
72251,or,0,0
72252,intravenous,0,0
72253,analgesia,0,1
72254,after,0,0
72255,gastrectomy,0,0
72256,for,0,0
72257,gastric,0,1
72258,carcinoma,0,0
72259,.,0,0
72260,Women,0,1
72261,'s,0,0
72262,responses,0,1
72263,to,0,0
72264,information,0,0
72265,on,0,0
72266,mammographic,0,1
72267,breast,0,0
72268,density,0,1
72269,.,0,0
72270,The,0,0
72271,objective,0,0
72272,of,0,0
72273,this,0,0
72274,study,0,0
72275,was,0,0
72276,to,0,0
72277,determine,0,0
72278,the,0,0
72279,negative,0,0
72280,and,0,0
72281,positive,0,1
72282,outcomes,0,1
72283,of,0,0
72284,providing,0,0
72285,mammographic,0,0
72286,breast,0,0
72287,density,0,1
72288,(,0,0
72289,MBD,0,0
72290,),0,0
72291,information,0,0
72292,to,0,0
72293,participants,0,0
72294,of,0,0
72295,a,0,0
72296,screening,0,0
72297,program,0,0
72298,.,0,0
72299,A,0,0
72300,randomized,0,0
72301,experiment,0,0
72302,was,0,0
72303,conducted,0,0
72304,with,0,0
72305,a,0,0
72306,sample,0,0
72307,of,0,0
72308,618,0,0
72309,women,0,0
72310,50,0,0
72311,years,0,0
72312,or,0,0
72313,older,0,0
72314,with,0,0
72315,MBD,0,0
72316,greater,0,0
72317,than,0,0
72318,50,0,0
72319,%,0,0
72320,of,0,0
72321,breast,0,0
72322,volume,0,1
72323,.,0,0
72324,The,0,0
72325,intervention,0,0
72326,consisted,0,0
72327,of,0,0
72328,reporting,0,0
72329,the,0,0
72330,presence,0,0
72331,of,0,0
72332,MBD,0,0
72333,in,0,0
72334,the,0,0
72335,screening,0,0
72336,mammography,0,0
72337,results,0,0
72338,letter,0,0
72339,that,0,0
72340,was,0,0
72341,sent,0,0
72342,along,0,0
72343,with,0,0
72344,an,0,0
72345,information,0,0
72346,pamphlet,0,0
72347,.,0,0
72348,Compared,0,0
72349,to,0,0
72350,the,0,0
72351,controls,0,0
72352,",",0,0
72353,more,0,0
72354,women,0,0
72355,in,0,0
72356,the,0,0
72357,intervention,0,0
72358,group,0,0
72359,described,0,0
72360,the,0,0
72361,term,0,1
72362,breast,1,0
72363,density,1,1
72364,correctly,0,0
72365,and,0,0
72366,recognized,0,0
72367,it,0,0
72368,as,0,0
72369,a,0,0
72370,risk,0,1
72371,factor,0,0
72372,for,0,0
72373,breast,0,0
72374,cancer,0,0
72375,.,0,0
72376,Although,0,0
72377,at,0,0
72378,the,0,0
72379,4-week,0,0
72380,follow-up,0,0
72381,the,0,0
72382,intervention,0,0
72383,group,0,0
72384,indicated,0,0
72385,that,0,0
72386,they,0,0
72387,were,0,0
72388,very,0,0
72389,likely,0,0
72390,to,0,0
72391,have,0,0
72392,an,0,0
72393,annual,0,0
72394,clinical,0,0
72395,breast,0,0
72396,examination,0,0
72397,more,0,0
72398,frequently,0,0
72399,than,0,0
72400,controls,0,0
72401,",",0,0
72402,no,0,0
72403,differences,0,0
72404,were,0,0
72405,detected,0,0
72406,at,0,0
72407,6,0,0
72408,months,0,0
72409,.,0,0
72410,There,0,0
72411,were,0,0
72412,no,0,0
72413,significant,0,0
72414,differences,0,0
72415,on,0,0
72416,other,0,0
72417,behavioural,1,0
72418,or,1,0
72419,psychological,1,1
72420,measures,1,1
72421,",",0,0
72422,although,0,0
72423,at,0,0
72424,the,0,0
72425,4-week,0,0
72426,follow-up,0,0
72427,the,0,0
72428,control,0,0
72429,group,0,0
72430,perceived,0,0
72431,their,0,0
72432,risk,0,0
72433,for,0,0
72434,breast,0,0
72435,cancer,0,0
72436,",",0,0
72437,relative,0,0
72438,to,0,0
72439,other,0,0
72440,women,0,0
72441,their,0,0
72442,age,0,0
72443,",",0,0
72444,as,0,0
72445,a,0,0
72446,lot,0,0
72447,lower,0,0
72448,than,0,0
72449,did,0,0
72450,women,0,0
72451,in,0,0
72452,the,0,0
72453,intervention,0,0
72454,group,0,0
72455,.,0,0
72456,The,0,0
72457,results,0,0
72458,demonstrate,0,0
72459,a,0,0
72460,feasible,0,0
72461,and,0,0
72462,non-threatening,0,0
72463,way,0,0
72464,to,0,0
72465,provide,0,0
72466,women,0,0
72467,with,0,0
72468,important,0,0
72469,personalized,0,0
72470,information,0,0
72471,about,0,0
72472,breast,1,0
72473,cancer,1,0
72474,risk,1,0
72475,.,1,0
72476,Similar,0,0
72477,effects,0,1
72478,of,0,0
72479,rofecoxib,0,0
72480,and,0,1
72481,indomethacin,0,0
72482,on,0,0
72483,the,0,0
72484,incidence,0,1
72485,of,0,0
72486,heterotopic,0,0
72487,ossification,0,0
72488,after,0,0
72489,hip,0,1
72490,arthroplasty,0,0
72491,.,0,0
72492,BACKGROUND,0,0
72493,Although,0,0
72494,indomethacin,0,0
72495,is,0,0
72496,effective,0,0
72497,in,0,0
72498,preventing,0,0
72499,heterotopic,1,0
72500,ossification,1,0
72501,(,1,0
72502,HO,1,1
72503,),1,0
72504,after,0,0
72505,primary,0,0
72506,total,0,1
72507,hip,0,1
72508,arthroplasty,0,1
72509,",",0,0
72510,side,1,1
72511,effects,1,1
72512,are,0,0
72513,frequently,0,0
72514,observed,0,0
72515,.,0,0
72516,In,0,0
72517,the,0,0
72518,last,0,0
72519,decade,0,0
72520,a,0,0
72521,new,0,0
72522,class,0,0
72523,of,0,0
72524,drugs,0,0
72525,--,0,0
72526,the,0,0
72527,COX-2,0,0
72528,selective,0,0
72529,nonsteroidal,0,0
72530,anti-inflammatory,0,0
72531,drugs,0,0
72532,--,0,0
72533,has,0,0
72534,been,0,0
72535,developed,0,0
72536,.,0,0
72537,To,0,0
72538,investigate,0,0
72539,the,0,0
72540,effect,0,0
72541,of,0,0
72542,these,0,0
72543,COX-2,0,0
72544,selective,0,0
72545,NSAIDs,1,0
72546,on,1,0
72547,heterotopic,1,1
72548,ossification,1,0
72549,(,1,0
72550,HO,1,1
72551,),1,0
72552,after,0,0
72553,primary,0,0
72554,total,0,1
72555,hip,0,1
72556,arthroplasty,0,1
72557,(,0,0
72558,THA,0,1
72559,),0,0
72560,",",0,0
72561,we,0,0
72562,conducted,0,0
72563,a,0,0
72564,randomized,0,0
72565,controlled,0,0
72566,trial,0,0
72567,using,0,0
72568,either,0,0
72569,indomethacin,0,0
72570,or,0,1
72571,rofecoxib,0,0
72572,for,0,0
72573,7,0,0
72574,days,0,0
72575,.,0,0
72576,METHODS,0,0
72577,186,0,0
72578,patients,0,0
72579,received,0,0
72580,either,0,0
72581,indomethacin,0,0
72582,3,0,0
72583,times,0,0
72584,daily,0,0
72585,",",0,0
72586,or,0,0
72587,rofecoxib,0,0
72588,twice,0,0
72589,",",0,0
72590,and,0,0
72591,1,0,0
72592,placebo,0,0
72593,",",0,0
72594,daily,0,0
72595,for,0,0
72596,7,0,0
72597,days,0,0
72598,.,0,0
72599,HO,1,0
72600,was,1,0
72601,graded,1,0
72602,according,0,0
72603,to,0,0
72604,the,0,0
72605,1-year,0,0
72606,postoperative,0,1
72607,radiographs,0,0
72608,according,0,0
72609,to,0,0
72610,the,0,0
72611,Brooker,0,0
72612,classification,0,1
72613,.,0,0
72614,RESULTS,0,0
72615,12,0,0
72616,of,0,0
72617,the,0,0
72618,186,0,0
72619,patients,0,0
72620,included,0,0
72621,discontinued,1,0
72622,their,0,0
72623,medication,0,0
72624,before,0,0
72625,the,0,0
72626,end,0,0
72627,of,0,0
72628,the,0,0
72629,trial,0,0
72630,due,0,0
72631,to,0,0
72632,side,1,0
72633,effects,1,0
72634,.,1,0
72635,The,0,0
72636,remaining,0,0
72637,174,0,0
72638,patients,0,0
72639,were,0,0
72640,included,0,0
72641,in,0,0
72642,the,0,0
72643,analysis,0,0
72644,.,0,0
72645,In,0,0
72646,the,0,0
72647,indomethacin,0,0
72648,group,0,0
72649,(,0,0
72650,n,0,0
72651,=,0,0
72652,89,0,0
72653,),0,0
72654,",",0,0
72655,77,0,0
72656,patients,0,0
72657,(,0,0
72658,87,0,0
72659,%,0,0
72660,),0,0
72661,showed,1,0
72662,no,1,0
72663,HO,1,0
72664,",",0,0
72665,9,0,0
72666,showed,1,0
72667,HO,1,0
72668,of,1,0
72669,grade,1,0
72670,1,1,0
72671,and,0,0
72672,3,0,0
72673,showed,1,0
72674,HO,1,0
72675,of,1,0
72676,grade,1,0
72677,2,1,0
72678,according,0,0
72679,to,0,0
72680,the,0,0
72681,Brooker,0,0
72682,classification,0,1
72683,.,0,0
72684,In,0,0
72685,the,0,0
72686,rofecoxib,0,0
72687,group,0,0
72688,(,0,0
72689,n,0,0
72690,=,0,0
72691,85,0,0
72692,),0,0
72693,73,0,0
72694,patients,0,0
72695,(,0,0
72696,86,0,0
72697,%,0,0
72698,),0,0
72699,showed,1,0
72700,no,1,0
72701,ossification,1,0
72702,",",0,0
72703,9,0,0
72704,showed,1,0
72705,grade,1,0
72706,1,1,0
72707,",",0,0
72708,and,0,0
72709,3,0,0
72710,showed,1,0
72711,grade,1,0
72712,2,1,0
72713,.,1,0
72714,INTERPRETATION,0,0
72715,The,0,0
72716,prophylactic,0,0
72717,effect,0,0
72718,of,0,0
72719,rofecoxib,0,0
72720,for,0,0
72721,7,0,0
72722,days,0,0
72723,in,0,0
72724,preventing,0,0
72725,heterotopic,0,0
72726,ossification,0,0
72727,after,0,0
72728,primary,0,0
72729,total,0,1
72730,hip,0,0
72731,arthroplasty,0,0
72732,is,0,0
72733,comparable,0,0
72734,to,0,0
72735,the,0,0
72736,effect,0,0
72737,of,0,0
72738,indomethacin,0,0
72739,given,0,0
72740,for,0,0
72741,7,0,0
72742,days,0,0
72743,.,0,0
72744,These,0,0
72745,results,0,0
72746,indicate,0,0
72747,that,0,0
72748,the,0,0
72749,development,0,0
72750,of,0,0
72751,HO,0,0
72752,follows,0,0
72753,a,0,0
72754,COX-2,0,0
72755,pathway,0,0
72756,.,0,0
72757,Development,0,1
72758,",",0,0
72759,description,0,0
72760,",",0,1
72761,and,0,1
72762,acceptability,0,1
72763,of,0,0
72764,a,0,0
72765,small-group,0,0
72766,",",0,0
72767,behavioral,0,1
72768,intervention,0,0
72769,to,0,0
72770,prevent,0,0
72771,HIV,0,1
72772,and,0,0
72773,hepatitis,0,0
72774,C,0,0
72775,virus,0,0
72776,infections,0,1
72777,among,0,0
72778,young,0,0
72779,adult,0,0
72780,injection,0,0
72781,drug,0,0
72782,users,0,0
72783,.,0,0
72784,Young,0,0
72785,injection,0,0
72786,drug,0,0
72787,users,0,0
72788,(,0,0
72789,IDUs,0,0
72790,),0,0
72791,who,0,0
72792,are,0,0
72793,not,0,0
72794,infected,0,0
72795,with,0,0
72796,HIV,0,1
72797,or,0,0
72798,hepatitis,0,0
72799,C,0,0
72800,virus,0,0
72801,are,0,0
72802,at,0,0
72803,great,0,0
72804,risk,0,1
72805,of,0,0
72806,acquiring,0,0
72807,one,0,0
72808,or,0,0
72809,both,0,0
72810,of,0,0
72811,these,0,0
72812,infections,0,0
72813,through,0,0
72814,their,0,0
72815,sexual,0,1
72816,or,0,0
72817,injection,0,0
72818,behaviors,0,1
72819,.,0,0
72820,We,0,0
72821,describe,0,0
72822,the,0,0
72823,development,0,0
72824,of,0,0
72825,a,0,0
72826,behavioral,0,1
72827,intervention,0,0
72828,designed,0,0
72829,to,0,0
72830,decrease,0,0
72831,sexual,1,1
72832,and,1,0
72833,injection,1,0
72834,risk,1,1
72835,behaviors,1,1
72836,among,0,0
72837,young,0,0
72838,IDUs,0,0
72839,.,0,0
72840,The,0,0
72841,intervention,0,0
72842,was,0,0
72843,developed,0,0
72844,through,0,0
72845,a,0,0
72846,dynamic,0,0
72847,and,0,0
72848,iterative,0,0
72849,process,0,0
72850,that,0,0
72851,involved,0,0
72852,extensive,0,0
72853,development,0,1
72854,activities,0,1
72855,",",0,0
72856,focus,0,0
72857,groups,0,0
72858,with,0,0
72859,the,0,0
72860,target,0,0
72861,population,0,0
72862,to,0,0
72863,pilot,0,0
72864,individual,0,0
72865,activities,0,1
72866,and,0,1
72867,intervention,0,0
72868,sessions,0,0
72869,",",0,0
72870,and,0,0
72871,later,0,1
72872,",",0,0
72873,pilot,0,0
72874,testing,0,0
72875,of,0,0
72876,the,0,0
72877,entire,0,0
72878,intervention,0,0
72879,.,0,0
72880,The,0,0
72881,six-session,0,0
72882,intervention,0,0
72883,that,0,0
72884,emerged,0,0
72885,from,0,0
72886,the,0,0
72887,development,0,1
72888,process,0,0
72889,relied,0,0
72890,on,0,0
72891,both,0,0
72892,social-cognitive,0,1
72893,theories,0,0
72894,and,0,0
72895,peer,0,0
72896,influence,0,0
72897,models,0,0
72898,.,0,0
72899,We,0,0
72900,also,0,0
72901,designed,0,0
72902,a,0,0
72903,control,0,0
72904,intervention,0,0
72905,",",0,0
72906,trained,0,0
72907,facilitators,0,0
72908,to,0,0
72909,deliver,0,0
72910,the,0,0
72911,interventions,0,0
72912,",",0,0
72913,and,0,1
72914,conducted,0,0
72915,quality,0,1
72916,assurance,0,1
72917,of,0,1
72918,intervention,0,0
72919,delivery,0,0
72920,.,0,0
72921,To,0,0
72922,better,0,0
72923,understand,0,0
72924,intervention,0,0
72925,trial,0,0
72926,findings,0,0
72927,",",0,0
72928,we,0,0
72929,asked,0,0
72930,participants,0,0
72931,about,0,0
72932,their,0,0
72933,intervention,0,0
72934,experiences,0,1
72935,and,0,1
72936,examined,0,0
72937,potential,0,1
72938,contamination,0,1
72939,across,0,0
72940,arms,0,0
72941,.,0,0
72942,Both,0,0
72943,interventions,0,0
72944,were,0,0
72945,delivered,0,0
72946,with,0,0
72947,high,0,0
72948,fidelity,0,1
72949,and,0,0
72950,participants,0,0
72951,in,0,0
72952,both,0,0
72953,groups,0,0
72954,reported,0,0
72955,positive,0,0
72956,experiences,0,0
72957,.,0,0
72958,More,0,0
72959,perceived,1,1
72960,impact,1,0
72961,was,0,0
72962,reported,0,0
72963,for,0,0
72964,injection,1,0
72965,risk,1,1
72966,behaviors,1,1
72967,than,0,0
72968,for,0,0
72969,sexual,1,1
72970,risk,1,1
72971,behaviors,1,1
72972,among,0,0
72973,participants,0,0
72974,in,0,0
72975,the,0,0
72976,intervention,0,0
72977,arm,0,0
72978,.,0,0
72979,Minimal,0,0
72980,evidence,0,0
72981,of,0,0
72982,contamination,1,1
72983,was,0,0
72984,found,0,0
72985,.,0,0
72986,Lessons,0,0
72987,learned,0,0
72988,can,0,0
72989,help,0,0
72990,future,0,0
72991,researchers,0,0
72992,to,0,0
72993,develop,0,0
72994,stronger,0,0
72995,interventions,0,0
72996,for,0,0
72997,this,0,0
72998,high-need,0,0
72999,population,0,0
73000,.,0,0
73001,Efficacy,1,1
73002,and,1,1
73003,safety,1,1
73004,of,0,0
73005,a,0,0
73006,very-low-protein,0,0
73007,diet,0,0
73008,when,0,0
73009,postponing,0,0
73010,dialysis,0,0
73011,in,0,0
73012,the,0,0
73013,elderly,0,0
73014,:,0,0
73015,a,0,0
73016,prospective,0,0
73017,randomized,0,0
73018,multicenter,0,0
73019,controlled,0,0
73020,study,0,0
73021,.,0,0
73022,BACKGROUND,0,0
73023,A,0,0
73024,supplemented,0,0
73025,very-low-protein,0,0
73026,diet,0,0
73027,(,0,0
73028,sVLPD,0,0
73029,),0,0
73030,seems,0,0
73031,to,0,0
73032,be,0,0
73033,safe,1,0
73034,when,0,0
73035,postponing,0,0
73036,dialysis,0,0
73037,therapy,0,0
73038,.,0,0
73039,STUDY,0,1
73040,DESIGN,0,0
73041,Prospective,0,0
73042,multicenter,0,0
73043,randomized,0,0
73044,controlled,0,0
73045,study,0,0
73046,designed,0,0
73047,to,0,0
73048,assess,0,0
73049,the,0,0
73050,noninferiority,0,0
73051,of,0,0
73052,diet,0,0
73053,versus,0,0
73054,dialysis,0,0
73055,in,0,0
73056,1-year,0,0
73057,mortality,0,1
73058,assessed,0,0
73059,by,0,0
73060,using,0,0
73061,intention-to-treat,0,0
73062,and,0,0
73063,per-protocol,0,0
73064,analysis,0,0
73065,.,0,0
73066,SETTING,0,0
73067,&,0,0
73068,PARTICIPANTS,0,1
73069,Italian,0,0
73070,uremic,0,1
73071,patients,0,0
73072,without,0,0
73073,diabetes,0,0
73074,older,0,0
73075,than,0,0
73076,70,0,0
73077,years,0,0
73078,with,0,0
73079,glomerular,0,1
73080,filtration,0,1
73081,rate,0,1
73082,of,0,0
73083,5,0,0
73084,to,0,0
73085,7,0,0
73086,mL/min,0,0
73087,(,0,0
73088,0.08,0,0
73089,to,0,0
73090,0.12,0,0
73091,mL/s,0,0
73092,),0,0
73093,.,0,0
73094,INTERVENTION,0,0
73095,Randomization,0,0
73096,to,0,0
73097,an,0,0
73098,sVLPD,0,0
73099,(,0,0
73100,diet,0,0
73101,group,0,0
73102,),0,0
73103,or,0,0
73104,dialysis,0,0
73105,.,0,0
73106,The,0,0
73107,sVLPD,0,0
73108,is,0,0
73109,a,0,0
73110,vegan,0,0
73111,diet,0,0
73112,(,0,0
73113,35,0,0
73114,kcal,0,0
73115,;,0,0
73116,proteins,0,0
73117,",",0,0
73118,0.3,0,0
73119,g/kg,0,0
73120,body,0,0
73121,weight,0,1
73122,daily,0,0
73123,),0,0
73124,supplemented,0,0
73125,with,0,0
73126,keto-analogues,0,0
73127,",",0,0
73128,amino,0,0
73129,acids,0,1
73130,",",0,0
73131,and,0,0
73132,vitamins,0,0
73133,.,0,0
73134,Patients,0,0
73135,following,0,0
73136,an,0,0
73137,sVLPD,0,0
73138,started,0,0
73139,dialysis,0,1
73140,therapy,0,0
73141,in,0,0
73142,the,0,0
73143,case,0,0
73144,of,0,0
73145,malnutrition,0,1
73146,",",0,0
73147,intractable,0,0
73148,fluid,0,1
73149,overload,0,1
73150,",",0,1
73151,hyperkalemia,0,1
73152,",",0,1
73153,or,0,1
73154,appearance,0,1
73155,of,0,1
73156,uremic,0,0
73157,symptoms,0,1
73158,.,0,0
73159,OUTCOMES,0,0
73160,&,0,0
73161,MEASUREMENTS,0,0
73162,Mortality,1,1
73163,",",1,0
73164,hospitalization,1,1
73165,",",1,1
73166,and,1,1
73167,metabolic,1,1
73168,markers,1,0
73169,.,1,0
73170,RESULTS,0,0
73171,56,0,0
73172,patients,0,0
73173,were,0,0
73174,randomly,0,0
73175,assigned,0,0
73176,to,0,0
73177,each,0,0
73178,group,0,0
73179,",",0,0
73180,median,0,1
73181,follow-up,0,0
73182,was,0,0
73183,26.5,0,0
73184,months,0,0
73185,(,0,0
73186,interquartile,0,1
73187,range,0,0
73188,",",0,0
73189,40,0,0
73190,),0,0
73191,",",0,0
73192,and,0,1
73193,patients,0,0
73194,in,0,0
73195,the,0,0
73196,diet,0,0
73197,group,0,0
73198,spent,0,0
73199,a,0,0
73200,median,0,0
73201,of,0,0
73202,10.7,0,0
73203,months,0,0
73204,(,0,0
73205,interquartile,0,1
73206,range,0,0
73207,",",0,0
73208,11,0,0
73209,),0,0
73210,following,0,0
73211,an,0,0
73212,sVLPD,0,0
73213,.,0,0
73214,Forty,0,0
73215,patients,0,0
73216,in,0,0
73217,the,0,0
73218,diet,0,0
73219,group,0,0
73220,started,0,0
73221,dialysis,0,1
73222,treatment,0,0
73223,because,0,0
73224,of,0,0
73225,either,0,0
73226,fluid,1,1
73227,overload,1,1
73228,or,1,0
73229,hyperkalemia,1,1
73230,.,1,0
73231,There,0,0
73232,were,0,0
73233,31,0,0
73234,deaths,0,1
73235,(,0,0
73236,55,0,0
73237,%,0,0
73238,),0,0
73239,in,0,0
73240,the,0,0
73241,dialysis,0,0
73242,group,0,0
73243,and,0,0
73244,28,0,0
73245,deaths,1,1
73246,(,0,0
73247,50,0,0
73248,%,0,0
73249,),0,0
73250,in,0,0
73251,the,0,0
73252,diet,0,0
73253,group,0,0
73254,.,0,0
73255,One-year,1,0
73256,observed,1,0
73257,survival,1,1
73258,rates,1,1
73259,at,0,0
73260,intention,0,0
73261,to,0,0
73262,treat,0,0
73263,were,0,0
73264,83.7,0,0
73265,%,0,0
73266,(,0,0
73267,95,0,0
73268,%,0,0
73269,confidence,0,0
73270,interval,0,0
73271,[,0,0
73272,CI,0,0
73273,],0,0
73274,",",0,0
73275,74.5,0,0
73276,to,0,0
73277,94.0,0,0
73278,),0,0
73279,in,0,0
73280,the,0,0
73281,dialysis,0,0
73282,group,0,0
73283,versus,0,0
73284,87.3,0,0
73285,%,0,0
73286,(,0,0
73287,95,0,0
73288,%,0,0
73289,CI,0,0
73290,",",0,0
73291,78.9,0,0
73292,to,0,0
73293,96.5,0,0
73294,),0,0
73295,in,0,0
73296,the,0,0
73297,diet,0,0
73298,group,0,0
73299,(,0,0
73300,log-rank,0,0
73301,test,0,1
73302,for,0,0
73303,noninferiority,0,0
73304,",",0,0
73305,P,0,0
73306,<,0,0
73307,0.001,0,0
73308,;,0,0
73309,for,0,0
73310,superiority,0,0
73311,",",0,0
73312,P,0,0
73313,=,0,0
73314,0.6,0,0
73315,),0,0
73316,:,0,0
73317,the,0,0
73318,difference,0,0
73319,in,0,0
73320,survival,1,1
73321,was,0,0
73322,-3.6,0,0
73323,%,0,0
73324,(,0,0
73325,95,0,0
73326,%,0,0
73327,CI,0,0
73328,",",0,0
73329,-17,0,1
73330,to,0,0
73331,+10,0,0
73332,;,0,0
73333,P,0,0
73334,=,0,0
73335,0.002,0,0
73336,),0,0
73337,.,0,0
73338,The,1,0
73339,hazard,1,1
73340,ratio,1,1
73341,for,1,0
73342,hospitalization,1,1
73343,was,0,0
73344,1.50,0,0
73345,for,0,0
73346,the,0,0
73347,dialysis,0,0
73348,group,0,0
73349,(,0,0
73350,95,0,0
73351,%,0,0
73352,CI,0,0
73353,",",0,0
73354,1.11,0,0
73355,to,0,0
73356,2.01,0,0
73357,;,0,0
73358,P,0,0
73359,<,0,0
73360,0.01,0,0
73361,),0,0
73362,.,0,0
73363,LIMITATIONS,0,0
73364,The,0,0
73365,unblinded,0,0
73366,nature,0,0
73367,of,0,0
73368,the,0,0
73369,study,0,0
73370,",",0,0
73371,exclusion,0,0
73372,of,0,0
73373,patients,0,0
73374,with,0,0
73375,diabetes,0,0
73376,",",0,0
73377,and,0,1
73378,incomplete,0,0
73379,enrollment,0,0
73380,.,0,0
73381,CONCLUSION,0,0
73382,An,0,0
73383,sVLPD,0,0
73384,was,0,0
73385,effective,1,1
73386,and,1,0
73387,safe,1,1
73388,when,0,0
73389,postponing,0,0
73390,dialysis,0,0
73391,treatment,0,0
73392,in,0,0
73393,elderly,0,0
73394,patients,0,0
73395,without,0,0
73396,diabetes,0,0
73397,.,0,0
73398,Fine,0,0
73399,needle,0,0
73400,aspiration,0,0
73401,coupled,0,0
73402,with,0,0
73403,real-time,0,0
73404,PCR,0,1
73405,:,0,0
73406,a,0,0
73407,painless,0,0
73408,methodology,0,0
73409,to,0,0
73410,study,0,0
73411,adaptive,0,1
73412,functional,0,0
73413,changes,0,1
73414,in,0,0
73415,skeletal,0,0
73416,muscle,0,0
73417,.,0,0
73418,BACKGROUND,0,0
73419,AND,0,0
73420,AIM,0,0
73421,In,0,0
73422,this,0,0
73423,study,0,0
73424,we,0,0
73425,developed,0,0
73426,a,0,0
73427,new,0,0
73428,methodology,0,0
73429,for,0,0
73430,obtaining,0,0
73431,human,0,0
73432,skeletal,0,0
73433,muscle,0,0
73434,samples,0,0
73435,to,0,0
73436,evaluate,0,0
73437,gene,0,0
73438,expression,0,1
73439,.,0,0
73440,This,0,0
73441,approach,0,0
73442,is,0,0
73443,based,0,0
73444,on,0,0
73445,a,0,0
73446,fine,0,0
73447,needle,0,0
73448,aspiration,0,0
73449,technique,0,0
73450,",",0,0
73451,which,0,0
73452,allows,0,0
73453,us,0,0
73454,to,0,0
73455,extract,0,0
73456,a,0,0
73457,small,0,0
73458,tissue,0,1
73459,sample,0,0
73460,in,0,0
73461,a,0,0
73462,significantly,0,0
73463,less,0,0
73464,invasive,0,0
73465,manner,0,0
73466,than,0,0
73467,with,0,0
73468,classic,0,0
73469,biopsy,0,0
73470,.,0,0
73471,METHODS,0,0
73472,AND,0,0
73473,RESULTS,0,0
73474,Multiplex,0,0
73475,tandem,0,0
73476,RT-PCR,0,0
73477,was,0,0
73478,used,0,0
73479,to,0,0
73480,determine,0,0
73481,the,0,0
73482,mRNA,0,0
73483,levels,0,1
73484,of,0,0
73485,genes,0,1
73486,involved,0,0
73487,in,0,0
73488,ATP,0,0
73489,production,0,1
73490,and,0,1
73491,mitochondrial,0,1
73492,biogenesis,0,0
73493,in,0,0
73494,muscle,0,0
73495,tissue,0,1
73496,.,0,0
73497,Samples,1,0
73498,of,1,0
73499,vastus,1,0
73500,lateralis,1,0
73501,muscle,1,1
73502,were,0,0
73503,obtained,0,0
73504,from,0,0
73505,21,0,0
73506,healthy,0,0
73507,subjects,0,0
73508,with,0,0
73509,different,0,0
73510,fitness,0,1
73511,levels,0,1
73512,.,0,0
73513,The,0,0
73514,principal,0,0
73515,findings,0,0
73516,in,0,0
73517,our,0,0
73518,study,0,0
73519,show,0,0
73520,a,0,0
73521,strong,0,0
73522,correlation,0,0
73523,between,0,0
73524,PGC-1alpha,1,1
73525,and,1,1
73526,COX5B,1,1
73527,(,0,0
73528,p,0,0
73529,<,0,0
73530,0.001,0,0
73531,),0,0
73532,and,0,0
73533,between,0,0
73534,PGC-1alpha,1,1
73535,and,1,1
73536,MT-CO2,1,0
73537,(,0,1
73538,p=0.017,0,0
73539,),0,0
73540,expression,0,1
73541,.,0,0
73542,Furthermore,0,0
73543,",",0,0
73544,a,0,0
73545,significant,0,0
73546,positive,0,0
73547,correlation,0,0
73548,between,0,0
73549,mtDNA,0,1
73550,content,0,1
73551,and,0,0
73552,the,0,0
73553,percentage,0,1
73554,of,0,0
73555,MHCI,0,0
73556,present,0,0
73557,in,0,0
73558,the,0,0
73559,aspired,0,0
73560,samples,0,0
73561,were,0,0
73562,found,0,0
73563,(,0,0
73564,p=0.028,0,0
73565,),0,0
73566,.,0,0
73567,These,0,0
73568,data,0,0
73569,are,0,0
73570,in,0,0
73571,agreement,0,0
73572,with,0,0
73573,current,0,0
73574,knowledge,0,0
73575,on,0,0
73576,skeletal,0,0
73577,muscle,0,1
73578,physiology,0,1
73579,and,0,0
73580,show,0,0
73581,the,0,0
73582,reliability,0,0
73583,of,0,0
73584,the,0,0
73585,proposed,0,0
73586,method,0,0
73587,.,0,0
73588,CONCLUSION,0,0
73589,This,0,0
73590,painless,0,0
73591,methodology,0,0
73592,can,0,0
73593,be,0,0
73594,used,0,0
73595,to,0,0
73596,investigate,0,0
73597,",",0,0
73598,in,0,0
73599,vivo,0,0
73600,",",0,0
73601,human,0,0
73602,muscle,0,1
73603,RNA,0,0
73604,and,0,1
73605,DNA,0,1
73606,adaptations,0,1
73607,in,0,0
73608,response,0,1
73609,to,0,0
73610,either,0,0
73611,physiological,0,0
73612,and/or,0,0
73613,pharmacological,0,0
73614,stimuli,0,0
73615,.,0,0
73616,This,0,0
73617,method,0,0
73618,has,0,0
73619,major,0,0
73620,clinical,0,0
73621,relevance,0,0
73622,",",0,0
73623,such,0,0
73624,as,0,0
73625,its,0,0
73626,application,0,0
73627,in,0,0
73628,clarifying,0,0
73629,the,0,0
73630,mechanisms,0,0
73631,underling,0,0
73632,metabolic,0,1
73633,and,0,0
73634,systemic,0,0
73635,disorders,0,0
73636,.,0,0
73637,[,0,0
73638,Laparoscopic,0,0
73639,lymphadenectomy,0,0
73640,as,0,0
73641,treatment,0,0
73642,of,0,0
73643,endometrial,0,1
73644,cancer,0,0
73645,],0,0
73646,.,0,0
73647,AIM,0,0
73648,This,0,0
73649,study,0,0
73650,compares,0,0
73651,the,0,0
73652,effects,1,0
73653,of,0,0
73654,laparoscopic,0,0
73655,lymphadenectomy,0,0
73656,versus,0,0
73657,those,0,0
73658,of,0,0
73659,abdominal,0,1
73660,lymphadenectomy,0,0
73661,in,0,0
73662,patients,0,0
73663,with,0,0
73664,endometrial,0,0
73665,cancer,0,0
73666,.,0,0
73667,METHODS,0,0
73668,A,0,0
73669,prospective,0,0
73670,randomized,0,0
73671,study,0,0
73672,was,0,0
73673,performed,0,0
73674,among,0,0
73675,80,0,0
73676,patients,0,0
73677,randomly,0,0
73678,assigned,0,0
73679,to,0,0
73680,laparoscopic,0,0
73681,lymphadenectomy,0,0
73682,and,0,0
73683,to,0,0
73684,abdominal,0,1
73685,lymphadenectomy,0,0
73686,in,0,0
73687,the,0,0
73688,treatment,0,0
73689,of,0,0
73690,endometrial,0,0
73691,cancer,0,0
73692,.,0,0
73693,Clinical,0,1
73694,outcomes,1,1
73695,and,0,0
73696,complications,1,1
73697,were,0,0
73698,compared,0,0
73699,for,0,0
73700,1,0,0
73701,year,0,0
73702,of,0,0
73703,follow-up,0,0
73704,.,0,0
73705,RESULTS,0,0
73706,Forty,0,0
73707,patients,0,0
73708,were,0,0
73709,assigned,0,0
73710,to,0,0
73711,laparoscopic,0,0
73712,lymphadenectomy,0,0
73713,and,0,0
73714,40,0,0
73715,patients,0,0
73716,to,0,0
73717,abdominal,0,0
73718,lymphadenectomy,0,0
73719,.,0,0
73720,The,0,0
73721,laparoscopic,0,0
73722,approach,0,0
73723,was,0,0
73724,associated,0,0
73725,with,0,0
73726,a,0,0
73727,longer,1,0
73728,operative,1,1
73729,time,1,1
73730,(,0,0
73731,234.1,0,0
73732,min,0,0
73733,vs,0,0
73734,137.3,0,0
73735,min,0,0
73736,),0,0
73737,but,0,0
73738,was,0,0
73739,less,1,0
73740,painful,1,1
73741,(,0,0
73742,VAS,0,0
73743,5.3,0,0
73744,vs,0,0
73745,7.9,0,0
73746,;,0,0
73747,P,0,0
73748,<,0,0
73749,0.000,0,0
73750,),0,0
73751,and,0,0
73752,resulted,0,0
73753,in,0,0
73754,a,0,0
73755,shorter,1,0
73756,hospital,1,1
73757,stay,1,1
73758,(,0,0
73759,4.4+/-1,0,0
73760,vs,0,0
73761,7.9+/-1.2,0,0
73762,days,0,0
73763,;,0,0
73764,P,0,0
73765,<,0,0
73766,0.000,0,0
73767,),0,0
73768,.,0,0
73769,At,0,0
73770,6,0,0
73771,weeks,0,0
73772,the,0,0
73773,quality,1,1
73774,of,1,0
73775,life,1,1
73776,was,0,0
73777,better,0,0
73778,in,0,0
73779,patients,0,0
73780,who,0,0
73781,had,0,0
73782,laparoscopic,0,0
73783,lymphadenectomy,0,0
73784,(,0,0
73785,SF-12,0,0
73786,),0,0
73787,.,0,0
73788,CONCLUSION,0,0
73789,Laparoscopic,0,0
73790,lymphadenectomy,0,0
73791,was,0,0
73792,associated,0,0
73793,with,0,0
73794,a,0,0
73795,significantly,0,0
73796,lower,0,0
73797,rate,1,1
73798,of,1,1
73799,major,1,0
73800,and,1,0
73801,minor,1,0
73802,postoperative,1,1
73803,complications,1,1
73804,and,0,0
73805,a,0,0
73806,better,0,0
73807,short,0,1
73808,term,0,1
73809,quality,1,1
73810,of,1,0
73811,life,1,1
73812,.,1,0
73813,Bright,0,0
73814,light,0,1
73815,therapy,0,0
73816,in,0,0
73817,Parkinson,0,0
73818,'s,0,0
73819,disease,0,0
73820,:,0,0
73821,a,0,0
73822,pilot,0,0
73823,study,0,0
73824,.,0,0
73825,Several,0,0
73826,observations,0,0
73827,suggest,0,0
73828,a,0,0
73829,beneficial,0,0
73830,effect,0,0
73831,of,0,0
73832,melatonin,0,0
73833,antagonism,0,1
73834,for,0,0
73835,Parkinson,0,0
73836,'s,0,1
73837,disease,0,1
73838,(,0,0
73839,PD,0,0
73840,),0,0
73841,.,0,0
73842,Although,0,0
73843,bright,0,0
73844,light,0,1
73845,therapy,0,0
73846,(,0,0
73847,BLT,0,0
73848,),0,0
73849,suppresses,0,1
73850,melatonin,0,0
73851,release,0,0
73852,and,0,0
73853,is,0,0
73854,an,0,0
73855,established,0,0
73856,treatment,0,0
73857,for,0,0
73858,depression,0,1
73859,and,0,0
73860,sleep,0,1
73861,disturbances,0,1
73862,",",0,0
73863,it,0,0
73864,has,0,0
73865,not,0,0
73866,been,0,0
73867,evaluated,0,0
73868,in,0,0
73869,PD,0,0
73870,.,0,0
73871,We,0,0
73872,examined,0,0
73873,effects,0,0
73874,of,0,0
73875,BLT,0,0
73876,on,0,0
73877,motor,1,1
73878,symptoms,1,1
73879,",",1,1
73880,depression,1,1
73881,",",0,1
73882,and,0,1
73883,sleep,1,1
73884,in,0,0
73885,PD,0,0
73886,in,0,0
73887,a,0,0
73888,randomized,0,0
73889,placebo-controlled,0,0
73890,double-blind,0,0
73891,study,0,0
73892,in,0,0
73893,36,0,0
73894,PD,0,0
73895,patients,0,0
73896,",",0,0
73897,using,0,0
73898,Parkinson,1,0
73899,'s,1,0
73900,Disease,1,1
73901,Rating,1,1
73902,Scale,1,1
73903,(,1,0
73904,UPDRS,1,0
73905,),1,0
73906,I-IV,1,1
73907,",",1,0
73908,Beck,1,1
73909,'s,1,1
73910,Depression,1,1
73911,Inventory,1,1
73912,",",0,0
73913,and,0,1
73914,Epworth,1,1
73915,Sleepiness,1,1
73916,Scale,1,1
73917,.,1,0
73918,All,0,0
73919,patients,0,0
73920,received,0,0
73921,BLT,0,0
73922,for,0,0
73923,15,0,0
73924,days,0,0
73925,in,0,0
73926,the,0,0
73927,morning,0,0
73928,",",0,0
73929,30,0,0
73930,min,0,0
73931,daily,0,0
73932,.,0,0
73933,Illuminance,1,0
73934,was,0,0
73935,7.500,0,0
73936,lux,0,0
73937,in,0,0
73938,the,0,0
73939,active,0,0
73940,treatment,0,0
73941,group,0,0
73942,and,0,0
73943,950,0,0
73944,lux,0,0
73945,in,0,0
73946,the,0,0
73947,placebo,0,0
73948,group,0,0
73949,.,0,0
73950,Although,0,0
73951,group,0,0
73952,differences,0,0
73953,were,0,0
73954,small,0,0
73955,",",0,0
73956,BLT,0,0
73957,led,0,0
73958,to,0,0
73959,significant,0,0
73960,improvement,1,1
73961,of,1,0
73962,tremor,1,1
73963,",",1,0
73964,UPDRS,1,0
73965,I,1,0
73966,",",1,0
73967,II,1,0
73968,",",1,1
73969,and,1,1
73970,IV,1,1
73971,",",1,1
73972,and,1,1
73973,depression,1,1
73974,in,0,0
73975,the,0,0
73976,active,0,0
73977,treatment,0,0
73978,group,0,0
73979,but,0,0
73980,not,0,0
73981,in,0,0
73982,the,0,0
73983,placebo,0,0
73984,group,0,0
73985,.,0,0
73986,It,0,0
73987,was,0,0
73988,very,0,0
73989,well,0,0
73990,tolerated,1,1
73991,.,1,0
73992,Follow,0,0
73993,up,0,0
73994,studies,0,0
73995,in,0,0
73996,more,0,0
73997,advanced,0,0
73998,patient,0,0
73999,populations,0,0
74000,employing,0,0
74001,longer,0,0
74002,treatment,0,0
74003,durations,0,0
74004,are,0,0
74005,warranted,0,0
74006,.,0,0
74007,Comparison,0,0
74008,of,0,0
74009,the,0,0
74010,impact,0,0
74011,of,0,0
74012,vaginal,0,0
74013,and,0,0
74014,oral,0,0
74015,administration,0,0
74016,of,0,0
74017,combined,0,0
74018,hormonal,0,0
74019,contraceptives,0,0
74020,on,0,0
74021,hepatic,0,0
74022,proteins,0,0
74023,sensitive,0,0
74024,to,0,0
74025,estrogen,0,0
74026,.,0,0
74027,OBJECTIVE,0,0
74028,We,0,0
74029,evaluated,0,0
74030,the,0,0
74031,effects,0,0
74032,of,0,0
74033,a,0,0
74034,new,0,0
74035,combined,0,0
74036,hormonal,0,0
74037,contraceptive,0,0
74038,vaginal,0,0
74039,ring,0,0
74040,(,0,0
74041,CVR,0,0
74042,),0,0
74043,delivering,0,0
74044,the,0,0
74045,nonandrogenic,0,0
74046,progestin,0,0
74047,Nestorone,0,0
74048,(,0,0
74049,NES,0,0
74050,),0,0
74051,and,0,0
74052,ethinyl,0,0
74053,estradiol,0,1
74054,(,0,0
74055,EE,0,0
74056,),0,0
74057,on,0,0
74058,several,0,0
74059,key,0,0
74060,estrogen-sensitive,0,0
74061,hepatic,0,0
74062,proteins,0,0
74063,that,0,0
74064,may,0,0
74065,be,0,0
74066,markers,0,0
74067,for,0,0
74068,the,0,0
74069,risk,0,0
74070,of,0,0
74071,arterial,0,1
74072,or,0,0
74073,venous,0,1
74074,disease,0,1
74075,events,0,1
74076,and,0,0
74077,on,0,0
74078,blood,0,1
74079,pressure,0,1
74080,(,0,0
74081,BP,0,1
74082,),0,0
74083,.,0,0
74084,Because,0,0
74085,the,0,0
74086,pharmacologic,0,0
74087,androgenicity,0,1
74088,of,0,0
74089,the,0,0
74090,progestin,0,0
74091,in,0,0
74092,these,0,0
74093,formulations,0,0
74094,influences,0,0
74095,the,0,0
74096,hepatic,0,0
74097,impact,0,0
74098,of,0,0
74099,EE,0,0
74100,",",0,0
74101,we,0,0
74102,selected,0,0
74103,an,0,0
74104,oral,0,0
74105,contraceptive,0,0
74106,(,0,0
74107,OC,0,0
74108,),0,0
74109,delivering,0,0
74110,the,0,0
74111,androgenic,0,1
74112,progestin,0,0
74113,levonorgestrel,0,0
74114,(,0,0
74115,LNG,0,1
74116,),0,0
74117,and,0,0
74118,EE,0,0
74119,as,0,0
74120,the,0,0
74121,comparator,0,0
74122,.,0,0
74123,We,0,0
74124,also,0,0
74125,investigated,0,0
74126,the,0,0
74127,effect,0,0
74128,of,0,0
74129,delivery,0,1
74130,route,0,0
74131,",",0,0
74132,which,0,0
74133,is,0,0
74134,known,0,0
74135,to,0,0
74136,modify,0,0
74137,the,0,0
74138,hepatic,0,0
74139,effects,0,0
74140,of,0,0
74141,estradiol,0,1
74142,",",0,0
74143,but,0,0
74144,has,0,0
74145,not,0,0
74146,been,0,0
74147,widely,0,0
74148,studied,0,0
74149,with,0,0
74150,EE,0,0
74151,.,0,0
74152,STUDY,0,1
74153,METHODS,0,0
74154,Women,0,0
74155,",",0,0
74156,aged,0,0
74157,18-34,0,0
74158,years,0,0
74159,",",0,0
74160,with,0,0
74161,no,0,0
74162,contraindications,0,0
74163,to,0,0
74164,the,0,0
74165,use,0,0
74166,of,0,0
74167,combined,0,0
74168,OCs,0,0
74169,",",0,0
74170,were,0,0
74171,randomized,0,0
74172,to,0,0
74173,three,0,0
74174,cycles,0,0
74175,of,0,0
74176,treatment,0,0
74177,with,0,0
74178,a,0,0
74179,CVR,0,0
74180,delivering,0,0
74181,NES/EE,0,1
74182,(,0,0
74183,150/15,0,0
74184,microg/day,0,0
74185,),0,0
74186,or,0,0
74187,a,0,0
74188,combined,0,0
74189,OC,0,0
74190,providing,0,0
74191,LNG,0,0
74192,and,0,1
74193,EE,0,0
74194,(,0,0
74195,150/30,0,0
74196,microg,0,0
74197,per,0,0
74198,tablet,0,0
74199,),0,0
74200,.,0,0
74201,Each,0,0
74202,cycle,0,1
74203,consisted,0,0
74204,of,0,0
74205,21,0,0
74206,days,0,0
74207,of,0,0
74208,active,0,0
74209,treatment,0,0
74210,",",0,0
74211,followed,0,0
74212,by,0,0
74213,7,0,0
74214,days,0,0
74215,without,0,0
74216,treatment,0,0
74217,.,0,0
74218,During,0,0
74219,the,0,0
74220,last,0,0
74221,weeks,0,0
74222,of,0,0
74223,the,0,0
74224,pretreatment,0,0
74225,and,0,0
74226,third,0,1
74227,treatment,0,0
74228,cycles,0,0
74229,",",0,0
74230,blood,1,1
74231,samples,1,0
74232,were,0,0
74233,obtained,0,0
74234,for,0,0
74235,determinations,0,0
74236,of,0,0
74237,plasma,1,1
74238,concentrations,1,1
74239,of,1,0
74240,angiotensinogen,1,0
74241,",",1,0
74242,an,1,0
74243,estrogen-sensitive,1,1
74244,hepatic,1,0
74245,protein,1,1
74246,",",1,0
74247,and,1,1
74248,serum,1,1
74249,concentrations,1,1
74250,of,1,0
74251,sex,1,0
74252,hormone-binding,1,1
74253,globulin,1,1
74254,(,1,0
74255,SHBG,1,0
74256,),1,0
74257,",",1,0
74258,total,1,1
74259,cholesterol,1,1
74260,(,1,0
74261,TC,1,1
74262,),1,0
74263,",",1,0
74264,high-density,1,1
74265,lipoprotein,1,1
74266,cholesterol,1,1
74267,(,1,0
74268,HDL-C,1,1
74269,),1,0
74270,",",1,0
74271,low-density,1,1
74272,lipoprotein,1,1
74273,cholesterol,1,1
74274,(,1,0
74275,LDL-C,1,1
74276,),1,0
74277,",",1,0
74278,triglycerides,1,1
74279,(,1,0
74280,TG,1,1
74281,),1,0
74282,and,1,0
74283,estrogen-,1,1
74284,and,1,1
74285,androgen-sensitive,1,0
74286,proteins,1,0
74287,.,1,0
74288,BP,1,1
74289,was,0,0
74290,also,0,0
74291,measured,0,0
74292,.,0,0
74293,RESULTS,0,0
74294,Of,0,0
74295,47,0,0
74296,women,0,0
74297,randomized,0,0
74298,",",0,0
74299,45,0,0
74300,completed,0,0
74301,the,0,0
74302,study,0,0
74303,(,0,0
74304,CVR,0,0
74305,:,0,0
74306,23,0,0
74307,;,0,0
74308,OC,0,0
74309,:,0,0
74310,22,0,0
74311,),0,0
74312,.,0,0
74313,Within-group,0,0
74314,comparisons,0,0
74315,over,0,0
74316,time,0,1
74317,by,0,0
74318,repeated-measure,0,0
74319,analysis,0,0
74320,of,0,0
74321,variance,0,0
74322,demonstrated,0,0
74323,statistically,0,0
74324,significant,0,0
74325,changes,0,1
74326,over,0,0
74327,time,0,1
74328,with,0,0
74329,both,0,0
74330,treatments,0,0
74331,for,0,0
74332,all,0,0
74333,hepatic,0,0
74334,proteins,0,0
74335,(,0,0
74336,p,0,0
74337,<,0,0
74338,.02,0,0
74339,),0,0
74340,but,0,0
74341,not,0,0
74342,for,0,0
74343,TC,0,0
74344,.,0,0
74345,The,0,0
74346,within-group,0,0
74347,effects,0,1
74348,",",0,0
74349,presented,0,0
74350,as,0,0
74351,relative,0,0
74352,percent,0,1
74353,difference,0,0
74354,[,0,0
74355,95,0,0
74356,%,0,0
74357,confidence,0,0
74358,interval,0,0
74359,(,0,0
74360,CI,0,0
74361,),0,1
74362,],0,0
74363,",",0,0
74364,were,0,0
74365,greatest,0,0
74366,for,0,0
74367,angiotensinogen,1,0
74368,[,0,0
74369,CVR,0,0
74370,:,0,0
74371,227,0,0
74372,%,0,0
74373,(,0,0
74374,195-262,0,0
74375,%,0,0
74376,),0,0
74377,;,0,0
74378,OC,0,0
74379,:,0,0
74380,251.3,0,0
74381,%,0,0
74382,(,0,0
74383,218-288,0,0
74384,%,0,0
74385,),0,0
74386,],0,0
74387,and,0,0
74388,SHBG,0,0
74389,[,0,0
74390,CVR,0,0
74391,:,0,0
74392,306,0,0
74393,%,0,0
74394,(,0,0
74395,237-389,0,0
74396,%,0,0
74397,),0,0
74398,;,0,0
74399,OC,0,0
74400,:,0,0
74401,55,0,0
74402,%,0,0
74403,(,0,0
74404,30-86,0,0
74405,),0,0
74406,],0,0
74407,.,0,0
74408,Both,0,0
74409,treatments,0,0
74410,were,0,0
74411,associated,0,0
74412,with,0,0
74413,small,0,0
74414,changes,0,1
74415,in,0,0
74416,systolic,1,1
74417,BP,1,1
74418,and,1,0
74419,diastolic,1,1
74420,BP,1,1
74421,(,0,0
74422,DBP,0,1
74423,),0,1
74424,",",0,0
74425,but,0,0
74426,only,0,0
74427,the,0,0
74428,within-group,0,0
74429,change,0,0
74430,in,0,0
74431,DBP,1,0
74432,for,0,0
74433,the,0,0
74434,OC,0,0
74435,group,0,0
74436,was,0,0
74437,statistically,0,0
74438,significant,0,0
74439,(,0,0
74440,p,0,0
74441,=,0,0
74442,.04,0,0
74443,),0,0
74444,.,0,0
74445,Between-treatment,0,0
74446,comparisons,0,0
74447,of,0,0
74448,third,0,0
74449,treatment,0,0
74450,cycle,0,1
74451,mean,0,1
74452,values,0,1
74453,were,0,0
74454,performed,0,0
74455,by,0,0
74456,analysis,0,0
74457,of,0,0
74458,covariance,0,1
74459,(,0,0
74460,baseline,0,0
74461,values,0,1
74462,as,0,0
74463,covariate,0,0
74464,),0,0
74465,.,0,0
74466,No,0,0
74467,statistically,0,0
74468,significant,0,0
74469,between-treatment,0,0
74470,differences,0,0
74471,were,0,0
74472,found,0,0
74473,for,0,0
74474,angiotensinogen,1,0
74475,",",1,0
74476,sensitive,1,0
74477,only,1,0
74478,to,1,0
74479,estrogen,1,0
74480,",",1,0
74481,or,1,0
74482,BP,1,1
74483,.,1,0
74484,Statistically,0,0
74485,significant,0,0
74486,treatment,0,0
74487,differences,0,0
74488,were,0,0
74489,found,0,0
74490,for,0,0
74491,all,0,0
74492,estrogen-,1,1
74493,and,1,0
74494,androgen-sensitive,1,1
74495,proteins,1,1
74496,(,0,0
74497,p,0,0
74498,<,0,0
74499,or,0,0
74500,=,0,0
74501,.002,0,0
74502,),0,0
74503,but,0,0
74504,not,0,0
74505,for,0,0
74506,TC,1,0
74507,.,1,0
74508,When,0,0
74509,presented,0,0
74510,as,0,0
74511,relative,0,0
74512,percent,0,0
74513,difference,0,0
74514,between,0,0
74515,the,0,0
74516,effects,0,0
74517,of,0,0
74518,treatment,0,0
74519,(,0,0
74520,CVR-OC/OC,0,0
74521,;,0,0
74522,95,0,0
74523,%,0,0
74524,CI,0,0
74525,of,0,0
74526,percent,0,1
74527,difference,0,0
74528,),0,0
74529,",",0,0
74530,the,0,0
74531,difference,0,0
74532,was,0,0
74533,largest,0,0
74534,for,0,0
74535,SHBG,1,0
74536,(,0,0
74537,159,0,0
74538,%,0,0
74539,[,0,0
74540,117-210,0,0
74541,%,0,0
74542,],0,0
74543,),0,0
74544,;,0,0
74545,smaller,0,0
74546,relative,0,1
74547,percent,0,1
74548,differences,0,0
74549,were,0,0
74550,found,0,0
74551,for,0,0
74552,HDL-C,1,0
74553,[,0,0
74554,31.9,0,0
74555,%,0,0
74556,(,0,0
74557,18.5-46.8,0,0
74558,%,0,0
74559,),0,0
74560,],0,0
74561,",",0,0
74562,LDL-C,1,1
74563,[,0,0
74564,23.6,0,0
74565,%,0,0
74566,(,0,0
74567,33.4,0,0
74568,%,0,0
74569,to,0,0
74570,-2.4,0,0
74571,%,0,0
74572,),0,0
74573,],0,0
74574,and,0,0
74575,TG,1,0
74576,[,0,0
74577,39.0,0,0
74578,%,0,0
74579,(,0,0
74580,14.0-69.4,0,0
74581,%,0,0
74582,),0,0
74583,],0,0
74584,",",0,0
74585,but,0,0
74586,not,0,0
74587,TC,0,0
74588,.,0,0
74589,CONCLUSION,0,0
74590,Vaginal,0,0
74591,delivery,0,0
74592,of,0,0
74593,a,0,0
74594,combined,0,0
74595,hormonal,0,0
74596,contraceptive,0,0
74597,did,0,0
74598,not,0,0
74599,reduce,0,0
74600,the,0,0
74601,EE-associated,1,0
74602,changes,1,0
74603,in,1,0
74604,estrogen-sensitive,1,0
74605,hepatic,1,0
74606,proteins,1,0
74607,observed,0,0
74608,after,0,0
74609,use,0,0
74610,of,0,0
74611,a,0,0
74612,combined,0,0
74613,OC,0,0
74614,.,0,0
74615,Significant,0,0
74616,treatment,0,0
74617,differences,0,0
74618,between,0,0
74619,the,0,0
74620,NES/EE,0,0
74621,CVR,0,0
74622,and,0,0
74623,the,0,0
74624,LNG/EE,0,0
74625,OC,0,0
74626,were,0,0
74627,found,0,0
74628,for,0,0
74629,SHBG,0,0
74630,",",0,0
74631,HDL-C,0,1
74632,",",0,1
74633,LDL-C,0,1
74634,",",0,1
74635,and,0,1
74636,TG,0,1
74637,",",0,0
74638,proteins,0,0
74639,sensitive,0,0
74640,to,0,0
74641,androgen,0,1
74642,as,0,0
74643,well,0,0
74644,as,0,0
74645,estrogen,0,0
74646,.,0,0
74647,No,0,0
74648,treatment,0,0
74649,difference,0,0
74650,was,0,0
74651,observed,0,0
74652,for,0,0
74653,angiotensinogen,0,0
74654,",",0,0
74655,which,0,0
74656,is,0,0
74657,sensitive,0,0
74658,only,0,0
74659,to,0,0
74660,estrogen,0,0
74661,.,0,0
74662,The,0,0
74663,observed,0,0
74664,treatment,0,0
74665,differences,0,0
74666,were,0,0
74667,therefore,0,0
74668,most,0,0
74669,likely,0,0
74670,due,0,0
74671,to,0,0
74672,the,0,0
74673,difference,0,0
74674,in,0,0
74675,androgenicity,0,1
74676,between,0,0
74677,NES,0,0
74678,and,0,0
74679,LNG,0,0
74680,.,0,0
74681,Using,0,0
74682,the,0,0
74683,demand-control,0,0
74684,model,0,0
74685,of,0,0
74686,job,0,0
74687,strain,0,0
74688,to,0,0
74689,predict,0,0
74690,caregiver,1,1
74691,burden,1,1
74692,and,0,1
74693,caregiver,1,1
74694,satisfaction,1,1
74695,in,0,0
74696,the,0,0
74697,informal,0,0
74698,caregivers,0,0
74699,of,0,0
74700,heart,0,1
74701,failure,0,1
74702,patients,0,0
74703,.,0,0
74704,OBJECTIVES,0,0
74705,The,0,0
74706,demand-control,0,0
74707,(,0,0
74708,D-C,0,0
74709,),0,0
74710,model,0,0
74711,of,0,0
74712,job,0,0
74713,strain,0,0
74714,has,0,0
74715,generated,0,0
74716,a,0,0
74717,considerable,0,0
74718,body,0,1
74719,of,0,0
74720,empirical,0,0
74721,support,0,0
74722,in,0,0
74723,predicting,0,1
74724,psychological,0,1
74725,health,0,1
74726,outcomes,0,0
74727,in,0,0
74728,the,0,0
74729,context,0,0
74730,of,0,0
74731,work,0,0
74732,.,0,0
74733,This,0,0
74734,study,0,0
74735,aimed,0,0
74736,to,0,0
74737,extend,0,0
74738,previous,0,0
74739,work,0,0
74740,using,0,0
74741,the,0,0
74742,D-C,0,0
74743,model,0,0
74744,of,0,0
74745,job,0,0
74746,strain,0,0
74747,to,0,0
74748,predict,0,0
74749,caregiver,1,1
74750,burden,1,1
74751,and,0,1
74752,satisfaction,1,1
74753,in,0,0
74754,the,0,0
74755,informal,0,0
74756,caregivers,0,0
74757,of,0,0
74758,patients,0,0
74759,with,0,0
74760,heart,0,0
74761,failure,0,1
74762,.,0,0
74763,DESIGN,0,0
74764,AND,0,0
74765,METHOD,0,0
74766,Data,0,1
74767,were,0,0
74768,gathered,0,0
74769,from,0,0
74770,60,0,0
74771,caregiver/patient,0,0
74772,dyads,0,0
74773,in,0,0
74774,a,0,0
74775,cross-sectional,0,0
74776,design,0,0
74777,.,0,0
74778,Patients,0,0
74779,with,0,0
74780,chronic,0,0
74781,stable,0,1
74782,heart,0,1
74783,failure,0,1
74784,were,0,0
74785,recruited,0,0
74786,from,0,0
74787,out-patient,0,0
74788,clinics,0,0
74789,.,0,0
74790,The,0,0
74791,dependent,0,0
74792,variables,0,0
74793,were,0,0
74794,caregiver,1,1
74795,burden,1,1
74796,and,1,0
74797,satisfaction,1,1
74798,.,1,1
74799,Demand,1,0
74800,and,1,0
74801,control,1,0
74802,were,0,0
74803,measured,0,0
74804,using,0,0
74805,both,0,0
74806,patient-,1,1
74807,and,1,0
74808,caregiver-derived,1,0
74809,measures,1,0
74810,.,1,0
74811,RESULTS,0,0
74812,The,0,0
74813,D-C,0,0
74814,model,0,0
74815,accounted,0,0
74816,for,0,0
74817,15,0,0
74818,and,0,0
74819,19,0,0
74820,%,0,0
74821,of,0,0
74822,the,0,0
74823,variance,0,0
74824,in,0,0
74825,caregiver,1,1
74826,burden,1,1
74827,",",0,0
74828,after,0,0
74829,controlling,0,0
74830,for,0,0
74831,age,0,0
74832,",",0,0
74833,gender,0,1
74834,and,0,1
74835,relationship,0,0
74836,to,0,0
74837,the,0,0
74838,patient,0,0
74839,.,0,0
74840,Lower,0,0
74841,control,1,0
74842,was,0,0
74843,associated,0,0
74844,with,0,0
74845,higher,1,0
74846,burden,1,1
74847,.,1,0
74848,The,0,0
74849,D-C,0,0
74850,model,0,0
74851,did,0,0
74852,not,0,0
74853,predict,0,0
74854,caregiver,1,1
74855,satisfaction,1,1
74856,.,1,0
74857,CONCLUSION,0,0
74858,The,0,0
74859,D-C,0,0
74860,model,0,0
74861,was,0,0
74862,associated,0,0
74863,with,0,0
74864,caregiver,1,1
74865,burden,1,1
74866,",",0,0
74867,but,0,0
74868,not,0,0
74869,satisfaction,1,1
74870,in,0,0
74871,caregivers,0,1
74872,",",0,0
74873,with,0,0
74874,control,0,0
74875,being,0,0
74876,the,0,0
74877,dominant,0,0
74878,predictor,0,0
74879,.,0,0
74880,Research,0,0
74881,linking,0,0
74882,the,0,0
74883,theory,0,0
74884,and,0,0
74885,findings,0,0
74886,from,0,0
74887,job,0,1
74888,strain,0,1
74889,and,0,1
74890,informal,0,0
74891,caregiving,0,1
74892,studies,0,0
74893,may,0,0
74894,elucidate,0,0
74895,both,0,0
74896,fields,0,0
74897,of,0,0
74898,research,0,0
74899,.,0,0
74900,Using,0,0
74901,the,0,0
74902,demand-control,0,0
74903,model,0,0
74904,of,0,0
74905,job,0,0
74906,strain,0,0
74907,to,0,0
74908,predict,0,0
74909,caregiver,1,1
74910,burden,1,1
74911,and,0,1
74912,caregiver,1,1
74913,satisfaction,1,1
74914,in,0,0
74915,the,0,0
74916,informal,0,0
74917,caregivers,0,0
74918,of,0,0
74919,heart,0,1
74920,failure,0,1
74921,patients,0,0
74922,.,0,0
74923,Lowering,0,0
74924,of,0,0
74925,glucose,0,1
74926,in,0,0
74927,critical,0,0
74928,care,0,0
74929,:,0,0
74930,a,0,0
74931,randomized,0,0
74932,pilot,0,0
74933,trial,0,0
74934,.,0,0
74935,BACKGROUND,0,0
74936,Similar,0,0
74937,to,0,0
74938,cardiac,0,1
74939,surgery,0,0
74940,patients,0,0
74941,",",0,0
74942,medical-surgical,0,0
74943,critically,0,0
74944,ill,0,0
74945,patients,0,0
74946,may,0,0
74947,benefit,0,0
74948,from,0,0
74949,intensive,0,0
74950,insulin,0,1
74951,therapy,0,0
74952,.,0,0
74953,The,0,0
74954,objectives,0,0
74955,of,0,0
74956,this,0,0
74957,pilot,0,0
74958,trial,0,0
74959,were,0,0
74960,to,0,0
74961,evaluate,0,0
74962,the,0,0
74963,feasibility,0,0
74964,of,0,0
74965,a,0,0
74966,randomized,0,0
74967,trial,0,0
74968,of,0,0
74969,intensive,0,0
74970,insulin,0,1
74971,therapy,0,0
74972,with,0,0
74973,respect,0,0
74974,to,0,0
74975,(,0,0
74976,a,0,0
74977,),0,0
74978,achieving,0,0
74979,target,0,0
74980,glucose,0,1
74981,values,0,1
74982,in,0,0
74983,the,0,0
74984,2,0,0
74985,ranges,0,0
74986,of,0,0
74987,5,0,0
74988,to,0,0
74989,7,0,0
74990,and,0,0
74991,8,0,0
74992,to,0,0
74993,10,0,0
74994,mmol/L,0,0
74995,and,0,0
74996,(,0,0
74997,b,0,0
74998,),0,0
74999,uncovering,0,0
75000,problems,0,0
75001,with,0,0
75002,the,0,0
75003,protocol,0,0
75004,in,0,0
75005,anticipation,0,1
75006,of,0,0
75007,a,0,0
75008,larger,0,0
75009,trial,0,0
75010,.,0,0
75011,SETTING,0,0
75012,The,0,0
75013,trial,0,0
75014,was,0,0
75015,conducted,0,0
75016,in,0,0
75017,a,0,0
75018,15-bed,0,0
75019,medical-surgical,0,0
75020,university-affiliated,0,0
75021,intensive,0,0
75022,care,0,0
75023,unit,0,0
75024,(,0,0
75025,ICU,0,0
75026,),0,0
75027,.,0,0
75028,METHODS,0,0
75029,We,0,0
75030,included,0,0
75031,patients,0,0
75032,older,0,0
75033,than,0,0
75034,18,0,0
75035,years,0,0
75036,",",0,0
75037,expected,0,0
75038,to,0,0
75039,be,0,0
75040,in,0,0
75041,ICU,0,0
75042,for,0,0
75043,more,0,0
75044,than,0,0
75045,72,0,0
75046,hours,0,0
75047,",",0,0
75048,with,0,0
75049,a,0,0
75050,glucose,0,1
75051,value,0,0
75052,of,0,0
75053,more,0,0
75054,than,0,0
75055,10,0,0
75056,mmol/L,0,0
75057,within,0,0
75058,48,0,0
75059,hours,0,0
75060,of,0,0
75061,ICU,0,0
75062,admission,0,1
75063,.,0,0
75064,Exclusion,0,0
75065,criteria,0,0
75066,were,0,0
75067,diabetic,0,0
75068,ketoacidosis,0,1
75069,",",0,0
75070,severe,0,1
75071,hepatic,0,1
75072,failure,0,1
75073,or,0,0
75074,hepatic,0,1
75075,resection,0,0
75076,",",0,0
75077,pancreatitis,0,1
75078,",",0,1
75079,glucose,0,1
75080,of,0,0
75081,less,0,0
75082,than,0,0
75083,2.2,0,0
75084,mmol/L,0,0
75085,on,0,0
75086,admission,0,1
75087,to,0,0
75088,hospital,0,1
75089,",",0,0
75090,insulin,0,1
75091,infusion,0,0
75092,on,0,0
75093,admission,0,1
75094,to,0,0
75095,ICU,0,1
75096,",",0,0
75097,planned,0,0
75098,withdrawal,0,1
75099,of,0,1
75100,life,0,1
75101,support,0,0
75102,",",0,1
75103,and,0,1
75104,inability,0,0
75105,to,0,0
75106,obtain,0,0
75107,informed,0,0
75108,consent,0,0
75109,.,0,0
75110,Patients,0,0
75111,underwent,0,0
75112,concealed,0,0
75113,random,0,0
75114,allocation,0,0
75115,to,0,0
75116,a,0,0
75117,target,0,0
75118,glucose,0,1
75119,range,0,0
75120,of,0,0
75121,5,0,0
75122,to,0,0
75123,7,0,0
75124,or,0,0
75125,8,0,0
75126,to,0,0
75127,10,0,0
75128,mmol/L,0,0
75129,using,0,0
75130,pretested,0,0
75131,algorithms,0,0
75132,of,0,0
75133,insulin,0,1
75134,infusions,0,0
75135,.,0,0
75136,Dedicated,0,0
75137,glucometer,0,0
75138,measurement,0,0
75139,of,0,0
75140,arterial,0,1
75141,glucose,0,1
75142,values,0,1
75143,was,0,0
75144,calibrated,0,0
75145,daily,0,0
75146,to,0,0
75147,values,0,1
75148,measured,0,0
75149,in,0,0
75150,the,0,0
75151,laboratory,0,0
75152,.,0,0
75153,RESULTS,0,0
75154,We,0,0
75155,enrolled,0,0
75156,20,0,0
75157,patients,0,0
75158,with,0,0
75159,a,0,0
75160,mean,0,1
75161,(,0,0
75162,SD,0,0
75163,),0,0
75164,Acute,1,0
75165,Physiology,1,1
75166,and,1,0
75167,Chronic,1,0
75168,Health,1,1
75169,Evaluation,1,0
75170,(,1,0
75171,APACHE,1,1
75172,),1,0
75173,II,1,0
75174,score,1,1
75175,of,0,0
75176,32,0,0
75177,(,0,0
75178,10.2,0,0
75179,),0,0
75180,;,0,0
75181,14,0,0
75182,were,0,0
75183,insulin-dependent,0,0
75184,pre-ICU,0,0
75185,",",0,0
75186,and,0,0
75187,all,0,0
75188,were,0,0
75189,medical,0,0
75190,admissions,0,1
75191,.,0,0
75192,Mean,1,0
75193,glucose,1,1
75194,values,1,1
75195,were,0,0
75196,different,0,0
75197,in,0,0
75198,the,0,0
75199,2,0,0
75200,groups,0,0
75201,(,0,0
75202,7.1,0,0
75203,+/-,0,0
75204,2.6,0,0
75205,vs,0,0
75206,9.4,0,0
75207,+/-,0,0
75208,2.1,0,0
75209,mmol/L,0,0
75210,",",0,0
75211,P,0,0
75212,<,0,0
75213,.001,0,0
75214,),0,0
75215,.,0,0
75216,Although,0,0
75217,the,0,0
75218,intensive,0,0
75219,insulin,0,1
75220,therapy,0,0
75221,group,0,0
75222,had,0,0
75223,more,0,0
75224,glucose,1,1
75225,measurements,1,0
75226,performed,0,0
75227,than,0,0
75228,the,0,0
75229,control,0,0
75230,group,0,0
75231,",",0,0
75232,a,0,0
75233,similar,0,0
75234,proportion,0,0
75235,of,0,0
75236,values,0,1
75237,were,0,0
75238,within,0,0
75239,the,0,0
75240,target,0,0
75241,range,0,0
75242,(,0,0
75243,682,0,0
75244,[,0,0
75245,42.4,0,0
75246,%,0,0
75247,],0,0
75248,of,0,0
75249,1607,0,0
75250,values,0,0
75251,in,0,0
75252,the,0,0
75253,5-,0,0
75254,to,0,0
75255,7-mmol/L,0,0
75256,range,0,0
75257,;,0,0
75258,250,0,0
75259,[,0,0
75260,38.7,0,0
75261,%,0,0
75262,],0,0
75263,of,0,0
75264,660,0,0
75265,values,0,0
75266,in,0,0
75267,the,0,0
75268,8-,0,0
75269,to,0,0
75270,10-mmol/L,0,0
75271,range,0,0
75272,",",0,0
75273,P,0,0
75274,=,0,0
75275,.35,0,0
75276,),0,0
75277,.,0,0
75278,Glucose,1,1
75279,values,1,1
75280,of,0,0
75281,less,0,0
75282,than,0,0
75283,2.5,0,0
75284,mmol/L,0,0
75285,developed,0,0
75286,7,0,0
75287,times,0,0
75288,in,0,0
75289,5,0,0
75290,patients,0,0
75291,",",0,0
75292,4,0,0
75293,of,0,0
75294,whom,0,0
75295,were,0,0
75296,in,0,0
75297,the,0,0
75298,intensive,0,0
75299,insulin,0,1
75300,therapy,0,0
75301,group,0,0
75302,;,0,0
75303,however,0,0
75304,",",0,0
75305,no,0,0
75306,adverse,0,1
75307,consequences,0,0
75308,were,0,0
75309,documented,0,0
75310,.,0,0
75311,As,0,0
75312,expected,0,0
75313,",",0,0
75314,there,0,0
75315,were,0,0
75316,no,0,0
75317,differences,0,0
75318,in,0,0
75319,clinically,0,0
75320,important,0,0
75321,outcomes,0,0
75322,.,0,0
75323,CONCLUSIONS,0,0
75324,In,0,0
75325,this,0,0
75326,pilot,0,0
75327,trial,0,0
75328,of,0,0
75329,ICU,0,0
75330,patients,0,0
75331,with,0,0
75332,high,0,0
75333,illness,0,1
75334,severity,0,1
75335,",",0,0
75336,glucose,1,1
75337,values,1,1
75338,were,0,0
75339,in,0,0
75340,the,0,0
75341,2,0,0
75342,target,0,0
75343,ranges,0,0
75344,only,0,0
75345,40,0,0
75346,%,0,0
75347,of,0,0
75348,the,0,0
75349,time,0,1
75350,",",0,0
75351,using,0,0
75352,well-accepted,0,0
75353,initiation,0,0
75354,and,0,1
75355,maintenance,0,0
75356,insulin,0,1
75357,infusion,0,0
75358,algorithms,0,0
75359,.,0,0
75360,A,0,0
75361,large,0,0
75362,randomized,0,0
75363,trial,0,0
75364,of,0,0
75365,glycemic,0,0
75366,control,0,0
75367,is,0,0
75368,feasible,0,0
75369,in,0,0
75370,this,0,0
75371,population,0,0
75372,to,0,0
75373,examine,0,0
75374,clinically,0,0
75375,important,0,0
75376,outcomes,0,1
75377,",",0,0
75378,but,0,0
75379,will,0,0
75380,require,0,0
75381,refined,0,0
75382,insulin,0,1
75383,algorithms,0,0
75384,and,0,0
75385,more,0,0
75386,comprehensive,0,0
75387,behavior,0,1
75388,change,0,1
75389,strategies,0,0
75390,to,0,0
75391,achieve,0,0
75392,target,0,0
75393,values,0,1
75394,.,0,0
75395,Comparison,0,0
75396,of,0,0
75397,split-course,0,0
75398,radiation,0,0
75399,therapy,0,0
75400,and,0,1
75401,continuous,0,0
75402,radiation,0,0
75403,therapy,0,0
75404,for,0,0
75405,unresectable,0,0
75406,bronchogenic,0,0
75407,carcinoma,0,0
75408,:,0,0
75409,5,0,0
75410,year,0,0
75411,results,0,0
75412,.,0,0
75413,One,0,0
75414,hundred,0,0
75415,and,0,0
75416,eighty-eight,0,0
75417,patients,0,0
75418,with,0,0
75419,inoperable,0,0
75420,or,0,0
75421,unresectable,0,0
75422,bronchogenic,0,0
75423,carcinoma,0,0
75424,were,0,0
75425,stratified,0,0
75426,by,0,0
75427,cell,0,0
75428,type,0,0
75429,",",0,0
75430,TNM,0,1
75431,staging,0,1
75432,",",0,0
75433,and,0,0
75434,prior,0,0
75435,surgery,0,0
75436,and,0,0
75437,then,0,0
75438,randomized,0,0
75439,into,0,0
75440,two,0,0
75441,treatment,0,0
75442,groups,0,0
75443,:,0,0
75444,continuous,0,0
75445,radiation,0,0
75446,therapy,0,0
75447,and,0,1
75448,split-course,0,0
75449,radiation,0,0
75450,therapy,0,0
75451,.,0,0
75452,There,0,0
75453,was,0,0
75454,no,0,0
75455,difference,0,0
75456,in,0,0
75457,clinical,0,0
75458,or,0,0
75459,objective,0,0
75460,improvement,0,1
75461,in,0,0
75462,the,0,0
75463,two,0,0
75464,groups,0,0
75465,.,0,0
75466,Survival,1,1
75467,rates,1,1
75468,for,0,0
75469,cases,0,0
75470,of,0,0
75471,squamous,0,0
75472,cell,0,1
75473,carcinoma,0,0
75474,",",0,0
75475,small,0,1
75476,cell,0,1
75477,carcinoma,0,0
75478,",",0,1
75479,and,0,1
75480,adrenocarcinoma,0,0
75481,were,0,0
75482,the,0,0
75483,same,0,0
75484,after,0,0
75485,both,0,0
75486,regimens,0,0
75487,of,0,0
75488,therapy,0,0
75489,.,0,0
75490,Split-course,1,0
75491,therapy,1,0
75492,resulted,0,0
75493,in,0,0
75494,a,0,0
75495,significantly,0,0
75496,better,0,0
75497,survival,0,1
75498,rate,0,1
75499,in,0,0
75500,cases,0,0
75501,of,0,0
75502,large,0,0
75503,cell,0,1
75504,carcinoma,0,0
75505,but,0,0
75506,the,0,0
75507,number,0,1
75508,of,0,0
75509,cases,0,0
75510,was,0,0
75511,small,0,0
75512,.,0,0
75513,We,0,0
75514,doubt,0,0
75515,that,0,0
75516,the,0,0
75517,difference,0,0
75518,is,0,0
75519,clinically,0,0
75520,significant,0,0
75521,.,0,0
75522,Objective,1,1
75523,roentgenographic,1,1
75524,response,1,1
75525,was,0,0
75526,accompanied,0,0
75527,by,0,0
75528,improved,1,0
75529,survival,1,1
75530,in,0,0
75531,squamous,0,0
75532,cell,0,1
75533,carcinoma,0,0
75534,",",0,0
75535,but,0,0
75536,not,0,0
75537,in,0,0
75538,the,0,0
75539,other,0,0
75540,three,0,0
75541,cell,0,0
75542,types,0,0
75543,.,0,0
75544,Split-course,0,0
75545,radiation,0,0
75546,therapy,0,0
75547,is,0,0
75548,superior,0,0
75549,to,0,0
75550,continuous,0,0
75551,radiation,0,0
75552,therapy,0,0
75553,because,0,0
75554,it,0,0
75555,is,0,0
75556,better,1,0
75557,tolerated,1,1
75558,by,0,0
75559,the,0,0
75560,patient,0,0
75561,and,0,0
75562,because,0,0
75563,re-examination,0,0
75564,of,0,0
75565,the,0,0
75566,patient,0,0
75567,prior,0,0
75568,to,0,0
75569,the,0,0
75570,second,0,0
75571,half,0,0
75572,of,0,0
75573,split-course,0,0
75574,therapy,0,0
75575,permits,0,0
75576,the,0,0
75577,detection,0,0
75578,of,0,0
75579,new,0,0
75580,metastatic,0,0
75581,disease,0,0
75582,that,0,0
75583,has,0,0
75584,become,0,0
75585,manifest,0,0
75586,during,0,0
75587,the,0,0
75588,rest,0,0
75589,period,0,0
75590,and,0,0
75591,spares,0,0
75592,the,0,0
75593,patient,0,0
75594,the,0,0
75595,futile,0,0
75596,second,0,0
75597,half,0,0
75598,of,0,0
75599,radiation,0,0
75600,therapy,0,0
75601,.,0,0
75602,The,0,0
75603,relationship,0,0
75604,between,0,0
75605,histology,1,1
75606,and,1,1
75607,outcome,1,1
75608,in,0,0
75609,advanced,0,0
75610,and,0,0
75611,recurrent,0,1
75612,endometrial,0,1
75613,cancer,0,0
75614,patients,0,0
75615,participating,0,0
75616,in,0,0
75617,first-line,0,0
75618,chemotherapy,0,0
75619,trials,0,0
75620,:,0,0
75621,a,0,0
75622,Gynecologic,0,0
75623,Oncology,0,0
75624,Group,0,0
75625,study,0,0
75626,.,0,0
75627,OBJECTIVES,0,0
75628,To,0,0
75629,explore,0,0
75630,associations,0,0
75631,between,0,0
75632,histology,1,1
75633,and,1,1
75634,outcome,1,1
75635,in,0,0
75636,advanced,0,0
75637,or,0,0
75638,recurrent,0,1
75639,endometrial,0,1
75640,cancer,0,0
75641,patients,0,0
75642,participating,0,0
75643,in,0,0
75644,Gynecologic,0,0
75645,Oncology,0,0
75646,Group,0,0
75647,chemotherapy,0,0
75648,trials,0,0
75649,.,0,0
75650,METHODS,0,0
75651,Age,1,1
75652,",",1,0
75653,race,1,0
75654,",",1,1
75655,performance,1,1
75656,status,1,1
75657,",",1,0
75658,histologic,1,1
75659,type,1,0
75660,(,1,0
75661,serous=S,1,1
75662,;,1,0
75663,clear,1,0
75664,cell=CC,1,0
75665,;,1,0
75666,endometrioid=E,1,0
75667,),1,0
75668,",",1,0
75669,disease,1,1
75670,stage,1,1
75671,",",1,0
75672,and,1,1
75673,prior,1,1
75674,radiation,1,0
75675,were,0,0
75676,evaluated,0,0
75677,using,0,0
75678,various,0,0
75679,analytic,0,0
75680,methods,0,0
75681,to,0,0
75682,evaluate,0,0
75683,the,0,0
75684,probability,0,0
75685,of,0,0
75686,response,0,1
75687,and,0,0
75688,identify,0,0
75689,independent,0,0
75690,predictors,0,0
75691,of,0,0
75692,progression-free,1,1
75693,survival,1,1
75694,(,1,0
75695,PFS,1,1
75696,),1,0
75697,and,1,0
75698,overall,1,1
75699,survival,1,1
75700,(,1,0
75701,OS,1,1
75702,),1,0
75703,.,1,0
75704,RESULTS,0,0
75705,Single,0,0
75706,agent,0,0
75707,or,0,0
75708,combination,0,0
75709,chemotherapy,0,0
75710,regimens,0,0
75711,including,0,0
75712,doxorubicin,0,0
75713,(,0,0
75714,A,0,0
75715,),0,0
75716,(,0,0
75717,12,0,0
75718,%,0,0
75719,),0,0
75720,",",0,0
75721,doxorubicin/cisplatin,0,0
75722,(,0,1
75723,AP,0,0
75724,),0,0
75725,(,0,0
75726,63,0,0
75727,%,0,0
75728,),0,0
75729,",",0,0
75730,doxorubicin/paclitaxel,0,0
75731,(,0,0
75732,AT,0,0
75733,),0,0
75734,(,0,0
75735,13,0,0
75736,%,0,0
75737,),0,0
75738,",",0,0
75739,and,0,1
75740,paclitaxel/doxorubicin/cisplatin,0,0
75741,(,0,1
75742,TAP,0,1
75743,),0,0
75744,(,0,0
75745,11,0,0
75746,%,0,0
75747,),0,0
75748,were,0,0
75749,used,0,0
75750,among,0,0
75751,1203,0,0
75752,patients,0,0
75753,treated,0,0
75754,on,0,0
75755,4,0,0
75756,randomized,0,0
75757,clinical,0,0
75758,trials,0,0
75759,.,0,0
75760,Breakdown,0,1
75761,of,0,0
75762,disease,1,1
75763,stage,1,0
75764,was,0,0
75765,7.8,0,0
75766,%,0,0
75767,stage,0,0
75768,III,0,0
75769,",",0,0
75770,22.8,0,0
75771,%,0,0
75772,stage,0,0
75773,IV,0,1
75774,",",0,0
75775,and,0,0
75776,69.4,0,0
75777,%,0,0
75778,recurrent,0,0
75779,disease,0,0
75780,.,0,0
75781,Histologic,1,1
75782,distribution,1,0
75783,was,0,0
75784,18,0,0
75785,%,0,0
75786,S,0,0
75787,",",0,0
75788,3.7,0,0
75789,%,0,0
75790,CC,0,0
75791,",",0,0
75792,8.5,0,0
75793,%,0,0
75794,mixed,0,0
75795,",",0,0
75796,51.7,0,0
75797,%,0,0
75798,E,0,0
75799,and,0,0
75800,18.1,0,0
75801,%,0,0
75802,other,0,0
75803,.,0,0
75804,More,0,0
75805,S/CC,0,1
75806,patients,0,0
75807,enrolled,0,0
75808,on,0,0
75809,trials,0,0
75810,with,0,0
75811,advanced,0,0
75812,stage,0,0
75813,(,0,0
75814,III-IV,0,1
75815,),0,1
75816,disease,0,1
75817,(,0,0
75818,as,0,0
75819,opposed,0,0
75820,to,0,0
75821,recurrent,0,0
75822,disease,0,0
75823,),0,0
75824,compared,0,0
75825,to,0,0
75826,E,0,0
75827,patients,0,0
75828,(,0,0
75829,45,0,0
75830,%,0,0
75831,vs.,0,0
75832,24,0,0
75833,%,0,0
75834,",",0,0
75835,p,0,0
75836,<,0,0
75837,0.05,0,0
75838,),0,0
75839,.,0,0
75840,Overall,1,0
75841,response,1,1
75842,rate,1,1
75843,was,0,0
75844,42,0,0
75845,%,0,0
75846,(,0,0
75847,E=44,0,0
75848,%,0,0
75849,",",0,0
75850,S=44,0,1
75851,%,0,0
75852,",",0,0
75853,CC=32,0,1
75854,%,0,0
75855,),0,0
75856,.,0,0
75857,Histologic,1,1
75858,type,1,0
75859,was,0,0
75860,not,0,0
75861,an,0,0
75862,independent,0,0
75863,predictor,0,0
75864,of,0,0
75865,response,0,1
75866,.,0,0
75867,Independent,0,0
75868,predictors,0,0
75869,of,0,0
75870,PFS,0,1
75871,included,0,0
75872,race,1,0
75873,",",1,1
75874,performance,1,1
75875,status,1,1
75876,",",1,1
75877,disease,1,1
75878,stage,1,1
75879,",",1,0
75880,and,1,1
75881,CC,1,0
75882,histology,1,1
75883,.,1,0
75884,Histology,1,0
75885,was,0,0
75886,also,0,0
75887,an,0,0
75888,independent,0,0
75889,predictor,0,0
75890,of,0,0
75891,OS,0,1
75892,;,0,0
75893,the,0,0
75894,relative,1,0
75895,hazard,1,1
75896,ratio,1,1
75897,for,0,0
75898,S,0,0
75899,histology,0,1
75900,was,0,0
75901,1.2,0,0
75902,(,0,0
75903,1.02-1.4,0,0
75904,;,0,0
75905,p=0.03,0,0
75906,),0,0
75907,",",0,0
75908,and,0,0
75909,for,0,0
75910,CC,0,0
75911,was,0,0
75912,1.51,0,0
75913,(,0,0
75914,1.1-2.07,0,0
75915,;,0,0
75916,p=0.01,0,0
75917,),0,0
75918,.,0,0
75919,CONCLUSION,0,0
75920,In,0,0
75921,patients,0,0
75922,with,0,0
75923,advanced/recurrent,0,0
75924,endometrial,0,1
75925,cancer,0,0
75926,treated,0,0
75927,with,0,0
75928,A,0,0
75929,",",0,0
75930,P,0,0
75931,and/or,0,0
75932,T,0,0
75933,",",0,0
75934,response,0,1
75935,was,0,0
75936,not,1,0
75937,associated,1,0
75938,with,1,0
75939,histology,1,0
75940,.,1,0
75941,This,0,0
75942,exploratory,0,0
75943,analysis,0,0
75944,does,0,0
75945,not,0,0
75946,support,0,0
75947,exclusion,0,0
75948,of,0,0
75949,S,0,0
75950,tumors,0,0
75951,in,0,0
75952,future,0,0
75953,trials,0,0
75954,.,0,0
75955,Poorer,1,1
75956,PFS,1,1
75957,and,1,1
75958,OS,1,1
75959,were,0,0
75960,observed,0,0
75961,in,0,0
75962,CC,0,0
75963,compared,0,0
75964,to,0,0
75965,other,0,0
75966,types,0,0
75967,",",0,0
75968,but,0,0
75969,a,0,0
75970,lack,0,0
75971,of,0,0
75972,benefit,0,0
75973,from,0,0
75974,chemotherapy,0,0
75975,was,0,0
75976,not,0,0
75977,shown,0,0
75978,",",0,0
75979,and,0,0
75980,as,0,0
75981,this,0,0
75982,histology,0,0
75983,represents,0,0
75984,such,0,0
75985,a,0,0
75986,small,0,0
75987,fraction,0,1
75988,",",0,0
75989,it,0,0
75990,does,0,0
75991,not,0,0
75992,seem,0,0
75993,feasible,0,0
75994,to,0,0
75995,have,0,0
75996,separate,0,0
75997,chemotherapy,0,0
75998,trials,0,0
75999,for,0,0
76000,CC,0,0
76001,.,0,0
76002,Use,0,0
76003,of,0,0
76004,a,0,0
76005,DNAemia,0,1
76006,cut-off,0,1
76007,for,0,0
76008,monitoring,0,0
76009,human,0,0
76010,cytomegalovirus,0,0
76011,infection,0,0
76012,reduces,0,0
76013,the,0,0
76014,number,1,1
76015,of,1,0
76016,preemptively,1,0
76017,treated,1,0
76018,children,1,0
76019,and,0,0
76020,young,0,0
76021,adults,0,0
76022,receiving,0,0
76023,hematopoietic,0,0
76024,stem-cell,0,0
76025,transplantation,0,0
76026,compared,0,0
76027,with,0,0
76028,qualitative,0,0
76029,pp65,0,0
76030,antigenemia,0,0
76031,.,0,0
76032,We,0,0
76033,performed,0,0
76034,a,0,0
76035,randomized,0,0
76036,trial,0,0
76037,comparing,0,0
76038,the,0,0
76039,use,0,0
76040,of,0,0
76041,quantitative,0,0
76042,DNAemia,0,1
76043,versus,0,0
76044,positive,0,1
76045,antigenemia,0,0
76046,for,0,0
76047,starting,0,0
76048,preemptive,0,0
76049,antihuman,0,0
76050,cytomegalovirus,0,1
76051,(,0,0
76052,HCMV,0,0
76053,),0,0
76054,therapy,0,0
76055,in,0,0
76056,hematopoietic,0,0
76057,stem-cell,0,0
76058,transplantation,0,0
76059,(,0,0
76060,HSCT,0,1
76061,),0,0
76062,recipients,0,0
76063,.,0,0
76064,In,0,0
76065,the,0,0
76066,DNAemia,0,1
76067,arm,0,0
76068,",",0,0
76069,antiviral,0,0
76070,therapy,0,0
76071,was,0,0
76072,initiated,0,0
76073,on,0,0
76074,reaching,0,0
76075,a,0,0
76076,DNAemia,0,1
76077,cut-off,0,0
76078,of,0,0
76079,10,0,0
76080,000,0,0
76081,DNA,0,0
76082,copies/mL,0,0
76083,of,0,0
76084,whole,0,0
76085,blood,0,1
76086,",",0,0
76087,whereas,0,0
76088,in,0,0
76089,the,0,0
76090,antigenemia,0,0
76091,arm,0,0
76092,",",0,1
76093,therapy,0,0
76094,was,0,0
76095,started,0,0
76096,in,0,0
76097,the,0,0
76098,presence,0,0
76099,of,0,0
76100,a,0,0
76101,positive,0,0
76102,antigenemia,0,0
76103,.,0,0
76104,The,0,0
76105,aim,0,0
76106,of,0,0
76107,the,0,0
76108,study,0,0
76109,was,0,0
76110,to,0,0
76111,compare,0,0
76112,the,0,0
76113,number,0,1
76114,of,0,0
76115,patients,0,0
76116,treated,0,0
76117,in,0,0
76118,the,0,0
76119,2,0,0
76120,arms,0,0
76121,.,0,0
76122,On,0,0
76123,the,0,0
76124,whole,0,0
76125,",",0,0
76126,178,0,0
76127,patients,0,0
76128,(,0,0
76129,89,0,0
76130,in,0,0
76131,each,0,0
76132,arm,0,0
76133,),0,0
76134,",",0,0
76135,receiving,0,0
76136,unmanipulated,0,0
76137,HSCT,0,1
76138,from,0,0
76139,either,0,0
76140,a,0,0
76141,relative,0,0
76142,or,0,0
76143,an,0,0
76144,unrelated,0,0
76145,donor,0,0
76146,",",0,0
76147,completed,0,0
76148,the,0,0
76149,study,0,0
76150,.,0,0
76151,Although,0,0
76152,the,0,0
76153,incidence,0,1
76154,of,0,0
76155,HCMV,1,0
76156,infection,1,1
76157,was,0,0
76158,comparable,0,0
76159,in,0,0
76160,DNAemia,0,1
76161,and,0,0
76162,antigenemia,0,1
76163,arms,0,0
76164,(,0,0
76165,34,0,0
76166,%,0,0
76167,vs,0,0
76168,42,0,0
76169,%,0,0
76170,",",0,0
76171,respectively,0,0
76172,",",0,0
76173,P,0,0
76174,=,0,0
76175,.259,0,0
76176,),0,0
76177,",",0,0
76178,the,0,0
76179,number,1,1
76180,of,1,0
76181,patients,1,0
76182,treated,1,0
76183,was,0,0
76184,significantly,0,0
76185,lower,0,0
76186,in,0,0
76187,the,0,0
76188,DNAemia,0,1
76189,arm,0,0
76190,(,0,0
76191,18,0,0
76192,%,0,0
76193,vs,0,0
76194,31,0,0
76195,%,0,0
76196,",",0,0
76197,P,0,0
76198,=,0,0
76199,.026,0,0
76200,),0,0
76201,.,0,0
76202,No,0,0
76203,patient,0,0
76204,developed,0,0
76205,HCMV,1,0
76206,disease,1,0
76207,.,1,0
76208,The,0,0
76209,use,0,0
76210,of,0,0
76211,a,0,0
76212,DNAemia,0,1
76213,cut-off,0,1
76214,avoids,0,0
76215,unnecessary,0,0
76216,antiviral,0,0
76217,treatment,0,0
76218,.,0,0
76219,Long-term,0,1
76220,growth,0,1
76221,hormone,0,1
76222,treatment,0,0
76223,in,0,0
76224,growth,0,1
76225,hormone,0,1
76226,deficient,0,0
76227,adults,0,0
76228,.,0,0
76229,Growth,0,1
76230,hormone,0,1
76231,treatment,0,0
76232,in,0,0
76233,GH-deficient,0,0
76234,adults,0,0
76235,has,0,0
76236,proved,0,0
76237,beneficial,0,0
76238,in,0,0
76239,recent,0,0
76240,short-term,0,0
76241,trials,0,0
76242,",",0,0
76243,but,0,0
76244,long-term,0,0
76245,results,0,0
76246,have,0,0
76247,not,0,0
76248,yet,0,0
76249,been,0,0
76250,reported,0,0
76251,.,0,0
76252,Thirteen,0,0
76253,GH-deficient,0,0
76254,adults,0,0
76255,(,0,0
76256,4,0,0
76257,females,0,0
76258,",",0,0
76259,9,0,0
76260,males,0,0
76261,;,0,0
76262,mean,0,1
76263,(,0,0
76264,SEM,0,0
76265,),0,0
76266,age,0,0
76267,26.4,0,0
76268,(,0,0
76269,1.7,0,0
76270,),0,0
76271,years,0,0
76272,),0,0
76273,",",0,0
76274,who,0,0
76275,had,0,0
76276,completed,0,0
76277,4,0,0
76278,months,0,0
76279,of,0,0
76280,GH,0,0
76281,therapy,0,0
76282,in,0,0
76283,a,0,0
76284,double-blind,0,0
76285,placebo-controlled,0,0
76286,cross-over,0,0
76287,study,0,0
76288,were,0,0
76289,followed,0,0
76290,",",0,0
76291,for,0,0
76292,further,0,0
76293,16.1,0,0
76294,(,0,0
76295,0.8,0,0
76296,),0,0
76297,months,0,0
76298,of,0,0
76299,uninterrupted,0,0
76300,GH,0,0
76301,therapy,0,0
76302,in,0,0
76303,an,0,0
76304,open,0,0
76305,design,0,0
76306,.,0,0
76307,A,0,0
76308,significant,0,0
76309,mean,0,1
76310,increase,0,0
76311,of,0,0
76312,1.3,0,0
76313,cm,0,0
76314,in,0,0
76315,linear,1,0
76316,height,1,1
76317,was,0,0
76318,recorded,0,0
76319,",",0,0
76320,whereas,0,0
76321,body,1,1
76322,mass,1,1
76323,index,1,1
76324,remained,0,0
76325,unchanged,0,0
76326,.,0,0
76327,Mean,1,0
76328,muscle,1,1
76329,volume,1,1
76330,of,1,0
76331,the,1,0
76332,thigh,1,1
76333,",",1,0
76334,estimated,1,0
76335,by,1,0
76336,computerised,1,0
76337,tomography,1,0
76338,",",0,0
76339,increased,0,0
76340,significantly,0,0
76341,compared,0,0
76342,with,0,0
76343,that,0,0
76344,of,0,0
76345,the,0,0
76346,initial,0,0
76347,placebo,0,0
76348,period,0,0
76349,(,0,0
76350,p,0,0
76351,=,0,0
76352,0.01,0,0
76353,),0,0
76354,",",0,0
76355,and,0,0
76356,a,0,0
76357,slight,0,1
76358,decrease,0,0
76359,was,0,0
76360,recorded,0,0
76361,in,0,0
76362,adipose,1,0
76363,tissue,1,1
76364,volume,1,1
76365,of,1,0
76366,the,1,0
76367,thigh,1,1
76368,(,0,0
76369,p,0,0
76370,=,0,0
76371,0.10,0,0
76372,),0,0
76373,and,0,0
76374,subscapular,1,1
76375,skinfold,1,1
76376,thickness,1,1
76377,(,0,0
76378,p,0,0
76379,=,0,0
76380,0.10,0,0
76381,),0,0
76382,.,0,0
76383,Still,0,0
76384,",",0,0
76385,the,0,0
76386,muscle,1,0
76387,to,1,0
76388,fat,1,1
76389,ratio,1,1
76390,of,1,0
76391,the,1,0
76392,thigh,1,1
76393,was,0,0
76394,significantly,0,0
76395,lower,0,0
76396,compared,0,0
76397,with,0,0
76398,that,0,0
76399,of,0,0
76400,normal,0,0
76401,subjects,0,0
76402,(,0,0
76403,72.6/27.4,0,0
76404,vs,0,0
76405,77.9/22.1,0,0
76406,),0,0
76407,(,0,0
76408,p,0,0
76409,less,0,0
76410,than,0,0
76411,0.01,0,0
76412,),0,0
76413,.,0,0
76414,The,0,0
76415,mean,1,1
76416,isometric,1,0
76417,strength,1,1
76418,of,1,0
76419,the,1,0
76420,quadriceps,1,0
76421,muscles,1,0
76422,increased,1,0
76423,significantly,0,0
76424,during,0,0
76425,long-term,0,0
76426,GH,0,0
76427,therapy,0,0
76428,(,0,0
76429,p,0,0
76430,less,0,0
76431,than,0,0
76432,0.01,0,0
76433,),0,0
76434,",",0,0
76435,but,0,0
76436,remained,0,0
76437,lower,0,0
76438,compared,0,0
76439,with,0,0
76440,that,0,0
76441,of,0,0
76442,normal,0,0
76443,subjects,0,0
76444,(,0,0
76445,1.66,0,0
76446,(,0,0
76447,0.10,0,0
76448,),0,0
76449,vs,0,0
76450,2.13,0,0
76451,(,0,0
76452,0.11,0,0
76453,),0,0
76454,Nm/kg,0,0
76455,body,0,1
76456,weight,0,1
76457,),0,0
76458,.,0,0
76459,Exercise,1,0
76460,capacity,1,1
76461,performed,1,0
76462,on,1,0
76463,a,1,0
76464,bicycle,1,0
76465,ergometer,1,0
76466,increased,0,0
76467,significantly,0,0
76468,after,0,0
76469,long-term,0,0
76470,therapy,0,0
76471,(,0,0
76472,p,0,0
76473,less,0,0
76474,than,0,0
76475,0.05,0,0
76476,),0,0
76477,",",0,0
76478,but,0,0
76479,still,0,0
76480,did,0,0
76481,not,0,0
76482,reach,0,0
76483,the,0,0
76484,values,0,1
76485,seen,0,0
76486,in,0,0
76487,normal,0,0
76488,subjects,0,0
76489,(,0,0
76490,22.5,0,0
76491,(,0,0
76492,3.4,0,0
76493,),0,0
76494,vs,0,0
76495,37.4,0,0
76496,(,0,0
76497,4.2,0,0
76498,),0,0
76499,watt.min.kg-1,0,0
76500,.,0,0
76501,No,0,0
76502,adverse,1,1
76503,reactions,1,1
76504,were,0,0
76505,recorded,0,0
76506,during,0,0
76507,long-term,0,0
76508,therapy,0,0
76509,and,0,1
76510,hemoglobin,1,1
76511,A1c,1,1
76512,remained,0,0
76513,unchanged,0,0
76514,.,0,0
76515,These,0,0
76516,data,0,0
76517,suggest,0,0
76518,that,0,0
76519,long-term,0,0
76520,GH,0,0
76521,replacement,0,0
76522,therapy,0,0
76523,in,0,0
76524,GH-deficient,0,0
76525,adults,0,0
76526,has,0,0
76527,beneficial,0,0
76528,effects,0,0
76529,on,0,0
76530,several,0,0
76531,physiological,0,0
76532,features,0,0
76533,which,0,0
76534,are,0,0
76535,subnormal,0,1
76536,in,0,0
76537,these,0,0
76538,patients,0,0
76539,.,0,0
76540,A,0,0
76541,prospective,0,0
76542,",",0,0
76543,randomized,0,0
76544,trial,0,0
76545,of,0,0
76546,clear,0,0
76547,liquids,0,0
76548,versus,0,0
76549,low-fat,0,0
76550,solid,0,0
76551,diet,0,0
76552,as,0,0
76553,the,0,0
76554,initial,0,0
76555,meal,0,0
76556,in,0,0
76557,mild,0,1
76558,acute,0,0
76559,pancreatitis,0,0
76560,.,0,0
76561,BACKGROUND,0,0
76562,&,0,0
76563,AIMS,0,1
76564,Patients,0,0
76565,recovering,0,0
76566,from,0,0
76567,mild,0,1
76568,acute,0,0
76569,pancreatitis,0,0
76570,typically,0,0
76571,receive,0,0
76572,a,0,0
76573,clear,0,0
76574,liquid,0,0
76575,diet,0,0
76576,(,0,0
76577,CLD,0,0
76578,),0,0
76579,when,0,0
76580,ready,0,0
76581,to,0,0
76582,initiate,0,0
76583,oral,0,0
76584,nutrition,0,0
76585,.,0,0
76586,Patient,0,1
76587,discharge,0,0
76588,then,0,0
76589,depends,0,0
76590,on,0,0
76591,their,0,0
76592,successful,0,0
76593,advancement,0,0
76594,to,0,0
76595,solid,0,0
76596,food,0,0
76597,.,0,0
76598,We,0,0
76599,hypothesized,0,0
76600,that,0,0
76601,initiating,0,0
76602,oral,0,0
76603,nutrition,0,0
76604,with,0,0
76605,a,0,0
76606,low-fat,0,0
76607,solid,0,0
76608,diet,0,0
76609,(,0,0
76610,LFSD,0,0
76611,),0,0
76612,after,0,0
76613,mild,0,0
76614,pancreatitis,0,0
76615,would,0,0
76616,be,0,0
76617,well,0,0
76618,tolerated,0,1
76619,and,0,0
76620,would,0,0
76621,result,0,0
76622,in,0,0
76623,a,0,0
76624,shorter,0,0
76625,length,1,1
76626,of,1,1
76627,hospitalization,1,1
76628,(,0,0
76629,LOH,0,1
76630,),0,0
76631,.,0,0
76632,METHODS,0,0
76633,Patients,0,0
76634,with,0,0
76635,mild,0,1
76636,pancreatitis,0,0
76637,were,0,0
76638,randomized,0,0
76639,to,0,0
76640,a,0,0
76641,CLD,0,0
76642,or,0,0
76643,LFSD,0,0
76644,when,0,0
76645,they,0,0
76646,were,0,0
76647,ready,0,0
76648,to,0,0
76649,resume,0,0
76650,oral,0,0
76651,nutrition,0,0
76652,.,0,0
76653,Decisions,0,0
76654,about,0,0
76655,diet,0,0
76656,advancement,0,0
76657,and,0,1
76658,hospital,0,1
76659,discharge,0,1
76660,were,0,0
76661,at,0,0
76662,the,0,0
76663,discretion,0,0
76664,of,0,0
76665,the,0,0
76666,medical,0,0
76667,team,0,0
76668,",",0,0
76669,without,0,0
76670,input,0,1
76671,from,0,0
76672,study,0,0
76673,team,0,0
76674,members,0,0
76675,.,0,0
76676,Patients,0,0
76677,were,0,0
76678,monitored,0,0
76679,daily,0,0
76680,for,0,0
76681,recurrence,0,1
76682,of,0,0
76683,pain,1,1
76684,",",1,0
76685,need,1,0
76686,to,1,0
76687,stop,1,0
76688,feeding,1,0
76689,",",1,0
76690,post-refeeding,1,1
76691,LOH,1,1
76692,(,0,0
76693,primary,0,0
76694,end,0,0
76695,point,0,0
76696,),0,1
76697,",",0,0
76698,and,0,0
76699,for,0,0
76700,28,0,0
76701,days,0,0
76702,post-refeeding,0,0
76703,to,0,0
76704,capture,0,0
76705,re-admission,1,1
76706,rates,1,1
76707,.,1,0
76708,RESULTS,0,0
76709,We,0,0
76710,randomized,0,0
76711,121,0,0
76712,patients,0,0
76713,:,0,0
76714,66,0,0
76715,to,0,0
76716,CLD,0,0
76717,and,0,0
76718,55,0,0
76719,to,0,0
76720,LFSD,0,0
76721,.,0,0
76722,The,0,0
76723,number,1,1
76724,of,1,0
76725,patients,1,0
76726,requiring,1,0
76727,cessation,1,0
76728,of,1,0
76729,feeding,1,0
76730,because,1,0
76731,of,1,0
76732,pain,1,1
76733,or,1,0
76734,nausea,1,1
76735,was,0,0
76736,similar,0,0
76737,in,0,0
76738,both,0,0
76739,groups,0,0
76740,(,0,0
76741,6,0,0
76742,%,0,0
76743,for,0,0
76744,CLD,0,0
76745,",",0,0
76746,11,0,0
76747,%,0,0
76748,for,0,0
76749,LFSD,0,0
76750,;,0,0
76751,P,0,0
76752,=,0,0
76753,.51,0,0
76754,),0,0
76755,.,0,0
76756,The,0,0
76757,median,1,0
76758,LOH,1,0
76759,after,1,0
76760,refeeding,1,0
76761,was,0,0
76762,identical,0,0
76763,in,0,0
76764,both,0,0
76765,groups,0,0
76766,(,0,0
76767,1-day,0,0
76768,interquartile,0,1
76769,range,0,0
76770,",",0,0
76771,1-2,0,0
76772,;,0,0
76773,P,0,0
76774,=,0,0
76775,.77,0,0
76776,),0,0
76777,.,0,0
76778,Patients,0,0
76779,in,0,0
76780,the,0,0
76781,LFSD,0,0
76782,arm,0,0
76783,consumed,0,0
76784,significantly,0,0
76785,more,0,0
76786,calories,1,1
76787,and,1,1
76788,grams,1,1
76789,of,1,1
76790,fat,1,0
76791,than,0,0
76792,those,0,0
76793,in,0,0
76794,the,0,0
76795,CLD,0,0
76796,arm,0,0
76797,during,0,0
76798,their,0,0
76799,first,0,0
76800,meal,0,1
76801,and,0,0
76802,on,0,0
76803,study,0,0
76804,day,0,0
76805,1,0,0
76806,.,0,0
76807,There,0,0
76808,was,0,0
76809,no,0,0
76810,difference,0,0
76811,in,0,0
76812,the,0,0
76813,28-day,1,1
76814,re-admission,1,1
76815,rates,1,1
76816,between,0,0
76817,the,0,0
76818,2,0,0
76819,arms,0,0
76820,.,0,0
76821,CONCLUSIONS,0,0
76822,Initiating,0,0
76823,oral,0,0
76824,nutrition,0,0
76825,after,0,0
76826,mild,1,1
76827,acute,1,0
76828,pancreatitis,1,0
76829,with,0,0
76830,an,0,0
76831,LFSD,1,0
76832,appeared,0,0
76833,safe,0,1
76834,and,0,0
76835,provided,0,0
76836,more,0,0
76837,calories,0,1
76838,than,0,0
76839,a,0,0
76840,CLD,0,0
76841,",",0,0
76842,but,0,0
76843,did,0,0
76844,not,0,0
76845,result,0,0
76846,in,0,0
76847,a,0,0
76848,shorter,0,0
76849,LOH,1,0
76850,.,1,0
76851,The,0,0
76852,peroxisome,0,0
76853,proliferator-activated,0,0
76854,receptor-gamma,0,0
76855,agonist,0,0
76856,pioglitazone,0,0
76857,increases,0,1
76858,number,1,1
76859,and,1,1
76860,function,1,1
76861,of,1,1
76862,endothelial,1,1
76863,progenitor,1,1
76864,cells,1,1
76865,in,0,0
76866,patients,0,0
76867,with,0,0
76868,coronary,0,0
76869,artery,0,1
76870,disease,0,1
76871,and,0,1
76872,normal,0,0
76873,glucose,0,1
76874,tolerance,0,1
76875,.,0,0
76876,OBJECTIVE,0,0
76877,Peroxisome,0,0
76878,proliferator-activated,0,0
76879,receptor-gamma,0,0
76880,(,0,0
76881,PPAR,0,1
76882,gamma,0,0
76883,),0,0
76884,agonists,0,0
76885,(,0,0
76886,thiazolidinediones,0,1
76887,[,0,0
76888,TZDs,0,0
76889,],0,0
76890,),0,0
76891,are,0,0
76892,used,0,0
76893,for,0,0
76894,the,0,0
76895,treatment,0,0
76896,of,0,0
76897,diabetes,0,0
76898,.,0,0
76899,Bone,0,0
76900,marrow-derived,0,0
76901,endothelial,0,0
76902,progenitor,0,1
76903,cells,0,1
76904,(,0,0
76905,EPCs,0,0
76906,),0,0
76907,improve,0,0
76908,vascular,1,1
76909,function,1,1
76910,and,0,1
76911,predict,0,1
76912,cardiovascular,1,1
76913,risk,1,0
76914,.,1,0
76915,The,0,0
76916,effect,0,0
76917,of,0,0
76918,pioglitazone,0,0
76919,therapy,0,0
76920,on,0,0
76921,EPCs,0,0
76922,was,0,0
76923,examined,0,0
76924,.,0,0
76925,RESEARCH,0,0
76926,DESIGN,0,0
76927,AND,0,0
76928,METHODS,0,0
76929,AND,0,0
76930,RESULTS,0,0
76931,We,0,0
76932,performed,0,0
76933,a,0,0
76934,prospective,0,0
76935,",",0,0
76936,randomized,0,0
76937,",",0,0
76938,double-blind,0,0
76939,study,0,0
76940,on,0,0
76941,patients,0,0
76942,with,0,0
76943,documented,0,0
76944,stable,0,0
76945,coronary,0,0
76946,artery,0,1
76947,disease,0,1
76948,and,0,1
76949,normal,0,0
76950,glucose,0,1
76951,tolerance,0,1
76952,.,0,0
76953,Of,0,0
76954,54,0,0
76955,patients,0,0
76956,with,0,0
76957,normal,0,0
76958,fasting,0,1
76959,glucose,0,1
76960,levels,0,1
76961,",",0,0
76962,18,0,0
76963,showed,0,0
76964,impaired,0,0
76965,glucose,0,1
76966,tolerance,0,1
76967,and,0,0
76968,36,0,0
76969,patients,0,0
76970,with,0,0
76971,normal,0,0
76972,glucose,0,1
76973,tolerance,0,1
76974,were,0,0
76975,randomized,0,0
76976,to,0,0
76977,30-day,0,1
76978,treatment,0,0
76979,with,0,0
76980,pioglitazone,0,0
76981,(,0,0
76982,45,0,0
76983,mg,0,0
76984,),0,0
76985,or,0,0
76986,placebo,0,0
76987,in,0,0
76988,addition,0,0
76989,to,0,0
76990,optimal,0,0
76991,medical,0,0
76992,therapy,0,0
76993,.,0,0
76994,All,0,0
76995,patients,0,0
76996,in,0,0
76997,the,0,0
76998,TZD,0,0
76999,group,0,0
77000,showed,0,0
77001,an,0,0
77002,increase,0,0
77003,of,0,0
77004,adiponectin,1,1
77005,levels,1,1
77006,as,0,0
77007,an,0,0
77008,indicator,0,0
77009,of,0,0
77010,compliance,0,1
77011,(,0,0
77012,11.4,0,0
77013,+/-,0,0
77014,1.1,0,0
77015,to,0,0
77016,36.8,0,0
77017,+/-,0,0
77018,2.1,0,0
77019,microg/ml,0,0
77020,;,0,0
77021,P,0,0
77022,<,0,0
77023,0.001,0,0
77024,),0,0
77025,.,0,0
77026,TZD,0,0
77027,",",0,0
77028,but,0,0
77029,not,0,0
77030,placebo,0,0
77031,",",0,0
77032,decreased,0,0
77033,mean,1,1
77034,high-sensitivity,1,0
77035,C-reactive,1,1
77036,protein,1,0
77037,to,0,0
77038,43,0,0
77039,+/-,0,0
77040,19,0,0
77041,%,0,0
77042,(,0,0
77043,P,0,0
77044,<,0,0
77045,0.05,0,0
77046,),0,0
77047,.,0,0
77048,Pioglitazone,0,0
77049,increased,0,0
77050,CD34,1,0
77051,(,1,0
77052,+,1,0
77053,),1,0
77054,/kinase,1,0
77055,insert,1,1
77056,domain,1,0
77057,receptor,1,1
77058,(,1,0
77059,+,1,0
77060,),1,0
77061,EPCs,1,0
77062,to,0,0
77063,142,0,0
77064,+/-,0,0
77065,9,0,0
77066,%,0,0
77067,and,0,0
77068,cultured,1,1
77069,"1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine-labeled",1,1
77070,acetylated,1,0
77071,LDL,1,1
77072,(,1,0
77073,+,1,0
77074,),1,1
77075,/lectin,1,1
77076,(,1,0
77077,+,1,0
77078,),1,0
77079,EPCs,1,0
77080,to,0,0
77081,180,0,0
77082,+/-,0,0
77083,3,0,0
77084,%,0,0
77085,(,0,0
77086,P,0,0
77087,<,0,0
77088,0.05,0,0
77089,),0,0
77090,.,0,0
77091,EPC,1,0
77092,numbers,1,1
77093,were,0,0
77094,not,0,0
77095,changed,0,0
77096,in,0,0
77097,the,0,0
77098,placebo,0,0
77099,group,0,0
77100,.,0,0
77101,TZD,0,0
77102,increased,0,0
77103,the,0,0
77104,SDF-1-induced,1,1
77105,migratory,1,1
77106,capacity,1,1
77107,to,0,0
77108,146,0,0
77109,+/-,0,0
77110,9,0,0
77111,%,0,0
77112,per,0,0
77113,EPC,0,1
77114,number,0,1
77115,(,0,0
77116,P,0,0
77117,<,0,0
77118,0.05,0,0
77119,),0,0
77120,and,0,0
77121,upregulated,0,0
77122,the,0,0
77123,clonogenic,1,1
77124,potential,1,0
77125,of,1,0
77126,EPCs,1,0
77127,",",0,0
77128,increasing,0,0
77129,the,1,0
77130,colony-forming,1,1
77131,units,1,0
77132,to,0,0
77133,172,0,0
77134,+/-,0,0
77135,12,0,0
77136,%,0,0
77137,(,0,0
77138,P,0,0
77139,<,0,0
77140,0.001,0,0
77141,),0,0
77142,.,0,0
77143,In,0,0
77144,cultured,0,0
77145,human,0,0
77146,EPCs,0,0
77147,",",0,0
77148,TZD,0,0
77149,increased,0,0
77150,EPC,1,1
77151,numbers,1,1
77152,and,1,1
77153,migration,1,1
77154,and,1,1
77155,reduced,1,1
77156,NADPH-oxidase,1,0
77157,activity,1,1
77158,.,1,0
77159,The,0,0
77160,TZD,0,0
77161,effect,0,0
77162,was,0,0
77163,reversed,0,0
77164,by,0,0
77165,the,0,0
77166,PPAR,0,0
77167,gamma,0,1
77168,antagonist,0,0
77169,GW9662,0,0
77170,and,0,0
77171,mimicked,0,0
77172,by,0,0
77173,treatment,0,0
77174,with,0,0
77175,adiponectin,0,1
77176,.,0,0
77177,CONCLUSIONS,0,0
77178,The,0,0
77179,PPAR,0,0
77180,gamma,0,1
77181,agonist,0,0
77182,pioglitazone,0,0
77183,increases,0,1
77184,the,0,0
77185,number,1,1
77186,and,1,0
77187,function,1,1
77188,of,1,1
77189,EPCs,1,0
77190,in,0,0
77191,patients,0,0
77192,with,0,0
77193,coronary,0,0
77194,artery,0,0
77195,disease,0,0
77196,.,0,0
77197,The,0,0
77198,effect,0,0
77199,represents,0,0
77200,a,0,0
77201,potential,0,0
77202,regenerative,0,0
77203,mechanism,0,0
77204,in,0,0
77205,atherosclerosis,0,0
77206,and,0,0
77207,is,0,0
77208,observed,0,0
77209,in,0,0
77210,normoglycemic,0,0
77211,individuals,0,0
77212,with,0,0
77213,stable,0,0
77214,coronary,0,0
77215,artery,0,0
77216,disease,0,0
77217,.,0,0
77218,Efficacy,1,1
77219,and,1,1
77220,safety,1,1
77221,of,0,1
77222,sildenafil,0,0
77223,in,0,0
77224,Asian,0,1
77225,males,0,0
77226,with,0,0
77227,erectile,0,1
77228,dysfunction,0,1
77229,and,0,0
77230,cardiovascular,0,1
77231,risk,0,1
77232,.,0,0
77233,OBJECTIVE,0,0
77234,Assess,0,0
77235,the,0,0
77236,effectiveness,0,1
77237,of,0,0
77238,sildenafil,0,0
77239,in,0,0
77240,Asian,0,1
77241,males,0,0
77242,with,0,0
77243,erectile,0,1
77244,dysfunction,0,1
77245,(,0,0
77246,ED,0,0
77247,),0,0
77248,and,0,0
77249,one,0,0
77250,or,0,0
77251,more,0,0
77252,of,0,0
77253,the,0,0
77254,co-morbidities,0,0
77255,",",0,0
77256,mild-to-moderate,0,0
77257,hypertension,0,1
77258,",",0,0
77259,dyslipidemia,0,1
77260,",",0,1
77261,and,0,0
77262,diabetes,0,0
77263,.,0,0
77264,MATERIAL,0,0
77265,AND,0,0
77266,METHOD,0,0
77267,A,0,0
77268,six-week,0,0
77269,",",0,0
77270,double-blind,0,0
77271,",",0,0
77272,randomized,0,0
77273,",",0,0
77274,placebo-controlled,0,0
77275,",",0,0
77276,multicenter,0,0
77277,study,0,0
77278,was,0,0
77279,carried,0,0
77280,out,0,0
77281,in,0,0
77282,Thailand,0,0
77283,",",0,0
77284,Malaysia,0,0
77285,and,0,0
77286,Singapore,0,0
77287,.,0,0
77288,One,0,0
77289,hundred,0,0
77290,and,0,0
77291,fifty,0,0
77292,five,0,0
77293,male,0,0
77294,subjects,0,0
77295,were,0,0
77296,randomized,0,0
77297,(,0,0
77298,2:1,0,0
77299,),0,0
77300,to,0,0
77301,sildenafil,0,0
77302,(,0,0
77303,n,0,0
77304,=,0,0
77305,104,0,0
77306,),0,0
77307,or,0,0
77308,placebo,0,0
77309,(,0,0
77310,n,0,0
77311,=,0,0
77312,51,0,0
77313,),0,0
77314,.,0,0
77315,Sildenafil,0,0
77316,was,0,0
77317,started,0,0
77318,at,0,0
77319,50,0,0
77320,mg,0,0
77321,and,0,0
77322,increased,0,0
77323,(,0,0
77324,100,0,0
77325,mg,0,0
77326,),0,0
77327,or,0,0
77328,decreased,0,0
77329,(,0,0
77330,25,0,0
77331,mg,0,0
77332,),0,0
77333,at,0,0
77334,week,0,0
77335,2,0,0
77336,if,0,0
77337,necessary,0,0
77338,.,0,0
77339,RESULTS,0,0
77340,On,0,0
77341,the,0,0
77342,primary,0,0
77343,efficacy,0,1
77344,endpoint,0,1
77345,",",0,0
77346,sildenafil-treated,0,0
77347,subjects,0,0
77348,had,0,0
77349,significantly,0,0
77350,better,0,0
77351,scores,1,1
77352,on,0,0
77353,the,0,0
77354,International,1,0
77355,Index,1,0
77356,of,1,0
77357,Erectile,1,0
77358,Function,1,1
77359,(,1,0
77360,IIEF,1,0
77361,),1,0
77362,questions,1,0
77363,3,1,0
77364,and,1,0
77365,4,1,0
77366,than,0,0
77367,placebo,0,0
77368,(,0,0
77369,p,0,0
77370,<,0,0
77371,0.001,0,0
77372,",",0,0
77373,both,0,0
77374,questions,0,0
77375,),0,0
77376,.,0,0
77377,When,0,0
77378,accumulated,0,0
77379,into,0,0
77380,IIEF,0,0
77381,domains,0,1
77382,",",0,0
77383,all,0,0
77384,five,0,0
77385,domains,0,0
77386,were,0,0
77387,significant,0,0
77388,in,0,0
77389,favor,0,0
77390,of,0,0
77391,sildenafil,0,0
77392,.,0,0
77393,In,0,0
77394,addition,0,0
77395,",",0,0
77396,sildenafil-treated,0,0
77397,subjects,0,0
77398,were,0,0
77399,more,0,0
77400,satisfied,1,1
77401,with,0,0
77402,treatment,0,0
77403,and,0,0
77404,had,0,0
77405,a,0,0
77406,higher,0,0
77407,intercourse,1,1
77408,success,1,1
77409,rate,1,1
77410,.,1,0
77411,The,0,0
77412,majority,0,0
77413,of,0,0
77414,adverse,0,1
77415,events,0,1
77416,were,0,0
77417,mild,0,0
77418,in,0,0
77419,severity,1,1
77420,;,1,0
77421,the,0,0
77422,most,0,0
77423,commonly,0,0
77424,reported,0,0
77425,treatment-related,0,1
77426,events,0,1
77427,were,0,0
77428,dizziness,1,0
77429,(,0,0
77430,7.7,0,0
77431,%,0,0
77432,),0,0
77433,and,0,1
77434,tinnitus,1,1
77435,(,0,0
77436,2.9,0,0
77437,%,0,0
77438,),0,0
77439,.,0,0
77440,CONCLUSION,0,0
77441,Sildenafil,0,0
77442,(,0,0
77443,25,0,0
77444,",",0,0
77445,50,0,0
77446,",",0,0
77447,and,0,0
77448,100,0,0
77449,mg,0,0
77450,),0,0
77451,was,0,0
77452,found,0,0
77453,to,0,0
77454,be,0,0
77455,an,0,0
77456,effective,0,0
77457,",",0,0
77458,safe,0,1
77459,",",0,0
77460,and,0,1
77461,well-tolerated,0,0
77462,treatment,0,0
77463,for,0,0
77464,ED,0,0
77465,in,0,0
77466,the,0,0
77467,present,0,0
77468,study,0,0
77469,population,0,0
77470,of,0,0
77471,Thai,0,0
77472,",",0,0
77473,Malaysian,0,0
77474,",",0,1
77475,and,0,1
77476,Singaporean,0,0
77477,males,0,0
77478,who,0,0
77479,also,0,0
77480,had,0,0
77481,increased,0,0
77482,cardiovascular,0,1
77483,risk,0,1
77484,Efficacy,1,1
77485,of,0,0
77486,amantadine,0,0
77487,on,0,0
77488,quality,1,1
77489,of,1,0
77490,life,1,1
77491,in,0,0
77492,patients,0,0
77493,with,0,0
77494,chronic,0,0
77495,hepatitis,0,0
77496,C,0,0
77497,treated,0,0
77498,with,0,0
77499,interferon-alpha,0,0
77500,and,0,0
77501,ribavirin,0,0
77502,:,0,0
77503,results,0,0
77504,from,0,0
77505,a,0,0
77506,randomized,0,0
77507,",",0,0
77508,placebo-controlled,0,0
77509,",",0,0
77510,double-blind,0,0
77511,trial,0,0
77512,.,0,0
77513,AIM,0,0
77514,The,0,0
77515,aim,0,0
77516,of,0,0
77517,this,0,0
77518,study,0,0
77519,was,0,0
77520,to,0,0
77521,investigate,0,0
77522,whether,0,0
77523,amantadine,0,0
77524,reduces,0,0
77525,deterioration,1,1
77526,of,1,0
77527,quality,1,1
77528,of,1,0
77529,life,1,1
77530,in,0,0
77531,patients,0,0
77532,with,0,0
77533,chronic,0,0
77534,hepatitis,0,0
77535,C,0,0
77536,during,0,0
77537,and,0,0
77538,after,0,0
77539,treatment,0,0
77540,with,0,0
77541,interferon-alpha,0,0
77542,(,0,0
77543,IFN-alpha,0,0
77544,),0,1
77545,and,0,0
77546,ribavirin,0,0
77547,.,0,1
77548,PATIENTS,0,0
77549,AND,0,0
77550,METHODS,0,0
77551,In,0,0
77552,this,0,0
77553,randomized,0,0
77554,",",0,0
77555,prospective,0,0
77556,",",0,0
77557,placebo-controlled,0,0
77558,",",0,0
77559,multicenter,0,0
77560,trial,0,0
77561,",",0,0
77562,previously,0,0
77563,untreated,0,0
77564,patients,0,0
77565,with,0,0
77566,chronic,0,0
77567,hepatitis,0,0
77568,C,0,0
77569,were,0,0
77570,treated,0,0
77571,with,0,0
77572,IFN-alpha,0,0
77573,plus,0,0
77574,ribavirin,0,0
77575,[,0,0
77576,17,0,0
77577,],0,0
77578,and,0,0
77579,randomized,0,0
77580,for,0,0
77581,treatment,0,0
77582,with,0,0
77583,amantadine,0,0
77584,(,0,0
77585,200,0,0
77586,mg/day,0,0
77587,",",0,0
77588,orally,0,0
77589,",",0,0
77590,n=136,0,0
77591,),0,1
77592,or,0,0
77593,placebo,0,0
77594,(,0,1
77595,n=131,0,0
77596,),0,0
77597,.,0,0
77598,Quality,1,1
77599,of,1,0
77600,life,1,1
77601,was,0,0
77602,assessed,0,0
77603,with,0,0
77604,the,0,0
77605,'Profile,1,0
77606,of,1,0
77607,Mood,1,1
77608,States,1,1
77609,',1,0
77610,scale,1,1
77611,and,1,0
77612,the,1,0
77613,'Everyday,1,1
77614,Life,1,0
77615,',1,0
77616,questionnaire,1,1
77617,at,0,0
77618,baseline,0,0
77619,",",0,0
77620,treatment,0,0
77621,week,0,0
77622,(,0,0
77623,TW,0,0
77624,),0,0
77625,8,0,0
77626,",",0,0
77627,TW24,0,0
77628,",",0,1
77629,TW48,0,0
77630,",",0,1
77631,and,0,0
77632,at,0,0
77633,follow-up,0,0
77634,.,0,0
77635,RESULTS,0,0
77636,Early,0,0
77637,during,0,0
77638,treatment,0,0
77639,at,0,0
77640,TW8,0,0
77641,",",0,0
77642,quality,1,1
77643,of,1,1
77644,life,1,1
77645,was,0,0
77646,not,0,0
77647,different,0,0
77648,between,0,0
77649,patients,0,0
77650,in,0,0
77651,the,0,0
77652,control,0,0
77653,and,0,0
77654,the,0,0
77655,amantadine,0,0
77656,group,0,0
77657,.,0,0
77658,At,0,0
77659,TW24,0,0
77660,",",0,0
77661,the,0,0
77662,control,0,0
77663,group,0,0
77664,but,0,0
77665,not,0,0
77666,the,0,0
77667,amantadine,0,0
77668,group,0,0
77669,",",0,0
77670,however,0,0
77671,",",0,0
77672,showed,0,0
77673,significant,0,0
77674,deterioration,0,1
77675,of,0,0
77676,the,0,0
77677,modalities,1,0
77678,depression,1,1
77679,",",1,0
77680,fatigue,1,1
77681,",",1,1
77682,and,1,1
77683,vigor,1,1
77684,compared,0,0
77685,with,0,0
77686,baseline,0,0
77687,.,0,0
77688,Especially,0,0
77689,",",0,0
77690,nonresponders,0,0
77691,in,0,0
77692,the,0,0
77693,amantadine,0,0
77694,group,0,0
77695,showed,0,0
77696,significantly,0,0
77697,lower,1,0
77698,deterioration,1,1
77699,of,1,1
77700,depression,1,1
77701,",",1,0
77702,anger,1,1
77703,",",1,1
77704,mind,1,0
77705,function,1,1
77706,",",1,0
77707,everyday,1,0
77708,life,1,1
77709,",",1,0
77710,and,1,1
77711,zest,1,1
77712,for,1,0
77713,life,1,1
77714,than,0,0
77715,those,0,0
77716,in,0,0
77717,the,0,0
77718,placebo,0,0
77719,group,0,0
77720,.,0,0
77721,After,0,0
77722,treatment,0,0
77723,",",0,0
77724,the,0,0
77725,beneficial,1,0
77726,effects,1,0
77727,of,0,0
77728,amantadine,0,0
77729,disappeared,0,0
77730,.,0,0
77731,CONCLUSION,0,0
77732,The,0,0
77733,addition,0,0
77734,of,0,0
77735,amantadine,0,0
77736,to,0,0
77737,IFN-alpha,0,0
77738,plus,0,0
77739,ribavirin,0,0
77740,combination,0,0
77741,therapy,0,0
77742,may,0,0
77743,reduce,0,0
77744,deterioration,1,1
77745,of,1,0
77746,depression,1,1
77747,",",1,0
77748,fatigue,1,1
77749,",",1,1
77750,and,1,1
77751,vigor,1,1
77752,during,0,0
77753,treatment,0,0
77754,but,0,0
77755,does,0,0
77756,not,0,0
77757,affect,0,0
77758,quality,1,1
77759,of,1,0
77760,life,1,1
77761,after,0,0
77762,treatment,0,0
77763,.,0,0
77764,A,0,0
77765,randomized,0,0
77766,placebo-controlled,0,0
77767,trial,0,0
77768,comparing,0,0
77769,the,0,0
77770,efficacy,0,1
77771,of,0,0
77772,etoricoxib,0,0
77773,30,0,0
77774,mg,0,0
77775,and,0,0
77776,ibuprofen,0,0
77777,2400,0,0
77778,mg,0,0
77779,for,0,0
77780,the,0,0
77781,treatment,0,0
77782,of,0,0
77783,patients,0,0
77784,with,0,0
77785,osteoarthritis,0,0
77786,.,0,0
77787,OBJECTIVE,0,0
77788,We,0,0
77789,compared,0,0
77790,the,0,0
77791,efficacy,0,1
77792,of,0,0
77793,etoricoxib,0,0
77794,30,0,0
77795,mg,0,0
77796,to,0,0
77797,placebo,0,0
77798,and,0,0
77799,ibuprofen,0,0
77800,2400,0,0
77801,mg,0,0
77802,for,0,0
77803,the,0,0
77804,treatment,0,0
77805,of,0,0
77806,osteoarthritis,0,1
77807,(,0,0
77808,OA,0,0
77809,),0,0
77810,of,0,0
77811,the,0,0
77812,hip,0,1
77813,and,0,0
77814,knee,0,1
77815,.,0,1
77816,DESIGN,0,0
77817,In,0,0
77818,this,0,0
77819,12-week,0,0
77820,",",0,0
77821,randomized,0,0
77822,",",0,0
77823,double-blind,0,0
77824,",",0,0
77825,placebo-,0,0
77826,and,0,1
77827,active-comparator-controlled,0,0
77828,trial,0,0
77829,",",0,0
77830,548,0,0
77831,patients,0,0
77832,(,0,0
77833,median,0,0
77834,age,0,0
77835,63,0,0
77836,years,0,0
77837,),0,0
77838,with,0,0
77839,OA,0,0
77840,of,0,0
77841,the,0,0
77842,hip,0,1
77843,or,0,0
77844,knee,0,1
77845,were,0,0
77846,randomized,0,0
77847,to,0,0
77848,receive,0,0
77849,placebo,0,0
77850,",",0,0
77851,etoricoxib,0,0
77852,30,0,0
77853,mg,0,0
77854,q.d.,0,0
77855,",",0,0
77856,or,0,0
77857,ibuprofen,0,0
77858,800,0,0
77859,mg,0,0
77860,t.i.d,0,0
77861,.,0,0
77862,Demonstration,0,0
77863,of,0,0
77864,etoricoxib,0,0
77865,'s,0,1
77866,efficacy,0,1
77867,vs,0,0
77868,placebo,0,0
77869,and,0,1
77870,comparison,0,0
77871,of,0,0
77872,its,0,0
77873,efficacy,0,0
77874,to,0,0
77875,ibuprofen,0,0
77876,were,0,0
77877,assessed,0,0
77878,using,0,0
77879,three,0,0
77880,co-primary,0,0
77881,endpoints,0,0
77882,:,0,0
77883,Western,1,0
77884,Ontario,1,0
77885,and,1,0
77886,McMaster,1,1
77887,'s,1,1
77888,University,1,0
77889,Osteoarthritis,1,0
77890,Index,1,0
77891,(,1,0
77892,WOMAC,1,1
77893,),1,0
77894,Pain,1,1
77895,Subscale,1,1
77896,(,1,0
77897,WOMAC-PS,1,0
77898,),1,0
77899,;,1,0
77900,WOMAC,1,1
77901,Physical,1,1
77902,Function,1,1
77903,Subscale,1,1
77904,(,1,0
77905,WOMAC-PFS,1,0
77906,),1,0
77907,;,1,0
77908,and,1,0
77909,Patient,1,1
77910,Global,1,1
77911,Assessment,1,0
77912,of,1,0
77913,Disease,1,1
77914,Status,1,1
77915,(,1,0
77916,PGADS,1,0
77917,),1,0
77918,.,1,0
77919,Each,0,0
77920,primary,0,0
77921,endpoint,0,0
77922,utilizes,0,0
77923,a,0,0
77924,0-100,0,0
77925,mm,0,0
77926,visual,0,1
77927,analog,0,1
77928,scale,0,1
77929,.,0,0
77930,To,0,0
77931,demonstrate,0,0
77932,comparable,0,0
77933,efficacy,0,1
77934,of,0,0
77935,etoricoxib,0,0
77936,vs,0,0
77937,ibuprofen,0,0
77938,",",0,0
77939,the,0,0
77940,95,0,0
77941,%,0,0
77942,confidence,0,0
77943,intervals,0,0
77944,(,0,0
77945,CIs,0,1
77946,),0,0
77947,for,0,0
77948,the,0,0
77949,difference,0,0
77950,in,0,0
77951,the,0,0
77952,least,1,0
77953,squares,1,0
77954,(,1,0
77955,LS,1,0
77956,),1,0
77957,mean,1,1
77958,change,1,0
77959,over,0,0
77960,12,0,0
77961,weeks,0,0
77962,for,0,0
77963,all,0,0
77964,three,0,0
77965,co-primary,0,0
77966,endpoints,0,0
77967,had,0,0
77968,to,0,0
77969,fall,0,0
77970,within,0,0
77971,+/-10,0,0
77972,mm,0,0
77973,.,0,0
77974,Safety,1,1
77975,and,1,0
77976,tolerability,1,1
77977,data,1,0
77978,were,0,0
77979,collected,0,0
77980,throughout,0,0
77981,the,0,0
77982,study,0,0
77983,.,0,0
77984,RESULTS,0,0
77985,Mean,1,1
77986,baseline,1,0
77987,values,1,1
77988,for,0,0
77989,the,0,0
77990,three,0,0
77991,co-primary,0,0
77992,endpoints,0,0
77993,ranged,0,0
77994,from,0,0
77995,62.52,0,0
77996,to,0,0
77997,70.14,0,0
77998,mm,0,0
77999,.,0,0
78000,Both,0,0
78001,etoricoxib,0,0
78002,and,0,0
78003,ibuprofen,0,0
78004,demonstrated,0,0
78005,superior,0,0
78006,(,0,0
78007,P,0,0
78008,<,0,0
78009,or,0,0
78010,=0.002,0,0
78011,),0,1
78012,efficacy,1,1
78013,for,0,0
78014,all,0,0
78015,primary,0,0
78016,endpoints,0,1
78017,.,0,0
78018,The,0,0
78019,LS,0,0
78020,mean,0,1
78021,(,0,0
78022,mm,0,0
78023,),0,1
78024,changes,0,1
78025,(,0,0
78026,95,0,0
78027,%,0,0
78028,CI,0,0
78029,),0,0
78030,over,0,0
78031,12,0,0
78032,weeks,0,0
78033,for,0,0
78034,etoricoxib,0,0
78035,and,0,1
78036,ibuprofen,0,0
78037,",",0,0
78038,respectively,0,0
78039,",",0,0
78040,compared,0,0
78041,to,0,0
78042,placebo,0,0
78043,were,0,0
78044,given,0,0
78045,as,0,0
78046,follows,0,0
78047,:,0,0
78048,WOMAC-PS,1,0
78049,:,1,0
78050,-11.66,0,0
78051,(,0,0
78052,-16.31,0,0
78053,",",0,0
78054,-7.01,0,0
78055,),0,1
78056,and,0,0
78057,-7.62,0,0
78058,(,0,0
78059,-12.30,0,0
78060,",",0,0
78061,-2.94,0,0
78062,),0,0
78063,;,0,0
78064,WOMAC-PFS,1,0
78065,:,1,0
78066,-10.15,0,0
78067,(,0,0
78068,-14.74,0,0
78069,",",0,0
78070,-5.57,0,0
78071,),0,1
78072,and,0,0
78073,-7.23,0,0
78074,(,0,0
78075,-11.85,0,0
78076,",",0,0
78077,-2.61,0,0
78078,),0,0
78079,;,0,0
78080,PGADS,1,0
78081,:,1,0
78082,-11.65,0,0
78083,(,0,0
78084,-16.81,0,0
78085,",",0,0
78086,-6.50,0,0
78087,),0,1
78088,and,0,0
78089,-8.11,0,0
78090,(,0,0
78091,-13.30,0,0
78092,",",0,0
78093,-2.92,0,0
78094,),0,0
78095,.,0,0
78096,The,0,0
78097,efficacy,1,1
78098,of,0,0
78099,etoricoxib,0,0
78100,30,0,0
78101,mg,0,0
78102,was,0,0
78103,comparable,0,0
78104,to,0,0
78105,ibuprofen,0,0
78106,2400,0,0
78107,mg.,0,0
78108,All,0,0
78109,treatments,0,0
78110,were,0,0
78111,similarly,0,0
78112,well,0,0
78113,tolerated,1,1
78114,.,1,0
78115,CONCLUSION,0,0
78116,Treatment,0,0
78117,with,0,0
78118,etoricoxib,0,0
78119,30,0,0
78120,mg,0,0
78121,q.d,0,0
78122,.,0,0
78123,provides,0,0
78124,superior,0,0
78125,efficacy,1,1
78126,vs,0,0
78127,placebo,0,0
78128,and,0,1
78129,comparable,0,0
78130,clinical,0,0
78131,efficacy,0,1
78132,vs,0,0
78133,ibuprofen,0,0
78134,2400,0,0
78135,mg,0,0
78136,(,0,0
78137,800,0,0
78138,mg,0,0
78139,t.i.d,0,0
78140,.,0,0
78141,),0,0
78142,for,0,0
78143,the,0,0
78144,treatment,0,0
78145,of,0,0
78146,OA,0,0
78147,of,0,0
78148,the,0,0
78149,hip,0,1
78150,and,0,0
78151,knee,0,1
78152,.,0,0
78153,Protein,0,0
78154,ingestion,0,1
78155,further,0,0
78156,augments,0,1
78157,S6K1,0,0
78158,phosphorylation,0,0
78159,in,0,0
78160,skeletal,0,0
78161,muscle,0,0
78162,following,0,0
78163,resistance,0,1
78164,type,0,0
78165,exercise,0,0
78166,in,0,0
78167,males,0,0
78168,.,0,0
78169,Our,0,0
78170,objective,0,0
78171,was,0,0
78172,to,0,0
78173,determine,0,0
78174,the,0,0
78175,impact,0,0
78176,of,0,0
78177,carbohydrate,0,1
78178,and/or,0,0
78179,protein,0,1
78180,ingestion,0,1
78181,before,0,0
78182,and,0,0
78183,after,0,0
78184,exercise,0,0
78185,on,0,0
78186,ribosomal,0,0
78187,protein,0,1
78188,S6,0,0
78189,kinase,0,0
78190,(,0,0
78191,S6K1,0,0
78192,),0,0
78193,and,0,0
78194,S6,0,0
78195,phosphorylation,0,1
78196,status,0,1
78197,in,0,0
78198,human,0,0
78199,skeletal,0,0
78200,muscle,0,0
78201,tissue,0,1
78202,.,0,0
78203,Seven,0,1
78204,healthy,0,0
78205,",",0,0
78206,untrained,0,0
78207,men,0,0
78208,(,0,0
78209,22.5,0,0
78210,+/-,0,0
78211,0.9,0,0
78212,y,0,0
78213,),0,0
78214,were,0,0
78215,randomly,0,0
78216,assigned,0,0
78217,to,0,0
78218,2,0,0
78219,cross-over,0,0
78220,experiments,0,0
78221,.,0,0
78222,Before,0,0
78223,",",0,0
78224,immediately,0,0
78225,after,0,0
78226,",",0,0
78227,and,0,0
78228,1,0,0
78229,h,0,0
78230,after,0,0
78231,a,0,0
78232,single,0,0
78233,bout,0,1
78234,of,0,0
78235,resistance,0,1
78236,exercise,0,0
78237,",",0,0
78238,subjects,0,0
78239,consumed,0,0
78240,0.3,0,0
78241,g,0,0
78242,x,0,0
78243,kg,0,0
78244,(,0,0
78245,-1,0,0
78246,),0,0
78247,carbohydrate,0,0
78248,with,0,0
78249,or,0,0
78250,without,0,0
78251,0.3,0,0
78252,g,0,0
78253,x,0,0
78254,kg,0,0
78255,(,0,0
78256,-1,0,0
78257,),0,1
78258,protein,0,1
78259,hydrolysate,0,1
78260,(,0,0
78261,CHO+PRO,0,0
78262,and,0,1
78263,CHO,0,0
78264,",",0,0
78265,respectively,0,0
78266,),0,0
78267,.,0,0
78268,Muscle,0,1
78269,biopsies,0,0
78270,were,0,0
78271,taken,0,0
78272,before,0,0
78273,and,0,0
78274,immediately,0,0
78275,after,0,0
78276,exercise,0,0
78277,and,0,0
78278,after,0,0
78279,1,0,0
78280,and,0,0
78281,4,0,0
78282,h,0,0
78283,of,0,0
78284,postexercise,0,0
78285,recovery,0,1
78286,to,0,0
78287,determine,0,0
78288,4E-BP1,0,0
78289,",",0,0
78290,S6K1,0,0
78291,(,0,0
78292,both,0,0
78293,T,0,0
78294,(,0,0
78295,421,0,0
78296,),0,0
78297,/S,0,0
78298,(,0,0
78299,424,0,0
78300,),0,0
78301,and,0,0
78302,T,0,0
78303,(,0,0
78304,389,0,0
78305,),0,0
78306,),0,0
78307,",",0,0
78308,and,0,1
78309,S6,0,0
78310,phosphorylation,0,1
78311,status,0,1
78312,.,0,0
78313,Following,1,0
78314,resistance,1,1
78315,exercise,1,0
78316,",",1,0
78317,4E-BP1,1,1
78318,phosphorylation,1,1
78319,was,1,0
78320,reduced,1,0
78321,to,1,0
78322,a,1,0
78323,greater,1,0
78324,extent,1,0
78325,in,1,0
78326,the,1,0
78327,CHO,1,0
78328,treatment,1,0
78329,(,1,0
78330,-48,1,0
78331,+/-,1,0
78332,7,1,0
78333,%,1,0
78334,),1,0
78335,than,1,0
78336,in,1,0
78337,the,1,0
78338,CHO+PRO,1,0
78339,treatment,1,0
78340,(,1,0
78341,-15,1,0
78342,+/-,1,0
78343,14,1,0
78344,%,1,0
78345,",",1,0
78346,P,1,0
78347,<,1,0
78348,0.01,1,0
78349,),1,0
78350,.,1,0
78351,During,1,0
78352,recovery,1,1
78353,",",1,0
78354,4E-BP1,1,0
78355,phosphorylation,1,1
78356,increased,1,0
78357,in,1,0
78358,both,1,0
78359,experiments,1,0
78360,(,1,0
78361,P,1,0
78362,<,1,0
78363,0.01,1,0
78364,),1,0
78365,",",1,0
78366,and,1,0
78367,tended,1,0
78368,to,1,0
78369,be,1,0
78370,higher,1,0
78371,in,1,0
78372,the,1,0
78373,CHO+PRO,1,0
78374,test,1,1
78375,(,1,0
78376,P,1,0
78377,=,1,0
78378,0.08,1,0
78379,),1,0
78380,.,1,0
78381,S6K1,1,0
78382,phosphorylation,1,0
78383,at,1,0
78384,T,1,0
78385,(,1,0
78386,421,1,0
78387,),1,0
78388,/S,1,0
78389,(,1,0
78390,424,1,0
78391,),1,0
78392,substantially,1,0
78393,increased,1,0
78394,following,1,0
78395,exercise,1,0
78396,and,1,0
78397,remained,1,0
78398,elevated,1,0
78399,during,1,0
78400,recovery,1,0
78401,with,1,0
78402,no,1,0
78403,differences,1,0
78404,between,1,0
78405,treatments,1,0
78406,.,1,0
78407,In,1,0
78408,contrast,1,0
78409,to,1,0
78410,the,1,0
78411,CHO,1,0
78412,treatment,1,0
78413,(,1,0
78414,-4,1,0
78415,+/-,1,0
78416,2,1,0
78417,%,1,0
78418,),1,0
78419,",",1,0
78420,S6K1,1,0
78421,phosphorylation,1,1
78422,at,1,0
78423,T,1,0
78424,(,1,0
78425,389,1,0
78426,),1,0
78427,was,1,0
78428,higher,1,0
78429,following,1,0
78430,exercise,1,0
78431,in,1,0
78432,the,1,0
78433,CHO+PRO,1,0
78434,treatment,1,0
78435,only,1,0
78436,(,1,0
78437,+78,1,0
78438,+/-,1,0
78439,2,1,0
78440,%,1,0
78441,",",1,0
78442,P,1,0
78443,<,1,0
78444,0.01,1,0
78445,),1,0
78446,.,1,0
78447,During,1,0
78448,recovery,1,1
78449,",",1,0
78450,S6K1,1,0
78451,phosphorylation,1,1
78452,at,1,0
78453,T,1,0
78454,(,1,0
78455,389,1,0
78456,),1,0
78457,remained,1,0
78458,higher,1,0
78459,in,1,0
78460,CHO+PRO,1,0
78461,than,1,0
78462,in,1,0
78463,CHO,1,0
78464,(,1,0
78465,P,1,0
78466,<,1,0
78467,0.05,1,0
78468,),1,0
78469,.,1,0
78470,S6,1,0
78471,phosphorylation,1,1
78472,was,1,0
78473,substantially,1,0
78474,higher,1,0
78475,following,1,0
78476,exercise,1,0
78477,in,1,0
78478,the,1,0
78479,CHO+PRO,1,0
78480,(,1,0
78481,1.69,1,0
78482,+/-,1,0
78483,0.35,1,0
78484,),1,0
78485,than,1,0
78486,in,1,0
78487,the,1,0
78488,CHO,1,0
78489,experiment,1,0
78490,(,1,0
78491,0.45,1,0
78492,+/-,1,0
78493,0.07,1,0
78494,",",1,0
78495,P,1,0
78496,<,1,0
78497,0.01,1,0
78498,),1,0
78499,and,1,0
78500,remained,1,0
78501,elevated,1,0
78502,during,1,0
78503,recovery,1,1
78504,(,1,0
78505,P,1,0
78506,<,1,0
78507,0.05,1,0
78508,),1,0
78509,.,1,0
78510,We,0,0
78511,conclude,0,0
78512,that,0,0
78513,the,0,0
78514,availability,0,0
78515,of,0,0
78516,dietary,0,0
78517,protein,0,0
78518,further,0,0
78519,enhances,0,0
78520,phosphorylation,0,0
78521,of,0,0
78522,S6K1,0,0
78523,during,0,0
78524,recovery,0,1
78525,from,0,0
78526,resistance,0,1
78527,type,0,0
78528,exercise,0,0
78529,.,0,0
78530,A,0,0
78531,randomized,0,0
78532,",",0,0
78533,controlled,0,0
78534,trial,0,0
78535,of,0,0
78536,a,0,0
78537,home-based,0,0
78538,intervention,0,0
78539,program,0,0
78540,for,0,0
78541,children,0,0
78542,with,0,0
78543,autism,0,0
78544,and,0,0
78545,developmental,0,0
78546,delay,0,1
78547,.,0,0
78548,OBJECTIVE,0,0
78549,This,0,0
78550,study,0,0
78551,aimed,0,0
78552,to,0,0
78553,(,0,0
78554,1,0,0
78555,),0,0
78556,investigate,0,0
78557,whether,0,0
78558,provision,0,0
78559,of,0,0
78560,a,0,0
78561,home-based,0,0
78562,program,0,0
78563,in,0,0
78564,addition,0,0
78565,to,0,0
78566,a,0,0
78567,center-based,0,0
78568,program,0,0
78569,improves,0,1
78570,development,0,1
78571,in,0,0
78572,young,0,0
78573,children,0,0
78574,with,0,0
78575,disabilities,0,0
78576,and,0,0
78577,coping,0,1
78578,abilities,0,1
78579,of,0,0
78580,their,0,0
78581,families,0,0
78582,and,0,0
78583,(,0,0
78584,2,0,0
78585,),0,0
78586,describe,0,0
78587,the,0,0
78588,characteristics,0,0
78589,of,0,0
78590,children,0,0
78591,and,0,0
78592,families,0,0
78593,who,0,0
78594,benefit,0,0
78595,most,0,0
78596,from,0,0
78597,the,0,0
78598,intervention,0,0
78599,.,0,0
78600,METHODS,0,0
78601,Fifty-nine,0,0
78602,children,0,0
78603,",",0,0
78604,aged,0,0
78605,3-5,0,0
78606,years,0,0
78607,",",0,0
78608,with,0,0
78609,no,0,0
78610,cerebral,0,1
78611,palsy,0,0
78612,",",0,0
78613,participated,0,0
78614,in,0,0
78615,the,0,0
78616,study,0,0
78617,.,0,0
78618,Half,0,0
78619,of,0,0
78620,the,0,0
78621,group,0,0
78622,was,0,0
78623,randomized,0,0
78624,to,0,0
78625,receive,0,0
78626,an,0,0
78627,additional,0,0
78628,program,0,0
78629,in,0,0
78630,their,0,0
78631,homes,0,0
78632,.,0,0
78633,A,0,0
78634,special,0,0
78635,education,0,0
78636,teacher,0,0
78637,provided,0,0
78638,40,0,0
78639,visits,0,0
78640,over,0,0
78641,12,0,0
78642,months,0,0
78643,working,0,0
78644,with,0,0
78645,the,0,0
78646,families,0,0
78647,to,0,0
78648,help,0,0
78649,generalize,0,0
78650,skills,0,1
78651,to,0,0
78652,the,0,0
78653,home,0,0
78654,environment,0,0
78655,and,0,1
78656,assist,0,0
78657,with,0,0
78658,their,0,0
78659,concerns,0,0
78660,.,0,0
78661,All,0,0
78662,children,0,0
78663,were,0,0
78664,assessed,0,0
78665,before,0,0
78666,and,0,0
78667,after,0,0
78668,the,0,0
78669,intervention,0,0
78670,",",0,0
78671,and,0,1
78672,families,0,0
78673,completed,0,0
78674,questionnaires,0,0
78675,assessing,0,0
78676,family,1,0
78677,stress,1,1
78678,",",1,1
78679,support,1,0
78680,",",1,1
78681,and,1,1
78682,empowerment,1,1
78683,on,0,0
78684,both,0,0
78685,occasions,0,0
78686,.,0,0
78687,Differences,0,0
78688,in,0,0
78689,change,0,0
78690,over,0,0
78691,time,0,1
78692,and,0,0
78693,between,0,0
78694,the,0,0
78695,intervention,0,0
78696,and,0,1
78697,control,0,0
78698,group,0,0
78699,were,0,0
78700,analyzed,0,0
78701,by,0,0
78702,repeated,0,0
78703,measures,0,1
78704,and,0,0
78705,the,0,0
78706,association,0,0
78707,between,0,0
78708,characteristics,0,0
78709,of,0,0
78710,children,0,0
78711,and,0,0
78712,families,0,0
78713,with,0,0
78714,improved,0,1
78715,outcome,0,0
78716,by,0,0
78717,multivariate,0,0
78718,analysis,0,0
78719,of,0,0
78720,variance,0,0
78721,.,0,0
78722,RESULTS,0,0
78723,Change,1,0
78724,in,1,0
78725,cognitive,1,1
78726,development,1,1
78727,and,1,1
78728,behavior,1,1
78729,(,0,0
78730,in,0,0
78731,the,0,0
78732,centers,0,0
78733,),0,0
78734,over,0,0
78735,time,0,1
78736,favored,0,0
78737,the,0,0
78738,children,0,0
78739,who,0,0
78740,received,0,0
78741,the,0,0
78742,extra,0,0
78743,intervention,0,0
78744,(,0,0
78745,p,0,0
78746,=,0,0
78747,.007,0,0
78748,and,0,0
78749,p,0,0
78750,=,0,0
78751,.007,0,0
78752,",",0,0
78753,respectively,0,0
78754,),0,0
78755,.,0,0
78756,The,0,0
78757,groups,0,0
78758,did,0,0
78759,not,0,0
78760,differ,1,0
78761,on,0,0
78762,any,0,0
78763,of,0,0
78764,the,0,0
78765,family,1,0
78766,measures,1,1
78767,of,1,0
78768,change,1,0
78769,.,1,0
78770,Multivariate,0,0
78771,analysis,0,0
78772,of,0,0
78773,variance,0,0
78774,revealed,0,0
78775,more,0,0
78776,improvement,0,1
78777,for,0,0
78778,children,0,0
78779,in,0,0
78780,the,0,0
78781,intervention,0,0
78782,group,0,0
78783,from,0,0
78784,higher,0,0
78785,than,0,0
78786,lower,0,0
78787,stressed,0,0
78788,families,0,0
78789,.,0,0
78790,CONCLUSIONS,0,0
78791,Results,0,0
78792,suggest,0,0
78793,the,0,0
78794,need,0,0
78795,for,0,0
78796,daily,0,0
78797,reinforcement,0,1
78798,of,0,0
78799,skills,0,1
78800,learned,0,0
78801,at,0,0
78802,the,0,0
78803,center-based,0,0
78804,program,0,0
78805,and,0,0
78806,the,0,0
78807,importance,0,0
78808,of,0,0
78809,involving,0,0
78810,families,0,0
78811,",",0,0
78812,especially,0,0
78813,those,0,0
78814,with,0,0
78815,few,0,0
78816,resources,0,0
78817,and,0,0
78818,relatively,0,0
78819,high,0,0
78820,stress,0,1
78821,.,0,0
78822,Should,0,0
78823,snacks,0,0
78824,be,0,0
78825,recommended,0,0
78826,in,0,0
78827,obesity,0,0
78828,treatment,0,0
78829,?,0,0
78830,A,0,0
78831,1-year,0,0
78832,randomized,0,0
78833,clinical,0,0
78834,trial,0,0
78835,.,0,0
78836,OBJECTIVE,0,0
78837,To,0,0
78838,study,0,0
78839,the,0,0
78840,effect,0,0
78841,to,0,0
78842,recommend,0,0
78843,no,0,0
78844,snacks,0,0
78845,vs,0,0
78846,three,0,0
78847,snacks,0,0
78848,per,0,0
78849,day,0,0
78850,on,0,0
78851,1-year,0,0
78852,weight,0,1
78853,loss,0,1
78854,.,0,0
78855,The,0,0
78856,hypothesis,0,0
78857,was,0,0
78858,that,0,0
78859,it,0,0
78860,is,0,0
78861,easier,0,0
78862,to,0,0
78863,control,0,0
78864,energy,0,1
78865,intake,0,1
78866,and,0,1
78867,lose,0,1
78868,weight,0,1
78869,if,0,0
78870,snacks,0,0
78871,in,0,0
78872,between,0,0
78873,meals,0,0
78874,are,0,0
78875,omitted,0,0
78876,.,0,0
78877,SUBJECTS/METHOD,0,0
78878,In,0,0
78879,total,0,0
78880,140,0,0
78881,patients,0,0
78882,(,0,0
78883,36,0,0
78884,men,0,0
78885,",",0,0
78886,104,0,0
78887,women,0,0
78888,),0,0
78889,",",0,0
78890,aged,0,0
78891,18-60,0,0
78892,years,0,0
78893,and,0,0
78894,body,0,1
78895,mass,0,1
78896,index,0,1
78897,>,0,0
78898,30,0,0
78899,kg/m,0,0
78900,(,0,0
78901,2,0,0
78902,),0,0
78903,were,0,0
78904,randomized,0,0
78905,and,0,0
78906,93,0,0
78907,patients,0,0
78908,(,0,0
78909,27,0,0
78910,men,0,0
78911,",",0,0
78912,66,0,0
78913,women,0,0
78914,),0,0
78915,completed,0,0
78916,the,0,0
78917,study,0,0
78918,.,0,0
78919,A,0,0
78920,1-year,0,0
78921,randomized,0,0
78922,intervention,0,0
78923,trial,0,0
78924,was,0,0
78925,conducted,0,0
78926,with,0,0
78927,two,0,0
78928,treatment,0,0
78929,arms,0,0
78930,with,0,0
78931,different,0,0
78932,eating,0,1
78933,frequencies,0,0
78934,;,0,0
78935,3,0,0
78936,meals/day,0,0
78937,(,0,0
78938,3M,0,0
78939,),0,0
78940,or,0,0
78941,3,0,0
78942,meals,0,0
78943,and,0,0
78944,3,0,0
78945,snacks/day,0,1
78946,(,0,0
78947,3+3M,0,0
78948,),0,0
78949,.,0,0
78950,The,0,0
78951,patients,0,0
78952,received,0,0
78953,regular,0,0
78954,and,0,0
78955,individualized,0,0
78956,counseling,0,0
78957,by,0,0
78958,dieticians,0,0
78959,.,0,0
78960,Information,1,0
78961,on,1,0
78962,eating,1,1
78963,patterns,1,1
78964,",",1,0
78965,dietary,1,1
78966,intake,1,1
78967,",",1,0
78968,weight,1,1
78969,and,1,1
78970,metabolic,1,1
78971,variables,1,1
78972,was,0,0
78973,collected,0,0
78974,at,0,0
78975,baseline,0,0
78976,and,0,0
78977,after,0,0
78978,1,0,0
78979,year,0,0
78980,.,0,0
78981,RESULTS,0,0
78982,Over,0,0
78983,1,0,0
78984,year,0,0
78985,the,0,0
78986,3M,0,0
78987,group,0,0
78988,reported,0,0
78989,a,0,0
78990,decrease,0,0
78991,in,0,0
78992,the,0,0
78993,number,1,1
78994,of,1,0
78995,snacks,1,0
78996,whereas,0,0
78997,the,0,0
78998,3+3M,0,0
78999,group,0,0
79000,reported,0,0
79001,an,0,0
79002,increase,0,0
79003,(,0,0
79004,-1.1,0,0
79005,vs,0,0
79006,+0.4,0,0
79007,snacks/day,0,1
79008,",",0,0
79009,respectively,0,0
79010,",",0,0
79011,P,0,0
79012,<,0,0
79013,0.0001,0,0
79014,),0,0
79015,.,0,0
79016,Both,0,0
79017,groups,0,0
79018,decreased,0,0
79019,energy,1,1
79020,intake,1,1
79021,and,0,1
79022,E,1,1
79023,%,1,0
79024,(,1,0
79025,energy,1,1
79026,percent,1,1
79027,),1,1
79028,fat,1,1
79029,and,0,0
79030,increased,0,1
79031,E,1,1
79032,%,1,0
79033,protein,1,0
79034,and,1,1
79035,fiber,1,0
79036,intake,1,1
79037,but,0,0
79038,there,0,0
79039,was,0,0
79040,no,0,0
79041,differences,0,0
79042,between,0,0
79043,the,0,0
79044,groups,0,0
79045,.,0,0
79046,Both,0,0
79047,groups,0,0
79048,lost,1,1
79049,weight,1,1
79050,",",0,1
79051,but,0,0
79052,there,0,0
79053,was,0,0
79054,no,0,0
79055,significant,0,0
79056,difference,0,0
79057,in,0,0
79058,weight,1,1
79059,loss,1,1
79060,after,0,0
79061,1,0,0
79062,year,0,0
79063,of,0,0
79064,treatment,0,0
79065,(,0,0
79066,3M,0,0
79067,vs,0,0
79068,3+3M=-4.1+/-6.1,0,0
79069,vs,0,0
79070,-5.9+/-9.4,0,0
79071,kg,0,0
79072,;,0,0
79073,P=0.31,0,0
79074,),0,0
79075,.,0,0
79076,Changes,0,1
79077,in,0,0
79078,metabolic,1,1
79079,variables,1,0
79080,did,0,0
79081,not,0,0
79082,differ,0,0
79083,between,0,0
79084,the,0,0
79085,groups,0,0
79086,",",0,0
79087,except,0,0
79088,for,0,0
79089,high-density,1,1
79090,lipoprotein,1,1
79091,that,0,0
79092,increased,0,0
79093,in,0,0
79094,the,0,0
79095,3M,0,0
79096,group,0,0
79097,but,0,0
79098,not,0,0
79099,in,0,0
79100,3+3M,0,0
79101,group,0,0
79102,(,0,0
79103,P,0,0
79104,<,0,0
79105,0.033,0,0
79106,for,0,0
79107,group,0,0
79108,difference,0,0
79109,),0,0
79110,.,0,0
79111,CONCLUSION,0,0
79112,Recommending,0,0
79113,snacks,0,0
79114,or,0,0
79115,not,0,0
79116,between,0,0
79117,meals,0,0
79118,does,0,0
79119,not,0,0
79120,influence,0,0
79121,1-year,1,0
79122,weight,1,1
79123,loss,1,1
79124,.,1,0
79125,Multitomographic,0,0
79126,evaluation,0,0
79127,of,0,0
79128,the,0,0
79129,dental,1,0
79130,effects,1,0
79131,of,0,0
79132,two,0,0
79133,different,0,0
79134,rapid,0,0
79135,palatal,0,1
79136,expansion,0,0
79137,appliances,0,0
79138,.,0,0
79139,Rapid,0,1
79140,palatal,0,1
79141,expansion,0,0
79142,(,0,0
79143,RPE,0,0
79144,),0,0
79145,is,0,0
79146,widely,0,0
79147,used,0,0
79148,in,0,0
79149,the,0,0
79150,treatment,0,0
79151,of,0,0
79152,transverse,0,1
79153,maxillary,0,0
79154,deficiencies,0,0
79155,.,0,0
79156,Generally,0,0
79157,",",0,0
79158,there,0,0
79159,are,0,0
79160,two,0,0
79161,types,0,0
79162,of,0,0
79163,RPE,0,0
79164,appliances,0,0
79165,:,0,0
79166,banded,0,0
79167,and,0,0
79168,bonded,0,0
79169,expanders,0,0
79170,.,0,0
79171,The,0,0
79172,purpose,0,0
79173,of,0,0
79174,this,0,0
79175,prospective,0,0
79176,study,0,0
79177,was,0,0
79178,to,0,0
79179,compare,0,0
79180,the,0,0
79181,dental,1,0
79182,effects,1,0
79183,of,0,0
79184,banded,0,1
79185,and,0,0
79186,bonded,0,0
79187,appliances,0,0
79188,.,0,0
79189,The,0,0
79190,study,0,0
79191,consisted,0,0
79192,of,0,0
79193,23,0,0
79194,patients,0,0
79195,(,0,0
79196,13,0,0
79197,females,0,0
79198,and,0,0
79199,10,0,0
79200,males,0,0
79201,),0,0
79202,with,0,0
79203,a,0,0
79204,bilateral,0,0
79205,maxillary,0,0
79206,deficiency,0,0
79207,.,0,0
79208,Twelve,0,0
79209,patients,0,0
79210,(,0,0
79211,seven,0,0
79212,females,0,0
79213,and,0,0
79214,five,0,0
79215,males,0,0
79216,),0,0
79217,with,0,0
79218,a,0,0
79219,mean,0,1
79220,age,0,0
79221,of,0,0
79222,14.8,0,0
79223,+/-,0,0
79224,0.3,0,0
79225,years,0,0
79226,were,0,0
79227,treated,0,0
79228,with,0,0
79229,banded,0,0
79230,RPE,0,0
79231,and,0,0
79232,11,0,0
79233,patients,0,0
79234,(,0,0
79235,six,0,0
79236,females,0,0
79237,and,0,0
79238,five,0,0
79239,males,0,0
79240,),0,0
79241,with,0,0
79242,a,0,0
79243,mean,0,1
79244,age,0,0
79245,of,0,0
79246,15.1,0,0
79247,+/-,0,0
79248,0.7,0,0
79249,years,0,0
79250,with,0,0
79251,bonded,0,0
79252,RPE,0,0
79253,.,0,0
79254,Multitomographic,0,1
79255,radiographs,0,1
79256,were,0,0
79257,taken,0,0
79258,before,0,0
79259,(,0,0
79260,T0,0,0
79261,),0,0
79262,and,0,0
79263,at,0,0
79264,the,0,0
79265,end,0,0
79266,(,0,0
79267,T1,0,0
79268,),0,0
79269,of,0,0
79270,expansion,0,0
79271,while,0,0
79272,the,0,0
79273,patients,0,0
79274,were,0,0
79275,wearing,0,0
79276,an,0,0
79277,acrylic,0,0
79278,mandibular,0,0
79279,appliance,0,0
79280,in,0,0
79281,which,0,0
79282,ball,0,1
79283,bearings,0,0
79284,and,0,0
79285,bars,0,0
79286,were,0,0
79287,embedded,0,0
79288,.,0,0
79289,Statistical,0,0
79290,analyses,0,0
79291,of,0,0
79292,the,0,0
79293,measurements,0,0
79294,at,0,0
79295,T0,0,0
79296,and,0,0
79297,T1,0,1
79298,were,0,0
79299,undertaken,0,0
79300,with,0,0
79301,a,0,0
79302,paired,0,0
79303,t-test,0,0
79304,",",0,0
79305,and,0,0
79306,the,0,0
79307,difference,0,0
79308,between,0,0
79309,the,0,0
79310,groups,0,0
79311,assesed,0,0
79312,with,0,0
79313,a,0,0
79314,Student,0,1
79315,'s,0,0
79316,t-test,0,0
79317,.,0,0
79318,In,0,0
79319,both,0,0
79320,groups,0,0
79321,",",0,0
79322,the,0,0
79323,angle,1,1
79324,between,1,0
79325,the,1,0
79326,radiographic,1,1
79327,image,1,0
79328,of,1,0
79329,the,1,0
79330,bar,1,0
79331,and,1,0
79332,the,1,0
79333,axial,1,0
79334,inclination,1,1
79335,of,1,0
79336,the,1,0
79337,upper,1,0
79338,first,1,0
79339,premolar,1,0
79340,and,1,0
79341,molar,1,1
79342,teeth,1,1
79343,was,0,0
79344,(,0,0
79345,5.34,0,0
79346,and,0,0
79347,2.73,0,0
79348,degrees,0,0
79349,for,0,0
79350,the,0,0
79351,right,0,0
79352,premolars,0,0
79353,",",0,0
79354,5.17,0,0
79355,and,0,0
79356,2.28,0,0
79357,degrees,0,0
79358,for,0,0
79359,the,0,0
79360,left,0,0
79361,premolars,0,0
79362,",",0,0
79363,11.83,0,0
79364,and,0,0
79365,3.73,0,0
79366,degrees,0,0
79367,for,0,0
79368,the,0,0
79369,right,0,0
79370,molars,0,0
79371,",",0,0
79372,and,0,0
79373,9.75,0,0
79374,and,0,0
79375,5.64,0,0
79376,degrees,0,0
79377,for,0,0
79378,the,0,0
79379,left,0,0
79380,molars,0,0
79381,in,0,0
79382,the,0,0
79383,banded,0,0
79384,and,0,0
79385,bonded,0,0
79386,groups,0,0
79387,",",0,0
79388,respectively,0,0
79389,.,0,0
79390,The,0,0
79391,distance,1,0
79392,from,1,0
79393,the,1,0
79394,vestibular,1,0
79395,cortical,1,1
79396,plate,1,0
79397,to,1,0
79398,the,1,0
79399,palatal,1,1
79400,root,1,0
79401,of,1,0
79402,these,1,0
79403,teeth,1,0
79404,(,0,0
79405,1.17,0,0
79406,and,0,0
79407,1.23,0,0
79408,mm,0,0
79409,for,0,0
79410,the,0,0
79411,right,0,0
79412,premolars,0,0
79413,",",0,0
79414,2.46,0,0
79415,and,0,0
79416,1.09,0,0
79417,mm,0,0
79418,for,0,0
79419,the,0,0
79420,left,0,0
79421,premolars,0,0
79422,",",0,0
79423,2.75,0,0
79424,and,0,0
79425,0.64,0,0
79426,mm,0,0
79427,for,0,0
79428,the,0,0
79429,right,0,0
79430,molars,0,0
79431,",",0,0
79432,2.23,0,0
79433,and,0,0
79434,0.96,0,0
79435,mm,0,0
79436,for,0,0
79437,the,0,0
79438,left,0,0
79439,molars,0,0
79440,in,0,0
79441,the,0,0
79442,banded,0,0
79443,and,0,0
79444,bonded,0,0
79445,groups,0,0
79446,",",0,0
79447,respectively,0,0
79448,),0,0
79449,increased,0,0
79450,(,0,0
79451,both,0,0
79452,P,0,0
79453,<,0,0
79454,0.01,0,0
79455,),0,0
79456,.,0,0
79457,These,0,0
79458,increases,0,1
79459,indicated,0,0
79460,buccal,1,1
79461,tipping,1,1
79462,of,0,0
79463,the,0,0
79464,teeth,0,0
79465,.,0,0
79466,Comparison,0,0
79467,of,0,0
79468,the,0,0
79469,two,0,0
79470,groups,0,0
79471,showed,0,0
79472,that,0,0
79473,tipping,1,1
79474,of,1,0
79475,the,1,0
79476,first,1,0
79477,molar,1,0
79478,and,1,0
79479,premolar,1,0
79480,teeth,1,0
79481,in,0,0
79482,the,0,0
79483,banded,0,0
79484,group,0,0
79485,was,0,0
79486,significantly,0,0
79487,more,0,0
79488,than,0,0
79489,in,0,0
79490,the,0,0
79491,bonded,0,0
79492,group,0,0
79493,(,0,0
79494,P,0,0
79495,<,0,0
79496,0.01,0,0
79497,and,0,0
79498,P,0,0
79499,<,0,0
79500,0.001,0,0
79501,",",0,0
79502,respectively,0,0
79503,),0,0
79504,.,0,0
79505,Clinical,0,1
79506,application,0,0
79507,of,0,0
79508,C-reactive,0,1
79509,protein,0,0
79510,across,0,0
79511,the,0,0
79512,spectrum,0,0
79513,of,0,0
79514,acute,0,0
79515,coronary,0,0
79516,syndromes,0,0
79517,.,0,0
79518,BACKGROUND,0,0
79519,High-sensitivity,0,1
79520,C-reactive,0,1
79521,protein,0,1
79522,(,0,0
79523,hsCRP,0,0
79524,),0,0
79525,is,0,0
79526,associated,0,0
79527,with,0,0
79528,adverse,0,1
79529,cardiovascular,0,1
79530,outcomes,0,0
79531,in,0,0
79532,acute,0,0
79533,coronary,0,0
79534,syndromes,0,0
79535,(,0,0
79536,ACS,0,0
79537,),0,0
79538,.,0,0
79539,The,0,0
79540,ability,0,0
79541,to,0,0
79542,formulate,0,0
79543,recommendations,0,0
79544,regarding,0,0
79545,clinical,0,0
79546,use,0,0
79547,of,0,0
79548,hsCRP,0,0
79549,is,0,0
79550,limited,0,0
79551,by,0,0
79552,a,0,0
79553,paucity,0,0
79554,of,0,0
79555,data,0,0
79556,regarding,0,0
79557,several,0,0
79558,key,0,0
79559,issues,0,0
79560,.,0,0
79561,The,0,0
79562,purpose,0,0
79563,of,0,0
79564,this,0,0
79565,study,0,0
79566,was,0,0
79567,to,0,0
79568,evaluate,0,0
79569,hsCRP,0,0
79570,across,0,0
79571,the,0,0
79572,spectrum,0,0
79573,of,0,0
79574,ACS,0,0
79575,.,0,0
79576,METHODS,0,0
79577,hsCRP,1,0
79578,was,0,0
79579,measured,0,0
79580,on,0,0
79581,admission,0,0
79582,in,0,0
79583,3225,0,0
79584,patients,0,0
79585,with,0,0
79586,ACS,0,0
79587,.,0,0
79588,hsCRP,1,0
79589,concentrations,1,1
79590,were,0,0
79591,compared,0,0
79592,in,0,0
79593,patients,0,0
79594,who,0,0
79595,suffered,0,0
79596,an,0,0
79597,adverse,0,1
79598,cardiac,0,1
79599,outcome,0,0
79600,within,0,0
79601,10,0,0
79602,months,0,0
79603,of,0,0
79604,study,0,0
79605,entry,0,1
79606,and,0,0
79607,in,0,0
79608,patients,0,0
79609,who,0,0
79610,had,0,0
79611,no,0,0
79612,adverse,0,1
79613,event,0,0
79614,.,0,0
79615,Because,0,0
79616,of,0,0
79617,heterogeneity,0,0
79618,in,0,0
79619,the,0,0
79620,relationship,0,0
79621,between,0,0
79622,hsCRP,0,0
79623,and,0,0
79624,clinical,0,1
79625,outcomes,0,1
79626,",",0,0
79627,evaluation,0,0
79628,was,0,0
79629,limited,0,0
79630,to,0,0
79631,patients,0,0
79632,from,0,0
79633,whom,0,0
79634,samples,0,0
79635,were,0,0
79636,collected,0,0
79637,within,0,0
79638,48,0,0
79639,h,0,0
79640,of,0,0
79641,symptom,0,1
79642,onset,0,1
79643,.,0,0
79644,RESULTS,0,0
79645,Patients,0,0
79646,in,0,0
79647,the,0,0
79648,highest,0,0
79649,quartile,0,1
79650,of,0,0
79651,hsCRP,0,0
79652,compared,0,0
79653,to,0,0
79654,those,0,0
79655,in,0,0
79656,the,0,0
79657,lowest,0,0
79658,quartile,0,1
79659,were,0,0
79660,at,0,0
79661,increased,0,0
79662,risk,1,0
79663,of,1,0
79664,death,1,1
79665,at,0,0
79666,30,0,0
79667,days,0,0
79668,[,0,0
79669,adjusted,0,0
79670,hazard,0,1
79671,ratio,0,1
79672,(,0,0
79673,adjHR,0,0
79674,),0,0
79675,4.6,0,0
79676,",",0,0
79677,P,0,0
79678,<,0,0
79679,0.001,0,0
79680,],0,0
79681,and,0,0
79682,10,0,0
79683,months,0,0
79684,(,0,0
79685,adjHR,0,0
79686,3.9,0,0
79687,",",0,0
79688,P,0,0
79689,<,0,0
79690,0.001,0,0
79691,),0,0
79692,.,0,0
79693,In,0,0
79694,patients,0,0
79695,with,0,0
79696,unstable,0,0
79697,angina/non-ST-elevation,0,0
79698,myocardial,0,1
79699,infarction,0,1
79700,(,0,0
79701,STEMI,0,0
79702,),0,0
79703,",",0,0
79704,hsCRP,0,0
79705,>,0,0
79706,3,0,0
79707,mg/L,0,0
79708,was,0,0
79709,associated,0,0
79710,with,0,0
79711,increased,1,0
79712,10-month,1,0
79713,mortality,1,1
79714,(,0,0
79715,adjHR,0,0
79716,2.3,0,0
79717,",",0,0
79718,P,0,0
79719,=,0,0
79720,0.002,0,0
79721,),0,0
79722,",",0,0
79723,whereas,0,0
79724,in,0,0
79725,STEMI,0,0
79726,a,0,0
79727,relationship,0,0
79728,with,0,0
79729,mortality,0,1
79730,was,0,0
79731,seen,0,0
79732,at,0,0
79733,hsCRP,0,0
79734,>,0,0
79735,10,0,0
79736,mg/L,0,0
79737,(,0,0
79738,adjHR,0,0
79739,3.0,0,0
79740,",",0,0
79741,P,0,0
79742,=,0,0
79743,0.008,0,0
79744,),0,0
79745,.,0,0
79746,Increased,0,0
79747,concentrations,0,1
79748,of,0,0
79749,hsCRP,1,0
79750,were,0,0
79751,strongly,0,0
79752,associated,0,0
79753,with,0,0
79754,the,0,0
79755,development,0,0
79756,of,0,0
79757,heart,1,1
79758,failure,1,0
79759,at,0,0
79760,30,0,0
79761,days,0,0
79762,(,0,0
79763,adjHR,0,0
79764,8.2,0,0
79765,",",0,0
79766,P,0,0
79767,=,0,0
79768,0.001,0,0
79769,),0,0
79770,and,0,0
79771,10,0,0
79772,months,0,0
79773,(,0,0
79774,adjHR,0,0
79775,2.6,0,0
79776,",",0,0
79777,P,0,0
79778,=,0,0
79779,0.014,0,0
79780,),0,0
79781,.,0,0
79782,CONCLUSION,0,0
79783,Increased,0,0
79784,baseline,1,0
79785,concentrations,1,1
79786,of,1,0
79787,hsCRP,1,0
79788,are,0,0
79789,strongly,0,0
79790,associated,0,0
79791,with,0,0
79792,mortality,1,1
79793,and,1,1
79794,heart,1,1
79795,failure,1,1
79796,across,0,0
79797,the,0,0
79798,ACS,0,0
79799,spectrum,0,0
79800,.,0,0
79801,hsCRP,0,0
79802,measurement,0,0
79803,should,0,0
79804,be,0,0
79805,performed,0,0
79806,early,0,0
79807,after,0,0
79808,presentation,0,1
79809,and,0,1
79810,index,0,1
79811,diagnosis-specific,0,0
79812,cutpoints,0,0
79813,should,0,0
79814,be,0,0
79815,used,0,0
79816,.,0,0
79817,New,0,1
79818,mini-extracorporeal,0,0
79819,circulation,0,1
79820,system,0,0
79821,(,0,0
79822,ECC.O,0,0
79823,),0,0
79824,is,0,0
79825,a,0,0
79826,safe,0,0
79827,technique,0,0
79828,in,0,0
79829,coronary,0,0
79830,surgery,0,0
79831,.,0,0
79832,OBJECTIVES,0,0
79833,Cardiopulmonary,0,1
79834,bypass,0,0
79835,(,0,0
79836,CPB,0,0
79837,),0,0
79838,is,0,0
79839,known,0,0
79840,to,0,0
79841,cause,0,0
79842,the,0,0
79843,systemic,0,0
79844,inflammatory,0,1
79845,reaction,0,1
79846,after,0,0
79847,cardiac,0,1
79848,surgery,0,0
79849,.,0,0
79850,New,0,1
79851,coated,0,0
79852,and,0,0
79853,closed,0,0
79854,loop,0,0
79855,circuit,0,1
79856,systems,0,0
79857,may,0,0
79858,reduce,0,0
79859,this,0,0
79860,inflammation,1,1
79861,response,1,1
79862,and,1,0
79863,improve,1,0
79864,the,1,0
79865,surgical,1,0
79866,outcome,1,0
79867,.,1,0
79868,This,0,0
79869,study,0,0
79870,was,0,0
79871,designed,0,0
79872,to,0,0
79873,evaluate,0,0
79874,the,0,0
79875,safety,0,1
79876,and,0,0
79877,efficacy,0,1
79878,of,0,0
79879,the,0,0
79880,mini-extracorporeal,0,0
79881,circulation,0,1
79882,system,0,0
79883,(,0,0
79884,ECC.O,0,0
79885,),0,0
79886,in,0,0
79887,CABG,0,1
79888,patients,0,0
79889,.,0,0
79890,DESIGN,0,0
79891,Forty,0,0
79892,patients,0,0
79893,undergoing,0,0
79894,elective,0,0
79895,coronary,0,0
79896,surgery,0,0
79897,were,0,0
79898,randomized,0,0
79899,into,0,0
79900,two,0,0
79901,groups,0,0
79902,",",0,0
79903,the,0,0
79904,ECC.O,0,0
79905,group,0,0
79906,and,0,0
79907,the,0,0
79908,standard,0,0
79909,CPB,0,0
79910,group,0,0
79911,.,0,0
79912,Routine,0,1
79913,hemodynamic,0,1
79914,monitoring,0,0
79915,and,0,0
79916,biochemical,0,1
79917,measurements,0,0
79918,were,0,0
79919,registered,0,0
79920,according,0,0
79921,to,0,0
79922,the,0,0
79923,hospital,0,0
79924,practice,0,0
79925,.,0,0
79926,RESULTS,0,0
79927,The,0,0
79928,clinical,0,0
79929,outcome,0,0
79930,of,0,0
79931,the,0,0
79932,patients,0,0
79933,was,0,0
79934,similar,0,0
79935,in,0,0
79936,both,0,0
79937,groups,0,0
79938,.,0,0
79939,There,0,0
79940,were,0,0
79941,no,0,0
79942,significant,0,0
79943,differences,0,0
79944,between,0,0
79945,the,0,0
79946,groups,0,0
79947,in,0,0
79948,the,0,0
79949,duration,1,1
79950,of,1,0
79951,intubation,1,0
79952,following,1,0
79953,surgery,1,0
79954,",",1,0
79955,the,1,0
79956,length,1,1
79957,of,1,0
79958,intensive,1,0
79959,care,1,0
79960,unit-stay,1,1
79961,or,1,0
79962,the,1,0
79963,total,1,1
79964,hospital,1,0
79965,stay,1,1
79966,.,1,0
79967,The,0,0
79968,haemoglobin,1,1
79969,level,1,1
79970,was,0,0
79971,significantly,0,0
79972,higher,0,0
79973,(,0,0
79974,p=0.0069,0,0
79975,),0,0
79976,during,0,0
79977,and,0,0
79978,after,0,0
79979,the,0,0
79980,perfusion,0,0
79981,in,0,0
79982,the,0,0
79983,ECC.O,0,0
79984,group,0,0
79985,.,0,0
79986,CONCLUSIONS,0,0
79987,The,0,0
79988,ECC.O,0,0
79989,system,0,0
79990,can,0,0
79991,be,0,0
79992,safely,0,0
79993,used,0,0
79994,in,0,0
79995,CABG,0,1
79996,patients,0,0
79997,and,0,0
79998,it,0,0
79999,maintains,0,0
80000,haemoglobin,0,1
80001,level,0,1
80002,better,0,0
80003,than,0,0
80004,conventional,0,0
80005,CPB,0,0
80006,.,0,0
80007,Continuous,0,0
80008,event,0,1
80009,recorders,0,0
80010,did,0,0
80011,not,0,0
80012,affect,0,0
80013,anxiety,1,1
80014,or,0,0
80015,quality,1,1
80016,of,1,1
80017,life,1,1
80018,in,0,0
80019,patients,0,0
80020,with,0,0
80021,palpitations,0,1
80022,.,0,0
80023,OBJECTIVES,0,0
80024,Palpitations,0,0
80025,can,0,0
80026,generate,0,0
80027,feelings,0,1
80028,of,0,0
80029,anxiety,1,1
80030,and,0,1
80031,decrease,0,1
80032,quality,1,1
80033,of,1,1
80034,life,1,1
80035,(,1,0
80036,QoL,1,0
80037,),1,0
80038,due,0,0
80039,to,0,0
80040,fear,0,1
80041,of,0,0
80042,a,0,0
80043,cardiac,0,0
80044,abnormality,0,0
80045,.,0,0
80046,Continuous,0,0
80047,event,0,1
80048,recorders,0,0
80049,(,0,0
80050,CERs,0,0
80051,),0,0
80052,have,0,0
80053,proven,0,0
80054,to,0,0
80055,be,0,0
80056,successful,0,0
80057,in,0,0
80058,diagnosing,0,0
80059,causes,0,0
80060,of,0,0
80061,palpitations,0,1
80062,but,0,0
80063,may,0,0
80064,affect,0,0
80065,patient,0,1
80066,QoL,1,1
80067,and,0,0
80068,anxiety,1,1
80069,.,1,0
80070,The,0,0
80071,aim,0,0
80072,is,0,0
80073,to,0,0
80074,determine,0,0
80075,anxiety,1,1
80076,and,0,1
80077,health-related,1,1
80078,(,1,0
80079,HR,1,1
80080,),1,1
80081,-QoL,1,0
80082,and,0,0
80083,evaluate,0,0
80084,the,0,0
80085,burden,0,1
80086,of,0,0
80087,carrying,0,0
80088,a,0,0
80089,CER,0,0
80090,in,0,0
80091,general,0,0
80092,practice,0,0
80093,populations,0,0
80094,.,0,0
80095,STUDY,0,1
80096,DESIGN,0,0
80097,AND,0,0
80098,SETTING,0,0
80099,Patients,0,0
80100,(,0,0
80101,n=244,0,0
80102,),0,0
80103,participated,0,0
80104,in,0,0
80105,a,0,0
80106,randomized,0,0
80107,trial,0,0
80108,.,0,0
80109,One,0,0
80110,group,0,0
80111,(,0,0
80112,n=127,0,0
80113,),0,0
80114,carried,0,0
80115,a,0,0
80116,CER,0,0
80117,during,0,0
80118,4,0,0
80119,weeks,0,0
80120,.,0,0
80121,One,0,0
80122,hundred,0,0
80123,and,0,0
80124,seventeen,0,0
80125,patients,0,0
80126,formed,0,0
80127,the,0,0
80128,usual,0,0
80129,care,0,0
80130,(,0,0
80131,UC,0,1
80132,),0,0
80133,group,0,0
80134,.,0,0
80135,State-Trait,1,1
80136,Anxiety,1,1
80137,Inventory,1,1
80138,(,1,0
80139,STAI,1,0
80140,),1,0
80141,and,1,0
80142,the,1,0
80143,Short,1,0
80144,Form-36,1,1
80145,(,1,0
80146,SF-36,1,1
80147,),1,0
80148,were,0,0
80149,administered,0,0
80150,at,0,0
80151,study,0,0
80152,inclusion,0,0
80153,",",0,0
80154,after,0,0
80155,1,0,0
80156,",",0,0
80157,6,0,0
80158,months,0,0
80159,.,0,0
80160,RESULTS,0,0
80161,At,0,0
80162,baseline,0,0
80163,",",0,0
80164,patients,0,0
80165,reported,0,0
80166,greater,0,0
80167,anxiety,1,1
80168,and,0,1
80169,lower,1,0
80170,QoL,1,1
80171,than,0,0
80172,healthy,0,0
80173,populations,0,0
80174,.,0,0
80175,The,0,0
80176,CER,0,1
80177,group,0,0
80178,had,0,0
80179,three,0,0
80180,times,0,0
80181,more,0,0
80182,cardiac,1,1
80183,diagnoses,1,0
80184,than,0,0
80185,the,0,0
80186,UC,0,1
80187,group,0,0
80188,.,0,0
80189,No,0,0
80190,differences,0,0
80191,were,0,0
80192,found,0,0
80193,between,0,0
80194,CER,0,1
80195,group,0,0
80196,and,0,1
80197,UC,0,1
80198,group,0,0
80199,at,0,0
80200,6,0,0
80201,weeks,0,0
80202,.,0,0
80203,At,0,0
80204,6,0,0
80205,months,0,0
80206,",",0,0
80207,the,0,0
80208,UC,0,1
80209,group,0,0
80210,showed,0,0
80211,QoL,1,0
80212,improvement,1,1
80213,and,0,0
80214,less,0,0
80215,anxiety,1,1
80216,compared,0,0
80217,to,0,0
80218,the,0,0
80219,CER,0,0
80220,group,0,0
80221,.,0,0
80222,Type,1,0
80223,of,1,0
80224,diagnosis,1,0
80225,had,0,0
80226,influence,0,0
80227,",",0,1
80228,but,0,0
80229,did,0,0
80230,not,0,0
80231,fully,0,0
80232,explain,0,0
80233,these,0,0
80234,differences,0,0
80235,.,0,0
80236,CONCLUSION,0,0
80237,A,0,0
80238,CER,0,0
80239,does,0,0
80240,not,0,0
80241,negatively,0,0
80242,influence,0,0
80243,anxiety,1,1
80244,or,0,0
80245,QoL,1,0
80246,.,1,0
80247,Better,0,0
80248,outcomes,0,0
80249,in,0,0
80250,the,0,0
80251,UC,0,1
80252,group,0,0
80253,might,0,0
80254,be,0,0
80255,attributed,0,0
80256,to,0,0
80257,less,0,0
80258,cardiac,1,1
80259,diagnosis,1,0
80260,and,0,0
80261,more,0,0
80262,emphasis,0,0
80263,on,0,0
80264,psychological,1,1
80265,well-being,1,1
80266,.,1,0
80267,Rehabilitation,0,0
80268,of,0,0
80269,therapy-related,0,1
80270,cognitive,0,1
80271,deficits,0,0
80272,in,0,0
80273,patients,0,0
80274,after,0,0
80275,hematopoietic,0,0
80276,stem,0,1
80277,cell,0,0
80278,transplantation,0,0
80279,.,0,0
80280,Neuropsychological,0,0
80281,deficits,0,0
80282,are,0,0
80283,potential,0,0
80284,side,0,1
80285,effects,0,1
80286,of,0,0
80287,hematopoietic,0,0
80288,stem,0,1
80289,cell,0,1
80290,therapy,0,0
80291,(,0,0
80292,HSCT,0,1
80293,),0,0
80294,.,0,0
80295,Systematic,0,0
80296,data,0,0
80297,on,0,0
80298,the,0,0
80299,long-term,0,0
80300,course,0,0
80301,of,0,0
80302,and,0,0
80303,therapeutic,0,0
80304,options,0,0
80305,for,0,0
80306,these,0,0
80307,consequences,0,0
80308,are,0,0
80309,limited,0,0
80310,.,0,0
80311,One,0,0
80312,hundred,0,0
80313,fifty-seven,0,0
80314,patients,0,0
80315,were,0,0
80316,screened,0,0
80317,for,0,0
80318,cognitive,0,0
80319,deficits,0,0
80320,following,0,0
80321,HSCT,0,1
80322,for,0,0
80323,malignant,0,0
80324,diseases,0,0
80325,at,0,0
80326,an,0,0
80327,in-patient,0,0
80328,oncologic,0,0
80329,rehabilitation,0,0
80330,clinic,0,0
80331,.,0,0
80332,Patients,0,0
80333,showing,0,0
80334,evidence,0,0
80335,of,0,0
80336,impairment,0,1
80337,were,0,0
80338,randomly,0,0
80339,assigned,0,0
80340,to,0,0
80341,one,0,0
80342,of,0,0
80343,two,0,0
80344,training,0,0
80345,groups,0,0
80346,:,0,0
80347,individualized,0,0
80348,PC-supported,0,0
80349,training,0,0
80350,or,0,0
80351,neuropsychological,0,1
80352,group,0,0
80353,therapy,0,0
80354,.,0,0
80355,The,0,0
80356,control,0,0
80357,group,0,0
80358,consisted,0,0
80359,of,0,0
80360,patients,0,0
80361,who,0,0
80362,received,0,0
80363,no,0,0
80364,specific,0,0
80365,training,0,0
80366,.,0,0
80367,During,0,0
80368,in-patient,0,0
80369,rehabilitation,0,0
80370,",",0,0
80371,the,0,0
80372,results,1,0
80373,of,1,0
80374,a,1,0
80375,comprehensive,1,0
80376,neuropsychological,1,0
80377,test,1,1
80378,battery,1,0
80379,improved,0,0
80380,significantly,0,0
80381,in,0,0
80382,all,0,0
80383,three,0,0
80384,groups,0,0
80385,",",0,0
80386,and,0,0
80387,no,0,0
80388,specific,0,0
80389,intervention,0,0
80390,effects,0,1
80391,were,0,0
80392,identified,0,0
80393,.,0,0
80394,Neuropsychological,1,0
80395,deficits,1,0
80396,were,0,0
80397,still,0,0
80398,evident,0,0
80399,in,0,0
80400,a,0,0
80401,subgroup,0,0
80402,of,0,0
80403,patients,0,0
80404,6,0,0
80405,months,0,0
80406,later,0,0
80407,.,0,0
80408,Correlation,1,0
80409,between,1,0
80410,neuropsychological,1,1
80411,testing,1,0
80412,and,1,0
80413,patients,1,0
80414,',1,1
80415,self-evaluation,1,1
80416,of,1,0
80417,cognitive,1,1
80418,functioning,1,1
80419,in,1,0
80420,daily,1,0
80421,life,1,1
80422,was,0,0
80423,generally,0,0
80424,low,0,0
80425,.,0,0
80426,Sustained,1,1
80427,attention,1,0
80428,and,1,0
80429,verbal-semantic,1,1
80430,memory,1,1
80431,played,0,0
80432,the,0,0
80433,main,0,0
80434,role,0,0
80435,for,0,0
80436,self-appraisal,0,1
80437,and,0,0
80438,in,0,0
80439,the,0,0
80440,designation,0,0
80441,as,0,0
80442,'neuropsychologically,0,0
80443,impaired,0,0
80444,',0,0
80445,.,0,0
80446,In,0,0
80447,conclusion,0,0
80448,",",0,0
80449,a,0,0
80450,substantial,0,0
80451,number,0,1
80452,of,0,0
80453,patients,0,0
80454,revealed,0,0
80455,evidence,0,0
80456,of,0,0
80457,cognitive,0,1
80458,deficits,0,0
80459,a,0,0
80460,long,0,0
80461,time,0,1
80462,after,0,0
80463,HSCT,0,1
80464,.,0,0
80465,There,0,0
80466,is,0,0
80467,a,0,0
80468,need,0,0
80469,for,0,0
80470,more,0,0
80471,studies,0,0
80472,and,0,0
80473,for,0,0
80474,the,0,0
80475,development,0,0
80476,of,0,0
80477,differentiated,0,1
80478,rehabilitative,0,0
80479,measures,0,1
80480,for,0,0
80481,such,0,0
80482,therapeutic,0,0
80483,consequences,0,0
80484,.,0,0
80485,Midazolam,0,0
80486,as,0,0
80487,a,0,0
80488,main,0,0
80489,anesthesia,0,0
80490,induction,0,0
80491,agent,0,0
80492,--,0,0
80493,a,0,0
80494,comparison,0,0
80495,with,0,0
80496,thiopental,0,0
80497,and,0,0
80498,diazepam,0,0
80499,.,0,0
80500,A,0,0
80501,clinical,0,0
80502,randomized,0,0
80503,investigation,0,0
80504,was,0,0
80505,undertaken,0,0
80506,to,0,0
80507,determine,0,0
80508,the,0,0
80509,value,1,0
80510,of,0,0
80511,midazolam,0,0
80512,as,0,0
80513,a,0,0
80514,narcotic,0,0
80515,adjuvant,0,0
80516,for,0,0
80517,anesthetic,0,0
80518,induction,0,0
80519,.,0,0
80520,Thirty,0,0
80521,ASA,0,0
80522,I-II,0,1
80523,adult,0,0
80524,patients,0,0
80525,undergoing,0,0
80526,selective,0,0
80527,surgery,0,0
80528,were,0,0
80529,allocated,0,0
80530,randomly,0,0
80531,into,0,0
80532,two,0,0
80533,groups,0,0
80534,to,0,0
80535,receive,0,0
80536,one,0,0
80537,of,0,0
80538,the,0,0
80539,following,0,0
80540,agents,0,0
80541,:,0,0
80542,midazolam,0,0
80543,0.3,0,0
80544,mg/kg,0,0
80545,",",0,0
80546,thiopental,0,0
80547,5,0,0
80548,mg/kg,0,0
80549,",",0,0
80550,or,0,0
80551,diazepam,0,0
80552,0.4,0,0
80553,mg/kg,0,0
80554,.,0,0
80555,The,0,0
80556,induction,1,0
80557,time,1,1
80558,as,1,0
80559,measured,1,0
80560,from,1,0
80561,the,1,0
80562,onset,1,1
80563,of,1,0
80564,injection,1,0
80565,to,1,0
80566,loss,1,1
80567,of,1,0
80568,the,1,0
80569,eyelash,1,1
80570,reflex,1,1
80571,was,0,0
80572,shortest,0,1
80573,in,0,0
80574,the,0,0
80575,case,0,0
80576,of,0,0
80577,thiopental,0,0
80578,;,0,0
80579,while,0,0
80580,a,0,0
80581,lower,1,0
80582,frequency,1,1
80583,of,1,1
80584,apnea,1,1
80585,",",1,0
80586,lesser,1,0
80587,suppression,1,1
80588,of,1,1
80589,circulation,1,1
80590,",",0,0
80591,and,0,1
80592,lack,1,0
80593,of,1,1
80594,venous,1,1
80595,irritation,1,1
80596,were,0,0
80597,points,0,0
80598,favoring,0,0
80599,midazolam,0,0
80600,.,0,0
80601,However,0,0
80602,",",0,0
80603,further,0,0
80604,study,0,0
80605,is,0,0
80606,needed,0,0
80607,to,0,0
80608,clarify,0,0
80609,the,0,0
80610,moderate,1,0
80611,cardiovascular,1,1
80612,response,1,1
80613,seen,0,0
80614,during,0,0
80615,intubation,0,0
80616,in,0,0
80617,some,0,0
80618,cases,0,0
80619,as,0,0
80620,well,0,0
80621,as,0,0
80622,to,0,0
80623,elucidate,0,0
80624,any,0,0
80625,patient,0,0
80626,population,0,0
80627,differences,0,0
80628,.,0,0
80629,Tubeless,0,0
80630,percutaneous,0,0
80631,nephrolithotomy,0,0
80632,:,0,0
80633,safe,0,0
80634,even,0,0
80635,in,0,0
80636,supracostal,0,0
80637,access,0,0
80638,.,0,0
80639,PURPOSE,0,0
80640,This,0,0
80641,study,0,0
80642,was,0,0
80643,designed,0,0
80644,to,0,0
80645,determine,0,0
80646,the,0,0
80647,outcome,1,1
80648,and,1,0
80649,safety,1,1
80650,of,0,1
80651,tubeless,0,0
80652,percutaneous,0,0
80653,nephrolithotomy,0,0
80654,(,0,0
80655,PCNL,0,0
80656,),0,0
80657,in,0,0
80658,the,0,0
80659,treatment,0,0
80660,of,0,0
80661,renal,0,1
80662,calculi,0,0
80663,.,0,0
80664,PATIENTS,0,0
80665,AND,0,0
80666,METHODS,0,0
80667,Between,0,0
80668,November,0,0
80669,2005,0,0
80670,and,0,0
80671,March,0,0
80672,2006,0,0
80673,",",0,0
80674,48,0,0
80675,patients,0,0
80676,were,0,0
80677,randomized,0,0
80678,to,0,0
80679,either,0,0
80680,an,0,0
80681,18F,0,0
80682,Re-entry,0,0
80683,nephrostomy,0,0
80684,tube,0,0
80685,(,0,0
80686,group,0,0
80687,1,0,0
80688,),0,0
80689,or,0,0
80690,a,0,0
80691,6F,0,0
80692,Double-J,0,0
80693,stent,0,0
80694,(,0,0
80695,group,0,0
80696,2,0,0
80697,),0,0
80698,.,0,0
80699,The,0,0
80700,two,0,0
80701,groups,0,0
80702,were,0,0
80703,well,0,0
80704,matched,0,0
80705,for,0,0
80706,age,0,0
80707,",",0,0
80708,sex,0,0
80709,",",0,1
80710,stone,0,1
80711,size,0,1
80712,",",0,1
80713,stone,0,1
80714,laterality,0,1
80715,",",0,1
80716,and,0,1
80717,number,0,1
80718,of,0,1
80719,previous,0,0
80720,renal,0,0
80721,procedures,0,0
80722,.,0,0
80723,All,0,0
80724,PCNL,0,0
80725,procedures,0,0
80726,were,0,0
80727,performed,0,0
80728,by,0,0
80729,the,0,0
80730,same,0,0
80731,surgeon,0,0
80732,.,0,0
80733,Postoperative,1,0
80734,visual,1,1
80735,analog,1,1
80736,pain,1,1
80737,scale,1,1
80738,(,1,0
80739,VAS,1,0
80740,),1,0
80741,scores,1,1
80742,at,0,0
80743,8,0,0
80744,and,0,0
80745,24,0,0
80746,hours,0,0
80747,and,0,0
80748,14,0,0
80749,days,0,0
80750,after,0,0
80751,surgery,0,0
80752,",",0,0
80753,in-hospital,1,1
80754,analgesic,1,1
80755,use,1,0
80756,",",1,0
80757,length,1,1
80758,of,1,1
80759,hospital,1,1
80760,stay,1,1
80761,",",1,1
80762,success,1,1
80763,rate,1,1
80764,",",1,1
80765,blood,1,1
80766,transfusion,1,1
80767,rate,1,1
80768,",",1,0
80769,and,1,1
80770,postoperative,1,1
80771,complications,1,1
80772,were,0,0
80773,compared,0,0
80774,for,0,0
80775,the,0,0
80776,two,0,0
80777,groups,0,0
80778,.,0,0
80779,RESULTS,0,0
80780,The,0,0
80781,mean,1,1
80782,hospital,1,1
80783,stays,1,1
80784,in,0,0
80785,groups,0,0
80786,1,0,0
80787,and,0,0
80788,2,0,0
80789,were,0,0
80790,3.1,0,0
80791,and,0,0
80792,1.6,0,0
80793,days,0,0
80794,",",0,0
80795,respectively,0,0
80796,(,0,0
80797,P,0,0
80798,=,0,0
80799,0.003,0,0
80800,),0,0
80801,.,0,0
80802,The,0,0
80803,mean,1,0
80804,VAS,1,0
80805,scores,1,1
80806,8,0,0
80807,and,0,0
80808,24,0,0
80809,hours,0,0
80810,after,0,0
80811,surgery,0,0
80812,were,0,0
80813,significantly,0,0
80814,lower,0,0
80815,in,0,0
80816,group,0,0
80817,2,0,0
80818,than,0,0
80819,in,0,0
80820,group,0,0
80821,1,0,0
80822,(,0,0
80823,P,0,0
80824,=,0,0
80825,0.001,0,0
80826,),0,0
80827,.,0,0
80828,The,0,0
80829,postoperative,1,1
80830,analgesic,1,1
80831,requirement,1,1
80832,(,0,0
80833,diclofenac,0,0
80834,sodium,0,0
80835,),0,0
80836,was,0,0
80837,significantly,0,0
80838,higher,0,0
80839,in,0,0
80840,group,0,0
80841,1,0,0
80842,(,0,0
80843,263,0,0
80844,mg,0,0
80845,),0,0
80846,than,0,0
80847,in,0,0
80848,group,0,0
80849,2,0,0
80850,(,0,0
80851,120,0,0
80852,mg,0,0
80853,;,0,0
80854,P,0,0
80855,=,0,0
80856,0.02,0,0
80857,),0,0
80858,.,0,0
80859,The,0,0
80860,rate,1,1
80861,of,1,0
80862,blood,1,1
80863,transfusion,1,1
80864,in,0,0
80865,the,0,0
80866,two,0,0
80867,groups,0,0
80868,was,0,0
80869,similar,0,0
80870,(,0,0
80871,P,0,0
80872,=,0,0
80873,NS,0,1
80874,),0,0
80875,.,0,0
80876,There,0,0
80877,was,0,0
80878,no,0,0
80879,difference,0,0
80880,between,0,0
80881,the,0,0
80882,groups,0,0
80883,in,0,0
80884,VAS,1,0
80885,scores,1,1
80886,on,0,0
80887,postoperative,0,0
80888,day,0,0
80889,14,0,0
80890,.,0,0
80891,The,0,0
80892,number,1,1
80893,of,1,0
80894,supracostal,1,0
80895,accesses,1,0
80896,was,0,0
80897,significantly,0,0
80898,higher,0,0
80899,in,0,0
80900,group,0,0
80901,2,0,0
80902,than,0,0
80903,in,0,0
80904,group,0,0
80905,1,0,0
80906,(,0,0
80907,P,0,0
80908,=,0,0
80909,0.02,0,0
80910,),0,0
80911,.,0,0
80912,The,0,0
80913,stone-free,1,1
80914,rates,1,1
80915,and,1,0
80916,the,1,0
80917,numbers,1,1
80918,of,1,0
80919,patients,1,0
80920,with,0,0
80921,insignificant,1,0
80922,residual,1,1
80923,fragments,1,1
80924,were,0,0
80925,similar,0,0
80926,in,0,0
80927,the,0,0
80928,two,0,0
80929,groups,0,0
80930,.,0,0
80931,There,0,0
80932,was,0,0
80933,no,1,0
80934,urine,1,1
80935,leakage,1,1
80936,or,1,0
80937,formation,1,1
80938,of,1,1
80939,urinoma,1,1
80940,in,0,0
80941,patients,0,0
80942,with,0,0
80943,Double-J,0,0
80944,stents,0,0
80945,.,0,0
80946,CONCLUSION,0,0
80947,Tubeless,0,0
80948,PCNL,0,0
80949,is,0,0
80950,safe,0,0
80951,and,0,0
80952,effective,0,1
80953,even,0,0
80954,after,0,0
80955,supracostal,0,0
80956,access,0,0
80957,and,0,0
80958,is,0,0
80959,associated,0,0
80960,with,0,0
80961,less,0,0
80962,postoperative,1,1
80963,pain,1,1
80964,and,0,0
80965,a,1,0
80966,shorter,1,1
80967,hospital,1,1
80968,stay,1,1
80969,.,1,0
80970,Lactoferrin,0,1
80971,supplementation,0,0
80972,to,0,0
80973,Holstein,0,0
80974,calves,0,0
80975,during,0,0
80976,the,0,0
80977,preweaning,0,0
80978,and,0,0
80979,postweaning,0,0
80980,phases,0,0
80981,.,0,0
80982,Sixty,0,0
80983,Holstein,0,0
80984,calves,0,0
80985,(,0,0
80986,30,0,0
80987,bulls,0,0
80988,",",0,0
80989,30,0,0
80990,heifers,0,0
80991,),0,0
80992,were,0,0
80993,used,0,0
80994,to,0,0
80995,examine,0,0
80996,the,0,0
80997,effects,0,0
80998,of,0,0
80999,supplemental,0,0
81000,lactoferrin,0,1
81001,on,0,0
81002,feed,1,1
81003,intake,1,1
81004,",",1,1
81005,growth,1,1
81006,",",1,1
81007,and,1,1
81008,health,1,1
81009,during,0,0
81010,the,0,0
81011,preweaning,0,0
81012,and,0,0
81013,postweaning,0,0
81014,periods,0,0
81015,.,0,0
81016,One,0,0
81017,of,0,0
81018,3,0,0
81019,levels,0,1
81020,of,0,0
81021,lactoferrin,0,1
81022,was,0,0
81023,supplemented,0,0
81024,from,0,0
81025,3,0,0
81026,to,0,0
81027,56,0,0
81028,d,0,0
81029,in,0,0
81030,either,0,0
81031,whole,0,0
81032,milk,0,1
81033,or,0,0
81034,water,0,1
81035,to,0,0
81036,produce,0,0
81037,3,0,0
81038,dietary,0,0
81039,treatments,0,0
81040,:,0,0
81041,1,0,0
81042,),0,0
81043,0,0,0
81044,g/d,0,0
81045,",",0,0
81046,2,0,0
81047,),0,0
81048,0.5,0,0
81049,g/d,0,0
81050,",",0,0
81051,and,0,0
81052,3,0,0
81053,),0,0
81054,1,0,0
81055,g/d,0,0
81056,.,0,0
81057,Whole,0,0
81058,milk,0,0
81059,(,0,0
81060,3.8,0,0
81061,L/d,0,0
81062,),0,0
81063,containing,0,0
81064,lactoferrin,0,1
81065,supplements,0,0
81066,was,0,0
81067,fed,0,0
81068,from,0,0
81069,bottles,0,0
81070,until,0,0
81071,weaning,0,0
81072,at,0,0
81073,35,0,0
81074,d.,0,0
81075,From,0,0
81076,d,0,0
81077,36,0,0
81078,to,0,0
81079,56,0,0
81080,",",0,0
81081,lactoferrin,0,0
81082,supplements,0,0
81083,were,0,0
81084,added,0,0
81085,to,0,0
81086,water,0,0
81087,(,0,0
81088,15,0,0
81089,to,0,0
81090,25,0,0
81091,mL,0,0
81092,),0,0
81093,and,0,0
81094,fed,0,0
81095,from,0,0
81096,bottles,0,0
81097,.,0,0
81098,Lactoferrin,0,1
81099,supplementation,0,0
81100,had,0,0
81101,no,0,0
81102,effect,0,0
81103,on,0,0
81104,feed,1,1
81105,intake,1,1
81106,",",1,1
81107,body,1,1
81108,weight,1,1
81109,",",1,0
81110,average,1,1
81111,daily,1,0
81112,gain,1,1
81113,",",1,0
81114,heart,1,1
81115,girth,1,1
81116,",",1,1
81117,body,1,1
81118,temperature,1,1
81119,",",1,0
81120,fecal,1,1
81121,scores,1,1
81122,",",1,0
81123,respiratory,1,1
81124,scores,1,1
81125,",",1,0
81126,or,1,0
81127,haptoglobin,1,1
81128,concentrations,1,1
81129,.,1,0
81130,Calves,0,0
81131,were,0,0
81132,housed,0,0
81133,in,0,0
81134,individual,0,0
81135,pens,0,0
81136,in,0,0
81137,either,0,0
81138,an,0,0
81139,open-sided,0,0
81140,barn,0,0
81141,or,0,0
81142,hutches,0,0
81143,.,0,1
81144,Calves,0,0
81145,raised,0,0
81146,in,0,0
81147,the,0,0
81148,barn,0,0
81149,consumed,0,0
81150,more,0,0
81151,calf,0,1
81152,starter,0,0
81153,and,0,0
81154,therefore,0,0
81155,grew,0,0
81156,better,0,0
81157,than,0,0
81158,calves,0,0
81159,raised,0,0
81160,in,0,0
81161,hutches,0,0
81162,.,0,0
81163,Under,0,0
81164,the,0,0
81165,conditions,0,0
81166,of,0,0
81167,this,0,0
81168,study,0,0
81169,",",0,0
81170,lactoferrin,0,1
81171,supplementation,0,0
81172,was,0,0
81173,not,0,0
81174,beneficial,0,0
81175,.,0,0
81176,Further,0,0
81177,research,0,0
81178,is,0,0
81179,needed,0,0
81180,to,0,0
81181,fully,0,0
81182,elucidate,0,0
81183,the,0,0
81184,role,0,0
81185,of,0,0
81186,lactoferrin,0,1
81187,",",0,0
81188,and,0,1
81189,possible,0,0
81190,benefits,0,0
81191,during,0,0
81192,different,0,0
81193,feeding,0,0
81194,conditions,0,0
81195,or,0,0
81196,milk,0,1
81197,sources,0,0
81198,.,0,0
81199,Sivelestat,0,0
81200,sodium,0,0
81201,hydrate,0,0
81202,improves,0,1
81203,septic,0,1
81204,acute,0,0
81205,lung,0,1
81206,injury,0,1
81207,by,0,0
81208,reducing,0,0
81209,alveolar,0,1
81210,dysfunction,0,0
81211,.,0,0
81212,Sivelestat,0,0
81213,sodium,0,0
81214,hydrate,0,0
81215,(,0,0
81216,sivelestat,0,0
81217,),0,0
81218,is,0,0
81219,a,0,0
81220,selective,0,0
81221,inhibitor,0,0
81222,of,0,0
81223,polymorphonuclear,0,1
81224,leukocyte,0,1
81225,elastase,0,1
81226,(,0,0
81227,PMN-E,0,0
81228,),0,0
81229,.,0,0
81230,We,0,0
81231,administered,0,0
81232,sivelestat,0,0
81233,to,0,0
81234,patients,0,0
81235,with,0,0
81236,septic,0,1
81237,acute,0,0
81238,lung,0,1
81239,injury,0,1
81240,(,0,0
81241,ALI,0,0
81242,),0,0
81243,to,0,0
81244,examine,0,0
81245,its,0,0
81246,usefulness,0,0
81247,.,0,0
81248,The,0,0
81249,primary,0,0
81250,endpoints,0,1
81251,in,0,0
81252,the,0,0
81253,study,0,0
81254,were,0,0
81255,the,0,0
81256,duration,1,1
81257,of,1,0
81258,artificial,1,0
81259,ventilation,1,0
81260,and,1,0
81261,pulmonary,1,1
81262,oxygenation,1,1
81263,ability,1,1
81264,",",0,0
81265,and,0,0
81266,the,0,0
81267,secondary,0,0
81268,endpoints,0,1
81269,were,0,0
81270,mortality,1,1
81271,and,1,0
81272,the,1,0
81273,concentrations,1,1
81274,of,1,0
81275,PMN-E,1,0
81276,",",1,0
81277,SP-D,1,1
81278,",",1,1
81279,TNF-alpha,1,1
81280,and,1,1
81281,IL-8,1,1
81282,in,1,0
81283,blood,1,1
81284,.,1,0
81285,In,0,0
81286,the,0,0
81287,sivelestat,0,0
81288,group,0,0
81289,",",0,0
81290,the,0,0
81291,duration,1,1
81292,of,1,0
81293,artificial,1,0
81294,ventilation,1,0
81295,",",1,0
81296,pulmonary,1,1
81297,oxygenation,1,1
81298,ability,1,1
81299,",",1,0
81300,and,1,0
81301,the,1,0
81302,blood,1,1
81303,PMN-E,1,0
81304,",",1,0
81305,SP-D,1,1
81306,",",1,1
81307,TNF-alpha,1,1
81308,and,1,1
81309,IL-8,1,1
81310,concentrations,1,1
81311,decreased,0,0
81312,significantly,0,0
81313,.,0,0
81314,Administration,0,0
81315,of,0,0
81316,sivelestat,0,0
81317,was,0,0
81318,found,0,0
81319,to,0,0
81320,reduce,0,0
81321,alveolar,1,1
81322,dysfunction,1,0
81323,and,0,0
81324,improve,0,0
81325,respiratory,1,1
81326,function,1,1
81327,",",0,0
81328,and,0,0
81329,it,0,0
81330,was,0,0
81331,suggested,0,0
81332,that,0,0
81333,early,0,0
81334,administration,0,0
81335,might,0,0
81336,be,0,0
81337,useful,0,0
81338,.,0,0
81339,Exploring,0,0
81340,effects,0,0
81341,of,0,0
81342,different,0,0
81343,treadmill,0,0
81344,interventions,0,0
81345,on,0,0
81346,walking,1,1
81347,onset,1,1
81348,and,0,1
81349,gait,1,1
81350,patterns,1,1
81351,in,0,0
81352,infants,0,0
81353,with,0,0
81354,Down,0,0
81355,syndrome,0,0
81356,.,0,0
81357,Two,0,0
81358,cohorts,0,0
81359,of,0,0
81360,participants,0,0
81361,were,0,0
81362,included,0,0
81363,to,0,0
81364,investigate,0,0
81365,the,0,0
81366,effects,0,0
81367,of,0,0
81368,different,0,0
81369,treadmill,0,0
81370,interventions,0,0
81371,on,0,0
81372,walking,1,1
81373,onset,1,1
81374,and,0,1
81375,gait,1,1
81376,patterns,1,1
81377,in,0,0
81378,infants,0,0
81379,with,0,0
81380,Down,0,0
81381,syndrome,0,0
81382,(,0,0
81383,DS,0,1
81384,),0,0
81385,.,0,0
81386,The,0,0
81387,first,0,0
81388,cohort,0,0
81389,included,0,0
81390,30,0,0
81391,infants,0,0
81392,with,0,0
81393,DS,0,1
81394,(,0,0
81395,17,0,0
81396,males,0,0
81397,",",0,0
81398,13,0,0
81399,females,0,0
81400,;,0,0
81401,mean,0,1
81402,age,0,0
81403,10,0,0
81404,mo,0,0
81405,[,0,0
81406,SD,0,0
81407,1.9,0,0
81408,mo,0,0
81409,],0,0
81410,),0,0
81411,who,0,0
81412,were,0,0
81413,randomly,0,0
81414,assigned,0,0
81415,to,0,0
81416,either,0,0
81417,a,0,0
81418,lower-intensity-generalized,0,0
81419,(,0,0
81420,LG,0,0
81421,),0,0
81422,training,0,0
81423,group,0,0
81424,",",0,0
81425,or,0,0
81426,a,0,0
81427,higher-intensity-individualized,0,0
81428,(,0,0
81429,HI,0,0
81430,),0,0
81431,training,0,0
81432,group,0,0
81433,.,0,0
81434,A,0,0
81435,control,0,0
81436,(,0,0
81437,C,0,0
81438,),0,0
81439,group,0,0
81440,from,0,0
81441,another,0,0
81442,study,0,0
81443,",",0,0
81444,who,0,0
81445,did,0,0
81446,not,0,0
81447,receive,0,0
81448,treadmill,0,0
81449,training,0,0
81450,",",0,0
81451,served,0,0
81452,as,0,0
81453,the,0,0
81454,control,0,0
81455,(,0,0
81456,eight,0,0
81457,males,0,0
81458,",",0,0
81459,seven,0,0
81460,females,0,0
81461,;,0,0
81462,mean,0,1
81463,age,0,0
81464,10.4,0,0
81465,mo,0,0
81466,[,0,0
81467,SD,0,0
81468,2.2,0,0
81469,mo,0,0
81470,],0,0
81471,),0,0
81472,.,0,0
81473,Mean,1,0
81474,age,1,0
81475,at,1,0
81476,walking,1,1
81477,onset,1,1
81478,was,0,0
81479,19.2,0,0
81480,",",0,0
81481,21.4,0,0
81482,",",0,0
81483,and,0,0
81484,23.9,0,0
81485,months,0,0
81486,for,0,0
81487,the,0,0
81488,HI,0,0
81489,",",0,0
81490,LG,0,0
81491,",",0,1
81492,and,0,1
81493,C,0,0
81494,groups,0,0
81495,respectively,0,0
81496,.,0,0
81497,At,0,0
81498,walking,1,0
81499,onset,1,0
81500,the,0,0
81501,HI,0,0
81502,group,0,0
81503,was,0,0
81504,significantly,0,0
81505,younger,0,0
81506,than,0,0
81507,the,0,0
81508,C,0,0
81509,group,0,0
81510,(,0,0
81511,p=0.011,0,0
81512,),0,0
81513,.,0,0
81514,At,0,0
81515,the,0,0
81516,gait,0,1
81517,follow-up,0,0
81518,that,0,0
81519,was,0,0
81520,conducted,0,0
81521,between,0,0
81522,1,0,0
81523,and,0,0
81524,3,0,0
81525,months,0,0
81526,after,0,0
81527,walking,0,1
81528,onset,0,1
81529,",",0,0
81530,three,0,0
81531,groups,0,0
81532,significantly,0,0
81533,different,0,0
81534,in,0,0
81535,overall,0,1
81536,gait,0,1
81537,patterns,0,1
81538,(,0,0
81539,p=0.037,0,0
81540,),0,0
81541,were,0,0
81542,examined,0,0
81543,by,0,0
81544,six,0,0
81545,basic,0,0
81546,gait,0,0
81547,parameters,0,1
81548,including,0,0
81549,average,1,1
81550,velocity,1,1
81551,",",1,0
81552,stride,1,1
81553,length,1,1
81554,",",1,0
81555,step,1,1
81556,width,1,1
81557,",",1,0
81558,stride,1,1
81559,time,1,1
81560,",",1,0
81561,stance,1,1
81562,time,1,1
81563,",",1,0
81564,and,1,1
81565,dynamic,1,0
81566,base,1,0
81567,.,1,0
81568,Post-hoc,0,0
81569,analyses,0,0
81570,demonstrated,0,0
81571,that,0,0
81572,stride,1,1
81573,length,1,1
81574,was,0,0
81575,the,0,0
81576,gait,0,1
81577,parameter,0,1
81578,largely,0,0
81579,contributing,0,0
81580,to,0,0
81581,this,0,0
81582,overall,0,1
81583,group,0,0
81584,difference,0,1
81585,(,0,0
81586,p=0.033,0,0
81587,),0,1
81588,",",0,0
81589,and,0,0
81590,the,0,0
81591,HI,0,0
81592,group,0,0
81593,produced,0,0
81594,a,0,0
81595,significantly,0,0
81596,longer,0,0
81597,stride,1,1
81598,length,1,1
81599,than,0,0
81600,the,0,0
81601,C,0,0
81602,group,0,0
81603,(,0,0
81604,p=0.030,0,0
81605,),0,0
81606,.,0,0
81607,In,0,0
81608,conclusion,0,0
81609,",",0,0
81610,the,0,0
81611,HI,0,0
81612,treadmill,0,0
81613,intervention,0,0
81614,significantly,0,0
81615,promoted,0,0
81616,earlier,0,0
81617,walking,1,1
81618,onset,1,1
81619,and,0,0
81620,elicited,0,1
81621,more,0,0
81622,advanced,0,0
81623,gait,1,1
81624,patterns,1,1
81625,(,0,0
81626,particularly,0,0
81627,in,0,0
81628,stride,0,1
81629,length,0,1
81630,),0,0
81631,in,0,0
81632,infants,0,0
81633,with,0,0
81634,DS,0,0
81635,.,0,0
81636,Home,0,0
81637,blood,1,1
81638,pressure,1,1
81639,monitoring,0,0
81640,:,0,0
81641,advantages,0,0
81642,and,0,0
81643,limitations,0,0
81644,.,0,0
81645,Home,0,0
81646,blood,0,1
81647,pressure,0,1
81648,monitoring,0,0
81649,is,0,0
81650,a,0,0
81651,useful,0,0
81652,tool,0,0
81653,for,0,0
81654,clinical,1,0
81655,management,1,0
81656,of,0,0
81657,patients,0,0
81658,with,0,0
81659,hypertension,0,0
81660,.,0,0
81661,Its,0,0
81662,major,0,0
81663,advantages,0,0
81664,are,0,0
81665,the,0,0
81666,ease,0,0
81667,with,0,0
81668,which,0,0
81669,the,0,0
81670,techniques,0,0
81671,can,0,0
81672,be,0,0
81673,learned,0,0
81674,",",0,0
81675,reproducibility,0,1
81676,of,0,1
81677,values,0,1
81678,",",0,0
81679,sensitivity,0,1
81680,of,0,1
81681,measurement,0,1
81682,and,0,1
81683,availability,0,1
81684,of,0,1
81685,normotensive,0,0
81686,data,0,0
81687,.,0,0
81688,In,0,0
81689,spite,0,0
81690,of,0,0
81691,the,0,0
81692,ability,0,0
81693,to,0,0
81694,tell,0,0
81695,whether,0,0
81696,a,0,0
81697,subject,0,0
81698,has,0,0
81699,normal,0,0
81700,or,0,0
81701,abnormal,0,1
81702,values,0,1
81703,",",0,0
81704,because,0,0
81705,of,0,0
81706,the,0,0
81707,lack,0,0
81708,of,0,0
81709,prospective,0,0
81710,mortality/morbidity,0,1
81711,data,0,0
81712,",",0,0
81713,home,0,0
81714,blood,0,1
81715,pressure,0,1
81716,monitoring,0,0
81717,can,0,0
81718,not,0,0
81719,be,0,0
81720,used,0,0
81721,to,0,0
81722,decide,0,0
81723,whether,0,0
81724,treatment,0,0
81725,is,0,0
81726,indicated,0,0
81727,.,0,0
81728,The,0,0
81729,treatment,0,0
81730,decision,0,0
81731,must,0,0
81732,be,0,0
81733,based,0,0
81734,on,0,0
81735,repeated,0,0
81736,clinic,1,0
81737,blood,1,1
81738,pressure,1,1
81739,readings,1,0
81740,.,1,0
81741,After,0,0
81742,that,0,0
81743,the,0,0
81744,home,0,0
81745,blood,1,1
81746,pressure,1,1
81747,monitoring,0,0
81748,can,0,0
81749,be,0,0
81750,used,0,0
81751,to,0,0
81752,exclude,0,0
81753,individuals,0,0
81754,who,0,0
81755,are,0,0
81756,at,0,0
81757,risk,0,1
81758,for,0,0
81759,side,0,1
81760,effects,0,1
81761,due,0,0
81762,to,0,0
81763,low,0,0
81764,out-of-office,0,1
81765,blood,1,1
81766,pressure,1,1
81767,readings,0,0
81768,and,0,0
81769,to,0,0
81770,precisely,0,0
81771,monitor,0,0
81772,the,0,0
81773,blood,1,1
81774,pressure,1,1
81775,response,1,1
81776,to,0,0
81777,therapy,0,0
81778,.,0,0
81779,Home,0,0
81780,blood,0,1
81781,pressure,0,1
81782,monitoring,0,0
81783,is,0,0
81784,frequently,0,0
81785,used,0,0
81786,to,0,0
81787,find,0,0
81788,subjects,0,0
81789,with,0,0
81790,'white-coat,1,0
81791,',1,0
81792,hypertension,1,0
81793,.,1,0
81794,In,0,0
81795,our,0,0
81796,study,0,0
81797,of,0,0
81798,borderline,0,0
81799,hypertension,0,1
81800,in,0,0
81801,Tecumseh,0,0
81802,",",0,0
81803,white-coat,0,0
81804,hypertension,0,0
81805,is,0,0
81806,present,0,0
81807,in,0,0
81808,7.1,0,0
81809,%,0,0
81810,of,0,0
81811,the,0,0
81812,whole,0,0
81813,population,0,0
81814,and,0,0
81815,in,0,0
81816,58,0,0
81817,%,0,0
81818,of,0,0
81819,all,0,0
81820,subjects,0,0
81821,with,0,0
81822,elevated,0,1
81823,blood,1,1
81824,pressures,1,1
81825,in,0,0
81826,the,0,0
81827,clinic,0,0
81828,.,0,0
81829,Subjects,0,0
81830,with,0,0
81831,white-coat,0,0
81832,hypertension,0,1
81833,in,0,0
81834,Tecumseh,0,0
81835,appear,0,0
81836,to,0,0
81837,be,0,0
81838,at,0,0
81839,an,0,0
81840,increased,0,0
81841,risk,0,0
81842,for,0,0
81843,coronary,1,0
81844,heart,1,0
81845,disease,1,0
81846,:,1,0
81847,they,0,0
81848,show,0,0
81849,repeated,0,0
81850,elevated,0,0
81851,clinic,1,0
81852,readings,1,0
81853,throughout,0,0
81854,their,0,0
81855,life,0,1
81856,time,0,1
81857,",",0,0
81858,their,0,0
81859,parents,0,0
81860,have,0,0
81861,higher,0,0
81862,blood,1,1
81863,pressure,1,1
81864,",",0,0
81865,their,0,0
81866,high-density,1,0
81867,lipoprotein,1,1
81868,is,0,0
81869,decreased,0,0
81870,and,0,0
81871,insulin,1,1
81872,",",1,1
81873,cholesterol,1,1
81874,and,1,0
81875,triglycerides,1,1
81876,are,0,0
81877,elevated,0,0
81878,.,0,0
81879,Whereas,0,0
81880,subjects,0,0
81881,with,0,0
81882,white-coat,0,0
81883,hypertension,0,0
81884,should,0,0
81885,not,0,0
81886,be,0,0
81887,treated,0,0
81888,with,0,0
81889,antihypertensive,0,0
81890,agents,0,0
81891,",",0,0
81892,they,0,0
81893,must,0,0
81894,be,0,0
81895,followed,0,0
81896,and,0,0
81897,managed,0,0
81898,through,0,0
81899,non-pharmacologic,0,0
81900,means,0,0
81901,.,0,0
81902,The,0,0
81903,value-congruence,0,0
81904,model,0,0
81905,of,0,0
81906,memory,1,1
81907,for,1,0
81908,emotional,1,1
81909,experiences,1,0
81910,:,1,0
81911,an,0,0
81912,explanation,0,0
81913,for,0,0
81914,cultural,0,0
81915,differences,0,0
81916,in,0,0
81917,emotional,0,1
81918,self-reports,0,0
81919,.,0,0
81920,In,0,0
81921,3,0,0
81922,studies,0,0
81923,",",0,0
81924,the,0,0
81925,authors,0,0
81926,found,0,0
81927,support,0,0
81928,for,0,0
81929,the,0,0
81930,value-congruence,0,0
81931,model,0,0
81932,that,0,0
81933,accounts,0,0
81934,for,0,0
81935,cultural,0,0
81936,variations,0,0
81937,in,0,0
81938,memory,1,1
81939,for,1,0
81940,emotional,1,1
81941,experiences,1,0
81942,.,1,0
81943,In,0,0
81944,Study,0,0
81945,1,0,0
81946,",",0,0
81947,the,0,0
81948,authors,0,0
81949,found,0,0
81950,that,0,0
81951,in,0,0
81952,the,0,0
81953,made-in-the-U.S.,0,0
81954,scenario,0,0
81955,condition,0,0
81956,",",0,0
81957,European,0,0
81958,Americans,0,0
81959,were,0,0
81960,more,0,0
81961,accurate,0,1
81962,than,0,0
81963,were,0,0
81964,Asian,0,0
81965,Americans,0,0
81966,in,0,0
81967,their,0,0
81968,retrospective,1,0
81969,frequency,1,1
81970,judgments,1,1
81971,of,1,0
81972,emotions,1,1
81973,.,1,0
81974,However,0,0
81975,",",0,0
81976,in,0,0
81977,the,0,0
81978,made-in-Japan,0,0
81979,scenario,0,0
81980,condition,0,0
81981,",",0,0
81982,European,0,0
81983,Americans,0,0
81984,were,0,0
81985,less,0,0
81986,accurate,0,1
81987,than,0,0
81988,were,0,0
81989,Asian,0,0
81990,Americans,0,0
81991,.,0,0
81992,In,0,0
81993,Study,0,0
81994,2,0,0
81995,",",0,0
81996,the,0,0
81997,authors,0,0
81998,demonstrated,0,0
81999,that,0,0
82000,value,0,0
82001,orientation,0,0
82002,mediates,0,0
82003,the,0,0
82004,CulturexType,1,0
82005,of,1,0
82006,Event,1,0
82007,congruence,1,0
82008,effect,1,0
82009,.,1,0
82010,In,0,0
82011,Study,0,0
82012,3,0,0
82013,(,0,0
82014,a,0,0
82015,daily,0,0
82016,event,0,0
82017,sampling,0,0
82018,study,0,0
82019,),0,0
82020,",",0,0
82021,the,0,0
82022,authors,0,0
82023,showed,0,0
82024,that,0,0
82025,the,0,0
82026,congruence,1,1
82027,effect,1,0
82028,was,0,0
82029,explained,0,0
82030,by,0,0
82031,the,0,0
82032,importance,0,0
82033,of,0,0
82034,parental,0,1
82035,approval,0,0
82036,.,0,0
82037,In,0,0
82038,sum,0,1
82039,",",0,0
82040,emotional,0,1
82041,events,0,1
82042,congruent,0,0
82043,with,0,0
82044,personal,1,0
82045,values,1,0
82046,remain,0,0
82047,in,0,0
82048,memory,0,1
82049,longer,0,1
82050,and,0,1
82051,influence,0,1
82052,retrospective,1,0
82053,frequency,1,1
82054,judgments,1,1
82055,of,1,0
82056,emotion,1,0
82057,more,0,0
82058,than,0,0
82059,do,0,0
82060,incongruent,0,0
82061,events,0,1
82062,.,0,0
82063,A,0,0
82064,systems,0,0
82065,analysis,0,0
82066,of,0,0
82067,obstetric,0,0
82068,triage,0,0
82069,.,0,0
82070,OBJECTIVE,0,0
82071,The,0,0
82072,purpose,0,0
82073,of,0,0
82074,this,0,0
82075,study,0,0
82076,is,0,0
82077,to,0,0
82078,examine,0,0
82079,some,0,0
82080,of,0,0
82081,the,0,0
82082,variables,0,0
82083,involved,0,0
82084,in,0,0
82085,obstetric,0,0
82086,triage,0,0
82087,in,0,0
82088,an,0,0
82089,effort,0,0
82090,to,0,0
82091,develop,0,0
82092,a,0,0
82093,more,0,0
82094,efficient,0,1
82095,patient,0,1
82096,care,0,0
82097,delivery,0,1
82098,system,0,0
82099,in,0,0
82100,a,0,0
82101,high-volume,0,0
82102,obstetric,0,0
82103,unit,0,0
82104,.,0,0
82105,An,0,0
82106,efficient,0,0
82107,triage,0,0
82108,system,0,0
82109,is,0,0
82110,essential,0,0
82111,to,0,0
82112,a,0,0
82113,busy,0,0
82114,labor,0,1
82115,and,0,1
82116,delivery,0,1
82117,unit,0,0
82118,for,0,0
82119,the,0,0
82120,evaluation,0,0
82121,of,0,0
82122,unscheduled,0,1
82123,patient,0,0
82124,visits,0,0
82125,.,0,0
82126,In,0,0
82127,hospitals,0,0
82128,that,0,0
82129,lack,0,0
82130,an,0,0
82131,efficient,0,0
82132,obstetric,0,0
82133,triage,0,0
82134,system,0,0
82135,",",0,0
82136,it,0,0
82137,is,0,0
82138,very,0,0
82139,difficult,0,0
82140,to,0,0
82141,regulate,0,0
82142,patient,0,1
82143,flow,0,1
82144,and,0,1
82145,wait,0,0
82146,times,0,1
82147,.,0,0
82148,METHOD,0,0
82149,The,0,0
82150,study,0,0
82151,was,0,0
82152,designed,0,0
82153,to,0,0
82154,determine,0,0
82155,whether,0,0
82156,a,0,0
82157,triage,0,0
82158,room,0,0
82159,and/or,0,0
82160,standing,0,1
82161,orders,0,0
82162,decreased,0,0
82163,length,1,1
82164,of,1,0
82165,stay,1,1
82166,as,0,0
82167,compared,0,0
82168,to,0,0
82169,the,0,0
82170,existing,0,0
82171,system,0,0
82172,of,0,0
82173,evaluating,0,0
82174,women,0,0
82175,in,0,0
82176,labor,0,1
82177,rooms,0,0
82178,.,0,0
82179,In,0,0
82180,2,0,0
82181,separate,0,0
82182,phases,0,0
82183,",",0,0
82184,women,0,0
82185,who,0,0
82186,met,0,0
82187,triage,0,0
82188,criteria,0,0
82189,were,0,0
82190,randomly,0,0
82191,assigned,0,0
82192,to,0,0
82193,either,0,0
82194,the,0,0
82195,triage,0,1
82196,room,0,0
82197,or,0,0
82198,the,0,0
82199,standard,0,0
82200,care,0,0
82201,labor,0,1
82202,room,0,0
82203,.,0,0
82204,During,0,0
82205,phase,0,0
82206,1,0,0
82207,",",0,0
82208,the,0,0
82209,effect,0,0
82210,of,0,0
82211,room,0,1
82212,assignment,0,0
82213,was,0,0
82214,evaluated,0,0
82215,.,0,0
82216,During,0,0
82217,phase,0,0
82218,2,0,0
82219,",",0,0
82220,the,0,0
82221,effect,0,0
82222,of,0,0
82223,room,0,1
82224,assignment,0,0
82225,and,0,0
82226,the,0,0
82227,intervention,0,0
82228,of,0,0
82229,standing,0,0
82230,orders,0,0
82231,in,0,0
82232,common,0,0
82233,obstetric,0,1
82234,problems,0,1
82235,were,0,0
82236,utilized,0,0
82237,.,0,0
82238,The,0,0
82239,total,0,1
82240,sample,0,0
82241,size,0,1
82242,was,0,0
82243,398,0,0
82244,patients,0,0
82245,.,0,0
82246,The,0,0
82247,study,0,0
82248,took,0,0
82249,place,0,0
82250,on,0,0
82251,a,0,0
82252,midsize,0,0
82253,labor,0,1
82254,and,0,1
82255,delivery,0,1
82256,unit,0,1
82257,",",0,0
82258,in,0,0
82259,an,0,0
82260,academic,0,0
82261,medical,0,0
82262,center,0,0
82263,averaging,0,0
82264,3600,0,0
82265,births,0,0
82266,per,0,0
82267,year,0,0
82268,.,0,0
82269,RESULTS,0,0
82270,Results,0,0
82271,showed,0,0
82272,that,0,0
82273,using,0,0
82274,a,0,0
82275,triage,0,0
82276,room,0,0
82277,and/or,0,0
82278,standing,0,1
82279,orders,0,0
82280,did,0,0
82281,not,0,0
82282,significantly,0,0
82283,decrease,0,0
82284,length,1,1
82285,of,1,0
82286,stay,1,1
82287,.,1,0
82288,CONCLUSION,0,0
82289,The,0,0
82290,results,0,0
82291,of,0,0
82292,this,0,0
82293,study,0,0
82294,suggest,0,0
82295,that,0,0
82296,the,0,0
82297,triage,0,0
82298,process,0,0
82299,in,0,0
82300,this,0,0
82301,setting,0,0
82302,is,0,0
82303,strongly,0,0
82304,dependent,0,0
82305,on,0,0
82306,the,0,0
82307,provider,0,1
82308,'s,0,0
82309,availability,0,0
82310,to,0,0
82311,assess,0,0
82312,",",0,0
82313,triage,0,1
82314,",",0,1
82315,and,0,1
82316,discharge,0,1
82317,patients,0,0
82318,.,0,0
82319,Results,0,0
82320,of,0,0
82321,a,0,0
82322,phase,0,0
82323,III,0,0
82324,",",0,0
82325,8-week,0,0
82326,",",0,1
82327,multicenter,0,0
82328,",",0,1
82329,prospective,0,0
82330,",",0,0
82331,randomized,0,0
82332,",",0,0
82333,double-blind,0,0
82334,",",0,0
82335,parallel-group,0,0
82336,clinical,0,0
82337,trial,0,0
82338,to,0,0
82339,assess,0,0
82340,the,0,0
82341,effects,0,0
82342,of,0,0
82343,amlodipine,0,0
82344,camsylate,0,0
82345,versus,0,0
82346,amlodipine,0,0
82347,besylate,0,0
82348,in,0,0
82349,Korean,0,0
82350,adults,0,0
82351,with,0,0
82352,mild,0,0
82353,to,0,0
82354,moderate,0,0
82355,hypertension,0,0
82356,.,0,0
82357,BACKGROUND,0,0
82358,Amlodipine,0,0
82359,besylate,0,0
82360,has,0,0
82361,been,0,0
82362,used,0,0
82363,in,0,0
82364,Korea,0,0
82365,for,0,0
82366,the,0,0
82367,treatment,0,0
82368,of,0,0
82369,hypertension,0,1
82370,for,0,0
82371,>,0,0
82372,17,0,0
82373,years,0,0
82374,",",0,0
82375,with,0,0
82376,well-established,0,0
82377,efficacy,0,1
82378,and,0,0
82379,tolerability,0,1
82380,.,0,1
82381,Amlodipine,0,0
82382,camsylate,0,0
82383,is,0,0
82384,a,0,0
82385,newer,0,0
82386,formulation,0,0
82387,developed,0,1
82388,for,0,0
82389,generic,0,0
82390,use,0,0
82391,.,0,0
82392,It,0,0
82393,has,0,0
82394,been,0,0
82395,assessed,0,0
82396,in,0,0
82397,terms,0,0
82398,of,0,0
82399,physical,0,1
82400,stability,0,1
82401,and,0,1
82402,pharmacokinetic,0,1
82403,and,0,1
82404,pharmacodynamic,0,1
82405,properties,0,1
82406,and,0,0
82407,been,0,0
82408,found,0,0
82409,to,0,0
82410,be,0,0
82411,effective,0,0
82412,in,0,0
82413,lowering,0,0
82414,blood,0,1
82415,pressure,0,1
82416,in,0,0
82417,preclinical,0,0
82418,and,0,0
82419,Phase,0,0
82420,I,0,0
82421,and,0,0
82422,II,0,0
82423,trials,0,0
82424,.,0,0
82425,However,0,0
82426,",",0,0
82427,to,0,0
82428,date,0,0
82429,",",0,0
82430,no,0,0
82431,studies,0,0
82432,have,0,0
82433,compared,0,0
82434,the,0,0
82435,clinical,0,0
82436,effectiveness,0,1
82437,of,0,0
82438,amlodipine,0,0
82439,camsylate,0,0
82440,and,0,0
82441,amlodipine,0,0
82442,besylate,0,0
82443,in,0,0
82444,treating,0,0
82445,hypertension,0,0
82446,.,0,0
82447,OBJECTIVE,0,0
82448,This,0,0
82449,study,0,0
82450,was,0,0
82451,designed,0,0
82452,to,0,0
82453,determine,0,0
82454,the,0,0
82455,effectiveness,1,1
82456,and,1,0
82457,tolerability,1,1
82458,of,0,1
82459,amlodipine,0,0
82460,camsylate,0,0
82461,compared,0,0
82462,with,0,0
82463,amlodipine,0,0
82464,besylate,0,0
82465,in,0,0
82466,Korean,0,0
82467,patients,0,0
82468,with,0,0
82469,mild,0,0
82470,to,0,0
82471,moderate,0,0
82472,hypertension,0,0
82473,.,0,0
82474,METHODS,0,0
82475,This,0,0
82476,Phase,0,0
82477,III,0,0
82478,",",0,0
82479,8-week,0,0
82480,",",0,0
82481,prospective,0,0
82482,",",0,0
82483,randomized,0,0
82484,",",0,0
82485,double-blind,0,0
82486,",",0,0
82487,parallel-group,0,0
82488,study,0,0
82489,was,0,0
82490,conducted,0,0
82491,in,0,0
82492,13,0,0
82493,cardiology,0,0
82494,centers,0,0
82495,across,0,0
82496,the,0,0
82497,Republic,0,0
82498,of,0,0
82499,Korea,0,0
82500,.,0,0
82501,Male,0,0
82502,and,0,0
82503,female,0,0
82504,Korean,0,0
82505,patients,0,0
82506,aged,0,0
82507,18,0,0
82508,to,0,0
82509,75,0,0
82510,years,0,0
82511,having,0,0
82512,uncomplicated,0,0
82513,",",0,0
82514,mild,0,0
82515,to,0,0
82516,moderate,0,0
82517,",",0,0
82518,essential,0,0
82519,hypertension,0,1
82520,(,0,0
82521,sitting,0,1
82522,diastolic,0,1
82523,blood,0,1
82524,pressure,0,1
82525,[,0,0
82526,SiDBP,0,0
82527,],0,0
82528,90-,0,0
82529,<,0,0
82530,110,0,0
82531,mm,0,0
82532,Hg,0,0
82533,),0,0
82534,and,0,0
82535,receiving,0,0
82536,no,0,0
82537,antihypertensives,0,0
82538,in,0,0
82539,the,0,0
82540,2,0,0
82541,weeks,0,0
82542,before,0,0
82543,randomization,0,0
82544,were,0,0
82545,eligible,0,0
82546,.,0,0
82547,Patients,0,0
82548,were,0,0
82549,randomly,0,0
82550,assigned,0,0
82551,to,0,0
82552,receive,0,0
82553,oral,0,0
82554,treatment,0,0
82555,with,0,0
82556,amlodipine,0,0
82557,camsylate,0,0
82558,or,0,0
82559,amlodipine,0,0
82560,besylate,0,0
82561,.,0,0
82562,For,0,0
82563,the,0,0
82564,first,0,0
82565,4,0,0
82566,weeks,0,0
82567,",",0,0
82568,patients,0,0
82569,received,0,0
82570,amlodipine,0,0
82571,5,0,0
82572,mg,0,0
82573,QD,0,0
82574,(,0,0
82575,morning,0,0
82576,),0,0
82577,.,0,0
82578,After,0,0
82579,4,0,0
82580,weeks,0,0
82581,",",0,0
82582,if,0,0
82583,either,0,0
82584,blood,1,1
82585,pressure,1,1
82586,was,0,0
82587,>,0,0
82588,or,0,0
82589,=140/,0,0
82590,>,0,0
82591,or,0,0
82592,=90,0,0
82593,mm,0,0
82594,Hg,0,0
82595,or,0,0
82596,SiDBP,0,1
82597,had,0,0
82598,not,0,0
82599,decreased,0,0
82600,by,0,0
82601,>,0,0
82602,or,0,0
82603,=10,0,0
82604,mm,0,0
82605,Hg,0,0
82606,from,0,0
82607,baseline,0,0
82608,",",0,0
82609,the,0,0
82610,dose,0,0
82611,of,0,0
82612,amlodipine,0,0
82613,was,0,0
82614,increased,0,0
82615,to,0,0
82616,10,0,0
82617,mg,0,0
82618,QD,0,0
82619,for,0,0
82620,4,0,0
82621,weeks,0,0
82622,.,0,0
82623,Trough,1,0
82624,blood,1,1
82625,pressure,1,1
82626,and,1,1
82627,heart,1,1
82628,rate,1,1
82629,were,0,0
82630,measured,0,0
82631,in,0,0
82632,duplicate,0,0
82633,with,0,0
82634,the,0,0
82635,patient,0,0
82636,in,0,0
82637,the,0,0
82638,sitting,0,1
82639,position,0,0
82640,at,0,0
82641,each,0,0
82642,clinic,0,0
82643,visit,0,1
82644,(,0,0
82645,baseline,0,0
82646,[,0,0
82647,week,0,0
82648,0,0,0
82649,],0,0
82650,and,0,0
82651,weeks,0,0
82652,4,0,0
82653,and,0,0
82654,8,0,0
82655,of,0,0
82656,treatment,0,0
82657,),0,0
82658,;,0,0
82659,mean,0,1
82660,values,0,1
82661,were,0,0
82662,calculated,0,0
82663,and,0,0
82664,recorded,0,0
82665,.,0,0
82666,At,0,0
82667,weeks,0,0
82668,4,0,0
82669,and,0,0
82670,8,0,0
82671,",",0,0
82672,tolerability,1,0
82673,was,0,0
82674,assessed,0,0
82675,using,0,0
82676,history,0,0
82677,taking,0,0
82678,and,0,1
82679,laboratory,0,1
82680,analysis,0,0
82681,",",0,1
82682,and,0,1
82683,compliance,0,1
82684,was,0,0
82685,assessed,0,0
82686,using,0,0
82687,pill,0,0
82688,counts,0,1
82689,.,0,0
82690,The,0,0
82691,primary,0,0
82692,end,0,0
82693,point,0,0
82694,was,0,0
82695,change,0,1
82696,from,0,0
82697,baseline,0,0
82698,in,0,0
82699,SiDBP,1,0
82700,at,0,0
82701,week,0,0
82702,8,0,0
82703,.,0,0
82704,Secondary,0,0
82705,end,0,0
82706,points,0,0
82707,were,0,0
82708,change,0,0
82709,from,0,0
82710,baseline,0,0
82711,in,0,0
82712,sitting,1,1
82713,systolic,1,1
82714,blood,1,1
82715,pressure,1,1
82716,(,0,0
82717,SiSBP,0,0
82718,),0,0
82719,at,0,0
82720,week,0,0
82721,8,0,0
82722,in,0,0
82723,the,0,0
82724,total,0,1
82725,population,0,0
82726,and,0,0
82727,in,0,0
82728,the,0,0
82729,subgroup,0,0
82730,of,0,0
82731,patients,0,0
82732,who,0,0
82733,had,0,0
82734,previously,0,0
82735,received,0,0
82736,antihypertensive,0,0
82737,treatment,0,0
82738,versus,0,0
82739,those,0,0
82740,who,0,0
82741,had,0,0
82742,not,0,0
82743,.,0,0
82744,RESULTS,0,0
82745,A,0,0
82746,total,0,0
82747,of,0,0
82748,189,0,0
82749,patients,0,0
82750,were,0,0
82751,enrolled,0,0
82752,(,0,0
82753,mean,0,1
82754,age,0,0
82755,",",0,0
82756,53,0,0
82757,years,0,0
82758,;,0,0
82759,105,0,0
82760,women,0,0
82761,",",0,0
82762,84,0,0
82763,men,0,0
82764,;,0,0
82765,mean,0,1
82766,body,0,1
82767,weight,0,1
82768,",",0,0
82769,65.8,0,0
82770,kg,0,0
82771,),0,0
82772,.,0,0
82773,One,0,0
82774,patient,0,0
82775,in,0,0
82776,the,0,0
82777,amlodipine,0,0
82778,camsylate,0,0
82779,group,0,0
82780,dropped,0,0
82781,out,0,0
82782,of,0,0
82783,the,0,0
82784,study,0,0
82785,at,0,0
82786,week,0,0
82787,0,0,0
82788,of,0,0
82789,treatment,0,0
82790,(,0,0
82791,this,0,0
82792,patient,0,0
82793,did,0,0
82794,not,0,0
82795,use,0,0
82796,any,0,0
82797,study,0,0
82798,medication,0,1
82799,),0,1
82800,and,0,0
82801,was,0,0
82802,excluded,0,0
82803,from,0,0
82804,the,0,0
82805,modified,0,0
82806,intent-to-treat,0,0
82807,(,0,0
82808,ITT,0,0
82809,),0,0
82810,analysis,0,0
82811,.,0,0
82812,Thus,0,0
82813,",",0,0
82814,188,0,0
82815,patients,0,0
82816,were,0,0
82817,treated,0,0
82818,and,0,0
82819,included,0,0
82820,in,0,0
82821,the,0,0
82822,ITT,0,0
82823,analysis,0,0
82824,(,0,0
82825,94,0,0
82826,patients,0,0
82827,per,0,0
82828,treatment,0,0
82829,group,0,0
82830,;,0,0
82831,ITT,0,0
82832,analysis,0,0
82833,),0,0
82834,;,0,0
82835,161,0,0
82836,patients,0,0
82837,were,0,0
82838,included,0,0
82839,in,0,0
82840,the,0,0
82841,perprotocol,0,0
82842,(,0,0
82843,PP,0,0
82844,),0,1
82845,analysis,0,0
82846,(,0,0
82847,n,0,0
82848,=,0,0
82849,80,0,0
82850,for,0,0
82851,amlodipine,0,0
82852,camsylate,0,0
82853,",",0,0
82854,n,0,0
82855,=,0,0
82856,81,0,0
82857,for,0,0
82858,amlodipine,0,0
82859,besylate,0,0
82860,),0,0
82861,(,0,0
82862,14,0,0
82863,patients,0,0
82864,in,0,0
82865,the,0,0
82866,amlodipine,0,0
82867,camsylate,0,0
82868,group,0,0
82869,and,0,0
82870,13,0,0
82871,patients,0,0
82872,in,0,0
82873,the,0,0
82874,amlodipine,0,0
82875,besylate,0,0
82876,group,0,0
82877,were,0,0
82878,excluded,0,0
82879,from,0,0
82880,the,0,0
82881,PP,0,0
82882,analysis,0,0
82883,due,0,0
82884,to,0,0
82885,consistent,0,0
82886,withdrawal,0,1
82887,or,0,0
82888,protocol,0,0
82889,violation,0,0
82890,),0,0
82891,.,0,0
82892,Mean,1,0
82893,(,1,0
82894,SD,1,0
82895,),1,0
82896,SiSBP,1,0
82897,and,1,0
82898,SiDBP,1,1
82899,were,0,0
82900,significantly,0,0
82901,decreased,0,0
82902,from,0,0
82903,baseline,0,0
82904,in,0,0
82905,both,0,0
82906,groups,0,0
82907,(,0,0
82908,amlodipine,0,0
82909,camsylate,0,0
82910,",",0,0
82911,from,0,0
82912,146.7,0,0
82913,[,0,0
82914,12.3,0,0
82915,],0,0
82916,/96.6,0,0
82917,[,0,0
82918,5.4,0,0
82919,],0,0
82920,to,0,0
82921,127.9,0,0
82922,[,0,0
82923,14.8,0,0
82924,],0,0
82925,/83.4,0,0
82926,[,0,0
82927,7.7,0,0
82928,],0,0
82929,mm,0,0
82930,Hg,0,0
82931,[,0,0
82932,both,0,0
82933,",",0,0
82934,P,0,0
82935,<,0,0
82936,0.001,0,0
82937,],0,0
82938,;,0,0
82939,amlodipine,0,0
82940,besylate,0,0
82941,",",0,0
82942,from,0,0
82943,146.8,0,0
82944,[,0,0
82945,12.8,0,0
82946,],0,0
82947,/96.7,0,0
82948,[,0,0
82949,5.1,0,0
82950,],0,0
82951,to,0,0
82952,128.0,0,0
82953,[,0,0
82954,10.1,0,0
82955,],0,0
82956,/83.8,0,0
82957,[,0,0
82958,7.5,0,0
82959,],0,0
82960,mm,0,0
82961,Hg,0,0
82962,[,0,0
82963,both,0,0
82964,",",0,0
82965,P,0,0
82966,<,0,0
82967,0.001,0,0
82968,],0,0
82969,),0,0
82970,.,0,0
82971,The,0,0
82972,differences,0,0
82973,in,0,0
82974,SiSBP/SiDBP,1,0
82975,between,0,0
82976,the,0,0
82977,2,0,0
82978,groups,0,0
82979,at,0,0
82980,week,0,0
82981,8,0,0
82982,were,0,0
82983,not,0,0
82984,significant,0,0
82985,.,0,0
82986,The,0,0
82987,SiDBP,1,0
82988,response,1,1
82989,rates,1,1
82990,in,0,0
82991,the,0,0
82992,subgroups,0,0
82993,that,0,0
82994,had,0,0
82995,and,0,0
82996,had,0,0
82997,not,0,0
82998,been,0,0
82999,previously,0,0
83000,treated,0,0
83001,with,0,0
83002,antihypertensives,0,0
83003,were,0,0
83004,statistically,0,0
83005,similar,0,0
83006,(,0,0
83007,56/69,0,0
83008,[,0,0
83009,81.2,0,0
83010,%,0,0
83011,],0,0
83012,and,0,0
83013,83/92,0,0
83014,[,0,0
83015,90.2,0,0
83016,%,0,0
83017,],0,0
83018,",",0,0
83019,respectively,0,0
83020,),0,0
83021,.,0,0
83022,The,0,0
83023,prevalences,0,0
83024,of,0,0
83025,clinical,1,0
83026,adverse,1,1
83027,events,1,1
83028,(,0,0
83029,AEs,0,1
83030,),0,0
83031,were,0,0
83032,not,0,0
83033,significantly,0,0
83034,different,0,0
83035,between,0,0
83036,the,0,0
83037,2,0,0
83038,treatment,0,0
83039,groups,0,0
83040,(,0,0
83041,amlodipine,0,0
83042,camsylate,0,0
83043,",",0,0
83044,27.3,0,0
83045,%,0,0
83046,;,0,0
83047,amlodipine,0,0
83048,besylate,0,0
83049,",",0,0
83050,28.7,0,0
83051,%,0,0
83052,),0,0
83053,.,0,0
83054,The,0,0
83055,most,0,0
83056,common,0,0
83057,AEs,0,1
83058,were,0,0
83059,dizziness,1,1
83060,and,1,1
83061,dyspnea,1,1
83062,(,0,0
83063,both,0,0
83064,in,0,0
83065,3/94,0,0
83066,[,0,0
83067,3.2,0,0
83068,%,0,0
83069,],0,0
83070,and,0,0
83071,1/94,0,0
83072,[,0,0
83073,1.1,0,0
83074,%,0,0
83075,],0,0
83076,patients,0,0
83077,who,0,0
83078,received,0,0
83079,amlodipine,0,0
83080,camsylate,0,0
83081,and,0,1
83082,amlodipine,0,0
83083,besylate,0,0
83084,",",0,0
83085,respectively,0,0
83086,),0,0
83087,.,0,0
83088,CONCLUSION,0,0
83089,The,0,0
83090,effectiveness,0,1
83091,and,0,0
83092,tolerability,0,1
83093,of,0,1
83094,amlodipine,0,0
83095,camsylate,0,0
83096,were,0,0
83097,not,0,0
83098,significantly,0,0
83099,different,0,0
83100,from,0,0
83101,those,0,0
83102,of,0,0
83103,amlodipine,0,0
83104,besylate,0,0
83105,in,0,0
83106,these,0,0
83107,Korean,0,0
83108,adults,0,0
83109,with,0,0
83110,mild,0,0
83111,to,0,0
83112,moderate,0,0
83113,hypertension,0,0
83114,.,0,0
83115,Short-term,0,0
83116,aerobic,0,0
83117,exercise,0,0
83118,training,0,0
83119,in,0,0
83120,obese,0,0
83121,humans,0,0
83122,with,0,0
83123,type,0,0
83124,2,0,0
83125,diabetes,0,0
83126,mellitus,0,0
83127,improves,0,0
83128,whole-body,0,1
83129,insulin,0,1
83130,sensitivity,0,1
83131,through,0,0
83132,gains,0,1
83133,in,0,0
83134,peripheral,0,1
83135,",",0,0
83136,not,0,0
83137,hepatic,0,1
83138,insulin,0,1
83139,sensitivity,0,1
83140,.,0,0
83141,CONTEXT,0,0
83142,Short-term,0,0
83143,aerobic,0,0
83144,exercise,0,0
83145,training,0,0
83146,can,0,0
83147,improve,0,0
83148,whole-body,1,1
83149,insulin,1,1
83150,sensitivity,1,1
83151,in,0,0
83152,humans,0,0
83153,with,0,0
83154,type,0,0
83155,2,0,0
83156,diabetes,0,0
83157,mellitus,0,0
83158,;,0,0
83159,however,0,0
83160,",",0,0
83161,the,0,0
83162,contributions,0,0
83163,of,0,0
83164,peripheral,0,1
83165,and,0,0
83166,hepatic,0,0
83167,tissues,0,1
83168,to,0,0
83169,these,0,0
83170,improvements,0,0
83171,are,0,0
83172,not,0,0
83173,known,0,0
83174,.,0,0
83175,OBJECTIVE,0,0
83176,Our,0,0
83177,objective,0,0
83178,was,0,0
83179,to,0,0
83180,determine,0,0
83181,the,0,0
83182,effect,0,0
83183,of,0,0
83184,7-d,0,0
83185,aerobic,0,0
83186,exercise,0,0
83187,training,0,0
83188,on,0,0
83189,peripheral,0,1
83190,and,0,0
83191,hepatic,0,1
83192,insulin,0,1
83193,sensitivity,0,1
83194,during,0,0
83195,isoglycemic/hyperinsulinemic,0,0
83196,clamp,0,0
83197,conditions,0,0
83198,.,0,0
83199,DESIGN,0,0
83200,Subjects,0,0
83201,were,0,0
83202,randomly,0,0
83203,assigned,0,0
83204,to,0,0
83205,one,0,0
83206,of,0,0
83207,two,0,0
83208,groups,0,0
83209,.,0,0
83210,The,0,0
83211,energy,0,1
83212,balance,0,1
83213,group,0,0
83214,consumed,0,0
83215,an,0,0
83216,isocaloric,0,0
83217,diet,0,0
83218,consisting,0,0
83219,of,0,0
83220,50,0,0
83221,%,0,0
83222,carbohydrate,0,0
83223,",",0,0
83224,30,0,0
83225,%,0,0
83226,fat,0,0
83227,",",0,0
83228,and,0,0
83229,20,0,0
83230,%,0,0
83231,protein,0,0
83232,for,0,0
83233,15,0,0
83234,d.,0,0
83235,The,0,0
83236,energy,0,1
83237,balance,0,1
83238,plus,0,0
83239,exercise,0,0
83240,group,0,0
83241,consumed,0,0
83242,a,0,0
83243,similar,0,0
83244,diet,0,0
83245,over,0,0
83246,the,0,0
83247,15,0,0
83248,d,0,0
83249,and,0,0
83250,performed,0,0
83251,50-min,0,0
83252,of,0,0
83253,treadmill,0,0
83254,walking,0,0
83255,at,0,0
83256,70,0,0
83257,%,0,0
83258,of,0,0
83259,maximum,0,1
83260,oxygen,0,1
83261,consumption,0,1
83262,maximum,0,1
83263,during,0,0
83264,the,0,0
83265,second,0,0
83266,7,0,0
83267,d,0,0
83268,of,0,0
83269,the,0,0
83270,15-d,0,0
83271,study,0,0
83272,period,0,0
83273,.,0,0
83274,Each,0,0
83275,subject,0,0
83276,underwent,0,0
83277,an,0,0
83278,initial,0,0
83279,isoglycemic/hyperinsulinemic,0,0
83280,clamp,0,0
83281,after,0,0
83282,1-wk,0,0
83283,dietary,0,0
83284,control,0,0
83285,and,0,0
83286,a,0,0
83287,second,0,0
83288,clamp,0,0
83289,after,0,0
83290,completing,0,0
83291,the,0,0
83292,study,0,0
83293,.,0,0
83294,SETTING,0,0
83295,The,0,0
83296,study,0,0
83297,was,0,0
83298,performed,0,0
83299,at,0,0
83300,Ohio,0,0
83301,State,0,1
83302,University,0,0
83303,'s,0,0
83304,General,0,1
83305,Clinical,0,1
83306,Research,0,0
83307,Center,0,0
83308,.,0,0
83309,PARTICIPANTS,0,0
83310,There,0,0
83311,were,0,0
83312,18,0,0
83313,obese,0,0
83314,",",0,0
83315,mildly,0,0
83316,diabetic,0,0
83317,humans,0,0
83318,included,0,0
83319,in,0,0
83320,the,0,0
83321,study,0,0
83322,.,0,0
83323,INTERVENTION,0,1
83324,Aerobic,0,0
83325,exercise,0,0
83326,training,0,0
83327,was,0,0
83328,performed,0,0
83329,for,0,0
83330,7,0,0
83331,d.,0,0
83332,MAIN,0,0
83333,OUTCOME,0,0
83334,MEASURES,0,0
83335,Whole-body,1,1
83336,",",1,0
83337,peripheral,1,1
83338,",",1,0
83339,and,1,1
83340,hepatic,1,1
83341,insulin,1,1
83342,sensitivity,1,1
83343,were,0,0
83344,measured,0,0
83345,.,0,0
83346,RESULTS,0,0
83347,Exercise,0,0
83348,training,0,0
83349,did,0,0
83350,not,0,0
83351,have,0,0
83352,an,0,0
83353,impact,0,0
83354,on,0,0
83355,peripheral,1,1
83356,glucose,1,1
83357,uptake,1,1
83358,or,1,0
83359,endogenous,1,1
83360,glucose,1,1
83361,production,1,1
83362,during,0,0
83363,the,0,0
83364,basal,0,1
83365,state,0,0
83366,or,0,0
83367,low-dose,0,0
83368,insulin,0,1
83369,.,0,0
83370,Likewise,0,0
83371,",",0,0
83372,it,0,0
83373,did,0,0
83374,not,0,0
83375,alter,0,0
83376,endogenous,1,0
83377,glucose,1,1
83378,production,1,1
83379,during,0,0
83380,high-dose,0,0
83381,insulin,0,0
83382,.,0,0
83383,However,0,0
83384,",",0,0
83385,1-wk,0,0
83386,of,0,0
83387,exercise,0,0
83388,training,0,0
83389,increased,0,0
83390,both,0,0
83391,whole-body,1,1
83392,(,1,0
83393,P,1,0
83394,<,1,0
83395,0.05,1,0
83396,),1,0
83397,and,1,0
83398,peripheral,1,1
83399,insulin,1,1
83400,sensitivity,1,1
83401,(,0,0
83402,P,0,0
83403,<,0,0
83404,0.0001,0,0
83405,),0,0
83406,during,0,0
83407,high-dose,0,0
83408,insulin,0,0
83409,.,0,0
83410,CONCLUSION,0,0
83411,Improvements,0,1
83412,to,0,0
83413,whole,0,0
83414,body,0,1
83415,insulin,0,1
83416,sensitivity,0,1
83417,after,0,0
83418,short-term,0,0
83419,aerobic,0,0
83420,exercise,0,0
83421,training,0,0
83422,are,0,0
83423,due,0,0
83424,to,0,0
83425,gains,0,1
83426,in,0,0
83427,peripheral,0,1
83428,",",0,0
83429,not,0,0
83430,heptic,0,0
83431,insulin,0,1
83432,sensitivity,0,1
83433,.,0,0
83434,Minimally,0,0
83435,invasive,0,0
83436,treatment,0,0
83437,combined,0,0
83438,with,0,0
83439,cytokine-induced,0,0
83440,killer,0,0
83441,cells,0,1
83442,therapy,0,0
83443,lower,0,0
83444,the,0,0
83445,short-term,0,0
83446,recurrence,0,1
83447,rates,0,1
83448,of,0,0
83449,hepatocellular,0,0
83450,carcinomas,0,0
83451,.,0,0
83452,The,0,0
83453,recurrence,0,1
83454,of,0,0
83455,hepatocellular,0,0
83456,carcinoma,0,0
83457,(,0,0
83458,HCC,0,0
83459,),0,0
83460,after,0,0
83461,minimally,0,0
83462,invasive,0,0
83463,therapy,0,0
83464,is,0,0
83465,frequent,0,0
83466,.,0,0
83467,Adoptive,0,0
83468,immunotherapy,0,0
83469,is,0,0
83470,thought,0,0
83471,to,0,0
83472,be,0,0
83473,an,0,0
83474,effective,0,0
83475,method,0,0
83476,to,0,0
83477,lower,0,0
83478,recurrence,0,1
83479,and,0,1
83480,metastasis,0,1
83481,rates,0,1
83482,of,0,0
83483,malignant,0,0
83484,tumors,0,0
83485,.,0,0
83486,Therefore,0,0
83487,",",0,0
83488,85,0,0
83489,HCC,0,0
83490,patients,0,0
83491,after,0,0
83492,transcatheter,0,0
83493,arterial,0,1
83494,chemoembolization,0,0
83495,and,0,1
83496,radiofrequency,0,0
83497,ablation,0,0
83498,therapy,0,0
83499,were,0,0
83500,randomized,0,0
83501,to,0,0
83502,immunotherapy,0,0
83503,group,0,0
83504,and,0,0
83505,no,0,0
83506,adjuvant,0,0
83507,therapy,0,0
83508,group,0,0
83509,.,0,0
83510,Autologous,0,0
83511,cytokine-induced,0,1
83512,killer,0,1
83513,(,0,0
83514,CIK,0,0
83515,),0,0
83516,cells,0,1
83517,were,0,0
83518,transfused,0,1
83519,via,0,0
83520,hepatic,0,0
83521,artery,0,0
83522,to,0,0
83523,the,0,0
83524,patients,0,0
83525,.,0,0
83526,The,0,0
83527,alteration,0,0
83528,of,0,0
83529,levels,0,1
83530,of,0,0
83531,lymphocyte,0,1
83532,subsets,0,0
83533,in,0,0
83534,peripheral,0,1
83535,blood,0,1
83536,of,0,0
83537,patients,0,0
83538,was,0,0
83539,examined,0,0
83540,by,0,0
83541,flow,0,1
83542,cytometry,0,0
83543,.,0,0
83544,All,0,0
83545,patients,0,0
83546,were,0,0
83547,screened,0,0
83548,by,0,0
83549,computed,0,0
83550,tomography,0,0
83551,every,0,0
83552,2,0,0
83553,months,0,0
83554,to,0,0
83555,observe,0,0
83556,the,0,0
83557,tumor,0,1
83558,recurrent,0,0
83559,conditions,0,0
83560,.,0,0
83561,After,0,0
83562,CIK,0,0
83563,cell,0,1
83564,infusions,0,0
83565,",",0,0
83566,the,0,0
83567,percentages,1,0
83568,of,1,0
83569,CD3+,1,0
83570,",",1,0
83571,CD4+,1,1
83572,",",1,1
83573,CD56+,1,1
83574,",",1,1
83575,CD3+CD56+,1,1
83576,cells,1,1
83577,",",1,0
83578,and,1,0
83579,CD4+/CD8+,1,1
83580,ratio,1,1
83581,increased,0,0
83582,from,0,0
83583,68.6+/-11.0,0,0
83584,%,0,0
83585,",",0,0
83586,31.1+/-9.0,0,0
83587,%,0,0
83588,",",0,0
83589,15.6+/-7.9,0,0
83590,%,0,0
83591,",",0,0
83592,5.2+/-3.1,0,0
83593,%,0,0
83594,",",0,0
83595,and,0,0
83596,1.1+/-0.5,0,0
83597,to,0,0
83598,70.7+/-10.1,0,0
83599,%,0,0
83600,",",0,0
83601,33.5+/-8.0,0,0
83602,%,0,0
83603,",",0,0
83604,18.4+/-9.4,0,0
83605,%,0,0
83606,",",0,0
83607,5.9+/-2.8,0,0
83608,%,0,0
83609,",",0,0
83610,and,0,1
83611,1.3+/-0.7,0,0
83612,",",0,0
83613,respectively,0,0
83614,(,0,0
83615,P,0,0
83616,<,0,0
83617,0.05,0,0
83618,),0,0
83619,;,0,0
83620,whereas,0,0
83621,the,0,0
83622,percentage,1,1
83623,of,1,0
83624,CD8,1,0
83625,cells,1,1
83626,decreased,0,0
83627,from,0,0
83628,31.1+/-7.8,0,0
83629,%,0,0
83630,to,0,0
83631,28.6+/-8.3,0,0
83632,%,0,0
83633,(,0,0
83634,P,0,0
83635,<,0,0
83636,0.05,0,0
83637,),0,0
83638,.,0,0
83639,The,0,0
83640,1-year,1,0
83641,and,1,0
83642,18-month,1,0
83643,recurrence,1,1
83644,rates,1,1
83645,of,1,0
83646,the,1,0
83647,study,1,0
83648,group,1,0
83649,were,0,0
83650,8.9,0,0
83651,%,0,0
83652,and,0,0
83653,15.6,0,0
83654,%,0,0
83655,",",0,0
83656,compared,0,0
83657,with,0,0
83658,30.0,0,0
83659,%,0,0
83660,and,0,0
83661,40.0,0,0
83662,%,0,0
83663,of,0,0
83664,the,0,0
83665,control,0,0
83666,group,0,0
83667,(,0,0
83668,both,0,0
83669,P,0,0
83670,value,0,0
83671,<,0,0
83672,0.05,0,0
83673,),0,0
83674,.,0,0
83675,The,0,0
83676,data,0,0
83677,suggest,0,0
83678,that,0,0
83679,CIK,0,0
83680,cell,0,0
83681,transfusion,0,0
83682,is,0,0
83683,an,0,0
83684,effective,0,0
83685,treatment,0,0
83686,.,0,0
83687,It,0,0
83688,can,0,0
83689,boost,0,0
83690,the,0,0
83691,immunologic,0,1
83692,function,0,1
83693,in,0,0
83694,HCC,0,0
83695,patients,0,0
83696,and,0,0
83697,plays,0,0
83698,an,0,0
83699,important,0,0
83700,role,0,0
83701,in,0,0
83702,reducing,0,0
83703,the,0,0
83704,recurrence,0,1
83705,rate,0,1
83706,of,0,0
83707,HCC,0,0
83708,.,0,0
83709,A,0,0
83710,randomised,0,0
83711,double-blind,0,0
83712,trial,0,0
83713,of,0,0
83714,cyclosporin,0,0
83715,and,0,1
83716,azathioprine,0,0
83717,in,0,0
83718,refractory,0,0
83719,rheumatoid,0,0
83720,arthritis,0,0
83721,.,0,0
83722,Fifty-two,0,0
83723,patients,0,0
83724,with,0,0
83725,severe,0,1
83726,rheumatoid,0,1
83727,arthritis,0,0
83728,(,0,0
83729,RA,0,0
83730,),0,0
83731,from,0,0
83732,four,0,0
83733,Australian,0,0
83734,centres,0,0
83735,were,0,0
83736,randomised,0,0
83737,to,0,0
83738,receive,0,0
83739,cyclosporin,0,0
83740,A,0,0
83741,(,0,0
83742,CSA,0,0
83743,),0,0
83744,(,0,0
83745,n,0,0
83746,=,0,0
83747,25,0,0
83748,),0,0
83749,or,0,0
83750,azathioprine,0,0
83751,(,0,1
83752,AZA,0,1
83753,),0,0
83754,(,0,0
83755,n,0,0
83756,=,0,0
83757,27,0,0
83758,),0,0
83759,for,0,0
83760,six,0,0
83761,months,0,0
83762,.,0,0
83763,Initial,0,1
83764,mean,0,1
83765,doses,0,0
83766,of,0,0
83767,CSA,0,0
83768,and,0,0
83769,AZA,0,1
83770,were,0,0
83771,4.2,0,0
83772,mg/kg,0,0
83773,and,0,0
83774,1.7,0,0
83775,mg/kg,0,0
83776,respectively,0,0
83777,.,0,0
83778,The,0,0
83779,mean,0,1
83780,doses,0,0
83781,of,0,0
83782,CSA,0,0
83783,and,0,0
83784,AZA,0,1
83785,at,0,0
83786,six,0,0
83787,months,0,0
83788,were,0,0
83789,3.4,0,0
83790,mg/kg,0,0
83791,and,0,0
83792,1.9,0,0
83793,mg/kg,0,0
83794,.,0,0
83795,Assessments,0,0
83796,of,0,0
83797,side-effects,0,1
83798,and,0,0
83799,outcomes,0,1
83800,of,0,1
83801,benefit,0,0
83802,were,0,0
83803,made,0,0
83804,monthly,0,0
83805,by,0,0
83806,independent,0,0
83807,",",0,0
83808,blinded,0,0
83809,observers,0,0
83810,.,0,0
83811,Both,0,0
83812,treatment,0,0
83813,groups,0,0
83814,exhibited,0,0
83815,statistically,0,0
83816,significant,0,0
83817,improvement,0,1
83818,in,0,0
83819,standard,0,0
83820,outcome,0,1
83821,parameters,0,1
83822,when,0,0
83823,compared,0,0
83824,with,0,0
83825,baseline,0,0
83826,values,0,1
83827,.,0,0
83828,However,0,0
83829,",",0,0
83830,there,0,0
83831,were,0,0
83832,no,0,0
83833,statistically,0,0
83834,significant,0,0
83835,differences,0,0
83836,in,0,0
83837,these,0,0
83838,parameters,0,0
83839,between,0,0
83840,the,0,0
83841,two,0,0
83842,groups,0,0
83843,.,0,0
83844,There,0,0
83845,was,0,0
83846,a,0,0
83847,mean,0,1
83848,increase,0,0
83849,in,0,0
83850,serum,1,1
83851,creatinine,1,1
83852,concentration,1,1
83853,associated,0,0
83854,with,0,0
83855,CSA,0,0
83856,;,0,0
83857,no,0,0
83858,persons,0,0
83859,were,0,0
83860,withdrawn,0,0
83861,from,0,0
83862,the,0,0
83863,study,0,0
83864,for,0,0
83865,this,0,0
83866,reason,0,0
83867,.,0,0
83868,Seven,0,1
83869,CSA,0,0
83870,recipients,0,0
83871,(,1,0
83872,three,1,0
83873,gastrointestinal,1,1
83874,symptoms,1,0
83875,",",1,0
83876,two,1,0
83877,neurological,1,1
83878,symptoms,1,0
83879,",",1,0
83880,two,1,0
83881,other,1,0
83882,),1,0
83883,and,0,0
83884,12,0,0
83885,AZA,0,1
83886,recipients,0,0
83887,(,1,0
83888,six,1,0
83889,gastrointestinal,1,1
83890,symptoms,1,0
83891,",",1,0
83892,four,1,0
83893,inefficacy,1,0
83894,",",1,0
83895,two,1,0
83896,other,1,0
83897,),1,0
83898,withdrew,1,0
83899,from,0,0
83900,treatment,0,0
83901,prematurely,0,0
83902,.,0,0
83903,Seven,0,1
83904,CSA,0,0
83905,recipients,0,0
83906,became,0,0
83907,hypertensive,1,0
83908,and,0,0
83909,four,0,0
83910,required,0,0
83911,anti-hypertensive,1,0
83912,therapy,1,0
83913,.,1,0
83914,Adverse,0,1
83915,events,0,1
83916,not,0,0
83917,requiring,0,0
83918,cessation,0,0
83919,of,0,0
83920,therapy,0,0
83921,were,0,0
83922,more,0,0
83923,commonly,0,0
83924,seen,0,0
83925,among,0,0
83926,CSA,0,0
83927,patients,0,0
83928,.,0,0
83929,In,0,0
83930,this,0,0
83931,group,0,0
83932,of,0,0
83933,severely,0,0
83934,affected,0,0
83935,patients,0,0
83936,with,0,0
83937,RA,0,0
83938,both,0,0
83939,cyclosporin,0,0
83940,and,0,1
83941,azathioprine,0,0
83942,were,0,0
83943,effective,0,0
83944,therapies,0,0
83945,.,0,0
83946,CSA,1,0
83947,toxicities,1,1
83948,were,0,0
83949,predictable,0,0
83950,and,0,1
83951,manageable,0,1
83952,but,0,0
83953,required,0,0
83954,close,0,0
83955,monitoring,0,0
83956,.,0,0
83957,Feasibility,0,0
83958,of,0,0
83959,two,0,0
83960,dose-dense,0,0
83961,FEC,0,0
83962,regimens,0,0
83963,with,0,0
83964,growth,0,1
83965,factor,0,1
83966,support,0,0
83967,for,0,0
83968,adjuvant,0,0
83969,therapy,0,0
83970,in,0,0
83971,patients,0,0
83972,with,0,0
83973,early,0,0
83974,breast,0,0
83975,cancer,0,0
83976,:,0,0
83977,results,0,0
83978,from,0,0
83979,a,0,0
83980,randomised,0,0
83981,study,0,0
83982,of,0,0
83983,the,0,0
83984,Central,0,1
83985,European,0,0
83986,Cooperative,0,0
83987,Oncology,0,0
83988,Group,0,0
83989,(,0,0
83990,CECOG,0,0
83991,),0,0
83992,.,0,0
83993,Addition,0,0
83994,of,0,0
83995,epirubicin,0,0
83996,to,0,0
83997,adjuvant,0,0
83998,chemotherapy,0,0
83999,can,0,0
84000,provide,0,0
84001,important,0,0
84002,benefits,0,0
84003,for,0,0
84004,patients,0,0
84005,with,0,0
84006,early,0,0
84007,breast,0,0
84008,cancer,0,0
84009,",",0,0
84010,but,0,0
84011,the,0,0
84012,optimal,0,0
84013,dose,0,0
84014,remains,0,0
84015,unclear,0,0
84016,.,0,0
84017,Further,0,0
84018,improvements,0,0
84019,can,0,0
84020,be,0,0
84021,achieved,0,0
84022,with,0,0
84023,dose-dense,0,0
84024,regimens,0,0
84025,",",0,0
84026,but,0,0
84027,densification,0,1
84028,of,0,1
84029,fluorouracil/epirubicin/cyclophosphamide,0,0
84030,(,0,0
84031,FEC,0,1
84032,),0,0
84033,has,0,0
84034,proved,0,0
84035,difficult,0,0
84036,",",0,0
84037,with,0,0
84038,FEC,0,1
84039,(,0,0
84040,60,0,0
84041,),0,0
84042,providing,0,0
84043,little,0,0
84044,benefit,0,0
84045,over,0,0
84046,standard,0,0
84047,chemotherapy,0,0
84048,and,0,1
84049,FEC,0,1
84050,(,0,0
84051,100,0,0
84052,),0,0
84053,associated,0,0
84054,with,0,0
84055,toxicity,0,1
84056,.,0,0
84057,We,0,0
84058,investigated,0,0
84059,the,0,0
84060,feasibility,0,0
84061,of,0,0
84062,two,0,0
84063,intermediate,0,0
84064,dose-dense,0,0
84065,FEC,0,1
84066,regimens,0,0
84067,.,0,0
84068,Patients,0,0
84069,were,0,0
84070,randomised,0,0
84071,to,0,0
84072,six,0,0
84073,cycles,0,0
84074,of,0,0
84075,FEC,0,1
84076,(,0,0
84077,75,0,0
84078,),0,0
84079,or,0,0
84080,FEC,0,1
84081,(,0,0
84082,90,0,0
84083,),0,0
84084,",",0,0
84085,with,0,0
84086,all,0,0
84087,three,0,0
84088,drugs,0,0
84089,given,0,0
84090,on,0,0
84091,day,0,0
84092,1,0,0
84093,of,0,0
84094,each,0,0
84095,14-day,0,0
84096,cycle,0,0
84097,.,0,0
84098,Patients,0,0
84099,also,0,0
84100,received,0,0
84101,pegfilgrastim,0,0
84102,6,0,0
84103,mg,0,0
84104,as,0,0
84105,a,0,0
84106,single,0,0
84107,subcutaneous,0,0
84108,injection,0,0
84109,on,0,0
84110,day,0,0
84111,2,0,0
84112,of,0,0
84113,each,0,0
84114,cycle,0,0
84115,.,0,0
84116,The,0,0
84117,primary,0,0
84118,efficacy,0,1
84119,endpoint,0,1
84120,was,0,0
84121,the,0,0
84122,proportion,1,0
84123,of,1,0
84124,subjects,1,0
84125,receiving,1,0
84126,>,1,0
84127,or,1,0
84128,=85,1,0
84129,%,1,0
84130,relative,1,0
84131,dose,1,0
84132,intensity,1,1
84133,and,0,0
84134,was,0,0
84135,achieved,0,0
84136,by,0,0
84137,96,0,0
84138,%,0,0
84139,and,0,0
84140,88,0,0
84141,%,0,0
84142,of,0,0
84143,patients,0,0
84144,in,0,0
84145,the,0,0
84146,FEC,0,1
84147,(,0,0
84148,75,0,0
84149,),0,0
84150,and,0,0
84151,FEC,0,1
84152,(,0,0
84153,90,0,0
84154,),0,0
84155,arms,0,0
84156,",",0,0
84157,respectively,0,0
84158,.,0,0
84159,Of,0,0
84160,147,0,0
84161,FEC,0,0
84162,(,0,0
84163,75,0,0
84164,),0,0
84165,infusions,0,0
84166,",",0,0
84167,4.1,0,0
84168,%,0,0
84169,were,0,0
84170,delayed,0,0
84171,",",0,0
84172,while,0,0
84173,9.8,0,0
84174,%,0,0
84175,of,0,0
84176,143,0,0
84177,FEC,0,0
84178,(,0,0
84179,90,0,0
84180,),0,0
84181,infusions,0,0
84182,were,0,0
84183,delayed,0,0
84184,.,0,0
84185,The,0,0
84186,most,0,0
84187,common,0,0
84188,reasons,0,0
84189,for,0,0
84190,delay,0,1
84191,were,0,0
84192,adverse,1,1
84193,events,1,1
84194,and,0,0
84195,personal/logistical,1,0
84196,reasons,1,0
84197,.,1,0
84198,One,0,0
84199,dose,0,0
84200,reduction,0,0
84201,occurred,0,0
84202,during,0,0
84203,the,0,0
84204,study,0,0
84205,(,0,0
84206,FEC,0,1
84207,(,0,0
84208,90,0,0
84209,),0,0
84210,),0,0
84211,",",0,0
84212,related,0,0
84213,to,0,0
84214,diarrhoea,1,0
84215,.,1,0
84216,Grade,1,0
84217,3-4,1,0
84218,haematological,1,1
84219,toxicities,1,1
84220,were,0,0
84221,reported,0,0
84222,in,0,0
84223,two,0,0
84224,patients,0,0
84225,in,0,0
84226,the,0,0
84227,FEC,0,1
84228,(,0,0
84229,90,0,0
84230,),0,0
84231,arm,0,0
84232,.,0,0
84233,There,0,0
84234,were,0,0
84235,no,0,0
84236,incidences,0,1
84237,of,0,0
84238,febrile,1,1
84239,neutropenia,1,1
84240,during,0,0
84241,the,0,0
84242,study,0,0
84243,.,0,0
84244,The,0,0
84245,most,0,0
84246,common,0,0
84247,adverse,0,1
84248,events,0,1
84249,were,0,0
84250,increases,0,1
84251,in,0,0
84252,liver,1,0
84253,enzymes,1,1
84254,and,1,1
84255,gastrointestinal,1,1
84256,events,1,1
84257,;,1,0
84258,no,0,0
84259,event,0,0
84260,resulted,0,0
84261,in,0,0
84262,discontinuation,0,0
84263,.,0,0
84264,Only,0,0
84265,one,0,0
84266,patient,0,0
84267,(,0,0
84268,FEC,0,1
84269,(,0,0
84270,90,0,0
84271,),0,0
84272,),0,0
84273,experienced,0,0
84274,serious,1,1
84275,adverse,1,1
84276,events,1,1
84277,(,1,0
84278,vomiting,1,1
84279,and,1,0
84280,throat,1,1
84281,oedema,1,1
84282,),1,0
84283,.,1,0
84284,In,0,0
84285,conclusion,0,0
84286,",",0,0
84287,dose-dense,0,0
84288,FEC,0,1
84289,(,0,0
84290,75,0,0
84291,),0,0
84292,and,0,0
84293,FEC,0,1
84294,(,0,0
84295,90,0,0
84296,),0,0
84297,are,0,0
84298,feasible,0,0
84299,with,0,0
84300,pegfilgrastim,0,0
84301,support,0,0
84302,.,0,0
84303,These,0,0
84304,regimens,0,0
84305,are,0,0
84306,associated,0,0
84307,with,0,0
84308,a,0,0
84309,very,0,0
84310,low,0,0
84311,risk,0,1
84312,of,0,0
84313,Grade,1,1
84314,3-4,1,0
84315,toxicity,1,1
84316,.,1,0
84317,The,0,0
84318,impact,0,0
84319,of,0,0
84320,fasting,0,1
84321,and,0,0
84322,treatment,0,0
84323,omission,0,0
84324,on,0,0
84325,susceptibility,1,1
84326,to,1,0
84327,hypoglycaemia,1,1
84328,in,0,0
84329,children,0,0
84330,and,0,0
84331,adolescents,0,0
84332,with,0,0
84333,GH,0,0
84334,and,0,0
84335,cortisol,0,1
84336,insufficiency,0,1
84337,.,0,0
84338,OBJECTIVE,0,0
84339,Hypoglycaemia,0,1
84340,may,0,0
84341,be,0,0
84342,a,0,0
84343,frequent,0,0
84344,occurrence,0,0
84345,in,0,0
84346,young,0,0
84347,GH,0,0
84348,deficient,0,0
84349,patients,0,0
84350,and,0,0
84351,so,0,0
84352,we,0,0
84353,studied,0,0
84354,the,0,0
84355,response,0,1
84356,to,0,0
84357,fasting,0,1
84358,in,0,0
84359,children,0,0
84360,and,0,0
84361,adolescents,0,0
84362,with,0,0
84363,GH,0,0
84364,and/or,0,0
84365,cortisol,0,1
84366,deficiency,0,0
84367,.,0,0
84368,METHODS,0,0
84369,A,0,0
84370,total,0,1
84371,of,0,0
84372,20,0,0
84373,patients,0,0
84374,(,0,0
84375,2-18,0,0
84376,years,0,0
84377,),0,0
84378,fasted,0,0
84379,for,0,0
84380,14,0,0
84381,h,0,0
84382,(,0,0
84383,22.00-12.00,0,1
84384,h,0,0
84385,),0,0
84386,on,0,0
84387,two,0,0
84388,occasions,0,0
84389,as,0,0
84390,part,0,0
84391,of,0,0
84392,a,0,0
84393,randomized,0,0
84394,cross-over,0,0
84395,study,0,0
84396,.,0,0
84397,Fourteen,0,0
84398,had,0,0
84399,pituitary,0,1
84400,hormone,0,1
84401,deficiency,0,0
84402,(,0,0
84403,PHD,0,1
84404,),0,0
84405,including,0,0
84406,GH,0,0
84407,deficiency,0,0
84408,(,0,0
84409,GHD,0,0
84410,),0,0
84411,.,0,0
84412,Of,0,0
84413,the,0,0
84414,14,0,0
84415,patients,0,0
84416,",",0,0
84417,seven,0,0
84418,were,0,0
84419,ACTH,0,0
84420,sufficient,0,0
84421,(,0,0
84422,PHDC+,0,0
84423,),0,0
84424,and,0,0
84425,seven,0,0
84426,ACTH,0,0
84427,deficient,0,0
84428,(,0,0
84429,PHDC-,0,0
84430,),0,0
84431,.,0,0
84432,Six,0,0
84433,had,0,0
84434,primary,0,0
84435,adrenal,0,1
84436,failure,0,1
84437,(,0,0
84438,PAF,0,1
84439,),0,0
84440,.,0,0
84441,Subjects,0,0
84442,administered,0,0
84443,or,0,0
84444,omitted,0,0
84445,their,0,0
84446,normal,0,0
84447,dose,0,0
84448,of,0,0
84449,evening,0,0
84450,GH,0,0
84451,and/or,0,0
84452,morning,0,0
84453,hydrocortisone,0,0
84454,.,0,0
84455,Glucose,1,1
84456,",",1,0
84457,insulin,1,1
84458,",",1,1
84459,GH,1,1
84460,",",1,1
84461,cortisol,1,1
84462,",",1,1
84463,ketones,1,1
84464,and,1,1
84465,catecholamines,1,1
84466,were,0,0
84467,measured,0,0
84468,at,0,0
84469,04.00,0,0
84470,h,0,0
84471,and,0,0
84472,regularly,0,0
84473,from,0,0
84474,07.00,0,0
84475,to,0,0
84476,12.00,0,0
84477,h.,0,0
84478,Insulin,1,0
84479,sensitivity,1,1
84480,was,0,0
84481,assessed,0,0
84482,by,0,0
84483,HOMA,1,0
84484,and,0,0
84485,hypoglycaemia,1,1
84486,defined,0,0
84487,as,0,0
84488,a,0,0
84489,blood,1,1
84490,glucose,1,1
84491,(,0,0
84492,BG,0,0
84493,),0,0
84494,<,0,0
84495,/=,0,0
84496,3.3,0,0
84497,mmol/l,0,0
84498,.,0,0
84499,RESULTS,0,0
84500,BG,0,0
84501,was,0,0
84502,related,0,0
84503,to,0,0
84504,age,1,0
84505,and,1,1
84506,body,1,1
84507,mass,1,1
84508,index,1,1
84509,on,0,0
84510,treatment,0,0
84511,but,0,0
84512,no,0,0
84513,subject,0,0
84514,became,0,0
84515,hypoglycaemic,0,1
84516,on,0,0
84517,or,0,0
84518,off,0,0
84519,therapy,0,0
84520,prior,0,0
84521,to,0,0
84522,07.00,0,0
84523,h.,0,0
84524,Five,0,0
84525,children,0,0
84526,(,0,0
84527,aged,0,0
84528,3,0,0
84529,",",0,0
84530,4,0,0
84531,",",0,0
84532,7,0,0
84533,",",0,0
84534,8,0,0
84535,and,0,0
84536,11,0,0
84537,years,0,0
84538,),0,0
84539,were,0,0
84540,hypoglycaemic,1,1
84541,between,0,0
84542,07.00,0,0
84543,and,0,0
84544,12.00,0,0
84545,h,0,0
84546,off,0,0
84547,treatment,0,0
84548,.,0,0
84549,There,0,0
84550,was,0,0
84551,a,0,0
84552,positive,0,0
84553,relationship,0,0
84554,between,0,0
84555,GH,1,0
84556,AUC,1,0
84557,and,1,0
84558,minimum,1,1
84559,BG,1,0
84560,in,0,0
84561,patients,0,0
84562,with,0,0
84563,PHD,0,0
84564,on,0,0
84565,treatment,0,0
84566,(,0,0
84567,r,0,0
84568,(,0,0
84569,2,0,0
84570,),0,0
84571,=,0,0
84572,0.45,0,0
84573,",",0,0
84574,P,0,0
84575,=,0,0
84576,0.012,0,0
84577,),0,0
84578,with,0,0
84579,increased,0,0
84580,insulin,1,1
84581,sensitivity,1,1
84582,off,0,0
84583,treatment,0,0
84584,.,0,0
84585,Increased,1,0
84586,cortisol,1,1
84587,levels,1,1
84588,were,0,0
84589,seen,0,0
84590,in,0,0
84591,PHDC+,0,0
84592,patients,0,0
84593,off,0,0
84594,GH,0,0
84595,(,0,0
84596,P,0,0
84597,<,0,0
84598,0.001,0,0
84599,),0,0
84600,.,0,0
84601,A,0,0
84602,negative,0,1
84603,relationship,0,0
84604,was,0,0
84605,observed,0,0
84606,between,0,0
84607,minimum,0,1
84608,BG,1,0
84609,and,1,1
84610,adrenaline,1,1
84611,(,0,1
84612,r,0,0
84613,(,0,0
84614,2,0,0
84615,),0,0
84616,=,0,0
84617,0.37,0,0
84618,",",0,0
84619,P,0,0
84620,=,0,0
84621,0.01,0,0
84622,),0,0
84623,",",0,0
84624,ketone,1,1
84625,bodies,1,1
84626,(,0,0
84627,r,0,0
84628,(,0,0
84629,2,0,0
84630,),0,0
84631,=,0,0
84632,-0.20,0,0
84633,",",0,0
84634,P,0,0
84635,=,0,0
84636,0.05,0,0
84637,),0,0
84638,and,0,0
84639,NEFA,1,1
84640,(,0,1
84641,r,0,0
84642,(,0,0
84643,2,0,0
84644,),0,0
84645,=,0,0
84646,-0.35,0,0
84647,",",0,0
84648,P,0,0
84649,=,0,0
84650,0.02,0,0
84651,),0,0
84652,.,0,0
84653,Noradrenaline,1,0
84654,levels,1,1
84655,were,0,0
84656,reduced,0,0
84657,in,0,0
84658,patients,0,0
84659,with,0,0
84660,PHDC-,0,0
84661,.,0,0
84662,Low,0,0
84663,BMI,1,1
84664,(,0,0
84665,on,0,0
84666,treatment,0,0
84667,),0,0
84668,and,0,0
84669,young,0,0
84670,age,0,0
84671,(,0,0
84672,off,0,0
84673,treatment,0,0
84674,),0,0
84675,were,0,0
84676,determinants,0,0
84677,of,0,0
84678,low,1,0
84679,BG,1,0
84680,levels,1,1
84681,in,0,0
84682,a,0,0
84683,multiple,0,0
84684,regression,0,0
84685,model,0,0
84686,.,0,0
84687,CONCLUSIONS,0,0
84688,Unrecognized,0,0
84689,overnight,0,0
84690,hypoglycaemia,0,1
84691,in,0,0
84692,children,0,0
84693,and,0,0
84694,adolescents,0,0
84695,on,0,0
84696,pituitary,0,1
84697,hormone,0,0
84698,replacement,0,0
84699,is,0,0
84700,uncommon,0,0
84701,but,0,0
84702,BG,1,0
84703,levels,1,1
84704,quickly,0,0
84705,become,0,0
84706,abnormal,0,1
84707,when,0,0
84708,treatment,0,0
84709,and,0,0
84710,meals,0,0
84711,are,0,0
84712,omitted,0,0
84713,.,0,0
84714,The,0,0
84715,insulin,1,1
84716,antagonistic,1,0
84717,actions,1,1
84718,of,1,0
84719,GH,1,0
84720,are,0,0
84721,important,0,0
84722,in,0,0
84723,preventing,0,0
84724,hypoglycaemia,0,1
84725,.,0,0
84726,Patients,0,0
84727,with,0,0
84728,PHD,0,0
84729,have,0,0
84730,altered,0,0
84731,sympathetic,1,0
84732,nerve,1,0
84733,activity,1,1
84734,.,1,0
84735,Effect,0,0
84736,of,0,0
84737,vitamin,0,0
84738,K2,0,1
84739,on,0,0
84740,the,0,0
84741,recurrence,1,1
84742,in,0,0
84743,patients,0,0
84744,with,0,0
84745,hepatocellular,0,0
84746,carcinoma,0,0
84747,.,0,0
84748,BACKGROUND/AIMS,0,0
84749,Vitamin,0,0
84750,K2,0,1
84751,(,0,0
84752,VK2,0,0
84753,),0,0
84754,appears,0,0
84755,to,0,0
84756,have,0,0
84757,a,0,0
84758,potent,0,0
84759,inhibitory,0,1
84760,activity,0,1
84761,for,0,0
84762,cell,0,1
84763,growth,0,1
84764,including,0,0
84765,HCC,0,0
84766,cells,0,1
84767,.,0,0
84768,We,0,0
84769,investigated,0,0
84770,whether,0,0
84771,VK2,0,0
84772,could,0,0
84773,reduce,0,0
84774,incidence,0,1
84775,of,0,0
84776,tumor,0,1
84777,recurrence,0,1
84778,after,0,0
84779,treatment,0,0
84780,of,0,0
84781,HCC,0,0
84782,.,0,0
84783,Forty-five,0,0
84784,patients,0,0
84785,with,0,0
84786,cured,0,0
84787,or,0,0
84788,possibly,0,0
84789,cured,0,0
84790,HCC,0,0
84791,were,0,0
84792,randomly,0,0
84793,selected,0,0
84794,",",0,0
84795,assigning,0,0
84796,patients,0,0
84797,to,0,0
84798,treatment,0,0
84799,(,0,0
84800,n=21,0,0
84801,),0,0
84802,or,0,0
84803,control,0,0
84804,group,0,0
84805,(,0,0
84806,n=24,0,0
84807,),0,1
84808,with,0,0
84809,randomization,0,0
84810,list,0,0
84811,.,0,0
84812,METHODOLOGY,0,0
84813,For,0,0
84814,the,0,0
84815,treatment,0,0
84816,group,0,0
84817,",",0,0
84818,forty-five,0,0
84819,mg,0,0
84820,of,0,0
84821,Glakay,0,0
84822,was,0,0
84823,given,0,0
84824,orally,0,0
84825,every,0,0
84826,day,0,0
84827,after,0,0
84828,therapy,0,0
84829,for,0,0
84830,HCC,0,0
84831,.,0,0
84832,No,0,0
84833,patients,0,0
84834,complained,0,0
84835,of,0,0
84836,adverse,1,1
84837,effects,1,0
84838,.,1,0
84839,Abdominal,0,1
84840,ultrasonography,0,1
84841,and,0,0
84842,dynamic,0,1
84843,CT,0,1
84844,were,0,0
84845,performed,0,0
84846,at,0,0
84847,3-month,0,0
84848,intervals,0,0
84849,.,0,0
84850,Recurrence,1,1
84851,was,0,0
84852,confirmed,0,0
84853,by,0,0
84854,abdominal,0,0
84855,angiography,0,0
84856,.,0,0
84857,RESULTS,0,0
84858,Recurrence,1,1
84859,of,1,0
84860,HCC,1,0
84861,occurred,0,0
84862,in,0,0
84863,7,0,0
84864,cases,0,0
84865,(,0,0
84866,33.3,0,0
84867,%,0,0
84868,),0,0
84869,for,0,0
84870,the,0,0
84871,treatment,0,0
84872,group,0,0
84873,and,0,0
84874,12,0,0
84875,cases,0,0
84876,(,0,0
84877,50.0,0,0
84878,%,0,0
84879,),0,0
84880,for,0,0
84881,the,0,0
84882,control,0,0
84883,group,0,0
84884,during,0,0
84885,mean,0,1
84886,observation,0,0
84887,periods,0,0
84888,of,0,0
84889,19.5,0,0
84890,and,0,0
84891,16.5,0,0
84892,months,0,0
84893,",",0,0
84894,respectively,0,0
84895,.,0,0
84896,Administration,0,0
84897,of,0,0
84898,VK2,0,1
84899,was,0,0
84900,not,0,0
84901,an,0,0
84902,independent,0,0
84903,variable,0,0
84904,for,0,0
84905,the,0,0
84906,recurrence,1,1
84907,on,0,0
84908,univariate,0,0
84909,analysis,0,0
84910,.,0,0
84911,Cumulative,1,1
84912,incidence,1,1
84913,of,1,0
84914,HCC,1,0
84915,recurrence,1,1
84916,did,0,0
84917,not,0,0
84918,differ,0,0
84919,between,0,0
84920,the,0,0
84921,two,0,0
84922,groups,0,0
84923,",",0,0
84924,and,0,0
84925,the,0,0
84926,cumulative,1,1
84927,survival,1,1
84928,rate,1,1
84929,tended,0,0
84930,to,0,0
84931,be,0,0
84932,high,0,0
84933,in,0,0
84934,treatment,0,0
84935,group,0,0
84936,(,0,0
84937,p,0,0
84938,=0.054,0,0
84939,),0,0
84940,.,0,0
84941,Cox,0,0
84942,regression,0,1
84943,analysis,0,0
84944,revealed,0,0
84945,that,0,0
84946,serum,1,1
84947,albumin,1,1
84948,concentration,1,1
84949,alone,0,0
84950,was,0,0
84951,an,0,0
84952,independent,0,0
84953,factor,0,0
84954,affecting,0,0
84955,the,0,0
84956,recurrence,0,1
84957,.,0,0
84958,CONCLUSIONS,0,0
84959,These,0,0
84960,findings,0,0
84961,suggest,0,0
84962,that,0,0
84963,VK2,0,0
84964,does,0,0
84965,not,0,0
84966,appear,0,0
84967,to,0,0
84968,prevent,0,0
84969,recurrence,1,1
84970,of,1,0
84971,HCC,1,0
84972,after,0,0
84973,curative,0,0
84974,treatment,0,0
84975,.,0,0
84976,Our,0,0
84977,study,0,0
84978,is,0,0
84979,preliminary,0,0
84980,and,0,0
84981,large-scale,0,0
84982,trials,0,0
84983,are,0,0
84984,needed,0,0
84985,to,0,0
84986,determine,0,0
84987,whether,0,0
84988,VK2,0,0
84989,is,0,0
84990,of,0,0
84991,benefit,0,0
84992,to,0,0
84993,decrease,0,0
84994,the,0,0
84995,recurrence,1,1
84996,of,1,0
84997,HCC,1,0
84998,.,1,0
84999,Chronology,0,0
85000,of,0,0
85001,panic,0,1
85002,and,0,1
85003,avoidance,0,1
85004,",",0,1
85005,age,0,0
85006,of,0,1
85007,onset,0,1
85008,in,0,0
85009,panic,0,1
85010,disorder,0,0
85011,",",0,0
85012,and,0,1
85013,prediction,0,1
85014,of,0,1
85015,treatment,0,0
85016,response,0,1
85017,.,0,0
85018,A,0,0
85019,report,0,0
85020,from,0,0
85021,the,0,0
85022,Cross-National,0,0
85023,Collaborative,0,0
85024,Panic,0,0
85025,Study,0,0
85026,.,0,0
85027,The,0,0
85028,relevance,0,0
85029,of,0,0
85030,the,0,0
85031,chronology,0,0
85032,between,0,0
85033,panic,0,1
85034,disorder,0,0
85035,and,0,1
85036,avoidance,0,1
85037,behavior,0,1
85038,and,0,0
85039,of,0,0
85040,an,0,0
85041,early,0,0
85042,",",0,0
85043,medium,0,0
85044,or,0,1
85045,late,0,1
85046,onset,0,1
85047,of,0,0
85048,panic,0,1
85049,disorder,0,0
85050,was,0,0
85051,tested,0,0
85052,.,0,0
85053,Groups,0,0
85054,from,0,0
85055,the,0,0
85056,sample,0,0
85057,of,0,0
85058,the,0,0
85059,cross-national,0,0
85060,collaborative,0,0
85061,panic,0,1
85062,study,0,0
85063,(,0,0
85064,CNCPS,0,1
85065,),0,0
85066,were,0,0
85067,compared,0,0
85068,for,0,0
85069,differences,0,0
85070,in,0,0
85071,basic,0,0
85072,characteristics,0,1
85073,and,0,0
85074,for,0,0
85075,the,0,0
85076,ability,0,0
85077,to,0,0
85078,predict,0,0
85079,treatment,0,0
85080,response,0,1
85081,.,0,0
85082,Patients,0,0
85083,who,0,0
85084,developed,0,0
85085,avoidance,1,1
85086,behavior,1,1
85087,before,0,0
85088,the,0,0
85089,full,0,0
85090,syndrome,0,0
85091,of,0,0
85092,panic,1,1
85093,disorder,1,0
85094,had,0,0
85095,less,0,0
85096,often,0,0
85097,a,0,0
85098,full,0,0
85099,agoraphobia,1,0
85100,but,0,0
85101,were,0,0
85102,not,0,0
85103,different,0,0
85104,in,0,0
85105,their,0,0
85106,response,0,1
85107,to,0,0
85108,treatment,0,0
85109,.,0,0
85110,Patients,0,0
85111,with,0,0
85112,an,0,0
85113,early,1,0
85114,onset,1,1
85115,of,1,0
85116,panic,1,1
85117,disorder,1,0
85118,suffered,0,0
85119,more,0,0
85120,often,0,0
85121,from,0,0
85122,agoraphobia,1,0
85123,.,1,0
85124,The,0,0
85125,treatment,1,0
85126,response,1,1
85127,was,0,0
85128,similar,1,0
85129,in,0,0
85130,the,0,0
85131,groups,0,0
85132,with,0,0
85133,early,1,0
85134,",",1,0
85135,medium,1,0
85136,or,1,1
85137,late,1,1
85138,onset,1,1
85139,of,1,0
85140,panic,1,1
85141,disorder,1,0
85142,.,1,0
85143,Neither,0,0
85144,the,0,0
85145,chronology,0,0
85146,between,0,0
85147,panic,1,1
85148,disorder,1,0
85149,and,1,1
85150,avoidance,1,1
85151,behavior,1,1
85152,nor,0,0
85153,the,0,0
85154,age,1,0
85155,of,1,0
85156,onset,1,1
85157,of,1,0
85158,panic,1,1
85159,disorder,1,0
85160,predicted,0,1
85161,outcome,0,1
85162,in,0,0
85163,short-term,0,0
85164,treatment,0,0
85165,with,0,0
85166,alprazolam,0,0
85167,or,0,0
85168,imipramine,0,0
85169,.,0,0
85170,[,0,0
85171,How,0,0
85172,to,0,0
85173,treat,0,0
85174,the,0,0
85175,relapse,1,1
85176,of,1,0
85177,NSCLC,1,1
85178,after,0,0
85179,surgery,0,0
85180,and,0,0
85181,chemotherapy,0,0
85182,?,0,0
85183,IFTC,0,0
85184,0702,0,0
85185,randomized,0,0
85186,phase,0,0
85187,III,0,1
85188,study,0,0
85189,],0,0
85190,.,0,0
85191,BACKGROUND,0,0
85192,As,0,0
85193,chemotherapy,0,0
85194,gains,0,1
85195,wider,0,0
85196,acceptance,0,1
85197,for,0,0
85198,the,0,0
85199,treatment,0,0
85200,of,0,0
85201,earlier,0,0
85202,stages,0,0
85203,of,0,1
85204,NSCLC,0,1
85205,",",0,0
85206,particularly,0,0
85207,in,0,0
85208,the,0,0
85209,adjuvant,0,0
85210,and,0,0
85211,neoadjuvant,0,0
85212,setting,0,0
85213,",",0,0
85214,physicians,0,0
85215,face,0,0
85216,a,0,0
85217,growing,0,0
85218,population,0,0
85219,of,0,0
85220,high,0,0
85221,performance,0,1
85222,status,0,1
85223,patients,0,0
85224,who,0,0
85225,have,0,0
85226,relapsed,0,0
85227,after,0,0
85228,their,0,0
85229,first-line,0,0
85230,chemotherapy,0,0
85231,.,0,0
85232,The,0,0
85233,type,0,0
85234,of,0,0
85235,second-line,0,0
85236,chemotherapy,0,0
85237,after,0,0
85238,initial,0,0
85239,adjuvant,0,0
85240,or,0,0
85241,neoadjuvant,0,0
85242,treatment,0,0
85243,with,0,0
85244,a,0,0
85245,platinum-based,0,0
85246,regimen,0,0
85247,remains,0,0
85248,largely,0,0
85249,undefined,0,0
85250,.,0,0
85251,The,0,0
85252,current,0,0
85253,study,0,0
85254,has,0,0
85255,been,0,0
85256,designed,0,0
85257,to,0,0
85258,compare,0,0
85259,the,0,0
85260,classical,0,0
85261,mono,0,0
85262,chemotherapy,0,0
85263,docetaxel,0,0
85264,with,0,0
85265,a,0,0
85266,docetaxel,0,0
85267,cisplatin,0,0
85268,doublet,0,0
85269,.,0,0
85270,METHODS,0,0
85271,Patients,0,0
85272,will,0,0
85273,be,0,0
85274,randomized,0,0
85275,in,0,0
85276,2,0,0
85277,arms,0,0
85278,.,0,0
85279,Arm,0,0
85280,:,0,0
85281,docetaxel,0,0
85282,cisplatin,0,0
85283,(,0,0
85284,cycles,0,0
85285,repeated,0,0
85286,every,0,0
85287,21,0,0
85288,days,0,0
85289,),0,0
85290,",",0,0
85291,4,0,0
85292,cycles,0,0
85293,followed,0,0
85294,by,0,0
85295,2,0,0
85296,cycles,0,0
85297,of,0,0
85298,docetaxel,0,0
85299,alone,0,0
85300,in,0,0
85301,case,0,0
85302,of,0,0
85303,objective,1,0
85304,response,1,1
85305,or,0,0
85306,stabilisation,1,1
85307,.,1,1
85308,Arm,0,0
85309,B,0,0
85310,:,0,0
85311,docetaxel,0,0
85312,alone,0,0
85313,(,0,0
85314,cycles,0,0
85315,repeated,0,0
85316,every,0,0
85317,21,0,0
85318,days,0,0
85319,),0,0
85320,",",0,0
85321,4,0,0
85322,cycles,0,0
85323,followed,0,0
85324,by,0,0
85325,2,0,0
85326,cycles,0,0
85327,of,0,0
85328,docetaxel,0,0
85329,alone,0,0
85330,in,0,0
85331,case,0,0
85332,of,0,0
85333,objective,1,0
85334,response,1,1
85335,or,0,0
85336,stabilisation,1,1
85337,.,1,0
85338,EXPECTED,0,0
85339,RESULTS,0,0
85340,300,0,0
85341,patients,0,0
85342,will,0,0
85343,be,0,0
85344,randomized,0,0
85345,with,0,0
85346,a,0,0
85347,statistical,0,0
85348,hypothesis,0,0
85349,of,0,0
85350,a,0,0
85351,progression,1,1
85352,free,1,1
85353,survival,1,1
85354,of,0,0
85355,3,0,0
85356,months,0,0
85357,in,0,0
85358,the,0,0
85359,control,0,0
85360,arm,0,0
85361,and,0,0
85362,of,0,0
85363,4.5,0,0
85364,months,0,0
85365,in,0,0
85366,the,0,0
85367,experimental,0,0
85368,arm,0,0
85369,.,0,0
85370,Effect,0,0
85371,of,0,0
85372,food,0,0
85373,on,0,0
85374,the,0,0
85375,antiviral,1,0
85376,activity,1,1
85377,of,0,0
85378,didanosine,0,0
85379,enteric-coated,0,0
85380,capsules,0,0
85381,:,0,0
85382,a,0,0
85383,pilot,0,0
85384,comparative,0,0
85385,study,0,0
85386,.,0,0
85387,OBJECTIVES,0,0
85388,To,0,0
85389,determine,0,0
85390,the,0,0
85391,effect,0,0
85392,of,0,0
85393,food,0,0
85394,on,0,0
85395,the,0,0
85396,antiviral,0,0
85397,activity,0,1
85398,of,0,0
85399,enteric-coated,0,0
85400,(,0,0
85401,EC,0,1
85402,),0,0
85403,capsules,0,0
85404,of,0,0
85405,didanosine,0,0
85406,(,0,0
85407,ddI,0,0
85408,),0,0
85409,.,0,0
85410,METHODS,0,0
85411,We,0,0
85412,conducted,0,0
85413,a,0,0
85414,pilot,0,0
85415,",",0,0
85416,randomized,0,0
85417,",",0,0
85418,open-label,0,0
85419,study,0,0
85420,of,0,0
85421,28-day,0,1
85422,ddI-EC,0,0
85423,capsules,0,0
85424,monotherapy-administered,0,0
85425,in,0,0
85426,a,0,0
85427,fasted,0,0
85428,state,0,0
85429,(,0,0
85430,group,0,0
85431,1,0,0
85432,",",0,0
85433,n=11,0,0
85434,),0,1
85435,or,0,0
85436,with,0,0
85437,food,0,0
85438,(,0,0
85439,group,0,0
85440,2,0,0
85441,",",0,0
85442,n=10,0,0
85443,),0,0
85444,to,0,0
85445,treatment-na?ve,0,0
85446,chronically,0,0
85447,HIV-1-infected,0,0
85448,individuals,0,0
85449,.,0,0
85450,To,0,0
85451,assess,0,0
85452,the,1,0
85453,antiviral,1,0
85454,efficacy,1,1
85455,",",1,0
85456,HIV-1,1,1
85457,RNA,1,0
85458,was,0,0
85459,determined,0,0
85460,at,0,0
85461,baseline,0,0
85462,",",0,0
85463,day,0,0
85464,3,0,0
85465,",",0,0
85466,day,0,0
85467,7,0,0
85468,and,0,0
85469,weekly,0,0
85470,thereafter,0,0
85471,.,0,0
85472,The,0,0
85473,area,0,0
85474,under,0,0
85475,the,0,0
85476,HIV-1,0,0
85477,RNA,0,0
85478,curve,0,1
85479,minus,0,0
85480,baseline,0,0
85481,weighted,0,0
85482,by,0,0
85483,time,1,1
85484,(,1,0
85485,AUCMB/day,1,0
85486,),1,0
85487,was,0,0
85488,calculated,0,0
85489,.,0,0
85490,RESULTS,1,0
85491,Mean,1,0
85492,baseline,1,0
85493,HIV-1,1,0
85494,RNA,1,0
85495,was,0,0
85496,4.2,0,0
85497,log,0,1
85498,(,0,0
85499,10,0,0
85500,),0,0
85501,copies/mL,0,0
85502,in,0,0
85503,group,0,0
85504,1,0,0
85505,and,0,0
85506,3.8,0,0
85507,log,0,1
85508,(,0,0
85509,10,0,0
85510,),0,0
85511,copies/mL,0,0
85512,in,0,0
85513,group,0,0
85514,2,0,0
85515,.,0,0
85516,After,0,0
85517,28,0,0
85518,days,0,0
85519,",",0,0
85520,the,1,0
85521,mean,1,1
85522,HIV-1,1,0
85523,RNA,1,0
85524,reduction,1,1
85525,was,0,0
85526,0.99,0,0
85527,log,0,1
85528,(,0,0
85529,10,0,0
85530,),0,0
85531,copies/mL,0,0
85532,[,0,0
85533,95,0,0
85534,%,0,0
85535,confidence,0,0
85536,interval,0,0
85537,(,0,0
85538,CI,0,0
85539,),0,0
85540,0.45-1.53,0,0
85541,],0,0
85542,for,0,0
85543,group,0,0
85544,1,0,0
85545,and,0,0
85546,0.89,0,0
85547,log,0,1
85548,(,0,0
85549,10,0,0
85550,),0,0
85551,copies/mL,0,0
85552,(,0,0
85553,95,0,0
85554,%,0,0
85555,CI,0,0
85556,0.38-1.40,0,0
85557,),0,0
85558,for,0,0
85559,group,0,0
85560,2,0,0
85561,.,0,0
85562,AUCMB/day,1,0
85563,values,1,1
85564,were,0,0
85565,0.775,0,0
85566,log,0,1
85567,(,0,0
85568,10,0,0
85569,),0,0
85570,copies/mL,0,0
85571,(,0,0
85572,95,0,0
85573,%,0,0
85574,CI,0,0
85575,0.33-1.22,0,0
85576,),0,0
85577,and,0,0
85578,0.774,0,0
85579,log,0,1
85580,(,0,0
85581,10,0,0
85582,),0,0
85583,copies/mL,0,0
85584,(,0,0
85585,95,0,0
85586,%,0,0
85587,CI,0,0
85588,0.48-1.07,0,0
85589,),0,0
85590,",",0,0
85591,respectively,0,0
85592,",",0,0
85593,showing,0,0
85594,no,0,0
85595,difference,0,0
85596,in,0,0
85597,the,0,0
85598,rate,0,1
85599,of,0,0
85600,decrease,0,0
85601,of,1,0
85602,HIV-1,1,0
85603,RNA,1,0
85604,(,0,0
85605,P=0.995,0,0
85606,),0,0
85607,.,0,0
85608,Mean,1,0
85609,ddI,1,1
85610,plasma,1,1
85611,levels,1,1
85612,at,0,0
85613,day,0,0
85614,28,0,0
85615,were,0,0
85616,0.0234,0,0
85617,mg/L,0,0
85618,for,0,0
85619,group,0,0
85620,1,0,0
85621,and,0,0
85622,0.0227,0,0
85623,mg/L,0,0
85624,for,0,0
85625,group,0,0
85626,2,0,0
85627,(,0,0
85628,P=0.96,0,0
85629,),0,0
85630,.,0,0
85631,CONCLUSIONS,0,0
85632,In,0,0
85633,this,0,0
85634,pilot,0,0
85635,study,0,0
85636,",",0,0
85637,the,0,0
85638,administration,0,0
85639,of,0,0
85640,food,0,0
85641,did,0,0
85642,not,0,0
85643,have,0,0
85644,any,0,0
85645,significant,0,0
85646,effect,0,0
85647,on,0,0
85648,the,1,0
85649,antiviral,1,0
85650,activity,1,1
85651,of,1,0
85652,ddI-EC,1,0
85653,capsules,1,0
85654,.,1,0
85655,Safety,1,1
85656,and,1,1
85657,tolerability,1,1
85658,of,0,1
85659,cold-adapted,0,0
85660,influenza,0,0
85661,vaccine,0,0
85662,",",0,1
85663,trivalent,0,0
85664,",",0,0
85665,in,0,0
85666,infants,0,0
85667,younger,0,0
85668,than,0,0
85669,6,0,0
85670,months,0,0
85671,of,0,0
85672,age,0,0
85673,.,0,0
85674,OBJECTIVE,0,0
85675,Young,0,0
85676,children,0,0
85677,are,0,0
85678,at,0,0
85679,high,0,0
85680,risk,0,1
85681,for,0,0
85682,influenza-related,0,1
85683,complications,0,1
85684,.,0,0
85685,Vaccination,0,0
85686,of,0,0
85687,close,0,0
85688,household,0,1
85689,contacts,0,0
85690,is,0,0
85691,recommended,0,0
85692,to,0,0
85693,provide,0,0
85694,indirect,0,0
85695,protection,0,1
85696,to,0,0
85697,children,0,0
85698,<,0,0
85699,6,0,0
85700,months,0,0
85701,of,0,0
85702,age,0,0
85703,.,0,0
85704,Studies,0,0
85705,have,0,0
85706,shown,0,0
85707,that,0,0
85708,live,0,0
85709,",",0,0
85710,cold-adapted,0,0
85711,influenza,0,1
85712,vaccine,0,0
85713,",",0,1
85714,trivalent,0,0
85715,",",0,0
85716,is,0,0
85717,efficacious,0,1
85718,in,0,0
85719,children,0,0
85720,.,0,0
85721,To,0,0
85722,assess,0,0
85723,the,0,0
85724,risks,0,1
85725,associated,0,0
85726,with,0,0
85727,inadvertent,0,0
85728,exposure,0,0
85729,of,0,0
85730,infants,0,0
85731,to,0,0
85732,vaccine,0,0
85733,viruses,0,0
85734,from,0,0
85735,vaccinated,0,0
85736,contacts,0,0
85737,",",0,0
85738,this,0,0
85739,study,0,0
85740,was,0,0
85741,designed,0,0
85742,to,0,0
85743,evaluate,0,0
85744,the,0,0
85745,safety,1,1
85746,and,1,0
85747,tolerability,1,1
85748,of,0,1
85749,cold-adapted,0,0
85750,influenza,0,0
85751,vaccine,0,0
85752,",",0,1
85753,trivalent,0,0
85754,",",0,0
85755,administered,0,0
85756,intranasally,0,0
85757,to,0,0
85758,healthy,0,0
85759,children,0,0
85760,6,0,0
85761,to,0,0
85762,<,0,0
85763,24,0,0
85764,weeks,0,0
85765,of,0,0
85766,age,0,0
85767,.,0,0
85768,METHODS,0,0
85769,Healthy,0,0
85770,infants,0,0
85771,aged,0,0
85772,6,0,0
85773,to,0,0
85774,<,0,0
85775,16,0,0
85776,weeks,0,0
85777,and,0,0
85778,16,0,0
85779,to,0,0
85780,<,0,0
85781,24,0,0
85782,weeks,0,0
85783,",",0,0
85784,respectively,0,0
85785,",",0,0
85786,were,0,0
85787,randomly,0,0
85788,assigned,0,0
85789,to,0,0
85790,receive,0,0
85791,2,0,0
85792,doses,0,0
85793,of,0,0
85794,influenza,0,0
85795,vaccine,0,0
85796,",",0,0
85797,or,0,0
85798,placebo,0,0
85799,intranasally,0,0
85800,35,0,0
85801,+/-,0,0
85802,7,0,0
85803,days,0,0
85804,apart,0,0
85805,.,0,0
85806,Reactogenicity,0,1
85807,events,0,1
85808,were,0,0
85809,monitored,0,0
85810,for,0,0
85811,11,0,0
85812,days,0,0
85813,after,0,0
85814,each,0,0
85815,dose,0,0
85816,.,0,0
85817,Other,0,0
85818,adverse,0,1
85819,events,0,1
85820,were,0,0
85821,monitored,0,0
85822,through,0,0
85823,28,0,0
85824,to,0,0
85825,35,0,0
85826,days,0,0
85827,after,0,0
85828,dose,0,0
85829,2,0,0
85830,.,0,0
85831,RESULTS,0,0
85832,Of,0,0
85833,the,0,0
85834,infants,0,0
85835,aged,0,0
85836,6,0,0
85837,to,0,0
85838,<,0,0
85839,16,0,0
85840,weeks,0,0
85841,",",0,0
85842,31,0,0
85843,received,0,0
85844,influenza,0,0
85845,vaccine,0,0
85846,and,0,0
85847,28,0,0
85848,received,0,0
85849,placebo,0,0
85850,",",0,1
85851,and,0,0
85852,of,0,0
85853,those,0,0
85854,aged,0,0
85855,16,0,0
85856,to,0,0
85857,<,0,0
85858,24,0,0
85859,weeks,0,0
85860,",",0,0
85861,30,0,0
85862,received,0,0
85863,influenza,0,0
85864,vaccine,0,0
85865,and,0,0
85866,31,0,0
85867,received,0,0
85868,placebo,0,0
85869,.,0,0
85870,In,0,0
85871,the,0,0
85872,6-,0,0
85873,to,0,0
85874,<,0,0
85875,16-week,0,0
85876,cohort,0,0
85877,",",0,0
85878,more,0,0
85879,influenza,0,1
85880,vaccine,0,0
85881,",",0,0
85882,recipients,0,0
85883,experienced,0,1
85884,irritability,1,1
85885,(,0,0
85886,66.7,0,0
85887,%,0,0
85888,vs,0,0
85889,35.7,0,0
85890,%,0,0
85891,),0,0
85892,and,0,0
85893,runny,1,1
85894,nose,1,1
85895,or,1,0
85896,nasal,1,1
85897,congestion,1,1
85898,(,0,0
85899,63.3,0,0
85900,%,0,0
85901,vs,0,0
85902,33.3,0,0
85903,%,0,0
85904,),0,0
85905,after,0,0
85906,dose,0,0
85907,1,0,0
85908,but,0,0
85909,not,0,0
85910,dose,0,0
85911,2,0,0
85912,.,0,0
85913,There,0,0
85914,were,0,0
85915,no,0,0
85916,significant,0,0
85917,increases,0,0
85918,in,0,0
85919,any,0,0
85920,other,0,0
85921,reactogenicity,1,1
85922,events,1,1
85923,or,1,0
85924,adverse,1,1
85925,events,1,1
85926,in,0,0
85927,the,0,0
85928,vaccine,0,0
85929,recipients,0,0
85930,compared,0,0
85931,with,0,0
85932,the,0,0
85933,placebo,0,0
85934,group,0,0
85935,.,0,0
85936,CONCLUSIONS,0,0
85937,Although,0,0
85938,there,0,0
85939,was,0,0
85940,an,0,0
85941,increase,0,0
85942,in,0,0
85943,mild,1,1
85944,reactogenicity,1,1
85945,events,1,1
85946,in,0,0
85947,children,0,0
85948,6,0,0
85949,to,0,0
85950,<,0,0
85951,16,0,0
85952,weeks,0,0
85953,of,0,0
85954,age,0,0
85955,",",0,0
85956,cold-adapted,0,0
85957,influenza,0,1
85958,vaccine,0,0
85959,",",0,1
85960,trivalent,0,0
85961,",",0,1
85962,was,0,0
85963,generally,0,0
85964,well,0,0
85965,tolerated,0,1
85966,in,0,0
85967,infants,0,0
85968,6,0,0
85969,to,0,0
85970,<,0,0
85971,24,0,0
85972,weeks,0,0
85973,of,0,0
85974,age,0,0
85975,.,0,0
85976,These,0,0
85977,findings,0,0
85978,support,0,0
85979,further,0,0
85980,evaluation,0,0
85981,of,0,0
85982,cold-adapted,0,0
85983,influenza,0,0
85984,vaccine,0,0
85985,",",0,1
85986,trivalent,0,0
85987,",",0,0
85988,in,0,0
85989,infants,0,0
85990,<,0,0
85991,6,0,0
85992,months,0,0
85993,of,0,0
85994,age,0,0
85995,.,0,0
85996,Prognosis,0,1
85997,of,0,0
85998,advanced,0,0
85999,hepatocellular,0,0
86000,carcinoma,0,0
86001,:,0,0
86002,comparison,0,0
86003,of,0,0
86004,three,0,0
86005,staging,0,0
86006,systems,0,0
86007,in,0,0
86008,two,0,0
86009,French,0,0
86010,clinical,0,0
86011,trials,0,0
86012,.,0,0
86013,OBJECTIVE,0,0
86014,The,0,0
86015,objective,0,0
86016,of,0,0
86017,this,0,0
86018,study,0,0
86019,was,0,0
86020,to,0,0
86021,assess,0,0
86022,the,0,0
86023,performance,0,1
86024,of,0,0
86025,three,0,0
86026,staging,0,0
86027,systems,0,0
86028,[,0,0
86029,Okuda,0,1
86030,",",0,0
86031,Cancer,0,0
86032,of,0,0
86033,the,0,0
86034,Liver,0,0
86035,Italian,0,0
86036,Program,0,0
86037,(,0,0
86038,CLIP,0,1
86039,),0,0
86040,and,0,0
86041,Barcelona,0,0
86042,Clinic,0,1
86043,Liver,0,0
86044,Cancer,0,1
86045,group,0,0
86046,(,0,0
86047,BCLC,0,0
86048,),0,1
86049,],0,0
86050,",",0,0
86051,for,0,0
86052,predicting,0,1
86053,survival,1,1
86054,in,0,0
86055,patients,0,0
86056,with,0,0
86057,hepatocellular,0,0
86058,carcinoma,0,0
86059,(,0,0
86060,HCC,0,0
86061,),0,0
86062,and,0,0
86063,to,0,0
86064,explore,0,0
86065,how,0,0
86066,to,0,0
86067,improve,0,0
86068,prognostic,0,1
86069,classification,0,1
86070,among,0,0
86071,French,0,0
86072,patients,0,0
86073,with,0,0
86074,HCC,0,0
86075,whose,0,0
86076,main,0,0
86077,etiology,0,0
86078,is,0,0
86079,alcoholic,0,0
86080,cirrhosis,0,0
86081,.,0,0
86082,METHODS,0,0
86083,We,0,0
86084,have,0,0
86085,pooled,0,0
86086,two,0,0
86087,randomized,0,0
86088,clinical,0,0
86089,trials,0,0
86090,in,0,0
86091,palliative,0,0
86092,condition,0,0
86093,from,0,0
86094,the,0,0
86095,F?d?ration,0,0
86096,Francophone,0,0
86097,de,0,0
86098,Cancerologie,0,0
86099,Digestive,0,1
86100,.,0,0
86101,They,0,0
86102,had,0,0
86103,included,0,0
86104,416,0,0
86105,and,0,0
86106,122,0,0
86107,patients,0,0
86108,.,0,0
86109,Performances,0,1
86110,of,0,0
86111,Okuda,0,1
86112,",",0,0
86113,CLIP,0,1
86114,and,0,1
86115,BCLC,0,0
86116,scores,0,1
86117,have,0,0
86118,been,0,0
86119,compared,0,0
86120,using,0,0
86121,Akaike,0,0
86122,information,0,1
86123,criterion,0,1
86124,",",0,0
86125,discriminatory,0,1
86126,ability,0,1
86127,(,0,0
86128,Harrell,0,1
86129,'s,0,1
86130,C,0,0
86131,and,0,0
86132,the,0,0
86133,Royston,0,0
86134,'s,0,0
86135,D,0,1
86136,statistics,0,0
86137,),0,0
86138,",",0,0
86139,monotonicity,0,1
86140,of,0,1
86141,gradients,0,1
86142,and,0,0
86143,predictive,0,1
86144,accuracy,0,1
86145,(,0,0
86146,Schemper,0,0
86147,statistics,0,0
86148,Vs,0,0
86149,),0,0
86150,.,0,0
86151,To,0,0
86152,explore,0,0
86153,how,0,0
86154,to,0,0
86155,improve,0,0
86156,classifications,0,1
86157,",",0,0
86158,univariate,0,0
86159,and,0,0
86160,multivariate,0,0
86161,Cox,0,0
86162,model,0,0
86163,analyses,0,0
86164,were,0,0
86165,carried,0,0
86166,out,0,0
86167,.,0,0
86168,RESULTS,0,0
86169,The,0,0
86170,pooled,0,0
86171,database,0,0
86172,included,0,0
86173,538,0,0
86174,patients,1,0
86175,.,1,0
86176,The,1,0
86177,median,1,0
86178,survival,1,1
86179,was,1,0
86180,5.3,0,0
86181,months,0,0
86182,(,0,0
86183,95,0,0
86184,%,0,0
86185,confidence,0,0
86186,interval,0,0
86187,4.6-6.2,0,0
86188,),0,0
86189,.,0,0
86190,For,0,0
86191,all,1,0
86192,statistics,1,0
86193,CLIP,1,1
86194,staging,1,0
86195,system,1,0
86196,had,1,0
86197,a,0,0
86198,better,1,0
86199,prognostic,1,1
86200,ability,1,0
86201,.,1,0
86202,Performances,1,0
86203,of,1,0
86204,all,0,0
86205,staging,0,0
86206,systems,0,0
86207,were,0,0
86208,rather,1,0
86209,disappointing,1,0
86210,.,1,0
86211,World,1,0
86212,Health,1,1
86213,Organization,1,1
86214,performance,1,1
86215,status,1,1
86216,(,1,0
86217,WHO,1,1
86218,PS,1,0
86219,),1,0
86220,for,1,0
86221,CLIP,0,1
86222,or,0,0
86223,alpha-fetoprotein,0,1
86224,for,0,0
86225,BCLC,0,0
86226,allowed,0,0
86227,a,0,0
86228,significant,1,0
86229,improvement,1,1
86230,of,1,0
86231,prognostic,1,1
86232,information,1,0
86233,.,1,0
86234,CONCLUSION,0,0
86235,Our,0,0
86236,results,0,0
86237,indicate,0,0
86238,that,0,0
86239,CLIP,0,1
86240,staging,0,0
86241,seems,0,0
86242,to,0,0
86243,be,0,0
86244,most,0,0
86245,adapted,0,0
86246,to,0,0
86247,palliative,0,0
86248,setting,0,0
86249,and,0,0
86250,that,0,0
86251,it,0,0
86252,could,0,0
86253,be,0,0
86254,better,0,0
86255,by,0,0
86256,associating,1,0
86257,WHO,1,0
86258,PS,1,0
86259,.,1,0
86260,The,0,0
86261,dipeptidyl,0,0
86262,peptidase-4,0,0
86263,inhibitor,0,0
86264,PHX1149,0,0
86265,improves,0,1
86266,blood,1,1
86267,glucose,1,1
86268,control,1,0
86269,in,0,0
86270,patients,0,0
86271,with,0,0
86272,type,0,0
86273,2,0,0
86274,diabetes,0,0
86275,mellitus,0,0
86276,.,0,0
86277,AIM,0,0
86278,To,0,0
86279,determine,0,0
86280,the,0,0
86281,efficacy,1,1
86282,and,1,0
86283,tolerability,1,1
86284,of,0,1
86285,PHX1149,0,0
86286,",",0,0
86287,a,0,0
86288,novel,0,0
86289,dipeptidyl,0,0
86290,peptidase-4,0,0
86291,(,0,0
86292,DPP4,0,0
86293,),0,1
86294,inhibitor,0,0
86295,",",0,0
86296,in,0,0
86297,patients,0,0
86298,with,0,0
86299,type,0,0
86300,2,0,0
86301,diabetes,0,0
86302,.,0,0
86303,METHODS,0,0
86304,This,0,0
86305,is,0,0
86306,a,0,0
86307,multicentre,0,0
86308,",",0,0
86309,randomized,0,0
86310,",",0,0
86311,double-blind,0,0
86312,",",0,0
86313,placebo-controlled,0,0
86314,",",0,0
86315,4-week,0,0
86316,study,0,0
86317,in,0,0
86318,patients,0,0
86319,with,0,0
86320,type,0,0
86321,2,0,0
86322,diabetes,0,0
86323,with,0,0
86324,suboptimal,0,0
86325,metabolic,0,0
86326,control,0,0
86327,.,0,0
86328,Patients,0,0
86329,with,0,0
86330,a,0,0
86331,baseline,0,0
86332,haemoglobin,0,1
86333,A,0,0
86334,(,0,0
86335,1c,0,1
86336,),0,0
86337,(,0,0
86338,HbA,0,0
86339,(,0,0
86340,1c,0,1
86341,),0,0
86342,),0,0
86343,of,0,0
86344,7.3,0,0
86345,to,0,0
86346,11.0,0,0
86347,%,0,0
86348,were,0,0
86349,randomized,0,0
86350,1,0,0
86351,:,0,0
86352,1,0,0
86353,:,0,0
86354,1,0,0
86355,:,0,0
86356,1,0,0
86357,to,0,0
86358,receive,0,0
86359,once-daily,0,0
86360,oral,0,0
86361,therapy,0,0
86362,with,0,0
86363,either,0,0
86364,PHX1149,0,0
86365,(,0,0
86366,100,0,0
86367,",",0,0
86368,200,0,0
86369,or,0,0
86370,400,0,0
86371,mg,0,0
86372,),0,0
86373,or,0,0
86374,placebo,0,0
86375,;,0,0
86376,patients,0,0
86377,were,0,0
86378,on,0,0
86379,a,0,0
86380,constant,0,0
86381,background,0,0
86382,therapy,0,0
86383,of,0,0
86384,either,0,0
86385,metformin,0,0
86386,alone,0,0
86387,or,0,0
86388,metformin,0,0
86389,plus,0,0
86390,a,0,0
86391,glitazone,0,0
86392,.,0,0
86393,RESULTS,0,0
86394,Treatment,0,0
86395,with,0,0
86396,100,0,0
86397,",",0,0
86398,200,0,0
86399,or,0,0
86400,400,0,0
86401,mg,0,0
86402,of,0,0
86403,PHX1149,0,0
86404,significantly,0,0
86405,decreased,0,0
86406,postprandial,1,1
86407,glucose,1,1
86408,area,1,0
86409,under,1,0
86410,the,1,0
86411,curve,1,1
86412,AUC,1,0
86413,(,1,0
86414,0-2,1,0
86415,h,0,0
86416,),0,0
86417,by,0,0
86418,approximately,0,0
86419,20,0,0
86420,%,0,0
86421,(,0,0
86422,+0.11,0,0
86423,+/-,0,0
86424,0.50,0,0
86425,",",0,0
86426,-2.08,0,0
86427,+/-,0,0
86428,0.51,0,0
86429,",",0,0
86430,-1.73,0,0
86431,+/-,0,0
86432,0.49,0,0
86433,and,0,0
86434,-1.88,0,0
86435,+/-,0,0
86436,0.48,0,0
86437,mmol/l,0,0
86438,x,0,0
86439,h,0,0
86440,",",0,0
86441,respectively,0,0
86442,",",0,0
86443,for,0,0
86444,placebo,0,0
86445,and,0,0
86446,100,0,0
86447,",",0,0
86448,200,0,0
86449,and,0,0
86450,400,0,0
86451,mg,0,0
86452,(,0,0
86453,p,0,0
86454,=,0,0
86455,0.002,0,0
86456,",",0,0
86457,0.008,0,0
86458,and,0,0
86459,0.004,0,0
86460,vs.,0,0
86461,placebo,0,0
86462,),0,0
86463,.,0,0
86464,Postprandial,1,1
86465,AUC,1,0
86466,(,1,0
86467,0-2,1,0
86468,h,1,0
86469,),1,0
86470,of,1,0
86471,intact,1,0
86472,glucagon-like,1,1
86473,peptide-1,1,0
86474,",",0,0
86475,the,0,0
86476,principal,0,0
86477,mediator,0,1
86478,of,0,0
86479,the,0,0
86480,biological,0,0
86481,effects,0,0
86482,of,0,0
86483,DPP4,0,0
86484,inhibitors,0,0
86485,",",0,0
86486,was,0,0
86487,increased,0,0
86488,by,0,0
86489,3.90,0,0
86490,+/-,0,0
86491,2.83,0,0
86492,",",0,0
86493,11.63,0,0
86494,+/-,0,0
86495,2.86,0,0
86496,",",0,0
86497,16.42,0,0
86498,+/-,0,0
86499,2.72,0,0
86500,and,0,0
86501,15.75,0,0
86502,+/-,0,0
86503,2.71,0,0
86504,pmol/l,0,0
86505,x,0,0
86506,h,0,0
86507,",",0,0
86508,respectively,0,0
86509,",",0,0
86510,for,0,0
86511,placebo,0,0
86512,and,0,0
86513,100,0,0
86514,",",0,0
86515,200,0,0
86516,and,0,0
86517,400,0,0
86518,mg,0,0
86519,(,0,0
86520,p,0,0
86521,=,0,0
86522,0.053,0,0
86523,",",0,0
86524,0.001,0,0
86525,and,0,0
86526,0.002,0,0
86527,vs.,0,0
86528,placebo,0,0
86529,),0,0
86530,.,0,0
86531,Mean,1,0
86532,HbA,1,0
86533,(,1,0
86534,1c,1,1
86535,),1,0
86536,was,0,0
86537,lower,0,0
86538,in,0,0
86539,all,0,0
86540,dose,0,0
86541,groups,0,0
86542,;,0,0
86543,the,0,0
86544,placebo-corrected,0,0
86545,change,0,0
86546,in,0,0
86547,the,0,0
86548,groups,0,0
86549,receiving,0,0
86550,400,0,0
86551,mg,0,0
86552,PHX1149,0,0
86553,was,0,0
86554,-0.28,0,0
86555,%,0,0
86556,(,0,0
86557,p,0,0
86558,=,0,0
86559,0.02,0,0
86560,),0,0
86561,.,0,0
86562,DPP4,1,0
86563,inhibition,1,1
86564,on,0,0
86565,day,0,0
86566,28,0,0
86567,was,0,0
86568,53,0,0
86569,",",0,0
86570,73,0,0
86571,and,0,0
86572,78,0,0
86573,%,0,0
86574,at,0,0
86575,24,0,0
86576,h,0,0
86577,postdose,0,0
86578,in,0,0
86579,the,0,0
86580,groups,0,0
86581,receiving,0,0
86582,100,0,0
86583,",",0,0
86584,200,0,0
86585,and,0,0
86586,400,0,0
86587,mg,0,0
86588,PHX1149,0,0
86589,",",0,0
86590,respectively,0,0
86591,.,0,0
86592,There,0,0
86593,were,0,0
86594,no,0,0
86595,differences,0,0
86596,in,0,0
86597,adverse,1,1
86598,events,1,1
86599,between,0,0
86600,PHX1149-treated,0,0
86601,and,0,0
86602,placebo,0,0
86603,subjects,0,0
86604,.,0,0
86605,CONCLUSIONS,0,0
86606,Addition,0,0
86607,of,0,0
86608,the,0,0
86609,DPP4,0,0
86610,inhibitor,0,0
86611,PHX1149,0,0
86612,to,0,0
86613,a,0,0
86614,stable,0,0
86615,regimen,0,0
86616,of,0,0
86617,metformin,0,0
86618,or,0,0
86619,metformin,0,0
86620,plus,0,0
86621,a,0,0
86622,glitazone,0,0
86623,in,0,0
86624,patients,0,0
86625,with,0,0
86626,type,0,0
86627,2,0,0
86628,diabetes,0,0
86629,was,0,0
86630,well,1,0
86631,tolerated,1,1
86632,and,0,0
86633,improved,1,1
86634,blood,1,1
86635,glucose,1,1
86636,control,1,0
86637,.,1,0
86638,Clinical,0,1
86639,outcome,0,1
86640,of,0,0
86641,postoperative,0,1
86642,adjuvant,0,0
86643,immunochemotherapy,0,0
86644,with,0,0
86645,sizofiran,0,0
86646,for,0,0
86647,patients,0,0
86648,with,0,0
86649,resectable,0,0
86650,gastric,0,0
86651,cancer,0,0
86652,:,0,0
86653,a,0,0
86654,randomised,0,0
86655,controlled,0,0
86656,study,0,0
86657,.,0,0
86658,Adjuvant,0,0
86659,immunochemotherapy,0,0
86660,using,0,0
86661,the,0,0
86662,antitumour,0,1
86663,polysaccharide,0,0
86664,sizofiran,0,0
86665,(,0,0
86666,SPG,0,1
86667,),0,0
86668,",",0,0
86669,an,0,0
86670,extract,0,0
86671,from,0,0
86672,the,0,0
86673,culture,0,1
86674,broth,0,0
86675,of,0,0
86676,Schizophyllum,0,0
86677,commune,0,0
86678,Fries,0,0
86679,",",0,0
86680,was,0,0
86681,prescribed,0,0
86682,randomly,0,0
86683,for,0,0
86684,386,0,0
86685,Japanese,0,0
86686,patients,0,0
86687,with,0,0
86688,resectable,0,0
86689,gastric,0,1
86690,cancer,0,0
86691,.,0,0
86692,Although,0,0
86693,the,0,0
86694,overall,1,1
86695,survival,1,1
86696,probability,1,0
86697,for,0,0
86698,5,0,0
86699,years,0,0
86700,did,0,0
86701,not,0,0
86702,differ,0,0
86703,between,0,0
86704,the,0,0
86705,SPG,0,0
86706,and,0,0
86707,control,0,0
86708,groups,0,0
86709,",",0,0
86710,in,0,0
86711,264,0,0
86712,patients,0,0
86713,with,0,0
86714,curatively,0,0
86715,resected,0,0
86716,cancer,0,0
86717,",",0,0
86718,the,0,0
86719,probability,0,0
86720,to,0,0
86721,5,0,0
86722,year,0,0
86723,survival,0,1
86724,and,0,0
86725,to,0,0
86726,recurrence,1,1
86727,in,0,0
86728,the,0,0
86729,sizofiran-administered,0,0
86730,patients,0,0
86731,was,0,0
86732,better,0,0
86733,than,0,0
86734,in,0,0
86735,the,0,0
86736,controls,0,0
86737,.,0,0
86738,In,0,0
86739,the,0,0
86740,multivariate,1,0
86741,analysis,1,0
86742,",",0,0
86743,four,0,0
86744,of,0,0
86745,six,0,0
86746,prognostic,0,0
86747,factors,0,0
86748,correlated,0,0
86749,with,0,0
86750,the,0,0
86751,prognosis,0,0
86752,of,0,0
86753,the,0,0
86754,264,0,0
86755,patients,0,0
86756,who,0,0
86757,underwent,0,0
86758,curative,0,0
86759,surgery,0,0
86760,",",0,0
86761,that,0,0
86762,is,0,0
86763,",",0,0
86764,nodal,1,1
86765,involvement,1,1
86766,(,0,0
86767,chi,0,0
86768,2,0,0
86769,=,0,0
86770,21.426,0,0
86771,",",0,0
86772,P,0,0
86773,=,0,0
86774,less,0,0
86775,than,0,0
86776,0.0001,0,0
86777,),0,0
86778,",",0,0
86779,age,1,0
86780,distribution,1,1
86781,(,0,0
86782,chi,0,0
86783,2,0,0
86784,=,0,0
86785,9.262,0,0
86786,",",0,0
86787,P,0,0
86788,=,0,0
86789,0.010,0,0
86790,),0,0
86791,",",0,0
86792,sizofiran,1,0
86793,administration,1,0
86794,(,0,0
86795,chi,0,0
86796,2,0,0
86797,=,0,0
86798,6.507,0,0
86799,",",0,0
86800,P,0,0
86801,=,0,0
86802,0.011,0,0
86803,),0,0
86804,",",0,0
86805,and,0,1
86806,primary,1,1
86807,tumour,1,1
86808,size,1,1
86809,(,0,0
86810,chi,0,0
86811,2,0,0
86812,=,0,0
86813,9.345,0,0
86814,",",0,0
86815,P,0,0
86816,=,0,0
86817,0.025,0,0
86818,),0,0
86819,.,0,0
86820,Thus,0,0
86821,",",0,0
86822,patients,0,0
86823,with,0,0
86824,a,0,0
86825,curatively,0,0
86826,resected,0,0
86827,gastric,0,1
86828,cancer,0,0
86829,had,0,0
86830,a,0,0
86831,better,0,0
86832,prognosis,0,1
86833,when,0,0
86834,sizofiran,0,0
86835,was,0,0
86836,prescribed,0,0
86837,in,0,0
86838,combination,0,0
86839,with,0,0
86840,antitumour,0,1
86841,drugs,0,0
86842,.,0,0
86843,Effect,0,0
86844,of,0,0
86845,intestinal,0,1
86846,production,0,1
86847,of,0,0
86848,equol,0,0
86849,on,0,0
86850,menopausal,1,0
86851,symptoms,1,1
86852,in,0,0
86853,women,0,0
86854,treated,0,0
86855,with,0,0
86856,soy,0,0
86857,isoflavones,0,0
86858,.,0,0
86859,OBJECTIVE,0,0
86860,To,0,0
86861,evaluate,0,0
86862,the,0,0
86863,effect,0,0
86864,of,0,0
86865,soy,0,0
86866,isoflavones,0,0
86867,on,0,0
86868,menopausal,0,0
86869,symptoms,0,1
86870,in,0,0
86871,women,0,0
86872,who,0,0
86873,do,0,0
86874,and,0,0
86875,who,0,0
86876,do,0,0
86877,not,0,0
86878,produce,0,0
86879,equol,0,0
86880,",",0,0
86881,a,0,0
86882,daidzein,0,0
86883,metabolite,0,0
86884,.,0,0
86885,METHOD,0,0
86886,A,0,0
86887,randomized,0,0
86888,",",0,0
86889,double-blind,0,0
86890,",",0,0
86891,placebo-controlled,0,0
86892,clinical,0,0
86893,trial,0,0
86894,was,0,0
86895,conducted,0,0
86896,over,0,0
86897,6,0,0
86898,months,0,0
86899,with,0,0
86900,96,0,0
86901,healthy,0,0
86902,menopausal,0,0
86903,women,0,0
86904,.,0,0
86905,After,0,0
86906,taking,0,0
86907,take,0,0
86908,135,0,0
86909,mg,0,0
86910,of,0,0
86911,isoflavones,0,0
86912,daily,0,0
86913,for,0,0
86914,1,0,0
86915,week,0,0
86916,",",0,0
86917,the,0,0
86918,women,0,0
86919,in,0,0
86920,the,0,0
86921,study,0,0
86922,group,0,0
86923,were,0,0
86924,assigned,0,0
86925,to,0,0
86926,the,0,0
86927,equol-producing,0,0
86928,(,0,0
86929,EP,0,1
86930,),0,0
86931,or,0,0
86932,the,0,0
86933,non-EP,0,0
86934,group,0,0
86935,according,0,0
86936,to,0,0
86937,the,0,0
86938,presence,0,0
86939,or,0,0
86940,absence,0,0
86941,of,0,1
86942,equol,0,0
86943,in,0,0
86944,their,0,0
86945,urine,0,1
86946,.,0,0
86947,Menopausal,0,0
86948,symptoms,0,1
86949,were,0,0
86950,evaluated,0,0
86951,using,0,0
86952,a,0,0
86953,modified,0,0
86954,Kupperman,0,0
86955,Index,0,0
86956,.,0,0
86957,RESULT,0,0
86958,Compared,0,0
86959,with,0,0
86960,the,0,0
86961,placebo,0,0
86962,group,0,0
86963,",",0,0
86964,the,0,0
86965,scores,0,1
86966,for,0,0
86967,hot,1,1
86968,flashes,1,1
86969,and,1,0
86970,excessive,1,1
86971,sweating,1,1
86972,were,0,0
86973,significantly,0,0
86974,reduced,0,0
86975,after,0,0
86976,3,0,0
86977,months,0,0
86978,",",0,0
86979,and,0,0
86980,the,0,0
86981,scores,0,1
86982,for,0,0
86983,weakness,1,1
86984,",",1,0
86985,palpitations,1,1
86986,",",1,1
86987,limb,1,1
86988,paresthesia,1,1
86989,",",1,0
86990,and,1,1
86991,total,1,1
86992,symptoms,1,1
86993,after,0,0
86994,6,0,0
86995,months,0,0
86996,",",0,0
86997,in,0,0
86998,the,0,0
86999,EP,0,0
87000,group,0,0
87001,only,0,0
87002,.,0,0
87003,CONCLUSIONS,0,0
87004,Isoflavone,0,0
87005,supplementation,0,0
87006,improves,0,1
87007,menopausal,1,0
87008,symptoms,1,1
87009,only,0,0
87010,in,0,0
87011,women,0,0
87012,with,0,0
87013,the,0,0
87014,ability,0,0
87015,to,0,0
87016,produce,0,0
87017,equol,0,0
87018,.,0,0
87019,Effect,0,0
87020,of,0,0
87021,radiotherapy,0,0
87022,on,0,0
87023,blood,1,1
87024,lymphocyte,1,1
87025,population,1,0
87026,in,0,0
87027,mammary,0,0
87028,carcinoma,0,0
87029,.,0,0
87030,Effect,0,0
87031,of,0,0
87032,prophylactic,0,0
87033,transluminal,0,0
87034,balloon,0,0
87035,angioplasty,0,0
87036,on,0,0
87037,cerebral,1,1
87038,vasospasm,1,1
87039,and,0,1
87040,outcome,0,1
87041,in,0,0
87042,patients,0,0
87043,with,0,0
87044,Fisher,0,0
87045,grade,0,1
87046,III,0,0
87047,subarachnoid,0,0
87048,hemorrhage,0,1
87049,:,0,0
87050,results,0,0
87051,of,0,0
87052,a,0,0
87053,phase,0,0
87054,II,0,0
87055,multicenter,0,0
87056,",",0,0
87057,randomized,0,0
87058,",",0,0
87059,clinical,0,0
87060,trial,0,0
87061,.,0,0
87062,BACKGROUND,0,0
87063,AND,0,0
87064,PURPOSE,0,0
87065,Cerebral,0,1
87066,vasospasm,0,1
87067,continues,0,0
87068,to,0,0
87069,be,0,0
87070,a,0,0
87071,major,0,0
87072,cause,0,0
87073,of,0,0
87074,poor,0,1
87075,outcome,0,1
87076,in,0,0
87077,patients,0,0
87078,with,0,0
87079,ruptured,0,0
87080,aneurysms,0,0
87081,.,0,0
87082,Prophylactic,0,0
87083,Transluminal,0,0
87084,Balloon,0,1
87085,Angioplasty,0,0
87086,(,0,0
87087,pTBA,0,0
87088,),0,0
87089,appeared,0,0
87090,to,0,0
87091,prevent,0,0
87092,delayed,1,0
87093,ischemic,1,0
87094,neurological,1,1
87095,deficit,1,0
87096,in,0,0
87097,a,0,0
87098,pilot,0,0
87099,study,0,0
87100,.,0,0
87101,A,0,0
87102,phase,0,0
87103,II,0,0
87104,multicenter,0,0
87105,randomized,0,0
87106,clinical,0,0
87107,trial,0,0
87108,was,0,0
87109,subsequently,0,0
87110,designed,0,0
87111,.,0,0
87112,METHODS,0,0
87113,One,0,0
87114,hundred,0,0
87115,and,0,0
87116,seventy,0,0
87117,patients,0,0
87118,with,0,0
87119,Fisher,0,0
87120,Grade,0,1
87121,III,0,0
87122,subarachnoid,0,0
87123,hemorrhage,0,1
87124,were,0,0
87125,enrolled,0,0
87126,in,0,0
87127,the,0,0
87128,study,0,0
87129,.,0,0
87130,Of,0,0
87131,these,0,0
87132,",",0,0
87133,85,0,0
87134,patients,0,0
87135,were,0,0
87136,randomized,0,0
87137,to,0,0
87138,the,0,0
87139,treatment,0,0
87140,group,0,0
87141,and,0,1
87142,underwent,0,0
87143,pTBA,0,0
87144,within,0,0
87145,96,0,0
87146,hours,0,0
87147,after,0,0
87148,subarachnoid,0,0
87149,hemorrhage,0,1
87150,.,0,0
87151,Main,0,0
87152,end,0,0
87153,points,0,0
87154,of,0,0
87155,the,0,0
87156,study,0,0
87157,included,0,0
87158,the,0,0
87159,3-month,1,0
87160,dichotomized,1,0
87161,Glasgow,1,0
87162,Outcome,1,1
87163,Score,1,0
87164,(,1,0
87165,GOS,1,0
87166,),1,0
87167,",",1,0
87168,development,1,1
87169,of,1,0
87170,delayed,1,0
87171,ischemic,1,0
87172,neurological,1,1
87173,deficit,1,1
87174,(,1,0
87175,DIND,1,0
87176,),1,0
87177,",",1,0
87178,occurrence,1,1
87179,of,1,0
87180,Transcranial,1,1
87181,Doppler,1,1
87182,(,1,0
87183,TCD,1,0
87184,),1,1
87185,vasospasm,1,1
87186,",",1,0
87187,and,1,1
87188,length,1,1
87189,of,1,1
87190,stay,1,1
87191,in,1,0
87192,the,1,0
87193,ICU,1,0
87194,and,0,0
87195,hospital,0,0
87196,.,0,0
87197,RESULTS,0,0
87198,The,0,0
87199,incidence,1,1
87200,of,1,0
87201,DIND,1,0
87202,was,0,0
87203,lower,0,0
87204,in,0,0
87205,the,0,0
87206,pTBA,0,0
87207,group,0,0
87208,(,0,0
87209,P=0.30,0,0
87210,),0,0
87211,and,0,0
87212,fewer,0,0
87213,patients,0,0
87214,required,0,1
87215,therapeutic,0,0
87216,angioplasty,0,0
87217,to,0,0
87218,treat,0,0
87219,DIND,0,0
87220,(,0,0
87221,P=0.03,0,0
87222,),0,0
87223,.,0,0
87224,Overall,0,1
87225,pTBA,1,0
87226,resulted,0,0
87227,in,0,0
87228,an,0,0
87229,absolute,0,1
87230,risk,1,1
87231,reduction,1,1
87232,of,0,0
87233,5.9,0,0
87234,%,0,0
87235,and,0,0
87236,a,0,0
87237,relative,1,1
87238,risk,1,1
87239,reduction,1,1
87240,of,0,0
87241,10.4,0,0
87242,%,0,0
87243,unfavorable,0,0
87244,outcome,0,1
87245,(,0,0
87246,P=0.54,0,0
87247,),0,0
87248,.,0,0
87249,Good,0,1
87250,grade,0,1
87251,patients,0,0
87252,had,0,0
87253,absolute,1,1
87254,and,1,0
87255,relative,1,1
87256,risk,1,1
87257,reductions,1,1
87258,of,0,0
87259,respectively,0,0
87260,9.5,0,0
87261,and,0,0
87262,29.4,0,0
87263,%,0,0
87264,(,0,0
87265,P=0.73,0,0
87266,),0,0
87267,.,0,0
87268,Length,1,1
87269,of,1,0
87270,stay,1,1
87271,in,1,0
87272,ICU,1,1
87273,and,0,1
87274,hospital,0,1
87275,was,0,0
87276,similar,0,0
87277,in,0,0
87278,both,0,0
87279,groups,0,0
87280,.,0,0
87281,Four,0,0
87282,patients,0,0
87283,had,0,0
87284,a,0,0
87285,procedure-related,1,1
87286,vessel,1,1
87287,perforation,1,1
87288,",",0,0
87289,of,0,0
87290,which,0,0
87291,three,0,0
87292,patients,0,0
87293,died,0,0
87294,.,0,0
87295,CONCLUSIONS,0,0
87296,While,0,0
87297,the,0,0
87298,trial,0,0
87299,is,0,0
87300,unsuccessful,0,0
87301,as,0,0
87302,defined,0,0
87303,by,0,0
87304,the,0,0
87305,primary,0,0
87306,end,0,0
87307,point,0,0
87308,(,0,0
87309,GOS,0,1
87310,),0,0
87311,",",0,0
87312,proof,0,0
87313,of,0,0
87314,concept,0,0
87315,is,0,0
87316,confirmed,0,0
87317,by,0,0
87318,these,0,0
87319,results,0,0
87320,.,0,0
87321,Fewer,0,0
87322,patients,0,0
87323,tend,0,0
87324,to,0,0
87325,develop,0,0
87326,vasospasm,1,1
87327,after,0,0
87328,treatment,0,0
87329,with,0,0
87330,pTBA,0,0
87331,and,0,0
87332,there,0,0
87333,is,0,0
87334,a,0,0
87335,statistically,0,0
87336,significantly,0,0
87337,decreased,0,0
87338,need,1,0
87339,for,1,0
87340,therapeutic,1,0
87341,angioplasty,1,0
87342,.,1,0
87343,pTBA,0,0
87344,does,0,0
87345,not,0,0
87346,improve,0,0
87347,the,0,0
87348,poor,0,1
87349,outcome,0,0
87350,of,0,0
87351,patients,0,0
87352,with,0,0
87353,Fisher,0,0
87354,grade,0,1
87355,III,0,1
87356,subarachnoid,0,0
87357,hemorrhage,0,1
87358,.,0,0
87359,Evaluation,1,0
87360,of,0,0
87361,a,0,0
87362,device,0,0
87363,to,0,0
87364,facilitate,0,0
87365,female,0,0
87366,urethral,0,1
87367,catheterization,0,0
87368,.,0,0
87369,Urethral,0,0
87370,catheterization,0,0
87371,is,0,0
87372,a,0,0
87373,skilled,0,0
87374,procedure,0,0
87375,that,0,0
87376,nurses,0,0
87377,in,0,0
87378,hospital,0,0
87379,settings,0,0
87380,perform,0,0
87381,routinely,0,0
87382,.,0,0
87383,The,0,0
87384,opening,0,0
87385,of,0,0
87386,the,0,0
87387,female,0,0
87388,urethra,0,0
87389,is,0,0
87390,located,0,0
87391,within,0,0
87392,the,0,0
87393,vulvar,0,0
87394,vestibule,0,0
87395,",",0,0
87396,making,0,0
87397,insertion,0,0
87398,of,0,0
87399,urinary,0,1
87400,catheters,0,0
87401,into,0,0
87402,females,0,0
87403,a,0,0
87404,greater,0,0
87405,technical,0,1
87406,challenge,0,0
87407,than,0,0
87408,in,0,0
87409,males,0,0
87410,.,0,0
87411,Researchers,0,0
87412,evaluated,0,0
87413,whether,0,0
87414,a,0,0
87415,new,0,0
87416,device,0,0
87417,might,0,0
87418,decrease,0,0
87419,the,0,0
87420,time,1,1
87421,required,1,0
87422,for,1,0
87423,catheter,1,0
87424,insertion,1,0
87425,",",1,0
87426,increase,1,0
87427,the,1,0
87428,likelihood,1,0
87429,of,1,0
87430,inserting,1,0
87431,the,1,0
87432,catheter,1,0
87433,on,1,0
87434,the,1,0
87435,first,1,0
87436,attempt,1,0
87437,(,1,0
87438,improved,1,1
87439,accuracy,1,1
87440,),1,0
87441,",",0,0
87442,and,0,0
87443,reduce,1,0
87444,patient,1,1
87445,discomfort,1,1
87446,.,1,0
87447,Comments,0,0
87448,about,0,0
87449,the,0,0
87450,device,0,0
87451,from,0,0
87452,both,0,0
87453,patients,0,0
87454,and,0,0
87455,nurses,0,0
87456,also,0,0
87457,are,0,0
87458,reported,0,0
87459,.,0,0
87460,Science,0,1
87461,to,0,0
87462,practice,0,0
87463,in,0,0
87464,underserved,0,0
87465,communities,0,0
87466,:,0,0
87467,the,0,0
87468,effectiveness,1,1
87469,of,0,0
87470,school,0,0
87471,mental,0,1
87472,health,0,1
87473,programming,0,0
87474,.,0,0
87475,This,0,0
87476,study,0,0
87477,examined,0,0
87478,the,0,0
87479,effectiveness,0,0
87480,of,0,0
87481,a,0,0
87482,treatment,0,0
87483,program,0,0
87484,comprised,0,0
87485,of,0,0
87486,several,0,0
87487,components,0,0
87488,based,0,0
87489,on,0,0
87490,evidence-based,0,0
87491,treatments,0,0
87492,(,0,0
87493,EBTs,0,0
87494,),0,0
87495,for,0,0
87496,disruptive,0,1
87497,behavior,0,1
87498,problems,0,1
87499,delivered,0,0
87500,to,0,0
87501,youth,0,0
87502,participating,0,0
87503,in,0,0
87504,a,0,0
87505,school,0,0
87506,mental,0,1
87507,health,0,1
87508,program,0,0
87509,in,0,0
87510,an,0,0
87511,underserved,0,0
87512,community,0,0
87513,in,0,0
87514,the,0,0
87515,Appalachian,0,0
87516,region,0,0
87517,.,0,0
87518,Participants,0,0
87519,were,0,0
87520,117,0,0
87521,children,0,0
87522,in,0,0
87523,kindergarten,0,0
87524,through,0,0
87525,6th,0,0
87526,grade,0,0
87527,including,0,0
87528,91,0,0
87529,children,0,0
87530,(,0,0
87531,78,0,0
87532,%,0,0
87533,male,0,0
87534,),0,0
87535,from,0,0
87536,5,0,0
87537,schools,0,0
87538,who,0,0
87539,were,0,0
87540,consecutively,0,0
87541,referred,0,0
87542,to,0,0
87543,the,0,0
87544,intervention,0,0
87545,program,0,0
87546,and,0,0
87547,26,0,0
87548,children,0,0
87549,(,0,0
87550,73,0,0
87551,%,0,0
87552,male,0,0
87553,),0,0
87554,from,0,0
87555,3,0,0
87556,schools,0,0
87557,in,0,0
87558,which,0,0
87559,program,0,0
87560,implementation,0,0
87561,was,0,0
87562,delayed,0,0
87563,for,0,0
87564,1,0,0
87565,year,0,0
87566,.,0,0
87567,Treatment,0,0
87568,outcome,0,1
87569,was,0,0
87570,measured,0,0
87571,via,0,0
87572,parent,1,0
87573,and,1,0
87574,teacher,1,0
87575,ratings,1,1
87576,of,1,0
87577,child,1,0
87578,symptoms,1,1
87579,and,1,0
87580,functioning,1,1
87581,.,1,0
87582,The,0,0
87583,treatment,0,0
87584,condition,0,0
87585,resulted,0,0
87586,in,0,0
87587,significant,0,0
87588,reduction,0,1
87589,in,0,0
87590,hyperactivity/impulsivity,1,1
87591,and,1,0
87592,early,1,0
87593,aggressive,1,1
87594,and,1,0
87595,delinquent,1,1
87596,behavior,1,1
87597,",",1,0
87598,as,1,0
87599,well,1,0
87600,as,1,0
87601,significant,1,0
87602,improvement,1,1
87603,in,1,0
87604,several,1,0
87605,other,1,0
87606,functional,1,0
87607,domains,1,0
87608,.,1,0
87609,Results,0,0
87610,suggest,0,0
87611,that,0,0
87612,EBTs,0,0
87613,can,0,0
87614,retain,0,0
87615,their,0,0
87616,effectiveness,1,0
87617,when,0,0
87618,transported,0,0
87619,to,0,0
87620,a,0,0
87621,community,0,0
87622,context,0,0
87623,.,0,0
87624,A,0,0
87625,comparison,0,0
87626,of,0,0
87627,single-dose,0,0
87628,versus,0,0
87629,conventional-dose,0,0
87630,antibiotic,0,0
87631,treatment,0,0
87632,of,0,0
87633,bacteriuria,0,1
87634,in,0,0
87635,elderly,0,0
87636,women,0,0
87637,.,0,0
87638,The,0,0
87639,efficacy,0,1
87640,of,0,0
87641,single-dose,0,0
87642,antibiotic,0,0
87643,therapy,0,0
87644,for,0,0
87645,the,0,0
87646,treatment,0,0
87647,of,0,0
87648,bacteriuria,0,1
87649,in,0,0
87650,a,0,0
87651,group,0,0
87652,of,0,0
87653,non-catheterized,0,0
87654,elderly,0,0
87655,women,0,0
87656,was,0,0
87657,compared,0,0
87658,with,0,0
87659,that,0,0
87660,of,0,0
87661,conventional,0,0
87662,7-10,0,0
87663,day,0,0
87664,courses,0,0
87665,of,0,0
87666,antibiotic,0,0
87667,therapy,0,0
87668,.,0,0
87669,Thirty-one,0,0
87670,women,0,0
87671,received,0,0
87672,single-dose,0,0
87673,treatment,0,0
87674,and,0,0
87675,22,0,0
87676,conventional-dose,0,0
87677,treatment,0,0
87678,.,0,0
87679,The,0,0
87680,cure,1,1
87681,rates,1,1
87682,at,0,0
87683,1,0,0
87684,and,0,0
87685,6,0,0
87686,weeks,0,0
87687,for,0,0
87688,the,0,0
87689,single-dose,0,0
87690,treatments,0,0
87691,were,0,0
87692,52,0,0
87693,%,0,0
87694,and,0,0
87695,38,0,0
87696,%,0,0
87697,",",0,0
87698,respectively,0,0
87699,",",0,0
87700,and,0,0
87701,the,0,0
87702,cure,1,1
87703,rates,1,1
87704,for,0,0
87705,the,0,0
87706,conventional-dose,0,0
87707,treatments,0,0
87708,at,0,0
87709,1,0,0
87710,and,0,0
87711,6,0,0
87712,weeks,0,0
87713,were,0,0
87714,59,0,0
87715,%,0,0
87716,and,0,0
87717,52,0,0
87718,%,0,0
87719,",",0,0
87720,respectively,0,0
87721,.,0,0
87722,It,0,0
87723,is,0,0
87724,concluded,0,0
87725,that,0,0
87726,there,0,0
87727,may,0,0
87728,be,0,0
87729,a,0,0
87730,place,0,0
87731,for,0,0
87732,the,0,0
87733,use,0,0
87734,of,0,0
87735,single-dose,0,0
87736,antibiotic,0,0
87737,therapy,0,0
87738,for,0,0
87739,the,0,0
87740,treatment,0,0
87741,of,0,0
87742,selected,0,0
87743,elderly,0,0
87744,women,0,0
87745,with,0,0
87746,bacteriuria,0,1
87747,",",0,0
87748,but,0,0
87749,larger,0,0
87750,studies,0,0
87751,are,0,0
87752,needed,0,0
87753,.,0,0
87754,Use,0,0
87755,of,0,0
87756,topical,0,0
87757,selamectin,0,0
87758,for,0,0
87759,the,0,0
87760,treatment,0,0
87761,of,0,0
87762,Syphacia,0,0
87763,muris,0,1
87764,infection,0,1
87765,in,0,0
87766,laboratory,0,0
87767,rats,0,0
87768,.,0,0
87769,Efficacy,1,0
87770,of,0,0
87771,selamectin,0,0
87772,was,0,0
87773,studied,0,0
87774,in,0,0
87775,naturally,0,0
87776,acquired,0,0
87777,S.,0,0
87778,muris,0,1
87779,infections,0,1
87780,in,0,0
87781,rats,0,0
87782,.,0,0
87783,Fourty-eight,0,0
87784,S.,0,0
87785,muris-positive,0,1
87786,rats,0,0
87787,were,0,0
87788,divided,0,0
87789,into,0,0
87790,six,0,0
87791,treated,0,0
87792,and,0,0
87793,two,0,0
87794,control,0,0
87795,groups,0,0
87796,.,0,0
87797,Selamectin,0,0
87798,(,0,0
87799,6,0,0
87800,mg/kg,0,0
87801,),0,0
87802,was,0,0
87803,applied,0,0
87804,topically,0,0
87805,to,0,0
87806,the,0,0
87807,skin,0,0
87808,in,0,0
87809,a,0,0
87810,single,0,0
87811,spot,0,0
87812,at,0,0
87813,the,0,0
87814,base,0,0
87815,of,0,0
87816,the,0,0
87817,neck,0,0
87818,in,0,0
87819,the,0,0
87820,treatment,0,0
87821,group,0,0
87822,.,0,0
87823,The,0,0
87824,rats,0,0
87825,of,0,0
87826,treated,0,0
87827,and,0,0
87828,control,0,0
87829,groups,0,0
87830,were,0,0
87831,necropsied,0,0
87832,on,0,0
87833,the,0,0
87834,24th,0,0
87835,day,0,0
87836,after,0,0
87837,the,0,0
87838,treatment,0,0
87839,.,0,0
87840,Topical,0,1
87841,selamectin,0,0
87842,was,0,0
87843,found,0,0
87844,to,0,0
87845,be,0,0
87846,40.7-63.3,0,0
87847,%,0,0
87848,effective,1,1
87849,(,1,0
87850,based,1,0
87851,on,1,0
87852,egg,1,0
87853,per,1,0
87854,gram,1,1
87855,method,1,0
87856,),1,0
87857,in,1,0
87858,eliminating,1,0
87859,S.,1,0
87860,muris,1,1
87861,infection,1,1
87862,in,0,0
87863,rats,0,0
87864,.,0,0
87865,The,0,0
87866,efficacy,1,1
87867,of,1,0
87868,the,1,0
87869,treatment,1,0
87870,against,0,0
87871,S.,0,0
87872,muris,0,1
87873,(,0,0
87874,based,0,0
87875,on,0,0
87876,adult,0,0
87877,worm,0,1
87878,counts,0,1
87879,),0,0
87880,in,0,0
87881,male,0,0
87882,and,0,0
87883,female,0,0
87884,rats,0,0
87885,was,0,0
87886,35.14-58.88,0,0
87887,%,0,0
87888,",",0,0
87889,respectively,0,0
87890,(,0,0
87891,mean,0,0
87892,48.39,0,0
87893,%,0,0
87894,),0,0
87895,.,0,0
87896,Central,0,1
87897,neuronal,0,1
87898,mechanisms,0,0
87899,of,0,0
87900,gastric,0,1
87901,electrical,0,1
87902,stimulation,0,0
87903,in,0,0
87904,diabetic,0,0
87905,gastroparesis,0,0
87906,.,0,0
87907,OBJECTIVE,0,0
87908,The,0,0
87909,mechanisms,0,0
87910,underlying,0,0
87911,symptom,0,1
87912,improvement,0,1
87913,in,0,0
87914,gastric,0,1
87915,electrical,0,1
87916,stimulation,0,0
87917,(,0,0
87918,GES,0,0
87919,),0,0
87920,are,0,0
87921,not,0,0
87922,fully,0,0
87923,understood,0,0
87924,.,0,0
87925,Modulation,0,0
87926,of,0,0
87927,the,0,0
87928,central,0,0
87929,nervous,0,0
87930,system,0,0
87931,excitability,0,1
87932,may,0,0
87933,be,0,0
87934,involved,0,0
87935,.,0,0
87936,The,0,0
87937,objective,0,0
87938,of,0,0
87939,the,0,0
87940,study,0,0
87941,was,0,0
87942,to,0,0
87943,investigate,0,0
87944,the,0,0
87945,central,0,0
87946,effects,0,0
87947,of,0,0
87948,GES,0,1
87949,",",0,0
87950,including,0,0
87951,the,0,0
87952,possible,0,0
87953,modulation,0,0
87954,of,0,0
87955,the,0,0
87956,visceral,0,1
87957,sensory,0,1
87958,nervous,0,0
87959,system,0,0
87960,.,0,0
87961,MATERIAL,0,0
87962,AND,0,0
87963,METHODS,0,0
87964,A,0,0
87965,gastric,0,1
87966,electrical,0,1
87967,stimulator,0,0
87968,was,0,0
87969,implanted,0,0
87970,in,0,0
87971,seven,0,0
87972,diabetic,0,0
87973,patients,0,0
87974,with,0,0
87975,medically,0,0
87976,refractory,0,0
87977,gastroparesis,0,0
87978,.,0,0
87979,A,0,0
87980,double-blinded,0,0
87981,protocol,0,0
87982,was,0,0
87983,used,0,0
87984,to,0,0
87985,investigate,0,0
87986,the,0,0
87987,patients,0,0
87988,at,0,0
87989,baseline,0,0
87990,and,0,0
87991,one,0,0
87992,month,0,0
87993,after,0,0
87994,recovery,0,1
87995,with,0,0
87996,the,0,0
87997,stimulator,0,0
87998,turned,0,0
87999,on,0,0
88000,and,0,0
88001,off,0,0
88002,(,0,0
88003,1-month,0,0
88004,periods,0,0
88005,),0,0
88006,.,0,0
88007,The,0,0
88008,following,0,0
88009,assessments,0,0
88010,were,0,0
88011,carried,0,0
88012,out,0,0
88013,:,0,0
88014,mechanical,0,0
88015,",",0,0
88016,thermal,0,1
88017,and,0,1
88018,electrical,0,1
88019,stimulations,0,0
88020,with,0,0
88021,sensory,0,1
88022,recordings,0,0
88023,in,0,0
88024,the,0,0
88025,esophagus,0,0
88026,and,0,1
88027,duodenum,0,1
88028,",",0,1
88029,and,0,1
88030,standardized,0,0
88031,",",0,0
88032,self-administered,0,0
88033,",",0,0
88034,daily,0,0
88035,symptom,0,1
88036,questionnaires,0,0
88037,.,0,0
88038,RESULTS,0,0
88039,No,0,0
88040,difference,0,0
88041,was,0,0
88042,found,0,0
88043,between,0,0
88044,baseline,0,0
88045,and,0,0
88046,the,0,0
88047,on-,0,0
88048,and,0,0
88049,off,0,0
88050,periods,0,0
88051,in,0,0
88052,overall,1,1
88053,gut,1,1
88054,pain,1,1
88055,thresholds,0,1
88056,across,0,0
88057,all,0,0
88058,stimulus,0,1
88059,modalities,0,0
88060,in,0,0
88061,the,0,0
88062,esophagus,0,0
88063,(,0,0
88064,p=0.63,0,0
88065,),0,1
88066,",",0,0
88067,duodenum,0,1
88068,(,0,1
88069,p=0.19,0,0
88070,),0,1
88071,or,0,0
88072,esophagus,0,1
88073,and,0,1
88074,duodenum,0,1
88075,combined,0,0
88076,(,0,0
88077,p=0.76,0,0
88078,),0,0
88079,.,0,0
88080,No,0,0
88081,difference,0,0
88082,in,0,0
88083,the,0,0
88084,sensory,1,0
88085,response,1,1
88086,to,1,0
88087,mechanical,1,0
88088,stimulation,1,0
88089,was,0,0
88090,found,0,0
88091,in,0,0
88092,the,0,0
88093,esophagus,0,0
88094,before,0,0
88095,(,0,0
88096,all,0,0
88097,p,0,0
88098,>,0,0
88099,0.31,0,0
88100,),0,0
88101,and,0,0
88102,after,0,0
88103,(,0,0
88104,all,0,0
88105,p,0,0
88106,>,0,0
88107,0.43,0,0
88108,),0,0
88109,smooth,0,0
88110,muscle,0,1
88111,relaxation,0,1
88112,with,0,0
88113,butylscopolamine,0,0
88114,.,0,0
88115,Similar,0,0
88116,findings,0,0
88117,were,0,0
88118,observed,0,0
88119,in,0,0
88120,the,0,0
88121,duodenum,0,0
88122,.,0,0
88123,No,0,0
88124,differences,0,0
88125,were,0,0
88126,found,0,0
88127,in,0,0
88128,thermal,1,0
88129,sensitivity,1,1
88130,(,0,0
88131,esophagus,0,1
88132,(,0,0
88133,p=0.67,0,0
88134,),0,1
88135,and,0,1
88136,duodenum,1,1
88137,(,0,1
88138,p=0.17,0,0
88139,),0,0
88140,),0,0
88141,",",0,0
88142,sensory,1,1
88143,response,1,1
88144,to,1,0
88145,electrical,1,1
88146,stimulation,1,0
88147,(,0,0
88148,esophagus,0,1
88149,(,0,0
88150,p=0.57,0,0
88151,),0,1
88152,and,0,1
88153,duodenum,1,1
88154,(,0,1
88155,p=0.52,0,0
88156,),0,0
88157,),0,0
88158,or,0,0
88159,induced,1,0
88160,somatic,1,1
88161,referred,1,0
88162,pain,1,1
88163,areas,1,1
88164,(,0,0
88165,esophagus,0,1
88166,(,0,0
88167,p=0.75,0,0
88168,),0,1
88169,and,0,1
88170,duodenum,0,1
88171,(,0,1
88172,p=0.51,0,0
88173,),0,0
88174,),0,0
88175,.,0,0
88176,No,0,0
88177,difference,0,0
88178,was,0,0
88179,seen,0,0
88180,in,0,0
88181,the,0,0
88182,induced,0,0
88183,somatic,1,1
88184,referred,1,0
88185,pain,1,1
88186,areas,1,1
88187,or,1,0
88188,self-reported,1,1
88189,symptoms,1,1
88190,.,1,0
88191,CONCLUSIONS,0,0
88192,No,0,0
88193,evidence,0,0
88194,was,0,0
88195,found,0,0
88196,for,0,0
88197,GES-induced,0,0
88198,modulation,0,0
88199,of,0,0
88200,the,0,0
88201,visceral,0,1
88202,sensory,0,1
88203,system,0,0
88204,and,0,1
88205,central,0,1
88206,excitability,0,1
88207,.,0,0
88208,However,0,0
88209,",",0,0
88210,GES,0,0
88211,has,0,0
88212,been,0,0
88213,proven,0,0
88214,to,0,0
88215,modulate,0,0
88216,the,0,0
88217,central,0,0
88218,nervous,0,0
88219,system,0,0
88220,in,0,0
88221,animal,0,0
88222,studies,0,0
88223,",",0,0
88224,necessitating,0,0
88225,further,0,0
88226,human,0,0
88227,experiments,0,0
88228,in,0,0
88229,order,0,0
88230,unambiguously,0,0
88231,to,0,0
88232,establish,0,0
88233,the,0,0
88234,possible,0,0
88235,central,0,0
88236,effects,0,0
88237,of,0,0
88238,GES,0,0
88239,.,0,0
88240,Randomized,0,0
88241,trial,0,0
88242,of,0,0
88243,a,0,0
88244,decision,0,0
88245,aid,0,0
88246,for,0,0
88247,individuals,0,0
88248,considering,0,0
88249,genetic,0,0
88250,testing,0,0
88251,for,0,0
88252,hereditary,0,0
88253,nonpolyposis,0,1
88254,colorectal,0,0
88255,cancer,0,0
88256,risk,0,1
88257,.,0,0
88258,BACKGROUND,0,0
88259,Despite,0,0
88260,the,0,0
88261,potential,0,0
88262,benefits,0,0
88263,of,0,0
88264,genetic,0,0
88265,testing,0,0
88266,for,0,0
88267,hereditary,0,0
88268,nonpolyposis,0,1
88269,colorectal,0,0
88270,cancer,0,0
88271,(,0,0
88272,HNPCC,0,0
88273,),0,1
88274,risk,0,1
88275,",",0,0
88276,individuals,0,0
88277,can,0,0
88278,find,0,0
88279,the,0,0
88280,genetic,0,0
88281,testing,0,0
88282,decision-making,0,1
88283,process,0,0
88284,complicated,0,0
88285,and,0,0
88286,challenging,0,0
88287,.,0,0
88288,The,0,0
88289,goal,0,0
88290,of,0,0
88291,the,0,0
88292,current,0,0
88293,study,0,0
88294,was,0,0
88295,to,0,0
88296,measure,0,0
88297,the,0,0
88298,effectiveness,1,0
88299,of,1,0
88300,a,1,0
88301,tailored,1,0
88302,decision,1,0
88303,aid,1,0
88304,designed,0,0
88305,specifically,0,0
88306,to,0,0
88307,assist,0,0
88308,individuals,0,0
88309,to,0,0
88310,make,0,0
88311,informed,0,0
88312,decisions,0,0
88313,regarding,0,0
88314,genetic,0,0
88315,testing,0,0
88316,for,0,0
88317,HNPCC,0,0
88318,risk,0,0
88319,.,0,0
88320,METHODS,0,0
88321,In,0,0
88322,all,0,0
88323,",",0,0
88324,153,0,0
88325,individuals,0,0
88326,were,0,0
88327,randomized,0,0
88328,to,0,0
88329,receive,0,0
88330,the,0,0
88331,decision,0,0
88332,aid,0,0
88333,or,0,0
88334,a,0,0
88335,control,0,0
88336,pamphlet,0,0
88337,at,0,0
88338,the,0,0
88339,end,0,0
88340,of,0,0
88341,their,0,0
88342,first,0,0
88343,genetic,0,0
88344,counseling,0,0
88345,consultation,0,0
88346,.,0,0
88347,Of,0,0
88348,these,0,0
88349,",",0,0
88350,109,0,0
88351,(,0,0
88352,71.2,0,0
88353,%,0,0
88354,),0,0
88355,completed,0,0
88356,the,0,0
88357,first,0,0
88358,questionnaire,1,0
88359,1,0,0
88360,week,0,0
88361,after,0,0
88362,consultation,0,0
88363,",",0,0
88364,whereas,0,0
88365,95,0,0
88366,(,0,0
88367,62.1,0,0
88368,%,0,0
88369,),0,0
88370,completed,0,0
88371,the,0,0
88372,6-month,0,0
88373,follow-up,1,0
88374,questionnaire,1,1
88375,.,1,0
88376,RESULTS,0,0
88377,Although,0,0
88378,the,0,0
88379,decision,0,0
88380,aid,0,0
88381,had,0,0
88382,no,0,0
88383,significant,0,0
88384,effect,0,0
88385,on,0,0
88386,postdecisional,0,1
88387,regret,0,1
88388,or,0,0
88389,actual,0,1
88390,genetic,0,0
88391,testing,0,0
88392,decision,0,0
88393,",",0,0
88394,the,0,0
88395,trial,0,0
88396,results,0,0
88397,demonstrated,0,0
88398,that,0,0
88399,participants,0,0
88400,who,0,0
88401,received,0,0
88402,the,0,0
88403,decision,0,1
88404,aid,0,0
88405,had,0,0
88406,significantly,0,0
88407,lower,0,0
88408,levels,0,1
88409,of,0,1
88410,decisional,1,1
88411,conflict,1,0
88412,(,1,0
88413,ie,1,0
88414,",",1,0
88415,uncertainty,1,1
88416,),1,0
88417,regarding,0,0
88418,genetic,1,0
88419,testing,1,0
88420,(,0,0
88421,chi-square,0,0
88422,(,0,0
88423,1,0,0
88424,),0,0
88425,=,0,0
88426,8.97,0,0
88427,;,0,0
88428,P,0,0
88429,=,0,0
88430,.003,0,0
88431,),0,0
88432,and,0,0
88433,were,0,0
88434,more,0,0
88435,likely,0,0
88436,to,0,0
88437,be,0,0
88438,classified,0,0
88439,as,0,0
88440,having,0,0
88441,made,0,0
88442,an,0,0
88443,informed,1,0
88444,choice,1,0
88445,concerning,0,0
88446,genetic,0,1
88447,testing,0,0
88448,(,0,0
88449,chi-square,0,0
88450,(,0,0
88451,1,0,0
88452,),0,0
88453,=,0,0
88454,4.37,0,0
88455,;,0,0
88456,P,0,0
88457,=,0,0
88458,.037,0,0
88459,),0,0
88460,than,0,0
88461,participants,0,0
88462,who,0,0
88463,received,0,0
88464,a,0,0
88465,control,0,0
88466,pamphlet,0,0
88467,.,0,0
88468,Also,0,0
88469,",",0,0
88470,men,0,0
88471,who,0,0
88472,received,0,0
88473,the,0,0
88474,decision,0,1
88475,aid,0,0
88476,had,0,0
88477,significantly,0,0
88478,higher,1,0
88479,knowledge,1,1
88480,levels,1,1
88481,regarding,0,0
88482,genetic,0,0
88483,testing,0,0
88484,compared,0,0
88485,with,0,0
88486,men,0,0
88487,who,0,0
88488,received,0,0
88489,the,0,0
88490,control,0,0
88491,pamphlet,0,0
88492,",",0,0
88493,whereas,0,0
88494,no,0,0
88495,such,0,0
88496,differences,0,0
88497,were,0,0
88498,found,0,0
88499,for,0,0
88500,women,0,0
88501,(,0,0
88502,chi-square,0,0
88503,(,0,0
88504,2,0,0
88505,),0,0
88506,=,0,0
88507,6.76,0,0
88508,;,0,0
88509,P,0,0
88510,=,0,0
88511,.034,0,0
88512,),0,0
88513,.,0,0
88514,CONCLUSIONS,0,0
88515,A,0,0
88516,decision,0,0
88517,aid,0,0
88518,for,0,0
88519,individuals,0,0
88520,considering,0,0
88521,genetic,0,0
88522,testing,0,0
88523,for,0,0
88524,HNPCC,0,0
88525,is,0,0
88526,an,0,0
88527,effective,0,0
88528,intervention,0,0
88529,to,0,0
88530,reduce,0,0
88531,uncertainty,0,1
88532,and,0,0
88533,assist,0,0
88534,individuals,0,0
88535,to,0,0
88536,make,0,0
88537,an,0,0
88538,informed,0,0
88539,choice,0,0
88540,regarding,0,0
88541,genetic,0,0
88542,testing,0,0
88543,for,0,0
88544,HNPCC,0,0
88545,after,0,0
88546,genetic,0,0
88547,counseling,0,0
88548,.,0,0
88549,Local,0,0
88550,delivery,0,0
88551,of,0,0
88552,a,0,0
88553,recombinant,0,0
88554,adenoassociated,0,0
88555,vector,0,0
88556,containing,0,0
88557,a,0,0
88558,tumour,0,0
88559,necrosis,0,1
88560,factor,0,0
88561,alpha,0,1
88562,antagonist,0,0
88563,gene,0,1
88564,in,0,0
88565,inflammatory,0,1
88566,arthritis,0,0
88567,:,0,0
88568,a,0,0
88569,phase,0,0
88570,1,0,0
88571,dose-escalation,0,0
88572,safety,1,1
88573,and,1,1
88574,tolerability,1,1
88575,study,0,0
88576,.,0,0
88577,OBJECTIVE,0,0
88578,To,0,0
88579,examine,0,0
88580,the,0,0
88581,safety,1,1
88582,and,1,0
88583,tolerability,1,1
88584,of,0,0
88585,a,0,0
88586,single,0,0
88587,intra-articular,0,0
88588,injection,0,0
88589,of,0,0
88590,rAAV2-TNFR,0,0
88591,:,0,0
88592,Fc,0,0
88593,",",0,0
88594,an,0,0
88595,adenoassociated,0,0
88596,virus,0,0
88597,serotype,0,0
88598,2,0,0
88599,vector,0,0
88600,containing,0,0
88601,the,0,0
88602,cDNA,0,0
88603,for,0,0
88604,the,0,0
88605,human,0,0
88606,tumour,0,0
88607,necrosis,0,1
88608,factor-immunoglobulin,0,1
88609,Fc,0,0
88610,fusion,0,1
88611,gene,0,1
88612,(,0,0
88613,tgAAC94,0,0
88614,),0,0
88615,",",0,0
88616,in,0,0
88617,subjects,0,0
88618,with,0,0
88619,inflammatory,0,1
88620,arthritis,0,0
88621,.,0,0
88622,METHODS,0,0
88623,In,0,0
88624,a,0,0
88625,double-blind,0,0
88626,",",0,0
88627,placebo-controlled,0,0
88628,",",0,0
88629,phase,0,0
88630,1,0,0
88631,",",0,0
88632,dose-escalation,0,0
88633,study,0,0
88634,",",0,0
88635,15,0,0
88636,subjects,0,0
88637,with,0,0
88638,inflammatory,0,1
88639,arthritis,0,0
88640,(,0,0
88641,14,0,0
88642,with,0,0
88643,rheumatoid,0,0
88644,arthritis,0,0
88645,and,0,0
88646,1,0,0
88647,with,0,0
88648,ankylosing,0,0
88649,spondylitis,0,0
88650,),0,0
88651,not,0,0
88652,receiving,0,0
88653,tumour,0,1
88654,necrosis,0,1
88655,factor,0,1
88656,alpha,0,1
88657,(,0,0
88658,TNFalpha,0,1
88659,),0,0
88660,inhibitors,0,0
88661,with,0,0
88662,persistent,0,0
88663,moderate,0,0
88664,(,0,0
88665,grade,0,0
88666,2,0,0
88667,),0,0
88668,or,0,0
88669,severe,0,1
88670,(,0,0
88671,grade,0,0
88672,3,0,0
88673,),0,0
88674,swelling,0,0
88675,in,0,0
88676,a,0,0
88677,target,0,0
88678,joint,0,1
88679,due,0,0
88680,to,0,0
88681,inflammatory,0,1
88682,arthritis,0,0
88683,received,0,0
88684,a,0,0
88685,single,0,0
88686,intra-articular,0,0
88687,injection,0,0
88688,of,0,0
88689,rAAV2-TNFR,0,0
88690,:,0,0
88691,Fc,0,0
88692,at,0,0
88693,1,0,0
88694,x,0,0
88695,10,0,0
88696,(,0,0
88697,10,0,0
88698,),0,0
88699,(,0,0
88700,n,0,0
88701,=,0,0
88702,5,0,0
88703,),0,0
88704,or,0,0
88705,1,0,0
88706,x,0,0
88707,10,0,0
88708,(,0,0
88709,11,0,0
88710,),0,0
88711,(,0,0
88712,n,0,0
88713,=,0,0
88714,6,0,0
88715,),0,0
88716,DNase,0,0
88717,resistant,0,0
88718,particles,0,0
88719,per,0,0
88720,ml,0,0
88721,joint,0,1
88722,volume,0,1
88723,or,0,1
88724,placebo,0,0
88725,(,0,0
88726,n,0,0
88727,=,0,0
88728,4,0,0
88729,),0,0
88730,into,0,0
88731,a,0,0
88732,knee,0,1
88733,(,0,0
88734,n,0,0
88735,=,0,0
88736,14,0,0
88737,),0,0
88738,or,0,0
88739,ankle,0,1
88740,(,0,0
88741,n,0,0
88742,=,0,0
88743,1,0,0
88744,),0,0
88745,.,0,0
88746,Safety,1,1
88747,was,0,0
88748,assessed,0,0
88749,through,0,0
88750,adverse,0,1
88751,event,0,0
88752,monitoring,0,0
88753,.,0,0
88754,As,0,0
88755,a,0,0
88756,secondary,0,0
88757,objective,0,0
88758,",",0,0
88759,changes,1,1
88760,in,1,0
88761,injected,1,0
88762,joint,1,1
88763,tenderness,1,1
88764,and,1,0
88765,swelling,1,1
88766,scores,1,1
88767,",",0,0
88768,each,0,0
88769,measured,0,0
88770,on,0,0
88771,a,0,0
88772,four-point,0,1
88773,scale,0,1
88774,",",0,0
88775,were,0,0
88776,evaluated,0,0
88777,.,0,0
88778,RESULTS,0,0
88779,Intra-articular,0,0
88780,injections,0,0
88781,of,0,0
88782,rAAV2-TNFR,0,0
88783,:,0,0
88784,Fc,0,0
88785,were,0,0
88786,well,0,0
88787,tolerated,0,1
88788,with,0,0
88789,no,0,0
88790,major,0,0
88791,safety,0,1
88792,issues,0,0
88793,.,0,0
88794,One,0,0
88795,event,0,0
88796,",",0,0
88797,mild,0,1
88798,knee,0,1
88799,pruritus,0,1
88800,",",0,0
88801,was,0,0
88802,considered,0,0
88803,probably,0,0
88804,related,0,0
88805,.,0,0
88806,Synovial,1,0
88807,fluid,1,0
88808,TNFR,1,0
88809,:,1,0
88810,Fc,1,0
88811,protein,1,1
88812,was,0,0
88813,not,0,0
88814,detected,0,0
88815,(,0,0
88816,nor,0,0
88817,expected,0,0
88818,),0,0
88819,at,0,0
88820,the,0,0
88821,doses,0,0
88822,used,0,0
88823,.,0,0
88824,At,0,0
88825,12,0,0
88826,weeks,0,0
88827,after,0,0
88828,injection,0,0
88829,",",0,0
88830,a,0,0
88831,two-point,0,1
88832,decrease,1,0
88833,in,1,0
88834,swelling,1,1
88835,was,0,0
88836,noted,0,0
88837,in,0,0
88838,2/11,0,0
88839,and,0,0
88840,2/4,0,0
88841,subjects,0,0
88842,injected,0,0
88843,with,0,0
88844,rAAV2-TNFR,0,0
88845,:,0,0
88846,Fc,0,0
88847,and,0,1
88848,placebo,0,0
88849,",",0,0
88850,respectively,0,0
88851,.,0,0
88852,CONCLUSION,0,0
88853,A,0,0
88854,single,0,0
88855,dose,0,0
88856,of,0,0
88857,intra-articular,0,0
88858,rAAV2-TNFR,0,0
88859,:,0,0
88860,Fc,0,0
88861,appears,0,0
88862,to,0,0
88863,be,0,0
88864,safe,0,0
88865,and,0,0
88866,well,0,0
88867,tolerated,0,1
88868,in,0,0
88869,subjects,0,0
88870,without,0,0
88871,concurrent,0,0
88872,systemic,0,0
88873,TNFalpha,0,1
88874,antagonist,0,0
88875,use,0,0
88876,.,0,0
88877,It,0,0
88878,is,0,0
88879,thus,0,0
88880,feasible,0,0
88881,to,0,0
88882,proceed,0,0
88883,with,0,0
88884,larger,0,0
88885,trials,0,0
88886,to,0,0
88887,further,0,0
88888,test,0,0
88889,the,0,0
88890,safety,1,1
88891,and,1,0
88892,efficacy,1,1
88893,of,0,1
88894,local,0,0
88895,TNFR,0,0
88896,:,0,0
88897,Fc,0,0
88898,gene,0,1
88899,transfer,0,0
88900,as,0,0
88901,a,0,0
88902,therapeutic,0,0
88903,modality,0,0
88904,for,0,0
88905,patients,0,0
88906,with,0,0
88907,inflammatory,0,1
88908,arthritis,0,0
88909,.,0,0
88910,Smoking,1,0
88911,cessation,1,0
88912,with,0,0
88913,smokeless,0,0
88914,tobacco,0,0
88915,and,0,1
88916,group,0,0
88917,therapy,0,0
88918,:,0,0
88919,an,0,0
88920,open,0,0
88921,",",0,0
88922,randomized,0,0
88923,",",0,0
88924,controlled,0,0
88925,trial,0,0
88926,.,0,0
88927,Smokeless,0,0
88928,tobacco,0,0
88929,might,0,0
88930,be,0,0
88931,effective,0,0
88932,as,0,0
88933,an,0,0
88934,adjunct,0,0
88935,for,0,0
88936,smoking,1,0
88937,cessation,1,0
88938,.,1,0
88939,We,0,0
88940,evaluated,0,0
88941,the,0,0
88942,efficacy,0,1
88943,of,0,0
88944,smokeless,0,0
88945,tobacco,0,0
88946,and,0,1
88947,group,0,0
88948,support,0,0
88949,for,0,0
88950,smoking,1,0
88951,cessation,1,0
88952,in,0,0
88953,an,0,0
88954,open,0,0
88955,",",0,0
88956,randomized,0,0
88957,study,0,0
88958,that,0,0
88959,compared,0,0
88960,smokeless,0,0
88961,tobacco,0,0
88962,plus,0,0
88963,group,0,0
88964,support,0,0
88965,versus,0,0
88966,group,0,0
88967,support,0,0
88968,only,0,0
88969,.,0,0
88970,The,0,0
88971,study,0,0
88972,enrolled,0,0
88973,263,0,0
88974,healthy,0,0
88975,smokers,0,0
88976,(,0,0
88977,M,0,0
88978,(,0,0
88979,age,0,0
88980,),0,0
88981,=,0,0
88982,49,0,0
88983,years,0,0
88984,),0,0
88985,who,0,0
88986,smoked,0,0
88987,a,0,0
88988,mean,0,0
88989,of,0,0
88990,24,0,0
88991,cigarettes/day,0,0
88992,",",0,0
88993,with,0,0
88994,a,0,0
88995,mean,0,0
88996,of,0,0
88997,31,0,0
88998,pack-years,0,0
88999,.,0,0
89000,Smokeless,0,0
89001,tobacco,0,0
89002,was,0,0
89003,provided,0,0
89004,for,0,0
89005,7,0,0
89006,weeks,0,0
89007,(,0,0
89008,or,0,0
89009,up,0,0
89010,to,0,0
89011,12,0,0
89012,),0,0
89013,",",0,0
89014,combined,0,0
89015,with,0,0
89016,eight,0,0
89017,group,0,0
89018,support,0,0
89019,visits,0,0
89020,provided,0,0
89021,by,0,0
89022,nurses,0,0
89023,.,0,0
89024,The,0,0
89025,control,0,0
89026,group,0,0
89027,received,0,0
89028,group,0,0
89029,support,0,0
89030,only,0,0
89031,.,0,0
89032,Smoking,1,0
89033,cessation,1,0
89034,rates,1,1
89035,were,0,0
89036,statistically,0,0
89037,significantly,0,0
89038,better,0,0
89039,in,0,0
89040,the,0,0
89041,smokeless,0,0
89042,tobacco,0,0
89043,group,0,0
89044,than,0,0
89045,in,0,0
89046,the,0,0
89047,control,0,0
89048,group,0,0
89049,during,0,0
89050,the,0,0
89051,first,0,0
89052,7,0,0
89053,weeks,0,0
89054,.,0,0
89055,Point-prevalence,1,1
89056,abstinence,1,1
89057,rates,1,1
89058,at,0,0
89059,7,0,0
89060,weeks,0,0
89061,were,0,0
89062,36.4,0,0
89063,%,0,0
89064,versus,0,0
89065,20.8,0,0
89066,%,0,0
89067,(,0,0
89068,OR,0,0
89069,=,0,0
89070,2.52,0,0
89071,",",0,0
89072,p,0,0
89073,=,0,0
89074,.001,0,0
89075,),0,0
89076,",",0,0
89077,respectively,0,0
89078,;,0,0
89079,and,0,0
89080,continuous,1,0
89081,abstinence,1,1
89082,rates,1,1
89083,from,0,0
89084,weeks,0,0
89085,4,0,0
89086,to,0,0
89087,7,0,0
89088,were,0,0
89089,31.5,0,0
89090,%,0,0
89091,versus,0,0
89092,19.2,0,0
89093,%,0,0
89094,(,0,0
89095,OR,0,0
89096,=,0,0
89097,1.94,0,0
89098,",",0,0
89099,p,0,0
89100,=,0,0
89101,.023,0,0
89102,),0,0
89103,",",0,0
89104,respectively,0,0
89105,.,0,0
89106,The,0,0
89107,primary,0,0
89108,outcomes,0,1
89109,(,0,0
89110,i.e.,0,0
89111,",",0,0
89112,6-month,1,0
89113,point,1,1
89114,prevalence,1,1
89115,),1,0
89116,were,0,0
89117,23.1,0,0
89118,%,0,0
89119,versus,0,0
89120,20.8,0,0
89121,%,0,0
89122,",",0,0
89123,respectively,0,0
89124,(,0,0
89125,OR,0,0
89126,=,0,0
89127,1.31,0,0
89128,",",0,0
89129,ns,0,0
89130,),0,0
89131,.,0,0
89132,Smokeless,0,0
89133,tobacco,0,0
89134,was,0,0
89135,relatively,0,0
89136,well,0,0
89137,tolerated,1,1
89138,",",0,0
89139,although,0,0
89140,15,0,0
89141,subjects,0,0
89142,(,0,0
89143,11.2,0,0
89144,%,0,0
89145,),0,0
89146,stopped,0,0
89147,use,0,0
89148,due,0,0
89149,to,0,0
89150,adverse,1,1
89151,events,1,1
89152,.,1,0
89153,A,0,0
89154,total,0,0
89155,of,0,0
89156,25,0,0
89157,subjects,0,0
89158,(,0,0
89159,17.5,0,0
89160,%,0,0
89161,),0,0
89162,were,0,0
89163,still,0,0
89164,using,0,0
89165,smokeless,0,0
89166,tobacco,0,0
89167,after,0,0
89168,6,0,0
89169,months,0,0
89170,.,0,0
89171,This,0,0
89172,trial,0,0
89173,demonstrated,0,0
89174,short-term,1,0
89175,efficacy,1,1
89176,of,1,0
89177,smokeless,1,0
89178,tobacco,1,0
89179,in,0,0
89180,combination,0,0
89181,with,0,0
89182,group,0,0
89183,support,0,0
89184,for,0,0
89185,smoking,0,0
89186,cessation,0,0
89187,but,0,0
89188,no,0,0
89189,long-term,1,0
89190,efficacy,1,0
89191,.,1,0
89192,Long-term,0,0
89193,follow-up,0,0
89194,of,0,0
89195,a,0,0
89196,phase,0,0
89197,I/II,0,0
89198,randomized,0,0
89199,",",0,0
89200,placebo-controlled,0,0
89201,trial,0,0
89202,of,0,0
89203,palifermin,0,0
89204,to,0,0
89205,prevent,0,0
89206,graft-versus-host,0,1
89207,disease,0,1
89208,(,0,0
89209,GVHD,0,1
89210,),0,0
89211,after,0,0
89212,related,0,0
89213,donor,0,0
89214,allogeneic,0,0
89215,hematopoietic,0,0
89216,cell,0,1
89217,transplantation,0,0
89218,(,0,0
89219,HCT,0,1
89220,),0,0
89221,.,0,0
89222,We,0,0
89223,previously,0,0
89224,conducted,0,0
89225,a,0,0
89226,randomized,0,0
89227,",",0,0
89228,double-blind,0,0
89229,",",0,0
89230,placebo-controlled,0,0
89231,study,0,0
89232,conducted,0,0
89233,from,0,0
89234,2000,0,0
89235,to,0,0
89236,2003,0,0
89237,of,0,0
89238,palifermin,0,0
89239,",",0,0
89240,a,0,0
89241,recombinant,0,0
89242,human,0,0
89243,keratinocyte,0,1
89244,growth,0,1
89245,factor,0,1
89246,",",0,0
89247,dosed,0,0
89248,from,0,0
89249,240,0,0
89250,microg/kg,0,0
89251,to,0,0
89252,720,0,0
89253,microg/kg,0,0
89254,",",0,0
89255,in,0,0
89256,100,0,0
89257,allogeneic,0,0
89258,hematopoietic,0,0
89259,stem,0,1
89260,cell,0,1
89261,transplantation,0,0
89262,(,0,0
89263,HCT,0,1
89264,),0,0
89265,recipients,0,0
89266,.,0,0
89267,Treatment,0,0
89268,with,0,0
89269,palifermin,0,0
89270,showed,0,0
89271,beneficial,0,0
89272,effects,1,1
89273,on,0,0
89274,mucositis,1,1
89275,",",1,0
89276,but,1,0
89277,no,1,0
89278,significant,1,0
89279,effect,1,0
89280,on,1,0
89281,engraftment,1,1
89282,",",1,0
89283,acute,1,1
89284,graft-versus-host,1,1
89285,disease,1,1
89286,(,1,0
89287,GVHD,1,1
89288,),1,1
89289,",",1,0
89290,or,1,0
89291,early,1,0
89292,survival,1,1
89293,.,1,0
89294,In,0,0
89295,addition,0,0
89296,to,0,0
89297,the,0,0
89298,effect,0,0
89299,of,0,0
89300,palifermin,0,0
89301,on,0,0
89302,mucosa,1,1
89303,",",1,0
89304,other,1,0
89305,pleotrophic,1,1
89306,effects,1,1
89307,",",1,0
89308,including,1,0
89309,more,1,0
89310,rapid,1,1
89311,immune,1,1
89312,reconstitution,1,0
89313,",",0,0
89314,have,0,0
89315,been,0,0
89316,seen,0,0
89317,in,0,0
89318,experimental,0,0
89319,transplant,0,0
89320,models,0,0
89321,.,0,0
89322,Therefore,0,0
89323,",",0,0
89324,we,0,0
89325,investigated,0,0
89326,whether,0,0
89327,with,0,0
89328,longer,0,0
89329,follow-up,0,0
89330,we,0,0
89331,could,0,0
89332,detect,0,0
89333,additional,1,0
89334,differences,1,0
89335,between,0,0
89336,the,0,0
89337,palifermin-treated,0,0
89338,and,0,0
89339,placebo,0,0
89340,cohorts,0,0
89341,.,0,0
89342,We,0,0
89343,found,0,0
89344,no,0,0
89345,differences,0,0
89346,in,0,0
89347,CMV,1,0
89348,or,1,0
89349,invasive,1,1
89350,fungal,1,0
89351,infections,1,1
89352,",",1,0
89353,chronic,1,0
89354,GVHD,1,1
89355,",",1,0
89356,or,1,0
89357,long-term,1,1
89358,survival,1,1
89359,between,0,0
89360,cohorts,0,0
89361,.,0,0
89362,We,0,0
89363,conclude,0,0
89364,that,0,0
89365,the,0,0
89366,benefits,0,0
89367,of,0,0
89368,palifermin,0,0
89369,appear,0,0
89370,primarily,0,0
89371,to,0,0
89372,be,0,0
89373,limited,0,0
89374,to,0,0
89375,ameliorating,0,0
89376,mucotoxicity,1,1
89377,when,0,0
89378,given,0,0
89379,to,0,0
89380,allogeneic,0,0
89381,HCT,0,1
89382,recipients,0,0
89383,.,0,0
89384,Positive,0,1
89385,effects,0,1
89386,of,0,0
89387,methylphenidate,0,0
89388,on,0,0
89389,social,1,1
89390,communication,1,1
89391,and,1,1
89392,self-regulation,1,1
89393,in,0,0
89394,children,0,0
89395,with,0,0
89396,pervasive,0,0
89397,developmental,0,0
89398,disorders,0,0
89399,and,0,0
89400,hyperactivity,0,0
89401,.,0,0
89402,This,0,0
89403,report,0,0
89404,examined,0,0
89405,the,0,0
89406,effect,0,0
89407,of,0,0
89408,methylphenidate,0,0
89409,on,0,0
89410,social,1,1
89411,communication,1,1
89412,and,1,1
89413,self-regulation,1,1
89414,in,0,0
89415,children,0,0
89416,with,0,0
89417,pervasive,0,0
89418,developmental,0,0
89419,disorders,0,0
89420,and,0,1
89421,hyperactivity,0,0
89422,in,0,0
89423,a,0,0
89424,secondary,0,0
89425,analysis,0,0
89426,of,0,0
89427,RUPP,0,0
89428,Autism,0,1
89429,Network,0,0
89430,data,0,0
89431,.,0,0
89432,Participants,0,0
89433,were,0,0
89434,33,0,0
89435,children,0,0
89436,(,0,0
89437,29,0,0
89438,boys,0,0
89439,),0,0
89440,between,0,0
89441,the,0,0
89442,ages,0,0
89443,of,0,0
89444,5,0,0
89445,and,0,0
89446,13,0,0
89447,years,0,0
89448,who,0,0
89449,participated,0,0
89450,in,0,0
89451,a,0,0
89452,four-week,0,0
89453,crossover,0,0
89454,trial,0,0
89455,of,0,1
89456,placebo,0,0
89457,and,0,0
89458,increasing,0,0
89459,doses,0,0
89460,of,0,0
89461,methylphenidate,0,0
89462,given,0,0
89463,in,0,0
89464,random,0,0
89465,order,0,0
89466,each,0,0
89467,for,0,0
89468,one,0,0
89469,week,0,0
89470,.,0,0
89471,Observational,0,0
89472,measures,0,1
89473,of,0,0
89474,certain,0,0
89475,aspects,0,0
89476,of,0,0
89477,children,0,0
89478,'s,0,0
89479,social,1,1
89480,communication,1,1
89481,",",1,0
89482,self-regulation,1,1
89483,",",1,1
89484,and,1,1
89485,affective,1,1
89486,behavior,1,1
89487,were,0,0
89488,obtained,0,0
89489,each,0,0
89490,week,0,0
89491,.,0,0
89492,A,0,0
89493,significant,0,0
89494,positive,0,0
89495,effect,0,0
89496,of,0,0
89497,methylphenidate,0,0
89498,was,0,0
89499,seen,0,0
89500,on,0,0
89501,children,0,0
89502,'s,0,0
89503,use,0,0
89504,of,0,0
89505,joint,1,1
89506,attention,1,0
89507,initiations,1,0
89508,",",1,0
89509,response,1,1
89510,to,1,0
89511,bids,1,0
89512,for,1,0
89513,joint,1,1
89514,attention,1,0
89515,",",1,0
89516,self-regulation,1,1
89517,",",1,1
89518,and,1,1
89519,regulated,1,1
89520,affective,1,1
89521,state,1,0
89522,.,1,0
89523,The,0,0
89524,results,0,0
89525,go,0,0
89526,beyond,0,0
89527,the,0,0
89528,recent,0,0
89529,literature,0,0
89530,and,0,0
89531,suggest,0,0
89532,that,0,0
89533,methylphenidate,0,0
89534,may,0,0
89535,have,0,0
89536,positive,0,0
89537,effects,0,0
89538,on,0,0
89539,social,1,1
89540,behaviors,1,1
89541,in,0,0
89542,children,0,0
89543,with,0,0
89544,PDD,0,1
89545,and,0,0
89546,hyperactivity,0,0
89547,.,0,0
89548,A,0,0
89549,randomized,0,0
89550,trial,0,0
89551,of,0,0
89552,etoposide,0,0
89553,and,0,0
89554,G-CSF,0,0
89555,with,0,0
89556,or,0,0
89557,without,0,0
89558,rituximab,0,0
89559,for,0,0
89560,PBSC,0,0
89561,mobilization,0,0
89562,in,0,0
89563,B-cell,0,1
89564,non-Hodgkin,0,1
89565,'s,0,0
89566,lymphoma,0,0
89567,.,0,0
89568,Some,0,0
89569,reports,0,0
89570,have,0,0
89571,suggested,0,0
89572,that,0,0
89573,rituximab,0,0
89574,administration,0,0
89575,before,0,0
89576,PBSC,0,0
89577,mobilization,0,0
89578,may,0,0
89579,adversely,0,0
89580,affect,0,0
89581,PBSC,0,0
89582,yield,0,0
89583,.,0,0
89584,We,0,0
89585,conducted,0,0
89586,a,0,0
89587,prospective,0,0
89588,randomized,0,0
89589,trial,0,0
89590,of,0,0
89591,PBSC,0,0
89592,mobilization,0,0
89593,using,0,0
89594,etoposide,0,0
89595,and,0,0
89596,G-CSF,0,0
89597,with,0,0
89598,or,0,0
89599,without,0,0
89600,rituximab,0,0
89601,to,0,0
89602,determine,0,0
89603,whether,0,0
89604,its,0,0
89605,addition,0,0
89606,would,0,0
89607,adversely,0,0
89608,affect,0,0
89609,CD34+,1,0
89610,cell,1,1
89611,yield,1,1
89612,in,0,0
89613,patients,0,0
89614,with,0,0
89615,non-Hodgkin,0,0
89616,'s,0,0
89617,lymphoma,0,0
89618,.,0,0
89619,Twenty,0,0
89620,seven,0,0
89621,patients,0,0
89622,were,0,0
89623,mobilized,0,0
89624,with,0,0
89625,etoposide,0,0
89626,and,0,0
89627,G-CSF,0,0
89628,and,0,0
89629,28,0,0
89630,with,0,0
89631,etoposide,0,0
89632,",",0,0
89633,G-CSF,0,0
89634,and,0,0
89635,rituximab,0,0
89636,.,0,0
89637,There,0,0
89638,were,0,0
89639,no,0,0
89640,adverse,0,1
89641,consequences,0,0
89642,of,0,0
89643,rituximab,0,0
89644,on,0,0
89645,CD34+,1,0
89646,cell,1,1
89647,yield,1,1
89648,",",1,0
89649,or,1,1
89650,hematopoietic,1,1
89651,recovery,1,1
89652,or,1,0
89653,immunoglobulin,1,1
89654,levels,1,1
89655,after,0,0
89656,transplantation,0,0
89657,.,0,0
89658,Levels,0,1
89659,of,0,0
89660,opioid,0,1
89661,physical,0,1
89662,dependence,0,0
89663,in,0,0
89664,heroin,0,0
89665,addicts,0,0
89666,.,0,0
89667,The,0,0
89668,levels,0,1
89669,of,0,0
89670,opioid,0,0
89671,physical,0,1
89672,dependence,0,0
89673,in,0,0
89674,a,0,0
89675,group,0,0
89676,of,0,0
89677,long-term,0,0
89678,heroin,0,0
89679,addicts,0,0
89680,were,0,0
89681,ascertained,0,0
89682,by,0,0
89683,measuring,0,0
89684,the,0,0
89685,severity,0,1
89686,of,0,0
89687,the,0,0
89688,opioid,1,0
89689,withdrawal,1,0
89690,syndrome,1,0
89691,before,0,0
89692,and,0,0
89693,after,0,0
89694,pharmacological,0,0
89695,challenge,0,0
89696,with,0,0
89697,either,0,0
89698,0.4,0,0
89699,mg,0,0
89700,naloxone,0,0
89701,or,0,0
89702,placebo,0,0
89703,.,0,0
89704,Prior,0,0
89705,to,0,0
89706,challenge,0,0
89707,",",0,0
89708,patients,0,0
89709,manifested,0,0
89710,some,0,0
89711,subjective,1,1
89712,symptoms,1,1
89713,but,0,0
89714,few,0,0
89715,objective,0,0
89716,signs,0,1
89717,of,0,0
89718,opioid,0,0
89719,withdrawal,0,0
89720,.,0,0
89721,Patients,0,0
89722,who,0,0
89723,received,0,0
89724,placebo,0,0
89725,(,0,0
89726,n,0,0
89727,=,0,0
89728,18,0,0
89729,),0,0
89730,showed,0,0
89731,a,0,0
89732,significant,0,0
89733,increase,0,0
89734,in,0,0
89735,the,0,0
89736,mean,0,1
89737,score,0,1
89738,on,0,0
89739,one,0,0
89740,of,0,0
89741,three,0,0
89742,rating,0,1
89743,scales,0,1
89744,used,0,0
89745,to,0,0
89746,assess,0,0
89747,opioid,0,0
89748,withdrawal,0,0
89749,.,0,0
89750,Patients,0,0
89751,who,0,0
89752,received,0,0
89753,naloxone,0,0
89754,(,0,0
89755,n,0,0
89756,=,0,0
89757,58,0,0
89758,),0,0
89759,showed,0,0
89760,significant,0,0
89761,increases,0,1
89762,in,0,0
89763,mean,0,1
89764,scores,0,1
89765,on,0,0
89766,all,0,0
89767,three,0,0
89768,rating,0,1
89769,scales,0,1
89770,",",0,0
89771,but,0,0
89772,this,0,0
89773,was,0,0
89774,due,0,0
89775,primarily,0,0
89776,to,0,0
89777,increases,0,1
89778,observed,0,0
89779,in,0,0
89780,a,0,0
89781,minority,0,0
89782,of,0,0
89783,patients,0,0
89784,.,0,0
89785,Sixty-one,0,0
89786,percent,0,0
89787,of,0,0
89788,patients,0,0
89789,failed,0,0
89790,to,0,0
89791,manifest,0,0
89792,clinically,0,0
89793,significant,0,0
89794,changes,0,1
89795,in,0,0
89796,subjective,1,1
89797,symptoms,1,1
89798,",",0,0
89799,and,0,0
89800,74,0,0
89801,%,0,0
89802,of,0,0
89803,patients,0,0
89804,failed,0,0
89805,to,0,0
89806,manifest,0,0
89807,clinically,0,0
89808,significant,0,0
89809,changes,0,1
89810,in,0,0
89811,objective,1,0
89812,signs,1,1
89813,of,1,0
89814,opioid,1,0
89815,withdrawal,1,0
89816,following,0,0
89817,naloxone,0,0
89818,administration,0,0
89819,.,0,0
89820,The,0,0
89821,results,0,0
89822,suggest,0,0
89823,that,0,0
89824,a,0,0
89825,substantial,0,0
89826,subgroup,0,0
89827,of,0,0
89828,heroin,0,0
89829,addicts,0,0
89830,are,0,0
89831,able,0,0
89832,to,0,0
89833,use,0,0
89834,opioids,0,0
89835,regularly,0,0
89836,while,0,0
89837,maintaining,0,0
89838,relatively,0,0
89839,low,0,0
89840,levels,0,1
89841,of,0,0
89842,physical,0,0
89843,dependence,0,0
89844,.,0,0
89845,Development,0,1
89846,of,0,0
89847,autistic,0,0
89848,children,0,0
89849,based,0,0
89850,on,0,0
89851,maternal,0,1
89852,responses,0,1
89853,to,0,0
89854,the,0,0
89855,Autism,0,1
89856,Behavior,0,1
89857,Checklist,0,1
89858,.,0,0
89859,BACKGROUND,0,0
89860,language,0,1
89861,and,0,1
89862,speech-language,0,0
89863,intervention,0,0
89864,.,0,0
89865,AIM,0,0
89866,to,0,0
89867,evaluate,0,0
89868,the,0,0
89869,development,0,1
89870,process,0,0
89871,of,0,0
89872,autistic,0,0
89873,children,0,0
89874,",",0,0
89875,in,0,0
89876,a,0,0
89877,direct,0,0
89878,and,0,0
89879,indirect,0,1
89880,intervention,0,0
89881,context,0,0
89882,based,0,0
89883,on,0,0
89884,the,0,0
89885,responses,0,1
89886,of,0,0
89887,mothers,0,0
89888,to,0,0
89889,the,0,0
89890,Autism,0,1
89891,Behavior,0,1
89892,Checklist,0,1
89893,.,0,0
89894,METHOD,0,0
89895,the,0,0
89896,research,0,0
89897,sample,0,0
89898,consisted,0,0
89899,of,0,0
89900,11,0,0
89901,mothers,0,0
89902,of,0,0
89903,children,0,0
89904,diagnosed,0,0
89905,",",0,0
89906,according,0,0
89907,to,0,0
89908,the,0,0
89909,criteria,0,0
89910,established,0,0
89911,by,0,0
89912,the,0,0
89913,DSM,0,0
89914,IVtr,0,1
89915,(,0,0
89916,APA,0,1
89917,",",0,0
89918,2002,0,0
89919,),0,0
89920,",",0,0
89921,with,0,0
89922,autism,0,0
89923,(,0,0
89924,six,0,0
89925,),0,0
89926,and,0,0
89927,with,0,0
89928,Asperger,0,1
89929,Syndrome,0,0
89930,(,0,0
89931,five,0,0
89932,),0,0
89933,and,0,0
89934,who,0,0
89935,were,0,0
89936,seen,0,0
89937,at,0,0
89938,the,0,0
89939,Investigation,0,0
89940,Laboratory,0,0
89941,of,0,0
89942,Global,0,1
89943,Developmental,0,0
89944,Disorders,0,0
89945,of,0,0
89946,the,0,0
89947,Federal,0,0
89948,University,0,0
89949,of,0,0
89950,S?o,0,0
89951,Paulo,0,0
89952,.,0,0
89953,These,0,0
89954,children,0,0
89955,were,0,0
89956,randomly,0,0
89957,divided,0,0
89958,into,0,0
89959,two,0,0
89960,groups,0,0
89961,:,0,0
89962,Six,0,0
89963,were,0,0
89964,receiving,0,0
89965,both,0,0
89966,direct,0,0
89967,and,0,0
89968,indirect,0,1
89969,intervention,0,0
89970,(,0,0
89971,TG,0,1
89972,),0,1
89973,",",0,0
89974,and,0,0
89975,five,0,0
89976,were,0,0
89977,receiving,0,0
89978,indirect,0,0
89979,intervention,0,0
89980,exclusively,0,0
89981,(,0,0
89982,OG,0,1
89983,),0,0
89984,.,0,0
89985,The,1,0
89986,Autism,1,1
89987,Behavior,1,1
89988,Checklist,1,1
89989,(,0,0
89990,Krug,0,0
89991,et,0,0
89992,al.,0,0
89993,",",0,0
89994,1993,0,0
89995,),0,0
89996,was,0,0
89997,used,0,0
89998,",",0,0
89999,adapted,0,0
90000,to,0,0
90001,the,0,0
90002,Portuguese,0,0
90003,language,0,0
90004,by,0,0
90005,Marteleto,0,0
90006,(,0,0
90007,2003,0,0
90008,),0,0
90009,.,0,0
90010,This,0,0
90011,behavior,0,1
90012,checklist,0,0
90013,(,0,0
90014,57,0,0
90015,items,0,0
90016,),0,0
90017,allows,0,0
90018,the,0,0
90019,detailed,0,0
90020,description,0,0
90021,of,1,0
90022,non-adaptable,1,0
90023,characteristics,1,0
90024,regarding,0,0
90025,the,0,0
90026,following,0,0
90027,areas,1,0
90028,:,1,0
90029,sensory,1,1
90030,",",1,0
90031,use,1,0
90032,of,1,0
90033,the,1,0
90034,body,1,1
90035,and,1,1
90036,object,1,1
90037,",",1,1
90038,Language,1,1
90039,",",1,1
90040,Psycho-social,1,1
90041,and,1,0
90042,Relational,1,0
90043,.,1,0
90044,The,0,0
90045,questionnaire,0,1
90046,was,0,0
90047,filled,0,0
90048,in,0,0
90049,during,0,0
90050,an,0,0
90051,interview,0,0
90052,on,0,0
90053,three,0,0
90054,occasions,0,0
90055,:,0,0
90056,at,0,0
90057,the,0,0
90058,beginning,0,0
90059,of,0,0
90060,intervention,0,0
90061,",",0,0
90062,after,0,0
90063,six,0,0
90064,months,0,0
90065,and,0,0
90066,at,0,0
90067,the,0,0
90068,end,0,0
90069,of,0,0
90070,12,0,0
90071,months,0,0
90072,.,0,0
90073,RESULTS,0,0
90074,after,0,0
90075,statistical,0,0
90076,analysis,0,0
90077,it,0,0
90078,was,0,0
90079,observed,0,0
90080,that,0,0
90081,there,0,0
90082,was,0,0
90083,a,0,0
90084,greater,0,0
90085,development,0,0
90086,in,0,0
90087,the,1,0
90088,total,1,1
90089,scores,1,1
90090,and,1,0
90091,in,1,0
90092,the,1,0
90093,areas,1,0
90094,of,1,0
90095,language,1,1
90096,",",1,0
90097,psycho-social,1,1
90098,and,1,0
90099,relational,1,1
90100,for,1,0
90101,the,1,0
90102,TG,1,0
90103,.,1,0
90104,This,0,0
90105,suggests,0,0
90106,a,0,0
90107,greater,0,0
90108,development,0,1
90109,pattern,0,0
90110,during,0,0
90111,the,0,0
90112,studied,0,0
90113,period,0,0
90114,for,0,0
90115,this,0,0
90116,group,0,0
90117,.,0,0
90118,CONCLUSION,0,0
90119,the,0,0
90120,mothers,0,0
90121,of,0,0
90122,both,0,0
90123,groups,0,0
90124,observed,1,0
90125,behavioral,1,1
90126,changes,1,0
90127,.,1,0
90128,The,0,0
90129,better,0,0
90130,scores,0,1
90131,observed,0,0
90132,for,0,0
90133,the,0,0
90134,TG,0,0
90135,is,0,0
90136,probably,0,0
90137,related,0,0
90138,to,0,0
90139,the,0,0
90140,effectiveness,0,0
90141,of,0,0
90142,direct,0,0
90143,intervention,0,0
90144,",",0,0
90145,and,0,0
90146,not,0,0
90147,to,0,0
90148,the,0,0
90149,lack,0,0
90150,of,0,0
90151,attention,0,0
90152,of,0,0
90153,parents,0,0
90154,in,0,0
90155,the,0,0
90156,OG,0,1
90157,in,0,0
90158,recognizing,0,0
90159,behavioral,0,1
90160,changes,0,1
90161,in,0,0
90162,their,0,0
90163,children,0,0
90164,.,0,0
90165,Bacterial,0,1
90166,ribosomal,0,0
90167,immunostimulants,0,0
90168,prime,0,0
90169,alveolar,0,1
90170,macrophages,0,0
90171,in,0,0
90172,vivo,0,0
90173,to,0,0
90174,produce,0,0
90175,interleukin,1,0
90176,1,1,0
90177,in,0,0
90178,vitro,0,0
90179,.,0,0
90180,Alveolar,0,1
90181,macrophages,0,1
90182,(,0,0
90183,AMs,0,0
90184,),0,0
90185,may,0,0
90186,play,0,0
90187,a,0,0
90188,key,0,0
90189,role,0,0
90190,in,0,0
90191,human,0,0
90192,respiratory,0,1
90193,immune,0,1
90194,defenses,0,1
90195,",",0,0
90196,partially,0,0
90197,by,0,0
90198,synthesizing,0,1
90199,and,0,0
90200,releasing,0,0
90201,interleukin,1,1
90202,1,1,0
90203,(,1,0
90204,IL,1,0
90205,=,1,0
90206,1,1,0
90207,),1,0
90208,.,1,0
90209,D53,0,0
90210,(,0,0
90211,Ribomunyl,0,0
90212,),0,0
90213,",",0,0
90214,a,0,0
90215,composite,0,1
90216,bacterial,0,1
90217,ribosomal,0,0
90218,immunostimulant,0,0
90219,",",0,0
90220,has,0,0
90221,been,0,0
90222,recognized,0,0
90223,as,0,0
90224,an,0,0
90225,efficient,0,0
90226,prevention,0,0
90227,of,0,0
90228,respiratory,1,1
90229,tract,1,0
90230,infections,1,0
90231,.,1,0
90232,In,0,0
90233,vitro,0,0
90234,",",0,0
90235,D53,0,0
90236,enhances,0,0
90237,the,0,0
90238,IL-1,1,0
90239,production,1,1
90240,by,0,0
90241,mouse,0,0
90242,spleen,0,1
90243,adherent,0,1
90244,cells,0,1
90245,.,0,0
90246,A,0,0
90247,thymocyte,0,0
90248,proliferative,0,1
90249,response,0,1
90250,assay,0,0
90251,was,0,0
90252,used,0,0
90253,to,0,0
90254,evaluate,0,0
90255,the,0,0
90256,in,1,0
90257,vitro,1,0
90258,IL-1,1,0
90259,production,1,1
90260,by,0,0
90261,AMs,0,1
90262,in,0,0
90263,healthy,0,0
90264,subjects,0,0
90265,who,0,0
90266,received,0,0
90267,D53,0,0
90268,immunostimulant,0,0
90269,.,0,0
90270,Twelve,0,0
90271,nonsmoking,0,0
90272,healthy,0,0
90273,subjects,0,0
90274,took,0,0
90275,part,0,0
90276,in,0,0
90277,a,0,0
90278,prospective,0,0
90279,double-blind,0,0
90280,placebo,0,0
90281,control,0,0
90282,study,0,0
90283,.,0,0
90284,On,0,0
90285,day,0,0
90286,1,0,0
90287,",",0,0
90288,a,0,0
90289,first,0,0
90290,bronchoalveolar,0,1
90291,lavage,0,0
90292,(,0,0
90293,BAL,0,1
90294,),0,0
90295,was,0,0
90296,performed,0,0
90297,to,0,0
90298,assess,0,0
90299,IL-1,1,0
90300,production,1,1
90301,by,0,0
90302,unstimulated,0,1
90303,and,0,0
90304,lipopolysaccharide,0,1
90305,(,0,0
90306,LPS,0,1
90307,),0,0
90308,stimulated,0,0
90309,AM,0,0
90310,.,0,0
90311,Then,0,0
90312,",",0,0
90313,subjects,0,0
90314,were,0,0
90315,randomized,0,0
90316,to,0,0
90317,receive,0,0
90318,D53,0,0
90319,(,0,0
90320,n,0,0
90321,=,0,0
90322,6,0,0
90323,),0,0
90324,or,0,0
90325,its,0,0
90326,placebo,0,0
90327,(,0,0
90328,n,0,0
90329,=,0,0
90330,6,0,0
90331,),0,0
90332,by,0,0
90333,both,0,0
90334,oral,0,0
90335,and,0,0
90336,subcutaneous,0,0
90337,injection,0,0
90338,routes,0,0
90339,from,0,0
90340,day,0,0
90341,1,0,0
90342,to,0,0
90343,day,0,0
90344,15,0,0
90345,.,0,0
90346,On,0,0
90347,day,0,0
90348,15,0,0
90349,",",0,0
90350,a,0,0
90351,second,0,0
90352,BAL,0,0
90353,was,0,0
90354,done,0,0
90355,and,0,0
90356,AM,1,1
90357,IL-1,1,0
90358,production,1,1
90359,was,0,0
90360,again,0,0
90361,tested,0,0
90362,.,0,0
90363,IL-1,1,0
90364,production,1,1
90365,on,0,0
90366,day,0,0
90367,15,0,0
90368,did,0,0
90369,not,0,0
90370,significantly,0,0
90371,differ,0,0
90372,from,0,0
90373,day,0,0
90374,1,0,0
90375,in,0,0
90376,both,0,0
90377,D53-treated,0,0
90378,and,0,0
90379,placebo,0,0
90380,groups,0,0
90381,either,0,0
90382,when,0,0
90383,AMs,0,1
90384,were,0,0
90385,unstimulated,0,1
90386,or,0,0
90387,were,0,0
90388,stimulated,0,1
90389,with,0,0
90390,concentrations,0,1
90391,of,0,0
90392,LPS,0,0
90393,resulting,0,0
90394,in,0,0
90395,maximal,0,1
90396,IL-1,1,0
90397,production,1,1
90398,.,1,0
90399,However,0,0
90400,",",0,0
90401,in,0,0
90402,the,0,0
90403,D53-treated,0,0
90404,group,0,0
90405,",",0,0
90406,but,0,0
90407,not,0,0
90408,in,0,0
90409,the,0,0
90410,placebo,0,0
90411,group,0,0
90412,",",0,0
90413,IL-1,1,0
90414,production,1,1
90415,induced,0,0
90416,by,0,0
90417,low,0,0
90418,LPS,1,1
90419,concentration,1,1
90420,(,0,0
90421,5,0,0
90422,mg/L,0,0
90423,),0,0
90424,was,0,0
90425,significantly,0,0
90426,higher,0,0
90427,(,0,0
90428,mean,0,1
90429,+/-,0,0
90430,SEM,0,0
90431,:,0,0
90432,"1,238",0,0
90433,+/-,0,0
90434,287,0,0
90435,U/10,0,0
90436,(,0,0
90437,6,0,0
90438,),0,0
90439,AM,0,0
90440,),0,0
90441,on,0,0
90442,day,0,0
90443,15,0,0
90444,in,0,0
90445,comparison,0,0
90446,with,0,0
90447,day,0,0
90448,1,0,0
90449,(,0,0
90450,577,0,0
90451,+/-,0,0
90452,113,0,0
90453,U/10,0,0
90454,(,0,0
90455,6,0,0
90456,),0,0
90457,AM,0,0
90458,;,0,0
90459,p,0,0
90460,less,0,0
90461,than,0,0
90462,0.05,0,0
90463,",",0,0
90464,Wilcoxon,0,0
90465,W,0,1
90466,test,0,1
90467,),0,0
90468,and,0,0
90469,in,0,0
90470,comparison,0,0
90471,with,0,0
90472,the,0,0
90473,control,0,0
90474,group,0,0
90475,(,0,0
90476,day,0,0
90477,15,0,0
90478,IL-1,1,0
90479,production,0,0
90480,induced,0,0
90481,by,0,0
90482,5,0,0
90483,mg/L,0,0
90484,LPS,0,0
90485,",",0,0
90486,758,0,0
90487,+/-,0,0
90488,175,0,0
90489,U/10,0,0
90490,(,0,0
90491,6,0,0
90492,),0,0
90493,AM,0,0
90494,;,0,0
90495,p,0,0
90496,less,0,0
90497,than,0,0
90498,0.05,0,0
90499,",",0,0
90500,Mann-Whitney,0,0
90501,U,0,1
90502,test,0,0
90503,),0,0
90504,.,0,0
90505,Moreover,0,0
90506,",",0,0
90507,in,0,0
90508,the,0,0
90509,D53-treated,0,0
90510,group,0,0
90511,",",0,0
90512,the,0,0
90513,optimal,1,0
90514,LPS,1,0
90515,concentration,1,1
90516,(,0,0
90517,ie,0,0
90518,",",0,0
90519,LPS,0,1
90520,concentration,0,1
90521,that,0,0
90522,induced,0,0
90523,maximal,0,1
90524,IL-1,0,0
90525,production,0,1
90526,),0,0
90527,was,0,0
90528,significantly,0,0
90529,lower,0,0
90530,on,0,0
90531,day,0,0
90532,15,0,0
90533,(,0,0
90534,mean,0,0
90535,+/-,0,0
90536,SD,0,0
90537,:,0,0
90538,11,0,0
90539,+/-,0,0
90540,7,0,0
90541,mg/L,0,0
90542,),0,0
90543,than,0,0
90544,on,0,0
90545,day,0,0
90546,1,0,0
90547,(,0,0
90548,16,0,0
90549,+/-,0,0
90550,7,0,0
90551,mg/L,0,0
90552,;,0,0
90553,p,0,0
90554,less,0,0
90555,than,0,0
90556,0.05,0,0
90557,Wilcoxon,0,0
90558,W,0,0
90559,test,0,0
90560,),0,0
90561,.,0,0
90562,We,0,0
90563,conclude,0,0
90564,that,0,0
90565,D53,0,0
90566,immunostimulant,0,0
90567,in,0,0
90568,vivo,0,0
90569,primes,0,0
90570,AM,0,0
90571,to,0,0
90572,produce,0,0
90573,IL-1,1,0
90574,following,0,0
90575,low,1,0
90576,LPS,1,0
90577,concentration,1,1
90578,stimulation,0,0
90579,.,0,0
90580,This,0,0
90581,may,0,0
90582,partially,0,0
90583,explain,0,0
90584,the,0,0
90585,protective,0,0
90586,effect,0,0
90587,of,0,0
90588,D53,0,0
90589,immunostimulant,0,0
90590,against,0,1
90591,respiratory,1,1
90592,tract,1,0
90593,infection,1,1
90594,.,1,0
90595,Direct,0,1
90596,and,0,0
90597,indirect,0,1
90598,effects,0,1
90599,of,0,0
90600,interdental,0,0
90601,hygiene,0,1
90602,in,0,0
90603,a,0,0
90604,clinical,0,0
90605,trial,0,0
90606,.,0,0
90607,Many,0,1
90608,randomized,0,0
90609,controlled,0,0
90610,trials,0,0
90611,(,0,0
90612,RCTs,0,0
90613,),0,0
90614,in,0,0
90615,dental,0,0
90616,research,0,0
90617,test,0,0
90618,the,0,0
90619,efficacy,0,1
90620,of,0,0
90621,interventions,0,0
90622,on,0,0
90623,more,0,0
90624,than,0,0
90625,one,0,0
90626,outcome,0,0
90627,variable,0,0
90628,.,0,0
90629,Univariate,0,0
90630,methods,0,0
90631,",",0,0
90632,such,0,0
90633,as,0,0
90634,the,0,0
90635,t,0,0
90636,test,0,0
90637,or,0,0
90638,analysis,0,0
90639,of,0,1
90640,covariance,0,0
90641,",",0,0
90642,can,0,0
90643,not,0,0
90644,evaluate,0,0
90645,the,0,0
90646,efficacy,0,1
90647,of,0,0
90648,interventions,0,0
90649,on,0,0
90650,multiple,0,0
90651,outcomes,0,0
90652,simultaneously,0,0
90653,.,0,0
90654,The,0,0
90655,aim,0,0
90656,of,0,0
90657,this,0,0
90658,study,0,0
90659,was,0,0
90660,to,0,0
90661,use,0,0
90662,structural,0,0
90663,equation,0,0
90664,modeling,0,0
90665,(,0,0
90666,SEM,0,0
90667,),0,0
90668,to,0,0
90669,re-analyze,0,0
90670,a,0,0
90671,RCT,0,0
90672,",",0,0
90673,comparing,0,0
90674,the,0,0
90675,effects,0,0
90676,of,0,0
90677,pre-curved,0,0
90678,interdental,0,1
90679,brushes,0,0
90680,and,0,0
90681,flossing,0,0
90682,on,0,0
90683,probing,0,1
90684,pocket,0,1
90685,depth,0,1
90686,(,0,0
90687,PPD,0,1
90688,),0,0
90689,",",0,0
90690,plaque,0,1
90691,indices,0,1
90692,",",0,0
90693,and,0,0
90694,bleeding,0,1
90695,on,0,0
90696,probing,0,1
90697,(,0,0
90698,BOP,0,1
90699,),0,0
90700,measured,0,0
90701,at,0,0
90702,baseline,0,0
90703,",",0,0
90704,intermediate,0,1
90705,",",0,1
90706,and,0,1
90707,final,0,1
90708,examinations,0,0
90709,.,0,0
90710,Results,0,0
90711,of,0,0
90712,SEM,0,0
90713,showed,0,0
90714,that,0,0
90715,the,0,0
90716,observed,0,0
90717,greater,1,0
90718,reduction,1,1
90719,in,1,0
90720,PPD,1,0
90721,and,1,0
90722,BOP,1,1
90723,in,0,0
90724,persons,0,0
90725,using,0,0
90726,interdental,0,0
90727,brushing,0,0
90728,than,0,0
90729,in,0,0
90730,those,0,0
90731,flossing,0,0
90732,is,0,0
90733,due,0,0
90734,mainly,0,0
90735,to,0,0
90736,the,0,0
90737,greater,0,0
90738,efficiency,1,1
90739,in,1,0
90740,plaque,1,1
90741,removal,1,0
90742,with,0,0
90743,the,0,0
90744,interdental,0,0
90745,brushes,0,0
90746,(,0,0
90747,indirect,0,1
90748,effect,0,0
90749,),0,0
90750,rather,0,0
90751,than,0,0
90752,to,0,0
90753,the,0,0
90754,compression,0,0
90755,of,0,0
90756,the,0,0
90757,interdental,0,0
90758,papillae,0,1
90759,(,0,0
90760,direct,0,1
90761,effect,0,0
90762,),0,0
90763,.,0,0
90764,In,0,0
90765,contrast,0,0
90766,",",0,0
90767,smokers,0,0
90768,showed,0,0
90769,less,0,0
90770,BOP,1,1
90771,at,0,0
90772,baseline,0,0
90773,but,0,0
90774,also,0,0
90775,less,0,0
90776,improvement,0,1
90777,in,0,0
90778,BOP,1,0
90779,through,0,0
90780,direct,0,0
90781,effects,0,0
90782,.,0,0
90783,Is,0,0
90784,adjuvant,0,0
90785,chemotherapy,0,0
90786,of,0,0
90787,benefit,0,0
90788,for,0,0
90789,postmenopausal,0,0
90790,women,0,0
90791,who,0,0
90792,receive,0,0
90793,endocrine,0,1
90794,treatment,0,0
90795,for,0,0
90796,highly,0,0
90797,endocrine-responsive,0,0
90798,",",0,0
90799,node-positive,0,0
90800,breast,0,0
90801,cancer,0,0
90802,?,0,0
90803,International,0,0
90804,Breast,0,1
90805,Cancer,0,0
90806,Study,0,0
90807,Group,0,0
90808,Trials,0,1
90809,VII,0,0
90810,and,0,0
90811,12-93,0,0
90812,.,0,0
90813,To,0,0
90814,compare,0,0
90815,the,0,0
90816,efficacy,1,1
90817,of,0,0
90818,chemoendocrine,0,0
90819,treatment,0,0
90820,with,0,0
90821,that,0,0
90822,of,0,0
90823,endocrine,0,1
90824,treatment,0,0
90825,(,0,0
90826,ET,0,1
90827,),0,0
90828,alone,0,0
90829,for,0,0
90830,postmenopausal,0,0
90831,women,0,0
90832,with,0,0
90833,highly,0,0
90834,endocrine,0,0
90835,responsive,0,0
90836,breast,0,0
90837,cancer,0,0
90838,.,0,0
90839,In,0,0
90840,the,0,0
90841,International,0,0
90842,Breast,0,1
90843,Cancer,0,0
90844,Study,0,0
90845,Group,0,0
90846,(,0,0
90847,IBCSG,0,0
90848,),0,0
90849,Trials,0,1
90850,VII,0,0
90851,and,0,1
90852,12-93,0,0
90853,",",0,0
90854,postmenopausal,0,0
90855,women,0,0
90856,with,0,0
90857,node-positive,0,0
90858,",",0,0
90859,estrogen,0,1
90860,receptor,0,1
90861,(,0,0
90862,ER,0,0
90863,),0,0
90864,-positive,0,0
90865,or,0,0
90866,ER-negative,0,0
90867,",",0,0
90868,operable,0,0
90869,breast,0,0
90870,cancer,0,0
90871,were,0,0
90872,randomized,0,0
90873,to,0,0
90874,receive,0,0
90875,either,0,0
90876,chemotherapy,0,0
90877,or,0,0
90878,endocrine,0,1
90879,therapy,0,0
90880,or,0,0
90881,combined,0,0
90882,chemoendocrine,0,0
90883,treatment,0,0
90884,.,0,0
90885,Results,0,0
90886,were,0,0
90887,analyzed,0,0
90888,overall,0,1
90889,in,0,0
90890,the,0,0
90891,cohort,0,0
90892,of,0,0
90893,893,0,0
90894,patients,0,0
90895,with,0,0
90896,endocrine-responsive,0,0
90897,disease,0,1
90898,",",0,0
90899,and,0,0
90900,according,0,0
90901,to,0,0
90902,prospectively,0,0
90903,defined,0,0
90904,categories,0,0
90905,of,0,0
90906,ER,0,0
90907,",",0,0
90908,age,0,0
90909,and,0,1
90910,nodal,0,1
90911,status,0,1
90912,.,0,0
90913,STEPP,1,0
90914,analyses,1,0
90915,assessed,1,0
90916,chemotherapy,1,0
90917,effect,1,0
90918,.,1,0
90919,The,0,0
90920,median,0,0
90921,follow-up,0,0
90922,was,0,0
90923,13,0,0
90924,years,0,0
90925,.,0,0
90926,Adding,0,0
90927,chemotherapy,0,0
90928,reduced,0,0
90929,the,0,0
90930,relative,1,0
90931,risk,1,0
90932,of,1,0
90933,a,1,0
90934,disease-free,1,1
90935,survival,1,1
90936,event,1,0
90937,by,0,0
90938,19,0,0
90939,%,0,0
90940,(,0,0
90941,P,0,0
90942,=,0,0
90943,0.02,0,0
90944,),0,0
90945,compared,0,0
90946,with,0,0
90947,ET,0,0
90948,alone,0,0
90949,.,0,0
90950,STEPP,0,0
90951,analyses,0,0
90952,showed,0,0
90953,little,0,0
90954,effect,0,0
90955,of,0,0
90956,chemotherapy,0,0
90957,for,0,0
90958,tumors,0,0
90959,with,0,0
90960,high,0,0
90961,levels,1,1
90962,of,1,0
90963,ER,1,0
90964,expression,1,1
90965,(,0,0
90966,P,0,0
90967,=,0,0
90968,0.07,0,0
90969,),0,0
90970,",",0,0
90971,or,0,0
90972,for,0,0
90973,the,0,0
90974,cohort,0,0
90975,with,0,0
90976,one,0,0
90977,positive,0,0
90978,node,0,0
90979,(,0,0
90980,P,0,0
90981,=,0,0
90982,0.03,0,0
90983,),0,0
90984,.,0,0
90985,Chemotherapy,0,0
90986,significantly,0,0
90987,improves,0,0
90988,disease-free,1,1
90989,survival,1,1
90990,for,1,0
90991,postmenopausal,0,0
90992,women,0,0
90993,with,0,0
90994,endocrine-responsive,0,0
90995,breast,0,0
90996,cancer,0,0
90997,",",0,0
90998,but,0,0
90999,the,0,0
91000,magnitude,0,1
91001,of,0,0
91002,the,0,0
91003,effect,0,0
91004,is,0,0
91005,substantially,0,0
91006,attenuated,0,0
91007,if,0,0
91008,ER,0,0
91009,levels,0,1
91010,are,0,0
91011,high,0,0
91012,.,0,0
91013,Comparison,0,0
91014,of,0,0
91015,40,0,0
91016,milliliters,0,0
91017,of,0,0
91018,0.25,0,0
91019,%,0,0
91020,intrapleural,0,0
91021,bupivacaine,0,0
91022,with,0,0
91023,epinephrine,0,0
91024,with,0,0
91025,20,0,0
91026,milliliters,0,0
91027,of,0,0
91028,0.5,0,0
91029,%,0,0
91030,intrapleural,0,0
91031,bupivacaine,0,0
91032,with,0,0
91033,epinephrine,0,0
91034,after,0,0
91035,cholecystectomy,0,0
91036,.,0,0
91037,To,0,0
91038,determine,0,0
91039,the,0,0
91040,influence,0,0
91041,of,0,0
91042,the,0,0
91043,volume,0,1
91044,of,0,0
91045,local,0,0
91046,anesthetic,0,0
91047,injected,0,0
91048,for,0,0
91049,intrapleural,0,0
91050,analgesia,0,0
91051,",",0,0
91052,40,0,0
91053,patients,0,0
91054,undergoing,0,0
91055,cholecystectomy,0,0
91056,were,0,0
91057,randomly,0,0
91058,allocated,0,0
91059,to,0,0
91060,two,0,0
91061,groups,0,0
91062,of,0,0
91063,20,0,0
91064,patients,0,0
91065,each,0,0
91066,.,0,0
91067,One,0,0
91068,group,0,0
91069,received,0,0
91070,40,0,0
91071,mL,0,0
91072,of,0,0
91073,0.25,0,0
91074,%,0,0
91075,bupivacaine,0,0
91076,with,0,0
91077,epinephrine,0,0
91078,injected,0,0
91079,intrapleurally,0,0
91080,postoperatively,0,0
91081,.,0,0
91082,The,0,0
91083,other,0,0
91084,group,0,0
91085,received,0,0
91086,20,0,0
91087,mL,0,0
91088,of,0,0
91089,0.5,0,0
91090,%,0,0
91091,bupivacaine,0,0
91092,with,0,0
91093,epinephrine,0,0
91094,.,0,0
91095,The,0,0
91096,onset,1,1
91097,time,1,1
91098,of,1,0
91099,analgesia,1,1
91100,was,0,0
91101,nearly,0,0
91102,the,0,0
91103,same,0,0
91104,in,0,0
91105,both,0,0
91106,groups,0,0
91107,and,0,0
91108,within,0,0
91109,25,0,0
91110,min,0,0
91111,all,0,0
91112,patients,0,0
91113,were,0,0
91114,nearly,0,0
91115,pain,0,1
91116,free,0,1
91117,.,0,0
91118,Our,0,0
91119,data,0,0
91120,demonstrate,0,0
91121,that,0,0
91122,100,0,0
91123,mg,0,0
91124,of,0,0
91125,bupivacaine,0,0
91126,with,0,0
91127,epinephrine,0,0
91128,elicits,0,0
91129,effective,0,1
91130,analgesia,0,1
91131,after,0,0
91132,cholecystectomy,0,0
91133,.,0,0
91134,There,0,0
91135,are,0,0
91136,only,0,0
91137,minor,0,0
91138,differences,0,0
91139,between,0,0
91140,20,0,0
91141,and,0,0
91142,40,0,0
91143,mL,0,0
91144,with,0,0
91145,regard,0,0
91146,to,0,0
91147,pain,1,1
91148,relief,1,1
91149,.,1,0
91150,The,0,0
91151,authors,0,0
91152,conclude,0,0
91153,that,0,0
91154,the,0,0
91155,volume,0,1
91156,of,0,0
91157,local,0,0
91158,anesthetic,0,0
91159,within,0,0
91160,the,0,0
91161,range,0,0
91162,of,0,0
91163,20-40,0,0
91164,mL,0,0
91165,in,0,0
91166,an,0,0
91167,adult,0,0
91168,has,0,0
91169,little,0,0
91170,influence,0,0
91171,on,0,0
91172,the,0,0
91173,extent,0,0
91174,or,0,0
91175,duration,0,1
91176,of,0,1
91177,intrapleural,0,0
91178,analgesia,0,0
91179,.,0,0
91180,Phosphate,0,0
91181,binder,0,0
91182,impact,0,0
91183,on,0,0
91184,bone,1,1
91185,remodeling,1,1
91186,and,1,1
91187,coronary,1,0
91188,calcification,1,1
91189,--,1,0
91190,results,1,0
91191,from,0,0
91192,the,0,0
91193,BRiC,0,0
91194,study,0,0
91195,.,0,0
91196,BACKGROUND,0,0
91197,AND,0,0
91198,AIMS,0,1
91199,Calcium-containing,0,0
91200,phosphate,0,0
91201,binders,0,0
91202,have,0,0
91203,been,0,0
91204,shown,0,0
91205,to,0,0
91206,increase,0,0
91207,the,0,0
91208,progression,0,1
91209,of,0,0
91210,vascular,1,1
91211,calcification,1,1
91212,in,0,0
91213,hemodialysis,0,0
91214,patients,0,0
91215,.,0,0
91216,This,0,0
91217,is,0,0
91218,a,0,0
91219,prospective,0,0
91220,study,0,0
91221,that,0,0
91222,compares,0,0
91223,the,0,0
91224,effects,0,0
91225,of,0,0
91226,calcium,0,0
91227,acetate,0,0
91228,and,0,1
91229,sevelamer,0,1
91230,on,0,0
91231,coronary,1,0
91232,calcification,1,1
91233,(,0,0
91234,CAC,0,0
91235,),0,0
91236,and,0,0
91237,bone,1,1
91238,histology,1,1
91239,.,1,0
91240,METHODS,0,0
91241,101,0,0
91242,hemodialysis,0,0
91243,patients,0,0
91244,were,0,0
91245,randomized,0,0
91246,for,0,0
91247,each,0,0
91248,phosphate,0,0
91249,binder,0,0
91250,and,0,0
91251,submitted,0,0
91252,to,0,0
91253,multislice,0,0
91254,coronary,0,0
91255,tomographies,0,0
91256,and,0,1
91257,bone,0,1
91258,biopsies,0,1
91259,at,0,0
91260,entry,0,0
91261,and,0,0
91262,12,0,0
91263,months,0,0
91264,.,0,0
91265,RESULTS,0,0
91266,The,0,0
91267,71,0,0
91268,patients,0,0
91269,who,0,0
91270,concluded,0,0
91271,the,0,0
91272,study,0,0
91273,had,0,0
91274,similar,0,0
91275,baseline,0,0
91276,characteristics,0,0
91277,.,0,0
91278,On,0,0
91279,follow-up,0,0
91280,",",0,0
91281,the,0,0
91282,sevelamer,0,1
91283,group,0,0
91284,had,0,0
91285,higher,0,0
91286,levels,0,1
91287,of,0,1
91288,intact,1,0
91289,parathyroid,1,1
91290,hormone,1,0
91291,(,0,0
91292,498,0,0
91293,+/-,0,0
91294,352,0,0
91295,vs.,0,0
91296,326,0,0
91297,+/-,0,0
91298,236,0,0
91299,pg/ml,0,0
91300,",",0,0
91301,p,0,0
91302,=,0,0
91303,0.017,0,0
91304,),0,0
91305,",",0,0
91306,bone,1,1
91307,alkaline,1,1
91308,phosphatase,1,1
91309,(,0,0
91310,38,0,0
91311,+/-,0,0
91312,24,0,0
91313,vs.,0,0
91314,28,0,0
91315,+/-,0,0
91316,15,0,0
91317,U/l,0,0
91318,",",0,0
91319,p,0,0
91320,=,0,0
91321,0.03,0,0
91322,),0,0
91323,and,0,0
91324,deoxypyridinoline,1,1
91325,(,0,0
91326,135,0,0
91327,+/-,0,0
91328,107,0,0
91329,vs.,0,0
91330,89,0,0
91331,+/-,0,0
91332,71,0,0
91333,nmol/l,0,0
91334,",",0,0
91335,p,0,0
91336,=,0,0
91337,0.03,0,0
91338,),0,0
91339,and,0,0
91340,lower,1,0
91341,LDL,1,1
91342,cholesterol,1,1
91343,(,0,0
91344,74,0,0
91345,+/-,0,0
91346,21,0,0
91347,vs.,0,0
91348,91,0,0
91349,+/-,0,0
91350,28,0,0
91351,mg/dl,0,0
91352,",",0,0
91353,p,0,0
91354,=,0,0
91355,0.015,0,0
91356,),0,0
91357,.,0,0
91358,Phosphorus,1,0
91359,(,0,0
91360,5.8,0,0
91361,+/-,0,0
91362,1.0,0,0
91363,vs.,0,0
91364,6,0,0
91365,+/-,0,0
91366,1.0,0,0
91367,mg/dl,0,0
91368,",",0,0
91369,p,0,0
91370,=,0,0
91371,0.47,0,0
91372,),0,0
91373,and,0,0
91374,calcium,1,0
91375,(,0,0
91376,1.27,0,0
91377,+/-,0,0
91378,0.07,0,0
91379,vs.,0,0
91380,1.23,0,0
91381,+/-,0,0
91382,0.08,0,0
91383,mmol/l,0,0
91384,",",0,0
91385,p,0,0
91386,=,0,0
91387,0.68,0,0
91388,),0,0
91389,levels,1,1
91390,did,0,0
91391,not,0,0
91392,differ,0,0
91393,between,0,0
91394,groups,0,0
91395,.,0,0
91396,CAC,1,0
91397,progression,1,1
91398,(,0,0
91399,35,0,0
91400,vs.,0,0
91401,24,0,0
91402,%,0,0
91403,",",0,0
91404,p,0,0
91405,=,0,0
91406,0.94,0,0
91407,),0,0
91408,and,0,0
91409,bone,1,1
91410,histological,1,1
91411,diagnosis,1,0
91412,at,0,0
91413,baseline,0,0
91414,and,0,0
91415,12,0,0
91416,months,0,0
91417,were,0,0
91418,similar,0,0
91419,in,0,0
91420,both,0,0
91421,groups,0,0
91422,.,0,0
91423,Patients,0,0
91424,of,0,0
91425,the,0,0
91426,sevelamer,0,0
91427,group,0,0
91428,with,0,0
91429,a,0,0
91430,high,0,0
91431,turnover,0,1
91432,at,0,0
91433,baseline,0,0
91434,had,0,0
91435,an,0,0
91436,increase,0,0
91437,in,0,0
91438,bone,1,1
91439,resorption,1,1
91440,(,0,0
91441,eroded,0,0
91442,surface,0,0
91443,",",0,0
91444,ES/BS,0,0
91445,=,0,0
91446,9.0,0,0
91447,+/-,0,0
91448,5.9,0,0
91449,vs.,0,0
91450,13.1,0,0
91451,+/-,0,0
91452,9.5,0,0
91453,%,0,0
91454,",",0,0
91455,p,0,0
91456,=,0,0
91457,0.05,0,0
91458,),0,0
91459,",",0,0
91460,whereas,0,0
91461,patients,0,0
91462,of,0,0
91463,both,0,0
91464,groups,0,0
91465,with,0,0
91466,low,0,0
91467,turnover,0,1
91468,at,0,0
91469,baseline,0,0
91470,had,0,0
91471,an,0,0
91472,improvement,0,1
91473,in,0,0
91474,bone,1,1
91475,formation,1,1
91476,rate,1,1
91477,(,0,0
91478,BFR/BS,0,0
91479,=,0,0
91480,0.015,0,0
91481,+/-,0,0
91482,0.016,0,0
91483,vs.,0,0
91484,0.062,0,0
91485,+/-,0,0
91486,0.078,0,0
91487,",",0,0
91488,p,0,0
91489,=,0,0
91490,0.003,0,0
91491,for,0,0
91492,calcium,0,0
91493,and,0,0
91494,0.017,0,0
91495,+/-,0,0
91496,0.016,0,0
91497,vs.,0,0
91498,0.071,0,0
91499,+/-,0,0
91500,0.084,0,0
91501,microm,0,0
91502,(,0,0
91503,3,0,0
91504,),0,0
91505,/microm,0,0
91506,(,0,0
91507,2,0,0
91508,),0,0
91509,/day,0,0
91510,",",0,0
91511,p,0,0
91512,=,0,0
91513,0.010,0,0
91514,for,0,0
91515,sevelamer,0,0
91516,),0,0
91517,.,0,0
91518,CONCLUSIONS,0,0
91519,There,0,0
91520,was,0,0
91521,no,0,0
91522,difference,0,0
91523,in,0,0
91524,CAC,1,0
91525,progression,1,1
91526,or,0,0
91527,changes,0,1
91528,in,0,0
91529,bone,1,1
91530,remodeling,1,0
91531,between,0,0
91532,the,0,0
91533,calcium,0,0
91534,and,0,0
91535,the,0,0
91536,sevelamer,0,0
91537,groups,0,0
91538,.,0,0
91539,Comparing,0,0
91540,two,0,0
91541,web-based,0,0
91542,smoking,1,0
91543,cessation,1,0
91544,programs,0,0
91545,:,0,0
91546,randomized,0,0
91547,controlled,0,0
91548,trial,0,0
91549,.,0,0
91550,BACKGROUND,0,0
91551,Smoking,1,0
91552,cessation,1,0
91553,remains,0,0
91554,a,0,0
91555,significant,0,0
91556,public,0,0
91557,health,0,0
91558,problem,0,0
91559,.,0,0
91560,Innovative,0,0
91561,interventions,0,0
91562,that,0,0
91563,use,0,0
91564,the,0,0
91565,Internet,0,0
91566,have,0,0
91567,begun,0,0
91568,to,0,0
91569,emerge,0,0
91570,that,0,0
91571,offer,0,0
91572,great,0,0
91573,promise,0,0
91574,in,0,0
91575,reaching,0,0
91576,large,0,0
91577,numbers,0,1
91578,of,0,0
91579,participants,0,0
91580,and,0,0
91581,encouraging,0,0
91582,widespread,0,1
91583,behavior,0,1
91584,change,0,0
91585,.,0,0
91586,To,0,0
91587,date,0,0
91588,",",0,0
91589,the,0,0
91590,relatively,0,0
91591,few,0,0
91592,controlled,0,0
91593,trials,0,0
91594,of,0,0
91595,Web-based,0,0
91596,smoking,1,0
91597,cessation,1,0
91598,programs,0,0
91599,have,0,0
91600,been,0,0
91601,limited,0,0
91602,by,0,0
91603,short,0,0
91604,follow-up,0,0
91605,intervals,0,0
91606,.,0,0
91607,OBJECTIVE,0,0
91608,We,0,0
91609,describe,0,0
91610,the,0,0
91611,6-month,0,0
91612,follow-up,0,0
91613,results,0,0
91614,of,0,0
91615,a,0,0
91616,randomized,0,0
91617,controlled,0,0
91618,trial,0,0
91619,in,0,0
91620,which,0,0
91621,participants,0,0
91622,recruited,0,0
91623,online,0,0
91624,were,0,0
91625,randomly,0,0
91626,assigned,0,0
91627,to,0,0
91628,either,0,0
91629,a,0,0
91630,Web-based,0,0
91631,smoking,1,0
91632,cessation,1,1
91633,program,0,0
91634,(,0,0
91635,Quit,0,1
91636,Smoking,0,1
91637,Network,0,0
91638,;,0,0
91639,QSN,0,0
91640,),0,0
91641,or,0,0
91642,a,0,0
91643,Web-based,0,0
91644,exercise,0,0
91645,enhancement,0,1
91646,program,0,0
91647,(,0,0
91648,Active,0,0
91649,Lives,0,0
91650,),0,0
91651,adapted,0,0
91652,somewhat,0,0
91653,to,0,0
91654,encourage,0,0
91655,smoking,0,0
91656,cessation,0,0
91657,.,0,0
91658,METHODS,0,0
91659,The,0,0
91660,study,0,0
91661,was,0,0
91662,a,0,0
91663,two-arm,0,0
91664,randomized,0,0
91665,controlled,0,0
91666,trial,0,0
91667,that,0,0
91668,compared,0,0
91669,two,0,0
91670,Web-based,0,0
91671,smoking,1,0
91672,cessation,1,0
91673,programs,0,0
91674,:,0,0
91675,(,0,0
91676,1,0,0
91677,),0,0
91678,the,0,0
91679,QSN,0,0
91680,intervention,0,0
91681,condition,0,0
91682,presented,0,0
91683,cognitive-behavioral,0,0
91684,strategies,0,0
91685,",",0,0
91686,and,0,0
91687,(,0,0
91688,2,0,0
91689,),0,0
91690,the,0,0
91691,Active,0,0
91692,Lives,0,0
91693,control,0,0
91694,condition,0,0
91695,provided,0,0
91696,participants,0,0
91697,with,0,0
91698,guidance,0,0
91699,in,0,0
91700,developing,0,0
91701,a,0,0
91702,physical,0,1
91703,activity,0,1
91704,program,0,0
91705,to,0,0
91706,assist,0,0
91707,them,0,0
91708,with,0,0
91709,quitting,0,0
91710,.,0,0
91711,The,0,0
91712,QSN,0,0
91713,condition,0,0
91714,provided,0,0
91715,smoking,0,0
91716,cessation,0,1
91717,information,0,1
91718,and,0,1
91719,behavior,0,1
91720,change,0,1
91721,strategies,0,0
91722,while,0,0
91723,the,0,0
91724,Active,0,0
91725,Lives,0,0
91726,condition,0,0
91727,provided,0,0
91728,participants,0,0
91729,with,0,0
91730,physical,0,1
91731,activity,0,1
91732,recommendations,0,0
91733,and,0,1
91734,goal,0,0
91735,setting,0,0
91736,.,0,0
91737,The,0,0
91738,QSN,0,0
91739,condition,0,0
91740,was,0,0
91741,designed,0,0
91742,to,0,0
91743,be,0,0
91744,more,0,0
91745,engaging,0,0
91746,(,0,1
91747,eg,0,0
91748,",",0,0
91749,it,0,0
91750,included,0,0
91751,multimedia,0,0
91752,components,0,1
91753,),0,0
91754,and,0,0
91755,to,0,0
91756,present,0,0
91757,much,0,0
91758,greater,0,0
91759,content,0,1
91760,than,0,0
91761,is,0,0
91762,typically,0,0
91763,found,0,0
91764,in,0,0
91765,smoking,0,0
91766,cessation,0,0
91767,programs,0,0
91768,.,0,0
91769,RESULTS,0,0
91770,Contrary,0,0
91771,to,0,0
91772,our,0,0
91773,hypotheses,0,0
91774,",",0,0
91775,no,0,0
91776,between-condition,0,0
91777,differences,0,0
91778,in,0,0
91779,smoking,1,0
91780,abstinence,1,1
91781,were,0,0
91782,found,0,0
91783,at,0,0
91784,3-,0,0
91785,and,0,0
91786,6-month,0,0
91787,follow-up,0,0
91788,assessments,0,0
91789,.,0,0
91790,While,0,0
91791,participants,0,0
91792,in,0,0
91793,the,0,0
91794,QSN,0,0
91795,intervention,0,0
91796,condition,0,0
91797,spent,0,1
91798,more,0,0
91799,time,0,1
91800,than,0,0
91801,controls,0,0
91802,visiting,0,0
91803,the,0,0
91804,online,0,0
91805,program,0,0
91806,",",0,0
91807,the,0,0
91808,median,0,1
91809,number,0,0
91810,of,0,0
91811,1.0,0,0
91812,visit,0,0
91813,in,0,0
91814,each,0,0
91815,condition,0,0
91816,and,0,0
91817,the,0,0
91818,substantial,0,0
91819,attrition,0,0
91820,(,0,0
91821,60.8,0,0
91822,%,0,0
91823,at,0,0
91824,the,0,0
91825,6-month,0,0
91826,follow-up,0,0
91827,),0,0
91828,indicate,0,0
91829,that,0,0
91830,participants,0,0
91831,were,0,0
91832,not,0,0
91833,as,0,0
91834,engaged,0,0
91835,as,0,0
91836,we,0,0
91837,had,0,0
91838,expected,0,0
91839,.,0,0
91840,CONCLUSIONS,0,0
91841,Contrary,0,0
91842,to,0,0
91843,our,0,0
91844,hypothesis,0,0
91845,",",0,0
91846,our,0,0
91847,test,0,0
91848,of,0,0
91849,two,0,0
91850,Web-based,0,0
91851,smoking,1,0
91852,cessation,1,0
91853,conditions,0,0
91854,",",0,0
91855,an,0,0
91856,intervention,0,0
91857,and,0,0
91858,an,0,0
91859,attention,0,1
91860,placebo,0,0
91861,control,0,0
91862,",",0,0
91863,failed,0,0
91864,to,0,0
91865,show,0,0
91866,differences,0,0
91867,at,0,0
91868,3-,0,0
91869,and,0,0
91870,6-month,0,0
91871,assessments,0,0
91872,.,0,0
91873,We,0,0
91874,explored,0,0
91875,possible,0,0
91876,reasons,0,0
91877,for,0,0
91878,this,0,0
91879,finding,0,0
91880,",",0,0
91881,including,0,0
91882,limited,0,0
91883,engagement,0,1
91884,of,0,0
91885,participants,0,0
91886,and,0,0
91887,simplifying,0,0
91888,program,0,0
91889,content,0,1
91890,and,0,0
91891,architecture,0,1
91892,.,0,1
91893,Future,0,0
91894,research,0,0
91895,needs,0,0
91896,to,0,0
91897,address,0,0
91898,methods,0,0
91899,to,0,0
91900,improve,0,0
91901,participant,0,0
91902,engagement,0,1
91903,in,0,0
91904,online,0,0
91905,smoking,0,0
91906,cessation,0,0
91907,programs,0,0
91908,.,0,0
91909,Possible,0,0
91910,approaches,0,0
91911,in,0,0
91912,this,0,0
91913,regard,0,0
91914,can,0,0
91915,include,0,0
91916,new,0,0
91917,informed,0,0
91918,consent,0,0
91919,procedures,0,0
91920,that,0,0
91921,better,0,0
91922,explain,0,0
91923,the,0,0
91924,roles,0,0
91925,and,0,0
91926,responsibilities,0,0
91927,of,0,0
91928,being,0,0
91929,a,0,0
91930,research,0,0
91931,participant,0,0
91932,",",0,0
91933,new,0,1
91934,program,0,0
91935,designs,0,0
91936,that,0,0
91937,add,0,0
91938,more,0,0
91939,vitality,0,1
91940,(,0,0
91941,changing,0,0
91942,content,0,1
91943,from,0,0
91944,visit,0,1
91945,to,0,0
91946,visit,0,1
91947,),0,0
91948,",",0,0
91949,and,0,1
91950,new,0,1
91951,types,0,0
91952,of,0,0
91953,reminders,0,0
91954,pushed,0,0
91955,out,0,0
91956,to,0,0
91957,participants,0,0
91958,to,0,0
91959,encourage,0,0
91960,return,0,0
91961,visits,0,0
91962,.,0,0
91963,Simplifying,0,0
91964,program,0,0
91965,content,0,1
91966,through,0,0
91967,a,0,0
91968,combination,0,0
91969,of,0,0
91970,enhanced,0,0
91971,tailoring,0,0
91972,and,0,1
91973,information,0,1
91974,architecture,0,0
91975,also,0,0
91976,merits,0,0
91977,further,0,0
91978,research,0,0
91979,attention,0,0
91980,.,0,0
91981,Parecoxib,0,0
91982,for,0,0
91983,analgesia,0,1
91984,after,0,0
91985,craniotomy,0,0
91986,.,0,0
91987,BACKGROUND,0,0
91988,Pain,1,1
91989,after,0,0
91990,craniotomy,0,0
91991,is,0,0
91992,often,0,0
91993,under-treated,0,0
91994,.,0,0
91995,Opiates,0,0
91996,carry,0,0
91997,distinct,0,0
91998,disadvantages,0,0
91999,.,0,0
92000,Non-steroidal,0,0
92001,anti-inflammatory,0,0
92002,drugs,0,0
92003,have,0,0
92004,an,0,0
92005,anti-platelet,0,0
92006,action,0,0
92007,and,0,0
92008,carry,0,0
92009,a,0,0
92010,bleeding,0,1
92011,risk,0,0
92012,.,0,0
92013,Cyclo-oxygenase,0,0
92014,2,0,0
92015,inhibitors,0,0
92016,such,0,0
92017,as,0,0
92018,parecoxib,0,0
92019,are,0,0
92020,not,0,0
92021,associated,0,0
92022,with,0,0
92023,a,0,0
92024,bleeding,0,1
92025,risk,0,0
92026,and,0,0
92027,would,0,0
92028,be,0,0
92029,welcome,0,0
92030,analgesics,0,0
92031,if,0,0
92032,shown,0,0
92033,to,0,0
92034,be,0,0
92035,effective,0,0
92036,.,0,0
92037,METHODS,0,0
92038,In,0,0
92039,a,0,0
92040,prospective,0,0
92041,double-blind,0,0
92042,",",0,0
92043,randomized,0,0
92044,",",0,0
92045,placebo-controlled,0,0
92046,study,0,0
92047,",",0,0
92048,we,0,0
92049,investigated,0,0
92050,the,0,0
92051,analgesic,0,1
92052,effect,0,0
92053,of,0,0
92054,a,0,0
92055,single,0,0
92056,dose,0,0
92057,of,0,0
92058,parecoxib,0,0
92059,40,0,0
92060,mg,0,0
92061,given,0,0
92062,at,0,0
92063,dural,0,0
92064,closure,0,0
92065,in,0,0
92066,82,0,0
92067,patients,0,0
92068,undergoing,0,0
92069,elective,0,0
92070,craniotomies,0,0
92071,.,0,0
92072,Remifentanil,0,0
92073,was,0,0
92074,used,0,0
92075,intraoperatively,0,0
92076,",",0,0
92077,and,0,0
92078,i.v,0,0
92079,.,0,1
92080,morphine,0,0
92081,was,0,0
92082,titrated,0,0
92083,to,0,0
92084,the,0,0
92085,requirement,0,0
92086,in,0,0
92087,the,0,0
92088,post-anaesthetic,0,0
92089,unit,0,0
92090,.,0,0
92091,On,0,0
92092,the,0,0
92093,ward,0,0
92094,",",0,0
92095,i.m,0,0
92096,.,0,0
92097,morphine,0,0
92098,5,0,0
92099,mg,0,0
92100,as,0,0
92101,required,0,0
92102,and,0,0
92103,regular,0,0
92104,acetaminophen,0,0
92105,was,0,0
92106,prescribed,0,0
92107,.,0,0
92108,Morphine,0,0
92109,use,0,0
92110,and,0,1
92111,visual,1,1
92112,analogue,1,1
92113,pain,1,1
92114,scores,1,1
92115,were,0,0
92116,recorded,0,0
92117,at,0,0
92118,1,0,0
92119,",",0,0
92120,6,0,0
92121,",",0,0
92122,12,0,0
92123,",",0,0
92124,and,0,0
92125,24,0,0
92126,h,0,0
92127,after,0,0
92128,surgery,0,0
92129,.,0,0
92130,RESULTS,0,0
92131,Parecoxib,0,0
92132,reduced,1,0
92133,pain,1,1
92134,scores,1,1
92135,at,0,0
92136,6,0,0
92137,h,0,0
92138,and,0,0
92139,morphine,0,1
92140,use,0,0
92141,at,0,0
92142,6,0,0
92143,and,0,0
92144,12,0,0
92145,h,0,0
92146,after,0,0
92147,operation,0,0
92148,.,0,0
92149,However,0,0
92150,",",0,0
92151,overall,0,1
92152,",",0,0
92153,it,0,0
92154,had,0,0
92155,only,0,0
92156,minimal,0,1
92157,impact,0,0
92158,on,0,0
92159,postoperative,1,1
92160,analgesia,1,0
92161,.,1,0
92162,We,0,0
92163,found,0,0
92164,a,0,0
92165,wide,0,0
92166,variability,0,1
92167,in,0,0
92168,analgesic,0,1
92169,requirements,0,0
92170,where,0,0
92171,11,0,0
92172,%,0,0
92173,of,0,0
92174,patients,0,0
92175,required,0,0
92176,no,0,0
92177,opioids,0,0
92178,and,0,0
92179,16,0,0
92180,%,0,0
92181,required,0,0
92182,more,0,0
92183,than,0,0
92184,15,0,0
92185,mg,0,0
92186,i.v,0,0
92187,.,0,0
92188,morphine,0,0
92189,1,0,0
92190,h,0,0
92191,after,0,0
92192,the,0,0
92193,surgery,0,0
92194,.,0,0
92195,CONCLUSIONS,0,0
92196,We,0,0
92197,found,0,0
92198,only,0,0
92199,limited,0,0
92200,evidence,0,0
92201,to,0,0
92202,support,0,0
92203,parecoxib,0,0
92204,as,0,0
92205,an,0,0
92206,analgesic,0,1
92207,after,0,0
92208,craniotomy,0,0
92209,.,0,0
92210,Acceptability,0,1
92211,of,0,0
92212,an,0,0
92213,Electronic,0,0
92214,Self-Report,0,0
92215,Assessment,0,0
92216,Program,0,0
92217,for,0,0
92218,patients,0,0
92219,with,0,0
92220,cancer,0,0
92221,.,0,0
92222,Eliciting,0,1
92223,symptom,0,1
92224,and,0,1
92225,quality,0,1
92226,of,0,1
92227,life,0,1
92228,information,0,0
92229,from,0,0
92230,patients,0,0
92231,is,0,0
92232,an,0,0
92233,important,0,0
92234,component,0,0
92235,of,0,0
92236,medical,0,0
92237,and,0,0
92238,nursing,0,0
92239,care,0,0
92240,processes,0,1
92241,.,0,0
92242,Traditionally,0,0
92243,",",0,0
92244,this,0,0
92245,information,0,0
92246,has,0,0
92247,been,0,0
92248,collected,0,0
92249,with,0,0
92250,paper,0,0
92251,and,0,0
92252,pencil,0,0
92253,.,0,0
92254,However,0,0
92255,",",0,0
92256,this,0,0
92257,approach,0,0
92258,presents,0,0
92259,several,0,0
92260,barriers,0,0
92261,",",0,0
92262,including,0,0
92263,delays,0,1
92264,in,0,0
92265,receiving,0,0
92266,information,0,0
92267,",",0,0
92268,difficulty,0,1
92269,in,0,0
92270,integrating,0,0
92271,responses,0,1
92272,with,0,0
92273,electronic,0,0
92274,records,0,0
92275,",",0,0
92276,and,0,0
92277,the,0,0
92278,time,0,1
92279,required,0,0
92280,to,0,0
92281,manually,0,0
92282,score,0,1
92283,questionnaires,0,0
92284,for,0,0
92285,measurement,0,0
92286,purposes,0,0
92287,.,0,0
92288,One,0,0
92289,solution,0,0
92290,that,0,0
92291,addresses,0,0
92292,many,0,0
92293,of,0,0
92294,these,0,0
92295,barriers,0,0
92296,is,0,0
92297,the,0,0
92298,adoption,0,0
92299,of,0,0
92300,computerized,0,0
92301,screening,0,0
92302,for,0,0
92303,symptom,0,1
92304,and,0,0
92305,quality-of-life,0,1
92306,information,0,0
92307,.,0,0
92308,This,0,0
92309,research,0,0
92310,explored,0,0
92311,the,0,0
92312,acceptability,1,1
92313,of,0,0
92314,asking,0,0
92315,symptom,0,1
92316,and,0,0
92317,quality-of-life,0,1
92318,questions,0,0
92319,using,0,0
92320,the,0,0
92321,Electronic,0,0
92322,Self,0,1
92323,Report,0,0
92324,Assessment-Cancer,0,1
92325,program,0,0
92326,on,0,0
92327,wireless,0,0
92328,laptops,0,0
92329,equipped,0,0
92330,with,0,0
92331,touch-screen,0,0
92332,format,0,0
92333,.,0,0
92334,Acceptability,1,1
92335,data,1,0
92336,were,0,0
92337,explored,0,0
92338,with,0,0
92339,respect,0,0
92340,to,0,0
92341,whether,0,0
92342,any,0,0
92343,differences,0,0
92344,may,0,0
92345,be,0,0
92346,attributed,0,0
92347,to,0,0
92348,demographics,0,1
92349,and,0,1
92350,symptom,0,1
92351,and,0,1
92352,quality-of-life,1,1
92353,levels,1,1
92354,",",0,0
92355,such,0,0
92356,as,0,0
92357,depression,1,1
92358,and,1,1
92359,cognitive,1,1
92360,and,1,1
92361,emotional,1,1
92362,functioning,1,1
92363,.,1,0
92364,This,0,0
92365,evaluation,0,0
92366,used,0,0
92367,descriptive,0,0
92368,and,0,0
92369,univariate,0,0
92370,statistics,0,0
92371,to,0,0
92372,examine,0,0
92373,data,0,0
92374,from,0,0
92375,342,0,0
92376,participants,0,0
92377,from,0,0
92378,the,0,0
92379,ongoing,0,0
92380,ESRA-C,0,0
92381,randomized,0,0
92382,clinical,0,0
92383,trial,0,0
92384,.,0,0
92385,Research,0,0
92386,participants,0,0
92387,for,0,0
92388,the,0,0
92389,ESRA-C,0,0
92390,study,0,0
92391,were,0,0
92392,recruited,0,0
92393,from,0,0
92394,the,0,0
92395,Seattle,0,0
92396,Cancer,0,0
92397,Care,0,0
92398,Alliance,0,0
92399,",",0,0
92400,a,0,0
92401,consortium,0,0
92402,among,0,0
92403,the,0,0
92404,University,0,0
92405,of,0,0
92406,Washington,0,0
92407,Medical,0,0
92408,Center,0,0
92409,",",0,0
92410,Fred,0,1
92411,Hutchinson,0,0
92412,Cancer,0,0
92413,Research,0,0
92414,Center,0,0
92415,",",0,0
92416,and,0,1
92417,Children,0,1
92418,'s,0,1
92419,Hospital,0,1
92420,and,0,0
92421,Regional,0,1
92422,Medical,0,0
92423,Center,0,0
92424,in,0,0
92425,Seattle,0,1
92426,",",0,0
92427,WA,0,0
92428,.,0,0
92429,The,0,0
92430,sample,0,0
92431,consisted,0,0
92432,of,0,0
92433,342,0,0
92434,adult,0,0
92435,participants,0,0
92436,who,0,0
92437,completed,0,0
92438,both,0,0
92439,baseline,0,0
92440,and,0,0
92441,follow-up,0,1
92442,survey,0,0
92443,sessions,0,0
92444,.,0,0
92445,Medical,0,0
92446,oncology,0,0
92447,represented,0,0
92448,the,0,0
92449,largest,0,0
92450,recruitment,0,0
92451,group,0,0
92452,(,0,0
92453,45.3,0,0
92454,%,0,0
92455,),0,0
92456,",",0,0
92457,followed,0,0
92458,by,0,0
92459,stem,0,0
92460,cell,0,1
92461,transplant,0,0
92462,(,0,0
92463,34.5,0,0
92464,%,0,0
92465,),0,0
92466,and,0,0
92467,radiation,0,1
92468,oncology,0,0
92469,(,0,0
92470,20.2,0,0
92471,%,0,0
92472,),0,0
92473,.,0,0
92474,The,0,0
92475,primary,0,0
92476,finding,0,0
92477,was,0,0
92478,that,0,0
92479,patients,0,0
92480,were,0,0
92481,generally,0,0
92482,able,1,0
92483,to,1,0
92484,use,1,0
92485,ESRA-C,1,0
92486,quickly,1,0
92487,and,0,0
92488,without,0,0
92489,difficulty,0,1
92490,in,0,0
92491,a,0,0
92492,real-world,0,0
92493,clinical,0,0
92494,setting,0,0
92495,and,0,0
92496,that,0,0
92497,they,0,0
92498,were,0,0
92499,overall,0,1
92500,quite,0,0
92501,satisfied,1,0
92502,with,1,0
92503,the,1,0
92504,ESRA-C,1,0
92505,program,1,0
92506,.,1,0
92507,Significant,0,0
92508,differences,0,0
92509,were,0,0
92510,found,0,0
92511,in,0,0
92512,several,0,0
92513,acceptability,1,1
92514,areas,1,1
92515,with,0,0
92516,respect,0,0
92517,to,0,0
92518,demographics,0,1
92519,and,0,0
92520,quality,0,1
92521,of,0,1
92522,life,0,1
92523,measures,0,1
92524,such,0,0
92525,as,0,0
92526,age,0,0
92527,",",0,0
92528,sex,0,0
92529,",",0,1
92530,and,0,1
92531,severe,0,1
92532,distress,0,1
92533,.,0,0
92534,This,0,0
92535,analysis,0,0
92536,confirms,0,0
92537,that,0,0
92538,the,0,0
92539,ESRA-C,0,0
92540,application,0,0
92541,for,0,0
92542,collecting,0,1
92543,symptom,0,1
92544,and,0,1
92545,quality,0,1
92546,of,0,1
92547,life,0,1
92548,information,0,0
92549,is,0,0
92550,easy,0,0
92551,for,0,0
92552,patients,0,0
92553,to,0,0
92554,use,0,0
92555,and,0,0
92556,acceptable,0,0
92557,across,0,0
92558,a,0,0
92559,range,0,0
92560,of,0,0
92561,user,0,0
92562,characteristics,0,0
92563,.,0,0
92564,We,0,0
92565,intend,0,0
92566,to,0,0
92567,build,0,0
92568,on,0,0
92569,our,0,0
92570,work,0,0
92571,by,0,0
92572,using,0,0
92573,the,0,0
92574,survey,0,0
92575,platform,0,0
92576,in,0,0
92577,other,0,0
92578,modalities,0,0
92579,while,0,0
92580,ensuring,0,0
92581,that,0,0
92582,the,0,0
92583,patient,0,1
92584,'s,0,0
92585,preferences,0,0
92586,are,0,0
92587,considered,0,0
92588,at,0,0
92589,all,0,0
92590,times,0,0
92591,.,0,0
92592,Pre-operative,0,0
92593,radiochemotherapy,0,0
92594,for,0,0
92595,rectal,0,1
92596,cancer,0,0
92597,.,0,0
92598,A,0,0
92599,prospective,0,0
92600,randomized,0,0
92601,trial,0,0
92602,comparing,0,0
92603,pre-operative,0,0
92604,vs.,0,0
92605,postoperative,0,1
92606,radiochemotherapy,0,0
92607,in,0,0
92608,rectal,0,1
92609,cancer,0,0
92610,patients,0,0
92611,.,0,0
92612,PURPOSE,0,0
92613,The,0,0
92614,aim,0,0
92615,of,0,0
92616,the,0,0
92617,study,0,0
92618,was,0,0
92619,to,0,0
92620,find,0,0
92621,out,0,0
92622,whether,0,0
92623,pre-operative,0,1
92624,radiochemotherapy,0,0
92625,had,0,0
92626,any,0,0
92627,survival,1,1
92628,advantage,1,0
92629,over,0,0
92630,postoperative,0,1
92631,radiochemotherapy,0,0
92632,for,0,0
92633,rectal,0,1
92634,carcinoma,0,0
92635,patients,0,0
92636,without,0,0
92637,distant,0,1
92638,metastasis,0,1
92639,or,0,0
92640,peritoneal,0,0
92641,carcinomatosis,0,0
92642,.,0,0
92643,MATERIAL,0,0
92644,AND,0,0
92645,METHODS,0,0
92646,Between,0,0
92647,January,0,0
92648,1998,0,0
92649,and,0,0
92650,December,0,0
92651,2003,0,0
92652,",",0,0
92653,51,0,0
92654,rectal,0,0
92655,carcinoma,0,0
92656,patients,0,0
92657,without,0,0
92658,distant,0,1
92659,metastasis,0,1
92660,or,0,0
92661,peritoneal,0,1
92662,carcinomatosis,0,0
92663,were,0,0
92664,randomly,0,0
92665,divided,0,0
92666,into,0,0
92667,pre-operative,0,0
92668,(,0,0
92669,PRE,0,0
92670,),0,0
92671,and,0,0
92672,postoperative,0,1
92673,(,0,0
92674,POST,0,0
92675,),0,0
92676,radiochemotherapy,0,0
92677,groups,0,0
92678,.,0,0
92679,Twenty-six,0,0
92680,were,0,0
92681,assigned,0,0
92682,to,0,0
92683,the,0,0
92684,PRE,0,0
92685,group,0,0
92686,and,0,1
92687,were,0,0
92688,operated,0,0
92689,on,0,0
92690,5,0,0
92691,to,0,0
92692,8,0,0
92693,weeks,0,0
92694,after,0,0
92695,the,0,0
92696,completion,0,0
92697,of,0,0
92698,radiotherapy,0,0
92699,.,0,0
92700,The,0,0
92701,other,0,0
92702,25,0,0
92703,patients,0,0
92704,were,0,0
92705,operated,0,0
92706,on,0,0
92707,immediately,0,0
92708,and,0,0
92709,received,0,0
92710,radiotherapy,0,0
92711,postoperatively,0,0
92712,2,0,0
92713,to,0,0
92714,4,0,0
92715,weeks,0,0
92716,after,0,0
92717,surgery,0,0
92718,.,0,0
92719,The,0,0
92720,patients,0,0
92721,were,0,0
92722,followed,0,0
92723,up,0,0
92724,for,0,0
92725,between,0,0
92726,4,0,0
92727,to,0,0
92728,51,0,0
92729,months,0,0
92730,.,0,0
92731,RESULTS,0,0
92732,In,0,0
92733,the,0,0
92734,PRE,0,0
92735,group,0,0
92736,the,0,0
92737,rates,1,1
92738,of,1,0
92739,disease-free,1,1
92740,survival,1,1
92741,were,0,0
92742,92,0,0
92743,%,0,0
92744,",",0,0
92745,70,0,0
92746,%,0,0
92747,",",0,0
92748,56,0,0
92749,%,0,0
92750,and,0,0
92751,56,0,0
92752,%,0,0
92753,at,0,0
92754,the,0,0
92755,end,0,0
92756,of,0,0
92757,the,0,0
92758,1st,0,0
92759,",",0,0
92760,2nd,0,0
92761,",",0,0
92762,3rd,0,0
92763,and,0,0
92764,4th,0,0
92765,years,0,0
92766,",",0,0
92767,respectively,0,0
92768,.,0,0
92769,In,0,0
92770,the,0,0
92771,POST,0,0
92772,group,0,0
92773,those,0,0
92774,percentages,0,0
92775,were,0,0
92776,83,0,0
92777,%,0,0
92778,",",0,0
92779,68,0,0
92780,%,0,0
92781,",",0,0
92782,51,0,0
92783,%,0,0
92784,and,0,0
92785,51,0,0
92786,%,0,0
92787,at,0,0
92788,the,0,0
92789,1st,0,0
92790,",",0,0
92791,2nd,0,0
92792,",",0,0
92793,3rd,0,0
92794,and,0,0
92795,4th,0,0
92796,years,0,0
92797,",",0,0
92798,respectively,0,0
92799,(,0,0
92800,p,0,0
92801,=,0,0
92802,0.707,0,0
92803,),0,0
92804,.,0,0
92805,One-year,1,0
92806,and,1,0
92807,4-year,1,0
92808,overall,1,1
92809,survival,1,1
92810,rates,1,1
92811,in,0,0
92812,the,0,0
92813,PRE,0,0
92814,group,0,0
92815,were,0,0
92816,100,0,0
92817,%,0,0
92818,and,0,0
92819,86,0,0
92820,%,0,0
92821,respectively,0,0
92822,and,0,0
92823,100,0,0
92824,%,0,0
92825,and,0,0
92826,60,0,0
92827,%,0,0
92828,in,0,0
92829,the,0,0
92830,POST,0,0
92831,group,0,0
92832,(,0,0
92833,p,0,0
92834,=,0,0
92835,0.520,0,0
92836,),0,0
92837,.,0,0
92838,CONCLUSION,0,0
92839,No,0,0
92840,statistical,0,1
92841,difference,0,0
92842,was,0,0
92843,found,0,0
92844,between,0,0
92845,the,0,0
92846,survival,1,1
92847,rates,1,1
92848,of,0,0
92849,the,0,0
92850,rectal,0,1
92851,carcinoma,0,0
92852,patients,0,0
92853,receiving,0,0
92854,radiotherapy,0,0
92855,either,0,0
92856,pre-operatively,0,0
92857,or,0,0
92858,postoperatively,0,0
92859,.,0,0
92860,However,0,0
92861,",",0,0
92862,the,0,0
92863,disease-free,1,1
92864,survival,1,1
92865,rates,1,1
92866,of,0,0
92867,the,0,0
92868,PRE,0,0
92869,group,0,0
92870,were,0,0
92871,higher,0,0
92872,than,0,0
92873,the,0,0
92874,POST,0,0
92875,group,0,0
92876,'s,0,0
92877,during,0,0
92878,each,0,0
92879,year,0,0
92880,and,0,0
92881,overall,1,1
92882,survival,1,1
92883,rates,1,1
92884,were,0,0
92885,higher,0,0
92886,after,0,0
92887,the,0,0
92888,third,0,0
92889,and,0,0
92890,fourth,0,0
92891,years,0,0
92892,.,0,0
92893,We,0,0
92894,conclude,0,0
92895,that,0,0
92896,pre-operative,0,0
92897,radiotherapy,0,0
92898,is,0,0
92899,at,1,0
92900,least,1,0
92901,as,1,0
92902,effective,1,0
92903,as,1,0
92904,postoperative,0,1
92905,radiotherapy,0,0
92906,.,0,0
92907,Maintenance,0,0
92908,of,0,0
92909,response,0,1
92910,following,0,0
92911,stabilization,0,0
92912,of,0,0
92913,mixed,0,0
92914,index,0,1
92915,episodes,0,1
92916,with,0,0
92917,olanzapine,0,0
92918,monotherapy,0,0
92919,in,0,0
92920,a,0,0
92921,randomized,0,0
92922,",",0,0
92923,double-blind,0,0
92924,",",0,0
92925,placebo-controlled,0,0
92926,study,0,0
92927,of,0,0
92928,bipolar,0,0
92929,1,0,0
92930,disorder,0,0
92931,.,0,0
92932,BACKGROUND,0,0
92933,In,0,0
92934,a,0,0
92935,population,0,0
92936,of,0,0
92937,patients,0,0
92938,with,0,0
92939,manic,0,0
92940,and,0,0
92941,mixed,0,0
92942,mood,0,1
92943,episodes,0,1
92944,",",0,0
92945,olanzapine,0,0
92946,has,0,0
92947,proven,0,0
92948,effective,0,0
92949,in,0,0
92950,maintaining,0,0
92951,response,0,1
92952,",",0,0
92953,as,0,0
92954,compared,0,0
92955,to,0,0
92956,placebo,0,0
92957,.,0,0
92958,Whether,0,0
92959,this,0,0
92960,is,0,0
92961,true,0,0
92962,for,0,0
92963,the,0,0
92964,subpopulation,0,0
92965,of,0,0
92966,patients,0,0
92967,with,0,0
92968,a,0,0
92969,mixed,0,0
92970,index,0,1
92971,episode,0,0
92972,is,0,0
92973,not,0,0
92974,known,0,0
92975,.,0,0
92976,METHODS,0,0
92977,Post-hoc,0,0
92978,analyses,0,0
92979,were,0,0
92980,conducted,0,0
92981,on,0,0
92982,data,0,0
92983,from,0,0
92984,patients,0,0
92985,presenting,0,0
92986,with,0,0
92987,a,0,0
92988,mixed,0,0
92989,index,0,1
92990,episode,0,1
92991,who,0,0
92992,were,0,0
92993,enrolled,0,0
92994,in,0,0
92995,a,0,0
92996,larger,0,0
92997,double-blind,0,0
92998,",",0,1
92999,placebo-controlled,0,0
93000,trial,0,0
93001,.,0,0
93002,Patients,0,0
93003,who,0,0
93004,met,0,0
93005,remission,0,1
93006,criteria,0,0
93007,at,0,0
93008,2,0,0
93009,consecutive,0,0
93010,weekly,0,0
93011,visits,0,0
93012,during,0,0
93013,6,0,0
93014,to,0,0
93015,12,0,0
93016,weeks,0,0
93017,of,0,0
93018,open-label,0,0
93019,olanzapine,0,0
93020,treatment,0,0
93021,were,0,0
93022,randomly,0,0
93023,assigned,0,0
93024,to,0,0
93025,olanzapine,0,0
93026,or,0,0
93027,placebo,0,0
93028,treatment,0,0
93029,for,0,0
93030,48,0,0
93031,weeks,0,0
93032,.,0,0
93033,The,0,0
93034,incidence,0,1
93035,of,0,0
93036,and,0,0
93037,time,0,1
93038,to,0,0
93039,symptomatic,1,1
93040,relapse,1,1
93041,were,0,0
93042,calculated,0,0
93043,for,0,0
93044,any,0,0
93045,mood,0,1
93046,episode,0,1
93047,",",0,0
93048,and,0,1
93049,for,0,0
93050,depressive,0,1
93051,",",0,0
93052,manic,0,1
93053,",",0,0
93054,hypo-manic,0,1
93055,",",0,0
93056,and,0,1
93057,mixed,0,0
93058,mood,0,1
93059,episodes,0,1
93060,.,0,0
93061,RESULTS,0,0
93062,A,0,0
93063,total,0,0
93064,of,0,0
93065,121,0,0
93066,of,0,0
93067,304,0,0
93068,patients,0,0
93069,(,0,0
93070,39.8,0,0
93071,%,0,0
93072,),0,0
93073,met,0,0
93074,criteria,0,0
93075,for,0,0
93076,symptomatic,1,0
93077,remission,1,1
93078,in,0,0
93079,the,0,0
93080,open-label,0,0
93081,treatment,0,0
93082,phase,0,0
93083,and,0,1
93084,were,0,0
93085,randomly,0,0
93086,assigned,0,0
93087,to,0,0
93088,olanzapine,0,0
93089,(,0,0
93090,n=76,0,0
93091,),0,1
93092,or,0,0
93093,placebo,0,0
93094,(,0,1
93095,n=45,0,0
93096,),0,0
93097,.,0,0
93098,Compared,0,0
93099,to,0,0
93100,the,0,0
93101,placebo,0,0
93102,group,0,0
93103,",",0,0
93104,the,0,0
93105,olanzapine,0,0
93106,group,0,0
93107,had,0,0
93108,a,0,0
93109,lower,0,0
93110,incidence,0,1
93111,of,0,0
93112,(,0,0
93113,59.2,0,0
93114,%,0,0
93115,versus,0,0
93116,91.1,0,0
93117,%,0,0
93118,",",0,0
93119,p,0,0
93120,<,0,0
93121,0.001,0,0
93122,),0,0
93123,and,0,0
93124,a,0,0
93125,longer,0,0
93126,time,0,1
93127,to,0,0
93128,(,0,0
93129,46,0,0
93130,versus,0,0
93131,15,0,0
93132,days,0,0
93133,",",0,0
93134,p,0,0
93135,<,0,0
93136,0.001,0,0
93137,),0,0
93138,symptomatic,1,0
93139,relapse,1,1
93140,of,0,0
93141,any,0,0
93142,kind,0,0
93143,.,0,0
93144,Olanzapine-treated,0,0
93145,patients,0,0
93146,also,0,0
93147,experienced,0,0
93148,longer,0,0
93149,time,1,1
93150,to,1,0
93151,depressive,1,1
93152,symptomatic,1,1
93153,relapse,1,1
93154,(,0,0
93155,85,0,0
93156,versus,0,0
93157,22,0,0
93158,days,0,0
93159,",",0,0
93160,p=0.001,0,1
93161,),0,1
93162,and,0,0
93163,manic,1,1
93164,symptomatic,1,1
93165,relapse,1,1
93166,(,0,0
93167,too,0,0
93168,few,0,0
93169,relapses,0,1
93170,to,0,0
93171,calculate,0,0
93172,versus,0,0
93173,42,0,0
93174,days,0,0
93175,",",0,0
93176,p,0,0
93177,<,0,0
93178,0.001,0,0
93179,),0,0
93180,than,0,0
93181,did,0,0
93182,placebo-treated,0,0
93183,patients,0,0
93184,.,0,0
93185,CONCLUSIONS,0,0
93186,Compared,0,0
93187,with,0,0
93188,placebo,0,0
93189,",",0,0
93190,olanzapine,0,0
93191,treatment,0,0
93192,was,0,0
93193,associated,0,0
93194,with,0,0
93195,longer,0,0
93196,maintenance,1,0
93197,of,1,1
93198,response,1,1
93199,in,0,0
93200,patients,0,0
93201,presenting,0,0
93202,with,0,0
93203,a,0,0
93204,mixed,0,0
93205,index,0,1
93206,episode,0,1
93207,of,0,0
93208,bipolar,0,0
93209,I,0,0
93210,disorder,0,0
93211,.,0,0
93212,Three-year,0,0
93213,clinical,0,0
93214,outcome,0,0
93215,after,0,0
93216,primary,0,0
93217,stenting,0,0
93218,of,0,0
93219,totally,0,0
93220,occluded,0,0
93221,native,0,0
93222,coronary,0,0
93223,arteries,0,0
93224,:,0,0
93225,a,0,0
93226,randomized,0,0
93227,comparison,0,0
93228,of,0,0
93229,bare-metal,0,0
93230,stent,0,0
93231,implantation,0,0
93232,with,0,0
93233,sirolimus-eluting,0,0
93234,stent,0,0
93235,implantation,0,0
93236,for,0,0
93237,the,0,0
93238,treatment,0,0
93239,of,0,0
93240,total,0,1
93241,coronary,0,0
93242,occlusions,0,1
93243,(,0,0
93244,Primary,0,0
93245,Stenting,0,0
93246,of,0,0
93247,Totally,0,0
93248,Occluded,0,0
93249,Native,0,1
93250,Coronary,0,0
93251,Arteries,0,0
93252,[,0,0
93253,PRISON,0,1
93254,],0,0
93255,II,0,0
93256,study,0,0
93257,),0,0
93258,.,0,0
93259,BACKGROUND,0,0
93260,The,0,0
93261,purpose,0,0
93262,of,0,0
93263,this,0,0
93264,study,0,0
93265,was,0,0
93266,to,0,0
93267,examine,0,0
93268,the,0,0
93269,3-year,0,0
93270,clinical,0,0
93271,outcome,0,1
93272,in,0,0
93273,patients,0,0
93274,enrolled,0,0
93275,in,0,0
93276,the,0,0
93277,Primary,0,0
93278,Stenting,0,0
93279,of,0,0
93280,Totally,0,0
93281,Occluded,0,0
93282,Native,0,1
93283,Coronary,0,0
93284,Arteries,0,0
93285,II,0,0
93286,study,0,0
93287,.,0,0
93288,METHODS,0,0
93289,Patients,0,0
93290,with,0,0
93291,totally,0,0
93292,occluded,0,0
93293,coronary,0,0
93294,arteries,0,0
93295,randomized,0,0
93296,to,0,0
93297,either,0,0
93298,sirolimus-eluting,0,0
93299,Cypher,0,0
93300,stents,0,0
93301,(,0,0
93302,SESs,0,0
93303,),0,0
93304,(,0,0
93305,Cordis,0,0
93306,",",0,0
93307,a,0,0
93308,Johnson,0,0
93309,&,0,0
93310,Joshson,0,1
93311,Company,0,0
93312,",",0,0
93313,Miami,0,0
93314,Lakes,0,1
93315,",",0,0
93316,FL,0,1
93317,),0,0
93318,(,0,0
93319,100,0,0
93320,patients,0,0
93321,),0,0
93322,or,0,0
93323,bare-metal,0,0
93324,BxVelocity,0,1
93325,stents,0,0
93326,(,0,0
93327,BMSs,0,0
93328,),0,0
93329,(,0,0
93330,Cordis,0,0
93331,),0,0
93332,(,0,0
93333,100,0,0
93334,patients,0,0
93335,),0,0
93336,were,0,0
93337,followed,0,0
93338,clinically,0,0
93339,for,0,0
93340,3,0,0
93341,years,0,0
93342,.,0,0
93343,RESULTS,0,0
93344,Between,0,0
93345,1,0,0
93346,and,0,0
93347,3,0,0
93348,years,0,0
93349,",",0,0
93350,there,0,0
93351,were,0,0
93352,infrequent,0,0
93353,additional,0,0
93354,clinical,0,0
93355,events,0,1
93356,that,0,0
93357,were,0,0
93358,equally,0,0
93359,distributed,0,0
93360,between,0,0
93361,the,0,0
93362,SES,0,0
93363,and,0,0
93364,the,0,0
93365,BMS,0,0
93366,group,0,0
93367,.,0,0
93368,After,0,0
93369,3,0,0
93370,years,0,0
93371,",",0,0
93372,target,1,1
93373,lesion,1,1
93374,revascularization,1,1
93375,was,0,0
93376,7,0,0
93377,%,0,0
93378,in,0,0
93379,the,0,0
93380,SES,0,0
93381,group,0,0
93382,versus,0,0
93383,27,0,0
93384,%,0,0
93385,in,0,0
93386,the,0,0
93387,BMS,0,1
93388,group,0,0
93389,(,0,0
93390,P,0,0
93391,<,0,0
93392,.001,0,0
93393,),0,0
93394,;,0,0
93395,and,0,0
93396,target,0,0
93397,vessel,1,1
93398,revascularization,1,1
93399,was,0,0
93400,seen,0,0
93401,in,0,0
93402,11,0,0
93403,%,0,0
93404,in,0,0
93405,the,0,0
93406,SES,0,0
93407,group,0,0
93408,versus,0,0
93409,30,0,0
93410,%,0,0
93411,in,0,0
93412,the,0,0
93413,BMS,0,1
93414,group,0,0
93415,(,0,0
93416,P,0,0
93417,=,0,0
93418,.002,0,0
93419,),0,0
93420,.,0,0
93421,Major,1,0
93422,adverse,1,1
93423,cardiac,1,1
93424,events,1,1
93425,were,0,0
93426,noted,0,0
93427,in,0,0
93428,10,0,0
93429,%,0,0
93430,of,0,0
93431,the,0,0
93432,SES,0,0
93433,group,0,0
93434,versus,0,0
93435,34,0,0
93436,%,0,0
93437,in,0,0
93438,the,0,0
93439,BMS,0,1
93440,group,0,0
93441,(,0,0
93442,P,0,0
93443,<,0,0
93444,.001,0,0
93445,),0,0
93446,.,0,0
93447,There,0,0
93448,were,0,0
93449,no,0,0
93450,statistically,0,0
93451,significant,0,0
93452,differences,0,0
93453,in,0,0
93454,death,1,1
93455,",",1,0
93456,myocardial,1,1
93457,infarction,1,1
93458,",",1,0
93459,and,1,1
93460,stent,1,1
93461,thrombosis,1,1
93462,according,0,0
93463,to,0,0
93464,the,0,0
93465,Academic,0,0
93466,Research,0,0
93467,Consortium,0,0
93468,criteria,0,0
93469,between,0,0
93470,the,0,0
93471,2,0,0
93472,groups,0,0
93473,.,0,0
93474,CONCLUSIONS,0,0
93475,Clinical,0,1
93476,outcome,0,0
93477,up,0,0
93478,to,0,0
93479,3,0,0
93480,years,0,0
93481,after,0,0
93482,implantation,0,0
93483,of,0,0
93484,SESs,0,0
93485,for,0,0
93486,total,0,1
93487,coronary,0,0
93488,occlusions,0,0
93489,continues,0,0
93490,to,0,0
93491,demonstrate,0,0
93492,a,0,0
93493,significant,0,0
93494,reduction,0,1
93495,in,0,0
93496,adverse,0,1
93497,clinical,0,0
93498,events,0,1
93499,compared,0,0
93500,with,0,0
93501,BMSs,0,0
93502,without,0,0
93503,the,0,0
93504,evidence,0,0
93505,for,0,0
93506,either,0,0
93507,disproportionate,0,0
93508,late,0,1
93509,restenosis,0,1
93510,or,0,0
93511,late,0,1
93512,stent,0,0
93513,thrombosis,0,0
93514,.,0,0
93515,Recombinant,0,0
93516,human,0,0
93517,granulocyte-macrophage,0,1
93518,colony,0,1
93519,stimulating,0,1
93520,factor,0,1
93521,(,0,0
93522,rhGM-CSF,0,0
93523,),0,0
93524,reduces,0,0
93525,infection-related,1,1
93526,mortality,1,1
93527,after,0,0
93528,allogeneic,0,0
93529,T-cell,0,1
93530,depleted,0,0
93531,BMT,0,0
93532,.,0,0
93533,Validation,0,0
93534,of,0,0
93535,an,0,0
93536,FFQ,0,0
93537,for,0,0
93538,evaluation,0,0
93539,of,0,0
93540,EPA,1,1
93541,and,1,0
93542,DHA,1,0
93543,intake,1,1
93544,.,1,0
93545,OBJECTIVE,0,0
93546,To,0,0
93547,validate,0,0
93548,an,0,0
93549,FFQ,0,0
93550,for,0,0
93551,the,0,0
93552,assessment,0,0
93553,of,0,0
93554,dietary,0,0
93555,EPA,1,1
93556,and,1,0
93557,DHA,1,1
93558,against,0,0
93559,their,0,0
93560,relative,1,0
93561,concentrations,1,1
93562,in,1,0
93563,red,1,1
93564,blood,1,1
93565,cells,1,1
93566,(,1,0
93567,RBC,1,0
93568,),1,0
93569,.,1,0
93570,DESIGN,0,0
93571,Cross-sectional,0,1
93572,analysis,0,0
93573,of,0,0
93574,baseline,0,0
93575,data,0,0
93576,.,0,0
93577,Intakes,0,1
93578,of,0,0
93579,marine,0,0
93580,food,0,0
93581,products,0,1
93582,and,0,1
93583,EPA,0,1
93584,and,0,1
93585,DHA,0,1
93586,were,0,0
93587,estimated,0,0
93588,by,0,0
93589,FFQ,0,0
93590,on,0,0
93591,the,0,0
93592,basis,0,0
93593,of,0,0
93594,consumption,0,1
93595,of,0,0
93596,marine,0,0
93597,food,0,0
93598,products,0,0
93599,in,0,0
93600,the,0,0
93601,last,0,0
93602,month,0,0
93603,.,0,0
93604,Fatty,0,0
93605,acid,0,0
93606,composition,0,0
93607,of,0,0
93608,RBC,0,1
93609,membranes,0,1
93610,was,0,0
93611,quantified,0,0
93612,by,0,0
93613,GC,0,0
93614,.,0,0
93615,SETTING,0,0
93616,Saint-Fran?ois,0,0
93617,d'Assise,0,0
93618,Hospital,0,1
93619,",",0,0
93620,Qu?bec,0,1
93621,",",0,0
93622,Canada,0,0
93623,.,0,0
93624,SUBJECTS,0,0
93625,A,0,0
93626,total,0,1
93627,of,0,0
93628,sixty-five,0,0
93629,middle-aged,0,0
93630,women,0,0
93631,who,0,0
93632,participated,0,0
93633,in,0,0
93634,a,0,0
93635,randomized,0,0
93636,clinical,0,0
93637,trial,0,0
93638,.,0,0
93639,RESULTS,0,0
93640,Spearman,0,1
93641,'s,0,1
93642,correlation,0,0
93643,coefficient,0,1
93644,between,1,0
93645,intake,1,1
93646,of,1,0
93647,EPA,1,1
93648,",",1,0
93649,DHA,1,1
93650,and,1,1
93651,EPA,1,1
93652,+,1,0
93653,DHA,1,1
93654,and,1,0
93655,their,0,0
93656,corresponding,1,0
93657,concentration,1,1
93658,in,1,0
93659,RBC,1,0
93660,was,1,0
93661,0.46,0,0
93662,",",0,0
93663,0.40,0,0
93664,and,0,0
93665,0.42,0,0
93666,",",0,0
93667,respectively,0,0
93668,(,0,0
93669,all,0,0
93670,P,0,0
93671,<,0,0
93672,0.05,0,0
93673,),0,0
93674,.,0,0
93675,Multiple,0,0
93676,regression,0,0
93677,analysis,0,0
93678,of,0,0
93679,EPA+DHA,1,1
93680,intake,1,1
93681,and,1,0
93682,RBC,1,1
93683,EPA,1,1
93684,+,1,0
93685,DHA,1,1
93686,concentration,1,1
93687,indicated,1,0
93688,positive,0,1
93689,and,0,0
93690,significant,0,0
93691,correlations,0,0
93692,for,0,0
93693,oily,0,0
93694,fish,0,0
93695,(,0,0
93696,beta,0,0
93697,=,0,0
93698,0.44,0,0
93699,",",0,0
93700,95,0,0
93701,%,0,0
93702,CI,0,0
93703,0.16,0,0
93704,",",0,0
93705,0.72,0,0
93706,",",0,0
93707,P,0,0
93708,=,0,0
93709,0.0027,0,0
93710,),0,0
93711,",",0,0
93712,total,0,1
93713,fish,0,0
93714,(,0,0
93715,beta,0,0
93716,=,0,0
93717,0.42,0,0
93718,",",0,0
93719,95,0,0
93720,%,0,0
93721,CI,0,0
93722,0.19,0,0
93723,",",0,0
93724,0.64,0,0
93725,",",0,0
93726,P,0,0
93727,=,0,0
93728,0.0005,0,0
93729,),0,0
93730,and,0,0
93731,marine,0,0
93732,food,0,0
93733,products,0,1
93734,(,0,0
93735,beta,0,0
93736,=,0,0
93737,0.42,0,0
93738,",",0,0
93739,95,0,0
93740,%,0,0
93741,CI,0,0
93742,0.20,0,0
93743,",",0,0
93744,0.64,0,0
93745,",",0,0
93746,P,0,0
93747,=,0,0
93748,0.0003,0,0
93749,),0,0
93750,.,0,0
93751,No,0,0
93752,other,0,0
93753,marine,0,0
93754,food,0,0
93755,products,0,1
93756,significantly,0,0
93757,predicted,1,0
93758,RBC,1,1
93759,EPA,1,1
93760,+,1,0
93761,DHA,1,1
93762,concentration,1,1
93763,.,1,0
93764,CONCLUSIONS,0,0
93765,Although,0,0
93766,the,0,0
93767,present,0,0
93768,validation,0,0
93769,study,0,0
93770,was,0,0
93771,undertaken,0,0
93772,among,0,0
93773,middle-aged,0,0
93774,women,0,0
93775,with,0,0
93776,low,0,0
93777,consumption,0,1
93778,of,0,0
93779,marine,0,0
93780,food,0,0
93781,products,0,1
93782,(,0,0
93783,<,0,0
93784,3,0,0
93785,servings/week,0,0
93786,),0,0
93787,",",0,0
93788,our,0,0
93789,FFQ,0,0
93790,provided,0,0
93791,estimates,0,0
93792,of,0,0
93793,EPA,1,1
93794,and,1,0
93795,DHA,1,1
93796,intakes,1,1
93797,that,1,0
93798,correlated,0,0
93799,fairly,0,0
93800,well,0,0
93801,with,0,0
93802,their,1,0
93803,RBC,1,0
93804,concentrations,1,1
93805,.,1,0
93806,However,0,0
93807,",",0,0
93808,the,0,0
93809,absence,0,0
93810,of,0,0
93811,correlations,0,0
93812,between,1,0
93813,EPA,1,1
93814,+,1,0
93815,DHA,1,1
93816,intakes,1,1
93817,from,1,0
93818,different,0,0
93819,marine,0,0
93820,species,0,0
93821,suggests,0,0
93822,that,0,0
93823,a,0,0
93824,minimum,0,1
93825,EPA,0,1
93826,+,0,0
93827,DHA,0,0
93828,intake,0,1
93829,is,0,0
93830,necessary,0,0
93831,to,0,0
93832,observe,0,0
93833,a,0,0
93834,relationship,0,0
93835,with,1,0
93836,RBC,1,1
93837,EPA,1,1
93838,+,1,0
93839,DHA,1,0
93840,concentrations,1,1
93841,.,1,0
93842,Two,0,0
93843,different,0,0
93844,methods,0,0
93845,for,0,0
93846,donor,0,0
93847,hepatic,0,0
93848,transection,0,0
93849,:,0,0
93850,cavitron,0,0
93851,ultrasonic,0,0
93852,surgical,0,0
93853,aspirator,0,1
93854,with,0,0
93855,bipolar,0,0
93856,cautery,0,0
93857,versus,0,0
93858,cavitron,0,0
93859,ultrasonic,0,0
93860,surgical,0,0
93861,aspirator,0,1
93862,with,0,0
93863,radiofrequency,0,0
93864,coagulator-A,0,0
93865,randomized,0,0
93866,controlled,0,0
93867,trial,0,0
93868,.,0,0
93869,The,0,0
93870,aim,0,0
93871,of,0,0
93872,this,0,0
93873,study,0,0
93874,was,0,0
93875,to,0,0
93876,compare,0,0
93877,the,0,0
93878,Cavitron,0,0
93879,ultrasonic,0,0
93880,surgical,0,0
93881,aspirator,0,1
93882,(,0,0
93883,CUSA,0,0
93884,),0,0
93885,with,0,0
93886,bipolar,0,0
93887,cautery,0,0
93888,(,0,0
93889,BP,0,1
93890,),0,0
93891,to,0,0
93892,CUSA,0,0
93893,with,0,0
93894,a,0,0
93895,radiofrequency,0,0
93896,coagulator,0,0
93897,[,0,0
93898,TissueLink,0,0
93899,(,0,0
93900,TL,0,0
93901,),0,0
93902,],0,0
93903,in,0,0
93904,terms,0,0
93905,of,0,0
93906,efficacy,0,1
93907,and,0,1
93908,safety,0,1
93909,for,0,0
93910,hepatic,0,1
93911,transection,0,0
93912,in,0,0
93913,living,0,0
93914,donor,0,0
93915,liver,0,0
93916,transplantation,0,0
93917,.,0,0
93918,Twenty-four,0,0
93919,living,0,0
93920,liver,0,0
93921,donors,0,0
93922,(,0,0
93923,n,0,0
93924,=,0,0
93925,12,0,0
93926,for,0,0
93927,each,0,0
93928,group,0,0
93929,),0,0
93930,were,0,0
93931,randomized,0,0
93932,to,0,0
93933,undergo,0,0
93934,hepatic,0,0
93935,transection,0,0
93936,using,0,0
93937,CUSA,0,0
93938,with,0,0
93939,BP,0,1
93940,or,0,0
93941,CUSA,0,0
93942,with,0,0
93943,TL,0,0
93944,.,0,0
93945,Blood,1,1
93946,loss,1,1
93947,during,1,0
93948,parenchymal,1,1
93949,transection,1,0
93950,and,1,1
93951,speed,1,1
93952,of,1,1
93953,transection,1,0
93954,were,0,0
93955,the,0,0
93956,primary,0,0
93957,endpoints,0,1
93958,",",0,0
93959,whereas,0,0
93960,the,0,0
93961,degree,1,1
93962,of,1,0
93963,postoperative,1,1
93964,liver,1,0
93965,injury,1,1
93966,and,1,1
93967,morbidity,1,1
93968,were,0,0
93969,secondary,0,0
93970,endpoints,0,1
93971,.,0,0
93972,Median,1,1
93973,blood,1,1
93974,loss,1,1
93975,during,1,0
93976,liver,1,0
93977,transection,1,0
93978,was,0,0
93979,significantly,0,0
93980,lower,0,0
93981,in,0,0
93982,the,0,0
93983,TL,0,0
93984,group,0,0
93985,than,0,0
93986,in,0,0
93987,the,0,0
93988,BP,0,1
93989,group,0,0
93990,(,0,0
93991,195.2,0,0
93992,+/-,0,0
93993,84.5,0,0
93994,versus,0,0
93995,343.3,0,0
93996,+/-,0,0
93997,198.4,0,0
93998,mL,0,0
93999,;,0,0
94000,P,0,0
94001,=,0,0
94002,0.023,0,0
94003,),0,0
94004,",",0,0
94005,and,0,1
94006,liver,1,1
94007,transection,1,0
94008,was,0,0
94009,significantly,0,0
94010,faster,0,0
94011,in,0,0
94012,the,0,0
94013,TL,0,0
94014,group,0,0
94015,than,0,0
94016,in,0,0
94017,the,0,0
94018,BP,0,1
94019,group,0,0
94020,(,0,0
94021,0.7,0,0
94022,+/-,0,0
94023,0.2,0,0
94024,versus,0,0
94025,0.5,0,0
94026,+/-,0,0
94027,0.2,0,0
94028,cm,0,0
94029,(,0,0
94030,2,0,0
94031,),0,0
94032,/minute,0,0
94033,;,0,0
94034,P,0,0
94035,=,0,0
94036,0.048,0,0
94037,),0,0
94038,.,0,0
94039,Significantly,0,0
94040,fewer,1,0
94041,ties,1,1
94042,were,0,0
94043,required,0,0
94044,during,0,0
94045,liver,0,0
94046,transection,0,0
94047,in,0,0
94048,the,0,0
94049,TL,0,0
94050,group,0,0
94051,than,0,0
94052,in,0,0
94053,the,0,0
94054,BP,0,1
94055,group,0,0
94056,(,0,0
94057,15.8,0,0
94058,+/-,0,0
94059,4.8,0,0
94060,versus,0,0
94061,22.8,0,0
94062,+/-,0,0
94063,7.9,0,0
94064,ties,0,0
94065,;,0,0
94066,P,0,0
94067,=,0,0
94068,0.023,0,0
94069,),0,0
94070,.,0,0
94071,The,0,0
94072,morbidity,1,1
94073,rates,1,1
94074,were,0,0
94075,similar,0,0
94076,for,0,0
94077,the,0,0
94078,2,0,0
94079,groups,0,0
94080,.,0,0
94081,In,0,0
94082,conclusion,0,0
94083,",",0,0
94084,CUSA,0,0
94085,with,0,0
94086,TL,0,0
94087,is,0,0
94088,superior,0,0
94089,to,0,0
94090,CUSA,0,0
94091,with,0,0
94092,BP,0,1
94093,for,0,0
94094,donor,0,0
94095,hepatectomy,0,0
94096,in,0,0
94097,terms,0,0
94098,of,0,0
94099,blood,1,1
94100,loss,1,1
94101,and,1,1
94102,speed,1,1
94103,of,1,1
94104,transection,1,0
94105,with,1,0
94106,no,1,0
94107,increase,1,0
94108,in,1,0
94109,morbidity,1,1
94110,.,1,0
94111,Effect,0,0
94112,of,0,0
94113,testosterone,0,1
94114,and,0,0
94115,a,0,0
94116,nutritional,0,1
94117,supplement,0,0
94118,",",0,0
94119,alone,0,0
94120,and,0,0
94121,in,0,0
94122,combination,0,0
94123,",",0,0
94124,on,0,0
94125,hospital,1,1
94126,admissions,1,1
94127,in,0,0
94128,undernourished,0,0
94129,older,0,0
94130,men,0,0
94131,and,0,1
94132,women,0,0
94133,.,0,0
94134,BACKGROUND,0,0
94135,In,0,0
94136,older,0,0
94137,people,0,0
94138,",",0,0
94139,undernutrition,0,0
94140,is,0,0
94141,associated,0,0
94142,with,0,0
94143,increased,0,0
94144,hospitalization,1,1
94145,rates,1,1
94146,and,1,0
94147,mortality,1,1
94148,.,1,0
94149,Because,0,0
94150,weight,0,1
94151,loss,0,1
94152,in,0,0
94153,older,0,0
94154,people,0,0
94155,often,0,0
94156,reflects,0,0
94157,a,0,0
94158,disproportionate,0,0
94159,reduction,0,1
94160,of,0,0
94161,skeletal,0,0
94162,muscle,0,0
94163,",",0,0
94164,anabolic,0,0
94165,treatments,0,0
94166,may,0,0
94167,be,0,0
94168,beneficial,0,0
94169,.,0,0
94170,OBJECTIVE,0,0
94171,Our,0,0
94172,aim,0,0
94173,was,0,0
94174,to,0,0
94175,evaluate,0,0
94176,the,0,0
94177,hypothesis,0,0
94178,that,0,0
94179,testosterone,0,1
94180,treatment,0,0
94181,and,0,0
94182,a,0,0
94183,nutritional,0,0
94184,supplement,0,0
94185,have,0,0
94186,additive,0,0
94187,benefits,0,0
94188,.,0,0
94189,DESIGN,0,0
94190,Oral,0,1
94191,testosterone,0,1
94192,undecanoate,0,0
94193,(,0,0
94194,40,0,0
94195,mg,0,0
94196,daily,0,0
94197,for,0,0
94198,women,0,0
94199,",",0,0
94200,80,0,0
94201,mg,0,0
94202,twice,0,0
94203,daily,0,0
94204,for,0,0
94205,men,0,0
94206,),0,0
94207,and,0,0
94208,an,0,0
94209,oral,0,0
94210,nutritional,0,1
94211,supplement,0,0
94212,(,0,0
94213,475,0,0
94214,kcal/d,0,0
94215,),0,0
94216,were,0,0
94217,administered,0,0
94218,",",0,0
94219,alone,0,0
94220,or,0,0
94221,combined,0,0
94222,",",0,0
94223,for,0,0
94224,1,0,0
94225,y,0,0
94226,to,0,0
94227,49,0,0
94228,community-dwelling,0,0
94229,",",0,0
94230,undernourished,0,0
94231,people,0,0
94232,[,0,0
94233,Mini,0,0
94234,Nutritional,0,1
94235,Assessment,0,0
94236,score,0,1
94237,<,0,0
94238,24,0,0
94239,and,0,0
94240,low,0,0
94241,body,0,1
94242,weight,0,1
94243,(,0,0
94244,body,0,1
94245,mass,0,1
94246,index,0,1
94247,",",0,0
94248,in,0,0
94249,kg/m,0,1
94250,(,0,0
94251,2,0,0
94252,),0,0
94253,:,0,0
94254,<,0,0
94255,22,0,0
94256,),0,0
94257,or,0,0
94258,recent,0,0
94259,weight,0,1
94260,loss,0,1
94261,(,0,0
94262,>,0,0
94263,7.5,0,0
94264,%,0,0
94265,over,0,0
94266,3,0,0
94267,mo,0,0
94268,),0,0
94269,],0,0
94270,aged,0,0
94271,>,0,0
94272,65,0,0
94273,y,0,0
94274,(,0,0
94275,mean,0,1
94276,age,0,0
94277,:,0,0
94278,77,0,0
94279,y,0,0
94280,;,0,0
94281,26,0,0
94282,women,0,0
94283,and,0,0
94284,23,0,0
94285,men,0,0
94286,),0,0
94287,.,0,0
94288,Hospital,1,1
94289,admissions,1,1
94290,and,0,0
94291,other,1,0
94292,variables,1,1
94293,were,0,0
94294,assessed,0,0
94295,.,0,0
94296,RESULTS,0,0
94297,In,0,0
94298,subjects,0,0
94299,receiving,0,0
94300,combined,0,0
94301,testosterone,0,1
94302,and,0,0
94303,nutritional,0,1
94304,supplements,0,0
94305,(,0,0
94306,n,0,0
94307,=,0,0
94308,11,0,0
94309,),0,0
94310,",",0,0
94311,there,0,0
94312,were,0,0
94313,no,0,0
94314,hospital,1,1
94315,admissions,1,1
94316,",",0,0
94317,whereas,0,0
94318,there,0,0
94319,were,0,0
94320,9,0,0
94321,admissions,0,0
94322,(,0,0
94323,2,0,0
94324,elective,0,0
94325,),0,0
94326,in,0,0
94327,13,0,0
94328,subjects,0,0
94329,in,0,0
94330,the,0,0
94331,no-treatment,0,0
94332,group,0,0
94333,",",0,0
94334,4,0,0
94335,in,0,0
94336,the,0,0
94337,testosterone-treated,0,0
94338,group,0,0
94339,(,0,0
94340,n,0,0
94341,=,0,0
94342,12,0,0
94343,),0,0
94344,",",0,0
94345,and,0,0
94346,5,0,0
94347,in,0,0
94348,the,0,0
94349,supplement-treated,0,0
94350,group,0,0
94351,(,0,0
94352,n,0,0
94353,=,0,0
94354,13,0,0
94355,),0,0
94356,;,0,0
94357,P,0,0
94358,=,0,0
94359,0.06,0,0
94360,with,0,0
94361,no-treatment,0,0
94362,compared,0,0
94363,with,0,0
94364,combined,0,0
94365,treatment,0,0
94366,.,0,0
94367,When,0,0
94368,compared,0,0
94369,with,0,0
94370,the,0,0
94371,no-treatment,0,0
94372,group,0,0
94373,",",0,0
94374,the,0,0
94375,combined-treatment,0,0
94376,group,0,0
94377,had,0,0
94378,significantly,0,0
94379,fewer,0,0
94380,subjects,1,0
94381,admitted,1,0
94382,to,1,0
94383,hospital,1,0
94384,(,0,0
94385,0,0,0
94386,compared,0,0
94387,with,0,0
94388,5,0,0
94389,",",0,0
94390,P,0,0
94391,=,0,0
94392,0.03,0,0
94393,),0,0
94394,",",0,0
94395,fewer,0,0
94396,days,1,0
94397,in,1,0
94398,hospital,1,1
94399,(,0,0
94400,0,0,0
94401,compared,0,0
94402,with,0,0
94403,74,0,0
94404,",",0,0
94405,P,0,0
94406,=,0,0
94407,0.041,0,0
94408,),0,0
94409,",",0,0
94410,and,0,0
94411,a,0,0
94412,longer,0,0
94413,time,0,1
94414,to,0,0
94415,hospital,0,1
94416,admission,0,1
94417,(,0,0
94418,P,0,0
94419,=,0,0
94420,0.017,0,0
94421,),0,0
94422,.,0,0
94423,CONCLUSIONS,0,0
94424,In,0,0
94425,undernourished,0,0
94426,older,0,0
94427,people,0,0
94428,",",0,1
94429,combined,0,0
94430,treatment,0,0
94431,with,0,0
94432,testosterone,0,1
94433,and,0,0
94434,nutritional,0,1
94435,supplementation,0,0
94436,reduced,0,0
94437,the,0,0
94438,number,0,1
94439,of,0,0
94440,people,0,0
94441,hospitalized,0,0
94442,and,0,0
94443,the,0,0
94444,duration,0,1
94445,of,0,0
94446,hospital,0,1
94447,admissions,0,1
94448,",",0,0
94449,which,0,0
94450,are,0,0
94451,important,0,0
94452,endpoints,0,1
94453,in,0,0
94454,this,0,0
94455,group,0,0
94456,.,0,0
94457,Larger,0,1
94458,",",0,0
94459,confirmatory,0,0
94460,studies,0,0
94461,are,0,0
94462,now,0,0
94463,needed,0,0
94464,.,0,0
94465,This,0,0
94466,trial,0,0
94467,was,0,0
94468,registered,0,0
94469,before,0,0
94470,commencement,0,0
94471,at,0,0
94472,clinical,0,0
94473,trials.gov,0,0
94474,as,0,0
94475,NCT00117000,0,0
94476,.,0,0
94477,Randomized,0,0
94478,prospective,0,0
94479,study,0,0
94480,to,0,0
94481,evaluate,0,0
94482,child,0,0
94483,abuse,1,1
94484,documentation,0,1
94485,in,0,0
94486,the,0,0
94487,emergency,0,0
94488,department,0,0
94489,.,0,0
94490,OBJECTIVES,0,0
94491,The,0,0
94492,objective,0,0
94493,was,0,0
94494,to,0,0
94495,determine,0,0
94496,whether,0,0
94497,an,0,0
94498,educational,0,0
94499,intervention,0,0
94500,for,0,0
94501,health,0,1
94502,care,0,0
94503,providers,0,0
94504,would,0,0
94505,result,0,0
94506,in,0,0
94507,improved,0,1
94508,documentation,1,1
94509,of,0,0
94510,cases,0,0
94511,of,0,0
94512,possible,0,0
94513,physical,0,1
94514,child,0,0
94515,abuse,0,0
94516,in,0,0
94517,children,0,0
94518,<,0,0
94519,36,0,0
94520,months,0,0
94521,old,0,0
94522,treated,0,0
94523,in,0,0
94524,the,0,0
94525,emergency,0,1
94526,department,0,0
94527,(,0,0
94528,ED,0,0
94529,),0,0
94530,setting,0,0
94531,.,0,0
94532,METHODS,0,0
94533,This,0,0
94534,study,0,0
94535,had,0,0
94536,a,0,0
94537,statewide,0,0
94538,group-randomized,0,0
94539,prospective,0,0
94540,trial,0,0
94541,design,0,0
94542,.,0,0
94543,Participating,0,0
94544,EDs,0,0
94545,were,0,0
94546,randomized,0,0
94547,to,0,0
94548,one,0,0
94549,of,0,0
94550,three,0,0
94551,intervention,0,0
94552,groups,0,0
94553,:,0,0
94554,no,0,0
94555,intervention,0,0
94556,",",0,0
94557,partial,0,1
94558,intervention,0,0
94559,",",0,0
94560,or,0,1
94561,full,0,0
94562,intervention,0,0
94563,.,0,0
94564,Medical,0,0
94565,records,0,0
94566,for,0,0
94567,children,0,0
94568,<,0,0
94569,36,0,0
94570,months,0,0
94571,of,0,0
94572,age,0,0
94573,were,0,0
94574,abstracted,0,0
94575,before,0,0
94576,",",0,0
94577,during,0,0
94578,",",0,0
94579,and,0,0
94580,after,0,0
94581,the,0,0
94582,intervention,0,0
94583,periods,0,0
94584,for,0,0
94585,specific,0,0
94586,documentation,0,0
94587,elements,0,0
94588,.,0,0
94589,The,0,0
94590,main,0,0
94591,outcome,0,1
94592,measure,0,0
94593,was,0,0
94594,the,0,0
94595,change,0,0
94596,in,0,0
94597,documentation,0,1
94598,from,0,0
94599,baseline,0,0
94600,.,0,0
94601,Generalized,0,0
94602,estimating,0,0
94603,equations,0,1
94604,(,0,0
94605,GEEs,0,0
94606,),0,0
94607,were,0,0
94608,used,0,0
94609,to,0,0
94610,test,0,0
94611,for,0,0
94612,intervention,0,0
94613,effect,0,0
94614,.,0,0
94615,RESULTS,0,0
94616,A,0,0
94617,total,0,0
94618,of,0,0
94619,"1,575",0,0
94620,charts,0,0
94621,from,0,0
94622,14,0,0
94623,hospitals,0,0
94624,EDs,0,0
94625,were,0,0
94626,abstracted,0,0
94627,.,0,0
94628,Hospital,0,1
94629,and,0,0
94630,demographic,0,1
94631,characteristics,0,1
94632,were,0,0
94633,similar,0,0
94634,across,0,0
94635,intervention,0,0
94636,groups,0,0
94637,.,0,0
94638,There,0,0
94639,were,0,0
94640,922,0,0
94641,(,0,0
94642,59,0,0
94643,%,0,0
94644,),0,0
94645,injury,0,1
94646,visits,0,0
94647,and,0,0
94648,653,0,0
94649,(,0,0
94650,41,0,0
94651,%,0,0
94652,),0,0
94653,noninjury,0,0
94654,visits,0,0
94655,.,0,0
94656,For,0,0
94657,each,0,0
94658,specific,0,0
94659,documentation,0,1
94660,element,0,0
94661,",",0,0
94662,a,0,0
94663,GEE,0,0
94664,model,0,0
94665,gave,0,0
94666,p-values,0,0
94667,of,0,0
94668,>,0,0
94669,0.2,0,0
94670,in,0,0
94671,independent,0,0
94672,tests,0,0
94673,",",0,0
94674,indicating,0,0
94675,no,0,0
94676,evidence,0,0
94677,of,0,0
94678,significant,0,0
94679,change,0,0
94680,in,0,0
94681,documentation,0,0
94682,after,0,0
94683,the,0,0
94684,intervention,0,0
94685,.,0,0
94686,Even,0,0
94687,among,0,0
94688,the,0,0
94689,26,0,0
94690,charts,0,0
94691,in,0,0
94692,which,0,0
94693,the,0,0
94694,possibility,0,0
94695,of,0,0
94696,physical,0,1
94697,abuse,0,0
94698,was,0,0
94699,noted,0,0
94700,",",0,0
94701,documentation,0,1
94702,remained,0,0
94703,variable,0,0
94704,.,0,0
94705,CONCLUSIONS,0,0
94706,The,0,0
94707,educational,0,0
94708,interventions,0,0
94709,studied,0,0
94710,did,0,0
94711,not,0,0
94712,improve,0,0
94713,ED,1,0
94714,documentation,1,1
94715,of,0,0
94716,cases,0,0
94717,of,0,0
94718,possible,0,0
94719,physical,0,1
94720,child,0,0
94721,abuse,0,0
94722,.,0,0
94723,The,0,0
94724,need,0,0
94725,for,0,0
94726,improved,0,1
94727,health,0,1
94728,care,0,0
94729,provider,0,1
94730,education,0,0
94731,in,0,0
94732,child,0,1
94733,abuse,0,1
94734,identification,0,1
94735,and,0,1
94736,documentation,0,1
94737,remains,0,0
94738,.,0,0
94739,Future,0,0
94740,innovative,0,0
94741,educational,0,0
94742,studies,0,0
94743,to,0,0
94744,improve,0,0
94745,recognition,1,0
94746,of,1,0
94747,abuse,1,0
94748,are,0,0
94749,warranted,0,0
94750,.,0,0
94751,BNP-guided,0,0
94752,vs,0,0
94753,symptom-guided,0,0
94754,heart,0,1
94755,failure,0,1
94756,therapy,0,0
94757,:,0,0
94758,the,0,0
94759,Trial,0,0
94760,of,0,0
94761,Intensified,0,0
94762,vs,0,0
94763,Standard,0,0
94764,Medical,0,0
94765,Therapy,0,0
94766,in,0,0
94767,Elderly,0,0
94768,Patients,0,0
94769,With,0,0
94770,Congestive,0,1
94771,Heart,0,0
94772,Failure,0,1
94773,(,0,0
94774,TIME-CHF,0,1
94775,),0,0
94776,randomized,0,0
94777,trial,0,0
94778,.,0,0
94779,CONTEXT,0,0
94780,It,0,0
94781,is,0,0
94782,uncertain,0,0
94783,whether,0,0
94784,intensified,0,0
94785,heart,0,1
94786,failure,0,1
94787,therapy,0,0
94788,guided,0,0
94789,by,0,0
94790,N-terminal,0,0
94791,brain,0,1
94792,natriuretic,0,1
94793,peptide,0,1
94794,(,0,0
94795,BNP,0,0
94796,),0,0
94797,is,0,0
94798,superior,0,0
94799,to,0,0
94800,symptom-guided,0,0
94801,therapy,0,0
94802,.,0,0
94803,OBJECTIVE,0,0
94804,To,0,0
94805,compare,0,0
94806,18-month,0,0
94807,outcomes,0,0
94808,of,0,0
94809,N-terminal,0,1
94810,BNP-guided,0,0
94811,vs,0,0
94812,symptom-guided,0,0
94813,heart,0,1
94814,failure,0,1
94815,therapy,0,0
94816,.,0,0
94817,DESIGN,0,0
94818,",",0,0
94819,SETTING,0,0
94820,",",0,0
94821,AND,0,0
94822,PATIENTS,0,1
94823,Randomized,0,0
94824,controlled,0,0
94825,multicenter,0,0
94826,Trial,0,0
94827,of,0,0
94828,Intensified,0,0
94829,vs,0,0
94830,Standard,0,0
94831,Medical,0,0
94832,Therapy,0,0
94833,in,0,0
94834,Elderly,0,0
94835,Patients,0,0
94836,With,0,0
94837,Congestive,0,1
94838,Heart,0,0
94839,Failure,0,1
94840,(,0,0
94841,TIME-CHF,0,0
94842,),0,0
94843,of,0,0
94844,499,0,0
94845,patients,0,0
94846,aged,0,0
94847,60,0,0
94848,years,0,0
94849,or,0,0
94850,older,0,0
94851,with,0,0
94852,systolic,0,1
94853,heart,0,1
94854,failure,0,1
94855,(,0,0
94856,ejection,0,1
94857,fraction,0,1
94858,<,0,0
94859,or,0,0
94860,=,0,0
94861,45,0,0
94862,%,0,0
94863,),0,0
94864,",",0,0
94865,New,0,1
94866,York,0,0
94867,Heart,0,0
94868,Association,0,0
94869,(,0,0
94870,NYHA,0,0
94871,),0,0
94872,class,0,0
94873,of,0,0
94874,II,0,0
94875,or,0,0
94876,greater,0,0
94877,",",0,1
94878,prior,0,1
94879,hospitalization,0,1
94880,for,0,0
94881,heart,0,1
94882,failure,0,0
94883,within,0,0
94884,1,0,0
94885,year,0,0
94886,",",0,0
94887,and,0,1
94888,N-terminal,0,1
94889,BNP,0,1
94890,level,0,1
94891,of,0,0
94892,2,0,0
94893,or,0,0
94894,more,0,0
94895,times,0,1
94896,the,0,0
94897,upper,0,0
94898,limit,0,0
94899,of,0,0
94900,normal,0,0
94901,.,0,0
94902,The,0,0
94903,study,0,0
94904,had,0,0
94905,an,0,0
94906,18-month,0,0
94907,follow-up,0,0
94908,and,0,0
94909,it,0,0
94910,was,0,0
94911,conducted,0,0
94912,at,0,0
94913,15,0,0
94914,outpatient,0,0
94915,centers,0,0
94916,in,0,0
94917,Switzerland,0,0
94918,and,0,0
94919,Germany,0,0
94920,between,0,0
94921,January,0,0
94922,2003,0,0
94923,and,0,0
94924,June,0,0
94925,2008,0,0
94926,.,0,0
94927,INTERVENTION,0,0
94928,Uptitration,0,0
94929,of,0,0
94930,guideline-based,0,0
94931,treatments,0,0
94932,to,0,0
94933,reduce,0,0
94934,symptoms,0,1
94935,to,0,0
94936,NYHA,0,0
94937,class,0,0
94938,of,0,0
94939,II,0,0
94940,or,0,0
94941,less,0,0
94942,(,0,0
94943,symptom-guided,0,1
94944,therapy,0,0
94945,),0,0
94946,and,0,0
94947,BNP,0,1
94948,level,0,1
94949,of,0,0
94950,2,0,0
94951,times,0,0
94952,or,0,0
94953,less,0,0
94954,the,0,0
94955,upper,0,0
94956,limit,0,0
94957,of,0,0
94958,normal,0,0
94959,and,0,0
94960,symptoms,0,1
94961,to,0,0
94962,NYHA,0,0
94963,class,0,0
94964,of,0,0
94965,II,0,0
94966,or,0,0
94967,less,0,0
94968,(,0,0
94969,BNP-guided,0,0
94970,therapy,0,0
94971,),0,0
94972,.,0,0
94973,MAIN,0,0
94974,OUTCOME,0,0
94975,MEASURES,0,0
94976,Primary,0,1
94977,outcomes,0,1
94978,were,0,0
94979,18-month,1,0
94980,survival,1,1
94981,free,1,1
94982,of,1,0
94983,all-cause,1,1
94984,hospitalizations,1,1
94985,and,1,0
94986,quality,1,1
94987,of,1,1
94988,life,1,1
94989,as,1,0
94990,assessed,1,0
94991,by,1,0
94992,structured,1,0
94993,validated,1,0
94994,questionnaires,1,0
94995,.,1,0
94996,RESULTS,0,0
94997,Heart,0,0
94998,failure,0,1
94999,therapy,0,0
95000,guided,0,0
95001,by,0,0
95002,N-terminal,0,0
95003,BNP,0,0
95004,and,0,0
95005,symptom-guided,0,1
95006,therapy,0,0
95007,resulted,0,0
95008,in,0,0
95009,similar,0,0
95010,rates,0,1
95011,of,0,0
95012,survival,1,1
95013,free,1,1
95014,of,1,0
95015,all-cause,1,1
95016,hospitalizations,1,1
95017,(,0,0
95018,41,0,0
95019,%,0,0
95020,vs,0,0
95021,40,0,0
95022,%,0,0
95023,",",0,0
95024,respectively,0,0
95025,;,0,0
95026,hazard,0,0
95027,ratio,0,1
95028,[,0,0
95029,HR,0,1
95030,],0,0
95031,",",0,0
95032,0.91,0,0
95033,[,0,0
95034,95,0,0
95035,%,0,0
95036,CI,0,0
95037,",",0,0
95038,0.72-1.14,0,0
95039,],0,0
95040,;,0,0
95041,P,0,0
95042,=,0,0
95043,.39,0,0
95044,),0,0
95045,.,0,0
95046,Patients,1,0
95047,',1,0
95048,quality-of-life,1,1
95049,metrics,1,0
95050,improved,0,0
95051,over,0,0
95052,18,0,0
95053,months,0,0
95054,of,0,0
95055,follow-up,0,0
95056,but,0,0
95057,these,0,0
95058,improvements,0,1
95059,were,0,0
95060,similar,0,0
95061,in,0,0
95062,both,0,0
95063,the,0,0
95064,N-terminal,0,0
95065,BNP-guided,0,0
95066,and,0,0
95067,symptom-guided,0,0
95068,strategies,0,0
95069,.,0,0
95070,Compared,0,0
95071,with,0,0
95072,the,0,0
95073,symptom-guided,0,0
95074,group,0,0
95075,",",0,0
95076,survival,1,1
95077,free,1,1
95078,of,1,0
95079,hospitalization,1,1
95080,for,1,0
95081,heart,1,1
95082,failure,1,1
95083,",",0,0
95084,a,0,0
95085,secondary,0,0
95086,end,0,0
95087,point,0,1
95088,",",0,0
95089,was,0,0
95090,higher,0,0
95091,among,0,0
95092,those,0,0
95093,in,0,0
95094,the,0,0
95095,N-terminal,0,0
95096,BNP-guided,0,0
95097,group,0,0
95098,(,0,0
95099,72,0,0
95100,%,0,0
95101,vs,0,0
95102,62,0,0
95103,%,0,0
95104,",",0,0
95105,respectively,0,0
95106,;,0,0
95107,HR,0,0
95108,",",0,0
95109,0.68,0,0
95110,[,0,0
95111,95,0,0
95112,%,0,0
95113,CI,0,0
95114,",",0,0
95115,0.50-0.92,0,0
95116,],0,0
95117,;,0,0
95118,P,0,0
95119,=,0,0
95120,.01,0,0
95121,),0,0
95122,.,0,0
95123,Heart,0,0
95124,failure,0,1
95125,therapy,0,0
95126,guided,0,0
95127,by,0,0
95128,N-terminal,0,1
95129,BNP,0,1
95130,improved,0,0
95131,outcomes,0,1
95132,in,0,0
95133,patients,0,0
95134,aged,0,0
95135,60,0,0
95136,to,0,0
95137,75,0,0
95138,years,0,0
95139,but,0,0
95140,not,0,0
95141,in,0,0
95142,those,0,0
95143,aged,0,0
95144,75,0,0
95145,years,0,0
95146,or,0,0
95147,older,0,0
95148,(,0,0
95149,P,0,0
95150,<,0,0
95151,.02,0,0
95152,for,0,0
95153,interaction,0,1
95154,),0,0
95155,CONCLUSION,0,0
95156,Heart,0,0
95157,failure,0,1
95158,therapy,0,0
95159,guided,0,0
95160,by,0,0
95161,N-terminal,0,0
95162,BNP,0,0
95163,did,0,0
95164,not,0,0
95165,improve,0,0
95166,overall,0,1
95167,clinical,0,0
95168,outcomes,1,1
95169,or,0,0
95170,quality,1,1
95171,of,1,1
95172,life,1,1
95173,compared,0,0
95174,with,0,0
95175,symptom-guided,0,0
95176,treatment,0,0
95177,.,0,0
95178,TRIAL,0,0
95179,REGISTRATION,0,0
95180,isrctn.org,0,0
95181,Identifier,0,0
95182,:,0,0
95183,ISRCTN43596477,0,0
95184,.,0,0
95185,Effects,0,0
95186,of,0,0
95187,propranolol,0,0
95188,on,0,0
95189,bone,1,1
95190,metabolism,1,0
95191,in,0,0
95192,the,0,0
95193,rat,0,0
95194,.,0,0
95195,Propranolol,0,0
95196,",",0,0
95197,a,0,0
95198,nonspecific,0,0
95199,beta-blocker,0,0
95200,has,0,0
95201,many,0,0
95202,physiologic,0,0
95203,effects,0,0
95204,.,0,0
95205,Its,0,0
95206,effects,0,0
95207,on,0,0
95208,bone,1,1
95209,in,0,0
95210,vivo,0,0
95211,are,0,0
95212,unknown,0,0
95213,",",0,0
95214,although,0,0
95215,beta,0,1
95216,receptor,0,0
95217,sites,0,0
95218,have,0,0
95219,been,0,0
95220,found,0,0
95221,on,0,0
95222,osteoblasts,0,0
95223,.,0,0
95224,In,0,0
95225,this,0,0
95226,study,0,0
95227,",",0,0
95228,the,0,0
95229,hypothesis,0,0
95230,tested,0,0
95231,was,0,0
95232,that,0,0
95233,low,0,0
95234,doses,0,0
95235,of,0,0
95236,propranolol,0,0
95237,could,0,0
95238,alter,0,0
95239,bone,1,1
95240,properties,1,1
95241,and,0,1
95242,enhance,0,0
95243,orthotopic,1,0
95244,endochondral,1,0
95245,bone,1,1
95246,formation,1,1
95247,.,1,0
95248,In,0,0
95249,a,0,0
95250,group,0,0
95251,of,0,0
95252,nonsurgical,0,0
95253,rats,0,0
95254,",",0,0
95255,propranolol,0,0
95256,treatment,0,0
95257,increased,0,0
95258,femoral,1,1
95259,torsional,1,1
95260,strength,1,1
95261,on,0,0
95262,biomechanical,0,0
95263,testing,0,0
95264,.,0,0
95265,In,0,0
95266,the,0,0
95267,rat,0,0
95268,surgical,0,0
95269,model,0,0
95270,used,0,0
95271,",",0,0
95272,right,0,0
95273,femora,0,1
95274,were,0,0
95275,fixed,0,0
95276,to,0,0
95277,a,0,0
95278,polyethylene,0,0
95279,plate,0,0
95280,and,0,0
95281,then,0,0
95282,defects,0,0
95283,were,0,0
95284,created,0,0
95285,mid-diaphysis,0,1
95286,and,0,0
95287,subsequently,0,0
95288,filled,0,0
95289,with,0,0
95290,demineralized,0,0
95291,bone,0,1
95292,matrix,0,0
95293,.,0,0
95294,These,0,0
95295,rats,0,0
95296,(,0,0
95297,defect,0,1
95298,rats,0,0
95299,),0,0
95300,were,0,0
95301,randomly,0,0
95302,divided,0,0
95303,into,0,0
95304,groups,0,0
95305,that,0,0
95306,were,0,0
95307,given,0,0
95308,propranolol,0,0
95309,or,0,0
95310,a,0,0
95311,saline,0,0
95312,carrier,0,0
95313,for,0,0
95314,19,0,0
95315,consecutive,0,0
95316,days,0,0
95317,.,0,0
95318,In,0,0
95319,the,0,0
95320,defect,0,0
95321,rats,0,0
95322,",",0,0
95323,increased,0,0
95324,trabecular,1,1
95325,femoral,1,1
95326,metaphyseal,1,1
95327,mineral,1,1
95328,apposition,1,1
95329,rates,1,1
95330,were,0,0
95331,observed,0,0
95332,in,0,0
95333,propranolol-treated,0,0
95334,groups,0,0
95335,.,0,0
95336,Densitometry,0,0
95337,and,0,0
95338,roentgenographic,0,1
95339,scoring,0,1
95340,of,0,0
95341,callus,0,0
95342,formation,0,1
95343,after,0,0
95344,12,0,0
95345,weeks,0,0
95346,in,0,0
95347,propranolol-treated,0,0
95348,rats,0,0
95349,revealed,0,0
95350,increased,0,0
95351,callus,1,0
95352,and,1,1
95353,bone,1,1
95354,union,1,0
95355,.,1,0
95356,The,0,0
95357,results,0,0
95358,of,0,0
95359,this,0,0
95360,study,0,0
95361,indicate,0,0
95362,that,0,0
95363,propranolol,0,0
95364,treatment,0,0
95365,can,0,0
95366,significantly,0,0
95367,affect,0,0
95368,bone,1,1
95369,properties,1,0
95370,.,1,0
95371,Effect,0,0
95372,of,0,0
95373,light-cured,0,0
95374,filled,0,0
95375,sealant,0,0
95376,on,0,0
95377,shear,0,1
95378,bond,0,1
95379,strength,0,1
95380,of,0,1
95381,metal,0,0
95382,and,0,0
95383,ceramic,0,0
95384,brackets,0,0
95385,bonded,0,0
95386,with,0,0
95387,a,0,0
95388,resin-modified,0,0
95389,glass,0,0
95390,ionomer,0,0
95391,cement,0,0
95392,.,0,0
95393,INTRODUCTION,0,0
95394,Our,0,0
95395,objective,0,0
95396,was,0,0
95397,to,0,0
95398,evaluate,0,0
95399,the,0,0
95400,effects,0,0
95401,of,0,0
95402,a,0,0
95403,highly,0,0
95404,filled,0,0
95405,light-cured,0,0
95406,sealant,0,0
95407,(,0,0
95408,HFLCS,0,1
95409,),0,0
95410,on,0,0
95411,the,0,0
95412,shear,0,1
95413,bond,0,1
95414,strength,0,1
95415,and,0,1
95416,bond,0,1
95417,failure,0,1
95418,site,0,1
95419,of,0,1
95420,metal,0,0
95421,and,0,0
95422,ceramic,0,0
95423,brackets,0,0
95424,bonded,0,0
95425,with,0,0
95426,resin-modified,0,0
95427,glass,0,0
95428,ionomer,0,0
95429,cement,0,1
95430,(,0,0
95431,RMGIC,0,0
95432,),0,0
95433,.,0,0
95434,METHODS,0,0
95435,Eighty,0,0
95436,freshly,0,0
95437,extracted,0,0
95438,maxillary,0,0
95439,premolars,0,0
95440,were,0,0
95441,randomly,0,0
95442,divided,0,0
95443,into,0,0
95444,4,0,0
95445,groups,0,0
95446,(,0,0
95447,20,0,0
95448,in,0,0
95449,each,0,0
95450,group,0,0
95451,),0,0
95452,.,0,0
95453,In,0,0
95454,all,0,0
95455,groups,0,0
95456,",",0,0
95457,the,0,0
95458,teeth,0,0
95459,were,0,0
95460,etched,0,0
95461,with,0,0
95462,37,0,0
95463,%,0,0
95464,phosphoric,0,0
95465,acid,0,0
95466,for,0,0
95467,20,0,0
95468,seconds,0,0
95469,",",0,0
95470,and,0,1
95471,RMGIC,0,1
95472,(,0,0
95473,Fuji,0,1
95474,Ortho,0,1
95475,LC,0,0
95476,",",0,0
95477,GC,0,1
95478,Europe,0,0
95479,",",0,0
95480,Leuven,0,0
95481,",",0,1
95482,Belgium,0,0
95483,),0,0
95484,was,0,0
95485,used,0,0
95486,for,0,0
95487,bracket,0,0
95488,bonding,0,1
95489,.,0,0
95490,In,0,0
95491,groups,0,0
95492,1,0,0
95493,and,0,0
95494,3,0,0
95495,",",0,0
95496,the,0,0
95497,brackets,0,0
95498,were,0,0
95499,bonded,0,0
95500,directly,0,0
95501,to,0,0
95502,etched,0,0
95503,enamel,0,0
95504,surfaces,0,0
95505,;,0,0
95506,in,0,0
95507,groups,0,0
95508,2,0,0
95509,and,0,0
95510,4,0,0
95511,",",0,0
95512,the,0,0
95513,etched,0,0
95514,enamel,0,0
95515,was,0,0
95516,covered,0,0
95517,with,0,0
95518,HFLCS,0,1
95519,(,0,0
95520,Pro,0,0
95521,Seal,0,1
95522,",",0,0
95523,Reliance,0,1
95524,Orthodontic,0,1
95525,Products,0,1
95526,",",0,0
95527,Itasca,0,1
95528,",",0,1
95529,Ill,0,0
95530,),0,0
95531,.,0,0
95532,Groups,0,0
95533,1,0,0
95534,and,0,0
95535,2,0,0
95536,received,0,0
95537,metal,0,0
95538,brackets,0,0
95539,",",0,0
95540,and,0,0
95541,groups,0,0
95542,3,0,0
95543,and,0,0
95544,4,0,0
95545,had,0,0
95546,ceramic,0,0
95547,brackets,0,0
95548,.,0,0
95549,The,0,0
95550,specimens,0,0
95551,were,0,0
95552,stored,0,0
95553,in,0,0
95554,distilled,0,0
95555,water,0,1
95556,at,0,0
95557,room,0,0
95558,temperature,0,1
95559,for,0,0
95560,24,0,0
95561,hours,0,0
95562,and,0,0
95563,subsequently,0,0
95564,tested,0,0
95565,in,0,0
95566,shear,0,1
95567,mode,0,0
95568,with,0,0
95569,a,0,0
95570,universal,0,0
95571,testing,0,0
95572,machine,0,0
95573,.,0,0
95574,After,0,0
95575,debonding,0,0
95576,",",0,0
95577,the,0,0
95578,teeth,0,0
95579,and,0,0
95580,the,0,0
95581,brackets,0,0
95582,were,0,0
95583,examined,0,0
95584,under,0,0
95585,a,0,0
95586,stereomicroscope,0,0
95587,(,0,0
95588,model,0,0
95589,SMZ-1B,0,0
95590,",",0,0
95591,Nikon,0,0
95592,",",0,1
95593,Osaka,0,1
95594,",",0,1
95595,Japan,0,0
95596,),0,0
95597,at,0,0
95598,20-times,0,0
95599,magnification,0,0
95600,to,0,0
95601,assess,0,0
95602,the,0,0
95603,residual,0,0
95604,adhesive,0,0
95605,on,0,0
95606,the,0,0
95607,tooth,0,0
95608,surfaces,0,0
95609,.,0,0
95610,RESULTS,0,0
95611,Interaction,0,0
95612,between,0,0
95613,HFLCS,0,1
95614,and,0,1
95615,bracket,0,1
95616,type,0,0
95617,was,0,0
95618,not,0,0
95619,statistically,0,0
95620,significant,0,0
95621,(,0,0
95622,P,0,0
95623,=,0,0
95624,0.15,0,0
95625,),0,0
95626,.,0,0
95627,Pretreatment,0,0
95628,with,0,0
95629,HFLCS,1,1
95630,did,1,0
95631,not,1,0
95632,cause,1,0
95633,a,1,0
95634,statistically,1,0
95635,significant,1,0
95636,change,1,0
95637,in,1,0
95638,the,1,0
95639,shear,1,1
95640,bond,1,1
95641,values,1,1
95642,of,1,0
95643,either,1,0
95644,metal,1,0
95645,or,1,0
95646,ceramic,1,0
95647,brackets,1,0
95648,(,0,0
95649,P,0,0
95650,=,0,0
95651,0.38,0,0
95652,),0,0
95653,.,0,0
95654,Shear,1,0
95655,bond,1,1
95656,values,1,1
95657,of,1,0
95658,the,1,0
95659,ceramic,1,0
95660,brackets,1,0
95661,were,0,0
95662,higher,0,0
95663,than,0,0
95664,those,0,0
95665,of,0,0
95666,the,0,0
95667,metal,0,0
95668,brackets,0,0
95669,independent,0,0
95670,of,0,0
95671,HFLCS,0,1
95672,application,0,0
95673,(,0,0
95674,P,0,0
95675,<,0,0
95676,0.001,0,0
95677,),0,0
95678,.,0,0
95679,No,0,0
95680,significant,0,0
95681,differences,0,0
95682,were,0,0
95683,found,0,0
95684,in,0,0
95685,bond,1,1
95686,failure,1,0
95687,modes,1,0
95688,in,0,0
95689,the,0,0
95690,4,0,0
95691,groups,0,0
95692,.,0,0
95693,CONCLUSIONS,0,0
95694,HFLCS,0,1
95695,application,0,0
95696,on,0,0
95697,enamel,0,0
95698,etched,0,0
95699,with,0,0
95700,37,0,0
95701,%,0,0
95702,phosphoric,0,0
95703,acid,0,0
95704,did,0,0
95705,not,0,0
95706,affect,0,0
95707,the,0,0
95708,bond,1,1
95709,strength,1,1
95710,values,1,1
95711,and,0,0
95712,the,0,0
95713,bond,1,1
95714,failure,1,1
95715,modes,1,0
95716,of,0,1
95717,metal,0,0
95718,and,0,0
95719,ceramic,0,0
95720,brackets,0,0
95721,bonded,0,0
95722,with,0,0
95723,RMGIC,0,0
95724,.,0,0
95725,RESULTS,0,0
95726,Interaction,0,0
95727,between,0,0
95728,HFLCS,0,1
95729,and,0,1
95730,bracket,0,1
95731,type,0,0
95732,was,0,0
95733,not,0,0
95734,statistically,0,0
95735,significant,0,0
95736,(,0,0
95737,P,0,0
95738,=,0,0
95739,0.15,0,0
95740,),0,0
95741,.,0,0
95742,Pretreatment,0,0
95743,with,0,0
95744,HFLCS,0,1
95745,did,0,0
95746,not,0,0
95747,cause,0,0
95748,a,0,0
95749,statistically,0,0
95750,significant,0,0
95751,change,0,0
95752,in,0,0
95753,the,0,0
95754,shear,1,1
95755,bond,1,1
95756,values,1,1
95757,of,1,0
95758,either,1,0
95759,metal,1,0
95760,or,1,0
95761,ceramic,1,0
95762,brackets,1,0
95763,(,0,0
95764,P,0,0
95765,=,0,0
95766,0.38,0,0
95767,),0,0
95768,.,0,0
95769,Shear,1,0
95770,bond,1,1
95771,values,1,1
95772,of,1,0
95773,the,1,0
95774,ceramic,1,0
95775,brackets,1,0
95776,were,0,0
95777,higher,0,0
95778,than,0,0
95779,those,0,0
95780,of,0,0
95781,the,0,0
95782,metal,0,0
95783,brackets,0,0
95784,independent,0,0
95785,of,0,0
95786,HFLCS,0,1
95787,application,0,0
95788,(,0,0
95789,P,0,0
95790,<,0,0
95791,0.001,0,0
95792,),0,0
95793,.,0,0
95794,No,0,0
95795,significant,0,0
95796,differences,0,0
95797,were,0,0
95798,found,0,0
95799,in,0,0
95800,bond,0,1
95801,failure,0,0
95802,modes,0,0
95803,in,0,0
95804,the,0,0
95805,4,0,0
95806,groups,0,0
95807,.,0,0
95808,CONCLUSIONS,0,0
95809,HFLCS,0,1
95810,application,0,0
95811,on,0,0
95812,enamel,0,0
95813,etched,0,0
95814,with,0,0
95815,37,0,0
95816,%,0,0
95817,phosphoric,0,0
95818,acid,0,0
95819,did,0,0
95820,not,0,0
95821,affect,0,0
95822,the,0,0
95823,bond,0,1
95824,strength,0,1
95825,values,0,1
95826,and,0,0
95827,the,0,0
95828,bond,0,1
95829,failure,0,1
95830,modes,0,0
95831,of,0,1
95832,metal,0,0
95833,and,0,0
95834,ceramic,0,0
95835,brackets,0,0
95836,bonded,0,0
95837,with,0,0
95838,RMGIC,0,0
95839,.,0,0
95840,Cardiac,0,1
95841,failure,0,0
95842,:,0,0
95843,symptoms,0,1
95844,and,0,0
95845,functional,0,0
95846,status,0,1
95847,.,0,0
95848,The,0,0
95849,associations,0,0
95850,between,0,0
95851,exercise,0,0
95852,capacity,0,1
95853,",",0,0
95854,symptoms,0,1
95855,and,0,1
95856,specific,0,0
95857,aspects,0,0
95858,of,0,0
95859,quality,0,1
95860,of,0,0
95861,life,0,1
95862,were,0,0
95863,examined,0,0
95864,in,0,0
95865,subjects,0,0
95866,participating,0,0
95867,in,0,0
95868,a,0,0
95869,trial,0,0
95870,of,0,0
95871,the,0,0
95872,treatment,0,0
95873,of,0,0
95874,heart,0,1
95875,failure,0,1
95876,.,0,0
95877,Patients,0,0
95878,were,0,0
95879,assessed,0,0
95880,on,0,0
95881,entry,0,0
95882,and,0,0
95883,after,0,0
95884,three,0,0
95885,months,0,0
95886,treatment,0,0
95887,.,0,0
95888,The,0,0
95889,principle,0,0
95890,symptoms,0,1
95891,were,0,0
95892,fatigue,0,1
95893,",",0,0
95894,breathlessness,0,1
95895,and,0,1
95896,chest,0,1
95897,pain,0,1
95898,.,0,0
95899,These,0,0
95900,limited,0,0
95901,the,0,0
95902,extent,0,0
95903,and,0,0
95904,speed,0,1
95905,of,0,1
95906,physical,0,1
95907,activities,0,1
95908,",",0,0
95909,restricted,0,0
95910,social,0,1
95911,",",0,0
95912,leisure,0,1
95913,and,0,1
95914,family,0,1
95915,life,0,1
95916,and,0,1
95917,were,0,0
95918,associated,0,0
95919,with,0,0
95920,emotional,0,1
95921,distress,0,1
95922,.,0,0
95923,There,0,0
95924,were,0,0
95925,associations,0,0
95926,between,0,0
95927,baseline,1,0
95928,exercise,1,0
95929,capacity,1,1
95930,and,1,1
95931,measures,1,1
95932,of,1,1
95933,quality,1,1
95934,of,1,0
95935,life,1,1
95936,.,1,0
95937,Change,0,0
95938,in,0,0
95939,exercise,0,0
95940,capacity,0,1
95941,during,0,0
95942,three,0,0
95943,months,0,0
95944,treatment,0,0
95945,was,0,0
95946,correlated,0,0
95947,with,0,0
95948,changes,0,0
95949,in,0,0
95950,measures,1,1
95951,of,1,0
95952,symptoms,1,1
95953,",",1,0
95954,limitation,1,0
95955,of,1,1
95956,activity,1,1
95957,and,1,1
95958,quality,1,1
95959,of,1,0
95960,life,1,1
95961,.,1,0
95962,The,0,0
95963,findings,0,0
95964,confirm,0,0
95965,the,0,0
95966,value,0,0
95967,of,0,0
95968,change,0,1
95969,in,0,0
95970,exercise,1,0
95971,capacity,1,1
95972,as,0,0
95973,a,0,0
95974,measure,0,0
95975,of,0,0
95976,functional,0,0
95977,status,0,1
95978,and,0,0
95979,suggest,0,0
95980,that,0,0
95981,it,0,0
95982,should,0,0
95983,be,0,0
95984,supported,0,0
95985,by,0,0
95986,a,0,0
95987,limited,0,0
95988,number,0,1
95989,of,0,0
95990,specific,0,0
95991,measures,0,1
95992,of,0,0
95993,quality,1,1
95994,of,1,0
95995,life,1,1
95996,.,1,0
95997,A,0,0
95998,comparison,0,0
95999,of,0,0
96000,single-dose,0,0
96001,cefixime,0,0
96002,with,0,0
96003,ceftriaxone,0,0
96004,as,0,0
96005,treatment,0,0
96006,for,0,0
96007,uncomplicated,1,0
96008,gonorrhea,1,0
96009,.,1,0
96010,The,0,0
96011,Gonorrhea,0,1
96012,Treatment,0,0
96013,Study,0,0
96014,Group,0,0
96015,.,0,0
96016,BACKGROUND,0,0
96017,Because,0,0
96018,of,0,0
96019,the,0,0
96020,widespread,0,0
96021,existence,0,0
96022,of,0,0
96023,Neisseria,0,0
96024,gonorrhoeae,0,0
96025,resistant,0,0
96026,to,0,0
96027,penicillin,0,0
96028,or,0,0
96029,tetracycline,0,0
96030,",",0,0
96031,ceftriaxone,0,0
96032,is,0,0
96033,now,0,0
96034,recommended,0,0
96035,for,0,0
96036,the,0,0
96037,treatment,0,0
96038,of,0,0
96039,gonorrhea,1,0
96040,.,1,0
96041,There,0,0
96042,is,0,0
96043,",",0,0
96044,however,0,0
96045,",",0,0
96046,a,0,0
96047,need,0,0
96048,for,0,0
96049,effective,0,1
96050,antibiotics,0,0
96051,that,0,0
96052,can,0,0
96053,be,0,0
96054,administered,0,0
96055,orally,0,0
96056,as,0,0
96057,an,0,0
96058,alternative,0,0
96059,to,0,0
96060,ceftriaxone,0,0
96061,",",0,0
96062,which,0,0
96063,requires,0,0
96064,intramuscular,0,0
96065,administration,0,0
96066,.,0,0
96067,Cefixime,0,0
96068,is,0,0
96069,an,0,0
96070,orally,0,0
96071,absorbed,0,0
96072,cephalosporin,0,0
96073,that,0,0
96074,is,0,0
96075,active,0,0
96076,against,0,0
96077,resistant,0,0
96078,gonococci,0,0
96079,and,0,0
96080,has,0,0
96081,pharmacokinetic,0,1
96082,activity,0,1
96083,suitable,0,0
96084,for,0,0
96085,single-dose,0,0
96086,administration,0,0
96087,.,0,0
96088,METHODS,0,0
96089,AND,0,0
96090,RESULTS,0,0
96091,In,0,0
96092,a,0,0
96093,randomized,0,0
96094,",",0,0
96095,unblinded,0,0
96096,multicenter,0,0
96097,study,0,0
96098,of,0,0
96099,209,0,0
96100,men,0,0
96101,and,0,0
96102,124,0,0
96103,women,0,0
96104,with,0,0
96105,uncomplicated,0,0
96106,gonorrhea,0,0
96107,",",0,0
96108,we,0,0
96109,compared,0,0
96110,three,0,0
96111,single-dose,0,0
96112,treatment,0,0
96113,regimens,0,0
96114,:,0,0
96115,400,0,0
96116,mg,0,0
96117,or,0,0
96118,800,0,0
96119,mg,0,0
96120,of,0,0
96121,cefixime,0,0
96122,",",0,0
96123,administered,0,0
96124,orally,0,0
96125,",",0,0
96126,and,0,0
96127,250,0,0
96128,mg,0,0
96129,of,0,0
96130,ceftriaxone,0,0
96131,administered,0,0
96132,intramuscularly,0,0
96133,.,0,0
96134,The,0,0
96135,overall,1,1
96136,cure,1,1
96137,rates,1,1
96138,were,0,0
96139,96,0,0
96140,percent,0,0
96141,for,0,0
96142,the,0,0
96143,400-mg,0,0
96144,dose,0,0
96145,of,0,0
96146,cefixime,0,0
96147,(,0,0
96148,89,0,0
96149,of,0,0
96150,93,0,0
96151,patients,0,0
96152,),0,0
96153,(,0,0
96154,95,0,0
96155,percent,0,0
96156,confidence,0,0
96157,interval,0,0
96158,",",0,0
96159,93.5,0,0
96160,percent,0,0
96161,to,0,0
96162,97.8,0,0
96163,percent,0,0
96164,),0,0
96165,;,0,0
96166,98,0,0
96167,percent,0,0
96168,for,0,0
96169,the,0,0
96170,800-mg,0,0
96171,dose,0,0
96172,of,0,0
96173,cefixime,0,0
96174,(,0,0
96175,86,0,0
96176,of,0,0
96177,88,0,0
96178,patients,0,0
96179,),0,0
96180,(,0,0
96181,95,0,0
96182,percent,0,0
96183,confidence,0,0
96184,interval,0,0
96185,",",0,0
96186,94.6,0,0
96187,percent,0,0
96188,to,0,0
96189,100,0,0
96190,percent,0,0
96191,),0,0
96192,;,0,0
96193,and,0,0
96194,98,0,0
96195,percent,0,0
96196,for,0,0
96197,ceftriaxone,0,0
96198,(,0,0
96199,92,0,0
96200,of,0,0
96201,94,0,0
96202,patients,0,0
96203,),0,0
96204,(,0,0
96205,95,0,0
96206,percent,0,0
96207,confidence,0,0
96208,interval,0,0
96209,",",0,0
96210,94.9,0,0
96211,to,0,0
96212,100,0,0
96213,percent,0,0
96214,),0,0
96215,.,0,0
96216,The,0,0
96217,cure,1,1
96218,rates,1,1
96219,were,0,0
96220,similar,0,0
96221,in,0,0
96222,men,0,0
96223,and,0,1
96224,women,0,0
96225,",",0,1
96226,and,0,1
96227,pharyngeal,1,1
96228,infection,1,1
96229,was,0,0
96230,eradicated,0,0
96231,in,0,0
96232,20,0,0
96233,of,0,0
96234,22,0,0
96235,patients,0,0
96236,(,0,0
96237,91,0,0
96238,percent,0,0
96239,),0,0
96240,.,0,0
96241,Thirty-nine,0,0
96242,percent,0,0
96243,of,0,0
96244,303,0,0
96245,pretreatment,0,0
96246,gonococcal,0,0
96247,isolates,0,0
96248,had,0,0
96249,one,0,0
96250,or,0,0
96251,more,0,0
96252,types,0,0
96253,of,0,1
96254,antimicrobial,0,0
96255,resistance,0,1
96256,;,0,0
96257,the,0,0
96258,efficacy,1,1
96259,of,0,0
96260,all,0,0
96261,three,0,0
96262,regimens,0,0
96263,was,0,0
96264,independent,0,0
96265,of,0,0
96266,the,0,0
96267,resistance,0,1
96268,pattern,0,0
96269,.,0,0
96270,Chlamydia,1,1
96271,trachomatis,1,0
96272,infection,1,1
96273,persisted,0,0
96274,in,0,0
96275,at,0,0
96276,least,0,0
96277,half,0,0
96278,the,0,0
96279,patients,0,0
96280,infected,0,0
96281,in,0,0
96282,each,0,0
96283,treatment,0,0
96284,group,0,0
96285,.,0,0
96286,All,0,0
96287,three,0,0
96288,regimens,0,0
96289,were,0,0
96290,well,0,0
96291,tolerated,1,1
96292,.,1,0
96293,CONCLUSIONS,0,0
96294,In,0,0
96295,the,0,0
96296,treatment,0,0
96297,of,0,0
96298,uncomplicated,1,0
96299,gonorrhea,1,0
96300,",",0,0
96301,a,0,0
96302,single,0,0
96303,dose,0,0
96304,of,0,0
96305,cefixime,0,0
96306,(,0,0
96307,400,0,0
96308,or,0,0
96309,800,0,0
96310,mg,0,0
96311,),0,0
96312,given,0,0
96313,orally,0,0
96314,appears,0,0
96315,to,0,0
96316,be,0,0
96317,as,0,0
96318,effective,1,0
96319,as,0,0
96320,the,0,0
96321,currently,0,0
96322,recommended,0,0
96323,regimen,0,0
96324,of,0,0
96325,ceftriaxone,0,0
96326,(,0,0
96327,250,0,0
96328,mg,0,0
96329,given,0,0
96330,intramuscularly,0,0
96331,),0,0
96332,.,0,0
96333,Cardiovascular,1,1
96334,safety,1,1
96335,and,1,0
96336,gastrointestinal,1,1
96337,tolerability,1,1
96338,of,0,0
96339,etoricoxib,0,0
96340,vs,0,0
96341,diclofenac,0,0
96342,in,0,0
96343,a,0,0
96344,randomized,0,0
96345,controlled,0,0
96346,clinical,0,0
96347,trial,0,0
96348,(,0,0
96349,The,0,0
96350,MEDAL,0,0
96351,study,0,0
96352,),0,0
96353,.,0,0
96354,OBJECTIVE,0,0
96355,To,0,0
96356,compare,0,0
96357,cardiovascular,1,1
96358,(,1,0
96359,CV,1,1
96360,),1,0
96361,and,1,0
96362,other,1,0
96363,safety,1,1
96364,and,1,1
96365,efficacy,1,1
96366,parameters,1,1
96367,of,0,0
96368,etoricoxib,0,0
96369,60,0,0
96370,and,0,0
96371,90,0,0
96372,mg,0,0
96373,",",0,0
96374,and,0,0
96375,diclofenac,0,0
96376,150,0,0
96377,mg.,0,0
96378,METHODS,0,0
96379,This,0,0
96380,double-blind,0,0
96381,study,0,0
96382,randomized,0,0
96383,OA,0,0
96384,patients,0,0
96385,to,0,0
96386,etoricoxib,0,0
96387,90,0,0
96388,mg,0,0
96389,",",0,0
96390,then,0,0
96391,to,0,0
96392,60,0,0
96393,mg,0,0
96394,once,0,0
96395,daily,0,0
96396,vs,0,0
96397,diclofenac,0,0
96398,75,0,0
96399,mg,0,0
96400,twice,0,0
96401,daily,0,0
96402,;,0,0
96403,RA,0,0
96404,patients,0,0
96405,were,0,0
96406,randomized,0,0
96407,to,0,0
96408,etoricoxib,0,0
96409,90,0,0
96410,mg,0,0
96411,once,0,0
96412,daily,0,0
96413,or,0,0
96414,diclofenac,0,0
96415,75,0,0
96416,mg,0,0
96417,twice,0,0
96418,daily,0,0
96419,.,0,0
96420,The,0,0
96421,primary,0,0
96422,endpoint,0,1
96423,was,0,0
96424,non-inferiority,0,0
96425,of,0,0
96426,etoricoxib,0,0
96427,vs,0,0
96428,diclofenac,0,0
96429,for,0,0
96430,thrombotic,0,1
96431,CV,0,1
96432,events,0,1
96433,(,0,0
96434,95,0,0
96435,%,0,0
96436,CI,0,0
96437,upper,0,0
96438,bound,0,0
96439,of,0,0
96440,hazard,0,1
96441,ratio,0,1
96442,<,0,0
96443,1.30,0,0
96444,),0,0
96445,.,0,0
96446,Other,1,0
96447,safety,1,1
96448,and,1,1
96449,efficacy,1,1
96450,parameters,1,1
96451,were,0,0
96452,evaluated,0,0
96453,in,0,0
96454,cohorts,0,0
96455,of,0,0
96456,patients,0,0
96457,based,0,0
96458,on,0,0
96459,etoricoxib,0,0
96460,dose,0,0
96461,and,0,0
96462,disease,0,0
96463,.,0,0
96464,RESULTS,0,0
96465,A,0,0
96466,total,0,0
96467,of,0,0
96468,23,0,0
96469,504,0,0
96470,patients,0,0
96471,were,0,0
96472,randomized,0,0
96473,with,0,0
96474,mean,0,1
96475,treatment,0,0
96476,duration,0,1
96477,from,0,0
96478,19.4,0,0
96479,to,0,0
96480,20.8,0,0
96481,months,0,0
96482,.,0,0
96483,The,0,0
96484,thrombotic,1,1
96485,CV,1,1
96486,risk,1,1
96487,hazard,1,1
96488,ratio,1,1
96489,(,1,0
96490,HR,1,1
96491,),1,0
96492,(,0,0
96493,etoricoxib,0,0
96494,to,0,0
96495,diclofenac,0,0
96496,),0,0
96497,was,0,0
96498,0.96,0,0
96499,(,0,0
96500,95,0,0
96501,%,0,0
96502,CI,0,0
96503,0.81,0,0
96504,",",0,0
96505,1.15,0,0
96506,),0,0
96507,",",0,0
96508,consistent,0,0
96509,with,0,0
96510,non-inferiority,0,0
96511,of,0,0
96512,etoricoxib,0,0
96513,to,0,0
96514,diclofenac,0,0
96515,.,0,0
96516,The,0,0
96517,cumulative,1,1
96518,gastrointestinal,1,1
96519,(,1,0
96520,GI,1,0
96521,),1,0
96522,/liver,1,0
96523,adverse,1,1
96524,events,1,1
96525,(,1,0
96526,AEs,1,1
96527,),1,1
96528,discontinuation,1,1
96529,rate,1,1
96530,was,0,0
96531,significantly,0,0
96532,lower,0,0
96533,for,0,0
96534,etoricoxib,0,0
96535,than,0,0
96536,diclofenac,0,0
96537,in,0,0
96538,each,0,0
96539,patient,0,0
96540,cohort,0,0
96541,;,0,0
96542,HR,0,1
96543,(,0,0
96544,95,0,0
96545,%,0,0
96546,CI,0,0
96547,),0,0
96548,of,0,0
96549,0.46,0,0
96550,(,0,0
96551,0.39,0,0
96552,",",0,0
96553,0.54,0,0
96554,),0,0
96555,",",0,0
96556,0.52,0,0
96557,(,0,0
96558,0.42,0,0
96559,",",0,0
96560,0.63,0,0
96561,),0,0
96562,and,0,0
96563,0.49,0,0
96564,(,0,0
96565,0.39,0,0
96566,",",0,0
96567,0.62,0,0
96568,),0,0
96569,for,0,0
96570,the,0,0
96571,60,0,0
96572,mg,0,0
96573,OA,0,0
96574,",",0,0
96575,90,0,0
96576,mg,0,0
96577,OA,0,0
96578,and,0,1
96579,RA,0,0
96580,cohorts,0,0
96581,.,0,0
96582,The,0,0
96583,maximum,1,1
96584,average,1,0
96585,change,1,0
96586,in,1,0
96587,systolic,1,1
96588,blood,1,1
96589,pressure,1,1
96590,(,1,0
96591,BP,1,1
96592,),1,0
96593,with,0,0
96594,etoricoxib,0,0
96595,was,0,0
96596,3.4-3.6,0,0
96597,mmHg,0,0
96598,(,0,0
96599,diastolic,0,1
96600,BP,0,1
96601,:,0,0
96602,1.0-1.5,0,0
96603,mmHg,0,0
96604,),0,0
96605,",",0,0
96606,while,0,0
96607,diclofenac,0,0
96608,produced,0,0
96609,a,0,0
96610,maximum,0,1
96611,average,0,0
96612,change,0,0
96613,of,0,0
96614,0.9-1.9,0,0
96615,mmHg,0,0
96616,(,0,0
96617,diastolic,0,1
96618,BP,0,1
96619,:,0,0
96620,0.0-0.5,0,0
96621,mmHg,0,0
96622,),0,0
96623,.,0,0
96624,Both,0,0
96625,agents,0,0
96626,resulted,0,0
96627,in,0,0
96628,similar,0,0
96629,efficacy,1,1
96630,regardless,0,0
96631,of,0,1
96632,etoricoxib,0,0
96633,dose,0,0
96634,.,0,0
96635,CONCLUSION,0,0
96636,Long-term,0,1
96637,etoricoxib,0,0
96638,use,0,0
96639,is,0,0
96640,associated,0,0
96641,with,0,0
96642,a,0,0
96643,risk,1,0
96644,of,1,0
96645,thrombotic,1,1
96646,CV,1,1
96647,events,1,1
96648,comparable,0,0
96649,with,0,0
96650,that,0,0
96651,of,0,0
96652,diclofenac,0,0
96653,.,0,0
96654,Compared,0,0
96655,with,0,0
96656,diclofenac,0,0
96657,",",0,0
96658,etoricoxib,0,0
96659,demonstrated,0,0
96660,a,0,0
96661,greater,0,0
96662,risk,1,1
96663,of,1,1
96664,renovascular,1,0
96665,AEs,1,1
96666,",",0,0
96667,but,0,0
96668,a,0,0
96669,more,0,0
96670,favourable,0,0
96671,GI/liver,1,0
96672,tolerability,1,1
96673,profile,1,1
96674,.,1,0
96675,[,0,0
96676,Efficacy,0,0
96677,of,0,0
96678,immunomodulating,0,0
96679,treatment,0,0
96680,in,0,0
96681,patients,0,0
96682,with,0,0
96683,different,0,0
96684,degrees,0,0
96685,of,0,0
96686,immunosuppression,0,0
96687,],0,0
96688,.,0,0
96689,Immunodepression,0,0
96690,is,0,0
96691,a,0,0
96692,common,0,0
96693,condition,0,0
96694,in,0,0
96695,patients,0,0
96696,undergoing,0,0
96697,elective,0,0
96698,operations,0,0
96699,and,0,0
96700,it,0,0
96701,constitutes,0,0
96702,a,0,0
96703,high,0,0
96704,risk,0,0
96705,for,0,0
96706,the,0,0
96707,onset,0,1
96708,of,0,0
96709,postoperative,0,1
96710,infective,0,1
96711,complications,0,1
96712,.,0,0
96713,The,0,0
96714,use,0,0
96715,of,0,0
96716,immunomodulatory,0,0
96717,drugs,0,0
96718,has,0,0
96719,proved,0,0
96720,useful,0,0
96721,in,0,0
96722,the,0,0
96723,prophylaxis,0,0
96724,of,0,0
96725,these,0,0
96726,complications,0,1
96727,",",0,0
96728,although,0,0
96729,the,0,0
96730,precise,0,0
96731,indications,0,0
96732,for,0,0
96733,each,0,0
96734,drug,0,0
96735,have,0,0
96736,not,0,0
96737,yet,0,0
96738,been,0,0
96739,clearly,0,0
96740,codified,0,0
96741,.,0,0
96742,The,0,0
96743,present,0,0
96744,study,0,0
96745,aimed,0,0
96746,to,0,0
96747,assess,0,0
96748,the,0,0
96749,effects,0,0
96750,of,0,0
96751,thymostimulin,0,0
96752,in,0,0
96753,patients,0,0
96754,with,0,0
96755,different,0,0
96756,degrees,0,0
96757,of,0,0
96758,immunodepression,0,1
96759,",",0,0
96760,by,0,0
96761,evaluating,0,0
96762,both,0,0
96763,the,0,0
96764,incidence,1,1
96765,of,1,0
96766,postoperative,1,1
96767,infections,1,0
96768,and,0,0
96769,the,0,0
96770,changes,1,1
96771,induced,1,0
96772,in,0,0
96773,various,0,0
96774,immunological,1,0
96775,parameters,1,0
96776,.,1,0
96777,The,0,0
96778,results,0,0
96779,obtained,0,0
96780,indicated,0,0
96781,that,0,0
96782,those,0,0
96783,subjects,0,0
96784,with,0,0
96785,the,0,0
96786,highest,0,0
96787,degree,0,1
96788,of,0,0
96789,immunodepression,0,1
96790,(,0,0
96791,hypo-anergic,0,0
96792,),0,0
96793,benefited,0,0
96794,most,0,0
96795,from,0,0
96796,drug,0,0
96797,therapy,0,0
96798,in,0,0
96799,comparison,0,0
96800,to,0,0
96801,those,0,0
96802,with,0,0
96803,a,0,0
96804,lesser,0,0
96805,degree,0,1
96806,of,0,1
96807,immunodepression,0,1
96808,(,0,0
96809,relatively,0,0
96810,hypo-ergic,0,0
96811,),0,0
96812,.,0,0
96813,The,0,0
96814,advantages,0,0
96815,were,0,0
96816,evident,0,0
96817,in,0,0
96818,hypo-anergic,0,0
96819,subjects,0,0
96820,both,0,0
96821,with,0,0
96822,regard,0,0
96823,to,0,0
96824,the,0,0
96825,frequency,1,1
96826,of,1,0
96827,early,1,0
96828,postoperative,1,1
96829,infections,1,1
96830,",",0,0
96831,and,0,1
96832,with,0,0
96833,regard,0,0
96834,to,0,0
96835,immunological,1,0
96836,parameters,1,1
96837,.,1,0
96838,On,0,0
96839,the,0,0
96840,other,0,0
96841,hand,0,0
96842,",",0,0
96843,in,0,0
96844,relatively,0,0
96845,hypo-ergic,0,0
96846,subjects,0,0
96847,",",0,0
96848,benefits,0,1
96849,were,0,0
96850,limited,0,0
96851,to,0,0
96852,the,0,0
96853,improvement,0,0
96854,of,0,0
96855,some,0,0
96856,immunological,1,0
96857,parameters,1,1
96858,.,1,0
96859,In,0,0
96860,our,0,0
96861,opinion,0,0
96862,",",0,0
96863,the,0,0
96864,use,0,0
96865,of,0,0
96866,thymostimulin,0,0
96867,is,0,0
96868,of,0,0
96869,particular,0,0
96870,use,0,0
96871,only,0,0
96872,in,0,0
96873,those,0,0
96874,subjects,0,0
96875,with,0,0
96876,marked,0,0
96877,immunodepression,0,1
96878,since,0,0
96879,the,0,0
96880,incidence,0,1
96881,of,0,0
96882,post-operative,1,0
96883,sepsis,1,0
96884,is,0,0
96885,highest,0,0
96886,in,0,0
96887,this,0,0
96888,group,0,0
96889,.,0,0
96890,FDA,0,1
96891,review,0,0
96892,of,0,0
96893,a,0,0
96894,panitumumab,0,0
96895,(,0,0
96896,Vectibix,0,0
96897,),0,0
96898,clinical,0,0
96899,trial,0,0
96900,for,0,0
96901,first-line,0,0
96902,treatment,0,0
96903,of,0,0
96904,metastatic,0,0
96905,colorectal,0,0
96906,cancer,0,0
96907,.,0,0
96908,On,0,0
96909,September,0,0
96910,27,0,0
96911,",",0,0
96912,2006,0,0
96913,",",0,0
96914,the,0,0
96915,U.S.,0,0
96916,Food,0,1
96917,and,0,0
96918,Drug,0,0
96919,Administration,0,0
96920,granted,0,0
96921,accelerated,0,0
96922,approval,0,0
96923,to,0,0
96924,panitumumab,0,0
96925,(,0,0
96926,Vectibix,0,0
96927,;,0,0
96928,Amgen,0,0
96929,",",0,0
96930,Inc.,0,1
96931,",",0,0
96932,Thousand,0,0
96933,Oaks,0,0
96934,",",0,0
96935,CA,0,0
96936,),0,0
96937,for,0,0
96938,the,0,0
96939,treatment,0,0
96940,of,0,0
96941,patients,0,0
96942,with,0,0
96943,epidermal,0,1
96944,growth,0,1
96945,factor,0,1
96946,receptor-expressing,0,1
96947,",",0,0
96948,metastatic,0,0
96949,colorectal,0,0
96950,carcinoma,0,0
96951,with,0,0
96952,disease,0,1
96953,progression,0,1
96954,on,0,0
96955,or,0,0
96956,following,0,0
96957,fluoropyrimidine-,0,0
96958,",",0,0
96959,oxaliplatin-,0,1
96960,",",0,0
96961,and,0,1
96962,irinotecan-containing,0,0
96963,chemotherapy,0,0
96964,regimens,0,0
96965,.,0,0
96966,Accelerated,0,1
96967,approval,0,0
96968,was,0,0
96969,based,0,0
96970,on,0,0
96971,demonstration,0,0
96972,of,0,0
96973,a,0,0
96974,beneficial,0,0
96975,effect,0,0
96976,on,0,0
96977,progression-free,0,1
96978,survival,0,1
96979,(,0,0
96980,PFS,0,0
96981,),0,0
96982,.,0,0
96983,The,0,0
96984,present,0,0
96985,submission,0,0
96986,summarizes,0,0
96987,a,0,0
96988,second,0,0
96989,clinical,0,0
96990,trial,0,0
96991,",",0,0
96992,to,0,0
96993,be,0,0
96994,included,0,0
96995,in,0,0
96996,the,0,0
96997,panitumumab,0,0
96998,package,0,0
96999,insert,0,0
97000,in,0,0
97001,June,0,0
97002,2008,0,0
97003,",",0,0
97004,of,0,0
97005,chemotherapy,0,0
97006,and,0,1
97007,bevacizumab,0,0
97008,with,0,0
97009,and,0,0
97010,without,0,0
97011,panitumumab,0,0
97012,in,0,0
97013,the,0,0
97014,first-line,0,0
97015,treatment,0,0
97016,of,0,0
97017,patients,0,0
97018,with,0,0
97019,metastatic,0,0
97020,colorectal,0,0
97021,cancer,0,0
97022,.,0,0
97023,The,0,0
97024,study,0,0
97025,was,0,0
97026,closed,0,0
97027,when,0,0
97028,inferior,0,0
97029,PFS,0,1
97030,and,0,0
97031,greater,0,1
97032,toxicity,0,1
97033,were,0,0
97034,demonstrated,0,0
97035,at,0,0
97036,the,0,0
97037,time,0,1
97038,of,0,0
97039,the,0,0
97040,planned,0,0
97041,interim,0,0
97042,efficacy,0,1
97043,analysis,0,0
97044,.,0,0
97045,Patients,0,0
97046,receiving,0,0
97047,panitumumab,0,0
97048,in,0,0
97049,combination,0,0
97050,with,0,0
97051,bevacizumab,0,0
97052,and,0,1
97053,chemotherapy,0,0
97054,experienced,0,0
97055,a,0,0
97056,higher,0,0
97057,incidence,0,1
97058,of,0,1
97059,death,1,1
97060,(,0,0
97061,9,0,0
97062,%,0,0
97063,versus,0,0
97064,4,0,0
97065,%,0,0
97066,),0,0
97067,and,0,0
97068,a,0,0
97069,higher,0,0
97070,risk,0,1
97071,for,0,0
97072,grade,1,0
97073,3,1,0
97074,and,1,0
97075,4,1,0
97076,toxicities,1,1
97077,than,0,0
97078,patients,0,0
97079,receiving,0,0
97080,bevacizumab,0,0
97081,and,0,1
97082,chemotherapy,0,0
97083,alone,0,0
97084,.,0,0
97085,The,0,0
97086,incidences,1,1
97087,of,1,0
97088,any,1,0
97089,Common,1,0
97090,Terminology,1,0
97091,Criteria,1,0
97092,for,1,0
97093,Adverse,1,1
97094,Events,1,0
97095,grade,1,0
97096,3,1,0
97097,and,1,0
97098,4,1,0
97099,adverse,1,1
97100,events,1,1
97101,(,1,0
97102,AEs,1,1
97103,),1,0
97104,were,0,0
97105,87,0,0
97106,%,0,0
97107,and,0,0
97108,72,0,0
97109,%,0,0
97110,in,0,0
97111,the,0,0
97112,panitumumab,0,0
97113,and,0,0
97114,control,0,0
97115,groups,0,0
97116,",",0,0
97117,respectively,0,0
97118,.,0,0
97119,Grade,1,0
97120,3,1,0
97121,and,1,0
97122,4,1,0
97123,AEs,1,0
97124,occurring,0,0
97125,more,0,0
97126,commonly,0,0
97127,in,0,0
97128,panitumumab-treated,0,0
97129,patients,0,0
97130,included,0,0
97131,rash/acneiform,1,1
97132,dermatitis,1,1
97133,",",1,1
97134,diarrhea,1,1
97135,",",1,1
97136,dehydration,1,1
97137,",",1,0
97138,primarily,1,0
97139,resulting,1,0
97140,from,1,0
97141,diarrhea,1,1
97142,",",1,0
97143,hypokalemia,1,1
97144,",",1,1
97145,stomatitis/mucositis,1,1
97146,",",1,1
97147,and,1,1
97148,pulmonary,1,1
97149,embolism,1,1
97150,.,1,0
97151,The,0,0
97152,addition,0,0
97153,of,0,0
97154,panitumumab,0,0
97155,to,0,0
97156,bevacizumab,0,0
97157,and,0,0
97158,chemotherapy,0,0
97159,for,0,0
97160,the,0,0
97161,first-line,0,0
97162,treatment,0,0
97163,of,0,0
97164,metastatic,0,0
97165,colorectal,0,0
97166,cancer,0,0
97167,was,0,0
97168,harmful,0,0
97169,when,0,0
97170,compared,0,0
97171,with,0,0
97172,bevacizumab,0,0
97173,and,0,1
97174,chemotherapy,0,0
97175,alone,0,0
97176,.,0,0
97177,The,0,0
97178,use,0,0
97179,of,0,0
97180,panitumumab,0,0
97181,in,0,0
97182,this,0,0
97183,setting,0,0
97184,can,0,0
97185,not,0,0
97186,be,0,0
97187,recommended,0,0
97188,.,0,0
97189,Ongoing,0,0
97190,Telmisartan,0,0
97191,Alone,0,1
97192,and,0,0
97193,in,0,0
97194,Combination,0,0
97195,With,0,0
97196,Ramipril,0,0
97197,Global,0,1
97198,Endpoint,0,1
97199,Trial,0,0
97200,(,0,0
97201,ONTARGET,0,0
97202,),0,0
97203,:,0,0
97204,implications,0,0
97205,for,0,0
97206,reduced,0,0
97207,cardiovascular,1,1
97208,risk,1,0
97209,.,1,0
97210,The,0,0
97211,recently,0,0
97212,published,0,0
97213,Ongoing,0,0
97214,Telmisartan,0,0
97215,Alone,0,1
97216,and,0,0
97217,in,0,0
97218,Combination,0,0
97219,With,0,0
97220,Ramipril,0,0
97221,Global,0,1
97222,Endpoint,0,1
97223,Trial,0,0
97224,(,0,0
97225,ONTARGET,0,0
97226,),0,0
97227,in,0,0
97228,patients,0,0
97229,with,0,0
97230,vascular,0,1
97231,disease,0,1
97232,or,0,0
97233,high-risk,0,0
97234,diabetes,0,0
97235,",",0,0
97236,as,0,0
97237,the,0,0
97238,largest,0,0
97239,published,0,0
97240,comparative,0,0
97241,trial,0,0
97242,of,0,0
97243,these,0,0
97244,agent,0,0
97245,classes,0,0
97246,",",0,0
97247,provides,0,0
97248,further,0,0
97249,evidence,0,0
97250,concerning,0,0
97251,the,0,0
97252,comparison,0,0
97253,between,0,0
97254,the,0,0
97255,angiotensin-receptor,0,0
97256,blockers,0,0
97257,(,0,0
97258,ARBs,0,1
97259,),0,0
97260,and,0,0
97261,the,0,0
97262,angiotensin-converting,0,0
97263,enzyme,0,0
97264,inhibitors,0,0
97265,(,0,0
97266,ACEIs,0,0
97267,),0,0
97268,.,0,0
97269,In,0,0
97270,this,0,0
97271,trial,0,0
97272,",",0,0
97273,telmisartan,0,0
97274,(,0,0
97275,an,0,0
97276,ARB,0,0
97277,),0,0
97278,was,0,0
97279,non-inferior,0,0
97280,to,0,0
97281,ramipril,0,0
97282,(,0,0
97283,an,0,0
97284,ACEI,0,0
97285,),0,0
97286,in,0,0
97287,reducing,0,0
97288,fatal,1,1
97289,and,1,0
97290,nonfatal,1,1
97291,cardiovascular,1,1
97292,events,1,1
97293,.,1,0
97294,Moreover,0,0
97295,",",0,0
97296,ONTARGET,0,0
97297,is,0,0
97298,an,0,0
97299,example,0,0
97300,of,0,0
97301,a,0,0
97302,high-quality,0,0
97303,noninferiority,0,0
97304,trial,0,0
97305,.,0,0
97306,However,0,0
97307,",",0,0
97308,the,0,0
97309,combination,0,0
97310,of,0,0
97311,the,0,0
97312,2,0,0
97313,agents,0,0
97314,was,0,0
97315,associated,0,0
97316,with,0,0
97317,more,0,0
97318,adverse,1,1
97319,effects,1,1
97320,without,0,0
97321,an,0,0
97322,increase,0,0
97323,in,0,0
97324,benefit,0,0
97325,.,0,0
97326,The,0,0
97327,study,0,0
97328,differed,0,0
97329,from,0,0
97330,several,0,0
97331,other,0,0
97332,comparative,0,0
97333,studies,0,0
97334,in,0,0
97335,which,0,0
97336,the,0,0
97337,dose,0,0
97338,and,0,0
97339,choice,0,0
97340,of,0,1
97341,ACEI,0,0
97342,was,0,0
97343,left,0,0
97344,to,0,0
97345,individual,0,0
97346,physicians,0,0
97347,.,0,0
97348,Further,0,0
97349,",",0,0
97350,in,0,0
97351,ONTARGET,0,0
97352,",",0,0
97353,the,0,0
97354,ACEI,0,0
97355,was,0,0
97356,not,0,0
97357,titrated,0,0
97358,to,0,0
97359,the,0,0
97360,maximum,0,1
97361,dose,0,0
97362,and,0,0
97363,patients,0,0
97364,with,0,0
97365,heart,0,1
97366,failure,0,1
97367,were,0,0
97368,excluded,0,0
97369,.,0,0
97370,Mastication,1,0
97371,and,1,0
97372,late,1,1
97373,mandibular,1,0
97374,fracture,1,1
97375,after,0,0
97376,surgery,0,0
97377,of,0,0
97378,impacted,0,0
97379,third,0,0
97380,molars,0,0
97381,associated,0,0
97382,with,0,0
97383,no,0,0
97384,gross,0,1
97385,pathology,0,0
97386,.,0,0
97387,PURPOSE,0,0
97388,This,0,0
97389,study,0,0
97390,was,0,0
97391,undertaken,0,0
97392,with,0,0
97393,the,0,0
97394,null,0,0
97395,hypothesis,0,0
97396,that,0,0
97397,in,0,0
97398,patients,0,0
97399,",",0,0
97400,fully,0,0
97401,denate,0,0
97402,or,0,0
97403,with,0,0
97404,1,0,0
97405,or,0,0
97406,2,0,0
97407,teeth,0,0
97408,missing,0,0
97409,and,0,0
97410,older,0,0
97411,than,0,0
97412,25,0,0
97413,years,0,0
97414,",",0,0
97415,mastication,0,1
97416,does,0,0
97417,not,0,0
97418,affect,0,0
97419,late,0,0
97420,mandibular,1,0
97421,fracture,1,1
97422,after,0,0
97423,surgical,0,0
97424,removal,0,0
97425,of,0,0
97426,impacted,0,0
97427,third,0,0
97428,molars,0,0
97429,(,0,0
97430,M3s,0,1
97431,),0,0
97432,associated,0,0
97433,with,0,0
97434,no,0,0
97435,gross,0,1
97436,pathology,0,0
97437,.,0,0
97438,MATERIALS,0,0
97439,AND,0,0
97440,METHODS,0,0
97441,Five,0,1
97442,hundred,0,0
97443,sixty,0,0
97444,patients,0,0
97445,",",0,0
97446,fully,0,0
97447,dentate,0,0
97448,or,0,0
97449,with,0,0
97450,1,0,0
97451,or,0,0
97452,2,0,0
97453,teeth,0,0
97454,missing,0,0
97455,and,0,0
97456,older,0,0
97457,than,0,0
97458,25,0,0
97459,years,0,0
97460,who,0,0
97461,had,0,0
97462,no,0,0
97463,gross,0,1
97464,pathology,0,0
97465,associated,0,0
97466,with,0,0
97467,their,0,0
97468,impacted,0,0
97469,lower,0,0
97470,M3s,0,1
97471,",",0,1
97472,were,0,0
97473,recruited,0,0
97474,in,0,0
97475,this,0,0
97476,study,0,0
97477,.,0,0
97478,They,0,0
97479,were,0,0
97480,operated,0,0
97481,on,0,0
97482,under,0,0
97483,local,0,0
97484,anesthesia,0,0
97485,using,0,0
97486,a,0,0
97487,standard,0,0
97488,technique,0,0
97489,and,0,0
97490,randomly,0,0
97491,assigned,0,0
97492,into,0,0
97493,2,0,0
97494,groups,0,0
97495,for,0,0
97496,nonroutine,0,1
97497,(,0,0
97498,NR,0,0
97499,group,0,0
97500,),0,0
97501,and,0,0
97502,routine,0,0
97503,(,0,0
97504,R,0,1
97505,group,0,0
97506,),0,0
97507,postoperative,0,1
97508,instructions,0,0
97509,.,0,0
97510,In,0,0
97511,the,0,0
97512,NR,0,0
97513,group,0,0
97514,",",0,0
97515,patients,0,0
97516,were,0,0
97517,postoperatively,0,0
97518,educated,0,0
97519,in,0,0
97520,the,0,0
97521,possibility,0,0
97522,of,0,0
97523,mandibular,1,0
97524,fracture,1,1
97525,and,0,0
97526,were,0,0
97527,given,0,0
97528,an,0,0
97529,emphasis,0,0
97530,on,0,0
97531,the,0,0
97532,necessity,0,0
97533,of,0,0
97534,limiting,1,0
97535,mastication,1,1
97536,to,0,0
97537,a,0,0
97538,soft,0,0
97539,diet,0,0
97540,for,0,0
97541,4,0,0
97542,weeks,0,0
97543,.,0,0
97544,In,0,0
97545,the,0,0
97546,R,0,0
97547,group,0,0
97548,",",0,0
97549,patients,0,0
97550,were,0,0
97551,given,0,0
97552,no,0,0
97553,such,0,0
97554,education,0,0
97555,or,0,0
97556,emphasis,0,0
97557,.,0,1
97558,Patients,0,0
97559,were,0,0
97560,followed,0,0
97561,up,0,0
97562,for,0,0
97563,2,0,0
97564,months,0,0
97565,",",0,0
97566,and,0,1
97567,data,1,0
97568,concerning,1,0
97569,patients,1,0
97570,',1,0
97571,age,1,0
97572,and,1,0
97573,gender,1,0
97574,;,1,0
97575,tooth,1,1
97576,position,1,1
97577,",",1,1
97578,angulation,1,1
97579,",",1,1
97580,and,1,0
97581,depth,1,1
97582,;,1,0
97583,date,1,1
97584,and,1,1
97585,site,1,1
97586,of,1,0
97587,surgery,1,0
97588,;,1,0
97589,and,1,0
97590,occurrence,1,1
97591,of,1,1
97592,late,1,0
97593,mandibular,1,0
97594,fracture,1,1
97595,were,1,0
97596,recorded,1,0
97597,and,0,0
97598,statistically,0,0
97599,analyzed,0,0
97600,.,0,0
97601,A,0,0
97602,value,0,0
97603,of,0,0
97604,P,0,0
97605,less,0,0
97606,than,0,0
97607,.05,0,0
97608,was,0,0
97609,considered,0,0
97610,statistically,0,0
97611,significant,0,0
97612,.,0,0
97613,RESULTS,0,0
97614,In,0,0
97615,no,0,0
97616,patient,0,0
97617,group,0,0
97618,was,0,0
97619,there,0,0
97620,a,0,0
97621,late,1,0
97622,mandibular,1,0
97623,fracture,1,0
97624,recorded,0,0
97625,.,0,0
97626,All,0,0
97627,patients,0,0
97628,completed,0,0
97629,the,0,0
97630,follow-up,0,0
97631,period,0,0
97632,",",0,0
97633,and,0,1
97634,most,0,0
97635,of,0,0
97636,the,0,0
97637,R,0,0
97638,group,0,0
97639,patients,0,0
97640,had,0,0
97641,normal,0,0
97642,eating,0,1
97643,habits,0,0
97644,10,0,0
97645,to,0,0
97646,14,0,0
97647,days,0,0
97648,after,0,0
97649,surgery,0,0
97650,.,0,0
97651,In,0,0
97652,no,0,0
97653,patient,0,0
97654,group,0,0
97655,was,0,0
97656,there,0,0
97657,a,0,0
97658,statistically,0,0
97659,significant,0,0
97660,difference,0,0
97661,in,0,0
97662,relation,0,0
97663,to,0,0
97664,gender,0,0
97665,(,0,0
97666,P,0,0
97667,=,0,0
97668,.735,0,0
97669,),0,0
97670,",",0,0
97671,site,0,1
97672,of,0,1
97673,surgery,0,0
97674,(,0,0
97675,P,0,0
97676,=,0,0
97677,.552,0,0
97678,),0,0
97679,",",0,0
97680,class,0,0
97681,horizontal,0,1
97682,space,0,1
97683,available,0,0
97684,(,0,0
97685,P,0,0
97686,=,0,0
97687,.427,0,0
97688,),0,0
97689,",",0,0
97690,class,0,0
97691,highest,0,1
97692,portion,0,0
97693,of,0,0
97694,the,0,0
97695,M3,0,1
97696,crown,0,1
97697,(,0,0
97698,P,0,0
97699,=,0,0
97700,.424,0,0
97701,),0,0
97702,",",0,0
97703,angulations,0,1
97704,of,0,0
97705,the,0,0
97706,teeth,0,0
97707,(,0,0
97708,P,0,0
97709,=,0,0
97710,.925,0,0
97711,),0,0
97712,",",0,0
97713,and,0,1
97714,severity,1,1
97715,of,1,1
97716,impaction,1,1
97717,(,0,0
97718,P,0,0
97719,=,0,0
97720,.445,0,0
97721,),0,0
97722,.,0,0
97723,CONCLUSIONS,0,0
97724,In,0,0
97725,patients,0,0
97726,",",0,0
97727,fully,0,0
97728,dentate,0,0
97729,or,0,0
97730,with,0,0
97731,1,0,0
97732,or,0,0
97733,2,0,0
97734,teeth,0,0
97735,missing,0,0
97736,and,0,0
97737,older,0,0
97738,than,0,0
97739,25,0,0
97740,years,0,0
97741,who,0,0
97742,have,0,0
97743,no,0,0
97744,jawbone,0,1
97745,atrophy,0,1
97746,and,0,0
97747,no,0,0
97748,systemic,0,0
97749,problems,0,0
97750,that,0,0
97751,may,0,0
97752,impair,1,0
97753,bone,1,1
97754,strength,1,1
97755,",",0,0
97756,mastication,0,1
97757,seems,0,0
97758,not,0,0
97759,to,0,0
97760,affect,0,0
97761,late,1,0
97762,mandibular,1,0
97763,fracture,1,1
97764,after,0,0
97765,surgical,0,0
97766,removal,0,0
97767,of,0,0
97768,impacted,0,0
97769,M3s,0,1
97770,associated,0,0
97771,with,0,0
97772,no,0,0
97773,gross,0,1
97774,pathology,0,0
97775,.,0,0
97776,The,0,0
97777,remote,0,0
97778,possible,0,0
97779,risk,0,0
97780,of,0,0
97781,the,0,0
97782,late,1,0
97783,fracture,1,1
97784,shown,0,0
97785,in,0,0
97786,our,0,0
97787,patients,0,0
97788,indicates,0,0
97789,the,0,0
97790,need,0,0
97791,for,0,0
97792,no,0,0
97793,special,0,0
97794,precautions,0,0
97795,.,0,0
97796,Diverting,1,0
97797,stoma,1,1
97798,after,0,0
97799,low,0,0
97800,anterior,0,0
97801,resection,0,0
97802,:,0,0
97803,more,0,0
97804,arguments,0,0
97805,in,0,0
97806,favor,0,0
97807,.,0,0
97808,PURPOSE,0,0
97809,The,0,0
97810,necessity,0,0
97811,of,0,0
97812,a,0,0
97813,protective,0,0
97814,stoma,0,0
97815,in,0,0
97816,patients,0,0
97817,undergoing,0,0
97818,low,0,0
97819,anterior,0,1
97820,resection,0,0
97821,with,0,0
97822,total,0,1
97823,mesorectal,0,0
97824,excision,0,0
97825,for,0,0
97826,primary,0,0
97827,rectal,0,0
97828,cancer,0,0
97829,is,0,0
97830,discussed,0,0
97831,controversially,0,0
97832,.,0,0
97833,We,0,0
97834,conducted,0,0
97835,a,0,0
97836,randomized,0,0
97837,",",0,0
97838,controlled,0,0
97839,",",0,0
97840,pilot-study,0,0
97841,to,0,0
97842,evaluate,0,0
97843,the,0,0
97844,need,0,0
97845,for,0,0
97846,diverting,1,0
97847,ileostomy,1,0
97848,in,0,0
97849,patients,0,0
97850,undergoing,0,0
97851,low,0,0
97852,anterior,0,1
97853,resection,0,0
97854,[,0,0
97855,NCT00457327,0,0
97856,],0,0
97857,.,0,0
97858,METHODS,0,0
97859,Forty,0,0
97860,patients,0,0
97861,after,0,0
97862,elective,0,0
97863,sphincter-saving,0,0
97864,low,0,0
97865,anterior,0,1
97866,resection,0,0
97867,were,0,0
97868,eligible,0,0
97869,for,0,0
97870,intraoperative,0,0
97871,randomization,0,0
97872,.,0,0
97873,The,0,0
97874,primary,0,0
97875,objective,0,0
97876,of,0,0
97877,this,0,0
97878,trial,0,0
97879,was,0,0
97880,to,0,0
97881,demonstrate,0,0
97882,similar,1,0
97883,risks,1,1
97884,after,0,0
97885,the,0,0
97886,resection,0,0
97887,with,0,0
97888,both,0,0
97889,techniques,0,0
97890,.,0,0
97891,A,0,0
97892,priori,0,0
97893,stopping,0,0
97894,rules,0,0
97895,were,0,0
97896,defined,0,0
97897,for,0,0
97898,early,0,0
97899,termination,0,0
97900,of,0,0
97901,the,0,0
97902,trial,0,0
97903,.,0,0
97904,RESULTS,0,0
97905,Between,0,0
97906,July,0,0
97907,4,0,0
97908,",",0,0
97909,2006,0,0
97910,and,0,0
97911,March,0,0
97912,12,0,0
97913,",",0,0
97914,2007,0,0
97915,",",0,0
97916,a,0,0
97917,total,0,1
97918,of,0,0
97919,41,0,0
97920,patients,0,0
97921,were,0,0
97922,screened,0,0
97923,and,0,0
97924,34,0,0
97925,patients,0,0
97926,were,0,0
97927,randomized,0,0
97928,.,0,0
97929,Eighteen,0,0
97930,patients,0,0
97931,were,0,0
97932,randomized,0,0
97933,to,0,0
97934,the,0,0
97935,stoma,0,1
97936,group,0,0
97937,and,0,0
97938,16,0,0
97939,patients,0,0
97940,to,0,0
97941,the,0,0
97942,nonstoma,0,0
97943,group,0,0
97944,The,1,0
97945,symptomatic,1,0
97946,anastomotic,1,1
97947,leakage,1,1
97948,rate,1,1
97949,was,0,0
97950,significantly,0,0
97951,higher,0,0
97952,in,0,0
97953,the,0,0
97954,nonstoma,0,0
97955,group,0,0
97956,(,0,0
97957,37.5,0,0
97958,percent,0,0
97959,),0,0
97960,than,0,0
97961,in,0,0
97962,the,0,0
97963,stoma,0,1
97964,group,0,0
97965,(,0,0
97966,5.5,0,0
97967,percent,0,0
97968,",",0,0
97969,P,0,0
97970,=,0,0
97971,0.02,0,0
97972,),0,0
97973,.,0,0
97974,In,0,0
97975,all,0,0
97976,six,0,0
97977,cases,0,0
97978,in,0,0
97979,the,0,0
97980,nonstoma,0,0
97981,group,0,0
97982,",",0,0
97983,reoperations,1,1
97984,were,0,0
97985,necessary,0,0
97986,.,0,0
97987,The,0,0
97988,study,0,0
97989,was,0,0
97990,stopped,0,0
97991,after,0,0
97992,34,0,0
97993,patients,0,0
97994,were,0,0
97995,included,0,0
97996,.,0,0
97997,A,0,0
97998,meta-analysis,0,0
97999,of,0,0
98000,the,0,0
98001,available,0,0
98002,data,0,0
98003,confirmed,0,0
98004,the,0,0
98005,value,0,0
98006,of,0,0
98007,a,0,0
98008,protective,0,0
98009,ostomy,0,0
98010,for,0,0
98011,patients,0,0
98012,undergoing,0,0
98013,low,0,0
98014,anterior,0,0
98015,resection,0,0
98016,.,0,0
98017,CONCLUSIONS,0,0
98018,The,0,0
98019,data,0,0
98020,demonstrate,0,0
98021,a,0,0
98022,high,0,0
98023,risk,0,0
98024,for,0,0
98025,patients,0,0
98026,undergoing,0,0
98027,low,0,0
98028,anterior,0,1
98029,resection,0,0
98030,without,0,0
98031,diverting,0,0
98032,ileostomy,0,0
98033,.,0,0
98034,Pregabalin,0,0
98035,versus,0,0
98036,naltrexone,0,0
98037,in,0,0
98038,alcohol,0,0
98039,dependence,0,0
98040,:,0,0
98041,a,0,0
98042,randomised,0,0
98043,",",0,0
98044,double-blind,0,0
98045,",",0,0
98046,comparison,0,0
98047,trial,0,0
98048,.,0,0
98049,Pregabalin,0,0
98050,(,0,0
98051,PRE,0,0
98052,),0,0
98053,acts,0,0
98054,as,0,0
98055,a,0,0
98056,presynaptic,0,0
98057,inhibitor,0,0
98058,of,0,0
98059,the,0,0
98060,release,0,0
98061,of,0,0
98062,excessive,0,1
98063,levels,0,1
98064,of,0,0
98065,excitatory,0,0
98066,neurotransmitters,0,1
98067,by,0,0
98068,selectively,0,0
98069,binding,0,0
98070,to,0,0
98071,the,0,0
98072,alpha,0,0
98073,(,0,0
98074,2,0,0
98075,),0,0
98076,-delta,0,0
98077,subunit,0,0
98078,of,0,0
98079,voltage-gated,0,1
98080,calcium,0,0
98081,channels,0,0
98082,.,0,0
98083,In,0,0
98084,this,0,0
98085,randomised,0,0
98086,",",0,0
98087,double-blind,0,0
98088,comparison,0,0
98089,trial,0,0
98090,with,0,0
98091,naltrexone,0,0
98092,(,0,0
98093,NAL,0,0
98094,),0,0
98095,",",0,0
98096,we,0,0
98097,aimed,0,0
98098,to,0,0
98099,investigate,0,0
98100,the,0,0
98101,efficacy,0,1
98102,of,0,0
98103,PRE,0,0
98104,on,0,0
98105,alcohol,1,0
98106,drinking,1,1
98107,indices,1,1
98108,.,1,0
98109,Craving,1,0
98110,reduction,1,1
98111,and,0,1
98112,improvement,1,1
98113,of,1,1
98114,psychiatric,1,0
98115,symptoms,1,1
98116,were,0,0
98117,the,0,0
98118,secondary,0,0
98119,endpoints,0,1
98120,.,0,0
98121,Seventy-one,0,0
98122,alcohol-dependent,0,0
98123,subjects,0,0
98124,were,0,0
98125,detoxified,0,0
98126,and,0,0
98127,subsequently,0,0
98128,randomised,0,0
98129,into,0,0
98130,two,0,0
98131,groups,0,0
98132,",",0,0
98133,receiving,0,0
98134,50,0,0
98135,mg,0,0
98136,of,0,0
98137,NAL,0,0
98138,or,0,0
98139,150-450,0,1
98140,mg,0,0
98141,of,0,0
98142,PRE,0,0
98143,.,0,0
98144,Craving,1,1
98145,(,1,0
98146,VAS,1,0
98147,;,1,0
98148,OCDS,1,0
98149,),1,0
98150,",",1,0
98151,withdrawal,1,1
98152,(,1,1
98153,CIWA-Ar,1,1
98154,),1,0
98155,and,1,0
98156,psychiatric,1,0
98157,symptoms,1,1
98158,(,1,0
98159,SCL-90-R,1,1
98160,),1,0
98161,rating,1,1
98162,scales,1,1
98163,were,0,0
98164,applied,0,0
98165,.,0,0
98166,Alcohol,1,0
98167,drinking,1,1
98168,indices,1,1
98169,and,1,0
98170,craving,1,1
98171,scores,1,1
98172,were,0,0
98173,not,0,0
98174,significantly,0,0
98175,different,0,0
98176,between,0,0
98177,groups,0,0
98178,.,0,0
98179,Compared,0,0
98180,with,0,0
98181,NAL,0,0
98182,",",0,0
98183,PRE,0,0
98184,resulted,0,0
98185,in,0,0
98186,greater,0,0
98187,improvement,0,1
98188,of,0,1
98189,specific,0,0
98190,symptoms,0,1
98191,in,0,0
98192,the,0,0
98193,areas,0,0
98194,of,0,0
98195,anxiety,1,1
98196,",",1,0
98197,hostility,1,1
98198,and,1,1
98199,psychoticism,1,1
98200,",",1,1
98201,and,1,1
98202,survival,1,1
98203,function,1,1
98204,(,1,0
98205,duration,1,1
98206,of,1,0
98207,abstinence,1,1
98208,from,1,0
98209,alcohol,1,0
98210,),1,0
98211,.,0,0
98212,PRE,0,0
98213,also,0,0
98214,resulted,0,0
98215,in,0,0
98216,better,0,0
98217,outcome,0,1
98218,in,0,0
98219,patients,0,0
98220,reporting,0,0
98221,a,0,0
98222,comorbid,0,0
98223,psychiatric,0,0
98224,disorder,0,0
98225,.,0,0
98226,Results,0,0
98227,from,0,0
98228,this,0,0
98229,study,0,0
98230,globally,0,0
98231,place,0,0
98232,PRE,0,0
98233,within,0,0
98234,the,0,0
98235,same,0,0
98236,range,0,0
98237,of,0,0
98238,efficacy,0,1
98239,as,0,0
98240,that,0,0
98241,of,0,0
98242,NAL,0,0
98243,.,0,0
98244,The,0,0
98245,mechanism,0,0
98246,involved,0,0
98247,in,0,0
98248,the,0,0
98249,efficacy,0,1
98250,of,0,0
98251,PRE,0,0
98252,in,0,0
98253,relapse,0,1
98254,prevention,0,0
98255,could,0,0
98256,be,0,0
98257,less,0,0
98258,related,0,0
98259,to,0,0
98260,alcohol,1,0
98261,craving,1,1
98262,and,0,0
98263,more,0,0
98264,associated,0,0
98265,with,0,0
98266,the,0,0
98267,treatment,0,0
98268,of,0,0
98269,the,0,0
98270,comorbid,0,0
98271,psychiatric,0,0
98272,symptomatology,0,1
98273,.,0,0
98274,Deep,1,0
98275,vein,1,1
98276,thrombosis,1,1
98277,in,0,0
98278,acute,0,0
98279,spinal,0,0
98280,cord,0,0
98281,injury,0,0
98282,.,0,0
98283,STUDY,0,1
98284,DESIGN,0,0
98285,Randomized,0,0
98286,study,0,0
98287,.,0,0
98288,OBJECTIVES,0,0
98289,To,0,0
98290,find,0,0
98291,out,0,0
98292,the,0,0
98293,incidence,0,1
98294,of,0,0
98295,deep,0,0
98296,vein,0,1
98297,thrombosis,0,1
98298,(,0,0
98299,DVT,0,1
98300,),0,0
98301,in,0,0
98302,acute,0,0
98303,spinal,0,0
98304,cord,0,1
98305,injury,0,1
98306,(,0,0
98307,SCI,0,1
98308,),0,0
98309,patients,0,0
98310,with,0,0
98311,and,0,0
98312,without,0,0
98313,therapeutic,0,0
98314,prophylaxis,0,0
98315,.,0,0
98316,SETTING,0,0
98317,Patients,0,0
98318,admitted,0,0
98319,in,0,0
98320,the,0,0
98321,department,0,0
98322,of,0,0
98323,Physical,0,1
98324,Medicine,0,0
98325,&,0,0
98326,Rehabilitation,0,1
98327,",",0,0
98328,SMS,0,1
98329,Medical,0,0
98330,College,0,0
98331,",",0,0
98332,Jaipur,0,0
98333,",",0,0
98334,India,0,0
98335,.,0,0
98336,METHODS,0,0
98337,All,0,0
98338,297,0,0
98339,patients,0,0
98340,received,0,0
98341,physical,0,1
98342,therapy,0,0
98343,measures,0,1
98344,and,0,1
98345,were,0,0
98346,randomly,0,0
98347,divided,0,0
98348,into,0,0
98349,two,0,0
98350,groups,0,0
98351,.,0,0
98352,166,0,0
98353,patients,0,0
98354,received,0,0
98355,prophylactic,0,0
98356,heparin,0,0
98357,",",0,0
98358,whereas,0,0
98359,131,0,0
98360,patients,0,0
98361,did,0,0
98362,not,0,0
98363,.,0,0
98364,RESULTS,0,0
98365,A,0,0
98366,total,0,0
98367,of,0,0
98368,three,0,0
98369,cases,0,0
98370,(,0,0
98371,1.8,0,0
98372,%,0,0
98373,),0,0
98374,in,0,0
98375,study,0,0
98376,group,0,0
98377,and,0,0
98378,four,0,0
98379,cases,0,0
98380,(,0,0
98381,3,0,0
98382,%,0,0
98383,),0,0
98384,in,0,0
98385,control,0,0
98386,group,0,0
98387,developed,0,0
98388,DVT,0,0
98389,.,0,0
98390,This,0,0
98391,difference,1,0
98392,was,1,0
98393,statistically,1,0
98394,insignificant,1,0
98395,(,0,0
98396,P,0,0
98397,>,0,0
98398,0.05,0,0
98399,),0,0
98400,.,0,0
98401,CONCLUSION,0,0
98402,Incidence,1,1
98403,of,1,0
98404,DVT,1,0
98405,in,0,0
98406,SCI,0,0
98407,is,0,0
98408,low,1,0
98409,in,0,0
98410,our,0,0
98411,study,0,0
98412,.,0,0
98413,Social,0,1
98414,competence,0,1
98415,and,0,1
98416,social,0,1
98417,skills,0,1
98418,training,0,0
98419,and,0,0
98420,intervention,0,0
98421,for,0,0
98422,children,0,0
98423,with,0,0
98424,Autism,0,1
98425,Spectrum,0,0
98426,Disorders,0,0
98427,.,0,0
98428,This,0,0
98429,study,0,0
98430,examined,0,0
98431,the,0,0
98432,effectiveness,0,0
98433,of,0,0
98434,a,0,0
98435,30,0,0
98436,week,0,0
98437,social,0,1
98438,competence,0,1
98439,and,0,0
98440,social,0,1
98441,skills,0,1
98442,group,0,0
98443,intervention,0,0
98444,program,0,0
98445,with,0,0
98446,children,0,0
98447,",",0,0
98448,ages,0,0
98449,7-11,0,0
98450,",",0,0
98451,diagnosed,0,0
98452,with,0,0
98453,Autism,0,1
98454,Spectrum,0,0
98455,Disorders,0,1
98456,(,0,0
98457,ASD,0,0
98458,),0,0
98459,.,0,0
98460,Eighteen,0,0
98461,children,0,0
98462,with,0,0
98463,ASD,0,0
98464,were,0,0
98465,assessed,0,0
98466,with,0,0
98467,pretreatment,0,0
98468,and,0,1
98469,posttreatment,0,1
98470,measures,0,1
98471,on,0,0
98472,the,0,0
98473,Walker-McConnell,1,0
98474,Scale,1,1
98475,(,1,0
98476,WMS,1,0
98477,),1,0
98478,and,1,0
98479,the,1,0
98480,MGH,1,0
98481,YouthCare,1,1
98482,Social,1,1
98483,Competence,1,1
98484,Development,1,0
98485,Scale,1,1
98486,.,1,0
98487,Each,0,0
98488,received,0,0
98489,the,0,0
98490,30-week,0,0
98491,intervention,0,0
98492,program,0,0
98493,.,0,0
98494,For,0,0
98495,comparison,0,0
98496,",",0,0
98497,a,0,0
98498,matched,0,0
98499,sample,0,0
98500,of,0,0
98501,ten,0,0
98502,non-ASD,0,0
98503,children,0,0
98504,was,0,0
98505,also,0,0
98506,assessed,0,0
98507,",",0,0
98508,but,0,0
98509,received,0,0
98510,no,0,0
98511,treatment,0,0
98512,.,0,0
98513,The,0,0
98514,findings,0,0
98515,indicated,0,0
98516,that,0,0
98517,each,0,0
98518,ASD,0,0
98519,intervention,0,0
98520,group,0,0
98521,demonstrated,0,0
98522,significant,0,0
98523,gains,0,1
98524,on,0,0
98525,the,0,0
98526,WMS,1,0
98527,and,0,0
98528,significant,0,0
98529,improvement,0,1
98530,in,0,0
98531,the,0,0
98532,areas,0,0
98533,of,0,0
98534,anxiety,1,1
98535,management,1,0
98536,",",1,0
98537,joint,1,1
98538,attention,1,1
98539,",",1,0
98540,and,1,0
98541,flexibility/transitions,1,0
98542,.,1,0
98543,Results,0,0
98544,suggest,0,0
98545,that,0,0
98546,this,0,0
98547,approach,0,0
98548,can,0,0
98549,be,0,0
98550,effective,0,0
98551,in,0,0
98552,improving,0,1
98553,core,0,0
98554,social,1,1
98555,deficits,1,0
98556,in,0,0
98557,individuals,0,0
98558,with,0,0
98559,ASD,0,0
98560,.,0,0
98561,Rationale,0,1
98562,and,0,0
98563,design,0,0
98564,of,0,0
98565,RE-LY,0,0
98566,:,0,0
98567,randomized,0,0
98568,evaluation,0,0
98569,of,0,0
98570,long-term,0,0
98571,anticoagulant,0,1
98572,therapy,0,0
98573,",",0,0
98574,warfarin,0,0
98575,",",0,0
98576,compared,0,0
98577,with,0,0
98578,dabigatran,0,0
98579,.,0,0
98580,Vitamin,0,0
98581,K,0,0
98582,antagonists,0,0
98583,(,0,0
98584,VKAs,0,0
98585,),0,0
98586,are,0,0
98587,effective,0,0
98588,for,0,0
98589,stroke,0,1
98590,prevention,0,0
98591,in,0,0
98592,patients,0,0
98593,with,0,0
98594,atrial,0,1
98595,fibrillation,0,1
98596,(,0,0
98597,AF,0,1
98598,),0,0
98599,but,0,0
98600,are,0,0
98601,difficult,0,0
98602,to,0,0
98603,use,0,0
98604,.,0,0
98605,Dabigatran,0,0
98606,etexilate,0,0
98607,is,0,0
98608,a,0,0
98609,prodrug,0,0
98610,that,0,0
98611,is,0,0
98612,rapidly,0,0
98613,converted,0,0
98614,to,0,0
98615,the,0,0
98616,active,0,0
98617,direct,0,0
98618,thrombin,0,1
98619,inhibitor,0,0
98620,dabigatran,0,0
98621,.,0,0
98622,It,0,0
98623,is,0,0
98624,administered,0,0
98625,in,0,0
98626,a,0,0
98627,fixed,0,0
98628,dose,0,0
98629,without,0,0
98630,laboratory,0,0
98631,monitoring,0,0
98632,and,0,0
98633,is,0,0
98634,being,0,0
98635,compared,0,0
98636,with,0,0
98637,warfarin,0,0
98638,(,0,0
98639,international,0,0
98640,normalized,0,0
98641,ratio,0,1
98642,2-3,0,0
98643,),0,0
98644,in,0,0
98645,the,0,0
98646,RE-LY,0,0
98647,trial,0,0
98648,.,0,0
98649,Two,0,0
98650,doses,0,0
98651,of,0,0
98652,dabigatran,0,0
98653,(,0,0
98654,110,0,0
98655,and,0,0
98656,150,0,0
98657,mg,0,0
98658,BID,0,0
98659,),0,0
98660,are,0,0
98661,being,0,0
98662,evaluated,0,0
98663,.,0,0
98664,RE-LY,0,0
98665,is,0,0
98666,a,0,0
98667,phase,0,0
98668,3,0,0
98669,",",0,0
98670,prospective,0,0
98671,",",0,0
98672,randomized,0,0
98673,",",0,0
98674,open-label,0,0
98675,multinational,0,0
98676,(,0,0
98677,44,0,0
98678,countries,0,0
98679,),0,0
98680,trial,0,0
98681,of,0,0
98682,patients,0,0
98683,with,0,0
98684,nonvalvular,0,0
98685,AF,0,0
98686,and,0,0
98687,at,0,0
98688,least,0,0
98689,1,0,0
98690,risk,0,0
98691,factor,0,0
98692,for,0,0
98693,stroke,0,1
98694,.,0,0
98695,Recruitment,0,1
98696,concluded,0,0
98697,with,0,0
98698,a,0,0
98699,total,0,0
98700,of,0,0
98701,"18,113",0,0
98702,patients,0,0
98703,.,0,0
98704,Patients,0,0
98705,who,0,0
98706,were,0,0
98707,VKA-naive,0,0
98708,and,0,0
98709,experienced,0,0
98710,are,0,0
98711,included,0,0
98712,in,0,0
98713,balanced,0,0
98714,proportions,0,0
98715,.,0,0
98716,The,0,0
98717,primary,0,0
98718,outcome,0,0
98719,is,0,0
98720,stroke,1,1
98721,(,1,0
98722,including,1,0
98723,hemorrhagic,1,1
98724,),1,0
98725,or,0,0
98726,systemic,1,1
98727,embolism,1,1
98728,.,1,0
98729,Safety,0,1
98730,outcomes,0,0
98731,are,0,0
98732,bleeding,1,1
98733,",",1,0
98734,liver,1,1
98735,function,1,1
98736,abnormalities,1,1
98737,",",1,0
98738,and,1,1
98739,other,1,0
98740,adverse,1,1
98741,events,1,1
98742,.,1,0
98743,Adjudication,0,1
98744,of,0,0
98745,end,0,0
98746,points,0,0
98747,is,0,0
98748,blinded,0,0
98749,to,0,0
98750,drug,0,0
98751,assignment,0,0
98752,.,0,0
98753,The,0,0
98754,trial,0,0
98755,is,0,0
98756,expected,0,0
98757,to,0,0
98758,accrue,0,0
98759,a,0,0
98760,minimum,0,0
98761,of,0,0
98762,450,0,0
98763,events,0,1
98764,with,0,0
98765,a,0,0
98766,minimum,0,1
98767,1-year,0,0
98768,of,0,0
98769,follow-up,0,0
98770,.,0,0
98771,RE-LY,0,0
98772,is,0,0
98773,the,0,0
98774,largest,0,0
98775,AF,0,0
98776,stroke,0,1
98777,prevention,0,0
98778,trial,0,0
98779,yet,0,0
98780,undertaken,0,0
98781,.,0,0
98782,It,0,0
98783,is,0,0
98784,unique,0,0
98785,because,0,0
98786,it,0,0
98787,includes,0,0
98788,equal,0,0
98789,numbers,0,1
98790,of,0,0
98791,VKA-experienced,0,0
98792,and,0,0
98793,naive,0,0
98794,patients,0,0
98795,and,0,0
98796,evaluates,0,0
98797,2,0,0
98798,different,0,0
98799,dosages,0,0
98800,of,0,0
98801,dabigatran,0,0
98802,",",0,0
98803,which,0,0
98804,may,0,0
98805,allow,0,0
98806,tailoring,0,0
98807,of,0,0
98808,dosing,0,0
98809,to,0,0
98810,individual,0,0
98811,patient,0,0
98812,needs,0,0
98813,.,0,0
98814,The,0,0
98815,worldwide,0,0
98816,site,0,1
98817,distribution,0,1
98818,and,0,1
98819,broad,0,0
98820,range,0,0
98821,of,0,0
98822,stroke,0,1
98823,risk,0,0
98824,further,0,0
98825,increase,0,0
98826,the,0,0
98827,general,0,0
98828,applicability,0,0
98829,of,0,0
98830,the,0,0
98831,trial,0,0
98832,.,0,0
98833,Results,0,0
98834,are,0,0
98835,expected,0,0
98836,in,0,0
98837,2009,0,0
98838,.,0,0
98839,Pulse,0,1
98840,oximeter,0,0
98841,perfusion,0,1
98842,index,0,1
98843,as,0,0
98844,an,0,0
98845,early,0,0
98846,indicator,0,0
98847,of,0,0
98848,sympathectomy,0,0
98849,after,0,0
98850,epidural,0,0
98851,anesthesia,0,0
98852,.,0,0
98853,BACKGROUND,0,0
98854,The,0,0
98855,pulse,0,0
98856,oximeter,0,0
98857,perfusion,0,1
98858,index,0,1
98859,(,0,0
98860,PI,0,0
98861,),0,0
98862,has,0,0
98863,been,0,0
98864,used,0,0
98865,to,0,0
98866,indicate,0,0
98867,sympathectomy-induced,0,0
98868,vasodilatation,0,1
98869,.,0,0
98870,We,0,0
98871,hypothesized,0,0
98872,that,0,0
98873,pulse,0,1
98874,oximeter,0,0
98875,PI,0,0
98876,provides,0,0
98877,an,0,0
98878,earlier,0,0
98879,and,0,0
98880,clearer,0,1
98881,indication,0,0
98882,of,0,1
98883,sympathectomy,0,0
98884,following,0,0
98885,epidural,0,0
98886,anesthesia,0,0
98887,than,0,0
98888,skin,0,1
98889,temperature,0,1
98890,and,0,0
98891,arterial,0,1
98892,pressure,0,1
98893,.,0,0
98894,METHODS,0,0
98895,Forty,0,0
98896,patients,0,0
98897,received,0,0
98898,lumbar,0,0
98899,epidural,0,0
98900,catheters,0,0
98901,.,0,0
98902,Patients,0,0
98903,were,0,0
98904,randomized,0,0
98905,to,0,0
98906,receive,0,0
98907,either,0,0
98908,10,0,0
98909,ml,0,0
98910,0.5,0,0
98911,%,0,0
98912,bupivacaine,0,0
98913,or,0,0
98914,10,0,0
98915,ml,0,0
98916,0.25,0,0
98917,%,0,0
98918,bupivacaine,0,0
98919,.,0,0
98920,PI,1,0
98921,in,1,0
98922,the,1,0
98923,toe,1,1
98924,",",1,0
98925,mean,1,1
98926,arterial,1,1
98927,pressure,1,1
98928,(,1,0
98929,MAP,1,1
98930,),1,0
98931,and,1,0
98932,toe,1,1
98933,temperature,1,1
98934,were,0,0
98935,all,0,0
98936,assessed,0,0
98937,at,0,0
98938,baseline,0,0
98939,and,0,0
98940,at,0,0
98941,5,0,0
98942,",",0,0
98943,10,0,0
98944,and,0,0
98945,20,0,0
98946,min,0,0
98947,following,0,0
98948,epidural,0,0
98949,anesthesia,0,0
98950,.,0,0
98951,The,0,0
98952,effect,1,0
98953,of,0,0
98954,epidural,0,0
98955,anesthesia,0,0
98956,over,0,0
98957,time,0,1
98958,was,0,0
98959,assessed,0,0
98960,by,0,0
98961,repeated,0,0
98962,measures,1,1
98963,analysis,1,0
98964,of,1,0
98965,variance,1,0
98966,.,1,0
98967,Additionally,0,0
98968,",",0,0
98969,we,0,0
98970,defined,0,0
98971,clinically,1,0
98972,evident,1,0
98973,sympathectomy,1,0
98974,criteria,1,0
98975,(,1,0
98976,a,1,0
98977,100,1,0
98978,%,1,0
98979,increase,1,0
98980,in,1,0
98981,the,1,0
98982,PI,1,0
98983,",",1,0
98984,a,1,0
98985,15,1,0
98986,%,1,0
98987,decrease,1,0
98988,in,1,0
98989,MAP,1,0
98990,and,1,0
98991,a,1,0
98992,1,1,0
98993,degrees,1,0
98994,C,1,0
98995,increase,1,0
98996,in,1,0
98997,toe,1,1
98998,temperature,1,1
98999,),1,0
99000,.,1,0
99001,The,0,0
99002,numbers,0,1
99003,of,0,0
99004,patients,0,0
99005,demonstrating,0,0
99006,these,0,0
99007,changes,1,0
99008,for,0,0
99009,each,0,0
99010,test,0,0
99011,were,0,0
99012,compared,0,0
99013,using,0,0
99014,the,0,0
99015,McNemar,1,0
99016,test,1,0
99017,for,0,0
99018,each,0,0
99019,time,0,1
99020,point,0,0
99021,.,0,0
99022,RESULTS,0,0
99023,Twenty-nine,0,0
99024,subjects,0,0
99025,had,0,0
99026,photoplethysmography,1,0
99027,signals,1,1
99028,that,0,0
99029,met,0,0
99030,a,0,0
99031,priori,0,0
99032,signal,0,1
99033,quality,0,1
99034,criteria,0,0
99035,for,0,0
99036,analysis,0,0
99037,.,0,0
99038,By,0,0
99039,20,0,0
99040,min,0,0
99041,",",0,0
99042,PI,1,0
99043,increased,0,0
99044,by,0,0
99045,326,0,0
99046,%,0,0
99047,",",0,0
99048,compared,0,0
99049,with,0,0
99050,a,0,0
99051,10,0,0
99052,%,0,0
99053,decrease,0,0
99054,and,0,0
99055,a,0,0
99056,3,0,0
99057,%,0,0
99058,increase,0,0
99059,in,0,0
99060,MAP,1,0
99061,and,1,0
99062,toe,1,1
99063,temperature,1,1
99064,",",0,0
99065,respectively,0,0
99066,.,0,0
99067,For,0,0
99068,PI,0,0
99069,15/29,0,0
99070,",",0,0
99071,26/29,0,0
99072,and,0,0
99073,29/29,0,0
99074,of,0,0
99075,the,0,0
99076,subjects,0,0
99077,met,0,0
99078,the,0,0
99079,sympathectomy,1,0
99080,criteria,1,0
99081,at,0,0
99082,5,0,0
99083,",",0,0
99084,10,0,0
99085,and,0,0
99086,20,0,0
99087,min,0,0
99088,",",0,0
99089,respectively,0,0
99090,",",0,0
99091,compared,0,0
99092,with,0,0
99093,4/29,0,0
99094,",",0,0
99095,6/29,0,0
99096,and,0,0
99097,18/29,0,0
99098,for,0,0
99099,MAP,1,0
99100,changes,0,1
99101,and,0,0
99102,3/29,0,0
99103,",",0,0
99104,8/29,0,0
99105,and,0,0
99106,14/29,0,0
99107,for,0,0
99108,toe,0,0
99109,temperature,1,1
99110,changes,1,1
99111,.,1,0
99112,CONCLUSIONS,0,0
99113,PI,0,0
99114,was,0,0
99115,an,0,0
99116,earlier,0,0
99117,",",0,0
99118,clearer,0,1
99119,and,0,1
99120,more,0,0
99121,sensitive,0,1
99122,indicator,0,0
99123,of,0,0
99124,the,0,0
99125,development,0,0
99126,of,0,0
99127,epidural-induced,0,0
99128,sympathectomy,0,0
99129,than,0,0
99130,either,0,0
99131,skin,1,1
99132,temperature,1,1
99133,or,0,0
99134,MAP,1,0
99135,.,1,0
99136,Ambulatory,0,1
99137,blood,1,1
99138,pressure,1,1
99139,control,0,0
99140,with,0,0
99141,bedtime,0,0
99142,aspirin,0,0
99143,administration,0,0
99144,in,0,0
99145,subjects,0,0
99146,with,0,0
99147,prehypertension,0,0
99148,.,0,0
99149,BACKGROUND,0,0
99150,Aspirin,0,0
99151,has,0,0
99152,been,0,0
99153,found,0,0
99154,to,0,0
99155,prevent,0,0
99156,angiotensin,0,0
99157,II-induced,0,0
99158,hypertension,0,1
99159,and,0,0
99160,to,0,0
99161,induce,0,0
99162,nitric,0,1
99163,oxide,0,0
99164,(,0,0
99165,NO,0,1
99166,),0,0
99167,release,0,1
99168,from,0,0
99169,vascular,0,1
99170,endothelium,0,0
99171,.,0,0
99172,Low-dose,0,0
99173,aspirin,0,0
99174,has,0,0
99175,also,0,0
99176,been,0,0
99177,shown,0,0
99178,to,0,0
99179,reduce,0,0
99180,blood,1,1
99181,pressure,1,1
99182,(,1,0
99183,BP,1,1
99184,),1,0
99185,when,0,0
99186,administered,0,0
99187,at,0,0
99188,bedtime,0,0
99189,",",0,0
99190,as,0,0
99191,opposed,0,0
99192,to,0,0
99193,upon,0,0
99194,awakening,0,1
99195,",",0,0
99196,in,0,0
99197,untreated,0,0
99198,hypertensive,0,0
99199,patients,0,0
99200,and,0,0
99201,high-risk,0,0
99202,pregnant,0,0
99203,women,0,0
99204,.,0,0
99205,Accordingly,0,0
99206,",",0,0
99207,we,0,0
99208,investigated,0,0
99209,the,0,0
99210,effects,0,0
99211,on,0,0
99212,ambulatory,1,0
99213,BP,1,1
99214,of,0,0
99215,aspirin,0,0
99216,administered,0,0
99217,at,0,0
99218,different,0,0
99219,times,0,0
99220,of,0,0
99221,the,0,0
99222,day,0,0
99223,in,0,0
99224,prehypertension,0,0
99225,.,0,0
99226,METHODS,0,0
99227,We,0,0
99228,studied,0,0
99229,244,0,0
99230,subjects,0,0
99231,with,0,0
99232,prehypertension,0,0
99233,",",0,0
99234,43.0,0,0
99235,+/-,0,0
99236,13.0,0,0
99237,years,0,0
99238,of,0,0
99239,age,0,0
99240,",",0,0
99241,randomly,0,0
99242,divided,0,0
99243,in,0,0
99244,three,0,0
99245,groups,0,0
99246,:,0,0
99247,nonpharmacological,0,0
99248,hygienic-dietary,0,0
99249,recommendations,0,0
99250,;,0,0
99251,the,0,0
99252,same,0,0
99253,recommendations,0,0
99254,and,0,1
99255,aspirin,0,0
99256,(,0,0
99257,100,0,0
99258,mg/day,0,0
99259,),0,0
99260,on,0,0
99261,awakening,0,1
99262,;,0,0
99263,or,0,0
99264,the,0,0
99265,same,0,0
99266,recommendations,0,0
99267,and,0,0
99268,aspirin,0,0
99269,at,0,0
99270,bedtime,0,0
99271,.,0,0
99272,BP,1,1
99273,was,0,0
99274,measured,0,0
99275,for,0,0
99276,48,0,0
99277,consecutive,0,0
99278,hours,0,0
99279,before,0,0
99280,and,0,0
99281,after,0,0
99282,3,0,0
99283,months,0,0
99284,of,0,0
99285,intervention,0,0
99286,.,0,0
99287,RESULTS,0,0
99288,Ambulatory,1,1
99289,BP,1,1
99290,was,0,0
99291,unchanged,0,0
99292,in,0,0
99293,subjects,0,0
99294,randomized,0,0
99295,to,0,0
99296,either,0,0
99297,nonpharmacological,0,0
99298,intervention,0,0
99299,or,0,0
99300,aspirin,0,0
99301,on,0,0
99302,awakening,0,1
99303,.,0,0
99304,A,0,0
99305,significant,0,0
99306,ambulatory,1,0
99307,BP,1,1
99308,reduction,0,1
99309,was,0,0
99310,",",0,0
99311,however,0,0
99312,",",0,0
99313,observed,0,0
99314,in,0,0
99315,the,0,0
99316,subjects,0,0
99317,who,0,0
99318,received,0,0
99319,aspirin,0,0
99320,at,0,0
99321,bedtime,0,0
99322,(,0,0
99323,decrease,0,0
99324,of,0,0
99325,6/3,0,0
99326,mm,0,0
99327,Hg,0,0
99328,in,0,0
99329,the,0,0
99330,24-h,0,1
99331,mean,0,1
99332,of,0,0
99333,systolic,1,1
99334,(,1,0
99335,SBP,1,1
99336,),1,0
99337,/diastolic,1,0
99338,BP,1,1
99339,(,1,0
99340,DBP,1,1
99341,),1,0
99342,",",0,0
99343,respectively,0,0
99344,;,0,0
99345,P,0,0
99346,<,0,0
99347,0.001,0,0
99348,),0,0
99349,",",0,0
99350,without,0,0
99351,changes,0,1
99352,in,0,0
99353,heart,1,1
99354,rate,1,1
99355,(,1,0
99356,HR,1,1
99357,),1,0
99358,from,0,0
99359,baseline,0,0
99360,.,0,0
99361,BP,1,1
99362,was,0,0
99363,homogeneously,0,0
99364,controlled,0,0
99365,along,0,0
99366,the,0,0
99367,24,0,0
99368,h,0,0
99369,after,0,0
99370,bedtime,0,0
99371,aspirin,0,0
99372,administration,0,0
99373,(,0,0
99374,6/4,0,0
99375,mm,0,0
99376,Hg,0,0
99377,reduction,0,1
99378,in,0,0
99379,activity,0,1
99380,mean,0,1
99381,of,0,0
99382,SBP/DBP,0,0
99383,;,0,0
99384,6/3,0,0
99385,mm,0,0
99386,Hg,0,0
99387,reduction,0,1
99388,in,0,0
99389,sleep-time,0,1
99390,mean,0,1
99391,",",0,0
99392,respectively,0,0
99393,),0,0
99394,.,0,0
99395,CONCLUSIONS,0,0
99396,This,0,0
99397,prospective,0,0
99398,trial,0,0
99399,documents,0,0
99400,a,0,0
99401,significant,0,0
99402,effect,0,0
99403,on,0,0
99404,BP,1,1
99405,of,0,0
99406,low,0,0
99407,dose,0,0
99408,aspirin,0,0
99409,only,0,0
99410,when,0,0
99411,ingested,0,0
99412,at,0,0
99413,bedtime,0,0
99414,by,0,0
99415,prehypertensive,0,0
99416,subjects,0,0
99417,.,0,0
99418,The,0,0
99419,timed,0,0
99420,administration,0,0
99421,of,0,0
99422,low-dose,0,0
99423,aspirin,0,0
99424,could,0,0
99425,thus,0,0
99426,provide,0,0
99427,a,0,0
99428,valuable,0,0
99429,and,0,0
99430,cost-effective,0,0
99431,approach,0,0
99432,for,0,0
99433,BP,1,1
99434,control,1,0
99435,in,0,0
99436,subjects,0,0
99437,at,0,0
99438,elevated,0,0
99439,risk,0,1
99440,of,0,0
99441,developing,0,0
99442,hypertension,0,0
99443,.,0,0
99444,Randomized,0,0
99445,",",0,0
99446,double-blind,0,0
99447,",",0,1
99448,multicenter,0,0
99449,",",0,1
99450,controlled,0,0
99451,trial,0,0
99452,of,0,0
99453,ibuprofen,0,0
99454,versus,0,0
99455,acetaminophen,0,0
99456,(,0,0
99457,paracetamol,0,0
99458,),0,1
99459,and,0,0
99460,placebo,0,0
99461,for,0,0
99462,treatment,0,0
99463,of,0,0
99464,symptoms,1,1
99465,of,1,0
99466,tonsillitis,1,0
99467,and,1,1
99468,pharyngitis,1,1
99469,in,0,0
99470,children,0,0
99471,.,0,0
99472,MDM2,0,1
99473,and,0,1
99474,Ki-67,0,0
99475,predict,0,0
99476,for,0,0
99477,distant,1,1
99478,metastasis,1,1
99479,and,1,1
99480,mortality,1,1
99481,in,0,0
99482,men,0,0
99483,treated,0,0
99484,with,0,0
99485,radiotherapy,0,0
99486,and,0,1
99487,androgen,0,1
99488,deprivation,0,0
99489,for,0,0
99490,prostate,0,0
99491,cancer,0,0
99492,:,0,0
99493,RTOG,0,0
99494,92-02,0,0
99495,.,0,0
99496,PURPOSE,0,0
99497,MDM2,0,0
99498,regulates,0,1
99499,p53,0,1
99500,",",0,0
99501,which,0,0
99502,controls,0,0
99503,cell,0,1
99504,cycle,0,1
99505,arrest,0,1
99506,and,0,0
99507,apoptosis,0,1
99508,.,0,0
99509,Both,0,0
99510,proteins,0,0
99511,",",0,0
99512,along,0,0
99513,with,0,0
99514,Ki-67,0,0
99515,",",0,0
99516,which,0,0
99517,is,0,0
99518,an,0,0
99519,established,0,0
99520,strong,0,0
99521,determinant,0,0
99522,of,0,0
99523,metastasis,0,1
99524,",",0,0
99525,have,0,0
99526,shown,0,0
99527,promise,0,0
99528,in,0,0
99529,predicting,0,0
99530,the,0,0
99531,outcome,0,0
99532,of,0,0
99533,men,0,0
99534,treated,0,0
99535,with,0,0
99536,radiation,0,0
99537,therapy,0,0
99538,(,0,0
99539,RT,0,0
99540,),0,0
99541,with,0,0
99542,or,0,0
99543,without,0,0
99544,short-term,0,1
99545,androgen,0,1
99546,deprivation,0,0
99547,(,0,0
99548,STAD,0,0
99549,),0,0
99550,.,0,0
99551,This,0,0
99552,report,0,0
99553,compares,0,0
99554,the,0,0
99555,utility,0,0
99556,of,0,0
99557,abnormal,0,1
99558,expression,0,1
99559,of,0,0
99560,these,0,0
99561,biomarkers,0,0
99562,in,0,0
99563,estimating,0,0
99564,progression,0,1
99565,in,0,0
99566,a,0,0
99567,cohort,0,0
99568,of,0,0
99569,men,0,0
99570,treated,0,0
99571,on,0,0
99572,RTOG,0,0
99573,92-02,0,0
99574,.,0,0
99575,PATIENTS,0,0
99576,AND,0,0
99577,METHODS,0,0
99578,Adequate,0,0
99579,tissue,0,1
99580,for,0,0
99581,immunohistochemistry,0,1
99582,was,0,0
99583,available,0,0
99584,for,0,0
99585,p53,0,1
99586,",",0,0
99587,Ki-67,0,1
99588,",",0,1
99589,and,0,1
99590,MDM2,0,1
99591,analyses,0,0
99592,in,0,0
99593,478,0,0
99594,patient,0,0
99595,cases,0,0
99596,.,0,0
99597,The,0,0
99598,percentage,0,1
99599,of,0,0
99600,tumor,1,1
99601,nuclei,1,1
99602,staining,1,1
99603,positive,1,1
99604,(,0,0
99605,PSP,0,1
99606,),0,0
99607,was,0,0
99608,quantified,0,0
99609,manually,0,0
99610,or,0,0
99611,by,0,0
99612,image,0,1
99613,analysis,0,0
99614,",",0,0
99615,and,0,0
99616,the,0,0
99617,per-sample,1,1
99618,mean,1,1
99619,intensity,1,1
99620,score,1,1
99621,(,1,0
99622,MIS,1,1
99623,),1,0
99624,was,0,0
99625,quantified,0,0
99626,by,0,0
99627,image,0,0
99628,analysis,0,0
99629,.,0,0
99630,Cox,0,0
99631,regression,0,0
99632,models,0,0
99633,were,0,0
99634,used,0,0
99635,to,0,0
99636,estimate,0,0
99637,overall,1,1
99638,mortality,1,1
99639,(,1,0
99640,OM,1,1
99641,),1,1
99642,",",0,0
99643,and,0,1
99644,Fine,0,0
99645,and,0,1
99646,Gray,0,1
99647,'s,0,1
99648,regressions,0,0
99649,were,0,0
99650,applied,0,0
99651,to,0,0
99652,the,0,0
99653,end,0,0
99654,points,0,0
99655,of,0,0
99656,distant,1,1
99657,metastasis,1,1
99658,(,1,0
99659,DM,1,0
99660,),1,0
99661,and,1,0
99662,cause-specific,1,1
99663,mortality,1,1
99664,(,1,0
99665,CSM,1,1
99666,),1,0
99667,.,1,0
99668,Results,0,0
99669,In,0,0
99670,multivariate,0,0
99671,analyses,0,0
99672,that,0,0
99673,adjusted,0,0
99674,for,0,0
99675,all,0,0
99676,markers,0,1
99677,and,0,0
99678,treatment,0,0
99679,covariates,0,1
99680,",",0,0
99681,MDM2,1,1
99682,overexpression,1,1
99683,was,0,0
99684,significantly,0,0
99685,related,0,0
99686,to,0,0
99687,DM,1,0
99688,(,0,0
99689,P,0,0
99690,=,0,0
99691,.02,0,0
99692,),0,0
99693,and,0,0
99694,OM,0,1
99695,(,0,0
99696,P,0,0
99697,=,0,0
99698,.003,0,0
99699,),0,0
99700,",",0,0
99701,and,0,1
99702,Ki-67,1,1
99703,overexpression,1,1
99704,was,0,0
99705,significantly,0,0
99706,related,0,0
99707,to,0,0
99708,DM,1,0
99709,(,0,0
99710,P,0,0
99711,<,0,0
99712,.0001,0,0
99713,),0,0
99714,",",0,0
99715,CSM,1,1
99716,(,0,0
99717,P,0,0
99718,=,0,0
99719,.0007,0,0
99720,),0,0
99721,",",0,0
99722,and,0,1
99723,OM,1,1
99724,(,0,0
99725,P,0,0
99726,=,0,0
99727,.01,0,0
99728,),0,0
99729,.,0,0
99730,P53,1,0
99731,overexpression,1,1
99732,was,0,0
99733,significantly,0,0
99734,related,0,0
99735,to,0,0
99736,OM,1,0
99737,(,0,0
99738,P,0,0
99739,=,0,0
99740,.02,0,0
99741,),0,0
99742,.,0,0
99743,When,0,0
99744,considered,0,0
99745,in,0,0
99746,combination,0,0
99747,",",0,0
99748,the,0,0
99749,overexpression,1,1
99750,of,1,0
99751,both,1,0
99752,Ki-67,1,0
99753,and,1,0
99754,MDM2,1,1
99755,at,0,0
99756,high,0,0
99757,levels,0,1
99758,was,0,0
99759,associated,0,0
99760,with,0,0
99761,significantly,1,0
99762,increased,1,0
99763,failure,1,0
99764,rates,1,1
99765,for,0,0
99766,all,0,0
99767,end,0,0
99768,points,0,0
99769,(,0,0
99770,P,0,0
99771,<,0,0
99772,.001,0,0
99773,for,0,0
99774,DM,0,0
99775,",",0,0
99776,CSM,0,1
99777,",",0,1
99778,and,0,1
99779,OM,0,1
99780,),0,0
99781,.,0,0
99782,CONCLUSION,0,0
99783,Combined,0,0
99784,MDM2,1,1
99785,and,1,1
99786,Ki-67,1,1
99787,expression,1,1
99788,levels,1,1
99789,were,0,0
99790,independently,0,0
99791,related,0,0
99792,to,0,0
99793,distant,1,1
99794,metastasis,1,1
99795,and,1,1
99796,mortality,1,1
99797,and,0,1
99798,",",0,0
99799,if,0,0
99800,validated,0,0
99801,",",0,0
99802,could,0,0
99803,be,0,0
99804,considered,0,0
99805,for,0,0
99806,risk,0,1
99807,stratification,0,0
99808,of,0,0
99809,patients,0,0
99810,with,0,0
99811,prostate,0,0
99812,cancer,0,0
99813,in,0,0
99814,clinical,0,0
99815,trials,0,0
99816,.,0,0
99817,Transdermal,0,0
99818,scopolamine,0,0
99819,patch,0,0
99820,in,0,0
99821,addition,0,0
99822,to,0,0
99823,ondansetron,0,0
99824,for,0,0
99825,postoperative,0,1
99826,nausea,0,1
99827,and,0,0
99828,vomiting,0,1
99829,prophylaxis,0,0
99830,in,0,0
99831,patients,0,0
99832,undergoing,0,0
99833,ambulatory,0,0
99834,cosmetic,0,0
99835,surgery,0,0
99836,.,0,0
99837,STUDY,0,0
99838,OBJECTIVE,0,0
99839,To,0,0
99840,determine,0,0
99841,the,0,0
99842,efficacy,0,1
99843,of,0,0
99844,transdermal,0,0
99845,scopolamine,0,0
99846,in,0,0
99847,addition,0,0
99848,to,0,0
99849,ondansetron,0,0
99850,in,0,0
99851,decreasing,0,0
99852,the,0,0
99853,incidence,0,1
99854,of,0,0
99855,postoperative,1,1
99856,nausea,1,1
99857,and,1,1
99858,vomiting,1,1
99859,(,0,1
99860,PONV,0,0
99861,),0,0
99862,.,0,0
99863,DESIGN,0,0
99864,Randomized,0,0
99865,controlled,0,0
99866,trial,0,0
99867,.,0,0
99868,SETTING,0,0
99869,Academic,0,1
99870,hospital,0,1
99871,.,0,0
99872,PATIENTS,0,0
99873,126,0,0
99874,ASA,0,0
99875,physical,0,0
99876,status,0,1
99877,I,0,0
99878,and,0,0
99879,II,0,0
99880,patients,0,0
99881,undergoing,0,0
99882,outpatient,0,0
99883,plastic,0,0
99884,surgery,0,0
99885,with,0,0
99886,three,0,0
99887,or,0,0
99888,more,0,0
99889,risk,0,1
99890,factors,0,1
99891,for,0,0
99892,PONV,0,0
99893,.,0,0
99894,INTERVENTIONS,0,1
99895,Patients,0,0
99896,were,0,0
99897,randomly,0,0
99898,assigned,0,0
99899,to,0,0
99900,one,0,0
99901,of,0,0
99902,two,0,0
99903,groups,0,0
99904,to,0,0
99905,receive,0,0
99906,(,0,0
99907,Group,0,0
99908,1,0,0
99909,),0,0
99910,a,0,0
99911,transdermal,0,0
99912,scopolamine,0,0
99913,(,0,0
99914,TDS,0,0
99915,),0,1
99916,patch,0,0
99917,or,0,0
99918,(,0,0
99919,Group,0,0
99920,2,0,0
99921,),0,0
99922,",",0,0
99923,a,0,0
99924,placebo,0,0
99925,patch,0,0
99926,two,0,0
99927,hours,0,0
99928,before,0,0
99929,surgery,0,0
99930,.,0,0
99931,MEASUREMENTS,0,0
99932,Occurrence,1,1
99933,of,1,0
99934,vomiting,1,1
99935,",",1,0
99936,severity,1,1
99937,of,1,1
99938,nausea,1,1
99939,using,1,0
99940,a,1,0
99941,visual,1,1
99942,analog,1,1
99943,scale,1,1
99944,(,1,0
99945,VAS,1,1
99946,),1,0
99947,",",1,0
99948,rescue,1,1
99949,medication,1,1
99950,",",1,0
99951,pain,1,1
99952,intensity,1,1
99953,and,1,1
99954,pain,1,1
99955,medications,1,1
99956,",",1,0
99957,and,1,1
99958,side,1,1
99959,effects,1,1
99960,were,0,0
99961,recorded,0,0
99962,every,0,0
99963,hour,0,0
99964,until,0,0
99965,discharge,0,1
99966,from,0,0
99967,hospital,0,1
99968,",",0,0
99969,then,0,0
99970,every,0,0
99971,4,0,0
99972,hours,0,0
99973,thereafter,0,0
99974,for,0,0
99975,a,0,0
99976,total,0,0
99977,of,0,0
99978,24,0,0
99979,hours,0,0
99980,.,0,0
99981,MAIN,0,0
99982,RESULTS,0,0
99983,A,0,0
99984,statistically,0,0
99985,significant,0,0
99986,reduction,0,1
99987,in,0,0
99988,postoperative,1,1
99989,nausea,1,1
99990,between,0,0
99991,8,0,0
99992,and,0,0
99993,24,0,0
99994,hours,0,0
99995,in,0,0
99996,patients,0,0
99997,receiving,0,0
99998,TDS,0,0
99999,was,0,0
100000,noted,0,0
100001,.,0,0
100002,CONCLUSIONS,0,0
100003,Transdermal,0,0
100004,scopolamine,0,0
100005,in,0,0
100006,addition,0,0
100007,to,0,0
100008,ondansetron,0,0
100009,benefits,0,0
100010,patients,0,0
100011,at,0,0
100012,high,0,0
100013,risk,0,1
100014,for,0,0
100015,PONV,0,1
100016,undergoing,0,0
100017,outpatient,0,0
100018,plastic,0,0
100019,surgery,0,0
100020,for,0,0
100021,up,0,0
100022,to,0,0
100023,20,0,0
100024,hours,0,0
100025,after,0,0
100026,surgery,0,0
100027,.,0,0
100028,One-year,0,0
100029,follow-up,0,0
100030,of,0,0
100031,the,0,0
100032,outcome,0,0
100033,of,0,0
100034,a,0,0
100035,randomized,0,0
100036,controlled,0,0
100037,trial,0,0
100038,of,0,0
100039,a,0,0
100040,home-based,0,0
100041,intervention,0,0
100042,programme,0,0
100043,for,0,0
100044,children,0,0
100045,with,0,0
100046,autism,0,0
100047,and,0,0
100048,developmental,0,1
100049,delay,0,1
100050,and,0,0
100051,their,0,0
100052,families,0,0
100053,.,0,0
100054,INTRODUCTION,0,0
100055,There,0,0
100056,is,0,0
100057,debate,0,0
100058,about,0,0
100059,the,0,0
100060,type,0,0
100061,and,0,0
100062,intensity,0,1
100063,of,0,1
100064,early,0,0
100065,childhood,0,0
100066,intervention,0,0
100067,that,0,0
100068,is,0,0
100069,most,0,0
100070,helpful,0,0
100071,for,0,0
100072,children,0,0
100073,with,0,0
100074,developmental,0,0
100075,problems,0,0
100076,.,0,0
100077,The,0,0
100078,aim,0,0
100079,of,0,0
100080,the,0,0
100081,study,0,0
100082,was,0,0
100083,to,0,0
100084,determine,0,0
100085,whether,0,0
100086,a,0,0
100087,home-based,0,0
100088,programme,0,0
100089,provided,0,0
100090,over,0,0
100091,12,0,0
100092,months,0,0
100093,resulted,0,0
100094,in,0,0
100095,sustained,1,0
100096,improvement,1,1
100097,in,1,0
100098,development,1,1
100099,and,1,0
100100,behaviour,1,1
100101,12,0,0
100102,months,0,0
100103,after,0,0
100104,the,0,0
100105,intervention,0,0
100106,ceased,0,0
100107,.,0,0
100108,The,0,0
100109,characteristics,0,0
100110,of,0,0
100111,the,0,0
100112,children,0,0
100113,and,0,0
100114,families,0,0
100115,who,0,0
100116,benefited,0,0
100117,most,0,0
100118,from,0,0
100119,the,0,0
100120,intervention,0,0
100121,were,0,0
100122,also,0,0
100123,studied,0,0
100124,.,0,0
100125,METHOD,0,0
100126,Randomized,0,0
100127,controlled,0,0
100128,trial,0,0
100129,.,0,0
100130,Participants,0,0
100131,A,0,0
100132,total,0,0
100133,of,0,0
100134,59,0,0
100135,children,0,0
100136,",",0,0
100137,aged,0,0
100138,3-5,0,0
100139,years,0,0
100140,",",0,0
100141,attending,0,0
100142,two,0,0
100143,early,0,0
100144,childhood,0,0
100145,intervention,0,0
100146,centres,0,0
100147,in,0,0
100148,Melbourne,0,0
100149,",",0,0
100150,Australia,0,0
100151,.,0,0
100152,Intervention,0,0
100153,Half,0,0
100154,of,0,0
100155,the,0,0
100156,subjects,0,0
100157,received,0,0
100158,an,0,0
100159,additional,0,0
100160,home-based,0,0
100161,programme,0,0
100162,consisting,0,0
100163,of,0,0
100164,40,0,0
100165,weekly,0,0
100166,visits,0,0
100167,.,0,0
100168,MAIN,0,0
100169,OUTCOME,0,0
100170,MEASURES,0,0
100171,Bayley,1,0
100172,Scales,1,1
100173,of,1,0
100174,Infant,1,1
100175,Development,1,1
100176,and,1,0
100177,Wechsler,1,0
100178,Preschool,1,1
100179,and,1,0
100180,Primary,1,1
100181,Scale,1,1
100182,of,1,0
100183,Intelligence,1,1
100184,Revised,1,0
100185,",",1,0
100186,Preschool,1,1
100187,Behaviour,1,1
100188,Checklist,1,1
100189,",",1,0
100190,Bayley,1,1
100191,Behaviour,1,1
100192,Rating,1,1
100193,Scale,1,1
100194,and,1,0
100195,Behaviour,1,1
100196,Screening,1,0
100197,Questionnaire,1,0
100198,.,1,0
100199,All,0,0
100200,tests,0,0
100201,administered,0,0
100202,pre-intervention,0,0
100203,",",0,0
100204,following,0,0
100205,the,0,0
100206,intervention,0,0
100207,and,0,0
100208,12,0,0
100209,months,0,0
100210,later,0,0
100211,.,0,0
100212,Secondary,0,0
100213,outcome,1,1
100214,measures,1,1
100215,Family,1,1
100216,stress,1,1
100217,",",1,1
100218,support,1,0
100219,and,1,1
100220,empowerment,1,1
100221,.,1,0
100222,RESULTS,0,0
100223,Fifty-four,0,0
100224,children,0,0
100225,completed,0,0
100226,the,0,0
100227,assessments,0,0
100228,12,0,0
100229,months,0,0
100230,after,0,0
100231,conclusion,0,0
100232,of,0,0
100233,the,0,0
100234,intervention,0,0
100235,.,0,0
100236,Compared,0,0
100237,with,0,0
100238,the,0,0
100239,control,0,0
100240,group,0,0
100241,",",0,0
100242,improvement,1,1
100243,in,1,0
100244,aspects,1,0
100245,of,1,0
100246,cognitive,1,1
100247,development,1,0
100248,in,0,0
100249,the,0,0
100250,children,0,0
100251,who,0,0
100252,received,0,0
100253,the,0,0
100254,extra,0,0
100255,intervention,0,0
100256,was,0,0
100257,sustained,0,0
100258,1,0,0
100259,year,0,0
100260,later,0,0
100261,(,0,0
100262,P=,0,0
100263,0.007,0,0
100264,),0,0
100265,while,0,0
100266,significant,0,0
100267,behavioural,1,0
100268,differences,1,0
100269,post,0,0
100270,intervention,0,0
100271,were,0,0
100272,not,0,0
100273,.,0,0
100274,Analyses,0,0
100275,of,0,0
100276,the,0,0
100277,data,0,0
100278,by,0,0
100279,the,0,0
100280,Reliable,1,0
100281,Change,1,0
100282,Index,1,0
100283,indicated,0,0
100284,improvement,0,1
100285,of,0,0
100286,clinical,0,0
100287,significance,0,1
100288,occurred,0,0
100289,in,0,0
100290,non-verbal,1,0
100291,areas,1,0
100292,.,1,0
100293,In,0,0
100294,contrast,0,0
100295,to,0,0
100296,the,0,0
100297,control,0,0
100298,group,0,0
100299,who,0,0
100300,deteriorated,0,0
100301,",",0,0
100302,language,1,1
100303,skills,1,1
100304,in,0,0
100305,the,0,0
100306,intervention,0,0
100307,group,0,0
100308,remained,0,0
100309,stable,0,0
100310,.,0,0
100311,Improvements,0,1
100312,were,0,0
100313,significantly,0,0
100314,associated,0,0
100315,with,0,0
100316,higher,0,0
100317,stress,1,1
100318,in,0,0
100319,the,0,0
100320,families,0,0
100321,.,0,0
100322,CONCLUSION,0,0
100323,Improvements,1,1
100324,following,0,0
100325,the,0,0
100326,provision,0,0
100327,of,0,0
100328,a,0,0
100329,home-based,0,0
100330,programme,0,0
100331,to,0,0
100332,preschool,0,0
100333,children,0,0
100334,with,0,0
100335,developmental,0,0
100336,disabilities,0,0
100337,were,0,0
100338,sustained,0,0
100339,1,0,0
100340,year,0,0
100341,later,0,0
100342,.,0,0
100343,Children,0,0
100344,from,0,0
100345,highly,0,0
100346,stressed,1,0
100347,families,0,0
100348,appeared,0,0
100349,to,0,0
100350,benefit,0,0
100351,most,0,0
100352,",",0,0
100353,reinforcing,0,0
100354,the,0,0
100355,importance,0,0
100356,of,0,0
100357,involving,0,0
100358,families,0,0
100359,in,0,0
100360,early,0,0
100361,childhood,0,0
100362,intervention,0,0
100363,programmes,0,0
100364,.,0,0
100365,Loss,0,0
100366,of,0,0
100367,bone,1,1
100368,mineral,1,1
100369,density,1,1
100370,after,0,0
100371,antiretroviral,0,0
100372,therapy,0,0
100373,initiation,0,0
100374,",",0,0
100375,independent,0,0
100376,of,0,0
100377,antiretroviral,0,0
100378,regimen,0,0
100379,.,0,0
100380,BACKGROUND,0,0
100381,Decreased,0,0
100382,bone,1,1
100383,mineral,1,1
100384,density,1,1
100385,(,1,0
100386,BMD,1,1
100387,),1,0
100388,has,0,0
100389,been,0,0
100390,described,0,0
100391,in,0,0
100392,HIV-infected,0,0
100393,patients,0,0
100394,initiating,0,0
100395,antiretroviral,0,0
100396,therapy,0,0
100397,(,0,0
100398,ART,0,1
100399,),0,1
100400,",",0,0
100401,but,0,0
100402,the,0,0
100403,contributions,0,0
100404,of,0,0
100405,ART,0,0
100406,and,0,0
100407,immunologic,0,1
100408,and/or,0,0
100409,virologic,0,0
100410,factors,0,0
100411,remain,0,0
100412,unclear,0,0
100413,.,0,0
100414,METHODS,0,0
100415,We,0,0
100416,compared,0,0
100417,total,0,1
100418,BMD,1,1
100419,changes,0,0
100420,over,0,0
100421,96,0,0
100422,weeks,0,0
100423,in,0,0
100424,106,0,0
100425,ART-naive,0,0
100426,HIV-infected,0,0
100427,subjects,0,0
100428,who,0,0
100429,were,0,0
100430,randomized,0,0
100431,to,0,0
100432,receive,0,0
100433,efavirenz,0,0
100434,(,0,0
100435,EFV,0,1
100436,),0,0
100437,+,0,0
100438,zidovudine/lamivudine,0,0
100439,(,0,0
100440,n,0,0
100441,=,0,0
100442,32,0,0
100443,),0,0
100444,or,0,0
100445,lopinavir/ritonavir,0,0
100446,(,0,1
100447,LPV/r,0,0
100448,),0,0
100449,+,0,0
100450,zidovudine/lamivudine,0,0
100451,induction,0,1
100452,(,0,0
100453,n,0,0
100454,=,0,0
100455,74,0,0
100456,),0,0
100457,for,0,0
100458,24-48,0,0
100459,weeks,0,0
100460,followed,0,0
100461,by,0,0
100462,LPV/r,0,0
100463,monotherapy,0,0
100464,.,0,0
100465,We,0,0
100466,also,0,0
100467,sought,0,0
100468,to,0,0
100469,identify,0,0
100470,factors,0,0
100471,associated,0,0
100472,with,0,0
100473,BMD,0,1
100474,loss,0,1
100475,",",0,0
100476,including,0,0
100477,markers,0,1
100478,of,0,0
100479,systemic,0,0
100480,inflammation,0,1
100481,[,0,0
100482,soluble,0,1
100483,tumor,0,1
100484,necrosis,0,1
100485,factor-alpha,0,1
100486,receptors,0,0
100487,(,0,0
100488,sTNFR,0,0
100489,I,0,0
100490,and,0,0
100491,II,0,0
100492,),0,0
100493,],0,0
100494,.,0,0
100495,RESULTS,0,0
100496,After,0,0
100497,96,0,0
100498,weeks,0,0
100499,",",0,0
100500,the,0,0
100501,mean,0,1
100502,percent,1,0
100503,change,1,1
100504,from,1,0
100505,baseline,1,0
100506,in,1,0
100507,total,1,1
100508,BMD,1,1
100509,was,0,0
100510,-2.5,0,0
100511,%,0,0
100512,(,0,0
100513,LPV/r,0,0
100514,),0,0
100515,and,0,0
100516,-2.3,0,0
100517,%,0,0
100518,(,0,0
100519,EFV,0,1
100520,),0,0
100521,(,0,0
100522,P,0,0
100523,<,0,0
100524,0.01,0,0
100525,for,0,0
100526,within-group,0,0
100527,changes,0,0
100528,in,0,0
100529,either,0,0
100530,arm,0,0
100531,;,0,0
100532,P,0,0
100533,=,0,0
100534,0.86,0,0
100535,for,0,0
100536,between-group,0,0
100537,differences,0,0
100538,),0,0
100539,.,0,0
100540,No,0,0
100541,alteration,0,0
100542,in,0,0
100543,the,0,0
100544,rate,1,1
100545,of,1,0
100546,BMD,1,1
100547,change,1,1
100548,was,0,0
100549,observed,0,0
100550,upon,0,0
100551,simplification,0,0
100552,to,0,0
100553,LPV/r,0,0
100554,monotherapy,0,0
100555,.,0,0
100556,Although,0,0
100557,soluble,0,1
100558,tumor,0,1
100559,necrosis,0,1
100560,factor-alpha,0,1
100561,receptor,0,1
100562,II,0,0
100563,concentrations,0,1
100564,at,0,0
100565,baseline,0,0
100566,and,0,0
100567,24,0,0
100568,weeks,0,0
100569,were,0,0
100570,at,0,0
100571,least,0,0
100572,marginally,0,0
100573,associated,0,0
100574,with,0,0
100575,subsequent,0,0
100576,changes,0,1
100577,in,0,0
100578,BMD,1,1
100579,(,0,0
100580,P,0,0
100581,=,0,0
100582,0.06,0,0
100583,and,0,0
100584,P,0,0
100585,=,0,0
100586,0.028,0,0
100587,",",0,0
100588,respectively,0,0
100589,),0,0
100590,",",0,0
100591,these,0,0
100592,associations,0,0
100593,were,0,0
100594,no,0,0
100595,longer,0,0
100596,significant,0,0
100597,after,0,0
100598,adjustment,0,0
100599,for,0,0
100600,CD4,0,1
100601,T,0,1
100602,cell,0,0
100603,count,0,1
100604,.,0,0
100605,Subjects,0,0
100606,with,0,0
100607,lower,0,0
100608,baseline,0,0
100609,CD4,0,1
100610,T,0,1
100611,cell,0,1
100612,count,0,1
100613,",",0,0
100614,non-black,0,0
100615,race,0,0
100616,",",0,0
100617,and,0,1
100618,higher,0,1
100619,baseline,0,1
100620,glucose,0,1
100621,demonstrated,0,0
100622,a,0,0
100623,higher,0,0
100624,risk,0,1
100625,for,0,0
100626,>,0,0
100627,5,0,0
100628,%,0,0
100629,decrease,0,0
100630,in,0,0
100631,BMD,1,1
100632,.,1,0
100633,CONCLUSIONS,0,0
100634,Similar,0,0
100635,decreases,0,0
100636,in,0,0
100637,BMD,1,1
100638,over,0,0
100639,96,0,0
100640,weeks,0,0
100641,occurred,0,0
100642,in,0,0
100643,ART-naive,0,0
100644,subjects,0,0
100645,receiving,0,0
100646,either,0,0
100647,EFV-based,0,0
100648,regimen,0,0
100649,or,0,0
100650,LPV/r-based,0,0
100651,regimen,0,0
100652,",",0,0
100653,which,0,0
100654,was,0,0
100655,not,0,0
100656,altered,0,0
100657,by,0,0
100658,simplification,0,0
100659,to,0,0
100660,LPV/r,0,0
100661,monotherapy,0,0
100662,and,0,1
100663,was,0,0
100664,unrelated,0,0
100665,to,0,0
100666,markers,0,1
100667,of,0,0
100668,tumor,0,1
100669,necrosis,0,1
100670,factor-alpha,0,0
100671,activity,0,1
100672,.,0,0
100673,Gemcitabine,0,0
100674,combined,0,0
100675,with,0,0
100676,either,0,0
100677,pemetrexed,0,0
100678,or,0,0
100679,paclitaxel,0,0
100680,in,0,0
100681,the,0,0
100682,treatment,0,0
100683,of,0,0
100684,advanced,0,0
100685,non-small,0,0
100686,cell,0,1
100687,lung,0,0
100688,cancer,0,0
100689,:,0,0
100690,a,0,0
100691,randomized,0,0
100692,phase,0,0
100693,II,0,0
100694,SICOG,0,0
100695,trial,0,0
100696,.,0,0
100697,PURPOSE,0,0
100698,To,0,0
100699,estimate,0,0
100700,the,0,0
100701,safety,1,1
100702,",",1,0
100703,activity,1,1
100704,",",1,1
100705,and,1,1
100706,impact,1,1
100707,on,1,0
100708,quality,1,1
100709,of,1,0
100710,life,1,1
100711,of,0,0
100712,a,0,0
100713,combination,0,0
100714,of,0,0
100715,gemcitabine,0,0
100716,and,0,1
100717,pemetrexed,0,0
100718,in,0,0
100719,patients,0,0
100720,with,0,0
100721,locally,0,0
100722,advanced,0,0
100723,or,0,0
100724,metastatic,0,0
100725,non-small,0,0
100726,cell,0,1
100727,lung,0,1
100728,cancer,0,0
100729,(,0,0
100730,NSCLC,0,1
100731,),0,0
100732,in,0,0
100733,the,0,0
100734,context,0,0
100735,of,0,0
100736,a,0,0
100737,randomized,0,0
100738,two-stage,0,0
100739,phase,0,0
100740,II,0,0
100741,study,0,0
100742,.,0,0
100743,PATIENTS,0,0
100744,AND,0,0
100745,METHODS,0,0
100746,Patients,0,0
100747,in,0,0
100748,stage,0,0
100749,IIIB,0,1
100750,or,0,0
100751,IV,0,1
100752,NSCLC,0,1
100753,were,0,0
100754,randomly,0,0
100755,allocated,0,0
100756,to,0,0
100757,receive,0,0
100758,either,0,0
100759,gemcitabine,0,0
100760,1250,0,0
100761,mg/m,0,0
100762,(,0,0
100763,2,0,0
100764,),0,0
100765,on,0,0
100766,day,0,0
100767,1,0,0
100768,",",0,0
100769,and,0,0
100770,pemetrexed,0,0
100771,(,0,1
100772,Alimta,0,0
100773,),0,0
100774,500,0,0
100775,mg/m,0,0
100776,(,0,0
100777,2,0,0
100778,),0,0
100779,followed,0,0
100780,by,0,0
100781,gemcitabine,0,0
100782,1250,0,0
100783,mg/m,0,0
100784,(,0,0
100785,2,0,0
100786,),0,0
100787,on,0,0
100788,day,0,0
100789,8,0,0
100790,of,0,0
100791,a,0,0
100792,3-weekly,0,0
100793,cycle,0,1
100794,(,0,0
100795,GA,0,0
100796,arm,0,0
100797,),0,0
100798,",",0,0
100799,or,0,0
100800,paclitaxel,0,0
100801,120,0,0
100802,mg/m,0,0
100803,(,0,0
100804,2,0,0
100805,),0,0
100806,followed,0,0
100807,by,0,0
100808,gemcitabine,0,0
100809,1000,0,0
100810,mg/m,0,0
100811,(,0,0
100812,2,0,0
100813,),0,0
100814,",",0,0
100815,both,0,0
100816,given,0,0
100817,on,0,0
100818,days,0,0
100819,1,0,0
100820,and,0,0
100821,8,0,0
100822,of,0,0
100823,a,0,0
100824,3-weekly,0,0
100825,cycle,0,1
100826,(,0,0
100827,PG,0,1
100828,arm,0,0
100829,),0,0
100830,.,0,0
100831,RESULTS,0,0
100832,105,0,0
100833,(,0,0
100834,GA,0,0
100835,arm,0,0
100836,",",0,0
100837,51,0,0
100838,;,0,0
100839,PG,0,0
100840,arm,0,0
100841,",",0,0
100842,54,0,0
100843,),0,0
100844,eligible,0,0
100845,patients,0,0
100846,(,0,0
100847,stage,0,0
100848,IV,0,1
100849,",",0,0
100850,32,0,0
100851,and,0,0
100852,30,0,0
100853,",",0,0
100854,respectively,0,0
100855,),0,0
100856,were,0,0
100857,enrolled,0,0
100858,into,0,0
100859,this,0,0
100860,study,0,0
100861,;,0,0
100862,thereafter,0,0
100863,",",0,0
100864,accrual,0,1
100865,was,0,0
100866,stopped,0,0
100867,due,0,0
100868,to,0,0
100869,first-stage,0,0
100870,analysis,0,0
100871,.,0,0
100872,The,0,0
100873,response,1,1
100874,rate,1,1
100875,was,0,0
100876,20,0,0
100877,%,0,0
100878,(,0,0
100879,95,0,0
100880,%,0,0
100881,confidence,0,0
100882,interval,0,0
100883,[,0,0
100884,CI,0,0
100885,],0,0
100886,",",0,0
100887,10-33,0,0
100888,%,0,0
100889,),0,0
100890,in,0,0
100891,the,0,0
100892,GA,0,0
100893,arm,0,0
100894,",",0,0
100895,and,0,0
100896,32,0,0
100897,%,0,0
100898,(,0,0
100899,95,0,0
100900,%,0,0
100901,CI,0,0
100902,",",0,0
100903,20-46,0,0
100904,%,0,0
100905,),0,0
100906,in,0,0
100907,the,0,0
100908,PG,0,0
100909,arm,0,0
100910,.,0,0
100911,Median,1,1
100912,progression-free,1,1
100913,survival,1,1
100914,was,0,0
100915,5.1,0,0
100916,(,0,0
100917,95,0,0
100918,%,0,0
100919,CI,0,0
100920,",",0,0
100921,3.7-6.5,0,0
100922,),0,0
100923,months,0,0
100924,in,0,0
100925,the,0,0
100926,GA,0,0
100927,arm,0,0
100928,",",0,0
100929,and,0,0
100930,8.3,0,0
100931,(,0,0
100932,95,0,0
100933,%,0,0
100934,CI,0,0
100935,",",0,0
100936,5.9-10.7,0,0
100937,),0,0
100938,months,0,0
100939,in,0,0
100940,the,0,0
100941,PG,0,0
100942,arm,0,0
100943,",",0,0
100944,while,0,0
100945,median,1,1
100946,overall,1,1
100947,survival,1,1
100948,was,0,0
100949,10.5,0,0
100950,(,0,0
100951,95,0,0
100952,%,0,0
100953,CI,0,0
100954,7.1-13.9,0,0
100955,),0,0
100956,",",0,0
100957,and,0,0
100958,13.3,0,0
100959,(,0,0
100960,95,0,0
100961,%,0,0
100962,CI,0,0
100963,11.7-14.9,0,0
100964,),0,0
100965,months,0,0
100966,",",0,0
100967,respectively,0,0
100968,.,0,0
100969,Severe,1,1
100970,neutropenia,1,1
100971,(,0,0
100972,36,0,0
100973,%,0,0
100974,vs,0,0
100975,22,0,0
100976,%,0,0
100977,),0,0
100978,",",0,0
100979,and,0,1
100980,febrile,1,1
100981,neutropenia,1,1
100982,(,0,0
100983,14,0,0
100984,%,0,0
100985,vs,0,0
100986,7,0,0
100987,%,0,0
100988,),0,0
100989,were,0,0
100990,more,0,0
100991,common,0,0
100992,with,0,0
100993,the,0,0
100994,GA,0,0
100995,regimen,0,0
100996,",",0,0
100997,while,0,0
100998,hair,1,1
100999,loss,1,1
101000,(,0,0
101001,52,0,0
101002,%,0,0
101003,vs,0,0
101004,16,0,0
101005,%,0,0
101006,),0,0
101007,and,0,0
101008,any,1,0
101009,grade,1,1
101010,peripheral,1,1
101011,neuropathy,1,0
101012,(,0,0
101013,31,0,0
101014,%,0,0
101015,vs,0,0
101016,2,0,0
101017,%,0,0
101018,),0,0
101019,occurred,0,0
101020,more,0,0
101021,frequently,0,0
101022,with,0,0
101023,PG,0,0
101024,regimen,0,0
101025,.,0,0
101026,Other,0,0
101027,severe,1,1
101028,side,1,1
101029,effects,1,1
101030,of,0,0
101031,GA,0,0
101032,regimen,0,0
101033,were,0,0
101034,diarrhoea,1,1
101035,(,0,0
101036,10,0,0
101037,%,0,0
101038,),0,0
101039,",",0,0
101040,liver,1,0
101041,enzyme,1,0
101042,derangement,1,0
101043,(,0,0
101044,10,0,0
101045,%,0,0
101046,),0,0
101047,",",0,0
101048,and,0,1
101049,fatigue,1,1
101050,(,0,0
101051,8,0,0
101052,%,0,0
101053,),0,0
101054,.,0,0
101055,CONCLUSION,0,0
101056,The,0,0
101057,GA,0,0
101058,regimen,0,0
101059,was,0,0
101060,tolerated,1,1
101061,and,1,0
101062,moderately,1,0
101063,active,1,0
101064,in,0,0
101065,advanced,0,0
101066,or,0,0
101067,metastatic,0,0
101068,NSCLC,0,1
101069,.,0,0
101070,However,0,0
101071,",",0,0
101072,this,0,0
101073,combination,0,0
101074,did,0,0
101075,not,0,0
101076,yield,0,0
101077,any,0,0
101078,advantage,0,0
101079,in,0,0
101080,comparison,0,0
101081,with,0,0
101082,the,0,0
101083,PG,0,0
101084,regimen,0,0
101085,",",0,0
101086,and,0,0
101087,does,0,0
101088,not,0,0
101089,deserve,0,0
101090,further,0,0
101091,evaluation,0,0
101092,.,0,0
101093,A,0,0
101094,randomized,0,0
101095,double-blind,0,0
101096,placebo-controlled,0,0
101097,study,0,0
101098,of,0,0
101099,the,0,0
101100,long-term,0,0
101101,efficacy,0,1
101102,and,0,1
101103,safety,0,1
101104,of,0,1
101105,diethylpropion,0,0
101106,in,0,0
101107,the,0,0
101108,treatment,0,0
101109,of,0,0
101110,obese,0,0
101111,subjects,0,0
101112,.,0,0
101113,OBJECTIVE,0,0
101114,To,0,0
101115,evaluate,0,0
101116,the,0,0
101117,efficacy,0,1
101118,of,0,0
101119,diethylpropion,0,0
101120,on,0,0
101121,a,0,0
101122,long-term,0,0
101123,basis,0,0
101124,",",0,0
101125,with,0,0
101126,emphasis,0,0
101127,in,0,0
101128,cardiovascular,0,1
101129,and,0,0
101130,psychiatric,0,0
101131,safety,0,1
101132,aspects,0,0
101133,.,0,0
101134,DESIGN,0,0
101135,Randomized,0,0
101136,",",0,0
101137,double-blind,0,0
101138,",",0,1
101139,placebo-controlled,0,0
101140,trial,0,0
101141,.,0,0
101142,MEASUREMENTS,0,0
101143,Following,0,0
101144,a,0,0
101145,2-week,0,0
101146,screening,0,0
101147,period,0,0
101148,",",0,0
101149,69,0,0
101150,obese,0,0
101151,healthy,0,0
101152,adults,0,0
101153,received,0,0
101154,a,0,0
101155,hypocaloric,0,0
101156,diet,0,0
101157,and,0,0
101158,were,0,0
101159,randomized,0,0
101160,to,0,0
101161,diethylpropion,0,0
101162,50,0,0
101163,mg,0,0
101164,BID,0,0
101165,(,0,0
101166,n=37,0,0
101167,),0,1
101168,or,0,0
101169,placebo,0,0
101170,(,0,1
101171,n=32,0,0
101172,),0,0
101173,for,0,0
101174,6,0,0
101175,months,0,0
101176,.,0,0
101177,After,0,0
101178,this,0,0
101179,period,0,0
101180,",",0,0
101181,all,0,0
101182,participants,0,0
101183,received,0,0
101184,diethylpropion,0,0
101185,in,0,0
101186,an,0,0
101187,open-label,0,0
101188,extension,0,0
101189,for,0,0
101190,an,0,0
101191,additional,0,0
101192,6,0,0
101193,months,0,0
101194,.,0,0
101195,The,0,0
101196,primary,0,0
101197,outcome,0,1
101198,was,0,0
101199,percentage,1,1
101200,change,1,1
101201,in,1,0
101202,body,1,1
101203,weight,1,1
101204,.,1,0
101205,Electrocardiogram,1,1
101206,(,1,0
101207,ECG,1,1
101208,),1,0
101209,",",1,0
101210,echocardiography,1,1
101211,and,1,1
101212,clinical,1,1
101213,chemistry,1,1
101214,were,0,0
101215,performed,0,0
101216,at,0,0
101217,baseline,0,0
101218,and,0,0
101219,every,0,0
101220,6,0,0
101221,months,0,0
101222,.,0,0
101223,Psychiatric,1,1
101224,evaluation,1,0
101225,and,1,1
101226,application,1,0
101227,of,1,1
101228,Hamilton,1,1
101229,rating,1,1
101230,scales,1,1
101231,for,1,0
101232,depression,1,1
101233,and,1,1
101234,anxiety,1,1
101235,were,0,0
101236,also,0,0
101237,performed,0,0
101238,by,0,0
101239,experienced,0,0
101240,psychiatrists,0,0
101241,at,0,0
101242,baseline,0,0
101243,and,0,0
101244,every,0,0
101245,3,0,0
101246,months,0,0
101247,.,0,0
101248,RESULTS,0,0
101249,After,0,0
101250,6,0,0
101251,months,0,0
101252,",",0,0
101253,the,0,0
101254,diethylpropion,0,0
101255,group,0,0
101256,lost,0,1
101257,an,0,0
101258,average,0,0
101259,of,0,0
101260,9.8,0,0
101261,%,0,0
101262,(,0,0
101263,s.d,0,0
101264,.,0,0
101265,6.9,0,0
101266,%,0,0
101267,),0,0
101268,of,0,0
101269,initial,0,0
101270,body,1,1
101271,weight,1,0
101272,vs,0,0
101273,3.2,0,0
101274,%,0,0
101275,(,0,0
101276,3.7,0,0
101277,%,0,0
101278,),0,0
101279,in,0,0
101280,the,0,0
101281,placebo,0,0
101282,group,0,0
101283,(,0,0
101284,P,0,0
101285,<,0,0
101286,0.0001,0,0
101287,),0,0
101288,.,0,0
101289,From,0,0
101290,baseline,0,0
101291,to,0,0
101292,month,0,0
101293,12,0,0
101294,",",0,0
101295,the,0,0
101296,mean,1,1
101297,weight,1,1
101298,loss,1,1
101299,produced,0,0
101300,by,0,0
101301,diethylpropion,0,0
101302,was,0,0
101303,10.6,0,0
101304,%,0,0
101305,(,0,0
101306,8.3,0,0
101307,%,0,0
101308,),0,0
101309,.,0,0
101310,Participants,0,0
101311,in,0,0
101312,the,0,0
101313,placebo,0,0
101314,group,0,0
101315,who,0,0
101316,were,0,0
101317,switched,0,0
101318,to,0,0
101319,diethylpropion,0,0
101320,after,0,0
101321,6,0,0
101322,months,0,0
101323,lost,0,0
101324,an,0,0
101325,average,0,0
101326,of,0,0
101327,7.0,0,0
101328,%,0,0
101329,(,0,0
101330,7.7,0,0
101331,%,0,0
101332,),0,0
101333,of,0,0
101334,initial,1,0
101335,body,1,1
101336,weight,1,1
101337,.,1,0
101338,The,0,0
101339,difference,0,0
101340,between,0,0
101341,groups,0,0
101342,at,0,0
101343,month,0,0
101344,12,0,0
101345,was,0,0
101346,not,0,0
101347,significant,0,0
101348,(,0,0
101349,P=0.07,0,0
101350,),0,0
101351,.,0,0
101352,No,0,0
101353,differences,0,0
101354,in,0,0
101355,blood,1,1
101356,pressure,1,1
101357,",",1,0
101358,pulse,1,1
101359,rate,1,1
101360,",",1,0
101361,ECG,1,1
101362,and,1,1
101363,psychiatric,1,1
101364,evaluation,1,0
101365,were,0,0
101366,observed,0,0
101367,.,0,0
101368,Dry,1,1
101369,mouth,1,1
101370,and,1,1
101371,insomnia,1,1
101372,were,0,0
101373,the,0,0
101374,most,0,0
101375,frequent,0,0
101376,adverse,0,1
101377,events,0,1
101378,.,0,0
101379,CONCLUSION,0,0
101380,Diethylpropion,0,0
101381,plus,0,0
101382,diet,0,0
101383,produced,0,0
101384,sustained,0,0
101385,and,0,0
101386,clinically,0,0
101387,significant,0,0
101388,weight,1,1
101389,loss,1,1
101390,over,0,0
101391,1,0,0
101392,year,0,0
101393,.,0,0
101394,It,0,0
101395,seems,0,0
101396,to,0,0
101397,be,0,0
101398,safe,0,0
101399,in,0,0
101400,relation,0,0
101401,to,0,0
101402,cardiovascular,0,1
101403,and,0,0
101404,psychiatric,0,0
101405,aspects,0,0
101406,in,0,0
101407,a,0,0
101408,well-selected,0,0
101409,population,0,0
101410,.,0,0
101411,Treatment,0,0
101412,of,0,0
101413,hepatitis,0,0
101414,B,0,0
101415,virus,0,0
101416,infection,0,1
101417,with,0,0
101418,interferon,0,0
101419,.,0,0
101420,Factors,0,0
101421,predicting,0,1
101422,response,0,1
101423,to,0,0
101424,interferon,0,0
101425,.,0,0
101426,Several,0,0
101427,randomised,0,0
101428,controlled,0,0
101429,trials,0,0
101430,have,0,0
101431,been,0,0
101432,undertaken,0,0
101433,to,0,0
101434,evaluate,0,0
101435,the,0,0
101436,efficacy,0,1
101437,of,0,0
101438,alpha-interferon,0,0
101439,in,0,0
101440,the,0,0
101441,therapy,0,0
101442,of,0,0
101443,chronic,0,0
101444,hepatitis,0,0
101445,B,0,0
101446,.,0,0
101447,In,0,0
101448,patients,0,0
101449,with,0,0
101450,HBe,0,0
101451,antigen-positive,0,1
101452,disease,0,1
101453,acquired,0,0
101454,in,0,0
101455,adult,0,0
101456,life,0,1
101457,the,0,0
101458,response,0,1
101459,rates,0,1
101460,vary,0,0
101461,from,0,0
101462,25-50,0,0
101463,%,0,0
101464,.,0,0
101465,In,0,0
101466,those,0,0
101467,infected,0,0
101468,at,0,0
101469,birth,0,0
101470,",",0,0
101471,response,0,1
101472,rates,0,1
101473,are,0,0
101474,lower,0,0
101475,.,0,0
101476,Twenty-one,0,0
101477,pretreatment,0,0
101478,variables,0,0
101479,were,0,0
101480,assessed,0,0
101481,for,0,0
101482,their,0,0
101483,significance,0,0
101484,in,0,0
101485,response,1,1
101486,prediction,0,1
101487,using,0,0
101488,data,0,0
101489,from,0,0
101490,114,0,0
101491,patients,0,0
101492,given,0,0
101493,alpha-interferon,0,0
101494,for,0,0
101495,chronic,0,0
101496,hepatitis,0,0
101497,B,0,0
101498,virus,0,0
101499,infection,0,1
101500,.,0,0
101501,In,0,0
101502,those,0,0
101503,patients,0,0
101504,who,0,0
101505,had,0,0
101506,received,0,0
101507,a,0,0
101508,minimum,0,0
101509,of,0,0
101510,90,0,0
101511,million,0,0
101512,units,0,0
101513,per,0,0
101514,m2,0,0
101515,total,0,1
101516,dose,0,0
101517,over,0,0
101518,12,0,0
101519,weeks,0,0
101520,",",0,0
101521,a,0,0
101522,negative,0,1
101523,anti-human,1,0
101524,immunodeficiency,1,0
101525,virus,1,0
101526,antibody,1,1
101527,status,1,1
101528,(,0,0
101529,p,0,0
101530,less,0,0
101531,than,0,0
101532,0.001,0,0
101533,),0,0
101534,",",0,0
101535,chronic,1,0
101536,active,1,0
101537,hepatitis,1,0
101538,on,1,0
101539,liver,1,1
101540,biopsy,1,0
101541,(,0,0
101542,p,0,0
101543,less,0,0
101544,than,0,0
101545,0.005,0,0
101546,),0,0
101547,",",0,0
101548,high,0,0
101549,AST,1,1
101550,level,1,1
101551,(,0,0
101552,p,0,0
101553,less,0,0
101554,than,0,0
101555,0.001,0,0
101556,),0,0
101557,",",0,0
101558,low,0,0
101559,hepatitis,1,0
101560,B,1,0
101561,virus,1,0
101562,DNA,1,1
101563,level,1,1
101564,(,0,0
101565,p,0,0
101566,less,0,0
101567,than,0,0
101568,0.001,0,0
101569,),0,0
101570,and,0,0
101571,a,0,0
101572,history,0,0
101573,of,0,0
101574,acute,1,0
101575,hepatitis,1,0
101576,(,0,0
101577,p,0,0
101578,less,0,0
101579,than,0,0
101580,0.005,0,0
101581,),0,0
101582,were,0,0
101583,all,0,0
101584,associated,0,0
101585,with,0,0
101586,an,0,0
101587,increased,0,0
101588,likelihood,0,0
101589,of,0,0
101590,response,0,1
101591,on,0,0
101592,univariate,0,0
101593,analysis,0,0
101594,.,0,0
101595,On,0,0
101596,stepwise,0,0
101597,logistic,0,0
101598,regression,0,1
101599,analysis,0,0
101600,",",0,0
101601,hepatitis,0,0
101602,B,0,0
101603,virus,0,0
101604,DNA,0,1
101605,",",0,0
101606,AST,0,0
101607,and,0,0
101608,a,0,0
101609,history,0,0
101610,of,0,0
101611,acute,0,0
101612,hepatitis,0,0
101613,predicted,0,1
101614,response,0,1
101615,independently,0,1
101616,(,0,0
101617,p,0,0
101618,less,0,0
101619,than,0,0
101620,0.05,0,0
101621,),0,0
101622,.,0,0
101623,The,0,0
101624,most,0,0
101625,reliable,0,0
101626,combination,0,0
101627,of,0,0
101628,predictive,0,1
101629,factors,0,0
101630,was,0,0
101631,a,0,0
101632,negative,0,1
101633,anti-human,1,0
101634,immunodeficiency,1,0
101635,virus,1,0
101636,antibody,1,1
101637,status,1,1
101638,",",0,0
101639,with,0,0
101640,either,0,0
101641,a,0,0
101642,positive,0,0
101643,history,0,0
101644,of,0,0
101645,acute,1,0
101646,icteric,1,1
101647,hepatitis,1,0
101648,and,0,0
101649,AST,0,0
101650,greater,0,0
101651,than,0,0
101652,45,0,0
101653,IU,0,0
101654,per,0,0
101655,liter,0,0
101656,or,0,0
101657,no,0,0
101658,history,0,0
101659,of,0,0
101660,acute,0,0
101661,icteric,0,1
101662,hepatitis,0,0
101663,and,0,0
101664,AST,0,0
101665,greater,0,0
101666,than,0,0
101667,85,0,0
101668,IU,0,0
101669,per,0,0
101670,liter,0,0
101671,",",0,0
101672,which,0,0
101673,predicted,0,1
101674,response,0,1
101675,in,0,0
101676,77,0,0
101677,%,0,0
101678,with,0,0
101679,a,0,0
101680,specificity,0,0
101681,of,0,0
101682,79,0,0
101683,%,0,0
101684,(,0,0
101685,p,0,0
101686,less,0,0
101687,than,0,0
101688,0.001,0,0
101689,),0,0
101690,.,0,0
101691,The,0,0
101692,loss,0,1
101693,of,0,0
101694,HBsAg,1,0
101695,in,0,0
101696,addition,0,0
101697,to,0,0
101698,HBeAg,1,0
101699,and,0,0
101700,hepatitis,1,0
101701,B,1,0
101702,virus,1,0
101703,DNA,1,1
101704,was,0,0
101705,more,0,0
101706,likely,0,0
101707,to,0,0
101708,occur,0,0
101709,in,0,0
101710,patients,0,0
101711,with,0,0
101712,chronic,0,0
101713,infection,0,1
101714,of,0,0
101715,less,0,0
101716,than,0,0
101717,2,0,0
101718,years,0,0
101719,duration,0,1
101720,(,0,0
101721,p,0,0
101722,less,0,0
101723,than,0,0
101724,0.001,0,0
101725,),0,0
101726,.,0,0
101727,Seven-star,0,0
101728,needle,0,0
101729,stimulation,0,0
101730,improves,0,1
101731,language,1,1
101732,and,1,0
101733,social,1,1
101734,interaction,1,1
101735,of,0,0
101736,children,0,0
101737,with,0,0
101738,autistic,0,0
101739,spectrum,0,0
101740,disorders,0,0
101741,.,0,0
101742,This,0,0
101743,is,0,0
101744,a,0,0
101745,randomized,0,0
101746,controlled,0,0
101747,trial,0,0
101748,that,0,0
101749,aimed,0,0
101750,to,0,0
101751,evaluate,0,0
101752,the,0,0
101753,effect,0,0
101754,of,0,0
101755,the,0,0
101756,Seven-star,0,0
101757,Needle,0,0
101758,Stimulation,0,0
101759,treatment,0,0
101760,on,0,0
101761,children,0,0
101762,with,0,0
101763,Autistic,0,0
101764,Spectrum,0,0
101765,Disorders,0,1
101766,(,0,0
101767,ASD,0,0
101768,),0,0
101769,.,0,0
101770,Thirty-two,0,0
101771,children,0,0
101772,with,0,0
101773,ASD,0,0
101774,were,0,0
101775,assigned,0,0
101776,randomly,0,0
101777,into,0,0
101778,the,0,0
101779,treatment,0,0
101780,and,0,0
101781,control,0,0
101782,groups,0,0
101783,.,0,0
101784,Children,0,0
101785,in,0,0
101786,the,0,0
101787,treatment,0,0
101788,group,0,0
101789,underwent,0,0
101790,30,0,0
101791,sessions,0,0
101792,of,0,0
101793,stimulation,0,0
101794,over,0,0
101795,6,0,0
101796,weeks,0,0
101797,",",0,0
101798,while,0,0
101799,children,0,0
101800,in,0,0
101801,the,0,0
101802,control,0,0
101803,group,0,0
101804,were,0,0
101805,on,0,0
101806,a,0,0
101807,waiting,0,0
101808,list,0,0
101809,and,0,0
101810,did,0,0
101811,not,0,0
101812,receive,0,0
101813,treatment,0,0
101814,during,0,0
101815,this,0,0
101816,period,0,0
101817,of,0,0
101818,time,0,1
101819,.,0,0
101820,Intervention,0,0
101821,consisted,0,0
101822,of,0,0
101823,a,0,0
101824,treatment,0,0
101825,regime,0,0
101826,comprising,0,0
101827,of,0,0
101828,30,0,0
101829,sessions,0,0
101830,of,0,0
101831,Seven-star,0,0
101832,Needle,0,1
101833,Stimulation,0,0
101834,",",0,0
101835,delivered,0,0
101836,over,0,0
101837,6,0,0
101838,weeks,0,0
101839,.,0,0
101840,Each,0,0
101841,session,0,0
101842,lasted,0,0
101843,5,0,0
101844,to,0,0
101845,10,0,0
101846,min,0,0
101847,",",0,0
101848,children,0,0
101849,in,0,0
101850,the,0,0
101851,treatment,0,0
101852,group,0,0
101853,were,0,0
101854,stimulated,0,0
101855,at,0,0
101856,the,0,0
101857,front,0,1
101858,and,0,0
101859,back,0,0
101860,sides,0,0
101861,of,0,0
101862,their,0,0
101863,body,0,0
101864,and,0,0
101865,the,0,0
101866,head,0,0
101867,by,0,0
101868,using,0,0
101869,Seven-star,0,0
101870,Needles,0,0
101871,.,0,0
101872,The,0,0
101873,change,0,0
101874,in,0,0
101875,the,0,0
101876,children,1,0
101877,'s,1,0
101878,behavior,1,1
101879,was,0,0
101880,evaluated,0,0
101881,using,0,0
101882,parents,0,0
101883,',0,0
101884,report,0,0
101885,and,0,0
101886,neurophysiological,0,1
101887,changes,0,1
101888,were,0,0
101889,measured,0,0
101890,by,0,0
101891,quantitative,0,0
101892,EEG,0,0
101893,(,0,0
101894,qEEG,0,0
101895,),0,0
101896,.,0,0
101897,Results,0,0
101898,showed,0,0
101899,that,0,0
101900,the,0,0
101901,treatment,0,0
101902,group,0,0
101903,demonstrated,0,0
101904,significant,0,0
101905,improvement,0,1
101906,in,0,0
101907,language,1,1
101908,and,1,0
101909,social,1,1
101910,interaction,1,1
101911,",",0,0
101912,but,0,0
101913,not,0,0
101914,in,0,0
101915,stereotyped,1,1
101916,behavior,1,1
101917,or,1,0
101918,motor,1,1
101919,function,1,1
101920,",",0,0
101921,compared,0,0
101922,to,0,0
101923,the,0,0
101924,control,0,0
101925,group,0,0
101926,.,0,0
101927,qEEG,1,0
101928,spectral,1,0
101929,amplitudes,1,0
101930,in,0,0
101931,the,0,0
101932,treatment,0,0
101933,",",0,0
101934,but,0,0
101935,not,0,0
101936,in,0,0
101937,the,0,0
101938,control,0,0
101939,group,0,0
101940,",",0,0
101941,were,0,0
101942,also,0,0
101943,reduced,0,0
101944,significantly,0,0
101945,.,0,0
101946,The,0,0
101947,results,0,0
101948,suggested,0,0
101949,that,0,0
101950,Seven-star,0,0
101951,Needle,0,0
101952,Stimulation,0,0
101953,might,0,0
101954,be,0,0
101955,an,0,0
101956,effective,0,0
101957,intervention,0,0
101958,to,0,0
101959,improve,0,0
101960,language,1,1
101961,and,1,0
101962,social,1,1
101963,functioning,1,1
101964,of,0,0
101965,children,0,0
101966,with,0,0
101967,ASD,0,0
101968,.,0,0
101969,Isometric,0,1
101970,contractions,0,1
101971,reduce,0,0
101972,plantar,1,1
101973,flexor,1,1
101974,moment,1,1
101975,",",1,0
101976,Achilles,1,0
101977,tendon,1,1
101978,stiffness,1,1
101979,",",1,0
101980,and,1,1
101981,neuromuscular,1,1
101982,activity,1,1
101983,but,0,0
101984,remove,0,0
101985,the,0,0
101986,subsequent,0,0
101987,effects,0,0
101988,of,0,0
101989,stretch,0,0
101990,.,0,0
101991,The,0,0
101992,effects,0,0
101993,of,0,0
101994,isometric,0,0
101995,contractions,0,1
101996,and,0,0
101997,passive,0,1
101998,stretching,0,0
101999,on,0,0
102000,muscle-tendon,0,1
102001,mechanics,0,1
102002,and,0,1
102003,muscle,0,1
102004,activity,0,1
102005,were,0,0
102006,studied,0,0
102007,in,0,0
102008,16,0,0
102009,healthy,0,0
102010,human,0,0
102011,volunteers,0,0
102012,.,0,0
102013,First,0,1
102014,",",0,0
102015,peak,0,1
102016,concentric,0,0
102017,and,0,1
102018,passive,0,1
102019,ankle,0,1
102020,joint,0,1
102021,moment,0,1
102022,data,0,0
102023,were,0,0
102024,recorded,0,0
102025,on,0,0
102026,an,0,0
102027,isokinetic,0,0
102028,dynamometer,0,0
102029,with,0,0
102030,electromyographic,0,1
102031,monitoring,0,0
102032,of,0,0
102033,the,0,0
102034,triceps,0,0
102035,surae,0,0
102036,;,0,0
102037,real-time,0,0
102038,motion,0,1
102039,analysis,0,0
102040,of,0,0
102041,the,0,0
102042,lower,0,0
102043,leg,0,1
102044,and,0,1
102045,ultrasound,0,1
102046,imaging,0,0
102047,of,0,0
102048,the,0,0
102049,Achilles-medial,0,0
102050,gastrocnemius,0,0
102051,muscle-tendon,0,1
102052,junction,0,1
102053,were,0,0
102054,simultaneously,0,0
102055,conducted,0,0
102056,.,0,0
102057,Second,0,0
102058,",",0,0
102059,the,0,0
102060,subjects,0,0
102061,performed,0,0
102062,six,0,0
102063,8-s,0,0
102064,maximal,0,0
102065,voluntary,0,0
102066,isometric,0,0
102067,contractions,0,1
102068,(,0,0
102069,MVICs,0,0
102070,),0,0
102071,before,0,0
102072,repeating,0,0
102073,the,0,0
102074,passive,0,0
102075,and,0,0
102076,active,0,0
102077,trials,0,0
102078,.,0,0
102079,Although,0,0
102080,there,0,0
102081,was,0,0
102082,no,0,0
102083,decrease,0,0
102084,in,0,0
102085,isometric,1,0
102086,joint,1,1
102087,moment,1,1
102088,after,0,0
102089,MVICs,0,0
102090,",",0,0
102091,peak,1,1
102092,concentric,1,0
102093,moment,1,1
102094,was,0,0
102095,significantly,0,0
102096,reduced,0,0
102097,(,0,0
102098,11.5,0,0
102099,%,0,0
102100,",",0,0
102101,P,0,0
102102,<,0,0
102103,0.01,0,0
102104,),0,0
102105,.,0,0
102106,This,0,0
102107,was,0,0
102108,accompanied,0,0
102109,by,0,0
102110,",",0,0
102111,and,0,0
102112,correlated,0,1
102113,with,0,0
102114,(,0,0
102115,r,0,0
102116,=,0,0
102117,0.90,0,0
102118,",",0,0
102119,P,0,0
102120,<,0,0
102121,0.01,0,0
102122,),0,0
102123,",",0,0
102124,significant,0,0
102125,reductions,0,1
102126,in,0,0
102127,peak,1,1
102128,triceps,1,0
102129,surae,1,1
102130,electromyographic,1,1
102131,amplitude,1,1
102132,(,0,0
102133,21.0,0,0
102134,%,0,0
102135,",",0,0
102136,P,0,0
102137,<,0,0
102138,0.01,0,0
102139,),0,0
102140,.,0,0
102141,Achilles,1,0
102142,tendon,1,1
102143,stiffness,1,1
102144,(,0,0
102145,10.9,0,0
102146,%,0,0
102147,",",0,0
102148,P,0,0
102149,<,0,0
102150,0.01,0,0
102151,),0,0
102152,and,0,0
102153,passive,1,1
102154,joint,1,1
102155,moment,1,1
102156,(,0,0
102157,4.9,0,0
102158,%,0,0
102159,",",0,0
102160,P,0,0
102161,<,0,0
102162,0.01,0,0
102163,),0,0
102164,were,0,0
102165,also,0,0
102166,significantly,0,0
102167,reduced,0,0
102168,.,0,0
102169,Third,0,0
102170,",",0,0
102171,the,0,0
102172,subjects,0,0
102173,performed,0,0
102174,three,0,0
102175,60-s,0,0
102176,static,0,0
102177,plantar,0,1
102178,flexor,0,1
102179,stretches,0,0
102180,before,0,0
102181,being,0,0
102182,retested,0,0
102183,2,0,0
102184,and,0,0
102185,30,0,0
102186,min,0,0
102187,after,0,0
102188,stretch,0,0
102189,.,0,0
102190,The,0,0
102191,stretch,0,0
102192,protocol,0,0
102193,caused,0,0
102194,no,0,0
102195,significant,0,0
102196,change,0,0
102197,in,0,0
102198,any,0,0
102199,measure,0,0
102200,.,0,0
102201,At,0,0
102202,30,0,0
102203,min,0,0
102204,after,0,0
102205,stretching,0,0
102206,",",0,0
102207,significant,0,0
102208,recovery,0,1
102209,in,0,0
102210,concentric,1,0
102211,moment,1,1
102212,and,1,1
102213,muscle,1,1
102214,activity,1,1
102215,was,0,0
102216,detected,0,0
102217,at,0,0
102218,dorsiflexed,0,0
102219,joint,0,1
102220,angles,0,1
102221,",",0,0
102222,while,0,0
102223,Achilles,1,1
102224,tendon,1,1
102225,stiffness,1,1
102226,and,1,1
102227,passive,1,1
102228,joint,1,1
102229,moment,1,1
102230,remained,0,0
102231,significantly,0,0
102232,reduced,0,0
102233,.,0,0
102234,These,0,0
102235,data,0,0
102236,show,0,0
102237,that,0,0
102238,the,0,0
102239,performance,0,1
102240,of,0,0
102241,MVICs,0,0
102242,interrupts,0,0
102243,the,0,0
102244,normal,0,0
102245,stretch-induced,0,0
102246,losses,0,1
102247,in,0,0
102248,active,0,0
102249,and,0,0
102250,passive,0,1
102251,plantar,0,1
102252,flexor,0,1
102253,joint,0,1
102254,moment,0,1
102255,and,0,0
102256,neuromuscular,0,1
102257,activity,0,1
102258,",",0,0
102259,largely,0,0
102260,because,0,0
102261,concentric,0,0
102262,strength,0,1
102263,and,0,1
102264,tendon,0,1
102265,properties,0,1
102266,were,0,0
102267,already,0,0
102268,affected,0,0
102269,.,0,0
102270,Importantly,0,0
102271,",",0,0
102272,the,0,0
102273,decrease,0,0
102274,in,0,0
102275,Achilles,1,1
102276,tendon,1,1
102277,stiffness,1,1
102278,remained,0,0
102279,30,0,0
102280,min,0,0
102281,later,0,0
102282,",",0,0
102283,which,0,0
102284,may,0,0
102285,be,0,0
102286,an,0,0
102287,important,0,0
102288,etiological,0,0
102289,factor,0,0
102290,for,0,0
102291,muscle-tendon,0,1
102292,strain,0,1
102293,injury,0,1
102294,risk,0,0
102295,.,0,0
102296,Sustained,0,1
102297,benefit,0,0
102298,of,0,0
102299,continuous,0,0
102300,glucose,0,1
102301,monitoring,0,0
102302,on,0,0
102303,A1C,0,0
102304,",",0,0
102305,glucose,0,1
102306,profiles,0,1
102307,",",0,0
102308,and,0,1
102309,hypoglycemia,0,1
102310,in,0,0
102311,adults,0,0
102312,with,0,0
102313,type,0,0
102314,1,0,0
102315,diabetes,0,0
102316,.,0,0
102317,OBJECTIVE,0,0
102318,To,0,0
102319,evaluate,0,0
102320,long-term,0,0
102321,effects,0,0
102322,of,0,0
102323,continuous,0,0
102324,glucose,0,1
102325,monitoring,0,0
102326,(,0,0
102327,CGM,0,1
102328,),0,0
102329,in,0,0
102330,intensively,0,0
102331,treated,0,0
102332,adults,0,0
102333,with,0,0
102334,type,0,0
102335,1,0,0
102336,diabetes,0,0
102337,.,0,0
102338,RESEARCH,0,0
102339,DESIGN,0,0
102340,AND,0,0
102341,METHODS,0,0
102342,We,0,0
102343,studied,0,0
102344,83,0,0
102345,of,0,0
102346,86,0,0
102347,individuals,0,0
102348,>,0,0
102349,or=25,0,0
102350,years,0,0
102351,of,0,0
102352,age,0,0
102353,with,0,0
102354,type,0,0
102355,1,0,0
102356,diabetes,0,0
102357,who,0,0
102358,used,0,0
102359,CGM,0,0
102360,as,0,0
102361,part,0,0
102362,of,0,0
102363,a,0,0
102364,6-month,0,0
102365,randomized,0,0
102366,clinical,0,0
102367,trial,0,0
102368,in,0,0
102369,a,0,0
102370,subsequent,0,0
102371,6-month,0,0
102372,extension,0,0
102373,study,0,0
102374,.,0,0
102375,RESULTS,0,0
102376,After,0,0
102377,12,0,0
102378,months,0,0
102379,",",0,0
102380,median,0,1
102381,CGM,0,1
102382,use,0,0
102383,was,0,0
102384,6.8,0,0
102385,days,0,0
102386,per,0,0
102387,week,0,0
102388,.,0,0
102389,Mean,1,0
102390,change,1,0
102391,in,1,0
102392,A1C,1,0
102393,level,1,1
102394,from,0,0
102395,baseline,0,0
102396,to,0,0
102397,12,0,0
102398,months,0,0
102399,was,0,0
102400,-0.4,0,0
102401,+/-,0,0
102402,0.6,0,0
102403,%,0,0
102404,(,0,0
102405,P,0,0
102406,<,0,0
102407,0.001,0,0
102408,),0,0
102409,in,0,0
102410,subjects,0,0
102411,with,0,0
102412,baseline,0,0
102413,A1C,0,0
102414,>,0,0
102415,or=7.0,0,0
102416,%,0,0
102417,.,0,0
102418,A1C,1,0
102419,remained,0,0
102420,stable,0,0
102421,at,0,0
102422,6.4,0,0
102423,%,0,0
102424,in,0,0
102425,those,0,0
102426,with,0,0
102427,baseline,0,0
102428,A1C,0,0
102429,<,0,0
102430,7.0,0,0
102431,%,0,0
102432,.,0,0
102433,The,0,0
102434,incidence,1,1
102435,rate,1,1
102436,of,1,0
102437,severe,1,1
102438,hypoglycemia,1,1
102439,was,0,0
102440,21.8,0,0
102441,and,0,0
102442,7.1,0,0
102443,events,0,1
102444,per,0,0
102445,100,0,0
102446,person-years,0,0
102447,in,0,0
102448,the,0,0
102449,first,0,0
102450,and,0,0
102451,last,0,0
102452,6,0,0
102453,months,0,0
102454,",",0,0
102455,respectively,0,0
102456,.,0,0
102457,Time,1,0
102458,per,1,0
102459,day,1,0
102460,with,1,0
102461,glucose,1,1
102462,levels,1,1
102463,in,0,0
102464,the,0,0
102465,range,0,0
102466,of,0,0
102467,71-180,0,0
102468,mg/dl,0,0
102469,increased,0,0
102470,significantly,0,0
102471,(,0,0
102472,P,0,0
102473,=,0,0
102474,0.02,0,0
102475,),0,0
102476,from,0,0
102477,baseline,0,0
102478,to,0,0
102479,12,0,0
102480,months,0,0
102481,.,0,0
102482,CONCLUSIONS,0,0
102483,In,0,0
102484,intensively,0,0
102485,treated,0,0
102486,adults,0,0
102487,with,0,0
102488,type,0,0
102489,1,0,0
102490,diabetes,0,0
102491,",",0,0
102492,CGM,0,1
102493,use,0,1
102494,and,0,0
102495,benefit,0,0
102496,can,0,0
102497,be,0,0
102498,sustained,0,0
102499,for,0,0
102500,12,0,0
102501,months,0,0
102502,.,0,0
102503,Depiction,1,1
102504,of,1,0
102505,hypervascular,1,1
102506,hepatocellular,1,0
102507,carcinoma,1,0
102508,with,0,0
102509,64-MDCT,1,0
102510,:,1,0
102511,comparison,0,0
102512,of,0,0
102513,moderate-,0,0
102514,and,0,0
102515,high-concentration,0,1
102516,contrast,0,0
102517,material,0,1
102518,with,0,0
102519,and,0,0
102520,without,0,0
102521,saline,0,0
102522,flush,0,0
102523,.,0,0
102524,OBJECTIVE,0,0
102525,The,0,0
102526,purpose,0,0
102527,of,0,0
102528,this,0,0
102529,study,0,0
102530,was,0,0
102531,to,0,0
102532,evaluate,0,0
102533,prospectively,0,0
102534,the,0,0
102535,depiction,1,0
102536,of,1,0
102537,hypervascular,1,1
102538,hepatocellular,1,0
102539,carcinoma,1,0
102540,on,0,0
102541,64-MDCT,0,0
102542,scans,0,0
102543,obtained,0,0
102544,with,0,0
102545,contrast,0,0
102546,agents,0,0
102547,of,0,0
102548,varying,0,0
102549,iodine,0,0
102550,concentrations,0,1
102551,administered,0,0
102552,with,0,0
102553,and,0,0
102554,without,0,0
102555,saline,0,0
102556,flush,0,0
102557,.,0,0
102558,SUBJECTS,0,0
102559,AND,0,0
102560,METHODS,0,0
102561,The,0,0
102562,study,0,0
102563,included,0,0
102564,149,0,0
102565,patients,0,0
102566,",",0,0
102567,among,0,0
102568,whom,0,0
102569,36,0,0
102570,patients,0,0
102571,with,0,0
102572,hypervascular,0,0
102573,hepatocellular,0,0
102574,carcinoma,0,0
102575,were,0,0
102576,identified,0,0
102577,.,0,0
102578,Patients,0,0
102579,were,0,0
102580,randomly,0,0
102581,assigned,0,0
102582,to,0,0
102583,one,0,0
102584,of,0,0
102585,three,0,0
102586,protocols,0,0
102587,:,0,0
102588,A,0,0
102589,",",0,0
102590,contrast,0,0
102591,material,0,0
102592,of,0,0
102593,300,0,0
102594,mg,0,0
102595,I/mL,0,0
102596,;,0,0
102597,B,0,0
102598,",",0,0
102599,370,0,0
102600,mg,0,0
102601,I/mL,0,0
102602,;,0,0
102603,C,0,0
102604,",",0,0
102605,370,0,0
102606,mg,0,0
102607,I/mL,0,0
102608,plus,0,0
102609,saline,0,0
102610,flush,0,0
102611,.,0,0
102612,In,0,0
102613,all,0,0
102614,protocols,0,0
102615,",",0,0
102616,the,0,0
102617,same,0,0
102618,iodine,0,1
102619,load,0,1
102620,per,0,0
102621,kilogram,0,0
102622,of,0,0
102623,body,0,1
102624,weight,0,1
102625,(,0,0
102626,516,0,0
102627,mg/kg,0,0
102628,),0,0
102629,was,0,0
102630,administered,0,0
102631,for,0,0
102632,the,0,0
102633,same,0,0
102634,injection,0,0
102635,duration,0,1
102636,(,0,0
102637,30,0,0
102638,seconds,0,0
102639,),0,0
102640,.,0,0
102641,Enhancement,1,0
102642,values,1,1
102643,in,1,0
102644,the,1,0
102645,aorta,1,0
102646,",",1,0
102647,liver,1,1
102648,",",1,1
102649,and,1,1
102650,portal,1,1
102651,vein,1,1
102652,and,1,0
102653,tumor-liver,1,1
102654,contrast,1,0
102655,were,0,0
102656,measured,0,0
102657,at,0,0
102658,multiphase,0,0
102659,CT,0,1
102660,.,0,0
102661,RESULTS,0,0
102662,Aortic,1,0
102663,enhancement,1,0
102664,was,0,0
102665,significantly,0,0
102666,different,0,0
102667,between,0,0
102668,protocols,0,0
102669,A,0,0
102670,and,0,1
102671,B,0,0
102672,(,0,0
102673,p,0,0
102674,=,0,0
102675,0.04,0,0
102676,",",0,0
102677,p,0,0
102678,<,0,0
102679,0.0001,0,0
102680,),0,0
102681,and,0,0
102682,protocols,0,0
102683,B,0,0
102684,and,0,1
102685,C,0,0
102686,(,0,0
102687,p,0,0
102688,=,0,0
102689,0.02,0,0
102690,",",0,0
102691,p,0,0
102692,<,0,0
102693,0.001,0,0
102694,),0,0
102695,in,0,0
102696,the,0,0
102697,first,0,0
102698,and,0,0
102699,second,0,0
102700,phases,0,0
102701,.,0,0
102702,Portal,1,0
102703,venous,1,1
102704,enhancement,1,0
102705,was,0,0
102706,significantly,0,0
102707,different,0,0
102708,between,0,0
102709,protocols,0,0
102710,B,0,0
102711,and,0,1
102712,C,0,0
102713,(,0,0
102714,p,0,0
102715,=,0,0
102716,0.02,0,0
102717,),0,0
102718,in,0,0
102719,the,0,0
102720,first,0,0
102721,phase,0,0
102722,and,0,0
102723,between,0,0
102724,protocols,0,0
102725,B,0,0
102726,and,0,1
102727,C,0,0
102728,and,0,0
102729,protocols,0,0
102730,A,0,0
102731,and,0,0
102732,C,0,0
102733,(,0,0
102734,p,0,0
102735,<,0,0
102736,0.01,0,0
102737,",",0,0
102738,p,0,0
102739,=,0,0
102740,0.02,0,0
102741,),0,0
102742,in,0,0
102743,the,0,0
102744,second,0,0
102745,phase,0,0
102746,.,0,0
102747,Tumor-liver,1,1
102748,contrast,1,0
102749,was,0,0
102750,significantly,0,0
102751,different,0,0
102752,between,0,0
102753,protocols,0,0
102754,A,0,0
102755,and,0,1
102756,B,0,0
102757,(,0,0
102758,p,0,0
102759,=,0,0
102760,0.03,0,0
102761,",",0,0
102762,p,0,0
102763,=,0,0
102764,0.02,0,0
102765,),0,0
102766,and,0,0
102767,protocols,0,0
102768,B,0,0
102769,and,0,1
102770,C,0,0
102771,(,0,0
102772,p,0,0
102773,=,0,0
102774,0.03,0,0
102775,",",0,0
102776,p,0,0
102777,=,0,0
102778,0.04,0,0
102779,),0,0
102780,in,0,0
102781,the,0,0
102782,first,0,0
102783,and,0,0
102784,second,0,0
102785,phases,0,0
102786,but,0,0
102787,not,0,0
102788,between,0,0
102789,protocols,0,0
102790,A,0,0
102791,and,0,0
102792,C.,0,1
102793,There,0,0
102794,was,0,0
102795,no,0,0
102796,significant,0,0
102797,difference,0,0
102798,in,0,0
102799,hepatic,1,1
102800,enhancement,1,0
102801,among,0,0
102802,the,0,0
102803,three,0,0
102804,protocols,0,0
102805,.,0,0
102806,CONCLUSION,0,0
102807,Use,0,0
102808,of,0,0
102809,moderate,0,0
102810,concentration,0,1
102811,was,0,0
102812,more,0,0
102813,effective,0,1
102814,than,0,0
102815,use,0,0
102816,of,0,0
102817,a,0,0
102818,high,0,0
102819,concentration,0,1
102820,of,0,0
102821,contrast,0,0
102822,material,0,1
102823,for,0,0
102824,depiction,0,0
102825,of,0,0
102826,hepatocellular,0,0
102827,carcinoma,0,0
102828,.,0,0
102829,Adding,0,0
102830,a,0,0
102831,saline,0,0
102832,flush,0,0
102833,to,0,0
102834,the,0,0
102835,high-concentration,0,0
102836,protocol,0,0
102837,eliminated,0,0
102838,the,0,0
102839,difference,0,0
102840,in,0,0
102841,depiction,1,0
102842,of,1,0
102843,hepatocellular,1,0
102844,carcinoma,1,0
102845,between,0,0
102846,the,0,0
102847,moderate-,0,0
102848,and,0,0
102849,high-concentration,0,1
102850,protocols,0,0
102851,.,0,0
102852,Qigong,0,0
102853,massage,0,0
102854,treatment,0,0
102855,for,0,0
102856,sensory,1,1
102857,and,1,0
102858,self-regulation,1,1
102859,problems,1,1
102860,in,0,0
102861,young,0,0
102862,children,0,0
102863,with,0,0
102864,autism,0,0
102865,:,0,0
102866,a,0,0
102867,randomized,0,0
102868,controlled,0,0
102869,trial,0,0
102870,.,0,0
102871,Autism,0,0
102872,is,0,0
102873,commonly,0,0
102874,associated,0,0
102875,with,0,0
102876,sensory,1,1
102877,and,1,0
102878,self-regulatory,1,1
102879,disturbances,1,1
102880,.,1,0
102881,This,0,0
102882,article,0,0
102883,presents,0,0
102884,a,0,0
102885,randomized,0,0
102886,controlled,0,0
102887,study,0,0
102888,evaluating,0,0
102889,the,0,0
102890,effect,0,0
102891,of,0,0
102892,a,0,0
102893,5-month,0,0
102894,intervention,0,0
102895,directed,0,0
102896,toward,0,0
102897,improving,0,1
102898,sensory,1,1
102899,impairment,1,1
102900,",",1,0
102901,digestion,1,1
102902,",",1,1
102903,and,1,1
102904,sleep,1,1
102905,in,0,0
102906,46,0,0
102907,children,0,0
102908,with,0,0
102909,autism,0,0
102910,<,0,0
102911,age,0,0
102912,6,0,0
102913,.,0,0
102914,The,0,0
102915,intervention,0,0
102916,",",0,0
102917,Qigong,0,0
102918,Sensory,0,1
102919,Training,0,0
102920,(,0,0
102921,QST,0,0
102922,),0,0
102923,",",0,0
102924,is,0,0
102925,a,0,0
102926,qigong,0,0
102927,massage,0,0
102928,intervention,0,0
102929,based,0,0
102930,in,0,0
102931,Chinese,0,0
102932,medicine,0,0
102933,.,0,0
102934,It,0,0
102935,is,0,0
102936,two-pronged,0,0
102937,:,0,0
102938,Trainers,0,0
102939,work,0,0
102940,with,0,0
102941,children,0,0
102942,directly,0,0
102943,20,0,0
102944,times,0,0
102945,over,0,0
102946,5,0,0
102947,months,0,0
102948,",",0,0
102949,and,0,0
102950,parents,0,0
102951,give,0,0
102952,the,0,0
102953,massage,0,0
102954,daily,0,0
102955,to,0,0
102956,their,0,0
102957,children,0,0
102958,.,0,0
102959,Improvement,0,1
102960,was,0,0
102961,evaluated,0,0
102962,in,0,0
102963,two,0,0
102964,settings,0,0
102965,--,0,0
102966,preschool,0,0
102967,and,0,0
102968,home,0,0
102969,--,0,0
102970,by,0,0
102971,teachers,0,0
102972,(,0,0
102973,blind,0,0
102974,to,0,0
102975,group,0,0
102976,),0,0
102977,and,0,0
102978,parents,0,0
102979,.,0,1
102980,Teacher,0,0
102981,evaluations,0,0
102982,showed,0,0
102983,that,0,0
102984,treated,0,0
102985,children,0,0
102986,had,0,0
102987,significant,0,0
102988,classroom,0,0
102989,improvement,0,1
102990,of,0,0
102991,social,1,1
102992,and,1,0
102993,language,1,1
102994,skills,1,1
102995,and,0,1
102996,reduction,1,1
102997,in,1,0
102998,autistic,1,0
102999,behavior,1,1
103000,compared,0,0
103001,with,0,0
103002,wait-list,0,0
103003,control,0,0
103004,participants,0,0
103005,.,0,0
103006,These,0,0
103007,findings,0,0
103008,were,0,0
103009,confirmed,0,0
103010,by,0,0
103011,parent,0,0
103012,data,0,0
103013,",",0,0
103014,indicating,0,0
103015,that,0,0
103016,the,0,0
103017,gains,1,1
103018,had,0,0
103019,generalized,0,0
103020,across,0,0
103021,contexts,0,0
103022,.,0,0
103023,A,0,0
103024,model,0,0
103025,and,0,0
103026,supporting,0,0
103027,data,0,0
103028,for,0,0
103029,understanding,0,0
103030,and,0,0
103031,treating,0,0
103032,sensory,1,1
103033,and,1,0
103034,self-regulation,1,1
103035,problems,1,1
103036,in,0,0
103037,autism,0,0
103038,is,0,0
103039,presented,0,0
103040,.,0,0
103041,Prospective,0,0
103042,randomised,0,0
103043,multicentre,0,0
103044,trial,0,0
103045,with,0,0
103046,the,0,0
103047,birth,0,0
103048,trainer,0,0
103049,EPI-NO,0,0
103050,for,0,0
103051,the,0,0
103052,prevention,0,0
103053,of,0,0
103054,perineal,1,1
103055,trauma,1,0
103056,.,1,0
103057,BACKGROUND,0,0
103058,In,0,0
103059,several,0,0
103060,non-randomised,0,0
103061,trials,0,0
103062,training,0,0
103063,with,0,0
103064,EPI-NO,0,0
103065,increased,0,0
103066,the,0,0
103067,rate,0,1
103068,of,0,0
103069,intact,0,0
103070,perineum,0,1
103071,and,0,0
103072,decreased,0,1
103073,episiotomy,0,1
103074,rates,0,1
103075,",",0,0
103076,shortened,0,0
103077,the,0,0
103078,second,0,0
103079,stage,0,0
103080,of,0,0
103081,labour,0,1
103082,and,0,0
103083,lowered,0,0
103084,use,0,0
103085,of,0,0
103086,pain,0,1
103087,killers,0,1
103088,.,0,0
103089,AIMS,0,0
103090,To,0,0
103091,verify,0,0
103092,the,0,0
103093,preliminary,0,0
103094,results,0,0
103095,with,0,0
103096,EPI-NO,0,0
103097,in,0,0
103098,a,0,0
103099,prospective,0,0
103100,randomised,0,0
103101,trial,0,0
103102,.,0,0
103103,METHODS,0,0
103104,Randomised,0,0
103105,",",0,0
103106,single-blind,0,0
103107,multicentre,0,0
103108,trial,0,0
103109,in,0,0
103110,four,0,0
103111,university,0,0
103112,hospitals,0,0
103113,in,0,0
103114,Germany,0,0
103115,including,0,0
103116,276,0,0
103117,primigravidae,0,0
103118,.,0,0
103119,RESULTS,0,0
103120,After,0,0
103121,training,0,0
103122,with,0,0
103123,EPI-NO,0,0
103124,we,0,0
103125,observed,0,0
103126,a,0,0
103127,significant,0,0
103128,increase,0,0
103129,in,0,0
103130,the,0,0
103131,incidence,1,1
103132,of,1,0
103133,intact,1,0
103134,perineum,1,1
103135,(,0,0
103136,37.4,0,0
103137,%,0,0
103138,vs,0,0
103139,25.7,0,0
103140,%,0,0
103141,;,0,0
103142,P,0,0
103143,=,0,0
103144,0.05,0,0
103145,),0,0
103146,and,0,0
103147,a,0,0
103148,tendency,0,0
103149,towards,0,0
103150,lower,1,0
103151,episiotomy,1,1
103152,rates,1,1
103153,(,0,0
103154,41.9,0,0
103155,%,0,0
103156,vs,0,0
103157,50.5,0,0
103158,%,0,0
103159,;,0,0
103160,P,0,0
103161,=,0,0
103162,0.11,0,0
103163,),0,0
103164,.,0,0
103165,We,0,0
103166,found,0,0
103167,no,0,0
103168,significant,0,0
103169,differences,0,0
103170,between,0,0
103171,the,0,0
103172,two,0,0
103173,groups,0,0
103174,regarding,0,0
103175,incidence,1,1
103176,of,1,0
103177,perineal,1,1
103178,tears,1,1
103179,",",1,0
103180,duration,1,1
103181,of,1,1
103182,second,1,0
103183,stage,1,0
103184,of,1,0
103185,labour,1,1
103186,",",1,0
103187,use,1,1
103188,of,1,1
103189,pain,1,1
103190,relief,1,1
103191,and,1,1
103192,rate,1,1
103193,of,1,1
103194,vaginal,1,0
103195,infection,1,1
103196,.,1,0
103197,CONCLUSIONS,0,0
103198,Training,0,0
103199,with,0,0
103200,EPI-NO,0,0
103201,increases,0,0
103202,significantly,0,0
103203,the,0,0
103204,likelihood,0,0
103205,of,0,0
103206,having,1,0
103207,an,1,0
103208,intact,1,0
103209,perineum,1,1
103210,and,1,0
103211,reduces,1,0
103212,the,1,0
103213,episiotomy,1,0
103214,rate,1,1
103215,.,1,0
103216,The,0,0
103217,experience,0,0
103218,of,0,0
103219,pleasure,0,1
103220,before,0,0
103221,and,0,0
103222,after,0,0
103223,hearing,0,1
103224,rehabilitation,0,0
103225,.,0,0
103226,Hearing,0,0
103227,loss,0,1
103228,may,0,0
103229,lead,0,0
103230,to,0,0
103231,major,0,0
103232,changes,0,0
103233,in,0,0
103234,the,0,0
103235,social,0,1
103236,and,0,0
103237,emotional,0,1
103238,aspects,0,0
103239,of,0,0
103240,daily,0,0
103241,life,0,1
103242,.,0,0
103243,This,0,0
103244,follow-up,0,0
103245,study,0,0
103246,investigated,0,0
103247,the,0,0
103248,effect,0,0
103249,of,0,0
103250,hearing-aid,0,1
103251,use,0,0
103252,on,0,0
103253,emotional,0,1
103254,experience,0,0
103255,in,0,0
103256,adults,0,0
103257,with,0,0
103258,hearing,0,1
103259,impairment,0,1
103260,.,0,0
103261,Thirteen,0,0
103262,individuals,0,0
103263,with,0,0
103264,impaired,0,1
103265,hearing,0,1
103266,were,0,0
103267,tested,0,0
103268,before,0,0
103269,and,0,0
103270,after,0,0
103271,6,0,0
103272,months,0,0
103273,of,0,0
103274,hearing-aid,0,1
103275,use,0,0
103276,",",0,0
103277,and,0,1
103278,were,0,0
103279,compared,0,0
103280,with,0,0
103281,19,0,0
103282,individuals,0,0
103283,who,0,0
103284,had,0,0
103285,worn,0,0
103286,hearing,0,1
103287,aids,0,0
103288,for,0,0
103289,many,0,0
103290,years,0,0
103291,.,0,0
103292,The,0,0
103293,participants,0,0
103294,reported,0,0
103295,their,0,0
103296,daily,1,0
103297,emotional,1,1
103298,experiences,1,1
103299,",",0,0
103300,by,0,0
103301,completing,0,0
103302,questionnaires,1,0
103303,relating,1,0
103304,to,1,0
103305,sensory,1,1
103306,and,1,0
103307,social,1,1
103308,pleasure,1,1
103309,.,1,0
103310,After,0,0
103311,6,0,0
103312,months,0,0
103313,of,0,0
103314,hearing-aid,0,1
103315,use,0,0
103316,",",0,0
103317,individuals,0,0
103318,experienced,0,0
103319,more,0,0
103320,physical,1,1
103321,and,1,1
103322,social,1,1
103323,pleasure,1,1
103324,",",0,0
103325,whereas,0,0
103326,individuals,0,0
103327,using,0,0
103328,hearing,0,1
103329,aids,0,0
103330,for,0,0
103331,long,0,0
103332,periods,0,0
103333,of,0,0
103334,time,0,1
103335,reported,0,0
103336,similar,0,0
103337,levels,0,1
103338,of,0,0
103339,pleasure,0,1
103340,at,0,0
103341,the,0,0
103342,beginning,0,0
103343,and,0,0
103344,at,0,0
103345,the,0,0
103346,end,0,0
103347,of,0,0
103348,a,0,0
103349,6-month,0,0
103350,interval,0,0
103351,.,0,0
103352,The,0,0
103353,participants,0,0
103354,also,0,0
103355,performed,0,0
103356,a,0,0
103357,visual,0,1
103358,task,0,0
103359,",",0,0
103360,in,0,0
103361,which,0,0
103362,they,0,0
103363,rated,0,0
103364,the,0,0
103365,intensity,1,1
103366,of,1,0
103367,pleasure,1,1
103368,they,1,0
103369,experienced,1,0
103370,in,1,0
103371,response,1,1
103372,to,1,0
103373,emotionally,1,1
103374,positive,1,0
103375,and,1,0
103376,neutral,1,0
103377,pictures,1,0
103378,differing,1,0
103379,in,1,0
103380,luminance,1,1
103381,contrast,1,0
103382,.,1,0
103383,In,0,0
103384,this,0,0
103385,task,0,0
103386,",",0,0
103387,pleasure,0,1
103388,typically,0,0
103389,decreases,0,0
103390,with,0,0
103391,decreasing,0,0
103392,contrast,0,0
103393,of,0,0
103394,the,0,0
103395,positive,0,0
103396,images,0,0
103397,displayed,0,0
103398,.,0,0
103399,Once,0,0
103400,they,0,0
103401,had,0,0
103402,been,0,0
103403,fitted,0,0
103404,with,0,0
103405,hearing,0,1
103406,aids,0,0
103407,",",0,0
103408,the,0,0
103409,participants,0,0
103410,reported,0,0
103411,lower,0,0
103412,levels,1,1
103413,of,1,1
103414,pleasure,1,1
103415,",",0,0
103416,especially,0,0
103417,at,0,0
103418,low,0,0
103419,contrast,0,0
103420,.,0,0
103421,These,0,0
103422,findings,0,0
103423,highlight,0,0
103424,that,0,0
103425,the,0,0
103426,anhedonia,1,0
103427,scales,1,1
103428,provide,0,0
103429,a,0,0
103430,measure,0,0
103431,sensitive,0,0
103432,to,0,0
103433,emotional,0,1
103434,improvements,0,0
103435,that,0,0
103436,accompany,0,0
103437,the,0,0
103438,partial,0,0
103439,restoration,0,0
103440,of,0,0
103441,hearing,0,1
103442,function,0,1
103443,",",0,0
103444,although,0,0
103445,these,0,0
103446,scales,0,1
103447,were,0,0
103448,not,0,0
103449,specifically,0,0
103450,designed,0,0
103451,for,0,0
103452,hearing-impaired,0,0
103453,populations,0,0
103454,.,0,0
103455,In,0,0
103456,contrast,0,0
103457,",",0,0
103458,the,0,0
103459,surprising,0,0
103460,decrease,0,0
103461,in,0,0
103462,pleasure,0,1
103463,ratings,0,1
103464,for,0,0
103465,pictures,0,0
103466,after,0,0
103467,the,0,0
103468,introduction,0,0
103469,of,0,0
103470,hearing-aid,0,0
103471,use,0,0
103472,may,0,0
103473,be,0,0
103474,because,0,0
103475,of,0,0
103476,the,0,0
103477,compensation,0,0
103478,of,0,0
103479,hearing,0,1
103480,loss,0,1
103481,by,0,0
103482,changes,0,1
103483,in,0,0
103484,visual,0,1
103485,attention,0,0
103486,functions,0,0
103487,.,0,0
103488,Comparison,0,0
103489,of,0,0
103490,fluid,0,1
103491,types,0,0
103492,for,0,0
103493,resuscitation,0,0
103494,after,0,0
103495,acute,1,0
103496,blood,1,1
103497,loss,1,1
103498,in,0,0
103499,mallard,0,0
103500,ducks,0,0
103501,(,0,0
103502,Anas,0,0
103503,platyrhynchos,0,0
103504,),0,0
103505,.,0,0
103506,OBJECTIVE,0,0
103507,The,0,0
103508,purpose,0,0
103509,of,0,0
103510,this,0,0
103511,study,0,0
103512,was,0,0
103513,to,0,0
103514,determine,0,0
103515,the,0,0
103516,LD,0,0
103517,(,0,0
103518,50,0,0
103519,),0,0
103520,for,0,0
103521,acute,0,0
103522,blood,0,1
103523,loss,0,1
103524,in,0,0
103525,mallard,0,0
103526,ducks,0,0
103527,(,0,0
103528,Anas,0,0
103529,platyrhynchos,0,0
103530,),0,0
103531,",",0,0
103532,compare,0,0
103533,the,0,0
103534,mortality,0,1
103535,rate,0,1
103536,among,0,0
103537,3,0,0
103538,fluid,0,0
103539,resuscitation,0,0
103540,groups,0,0
103541,",",0,0
103542,and,0,0
103543,determine,0,0
103544,the,0,0
103545,time,0,1
103546,required,0,0
103547,for,0,0
103548,a,0,0
103549,regenerative,0,0
103550,RBC,0,0
103551,response,0,1
103552,.,0,0
103553,DESIGN,0,0
103554,Prospective,0,0
103555,study,0,0
103556,.,0,0
103557,SETTING,0,0
103558,Medical,0,0
103559,College,0,0
103560,of,0,0
103561,Wisconsin,0,0
103562,Research,0,0
103563,facility,0,0
103564,.,0,0
103565,ANIMALS,0,0
103566,Eighteen,0,1
103567,mallard,0,0
103568,ducks,0,0
103569,were,0,0
103570,included,0,0
103571,for,0,0
103572,the,0,0
103573,LD,0,0
103574,(,0,0
103575,50,0,0
103576,),0,0
103577,study,0,0
103578,and,0,0
103579,28,0,0
103580,for,0,0
103581,the,0,0
103582,fluid,0,1
103583,resuscitation,0,0
103584,study,0,0
103585,.,0,0
103586,INTERVENTIONS,0,1
103587,Phlebotomy,0,0
103588,was,0,0
103589,performed,0,0
103590,during,0,0
103591,both,0,0
103592,the,0,0
103593,LD,0,0
103594,(,0,0
103595,50,0,0
103596,),0,0
103597,and,0,0
103598,fluid,0,1
103599,resuscitation,0,0
103600,studies,0,0
103601,.,0,0
103602,Ducks,0,0
103603,in,0,0
103604,the,0,0
103605,fluid,0,1
103606,resuscitation,0,1
103607,study,0,0
103608,received,0,0
103609,a,0,0
103610,5,0,0
103611,mL/kg,0,0
103612,intravenous,0,0
103613,bolus,0,0
103614,of,0,0
103615,crystalloids,0,0
103616,",",0,0
103617,hetastarch,0,0
103618,(,0,1
103619,HES,0,1
103620,),0,1
103621,",",0,0
103622,or,0,0
103623,a,0,0
103624,hemoglobin-based,0,0
103625,oxygen-carrying,0,0
103626,solution,0,0
103627,(,0,0
103628,HBOCS,0,1
103629,),0,0
103630,.,0,0
103631,MEASUREMENTS,0,0
103632,AND,0,0
103633,MAIN,0,0
103634,RESULTS,0,0
103635,The,0,0
103636,LD,0,0
103637,(,0,0
103638,50,0,0
103639,),0,0
103640,for,0,0
103641,acute,1,0
103642,blood,1,1
103643,loss,1,1
103644,was,0,0
103645,60,0,0
103646,%,0,0
103647,of,0,0
103648,total,1,1
103649,blood,1,1
103650,volume,1,1
103651,.,1,0
103652,This,0,0
103653,blood,0,1
103654,volume,0,1
103655,was,0,0
103656,removed,0,0
103657,in,0,0
103658,the,0,0
103659,fluid,0,1
103660,resuscitation,0,0
103661,study,0,0
103662,to,0,0
103663,create,0,0
103664,a,0,0
103665,model,0,0
103666,of,0,0
103667,acute,0,0
103668,blood,0,1
103669,loss,0,1
103670,.,0,0
103671,Following,0,0
103672,fluid,0,1
103673,administration,0,0
103674,",",0,0
103675,6,0,0
103676,birds,0,0
103677,in,0,0
103678,the,0,0
103679,crystalloid,0,0
103680,group,0,0
103681,(,0,0
103682,66,0,0
103683,%,0,0
103684,),0,0
103685,",",0,0
103686,4,0,0
103687,birds,0,0
103688,in,0,0
103689,the,0,0
103690,HES,0,0
103691,group,0,0
103692,(,0,0
103693,40,0,0
103694,%,0,0
103695,),0,0
103696,",",0,0
103697,and,0,0
103698,2,0,0
103699,birds,0,0
103700,in,0,0
103701,the,0,0
103702,HBOCS,0,1
103703,group,0,0
103704,(,0,0
103705,20,0,0
103706,%,0,0
103707,),0,0
103708,died,0,0
103709,.,0,0
103710,No,0,0
103711,statistical,0,1
103712,difference,0,0
103713,in,0,0
103714,mortality,1,1
103715,rate,1,1
103716,was,0,0
103717,seen,0,0
103718,among,0,0
103719,the,0,0
103720,3,0,0
103721,fluid,0,0
103722,resuscitation,0,0
103723,groups,0,0
103724,.,0,0
103725,Relative,0,0
103726,polychromasia,0,1
103727,evaluated,0,0
103728,post-phlebotomy,0,1
103729,demonstrated,0,0
103730,regeneration,0,0
103731,starting,0,0
103732,at,0,0
103733,24,0,0
103734,hours,0,0
103735,and,0,0
103736,continuing,0,0
103737,through,0,0
103738,48,0,0
103739,hours,0,0
103740,.,0,0
103741,CONCLUSIONS,0,0
103742,The,0,0
103743,LD,0,0
103744,(,0,0
103745,50,0,0
103746,),0,0
103747,for,0,0
103748,acute,1,0
103749,blood,1,1
103750,loss,1,1
103751,in,0,0
103752,mallard,0,0
103753,ducks,0,0
103754,was,0,0
103755,60,0,0
103756,%,0,0
103757,of,0,0
103758,their,0,0
103759,total,0,1
103760,blood,0,1
103761,volume,0,1
103762,.,0,0
103763,Although,0,0
103764,no,0,0
103765,statistical,0,0
103766,difference,0,0
103767,in,0,0
103768,mortality,1,1
103769,rate,1,1
103770,was,0,0
103771,appreciated,0,0
103772,among,0,0
103773,the,0,0
103774,3,0,0
103775,fluid,0,0
103776,resuscitation,0,0
103777,groups,0,0
103778,",",0,0
103779,a,0,0
103780,trend,0,0
103781,of,0,0
103782,decreased,0,0
103783,mortality,1,1
103784,rate,1,1
103785,was,0,0
103786,observed,0,0
103787,in,0,0
103788,the,0,0
103789,HBOCS,0,0
103790,group,0,0
103791,.,0,0
103792,An,0,0
103793,early,0,0
103794,regenerative,0,0
103795,response,0,1
103796,was,0,0
103797,apparent,0,0
103798,following,0,0
103799,acute,1,0
103800,blood,1,1
103801,loss,1,1
103802,.,1,0
103803,Medication,0,0
103804,and,0,1
103805,parent,0,1
103806,training,0,0
103807,in,0,0
103808,children,0,0
103809,with,0,0
103810,pervasive,0,0
103811,developmental,0,0
103812,disorders,0,0
103813,and,0,1
103814,serious,0,1
103815,behavior,0,1
103816,problems,0,1
103817,:,0,0
103818,results,0,0
103819,from,0,0
103820,a,0,0
103821,randomized,0,0
103822,clinical,0,0
103823,trial,0,0
103824,.,0,0
103825,OBJECTIVE,0,0
103826,Many,0,1
103827,children,0,0
103828,with,0,0
103829,pervasive,0,0
103830,developmental,0,0
103831,disorders,0,0
103832,(,0,0
103833,PDDs,0,0
103834,),0,0
103835,have,0,0
103836,serious,1,1
103837,",",1,0
103838,functionally,1,0
103839,impairing,1,0
103840,behavioral,1,1
103841,problems,1,0
103842,.,1,0
103843,We,0,0
103844,tested,0,0
103845,whether,0,0
103846,combined,0,0
103847,treatment,0,0
103848,(,0,0
103849,COMB,0,0
103850,),0,0
103851,with,0,0
103852,risperidone,0,0
103853,and,0,1
103854,parent,0,1
103855,training,0,0
103856,(,0,0
103857,PT,0,1
103858,),0,0
103859,in,0,0
103860,behavior,0,1
103861,management,0,0
103862,is,0,0
103863,superior,0,0
103864,to,0,0
103865,medication,0,0
103866,alone,0,0
103867,(,0,0
103868,MED,0,1
103869,),0,0
103870,in,0,0
103871,improving,0,1
103872,severe,1,1
103873,behavioral,1,1
103874,problems,1,1
103875,in,0,0
103876,children,0,0
103877,with,0,0
103878,PDDs,0,0
103879,.,0,0
103880,METHOD,0,0
103881,This,0,0
103882,24-week,0,0
103883,",",0,0
103884,three-site,0,0
103885,",",0,0
103886,randomized,0,0
103887,",",0,0
103888,parallel-groups,0,0
103889,clinical,0,0
103890,trial,0,0
103891,enrolled,0,0
103892,124,0,0
103893,children,0,0
103894,",",0,0
103895,aged,0,0
103896,4,0,0
103897,through,0,0
103898,13,0,0
103899,years,0,0
103900,",",0,0
103901,with,0,0
103902,PDDs,0,1
103903,",",0,0
103904,accompanied,0,0
103905,by,0,0
103906,frequent,0,0
103907,tantrums,0,1
103908,",",0,0
103909,self-injury,0,1
103910,",",0,1
103911,and,0,1
103912,aggression,0,1
103913,.,0,0
103914,The,0,0
103915,children,0,0
103916,were,0,0
103917,randomized,0,0
103918,3:2,0,0
103919,to,0,0
103920,COMB,0,0
103921,(,0,0
103922,n,0,0
103923,=,0,0
103924,75,0,0
103925,),0,0
103926,or,0,0
103927,MED,0,1
103928,(,0,0
103929,n,0,0
103930,=,0,0
103931,49,0,0
103932,),0,0
103933,.,0,0
103934,The,0,0
103935,participants,0,0
103936,received,0,0
103937,risperidone,0,0
103938,monotherapy,0,0
103939,from,0,0
103940,0.5,0,0
103941,to,0,0
103942,3.5,0,0
103943,mg/day,0,0
103944,(,0,0
103945,with,0,0
103946,switch,0,0
103947,to,0,0
103948,aripiprazole,0,0
103949,if,0,0
103950,risperidone,0,0
103951,was,0,0
103952,ineffective,0,0
103953,),0,0
103954,.,0,0
103955,Parents,0,0
103956,in,0,0
103957,the,0,0
103958,COMB,0,0
103959,group,0,0
103960,(,0,0
103961,n,0,0
103962,=,0,0
103963,75,0,0
103964,;,0,0
103965,60.5,0,0
103966,%,0,0
103967,),0,0
103968,received,0,0
103969,a,0,0
103970,mean,0,0
103971,of,0,0
103972,10.9,0,0
103973,PT,0,0
103974,sessions,0,0
103975,.,0,0
103976,The,0,0
103977,primary,0,0
103978,measure,0,0
103979,of,0,0
103980,compliance,0,1
103981,was,0,0
103982,the,0,0
103983,Home,1,0
103984,Situations,1,1
103985,Questionnaire,1,1
103986,(,1,0
103987,HSQ,1,1
103988,),1,0
103989,score,1,1
103990,.,1,0
103991,RESULTS,0,0
103992,Primary,0,0
103993,:,0,0
103994,intent-to-treat,0,0
103995,random,0,0
103996,effects,0,1
103997,regression,0,0
103998,showed,0,0
103999,that,0,0
104000,COMB,0,0
104001,was,0,0
104002,superior,0,0
104003,to,0,0
104004,MED,0,0
104005,on,0,0
104006,HSQ,1,1
104007,(,0,0
104008,p,0,0
104009,=,0,0
104010,.006,0,0
104011,),0,0
104012,[,0,0
104013,effect,0,0
104014,size,0,1
104015,at,0,0
104016,week,0,0
104017,24,0,0
104018,(,0,0
104019,d,0,0
104020,),0,0
104021,=,0,0
104022,0.34,0,0
104023,],0,0
104024,.,0,0
104025,The,0,0
104026,HSQ,1,1
104027,score,1,1
104028,declined,0,0
104029,from,0,0
104030,4.31,0,0
104031,(,0,0
104032,?,0,0
104033,1.67,0,0
104034,),0,0
104035,to,0,0
104036,1.23,0,0
104037,(,0,0
104038,?,0,0
104039,1.36,0,0
104040,),0,0
104041,for,0,0
104042,COMB,0,0
104043,compared,0,0
104044,with,0,0
104045,4.16,0,0
104046,(,0,0
104047,?,0,0
104048,1.47,0,0
104049,),0,0
104050,to,0,0
104051,1.68,0,0
104052,(,0,0
104053,?,0,0
104054,1.36,0,0
104055,),0,0
104056,for,0,0
104057,MED,0,0
104058,.,0,0
104059,Secondary,0,0
104060,:,0,0
104061,groups,0,0
104062,did,0,0
104063,not,0,0
104064,differ,1,0
104065,on,1,0
104066,Clinical,1,1
104067,Global,1,1
104068,Impressions-Improvement,1,1
104069,scores,1,1
104070,at,1,0
104071,endpoint,0,0
104072,;,0,0
104073,compared,0,0
104074,with,0,0
104075,MED,0,0
104076,",",0,0
104077,COMB,0,0
104078,showed,0,0
104079,significant,0,0
104080,reductions,1,1
104081,on,1,0
104082,Aberrant,1,0
104083,Behavior,1,1
104084,Checklist,1,1
104085,Irritability,1,1
104086,(,1,0
104087,d,1,0
104088,=,0,0
104089,0.48,0,0
104090,;,0,0
104091,p,0,0
104092,=,0,0
104093,.01,0,0
104094,),0,0
104095,",",1,0
104096,Stereotypic,1,1
104097,Behavior,1,1
104098,(,1,0
104099,d,1,0
104100,=,0,0
104101,0.23,0,0
104102,;,0,0
104103,p,0,0
104104,=,0,0
104105,.04,0,0
104106,),0,0
104107,",",0,0
104108,and,0,1
104109,Hyperactivity/Noncompliance,1,1
104110,subscales,1,1
104111,(,1,0
104112,d,1,0
104113,=,0,0
104114,0.55,0,0
104115,;,0,0
104116,p,0,0
104117,=,0,0
104118,.04,0,0
104119,),0,0
104120,.,0,0
104121,Final,0,1
104122,risperidone,1,0
104123,mean,1,1
104124,dose,1,0
104125,for,1,0
104126,MED,0,0
104127,was,0,0
104128,2.26,0,0
104129,mg/day,0,0
104130,(,0,0
104131,0.071,0,0
104132,mg/kg,0,0
104133,),0,0
104134,",",0,0
104135,compared,0,0
104136,with,0,0
104137,1.98,0,0
104138,mg/day,0,0
104139,for,0,0
104140,COMB,0,0
104141,(,0,0
104142,0.066,0,0
104143,mg/kg,0,0
104144,),0,0
104145,(,0,0
104146,p,0,0
104147,=,0,0
104148,.04,0,0
104149,),0,0
104150,.,0,0
104151,CONCLUSIONS,0,0
104152,Medication,0,0
104153,plus,0,0
104154,PT,0,1
104155,resulted,0,0
104156,in,0,0
104157,greater,1,0
104158,reduction,1,1
104159,of,1,1
104160,serious,1,1
104161,maladaptive,1,1
104162,behavior,1,1
104163,than,1,0
104164,MED,0,1
104165,in,0,0
104166,children,0,0
104167,with,0,0
104168,PDDs,0,0
104169,",",0,0
104170,with,0,0
104171,a,0,0
104172,lower,0,0
104173,risperidone,0,0
104174,dose,0,0
104175,.,0,0
104176,Enhancing,0,1
104177,antiepileptic,0,0
104178,drug,0,0
104179,adherence,0,0
104180,:,0,0
104181,a,0,0
104182,randomized,0,0
104183,controlled,0,0
104184,trial,0,0
104185,.,0,0
104186,Suboptimal,0,0
104187,adherence,0,1
104188,to,0,0
104189,antiepileptic,0,0
104190,drug,0,0
104191,(,0,0
104192,AED,0,0
104193,),0,0
104194,treatment,0,0
104195,is,0,0
104196,commonplace,0,0
104197,",",0,0
104198,and,0,0
104199,increases,0,1
104200,the,0,0
104201,risk,0,0
104202,of,0,0
104203,status,0,1
104204,epilepticus,0,1
104205,and,0,1
104206,sudden,0,1
104207,unexplained,0,0
104208,death,0,1
104209,in,0,0
104210,epilepsy,0,0
104211,.,0,0
104212,This,0,0
104213,randomized,0,0
104214,controlled,0,0
104215,trial,0,0
104216,was,0,0
104217,designed,0,0
104218,to,0,0
104219,demonstrate,0,0
104220,whether,0,0
104221,an,0,0
104222,implementation,0,0
104223,intention,0,1
104224,intervention,0,0
104225,involving,0,0
104226,the,0,0
104227,completion,0,0
104228,of,0,0
104229,a,0,0
104230,simple,0,0
104231,self-administered,0,0
104232,questionnaire,0,1
104233,linking,0,0
104234,the,0,0
104235,intention,0,0
104236,of,0,0
104237,taking,0,0
104238,medication,0,0
104239,with,0,0
104240,a,0,0
104241,particular,0,0
104242,time,0,1
104243,",",0,0
104244,place,0,0
104245,",",0,1
104246,and,0,1
104247,other,0,0
104248,activity,0,1
104249,can,0,0
104250,improve,0,0
104251,AED,0,0
104252,treatment,0,0
104253,schedule,0,0
104254,adherence,0,1
104255,.,0,0
104256,Of,0,0
104257,the,0,0
104258,81,0,0
104259,patients,0,0
104260,with,0,0
104261,epilepsy,0,0
104262,who,0,0
104263,were,0,0
104264,randomized,0,0
104265,",",0,0
104266,69,0,0
104267,completed,0,0
104268,a,0,0
104269,1-month,0,0
104270,monitoring,0,0
104271,period,0,0
104272,with,0,0
104273,an,0,0
104274,objective,0,0
104275,measure,0,0
104276,of,0,0
104277,tablet,0,0
104278,taking,0,0
104279,(,0,0
104280,electronic,0,0
104281,registration,0,0
104282,of,0,0
104283,pill,0,0
104284,bottle,0,0
104285,openings,0,1
104286,",",0,0
104287,Medication,0,0
104288,Event,0,0
104289,Monitoring,0,0
104290,System,0,0
104291,[,0,0
104292,MEMS,0,0
104293,],0,0
104294,),0,0
104295,.,0,0
104296,Intervention,0,0
104297,participants,0,0
104298,showed,0,0
104299,improved,1,0
104300,adherence,1,0
104301,relative,1,0
104302,to,1,0
104303,controls,1,0
104304,on,0,0
104305,all,0,0
104306,three,0,0
104307,outcomes,0,0
104308,:,0,0
104309,doses,1,0
104310,taken,1,0
104311,in,1,0
104312,total,1,0
104313,(,0,0
104314,93.4,0,0
104315,%,0,0
104316,vs.,0,0
104317,79.1,0,0
104318,%,0,0
104319,),0,0
104320,",",0,0
104321,days,0,0
104322,on,0,0
104323,which,0,0
104324,correct,1,0
104325,dose,1,0
104326,was,1,0
104327,taken,1,0
104328,(,0,0
104329,88.7,0,0
104330,%,0,0
104331,vs.,0,0
104332,65.3,0,0
104333,%,0,0
104334,),0,0
104335,",",0,0
104336,and,0,0
104337,doses,1,0
104338,taken,1,0
104339,on,1,0
104340,schedule,1,0
104341,(,0,0
104342,78.8,0,0
104343,%,0,0
104344,vs.,0,0
104345,55.3,0,0
104346,%,0,0
104347,),0,0
104348,(,0,0
104349,P,0,0
104350,<,0,0
104351,0.01,0,0
104352,),0,0
104353,.,0,0
104354,The,0,0
104355,implementation,0,0
104356,intention,0,0
104357,intervention,0,0
104358,may,0,0
104359,be,0,0
104360,an,0,0
104361,easy-to-administer,0,0
104362,and,0,0
104363,effective,0,1
104364,means,0,0
104365,of,0,0
104366,promoting,0,0
104367,AED,0,0
104368,adherence,0,0
104369,.,0,0
104370,The,0,0
104371,effect,0,0
104372,of,0,0
104373,cessation,0,0
104374,of,0,0
104375,raloxifene,0,0
104376,treatment,0,0
104377,on,0,0
104378,bone,0,1
104379,turnover,0,1
104380,in,0,0
104381,postmenopausal,0,0
104382,women,0,0
104383,.,0,0
104384,There,0,0
104385,is,0,0
104386,evidence,0,0
104387,to,0,0
104388,suggest,0,0
104389,accelerated,0,1
104390,bone,1,1
104391,loss,1,1
104392,following,0,0
104393,estrogen,0,0
104394,cessation,0,0
104395,.,0,0
104396,The,0,0
104397,effect,0,0
104398,of,0,0
104399,cessation,0,0
104400,of,0,0
104401,raloxifene,0,0
104402,therapy,0,0
104403,on,0,0
104404,bone,0,1
104405,turnover,0,1
104406,is,0,0
104407,unknown,0,0
104408,.,0,0
104409,Our,0,0
104410,aim,0,0
104411,was,0,0
104412,to,0,0
104413,determine,0,0
104414,the,0,0
104415,effect,0,0
104416,of,0,0
104417,cessation,0,0
104418,of,0,0
104419,raloxifene,0,0
104420,treatment,0,0
104421,on,0,0
104422,bone,1,1
104423,turnover,1,1
104424,and,0,1
104425,bone,1,1
104426,mineral,1,1
104427,density,1,1
104428,(,1,0
104429,BMD,1,1
104430,),1,0
104431,in,0,0
104432,postmenopausal,0,0
104433,",",0,0
104434,osteopenic,0,0
104435,women,0,0
104436,.,0,0
104437,Women,0,0
104438,aged,0,0
104439,50,0,0
104440,to,0,0
104441,80,0,0
104442,years,0,0
104443,received,0,0
104444,raloxifene,0,0
104445,for,0,0
104446,96,0,0
104447,weeks,0,0
104448,and,0,0
104449,were,0,0
104450,then,0,0
104451,randomized,0,0
104452,to,0,0
104453,continue,0,0
104454,raloxifene,0,0
104455,(,0,0
104456,group,0,0
104457,1,0,0
104458,",",0,0
104459,n=20,0,0
104460,),0,1
104461,or,0,0
104462,placebo,0,0
104463,(,0,0
104464,group,0,0
104465,2,0,0
104466,",",0,0
104467,n=20,0,0
104468,),0,0
104469,for,0,0
104470,a,0,0
104471,further,0,0
104472,96,0,0
104473,weeks,0,0
104474,.,0,0
104475,A,0,0
104476,third,0,0
104477,group,0,0
104478,(,0,0
104479,group,0,0
104480,3,0,0
104481,",",0,0
104482,n=14,0,0
104483,),0,0
104484,received,0,0
104485,no,0,0
104486,treatment,0,0
104487,.,0,0
104488,Bone,1,0
104489,turnover,1,1
104490,markers,1,1
104491,and,1,1
104492,bone,1,1
104493,density,1,1
104494,(,1,0
104495,BMD,1,1
104496,),1,0
104497,were,0,0
104498,measured,0,0
104499,throughout,0,0
104500,the,0,0
104501,study,0,0
104502,.,0,0
104503,Raloxifene,0,0
104504,treatment,0,0
104505,for,0,0
104506,96,0,0
104507,weeks,0,0
104508,resulted,0,0
104509,in,0,0
104510,a,0,0
104511,decrease,1,0
104512,in,1,0
104513,bone,1,1
104514,turnover,1,1
104515,(,0,0
104516,PINP,0,0
104517,by,0,0
104518,31,0,0
104519,%,0,0
104520,),0,0
104521,and,0,0
104522,an,0,0
104523,increase,1,0
104524,in,1,0
104525,spine,1,0
104526,BMD,1,1
104527,(,0,0
104528,by,0,0
104529,2,0,0
104530,%,0,0
104531,),0,0
104532,but,0,0
104533,no,0,0
104534,change,0,1
104535,in,0,0
104536,hip,1,1
104537,BMD,1,1
104538,for,0,0
104539,groups,0,0
104540,1,0,0
104541,and,0,0
104542,2,0,0
104543,.,0,0
104544,Continuation,0,0
104545,of,0,0
104546,raloxifene,0,0
104547,(,0,0
104548,group,0,0
104549,1,0,0
104550,),0,0
104551,maintained,0,0
104552,these,0,0
104553,changes,0,0
104554,.,0,0
104555,Following,0,0
104556,cessation,0,0
104557,of,0,0
104558,raloxifene,0,0
104559,(,0,0
104560,group,0,0
104561,2,0,0
104562,),0,0
104563,",",0,0
104564,bone,1,1
104565,markers,1,1
104566,returned,0,0
104567,to,0,0
104568,baseline,0,0
104569,levels,0,1
104570,(,0,0
104571,by,0,0
104572,120,0,0
104573,weeks,0,0
104574,),0,0
104575,.,0,0
104576,Hip,1,0
104577,BMD,1,1
104578,was,0,0
104579,decreased,0,0
104580,by,0,0
104581,2,0,0
104582,%,0,0
104583,at,0,0
104584,192,0,0
104585,weeks,0,0
104586,compared,0,0
104587,to,0,0
104588,baseline,0,0
104589,.,0,0
104590,Bone,1,0
104591,markers,1,1
104592,in,0,0
104593,the,0,0
104594,controls,0,0
104595,(,0,0
104596,group,0,0
104597,3,0,0
104598,),0,0
104599,remained,0,0
104600,at,0,0
104601,the,0,0
104602,upper,0,0
104603,limit,0,0
104604,of,0,0
104605,the,0,0
104606,reference,0,0
104607,range,0,0
104608,throughout,0,0
104609,",",0,0
104610,with,0,0
104611,decreases,0,1
104612,in,0,0
104613,BMD,1,1
104614,of,0,0
104615,2.3,0,0
104616,%,0,0
104617,(,0,0
104618,spine,0,0
104619,),0,0
104620,and,0,0
104621,2.8,0,0
104622,%,0,0
104623,(,0,0
104624,hip,0,1
104625,),0,0
104626,.,0,0
104627,Bone,1,0
104628,loss,1,1
104629,following,0,0
104630,cessation,0,0
104631,of,0,0
104632,raloxifene,0,0
104633,therapy,0,0
104634,at,0,0
104635,96,0,0
104636,weeks,0,0
104637,was,0,0
104638,greater,0,0
104639,than,0,0
104640,in,0,0
104641,the,0,0
104642,control,0,0
104643,group,0,0
104644,",",0,0
104645,suggesting,0,0
104646,accelerated,0,0
104647,bone,0,1
104648,loss,0,1
104649,.,0,0
104650,The,0,0
104651,beneficial,0,0
104652,effect,0,0
104653,on,0,0
104654,bone,1,1
104655,turnover,1,1
104656,of,0,0
104657,96,0,0
104658,weeks,0,0
104659,of,0,0
104660,raloxifene,0,0
104661,was,0,0
104662,lost,0,0
104663,6,0,0
104664,months,0,0
104665,after,0,0
104666,cessation,0,0
104667,of,0,0
104668,treatment,0,0
104669,.,0,0
104670,Intranasal,0,0
104671,oxytocin,0,0
104672,improves,0,0
104673,emotion,1,1
104674,recognition,1,0
104675,for,0,0
104676,youth,0,0
104677,with,0,0
104678,autism,0,0
104679,spectrum,0,0
104680,disorders,0,0
104681,.,0,0
104682,BACKGROUND,0,0
104683,A,0,0
104684,diagnostic,0,0
104685,hallmark,0,0
104686,of,0,0
104687,autism,0,0
104688,spectrum,0,0
104689,disorders,0,0
104690,is,0,0
104691,a,0,0
104692,qualitative,0,0
104693,impairment,0,1
104694,in,0,0
104695,social,0,1
104696,communication,0,1
104697,and,0,0
104698,interaction,0,1
104699,.,0,0
104700,Deficits,0,0
104701,in,0,0
104702,the,0,0
104703,ability,0,0
104704,to,0,0
104705,recognize,0,0
104706,the,0,0
104707,emotions,0,1
104708,of,0,0
104709,others,0,0
104710,are,0,0
104711,believed,0,0
104712,to,0,0
104713,contribute,0,0
104714,to,0,0
104715,this,0,0
104716,.,0,0
104717,There,0,0
104718,is,0,0
104719,currently,0,0
104720,no,0,0
104721,effective,0,0
104722,treatment,0,0
104723,for,0,0
104724,these,0,0
104725,problems,0,0
104726,.,0,0
104727,METHODS,0,0
104728,In,0,0
104729,a,0,0
104730,double-blind,0,0
104731,",",0,0
104732,randomized,0,0
104733,",",0,0
104734,placebo-controlled,0,0
104735,",",0,0
104736,crossover,0,0
104737,design,0,0
104738,",",0,0
104739,we,0,0
104740,administered,0,0
104741,oxytocin,0,0
104742,nasal,0,1
104743,spray,0,0
104744,(,0,0
104745,18,0,0
104746,or,0,0
104747,24,0,0
104748,IU,0,0
104749,),0,0
104750,or,0,0
104751,a,0,0
104752,placebo,0,0
104753,to,0,0
104754,16,0,0
104755,male,0,0
104756,youth,0,0
104757,aged,0,0
104758,12,0,0
104759,to,0,0
104760,19,0,0
104761,who,0,0
104762,were,0,0
104763,diagnosed,0,0
104764,with,0,0
104765,Autistic,0,0
104766,or,0,0
104767,Asperger,0,1
104768,'s,0,0
104769,Disorder,0,0
104770,.,0,0
104771,Participants,0,0
104772,then,0,0
104773,completed,0,0
104774,the,0,0
104775,Reading,1,0
104776,the,1,0
104777,Mind,1,0
104778,in,1,0
104779,the,1,0
104780,Eyes,1,0
104781,Task,1,0
104782,",",0,0
104783,a,0,0
104784,widely,0,0
104785,used,0,0
104786,and,0,0
104787,reliable,0,0
104788,test,0,1
104789,of,0,0
104790,emotion,1,1
104791,recognition,1,0
104792,.,1,0
104793,RESULTS,0,0
104794,In,0,0
104795,comparison,0,0
104796,with,0,0
104797,placebo,0,0
104798,",",0,0
104799,oxytocin,0,1
104800,administration,0,0
104801,improved,0,1
104802,performance,1,1
104803,on,1,0
104804,the,1,0
104805,Reading,1,0
104806,the,1,0
104807,Mind,1,0
104808,in,1,0
104809,the,1,0
104810,Eyes,1,0
104811,Task,1,0
104812,.,1,0
104813,This,0,0
104814,effect,0,0
104815,was,0,0
104816,also,0,0
104817,shown,0,0
104818,when,0,0
104819,analysis,0,0
104820,was,0,0
104821,restricted,0,0
104822,to,0,0
104823,the,0,0
104824,younger,0,0
104825,participants,0,0
104826,aged,0,0
104827,12,0,0
104828,to,0,0
104829,15,0,0
104830,who,0,0
104831,received,0,0
104832,the,0,0
104833,lower,0,0
104834,dose,0,0
104835,.,0,0
104836,CONCLUSIONS,0,0
104837,This,0,0
104838,study,0,0
104839,provides,0,0
104840,the,0,0
104841,first,0,0
104842,evidence,0,0
104843,that,0,0
104844,oxytocin,0,1
104845,nasal,0,0
104846,spray,0,0
104847,improves,0,1
104848,emotion,1,1
104849,recognition,1,1
104850,in,0,0
104851,young,0,0
104852,people,0,0
104853,diagnosed,0,0
104854,with,0,0
104855,autism,0,0
104856,spectrum,0,0
104857,disorders,0,0
104858,.,0,0
104859,Findings,0,0
104860,suggest,0,0
104861,the,0,0
104862,potential,0,0
104863,of,0,0
104864,earlier,0,0
104865,intervention,0,0
104866,and,0,1
104867,further,0,0
104868,evaluation,0,0
104869,of,0,0
104870,oxytocin,0,1
104871,nasal,0,1
104872,spray,0,0
104873,as,0,0
104874,a,0,0
104875,treatment,0,0
104876,to,0,0
104877,improve,0,0
104878,social,0,1
104879,communication,0,1
104880,and,0,1
104881,interaction,0,1
104882,in,0,0
104883,young,0,0
104884,people,0,0
104885,with,0,0
104886,autism,0,0
104887,spectrum,0,0
104888,disorders,0,0
104889,.,0,0
104890,Brief,0,0
104891,Report,0,0
104892,:,0,0
104893,Randomized,0,0
104894,test,0,0
104895,of,0,0
104896,the,0,0
104897,efficacy,0,1
104898,of,0,0
104899,picture,0,1
104900,exchange,0,1
104901,communication,0,1
104902,system,0,0
104903,on,0,0
104904,highly,0,0
104905,generalized,1,0
104906,picture,1,1
104907,exchanges,1,1
104908,in,0,0
104909,children,0,0
104910,with,0,0
104911,ASD,0,0
104912,.,0,0
104913,A,0,0
104914,randomized,0,0
104915,control,0,0
104916,trial,0,0
104917,comparing,0,0
104918,two,0,0
104919,social-communication,0,0
104920,interventions,0,0
104921,in,0,0
104922,young,0,0
104923,children,0,0
104924,with,0,0
104925,autism,0,0
104926,examined,0,0
104927,far-transfer,1,0
104928,of,1,0
104929,the,1,0
104930,use,1,0
104931,of,1,0
104932,picture,1,1
104933,exchange,1,1
104934,to,1,0
104935,communicate,1,0
104936,.,1,0
104937,Thirty-six,0,0
104938,children,0,0
104939,were,0,0
104940,randomly,0,0
104941,assigned,0,0
104942,to,0,0
104943,one,0,0
104944,of,0,0
104945,two,0,0
104946,treatment,0,0
104947,conditions,0,0
104948,",",0,0
104949,one,0,0
104950,of,0,0
104951,which,0,0
104952,was,0,0
104953,the,0,0
104954,Picture,0,0
104955,Exchange,0,0
104956,Communication,0,1
104957,System,0,0
104958,(,0,0
104959,PECS,0,0
104960,),0,0
104961,.,0,0
104962,All,0,0
104963,children,0,0
104964,had,0,0
104965,access,0,0
104966,to,0,0
104967,picture,0,1
104968,symbols,0,0
104969,during,0,0
104970,assessments,0,0
104971,.,0,0
104972,Post-treatment,0,0
104973,measurement,0,0
104974,of,0,0
104975,the,0,0
104976,number,1,1
104977,of,1,0
104978,picture,1,1
104979,exchanges,1,0
104980,in,1,0
104981,a,1,0
104982,far-transfer,1,0
104983,",",0,0
104984,assessment,0,1
104985,context,0,0
104986,favored,0,0
104987,the,0,0
104988,PECS,0,0
104989,intervention,0,0
104990,.,0,0
104991,These,0,0
104992,findings,0,0
104993,were,0,0
104994,interpreted,0,0
104995,as,0,0
104996,support,0,0
104997,for,0,0
104998,the,0,0
104999,hypothesis,0,0
105000,that,0,0
105001,the,0,0
105002,PECS,0,0
105003,curriculum,0,0
105004,can,0,0
105005,successfully,0,0
105006,teach,0,0
105007,a,0,0
105008,generalized,0,0
105009,means,0,0
105010,of,0,0
105011,showing,0,0
105012,coordinated,1,0
105013,attention,1,0
105014,to,1,0
105015,object,1,1
105016,and,1,0
105017,person,1,0
105018,without,1,0
105019,requiring,1,0
105020,eye,1,0
105021,contact,1,1
105022,to,0,0
105023,children,0,0
105024,with,0,0
105025,ASD,0,0
105026,.,0,0
105027,Effects,0,0
105028,of,0,0
105029,fluoride,0,0
105030,and,0,1
105031,chlorhexidine,0,0
105032,on,0,0
105033,the,0,0
105034,microflora,1,0
105035,of,1,0
105036,dental,1,0
105037,root,1,0
105038,surfaces,1,0
105039,and,0,1
105040,progression,0,1
105041,of,0,1
105042,root-surface,0,0
105043,caries,0,0
105044,.,0,0
105045,The,0,0
105046,effects,0,0
105047,of,0,0
105048,fluoride,0,0
105049,and,0,1
105050,chlorhexidine,0,0
105051,varnishes,0,0
105052,on,0,0
105053,the,0,0
105054,microflora,0,0
105055,of,0,0
105056,dental,0,0
105057,root,0,0
105058,surfaces,0,0
105059,and,0,0
105060,on,0,0
105061,the,0,0
105062,progression,0,1
105063,of,0,0
105064,root-surface,0,1
105065,caries,0,0
105066,were,0,0
105067,studied,0,0
105068,.,0,0
105069,Forty-four,0,0
105070,patients,0,0
105071,",",0,0
105072,surgically,0,0
105073,treated,0,0
105074,for,0,0
105075,advanced,0,0
105076,periodontal,0,0
105077,disease,0,1
105078,",",0,0
105079,were,0,0
105080,distributed,0,0
105081,at,0,0
105082,random,0,0
105083,among,0,0
105084,three,0,0
105085,groups,0,0
105086,.,0,0
105087,All,0,0
105088,patients,0,0
105089,received,0,0
105090,a,0,0
105091,standardized,0,0
105092,preventive,0,0
105093,treatment,0,0
105094,.,0,0
105095,Furthermore,0,0
105096,",",0,0
105097,the,0,0
105098,dentition,0,1
105099,of,0,0
105100,the,0,0
105101,patients,0,0
105102,in,0,0
105103,the,0,0
105104,two,0,0
105105,experimental,0,0
105106,groups,0,0
105107,was,0,0
105108,treated,0,0
105109,",",0,0
105110,at,0,0
105111,three-month,0,0
105112,intervals,0,0
105113,",",0,0
105114,with,0,0
105115,chlorhexidine,0,0
105116,and,0,0
105117,fluoride,0,0
105118,varnish,0,0
105119,",",0,0
105120,respectively,0,0
105121,.,0,0
105122,Patients,0,0
105123,in,0,0
105124,the,0,0
105125,control,0,0
105126,group,0,0
105127,received,0,0
105128,no,0,0
105129,additional,0,0
105130,treatment,0,0
105131,.,0,0
105132,In,0,0
105133,the,0,0
105134,experimental,0,0
105135,groups,0,0
105136,",",0,0
105137,plaque,0,1
105138,samples,0,0
105139,were,0,0
105140,collected,0,0
105141,from,0,0
105142,selected,0,0
105143,sound,0,0
105144,and,0,0
105145,carious,0,1
105146,root,0,0
105147,surfaces,0,0
105148,at,0,0
105149,baseline,0,0
105150,and,0,0
105151,at,0,0
105152,three,0,0
105153,",",0,0
105154,six,0,0
105155,",",0,0
105156,and,0,0
105157,nine,0,0
105158,months,0,0
105159,after,0,0
105160,the,0,0
105161,onset,0,0
105162,of,0,0
105163,the,0,0
105164,study,0,0
105165,.,0,0
105166,The,0,0
105167,presence,0,0
105168,of,0,0
105169,root-surface,0,1
105170,caries,0,0
105171,was,0,0
105172,scored,0,0
105173,at,0,0
105174,baseline,0,0
105175,and,0,0
105176,after,0,0
105177,one,0,0
105178,year,0,0
105179,.,0,0
105180,In,0,0
105181,addition,0,0
105182,",",0,0
105183,the,0,0
105184,texture,0,1
105185,",",0,0
105186,depth,0,1
105187,",",0,1
105188,and,0,1
105189,color,0,1
105190,of,0,0
105191,the,0,0
105192,root-surface,0,0
105193,lesions,0,1
105194,were,0,0
105195,monitored,0,0
105196,.,0,0
105197,Mutans,1,0
105198,streptococci,1,0
105199,on,1,0
105200,root,1,0
105201,surfaces,1,0
105202,were,1,0
105203,suppressed,1,0
105204,significantly,0,0
105205,(,0,0
105206,p,0,0
105207,less,0,0
105208,than,0,0
105209,0.05,0,0
105210,),0,0
105211,during,0,0
105212,the,0,0
105213,whole,0,0
105214,experimental,0,0
105215,period,0,0
105216,in,0,0
105217,the,0,0
105218,chlorhexidine,0,0
105219,varnish,0,0
105220,group,0,0
105221,",",0,0
105222,but,0,0
105223,not,0,0
105224,in,0,0
105225,the,0,0
105226,fluoride,0,0
105227,varnish,0,0
105228,group,0,0
105229,.,0,0
105230,A,0,0
105231,non-significant,0,0
105232,increase,1,0
105233,in,1,0
105234,the,1,0
105235,number,1,1
105236,of,1,0
105237,Actinomyces,1,1
105238,viscosus/naeslundii,1,0
105239,was,0,0
105240,noted,0,0
105241,after,0,0
105242,treatment,0,0
105243,with,0,0
105244,chlorhexidine,0,0
105245,and,0,0
105246,fluoride,0,0
105247,varnish,0,0
105248,.,0,0
105249,The,0,0
105250,increase,1,0
105251,in,1,0
105252,the,1,0
105253,number,1,1
105254,of,1,0
105255,decayed,1,1
105256,and,1,0
105257,filled,1,0
105258,root,1,0
105259,surfaces,1,0
105260,after,0,0
105261,one,0,0
105262,year,0,0
105263,was,0,0
105264,significantly,0,0
105265,lower,0,0
105266,in,0,0
105267,the,0,0
105268,experimental,0,0
105269,groups,0,0
105270,than,0,0
105271,in,0,0
105272,the,0,0
105273,control,0,0
105274,group,0,0
105275,.,0,0
105276,After,0,0
105277,treatment,0,0
105278,with,0,0
105279,chlorhexidine,0,0
105280,varnish,0,0
105281,",",0,0
105282,significantly,0,0
105283,more,0,0
105284,initial,1,0
105285,root-surface,1,0
105286,lesions,1,1
105287,had,1,0
105288,hardened,1,0
105289,than,0,0
105290,in,0,0
105291,the,0,0
105292,other,0,0
105293,groups,0,0
105294,.,0,0
105295,The,0,0
105296,effect,1,0
105297,of,0,0
105298,posture,0,1
105299,on,0,0
105300,Cheyne-Stokes,0,0
105301,respirations,0,1
105302,and,0,0
105303,hemodynamics,0,1
105304,in,0,0
105305,patients,0,0
105306,with,0,0
105307,heart,0,0
105308,failure,0,1
105309,.,0,0
105310,STUDY,0,1
105311,OBJECTIVES,0,0
105312,Cheyne-Stokes,0,0
105313,respirations,0,1
105314,occur,0,0
105315,in,0,0
105316,40,0,0
105317,%,0,0
105318,of,0,0
105319,patients,0,0
105320,with,0,0
105321,heart,0,0
105322,failure,0,1
105323,.,0,0
105324,Orthopnea,0,0
105325,is,0,0
105326,a,0,0
105327,cardinal,0,0
105328,symptom,0,1
105329,of,0,0
105330,heart,0,1
105331,failure,0,0
105332,and,0,0
105333,may,0,0
105334,affect,0,0
105335,the,0,0
105336,patient,0,1
105337,'s,0,0
105338,sleeping,0,1
105339,angle,0,0
105340,.,0,0
105341,The,0,0
105342,objective,0,0
105343,of,0,0
105344,this,0,0
105345,study,0,0
105346,was,0,0
105347,to,0,0
105348,assess,1,0
105349,the,1,0
105350,respiratory,1,1
105351,and,1,0
105352,hemodynamic,1,1
105353,response,1,1
105354,to,0,0
105355,sleeping,0,1
105356,angle,0,0
105357,in,0,0
105358,a,0,0
105359,group,0,0
105360,of,0,0
105361,subjects,0,0
105362,with,0,0
105363,stable,0,1
105364,heart,0,0
105365,failure,0,1
105366,.,0,0
105367,DESIGN,0,0
105368,Twenty-five,0,0
105369,patients,0,0
105370,underwent,0,0
105371,overnight,0,0
105372,polysomnography,0,0
105373,with,0,0
105374,simultaneous,0,0
105375,and,0,0
105376,continuous,0,0
105377,impedance,0,1
105378,cardiographic,0,1
105379,monitoring,0,0
105380,.,0,0
105381,Sleeping,1,1
105382,polysomnographic,1,1
105383,and,1,0
105384,impedance,1,1
105385,cardiographic,1,1
105386,data,1,0
105387,were,0,0
105388,recorded,0,0
105389,.,0,0
105390,SETTING,0,0
105391,The,0,0
105392,study,0,0
105393,was,0,0
105394,conducted,0,0
105395,in,0,0
105396,a,0,0
105397,sleep,0,1
105398,center,0,0
105399,.,0,0
105400,PATIENTS,0,0
105401,All,0,0
105402,25,0,0
105403,patients,0,0
105404,had,0,0
105405,clinically,0,0
105406,stable,0,0
105407,heart,0,1
105408,failure,0,1
105409,and,0,1
105410,left,0,1
105411,ventricular,0,1
105412,ejection,0,0
105413,fractions,0,0
105414,<,0,0
105415,40,0,0
105416,%,0,0
105417,.,0,0
105418,INTERVENTIONS,0,0
105419,The,0,0
105420,patients,0,0
105421,slept,0,0
105422,at,0,0
105423,0,0,0
105424,degrees,0,0
105425,",",0,0
105426,15,0,0
105427,degrees,0,0
105428,",",0,0
105429,30,0,0
105430,degrees,0,0
105431,",",0,0
105432,and,0,0
105433,45,0,0
105434,degrees,0,0
105435,in,0,0
105436,random,0,0
105437,order,0,0
105438,.,0,0
105439,MEASUREMENTS,0,0
105440,AND,0,0
105441,RESULTS,0,0
105442,Seventeen,0,1
105443,patients,0,0
105444,had,0,0
105445,Cheyne-Stokes,1,0
105446,apneas,1,1
105447,(,0,0
105448,index,0,1
105449,>,0,0
105450,5/h,0,0
105451,),0,0
105452,and,0,0
105453,23,0,0
105454,patients,0,0
105455,had,0,0
105456,hypopneas,1,1
105457,(,0,0
105458,index,0,1
105459,>,0,0
105460,5/h,0,0
105461,),0,0
105462,.,0,0
105463,The,0,0
105464,hypopnea,1,1
105465,index,1,1
105466,showed,0,0
105467,no,0,0
105468,response,0,1
105469,to,0,0
105470,sleeping,0,1
105471,angle,0,0
105472,.,0,0
105473,The,0,0
105474,Cheyne-Stokes,1,0
105475,apnea,1,1
105476,index,1,1
105477,decreased,0,0
105478,with,0,0
105479,increasing,0,0
105480,sleeping,0,1
105481,angle,0,1
105482,(,0,0
105483,P,0,0
105484,<,0,0
105485,0.001,0,0
105486,),0,0
105487,.,0,0
105488,This,0,0
105489,effect,0,0
105490,was,0,0
105491,seen,0,0
105492,only,0,0
105493,during,0,0
105494,supine,0,0
105495,sleep,0,1
105496,and,0,0
105497,non-rapid,0,1
105498,eye,0,1
105499,movement,0,1
105500,sleep,0,1
105501,and,0,1
105502,was,0,0
105503,absent,0,0
105504,in,0,0
105505,non-supine,0,0
105506,sleep,0,1
105507,",",0,0
105508,rapid,0,1
105509,eye,0,1
105510,movement,0,1
105511,sleep,0,1
105512,",",0,0
105513,and,0,1
105514,during,0,0
105515,periods,0,1
105516,of,0,0
105517,wakefulness,0,1
105518,.,0,0
105519,Thoracic,1,0
105520,fluid,1,1
105521,content,1,1
105522,index,1,1
105523,and,1,1
105524,left,1,1
105525,ventricular,1,1
105526,hemodynamics,1,1
105527,measured,0,0
105528,by,0,0
105529,impedance,0,1
105530,cardiography,0,0
105531,showed,0,0
105532,no,0,0
105533,response,0,1
105534,to,0,0
105535,sleeping,0,1
105536,angle,0,1
105537,.,0,0
105538,CONCLUSIONS,0,0
105539,Changing,0,0
105540,the,0,0
105541,heart,0,1
105542,failure,0,1
105543,patient,0,1
105544,'s,0,0
105545,sleeping,0,1
105546,angle,0,0
105547,from,0,0
105548,0,0,0
105549,degrees,0,0
105550,to,0,0
105551,45,0,0
105552,degrees,0,0
105553,results,0,0
105554,in,0,0
105555,a,0,0
105556,significant,0,0
105557,decrease,0,0
105558,in,0,0
105559,Cheyne-Stokes,0,0
105560,apneas,0,1
105561,.,0,0
105562,This,0,0
105563,decrease,0,0
105564,occurs,0,0
105565,on,0,0
105566,a,0,0
105567,constant,0,0
105568,base,0,0
105569,of,0,0
105570,hypopneas,0,1
105571,.,0,0
105572,The,0,0
105573,changes,0,0
105574,in,0,0
105575,Cheyne-Stokes,0,0
105576,apneas,0,1
105577,are,0,0
105578,not,0,0
105579,related,0,0
105580,to,0,0
105581,changes,0,0
105582,in,0,0
105583,lung,0,0
105584,congestion,0,1
105585,and,0,1
105586,left,0,1
105587,ventricular,0,1
105588,hemodynamics,0,1
105589,.,0,0
105590,Aripiprazole,0,0
105591,in,0,0
105592,the,0,0
105593,treatment,0,0
105594,of,0,0
105595,irritability,1,1
105596,in,0,0
105597,children,0,0
105598,and,0,0
105599,adolescents,0,0
105600,with,0,0
105601,autistic,0,0
105602,disorder,0,0
105603,.,0,0
105604,OBJECTIVE,0,0
105605,The,0,0
105606,objective,0,0
105607,of,0,0
105608,this,0,0
105609,study,0,0
105610,was,0,0
105611,to,0,0
105612,evaluate,0,0
105613,short-term,1,0
105614,efficacy,1,1
105615,and,1,1
105616,safety,1,1
105617,of,0,1
105618,aripiprazole,0,0
105619,in,0,0
105620,the,0,0
105621,treatment,0,0
105622,of,0,0
105623,irritability,1,1
105624,in,0,0
105625,children,0,0
105626,and,0,0
105627,adolescents,0,0
105628,with,0,0
105629,autistic,0,0
105630,disorder,0,0
105631,who,0,0
105632,were,0,0
105633,manifesting,0,0
105634,behaviors,0,1
105635,such,0,0
105636,as,0,0
105637,tantrums,0,1
105638,",",0,0
105639,aggression,0,1
105640,",",0,1
105641,self-injurious,0,1
105642,behavior,0,1
105643,",",0,0
105644,or,0,0
105645,a,0,0
105646,combination,0,0
105647,of,0,0
105648,these,0,0
105649,.,0,0
105650,METHODS,0,0
105651,This,0,0
105652,8-week,0,0
105653,",",0,0
105654,double-blind,0,0
105655,",",0,0
105656,randomized,0,0
105657,",",0,0
105658,placebo-controlled,0,0
105659,",",0,0
105660,parallel-group,0,0
105661,study,0,0
105662,was,0,0
105663,conducted,0,0
105664,of,0,0
105665,children,0,0
105666,and,0,1
105667,adolescents,0,0
105668,(,0,0
105669,aged,0,0
105670,6-17,0,0
105671,years,0,0
105672,),0,0
105673,with,0,0
105674,autistic,0,0
105675,disorder,0,0
105676,.,0,0
105677,Patients,0,0
105678,were,0,0
105679,randomly,0,0
105680,assigned,0,0
105681,(,0,0
105682,1:1,0,0
105683,),0,0
105684,to,0,0
105685,flexibly,0,0
105686,dosed,0,0
105687,aripiprazole,0,0
105688,(,0,0
105689,target,0,0
105690,dosage,0,0
105691,:,0,0
105692,5,0,0
105693,",",0,0
105694,10,0,0
105695,",",0,0
105696,or,0,0
105697,15,0,0
105698,mg/day,0,0
105699,),0,0
105700,or,0,0
105701,placebo,0,0
105702,.,0,0
105703,Efficacy,0,1
105704,outcome,0,1
105705,measures,0,1
105706,included,0,0
105707,the,0,0
105708,Aberrant,1,0
105709,Behavior,1,1
105710,Checklist,1,1
105711,irritability,1,1
105712,subscale,1,1
105713,and,1,0
105714,the,1,0
105715,Clinical,1,1
105716,Global,1,1
105717,Impression-Improvement,1,1
105718,score,1,1
105719,(,1,0
105720,CGI-I,1,0
105721,),1,0
105722,.,1,0
105723,Safety,1,1
105724,and,1,1
105725,tolerability,1,1
105726,were,0,0
105727,also,0,0
105728,assessed,0,0
105729,.,0,0
105730,RESULTS,0,0
105731,Ninety-eight,0,0
105732,patients,0,0
105733,were,0,0
105734,randomly,0,0
105735,assigned,0,0
105736,to,0,0
105737,receive,0,0
105738,placebo,0,0
105739,(,0,0
105740,n,0,0
105741,=,0,0
105742,51,0,0
105743,),0,0
105744,or,0,0
105745,aripiprazole,0,0
105746,(,0,0
105747,n,0,0
105748,=,0,0
105749,47,0,0
105750,),0,0
105751,.,0,0
105752,Mean,0,0
105753,improvement,0,1
105754,in,0,0
105755,Aberrant,1,1
105756,Behavior,1,1
105757,Checklist,1,1
105758,irritability,1,1
105759,subscale,1,1
105760,score,1,1
105761,was,0,0
105762,significantly,0,0
105763,greater,0,0
105764,with,0,0
105765,aripiprazole,0,0
105766,than,0,0
105767,with,0,0
105768,placebo,0,0
105769,from,0,0
105770,week,0,0
105771,1,0,0
105772,through,0,0
105773,week,0,0
105774,8,0,0
105775,.,0,0
105776,Aripiprazole,0,0
105777,demonstrated,0,0
105778,significantly,0,0
105779,greater,0,0
105780,global,0,1
105781,improvements,0,1
105782,than,0,0
105783,placebo,0,0
105784,",",0,0
105785,as,0,0
105786,assessed,0,0
105787,by,0,0
105788,the,0,0
105789,mean,0,1
105790,CGI-I,1,0
105791,score,1,1
105792,from,0,0
105793,week,0,0
105794,1,0,0
105795,through,0,0
105796,week,0,0
105797,8,0,0
105798,;,0,0
105799,however,0,0
105800,",",0,0
105801,clinically,0,1
105802,significant,0,0
105803,residual,1,0
105804,symptoms,1,1
105805,may,0,0
105806,still,0,0
105807,persist,0,0
105808,for,0,0
105809,some,0,0
105810,patients,0,0
105811,.,0,0
105812,Discontinuation,1,0
105813,rates,1,1
105814,as,0,0
105815,a,0,0
105816,result,0,0
105817,of,0,0
105818,adverse,0,1
105819,events,0,1
105820,(,0,0
105821,AEs,0,1
105822,),0,0
105823,were,0,0
105824,10.6,0,0
105825,%,0,0
105826,for,0,0
105827,aripiprazole,0,0
105828,and,0,0
105829,5.9,0,0
105830,%,0,0
105831,for,0,0
105832,placebo,0,0
105833,.,0,0
105834,Extrapyramidal,1,1
105835,symptom-related,1,1
105836,AE,1,1
105837,rates,1,1
105838,were,0,0
105839,14.9,0,0
105840,%,0,0
105841,for,0,0
105842,aripiprazole,0,0
105843,and,0,0
105844,8.0,0,0
105845,%,0,0
105846,for,0,0
105847,placebo,0,0
105848,.,0,0
105849,No,0,0
105850,serious,0,1
105851,AEs,0,1
105852,were,0,0
105853,reported,0,0
105854,.,0,0
105855,Mean,0,0
105856,weight,1,1
105857,gain,1,1
105858,was,0,0
105859,2.0,0,0
105860,kg,0,0
105861,on,0,0
105862,aripiprazole,0,0
105863,and,0,0
105864,0.8,0,0
105865,kg,0,0
105866,on,0,0
105867,placebo,0,0
105868,at,0,0
105869,week,0,0
105870,8,0,0
105871,.,0,0
105872,CONCLUSIONS,0,0
105873,Aripiprazole,0,0
105874,was,0,0
105875,efficacious,0,0
105876,in,0,0
105877,children,0,0
105878,and,0,0
105879,adolescents,0,0
105880,with,0,0
105881,irritability,0,1
105882,associated,0,0
105883,with,0,0
105884,autistic,0,0
105885,disorder,0,0
105886,and,0,0
105887,was,0,0
105888,generally,0,0
105889,safe,0,0
105890,and,0,0
105891,well,0,0
105892,tolerated,0,1
105893,.,0,0
105894,Breast,0,0
105895,reduction,0,0
105896,alleviates,0,0
105897,depression,1,1
105898,and,1,1
105899,anxiety,1,1
105900,and,0,0
105901,restores,0,0
105902,self-esteem,1,1
105903,:,1,0
105904,a,0,0
105905,prospective,0,0
105906,randomised,0,0
105907,clinical,0,0
105908,trial,0,0
105909,.,0,0
105910,Of,0,0
105911,women,0,0
105912,who,0,0
105913,seek,0,0
105914,reduction,0,1
105915,mammaplasty,0,1
105916,",",0,0
105917,up,0,0
105918,to,0,0
105919,a,0,0
105920,third,0,0
105921,have,0,0
105922,pathological,0,1
105923,degrees,0,0
105924,of,0,0
105925,anxiety,1,1
105926,or,1,0
105927,depression,1,1
105928,",",0,0
105929,or,0,0
105930,both,0,0
105931,.,0,0
105932,The,0,0
105933,psychological,1,1
105934,aspect,1,1
105935,of,0,0
105936,reduction,0,0
105937,mammaplasty,0,0
105938,is,0,0
105939,therefore,0,0
105940,an,0,0
105941,important,0,0
105942,consideration,0,0
105943,.,0,0
105944,We,0,0
105945,did,0,0
105946,a,0,0
105947,prospective,0,0
105948,randomised,0,0
105949,clinical,0,0
105950,trial,0,0
105951,to,0,0
105952,see,0,0
105953,how,0,0
105954,reduction,0,1
105955,mammaplasty,0,0
105956,affected,0,0
105957,macromastia,0,1
105958,patients,0,0
105959,',0,0
105960,depression,1,1
105961,",",1,0
105962,anxiety,1,1
105963,",",1,1
105964,and,1,0
105965,self-esteem,1,1
105966,.,1,0
105967,Eighty-two,0,0
105968,patients,0,0
105969,were,0,0
105970,randomised,0,0
105971,",",0,0
105972,40,0,0
105973,to,0,0
105974,have,0,0
105975,the,0,0
105976,operation,0,0
105977,",",0,0
105978,and,0,0
105979,42,0,0
105980,patients,0,0
105981,to,0,0
105982,conservative,0,0
105983,treatment,0,0
105984,.,0,0
105985,Both,0,0
105986,groups,0,0
105987,were,0,0
105988,followed,0,0
105989,for,0,0
105990,six,0,0
105991,months,0,0
105992,.,0,0
105993,The,0,0
105994,patients,0,0
105995,completed,0,0
105996,the,0,0
105997,RBDI,1,0
105998,questionnaire,1,1
105999,(,1,0
106000,Raitasalo,1,1
106001,'s,1,1
106002,modification,1,0
106003,of,1,0
106004,the,1,0
106005,short,1,0
106006,form,1,0
106007,of,1,0
106008,the,1,0
106009,Beck,1,0
106010,Depression,1,1
106011,Inventory,1,1
106012,),1,0
106013,.,1,0
106014,Twenty-nine,0,0
106015,patients,0,0
106016,in,0,0
106017,the,0,0
106018,operated,0,0
106019,group,0,0
106020,and,0,0
106021,35,0,0
106022,patients,0,0
106023,in,0,0
106024,the,0,0
106025,conservative,0,0
106026,group,0,0
106027,completed,0,0
106028,the,0,0
106029,study,0,0
106030,.,0,0
106031,At,0,0
106032,the,0,0
106033,second,0,0
106034,examination,0,0
106035,",",0,0
106036,the,0,0
106037,patients,0,0
106038,who,0,0
106039,had,0,0
106040,been,0,0
106041,operated,0,0
106042,on,0,0
106043,",",0,0
106044,had,0,0
106045,significantly,0,0
106046,less,0,0
106047,depression,1,1
106048,(,0,0
106049,p,0,0
106050,<,0,0
106051,0.01,0,0
106052,),0,0
106053,and,0,0
106054,better,1,0
106055,self-esteem,1,1
106056,(,0,1
106057,p=0.03,0,0
106058,),0,0
106059,than,0,0
106060,the,0,0
106061,conservative,0,0
106062,group,0,0
106063,.,0,0
106064,The,0,0
106065,proportions,1,0
106066,of,0,0
106067,depressed,1,1
106068,(,0,0
106069,p,0,0
106070,<,0,0
106071,0.01,0,0
106072,),0,0
106073,and,0,0
106074,anxious,1,1
106075,(,0,0
106076,p=0.04,0,0
106077,),0,1
106078,patients,0,0
106079,were,0,0
106080,also,0,0
106081,smaller,0,0
106082,in,0,0
106083,the,0,0
106084,group,0,0
106085,who,0,0
106086,were,0,0
106087,operated,0,0
106088,on,0,0
106089,.,0,0
106090,There,0,0
106091,is,0,0
106092,significantly,0,0
106093,less,0,0
106094,depression,1,1
106095,and,1,1
106096,anxiety,1,1
106097,after,0,0
106098,reduction,0,1
106099,mammaplasty,0,1
106100,",",0,1
106101,and,0,1
106102,patients,0,0
106103,',0,0
106104,self-esteem,1,1
106105,is,0,0
106106,restored,0,0
106107,.,0,0
106108,The,0,0
106109,6,0,0
106110,minute,0,0
106111,walk,0,0
106112,in,0,0
106113,idiopathic,0,0
106114,pulmonary,0,0
106115,fibrosis,0,0
106116,:,0,0
106117,longitudinal,0,0
106118,changes,0,1
106119,and,0,0
106120,minimum,0,1
106121,important,0,0
106122,difference,0,0
106123,.,0,0
106124,RATIONALE,0,0
106125,The,0,0
106126,response,0,1
106127,characteristics,0,0
106128,of,0,0
106129,the,0,0
106130,6,0,0
106131,minute,0,0
106132,walk,0,0
106133,test,0,1
106134,(,0,0
106135,6MWT,0,0
106136,),0,0
106137,in,0,0
106138,studies,0,0
106139,of,0,0
106140,idiopathic,0,0
106141,pulmonary,0,1
106142,fibrosis,0,1
106143,(,0,0
106144,IPF,0,0
106145,),0,0
106146,are,0,0
106147,only,0,0
106148,poorly,0,0
106149,understood,0,0
106150,",",0,0
106151,and,0,0
106152,the,0,0
106153,change,0,1
106154,in,0,0
106155,walk,0,1
106156,distance,0,1
106157,that,0,0
106158,constitutes,0,0
106159,the,0,0
106160,minimum,0,1
106161,important,0,0
106162,difference,0,0
106163,(,0,0
106164,MID,0,0
106165,),0,0
106166,over,0,0
106167,time,0,1
106168,is,0,0
106169,unknown,0,0
106170,.,0,0
106171,OBJECTIVES,0,0
106172,To,0,0
106173,examine,0,0
106174,changes,0,1
106175,over,0,0
106176,time,1,1
106177,in,1,0
106178,distance,1,1
106179,walked,1,1
106180,(,0,0
106181,ie,0,0
106182,",",0,0
106183,6MWD,0,1
106184,),0,0
106185,during,0,0
106186,the,0,0
106187,6MWT,0,0
106188,and,0,0
106189,to,0,0
106190,estimate,0,0
106191,the,0,0
106192,change,0,0
106193,in,0,0
106194,distance,0,0
106195,that,0,0
106196,constitutes,0,0
106197,the,0,0
106198,MID,0,0
106199,in,0,0
106200,patients,0,0
106201,with,0,0
106202,IPF,0,0
106203,.,0,0
106204,METHODS,0,0
106205,Data,0,0
106206,from,0,0
106207,a,0,0
106208,recently,0,0
106209,completed,0,0
106210,trial,0,0
106211,that,0,0
106212,included,0,0
106213,subjects,0,0
106214,with,0,0
106215,IPF,0,1
106216,who,0,0
106217,completed,0,0
106218,the,0,0
106219,6MWT,0,0
106220,",",0,0
106221,Saint,0,0
106222,George,0,1
106223,'s,0,0
106224,Respiratory,0,1
106225,Questionnaire,0,1
106226,(,0,0
106227,SGRQ,0,1
106228,),0,0
106229,and,0,0
106230,forced,0,0
106231,vital,0,1
106232,capacity,0,1
106233,(,0,0
106234,FVC,0,0
106235,),0,0
106236,at,0,0
106237,6,0,0
106238,and,0,0
106239,12,0,0
106240,months,0,0
106241,were,0,0
106242,used,0,0
106243,to,0,0
106244,examine,0,0
106245,longitudinal,0,0
106246,changes,0,0
106247,in,0,0
106248,6MWD,0,0
106249,.,0,0
106250,Both,0,0
106251,anchor-,0,1
106252,and,0,0
106253,distribution-based,0,1
106254,approaches,0,0
106255,as,0,0
106256,well,0,0
106257,as,0,0
106258,linear,0,0
106259,regression,0,0
106260,analyses,0,0
106261,were,0,0
106262,used,0,0
106263,to,0,0
106264,determine,0,0
106265,the,0,0
106266,MID,0,0
106267,for,0,0
106268,6MWD,0,0
106269,.,0,0
106270,The,0,0
106271,SGRQ,1,0
106272,Total,1,1
106273,score,1,1
106274,and,1,1
106275,FVC,1,1
106276,were,0,0
106277,used,0,0
106278,as,0,0
106279,clinical,0,0
106280,anchors,0,0
106281,.,0,0
106282,MAIN,0,0
106283,RESULTS,0,0
106284,Among,0,0
106285,123,0,0
106286,subjects,0,0
106287,alive,0,0
106288,and,0,0
106289,able,0,0
106290,to,0,0
106291,complete,0,0
106292,the,0,0
106293,6MWT,0,0
106294,at,0,0
106295,both,0,0
106296,follow-up,0,0
106297,time,0,1
106298,points,0,0
106299,",",0,0
106300,6MWD,1,1
106301,did,0,0
106302,not,0,0
106303,change,0,0
106304,significantly,0,0
106305,over,0,0
106306,time,0,1
106307,(,0,0
106308,378.1,0,0
106309,m,0,0
106310,at,0,0
106311,baseline,0,0
106312,vs,0,0
106313,376.8,0,0
106314,m,0,0
106315,at,0,0
106316,6,0,0
106317,months,0,0
106318,vs,0,0
106319,361.3,0,0
106320,m,0,0
106321,at,0,0
106322,12,0,0
106323,months,0,0
106324,",",0,0
106325,p=0.5,0,0
106326,),0,0
106327,.,0,0
106328,The,0,0
106329,point,0,0
106330,estimate,0,0
106331,for,0,0
106332,the,0,0
106333,6MWD,1,0
106334,MID,1,0
106335,was,0,0
106336,28,0,0
106337,m,0,0
106338,with,0,0
106339,a,0,0
106340,range,0,0
106341,of,0,0
106342,10.8-58.5,0,0
106343,m.,0,0
106344,CONCLUSION,0,0
106345,In,0,0
106346,a,0,0
106347,group,0,0
106348,of,0,0
106349,patients,0,0
106350,with,0,0
106351,IPF,0,0
106352,with,0,0
106353,moderate,0,0
106354,physiological,0,0
106355,impairment,0,1
106356,",",0,0
106357,for,0,0
106358,those,0,0
106359,alive,0,0
106360,and,0,0
106361,able,0,0
106362,to,0,0
106363,complete,0,0
106364,a,0,0
106365,6MWT,0,0
106366,",",0,0
106367,6MWD,1,0
106368,does,0,0
106369,not,0,0
106370,change,0,0
106371,over,0,0
106372,12,0,0
106373,months,0,0
106374,.,0,0
106375,At,0,0
106376,the,0,0
106377,population,0,0
106378,level,0,1
106379,",",0,0
106380,the,0,0
106381,MID,0,0
106382,for,0,0
106383,6MWD,1,0
106384,appears,0,0
106385,to,0,0
106386,be,0,0
106387,approximately,0,0
106388,28,0,0
106389,m.,0,0
106390,Further,0,0
106391,investigation,0,0
106392,using,0,0
106393,other,0,0
106394,anchors,0,1
106395,and,0,1
106396,derivation,0,1
106397,methods,0,0
106398,is,0,0
106399,required,0,0
106400,to,0,0
106401,refine,0,0
106402,estimates,0,0
106403,of,0,0
106404,the,0,0
106405,MID,0,0
106406,for,0,0
106407,6MWD,0,0
106408,in,0,0
106409,this,0,0
106410,patient,0,0
106411,population,0,0
106412,.,0,0
106413,Randomized,0,0
106414,clinical,0,0
106415,trial,0,0
106416,of,0,0
106417,radiofrequency,0,0
106418,ablation,0,0
106419,or,0,0
106420,conventional,0,0
106421,high,0,1
106422,ligation,0,0
106423,and,0,0
106424,stripping,0,0
106425,for,0,0
106426,great,0,0
106427,saphenous,0,1
106428,varicose,0,0
106429,veins,0,0
106430,.,0,0
106431,BACKGROUND,0,0
106432,This,0,0
106433,randomized,0,0
106434,clinical,0,0
106435,trial,0,0
106436,compared,0,0
106437,early,0,0
106438,outcomes,0,0
106439,after,0,0
106440,radiofrequency,0,0
106441,ablation,0,0
106442,(,0,0
106443,RFA,0,1
106444,),0,0
106445,and,0,0
106446,conventional,0,0
106447,surgery,0,0
106448,for,0,0
106449,varicose,0,0
106450,veins,0,0
106451,.,0,0
106452,METHODS,0,0
106453,Consecutive,0,0
106454,patients,0,0
106455,with,0,0
106456,symptomatic,0,1
106457,varicose,0,1
106458,veins,0,0
106459,due,0,0
106460,to,0,0
106461,isolated,0,0
106462,great,0,0
106463,saphenous,0,1
106464,vein,0,0
106465,(,0,0
106466,GSV,0,0
106467,),0,1
106468,incompetence,0,1
106469,and,0,0
106470,suitable,0,0
106471,for,0,0
106472,RFA,0,0
106473,were,0,0
106474,randomized,0,0
106475,to,0,0
106476,either,0,0
106477,RFA,0,0
106478,or,0,0
106479,conventional,0,0
106480,surgery,0,0
106481,(,0,0
106482,saphenofemoral,0,1
106483,disconnection,0,1
106484,and,0,1
106485,stripping,0,0
106486,),0,0
106487,.,0,0
106488,Clinical,1,1
106489,",",1,0
106490,radiological,1,1
106491,and,1,1
106492,patient-based,1,1
106493,outcomes,1,1
106494,were,0,0
106495,recorded,0,0
106496,at,0,0
106497,1,0,0
106498,and,0,0
106499,5,0,0
106500,weeks,0,0
106501,after,0,0
106502,intervention,0,0
106503,.,0,0
106504,RESULTS,0,0
106505,RFA,0,0
106506,resulted,0,0
106507,in,0,0
106508,successful,0,0
106509,obliteration,0,0
106510,of,0,0
106511,the,0,0
106512,GSV,0,0
106513,in,0,0
106514,all,0,0
106515,47,0,0
106516,patients,0,0
106517,.,0,0
106518,Complete,1,0
106519,above-knee,1,0
106520,stripping,1,0
106521,was,0,0
106522,unsuccessful,0,0
106523,in,0,0
106524,seven,0,0
106525,of,0,0
106526,41,0,0
106527,patients,0,0
106528,.,0,0
106529,RFA,0,0
106530,took,0,0
106531,longer,0,0
106532,than,0,0
106533,conventional,0,0
106534,surgery,0,0
106535,:,0,0
106536,median,0,1
106537,interquartile,0,0
106538,range,0,0
106539,76,0,0
106540,(,0,0
106541,67-84,0,0
106542,),0,0
106543,versus,0,0
106544,48,0,0
106545,(,0,0
106546,39-54,0,0
106547,),0,0
106548,min,0,0
106549,;,0,0
106550,P,0,0
106551,<,0,0
106552,0.001,0,0
106553,.,0,0
106554,Patients,0,0
106555,returned,1,0
106556,to,1,0
106557,their,1,0
106558,normal,1,0
106559,activities,1,1
106560,significantly,0,0
106561,earlier,0,0
106562,after,0,0
106563,RFA,0,0
106564,(,0,0
106565,median,0,0
106566,3,0,0
106567,(,0,0
106568,2-5,0,0
106569,),0,0
106570,versus,0,0
106571,12.5,0,0
106572,(,0,0
106573,4-21,0,0
106574,),0,0
106575,days,0,0
106576,;,0,0
106577,P,0,0
106578,<,0,0
106579,0.001,0,0
106580,),0,0
106581,.,0,0
106582,Postoperative,1,0
106583,pain,1,1
106584,was,0,0
106585,significantly,0,0
106586,less,0,0
106587,after,0,0
106588,RFA,0,1
106589,(,0,0
106590,median,0,1
106591,score,0,1
106592,on,0,0
106593,visual,0,1
106594,analogue,0,1
106595,scale,0,1
106596,1.70,0,0
106597,(,0,0
106598,0.50-4.30,0,0
106599,),0,0
106600,versus,0,0
106601,4.0,0,0
106602,(,0,0
106603,2.35-6.05,0,0
106604,),0,0
106605,;,0,0
106606,P,0,0
106607,=,0,0
106608,0.001,0,0
106609,),0,0
106610,.,0,0
106611,Patient,1,1
106612,satisfaction,1,1
106613,",",1,0
106614,quality,1,1
106615,of,1,1
106616,life,1,1
106617,improvement,1,1
106618,and,1,1
106619,analgesic,1,1
106620,requirements,1,1
106621,significantly,0,0
106622,favoured,0,0
106623,RFA,0,0
106624,.,0,0
106625,CONCLUSION,0,0
106626,RFA,0,0
106627,took,0,0
106628,longer,0,0
106629,to,0,0
106630,perform,0,0
106631,but,0,0
106632,resulted,0,0
106633,in,0,0
106634,a,0,0
106635,significantly,1,0
106636,better,1,0
106637,early,1,0
106638,outcome,1,0
106639,than,0,0
106640,conventional,0,0
106641,surgery,0,0
106642,in,0,0
106643,suitable,0,0
106644,patients,0,0
106645,with,0,0
106646,great,0,0
106647,saphenous,0,1
106648,varicose,0,0
106649,veins,0,0
106650,.,0,0
106651,A,0,0
106652,phase,0,0
106653,II,0,0
106654,study,0,0
106655,of,0,1
106656,cetuximab,0,0
106657,",",0,0
106658,capecitabine,0,0
106659,and,0,1
106660,radiotherapy,0,0
106661,in,0,0
106662,neoadjuvant,0,0
106663,treatment,0,0
106664,of,0,0
106665,patients,0,0
106666,with,0,0
106667,locally,0,0
106668,advanced,0,0
106669,resectable,0,0
106670,rectal,0,0
106671,cancer,0,0
106672,.,0,0
106673,BACKGROUND,0,0
106674,Neoadjuvant,0,0
106675,chemoradiotherapy,0,0
106676,(,0,0
106677,CRT,0,0
106678,),0,0
106679,reduces,0,0
106680,local,0,0
106681,tumor,0,1
106682,recurrence,0,1
106683,in,0,0
106684,locally,0,0
106685,advanced,0,0
106686,rectal,0,1
106687,cancer,0,0
106688,(,0,0
106689,LARC,0,1
106690,),0,0
106691,.,0,0
106692,This,0,0
106693,phase,0,0
106694,II,0,0
106695,study,0,0
106696,assessed,0,0
106697,neoadjuvant,0,0
106698,cetuximab,0,0
106699,with,0,0
106700,capecitabine-based,0,0
106701,CRT,0,0
106702,in,0,0
106703,LARC,0,0
106704,.,0,0
106705,METHODS,0,0
106706,Patients,0,0
106707,with,0,0
106708,stage,0,0
106709,II/III,0,1
106710,LARC,0,1
106711,received,0,0
106712,capecitabine,0,0
106713,1250,0,0
106714,mg/m,0,0
106715,(,0,0
106716,2,0,0
106717,),0,0
106718,twice,0,0
106719,daily,0,0
106720,for,0,0
106721,2,0,0
106722,weeks,0,0
106723,followed,0,0
106724,by,0,0
106725,intravenous,0,0
106726,cetuximab,0,0
106727,400,0,0
106728,mg/m,0,0
106729,(,0,0
106730,2,0,0
106731,),0,0
106732,at,0,0
106733,week,0,0
106734,3,0,0
106735,",",0,0
106736,then,0,0
106737,weekly,0,0
106738,intravenous,0,0
106739,250,0,0
106740,mg/m,0,0
106741,(,0,0
106742,2,0,0
106743,),0,0
106744,cetuximab,0,0
106745,plus,0,0
106746,CRT,0,0
106747,including,0,0
106748,capecitabine,0,0
106749,825,0,0
106750,mg/m,0,0
106751,(,0,0
106752,2,0,0
106753,),0,0
106754,twice,0,0
106755,daily,0,0
106756,(,0,0
106757,including,0,0
106758,weekends,0,0
106759,during,0,0
106760,radiotherapy,0,0
106761,),0,0
106762,with,0,0
106763,radiotherapy,0,0
106764,of,0,0
106765,45,0,0
106766,Gy,0,0
106767,(,0,0
106768,25,0,0
106769,x,0,0
106770,1.8,0,0
106771,Gy,0,0
106772,),0,0
106773,",",0,0
106774,5,0,0
106775,days,0,0
106776,a,0,0
106777,week,0,0
106778,for,0,0
106779,5,0,0
106780,weeks,0,0
106781,.,0,0
106782,Total,0,0
106783,mesorectal,0,0
106784,excision,0,0
106785,was,0,0
106786,scheduled,0,0
106787,4-6,0,0
106788,weeks,0,0
106789,following,0,0
106790,completion,0,0
106791,of,0,0
106792,CRT,0,0
106793,.,0,0
106794,The,0,0
106795,primary,0,0
106796,endpoint,0,1
106797,was,0,0
106798,pathological,1,1
106799,complete,1,1
106800,response,1,1
106801,(,1,0
106802,pCR,1,0
106803,),1,0
106804,.,0,0
106805,RESULTS,0,0
106806,Thirty-seven,0,0
106807,patients,0,0
106808,were,0,0
106809,eligible,0,0
106810,for,0,0
106811,safety,1,1
106812,and,1,0
106813,efficacy,1,1
106814,.,1,0
106815,TMN,1,0
106816,staging,0,0
106817,at,0,0
106818,baseline,0,0
106819,was,0,0
106820,:,0,0
106821,T4N2,0,0
106822,",",0,0
106823,11,0,0
106824,%,0,0
106825,;,0,0
106826,T3N2,0,0
106827,",",0,0
106828,40,0,0
106829,%,0,0
106830,;,0,0
106831,T2N2,0,0
106832,",",0,0
106833,3,0,0
106834,%,0,0
106835,;,0,0
106836,T3N1,0,0
106837,",",0,0
106838,35,0,0
106839,%,0,0
106840,;,0,0
106841,T2N1,0,0
106842,",",0,0
106843,3,0,0
106844,%,0,0
106845,and,0,0
106846,T3N0,0,0
106847,8,0,0
106848,%,0,0
106849,.,0,0
106850,The,0,0
106851,most,0,0
106852,common,0,0
106853,adverse,0,1
106854,events,0,1
106855,included,0,0
106856,",",0,0
106857,grade,1,0
106858,1/2,1,0
106859,acneiform,1,0
106860,skin,1,1
106861,rash,1,1
106862,(,0,0
106863,86,0,0
106864,%,0,0
106865,),0,0
106866,",",0,0
106867,and,0,0
106868,grade,1,0
106869,3,1,0
106870,radiodermatitis,1,1
106871,",",0,0
106872,(,0,0
106873,16,0,0
106874,%,0,0
106875,),0,0
106876,",",0,0
106877,diarrhea,1,1
106878,(,0,0
106879,11,0,0
106880,%,0,0
106881,),0,0
106882,and,0,1
106883,hypersensitivity,1,1
106884,(,0,0
106885,5,0,0
106886,%,0,0
106887,),0,0
106888,.,0,0
106889,pCR,1,0
106890,was,0,0
106891,achieved,0,0
106892,in,0,0
106893,3,0,0
106894,patients,0,0
106895,(,0,0
106896,8,0,0
106897,%,0,0
106898,),0,0
106899,.,0,0
106900,Overall-,0,1
106901,",",0,0
106902,T-,1,0
106903,and,1,1
106904,N-downstaging,1,1
106905,rates,1,1
106906,were,0,0
106907,73,0,0
106908,%,0,0
106909,",",0,0
106910,57,0,0
106911,%,0,0
106912,and,0,0
106913,81,0,0
106914,%,0,0
106915,respectively,0,0
106916,.,0,0
106917,Total,1,0
106918,sphincter,1,1
106919,preservation,1,0
106920,rate,1,1
106921,was,0,0
106922,76,0,0
106923,%,0,0
106924,",",0,0
106925,and,0,0
106926,53,0,0
106927,%,0,0
106928,in,0,0
106929,17,0,0
106930,patients,0,0
106931,whose,0,0
106932,tumors,0,0
106933,were,0,0
106934,located,0,0
106935,within,0,0
106936,5,0,0
106937,cm,0,0
106938,from,0,0
106939,the,0,0
106940,anal,0,0
106941,verge,0,1
106942,.,0,0
106943,Non-fatal,1,1
106944,perioperative,1,0
106945,complications,1,1
106946,occurred,0,0
106947,in,0,0
106948,13,0,0
106949,patients,0,0
106950,(,0,0
106951,35,0,0
106952,%,0,0
106953,),0,0
106954,with,0,0
106955,delayed,1,0
106956,wound,1,0
106957,healing,1,1
106958,occurring,0,0
106959,in,0,0
106960,6,0,0
106961,patients,0,0
106962,(,0,0
106963,16,0,0
106964,%,0,0
106965,),0,0
106966,.,0,0
106967,One,0,0
106968,death,0,1
106969,was,0,0
106970,recorded,0,0
106971,due,0,0
106972,to,0,0
106973,sepsis,0,0
106974,following,0,0
106975,colonic,0,0
106976,necrosis,0,0
106977,.,0,0
106978,CONCLUSION,0,0
106979,Neoadjuvant,0,0
106980,cetuximab,0,0
106981,with,0,0
106982,capecitabine-based,0,0
106983,CRT,0,0
106984,is,0,0
106985,tolerable,0,1
106986,in,0,0
106987,patients,0,0
106988,with,0,0
106989,resectable,0,0
106990,LARC,0,0
106991,.,0,0
106992,Whilst,0,0
106993,the,0,0
106994,pCR,0,0
106995,rate,0,1
106996,was,0,0
106997,similar,0,0
106998,to,0,0
106999,recent,0,0
107000,reports,0,0
107001,",",0,0
107002,a,0,0
107003,high,0,0
107004,pathological,0,0
107005,downstaging,0,1
107006,rate,0,1
107007,was,0,0
107008,achieved,0,0
107009,.,0,0
107010,[,0,0
107011,Evaluation,0,0
107012,of,0,0
107013,Stepping,0,0
107014,Stones,0,1
107015,Triple,0,0
107016,P,0,0
107017,:,0,0
107018,Interims,0,0
107019,analysis,0,0
107020,of,0,0
107021,the,0,0
107022,Stepping-Stones-SPC-Multicentric,0,0
107023,Study,0,0
107024,],0,0
107025,.,0,0
107026,Stepping,0,0
107027,Stones,0,1
107028,Triple,0,0
107029,P,0,0
107030,is,0,0
107031,a,0,0
107032,behavioural,0,0
107033,parenting,0,0
107034,training,0,0
107035,for,0,0
107036,families,0,0
107037,with,0,0
107038,a,0,0
107039,handicapped,0,0
107040,child,0,0
107041,",",0,0
107042,which,0,0
107043,has,0,0
107044,already,0,0
107045,been,0,0
107046,successfully,0,0
107047,evaluated,0,0
107048,in,0,0
107049,its,0,0
107050,country,0,0
107051,of,0,0
107052,origin,0,0
107053,",",0,0
107054,Australia,0,0
107055,.,0,0
107056,Within,0,0
107057,a,0,0
107058,multicentric,0,0
107059,study,0,0
107060,of,0,0
107061,several,0,0
107062,Social,0,1
107063,Pediatric,0,0
107064,Centers,0,0
107065,(,0,0
107066,SPCs,0,0
107067,),0,0
107068,and,0,0
107069,further,0,0
107070,clinics/institutions,0,0
107071,in,0,0
107072,Germany,0,0
107073,",",0,0
107074,it,0,0
107075,has,0,0
107076,been,0,0
107077,established,0,0
107078,as,0,0
107079,a,0,0
107080,group,0,0
107081,parenting,0,1
107082,training,0,0
107083,(,0,0
107084,3-7,0,0
107085,families,0,0
107086,per,0,0
107087,training,0,0
107088,),0,0
107089,.,0,0
107090,Statistical,0,0
107091,analysis,0,0
107092,proved,0,0
107093,significant,0,0
107094,effects,1,1
107095,concerning,0,0
107096,dysfunctional,1,0
107097,parenting,1,0
107098,",",1,0
107099,parental,1,1
107100,stress,1,1
107101,and,1,0
107102,child,1,1
107103,behaviour,1,1
107104,problems,1,1
107105,as,0,0
107106,well,0,0
107107,as,0,0
107108,little,1,0
107109,side,1,1
107110,effects,1,1
107111,and,0,0
107112,a,0,0
107113,positive,1,1
107114,acceptance,1,1
107115,of,0,0
107116,stepping,0,0
107117,stones,0,0
107118,by,0,0
107119,the,0,0
107120,families,0,0
107121,.,0,0
107122,Comparable,0,0
107123,patencies,0,0
107124,of,0,0
107125,the,0,0
107126,radial,0,1
107127,artery,0,0
107128,and,0,0
107129,right,0,0
107130,internal,0,0
107131,thoracic,0,0
107132,artery,0,1
107133,or,0,0
107134,saphenous,0,1
107135,vein,0,0
107136,beyond,0,0
107137,5,0,0
107138,years,0,0
107139,:,0,0
107140,results,0,0
107141,from,0,0
107142,the,0,0
107143,Radial,0,1
107144,Artery,0,0
107145,Patency,0,1
107146,and,0,0
107147,Clinical,0,1
107148,Outcomes,0,1
107149,trial,0,0
107150,.,0,0
107151,OBJECTIVE,0,0
107152,To,0,0
107153,investigate,0,0
107154,the,0,0
107155,optimum,0,1
107156,conduit,0,0
107157,for,0,0
107158,coronary,0,0
107159,targets,0,0
107160,other,0,0
107161,than,0,0
107162,the,0,0
107163,left,0,0
107164,anterior,0,0
107165,descending,0,1
107166,artery,0,0
107167,",",0,0
107168,we,0,0
107169,evaluated,0,0
107170,long-term,0,0
107171,patencies,0,1
107172,and,0,0
107173,clinical,0,0
107174,outcomes,0,1
107175,of,0,0
107176,the,0,0
107177,radial,0,1
107178,artery,0,0
107179,",",0,0
107180,right,0,0
107181,internal,0,0
107182,thoracic,0,0
107183,artery,0,1
107184,",",0,0
107185,and,0,1
107186,saphenous,0,1
107187,vein,0,0
107188,through,0,0
107189,the,0,0
107190,Radial,0,1
107191,Artery,0,0
107192,Patency,0,1
107193,and,0,0
107194,Clinical,0,1
107195,Outcomes,0,1
107196,trial,0,0
107197,.,0,0
107198,METHODS,0,0
107199,As,0,0
107200,part,0,0
107201,of,0,0
107202,a,0,0
107203,10-year,0,1
107204,prospective,0,0
107205,",",0,0
107206,randomized,0,0
107207,",",0,0
107208,single-center,0,0
107209,trial,0,0
107210,",",0,0
107211,patients,0,0
107212,undergoing,0,0
107213,primary,0,0
107214,coronary,0,0
107215,surgery,0,0
107216,were,0,0
107217,allocated,0,0
107218,to,0,0
107219,the,0,0
107220,radial,0,1
107221,artery,0,0
107222,(,0,0
107223,n,0,0
107224,=,0,0
107225,198,0,0
107226,),0,0
107227,or,0,0
107228,free,0,1
107229,right,0,0
107230,internal,0,0
107231,thoracic,0,0
107232,artery,0,1
107233,(,0,0
107234,n,0,0
107235,=,0,0
107236,196,0,0
107237,),0,0
107238,if,0,0
107239,aged,0,0
107240,less,0,0
107241,than,0,0
107242,70,0,0
107243,years,0,0
107244,(,0,0
107245,group,0,0
107246,1,0,0
107247,),0,0
107248,",",0,0
107249,or,0,0
107250,radial,0,1
107251,artery,0,1
107252,(,0,0
107253,n,0,0
107254,=,0,0
107255,113,0,0
107256,),0,0
107257,or,0,0
107258,saphenous,0,1
107259,vein,0,1
107260,(,0,0
107261,n,0,0
107262,=,0,0
107263,112,0,0
107264,),0,0
107265,if,0,0
107266,aged,0,0
107267,at,0,0
107268,least,0,0
107269,70,0,0
107270,years,0,0
107271,(,0,0
107272,group,0,0
107273,2,0,0
107274,),0,0
107275,.,0,0
107276,All,0,0
107277,patients,0,0
107278,received,0,0
107279,a,0,0
107280,left,0,0
107281,internal,0,0
107282,thoracic,0,0
107283,artery,0,0
107284,to,0,0
107285,the,0,0
107286,left,0,0
107287,anterior,0,0
107288,descending,0,1
107289,",",0,0
107290,and,0,0
107291,the,0,0
107292,randomized,0,0
107293,conduit,0,1
107294,was,0,0
107295,used,0,0
107296,to,0,0
107297,graft,0,0
107298,the,0,0
107299,second,0,0
107300,largest,0,0
107301,target,0,0
107302,.,0,0
107303,Protocol-directed,0,0
107304,angiography,0,0
107305,has,0,0
107306,been,0,0
107307,performed,0,0
107308,at,0,0
107309,randomly,0,0
107310,assigned,0,0
107311,intervals,0,0
107312,",",0,0
107313,weighted,0,0
107314,toward,0,0
107315,the,0,0
107316,end,0,0
107317,of,0,0
107318,the,0,0
107319,study,0,0
107320,period,0,0
107321,.,0,0
107322,Grafts,0,0
107323,are,0,0
107324,defined,0,0
107325,as,0,0
107326,failed,0,0
107327,if,0,0
107328,there,0,0
107329,was,0,0
107330,occlusion,0,0
107331,",",0,0
107332,string,0,1
107333,sign,0,1
107334,",",0,0
107335,or,0,0
107336,greater,0,0
107337,than,0,0
107338,80,0,0
107339,%,0,0
107340,stenosis,0,0
107341,",",0,0
107342,independently,0,0
107343,reported,0,0
107344,by,0,0
107345,3,0,0
107346,assessors,0,0
107347,.,0,0
107348,Analysis,0,0
107349,is,0,0
107350,by,0,0
107351,intention,0,0
107352,to,0,0
107353,treat,0,0
107354,.,0,0
107355,RESULTS,0,0
107356,At,0,0
107357,mean,0,0
107358,follow,0,0
107359,up,0,0
107360,of,0,0
107361,5.5,0,0
107362,years,0,0
107363,",",0,0
107364,protocol,0,0
107365,angiography,0,0
107366,has,0,0
107367,been,0,0
107368,performed,0,0
107369,in,0,0
107370,groups,0,0
107371,1,0,0
107372,and,0,0
107373,2,0,0
107374,in,0,0
107375,237,0,0
107376,and,0,0
107377,113,0,0
107378,patients,0,0
107379,",",0,0
107380,respectively,0,0
107381,.,0,0
107382,There,0,0
107383,are,0,0
107384,no,0,0
107385,significant,0,0
107386,differences,0,0
107387,within,0,0
107388,each,0,0
107389,group,0,0
107390,in,0,0
107391,preoperative,0,0
107392,comorbidity,0,1
107393,",",0,0
107394,age,0,0
107395,",",0,1
107396,or,0,0
107397,urgency,0,1
107398,.,0,1
107399,Patencies,1,1
107400,were,0,0
107401,similar,0,0
107402,for,0,0
107403,either,0,0
107404,of,0,0
107405,the,0,0
107406,2,0,0
107407,conduits,0,0
107408,in,0,0
107409,each,0,0
107410,group,0,0
107411,(,0,0
107412,log,0,1
107413,rank,0,1
107414,analysis,0,0
107415,",",0,0
107416,P,0,0
107417,=,0,0
107418,.06,0,0
107419,and,0,0
107420,P,0,0
107421,=,0,0
107422,.54,0,0
107423,",",0,0
107424,respectively,0,0
107425,),0,0
107426,.,0,0
107427,The,0,0
107428,differences,0,0
107429,in,0,0
107430,estimated,0,0
107431,5-year,1,0
107432,patencies,1,0
107433,were,0,0
107434,6.6,0,0
107435,%,0,0
107436,(,0,0
107437,radial,0,1
107438,minus,0,0
107439,right,0,0
107440,internal,0,0
107441,thoracic,0,0
107442,artery,0,1
107443,),0,0
107444,in,0,0
107445,group,0,0
107446,1,0,0
107447,and,0,0
107448,2.9,0,0
107449,%,0,0
107450,(,0,0
107451,radial,0,1
107452,minus,0,0
107453,saphenous,0,1
107454,vein,0,1
107455,graft,0,1
107456,),0,0
107457,in,0,0
107458,group,0,0
107459,2,0,0
107460,.,0,0
107461,CONCLUSION,0,0
107462,At,0,0
107463,mean,0,1
107464,5-year,0,0
107465,angiography,0,0
107466,in,0,0
107467,largely,0,0
107468,asymptomatic,0,0
107469,patients,0,0
107470,",",0,0
107471,the,0,0
107472,selection,0,0
107473,of,0,0
107474,arterial,0,1
107475,or,0,0
107476,venous,0,1
107477,conduit,0,1
107478,for,0,0
107479,the,0,0
107480,second,0,0
107481,graft,0,0
107482,has,0,0
107483,not,0,0
107484,significantly,0,0
107485,affected,0,0
107486,patency,0,1
107487,.,0,0
107488,This,0,0
107489,finding,0,0
107490,offers,0,0
107491,surgeons,0,0
107492,",",0,0
107493,for,0,0
107494,now,0,0
107495,",",0,0
107496,enhanced,0,0
107497,flexibility,0,1
107498,in,0,0
107499,planning,0,0
107500,revascularization,0,0
107501,.,0,0
107502,Prophylactic,0,0
107503,amnioinfusion,0,0
107504,in,0,0
107505,pregnancies,0,0
107506,complicated,0,0
107507,by,0,0
107508,oligohydramnios,0,0
107509,:,0,0
107510,a,0,0
107511,prospective,0,0
107512,study,0,0
107513,.,0,0
107514,Prophylactic,0,0
107515,amnioinfusion,0,0
107516,was,0,0
107517,assessed,0,0
107518,in,0,0
107519,term,0,1
107520,and,0,0
107521,post-dates,0,0
107522,pregnancies,0,1
107523,with,0,0
107524,decreased,0,0
107525,amniotic,0,1
107526,fluid,0,1
107527,volume,0,1
107528,.,0,0
107529,Subjects,0,0
107530,were,0,0
107531,randomly,0,0
107532,assigned,0,0
107533,to,0,0
107534,one,0,0
107535,of,0,0
107536,three,0,0
107537,groups,0,0
107538,:,0,0
107539,amnioinfusion,0,0
107540,with,0,0
107541,warmed,0,0
107542,saline,0,0
107543,solution,0,0
107544,",",0,0
107545,room-temperature,0,0
107546,saline,0,0
107547,",",0,0
107548,or,0,0
107549,control,0,0
107550,.,0,0
107551,Patients,0,0
107552,receiving,0,0
107553,prophylactic,0,0
107554,amnioinfusion,0,0
107555,had,0,0
107556,a,0,0
107557,significant,0,0
107558,decrease,0,0
107559,in,0,0
107560,both,0,0
107561,the,0,0
107562,frequency,1,1
107563,and,1,0
107564,severity,1,1
107565,of,1,1
107566,variable,1,0
107567,decelerations,1,0
107568,in,1,0
107569,the,1,0
107570,first,1,0
107571,stage,1,0
107572,of,1,0
107573,labor,1,1
107574,(,0,0
107575,P,0,0
107576,=,0,0
107577,.006,0,0
107578,),0,0
107579,and,0,0
107580,in,0,0
107581,the,0,0
107582,average,0,0
107583,total,0,1
107584,number,0,1
107585,of,0,0
107586,variable,0,0
107587,decelerations,0,0
107588,in,0,0
107589,the,0,0
107590,first,0,0
107591,and,0,0
107592,second,0,0
107593,stages,0,1
107594,of,0,0
107595,labor,0,1
107596,(,0,0
107597,P,0,0
107598,=,0,0
107599,.01,0,0
107600,),0,0
107601,compared,0,0
107602,with,0,0
107603,controls,0,0
107604,.,0,0
107605,There,0,0
107606,was,0,0
107607,no,0,0
107608,observed,0,0
107609,effect,0,0
107610,on,0,0
107611,newborn,1,0
107612,serum,1,1
107613,electrolyte,1,1
107614,levels,1,1
107615,with,0,0
107616,amnioinfusion,0,0
107617,",",0,0
107618,nor,0,0
107619,was,0,0
107620,there,0,0
107621,any,0,0
107622,apparent,0,0
107623,benefit,0,0
107624,of,0,0
107625,infusion,0,0
107626,of,0,0
107627,warmed,0,0
107628,saline,0,0
107629,compared,0,0
107630,with,0,0
107631,room-temperature,0,0
107632,saline,0,0
107633,.,0,0
107634,In,0,0
107635,contrast,0,0
107636,to,0,0
107637,premature,0,0
107638,gestations,0,0
107639,with,0,0
107640,oligohydramnios,0,1
107641,",",0,0
107642,prophylactic,0,0
107643,amnioinfusion,0,1
107644,was,0,0
107645,not,0,0
107646,associated,0,0
107647,with,0,0
107648,a,0,0
107649,significant,0,0
107650,improvement,0,1
107651,in,0,0
107652,mean,1,1
107653,umbilical,1,1
107654,arterial,1,1
107655,and,1,0
107656,venous,1,1
107657,pH,1,0
107658,or,0,0
107659,a,0,0
107660,significant,1,0
107661,decrease,1,0
107662,in,0,0
107663,cesarean,1,1
107664,delivery,1,0
107665,for,1,0
107666,fetal,1,1
107667,distress,1,1
107668,(,0,0
107669,P,0,0
107670,=,0,0
107671,.09,0,0
107672,),0,0
107673,.,0,0
107674,This,0,0
107675,is,0,0
107676,perhaps,0,0
107677,because,0,0
107678,the,0,0
107679,term,0,0
107680,fetus,0,0
107681,has,0,0
107682,an,0,0
107683,enhanced,0,0
107684,ability,0,0
107685,to,0,0
107686,tolerate,0,0
107687,recurrent,0,0
107688,episodes,0,1
107689,of,0,0
107690,heart,1,1
107691,rate,1,1
107692,decelerations,1,1
107693,without,0,0
107694,demonstrating,0,0
107695,the,0,0
107696,rapid,0,0
107697,metabolic,0,0
107698,changes,0,1
107699,seen,0,0
107700,in,0,0
107701,the,0,0
107702,premature,0,0
107703,fetus,0,0
107704,.,0,0
107705,Relief,0,1
107706,of,0,0
107707,periorbital,0,1
107708,pain,0,1
107709,after,0,0
107710,acute,0,0
107711,angle,0,1
107712,closure,0,0
107713,glaucoma,0,0
107714,attack,0,1
107715,by,0,0
107716,botulinum,0,0
107717,toxin,0,0
107718,type,0,0
107719,A,0,0
107720,.,0,0
107721,PURPOSE,0,0
107722,To,0,0
107723,assess,0,0
107724,the,0,0
107725,efficacy,0,1
107726,and,0,0
107727,safety,0,1
107728,of,0,1
107729,botulinum,0,0
107730,toxin,0,0
107731,type,0,0
107732,A,0,0
107733,(,0,0
107734,BoNT-A,0,0
107735,),0,0
107736,injection,0,0
107737,in,0,0
107738,patients,0,0
107739,suffering,0,0
107740,from,0,0
107741,intractable,0,0
107742,periorbital,0,1
107743,pain,0,1
107744,after,0,0
107745,acute,0,0
107746,angle,0,1
107747,closure,0,0
107748,glaucoma,0,0
107749,(,0,0
107750,AACG,0,1
107751,),0,0
107752,.,0,0
107753,PATIENTS,0,0
107754,AND,0,0
107755,METHODS,0,0
107756,In,0,0
107757,this,0,0
107758,prospective,0,0
107759,randomized,0,0
107760,intervention,0,0
107761,study,0,0
107762,",",0,0
107763,19,0,0
107764,patients,0,0
107765,suffering,0,0
107766,from,0,0
107767,periorbital,0,1
107768,pain,0,1
107769,after,0,0
107770,an,0,0
107771,AACG,0,1
107772,attack,0,1
107773,were,0,0
107774,injected,0,0
107775,with,0,0
107776,BoNT-A,0,0
107777,or,0,0
107778,placebo,0,0
107779,for,0,0
107780,pain,0,1
107781,relief,0,1
107782,.,0,0
107783,Patients,0,0
107784,were,0,0
107785,assessed,0,0
107786,on,0,0
107787,days,0,0
107788,1,0,0
107789,",",0,0
107790,2,0,0
107791,",",0,0
107792,7,0,0
107793,",",0,0
107794,14,0,0
107795,",",0,0
107796,30,0,0
107797,",",0,0
107798,60,0,0
107799,",",0,0
107800,and,0,0
107801,90,0,0
107802,.,0,0
107803,The,0,0
107804,main,0,0
107805,outcomes,0,0
107806,were,0,0
107807,mean,0,1
107808,change,0,1
107809,of,0,0
107810,visual,0,1
107811,analog,0,1
107812,rating,0,1
107813,scale,0,1
107814,(,0,0
107815,VARS,0,0
107816,),0,1
107817,and,0,0
107818,index,0,1
107819,scores,0,1
107820,measured,0,0
107821,through,0,0
107822,a,0,0
107823,quality-of-life,0,1
107824,questionnaire,0,1
107825,(,0,0
107826,EQ-5D,0,0
107827,),0,1
107828,",",0,0
107829,and,0,1
107830,changes,0,1
107831,in,0,0
107832,the,0,0
107833,visual,1,1
107834,analog,1,1
107835,scale,1,1
107836,(,0,0
107837,VAS,0,1
107838,),0,0
107839,",",0,0
107840,all,0,0
107841,of,0,0
107842,which,0,0
107843,were,0,0
107844,assessed,0,0
107845,at,0,0
107846,each,0,0
107847,visit,0,0
107848,.,0,0
107849,A,0,0
107850,secondary,0,0
107851,outcome,0,0
107852,was,0,0
107853,the,0,0
107854,frequency,0,1
107855,and,0,0
107856,nature,0,0
107857,of,0,1
107858,adverse,0,1
107859,events,0,1
107860,and,0,0
107861,the,0,0
107862,number,0,1
107863,of,0,0
107864,patients,0,0
107865,who,0,0
107866,withdrew,0,0
107867,from,0,0
107868,the,0,0
107869,study,0,0
107870,as,0,0
107871,a,0,0
107872,result,0,0
107873,.,0,0
107874,RESULTS,0,0
107875,In,0,0
107876,the,0,0
107877,treatment,0,0
107878,group,0,0
107879,(,0,0
107880,n=10,0,0
107881,),0,0
107882,",",0,0
107883,the,0,0
107884,mean,1,1
107885,index,1,1
107886,score,1,1
107887,of,1,0
107888,EQ-5D,1,0
107889,and,1,0
107890,VAS,1,1
107891,changed,0,0
107892,significantly,0,0
107893,from,0,0
107894,the,0,0
107895,placebo,0,0
107896,group,0,0
107897,(,0,0
107898,by,0,0
107899,0.299,0,0
107900,and,0,0
107901,2.61,0,0
107902,",",0,0
107903,respectively,0,0
107904,),0,0
107905,from,0,0
107906,day,0,0
107907,2,0,0
107908,(,0,0
107909,P,0,0
107910,<,0,0
107911,0.01,0,0
107912,),0,0
107913,.,0,0
107914,The,0,0
107915,VARS,1,0
107916,of,1,0
107917,EQ-5D,1,0
107918,also,0,0
107919,disclosed,0,0
107920,significant,0,0
107921,changes,0,1
107922,from,0,0
107923,day,0,0
107924,2,0,0
107925,(,0,0
107926,17,0,0
107927,",",0,0
107928,P,0,0
107929,<,0,0
107930,0.01,0,0
107931,),0,0
107932,.,0,0
107933,In,0,0
107934,addition,0,0
107935,",",0,0
107936,efficacy,1,1
107937,was,0,0
107938,maintained,0,0
107939,mainly,0,0
107940,between,0,0
107941,days,0,0
107942,2,0,0
107943,and,0,0
107944,60,0,0
107945,but,0,0
107946,declined,0,0
107947,slightly,0,0
107948,by,0,0
107949,day,0,0
107950,90,0,0
107951,.,0,0
107952,The,0,0
107953,most,0,0
107954,frequently,0,0
107955,reported,0,0
107956,treatment-related,0,1
107957,adverse,0,1
107958,events,0,1
107959,in,0,0
107960,the,0,0
107961,treatment,0,0
107962,and,0,0
107963,placebo,0,0
107964,groups,0,0
107965,were,0,0
107966,local,1,0
107967,tenderness,1,1
107968,(,0,0
107969,21,0,0
107970,%,0,0
107971,),0,0
107972,",",0,0
107973,subcutaneous,1,0
107974,hemorrhage,1,1
107975,(,0,0
107976,10.5,0,0
107977,%,0,0
107978,),0,0
107979,",",0,0
107980,and,0,1
107981,conjunctivitis,1,1
107982,(,0,0
107983,10.5,0,0
107984,%,0,0
107985,),0,0
107986,.,0,0
107987,No,0,0
107988,severe,1,1
107989,adverse,1,1
107990,events,1,1
107991,were,0,0
107992,reported,0,0
107993,during,0,0
107994,the,0,0
107995,study,0,0
107996,or,0,0
107997,follow-up,0,0
107998,period,0,0
107999,.,0,0
108000,CONCLUSIONS,0,0
108001,BoNT-A,0,0
108002,is,0,0
108003,effective,0,1
108004,and,0,0
108005,well,0,0
108006,tolerated,0,1
108007,for,0,0
108008,the,0,0
108009,treatment,0,0
108010,of,0,0
108011,periorbital,0,1
108012,pain,0,1
108013,after,0,0
108014,an,0,0
108015,AACG,0,1
108016,attack,0,0
108017,.,0,0
108018,Its,0,0
108019,effects,0,0
108020,may,0,0
108021,be,0,0
108022,maintained,0,0
108023,for,0,0
108024,3,0,0
108025,months,0,0
108026,.,0,0
108027,Differential,0,0
108028,response,0,1
108029,to,0,0
108030,resistance,0,1
108031,training,0,0
108032,in,0,0
108033,CHF,0,0
108034,according,0,0
108035,to,0,0
108036,ACE,0,0
108037,genotype,0,0
108038,.,0,0
108039,BACKGROUND,0,0
108040,The,0,0
108041,Angiotensin,0,0
108042,Converting,0,0
108043,Enzyme,0,1
108044,(,0,0
108045,ACE,0,1
108046,),0,0
108047,gene,0,0
108048,may,0,0
108049,influence,0,0
108050,the,0,0
108051,risk,0,0
108052,of,0,0
108053,heart,0,1
108054,disease,0,1
108055,and,0,0
108056,the,0,0
108057,response,0,1
108058,to,0,0
108059,various,0,0
108060,forms,0,0
108061,of,0,0
108062,exercise,0,0
108063,training,0,0
108064,may,0,0
108065,be,0,0
108066,at,0,0
108067,least,0,0
108068,partly,0,0
108069,dependent,0,0
108070,on,0,0
108071,the,0,0
108072,ACE,0,0
108073,genotype,0,0
108074,.,0,0
108075,We,0,0
108076,aimed,0,0
108077,to,0,0
108078,determine,0,0
108079,the,0,0
108080,effect,0,0
108081,of,0,0
108082,ACE,0,1
108083,genotype,0,0
108084,on,0,0
108085,the,0,0
108086,response,0,0
108087,to,0,0
108088,moderate,0,0
108089,intensity,0,1
108090,circuit,0,1
108091,resistance,0,1
108092,training,0,0
108093,in,0,0
108094,chronic,0,0
108095,heart,0,1
108096,failure,0,1
108097,(,0,0
108098,CHF,0,0
108099,),0,0
108100,patients,0,0
108101,.,0,0
108102,METHODS,0,0
108103,The,0,0
108104,relationship,0,0
108105,between,0,0
108106,ACE,0,1
108107,genotype,0,0
108108,and,0,0
108109,the,0,0
108110,response,0,1
108111,to,0,0
108112,11weeks,0,0
108113,of,0,0
108114,resistance,0,0
108115,exercise,0,0
108116,training,0,0
108117,was,0,0
108118,determined,0,0
108119,in,0,0
108120,37,0,0
108121,CHF,0,0
108122,patients,0,0
108123,(,0,0
108124,New,0,1
108125,York,0,0
108126,Heart,0,0
108127,Association,0,0
108128,Functional,0,0
108129,Class=2.3?0.5,0,0
108130,;,0,0
108131,left,0,0
108132,ventricular,0,1
108133,ejection,0,0
108134,fraction,0,0
108135,28?7,0,0
108136,%,0,0
108137,;,0,0
108138,age,0,0
108139,64?12years,0,0
108140,;,0,0
108141,32:5,0,0
108142,male,0,0
108143,:,0,0
108144,female,0,0
108145,),0,0
108146,who,0,0
108147,were,0,0
108148,randomised,0,0
108149,to,0,0
108150,either,0,0
108151,resistance,0,1
108152,exercise,0,0
108153,(,0,0
108154,n=19,0,0
108155,),0,0
108156,or,0,0
108157,inactive,0,0
108158,control,0,0
108159,group,0,0
108160,(,0,0
108161,n=18,0,0
108162,),0,0
108163,.,0,0
108164,Outcome,0,1
108165,measures,0,1
108166,included,1,0
108167,V?O,1,0
108168,(,1,0
108169,2peak,1,0
108170,),1,0
108171,",",1,0
108172,peak,1,1
108173,power,1,1
108174,output,1,1
108175,and,1,1
108176,muscle,1,1
108177,strength,1,1
108178,and,1,0
108179,endurance,1,1
108180,.,1,1
108181,ACE,1,1
108182,genotype,0,0
108183,was,0,0
108184,determined,0,0
108185,using,0,0
108186,standard,0,0
108187,methods,0,0
108188,.,0,0
108189,RESULTS,0,0
108190,At,0,0
108191,baseline,0,0
108192,",",0,0
108193,patients,0,0
108194,who,0,0
108195,were,0,0
108196,homozygous,0,0
108197,for,0,0
108198,the,0,0
108199,I,0,0
108200,allele,0,0
108201,had,0,0
108202,higher,1,0
108203,V?O,1,0
108204,(,1,0
108205,2peak,1,1
108206,),1,0
108207,(,1,0
108208,p=0.02,1,0
108209,),1,1
108210,and,1,0
108211,peak,1,1
108212,power,1,1
108213,(,1,0
108214,p=0.003,1,0
108215,),0,0
108216,compared,0,0
108217,to,0,0
108218,patients,0,0
108219,who,0,0
108220,were,0,0
108221,homozygous,0,0
108222,for,0,0
108223,the,0,0
108224,D,0,0
108225,allele,0,0
108226,.,0,0
108227,Patients,0,0
108228,with,0,0
108229,the,0,0
108230,D,0,1
108231,allele,0,0
108232,",",0,0
108233,who,0,0
108234,were,0,0
108235,randomised,0,0
108236,to,0,0
108237,resistance,0,1
108238,training,0,0
108239,",",0,0
108240,compared,0,0
108241,to,0,0
108242,non-exercising,0,0
108243,controls,0,0
108244,",",0,0
108245,had,0,0
108246,greater,0,0
108247,peak,0,1
108248,power,0,1
108249,increases,0,1
108250,(,0,0
108251,ID,0,0
108252,p,0,0
108253,<,0,0
108254,0.001,0,0
108255,;,0,0
108256,DD,0,0
108257,p,0,0
108258,<,0,0
108259,0.001,0,0
108260,),0,0
108261,when,0,0
108262,compared,0,0
108263,with,0,0
108264,patients,0,0
108265,homozygous,0,0
108266,for,0,0
108267,the,0,0
108268,I,0,0
108269,allele,0,0
108270,",",0,0
108271,who,0,0
108272,did,0,0
108273,not,0,0
108274,improve,0,0
108275,.,0,0
108276,No,0,0
108277,significant,0,0
108278,genotype-dependent,0,0
108279,changes,0,1
108280,were,0,0
108281,observed,1,0
108282,in,1,0
108283,V?O,1,0
108284,(,1,0
108285,2peak,1,0
108286,),1,0
108287,",",1,0
108288,muscle,1,1
108289,strength,1,1
108290,",",1,1
108291,muscle,1,1
108292,endurance,1,1
108293,or,1,1
108294,lactate,1,1
108295,threshold,1,1
108296,.,1,0
108297,CONCLUSION,1,0
108298,ACE,0,0
108299,genotype,0,0
108300,may,0,0
108301,have,0,0
108302,a,0,0
108303,role,0,0
108304,in,0,0
108305,exercise,0,0
108306,tolerance,0,1
108307,in,0,0
108308,CHF,0,0
108309,and,0,0
108310,could,0,0
108311,also,0,0
108312,influence,0,0
108313,the,0,0
108314,effectiveness,0,1
108315,of,0,0
108316,resistance,0,1
108317,training,0,0
108318,in,0,0
108319,this,0,0
108320,condition,0,0
108321,.,0,0
108322,The,0,0
108323,development,0,0
108324,of,0,0
108325,a,0,0
108326,web-,0,0
108327,and,0,0
108328,a,0,0
108329,print-based,0,0
108330,decision,0,0
108331,aid,0,0
108332,for,0,0
108333,prostate,1,0
108334,cancer,1,0
108335,screening,1,0
108336,.,1,0
108337,BACKGROUND,0,0
108338,Whether,0,0
108339,early,0,0
108340,detection,0,1
108341,and,0,1
108342,treatment,0,0
108343,of,0,1
108344,prostate,0,0
108345,cancer,0,0
108346,(,0,0
108347,PCa,0,0
108348,),0,0
108349,will,0,0
108350,reduce,0,0
108351,disease-related,1,1
108352,mortality,1,1
108353,remains,0,0
108354,uncertain,0,0
108355,.,0,0
108356,As,0,0
108357,a,0,0
108358,result,0,0
108359,",",0,0
108360,tools,0,1
108361,are,0,0
108362,needed,0,0
108363,to,0,0
108364,facilitate,0,0
108365,informed,0,0
108366,decision,1,0
108367,making,1,0
108368,.,1,0
108369,While,0,0
108370,there,0,0
108371,have,0,0
108372,been,0,0
108373,several,0,0
108374,decision,0,0
108375,aids,0,0
108376,(,0,0
108377,DAs,0,0
108378,),0,1
108379,developed,0,0
108380,and,0,0
108381,tested,0,0
108382,",",0,0
108383,very,0,0
108384,few,0,0
108385,have,0,0
108386,included,0,0
108387,an,0,0
108388,exercise,0,0
108389,to,0,0
108390,help,0,0
108391,men,0,0
108392,clarify,0,0
108393,their,0,0
108394,values,1,1
108395,and,1,0
108396,preferences,1,0
108397,about,0,0
108398,PCa,0,0
108399,screening,0,0
108400,.,0,0
108401,Further,0,1
108402,",",0,0
108403,only,0,0
108404,one,0,0
108405,DA,0,0
108406,has,0,0
108407,utilized,0,0
108408,an,0,0
108409,interactive,0,0
108410,web-based,0,0
108411,format,0,0
108412,",",0,0
108413,which,0,0
108414,allows,0,0
108415,for,0,0
108416,an,0,0
108417,expansion,0,0
108418,and,0,0
108419,customization,0,0
108420,of,0,0
108421,the,0,0
108422,material,0,0
108423,.,0,0
108424,We,0,0
108425,describe,0,0
108426,the,0,0
108427,development,0,0
108428,of,0,0
108429,two,0,0
108430,DAs,0,0
108431,",",0,0
108432,a,0,0
108433,booklet,0,0
108434,and,0,0
108435,an,0,0
108436,interactive,0,0
108437,website,0,0
108438,",",0,0
108439,each,0,0
108440,with,0,0
108441,a,0,0
108442,values,0,1
108443,clarification,0,0
108444,component,0,1
108445,and,0,0
108446,designed,0,0
108447,for,0,0
108448,use,0,0
108449,in,0,0
108450,diverse,0,0
108451,settings,0,0
108452,.,0,0
108453,METHODS,0,0
108454,We,0,0
108455,conducted,0,0
108456,two,0,0
108457,feasibility,0,0
108458,studies,0,0
108459,to,0,0
108460,assess,0,0
108461,men,0,0
108462,'s,0,0
108463,(,0,0
108464,45-70,0,0
108465,years,0,0
108466,),0,0
108467,Internet,0,0
108468,access,0,0
108469,and,0,0
108470,their,0,0
108471,willingness,0,0
108472,to,0,0
108473,use,0,0
108474,a,0,0
108475,web-,0,0
108476,vs.,0,0
108477,a,0,0
108478,print-based,0,0
108479,tool,0,0
108480,.,0,0
108481,The,0,0
108482,booklet,0,0
108483,was,0,0
108484,adapted,0,0
108485,from,0,0
108486,two,0,0
108487,previous,0,0
108488,versions,0,0
108489,evaluated,0,0
108490,in,0,0
108491,randomized,0,0
108492,controlled,0,0
108493,trials,0,0
108494,(,0,0
108495,RCTs,0,0
108496,),0,0
108497,and,0,0
108498,the,0,0
108499,website,0,0
108500,was,0,0
108501,created,0,0
108502,to,0,0
108503,closely,0,0
108504,match,0,0
108505,the,0,0
108506,content,0,0
108507,of,0,0
108508,the,0,0
108509,revised,0,0
108510,booklet,0,0
108511,.,0,0
108512,Usability,1,1
108513,testing,1,0
108514,was,0,0
108515,conducted,0,0
108516,to,0,0
108517,obtain,0,0
108518,feedback,0,0
108519,regarding,0,0
108520,draft,0,1
108521,versions,0,0
108522,of,0,0
108523,the,0,0
108524,materials,0,0
108525,.,0,0
108526,The,0,0
108527,tools,0,1
108528,were,0,0
108529,also,0,0
108530,reviewed,0,0
108531,by,0,0
108532,a,0,0
108533,plain,0,0
108534,language,0,1
108535,expert,0,0
108536,and,0,0
108537,the,0,0
108538,interdisciplinary,0,0
108539,research,0,0
108540,team,0,0
108541,.,0,0
108542,Feedback,0,0
108543,on,0,0
108544,the,0,0
108545,content,0,1
108546,and,0,1
108547,presentation,0,1
108548,led,0,0
108549,to,0,0
108550,iterative,0,0
108551,modifications,0,0
108552,of,0,0
108553,the,0,0
108554,tools,0,0
108555,.,0,0
108556,RESULTS,0,0
108557,The,0,0
108558,feasibility,0,0
108559,studies,0,0
108560,confirmed,0,0
108561,that,0,0
108562,the,0,0
108563,Internet,1,0
108564,was,0,0
108565,a,0,0
108566,viable,0,0
108567,medium,0,0
108568,",",0,0
108569,as,0,0
108570,the,0,0
108571,majority,0,0
108572,of,0,0
108573,men,0,0
108574,used,1,0
108575,a,1,0
108576,computer,1,0
108577,",",0,0
108578,had,0,0
108579,access,1,0
108580,to,1,0
108581,the,1,0
108582,Internet,1,0
108583,",",0,0
108584,and,0,1
108585,Internet,1,0
108586,use,1,1
108587,increased,0,0
108588,over,0,0
108589,time,0,1
108590,.,0,0
108591,Feedback,0,0
108592,from,0,0
108593,the,0,0
108594,usability,0,0
108595,testing,0,0
108596,on,0,0
108597,the,0,0
108598,length,1,1
108599,",",1,0
108600,presentation,1,1
108601,",",1,1
108602,and,1,1
108603,content,1,1
108604,of,1,0
108605,the,1,0
108606,materials,1,0
108607,was,0,0
108608,incorporated,0,0
108609,into,0,0
108610,the,0,0
108611,final,0,0
108612,versions,0,0
108613,of,0,0
108614,the,0,0
108615,booklet,0,0
108616,and,0,0
108617,website,0,0
108618,.,0,0
108619,Both,0,0
108620,the,0,0
108621,feasibility,1,0
108622,studies,1,0
108623,and,1,0
108624,the,1,0
108625,usability,1,0
108626,testing,1,0
108627,highlighted,0,0
108628,the,0,0
108629,need,0,0
108630,to,0,0
108631,address,0,0
108632,men,0,0
108633,'s,0,0
108634,informed,0,0
108635,decision,0,0
108636,making,0,0
108637,regarding,0,0
108638,screening,0,0
108639,.,0,0
108640,CONCLUSIONS,0,0
108641,Informed,0,0
108642,decision,0,1
108643,making,0,0
108644,for,0,0
108645,PCa,0,0
108646,screening,0,0
108647,is,0,0
108648,crucial,0,0
108649,at,0,0
108650,present,0,0
108651,and,0,0
108652,may,0,0
108653,be,0,0
108654,important,0,0
108655,for,0,0
108656,some,0,0
108657,time,0,1
108658,",",0,0
108659,particularly,0,0
108660,if,0,0
108661,a,0,0
108662,definitive,0,0
108663,recommendation,0,0
108664,either,0,0
108665,for,0,0
108666,or,0,0
108667,against,0,0
108668,screening,0,0
108669,does,0,0
108670,not,0,0
108671,emerge,0,0
108672,from,0,0
108673,ongoing,0,0
108674,prostate,0,0
108675,cancer,0,0
108676,screening,0,0
108677,trials,0,0
108678,.,0,0
108679,We,0,0
108680,have,0,0
108681,detailed,0,0
108682,our,0,0
108683,efforts,0,0
108684,at,0,0
108685,developing,0,0
108686,print-,0,0
108687,and,0,0
108688,web-based,0,0
108689,DAs,0,0
108690,to,0,0
108691,assist,0,0
108692,men,0,0
108693,in,0,0
108694,determining,0,0
108695,how,0,0
108696,to,0,0
108697,best,0,0
108698,meet,0,0
108699,their,0,0
108700,PCa,0,0
108701,screening,0,0
108702,preferences,0,0
108703,.,0,0
108704,Following,0,0
108705,completion,0,0
108706,of,0,0
108707,our,0,0
108708,ongoing,0,0
108709,RCT,0,0
108710,designed,0,0
108711,to,0,0
108712,test,0,0
108713,these,0,0
108714,materials,0,0
108715,",",0,0
108716,our,0,0
108717,goal,0,0
108718,will,0,0
108719,be,0,0
108720,to,0,0
108721,develop,0,0
108722,a,0,0
108723,dissemination,1,0
108724,project,1,0
108725,for,0,0
108726,the,0,0
108727,more,0,0
108728,effective,0,0
108729,tool,0,0
108730,.,0,0
108731,TRIAL,0,0
108732,REGISTRATION,0,0
108733,NCT00623090,0,0
108734,.,0,0
108735,Comparison,0,0
108736,of,0,0
108737,neodymium-doped,0,0
108738,yttrium,0,0
108739,aluminum,0,0
108740,garnet,0,0
108741,laser,0,0
108742,treatment,0,0
108743,with,0,0
108744,cold,0,1
108745,knife,0,0
108746,endoscopic,0,1
108747,incision,0,0
108748,of,0,0
108749,urethral,0,1
108750,strictures,0,1
108751,in,0,0
108752,male,0,0
108753,patients,0,0
108754,.,0,0
108755,OBJECTIVE,0,0
108756,To,0,0
108757,assess,0,0
108758,the,0,0
108759,effectiveness,1,0
108760,of,0,0
108761,visual,0,1
108762,laser,0,0
108763,ablation,0,0
108764,treatment,0,0
108765,with,0,0
108766,neodymium-doped,0,0
108767,yttrium,0,0
108768,aluminum,0,0
108769,garnet,0,0
108770,(,0,0
108771,Nd,0,0
108772,:,0,0
108773,YAG,0,0
108774,),0,0
108775,laser,0,0
108776,in,0,0
108777,male,0,0
108778,patients,0,0
108779,with,0,0
108780,urethral,0,1
108781,strictures,0,1
108782,and,0,0
108783,to,0,0
108784,compare,0,0
108785,the,0,0
108786,effects,0,0
108787,with,0,0
108788,those,0,0
108789,obtained,0,0
108790,in,0,0
108791,patients,0,0
108792,treated,0,0
108793,with,0,0
108794,Sachse,0,1
108795,'s,0,0
108796,optical,0,0
108797,urethrotomy,0,0
108798,.,0,0
108799,MATERIALS,0,0
108800,AND,0,0
108801,METHODS,0,0
108802,Fifty,0,0
108803,patients,0,0
108804,aged,0,0
108805,22,0,0
108806,to,0,0
108807,83,0,0
108808,(,0,0
108809,mean,0,0
108810,age,0,0
108811,61.8,0,0
108812,),0,0
108813,with,0,0
108814,primary,0,0
108815,(,0,0
108816,n,0,0
108817,=,0,0
108818,26,0,0
108819,",",0,0
108820,52,0,0
108821,%,0,0
108822,),0,0
108823,and,0,1
108824,recurrent,0,1
108825,(,0,0
108826,n,0,0
108827,=,0,0
108828,24,0,0
108829,",",0,0
108830,48,0,0
108831,%,0,0
108832,),0,0
108833,urethral,0,0
108834,strictures,0,0
108835,0.3,0,0
108836,to,0,0
108837,2.4,0,0
108838,cm,0,0
108839,long,0,0
108840,qualified,0,0
108841,for,0,0
108842,the,0,0
108843,study,0,0
108844,.,0,0
108845,The,0,0
108846,patients,0,0
108847,were,0,0
108848,randomized,0,0
108849,into,0,0
108850,two,0,0
108851,groups,0,0
108852,:,0,0
108853,30,0,0
108854,men,0,0
108855,treated,0,0
108856,using,0,0
108857,visual,0,1
108858,laser,0,0
108859,ablation,0,0
108860,of,0,0
108861,urethral,0,1
108862,strictures,0,1
108863,(,0,0
108864,VLASU,0,0
108865,),0,0
108866,with,0,0
108867,Nd,0,0
108868,:,0,0
108869,YAGlaser,0,0
108870,and,0,0
108871,20,0,0
108872,men,0,0
108873,treated,0,0
108874,by,0,0
108875,correction,0,0
108876,of,0,0
108877,urethral,0,1
108878,strictures,0,1
108879,using,0,0
108880,Sachse,0,1
108881,'s,0,0
108882,optical,0,0
108883,urethrotomy,0,0
108884,.,0,0
108885,RESULTS,0,0
108886,At,0,0
108887,12-month,0,0
108888,follow-up,0,0
108889,",",0,0
108890,seven,0,0
108891,(,0,0
108892,35,0,0
108893,%,0,0
108894,),0,0
108895,patients,0,0
108896,who,0,0
108897,underwent,0,0
108898,optical,0,0
108899,urethrotomy,0,0
108900,and,0,0
108901,21,0,0
108902,(,0,0
108903,70,0,0
108904,%,0,0
108905,),0,0
108906,in,0,0
108907,the,0,0
108908,VLASU,0,0
108909,group,0,0
108910,did,0,0
108911,not,0,0
108912,require,0,0
108913,repetition,1,0
108914,of,1,0
108915,the,1,0
108916,procedure,1,0
108917,.,1,0
108918,The,0,0
108919,choice,0,0
108920,of,0,0
108921,VLASU,0,0
108922,as,0,0
108923,a,0,0
108924,method,0,0
108925,of,0,0
108926,treatment,0,0
108927,significantly,0,0
108928,decreased,1,0
108929,the,1,0
108930,probability,1,0
108931,of,1,0
108932,therapeutic,1,0
108933,failure,1,1
108934,and,1,1
108935,recurrence,1,1
108936,of,1,1
108937,urethral,1,1
108938,strictures,1,1
108939,(,0,0
108940,p,0,0
108941,=,0,0
108942,0.02,0,0
108943,),0,0
108944,.,0,0
108945,CONCLUSION,0,0
108946,VLASU,0,0
108947,can,0,0
108948,be,0,0
108949,used,0,0
108950,as,0,0
108951,a,0,0
108952,method,0,0
108953,of,0,0
108954,treatment,0,0
108955,of,0,0
108956,this,0,0
108957,disorder,0,0
108958,.,0,0
108959,It,0,0
108960,is,0,0
108961,an,0,0
108962,effective,0,0
108963,",",0,0
108964,modern,0,0
108965,",",0,0
108966,low-invasive,0,0
108967,",",0,0
108968,and,0,1
108969,repeatable,0,1
108970,technique,0,0
108971,and,0,0
108972,is,0,0
108973,technically,0,0
108974,simple,0,0
108975,and,0,0
108976,easy,0,0
108977,to,0,0
108978,master,0,0
108979,.,0,0
108980,It,0,0
108981,can,0,0
108982,be,0,0
108983,used,0,0
108984,in,0,0
108985,cases,0,0
108986,in,0,0
108987,which,0,0
108988,introduction,0,0
108989,of,0,0
108990,a,0,0
108991,22,0,0
108992,Char,0,0
108993,optical,0,0
108994,urethrotome,0,0
108995,into,0,0
108996,the,0,0
108997,stricture,0,0
108998,site,0,0
108999,is,0,0
109000,impossible,0,0
109001,",",0,0
109002,as,0,0
109003,well,0,0
109004,as,0,0
109005,for,0,0
109006,treatment,0,0
109007,of,0,0
109008,multiple,0,0
109009,strictures,0,0
109010,during,0,0
109011,one,0,0
109012,procedure,0,0
109013,.,0,0
109014,Effect,0,0
109015,of,0,0
109016,topical,0,0
109017,anesthesia,0,0
109018,and,0,1
109019,age,0,0
109020,on,0,0
109021,pain,1,1
109022,scores,1,1
109023,during,0,0
109024,retinopathy,0,1
109025,of,0,0
109026,prematurity,0,1
109027,screening,0,0
109028,.,0,0
109029,OBJECTIVE,0,0
109030,The,0,0
109031,efficacy,1,1
109032,of,0,0
109033,topical,0,0
109034,anesthesia,0,0
109035,during,0,0
109036,retinopathy,0,1
109037,of,0,0
109038,prematurity,0,1
109039,(,0,0
109040,ROP,0,1
109041,),0,0
109042,screening,0,0
109043,has,0,0
109044,been,0,0
109045,a,0,0
109046,controversial,0,0
109047,issue,0,0
109048,.,0,0
109049,To,0,0
109050,determine,0,0
109051,the,0,0
109052,efficacy,1,1
109053,of,0,0
109054,proparacaine,0,0
109055,eye,0,1
109056,drops,0,0
109057,(,0,0
109058,0.5,0,0
109059,%,0,0
109060,),0,0
109061,",",0,0
109062,we,0,0
109063,compared,0,0
109064,the,0,0
109065,Premature,1,0
109066,Infant,1,1
109067,Pain,1,1
109068,Profile,1,1
109069,(,1,0
109070,PIPP,1,0
109071,),1,0
109072,scores,0,1
109073,in,0,0
109074,40,0,0
109075,preterm,0,0
109076,infants,0,0
109077,undergoing,0,0
109078,ROP,0,0
109079,screening,0,0
109080,.,0,0
109081,STUDY,0,1
109082,DESIGN,0,0
109083,Prospective,0,0
109084,randomized,0,0
109085,double,0,0
109086,masked,0,0
109087,cross-over,0,0
109088,clinical,0,0
109089,trial,0,0
109090,.,0,0
109091,The,0,0
109092,study,0,0
109093,was,0,0
109094,conducted,0,0
109095,in,0,0
109096,the,0,0
109097,neonatal,0,1
109098,intensive,0,0
109099,units,0,0
109100,for,0,0
109101,infants,0,0
109102,undergoing,0,0
109103,routine,0,0
109104,ROP,0,0
109105,screening,0,0
109106,exams,0,0
109107,.,0,0
109108,Baseline,1,0
109109,PIPP,1,0
109110,scores,1,1
109111,and,0,1
109112,post-examination,1,0
109113,PIPP,1,0
109114,scores,1,1
109115,at,0,0
109116,1,0,0
109117,and,0,0
109118,5,0,0
109119,min,0,0
109120,were,0,0
109121,compared,0,0
109122,for,0,0
109123,:,0,0
109124,(,0,0
109125,1,0,0
109126,),0,0
109127,those,0,0
109128,receiving,0,0
109129,saline,0,0
109130,vs,0,0
109131,proparacaine,0,0
109132,eye,0,1
109133,drops,0,0
109134,(,0,0
109135,2,0,0
109136,),0,0
109137,first,0,0
109138,ROP,0,0
109139,screening,0,0
109140,vs,0,0
109141,second,0,0
109142,ROP,0,1
109143,screening,0,0
109144,",",0,0
109145,regardless,0,0
109146,of,0,0
109147,the,0,0
109148,type,0,0
109149,of,0,0
109150,eye,0,0
109151,drops,0,0
109152,used,0,0
109153,.,0,0
109154,Wilcoxon,0,0
109155,signed-ranks,0,0
109156,test,0,0
109157,was,0,0
109158,used,0,0
109159,to,0,0
109160,pair,1,0
109161,pain,1,1
109162,scores,1,1
109163,.,1,0
109164,RESULT,0,0
109165,Forty,0,0
109166,preterm,0,1
109167,infants,0,0
109168,were,0,0
109169,included,0,0
109170,in,0,0
109171,the,0,0
109172,study,1,0
109173,.,1,0
109174,Mean,1,0
109175,gestational,1,1
109176,age,1,0
109177,(,1,0
109178,GA,1,0
109179,),1,0
109180,at,1,0
109181,first,0,0
109182,and,0,0
109183,second,0,0
109184,examinations,0,0
109185,was,0,0
109186,33.3,0,0
109187,and,0,0
109188,35.3,0,0
109189,weeks,0,0
109190,",",0,0
109191,respectively,0,0
109192,.,0,0
109193,Proparacaine,0,0
109194,use,0,0
109195,significantly,0,0
109196,lowered,1,0
109197,mean,1,1
109198,PIPP,1,0
109199,scores,1,1
109200,(,1,0
109201,P=0.027,0,0
109202,),0,0
109203,and,1,0
109204,delta,1,1
109205,scores,1,1
109206,(,1,0
109207,P=0.013,0,0
109208,),0,0
109209,at,0,0
109210,1,0,0
109211,min,0,0
109212,after,0,0
109213,examination,0,0
109214,",",0,0
109215,but,0,0
109216,there,0,0
109217,was,0,0
109218,no,0,0
109219,difference,0,0
109220,at,0,0
109221,5,0,0
109222,min,0,0
109223,after,0,0
109224,examination,0,0
109225,.,0,0
109226,Second,0,0
109227,examinations,0,0
109228,showed,0,0
109229,significantly,0,0
109230,lower,0,0
109231,mean,1,1
109232,PIPP,1,0
109233,scores,1,1
109234,after,1,0
109235,examination,0,0
109236,(,0,0
109237,1,0,0
109238,min,0,0
109239,(,0,0
109240,P=0.003,0,0
109241,),0,0
109242,and,0,0
109243,5,0,0
109244,min,0,0
109245,(,0,0
109246,P=0.025,0,0
109247,),0,0
109248,),0,0
109249,",",0,0
109250,regardless,0,0
109251,of,0,0
109252,the,0,0
109253,type,0,0
109254,of,0,0
109255,drop,0,0
109256,used,0,0
109257,.,0,0
109258,CONCLUSION,0,0
109259,Proparacaine,0,0
109260,eye,0,0
109261,drops,0,0
109262,offer,0,0
109263,significant,1,0
109264,relief,1,1
109265,of,1,0
109266,pain,1,1
109267,that,1,0
109268,is,0,0
109269,apparently,0,0
109270,short,0,0
109271,lived,0,0
109272,.,0,0
109273,Significantly,1,0
109274,lower,1,0
109275,PIPP,1,0
109276,scores,1,1
109277,at,1,0
109278,second,0,0
109279,ROP,0,1
109280,examinations,0,0
109281,suggested,0,0
109282,that,0,0
109283,infants,0,0
109284,of,0,0
109285,older,0,0
109286,GA,0,0
109287,may,0,0
109288,have,0,0
109289,a,0,0
109290,greater,0,0
109291,ability,0,0
109292,to,0,0
109293,tolerate,0,0
109294,ROP,0,0
109295,screening,0,0
109296,.,0,0
109297,We,0,0
109298,recommend,0,0
109299,the,0,0
109300,use,0,0
109301,of,0,0
109302,proparacaine,0,0
109303,eye,0,0
109304,drops,0,0
109305,for,0,0
109306,the,0,0
109307,short,0,1
109308,term,0,1
109309,",",0,0
109310,immediate,0,1
109311,relief,0,1
109312,of,0,0
109313,pain,1,1
109314,during,1,0
109315,ROP,1,0
109316,screening,0,0
109317,in,0,0
109318,preterm,0,0
109319,infants,0,0
109320,of,0,0
109321,lesser,0,0
109322,GA,0,0
109323,.,0,0
109324,Improvement,0,1
109325,of,0,0
109326,pain,0,1
109327,related,0,0
109328,self,0,1
109329,management,0,0
109330,for,0,0
109331,oncologic,0,0
109332,patients,0,0
109333,through,0,0
109334,a,0,0
109335,trans,0,0
109336,institutional,0,0
109337,modular,0,1
109338,nursing,0,0
109339,intervention,0,0
109340,:,0,0
109341,protocol,0,0
109342,of,0,0
109343,a,0,0
109344,cluster,0,0
109345,randomized,0,0
109346,multicenter,0,0
109347,trial,0,0
109348,.,0,0
109349,BACKGROUND,0,0
109350,Pain,0,0
109351,is,0,0
109352,one,0,0
109353,of,0,0
109354,the,0,0
109355,most,0,0
109356,frequent,0,0
109357,and,0,0
109358,distressing,0,1
109359,symptoms,0,1
109360,in,0,0
109361,cancer,0,0
109362,patients,0,0
109363,.,0,0
109364,For,0,0
109365,the,0,0
109366,majority,0,0
109367,of,0,0
109368,the,0,0
109369,patients,0,0
109370,",",0,0
109371,sufficient,0,0
109372,pain,0,1
109373,relief,0,1
109374,can,0,0
109375,be,0,0
109376,obtained,0,0
109377,if,0,0
109378,adequate,0,0
109379,treatment,0,0
109380,is,0,0
109381,provided,0,0
109382,.,0,0
109383,However,0,0
109384,",",0,0
109385,pain,0,1
109386,remains,0,0
109387,often,0,0
109388,undertreated,0,0
109389,due,0,0
109390,to,0,0
109391,institutional,0,0
109392,",",0,0
109393,health,0,1
109394,care,0,1
109395,professional,0,1
109396,and,0,0
109397,patient,0,1
109398,related,0,0
109399,barriers,0,0
109400,.,0,0
109401,Patients,0,0
109402,self,0,1
109403,management,0,0
109404,skills,0,1
109405,are,0,0
109406,affected,0,0
109407,by,0,0
109408,the,0,0
109409,patients,0,0
109410,',0,0
109411,knowledge,0,1
109412,",",0,0
109413,activities,0,1
109414,and,0,1
109415,attitude,0,1
109416,to,0,0
109417,pain,0,1
109418,management,0,0
109419,.,0,0
109420,This,0,0
109421,trial,0,0
109422,protocol,0,0
109423,is,0,0
109424,aimed,0,0
109425,to,0,0
109426,test,0,0
109427,the,0,0
109428,SCION-PAIN,0,0
109429,program,0,0
109430,",",0,0
109431,a,0,0
109432,multi,0,0
109433,modular,0,1
109434,structured,0,0
109435,intervention,0,0
109436,to,0,0
109437,improve,0,0
109438,self,0,1
109439,management,0,0
109440,in,0,0
109441,cancer,0,0
109442,patients,0,0
109443,with,0,0
109444,pain,0,1
109445,.,0,0
109446,METHODS,0,0
109447,240,0,0
109448,patients,0,0
109449,with,0,0
109450,diagnosed,0,0
109451,malignancy,0,0
109452,and,0,0
109453,pain,0,1
109454,>,0,0
109455,3,0,0
109456,days,0,0
109457,and,0,0
109458,average,0,1
109459,pain,0,1
109460,>,0,0
109461,or=,0,0
109462,3/10,0,0
109463,will,0,0
109464,participate,0,0
109465,in,0,0
109466,a,0,0
109467,cluster,0,0
109468,randomized,0,0
109469,trial,0,0
109470,on,0,0
109471,18,0,0
109472,wards,0,0
109473,in,0,0
109474,2,0,0
109475,German,0,0
109476,university,0,0
109477,hospitals,0,0
109478,.,0,0
109479,Patients,0,0
109480,from,0,0
109481,the,0,0
109482,intervention,0,0
109483,wards,0,0
109484,will,0,0
109485,receive,0,0
109486,",",0,0
109487,additionally,0,0
109488,to,0,0
109489,standard,0,0
109490,pain,0,1
109491,treatment,0,0
109492,",",0,0
109493,the,0,0
109494,SCION-PAIN,0,0
109495,program,0,0
109496,consisting,0,0
109497,of,0,0
109498,3,0,0
109499,modules,0,0
109500,:,0,0
109501,pharmacologic,0,0
109502,pain,0,1
109503,management,0,0
109504,",",0,0
109505,nonpharmacologic,0,0
109506,pain,0,1
109507,management,0,0
109508,and,0,1
109509,discharge,0,1
109510,management,0,0
109511,.,0,0
109512,The,0,0
109513,intervention,0,0
109514,will,0,0
109515,be,0,0
109516,conducted,0,0
109517,by,0,0
109518,specially,0,0
109519,trained,0,0
109520,oncology,0,0
109521,nurses,0,0
109522,and,0,0
109523,includes,0,0
109524,components,0,0
109525,of,0,0
109526,patient,0,1
109527,education,0,0
109528,",",0,0
109529,skills,0,1
109530,training,0,0
109531,and,0,0
109532,counseling,0,0
109533,to,0,0
109534,improve,0,0
109535,self,0,0
109536,care,0,0
109537,regarding,0,0
109538,pain,0,1
109539,management,0,0
109540,beginning,0,0
109541,with,0,0
109542,admission,0,1
109543,followed,0,0
109544,by,0,0
109545,booster,0,0
109546,session,0,0
109547,every,0,0
109548,3rd,0,0
109549,day,0,0
109550,and,0,0
109551,one,0,0
109552,follow,0,0
109553,up,0,0
109554,telephone,0,0
109555,counseling,0,0
109556,within,0,0
109557,2,0,0
109558,to,0,0
109559,3,0,0
109560,days,0,0
109561,after,0,0
109562,discharge,0,0
109563,.,0,0
109564,Patients,0,0
109565,in,0,0
109566,the,0,0
109567,control,0,0
109568,group,0,0
109569,will,0,0
109570,receive,0,0
109571,standard,0,0
109572,care,0,0
109573,.,0,0
109574,Primary,0,0
109575,endpoint,0,0
109576,is,0,0
109577,the,0,0
109578,group,1,0
109579,difference,1,0
109580,in,1,0
109581,patient,1,1
109582,related,1,0
109583,barriers,1,0
109584,to,1,0
109585,management,1,0
109586,of,1,0
109587,cancer,1,0
109588,pain,1,1
109589,(,0,0
109590,BQII,0,0
109591,),0,0
109592,",",0,0
109593,7,0,0
109594,days,0,0
109595,after,0,0
109596,discharge,0,0
109597,.,0,0
109598,Secondary,0,0
109599,endpoints,0,0
109600,are,0,0
109601,:,0,0
109602,pain,1,1
109603,intensity,1,1
109604,&,1,0
109605,interference,1,1
109606,",",1,1
109607,adherence,1,1
109608,",",1,1
109609,coping,1,1
109610,and,1,0
109611,HRQoL,1,1
109612,.,1,0
109613,DISCUSSION,0,0
109614,The,0,0
109615,study,0,0
109616,will,0,0
109617,determine,0,0
109618,if,0,0
109619,the,0,0
109620,acquired,0,0
109621,self,0,1
109622,management,0,0
109623,skills,0,1
109624,of,0,0
109625,the,0,0
109626,patients,0,0
109627,continue,0,0
109628,to,0,0
109629,be,0,0
109630,used,0,0
109631,after,0,0
109632,discharge,0,0
109633,from,0,0
109634,hospital,0,0
109635,.,0,0
109636,It,0,0
109637,is,0,0
109638,hypothesized,0,0
109639,that,0,0
109640,patients,0,0
109641,who,0,0
109642,receive,0,0
109643,the,0,0
109644,multi,0,0
109645,modular,0,1
109646,structured,0,0
109647,intervention,0,0
109648,will,0,0
109649,have,0,0
109650,less,0,0
109651,patient,0,1
109652,related,0,0
109653,barriers,0,0
109654,and,0,0
109655,a,0,0
109656,better,0,0
109657,self,0,1
109658,management,0,0
109659,of,0,0
109660,cancer,1,0
109661,pain,1,1
109662,.,1,0
109663,TRIAL,0,0
109664,REGISTRATION,0,0
109665,ClinicalTrials,0,1
109666,NCT00779597,0,0
109667,.,0,0
109668,[,0,0
109669,Observation,0,0
109670,of,0,0
109671,curative,0,0
109672,effect,0,0
109673,on,0,0
109674,fixed-point,0,0
109675,spin,0,0
109676,reduction,0,1
109677,of,0,0
109678,spinal,0,0
109679,manipulation,0,0
109680,therapy,0,0
109681,for,0,0
109682,cervical,0,0
109683,vertigo,0,1
109684,],0,0
109685,.,0,0
109686,OBJECTIVE,0,0
109687,To,0,0
109688,explore,0,0
109689,the,0,0
109690,role,0,0
109691,of,0,0
109692,fixed-point,0,0
109693,spin,0,0
109694,reduction,0,1
109695,of,0,0
109696,spinal,0,0
109697,manipulation,0,0
109698,therapy,0,0
109699,in,0,0
109700,the,0,0
109701,treatment,0,0
109702,of,0,0
109703,cervical,0,0
109704,vertigo,0,1
109705,and,0,0
109706,its,0,0
109707,effect,0,0
109708,on,0,0
109709,cervical,0,0
109710,artery,0,1
109711,spasm,0,1
109712,index,0,1
109713,(,0,0
109714,RI,0,0
109715,),0,0
109716,and,0,0
109717,atlantoaxial,0,1
109718,displacement,0,1
109719,index,0,1
109720,(,0,0
109721,ADI,0,0
109722,),0,0
109723,.,0,0
109724,METHODS,0,0
109725,From,0,0
109726,January,0,0
109727,2002,0,0
109728,to,0,0
109729,May,0,0
109730,2008,0,0
109731,",",0,0
109732,168,0,0
109733,patients,0,0
109734,with,0,0
109735,cervical,0,0
109736,vertigo,0,1
109737,were,0,0
109738,randomly,0,0
109739,divided,0,0
109740,into,0,0
109741,treatment,0,0
109742,group,0,0
109743,(,0,0
109744,84,0,0
109745,cases,0,0
109746,),0,0
109747,and,0,0
109748,the,0,0
109749,control,0,0
109750,group,0,0
109751,(,0,0
109752,84,0,0
109753,cases,0,0
109754,),0,0
109755,",",0,0
109756,22,0,0
109757,males,0,0
109758,and,0,0
109759,62,0,0
109760,females,0,0
109761,in,0,0
109762,treatment,0,0
109763,group,0,0
109764,;,0,0
109765,24,0,0
109766,males,0,0
109767,and,0,0
109768,60,0,0
109769,females,0,0
109770,in,0,0
109771,control,0,0
109772,group,0,0
109773,.,0,0
109774,The,0,0
109775,patients,0,0
109776,of,0,0
109777,treatment,0,0
109778,group,0,0
109779,and,0,1
109780,control,0,0
109781,group,0,0
109782,were,0,0
109783,respectively,0,0
109784,treated,0,0
109785,with,0,0
109786,fixed-point,0,0
109787,spin,0,0
109788,reduction,0,1
109789,of,0,0
109790,spinal,0,0
109791,manipulation,0,0
109792,therapy,0,0
109793,and,0,1
109794,dialectical,0,0
109795,prescription,0,0
109796,.,0,0
109797,The,0,0
109798,score,0,1
109799,of,0,0
109800,symptoms,0,1
109801,and,0,1
109802,signs,0,1
109803,",",0,1
109804,RI,0,0
109805,",",0,1
109806,ADI,0,1
109807,were,0,0
109808,observed,0,0
109809,and,0,0
109810,compared,0,0
109811,between,0,0
109812,two,0,0
109813,groups,0,0
109814,.,0,0
109815,RESULTS,0,0
109816,The,0,0
109817,score,1,1
109818,of,1,0
109819,symptoms,1,1
109820,and,1,0
109821,signs,1,1
109822,markedly,0,0
109823,decreased,0,0
109824,after,0,0
109825,treatment,0,0
109826,",",0,0
109827,in,0,0
109828,treatment,0,0
109829,group,0,0
109830,:,0,0
109831,vertigo,1,1
109832,had,0,0
109833,(,0,0
109834,2.75,0,0
109835,+/-,0,0
109836,1.01,0,0
109837,),0,0
109838,scores,0,1
109839,",",0,0
109840,neck-shoulder,1,1
109841,pain,1,1
109842,(,0,0
109843,1.58,0,0
109844,+/-,0,0
109845,0.36,0,0
109846,),0,0
109847,",",0,0
109848,headache,1,1
109849,(,0,0
109850,0.39,0,0
109851,+/-,0,0
109852,0.09,0,0
109853,),0,0
109854,",",0,0
109855,nausea-vomiting,1,1
109856,(,0,0
109857,1.58,0,0
109858,+/-,0,0
109859,1.30,0,0
109860,),0,0
109861,",",0,0
109862,ear,1,1
109863,noises,1,1
109864,(,0,0
109865,0.48,0,0
109866,+/-,0,0
109867,0.32,0,0
109868,),0,0
109869,",",0,0
109870,positive,1,1
109871,neck,1,1
109872,rotation,1,1
109873,test,1,1
109874,(,0,0
109875,0.59,0,0
109876,+/-,0,0
109877,0.21,0,0
109878,),0,0
109879,;,0,0
109880,and,0,0
109881,in,0,0
109882,control,0,0
109883,group,0,0
109884,:,0,0
109885,vertigo,1,1
109886,had,0,0
109887,(,0,0
109888,5.68,0,0
109889,+/-,0,0
109890,2.02,0,0
109891,),0,0
109892,scores,0,1
109893,",",0,0
109894,neck-shoulder,1,1
109895,pain,1,1
109896,(,0,0
109897,3.12,0,0
109898,+/-,0,0
109899,1.82,0,0
109900,),0,0
109901,",",0,0
109902,headache,1,1
109903,(,0,0
109904,1.86,0,0
109905,+/-,0,0
109906,0.65,0,0
109907,),0,0
109908,",",0,0
109909,nausea-vomiting,1,1
109910,(,0,0
109911,3.25,0,0
109912,+/-,0,0
109913,0.69,0,0
109914,),0,0
109915,",",0,0
109916,ear,1,1
109917,noises,1,1
109918,(,0,0
109919,1.64,0,0
109920,+/-,0,0
109921,0.61,0,0
109922,),0,0
109923,",",0,0
109924,positive,1,1
109925,neck,1,1
109926,rotation,1,1
109927,test,1,1
109928,(,0,0
109929,1.79,0,0
109930,+/-,0,0
109931,0.67,0,0
109932,),0,0
109933,.,0,0
109934,Cervical,1,0
109935,artery,1,1
109936,spasm,1,1
109937,index,1,1
109938,and,1,1
109939,atlantoaxial,1,1
109940,displacement,1,1
109941,index,1,1
109942,had,0,0
109943,been,0,0
109944,significantly,0,0
109945,improved,0,0
109946,",",0,0
109947,cervical,1,0
109948,artery,1,1
109949,spasm,1,1
109950,index,1,1
109951,was,0,0
109952,respectively,0,0
109953,0.54,0,0
109954,+/-,0,0
109955,0.07,0,0
109956,and,0,0
109957,0.52,0,0
109958,+/-,0,0
109959,0.13,0,0
109960,",",0,0
109961,atlantoaxial,1,0
109962,displacement,1,1
109963,index,1,1
109964,was,0,0
109965,respectively,0,0
109966,2.92,0,0
109967,+/-,0,0
109968,0.82,0,0
109969,and,0,0
109970,4.50,0,0
109971,+/-,0,0
109972,1.32,0,0
109973,between,0,0
109974,treatment,0,0
109975,group,0,0
109976,and,0,1
109977,control,0,0
109978,group,0,0
109979,.,0,0
109980,CONCLUSION,0,0
109981,Fixed-point,0,1
109982,spin,0,0
109983,reduction,0,1
109984,of,0,0
109985,spinal,0,0
109986,manipulation,0,0
109987,therapy,0,0
109988,for,0,0
109989,cervical,0,0
109990,vertigo,0,0
109991,can,0,0
109992,accurately,0,0
109993,correct,0,0
109994,single,0,0
109995,or,0,0
109996,multiple,0,1
109997,vertebral,0,1
109998,body,0,1
109999,displacement,0,1
110000,",",0,0
110001,restore,0,0
110002,normal,0,0
110003,spinal,0,0
110004,position,0,0
110005,",",0,0
110006,reduce,0,0
110007,the,0,0
110008,oppression,0,0
110009,and,0,0
110010,stimulus,0,1
110011,of,0,0
110012,the,0,0
110013,vertebral,0,0
110014,artery,0,0
110015,",",0,0
110016,release,0,1
110017,ischemia,0,1
110018,of,0,0
110019,vestibular,0,0
110020,labyrinth,0,1
110021,",",0,0
110022,eliminate,0,0
110023,symptoms,0,1
110024,of,0,0
110025,vertigo,0,0
110026,.,0,0
110027,The,0,0
110028,effect,0,0
110029,of,0,0
110030,prophylactic,0,0
110031,fentanyl,0,0
110032,on,0,0
110033,shivering,1,1
110034,in,1,0
110035,elective,1,0
110036,caesarean,1,1
110037,section,1,0
110038,under,0,0
110039,epidural,0,0
110040,analgesia,0,0
110041,.,0,0
110042,The,0,0
110043,aims,0,0
110044,of,0,0
110045,this,0,0
110046,randomised,0,0
110047,double-blind,0,0
110048,study,0,0
110049,were,0,0
110050,to,0,0
110051,investigate,0,0
110052,whether,0,0
110053,25,0,0
110054,micrograms,0,0
110055,of,0,0
110056,fentanyl,0,0
110057,administered,0,0
110058,prophylactically,0,0
110059,by,0,0
110060,the,0,0
110061,epidural,0,0
110062,route,0,0
110063,would,0,0
110064,influence,0,0
110065,the,0,0
110066,incidence,1,1
110067,of,1,0
110068,shivering,1,1
110069,in,0,0
110070,parturients,0,0
110071,who,0,0
110072,underwent,0,0
110073,elective,0,0
110074,Caesarean,0,1
110075,section,0,0
110076,under,0,0
110077,epidural,0,0
110078,analgesia,0,1
110079,and,0,0
110080,whether,0,0
110081,it,0,0
110082,would,0,0
110083,affect,0,0
110084,the,0,0
110085,axillary,1,0
110086,and,1,0
110087,calf,1,1
110088,temperatures,1,0
110089,.,1,0
110090,There,0,0
110091,was,0,0
110092,a,0,0
110093,50,0,0
110094,%,0,0
110095,reduction,0,0
110096,(,0,0
110097,p,0,0
110098,less,0,0
110099,than,0,0
110100,0.05,0,0
110101,),0,0
110102,in,0,0
110103,the,0,0
110104,overall,0,1
110105,incidence,1,1
110106,of,1,0
110107,shivering,1,1
110108,in,0,0
110109,patients,0,0
110110,who,0,0
110111,received,0,0
110112,fentanyl,0,0
110113,and,0,1
110114,there,0,0
110115,was,0,0
110116,some,0,0
110117,evidence,0,0
110118,to,0,0
110119,suggest,0,0
110120,that,0,0
110121,low-dose,0,0
110122,epidural,0,0
110123,fentanyl,0,0
110124,might,0,0
110125,reduce,0,0
110126,shivering,1,1
110127,by,0,0
110128,an,0,0
110129,influence,0,0
110130,on,0,0
110131,thermoregulation,1,1
110132,.,1,0
110133,Effect,0,0
110134,of,0,0
110135,zoledronic,0,0
110136,acid,0,0
110137,on,0,0
110138,disseminated,0,0
110139,tumour,0,1
110140,cells,0,1
110141,in,0,0
110142,women,0,0
110143,with,0,0
110144,locally,0,0
110145,advanced,0,0
110146,breast,0,0
110147,cancer,0,0
110148,:,0,0
110149,an,0,0
110150,open,0,0
110151,label,0,0
110152,",",0,0
110153,randomised,0,0
110154,",",0,0
110155,phase,0,0
110156,2,0,0
110157,trial,0,0
110158,.,0,0
110159,BACKGROUND,0,0
110160,Treatment,0,0
110161,with,0,0
110162,bisphosphonates,0,0
110163,decreases,0,0
110164,bone,0,1
110165,loss,0,1
110166,and,0,0
110167,can,0,0
110168,increase,0,0
110169,disease-free,0,1
110170,survival,0,1
110171,in,0,0
110172,patients,0,0
110173,with,0,0
110174,breast,0,0
110175,cancer,0,0
110176,.,0,0
110177,The,0,0
110178,aim,0,0
110179,of,0,0
110180,our,0,0
110181,study,0,0
110182,was,0,0
110183,to,0,0
110184,assess,0,0
110185,the,0,0
110186,effect,0,0
110187,of,0,0
110188,zoledronic,0,0
110189,acid,0,0
110190,on,0,0
110191,clearance,0,1
110192,of,0,0
110193,disseminated,1,0
110194,tumour,1,1
110195,cells,1,1
110196,(,1,0
110197,DTCs,1,0
110198,),1,0
110199,from,0,0
110200,the,0,0
110201,bone,0,1
110202,marrow,0,0
110203,in,0,0
110204,women,0,0
110205,undergoing,0,0
110206,neoadjuvant,0,0
110207,chemotherapy,0,0
110208,for,0,0
110209,breast,0,0
110210,cancer,0,0
110211,.,0,0
110212,METHODS,0,0
110213,Patients,0,0
110214,were,0,0
110215,recruited,0,0
110216,for,0,0
110217,this,0,0
110218,open-label,0,0
110219,",",0,0
110220,phase,0,0
110221,2,0,0
110222,randomised,0,0
110223,trial,0,0
110224,between,0,0
110225,March,0,0
110226,17,0,0
110227,",",0,0
110228,2003,0,0
110229,",",0,0
110230,and,0,0
110231,May,0,0
110232,19,0,0
110233,",",0,0
110234,2006,0,0
110235,",",0,0
110236,at,0,0
110237,a,0,0
110238,single,0,0
110239,centre,0,0
110240,.,0,0
110241,Eligible,0,0
110242,patients,0,0
110243,had,0,0
110244,clinical,0,0
110245,stage,0,0
110246,II-III,0,0
110247,(,0,0
110248,>,0,0
110249,or,0,0
110250,=,0,0
110251,T2,0,0
110252,and/or,0,0
110253,>,0,0
110254,or,0,0
110255,=,0,0
110256,N1,0,1
110257,),0,0
110258,newly,0,0
110259,diagnosed,0,0
110260,breast,0,0
110261,cancer,0,0
110262,",",0,0
110263,Eastern,0,0
110264,Cooperative,0,0
110265,Oncology,0,0
110266,Group,0,0
110267,performance,0,1
110268,status,0,1
110269,of,0,0
110270,0,0,0
110271,or,0,0
110272,1,0,0
110273,",",0,0
110274,and,0,0
110275,normal,0,1
110276,cardiac,0,1
110277,",",0,0
110278,renal,0,1
110279,",",0,0
110280,and,0,1
110281,liver,0,1
110282,function,0,1
110283,.,0,0
110284,120,0,0
110285,women,0,0
110286,were,0,0
110287,randomly,0,0
110288,assigned,0,0
110289,",",0,0
110290,using,0,0
110291,allocation,0,1
110292,concealment,0,0
110293,",",0,0
110294,to,0,0
110295,receive,0,0
110296,4,0,0
110297,mg,0,0
110298,zoledronic,0,0
110299,acid,0,0
110300,intravenously,0,0
110301,every,0,0
110302,3,0,0
110303,weeks,0,0
110304,(,0,0
110305,n=60,0,0
110306,),0,1
110307,",",0,0
110308,or,0,0
110309,no,0,0
110310,zoledronic,0,0
110311,acid,0,0
110312,(,0,0
110313,n=60,0,0
110314,),0,0
110315,",",0,0
110316,for,0,0
110317,1,0,0
110318,year,0,0
110319,concomitant,0,0
110320,with,0,0
110321,four,0,0
110322,cycles,0,0
110323,of,0,0
110324,neoadjuvant,0,0
110325,epirubicin,0,0
110326,(,0,0
110327,75,0,0
110328,mg/m,0,0
110329,(,0,0
110330,2,0,0
110331,),0,0
110332,),0,0
110333,plus,0,0
110334,docetaxel,0,0
110335,(,0,0
110336,75,0,0
110337,mg/m,0,0
110338,(,0,0
110339,2,0,0
110340,),0,0
110341,),0,0
110342,and,0,0
110343,two,0,0
110344,cycles,0,0
110345,of,0,0
110346,adjuvant,0,0
110347,epirubicin,0,0
110348,plus,0,0
110349,docetaxel,0,0
110350,.,0,0
110351,The,0,0
110352,primary,0,0
110353,endpoint,0,0
110354,was,0,0
110355,the,0,0
110356,number,0,1
110357,of,0,0
110358,patients,0,0
110359,with,0,0
110360,detectable,1,1
110361,DTCs,1,0
110362,at,0,0
110363,3,0,0
110364,months,0,0
110365,.,0,0
110366,Final,0,1
110367,analysis,0,0
110368,was,0,0
110369,done,0,0
110370,1,0,0
110371,year,0,0
110372,after,0,0
110373,the,0,0
110374,last,0,0
110375,patient,0,0
110376,was,0,0
110377,enrolled,0,0
110378,.,0,0
110379,Analyses,0,0
110380,were,0,0
110381,done,0,0
110382,for,0,0
110383,all,0,0
110384,patients,0,0
110385,with,0,0
110386,available,0,0
110387,data,0,0
110388,at,0,0
110389,3,0,0
110390,months,0,0
110391,.,0,0
110392,This,0,0
110393,study,0,0
110394,is,0,0
110395,registered,0,0
110396,with,0,0
110397,ClinicalTrials.gov,0,0
110398,",",0,0
110399,number,0,1
110400,NCT00242203,0,0
110401,.,0,0
110402,FINDINGS,0,0
110403,Of,0,0
110404,the,0,0
110405,120,0,0
110406,patients,0,0
110407,initially,0,0
110408,enrolled,0,0
110409,",",0,0
110410,one,0,0
110411,withdrew,0,0
110412,after,0,0
110413,signing,0,0
110414,consent,0,0
110415,and,0,0
110416,one,0,0
110417,patient,0,1
110418,'s,0,0
110419,baseline,0,0
110420,bone,0,1
110421,marrow,0,0
110422,was,0,0
110423,not,0,0
110424,available,0,0
110425,.,0,0
110426,Both,0,0
110427,of,0,0
110428,these,0,0
110429,patients,0,0
110430,were,0,0
110431,in,0,0
110432,the,0,0
110433,control,0,0
110434,group,0,0
110435,.,0,0
110436,At,0,0
110437,3,0,0
110438,months,0,0
110439,",",0,0
110440,109,0,0
110441,bone-marrow,0,0
110442,samples,0,0
110443,were,0,0
110444,available,0,0
110445,for,0,0
110446,analysis,0,0
110447,.,0,0
110448,In,0,0
110449,the,0,0
110450,zoledronic,0,0
110451,acid,0,0
110452,group,0,0
110453,",",0,1
110454,bone,0,1
110455,marrow,0,1
110456,was,0,0
110457,not,0,0
110458,collected,0,0
110459,from,0,0
110460,one,0,0
110461,patient,0,0
110462,because,0,0
110463,of,0,0
110464,disease,0,1
110465,progression,0,1
110466,",",0,0
110467,one,0,0
110468,patient,0,0
110469,was,0,0
110470,taken,0,0
110471,off,0,0
110472,study,0,0
110473,because,0,0
110474,of,0,0
110475,severe,0,1
110476,diarrhoea,0,1
110477,",",0,0
110478,and,0,0
110479,two,0,0
110480,patients,0,0
110481,had,0,0
110482,not,0,0
110483,consented,0,0
110484,at,0,0
110485,the,0,0
110486,time,0,1
110487,of,0,0
110488,surgery,0,0
110489,.,0,0
110490,In,0,0
110491,the,0,0
110492,control,0,0
110493,group,0,0
110494,",",0,1
110495,bone,0,1
110496,marrow,0,1
110497,was,0,0
110498,not,0,0
110499,collected,0,0
110500,from,0,0
110501,two,0,0
110502,patients,0,0
110503,because,0,0
110504,of,0,0
110505,disease,0,1
110506,progression,0,1
110507,",",0,0
110508,one,0,0
110509,patient,0,0
110510,withdrew,0,0
110511,consent,0,0
110512,",",0,0
110513,and,0,0
110514,three,0,0
110515,patients,0,0
110516,were,0,0
110517,not,0,0
110518,consented,0,0
110519,at,0,0
110520,the,0,0
110521,time,0,1
110522,of,0,0
110523,surgery,0,0
110524,.,0,0
110525,At,0,0
110526,baseline,0,0
110527,",",0,0
110528,DTCs,0,1
110529,were,0,0
110530,detected,0,0
110531,in,0,0
110532,26,0,0
110533,of,0,0
110534,60,0,0
110535,patients,0,0
110536,in,0,0
110537,the,0,0
110538,zoledronic,0,0
110539,acid,0,0
110540,group,0,0
110541,and,0,0
110542,28,0,0
110543,of,0,0
110544,58,0,0
110545,patients,0,0
110546,in,0,0
110547,the,0,0
110548,control,0,0
110549,group,0,0
110550,.,0,0
110551,At,0,0
110552,3,0,0
110553,months,0,0
110554,",",0,0
110555,17,0,0
110556,of,0,0
110557,56,0,0
110558,patients,0,0
110559,receiving,0,0
110560,zoledronic,0,0
110561,acid,0,0
110562,versus,0,0
110563,25,0,0
110564,of,0,0
110565,53,0,0
110566,patients,0,0
110567,who,0,0
110568,did,0,0
110569,not,0,0
110570,receive,0,0
110571,zoledronic,0,0
110572,acid,0,0
110573,had,0,0
110574,detectable,0,1
110575,DTCs,0,1
110576,(,0,0
110577,p=0.054,0,0
110578,),0,0
110579,.,0,0
110580,The,0,0
110581,most,0,0
110582,common,0,0
110583,grade,0,1
110584,3-4,0,1
110585,toxicities,0,1
110586,were,0,0
110587,infection,0,1
110588,(,0,0
110589,five,0,0
110590,of,0,0
110591,60,0,0
110592,patients,0,0
110593,in,0,0
110594,the,0,0
110595,zoledronic,0,0
110596,acid,0,0
110597,group,0,0
110598,and,0,0
110599,six,0,0
110600,of,0,0
110601,59,0,0
110602,in,0,0
110603,the,0,0
110604,control,0,0
110605,group,0,0
110606,),0,1
110607,and,0,1
110608,thrombosis,0,1
110609,(,0,0
110610,five,0,0
110611,of,0,0
110612,60,0,0
110613,in,0,0
110614,the,0,0
110615,zoledronic,0,0
110616,acid,0,0
110617,and,0,0
110618,two,0,0
110619,of,0,0
110620,59,0,0
110621,in,0,0
110622,the,0,0
110623,control,0,0
110624,group,0,0
110625,),0,0
110626,.,0,0
110627,There,0,0
110628,was,0,0
110629,one,0,0
110630,documented,0,0
110631,case,0,0
110632,of,0,0
110633,osteonecrosis,1,1
110634,in,0,0
110635,the,0,0
110636,zoledronic,0,0
110637,acid,0,0
110638,group,0,0
110639,.,0,0
110640,INTERPRETATION,0,0
110641,Zoledronic,0,0
110642,acid,0,1
110643,administered,0,0
110644,with,0,0
110645,chemotherapy,0,0
110646,resulted,0,0
110647,in,0,0
110648,a,0,0
110649,decreased,0,0
110650,proportion,0,0
110651,of,0,0
110652,patients,0,0
110653,with,0,0
110654,DTCs,0,0
110655,detected,0,0
110656,in,0,0
110657,the,0,0
110658,bone,0,1
110659,marrow,0,0
110660,at,0,0
110661,the,0,0
110662,time,0,1
110663,of,0,0
110664,surgery,0,0
110665,.,0,0
110666,Our,0,0
110667,study,0,0
110668,supports,0,0
110669,the,0,0
110670,hypothesis,0,0
110671,that,0,0
110672,the,0,0
110673,antimetastatic,0,0
110674,effects,0,0
110675,of,0,0
110676,zoledronic,0,0
110677,acid,0,0
110678,may,0,0
110679,be,0,0
110680,through,0,0
110681,effects,0,0
110682,on,0,0
110683,DTCs,0,0
110684,.,0,0
110685,FUNDING,0,0
110686,Novartis,0,0
110687,Pharmaceuticals,0,0
110688,and,0,0
110689,Pfizer,0,0
110690,Inc,0,0
110691,.,0,0
110692,Parent-mediated,0,0
110693,communication-focused,0,0
110694,treatment,0,0
110695,in,0,0
110696,children,0,0
110697,with,0,0
110698,autism,0,0
110699,(,0,0
110700,PACT,0,0
110701,),0,0
110702,:,0,0
110703,a,0,0
110704,randomised,0,0
110705,controlled,0,0
110706,trial,0,0
110707,.,0,0
110708,BACKGROUND,0,0
110709,Results,0,0
110710,of,0,0
110711,small,0,0
110712,trials,0,0
110713,suggest,0,0
110714,that,0,0
110715,early,0,0
110716,interventions,0,0
110717,for,0,0
110718,social,0,1
110719,communication,0,0
110720,are,0,0
110721,effective,0,0
110722,for,0,0
110723,the,0,0
110724,treatment,0,0
110725,of,0,0
110726,autism,0,0
110727,in,0,0
110728,children,0,0
110729,.,0,0
110730,We,0,0
110731,therefore,0,0
110732,investigated,0,0
110733,the,0,0
110734,efficacy,1,1
110735,of,0,0
110736,such,0,0
110737,an,0,0
110738,intervention,0,0
110739,in,0,0
110740,a,0,0
110741,larger,0,0
110742,trial,0,0
110743,.,0,1
110744,METHODS,0,0
110745,Children,0,0
110746,with,0,0
110747,core,0,1
110748,autism,0,0
110749,(,0,0
110750,aged,0,0
110751,2,0,0
110752,years,0,0
110753,to,0,0
110754,4,0,0
110755,years,0,0
110756,and,0,0
110757,11,0,0
110758,months,0,0
110759,),0,0
110760,were,0,0
110761,randomly,0,0
110762,assigned,0,0
110763,in,0,0
110764,a,0,0
110765,one-to-one,0,0
110766,ratio,0,1
110767,to,0,0
110768,a,0,0
110769,parent-mediated,0,0
110770,communication-focused,0,0
110771,(,0,0
110772,Preschool,0,0
110773,Autism,0,1
110774,Communication,0,1
110775,Trial,0,0
110776,[,0,0
110777,PACT,0,1
110778,],0,0
110779,),0,0
110780,intervention,0,0
110781,or,0,0
110782,treatment,0,0
110783,as,0,0
110784,usual,0,0
110785,at,0,0
110786,three,0,0
110787,specialist,0,0
110788,centres,0,0
110789,in,0,0
110790,the,0,0
110791,UK,0,0
110792,.,0,0
110793,Those,0,0
110794,assigned,0,0
110795,to,0,0
110796,PACT,0,0
110797,were,0,0
110798,also,0,0
110799,given,0,0
110800,treatment,0,0
110801,as,0,0
110802,usual,0,0
110803,.,0,0
110804,Randomisation,0,0
110805,was,0,0
110806,by,0,0
110807,use,0,0
110808,of,0,0
110809,minimisation,0,0
110810,of,0,0
110811,probability,0,0
110812,in,0,0
110813,the,0,0
110814,marginal,0,1
110815,distribution,0,0
110816,of,0,0
110817,treatment,0,0
110818,centre,0,0
110819,",",0,1
110820,age,0,0
110821,(,0,0
110822,<,0,0
110823,/=42,0,0
110824,months,0,0
110825,or,0,0
110826,>,0,0
110827,42,0,0
110828,months,0,0
110829,),0,0
110830,",",0,0
110831,and,0,1
110832,autism,0,0
110833,severity,0,1
110834,(,0,0
110835,Autism,0,1
110836,Diagnostic,0,0
110837,Observation,0,0
110838,Schedule-Generic,0,0
110839,[,0,0
110840,ADOS-G,0,0
110841,],0,0
110842,algorithm,0,0
110843,score,0,1
110844,12-17,0,0
110845,or,0,0
110846,18-24,0,0
110847,),0,0
110848,.,0,0
110849,Primary,0,0
110850,outcome,0,1
110851,was,0,0
110852,severity,1,1
110853,of,1,1
110854,autism,1,0
110855,symptoms,1,1
110856,(,1,0
110857,a,1,0
110858,total,1,1
110859,score,1,1
110860,of,1,0
110861,social,1,1
110862,communication,1,1
110863,algorithm,1,0
110864,items,1,1
110865,from,1,0
110866,ADOS-G,1,0
110867,",",1,0
110868,higher,1,1
110869,score,1,1
110870,indicating,1,0
110871,greater,1,0
110872,severity,1,1
110873,),1,0
110874,at,1,0
110875,13,1,0
110876,months,1,0
110877,.,1,0
110878,Complementary,0,0
110879,secondary,0,0
110880,outcomes,0,1
110881,were,0,0
110882,measures,1,1
110883,of,1,0
110884,parent-child,1,0
110885,interaction,1,1
110886,",",1,0
110887,child,1,1
110888,language,1,1
110889,",",1,0
110890,and,1,1
110891,adaptive,1,1
110892,functioning,1,1
110893,in,1,0
110894,school,1,0
110895,.,1,0
110896,Analysis,0,1
110897,was,0,0
110898,by,0,0
110899,intention,0,0
110900,to,0,0
110901,treat,0,0
110902,.,0,0
110903,This,0,0
110904,study,0,0
110905,is,0,0
110906,registered,0,0
110907,as,0,0
110908,an,0,0
110909,International,0,0
110910,Standard,0,0
110911,Randomised,0,0
110912,Controlled,0,0
110913,Trial,0,0
110914,",",0,0
110915,number,0,1
110916,ISRCTN58133827,0,0
110917,.,0,0
110918,RESULTS,0,0
110919,152,0,0
110920,children,0,0
110921,were,0,0
110922,recruited,0,0
110923,.,0,0
110924,77,0,0
110925,were,0,0
110926,assigned,0,0
110927,to,0,0
110928,PACT,0,1
110929,(,0,0
110930,London,0,0
110931,[,0,0
110932,n=26,0,0
110933,],0,0
110934,",",0,0
110935,Manchester,0,0
110936,[,0,0
110937,n=26,0,0
110938,],0,0
110939,",",0,0
110940,and,0,1
110941,Newcastle,0,0
110942,[,0,0
110943,n=25,0,0
110944,],0,0
110945,),0,0
110946,;,0,0
110947,and,0,0
110948,75,0,0
110949,to,0,0
110950,treatment,0,0
110951,as,0,0
110952,usual,0,0
110953,(,0,0
110954,London,0,0
110955,[,0,0
110956,n=26,0,0
110957,],0,0
110958,",",0,0
110959,Manchester,0,0
110960,[,0,0
110961,n=26,0,0
110962,],0,0
110963,",",0,0
110964,and,0,1
110965,Newcastle,0,0
110966,[,0,0
110967,n=23,0,0
110968,],0,0
110969,),0,0
110970,.,0,0
110971,At,0,0
110972,the,0,0
110973,13-month,0,0
110974,endpoint,0,0
110975,",",0,0
110976,the,0,0
110977,severity,1,1
110978,of,1,0
110979,symptoms,1,1
110980,was,0,0
110981,reduced,0,0
110982,by,0,0
110983,3.9,0,0
110984,points,0,0
110985,(,0,0
110986,SD,0,0
110987,4.7,0,0
110988,),0,0
110989,on,0,0
110990,the,0,0
110991,ADOS-G,0,0
110992,algorithm,0,0
110993,in,0,0
110994,the,0,0
110995,group,0,0
110996,assigned,0,0
110997,to,0,0
110998,PACT,0,1
110999,",",0,0
111000,and,0,0
111001,2.9,0,0
111002,(,0,0
111003,3.9,0,0
111004,),0,0
111005,in,0,0
111006,the,0,0
111007,group,0,0
111008,assigned,0,0
111009,to,0,0
111010,treatment,0,0
111011,as,0,0
111012,usual,0,0
111013,",",0,0
111014,representing,0,0
111015,a,0,0
111016,between-group,0,0
111017,effect,0,0
111018,size,0,1
111019,of,0,1
111020,-0.24,0,0
111021,(,0,0
111022,95,0,0
111023,%,0,0
111024,CI,0,0
111025,-0.59,0,0
111026,to,0,0
111027,0.11,0,0
111028,),0,0
111029,",",0,0
111030,after,0,0
111031,adjustment,0,0
111032,for,0,0
111033,centre,0,0
111034,",",0,0
111035,sex,0,0
111036,",",0,1
111037,socioeconomic,0,1
111038,status,0,1
111039,",",0,0
111040,age,0,0
111041,",",0,1
111042,and,0,1
111043,verbal,0,1
111044,and,0,1
111045,non-verbal,0,1
111046,abilities,0,1
111047,.,0,0
111048,Treatment,0,0
111049,effect,0,0
111050,was,0,0
111051,positive,0,0
111052,for,0,0
111053,parental,1,1
111054,synchronous,1,0
111055,response,1,1
111056,to,0,0
111057,child,0,0
111058,(,0,0
111059,1.22,0,0
111060,",",0,0
111061,0.85,0,0
111062,to,0,0
111063,1.59,0,0
111064,),0,0
111065,",",0,0
111066,child,0,1
111067,initiations,0,0
111068,with,0,0
111069,parent,0,0
111070,(,0,0
111071,0.41,0,0
111072,",",0,0
111073,0.08,0,0
111074,to,0,0
111075,0.74,0,0
111076,),0,0
111077,",",0,0
111078,and,0,0
111079,for,0,0
111080,parent-child,0,0
111081,shared,0,0
111082,attention,0,0
111083,(,0,0
111084,0.33,0,0
111085,",",0,0
111086,-0.02,0,0
111087,to,0,0
111088,0.68,0,0
111089,),0,0
111090,.,0,0
111091,Effects,0,0
111092,on,0,0
111093,directly,1,0
111094,assessed,1,0
111095,language,1,0
111096,and,1,0
111097,adaptive,1,1
111098,functioning,1,1
111099,in,0,0
111100,school,0,0
111101,were,0,0
111102,small,0,0
111103,.,0,0
111104,INTERPRETATION,0,0
111105,On,0,0
111106,the,0,0
111107,basis,0,0
111108,of,0,0
111109,our,0,0
111110,findings,0,0
111111,",",0,0
111112,we,0,0
111113,can,0,0
111114,not,0,0
111115,recommend,0,0
111116,the,0,0
111117,addition,0,0
111118,of,0,0
111119,the,0,0
111120,PACT,0,0
111121,intervention,0,0
111122,to,0,0
111123,treatment,0,0
111124,as,0,0
111125,usual,0,0
111126,for,0,0
111127,the,0,0
111128,reduction,0,1
111129,of,0,0
111130,autism,0,0
111131,symptoms,0,1
111132,;,0,0
111133,however,0,0
111134,",",0,0
111135,a,0,0
111136,clear,0,0
111137,benefit,0,0
111138,was,0,0
111139,noted,0,0
111140,for,0,0
111141,parent-child,1,0
111142,dyadic,1,1
111143,social,1,1
111144,communication,1,0
111145,.,1,0
111146,FUNDING,0,0
111147,UK,0,1
111148,Medical,0,0
111149,Research,0,0
111150,Council,0,1
111151,",",0,0
111152,and,0,1
111153,UK,0,1
111154,Department,0,0
111155,for,0,0
111156,Children,0,0
111157,",",0,0
111158,Schools,0,0
111159,and,0,0
111160,Families,0,0
111161,.,0,0
111162,Efficacy,0,1
111163,and,0,1
111164,safety,0,1
111165,of,0,0
111166,de,0,0
111167,novo,0,0
111168,or,0,0
111169,early,0,0
111170,everolimus,0,0
111171,with,0,0
111172,low,0,0
111173,cyclosporine,0,0
111174,in,0,0
111175,deceased-donor,0,0
111176,kidney,0,0
111177,transplant,0,0
111178,recipients,0,0
111179,at,0,0
111180,specified,0,0
111181,risk,0,0
111182,of,0,0
111183,delayed,0,0
111184,graft,0,0
111185,function,0,1
111186,:,0,0
111187,12-month,0,0
111188,results,0,0
111189,of,0,0
111190,a,0,0
111191,randomized,0,0
111192,",",0,0
111193,multicenter,0,0
111194,trial,0,0
111195,.,0,0
111196,Immediate,0,1
111197,or,0,0
111198,early,0,0
111199,use,0,0
111200,of,0,0
111201,proliferation,0,1
111202,signal,0,1
111203,inhibitor,0,0
111204,(,0,0
111205,PSI,0,0
111206,),0,0
111207,/mammalian,0,0
111208,target,0,0
111209,of,0,0
111210,rapamycin,0,0
111211,(,0,0
111212,mTOR,0,1
111213,),0,1
111214,inhibitor,0,0
111215,therapy,0,0
111216,can,0,0
111217,avoid,0,0
111218,high,0,0
111219,exposure,0,0
111220,to,0,0
111221,calcineurin,0,0
111222,inhibitors,0,0
111223,but,0,0
111224,concerns,0,0
111225,exist,0,0
111226,relating,0,0
111227,to,0,0
111228,the,0,0
111229,risk,0,0
111230,of,0,0
111231,delayed,1,0
111232,graft,1,1
111233,function,1,1
111234,(,1,0
111235,DGF,1,1
111236,),1,0
111237,and,1,0
111238,impaired,1,1
111239,wound,1,1
111240,healing,1,1
111241,with,0,0
111242,the,0,0
111243,mTOR,0,0
111244,sirolimus,0,0
111245,.,0,0
111246,CALLISTO,0,0
111247,was,0,0
111248,a,0,0
111249,12-month,0,0
111250,",",0,0
111251,prospective,0,0
111252,",",0,1
111253,multicenter,0,0
111254,",",0,1
111255,open-label,0,0
111256,study,0,0
111257,.,0,0
111258,Deceased-donor,0,0
111259,kidney,0,1
111260,transplant,0,0
111261,patients,0,0
111262,at,0,0
111263,protocol-specified,0,0
111264,risk,0,1
111265,of,0,0
111266,DGF,0,0
111267,were,0,0
111268,randomized,0,0
111269,to,0,0
111270,start,0,0
111271,everolimus,0,0
111272,on,0,0
111273,day,0,0
111274,1,0,0
111275,(,0,0
111276,immediate,0,0
111277,everolimus,0,0
111278,",",0,0
111279,IE,0,0
111280,;,0,0
111281,n,0,0
111282,=,0,0
111283,65,0,0
111284,),0,0
111285,or,0,0
111286,week,0,0
111287,5,0,0
111288,(,0,0
111289,delayed,0,0
111290,everolimus,0,0
111291,",",0,0
111292,DE,0,1
111293,;,0,0
111294,n,0,0
111295,=,0,0
111296,74,0,0
111297,),0,0
111298,.,0,0
111299,Incidence,0,0
111300,of,0,0
111301,the,0,0
111302,primary,0,0
111303,endpoint,0,1
111304,(,1,0
111305,biopsy-proven,1,1
111306,acute,1,1
111307,rejection,1,1
111308,",",1,0
111309,BPAR,1,1
111310,;,1,0
111311,graft,1,1
111312,loss,1,1
111313,",",1,1
111314,death,1,1
111315,",",1,1
111316,DGF,1,1
111317,",",1,0
111318,wound,1,1
111319,healing,1,1
111320,complications,1,1
111321,related,1,0
111322,to,1,0
111323,transplant,1,0
111324,surgery,1,0
111325,or,1,0
111326,loss,1,1
111327,to,1,0
111328,follow-up,1,0
111329,),1,0
111330,was,1,0
111331,64.6,1,0
111332,%,0,0
111333,and,0,0
111334,66.2,0,0
111335,%,0,0
111336,in,0,0
111337,the,0,0
111338,IE,0,0
111339,and,0,0
111340,DE,0,1
111341,groups,0,0
111342,",",0,0
111343,respectively,0,0
111344,",",0,0
111345,at,0,0
111346,month,0,0
111347,12,0,0
111348,(,0,0
111349,P,0,0
111350,=,0,0
111351,0.860,0,0
111352,),0,0
111353,.,0,0
111354,The,0,0
111355,overall,0,1
111356,incidence,0,1
111357,of,0,0
111358,BPAR,0,0
111359,was,0,0
111360,20.1,0,0
111361,%,0,0
111362,.,0,0
111363,Median,0,1
111364,estimated,1,0
111365,glomerular,1,1
111366,filtration,1,1
111367,rate,1,1
111368,was,1,0
111369,48,1,0
111370,ml/min/1.73,0,0
111371,m,0,0
111372,(,0,0
111373,2,0,0
111374,),0,0
111375,and,0,0
111376,49,0,0
111377,ml/min/1.73,0,0
111378,m,0,0
111379,(,0,0
111380,2,0,0
111381,),0,0
111382,in,0,0
111383,the,0,0
111384,IE,0,0
111385,and,0,0
111386,DE,0,1
111387,groups,0,0
111388,",",0,0
111389,respectively,0,0
111390,",",0,0
111391,at,0,0
111392,month,1,0
111393,12,1,0
111394,.,1,0
111395,DGF,1,0
111396,and,1,0
111397,wound,1,1
111398,healing,1,1
111399,complications,1,1
111400,were,1,0
111401,similar,0,0
111402,between,0,0
111403,groups,1,0
111404,.,1,0
111405,Adverse,1,1
111406,events,1,1
111407,led,1,0
111408,to,0,0
111409,study,0,0
111410,drug,0,0
111411,discontinuation,0,0
111412,in,0,0
111413,17,0,0
111414,IE,0,0
111415,patients,0,0
111416,(,0,0
111417,26.2,0,0
111418,%,0,0
111419,),0,0
111420,and,0,0
111421,28,0,0
111422,DE,0,1
111423,patients,0,0
111424,(,0,0
111425,37.8,0,0
111426,%,0,0
111427,),0,0
111428,(,0,0
111429,NS,0,1
111430,),0,0
111431,.,0,0
111432,In,0,0
111433,conclusion,0,0
111434,",",0,0
111435,introduction,0,0
111436,of,0,1
111437,everolimus,0,0
111438,immediately,0,0
111439,or,0,0
111440,early,0,0
111441,posttransplant,0,0
111442,in,0,0
111443,DGF-risk,0,0
111444,patients,0,0
111445,is,0,0
111446,associated,0,0
111447,with,0,0
111448,good,1,0
111449,efficacy,1,1
111450,",",1,0
111451,renal,1,1
111452,function,1,1
111453,and,1,1
111454,safety,1,1
111455,profile,1,1
111456,.,1,0
111457,There,1,0
111458,seems,0,0
111459,no,0,0
111460,benefit,0,0
111461,in,0,0
111462,delaying,0,0
111463,initiation,0,0
111464,of,0,0
111465,everolimus,0,0
111466,.,0,0
111467,Improving,0,0
111468,the,0,0
111469,immunogenicity,1,1
111470,of,0,0
111471,pneumococcal,0,1
111472,conjugate,0,0
111473,vaccine,0,0
111474,in,0,0
111475,HIV-infected,0,0
111476,adults,0,0
111477,with,0,0
111478,a,0,0
111479,toll-like,0,0
111480,receptor,0,0
111481,9,0,0
111482,agonist,0,0
111483,adjuvant,0,0
111484,:,0,0
111485,a,0,0
111486,randomized,0,0
111487,",",0,0
111488,controlled,0,0
111489,trial,0,0
111490,.,0,0
111491,BACKGROUND,0,0
111492,Persons,0,0
111493,infected,0,0
111494,with,0,0
111495,human,0,0
111496,immunodeficiency,0,0
111497,virus,0,0
111498,(,0,0
111499,HIV,0,0
111500,),0,0
111501,are,0,0
111502,often,0,0
111503,hyporesponsive,0,0
111504,to,0,0
111505,immunization,0,0
111506,",",0,0
111507,including,0,0
111508,pneumococcal,0,0
111509,vaccines,0,0
111510,.,0,0
111511,We,0,0
111512,hypothesized,0,0
111513,that,0,0
111514,adding,0,0
111515,CPG,0,1
111516,7909,0,0
111517,",",0,0
111518,a,0,0
111519,toll-like,0,0
111520,receptor,0,0
111521,9,0,0
111522,(,0,0
111523,TLR9,0,0
111524,),0,1
111525,agonist,0,0
111526,and,0,1
111527,vaccine,0,1
111528,adjuvant,0,0
111529,",",0,0
111530,to,0,0
111531,7-valent,0,0
111532,pneumococcal,0,0
111533,conjugate,0,0
111534,vaccine,0,0
111535,(,0,0
111536,7vPnC,0,0
111537,),0,0
111538,would,0,0
111539,increase,0,0
111540,its,0,0
111541,immunogenicity,0,1
111542,in,0,0
111543,HIV-infected,0,0
111544,adults,0,0
111545,.,0,0
111546,METHODS,0,0
111547,We,0,0
111548,performed,0,0
111549,a,0,0
111550,double-blind,0,0
111551,",",0,0
111552,placebo-controlled,0,0
111553,",",0,0
111554,phase,0,0
111555,1b/2a,0,0
111556,trial,0,0
111557,randomizing,0,0
111558,HIV-positive,0,0
111559,patients,0,0
111560,to,0,0
111561,receive,0,0
111562,double,0,0
111563,doses,0,0
111564,of,0,0
111565,7vPnC,0,0
111566,(,0,0
111567,Prevnar,0,0
111568,),0,0
111569,at,0,0
111570,0,0,0
111571,and,0,0
111572,3,0,0
111573,months,0,0
111574,and,0,0
111575,1,0,0
111576,dose,0,0
111577,of,0,0
111578,23-valent,0,0
111579,pneumococcal,0,0
111580,polysaccharide,0,0
111581,vaccine,0,0
111582,(,0,0
111583,PPV-23,0,0
111584,;,0,0
111585,Pneumo,0,0
111586,Novum,0,0
111587,),0,0
111588,at,0,0
111589,9,0,0
111590,months,0,0
111591,",",0,0
111592,with,0,0
111593,experimental,0,0
111594,patients,0,0
111595,receiving,0,0
111596,1,0,0
111597,mg,0,0
111598,of,0,0
111599,CPG,0,1
111600,7909,0,0
111601,added,0,0
111602,to,0,0
111603,each,0,0
111604,of,0,0
111605,their,0,0
111606,3,0,0
111607,vaccine,0,0
111608,doses,0,0
111609,;,0,0
111610,control,0,0
111611,patients,0,0
111612,had,0,0
111613,phosphate-buffered,0,0
111614,saline,0,0
111615,added,0,0
111616,instead,0,0
111617,.,0,0
111618,Immunogenicity,1,1
111619,and,1,1
111620,safety,1,1
111621,were,0,0
111622,evaluated,0,0
111623,for,0,0
111624,up,0,0
111625,to,0,0
111626,10,0,0
111627,months,0,0
111628,.,0,0
111629,The,0,0
111630,primary,0,0
111631,end,0,0
111632,point,0,0
111633,was,0,0
111634,the,0,0
111635,proportion,1,0
111636,of,1,0
111637,vaccine,1,0
111638,high,1,0
111639,responders,1,0
111640,at,1,0
111641,9,1,0
111642,months,1,0
111643,",",0,0
111644,defined,0,0
111645,as,0,0
111646,a,0,0
111647,2-fold,0,0
111648,increase,0,0
111649,in,0,0
111650,IgG,0,0
111651,levels,0,1
111652,to,0,0
111653,>,0,0
111654,or,0,0
111655,=,0,0
111656,1,0,0
111657,microg/mL,0,0
111658,for,0,0
111659,at,0,0
111660,least,0,0
111661,5,0,0
111662,of,0,0
111663,7,0,0
111664,of,0,0
111665,the,0,0
111666,7vPnC,0,0
111667,serotypes,0,0
111668,.,0,0
111669,RESULTS,0,0
111670,Ninety-seven,0,0
111671,participants,0,0
111672,were,0,0
111673,included,0,0
111674,in,0,0
111675,the,0,0
111676,study,0,0
111677,.,0,0
111678,The,0,0
111679,proportion,1,0
111680,of,1,0
111681,vaccine,1,0
111682,high,1,0
111683,responders,1,0
111684,was,0,0
111685,higher,0,0
111686,in,0,0
111687,the,0,0
111688,experimental,0,0
111689,group,0,0
111690,(,0,0
111691,n,0,0
111692,=,0,0
111693,48,0,0
111694,),0,0
111695,than,0,0
111696,among,0,0
111697,controls,0,0
111698,(,0,0
111699,n,0,0
111700,=,0,0
111701,49,0,0
111702,;,0,0
111703,48.8,0,0
111704,%,0,0
111705,vs,0,0
111706,25.0,0,0
111707,%,0,0
111708,;,0,0
111709,P,0,0
111710,=,0,0
111711,.02,0,0
111712,),0,0
111713,at,0,0
111714,9,0,0
111715,months,0,0
111716,.,0,0
111717,Greater,0,0
111718,proportions,1,1
111719,of,1,0
111720,high,1,0
111721,responders,1,0
111722,were,0,0
111723,also,0,0
111724,observed,0,0
111725,at,0,0
111726,3,0,0
111727,(,0,0
111728,51.1,0,0
111729,%,0,0
111730,vs,0,0
111731,39.6,0,0
111732,%,0,0
111733,;,0,0
111734,P,0,0
111735,=,0,0
111736,.26,0,0
111737,),0,0
111738,",",0,0
111739,4,0,0
111740,(,0,0
111741,77.3,0,0
111742,%,0,0
111743,vs,0,0
111744,56.3,0,0
111745,%,0,0
111746,;,0,0
111747,P,0,0
111748,=,0,0
111749,.03,0,0
111750,),0,0
111751,",",0,0
111752,and,0,0
111753,10,0,0
111754,months,0,0
111755,(,0,0
111756,87.8,0,0
111757,%,0,0
111758,vs,0,0
111759,51.1,0,0
111760,%,0,0
111761,;,0,0
111762,P,0,0
111763,<,0,0
111764,.001,0,0
111765,),0,0
111766,.,0,0
111767,Mild,1,0
111768,systemic,1,1
111769,and,1,0
111770,injection,1,0
111771,site,1,1
111772,reactions,1,1
111773,to,0,0
111774,7vPnC,0,0
111775,were,0,0
111776,more,0,0
111777,common,0,0
111778,in,0,0
111779,the,0,0
111780,experimental,0,0
111781,group,0,0
111782,than,0,0
111783,the,0,0
111784,control,0,0
111785,group,0,0
111786,(,0,0
111787,100,0,0
111788,%,0,0
111789,vs,0,0
111790,81.3,0,0
111791,%,0,0
111792,;,0,0
111793,P,0,0
111794,=,0,0
111795,.002,0,0
111796,),0,0
111797,.,0,0
111798,CPG,0,0
111799,7909,0,0
111800,did,0,0
111801,not,0,0
111802,increase,0,0
111803,non-7vPnC,1,0
111804,IgG,1,0
111805,levels,1,1
111806,after,0,0
111807,PPV-23,0,0
111808,immunization,0,0
111809,.,0,0
111810,No,0,0
111811,adverse,0,1
111812,effects,0,0
111813,on,0,0
111814,CD4,1,1
111815,(,1,0
111816,+,1,0
111817,),1,1
111818,cell,1,1
111819,count,1,1
111820,or,1,0
111821,organ,1,1
111822,functions,1,1
111823,occurred,0,0
111824,in,0,0
111825,either,0,0
111826,group,0,0
111827,.,0,0
111828,CONCLUSIONS,0,0
111829,The,0,0
111830,addition,0,0
111831,of,0,0
111832,a,0,0
111833,TLR9,0,0
111834,agonist,0,0
111835,to,0,0
111836,7vPnC,0,0
111837,significantly,0,0
111838,enhanced,0,0
111839,the,0,0
111840,proportion,0,0
111841,of,0,0
111842,vaccine,1,0
111843,high,1,0
111844,responders,1,0
111845,.,1,0
111846,TRIAL,0,0
111847,REGISTRATION,0,0
111848,ClinicalTrials.gov,0,0
111849,identifier,0,0
111850,:,0,0
111851,NCT00562939,0,0
111852,.,0,0
111853,Recombinant,0,0
111854,human,0,0
111855,thyrotropin-stimulated,0,1
111856,radioiodine,0,0
111857,therapy,0,0
111858,of,0,0
111859,nodular,0,0
111860,goiter,0,0
111861,allows,0,0
111862,major,0,0
111863,reduction,0,0
111864,of,0,0
111865,the,0,0
111866,radiation,1,0
111867,burden,1,1
111868,with,0,0
111869,retained,0,0
111870,efficacy,1,1
111871,.,1,0
111872,CONTEXT,0,0
111873,AND,0,0
111874,OBJECTIVE,0,0
111875,Stimulation,0,0
111876,with,0,0
111877,recombinant,0,0
111878,human,0,0
111879,TSH,0,0
111880,(,0,0
111881,rhTSH,0,0
111882,),0,0
111883,before,0,0
111884,radioiodine,0,0
111885,(,0,0
111886,131I,0,0
111887,),0,0
111888,therapy,0,0
111889,augments,0,1
111890,goiter,1,1
111891,volume,1,1
111892,reduction,1,1
111893,(,1,0
111894,GVR,1,1
111895,),1,0
111896,.,1,0
111897,Observations,0,0
111898,indicate,0,0
111899,that,0,0
111900,rhTSH,0,0
111901,has,0,0
111902,a,0,0
111903,preconditioning,0,0
111904,effect,0,0
111905,beyond,0,0
111906,increasing,0,0
111907,thyroid,0,0
111908,(,0,0
111909,131,0,0
111910,),0,0
111911,I,0,0
111912,uptake,0,0
111913,.,0,0
111914,We,0,0
111915,test,0,0
111916,the,0,0
111917,hypothesis,0,0
111918,that,0,0
111919,an,0,0
111920,equivalent,0,0
111921,GVR,0,0
111922,might,0,0
111923,be,0,0
111924,obtained,0,0
111925,by,0,0
111926,an,0,0
111927,absorbed,0,0
111928,thyroid,0,0
111929,dose,0,0
111930,well,0,0
111931,below,0,0
111932,what,0,0
111933,has,0,0
111934,been,0,0
111935,used,0,0
111936,previously,0,0
111937,.,0,0
111938,PATIENTS,0,0
111939,AND,0,0
111940,DESIGN,0,0
111941,In,0,0
111942,a,0,0
111943,double-blinded,0,0
111944,setup,0,0
111945,",",0,0
111946,90,0,0
111947,patients,0,0
111948,(,0,0
111949,78,0,0
111950,women,0,0
111951,;,0,0
111952,median,0,1
111953,age,0,0
111954,",",0,0
111955,52,0,0
111956,yr,0,0
111957,;,0,0
111958,range,0,0
111959,",",0,0
111960,22-83,0,0
111961,),0,0
111962,with,0,0
111963,a,0,0
111964,nontoxic,0,0
111965,nodular,0,0
111966,goiter,0,0
111967,(,0,0
111968,median,0,1
111969,size,0,1
111970,",",0,0
111971,63,0,0
111972,ml,0,0
111973,;,0,0
111974,range,0,0
111975,",",0,0
111976,25-379,0,0
111977,ml,0,0
111978,),0,0
111979,were,0,0
111980,randomized,0,0
111981,to,0,0
111982,either,0,0
111983,0.1,0,0
111984,mg,0,0
111985,rhTSH,0,0
111986,(,0,0
111987,n=60,0,0
111988,),0,0
111989,followed,0,0
111990,by,0,0
111991,a,0,0
111992,thyroid,0,0
111993,dose,0,0
111994,of,0,0
111995,50,0,0
111996,Gy,0,0
111997,or,0,0
111998,placebo,0,0
111999,followed,0,0
112000,by,0,0
112001,100,0,0
112002,Gy,0,0
112003,(,0,0
112004,n=30,0,0
112005,),0,0
112006,.,0,0
112007,RESULTS,0,0
112008,At,0,0
112009,12,0,0
112010,months,0,0
112011,",",0,0
112012,the,0,0
112013,mean,0,1
112014,relative,1,0
112015,GVR,1,1
112016,in,0,0
112017,the,0,0
112018,placebo,0,0
112019,and,0,0
112020,the,0,0
112021,rhTSH,0,1
112022,group,0,0
112023,was,0,0
112024,identical,0,0
112025,(,0,0
112026,35+/-3,0,0
112027,%,0,0
112028,;,0,0
112029,P=0.81,0,0
112030,),0,0
112031,.,0,0
112032,The,0,0
112033,median,0,0
112034,administered,0,0
112035,131I-activity,1,1
112036,was,0,0
112037,170,0,0
112038,MBq,0,0
112039,(,0,0
112040,45-1269,0,0
112041,),0,0
112042,in,0,0
112043,the,0,0
112044,rhTSH,0,0
112045,group,0,0
112046,and,0,0
112047,559,0,0
112048,MBq,0,0
112049,(,0,0
112050,245-3530,0,0
112051,),0,0
112052,in,0,0
112053,the,0,0
112054,placebo,0,0
112055,group,0,0
112056,(,0,0
112057,70,0,0
112058,%,0,0
112059,reduction,0,0
112060,",",0,0
112061,P,0,0
112062,<,0,0
112063,0.0001,0,0
112064,),0,0
112065,.,0,0
112066,According,0,0
112067,to,0,0
112068,the,0,0
112069,official,0,0
112070,radiation,0,0
112071,regulation,0,1
112072,",",0,1
112073,hospitalization,1,1
112074,was,0,0
112075,required,0,0
112076,in,0,0
112077,14,0,0
112078,patients,0,0
112079,in,0,0
112080,the,0,0
112081,placebo,0,0
112082,group,0,0
112083,vs.,0,0
112084,one,0,0
112085,patient,0,0
112086,in,0,0
112087,the,0,0
112088,rhTSH,0,0
112089,group,0,0
112090,(,0,0
112091,P,0,0
112092,<,0,0
112093,0.0001,0,0
112094,),0,0
112095,.,0,0
112096,In,0,0
112097,both,0,0
112098,groups,0,0
112099,",",0,0
112100,goiter-related,1,1
112101,symptoms,1,1
112102,were,0,0
112103,effectively,0,0
112104,relieved,0,0
112105,in,0,0
112106,the,0,0
112107,majority,0,0
112108,of,0,0
112109,patients,0,0
112110,.,0,0
112111,The,0,0
112112,prevalence,0,0
112113,of,0,0
112114,myxedema,1,0
112115,(,0,0
112116,10,0,0
112117,%,0,0
112118,),0,0
112119,did,0,0
112120,not,0,0
112121,differ,0,0
112122,among,0,0
112123,groups,0,0
112124,.,0,0
112125,CONCLUSIONS,0,0
112126,This,0,0
112127,is,0,0
112128,the,0,0
112129,first,0,0
112130,study,0,0
112131,to,0,0
112132,demonstrate,0,0
112133,that,0,0
112134,rhTSH,0,0
112135,not,0,0
112136,only,0,0
112137,increases,0,0
112138,the,0,0
112139,thyroid,1,0
112140,131I,1,0
112141,uptake,1,1
112142,",",0,0
112143,but,0,0
112144,per,0,0
112145,se,0,0
112146,potentiates,0,0
112147,the,0,0
112148,effect,0,0
112149,of,0,0
112150,131I-therapy,0,0
112151,",",0,0
112152,allowing,0,0
112153,a,0,0
112154,major,0,0
112155,reduction,0,0
112156,of,0,0
112157,the,0,0
112158,131I-activity,1,1
112159,without,0,0
112160,compromising,0,0
112161,efficacy,1,1
112162,.,1,0
112163,This,0,0
112164,approach,0,0
112165,is,0,0
112166,attractive,0,0
112167,in,0,0
112168,terms,0,0
112169,of,0,0
112170,minimizing,0,0
112171,posttherapeutic,1,1
112172,restrictions,1,0
112173,and,0,0
112174,in,0,0
112175,reducing,0,0
112176,the,0,0
112177,potential,0,0
112178,risk,0,0
112179,of,0,0
112180,radiation-induced,1,0
112181,malignancy,1,0
112182,.,0,0
112183,Effect,0,0
112184,of,0,0
112185,addition,0,0
112186,of,0,0
112187,single,0,0
112188,dose,0,0
112189,of,0,0
112190,oral,0,0
112191,montelukast,0,0
112192,to,0,0
112193,standard,0,0
112194,treatment,0,0
112195,in,0,0
112196,acute,0,0
112197,moderate,0,0
112198,to,0,0
112199,severe,0,1
112200,asthma,0,0
112201,in,0,0
112202,children,0,0
112203,between,0,0
112204,5,0,0
112205,and,0,0
112206,15,0,0
112207,years,0,0
112208,of,0,0
112209,age,0,0
112210,:,0,0
112211,a,0,0
112212,randomised,0,0
112213,",",0,0
112214,double-blind,0,0
112215,",",0,1
112216,placebo,0,0
112217,controlled,0,0
112218,trial,0,0
112219,.,0,0
112220,OBJECTIVE,0,0
112221,To,0,0
112222,study,0,0
112223,the,0,0
112224,effect,0,0
112225,of,0,0
112226,the,0,0
112227,addition,0,0
112228,of,0,0
112229,a,0,0
112230,single,0,0
112231,dose,0,0
112232,of,0,0
112233,oral,0,0
112234,montelukast,0,0
112235,to,0,0
112236,standard,0,0
112237,therapy,0,0
112238,in,0,0
112239,acute,0,0
112240,moderate,0,0
112241,to,0,0
112242,severe,0,0
112243,asthma,0,0
112244,.,0,0
112245,DESIGN,0,0
112246,Double-blind,0,0
112247,randomised,0,0
112248,controlled,0,0
112249,trial,0,0
112250,.,0,0
112251,Setting,0,0
112252,Emergency,0,1
112253,room/outpatient,0,0
112254,paediatric,0,0
112255,services,0,0
112256,of,0,0
112257,a,0,0
112258,tertiary,0,0
112259,care,0,0
112260,hospital,0,1
112261,.,0,0
112262,PATIENTS,0,0
112263,Children,0,0
112264,aged,0,0
112265,5-15,0,0
112266,years,0,0
112267,(,0,0
112268,without,0,0
112269,prior,0,0
112270,use,0,0
112271,of,0,0
112272,montelukast,0,0
112273,),0,0
112274,with,0,0
112275,acute,0,0
112276,moderate,0,0
112277,to,0,0
112278,severe,0,1
112279,asthma,0,0
112280,exacerbation,0,1
112281,",",0,0
112282,as,0,0
112283,defined,0,0
112284,using,0,0
112285,Modified,1,0
112286,Pulmonary,1,1
112287,Index,1,0
112288,Score,1,0
112289,(,1,0
112290,MPIS,1,1
112291,),1,1
112292,>,0,0
112293,or,0,0
112294,=9,0,1
112295,",",0,1
112296,were,0,0
112297,enrolled,0,0
112298,.,0,0
112299,INTERVENTION,0,0
112300,Children,0,0
112301,received,0,0
112302,montelukast,0,0
112303,(,0,0
112304,5-12,0,0
112305,years,0,0
112306,:,0,0
112307,5,0,0
112308,mg,0,0
112309,and,0,0
112310,>,0,0
112311,12,0,0
112312,years,0,0
112313,:,0,0
112314,10,0,0
112315,mg,0,0
112316,),0,0
112317,or,0,0
112318,placebo,0,0
112319,orally,0,0
112320,in,0,0
112321,addition,0,0
112322,to,0,0
112323,the,0,0
112324,standard,0,0
112325,therapy,0,0
112326,.,0,0
112327,MPIS,1,1
112328,and,1,0
112329,forced,1,0
112330,expiratory,1,1
112331,volume,1,1
112332,in,1,0
112333,1,1,0
112334,second,1,0
112335,(,1,0
112336,FEV,1,0
112337,(,1,0
112338,1,1,0
112339,),1,0
112340,),1,0
112341,were,0,0
112342,recorded,0,0
112343,before,0,0
112344,administering,0,0
112345,study,0,0
112346,medication,0,1
112347,and,0,0
112348,thereafter,0,0
112349,",",0,0
112350,hourly,0,0
112351,for,0,0
112352,4,0,0
112353,hours,0,0
112354,.,0,0
112355,MAIN,0,0
112356,OUTCOME,0,0
112357,MEASURES,0,0
112358,The,0,0
112359,primary,0,0
112360,outcome,0,1
112361,was,0,0
112362,decrease,1,0
112363,in,1,0
112364,MPIS,1,1
112365,to,0,0
112366,less,0,0
112367,than,0,0
112368,9,0,0
112369,at,0,0
112370,the,0,0
112371,end,0,0
112372,of,0,0
112373,4,0,0
112374,hours,0,0
112375,.,0,0
112376,RESULTS,0,0
112377,117,0,0
112378,children,0,0
112379,(,0,0
112380,60,0,0
112381,in,0,0
112382,montelukast,0,0
112383,group,0,0
112384,and,0,0
112385,57,0,0
112386,in,0,0
112387,placebo,0,0
112388,group,0,0
112389,),0,0
112390,were,0,0
112391,enrolled,0,0
112392,in,0,0
112393,the,0,0
112394,study,0,0
112395,.,0,0
112396,The,0,0
112397,number,0,1
112398,of,0,0
112399,children,0,0
112400,with,0,0
112401,decrease,1,0
112402,in,1,0
112403,MPIS,1,1
112404,to,0,0
112405,less,0,0
112406,than,0,0
112407,9,0,0
112408,at,0,0
112409,4,0,0
112410,hours,0,0
112411,was,0,0
112412,33,0,0
112413,(,0,0
112414,55,0,0
112415,%,0,0
112416,),0,0
112417,in,0,0
112418,the,0,0
112419,montelukast,0,0
112420,group,0,0
112421,and,0,0
112422,36,0,0
112423,(,0,0
112424,63.2,0,0
112425,%,0,0
112426,),0,0
112427,in,0,0
112428,the,0,0
112429,placebo,0,0
112430,group,0,0
112431,(,0,0
112432,p=0.37,0,0
112433,),0,0
112434,.,0,0
112435,There,0,0
112436,was,0,0
112437,significant,0,0
112438,improvement,1,1
112439,in,1,0
112440,MPIS,1,1
112441,and,1,1
112442,FEV,1,1
112443,(,1,0
112444,1,1,0
112445,),1,0
112446,within,0,0
112447,both,0,0
112448,the,0,0
112449,groups,0,0
112450,from,0,0
112451,baseline,0,0
112452,to,0,0
112453,the,0,0
112454,end,0,0
112455,of,0,0
112456,4,0,0
112457,hours,0,0
112458,.,0,0
112459,No,0,0
112460,differences,0,0
112461,in,0,0
112462,side,1,1
112463,effects,1,1
112464,and,1,1
112465,hospitalisation,1,1
112466,rates,1,1
112467,were,0,0
112468,noticed,0,0
112469,between,0,0
112470,the,0,0
112471,two,0,0
112472,groups,0,0
112473,.,0,0
112474,CONCLUSION,0,0
112475,Single,0,0
112476,dose,0,0
112477,oral,0,0
112478,montelukast,0,0
112479,added,0,0
112480,to,0,0
112481,standard,0,0
112482,therapy,0,0
112483,of,0,0
112484,inhaled,0,0
112485,bronchodilators,0,0
112486,and,0,0
112487,systemic,0,1
112488,glucocorticoids,0,1
112489,did,0,0
112490,not,0,0
112491,provide,0,0
112492,additional,0,0
112493,clinical,0,0
112494,benefit,0,0
112495,in,0,0
112496,children,0,0
112497,with,0,0
112498,acute,0,0
112499,moderate,0,0
112500,to,0,0
112501,severe,0,0
112502,asthma,0,0
112503,.,0,0
112504,Trial,0,0
112505,registration,0,0
112506,number,0,1
112507,The,0,0
112508,trial,0,0
112509,was,0,0
112510,registered,0,0
112511,at,0,0
112512,the,0,0
112513,http,0,0
112514,:,0,0
112515,//clinicaltrials.gov,0,0
112516,site,0,1
112517,(,0,0
112518,trial,0,0
112519,ID,0,0
112520,:,0,0
112521,NCT00565955,0,0
112522,),0,0
112523,.,0,0
112524,Influence,0,1
112525,of,0,0
112526,diets,0,0
112527,rich,0,0
112528,in,0,0
112529,Maillard,0,0
112530,reaction,0,1
112531,products,0,1
112532,on,0,0
112533,calcium,1,0
112534,bioavailability,1,1
112535,.,1,0
112536,Assays,0,0
112537,in,0,0
112538,male,0,0
112539,adolescents,0,0
112540,and,0,0
112541,in,0,0
112542,Caco-2,0,1
112543,cells,0,1
112544,.,0,0
112545,The,0,0
112546,effects,0,0
112547,of,0,0
112548,the,0,0
112549,high,0,0
112550,intake,0,1
112551,of,0,0
112552,Maillard,0,0
112553,reaction,0,1
112554,products,0,1
112555,(,0,0
112556,MRP,0,1
112557,),0,0
112558,on,0,0
112559,calcium,1,0
112560,availability,1,1
112561,in,0,0
112562,adolescents,0,0
112563,and,0,0
112564,across,0,0
112565,Caco-2,0,1
112566,cell,0,1
112567,monolayers,0,0
112568,were,0,0
112569,examined,0,0
112570,.,0,0
112571,In,0,0
112572,a,0,0
112573,2,0,0
112574,week,0,0
112575,randomized,0,0
112576,two-period,0,0
112577,crossover,0,0
112578,trial,0,0
112579,",",0,0
112580,18,0,0
112581,male,0,0
112582,adolescents,0,0
112583,consumed,0,0
112584,two,0,0
112585,diets,0,0
112586,",",0,0
112587,named,0,0
112588,white,0,0
112589,diet,0,0
112590,(,0,0
112591,WD,0,0
112592,),0,0
112593,and,0,0
112594,brown,0,0
112595,diet,0,0
112596,(,0,0
112597,BD,0,0
112598,),0,0
112599,",",0,0
112600,which,0,0
112601,were,0,0
112602,poor,0,1
112603,and,0,0
112604,rich,0,0
112605,in,0,0
112606,MRP,0,1
112607,",",0,0
112608,respectively,0,0
112609,.,0,0
112610,A,0,0
112611,3,0,0
112612,day,0,0
112613,balance,0,1
112614,was,0,0
112615,performed,0,0
112616,at,0,0
112617,the,0,0
112618,end,0,0
112619,of,0,0
112620,each,0,0
112621,period,0,0
112622,",",0,0
112623,and,0,1
112624,fasting,1,1
112625,blood,1,1
112626,samples,1,0
112627,were,0,0
112628,collected,0,0
112629,.,0,0
112630,Calcium,1,0
112631,solubility,1,1
112632,and,1,1
112633,absorption,1,1
112634,across,1,0
112635,Caco-2,1,1
112636,cells,1,1
112637,were,0,0
112638,studied,0,0
112639,after,0,0
112640,the,0,0
112641,in,0,0
112642,vitro,0,0
112643,digestion,0,0
112644,of,0,0
112645,the,0,0
112646,diets,0,0
112647,.,0,0
112648,The,0,0
112649,in,0,0
112650,vitro,0,1
112651,assay,0,0
112652,showed,0,0
112653,similar,0,0
112654,solubility,1,1
112655,after,0,0
112656,the,0,0
112657,in,0,0
112658,vitro,0,0
112659,digestion,0,1
112660,and,0,0
112661,similar,0,0
112662,transport,0,1
112663,across,0,0
112664,Caco-2,0,1
112665,cells,0,1
112666,.,0,0
112667,In,0,0
112668,accordance,0,0
112669,",",0,0
112670,calcium,1,1
112671,bioavailability,1,1
112672,in,0,0
112673,adolescents,0,0
112674,did,0,0
112675,not,0,0
112676,vary,0,0
112677,between,0,0
112678,the,0,0
112679,diets,0,0
112680,(,0,0
112681,%,0,0
112682,WD,0,0
112683,=,0,0
112684,40.4,0,0
112685,+/-,0,0
112686,5.1,0,0
112687,",",0,0
112688,%,0,0
112689,BD,0,0
112690,=,0,0
112691,38.2,0,0
112692,+/-,0,0
112693,3.6,0,0
112694,),0,0
112695,.,0,0
112696,Serum,1,1
112697,and,1,0
112698,urine,1,1
112699,biochemical,1,1
112700,parameters,1,1
112701,related,1,0
112702,to,1,0
112703,calcium,1,0
112704,status,1,1
112705,and,1,1
112706,bone,1,1
112707,metabolism,1,1
112708,remained,0,0
112709,unaltered,0,0
112710,.,0,0
112711,Only,0,0
112712,deoxypyridinoline,1,0
112713,values,1,1
112714,were,0,0
112715,significantly,0,0
112716,lower,0,0
112717,after,0,0
112718,consumption,0,1
112719,of,0,0
112720,the,0,0
112721,BD,0,0
112722,(,0,0
112723,13.0,0,0
112724,+/-,0,0
112725,1.1,0,0
112726,compared,0,0
112727,to,0,0
112728,18.3,0,0
112729,+/-,0,0
112730,2.1,0,0
112731,nM/Mm,0,0
112732,Cr,0,0
112733,in,0,0
112734,the,0,0
112735,WD,0,0
112736,),0,0
112737,",",0,0
112738,possibly,0,0
112739,indicative,0,0
112740,of,0,0
112741,less,1,0
112742,efficient,1,1
112743,bone,1,1
112744,turnover,1,1
112745,during,0,0
112746,this,0,0
112747,period,0,0
112748,.,0,0
112749,As,0,0
112750,calcium,0,0
112751,acquired,0,0
112752,during,0,0
112753,adolescence,0,0
112754,is,0,0
112755,essential,0,0
112756,to,0,0
112757,maximize,0,0
112758,peak,0,1
112759,bone,0,1
112760,mass,0,1
112761,and,0,0
112762,to,0,0
112763,prevent,0,0
112764,osteoporosis,0,0
112765,",",0,0
112766,possible,0,0
112767,long-term,0,0
112768,effects,0,0
112769,of,0,0
112770,excessive,0,1
112771,MRP,0,1
112772,intake,0,1
112773,during,0,0
112774,this,0,0
112775,period,0,0
112776,warrant,0,0
112777,attention,0,0
112778,.,0,0
112779,Hematologic,0,0
112780,patients,0,0
112781,',0,0
112782,clinical,0,0
112783,and,0,0
112784,psychosocial,0,1
112785,experiences,0,1
112786,with,0,0
112787,implanted,0,0
112788,long-term,0,0
112789,central,0,0
112790,venous,0,1
112791,catheter,0,0
112792,:,0,0
112793,self-management,0,0
112794,versus,0,0
112795,professionally,0,0
112796,controlled,0,0
112797,care,0,0
112798,.,0,0
112799,BACKGROUND,0,0
112800,A,0,0
112801,significant,0,0
112802,decrease,0,0
112803,in,0,0
112804,catheter-related,0,1
112805,infections,0,1
112806,was,0,0
112807,demonstrated,0,0
112808,in,0,0
112809,our,0,0
112810,earlier,0,0
112811,randomized,0,0
112812,controlled,0,0
112813,trial,0,0
112814,of,0,0
112815,central,0,0
112816,venous,0,1
112817,catheter,0,0
112818,(,0,0
112819,CVC,0,0
112820,),0,0
112821,care,0,0
112822,in,0,0
112823,hematologic,0,0
112824,patients,0,0
112825,.,0,0
112826,OBJECTIVE,0,0
112827,This,0,0
112828,article,0,0
112829,focuses,0,0
112830,on,0,0
112831,patients,0,0
112832,',0,0
112833,clinical,0,0
112834,and,0,0
112835,psychosocial,0,1
112836,experiences,0,1
112837,with,0,0
112838,CVC,0,0
112839,self-care,0,1
112840,compared,0,0
112841,with,0,0
112842,professionally,0,0
112843,controlled,0,0
112844,CVC,0,0
112845,care,0,0
112846,.,0,0
112847,METHODS,0,0
112848,Eighty-two,0,0
112849,patients,0,0
112850,with,0,0
112851,tunneled,0,0
112852,CVCs,0,0
112853,were,0,0
112854,enrolled,0,0
112855,in,0,0
112856,the,0,0
112857,randomized,0,0
112858,controlled,0,0
112859,trial,0,0
112860,.,0,0
112861,The,0,0
112862,intervention,0,0
112863,group,0,0
112864,(,0,0
112865,n,0,0
112866,=,0,0
112867,42,0,0
112868,),0,0
112869,was,0,0
112870,trained,0,0
112871,to,0,0
112872,perform,0,0
112873,CVC,0,0
112874,self-care,0,1
112875,.,0,0
112876,The,0,0
112877,control,0,0
112878,group,0,0
112879,(,0,0
112880,n,0,0
112881,=,0,0
112882,40,0,0
112883,),0,0
112884,followed,0,0
112885,standard,0,0
112886,CVC,0,0
112887,procedure,0,0
112888,provided,0,0
112889,by,0,0
112890,nurses,0,0
112891,.,0,0
112892,Eighteen,0,0
112893,patients,0,0
112894,were,0,0
112895,selected,0,0
112896,for,0,0
112897,semistructured,0,0
112898,interviews,0,0
112899,focusing,0,0
112900,on,0,0
112901,patients,0,0
112902,',0,0
112903,clinical,0,0
112904,and,0,0
112905,psychosocial,0,1
112906,experiences,0,1
112907,with,0,0
112908,CVCs,0,0
112909,.,0,0
112910,RESULTS,0,0
112911,Methods,0,0
112912,of,0,0
112913,CVC,0,0
112914,care,0,0
112915,have,0,0
112916,different,0,0
112917,influences,0,0
112918,on,0,0
112919,the,0,0
112920,patients,0,0
112921,',0,0
112922,clinical,1,0
112923,and,1,0
112924,psychosocial,1,1
112925,outcomes,1,1
112926,",",0,0
112927,depending,0,0
112928,on,0,0
112929,whether,0,0
112930,they,0,0
112931,were,0,0
112932,hospitalized,0,0
112933,or,0,0
112934,outpatients,0,0
112935,.,0,0
112936,Central,0,1
112937,venous,0,1
112938,catheter,0,0
112939,was,0,0
112940,viewed,0,0
112941,as,0,0
112942,important,0,0
112943,because,0,0
112944,it,0,0
112945,was,0,0
112946,the,0,0
112947,main,0,0
112948,port,0,0
112949,of,0,0
112950,treatment,0,0
112951,toward,0,0
112952,a,0,0
112953,cure,0,1
112954,",",0,0
112955,although,0,0
112956,patients,0,0
112957,constantly,0,0
112958,fear,0,1
112959,complications,0,1
112960,.,0,0
112961,Central,0,1
112962,venous,0,1
112963,catheter,0,0
112964,self-care,0,1
112965,increased,0,0
112966,patients,1,0
112967,',1,0
112968,independence,1,1
112969,from,0,0
112970,health,0,1
112971,professionals,0,0
112972,and,0,1
112973,supported,0,0
112974,perceived,0,1
112975,self-efficacy,1,1
112976,and,0,0
112977,control,0,0
112978,.,0,0
112979,Central,0,1
112980,venous,0,1
112981,catheters,0,0
112982,cause,0,0
112983,psychosocial,1,0
112984,problems,1,1
112985,including,0,0
112986,altered,1,0
112987,body,1,1
112988,perception,1,1
112989,",",1,0
112990,sexual,1,1
112991,activity,1,1
112992,avoidance,1,1
112993,",",1,0
112994,and,1,1
112995,feeling,1,1
112996,stigmatized,1,0
112997,.,1,0
112998,CONCLUSIONS,0,0
112999,Patients,0,0
113000,experience,0,0
113001,increased,0,0
113002,perceived,1,1
113003,self-control,1,1
113004,and,1,0
113005,independence,1,1
113006,when,0,0
113007,individually,0,0
113008,supervised,0,0
113009,and,0,0
113010,trained,0,0
113011,in,0,0
113012,CVC,0,0
113013,self-management,0,0
113014,.,0,0
113015,Assuming,0,0
113016,ownership,0,1
113017,of,0,0
113018,CVC,0,0
113019,care,0,0
113020,can,0,0
113021,encourage,0,0
113022,patients,0,0
113023,to,0,0
113024,feel,0,0
113025,less,0,0
113026,inhibited,0,0
113027,about,0,0
113028,sexual,1,1
113029,activity,1,1
113030,and,1,0
113031,socialization,1,1
113032,.,1,0
113033,IMPLICATIONS,0,0
113034,FOR,0,0
113035,PRACTICE,0,0
113036,Placement,0,0
113037,of,0,0
113038,a,0,0
113039,tunneled,0,0
113040,CVC,0,0
113041,should,0,0
113042,engage,0,0
113043,nurses,0,0
113044,to,0,0
113045,organize,0,0
113046,individualized,0,0
113047,structured,0,0
113048,and,0,0
113049,supervised,0,0
113050,patient,0,0
113051,education,0,0
113052,.,0,0
113053,Stigma,0,0
113054,originating,0,0
113055,from,0,0
113056,CVCs,0,0
113057,should,0,0
113058,be,0,0
113059,carefully,0,0
113060,considered,0,0
113061,by,0,0
113062,health,0,0
113063,professionals,0,0
113064,when,0,0
113065,maintaining,0,0
113066,CVC,0,0
113067,insertion,0,0
113068,for,0,0
113069,longer,0,0
113070,periods,0,0
113071,.,0,0
113072,Central,0,1
113073,venous,0,0
113074,catheters,0,0
113075,should,0,0
113076,be,0,0
113077,removed,0,0
113078,whenever,0,0
113079,the,0,0
113080,potential,0,0
113081,risks,0,0
113082,exceed,0,0
113083,the,0,0
113084,catheter,0,0
113085,'s,0,0
113086,functional,0,0
113087,necessity,0,0
113088,.,0,0
113089,Losartan,0,0
113090,vs.,0,0
113091,amlodipine,0,0
113092,treatment,0,0
113093,in,0,0
113094,elderly,0,0
113095,oncologic,0,0
113096,hypertensive,0,0
113097,patients,0,0
113098,:,0,0
113099,a,0,0
113100,randomized,0,0
113101,clinical,0,0
113102,trial,0,0
113103,.,0,0
113104,Elderly,0,0
113105,neoplastic,0,0
113106,patients,0,0
113107,frequently,0,0
113108,may,0,0
113109,show,0,0
113110,hypertension,0,1
113111,and,0,1
113112,hyperuricemia,0,1
113113,",",0,1
113114,before,0,0
113115,and,0,0
113116,after,0,0
113117,chemotherapeutic,0,0
113118,treatments,0,0
113119,.,0,0
113120,The,0,0
113121,purpose,0,0
113122,of,0,0
113123,this,0,0
113124,study,0,0
113125,was,0,0
113126,to,0,0
113127,evaluate,0,0
113128,the,0,0
113129,efficacy,0,1
113130,of,0,0
113131,losartan,0,0
113132,which,0,0
113133,is,0,0
113134,an,0,0
113135,antihypertensive,0,0
113136,drug,0,0
113137,with,0,0
113138,uricosuric,0,1
113139,properties,0,1
113140,vs.,0,0
113141,amlodipine,0,0
113142,in,0,0
113143,hypertensive,0,0
113144,neoplastic,0,0
113145,elderly,0,0
113146,patients,0,0
113147,.,0,0
113148,This,0,0
113149,was,0,0
113150,an,0,0
113151,open-labeled,0,0
113152,",",0,0
113153,randomized,0,0
113154,",",0,0
113155,comparative,0,0
113156,trial,0,0
113157,.,0,0
113158,The,0,0
113159,study,0,0
113160,was,0,0
113161,performed,0,0
113162,as,0,0
113163,a,0,0
113164,30-day,0,1
113165,study,0,0
113166,.,0,0
113167,Seventy,0,0
113168,patients,0,0
113169,with,0,0
113170,cancer,0,0
113171,were,0,0
113172,randomly,0,0
113173,assigned,0,0
113174,to,0,0
113175,receive,0,0
113176,losartan,0,0
113177,or,0,0
113178,amlodipine,0,0
113179,.,0,1
113180,Blood,1,1
113181,pressure,1,1
113182,(,1,0
113183,BP,1,1
113184,),1,1
113185,",",1,0
113186,blood,1,1
113187,urea,1,1
113188,nitrogen,1,0
113189,(,1,0
113190,BUN,1,0
113191,),1,0
113192,levels,1,1
113193,",",1,0
113194,creatinine,1,1
113195,",",1,1
113196,serum,1,1
113197,and,1,1
113198,urinary,1,1
113199,uric,1,1
113200,acid,1,0
113201,",",1,0
113202,creatinine,1,1
113203,and,1,1
113204,uric,1,1
113205,acid,1,1
113206,clearance,1,1
113207,were,0,0
113208,determined,0,0
113209,before,0,0
113210,and,0,0
113211,after,0,0
113212,chemotherapy,0,0
113213,.,0,0
113214,One,0,0
113215,day,0,0
113216,after,0,0
113217,chemotherapy,0,0
113218,in,0,0
113219,losartan,0,0
113220,group,0,0
113221,vs.,0,0
113222,amlodipine,0,0
113223,group,0,0
113224,we,0,0
113225,observed,0,0
113226,a,0,0
113227,significant,0,0
113228,difference,0,0
113229,in,0,0
113230,urinary,1,1
113231,uric,1,1
113232,acid,1,0
113233,(,0,0
113234,p,0,0
113235,<,0,0
113236,0.001,0,0
113237,),0,0
113238,of,0,0
113239,18,0,0
113240,mg/24,0,0
113241,h,0,0
113242,vs.,0,0
113243,40,0,0
113244,mg/24,0,0
113245,h.,0,0
113246,Thirty,0,0
113247,days,0,0
113248,after,0,0
113249,chemotherapy,0,0
113250,we,0,0
113251,observed,0,0
113252,a,0,0
113253,significant,0,0
113254,difference,0,0
113255,in,0,0
113256,azotemia,1,0
113257,of,0,0
113258,0.0,0,0
113259,mg/dl,0,0
113260,vs.,0,0
113261,3.8,0,0
113262,mg/dl,0,0
113263,(,0,0
113264,p,0,0
113265,<,0,0
113266,0.001,0,0
113267,),0,0
113268,",",0,0
113269,serum,1,1
113270,uric,1,1
113271,acid,1,0
113272,of,0,0
113273,0.05,0,0
113274,mg/dl,0,0
113275,vs.,0,0
113276,0.49,0,0
113277,mg/dl,0,0
113278,(,0,0
113279,p,0,0
113280,<,0,0
113281,0.001,0,0
113282,),0,0
113283,",",0,0
113284,urinary,1,1
113285,uric,1,1
113286,acid,1,0
113287,(,0,0
113288,p,0,0
113289,<,0,0
113290,0.001,0,0
113291,),0,0
113292,of,0,0
113293,23,0,0
113294,mg/24,0,0
113295,h,0,0
113296,vs.,0,0
113297,0.0,0,0
113298,mg/24,0,0
113299,h,0,0
113300,",",0,0
113301,GFR,0,0
113302,of,0,0
113303,2,0,0
113304,ml/min/1.73,0,0
113305,m,0,0
113306,(,0,0
113307,2,0,0
113308,),0,0
113309,vs.,0,0
113310,-8,0,0
113311,ml/min/1.73,0,0
113312,m,0,0
113313,(,0,0
113314,2,0,0
113315,),0,0
113316,(,0,0
113317,p,0,0
113318,<,0,0
113319,0.05,0,0
113320,),0,0
113321,and,0,0
113322,systolic,1,1
113323,BP,1,1
113324,(,0,0
113325,SBP,0,1
113326,),0,0
113327,of,0,0
113328,3.6,0,0
113329,mmHg,0,0
113330,vs.,0,0
113331,0.8,0,0
113332,mmHg,0,0
113333,(,0,0
113334,p,0,0
113335,<,0,0
113336,0.05,0,0
113337,),0,0
113338,.,0,0
113339,The,0,0
113340,findings,0,0
113341,of,0,0
113342,the,0,0
113343,present,0,0
113344,study,0,0
113345,support,0,0
113346,the,0,0
113347,effective,0,1
113348,role,0,0
113349,of,0,0
113350,losartan,0,0
113351,compared,0,0
113352,to,0,0
113353,amlodipine,0,0
113354,in,0,0
113355,treating,0,0
113356,hypertension,0,1
113357,and,0,1
113358,hyperuricemia,0,1
113359,in,0,0
113360,elderly,0,0
113361,patients,0,0
113362,under,0,0
113363,chemotherapeutic,0,0
113364,treatment,0,0
113365,.,0,0
113366,Comorbidity,1,1
113367,",",1,0
113368,age,1,0
113369,and,0,1
113370,overall,1,1
113371,survival,1,1
113372,in,0,0
113373,cetuximab-treated,0,0
113374,patients,0,0
113375,with,0,0
113376,advanced,0,0
113377,colorectal,0,0
113378,cancer,0,0
113379,(,0,0
113380,ACRC,0,0
113381,),0,0
113382,--,0,0
113383,results,0,0
113384,from,0,0
113385,NCIC,0,0
113386,CTG,0,1
113387,CO.17,0,0
113388,:,0,0
113389,a,0,0
113390,phase,0,0
113391,III,0,0
113392,trial,0,0
113393,of,0,0
113394,cetuximab,0,0
113395,versus,0,0
113396,best,0,0
113397,supportive,0,0
113398,care,0,0
113399,.,0,0
113400,BACKGROUND,0,0
113401,the,0,0
113402,interplay,0,0
113403,between,0,0
113404,comorbidity,1,1
113405,",",1,0
113406,age,1,0
113407,and,0,1
113408,performance,1,1
113409,status,1,1
113410,(,1,0
113411,PS,1,0
113412,),1,0
113413,as,0,0
113414,predictors,0,0
113415,of,0,0
113416,outcome,0,0
113417,in,0,0
113418,advanced,0,0
113419,colorectal,0,0
113420,cancer,0,0
113421,(,0,0
113422,ACRC,0,0
113423,),0,0
113424,is,0,0
113425,poorly,0,0
113426,understood,0,0
113427,.,0,0
113428,We,0,0
113429,examined,0,0
113430,these,0,0
113431,factors,0,0
113432,as,0,0
113433,predictors,0,0
113434,of,0,0
113435,treatment,0,0
113436,toxicity,1,1
113437,and,0,1
113438,outcome,0,1
113439,in,0,0
113440,cetuximab-treated,0,0
113441,patients,0,0
113442,with,0,0
113443,ACRC,0,0
113444,.,0,0
113445,PATIENTS,0,0
113446,AND,0,0
113447,METHODS,0,0
113448,comorbidity,0,1
113449,was,0,0
113450,independently,0,0
113451,evaluated,0,0
113452,using,0,0
113453,the,0,0
113454,Charlson,1,0
113455,Comorbidity,1,1
113456,Index,1,0
113457,(,1,0
113458,CCI,1,1
113459,),1,0
113460,",",0,0
113461,a,0,0
113462,validated,0,0
113463,measure,0,0
113464,of,0,0
113465,comorbidity,1,1
113466,based,0,0
113467,on,0,0
113468,the,0,0
113469,presence,0,0
113470,of,0,0
113471,medical,0,0
113472,conditions,0,0
113473,weighted,0,0
113474,according,0,0
113475,to,0,0
113476,their,0,0
113477,effect,0,0
113478,on,0,0
113479,mortality,0,1
113480,.,0,0
113481,CCI,1,1
113482,score,1,1
113483,was,0,0
113484,correlated,0,0
113485,with,0,0
113486,clinical,0,0
113487,and,0,0
113488,outcome,0,1
113489,data,0,0
113490,.,0,0
113491,RESULTS,0,0
113492,five,0,0
113493,hundred,0,0
113494,and,0,0
113495,seventy-two,0,0
113496,patients,0,0
113497,were,0,0
113498,included,0,0
113499,;,0,0
113500,41,0,0
113501,%,0,0
113502,were,0,0
113503,?,0,0
113504,65,0,0
113505,years,0,0
113506,and,0,0
113507,25,0,0
113508,%,0,0
113509,had,0,0
113510,comorbidities,0,0
113511,at,0,0
113512,randomization,0,0
113513,.,0,0
113514,In,0,0
113515,multivariate,0,0
113516,analysis,0,0
113517,(,0,0
113518,MVA,0,0
113519,),0,0
113520,of,0,0
113521,all,0,0
113522,covariates,0,0
113523,",",0,0
113524,only,0,0
113525,older,0,0
113526,age,0,0
113527,was,0,0
113528,associated,0,0
113529,with,0,0
113530,greater,0,0
113531,comorbidity,0,1
113532,(,0,0
113533,P,0,0
113534,=,0,0
113535,0.008,1,0
113536,),1,0
113537,.,1,0
113538,Overall,1,1
113539,survival,1,1
113540,(,1,0
113541,OS,1,1
113542,),1,0
113543,was,1,0
113544,significantly,0,0
113545,better,0,0
113546,for,0,0
113547,patients,0,0
113548,with,0,0
113549,greater,0,0
113550,comorbidity,0,1
113551,in,0,0
113552,univariate,0,0
113553,analysis,0,0
113554,(,0,0
113555,P,0,0
113556,=,0,0
113557,0.047,0,0
113558,),0,0
113559,.,0,0
113560,Conversely,0,0
113561,",",0,0
113562,better,1,0
113563,PS,1,0
113564,was,1,0
113565,associated,0,0
113566,with,0,0
113567,better,1,0
113568,OS,1,1
113569,in,1,0
113570,MVA,0,0
113571,(,0,0
113572,hazard,0,1
113573,ratio,0,0
113574,1.92,0,0
113575,for,0,0
113576,PS,0,0
113577,=,0,0
113578,2,0,0
113579,versus,0,0
113580,PS,0,0
113581,=,0,0
113582,0,0,0
113583,",",0,0
113584,P,0,0
113585,<,0,0
113586,0.0001,0,0
113587,),0,0
113588,.,0,0
113589,Age,0,1
113590,was,0,0
113591,not,0,0
113592,associated,0,0
113593,with,1,0
113594,OS,1,1
113595,(,1,0
113596,P,0,0
113597,=,0,0
113598,0.13,0,0
113599,),0,0
113600,.,0,0
113601,Elderly,0,0
113602,patients,0,0
113603,had,0,0
113604,significantly,0,0
113605,less,1,0
113606,grade,1,1
113607,?,1,0
113608,3,1,0
113609,vomiting,1,1
113610,(,1,0
113611,P,1,0
113612,=,0,0
113613,0.034,0,0
113614,),0,0
113615,but,0,0
113616,more,0,0
113617,dyspnea,1,1
113618,(,1,0
113619,P,1,0
113620,=,0,0
113621,0.005,0,0
113622,),0,0
113623,.,0,0
113624,Patients,0,0
113625,with,0,0
113626,greater,0,0
113627,comorbidity,0,1
113628,had,0,0
113629,significantly,0,0
113630,less,0,0
113631,grade,1,1
113632,?,1,0
113633,3,1,0
113634,vomiting,1,1
113635,(,1,0
113636,P,1,0
113637,=,1,0
113638,0.002,0,0
113639,),0,0
113640,but,0,0
113641,more,0,0
113642,non-neutropenic,1,1
113643,fever,1,1
113644,(,1,0
113645,P,0,0
113646,=,0,0
113647,0.005,0,0
113648,),0,0
113649,.,0,0
113650,CONCLUSION,1,0
113651,better,1,0
113652,PS,1,0
113653,was,1,0
113654,associated,0,0
113655,with,0,0
113656,improved,0,0
113657,OS,1,1
113658,.,1,0
113659,For,1,0
113660,patients,0,0
113661,with,0,0
113662,good,1,0
113663,PS,1,0
113664,",",0,0
113665,restricting,0,0
113666,cetuximab,0,0
113667,use,0,0
113668,in,0,0
113669,the,0,0
113670,setting,0,0
113671,of,0,0
113672,significant,0,0
113673,comorbidity,0,1
113674,does,0,0
113675,not,0,0
113676,appear,0,0
113677,justified,0,0
113678,.,0,0
113679,Translucency,0,1
113680,of,0,0
113681,zirconia,0,0
113682,copings,0,1
113683,made,0,0
113684,with,0,0
113685,different,0,0
113686,CAD/CAM,0,0
113687,systems,0,0
113688,.,0,0
113689,STATEMENT,0,0
113690,OF,0,0
113691,PROBLEM,0,0
113692,Zirconia,0,0
113693,cores,0,0
113694,are,0,0
113695,reported,0,0
113696,to,0,0
113697,be,0,0
113698,less,0,0
113699,translucent,0,1
113700,than,0,0
113701,glass,0,0
113702,",",0,0
113703,lithium,0,1
113704,disilicate,0,0
113705,",",0,0
113706,or,0,0
113707,alumina,0,0
113708,cores,0,0
113709,.,0,0
113710,This,0,0
113711,could,0,0
113712,affect,0,0
113713,the,0,0
113714,esthetic,0,1
113715,appearance,0,0
113716,and,0,0
113717,the,0,0
113718,clinical,0,0
113719,choices,0,0
113720,made,0,0
113721,when,0,0
113722,using,0,0
113723,zirconia-based,0,0
113724,restorations,0,0
113725,.,0,0
113726,PURPOSE,0,0
113727,The,0,0
113728,purpose,0,0
113729,of,0,0
113730,this,0,0
113731,in,0,0
113732,vitro,0,1
113733,study,0,0
113734,was,0,0
113735,to,0,0
113736,evaluate,0,0
113737,the,0,0
113738,translucency,1,1
113739,of,0,0
113740,zirconia,0,0
113741,copings,0,1
113742,for,0,0
113743,single,0,0
113744,crowns,0,0
113745,fabricated,0,0
113746,using,0,0
113747,different,0,0
113748,CAD/CAM,0,0
113749,systems,0,0
113750,",",0,0
113751,using,0,0
113752,lithium,0,0
113753,disilicate,0,0
113754,glass,0,1
113755,ceramic,0,0
113756,as,0,0
113757,a,0,0
113758,control,0,0
113759,.,0,0
113760,MATERIAL,0,0
113761,AND,0,0
113762,METHODS,0,0
113763,Using,0,0
113764,impressions,0,0
113765,made,0,0
113766,from,0,0
113767,a,0,0
113768,stainless,0,0
113769,steel,0,0
113770,complete-crown,0,0
113771,master,0,0
113772,die,0,0
113773,",",0,0
113774,9,0,0
113775,stone,0,1
113776,cast,0,0
113777,replicas,0,0
113778,were,0,0
113779,fabricated,0,0
113780,",",0,0
113781,numbered,0,0
113782,",",0,0
113783,and,0,0
113784,distributed,0,0
113785,into,0,0
113786,8,0,0
113787,ceramic,0,0
113788,ZrO,0,0
113789,(,0,0
113790,2,0,0
113791,),0,0
113792,CAD/CAM,0,0
113793,system,0,0
113794,groups,0,0
113795,(,0,0
113796,Lava,0,0
113797,Frame,0,0
113798,0.3,0,0
113799,and,0,0
113800,0.5,0,0
113801,",",0,0
113802,IPS,0,0
113803,e.max,0,0
113804,ZirCAD,0,0
113805,",",0,0
113806,VITA,0,0
113807,YZ,0,1
113808,",",0,0
113809,Procera,0,1
113810,AllZircon,0,0
113811,",",0,0
113812,Digizon,0,1
113813,",",0,0
113814,DC,0,0
113815,Zircon,0,1
113816,",",0,0
113817,and,0,1
113818,Cercon,0,0
113819,Base,0,1
113820,),0,0
113821,and,0,0
113822,to,0,0
113823,a,0,0
113824,lithium,0,0
113825,disilicate,0,0
113826,glass-ceramic,0,0
113827,control,0,0
113828,group,0,0
113829,(,0,0
113830,IPS,0,0
113831,e.max,0,0
113832,Press,0,0
113833,),0,0
113834,using,0,0
113835,a,0,0
113836,simple,0,0
113837,computer-generated,0,0
113838,randomization,0,0
113839,method,0,0
113840,.,0,0
113841,From,0,0
113842,each,0,0
113843,die,0,0
113844,",",0,0
113845,the,0,0
113846,manufacturer,0,0
113847,'s,0,0
113848,authorized,0,0
113849,milling,0,0
113850,centers,0,0
113851,supplied,0,0
113852,5,0,0
113853,copings,0,0
113854,per,0,0
113855,group,0,0
113856,without,0,0
113857,applying,0,0
113858,any,0,0
113859,dying,0,0
113860,technique,0,0
113861,to,0,0
113862,the,0,0
113863,ceramic,0,0
113864,base,0,0
113865,material,0,0
113866,.,0,0
113867,The,0,0
113868,copings,0,0
113869,were,0,0
113870,prepared,0,0
113871,to,0,0
113872,allow,0,0
113873,for,0,0
113874,a,0,0
113875,40-mum,0,0
113876,cement,0,0
113877,layer,0,1
113878,and,0,1
113879,were,0,0
113880,of,0,0
113881,different,0,0
113882,thicknesses,0,1
113883,according,0,0
113884,to,0,0
113885,system,0,0
113886,specifications,0,0
113887,.,0,0
113888,Translucency,1,1
113889,was,0,0
113890,measured,0,0
113891,by,0,0
113892,the,0,0
113893,direct,0,0
113894,transmission,0,1
113895,method,0,0
113896,with,0,0
113897,a,0,0
113898,digital,0,0
113899,photoradiometer,0,0
113900,mounted,0,0
113901,in,0,0
113902,a,0,0
113903,dark,0,0
113904,chamber,0,0
113905,.,0,0
113906,The,0,0
113907,light,0,0
113908,source,0,0
113909,was,0,0
113910,a,0,0
113911,150-W,0,0
113912,halogen,0,0
113913,lamp,0,1
113914,beam,0,1
113915,.,0,0
113916,Measurements,0,0
113917,were,0,0
113918,repeated,0,0
113919,3,0,0
113920,times,0,0
113921,for,0,0
113922,each,0,0
113923,specimen,0,0
113924,.,0,0
113925,Data,0,0
113926,obtained,0,0
113927,were,0,0
113928,analyzed,0,0
113929,using,0,0
113930,1-way,0,0
113931,ANOVA,0,0
113932,and,0,0
113933,the,0,0
113934,Bonferroni,0,1
113935,multiple,0,0
113936,comparison,0,0
113937,test,0,1
113938,(,0,0
113939,alpha=.05,0,0
113940,),0,0
113941,.,0,0
113942,RESULTS,0,0
113943,Among,0,0
113944,ZrO,0,1
113945,(,0,0
113946,2,0,0
113947,),0,0
113948,copings,0,0
113949,",",0,0
113950,Lava,0,1
113951,(,0,0
113952,0.3,0,0
113953,mm,0,0
113954,and,0,0
113955,0.5,0,0
113956,mm,0,0
113957,thick,0,0
113958,),0,0
113959,showed,0,0
113960,the,0,0
113961,highest,0,0
113962,(,0,0
113963,P,0,0
113964,<,0,0
113965,.05,0,0
113966,),0,0
113967,values,1,1
113968,of,1,0
113969,translucency,1,1
113970,measured,0,0
113971,as,0,0
113972,light,0,0
113973,flow,0,1
113974,units,0,0
113975,(,0,0
113976,3.572,0,0
113977,+,0,0
113978,or,0,0
113979,-,0,0
113980,018,0,0
113981,x,0,0
113982,10,0,0
113983,(,0,0
113984,3,0,0
113985,),0,0
113986,lx,0,0
113987,and,0,0
113988,3.181,0,0
113989,+,0,0
113990,or,0,0
113991,-,0,0
113992,0.13,0,0
113993,x,0,0
113994,10,0,0
113995,(,0,0
113996,3,0,0
113997,),0,0
113998,lx,0,0
113999,",",0,0
114000,respectively,0,0
114001,),0,0
114002,.,0,0
114003,These,0,0
114004,values,0,0
114005,represent,0,0
114006,71.7,0,0
114007,%,0,0
114008,and,0,0
114009,63.9,0,0
114010,%,0,0
114011,",",0,0
114012,respectively,0,0
114013,",",0,0
114014,of,0,0
114015,the,0,0
114016,glass-ceramic,0,0
114017,control,0,0
114018,group,0,0
114019,(,0,0
114020,4.98,0,0
114021,x,0,0
114022,10,0,0
114023,(,0,0
114024,3,0,0
114025,),0,0
114026,lx,0,0
114027,),0,0
114028,.,0,0
114029,CONCLUSIONS,0,0
114030,All,0,0
114031,ZrO,0,1
114032,(,0,0
114033,2,0,0
114034,),0,0
114035,copings,0,0
114036,demonstrated,0,0
114037,different,0,0
114038,levels,0,1
114039,of,0,0
114040,light,0,1
114041,transmission,0,1
114042,",",0,0
114043,with,0,0
114044,the,0,0
114045,2,0,0
114046,Lava,0,0
114047,specimens,0,0
114048,showing,0,0
114049,the,0,0
114050,highest,0,0
114051,values,0,1
114052,.,0,0
114053,Translucency,1,1
114054,of,0,0
114055,zirconia,0,0
114056,copings,0,1
114057,was,0,0
114058,significantly,0,0
114059,lower,0,0
114060,(,0,0
114061,P=.001,0,1
114062,),0,0
114063,than,0,0
114064,that,0,0
114065,of,0,0
114066,the,0,0
114067,lithium,0,0
114068,disilicate,0,0
114069,glass-ceramic,0,0
114070,control,0,0
114071,.,0,0
114072,Tensile,1,1
114073,bond,1,1
114074,strength,1,1
114075,of,0,0
114076,a,0,0
114077,lithium-disilicate,0,0
114078,pressed,0,0
114079,glass,0,0
114080,ceramic,0,0
114081,to,0,0
114082,dentin,0,0
114083,of,0,0
114084,different,0,0
114085,surface,0,0
114086,treatments,0,0
114087,.,0,0
114088,The,0,0
114089,effects,0,0
114090,of,0,0
114091,desensitizer,0,0
114092,",",0,0
114093,disinfectant,0,1
114094,",",0,1
114095,saliva,0,1
114096,",",0,1
114097,blood,0,1
114098,",",0,1
114099,and,0,1
114100,hydrogen,0,1
114101,peroxide,0,1
114102,on,0,0
114103,the,0,0
114104,tensile,1,1
114105,bond,1,1
114106,strength,1,1
114107,between,0,0
114108,adhesive,0,0
114109,and,0,0
114110,ceramic,0,0
114111,as,0,0
114112,well,0,0
114113,as,0,0
114114,between,0,0
114115,adhesive,0,0
114116,and,0,0
114117,dentin,0,0
114118,were,0,0
114119,examined,0,0
114120,.,0,0
114121,Sixty,0,0
114122,7x3,0,0
114123,mm,0,0
114124,pressed,0,0
114125,ceramic,0,0
114126,discs,0,0
114127,of,0,0
114128,IPS,0,0
114129,e.max,0,0
114130,were,0,0
114131,fabricated,0,0
114132,and,0,0
114133,randomly,0,0
114134,assigned,0,0
114135,to,0,0
114136,six,0,0
114137,groups,0,0
114138,of,0,0
114139,different,0,0
114140,dentin,0,0
114141,surface,0,0
114142,treatments,0,0
114143,(,0,0
114144,control,0,0
114145,",",0,1
114146,desensitizer,0,0
114147,",",0,1
114148,disinfectant,0,1
114149,",",0,1
114150,saliva,0,1
114151,",",0,1
114152,blood,0,1
114153,",",0,0
114154,and,0,1
114155,hydrogen,0,1
114156,peroxide,0,1
114157,),0,0
114158,.,0,0
114159,Representative,0,0
114160,samples,0,0
114161,of,0,0
114162,fractured,0,1
114163,specimens,0,0
114164,were,0,0
114165,observed,0,0
114166,by,0,0
114167,SEM,0,0
114168,(,0,0
114169,scanning,0,0
114170,electron,0,0
114171,microscopy,0,0
114172,),0,0
114173,.,0,0
114174,There,0,0
114175,were,0,0
114176,significant,0,0
114177,differences,0,0
114178,between,0,0
114179,the,0,0
114180,control,0,0
114181,group,0,0
114182,and,0,1
114183,saliva,0,1
114184,",",0,1
114185,blood,0,1
114186,",",0,1
114187,and,0,1
114188,hydrogen,0,1
114189,peroxide,0,1
114190,groups,0,0
114191,(,0,0
114192,p,0,0
114193,<,0,0
114194,0.05,0,0
114195,),0,0
114196,.,0,0
114197,However,0,0
114198,",",0,0
114199,there,0,0
114200,were,0,0
114201,no,0,0
114202,significant,0,0
114203,differences,0,0
114204,between,0,0
114205,any,0,0
114206,other,0,0
114207,dentin,0,0
114208,surface,0,0
114209,treatment,0,0
114210,groups,0,0
114211,(,0,0
114212,p,0,0
114213,>,0,0
114214,0.05,0,0
114215,),0,0
114216,.,0,0
114217,Results,0,0
114218,of,0,0
114219,this,0,0
114220,study,0,0
114221,suggested,0,0
114222,that,0,0
114223,only,0,0
114224,saliva,0,0
114225,",",0,0
114226,blood,0,1
114227,",",0,1
114228,and,0,1
114229,hydrogen,0,1
114230,peroxide,0,1
114231,influenced,0,0
114232,the,0,0
114233,tensile,1,1
114234,bond,1,1
114235,strength,1,1
114236,between,0,0
114237,dentin,0,0
114238,and,0,0
114239,ceramic,0,0
114240,.,0,0
114241,[,0,0
114242,A,0,0
114243,prospective,0,0
114244,randomized,0,0
114245,study,0,0
114246,of,0,0
114247,the,0,0
114248,radiotherapy,0,0
114249,volume,0,1
114250,for,0,0
114251,limited-stage,0,0
114252,small,0,0
114253,cell,0,1
114254,lung,0,0
114255,cancer,0,0
114256,:,0,0
114257,a,0,0
114258,preliminary,0,0
114259,report,0,0
114260,],0,0
114261,.,0,0
114262,BACKGROUND,0,0
114263,AND,0,0
114264,OBJECTIVE,0,0
114265,Controversies,0,0
114266,exists,0,0
114267,with,0,0
114268,regard,0,0
114269,to,0,0
114270,target,0,0
114271,volumes,0,1
114272,as,0,0
114273,far,0,0
114274,as,0,0
114275,thoracic,0,0
114276,radiotherapy,0,0
114277,(,0,0
114278,TRT,0,1
114279,),0,0
114280,is,0,0
114281,concerned,0,0
114282,in,0,0
114283,the,0,0
114284,multimodality,0,0
114285,treatment,0,0
114286,for,0,0
114287,limited-stage,0,0
114288,small,0,0
114289,cell,0,1
114290,lung,0,1
114291,cancer,0,0
114292,(,0,0
114293,LSCLC,0,0
114294,),0,0
114295,.,0,0
114296,The,0,0
114297,aim,0,0
114298,of,0,0
114299,this,0,0
114300,study,0,0
114301,is,0,0
114302,to,0,0
114303,prospectively,0,0
114304,compare,0,0
114305,the,0,0
114306,local,0,0
114307,control,0,0
114308,rate,0,1
114309,",",0,0
114310,toxicity,0,1
114311,profiles,0,1
114312,",",0,0
114313,and,0,1
114314,overall,0,1
114315,survival,0,1
114316,(,0,0
114317,OS,0,1
114318,),0,0
114319,between,0,0
114320,patients,0,0
114321,received,0,0
114322,different,0,0
114323,target,0,0
114324,volumes,0,1
114325,irradiation,0,0
114326,after,0,0
114327,induction,0,0
114328,chemotherapy,0,0
114329,.,0,0
114330,METHODS,0,0
114331,LSCLC,0,0
114332,patients,0,0
114333,received,0,0
114334,2,0,0
114335,cycles,0,0
114336,of,0,0
114337,etoposide,0,0
114338,and,0,1
114339,cisplatin,0,0
114340,(,0,1
114341,EP,0,1
114342,),0,1
114343,induction,0,1
114344,chemotherapy,0,0
114345,and,0,1
114346,were,0,0
114347,randomly,0,0
114348,assigned,0,0
114349,to,0,0
114350,receive,0,0
114351,TRT,0,0
114352,to,0,0
114353,either,0,0
114354,the,0,0
114355,post-,0,0
114356,or,0,0
114357,pre-chemotherapy,0,0
114358,tumor,0,1
114359,extent,0,0
114360,(,0,0
114361,GTV-T,0,0
114362,),0,0
114363,as,0,0
114364,study,0,0
114365,arm,0,0
114366,and,0,1
114367,control,0,0
114368,arm,0,0
114369,",",0,0
114370,CTV-N,0,0
114371,included,0,0
114372,the,0,0
114373,positive,0,0
114374,nodal,0,0
114375,drainage,0,0
114376,area,0,1
114377,for,0,0
114378,both,0,0
114379,arms,0,0
114380,.,0,0
114381,One,0,0
114382,to,0,0
114383,2,0,0
114384,weeks,0,0
114385,after,0,0
114386,induction,0,1
114387,chemotherapy,0,0
114388,",",0,0
114389,45,0,0
114390,Gy/30,0,0
114391,Fx/19,0,0
114392,d,0,0
114393,TRT,0,1
114394,was,0,0
114395,administered,0,0
114396,concurrently,0,0
114397,with,0,0
114398,the,0,0
114399,third,0,0
114400,cycle,0,1
114401,of,0,0
114402,EP,0,0
114403,regimen,0,0
114404,.,0,0
114405,After,0,0
114406,that,0,0
114407,",",0,0
114408,additional,0,0
114409,3,0,0
114410,cycles,0,0
114411,of,0,0
114412,EP,0,1
114413,consolidation,0,1
114414,were,0,0
114415,administered,0,0
114416,.,0,0
114417,Prophylactic,0,0
114418,cranial,0,0
114419,irradiation,0,0
114420,(,0,0
114421,PCI,0,1
114422,),0,0
114423,was,0,0
114424,administered,0,0
114425,to,0,0
114426,patients,0,0
114427,with,0,0
114428,a,0,0
114429,complete,0,0
114430,response,0,1
114431,.,0,0
114432,RESULTS,0,0
114433,Thirty-seven,0,0
114434,and,0,0
114435,40,0,0
114436,patients,0,0
114437,were,0,0
114438,randomly,0,0
114439,assigned,0,0
114440,to,0,0
114441,study,0,0
114442,arm,0,0
114443,and,0,1
114444,control,0,0
114445,arm,0,0
114446,.,0,0
114447,The,0,0
114448,local,1,0
114449,recurrence,1,1
114450,rates,1,1
114451,were,0,0
114452,32.4,0,0
114453,%,0,0
114454,and,0,0
114455,28.2,0,0
114456,%,0,0
114457,respectively,0,0
114458,(,0,0
114459,P,0,0
114460,=,0,0
114461,0.80,0,0
114462,),0,0
114463,;,0,0
114464,the,0,0
114465,isolated,0,0
114466,nodal,1,0
114467,failure,1,1
114468,(,1,0
114469,INF,1,0
114470,),1,0
114471,rates,0,1
114472,were,0,0
114473,3.0,0,0
114474,%,0,0
114475,and,0,0
114476,2.6,0,0
114477,%,0,0
114478,respectively,0,0
114479,(,0,0
114480,P,0,0
114481,=,0,0
114482,0.91,0,0
114483,),0,0
114484,;,0,0
114485,all,0,0
114486,INF,0,0
114487,sites,0,0
114488,were,0,0
114489,in,0,0
114490,the,0,0
114491,ipsilateral,0,0
114492,supraclavicular,0,0
114493,fossa,0,0
114494,.,0,0
114495,Medastinal,1,0
114496,N3,1,0
114497,disease,1,0
114498,was,0,0
114499,the,0,0
114500,risk,0,1
114501,factor,0,0
114502,for,0,0
114503,INF,0,0
114504,(,0,0
114505,P,0,0
114506,=,0,0
114507,0.02,0,0
114508,",",0,0
114509,OR,0,0
114510,=,0,0
114511,14.13,0,0
114512,",",0,0
114513,95,0,0
114514,%,0,0
114515,CI,0,0
114516,:,0,0
114517,1.47-136.13,0,0
114518,),0,0
114519,.,0,0
114520,During,0,0
114521,radiotherapy,0,0
114522,",",0,0
114523,grade,1,1
114524,I,1,0
114525,",",1,0
114526,II,1,0
114527,weight,1,1
114528,loss,1,1
114529,was,0,0
114530,observed,0,0
114531,in,0,0
114532,29.4,0,0
114533,%,0,0
114534,",",0,0
114535,5.9,0,0
114536,%,0,0
114537,and,0,0
114538,56.4,0,0
114539,%,0,0
114540,",",0,0
114541,7.7,0,0
114542,%,0,0
114543,patients,0,0
114544,respectively,0,0
114545,(,0,0
114546,P,0,0
114547,=,0,0
114548,0.04,0,0
114549,),0,0
114550,.,0,0
114551,Grade,1,0
114552,0-I,1,0
114553,and,1,0
114554,II-III,1,1
114555,late,1,1
114556,pulmonary,1,1
114557,injury,1,1
114558,was,0,0
114559,developed,0,0
114560,in,0,0
114561,97.1,0,0
114562,%,0,0
114563,",",0,0
114564,2.9,0,0
114565,%,0,0
114566,and,0,0
114567,86.4,0,0
114568,%,0,0
114569,",",0,0
114570,15.4,0,0
114571,%,0,0
114572,patients,0,0
114573,respectively,0,0
114574,(,0,0
114575,P,0,0
114576,=,0,0
114577,0.07,0,0
114578,),0,0
114579,.,0,0
114580,Median,1,1
114581,survival,1,1
114582,time,1,1
114583,was,0,0
114584,22.1,0,0
114585,months,0,0
114586,and,0,0
114587,26.9,0,0
114588,months,0,0
114589,respectively,0,0
114590,.,0,0
114591,The,0,0
114592,1,1,0
114593,to,1,0
114594,3-year,1,0
114595,OS,1,1
114596,were,0,0
114597,77.9,0,0
114598,%,0,0
114599,",",0,0
114600,44.4,0,0
114601,%,0,0
114602,",",0,0
114603,37.3,0,0
114604,%,0,0
114605,and,0,0
114606,75.8,0,0
114607,%,0,0
114608,",",0,0
114609,56.3,0,0
114610,%,0,0
114611,",",0,0
114612,41.7,0,0
114613,%,0,0
114614,respectively,0,0
114615,(,0,0
114616,P,0,0
114617,=,0,0
114618,0.79,0,0
114619,),0,0
114620,.,0,0
114621,CONCLUSIONS,0,0
114622,The,0,0
114623,preliminary,0,0
114624,results,0,0
114625,of,0,0
114626,this,0,0
114627,study,0,0
114628,indicate,0,0
114629,that,0,0
114630,irradiant,0,0
114631,the,0,0
114632,post-chemotherapy,0,0
114633,tumor,0,1
114634,extent,0,0
114635,(,0,0
114636,GTV-T,0,1
114637,),0,0
114638,and,0,0
114639,positive,0,1
114640,nodal,0,1
114641,drainage,0,0
114642,area,0,1
114643,did,0,0
114644,not,0,0
114645,decrease,0,0
114646,local,0,0
114647,control,0,0
114648,and,0,0
114649,overall,0,1
114650,survival,0,1
114651,while,0,0
114652,radiation,0,0
114653,toxicity,0,1
114654,was,0,0
114655,reduced,0,0
114656,.,0,0
114657,But,0,0
114658,the,0,0
114659,current,0,0
114660,sample,0,0
114661,size,0,0
114662,has,0,0
114663,not,0,0
114664,met,0,0
114665,designed,0,0
114666,requirements,0,0
114667,",",0,0
114668,and,0,1
114669,further,0,0
114670,investigation,0,0
114671,is,0,0
114672,warranted,0,0
114673,before,0,0
114674,final,0,0
114675,conclusions,0,0
114676,could,0,0
114677,be,0,0
114678,drawn,0,0
114679,.,0,0
114680,Cost-effectiveness,1,1
114681,of,0,0
114682,cognitive-behavioral,0,0
114683,group,0,0
114684,therapy,0,0
114685,for,0,0
114686,dysfunctional,0,0
114687,fear,0,1
114688,of,0,0
114689,progression,0,1
114690,in,0,0
114691,cancer,0,0
114692,patients,0,0
114693,.,0,0
114694,Anxiety,1,1
114695,and,1,0
114696,fear,1,1
114697,are,0,0
114698,often,0,0
114699,associated,0,0
114700,with,0,0
114701,chronic,0,0
114702,conditions,0,0
114703,such,0,0
114704,as,0,0
114705,cancer,0,0
114706,.,0,0
114707,This,0,0
114708,paper,0,0
114709,targets,0,0
114710,the,0,0
114711,cost-effectiveness,1,0
114712,analysis,1,0
114713,of,0,0
114714,a,0,0
114715,cognitive-behavioral,0,0
114716,group,0,0
114717,therapy,0,0
114718,(,0,0
114719,CBT,0,0
114720,),0,0
114721,in,0,0
114722,comparison,0,0
114723,to,0,0
114724,a,0,0
114725,client-centered,0,0
114726,",",0,0
114727,supportive-experiential,0,0
114728,group,0,0
114729,therapy,0,0
114730,(,0,0
114731,SET,0,0
114732,),0,0
114733,in,0,0
114734,cancer,0,0
114735,patients,0,0
114736,with,0,0
114737,dysfunctional,0,0
114738,fear,0,1
114739,of,0,0
114740,progression,0,1
114741,.,0,0
114742,An,0,0
114743,incremental,0,0
114744,cost-effectiveness,1,0
114745,analysis,1,0
114746,was,0,0
114747,performed,0,0
114748,using,0,0
114749,data,0,0
114750,from,0,0
114751,a,0,0
114752,randomized,0,0
114753,controlled,0,0
114754,trial,0,0
114755,among,0,0
114756,cancer,0,0
114757,patients,0,0
114758,receiving,0,0
114759,inpatient,0,0
114760,rehabilitation,0,0
114761,.,0,0
114762,The,0,0
114763,means,1,0
114764,",",1,0
114765,95,1,0
114766,%,1,0
114767,confidence,1,0
114768,intervals,1,0
114769,[,1,0
114770,95,1,0
114771,%,1,0
114772,CI,1,0
114773,],1,0
114774,",",1,0
114775,incremental,1,1
114776,cost-effectiveness,1,0
114777,graphic,1,1
114778,and,1,1
114779,acceptability,1,1
114780,curve,1,1
114781,were,0,0
114782,obtained,0,0
114783,from,0,0
114784,"1,000",0,0
114785,bootstrap,0,0
114786,replications,0,0
114787,.,0,0
114788,A,0,0
114789,total,0,0
114790,of,0,0
114791,174,0,0
114792,patients,0,0
114793,were,0,0
114794,included,0,0
114795,in,0,0
114796,the,0,0
114797,economic,0,0
114798,evaluation,0,0
114799,.,0,0
114800,The,0,0
114801,estimated,1,0
114802,means,1,0
114803,[,0,0
114804,95,0,0
114805,%,0,0
114806,CI,0,0
114807,],0,0
114808,of,1,0
114809,direct,1,0
114810,costs,1,1
114811,and,1,0
114812,reduction,1,1
114813,of,1,1
114814,fear,1,1
114815,of,1,0
114816,progression,1,1
114817,were,0,0
114818,<,0,0
114819,euro,0,0
114820,>,0,0
114821,"9,045.03",0,0
114822,[,0,0
114823,"6,359.07",0,0
114824,;,0,0
114825,"12,091.87",0,0
114826,],0,0
114827,and,0,0
114828,1.41,0,0
114829,[,0,0
114830,0.93,0,0
114831,;,0,0
114832,1.92,0,0
114833,],0,0
114834,for,0,0
114835,patients,0,0
114836,in,0,0
114837,the,0,0
114838,SET,0,0
114839,and,0,0
114840,<,0,0
114841,euro,0,0
114842,>,0,0
114843,"6,682.78",0,0
114844,[,0,0
114845,"4,998.09",0,0
114846,;,0,0
114847,"8,440.95",0,0
114848,],0,0
114849,and,0,0
114850,1.44,0,0
114851,[,0,0
114852,1.02,0,0
114853,;,0,0
114854,1.09,0,0
114855,],0,0
114856,for,0,0
114857,patients,0,0
114858,in,0,0
114859,the,0,0
114860,CBT,0,0
114861,.,0,0
114862,The,0,0
114863,incremental,1,0
114864,cost-effectiveness,1,0
114865,ratio,1,1
114866,[,0,0
114867,95,0,0
114868,%,0,0
114869,CI,0,0
114870,],0,0
114871,amounts,0,1
114872,to,0,0
114873,minus,0,0
114874,<,0,0
114875,euro,0,0
114876,>,0,0
114877,"78,741.66",0,0
114878,[,0,0
114879,"-154,987.20",0,0
114880,;,0,0
114881,"110,486.32",0,0
114882,],0,0
114883,for,0,0
114884,an,0,0
114885,additional,0,0
114886,unit,0,0
114887,of,0,0
114888,effect,0,0
114889,.,0,0
114890,Given,0,0
114891,the,0,0
114892,acceptability,1,1
114893,curve,1,1
114894,",",0,0
114895,there,0,0
114896,is,0,0
114897,a,0,0
114898,92.4,0,0
114899,%,0,0
114900,chance,0,0
114901,that,0,0
114902,the,0,0
114903,CBT,0,0
114904,",",0,0
114905,compared,0,0
114906,with,0,0
114907,the,0,0
114908,SET,0,0
114909,",",0,0
114910,is,0,0
114911,cost-effective,1,0
114912,without,0,0
114913,the,0,0
114914,need,0,0
114915,of,0,0
114916,additional,0,0
114917,costs,0,1
114918,to,0,0
114919,payers,0,0
114920,.,0,0
114921,Our,0,0
114922,main,0,0
114923,result,0,0
114924,is,0,0
114925,the,0,0
114926,superior,0,0
114927,cost-effectiveness,1,0
114928,of,0,0
114929,the,0,0
114930,cognitive-behavioral,0,0
114931,intervention,0,0
114932,program,0,0
114933,in,0,0
114934,comparison,0,0
114935,to,0,0
114936,the,0,0
114937,non-directive,0,0
114938,encounter,0,0
114939,group,0,0
114940,for,0,0
114941,our,0,0
114942,sample,0,0
114943,of,0,0
114944,cancer,0,0
114945,patients,0,0
114946,with,0,0
114947,high,0,0
114948,levels,0,1
114949,of,0,0
114950,anxiety,1,1
114951,.,1,0
114952,Promoting,0,0
114953,imitation,0,0
114954,in,0,0
114955,young,0,0
114956,children,0,0
114957,with,0,0
114958,autism,0,0
114959,:,0,0
114960,a,0,0
114961,comparison,0,0
114962,of,0,0
114963,reciprocal,0,1
114964,imitation,0,1
114965,training,0,0
114966,and,0,1
114967,video,0,0
114968,modeling,0,0
114969,.,0,0
114970,The,0,0
114971,inability,0,0
114972,to,0,0
114973,imitate,0,0
114974,is,0,0
114975,a,0,0
114976,salient,0,0
114977,diagnostic,0,0
114978,marker,0,1
114979,for,0,0
114980,autism,0,0
114981,.,0,0
114982,It,0,0
114983,has,0,0
114984,been,0,0
114985,suggested,0,0
114986,that,0,0
114987,for,0,0
114988,children,0,0
114989,with,0,0
114990,autism,0,0
114991,",",0,0
114992,imitation,0,0
114993,may,0,0
114994,be,0,0
114995,a,0,0
114996,prerequisite,0,0
114997,skill,0,1
114998,that,0,0
114999,can,0,0
115000,assist,0,0
115001,in,0,0
115002,the,0,0
115003,development,0,0
115004,of,0,0
115005,various,0,0
115006,skills,0,1
115007,.,0,0
115008,Using,0,0
115009,a,0,0
115010,multiple,0,0
115011,baseline,0,0
115012,design,0,0
115013,across,0,0
115014,subjects,0,0
115015,",",0,0
115016,the,0,0
115017,purpose,0,0
115018,of,0,0
115019,this,0,0
115020,research,0,0
115021,was,0,0
115022,to,0,0
115023,determine,0,0
115024,if,0,0
115025,two,0,0
115026,interventions,0,0
115027,",",0,0
115028,reciprocal,0,1
115029,imitation,0,1
115030,training,0,0
115031,and,0,1
115032,video,0,0
115033,modeling,0,0
115034,were,0,0
115035,effective,0,0
115036,in,0,0
115037,promoting,1,0
115038,imitation,1,0
115039,acquisition,1,0
115040,in,0,0
115041,young,0,0
115042,children,0,0
115043,with,0,0
115044,autism,0,0
115045,.,0,0
115046,Six,0,0
115047,boys,0,0
115048,were,0,0
115049,matched,0,0
115050,across,0,0
115051,various,0,0
115052,features,0,0
115053,(,0,0
115054,i.e.,0,0
115055,",",0,0
115056,age,0,0
115057,",",0,1
115058,language,0,1
115059,",",0,1
115060,autism,0,0
115061,severity,0,1
115062,),0,0
115063,and,0,0
115064,randomly,0,0
115065,placed,0,0
115066,in,0,0
115067,a,0,0
115068,treatment,0,0
115069,condition,0,0
115070,.,0,0
115071,Results,0,0
115072,indicated,0,0
115073,that,0,0
115074,all,0,0
115075,six,0,0
115076,participants,0,0
115077,increased,0,0
115078,their,0,0
115079,imitation,1,0
115080,skills,1,1
115081,to,0,0
115082,varying,0,0
115083,degrees,0,0
115084,in,0,0
115085,both,0,0
115086,conditions,0,0
115087,",",0,0
115088,and,0,1
115089,imitation,0,1
115090,maintained,0,1
115091,and,0,0
115092,generalized,0,1
115093,at,0,0
115094,higher,0,0
115095,than,0,0
115096,baseline,0,0
115097,levels,0,1
115098,post,0,0
115099,treatment,0,0
115100,.,0,0
115101,Changes,0,1
115102,in,0,0
115103,sleep,0,1
115104,quality,0,1
115105,",",0,0
115106,but,0,0
115107,not,0,0
115108,hormones,0,1
115109,predict,0,0
115110,time,0,1
115111,to,0,0
115112,postpartum,0,1
115113,depression,0,1
115114,recurrence,0,1
115115,.,0,0
115116,BACKGROUND,0,0
115117,Poor,0,0
115118,sleep,0,1
115119,quality,0,1
115120,",",0,0
115121,dysregulation,0,1
115122,of,0,1
115123,hormones,0,1
115124,and,0,0
115125,increased,0,0
115126,inflammatory,0,1
115127,cytokines,0,0
115128,are,0,0
115129,all,0,0
115130,associated,0,0
115131,with,0,0
115132,the,0,0
115133,risk,0,0
115134,for,0,0
115135,postpartum,0,1
115136,major,0,1
115137,depression,0,1
115138,(,0,0
115139,PPMD,0,0
115140,),0,0
115141,.,0,0
115142,We,0,0
115143,evaluated,0,0
115144,change,0,0
115145,over,0,0
115146,time,0,1
115147,in,0,0
115148,sleep,1,1
115149,quality,1,1
115150,and,0,0
115151,hormones,1,1
115152,during,0,0
115153,the,0,0
115154,first,0,0
115155,17,0,0
115156,weeks,0,0
115157,postpartum,0,0
115158,",",0,0
115159,as,0,0
115160,well,0,0
115161,as,0,0
115162,a,0,0
115163,single,0,0
115164,cytokine,0,1
115165,measure,0,1
115166,",",0,0
115167,and,0,0
115168,their,0,0
115169,association,0,0
115170,with,0,0
115171,PPMD,0,0
115172,recurrence,0,1
115173,.,0,0
115174,METHODS,0,0
115175,Participants,0,0
115176,were,0,0
115177,pregnant,0,0
115178,women,0,0
115179,(,0,0
115180,N=56,0,1
115181,),0,0
115182,",",0,0
115183,with,0,0
115184,past,0,0
115185,histories,0,0
115186,of,0,0
115187,MDD/PPMD,0,0
115188,but,0,0
115189,not,0,0
115190,depressed,0,0
115191,in,0,0
115192,their,0,0
115193,current,0,0
115194,pregnancy,0,0
115195,.,0,0
115196,The,0,0
115197,Pittsburgh,1,0
115198,Sleep,1,0
115199,Quality,1,1
115200,Index,1,0
115201,(,0,0
115202,PSQI,0,1
115203,),0,1
115204,and,0,0
115205,blood,0,1
115206,samples,0,0
115207,were,0,0
115208,collected,0,0
115209,8,0,0
115210,times,0,0
115211,during,0,0
115212,the,0,0
115213,first,0,0
115214,17,0,0
115215,weeks,0,0
115216,postpartum,0,0
115217,.,0,0
115218,Estradiol,1,0
115219,",",1,0
115220,prolactin,1,1
115221,and,1,1
115222,cortisol,1,1
115223,",",1,0
115224,and,1,0
115225,a,1,0
115226,single,1,0
115227,measure,1,0
115228,of,1,0
115229,IL-6,1,0
115230,were,0,0
115231,assayed,0,0
115232,.,0,0
115233,Recurrence,0,1
115234,was,0,0
115235,determined,0,0
115236,by,0,0
115237,two,0,0
115238,consecutive,0,0
115239,21-item,1,0
115240,Hamilton,1,1
115241,Rating,1,1
115242,Scale,1,1
115243,for,1,0
115244,Depression,1,1
115245,(,1,0
115246,HRSD,1,1
115247,),1,1
115248,scores?15,1,1
115249,and,1,0
115250,clinician,1,0
115251,interview,1,0
115252,.,1,0
115253,RESULTS,0,0
115254,In,0,0
115255,the,0,0
115256,analyses,0,0
115257,of,0,0
115258,time,0,1
115259,to,0,0
115260,PPMD,1,1
115261,recurrence,1,1
115262,",",1,0
115263,poor,1,1
115264,sleep,1,1
115265,quality,1,1
115266,",",1,0
115267,but,0,0
115268,none,0,0
115269,of,0,0
115270,the,0,0
115271,hormones,0,1
115272,",",0,0
115273,was,0,0
115274,associated,0,0
115275,with,1,0
115276,PPMD,1,1
115277,recurrence,1,1
115278,(,1,0
115279,p,0,0
115280,<,0,0
115281,.05,0,0
115282,),0,0
115283,after,0,0
115284,controlling,0,0
115285,for,0,0
115286,medication,0,0
115287,assignment,0,0
115288,.,0,0
115289,With,0,0
115290,every,0,0
115291,one,0,0
115292,point,0,0
115293,increase,0,0
115294,in,0,0
115295,PSQI,0,1
115296,scores,0,1
115297,across,0,0
115298,time,0,1
115299,",",0,0
115300,a,0,0
115301,woman,0,0
115302,'s,0,0
115303,risk,0,1
115304,for,0,0
115305,recurrence,0,1
115306,increased,0,0
115307,by,0,0
115308,approximately,0,0
115309,25,0,0
115310,%,0,0
115311,There,0,0
115312,was,0,0
115313,no,0,0
115314,significant,0,0
115315,association,0,0
115316,between,1,0
115317,PSQI,1,1
115318,scores,1,1
115319,and,1,0
115320,IL-6,1,1
115321,concentrations,1,1
115322,in,0,0
115323,early,0,0
115324,postpartum,0,0
115325,(,0,0
115326,?,0,0
115327,(,0,0
115328,2,0,0
115329,),0,0
115330,=0.98,0,0
115331,",",0,0
115332,p=.32,0,0
115333,),0,0
115334,.,0,0
115335,CONCLUSIONS,0,0
115336,Poor,0,0
115337,sleep,0,1
115338,quality,0,1
115339,across,0,0
115340,the,0,0
115341,first,0,0
115342,17,0,0
115343,weeks,0,0
115344,post-delivery,0,0
115345,increases,0,0
115346,the,0,0
115347,risk,0,0
115348,for,0,0
115349,recurrent,0,1
115350,PPMD,0,0
115351,among,0,0
115352,women,0,0
115353,with,0,0
115354,a,0,0
115355,history,0,0
115356,of,0,0
115357,MDD,0,0
115358,.,0,0
115359,Changes,0,1
115360,in,0,0
115361,the,0,0
115362,hormonal,0,0
115363,milieu,0,0
115364,were,0,0
115365,not,0,0
115366,associated,0,0
115367,with,0,0
115368,recurrence,0,1
115369,.,0,0
115370,Further,0,0
115371,exploration,0,0
115372,of,0,0
115373,the,0,0
115374,degree,0,1
115375,to,0,0
115376,which,0,0
115377,poor,0,1
115378,sleep,0,1
115379,contributes,0,0
115380,to,0,0
115381,hormonal,0,0
115382,and,0,0
115383,cytokine,0,1
115384,dysregulation,0,1
115385,and,0,0
115386,how,0,0
115387,they,0,0
115388,are,0,0
115389,involved,0,0
115390,in,0,0
115391,the,0,0
115392,pathophysiology,0,0
115393,of,0,0
115394,PPMD,0,0
115395,is,0,0
115396,warranted,0,0
115397,.,0,0
115398,The,0,0
115399,effect,1,0
115400,of,0,0
115401,perindopril,0,0
115402,and,0,0
115403,hydrochlorothiazide,0,0
115404,alone,0,0
115405,and,0,0
115406,in,0,0
115407,combination,0,0
115408,on,0,0
115409,blood,0,1
115410,pressure,0,1
115411,and,0,0
115412,on,0,0
115413,the,0,0
115414,renin-angiotensin,0,0
115415,system,0,0
115416,in,0,0
115417,hypertensive,0,0
115418,subjects,0,0
115419,.,0,0
115420,The,0,0
115421,pharmacodynamic,1,1
115422,effects,1,1
115423,and,0,0
115424,acceptability,1,1
115425,of,0,1
115426,perindopril,0,0
115427,(,0,0
115428,4,0,0
115429,mg,0,0
115430,daily,0,0
115431,),0,0
115432,and,0,0
115433,hydrochlorothiazide,0,0
115434,(,0,0
115435,25,0,0
115436,mg,0,0
115437,daily,0,0
115438,),0,0
115439,given,0,0
115440,alone,0,0
115441,or,0,0
115442,in,0,0
115443,combination,0,0
115444,for,0,0
115445,1,0,0
115446,month,0,0
115447,were,0,0
115448,investigated,0,0
115449,in,0,0
115450,a,0,0
115451,double-blind,0,0
115452,",",0,0
115453,placebo,0,0
115454,controlled,0,0
115455,",",0,0
115456,parallel,0,0
115457,group,0,0
115458,study,0,0
115459,.,0,0
115460,The,0,0
115461,pharmacokinetics,1,0
115462,of,0,0
115463,perindopril,0,0
115464,and,0,0
115465,its,0,0
115466,active,0,0
115467,metabolite,0,1
115468,perindoprilat,0,0
115469,and,0,0
115470,the,0,0
115471,time,1,1
115472,course,1,0
115473,of,1,0
115474,angiotensin,1,0
115475,converting,1,0
115476,enzyme,1,1
115477,inhibition,1,1
115478,were,0,0
115479,studied,0,0
115480,for,0,0
115481,72,0,0
115482,h,0,0
115483,following,0,0
115484,the,0,0
115485,last,0,0
115486,dose,0,0
115487,of,0,0
115488,treatment,0,0
115489,in,0,0
115490,the,0,0
115491,two,0,0
115492,appropriate,0,0
115493,groups,0,0
115494,.,0,0
115495,Similar,0,0
115496,decreases,0,0
115497,in,0,0
115498,blood,1,1
115499,pressure,1,1
115500,were,0,0
115501,seen,0,0
115502,24,0,0
115503,h,0,0
115504,after,0,0
115505,the,0,0
115506,last,0,0
115507,dose,0,0
115508,of,0,0
115509,perindopril,0,0
115510,or,0,0
115511,hydrochlorothiazide,0,0
115512,(,0,0
115513,11/7,0,0
115514,mm,0,0
115515,Hg,0,0
115516,supine,0,0
115517,),0,0
115518,given,0,0
115519,alone,0,0
115520,at,0,0
115521,these,0,0
115522,doses,0,0
115523,.,0,0
115524,The,0,0
115525,effect,0,0
115526,of,0,0
115527,these,0,0
115528,drugs,0,0
115529,given,0,0
115530,together,0,0
115531,was,0,0
115532,additive,0,0
115533,on,0,0
115534,diastolic,1,1
115535,blood,1,1
115536,pressure,1,1
115537,and,0,1
115538,synergistic,0,0
115539,on,0,0
115540,systolic,1,1
115541,blood,1,1
115542,pressure,1,1
115543,(,0,0
115544,24.5/12.6,0,0
115545,mm,0,0
115546,Hg,0,0
115547,supine,0,0
115548,),0,0
115549,taking,0,0
115550,into,0,0
115551,account,0,0
115552,the,0,0
115553,placebo,0,0
115554,response,0,1
115555,.,0,0
115556,The,0,0
115557,significant,0,0
115558,increase,0,0
115559,in,0,0
115560,plasma,1,1
115561,renin,1,1
115562,activity,1,1
115563,produced,0,0
115564,by,0,0
115565,perindopril,0,0
115566,alone,0,0
115567,was,0,0
115568,potentiated,0,0
115569,by,0,0
115570,concurrent,0,0
115571,administration,0,0
115572,of,0,0
115573,hydrochlorothiazide,0,0
115574,.,0,0
115575,The,0,0
115576,formation,0,1
115577,of,0,0
115578,perindoprilat,1,0
115579,was,0,0
115580,slightly,0,0
115581,reduced,0,0
115582,in,0,0
115583,the,0,0
115584,group,0,0
115585,also,0,0
115586,receiving,0,0
115587,hydrochlorothiazide,0,0
115588,and,0,0
115589,there,0,0
115590,was,0,0
115591,a,0,0
115592,very,0,0
115593,small,0,0
115594,reduction,0,1
115595,in,0,0
115596,ACE,1,1
115597,inhibition,1,1
115598,in,0,0
115599,this,0,0
115600,group,0,0
115601,.,0,0
115602,Perindopril,0,0
115603,",",0,0
115604,whether,0,0
115605,given,0,0
115606,alone,0,0
115607,or,0,0
115608,in,0,0
115609,combination,0,0
115610,with,0,0
115611,hydrochlorothiazide,0,0
115612,",",0,0
115613,was,0,0
115614,well,1,0
115615,tolerated,1,1
115616,and,0,0
115617,produced,0,0
115618,no,0,0
115619,clinically,1,0
115620,significant,1,0
115621,change,1,0
115622,in,1,0
115623,routine,1,0
115624,haematology,1,1
115625,or,1,0
115626,serum,1,1
115627,biochemistry,1,0
115628,.,1,0
115629,The,0,0
115630,additive,0,0
115631,or,0,0
115632,synergistic,0,0
115633,effects,0,1
115634,of,0,0
115635,perindopril,0,0
115636,and,0,1
115637,hydrochlorothiazide,0,0
115638,on,0,0
115639,blood,0,1
115640,pressure,0,1
115641,must,0,0
115642,be,0,0
115643,due,0,0
115644,to,0,0
115645,their,0,0
115646,complementary,0,0
115647,physiological,0,0
115648,actions,0,1
115649,and,0,0
115650,not,0,0
115651,to,0,0
115652,a,0,0
115653,pharmacokinetic,0,0
115654,interaction,0,0
115655,.,0,0
115656,Green,0,0
115657,banana-supplemented,0,0
115658,diet,0,0
115659,in,0,0
115660,the,0,0
115661,home,0,0
115662,management,0,0
115663,of,0,1
115664,acute,1,0
115665,and,1,0
115666,prolonged,1,1
115667,diarrhoea,1,1
115668,in,1,0
115669,children,1,0
115670,:,1,0
115671,a,0,0
115672,community-based,0,0
115673,trial,0,0
115674,in,0,0
115675,rural,0,0
115676,Bangladesh,0,0
115677,.,0,0
115678,SUMMARY,0,0
115679,OBJECTIVE,0,0
115680,To,0,0
115681,determine,0,0
115682,the,0,0
115683,effectiveness,0,0
115684,of,0,0
115685,green,0,0
115686,banana,0,0
115687,in,0,0
115688,the,0,0
115689,home,0,0
115690,management,0,0
115691,of,0,1
115692,acute,1,0
115693,(,0,0
115694,<,0,0
115695,7,0,0
115696,days,0,0
115697,),0,0
115698,or,0,0
115699,prolonged,1,1
115700,(,0,0
115701,?,0,0
115702,7,0,0
115703,days,1,0
115704,),1,0
115705,diarrhoea,1,1
115706,at,1,0
115707,the,0,0
115708,community,0,0
115709,level,0,1
115710,.,0,0
115711,METHODS,0,0
115712,A,0,0
115713,cluster,0,0
115714,randomized,0,0
115715,field,0,0
115716,trial,0,0
115717,was,0,0
115718,conducted,0,0
115719,among,0,0
115720,2968,0,0
115721,Bangladeshi,0,0
115722,rural,0,0
115723,children,0,0
115724,6-36,0,0
115725,months,0,0
115726,old,0,0
115727,.,0,0
115728,Wards,0,0
115729,(,0,0
115730,villages,0,0
115731,),0,0
115732,were,0,0
115733,randomly,0,0
115734,assigned,0,0
115735,to,0,0
115736,either,0,0
115737,a,0,0
115738,standard,0,0
115739,care,0,0
115740,group,0,0
115741,or,0,0
115742,a,0,0
115743,standard,0,0
115744,care,0,0
115745,plus,0,0
115746,green,0,1
115747,banana,0,0
115748,group,0,0
115749,where,0,0
115750,mothers,0,0
115751,were,0,0
115752,instructed,0,0
115753,to,0,0
115754,add,0,0
115755,cooked,0,0
115756,green,0,0
115757,banana,0,0
115758,to,0,0
115759,the,0,0
115760,diets,0,0
115761,of,0,0
115762,diarrhoeal,0,1
115763,children,0,0
115764,.,0,0
115765,Through,0,0
115766,a,0,0
115767,village-based,0,0
115768,surveillance,0,1
115769,system,1,0
115770,",",1,0
115771,diarrhoeal,1,1
115772,morbidity,1,1
115773,data,1,0
115774,(,1,0
115775,severity,1,1
115776,",",1,1
115777,duration,1,1
115778,",",1,1
115779,compliance,1,1
115780,),1,1
115781,were,1,0
115782,collected,0,0
115783,for,0,0
115784,14,0,0
115785,days,0,0
115786,.,0,0
115787,Treatment,0,0
115788,effects,0,1
115789,were,0,0
115790,determined,0,0
115791,by,0,0
115792,analysing,1,0
115793,cumulative,1,1
115794,probability,1,1
115795,of,1,0
115796,cure,1,1
115797,by,1,0
115798,testing,1,0
115799,Cox,1,0
115800,proportional,1,0
115801,hazards,1,1
115802,models,1,0
115803,and,1,0
115804,relative,1,1
115805,risk,1,1
115806,(,1,0
115807,RR,0,0
115808,),0,0
115809,.,0,0
115810,RESULTS,0,0
115811,The,1,0
115812,cumulative,1,1
115813,probability,1,0
115814,of,1,0
115815,cure,1,1
115816,was,1,0
115817,significantly,0,0
115818,(,0,0
115819,P,0,0
115820,<,0,0
115821,0.001,0,0
115822,),0,0
115823,different,0,0
115824,in,0,0
115825,children,0,0
115826,receiving,0,0
115827,GB,0,1
115828,for,0,0
115829,both,1,0
115830,acute,1,0
115831,[,1,0
115832,hazard,0,1
115833,ratio,0,1
115834,(,0,0
115835,HR,0,0
115836,),0,0
115837,=,0,0
115838,0.63,0,0
115839,(,0,0
115840,95,0,0
115841,%,0,0
115842,CI,0,0
115843,:,0,0
115844,0.56-0.67,0,0
115845,),0,0
115846,],0,0
115847,and,1,1
115848,prolonged,1,1
115849,diarrhoea,1,1
115850,[,1,0
115851,HR,0,0
115852,=,0,0
115853,0.38,0,0
115854,(,0,0
115855,95,0,0
115856,%,0,0
115857,CI,0,0
115858,:,0,0
115859,0.26-0.59,0,0
115860,),0,0
115861,],0,0
115862,.,0,0
115863,The,1,0
115864,recovery,1,1
115865,rates,1,1
115866,of,1,0
115867,children,1,0
115868,with,1,0
115869,acute,1,0
115870,diarrhoea,1,1
115871,receiving,1,0
115872,GB,0,1
115873,(,0,0
115874,vs.,0,0
115875,control,0,0
115876,),0,0
115877,were,0,0
115878,significantly,0,0
115879,more,0,0
115880,by,0,0
115881,day,0,0
115882,3,0,0
115883,:,0,0
115884,79.9,0,0
115885,%,0,0
115886,vs,0,0
115887,.,0,0
115888,53.3,0,0
115889,%,0,0
115890,[,0,0
115891,(,0,0
115892,RR,0,0
115893,),0,0
115894,=,0,0
115895,0.47,0,0
115896,",",0,0
115897,95,0,0
115898,%,0,0
115899,CI,0,0
115900,:,0,0
115901,0.41-0.55,0,0
115902,],0,0
115903,",",0,0
115904,(,0,0
115905,P,0,0
115906,<,0,0
115907,0.001,0,0
115908,),0,0
115909,and,0,0
115910,day,0,0
115911,7,0,0
115912,:,0,0
115913,96.6,0,0
115914,%,0,0
115915,vs,0,0
115916,.,0,0
115917,89.1,0,0
115918,%,0,0
115919,(,0,0
115920,RR,0,0
115921,=,0,0
115922,0.32,0,0
115923,;,0,0
115924,0.22-0.46,0,0
115925,),0,0
115926,",",0,0
115927,(,0,0
115928,P,0,0
115929,<,0,0
115930,0.001,0,0
115931,),0,0
115932,.,0,0
115933,Children,0,0
115934,with,0,0
115935,prolonged,0,1
115936,diarrhoea,0,1
115937,receiving,0,0
115938,green,0,0
115939,banana,0,0
115940,had,0,0
115941,significantly,0,0
115942,higher,1,0
115943,recovery,1,1
115944,rates,1,1
115945,by,1,0
115946,day,0,0
115947,10,0,0
115948,:,0,0
115949,79.8,0,0
115950,%,0,0
115951,vs,0,0
115952,.,0,0
115953,51.9,0,0
115954,%,0,0
115955,(,0,0
115956,RR,0,0
115957,=,0,0
115958,0.42,0,0
115959,;,0,0
115960,0.23-0.73,0,0
115961,),0,0
115962,",",0,0
115963,(,0,0
115964,P,0,0
115965,<,0,0
115966,0.001,0,0
115967,),0,0
115968,and,0,0
115969,day,0,0
115970,14,0,0
115971,:,0,0
115972,93.6,0,0
115973,%,0,0
115974,vs,0,0
115975,.,0,0
115976,67.2,0,0
115977,%,0,0
115978,(,0,0
115979,RR,0,0
115980,=,0,0
115981,0.22,0,0
115982,;,0,0
115983,0.08-0.54,0,0
115984,),0,0
115985,",",0,0
115986,(,0,0
115987,P,0,0
115988,<,0,0
115989,0.001,0,0
115990,),0,0
115991,.,0,0
115992,CONCLUSION,0,0
115993,A,0,0
115994,green,0,0
115995,banana-supplemented,0,0
115996,diet,1,0
115997,hastened,1,1
115998,recovery,1,1
115999,of,1,1
116000,acute,0,1
116001,and,0,1
116002,prolonged,0,1
116003,childhood,0,0
116004,diarrhoea,0,1
116005,managed,0,0
116006,at,0,0
116007,home,0,0
116008,in,0,0
116009,rural,0,0
116010,Bangladesh,0,0
116011,.,0,0
116012,Effect,0,0
116013,of,0,0
116014,a,0,0
116015,synthetic,0,0
116016,appeasing,0,0
116017,pheromone,0,1
116018,on,0,0
116019,behavioral,0,1
116020,",",0,0
116021,neuroendocrine,0,1
116022,",",0,0
116023,immune,0,1
116024,",",0,0
116025,and,0,1
116026,acute-phase,0,1
116027,perioperative,0,1
116028,stress,0,1
116029,responses,0,1
116030,in,0,0
116031,dogs,0,0
116032,.,0,0
116033,OBJECTIVE,0,0
116034,To,0,0
116035,study,0,0
116036,the,0,0
116037,effects,0,0
116038,of,0,0
116039,a,0,0
116040,synthetic,0,0
116041,",",0,0
116042,dog-appeasing,0,1
116043,pheromone,0,1
116044,(,0,0
116045,sDAP,0,1
116046,),0,0
116047,on,0,0
116048,the,0,0
116049,behavioral,0,1
116050,",",0,0
116051,neuroendocrine,0,1
116052,",",0,0
116053,immune,0,1
116054,",",0,0
116055,and,0,1
116056,acute-phase,0,1
116057,perioperative,0,1
116058,stress,0,1
116059,responses,0,1
116060,in,0,0
116061,dogs,0,0
116062,undergoing,0,0
116063,elective,0,0
116064,orchiectomy,0,0
116065,or,0,0
116066,ovariohysterectomy,0,0
116067,.,0,0
116068,DESIGN,0,0
116069,Randomized,0,0
116070,",",0,0
116071,controlled,0,0
116072,clinical,0,0
116073,trial,0,0
116074,.,0,0
116075,ANIMALS,0,0
116076,46,0,0
116077,dogs,0,0
116078,housed,0,0
116079,in,0,0
116080,animal,0,0
116081,shelters,0,0
116082,and,0,0
116083,undergoing,0,0
116084,elective,0,0
116085,orchiectomy,0,0
116086,or,0,0
116087,ovariohysterectomy,0,0
116088,.,0,0
116089,PROCEDURES,0,1
116090,Intensive,0,0
116091,care,0,0
116092,unit,0,0
116093,cages,0,0
116094,were,0,0
116095,sprayed,0,0
116096,with,0,0
116097,sDAP,0,0
116098,solution,0,0
116099,or,0,0
116100,sham,0,0
116101,treated,0,0
116102,with,0,0
116103,the,0,0
116104,carrier,0,0
116105,used,0,0
116106,in,0,0
116107,the,0,0
116108,solution,0,0
116109,20,0,0
116110,minutes,0,0
116111,prior,0,0
116112,to,0,0
116113,use,0,0
116114,.,0,0
116115,Dogs,0,0
116116,(,0,0
116117,n,0,0
116118,=,0,0
116119,24,0,0
116120,and,0,0
116121,22,0,0
116122,in,0,0
116123,the,0,0
116124,sDAP,0,0
116125,and,0,0
116126,sham,0,0
116127,treatment,0,0
116128,exposure,0,1
116129,groups,0,0
116130,",",0,0
116131,respectively,0,0
116132,),0,0
116133,were,0,0
116134,placed,0,0
116135,in,0,0
116136,treated,0,0
116137,cages,0,0
116138,for,0,0
116139,30,0,0
116140,minutes,0,0
116141,before,0,0
116142,and,0,0
116143,after,0,0
116144,surgery,0,0
116145,.,0,0
116146,Indicators,0,0
116147,of,0,0
116148,stress,0,1
116149,(,0,0
116150,ie,0,0
116151,",",0,0
116152,alterations,0,1
116153,in,0,0
116154,behavioral,1,1
116155,",",1,0
116156,neuroendocrine,1,1
116157,",",1,0
116158,immune,1,1
116159,",",1,0
116160,and,1,1
116161,acute-phase,1,1
116162,responses,1,1
116163,),1,0
116164,were,0,0
116165,evaluated,0,0
116166,perioperatively,0,0
116167,.,0,0
116168,Behavioral,1,0
116169,response,1,1
116170,variables,1,1
116171,",",1,0
116172,salivary,1,1
116173,cortisol,1,1
116174,concentration,1,1
116175,",",1,0
116176,WBC,1,1
116177,count,1,1
116178,",",1,0
116179,and,1,1
116180,serum,1,1
116181,concentrations,1,1
116182,of,1,0
116183,glucose,1,1
116184,",",1,0
116185,prolactin,1,1
116186,",",1,1
116187,haptoglobin,1,1
116188,",",1,1
116189,and,1,1
116190,C-reactive,1,1
116191,protein,1,1
116192,were,0,0
116193,analyzed,0,0
116194,.,0,0
116195,RESULTS,0,0
116196,Behavioral,1,0
116197,response,1,1
116198,variables,1,1
116199,and,1,1
116200,serum,1,1
116201,prolactin,1,1
116202,concentration,1,1
116203,were,0,0
116204,influenced,0,0
116205,by,0,0
116206,sDAP,0,0
116207,exposure,0,0
116208,.,0,0
116209,Dogs,0,0
116210,exposed,0,0
116211,to,0,0
116212,sDAP,0,0
116213,were,0,0
116214,more,0,0
116215,likely,0,0
116216,to,0,0
116217,have,0,0
116218,alertness,1,1
116219,and,1,0
116220,visual,1,1
116221,exploration,1,0
116222,behaviors,1,1
116223,after,0,0
116224,surgery,0,0
116225,than,0,0
116226,were,0,0
116227,dogs,0,0
116228,exposed,0,0
116229,to,0,0
116230,sham,0,0
116231,treatment,0,0
116232,.,0,0
116233,Decreases,0,0
116234,in,0,0
116235,serum,1,1
116236,prolactin,1,1
116237,concentrations,1,1
116238,in,0,0
116239,response,0,1
116240,to,0,0
116241,perioperative,0,1
116242,stress,0,1
116243,were,0,0
116244,significantly,0,0
116245,smaller,0,0
116246,in,0,0
116247,dogs,0,0
116248,exposed,0,0
116249,to,0,0
116250,sDAP,0,0
116251,",",0,0
116252,compared,0,0
116253,with,0,0
116254,findings,0,0
116255,in,0,0
116256,dogs,0,0
116257,exposed,0,0
116258,to,0,0
116259,the,0,0
116260,sham,0,0
116261,treatment,0,0
116262,.,0,0
116263,Variables,0,0
116264,examined,0,0
116265,to,0,0
116266,evaluate,0,0
116267,the,0,0
116268,hypothalamic-pituitary-adrenal,0,1
116269,axis,0,0
116270,",",0,0
116271,immune,0,1
116272,system,0,0
116273,",",0,0
116274,and,0,1
116275,acute-phase,0,1
116276,responses,0,1
116277,were,0,0
116278,unaffected,0,0
116279,by,0,0
116280,treatment,0,0
116281,.,0,0
116282,CONCLUSIONS,0,0
116283,AND,0,0
116284,CLINICAL,0,1
116285,RELEVANCE,0,1
116286,sDAP,0,0
116287,appeared,0,0
116288,to,0,0
116289,affect,0,0
116290,behavioral,1,1
116291,and,1,0
116292,neuroendocrine,1,1
116293,perioperative,1,1
116294,stress,1,1
116295,responses,1,1
116296,by,0,0
116297,modification,0,0
116298,of,0,0
116299,lactotropic,0,1
116300,axis,0,0
116301,activity,0,1
116302,.,0,0
116303,Use,0,0
116304,of,0,0
116305,sDAP,0,0
116306,in,0,0
116307,a,0,0
116308,clinical,0,0
116309,setting,0,0
116310,may,0,0
116311,improve,0,0
116312,the,0,0
116313,recovery,1,1
116314,and,0,0
116315,welfare,0,1
116316,of,0,1
116317,dogs,0,0
116318,undergoing,0,0
116319,surgery,0,0
116320,.,0,0
116321,Cardiovascular,0,0
116322,safety,0,1
116323,of,0,0
116324,degarelix,0,0
116325,:,0,0
116326,results,0,0
116327,from,0,0
116328,a,0,0
116329,12-month,0,0
116330,",",0,0
116331,comparative,0,0
116332,",",0,0
116333,randomized,0,0
116334,",",0,0
116335,open,0,0
116336,label,0,0
116337,",",0,0
116338,parallel,0,0
116339,group,0,0
116340,phase,0,0
116341,III,0,0
116342,trial,0,0
116343,in,0,0
116344,patients,0,0
116345,with,0,0
116346,prostate,0,0
116347,cancer,0,0
116348,.,0,0
116349,PURPOSE,0,0
116350,We,0,0
116351,assessed,0,0
116352,the,0,0
116353,cardiovascular,0,1
116354,safety,0,1
116355,profile,0,1
116356,of,0,1
116357,degarelix,0,0
116358,",",0,0
116359,a,0,0
116360,new,0,0
116361,gonadotropin-releasing,0,0
116362,hormone,0,0
116363,antagonist,0,0
116364,.,0,0
116365,MATERIALS,0,0
116366,AND,0,0
116367,METHODS,0,0
116368,This,0,0
116369,is,0,0
116370,the,0,0
116371,first,0,0
116372,report,0,0
116373,to,0,0
116374,our,0,0
116375,knowledge,0,0
116376,on,0,0
116377,cardiovascular,0,1
116378,safety,0,1
116379,data,0,0
116380,from,0,0
116381,a,0,0
116382,completed,0,0
116383,1-year,0,0
116384,randomized,0,0
116385,controlled,0,0
116386,trial,0,0
116387,of,0,0
116388,leuprolide,0,0
116389,acetate,0,0
116390,vs,0,0
116391,degarelix,0,0
116392,.,0,0
116393,Outcomes,0,0
116394,considered,0,0
116395,in,0,0
116396,these,0,0
116397,analyses,0,0
116398,included,0,0
116399,the,0,0
116400,QT,1,1
116401,interval,1,0
116402,by,1,0
116403,central,1,1
116404,reading,1,0
116405,and,1,1
116406,analysis,1,0
116407,",",1,1
116408,and,1,1
116409,cardiovascular,1,1
116410,adverse,1,1
116411,events,1,1
116412,.,1,0
116413,On,0,0
116414,multivariate,0,0
116415,analyses,0,0
116416,relationships,0,0
116417,between,0,0
116418,selected,0,0
116419,baseline,0,0
116420,factors,0,0
116421,and,0,1
116422,cardiovascular,1,1
116423,events,1,1
116424,were,0,0
116425,evaluated,0,0
116426,.,0,0
116427,RESULTS,0,0
116428,There,0,0
116429,were,0,0
116430,no,0,0
116431,significant,0,0
116432,differences,0,0
116433,between,0,0
116434,treatment,0,0
116435,groups,0,0
116436,for,0,0
116437,mean,0,1
116438,change,0,0
116439,in,0,0
116440,Fridericia,0,1
116441,'s,0,0
116442,correction,0,0
116443,of,0,0
116444,QT,0,1
116445,during,0,0
116446,the,0,0
116447,trial,0,0
116448,.,0,0
116449,Markedly,1,0
116450,abnormal,1,1
116451,Fridericia,1,1
116452,'s,1,0
116453,correction,1,0
116454,of,1,0
116455,QT,1,1
116456,values,1,1
116457,(,0,0
116458,500,0,0
116459,milliseconds,0,0
116460,or,0,0
116461,greater,0,0
116462,),0,1
116463,were,0,0
116464,observed,0,0
116465,in,0,0
116466,only,0,0
116467,a,0,0
116468,small,0,0
116469,number,0,1
116470,of,0,0
116471,subjects,0,0
116472,by,0,0
116473,treatment,0,0
116474,group,0,0
116475,",",0,0
116476,that,0,0
116477,is,0,0
116478,2,0,0
116479,(,0,0
116480,less,0,0
116481,than,0,0
116482,1,0,0
116483,%,0,0
116484,),0,0
116485,in,0,0
116486,the,0,0
116487,pooled,0,0
116488,degarelix,0,0
116489,group,0,0
116490,and,0,0
116491,2,0,0
116492,(,0,0
116493,1,0,0
116494,%,0,0
116495,),0,0
116496,in,0,0
116497,the,0,0
116498,leuprolide,0,0
116499,group,0,0
116500,.,0,0
116501,Supraventricular,1,1
116502,arrhythmias,1,1
116503,were,0,0
116504,the,0,0
116505,most,0,0
116506,common,0,0
116507,type,0,0
116508,of,0,0
116509,arrhythmias,0,1
116510,",",0,0
116511,affecting,0,0
116512,2,0,0
116513,%,0,0
116514,of,0,0
116515,subjects,0,0
116516,in,0,0
116517,the,0,0
116518,pooled,0,0
116519,degarelix,0,0
116520,group,0,0
116521,and,0,0
116522,4,0,0
116523,%,0,0
116524,in,0,0
116525,the,0,0
116526,leuprolide,0,0
116527,group,0,0
116528,.,0,0
116529,Other,1,0
116530,arrhythmias,1,1
116531,occurred,0,0
116532,in,0,0
116533,1,0,0
116534,%,0,0
116535,or,0,0
116536,less,0,0
116537,of,0,1
116538,subjects,0,0
116539,by,0,0
116540,treatment,0,0
116541,group,0,0
116542,.,0,0
116543,The,0,0
116544,most,0,0
116545,frequently,0,0
116546,reported,0,0
116547,cardiac,0,1
116548,disorder,0,0
116549,was,0,0
116550,ischemic,1,1
116551,heart,1,1
116552,disease,1,1
116553,",",0,0
116554,which,0,0
116555,occurred,0,0
116556,in,0,0
116557,4,0,0
116558,%,0,0
116559,of,0,0
116560,subjects,0,0
116561,treated,0,0
116562,with,0,0
116563,degarelix,0,0
116564,and,0,0
116565,10,0,0
116566,%,0,0
116567,of,0,0
116568,those,0,0
116569,on,0,0
116570,leuprolide,0,0
116571,.,0,0
116572,Cox,0,0
116573,proportional,0,1
116574,hazard,0,1
116575,ratio,0,1
116576,estimates,0,0
116577,for,0,0
116578,selected,0,0
116579,baseline,0,0
116580,covariates,0,0
116581,showed,0,0
116582,a,0,0
116583,significantly,0,0
116584,increased,0,0
116585,risk,0,0
116586,of,0,0
116587,cardiovascular,0,1
116588,events,0,1
116589,by,0,0
116590,age,0,0
116591,(,0,0
116592,p=0.0459,0,0
116593,),0,1
116594,and,0,0
116595,systolic,0,1
116596,blood,0,1
116597,pressure,0,1
116598,(,0,0
116599,p=0.0061,0,0
116600,),0,0
116601,.,0,0
116602,CONCLUSIONS,0,0
116603,In,0,0
116604,men,0,0
116605,with,0,0
116606,prostate,0,0
116607,cancer,0,0
116608,degarelix,0,0
116609,and,0,0
116610,leuprolide,0,0
116611,have,0,0
116612,similar,0,0
116613,cardiovascular,0,1
116614,safety,0,1
116615,profiles,0,0
116616,.,0,0
116617,These,0,0
116618,observations,0,0
116619,suggest,0,0
116620,that,0,0
116621,the,0,0
116622,cardiovascular,0,1
116623,events,0,1
116624,associated,0,0
116625,with,0,0
116626,both,0,0
116627,agents,0,0
116628,result,0,0
116629,from,0,0
116630,hypogonadism,0,0
116631,rather,0,0
116632,than,0,0
116633,a,0,0
116634,direct,0,0
116635,drug,0,0
116636,effect,0,0
116637,.,0,0
116638,A,0,0
116639,comparison,0,0
116640,of,0,0
116641,human,0,0
116642,papillomavirus,0,0
116643,testing,0,0
116644,of,0,0
116645,clinician-collected,0,0
116646,and,0,0
116647,self-collected,0,0
116648,samples,0,0
116649,during,0,0
116650,follow-up,0,0
116651,after,0,0
116652,screen-and-treat,0,0
116653,.,0,0
116654,Screen-and-treat,0,0
116655,cervical,0,0
116656,cancer,0,0
116657,prevention,0,0
116658,programs,0,0
116659,based,0,0
116660,on,0,0
116661,high-risk,0,0
116662,human,0,0
116663,papillomavirus,0,0
116664,(,0,0
116665,HPV,0,1
116666,),0,1
116667,testing,0,0
116668,and,0,0
116669,cryotherapy,0,0
116670,have,0,0
116671,been,0,0
116672,shown,0,0
116673,to,0,0
116674,be,0,0
116675,effective,0,0
116676,in,0,0
116677,resource-limited,0,0
116678,settings,0,0
116679,.,0,0
116680,However,0,0
116681,",",0,0
116682,because,0,0
116683,cryotherapy,0,0
116684,is,0,0
116685,not,0,0
116686,100,0,0
116687,%,0,0
116688,effective,0,0
116689,",",0,0
116690,follow-up,0,0
116691,is,0,0
116692,needed,0,0
116693,after,0,0
116694,treatment,0,0
116695,to,0,0
116696,detect,0,0
116697,post-treatment,0,0
116698,failures,0,0
116699,.,0,0
116700,We,0,0
116701,compared,0,0
116702,the,0,0
116703,test,0,0
116704,performances,0,1
116705,of,0,0
116706,high-risk,0,0
116707,HPV,0,1
116708,testing,0,0
116709,(,0,0
116710,Hybrid,0,0
116711,Capture,0,1
116712,2,0,0
116713,),0,0
116714,using,0,0
116715,self-collected,0,0
116716,and,0,0
116717,clinician-collected,0,0
116718,samples,0,0
116719,as,0,0
116720,well,0,0
116721,as,0,0
116722,cervical,0,0
116723,cytology,0,1
116724,for,0,0
116725,identifying,0,0
116726,cervical,0,0
116727,intraepithelial,0,1
116728,neoplasia,0,0
116729,grades,0,0
116730,2,0,0
116731,or,0,0
116732,3,0,0
116733,or,0,0
116734,invasive,0,0
116735,cervical,0,1
116736,cancer,0,0
116737,(,0,0
116738,CIN2+,0,0
116739,),0,0
116740,among,0,0
116741,women,0,0
116742,who,0,0
116743,did,0,0
116744,(,0,0
116745,n=812,0,0
116746,),0,1
116747,and,0,0
116748,did,0,0
116749,not,0,0
116750,(,0,0
116751,n=1858,0,0
116752,),0,0
116753,undergo,0,0
116754,cryotherapy,0,0
116755,in,0,0
116756,a,0,0
116757,South,0,0
116758,African,0,0
116759,screen-and-treat,0,0
116760,trial,0,0
116761,.,0,0
116762,At,0,0
116763,6,0,0
116764,months,0,0
116765,after,0,0
116766,enrolment,0,0
116767,(,0,0
116768,and,0,0
116769,after,0,0
116770,cryotherapy,0,0
116771,",",0,0
116772,if,0,0
116773,performed,0,0
116774,),0,0
116775,",",0,0
116776,women,0,0
116777,were,0,0
116778,tested,0,0
116779,using,0,0
116780,all,0,0
116781,three,0,0
116782,screening,0,0
116783,methods,0,0
116784,and,0,0
116785,then,0,0
116786,underwent,0,0
116787,colposcopy/biopsy,0,0
116788,.,0,0
116789,A,0,0
116790,predefined,0,0
116791,subset,0,0
116792,of,0,0
116793,women,0,0
116794,(,0,0
116795,"n=1,455",0,0
116796,),0,0
116797,had,0,0
116798,extended,0,0
116799,follow-up,0,0
116800,with,0,0
116801,colposcopy/biopsy,0,0
116802,at,0,0
116803,12,0,0
116804,months,0,0
116805,.,0,0
116806,A,0,0
116807,total,0,0
116808,of,0,0
116809,33,0,0
116810,and,0,0
116811,91,0,0
116812,cases,0,0
116813,of,0,0
116814,CIN2+,0,0
116815,were,0,0
116816,detected,0,0
116817,among,0,0
116818,treated,0,0
116819,and,0,0
116820,untreated,0,0
116821,women,0,0
116822,",",0,0
116823,respectively,0,0
116824,.,0,0
116825,The,0,0
116826,sensitivity,1,1
116827,of,1,0
116828,HPV,1,1
116829,testing,1,0
116830,using,0,0
116831,clinician-collected,0,0
116832,samples,0,0
116833,and,0,0
116834,cervical,0,1
116835,cytology,0,1
116836,did,0,0
116837,not,0,0
116838,differ,0,0
116839,by,0,0
116840,treatment,0,0
116841,status,0,1
116842,.,0,0
116843,HPV,0,1
116844,testing,0,0
116845,of,0,0
116846,clinician-collected,0,0
116847,samples,0,0
116848,detected,0,0
116849,the,0,0
116850,most,0,0
116851,cases,0,0
116852,of,0,0
116853,CIN2+,1,0
116854,among,0,0
116855,both,0,0
116856,treated,0,0
116857,(,0,0
116858,85,0,0
116859,%,0,0
116860,),0,0
116861,and,0,0
116862,untreated,0,0
116863,(,0,0
116864,91,0,0
116865,%,0,0
116866,),0,0
116867,women,0,0
116868,(,0,0
116869,p=0.31,0,0
116870,),0,0
116871,.,0,0
116872,Cytology,1,0
116873,(,0,0
116874,at,0,0
116875,a,0,0
116876,cutoff,0,0
116877,of,0,0
116878,atypical,0,0
116879,squamous,0,0
116880,cells,0,1
116881,of,0,0
116882,undetermined,0,0
116883,significance,0,1
116884,or,0,0
116885,greater,0,0
116886,),0,0
116887,detected,0,0
116888,76,0,0
116889,%,0,0
116890,of,0,0
116891,cases,0,0
116892,among,0,0
116893,both,0,0
116894,treated,0,0
116895,and,0,0
116896,untreated,0,0
116897,women,0,0
116898,.,0,0
116899,However,0,0
116900,",",0,0
116901,the,0,0
116902,sensitivity,1,1
116903,of,1,0
116904,HPV,1,1
116905,testing,1,0
116906,using,0,0
116907,self-collected,0,0
116908,samples,0,0
116909,was,0,0
116910,significantly,0,0
116911,lower,0,0
116912,among,0,0
116913,treated,0,0
116914,versus,0,0
116915,untreated,0,0
116916,women,0,0
116917,(,0,0
116918,55,0,0
116919,%,0,0
116920,vs.,0,0
116921,78,0,0
116922,%,0,0
116923,",",0,0
116924,p=0.01,0,0
116925,),0,0
116926,.,0,0
116927,HPV,0,1
116928,testing,0,0
116929,using,0,0
116930,self-collected,0,0
116931,vaginal,0,0
116932,specimens,0,0
116933,may,0,0
116934,be,0,0
116935,useful,0,0
116936,in,0,0
116937,primary,0,0
116938,screening,0,0
116939,but,0,0
116940,performs,0,0
116941,poorly,0,0
116942,for,0,0
116943,detecting,0,0
116944,post-treatment,1,0
116945,failures,1,0
116946,.,1,0
116947,Five-year,0,0
116948,outcome,0,0
116949,of,0,0
116950,surgical,0,0
116951,treatment,0,0
116952,of,0,0
116953,migraine,1,0
116954,headaches,1,1
116955,.,1,0
116956,BACKGROUND,0,0
116957,This,0,0
116958,study,0,0
116959,was,0,0
116960,designed,0,0
116961,to,0,0
116962,assess,0,0
116963,the,0,0
116964,long-term,0,0
116965,efficacy,0,1
116966,of,0,0
116967,surgical,0,0
116968,deactivation,0,1
116969,of,0,0
116970,migraine,1,1
116971,headache,1,1
116972,trigger,0,0
116973,sites,0,0
116974,.,0,0
116975,METHODS,0,0
116976,One,0,0
116977,hundred,0,0
116978,twenty-five,0,0
116979,volunteers,0,0
116980,were,0,0
116981,randomly,0,0
116982,assigned,0,0
116983,to,0,0
116984,the,0,0
116985,treatment,0,0
116986,(,0,0
116987,n,0,0
116988,=,0,0
116989,100,0,0
116990,),0,0
116991,or,0,0
116992,control,0,0
116993,group,0,0
116994,(,0,0
116995,n,0,0
116996,=,0,0
116997,25,0,0
116998,),0,0
116999,after,0,0
117000,examination,0,0
117001,by,0,0
117002,the,0,0
117003,team,0,0
117004,neurologist,0,0
117005,to,0,0
117006,ensure,0,0
117007,a,0,0
117008,diagnosis,0,0
117009,of,0,0
117010,migraine,1,0
117011,headache,1,1
117012,.,1,0
117013,Patients,0,0
117014,were,0,0
117015,asked,0,0
117016,to,0,0
117017,complete,0,0
117018,the,0,0
117019,Medical,1,0
117020,Outcomes,1,1
117021,Study,1,0
117022,36-Item,1,0
117023,Short,1,0
117024,Form,1,0
117025,Health,1,1
117026,Survey,1,0
117027,",",1,0
117028,Migraine-Specific,1,1
117029,Quality,1,1
117030,of,1,0
117031,Life,1,0
117032,",",1,0
117033,and,1,1
117034,Migraine,1,0
117035,Disability,1,1
117036,Assessment,1,0
117037,questionnaires,1,0
117038,before,0,0
117039,treatment,0,0
117040,and,0,0
117041,at,0,0
117042,12-,0,1
117043,and,0,0
117044,60-month,0,0
117045,postoperative,0,1
117046,follow-up,0,0
117047,.,0,0
117048,The,0,0
117049,treatment,0,0
117050,group,0,0
117051,received,0,0
117052,botulinum,0,0
117053,toxin,0,0
117054,to,0,0
117055,confirm,0,0
117056,the,0,0
117057,trigger,0,0
117058,sites,0,0
117059,;,0,0
117060,controls,0,0
117061,received,0,0
117062,saline,0,0
117063,injections,0,0
117064,.,0,0
117065,Treated,0,1
117066,patients,0,0
117067,underwent,0,0
117068,surgical,0,0
117069,deactivation,0,1
117070,of,0,0
117071,trigger,0,1
117072,site,0,1
117073,(,0,0
117074,s,0,0
117075,),0,0
117076,.,0,0
117077,Results,0,0
117078,were,0,0
117079,analyzed,0,0
117080,at,0,0
117081,1,0,0
117082,year,0,0
117083,(,0,0
117084,previously,0,0
117085,published,0,0
117086,),0,0
117087,and,0,0
117088,5,0,0
117089,years,0,0
117090,postoperatively,0,0
117091,(,0,0
117092,the,0,0
117093,subject,0,0
117094,of,0,0
117095,this,0,0
117096,report,0,0
117097,),0,0
117098,.,0,0
117099,RESULTS,0,0
117100,Eighty-nine,0,0
117101,of,0,0
117102,100,0,0
117103,patients,0,0
117104,in,0,0
117105,the,0,0
117106,treatment,0,0
117107,group,0,0
117108,underwent,0,0
117109,surgery,0,0
117110,",",0,0
117111,and,0,0
117112,79,0,0
117113,were,0,0
117114,followed,0,0
117115,for,0,0
117116,5,0,0
117117,years,0,0
117118,.,0,0
117119,Ten,0,0
117120,patients,0,0
117121,underwent,0,0
117122,deactivation,0,1
117123,of,0,0
117124,additional,0,0
117125,(,0,0
117126,different,0,0
117127,),0,0
117128,trigger,0,0
117129,sites,0,0
117130,during,0,0
117131,the,0,0
117132,follow-up,0,0
117133,period,0,0
117134,and,0,0
117135,were,0,0
117136,not,0,0
117137,included,0,0
117138,in,0,0
117139,the,0,0
117140,data,0,0
117141,analysis,0,0
117142,.,0,0
117143,The,0,0
117144,final,0,1
117145,outcome,0,1
117146,with,0,0
117147,or,0,0
117148,without,0,0
117149,inclusion,0,0
117150,of,0,0
117151,these,0,0
117152,10,0,0
117153,patients,0,0
117154,was,0,0
117155,not,0,0
117156,statistically,0,0
117157,different,0,0
117158,.,0,0
117159,Sixty-one,0,0
117160,(,0,0
117161,88,0,0
117162,percent,0,0
117163,),0,0
117164,of,0,0
117165,69,0,0
117166,patients,0,0
117167,have,0,0
117168,experienced,0,0
117169,a,0,0
117170,positive,1,0
117171,response,1,1
117172,to,0,0
117173,the,0,0
117174,surgery,0,0
117175,after,0,0
117176,5,0,0
117177,years,0,0
117178,.,0,0
117179,Twenty,0,0
117180,(,0,0
117181,29,0,0
117182,percent,0,0
117183,),0,0
117184,reported,0,0
117185,complete,1,1
117186,elimination,1,0
117187,of,1,0
117188,migraine,1,1
117189,headache,1,1
117190,",",0,0
117191,41,0,0
117192,(,0,0
117193,59,0,0
117194,percent,0,0
117195,),0,0
117196,noticed,0,0
117197,a,0,0
117198,significant,0,0
117199,decrease,0,0
117200,",",0,0
117201,and,0,0
117202,eight,0,0
117203,(,0,0
117204,12,0,0
117205,percent,0,0
117206,),0,0
117207,experienced,0,0
117208,no,0,0
117209,significant,0,0
117210,change,0,0
117211,.,0,0
117212,When,0,0
117213,compared,0,0
117214,with,0,0
117215,the,0,0
117216,baseline,0,0
117217,values,0,1
117218,",",0,0
117219,all,0,0
117220,measured,0,0
117221,variables,0,0
117222,at,0,0
117223,60,0,0
117224,months,0,0
117225,improved,0,0
117226,significantly,0,0
117227,(,0,0
117228,p,0,0
117229,<,0,0
117230,0.0001,0,0
117231,),0,0
117232,.,0,0
117233,CONCLUSION,0,0
117234,Based,0,0
117235,on,0,0
117236,the,0,0
117237,5-year,0,0
117238,follow-up,0,0
117239,data,0,0
117240,",",0,0
117241,there,0,0
117242,is,0,0
117243,strong,0,0
117244,evidence,0,0
117245,that,0,0
117246,surgical,0,0
117247,manipulation,0,0
117248,of,0,0
117249,one,0,0
117250,or,0,0
117251,more,0,0
117252,migraine,0,1
117253,trigger,0,0
117254,sites,0,0
117255,can,0,0
117256,successfully,0,0
117257,eliminate,1,0
117258,or,1,0
117259,reduce,1,0
117260,the,1,0
117261,frequency,1,1
117262,",",1,0
117263,duration,1,1
117264,",",1,1
117265,and,1,1
117266,intensity,1,1
117267,of,1,1
117268,migraine,1,1
117269,headache,1,1
117270,in,0,0
117271,a,0,0
117272,lasting,0,0
117273,manner,0,0
117274,.,0,0
117275,Pre-transplant,0,0
117276,pharmacokinetic,0,1
117277,profiling,0,0
117278,and,0,1
117279,tacrolimus,1,0
117280,requirements,1,1
117281,post-transplant,1,0
117282,.,1,0
117283,AIM,0,0
117284,To,0,0
117285,determine,0,0
117286,the,0,0
117287,proportion,0,0
117288,of,0,0
117289,patients,0,0
117290,achieving,0,0
117291,tacrolimus,1,0
117292,whole-blood,1,0
117293,concentrations,1,1
117294,of,0,0
117295,?10,0,0
117296,ng/mL,0,0
117297,within,0,0
117298,3,0,0
117299,days,0,0
117300,of,0,0
117301,kidney,0,1
117302,transplantation,0,0
117303,",",0,0
117304,after,0,0
117305,randomization,0,0
117306,either,0,0
117307,to,0,0
117308,standard,0,0
117309,dosing,0,0
117310,(,0,0
117311,control,0,0
117312,group,0,0
117313,),0,0
117314,or,0,0
117315,post-transplantation,0,1
117316,dosing,0,0
117317,guided,0,0
117318,by,0,0
117319,a,0,0
117320,2-hour,0,0
117321,(,0,0
117322,C,0,0
117323,(,0,0
117324,2,0,0
117325,),0,0
117326,),0,0
117327,level,0,1
117328,following,0,0
117329,a,0,0
117330,preoperative,0,0
117331,tacrolimus,0,0
117332,dose,0,0
117333,(,0,0
117334,T2,0,0
117335,group,0,0
117336,),0,0
117337,.,0,0
117338,METHODS,0,0
117339,The,0,0
117340,first,0,0
117341,postoperative,0,1
117342,tacrolimus,0,0
117343,dose,0,0
117344,was,0,0
117345,given,0,0
117346,either,0,0
117347,according,0,0
117348,to,0,0
117349,standard,0,0
117350,care,0,0
117351,(,0,0
117352,control,0,0
117353,group,0,0
117354,),0,0
117355,or,0,0
117356,0.15,0,0
117357,mg/kg,0,0
117358,b.d,0,0
117359,.,0,0
117360,if,0,0
117361,the,0,0
117362,pre-transplant,0,0
117363,C,0,0
117364,(,0,0
117365,2,0,0
117366,),0,0
117367,level,0,0
117368,was,0,0
117369,?20,0,0
117370,ng/mL,0,0
117371,",",0,0
117372,0.1,0,0
117373,mg/kg,0,0
117374,b.d,0,0
117375,.,0,0
117376,if,0,0
117377,the,0,0
117378,C,0,0
117379,(,0,0
117380,2,0,0
117381,),0,0
117382,level,0,0
117383,was,0,0
117384,21-59,0,0
117385,ng/mL,0,0
117386,or,0,0
117387,0.05,0,0
117388,mg/kg,0,0
117389,b.d,0,0
117390,.,0,0
117391,if,0,0
117392,the,0,0
117393,C,0,0
117394,(,0,0
117395,2,0,0
117396,),0,0
117397,level,0,0
117398,was,0,0
117399,?60,0,0
117400,ng/mL,0,0
117401,(,0,0
117402,T2,0,0
117403,group,0,0
117404,),0,0
117405,.,0,0
117406,Subsequent,0,0
117407,dosing,0,0
117408,in,0,0
117409,both,0,0
117410,groups,0,0
117411,was,0,0
117412,based,0,0
117413,upon,0,0
117414,tacrolimus,0,0
117415,trough,0,1
117416,level,0,1
117417,monitoring,0,0
117418,.,0,0
117419,Participants,0,0
117420,received,0,0
117421,concomitant,0,0
117422,mycophenolate,0,0
117423,mofetil,0,0
117424,and,0,0
117425,steroids,0,0
117426,.,0,0
117427,RESULTS,0,0
117428,Ninety,0,0
117429,patients,0,0
117430,were,0,0
117431,recruited,0,0
117432,",",0,0
117433,of,0,0
117434,which,0,0
117435,84,0,0
117436,were,0,0
117437,included,0,0
117438,in,0,0
117439,the,0,0
117440,analysis,0,0
117441,(,0,0
117442,control,0,0
117443,group,0,0
117444,n=43,0,0
117445,;,0,0
117446,T2,0,0
117447,group,0,0
117448,n=41,0,0
117449,),0,0
117450,.,0,0
117451,There,0,0
117452,was,0,0
117453,no,0,0
117454,difference,0,0
117455,in,0,0
117456,the,0,0
117457,proportion,1,0
117458,of,1,0
117459,subjects,1,0
117460,achieving,1,0
117461,tacrolimus,1,0
117462,trough,1,0
117463,levels,1,1
117464,?10,1,0
117465,ng/mL,1,0
117466,(,0,0
117467,82.9,0,0
117468,%,0,0
117469,Control,0,0
117470,vs,0,0
117471,93.0,0,0
117472,%,0,0
117473,T2,0,0
117474,;,0,0
117475,P=0.19,0,0
117476,),0,0
117477,or,0,0
117478,between,0,0
117479,10,0,0
117480,and,0,0
117481,15,0,0
117482,ng/mL,0,0
117483,(,0,0
117484,41.5,0,0
117485,%,0,0
117486,Control,0,0
117487,vs,0,0
117488,41.9,0,0
117489,%,0,0
117490,T2,0,0
117491,;,0,0
117492,P=0.97,0,0
117493,),0,0
117494,at,0,0
117495,day,0,0
117496,3,0,0
117497,post,0,0
117498,transplant,0,0
117499,.,0,0
117500,The,0,0
117501,T2,0,0
117502,group,0,0
117503,achieved,0,0
117504,tacrolimus,1,0
117505,trough,1,1
117506,levels,1,1
117507,of,1,0
117508,?10,1,0
117509,ng/mL,1,0
117510,significantly,1,0
117511,faster,0,0
117512,than,0,0
117513,the,0,0
117514,control,0,0
117515,group,0,0
117516,(,0,0
117517,100,0,0
117518,%,0,0
117519,achievement,0,0
117520,in,0,0
117521,14,0,0
117522,days,0,0
117523,(,0,0
117524,Control,0,0
117525,),0,0
117526,versus,0,0
117527,4,0,0
117528,days,0,0
117529,(,0,0
117530,T2,0,0
117531,),0,0
117532,;,0,0
117533,P=0.01,0,0
117534,),0,0
117535,.,0,0
117536,CONCLUSION,0,0
117537,Performing,0,0
117538,a,0,0
117539,pre-transplant,0,0
117540,tacrolimus,0,0
117541,C,0,0
117542,(,0,0
117543,2,0,0
117544,),0,0
117545,does,0,0
117546,not,0,0
117547,significantly,0,0
117548,increase,0,0
117549,the,1,0
117550,high,1,0
117551,proportion,1,0
117552,of,1,0
117553,subjects,1,0
117554,achieving,1,0
117555,10,1,0
117556,ng/mL,1,0
117557,tacrolimus,1,0
117558,concentrations,1,1
117559,by,1,0
117560,day,1,0
117561,3,1,0
117562,using,0,0
117563,routine,0,0
117564,protocols,0,0
117565,.,0,0
117566,However,0,0
117567,",",0,0
117568,compared,0,0
117569,with,0,0
117570,standard,0,0
117571,care,0,0
117572,",",0,0
117573,performing,0,0
117574,a,0,0
117575,pre-transplant,0,0
117576,tacrolimus,0,0
117577,C,0,0
117578,(,0,0
117579,2,0,0
117580,),0,0
117581,does,0,0
117582,lead,0,0
117583,to,0,0
117584,patients,0,0
117585,achieving,0,0
117586,a,1,0
117587,whole-blood,1,0
117588,concentration,1,1
117589,of,1,0
117590,?10,1,0
117591,ng/mL,1,0
117592,sooner,0,0
117593,.,0,0
117594,Detection,1,1
117595,rates,1,1
117596,of,1,0
117597,cancer,1,0
117598,",",1,0
117599,high,1,0
117600,grade,1,1
117601,PIN,1,0
117602,and,1,1
117603,atypical,1,0
117604,lesions,1,1
117605,suspicious,1,0
117606,for,1,0
117607,cancer,1,0
117608,in,0,0
117609,the,0,0
117610,European,0,0
117611,Randomized,0,0
117612,Study,0,0
117613,of,0,0
117614,Screening,0,0
117615,for,0,0
117616,Prostate,0,0
117617,Cancer,0,0
117618,.,0,0
117619,THE,0,0
117620,AIM,0,0
117621,OF,0,0
117622,THE,0,0
117623,STUDY,0,0
117624,This,0,0
117625,article,0,0
117626,presents,0,0
117627,the,0,0
117628,incidence,0,1
117629,of,0,0
117630,prostate,0,0
117631,cancer,0,0
117632,",",0,0
117633,isolated,0,0
117634,high,0,0
117635,grade,0,1
117636,prostatic,0,0
117637,intraepithelial,0,1
117638,neoplasia,0,0
117639,(,0,0
117640,PIN,0,0
117641,),0,0
117642,and,0,0
117643,atypical,0,0
117644,lesions,0,1
117645,suspicious,0,0
117646,for,0,0
117647,prostate,0,0
117648,cancer,0,0
117649,(,0,0
117650,LSPC,0,0
117651,),0,0
117652,during,0,0
117653,subsequent,0,0
117654,screening,0,0
117655,rounds,0,0
117656,in,0,0
117657,the,0,0
117658,centres,0,0
117659,of,0,0
117660,five,0,0
117661,of,0,0
117662,the,0,0
117663,countries,0,0
117664,participating,0,0
117665,in,0,0
117666,the,0,0
117667,European,0,0
117668,Randomized,0,0
117669,Study,0,0
117670,of,0,0
117671,Screening,0,0
117672,for,0,0
117673,Prostate,0,0
117674,Cancer,0,0
117675,(,0,0
117676,ERSPC,0,1
117677,),0,0
117678,.,0,0
117679,The,0,0
117680,incidence,0,1
117681,and,0,0
117682,predictive,0,1
117683,value,0,1
117684,of,0,0
117685,high,0,0
117686,grade,0,1
117687,PIN,0,0
117688,and,0,0
117689,LSPC,0,1
117690,for,0,0
117691,prostate,0,0
117692,cancer,0,0
117693,in,0,0
117694,subsequent,0,0
117695,biopsy,0,0
117696,following,0,0
117697,these,0,0
117698,diagnoses,0,0
117699,were,0,0
117700,evaluated,0,0
117701,.,0,0
117702,PATIENTS,0,0
117703,AND,0,0
117704,METHODS,0,0
117705,Study,0,0
117706,group,0,0
117707,consisted,0,0
117708,of,0,0
117709,"56,653",0,0
117710,screened,0,0
117711,men,0,0
117712,in,0,0
117713,the,0,0
117714,ERSPC,0,0
117715,centres,0,0
117716,of,0,0
117717,Finland,0,0
117718,",",0,0
117719,Italy,0,0
117720,",",0,1
117721,Netherlands,0,0
117722,",",0,1
117723,Sweden,0,0
117724,and,0,1
117725,Switzerland,0,0
117726,",",0,1
117727,who,0,0
117728,underwent,0,0
117729,3-7,0,0
117730,screening,0,0
117731,rounds,0,0
117732,at,0,0
117733,2-4,0,0
117734,year,0,0
117735,interval,0,0
117736,.,0,0
117737,Data,0,0
117738,for,0,0
117739,prostate,0,0
117740,cancer,0,0
117741,were,0,0
117742,obtained,0,0
117743,from,0,0
117744,the,0,0
117745,ERSPC,0,1
117746,central,0,0
117747,database,0,0
117748,.,0,0
117749,Data,0,0
117750,for,0,0
117751,high,0,0
117752,grade,0,1
117753,PIN,0,0
117754,and,0,1
117755,LSPC,0,1
117756,were,0,0
117757,gathered,0,0
117758,from,0,0
117759,each,0,0
117760,ERSPC,0,0
117761,centre,0,0
117762,.,0,0
117763,Detection,1,1
117764,rates,1,1
117765,of,0,0
117766,subsequent,1,0
117767,prostate,1,0
117768,cancer,1,0
117769,in,0,0
117770,the,0,0
117771,first,0,0
117772,re-biopsy,0,0
117773,after,0,0
117774,these,0,0
117775,diagnoses,0,0
117776,were,0,0
117777,determined,0,0
117778,.,0,0
117779,RESULTS,0,0
117780,The,0,0
117781,average,1,0
117782,cancer,1,0
117783,detection,1,1
117784,rate,1,1
117785,was,0,0
117786,3.5,0,0
117787,%,0,0
117788,",",0,0
117789,3.2,0,0
117790,%,0,0
117791,and,0,0
117792,3.5,0,0
117793,%,0,0
117794,for,0,0
117795,the,0,0
117796,completed,0,0
117797,rounds,0,0
117798,1,0,0
117799,",",0,0
117800,2,0,0
117801,and,0,0
117802,3,0,0
117803,",",0,0
117804,respectively,0,0
117805,",",0,0
117806,in,0,0
117807,all,0,0
117808,five,0,0
117809,centres,0,0
117810,.,0,0
117811,Incidence,1,1
117812,of,1,0
117813,high,1,0
117814,grade,1,1
117815,PIN,1,0
117816,increased,0,0
117817,from,0,0
117818,1.5,0,0
117819,%,0,0
117820,in,0,0
117821,the,0,0
117822,first,0,0
117823,round,0,0
117824,to,0,0
117825,5.0,0,0
117826,%,0,0
117827,in,0,0
117828,the,0,0
117829,third,0,0
117830,round,0,0
117831,",",0,0
117832,varying,0,0
117833,among,0,0
117834,centres,0,0
117835,in,0,0
117836,the,0,0
117837,first,0,0
117838,round,0,0
117839,between,0,0
117840,0.8,0,0
117841,%,0,0
117842,and,0,0
117843,7.6,0,0
117844,%,0,0
117845,.,0,0
117846,The,0,0
117847,cancer,1,0
117848,detection,1,1
117849,rate,1,1
117850,in,0,0
117851,the,0,0
117852,first,0,0
117853,re-biopsy,0,0
117854,after,0,0
117855,the,0,0
117856,diagnosis,0,0
117857,of,0,0
117858,high,0,0
117859,grade,0,1
117860,PIN,0,0
117861,was,0,0
117862,12.9,0,0
117863,%,0,0
117864,.,0,0
117865,Incidence,1,1
117866,of,1,0
117867,LSPC,1,0
117868,was,0,0
117869,2.4,0,0
117870,%,0,0
117871,",",0,0
117872,2.7,0,0
117873,%,0,0
117874,",",0,0
117875,2.2,0,0
117876,%,0,0
117877,and,0,0
117878,2.6,0,0
117879,%,0,0
117880,in,0,0
117881,the,0,0
117882,first,0,0
117883,",",0,0
117884,second,0,0
117885,",",0,0
117886,third,0,1
117887,and,0,1
117888,fourth,0,0
117889,round,0,0
117890,",",0,0
117891,respectively,0,0
117892,.,0,0
117893,The,0,0
117894,cancer,1,0
117895,detection,1,1
117896,rate,1,1
117897,at,0,0
117898,the,0,0
117899,first,0,0
117900,re-biopsy,0,0
117901,after,0,0
117902,the,0,0
117903,diagnosis,0,0
117904,of,0,0
117905,LSPC,0,0
117906,was,0,0
117907,in,0,0
117908,average,0,0
117909,33.8,0,0
117910,%,0,0
117911,.,0,0
117912,CONCLUSIONS,0,0
117913,Cancer,1,1
117914,detection,1,1
117915,rate,1,1
117916,was,0,0
117917,stable,0,0
117918,during,0,0
117919,the,0,0
117920,three,0,0
117921,screening,0,0
117922,rounds,0,0
117923,.,0,0
117924,The,0,0
117925,wide,0,0
117926,variation,0,1
117927,in,0,0
117928,frequency,0,1
117929,in,0,0
117930,particular,0,0
117931,of,0,0
117932,high,0,0
117933,grade,0,1
117934,PIN,0,0
117935,among,0,0
117936,the,0,0
117937,ERSPC,0,0
117938,centres,0,0
117939,suggests,0,0
117940,a,0,0
117941,considerable,0,0
117942,inter-observer,0,0
117943,variation,0,0
117944,.,0,0
117945,The,0,0
117946,average,0,0
117947,comparatively,0,0
117948,low,0,0
117949,detection,1,1
117950,rate,1,1
117951,of,0,0
117952,isolated,0,0
117953,high,0,0
117954,grade,0,1
117955,PIN,0,0
117956,in,0,0
117957,the,0,0
117958,first,0,0
117959,screening,0,0
117960,round,0,0
117961,may,0,0
117962,be,0,0
117963,screening-related,0,0
117964,",",0,0
117965,while,0,0
117966,its,0,0
117967,consistent,0,0
117968,increase,0,0
117969,during,0,0
117970,three,0,0
117971,screening,0,0
117972,rounds,0,0
117973,could,0,0
117974,be,0,0
117975,the,0,0
117976,consequence,0,0
117977,of,0,0
117978,a.o,0,0
117979,.,0,0
117980,previous,0,0
117981,screening,0,0
117982,and,0,1
117983,ageing,0,0
117984,of,0,0
117985,the,0,0
117986,population,0,0
117987,.,0,0
117988,The,0,0
117989,observed,0,0
117990,low,1,0
117991,risk,1,1
117992,of,1,0
117993,prostate,1,0
117994,cancer,1,0
117995,after,0,0
117996,isolated,0,0
117997,high,0,0
117998,grade,0,1
117999,PIN,0,0
118000,in,0,0
118001,this,0,0
118002,screening,0,0
118003,setting,0,0
118004,is,0,0
118005,in,0,0
118006,line,0,0
118007,with,0,0
118008,the,0,0
118009,current,0,0
118010,recommendation,0,0
118011,to,0,0
118012,abstain,0,0
118013,from,0,0
118014,early,0,0
118015,repeat,0,1
118016,biopsies,0,0
118017,after,0,0
118018,this,0,0
118019,diagnosis,0,0
118020,.,0,0
118021,The,0,0
118022,association,0,0
118023,of,0,0
118024,LSPC,0,0
118025,with,0,0
118026,high,0,0
118027,incidence,0,1
118028,of,0,0
118029,prostate,0,0
118030,cancer,0,0
118031,in,0,0
118032,re-biopsies,0,0
118033,confirms,0,0
118034,the,0,0
118035,need,0,0
118036,for,0,0
118037,early,0,0
118038,repeat,0,1
118039,biopsies,0,0
118040,and,0,1
118041,follow-up,0,0
118042,of,0,0
118043,these,0,0
118044,men,0,0
118045,.,0,0
118046,The,0,0
118047,low,0,0
118048,percentage,0,1
118049,of,0,0
118050,LSPC,0,0
118051,(,0,0
118052,<,0,0
118053,3,0,0
118054,%,0,0
118055,of,0,0
118056,biopsies,0,0
118057,),0,0
118058,throughout,0,0
118059,all,0,0
118060,rounds,0,0
118061,is,0,0
118062,reassuring,0,0
118063,as,0,0
118064,it,0,0
118065,limits,0,0
118066,the,0,0
118067,biopsy,0,0
118068,burden,0,1
118069,in,0,0
118070,a,0,0
118071,screening,0,0
118072,setting,0,0
118073,.,0,0
118074,Denosumab,0,0
118075,compared,0,0
118076,with,0,0
118077,zoledronic,0,0
118078,acid,0,0
118079,for,0,0
118080,the,0,0
118081,treatment,0,0
118082,of,0,0
118083,bone,0,1
118084,metastases,0,0
118085,in,0,0
118086,patients,0,0
118087,with,0,0
118088,advanced,0,0
118089,breast,0,0
118090,cancer,0,0
118091,:,0,0
118092,a,0,0
118093,randomized,0,0
118094,",",0,0
118095,double-blind,0,0
118096,study,0,0
118097,.,0,0
118098,PURPOSE,0,0
118099,This,0,0
118100,randomized,0,0
118101,study,0,0
118102,compared,0,0
118103,denosumab,0,0
118104,",",0,0
118105,a,0,0
118106,fully,0,0
118107,human,0,0
118108,monoclonal,0,0
118109,antibody,0,0
118110,against,0,1
118111,receptor,0,1
118112,activator,0,0
118113,of,0,0
118114,nuclear,0,0
118115,factor,0,0
118116,?,0,0
118117,B,0,0
118118,(,0,0
118119,RANK,0,0
118120,),0,1
118121,ligand,0,0
118122,",",0,0
118123,with,0,0
118124,zoledronic,0,0
118125,acid,0,0
118126,in,0,0
118127,delaying,0,0
118128,or,0,0
118129,preventing,0,0
118130,skeletal-related,0,1
118131,events,0,1
118132,(,0,0
118133,SREs,0,0
118134,),0,0
118135,in,0,0
118136,patients,0,0
118137,with,0,0
118138,breast,0,0
118139,cancer,0,0
118140,with,0,0
118141,bone,0,1
118142,metastases,0,0
118143,.,0,0
118144,PATIENTS,0,0
118145,AND,0,0
118146,METHODS,0,0
118147,Patients,0,0
118148,were,0,0
118149,randomly,0,0
118150,assigned,0,0
118151,to,0,0
118152,receive,0,0
118153,either,0,0
118154,subcutaneous,0,0
118155,denosumab,0,0
118156,120,0,0
118157,mg,0,0
118158,and,0,0
118159,intravenous,0,0
118160,placebo,0,0
118161,(,0,0
118162,n,0,0
118163,=,0,0
118164,"1,026",0,0
118165,),0,0
118166,or,0,0
118167,intravenous,0,0
118168,zoledronic,0,0
118169,acid,0,0
118170,4,0,0
118171,mg,0,0
118172,adjusted,0,0
118173,for,0,0
118174,creatinine,0,1
118175,clearance,0,1
118176,and,0,0
118177,subcutaneous,0,0
118178,placebo,0,0
118179,(,0,0
118180,n,0,0
118181,=,0,0
118182,"1,020",0,0
118183,),0,0
118184,every,0,0
118185,4,0,0
118186,weeks,0,0
118187,.,0,0
118188,All,0,0
118189,patients,0,0
118190,were,0,0
118191,strongly,0,0
118192,recommended,0,0
118193,to,0,0
118194,take,0,0
118195,daily,0,0
118196,calcium,0,0
118197,and,0,1
118198,vitamin,0,0
118199,D,0,1
118200,supplements,0,0
118201,.,0,0
118202,The,0,0
118203,primary,0,0
118204,end,0,0
118205,point,0,0
118206,was,0,0
118207,time,0,1
118208,to,1,0
118209,first,1,0
118210,on-study,1,0
118211,SRE,1,1
118212,(,1,0
118213,defined,1,0
118214,as,1,0
118215,pathologic,1,1
118216,fracture,1,1
118217,",",1,0
118218,radiation,1,1
118219,or,1,0
118220,surgery,1,0
118221,to,1,0
118222,bone,1,1
118223,",",1,0
118224,or,1,0
118225,spinal,1,1
118226,cord,1,1
118227,compression,1,0
118228,),1,0
118229,.,1,0
118230,RESULTS,0,0
118231,Denosumab,0,0
118232,was,0,0
118233,superior,0,0
118234,to,0,0
118235,zoledronic,0,0
118236,acid,0,0
118237,in,1,0
118238,delaying,1,0
118239,time,1,1
118240,to,1,0
118241,first,1,0
118242,on-study,1,0
118243,SRE,1,1
118244,(,0,0
118245,hazard,0,1
118246,ratio,0,1
118247,",",0,0
118248,0.82,0,0
118249,;,0,0
118250,95,0,0
118251,%,0,0
118252,CI,0,0
118253,",",0,0
118254,0.71,0,0
118255,to,0,0
118256,0.95,0,0
118257,;,0,0
118258,P,0,0
118259,=,0,0
118260,.01,0,0
118261,superiority,0,0
118262,),0,0
118263,and,1,0
118264,time,1,1
118265,to,1,0
118266,first,1,0
118267,and,1,0
118268,subsequent,1,0
118269,(,1,0
118270,multiple,1,0
118271,),1,0
118272,on-study,1,1
118273,SREs,1,1
118274,(,0,0
118275,rate,0,1
118276,ratio,0,1
118277,",",0,0
118278,0.77,0,0
118279,;,0,0
118280,95,0,0
118281,%,0,0
118282,CI,0,0
118283,",",0,0
118284,0.66,0,0
118285,to,0,0
118286,0.89,0,0
118287,;,0,0
118288,P,0,0
118289,=,0,0
118290,.001,0,0
118291,),0,0
118292,.,0,0
118293,Reduction,1,0
118294,in,1,0
118295,bone,1,1
118296,turnover,1,1
118297,markers,1,1
118298,was,0,0
118299,greater,0,0
118300,with,0,0
118301,denosumab,0,0
118302,.,0,0
118303,Overall,1,1
118304,survival,1,1
118305,",",1,0
118306,disease,1,1
118307,progression,1,1
118308,",",1,1
118309,and,1,1
118310,rates,1,1
118311,of,1,1
118312,adverse,1,1
118313,events,1,1
118314,(,1,0
118315,AEs,1,1
118316,),1,0
118317,and,1,0
118318,serious,1,1
118319,AEs,1,1
118320,were,0,0
118321,similar,0,0
118322,between,0,0
118323,groups,0,0
118324,.,0,0
118325,An,1,0
118326,excess,1,0
118327,of,1,0
118328,renal,1,1
118329,AEs,1,1
118330,and,1,0
118331,acute-phase,1,1
118332,reactions,1,1
118333,occurred,0,0
118334,with,0,0
118335,zoledronic,0,0
118336,acid,1,0
118337,;,1,0
118338,hypocalcemia,1,1
118339,occurred,0,0
118340,more,0,0
118341,frequently,0,0
118342,with,0,0
118343,denosumab,0,0
118344,.,0,0
118345,Osteonecrosis,1,1
118346,of,1,0
118347,the,1,0
118348,jaw,1,1
118349,occurred,0,0
118350,infrequently,0,0
118351,(,0,0
118352,2.0,0,0
118353,%,0,0
118354,",",0,0
118355,denosumab,0,0
118356,;,0,0
118357,1.4,0,0
118358,%,0,0
118359,",",0,0
118360,zoledronic,0,0
118361,acid,0,0
118362,;,0,0
118363,P,0,0
118364,=,0,0
118365,.39,0,0
118366,),0,0
118367,.,0,0
118368,CONCLUSION,0,0
118369,Denosumab,0,0
118370,was,0,0
118371,superior,0,0
118372,to,0,0
118373,zoledronic,0,0
118374,acid,0,0
118375,in,0,0
118376,delaying,0,0
118377,or,0,0
118378,preventing,0,0
118379,SREs,0,0
118380,in,0,0
118381,patients,0,0
118382,with,0,0
118383,breast,0,0
118384,cancer,0,0
118385,metastatic,0,0
118386,to,0,0
118387,bone,0,1
118388,and,0,0
118389,was,0,0
118390,generally,0,0
118391,well,0,0
118392,tolerated,0,1
118393,.,0,0
118394,With,0,0
118395,the,0,0
118396,convenience,0,0
118397,of,0,0
118398,a,0,0
118399,subcutaneous,0,0
118400,injection,0,0
118401,and,0,0
118402,no,0,0
118403,requirement,0,1
118404,for,0,0
118405,renal,0,1
118406,monitoring,0,0
118407,",",0,0
118408,denosumab,0,0
118409,represents,0,0
118410,a,0,0
118411,potential,0,0
118412,treatment,0,0
118413,option,0,0
118414,for,0,0
118415,patients,0,0
118416,with,0,0
118417,bone,0,1
118418,metastases,0,0
118419,.,0,0
118420,The,0,0
118421,effect,0,0
118422,of,0,0
118423,HCG,0,1
118424,supplementation,0,0
118425,after,0,0
118426,combined,0,0
118427,GnRH,0,0
118428,agonist/HMG,0,0
118429,treatment,0,0
118430,in,0,0
118431,an,0,0
118432,IVF,0,0
118433,programme,0,0
118434,.,0,0
118435,The,0,0
118436,necessity,0,0
118437,of,0,0
118438,luteal-phase,0,0
118439,supplementation,0,0
118440,in,0,0
118441,an,0,0
118442,IVF,0,0
118443,programme,0,0
118444,is,0,0
118445,of,0,0
118446,continuing,0,0
118447,interest,0,0
118448,.,0,0
118449,After,0,0
118450,ovarian,0,0
118451,stimulation,0,0
118452,with,0,0
118453,clomiphene,0,0
118454,and,0,0
118455,human,0,0
118456,menopausal,0,1
118457,gonadotrophin,0,1
118458,(,0,0
118459,HMG,0,0
118460,),0,0
118461,",",0,0
118462,the,0,0
118463,beneficial,0,0
118464,effect,0,0
118465,of,0,0
118466,supporting,0,0
118467,the,0,0
118468,luteal,0,0
118469,phase,0,0
118470,has,0,0
118471,never,0,0
118472,been,0,0
118473,scientifically,0,0
118474,demonstrated,0,0
118475,.,0,0
118476,After,0,0
118477,ovarian,0,0
118478,stimulation,0,0
118479,with,0,0
118480,GnRH,0,1
118481,agonist/HMG,0,0
118482,",",0,0
118483,the,0,0
118484,luteal,0,0
118485,phase,0,0
118486,seems,0,0
118487,to,0,0
118488,be,0,0
118489,inadequate,0,0
118490,",",0,0
118491,but,0,0
118492,in,0,0
118493,a,0,0
118494,previous,0,0
118495,study,0,0
118496,we,0,0
118497,did,0,0
118498,not,0,0
118499,find,0,0
118500,evidence,0,0
118501,to,0,0
118502,support,0,0
118503,the,0,0
118504,need,0,0
118505,for,0,0
118506,oral,0,0
118507,progesterone,0,1
118508,supplementation,0,0
118509,.,0,0
118510,To,0,0
118511,evaluate,0,0
118512,the,0,0
118513,beneficial,0,0
118514,effect,0,0
118515,of,0,0
118516,human,0,0
118517,chorionic,0,1
118518,gonadotrophin,0,1
118519,(,0,0
118520,HCG,0,1
118521,),0,1
118522,supplementation,0,0
118523,",",0,0
118524,we,0,0
118525,performed,0,0
118526,a,0,0
118527,multicentre,0,0
118528,",",0,0
118529,double-blind,0,0
118530,",",0,0
118531,randomized,0,0
118532,study,0,0
118533,with,0,0
118534,HCG,0,1
118535,(,0,0
118536,193,0,0
118537,transfers,0,0
118538,),0,0
118539,against,0,1
118540,placebo,0,0
118541,(,0,0
118542,194,0,0
118543,transfers,0,0
118544,),0,0
118545,.,0,0
118546,The,0,0
118547,ongoing,1,0
118548,pregnancy,1,1
118549,rate,1,1
118550,per,1,0
118551,transfer,1,1
118552,cycle,1,1
118553,was,0,0
118554,significantly,0,0
118555,better,0,0
118556,with,0,0
118557,HCG,0,1
118558,(,0,0
118559,18.7,0,0
118560,versus,0,0
118561,9.3,0,0
118562,),0,0
118563,.,0,0
118564,This,0,0
118565,is,0,0
118566,the,0,0
118567,first,0,0
118568,truly,0,0
118569,objective,0,0
118570,(,0,0
118571,randomized,0,0
118572,),0,0
118573,study,0,0
118574,demonstrating,0,0
118575,the,0,0
118576,beneficial,0,0
118577,effect,0,0
118578,of,0,0
118579,supporting,0,0
118580,the,0,0
118581,luteal,0,0
118582,phase,0,0
118583,in,0,0
118584,an,0,0
118585,IVF,0,0
118586,programme,0,0
118587,.,0,0
118588,Plasma,0,1
118589,pH,0,0
118590,does,0,0
118591,not,0,0
118592,influence,0,0
118593,the,0,0
118594,cerebral,0,0
118595,metabolic,0,1
118596,ratio,0,1
118597,during,0,0
118598,maximal,0,1
118599,whole,0,0
118600,body,0,1
118601,exercise,0,0
118602,.,0,0
118603,Exercise,0,0
118604,lowers,0,0
118605,the,0,0
118606,cerebral,0,0
118607,metabolic,0,1
118608,ratio,0,1
118609,of,0,0
118610,O2,0,0
118611,to,0,0
118612,carbohydrate,0,0
118613,(,0,0
118614,glucose+1/2,0,1
118615,lactate,0,1
118616,),0,0
118617,and,0,0
118618,metabolic,0,1
118619,acidosis,0,1
118620,appears,0,0
118621,to,0,0
118622,promote,1,0
118623,cerebral,1,1
118624,lactate,1,1
118625,uptake,1,1
118626,.,1,0
118627,However,0,0
118628,",",0,0
118629,the,0,0
118630,influence,0,0
118631,of,0,0
118632,pH,0,0
118633,on,0,0
118634,cerebral,0,1
118635,lactate,0,1
118636,uptake,0,1
118637,and,0,0
118638,",",0,0
118639,in,0,0
118640,turn,0,1
118641,",",0,0
118642,on,0,0
118643,the,0,0
118644,cerebral,0,0
118645,metabolic,0,1
118646,ratio,0,1
118647,during,0,0
118648,exercise,0,0
118649,is,0,0
118650,not,0,0
118651,known,0,0
118652,.,0,0
118653,Sodium,0,0
118654,bicarbonate,0,0
118655,(,0,0
118656,Bicarb,0,0
118657,",",0,0
118658,1,0,0
118659,M,0,0
118660,;,0,0
118661,350-500,0,0
118662,ml,0,0
118663,),0,0
118664,or,0,0
118665,an,0,0
118666,equal,0,0
118667,volume,0,1
118668,of,0,0
118669,normal,0,0
118670,saline,0,0
118671,(,0,0
118672,Sal,0,1
118673,),0,0
118674,was,0,0
118675,infused,0,0
118676,intravenously,0,0
118677,at,0,0
118678,a,0,0
118679,constant,0,0
118680,rate,0,1
118681,during,0,0
118682,a,0,0
118683,'2000,0,0
118684,m,0,0
118685,',0,0
118686,maximal,0,1
118687,ergometer,0,0
118688,row,0,0
118689,in,0,0
118690,six,0,0
118691,male,0,0
118692,oarsmen,0,0
118693,(,0,0
118694,23?2,0,0
118695,years,0,0
118696,;,0,0
118697,mean?S.D.,0,0
118698,),0,0
118699,.,0,0
118700,During,0,0
118701,the,0,0
118702,Sal,0,0
118703,trial,1,0
118704,",",1,1
118705,pH,1,1
118706,decreased,1,0
118707,from,0,0
118708,7.41?0.01,0,0
118709,at,0,0
118710,rest,0,0
118711,to,0,0
118712,7.02?0.02,0,0
118713,but,0,0
118714,only,0,0
118715,to,0,0
118716,7.36?0.02,0,0
118717,(,0,0
118718,P,0,0
118719,<,0,0
118720,0.05,0,0
118721,),0,0
118722,during,0,0
118723,the,0,0
118724,Bicarb,0,0
118725,trial,0,0
118726,.,1,0
118727,Arterial,1,0
118728,lactate,1,1
118729,increased,1,0
118730,to,0,0
118731,21.4?0.8,0,0
118732,and,0,0
118733,32.7?2.3,0,0
118734,mM,0,0
118735,during,0,0
118736,the,0,0
118737,Sal,0,0
118738,and,0,0
118739,Bicarb,0,0
118740,trials,0,0
118741,",",0,0
118742,respectively,0,0
118743,(,0,0
118744,P,0,0
118745,<,0,0
118746,0.05,0,0
118747,),0,0
118748,.,0,0
118749,Also,0,0
118750,",",0,0
118751,the,1,0
118752,arterial-jugular,1,1
118753,venous,1,1
118754,lactate,1,1
118755,difference,1,0
118756,increased,0,0
118757,from-0.03?0.01,0,0
118758,mM,0,0
118759,at,0,0
118760,rest,0,0
118761,to,0,0
118762,3.2?0.9,0,0
118763,mM,0,0
118764,(,0,0
118765,P,0,0
118766,<,0,0
118767,0.05,0,0
118768,),0,0
118769,and,0,0
118770,3.4?1.4,0,0
118771,mM,0,0
118772,(,0,0
118773,P,0,0
118774,<,0,0
118775,0.05,0,0
118776,),0,0
118777,following,0,0
118778,the,0,0
118779,Sal,0,0
118780,and,0,0
118781,Bicarb,0,0
118782,trials,0,0
118783,",",0,0
118784,respectively,0,0
118785,.,0,0
118786,Accordingly,1,0
118787,",",1,0
118788,the,1,0
118789,cerebral,1,1
118790,metabolic,1,1
118791,ratio,1,1
118792,decreased,1,0
118793,equally,0,0
118794,during,0,0
118795,the,0,0
118796,Sal,0,0
118797,and,0,0
118798,Bicarb,0,0
118799,trials,0,0
118800,:,0,0
118801,from,0,0
118802,5.8?0.6,0,0
118803,at,0,0
118804,rest,0,0
118805,to,0,0
118806,1.7?0.1,0,0
118807,and,0,0
118808,1.8?0.2,0,0
118809,",",0,0
118810,respectively,0,0
118811,.,0,0
118812,The,1,0
118813,enlarged,1,1
118814,blood-buffering,1,1
118815,capacity,1,1
118816,after,1,0
118817,infusion,0,0
118818,of,0,0
118819,Bicarb,0,0
118820,eliminated,1,0
118821,metabolic,1,1
118822,acidosis,1,1
118823,during,1,0
118824,maximal,0,1
118825,exercise,0,0
118826,but,0,0
118827,that,0,0
118828,did,0,0
118829,not,0,0
118830,affect,0,0
118831,the,1,0
118832,cerebral,1,1
118833,lactate,1,1
118834,uptake,1,1
118835,and,1,1
118836,",",1,0
118837,therefore,0,0
118838,",",0,0
118839,the,0,0
118840,decrease,0,0
118841,in,0,0
118842,the,1,0
118843,cerebral,1,1
118844,metabolic,1,0
118845,ratio,1,1
118846,.,1,0
118847,The,0,0
118848,Toronto,0,0
118849,prehospital,0,0
118850,hypertonic,0,0
118851,resuscitation,0,0
118852,--,0,0
118853,head,0,0
118854,injury,0,1
118855,and,0,0
118856,multiorgan,0,1
118857,dysfunction,0,1
118858,trial,0,0
118859,:,0,0
118860,feasibility,0,0
118861,study,0,0
118862,of,0,0
118863,a,0,0
118864,randomized,0,0
118865,controlled,0,0
118866,trial,0,0
118867,.,0,0
118868,OBJECTIVE,0,0
118869,The,0,0
118870,aim,0,0
118871,of,0,0
118872,the,0,0
118873,study,0,0
118874,was,0,0
118875,to,0,0
118876,evaluate,0,0
118877,the,0,0
118878,feasibility,0,0
118879,of,0,0
118880,a,0,0
118881,prehospital,0,0
118882,trial,0,0
118883,comparing,0,0
118884,hypertonic,0,0
118885,saline,0,0
118886,and,0,1
118887,dextran,0,0
118888,(,0,1
118889,HSD,0,0
118890,),0,0
118891,with,0,0
118892,normal,0,0
118893,saline,0,0
118894,(,0,0
118895,NS,0,1
118896,),0,0
118897,in,0,0
118898,blunt,0,1
118899,head,0,0
118900,injury,0,1
118901,patients,0,0
118902,.,0,0
118903,DESIGN,0,0
118904,The,0,0
118905,study,0,0
118906,used,0,0
118907,a,0,0
118908,double,0,0
118909,blind,0,0
118910,randomized,0,0
118911,trial,0,0
118912,.,0,0
118913,SETTING,0,0
118914,The,0,0
118915,study,0,0
118916,was,0,0
118917,conducted,0,0
118918,in,0,0
118919,air,0,0
118920,and,0,1
118921,land,0,0
118922,emergency,0,1
118923,medical,0,0
118924,services,0,0
118925,and,0,0
118926,2,0,0
118927,trauma,0,0
118928,centers,0,0
118929,serving,0,0
118930,a,0,0
118931,population,0,0
118932,of,0,0
118933,4,0,0
118934,million,0,0
118935,people,0,0
118936,.,0,0
118937,PATIENTS,0,0
118938,The,0,0
118939,study,0,0
118940,population,0,0
118941,consisted,0,0
118942,of,0,0
118943,head,0,0
118944,injured,0,0
118945,",",0,0
118946,blunt,0,0
118947,trauma,0,0
118948,adult,0,0
118949,patients,0,0
118950,with,0,0
118951,a,0,0
118952,Glasgow,0,0
118953,Coma,0,0
118954,Scale,0,1
118955,of,0,0
118956,lower,0,0
118957,than,0,0
118958,9,0,0
118959,.,0,0
118960,INTERVENTIONS,0,0
118961,We,0,0
118962,used,0,0
118963,250,0,0
118964,mL,0,0
118965,of,0,0
118966,HSD,0,0
118967,vs,0,0
118968,NS,0,1
118969,given,0,0
118970,within,0,0
118971,4,0,0
118972,hours,0,0
118973,of,0,0
118974,the,0,0
118975,accident,0,0
118976,.,0,0
118977,MEASUREMENTS,0,0
118978,The,0,0
118979,specific,0,0
118980,objectives,0,0
118981,were,0,0
118982,to,0,0
118983,assess,1,0
118984,protocol-related,1,0
118985,logistical,1,0
118986,issues,1,0
118987,",",1,0
118988,randomization,1,0
118989,",",1,1
118990,HSD,1,1
118991,safety,1,1
118992,",",1,0
118993,and,1,1
118994,follow,1,0
118995,up,1,0
118996,rates,1,1
118997,and,0,0
118998,to,0,0
118999,obtain,0,0
119000,survival,1,1
119001,and,1,0
119002,neurocognitive,1,1
119003,end,1,0
119004,point,1,0
119005,estimates,1,0
119006,.,1,0
119007,MAIN,0,0
119008,RESULTS,0,0
119009,Of,0,0
119010,132,0,0
119011,eligible,0,0
119012,patients,0,0
119013,",",0,0
119014,113,0,0
119015,were,0,0
119016,randomized,0,0
119017,.,0,0
119018,Nineteen,0,0
119019,eligible,0,0
119020,patients,0,0
119021,were,0,0
119022,missed,0,0
119023,because,0,0
119024,of,0,0
119025,lack,0,0
119026,of,0,0
119027,time,0,1
119028,(,0,0
119029,9,0,0
119030,[,0,0
119031,22,0,0
119032,%,0,0
119033,],0,0
119034,),0,0
119035,",",0,0
119036,paramedic,0,0
119037,discretion,0,0
119038,(,0,0
119039,3,0,0
119040,[,0,0
119041,7,0,0
119042,%,0,0
119043,],0,0
119044,),0,0
119045,",",0,0
119046,the,0,0
119047,paramedic,0,0
119048,forgot,0,0
119049,(,0,0
119050,6,0,0
119051,[,0,0
119052,15,0,0
119053,%,0,0
119054,],0,0
119055,),0,1
119056,",",0,0
119057,and,0,0
119058,the,0,0
119059,paramedic,0,0
119060,refused,0,0
119061,(,0,0
119062,1,0,0
119063,[,0,0
119064,2,0,0
119065,%,0,0
119066,],0,0
119067,),0,0
119068,.,0,0
119069,Randomization,0,0
119070,compliance,0,1
119071,was,0,0
119072,96,0,0
119073,%,0,0
119074,(,0,0
119075,109/113,0,0
119076,),0,0
119077,.,0,0
119078,Four,0,0
119079,randomized,0,0
119080,cases,0,0
119081,met,0,0
119082,exclusion,0,0
119083,criteria,0,0
119084,:,0,0
119085,penetrating,0,0
119086,trauma,0,0
119087,(,0,0
119088,1,0,0
119089,),0,0
119090,",",0,0
119091,cardiac,0,1
119092,arrest,0,1
119093,(,0,0
119094,2,0,0
119095,),0,0
119096,",",0,0
119097,and,0,1
119098,fall,0,1
119099,from,0,0
119100,standing,0,0
119101,(,0,0
119102,1,0,0
119103,),0,0
119104,.,0,0
119105,Three,0,0
119106,randomized,0,0
119107,patients,0,0
119108,were,0,0
119109,excluded,0,0
119110,from,0,0
119111,the,0,0
119112,final,0,0
119113,analysis,0,0
119114,:,0,0
119115,2,0,0
119116,patients,0,0
119117,received,0,0
119118,less,0,0
119119,than,0,0
119120,50,0,0
119121,mL,0,0
119122,of,0,0
119123,study,0,0
119124,solution,0,0
119125,due,0,0
119126,to,0,0
119127,an,0,0
119128,interstitial,0,1
119129,intravenous,0,0
119130,line,0,0
119131,and,0,0
119132,1,0,0
119133,lost,0,0
119134,randomization,0,0
119135,identification,0,0
119136,.,0,0
119137,Fifty,0,0
119138,patients,0,0
119139,(,0,0
119140,47,0,0
119141,%,0,0
119142,),0,0
119143,were,0,0
119144,randomized,0,0
119145,to,0,0
119146,HSD,0,0
119147,and,0,0
119148,56,0,0
119149,(,0,0
119150,53,0,0
119151,%,0,0
119152,),0,0
119153,to,0,0
119154,NS,0,0
119155,.,0,0
119156,Mean,1,0
119157,injury,1,1
119158,severity,1,1
119159,score,1,1
119160,was,0,0
119161,32.7,0,0
119162,for,0,0
119163,HSD,0,0
119164,and,0,0
119165,32.6,0,0
119166,for,0,0
119167,NS,0,0
119168,.,0,0
119169,There,0,0
119170,was,0,0
119171,no,0,0
119172,difference,0,0
119173,in,0,0
119174,length,1,1
119175,of,1,0
119176,stay,1,1
119177,",",1,0
119178,Sequential,1,0
119179,Organ,1,0
119180,Failure,1,1
119181,Assessment,1,0
119182,maximum,1,1
119183,",",1,0
119184,Multiple,1,1
119185,Organ,1,0
119186,Dysfunction,1,1
119187,Score,1,0
119188,maximum,1,1
119189,",",1,0
119190,delta,1,1
119191,Multiple,1,1
119192,Organ,1,0
119193,Dysfunction,1,1
119194,Score,1,0
119195,",",1,0
119196,or,1,0
119197,Apache,1,1
119198,scores,1,1
119199,.,1,0
119200,Initial,1,1
119201,head,1,0
119202,scans,1,0
119203,scored,0,0
119204,3,0,0
119205,or,0,0
119206,higher,0,0
119207,by,0,0
119208,Marshall,0,1
119209,classification,0,1
119210,for,0,0
119211,12,0,0
119212,HSD,0,0
119213,and,0,0
119214,11,0,0
119215,NS,0,0
119216,patients,0,0
119217,.,0,0
119218,Zero,0,0
119219,adverse,1,1
119220,events,1,1
119221,occurred,0,0
119222,",",0,0
119223,and,0,1
119224,follow-up,0,0
119225,for,0,0
119226,the,0,0
119227,primary,0,0
119228,outcome,0,0
119229,was,0,0
119230,100,0,0
119231,%,0,0
119232,.,0,0
119233,Alive,1,0
119234,at,1,0
119235,30,1,0
119236,days,1,0
119237,for,0,0
119238,HSD,0,0
119239,and,0,1
119240,NS,0,1
119241,",",0,0
119242,respectively,0,0
119243,",",0,0
119244,was,0,0
119245,70,0,0
119246,%,0,0
119247,(,0,0
119248,35/50,0,0
119249,),0,0
119250,and,0,0
119251,75,0,0
119252,%,0,0
119253,(,0,0
119254,42/56,0,0
119255,),0,0
119256,and,0,0
119257,at,0,0
119258,discharge,0,1
119259,was,0,0
119260,68,0,0
119261,%,0,0
119262,(,0,0
119263,34/50,0,0
119264,),0,0
119265,and,0,0
119266,73,0,0
119267,%,0,0
119268,(,0,0
119269,41/56,0,0
119270,),0,0
119271,.,0,0
119272,Only,0,0
119273,49.3,0,0
119274,%,0,0
119275,(,0,0
119276,37/77,0,0
119277,),0,0
119278,of,0,0
119279,surviving,0,0
119280,patients,0,0
119281,consented,0,0
119282,to,0,0
119283,follow-up,0,0
119284,at,0,0
119285,4,0,0
119286,months,0,0
119287,and,0,0
119288,89,0,0
119289,%,0,0
119290,(,0,0
119291,33/37,0,0
119292,),0,0
119293,completed,0,0
119294,the,0,0
119295,assessment,0,0
119296,.,0,0
119297,Disability,1,1
119298,rating,1,1
119299,scale,1,1
119300,(,0,0
119301,median,0,1
119302,",",0,0
119303,interquartile,0,1
119304,range,0,0
119305,),0,0
119306,was,0,0
119307,3,0,0
119308,(,0,0
119309,0,0,0
119310,",",0,0
119311,6,0,0
119312,),0,0
119313,for,0,0
119314,HSD,0,0
119315,and,0,0
119316,was,0,0
119317,0,0,0
119318,(,0,0
119319,0,0,0
119320,",",0,0
119321,6,0,0
119322,),0,0
119323,for,0,0
119324,NS,0,0
119325,.,0,0
119326,Glasgow,1,0
119327,Outcome,1,1
119328,Scale,1,1
119329,Evaluation,1,0
119330,was,0,0
119331,higher,0,0
119332,than,0,0
119333,4,0,0
119334,for,0,0
119335,HSD,0,0
119336,(,0,0
119337,12/12,0,0
119338,[,0,0
119339,100,0,0
119340,%,0,0
119341,],0,0
119342,),0,0
119343,and,0,1
119344,NS,0,1
119345,(,0,0
119346,15/21,0,0
119347,[,0,0
119348,72,0,0
119349,%,0,0
119350,],0,0
119351,),0,0
119352,.,0,0
119353,Functional,1,0
119354,Independence,1,1
119355,Measure,1,1
119356,(,0,0
119357,mean,0,1
119358,",",0,1
119359,SD,0,0
119360,),0,0
119361,was,0,0
119362,62,0,0
119363,(,0,0
119364,37,0,0
119365,),0,0
119366,for,0,0
119367,HSD,0,0
119368,and,0,0
119369,80,0,0
119370,(,0,0
119371,32,0,0
119372,),0,0
119373,for,0,0
119374,NS,0,0
119375,.,0,0
119376,CONCLUSIONS,0,0
119377,It,0,0
119378,is,0,0
119379,feasible,0,0
119380,to,0,0
119381,conduct,0,0
119382,a,0,0
119383,prehospital,0,0
119384,randomized,0,0
119385,controlled,0,0
119386,trial,0,0
119387,with,0,0
119388,HSD,0,0
119389,for,0,0
119390,treatment,0,0
119391,of,0,0
119392,blunt,0,1
119393,trauma,0,0
119394,patients,0,0
119395,with,0,0
119396,head,0,0
119397,injuries,0,0
119398,;,0,0
119399,however,0,0
119400,",",0,0
119401,consent,0,0
119402,for,0,0
119403,neurofunctional,0,1
119404,outcomes,0,0
119405,in,0,0
119406,this,0,0
119407,cohort,0,0
119408,is,0,0
119409,problematic,0,0
119410,and,0,0
119411,threatens,0,0
119412,the,0,0
119413,feasibility,0,0
119414,of,0,0
119415,definitive,0,0
119416,trials,0,0
119417,using,0,0
119418,these,0,0
119419,potentially,0,0
119420,meaningful,0,0
119421,end,0,0
119422,points,0,0
119423,.,0,0
119424,A,0,0
119425,two-part,0,0
119426,phase,0,0
119427,II,0,0
119428,study,0,0
119429,of,0,0
119430,cediranib,0,0
119431,in,0,0
119432,patients,0,0
119433,with,0,0
119434,advanced,0,0
119435,solid,0,0
119436,tumours,0,0
119437,:,0,0
119438,the,0,0
119439,effect,0,0
119440,of,0,0
119441,food,0,0
119442,on,0,0
119443,single-dose,0,0
119444,pharmacokinetics,0,0
119445,and,0,0
119446,an,0,0
119447,evaluation,0,0
119448,of,0,0
119449,safety,1,1
119450,",",1,0
119451,efficacy,1,1
119452,and,1,1
119453,imaging,1,0
119454,pharmacodynamics,1,0
119455,.,1,0
119456,BACKGROUND,0,0
119457,Cediranib,0,0
119458,(,0,0
119459,RECENTIN?,0,0
119460,),0,0
119461,is,0,0
119462,an,0,0
119463,oral,0,0
119464,",",0,0
119465,highly,0,0
119466,potent,0,0
119467,VEGF,0,0
119468,inhibitor,0,0
119469,.,0,0
119470,This,0,0
119471,study,0,0
119472,evaluated,0,0
119473,the,0,0
119474,effect,0,0
119475,of,0,0
119476,food,0,0
119477,on,0,0
119478,the,0,0
119479,pharmacokinetics,0,0
119480,of,0,0
119481,cediranib,0,0
119482,and,0,0
119483,compared,0,0
119484,the,0,0
119485,administration,0,0
119486,of,0,0
119487,continual,0,1
119488,cediranib,0,0
119489,via,0,0
119490,two,0,0
119491,dosing,0,0
119492,strategies,0,0
119493,using,0,0
119494,this,0,0
119495,as,0,0
119496,a,0,0
119497,platform,0,0
119498,to,0,0
119499,investigate,0,0
119500,pharmacodynamic,0,1
119501,imaging,0,0
119502,biomarkers,0,0
119503,.,0,0
119504,METHODS,0,0
119505,Sixty,0,0
119506,patients,0,0
119507,were,0,0
119508,randomised,0,0
119509,to,0,0
119510,receive,0,0
119511,two,0,0
119512,single,0,0
119513,doses,0,0
119514,of,0,0
119515,cediranib,0,0
119516,in,0,0
119517,either,0,0
119518,fed/fasted,0,0
119519,or,0,0
119520,fasted/fed,0,1
119521,state,0,1
119522,(,0,0
119523,Part,0,1
119524,A,0,0
119525,),0,0
119526,.,0,0
119527,In,0,0
119528,continual,0,1
119529,dosage,0,0
119530,phase,0,0
119531,(,0,0
119532,Part,0,1
119533,B,0,0
119534,),0,0
119535,",",0,0
119536,patients,0,0
119537,were,0,0
119538,randomised,0,0
119539,to,0,0
119540,a,0,0
119541,fixed-dose,0,0
119542,or,0,0
119543,dose-escalation,0,0
119544,arm,1,0
119545,.,1,0
119546,Exploratory,1,0
119547,pharmacodynamic,1,1
119548,assessments,1,0
119549,were,1,0
119550,performed,0,0
119551,using,0,0
119552,DCE-MRI,0,0
119553,and,0,0
119554,CT,0,1
119555,enhancing,0,1
119556,fraction,0,1
119557,(,0,0
119558,EnF,0,0
119559,),0,0
119560,.,0,0
119561,RESULTS,0,0
119562,In,0,0
119563,part,0,0
119564,A,0,0
119565,",",0,0
119566,plasma,1,1
119567,AUC,1,1
119568,and,1,1
119569,C,1,0
119570,(,1,1
119571,max,1,1
119572,),1,0
119573,of,1,0
119574,cediranib,1,0
119575,were,1,0
119576,lower,0,0
119577,in,0,0
119578,the,0,0
119579,presence,0,0
119580,of,0,0
119581,food,0,0
119582,by,0,0
119583,a,0,0
119584,mean,0,0
119585,of,0,0
119586,24,0,0
119587,and,0,0
119588,33,0,0
119589,%,0,0
119590,",",0,0
119591,respectively,0,0
119592,(,0,0
119593,94,0,0
119594,%,0,0
119595,CI,0,0
119596,:,0,0
119597,AUC,0,0
119598,",",0,0
119599,12-34,0,0
119600,%,0,0
119601,and,0,0
119602,C,0,0
119603,(,0,1
119604,max,0,1
119605,),0,0
119606,",",0,0
119607,20-43,0,0
119608,%,0,0
119609,),0,0
119610,",",0,0
119611,indicating,0,0
119612,food,0,0
119613,reduces,1,0
119614,cediranib,1,0
119615,plasma,1,1
119616,exposure,1,0
119617,.,1,0
119618,In,0,0
119619,part,0,0
119620,B,0,0
119621,",",0,0
119622,cediranib,0,0
119623,30,0,0
119624,mg/day,0,0
119625,appeared,0,0
119626,to,0,0
119627,be,0,0
119628,the,0,0
119629,most,0,0
119630,sustainable,0,1
119631,for,0,0
119632,chronic,0,0
119633,dosing,0,0
119634,.,0,0
119635,Continuous,0,1
119636,cediranib,0,0
119637,therapy,0,0
119638,was,0,0
119639,associated,0,0
119640,with,1,0
119641,sustained,1,0
119642,antivascular,1,0
119643,effects,1,0
119644,up,1,0
119645,to,0,0
119646,16,0,0
119647,weeks,0,0
119648,",",0,0
119649,with,0,0
119650,significant,0,0
119651,reductions,1,1
119652,in,1,0
119653,DCE-MRI,1,0
119654,parameters,1,1
119655,and,1,0
119656,CT,1,1
119657,EnF,1,0
119658,.,0,0
119659,CONCLUSIONS,0,0
119660,It,0,0
119661,is,0,0
119662,recommended,0,0
119663,that,0,0
119664,cediranib,0,0
119665,be,0,0
119666,administered,0,0
119667,at,0,0
119668,least,0,0
119669,1,0,0
119670,h,0,0
119671,before,0,0
119672,or,0,0
119673,2,0,0
119674,h,0,0
119675,after,0,0
119676,food,0,0
119677,.,0,0
119678,Evidence,1,0
119679,of,1,0
119680,antitumour,1,1
119681,activity,1,1
119682,was,1,0
119683,observed,1,0
119684,",",0,0
119685,with,0,0
119686,significant,0,0
119687,sustained,0,0
119688,effects,1,0
119689,upon,1,0
119690,imaging,1,0
119691,vascular,1,0
119692,parameters,1,0
119693,.,1,0
119694,[,0,0
119695,GISSI-2,0,0
119696,;,0,0
119697,the,0,0
119698,beginning,0,0
119699,of,0,0
119700,the,0,0
119701,end,0,0
119702,or,0,0
119703,the,0,0
119704,end,0,0
119705,of,0,0
119706,the,0,0
119707,beginning,0,0
119708,for,0,0
119709,tissue,0,1
119710,plasminogen,0,1
119711,activator,0,0
119712,in,0,0
119713,acute,1,0
119714,myocardial,1,1
119715,infarct,1,1
119716,?,0,0
119717,],0,0
119718,.,0,0
119719,Effects,0,0
119720,of,0,0
119721,the,0,0
119722,810-nm,0,0
119723,diode,0,0
119724,laser,0,0
119725,on,0,0
119726,hair,0,1
119727,and,0,0
119728,on,0,0
119729,the,0,0
119730,biophysical,0,1
119731,properties,0,1
119732,of,0,0
119733,skin,0,1
119734,.,0,0
119735,INTRODUCTION,0,1
119736,Laser,0,0
119737,therapy,0,0
119738,is,0,0
119739,clinically,0,0
119740,effective,0,0
119741,in,0,0
119742,hair,0,1
119743,removal,0,0
119744,;,0,0
119745,however,0,0
119746,",",0,0
119747,despite,0,0
119748,the,0,0
119749,development,0,0
119750,of,0,0
119751,various,0,0
119752,strategies,0,0
119753,",",0,0
119754,laser,0,0
119755,procedures,0,0
119756,still,0,0
119757,present,0,0
119758,a,0,0
119759,risk,0,0
119760,of,0,0
119761,adverse,0,1
119762,effects,0,0
119763,due,0,0
119764,to,0,0
119765,the,0,0
119766,overheating,0,1
119767,of,0,0
119768,the,0,0
119769,skin,0,0
119770,.,0,0
119771,OBJECTIVE,0,0
119772,To,0,0
119773,investigate,0,0
119774,the,0,0
119775,effects,0,0
119776,of,0,0
119777,810-nm,0,0
119778,diode,0,0
119779,laser,0,0
119780,treatment,0,0
119781,on,0,0
119782,hair,0,1
119783,and,0,0
119784,on,0,0
119785,the,0,0
119786,biophysical,0,1
119787,properties,0,1
119788,of,0,0
119789,skin,0,1
119790,by,0,0
119791,using,0,0
119792,various,0,0
119793,non-invasive,0,0
119794,techniques,0,0
119795,on,0,0
119796,various,0,0
119797,parameters,0,1
119798,",",0,0
119799,including,0,0
119800,hair,0,1
119801,analysis,0,0
119802,",",0,1
119803,surface,0,1
119804,color,0,1
119805,changes,0,1
119806,",",0,0
119807,integrity,0,1
119808,of,0,1
119809,skin,0,1
119810,barrier,0,0
119811,",",0,0
119812,sebum,0,1
119813,production,0,1
119814,rate,0,1
119815,and,0,1
119816,pH,0,1
119817,level,0,1
119818,.,0,0
119819,METHODS,0,0
119820,In,0,0
119821,this,0,0
119822,randomized,0,0
119823,",",0,0
119824,right-left,0,1
119825,comparison,0,0
119826,study,0,0
119827,",",0,0
119828,35,0,0
119829,women,0,0
119830,with,0,0
119831,axillary,0,1
119832,hair,0,1
119833,received,0,0
119834,single-session,0,0
119835,diode,0,0
119836,laser,0,0
119837,therapy,0,0
119838,.,0,0
119839,Hair,0,1
119840,analysis,0,0
119841,and,0,1
119842,biophysical,0,1
119843,properties,0,1
119844,of,0,0
119845,the,0,0
119846,skin,0,1
119847,were,0,0
119848,assessed,0,0
119849,before,0,0
119850,treatment,0,0
119851,and,0,0
119852,at,0,0
119853,weeks,0,0
119854,2,0,0
119855,",",0,0
119856,4,0,0
119857,and,0,0
119858,6,0,0
119859,after,0,0
119860,the,0,0
119861,therapy,0,0
119862,.,0,0
119863,RESULTS,0,0
119864,Hair,1,1
119865,density,1,1
119866,and,1,0
119867,thicknesses,1,1
119868,statistically,1,0
119869,significantly,1,0
119870,decreased,1,0
119871,after,0,0
119872,the,0,0
119873,first,0,0
119874,post-treatment,0,0
119875,evaluation,0,0
119876,.,0,0
119877,Regarding,0,0
119878,comparison,0,0
119879,of,0,0
119880,the,0,0
119881,biophysical,0,1
119882,properties,0,0
119883,of,0,0
119884,the,0,0
119885,skin,0,1
119886,",",0,0
119887,there,0,0
119888,was,0,0
119889,no,0,0
119890,statistically,0,0
119891,significant,0,0
119892,difference,0,0
119893,in,0,0
119894,the,0,0
119895,assessments,0,0
119896,",",0,0
119897,except,0,0
119898,for,0,0
119899,the,0,0
119900,increase,0,0
119901,determined,0,0
119902,during,0,0
119903,the,0,0
119904,second,0,0
119905,week,0,0
119906,in,0,0
119907,the,0,0
119908,erythema,1,1
119909,index,1,1
119910,in,0,0
119911,the,0,0
119912,laser-treated,0,0
119913,areas,0,0
119914,.,0,0
119915,CONCLUSION,0,0
119916,The,0,0
119917,findings,0,0
119918,of,0,0
119919,this,0,0
119920,study,0,0
119921,showed,0,0
119922,that,0,0
119923,the,0,0
119924,diode,0,0
119925,laser,0,0
119926,can,0,0
119927,perform,0,0
119928,a,0,0
119929,significant,0,0
119930,reduction,0,0
119931,in,0,0
119932,the,0,0
119933,hair,1,1
119934,amount,1,1
119935,without,0,0
119936,significant,0,0
119937,epidermal,0,1
119938,damage,0,1
119939,",",0,0
119940,at,0,0
119941,least,0,0
119942,for,0,0
119943,a,0,0
119944,short,0,0
119945,period,0,0
119946,.,0,0
119947,Effect,0,0
119948,of,0,0
119949,weight,0,1
119950,loss,0,1
119951,on,0,0
119952,inflammation,0,1
119953,in,0,0
119954,patients,0,0
119955,with,0,0
119956,mild,0,1
119957,obstructive,0,0
119958,sleep,0,1
119959,apnea,0,1
119960,.,0,0
119961,BACKGROUND,0,0
119962,AND,0,0
119963,AIMS,0,1
119964,Inflammation,0,0
119965,may,0,0
119966,be,0,0
119967,one,0,0
119968,mediating,0,0
119969,mechanism,0,0
119970,for,0,0
119971,cardiovascular,0,1
119972,diseases,0,0
119973,in,0,0
119974,obstructive,0,0
119975,sleep,0,1
119976,apnea,0,1
119977,(,0,0
119978,OSA,0,0
119979,),0,0
119980,.,0,0
119981,However,0,0
119982,",",0,0
119983,little,0,0
119984,is,0,0
119985,known,0,0
119986,about,0,0
119987,subclinical,0,0
119988,inflammation,0,1
119989,or,0,0
119990,the,0,0
119991,effect,0,0
119992,of,0,0
119993,lifestyle,0,0
119994,intervention,0,0
119995,on,0,0
119996,inflammation,0,1
119997,in,0,0
119998,early,0,0
119999,stages,0,0
120000,of,0,0
120001,OSA,0,0
120002,.,0,0
120003,The,0,0
120004,aim,0,0
120005,of,0,0
120006,this,0,0
120007,substudy,0,0
120008,of,0,0
120009,an,0,0
120010,existing,0,0
120011,randomized,0,0
120012,controlled,0,0
120013,trial,0,0
120014,",",0,0
120015,with,0,0
120016,post,0,1
120017,hoc,0,0
120018,analyses,0,0
120019,",",0,0
120020,was,0,0
120021,to,0,0
120022,determine,0,0
120023,the,0,0
120024,impact,0,0
120025,of,0,0
120026,lifestyle,0,0
120027,changes,0,1
120028,aimed,0,0
120029,at,0,0
120030,weight,0,1
120031,reduction,0,1
120032,on,0,0
120033,inflammatory,0,1
120034,biomarkers,0,0
120035,in,0,0
120036,overweight,0,1
120037,patients,0,0
120038,with,0,0
120039,mild,0,0
120040,OSA,0,0
120041,.,0,0
120042,METHODS,0,0
120043,AND,0,0
120044,RESULTS,0,0
120045,Patients,0,0
120046,were,0,0
120047,randomized,0,0
120048,to,0,0
120049,supervised,0,0
120050,intensive,0,0
120051,lifestyle,0,0
120052,intervention,0,0
120053,group,0,0
120054,(,0,0
120055,N=28,0,1
120056,),0,0
120057,or,0,0
120058,to,0,0
120059,control,0,0
120060,group,0,0
120061,(,0,0
120062,N=31,0,0
120063,),0,0
120064,",",0,0
120065,which,0,0
120066,received,0,0
120067,routine,0,0
120068,lifestyle,0,0
120069,advices,0,0
120070,.,0,0
120071,Circulating,0,0
120072,concentrations,0,1
120073,of,0,0
120074,pro-,0,1
120075,and,0,0
120076,anti-inflammatory,0,0
120077,mediators,0,1
120078,were,0,0
120079,measured,0,0
120080,before,0,0
120081,and,0,0
120082,after,0,0
120083,the,0,0
120084,1-year,0,0
120085,intervention,0,0
120086,.,0,0
120087,The,0,0
120088,concentrations,0,1
120089,of,0,0
120090,two,0,0
120091,pro-inflammatory,0,0
120092,mediators,0,0
120093,",",0,0
120094,high-sensitivity,1,1
120095,C-reactive,1,1
120096,protein,1,1
120097,(,1,0
120098,hsCRP,1,1
120099,),1,1
120100,and,1,0
120101,interleukin,1,1
120102,(,1,0
120103,IL,1,0
120104,),1,1
120105,-6,1,1
120106,",",1,0
120107,decreased,1,0
120108,significantly,0,0
120109,in,0,0
120110,both,0,0
120111,groups,0,0
120112,.,0,0
120113,Although,0,0
120114,the,0,0
120115,changes,0,0
120116,in,0,0
120117,inflammatory,1,1
120118,biomarkers,1,0
120119,favored,1,0
120120,the,0,0
120121,supervised,0,0
120122,lifestyle,0,1
120123,intervention,0,0
120124,",",0,0
120125,the,0,0
120126,only,0,0
120127,significant,0,0
120128,reduction,0,1
120129,observed,0,0
120130,between,0,0
120131,the,0,0
120132,groups,0,0
120133,was,0,0
120134,for,0,0
120135,the,0,0
120136,anti-inflammatory,0,0
120137,IL-1,0,0
120138,receptor,0,1
120139,antagonist,0,0
120140,(,0,0
120141,IL-1RA,0,0
120142,),0,0
120143,.,0,0
120144,The,0,0
120145,change,1,0
120146,in,1,0
120147,hsCRP,1,0
120148,was,0,0
120149,associated,0,0
120150,with,0,0
120151,apnea-hypopnea,1,1
120152,index,1,1
120153,",",0,0
120154,and,0,1
120155,improving,1,1
120156,night-time,1,1
120157,oxygen,1,1
120158,saturation,1,1
120159,was,0,0
120160,related,0,0
120161,to,0,0
120162,tumor,0,0
120163,necrosis,0,1
120164,factor,0,0
120165,alpha,0,0
120166,.,0,0
120167,IL-1RA,0,0
120168,and,0,0
120169,IL-6,0,1
120170,were,0,0
120171,associated,0,0
120172,with,0,0
120173,insulin,0,0
120174,metabolism,0,0
120175,.,0,0
120176,CONCLUSION,0,0
120177,Weight,1,1
120178,loss,1,1
120179,resulted,0,0
120180,in,0,0
120181,reductions,0,1
120182,in,0,0
120183,concentrations,0,1
120184,of,0,0
120185,some,0,0
120186,pro-,0,1
120187,and,0,0
120188,anti-inflammatory,0,0
120189,mediators,0,1
120190,in,0,0
120191,overweight,0,1
120192,patients,0,0
120193,with,0,0
120194,mild,0,1
120195,OSA,0,0
120196,",",0,0
120197,overall,0,1
120198,favoring,0,0
120199,the,0,0
120200,supervised,0,0
120201,lifestyle,0,0
120202,intervention,0,0
120203,.,0,0
120204,These,0,0
120205,findings,0,0
120206,suggest,0,0
120207,that,0,0
120208,more,0,0
120209,intensive,0,0
120210,treatment,0,0
120211,of,0,0
120212,obesity,0,1
120213,in,0,0
120214,OSA,0,0
120215,patients,0,0
120216,might,0,0
120217,be,0,0
120218,well-justified,0,0
120219,.,0,0
120220,Controlled,0,0
120221,",",0,0
120222,prospective,0,0
120223,",",0,0
120224,randomized,0,0
120225,",",0,0
120226,clinical,0,0
120227,evaluation,0,0
120228,of,0,0
120229,partial,0,0
120230,ceramic,0,0
120231,crowns,0,0
120232,inserted,0,0
120233,with,0,0
120234,RelyX,0,0
120235,Unicem,0,1
120236,with,0,0
120237,or,0,0
120238,without,0,0
120239,selective,0,0
120240,enamel,0,0
120241,etching,0,0
120242,.,0,0
120243,1-year,0,0
120244,results,0,0
120245,.,0,0
120246,PURPOSE,0,0
120247,To,0,0
120248,compare,0,0
120249,the,0,0
120250,performance,0,1
120251,of,0,0
120252,partial,1,0
120253,ceramic,1,0
120254,crowns,1,0
120255,(,1,0
120256,PCCs,1,1
120257,),1,0
120258,inserted,0,0
120259,with,0,0
120260,RelyX,0,0
120261,Unicem,0,1
120262,(,0,0
120263,RXU,0,1
120264,),0,0
120265,either,0,0
120266,with,0,0
120267,(,0,0
120268,RXU+E,0,0
120269,),0,0
120270,or,0,0
120271,without,0,0
120272,(,0,0
120273,RXU,0,0
120274,),0,0
120275,selective,0,0
120276,enamel,0,0
120277,etching,0,0
120278,.,0,0
120279,METHODS,0,0
120280,34,0,0
120281,patients,0,0
120282,(,0,0
120283,15,0,0
120284,male,0,0
120285,",",0,0
120286,19,0,0
120287,female,0,0
120288,),0,0
120289,participated,0,0
120290,in,0,0
120291,the,0,0
120292,investigation,0,0
120293,",",0,0
120294,with,0,0
120295,a,0,0
120296,total,0,0
120297,of,0,0
120298,68,0,0
120299,PCC,0,0
120300,restorations,0,0
120301,.,0,0
120302,In,0,0
120303,each,0,0
120304,patient,0,0
120305,",",0,0
120306,one,0,0
120307,PCC,0,0
120308,was,0,0
120309,randomly,0,0
120310,assigned,0,0
120311,to,0,0
120312,insertion,0,0
120313,with,0,0
120314,RXU,0,0
120315,",",0,0
120316,the,0,0
120317,second,0,0
120318,PCC,0,0
120319,was,0,0
120320,assigned,0,0
120321,to,0,0
120322,insertion,0,0
120323,with,0,0
120324,RXU+E,0,0
120325,.,0,0
120326,The,0,0
120327,PCCs,0,0
120328,were,0,0
120329,CAD/CAM,0,0
120330,fabricated,0,0
120331,using,0,0
120332,the,0,0
120333,Cerec,0,0
120334,3,0,0
120335,system,0,0
120336,.,0,0
120337,RXU,0,0
120338,:,0,0
120339,25,0,0
120340,PCCs,0,0
120341,were,0,0
120342,placed,0,0
120343,in,0,0
120344,molars,0,0
120345,",",0,0
120346,nine,0,0
120347,in,0,0
120348,premolars,0,0
120349,.,0,0
120350,RXU+E,0,0
120351,:,0,0
120352,26,0,0
120353,PCCs,0,0
120354,were,0,0
120355,placed,0,0
120356,in,0,0
120357,molars,0,0
120358,",",0,0
120359,eight,0,0
120360,in,0,0
120361,premolars,0,0
120362,.,0,0
120363,The,0,0
120364,restorations,0,0
120365,were,0,0
120366,clinically,0,0
120367,rated,0,0
120368,using,0,0
120369,modified,0,0
120370,United,0,0
120371,States,0,0
120372,Public,0,0
120373,Health,0,1
120374,Service,0,0
120375,(,0,0
120376,USPHS,0,0
120377,),0,0
120378,criteria,0,0
120379,at,0,0
120380,baseline,0,0
120381,",",0,0
120382,6,0,0
120383,and,0,0
120384,12,0,0
120385,months,0,0
120386,after,0,0
120387,placement,0,0
120388,.,0,0
120389,The,0,0
120390,median,0,0
120391,patient,0,1
120392,age,0,0
120393,was,0,0
120394,41,0,0
120395,years,0,0
120396,(,0,0
120397,24-59,0,0
120398,years,0,0
120399,),0,0
120400,.,0,0
120401,The,0,0
120402,median,0,0
120403,(,0,0
120404,25-75,0,0
120405,%,0,0
120406,),0,0
120407,PBI,0,0
120408,was,0,0
120409,6,0,0
120410,%,0,0
120411,(,0,0
120412,3-9,0,0
120413,%,0,0
120414,),0,0
120415,.,0,0
120416,RESULTS,0,0
120417,All,0,0
120418,patients,0,0
120419,were,0,0
120420,available,0,0
120421,for,0,0
120422,the,0,0
120423,three,0,0
120424,recall,0,0
120425,appointments,0,0
120426,.,0,0
120427,One,0,0
120428,PCC,0,0
120429,(,0,0
120430,RXU,0,1
120431,),0,0
120432,debonded,1,0
120433,after,0,0
120434,11,0,0
120435,months,0,0
120436,in,0,0
120437,situ,0,0
120438,",",0,0
120439,one,0,0
120440,PCC,0,0
120441,(,0,0
120442,RXU+E,0,0
120443,),0,0
120444,fractured,1,0
120445,after,0,0
120446,12,0,0
120447,months,0,0
120448,in,0,0
120449,situ,0,0
120450,.,0,0
120451,Both,0,0
120452,restorations,1,0
120453,had,0,0
120454,to,0,0
120455,be,0,0
120456,replaced,1,0
120457,.,1,0
120458,At,0,0
120459,the,0,0
120460,12,0,0
120461,months,0,0
120462,recall,0,0
120463,",",0,0
120464,66,0,0
120465,of,0,0
120466,68,0,0
120467,controlled,0,0
120468,restorations,0,0
120469,were,0,0
120470,functional,1,0
120471,without,0,0
120472,need,0,0
120473,of,0,0
120474,replacement,0,0
120475,.,0,0
120476,The,0,0
120477,evaluation,0,0
120478,using,0,0
120479,USHPS,0,0
120480,criteria,0,0
120481,revealed,0,0
120482,a,0,0
120483,significant,0,0
120484,decrease,0,0
120485,of,0,0
120486,alfa,1,0
120487,ratings,1,1
120488,over,1,0
120489,time,1,1
120490,with,1,0
120491,respect,1,0
120492,to,1,0
120493,criteria,1,0
120494,marginal,1,1
120495,adaptation,1,1
120496,and,1,0
120497,marginal,1,1
120498,discoloration,1,1
120499,.,1,0
120500,No,0,0
120501,statistically,0,0
120502,significant,0,0
120503,differences,0,0
120504,between,0,0
120505,the,0,0
120506,two,0,0
120507,luting,0,0
120508,techniques,0,0
120509,",",0,0
120510,RXU,0,1
120511,and,0,1
120512,RXU+E,0,0
120513,",",0,0
120514,we,0,0
120515,reobserved,0,0
120516,during,0,0
120517,the,0,0
120518,observation,0,0
120519,period,0,0
120520,of,0,0
120521,1,0,0
120522,year,0,0
120523,.,0,0
120524,Within,0,0
120525,the,0,0
120526,limitations,0,0
120527,of,0,0
120528,the,0,0
120529,present,0,0
120530,study,0,0
120531,",",0,0
120532,adhesive,0,1
120533,luting,0,0
120534,with,0,0
120535,RXU,0,1
120536,with,0,0
120537,or,0,0
120538,without,0,0
120539,selective,0,1
120540,enamel,0,0
120541,etching,0,0
120542,can,0,0
120543,be,0,0
120544,recommended,0,0
120545,.,0,0
120546,Factors,0,0
120547,predictive,0,0
120548,of,0,0
120549,severe,1,1
120550,hypoglycemia,1,1
120551,in,0,0
120552,type,0,0
120553,1,0,0
120554,diabetes,0,0
120555,:,0,0
120556,analysis,0,0
120557,from,0,0
120558,the,0,0
120559,Juvenile,0,0
120560,Diabetes,0,1
120561,Research,0,0
120562,Foundation,0,0
120563,continuous,0,0
120564,glucose,0,1
120565,monitoring,0,0
120566,randomized,0,0
120567,control,0,0
120568,trial,0,0
120569,dataset,0,0
120570,.,0,0
120571,OBJECTIVE,0,0
120572,Identify,0,0
120573,factors,0,0
120574,predictive,0,0
120575,of,0,0
120576,severe,1,1
120577,hypoglycemia,1,1
120578,(,1,0
120579,SH,1,0
120580,),1,0
120581,and,0,0
120582,assess,0,0
120583,the,0,0
120584,clinical,1,0
120585,utility,1,0
120586,of,0,0
120587,continuous,1,0
120588,glucose,1,1
120589,monitoring,1,0
120590,(,1,0
120591,CGM,1,0
120592,),1,0
120593,to,0,0
120594,warn,0,0
120595,of,0,0
120596,impending,0,0
120597,SH,0,0
120598,.,0,0
120599,RESEARCH,0,0
120600,DESIGN,0,0
120601,AND,0,0
120602,METHODS,0,0
120603,In,0,0
120604,a,0,0
120605,multicenter,0,0
120606,randomized,0,0
120607,clinical,0,0
120608,trial,0,0
120609,",",0,0
120610,436,0,0
120611,children,0,0
120612,and,0,0
120613,adults,0,0
120614,with,0,0
120615,type,0,0
120616,1,0,0
120617,diabetes,0,0
120618,were,0,0
120619,randomized,0,0
120620,to,0,0
120621,a,0,0
120622,treatment,0,0
120623,group,0,0
120624,that,0,0
120625,used,0,0
120626,CGM,0,1
120627,(,0,0
120628,N,0,0
120629,=,0,0
120630,224,0,0
120631,),0,0
120632,",",0,0
120633,or,0,0
120634,a,0,0
120635,control,0,0
120636,group,0,0
120637,that,0,0
120638,used,0,0
120639,standard,0,0
120640,home,0,0
120641,blood,0,1
120642,glucose,0,1
120643,monitoring,0,0
120644,(,0,0
120645,N,0,0
120646,=,0,0
120647,212,0,0
120648,),0,0
120649,and,0,0
120650,completed,0,0
120651,12,0,0
120652,months,0,0
120653,of,0,0
120654,follow-up,0,0
120655,.,0,0
120656,After,0,0
120657,6,0,0
120658,months,0,0
120659,",",0,0
120660,the,0,0
120661,original,0,0
120662,control,0,0
120663,group,0,0
120664,initiated,0,0
120665,CGM,0,0
120666,while,0,0
120667,the,0,0
120668,treatment,0,0
120669,group,0,0
120670,continued,0,0
120671,use,0,0
120672,of,0,0
120673,CGM,0,0
120674,for,0,0
120675,6,0,0
120676,months,0,0
120677,.,0,0
120678,Baseline,0,0
120679,risk,0,1
120680,factors,0,0
120681,for,0,0
120682,SH,0,0
120683,were,0,0
120684,evaluated,0,0
120685,over,0,0
120686,12,0,0
120687,months,0,0
120688,of,0,0
120689,follow-up,0,0
120690,using,0,0
120691,proportional,0,0
120692,hazards,0,1
120693,regression,0,0
120694,.,0,0
120695,CGM-derived,1,0
120696,indices,1,1
120697,of,1,0
120698,hypoglycemia,1,1
120699,were,0,0
120700,used,0,0
120701,to,0,0
120702,predict,0,0
120703,episodes,0,1
120704,of,0,0
120705,SH,0,0
120706,over,0,0
120707,a,0,0
120708,24-h,0,1
120709,time,0,1
120710,horizon,0,0
120711,.,0,0
120712,RESULTS,0,0
120713,The,0,0
120714,SH,1,0
120715,rate,1,1
120716,was,0,0
120717,17.9,0,0
120718,per,0,0
120719,100,0,0
120720,person-years,0,0
120721,",",0,0
120722,and,0,0
120723,a,0,0
120724,higher,0,0
120725,rate,1,1
120726,was,0,0
120727,associated,0,0
120728,with,0,0
120729,the,0,0
120730,occurrence,0,0
120731,of,0,0
120732,SH,1,0
120733,in,0,0
120734,the,0,0
120735,prior,0,0
120736,6,0,0
120737,months,0,0
120738,and,0,0
120739,female,0,0
120740,sex,0,0
120741,.,0,0
120742,SH,1,0
120743,frequency,1,1
120744,increased,0,0
120745,eightfold,0,0
120746,when,0,0
120747,30,0,0
120748,%,0,0
120749,of,0,0
120750,CGM,1,1
120751,values,1,1
120752,were,0,0
120753,?,0,0
120754,70,0,0
120755,mg/dL,0,0
120756,on,0,0
120757,the,0,0
120758,prior,0,0
120759,day,0,0
120760,(,0,0
120761,4.5,0,0
120762,vs.,0,0
120763,0.5,0,0
120764,%,0,0
120765,;,0,0
120766,P,0,0
120767,<,0,0
120768,0.001,0,0
120769,),0,0
120770,",",0,0
120771,but,0,0
120772,the,1,0
120773,positive,1,1
120774,predictive,1,1
120775,value,1,1
120776,(,1,0
120777,PPV,1,1
120778,),1,0
120779,was,1,0
120780,low,0,0
120781,(,0,0
120782,<,0,0
120783,5,0,0
120784,%,0,0
120785,),0,0
120786,.,0,0
120787,Results,0,0
120788,were,0,0
120789,similar,0,0
120790,for,1,0
120791,hypoglycemic,1,1
120792,area,1,0
120793,under,1,0
120794,the,1,0
120795,curve,1,1
120796,and,1,0
120797,the,1,0
120798,low,1,0
120799,blood,1,1
120800,glucose,1,1
120801,index,1,1
120802,calculated,1,0
120803,by,0,0
120804,CGM,1,0
120805,.,1,0
120806,CONCLUSIONS,1,0
120807,SH,1,0
120808,in,1,0
120809,the,0,0
120810,6,0,0
120811,months,0,0
120812,prior,0,0
120813,to,0,0
120814,the,0,0
120815,study,0,0
120816,was,0,0
120817,the,0,0
120818,strongest,0,0
120819,predictor,0,0
120820,of,0,0
120821,SH,1,0
120822,during,1,0
120823,the,0,0
120824,study,1,0
120825,.,1,0
120826,CGM-measured,1,1
120827,hypoglycemia,1,1
120828,over,1,0
120829,a,0,0
120830,24-h,0,1
120831,span,0,0
120832,is,0,0
120833,highly,0,0
120834,associated,0,0
120835,with,1,0
120836,SH,1,0
120837,the,1,0
120838,following,0,0
120839,day,0,0
120840,(,0,0
120841,P,0,0
120842,<,0,0
120843,0.001,0,0
120844,),0,0
120845,",",0,0
120846,but,0,0
120847,the,1,0
120848,PPV,1,0
120849,is,1,0
120850,low,0,0
120851,.,0,0
120852,[,0,0
120853,Efficacy,0,1
120854,of,0,0
120855,naftopidil,0,0
120856,in,0,0
120857,patients,0,0
120858,with,0,0
120859,overactive,0,0
120860,bladder,0,0
120861,associated,0,0
120862,with,0,0
120863,benign,0,0
120864,prostatic,0,0
120865,hyperplasia,0,0
120866,:,0,0
120867,prospective,0,0
120868,randomized,0,0
120869,controlled,0,0
120870,study,0,0
120871,to,0,0
120872,compare,0,0
120873,differences,0,0
120874,in,0,0
120875,efficacy,0,1
120876,between,0,0
120877,morning,0,0
120878,and,0,0
120879,evening,0,0
120880,medication,0,1
120881,],0,0
120882,.,0,0
120883,A,0,0
120884,total,0,1
120885,of,0,0
120886,100,0,0
120887,patients,0,0
120888,with,0,0
120889,benign,0,0
120890,prostatic,0,0
120891,hyperplasia,0,1
120892,(,0,0
120893,BPH,0,1
120894,),0,0
120895,and,0,0
120896,overactive,0,0
120897,bladder,0,1
120898,(,0,0
120899,OAB,0,0
120900,),0,0
120901,symptoms,0,1
120902,(,0,0
120903,BPH/OAB,0,0
120904,),0,0
120905,",",0,0
120906,enrolled,0,0
120907,between,0,0
120908,June,0,0
120909,2006,0,0
120910,to,0,0
120911,March,0,0
120912,2008,0,0
120913,",",0,0
120914,were,0,0
120915,randomly,0,0
120916,divided,0,0
120917,into,0,0
120918,2,0,0
120919,groups,0,0
120920,of,0,0
120921,morning,0,0
120922,medication,0,1
120923,(,0,0
120924,M,0,0
120925,),0,0
120926,and,0,0
120927,evening,0,0
120928,medication,0,1
120929,(,0,0
120930,E,0,1
120931,),0,0
120932,groups,0,0
120933,",",0,0
120934,then,0,0
120935,50,0,0
120936,mg,0,0
120937,of,0,0
120938,naftopidil,0,0
120939,was,0,0
120940,given,0,0
120941,once,0,0
120942,a,0,0
120943,day,0,0
120944,after,0,0
120945,breakfast,0,0
120946,or,0,0
120947,supper,0,0
120948,for,0,0
120949,8,0,0
120950,weeks,0,0
120951,.,0,0
120952,Data,0,0
120953,were,0,0
120954,available,0,0
120955,for,0,0
120956,efficacy,0,1
120957,analysis,0,0
120958,on,0,0
120959,80,0,0
120960,patients,0,0
120961,(,0,0
120962,M,0,0
120963,group,0,0
120964,;,0,0
120965,43,0,0
120966,",",0,0
120967,E,0,0
120968,group,0,0
120969,;,0,0
120970,37,0,0
120971,),0,0
120972,.,0,0
120973,Naftopidil,0,0
120974,significantly,0,0
120975,improved,0,0
120976,the,0,0
120977,overall,1,1
120978,international,1,0
120979,prostatic,1,0
120980,symptom,1,1
120981,score,1,1
120982,;,0,0
120983,from,0,0
120984,19.2?7.9,0,0
120985,to,0,0
120986,11.7?5.8,0,0
120987,in,0,0
120988,the,0,0
120989,M,0,0
120990,group,0,0
120991,and,0,0
120992,from,0,0
120993,19.4?6.4,0,0
120994,to,0,0
120995,12.3?6.8,0,0
120996,in,0,0
120997,the,0,0
120998,E,0,0
120999,group,0,0
121000,(,0,0
121001,p,0,0
121002,<,0,0
121003,0.0001,0,0
121004,),0,0
121005,",",0,0
121006,QOL,0,1
121007,score,0,1
121008,from,0,0
121009,4.9?0.8,0,0
121010,to,0,0
121011,3.2?1.4,0,0
121012,in,0,0
121013,the,0,0
121014,M,0,0
121015,group,0,0
121016,and,0,0
121017,from,0,0
121018,5.0?0.8,0,0
121019,to,0,0
121020,3.6?1.3,0,0
121021,in,0,0
121022,the,0,0
121023,E,0,0
121024,group,0,0
121025,(,0,0
121026,p,0,0
121027,<,0,0
121028,0.0001,1,0
121029,),1,0
121030,",",1,0
121031,and,1,1
121032,OAB,1,1
121033,symptom,1,1
121034,score,1,1
121035,from,1,0
121036,7.8?2.6,0,0
121037,to,0,0
121038,5.0?2.5,0,0
121039,in,0,0
121040,the,0,0
121041,M,0,0
121042,group,0,0
121043,(,0,0
121044,p,0,0
121045,<,0,0
121046,0.0001,0,0
121047,),0,0
121048,and,0,0
121049,from,0,0
121050,8.6?2.9,0,0
121051,to,0,0
121052,5.8?,0,0
121053,3.3,0,0
121054,in,0,0
121055,the,0,0
121056,E,0,0
121057,group,0,0
121058,(,0,0
121059,p,0,0
121060,<,0,0
121061,0.0001,0,0
121062,),0,0
121063,.,0,0
121064,There,0,0
121065,was,0,0
121066,no,0,0
121067,significant,0,0
121068,difference,0,0
121069,in,0,0
121070,the,0,0
121071,incidence,0,1
121072,of,0,0
121073,adverse,1,1
121074,effects,1,0
121075,between,1,0
121076,the,0,0
121077,M,0,0
121078,group,0,0
121079,(,0,0
121080,6.1,0,0
121081,%,0,0
121082,),0,0
121083,and,0,0
121084,E,0,1
121085,group,0,0
121086,(,0,0
121087,2.2,0,0
121088,%,0,0
121089,),0,0
121090,.,0,0
121091,These,0,0
121092,results,0,0
121093,suggest,0,0
121094,that,0,0
121095,naftopidil,0,0
121096,improves,1,1
121097,storage,1,1
121098,symptoms,1,1
121099,as,1,0
121100,well,1,0
121101,as,1,0
121102,voiding,1,1
121103,symptoms,1,1
121104,regardless,1,0
121105,of,0,0
121106,timing,0,1
121107,of,0,0
121108,administration,0,0
121109,.,0,0
121110,Comparison,0,0
121111,of,0,0
121112,adaptive,0,1
121113,pacing,0,0
121114,therapy,0,0
121115,",",0,0
121116,cognitive,0,1
121117,behaviour,0,1
121118,therapy,0,0
121119,",",0,0
121120,graded,0,1
121121,exercise,0,0
121122,therapy,0,0
121123,",",0,0
121124,and,0,1
121125,specialist,0,0
121126,medical,0,0
121127,care,0,0
121128,for,0,0
121129,chronic,0,0
121130,fatigue,0,1
121131,syndrome,0,0
121132,(,0,0
121133,PACE,0,1
121134,),0,0
121135,:,0,0
121136,a,0,0
121137,randomised,0,0
121138,trial,0,0
121139,.,0,0
121140,BACKGROUND,0,0
121141,Trial,0,0
121142,findings,0,0
121143,show,0,0
121144,cognitive,0,1
121145,behaviour,0,1
121146,therapy,0,0
121147,(,0,0
121148,CBT,0,0
121149,),0,0
121150,and,0,0
121151,graded,0,1
121152,exercise,0,0
121153,therapy,0,0
121154,(,0,0
121155,GET,0,0
121156,),0,0
121157,can,0,0
121158,be,0,0
121159,effective,0,0
121160,treatments,0,0
121161,for,0,0
121162,chronic,0,0
121163,fatigue,0,1
121164,syndrome,0,0
121165,",",0,1
121166,but,0,0
121167,patients,0,0
121168,',0,0
121169,organisations,0,0
121170,have,0,0
121171,reported,0,0
121172,that,0,0
121173,these,0,0
121174,treatments,0,0
121175,can,0,0
121176,be,0,0
121177,harmful,0,1
121178,and,0,0
121179,favour,0,0
121180,pacing,0,0
121181,and,0,1
121182,specialist,0,0
121183,health,0,1
121184,care,0,0
121185,.,0,0
121186,We,0,0
121187,aimed,0,0
121188,to,0,0
121189,assess,0,0
121190,effectiveness,1,1
121191,and,1,1
121192,safety,1,1
121193,of,0,0
121194,all,0,0
121195,four,0,0
121196,treatments,0,0
121197,.,0,0
121198,METHODS,0,0
121199,In,0,0
121200,our,0,0
121201,parallel-group,0,0
121202,randomised,0,0
121203,trial,0,0
121204,",",0,0
121205,patients,0,0
121206,meeting,0,0
121207,Oxford,0,0
121208,criteria,0,0
121209,for,0,0
121210,chronic,0,0
121211,fatigue,0,1
121212,syndrome,0,0
121213,were,0,0
121214,recruited,0,0
121215,from,0,0
121216,six,0,0
121217,secondary-care,0,0
121218,clinics,0,0
121219,in,0,0
121220,the,0,0
121221,UK,0,0
121222,and,0,0
121223,randomly,0,0
121224,allocated,0,0
121225,by,0,0
121226,computer-generated,0,0
121227,sequence,0,0
121228,to,0,0
121229,receive,0,0
121230,specialist,0,0
121231,medical,0,0
121232,care,0,0
121233,(,0,0
121234,SMC,0,0
121235,),0,0
121236,alone,0,0
121237,or,0,0
121238,with,0,0
121239,adaptive,0,1
121240,pacing,0,0
121241,therapy,0,0
121242,(,0,0
121243,APT,0,1
121244,),0,0
121245,",",0,0
121246,CBT,0,0
121247,",",0,1
121248,or,0,0
121249,GET,0,0
121250,.,0,0
121251,Primary,0,0
121252,outcomes,0,1
121253,were,0,0
121254,fatigue,1,1
121255,(,1,0
121256,measured,1,0
121257,by,1,0
121258,Chalder,1,0
121259,fatigue,1,1
121260,questionnaire,1,1
121261,score,1,1
121262,),1,0
121263,and,1,0
121264,physical,1,1
121265,function,1,1
121266,(,1,0
121267,measured,1,0
121268,by,1,0
121269,short,1,0
121270,form-36,1,1
121271,subscale,1,1
121272,score,1,1
121273,),1,0
121274,up,0,0
121275,to,0,0
121276,52,0,0
121277,weeks,0,0
121278,after,0,0
121279,randomisation,0,0
121280,",",0,0
121281,and,0,1
121282,safety,0,1
121283,was,0,0
121284,assessed,0,0
121285,primarily,0,0
121286,by,0,0
121287,recording,0,0
121288,all,0,0
121289,serious,1,1
121290,adverse,1,1
121291,events,1,1
121292,",",0,0
121293,including,0,0
121294,serious,1,1
121295,adverse,1,1
121296,reactions,1,1
121297,to,0,0
121298,trial,0,0
121299,treatments,0,0
121300,.,0,0
121301,Primary,0,0
121302,outcomes,0,1
121303,were,0,0
121304,rated,0,0
121305,by,0,0
121306,participants,0,0
121307,",",0,0
121308,who,0,0
121309,were,0,0
121310,necessarily,0,0
121311,unmasked,0,0
121312,to,0,0
121313,treatment,0,0
121314,assignment,0,0
121315,;,0,0
121316,the,0,0
121317,statistician,0,0
121318,was,0,0
121319,masked,0,0
121320,to,0,0
121321,treatment,0,0
121322,assignment,0,0
121323,for,0,0
121324,the,0,0
121325,analysis,0,0
121326,of,0,0
121327,primary,0,0
121328,outcomes,0,0
121329,.,0,0
121330,We,0,0
121331,used,0,0
121332,longitudinal,0,0
121333,regression,0,0
121334,models,0,0
121335,to,0,0
121336,compare,0,0
121337,SMC,0,0
121338,alone,0,0
121339,with,0,0
121340,other,0,0
121341,treatments,0,0
121342,",",0,0
121343,APT,0,1
121344,with,0,0
121345,CBT,0,0
121346,",",0,0
121347,and,0,1
121348,APT,0,1
121349,with,0,0
121350,GET,0,0
121351,.,0,0
121352,The,0,0
121353,final,0,1
121354,analysis,0,0
121355,included,0,0
121356,all,0,0
121357,participants,0,0
121358,for,0,0
121359,whom,0,0
121360,we,0,0
121361,had,0,0
121362,data,0,0
121363,for,0,0
121364,primary,0,0
121365,outcomes,0,0
121366,.,0,0
121367,This,0,0
121368,trial,0,0
121369,is,0,0
121370,registered,0,0
121371,at,0,0
121372,http,0,0
121373,:,0,0
121374,//isrctn.org,0,0
121375,",",0,0
121376,number,0,1
121377,ISRCTN54285094,0,0
121378,.,0,0
121379,FINDINGS,0,0
121380,We,0,0
121381,recruited,0,0
121382,641,0,0
121383,eligible,0,0
121384,patients,0,0
121385,",",0,0
121386,of,0,0
121387,whom,0,0
121388,160,0,0
121389,were,0,0
121390,assigned,0,0
121391,to,0,0
121392,the,0,0
121393,APT,0,1
121394,group,0,0
121395,",",0,0
121396,161,0,0
121397,to,0,0
121398,the,0,0
121399,CBT,0,0
121400,group,0,0
121401,",",0,0
121402,160,0,0
121403,to,0,0
121404,the,0,0
121405,GET,0,0
121406,group,0,0
121407,",",0,0
121408,and,0,0
121409,160,0,0
121410,to,0,0
121411,the,0,0
121412,SMC-alone,0,0
121413,group,0,0
121414,.,0,0
121415,Compared,0,0
121416,with,0,0
121417,SMC,0,0
121418,alone,0,0
121419,",",0,0
121420,mean,1,1
121421,fatigue,1,1
121422,scores,1,1
121423,at,0,0
121424,52,0,0
121425,weeks,0,0
121426,were,0,0
121427,3?4,0,0
121428,(,0,0
121429,95,0,0
121430,%,0,0
121431,CI,0,0
121432,1?8,0,0
121433,to,0,0
121434,5?0,0,0
121435,),0,0
121436,points,0,0
121437,lower,0,0
121438,for,0,0
121439,CBT,0,0
121440,(,0,0
121441,p,0,0
121442,=,0,0
121443,0?0001,0,0
121444,),0,0
121445,and,0,0
121446,3?2,0,0
121447,(,0,0
121448,1?7,0,0
121449,to,0,0
121450,4?8,0,0
121451,),0,0
121452,points,0,0
121453,lower,0,0
121454,for,0,0
121455,GET,0,0
121456,(,0,0
121457,p,0,0
121458,=,0,0
121459,0?0003,0,0
121460,),0,0
121461,",",0,0
121462,but,0,0
121463,did,0,0
121464,not,0,0
121465,differ,0,0
121466,for,0,0
121467,APT,0,0
121468,(,0,0
121469,0?7,0,0
121470,[,0,0
121471,-0?9,0,0
121472,to,0,0
121473,2?3,0,0
121474,],0,0
121475,points,0,0
121476,lower,0,0
121477,;,0,0
121478,p,0,0
121479,=,0,0
121480,0?38,0,0
121481,),0,0
121482,.,0,0
121483,Compared,0,0
121484,with,0,0
121485,SMC,0,0
121486,alone,0,0
121487,",",0,0
121488,mean,0,1
121489,physical,1,1
121490,function,1,1
121491,scores,1,1
121492,were,0,0
121493,7?1,0,0
121494,(,0,0
121495,2?0,0,0
121496,to,0,0
121497,12?1,0,0
121498,),0,0
121499,points,0,0
121500,higher,0,0
121501,for,0,0
121502,CBT,0,0
121503,(,0,0
121504,p,0,0
121505,=,0,0
121506,0?0068,0,0
121507,),0,0
121508,and,0,0
121509,9?4,0,0
121510,(,0,0
121511,4?4,0,0
121512,to,0,0
121513,14?4,0,0
121514,),0,0
121515,points,0,0
121516,higher,0,0
121517,for,0,0
121518,GET,0,0
121519,(,0,0
121520,p,0,0
121521,=,0,0
121522,0?0005,0,0
121523,),0,0
121524,",",0,0
121525,but,0,0
121526,did,0,0
121527,not,0,0
121528,differ,0,0
121529,for,0,0
121530,APT,0,0
121531,(,0,0
121532,3?4,0,0
121533,[,0,0
121534,-1?6,0,0
121535,to,0,0
121536,8?4,0,0
121537,],0,0
121538,points,0,0
121539,lower,0,0
121540,;,0,0
121541,p=0?18,0,0
121542,),0,0
121543,.,0,0
121544,Compared,0,0
121545,with,0,0
121546,APT,0,0
121547,",",0,0
121548,CBT,0,0
121549,and,0,1
121550,GET,0,0
121551,were,0,0
121552,associated,0,0
121553,with,0,0
121554,less,1,0
121555,fatigue,1,1
121556,(,1,0
121557,CBT,1,0
121558,p,0,0
121559,=,0,0
121560,0?0027,0,0
121561,;,0,0
121562,GET,0,0
121563,p,0,0
121564,=,0,0
121565,0?0059,0,0
121566,),0,0
121567,and,0,0
121568,better,1,0
121569,physical,1,1
121570,function,1,1
121571,(,0,0
121572,CBT,0,0
121573,p=0?0002,0,0
121574,;,0,0
121575,GET,0,0
121576,p,0,0
121577,<,0,0
121578,0?0001,0,0
121579,),0,0
121580,.,0,0
121581,Subgroup,0,0
121582,analysis,0,0
121583,of,0,0
121584,427,0,0
121585,participants,0,0
121586,meeting,0,0
121587,international,0,0
121588,criteria,0,0
121589,for,0,0
121590,chronic,1,0
121591,fatigue,1,1
121592,syndrome,1,0
121593,and,0,0
121594,329,0,0
121595,participants,0,0
121596,meeting,0,0
121597,London,0,0
121598,criteria,0,0
121599,for,0,0
121600,myalgic,0,0
121601,encephalomyelitis,0,0
121602,yielded,0,0
121603,equivalent,0,0
121604,results,0,0
121605,.,0,0
121606,Serious,0,0
121607,adverse,1,1
121608,reactions,1,1
121609,were,0,0
121610,recorded,0,0
121611,in,0,0
121612,two,0,0
121613,(,0,0
121614,1,0,0
121615,%,0,0
121616,),0,0
121617,of,0,0
121618,159,0,0
121619,participants,0,0
121620,in,0,0
121621,the,0,0
121622,APT,0,1
121623,group,0,0
121624,",",0,0
121625,three,0,0
121626,(,0,0
121627,2,0,0
121628,%,0,0
121629,),0,0
121630,of,0,0
121631,161,0,0
121632,in,0,0
121633,the,0,0
121634,CBT,0,0
121635,group,0,0
121636,",",0,0
121637,two,0,0
121638,(,0,0
121639,1,0,0
121640,%,0,0
121641,),0,0
121642,of,0,0
121643,160,0,0
121644,in,0,0
121645,the,0,0
121646,GET,0,0
121647,group,0,0
121648,",",0,0
121649,and,0,0
121650,two,0,0
121651,(,0,0
121652,1,0,0
121653,%,0,0
121654,),0,0
121655,of,0,0
121656,160,0,0
121657,in,0,0
121658,the,0,0
121659,SMC-alone,0,0
121660,group,0,0
121661,.,0,0
121662,INTERPRETATION,0,0
121663,CBT,0,0
121664,and,0,0
121665,GET,0,0
121666,can,0,0
121667,safely,0,0
121668,be,0,0
121669,added,0,0
121670,to,0,0
121671,SMC,0,0
121672,to,0,0
121673,moderately,0,0
121674,improve,0,0
121675,outcomes,0,0
121676,for,0,0
121677,chronic,0,0
121678,fatigue,1,1
121679,syndrome,1,0
121680,",",0,0
121681,but,0,0
121682,APT,0,1
121683,is,0,0
121684,not,0,0
121685,an,0,0
121686,effective,0,0
121687,addition,0,0
121688,.,0,0
121689,FUNDING,0,0
121690,UK,0,1
121691,Medical,0,0
121692,Research,0,0
121693,Council,0,1
121694,",",0,0
121695,Department,0,0
121696,of,0,0
121697,Health,0,1
121698,for,0,0
121699,England,0,1
121700,",",0,0
121701,Scottish,0,0
121702,Chief,0,1
121703,Scientist,0,0
121704,Office,0,1
121705,",",0,0
121706,Department,0,0
121707,for,0,0
121708,Work,0,0
121709,and,0,0
121710,Pensions,0,1
121711,.,0,0
121712,Augmented,0,0
121713,soft,0,0
121714,tissue,0,1
121715,mobilization,0,0
121716,vs,0,0
121717,natural,0,0
121718,history,0,0
121719,in,0,0
121720,the,0,0
121721,treatment,0,0
121722,of,0,0
121723,lateral,0,0
121724,epicondylitis,0,0
121725,:,0,0
121726,a,0,0
121727,pilot,0,0
121728,study,0,0
121729,.,0,0
121730,OBJECTIVE,0,0
121731,The,0,0
121732,purpose,0,0
121733,of,0,0
121734,this,0,0
121735,study,0,0
121736,was,0,0
121737,to,0,0
121738,evaluate,0,0
121739,the,0,0
121740,effect,0,0
121741,of,0,0
121742,augmented,0,1
121743,soft,0,0
121744,tissue,0,1
121745,mobilization,0,0
121746,(,0,0
121747,ASTM,0,0
121748,),0,0
121749,on,0,0
121750,the,0,0
121751,treatment,0,0
121752,of,0,0
121753,lateral,0,0
121754,epicondylitis,0,0
121755,.,0,0
121756,METHODS,0,0
121757,This,0,0
121758,randomized,0,0
121759,clinical,0,0
121760,study,0,0
121761,assessed,0,0
121762,27,0,0
121763,subjects,0,0
121764,(,0,0
121765,12,0,0
121766,men,0,0
121767,and,0,0
121768,15,0,0
121769,women,0,0
121770,),0,0
121771,with,0,0
121772,lateral,0,0
121773,epicondylitis,0,1
121774,and,0,0
121775,were,0,0
121776,divided,0,0
121777,randomly,0,0
121778,into,0,0
121779,2,0,0
121780,groups,0,0
121781,.,0,0
121782,The,0,0
121783,experimental,0,0
121784,group,0,0
121785,(,0,0
121786,n,0,0
121787,=,0,0
121788,15,0,0
121789,),0,0
121790,received,0,0
121791,ASTM,0,0
121792,twice,0,0
121793,a,0,0
121794,week,0,0
121795,for,0,0
121796,5,0,0
121797,weeks,0,0
121798,.,0,0
121799,The,0,0
121800,subjects,0,0
121801,of,0,0
121802,the,0,0
121803,control,0,0
121804,group,0,0
121805,(,0,0
121806,n,0,0
121807,=,0,0
121808,12,0,0
121809,),0,0
121810,received,0,0
121811,advice,0,0
121812,on,0,0
121813,the,0,0
121814,natural,0,0
121815,evolution,0,1
121816,of,0,0
121817,lateral,0,0
121818,epicondylitis,0,0
121819,",",0,0
121820,computer,0,1
121821,ergonomics,0,1
121822,",",0,0
121823,and,0,0
121824,stretching,0,0
121825,exercises,0,0
121826,.,0,0
121827,Patient-rated,0,1
121828,outcome,0,1
121829,was,0,0
121830,assessed,0,0
121831,at,0,0
121832,baseline,0,0
121833,and,0,0
121834,after,0,0
121835,6,0,0
121836,weeks,0,0
121837,and,0,0
121838,3,0,0
121839,months,0,0
121840,using,0,0
121841,a,0,0
121842,visual,0,1
121843,analog,0,1
121844,scale,0,1
121845,and,0,0
121846,the,0,0
121847,Patient-Rated,0,1
121848,Tennis,0,0
121849,Elbow,0,0
121850,Evaluation,0,0
121851,.,0,0
121852,The,0,0
121853,function,0,1
121854,was,0,0
121855,assessed,0,0
121856,using,0,0
121857,the,0,0
121858,pain-free,1,0
121859,grip,1,1
121860,strength,1,1
121861,at,0,0
121862,baseline,0,0
121863,and,0,0
121864,after,0,0
121865,6,0,0
121866,weeks,0,0
121867,.,0,0
121868,RESULTS,0,0
121869,Both,0,0
121870,groups,0,0
121871,showed,0,0
121872,improvements,1,1
121873,in,1,0
121874,pain-free,1,0
121875,grip,1,1
121876,strength,1,1
121877,",",1,0
121878,visual,1,1
121879,analog,1,1
121880,scale,1,1
121881,",",1,0
121882,and,1,1
121883,Patient-Rated,1,1
121884,Tennis,1,0
121885,Elbow,1,0
121886,Evaluation,1,0
121887,.,1,0
121888,Sample,0,0
121889,size,0,1
121890,for,0,0
121891,larger,0,0
121892,future,0,0
121893,randomized,0,0
121894,clinical,0,0
121895,trial,0,0
121896,was,0,0
121897,116,0,0
121898,participants,0,0
121899,.,0,0
121900,CONCLUSION,0,0
121901,A,0,0
121902,larger,0,0
121903,study,0,0
121904,investigating,0,0
121905,the,0,0
121906,same,0,0
121907,hypothesis,0,0
121908,is,0,0
121909,warranted,0,0
121910,to,0,0
121911,detect,0,0
121912,difference,0,0
121913,in,0,0
121914,the,0,0
121915,effects,0,0
121916,of,0,0
121917,these,0,0
121918,treatments,0,0
121919,strategies,0,0
121920,.,0,0
121921,The,0,0
121922,study,0,0
121923,design,0,0
121924,is,0,0
121925,feasible,0,0
121926,",",0,0
121927,and,0,1
121928,minor,0,0
121929,improvements,0,0
121930,will,0,0
121931,help,0,0
121932,to,0,0
121933,minimize,0,0
121934,the,0,0
121935,potential,0,0
121936,bias,0,0
121937,.,0,0
121938,A,0,0
121939,prospective,0,0
121940,",",0,0
121941,double-blind,0,0
121942,",",0,0
121943,randomized,0,0
121944,",",0,0
121945,controlled,0,0
121946,clinical,0,0
121947,trial,0,0
121948,comparing,0,0
121949,standard,0,0
121950,wound,0,1
121951,care,0,0
121952,with,0,0
121953,adjunctive,0,0
121954,hyperbaric,0,0
121955,oxygen,0,1
121956,therapy,0,0
121957,(,0,0
121958,HBOT,0,0
121959,),0,0
121960,to,0,0
121961,standard,0,0
121962,wound,0,1
121963,care,0,0
121964,only,0,0
121965,for,0,0
121966,the,0,0
121967,treatment,0,0
121968,of,0,0
121969,chronic,1,0
121970,",",1,0
121971,non-healing,1,1
121972,ulcers,1,1
121973,of,0,0
121974,the,0,0
121975,lower,0,0
121976,limb,0,1
121977,in,0,0
121978,patients,0,0
121979,with,0,0
121980,diabetes,0,0
121981,mellitus,0,0
121982,:,0,0
121983,a,0,0
121984,study,0,0
121985,protocol,0,0
121986,.,0,0
121987,BACKGROUND,0,0
121988,It,0,0
121989,has,0,0
121990,been,0,0
121991,suggested,0,0
121992,that,0,0
121993,the,0,0
121994,use,0,0
121995,of,0,0
121996,adjunctive,0,0
121997,hyperbaric,0,0
121998,oxygen,0,1
121999,therapy,0,0
122000,improves,0,0
122001,the,0,0
122002,healing,0,1
122003,of,0,0
122004,diabetic,1,0
122005,foot,1,1
122006,ulcers,1,1
122007,",",0,0
122008,and,0,0
122009,decreases,0,1
122010,the,0,0
122011,risk,0,0
122012,of,0,0
122013,lower,1,0
122014,extremity,1,0
122015,amputations,1,0
122016,.,1,0
122017,A,0,0
122018,limited,0,0
122019,number,0,1
122020,of,0,0
122021,studies,0,0
122022,have,0,0
122023,used,0,0
122024,a,0,0
122025,double,0,0
122026,blind,0,0
122027,approach,0,0
122028,to,0,0
122029,evaluate,0,0
122030,the,0,0
122031,efficacy,0,1
122032,of,0,0
122033,hyperbaric,0,0
122034,oxygen,0,1
122035,therapy,0,0
122036,in,0,0
122037,the,0,0
122038,treatment,0,0
122039,of,0,0
122040,diabetic,0,0
122041,ulcers,0,0
122042,.,0,0
122043,The,0,0
122044,primary,0,0
122045,aim,0,0
122046,of,0,0
122047,this,0,0
122048,study,0,0
122049,is,0,0
122050,to,0,0
122051,assess,0,0
122052,the,0,0
122053,efficacy,0,1
122054,of,0,0
122055,hyperbaric,0,0
122056,oxygen,0,1
122057,therapy,0,0
122058,plus,0,0
122059,standard,0,0
122060,wound,0,1
122061,care,0,0
122062,compared,0,0
122063,with,0,0
122064,standard,0,0
122065,wound,0,1
122066,care,0,0
122067,alone,0,0
122068,in,0,0
122069,preventing,0,0
122070,the,0,0
122071,need,0,0
122072,for,0,0
122073,major,1,0
122074,amputation,1,1
122075,in,0,0
122076,patients,0,0
122077,with,0,0
122078,diabetes,0,0
122079,mellitus,0,0
122080,and,0,0
122081,chronic,0,0
122082,ulcers,0,1
122083,of,0,0
122084,the,0,0
122085,lower,0,0
122086,limb,0,1
122087,.,0,0
122088,METHODS/DESIGN,0,0
122089,One,0,0
122090,hundred,0,0
122091,and,0,0
122092,eighteen,0,0
122093,(,0,0
122094,59,0,0
122095,patients,0,0
122096,per,0,0
122097,arm,0,0
122098,),0,0
122099,patients,0,0
122100,with,0,0
122101,non-healing,0,0
122102,diabetic,0,0
122103,ulcers,0,0
122104,of,0,0
122105,the,0,0
122106,lower,0,0
122107,limb,0,1
122108,",",0,0
122109,referred,0,0
122110,to,0,0
122111,the,0,0
122112,Judy,0,0
122113,Dan,0,0
122114,Research,0,0
122115,and,0,0
122116,Treatment,0,0
122117,Centre,0,0
122118,are,0,0
122119,being,0,0
122120,recruited,0,0
122121,if,0,0
122122,they,0,0
122123,are,0,0
122124,at,0,0
122125,least,0,0
122126,18,0,0
122127,years,0,0
122128,of,0,0
122129,age,0,0
122130,",",0,0
122131,have,0,0
122132,either,0,0
122133,Type,0,0
122134,1,0,0
122135,or,0,0
122136,2,0,0
122137,diabetes,0,0
122138,with,0,0
122139,a,0,0
122140,Wagner,0,0
122141,grading,0,1
122142,of,0,0
122143,foot,0,1
122144,lesions,0,1
122145,2,0,0
122146,",",0,0
122147,3,0,0
122148,or,0,0
122149,4,0,0
122150,on,0,0
122151,lower,0,0
122152,limb,0,1
122153,not,0,0
122154,healing,0,1
122155,for,0,0
122156,at,0,0
122157,least,0,0
122158,4,0,0
122159,weeks,0,0
122160,.,0,0
122161,Patients,0,0
122162,receive,0,0
122163,hyperbaric,0,0
122164,oxygen,0,1
122165,therapy,0,0
122166,every,0,0
122167,day,0,0
122168,for,0,0
122169,6,0,0
122170,weeks,0,0
122171,during,0,0
122172,the,0,0
122173,treatment,0,0
122174,phase,0,0
122175,and,0,0
122176,are,0,0
122177,provided,0,0
122178,ongoing,0,0
122179,wound,0,1
122180,care,0,0
122181,and,0,1
122182,weekly,0,0
122183,assessments,0,0
122184,.,0,0
122185,Patients,0,0
122186,are,0,0
122187,required,0,0
122188,to,0,0
122189,return,0,0
122190,to,0,0
122191,the,0,0
122192,study,0,0
122193,centre,0,0
122194,every,0,0
122195,week,0,0
122196,for,0,0
122197,an,0,0
122198,additional,0,0
122199,6,0,0
122200,weeks,0,0
122201,of,0,0
122202,follow-up,0,0
122203,for,0,0
122204,wound,0,1
122205,evaluation,0,0
122206,and,0,0
122207,management,0,0
122208,.,0,0
122209,The,0,0
122210,primary,0,0
122211,outcome,0,0
122212,is,0,0
122213,freedom,1,1
122214,from,1,0
122215,having,1,0
122216,",",1,0
122217,or,1,0
122218,meeting,1,0
122219,the,1,0
122220,criteria,1,0
122221,for,1,0
122222,",",1,0
122223,a,1,0
122224,major,1,1
122225,amputation,1,1
122226,(,1,0
122227,below,1,0
122228,knee,1,1
122229,amputation,1,1
122230,",",1,0
122231,or,1,0
122232,metatarsal,1,1
122233,level,1,1
122234,),1,0
122235,up,0,0
122236,to,0,0
122237,12,0,0
122238,weeks,0,0
122239,after,0,0
122240,randomization,0,0
122241,.,0,0
122242,The,0,0
122243,decision,0,0
122244,to,0,0
122245,amputate,0,0
122246,is,0,0
122247,made,0,0
122248,by,0,0
122249,a,0,0
122250,vascular,0,0
122251,surgeon,0,0
122252,.,0,0
122253,Other,0,0
122254,outcomes,0,0
122255,include,0,0
122256,wound,1,1
122257,healing,1,1
122258,",",1,0
122259,effectiveness,1,1
122260,",",1,1
122261,safety,1,1
122262,",",1,1
122263,healthcare,1,1
122264,resource,1,0
122265,utilization,1,1
122266,",",1,0
122267,quality,1,1
122268,of,1,1
122269,life,1,1
122270,",",1,0
122271,and,1,1
122272,cost-effectiveness,1,0
122273,.,1,0
122274,The,0,0
122275,study,0,0
122276,will,0,0
122277,run,0,0
122278,for,0,0
122279,a,0,0
122280,total,0,1
122281,of,0,0
122282,about,0,0
122283,3,0,0
122284,years,0,0
122285,.,0,0
122286,DISCUSSION,0,0
122287,The,0,0
122288,results,0,0
122289,of,0,0
122290,this,0,0
122291,study,0,0
122292,will,0,0
122293,provide,0,0
122294,detailed,0,0
122295,information,0,0
122296,on,0,0
122297,the,0,0
122298,efficacy,0,1
122299,of,0,0
122300,hyperbaric,0,0
122301,oxygen,0,1
122302,therapy,0,0
122303,for,0,0
122304,the,0,0
122305,treatment,0,0
122306,of,0,0
122307,non-healing,0,0
122308,ulcers,0,0
122309,of,0,0
122310,the,0,0
122311,lower,0,0
122312,limb,0,1
122313,.,0,0
122314,This,0,0
122315,will,0,0
122316,be,0,0
122317,the,0,0
122318,first,0,0
122319,double-blind,0,0
122320,randomized,0,0
122321,controlled,0,0
122322,trial,0,0
122323,for,0,0
122324,this,0,0
122325,health,0,1
122326,technology,0,0
122327,which,0,0
122328,evaluates,0,0
122329,the,0,0
122330,efficacy,0,1
122331,of,0,0
122332,hyperbaric,0,0
122333,oxygen,0,1
122334,therapy,0,0
122335,in,0,0
122336,prevention,0,0
122337,of,0,0
122338,amputations,1,0
122339,in,0,0
122340,diabetic,0,0
122341,patients,0,0
122342,.,0,0
122343,TRIAL,0,0
122344,REGISTRATION,0,0
122345,ClinicalTrials.gov,0,0
122346,Identifier,0,0
122347,:,0,0
122348,NCT00621608,0,0
122349,.,0,0
122350,Noninfiltrative,0,0
122351,anesthesia,0,0
122352,for,0,0
122353,transrectal,0,0
122354,prostate,0,0
122355,biopsy,0,0
122356,:,0,0
122357,a,0,0
122358,randomized,0,0
122359,prospective,0,0
122360,study,0,0
122361,comparing,0,0
122362,lidocaine-prilocaine,0,0
122363,cream,0,0
122364,and,0,0
122365,lidocaine-ketorolac,0,0
122366,gel,0,0
122367,.,0,0
122368,OBJECTIVES,0,0
122369,Periprostatic,0,1
122370,nerve,0,1
122371,block,0,0
122372,(,0,0
122373,PPNB,0,0
122374,),0,0
122375,is,0,0
122376,the,0,0
122377,standard,0,0
122378,anesthesia,0,0
122379,for,0,0
122380,ultrasound,0,1
122381,(,0,0
122382,US,0,1
122383,),0,0
122384,guided,0,0
122385,transrectal,0,0
122386,prostate,0,0
122387,biopsy,0,0
122388,(,0,0
122389,TPB,0,0
122390,),0,1
122391,",",0,0
122392,but,0,0
122393,periprostatic,0,0
122394,infiltration,0,0
122395,itself,0,0
122396,constitutes,0,0
122397,a,0,0
122398,major,0,0
122399,",",0,0
122400,though,0,0
122401,often,0,0
122402,neglected,0,0
122403,",",0,0
122404,source,0,0
122405,of,0,1
122406,discomfort,0,1
122407,even,0,0
122408,in,0,0
122409,patients,0,0
122410,receiving,0,0
122411,perianal-intrarectal,0,0
122412,lidocaine-prilocaine,0,0
122413,(,0,0
122414,PILP,0,0
122415,),0,0
122416,cream,0,0
122417,before,0,0
122418,PPNB,0,0
122419,.,0,0
122420,Noninfiltrative,0,0
122421,anesthesia,0,0
122422,therefore,0,0
122423,represents,0,0
122424,an,0,0
122425,attractive,0,0
122426,alternative,0,0
122427,to,0,0
122428,periprostatic,0,0
122429,infiltration,0,1
122430,.,0,0
122431,With,0,0
122432,this,0,0
122433,in,0,0
122434,mind,0,0
122435,",",0,0
122436,we,0,0
122437,aimed,0,0
122438,to,0,0
122439,determine,0,0
122440,the,0,0
122441,efficacy,1,1
122442,and,1,0
122443,safety,1,1
122444,of,0,1
122445,perianal-intrarectal,0,0
122446,(,0,0
122447,PI,0,0
122448,),0,1
122449,lidocaine,0,0
122450,gel,0,0
122451,",",0,0
122452,lidocaine-ketorolac,0,0
122453,gel,0,0
122454,",",0,0
122455,and,0,1
122456,lidocaine-prilocaine,0,0
122457,cream,0,0
122458,in,0,0
122459,relieving,1,1
122460,pain,1,1
122461,during,0,0
122462,TPB,0,0
122463,.,0,0
122464,MATERIALS,0,0
122465,AND,0,0
122466,METHODS,0,0
122467,Three,0,0
122468,hundred,0,0
122469,consecutive,0,0
122470,patients,0,0
122471,scheduled,0,0
122472,for,0,0
122473,US-guided,0,0
122474,TPB,0,0
122475,were,0,0
122476,randomized,0,0
122477,1:1:1,0,0
122478,to,0,0
122479,receive,0,0
122480,PI,0,0
122481,administration,0,0
122482,of,0,0
122483,5,0,0
122484,g,0,0
122485,2.5,0,0
122486,%,0,0
122487,lidocaine,0,0
122488,gel,0,0
122489,10,0,0
122490,minutes,0,0
122491,before,0,0
122492,TPB,0,0
122493,(,0,0
122494,Group,0,0
122495,1,0,0
122496,),0,0
122497,",",0,0
122498,or,0,0
122499,a,0,0
122500,mixture,0,0
122501,of,0,0
122502,5,0,0
122503,g,0,0
122504,2.5,0,0
122505,%,0,0
122506,lidocaine,0,0
122507,gel,0,0
122508,and,0,0
122509,0.3,0,0
122510,%,0,0
122511,ketorolac,0,0
122512,tromethamine,0,0
122513,solution,0,0
122514,1,0,0
122515,hour,0,0
122516,before,0,0
122517,TPB,0,0
122518,(,0,0
122519,Group,0,0
122520,2,0,0
122521,),0,0
122522,",",0,0
122523,or,0,0
122524,5,0,0
122525,g,0,0
122526,2.5,0,0
122527,%,0,0
122528,lidocaine,0,0
122529,and,0,0
122530,2.5,0,0
122531,%,0,0
122532,prilocaine,0,0
122533,cream,0,0
122534,20,0,0
122535,minutes,0,0
122536,before,0,0
122537,TPB,0,0
122538,(,0,0
122539,Group,0,0
122540,3,0,0
122541,),0,0
122542,.,0,0
122543,The,0,0
122544,0-to-10,1,1
122545,points,1,0
122546,visual,1,1
122547,analogue,1,1
122548,scale,1,1
122549,(,1,0
122550,VAS,1,1
122551,),1,0
122552,was,0,0
122553,used,0,0
122554,for,0,0
122555,assessing,0,0
122556,pain,0,1
122557,at,0,0
122558,probe,0,0
122559,insertion,0,1
122560,and,0,1
122561,movements,0,1
122562,(,0,0
122563,VAS-1,0,0
122564,),0,0
122565,",",0,0
122566,at,0,0
122567,prostate,0,0
122568,sampling,0,0
122569,(,0,0
122570,VAS-2,0,0
122571,),0,1
122572,",",0,0
122573,and,0,1
122574,maximal,0,1
122575,procedural,0,1
122576,pain,0,1
122577,(,0,0
122578,MPP,0,0
122579,),0,0
122580,.,0,0
122581,Complications,0,1
122582,occurring,0,0
122583,up,0,0
122584,to,0,0
122585,20,0,0
122586,days,0,0
122587,after,0,0
122588,the,0,0
122589,procedure,0,0
122590,were,0,0
122591,also,0,0
122592,recorded,0,0
122593,.,0,0
122594,RESULTS,0,0
122595,Four,0,0
122596,(,0,0
122597,1.3,0,0
122598,%,0,0
122599,),0,0
122600,patients,0,0
122601,were,0,0
122602,excluded,0,0
122603,because,0,0
122604,of,0,0
122605,unbearable,1,1
122606,pain,1,1
122607,during,0,0
122608,the,0,0
122609,procedure,0,0
122610,",",0,0
122611,leaving,0,0
122612,Group,0,0
122613,1,0,0
122614,with,0,0
122615,98,0,0
122616,patients,0,0
122617,",",0,0
122618,Group,0,0
122619,2,0,0
122620,with,0,0
122621,99,0,0
122622,",",0,0
122623,and,0,0
122624,Group,0,0
122625,3,0,0
122626,with,0,0
122627,99,0,0
122628,;,0,0
122629,the,0,0
122630,3,0,0
122631,groups,0,0
122632,were,0,0
122633,comparable,0,0
122634,for,0,0
122635,patients,0,0
122636,',0,0
122637,age,0,0
122638,",",0,0
122639,serum,1,1
122640,PSA,1,1
122641,",",1,0
122642,prostate,1,0
122643,volume,1,1
122644,",",1,1
122645,and,1,1
122646,cancer,1,1
122647,detection,1,1
122648,rate,1,1
122649,.,1,0
122650,The,0,0
122651,addition,0,0
122652,of,0,0
122653,either,0,0
122654,ketorolac,0,0
122655,or,0,0
122656,prilocaine,0,0
122657,to,0,0
122658,lidocaine,0,0
122659,significantly,0,0
122660,(,0,0
122661,P,0,0
122662,<,0,0
122663,0.0001,0,0
122664,),0,0
122665,reduced,0,0
122666,probe-related,0,0
122667,",",0,0
122668,sampling-related,0,0
122669,",",0,0
122670,and,0,1
122671,maximal,0,1
122672,procedural,1,1
122673,pain,1,1
122674,.,1,0
122675,Compared,0,0
122676,with,0,0
122677,lidocaine-prilocaine,0,0
122678,",",0,0
122679,lidocaine-ketorolac,0,0
122680,was,0,0
122681,less,0,0
122682,effective,0,1
122683,in,0,0
122684,relieving,0,0
122685,probe-related,1,0
122686,pain,1,1
122687,(,0,0
122688,mean,0,1
122689,VAS-1,0,0
122690,:,0,0
122691,1.47,0,0
122692,?,0,0
122693,1.30,0,0
122694,vs.,0,0
122695,0.39,0,0
122696,?,0,0
122697,0.65,0,0
122698,;,0,0
122699,P,0,0
122700,<,0,0
122701,0.0001,0,0
122702,),0,0
122703,but,0,0
122704,more,0,0
122705,effective,0,1
122706,in,0,0
122707,relieving,1,0
122708,sampling-related,1,0
122709,pain,1,1
122710,(,1,0
122711,mean,0,1
122712,VAS-2,0,0
122713,:,0,0
122714,0.76,0,0
122715,?,0,0
122716,0.94,0,0
122717,vs.,0,0
122718,1.54,0,0
122719,?,0,0
122720,1.02,0,0
122721,;,0,0
122722,P,0,0
122723,<,0,0
122724,0.0001,0,0
122725,),0,0
122726,;,0,0
122727,there,0,0
122728,was,0,0
122729,no,0,0
122730,difference,0,0
122731,in,0,0
122732,MPP,0,0
122733,(,0,0
122734,mean,0,0
122735,1.82,0,0
122736,?,0,0
122737,1.21,0,0
122738,vs.,0,0
122739,1.67,0,0
122740,?,0,0
122741,0.95,0,0
122742,),0,0
122743,",",0,0
122744,probably,0,0
122745,due,0,0
122746,to,0,0
122747,such,0,0
122748,different,0,0
122749,efficacy,0,1
122750,on,0,0
122751,the,0,0
122752,two,1,0
122753,pain,1,0
122754,sources,1,0
122755,.,1,0
122756,Complications,1,1
122757,were,0,0
122758,similar,0,0
122759,in,0,0
122760,the,0,0
122761,3,0,0
122762,groups,0,0
122763,.,0,0
122764,CONCLUSIONS,0,0
122765,Lidocaine-prilocaine,0,0
122766,cream,0,0
122767,was,0,0
122768,most,0,0
122769,effective,0,1
122770,on,0,0
122771,probe-related,1,0
122772,pain,1,1
122773,",",1,0
122774,whereas,0,0
122775,lidocaine-ketorolac,0,0
122776,gel,0,0
122777,was,0,0
122778,most,0,0
122779,effective,0,1
122780,on,0,0
122781,sampling-related,0,0
122782,pain,0,1
122783,.,0,0
122784,These,0,0
122785,noninfiltrative,0,0
122786,anesthetics,0,0
122787,were,0,0
122788,safe,0,0
122789,",",0,0
122790,easy,0,0
122791,to,0,0
122792,administer,0,0
122793,",",0,0
122794,and,0,0
122795,well,0,0
122796,accepted,0,0
122797,by,0,0
122798,patients,0,0
122799,;,0,0
122800,the,0,0
122801,possibility,0,0
122802,to,0,0
122803,combine,0,0
122804,them,0,0
122805,to,0,0
122806,further,0,0
122807,improve,1,0
122808,pain,1,1
122809,control,1,0
122810,during,1,0
122811,TPB,0,0
122812,deserves,0,0
122813,further,0,0
122814,well-designed,0,0
122815,studies,0,0
122816,.,0,0
122817,An,0,0
122818,interactive,0,0
122819,computer,0,0
122820,program,0,0
122821,can,0,0
122822,effectively,0,0
122823,educate,0,0
122824,potential,0,0
122825,users,0,0
122826,of,0,0
122827,cystic,0,0
122828,fibrosis,0,1
122829,carrier,0,0
122830,tests,0,0
122831,.,0,0
122832,The,0,0
122833,demand,0,0
122834,for,0,0
122835,cystic,0,0
122836,fibrosis,0,1
122837,(,0,0
122838,CF,0,1
122839,),0,0
122840,carrier,0,0
122841,testing,0,0
122842,is,0,0
122843,steadily,0,0
122844,growing,0,0
122845,",",0,0
122846,not,0,0
122847,only,0,0
122848,from,0,0
122849,individuals,0,0
122850,with,0,0
122851,raised,0,0
122852,a,0,0
122853,priori,0,0
122854,carrier,0,0
122855,risk,0,1
122856,",",0,0
122857,but,0,0
122858,also,0,0
122859,from,0,0
122860,the,0,0
122861,general,0,0
122862,population,0,0
122863,.,0,0
122864,This,0,0
122865,trend,0,0
122866,will,0,0
122867,likely,0,0
122868,exceed,0,0
122869,the,0,0
122870,availability,0,0
122871,of,0,0
122872,genetic,0,0
122873,counselors,0,0
122874,",",0,0
122875,making,0,0
122876,it,0,0
122877,impossible,0,0
122878,to,0,0
122879,provide,0,0
122880,standard,0,0
122881,face-to-face,0,0
122882,genetic,0,0
122883,counseling,0,0
122884,to,0,0
122885,all,0,0
122886,those,0,0
122887,asking,0,0
122888,for,0,0
122889,the,0,0
122890,test,0,0
122891,.,0,0
122892,In,0,0
122893,order,0,0
122894,to,0,0
122895,reduce,0,0
122896,the,0,0
122897,time,0,1
122898,needed,0,0
122899,to,0,0
122900,educate,0,0
122901,individuals,0,0
122902,on,0,0
122903,the,0,0
122904,basics,0,0
122905,of,0,0
122906,the,0,0
122907,disease,0,0
122908,",",0,0
122909,its,0,0
122910,genetic,0,0
122911,transmission,0,1
122912,",",0,0
122913,and,0,1
122914,carrier,0,1
122915,testing,0,0
122916,peculiarities,0,0
122917,",",0,0
122918,we,0,0
122919,developed,0,0
122920,an,0,0
122921,educational,0,0
122922,method,0,0
122923,based,0,0
122924,on,0,0
122925,an,0,0
122926,interactive,0,0
122927,computer,0,0
122928,program,0,0
122929,(,0,0
122930,IC,0,0
122931,),0,0
122932,.,0,0
122933,To,0,0
122934,assess,0,0
122935,the,0,0
122936,effectiveness,0,0
122937,of,0,0
122938,this,0,0
122939,program,0,0
122940,and,0,0
122941,to,0,0
122942,compare,0,0
122943,it,0,0
122944,to,0,0
122945,a,0,0
122946,classical,0,0
122947,genetic,0,0
122948,counseling,0,0
122949,session,0,0
122950,",",0,0
122951,we,0,0
122952,conducted,0,0
122953,a,0,0
122954,comparative,0,0
122955,trial,0,0
122956,.,0,0
122957,In,0,0
122958,a,0,0
122959,population,0,0
122960,setting,0,0
122961,of,0,0
122962,people,0,0
122963,undergoing,0,0
122964,assisted,0,0
122965,reproduction,0,0
122966,",",0,0
122967,44,0,0
122968,individuals,0,0
122969,were,0,0
122970,randomly,0,0
122971,assigned,0,0
122972,to,0,0
122973,either,0,0
122974,receiving,0,0
122975,standard,0,0
122976,one-on-one,0,0
122977,genetic,0,0
122978,counseling,0,0
122979,or,0,0
122980,education,0,0
122981,by,0,0
122982,the,0,0
122983,IC,0,0
122984,program,0,0
122985,.,0,0
122986,We,0,0
122987,measured,0,0
122988,pre-,0,0
122989,and,0,1
122990,post-intervention,0,0
122991,knowledge,0,1
122992,about,0,0
122993,CF,0,1
122994,genetic,0,1
122995,transmission,0,1
122996,and,0,1
122997,carrier,0,1
122998,testing,0,0
122999,.,0,0
123000,Starting,1,0
123001,from,1,0
123002,an,1,0
123003,equivalent,1,0
123004,baseline,1,0
123005,of,1,0
123006,correct,1,0
123007,answers,1,0
123008,to,1,0
123009,a,1,0
123010,specially,1,0
123011,designed,1,0
123012,multiple-choice,1,1
123013,questionnaire,1,1
123014,(,1,0
123015,47,1,0
123016,%,1,0
123017,in,1,0
123018,the,1,0
123019,counselor,1,0
123020,group,1,0
123021,and,1,0
123022,45,1,0
123023,%,1,0
123024,in,1,0
123025,the,1,0
123026,computer,1,0
123027,group,1,0
123028,),1,0
123029,both,1,0
123030,groups,1,0
123031,showed,1,0
123032,a,1,0
123033,highly,1,0
123034,significant,1,0
123035,and,1,0
123036,similar,1,0
123037,increase,1,1
123038,(,1,0
123039,reaching,1,0
123040,84,1,0
123041,%,1,0
123042,in,1,0
123043,the,1,0
123044,counselor,1,0
123045,group,1,0
123046,and,1,0
123047,85,1,0
123048,%,1,0
123049,in,1,0
123050,the,1,0
123051,computer,1,0
123052,group,1,0
123053,),1,0
123054,.,1,0
123055,The,0,0
123056,computer,0,0
123057,program,0,0
123058,under,0,0
123059,evaluation,0,0
123060,can,0,0
123061,successfully,0,0
123062,educate,0,0
123063,individuals,0,0
123064,considering,0,0
123065,genetic,0,0
123066,testing,0,0
123067,for,0,0
123068,CF,0,0
123069,.,0,0
123070,[,0,0
123071,Protective,0,0
123072,effect,0,0
123073,of,0,0
123074,ischemia,0,1
123075,postconditioning,0,0
123076,on,0,0
123077,reperfusion,0,1
123078,injury,0,1
123079,in,0,0
123080,patients,0,0
123081,with,0,0
123082,ST-segment,0,0
123083,elevation,0,1
123084,acute,0,0
123085,myocardial,0,1
123086,infarction,0,0
123087,],0,0
123088,.,0,0
123089,OBJECTIVE,0,0
123090,To,0,0
123091,observe,0,0
123092,the,0,0
123093,effect,0,0
123094,of,0,0
123095,ischemia,0,1
123096,postconditioning,0,0
123097,during,0,0
123098,the,0,0
123099,first,0,0
123100,minutes,0,0
123101,of,0,0
123102,reperfusion,0,1
123103,for,0,0
123104,the,0,0
123105,myocardial,0,1
123106,reperfusion,0,1
123107,injury,0,1
123108,in,0,0
123109,ST-segment,0,1
123110,elevation,0,1
123111,acute,0,0
123112,myocardial,0,1
123113,infarction,0,1
123114,(,0,0
123115,STEMI,0,0
123116,),0,0
123117,patients,0,0
123118,undergoing,0,0
123119,emergency,0,1
123120,percutaneous,0,0
123121,coronary,0,0
123122,intervention,0,0
123123,(,0,0
123124,PCI,0,1
123125,),0,0
123126,.,0,0
123127,METHODS,0,0
123128,STEMI,0,0
123129,patients,0,0
123130,undergoing,0,0
123131,emergency,0,1
123132,PCI,0,1
123133,in,0,0
123134,affiliated,0,0
123135,hospital,0,1
123136,of,0,0
123137,Beihua,0,0
123138,University,0,0
123139,between,0,0
123140,October,0,0
123141,2006,0,0
123142,and,0,0
123143,January,0,0
123144,2009,0,0
123145,were,0,0
123146,randomly,0,0
123147,divided,0,0
123148,into,0,0
123149,two,0,0
123150,groups,0,0
123151,:,0,0
123152,the,0,0
123153,control,0,0
123154,group,0,0
123155,(,0,0
123156,n,0,0
123157,=,0,0
123158,34,0,0
123159,),0,0
123160,without,0,0
123161,any,0,0
123162,intervention,0,0
123163,after,0,0
123164,PTCA,0,0
123165,",",0,0
123166,and,0,0
123167,the,0,0
123168,postconditioning,0,0
123169,group,0,0
123170,(,0,0
123171,n,0,0
123172,=,0,0
123173,30,0,0
123174,),0,0
123175,with,0,0
123176,ischemia,0,1
123177,postconditioning,0,0
123178,within,0,0
123179,first,0,0
123180,minutes,0,0
123181,of,0,0
123182,reflow,0,1
123183,by,0,0
123184,3,0,0
123185,episodes,0,0
123186,of,0,0
123187,30-second,0,0
123188,inflation,0,0
123189,and,0,0
123190,30-second,0,1
123191,deflation,0,0
123192,with,0,0
123193,the,0,0
123194,angioplasty,0,0
123195,balloon,0,0
123196,.,0,0
123197,Reperfusion,1,1
123198,arrhythmias,1,1
123199,",",1,1
123200,CK,1,0
123201,and,1,1
123202,CKMB,1,1
123203,",",1,1
123204,corrected,1,0
123205,TIMI,1,1
123206,frame,1,0
123207,count,1,1
123208,(,1,0
123209,CTFC,1,0
123210,),1,0
123211,",",1,0
123212,wall,1,1
123213,motion,1,1
123214,score,1,1
123215,index,1,1
123216,(,1,0
123217,WMSI,1,0
123218,),1,1
123219,and,1,0
123220,left,1,1
123221,ventricular,1,1
123222,ejection,1,1
123223,fraction,1,1
123224,(,1,0
123225,LVEF,1,1
123226,),1,0
123227,by,0,0
123228,echocardiography,0,1
123229,were,0,0
123230,compared,0,0
123231,between,0,0
123232,the,0,0
123233,two,0,0
123234,groups,0,0
123235,.,0,0
123236,MI,0,0
123237,areas,0,1
123238,were,0,0
123239,evaluated,0,0
123240,with,0,0
123241,the,0,0
123242,ECG-54,0,0
123243,criteria/32,0,1
123244,system,0,0
123245,and,0,1
123246,myocardial,1,1
123247,blush,1,1
123248,grade,1,1
123249,(,1,0
123250,MBG,1,1
123251,),1,0
123252,was,0,0
123253,measured,0,0
123254,.,0,0
123255,RESULTS,0,0
123256,The,0,0
123257,incidence,1,1
123258,of,1,0
123259,reperfusion,1,1
123260,arrhythmias-frequent,1,1
123261,ventricular,1,1
123262,premature,1,0
123263,(,0,0
123264,26.7,0,0
123265,%,0,0
123266,vs.,0,0
123267,52.9,0,0
123268,%,0,0
123269,),0,0
123270,and,0,0
123271,short,1,1
123272,array,1,0
123273,ventricular,1,1
123274,tachycardia,1,1
123275,beat,1,1
123276,(,0,0
123277,23.3,0,0
123278,%,0,0
123279,vs.,0,0
123280,58.8,0,0
123281,%,0,0
123282,),0,0
123283,as,0,0
123284,well,0,0
123285,as,0,0
123286,values,0,1
123287,of,0,0
123288,peaks,1,1
123289,CK,1,0
123290,[,0,0
123291,(,0,0
123292,1162,0,0
123293,?,0,0
123294,548,0,0
123295,),0,0
123296,U/L,0,0
123297,vs.,0,0
123298,(,0,0
123299,1732,0,0
123300,?,0,0
123301,480,0,0
123302,),0,0
123303,U/L,0,0
123304,",",0,0
123305,P,0,0
123306,<,0,0
123307,0.01,0,0
123308,],0,0
123309,",",0,0
123310,CKMB,0,1
123311,[,0,0
123312,(,0,0
123313,165,0,0
123314,?,0,0
123315,70,0,0
123316,),0,0
123317,U/L,0,0
123318,vs.,0,0
123319,(,0,0
123320,280,0,0
123321,?,0,0
123322,99,0,0
123323,),0,0
123324,U/L,0,0
123325,",",0,0
123326,P,0,0
123327,<,0,0
123328,0.01,0,0
123329,],0,0
123330,",",0,0
123331,CTFC,0,0
123332,(,0,0
123333,22.23,0,0
123334,?,0,0
123335,3.81,0,0
123336,vs.,0,0
123337,26.97,0,0
123338,?,0,0
123339,3.42,0,0
123340,),0,0
123341,",",0,0
123342,WMSI,0,0
123343,(,0,0
123344,1.27,0,0
123345,?,0,0
123346,0.52,0,0
123347,vs.,0,0
123348,1.82,0,0
123349,?,0,0
123350,0.83,0,0
123351,),0,0
123352,",",0,0
123353,and,1,1
123354,infarction,1,1
123355,areas,1,1
123356,determined,1,0
123357,by,1,0
123358,ECG,1,0
123359,methods,0,0
123360,(,0,0
123361,10.60,0,0
123362,%,0,0
123363,?,0,0
123364,4.97,0,0
123365,%,0,0
123366,vs.14.65,0,0
123367,%,0,0
123368,?,0,0
123369,6.88,0,0
123370,%,0,0
123371,",",0,0
123372,all,0,0
123373,P,0,0
123374,<,0,0
123375,0.05,0,0
123376,),0,0
123377,were,0,0
123378,all,1,0
123379,significantly,1,0
123380,lower,1,0
123381,in,1,0
123382,the,0,0
123383,postconditioning,0,0
123384,group,0,0
123385,than,0,0
123386,in,0,0
123387,control,0,0
123388,group,0,0
123389,while,0,0
123390,LVEF,0,1
123391,(,0,0
123392,0.55,0,0
123393,?,0,0
123394,0.08,0,0
123395,vs.,0,0
123396,0.47,0,0
123397,?,0,0
123398,0.10,0,0
123399,),0,0
123400,and,0,0
123401,MBG,0,1
123402,(,0,0
123403,2.27,0,0
123404,?,0,0
123405,0.64,0,0
123406,vs.,0,0
123407,1.47,0,0
123408,?,0,0
123409,0.61,0,0
123410,",",0,0
123411,all,0,0
123412,P,0,0
123413,<,0,0
123414,0.05,0,0
123415,),0,0
123416,were,0,0
123417,significantly,1,0
123418,higher,1,0
123419,in,1,0
123420,the,1,0
123421,postconditioning,0,0
123422,group,0,0
123423,than,0,0
123424,in,0,0
123425,control,0,0
123426,group,0,0
123427,.,0,0
123428,CONCLUSIONS,0,0
123429,Ischemia,0,0
123430,postconditioning,0,0
123431,can,0,0
123432,significantly,0,0
123433,reduce,0,0
123434,myocardial,0,1
123435,reperfusion,0,1
123436,injury,0,1
123437,in,0,0
123438,patients,0,0
123439,with,0,0
123440,STEMI,0,0
123441,.,0,0
123442,Calcium,0,0
123443,channel,0,0
123444,blocker,0,0
123445,inhibition,0,1
123446,of,0,0
123447,AGE,0,0
123448,and,0,0
123449,RAGE,0,0
123450,axis,0,1
123451,limits,0,0
123452,renal,1,1
123453,injury,1,0
123454,in,0,0
123455,nondiabetic,0,0
123456,patients,0,0
123457,with,0,0
123458,stage,0,0
123459,I,0,0
123460,or,0,0
123461,II,0,0
123462,chronic,0,0
123463,kidney,0,0
123464,disease,0,0
123465,.,0,0
123466,BACKGROUND,0,0
123467,There,0,0
123468,is,0,0
123469,a,0,0
123470,growing,0,0
123471,body,0,1
123472,of,0,0
123473,evidence,0,0
123474,that,0,0
123475,advanced,0,0
123476,glycation,0,1
123477,end,0,0
123478,products,0,1
123479,(,0,0
123480,AGE,0,0
123481,),0,0
123482,and,0,0
123483,their,0,0
123484,receptor,0,1
123485,(,0,0
123486,RAGE,0,0
123487,),0,0
123488,system,0,0
123489,are,0,0
123490,implicated,0,0
123491,in,0,0
123492,chronic,0,0
123493,kidney,0,1
123494,disease,0,1
123495,(,0,0
123496,CKD,0,0
123497,),0,0
123498,.,0,0
123499,We,0,0
123500,have,0,0
123501,previously,0,0
123502,found,0,0
123503,that,0,0
123504,a,0,0
123505,long-acting,0,0
123506,calcium,0,0
123507,channel,0,0
123508,blocker,0,0
123509,",",0,1
123510,azelnidipine,0,0
123511,",",0,1
123512,but,0,0
123513,not,0,0
123514,amlodipine,0,0
123515,",",0,0
123516,improves,0,1
123517,renal,1,1
123518,injury,1,0
123519,in,0,0
123520,CKD,0,0
123521,patients,0,0
123522,.,0,0
123523,However,0,0
123524,",",0,0
123525,little,0,0
123526,is,0,0
123527,known,0,0
123528,about,0,0
123529,the,0,0
123530,effect,0,0
123531,of,0,0
123532,azelnidipine,0,0
123533,on,0,0
123534,the,0,0
123535,AGE-RAGE,1,0
123536,axis,1,0
123537,in,0,0
123538,humans,0,0
123539,.,0,0
123540,In,0,0
123541,this,0,0
123542,study,0,0
123543,",",0,0
123544,we,0,0
123545,examined,0,0
123546,whether,0,0
123547,azelnidipine,0,0
123548,addition,0,0
123549,could,0,0
123550,have,0,0
123551,renoprotective,1,0
123552,properties,1,1
123553,in,0,0
123554,hypertensive,0,0
123555,CKD,0,0
123556,patients,0,0
123557,by,0,0
123558,reducing,0,0
123559,serum,1,1
123560,levels,1,1
123561,of,1,0
123562,AGE,1,0
123563,and,1,0
123564,soluble,1,1
123565,form,1,0
123566,of,1,0
123567,RAGE,1,0
123568,(,1,0
123569,sRAGE,1,0
123570,),1,0
123571,.,1,0
123572,Thirty,0,0
123573,nondiabetic,0,0
123574,stage,0,0
123575,I,0,0
123576,or,0,0
123577,II,0,0
123578,CKD,0,0
123579,patients,0,0
123580,who,0,0
123581,had,0,0
123582,already,0,0
123583,been,0,0
123584,treated,0,0
123585,with,0,0
123586,angiotensin,0,0
123587,II,0,0
123588,receptor,0,1
123589,blockers,0,0
123590,were,0,0
123591,enrolled,0,0
123592,in,0,0
123593,this,0,0
123594,study,0,0
123595,.,0,0
123596,HYPOTHESIS,0,0
123597,We,0,0
123598,hypothesized,0,0
123599,that,0,0
123600,azelnidipine,0,0
123601,treatment,0,0
123602,could,0,0
123603,limit,0,0
123604,renal,0,1
123605,injury,0,0
123606,partly,0,0
123607,by,0,0
123608,blocking,0,0
123609,the,0,0
123610,AGE-RAGE,1,0
123611,axis,1,0
123612,.,1,0
123613,METHODS,0,0
123614,Patients,0,0
123615,were,0,0
123616,randomly,0,0
123617,divided,0,0
123618,into,0,0
123619,2,0,0
123620,groups,0,0
123621,;,0,0
123622,one,0,0
123623,group,0,0
123624,was,0,0
123625,treated,0,0
123626,with,0,0
123627,16,0,0
123628,mg,0,0
123629,azelnidipine,0,0
123630,and,0,0
123631,the,0,0
123632,other,0,0
123633,with,0,0
123634,5,0,0
123635,mg,0,0
123636,amlodipine,0,0
123637,once,0,0
123638,daily,0,0
123639,.,0,0
123640,They,0,0
123641,were,0,0
123642,followed,0,0
123643,up,0,0
123644,for,0,0
123645,6,0,0
123646,months,0,0
123647,.,0,0
123648,RESULTS,0,0
123649,Proteinuria,1,1
123650,was,0,0
123651,positively,0,0
123652,correlated,0,0
123653,with,0,0
123654,circulating,1,1
123655,AGE,1,0
123656,and,1,0
123657,sRAGE,1,0
123658,levels,1,1
123659,in,0,0
123660,our,0,0
123661,subjects,0,0
123662,.,0,0
123663,Both,0,0
123664,drugs,0,0
123665,exhibited,0,0
123666,comparable,0,0
123667,and,0,0
123668,significant,0,0
123669,blood,1,1
123670,pressure,1,1
123671,(,1,0
123672,BP,1,1
123673,),1,0
123674,-lowering,1,0
123675,effects,1,0
123676,.,1,0
123677,Although,0,0
123678,neither,0,0
123679,of,0,0
123680,them,0,0
123681,affected,0,0
123682,glucose,1,1
123683,",",1,1
123684,glycated,1,1
123685,hemoglobin,1,1
123686,",",1,0
123687,lipid,1,1
123688,levels,1,1
123689,",",1,0
123690,and,1,1
123691,estimated,1,0
123692,glomerular,1,1
123693,filtration,1,1
123694,rate,1,1
123695,",",1,0
123696,treatment,1,0
123697,with,1,0
123698,azelnidipine,1,0
123699,",",0,0
123700,but,0,0
123701,not,0,0
123702,amlodipine,0,0
123703,",",0,0
123704,decreased,0,0
123705,circulating,1,1
123706,AGE,1,0
123707,",",1,1
123708,sRAGE,1,1
123709,",",1,1
123710,proteinuria,1,1
123711,",",1,1
123712,and,1,1
123713,urinary,1,1
123714,levels,1,1
123715,of,1,0
123716,liver-type,1,0
123717,fatty,1,1
123718,acid,1,0
123719,binding,1,1
123720,protein,1,0
123721,",",0,0
123722,a,0,0
123723,marker,0,1
123724,of,0,0
123725,tubular,0,0
123726,injury,0,1
123727,",",0,0
123728,in,0,0
123729,a,0,0
123730,BP-lowering-independent,0,0
123731,manner,0,0
123732,.,0,0
123733,CONCLUSIONS,0,0
123734,Our,0,0
123735,present,0,0
123736,results,0,0
123737,suggest,0,0
123738,that,0,0
123739,azelnidipine,0,0
123740,may,0,0
123741,exert,0,0
123742,renoprotective,1,0
123743,properties,1,1
123744,in,0,0
123745,nondiabetic,0,0
123746,hypertensive,0,0
123747,CKD,0,0
123748,patients,0,0
123749,via,0,0
123750,its,0,0
123751,unique,0,0
123752,inhibitory,0,1
123753,effects,0,0
123754,on,0,0
123755,the,0,0
123756,AGE-RAGE,0,0
123757,axis,0,0
123758,.,0,0
123759,Specific,0,0
123760,exercises,0,0
123761,to,0,0
123762,treat,0,0
123763,pregnancy-related,0,1
123764,low,0,0
123765,back,0,0
123766,pain,0,1
123767,in,0,0
123768,a,0,0
123769,South,0,0
123770,African,0,0
123771,population,0,0
123772,.,0,0
123773,OBJECTIVE,0,0
123774,To,0,0
123775,investigate,0,0
123776,the,0,0
123777,effect,0,0
123778,of,0,0
123779,an,0,0
123780,exercise,0,0
123781,program,0,0
123782,",",0,0
123783,including,0,0
123784,specific,0,0
123785,stabilizing,0,1
123786,exercises,0,0
123787,",",0,0
123788,on,0,0
123789,pain,0,1
123790,intensity,0,1
123791,and,0,1
123792,functional,0,1
123793,ability,0,1
123794,in,0,0
123795,women,0,0
123796,with,0,0
123797,pregnancy-related,0,1
123798,low,0,0
123799,back,0,0
123800,pain,0,1
123801,.,0,0
123802,METHODS,0,0
123803,Fifty,0,0
123804,women,0,0
123805,between,0,0
123806,16,0,0
123807,and,0,0
123808,24,0,0
123809,weeks,0,0
123810,of,0,0
123811,pregnancy,0,1
123812,were,0,0
123813,recruited,0,0
123814,at,0,0
123815,Tygerberg,0,0
123816,and,0,0
123817,Paarl,0,1
123818,Hospitals,0,1
123819,",",0,0
123820,Western,0,0
123821,Cape,0,1
123822,",",0,0
123823,South,0,0
123824,Africa,0,0
123825,.,0,0
123826,Twenty-six,0,0
123827,women,0,0
123828,were,0,0
123829,randomized,0,0
123830,to,0,0
123831,a,0,0
123832,10-week,0,0
123833,exercise,0,0
123834,program,0,0
123835,and,0,0
123836,24,0,0
123837,were,0,0
123838,randomized,0,0
123839,as,0,0
123840,controls,0,0
123841,.,0,0
123842,RESULTS,0,0
123843,Overall,0,0
123844,",",0,0
123845,the,0,0
123846,most,0,0
123847,frequent,0,0
123848,type,0,0
123849,of,0,0
123850,back,0,0
123851,pain,0,1
123852,experienced,0,0
123853,was,0,0
123854,lumbar,1,0
123855,pain,1,1
123856,(,0,0
123857,36,0,0
123858,[,0,0
123859,72.0,0,0
123860,%,0,0
123861,],0,0
123862,),0,0
123863,.,0,0
123864,Pain,1,1
123865,intensity,1,1
123866,(,0,0
123867,P=0.76,0,0
123868,),0,0
123869,and,0,0
123870,functional,1,1
123871,ability,1,1
123872,(,0,0
123873,P=0.29,0,0
123874,),0,0
123875,were,0,0
123876,comparable,0,0
123877,between,0,0
123878,the,0,0
123879,groups,0,0
123880,on,0,0
123881,study,0,0
123882,entry,0,0
123883,.,0,0
123884,In,0,0
123885,the,0,0
123886,study,0,0
123887,group,0,0
123888,",",0,0
123889,there,0,0
123890,was,0,0
123891,a,0,0
123892,significant,0,0
123893,improvement,0,1
123894,in,0,0
123895,pain,1,1
123896,intensity,1,1
123897,(,0,0
123898,P,0,0
123899,<,0,0
123900,0.01,0,0
123901,),0,0
123902,and,0,0
123903,an,0,0
123904,improvement,0,1
123905,in,0,0
123906,functional,1,0
123907,ability,1,1
123908,(,0,0
123909,P=0.06,0,0
123910,),0,0
123911,at,0,0
123912,the,0,0
123913,end,0,0
123914,of,0,0
123915,the,0,0
123916,study,0,0
123917,.,0,0
123918,In,0,0
123919,the,0,0
123920,control,0,0
123921,group,0,0
123922,",",0,0
123923,there,0,0
123924,were,0,0
123925,no,0,0
123926,significant,0,0
123927,changes,0,1
123928,in,0,0
123929,pain,1,1
123930,intensity,1,1
123931,(,0,0
123932,P=0.89,0,0
123933,),0,0
123934,or,0,0
123935,functional,1,1
123936,ability,1,1
123937,(,0,0
123938,P=0.70,0,0
123939,),0,0
123940,at,0,0
123941,the,0,0
123942,end,0,0
123943,of,0,0
123944,the,0,0
123945,study,0,0
123946,.,0,0
123947,CONCLUSION,0,0
123948,A,0,0
123949,specific,0,0
123950,exercise,0,0
123951,program,0,0
123952,decreased,0,0
123953,back,0,0
123954,pain,0,1
123955,intensity,0,1
123956,and,0,0
123957,increased,0,0
123958,functional,0,0
123959,ability,0,1
123960,during,0,0
123961,pregnancy,0,1
123962,in,0,0
123963,South,0,0
123964,African,0,0
123965,women,0,0
123966,with,0,0
123967,lumbar,0,0
123968,and,0,0
123969,pelvic,0,0
123970,girdle,0,1
123971,pain,0,1
123972,.,0,0
123973,Influence,0,0
123974,of,0,0
123975,two,0,0
123976,different,0,0
123977,flap,0,0
123978,designs,0,0
123979,on,0,0
123980,the,0,0
123981,sequelae,0,1
123982,of,0,0
123983,mandibular,0,0
123984,third,0,0
123985,molar,0,0
123986,surgery,0,0
123987,.,0,0
123988,PURPOSE,0,0
123989,The,0,0
123990,aim,0,0
123991,of,0,0
123992,this,0,0
123993,study,0,0
123994,was,0,0
123995,to,0,0
123996,compare,0,0
123997,the,0,0
123998,influence,0,0
123999,of,0,0
124000,triangular,0,0
124001,and,0,1
124002,envelope,0,1
124003,flaps,0,1
124004,on,0,0
124005,trismus,1,1
124006,",",1,0
124007,pain,1,1
124008,",",1,1
124009,and,1,1
124010,facial,1,1
124011,swelling,1,1
124012,after,0,0
124013,mandibular,0,0
124014,third,0,0
124015,molar,0,0
124016,surgery,0,0
124017,.,0,0
124018,METHODS,0,0
124019,Twenty,0,0
124020,healthy,0,0
124021,patients,0,0
124022,with,0,0
124023,bilateral,0,0
124024,",",0,0
124025,symmetrically,0,1
124026,impacted,0,0
124027,mandibular,0,0
124028,third,0,0
124029,molars,0,0
124030,were,0,0
124031,included,0,0
124032,in,0,0
124033,this,0,0
124034,double-blinded,0,0
124035,",",0,0
124036,prospective,0,0
124037,",",0,0
124038,cross-over,0,0
124039,",",0,0
124040,randomized,0,0
124041,study,0,0
124042,.,0,0
124043,The,0,0
124044,patients,0,0
124045,were,0,0
124046,operated,0,0
124047,with,0,0
124048,envelope,0,0
124049,flap,0,0
124050,on,0,0
124051,one,0,0
124052,side,0,0
124053,and,0,0
124054,triangular,0,1
124055,flap,0,0
124056,on,0,0
124057,the,0,0
124058,other,0,0
124059,side,0,0
124060,.,0,0
124061,Trismus,1,1
124062,was,0,0
124063,determined,0,0
124064,by,0,0
124065,measuring,0,0
124066,maximum,0,1
124067,interincisal,0,1
124068,opening,0,1
124069,",",0,0
124070,and,0,1
124071,facial,1,1
124072,swelling,1,1
124073,was,0,0
124074,evaluated,0,0
124075,using,0,0
124076,a,0,0
124077,tape,0,0
124078,measuring,0,0
124079,method,0,0
124080,.,0,0
124081,Pain,1,1
124082,was,0,0
124083,determined,0,0
124084,using,0,0
124085,visual,0,1
124086,analog,0,1
124087,scale,0,1
124088,(,0,0
124089,VAS,0,1
124090,),0,0
124091,and,0,0
124092,recording,0,0
124093,the,0,0
124094,number,0,1
124095,of,0,0
124096,pain,0,1
124097,pills,0,0
124098,taken,0,0
124099,.,0,0
124100,RESULTS,0,0
124101,The,0,0
124102,facial,1,0
124103,swelling,1,1
124104,measurements,1,0
124105,and,1,1
124106,VAS,1,1
124107,scores,1,1
124108,were,0,0
124109,lower,0,0
124110,in,0,0
124111,the,0,0
124112,envelope,0,0
124113,flap,0,1
124114,group,0,0
124115,compared,0,0
124116,to,0,0
124117,the,0,0
124118,triangular,0,0
124119,flap,0,0
124120,group,0,0
124121,.,0,0
124122,There,0,0
124123,was,0,0
124124,no,0,0
124125,significant,0,0
124126,difference,0,0
124127,between,0,0
124128,the,0,0
124129,two,0,0
124130,flap,0,0
124131,designs,0,0
124132,in,0,0
124133,operation,1,0
124134,time,1,1
124135,",",1,0
124136,maximum,1,1
124137,interincisal,1,1
124138,opening,1,1
124139,",",1,0
124140,and,1,0
124141,the,1,0
124142,number,1,1
124143,of,1,0
124144,analgesics,1,0
124145,taken,1,0
124146,.,1,0
124147,CONCLUSION,0,0
124148,Envelope,0,0
124149,flap,0,0
124150,yields,0,0
124151,to,0,0
124152,less,0,0
124153,facial,1,1
124154,swelling,1,1
124155,and,0,0
124156,reduced,0,1
124157,VAS,1,1
124158,scores,1,1
124159,in,0,0
124160,comparison,0,0
124161,to,0,0
124162,triangular,0,0
124163,flap,0,0
124164,.,0,0
124165,There,0,0
124166,is,0,0
124167,no,0,0
124168,clinical,0,0
124169,difference,0,0
124170,in,0,0
124171,trismus,0,1
124172,between,0,0
124173,the,0,0
124174,two,0,0
124175,flap,0,0
124176,designs,0,0
124177,.,0,0
124178,Despite,0,0
124179,the,0,0
124180,higher,0,0
124181,VAS,0,1
124182,scores,0,1
124183,with,0,0
124184,triangular,0,0
124185,flap,0,0
124186,",",0,0
124187,no,0,0
124188,additional,0,0
124189,doses,0,0
124190,of,0,0
124191,analgesics,0,1
124192,were,0,0
124193,required,0,0
124194,in,0,0
124195,triangular,0,0
124196,flap,0,0
124197,.,0,0
124198,Effect,0,0
124199,of,0,0
124200,propranolol,0,0
124201,on,0,0
124202,word,0,1
124203,fluency,0,1
124204,in,0,0
124205,autism,0,0
124206,.,0,0
124207,OBJECTIVE,0,0
124208,AND,0,0
124209,BACKGROUND,0,0
124210,Autism,0,1
124211,is,0,0
124212,characterized,0,0
124213,by,0,0
124214,repetitive,0,1
124215,behaviors,0,1
124216,and,0,0
124217,impaired,0,1
124218,socialization,0,1
124219,and,0,0
124220,communication,0,1
124221,.,0,1
124222,Preliminary,0,0
124223,evidence,0,0
124224,showed,0,0
124225,possible,0,0
124226,language,0,1
124227,benefits,0,0
124228,in,0,0
124229,autism,0,0
124230,from,0,0
124231,the,0,0
124232,?-adrenergic,0,0
124233,antagonist,0,0
124234,propranolol,0,0
124235,.,0,0
124236,Earlier,0,0
124237,studies,0,0
124238,in,0,0
124239,other,0,0
124240,populations,0,0
124241,suggested,0,0
124242,propranolol,0,0
124243,might,0,0
124244,benefit,0,0
124245,performance,0,1
124246,on,0,0
124247,tasks,0,0
124248,involving,0,0
124249,a,0,0
124250,search,0,0
124251,of,0,0
124252,semantic,0,0
124253,and,0,0
124254,associative,0,1
124255,networks,0,0
124256,under,0,0
124257,certain,0,0
124258,conditions,0,0
124259,.,0,0
124260,Therefore,0,0
124261,",",0,0
124262,we,0,0
124263,wished,0,0
124264,to,0,0
124265,determine,0,0
124266,whether,0,0
124267,this,0,0
124268,benefit,0,0
124269,of,0,0
124270,propranolol,0,0
124271,includes,0,0
124272,an,0,0
124273,effect,0,0
124274,on,0,0
124275,semantic,0,0
124276,fluency,0,1
124277,in,0,0
124278,autism,0,0
124279,.,0,0
124280,METHODS,0,0
124281,A,0,0
124282,sample,0,0
124283,of,0,0
124284,14,0,0
124285,high-functioning,0,0
124286,adolescent,0,0
124287,and,0,1
124288,adult,0,0
124289,participants,0,0
124290,with,0,0
124291,autism,0,0
124292,and,0,0
124293,14,0,0
124294,matched,0,0
124295,controls,0,0
124296,were,0,0
124297,given,0,0
124298,letter,0,0
124299,and,0,0
124300,category,0,1
124301,word,0,1
124302,fluency,0,1
124303,tasks,0,0
124304,on,0,0
124305,2,0,0
124306,separate,0,0
124307,testing,0,0
124308,sessions,0,0
124309,;,0,0
124310,1,0,0
124311,test,0,0
124312,was,0,0
124313,given,0,0
124314,60,0,0
124315,minutes,0,0
124316,after,0,0
124317,the,0,0
124318,administration,0,0
124319,of,0,0
124320,40,0,0
124321,mg,0,0
124322,propranolol,0,0
124323,orally,0,0
124324,",",0,0
124325,and,0,0
124326,1,0,0
124327,test,0,0
124328,was,0,0
124329,given,0,0
124330,after,0,0
124331,placebo,0,0
124332,",",0,0
124333,administered,0,0
124334,in,0,0
124335,a,0,0
124336,double-blinded,0,0
124337,",",0,0
124338,counterbalanced,0,0
124339,manner,0,0
124340,.,0,0
124341,RESULTS,0,0
124342,Participants,0,0
124343,with,0,0
124344,autism,0,0
124345,were,0,0
124346,significantly,0,0
124347,impaired,0,0
124348,compared,0,0
124349,with,0,0
124350,controls,0,0
124351,on,0,0
124352,both,1,0
124353,fluency,1,1
124354,tasks,1,0
124355,.,1,0
124356,Propranolol,0,0
124357,significantly,0,0
124358,improved,1,0
124359,performance,1,1
124360,on,1,0
124361,category,1,1
124362,fluency,1,1
124363,",",1,0
124364,but,0,0
124365,not,1,0
124366,letter,1,0
124367,fluency,1,1
124368,among,0,0
124369,autism,0,0
124370,participants,0,0
124371,.,0,0
124372,No,1,0
124373,drug,1,0
124374,effect,1,0
124375,was,0,0
124376,observed,0,0
124377,among,0,0
124378,controls,0,0
124379,.,0,0
124380,Expected,0,0
124381,drug,0,0
124382,effects,0,1
124383,on,1,0
124384,heart,1,1
124385,rate,1,1
124386,and,1,1
124387,blood,1,1
124388,pressure,1,1
124389,were,0,0
124390,observed,0,0
124391,in,0,0
124392,both,0,0
124393,the,0,0
124394,groups,0,0
124395,.,0,0
124396,CONCLUSIONS,0,0
124397,Results,0,0
124398,are,0,0
124399,consistent,0,0
124400,with,0,0
124401,a,0,0
124402,selective,0,0
124403,beneficial,0,0
124404,effect,0,0
124405,of,0,0
124406,propranolol,0,0
124407,on,0,0
124408,flexibility,0,1
124409,of,0,0
124410,access,0,0
124411,to,0,0
124412,semantic,0,0
124413,and,0,0
124414,associative,0,1
124415,networks,0,0
124416,in,0,0
124417,autism,0,0
124418,",",0,0
124419,with,0,0
124420,no,0,0
124421,observed,0,0
124422,effect,0,0
124423,on,0,0
124424,phonological,0,0
124425,networks,0,0
124426,.,0,0
124427,Further,0,0
124428,study,0,0
124429,will,0,0
124430,be,0,0
124431,necessary,0,0
124432,to,0,0
124433,understand,0,0
124434,potential,0,0
124435,clinical,0,0
124436,implications,0,0
124437,of,0,0
124438,this,0,0
124439,finding,0,0
124440,.,0,0
124441,A,0,0
124442,randomized,0,0
124443,study,0,0
124444,on,0,0
124445,hormone-resistant,0,0
124446,prostatic,0,0
124447,cancer,0,0
124448,:,0,0
124449,estramustine,0,0
124450,phosphate,0,0
124451,versus,0,0
124452,low,0,0
124453,dose,0,0
124454,epirubicin,0,0
124455,with,0,0
124456,or,0,0
124457,without,0,0
124458,medroxyprogesterone,0,0
124459,acetate,0,0
124460,.,0,0
124461,A,0,0
124462,Norwegian,0,0
124463,multicenter,0,0
124464,study,0,0
124465,.,0,0
124466,A,0,0
124467,prospective,0,0
124468,randomized,0,0
124469,study,0,0
124470,has,0,0
124471,been,0,0
124472,carried,0,0
124473,out,0,0
124474,in,0,0
124475,order,0,0
124476,to,0,0
124477,compare,0,0
124478,three,0,0
124479,different,0,0
124480,treatment,0,0
124481,modalities,0,0
124482,for,0,0
124483,symptomatic,0,0
124484,metastatic,0,0
124485,hormone-resistant,0,0
124486,prostatic,0,0
124487,cancer,0,0
124488,.,0,0
124489,A,0,0
124490,total,0,0
124491,of,0,0
124492,79,0,0
124493,patients,0,0
124494,were,0,0
124495,included,0,0
124496,.,0,0
124497,One,0,0
124498,group,0,0
124499,was,0,0
124500,treated,0,0
124501,with,0,0
124502,estramustine,0,0
124503,phosphate,0,0
124504,",",0,0
124505,another,0,0
124506,with,0,0
124507,Epirubicin,0,0
124508,plus,0,0
124509,Medroxyprogesterone,0,0
124510,acetate,0,0
124511,(,0,0
124512,MPA,0,1
124513,),0,0
124514,",",0,0
124515,while,0,0
124516,the,0,0
124517,third,0,0
124518,arm,0,0
124519,consisted,0,0
124520,of,0,0
124521,Epirubicin,0,0
124522,plus,0,0
124523,placebo,0,0
124524,.,0,0
124525,Best,1,0
124526,palliation,1,0
124527,was,0,0
124528,obtained,0,0
124529,by,0,0
124530,the,0,0
124531,combination,0,0
124532,of,0,0
124533,Epirubicin,0,0
124534,and,0,0
124535,MPA,0,0
124536,.,0,0
124537,This,0,0
124538,combination,0,0
124539,also,0,0
124540,seemed,0,0
124541,to,0,0
124542,be,0,0
124543,associated,0,0
124544,with,0,0
124545,the,0,0
124546,longest,0,1
124547,response,0,1
124548,duration,0,1
124549,.,0,0
124550,A,0,0
124551,randomized,0,0
124552,placebo-controlled,0,0
124553,prevention,0,0
124554,trial,0,0
124555,of,0,1
124556,aspirin,0,0
124557,and/or,0,0
124558,resistant,0,1
124559,starch,0,0
124560,in,0,0
124561,young,0,0
124562,people,0,0
124563,with,0,0
124564,familial,1,1
124565,adenomatous,1,0
124566,polyposis,1,0
124567,.,1,0
124568,Evidence,0,1
124569,supporting,0,0
124570,aspirin,0,0
124571,and,0,0
124572,resistant,0,1
124573,starch,0,0
124574,(,0,0
124575,RS,0,1
124576,),0,0
124577,for,0,0
124578,colorectal,0,0
124579,cancer,0,0
124580,prevention,0,0
124581,comes,0,0
124582,from,0,0
124583,epidemiologic,0,0
124584,and,0,0
124585,laboratory,0,1
124586,studies,0,0
124587,(,0,0
124588,aspirin,0,0
124589,and,0,1
124590,RS,0,1
124591,),0,1
124592,and,0,0
124593,randomized,0,0
124594,controlled,0,0
124595,clinical,0,0
124596,trials,0,0
124597,(,0,0
124598,aspirin,0,0
124599,),0,0
124600,.,0,0
124601,Familial,0,0
124602,adenomatous,0,1
124603,polyposis,0,1
124604,(,0,0
124605,FAP,0,0
124606,),0,0
124607,strikes,0,0
124608,young,0,0
124609,people,0,0
124610,and,0,0
124611,",",0,1
124612,untreated,0,0
124613,",",0,0
124614,confers,0,0
124615,virtually,0,0
124616,a,0,0
124617,100,0,0
124618,%,0,0
124619,risk,0,0
124620,of,0,0
124621,colorectal,0,0
124622,cancer,0,0
124623,and,0,0
124624,early,0,0
124625,death,0,1
124626,.,0,0
124627,We,0,0
124628,conducted,0,0
124629,an,0,0
124630,international,0,0
124631,",",0,0
124632,multicenter,0,0
124633,",",0,1
124634,randomized,0,0
124635,",",0,0
124636,placebo-controlled,0,0
124637,trial,0,0
124638,of,0,0
124639,aspirin,0,0
124640,(,0,0
124641,600,0,0
124642,mg/d,0,0
124643,),0,0
124644,and/or,0,0
124645,RS,0,1
124646,(,0,0
124647,30,0,0
124648,g/d,0,0
124649,),0,0
124650,for,0,0
124651,from,0,0
124652,1,0,0
124653,to,0,0
124654,12,0,0
124655,years,0,0
124656,to,0,0
124657,prevent,0,0
124658,disease,0,1
124659,progression,0,1
124660,in,0,0
124661,FAP,0,1
124662,patients,0,0
124663,from,0,0
124664,10,0,0
124665,to,0,0
124666,21,0,0
124667,years,0,0
124668,of,0,0
124669,age,0,0
124670,.,0,0
124671,In,0,0
124672,a,0,0
124673,2,0,0
124674,?,0,0
124675,2,0,0
124676,factorial,0,0
124677,design,0,0
124678,",",0,0
124679,patients,0,0
124680,were,0,0
124681,randomly,0,0
124682,assigned,0,0
124683,to,0,0
124684,the,0,0
124685,following,0,0
124686,four,0,0
124687,study,0,0
124688,arms,0,0
124689,:,0,0
124690,aspirin,0,0
124691,plus,0,0
124692,RS,0,1
124693,placebo,0,0
124694,;,0,0
124695,RS,0,1
124696,plus,0,0
124697,aspirin,0,0
124698,placebo,0,0
124699,;,0,0
124700,aspirin,0,0
124701,plus,0,0
124702,RS,0,1
124703,;,0,0
124704,RS,0,1
124705,placebo,0,0
124706,plus,0,0
124707,aspirin,0,0
124708,placebo,0,0
124709,;,0,0
124710,they,0,0
124711,were,0,0
124712,followed,0,0
124713,with,0,0
124714,standard,0,0
124715,annual,0,0
124716,clinical,0,0
124717,examinations,0,0
124718,including,0,0
124719,endoscopy,0,0
124720,.,0,0
124721,The,1,0
124722,primary,1,0
124723,endpoint,1,1
124724,was,1,0
124725,polyp,1,1
124726,number,1,1
124727,in,1,0
124728,the,1,0
124729,rectum,1,1
124730,and,1,0
124731,sigmoid,1,1
124732,colon,1,1
124733,(,1,0
124734,at,1,0
124735,the,1,0
124736,end,1,0
124737,of,1,0
124738,intervention,1,0
124739,),1,0
124740,",",1,0
124741,and,1,0
124742,the,1,0
124743,major,1,0
124744,secondary,1,0
124745,endpoint,1,1
124746,was,1,0
124747,size,1,1
124748,of,1,0
124749,the,1,0
124750,largest,1,0
124751,polyp,1,0
124752,.,1,0
124753,A,0,0
124754,total,0,0
124755,of,0,0
124756,206,0,0
124757,randomized,0,0
124758,FAP,0,0
124759,patients,0,0
124760,commenced,0,0
124761,intervention,0,0
124762,",",0,0
124763,of,0,0
124764,whom,0,0
124765,133,0,0
124766,had,0,0
124767,at,0,0
124768,least,0,0
124769,one,0,0
124770,follow-up,0,0
124771,endoscopy,0,0
124772,and,0,0
124773,were,0,0
124774,therefore,0,0
124775,included,0,0
124776,in,0,0
124777,the,0,0
124778,primary,0,0
124779,analysis,0,0
124780,.,0,0
124781,Neither,0,0
124782,intervention,0,0
124783,significantly,0,0
124784,reduced,1,0
124785,polyp,1,0
124786,count,1,1
124787,in,1,0
124788,the,1,0
124789,rectum,1,1
124790,and,1,0
124791,sigmoid,1,0
124792,colon,1,0
124793,:,1,0
124794,aspirin,0,0
124795,relative,0,0
124796,risk,0,0
124797,=,0,0
124798,0.77,0,0
124799,(,0,0
124800,95,0,0
124801,%,0,0
124802,CI,0,0
124803,",",0,0
124804,0.54-1.10,0,0
124805,;,0,0
124806,versus,0,0
124807,nonaspirin,0,0
124808,arms,0,0
124809,),0,0
124810,;,0,0
124811,RS,0,0
124812,relative,0,0
124813,risk,0,0
124814,=,0,0
124815,1.05,0,0
124816,(,0,0
124817,95,0,0
124818,%,0,0
124819,CI,0,0
124820,",",0,0
124821,0.73-1.49,0,0
124822,;,0,0
124823,versus,0,0
124824,non-RS,0,0
124825,arms,0,0
124826,),0,0
124827,.,0,0
124828,There,0,0
124829,was,0,0
124830,a,0,0
124831,trend,0,0
124832,toward,0,0
124833,a,0,0
124834,smaller,0,0
124835,size,0,1
124836,of,0,1
124837,largest,0,0
124838,polyp,0,1
124839,in,0,0
124840,patients,0,0
124841,treated,0,0
124842,with,0,0
124843,aspirin,0,0
124844,versus,0,0
124845,nonaspirin,0,0
124846,--,0,0
124847,mean,0,0
124848,3.8,0,0
124849,mm,0,0
124850,versus,0,0
124851,5.5,0,0
124852,mm,0,0
124853,for,0,0
124854,patients,0,0
124855,treated,0,0
124856,1,0,0
124857,or,0,0
124858,more,0,0
124859,years,0,0
124860,(,0,0
124861,adjusted,0,0
124862,P,0,0
124863,=,0,0
124864,0.09,0,0
124865,),0,0
124866,and,0,0
124867,mean,0,0
124868,3.0,0,0
124869,mm,0,0
124870,versus,0,0
124871,6.0,0,0
124872,mm,0,0
124873,for,0,0
124874,patients,0,0
124875,treated,0,0
124876,more,0,0
124877,than,0,0
124878,1,0,0
124879,year,0,0
124880,(,0,0
124881,P,0,0
124882,=,0,0
124883,0.02,0,0
124884,),0,0
124885,;,0,0
124886,there,0,0
124887,were,0,0
124888,similar,0,0
124889,weaker,0,0
124890,trends,0,0
124891,with,0,0
124892,RS,0,0
124893,versus,0,0
124894,non-RS,0,0
124895,.,0,0
124896,Exploratory,0,0
124897,translational,0,0
124898,endpoints,0,1
124899,included,0,0
124900,crypt,0,1
124901,length,0,1
124902,(,0,0
124903,which,0,0
124904,was,0,0
124905,significantly,0,0
124906,shorter,0,0
124907,in,0,0
124908,normal-appearing,0,1
124909,mucosa,0,0
124910,in,0,0
124911,the,0,0
124912,RS,0,0
124913,group,0,0
124914,over,0,0
124915,time,0,1
124916,),0,0
124917,and,0,0
124918,laboratory,0,0
124919,measures,0,1
124920,of,0,0
124921,proliferation,0,1
124922,(,0,0
124923,including,0,0
124924,Ki67,0,1
124925,),0,0
124926,.,0,0
124927,This,0,0
124928,clinical,0,0
124929,trial,0,0
124930,is,0,0
124931,the,0,0
124932,largest,0,0
124933,ever,0,0
124934,conducted,0,0
124935,in,0,0
124936,the,0,0
124937,setting,0,0
124938,of,0,0
124939,FAP,0,1
124940,and,0,0
124941,found,0,0
124942,a,0,0
124943,trend,0,0
124944,of,0,0
124945,reduced,1,1
124946,polyp,1,1
124947,load,1,1
124948,(,0,0
124949,number,0,1
124950,and,0,1
124951,size,0,1
124952,),0,0
124953,with,0,0
124954,600,0,0
124955,mg,0,0
124956,of,0,0
124957,aspirin,0,0
124958,daily,0,0
124959,.,0,0
124960,RS,0,0
124961,had,0,0
124962,no,0,0
124963,clinical,0,0
124964,effect,0,0
124965,on,1,0
124966,adenomas,1,0
124967,.,1,0
124968,Comparison,0,0
124969,of,0,0
124970,the,0,0
124971,evolutional,1,0
124972,process,1,0
124973,of,0,0
124974,children,0,0
124975,with,0,0
124976,autism,0,0
124977,spectrum,0,0
124978,disorders,0,0
124979,in,0,0
124980,different,0,0
124981,language,0,1
124982,therapeutic,0,0
124983,interventions,0,0
124984,.,0,0
124985,PURPOSE,0,0
124986,To,0,0
124987,analyze,0,0
124988,and,0,0
124989,compare,0,0
124990,the,1,0
124991,extension,1,0
124992,and,1,0
124993,the,1,0
124994,speed,1,1
124995,of,1,0
124996,the,1,0
124997,evolutional,1,0
124998,process,1,0
124999,of,0,0
125000,children,0,0
125001,with,0,0
125002,Autism,0,1
125003,Spectrum,0,0
125004,Disorders,0,0
125005,in,0,0
125006,direct,0,0
125007,and,0,0
125008,indirect,0,0
125009,interventions,0,0
125010,as,0,0
125011,opposed,0,0
125012,to,0,0
125013,only,0,0
125014,indirect,0,0
125015,intervention,0,0
125016,.,0,0
125017,METHODS,0,0
125018,The,0,0
125019,design,0,0
125020,of,0,0
125021,this,0,0
125022,study,0,0
125023,is,0,0
125024,a,0,0
125025,clinical,0,0
125026,trial,0,0
125027,.,0,0
125028,The,0,0
125029,sample,0,0
125030,was,0,0
125031,composed,0,0
125032,of,0,0
125033,11,0,0
125034,children,0,0
125035,diagnosed,0,0
125036,with,0,0
125037,Autism,0,1
125038,(,0,0
125039,n=6,0,0
125040,),0,1
125041,and,0,0
125042,Asperger,0,0
125043,syndrome,0,0
125044,(,0,0
125045,n=5,0,0
125046,),0,0
125047,by,0,0
125048,a,0,0
125049,multidisciplinary,0,0
125050,team,0,0
125051,",",0,0
125052,that,0,0
125053,attended,0,0
125054,specialized,0,0
125055,speech-language,0,0
125056,pathology,0,1
125057,therapy,0,0
125058,at,0,0
125059,the,0,0
125060,institution,0,0
125061,were,0,0
125062,the,0,0
125063,study,0,0
125064,was,0,0
125065,carried,0,0
125066,out,0,0
125067,.,0,0
125068,These,0,0
125069,children,0,0
125070,were,0,0
125071,randomly,0,0
125072,divided,0,0
125073,into,0,0
125074,two,0,0
125075,groups,0,0
125076,:,0,0
125077,Therapy,0,0
125078,Group,0,0
125079,(,0,0
125080,TG,0,0
125081,),0,0
125082,-,0,0
125083,composed,0,0
125084,by,0,0
125085,six,0,0
125086,subjects,0,0
125087,receiving,0,0
125088,both,0,0
125089,direct,0,0
125090,and,0,0
125091,indirect,0,0
125092,intervention,0,0
125093,;,0,0
125094,and,0,0
125095,Orientation,0,1
125096,Group,0,0
125097,(,0,0
125098,OG,0,1
125099,),0,0
125100,-,0,0
125101,constituted,0,0
125102,by,0,0
125103,five,0,0
125104,subjects,0,0
125105,receiving,0,0
125106,exclusively,0,0
125107,indirect,0,0
125108,intervention,0,0
125109,.,0,0
125110,It,0,0
125111,was,0,0
125112,used,0,0
125113,the,0,0
125114,Autism,1,0
125115,Behavior,1,1
125116,Checklist,1,1
125117,(,1,0
125118,ABC,1,1
125119,),1,0
125120,to,0,0
125121,interview,0,0
125122,the,0,0
125123,mothers,0,0
125124,",",0,0
125125,and,0,0
125126,the,0,0
125127,Sample,1,0
125128,of,1,0
125129,Vocal,1,0
125130,Behavior,1,1
125131,(,1,0
125132,SVB,1,0
125133,),1,0
125134,",",0,0
125135,in,0,0
125136,three,0,0
125137,occasions,0,0
125138,:,0,0
125139,at,0,0
125140,the,0,0
125141,beginning,0,0
125142,of,0,0
125143,the,0,0
125144,intervention,0,0
125145,process,0,0
125146,(,0,0
125147,time,0,1
125148,0,0,0
125149,),0,0
125150,",",0,0
125151,six,0,0
125152,months,0,0
125153,later,0,0
125154,(,0,0
125155,time,0,1
125156,1,0,0
125157,),0,0
125158,and,0,0
125159,12,0,0
125160,months,0,0
125161,later,0,0
125162,(,0,0
125163,time,0,1
125164,2,0,0
125165,),0,0
125166,.,0,0
125167,RESULTS,0,0
125168,It,0,0
125169,was,0,0
125170,observed,0,0
125171,greater,0,0
125172,speed,1,1
125173,and,1,1
125174,extension,1,1
125175,in,1,0
125176,the,1,0
125177,evolutional,1,0
125178,process,1,0
125179,of,0,0
125180,the,0,0
125181,TG,0,0
125182,Group,0,0
125183,",",0,0
125184,both,0,0
125185,in,0,0
125186,the,0,0
125187,analysis,0,0
125188,of,0,0
125189,the,0,0
125190,Autism,1,1
125191,Behavior,1,1
125192,Checklist,1,1
125193,(,1,0
125194,total,1,1
125195,and,1,0
125196,partial,1,1
125197,scores,1,1
125198,),1,0
125199,and,0,0
125200,the,0,0
125201,Sample,1,0
125202,of,1,0
125203,Vocal,1,0
125204,Behavior,1,1
125205,",",0,0
125206,especially,0,0
125207,in,0,0
125208,the,0,0
125209,item,0,0
125210,Full,0,0
125211,Language,0,0
125212,.,0,0
125213,The,0,0
125214,performance,0,1
125215,of,0,0
125216,children,0,0
125217,with,0,0
125218,Asperger,0,0
125219,syndrome,0,0
125220,was,0,0
125221,considered,0,0
125222,more,0,0
125223,positive,0,0
125224,when,0,0
125225,compared,0,0
125226,to,0,0
125227,that,0,0
125228,of,0,0
125229,children,0,0
125230,with,0,0
125231,autism,0,0
125232,.,0,0
125233,There,0,0
125234,was,0,0
125235,greater,0,0
125236,evolution,1,1
125237,in,0,0
125238,younger,0,0
125239,children,0,0
125240,and,0,1
125241,with,0,0
125242,normal,0,0
125243,",",0,0
125244,mild,0,1
125245,",",0,0
125246,and,0,1
125247,moderate,0,0
125248,adaptive,1,1
125249,functioning,1,1
125250,.,1,0
125251,CONCLUSION,0,0
125252,The,0,0
125253,tendency,0,0
125254,towards,0,0
125255,better,0,0
125256,performance,1,1
125257,of,0,0
125258,the,0,0
125259,children,0,0
125260,attending,0,0
125261,direct,0,0
125262,and,0,0
125263,indirect,0,1
125264,intervention,0,0
125265,showed,0,0
125266,that,0,0
125267,this,0,0
125268,association,0,0
125269,is,0,0
125270,fundamental,0,0
125271,in,0,0
125272,the,0,0
125273,therapeutic,0,0
125274,process,0,0
125275,of,0,0
125276,children,0,0
125277,with,0,0
125278,Autism,0,1
125279,Spectrum,0,0
125280,Disorders,0,0
125281,.,0,0
125282,On,0,0
125283,the,0,0
125284,benign,0,0
125285,qualities,0,1
125286,of,0,0
125287,behavioral,0,1
125288,disinhibition,0,1
125289,:,0,0
125290,because,0,0
125291,of,0,0
125292,the,0,0
125293,prosocial,0,1
125294,nature,0,0
125295,of,0,0
125296,people,0,0
125297,",",0,0
125298,behavioral,0,1
125299,disinhibition,0,0
125300,can,0,0
125301,weaken,0,0
125302,pleasure,0,1
125303,with,0,0
125304,getting,0,0
125305,more,0,0
125306,than,0,0
125307,you,0,0
125308,deserve,0,0
125309,.,0,0
125310,This,0,0
125311,article,0,0
125312,focuses,0,0
125313,on,0,0
125314,social,0,1
125315,situations,0,0
125316,in,0,0
125317,which,0,0
125318,people,0,0
125319,are,0,0
125320,surprised,0,0
125321,about,0,0
125322,what,0,0
125323,is,0,0
125324,happening,0,0
125325,and,0,0
125326,inhibited,0,0
125327,about,0,0
125328,how,0,0
125329,to,0,0
125330,respond,0,0
125331,to,0,0
125332,the,0,0
125333,situation,0,0
125334,at,0,0
125335,hand,0,0
125336,.,0,0
125337,We,0,0
125338,study,0,0
125339,these,0,0
125340,situations,0,0
125341,by,0,0
125342,examining,0,0
125343,a,0,0
125344,classic,0,0
125345,topic,0,0
125346,in,0,0
125347,social,0,1
125348,psychology,0,0
125349,:,0,0
125350,how,0,0
125351,people,0,0
125352,respond,0,0
125353,to,0,0
125354,receiving,0,0
125355,better,0,0
125356,outcomes,0,0
125357,than,0,0
125358,are,0,0
125359,deserved,0,0
125360,.,0,0
125361,In,0,0
125362,these,0,0
125363,situations,0,0
125364,",",0,0
125365,the,0,0
125366,actions,0,1
125367,of,0,0
125368,an,0,0
125369,authority,0,0
125370,or,0,0
125371,a,0,0
125372,coworker,0,1
125373,push,0,0
125374,in,0,0
125375,the,0,0
125376,direction,0,0
125377,of,0,0
125378,accepting,0,0
125379,and,0,0
125380,enjoying,0,1
125381,the,0,0
125382,unfair,0,0
125383,outcome,0,1
125384,",",0,0
125385,whereas,0,0
125386,personal,0,1
125387,values,0,1
125388,for,0,0
125389,most,0,0
125390,people,0,0
125391,push,0,0
125392,in,0,0
125393,the,0,0
125394,direction,0,0
125395,of,0,0
125396,rejecting,0,0
125397,or,0,0
125398,being,0,0
125399,displeased,0,0
125400,with,0,0
125401,the,0,0
125402,outcome,0,0
125403,.,0,0
125404,This,0,0
125405,conflict,0,0
125406,may,0,0
125407,inhibit,0,0
125408,people,0,0
125409,'s,0,0
125410,response,0,1
125411,to,0,0
125412,the,0,0
125413,advantageous,0,0
125414,but,0,0
125415,unfair,0,0
125416,outcomes,0,1
125417,.,0,0
125418,If,0,0
125419,people,0,0
125420,are,0,0
125421,indeed,0,0
125422,inhibited,0,0
125423,about,0,0
125424,how,0,0
125425,to,0,0
125426,respond,0,0
125427,to,0,0
125428,these,0,0
125429,kinds,0,0
125430,of,0,0
125431,outcomes,0,1
125432,",",0,0
125433,then,0,0
125434,lowering,0,0
125435,behavioral,0,1
125436,inhibition,0,1
125437,by,0,0
125438,reminding,0,0
125439,people,0,0
125440,of,0,0
125441,having,0,0
125442,acted,0,0
125443,in,0,0
125444,the,0,0
125445,past,0,0
125446,without,0,0
125447,inhibitions,0,1
125448,(,0,0
125449,in,0,0
125450,a,0,0
125451,manner,0,0
125452,that,0,0
125453,is,0,0
125454,unrelated,0,0
125455,to,0,0
125456,the,0,0
125457,outcomes,0,0
125458,participants,0,0
125459,subsequently,0,0
125460,receive,0,0
125461,),0,0
125462,should,0,0
125463,affect,0,0
125464,reactions,0,1
125465,to,0,0
125466,the,0,0
125467,outcomes,0,0
125468,.,0,0
125469,Specifically,0,0
125470,",",0,0
125471,we,0,0
125472,hypothesize,0,0
125473,that,0,0
125474,because,0,0
125475,many,0,0
125476,people,0,0
125477,are,0,0
125478,prosocial,0,1
125479,and,0,0
125480,want,0,0
125481,to,0,0
125482,adhere,0,0
125483,to,0,0
125484,principles,0,0
125485,of,0,0
125486,fairness,0,1
125487,",",0,0
125488,reminders,0,0
125489,of,0,1
125490,behavioral,0,0
125491,disinhibition,0,0
125492,will,0,0
125493,lead,0,0
125494,to,0,0
125495,less,0,0
125496,pleasure,0,1
125497,with,0,0
125498,the,0,0
125499,unfairly,0,0
125500,obtained,0,0
125501,outcomes,0,0
125502,.,0,0
125503,The,0,0
125504,results,0,0
125505,of,0,0
125506,8,0,0
125507,experiments,0,0
125508,(,0,0
125509,conducted,0,0
125510,both,0,0
125511,inside,0,0
125512,and,0,0
125513,outside,0,0
125514,the,0,0
125515,psychology,0,0
125516,laboratory,0,0
125517,),0,0
125518,revealed,0,0
125519,evidence,0,0
125520,for,0,0
125521,this,0,0
125522,benign,0,0
125523,disinhibition,0,1
125524,effect,0,0
125525,on,0,0
125526,various,0,0
125527,reactions,0,1
125528,to,0,0
125529,outcomes,0,0
125530,that,0,0
125531,are,0,0
125532,better,0,0
125533,than,0,0
125534,deserved,0,0
125535,.,0,0
125536,In,0,0
125537,further,0,0
125538,accordance,0,0
125539,with,0,0
125540,our,0,0
125541,line,0,0
125542,of,0,0
125543,reasoning,0,1
125544,",",0,0
125545,the,0,0
125546,effect,0,0
125547,is,0,0
125548,particularly,0,0
125549,pronounced,0,0
125550,among,0,0
125551,those,0,0
125552,who,0,0
125553,adhere,0,0
125554,to,0,0
125555,a,0,0
125556,prosocial,0,1
125557,orientation,0,0
125558,or,0,0
125559,who,0,0
125560,have,0,0
125561,adopted,0,0
125562,a,0,0
125563,prosocial,0,1
125564,mindset,0,0
125565,and,0,0
125566,is,0,0
125567,not,0,0
125568,observed,0,0
125569,among,0,0
125570,those,0,0
125571,with,0,0
125572,proself,0,0
125573,orientations,0,1
125574,or,0,0
125575,mindsets,0,0
125576,.,0,0
125577,Poor,0,0
125578,self-rated,0,1
125579,health,0,0
125580,is,0,0
125581,not,0,0
125582,associated,0,0
125583,with,0,0
125584,a,0,0
125585,high,0,0
125586,total,0,1
125587,allostatic,0,1
125588,load,0,1
125589,in,0,0
125590,type,0,0
125591,2,0,0
125592,diabetic,0,0
125593,patients,0,0
125594,--,0,0
125595,but,0,0
125596,high,0,0
125597,blood,0,1
125598,pressure,0,1
125599,is,0,0
125600,.,0,0
125601,OBJECTIVE,0,0
125602,Allostatic,0,1
125603,load,0,1
125604,has,0,0
125605,been,0,0
125606,linked,0,0
125607,to,0,0
125608,self-rated,0,1
125609,health,0,1
125610,(,0,0
125611,SRH,0,0
125612,),0,0
125613,",",0,0
125614,cardiovascular,0,1
125615,disease,0,1
125616,and,0,1
125617,mortality,0,1
125618,in,0,0
125619,non-diabetic,0,0
125620,individuals,0,0
125621,.,0,0
125622,The,0,0
125623,aim,0,0
125624,of,0,0
125625,this,0,0
125626,study,0,0
125627,was,0,0
125628,to,0,0
125629,construct,0,0
125630,an,0,0
125631,allostatic,0,1
125632,load,0,1
125633,score,0,1
125634,and,0,0
125635,to,0,0
125636,find,0,0
125637,any,0,0
125638,correlations,0,0
125639,with,0,0
125640,SRH,0,0
125641,.,0,0
125642,METHODS,0,0
125643,The,0,0
125644,subjects,0,0
125645,included,0,0
125646,in,0,0
125647,the,0,0
125648,study,0,0
125649,came,0,0
125650,from,0,0
125651,a,0,0
125652,randomized,0,0
125653,",",0,0
125654,controlled,0,0
125655,trial,0,0
125656,of,0,0
125657,type,0,0
125658,2,0,0
125659,diabetes,0,0
125660,.,0,0
125661,Blood,0,1
125662,samples,0,0
125663,were,0,0
125664,drawn,0,0
125665,",",0,0
125666,urine,0,1
125667,was,0,0
125668,collected,0,0
125669,for,0,0
125670,24h,0,0
125671,",",0,0
125672,and,0,0
125673,questionnaires,0,1
125674,",",0,0
125675,including,0,0
125676,SRH,0,0
125677,",",0,0
125678,were,0,0
125679,filled,0,0
125680,out,0,0
125681,on,0,0
125682,three,0,0
125683,occasions,0,0
125684,:,0,0
125685,at,0,0
125686,baseline,0,0
125687,;,0,0
125688,after,0,0
125689,the,0,0
125690,10-week,0,0
125691,intervention,0,0
125692,;,0,0
125693,and,0,0
125694,at,0,0
125695,a,0,0
125696,follow-up,0,0
125697,3,0,0
125698,months,0,0
125699,after,0,0
125700,the,0,0
125701,intervention,0,0
125702,.,0,0
125703,Allostatic,0,1
125704,load,0,1
125705,was,0,0
125706,estimated,0,0
125707,using,0,0
125708,a,0,0
125709,wide,0,0
125710,range,0,0
125711,of,0,0
125712,variables,0,1
125713,",",0,0
125714,including,0,0
125715,systolic,1,1
125716,and,1,0
125717,diastolic,1,1
125718,blood,1,1
125719,pressure,1,1
125720,",",1,0
125721,pulse,1,1
125722,pressure,1,1
125723,",",1,0
125724,cortisol,1,1
125725,",",1,1
125726,catecholamines,1,1
125727,",",1,1
125728,HbA,1,1
125729,(,1,0
125730,1c,1,1
125731,),1,0
125732,",",1,0
125733,insulin,1,1
125734,",",1,0
125735,plasma,1,1
125736,glucose,1,1
125737,and,1,0
125738,waist,1,1
125739,circumference,1,1
125740,.,1,0
125741,RESULTS,0,0
125742,There,0,0
125743,was,0,0
125744,no,0,0
125745,association,0,0
125746,between,0,0
125747,SRH,0,0
125748,and,0,0
125749,allostatic,0,1
125750,load,0,1
125751,.,0,0
125752,However,0,0
125753,",",0,0
125754,three,0,0
125755,other,0,0
125756,components,0,0
125757,were,0,0
125758,significantly,0,0
125759,correlated,0,0
125760,with,0,0
125761,allostatic,0,1
125762,load,0,1
125763,at,0,0
125764,the,0,0
125765,baseline,0,0
125766,investigation,0,0
125767,and,0,0
125768,the,0,0
125769,two,0,0
125770,follow-up,0,0
125771,investigations,0,0
125772,-,0,0
125773,namely,0,0
125774,",",0,0
125775,systolic,1,1
125776,blood,1,1
125777,pressure,1,1
125778,",",1,0
125779,diastolic,1,1
125780,blood,1,1
125781,pressure,1,1
125782,and,1,1
125783,HbA,1,1
125784,(,1,0
125785,1c,1,0
125786,),1,0
125787,.,1,0
125788,CONCLUSION,0,0
125789,The,0,0
125790,absence,0,0
125791,of,0,0
125792,an,0,0
125793,association,0,0
125794,between,0,0
125795,allostatic,0,1
125796,load,0,1
125797,and,0,0
125798,SRH,1,0
125799,in,0,0
125800,diabetic,0,0
125801,individuals,0,0
125802,contrasts,0,0
125803,with,0,0
125804,previous,0,0
125805,findings,0,0
125806,in,0,0
125807,non-diabetic,0,0
125808,women,0,0
125809,",",0,0
125810,and,0,0
125811,shows,0,0
125812,that,0,0
125813,it,0,0
125814,is,0,0
125815,hazardous,0,0
125816,to,0,0
125817,apply,0,0
125818,findings,0,0
125819,in,0,0
125820,one,0,0
125821,population,0,0
125822,to,0,0
125823,another,0,0
125824,",",0,0
125825,especially,0,0
125826,diabetic,0,0
125827,and,0,0
125828,non-diabetic,0,0
125829,populations,0,0
125830,.,0,0
125831,Effectiveness,0,1
125832,of,0,0
125833,a,0,0
125834,short-term,0,0
125835,treatment,0,0
125836,with,0,0
125837,progesterone,0,1
125838,injections,0,0
125839,on,0,0
125840,synchrony,0,1
125841,of,0,0
125842,lambing,0,0
125843,and,0,1
125844,fertility,0,1
125845,in,0,0
125846,tropical,0,0
125847,hair,0,1
125848,sheep,0,0
125849,.,0,0
125850,The,0,0
125851,efficacy,0,1
125852,of,0,0
125853,using,0,0
125854,a,0,0
125855,low,0,0
125856,cost,0,1
125857,system,0,0
125858,for,0,0
125859,delivering,0,0
125860,progesterone,0,1
125861,as,0,0
125862,part,0,0
125863,of,0,0
125864,an,0,0
125865,estrous,0,0
125866,synchronization,0,1
125867,protocol,0,0
125868,in,0,0
125869,sheep,0,0
125870,was,0,0
125871,evaluated,0,0
125872,.,0,0
125873,In,0,0
125874,experiment,0,0
125875,1,0,0
125876,",",0,0
125877,Barbados,0,0
125878,Black,0,0
125879,Belly,0,0
125880,ewes,0,0
125881,(,0,0
125882,n=34,0,0
125883,),0,1
125884,and,0,0
125885,ewe,0,1
125886,lambs,0,0
125887,(,0,0
125888,n=35,0,0
125889,;,0,0
125890,37.5?0.9,0,0
125891,kg,0,0
125892,),0,0
125893,were,0,0
125894,assigned,0,0
125895,to,0,0
125896,be,0,0
125897,untreated,0,0
125898,",",0,0
125899,control,0,0
125900,animals,0,0
125901,(,0,0
125902,C,0,0
125903,),0,1
125904,",",0,0
125905,or,0,0
125906,to,0,0
125907,receive,0,0
125908,PGF,0,0
125909,(,0,0
125910,2?,0,0
125911,),0,0
125912,on,0,0
125913,d0,0,1
125914,(,0,0
125915,PG,0,0
125916,),0,1
125917,",",0,0
125918,or,0,0
125919,receive,0,0
125920,two,0,0
125921,injections,0,0
125922,of,0,0
125923,progesterone,0,1
125924,(,0,0
125925,200mg,0,0
125926,",",0,0
125927,i.m,0,0
125928,.,0,0
125929,each,0,0
125930,),0,0
125931,on,0,0
125932,D,0,1
125933,-5,0,0
125934,and,0,0
125935,on,0,0
125936,D,0,1
125937,-2.5,0,0
125938,",",0,0
125939,prior,0,0
125940,to,0,0
125941,PGF,0,0
125942,(,0,0
125943,2?,0,0
125944,),0,0
125945,",",0,0
125946,on,0,0
125947,D,0,0
125948,0,0,0
125949,(,0,0
125950,2PPG,0,0
125951,),0,0
125952,.,0,0
125953,Treatment,0,0
125954,with,0,0
125955,2PPG,0,0
125956,increased,0,0
125957,the,0,0
125958,proportion,1,0
125959,of,1,0
125960,animals,1,0
125961,lambing,1,0
125962,to,1,0
125963,the,0,0
125964,first,0,0
125965,service,0,0
125966,(,0,0
125967,P,0,0
125968,<,0,0
125969,0.05,0,0
125970,),0,0
125971,",",0,0
125972,an,0,0
125973,effect,0,0
125974,that,0,0
125975,was,0,0
125976,greater,0,0
125977,in,0,0
125978,ewe,0,1
125979,lambs,0,0
125980,than,0,0
125981,ewes,0,0
125982,(,0,0
125983,treatment,0,0
125984,?,0,0
125985,parity,0,1
125986,;,0,0
125987,P,0,0
125988,<,0,0
125989,0.05,0,0
125990,),0,0
125991,.,0,0
125992,The,0,0
125993,interval,0,0
125994,from,0,0
125995,ram,0,0
125996,introduction,1,0
125997,to,1,0
125998,lambing,1,0
125999,and,1,0
126000,the,1,0
126001,mean,1,1
126002,lambing,1,0
126003,day,1,0
126004,was,0,0
126005,less,0,0
126006,(,0,0
126007,P=0.04,0,0
126008,),0,0
126009,in,0,0
126010,the,0,0
126011,2PPG-treated,0,0
126012,animals,0,0
126013,compared,0,0
126014,to,0,0
126015,control,0,0
126016,animals,0,0
126017,.,0,0
126018,In,0,0
126019,Experiment,0,0
126020,2,0,0
126021,",",0,0
126022,lactating,0,0
126023,ewes,0,0
126024,from,0,0
126025,experiment,0,0
126026,1,0,0
126027,(,0,0
126028,n=61,0,0
126029,),0,0
126030,60-85,0,0
126031,days,0,0
126032,postpartum,0,1
126033,were,0,0
126034,assigned,0,0
126035,within,0,0
126036,parity,0,1
126037,and,0,1
126038,number,0,1
126039,of,0,1
126040,lambs,0,0
126041,reared,0,0
126042,to,0,0
126043,remain,0,0
126044,nursing,0,0
126045,(,0,0
126046,S,0,0
126047,;,0,0
126048,n=29,0,0
126049,),0,0
126050,or,0,0
126051,weaned,0,0
126052,(,0,0
126053,W,0,0
126054,;,0,0
126055,n=32,0,0
126056,),0,0
126057,3,0,0
126058,weeks,0,0
126059,prior,0,0
126060,to,0,0
126061,treatment,0,0
126062,with,0,0
126063,the,0,0
126064,2PPG,0,0
126065,protocol,0,0
126066,.,0,0
126067,There,0,0
126068,was,0,0
126069,no,0,0
126070,effect,0,0
126071,of,0,0
126072,treatment,0,0
126073,on,0,0
126074,the,0,0
126075,proportion,1,0
126076,of,1,0
126077,animals,1,0
126078,lambing,1,0
126079,to,1,0
126080,the,1,0
126081,first,1,0
126082,service,1,0
126083,or,1,0
126084,overall,1,1
126085,",",1,0
126086,interval,1,0
126087,from,0,0
126088,ram,0,0
126089,introduction,0,0
126090,to,0,0
126091,lambing,0,0
126092,and,0,0
126093,lambing,0,0
126094,interval,0,0
126095,.,0,0
126096,An,0,0
126097,8-month,1,0
126098,lambing,1,0
126099,interval,1,0
126100,was,1,0
126101,observed,0,0
126102,in,0,0
126103,ewes,0,0
126104,in,0,0
126105,which,0,0
126106,estrus,0,0
126107,was,0,0
126108,synchronized,0,0
126109,regardless,0,0
126110,of,0,0
126111,physiological,0,0
126112,state,0,0
126113,.,0,0
126114,In,0,0
126115,conclusion,0,0
126116,",",0,0
126117,the,0,0
126118,two-progesterone,0,0
126119,injection,0,0
126120,synchronization,0,1
126121,protocol,0,0
126122,may,0,0
126123,be,0,0
126124,used,0,0
126125,as,0,0
126126,a,0,0
126127,practical,0,0
126128,low,0,0
126129,cost,0,1
126130,and,0,0
126131,efficient,0,1
126132,method,0,0
126133,of,0,0
126134,synchronizing,0,0
126135,estrus,0,0
126136,to,0,0
126137,reduce,0,0
126138,the,0,0
126139,lambing,0,0
126140,interval,0,0
126141,and,0,1
126142,maximize,0,0
126143,productivity,0,1
126144,in,0,0
126145,tropical,0,0
126146,breeds,0,0
126147,of,0,0
126148,sheep,0,0
126149,.,0,0
126150,Exemestane,0,0
126151,for,0,0
126152,breast-cancer,0,0
126153,prevention,0,0
126154,in,0,0
126155,postmenopausal,0,0
126156,women,0,0
126157,.,0,0
126158,BACKGROUND,0,0
126159,Tamoxifen,0,0
126160,and,0,0
126161,raloxifene,0,0
126162,have,0,0
126163,limited,0,0
126164,patient,0,0
126165,acceptance,0,1
126166,for,0,0
126167,primary,0,0
126168,prevention,0,0
126169,of,0,0
126170,breast,0,0
126171,cancer,0,0
126172,.,0,0
126173,Aromatase,0,1
126174,inhibitors,0,0
126175,prevent,0,0
126176,more,0,0
126177,contralateral,0,0
126178,breast,0,0
126179,cancers,0,1
126180,and,0,1
126181,cause,0,1
126182,fewer,0,1
126183,side,0,1
126184,effects,0,1
126185,than,0,0
126186,tamoxifen,0,0
126187,in,0,0
126188,patients,0,0
126189,with,0,0
126190,early-stage,0,0
126191,breast,0,0
126192,cancer,0,0
126193,.,0,0
126194,METHODS,0,0
126195,In,0,0
126196,a,0,0
126197,randomized,0,0
126198,",",0,0
126199,placebo-controlled,0,0
126200,",",0,0
126201,double-blind,0,0
126202,trial,0,0
126203,of,0,0
126204,exemestane,0,0
126205,designed,0,0
126206,to,0,0
126207,detect,0,0
126208,a,0,0
126209,65,0,0
126210,%,0,0
126211,relative,0,0
126212,reduction,0,1
126213,in,0,0
126214,invasive,0,0
126215,breast,0,0
126216,cancer,0,0
126217,",",0,0
126218,eligible,0,0
126219,postmenopausal,0,0
126220,women,0,0
126221,35,0,0
126222,years,0,0
126223,of,0,0
126224,age,0,0
126225,or,0,0
126226,older,0,0
126227,had,0,0
126228,at,0,0
126229,least,0,0
126230,one,0,0
126231,of,0,0
126232,the,0,0
126233,following,0,0
126234,risk,0,0
126235,factors,0,0
126236,:,0,0
126237,60,0,0
126238,years,0,0
126239,of,0,0
126240,age,0,0
126241,or,0,0
126242,older,0,0
126243,;,0,0
126244,Gail,0,1
126245,5-year,0,0
126246,risk,0,1
126247,score,0,1
126248,greater,0,0
126249,than,0,0
126250,1.66,0,0
126251,%,0,0
126252,(,0,0
126253,chances,0,0
126254,in,0,0
126255,100,0,0
126256,of,0,0
126257,invasive,0,0
126258,breast,0,0
126259,cancer,0,0
126260,developing,0,0
126261,within,0,0
126262,5,0,0
126263,years,0,0
126264,),0,0
126265,;,0,0
126266,prior,0,0
126267,atypical,0,0
126268,ductal,0,1
126269,or,0,0
126270,lobular,0,1
126271,hyperplasia,0,1
126272,or,0,0
126273,lobular,0,1
126274,carcinoma,0,0
126275,in,0,0
126276,situ,0,0
126277,;,0,0
126278,or,0,0
126279,ductal,0,1
126280,carcinoma,0,0
126281,in,0,0
126282,situ,0,0
126283,with,0,0
126284,mastectomy,0,0
126285,.,0,0
126286,Toxic,1,1
126287,effects,1,1
126288,and,1,1
126289,health-related,1,1
126290,and,1,1
126291,menopause-specific,1,1
126292,qualities,1,1
126293,of,1,0
126294,life,1,1
126295,were,0,0
126296,measured,0,0
126297,.,0,0
126298,RESULTS,0,0
126299,A,0,0
126300,total,0,0
126301,of,0,0
126302,4560,0,0
126303,women,0,0
126304,for,0,0
126305,whom,0,0
126306,the,0,0
126307,median,0,0
126308,age,0,0
126309,was,0,0
126310,62.5,0,0
126311,years,0,0
126312,and,0,0
126313,the,0,0
126314,median,1,1
126315,Gail,1,0
126316,risk,1,1
126317,score,1,1
126318,was,0,0
126319,2.3,0,0
126320,%,0,0
126321,were,0,0
126322,randomly,0,0
126323,assigned,0,0
126324,to,0,0
126325,either,0,0
126326,exemestane,0,0
126327,or,0,0
126328,placebo,0,0
126329,.,0,0
126330,At,0,0
126331,a,0,0
126332,median,0,0
126333,follow-up,0,0
126334,of,0,0
126335,35,0,0
126336,months,0,0
126337,",",0,0
126338,11,0,0
126339,invasive,0,0
126340,breast,0,0
126341,cancers,0,1
126342,were,0,0
126343,detected,0,0
126344,in,0,0
126345,those,0,0
126346,given,0,0
126347,exemestane,0,0
126348,and,0,0
126349,in,0,0
126350,32,0,0
126351,of,0,0
126352,those,0,0
126353,given,0,0
126354,placebo,0,0
126355,",",0,0
126356,with,0,0
126357,a,0,0
126358,65,0,0
126359,%,0,0
126360,relative,0,0
126361,reduction,1,1
126362,in,1,0
126363,the,1,0
126364,annual,1,0
126365,incidence,1,1
126366,of,1,0
126367,invasive,1,0
126368,breast,1,0
126369,cancer,1,0
126370,(,0,0
126371,0.19,0,0
126372,%,0,0
126373,vs.,0,0
126374,0.55,0,0
126375,%,0,0
126376,;,0,0
126377,hazard,0,1
126378,ratio,0,1
126379,",",0,0
126380,0.35,0,0
126381,;,0,0
126382,95,0,0
126383,%,0,0
126384,confidence,0,0
126385,interval,0,0
126386,[,0,0
126387,CI,0,0
126388,],0,0
126389,",",0,0
126390,0.18,0,0
126391,to,0,0
126392,0.70,0,0
126393,;,0,0
126394,P=0.002,0,0
126395,),0,0
126396,.,0,0
126397,The,0,0
126398,annual,1,0
126399,incidence,1,1
126400,of,1,0
126401,invasive,1,0
126402,plus,1,0
126403,noninvasive,1,0
126404,(,1,0
126405,ductal,1,1
126406,carcinoma,1,0
126407,in,1,0
126408,situ,1,0
126409,),1,0
126410,breast,1,0
126411,cancers,1,0
126412,was,0,0
126413,0.35,0,0
126414,%,0,0
126415,on,0,0
126416,exemestane,0,0
126417,and,0,0
126418,0.77,0,0
126419,%,0,0
126420,on,0,0
126421,placebo,0,0
126422,(,0,0
126423,hazard,0,1
126424,ratio,0,1
126425,",",0,0
126426,0.47,0,0
126427,;,0,0
126428,95,0,0
126429,%,0,0
126430,CI,0,0
126431,",",0,0
126432,0.27,0,0
126433,to,0,0
126434,0.79,0,0
126435,;,0,0
126436,P=0.004,0,0
126437,),0,0
126438,.,0,0
126439,Adverse,1,1
126440,events,1,1
126441,occurred,0,0
126442,in,0,0
126443,88,0,0
126444,%,0,0
126445,of,0,0
126446,the,0,0
126447,exemestane,0,0
126448,group,0,0
126449,and,0,0
126450,85,0,0
126451,%,0,0
126452,of,0,0
126453,the,0,0
126454,placebo,0,0
126455,group,0,0
126456,(,0,0
126457,P=0.003,0,0
126458,),0,0
126459,",",0,0
126460,with,0,0
126461,no,0,0
126462,significant,0,0
126463,differences,0,0
126464,between,0,0
126465,the,0,0
126466,two,0,0
126467,groups,0,0
126468,in,0,0
126469,terms,0,0
126470,of,0,0
126471,skeletal,1,0
126472,fractures,1,1
126473,",",1,0
126474,cardiovascular,1,1
126475,events,1,1
126476,",",1,0
126477,other,1,0
126478,cancers,1,1
126479,",",1,0
126480,or,1,0
126481,treatment-related,1,1
126482,deaths,1,1
126483,.,1,0
126484,Minimal,0,0
126485,quality-of-life,1,1
126486,differences,0,0
126487,were,0,0
126488,observed,0,0
126489,.,0,0
126490,CONCLUSIONS,0,0
126491,Exemestane,0,0
126492,significantly,0,0
126493,reduced,0,0
126494,invasive,0,0
126495,breast,0,0
126496,cancers,0,0
126497,in,0,0
126498,postmenopausal,0,0
126499,women,0,0
126500,who,0,0
126501,were,0,0
126502,at,0,0
126503,moderately,0,0
126504,increased,0,0
126505,risk,0,0
126506,for,0,0
126507,breast,0,0
126508,cancer,0,0
126509,.,0,0
126510,During,0,0
126511,a,0,0
126512,median,0,0
126513,follow-up,0,0
126514,period,0,0
126515,of,0,0
126516,3,0,0
126517,years,0,0
126518,",",0,0
126519,exemestane,0,0
126520,was,0,0
126521,associated,0,0
126522,with,0,0
126523,no,0,0
126524,serious,0,1
126525,toxic,0,1
126526,effects,0,1
126527,and,0,0
126528,only,0,0
126529,minimal,0,1
126530,changes,0,1
126531,in,0,0
126532,health-related,0,1
126533,quality,0,1
126534,of,0,0
126535,life,0,1
126536,.,0,0
126537,(,0,0
126538,Funded,0,0
126539,by,0,0
126540,Pfizer,0,0
126541,and,0,0
126542,others,0,0
126543,;,0,0
126544,NCIC,0,0
126545,CTG,0,1
126546,MAP.3,0,0
126547,ClinicalTrials.gov,0,0
126548,number,0,1
126549,",",0,0
126550,NCT00083174,0,0
126551,.,0,0
126552,),0,0
126553,.,0,0
126554,?-Blockers,0,1
126555,in,0,0
126556,patients,0,0
126557,with,0,0
126558,intermittent,0,0
126559,claudication,0,1
126560,and,0,0
126561,arterial,0,1
126562,hypertension,0,1
126563,:,0,0
126564,results,0,0
126565,from,0,0
126566,the,0,0
126567,nebivolol,0,0
126568,or,0,0
126569,metoprolol,0,0
126570,in,0,0
126571,arterial,0,1
126572,occlusive,0,1
126573,disease,0,0
126574,trial,0,0
126575,.,0,0
126576,The,0,0
126577,use,0,0
126578,of,0,0
126579,?-receptor,0,0
126580,blockers,0,0
126581,in,0,0
126582,peripheral,0,1
126583,arterial,0,1
126584,disease,0,0
126585,is,0,0
126586,controversial,0,0
126587,for,0,0
126588,their,0,0
126589,impact,0,0
126590,on,0,0
126591,vasomotor,0,1
126592,tone,0,1
126593,.,0,0
126594,The,0,0
126595,?-blocker,0,0
126596,nebivolol,0,0
126597,possesses,0,0
126598,vasodilating,0,1
126599,",",0,0
126600,endothelium-dependent,0,1
126601,",",0,0
126602,NO-releasing,0,0
126603,properties,0,0
126604,that,0,0
126605,might,0,0
126606,be,0,0
126607,beneficial,0,0
126608,in,0,0
126609,peripheral,0,1
126610,arterial,0,1
126611,disease,0,0
126612,.,0,0
126613,The,0,0
126614,aim,0,0
126615,of,0,0
126616,the,0,0
126617,study,0,0
126618,was,0,0
126619,to,0,0
126620,evaluate,0,0
126621,the,0,0
126622,effects,1,1
126623,and,1,0
126624,tolerability,1,1
126625,of,1,1
126626,nebivolol,0,0
126627,in,0,0
126628,comparison,0,0
126629,with,0,0
126630,metoprolol,0,0
126631,in,0,0
126632,these,0,0
126633,patients,0,0
126634,.,0,0
126635,A,0,0
126636,total,0,0
126637,of,0,0
126638,128,0,0
126639,patients,0,0
126640,with,0,0
126641,intermittent,0,0
126642,claudication,0,1
126643,and,0,0
126644,essential,0,1
126645,hypertension,0,1
126646,were,0,0
126647,included,0,0
126648,and,0,0
126649,double-blind,0,0
126650,randomized,0,0
126651,to,0,0
126652,receive,0,0
126653,5,0,0
126654,mg,0,0
126655,of,0,0
126656,nebivolol,0,0
126657,(,0,0
126658,N=65,0,0
126659,),0,0
126660,or,0,0
126661,95,0,0
126662,mg,0,0
126663,of,0,0
126664,metoprolol,0,0
126665,(,0,0
126666,N=63,0,1
126667,),0,0
126668,once,0,0
126669,daily,0,0
126670,.,0,0
126671,End,0,0
126672,points,0,0
126673,were,0,0
126674,changes,0,1
126675,in,0,0
126676,ankle-brachial,1,1
126677,index,1,1
126678,",",1,0
126679,initial,1,1
126680,and,1,1
126681,absolute,1,1
126682,claudication,1,1
126683,distance,1,1
126684,",",1,0
126685,endothelial,1,1
126686,function,1,1
126687,assessed,1,0
126688,by,1,0
126689,flow-mediated,1,1
126690,dilatation,1,0
126691,of,1,0
126692,the,1,0
126693,brachial,1,0
126694,artery,1,0
126695,",",1,0
126696,blood,1,1
126697,pressure,1,1
126698,",",1,1
126699,and,1,1
126700,quality,1,1
126701,of,1,1
126702,life,1,1
126703,using,1,0
126704,the,1,0
126705,claudication,1,1
126706,scale,1,1
126707,questionnaire,1,1
126708,.,1,0
126709,End,1,0
126710,point,0,1
126711,analysis,0,0
126712,was,0,0
126713,possible,0,0
126714,in,0,0
126715,109,0,0
126716,patients,0,0
126717,(,0,0
126718,85.2,0,0
126719,%,0,0
126720,),0,0
126721,.,0,0
126722,After,0,0
126723,the,0,0
126724,48-week,0,0
126725,treatment,0,0
126726,period,1,0
126727,",",1,0
126728,ankle-brachial,1,1
126729,index,1,1
126730,and,1,0
126731,absolute,1,1
126732,claudication,1,1
126733,distance,1,1
126734,improved,1,0
126735,significantly,0,0
126736,in,0,0
126737,both,0,0
126738,patient,0,0
126739,groups,0,0
126740,(,0,0
126741,P,0,0
126742,<,0,0
126743,0.05,0,0
126744,for,0,0
126745,both,0,0
126746,),0,0
126747,",",0,0
126748,with,0,0
126749,no,0,0
126750,difference,0,0
126751,across,0,0
126752,treatments,0,0
126753,.,0,0
126754,A,0,0
126755,significant,0,0
126756,increase,0,0
126757,of,0,0
126758,initial,1,0
126759,claudication,1,1
126760,distance,1,1
126761,was,1,0
126762,found,0,0
126763,in,0,0
126764,the,0,0
126765,nebivolol,0,0
126766,group,0,0
126767,.,0,0
126768,Adjusted,0,1
126769,mean,0,1
126770,change,0,0
126771,of,0,0
126772,initial,1,0
126773,claudication,1,1
126774,distance,1,1
126775,was,1,0
126776,33.9,0,0
126777,%,0,0
126778,after,0,0
126779,nebivolol,0,0
126780,(,0,0
126781,P=0.003,0,0
126782,),0,0
126783,and,0,0
126784,16.6,0,0
126785,%,0,0
126786,after,0,0
126787,metoprolol,0,0
126788,(,0,0
126789,P=0.12,0,0
126790,),0,0
126791,treatment,1,0
126792,.,1,0
126793,Quality,1,1
126794,of,1,0
126795,life,1,1
126796,was,1,0
126797,not,0,0
126798,influenced,0,0
126799,by,0,0
126800,either,0,0
126801,treatment,0,0
126802,",",0,0
126803,and,0,1
126804,there,0,0
126805,was,0,0
126806,no,0,0
126807,relevant,0,0
126808,change,0,0
126809,in,0,0
126810,flow-mediated,1,1
126811,dilatation,1,1
126812,in,1,0
126813,patients,0,0
126814,treated,0,0
126815,with,0,0
126816,nebivolol,0,0
126817,or,0,0
126818,metoprolol,0,0
126819,(,0,1
126820,P=0.16,0,0
126821,),0,0
126822,.,0,0
126823,Both,0,0
126824,drugs,0,0
126825,were,0,0
126826,equally,0,0
126827,effective,0,0
126828,in,0,0
126829,lowering,1,0
126830,blood,1,1
126831,pressure,1,1
126832,.,1,0
126833,In,1,0
126834,conclusion,0,0
126835,",",0,0
126836,?-blocker,0,0
126837,therapy,0,0
126838,was,0,0
126839,well,0,0
126840,tolerated,0,1
126841,in,0,0
126842,patients,0,0
126843,with,0,0
126844,intermittent,0,0
126845,claudication,0,1
126846,and,0,0
126847,arterial,0,1
126848,hypertension,0,1
126849,during,0,0
126850,a,0,0
126851,treatment,0,0
126852,period,0,0
126853,of,0,0
126854,?1,0,0
126855,year,0,0
126856,.,0,0
126857,In,0,0
126858,the,0,0
126859,direct,0,0
126860,comparison,0,0
126861,",",0,0
126862,there,0,0
126863,was,0,0
126864,no,0,0
126865,significant,0,0
126866,difference,0,0
126867,between,0,0
126868,nebivolol,0,0
126869,and,0,0
126870,metoprolol,0,0
126871,.,0,0
126872,An,0,0
126873,allopurinol-controlled,0,0
126874,",",0,0
126875,randomized,0,0
126876,",",0,0
126877,double-dummy,0,0
126878,",",0,0
126879,double-blind,0,0
126880,",",0,0
126881,parallel,0,0
126882,between-group,0,0
126883,",",0,0
126884,comparative,1,0
126885,study,1,0
126886,of,0,0
126887,febuxostat,0,0
126888,(,0,0
126889,TMX-67,0,0
126890,),0,0
126891,",",0,0
126892,a,0,0
126893,non-purine-selective,0,0
126894,inhibitor,0,0
126895,of,0,0
126896,xanthine,0,0
126897,oxidase,0,0
126898,",",0,0
126899,in,0,0
126900,patients,0,0
126901,with,0,0
126902,hyperuricemia,0,0
126903,including,0,0
126904,those,0,0
126905,with,0,0
126906,gout,0,0
126907,in,0,0
126908,Japan,0,0
126909,:,0,0
126910,phase,0,0
126911,3,0,0
126912,clinical,0,0
126913,study,0,0
126914,.,0,0
126915,BACKGROUND,0,0
126916,Allopurinol,0,0
126917,has,0,0
126918,been,0,0
126919,widely,0,0
126920,used,0,0
126921,for,0,0
126922,treatment,0,0
126923,of,0,0
126924,hyperuricemia,0,1
126925,",",0,0
126926,however,0,0
126927,",",0,0
126928,it,0,0
126929,may,0,0
126930,be,0,0
126931,associated,0,0
126932,with,0,0
126933,various,0,0
126934,adverse,0,1
126935,effects,0,0
126936,.,0,0
126937,Febuxostat,0,0
126938,is,0,0
126939,potentially,0,0
126940,a,0,0
126941,safe,0,0
126942,and,0,0
126943,efficacious,0,1
126944,alternative,0,0
126945,.,0,0
126946,OBJECTIVES,0,0
126947,Febuxostat,0,0
126948,or,0,0
126949,allopurinol,0,0
126950,was,0,0
126951,administered,0,0
126952,to,0,0
126953,patients,0,0
126954,with,0,0
126955,hyperuricemia,0,0
126956,including,0,0
126957,gout,0,0
126958,for,0,0
126959,8,0,0
126960,weeks,0,0
126961,to,0,0
126962,compare,0,0
126963,the,0,0
126964,efficacy,1,1
126965,and,0,0
126966,safety,1,1
126967,of,0,0
126968,these,0,0
126969,drugs,0,0
126970,.,0,0
126971,METHODS,0,0
126972,Doses,0,1
126973,of,0,0
126974,febuxostat,0,0
126975,and,0,1
126976,allopurinol,0,0
126977,were,0,0
126978,10,0,0
126979,and,0,0
126980,100,0,0
126981,mg/d,0,0
126982,",",0,0
126983,respectively,0,0
126984,",",0,0
126985,during,0,0
126986,a,0,0
126987,12-day,0,0
126988,introduction,0,0
126989,period,0,0
126990,and,0,1
126991,were,0,0
126992,increased,0,0
126993,to,0,0
126994,40,0,0
126995,and,0,0
126996,200,0,0
126997,mg/d,0,0
126998,for,0,0
126999,the,0,0
127000,subsequent,0,0
127001,treatment,0,0
127002,period,0,0
127003,of,0,0
127004,44,0,0
127005,days,0,0
127006,.,0,0
127007,RESULTS,0,0
127008,:,0,0
127009,The,0,0
127010,percent,0,0
127011,changes,1,1
127012,in,1,0
127013,serum,1,1
127014,uric,1,1
127015,acid,1,0
127016,levels,1,1
127017,after,0,0
127018,8,0,0
127019,weeks,0,0
127020,were,0,0
127021,-40.75,0,0
127022,%,0,0
127023,for,0,0
127024,the,0,0
127025,febuxostat,0,0
127026,group,0,0
127027,and,0,0
127028,-34.41,0,0
127029,%,0,0
127030,for,0,0
127031,the,0,0
127032,allopurinol,0,0
127033,group,0,0
127034,(,0,0
127035,P,0,0
127036,<,0,0
127037,0.001,0,0
127038,",",0,0
127039,analysis,0,0
127040,of,0,1
127041,variance,0,0
127042,",",0,0
127043,closing,0,0
127044,testing,0,0
127045,procedure,0,0
127046,),0,0
127047,.,0,0
127048,The,0,0
127049,percentage,0,1
127050,of,0,0
127051,patients,0,0
127052,achieving,0,0
127053,serum,1,1
127054,uric,1,1
127055,acid,1,0
127056,levels,1,1
127057,6.0,0,0
127058,mg/dL,0,0
127059,or,0,0
127060,less,0,0
127061,after,0,0
127062,8,0,0
127063,weeks,0,0
127064,was,0,0
127065,82.0,0,0
127066,%,0,0
127067,for,0,0
127068,the,0,0
127069,febuxostat,0,0
127070,group,0,0
127071,and,0,0
127072,70.0,0,0
127073,%,0,0
127074,for,0,0
127075,the,0,0
127076,allopurinol,0,0
127077,group,0,0
127078,(,0,0
127079,P,0,0
127080,=,0,0
127081,0.019,0,0
127082,",",0,0
127083,logistic,0,0
127084,regression,0,1
127085,analysis,0,0
127086,),0,0
127087,.,0,0
127088,Regarding,0,0
127089,safety,1,1
127090,",",0,0
127091,213,0,0
127092,adverse,1,1
127093,events,1,1
127094,were,0,0
127095,observed,0,0
127096,in,0,0
127097,the,0,0
127098,febuxostat,0,0
127099,group,0,0
127100,and,0,0
127101,220,0,0
127102,events,0,1
127103,in,0,0
127104,the,0,0
127105,allopurinol,0,0
127106,group,0,0
127107,.,0,0
127108,For,0,0
127109,10,0,0
127110,patients,0,0
127111,(,0,0
127112,8.2,0,0
127113,%,0,0
127114,),0,0
127115,in,0,0
127116,the,0,0
127117,febuxostat,0,0
127118,group,0,0
127119,and,0,0
127120,14,0,0
127121,patients,0,0
127122,(,0,0
127123,11.6,0,0
127124,%,0,0
127125,),0,0
127126,in,0,0
127127,the,0,0
127128,allopurinol,0,0
127129,group,0,0
127130,",",0,0
127131,association,0,0
127132,with,0,0
127133,the,0,0
127134,study,0,0
127135,drugs,0,0
127136,could,0,0
127137,not,0,0
127138,be,0,0
127139,ruled,0,0
127140,out,0,0
127141,.,0,0
127142,There,0,0
127143,were,0,0
127144,no,0,0
127145,severe,1,1
127146,adverse,1,1
127147,drug,1,0
127148,reactions,1,1
127149,in,0,0
127150,the,0,0
127151,febuxostat,0,0
127152,group,0,0
127153,other,0,0
127154,than,0,0
127155,a,0,0
127156,high,0,0
127157,frequency,0,1
127158,of,0,0
127159,gout,1,1
127160,attacks,1,1
127161,induced,0,0
127162,by,0,0
127163,the,0,0
127164,sudden,1,1
127165,reduction,1,1
127166,in,1,0
127167,blood,1,1
127168,uric,1,1
127169,acid,1,0
127170,levels,1,1
127171,during,0,0
127172,the,0,0
127173,early,0,0
127174,treatment,0,0
127175,period,0,0
127176,.,0,0
127177,CONCLUSIONS,0,0
127178,Febuxostat,0,0
127179,at,0,0
127180,40,0,0
127181,mg/d,0,0
127182,demonstrated,0,0
127183,more,0,0
127184,potent,1,0
127185,hypouricemic,1,0
127186,effects,1,1
127187,than,0,0
127188,allopurinol,0,0
127189,at,0,0
127190,200,0,0
127191,mg/d,0,0
127192,",",0,0
127193,was,0,0
127194,efficacious,0,1
127195,regardless,0,0
127196,of,0,0
127197,medical,0,0
127198,history,0,0
127199,of,0,0
127200,gout,0,1
127201,",",0,0
127202,and,0,0
127203,is,0,0
127204,considered,0,0
127205,safe,0,0
127206,for,0,0
127207,treatment,0,0
127208,of,0,0
127209,hyperuricemia,1,0
127210,.,1,0
127211,Intervention,0,0
127212,to,0,0
127213,lower,0,0
127214,household,0,1
127215,wood,0,0
127216,smoke,0,1
127217,exposure,0,0
127218,in,0,0
127219,Guatemala,0,0
127220,reduces,0,0
127221,ST-segment,1,1
127222,depression,1,1
127223,on,1,0
127224,electrocardiograms,1,0
127225,.,1,0
127226,BACKGROUND,0,0
127227,A,0,0
127228,large,0,0
127229,body,0,1
127230,of,0,0
127231,evidence,0,0
127232,suggests,0,0
127233,that,0,0
127234,fine,0,1
127235,particulate,0,1
127236,matter,0,0
127237,(,0,0
127238,PM,0,0
127239,),0,1
127240,air,0,0
127241,pollution,0,0
127242,is,0,0
127243,a,0,0
127244,cause,0,0
127245,of,0,0
127246,cardiovascular,0,1
127247,disease,0,1
127248,",",0,0
127249,but,0,0
127250,little,0,0
127251,is,0,0
127252,known,0,0
127253,in,0,0
127254,particular,0,0
127255,about,0,0
127256,the,0,0
127257,cardiovascular,0,1
127258,effects,1,0
127259,of,0,0
127260,indoor,0,0
127261,air,0,0
127262,pollution,0,0
127263,from,0,0
127264,household,0,1
127265,use,0,0
127266,of,0,0
127267,solid,0,0
127268,fuels,0,0
127269,in,0,0
127270,developing,0,0
127271,countries,0,0
127272,.,0,0
127273,RESPIRE,0,0
127274,(,0,0
127275,Randomized,0,0
127276,Exposure,0,1
127277,Study,0,0
127278,of,0,0
127279,Pollution,0,1
127280,Indoors,0,0
127281,and,0,0
127282,Respiratory,0,1
127283,Effects,0,0
127284,),0,0
127285,was,0,0
127286,a,0,0
127287,randomized,0,0
127288,trial,0,0
127289,of,0,0
127290,a,0,0
127291,chimney,0,0
127292,woodstove,0,0
127293,that,0,0
127294,reduces,0,0
127295,wood,0,0
127296,smoke,0,0
127297,exposure,0,0
127298,.,0,0
127299,OBJECTIVES,0,0
127300,We,0,0
127301,tested,0,0
127302,the,0,0
127303,hypotheses,0,0
127304,that,0,0
127305,the,0,0
127306,stove,0,0
127307,intervention,0,0
127308,",",0,0
127309,compared,0,0
127310,with,0,0
127311,open,0,0
127312,fire,0,0
127313,use,0,0
127314,",",0,0
127315,would,0,0
127316,reduce,0,0
127317,ST-segment,1,1
127318,depression,1,1
127319,and,0,0
127320,increase,0,1
127321,heart,1,1
127322,rate,1,1
127323,variability,1,1
127324,(,1,0
127325,HRV,1,0
127326,),1,0
127327,.,1,0
127328,METHODS,0,0
127329,We,0,0
127330,used,0,0
127331,two,0,0
127332,complementary,0,0
127333,study,0,0
127334,designs,0,0
127335,:,0,0
127336,a,0,0
127337,),0,0
127338,between-groups,0,0
127339,comparisons,0,0
127340,based,0,0
127341,on,0,0
127342,randomized,0,0
127343,stove,0,0
127344,assignment,0,0
127345,",",0,1
127346,and,0,1
127347,b,0,1
127348,),0,1
127349,before-and-after,0,0
127350,comparisons,0,0
127351,within,0,0
127352,control,0,0
127353,subjects,0,0
127354,who,0,0
127355,used,0,0
127356,open,0,0
127357,fires,0,0
127358,during,0,0
127359,the,0,0
127360,trial,0,0
127361,and,0,0
127362,received,0,0
127363,chimney,0,0
127364,stoves,0,0
127365,after,0,0
127366,the,0,0
127367,trial,0,0
127368,.,0,0
127369,Electrocardiogram,0,1
127370,sessions,0,0
127371,that,0,0
127372,lasted,0,0
127373,20,0,0
127374,hr,0,0
127375,were,0,0
127376,repeated,0,0
127377,up,0,0
127378,to,0,0
127379,three,0,0
127380,times,0,0
127381,among,0,0
127382,49,0,0
127383,intervention,0,0
127384,and,0,0
127385,70,0,0
127386,control,0,0
127387,women,0,0
127388,38-84,0,0
127389,years,0,0
127390,of,0,0
127391,age,0,0
127392,",",0,0
127393,and,0,0
127394,55,0,0
127395,control,0,0
127396,subjects,0,0
127397,were,0,0
127398,also,0,0
127399,assessed,0,0
127400,after,0,0
127401,receiving,0,0
127402,stoves,0,0
127403,.,0,0
127404,HRV,1,1
127405,and,1,0
127406,ST-segment,1,1
127407,values,1,1
127408,were,0,0
127409,assessed,0,0
127410,for,0,0
127411,each,0,0
127412,30-min,0,0
127413,period,0,0
127414,.,0,0
127415,ST-segment,1,1
127416,depression,1,1
127417,was,0,0
127418,defined,0,0
127419,as,0,0
127420,an,0,0
127421,average,0,0
127422,value,0,0
127423,below,0,0
127424,-1.00,0,0
127425,mm,0,0
127426,.,0,0
127427,Personal,1,1
127428,fine,1,1
127429,PM,1,0
127430,[,0,0
127431,aerodynamic,0,1
127432,diameter,0,1
127433,?,0,0
127434,2.5,0,0
127435,?m,0,0
127436,(,0,0
127437,PM?.?,1,0
127438,],1,0
127439,exposures,1,0
127440,were,1,0
127441,measured,1,0
127442,for,0,0
127443,24,0,0
127444,hr,0,0
127445,before,0,0
127446,each,0,0
127447,electrocardiogram,0,1
127448,.,0,0
127449,RESULTS,0,0
127450,PM?.?,1,0
127451,exposure,1,1
127452,means,1,0
127453,were,0,0
127454,266,0,0
127455,and,0,0
127456,102,0,0
127457,?g/m?,0,0
127458,during,0,0
127459,the,0,0
127460,trial,0,0
127461,period,0,0
127462,in,0,0
127463,the,0,0
127464,control,0,0
127465,and,0,0
127466,intervention,0,0
127467,groups,0,0
127468,",",0,0
127469,respectively,0,0
127470,.,0,0
127471,During,0,0
127472,the,0,0
127473,trial,0,0
127474,",",0,0
127475,the,0,0
127476,stove,0,0
127477,intervention,0,0
127478,was,0,0
127479,associated,0,0
127480,with,0,0
127481,an,0,0
127482,odds,0,0
127483,ratio,0,1
127484,of,0,0
127485,0.26,0,0
127486,(,0,0
127487,95,0,0
127488,%,0,0
127489,confidence,0,0
127490,interval,0,0
127491,",",0,1
127492,0.08-0.90,0,0
127493,),0,0
127494,for,1,0
127495,ST-segment,1,0
127496,depression,1,0
127497,.,1,0
127498,We,0,0
127499,found,0,0
127500,similar,0,0
127501,associations,0,0
127502,with,0,0
127503,the,0,0
127504,before-and-after,0,0
127505,comparison,0,0
127506,.,0,0
127507,The,0,0
127508,intervention,0,0
127509,was,0,0
127510,not,0,0
127511,significantly,0,0
127512,associated,0,0
127513,with,1,0
127514,HRV,1,0
127515,.,1,0
127516,CONCLUSIONS,1,0
127517,The,0,0
127518,stove,0,0
127519,intervention,0,0
127520,was,0,0
127521,associated,0,0
127522,with,0,0
127523,reduced,0,0
127524,occurrence,0,1
127525,of,0,0
127526,nonspecific,1,0
127527,ST-segment,1,1
127528,depression,1,1
127529,",",1,0
127530,suggesting,0,0
127531,that,0,0
127532,household,0,1
127533,wood,0,0
127534,smoke,0,0
127535,exposures,0,0
127536,affect,1,0
127537,ventricular,1,1
127538,repolarization,1,1
127539,and,1,0
127540,potentially,1,0
127541,cardiovascular,0,1
127542,health,0,0
127543,.,0,0
127544,Cross-modal,0,0
127545,attention-switching,0,0
127546,is,0,0
127547,impaired,0,0
127548,in,0,0
127549,autism,0,0
127550,spectrum,0,0
127551,disorders,0,0
127552,.,0,0
127553,This,0,0
127554,investigation,0,0
127555,aimed,0,0
127556,to,0,0
127557,determine,0,0
127558,if,0,0
127559,children,0,0
127560,with,0,0
127561,ASD,0,0
127562,are,0,0
127563,impaired,0,0
127564,in,0,0
127565,their,0,0
127566,ability,0,0
127567,to,0,0
127568,switch,0,0
127569,attention,0,0
127570,between,0,0
127571,different,0,0
127572,tasks,0,1
127573,",",0,0
127574,and,0,1
127575,whether,0,0
127576,performance,0,1
127577,is,0,0
127578,further,0,0
127579,impaired,0,0
127580,when,0,0
127581,required,0,0
127582,to,0,0
127583,switch,0,0
127584,across,0,0
127585,two,0,0
127586,separate,0,0
127587,modalities,0,0
127588,(,0,0
127589,visual,0,1
127590,and,0,1
127591,auditory,0,1
127592,),0,0
127593,.,0,0
127594,Eighteen,0,0
127595,children,0,0
127596,with,0,0
127597,ASD,0,0
127598,(,0,0
127599,9-13,0,0
127600,years,0,0
127601,old,0,0
127602,),0,0
127603,were,0,0
127604,compared,0,0
127605,with,0,0
127606,18,0,0
127607,typically-developing,0,0
127608,children,0,0
127609,matched,0,0
127610,with,0,0
127611,the,0,0
127612,ASD,0,0
127613,group,0,0
127614,for,0,0
127615,mental,0,1
127616,age,0,0
127617,",",0,0
127618,and,0,0
127619,also,0,0
127620,with,0,0
127621,18,0,0
127622,subjects,0,0
127623,with,0,0
127624,learning,0,0
127625,difficulties,0,0
127626,matched,0,0
127627,with,0,0
127628,the,0,0
127629,ASD,0,0
127630,group,0,0
127631,for,0,0
127632,mental,0,1
127633,and,0,0
127634,chronological,0,0
127635,age,0,0
127636,.,0,0
127637,Individuals,0,0
127638,alternated,0,0
127639,between,0,0
127640,two,0,0
127641,different,0,0
127642,visual,0,0
127643,tasks,0,1
127644,",",0,0
127645,and,0,0
127646,between,0,0
127647,a,0,0
127648,different,0,0
127649,visual,0,1
127650,task,0,0
127651,and,0,0
127652,an,0,0
127653,auditory,0,1
127654,task,0,0
127655,.,0,0
127656,Children,0,0
127657,with,0,0
127658,ASD,0,0
127659,performed,1,0
127660,worse,1,0
127661,than,0,0
127662,both,0,0
127663,comparison,0,0
127664,groups,0,0
127665,at,0,0
127666,both,0,0
127667,switching,1,0
127668,tasks,1,0
127669,.,1,0
127670,Moreover,0,0
127671,",",0,0
127672,children,0,0
127673,with,0,0
127674,ASD,0,0
127675,had,0,0
127676,greater,1,0
127677,difficulty,1,1
127678,when,1,0
127679,different,1,0
127680,modalities,1,0
127681,were,1,0
127682,required,1,0
127683,than,1,0
127684,where,1,0
127685,only,1,0
127686,one,1,0
127687,modality,1,0
127688,was,1,0
127689,required,1,0
127690,in,1,0
127691,the,1,0
127692,switching,1,0
127693,task,1,0
127694,in,0,0
127695,comparison,0,0
127696,with,0,0
127697,participants,0,0
127698,matched,0,0
127699,in,0,0
127700,terms,0,0
127701,of,0,0
127702,mental,0,1
127703,and,0,0
127704,chronological,0,0
127705,age,0,0
127706,.,0,0
127707,Nepafenac,0,0
127708,for,0,0
127709,epiretinal,0,1
127710,membrane,0,0
127711,surgery,0,0
127712,.,0,0
127713,Nasal,0,1
127714,versus,0,0
127715,oronasal,0,0
127716,continuous,0,0
127717,positive,0,1
127718,airway,0,1
127719,pressure,0,1
127720,masks,0,0
127721,for,0,0
127722,obstructive,0,0
127723,sleep,0,1
127724,apnea,0,0
127725,:,0,0
127726,a,0,0
127727,pilot,0,0
127728,investigation,0,0
127729,of,0,1
127730,pressure,0,1
127731,requirement,0,1
127732,",",0,0
127733,residual,0,1
127734,disease,0,1
127735,",",0,0
127736,and,0,1
127737,leak,0,1
127738,.,0,0
127739,PURPOSE,0,0
127740,This,0,0
127741,single-blinded,0,0
127742,",",0,0
127743,randomized,0,0
127744,",",0,0
127745,controlled,0,0
127746,pilot,0,0
127747,study,0,0
127748,aimed,0,0
127749,to,0,0
127750,investigate,0,0
127751,whether,0,0
127752,there,0,0
127753,is,0,0
127754,a,0,0
127755,difference,0,0
127756,between,0,0
127757,nasal,0,1
127758,and,0,1
127759,oronasal,0,0
127760,masks,0,0
127761,in,0,0
127762,therapeutic,0,0
127763,continuous,0,0
127764,positive,0,1
127765,airway,0,1
127766,pressure,0,1
127767,(,0,0
127768,CPAP,0,0
127769,),0,1
127770,requirement,0,1
127771,",",0,0
127772,residual,0,1
127773,disease,0,1
127774,",",0,0
127775,or,0,0
127776,leak,0,1
127777,when,0,0
127778,treating,0,0
127779,obstructive,0,0
127780,sleep,0,1
127781,apnea,0,1
127782,(,0,0
127783,OSA,0,0
127784,),0,0
127785,and,0,0
127786,if,0,0
127787,differences,0,0
127788,were,0,0
127789,related,0,0
127790,to,0,0
127791,measures,0,0
127792,of,0,0
127793,upper,0,0
127794,airway,0,1
127795,size,0,1
127796,.,0,0
127797,METHODS,0,0
127798,Patients,0,0
127799,with,0,0
127800,severe,0,1
127801,OSA,0,0
127802,currently,0,0
127803,using,0,0
127804,CPAP,0,0
127805,at,0,0
127806,?4,0,0
127807,h/night,0,0
127808,with,0,0
127809,a,0,0
127810,nasal,0,1
127811,mask,0,0
127812,were,0,0
127813,examined,0,0
127814,(,0,0
127815,including,0,0
127816,Mallampati,0,1
127817,scale,0,1
127818,",",0,0
127819,incisal,0,1
127820,relationship,0,1
127821,",",0,0
127822,and,0,1
127823,mandibular,0,1
127824,protrusion,0,1
127825,),0,0
127826,and,0,0
127827,then,0,0
127828,randomized,0,0
127829,to,0,0
127830,receive,0,0
127831,auto-positive,0,0
127832,airway,0,1
127833,pressure,0,1
127834,(,0,0
127835,PAP,0,1
127836,),0,0
127837,or,0,0
127838,fixed,0,0
127839,CPAP,0,0
127840,at,0,0
127841,a,0,0
127842,manually,0,0
127843,titrated,0,0
127844,pressure,0,1
127845,for,0,0
127846,1,0,0
127847,week,0,0
127848,each,0,0
127849,at,0,0
127850,home,0,0
127851,",",0,0
127852,with,0,0
127853,immediate,0,1
127854,crossover,0,0
127855,.,0,0
127856,Within,0,0
127857,each,0,0
127858,week,0,0
127859,",",0,0
127860,a,0,0
127861,nasal,0,1
127862,mask,0,0
127863,and,0,0
127864,two,0,0
127865,oronasal,0,0
127866,masks,0,0
127867,were,0,0
127868,to,0,0
127869,be,0,0
127870,used,0,0
127871,for,0,0
127872,two,0,0
127873,or,0,0
127874,three,0,0
127875,nights,0,0
127876,each,0,0
127877,in,0,0
127878,random,0,0
127879,order,0,0
127880,.,0,0
127881,Data,0,0
127882,were,0,0
127883,downloaded,0,0
127884,from,0,0
127885,the,0,0
127886,device,0,0
127887,.,0,0
127888,RESULTS,0,0
127889,Twelve,0,0
127890,patients,0,0
127891,completed,0,0
127892,the,0,0
127893,trial,0,0
127894,(,0,0
127895,mean,0,1
127896,?,0,0
127897,SD,0,0
127898,AHI,0,0
127899,59.8,0,0
127900,?,0,0
127901,28.6,0,0
127902,events/h,0,0
127903,;,0,0
127904,CPAP,0,0
127905,11.1,0,0
127906,?,0,0
127907,3.2,0,0
127908,cmH,0,0
127909,(,0,0
127910,2,0,0
127911,),0,0
127912,O,0,0
127913,;,0,0
127914,BMI,0,0
127915,37.7,0,0
127916,?,0,0
127917,5.0,0,0
127918,kg/m,0,0
127919,(,0,0
127920,2,0,0
127921,),0,0
127922,),0,0
127923,.,0,0
127924,During,0,0
127925,auto-PAP,1,0
127926,",",1,0
127927,the,1,0
127928,median,1,0
127929,95th,1,1
127930,percentile,1,0
127931,pressure,1,0
127932,delivered,1,0
127933,with,0,0
127934,all,0,0
127935,masks,0,0
127936,was,0,0
127937,within,0,0
127938,0.5,0,0
127939,cmH,0,0
127940,(,0,0
127941,2,0,0
127942,),0,0
127943,O,0,0
127944,(,0,0
127945,p,0,0
127946,>,0,0
127947,0.05,0,0
127948,),0,0
127949,.,0,0
127950,During,0,0
127951,CPAP,0,0
127952,",",0,0
127953,median,1,1
127954,residual,1,1
127955,AHI,1,0
127956,was,1,0
127957,0.61,0,0
127958,(,0,0
127959,IQR,0,0
127960,=,0,0
127961,1.18,0,0
127962,),0,0
127963,for,0,0
127964,the,0,0
127965,nasal,0,1
127966,mask,0,0
127967,",",0,0
127968,1.70,0,0
127969,(,0,0
127970,IQR,0,0
127971,=,0,0
127972,4.04,0,0
127973,),0,0
127974,for,0,0
127975,oronasal,0,0
127976,mask,0,0
127977,1,0,0
127978,",",0,0
127979,and,0,0
127980,2.48,0,0
127981,(,0,0
127982,IQR,0,0
127983,=,0,0
127984,3.74,0,0
127985,),0,0
127986,for,0,0
127987,oronasal,0,0
127988,mask,0,0
127989,2,0,0
127990,(,0,0
127991,p,0,0
127992,=,0,0
127993,0.03,0,0
127994,),0,0
127995,.,0,0
127996,The,1,0
127997,95th,1,1
127998,percentile,1,0
127999,leak,1,0
128000,was,0,0
128001,lowest,0,0
128002,with,0,0
128003,the,0,0
128004,nasal,0,0
128005,mask,0,0
128006,during,0,0
128007,both,0,0
128008,CPAP,0,0
128009,and,0,1
128010,auto-PAP,0,1
128011,(,0,0
128012,both,0,0
128013,p,0,0
128014,<,0,0
128015,0.01,0,0
128016,),0,0
128017,.,0,0
128018,Differences,0,0
128019,in,0,0
128020,pressure,0,1
128021,or,0,0
128022,residual,0,1
128023,disease,0,1
128024,were,0,0
128025,not,0,0
128026,related,0,0
128027,to,0,0
128028,measures,0,0
128029,of,0,0
128030,upper,0,0
128031,airway,0,1
128032,shape,0,0
128033,or,0,1
128034,body,0,1
128035,habitus,0,1
128036,.,0,0
128037,CONCLUSIONS,0,0
128038,In,0,0
128039,obese,0,0
128040,OSA,0,0
128041,patients,0,0
128042,changing,0,0
128043,from,0,0
128044,a,0,0
128045,nasal,0,0
128046,to,0,0
128047,oronasal,0,0
128048,mask,0,0
128049,increased,1,0
128050,leak,1,1
128051,and,1,0
128052,residual,1,1
128053,AHI,1,1
128054,but,1,0
128055,did,0,0
128056,not,0,0
128057,affect,0,0
128058,the,0,0
128059,therapeutic,0,0
128060,pressure,0,1
128061,requirement,0,1
128062,.,0,0
128063,The,0,0
128064,findings,0,0
128065,of,0,0
128066,the,0,0
128067,current,0,0
128068,study,0,0
128069,highlight,0,0
128070,mask,0,0
128071,leak,0,0
128072,as,0,0
128073,the,0,0
128074,major,0,0
128075,difficulty,0,0
128076,in,0,0
128077,the,0,0
128078,use,0,0
128079,of,0,0
128080,oronasal,0,0
128081,masks,0,0
128082,.,0,0
128083,[,0,0
128084,Use,0,1
128085,of,0,0
128086,Tachocomb,0,0
128087,for,0,0
128088,prevention,0,0
128089,of,0,0
128090,postoperative,0,1
128091,lymphatic,1,0
128092,leaks,1,1
128093,in,0,0
128094,the,0,0
128095,abdomen,0,0
128096,],0,0
128097,.,0,0
128098,Predictors,0,1
128099,and,0,0
128100,moderators,0,0
128101,of,0,1
128102,parent,0,1
128103,training,0,0
128104,efficacy,0,1
128105,in,0,0
128106,a,0,0
128107,sample,0,0
128108,of,0,0
128109,children,0,0
128110,with,0,0
128111,autism,0,0
128112,spectrum,0,0
128113,disorders,0,0
128114,and,0,0
128115,serious,0,1
128116,behavioral,0,1
128117,problems,0,0
128118,.,0,0
128119,The,0,0
128120,Research,0,0
128121,Units,0,0
128122,on,0,0
128123,Pediatric,0,0
128124,Psychopharmacology,0,0
128125,--,0,0
128126,Autism,0,1
128127,Network,0,0
128128,reported,0,0
128129,additional,0,0
128130,benefit,0,0
128131,when,0,0
128132,adding,0,0
128133,parent,0,1
128134,training,0,0
128135,(,0,0
128136,PT,0,1
128137,),0,0
128138,to,0,0
128139,antipsychotic,0,0
128140,medication,0,1
128141,in,0,0
128142,children,0,0
128143,with,0,0
128144,autism,0,0
128145,spectrum,0,0
128146,disorders,0,0
128147,and,0,1
128148,serious,0,1
128149,behavior,0,1
128150,problems,0,0
128151,.,0,0
128152,The,0,0
128153,intent-to-treat,0,0
128154,analyses,0,0
128155,were,0,0
128156,rerun,0,0
128157,with,0,0
128158,putative,0,0
128159,predictors,0,0
128160,and,0,0
128161,moderators,0,0
128162,.,0,0
128163,The,0,0
128164,Home,1,0
128165,Situations,1,1
128166,Questionnaire,1,1
128167,(,1,0
128168,HSQ,1,1
128169,),1,0
128170,and,1,0
128171,the,1,0
128172,Hyperactivity/Noncompliance,1,1
128173,subscale,1,1
128174,of,1,0
128175,the,1,0
128176,Aberrant,1,0
128177,Behavior,1,1
128178,Checklist,1,1
128179,were,0,0
128180,used,0,0
128181,as,0,0
128182,outcome,0,0
128183,measures,0,0
128184,.,0,0
128185,Candidate,0,0
128186,predictors,0,1
128187,and,0,1
128188,moderators,0,0
128189,included,0,0
128190,21,0,0
128191,demographics,0,0
128192,and,0,0
128193,baseline,0,0
128194,measures,0,1
128195,of,0,0
128196,behavior,0,1
128197,.,0,0
128198,Higher,0,0
128199,baseline,0,0
128200,HSQ,1,1
128201,scores,1,1
128202,predicted,0,1
128203,greater,0,0
128204,improvement,0,1
128205,on,0,0
128206,the,0,0
128207,HSQ,0,0
128208,regardless,0,0
128209,of,0,0
128210,treatment,0,0
128211,assignment,0,0
128212,",",0,0
128213,but,0,0
128214,no,0,0
128215,other,0,0
128216,predictors,0,0
128217,of,0,0
128218,outcome,0,1
128219,were,0,0
128220,observed,0,0
128221,.,0,0
128222,None,0,0
128223,of,0,0
128224,the,0,0
128225,variables,0,0
128226,measured,0,0
128227,in,0,0
128228,this,0,0
128229,study,0,0
128230,moderated,0,0
128231,response,0,1
128232,to,0,0
128233,PT,0,1
128234,.,0,0
128235,Antipsychotic,0,0
128236,medication,0,1
128237,plus,0,0
128238,PT,0,1
128239,appears,0,0
128240,to,0,0
128241,be,0,0
128242,equally,0,0
128243,effective,0,0
128244,for,0,0
128245,children,0,0
128246,with,0,0
128247,a,0,0
128248,wide,0,0
128249,range,0,0
128250,of,0,0
128251,demographic,0,1
128252,and,0,0
128253,behavioral,0,1
128254,characteristics,0,0
128255,.,0,0
128256,Comparative,1,0
128257,effectiveness,1,1
128258,of,0,0
128259,exercise,0,0
128260,electrocardiography,0,1
128261,with,0,0
128262,or,0,0
128263,without,0,0
128264,myocardial,0,1
128265,perfusion,0,1
128266,single,0,0
128267,photon,0,1
128268,emission,0,0
128269,computed,0,0
128270,tomography,0,0
128271,in,0,0
128272,women,0,0
128273,with,0,0
128274,suspected,0,0
128275,coronary,0,0
128276,artery,0,0
128277,disease,0,0
128278,:,0,0
128279,results,0,0
128280,from,0,0
128281,the,0,0
128282,What,0,0
128283,Is,0,0
128284,the,0,0
128285,Optimal,0,0
128286,Method,0,0
128287,for,0,0
128288,Ischemia,0,1
128289,Evaluation,0,0
128290,in,0,0
128291,Women,0,0
128292,(,0,0
128293,WOMEN,0,0
128294,),0,0
128295,trial,0,0
128296,.,0,0
128297,BACKGROUND,0,0
128298,There,0,0
128299,is,0,0
128300,a,0,0
128301,paucity,0,0
128302,of,0,0
128303,randomized,0,0
128304,trials,0,0
128305,regarding,0,0
128306,diagnostic,0,0
128307,testing,0,0
128308,in,0,0
128309,women,0,0
128310,with,0,0
128311,suspected,0,0
128312,coronary,0,0
128313,artery,0,1
128314,disease,0,1
128315,(,0,0
128316,CAD,0,0
128317,),0,0
128318,.,0,0
128319,It,0,0
128320,remains,0,0
128321,unclear,0,0
128322,whether,0,0
128323,the,0,0
128324,addition,0,0
128325,of,0,0
128326,myocardial,0,1
128327,perfusion,0,1
128328,imaging,0,1
128329,(,0,0
128330,MPI,0,0
128331,),0,0
128332,to,0,0
128333,the,0,0
128334,standard,0,0
128335,ECG,0,1
128336,exercise,0,0
128337,treadmill,0,0
128338,test,0,1
128339,(,0,0
128340,ETT,0,1
128341,),0,0
128342,provides,0,0
128343,incremental,0,0
128344,information,0,0
128345,to,0,0
128346,improve,0,0
128347,clinical,0,0
128348,decision,0,1
128349,making,0,0
128350,in,0,0
128351,women,0,0
128352,with,0,0
128353,suspected,0,0
128354,CAD,0,0
128355,.,0,0
128356,METHODS,0,0
128357,AND,0,0
128358,RESULTS,0,0
128359,We,0,0
128360,randomized,0,0
128361,symptomatic,0,0
128362,women,0,0
128363,with,0,0
128364,suspected,0,0
128365,CAD,0,0
128366,",",0,0
128367,an,0,0
128368,interpretable,0,1
128369,ECG,0,1
128370,",",0,0
128371,and,0,1
128372,?5,0,1
128373,metabolic,0,1
128374,equivalents,0,0
128375,on,0,0
128376,the,0,0
128377,Duke,0,0
128378,Activity,0,1
128379,Status,0,0
128380,Index,0,0
128381,to,0,0
128382,1,0,0
128383,of,0,0
128384,2,0,0
128385,diagnostic,0,0
128386,strategies,0,0
128387,:,0,0
128388,ETT,0,1
128389,or,0,0
128390,exercise,0,0
128391,MPI,0,0
128392,.,0,0
128393,The,0,0
128394,primary,0,0
128395,end,0,0
128396,point,0,0
128397,was,1,0
128398,2-year,1,0
128399,incidence,1,1
128400,of,1,0
128401,major,1,0
128402,adverse,1,1
128403,cardiac,1,1
128404,events,1,1
128405,",",1,0
128406,defined,1,0
128407,as,1,0
128408,CAD,1,0
128409,death,1,1
128410,or,1,0
128411,hospitalization,1,1
128412,for,1,0
128413,an,1,0
128414,acute,1,0
128415,coronary,1,0
128416,syndrome,1,0
128417,or,1,0
128418,heart,1,1
128419,failure,1,1
128420,.,1,0
128421,A,0,0
128422,total,0,0
128423,of,0,0
128424,824,0,0
128425,women,0,0
128426,were,0,0
128427,randomized,0,0
128428,to,0,0
128429,ETT,0,1
128430,or,0,0
128431,exercise,0,0
128432,MPI,0,1
128433,.,0,0
128434,For,0,0
128435,women,0,0
128436,randomized,0,0
128437,to,0,0
128438,ETT,1,1
128439,",",1,0
128440,ECG,1,1
128441,results,1,0
128442,were,0,0
128443,normal,0,0
128444,in,0,0
128445,64,0,0
128446,%,0,0
128447,",",0,0
128448,indeterminate,0,0
128449,in,0,0
128450,16,0,0
128451,%,0,0
128452,",",0,0
128453,and,0,1
128454,abnormal,0,1
128455,in,0,0
128456,20,0,0
128457,%,0,0
128458,.,0,0
128459,By,0,1
128460,comparison,0,0
128461,",",0,0
128462,the,1,0
128463,exercise,1,0
128464,MPI,1,1
128465,results,1,0
128466,were,1,0
128467,normal,0,0
128468,in,0,0
128469,91,0,0
128470,%,0,0
128471,",",0,0
128472,mildly,0,0
128473,abnormal,0,1
128474,in,0,0
128475,3,0,0
128476,%,0,0
128477,",",0,0
128478,and,0,0
128479,moderate,0,0
128480,to,0,0
128481,severely,0,0
128482,abnormal,0,1
128483,in,0,0
128484,6,0,0
128485,%,0,0
128486,.,0,0
128487,At,0,0
128488,2,0,0
128489,years,0,0
128490,",",0,0
128491,there,0,0
128492,was,0,0
128493,no,0,0
128494,difference,0,0
128495,in,0,0
128496,major,1,0
128497,adverse,1,1
128498,cardiac,1,1
128499,events,1,1
128500,(,1,0
128501,98.0,0,0
128502,%,0,0
128503,for,0,0
128504,ETT,0,1
128505,and,0,0
128506,97.7,0,0
128507,%,0,0
128508,for,0,0
128509,MPI,0,0
128510,;,0,0
128511,P=0.59,0,0
128512,),0,0
128513,.,0,0
128514,Compared,0,0
128515,with,0,0
128516,ETT,1,1
128517,",",1,0
128518,index,1,1
128519,testing,1,0
128520,costs,1,1
128521,were,1,0
128522,higher,0,0
128523,for,0,0
128524,exercise,0,0
128525,MPI,0,1
128526,(,0,0
128527,P,0,0
128528,<,0,0
128529,0.001,0,0
128530,),0,0
128531,",",0,0
128532,whereas,0,0
128533,downstream,0,0
128534,procedural,0,1
128535,costs,0,1
128536,were,0,0
128537,slightly,0,0
128538,lower,0,0
128539,(,0,0
128540,P=0.0008,0,0
128541,),0,0
128542,.,0,0
128543,Overall,0,0
128544,",",0,0
128545,the,1,0
128546,cumulative,1,1
128547,diagnostic,1,0
128548,cost,1,1
128549,savings,1,0
128550,was,1,0
128551,48,0,0
128552,%,0,0
128553,for,0,0
128554,ETT,0,1
128555,compared,0,0
128556,with,0,0
128557,exercise,0,0
128558,MPI,0,1
128559,(,0,0
128560,P,0,0
128561,<,0,0
128562,0.001,0,0
128563,),0,0
128564,.,0,0
128565,CONCLUSIONS,0,0
128566,In,0,0
128567,low-risk,0,0
128568,",",0,0
128569,exercising,0,0
128570,women,0,0
128571,",",0,0
128572,a,0,0
128573,diagnostic,0,0
128574,strategy,0,0
128575,that,0,0
128576,uses,0,0
128577,ETT,0,1
128578,versus,0,0
128579,exercise,0,0
128580,MPI,0,1
128581,yields,0,1
128582,similar,0,0
128583,2-year,0,0
128584,posttest,0,0
128585,outcomes,0,1
128586,while,0,0
128587,providing,0,0
128588,significant,0,0
128589,diagnostic,0,0
128590,cost,0,1
128591,savings,0,0
128592,.,0,0
128593,The,0,0
128594,ETT,0,1
128595,with,0,0
128596,selective,0,0
128597,follow-up,0,0
128598,testing,0,0
128599,should,0,0
128600,be,0,0
128601,considered,0,0
128602,as,0,0
128603,the,0,0
128604,initial,0,0
128605,diagnostic,0,0
128606,strategy,0,0
128607,in,0,0
128608,symptomatic,0,0
128609,women,0,0
128610,with,0,0
128611,suspected,0,0
128612,CAD,0,0
128613,.,0,0
128614,CLINICAL,0,1
128615,TRIAL,0,0
128616,REGISTRATION,0,0
128617,http,0,0
128618,:,0,0
128619,//www.clinicaltrials.gov,0,0
128620,.,0,0
128621,Unique,0,0
128622,identifier,0,0
128623,:,0,0
128624,NCT00282711,0,0
128625,.,0,0
128626,Ameliorating,1,0
128627,intrusive,1,1
128628,memories,1,1
128629,of,1,0
128630,distressing,1,0
128631,experiences,1,0
128632,using,0,0
128633,computerized,0,0
128634,reappraisal,0,0
128635,training,0,0
128636,.,0,0
128637,The,0,0
128638,types,0,0
128639,of,0,0
128640,appraisals,0,0
128641,that,0,0
128642,follow,0,0
128643,traumatic,0,0
128644,experiences,0,0
128645,have,0,0
128646,been,0,0
128647,linked,0,0
128648,to,0,0
128649,the,0,0
128650,emergence,0,1
128651,of,0,0
128652,posttraumatic,0,0
128653,stress,0,1
128654,disorder,0,0
128655,(,0,0
128656,PTSD,0,0
128657,),0,0
128658,.,0,0
128659,Could,0,0
128660,changing,0,0
128661,reappraisals,0,0
128662,following,0,0
128663,a,0,0
128664,stressful,0,0
128665,event,0,0
128666,reduce,0,0
128667,the,0,0
128668,emergence,0,1
128669,of,0,0
128670,PTSD,0,0
128671,symptoms,0,1
128672,?,0,0
128673,The,0,0
128674,present,0,0
128675,proof-of-principle,0,0
128676,study,0,0
128677,examined,0,0
128678,whether,0,0
128679,a,0,0
128680,nonexplicit,0,0
128681,",",0,0
128682,systematic,0,0
128683,computerized,0,0
128684,training,0,0
128685,in,0,0
128686,reappraisal,0,0
128687,style,0,0
128688,following,0,0
128689,a,0,0
128690,stressful,0,1
128691,event,0,0
128692,(,0,0
128693,a,0,0
128694,highly,0,0
128695,distressing,0,0
128696,film,0,0
128697,),0,0
128698,could,0,0
128699,reduce,0,0
128700,intrusive,0,1
128701,memories,0,1
128702,of,0,0
128703,the,0,0
128704,film,0,0
128705,",",0,0
128706,and,0,1
128707,symptoms,0,1
128708,associated,0,0
128709,with,0,0
128710,posttraumatic,0,0
128711,distress,0,1
128712,over,0,0
128713,the,0,0
128714,subsequent,0,0
128715,week,0,0
128716,.,0,0
128717,Participants,0,0
128718,were,0,0
128719,trained,0,0
128720,to,0,0
128721,adopt,0,0
128722,a,0,0
128723,generally,0,0
128724,positive,0,0
128725,or,0,0
128726,negative,0,1
128727,poststressor,0,1
128728,appraisal,0,1
128729,style,0,1
128730,using,0,0
128731,a,0,0
128732,series,0,0
128733,of,0,0
128734,scripted,0,0
128735,vignettes,0,0
128736,after,0,0
128737,having,0,0
128738,been,0,0
128739,exposed,0,0
128740,to,0,0
128741,highly,0,0
128742,distressing,0,0
128743,film,0,0
128744,clips,0,0
128745,.,0,0
128746,The,0,0
128747,training,0,0
128748,targeted,0,0
128749,self-efficacy,0,1
128750,beliefs,0,1
128751,and,0,0
128752,reappraisals,0,1
128753,of,0,1
128754,secondary,0,0
128755,emotions,0,1
128756,(,0,0
128757,emotions,0,1
128758,in,0,0
128759,response,0,1
128760,to,0,0
128761,the,0,0
128762,emotional,0,1
128763,reactions,0,1
128764,elicited,0,0
128765,by,0,0
128766,the,0,0
128767,film,0,0
128768,),0,0
128769,.,0,0
128770,Successful,0,0
128771,appraisal,0,1
128772,induction,0,1
128773,was,0,0
128774,verified,0,0
128775,using,0,0
128776,novel,0,0
128777,vignettes,0,0
128778,and,0,0
128779,via,0,0
128780,change,0,1
128781,scores,0,1
128782,on,0,0
128783,the,0,0
128784,post,0,0
128785,traumatic,0,0
128786,cognitions,0,1
128787,inventory,0,0
128788,.,0,0
128789,Compared,0,0
128790,with,0,0
128791,those,0,0
128792,trained,0,0
128793,negatively,0,0
128794,",",0,0
128795,those,0,0
128796,trained,0,0
128797,positively,0,0
128798,reported,0,0
128799,in,0,0
128800,a,0,0
128801,diary,0,0
128802,fewer,0,0
128803,intrusive,1,1
128804,memories,1,1
128805,of,0,0
128806,the,0,0
128807,film,0,0
128808,during,0,0
128809,the,0,0
128810,subsequent,0,0
128811,week,0,0
128812,",",0,0
128813,and,0,1
128814,lower,0,1
128815,scores,0,1
128816,on,0,0
128817,the,0,0
128818,Impact,1,0
128819,of,1,0
128820,Event,1,0
128821,Scale,1,1
128822,(,0,0
128823,a,0,0
128824,widely,0,0
128825,used,0,0
128826,measure,0,0
128827,of,0,0
128828,posttraumatic,0,0
128829,stress,0,1
128830,symptoms,0,1
128831,),0,0
128832,.,0,0
128833,Results,0,0
128834,support,0,0
128835,the,0,0
128836,use,0,0
128837,of,0,0
128838,computerized,0,0
128839,",",0,0
128840,nonexplicit,0,0
128841,",",0,0
128842,reappraisal,0,0
128843,training,0,0
128844,after,0,0
128845,a,0,0
128846,stressful,0,0
128847,event,0,0
128848,has,0,0
128849,occurred,0,0
128850,and,0,0
128851,provide,0,0
128852,a,0,0
128853,platform,0,0
128854,for,0,0
128855,future,0,0
128856,translational,0,0
128857,studies,0,0
128858,with,0,0
128859,clinical,0,0
128860,populations,0,0
128861,that,0,0
128862,have,0,0
128863,experienced,0,0
128864,significant,0,0
128865,real-world,0,0
128866,stress,0,1
128867,or,0,0
128868,trauma,0,0
128869,.,0,0
128870,[,0,0
128871,The,0,0
128872,equipotency,0,1
128873,of,0,0
128874,ropivacaine,0,0
128875,",",0,0
128876,bupivacaine,0,0
128877,and,0,1
128878,etidocaine,0,0
128879,],0,0
128880,.,0,0
128881,Ropivacaine,0,0
128882,",",0,0
128883,congenerate,0,0
128884,to,0,0
128885,bupivacaine,0,0
128886,and,0,0
128887,mepivacaine,0,0
128888,has,0,0
128889,been,0,0
128890,widely,0,0
128891,studied,0,0
128892,in,0,0
128893,laboratory,0,0
128894,animals,0,0
128895,",",0,0
128896,but,0,0
128897,there,0,0
128898,have,0,0
128899,been,0,0
128900,few,0,0
128901,investigations,0,0
128902,of,0,0
128903,its,0,0
128904,efficacy,0,1
128905,in,0,0
128906,human,0,0
128907,epidural,0,0
128908,anesthesia,0,0
128909,and,0,0
128910,peripheral,0,1
128911,nerve,0,1
128912,blocks,0,0
128913,.,0,0
128914,The,0,0
128915,aim,0,0
128916,of,0,0
128917,this,0,0
128918,study,0,0
128919,was,0,0
128920,to,0,0
128921,compare,0,0
128922,the,0,0
128923,three,0,0
128924,long-acting,0,0
128925,local,0,0
128926,anesthetics,0,0
128927,(,0,0
128928,bupivacaine,0,0
128929,0.75,0,0
128930,%,0,0
128931,",",0,0
128932,ropivacaine,0,0
128933,1,0,0
128934,%,0,0
128935,and,0,0
128936,etidocaine,0,0
128937,1,0,0
128938,%,0,0
128939,),0,0
128940,and,0,0
128941,to,0,0
128942,try,0,0
128943,",",0,0
128944,with,0,0
128945,reference,0,0
128946,to,0,0
128947,previous,0,0
128948,studies,0,0
128949,",",0,0
128950,to,0,0
128951,make,0,0
128952,some,0,0
128953,statement,0,0
128954,about,0,0
128955,the,0,0
128956,equipotency,0,1
128957,of,0,0
128958,ropivacaine,0,0
128959,relative,0,0
128960,to,0,0
128961,bupivacaine,0,0
128962,and,0,0
128963,etidocaine,0,0
128964,.,0,0
128965,METHODS,0,0
128966,.,0,0
128967,In,0,0
128968,a,0,0
128969,double,0,0
128970,blind,0,0
128971,randomized,0,0
128972,study,0,0
128973,",",0,0
128974,epidural,0,0
128975,anesthesia,0,0
128976,was,0,0
128977,carried,0,0
128978,out,0,0
128979,with,0,0
128980,20,0,0
128981,ml,0,0
128982,bupivacaine,0,0
128983,0.75,0,0
128984,%,0,0
128985,(,0,0
128986,n,0,0
128987,=,0,0
128988,24,0,0
128989,),0,0
128990,and,0,0
128991,ropivacaine,0,0
128992,1,0,0
128993,%,0,0
128994,(,0,0
128995,n,0,0
128996,=,0,0
128997,21,0,0
128998,),0,0
128999,.,0,0
129000,Following,0,0
129001,this,0,0
129002,study,0,0
129003,epidural,0,0
129004,anesthesia,0,0
129005,was,0,0
129006,carried,0,0
129007,out,0,0
129008,with,0,0
129009,20,0,0
129010,ml,0,0
129011,etidocaine,0,0
129012,1,0,0
129013,%,0,0
129014,(,0,0
129015,n,0,0
129016,=,0,0
129017,20,0,0
129018,),0,0
129019,in,0,0
129020,an,0,0
129021,open,0,0
129022,study,0,0
129023,.,0,0
129024,Patients,0,0
129025,with,0,0
129026,ASA,0,0
129027,I,0,0
129028,or,0,0
129029,II,0,0
129030,were,0,0
129031,enrolled,0,0
129032,in,0,0
129033,the,0,0
129034,study,0,0
129035,.,0,0
129036,All,0,0
129037,patients,0,0
129038,were,0,0
129039,scheduled,0,0
129040,for,0,0
129041,varicose,0,0
129042,vein,0,0
129043,stripping,0,0
129044,.,0,0
129045,Male,0,0
129046,and,0,0
129047,female,0,0
129048,patients,0,0
129049,aged,0,0
129050,18-70,0,0
129051,years,0,0
129052,and,0,0
129053,weighing,0,0
129054,50-100,0,0
129055,kg,0,0
129056,were,0,0
129057,included,0,0
129058,in,0,0
129059,the,0,0
129060,study,0,0
129061,.,0,0
129062,Patients,0,0
129063,were,0,0
129064,all,0,0
129065,placed,0,0
129066,in,0,0
129067,a,0,0
129068,sitting,0,1
129069,position,0,0
129070,",",0,0
129071,after,0,0
129072,which,0,0
129073,the,0,0
129074,epidural,0,0
129075,space,0,0
129076,was,0,0
129077,identified,0,0
129078,by,0,0
129079,the,0,0
129080,loss,0,1
129081,of,0,0
129082,resistance,0,1
129083,technique,0,0
129084,and,0,0
129085,a,0,0
129086,midline,0,0
129087,approach,0,0
129088,",",0,0
129089,at,0,0
129090,the,0,0
129091,L-3/4,0,0
129092,interspace,0,0
129093,.,0,0
129094,Injections,0,0
129095,of,0,0
129096,3,0,0
129097,ml,0,0
129098,of,0,0
129099,the,0,0
129100,local,0,0
129101,anesthetic,0,0
129102,were,0,0
129103,given,0,0
129104,",",0,0
129105,followed,0,0
129106,by,0,0
129107,the,0,0
129108,remainder,0,0
129109,of,0,0
129110,the,0,0
129111,local,0,0
129112,anesthetic,0,0
129113,at,0,0
129114,10,0,0
129115,ml/min,0,0
129116,1,0,0
129117,min,0,0
129118,later,0,0
129119,.,0,0
129120,Following,0,0
129121,injection,0,0
129122,patients,0,0
129123,were,0,0
129124,immediately,0,0
129125,positioned,0,0
129126,supine,0,0
129127,.,0,0
129128,Analgesia,0,1
129129,was,0,0
129130,determined,0,0
129131,by,0,0
129132,the,0,0
129133,pin-prick,1,0
129134,method,1,0
129135,and,0,1
129136,motor,0,1
129137,blockade,0,0
129138,was,0,0
129139,assessed,0,0
129140,according,0,0
129141,to,0,0
129142,the,0,0
129143,Bromage,1,0
129144,scale,1,1
129145,.,1,0
129146,Heart,1,0
129147,rate,1,1
129148,and,1,1
129149,blood,1,1
129150,pressure,1,1
129151,were,0,0
129152,monitored,0,0
129153,until,0,0
129154,3,0,0
129155,h,0,0
129156,after,0,0
129157,injection,0,0
129158,.,0,0
129159,RESULTS,0,0
129160,.,0,0
129161,The,0,0
129162,latency,1,1
129163,of,1,0
129164,analgesia,1,0
129165,for,0,0
129166,the,0,0
129167,first,0,0
129168,blocked,0,0
129169,segment,0,0
129170,(,0,0
129171,T,0,0
129172,12,0,0
129173,for,0,0
129174,bupivacaine,0,0
129175,and,0,1
129176,ropivacaine,0,0
129177,and,0,1
129178,L-1,0,0
129179,for,0,0
129180,etidocaine,0,0
129181,),0,0
129182,was,0,0
129183,6.0,0,0
129184,min,0,0
129185,for,0,0
129186,bupivacaine,0,0
129187,0.75,0,0
129188,",",0,0
129189,5.5,0,0
129190,min,0,0
129191,for,0,0
129192,ropivacaine,0,0
129193,1,0,0
129194,%,0,0
129195,",",0,0
129196,and,0,0
129197,5.2,0,0
129198,min,0,0
129199,for,0,0
129200,etidocaine,0,0
129201,1,0,0
129202,%,0,0
129203,",",0,0
129204,and,0,0
129205,the,0,0
129206,highest,0,0
129207,thoracic,0,0
129208,dermatome,0,1
129209,(,0,0
129210,T,0,0
129211,5,0,0
129212,for,0,0
129213,bupivacaine,0,0
129214,",",0,0
129215,T,0,0
129216,4,0,0
129217,for,0,0
129218,ropivacaine,0,0
129219,and,0,0
129220,T,0,0
129221,7,0,0
129222,for,0,0
129223,etidocaine,0,0
129224,),0,0
129225,was,0,0
129226,reached,0,0
129227,after,0,0
129228,24,0,0
129229,+/-,0,0
129230,10,0,0
129231,",",0,0
129232,26,0,0
129233,+/-,0,0
129234,9,0,0
129235,",",0,0
129236,and,0,0
129237,30,0,0
129238,+/-,0,0
129239,18,0,0
129240,min,0,0
129241,for,0,0
129242,bupivacaine,0,0
129243,",",0,0
129244,ropivacaine,0,0
129245,",",0,1
129246,and,0,1
129247,etidocaine,0,0
129248,",",0,0
129249,respectively,0,0
129250,.,0,0
129251,The,0,0
129252,duration,1,1
129253,of,1,0
129254,sensory,1,1
129255,anesthesia,1,0
129256,at,0,0
129257,the,0,0
129258,T,0,0
129259,10,0,0
129260,dermatomal,0,0
129261,level,0,0
129262,was,0,0
129263,257,0,0
129264,+/-,0,0
129265,102,0,0
129266,",",0,0
129267,278,0,0
129268,+/-,0,0
129269,67,0,0
129270,",",0,0
129271,and,0,0
129272,191,0,0
129273,+/-,0,0
129274,86,0,0
129275,min,0,0
129276,for,0,0
129277,bupivacaine,0,0
129278,",",0,0
129279,ropivacaine,0,0
129280,",",0,1
129281,and,0,1
129282,etidocaine,0,0
129283,",",0,0
129284,respectively,0,0
129285,.,0,0
129286,The,0,0
129287,two-segment,1,0
129288,regression,1,0
129289,time,1,1
129290,was,0,0
129291,199,0,0
129292,+/-,0,0
129293,80,0,0
129294,min,0,0
129295,for,0,0
129296,bupivacaine,0,0
129297,",",0,0
129298,201,0,0
129299,+/-,0,0
129300,52,0,0
129301,min,0,0
129302,for,0,0
129303,ropivacaine,0,0
129304,",",0,0
129305,and,0,0
129306,174,0,0
129307,+/-,0,0
129308,81,0,0
129309,min,0,0
129310,for,0,0
129311,etidocaine,0,0
129312,.,0,0
129313,The,0,0
129314,total,1,1
129315,duration,1,1
129316,of,1,0
129317,sensory,1,1
129318,block,1,0
129319,was,0,0
129320,340,0,0
129321,+/-,0,0
129322,103,0,0
129323,min,0,0
129324,for,0,0
129325,bupivacaine,0,0
129326,",",0,0
129327,428,0,0
129328,+/-,0,0
129329,65,0,0
129330,min,0,0
129331,for,0,0
129332,ropivacaine,0,0
129333,and,0,0
129334,223,0,0
129335,+/-,0,0
129336,62,0,0
129337,min,0,0
129338,for,0,0
129339,etidocaine,0,0
129340,",",0,0
129341,respectively,0,0
129342,.,0,0
129343,In,0,0
129344,the,0,0
129345,ropivacaine,0,0
129346,and,0,0
129347,bupivacaine,0,0
129348,groups,0,0
129349,sensory,0,1
129350,anesthesia,0,0
129351,was,0,0
129352,considered,0,0
129353,adequate,0,0
129354,for,0,0
129355,surgery,0,0
129356,in,0,0
129357,all,0,0
129358,cases,0,0
129359,but,0,0
129360,one,0,0
129361,in,0,0
129362,each,0,0
129363,group,0,0
129364,;,0,0
129365,in,0,0
129366,the,0,0
129367,etidocaine,0,0
129368,group,0,0
129369,",",0,0
129370,however,0,0
129371,60,0,0
129372,%,0,0
129373,of,0,0
129374,the,0,0
129375,patients,0,0
129376,showed,0,0
129377,inadequate,1,0
129378,analgesia,1,1
129379,and,0,0
129380,all,0,0
129381,these,0,0
129382,patients,0,0
129383,(,0,0
129384,12/20,0,0
129385,),0,0
129386,required,0,0
129387,additional,0,0
129388,analgesics,0,0
129389,.,0,0
129390,Bupivacaine,0,0
129391,achieved,0,0
129392,an,0,0
129393,average,0,0
129394,of,0,0
129395,motor,0,1
129396,block,0,0
129397,2.1,0,0
129398,",",0,0
129399,ropivacaine,0,0
129400,2.3,0,0
129401,",",0,0
129402,and,0,0
129403,etidocaine,0,0
129404,2.4,0,0
129405,.,0,0
129406,CONCLUSION,0,0
129407,.,0,0
129408,The,0,0
129409,results,0,0
129410,of,0,0
129411,this,0,0
129412,study,0,0
129413,indicate,0,0
129414,that,0,0
129415,ropivacaine,0,0
129416,is,0,0
129417,an,0,0
129418,effective,0,0
129419,local,0,0
129420,anesthetic,0,0
129421,agent,0,0
129422,.,0,0
129423,Its,0,0
129424,potency,0,0
129425,is,0,0
129426,about,0,0
129427,equal,0,0
129428,to,0,0
129429,that,0,0
129430,of,0,0
129431,bupivacaine,0,0
129432,and,0,0
129433,much,0,0
129434,higher,0,0
129435,than,0,0
129436,that,0,0
129437,of,0,0
129438,etidocaine,0,0
129439,...,0,0
129440,Comparison,0,0
129441,of,0,0
129442,two,0,0
129443,artificial,0,0
129444,tear,0,1
129445,formulations,0,0
129446,for,0,0
129447,dry,0,0
129448,eye,0,0
129449,through,0,0
129450,high-resolution,0,0
129451,optical,0,0
129452,coherence,0,0
129453,tomography,0,0
129454,.,0,0
129455,PURPOSE,0,0
129456,The,0,0
129457,aim,0,0
129458,was,0,0
129459,to,0,0
129460,determine,0,0
129461,the,0,0
129462,efficacy,0,0
129463,of,0,0
129464,two,0,0
129465,artificial,0,0
129466,eye-drop,0,0
129467,formulations,0,0
129468,by,0,0
129469,analysing,0,0
129470,the,0,0
129471,lower,0,0
129472,tear,0,1
129473,film,0,1
129474,meniscus,0,1
129475,volume,0,1
129476,through,0,0
129477,a,0,0
129478,commercial,0,0
129479,high-resolution,0,0
129480,spectral-domain,0,0
129481,optical,0,0
129482,coherence,0,0
129483,tomographer,0,0
129484,.,0,0
129485,METHODS,0,0
129486,Twenty,0,0
129487,dry,0,0
129488,eye,0,0
129489,patients,0,0
129490,(,0,0
129491,12,0,0
129492,men,0,0
129493,",",0,0
129494,eight,0,0
129495,women,0,0
129496,",",0,0
129497,aged,0,0
129498,57.5,0,0
129499,?,0,0
129500,8.4,0,0
129501,years,0,0
129502,),0,0
129503,with,0,0
129504,refractive,0,1
129505,errors,0,0
129506,from,0,0
129507,-2.50,0,0
129508,to,0,0
129509,+0.75,0,0
129510,D,0,1
129511,(,0,0
129512,mean,0,1
129513,-1.34,0,0
129514,?,0,0
129515,1.02,0,0
129516,D,0,0
129517,),0,0
129518,and,0,0
129519,cylinders,0,0
129520,lower,0,0
129521,than,0,0
129522,1.00,0,0
129523,D,0,0
129524,were,0,0
129525,examined,1,0
129526,.,1,0
129527,Tear,1,0
129528,meniscus,1,1
129529,volume,1,1
129530,was,1,0
129531,measured,0,0
129532,before,0,0
129533,",",0,0
129534,immediately,0,0
129535,after,0,0
129536,and,0,0
129537,10,0,0
129538,",",0,0
129539,30,0,0
129540,and,0,0
129541,60,0,0
129542,minutes,0,0
129543,after,0,0
129544,instillation,0,0
129545,using,0,0
129546,the,0,0
129547,Copernicus,0,0
129548,high-resolution,0,0
129549,spectral-domain,0,0
129550,optical,0,0
129551,coherence,0,0
129552,tomographer,0,0
129553,(,0,0
129554,Optopol,0,0
129555,Tech,0,0
129556,SA,0,0
129557,",",0,0
129558,Zawiercie,0,1
129559,",",0,1
129560,Poland,0,0
129561,),0,0
129562,.,0,0
129563,Volume,0,1
129564,was,0,0
129565,calculated,0,0
129566,from,0,0
129567,the,0,0
129568,local,0,0
129569,area,0,1
129570,obtained,0,0
129571,from,0,0
129572,tomograms,0,0
129573,considering,0,0
129574,a,0,0
129575,regular,0,0
129576,distribution,0,0
129577,of,0,0
129578,the,0,0
129579,tear,0,1
129580,meniscus,0,0
129581,across,0,0
129582,the,0,0
129583,eyelid,0,0
129584,.,0,0
129585,Ten,0,0
129586,subjects,0,0
129587,were,0,0
129588,randomly,0,0
129589,assigned,0,0
129590,to,0,0
129591,first,0,0
129592,receive,0,0
129593,either,0,0
129594,polyethylene,0,0
129595,glycol,0,0
129596,(,0,0
129597,Blink,0,1
129598,Intensive,0,0
129599,",",0,0
129600,Abbot,0,1
129601,Medical,0,0
129602,Optics,0,1
129603,Inc,0,0
129604,",",0,0
129605,CA,0,0
129606,",",0,1
129607,USA,0,0
129608,),0,1
129609,or,0,0
129610,hypromellose,0,0
129611,(,0,0
129612,Artific,0,0
129613,",",0,0
129614,Farma-Lepori,0,1
129615,SA,0,0
129616,",",0,0
129617,Barcelona,0,0
129618,",",0,1
129619,Spain,0,0
129620,),0,0
129621,three,0,0
129622,times,0,0
129623,daily,0,0
129624,in,0,0
129625,both,0,0
129626,eyes,0,0
129627,for,0,0
129628,one,0,0
129629,month,0,0
129630,.,0,0
129631,Measures,0,1
129632,were,0,0
129633,then,0,0
129634,repeated,0,0
129635,and,0,0
129636,after,0,0
129637,a,0,0
129638,one-week,0,0
129639,wash-out,0,0
129640,period,0,0
129641,they,0,0
129642,were,0,0
129643,switched,0,0
129644,to,0,0
129645,the,0,0
129646,other,0,0
129647,eye-drop,0,0
129648,for,0,0
129649,another,0,0
129650,month,0,0
129651,.,0,0
129652,RESULTS,1,0
129653,Mean,1,1
129654,baseline,1,0
129655,volume,1,1
129656,was,1,0
129657,0.38,0,0
129658,?,0,0
129659,0.10,0,0
129660,?L,0,0
129661,",",0,0
129662,while,0,0
129663,mean,0,1
129664,baseline,0,0
129665,volume,0,1
129666,after,0,0
129667,the,0,0
129668,wash-out,0,0
129669,period,0,0
129670,was,0,0
129671,slightly,0,0
129672,higher,0,0
129673,",",0,0
129674,0.39,0,0
129675,?,0,0
129676,0.10,0,0
129677,?L,0,0
129678,(,0,0
129679,p,0,0
129680,=,0,0
129681,0.638,0,0
129682,),0,0
129683,.,0,0
129684,Analysis,0,0
129685,of,0,0
129686,variance,0,0
129687,showed,0,0
129688,significant,0,0
129689,differences,0,0
129690,in,0,0
129691,meniscus,0,1
129692,volume,0,1
129693,with,0,0
129694,time,0,1
129695,after,0,0
129696,instillation,0,0
129697,with,0,0
129698,both,0,0
129699,formulations,0,0
129700,(,0,0
129701,p,0,0
129702,<,0,0
129703,0.001,0,0
129704,),0,0
129705,",",1,0
129706,mean,1,1
129707,volume,1,1
129708,decreasing,1,0
129709,with,1,0
129710,time,1,1
129711,.,1,0
129712,At,0,0
129713,30,0,0
129714,and,0,0
129715,60,0,0
129716,minutes,0,0
129717,following,0,0
129718,instillation,0,0
129719,",",0,0
129720,values,0,1
129721,decreased,0,0
129722,to,0,0
129723,almost,0,0
129724,baseline,0,0
129725,(,0,0
129726,average,0,0
129727,difference,0,0
129728,0.02,0,0
129729,?,0,0
129730,0.03,0,0
129731,?L,0,0
129732,at,0,0
129733,t,0,0
129734,(,0,0
129735,30,0,0
129736,),0,0
129737,",",0,0
129738,p,0,0
129739,=,0,0
129740,0.016,0,0
129741,and,0,0
129742,0.01,0,0
129743,?,0,0
129744,0.01,0,0
129745,?L,0,0
129746,at,0,0
129747,t,0,0
129748,(,0,0
129749,60,0,0
129750,),0,0
129751,",",0,0
129752,p,0,0
129753,=,0,0
129754,0.098,0,0
129755,),0,0
129756,.,0,0
129757,CONCLUSION,0,0
129758,An,0,0
129759,increase,0,0
129760,in,0,0
129761,tear,0,1
129762,film,0,0
129763,meniscus,0,1
129764,volume,0,1
129765,in,0,0
129766,dry,0,0
129767,eyes,0,0
129768,from,0,0
129769,the,0,0
129770,use,0,0
129771,of,0,0
129772,eye-drops,0,0
129773,has,0,0
129774,been,0,0
129775,shown,0,0
129776,.,0,0
129777,High,0,0
129778,resolution,0,1
129779,imaging,0,0
129780,of,0,0
129781,lower,0,0
129782,tear,0,1
129783,film,0,1
129784,meniscus,0,1
129785,with,0,0
129786,clinical,0,0
129787,optical,0,0
129788,coherence,0,0
129789,tomography,0,0
129790,systems,0,0
129791,provides,0,0
129792,useful,0,0
129793,measures,0,1
129794,of,1,0
129795,tear,1,1
129796,volume,1,0
129797,.,1,0
129798,Both,1,0
129799,formulations,0,0
129800,assessed,0,0
129801,in,0,0
129802,the,0,0
129803,present,0,0
129804,study,0,0
129805,are,0,0
129806,efficient,0,0
129807,in,0,0
129808,increasing,0,0
129809,tear,1,1
129810,meniscus,1,1
129811,volume,1,1
129812,and,1,0
129813,reducing,1,0
129814,dry,1,0
129815,eye,1,0
129816,signs,1,1
129817,and,1,1
129818,symptoms,1,1
129819,",",1,0
129820,although,0,0
129821,results,0,0
129822,in,0,0
129823,terms,0,0
129824,of,0,0
129825,increase,0,0
129826,in,1,0
129827,meniscus,1,1
129828,volume,1,1
129829,were,1,0
129830,higher,0,0
129831,with,0,0
129832,the,0,0
129833,polyethylene,0,0
129834,glycol,0,0
129835,formulation,0,0
129836,.,0,0
129837,A,0,0
129838,controlled,0,0
129839,crossover,0,0
129840,trial,0,0
129841,of,0,0
129842,fenfluramine,0,0
129843,in,0,0
129844,autism,0,0
129845,.,0,0
129846,We,0,0
129847,report,0,0
129848,a,0,0
129849,12,0,0
129850,month,0,0
129851,double-blind,0,0
129852,randomized,0,0
129853,crossover,0,0
129854,trial,0,0
129855,of,0,0
129856,fenfluramine,0,0
129857,in,0,0
129858,20,0,0
129859,children,0,0
129860,with,0,0
129861,the,0,0
129862,syndrome,0,0
129863,of,0,0
129864,autism,0,0
129865,.,0,0
129866,On,0,0
129867,active,0,0
129868,drug,0,0
129869,most,0,0
129870,of,0,0
129871,the,0,0
129872,children,0,0
129873,lost,1,1
129874,weight,1,1
129875,and,1,1
129876,blood,1,1
129877,serotonin,1,1
129878,levels,1,1
129879,fell,0,0
129880,by,0,0
129881,an,0,0
129882,average,0,0
129883,of,0,0
129884,60,0,0
129885,%,0,0
129886,.,0,0
129887,There,0,0
129888,was,0,0
129889,a,0,0
129890,fall,0,1
129891,in,0,0
129892,urinary,1,1
129893,dopamine,1,0
129894,(,1,0
129895,DA,1,1
129896,),1,0
129897,and,1,0
129898,noradrenaline,1,1
129899,(,1,0
129900,NA,1,0
129901,),1,0
129902,levels,1,1
129903,and,1,0
129904,increased,1,1
129905,excretion,1,1
129906,of,1,0
129907,homovanillic,1,1
129908,acid,1,0
129909,(,1,0
129910,HVA,1,0
129911,),1,0
129912,.,1,0
129913,Some,0,0
129914,of,0,0
129915,the,0,0
129916,children,0,0
129917,showed,0,0
129918,improvement,0,1
129919,in,0,0
129920,tests,1,0
129921,of,1,0
129922,cognitive,1,1
129923,and,1,0
129924,language,1,1
129925,function,1,1
129926,",",0,0
129927,although,0,0
129928,the,0,0
129929,results,0,0
129930,did,0,0
129931,not,0,0
129932,achieve,0,0
129933,overall,0,1
129934,statistical,1,0
129935,significance,1,0
129936,.,1,0
129937,Event-related,1,1
129938,brain,1,1
129939,potentials,1,1
129940,(,1,0
129941,ERPs,1,0
129942,),1,0
129943,were,0,0
129944,obtained,0,0
129945,in,0,0
129946,seven,0,0
129947,subjects,0,0
129948,on,0,0
129949,an,0,0
129950,auditory,0,1
129951,choice,0,0
129952,reaction,0,1
129953,time,0,1
129954,task,0,0
129955,.,0,0
129956,Side,1,0
129957,effects,1,0
129958,of,0,0
129959,the,0,0
129960,drug,0,0
129961,included,0,0
129962,irritability,1,1
129963,and,1,0
129964,lethargy,1,1
129965,.,1,0
129966,Fenfluramine,0,0
129967,may,0,0
129968,have,0,0
129969,a,0,0
129970,limited,0,0
129971,place,0,0
129972,in,0,0
129973,the,0,0
129974,management,0,0
129975,of,0,0
129976,some,0,0
129977,patients,0,0
129978,with,0,0
129979,autistic,0,0
129980,disorder,0,0
129981,.,0,0
129982,Polymorphisms,0,0
129983,of,0,0
129984,ADORA2A,0,1
129985,modulate,0,0
129986,psychomotor,0,1
129987,vigilance,0,1
129988,and,0,0
129989,the,0,0
129990,effects,0,1
129991,of,0,0
129992,caffeine,0,0
129993,on,0,0
129994,neurobehavioural,1,1
129995,performance,1,1
129996,and,1,0
129997,sleep,1,1
129998,EEG,1,0
129999,after,0,0
130000,sleep,0,1
130001,deprivation,0,0
130002,.,0,0
130003,BACKGROUND,0,0
130004,AND,0,0
130005,PURPOSE,0,0
130006,Prolonged,0,1
130007,wakefulness,0,1
130008,impairs,0,0
130009,sustained,0,1
130010,vigilant,1,1
130011,attention,1,0
130012,",",0,0
130013,measured,0,0
130014,with,0,0
130015,the,0,0
130016,psychomotor,1,1
130017,vigilance,1,1
130018,task,1,1
130019,(,1,0
130020,PVT,1,1
130021,),1,1
130022,",",0,0
130023,and,0,0
130024,induces,0,0
130025,a,0,0
130026,compensatory,0,0
130027,increase,0,0
130028,in,0,0
130029,sleep,0,1
130030,intensity,0,1
130031,in,0,0
130032,recovery,0,1
130033,sleep,0,1
130034,",",0,0
130035,quantified,0,0
130036,by,0,0
130037,slow-wave,1,1
130038,activity,1,1
130039,(,1,0
130040,SWA,1,1
130041,),1,0
130042,in,0,0
130043,the,0,0
130044,sleep,1,1
130045,electroencephalogram,1,1
130046,(,1,0
130047,EEG,1,0
130048,),1,0
130049,.,0,0
130050,These,0,0
130051,effects,0,0
130052,of,0,0
130053,sleep,0,1
130054,deprivation,0,0
130055,are,0,0
130056,counteracted,0,0
130057,by,0,0
130058,the,0,0
130059,adenosine,0,0
130060,receptor,0,1
130061,antagonist,0,0
130062,caffeine,0,0
130063,",",0,0
130064,implying,0,0
130065,involvement,0,1
130066,of,0,0
130067,the,0,0
130068,adenosine,0,0
130069,neuromodulator/receptor,0,0
130070,system,0,0
130071,.,0,0
130072,To,0,0
130073,examine,0,0
130074,a,0,0
130075,role,0,0
130076,for,0,0
130077,adenosine,0,0
130078,A,0,0
130079,(,0,0
130080,2A,0,0
130081,),0,0
130082,receptors,0,0
130083,",",0,0
130084,we,0,0
130085,investigated,0,0
130086,whether,0,0
130087,variation,0,0
130088,of,0,0
130089,the,0,0
130090,A,0,0
130091,(,0,0
130092,2A,0,0
130093,),0,0
130094,receptor,0,0
130095,gene,0,1
130096,(,0,0
130097,ADORA2A,0,1
130098,),0,0
130099,modified,0,0
130100,effects,0,1
130101,of,0,0
130102,caffeine,0,0
130103,on,0,0
130104,PVT,1,1
130105,and,0,0
130106,SWA,1,1
130107,after,0,0
130108,sleep,0,1
130109,deprivation,0,0
130110,.,0,0
130111,EXPERIMENTAL,0,0
130112,APPROACH,0,0
130113,A,0,0
130114,haplotype,0,1
130115,analysis,0,0
130116,of,0,0
130117,eight,0,0
130118,single-nucleotide,0,0
130119,polymorphisms,0,0
130120,of,0,0
130121,ADORA2A,0,0
130122,was,0,0
130123,performed,0,0
130124,in,0,0
130125,82,0,0
130126,volunteers,0,0
130127,.,0,0
130128,In,0,0
130129,45,0,0
130130,young,0,0
130131,men,0,0
130132,carrying,0,0
130133,five,0,0
130134,different,0,0
130135,allele,0,0
130136,combinations,0,0
130137,",",0,0
130138,we,0,0
130139,investigated,0,0
130140,the,0,0
130141,effects,0,0
130142,of,0,0
130143,prolonged,0,1
130144,waking,0,1
130145,and,0,0
130146,2,0,0
130147,?,0,0
130148,200,0,0
130149,mg,0,0
130150,caffeine,0,0
130151,or,0,0
130152,2,0,0
130153,?,0,0
130154,100,0,0
130155,mg,0,0
130156,modafinil,0,0
130157,on,0,0
130158,psychomotor,0,1
130159,vigilance,0,1
130160,",",0,1
130161,sleepiness,0,1
130162,",",0,0
130163,and,0,0
130164,the,0,0
130165,waking,0,1
130166,and,1,0
130167,sleep,1,1
130168,EEG,1,0
130169,.,1,0
130170,KEY,0,1
130171,RESULTS,0,0
130172,Throughout,0,0
130173,extended,0,0
130174,wakefulness,0,1
130175,",",0,0
130176,the,0,0
130177,carriers,0,0
130178,of,0,0
130179,haplotype,0,1
130180,HT4,0,0
130181,performed,0,0
130182,faster,0,0
130183,on,0,0
130184,the,1,0
130185,PVT,1,0
130186,than,1,0
130187,carriers,0,0
130188,of,0,0
130189,non-HT4,0,0
130190,haplotype,0,0
130191,alleles,0,1
130192,.,0,0
130193,In,0,0
130194,haplotype,0,1
130195,HT4,0,0
130196,",",0,0
130197,caffeine,0,0
130198,failed,0,0
130199,to,0,0
130200,counteract,0,0
130201,the,0,0
130202,waking-induced,0,0
130203,impairment,0,1
130204,of,0,0
130205,PVT,1,1
130206,performance,1,1
130207,and,1,0
130208,the,0,0
130209,rebound,0,1
130210,of,0,0
130211,SWA,1,1
130212,in,1,0
130213,recovery,0,1
130214,sleep,0,1
130215,.,0,0
130216,However,0,0
130217,",",0,0
130218,caffeine,0,0
130219,was,0,0
130220,effective,0,0
130221,in,0,0
130222,non-HT4,0,0
130223,allele,0,0
130224,carriers,0,0
130225,",",0,0
130226,and,0,1
130227,modafinil,0,0
130228,reduced,0,0
130229,the,0,0
130230,consequences,0,0
130231,of,0,0
130232,prolonged,0,1
130233,waking,0,1
130234,",",0,0
130235,independently,0,0
130236,of,0,0
130237,ADORA2A,0,0
130238,haplotype,0,0
130239,.,0,0
130240,CONCLUSIONS,0,0
130241,AND,0,0
130242,IMPLICATIONS,0,0
130243,Common,0,1
130244,genetic,0,0
130245,variation,0,1
130246,of,0,0
130247,ADORA2A,0,0
130248,is,0,0
130249,an,0,0
130250,important,0,0
130251,determinant,0,1
130252,of,0,0
130253,psychomotor,1,1
130254,vigilance,1,1
130255,in,1,0
130256,rested,0,0
130257,and,0,0
130258,sleep-deprived,0,0
130259,state,0,0
130260,.,0,0
130261,It,0,0
130262,also,0,0
130263,modulates,0,0
130264,individual,0,0
130265,responses,0,1
130266,to,0,0
130267,caffeine,0,0
130268,after,0,0
130269,sleep,0,1
130270,deprivation,0,0
130271,.,0,0
130272,These,0,0
130273,findings,0,0
130274,demonstrate,0,0
130275,a,0,0
130276,role,0,0
130277,for,0,0
130278,adenosine,0,0
130279,A,0,0
130280,(,0,0
130281,2A,0,0
130282,),0,0
130283,receptors,0,0
130284,in,0,0
130285,the,0,0
130286,effects,0,0
130287,of,0,0
130288,prolonged,1,1
130289,wakefulness,1,1
130290,on,1,0
130291,vigilant,1,1
130292,attention,1,0
130293,and,1,0
130294,the,1,0
130295,sleep,1,1
130296,EEG,1,0
130297,.,1,0
130298,[,0,0
130299,Comparative,0,0
130300,effects,0,1
130301,of,0,0
130302,nebivolol,0,0
130303,and,0,1
130304,valsartan,0,0
130305,on,0,0
130306,atrial,1,1
130307,electromechanical,1,1
130308,coupling,1,0
130309,in,0,0
130310,newly,0,0
130311,diagnosed,0,0
130312,stage,0,0
130313,1,0,0
130314,hypertensive,0,0
130315,patients,0,0
130316,],0,0
130317,.,0,0
130318,OBJECTIVES,0,0
130319,Hypertension,0,0
130320,is,0,0
130321,an,0,0
130322,important,0,0
130323,cardiovascular,0,1
130324,risk,0,1
130325,factor,0,0
130326,for,0,0
130327,the,0,0
130328,development,0,0
130329,of,0,0
130330,atrial,1,1
130331,fibrillation,1,1
130332,(,1,0
130333,AF,1,0
130334,),1,0
130335,.,1,0
130336,Increased,0,0
130337,atrial,0,0
130338,electromechanical,0,1
130339,coupling,0,0
130340,time,0,1
130341,interval,0,0
130342,measured,0,0
130343,by,0,0
130344,tissue,0,0
130345,Doppler,0,0
130346,is,0,0
130347,accepted,0,0
130348,as,0,0
130349,an,0,0
130350,important,0,0
130351,factor,0,0
130352,for,0,0
130353,prediction,0,0
130354,of,0,0
130355,AF,1,1
130356,development,1,1
130357,in,0,0
130358,hypertensive,0,0
130359,patients,0,0
130360,.,0,0
130361,The,0,0
130362,aim,0,0
130363,of,0,0
130364,this,0,0
130365,study,0,0
130366,was,0,0
130367,to,0,0
130368,compare,0,0
130369,the,0,0
130370,effects,0,0
130371,of,0,0
130372,valsartan,0,0
130373,",",0,0
130374,an,0,0
130375,angiotensin,0,0
130376,receptor,0,1
130377,blocker,0,0
130378,",",0,0
130379,and,0,1
130380,nebivolol,0,0
130381,",",0,0
130382,a,0,0
130383,beta-blocker,0,0
130384,",",0,0
130385,on,0,0
130386,atrial,0,1
130387,electromechanical,0,1
130388,coupling,0,0
130389,in,0,0
130390,newly,0,0
130391,diagnosed,0,0
130392,stage,0,0
130393,1,0,0
130394,hypertensive,0,0
130395,patients,0,0
130396,.,0,0
130397,STUDY,0,0
130398,DESIGN,0,0
130399,The,0,0
130400,study,0,0
130401,included,0,0
130402,60,0,0
130403,newly,0,0
130404,diagnosed,0,0
130405,stage,0,0
130406,1,0,0
130407,hypertensive,0,0
130408,patients,0,0
130409,with,0,0
130410,no,0,0
130411,other,0,0
130412,systemic,0,0
130413,disease,0,0
130414,.,0,0
130415,The,0,0
130416,patients,0,0
130417,were,0,0
130418,randomized,0,0
130419,to,0,0
130420,receive,0,0
130421,nebivolol,0,0
130422,5,0,0
130423,mg,0,0
130424,(,0,0
130425,30,0,0
130426,patients,0,0
130427,;,0,0
130428,21,0,0
130429,women,0,0
130430,",",0,0
130431,9,0,0
130432,men,0,0
130433,;,0,0
130434,mean,0,1
130435,age,0,0
130436,48.4,0,0
130437,?,0,0
130438,11.4,0,0
130439,years,0,0
130440,),0,0
130441,and,0,0
130442,valsartan,0,0
130443,160,0,0
130444,mg,0,0
130445,(,0,0
130446,30,0,0
130447,patients,0,0
130448,;,0,0
130449,21,0,0
130450,women,0,0
130451,",",0,0
130452,9,0,0
130453,men,0,0
130454,;,0,0
130455,mean,0,1
130456,age,0,0
130457,49.8,0,0
130458,?,0,0
130459,11.3,0,0
130460,years,0,0
130461,),0,0
130462,.,0,0
130463,All,0,0
130464,the,0,0
130465,patients,0,0
130466,underwent,0,0
130467,tissue,0,1
130468,Doppler,0,1
130469,echocardiographic,0,1
130470,examination,0,0
130471,before,0,0
130472,and,0,0
130473,three,0,0
130474,months,0,0
130475,after,0,0
130476,treatment,0,0
130477,to,0,0
130478,compare,0,0
130479,the,0,0
130480,effects,0,0
130481,of,0,0
130482,the,0,0
130483,two,0,0
130484,drugs,0,0
130485,on,0,0
130486,atrial,1,1
130487,electromechanical,1,0
130488,coupling,1,0
130489,.,1,0
130490,RESULTS,1,0
130491,Baseline,1,0
130492,blood,1,1
130493,pressures,1,1
130494,",",1,0
130495,electrocardiographic,1,1
130496,and,1,1
130497,echocardiographic,1,1
130498,findings,1,0
130499,",",1,0
130500,and,1,1
130501,atrial,1,1
130502,electromechanical,1,1
130503,coupling,1,0
130504,were,1,0
130505,similar,0,0
130506,in,0,0
130507,both,0,0
130508,groups,0,0
130509,(,0,0
130510,p,0,0
130511,>,0,0
130512,0.05,0,0
130513,),0,0
130514,.,0,0
130515,Both,0,0
130516,drugs,0,0
130517,significantly,0,0
130518,reduced,1,0
130519,blood,1,1
130520,pressure,1,1
130521,after,1,0
130522,treatment,0,0
130523,",",0,0
130524,with,0,0
130525,similar,0,0
130526,efficacy,0,1
130527,(,0,0
130528,p,0,0
130529,>,1,0
130530,0.05,1,0
130531,),1,0
130532,.,1,0
130533,Atrial,1,0
130534,electromechanical,1,1
130535,coupling,1,0
130536,time,1,1
130537,intervals,1,0
130538,showed,1,0
130539,significant,0,0
130540,decreases,0,0
130541,in,0,0
130542,both,0,0
130543,groups,0,0
130544,.,0,0
130545,CONCLUSION,1,0
130546,Prolonged,1,0
130547,interatrial,1,0
130548,electromechanical,1,1
130549,time,1,1
130550,intervals,1,0
130551,in,1,0
130552,hypertensives,0,0
130553,are,0,0
130554,improved,0,0
130555,with,0,0
130556,antihypertensive,0,0
130557,treatment,0,0
130558,.,0,0
130559,Oral,0,1
130560,bioavailability,0,1
130561,of,0,0
130562,moxifloxacin,0,0
130563,after,0,0
130564,Roux-en-Y,0,0
130565,gastric,0,1
130566,bypass,0,0
130567,surgery,0,0
130568,.,0,0
130569,OBJECTIVES,0,0
130570,Roux-en-Y,0,0
130571,gastric,0,1
130572,bypass,0,0
130573,surgery,0,0
130574,is,0,0
130575,the,0,0
130576,most,0,0
130577,commonly,0,0
130578,performed,0,0
130579,procedure,0,0
130580,for,0,0
130581,the,0,0
130582,treatment,0,0
130583,of,0,0
130584,morbid,0,0
130585,obesity,0,0
130586,.,0,0
130587,This,0,0
130588,anatomical,0,0
130589,alteration,0,0
130590,may,0,0
130591,affect,0,0
130592,the,0,0
130593,absorption,0,1
130594,and,0,0
130595,consequently,0,0
130596,the,0,0
130597,bioavailability,0,1
130598,of,0,0
130599,oral,0,0
130600,drugs,0,0
130601,.,0,0
130602,This,0,0
130603,study,0,0
130604,aims,0,0
130605,to,0,0
130606,investigate,0,0
130607,the,0,0
130608,oral,1,0
130609,bioavailability,1,1
130610,of,0,0
130611,moxifloxacin,0,0
130612,in,0,0
130613,12,0,0
130614,healthy,0,0
130615,volunteers,0,0
130616,who,0,0
130617,underwent,0,0
130618,gastric,0,1
130619,bypass,0,0
130620,surgery,0,0
130621,.,0,0
130622,PATIENTS,0,0
130623,AND,0,0
130624,METHODS,0,0
130625,In,0,0
130626,this,0,0
130627,randomized,0,0
130628,crossover,0,0
130629,study,0,0
130630,",",0,0
130631,each,0,0
130632,subject,0,0
130633,received,0,0
130634,two,0,0
130635,single,0,0
130636,standard,0,0
130637,doses,0,0
130638,of,0,0
130639,400,0,0
130640,mg,0,0
130641,of,0,0
130642,moxifloxacin,0,0
130643,orally,0,0
130644,or,0,0
130645,intravenously,0,0
130646,administered,0,0
130647,on,0,0
130648,two,0,0
130649,occasions,0,0
130650,separated,0,0
130651,by,0,0
130652,a,0,0
130653,washout,0,0
130654,period,0,0
130655,of,0,0
130656,1,0,0
130657,week,0,0
130658,.,0,0
130659,Serial,0,0
130660,venous,0,1
130661,blood,0,1
130662,samples,0,0
130663,were,0,0
130664,drawn,0,0
130665,up,0,0
130666,to,0,0
130667,72,0,0
130668,h,0,0
130669,after,0,0
130670,dosing,0,0
130671,and,0,0
130672,moxifloxacin,1,0
130673,plasma,1,1
130674,levels,1,1
130675,were,0,0
130676,measured,0,0
130677,by,0,0
130678,a,0,0
130679,validated,0,0
130680,HPLC,0,1
130681,method,0,0
130682,with,0,0
130683,fluorescence,0,0
130684,detection,0,1
130685,.,0,0
130686,[,0,0
130687,clinicaltrials.gov,0,0
130688,database,0,0
130689,(,0,0
130690,identifier,0,0
130691,:,0,0
130692,NCT01130922,0,0
130693,),0,0
130694,.,0,0
130695,],0,0
130696,RESULTS,0,0
130697,After,0,0
130698,oral,0,0
130699,dosing,0,0
130700,",",0,0
130701,moxifloxacin,1,0
130702,plasma,1,1
130703,concentrations,1,1
130704,reached,0,0
130705,a,0,0
130706,maximum,0,1
130707,(,0,0
130708,C,0,0
130709,(,0,0
130710,max,0,1
130711,),0,0
130712,),0,0
130713,of,0,0
130714,3.38,0,0
130715,?,0,0
130716,1.41,0,0
130717,mg/L,0,0
130718,after,0,0
130719,1.75,0,0
130720,h,0,0
130721,(,0,0
130722,0.75-4.00,0,0
130723,),0,0
130724,.,0,0
130725,After,0,0
130726,intravenous,0,0
130727,dosing,0,0
130728,",",0,0
130729,C,0,0
130730,(,1,1
130731,max,1,1
130732,),1,1
130733,and,1,1
130734,T,1,1
130735,(,1,1
130736,max,1,1
130737,),1,0
130738,were,0,0
130739,4.53,0,0
130740,?,0,0
130741,1.43,0,0
130742,mg/L,0,0
130743,and,0,0
130744,1.03,0,0
130745,h,0,0
130746,(,0,0
130747,0.75-2.50,0,0
130748,),0,0
130749,",",0,0
130750,respectively,0,0
130751,.,0,0
130752,The,1,0
130753,mean,1,1
130754,areas,1,0
130755,under,1,0
130756,the,1,0
130757,plasma,1,1
130758,concentration,1,1
130759,time,1,1
130760,curve,1,1
130761,extrapolated,1,0
130762,to,0,0
130763,infinity,0,1
130764,(,0,0
130765,AUC,0,0
130766,(,0,0
130767,?,0,0
130768,),0,0
130769,),0,0
130770,were,0,0
130771,46.2,0,0
130772,?,0,0
130773,1.4,0,0
130774,mg,0,0
130775,?,0,0
130776,h/L,0,0
130777,after,0,0
130778,oral,0,0
130779,dosing,0,0
130780,and,0,0
130781,52.3,0,0
130782,?,0,0
130783,1.3,0,0
130784,mg,0,0
130785,?,0,0
130786,h/L,0,0
130787,after,0,0
130788,intravenous,0,0
130789,dosing,0,0
130790,",",0,0
130791,resulting,0,0
130792,in,0,0
130793,a,0,0
130794,mean,1,1
130795,oral,1,0
130796,bioavailability,1,1
130797,of,0,0
130798,88.32,0,0
130799,%,0,0
130800,[,0,0
130801,90,0,0
130802,%,0,0
130803,confidence,0,0
130804,interval,0,0
130805,(,0,0
130806,CI,0,0
130807,),0,0
130808,85.64,0,0
130809,%,0,0
130810,-91.08,0,0
130811,%,0,0
130812,],0,0
130813,.,0,0
130814,CONCLUSIONS,0,0
130815,This,0,0
130816,study,0,0
130817,confirms,0,0
130818,that,0,0
130819,exposure,0,0
130820,to,0,0
130821,moxifloxacin,0,0
130822,is,0,0
130823,equivalent,0,0
130824,for,0,0
130825,oral,0,0
130826,and,0,0
130827,intravenous,0,0
130828,administration,0,0
130829,of,0,0
130830,400,0,0
130831,mg,0,0
130832,dosages,0,0
130833,in,0,0
130834,healthy,0,0
130835,volunteers,0,0
130836,who,0,0
130837,underwent,0,0
130838,gastric,0,1
130839,bypass,0,0
130840,surgery,0,0
130841,.,0,0
130842,But,0,0
130843,these,0,0
130844,exposures,0,0
130845,were,0,0
130846,more,0,0
130847,than,0,0
130848,50,0,0
130849,%,0,0
130850,higher,0,0
130851,than,0,0
130852,those,0,0
130853,described,0,0
130854,for,0,0
130855,subjects,0,0
130856,without,0,0
130857,gastric,0,1
130858,bypass,0,0
130859,.,0,0
130860,This,0,0
130861,may,0,0
130862,suggest,0,0
130863,a,0,0
130864,higher,0,0
130865,enterohepatic,0,1
130866,recirculation,0,1
130867,of,0,0
130868,moxifloxacin,0,0
130869,after,0,0
130870,gastric,0,1
130871,bypass,0,0
130872,.,0,0
130873,[,0,0
130874,Treatment,0,0
130875,of,0,0
130876,primary,0,0
130877,osteoporosis,0,0
130878,with,0,0
130879,calcium,0,0
130880,and,0,0
130881,salmon,0,0
130882,calcitonin,0,1
130883,],0,0
130884,.,0,0
130885,Fifty-nine,0,0
130886,consecutive,0,0
130887,patients,0,0
130888,(,0,0
130889,19,0,0
130890,men,0,0
130891,",",0,0
130892,40,0,0
130893,women,0,0
130894,",",0,0
130895,mean,0,1
130896,age,0,0
130897,60.8,0,0
130898,[,0,0
130899,27-80,0,0
130900,],0,0
130901,years,0,0
130902,),0,0
130903,with,0,0
130904,primary,0,0
130905,osteoporosis,0,0
130906,were,0,0
130907,studied,0,0
130908,to,0,0
130909,see,0,0
130910,if,0,0
130911,there,0,0
130912,was,0,0
130913,any,0,0
130914,significant,0,0
130915,gain,0,1
130916,in,0,0
130917,bone,0,1
130918,mass,0,1
130919,after,0,0
130920,treatment,0,0
130921,with,0,0
130922,salmon,0,0
130923,calcitonin,0,0
130924,.,0,0
130925,All,0,0
130926,the,0,0
130927,patients,0,0
130928,were,0,0
130929,given,0,0
130930,1,0,0
130931,g,0,0
130932,calcium,0,0
130933,by,0,0
130934,mouth,0,0
130935,every,0,0
130936,morning,0,0
130937,.,0,0
130938,Group,0,0
130939,1,0,0
130940,(,0,0
130941,n,0,0
130942,=,0,0
130943,20,0,0
130944,),0,0
130945,received,0,0
130946,no,0,0
130947,other,0,0
130948,specific,0,0
130949,medication,0,1
130950,while,0,0
130951,group,0,0
130952,2,0,0
130953,(,0,0
130954,n,0,0
130955,=,0,0
130956,19,0,0
130957,),0,0
130958,were,0,0
130959,given,0,0
130960,100,0,0
130961,I.U,0,0
130962,.,0,0
130963,calcitonin,0,0
130964,subcutaneously,0,0
130965,every,0,0
130966,second,0,0
130967,evening,0,0
130968,and,0,0
130969,group,0,0
130970,3,0,0
130971,(,0,0
130972,n,0,0
130973,=,0,0
130974,20,0,0
130975,),0,0
130976,received,0,0
130977,the,0,0
130978,same,0,0
130979,dose,0,0
130980,every,0,0
130981,evening,0,0
130982,.,0,0
130983,The,0,0
130984,pain,1,1
130985,reported,0,0
130986,by,0,0
130987,the,0,0
130988,patients,0,0
130989,was,0,0
130990,subdivided,0,0
130991,into,0,0
130992,four,0,0
130993,severity,0,1
130994,grades,0,0
130995,",",0,0
130996,and,0,1
130997,analgesic,1,1
130998,consumption,1,1
130999,was,0,0
131000,recorded,0,0
131001,.,0,0
131002,In,0,0
131003,group,0,0
131004,1,0,0
131005,there,0,0
131006,was,0,0
131007,a,0,0
131008,nonsignificant,0,0
131009,decrease,0,0
131010,in,0,0
131011,pain,1,1
131012,",",0,0
131013,but,0,0
131014,in,0,0
131015,groups,0,0
131016,2,0,0
131017,and,0,0
131018,3,0,0
131019,there,0,0
131020,was,0,0
131021,a,0,0
131022,highly,0,0
131023,significant,0,0
131024,diminution,0,1
131025,in,0,0
131026,pain,1,1
131027,(,0,0
131028,P,0,0
131029,less,0,0
131030,than,0,0
131031,0.005,0,0
131032,),0,0
131033,and,0,0
131034,in,0,0
131035,analgesic,1,1
131036,intake,1,1
131037,(,0,0
131038,P,0,0
131039,less,0,0
131040,than,0,0
131041,0.01,0,0
131042,),0,0
131043,.,0,0
131044,Measurements,0,0
131045,of,0,0
131046,bone,1,1
131047,density,1,1
131048,carried,0,0
131049,out,0,0
131050,by,0,0
131051,photon,0,0
131052,absorption,0,0
131053,at,0,0
131054,the,0,0
131055,end,0,0
131056,of,0,0
131057,12,0,0
131058,months,0,0
131059,showed,0,0
131060,a,0,0
131061,5.5,0,0
131062,%,0,0
131063,increase,0,0
131064,in,0,0
131065,the,0,0
131066,distal,1,0
131067,radius,1,0
131068,in,0,0
131069,group,0,0
131070,2,0,0
131071,(,0,0
131072,P,0,0
131073,=,0,0
131074,0.0001,0,0
131075,),0,0
131076,and,0,0
131077,a,0,0
131078,7.1,0,0
131079,%,0,0
131080,increase,0,0
131081,in,0,0
131082,group,0,0
131083,3,0,0
131084,(,0,0
131085,P,0,0
131086,=,0,0
131087,0.0001,0,0
131088,),0,0
131089,",",0,0
131090,while,0,0
131091,in,0,0
131092,group,0,0
131093,1,0,0
131094,mineral,0,1
131095,content,0,0
131096,had,0,0
131097,decreased,0,0
131098,by,0,0
131099,4.3,0,0
131100,%,0,0
131101,(,0,0
131102,nonsignificant,0,0
131103,),0,0
131104,.,0,0
131105,These,0,0
131106,results,0,0
131107,show,0,0
131108,that,0,0
131109,a,0,0
131110,significant,0,0
131111,gain,0,1
131112,in,0,0
131113,bone,1,0
131114,mass,1,0
131115,can,0,0
131116,be,0,0
131117,achieved,0,0
131118,by,0,0
131119,administration,0,0
131120,of,0,0
131121,calcitonin,0,1
131122,",",0,0
131123,either,0,0
131124,daily,0,1
131125,or,0,0
131126,on,0,0
131127,alternate,0,0
131128,days,0,0
131129,.,0,0
131130,The,0,0
131131,incidence,0,1
131132,of,0,0
131133,extravertebral,0,1
131134,fractures,0,1
131135,and,0,0
131136,of,0,0
131137,new,0,0
131138,or,0,0
131139,progressive,0,1
131140,vertebral,0,1
131141,deformity,0,1
131142,tended,0,0
131143,to,0,0
131144,be,0,0
131145,lower,0,0
131146,in,0,0
131147,groups,0,0
131148,2,0,0
131149,and,0,0
131150,3,0,0
131151,than,0,0
131152,in,0,0
131153,group,0,0
131154,1,0,0
131155,.,0,0
131156,Effects,0,0
131157,of,0,0
131158,body,0,1
131159,orientation,0,1
131160,on,0,0
131161,maximum,0,1
131162,voluntary,0,0
131163,arm,0,0
131164,torques,0,1
131165,.,0,0
131166,INTRODUCTION,0,1
131167,Increased,0,0
131168,reliance,0,0
131169,on,0,0
131170,bulbospinal,0,1
131171,motor,0,1
131172,systems,0,0
131173,has,0,0
131174,been,0,0
131175,implicated,0,0
131176,in,0,0
131177,individuals,0,0
131178,with,0,0
131179,chronic,0,0
131180,stroke,0,1
131181,during,0,0
131182,maximum,0,1
131183,voluntary,0,0
131184,arm,0,0
131185,joint,0,1
131186,torque,0,1
131187,generation,0,1
131188,.,0,0
131189,METHODS,0,0
131190,Maximum,0,1
131191,isometric,1,1
131192,single-joint,1,0
131193,and,1,1
131194,multi-joint,1,1
131195,arm,1,0
131196,strength,1,1
131197,was,0,0
131198,observed,0,0
131199,in,0,0
131200,two,0,0
131201,body,0,0
131202,orientations,0,0
131203,(,0,0
131204,sitting,0,1
131205,and,0,1
131206,supine,0,1
131207,),0,0
131208,while,0,0
131209,maintaining,0,0
131210,identical,0,0
131211,head/neck/trunk/extremity,0,1
131212,joint,0,1
131213,configurations,0,0
131214,in,0,0
131215,order,0,0
131216,to,0,0
131217,identify,0,0
131218,bulbospinal,0,0
131219,contributions,0,0
131220,to,0,0
131221,maximum,0,1
131222,joint,0,1
131223,torque,0,1
131224,generation,0,1
131225,in,0,0
131226,11,0,0
131227,individuals,0,0
131228,with,0,0
131229,stroke,0,1
131230,and,0,0
131231,10,0,0
131232,individuals,0,0
131233,without,0,0
131234,stroke,0,0
131235,.,0,0
131236,RESULTS,0,0
131237,During,0,0
131238,sitting,0,1
131239,",",0,0
131240,shoulder,1,1
131241,flexion,1,1
131242,was,0,0
131243,greater,0,0
131244,for,0,0
131245,both,0,0
131246,groups,0,0
131247,",",0,0
131248,whereas,0,0
131249,shoulder,1,1
131250,extension,1,1
131251,and,1,0
131252,elbow,1,1
131253,flexion,1,1
131254,",",0,0
131255,part,0,0
131256,of,0,0
131257,the,0,0
131258,flexion,0,1
131259,synergy,0,1
131260,",",0,0
131261,were,0,0
131262,greater,0,0
131263,only,0,0
131264,in,0,0
131265,individuals,0,0
131266,with,0,0
131267,stroke,0,0
131268,.,0,0
131269,CONCLUSIONS,0,0
131270,Body,0,0
131271,orientation,0,1
131272,influenced,0,0
131273,isometric,1,1
131274,arm,1,0
131275,strength,1,1
131276,",",0,0
131277,notably,0,0
131278,the,0,0
131279,constituents,0,0
131280,of,0,0
131281,flexion,1,1
131282,synergy,1,1
131283,in,0,0
131284,individuals,0,0
131285,with,0,0
131286,stroke,0,1
131287,",",0,0
131288,suggesting,0,0
131289,bulbospinal,0,1
131290,motor,0,1
131291,pathway,0,0
131292,involvement,0,1
131293,.,0,0
131294,From,0,0
131295,a,0,0
131296,practical,0,0
131297,perspective,0,0
131298,",",0,0
131299,clinical,0,1
131300,evaluation,0,0
131301,of,0,0
131302,single,1,0
131303,joint,1,1
131304,strength,1,1
131305,in,0,0
131306,the,0,0
131307,supine,0,0
131308,position,0,0
131309,may,0,0
131310,underestimate,0,0
131311,strength,0,1
131312,available,0,0
131313,during,0,0
131314,activities,0,1
131315,of,0,0
131316,daily,0,0
131317,living,0,0
131318,that,0,0
131319,are,0,0
131320,performed,0,0
131321,in,0,0
131322,an,0,0
131323,upright,0,0
131324,orientation,0,0
131325,.,0,0
131326,Standard,0,0
131327,versus,0,0
131328,extended,0,0
131329,lymphadenectomy,0,0
131330,in,0,0
131331,radical,0,0
131332,pancreatoduodenectomy,0,0
131333,for,0,0
131334,ductal,0,1
131335,adenocarcinoma,0,0
131336,of,0,0
131337,the,0,0
131338,head,0,0
131339,of,0,0
131340,the,0,0
131341,pancreas,0,0
131342,:,0,0
131343,long-term,0,0
131344,results,0,0
131345,of,0,0
131346,a,0,0
131347,Japanese,0,0
131348,multicenter,0,0
131349,randomized,0,0
131350,controlled,0,0
131351,trial,0,0
131352,.,0,0
131353,BACKGROUND,0,0
131354,The,0,0
131355,value,0,0
131356,of,0,0
131357,pancreatoduodenectomy,0,0
131358,(,0,0
131359,PD,0,1
131360,),0,0
131361,with,0,0
131362,extended,0,0
131363,lymphadenectomy,0,0
131364,for,0,0
131365,pancreatic,0,0
131366,cancer,0,0
131367,has,0,0
131368,been,0,0
131369,evaluated,0,0
131370,by,0,0
131371,many,0,0
131372,retrospective,0,0
131373,studies,0,0
131374,and,0,0
131375,3,0,0
131376,randomized,0,0
131377,controlled,0,0
131378,trials,0,0
131379,(,0,0
131380,RCT,0,0
131381,),0,0
131382,.,0,0
131383,However,0,0
131384,",",0,0
131385,the,0,0
131386,protocols,0,0
131387,used,0,0
131388,and,0,0
131389,the,0,0
131390,results,0,0
131391,found,0,0
131392,in,0,0
131393,the,0,0
131394,3,0,0
131395,RCTs,0,0
131396,were,0,0
131397,diverse,0,0
131398,.,0,0
131399,Therefore,0,0
131400,",",0,0
131401,a,0,0
131402,multicenter,0,0
131403,RCT,0,0
131404,was,0,0
131405,proposed,0,0
131406,in,0,0
131407,1998,0,0
131408,to,0,0
131409,evaluate,0,0
131410,the,0,0
131411,primary,0,0
131412,end,0,0
131413,point,0,0
131414,of,0,0
131415,long-term,0,0
131416,survival,0,1
131417,and,0,0
131418,the,0,0
131419,secondary,0,0
131420,end,0,0
131421,points,0,0
131422,of,0,1
131423,morbidity,0,1
131424,",",0,0
131425,mortality,0,1
131426,and,0,1
131427,quality,0,1
131428,of,0,1
131429,life,0,1
131430,of,0,0
131431,patients,0,0
131432,undergoing,0,0
131433,standard,0,0
131434,versus,0,0
131435,extended,0,0
131436,lymphadenectomy,0,0
131437,in,0,0
131438,radical,0,0
131439,PD,0,0
131440,for,0,0
131441,pancreatic,0,1
131442,cancer,0,0
131443,.,0,0
131444,METHODS,0,0
131445,From,0,0
131446,March,0,0
131447,2000,0,0
131448,to,0,0
131449,May,0,0
131450,2003,0,0
131451,",",0,0
131452,112,0,0
131453,patients,0,0
131454,with,0,0
131455,potentially,0,0
131456,curable,0,0
131457,pancreatic,0,1
131458,head,0,0
131459,cancer,0,0
131460,were,0,0
131461,enrolled,0,0
131462,and,0,0
131463,intraoperatively,0,0
131464,randomized,0,0
131465,to,0,0
131466,a,0,0
131467,standard,0,0
131468,or,0,0
131469,extended,0,0
131470,lymphadenectomy,0,0
131471,group,0,0
131472,.,0,0
131473,No,0,0
131474,resected,0,0
131475,patients,0,0
131476,received,0,0
131477,any,0,0
131478,adjuvant,0,0
131479,treatments,0,0
131480,.,0,0
131481,RESULTS,0,0
131482,A,0,0
131483,hundred,0,0
131484,and,0,0
131485,one,0,0
131486,eligible,0,0
131487,patients,0,0
131488,were,0,0
131489,analyzed,0,0
131490,.,0,0
131491,Demographic,0,1
131492,and,0,0
131493,histopathological,0,1
131494,characteristics,0,0
131495,of,0,0
131496,the,0,0
131497,two,0,0
131498,groups,0,0
131499,were,0,0
131500,similar,0,0
131501,.,0,0
131502,The,0,0
131503,mean,1,1
131504,operating,1,1
131505,time,1,1
131506,",",1,0
131507,intraoperative,1,1
131508,blood,1,1
131509,loss,1,1
131510,and,1,1
131511,number,1,1
131512,of,1,1
131513,retrieved,1,0
131514,lymph,1,1
131515,nodes,1,1
131516,were,0,0
131517,greater,0,0
131518,in,0,0
131519,the,0,0
131520,extended,0,0
131521,group,0,0
131522,",",0,0
131523,but,0,0
131524,the,0,0
131525,other,0,0
131526,operative,0,1
131527,results,0,0
131528,were,0,0
131529,comparable,0,0
131530,.,0,0
131531,CONCLUSIONS,0,0
131532,Although,0,0
131533,this,0,0
131534,multicenter,0,0
131535,RCT,0,0
131536,was,0,0
131537,conducted,0,0
131538,in,0,0
131539,a,0,0
131540,strict,0,0
131541,setting,0,0
131542,",",0,0
131543,extended,0,0
131544,lymphadenectomy,0,0
131545,in,0,0
131546,radical,0,0
131547,PD,0,1
131548,did,0,0
131549,not,0,0
131550,benefit,0,0
131551,long-term,0,0
131552,survival,0,1
131553,in,0,0
131554,patients,0,0
131555,with,0,0
131556,resectable,0,0
131557,pancreatic,0,1
131558,head,0,0
131559,cancer,0,0
131560,and,0,0
131561,led,0,0
131562,to,0,0
131563,levels,0,1
131564,of,0,0
131565,morbidity,0,1
131566,",",0,0
131567,mortality,0,1
131568,and,0,1
131569,quality,0,1
131570,of,0,1
131571,life,0,1
131572,comparable,0,0
131573,to,0,0
131574,those,0,0
131575,found,0,0
131576,after,0,0
131577,standard,0,0
131578,lymphadenectomy,0,0
131579,.,0,0
131580,Armodafinil,0,0
131581,and,0,0
131582,modafinil,0,0
131583,in,0,0
131584,patients,0,0
131585,with,0,0
131586,excessive,0,1
131587,sleepiness,0,1
131588,associated,0,0
131589,with,0,0
131590,shift,0,0
131591,work,0,0
131592,disorder,0,0
131593,:,0,0
131594,a,0,0
131595,pharmacokinetic/pharmacodynamic,1,0
131596,model,0,0
131597,for,0,0
131598,predicting,0,1
131599,and,0,0
131600,comparing,0,0
131601,their,0,0
131602,concentration-effect,0,0
131603,relationships,0,0
131604,.,0,0
131605,Armodafinil,0,0
131606,",",0,0
131607,the,0,0
131608,longer,0,0
131609,lasting,0,1
131610,R-isomer,0,0
131611,of,0,0
131612,racemic,0,0
131613,modafinil,0,0
131614,",",0,0
131615,improves,0,1
131616,wakefulness,1,1
131617,in,0,0
131618,patients,0,0
131619,with,0,0
131620,excessive,1,1
131621,sleepiness,1,1
131622,associated,0,0
131623,with,0,0
131624,shift,1,0
131625,work,1,0
131626,disorder,1,0
131627,(,1,0
131628,SWD,1,0
131629,),1,0
131630,.,0,0
131631,Pharmacokinetic,0,0
131632,studies,0,0
131633,suggest,0,0
131634,that,0,0
131635,armodafinil,0,0
131636,achieves,0,0
131637,higher,0,0
131638,plasma,1,1
131639,concentrations,1,1
131640,than,0,0
131641,modafinil,0,0
131642,late,0,0
131643,in,0,0
131644,a,0,0
131645,dose,0,0
131646,interval,0,0
131647,following,0,0
131648,equal,0,0
131649,oral,0,0
131650,doses,0,0
131651,.,0,0
131652,Pooled,1,0
131653,Multiple,1,0
131654,Sleep,1,0
131655,Latency,1,1
131656,Test,1,1
131657,(,1,0
131658,MSLT,1,0
131659,),1,0
131660,data,0,0
131661,from,0,0
131662,2,0,0
131663,randomized,0,0
131664,",",0,0
131665,double-blind,0,0
131666,",",0,0
131667,placebo-controlled,0,0
131668,trials,0,0
131669,in,0,0
131670,463,0,0
131671,patients,0,0
131672,with,0,0
131673,SWD,0,0
131674,",",0,0
131675,1,0,0
131676,with,0,0
131677,armodafinil,0,0
131678,150,0,0
131679,mg/d,0,0
131680,and,0,0
131681,1,0,0
131682,with,0,0
131683,modafinil,0,0
131684,200,0,0
131685,mg/d,0,0
131686,(,0,0
131687,both,0,0
131688,administered,0,0
131689,around,0,0
131690,2200,0,0
131691,h,0,0
131692,before,0,0
131693,night,0,1
131694,shifts,0,0
131695,),0,0
131696,",",0,0
131697,were,0,0
131698,used,0,0
131699,to,0,0
131700,build,0,0
131701,a,0,0
131702,pharmacokinetic/pharmacodynamic,1,0
131703,model,0,0
131704,.,0,0
131705,Predicted,0,0
131706,plasma,1,1
131707,drug,1,0
131708,concentrations,1,1
131709,were,0,0
131710,obtained,0,0
131711,by,0,0
131712,developing,0,0
131713,and,0,0
131714,applying,0,0
131715,a,0,0
131716,population,0,0
131717,pharmacokinetic,1,1
131718,model,1,0
131719,using,0,0
131720,nonlinear,1,0
131721,mixed-effects,1,0
131722,modeling,1,0
131723,.,1,0
131724,Armodafinil,0,0
131725,200,0,0
131726,mg,0,0
131727,produced,0,0
131728,a,0,0
131729,plasma,1,1
131730,concentration,1,1
131731,above,0,0
131732,the,0,0
131733,EC,0,1
131734,(,0,0
131735,50,0,0
131736,),0,0
131737,(,0,0
131738,4.6,0,0
131739,?g/mL,0,0
131740,),0,0
131741,for,0,0
131742,9,0,0
131743,hours,0,0
131744,",",0,0
131745,whereas,0,0
131746,modafinil,0,0
131747,200,0,0
131748,mg,0,0
131749,did,0,0
131750,not,0,0
131751,exceed,0,0
131752,the,0,0
131753,EC,0,1
131754,(,0,0
131755,50,0,0
131756,),0,0
131757,.,0,0
131758,Consequently,0,0
131759,",",0,0
131760,armodafinil,1,0
131761,produced,0,0
131762,greater,0,0
131763,increases,0,1
131764,in,0,0
131765,predicted,0,1
131766,placebo-subtracted,1,0
131767,MSLT,1,0
131768,times,1,1
131769,of,0,0
131770,0.5-1,0,0
131771,minute,0,1
131772,(,0,0
131773,up,0,0
131774,to,0,0
131775,10,0,0
131776,hours,0,0
131777,after,0,0
131778,dosing,0,0
131779,),0,0
131780,compared,0,0
131781,with,0,0
131782,modafinil,0,0
131783,.,0,0
131784,On,0,0
131785,a,0,0
131786,milligram-to-milligram,0,0
131787,basis,0,0
131788,",",0,0
131789,armodafinil,0,0
131790,200,0,0
131791,mg,0,0
131792,consistently,1,0
131793,increased,1,0
131794,wakefulness,1,0
131795,more,0,0
131796,than,0,0
131797,modafinil,0,0
131798,200,0,0
131799,mg,0,0
131800,",",0,0
131801,including,0,0
131802,times,0,1
131803,late,0,0
131804,in,0,0
131805,the,0,0
131806,8-hour,0,0
131807,shift,0,0
131808,.,0,0
131809,Arthroscopic,0,0
131810,rotator,0,0
131811,cuff,0,0
131812,repair,0,0
131813,with,0,0
131814,and,0,0
131815,without,0,0
131816,acromioplasty,0,0
131817,in,0,0
131818,the,0,0
131819,treatment,0,0
131820,of,0,0
131821,full-thickness,0,1
131822,rotator,0,0
131823,cuff,0,0
131824,tears,0,0
131825,:,0,0
131826,a,0,0
131827,multicenter,0,0
131828,",",0,0
131829,randomized,0,0
131830,controlled,0,0
131831,trial,0,0
131832,.,0,0
131833,BACKGROUND,0,0
131834,The,0,0
131835,primary,0,0
131836,objective,0,0
131837,of,0,0
131838,this,0,0
131839,prospective,0,0
131840,randomized,0,0
131841,controlled,0,0
131842,trial,0,0
131843,was,0,0
131844,to,0,0
131845,compare,0,0
131846,functional,1,0
131847,and,1,0
131848,quality-of-life,1,1
131849,indices,1,1
131850,and,0,0
131851,rates,1,1
131852,of,1,1
131853,revision,1,1
131854,surgery,1,0
131855,in,0,0
131856,arthroscopic,0,0
131857,rotator,0,0
131858,cuff,0,0
131859,repair,0,0
131860,with,0,0
131861,and,0,0
131862,without,0,0
131863,acromioplasty,0,0
131864,.,0,0
131865,METHODS,0,0
131866,Eighty-six,0,0
131867,patients,0,0
131868,consented,0,0
131869,and,0,0
131870,were,0,0
131871,randomly,0,0
131872,assigned,0,0
131873,intraoperatively,0,0
131874,to,0,0
131875,one,0,0
131876,of,0,0
131877,two,0,0
131878,study,0,0
131879,groups,0,0
131880,",",0,0
131881,and,0,1
131882,sixty-eight,0,0
131883,of,0,0
131884,them,0,0
131885,completed,0,0
131886,the,0,0
131887,study,0,0
131888,.,0,0
131889,The,0,0
131890,primary,0,0
131891,outcome,0,0
131892,was,0,0
131893,the,0,0
131894,Western,1,0
131895,Ontario,1,0
131896,Rotator,1,1
131897,Cuff,1,1
131898,(,1,0
131899,WORC,1,0
131900,),1,0
131901,index,1,1
131902,.,1,0
131903,Secondary,0,0
131904,outcome,0,1
131905,measures,0,1
131906,included,0,0
131907,the,0,0
131908,American,1,0
131909,Shoulder,1,0
131910,and,1,0
131911,Elbow,1,0
131912,Surgeons,1,1
131913,(,1,0
131914,ASES,1,0
131915,),1,0
131916,shoulder,1,0
131917,assessment,1,1
131918,form,1,0
131919,and,1,0
131920,a,1,0
131921,count,1,1
131922,of,1,0
131923,revisions,1,0
131924,required,0,0
131925,in,0,0
131926,each,0,0
131927,group,0,0
131928,.,0,0
131929,Outcome,0,1
131930,measures,0,1
131931,were,0,0
131932,completed,0,0
131933,preoperatively,0,0
131934,and,0,0
131935,at,0,0
131936,three,0,0
131937,",",0,0
131938,six,0,0
131939,",",0,0
131940,twelve,0,0
131941,",",0,1
131942,eighteen,0,0
131943,",",0,1
131944,and,0,1
131945,twenty-four,0,0
131946,months,0,0
131947,after,0,0
131948,surgery,0,0
131949,.,0,0
131950,RESULTS,0,0
131951,WORC,1,0
131952,and,1,0
131953,ASES,1,0
131954,scores,1,1
131955,improved,0,0
131956,significantly,0,0
131957,in,0,0
131958,each,0,0
131959,group,0,0
131960,over,0,0
131961,time,0,1
131962,(,0,0
131963,p,0,0
131964,<,0,0
131965,0.001,0,0
131966,),0,0
131967,.,0,0
131968,There,0,0
131969,were,0,0
131970,no,0,0
131971,differences,0,0
131972,in,0,0
131973,WORC,1,0
131974,or,1,0
131975,ASES,1,0
131976,scores,1,1
131977,between,0,0
131978,the,0,0
131979,groups,0,0
131980,that,0,0
131981,had,0,0
131982,arthroscopic,0,0
131983,cuff,0,0
131984,repair,0,0
131985,with,0,0
131986,or,0,0
131987,without,0,0
131988,acromioplasty,0,0
131989,at,0,0
131990,any,0,0
131991,time,0,1
131992,point,0,0
131993,.,0,0
131994,There,0,0
131995,were,0,0
131996,no,0,0
131997,differences,0,0
131998,in,0,0
131999,scores,0,1
132000,on,0,0
132001,the,0,0
132002,basis,0,0
132003,of,0,0
132004,acromion,0,1
132005,type,0,0
132006,",",0,1
132007,nor,0,0
132008,were,0,0
132009,any,0,0
132010,interaction,0,1
132011,effects,0,1
132012,identified,0,0
132013,between,0,0
132014,group,0,0
132015,and,0,1
132016,acromion,0,1
132017,type,0,0
132018,.,0,0
132019,Four,0,0
132020,participants,0,0
132021,(,0,0
132022,9,0,0
132023,%,0,0
132024,),0,0
132025,in,0,0
132026,the,0,0
132027,group,0,0
132028,that,0,0
132029,had,0,0
132030,arthroscopic,0,0
132031,cuff,0,0
132032,repair,1,0
132033,alone,0,0
132034,",",0,0
132035,one,0,0
132036,with,0,0
132037,a,0,0
132038,Type-2,0,0
132039,and,0,0
132040,three,0,0
132041,with,0,0
132042,a,0,0
132043,Type-3,0,0
132044,acromion,0,1
132045,",",0,0
132046,required,0,1
132047,additional,1,0
132048,surgery,1,0
132049,by,0,0
132050,the,0,0
132051,twenty-four-month,0,0
132052,time,0,1
132053,point,0,0
132054,.,0,0
132055,The,0,0
132056,number,1,1
132057,of,1,0
132058,patients,1,0
132059,who,1,0
132060,required,1,0
132061,additional,1,0
132062,surgery,1,0
132063,was,0,0
132064,greater,0,0
132065,(,0,0
132066,p,0,0
132067,=,0,0
132068,0.05,0,0
132069,),0,0
132070,in,0,0
132071,the,0,0
132072,group,0,0
132073,that,0,0
132074,had,0,0
132075,arthroscopic,0,0
132076,cuff,0,0
132077,repair,0,0
132078,alone,0,0
132079,than,0,0
132080,in,0,0
132081,the,0,0
132082,group,0,0
132083,that,0,0
132084,had,0,0
132085,arthroscopic,0,0
132086,cuff,0,0
132087,repair,0,0
132088,and,0,0
132089,acromioplasty,0,0
132090,.,0,0
132091,CONCLUSIONS,0,0
132092,Our,0,0
132093,findings,0,0
132094,are,0,0
132095,consistent,0,0
132096,with,0,0
132097,previous,0,0
132098,research,0,0
132099,reports,0,0
132100,in,0,0
132101,which,0,0
132102,there,0,0
132103,was,0,0
132104,no,0,0
132105,difference,0,0
132106,in,0,0
132107,functional,1,0
132108,and,1,0
132109,quality-of-life,1,1
132110,indices,1,1
132111,for,0,0
132112,patients,0,0
132113,who,0,0
132114,had,0,0
132115,rotator,0,0
132116,cuff,0,0
132117,repair,0,0
132118,with,0,0
132119,or,0,0
132120,without,0,0
132121,acromioplasty,0,0
132122,.,0,0
132123,The,0,0
132124,higher,1,0
132125,reoperation,1,1
132126,rate,1,1
132127,was,0,0
132128,found,0,0
132129,in,0,0
132130,the,0,0
132131,group,0,0
132132,without,0,0
132133,acromioplasty,0,0
132134,.,0,0
132135,Further,0,0
132136,study,0,0
132137,that,0,0
132138,includes,0,0
132139,follow-up,0,0
132140,imaging,0,0
132141,and,0,0
132142,patient-reported,0,1
132143,outcomes,0,1
132144,over,0,0
132145,a,0,0
132146,greater,0,0
132147,follow-up,0,0
132148,period,0,0
132149,is,0,0
132150,needed,0,0
132151,.,0,0
132152,Effect,1,0
132153,of,0,0
132154,motivational,0,0
132155,music,0,0
132156,on,0,0
132157,lactate,1,1
132158,levels,1,1
132159,during,0,0
132160,recovery,0,1
132161,from,0,0
132162,intense,0,0
132163,exercise,0,0
132164,.,0,0
132165,The,0,0
132166,effects,0,0
132167,of,0,0
132168,music,0,0
132169,played,0,0
132170,during,0,0
132171,an,0,0
132172,exercise,0,0
132173,task,0,0
132174,on,0,0
132175,athletic,0,0
132176,performance,0,1
132177,have,0,0
132178,been,0,0
132179,previously,0,0
132180,studied,0,0
132181,.,0,0
132182,Yet,0,0
132183,",",0,0
132184,these,0,0
132185,results,0,0
132186,are,0,0
132187,not,0,0
132188,applicable,0,0
132189,for,0,0
132190,competitive,0,0
132191,athletes,0,0
132192,",",0,0
132193,who,0,0
132194,can,0,0
132195,use,0,0
132196,music,0,0
132197,only,0,0
132198,during,0,0
132199,warm-up,0,0
132200,or,0,0
132201,recovery,0,1
132202,from,0,0
132203,exercise,0,0
132204,.,0,0
132205,Therefore,0,0
132206,",",0,0
132207,the,0,0
132208,aim,0,0
132209,of,0,0
132210,this,0,0
132211,study,0,0
132212,was,0,0
132213,to,0,0
132214,determine,0,0
132215,the,0,0
132216,effect,0,0
132217,of,0,0
132218,motivational,0,1
132219,music,0,0
132220,(,0,0
132221,music,0,0
132222,that,0,0
132223,stimulates,0,0
132224,or,0,0
132225,inspires,0,0
132226,physical,0,1
132227,activity,0,1
132228,),0,0
132229,during,0,0
132230,recovery,1,1
132231,from,1,0
132232,intense,1,0
132233,exercise,1,0
132234,",",0,0
132235,on,0,0
132236,activity,1,1
132237,pattern,1,0
132238,",",1,0
132239,rate,1,1
132240,of,1,0
132241,perceived,1,1
132242,exertion,1,1
132243,(,1,0
132244,RPE,1,1
132245,),1,1
132246,",",1,0
132247,and,1,1
132248,blood,1,1
132249,lactate,1,1
132250,concentration,1,1
132251,.,1,0
132252,Twenty,0,0
132253,young,0,0
132254,",",0,0
132255,active,0,0
132256,men,0,0
132257,(,0,0
132258,mean,0,1
132259,age,0,0
132260,26.2,0,0
132261,?,0,0
132262,2.1,0,0
132263,years,0,0
132264,),0,0
132265,performed,0,0
132266,a,0,0
132267,6-minute,0,0
132268,run,0,0
132269,at,0,0
132270,peak,0,1
132271,oxygen,0,1
132272,consumption,0,1
132273,speed,0,1
132274,(,0,0
132275,predetermined,0,0
132276,from,0,0
132277,the,0,0
132278,VO,0,0
132279,(,0,0
132280,2,0,0
132281,),0,0
132282,max,0,0
132283,test,0,0
132284,),0,0
132285,.,0,0
132286,The,1,0
132287,mean,1,1
132288,heart,1,1
132289,rate,1,1
132290,(,1,0
132291,HR,1,1
132292,),1,0
132293,",",1,0
132294,RPE,1,1
132295,",",1,1
132296,number,1,1
132297,of,1,1
132298,steps,1,0
132299,(,1,0
132300,determined,1,0
132301,by,1,0
132302,step,1,0
132303,counter,1,1
132304,),1,1
132305,",",1,0
132306,and,1,1
132307,blood,1,1
132308,lactate,1,1
132309,concentrations,1,1
132310,were,0,0
132311,determined,0,0
132312,at,0,0
132313,3,0,0
132314,",",0,0
132315,6,0,0
132316,",",0,0
132317,9,0,0
132318,",",0,0
132319,12,0,0
132320,",",0,0
132321,and,0,0
132322,15,0,0
132323,minutes,0,0
132324,during,0,0
132325,the,0,0
132326,recovery,0,0
132327,from,0,0
132328,the,0,0
132329,exercise,0,0
132330,",",0,0
132331,with,0,0
132332,and,0,0
132333,without,0,0
132334,motivational,0,1
132335,music,0,0
132336,(,0,0
132337,2,0,0
132338,separate,0,0
132339,sessions,0,0
132340,",",0,0
132341,at,0,0
132342,random,0,0
132343,order,0,0
132344,),0,0
132345,.,0,0
132346,There,0,0
132347,was,0,0
132348,no,0,0
132349,difference,0,0
132350,in,0,0
132351,the,1,0
132352,mean,1,1
132353,HR,1,0
132354,during,0,0
132355,the,0,0
132356,recovery,0,1
132357,with,0,0
132358,and,0,0
132359,without,0,0
132360,music,0,0
132361,.,0,0
132362,Listening,0,1
132363,to,0,0
132364,motivational,0,0
132365,music,0,0
132366,during,0,0
132367,the,0,0
132368,recovery,0,1
132369,was,0,0
132370,associated,0,0
132371,with,0,0
132372,increased,1,0
132373,voluntary,1,0
132374,activity,1,1
132375,of,0,0
132376,the,0,0
132377,participants,0,0
132378,",",0,0
132379,determined,0,0
132380,by,0,0
132381,increased,1,0
132382,number,1,1
132383,of,1,0
132384,steps,1,0
132385,(,0,0
132386,499.4,0,0
132387,?,0,0
132388,220.1,0,0
132389,vs.,0,0
132390,413.2,0,0
132391,?,0,0
132392,150.6,0,0
132393,steps,0,0
132394,",",0,0
132395,with,0,0
132396,and,0,0
132397,without,0,0
132398,music,0,1
132399,",",0,0
132400,respectively,0,0
132401,;,0,0
132402,p,0,0
132403,?,0,0
132404,0.05,0,0
132405,),0,0
132406,.,0,0
132407,The,0,0
132408,increased,0,0
132409,number,1,1
132410,of,1,0
132411,steps,1,0
132412,during,1,0
132413,the,0,0
132414,recovery,0,1
132415,was,0,0
132416,accompanied,0,0
132417,by,0,0
132418,a,0,0
132419,significantly,0,0
132420,greater,0,0
132421,decrease,1,1
132422,in,1,0
132423,blood,1,1
132424,lactate,1,1
132425,concentration,1,1
132426,percentage,1,1
132427,(,0,0
132428,28.1,0,0
132429,?,0,0
132430,12.2,0,0
132431,vs.,0,0
132432,22.8,0,0
132433,?,0,0
132434,10.9,0,0
132435,%,0,0
132436,",",0,0
132437,with,0,0
132438,and,0,0
132439,without,0,0
132440,music,0,1
132441,",",0,0
132442,respectively,0,0
132443,",",0,0
132444,p,0,0
132445,?,0,0
132446,0.05,0,0
132447,),0,0
132448,.,0,0
132449,This,0,0
132450,was,0,0
132451,associated,0,0
132452,with,0,0
132453,a,0,0
132454,greater,0,0
132455,decrease,0,0
132456,in,1,0
132457,RPE,1,0
132458,(,1,0
132459,77.7,0,0
132460,?,0,0
132461,14.4,0,0
132462,vs.,0,0
132463,73.1,0,0
132464,?,0,0
132465,14.7,0,0
132466,%,0,0
132467,with,0,0
132468,and,0,0
132469,without,0,0
132470,music,0,1
132471,",",0,0
132472,respectively,0,0
132473,;,0,0
132474,p,0,0
132475,?,0,0
132476,0.05,0,0
132477,),0,0
132478,.,0,0
132479,Our,0,0
132480,results,0,0
132481,suggest,0,0
132482,that,0,0
132483,listening,0,0
132484,to,0,0
132485,motivational,0,0
132486,music,0,0
132487,during,0,0
132488,nonstructured,0,0
132489,recovery,0,1
132490,from,0,0
132491,intense,0,0
132492,exercise,0,0
132493,leads,0,0
132494,to,0,0
132495,increased,0,0
132496,activity,0,1
132497,",",0,0
132498,faster,0,1
132499,lactate,0,1
132500,clearance,0,1
132501,",",0,0
132502,and,0,1
132503,reduced,0,1
132504,RPE,0,1
132505,and,0,0
132506,therefore,0,0
132507,may,0,0
132508,be,0,0
132509,used,0,0
132510,by,0,0
132511,athletes,0,0
132512,in,0,0
132513,their,0,0
132514,effort,0,0
132515,to,0,0
132516,enhance,0,0
132517,recovery,0,0
132518,.,0,0
132519,Alkalinized,0,0
132520,lidocaine,0,0
132521,and,0,0
132522,heparin,0,0
132523,provide,0,0
132524,immediate,0,1
132525,relief,0,1
132526,of,0,0
132527,pain,1,1
132528,and,0,1
132529,urgency,0,1
132530,in,0,0
132531,patients,0,0
132532,with,0,0
132533,interstitial,0,1
132534,cystitis,0,1
132535,.,0,0
132536,INTRODUCTION,0,0
132537,It,0,0
132538,has,0,0
132539,been,0,0
132540,reported,0,0
132541,in,0,0
132542,an,0,0
132543,open-label,0,0
132544,study,0,0
132545,that,0,0
132546,the,0,0
132547,combination,0,0
132548,of,0,0
132549,alkalinized,0,0
132550,lidocaine,0,0
132551,and,0,0
132552,heparin,0,0
132553,can,0,0
132554,immediately,0,0
132555,relieve,0,0
132556,the,0,0
132557,symptoms,0,1
132558,of,0,0
132559,urinary,1,1
132560,urgency,1,1
132561,",",1,0
132562,frequency,1,1
132563,",",1,1
132564,and,1,1
132565,pain,1,1
132566,associated,0,0
132567,with,0,0
132568,interstitial,0,1
132569,cystitis,0,1
132570,(,0,0
132571,IC,0,0
132572,),0,0
132573,.,0,0
132574,This,0,0
132575,combination,0,0
132576,has,0,0
132577,also,0,0
132578,been,0,0
132579,reported,0,0
132580,to,0,0
132581,relieve,0,0
132582,pain,0,1
132583,associated,0,0
132584,with,0,0
132585,sex,0,0
132586,in,0,0
132587,patients,0,0
132588,with,0,0
132589,IC,0,0
132590,.,0,0
132591,AIM,0,0
132592,The,0,0
132593,aim,0,0
132594,of,0,0
132595,this,0,0
132596,study,0,0
132597,was,0,0
132598,to,0,0
132599,corroborate,0,0
132600,these,0,0
132601,findings,0,0
132602,in,0,0
132603,a,0,0
132604,multicenter,0,0
132605,setting,0,0
132606,.,0,0
132607,METHODS,0,0
132608,The,0,0
132609,study,0,0
132610,design,0,0
132611,was,0,0
132612,a,0,0
132613,multicenter,0,0
132614,prospective,0,0
132615,",",0,0
132616,double-blind,0,0
132617,",",0,1
132618,crossover,0,0
132619,",",0,1
132620,placebo-controlled,0,0
132621,trial,0,0
132622,.,0,0
132623,Each,0,0
132624,participant,0,0
132625,met,0,0
132626,all,0,0
132627,of,0,0
132628,the,0,0
132629,clinical,0,0
132630,National,0,0
132631,Institute,0,0
132632,of,0,0
132633,Diabetes,0,1
132634,and,0,1
132635,Digestive,0,1
132636,and,0,1
132637,Kidney,0,0
132638,Diseases,0,1
132639,criteria,0,0
132640,(,0,0
132641,excluding,0,0
132642,cystoscopy,0,0
132643,),0,0
132644,for,0,0
132645,IC,0,0
132646,.,0,0
132647,Each,0,0
132648,patient,0,0
132649,received,0,0
132650,drug,0,0
132651,and,0,0
132652,control,0,0
132653,",",0,0
132654,in,0,0
132655,random,0,0
132656,order,0,0
132657,",",0,0
132658,within,0,0
132659,48,0,0
132660,hours,0,0
132661,of,0,0
132662,enrolling,0,0
132663,in,0,0
132664,the,0,0
132665,study,0,0
132666,.,0,0
132667,MAIN,0,0
132668,OUTCOME,0,0
132669,MEASURES,0,0
132670,The,0,0
132671,primary,0,0
132672,outcome,0,1
132673,measure,0,0
132674,was,0,0
132675,percent,1,1
132676,change,1,1
132677,in,1,0
132678,pain,1,1
132679,score,1,1
132680,(,1,0
132681,11-point,1,1
132682,analog,1,1
132683,pain,1,1
132684,scale,1,1
132685,),1,0
132686,12,0,0
132687,hours,0,0
132688,after,0,0
132689,receiving,0,0
132690,the,0,0
132691,drug,0,0
132692,or,0,0
132693,control,0,0
132694,.,0,1
132695,Secondary,0,0
132696,measures,0,0
132697,were,0,0
132698,the,0,0
132699,global,0,1
132700,assessment,0,0
132701,response,0,1
132702,(,0,0
132703,GAR,0,0
132704,),0,0
132705,of,0,0
132706,symptoms,1,1
132707,and,0,0
132708,12-hour,1,1
132709,average,1,1
132710,urgency,1,1
132711,reduction,1,1
132712,determined,0,0
132713,from,0,0
132714,11-point,0,1
132715,urgency,0,1
132716,scales,0,1
132717,.,0,0
132718,RESULTS,0,0
132719,Eighteen,0,0
132720,(,0,0
132721,18,0,0
132722,),0,0
132723,patients,0,0
132724,completed,0,0
132725,the,0,0
132726,trial,0,0
132727,.,0,0
132728,The,0,0
132729,average,0,0
132730,reduction,0,1
132731,of,0,0
132732,pain,0,1
132733,over,0,0
132734,12,0,0
132735,hours,0,0
132736,was,0,0
132737,21,0,0
132738,%,0,0
132739,for,0,0
132740,control,0,0
132741,and,0,0
132742,42,0,0
132743,%,0,0
132744,for,0,0
132745,active,0,0
132746,drug,0,0
132747,(,0,0
132748,P,0,0
132749,=,0,0
132750,0.0363,0,0
132751,),0,0
132752,.,0,0
132753,GAR,0,0
132754,was,0,0
132755,13,0,0
132756,%,0,0
132757,for,0,0
132758,control,0,0
132759,and,0,0
132760,50,0,0
132761,%,0,0
132762,for,0,0
132763,drug,0,0
132764,(,0,0
132765,P,0,0
132766,=,0,0
132767,0.0137,0,0
132768,),0,0
132769,.,0,0
132770,Average,0,1
132771,urgency,0,1
132772,reduction,0,0
132773,was,0,0
132774,13,0,0
132775,%,0,0
132776,for,0,0
132777,control,0,0
132778,and,0,0
132779,35,0,0
132780,%,0,0
132781,for,0,0
132782,drug,0,0
132783,(,0,0
132784,P,0,0
132785,=,0,0
132786,0.0328,0,0
132787,),0,0
132788,.,0,0
132789,CONCLUSIONS,0,0
132790,The,0,0
132791,combination,0,0
132792,of,0,0
132793,alkalinized,0,0
132794,lidocaine,0,0
132795,and,0,0
132796,heparin,0,0
132797,provides,0,0
132798,up,0,0
132799,to,0,0
132800,12,0,0
132801,hours,0,0
132802,of,0,0
132803,relief,0,1
132804,from,0,0
132805,urgency,1,1
132806,and,1,1
132807,pain,1,1
132808,associated,0,0
132809,with,0,0
132810,IC,0,0
132811,.,0,0
132812,This,0,0
132813,combination,0,0
132814,provides,0,0
132815,significant,0,0
132816,immediate,0,0
132817,relief,0,1
132818,of,0,0
132819,symptoms,0,1
132820,for,0,0
132821,patients,0,0
132822,with,0,0
132823,IC,0,0
132824,.,0,0
132825,Factors,0,0
132826,associated,0,0
132827,with,0,0
132828,inadequate,0,0
132829,colorectal,0,0
132830,cancer,0,0
132831,screening,0,0
132832,with,0,0
132833,flexible,0,0
132834,sigmoidoscopy,0,0
132835,.,0,0
132836,BACKGROUND,0,0
132837,AND,0,0
132838,STUDY,0,1
132839,AIM,0,1
132840,Inadequate,0,1
132841,colorectal,0,0
132842,cancer,0,0
132843,screening,0,0
132844,wastes,0,0
132845,limited,0,0
132846,endoscopic,0,0
132847,resources,0,0
132848,.,0,0
132849,We,0,0
132850,examined,0,0
132851,patients,0,0
132852,factors,0,0
132853,associated,0,0
132854,with,0,0
132855,inadequate,0,0
132856,flexible,0,0
132857,sigmoidoscopy,0,0
132858,(,0,0
132859,FSG,0,0
132860,),0,0
132861,screening,0,0
132862,at,0,0
132863,baseline,0,0
132864,screening,0,0
132865,and,0,1
132866,repeat,0,1
132867,screening,0,0
132868,3-5,0,0
132869,years,0,0
132870,later,0,0
132871,in,0,0
132872,10,0,0
132873,geographically-dispersed,0,0
132874,screening,0,0
132875,centers,0,0
132876,participating,0,0
132877,in,0,0
132878,the,0,0
132879,ongoing,0,0
132880,Prostate,0,0
132881,",",0,0
132882,Lung,0,1
132883,",",0,1
132884,Colorectal,0,0
132885,",",0,1
132886,and,0,1
132887,Ovarian,0,1
132888,Cancer,0,1
132889,Screening,0,0
132890,Trial,0,0
132891,.,0,0
132892,METHODS,0,0
132893,A,0,0
132894,total,0,1
132895,of,0,0
132896,"64,554",0,0
132897,participants,0,0
132898,(,0,0
132899,aged,0,0
132900,55-74,0,0
132901,),0,0
132902,completed,0,0
132903,baseline,0,0
132904,questionnaires,0,1
132905,and,0,0
132906,underwent,0,0
132907,FSG,0,1
132908,at,0,0
132909,baseline,0,0
132910,.,0,0
132911,Of,0,0
132912,these,0,0
132913,",",0,0
132914,"39,385",0,0
132915,participants,0,0
132916,returned,0,0
132917,for,0,0
132918,repeat,0,1
132919,screening,0,0
132920,.,0,0
132921,We,0,0
132922,used,0,0
132923,logistic,0,0
132924,regression,0,0
132925,models,0,0
132926,to,0,0
132927,assess,0,0
132928,factors,0,0
132929,that,0,0
132930,are,0,0
132931,associated,0,0
132932,with,0,0
132933,inadequate,0,0
132934,FSG,0,0
132935,(,0,0
132936,defined,0,0
132937,as,0,0
132938,a,0,0
132939,study,0,0
132940,in,0,0
132941,which,0,0
132942,the,0,0
132943,depth,0,1
132944,of,0,0
132945,insertion,0,0
132946,of,0,0
132947,FSG,0,0
132948,was,0,0
132949,<,0,0
132950,50,0,0
132951,cm,0,0
132952,or,0,0
132953,visual,0,1
132954,inspection,0,0
132955,was,0,0
132956,limited,0,0
132957,to,0,0
132958,<,0,0
132959,90,0,0
132960,%,0,0
132961,of,0,0
132962,the,0,0
132963,mucosal,0,1
132964,surface,0,0
132965,but,0,0
132966,without,0,0
132967,detection,0,1
132968,of,0,0
132969,a,0,0
132970,polyp,0,1
132971,or,0,0
132972,mass,0,1
132973,),0,0
132974,.,0,0
132975,RESULTS,0,0
132976,Of,0,0
132977,7084,0,0
132978,(,0,0
132979,11,0,0
132980,%,0,0
132981,),0,0
132982,participants,0,0
132983,with,0,0
132984,inadequate,0,0
132985,FSG,0,0
132986,at,0,0
132987,baseline,0,0
132988,",",0,0
132989,6496,0,0
132990,(,0,0
132991,91.7,0,0
132992,%,0,0
132993,),0,0
132994,had,0,0
132995,<,0,0
132996,50,0,0
132997,cm,0,0
132998,depth,0,0
132999,of,0,1
133000,insertion,0,0
133001,(,0,0
133002,75.3,0,0
133003,%,0,0
133004,due,0,0
133005,to,0,0
133006,patient,0,0
133007,discomfort,0,1
133008,),0,0
133009,and,0,0
133010,500,0,0
133011,(,0,0
133012,7.1,0,0
133013,%,0,0
133014,),0,0
133015,participants,0,0
133016,had,0,0
133017,adequate,0,0
133018,depth,0,1
133019,of,0,0
133020,insertion,0,1
133021,but,0,0
133022,suboptimal,0,0
133023,bowel,0,1
133024,preparation,0,0
133025,.,0,0
133026,Compared,0,0
133027,to,0,0
133028,55-59,0,0
133029,year,0,0
133030,age,0,0
133031,group,0,0
133032,",",0,0
133033,advancing,0,1
133034,age,0,0
133035,in,0,0
133036,5-year,0,0
133037,increments,0,1
133038,(,0,0
133039,odds,0,1
133040,ratios,0,1
133041,(,0,0
133042,OR,0,1
133043,),0,0
133044,from,0,0
133045,1.08,0,0
133046,to,0,0
133047,1.51,0,0
133048,),0,0
133049,and,0,0
133050,female,0,0
133051,sex,0,0
133052,(,0,0
133053,OR,0,0
133054,=,0,0
133055,2.40,0,0
133056,;,0,0
133057,95,0,0
133058,%,0,0
133059,confidence,0,0
133060,interval,0,0
133061,(,0,0
133062,CI,0,0
133063,),0,0
133064,:,0,0
133065,2.27-2.54,0,0
133066,),0,0
133067,were,0,0
133068,associated,0,0
133069,with,0,0
133070,inadequate,0,0
133071,FSG,0,0
133072,.,0,0
133073,Obesity,1,1
133074,(,0,0
133075,BMI,0,0
133076,>,0,0
133077,30,0,0
133078,kg/m,0,0
133079,(,0,0
133080,2,0,0
133081,),0,0
133082,),0,0
133083,was,0,0
133084,associated,0,0
133085,with,0,0
133086,reduced,0,0
133087,odds,0,0
133088,(,0,0
133089,OR,0,0
133090,=,0,0
133091,0.67,0,0
133092,;,0,0
133093,95,0,0
133094,%,0,0
133095,CI,0,0
133096,:,0,0
133097,0.62-0.72,0,0
133098,),0,0
133099,.,0,0
133100,Inadequate,0,0
133101,FSG,0,0
133102,screening,0,0
133103,at,0,0
133104,baseline,0,0
133105,was,0,0
133106,associated,0,0
133107,with,0,0
133108,inadequate,0,0
133109,FSG,0,0
133110,at,0,0
133111,repeat,0,1
133112,screening,0,0
133113,(,0,0
133114,OR,0,0
133115,=,0,0
133116,6.24,0,0
133117,;,0,0
133118,95,0,0
133119,%,0,0
133120,CI,0,0
133121,:,0,0
133122,5.78-6.75,0,0
133123,),0,0
133124,.,0,0
133125,CONCLUSIONS,0,0
133126,Sedation,0,0
133127,should,0,0
133128,be,0,0
133129,considered,0,0
133130,for,0,0
133131,patients,0,0
133132,with,0,0
133133,inadequate,0,0
133134,FSG,0,0
133135,or,0,0
133136,an,0,0
133137,alternative,0,0
133138,colorectal,0,0
133139,cancer,0,0
133140,screening,0,0
133141,method,0,0
133142,should,0,0
133143,be,0,0
133144,recommended,0,0
133145,.,0,0
133146,Making,0,0
133147,the,0,0
133148,connection,0,0
133149,:,0,0
133150,randomized,0,0
133151,controlled,0,0
133152,trial,0,0
133153,of,0,0
133154,social,0,1
133155,skills,0,1
133156,at,0,0
133157,school,0,0
133158,for,0,0
133159,children,0,0
133160,with,0,0
133161,autism,0,0
133162,spectrum,0,0
133163,disorders,0,0
133164,.,0,0
133165,BACKGROUND,0,0
133166,This,0,0
133167,study,0,0
133168,compared,0,0
133169,two,0,0
133170,interventions,0,0
133171,for,0,0
133172,improving,0,0
133173,the,0,0
133174,social,1,1
133175,skills,1,1
133176,of,0,0
133177,high,0,0
133178,functioning,0,1
133179,children,0,0
133180,with,0,0
133181,autism,0,0
133182,spectrum,0,0
133183,disorders,0,0
133184,in,0,0
133185,general,0,0
133186,education,0,0
133187,classrooms,0,0
133188,.,0,0
133189,One,0,0
133190,intervention,0,0
133191,involved,0,0
133192,a,0,0
133193,peer-mediated,0,0
133194,approach,0,0
133195,(,0,0
133196,PEER,0,1
133197,),0,0
133198,and,0,0
133199,the,0,0
133200,other,0,0
133201,involved,0,0
133202,a,0,0
133203,child-assisted,0,0
133204,approach,0,0
133205,(,0,0
133206,CHILD,0,0
133207,),0,0
133208,.,0,0
133209,METHOD,0,0
133210,The,0,0
133211,two,0,0
133212,interventions,0,0
133213,were,0,0
133214,crossed,0,0
133215,in,0,0
133216,a,0,0
133217,2,0,0
133218,?,0,0
133219,2,0,0
133220,factorial,0,0
133221,design,0,0
133222,yielding,0,0
133223,control,0,0
133224,",",0,0
133225,PEER,0,1
133226,",",0,1
133227,CHILD,0,1
133228,",",0,0
133229,and,0,0
133230,both,0,0
133231,PEER,0,1
133232,and,0,0
133233,CHILD,0,0
133234,conditions,0,0
133235,.,0,0
133236,Sixty,0,0
133237,children,0,0
133238,participated,0,0
133239,from,0,0
133240,56,0,0
133241,classrooms,0,0
133242,in,0,0
133243,30,0,0
133244,schools,0,0
133245,.,0,0
133246,Interventions,0,0
133247,involved,0,0
133248,12,0,0
133249,sessions,0,0
133250,over,0,0
133251,6,0,0
133252,weeks,0,0
133253,",",0,0
133254,with,0,0
133255,a,0,0
133256,3-month,0,0
133257,follow-up,0,0
133258,.,0,0
133259,Outcome,0,1
133260,measures,0,1
133261,included,1,0
133262,self,1,1
133263,",",1,1
133264,peer,1,0
133265,and,1,1
133266,teacher,1,0
133267,reports,1,0
133268,of,1,1
133269,social,1,1
133270,skills,1,1
133271,and,1,0
133272,independent,1,0
133273,weekly,1,0
133274,observations,1,0
133275,of,1,0
133276,children,1,0
133277,on,1,0
133278,their,1,0
133279,school,1,0
133280,playground,1,0
133281,over,1,0
133282,the,1,0
133283,course,1,0
133284,of,1,0
133285,the,1,0
133286,intervention,1,0
133287,.,1,0
133288,RESULTS,1,0
133289,Significant,0,0
133290,improvements,0,1
133291,were,0,0
133292,found,0,0
133293,in,1,0
133294,social,1,1
133295,network,1,0
133296,salience,1,1
133297,",",1,0
133298,number,1,1
133299,of,1,1
133300,friendship,1,1
133301,nominations,1,1
133302,",",1,0
133303,teacher,1,0
133304,report,1,0
133305,of,1,0
133306,social,1,1
133307,skills,1,1
133308,in,1,0
133309,the,1,0
133310,classroom,1,0
133311,",",1,0
133312,and,1,1
133313,decreased,1,1
133314,isolation,1,0
133315,on,1,0
133316,the,1,0
133317,playground,1,0
133318,for,1,0
133319,children,0,0
133320,who,0,0
133321,received,0,0
133322,PEER,0,1
133323,interventions,0,0
133324,.,0,0
133325,Changes,0,1
133326,obtained,0,0
133327,at,0,0
133328,the,0,0
133329,end,0,0
133330,of,0,0
133331,the,0,0
133332,treatment,0,0
133333,persisted,0,0
133334,to,0,0
133335,the,0,0
133336,3-month,0,0
133337,follow-up,0,0
133338,.,0,0
133339,CONCLUSIONS,0,0
133340,These,0,0
133341,data,0,0
133342,suggest,0,0
133343,that,0,0
133344,significant,0,0
133345,improvements,0,0
133346,can,0,0
133347,be,0,0
133348,made,0,0
133349,in,1,0
133350,peer,1,0
133351,social,1,1
133352,connections,1,1
133353,for,1,0
133354,children,0,0
133355,with,0,0
133356,autism,0,0
133357,spectrum,0,0
133358,disorders,0,0
133359,in,0,0
133360,general,0,0
133361,education,0,0
133362,classrooms,0,0
133363,with,0,0
133364,a,0,0
133365,brief,0,0
133366,intervention,0,0
133367,",",0,0
133368,and,0,0
133369,that,0,0
133370,these,0,0
133371,gains,0,0
133372,persist,0,0
133373,over,0,0
133374,time,0,1
133375,.,0,0
133376,Response,0,1
133377,prediction,0,1
133378,in,0,0
133379,metastasised,0,1
133380,colorectal,0,0
133381,cancer,0,0
133382,using,0,0
133383,intratumoural,0,0
133384,thymidylate,0,0
133385,synthase,0,0
133386,:,0,0
133387,results,0,0
133388,of,0,0
133389,a,0,0
133390,randomised,0,0
133391,multicentre,0,0
133392,trial,0,0
133393,.,0,0
133394,BACKGROUND,0,0
133395,Molecular,0,0
133396,markers,0,0
133397,to,0,0
133398,predict,0,0
133399,response,0,1
133400,to,0,0
133401,5-fluorouracil,0,0
133402,(,0,0
133403,FU,0,1
133404,),0,0
133405,-based,0,0
133406,treatment,0,0
133407,of,0,1
133408,recurrent,0,1
133409,or,0,0
133410,metastasised,0,1
133411,colorectal,0,0
133412,cancer,0,0
133413,(,0,0
133414,mCRC,0,0
133415,),0,0
133416,are,0,0
133417,not,0,0
133418,established,0,0
133419,.,0,0
133420,The,0,0
133421,aim,0,0
133422,of,0,0
133423,this,0,0
133424,trial,0,0
133425,was,0,0
133426,to,0,0
133427,determine,0,0
133428,the,0,0
133429,value,0,0
133430,of,0,0
133431,thymidylate,0,1
133432,synthase,0,0
133433,(,0,0
133434,TS,0,0
133435,),0,0
133436,",",0,0
133437,a,0,0
133438,key,0,0
133439,enzyme,0,0
133440,of,0,0
133441,DNA,0,1
133442,synthesis,0,1
133443,and,0,1
133444,target,0,0
133445,of,0,1
133446,5-FU,0,0
133447,",",0,0
133448,to,0,0
133449,predict,1,0
133450,response,1,1
133451,to,0,0
133452,chemotherapy,0,0
133453,of,0,0
133454,mCRC,0,0
133455,.,0,0
133456,METHODS,0,0
133457,Tumour,0,1
133458,tissue,0,1
133459,was,0,0
133460,obtained,0,0
133461,from,0,0
133462,168,0,0
133463,patients,0,0
133464,with,0,0
133465,mCRC,0,0
133466,for,0,0
133467,relative,0,1
133468,thymidylate,1,1
133469,synthase,1,1
133470,(,1,0
133471,TS,1,0
133472,),1,1
133473,mRNA,0,0
133474,quantitation,0,0
133475,.,0,0
133476,Patients,0,0
133477,were,0,0
133478,randomised,0,0
133479,to,0,0
133480,receive,0,0
133481,either,0,0
133482,5-FU/folinic,0,0
133483,acid,0,0
133484,(,0,0
133485,FA,0,0
133486,",",0,0
133487,FUFA,0,1
133488,),0,0
133489,alone,0,0
133490,or,0,0
133491,in,0,0
133492,combination,0,0
133493,with,0,0
133494,irinotecan,0,0
133495,5-fluorouracil/folinic,0,0
133496,acid,0,0
133497,and,0,1
133498,irinotecan,0,0
133499,(,0,0
133500,FOLFIRI,0,0
133501,),0,0
133502,stratified,0,0
133503,by,0,0
133504,TS,0,0
133505,(,0,0
133506,low,0,0
133507,versus,0,0
133508,high,0,0
133509,),0,0
133510,.,0,0
133511,Primary,0,0
133512,end-point,0,1
133513,was,0,0
133514,overall,1,1
133515,response,1,1
133516,to,1,0
133517,first-line,1,0
133518,treatment,1,0
133519,among,0,0
133520,TS,0,0
133521,high,0,0
133522,patients,0,0
133523,.,0,0
133524,All,0,0
133525,parties,0,0
133526,",",0,0
133527,except,0,0
133528,for,0,0
133529,the,0,0
133530,randomisation,0,0
133531,centre,0,0
133532,",",0,0
133533,were,0,0
133534,blinded,0,0
133535,for,0,0
133536,TS,0,0
133537,status,0,1
133538,.,0,0
133539,RESULTS,0,0
133540,Biopsies,0,1
133541,(,0,0
133542,n=168,0,0
133543,),0,0
133544,were,0,0
133545,taken,0,0
133546,without,0,0
133547,complications,0,1
133548,.,0,0
133549,TS,1,0
133550,levels,1,1
133551,were,0,0
133552,available,0,0
133553,for,0,0
133554,147,0,0
133555,patients,0,0
133556,(,0,0
133557,87.5,0,0
133558,%,0,0
133559,),0,0
133560,.,0,0
133561,Analysing,0,0
133562,response,1,1
133563,to,1,0
133564,FUFA,1,1
133565,and,1,0
133566,FOLFIRI,1,0
133567,in,0,0
133568,the,0,0
133569,per,0,0
133570,protocol,0,0
133571,set,0,0
133572,(,0,0
133573,n=119,0,0
133574,),0,0
133575,after,0,0
133576,un-blinding,0,0
133577,TS,0,0
133578,in,0,0
133579,the,0,0
133580,data,0,0
133581,base,0,0
133582,revealed,0,0
133583,a,0,0
133584,trend,0,0
133585,to,0,0
133586,better,0,0
133587,overall,0,1
133588,response,0,1
133589,to,0,0
133590,FOLFIRI,0,0
133591,(,0,0
133592,9/19,0,0
133593,",",0,0
133594,47,0,0
133595,%,0,0
133596,),0,0
133597,in,0,0
133598,TS,0,0
133599,high,0,0
133600,compared,0,0
133601,to,0,0
133602,FUFA,0,0
133603,(,0,0
133604,5/23,0,0
133605,",",0,0
133606,22,0,0
133607,%,0,0
133608,",",0,0
133609,p=0.077,0,0
133610,),0,0
133611,.,0,0
133612,In,0,0
133613,patients,0,0
133614,with,0,0
133615,biopsies,0,0
133616,taken,0,0
133617,from,0,0
133618,liver,0,0
133619,lesions,0,1
133620,(,0,0
133621,n=91,0,0
133622,),0,0
133623,overall,0,1
133624,response,0,1
133625,to,0,0
133626,FOLFIRI,0,0
133627,and,0,0
133628,FUFA,0,1
133629,in,0,0
133630,TS,0,0
133631,high,0,0
133632,was,0,0
133633,53,0,0
133634,%,0,0
133635,(,0,0
133636,9/17,0,0
133637,),0,0
133638,and,0,0
133639,18,0,0
133640,%,0,0
133641,(,0,0
133642,3/17,0,0
133643,),0,0
133644,",",0,0
133645,respectively,0,0
133646,(,0,0
133647,p=0.035,0,0
133648,),0,0
133649,.,0,0
133650,In,0,0
133651,patients,0,0
133652,with,0,0
133653,low,0,0
133654,TS,0,0
133655,",",0,0
133656,no,0,0
133657,remarkable,0,0
133658,difference,0,0
133659,in,0,0
133660,overall,0,1
133661,response,0,1
133662,to,0,0
133663,FOLFIRI,0,0
133664,and,0,0
133665,FUFA,0,1
133666,was,0,0
133667,observed,0,0
133668,.,0,0
133669,CONCLUSIONS,0,0
133670,Taking,0,0
133671,a,0,0
133672,pre-treatment,0,0
133673,biopsy,0,0
133674,is,0,0
133675,a,0,0
133676,safe,0,0
133677,and,0,0
133678,feasible,0,0
133679,procedure,0,0
133680,in,0,0
133681,mCRC,0,0
133682,.,0,0
133683,After,0,0
133684,validation,0,0
133685,of,0,0
133686,our,0,0
133687,data,0,0
133688,in,0,0
133689,a,0,0
133690,larger,0,0
133691,group,0,0
133692,TS,0,0
133693,determination,0,0
133694,may,0,0
133695,have,0,0
133696,the,0,0
133697,potential,0,0
133698,to,0,0
133699,better,0,0
133700,help,0,0
133701,direct,0,1
133702,systemic,0,1
133703,treatment,0,0
133704,in,0,0
133705,patients,0,0
133706,with,0,0
133707,primarily,0,0
133708,non-resectable,0,0
133709,mCRC,0,0
133710,.,0,0
133711,Granulocyte-colony,0,1
133712,stimulating,0,1
133713,factor,0,0
133714,for,0,0
133715,mobilizing,0,0
133716,bone,0,1
133717,marrow,0,0
133718,stem,0,1
133719,cells,0,1
133720,in,0,0
133721,subacute,0,0
133722,stroke,0,0
133723,:,0,0
133724,the,0,0
133725,stem,0,0
133726,cell,0,0
133727,trial,0,0
133728,of,0,0
133729,recovery,0,1
133730,enhancement,0,1
133731,after,0,0
133732,stroke,0,0
133733,2,0,0
133734,randomized,0,0
133735,controlled,0,0
133736,trial,0,0
133737,.,0,0
133738,BACKGROUND,0,0
133739,AND,0,0
133740,PURPOSE,0,0
133741,Granulocyte-colony,0,1
133742,stimulating,0,1
133743,factor,0,0
133744,(,0,0
133745,G-CSF,0,0
133746,),0,0
133747,is,0,0
133748,neuroprotective,0,0
133749,in,0,0
133750,experimental,0,0
133751,stroke,0,0
133752,and,0,0
133753,mobilizes,0,0
133754,CD34,0,0
133755,(,0,0
133756,+,0,0
133757,),0,0
133758,peripheral,0,1
133759,blood,0,1
133760,stem,0,1
133761,cells,0,1
133762,into,0,0
133763,the,0,0
133764,circulation,0,0
133765,.,0,0
133766,We,0,0
133767,assessed,0,0
133768,the,0,0
133769,safety,0,1
133770,of,0,0
133771,G-CSF,0,0
133772,in,0,0
133773,recent,0,0
133774,stroke,0,0
133775,in,0,0
133776,a,0,0
133777,phase,0,0
133778,IIb,0,0
133779,single-center,0,0
133780,randomized,0,0
133781,",",0,0
133782,controlled,0,0
133783,trial,0,0
133784,.,0,0
133785,METHODS,0,0
133786,G-CSF,0,0
133787,(,0,0
133788,10,0,0
133789,?g/kg,0,0
133790,),0,0
133791,or,0,0
133792,placebo,0,0
133793,(,0,0
133794,ratio,0,0
133795,2:1,0,0
133796,),0,0
133797,was,0,0
133798,given,0,0
133799,SC,0,0
133800,for,0,0
133801,5,0,0
133802,days,0,0
133803,to,0,0
133804,60,0,0
133805,patients,0,0
133806,3,0,0
133807,to,0,0
133808,30,0,0
133809,days,0,0
133810,after,0,0
133811,ischemic,0,0
133812,or,0,0
133813,hemorrhagic,0,1
133814,stroke,0,0
133815,.,0,0
133816,The,0,0
133817,primary,0,0
133818,outcome,0,0
133819,was,0,0
133820,the,1,0
133821,frequency,1,1
133822,of,1,0
133823,serious,1,1
133824,adverse,1,1
133825,events,1,1
133826,.,1,0
133827,Peripheral,1,0
133828,blood,1,1
133829,counts,1,1
133830,",",1,0
133831,CD34,1,0
133832,(,1,0
133833,+,1,0
133834,),1,1
133835,count,1,1
133836,",",1,0
133837,and,1,1
133838,functional,1,1
133839,outcome,1,1
133840,were,0,0
133841,measured,0,0
133842,.,0,0
133843,MRI,0,0
133844,assessed,1,0
133845,lesion,1,1
133846,volume,1,1
133847,",",1,1
133848,atrophy,1,1
133849,",",1,0
133850,and,1,0
133851,the,1,0
133852,presence,1,0
133853,of,1,0
133854,iron-labeled,1,0
133855,CD34,1,0
133856,(,1,0
133857,+,1,0
133858,),1,0
133859,cells,1,1
133860,reinjected,0,0
133861,on,0,0
133862,day,0,0
133863,6,0,0
133864,.,0,0
133865,RESULTS,0,0
133866,Sixty,0,0
133867,patients,0,0
133868,were,0,0
133869,recruited,0,0
133870,at,1,0
133871,mean,1,0
133872,of,1,0
133873,8,1,0
133874,days,1,0
133875,(,0,0
133876,SD,0,0
133877,?,0,0
133878,5,0,0
133879,),0,0
133880,post,0,0
133881,ictus,0,1
133882,",",0,0
133883,with,0,0
133884,mean,0,1
133885,age,0,0
133886,71,0,0
133887,years,0,0
133888,(,0,0
133889,?,0,0
133890,12,0,0
133891,years,0,0
133892,),0,0
133893,and,0,0
133894,53,0,0
133895,%,0,0
133896,men,0,0
133897,.,0,0
133898,The,0,0
133899,groups,0,0
133900,were,0,0
133901,well,0,0
133902,matched,0,0
133903,for,0,0
133904,baseline,0,0
133905,minimization/prognostic,0,0
133906,factors,0,0
133907,.,0,0
133908,There,0,0
133909,were,0,0
133910,no,0,0
133911,significant,0,0
133912,differences,0,0
133913,between,0,0
133914,groups,0,0
133915,in,0,0
133916,the,0,0
133917,number,0,1
133918,of,0,0
133919,participants,0,0
133920,with,1,0
133921,serious,1,1
133922,adverse,1,1
133923,events,1,1
133924,:,1,0
133925,G-CSF,1,0
133926,15,1,0
133927,(,0,0
133928,37.5,0,0
133929,%,0,0
133930,),0,0
133931,of,0,0
133932,40,0,0
133933,versus,0,0
133934,placebo,0,0
133935,7,0,0
133936,(,0,0
133937,35,0,0
133938,%,0,0
133939,),0,0
133940,of,0,0
133941,20,0,0
133942,",",0,0
133943,death,1,1
133944,or,1,1
133945,dependency,1,1
133946,(,1,0
133947,modified,1,0
133948,Rankin,0,1
133949,Score,0,0
133950,:,0,0
133951,G-CSF,0,0
133952,3.3,0,0
133953,?,0,0
133954,1.3,0,0
133955,",",0,0
133956,placebo,0,0
133957,3.0,0,0
133958,?,0,0
133959,1.3,0,0
133960,),0,0
133961,at,0,0
133962,90,0,0
133963,days,0,0
133964,",",0,0
133965,or,0,0
133966,the,1,0
133967,number,1,1
133968,of,1,0
133969,injections,1,0
133970,received,1,0
133971,.,1,0
133972,G-CSF,1,0
133973,increased,1,0
133974,CD34,1,0
133975,(,1,0
133976,+,1,0
133977,),1,0
133978,and,1,0
133979,total,1,1
133980,white,1,0
133981,cell,1,0
133982,counts,1,1
133983,of,1,0
133984,9.5-,1,0
133985,and,0,0
133986,4.2-fold,0,0
133987,",",0,0
133988,respectively,0,0
133989,.,0,0
133990,There,0,0
133991,was,0,0
133992,a,0,0
133993,trend,0,0
133994,toward,0,0
133995,reduction,1,1
133996,in,1,0
133997,MRI,1,1
133998,ischemic,1,1
133999,lesion,1,1
134000,volume,1,1
134001,with,1,0
134002,respect,0,0
134003,to,0,0
134004,change,0,0
134005,from,0,0
134006,baseline,0,0
134007,in,0,0
134008,G-CSF-treated,0,0
134009,patients,0,0
134010,(,0,0
134011,P=0.06,0,0
134012,),0,0
134013,.,0,0
134014,In,0,0
134015,1,0,0
134016,participant,0,0
134017,",",0,0
134018,there,0,0
134019,was,0,0
134020,suggestion,0,0
134021,that,0,0
134022,labeled,1,0
134023,CD34,1,0
134024,(,1,0
134025,+,1,0
134026,),1,0
134027,cells,1,1
134028,had,1,0
134029,migrated,0,0
134030,to,0,0
134031,the,0,0
134032,ischemic,0,0
134033,lesion,0,0
134034,.,0,0
134035,CONCLUSIONS,0,0
134036,This,0,0
134037,randomized,0,0
134038,",",0,0
134039,double-blind,0,0
134040,",",0,0
134041,placebo-controlled,0,0
134042,trial,0,0
134043,suggests,0,0
134044,that,0,0
134045,G-CSF,0,0
134046,is,0,0
134047,safe,0,0
134048,when,0,0
134049,administered,0,0
134050,subacutely,0,0
134051,.,0,0
134052,It,0,0
134053,is,0,0
134054,feasible,0,0
134055,to,0,0
134056,label,0,0
134057,and,0,0
134058,readminister,0,0
134059,iron-labeled,0,0
134060,CD34,0,0
134061,(,0,0
134062,+,0,0
134063,),0,0
134064,cells,0,1
134065,in,0,0
134066,patients,0,0
134067,with,0,0
134068,ischemic,0,0
134069,stroke,0,0
134070,.,0,0
134071,CLINICAL,0,1
134072,TRIAL,0,0
134073,REGISTRATION,0,0
134074,URL,0,0
134075,:,0,0
134076,www.controlled-trials.com,0,0
134077,.,0,0
134078,Unique,0,0
134079,identifier,0,0
134080,:,0,0
134081,ISRCTN63336619,0,0
134082,.,0,0
134083,[,0,0
134084,Pharmacological,0,0
134085,correction,0,0
134086,of,0,0
134087,free,1,1
134088,radical,1,0
134089,disturbances,1,1
134090,and,1,0
134091,endotoxicosis,1,1
134092,in,0,0
134093,patients,0,0
134094,with,0,0
134095,diffuse,0,0
134096,peritonitis,0,1
134097,at,0,0
134098,the,0,0
134099,postoperative,0,1
134100,period,0,0
134101,],0,0
134102,.,0,0
134103,The,0,0
134104,examination,0,0
134105,and,0,0
134106,treatment,0,0
134107,of,0,0
134108,64,0,0
134109,patients,0,0
134110,have,0,0
134111,shown,0,0
134112,that,0,0
134113,inclusion,0,0
134114,of,0,0
134115,complex,0,0
134116,antioxidant,0,0
134117,cytoflavin,0,0
134118,in,0,0
134119,intensive,0,0
134120,therapy,0,0
134121,at,0,0
134122,the,0,0
134123,postoperative,0,1
134124,period,0,0
134125,of,0,0
134126,diffuse,0,0
134127,peritonitis,0,0
134128,allows,0,0
134129,the,0,0
134130,hypoxia,0,0
134131,degree,0,1
134132,to,0,0
134133,be,0,0
134134,decreased,0,0
134135,that,0,0
134136,in,0,0
134137,its,0,0
134138,turn,0,0
134139,results,0,0
134140,in,0,0
134141,quicker,0,0
134142,recovery,1,1
134143,of,1,0
134144,the,1,0
134145,antioxidant,1,0
134146,system,1,0
134147,and,1,0
134148,decreased,1,1
134149,activity,1,1
134150,of,1,0
134151,peroxidation,1,1
134152,and,1,1
134153,endotoxicosis,1,1
134154,level,1,1
134155,.,1,0
134156,The,0,0
134157,clinical,0,0
134158,course,0,0
134159,of,0,0
134160,the,0,0
134161,postoperative,0,1
134162,period,0,0
134163,of,0,0
134164,diffuse,0,0
134165,peritonitis,0,1
134166,with,0,0
134167,cytoflavin,0,0
134168,included,0,0
134169,in,0,0
134170,intensive,0,0
134171,therapy,0,0
134172,is,0,0
134173,characterized,0,0
134174,by,0,0
134175,shorter,0,0
134176,terms,0,0
134177,of,0,1
134178,artificial,1,0
134179,lung,1,0
134180,ventilation,1,0
134181,",",0,0
134182,shorter,0,1
134183,time,0,1
134184,of,0,0
134185,staying,1,0
134186,in,1,0
134187,critical,1,0
134188,condition,1,0
134189,",",0,0
134190,more,0,0
134191,favorable,0,1
134192,course,1,0
134193,of,1,0
134194,complications,1,1
134195,.,1,0
134196,Recombinant,0,0
134197,human,0,0
134198,erythropoietin,0,0
134199,.,0,0
134200,Effects,0,0
134201,of,0,0
134202,risperidone,0,0
134203,and,0,1
134204,parent,0,1
134205,training,0,0
134206,on,0,0
134207,adaptive,0,1
134208,functioning,0,1
134209,in,0,0
134210,children,0,0
134211,with,0,0
134212,pervasive,0,0
134213,developmental,0,0
134214,disorders,0,0
134215,and,0,0
134216,serious,0,1
134217,behavioral,0,1
134218,problems,0,0
134219,.,0,0
134220,OBJECTIVE,0,0
134221,Children,0,0
134222,with,0,0
134223,Pervasive,0,0
134224,Developmental,0,1
134225,Disorders,0,1
134226,(,0,0
134227,PDDs,0,0
134228,),0,0
134229,have,0,0
134230,social,0,1
134231,interaction,0,1
134232,deficits,0,1
134233,",",0,0
134234,delayed,0,1
134235,communication,0,1
134236,",",0,0
134237,and,0,1
134238,repetitive,0,1
134239,behaviors,0,1
134240,as,0,0
134241,well,0,0
134242,as,0,0
134243,impairments,0,0
134244,in,0,0
134245,adaptive,0,0
134246,functioning,0,1
134247,.,0,0
134248,Many,0,1
134249,children,0,0
134250,actually,0,0
134251,show,0,0
134252,a,0,0
134253,decline,0,0
134254,in,0,0
134255,adaptive,0,1
134256,skills,0,1
134257,compared,0,0
134258,with,0,0
134259,age,0,0
134260,mates,0,0
134261,over,0,0
134262,time,0,1
134263,.,0,0
134264,METHOD,0,0
134265,This,0,0
134266,24-week,0,0
134267,",",0,0
134268,three-site,0,0
134269,",",0,0
134270,controlled,0,0
134271,clinical,0,0
134272,trial,0,0
134273,randomized,0,0
134274,124,0,0
134275,children,0,0
134276,(,0,0
134277,4,0,0
134278,through,0,0
134279,13,0,0
134280,years,0,0
134281,of,0,0
134282,age,0,0
134283,),0,0
134284,with,0,0
134285,PDDs,0,0
134286,and,0,0
134287,serious,0,1
134288,behavioral,0,1
134289,problems,0,0
134290,to,0,0
134291,medication,0,0
134292,alone,0,0
134293,(,0,0
134294,MED,0,1
134295,;,0,0
134296,n,0,0
134297,=,0,0
134298,49,0,0
134299,;,0,0
134300,risperidone,0,0
134301,0.5,0,0
134302,to,0,0
134303,3.5,0,0
134304,mg/day,0,0
134305,;,0,0
134306,if,0,0
134307,ineffective,0,0
134308,",",0,0
134309,switch,0,0
134310,to,0,0
134311,aripiprazole,0,0
134312,was,0,0
134313,permitted,0,0
134314,),0,0
134315,or,0,0
134316,a,0,0
134317,combination,0,0
134318,of,0,0
134319,medication,0,1
134320,plus,0,0
134321,parent,0,1
134322,training,0,0
134323,(,0,0
134324,PT,0,1
134325,),0,0
134326,(,0,0
134327,COMB,0,0
134328,;,0,0
134329,n,0,0
134330,=,0,0
134331,75,0,0
134332,),0,0
134333,.,0,0
134334,Parents,0,0
134335,of,0,0
134336,children,0,0
134337,in,0,0
134338,COMB,0,0
134339,received,0,0
134340,an,0,0
134341,average,0,0
134342,of,0,0
134343,11.4,0,0
134344,PT,0,0
134345,sessions,0,0
134346,.,0,0
134347,Standard,0,0
134348,scores,0,1
134349,and,0,0
134350,Age-Equivalent,0,0
134351,scores,0,1
134352,on,0,0
134353,Vineland,0,0
134354,Adaptive,0,1
134355,Behavior,0,1
134356,Scales,0,1
134357,were,0,0
134358,the,0,0
134359,outcome,0,1
134360,measures,0,1
134361,of,0,0
134362,primary,0,0
134363,interest,0,0
134364,.,0,0
134365,RESULTS,0,0
134366,Seventeen,0,0
134367,subjects,0,0
134368,did,0,0
134369,not,0,0
134370,have,0,0
134371,a,0,0
134372,post-randomization,0,0
134373,Vineland,0,0
134374,assessment,0,0
134375,.,0,0
134376,Thus,0,0
134377,",",0,0
134378,we,0,0
134379,used,0,0
134380,a,0,0
134381,mixed,0,0
134382,model,0,0
134383,with,0,0
134384,outcome,0,1
134385,conditioned,0,0
134386,on,0,0
134387,the,0,0
134388,baseline,0,0
134389,Vineland,0,0
134390,scores,0,1
134391,.,0,0
134392,Both,0,0
134393,groups,0,0
134394,showed,0,0
134395,improvement,0,0
134396,over,0,0
134397,the,0,0
134398,24-week,0,0
134399,trial,0,0
134400,on,0,0
134401,all,0,0
134402,Vineland,0,0
134403,domains,0,1
134404,.,0,0
134405,Compared,0,0
134406,with,0,0
134407,MED,0,0
134408,",",0,0
134409,Vineland,1,1
134410,Socialization,1,1
134411,and,1,0
134412,Adaptive,1,1
134413,Composite,1,0
134414,Standard,1,0
134415,scores,1,1
134416,showed,0,0
134417,greater,0,0
134418,improvement,0,1
134419,in,0,0
134420,the,0,0
134421,COMB,0,0
134422,group,0,0
134423,(,0,0
134424,p,0,0
134425,=,0,0
134426,.01,0,0
134427,and,0,1
134428,.05,0,0
134429,",",0,1
134430,and,0,1
134431,effect,0,0
134432,sizes,0,1
134433,=,0,0
134434,0.35,0,0
134435,and,0,0
134436,0.22,0,0
134437,",",0,0
134438,respectively,0,0
134439,),0,0
134440,.,0,0
134441,On,0,0
134442,Age,0,1
134443,Equivalent,0,0
134444,scores,0,1
134445,",",0,0
134446,Socialization,1,1
134447,and,1,1
134448,Communication,1,1
134449,domains,1,1
134450,showed,0,0
134451,greater,0,0
134452,improvement,0,1
134453,in,0,0
134454,COMB,0,0
134455,versus,0,0
134456,MED,0,1
134457,(,0,0
134458,p,0,0
134459,=,0,0
134460,.03,0,0
134461,and,0,0
134462,0.05,0,0
134463,",",0,0
134464,and,0,0
134465,effect,0,0
134466,sizes,0,1
134467,=,0,0
134468,0.33,0,0
134469,and,0,0
134470,0.14,0,0
134471,",",0,0
134472,respectively,0,0
134473,),0,0
134474,.,0,0
134475,Using,0,0
134476,logistic,0,0
134477,regression,0,0
134478,",",0,0
134479,children,0,0
134480,in,0,0
134481,the,0,0
134482,COMB,0,0
134483,group,0,0
134484,were,0,0
134485,twice,0,0
134486,as,0,0
134487,likely,0,0
134488,to,0,0
134489,make,0,0
134490,at,0,0
134491,least,0,0
134492,6,0,0
134493,months,0,0
134494,',0,0
134495,gain,0,1
134496,(,0,0
134497,equal,0,0
134498,to,0,0
134499,the,0,0
134500,passage,0,0
134501,of,0,0
134502,time,0,1
134503,),0,0
134504,in,0,0
134505,the,0,0
134506,Vineland,1,0
134507,Communication,1,1
134508,Age,1,1
134509,Equivalent,1,0
134510,score,1,1
134511,compared,0,0
134512,with,0,0
134513,MED,0,0
134514,(,0,0
134515,p,0,0
134516,=,0,0
134517,.02,0,0
134518,),0,0
134519,.,0,0
134520,After,0,0
134521,controlling,0,0
134522,for,0,0
134523,IQ,0,0
134524,",",0,0
134525,this,0,0
134526,difference,0,0
134527,was,0,0
134528,no,0,0
134529,longer,0,0
134530,significant,0,0
134531,.,0,0
134532,CONCLUSION,0,0
134533,Reduction,0,0
134534,of,0,0
134535,serious,0,1
134536,maladaptive,0,1
134537,behavior,0,1
134538,promotes,0,0
134539,improvement,0,1
134540,in,0,0
134541,adaptive,0,1
134542,behavior,0,1
134543,.,0,0
134544,Medication,0,0
134545,plus,0,0
134546,PT,0,1
134547,shows,0,0
134548,modest,0,0
134549,additional,0,0
134550,benefit,0,0
134551,over,0,0
134552,medication,0,0
134553,alone,0,0
134554,.,0,0
134555,Clinical,0,1
134556,trial,0,0
134557,registration,0,0
134558,information-RUPP,0,0
134559,PI,0,0
134560,PDD,0,1
134561,:,0,0
134562,Drug,0,0
134563,and,0,0
134564,Behavioral,0,1
134565,Therapy,0,0
134566,for,0,0
134567,Children,0,0
134568,With,0,0
134569,Pervasive,0,0
134570,Developmental,0,0
134571,Disorders,0,0
134572,;,0,0
134573,http,0,0
134574,:,0,0
134575,//www.clinicaltrials.gov,0,0
134576,;,0,0
134577,NCT00080145,0,0
134578,.,0,0
134579,Effects,0,0
134580,of,0,0
134581,a,0,0
134582,common,0,0
134583,variant,0,0
134584,in,0,0
134585,the,0,0
134586,CD38,0,0
134587,gene,0,1
134588,on,0,0
134589,social,1,1
134590,processing,1,0
134591,in,0,0
134592,an,0,0
134593,oxytocin,0,0
134594,challenge,0,0
134595,study,0,0
134596,:,0,0
134597,possible,0,0
134598,links,0,0
134599,to,0,0
134600,autism,0,0
134601,.,0,0
134602,The,0,0
134603,intranasal,0,0
134604,application,0,0
134605,of,0,0
134606,oxytocin,0,1
134607,(,0,0
134608,OT,0,0
134609,),0,0
134610,has,0,0
134611,been,0,0
134612,shown,0,0
134613,to,0,0
134614,influence,0,0
134615,behavioral,1,1
134616,and,1,0
134617,neural,1,1
134618,correlates,1,0
134619,of,1,0
134620,social,1,1
134621,processing,1,0
134622,.,1,0
134623,These,0,0
134624,effects,0,0
134625,are,0,0
134626,probably,0,0
134627,mediated,0,0
134628,by,0,0
134629,genetic,0,0
134630,variations,0,0
134631,within,0,0
134632,the,0,0
134633,OT,0,0
134634,system,0,0
134635,.,0,0
134636,One,0,0
134637,potential,0,0
134638,candidate,0,0
134639,could,0,0
134640,be,0,0
134641,the,0,0
134642,CD38,0,0
134643,gene,0,1
134644,",",0,0
134645,which,0,0
134646,codes,0,0
134647,for,0,0
134648,a,0,0
134649,transmembrane,0,1
134650,protein,0,1
134651,engaged,0,0
134652,in,0,0
134653,OT,0,0
134654,secretion,0,1
134655,processes,0,0
134656,.,0,0
134657,A,0,0
134658,common,0,0
134659,variation,0,0
134660,in,0,0
134661,this,0,0
134662,gene,0,1
134663,(,0,0
134664,rs3796863,0,0
134665,),0,0
134666,was,0,0
134667,recently,0,0
134668,found,0,0
134669,to,0,0
134670,be,0,0
134671,associated,0,0
134672,with,0,0
134673,autism,0,0
134674,spectrum,0,0
134675,disorders,0,0
134676,(,0,0
134677,ASD,0,0
134678,),0,0
134679,.,0,0
134680,Using,0,0
134681,an,0,0
134682,imaging,0,0
134683,genetics,0,0
134684,approach,0,0
134685,",",0,0
134686,we,0,0
134687,studied,0,0
134688,differential,0,0
134689,effects,0,0
134690,of,0,0
134691,an,0,0
134692,intranasal,0,0
134693,OT,0,1
134694,application,0,0
134695,on,0,0
134696,neural,1,1
134697,processing,1,0
134698,of,1,0
134699,social,1,1
134700,stimuli,1,0
134701,in,0,0
134702,55,0,0
134703,healthy,0,0
134704,young,0,0
134705,men,0,0
134706,depending,0,0
134707,on,0,0
134708,their,0,0
134709,CD38,0,0
134710,gene,0,1
134711,variant,0,0
134712,in,0,0
134713,a,0,0
134714,double-blind,0,0
134715,placebo-controlled,0,0
134716,crossover,0,0
134717,design,0,0
134718,.,0,0
134719,Genotype,0,0
134720,had,0,0
134721,a,0,0
134722,significant,0,0
134723,influence,0,0
134724,on,0,0
134725,both,0,0
134726,behavioral,1,1
134727,and,1,0
134728,neuronal,1,1
134729,measures,1,1
134730,of,1,0
134731,social,1,1
134732,processing,1,0
134733,.,1,0
134734,Homozygotic,0,0
134735,risk,0,1
134736,allele,0,0
134737,carriers,0,0
134738,showed,0,0
134739,slower,1,0
134740,reaction,1,1
134741,times,1,1
134742,(,1,0
134743,RT,1,0
134744,),1,0
134745,and,0,0
134746,higher,1,0
134747,activation,1,1
134748,of,1,1
134749,left,1,1
134750,fusiform,1,1
134751,gyrus,1,1
134752,during,0,0
134753,visual,0,1
134754,processing,0,0
134755,of,0,0
134756,social,1,1
134757,stimuli,1,0
134758,.,1,0
134759,Under,0,0
134760,OT,0,1
134761,activation,1,1
134762,differences,1,0
134763,between,0,0
134764,genotypes,0,0
134765,were,0,0
134766,more,0,0
134767,evident,0,0
134768,(,0,0
134769,though,0,0
134770,not,0,0
134771,statistically,0,0
134772,significantly,0,0
134773,increased,0,0
134774,),0,0
134775,and,0,0
134776,RT,1,0
134777,were,0,0
134778,accelerated,0,0
134779,in,0,0
134780,homozygotic,0,0
134781,risk,0,1
134782,allele,0,0
134783,carriers,0,0
134784,.,0,0
134785,According,0,0
134786,to,0,0
134787,our,0,0
134788,data,0,0
134789,",",0,0
134790,rs3796863,1,0
134791,mainly,1,0
134792,influences,1,0
134793,fusiform,1,1
134794,gyrus,1,1
134795,activation,1,1
134796,",",0,0
134797,an,0,0
134798,area,0,0
134799,which,0,0
134800,has,0,0
134801,been,0,0
134802,widely,0,0
134803,discussed,0,0
134804,in,0,0
134805,ASD,0,0
134806,research,0,0
134807,.,0,0
134808,OT,0,0
134809,seems,0,0
134810,to,0,0
134811,modulate,0,0
134812,this,0,0
134813,effect,0,0
134814,by,0,0
134815,enhancing,0,0
134816,activation,1,1
134817,differences,1,0
134818,between,0,0
134819,allele,0,0
134820,groups,0,0
134821,",",0,0
134822,which,0,0
134823,suggests,0,0
134824,an,0,0
134825,interaction,0,0
134826,between,0,0
134827,genetic,1,0
134828,makeup,1,0
134829,and,0,1
134830,OT,1,1
134831,availability,1,1
134832,on,0,0
134833,fusiform,1,1
134834,gyrus,1,1
134835,activation,1,1
134836,.,1,0
134837,These,0,0
134838,results,0,0
134839,support,0,0
134840,recent,0,0
134841,approaches,0,0
134842,to,0,0
134843,apply,0,0
134844,OT,0,0
134845,as,0,0
134846,a,0,0
134847,pharmacological,0,0
134848,treatment,0,0
134849,of,0,0
134850,ASD,0,0
134851,symptoms,0,1
134852,.,0,0
134853,Predictors,0,1
134854,of,0,0
134855,response,0,1
134856,to,0,0
134857,ziprasidone,0,0
134858,:,0,0
134859,results,0,0
134860,from,0,0
134861,a,0,0
134862,6-week,0,0
134863,randomized,0,0
134864,double-blind,0,0
134865,",",0,0
134866,placebo-controlled,0,0
134867,trial,0,0
134868,for,0,0
134869,acute,0,0
134870,depressive,0,1
134871,mixed,0,0
134872,state,0,0
134873,.,0,0
134874,INTRODUCTION,0,0
134875,The,0,0
134876,present,0,0
134877,study,0,0
134878,is,0,0
134879,aimed,0,0
134880,at,0,0
134881,investigating,0,0
134882,possible,0,0
134883,predictors,0,0
134884,of,0,0
134885,response,0,1
134886,to,0,0
134887,ziprasidone,0,0
134888,in,0,0
134889,a,0,0
134890,sample,0,0
134891,of,0,0
134892,patients,0,0
134893,with,0,0
134894,mixed,0,0
134895,depressive,0,1
134896,state,0,0
134897,.,0,0
134898,METHODS,0,0
134899,72,0,0
134900,patients,0,0
134901,were,0,0
134902,randomized,0,0
134903,to,0,0
134904,either,0,0
134905,ziprasidone,0,0
134906,or,0,0
134907,placebo,0,0
134908,and,0,1
134909,treated,0,0
134910,prospectively,0,0
134911,for,0,0
134912,6,0,0
134913,weeks,0,0
134914,.,0,0
134915,The,0,0
134916,clinical,0,0
134917,response,0,1
134918,and,0,1
134919,remission,0,1
134920,were,0,0
134921,defined,0,0
134922,with,0,0
134923,various,0,0
134924,clinical,0,0
134925,variables,0,0
134926,including,0,0
134927,Montgomery,1,0
134928,Asberg,1,0
134929,Depression,1,1
134930,Rating,1,0
134931,Scale,1,1
134932,.,1,0
134933,Further,0,1
134934,outcome,0,1
134935,measures,0,1
134936,included,0,0
134937,predictors,0,0
134938,of,0,1
134939,remission,1,1
134940,and,0,0
134941,other,0,0
134942,clinical,0,0
134943,variables,0,0
134944,over,0,0
134945,time,0,1
134946,.,0,0
134947,RESULTS,0,0
134948,None,0,0
134949,of,0,0
134950,the,0,0
134951,variables,0,0
134952,under,0,0
134953,investigation,0,0
134954,were,0,0
134955,significantly,0,0
134956,associated,0,0
134957,with,0,0
134958,response,1,1
134959,or,1,0
134960,remission,1,1
134961,at,0,0
134962,6,0,0
134963,weeks,0,0
134964,(,0,0
134965,all,0,0
134966,p-values,0,0
134967,>,0,0
134968,0.003,0,0
134969,",",0,0
134970,respectively,0,0
134971,),0,0
134972,.,0,0
134973,CONCLUSIONS,0,0
134974,Further,0,0
134975,investigations,0,0
134976,are,0,0
134977,warranted,0,0
134978,due,0,0
134979,to,0,0
134980,clear,0,0
134981,limitations,0,0
134982,",",0,0
134983,mostly,0,0
134984,small,0,0
134985,sample,0,0
134986,size,0,1
134987,and,0,1
134988,use,0,1
134989,of,0,1
134990,concomitant,0,0
134991,medications,0,0
134992,.,0,0
134993,Effect,0,0
134994,of,0,1
134995,acute,0,0
134996,exercise,0,0
134997,on,0,0
134998,executive,1,1
134999,function,1,1
135000,in,0,0
135001,children,0,0
135002,with,0,0
135003,attention,0,0
135004,deficit,0,1
135005,hyperactivity,0,1
135006,disorder,0,0
135007,.,0,0
135008,This,0,0
135009,study,0,0
135010,was,0,0
135011,conducted,0,0
135012,to,0,0
135013,determine,0,0
135014,the,0,0
135015,effect,0,0
135016,of,0,0
135017,acute,0,0
135018,aerobic,0,0
135019,exercise,0,0
135020,on,0,0
135021,executive,1,1
135022,function,1,1
135023,in,0,0
135024,children,0,0
135025,with,0,0
135026,attention,0,0
135027,deficit,0,1
135028,hyperactivity,0,1
135029,disorder,0,0
135030,(,0,0
135031,ADHD,0,0
135032,),0,0
135033,.,0,0
135034,Forty,0,0
135035,children,0,0
135036,with,0,0
135037,ADHD,0,0
135038,were,0,0
135039,randomly,0,0
135040,assigned,0,0
135041,into,0,0
135042,exercise,0,0
135043,or,0,0
135044,control,0,0
135045,groups,0,0
135046,.,0,0
135047,Participants,0,0
135048,in,0,0
135049,the,0,0
135050,exercise,0,0
135051,group,0,0
135052,performed,0,0
135053,a,0,0
135054,moderate,0,0
135055,intensity,0,1
135056,aerobic,0,0
135057,exercise,0,0
135058,for,0,0
135059,30,0,0
135060,min,0,0
135061,",",0,0
135062,whereas,0,0
135063,the,0,0
135064,control,0,0
135065,group,0,0
135066,watched,0,0
135067,a,0,0
135068,running/exercise-related,0,1
135069,video,0,0
135070,.,0,0
135071,Neuropsychological,1,0
135072,tasks,1,0
135073,",",1,0
135074,the,1,0
135075,Stroop,1,0
135076,Test,1,1
135077,and,1,0
135078,the,1,0
135079,Wisconsin,1,0
135080,Card,1,0
135081,Sorting,1,1
135082,Test,1,1
135083,(,1,0
135084,WCST,1,1
135085,),1,1
135086,",",0,0
135087,were,0,0
135088,assessed,0,0
135089,before,0,0
135090,and,0,0
135091,after,0,0
135092,each,0,0
135093,treatment,0,0
135094,.,0,0
135095,The,0,0
135096,results,0,0
135097,indicated,0,0
135098,that,0,0
135099,acute,0,0
135100,exercise,0,0
135101,facilitated,0,0
135102,performance,0,1
135103,in,0,0
135104,the,0,0
135105,Stroop,0,0
135106,Test,0,1
135107,",",0,0
135108,particularly,0,0
135109,in,0,0
135110,the,0,0
135111,Stroop,1,0
135112,Color-Word,1,0
135113,condition,1,0
135114,.,1,0
135115,Additionally,0,0
135116,",",0,0
135117,children,0,0
135118,in,0,0
135119,the,0,0
135120,exercise,0,0
135121,group,0,0
135122,demonstrated,0,0
135123,improvement,0,1
135124,in,0,0
135125,specific,0,0
135126,WCST,1,1
135127,performances,1,1
135128,in,0,0
135129,Non-perseverative,1,1
135130,Errors,1,0
135131,and,1,0
135132,Categories,1,1
135133,Completed,1,0
135134,",",0,0
135135,whereas,0,0
135136,no,0,0
135137,influences,0,0
135138,were,0,0
135139,found,0,0
135140,in,0,0
135141,those,0,0
135142,performances,0,0
135143,in,0,0
135144,the,0,0
135145,control,0,0
135146,group,0,0
135147,.,0,0
135148,Tentative,0,0
135149,explanations,0,0
135150,for,0,0
135151,the,0,0
135152,exercise,0,0
135153,effect,0,0
135154,postulate,0,0
135155,that,0,0
135156,exercise,0,0
135157,allocates,0,0
135158,attention,1,1
135159,resources,0,0
135160,",",0,0
135161,influences,0,0
135162,the,0,0
135163,dorsolateral,1,0
135164,prefrontal,1,1
135165,cortex,1,1
135166,",",0,0
135167,and,0,0
135168,is,0,0
135169,implicated,0,0
135170,in,0,0
135171,exercise-induced,1,1
135172,dopamine,1,0
135173,release,1,0
135174,.,1,0
135175,These,0,0
135176,findings,0,0
135177,are,0,0
135178,promising,0,0
135179,and,0,0
135180,additional,0,0
135181,investigations,0,0
135182,to,0,0
135183,explore,0,0
135184,the,0,0
135185,efficacy,1,1
135186,of,0,0
135187,exercise,0,0
135188,on,0,0
135189,executive,0,1
135190,function,0,1
135191,in,0,0
135192,children,0,0
135193,with,0,0
135194,ADHD,0,0
135195,are,0,0
135196,encouraged,0,0
135197,.,0,0
135198,Prefrontal,0,1
135199,neuromodulation,0,0
135200,using,0,0
135201,rTMS,0,0
135202,improves,0,0
135203,error,0,1
135204,monitoring,0,0
135205,and,0,1
135206,correction,0,1
135207,function,0,1
135208,in,0,0
135209,autism,0,0
135210,.,0,0
135211,One,0,0
135212,important,0,0
135213,executive,0,0
135214,function,0,1
135215,known,0,0
135216,to,0,0
135217,be,0,0
135218,compromised,0,0
135219,in,0,0
135220,autism,0,0
135221,spectrum,0,0
135222,disorder,0,0
135223,(,0,0
135224,ASD,0,0
135225,),0,0
135226,is,0,0
135227,related,0,0
135228,to,0,0
135229,response,1,1
135230,error,1,1
135231,monitoring,1,0
135232,and,1,1
135233,post-error,1,1
135234,response,1,1
135235,correction,1,0
135236,.,1,0
135237,Several,0,0
135238,reports,0,0
135239,indicate,0,0
135240,that,0,0
135241,children,0,0
135242,with,0,0
135243,ASD,0,0
135244,show,0,0
135245,reduced,0,0
135246,error,1,1
135247,processing,1,1
135248,and,0,1
135249,deficient,0,0
135250,behavioral,1,1
135251,correction,1,0
135252,after,0,0
135253,an,0,0
135254,error,0,0
135255,is,0,0
135256,committed,0,0
135257,.,0,0
135258,Error,0,0
135259,sensitivity,0,1
135260,can,0,0
135261,be,0,0
135262,readily,0,0
135263,examined,0,0
135264,by,0,0
135265,measuring,0,0
135266,event-related,1,0
135267,potentials,1,1
135268,(,1,0
135269,ERP,1,0
135270,),1,0
135271,associated,0,0
135272,with,0,0
135273,responses,0,1
135274,to,0,0
135275,errors,0,0
135276,",",0,0
135277,the,0,0
135278,fronto-central,1,1
135279,error-related,1,1
135280,negativity,1,1
135281,(,1,0
135282,ERN,1,1
135283,),1,1
135284,",",1,0
135285,and,1,0
135286,the,1,0
135287,error-related,1,1
135288,positivity,1,1
135289,(,1,0
135290,Pe,1,0
135291,),1,0
135292,.,1,0
135293,The,0,0
135294,goal,0,0
135295,of,0,0
135296,our,0,0
135297,study,0,0
135298,was,0,0
135299,to,0,0
135300,investigate,0,0
135301,whether,0,0
135302,reaction,1,1
135303,time,1,1
135304,(,1,0
135305,RT,1,0
135306,),1,0
135307,",",1,0
135308,error,1,1
135309,rate,1,1
135310,",",1,0
135311,post-error,1,1
135312,RT,1,0
135313,change,1,1
135314,",",1,0
135315,ERN,1,1
135316,",",1,1
135317,and,1,0
135318,Pe,1,0
135319,will,0,0
135320,show,0,0
135321,positive,0,0
135322,changes,0,1
135323,following,0,0
135324,12-week,0,0
135325,long,0,0
135326,slow,0,0
135327,frequency,0,1
135328,repetitive,0,1
135329,TMS,0,0
135330,(,0,0
135331,rTMS,0,0
135332,),0,0
135333,over,0,0
135334,dorsolateral,0,0
135335,prefrontal,0,1
135336,cortex,0,1
135337,(,0,0
135338,DLPFC,0,1
135339,),0,0
135340,in,0,0
135341,high,0,0
135342,functioning,0,1
135343,children,0,0
135344,with,0,0
135345,ASD,0,0
135346,.,0,0
135347,We,0,0
135348,hypothesized,0,0
135349,that,0,0
135350,12,0,0
135351,sessions,0,0
135352,of,0,0
135353,1,0,0
135354,Hz,0,0
135355,rTMS,0,0
135356,bilaterally,0,0
135357,applied,0,0
135358,over,0,0
135359,the,0,0
135360,DLPFC,0,0
135361,will,0,0
135362,result,0,0
135363,in,0,0
135364,improvements,0,1
135365,reflected,0,0
135366,in,0,0
135367,both,0,0
135368,behavioral,1,1
135369,and,1,0
135370,ERP,1,0
135371,measures,1,1
135372,.,1,0
135373,Participants,0,0
135374,were,0,0
135375,randomly,0,0
135376,assigned,0,0
135377,to,0,0
135378,either,0,0
135379,active,0,0
135380,rTMS,0,0
135381,treatment,0,0
135382,or,0,1
135383,wait-list,0,0
135384,(,0,1
135385,WTL,0,1
135386,),0,0
135387,groups,0,0
135388,.,0,0
135389,Baseline,1,0
135390,and,1,0
135391,post-TMS/or,1,0
135392,WTL,1,1
135393,EEG,1,0
135394,was,0,0
135395,collected,0,0
135396,using,0,0
135397,128,0,0
135398,channel,0,0
135399,EEG,0,0
135400,system,0,0
135401,.,0,0
135402,The,0,0
135403,task,0,0
135404,involved,0,0
135405,the,0,0
135406,recognition,0,0
135407,of,0,0
135408,a,0,0
135409,specific,0,0
135410,illusory,0,0
135411,shape,0,0
135412,",",0,0
135413,in,0,0
135414,this,0,0
135415,case,0,0
135416,a,0,0
135417,square,0,0
135418,or,0,0
135419,triangle,0,1
135420,",",0,0
135421,created,0,0
135422,by,0,0
135423,three,0,0
135424,or,0,0
135425,four,0,0
135426,inducer,0,0
135427,disks,0,0
135428,.,0,0
135429,ERN,1,0
135430,in,0,0
135431,TMS,0,0
135432,treatment,0,0
135433,group,0,0
135434,became,0,0
135435,significantly,0,0
135436,more,0,0
135437,negative,0,0
135438,.,0,0
135439,The,0,0
135440,number,0,1
135441,of,0,0
135442,omission,1,0
135443,errors,1,1
135444,decreased,0,0
135445,post-TMS,0,0
135446,.,0,0
135447,The,0,0
135448,RT,1,0
135449,did,0,0
135450,not,0,0
135451,change,0,1
135452,",",0,0
135453,but,0,0
135454,post-error,1,1
135455,RT,1,0
135456,became,0,0
135457,slower,0,0
135458,.,0,0
135459,There,0,0
135460,were,0,0
135461,no,0,0
135462,changes,0,1
135463,in,0,0
135464,RT,1,0
135465,",",1,0
135466,error,1,1
135467,rate,1,1
135468,",",1,0
135469,post-error,1,1
135470,RT,1,1
135471,slowing,1,1
135472,",",1,0
135473,nor,1,0
135474,in,1,0
135475,ERN/Pe,1,0
135476,measures,1,0
135477,in,0,0
135478,the,0,0
135479,wait-list,0,0
135480,group,0,0
135481,.,0,0
135482,Our,0,0
135483,results,0,0
135484,show,0,0
135485,significant,0,0
135486,post-TMS,0,0
135487,differences,0,0
135488,in,0,0
135489,the,0,0
135490,response-locked,1,0
135491,ERP,1,0
135492,such,0,0
135493,as,0,0
135494,ERN,1,0
135495,",",0,0
135496,as,0,0
135497,well,0,0
135498,as,0,0
135499,behavioral,0,1
135500,response,0,1
135501,monitoring,0,0
135502,measures,0,1
135503,indicative,0,0
135504,of,0,0
135505,improved,0,1
135506,error,0,1
135507,monitoring,0,0
135508,and,0,1
135509,correction,0,1
135510,function,0,1
135511,.,0,0
135512,The,0,0
135513,ERN,1,0
135514,and,1,0
135515,Pe,1,1
135516,",",0,0
135517,along,0,0
135518,with,0,0
135519,behavioral,0,1
135520,performance,0,1
135521,measures,0,0
135522,",",0,0
135523,can,0,0
135524,be,0,0
135525,used,0,0
135526,as,0,0
135527,functional,0,0
135528,outcome,0,0
135529,measures,0,0
135530,to,0,0
135531,assess,0,0
135532,the,0,0
135533,effectiveness,0,1
135534,of,0,0
135535,neuromodulation,0,0
135536,(,0,0
135537,e.g.,0,0
135538,",",0,0
135539,rTMS,0,0
135540,),0,0
135541,in,0,0
135542,children,0,0
135543,with,0,0
135544,autism,0,0
135545,and,0,0
135546,thus,0,0
135547,may,0,0
135548,have,0,0
135549,important,0,0
135550,practical,0,0
135551,implications,0,0
135552,.,0,0
135553,Randomised,0,0
135554,clinical,0,0
135555,trial,0,0
135556,:,0,0
135557,efficacy,1,1
135558,of,0,0
135559,a,0,0
135560,new,0,0
135561,synbiotic,0,0
135562,formulation,0,0
135563,containing,0,0
135564,Lactobacillus,0,1
135565,paracasei,0,0
135566,B21060,0,0
135567,plus,0,0
135568,arabinogalactan,0,0
135569,and,0,0
135570,xilooligosaccharides,0,0
135571,in,0,0
135572,children,0,0
135573,with,0,0
135574,acute,0,0
135575,diarrhoea,0,1
135576,.,0,0
135577,BACKGROUND,0,0
135578,Acute,0,0
135579,diarrhoea,0,1
135580,is,0,0
135581,a,0,0
135582,frequent,0,0
135583,problem,0,0
135584,in,0,0
135585,children,0,0
135586,with,0,0
135587,heavy,0,0
135588,economic,0,0
135589,burden,0,1
135590,for,0,0
135591,families,0,0
135592,and,0,0
135593,society,0,0
135594,.,0,0
135595,AIM,0,0
135596,To,0,0
135597,test,0,0
135598,the,0,0
135599,efficacy,0,1
135600,of,0,0
135601,a,0,0
135602,new,0,0
135603,synbiotic,0,0
135604,formulation,0,0
135605,containing,0,0
135606,Lactobacillus,0,1
135607,paracasei,0,0
135608,B21060,0,0
135609,",",0,1
135610,arabinogalactan,0,0
135611,and,0,1
135612,xilooligosaccharides,0,0
135613,in,0,0
135614,children,0,0
135615,with,0,0
135616,acute,0,0
135617,diarrhoea,0,1
135618,.,0,0
135619,METHODS,0,0
135620,Double-blind,0,0
135621,",",0,0
135622,randomised,0,0
135623,",",0,0
135624,placebo-controlled,0,0
135625,trial,0,0
135626,",",0,0
135627,including,0,0
135628,children,0,0
135629,(,0,0
135630,age,0,0
135631,3-36,0,1
135632,m,0,0
135633,),0,0
135634,with,0,0
135635,acute,0,0
135636,diarrhoea,0,1
135637,who,0,0
135638,were,0,0
135639,allocated,0,0
135640,to,0,0
135641,placebo,0,0
135642,or,0,0
135643,synbiotic,0,0
135644,group,0,0
135645,.,0,0
135646,Major,0,1
135647,outcome,0,1
135648,was,0,0
135649,resolution,1,1
135650,rate,1,1
135651,of,1,0
135652,diarrhoea,1,1
135653,at,1,0
135654,72,1,0
135655,h.,1,0
135656,Total,0,0
135657,duration,1,1
135658,of,1,1
135659,diarrhoea,1,1
135660,",",1,0
135661,daily,1,1
135662,stool,1,1
135663,outputs,1,1
135664,",",1,0
135665,stool,1,1
135666,consistency,1,1
135667,",",1,0
135668,working,1,1
135669,days,1,0
135670,lost,1,1
135671,by,1,0
135672,parents,1,0
135673,",",1,0
135674,adjunctive,1,0
135675,medications,1,0
135676,",",1,0
135677,and,1,1
135678,hospitalisation,1,1
135679,were,0,0
135680,also,0,0
135681,assessed,0,0
135682,.,0,0
135683,RESULTS,0,0
135684,We,0,0
135685,enrolled,0,0
135686,55,0,0
135687,children,0,0
135688,in,0,0
135689,placebo,0,0
135690,group,0,0
135691,and,0,0
135692,52,0,0
135693,in,0,0
135694,synbiotic,0,0
135695,group,0,0
135696,.,0,0
135697,The,0,0
135698,two,0,0
135699,groups,0,0
135700,were,0,0
135701,similar,0,0
135702,for,0,0
135703,demographic,0,1
135704,and,0,0
135705,clinical,0,0
135706,characteristics,0,0
135707,.,0,0
135708,Resolution,1,0
135709,rate,1,1
135710,of,1,0
135711,diarrhoea,1,1
135712,at,0,0
135713,72,0,0
135714,h,0,0
135715,was,0,0
135716,significantly,0,0
135717,higher,0,0
135718,in,0,0
135719,synbiotic,0,0
135720,group,0,0
135721,(,0,0
135722,67,0,0
135723,%,0,0
135724,),0,0
135725,compared,0,0
135726,to,0,0
135727,placebo,0,0
135728,group,0,0
135729,(,0,0
135730,40,0,0
135731,%,0,0
135732,",",0,0
135733,P,0,0
135734,=,0,0
135735,0.005,0,0
135736,),0,0
135737,.,0,0
135738,Children,0,0
135739,in,0,0
135740,synbiotic,0,0
135741,group,0,0
135742,showed,0,0
135743,a,0,0
135744,significant,0,0
135745,reduction,0,0
135746,in,0,0
135747,the,0,0
135748,duration,1,1
135749,of,1,0
135750,diarrhoea,1,1
135751,(,0,0
135752,90.5,0,0
135753,h,0,0
135754,",",0,0
135755,78.1-102.9,0,0
135756,vs.,0,0
135757,109.8,0,0
135758,h,0,0
135759,",",0,0
135760,96.0-123.5,0,0
135761,",",0,0
135762,P,0,0
135763,=,0,0
135764,0.040,0,0
135765,),0,0
135766,",",0,0
135767,daily,1,0
135768,stool,1,1
135769,outputs,1,1
135770,(,0,0
135771,3.3,0,0
135772,",",0,0
135773,2.8-3.8,0,0
135774,vs.,0,0
135775,2.4,0,0
135776,",",0,0
135777,1.9-2.8,0,0
135778,",",0,0
135779,P,0,0
135780,=,0,0
135781,0.005,0,0
135782,),0,0
135783,and,0,0
135784,stool,1,1
135785,consistency,1,1
135786,(,0,0
135787,1.3,0,0
135788,",",0,0
135789,0.9-1.6,0,0
135790,vs.,0,0
135791,0.6,0,0
135792,",",0,0
135793,0.4-0.9,0,0
135794,",",0,0
135795,P,0,0
135796,=,0,0
135797,0.002,0,0
135798,),0,0
135799,compared,0,0
135800,to,0,0
135801,placebo,0,0
135802,group,0,0
135803,(,0,0
135804,data,0,0
135805,expressed,0,1
135806,as,0,0
135807,mean,0,0
135808,",",0,0
135809,95,0,0
135810,%,0,0
135811,CI,0,0
135812,),0,0
135813,.,0,0
135814,Rate,1,0
135815,of,1,0
135816,parents,1,0
135817,that,1,0
135818,missed,1,0
135819,at,1,0
135820,least,1,0
135821,one,1,0
135822,working,1,0
135823,day,1,0
135824,(,0,0
135825,41.8,0,0
135826,%,0,0
135827,vs.,0,0
135828,15.4,0,0
135829,%,0,0
135830,",",0,0
135831,P,0,0
135832,=,0,0
135833,0.003,0,0
135834,),0,0
135835,",",0,0
135836,rate,1,1
135837,of,1,0
135838,children,1,0
135839,that,1,0
135840,needed,1,0
135841,adjunctive,1,0
135842,medications,1,0
135843,(,0,0
135844,25.5,0,0
135845,%,0,0
135846,vs.,0,0
135847,5.8,0,0
135848,%,0,0
135849,",",0,0
135850,P,0,0
135851,=,0,0
135852,0.005,0,0
135853,),0,0
135854,or,0,0
135855,hospitalisation,1,1
135856,(,0,0
135857,10.9,0,0
135858,%,0,0
135859,vs.,0,0
135860,0,0,0
135861,%,0,0
135862,",",0,0
135863,P,0,0
135864,=,0,0
135865,0.014,0,0
135866,),0,0
135867,after,0,0
135868,the,0,0
135869,first,0,0
135870,72,0,0
135871,h,0,0
135872,of,0,0
135873,treatment,0,0
135874,",",0,0
135875,were,0,0
135876,reduced,0,0
135877,in,0,0
135878,synbiotic,0,0
135879,group,0,0
135880,.,0,0
135881,CONCLUSION,0,0
135882,The,0,0
135883,synbiotic,0,0
135884,formulation,0,0
135885,studied,0,0
135886,is,0,0
135887,effective,0,0
135888,in,0,0
135889,children,0,0
135890,with,0,0
135891,acute,0,0
135892,diarrhoea,0,1
135893,.,0,0
135894,Australian,0,0
135895,New,0,0
135896,Zealand,0,0
135897,Clinical,0,1
135898,Trials,0,1
135899,Registry,0,0
135900,(,0,0
135901,ACTRN12611000641998,0,0
135902,),0,0
135903,.,0,0
135904,The,0,0
135905,influence,0,0
135906,of,0,0
135907,penbutolol,0,0
135908,and,0,1
135909,placebo,0,0
135910,on,0,0
135911,blood,0,1
135912,sugar,0,1
135913,levels,0,1
135914,and,0,1
135915,insulin,0,1
135916,consumption,0,1
135917,in,0,0
135918,the,0,0
135919,glucose-controlled,0,0
135920,insulin,0,1
135921,infusion,0,0
135922,system,0,0
135923,(,0,0
135924,artificial,0,0
135925,endocrine,0,1
135926,pancreas,0,0
135927,),0,0
135928,.,0,0
135929,The,0,0
135930,aim,0,0
135931,of,0,0
135932,the,0,0
135933,study,0,0
135934,was,0,0
135935,to,0,0
135936,investigate,0,0
135937,the,0,0
135938,influence,0,0
135939,of,0,0
135940,40,0,0
135941,mg,0,0
135942,of,0,0
135943,the,0,0
135944,beta-blocker,0,0
135945,penbutolol,0,0
135946,(,0,0
135947,Betapressin,0,0
135948,TM,0,0
135949,;,0,0
135950,Hoechst,0,0
135951,Ltd.,0,0
135952,",",0,0
135953,Frankfurt/Main,0,0
135954,),0,0
135955,in,0,0
135956,comparison,0,0
135957,to,0,0
135958,placebo,0,0
135959,on,0,0
135960,the,0,0
135961,insulin,0,1
135962,consumption,0,1
135963,on,0,0
135964,the,0,0
135965,blood,0,1
135966,sugar,0,1
135967,profile,0,1
135968,in,0,0
135969,twelve,0,0
135970,insulin-dependent,0,0
135971,diabetes,0,0
135972,(,0,0
135973,IDDM,0,0
135974,),0,0
135975,patients,0,0
135976,.,0,0
135977,The,0,0
135978,patients,0,0
135979,were,0,0
135980,treated,0,0
135981,with,0,0
135982,penbutolol,0,0
135983,and,0,1
135984,placebo,0,0
135985,for,0,0
135986,a,0,0
135987,period,0,0
135988,of,0,0
135989,three,0,0
135990,days,0,0
135991,",",0,0
135992,and,0,0
135993,then,0,0
135994,were,0,0
135995,examined,0,0
135996,with,0,0
135997,the,0,0
135998,help,0,0
135999,of,0,0
136000,the,0,0
136001,glucose-controlled,0,0
136002,insulin,0,1
136003,infusion,0,0
136004,system,0,0
136005,.,0,0
136006,The,0,0
136007,blood,1,1
136008,sugar,1,1
136009,profile,1,1
136010,and,1,1
136011,insulin,1,1
136012,consumption,1,1
136013,over,0,0
136014,a,0,0
136015,24,0,0
136016,hour,0,0
136017,period,0,0
136018,was,0,0
136019,not,0,0
136020,affected,0,0
136021,by,0,0
136022,either,0,0
136023,penbutolol,0,0
136024,or,0,0
136025,placebo,0,0
136026,",",0,0
136027,nor,0,0
136028,could,0,0
136029,any,0,0
136030,changes,0,0
136031,be,0,0
136032,measured,0,0
136033,in,0,0
136034,these,0,0
136035,parameters,0,1
136036,when,0,0
136037,measured,0,0
136038,after,0,0
136039,food,0,0
136040,intake,0,1
136041,.,0,0
136042,After,0,0
136043,a,0,0
136044,submaximal,0,0
136045,exercise,0,0
136046,load,0,1
136047,on,0,0
136048,the,0,0
136049,bicycle,0,0
136050,ergometer,0,0
136051,(,0,0
136052,1,0,0
136053,watt,0,0
136054,per,0,0
136055,kg,0,0
136056,body,0,1
136057,weight,0,1
136058,),0,0
136059,following,0,0
136060,an,0,0
136061,evening,0,0
136062,meal,0,0
136063,",",0,0
136064,no,0,0
136065,difference,0,0
136066,could,0,0
136067,be,0,0
136068,observed,0,0
136069,between,0,0
136070,penbutolol,0,0
136071,and,0,1
136072,placebo,0,0
136073,in,0,0
136074,the,0,0
136075,above-mentioned,0,0
136076,parameters,0,0
136077,.,0,0
136078,The,0,0
136079,same,0,0
136080,was,0,0
136081,also,0,0
136082,true,0,0
136083,for,0,0
136084,hormonal,0,0
136085,parameters,0,1
136086,as,0,0
136087,STH,1,0
136088,",",1,0
136089,ACTH,1,1
136090,",",1,1
136091,cortisol,1,1
136092,",",1,1
136093,and,1,0
136094,catecholamines,1,1
136095,.,1,0
136096,These,0,0
136097,findings,0,0
136098,demonstrated,0,0
136099,that,0,0
136100,medication,0,1
136101,of,0,0
136102,penbutolol,0,0
136103,over,0,0
136104,a,0,0
136105,three-day,0,0
136106,period,0,0
136107,has,0,0
136108,no,0,0
136109,influence,0,0
136110,on,0,0
136111,the,0,0
136112,baseline,0,0
136113,blood,0,1
136114,sugar,0,1
136115,profile,0,1
136116,and,0,1
136117,insulin,0,1
136118,consumption,0,1
136119,or,0,0
136120,on,0,0
136121,insulin,0,1
136122,consumption,0,1
136123,after,0,0
136124,food,0,0
136125,intake,0,1
136126,during,0,0
136127,rest,0,0
136128,and,0,0
136129,physical,0,1
136130,exercise,0,0
136131,.,0,0
136132,Bilateral,0,1
136133,transversus,0,0
136134,abdominis,0,0
136135,plane,0,1
136136,block,0,0
136137,does,0,0
136138,not,0,0
136139,decrease,0,0
136140,postoperative,0,1
136141,pain,0,1
136142,after,0,0
136143,laparoscopic,0,0
136144,cholecystectomy,0,0
136145,when,0,0
136146,compared,0,0
136147,with,0,0
136148,local,0,0
136149,anesthetic,0,0
136150,infiltration,0,1
136151,of,0,0
136152,trocar,0,0
136153,insertion,0,0
136154,sites,0,0
136155,.,0,0
136156,BACKGROUND,0,0
136157,AND,0,0
136158,OBJECTIVES,0,0
136159,Transversus,0,0
136160,abdominis,0,0
136161,plane,0,1
136162,(,0,0
136163,TAP,0,1
136164,),0,0
136165,block,0,0
136166,has,0,0
136167,been,0,0
136168,shown,0,0
136169,to,0,0
136170,reduce,0,0
136171,pain,0,1
136172,and,0,0
136173,analgesic,0,1
136174,requirements,0,1
136175,after,0,0
136176,abdominal,0,0
136177,surgery,0,0
136178,.,0,0
136179,Our,0,0
136180,hypothesis,0,0
136181,was,0,0
136182,that,0,0
136183,bilateral,0,0
136184,TAP,0,1
136185,blocks,0,0
136186,decrease,0,1
136187,pain,0,1
136188,after,0,0
136189,laparoscopic,0,0
136190,cholecystectomy,0,0
136191,when,0,0
136192,compared,0,0
136193,with,0,0
136194,local,0,0
136195,anesthetic,0,0
136196,infiltration,0,1
136197,of,0,0
136198,trocar,0,0
136199,insertion,0,0
136200,sites,0,0
136201,.,0,0
136202,METHODS,0,0
136203,Eighty,0,1
136204,patients,0,0
136205,undergoing,0,0
136206,laparoscopic,0,0
136207,cholecystectomy,0,0
136208,were,0,0
136209,randomized,0,0
136210,to,0,0
136211,receive,0,0
136212,either,0,0
136213,bilateral,0,0
136214,TAP,0,1
136215,blocks,0,0
136216,or,0,0
136217,local,0,1
136218,anesthetic,0,0
136219,infiltration,0,1
136220,of,0,0
136221,trocar,0,0
136222,insertion,0,0
136223,sites,0,0
136224,with,0,0
136225,ropivacaine,0,0
136226,0.5,0,0
136227,%,0,0
136228,.,0,0
136229,Postoperative,1,0
136230,pain,1,1
136231,scores,0,1
136232,and,0,1
136233,analgesic,0,1
136234,use,0,0
136235,for,0,0
136236,the,0,0
136237,first,0,0
136238,24,0,0
136239,hrs,0,0
136240,were,0,0
136241,recorded,0,0
136242,.,0,0
136243,RESULTS,0,0
136244,Eighty,0,1
136245,patients,0,0
136246,were,0,0
136247,enrolled,0,0
136248,in,0,0
136249,the,0,0
136250,study,0,0
136251,.,0,0
136252,After,0,0
136253,exclusions,0,0
136254,",",0,0
136255,data,0,0
136256,were,0,0
136257,analyzed,0,0
136258,on,0,0
136259,39,0,0
136260,patients,0,0
136261,in,0,0
136262,group,0,0
136263,T,0,1
136264,(,0,0
136265,bilateral,0,0
136266,TAP,0,1
136267,block,0,0
136268,),0,0
136269,and,0,0
136270,35,0,0
136271,patients,0,0
136272,in,0,0
136273,group,0,0
136274,I,0,0
136275,(,0,0
136276,infiltration,0,1
136277,),0,0
136278,.,0,0
136279,There,0,0
136280,was,0,0
136281,no,0,0
136282,statistically,1,0
136283,significant,1,0
136284,difference,1,0
136285,in,0,0
136286,pain,1,1
136287,scores,1,1
136288,on,1,0
136289,the,1,0
136290,numeric,1,1
136291,analog,1,1
136292,scale,1,1
136293,(,0,0
136294,0-10,0,1
136295,),0,0
136296,between,0,0
136297,the,0,0
136298,groups,0,0
136299,at,0,0
136300,4,0,0
136301,hrs,0,0
136302,after,0,0
136303,surgery,0,0
136304,(,0,0
136305,P,0,0
136306,=,0,0
136307,0.18,0,0
136308,),0,0
136309,or,0,0
136310,during,0,0
136311,the,0,0
136312,24,0,0
136313,hrs,0,0
136314,after,0,0
136315,surgery,0,0
136316,(,0,0
136317,P,0,0
136318,=,0,0
136319,0.23,0,0
136320,),0,0
136321,.,0,0
136322,The,0,0
136323,time,1,1
136324,interval,1,0
136325,from,1,0
136326,anesthesia,1,0
136327,start,1,0
136328,to,1,0
136329,surgery,1,0
136330,start,1,0
136331,was,0,0
136332,greater,0,0
136333,in,0,0
136334,group,0,0
136335,T,0,0
136336,than,0,0
136337,group,0,0
136338,I,0,0
136339,(,0,0
136340,48,0,0
136341,vs,0,0
136342,35,0,0
136343,mins,0,0
136344,",",0,0
136345,P,0,0
136346,<,0,0
136347,0.001,0,0
136348,),0,0
136349,.,0,0
136350,There,0,0
136351,was,0,0
136352,no,0,0
136353,significant,1,0
136354,difference,1,0
136355,found,0,0
136356,in,0,0
136357,analgesic,1,1
136358,use,1,0
136359,during,0,0
136360,the,0,0
136361,first,0,0
136362,24,0,0
136363,hrs,0,0
136364,after,0,0
136365,surgery,0,0
136366,.,0,0
136367,CONCLUSIONS,0,0
136368,Bilateral,0,0
136369,ultrasound-guided,0,0
136370,TAP,0,1
136371,block,0,0
136372,is,0,0
136373,equivalent,0,0
136374,to,0,0
136375,local,0,0
136376,anesthetic,0,0
136377,infiltration,0,1
136378,of,0,0
136379,trocar,0,0
136380,insertion,0,0
136381,sites,0,0
136382,for,0,0
136383,overall,0,1
136384,postoperative,1,1
136385,pain,1,1
136386,in,0,0
136387,a,0,0
136388,heterogeneous,0,0
136389,group,0,0
136390,of,0,0
136391,patients,0,0
136392,undergoing,0,0
136393,laparoscopic,0,0
136394,cholecystectomy,0,0
136395,.,0,0
136396,A,0,0
136397,randomized,0,0
136398,controlled,0,0
136399,pilot,0,0
136400,trial,0,0
136401,of,0,0
136402,oral,0,0
136403,N-acetylcysteine,0,0
136404,in,0,0
136405,children,0,0
136406,with,0,0
136407,autism,0,0
136408,.,0,0
136409,BACKGROUND,0,0
136410,An,0,0
136411,imbalance,0,0
136412,in,0,0
136413,the,0,0
136414,excitatory/inhibitory,0,1
136415,systems,0,0
136416,with,0,0
136417,abnormalities,0,0
136418,in,0,0
136419,the,0,0
136420,glutamatergic,0,0
136421,pathways,0,0
136422,has,0,0
136423,been,0,0
136424,implicated,0,0
136425,in,0,0
136426,the,0,0
136427,pathophysiology,0,0
136428,of,0,0
136429,autism,0,0
136430,.,0,0
136431,Furthermore,0,0
136432,",",0,0
136433,chronic,0,0
136434,redox,0,1
136435,imbalance,0,1
136436,was,0,0
136437,also,0,0
136438,recently,0,0
136439,linked,0,0
136440,to,0,0
136441,this,0,0
136442,disorder,0,0
136443,.,0,0
136444,The,0,0
136445,goal,0,0
136446,of,0,0
136447,this,0,0
136448,pilot,0,0
136449,study,0,0
136450,was,0,0
136451,to,0,0
136452,assess,0,0
136453,the,0,0
136454,feasibility,0,0
136455,of,0,0
136456,using,0,0
136457,oral,0,0
136458,N-acetylcysteine,0,0
136459,(,0,0
136460,NAC,0,1
136461,),0,0
136462,",",0,0
136463,a,0,0
136464,glutamatergic,0,1
136465,modulator,0,0
136466,and,0,0
136467,an,0,0
136468,antioxidant,0,1
136469,",",0,0
136470,in,0,0
136471,the,0,0
136472,treatment,0,0
136473,of,0,0
136474,behavioral,0,1
136475,disturbance,0,1
136476,in,0,0
136477,children,0,0
136478,with,0,0
136479,autism,0,0
136480,.,0,0
136481,METHODS,0,0
136482,This,0,0
136483,was,0,0
136484,a,0,0
136485,12-week,0,0
136486,",",0,0
136487,double-blind,0,0
136488,",",0,0
136489,randomized,0,0
136490,",",0,0
136491,placebo-controlled,0,0
136492,study,0,0
136493,of,0,0
136494,NAC,0,1
136495,in,0,0
136496,children,0,0
136497,with,0,0
136498,autistic,0,0
136499,disorder,0,0
136500,.,0,0
136501,Subjects,0,0
136502,randomized,0,0
136503,to,0,0
136504,NAC,0,1
136505,were,0,0
136506,initiated,0,0
136507,at,0,0
136508,900,0,0
136509,mg,0,0
136510,daily,0,0
136511,for,0,0
136512,4,0,0
136513,weeks,0,0
136514,",",0,0
136515,then,0,0
136516,900,0,0
136517,mg,0,0
136518,twice,0,0
136519,daily,0,0
136520,for,0,0
136521,4,0,0
136522,weeks,0,0
136523,and,0,0
136524,900,0,0
136525,mg,0,0
136526,three,0,0
136527,times,0,0
136528,daily,0,0
136529,for,0,0
136530,4,0,0
136531,weeks,0,0
136532,.,0,0
136533,The,0,0
136534,primary,0,0
136535,behavioral,0,1
136536,measure,0,0
136537,(,1,0
136538,Aberrant,1,1
136539,Behavior,1,1
136540,Checklist,1,1
136541,[,1,0
136542,ABC,1,1
136543,],1,0
136544,irritability,1,1
136545,subscale,1,1
136546,),1,1
136547,and,0,0
136548,safety,0,1
136549,measures,0,1
136550,were,0,0
136551,performed,0,0
136552,at,0,0
136553,baseline,0,0
136554,and,0,0
136555,4,0,0
136556,",",0,0
136557,8,0,0
136558,",",0,0
136559,and,0,0
136560,12,0,0
136561,weeks,0,0
136562,.,0,0
136563,Secondary,0,0
136564,measures,0,0
136565,included,0,0
136566,the,0,0
136567,ABC,1,1
136568,stereotypy,1,1
136569,subscale,1,1
136570,",",1,0
136571,Repetitive,1,1
136572,Behavior,1,1
136573,Scale-Revised,1,1
136574,",",1,0
136575,and,1,1
136576,Social,1,1
136577,Responsiveness,1,1
136578,Scale,1,1
136579,.,1,0
136580,RESULTS,0,0
136581,Thirty-three,0,0
136582,subjects,0,0
136583,(,0,0
136584,31,0,0
136585,male,0,0
136586,subjects,0,0
136587,",",0,0
136588,2,0,0
136589,female,0,0
136590,subjects,0,0
136591,;,0,0
136592,aged,0,0
136593,3.2-10.7,0,0
136594,years,0,0
136595,),0,0
136596,were,0,0
136597,randomized,0,0
136598,in,0,0
136599,the,0,0
136600,study,0,0
136601,.,0,0
136602,Follow-up,0,0
136603,data,0,0
136604,was,0,0
136605,available,0,0
136606,on,0,0
136607,14,0,0
136608,subjects,0,0
136609,in,0,0
136610,the,0,0
136611,NAC,0,1
136612,group,0,0
136613,and,0,0
136614,15,0,0
136615,in,0,0
136616,the,0,0
136617,placebo,0,0
136618,group,0,0
136619,.,0,0
136620,Oral,0,1
136621,NAC,0,1
136622,was,0,0
136623,well,0,0
136624,tolerated,1,1
136625,with,0,0
136626,limited,0,0
136627,side,0,0
136628,effects,0,0
136629,.,0,0
136630,Compared,0,0
136631,with,0,0
136632,placebo,0,0
136633,",",0,0
136634,NAC,0,1
136635,resulted,0,0
136636,in,0,0
136637,significant,0,0
136638,improvements,0,1
136639,on,0,0
136640,ABC,1,1
136641,irritability,1,1
136642,subscale,1,1
136643,(,0,0
136644,F,0,0
136645,=,0,0
136646,6.80,0,0
136647,;,0,0
136648,p,0,0
136649,<,0,0
136650,.001,0,0
136651,;,0,0
136652,d,0,0
136653,=,0,0
136654,.96,0,0
136655,),0,0
136656,.,0,0
136657,CONCLUSIONS,0,0
136658,Data,0,0
136659,from,0,0
136660,this,0,0
136661,pilot,0,0
136662,investigation,0,0
136663,support,0,0
136664,the,0,0
136665,potential,0,0
136666,usefulness,0,0
136667,of,0,0
136668,NAC,0,1
136669,for,0,0
136670,treating,0,0
136671,irritability,0,1
136672,in,0,0
136673,children,0,0
136674,with,0,0
136675,autistic,0,0
136676,disorder,0,0
136677,.,0,0
136678,Large,0,0
136679,randomized,0,0
136680,controlled,0,0
136681,investigations,0,0
136682,are,0,0
136683,warranted,0,0
136684,.,0,0
136685,Use,0,0
136686,of,0,0
136687,a,0,0
136688,clay,0,0
136689,modeling,0,0
136690,task,0,0
136691,to,0,0
136692,reduce,0,0
136693,chocolate,1,0
136694,craving,1,0
136695,.,1,0
136696,Elaborated,0,0
136697,Intrusion,0,1
136698,theory,0,0
136699,(,0,0
136700,EI,0,0
136701,theory,0,0
136702,;,0,0
136703,Kavanagh,0,0
136704,",",0,0
136705,Andrade,0,1
136706,",",0,1
136707,&,0,0
136708,May,0,1
136709,",",0,0
136710,2005,0,0
136711,),0,0
136712,posits,0,0
136713,two,0,0
136714,main,0,0
136715,cognitive,0,0
136716,components,0,0
136717,in,0,0
136718,craving,1,0
136719,:,1,0
136720,associative,0,1
136721,processes,0,0
136722,that,0,0
136723,lead,0,0
136724,to,0,0
136725,intrusive,0,1
136726,thoughts,0,1
136727,about,0,0
136728,the,0,0
136729,craved,0,0
136730,substance,0,0
136731,or,0,0
136732,activity,0,1
136733,",",0,1
136734,and,0,1
136735,elaborative,0,1
136736,processes,0,1
136737,supporting,0,0
136738,mental,0,0
136739,imagery,0,0
136740,of,0,0
136741,the,0,0
136742,substance,0,0
136743,or,0,0
136744,activity,0,1
136745,.,0,0
136746,We,0,0
136747,used,0,0
136748,a,0,0
136749,novel,0,0
136750,visuospatial,0,0
136751,task,0,0
136752,to,0,0
136753,test,0,0
136754,the,0,0
136755,hypothesis,0,0
136756,that,0,0
136757,visual,0,1
136758,imagery,0,0
136759,plays,0,0
136760,a,0,0
136761,key,0,0
136762,role,0,0
136763,in,0,0
136764,craving,1,0
136765,.,1,0
136766,Experiment,0,0
136767,1,0,0
136768,showed,0,0
136769,that,0,0
136770,spending,0,0
136771,10,0,0
136772,min,0,0
136773,constructing,0,0
136774,shapes,0,0
136775,from,0,0
136776,modeling,0,0
136777,clay,0,0
136778,(,0,0
136779,plasticine,0,0
136780,),0,0
136781,reduced,0,0
136782,participants,0,0
136783,',0,0
136784,craving,1,0
136785,for,1,0
136786,chocolate,1,0
136787,compared,0,0
136788,with,0,0
136789,spending,0,0
136790,10,0,0
136791,min,0,0
136792,'letting,0,0
136793,your,0,1
136794,mind,0,0
136795,wander,0,1
136796,',0,0
136797,.,0,0
136798,Increasing,0,0
136799,the,0,0
136800,load,0,1
136801,on,0,0
136802,verbal,0,1
136803,working,0,0
136804,memory,0,1
136805,using,0,0
136806,a,0,0
136807,mental,0,0
136808,arithmetic,0,1
136809,task,0,0
136810,(,0,0
136811,counting,0,1
136812,backwards,0,1
136813,by,0,0
136814,threes,0,0
136815,),0,0
136816,did,0,0
136817,not,0,0
136818,reduce,0,0
136819,craving,1,0
136820,further,0,0
136821,.,0,0
136822,Experiment,0,0
136823,2,0,0
136824,compared,0,0
136825,effects,0,0
136826,on,0,0
136827,craving,1,0
136828,of,0,0
136829,a,0,0
136830,simpler,0,0
136831,verbal,0,1
136832,task,0,1
136833,(,0,0
136834,counting,0,1
136835,by,0,0
136836,ones,0,0
136837,),0,0
136838,and,0,0
136839,clay,0,0
136840,modeling,0,0
136841,.,0,0
136842,Clay,0,0
136843,modeling,0,0
136844,reduced,0,0
136845,overall,1,1
136846,craving,1,0
136847,strength,1,1
136848,and,0,1
136849,strength,1,1
136850,of,1,0
136851,craving,1,0
136852,imagery,1,0
136853,",",0,0
136854,and,0,0
136855,reduced,0,0
136856,the,0,0
136857,frequency,1,1
136858,of,1,0
136859,thoughts,1,1
136860,about,1,0
136861,chocolate,1,0
136862,.,1,0
136863,The,0,0
136864,results,0,0
136865,are,0,0
136866,consistent,0,0
136867,with,0,0
136868,EI,0,0
136869,theory,0,0
136870,",",0,0
136871,showing,0,0
136872,that,0,0
136873,craving,1,0
136874,is,0,0
136875,reduced,0,0
136876,by,0,0
136877,loading,0,0
136878,the,0,0
136879,visuospatial,0,0
136880,sketchpad,0,0
136881,of,0,0
136882,working,0,1
136883,memory,0,1
136884,but,0,0
136885,not,0,0
136886,by,0,0
136887,loading,0,0
136888,the,0,0
136889,phonological,0,0
136890,loop,0,0
136891,.,0,0
136892,Clay,0,0
136893,modeling,0,0
136894,might,0,0
136895,be,0,0
136896,a,0,0
136897,useful,0,0
136898,self-help,0,0
136899,tool,0,0
136900,to,0,0
136901,help,0,0
136902,manage,0,0
136903,craving,1,0
136904,for,0,0
136905,chocolate,0,0
136906,",",0,0
136907,snacks,0,0
136908,and,0,1
136909,other,0,0
136910,foods,0,0
136911,.,0,0
136912,Effects,0,0
136913,of,0,0
136914,large,0,0
136915,doses,0,0
136916,of,0,0
136917,arachidonic,0,1
136918,acid,0,0
136919,added,0,0
136920,to,0,0
136921,docosahexaenoic,0,0
136922,acid,0,0
136923,on,0,0
136924,social,0,1
136925,impairment,0,1
136926,in,0,0
136927,individuals,0,0
136928,with,0,0
136929,autism,0,0
136930,spectrum,0,0
136931,disorders,0,0
136932,:,0,0
136933,a,0,0
136934,double-blind,0,0
136935,",",0,0
136936,placebo-controlled,0,0
136937,",",0,0
136938,randomized,0,0
136939,trial,0,0
136940,.,0,0
136941,Autism,0,1
136942,spectrum,0,0
136943,disorders,0,0
136944,are,0,0
136945,a,0,0
136946,neurodevelopmental,0,0
136947,disorders,0,0
136948,with,0,0
136949,reduced,0,0
136950,cortical,0,1
136951,functional,0,0
136952,connectivity,0,0
136953,relating,0,0
136954,to,0,0
136955,social,0,1
136956,cognition,0,0
136957,.,0,0
136958,Polyunsaturated,0,1
136959,fatty,0,1
136960,acids,0,1
136961,arachidonic,0,1
136962,acid,0,0
136963,(,0,0
136964,ARA,0,1
136965,),0,0
136966,and,0,0
136967,docosahexaenoic,0,0
136968,acid,0,1
136969,(,0,0
136970,DHA,0,0
136971,),0,0
136972,may,0,0
136973,have,0,0
136974,key,0,0
136975,role,0,0
136976,in,0,0
136977,brain,0,1
136978,network,0,0
136979,maturation,0,1
136980,.,0,0
136981,In,0,0
136982,particularly,0,0
136983,",",0,0
136984,ARA,0,0
136985,is,0,0
136986,important,0,0
136987,in,0,0
136988,signal,0,1
136989,transduction,0,1
136990,related,0,0
136991,to,0,0
136992,neuronal,0,1
136993,maturation,0,1
136994,.,0,0
136995,Supplementation,0,0
136996,with,0,0
136997,larger,0,0
136998,ARA,0,0
136999,doses,0,0
137000,added,0,0
137001,to,0,0
137002,DHA,0,0
137003,may,0,0
137004,therefore,0,0
137005,mitigate,0,0
137006,social,0,1
137007,impairment,0,1
137008,.,0,0
137009,In,0,0
137010,a,0,0
137011,16-week,0,0
137012,",",0,0
137013,double-blind,0,0
137014,",",0,0
137015,randomized,0,0
137016,",",0,0
137017,placebo-controlled,0,0
137018,trial,0,0
137019,",",0,0
137020,we,0,0
137021,evaluated,0,0
137022,the,0,0
137023,efficacy,0,1
137024,of,0,0
137025,supplementation,0,0
137026,with,0,0
137027,large,0,0
137028,doses,0,0
137029,of,0,0
137030,ARA,0,0
137031,added,0,0
137032,to,0,0
137033,DHA,0,1
137034,(,0,0
137035,n,0,0
137036,=,0,0
137037,7,0,0
137038,),0,0
137039,or,0,0
137040,placebo,0,0
137041,(,0,0
137042,n,0,0
137043,=,0,0
137044,6,0,0
137045,),0,0
137046,in,0,0
137047,13,0,0
137048,participants,0,0
137049,(,0,0
137050,mean,0,1
137051,age,0,0
137052,",",0,0
137053,14.6,0,0
137054,[,0,0
137055,SD,0,0
137056,",",0,0
137057,5.9,0,0
137058,],0,0
137059,years,0,0
137060,),0,0
137061,.,0,0
137062,To,0,0
137063,examine,0,0
137064,underlying,0,0
137065,mechanisms,0,0
137066,underlying,0,0
137067,the,0,0
137068,effect,0,0
137069,of,0,0
137070,our,0,0
137071,supplementation,0,0
137072,regimen,0,0
137073,",",0,0
137074,we,0,0
137075,examined,0,0
137076,plasma,1,1
137077,levels,1,1
137078,of,1,0
137079,antioxidants,1,0
137080,transferrin,1,1
137081,and,1,0
137082,superoxide,1,1
137083,dismutase,1,1
137084,",",0,0
137085,which,0,0
137086,are,0,0
137087,useful,0,0
137088,markers,0,1
137089,of,0,0
137090,signal,0,1
137091,transduction,0,1
137092,.,0,0
137093,The,0,0
137094,outcome,0,1
137095,measures,0,1
137096,were,0,0
137097,the,0,0
137098,Social,1,1
137099,Responsiveness,1,1
137100,Scale,1,1
137101,and,1,0
137102,the,1,0
137103,Aberrant,1,1
137104,Behavior,1,1
137105,Checklist-Community,1,1
137106,.,1,0
137107,Repeated-measures,0,0
137108,analysis,0,0
137109,of,0,0
137110,variance,0,0
137111,revealed,0,0
137112,that,0,0
137113,our,0,0
137114,supplementation,0,0
137115,regimen,0,0
137116,significantly,0,0
137117,improved,0,0
137118,Aberrant,1,0
137119,Behavior,1,1
137120,Checklist-Community-measured,1,1
137121,social,1,1
137122,withdrawal,1,1
137123,and,0,0
137124,Social,1,1
137125,Responsiveness,1,1
137126,Scale-measured,1,0
137127,communication,1,0
137128,.,1,0
137129,Treatment,0,0
137130,effect,0,1
137131,sizes,0,1
137132,were,0,0
137133,more,0,0
137134,favorable,0,0
137135,for,0,0
137136,the,0,0
137137,treatment,0,0
137138,group,0,0
137139,compared,0,0
137140,with,0,0
137141,the,0,0
137142,placebo,0,0
137143,group,0,0
137144,(,0,0
137145,communication,0,1
137146,:,0,0
137147,treatment,0,0
137148,groups,0,0
137149,",",0,0
137150,0.87,0,0
137151,vs,0,0
137152,",",0,0
137153,placebo,0,0
137154,",",0,0
137155,0.44,0,0
137156,;,0,0
137157,social,0,0
137158,withdrawal,0,0
137159,:,0,0
137160,treatment,0,0
137161,groups,0,0
137162,",",0,0
137163,0.88,0,0
137164,",",0,0
137165,vs,0,0
137166,placebo,0,0
137167,",",0,0
137168,0.54,0,0
137169,),0,0
137170,.,0,0
137171,There,0,0
137172,was,0,0
137173,a,0,0
137174,significant,0,0
137175,difference,0,0
137176,in,0,0
137177,the,0,0
137178,change,1,0
137179,in,1,0
137180,plasma,1,1
137181,transferrin,1,1
137182,levels,1,1
137183,and,0,0
137184,a,0,0
137185,trend,0,0
137186,toward,0,0
137187,a,0,0
137188,significant,0,0
137189,difference,0,0
137190,in,0,0
137191,the,0,0
137192,change,0,0
137193,in,0,0
137194,plasma,1,1
137195,superoxide,1,1
137196,dismutase,1,1
137197,levels,1,1
137198,between,0,0
137199,the,0,0
137200,2,0,0
137201,groups,0,0
137202,.,0,0
137203,This,0,0
137204,preliminary,0,0
137205,study,0,0
137206,suggests,0,0
137207,that,0,0
137208,supplementation,0,0
137209,with,0,0
137210,larger,0,0
137211,ARA,0,0
137212,doses,0,0
137213,added,0,0
137214,to,0,0
137215,DHA,0,0
137216,improves,0,1
137217,impaired,0,0
137218,social,1,1
137219,interaction,1,1
137220,in,0,0
137221,individuals,0,0
137222,with,0,0
137223,autism,0,0
137224,spectrum,0,0
137225,disorder,0,0
137226,by,0,0
137227,up-regulating,0,1
137228,signal,0,1
137229,transduction,0,1
137230,.,0,0
137231,Combination,0,0
137232,peel,0,0
137233,with,0,0
137234,incorporated,0,0
137235,fractional,0,1
137236,prickle,0,0
137237,coral,0,1
137238,calcium,0,0
137239,for,0,0
137240,the,0,0
137241,treatment,0,0
137242,of,0,0
137243,keratosis,0,1
137244,pilaris,0,0
137245,:,0,0
137246,a,0,0
137247,pilot,0,0
137248,study,0,0
137249,.,0,0
137250,BACKGROUND,0,0
137251,Keratosis,0,1
137252,pilaris,0,0
137253,(,0,0
137254,KP,0,1
137255,),0,0
137256,is,0,0
137257,a,0,0
137258,common,0,0
137259,condition,0,0
137260,of,0,0
137261,follicular,0,0
137262,plugging,0,1
137263,with,0,0
137264,variable,0,0
137265,erythema,0,1
137266,.,0,0
137267,There,0,0
137268,is,0,0
137269,a,0,0
137270,lack,0,0
137271,of,0,0
137272,reliable,0,0
137273,response,0,1
137274,to,0,0
137275,the,0,0
137276,treatment,0,0
137277,of,0,0
137278,KP,0,1
137279,.,0,0
137280,OBJECTIVE,0,0
137281,We,0,0
137282,evaluated,0,0
137283,the,0,0
137284,effect,0,0
137285,and,0,0
137286,safety,0,1
137287,of,0,1
137288,combination,0,0
137289,peel,0,0
137290,with,0,0
137291,fractional,0,1
137292,prickle,0,0
137293,coral,0,1
137294,calcium,0,0
137295,(,0,0
137296,FCR?,0,1
137297,),0,0
137298,in,0,0
137299,the,0,0
137300,treatment,0,0
137301,of,0,0
137302,KP,0,1
137303,.,0,0
137304,MATERIALS,0,0
137305,AND,0,0
137306,METHODS,0,0
137307,Sixteen,0,0
137308,Korean,0,0
137309,patients,0,0
137310,were,0,0
137311,treated,0,0
137312,with,0,0
137313,FCR?,0,0
137314,on,0,0
137315,both,0,0
137316,upper,0,0
137317,arms,0,0
137318,for,0,0
137319,five,0,0
137320,sessions,0,0
137321,at,0,0
137322,2-week,0,0
137323,intervals,1,0
137324,.,1,0
137325,Clinical,1,1
137326,evaluations,1,0
137327,",",1,0
137328,mexameter,1,1
137329,measurements,1,1
137330,",",1,0
137331,and,1,1
137332,assessment,1,1
137333,of,1,1
137334,patients,1,0
137335,',1,0
137336,satisfaction,1,1
137337,and,1,0
137338,adverse,1,1
137339,events,1,1
137340,were,1,0
137341,performed,0,0
137342,at,0,0
137343,baseline,0,0
137344,and,0,0
137345,every,0,0
137346,visit,0,1
137347,.,0,0
137348,RESULTS,0,0
137349,After,0,0
137350,treatments,0,0
137351,",",0,0
137352,statistically,0,0
137353,significant,0,0
137354,improvements,0,0
137355,in,0,0
137356,the,0,0
137357,baseline,1,0
137358,KP,1,1
137359,were,0,0
137360,observed,0,0
137361,in,0,0
137362,erythema,0,1
137363,and,0,1
137364,melanin,0,1
137365,index,0,1
137366,of,0,0
137367,mexameter,0,0
137368,on,0,0
137369,treated,0,0
137370,upper,0,0
137371,arms,0,0
137372,.,0,0
137373,Both,0,0
137374,the,0,0
137375,physicians,0,1
137376,',0,0
137377,and,0,0
137378,patients,0,0
137379,',0,0
137380,assessments,0,0
137381,correlate,0,0
137382,with,0,0
137383,the,0,0
137384,results,0,0
137385,of,0,0
137386,mexameter,0,0
137387,scores,0,1
137388,.,0,0
137389,CONCLUSION,0,0
137390,Our,0,0
137391,results,0,0
137392,suggest,0,0
137393,FCR?,0,0
137394,should,0,0
137395,be,0,0
137396,considered,0,0
137397,as,0,0
137398,an,0,0
137399,effective,1,0
137400,and,1,0
137401,safe,1,1
137402,treatment,0,0
137403,option,0,0
137404,for,0,0
137405,the,0,0
137406,patients,0,0
137407,with,0,0
137408,KP,0,0
137409,.,0,0
137410,Theta,0,1
137411,burst,0,1
137412,stimulation,0,0
137413,in,0,0
137414,the,0,0
137415,rehabilitation,0,0
137416,of,0,0
137417,the,0,0
137418,upper,0,0
137419,limb,0,0
137420,:,0,0
137421,a,0,0
137422,semirandomized,0,0
137423,",",0,0
137424,placebo-controlled,0,0
137425,trial,0,0
137426,in,0,0
137427,chronic,0,0
137428,stroke,0,0
137429,patients,0,0
137430,.,0,0
137431,BACKGROUND,0,0
137432,Noninvasive,0,1
137433,cortical,0,1
137434,stimulation,0,0
137435,could,0,0
137436,represent,0,0
137437,an,0,0
137438,add-on,0,0
137439,treatment,0,0
137440,to,0,0
137441,enhance,0,0
137442,motor,1,1
137443,recovery,1,1
137444,after,0,0
137445,stroke,0,1
137446,.,0,0
137447,However,0,0
137448,",",0,0
137449,its,0,0
137450,clinical,0,0
137451,value,0,0
137452,",",0,0
137453,including,0,0
137454,anticipated,0,0
137455,size,0,1
137456,and,0,0
137457,duration,0,1
137458,of,0,0
137459,the,0,0
137460,treatment,0,0
137461,effects,0,0
137462,",",0,0
137463,remains,0,0
137464,largely,0,0
137465,unknown,0,0
137466,.,0,0
137467,OBJECTIVE,0,0
137468,The,0,0
137469,authors,0,0
137470,designed,0,0
137471,a,0,0
137472,small,0,0
137473,semi-randomized,0,0
137474,clinical,0,0
137475,trial,0,0
137476,to,0,0
137477,explore,0,0
137478,whether,0,0
137479,long-lasting,0,0
137480,clinically,0,0
137481,important,0,0
137482,gains,0,0
137483,can,0,0
137484,be,0,0
137485,achieved,0,0
137486,by,0,0
137487,adding,0,0
137488,theta,0,1
137489,burst,0,1
137490,stimulation,0,0
137491,(,0,0
137492,TBS,0,0
137493,),0,0
137494,",",0,0
137495,a,0,0
137496,form,0,0
137497,of,0,0
137498,repetitive,0,1
137499,transcranial,0,0
137500,magnetic,0,0
137501,stimulation,0,0
137502,(,0,0
137503,TMS,0,0
137504,),0,0
137505,",",0,0
137506,to,0,0
137507,a,0,0
137508,rehabilitation,0,0
137509,program,0,0
137510,for,0,0
137511,the,0,0
137512,hand,0,0
137513,.,0,0
137514,METHODS,0,0
137515,A,0,0
137516,total,0,1
137517,of,0,0
137518,41,0,0
137519,chronic,0,0
137520,stroke,0,0
137521,patients,0,0
137522,received,0,0
137523,excitatory,0,0
137524,TBS,0,0
137525,to,0,0
137526,the,0,0
137527,ipsilesional,0,1
137528,hemisphere,0,0
137529,or,0,0
137530,inhibitory,0,1
137531,TBS,0,0
137532,to,0,0
137533,the,0,0
137534,contralesional,0,0
137535,hemisphere,0,0
137536,in,0,0
137537,2,0,0
137538,centers,0,0
137539,;,0,0
137540,each,0,0
137541,active,0,0
137542,group,0,0
137543,was,0,0
137544,compared,0,0
137545,with,0,0
137546,a,0,0
137547,group,0,0
137548,receiving,0,0
137549,sham,0,0
137550,TBS,0,0
137551,.,0,0
137552,TBS,0,0
137553,was,0,0
137554,followed,0,0
137555,by,0,0
137556,physical,0,0
137557,therapy,0,0
137558,for,0,0
137559,10,0,0
137560,working,0,0
137561,days,0,0
137562,.,0,0
137563,Patients,0,0
137564,and,0,0
137565,therapists,0,0
137566,were,0,0
137567,blinded,0,0
137568,to,0,0
137569,the,0,0
137570,type,0,0
137571,of,0,0
137572,TBS,0,0
137573,.,0,0
137574,Primary,0,0
137575,outcome,0,1
137576,measures,0,1
137577,(,1,0
137578,9-hole,1,0
137579,Peg,1,0
137580,Test,1,1
137581,[,1,0
137582,9HPT,1,0
137583,],1,0
137584,",",1,0
137585,Jebsen,1,0
137586,Taylor,1,1
137587,Test,1,1
137588,[,1,0
137589,JTT,1,1
137590,],1,0
137591,",",1,0
137592,and,1,1
137593,grip,1,1
137594,and,1,1
137595,pinch-grip,1,1
137596,dynamometry,1,0
137597,),1,0
137598,were,1,0
137599,assessed,1,0
137600,4,0,0
137601,",",0,0
137602,30,0,0
137603,",",0,0
137604,and,0,0
137605,90,0,0
137606,days,0,0
137607,post,0,0
137608,treatment,0,0
137609,.,0,0
137610,The,0,0
137611,clinically,0,0
137612,important,0,0
137613,difference,0,0
137614,was,0,0
137615,defined,0,0
137616,as,0,0
137617,10,0,0
137618,%,0,0
137619,of,0,0
137620,the,0,0
137621,maximum,0,0
137622,score,0,1
137623,.,0,0
137624,RESULTS,0,0
137625,There,0,0
137626,were,0,0
137627,no,0,0
137628,differences,0,0
137629,between,0,0
137630,the,0,0
137631,active,0,0
137632,treatment,0,0
137633,and,0,1
137634,sham,0,0
137635,groups,0,0
137636,in,0,0
137637,any,0,0
137638,of,0,0
137639,the,0,0
137640,outcome,0,0
137641,measures,0,0
137642,.,0,0
137643,All,0,0
137644,patients,0,0
137645,achieved,0,0
137646,small,0,0
137647,sustainable,0,0
137648,improvements,1,0
137649,--,1,0
137650,9HPT,1,0
137651,",",1,0
137652,5,1,0
137653,%,1,0
137654,of,1,0
137655,maximum,1,1
137656,(,0,0
137657,confidence,0,0
137658,interval,0,0
137659,[,0,0
137660,CI,0,0
137661,],0,0
137662,=,0,0
137663,3,0,0
137664,%,0,0
137665,-7,0,0
137666,%,0,0
137667,),0,0
137668,;,0,0
137669,JTT,1,0
137670,",",0,0
137671,5.7,0,0
137672,%,0,0
137673,(,0,0
137674,CI,0,0
137675,=,0,0
137676,3,0,0
137677,%,0,0
137678,-8,0,0
137679,%,0,0
137680,),0,0
137681,;,0,0
137682,and,0,0
137683,grip,1,1
137684,strength,1,1
137685,",",0,0
137686,6,0,0
137687,%,0,0
137688,(,0,0
137689,CI,0,0
137690,=,0,0
137691,2,0,0
137692,%,0,0
137693,-10,0,0
137694,%,0,0
137695,),0,0
137696,--,0,0
137697,all,0,0
137698,below,0,0
137699,the,0,0
137700,defined,0,0
137701,clinically,0,0
137702,important,0,0
137703,level,0,1
137704,.,0,0
137705,CONCLUSIONS,0,0
137706,Cortical,0,1
137707,stimulation,0,0
137708,did,0,0
137709,not,0,0
137710,augment,0,0
137711,the,0,0
137712,gains,0,0
137713,from,0,0
137714,a,0,0
137715,late,0,0
137716,rehabilitation,0,0
137717,program,0,0
137718,.,0,0
137719,The,0,0
137720,effect,0,0
137721,size,0,1
137722,anticipated,0,0
137723,by,0,0
137724,the,0,0
137725,authors,0,0
137726,was,0,0
137727,overestimated,0,0
137728,.,0,0
137729,These,0,0
137730,results,0,0
137731,can,0,0
137732,improve,0,0
137733,the,0,0
137734,design,0,0
137735,of,0,0
137736,future,0,0
137737,work,0,0
137738,on,0,0
137739,therapeutic,0,0
137740,uses,0,0
137741,of,0,0
137742,TMS,0,0
137743,.,0,0
137744,Elevated,0,1
137745,concentration,0,1
137746,of,0,0
137747,placental,0,1
137748,growth,0,1
137749,factor,0,1
137750,(,0,0
137751,PlGF,0,0
137752,),0,0
137753,and,0,0
137754,long,0,0
137755,term,0,1
137756,risk,0,1
137757,in,0,0
137758,patients,0,0
137759,with,0,0
137760,acute,0,0
137761,coronary,0,0
137762,syndrome,0,0
137763,in,0,0
137764,the,0,0
137765,PROVE,0,0
137766,IT-TIMI,0,0
137767,22,0,0
137768,trial,0,0
137769,.,0,0
137770,Placental,1,1
137771,growth,1,1
137772,factor,1,1
137773,(,1,0
137774,PlGF,1,0
137775,),1,0
137776,",",0,0
137777,a,0,0
137778,member,0,0
137779,of,0,0
137780,the,0,0
137781,vascular,0,1
137782,endothelial,0,1
137783,growth,0,1
137784,factor,0,1
137785,(,0,0
137786,VEGF,0,1
137787,),0,1
137788,family,0,0
137789,",",0,0
137790,acts,0,0
137791,via,0,0
137792,the,0,0
137793,flt-1,0,1
137794,receptor,0,0
137795,and,0,0
137796,promotes,0,0
137797,endothelial,0,1
137798,activation,0,1
137799,and,0,1
137800,macrophage,0,1
137801,recruitment,0,0
137802,into,0,0
137803,atherosclerotic,0,1
137804,lesions,0,0
137805,.,0,0
137806,We,0,0
137807,investigated,0,0
137808,the,0,0
137809,relationship,0,0
137810,of,0,0
137811,PlGF,0,0
137812,with,0,0
137813,cardiovascular,0,1
137814,outcomes,0,0
137815,in,0,0
137816,a,0,0
137817,large,0,0
137818,cohort,0,0
137819,of,0,0
137820,patients,0,0
137821,presenting,0,0
137822,across,0,0
137823,the,0,0
137824,spectrum,0,0
137825,of,0,0
137826,ACS,0,0
137827,.,0,0
137828,PlGF,1,0
137829,was,0,0
137830,measured,0,0
137831,at,0,0
137832,baseline,0,0
137833,(,0,0
137834,n,0,0
137835,=,0,0
137836,"3,761",0,0
137837,),0,0
137838,and,0,0
137839,at,0,0
137840,four-months,0,0
137841,(,0,0
137842,n,0,0
137843,=,0,0
137844,"3,369",0,0
137845,),0,0
137846,in,0,0
137847,patients,0,0
137848,randomized,0,0
137849,to,0,0
137850,atorvastatin,0,0
137851,80,0,0
137852,mg,0,0
137853,or,0,0
137854,pravastatin,0,0
137855,40,0,0
137856,mg,0,0
137857,after,0,0
137858,ACS,0,0
137859,in,0,0
137860,the,0,0
137861,PROVE,0,0
137862,IT-TIMI,0,0
137863,22,0,0
137864,trial,0,0
137865,.,0,0
137866,The,0,0
137867,primary,0,0
137868,endpoint,0,1
137869,was,0,0
137870,death,1,1
137871,",",1,0
137872,myocardial,1,1
137873,infarction,1,1
137874,(,1,0
137875,MI,1,0
137876,),1,0
137877,",",1,0
137878,unstable,1,1
137879,angina,1,1
137880,",",1,0
137881,revascularization,1,1
137882,or,1,1
137883,stroke,1,1
137884,(,0,0
137885,mean,0,1
137886,follow-up,0,0
137887,24,0,0
137888,months,0,0
137889,),0,0
137890,.,0,0
137891,Elevated,0,1
137892,baseline,0,0
137893,PlGF,0,0
137894,was,0,0
137895,associated,0,0
137896,with,0,0
137897,a,0,0
137898,higher,0,0
137899,incidence,0,1
137900,of,0,0
137901,the,0,0
137902,primary,0,0
137903,endpoint,0,0
137904,through,0,0
137905,2,0,0
137906,years,0,0
137907,(,0,0
137908,Q1,0,1
137909,vs.,0,0
137910,Q5,0,0
137911,:,0,0
137912,18.7,0,0
137913,vs.,0,0
137914,29.3,0,0
137915,%,0,0
137916,",",0,0
137917,p,0,0
137918,<,0,0
137919,0.0001,0,0
137920,),0,0
137921,.,0,0
137922,The,0,0
137923,risk,1,0
137924,of,1,0
137925,death,1,1
137926,or,1,0
137927,MI,1,1
137928,was,0,0
137929,also,0,0
137930,higher,0,0
137931,in,0,0
137932,patients,0,0
137933,with,0,0
137934,elevated,0,0
137935,baseline,0,0
137936,PlGF,0,0
137937,(,0,0
137938,Q1,0,1
137939,vs.,0,0
137940,Q5,0,0
137941,:,0,0
137942,7.0,0,0
137943,vs.,0,0
137944,11.6,0,0
137945,%,0,0
137946,",",0,0
137947,p,0,0
137948,=,0,0
137949,0.029,0,0
137950,),0,0
137951,.,0,0
137952,Adjusting,0,0
137953,for,0,0
137954,baseline,0,0
137955,characteristics,0,1
137956,and,0,1
137957,risk,0,1
137958,factors,0,1
137959,",",0,0
137960,elevated,0,1
137961,baseline,0,0
137962,PlGF,0,0
137963,was,0,0
137964,independently,0,0
137965,associated,0,0
137966,with,0,0
137967,the,0,0
137968,risk,0,0
137969,of,0,0
137970,the,0,0
137971,primary,0,0
137972,endpoint,0,1
137973,(,0,0
137974,adjusted-HR,0,0
137975,for,0,0
137976,Q5,0,0
137977,vs.,0,0
137978,Q1,0,1
137979,1.45,0,0
137980,;,0,0
137981,95,0,0
137982,%,0,0
137983,CI,0,0
137984,1.16-1.83,0,0
137985,;,0,0
137986,p,0,0
137987,=,0,0
137988,0.001,0,0
137989,),0,0
137990,.,0,0
137991,Elevated,0,0
137992,PlGF,0,0
137993,at,0,0
137994,four,0,0
137995,months,0,0
137996,was,0,0
137997,associated,0,0
137998,with,0,0
137999,higher,0,0
138000,risk,1,1
138001,of,1,1
138002,death,1,1
138003,or,1,0
138004,MI,1,1
138005,(,0,0
138006,Adjusted,0,1
138007,HR,0,1
138008,Q5,0,0
138009,vs.,0,0
138010,Q1,0,1
138011,2.79,0,0
138012,",",0,0
138013,95,0,0
138014,%,0,0
138015,CI,0,0
138016,:,0,0
138017,1.37-5.68,0,0
138018,;,0,0
138019,p,0,0
138020,=,0,0
138021,0.005,0,0
138022,),0,0
138023,",",0,0
138024,and,0,1
138025,higher,0,1
138026,risk,0,1
138027,of,0,0
138028,the,0,0
138029,primary,0,0
138030,endpoint,0,1
138031,(,0,0
138032,Adjusted,0,1
138033,HR,0,1
138034,Q5,0,0
138035,vs.,0,0
138036,Q1,0,1
138037,1.78,0,0
138038,",",0,0
138039,95,0,0
138040,%,0,0
138041,CI,0,0
138042,:,0,0
138043,1.26-2.51,0,0
138044,;,0,0
138045,p,0,0
138046,=,0,0
138047,0.001,0,0
138048,),0,0
138049,.,0,0
138050,Higher,0,0
138051,concentration,0,1
138052,of,0,1
138053,PlGF,1,0
138054,after,0,0
138055,ACS,0,0
138056,is,0,0
138057,associated,0,0
138058,with,0,0
138059,long-term,0,0
138060,risk,0,1
138061,of,0,0
138062,recurrent,0,1
138063,cardiovascular,0,1
138064,events,0,1
138065,independent,0,0
138066,of,0,0
138067,traditional,0,0
138068,risk,0,0
138069,factors,0,0
138070,.,0,0
138071,This,0,0
138072,association,0,0
138073,is,0,0
138074,present,0,0
138075,early,0,0
138076,after,0,0
138077,ACS,0,0
138078,and,0,0
138079,appears,0,0
138080,to,0,0
138081,be,0,0
138082,stronger,0,0
138083,at,0,0
138084,four,0,0
138085,months,0,0
138086,.,0,0
138087,[,0,0
138088,Simvastatin,0,0
138089,versus,0,0
138090,gemfibrozil,0,0
138091,in,0,0
138092,the,0,0
138093,treatment,0,0
138094,of,0,0
138095,primary,0,0
138096,hypercholesterolemia,0,0
138097,in,0,0
138098,hypertensive,0,0
138099,patients,0,0
138100,treated,0,0
138101,with,0,0
138102,hydrochlorothiazide,0,0
138103,],0,0
138104,.,0,0
138105,Recent,0,0
138106,pharmacological,0,0
138107,studies,0,0
138108,confirmed,0,0
138109,the,0,0
138110,role,0,0
138111,of,0,0
138112,hypercholesterolemia,0,0
138113,in,0,0
138114,the,0,0
138115,pathogenesis,0,0
138116,of,0,0
138117,coronary,0,0
138118,atherosclerosis,0,0
138119,.,0,0
138120,A,0,0
138121,10,0,0
138122,%,0,0
138123,reduction,0,0
138124,in,0,0
138125,cholesterol,0,1
138126,levels,0,1
138127,can,0,0
138128,reduce,0,0
138129,the,0,0
138130,risk,0,0
138131,of,0,0
138132,coronary,0,0
138133,heart,0,1
138134,disease,0,0
138135,by,0,0
138136,15,0,0
138137,%,0,0
138138,.,0,0
138139,However,0,0
138140,many,0,0
138141,hypercholesterolemic,0,0
138142,patients,0,0
138143,often,0,0
138144,suffer,0,0
138145,from,0,0
138146,arterial,0,1
138147,hypertension,0,1
138148,and,0,0
138149,drugs,0,0
138150,such,0,0
138151,as,0,0
138152,thiazide,0,0
138153,diuretics,0,0
138154,cause,0,0
138155,an,0,0
138156,imbalance,0,0
138157,in,0,0
138158,lipid,0,0
138159,metabolism,0,0
138160,.,0,0
138161,The,0,0
138162,efficacy,1,1
138163,and,1,0
138164,the,1,0
138165,tolerability,1,1
138166,of,0,0
138167,simvastatin,0,0
138168,(,0,0
138169,a,0,0
138170,inhibitor,0,0
138171,of,0,0
138172,HGM-CoA,0,0
138173,reductase,0,1
138174,),0,0
138175,with,0,0
138176,that,0,0
138177,of,0,0
138178,gemfibrozil,0,0
138179,(,0,0
138180,a,0,0
138181,fibric,0,0
138182,acid,0,1
138183,derivative,0,0
138184,",",0,0
138185,which,0,0
138186,can,0,0
138187,reduce,0,0
138188,the,0,0
138189,VLDL,0,0
138190,level,0,1
138191,),0,0
138192,were,0,0
138193,compared,0,0
138194,in,0,0
138195,a,0,0
138196,placebo-controlled,0,0
138197,study,0,0
138198,in,0,0
138199,2,0,0
138200,groups,0,0
138201,of,0,0
138202,patients,0,0
138203,with,0,0
138204,primary,0,0
138205,hypercholesterolemia,0,0
138206,and,0,0
138207,mild-to-moderate,0,0
138208,essential,0,0
138209,hypertension,0,1
138210,treated,0,0
138211,with,0,0
138212,hydrochlorothiazide,0,0
138213,.,0,0
138214,After,0,0
138215,10,0,0
138216,weeks,0,0
138217,standard,0,0
138218,hypolipidemic,0,0
138219,diet,0,0
138220,and,0,1
138221,hydrochlorothiazide,0,0
138222,(,0,0
138223,25,0,0
138224,mg,0,0
138225,od,0,0
138226,),0,0
138227,therapy,0,0
138228,",",0,0
138229,30,0,0
138230,patients,0,0
138231,whose,0,0
138232,cholesterol,1,1
138233,levels,1,1
138234,were,0,0
138235,still,0,0
138236,greater,0,0
138237,than,0,0
138238,or,0,0
138239,equal,0,0
138240,to,0,0
138241,250,0,0
138242,mg/100,0,0
138243,ml,0,0
138244,and,0,0
138245,whose,0,0
138246,diastolic,1,1
138247,blood,1,1
138248,pressure,0,1
138249,was,0,0
138250,less,0,0
138251,than,0,0
138252,95,0,0
138253,mmHg,0,0
138254,were,0,0
138255,randomized,0,0
138256,to,0,0
138257,one,0,0
138258,of,0,0
138259,the,0,0
138260,following,0,0
138261,treatments,0,0
138262,:,0,0
138263,simvastatin,0,0
138264,",",0,0
138265,20,0,0
138266,mg,0,0
138267,od,0,0
138268,",",0,1
138269,gemfibrozil,0,0
138270,",",0,0
138271,600,0,0
138272,mg,0,0
138273,bid,0,0
138274,or,0,1
138275,placebo,0,0
138276,",",0,0
138277,while,0,0
138278,continuing,0,0
138279,dietetic,0,0
138280,and,0,0
138281,diuretic,0,0
138282,treatment,0,0
138283,.,0,0
138284,After,0,0
138285,24,0,0
138286,weeks,0,0
138287,treatment,0,0
138288,",",0,0
138289,simvastatin,0,0
138290,induced,0,0
138291,a,0,0
138292,37,0,0
138293,%,0,0
138294,reduction,0,0
138295,in,0,0
138296,cholesterol,1,1
138297,plasma,1,1
138298,levels,1,1
138299,",",0,0
138300,a,0,0
138301,9,0,0
138302,%,0,0
138303,increase,0,0
138304,of,0,0
138305,HDL,1,1
138306,and,0,0
138307,a,0,0
138308,16,0,0
138309,%,0,0
138310,reduction,0,0
138311,of,0,0
138312,LDL,1,0
138313,.,1,0
138314,APO-A1,1,0
138315,showed,0,0
138316,a,0,0
138317,4,0,0
138318,%,0,0
138319,increase,0,0
138320,",",0,0
138321,while,0,0
138322,APO-B,0,0
138323,showed,0,0
138324,a,0,0
138325,3,0,0
138326,%,0,0
138327,reduction,0,0
138328,.,0,0
138329,Gemfibrozil,0,0
138330,induced,0,0
138331,a,0,0
138332,20,0,0
138333,%,0,0
138334,reduction,0,0
138335,in,0,0
138336,plasma,1,1
138337,triglycerides,1,1
138338,and,0,0
138339,a,0,0
138340,13,0,0
138341,%,0,0
138342,decrease,0,0
138343,in,0,0
138344,plasma,1,1
138345,cholesterol,1,1
138346,",",0,0
138347,with,0,0
138348,a,0,0
138349,significant,0,0
138350,19,0,0
138351,%,0,0
138352,increase,0,0
138353,in,0,0
138354,HDL,1,1
138355,and,0,0
138356,a,0,0
138357,11,0,0
138358,%,0,0
138359,reduction,0,0
138360,in,0,0
138361,LDL,1,0
138362,.,1,0
138363,No,0,0
138364,significant,0,0
138365,variations,0,0
138366,in,0,0
138367,any,0,0
138368,of,0,0
138369,the,0,0
138370,lipid,0,0
138371,parameters,0,1
138372,monitored,0,0
138373,were,0,0
138374,observed,0,0
138375,in,0,0
138376,the,0,0
138377,placebo,0,0
138378,group,0,0
138379,.,0,0
138380,Treatment,0,0
138381,with,0,0
138382,simvastatin,0,0
138383,or,0,0
138384,gemfibrozil,0,0
138385,in,0,0
138386,hypertensive,0,0
138387,patients,0,0
138388,in,0,0
138389,hydrochlorothiazide,0,0
138390,monotherapy,0,0
138391,can,0,0
138392,reduce,0,0
138393,total,1,1
138394,cholesterol,1,1
138395,and,1,1
138396,LDL-cholesterol,1,1
138397,plasma,1,1
138398,levels,1,1
138399,",",0,0
138400,while,0,0
138401,significantly,0,0
138402,increasing,0,0
138403,HDL,1,1
138404,plasma,1,1
138405,levels,1,1
138406,compared,0,0
138407,to,0,0
138408,placebo,0,0
138409,.,0,0
138410,Simvastatin,0,0
138411,",",0,0
138412,however,0,0
138413,",",0,0
138414,resulted,0,0
138415,more,0,0
138416,efficient,0,1
138417,than,0,0
138418,gemfibrozil,0,0
138419,on,0,0
138420,total,1,1
138421,cholesterol,1,1
138422,or,1,0
138423,cholesterol,1,1
138424,fractions,1,1
138425,.,1,0
138426,Are,0,0
138427,prenatal,0,0
138428,ultrasound,0,1
138429,scans,0,0
138430,associated,0,0
138431,with,0,0
138432,the,0,0
138433,autism,1,0
138434,phenotype,1,1
138435,?,0,0
138436,Follow-up,0,0
138437,of,0,0
138438,a,0,0
138439,randomised,0,0
138440,controlled,0,0
138441,trial,0,0
138442,.,0,0
138443,An,0,0
138444,existing,0,0
138445,randomised,0,0
138446,controlled,0,0
138447,trial,0,0
138448,was,0,0
138449,used,0,0
138450,to,0,0
138451,investigate,0,0
138452,whether,0,0
138453,multiple,0,0
138454,ultrasound,0,0
138455,scans,0,0
138456,may,0,0
138457,be,0,0
138458,associated,0,0
138459,with,0,0
138460,the,0,0
138461,autism,1,0
138462,phenotype,1,1
138463,.,1,0
138464,From,0,0
138465,"2,834",0,0
138466,single,0,0
138467,pregnancies,0,0
138468,",",0,0
138469,"1,415",0,0
138470,were,0,0
138471,selected,0,0
138472,at,0,0
138473,random,0,0
138474,to,0,0
138475,receive,0,0
138476,ultrasound,0,1
138477,imaging,0,0
138478,and,0,0
138479,continuous,0,0
138480,wave,0,1
138481,Doppler,0,1
138482,flow,0,1
138483,studies,0,0
138484,at,0,0
138485,five,0,0
138486,points,0,0
138487,throughout,0,0
138488,pregnancy,0,1
138489,(,0,0
138490,Intensive,0,0
138491,),0,0
138492,and,0,0
138493,"1,419",0,0
138494,to,0,0
138495,receive,0,0
138496,a,0,0
138497,single,0,0
138498,imaging,0,0
138499,scan,0,0
138500,at,0,0
138501,18,0,0
138502,weeks,0,0
138503,(,0,0
138504,Regular,0,0
138505,),0,0
138506,",",0,0
138507,with,0,0
138508,further,0,0
138509,scans,0,0
138510,only,0,0
138511,as,0,0
138512,indicated,0,0
138513,on,0,0
138514,clinical,0,0
138515,grounds,0,0
138516,.,0,0
138517,There,0,0
138518,was,0,0
138519,no,0,0
138520,significant,0,0
138521,difference,0,0
138522,in,0,0
138523,the,0,0
138524,rate,1,1
138525,of,1,0
138526,Autism,1,1
138527,Spectrum,1,0
138528,Disorder,1,0
138529,between,0,0
138530,the,0,0
138531,Regular,0,0
138532,(,0,0
138533,"9/1,125",0,0
138534,",",0,0
138535,0.8,0,0
138536,%,0,0
138537,),0,0
138538,and,0,1
138539,Intensive,0,0
138540,(,0,0
138541,"7/1,167",0,0
138542,",",0,0
138543,0.6,0,0
138544,%,0,0
138545,),0,0
138546,groups,0,0
138547,",",0,0
138548,nor,0,0
138549,a,0,0
138550,difference,0,0
138551,between,0,0
138552,groups,0,0
138553,in,0,0
138554,the,0,0
138555,level,1,1
138556,of,1,0
138557,autistic-like,1,1
138558,traits,1,1
138559,in,0,0
138560,early,0,0
138561,adulthood,0,0
138562,.,0,0
138563,There,0,0
138564,is,0,0
138565,no,0,0
138566,clear,0,0
138567,link,0,0
138568,between,0,0
138569,the,0,0
138570,frequency,1,1
138571,and,0,0
138572,timing,1,1
138573,of,0,1
138574,prenatal,0,0
138575,ultrasound,0,1
138576,scans,0,0
138577,and,0,0
138578,the,0,0
138579,autism,1,0
138580,phenotype,1,0
138581,.,1,0
138582,Impact,0,0
138583,of,0,0
138584,the,0,0
138585,quantity,1,0
138586,and,1,0
138587,flavonoid,1,0
138588,content,1,1
138589,of,0,0
138590,fruits,0,0
138591,and,0,0
138592,vegetables,0,0
138593,on,0,0
138594,markers,0,1
138595,of,0,0
138596,intake,0,1
138597,in,0,0
138598,adults,0,0
138599,with,0,0
138600,an,0,0
138601,increased,0,0
138602,risk,0,0
138603,of,0,0
138604,cardiovascular,0,1
138605,disease,0,0
138606,:,0,0
138607,the,0,0
138608,FLAVURS,0,0
138609,trial,0,0
138610,.,0,0
138611,PURPOSE,0,0
138612,Limited,0,0
138613,robust,0,1
138614,randomised,0,0
138615,controlled,0,0
138616,trials,0,0
138617,investigating,0,0
138618,fruit,1,1
138619,and,1,1
138620,vegetable,1,0
138621,(,1,0
138622,F,1,0
138623,&,1,0
138624,V,1,0
138625,),1,0
138626,intake,1,1
138627,in,0,0
138628,people,0,0
138629,at,0,0
138630,risk,0,1
138631,of,0,0
138632,cardiovascular,0,1
138633,disease,0,1
138634,(,0,0
138635,CVD,0,1
138636,),0,0
138637,exist,0,0
138638,.,0,0
138639,We,0,0
138640,aimed,0,0
138641,to,0,0
138642,design,0,0
138643,and,0,0
138644,validate,0,0
138645,a,0,0
138646,dietary,0,0
138647,strategy,0,0
138648,of,0,0
138649,increasing,0,0
138650,flavonoid-rich,0,0
138651,versus,0,0
138652,flavonoid-poor,0,1
138653,F,1,0
138654,&,1,0
138655,V,1,1
138656,consumption,1,1
138657,on,0,0
138658,nutrient,0,1
138659,biomarker,0,0
138660,profile,0,1
138661,.,0,0
138662,METHODS,0,0
138663,A,0,0
138664,parallel,0,0
138665,",",0,0
138666,randomised,0,0
138667,",",0,0
138668,controlled,0,0
138669,",",0,0
138670,dose-response,0,0
138671,dietary,0,0
138672,intervention,0,0
138673,study,0,0
138674,.,0,0
138675,Participants,0,0
138676,with,0,0
138677,a,0,0
138678,CVD,0,1
138679,relative,0,0
138680,risk,0,0
138681,of,0,0
138682,1.5,0,0
138683,assessed,0,0
138684,by,0,0
138685,risk,0,1
138686,scores,0,1
138687,were,0,0
138688,randomly,0,0
138689,assigned,0,0
138690,to,0,0
138691,one,0,0
138692,of,0,0
138693,the,0,0
138694,3,0,0
138695,groups,0,0
138696,:,0,0
138697,habitual,0,1
138698,(,0,0
138699,control,0,0
138700,",",0,1
138701,CT,0,1
138702,),0,0
138703,",",0,0
138704,high-flavonoid,0,0
138705,(,0,0
138706,HF,0,0
138707,),0,0
138708,or,0,0
138709,low-flavonoid,0,0
138710,(,0,0
138711,LF,0,1
138712,),0,0
138713,diets,0,0
138714,.,0,0
138715,While,0,0
138716,the,0,0
138717,CT,0,1
138718,group,0,0
138719,(,0,0
138720,n,0,0
138721,=,0,0
138722,57,0,0
138723,),0,0
138724,consumed,0,0
138725,their,0,0
138726,habitual,0,0
138727,diet,0,0
138728,throughout,0,0
138729,",",0,0
138730,the,0,0
138731,HF,0,0
138732,(,0,0
138733,n,0,0
138734,=,0,0
138735,58,0,0
138736,),0,0
138737,and,0,0
138738,LF,0,1
138739,(,0,0
138740,n,0,0
138741,=,0,0
138742,59,0,0
138743,),0,0
138744,groups,0,0
138745,sequentially,0,0
138746,increased,0,0
138747,their,0,0
138748,daily,0,0
138749,F,0,0
138750,&,0,0
138751,V,0,1
138752,intake,0,1
138753,by,0,0
138754,an,0,0
138755,additional,0,0
138756,2,0,0
138757,",",0,0
138758,4,0,0
138759,and,0,0
138760,6,0,0
138761,portions,0,0
138762,for,0,0
138763,6-week,0,0
138764,periods,0,0
138765,during,0,0
138766,the,0,0
138767,18-week,0,0
138768,study,0,0
138769,.,0,0
138770,RESULTS,0,0
138771,Compliance,0,0
138772,to,0,0
138773,target,0,0
138774,numbers,0,1
138775,and,0,0
138776,types,0,0
138777,of,0,1
138778,F,0,0
138779,&,0,0
138780,V,0,1
138781,was,0,0
138782,broadly,0,0
138783,met,0,0
138784,and,0,0
138785,verified,0,0
138786,by,0,0
138787,dietary,0,0
138788,records,0,0
138789,",",0,0
138790,and,0,1
138791,plasma,1,1
138792,and,1,1
138793,urinary,1,1
138794,biomarkers,1,0
138795,.,1,0
138796,Mean,0,0
138797,(,0,0
138798,?,0,0
138799,SEM,0,0
138800,),0,0
138801,number,0,1
138802,of,1,0
138803,F,1,0
138804,&,1,0
138805,V,1,1
138806,portions/day,1,1
138807,consumed,0,0
138808,by,0,0
138809,the,0,0
138810,HF,0,0
138811,and,0,0
138812,LF,0,1
138813,groups,0,0
138814,at,0,0
138815,baseline,0,0
138816,(,0,0
138817,3.8,0,0
138818,?,0,0
138819,0.3,0,0
138820,and,0,0
138821,3.4,0,0
138822,?,0,0
138823,0.3,0,0
138824,),0,0
138825,",",0,0
138826,6,0,0
138827,weeks,0,0
138828,(,0,0
138829,6.3,0,0
138830,?,0,0
138831,0.4,0,0
138832,and,0,0
138833,5.8,0,0
138834,?,0,0
138835,0.3,0,0
138836,),0,0
138837,",",0,0
138838,12,0,0
138839,weeks,0,0
138840,(,0,0
138841,7.0,0,0
138842,?,0,0
138843,0.3,0,0
138844,and,0,0
138845,6.8,0,0
138846,?,0,0
138847,0.3,0,0
138848,),0,0
138849,and,0,0
138850,18,0,0
138851,weeks,0,0
138852,(,0,0
138853,7.6,0,0
138854,?,0,0
138855,0.4,0,0
138856,and,0,0
138857,8.1,0,0
138858,?,0,0
138859,0.4,0,0
138860,),0,0
138861,",",0,0
138862,respectively,0,0
138863,",",0,0
138864,was,0,0
138865,similar,0,0
138866,at,0,0
138867,baseline,0,0
138868,yet,0,0
138869,higher,0,0
138870,than,0,0
138871,the,0,0
138872,CT,0,1
138873,group,0,0
138874,(,0,0
138875,3.9,0,0
138876,?,0,0
138877,0.3,0,0
138878,",",0,0
138879,4.3,0,0
138880,?,0,0
138881,0.3,0,0
138882,",",0,0
138883,4.6,0,0
138884,?,0,0
138885,0.4,0,0
138886,",",0,0
138887,4.5,0,0
138888,?,0,0
138889,0.3,0,0
138890,),0,0
138891,(,0,0
138892,P,0,0
138893,=,0,0
138894,0.015,0,0
138895,),0,0
138896,.,0,0
138897,There,0,0
138898,was,0,0
138899,a,0,0
138900,dose-dependent,1,0
138901,increase,1,0
138902,in,1,0
138903,dietary,1,0
138904,and,1,0
138905,urinary,1,1
138906,flavonoids,1,0
138907,in,1,0
138908,the,0,0
138909,HF,0,0
138910,group,0,0
138911,",",0,0
138912,with,0,0
138913,no,0,0
138914,change,0,0
138915,in,0,0
138916,other,0,0
138917,groups,0,0
138918,(,0,0
138919,P,0,0
138920,=,0,0
138921,0.0001,0,0
138922,),0,0
138923,.,0,0
138924,Significantly,0,0
138925,higher,1,0
138926,dietary,1,0
138927,intakes,1,1
138928,of,1,0
138929,folate,1,1
138930,(,1,0
138931,P,1,0
138932,=,0,0
138933,0.035,0,0
138934,),0,0
138935,",",0,0
138936,non-starch,1,0
138937,polysaccharides,1,1
138938,(,1,0
138939,P,1,0
138940,=,1,0
138941,0.001,1,0
138942,),1,0
138943,",",1,0
138944,vitamin,0,0
138945,C,0,0
138946,(,0,0
138947,P,0,0
138948,=,0,0
138949,0.0001,0,0
138950,),0,0
138951,and,0,0
138952,carotenoids,1,1
138953,(,0,0
138954,P,0,0
138955,=,0,0
138956,0.0001,0,0
138957,),0,0
138958,were,0,0
138959,observed,0,0
138960,in,0,0
138961,both,0,0
138962,intervention,0,0
138963,groups,0,0
138964,compared,0,0
138965,with,0,0
138966,CT,0,1
138967,",",0,0
138968,which,0,0
138969,were,0,0
138970,broadly,0,0
138971,supported,0,0
138972,by,0,0
138973,nutrient,0,0
138974,biomarker,0,0
138975,analysis,0,0
138976,.,0,0
138977,CONCLUSIONS,0,0
138978,The,0,0
138979,success,0,1
138980,of,0,0
138981,improving,0,1
138982,nutrient,1,0
138983,profile,1,1
138984,by,1,0
138985,active,1,0
138986,encouragement,0,0
138987,of,1,0
138988,F,1,0
138989,&,1,0
138990,V,1,1
138991,intake,1,1
138992,in,1,0
138993,an,0,0
138994,intervention,0,0
138995,study,0,0
138996,implies,0,0
138997,the,0,0
138998,need,0,0
138999,for,0,0
139000,a,0,0
139001,more,0,0
139002,hands-on,0,0
139003,public,0,0
139004,health,0,0
139005,approach,0,0
139006,.,0,0
139007,Moclobemide,0,0
139008,",",0,0
139009,imipramine,0,0
139010,and,0,1
139011,placebo,0,0
139012,in,0,0
139013,the,0,0
139014,treatment,0,0
139015,of,0,0
139016,major,0,0
139017,depression,1,1
139018,.,1,0
139019,Moclobemide,0,0
139020,was,0,0
139021,compared,0,0
139022,with,0,0
139023,imipramine,0,0
139024,and,0,1
139025,placebo,0,0
139026,in,0,0
139027,the,0,0
139028,treatment,0,0
139029,of,0,0
139030,major,0,0
139031,depressive,0,1
139032,episodes,0,1
139033,in,0,0
139034,75,0,0
139035,outpatients,0,0
139036,.,0,0
139037,The,0,0
139038,dosage,0,0
139039,of,0,0
139040,moclobemide,0,0
139041,(,0,0
139042,25,0,0
139043,patients,0,0
139044,),0,0
139045,was,0,0
139046,300,0,0
139047,mg,0,0
139048,daily,0,0
139049,for,0,0
139050,the,0,0
139051,first,0,0
139052,5,0,0
139053,days,0,0
139054,",",0,0
139055,after,0,0
139056,which,0,0
139057,it,0,0
139058,could,0,0
139059,be,0,0
139060,increased,0,0
139061,to,0,0
139062,600,0,0
139063,mg.,0,0
139064,Imipramine,0,0
139065,(,0,0
139066,25,0,0
139067,patients,0,0
139068,),0,0
139069,was,0,0
139070,given,0,0
139071,in,0,0
139072,a,0,0
139073,dosage,0,0
139074,starting,0,0
139075,with,0,0
139076,33,0,0
139077,mg,0,0
139078,and,0,0
139079,gradually,0,0
139080,increased,0,0
139081,to,0,0
139082,100,0,0
139083,mg/day,0,0
139084,in,0,0
139085,the,0,0
139086,first,0,0
139087,5,0,0
139088,days,0,0
139089,",",0,0
139090,after,0,0
139091,which,0,0
139092,it,0,0
139093,could,0,0
139094,be,0,0
139095,further,0,0
139096,increased,0,0
139097,;,0,0
139098,25,0,0
139099,patients,0,0
139100,received,0,0
139101,placebo,0,0
139102,.,0,0
139103,Both,0,0
139104,drugs,0,0
139105,were,0,0
139106,equally,0,0
139107,effective,0,0
139108,as,0,0
139109,measured,0,0
139110,by,0,0
139111,the,0,0
139112,Hamilton,1,0
139113,Rating,1,0
139114,Scale,1,1
139115,for,1,0
139116,Depression,1,1
139117,",",0,0
139118,the,0,0
139119,overall,1,1
139120,assessment,1,0
139121,of,1,0
139122,efficacy,1,1
139123,and,0,0
139124,the,0,0
139125,Zung,1,0
139126,Self-rating,1,1
139127,Scale,1,1
139128,",",0,0
139129,and,0,0
139130,clearly,0,0
139131,superior,0,0
139132,to,0,0
139133,placebo,0,0
139134,;,0,0
139135,there,0,0
139136,were,0,0
139137,no,0,0
139138,significant,0,0
139139,differences,0,0
139140,between,0,0
139141,the,0,0
139142,2,0,0
139143,active,0,0
139144,drugs,0,0
139145,.,0,0
139146,Moclobemide,0,0
139147,was,0,0
139148,better,1,0
139149,tolerated,1,1
139150,than,0,0
139151,imipramine,0,0
139152,",",0,0
139153,and,0,1
139154,was,0,0
139155,almost,0,0
139156,comparable,0,0
139157,to,0,0
139158,placebo,0,0
139159,in,0,0
139160,this,0,0
139161,respect,0,0
139162,.,0,0
139163,Laryngeal,0,0
139164,preservation,0,0
139165,with,0,0
139166,induction,0,1
139167,chemotherapy,0,0
139168,for,0,0
139169,hypopharyngeal,0,0
139170,squamous,0,0
139171,cell,0,0
139172,carcinoma,0,0
139173,:,0,0
139174,10-year,0,1
139175,results,0,0
139176,of,0,0
139177,EORTC,0,0
139178,trial,0,0
139179,24891,0,0
139180,.,0,0
139181,BACKGROUND,0,0
139182,We,0,0
139183,report,0,0
139184,the,0,0
139185,10-year,0,1
139186,results,0,0
139187,of,0,0
139188,the,0,0
139189,EORTC,0,0
139190,trial,0,0
139191,24891,0,0
139192,comparing,0,0
139193,a,0,0
139194,larynx-preservation,0,0
139195,approach,0,0
139196,to,0,0
139197,immediate,0,0
139198,surgery,0,0
139199,in,0,0
139200,hypopharynx,0,0
139201,and,0,0
139202,lateral,0,1
139203,epilarynx,0,1
139204,squamous,0,0
139205,cell,0,0
139206,carcinoma,0,0
139207,.,0,0
139208,MATERIAL,0,0
139209,AND,0,0
139210,METHODS,0,0
139211,Two,0,0
139212,hundred,0,0
139213,and,0,0
139214,two,0,0
139215,patients,0,0
139216,were,0,0
139217,randomized,0,0
139218,to,0,0
139219,either,0,0
139220,the,0,0
139221,surgical,0,0
139222,approach,0,0
139223,(,0,0
139224,total,0,1
139225,laryngectomy,0,0
139226,with,0,0
139227,partial,0,0
139228,pharyngectomy,0,0
139229,and,0,1
139230,neck,0,1
139231,dissection,0,0
139232,",",0,0
139233,followed,0,0
139234,by,0,0
139235,irradiation,0,0
139236,),0,0
139237,or,0,0
139238,to,0,0
139239,the,0,0
139240,chemotherapy,0,0
139241,arm,0,0
139242,up,0,0
139243,to,0,0
139244,three,0,0
139245,cycles,0,0
139246,of,0,0
139247,induction,0,1
139248,chemotherapy,0,0
139249,(,0,0
139250,cisplatin,0,0
139251,100,0,0
139252,mg/m,0,0
139253,(,0,0
139254,2,0,0
139255,),0,0
139256,day,0,0
139257,1,0,0
139258,+,0,0
139259,5-FU,0,0
139260,1000,0,0
139261,mg/m,0,0
139262,(,0,0
139263,2,0,0
139264,),0,0
139265,day,0,0
139266,1-5,0,0
139267,),0,0
139268,followed,0,0
139269,for,0,0
139270,complete,0,1
139271,responders,0,0
139272,by,0,0
139273,irradiation,0,0
139274,and,0,0
139275,otherwise,0,0
139276,by,0,0
139277,conventional,0,0
139278,treatment,0,0
139279,.,0,0
139280,The,0,0
139281,end,0,0
139282,points,0,0
139283,were,0,0
139284,overall,1,1
139285,survival,1,1
139286,[,0,0
139287,OS,0,1
139288,",",0,0
139289,noninferiority,0,0
139290,:,0,0
139291,hazard,0,1
139292,ratio,0,1
139293,(,0,0
139294,preservation/surgery,0,0
139295,),0,0
139296,?,0,0
139297,1.428,0,0
139298,",",0,0
139299,one-sided,0,0
139300,?,0,0
139301,=,0,0
139302,0.05,1,0
139303,],1,0
139304,",",1,0
139305,progression-free,1,1
139306,survival,1,1
139307,(,1,0
139308,PFS,1,1
139309,),1,0
139310,and,1,0
139311,survival,1,1
139312,with,1,0
139313,a,1,0
139314,functional,1,0
139315,larynx,1,0
139316,(,1,0
139317,SFL,1,1
139318,),1,0
139319,.,1,0
139320,RESULTS,1,0
139321,At,0,0
139322,a,0,0
139323,median,0,0
139324,follow-up,0,0
139325,of,0,0
139326,10.5,0,0
139327,years,0,0
139328,on,0,0
139329,194,0,0
139330,eligible,0,0
139331,patients,1,0
139332,",",1,0
139333,disease,1,1
139334,evolution,1,1
139335,was,1,0
139336,seen,0,0
139337,in,0,0
139338,54,0,0
139339,and,0,0
139340,49,0,0
139341,patients,0,0
139342,in,0,0
139343,the,0,0
139344,surgery,0,0
139345,and,0,1
139346,chemotherapy,0,0
139347,arm,0,0
139348,",",0,0
139349,respectively,0,0
139350,",",0,0
139351,and,0,0
139352,81,0,0
139353,and,0,0
139354,83,0,0
139355,patients,0,0
139356,had,0,0
139357,died,0,0
139358,.,0,0
139359,The,0,0
139360,10-year,1,1
139361,OS,1,1
139362,rate,1,1
139363,was,1,0
139364,13.8,0,0
139365,%,0,0
139366,in,0,0
139367,the,0,0
139368,surgery,0,0
139369,arm,0,0
139370,and,0,0
139371,13.1,0,0
139372,%,0,0
139373,in,0,0
139374,the,0,0
139375,chemotherapy,0,0
139376,arm,0,0
139377,.,0,0
139378,The,0,0
139379,10-year,1,1
139380,PFS,1,0
139381,rates,1,1
139382,were,1,0
139383,8.5,0,0
139384,%,0,0
139385,and,0,0
139386,10.8,0,0
139387,%,0,0
139388,",",0,0
139389,respectively,0,0
139390,.,0,0
139391,In,0,0
139392,the,0,0
139393,chemotherapy,0,0
139394,arm,0,0
139395,",",0,0
139396,the,0,0
139397,10-year,1,1
139398,SFL,1,1
139399,rate,1,1
139400,was,1,0
139401,8.7,0,0
139402,%,0,0
139403,.,0,0
139404,CONCLUSION,0,0
139405,This,0,0
139406,strategy,0,0
139407,did,0,0
139408,not,0,0
139409,compromise,1,0
139410,disease,1,1
139411,control,1,0
139412,or,1,1
139413,survival,1,1
139414,(,1,0
139415,that,1,0
139416,remained,0,0
139417,poor,0,1
139418,),0,0
139419,and,0,0
139420,allowed,0,0
139421,more,0,0
139422,than,0,0
139423,half,0,0
139424,of,0,0
139425,the,0,0
139426,survivors,0,0
139427,to,0,0
139428,retain,0,0
139429,their,0,0
139430,larynx,0,0
139431,.,0,0
139432,The,0,0
139433,Social,0,1
139434,Communication,0,1
139435,Intervention,0,0
139436,Project,0,0
139437,:,0,0
139438,a,0,0
139439,randomized,0,0
139440,controlled,0,0
139441,trial,0,0
139442,of,0,0
139443,the,0,0
139444,effectiveness,0,1
139445,of,0,0
139446,speech,0,1
139447,and,0,1
139448,language,0,1
139449,therapy,0,0
139450,for,0,0
139451,school-age,0,0
139452,children,0,0
139453,who,0,0
139454,have,0,0
139455,pragmatic,0,0
139456,and,0,0
139457,social,0,1
139458,communication,0,1
139459,problems,0,1
139460,with,0,0
139461,or,0,0
139462,without,0,0
139463,autism,0,0
139464,spectrum,0,0
139465,disorder,0,0
139466,.,0,0
139467,BACKGROUND,0,0
139468,Children,0,0
139469,who,0,0
139470,show,0,0
139471,disproportionate,0,0
139472,difficulty,0,1
139473,with,0,0
139474,the,0,0
139475,pragmatic,0,0
139476,as,0,0
139477,compared,0,0
139478,with,0,0
139479,the,0,0
139480,structural,0,0
139481,aspects,0,0
139482,of,0,0
139483,language,0,0
139484,are,0,0
139485,described,0,0
139486,as,0,0
139487,having,0,0
139488,pragmatic,0,0
139489,language,0,1
139490,impairment,0,1
139491,(,0,0
139492,PLI,0,0
139493,),0,0
139494,or,0,0
139495,social,0,1
139496,communication,0,1
139497,disorder,0,0
139498,(,0,0
139499,SCD,0,1
139500,),0,0
139501,.,0,0
139502,Some,0,0
139503,children,0,0
139504,who,0,0
139505,have,0,0
139506,PLI,0,0
139507,also,0,0
139508,show,0,0
139509,mild,0,1
139510,social,0,1
139511,impairments,0,0
139512,associated,0,0
139513,with,0,0
139514,high-functioning,0,0
139515,autism,0,0
139516,or,0,0
139517,autism,0,0
139518,spectrum,0,0
139519,disorder,0,0
139520,(,0,0
139521,ASD,0,0
139522,),0,0
139523,.,0,0
139524,There,0,0
139525,is,0,0
139526,little,0,0
139527,robust,0,1
139528,evidence,0,0
139529,of,0,0
139530,effectiveness,0,1
139531,of,0,0
139532,speech-language,0,0
139533,interventions,0,0
139534,which,0,0
139535,target,0,0
139536,the,0,0
139537,language,0,0
139538,",",0,0
139539,pragmatic,0,0
139540,or,0,0
139541,social,0,1
139542,communication,0,1
139543,needs,0,0
139544,of,0,0
139545,these,0,0
139546,children,0,0
139547,.,0,0
139548,AIMS,0,0
139549,To,0,0
139550,evaluate,0,0
139551,the,0,0
139552,effectiveness,0,0
139553,of,0,0
139554,an,0,0
139555,intensive,0,0
139556,manualized,0,0
139557,social,0,1
139558,communication,0,1
139559,intervention,0,0
139560,(,0,0
139561,SCIP,0,1
139562,),0,0
139563,for,0,0
139564,children,0,0
139565,who,0,0
139566,have,0,0
139567,PLI,0,0
139568,with,0,0
139569,or,0,0
139570,without,0,0
139571,features,0,0
139572,of,0,0
139573,ASD,0,0
139574,.,0,0
139575,METHODS,0,0
139576,&,0,0
139577,PROCEDURES,0,0
139578,In,0,0
139579,a,0,0
139580,single-blind,0,0
139581,RCT,0,0
139582,design,0,0
139583,",",0,0
139584,88,0,0
139585,children,0,0
139586,with,0,0
139587,pragmatic,0,0
139588,and,0,0
139589,social,0,1
139590,communication,0,1
139591,needs,0,0
139592,aged,0,0
139593,5,0,0
139594,;,0,0
139595,11-10,0,0
139596,;,0,0
139597,8,0,0
139598,",",0,0
139599,recruited,0,0
139600,from,0,0
139601,UK,0,0
139602,speech,0,1
139603,and,0,1
139604,language,0,1
139605,therapy,0,0
139606,services,0,1
139607,",",0,0
139608,were,0,0
139609,randomly,0,0
139610,assigned,0,0
139611,in,0,0
139612,a,0,0
139613,2:1,0,0
139614,ratio,0,0
139615,to,0,0
139616,SCIP,0,1
139617,or,0,0
139618,to,0,0
139619,treatment-as-usual,0,0
139620,.,0,0
139621,Children,0,0
139622,in,0,0
139623,the,0,0
139624,SCIP,0,1
139625,condition,0,0
139626,received,0,0
139627,up,0,0
139628,to,0,0
139629,20,0,0
139630,sessions,0,0
139631,of,0,0
139632,direct,0,0
139633,intervention,0,0
139634,from,0,0
139635,a,0,0
139636,specialist,0,0
139637,research,0,0
139638,speech,0,1
139639,and,0,1
139640,language,0,1
139641,therapist,0,0
139642,working,0,1
139643,with,0,0
139644,supervised,0,0
139645,assistants,0,0
139646,.,0,0
139647,All,0,0
139648,therapy,0,0
139649,content,0,1
139650,and,0,1
139651,methodology,0,0
139652,was,0,0
139653,derived,0,0
139654,from,0,0
139655,an,0,0
139656,intervention,0,0
139657,manual,0,0
139658,.,0,0
139659,A,0,0
139660,primary,0,0
139661,outcome,0,1
139662,measure,0,0
139663,of,0,0
139664,structural,1,0
139665,language,1,1
139666,and,0,0
139667,secondary,0,1
139668,outcome,0,1
139669,measures,0,1
139670,of,0,0
139671,narrative,1,0
139672,",",1,0
139673,parent-reported,1,1
139674,pragmatic,1,0
139675,functioning,1,1
139676,and,1,0
139677,social,1,1
139678,communication,1,1
139679,",",1,0
139680,blind-rated,1,0
139681,perceptions,1,0
139682,of,1,0
139683,conversational,1,1
139684,competence,1,1
139685,and,1,0
139686,teacher-reported,1,1
139687,ratings,1,1
139688,of,1,0
139689,classroom,1,0
139690,learning,1,1
139691,skills,1,1
139692,were,0,0
139693,taken,0,0
139694,pre-intervention,0,0
139695,",",0,0
139696,immediately,0,0
139697,post-intervention,0,0
139698,and,0,0
139699,at,0,0
139700,6-month,0,0
139701,follow-up,0,0
139702,.,0,0
139703,Analysis,0,1
139704,was,0,0
139705,by,0,0
139706,intention,0,0
139707,to,0,0
139708,treat,0,0
139709,.,0,0
139710,OUTCOMES,0,0
139711,&,0,0
139712,RESULTS,0,0
139713,No,0,1
139714,significant,0,0
139715,treatment,0,0
139716,effect,0,1
139717,was,0,0
139718,found,0,0
139719,for,0,0
139720,the,0,0
139721,primary,0,0
139722,outcome,0,1
139723,measure,0,0
139724,of,0,0
139725,structural,1,0
139726,language,1,1
139727,ability,1,1
139728,or,1,0
139729,for,1,0
139730,a,1,0
139731,measure,1,0
139732,of,1,0
139733,narrative,1,0
139734,ability,1,0
139735,.,1,0
139736,Significant,0,0
139737,treatment,0,0
139738,effects,0,1
139739,were,0,0
139740,found,0,0
139741,for,0,0
139742,blind-rated,1,0
139743,perceptions,1,0
139744,of,1,0
139745,conversational,1,1
139746,competence,1,1
139747,",",1,0
139748,for,1,0
139749,parent-reported,1,1
139750,measures,1,1
139751,of,1,0
139752,pragmatic,1,0
139753,functioning,1,1
139754,and,1,0
139755,social,1,1
139756,communication,1,1
139757,",",1,0
139758,and,1,1
139759,for,1,0
139760,teacher-reported,1,1
139761,ratings,1,1
139762,of,1,0
139763,classroom,1,0
139764,learning,1,1
139765,skills,1,1
139766,.,1,0
139767,CONCLUSIONS,0,0
139768,&,0,0
139769,IMPLICATIONS,0,0
139770,There,0,0
139771,is,0,0
139772,some,0,0
139773,evidence,0,0
139774,of,0,0
139775,an,0,0
139776,intervention,0,0
139777,effect,0,0
139778,on,0,0
139779,blind,0,0
139780,and,0,0
139781,parent/teacher-reported,0,1
139782,communication,0,1
139783,outcomes,0,1
139784,",",0,0
139785,but,0,0
139786,not,0,0
139787,standardized,0,0
139788,language,0,1
139789,assessment,0,1
139790,outcomes,0,1
139791,",",0,0
139792,for,0,0
139793,6-11-year-old,0,0
139794,children,0,0
139795,who,0,0
139796,have,0,0
139797,pragmatic,0,0
139798,and,0,0
139799,social,0,1
139800,communication,0,1
139801,needs,0,0
139802,.,0,0
139803,These,0,0
139804,findings,0,0
139805,are,0,0
139806,discussed,0,0
139807,in,0,0
139808,the,0,0
139809,context,0,0
139810,of,0,0
139811,the,0,0
139812,increasingly,0,0
139813,central,0,0
139814,role,0,0
139815,of,0,0
139816,service,0,1
139817,user,0,0
139818,outcomes,0,1
139819,in,0,0
139820,providing,0,0
139821,evidence,0,0
139822,for,0,0
139823,an,0,0
139824,intervention,0,0
139825,.,0,0
139826,The,0,0
139827,substantial,0,0
139828,overlap,0,0
139829,between,0,0
139830,the,0,0
139831,presence,0,0
139832,of,0,0
139833,PLI,0,0
139834,and,0,1
139835,ASD,0,0
139836,(,0,0
139837,75,0,0
139838,%,0,0
139839,),0,0
139840,across,0,0
139841,the,0,0
139842,whole,0,0
139843,cohort,0,0
139844,suggests,0,0
139845,that,0,0
139846,the,0,0
139847,intervention,0,0
139848,may,0,0
139849,also,0,0
139850,be,0,0
139851,applicable,0,0
139852,to,0,0
139853,some,0,0
139854,verbally,0,0
139855,able,0,0
139856,children,0,0
139857,with,0,0
139858,ASD,0,0
139859,who,0,0
139860,have,0,0
139861,pragmatic,0,0
139862,communication,0,0
139863,needs,0,0
139864,.,0,0
139865,Efficacy,1,1
139866,and,1,1
139867,safety,1,1
139868,of,0,0
139869,10,0,0
139870,%,0,0
139871,HES,0,0
139872,130/0.4,0,0
139873,versus,0,0
139874,10,0,0
139875,%,0,0
139876,HES,0,0
139877,200/0.5,0,0
139878,for,0,0
139879,plasma,0,1
139880,volume,0,1
139881,expansion,0,0
139882,in,0,0
139883,cardiac,0,1
139884,surgery,0,0
139885,patients,0,0
139886,.,0,0
139887,AIM,0,0
139888,Hydroxyethyl,0,0
139889,starch,0,0
139890,(,0,0
139891,HES,0,1
139892,),0,0
139893,solutions,0,0
139894,are,0,0
139895,frequently,0,0
139896,used,0,0
139897,for,0,0
139898,perioperative,0,0
139899,volume,0,1
139900,replacement,0,0
139901,.,0,0
139902,Whereas,0,0
139903,older,0,0
139904,HES,0,1
139905,specimen,0,1
139906,tended,0,0
139907,to,0,0
139908,accumulate,0,0
139909,in,0,0
139910,the,0,0
139911,plasma,0,1
139912,and,0,0
139913,to,0,0
139914,cause,0,0
139915,negative,0,0
139916,effects,0,1
139917,on,0,0
139918,hemostasis,0,1
139919,",",0,0
139920,more,0,0
139921,recent,0,0
139922,products,0,1
139923,",",0,0
139924,e.g.,0,0
139925,",",0,0
139926,HES,0,0
139927,130/0.4,0,0
139928,",",0,0
139929,are,0,0
139930,characterised,0,0
139931,by,0,0
139932,improved,0,0
139933,pharmacological,0,0
139934,properties,0,0
139935,.,0,0
139936,The,0,0
139937,present,0,0
139938,study,0,0
139939,was,0,0
139940,designed,0,0
139941,to,0,0
139942,compare,0,0
139943,the,0,0
139944,efficacy,1,1
139945,and,1,0
139946,safety,1,1
139947,of,0,0
139948,10,0,0
139949,%,0,0
139950,HES,0,0
139951,130/0.4,0,0
139952,and,0,0
139953,10,0,0
139954,%,0,0
139955,HES,0,0
139956,200/0.5,0,0
139957,.,0,0
139958,METHODS,0,0
139959,In,0,0
139960,this,0,0
139961,post-hoc,0,0
139962,analysis,0,0
139963,of,0,0
139964,a,0,0
139965,prospective,0,0
139966,",",0,0
139967,randomised,0,0
139968,",",0,0
139969,double-blind,0,0
139970,",",0,0
139971,multi-center,0,0
139972,therapeutic,0,0
139973,equivalence,0,1
139974,trial,0,0
139975,",",0,0
139976,76,0,0
139977,patients,0,0
139978,undergoing,0,0
139979,elective,0,0
139980,on-pump,0,0
139981,cardiac,0,1
139982,surgery,0,0
139983,received,0,0
139984,perioperative,0,1
139985,volume,0,1
139986,replacement,0,0
139987,using,0,0
139988,either,0,0
139989,10,0,0
139990,%,0,0
139991,HES,0,0
139992,130/0.4,0,0
139993,(,0,0
139994,N.=37,0,0
139995,),0,0
139996,or,0,0
139997,10,0,0
139998,%,0,0
139999,HES,0,0
140000,200/0.5,0,0
140001,(,0,0
140002,N.=39,0,0
140003,),0,0
140004,up,0,0
140005,to,0,0
140006,a,0,0
140007,maximum,0,1
140008,dose,0,0
140009,of,0,0
140010,20,0,0
140011,mL,0,0
140012,kg-1,0,0
140013,.,0,0
140014,RESULTS,0,0
140015,Equivalent,1,0
140016,volumes,1,1
140017,of,1,0
140018,investigational,1,0
140019,medication,1,1
140020,were,0,0
140021,infused,0,0
140022,until,0,0
140023,24,0,0
140024,hours,0,0
140025,after,0,0
140026,the,0,0
140027,first,0,0
140028,administration,0,0
140029,(,0,0
140030,1577,0,0
140031,vs.,0,0
140032,1540,0,0
140033,mL,0,0
140034,;,0,0
140035,treatment,0,0
140036,difference,0,0
140037,37,0,0
140038,[,0,0
140039,-150,0,0
140040,;,0,0
140041,223,0,0
140042,],0,0
140043,mL,0,0
140044,;,0,0
140045,P,0,0
140046,<,0,0
140047,0.0001,0,0
140048,for,0,0
140049,equivalence,0,0
140050,),0,0
140051,.,0,0
140052,Whereas,0,0
140053,standard,1,0
140054,laboratory,1,0
140055,tests,1,1
140056,of,1,0
140057,coagulation,1,0
140058,were,0,0
140059,comparable,0,0
140060,between,0,0
140061,groups,0,0
140062,",",0,0
140063,von,1,0
140064,Willebrand,1,1
140065,factor,1,1
140066,activity,1,1
140067,on,0,0
140068,the,0,0
140069,first,0,0
140070,postoperative,0,1
140071,morning,0,0
140072,tended,0,0
140073,to,0,0
140074,be,0,0
140075,higher,0,0
140076,following,0,0
140077,treatment,0,0
140078,with,0,0
140079,10,0,0
140080,%,0,0
140081,HES,0,0
140082,130/0.4,0,0
140083,as,0,0
140084,compared,0,0
140085,to,0,0
140086,10,0,0
140087,%,0,0
140088,HES,0,0
140089,200/0.5,0,0
140090,(,0,0
140091,P=0.025,0,0
140092,),0,0
140093,with,0,0
140094,this,0,0
140095,difference,0,0
140096,being,0,0
140097,statistically,0,0
140098,significant,0,0
140099,only,0,0
140100,in,0,0
140101,the,0,0
140102,per-protocol,0,0
140103,analysis,0,0
140104,(,0,0
140105,P=0.02,0,0
140106,),0,0
140107,.,0,0
140108,Treatment,0,0
140109,groups,0,0
140110,were,0,0
140111,comparable,0,0
140112,concerning,0,0
140113,other,0,0
140114,safety,1,1
140115,parameters,1,1
140116,and,1,0
140117,the,1,0
140118,incidence,1,1
140119,of,1,0
140120,adverse,1,1
140121,drug,1,0
140122,reactions,1,1
140123,.,1,0
140124,In,0,0
140125,particular,0,0
140126,",",0,0
140127,renal,1,1
140128,function,1,1
140129,was,0,0
140130,well,0,0
140131,preserved,0,0
140132,in,0,0
140133,both,0,0
140134,groups,0,0
140135,.,0,0
140136,CONCLUSION,0,0
140137,Ten,0,0
140138,percent,0,0
140139,HES,0,0
140140,130/0.4,0,0
140141,was,0,0
140142,equally,0,0
140143,effective,0,0
140144,and,0,0
140145,safe,0,1
140146,as,0,0
140147,compared,0,0
140148,to,0,0
140149,10,0,0
140150,%,0,0
140151,HES,0,0
140152,200/0.5,0,0
140153,for,0,0
140154,volume,0,0
140155,therapy,0,0
140156,in,0,0
140157,patients,0,0
140158,undergoing,0,0
140159,cardiovascular,0,1
140160,surgery,0,0
140161,.,0,0
140162,Postoperative,1,1
140163,coagulation,1,0
140164,and,1,0
140165,renal,1,1
140166,function,1,1
140167,",",0,0
140168,as,0,0
140169,measured,0,0
140170,by,0,0
140171,standard,0,0
140172,laboratory,0,0
140173,tests,0,1
140174,",",0,0
140175,were,0,0
140176,similar,0,0
140177,among,0,0
140178,groups,0,0
140179,.,0,0
140180,Placebo-controlled,0,0
140181,pilot,0,0
140182,trial,0,0
140183,of,0,0
140184,mecamylamine,0,0
140185,for,0,0
140186,treatment,0,0
140187,of,0,0
140188,autism,1,0
140189,spectrum,1,0
140190,disorders,1,0
140191,.,1,0
140192,OBJECTIVE,0,0
140193,To,0,0
140194,explore,0,0
140195,possible,0,0
140196,benefits,0,0
140197,of,0,0
140198,a,0,0
140199,nicotinic,0,0
140200,acetylcholine,0,1
140201,receptor,0,1
140202,(,0,0
140203,nAChR,0,0
140204,),0,0
140205,agent,0,0
140206,for,0,0
140207,autistic,1,0
140208,symptoms,1,1
140209,based,0,0
140210,on,0,0
140211,postmortem,0,0
140212,observation,0,0
140213,of,0,0
140214,nAChR,0,0
140215,abnormalities,0,0
140216,(,0,0
140217,deficient,0,0
140218,?4?2,0,1
140219,nAChRs,0,0
140220,",",0,0
140221,excess,0,1
140222,?7,0,1
140223,nAChRs,0,0
140224,),0,0
140225,in,0,0
140226,brains,0,0
140227,of,0,0
140228,patients,0,0
140229,with,0,0
140230,autism,0,0
140231,.,0,0
140232,METHOD,0,0
140233,Mecamylamine,0,0
140234,",",0,0
140235,because,0,0
140236,of,0,0
140237,its,0,0
140238,safety,0,1
140239,record,0,0
140240,in,0,0
140241,children,0,0
140242,with,0,0
140243,other,0,0
140244,disorders,0,0
140245,",",0,0
140246,was,0,0
140247,chosen,0,0
140248,for,0,0
140249,this,0,0
140250,first,0,0
140251,exploration,0,0
140252,.,0,0
140253,Twenty,0,0
140254,children,0,0
140255,with,0,0
140256,autism,0,0
140257,spectrum,0,0
140258,disorder,0,0
140259,age,0,0
140260,4-12,0,0
140261,years,0,0
140262,were,0,0
140263,randomly,0,0
140264,assigned,0,0
140265,for,0,0
140266,14,0,0
140267,weeks,0,0
140268,to,0,0
140269,placebo,0,0
140270,(,0,0
140271,n=8,0,0
140272,),0,1
140273,or,0,0
140274,mecamylamine,0,0
140275,(,0,1
140276,n=12,0,0
140277,),0,0
140278,in,0,0
140279,ascending,0,0
140280,fixed,0,0
140281,doses,0,0
140282,:,0,0
140283,0.5,0,0
140284,mg/day,0,0
140285,for,0,0
140286,6,0,0
140287,weeks,0,0
140288,",",0,0
140289,2.5,0,0
140290,mg,0,0
140291,for,0,0
140292,2,0,0
140293,weeks,0,0
140294,",",0,0
140295,then,0,0
140296,5,0,0
140297,mg/day,0,0
140298,for,0,0
140299,6,0,0
140300,weeks,0,0
140301,.,0,0
140302,Improvement,0,1
140303,was,0,0
140304,rated,0,0
140305,by,0,0
140306,a,0,0
140307,blinded,0,0
140308,independent,0,0
140309,evaluator,0,0
140310,.,0,0
140311,Because,0,0
140312,of,0,0
140313,small,0,0
140314,sample,0,0
140315,",",0,0
140316,data,0,0
140317,analysis,0,0
140318,was,0,0
140319,descriptive,0,0
140320,.,0,0
140321,RESULTS,0,0
140322,Eighteen,0,1
140323,participants,0,0
140324,(,0,0
140325,10,0,0
140326,mecamylamine,0,0
140327,",",0,0
140328,8,0,0
140329,placebo,0,0
140330,),0,0
140331,completed,0,0
140332,the,0,0
140333,study,0,0
140334,.,0,0
140335,All,0,0
140336,doses,0,0
140337,were,0,0
140338,well,1,0
140339,tolerated,1,1
140340,;,1,0
140341,the,1,0
140342,only,0,0
140343,side,0,1
140344,effect,0,0
140345,of,0,1
140346,note,0,0
140347,was,0,0
140348,constipation,1,1
140349,(,1,0
140350,50,1,0
140351,%,0,0
140352,compared,0,0
140353,with,0,0
140354,25,0,0
140355,%,0,0
140356,of,0,0
140357,placebo,0,0
140358,group,0,0
140359,),0,0
140360,.,0,0
140361,Three,0,0
140362,children,0,0
140363,had,0,0
140364,clinically,1,0
140365,nonsignificant,1,0
140366,electrocardiographic,1,1
140367,QT,1,1
140368,prolongation,1,1
140369,.,1,0
140370,Both,1,0
140371,groups,0,0
140372,showed,0,0
140373,modest,0,0
140374,to,0,0
140375,moderate,0,0
140376,improvement,0,1
140377,",",0,0
140378,but,0,0
140379,differences,0,0
140380,between,0,0
140381,groups,0,0
140382,were,0,0
140383,negligible,0,0
140384,.,0,0
140385,On,0,0
140386,the,0,0
140387,primary,0,0
140388,outcome,0,1
140389,measure,0,0
140390,",",0,0
140391,the,0,0
140392,Ohio,1,0
140393,Autism,1,1
140394,Clinical,1,1
140395,Impressions,1,1
140396,Scale,1,1
140397,",",1,0
140398,90,1,0
140399,%,0,0
140400,of,0,0
140401,the,0,0
140402,active,0,0
140403,treatment,0,0
140404,group,0,0
140405,showed,0,0
140406,improvement,0,1
140407,at,0,0
140408,some,0,0
140409,point,0,0
140410,(,0,0
140411,but,0,0
140412,only,0,0
140413,40,0,0
140414,%,0,0
140415,sustained,0,0
140416,it,0,0
140417,),0,0
140418,",",0,0
140419,compared,0,0
140420,with,0,0
140421,62,0,0
140422,%,0,0
140423,on,0,0
140424,placebo,0,0
140425,.,0,0
140426,Of,0,0
140427,the,0,0
140428,four,0,0
140429,in,0,0
140430,active,0,0
140431,treatment,0,0
140432,that,0,0
140433,sustained,0,1
140434,improvement,0,1
140435,",",0,0
140436,three,0,0
140437,had,0,0
140438,a,0,0
140439,maximum,0,1
140440,dose,0,0
140441,of,0,0
140442,0.13-0.15,0,0
140443,mg/kg/day,0,0
140444,",",0,0
140445,while,0,0
140446,those,0,0
140447,who,0,0
140448,regressed,0,0
140449,had,0,0
140450,doses,0,0
140451,?0.18,0,0
140452,mg/kg/day,0,0
140453,.,0,0
140454,Graphed,0,1
140455,means,0,0
140456,suggested,0,0
140457,better,0,0
140458,outcome,0,1
140459,with,0,0
140460,lower,0,0
140461,mg/kg,0,0
140462,and,0,1
140463,longer,0,1
140464,medication,0,1
140465,duration,0,1
140466,.,0,0
140467,Four,0,0
140468,parents,0,0
140469,spontaneously,0,0
140470,reported,0,0
140471,reduced,1,0
140472,hyperactivity,1,1
140473,and,1,1
140474,irritability,1,1
140475,and,1,1
140476,better,1,0
140477,verbalization,1,1
140478,and,1,1
140479,continued,0,0
140480,mecamylamine,0,0
140481,at,0,0
140482,their,0,0
140483,own,0,0
140484,expense,0,0
140485,.,0,0
140486,CONCLUSION,0,0
140487,Mecamylamine,0,0
140488,appeared,0,0
140489,to,0,0
140490,be,0,0
140491,safe,0,1
140492,",",0,0
140493,but,0,0
140494,not,0,0
140495,very,0,0
140496,effective,1,0
140497,in,1,0
140498,autism,1,0
140499,.,1,0
140500,The,1,0
140501,suggestion,0,0
140502,of,0,0
140503,better,0,0
140504,results,0,0
140505,at,0,0
140506,lower,0,0
140507,doses,0,0
140508,and,0,1
140509,longer,0,0
140510,exposure,0,1
140511,warrants,0,0
140512,consideration,0,0
140513,for,0,0
140514,future,0,0
140515,trials,0,0
140516,.,0,0
140517,The,0,0
140518,next,0,0
140519,step,0,0
140520,would,0,0
140521,be,0,0
140522,exploration,0,0
140523,of,0,0
140524,a,0,0
140525,more,0,0
140526,specific,0,0
140527,?4?2,0,1
140528,nAChR,0,0
140529,agonist,0,0
140530,",",0,0
140531,such,0,0
140532,as,0,0
140533,varenicline,0,0
140534,.,0,0
140535,Spotty,0,0
140536,calcification,0,1
140537,as,0,0
140538,a,0,0
140539,marker,0,1
140540,of,0,0
140541,accelerated,0,1
140542,progression,1,1
140543,of,1,0
140544,coronary,1,0
140545,atherosclerosis,1,0
140546,:,1,0
140547,insights,0,0
140548,from,0,0
140549,serial,0,0
140550,intravascular,0,0
140551,ultrasound,0,1
140552,.,0,0
140553,OBJECTIVES,0,0
140554,The,0,0
140555,purpose,0,0
140556,of,0,0
140557,this,0,0
140558,study,0,0
140559,was,0,0
140560,to,0,0
140561,determine,0,0
140562,atheroma,1,1
140563,progression,1,1
140564,in,0,0
140565,patients,0,0
140566,with,0,0
140567,spotty,0,1
140568,calcification,0,1
140569,.,0,0
140570,BACKGROUND,0,0
140571,Although,0,0
140572,extensively,0,0
140573,calcified,0,0
140574,atherosclerotic,0,0
140575,lesions,0,0
140576,have,0,0
140577,been,0,0
140578,proposed,0,0
140579,to,0,0
140580,be,0,0
140581,clinically,0,0
140582,quiescent,0,0
140583,",",0,0
140584,the,0,0
140585,presence,0,0
140586,of,0,0
140587,spotty,0,1
140588,calcification,0,1
140589,within,0,0
140590,plaque,0,0
140591,has,0,0
140592,been,0,0
140593,reported,0,0
140594,to,0,0
140595,be,0,0
140596,associated,0,0
140597,with,0,0
140598,an,0,0
140599,increased,0,0
140600,incidence,0,1
140601,of,0,0
140602,ischemic,0,0
140603,cardiovascular,0,1
140604,events,0,1
140605,.,0,0
140606,The,0,0
140607,relationship,0,0
140608,between,0,0
140609,spotty,0,1
140610,calcification,0,1
140611,and,0,1
140612,disease,1,1
140613,progression,1,1
140614,has,0,0
140615,not,0,0
140616,been,0,0
140617,investigated,0,0
140618,.,0,0
140619,METHODS,0,0
140620,A,0,0
140621,total,0,1
140622,of,0,0
140623,"1,347",0,0
140624,stable,0,0
140625,patients,0,0
140626,with,0,0
140627,angiographic,0,1
140628,coronary,0,0
140629,artery,0,0
140630,disease,0,1
140631,underwent,0,0
140632,serial,0,0
140633,evaluation,0,0
140634,of,0,0
140635,atheroma,1,1
140636,burden,1,1
140637,with,0,0
140638,intravascular,0,1
140639,ultrasound,0,1
140640,imaging,0,0
140641,.,0,0
140642,Patients,0,0
140643,with,0,0
140644,spotty,0,1
140645,calcification,0,1
140646,were,0,0
140647,identified,0,0
140648,based,0,0
140649,on,0,0
140650,the,0,0
140651,presence,0,0
140652,of,0,0
140653,lesions,0,1
140654,(,0,0
140655,1,0,0
140656,to,0,0
140657,4,0,0
140658,mm,0,0
140659,in,0,0
140660,length,0,1
140661,),0,0
140662,containing,0,0
140663,an,0,0
140664,arc,0,0
140665,of,0,0
140666,calcification,0,1
140667,of,0,0
140668,<,0,0
140669,90?,0,0
140670,.,0,0
140671,Clinical,1,0
140672,characteristics,1,1
140673,and,1,1
140674,disease,1,1
140675,progression,1,1
140676,were,0,0
140677,compared,0,0
140678,between,0,0
140679,patients,0,0
140680,with,0,0
140681,spotty,0,1
140682,calcification,0,1
140683,(,0,0
140684,n,0,0
140685,=,0,0
140686,922,0,0
140687,),0,0
140688,and,0,0
140689,those,0,0
140690,with,0,0
140691,no,0,0
140692,calcification,0,1
140693,(,0,0
140694,n,0,0
140695,=,0,0
140696,425,0,0
140697,),0,0
140698,.,0,0
140699,RESULTS,0,0
140700,Patients,0,0
140701,with,1,0
140702,spotty,1,1
140703,calcification,1,1
140704,were,1,0
140705,older,1,0
140706,(,0,0
140707,age,0,0
140708,56,0,0
140709,years,0,0
140710,vs.,0,0
140711,54,0,0
140712,years,0,0
140713,;,0,0
140714,p,0,0
140715,=,0,0
140716,0.001,0,0
140717,),0,0
140718,",",0,0
140719,more,0,0
140720,likely,0,0
140721,to,0,0
140722,be,0,0
140723,male,0,0
140724,(,0,0
140725,68,0,0
140726,%,0,0
140727,vs.,0,0
140728,54,0,0
140729,%,0,0
140730,;,0,0
140731,p,0,0
140732,=,0,0
140733,0.01,0,0
140734,),0,0
140735,",",0,0
140736,and,0,0
140737,have,0,0
140738,a,0,0
140739,history,1,0
140740,of,1,0
140741,diabetes,1,0
140742,mellitus,1,0
140743,(,0,0
140744,30,0,0
140745,%,0,0
140746,vs.,0,0
140747,24,0,0
140748,%,0,0
140749,;,0,0
140750,p,0,0
140751,=,0,0
140752,0.01,0,0
140753,),0,0
140754,and,1,0
140755,myocardial,1,1
140756,infarction,1,1
140757,(,0,0
140758,28,0,0
140759,%,0,0
140760,vs.,0,0
140761,20,0,0
140762,%,0,0
140763,;,0,0
140764,p,0,0
140765,=,0,0
140766,0.004,0,0
140767,),0,0
140768,",",0,0
140769,and,0,0
140770,have,0,0
140771,lower,1,0
140772,on-treatment,1,1
140773,high-density,1,1
140774,lipoprotein,1,1
140775,cholesterol,1,1
140776,levels,1,1
140777,(,0,0
140778,48,0,0
140779,?,0,0
140780,16,0,0
140781,mg/dl,0,0
140782,vs.,0,0
140783,51,0,0
140784,?,0,0
140785,17,0,0
140786,mg/dl,0,0
140787,;,0,0
140788,p,0,0
140789,=,0,0
140790,0.001,0,0
140791,),0,0
140792,.,0,0
140793,Patients,0,0
140794,with,0,0
140795,spotty,0,1
140796,calcification,0,1
140797,demonstrated,0,0
140798,a,0,0
140799,greater,1,0
140800,percent,1,1
140801,atheroma,1,1
140802,volume,1,1
140803,(,1,0
140804,PAV,1,1
140805,),1,0
140806,(,1,0
140807,36.0,1,0
140808,?,0,0
140809,7.6,0,0
140810,%,0,0
140811,vs.,0,0
140812,29.0,0,0
140813,?,0,0
140814,8.5,0,0
140815,%,0,0
140816,;,0,0
140817,p,0,0
140818,<,0,0
140819,0.001,0,0
140820,),1,0
140821,and,1,0
140822,total,1,1
140823,atheroma,1,1
140824,volume,1,1
140825,(,1,0
140826,174.6,1,0
140827,?,0,0
140828,71.9,0,0
140829,mm,0,0
140830,(,0,0
140831,3,0,0
140832,),0,0
140833,vs.,0,0
140834,133.9,0,0
140835,?,0,0
140836,64.9,0,0
140837,mm,0,0
140838,(,0,0
140839,3,0,0
140840,),0,0
140841,;,0,0
140842,p,0,0
140843,<,0,0
140844,0.001,0,0
140845,),0,0
140846,.,0,0
140847,On,0,0
140848,serial,0,1
140849,evaluation,0,0
140850,",",0,0
140851,spotty,0,1
140852,calcification,0,1
140853,was,0,0
140854,associated,1,0
140855,with,1,0
140856,greater,1,0
140857,progression,1,1
140858,of,1,1
140859,PAV,1,1
140860,(,0,0
140861,+0.43,0,0
140862,?,0,0
140863,0.07,0,0
140864,%,0,0
140865,vs.,0,0
140866,+0.02,0,0
140867,?,0,0
140868,0.11,0,0
140869,%,0,0
140870,;,0,0
140871,p,0,0
140872,=,0,0
140873,0.002,0,0
140874,),0,0
140875,.,0,0
140876,Although,0,0
140877,intensive,0,0
140878,low-density,0,1
140879,lipoprotein,0,1
140880,cholesterol,0,1
140881,and,0,1
140882,blood,0,1
140883,pressure,0,1
140884,lowering,0,1
140885,therapy,0,0
140886,slowed,0,0
140887,disease,0,1
140888,progression,0,1
140889,",",0,0
140890,these,0,0
140891,efficacies,0,1
140892,were,0,0
140893,attenuated,0,0
140894,in,0,0
140895,patients,0,0
140896,with,0,0
140897,spotty,0,1
140898,calcification,0,0
140899,.,0,0
140900,CONCLUSIONS,0,0
140901,The,0,0
140902,presence,0,0
140903,of,0,0
140904,spotty,0,1
140905,calcification,0,1
140906,is,0,0
140907,associated,0,0
140908,with,0,0
140909,more,0,0
140910,extensive,0,0
140911,and,0,0
140912,diffuse,1,1
140913,coronary,1,1
140914,atherosclerosis,1,1
140915,and,1,0
140916,accelerated,1,1
140917,disease,0,1
140918,progression,0,1
140919,despite,0,0
140920,use,0,0
140921,of,0,0
140922,medical,0,0
140923,therapies,0,0
140924,.,0,0
140925,The,0,0
140926,Coping,0,1
140927,Cat,0,1
140928,program,0,0
140929,for,0,0
140930,children,0,0
140931,with,0,0
140932,anxiety,0,1
140933,and,0,1
140934,autism,0,0
140935,spectrum,0,0
140936,disorder,0,0
140937,:,0,0
140938,a,0,0
140939,pilot,0,0
140940,randomized,0,0
140941,controlled,0,0
140942,trial,0,0
140943,.,0,0
140944,The,0,0
140945,purpose,0,0
140946,of,0,0
140947,this,0,0
140948,pilot,0,0
140949,study,0,0
140950,was,0,0
140951,to,0,0
140952,evaluate,0,0
140953,whether,0,0
140954,a,0,0
140955,modified,0,0
140956,version,0,0
140957,of,0,0
140958,the,0,0
140959,Coping,0,1
140960,Cat,0,0
140961,program,0,0
140962,could,0,0
140963,be,0,0
140964,effective,0,0
140965,in,0,0
140966,reducing,0,0
140967,anxiety,1,1
140968,in,0,0
140969,children,0,0
140970,with,0,0
140971,autism,0,0
140972,spectrum,0,0
140973,disorder,0,0
140974,(,0,0
140975,ASD,0,0
140976,),0,0
140977,.,0,0
140978,Twenty-two,0,0
140979,children,0,0
140980,(,0,0
140981,ages,0,0
140982,8-14,0,0
140983,;,0,0
140984,IQ,0,0
140985,?,0,0
140986,70,0,0
140987,),0,0
140988,with,0,0
140989,ASD,0,0
140990,and,0,0
140991,clinically,0,1
140992,significant,0,0
140993,anxiety,0,1
140994,were,0,0
140995,randomly,0,0
140996,assigned,0,0
140997,to,0,0
140998,16,0,0
140999,sessions,0,0
141000,of,0,0
141001,the,0,0
141002,Coping,0,1
141003,Cat,0,1
141004,program,0,0
141005,(,0,0
141006,cognitive-behavioral,0,0
141007,therapy,0,0
141008,;,0,0
141009,CBT,0,0
141010,),0,0
141011,or,0,0
141012,a,0,0
141013,16-week,0,0
141014,waitlist,0,0
141015,.,0,0
141016,Children,0,0
141017,in,0,0
141018,the,0,0
141019,CBT,0,0
141020,condition,0,0
141021,evidenced,0,0
141022,significantly,0,0
141023,larger,0,0
141024,reductions,1,1
141025,in,1,0
141026,anxiety,1,1
141027,than,1,0
141028,those,0,0
141029,in,0,0
141030,the,0,0
141031,waitlist,0,0
141032,.,0,0
141033,Treatment,0,0
141034,gains,0,1
141035,were,0,0
141036,largely,0,0
141037,maintained,0,0
141038,at,0,0
141039,two-month,0,0
141040,follow-up,0,0
141041,.,0,0
141042,Results,0,0
141043,provide,0,0
141044,preliminary,0,0
141045,evidence,0,0
141046,that,0,0
141047,a,0,0
141048,modified,0,0
141049,version,0,0
141050,of,0,0
141051,the,0,0
141052,Coping,0,1
141053,Cat,0,0
141054,program,0,0
141055,may,0,0
141056,be,0,0
141057,a,0,0
141058,feasible,0,0
141059,and,0,0
141060,effective,0,1
141061,program,0,0
141062,for,0,0
141063,reducing,0,0
141064,clinically,0,0
141065,significant,0,0
141066,levels,1,1
141067,of,1,0
141068,anxiety,1,1
141069,in,1,0
141070,children,0,0
141071,with,0,0
141072,high-functioning,0,0
141073,ASD,0,0
141074,.,0,0
141075,Ambient,0,0
141076,temperature,0,1
141077,and,0,0
141078,biomarkers,0,1
141079,of,0,1
141080,heart,0,0
141081,failure,0,0
141082,:,0,0
141083,a,0,0
141084,repeated,0,0
141085,measures,0,0
141086,analysis,0,0
141087,.,0,0
141088,BACKGROUND,0,0
141089,Extreme,0,0
141090,temperatures,0,0
141091,have,0,0
141092,been,0,0
141093,associated,0,0
141094,with,0,0
141095,hospitalization,0,1
141096,and,0,1
141097,death,0,1
141098,among,0,0
141099,individuals,0,0
141100,with,0,0
141101,heart,0,1
141102,failure,0,1
141103,",",0,0
141104,but,0,0
141105,few,0,0
141106,studies,0,0
141107,have,0,0
141108,explored,0,0
141109,the,0,0
141110,underlying,0,0
141111,mechanisms,0,0
141112,.,0,0
141113,OBJECTIVES,0,0
141114,We,0,0
141115,hypothesized,0,0
141116,that,0,0
141117,outdoor,0,1
141118,temperature,0,1
141119,in,0,0
141120,the,0,0
141121,Boston,0,0
141122,",",0,0
141123,Massachusetts,0,0
141124,",",0,1
141125,area,0,1
141126,(,0,0
141127,1-,0,0
141128,to,0,0
141129,4-day,0,0
141130,moving,0,0
141131,averages,0,0
141132,),0,0
141133,would,0,0
141134,be,0,0
141135,associated,0,0
141136,with,0,0
141137,higher,1,0
141138,levels,1,1
141139,of,1,1
141140,biomarkers,1,0
141141,of,1,0
141142,inflammation,1,1
141143,and,0,0
141144,myocyte,1,1
141145,injury,1,0
141146,in,0,0
141147,a,0,0
141148,repeated-measures,0,0
141149,study,0,0
141150,of,0,0
141151,individuals,0,0
141152,with,0,0
141153,stable,0,1
141154,heart,0,0
141155,failure,0,1
141156,.,0,0
141157,METHODS,0,0
141158,We,0,0
141159,analyzed,0,0
141160,data,0,0
141161,from,0,0
141162,a,0,0
141163,completed,0,0
141164,clinical,0,0
141165,trial,0,0
141166,that,0,0
141167,randomized,0,0
141168,100,0,0
141169,patients,0,0
141170,to,0,0
141171,12,0,0
141172,weeks,0,0
141173,of,0,0
141174,tai,0,0
141175,chi,0,0
141176,classes,0,1
141177,or,0,0
141178,to,0,0
141179,time-matched,0,0
141180,education,0,0
141181,control,0,0
141182,.,0,0
141183,B-type,1,0
141184,natriuretic,1,1
141185,peptide,1,1
141186,(,1,0
141187,BNP,1,1
141188,),1,0
141189,",",1,0
141190,C-reactive,1,1
141191,protein,1,1
141192,(,1,0
141193,CRP,1,1
141194,),1,1
141195,",",1,0
141196,and,1,1
141197,tumor,1,1
141198,necrosis,1,1
141199,factor,1,1
141200,(,1,0
141201,TNF,1,0
141202,),1,0
141203,were,0,0
141204,measured,0,0
141205,at,0,0
141206,baseline,0,0
141207,",",0,0
141208,6,0,0
141209,weeks,0,0
141210,",",0,0
141211,and,0,0
141212,12,0,0
141213,weeks,0,0
141214,.,0,0
141215,Endothelin-1,1,1
141216,was,0,0
141217,measured,0,0
141218,at,0,0
141219,baseline,0,0
141220,and,0,0
141221,12,0,0
141222,weeks,0,0
141223,.,0,0
141224,We,0,0
141225,used,0,0
141226,fixed,0,0
141227,effects,0,0
141228,models,0,0
141229,to,0,0
141230,evaluate,0,0
141231,associations,0,0
141232,with,0,0
141233,measures,0,1
141234,of,0,0
141235,temperature,0,1
141236,that,0,0
141237,were,0,0
141238,adjusted,0,0
141239,for,0,0
141240,time-varying,0,0
141241,covariates,0,0
141242,.,0,0
141243,RESULTS,0,0
141244,Higher,0,0
141245,apparent,0,1
141246,temperature,0,1
141247,was,0,0
141248,associated,0,0
141249,with,0,0
141250,higher,0,0
141251,levels,0,1
141252,of,0,1
141253,BNP,1,0
141254,beginning,0,0
141255,with,0,0
141256,2-day,0,0
141257,moving,0,0
141258,averages,0,1
141259,and,0,0
141260,reached,0,0
141261,statistical,0,1
141262,significance,0,1
141263,for,0,0
141264,3-,0,0
141265,and,0,0
141266,4-day,0,1
141267,moving,0,0
141268,averages,0,0
141269,.,0,0
141270,CRP,1,1
141271,results,0,0
141272,followed,0,0
141273,a,0,0
141274,similar,0,0
141275,pattern,0,0
141276,but,0,0
141277,were,0,0
141278,delayed,0,0
141279,by,0,0
141280,1,0,0
141281,day,0,0
141282,.,0,0
141283,A,0,0
141284,5?C,0,0
141285,change,0,0
141286,in,0,0
141287,3-,0,0
141288,and,0,0
141289,4-day,0,1
141290,moving,0,0
141291,averages,0,0
141292,of,0,0
141293,apparent,1,0
141294,temperature,1,1
141295,was,0,0
141296,associated,0,0
141297,with,0,0
141298,11.3,0,0
141299,%,0,0
141300,[,0,0
141301,95,0,0
141302,%,0,0
141303,confidence,0,0
141304,interval,0,0
141305,(,0,0
141306,CI,0,0
141307,),0,0
141308,:,0,0
141309,1.1,0,0
141310,",",0,0
141311,22.5,0,0
141312,;,0,0
141313,p,0,0
141314,=,0,0
141315,0.03,0,0
141316,),0,0
141317,and,0,0
141318,11.4,0,0
141319,%,0,0
141320,(,0,0
141321,95,0,0
141322,%,0,0
141323,CI,0,0
141324,:,0,0
141325,1.2,0,0
141326,",",0,0
141327,22.5,0,0
141328,;,0,0
141329,p,0,0
141330,=,0,0
141331,0.03,0,0
141332,),0,0
141333,higher,1,0
141334,BNP,1,0
141335,.,1,0
141336,A,0,0
141337,5?C,0,0
141338,change,0,0
141339,in,0,0
141340,the,0,0
141341,4-day,0,0
141342,moving,0,0
141343,average,0,0
141344,of,0,0
141345,apparent,1,1
141346,temperature,1,1
141347,was,1,0
141348,associated,0,0
141349,with,0,0
141350,21.6,0,0
141351,%,0,0
141352,(,0,0
141353,95,0,0
141354,%,0,0
141355,CI,0,0
141356,:,0,0
141357,2.5,0,0
141358,",",0,0
141359,44.2,0,0
141360,;,0,0
141361,p,0,0
141362,=,0,0
141363,0.03,0,0
141364,),0,0
141365,higher,0,0
141366,CRP,1,0
141367,.,1,0
141368,No,0,0
141369,clear,0,0
141370,associations,0,0
141371,with,1,0
141372,TNF,1,0
141373,or,1,0
141374,endothelin-1,1,1
141375,were,1,0
141376,observed,0,0
141377,.,0,0
141378,CONCLUSIONS,0,0
141379,Among,0,0
141380,patients,0,0
141381,undergoing,0,0
141382,treatment,0,0
141383,for,0,0
141384,heart,0,1
141385,failure,0,1
141386,",",0,0
141387,we,0,0
141388,observed,0,0
141389,positive,0,0
141390,associations,0,0
141391,between,1,0
141392,temperature,1,1
141393,and,1,0
141394,both,1,0
141395,BNP,1,1
141396,and,1,0
141397,CRP-predictors,1,1
141398,of,1,1
141399,heart,1,1
141400,failure,1,1
141401,prognosis,1,1
141402,and,1,0
141403,severity,1,1
141404,.,1,0
141405,Controlled-release,0,0
141406,melatonin,0,0
141407,",",0,0
141408,singly,0,0
141409,and,0,0
141410,combined,0,0
141411,with,0,0
141412,cognitive,0,1
141413,behavioural,0,0
141414,therapy,0,0
141415,",",0,0
141416,for,0,0
141417,persistent,0,0
141418,insomnia,1,1
141419,in,0,0
141420,children,0,0
141421,with,0,0
141422,autism,0,0
141423,spectrum,0,0
141424,disorders,0,0
141425,:,0,0
141426,a,0,0
141427,randomized,0,0
141428,placebo-controlled,0,0
141429,trial,0,0
141430,.,0,0
141431,Although,0,0
141432,melatonin,0,0
141433,and,0,0
141434,cognitive-behavioural,0,0
141435,therapy,0,0
141436,have,0,0
141437,shown,0,0
141438,efficacy,0,1
141439,in,0,0
141440,treating,0,0
141441,sleep,0,1
141442,disorders,0,0
141443,in,0,0
141444,children,0,0
141445,with,0,0
141446,autism,0,0
141447,spectrum,0,0
141448,disorders,0,0
141449,",",0,0
141450,little,0,0
141451,is,0,0
141452,known,0,0
141453,about,0,0
141454,their,0,0
141455,relative,0,0
141456,or,0,0
141457,combined,0,0
141458,efficacy,0,1
141459,.,0,0
141460,One,0,0
141461,hundred,0,0
141462,and,0,0
141463,sixty,0,0
141464,children,0,0
141465,with,0,0
141466,autism,0,0
141467,spectrum,0,0
141468,disorders,0,0
141469,",",0,0
141470,aged,0,0
141471,4-10,0,0
141472,years,0,0
141473,",",0,0
141474,suffering,0,0
141475,from,0,0
141476,sleep,0,1
141477,onset,0,1
141478,insomnia,0,1
141479,and,0,1
141480,impaired,0,1
141481,sleep,0,1
141482,maintenance,0,0
141483,",",0,0
141484,were,0,0
141485,assigned,0,0
141486,randomly,0,0
141487,to,0,0
141488,either,0,0
141489,(,0,0
141490,1,0,0
141491,),0,0
141492,combination,0,0
141493,of,0,0
141494,controlled-release,0,0
141495,melatonin,0,0
141496,and,0,0
141497,cognitive-behavioural,0,0
141498,therapy,0,0
141499,;,0,0
141500,(,0,0
141501,2,0,0
141502,),0,0
141503,controlled-release,0,0
141504,melatonin,0,0
141505,;,0,0
141506,(,0,0
141507,3,0,0
141508,),0,0
141509,four,0,0
141510,sessions,0,0
141511,of,0,0
141512,cognitive-behavioural,0,0
141513,therapy,0,0
141514,;,0,0
141515,or,0,0
141516,(,0,0
141517,4,0,0
141518,),0,0
141519,placebo,0,0
141520,drug,0,0
141521,treatment,0,0
141522,condition,0,0
141523,for,0,0
141524,12,0,0
141525,weeks,0,0
141526,in,0,0
141527,a,0,0
141528,1,0,0
141529,:,0,0
141530,1,0,0
141531,:,0,0
141532,1,0,0
141533,:,0,0
141534,1,0,0
141535,ratio,0,0
141536,.,0,0
141537,Children,0,0
141538,were,0,0
141539,studied,0,0
141540,at,0,0
141541,baseline,0,0
141542,and,0,0
141543,after,0,0
141544,12,0,0
141545,weeks,0,0
141546,of,0,0
141547,treatment,0,0
141548,.,0,0
141549,Treatment,0,0
141550,response,0,1
141551,was,0,0
141552,assessed,0,0
141553,with,0,0
141554,1-week,0,0
141555,actigraphic,0,1
141556,monitoring,0,0
141557,",",0,0
141558,sleep,0,1
141559,diary,0,1
141560,and,0,0
141561,sleep,0,1
141562,questionnaire,0,1
141563,.,0,0
141564,Main,0,0
141565,outcome,0,1
141566,measures,0,1
141567,",",0,0
141568,derived,0,0
141569,actigraphically,0,1
141570,",",0,0
141571,were,0,0
141572,sleep,1,1
141573,latency,1,1
141574,",",1,0
141575,total,1,1
141576,sleep,1,1
141577,time,1,1
141578,",",1,0
141579,wake,1,0
141580,after,1,0
141581,sleep,1,1
141582,onset,1,1
141583,and,1,1
141584,number,1,1
141585,of,1,0
141586,awakenings,1,1
141587,.,1,0
141588,The,0,0
141589,active,0,0
141590,treatment,0,0
141591,groups,0,0
141592,all,0,0
141593,resulted,0,0
141594,in,0,0
141595,improvements,0,1
141596,across,0,0
141597,all,0,0
141598,outcome,0,1
141599,measures,0,1
141600,",",0,0
141601,with,0,0
141602,moderate-to-large,0,0
141603,effect,0,0
141604,sizes,0,1
141605,from,0,0
141606,baseline,0,0
141607,to,0,0
141608,a,0,0
141609,12-week,0,0
141610,assessment,0,0
141611,.,0,0
141612,Melatonin,0,1
141613,treatment,0,0
141614,was,0,0
141615,mainly,0,0
141616,effective,0,0
141617,in,0,0
141618,reducing,0,0
141619,insomnia,1,1
141620,symptoms,1,1
141621,",",0,0
141622,while,0,0
141623,cognitive-behavioural,0,0
141624,therapy,0,0
141625,had,0,0
141626,a,0,0
141627,light,0,0
141628,positive,0,0
141629,impact,0,0
141630,mainly,0,0
141631,on,0,0
141632,sleep,1,1
141633,latency,1,1
141634,",",0,0
141635,suggesting,0,0
141636,that,0,0
141637,some,0,0
141638,behavioural,0,0
141639,aspects,0,0
141640,might,0,0
141641,play,0,0
141642,a,0,0
141643,role,0,0
141644,in,0,0
141645,determining,0,0
141646,initial,1,0
141647,insomnia,1,1
141648,.,1,0
141649,The,0,0
141650,combination,0,0
141651,treatment,0,0
141652,group,0,0
141653,showed,0,0
141654,a,0,0
141655,trend,0,0
141656,to,0,0
141657,outperform,0,0
141658,other,0,0
141659,active,0,0
141660,treatment,0,0
141661,groups,0,0
141662,",",0,0
141663,with,0,0
141664,fewer,0,1
141665,dropouts,0,0
141666,and,0,0
141667,a,0,0
141668,greater,0,0
141669,proportion,0,1
141670,of,0,1
141671,treatment,0,0
141672,responders,0,0
141673,achieving,0,0
141674,clinically,0,0
141675,significant,0,0
141676,changes,0,1
141677,(,0,0
141678,63.38,0,0
141679,%,0,0
141680,normative,0,0
141681,sleep,0,1
141682,efficiency,0,1
141683,criterion,0,1
141684,of,0,0
141685,>,0,0
141686,85,0,0
141687,%,0,0
141688,and,0,0
141689,84.62,0,0
141690,%,0,0
141691,",",0,0
141692,sleep,0,1
141693,onset,0,1
141694,latency,0,1
141695,<,0,0
141696,30,0,0
141697,min,0,0
141698,),0,0
141699,.,0,0
141700,This,0,0
141701,study,0,0
141702,demonstrates,0,0
141703,that,0,0
141704,adding,0,0
141705,behavioural,0,0
141706,intervention,0,0
141707,to,0,0
141708,melatonin,0,0
141709,treatment,0,0
141710,seems,0,0
141711,to,0,0
141712,result,0,0
141713,in,0,0
141714,a,0,0
141715,better,0,0
141716,treatment,0,0
141717,response,0,1
141718,",",0,0
141719,at,0,0
141720,least,0,0
141721,in,0,0
141722,the,0,0
141723,short,0,0
141724,term,0,0
141725,.,0,0
141726,Can,0,0
141727,simvastatin,0,0
141728,improve,0,0
141729,erectile,1,1
141730,function,1,1
141731,and,0,0
141732,health-related,1,1
141733,quality,1,1
141734,of,1,0
141735,life,1,1
141736,in,0,0
141737,men,0,0
141738,aged,0,0
141739,?40,0,0
141740,years,0,0
141741,with,0,0
141742,erectile,0,1
141743,dysfunction,0,0
141744,?,0,0
141745,Results,0,0
141746,of,0,0
141747,the,0,0
141748,Erectile,0,0
141749,Dysfunction,0,1
141750,and,0,0
141751,Statins,0,1
141752,Trial,0,0
141753,[,0,0
141754,ISRCTN66772971,0,0
141755,],0,0
141756,.,0,0
141757,OBJECTIVE,0,0
141758,To,0,0
141759,evaluate,0,0
141760,the,1,0
141761,effectiveness,1,1
141762,and,1,0
141763,cost-effectiveness,1,0
141764,of,1,1
141765,simvastatin,0,0
141766,on,0,0
141767,erectile,1,1
141768,function,1,1
141769,and,1,0
141770,health-related,1,1
141771,quality,1,1
141772,of,1,0
141773,life,1,1
141774,in,1,0
141775,men,0,0
141776,aged,0,0
141777,?40,0,0
141778,years,0,0
141779,with,0,0
141780,erectile,0,1
141781,dysfunction,0,1
141782,(,0,0
141783,ED,0,0
141784,),0,0
141785,.,0,0
141786,PATIENTS,0,0
141787,AND,0,0
141788,METHODS,0,0
141789,ED,0,0
141790,is,0,0
141791,common,0,0
141792,in,0,0
141793,men,0,0
141794,aged,0,0
141795,?40,0,0
141796,years,0,0
141797,and,0,0
141798,impacts,0,0
141799,upon,0,0
141800,their,0,0
141801,overall,0,1
141802,health-related,0,1
141803,quality,0,1
141804,of,0,0
141805,life,0,1
141806,and,0,0
141807,that,0,0
141808,of,0,0
141809,their,0,0
141810,partners,0,0
141811,.,0,0
141812,Men,0,0
141813,aged,0,0
141814,?40,0,0
141815,years,0,0
141816,who,0,0
141817,were,0,0
141818,not,0,0
141819,receiving,0,0
141820,lipid,0,1
141821,lowering,0,1
141822,or,0,0
141823,anti-hypertensive,0,1
141824,medication,0,1
141825,and,0,0
141826,not,0,0
141827,at,0,0
141828,high,0,0
141829,cardiovascular,0,1
141830,risk,0,1
141831,were,0,0
141832,recruited,0,0
141833,from,0,0
141834,10,0,0
141835,general,0,0
141836,practices,0,0
141837,in,0,0
141838,the,0,0
141839,East,0,0
141840,of,0,0
141841,England,0,0
141842,.,0,0
141843,In,0,0
141844,total,0,1
141845,",",0,0
141846,173,0,0
141847,eligible,0,0
141848,men,0,0
141849,with,0,0
141850,untreated,0,0
141851,ED,0,0
141852,were,0,0
141853,randomized,0,0
141854,to,0,0
141855,double-blind,0,0
141856,treatment,0,0
141857,with,0,0
141858,40,0,0
141859,mg,0,0
141860,of,0,0
141861,simvastatin,0,0
141862,or,0,0
141863,placebo,0,0
141864,once,0,0
141865,daily,0,0
141866,for,0,0
141867,6,0,0
141868,months,0,0
141869,.,0,0
141870,Data,0,0
141871,were,0,0
141872,collected,0,0
141873,at,0,0
141874,three,0,0
141875,points,0,0
141876,over,0,0
141877,30,0,0
141878,weeks,0,0
141879,.,0,0
141880,The,0,0
141881,main,0,0
141882,outcome,0,1
141883,was,1,0
141884,erectile,1,1
141885,function,1,1
141886,(,1,0
141887,International,1,1
141888,Index,1,0
141889,of,1,0
141890,Erectile,1,0
141891,Function-5,1,1
141892,score,1,1
141893,),1,0
141894,.,1,0
141895,Secondary,0,0
141896,outcomes,0,1
141897,included,0,0
141898,male,1,0
141899,ED-specific,1,0
141900,quality,1,1
141901,of,1,0
141902,life,1,1
141903,(,1,0
141904,MED-QoL,1,0
141905,),1,0
141906,",",1,0
141907,quality-adjusted,1,1
141908,life,1,1
141909,years,1,0
141910,(,1,0
141911,QALYs,1,0
141912,),1,0
141913,using,1,0
141914,the,1,0
141915,generic,1,0
141916,Euroqol,1,1
141917,measure,1,0
141918,(,1,0
141919,EQ-5D,1,0
141920,),1,0
141921,",",1,0
141922,endothelial,1,1
141923,function,1,1
141924,",",1,0
141925,cardiovascular,1,1
141926,risk,1,1
141927,",",1,0
141928,cholesterol,1,1
141929,and,1,1
141930,health,1,1
141931,service,1,1
141932,costs,1,1
141933,.,1,0
141934,RESULTS,0,0
141935,There,0,0
141936,was,0,0
141937,no,0,0
141938,significant,0,0
141939,difference,1,0
141940,in,1,0
141941,erectile,1,1
141942,function,1,1
141943,between,1,0
141944,the,0,0
141945,simvastatin,0,0
141946,and,0,0
141947,placebo,0,0
141948,groups,0,0
141949,(,0,0
141950,mean,0,1
141951,change,0,0
141952,",",0,0
141953,1.28,0,0
141954,vs,0,0
141955,0.07,0,0
141956,",",0,0
141957,z,0,0
141958,=,0,0
141959,1.1,0,0
141960,",",0,0
141961,p,0,0
141962,=,0,0
141963,0.27,0,0
141964,),0,0
141965,",",0,0
141966,although,0,0
141967,a,0,0
141968,significant,0,0
141969,improvement,1,1
141970,in,1,0
141971,MED-QoL,1,0
141972,was,0,0
141973,observed,0,0
141974,(,0,0
141975,5,0,0
141976,%,0,0
141977,vs,0,0
141978,2,0,0
141979,%,0,0
141980,",",0,0
141981,z,0,0
141982,=,0,0
141983,2.09,0,0
141984,",",0,0
141985,p,0,0
141986,=,0,0
141987,0.04,0,0
141988,),0,0
141989,.,0,0
141990,Both,1,0
141991,10-year,1,1
141992,cardiovascular,1,1
141993,risk,1,1
141994,and,1,1
141995,low-density,1,1
141996,lipoprotein,1,1
141997,were,1,0
141998,reduced,1,0
141999,(,0,0
142000,cardiovascular,0,1
142001,risk,0,1
142002,",",0,0
142003,z,0,0
142004,=,0,0
142005,-3.67,0,0
142006,",",0,0
142007,p,0,0
142008,<,0,0
142009,0.001,0,0
142010,;,0,0
142011,low-density,0,0
142012,lipoprotein,0,1
142013,",",0,0
142014,z,0,0
142015,=,0,0
142016,-5.46,0,0
142017,",",0,0
142018,p,0,0
142019,<,0,0
142020,0.001,0,0
142021,),0,0
142022,",",0,0
142023,with,0,0
142024,no,0,0
142025,consistent,0,0
142026,change,0,0
142027,in,1,0
142028,endothelial,1,1
142029,function,1,1
142030,.,1,0
142031,The,1,0
142032,frequency,1,1
142033,of,1,0
142034,sexual,1,1
142035,encounters,1,0
142036,is,1,0
142037,correlated,1,0
142038,with,1,0
142039,improved,1,0
142040,erectile,1,1
142041,function,1,1
142042,.,1,0
142043,The,1,0
142044,joint,1,1
142045,distribution,1,0
142046,of,1,0
142047,costs,1,1
142048,and,1,0
142049,QALY,1,0
142050,benefits,1,0
142051,indicates,1,0
142052,that,0,0
142053,the,0,0
142054,probability,0,0
142055,of,0,0
142056,simvastatin,1,0
142057,being,1,0
142058,cost-effective,1,0
142059,for,1,0
142060,willingness-to-pay,1,0
142061,thresholds,0,1
142062,of,0,0
142063,"?20,000",0,0
142064,and,0,0
142065,"?30,000",0,0
142066,is,0,0
142067,86,0,0
142068,%,0,0
142069,and,0,0
142070,83,0,0
142071,%,0,0
142072,",",0,0
142073,respectively,0,0
142074,.,0,0
142075,CONCLUSIONS,0,0
142076,Identifying,0,0
142077,men,0,0
142078,with,0,0
142079,ED,0,0
142080,provides,0,0
142081,an,0,0
142082,opportunity,0,0
142083,to,0,0
142084,modify,0,0
142085,future,0,0
142086,cardiovascular,0,1
142087,risk,0,1
142088,and,0,0
142089,to,0,0
142090,improve,0,0
142091,MED-QoL,0,0
142092,by,0,0
142093,treating,0,0
142094,them,0,0
142095,with,0,0
142096,40,0,0
142097,mg,0,0
142098,of,0,0
142099,simvastatin,0,0
142100,.,0,0
142101,The,0,0
142102,joint,0,1
142103,analysis,0,0
142104,of,1,0
142105,costs,1,1
142106,and,0,0
142107,QALY,1,0
142108,benefits,1,0
142109,suggests,0,0
142110,that,0,0
142111,there,0,0
142112,is,0,0
142113,high,0,0
142114,probability,0,1
142115,that,0,0
142116,simvastatin,0,0
142117,is,0,0
142118,a,0,0
142119,cost-effective,0,0
142120,strategy,0,0
142121,in,0,0
142122,men,0,0
142123,with,0,0
142124,ED,0,0
142125,.,0,0
142126,The,0,0
142127,findings,0,0
142128,could,0,0
142129,influence,0,0
142130,urological,0,0
142131,and,0,0
142132,primary,0,0
142133,care,0,0
142134,practice,0,0
142135,by,0,0
142136,including,0,0
142137,questions,0,0
142138,on,0,0
142139,ED,0,0
142140,during,0,0
142141,routine,0,0
142142,consultations,0,0
142143,and,0,0
142144,relevant,0,0
142145,clinical,0,0
142146,protocols,0,0
142147,.,0,0
142148,This,0,0
142149,provides,0,0
142150,an,0,0
142151,opportunity,0,0
142152,to,0,0
142153,impart,0,0
142154,lifestyle,0,0
142155,advice,0,0
142156,.,0,0
142157,Effectiveness,0,1
142158,of,0,0
142159,web-based,0,0
142160,tailored,0,0
142161,smoking,0,0
142162,cessation,0,0
142163,advice,0,1
142164,reports,0,0
142165,(,0,0
142166,iQuit,0,0
142167,),0,0
142168,:,0,0
142169,a,0,0
142170,randomized,0,0
142171,trial,0,0
142172,.,0,0
142173,AIMS,0,0
142174,To,0,0
142175,determine,0,0
142176,whether,0,0
142177,web-based,0,0
142178,tailored,0,0
142179,cessation,0,0
142180,advice,0,0
142181,",",0,0
142182,based,0,0
142183,on,0,0
142184,social,0,1
142185,cognitive,0,1
142186,theory,0,0
142187,and,0,0
142188,the,0,0
142189,perspectives,0,0
142190,on,0,0
142191,change,0,1
142192,model,0,0
142193,",",0,0
142194,was,0,0
142195,more,0,0
142196,effective,0,1
142197,in,0,0
142198,aiding,0,0
142199,a,0,0
142200,quit,0,0
142201,attempt,0,0
142202,than,0,0
142203,broadly,0,0
142204,similar,0,0
142205,web-based,0,0
142206,advice,0,0
142207,that,0,0
142208,was,0,0
142209,not,0,0
142210,tailored,0,0
142211,.,0,0
142212,DESIGN,0,0
142213,Participants,0,0
142214,were,0,0
142215,allocated,0,0
142216,randomly,0,0
142217,to,0,0
142218,one,0,0
142219,of,0,0
142220,two,0,0
142221,groups,0,0
142222,",",0,0
142223,to,0,0
142224,receive,0,0
142225,either,0,0
142226,a,0,0
142227,cessation,0,0
142228,advice,0,1
142229,report,0,0
142230,and,0,1
142231,progress,0,1
142232,report,0,0
142233,that,0,0
142234,were,0,0
142235,tailored,0,0
142236,to,0,0
142237,individual-level,0,0
142238,characteristics,0,0
142239,or,0,0
142240,a,0,0
142241,cessation,0,0
142242,advice,0,0
142243,report,0,0
142244,that,0,0
142245,presented,0,0
142246,standardized,0,0
142247,(,0,0
142248,non-tailored,0,0
142249,),0,0
142250,content,0,1
142251,.,0,0
142252,Tailoring,0,0
142253,was,0,0
142254,based,0,0
142255,on,0,0
142256,smoking-related,0,0
142257,beliefs,0,1
142258,",",0,0
142259,personal,0,1
142260,characteristics,0,1
142261,and,0,1
142262,smoking,0,1
142263,patterns,0,1
142264,",",0,1
142265,self-efficacy,0,1
142266,and,0,1
142267,outcome,0,1
142268,expectations,0,0
142269,.,0,0
142270,SETTING,0,0
142271,Participant,0,0
142272,enrolment,0,0
142273,and,0,1
142274,baseline,0,1
142275,assessments,0,1
142276,were,0,0
142277,conducted,0,0
142278,remotely,0,0
142279,online,0,0
142280,via,0,0
142281,the,0,0
142282,study,0,0
142283,website,0,0
142284,",",0,0
142285,with,0,0
142286,the,0,0
142287,advice,0,0
142288,reports,0,0
142289,presented,0,0
142290,by,0,0
142291,the,0,0
142292,same,0,0
142293,website,0,0
142294,.,0,0
142295,PARTICIPANTS,0,0
142296,Participants,0,0
142297,(,0,0
142298,n,0,0
142299,=,0,0
142300,1758,0,0
142301,),0,0
142302,were,0,0
142303,visitors,0,0
142304,to,0,0
142305,the,0,0
142306,QUIT,0,0
142307,website,0,0
142308,who,0,0
142309,were,0,0
142310,based,0,0
142311,in,0,0
142312,the,0,0
142313,United,0,0
142314,Kingdom,0,0
142315,",",0,0
142316,aged,0,0
142317,18,0,0
142318,years,0,0
142319,or,0,0
142320,over,0,0
142321,and,0,0
142322,who,0,0
142323,smoked,0,1
142324,cigarettes,0,0
142325,or,0,0
142326,hand-rolled,0,0
142327,tobacco,0,0
142328,.,0,0
142329,MEASUREMENTS,0,0
142330,Follow-up,0,0
142331,assessments,0,0
142332,were,0,0
142333,made,0,0
142334,at,0,0
142335,6,0,0
142336,months,0,0
142337,by,0,0
142338,telephone,0,0
142339,interview,0,0
142340,.,0,0
142341,The,0,0
142342,primary,0,0
142343,outcome,0,1
142344,measure,0,0
142345,was,0,0
142346,self-reported,1,0
142347,3,1,0
142348,months,1,0
142349,prolonged,1,0
142350,abstinence,1,1
142351,",",1,0
142352,and,1,1
142353,secondary,0,1
142354,outcomes,0,1
142355,were,0,0
142356,1,1,0
142357,month,1,0
142358,prolonged,1,0
142359,abstinence,1,1
142360,",",1,1
142361,7-day,1,1
142362,and,1,1
142363,24-hour,1,1
142364,point,1,1
142365,prevalence,1,1
142366,abstinence,1,1
142367,.,1,0
142368,FINDINGS,1,0
142369,The,0,0
142370,intervention,0,0
142371,group,0,0
142372,did,0,0
142373,not,0,0
142374,differ,0,0
142375,from,0,0
142376,the,0,0
142377,control,0,0
142378,group,0,0
142379,on,0,0
142380,the,0,0
142381,primary,1,0
142382,outcome,1,0
142383,(,1,0
142384,9.1,1,0
142385,%,0,0
142386,versus,0,0
142387,9.3,0,0
142388,%,0,0
142389,;,0,0
142390,odds,0,0
142391,ratio,0,0
142392,=,0,0
142393,1.02,0,0
142394,95,0,0
142395,%,0,0
142396,confidence,0,0
142397,interval,0,0
142398,0.73-1.42,0,0
142399,),0,0
142400,or,0,0
142401,on,0,0
142402,any,0,0
142403,of,0,0
142404,the,1,0
142405,secondary,1,0
142406,outcomes,1,0
142407,.,1,0
142408,Intervention,1,0
142409,participants,0,0
142410,gave,0,0
142411,more,0,0
142412,positive,0,1
142413,evaluations,0,0
142414,of,0,0
142415,the,0,0
142416,materials,0,0
142417,than,0,0
142418,control,0,0
142419,participants,0,0
142420,.,0,0
142421,CONCLUSIONS,0,0
142422,A,0,0
142423,web-based,0,0
142424,intervention,0,0
142425,that,0,0
142426,tailored,0,0
142427,content,0,1
142428,according,0,0
142429,to,0,0
142430,smoking-related,0,0
142431,beliefs,0,1
142432,",",0,0
142433,personal,0,1
142434,characteristics,0,1
142435,and,0,1
142436,smoking,0,1
142437,patterns,0,1
142438,",",0,1
142439,self-efficacy,0,1
142440,and,0,1
142441,outcome,0,1
142442,expectations,0,1
142443,",",0,0
142444,was,0,0
142445,not,0,0
142446,more,0,0
142447,effective,0,1
142448,than,0,0
142449,web-based,0,0
142450,materials,0,0
142451,presenting,0,0
142452,broadly,0,0
142453,similar,0,0
142454,non-tailored,0,0
142455,information,0,0
142456,.,0,0
142457,The,0,0
142458,effects,1,0
142459,of,0,0
142460,different,0,0
142461,intensities,0,1
142462,and,0,0
142463,durations,0,0
142464,of,0,0
142465,the,0,0
142466,general,0,0
142467,warm-up,0,0
142468,on,1,0
142469,leg,1,1
142470,press,1,0
142471,1RM,1,0
142472,.,1,0
142473,The,0,0
142474,precision,0,0
142475,of,0,0
142476,maximum,0,1
142477,strength,0,1
142478,assessments,0,0
142479,(,0,0
142480,1,0,0
142481,repetition,0,0
142482,maximum,0,0
142483,;,0,0
142484,1RM,0,0
142485,),0,0
142486,is,0,0
142487,important,0,0
142488,to,0,0
142489,evaluate,0,0
142490,the,0,0
142491,functional,0,0
142492,capacity,0,1
142493,and,0,0
142494,to,0,0
142495,prescribe,0,0
142496,and,0,0
142497,monitor,0,0
142498,the,0,0
142499,training,0,0
142500,load,0,1
142501,.,0,0
142502,Several,0,0
142503,factors,0,0
142504,can,0,0
142505,affect,0,0
142506,the,0,0
142507,precision,0,0
142508,of,0,0
142509,1RM,0,0
142510,tests,0,0
142511,",",0,0
142512,including,0,0
142513,the,0,0
142514,warm-up,0,0
142515,procedure,0,0
142516,.,0,0
142517,General,0,1
142518,and,0,0
142519,specific,0,0
142520,warm-up,0,0
142521,routines,0,0
142522,are,0,0
142523,recommended,0,0
142524,to,0,0
142525,enhance,0,0
142526,performance,0,1
142527,.,0,0
142528,The,0,0
142529,effects,0,0
142530,of,0,0
142531,a,0,0
142532,specific,0,0
142533,warm-up,0,0
142534,have,0,0
142535,already,0,0
142536,been,0,0
142537,acknowledged,0,0
142538,in,0,0
142539,improving,0,0
142540,performance,0,1
142541,.,0,0
142542,However,0,0
142543,",",0,0
142544,the,0,0
142545,effects,0,0
142546,of,0,0
142547,a,0,0
142548,general,0,0
142549,warm-up,0,0
142550,(,0,0
142551,GWU,0,0
142552,),0,0
142553,are,0,0
142554,unclear,0,0
142555,but,0,0
142556,seem,0,0
142557,to,0,0
142558,depend,0,0
142559,on,0,0
142560,its,0,0
142561,ability,0,0
142562,to,0,0
142563,increase,0,0
142564,muscle,0,1
142565,temperature,0,1
142566,while,0,0
142567,avoiding,0,0
142568,fatigue,0,1
142569,.,0,0
142570,Furthermore,0,0
142571,",",0,0
142572,temperature,0,1
142573,elevation,0,1
142574,is,0,0
142575,dependent,0,0
142576,on,0,0
142577,both,0,0
142578,the,0,0
142579,duration,0,1
142580,and,0,0
142581,the,0,0
142582,intensity,0,0
142583,of,0,0
142584,the,0,0
142585,activity,0,1
142586,",",0,0
142587,which,0,0
142588,may,0,0
142589,eventually,0,0
142590,affect,0,0
142591,1RM,0,0
142592,performance,0,0
142593,.,0,0
142594,The,0,0
142595,objective,0,0
142596,of,0,0
142597,this,0,0
142598,study,0,0
142599,was,0,0
142600,to,0,0
142601,investigate,0,0
142602,the,0,0
142603,effect,1,0
142604,of,0,0
142605,different,0,0
142606,intensities,0,1
142607,and,0,0
142608,durations,0,1
142609,of,0,0
142610,GWU,0,0
142611,on,0,0
142612,1RM,0,0
142613,performance,0,0
142614,.,0,0
142615,Sixteen,0,0
142616,strength-trained,0,0
142617,men,0,0
142618,were,0,0
142619,tested,0,0
142620,for,0,0
142621,1RM,1,0
142622,leg,1,1
142623,press,1,0
142624,after,0,0
142625,4,0,0
142626,GWU,0,0
142627,conditions,0,0
142628,after,0,0
142629,specific,0,0
142630,warm-up,0,0
142631,:,0,0
142632,short,0,1
142633,duration,0,1
142634,and,0,0
142635,low,0,1
142636,intensity,0,1
142637,(,0,0
142638,SDLI,0,0
142639,;,0,0
142640,i.e.,0,0
142641,",",0,0
142642,5,0,0
142643,minutes,0,0
142644,at,0,0
142645,40,0,0
142646,%,0,0
142647,V,0,0
142648,[,0,0
142649,Combining,0,1
142650,Dot,0,1
142651,Above,0,1
142652,],0,0
142653,O2max,0,1
142654,),0,0
142655,",",0,0
142656,long,0,0
142657,duration,0,1
142658,and,0,0
142659,low,0,1
142660,intensity,0,1
142661,(,0,0
142662,LDLI,0,0
142663,;,0,0
142664,i.e.,0,0
142665,",",0,0
142666,15,0,0
142667,minutes,0,0
142668,at,0,0
142669,40,0,0
142670,%,0,0
142671,V,0,0
142672,[,0,0
142673,Combining,0,1
142674,Dot,0,1
142675,Above,0,1
142676,],0,0
142677,O2max,0,1
142678,),0,0
142679,",",0,0
142680,short,0,1
142681,duration,0,1
142682,and,0,0
142683,moderate,0,0
142684,intensity,0,1
142685,(,0,0
142686,SDMI,0,0
142687,;,0,0
142688,i.e.,0,0
142689,",",0,0
142690,5,0,0
142691,minutes,0,0
142692,at,0,0
142693,70,0,0
142694,%,0,0
142695,V,0,0
142696,[,0,0
142697,Combining,0,1
142698,Dot,0,1
142699,Above,0,1
142700,],0,0
142701,O2max,0,1
142702,),0,0
142703,",",0,0
142704,long,0,0
142705,duration,0,1
142706,and,0,0
142707,moderate,0,0
142708,intensity,0,1
142709,(,0,0
142710,LDMI,0,0
142711,;,0,0
142712,i.e.,0,0
142713,",",0,0
142714,15,0,0
142715,minutes,0,0
142716,at,0,0
142717,70,0,0
142718,%,0,0
142719,V,0,0
142720,[,0,0
142721,Combining,0,1
142722,Dot,0,1
142723,Above,0,1
142724,],0,0
142725,O2max,0,1
142726,),0,0
142727,",",0,0
142728,and,0,0
142729,the,0,0
142730,control,0,0
142731,(,0,0
142732,CTRL,0,1
142733,),0,0
142734,no-GWU,0,0
142735,condition,0,0
142736,.,0,0
142737,Leg,1,1
142738,press,1,0
142739,1RM,1,0
142740,values,1,0
142741,were,1,0
142742,higher,1,0
142743,(,0,0
142744,on,0,0
142745,average,0,0
142746,3,0,0
142747,%,0,0
142748,),0,0
142749,when,0,0
142750,subjects,0,0
142751,performed,0,0
142752,LDLI,0,0
142753,(,0,0
142754,367.8,0,0
142755,?,0,0
142756,70.1,0,0
142757,kg,0,0
142758,;,0,0
142759,p,0,0
142760,=,0,0
142761,0.01,0,0
142762,),0,0
142763,",",0,0
142764,compared,0,0
142765,with,0,0
142766,the,0,0
142767,other,0,0
142768,4,0,0
142769,conditions,0,0
142770,.,0,0
142771,After,0,0
142772,the,0,0
142773,LDMI,0,0
142774,condition,0,0
142775,",",0,0
142776,1RM,1,0
142777,values,1,1
142778,were,1,0
142779,lower,1,0
142780,(,0,0
142781,on,0,0
142782,average,0,0
142783,-4,0,0
142784,%,0,0
142785,),0,0
142786,than,0,0
142787,in,0,0
142788,the,0,0
142789,other,0,0
142790,4,0,0
142791,conditions,0,0
142792,(,0,0
142793,345.6,0,0
142794,?,0,0
142795,70.5,0,0
142796,kg,0,0
142797,;,0,0
142798,p,0,0
142799,=,0,0
142800,0.01,0,0
142801,),0,0
142802,.,0,0
142803,There,0,0
142804,were,1,0
142805,no,1,0
142806,differences,1,0
142807,between,1,0
142808,SDMI,1,0
142809,",",1,0
142810,SDLI,1,0
142811,",",1,1
142812,and,1,1
142813,CTRL,1,1
142814,(,1,0
142815,359.4,0,0
142816,?,0,0
142817,69.2,0,0
142818,kg,0,0
142819,",",0,0
142820,359.1,0,0
142821,?,0,0
142822,69.3,0,0
142823,kg,0,0
142824,",",0,0
142825,and,0,0
142826,359.4,0,0
142827,?,0,0
142828,70.4,0,0
142829,kg,0,0
142830,",",0,0
142831,respectively,0,0
142832,;,0,0
142833,p,0,0
142834,=,0,0
142835,0.99,0,0
142836,),0,0
142837,.,0,0
142838,According,0,0
142839,to,0,0
142840,our,0,0
142841,results,0,0
142842,",",0,0
142843,long-duration,0,0
142844,low-intensity,0,0
142845,general,0,0
142846,warm-up,0,0
142847,seems,0,0
142848,be,0,0
142849,appropriately,0,0
142850,to,0,0
142851,improve,0,0
142852,1RM,0,0
142853,performance,0,0
142854,in,0,0
142855,strength-trained,0,0
142856,individuals,0,0
142857,.,0,0
142858,Dietary,0,0
142859,patterns,0,0
142860,differ,0,0
142861,between,0,0
142862,urban,0,0
142863,and,0,0
142864,rural,0,0
142865,older,0,0
142866,",",0,0
142867,long-term,0,1
142868,survivors,0,1
142869,of,0,0
142870,breast,0,0
142871,",",0,0
142872,prostate,0,0
142873,",",0,1
142874,and,0,1
142875,colorectal,0,1
142876,cancer,0,0
142877,and,0,0
142878,are,0,0
142879,associated,0,0
142880,with,0,0
142881,body,0,1
142882,mass,0,1
142883,index,0,1
142884,.,0,0
142885,BACKGROUND,0,0
142886,Older,0,0
142887,adult,0,0
142888,cancer,0,0
142889,survivors,0,0
142890,are,0,0
142891,at,0,0
142892,greater,0,0
142893,risk,0,1
142894,of,0,1
142895,cancer,1,0
142896,recurrence,1,1
142897,and,0,1
142898,other,0,0
142899,comorbidities,1,0
142900,that,0,0
142901,can,0,0
142902,be,0,0
142903,prevented,0,0
142904,through,0,0
142905,improved,0,0
142906,diet,0,0
142907,and,0,0
142908,weight,0,1
142909,management,0,0
142910,.,0,0
142911,The,0,0
142912,tertiary,0,0
142913,prevention,0,0
142914,needs,0,0
142915,of,0,0
142916,rural-dwelling,0,0
142917,survivors,0,0
142918,can,0,0
142919,be,0,0
142920,even,0,0
142921,greater,0,0
142922,",",0,0
142923,yet,0,0
142924,little,0,0
142925,is,0,0
142926,known,0,0
142927,about,0,0
142928,rural,0,0
142929,and,0,0
142930,urban,0,0
142931,differences,0,0
142932,in,0,0
142933,lifestyle,0,0
142934,factors,0,0
142935,among,0,0
142936,this,0,0
142937,high-risk,0,0
142938,population,0,0
142939,.,0,0
142940,OBJECTIVES,0,0
142941,To,0,0
142942,compare,0,0
142943,dietary,0,0
142944,patterns,0,0
142945,of,0,0
142946,urban,0,0
142947,and,0,0
142948,rural,0,0
142949,cancer,0,0
142950,survivors,0,0
142951,and,0,0
142952,to,0,0
142953,examine,0,0
142954,associations,0,0
142955,of,0,0
142956,dietary,1,0
142957,patterns,1,0
142958,with,0,0
142959,body,1,1
142960,mass,1,1
142961,index,1,1
142962,(,1,0
142963,BMI,1,1
142964,),1,0
142965,.,1,0
142966,DESIGN,0,0
142967,A,0,0
142968,secondary,0,0
142969,analysis,0,0
142970,was,0,0
142971,performed,0,0
142972,of,0,0
142973,baseline,0,0
142974,data,0,0
142975,from,0,0
142976,the,0,0
142977,Reach,1,0
142978,Out,1,0
142979,to,1,0
142980,Enhance,1,0
142981,Wellness,1,1
142982,(,0,0
142983,RENEW,0,0
142984,),0,1
142985,trial,0,0
142986,",",0,0
142987,a,0,0
142988,diet,0,0
142989,and,0,0
142990,exercise,0,0
142991,intervention,0,0
142992,among,0,0
142993,overweight,0,1
142994,",",0,0
142995,long-term,0,0
142996,(,0,0
142997,?5,0,0
142998,years,0,0
142999,),0,0
143000,",",0,0
143001,older,0,0
143002,survivors,0,1
143003,of,0,1
143004,colorectal,0,0
143005,",",0,0
143006,breast,0,0
143007,",",0,1
143008,and,0,1
143009,prostate,0,0
143010,cancer,0,0
143011,.,0,0
143012,Survivors,0,0
143013,in,0,0
143014,the,0,0
143015,present,0,0
143016,analysis,0,0
143017,(,0,0
143018,n=729,0,0
143019,),0,0
143020,underwent,0,0
143021,two,0,0
143022,45-,0,0
143023,to,0,0
143024,60-minute,0,0
143025,telephone,0,0
143026,surveys,0,0
143027,",",0,0
143028,which,0,0
143029,included,0,0
143030,two,0,0
143031,24-hour,0,0
143032,dietary,0,0
143033,recalls,0,1
143034,.,0,0
143035,Principal,0,1
143036,components,0,1
143037,analysis,0,0
143038,and,0,0
143039,multivariable,0,0
143040,general,0,0
143041,linear,0,0
143042,models,0,0
143043,were,0,0
143044,used,0,0
143045,to,0,0
143046,derive,1,0
143047,dietary,1,0
143048,patterns,1,0
143049,and,1,0
143050,to,0,0
143051,evaluate,0,0
143052,associations,0,0
143053,between,1,0
143054,dietary,1,0
143055,patterns,1,0
143056,and,1,1
143057,BMI,1,1
143058,",",1,0
143059,respectively,0,0
143060,.,0,0
143061,RESULTS,0,0
143062,Principal,0,1
143063,components,0,1
143064,analysis,0,0
143065,identified,0,0
143066,three,1,0
143067,primary,1,0
143068,dietary,1,0
143069,patterns,1,0
143070,among,1,0
143071,rural,0,0
143072,dwellers,0,0
143073,(,0,0
143074,high,0,0
143075,sweets,0,0
143076,and,0,1
143077,starches,0,0
143078,",",0,1
143079,high,0,0
143080,reduced-fat,0,0
143081,dairy,0,0
143082,",",0,1
143083,cereal,0,0
143084,",",0,1
143085,nuts,0,0
143086,",",0,1
143087,and,0,1
143088,fruits,0,1
143089,",",0,1
143090,and,0,1
143091,mixed,0,0
143092,),0,0
143093,and,0,0
143094,three,0,0
143095,among,0,0
143096,urban,0,0
143097,dwellers,0,0
143098,(,0,0
143099,high,0,0
143100,fruits,0,0
143101,and,0,1
143102,vegetables,0,0
143103,",",0,1
143104,high,0,1
143105,meat,0,1
143106,and,0,1
143107,refined,0,0
143108,grains,0,0
143109,",",0,0
143110,and,0,1
143111,high,0,1
143112,sugar-sweetened,0,0
143113,beverages,0,0
143114,),0,0
143115,.,0,0
143116,Among,0,0
143117,rural,0,0
143118,survivors,0,0
143119,",",0,0
143120,greater,0,0
143121,adherence,0,1
143122,to,0,0
143123,the,0,0
143124,high,0,0
143125,reduced-fat,0,0
143126,dairy,0,0
143127,",",0,1
143128,cereal,0,0
143129,",",0,1
143130,nuts,0,0
143131,",",0,1
143132,and,0,1
143133,fruits,0,1
143134,pattern,0,1
143135,was,0,0
143136,positively,0,0
143137,associated,0,0
143138,with,0,0
143139,lower,1,0
143140,BMI,1,1
143141,(,1,1
143142,P,0,0
143143,trend,0,0
143144,<,0,0
143145,0.05,0,0
143146,),0,0
143147,",",0,0
143148,whereas,0,0
143149,higher,0,0
143150,scores,0,1
143151,on,0,0
143152,the,0,0
143153,mixed,0,0
143154,pattern,0,0
143155,was,0,0
143156,associated,0,0
143157,with,0,0
143158,greater,1,0
143159,BMI,1,1
143160,(,1,1
143161,P,0,0
143162,trend,0,0
143163,<,0,0
143164,0.05,0,0
143165,),0,0
143166,.,0,0
143167,Greater,0,0
143168,adherence,0,1
143169,to,0,0
143170,the,0,0
143171,high,0,0
143172,fruits,0,0
143173,and,0,0
143174,vegetables,0,0
143175,pattern,0,0
143176,among,0,0
143177,urban,0,0
143178,survivors,0,0
143179,was,0,0
143180,inversely,0,0
143181,associated,0,0
143182,with,1,0
143183,BMI,1,0
143184,(,1,0
143185,P,0,0
143186,trend,0,0
143187,<,0,0
143188,0.05,0,0
143189,),0,0
143190,.,0,0
143191,CONCLUSIONS,0,0
143192,Urban,0,0
143193,and,0,0
143194,rural,0,0
143195,differences,0,0
143196,in,0,0
143197,dietary,0,0
143198,intake,0,0
143199,behavior,0,0
143200,should,0,0
143201,be,0,0
143202,considered,0,0
143203,in,0,0
143204,designing,0,0
143205,public,0,0
143206,health,0,1
143207,interventions,0,0
143208,among,0,0
143209,the,1,0
143210,increasing,1,0
143211,population,1,0
143212,of,1,0
143213,older,0,0
143214,cancer,0,0
143215,survivors,0,1
143216,.,0,0
143217,In,0,0
143218,addition,0,0
143219,",",0,0
143220,targeting,0,0
143221,overall,0,1
143222,dietary,0,0
143223,patterns,0,0
143224,might,0,0
143225,be,0,0
143226,one,0,0
143227,approach,0,0
143228,to,0,0
143229,help,0,0
143230,reduce,0,0
143231,the,0,0
143232,burden,0,1
143233,of,0,0
143234,obesity,0,0
143235,among,0,0
143236,this,0,0
143237,population,0,0
143238,.,0,0
143239,A,0,0
143240,randomized,0,0
143241,double-blind,0,0
143242,study,0,0
143243,of,0,0
143244,atomoxetine,0,0
143245,versus,0,0
143246,placebo,0,0
143247,for,0,0
143248,attention-deficit/hyperactivity,0,0
143249,disorder,0,0
143250,symptoms,0,1
143251,in,0,0
143252,children,0,0
143253,with,0,0
143254,autism,0,0
143255,spectrum,0,0
143256,disorder,0,0
143257,.,0,0
143258,OBJECTIVE,0,0
143259,The,0,0
143260,efficacy,0,1
143261,of,0,0
143262,atomoxetine,0,0
143263,as,0,0
143264,treatment,0,0
143265,of,0,0
143266,symptoms,0,1
143267,of,0,0
143268,attention-deficit/hyperactivity,0,0
143269,disorder,0,0
143270,(,0,0
143271,ADHD,0,0
143272,),0,0
143273,in,0,0
143274,patients,0,0
143275,with,0,0
143276,autism,0,0
143277,spectrum,0,0
143278,disorder,0,0
143279,(,0,0
143280,ASD,0,0
143281,),0,0
143282,has,0,0
143283,not,0,0
143284,been,0,0
143285,established,0,0
143286,.,0,0
143287,METHOD,0,0
143288,In,0,0
143289,this,0,0
143290,study,0,0
143291,",",0,0
143292,97,0,0
143293,patients,0,0
143294,aged,0,0
143295,6,0,0
143296,to,0,0
143297,17,0,0
143298,years,0,0
143299,with,0,0
143300,ADHD,0,0
143301,and,0,0
143302,ASD,0,0
143303,were,0,0
143304,randomly,0,0
143305,assigned,0,0
143306,to,0,0
143307,double-blind,0,0
143308,treatment,0,0
143309,with,0,0
143310,1.2,0,0
143311,mg/kg/day,0,0
143312,atomoxetine,0,0
143313,or,0,0
143314,placebo,0,0
143315,for,0,0
143316,8,0,0
143317,weeks,0,0
143318,.,0,0
143319,The,0,0
143320,primary,0,0
143321,endpoint,0,0
143322,was,0,0
143323,the,0,0
143324,ADHD,1,0
143325,Rating,1,1
143326,Scale,1,1
143327,(,1,0
143328,ADHD-RS,1,0
143329,),1,0
143330,score,1,1
143331,;,1,0
143332,secondary,1,0
143333,endpoints,1,1
143334,were,1,0
143335,the,1,0
143336,Clinical,1,0
143337,Global,1,1
143338,Impression,1,1
143339,of,1,0
143340,ADHD-Improvement,1,1
143341,(,1,0
143342,CGI-I,1,1
143343,),1,0
143344,and,1,0
143345,the,1,0
143346,Conners,1,1
143347,Teacher,1,0
143348,Rating,1,0
143349,Scale-Revised,1,0
143350,:,1,0
143351,Short,1,0
143352,Form,1,0
143353,(,1,0
143354,CTRS-R,1,0
143355,:,1,0
143356,S,1,0
143357,),1,0
143358,score,1,1
143359,.,1,0
143360,RESULTS,0,0
143361,Baseline,0,0
143362,mean,0,1
143363,ADHD-RS,1,0
143364,scores,0,1
143365,for,0,0
143366,atomoxetine,0,0
143367,versus,0,0
143368,placebo,0,0
143369,were,0,0
143370,40.7,0,0
143371,and,0,0
143372,38.6,0,0
143373,;,0,0
143374,after,0,0
143375,8,0,0
143376,weeks,0,0
143377,",",0,0
143378,mixed-effect,0,1
143379,model,0,0
143380,repeated-measure,0,0
143381,means,0,0
143382,were,0,0
143383,31.6,0,0
143384,(,0,0
143385,95,0,0
143386,%,0,0
143387,confidence,0,0
143388,interval,0,0
143389,29.2-33.9,0,0
143390,),0,0
143391,and,0,0
143392,38.3,0,0
143393,(,0,0
143394,36.0-40.6,0,0
143395,),0,0
143396,",",0,0
143397,respectively,0,0
143398,",",0,0
143399,with,0,0
143400,a,0,0
143401,difference,0,0
143402,in,0,0
143403,least,0,0
143404,square,0,0
143405,means,0,0
143406,of,0,0
143407,-6.7,0,0
143408,(,0,0
143409,-10.0,0,0
143410,to,0,0
143411,-3.4,0,0
143412,;,0,0
143413,p,0,0
143414,<,0,0
143415,.001,0,0
143416,),0,0
143417,.,0,0
143418,The,0,0
143419,CTRS-R,1,0
143420,:,1,0
143421,S,1,0
143422,Hyperactivity,0,1
143423,subscore,0,1
143424,also,0,0
143425,improved,0,0
143426,significantly,0,0
143427,for,0,0
143428,atomoxetine,0,0
143429,compared,0,0
143430,with,0,0
143431,placebo,0,0
143432,",",0,0
143433,but,0,0
143434,not,0,0
143435,the,0,0
143436,other,0,0
143437,CTRS-R,1,0
143438,:,1,0
143439,S,1,0
143440,subscores,0,1
143441,.,0,0
143442,However,0,0
143443,",",0,0
143444,there,0,0
143445,were,0,0
143446,not,0,0
143447,significantly,0,0
143448,more,0,0
143449,patients,0,0
143450,on,0,0
143451,atomoxetine,0,0
143452,(,0,0
143453,20.9,0,0
143454,%,0,0
143455,),0,0
143456,who,0,0
143457,improved,0,0
143458,much,0,0
143459,",",0,0
143460,or,0,0
143461,very,0,0
143462,much,0,0
143463,according,0,0
143464,to,0,0
143465,the,0,0
143466,CGI-I,0,0
143467,",",0,0
143468,than,0,0
143469,on,0,0
143470,placebo,0,0
143471,(,0,0
143472,8.7,0,0
143473,%,0,0
143474,;,0,0
143475,p,0,0
143476,=,0,0
143477,0.14,0,0
143478,),0,0
143479,.,0,0
143480,Adverse,0,1
143481,events,0,1
143482,(,0,0
143483,mostly,0,0
143484,nausea,1,1
143485,",",0,0
143486,decrease,0,1
143487,in,0,0
143488,appetite,1,1
143489,",",1,0
143490,fatigue,1,1
143491,",",1,1
143492,and,1,1
143493,early,1,0
143494,morning,1,0
143495,awakening,1,1
143496,),1,0
143497,were,0,0
143498,reported,0,0
143499,in,0,0
143500,81.3,0,0
143501,%,0,0
143502,of,0,0
143503,atomoxetine,0,0
143504,patients,0,0
143505,and,0,0
143506,65.3,0,0
143507,%,0,0
143508,of,0,0
143509,placebo,0,0
143510,patients,0,0
143511,(,0,0
143512,p,0,0
143513,>,0,0
143514,.1,0,0
143515,),0,0
143516,.,0,0
143517,There,0,0
143518,were,0,0
143519,no,0,0
143520,serious,0,1
143521,adverse,1,1
143522,events,1,1
143523,.,1,0
143524,CONCLUSIONS,0,0
143525,Atomoxetine,0,0
143526,moderately,0,0
143527,improved,0,0
143528,ADHD,0,0
143529,symptoms,0,1
143530,in,0,0
143531,patients,0,0
143532,with,0,0
143533,ASD,0,0
143534,and,0,0
143535,was,0,0
143536,generally,0,0
143537,well,0,0
143538,tolerated,0,1
143539,.,0,0
143540,Adverse,0,0
143541,events,0,1
143542,in,0,0
143543,this,0,0
143544,study,0,0
143545,were,0,0
143546,similar,0,0
143547,to,0,0
143548,those,0,0
143549,in,0,0
143550,other,0,0
143551,studies,0,0
143552,with,0,0
143553,ADHD,0,0
143554,patients,0,0
143555,without,0,0
143556,ASD,0,0
143557,.,0,0
143558,Clinical,0,1
143559,trial,0,0
143560,registration,0,0
143561,information-A,0,0
143562,Randomized,0,0
143563,Double-Blind,0,0
143564,Study,0,0
143565,of,0,0
143566,Atomoxetine,0,0
143567,Versus,0,0
143568,Placebo,0,0
143569,for,0,0
143570,ADHD,0,0
143571,Symptoms,0,1
143572,in,0,0
143573,Children,0,0
143574,with,0,0
143575,ASD,0,0
143576,;,0,0
143577,www.clinicaltrials.gov,0,0
143578,;,0,0
143579,NCT00380692,0,0
143580,.,0,0
143581,Effectiveness,0,1
143582,and,0,1
143583,safety,0,1
143584,of,0,1
143585,donepezil,0,0
143586,in,0,0
143587,boys,0,0
143588,with,0,0
143589,fragile,0,0
143590,x,0,0
143591,syndrome,0,0
143592,:,0,0
143593,a,0,0
143594,double-blind,0,0
143595,",",0,0
143596,randomized,0,0
143597,",",0,0
143598,controlled,0,0
143599,pilot,0,0
143600,study,0,0
143601,.,0,0
143602,The,0,0
143603,present,0,0
143604,study,0,0
143605,was,0,0
143606,designed,0,0
143607,as,0,0
143608,a,0,0
143609,12-week,0,0
143610,",",0,0
143611,randomized,0,0
143612,",",0,0
143613,double-blind,0,0
143614,",",0,0
143615,placebo-controlled,0,0
143616,pilot,0,0
143617,study,0,0
143618,to,0,0
143619,evaluate,0,0
143620,the,0,0
143621,effectiveness,1,1
143622,and,1,0
143623,safety,1,1
143624,of,0,1
143625,donepezil,0,0
143626,in,0,0
143627,boys,0,0
143628,with,0,0
143629,fragile,0,0
143630,X,0,0
143631,syndrome,0,0
143632,.,0,0
143633,Twenty,0,0
143634,boys,0,0
143635,with,0,0
143636,fragile,0,0
143637,X,0,0
143638,syndrome,0,0
143639,were,0,0
143640,randomized,0,0
143641,to,0,0
143642,receive,0,0
143643,12,0,0
143644,weeks,0,0
143645,of,0,0
143646,treatment,0,0
143647,with,0,0
143648,either,0,0
143649,placebo,0,0
143650,or,0,0
143651,donepezil,0,0
143652,(,0,0
143653,2.5,0,0
143654,mg,0,0
143655,daily,0,0
143656,for,0,0
143657,initial,0,0
143658,4,0,0
143659,weeks,0,0
143660,followed,0,0
143661,by,0,0
143662,5,0,0
143663,mg,0,0
143664,daily,0,0
143665,for,0,0
143666,next,0,0
143667,8,0,0
143668,weeks,0,0
143669,),0,0
143670,.,0,0
143671,The,0,0
143672,outcome,0,1
143673,measures,0,1
143674,included,0,0
143675,change,1,0
143676,in,1,0
143677,intelligence,1,1
143678,quotient,1,1
143679,scores,1,1
143680,on,1,0
143681,Stanford-Binet,1,0
143682,Intelligence,1,1
143683,Scale,1,1
143684,(,1,0
143685,Hindi,1,1
143686,adaptation,1,1
143687,by,1,0
143688,Kulshrestha,1,0
143689,),1,0
143690,",",1,0
143691,change,1,1
143692,in,1,0
143693,behavioral,1,1
143694,scores,1,1
143695,by,1,0
143696,Conners,1,0
143697,3,1,0
143698,Parent,1,0
143699,Rating,1,0
143700,Scale,1,1
143701,(,1,0
143702,Short,1,0
143703,),1,0
143704,and,1,0
143705,Childhood,1,0
143706,Autism,1,1
143707,Rating,1,1
143708,Scale,1,1
143709,",",1,0
143710,safety,1,1
143711,",",1,1
143712,and,1,1
143713,tolerability,1,1
143714,of,1,0
143715,donepezil,1,0
143716,.,1,0
143717,The,0,0
143718,study,0,0
143719,failed,0,0
143720,to,0,0
143721,show,0,0
143722,significant,0,0
143723,difference,0,0
143724,in,0,0
143725,intelligence,1,1
143726,quotient,1,1
143727,and,0,1
143728,behavioral,1,1
143729,scales,1,1
143730,with,0,0
143731,donepezil,0,0
143732,therapy,0,0
143733,over,0,0
143734,12,0,0
143735,weeks,0,0
143736,.,0,0
143737,However,0,0
143738,",",0,0
143739,donepezil,0,0
143740,appeared,0,0
143741,to,0,0
143742,be,0,0
143743,safe,0,0
143744,and,0,0
143745,well,0,0
143746,tolerated,0,1
143747,.,0,0
143748,Effects,0,0
143749,of,0,0
143750,telephone,0,0
143751,call,0,1
143752,interventions,0,0
143753,on,0,0
143754,patients,0,0
143755,',0,0
143756,well-being,0,1
143757,in,0,0
143758,a,0,0
143759,radiation,0,0
143760,therapy,0,0
143761,department,0,0
143762,.,0,0
143763,This,0,0
143764,study,0,0
143765,examined,0,0
143766,the,0,0
143767,effects,0,1
143768,of,0,0
143769,telephone,0,0
143770,call,0,1
143771,interventions,0,0
143772,by,0,0
143773,a,0,0
143774,collaborative,0,0
143775,team,0,0
143776,on,0,0
143777,patients,0,0
143778,',0,0
143779,well-being,0,1
143780,.,0,0
143781,Fifty-five,0,0
143782,subjects,0,0
143783,undergoing,0,0
143784,radiation,0,0
143785,therapy,0,0
143786,for,0,0
143787,cure,0,1
143788,and,0,0
143789,who,0,0
143790,were,0,0
143791,able,0,0
143792,to,0,0
143793,communicate,0,0
143794,by,0,0
143795,telephone,0,0
143796,comprised,0,0
143797,the,0,0
143798,sample,0,0
143799,.,0,0
143800,Subjects,0,0
143801,were,0,0
143802,randomly,0,0
143803,assigned,0,0
143804,to,0,0
143805,a,0,0
143806,control,0,0
143807,group,0,0
143808,",",0,0
143809,who,0,0
143810,received,0,0
143811,the,0,0
143812,usual,0,0
143813,care,0,0
143814,or,0,0
143815,to,0,0
143816,an,0,0
143817,experimental,0,0
143818,group,0,0
143819,",",0,0
143820,who,0,0
143821,received,0,0
143822,a,0,0
143823,weekly,0,0
143824,telephone,0,0
143825,call,0,1
143826,intervention,0,0
143827,in,0,0
143828,addition,0,0
143829,to,0,0
143830,the,0,0
143831,usual,0,0
143832,care,0,0
143833,.,0,0
143834,Speilberger,1,0
143835,'s,1,0
143836,State,1,1
143837,Trait,1,1
143838,Inventory,1,1
143839,",",1,0
143840,the,1,0
143841,Side,1,0
143842,Effects,1,0
143843,Profile,1,1
143844,",",1,0
143845,and,1,0
143846,the,1,0
143847,Coping,1,1
143848,Strategies,1,0
143849,Profile,1,1
143850,were,0,0
143851,used,0,0
143852,along,0,0
143853,with,0,0
143854,a,0,0
143855,telephone,0,0
143856,survey,0,0
143857,to,0,0
143858,collect,0,0
143859,data,0,0
143860,.,0,0
143861,Analysis,0,0
143862,of,0,0
143863,the,0,0
143864,data,0,0
143865,showed,0,0
143866,no,0,0
143867,significant,0,0
143868,differences,0,0
143869,between,0,0
143870,groups,0,0
143871,in,0,0
143872,anxiety,1,1
143873,",",1,0
143874,severity,1,1
143875,of,1,1
143876,side,1,1
143877,effects,1,1
143878,",",1,0
143879,helpfulness,1,1
143880,of,1,1
143881,self-care,1,1
143882,strategies,1,0
143883,",",1,0
143884,and,1,0
143885,coping,1,1
143886,strategies,1,0
143887,.,1,0
143888,However,0,0
143889,",",0,0
143890,the,0,0
143891,survey,0,0
143892,indicated,0,0
143893,that,0,0
143894,the,0,0
143895,telephone,0,0
143896,calls,0,1
143897,were,0,0
143898,clinically,1,0
143899,significant,1,0
143900,and,0,0
143901,provided,0,0
143902,a,0,0
143903,mechanism,0,0
143904,for,0,0
143905,demonstrating,0,0
143906,that,0,0
143907,the,0,0
143908,health,0,1
143909,care,0,0
143910,professionals,0,0
143911,cared,0,0
143912,about,0,0
143913,their,0,0
143914,patients,0,0
143915,and,0,0
143916,provided,0,0
143917,an,0,0
143918,opportunity,0,0
143919,for,0,0
143920,patients,0,0
143921,to,0,0
143922,talk,0,0
143923,about,0,0
143924,their,0,0
143925,concerns,0,0
143926,.,0,0
143927,The,0,0
143928,investigators,0,0
143929,believe,0,0
143930,that,0,0
143931,collaboration,0,0
143932,",",0,0
143933,caring,0,1
143934,",",0,1
143935,and,0,0
143936,communication,0,1
143937,are,0,0
143938,the,0,0
143939,essence,0,0
143940,of,0,0
143941,exemplary,0,0
143942,health,0,0
143943,care,0,0
143944,.,0,0
143945,Reaching,0,0
143946,out,0,0
143947,",",0,0
143948,inviting,0,0
143949,back,0,0
143950,:,0,0
143951,using,0,0
143952,Interactive,0,0
143953,voice,0,1
143954,response,0,1
143955,(,0,0
143956,IVR,0,1
143957,),0,0
143958,technology,0,0
143959,to,0,0
143960,recycle,0,0
143961,relapsed,0,0
143962,smokers,0,0
143963,back,0,0
143964,to,0,0
143965,Quitline,0,0
143966,treatment,0,0
143967,--,0,0
143968,a,0,0
143969,randomized,0,0
143970,controlled,0,0
143971,trial,0,0
143972,.,0,0
143973,BACKGROUND,0,0
143974,Tobacco,0,0
143975,dependence,0,0
143976,is,0,0
143977,a,0,0
143978,chronic,0,0
143979,",",0,0
143980,relapsing,0,0
143981,condition,0,0
143982,that,0,0
143983,typically,0,0
143984,requires,0,0
143985,multiple,0,0
143986,quit,0,1
143987,attempts,0,1
143988,and,0,1
143989,extended,0,0
143990,treatment,0,0
143991,.,0,0
143992,When,0,0
143993,offered,0,0
143994,the,0,0
143995,opportunity,0,0
143996,",",0,0
143997,relapsed,0,0
143998,smokers,0,0
143999,are,0,0
144000,interested,0,0
144001,in,0,0
144002,recycling,0,0
144003,back,0,0
144004,into,0,0
144005,treatment,0,0
144006,for,0,0
144007,a,0,0
144008,new,0,0
144009,",",0,0
144010,assisted,0,0
144011,quit,0,0
144012,attempt,0,0
144013,.,0,0
144014,This,0,0
144015,manuscript,0,0
144016,presents,0,0
144017,the,0,0
144018,results,0,0
144019,of,0,0
144020,a,0,0
144021,randomized,0,0
144022,controlled,0,0
144023,trial,0,0
144024,testing,0,0
144025,the,0,0
144026,efficacy,0,1
144027,of,0,0
144028,interactive,0,0
144029,voice,0,1
144030,response,0,1
144031,(,0,0
144032,IVR,0,1
144033,),0,0
144034,in,0,0
144035,recycling,0,0
144036,low,0,0
144037,income,0,0
144038,smokers,0,0
144039,who,0,0
144040,had,0,0
144041,previously,0,0
144042,used,0,0
144043,quitline,0,0
144044,(,0,0
144045,QL,0,0
144046,),0,0
144047,support,0,0
144048,back,0,0
144049,to,0,0
144050,QL,0,0
144051,support,0,0
144052,for,0,0
144053,a,0,0
144054,new,0,0
144055,quit,0,0
144056,attempt,0,0
144057,.,0,0
144058,METHODS,0,0
144059,A,0,0
144060,sample,0,0
144061,of,0,0
144062,2985,0,0
144063,previous,0,0
144064,QL,0,0
144065,callers,0,1
144066,were,0,0
144067,randomized,0,0
144068,to,0,0
144069,either,0,0
144070,receive,0,0
144071,IVR,0,0
144072,screening,0,0
144073,for,0,0
144074,current,0,0
144075,smoking,0,0
144076,(,0,0
144077,control,0,0
144078,group,0,0
144079,),0,0
144080,or,0,0
144081,IVR,0,1
144082,screening,0,0
144083,plus,0,0
144084,an,0,0
144085,IVR,0,0
144086,intervention,0,0
144087,.,0,0
144088,The,0,0
144089,IVR,0,0
144090,intervention,0,0
144091,consists,0,0
144092,of,0,0
144093,automated,0,0
144094,questions,0,0
144095,to,0,0
144096,identify,0,0
144097,and,0,0
144098,address,0,0
144099,barriers,0,1
144100,to,0,0
144101,re-cycling,0,0
144102,in,0,0
144103,QL,0,0
144104,support,0,0
144105,",",0,0
144106,followed,0,0
144107,by,0,0
144108,an,0,0
144109,offer,0,0
144110,to,0,0
144111,be,0,0
144112,transferred,0,0
144113,to,0,0
144114,the,0,0
144115,QL,0,0
144116,and,0,0
144117,reinitiate,0,0
144118,treatment,0,0
144119,.,0,0
144120,Re-enrollment,0,0
144121,in,0,0
144122,QL,0,0
144123,services,0,0
144124,for,0,0
144125,both,0,0
144126,groups,0,0
144127,was,0,0
144128,documented,0,0
144129,.,0,0
144130,RESULTS,0,0
144131,The,0,0
144132,IVR,0,0
144133,system,0,0
144134,successfully,1,0
144135,reached,1,0
144136,715,0,0
144137,(,0,0
144138,23.9,0,0
144139,%,0,0
144140,),0,0
144141,former,0,0
144142,QL,0,0
144143,participants,0,0
144144,.,0,0
144145,Of,0,0
144146,those,0,0
144147,",",0,0
144148,27,0,0
144149,%,0,0
144150,(,0,0
144151,194/715,0,0
144152,),0,0
144153,reported,0,0
144154,to,0,0
144155,the,0,0
144156,IVR,0,0
144157,system,0,0
144158,that,0,0
144159,they,0,0
144160,had,0,0
144161,quit,1,1
144162,smoking,1,1
144163,and,0,1
144164,were,0,0
144165,therefore,0,0
144166,excluded,0,0
144167,from,0,0
144168,the,0,0
144169,study,0,0
144170,and,0,0
144171,analysis,0,0
144172,.,0,0
144173,The,0,0
144174,trial,0,0
144175,'s,0,0
144176,final,0,1
144177,sample,0,0
144178,was,0,0
144179,composed,0,0
144180,of,0,0
144181,521,0,0
144182,current,0,0
144183,smokers,0,0
144184,.,0,0
144185,The,0,0
144186,re-enrollment,1,0
144187,rate,1,1
144188,was,0,0
144189,3.3,0,0
144190,%,0,0
144191,for,0,0
144192,the,0,0
144193,control,0,0
144194,group,0,0
144195,and,0,0
144196,28.2,0,0
144197,%,0,0
144198,for,0,0
144199,the,0,0
144200,intervention,0,0
144201,group,0,0
144202,(,0,0
144203,p,0,0
144204,<,0,0
144205,.001,0,0
144206,),0,0
144207,.,0,0
144208,Logistic,0,0
144209,regression,0,0
144210,results,0,0
144211,indicated,0,0
144212,an,0,0
144213,11.2,0,0
144214,times,0,0
144215,higher,0,0
144216,odds,0,1
144217,for,0,0
144218,re-enrollment,0,0
144219,of,0,0
144220,the,0,0
144221,intervention,0,0
144222,group,0,0
144223,than,0,0
144224,the,0,0
144225,control,0,0
144226,group,0,0
144227,(,0,0
144228,p,0,0
144229,<,0,0
144230,.001,0,0
144231,),0,0
144232,.,0,0
144233,Results,1,0
144234,did,1,0
144235,not,1,0
144236,vary,1,0
144237,by,1,0
144238,gender,1,0
144239,",",1,0
144240,race,1,0
144241,",",1,1
144242,ethnicity,1,0
144243,",",1,1
144244,or,1,1
144245,level,1,1
144246,of,1,1
144247,education,1,0
144248,",",0,0
144249,however,0,0
144250,recycled,1,0
144251,smokers,1,0
144252,were,1,0
144253,older,1,0
144254,(,0,0
144255,Mean,0,1
144256,=,0,0
144257,45.2,0,0
144258,;,0,0
144259,SD,0,0
144260,=,0,0
144261,11.7,0,0
144262,),0,0
144263,than,0,0
144264,smokers,0,0
144265,who,0,0
144266,declined,0,0
144267,a,0,0
144268,new,0,0
144269,treatment,0,0
144270,cycle,0,1
144271,(,0,0
144272,Mean,0,0
144273,=,0,0
144274,41.8,0,0
144275,;,0,0
144276,SD,0,0
144277,=,0,0
144278,13.2,0,0
144279,),0,0
144280,;,0,0
144281,(,0,0
144282,p,0,0
144283,=,0,0
144284,0.013,0,0
144285,),0,0
144286,.,0,0
144287,The,0,0
144288,main,0,0
144289,barriers,0,0
144290,reported,0,0
144291,for,0,0
144292,not,0,0
144293,engaging,0,0
144294,in,0,0
144295,a,0,0
144296,new,0,0
144297,treatment,0,0
144298,cycle,0,1
144299,were,0,0
144300,low,0,0
144301,self-efficacy,1,1
144302,and,1,1
144303,lack,1,0
144304,of,1,1
144305,interest,1,0
144306,in,0,0
144307,quitting,0,0
144308,.,0,0
144309,After,0,0
144310,delivering,0,0
144311,IVR,0,0
144312,messages,0,0
144313,targeting,0,0
144314,these,0,0
144315,reported,0,0
144316,barriers,0,0
144317,",",0,0
144318,32,0,0
144319,%,0,0
144320,of,0,0
144321,the,0,0
144322,smokers,0,0
144323,reporting,0,0
144324,low,1,0
144325,self-efficacy,1,1
144326,and,0,0
144327,4.8,0,0
144328,%,0,0
144329,of,0,0
144330,those,0,0
144331,reporting,0,0
144332,lack,0,0
144333,of,0,0
144334,interest,0,0
144335,in,0,0
144336,quitting,0,0
144337,re-engaged,0,0
144338,in,0,0
144339,a,0,0
144340,new,0,0
144341,QL,0,0
144342,treatment,0,0
144343,cycle,0,1
144344,.,0,0
144345,CONCLUSION,0,0
144346,Proactive,0,0
144347,IVR,0,0
144348,outreach,0,0
144349,is,0,0
144350,a,0,0
144351,promising,0,0
144352,tool,0,0
144353,to,0,0
144354,engage,0,0
144355,low,0,0
144356,income,0,1
144357,",",0,0
144358,relapsed,0,0
144359,smokers,0,0
144360,back,0,0
144361,into,0,0
144362,a,0,0
144363,new,0,0
144364,cycle,0,1
144365,of,0,0
144366,treatment,0,0
144367,.,0,0
144368,Integration,0,0
144369,of,0,0
144370,IVR,0,1
144371,intervention,0,0
144372,for,0,0
144373,recycling,0,0
144374,smokers,0,0
144375,with,0,0
144376,previous,0,0
144377,QL,0,0
144378,treatment,0,0
144379,has,0,0
144380,the,0,0
144381,potential,0,0
144382,to,0,0
144383,decrease,0,0
144384,tobacco-related,0,0
144385,disparities,0,0
144386,.,0,0
144387,TRIAL,0,0
144388,REGISTRATION,0,0
144389,ClinicalTrials.gov,0,0
144390,Identifier,0,0
144391,:,0,0
144392,NCT01260597,0,0
144393,.,0,0
144394,Promoting,0,0
144395,physical,0,1
144396,activity,0,1
144397,in,0,0
144398,patients,0,0
144399,with,0,0
144400,colon,0,0
144401,adenomas,0,0
144402,:,0,0
144403,a,0,0
144404,randomized,0,0
144405,pilot,0,0
144406,intervention,0,0
144407,trial,0,0
144408,.,0,0
144409,BACKGROUND,0,0
144410,Physical,0,1
144411,activity,0,1
144412,decreases,0,1
144413,risk,0,1
144414,of,0,0
144415,colon,0,0
144416,polyps,0,0
144417,and,0,1
144418,colon,0,1
144419,cancer,0,0
144420,and,0,0
144421,might,0,0
144422,reduce,0,0
144423,risk,0,1
144424,of,0,0
144425,colon,0,0
144426,cancer,0,0
144427,recurrence,0,1
144428,.,0,0
144429,Focusing,0,0
144430,on,0,0
144431,recent,0,0
144432,calls,0,1
144433,for,0,0
144434,translation,0,0
144435,of,0,0
144436,epidemiologic,0,0
144437,evidence,0,0
144438,into,0,0
144439,clinical,0,0
144440,care,0,0
144441,",",0,0
144442,our,0,0
144443,pilot,0,0
144444,study,0,0
144445,delivered,0,0
144446,an,0,0
144447,evidence-based,0,0
144448,physical,0,1
144449,activity,0,1
144450,intervention,0,0
144451,in,0,0
144452,adults,0,0
144453,with,0,0
144454,polyps,0,0
144455,",",0,0
144456,who,0,0
144457,are,0,0
144458,thus,0,0
144459,at,0,0
144460,elevated,0,0
144461,risk,0,0
144462,of,0,0
144463,developing,0,0
144464,colon,0,0
144465,cancer,0,0
144466,.,0,0
144467,The,0,0
144468,objective,0,0
144469,was,0,0
144470,to,0,0
144471,evaluate,0,0
144472,change,0,0
144473,in,0,0
144474,physical,0,1
144475,activity,0,1
144476,",",0,0
144477,measured,0,1
144478,by,0,0
144479,steps,0,0
144480,per,0,0
144481,day,0,0
144482,and,0,0
144483,minutes,0,0
144484,of,0,0
144485,moderate/vigorous,1,1
144486,physical,0,0
144487,activity,0,1
144488,.,0,0
144489,METHODS,0,0
144490,Sixteen,0,0
144491,adults,0,0
144492,with,0,0
144493,adenomas,0,1
144494,detected,0,0
144495,and,0,0
144496,removed,0,0
144497,at,0,0
144498,screening,0,0
144499,colonoscopy,0,1
144500,were,0,0
144501,recruited,0,0
144502,to,0,0
144503,a,0,0
144504,12-week,0,0
144505,physical,0,1
144506,activity,0,1
144507,intervention,0,0
144508,.,0,0
144509,Participants,0,0
144510,were,0,0
144511,randomized,0,0
144512,to,0,0
144513,receive,0,0
144514,a,0,0
144515,standard,0,0
144516,(,0,0
144517,30,0,0
144518,minutes/day,0,0
144519,),0,0
144520,or,0,0
144521,high,0,0
144522,(,0,0
144523,60,0,0
144524,minutes/day,0,0
144525,),0,0
144526,walking,0,0
144527,program,0,0
144528,.,0,0
144529,Physical,0,1
144530,activity,0,1
144531,was,0,0
144532,measured,0,0
144533,via,0,0
144534,blinded,0,0
144535,pedometer,0,0
144536,and,0,0
144537,accelerometer,0,1
144538,at,0,0
144539,baseline,0,0
144540,and,0,0
144541,follow-up,0,0
144542,.,0,1
144543,Intervention,0,0
144544,messages,0,0
144545,focused,0,0
144546,on,0,0
144547,self-monitoring,0,1
144548,using,0,0
144549,pedometers,0,0
144550,and,0,0
144551,overcoming,0,0
144552,barriers,0,0
144553,to,0,0
144554,engaging,0,0
144555,in,0,0
144556,physical,0,0
144557,activity,0,1
144558,.,0,0
144559,RESULTS,0,0
144560,Participants,0,0
144561,in,0,0
144562,both,0,0
144563,arms,0,0
144564,significantly,0,0
144565,increased,0,0
144566,objectively,0,0
144567,measured,1,0
144568,minutes,1,0
144569,of,1,0
144570,moderate/vigorous,1,1
144571,physical,1,1
144572,activity,1,1
144573,over,0,0
144574,the,0,0
144575,course,0,0
144576,of,0,0
144577,the,0,0
144578,intervention,0,0
144579,.,0,0
144580,Both,0,0
144581,arms,0,0
144582,exceeded,0,0
144583,the,0,0
144584,intervention,0,0
144585,goal,0,0
144586,",",0,0
144587,but,0,0
144588,there,0,0
144589,was,0,0
144590,not,0,0
144591,a,0,0
144592,significant,0,0
144593,difference,0,0
144594,between,0,0
144595,arms,0,0
144596,at,0,0
144597,follow-up,0,0
144598,.,0,0
144599,Results,0,0
144600,were,0,0
144601,similar,0,0
144602,for,0,0
144603,pedometer,1,0
144604,measured,1,0
144605,physical,1,1
144606,activity,1,1
144607,",",0,0
144608,with,0,0
144609,a,0,0
144610,significant,0,0
144611,overall,0,1
144612,increase,1,0
144613,in,1,0
144614,steps/day,1,0
144615,from,0,0
144616,baseline,0,0
144617,to,0,0
144618,follow-up,0,0
144619,",",0,0
144620,but,0,0
144621,no,0,0
144622,between,0,0
144623,arm,0,0
144624,difference,0,0
144625,in,0,0
144626,change,0,0
144627,.,0,0
144628,CONCLUSION,0,0
144629,Simple,0,0
144630,interventions,0,0
144631,of,0,0
144632,minimal,0,1
144633,contact,0,1
144634,time,0,1
144635,focusing,0,0
144636,on,0,0
144637,walking,0,0
144638,can,0,0
144639,significantly,0,0
144640,increase,0,0
144641,physical,0,1
144642,activity,0,1
144643,in,0,0
144644,individuals,0,0
144645,at,0,0
144646,increased,0,0
144647,risk,0,0
144648,of,0,0
144649,developing,0,0
144650,colon,0,0
144651,cancer,0,0
144652,.,0,0
144653,TRIAL,0,0
144654,REGISTRATION,0,0
144655,ClinicalTrials.gov,0,0
144656,NCT01476631,0,0
144657,.,0,0
144658,[,0,0
144659,Localised,0,1
144660,prostate,0,0
144661,cancer,0,0
144662,:,0,0
144663,the,0,0
144664,PREFERE,0,1
144665,trial,0,0
144666,],0,0
144667,.,0,0
144668,Prostate,0,0
144669,cancer,0,0
144670,is,0,0
144671,the,0,0
144672,most,0,0
144673,common,0,0
144674,carcinoma,0,0
144675,of,0,0
144676,the,0,0
144677,elderly,0,0
144678,man,0,0
144679,and,0,0
144680,holds,0,0
144681,the,0,0
144682,third,0,0
144683,place,0,0
144684,in,0,0
144685,the,0,0
144686,ranking,0,0
144687,of,0,0
144688,cancer-specific,1,1
144689,mortality,1,1
144690,.,1,0
144691,However,0,0
144692,",",0,0
144693,mortality,1,1
144694,rates,1,1
144695,of,0,0
144696,3,0,0
144697,%,0,0
144698,are,0,0
144699,low,0,0
144700,",",0,0
144701,and,0,1
144702,half,0,0
144703,of,0,0
144704,the,0,0
144705,patients,0,0
144706,will,0,0
144707,die,0,0
144708,from,0,0
144709,intercurrent,0,0
144710,disease,0,0
144711,.,0,0
144712,Due,0,1
144713,to,0,0
144714,the,0,0
144715,significantly,0,0
144716,improved,0,0
144717,diagnostic,0,0
144718,methods,0,0
144719,and,0,0
144720,the,0,0
144721,increasing,0,0
144722,use,0,0
144723,of,0,0
144724,PSA,0,1
144725,screening,0,0
144726,",",0,0
144727,there,0,0
144728,has,0,0
144729,been,0,0
144730,a,0,0
144731,stage,0,0
144732,migration,0,1
144733,towards,0,0
144734,early,0,0
144735,tumour,0,0
144736,stages,0,0
144737,that,0,0
144738,are,0,0
144739,prognostically,0,0
144740,heterogeneous,0,0
144741,and,0,0
144742,require,0,0
144743,differentiated,0,1
144744,treatment,0,0
144745,.,0,0
144746,Based,0,0
144747,on,0,0
144748,the,0,0
144749,discussions,0,0
144750,of,0,0
144751,the,0,0
144752,Joint,0,1
144753,Federal,0,0
144754,Committee,0,0
144755,(,0,0
144756,G-BA,0,1
144757,),0,0
144758,and,0,0
144759,the,0,0
144760,conceptual,0,0
144761,work,0,0
144762,of,0,0
144763,the,0,0
144764,MDS,0,0
144765,",",0,0
144766,the,0,0
144767,Competence,0,1
144768,Centre,0,0
144769,Oncology,0,0
144770,of,0,0
144771,the,0,0
144772,MDK,0,0
144773,",",0,0
144774,the,0,0
144775,IQWIG,0,0
144776,and,0,0
144777,the,0,0
144778,National,0,0
144779,Association,0,0
144780,of,0,0
144781,Statutory,0,0
144782,Health,0,1
144783,Insurance,0,1
144784,Funds,0,0
144785,(,0,0
144786,GKV-Spitzenverband,0,0
144787,),0,0
144788,",",0,0
144789,a,0,0
144790,prospective,0,0
144791,randomised,0,0
144792,multicentre,0,0
144793,trial,0,0
144794,was,0,0
144795,developed,0,0
144796,comparing,0,0
144797,the,0,0
144798,four,0,0
144799,treatments,0,0
144800,actually,0,0
144801,recommended,0,0
144802,by,0,0
144803,the,0,0
144804,German,0,0
144805,and,0,0
144806,European,0,0
144807,guidelines,0,0
144808,for,0,0
144809,localised,0,0
144810,prostate,0,0
144811,cancer,0,0
144812,(,1,0
144813,radical,1,0
144814,prostatectomy,1,0
144815,",",1,0
144816,percutaneous,1,0
144817,radiotherapy,1,0
144818,and,1,0
144819,permanent,1,1
144820,seed,1,1
144821,implantation,1,0
144822,and,1,1
144823,active,1,1
144824,surveillance,1,1
144825,),1,0
144826,allowing,0,0
144827,a,0,0
144828,rejection,0,1
144829,of,0,0
144830,one,0,0
144831,or,0,0
144832,two,0,0
144833,treatment,0,0
144834,options,0,0
144835,.,0,0
144836,The,0,0
144837,trial,0,0
144838,is,0,0
144839,expected,0,0
144840,to,0,0
144841,start,0,0
144842,at,0,0
144843,the,0,0
144844,beginning,0,0
144845,of,0,0
144846,next,0,0
144847,year,0,0
144848,.,0,0
144849,Direct,0,1
144850,renin,0,0
144851,inhibition,0,1
144852,improves,0,1
144853,parasympathetic,0,1
144854,function,0,1
144855,in,0,0
144856,diabetes,0,0
144857,.,0,0
144858,AIM,0,0
144859,The,0,0
144860,renin-angiotensin-aldosterone,0,1
144861,system,0,0
144862,(,0,0
144863,RAAS,0,1
144864,),0,0
144865,and,0,0
144866,autonomic,0,1
144867,nervous,0,0
144868,system,0,0
144869,regulate,0,0
144870,the,0,0
144871,cardiovascular,0,1
144872,system,0,0
144873,.,0,0
144874,Blockade,0,0
144875,of,0,0
144876,the,0,0
144877,RAAS,0,0
144878,may,0,0
144879,slow,0,0
144880,the,0,0
144881,progression,0,1
144882,of,0,0
144883,end-organ,0,1
144884,damage,0,1
144885,.,0,0
144886,Direct,0,1
144887,renin,0,0
144888,inhibition,0,0
144889,offers,0,0
144890,a,0,0
144891,means,0,0
144892,for,0,0
144893,blocking,0,0
144894,the,0,0
144895,RAAS,0,0
144896,.,0,0
144897,The,0,0
144898,objective,0,0
144899,of,0,0
144900,this,0,0
144901,study,0,0
144902,was,0,0
144903,to,0,0
144904,examine,0,0
144905,the,0,0
144906,effect,0,0
144907,of,0,0
144908,direct,0,0
144909,renin,0,1
144910,inhibition,0,1
144911,on,0,0
144912,cardiovascular,0,1
144913,autonomic,0,0
144914,function,0,1
144915,.,0,0
144916,METHODS,0,0
144917,In,0,0
144918,this,0,0
144919,double-blind,0,0
144920,",",0,0
144921,placebo-controlled,0,0
144922,trial,0,0
144923,",",0,0
144924,60,0,0
144925,individuals,0,0
144926,with,0,0
144927,diabetes,0,0
144928,were,0,0
144929,randomly,0,0
144930,assigned,0,0
144931,to,0,0
144932,300,0,0
144933,mg,0,0
144934,of,0,0
144935,aliskiren,0,0
144936,or,0,0
144937,placebo,0,0
144938,once,0,0
144939,daily,0,0
144940,for,0,0
144941,6,0,0
144942,weeks,0,0
144943,.,0,0
144944,The,0,0
144945,primary,0,0
144946,end,0,0
144947,point,0,0
144948,was,0,0
144949,a,0,0
144950,change,1,0
144951,in,1,0
144952,tests,1,0
144953,of,1,0
144954,cardiovascular,1,1
144955,autonomic,1,0
144956,function,1,1
144957,.,1,0
144958,Autonomic,1,1
144959,function,1,1
144960,was,0,0
144961,assessed,0,0
144962,by,0,0
144963,power,0,0
144964,spectral,0,1
144965,analysis,0,0
144966,and,0,0
144967,RR-variation,0,1
144968,during,0,0
144969,deep,0,0
144970,breathing,0,0
144971,[,0,0
144972,i.e,0,0
144973,.,0,0
144974,mean,0,1
144975,circular,0,0
144976,resultant,0,0
144977,(,0,0
144978,MCR,0,0
144979,),0,0
144980,",",0,0
144981,expiration/inspiration,0,1
144982,(,0,1
144983,E/I,0,1
144984,),0,1
144985,ratio,0,1
144986,],0,0
144987,.,0,0
144988,The,0,0
144989,MCR,0,0
144990,and,0,0
144991,E/I,0,1
144992,ratio,0,1
144993,assess,0,0
144994,parasympathetic,0,1
144995,function,0,1
144996,.,0,0
144997,Secondary,0,0
144998,measures,0,1
144999,included,0,0
145000,change,1,0
145001,in,1,0
145002,biochemical,1,0
145003,parameters,1,1
145004,[,1,0
145005,e.g,1,0
145006,.,1,0
145007,plasma,1,1
145008,renin,1,1
145009,activity,1,1
145010,",",1,1
145011,leptin,1,1
145012,and,1,1
145013,interleukin-6,1,1
145014,],1,0
145015,.,1,0
145016,Change,1,0
145017,in,1,0
145018,cardiovascular,1,1
145019,autonomic,1,1
145020,function,1,1
145021,and,1,1
145022,blood,1,1
145023,analytes,1,1
145024,were,0,0
145025,analysed,0,0
145026,by,0,0
145027,a,0,0
145028,mixed,0,0
145029,effects,0,1
145030,model,0,0
145031,for,0,0
145032,repeated,0,0
145033,measures,0,0
145034,.,0,0
145035,RESULTS,0,0
145036,Baseline,0,0
145037,characteristics,0,1
145038,were,0,0
145039,similar,0,0
145040,between,0,0
145041,treatment,0,0
145042,groups,0,0
145043,.,0,0
145044,In,0,0
145045,response,0,1
145046,to,0,0
145047,aliskiren,0,0
145048,compared,0,0
145049,with,0,0
145050,placebo,0,0
145051,",",0,0
145052,blood,1,1
145053,pressure,1,1
145054,was,0,0
145055,reduced,0,0
145056,as,0,0
145057,well,0,0
145058,as,0,0
145059,plasma,0,1
145060,renin,0,0
145061,activity,0,1
145062,[,0,0
145063,from,0,0
145064,2.4,0,0
145065,?,0,0
145066,3.8,0,0
145067,(,0,0
145068,mean,0,0
145069,?,0,0
145070,standard,0,0
145071,deviation,0,0
145072,),0,0
145073,to,0,0
145074,0.5,0,0
145075,?,0,0
145076,0.4,0,0
145077,?g/l/h,0,0
145078,",",0,0
145079,p,0,0
145080,<,0,0
145081,0.001,0,0
145082,],0,0
145083,.,0,0
145084,There,0,0
145085,was,0,0
145086,a,0,0
145087,significant,0,0
145088,interaction,0,0
145089,(,0,0
145090,aliskiren,0,0
145091,?,0,0
145092,visit,0,1
145093,),0,0
145094,for,0,0
145095,MCR,0,0
145096,(,0,0
145097,p,0,0
145098,=,0,0
145099,0.003,0,0
145100,),0,0
145101,and,0,0
145102,E/I,0,1
145103,ratio,0,1
145104,(,0,0
145105,p,0,0
145106,=,0,0
145107,0.003,0,0
145108,),0,0
145109,indicating,0,0
145110,improvement,0,1
145111,in,0,0
145112,MCR,0,0
145113,and,0,0
145114,E/I,0,1
145115,ratio,0,1
145116,for,0,0
145117,those,0,0
145118,on,0,0
145119,aliskiren,0,0
145120,.,0,0
145121,MCR,0,0
145122,means,0,0
145123,",",0,0
145124,baseline,0,0
145125,vs.,0,0
145126,follow-up,0,0
145127,",",0,0
145128,were,0,0
145129,41.8,0,0
145130,?,0,0
145131,19.7,0,0
145132,vs.,0,0
145133,50.8,0,0
145134,?,0,0
145135,26.1,0,0
145136,(,0,0
145137,aliskiren,0,0
145138,),0,0
145139,and,0,0
145140,38.2,0,0
145141,?,0,0
145142,23.6,0,0
145143,vs.,0,0
145144,37.5,0,0
145145,?,0,0
145146,24.1,0,0
145147,(,0,0
145148,placebo,0,0
145149,),0,0
145150,.,0,0
145151,CONCLUSIONS,0,0
145152,Parasympathetic,0,1
145153,function,0,1
145154,(,0,0
145155,i.e,0,0
145156,.,0,0
145157,MCR,0,0
145158,and,0,0
145159,E/I,0,1
145160,ratio,0,1
145161,),0,0
145162,was,0,0
145163,enhanced,0,0
145164,by,0,0
145165,downregulation,0,0
145166,of,0,0
145167,the,0,0
145168,RAAS,0,0
145169,.,0,0
145170,Adjunctive,0,0
145171,perampanel,0,0
145172,for,0,0
145173,refractory,0,0
145174,partial-onset,0,0
145175,seizures,0,0
145176,:,0,0
145177,randomized,0,0
145178,phase,0,0
145179,III,0,0
145180,study,0,0
145181,304,0,0
145182,.,0,0
145183,OBJECTIVE,0,0
145184,To,0,0
145185,assess,0,0
145186,efficacy,0,1
145187,and,0,1
145188,safety,0,1
145189,of,0,0
145190,once-daily,0,0
145191,8,0,0
145192,or,0,0
145193,12,0,0
145194,mg,0,0
145195,perampanel,0,0
145196,",",0,0
145197,a,0,0
145198,noncompetitive,0,0
145199,?-amino-3-hydroxy-5-methyl-4-isoxazole-propionic,0,0
145200,acid,0,0
145201,(,0,0
145202,AMPA,0,1
145203,),0,1
145204,receptor,0,1
145205,antagonist,0,0
145206,",",0,0
145207,when,0,0
145208,added,0,0
145209,to,0,0
145210,concomitant,0,0
145211,antiepileptic,0,0
145212,drugs,0,0
145213,(,0,0
145214,AEDs,0,0
145215,),0,0
145216,in,0,0
145217,the,0,0
145218,treatment,0,0
145219,of,0,0
145220,drug-resistant,0,1
145221,partial-onset,0,0
145222,seizures,0,0
145223,.,0,0
145224,METHODS,0,0
145225,This,0,0
145226,was,0,0
145227,a,0,0
145228,multicenter,0,0
145229,",",0,0
145230,double-blind,0,0
145231,",",0,0
145232,placebo-controlled,0,0
145233,trial,0,0
145234,(,0,0
145235,ClinicalTrials.gov,0,0
145236,identifier,0,0
145237,:,0,0
145238,NCT00699972,0,0
145239,),0,0
145240,.,0,0
145241,Patients,0,0
145242,(,0,0
145243,?12,0,0
145244,years,0,0
145245,",",0,0
145246,with,0,0
145247,ongoing,0,0
145248,seizures,0,0
145249,despite,0,0
145250,1-3,0,0
145251,AEDs,0,0
145252,),0,0
145253,were,0,0
145254,randomized,0,0
145255,(,0,0
145256,1:1:1,0,0
145257,),0,0
145258,to,0,0
145259,once-daily,0,0
145260,perampanel,0,0
145261,8,0,0
145262,mg,0,0
145263,",",0,0
145264,12,0,0
145265,mg,0,0
145266,",",0,0
145267,or,0,0
145268,placebo,0,0
145269,.,0,0
145270,Following,0,0
145271,baseline,0,0
145272,(,0,0
145273,6,0,0
145274,weeks,0,0
145275,),0,0
145276,",",0,0
145277,patients,0,0
145278,entered,0,0
145279,a,0,0
145280,19-week,0,0
145281,double-blind,0,0
145282,phase,0,0
145283,:,0,0
145284,6-week,0,0
145285,titration,0,0
145286,(,0,0
145287,2,0,0
145288,mg/week,0,0
145289,increments,0,0
145290,to,0,0
145291,target,0,0
145292,dose,0,0
145293,),0,0
145294,followed,0,0
145295,by,0,0
145296,a,0,0
145297,13-week,0,0
145298,maintenance,0,0
145299,period,0,0
145300,.,0,0
145301,Percent,0,0
145302,change,0,0
145303,in,0,0
145304,seizure,0,1
145305,frequency,0,1
145306,was,0,0
145307,the,0,0
145308,primary,0,0
145309,endpoint,0,0
145310,;,0,0
145311,50,0,0
145312,%,0,0
145313,responder,0,0
145314,rate,0,1
145315,was,0,0
145316,the,0,0
145317,primary,0,0
145318,endpoint,0,0
145319,for,0,0
145320,EU,0,1
145321,registration,0,0
145322,.,0,0
145323,RESULTS,0,0
145324,Of,0,0
145325,388,0,0
145326,patients,0,0
145327,randomized,0,0
145328,and,0,0
145329,treated,0,0
145330,",",0,0
145331,387,0,0
145332,provided,0,0
145333,seizure,0,0
145334,frequency,0,1
145335,data,0,0
145336,.,0,0
145337,Using,0,0
145338,this,0,0
145339,intent-to-treat,0,0
145340,population,0,0
145341,over,0,0
145342,the,0,0
145343,double-blind,0,0
145344,phase,0,0
145345,",",0,0
145346,the,0,0
145347,median,1,1
145348,percent,1,0
145349,change,1,1
145350,in,1,0
145351,seizure,1,1
145352,frequency,1,1
145353,was,1,0
145354,-21.0,0,0
145355,%,0,0
145356,",",0,0
145357,-26.3,0,0
145358,%,0,0
145359,",",0,0
145360,and,0,0
145361,-34.5,0,0
145362,%,0,0
145363,for,0,0
145364,placebo,0,0
145365,and,0,0
145366,perampanel,0,0
145367,8,0,0
145368,and,0,0
145369,12,0,0
145370,mg,0,0
145371,",",0,0
145372,respectively,0,0
145373,(,0,0
145374,p,0,0
145375,=,0,0
145376,0.0261,0,0
145377,and,0,0
145378,p,0,0
145379,=,0,0
145380,0.0158,0,0
145381,for,0,0
145382,8,0,0
145383,and,0,0
145384,12,0,0
145385,mg,0,0
145386,vs,0,0
145387,placebo,0,0
145388,",",0,0
145389,respectively,0,0
145390,),0,0
145391,.,0,0
145392,Fifty,0,0
145393,percent,0,1
145394,responder,0,1
145395,rates,0,1
145396,during,0,0
145397,the,0,0
145398,maintenance,0,0
145399,period,0,0
145400,were,0,0
145401,26.4,0,0
145402,%,0,0
145403,",",0,0
145404,37.6,0,0
145405,%,0,0
145406,",",0,0
145407,and,0,0
145408,36.1,0,0
145409,%,0,0
145410,",",0,0
145411,respectively,0,0
145412,",",0,0
145413,for,0,0
145414,placebo,0,0
145415,",",0,0
145416,perampanel,0,0
145417,8,0,0
145418,mg,0,0
145419,",",0,0
145420,and,0,0
145421,perampanel,0,0
145422,12,0,0
145423,mg,0,0
145424,;,0,0
145425,these,0,0
145426,differences,0,0
145427,were,0,0
145428,not,0,0
145429,statistically,0,0
145430,significant,0,0
145431,for,0,0
145432,8,0,0
145433,mg,0,0
145434,(,0,0
145435,p,0,0
145436,=,0,0
145437,0.0760,0,0
145438,),0,0
145439,or,0,0
145440,12,0,0
145441,mg,0,0
145442,(,0,0
145443,p,0,0
145444,=,0,0
145445,0.0914,0,0
145446,),0,0
145447,.,0,0
145448,Sixty-eight,0,0
145449,(,0,0
145450,17.5,0,0
145451,%,0,0
145452,),0,0
145453,patients,0,0
145454,discontinued,0,0
145455,",",0,0
145456,including,0,0
145457,40,0,0
145458,(,0,0
145459,10.3,0,0
145460,%,0,0
145461,),0,0
145462,for,0,0
145463,adverse,0,1
145464,events,0,1
145465,.,0,0
145466,Most,0,0
145467,frequent,0,0
145468,treatment-emergent,0,1
145469,adverse,0,1
145470,events,0,1
145471,were,1,0
145472,dizziness,1,0
145473,",",1,0
145474,somnolence,1,1
145475,",",1,1
145476,irritability,1,1
145477,",",1,1
145478,headache,1,1
145479,",",1,1
145480,fall,1,1
145481,",",1,1
145482,and,1,0
145483,ataxia,1,0
145484,.,1,0
145485,CONCLUSIONS,1,0
145486,This,0,0
145487,trial,0,0
145488,demonstrated,0,0
145489,that,0,0
145490,once-daily,0,0
145491,",",0,0
145492,adjunctive,0,0
145493,perampanel,0,0
145494,at,0,0
145495,doses,0,0
145496,of,0,0
145497,8,0,0
145498,or,0,0
145499,12,0,0
145500,mg,0,0
145501,improved,1,0
145502,seizure,1,1
145503,control,1,0
145504,in,1,0
145505,patients,0,0
145506,with,0,0
145507,uncontrolled,0,0
145508,partial-onset,0,0
145509,seizures,0,0
145510,.,0,0
145511,Doses,0,0
145512,of,0,0
145513,perampanel,0,0
145514,8,0,0
145515,and,0,0
145516,12,0,0
145517,mg,0,0
145518,were,0,0
145519,safe,0,1
145520,",",0,0
145521,and,0,1
145522,tolerability,0,1
145523,was,0,0
145524,acceptable,0,0
145525,.,0,0
145526,CLASSIFICATION,0,0
145527,OF,0,0
145528,EVIDENCE,0,0
145529,This,0,0
145530,study,0,0
145531,provides,0,0
145532,Class,0,0
145533,I,0,0
145534,evidence,0,0
145535,that,0,0
145536,once-daily,0,0
145537,8,0,0
145538,and,0,0
145539,12,0,0
145540,mg,0,0
145541,doses,0,0
145542,of,0,0
145543,adjunctive,0,0
145544,perampanel,0,0
145545,are,0,0
145546,effective,0,0
145547,in,0,0
145548,patients,0,0
145549,with,0,0
145550,uncontrolled,0,0
145551,partial-onset,0,0
145552,seizures,0,0
145553,.,0,0
145554,Errors,0,0
145555,during,0,0
145556,the,0,0
145557,preparation,0,0
145558,of,0,0
145559,drug,0,0
145560,infusions,0,0
145561,:,0,0
145562,a,0,0
145563,randomized,0,0
145564,controlled,0,0
145565,trial,0,0
145566,.,0,0
145567,BACKGROUND,0,0
145568,We,0,0
145569,investigated,0,0
145570,the,0,0
145571,extent,0,0
145572,and,0,0
145573,frequency,0,1
145574,of,0,1
145575,dose,0,0
145576,errors,0,1
145577,and,0,1
145578,treatment,0,0
145579,delays,0,1
145580,made,0,0
145581,as,0,0
145582,a,0,0
145583,consequence,0,0
145584,of,0,0
145585,preparing,0,0
145586,drug,0,0
145587,infusions,0,0
145588,at,0,0
145589,the,0,0
145590,bedside,0,0
145591,",",0,0
145592,rather,0,0
145593,than,0,0
145594,using,0,0
145595,pre-filled,0,0
145596,syringes,0,0
145597,.,0,0
145598,METHODS,0,0
145599,Forty-eight,0,0
145600,nurses,0,0
145601,with,0,0
145602,critical,0,0
145603,care,0,0
145604,experience,0,0
145605,volunteered,0,0
145606,to,0,0
145607,take,0,0
145608,part,0,0
145609,in,0,0
145610,this,0,0
145611,randomized,0,0
145612,",",0,0
145613,blinded,0,0
145614,",",0,0
145615,controlled,0,0
145616,study,0,0
145617,conducted,0,0
145618,in,0,0
145619,the,0,0
145620,simulation,0,0
145621,centre,0,0
145622,of,0,0
145623,an,0,0
145624,urban,0,0
145625,hospital,0,0
145626,.,0,0
145627,They,0,0
145628,assisted,0,0
145629,in,0,0
145630,the,0,0
145631,management,0,0
145632,of,0,0
145633,a,0,0
145634,simulated,0,0
145635,patient,0,0
145636,with,0,0
145637,septic,0,0
145638,shock,0,0
145639,.,0,0
145640,Vasopressor,0,1
145641,infusions,0,0
145642,were,0,0
145643,prepared,0,0
145644,either,0,0
145645,by,0,0
145646,diluting,0,0
145647,concentrated,0,0
145648,drugs,0,0
145649,from,0,0
145650,ampoules,0,0
145651,or,0,0
145652,were,0,0
145653,provided,0,0
145654,in,0,0
145655,syringes,0,0
145656,pre-filled,0,0
145657,beforehand,0,0
145658,by,0,0
145659,an,0,0
145660,intensive,0,0
145661,care,0,0
145662,unit,0,0
145663,resident,0,0
145664,.,0,0
145665,RESULTS,0,0
145666,The,0,0
145667,time,0,1
145668,taken,0,0
145669,for,0,0
145670,the,0,0
145671,infusion,0,0
145672,to,0,0
145673,be,0,0
145674,started,0,0
145675,and,0,0
145676,the,0,0
145677,final,1,1
145678,concentration,1,1
145679,of,1,0
145680,the,1,0
145681,drugs,1,0
145682,were,1,0
145683,measured,1,0
145684,.,1,0
145685,We,0,0
145686,also,0,0
145687,measured,0,0
145688,the,0,0
145689,concentration,1,1
145690,of,1,0
145691,infusions,1,0
145692,prepared,0,0
145693,by,0,0
145694,a,0,0
145695,pharmacist,0,0
145696,and,0,0
145697,a,0,0
145698,pharmaceutical,0,0
145699,company,0,0
145700,.,0,0
145701,Nurses,0,0
145702,took,0,0
145703,156,0,0
145704,s,0,0
145705,to,0,0
145706,start,0,0
145707,infusions,0,0
145708,when,0,0
145709,using,0,0
145710,pre-filled,0,0
145711,syringes,0,0
145712,compared,0,0
145713,with,0,0
145714,276,0,0
145715,s,0,0
145716,when,0,0
145717,preparing,0,0
145718,them,0,0
145719,de,0,0
145720,novo,0,0
145721,",",0,0
145722,a,0,0
145723,mean,0,1
145724,delay,0,1
145725,of,0,0
145726,106,0,0
145727,s,0,0
145728,[,0,0
145729,95,0,0
145730,%,0,0
145731,confidence,0,0
145732,interval,0,0
145733,(,0,0
145734,CI,0,0
145735,),0,0
145736,73-140,0,0
145737,s,0,0
145738,",",0,0
145739,P,0,0
145740,<,0,0
145741,0.0001,0,0
145742,],0,0
145743,.,0,0
145744,One,0,0
145745,infusion,0,0
145746,prepared,0,0
145747,from,0,0
145748,ampoules,0,0
145749,contained,0,0
145750,one-fifth,0,0
145751,of,0,0
145752,the,0,0
145753,expected,0,0
145754,concentration,0,1
145755,of,0,0
145756,epinephrine,0,0
145757,;,0,0
145758,another,0,0
145759,contained,0,0
145760,none,0,0
145761,at,0,0
145762,all,0,0
145763,.,0,0
145764,Medication,1,0
145765,errors,1,0
145766,were,0,0
145767,17.0,0,0
145768,times,0,0
145769,less,0,0
145770,likely,0,0
145771,when,0,0
145772,pre-filled,0,0
145773,syringes,0,0
145774,were,0,0
145775,used,0,0
145776,(,0,0
145777,95,0,0
145778,%,0,0
145779,CI,0,0
145780,5.2-55.5,0,0
145781,),0,0
145782,",",0,0
145783,and,0,1
145784,infusions,0,0
145785,prepared,0,0
145786,by,0,0
145787,pharmacy,0,0
145788,and,0,1
145789,industry,0,1
145790,were,0,0
145791,significantly,0,0
145792,more,0,0
145793,likely,0,0
145794,to,0,0
145795,contain,0,0
145796,the,0,0
145797,expected,0,0
145798,concentration,0,1
145799,(,0,0
145800,P,0,0
145801,<,0,0
145802,0.001,0,0
145803,for,0,0
145804,norepinephrine,0,0
145805,and,0,0
145806,P=0.001,0,0
145807,for,0,0
145808,epinephrine,0,0
145809,),0,0
145810,.,0,0
145811,CONCLUSIONS,0,0
145812,Providing,0,0
145813,drug,0,0
145814,infusions,0,0
145815,in,0,0
145816,syringes,0,0
145817,pre-filled,0,0
145818,by,0,0
145819,pharmacists,0,0
145820,or,0,0
145821,pharmaceutical,0,0
145822,companies,0,0
145823,would,0,0
145824,reduce,0,0
145825,medication,1,1
145826,errors,1,1
145827,and,1,1
145828,treatment,1,0
145829,delays,1,1
145830,",",0,0
145831,and,0,1
145832,improve,0,1
145833,patient,1,1
145834,safety,1,1
145835,.,1,0
145836,However,0,0
145837,",",0,0
145838,this,0,0
145839,approach,0,0
145840,would,0,0
145841,have,0,0
145842,substantial,0,0
145843,financial,0,1
145844,implications,0,0
145845,for,0,0
145846,healthcare,0,1
145847,providers,0,0
145848,",",0,0
145849,especially,0,0
145850,in,0,0
145851,less,0,0
145852,developed,0,0
145853,countries,0,0
145854,.,0,0
145855,[,0,0
145856,Does,0,0
145857,urapidil,0,0
145858,attenuate,0,0
145859,the,0,0
145860,hypertensive,1,0
145861,response,1,0
145862,to,1,0
145863,tracheal,1,0
145864,intubation,1,0
145865,at,0,0
145866,the,0,0
145867,time,0,1
145868,of,0,0
145869,general,0,0
145870,anesthesia,0,0
145871,?,0,0
145872,],0,0
145873,.,0,0
145874,Who,0,0
145875,is,0,0
145876,at,0,0
145877,low,0,0
145878,risk,0,1
145879,for,0,0
145880,cardiovascular,0,1
145881,disease,0,0
145882,?,0,0
145883,An,0,0
145884,assessment,0,0
145885,of,0,0
145886,different,0,0
145887,definitions,0,0
145888,.,0,0
145889,BACKGROUND,0,0
145890,There,0,0
145891,is,0,0
145892,little,0,0
145893,information,0,0
145894,regarding,0,0
145895,the,0,0
145896,determinants,0,0
145897,and,0,0
145898,trends,0,0
145899,of,0,0
145900,the,0,0
145901,prevalence,0,0
145902,of,0,0
145903,low,1,0
145904,cardiovascular,1,1
145905,risk,1,1
145906,factor,1,1
145907,(,0,0
145908,RF,0,0
145909,),0,0
145910,profile,0,0
145911,in,0,0
145912,the,0,0
145913,general,0,0
145914,population,0,0
145915,.,0,0
145916,The,0,0
145917,aim,0,0
145918,of,0,0
145919,this,0,0
145920,study,0,0
145921,was,0,0
145922,to,0,0
145923,assess,0,0
145924,the,0,0
145925,prevalence,1,0
145926,and,1,0
145927,trends,1,1
145928,of,1,0
145929,low,1,0
145930,RF,1,0
145931,profile,1,1
145932,in,0,0
145933,the,0,0
145934,Swiss,0,0
145935,population,0,0
145936,according,0,0
145937,to,0,0
145938,different,0,0
145939,definitions,0,0
145940,.,0,0
145941,METHODS,0,0
145942,Population-based,0,0
145943,cross-sectional,0,0
145944,studies,0,0
145945,conducted,0,0
145946,in,0,0
145947,1984-1986,0,0
145948,(,0,0
145949,N=3300,0,0
145950,),0,0
145951,",",0,0
145952,1988-1989,0,0
145953,(,0,0
145954,N=3331,0,0
145955,),0,0
145956,",",0,0
145957,1992-1993,0,0
145958,(,0,0
145959,N=3133,0,0
145960,),0,0
145961,and,0,0
145962,2003-2006,0,0
145963,(,0,0
145964,N=6170,0,0
145965,),0,0
145966,and,0,0
145967,restricted,0,0
145968,to,0,0
145969,age,0,0
145970,group,0,0
145971,35-75,0,0
145972,years,0,0
145973,.,0,0
145974,Seven,0,0
145975,different,0,0
145976,definitions,0,0
145977,of,0,0
145978,low,0,0
145979,RF,0,0
145980,profile,0,1
145981,were,0,0
145982,used,0,0
145983,to,0,0
145984,assess,0,0
145985,determinants,0,0
145986,",",0,0
145987,while,0,0
145988,two,0,0
145989,definitions,0,0
145990,were,0,0
145991,used,0,0
145992,to,0,0
145993,assess,0,0
145994,trends,0,0
145995,.,0,0
145996,RESULTS,0,0
145997,Prevalence,0,1
145998,of,0,0
145999,low,1,0
146000,RF,1,0
146001,profile,1,1
146002,varied,0,0
146003,between,0,0
146004,6.5,0,0
146005,%,0,0
146006,(,0,0
146007,95,0,0
146008,%,0,0
146009,confidence,0,0
146010,interval,0,0
146011,:,0,0
146012,5.9-7.1,0,0
146013,),0,0
146014,and,0,0
146015,9.7,0,0
146016,%,0,0
146017,(,0,0
146018,9.0-10.5,0,0
146019,),0,0
146020,depending,0,0
146021,on,0,0
146022,the,0,0
146023,definition,0,0
146024,used,0,0
146025,.,0,0
146026,This,0,0
146027,prevalence,0,0
146028,was,0,0
146029,higher,0,0
146030,than,0,0
146031,in,0,0
146032,other,0,0
146033,countries,0,0
146034,.,0,0
146035,Irrespective,0,0
146036,of,0,0
146037,the,0,0
146038,definition,0,0
146039,used,0,0
146040,",",0,0
146041,the,0,0
146042,prevalence,0,0
146043,of,0,0
146044,low,1,0
146045,RF,1,0
146046,profile,1,1
146047,was,0,0
146048,higher,0,0
146049,in,0,0
146050,women,0,0
146051,and,0,0
146052,in,0,0
146053,physically,0,0
146054,active,0,0
146055,participants,0,0
146056,",",0,0
146057,and,0,1
146058,decreased,0,1
146059,with,0,0
146060,increasing,0,0
146061,age,0,0
146062,or,0,0
146063,in,0,0
146064,the,0,0
146065,presence,0,0
146066,of,0,0
146067,a,0,0
146068,family,0,0
146069,history,0,0
146070,of,0,0
146071,cardiovascular,0,1
146072,disease,0,0
146073,.,0,0
146074,Using,0,0
146075,one,0,0
146076,definition,0,0
146077,",",0,0
146078,the,0,0
146079,prevalence,0,0
146080,of,0,0
146081,low,0,0
146082,RF,1,0
146083,profile,1,1
146084,increased,0,0
146085,from,0,0
146086,3.8,0,0
146087,%,0,0
146088,(,0,0
146089,3.1-4.5,0,0
146090,),0,0
146091,in,0,0
146092,1984-1986,0,0
146093,to,0,0
146094,6.7,0,0
146095,%,0,0
146096,(,0,0
146097,6.1-7.3,0,0
146098,),0,0
146099,in,0,0
146100,2003-2006,0,0
146101,;,0,0
146102,using,0,0
146103,another,0,0
146104,definition,0,0
146105,",",0,0
146106,the,0,0
146107,results,0,0
146108,were,0,0
146109,5.9,0,0
146110,%,0,0
146111,(,0,0
146112,5.1-6.8,0,1
146113,),0,0
146114,and,0,0
146115,9.7,0,0
146116,%,0,0
146117,(,0,0
146118,9.0-10.5,0,0
146119,),0,0
146120,",",0,0
146121,respectively,0,0
146122,.,0,0
146123,CONCLUSION,0,0
146124,Switzerland,0,0
146125,is,0,0
146126,characterized,0,0
146127,by,0,0
146128,a,0,0
146129,high,0,0
146130,and,0,0
146131,increasing,0,0
146132,prevalence,0,1
146133,of,0,0
146134,low,0,0
146135,RF,0,0
146136,profile,0,1
146137,within,0,0
146138,the,0,0
146139,age,0,0
146140,group,0,0
146141,35,0,0
146142,to,0,0
146143,75,0,0
146144,",",0,0
146145,irrespective,0,0
146146,of,0,0
146147,the,0,0
146148,criteria,0,0
146149,used,0,0
146150,.,0,0
146151,This,0,0
146152,high,0,0
146153,prevalence,0,0
146154,might,0,0
146155,partly,0,0
146156,explain,0,0
146157,the,0,0
146158,low,0,0
146159,and,0,0
146160,decreasing,1,1
146161,trend,1,0
146162,in,1,0
146163,cardiovascular,1,1
146164,mortality,1,1
146165,rates,1,1
146166,.,1,0
146167,Long-term,0,0
146168,effects,0,0
146169,of,0,0
146170,ezetimibe-plus-statin,0,0
146171,therapy,0,0
146172,on,0,0
146173,low-density,1,1
146174,lipoprotein,1,1
146175,cholesterol,1,1
146176,levels,1,1
146177,as,0,0
146178,compared,0,0
146179,with,0,0
146180,double-dose,0,0
146181,statin,0,0
146182,therapy,0,0
146183,in,0,0
146184,patients,0,0
146185,with,0,0
146186,coronary,0,0
146187,artery,0,0
146188,disease,0,0
146189,.,0,0
146190,OBJECTIVE,0,0
146191,To,0,0
146192,assess,0,0
146193,the,0,0
146194,mechanism,0,0
146195,of,0,0
146196,long-term,0,0
146197,LDL-C-lowering,0,0
146198,effect,0,0
146199,of,0,0
146200,ezetimibe-plus-statin,0,0
146201,.,0,0
146202,METHODS,0,0
146203,Coronary,0,0
146204,artery,0,1
146205,disease,0,1
146206,patients,0,0
146207,whose,0,0
146208,LDL-C,0,0
146209,?,0,0
146210,70,0,0
146211,mg/dL,0,0
146212,after,0,0
146213,treatment,0,0
146214,with,0,0
146215,atorvastatin,0,0
146216,10,0,0
146217,mg/day,0,0
146218,or,0,0
146219,rosuvastatin,0,0
146220,2.5,0,0
146221,mg/day,0,0
146222,were,0,0
146223,randomly,0,0
146224,assigned,0,0
146225,to,0,0
146226,receive,0,0
146227,ezetimibe,0,0
146228,10,0,0
146229,mg/day,0,0
146230,+,0,0
146231,statin,0,0
146232,(,0,0
146233,n,0,0
146234,=,0,0
146235,78,0,0
146236,),0,0
146237,or,0,0
146238,double-dose,0,0
146239,statin,0,0
146240,(,0,0
146241,n,0,0
146242,=,0,0
146243,72,0,0
146244,),0,0
146245,for,0,0
146246,52,0,0
146247,weeks,0,0
146248,.,0,0
146249,RESULTS,0,0
146250,Greater,1,0
146251,LDL-C,1,1
146252,reduction,1,1
146253,was,1,0
146254,observed,0,0
146255,and,0,0
146256,maintained,0,0
146257,until,0,0
146258,52,0,0
146259,weeks,0,0
146260,in,0,0
146261,ezetimibe-plus-statin,0,0
146262,",",0,0
146263,while,1,0
146264,LDL-C,1,1
146265,levels,1,1
146266,re-increased,1,0
146267,after,0,0
146268,12,0,0
146269,weeks,0,0
146270,in,0,0
146271,double-dose,0,0
146272,statin,0,0
146273,.,0,0
146274,Although,1,0
146275,lathosterol/TC,1,0
146276,increased,1,0
146277,",",1,0
146278,campesterol/TC,1,1
146279,decreased,1,0
146280,more,0,0
146281,in,0,0
146282,ezetimibe-plus-statin,0,0
146283,.,0,0
146284,In,0,0
146285,contrast,1,0
146286,",",1,0
146287,lathosterol/TC,1,1
146288,unchanged,1,1
146289,and,1,1
146290,campesterol/TC,1,1
146291,increased,1,1
146292,",",0,0
146293,increasing,1,1
146294,campesterol/lathosterol,1,1
146295,ratio,1,1
146296,for,1,0
146297,52,0,0
146298,weeks,0,0
146299,in,0,0
146300,double-dose,0,0
146301,statin,1,0
146302,.,1,0
146303,Plasma,1,1
146304,PCSK9,1,0
146305,levels,1,1
146306,were,1,0
146307,higher,0,0
146308,in,0,0
146309,double-dose,0,0
146310,statin,0,0
146311,than,0,0
146312,in,0,0
146313,ezetimibe-plus-statin,0,0
146314,at,0,0
146315,12,0,0
146316,weeks,0,0
146317,",",0,0
146318,but,0,0
146319,similar,0,0
146320,at,0,0
146321,52,0,0
146322,weeks,0,0
146323,.,0,0
146324,CONCLUSION,0,0
146325,Although,0,0
146326,the,0,0
146327,difference,0,0
146328,in,0,0
146329,PCSK9,0,0
146330,between,0,0
146331,2,0,0
146332,groups,0,0
146333,was,0,0
146334,transient,0,1
146335,",",0,0
146336,that,0,0
146337,in,0,0
146338,both,0,0
146339,campesterol,0,1
146340,and,0,0
146341,lathosterol,0,1
146342,persisted,0,0
146343,until,0,0
146344,52,0,0
146345,weeks,0,0
146346,.,0,0
146347,These,0,0
146348,results,0,0
146349,demonstrated,0,0
146350,simultaneous,0,0
146351,inhibition,0,1
146352,of,0,0
146353,cholesterol,0,1
146354,absorption,0,1
146355,and,0,0
146356,synthesis,0,1
146357,provides,0,0
146358,stable,0,1
146359,and,0,0
146360,greater,0,0
146361,decrease,0,1
146362,in,0,0
146363,LDL-C,1,0
146364,levels,1,1
146365,.,1,0
146366,Irrigation,0,0
146367,with,0,0
146368,bupivacaine,0,0
146369,at,0,0
146370,the,0,0
146371,surgical,0,0
146372,bed,0,0
146373,for,0,0
146374,postoperative,1,1
146375,pain,1,1
146376,relief,1,1
146377,after,0,0
146378,laparoscopic,0,0
146379,cholecystectomy,0,0
146380,.,0,0
146381,PURPOSE,0,0
146382,The,0,0
146383,aim,0,0
146384,of,0,0
146385,this,0,0
146386,study,0,0
146387,was,0,0
146388,to,0,0
146389,evaluate,0,0
146390,the,0,0
146391,effect,1,0
146392,of,0,0
146393,bupivacaine,0,0
146394,irrigated,0,0
146395,at,0,0
146396,the,0,0
146397,surgical,0,0
146398,bed,0,0
146399,on,0,0
146400,postoperative,1,1
146401,pain,1,1
146402,relief,1,1
146403,in,0,0
146404,laparoscopic,0,0
146405,cholecystectomy,0,0
146406,patients,0,0
146407,.,0,0
146408,METHODS,0,0
146409,This,0,0
146410,study,0,0
146411,included,0,0
146412,60,0,0
146413,patients,0,0
146414,undergoing,0,0
146415,elective,0,0
146416,laparoscopic,0,0
146417,cholecystectomy,0,0
146418,who,0,0
146419,were,0,0
146420,prospectively,0,0
146421,randomized,0,0
146422,into,0,0
146423,2,0,0
146424,groups,0,0
146425,.,0,0
146426,The,0,0
146427,placebo,0,0
146428,group,0,0
146429,(,0,0
146430,n=30,0,0
146431,),0,0
146432,received,0,0
146433,20cc,0,0
146434,saline,0,0
146435,without,0,0
146436,bupivacaine,0,0
146437,",",0,0
146438,installed,0,0
146439,into,0,0
146440,the,0,0
146441,gallbladder,0,0
146442,bed,0,0
146443,.,0,0
146444,The,0,0
146445,bupivacaine,0,0
146446,group,0,0
146447,(,0,0
146448,n=30,0,0
146449,),0,0
146450,received,0,0
146451,20cc,0,0
146452,of,0,0
146453,0.5,0,0
146454,%,0,0
146455,bupivacaine,0,0
146456,in,0,0
146457,at,0,0
146458,the,0,0
146459,same,0,0
146460,surgical,0,0
146461,site,0,0
146462,.,0,0
146463,Pain,1,1
146464,was,0,0
146465,assessed,0,0
146466,at,0,0
146467,0,0,0
146468,",",0,0
146469,6,0,0
146470,",",0,0
146471,12,0,0
146472,",",0,0
146473,and,0,0
146474,24,0,0
146475,hours,0,0
146476,by,0,0
146477,using,0,0
146478,a,0,0
146479,visual,0,1
146480,analog,0,1
146481,scale,0,1
146482,(,0,0
146483,VAS,0,0
146484,),0,0
146485,.,0,0
146486,RESULTS,0,0
146487,A,0,0
146488,significant,0,0
146489,difference,0,0
146490,(,0,0
146491,P=.018,0,1
146492,),0,0
146493,was,0,0
146494,observed,0,0
146495,in,0,0
146496,pain,1,1
146497,levels,1,1
146498,between,0,0
146499,both,0,0
146500,groups,0,0
146501,at,0,0
146502,6,0,0
146503,hours,0,0
146504,postoperatively,0,0
146505,.,0,0
146506,The,0,0
146507,average,1,0
146508,analgesic,1,1
146509,requirement,1,1
146510,was,0,0
146511,lower,0,0
146512,in,0,0
146513,the,0,0
146514,bupivacaine,0,0
146515,group,0,0
146516,",",0,0
146517,but,0,0
146518,this,0,0
146519,did,0,0
146520,not,0,0
146521,reach,0,0
146522,statistical,0,0
146523,significance,0,0
146524,.,0,0
146525,CONCLUSIONS,0,0
146526,In,0,0
146527,our,0,0
146528,study,0,0
146529,",",0,0
146530,the,0,0
146531,use,0,0
146532,of,0,0
146533,bupivacaine,0,0
146534,irrigated,0,0
146535,over,0,0
146536,the,0,0
146537,surgical,0,0
146538,bed,0,0
146539,was,0,0
146540,an,0,0
146541,effective,0,1
146542,method,0,0
146543,for,0,0
146544,reducing,0,0
146545,pain,1,1
146546,during,0,0
146547,the,0,0
146548,first,0,0
146549,postoperative,0,1
146550,hours,0,0
146551,after,0,0
146552,laparoscopic,0,0
146553,cholecystectomy,0,0
146554,.,0,0
146555,Computer-delivered,0,0
146556,tailored,0,0
146557,intervention,0,0
146558,improves,0,1
146559,colon,1,0
146560,cancer,1,0
146561,screening,1,0
146562,knowledge,1,1
146563,and,0,1
146564,health,0,1
146565,beliefs,0,1
146566,of,0,0
146567,African-Americans,0,0
146568,.,0,0
146569,We,0,0
146570,conducted,0,0
146571,a,0,0
146572,randomized,0,0
146573,controlled,0,0
146574,trial,0,0
146575,among,0,0
146576,African-American,0,0
146577,patients,0,0
146578,attending,0,0
146579,a,0,0
146580,primary-care,0,0
146581,provider,0,0
146582,visit,0,1
146583,to,0,0
146584,compare,0,0
146585,efficacy,0,1
146586,of,0,0
146587,a,0,0
146588,computer-delivered,0,0
146589,tailored,0,0
146590,intervention,0,0
146591,to,0,0
146592,increase,0,0
146593,colorectal,1,0
146594,cancer,1,0
146595,(,1,0
146596,CRC,1,0
146597,),1,1
146598,screening,1,0
146599,(,0,0
146600,n,0,0
146601,=,0,0
146602,273,0,0
146603,),0,0
146604,with,0,0
146605,non-tailored,0,0
146606,print,0,0
146607,material-an,0,0
146608,American,0,0
146609,Cancer,0,0
146610,Society,0,0
146611,brochure,0,0
146612,on,0,0
146613,CRC,0,1
146614,screening,0,0
146615,(,0,0
146616,n,0,0
146617,=,0,0
146618,283,0,0
146619,),0,0
146620,.,0,0
146621,Health,0,1
146622,Belief,0,1
146623,Model,0,1
146624,constructs,0,1
146625,were,0,0
146626,used,0,0
146627,to,0,0
146628,develop,0,0
146629,tailored,0,0
146630,messages,0,0
146631,and,0,0
146632,examined,0,0
146633,as,0,0
146634,outcomes,0,1
146635,.,0,0
146636,Analysis,0,0
146637,of,0,0
146638,covariance,0,1
146639,models,0,0
146640,were,0,0
146641,used,0,0
146642,to,0,0
146643,compare,0,0
146644,changes,0,1
146645,between,0,0
146646,CRC,1,0
146647,knowledge,1,1
146648,and,1,1
146649,health,1,1
146650,belief,1,1
146651,scores,1,1
146652,at,0,0
146653,baseline,0,0
146654,and,0,0
146655,1,0,0
146656,week,0,0
146657,post-intervention,0,0
146658,.,0,0
146659,At,0,0
146660,1,0,0
146661,week,0,0
146662,",",0,0
146663,patients,0,0
146664,who,0,0
146665,received,0,0
146666,the,0,0
146667,computer-delivered,0,0
146668,tailored,0,0
146669,intervention,0,0
146670,had,0,0
146671,greater,0,0
146672,changes,0,1
146673,in,0,0
146674,CRC,1,0
146675,knowledge,1,1
146676,scores,1,1
146677,(,1,0
146678,P,1,0
146679,<,1,0
146680,0.001,1,0
146681,),1,0
146682,",",1,0
146683,perceived,1,1
146684,CRC,1,1
146685,risk,1,1
146686,scores,1,1
146687,(,1,0
146688,P,1,0
146689,=,1,0
146690,0.005,1,0
146691,),1,0
146692,",",1,0
146693,FOBT,1,1
146694,barriers,1,1
146695,scores,1,1
146696,(,1,0
146697,P,1,0
146698,=,1,0
146699,0.034,1,0
146700,),1,0
146701,and,1,0
146702,colonoscopy,1,1
146703,benefit,1,1
146704,scores,1,1
146705,(,1,0
146706,P,1,0
146707,<,1,0
146708,0.001,1,0
146709,),1,0
146710,.,1,0
146711,Findings,0,0
146712,show,0,0
146713,that,0,0
146714,computer-delivered,0,0
146715,tailored,0,0
146716,interventions,0,0
146717,are,0,0
146718,an,0,0
146719,effective,0,0
146720,adjunct,0,0
146721,to,0,0
146722,the,0,0
146723,clinical,0,0
146724,encounter,0,0
146725,that,0,0
146726,can,0,0
146727,improve,0,0
146728,knowledge,1,1
146729,and,1,1
146730,health,1,1
146731,beliefs,1,1
146732,about,1,0
146733,CRC,1,0
146734,screening,1,0
146735,",",0,0
146736,necessary,0,0
146737,precursors,0,1
146738,to,0,0
146739,behavior,0,1
146740,change,0,0
146741,.,0,0
146742,Psychological,0,0
146743,adjustment,0,0
146744,and,0,0
146745,levels,0,1
146746,of,0,1
146747,self,0,1
146748,esteem,0,1
146749,in,0,0
146750,children,0,0
146751,with,0,0
146752,visual-motor,0,1
146753,integration,0,0
146754,difficulties,0,0
146755,influences,0,0
146756,the,0,0
146757,results,0,0
146758,of,0,0
146759,a,0,0
146760,randomized,0,0
146761,intervention,0,0
146762,trial,0,0
146763,.,0,0
146764,This,0,0
146765,study,0,0
146766,evaluates,0,0
146767,how,0,0
146768,much,0,0
146769,the,0,0
146770,effects,0,0
146771,of,0,0
146772,intervention,0,0
146773,programs,0,0
146774,are,0,0
146775,influenced,0,0
146776,by,0,0
146777,pre-existing,0,0
146778,psychological,0,1
146779,adjustment,0,0
146780,and,0,0
146781,self-esteem,0,1
146782,levels,0,1
146783,in,0,0
146784,kindergarten,0,0
146785,and,0,0
146786,first,0,1
146787,grade,0,1
146788,children,0,0
146789,with,0,0
146790,poor,0,1
146791,visual-motor,0,1
146792,integration,0,1
146793,skills,0,1
146794,",",0,0
146795,from,0,0
146796,low,0,0
146797,socioeconomic,0,0
146798,backgrounds,0,0
146799,.,0,0
146800,One,0,0
146801,hundred,0,0
146802,and,0,0
146803,sixteen,0,0
146804,mainstream,0,0
146805,kindergarten,0,0
146806,and,0,1
146807,first-grade,0,0
146808,children,0,0
146809,",",0,0
146810,from,0,0
146811,low,0,0
146812,socioeconomic,0,0
146813,backgrounds,0,0
146814,",",0,0
146815,scoring,0,0
146816,below,0,0
146817,the,0,0
146818,25th,0,0
146819,percentile,0,0
146820,on,0,0
146821,a,0,0
146822,measure,0,0
146823,of,0,0
146824,visual-motor,0,1
146825,integration,0,1
146826,(,0,0
146827,VMI,0,1
146828,),0,0
146829,were,0,0
146830,recruited,0,0
146831,and,0,0
146832,randomly,0,0
146833,divided,0,0
146834,into,0,0
146835,two,0,0
146836,parallel,0,0
146837,intervention,0,0
146838,groups,0,0
146839,.,0,0
146840,One,0,0
146841,intervention,0,0
146842,group,0,0
146843,received,0,0
146844,directive,0,1
146845,visual-motor,0,1
146846,intervention,0,0
146847,(,0,0
146848,DVMI,0,0
146849,),0,0
146850,",",0,0
146851,while,0,0
146852,the,0,0
146853,second,0,0
146854,intervention,0,0
146855,group,0,0
146856,received,0,0
146857,a,0,0
146858,non-directive,0,0
146859,supportive,0,0
146860,intervention,0,0
146861,(,0,0
146862,NDSI,0,0
146863,),0,0
146864,.,0,0
146865,Tests,0,1
146866,were,0,0
146867,administered,0,0
146868,to,0,0
146869,evaluate,0,0
146870,visual-motor,0,0
146871,integration,0,0
146872,skills,0,1
146873,outcome,0,0
146874,.,0,0
146875,Children,0,0
146876,with,0,0
146877,higher,0,0
146878,baseline,0,0
146879,measures,0,1
146880,of,0,0
146881,psychological,0,1
146882,adjustment,0,0
146883,and,0,1
146884,self-esteem,0,1
146885,responded,0,0
146886,better,0,0
146887,in,0,0
146888,NDSI,0,0
146889,while,0,0
146890,children,0,0
146891,with,0,0
146892,lower,0,0
146893,baseline,0,0
146894,performance,0,1
146895,on,0,0
146896,psychological,0,1
146897,adjustment,0,0
146898,and,0,1
146899,self-esteem,0,1
146900,responded,0,0
146901,better,0,0
146902,in,0,0
146903,DVMI,0,0
146904,.,0,0
146905,This,0,0
146906,study,0,0
146907,suggests,0,0
146908,that,0,0
146909,children,0,0
146910,from,0,0
146911,low,0,0
146912,socioeconomic,0,0
146913,backgrounds,0,0
146914,with,0,0
146915,low,0,0
146916,VMI,0,0
146917,performance,0,1
146918,scores,0,1
146919,will,0,0
146920,benefit,0,0
146921,more,0,0
146922,from,0,0
146923,intervention,0,0
146924,programs,0,0
146925,if,0,0
146926,clinicians,0,0
146927,choose,0,0
146928,the,0,0
146929,type,0,0
146930,of,0,0
146931,intervention,0,0
146932,according,0,0
146933,to,0,0
146934,baseline,0,0
146935,psychological,0,1
146936,adjustment,0,0
146937,and,0,0
146938,self-esteem,0,1
146939,measures,0,0
146940,.,0,0
146941,Mindfulness-based,0,0
146942,therapy,0,0
146943,in,0,0
146944,adults,0,0
146945,with,0,0
146946,an,0,0
146947,autism,0,0
146948,spectrum,0,0
146949,disorder,0,0
146950,:,0,0
146951,a,0,0
146952,randomized,0,0
146953,controlled,0,0
146954,trial,0,0
146955,.,0,0
146956,Research,0,0
146957,shows,0,0
146958,that,0,0
146959,depression,0,1
146960,and,0,1
146961,anxiety,0,1
146962,disorders,0,0
146963,are,0,0
146964,the,0,0
146965,most,0,0
146966,common,0,0
146967,psychiatric,0,0
146968,concern,0,0
146969,in,0,0
146970,autism,0,0
146971,spectrum,0,0
146972,disorders,0,0
146973,(,0,0
146974,ASD,0,0
146975,),0,0
146976,.,0,0
146977,Mindfulness-based,0,0
146978,therapy,0,0
146979,(,0,0
146980,MBT,0,0
146981,),0,0
146982,has,0,0
146983,been,0,0
146984,found,0,0
146985,effective,0,0
146986,in,0,0
146987,reducing,0,0
146988,anxiety,1,1
146989,and,1,1
146990,depression,1,1
146991,symptoms,1,1
146992,",",0,0
146993,however,0,0
146994,research,0,0
146995,in,0,0
146996,autism,0,0
146997,is,0,0
146998,limited,0,0
146999,.,0,0
147000,Therefore,0,0
147001,",",0,0
147002,we,0,0
147003,examined,0,0
147004,the,0,0
147005,effects,0,0
147006,of,0,0
147007,a,0,0
147008,modified,0,0
147009,MBT,0,1
147010,protocol,0,0
147011,(,0,0
147012,MBT-AS,0,1
147013,),0,0
147014,in,0,0
147015,high-functioning,0,0
147016,adults,0,0
147017,with,0,0
147018,ASD,0,0
147019,.,0,0
147020,42,0,0
147021,participants,0,0
147022,were,0,0
147023,randomized,0,0
147024,into,0,0
147025,a,0,0
147026,9-week,0,0
147027,MBT-AS,0,0
147028,training,0,0
147029,or,0,0
147030,a,0,0
147031,wait-list,0,0
147032,control,0,0
147033,group,0,0
147034,.,0,0
147035,Results,0,0
147036,showed,0,0
147037,a,0,0
147038,significant,0,0
147039,reduction,0,1
147040,in,0,0
147041,depression,1,1
147042,",",1,0
147043,anxiety,1,1
147044,and,1,1
147045,rumination,1,1
147046,in,0,0
147047,the,0,0
147048,intervention,0,0
147049,group,0,0
147050,",",0,0
147051,as,0,0
147052,opposed,0,0
147053,to,0,0
147054,the,0,0
147055,control,0,0
147056,group,0,0
147057,.,0,0
147058,Furthermore,0,0
147059,",",0,0
147060,positive,1,1
147061,affect,1,0
147062,increased,0,0
147063,in,0,0
147064,the,0,0
147065,intervention,0,0
147066,group,0,0
147067,",",0,0
147068,but,0,0
147069,not,0,0
147070,in,0,0
147071,the,0,0
147072,control,0,0
147073,group,0,0
147074,.,0,0
147075,Concluding,0,0
147076,",",0,0
147077,the,0,0
147078,present,0,0
147079,study,0,0
147080,is,0,0
147081,the,0,0
147082,first,0,0
147083,controlled,0,0
147084,trial,0,0
147085,to,0,0
147086,demonstrate,0,0
147087,that,0,0
147088,adults,0,0
147089,with,0,0
147090,ASD,0,0
147091,can,0,0
147092,benefit,0,0
147093,from,0,0
147094,MBT-AS,0,0
147095,.,0,0
147096,Airway,1,1
147097,responses,1,1
147098,and,1,1
147099,inflammation,1,1
147100,in,0,0
147101,subjects,0,0
147102,with,0,0
147103,asthma,0,0
147104,after,0,0
147105,four,0,0
147106,days,0,0
147107,of,0,0
147108,repeated,0,0
147109,high-single-dose,0,0
147110,allergen,0,0
147111,challenge,0,0
147112,.,0,0
147113,BACKGROUND,0,0
147114,Both,0,0
147115,standard,0,0
147116,and,0,0
147117,low-dose,0,0
147118,allergen,0,0
147119,provocations,0,0
147120,are,0,0
147121,an,0,0
147122,established,0,0
147123,tool,0,0
147124,in,0,0
147125,asthma,0,0
147126,research,0,0
147127,to,0,0
147128,improve,0,0
147129,our,0,0
147130,understanding,0,0
147131,of,0,0
147132,the,0,0
147133,pathophysiological,0,0
147134,mechanism,0,0
147135,of,0,0
147136,allergic,0,0
147137,asthma,0,0
147138,.,0,0
147139,However,0,0
147140,",",0,0
147141,clinical,0,0
147142,symptoms,0,1
147143,are,0,0
147144,less,0,0
147145,likely,0,0
147146,to,0,0
147147,be,0,0
147148,induced,0,0
147149,.,0,0
147150,Therefore,0,0
147151,",",0,0
147152,we,0,0
147153,designed,0,0
147154,a,0,0
147155,protocol,0,0
147156,for,0,0
147157,repetitive,0,1
147158,high-dose,0,0
147159,bronchial,0,0
147160,allergen,0,0
147161,challenges,0,0
147162,to,0,0
147163,generate,0,0
147164,clinical,0,0
147165,symptoms,0,1
147166,and,0,0
147167,airway,0,1
147168,inflammation,0,1
147169,.,0,0
147170,METHODS,0,0
147171,A,0,0
147172,total,0,1
147173,of,0,0
147174,27,0,0
147175,patients,0,0
147176,aged,0,0
147177,18,0,0
147178,to,0,0
147179,40,0,0
147180,years,0,0
147181,with,0,0
147182,positive,0,0
147183,skin-prick,0,1
147184,tests,0,1
147185,and,0,0
147186,mild,0,1
147187,asthma,0,0
147188,underwent,0,0
147189,repetitive,0,1
147190,high-dose,0,0
147191,allergen,0,0
147192,challenges,0,0
147193,with,0,0
147194,household,0,1
147195,dust,0,0
147196,mites,0,0
147197,for,0,0
147198,four,0,0
147199,consecutive,0,0
147200,days,0,0
147201,.,0,0
147202,Pulmonary,1,1
147203,function,1,1
147204,and,1,0
147205,exhaled,1,1
147206,NO,1,1
147207,were,0,0
147208,measured,0,0
147209,at,0,0
147210,every,0,0
147211,visit,0,0
147212,.,0,0
147213,Induced,1,0
147214,sputum,1,0
147215,was,0,0
147216,analysed,0,0
147217,before,0,0
147218,and,0,0
147219,after,0,0
147220,the,0,0
147221,allergen,0,0
147222,challenges,0,0
147223,for,0,0
147224,cell,0,1
147225,counts,0,1
147226,",",0,0
147227,ECP,0,1
147228,",",0,1
147229,IL-5,0,0
147230,",",0,1
147231,INF-?,0,1
147232,",",0,1
147233,IL-8,0,1
147234,",",0,0
147235,and,0,0
147236,the,0,0
147237,transcription,0,1
147238,factor,0,0
147239,Foxp3,0,1
147240,.,0,0
147241,RESULTS,0,0
147242,We,0,0
147243,found,0,0
147244,a,0,0
147245,significant,0,0
147246,decrease,0,0
147247,in,1,0
147248,pulmonary,1,1
147249,function,1,1
147250,",",1,0
147251,an,0,0
147252,increased,0,0
147253,use,0,0
147254,of,0,0
147255,salbutamol,0,0
147256,and,0,0
147257,the,1,0
147258,development,1,0
147259,of,1,0
147260,a,1,0
147261,late,1,0
147262,asthmatic,1,0
147263,response,1,1
147264,and,1,0
147265,bronchial,1,1
147266,hyperresponsiveness,1,1
147267,",",1,0
147268,as,0,0
147269,well,0,0
147270,as,0,0
147271,a,0,0
147272,significant,1,0
147273,induction,1,0
147274,of,1,0
147275,eNO,1,0
147276,",",1,0
147277,eosinophils,1,1
147278,",",1,1
147279,and,1,1
147280,Th-2,1,0
147281,cytokines,1,1
147282,.,1,0
147283,Repeated,1,0
147284,provocation,1,0
147285,was,0,0
147286,feasible,0,0
147287,in,0,0
147288,the,0,0
147289,majority,0,0
147290,of,0,0
147291,patients,0,0
147292,.,0,0
147293,Two,0,0
147294,subjects,0,0
147295,had,1,0
147296,severe,1,1
147297,adverse,1,1
147298,events,1,1
147299,requiring,0,0
147300,prednisolone,0,0
147301,to,0,0
147302,cope,0,1
147303,with,0,0
147304,nocturnal,0,1
147305,asthma,0,0
147306,symptoms,0,1
147307,.,0,0
147308,CONCLUSIONS,0,0
147309,Repeated,0,0
147310,high-dose,0,0
147311,bronchial,0,0
147312,allergen,0,0
147313,challenges,0,0
147314,resulted,0,0
147315,in,0,0
147316,severe,0,1
147317,asthma,0,0
147318,symptoms,0,1
147319,and,0,1
147320,marked,1,0
147321,Th-2-mediated,1,1
147322,allergic,1,1
147323,airway,1,1
147324,inflammation,1,1
147325,.,1,0
147326,The,0,0
147327,high-dose,0,0
147328,challenge,0,0
147329,model,0,0
147330,is,0,0
147331,suitable,0,0
147332,only,0,0
147333,in,0,0
147334,an,0,0
147335,attenuated,0,0
147336,form,0,0
147337,in,0,0
147338,diseased,0,0
147339,volunteers,0,0
147340,for,0,0
147341,proof-of-concept,0,0
147342,studies,0,0
147343,and,0,0
147344,in,0,0
147345,clinical,0,0
147346,settings,0,0
147347,to,0,0
147348,reduce,0,0
147349,the,0,0
147350,risk,0,0
147351,of,0,0
147352,severe,0,1
147353,asthma,0,0
147354,exacerbations,0,1
147355,.,0,0
147356,TRIAL,0,0
147357,REGISTRATION,0,0
147358,ClinicalTrials.govNCT00677209,0,0
147359,.,0,0
147360,Duration,0,1
147361,of,0,0
147362,untreated,0,0
147363,negative,0,1
147364,and,0,0
147365,positive,0,1
147366,symptoms,0,1
147367,of,0,0
147368,psychosis,0,1
147369,and,0,0
147370,cognitive,0,1
147371,impairment,0,1
147372,in,0,0
147373,first,0,0
147374,episode,0,0
147375,psychosis,0,0
147376,.,0,0
147377,BACKGROUND,0,0
147378,Duration,0,1
147379,of,0,0
147380,untreated,0,0
147381,psychosis,0,1
147382,(,0,0
147383,DUP,0,0
147384,),0,0
147385,has,0,0
147386,been,0,0
147387,significantly,0,0
147388,associated,0,0
147389,with,0,0
147390,poor,1,1
147391,clinical,1,0
147392,and,1,0
147393,social,1,1
147394,outcomes,1,1
147395,in,0,0
147396,First,0,1
147397,Episode,0,1
147398,Psychosis,0,1
147399,(,0,0
147400,FEP,0,1
147401,),0,0
147402,patients,0,0
147403,",",0,0
147404,but,0,0
147405,an,0,0
147406,association,0,0
147407,with,0,0
147408,cognitive,0,0
147409,outcomes,0,0
147410,has,0,0
147411,not,0,0
147412,been,0,0
147413,clearly,0,0
147414,established,0,0
147415,.,0,0
147416,METHOD,0,0
147417,Seventy-seven,0,0
147418,consecutively,0,0
147419,admitted,0,0
147420,",",0,0
147421,drug-na?ve,0,0
147422,patients,0,0
147423,with,0,0
147424,FEP,0,1
147425,were,0,0
147426,assessed,0,0
147427,at,0,0
147428,baseline,0,0
147429,and,0,0
147430,at,0,0
147431,1month,0,0
147432,and,0,0
147433,6months,0,0
147434,.,0,0
147435,Underlying,0,0
147436,dimensions,0,1
147437,of,0,0
147438,DUP,0,0
147439,(,0,0
147440,general,0,0
147441,prodrome,0,1
147442,and,0,1
147443,positive,0,1
147444,",",0,0
147445,negative,0,1
147446,and,0,1
147447,disorganisation,0,1
147448,symptoms,0,1
147449,),0,0
147450,were,0,0
147451,assessed,0,0
147452,using,0,0
147453,the,1,0
147454,Symptom,1,1
147455,Onset,1,0
147456,in,1,0
147457,Schizophrenia,1,1
147458,(,1,0
147459,SOS,1,0
147460,),1,1
147461,inventory,1,1
147462,(,0,0
147463,Perkins,0,0
147464,et,0,0
147465,al.,0,0
147466,",",0,0
147467,2000,0,0
147468,),0,0
147469,.,0,0
147470,To,0,0
147471,assess,0,0
147472,the,0,0
147473,effect,0,0
147474,of,0,0
147475,DUP,0,0
147476,on,0,0
147477,the,1,0
147478,neuropsychological,1,0
147479,status,1,0
147480,of,0,0
147481,the,0,0
147482,patients,0,0
147483,",",0,0
147484,a,0,0
147485,linear,0,0
147486,mixed-effect,0,0
147487,model,0,0
147488,was,0,0
147489,fitted,0,0
147490,to,0,0
147491,each,0,0
147492,neuropsychological,0,0
147493,dimension,0,1
147494,.,0,0
147495,These,0,0
147496,models,0,0
147497,included,0,0
147498,a,0,0
147499,dichotomised,0,1
147500,version,0,0
147501,of,0,0
147502,DUP,0,0
147503,(,0,0
147504,short,0,1
147505,versus,0,0
147506,long,0,0
147507,duration,0,1
147508,),0,0
147509,as,0,0
147510,a,0,0
147511,fixed,0,0
147512,effect,0,0
147513,",",0,0
147514,several,0,0
147515,adjusting,0,0
147516,variables,0,0
147517,to,0,0
147518,account,0,0
147519,for,0,0
147520,patient,0,1
147521,differences,0,0
147522,",",0,0
147523,and,0,0
147524,a,0,0
147525,random,0,0
147526,effect,0,0
147527,to,0,0
147528,incorporate,0,0
147529,the,0,0
147530,longitudinal,0,0
147531,structure,0,0
147532,of,0,0
147533,the,0,0
147534,data,0,0
147535,.,0,0
147536,RESULTS,0,0
147537,Patients,0,0
147538,with,0,0
147539,a,0,0
147540,short,0,0
147541,duration,0,1
147542,of,0,0
147543,untreated,0,0
147544,negative,0,1
147545,symptoms,0,1
147546,(,0,0
147547,DUNS,0,0
147548,),0,0
147549,or,0,0
147550,a,0,0
147551,short,0,1
147552,duration,0,1
147553,of,0,0
147554,untreated,0,0
147555,positive,0,1
147556,symptoms,0,1
147557,(,0,0
147558,DUPS,1,0
147559,),1,0
147560,outperformed,0,0
147561,patients,0,0
147562,with,0,0
147563,a,0,0
147564,long,0,0
147565,duration,0,1
147566,of,0,0
147567,untreated,0,0
147568,symptoms,0,1
147569,on,1,0
147570,memory,1,1
147571,tasks,1,0
147572,and,1,0
147573,a,1,0
147574,pre-attentional,1,1
147575,visual,1,1
147576,task,1,0
147577,but,0,0
147578,not,0,0
147579,on,1,0
147580,measures,1,1
147581,of,1,0
147582,verbal,1,1
147583,fluency,1,1
147584,",",1,0
147585,attention,1,1
147586,",",1,1
147587,reaction,1,1
147588,time,1,1
147589,",",1,0
147590,visual,1,1
147591,processing,1,1
147592,and,1,1
147593,executive,1,1
147594,functions,1,0
147595,.,1,0
147596,CONCLUSIONS,0,0
147597,This,0,0
147598,study,0,0
147599,provides,0,0
147600,additional,0,0
147601,support,0,0
147602,for,0,0
147603,an,0,0
147604,early,0,0
147605,intervention,0,0
147606,to,0,0
147607,shorten,0,0
147608,DUP,0,0
147609,to,0,0
147610,facilitate,0,0
147611,a,0,0
147612,better,1,0
147613,outcome,1,1
147614,in,1,0
147615,memory,1,1
147616,and,1,0
147617,attentional,1,1
147618,domains,1,1
147619,of,0,0
147620,FEP,0,1
147621,patients,0,0
147622,.,0,0
147623,Memantine,0,0
147624,as,0,0
147625,adjunctive,0,0
147626,treatment,0,0
147627,to,0,0
147628,risperidone,0,0
147629,in,0,0
147630,children,0,0
147631,with,0,0
147632,autistic,0,0
147633,disorder,0,0
147634,:,0,0
147635,a,0,0
147636,randomized,0,0
147637,",",0,0
147638,double-blind,0,0
147639,",",0,0
147640,placebo-controlled,0,0
147641,trial,0,0
147642,.,0,0
147643,Autism,0,0
147644,is,0,0
147645,a,0,0
147646,neurodevelopmental,0,0
147647,disorder,0,0
147648,that,0,0
147649,causes,0,0
147650,significant,0,0
147651,impairment,0,1
147652,in,0,0
147653,socialization,0,1
147654,and,0,0
147655,communication,0,0
147656,.,0,0
147657,It,0,0
147658,is,0,0
147659,also,0,0
147660,associated,0,0
147661,with,0,0
147662,ritualistic,0,1
147663,and,0,0
147664,stereotypical,0,0
147665,behaviour,0,1
147666,.,0,0
147667,Recent,0,0
147668,studies,0,0
147669,propose,0,0
147670,both,0,0
147671,hyper-and,0,0
147672,hypoglutamatergic,0,1
147673,ideologies,0,0
147674,for,0,0
147675,autism,0,0
147676,.,0,0
147677,The,0,0
147678,objective,0,0
147679,of,0,0
147680,this,0,0
147681,study,0,0
147682,was,0,0
147683,to,0,0
147684,assess,0,0
147685,the,0,0
147686,effects,0,0
147687,of,0,0
147688,memantine,0,0
147689,plus,0,0
147690,risperidone,0,0
147691,in,0,0
147692,the,0,0
147693,treatment,0,0
147694,of,0,0
147695,children,0,0
147696,with,0,0
147697,autism,0,0
147698,.,0,0
147699,Children,0,0
147700,with,0,0
147701,autism,0,0
147702,were,0,0
147703,randomly,0,0
147704,allocated,0,0
147705,to,0,0
147706,risperidone,0,0
147707,plus,0,0
147708,memantine,0,0
147709,or,0,0
147710,placebo,0,0
147711,plus,0,0
147712,risperidone,0,0
147713,for,0,0
147714,a,0,0
147715,10-wk,0,0
147716,",",0,0
147717,double-blind,0,0
147718,",",0,0
147719,placebo-controlled,0,0
147720,study,0,0
147721,.,0,0
147722,The,0,0
147723,dose,0,0
147724,of,0,0
147725,risperidone,0,0
147726,was,0,0
147727,titrated,0,0
147728,up,0,0
147729,to,0,0
147730,3,0,0
147731,mg/d,0,0
147732,and,0,0
147733,memantine,0,0
147734,was,0,0
147735,titrated,0,0
147736,to,0,0
147737,20,0,0
147738,mg/d,0,0
147739,.,0,0
147740,Children,0,0
147741,were,0,0
147742,assessed,0,0
147743,at,0,0
147744,baseline,0,0
147745,and,0,0
147746,after,0,0
147747,2,0,0
147748,",",0,0
147749,4,0,0
147750,",",0,0
147751,6,0,0
147752,",",0,0
147753,8,0,0
147754,and,0,0
147755,10,0,0
147756,wk,0,0
147757,of,0,0
147758,starting,0,0
147759,medication,0,0
147760,protocol,0,0
147761,.,0,0
147762,The,0,0
147763,primary,0,0
147764,outcome,0,1
147765,measure,0,0
147766,was,0,0
147767,the,1,0
147768,irritability,1,1
147769,subscale,1,1
147770,of,1,0
147771,Aberrant,1,1
147772,Behavior,1,1
147773,Checklist-Community,1,1
147774,(,1,0
147775,ABC-C,1,0
147776,),1,0
147777,.,1,0
147778,Difference,0,0
147779,between,0,0
147780,the,0,0
147781,two,0,0
147782,treatment,0,0
147783,arms,0,0
147784,was,0,0
147785,significant,0,0
147786,as,0,0
147787,the,0,0
147788,group,0,0
147789,that,0,0
147790,received,0,0
147791,memantine,0,0
147792,had,0,0
147793,greater,0,0
147794,reduction,0,1
147795,in,0,0
147796,ABC-C,1,0
147797,subscale,1,1
147798,scores,1,1
147799,for,1,0
147800,irritability,1,1
147801,",",1,0
147802,stereotypic,1,1
147803,behaviour,1,1
147804,and,1,0
147805,hyperactivity,1,0
147806,.,1,0
147807,Eight,1,0
147808,side-effects,1,0
147809,were,1,0
147810,observed,0,0
147811,over,0,0
147812,the,0,0
147813,trial,0,0
147814,",",0,0
147815,out,0,0
147816,of,0,0
147817,the,0,0
147818,25,0,0
147819,side-effects,0,0
147820,that,0,0
147821,the,0,0
147822,checklist,0,0
147823,included,0,0
147824,.,0,0
147825,The,0,0
147826,difference,0,0
147827,between,0,0
147828,the,0,0
147829,two,0,0
147830,groups,0,0
147831,in,0,0
147832,the,0,0
147833,frequency,0,1
147834,of,0,0
147835,side-effects,0,1
147836,was,0,0
147837,not,0,0
147838,significant,0,0
147839,.,0,0
147840,The,0,0
147841,present,0,0
147842,study,0,0
147843,suggests,0,0
147844,that,0,0
147845,memantine,0,0
147846,may,0,0
147847,be,0,0
147848,a,0,0
147849,potential,0,0
147850,adjunctive,0,0
147851,treatment,0,0
147852,strategy,0,0
147853,for,0,0
147854,autism,0,0
147855,and,0,0
147856,it,0,0
147857,was,0,0
147858,generally,0,0
147859,well,0,0
147860,tolerated,0,1
147861,.,0,0
147862,This,0,0
147863,trial,0,0
147864,is,0,0
147865,registered,0,0
147866,with,0,0
147867,the,0,0
147868,Iranian,0,0
147869,Clinical,0,1
147870,Trials,0,1
147871,Registry,0,0
147872,(,0,0
147873,IRCT1138901151556N10,0,0
147874,;,0,0
147875,www.irct.ir,0,0
147876,),0,0
147877,.,0,0
147878,Improving,0,0
147879,RBC,0,1
147880,K,0,0
147881,transport,0,1
147882,and,0,1
147883,hemoglobin-O2,0,1
147884,binding,0,1
147885,by,0,0
147886,amiloride,0,0
147887,:,0,0
147888,A,0,0
147889,novel,0,0
147890,therapeutic,0,0
147891,approach,0,0
147892,for,0,0
147893,reversion,0,1
147894,of,0,0
147895,angina,0,1
147896,and,0,0
147897,myocardial,0,1
147898,ischemia,0,1
147899,in,0,0
147900,coronary,0,0
147901,heart,0,0
147902,diseases,0,0
147903,.,0,0
147904,UNLABELLED,0,0
147905,Coronary,0,0
147906,heart,0,1
147907,disease,0,1
147908,(,0,0
147909,CHD,0,0
147910,),0,0
147911,is,0,0
147912,the,0,0
147913,leading,0,0
147914,cause,0,0
147915,of,0,0
147916,morbidity,0,1
147917,and,0,1
147918,mortality,0,1
147919,across,0,0
147920,the,0,0
147921,entire,0,0
147922,world,0,0
147923,",",0,0
147924,in,0,0
147925,which,0,0
147926,reversion,0,1
147927,of,0,0
147928,angina,0,1
147929,or,0,0
147930,improvement,0,1
147931,of,0,0
147932,ECG,0,0
147933,remains,0,0
147934,an,0,0
147935,unrealistic,0,0
147936,therapeutic,0,0
147937,option,0,0
147938,for,0,0
147939,most,0,0
147940,patients,0,0
147941,",",0,0
147942,suggesting,0,0
147943,that,0,0
147944,microvascular,0,1
147945,dysfunction,0,1
147946,or,0,0
147947,impaired,0,1
147948,oxygen,0,1
147949,delivery,0,0
147950,might,0,0
147951,be,0,0
147952,critical,0,0
147953,factors,0,0
147954,in,0,0
147955,CHD,0,0
147956,.,0,0
147957,This,0,0
147958,research,0,0
147959,article,0,0
147960,",",0,0
147961,thus,0,0
147962,presents,0,0
147963,the,0,0
147964,rationale,0,0
147965,basis,0,0
147966,",",0,0
147967,clinical,0,1
147968,and,0,1
147969,experimental,0,0
147970,",",0,0
147971,for,0,0
147972,the,0,0
147973,first,0,0
147974,therapeutic,0,0
147975,innovation,0,0
147976,addressing,0,0
147977,the,0,0
147978,role,0,0
147979,of,0,0
147980,red,0,1
147981,blood,0,1
147982,cell,0,1
147983,(,0,0
147984,RBC,0,1
147985,),0,0
147986,H/K,0,0
147987,and,0,0
147988,O2/CO2,0,0
147989,exchanges,0,1
147990,in,0,0
147991,CHD,0,0
147992,.,0,0
147993,It,0,0
147994,is,0,0
147995,followed,0,0
147996,by,0,0
147997,a,0,0
147998,randomized,0,0
147999,single-blind,0,0
148000,trial,0,0
148001,of,0,0
148002,Amiloride,0,0
148003,and,0,0
148004,Optimal,0,1
148005,Medical,0,1
148006,Therapy,0,0
148007,(,0,0
148008,OMT,0,1
148009,",",0,0
148010,n=35,0,0
148011,cases,0,0
148012,),0,0
148013,vs,0,0
148014,OMT,0,1
148015,alone,0,0
148016,(,0,0
148017,n=35,0,0
148018,cases,0,0
148019,),0,0
148020,in,0,0
148021,patients,0,0
148022,having,0,0
148023,angina,0,0
148024,",",0,0
148025,ST-T,0,0
148026,alteration,0,0
148027,and,0,0
148028,a,0,0
148029,defective,0,0
148030,RBC-K,0,0
148031,transport,0,1
148032,.,0,0
148033,All,0,0
148034,patients,0,0
148035,had,0,0
148036,serial,0,0
148037,clinical,0,0
148038,evaluation,0,0
148039,",",0,0
148040,Ion,0,1
148041,Transport,0,1
148042,Studies,0,0
148043,",",0,0
148044,ECGs,0,1
148045,and,0,1
148046,non-invasive,0,1
148047,aortic,0,1
148048,waveform,0,1
148049,and,0,0
148050,cardiovascular,0,1
148051,hemodynamic,0,1
148052,recordings,0,0
148053,.,0,0
148054,Statistical,0,0
148055,analysis,0,0
148056,was,0,0
148057,performed,0,0
148058,by,0,0
148059,SAS,0,0
148060,.,0,0
148061,RESULTS,0,0
148062,Amiloride,0,0
148063,rapidly,0,0
148064,improved,0,0
148065,RBC-K,0,0
148066,(,0,0
148067,93.5,0,0
148068,?4,0,0
148069,vs,0,0
148070,84.5,0,0
148071,?4,0,0
148072,mmol/lc,0,0
148073,",",0,0
148074,p=,0,0
148075,<,0,0
148076,0.001,0,0
148077,),0,0
148078,",",0,0
148079,angina,0,0
148080,(,0,0
148081,80,0,0
148082,%,0,0
148083,of,0,0
148084,cases,0,0
148085,",",0,0
148086,1.5,0,0
148087,?0.3,0,0
148088,weeks,0,0
148089,",",0,0
148090,CI:1.72,0,0
148091,to,0,0
148092,1.45,0,0
148093,),0,0
148094,",",0,0
148095,CCS,0,0
148096,Class,0,1
148097,(,0,0
148098,1.3,0,0
148099,?0.5,0,0
148100,vs,0,0
148101,3.1,0,0
148102,?0.8,0,0
148103,",",0,0
148104,p,0,0
148105,<,0,0
148106,0.001,0,0
148107,),0,0
148108,vs,0,0
148109,patients,0,0
148110,with,0,0
148111,OMT,0,0
148112,alone,0,0
148113,CCS,0,0
148114,Class,0,0
148115,(,0,0
148116,3.2,0,0
148117,?,0,0
148118,0.4,0,0
148119,vs,0,0
148120,3.3,0,0
148121,?,0,0
148122,0.5,0,0
148123,",",0,0
148124,p,0,0
148125,=0.21,0,0
148126,),0,0
148127,.,0,0
148128,Reversion,0,0
148129,of,0,0
148130,angina,0,1
148131,was,0,0
148132,sustained,0,0
148133,through,0,0
148134,the,0,0
148135,next,0,0
148136,6-months,0,0
148137,(,0,0
148138,87,0,0
148139,%,0,0
148140,vs,0,0
148141,26,0,0
148142,%,0,0
148143,in,0,0
148144,OMT,0,1
148145,",",0,0
148146,RR,0,0
148147,2.1,0,0
148148,",",0,0
148149,odds,0,0
148150,ratio,0,1
148151,6.31,0,0
148152,",",0,0
148153,Pearson,0,0
148154,x2,0,0
148155,34.6,0,0
148156,",",0,0
148157,p,0,0
148158,<,0,0
148159,0.0001,0,0
148160,at,0,0
148161,95,0,0
148162,%,0,0
148163,CI,0,0
148164,),0,0
148165,and,0,0
148166,1-year,0,0
148167,(,0,0
148168,85,0,0
148169,%,0,0
148170,vs,0,0
148171,37,0,0
148172,%,0,0
148173,OMT,0,0
148174,),0,0
148175,.,0,0
148176,At,0,0
148177,6-months,0,0
148178,of,0,0
148179,amiloride,0,0
148180,",",0,0
148181,ECG,0,1
148182,became,0,0
148183,normal,0,0
148184,(,0,0
148185,29,0,0
148186,%,0,0
148187,vs,0,0
148188,0,0,0
148189,%,0,0
148190,",",0,0
148191,RR,0,0
148192,?,0,0
148193,uncalculated-time,0,1
148194,",",0,0
148195,odds,0,1
148196,ratio,0,1
148197,?,0,0
148198,",",0,0
148199,Pearson,0,1
148200,x2,0,0
148201,42.4,0,0
148202,at,0,0
148203,95,0,0
148204,%,0,0
148205,CI,0,0
148206,",",0,0
148207,p,0,0
148208,<,0,0
148209,0.0001,0,0
148210,),0,0
148211,",",0,0
148212,improved,0,0
148213,(,0,0
148214,55,0,0
148215,%,0,0
148216,vs,0,0
148217,29,0,0
148218,%,0,0
148219,;,0,0
148220,RR2.1,0,0
148221,",",0,0
148222,odds,0,0
148223,ratio,0,1
148224,3.16,0,0
148225,",",0,0
148226,95,0,0
148227,%,0,0
148228,CI,0,0
148229,",",0,0
148230,p,0,0
148231,<,0,0
148232,0.0001,0,0
148233,),0,0
148234,or,0,0
148235,unchanged,0,0
148236,(,0,0
148237,15,0,0
148238,%,0,0
148239,vs,0,0
148240,67,0,0
148241,%,0,0
148242,OMT,0,0
148243,),0,0
148244,.,0,0
148245,At,0,0
148246,1-year,0,0
148247,",",0,0
148248,seven,0,0
148249,patients,0,0
148250,on,0,0
148251,amiloride,0,0
148252,(,0,0
148253,18,0,0
148254,%,0,0
148255,),0,0
148256,exhibited,0,0
148257,evidence,0,0
148258,of,0,0
148259,electrical,0,1
148260,regeneration,0,0
148261,of,0,0
148262,the,0,0
148263,heart,0,0
148264,",",0,0
148265,not,0,0
148266,observed,0,0
148267,with,0,0
148268,placebo,0,0
148269,.,0,0
148270,IN,0,0
148271,CONCLUSION,0,0
148272,This,0,0
148273,therapeutical,0,0
148274,innovation,0,0
148275,of,0,0
148276,amiloride,0,0
148277,improves,0,0
148278,RBC,0,1
148279,H/K,0,0
148280,and,0,1
148281,O2/CO2,0,0
148282,function,0,1
148283,",",0,0
148284,and,0,0
148285,reverses,0,0
148286,angina,0,1
148287,",",0,0
148288,ST-T,0,0
148289,alterations,0,0
148290,while,0,0
148291,inducing,0,0
148292,electrical,0,1
148293,regeneration,0,0
148294,of,0,0
148295,the,0,0
148296,heart,0,0
148297,",",0,0
148298,in,0,0
148299,patients,0,0
148300,receiving,0,0
148301,optimal,0,0
148302,medical,0,0
148303,treatment,0,0
148304,for,0,0
148305,angina,0,0
148306,.,0,0
148307,The,0,0
148308,article,0,0
148309,has,0,0
148310,short,0,1
148311,discussion,0,0
148312,on,0,0
148313,the,0,0
148314,relevant,0,0
148315,patents,0,0
148316,to,0,0
148317,the,0,0
148318,topic,0,0
148319,.,0,0
148320,Adherence,1,1
148321,to,1,0
148322,lifestyle,1,0
148323,recommendations,1,0
148324,by,0,0
148325,patients,0,0
148326,with,0,0
148327,depression,0,1
148328,.,0,0
148329,INTRODUCTION,0,0
148330,There,0,0
148331,is,0,0
148332,an,0,0
148333,increasing,0,0
148334,amount,0,1
148335,of,0,0
148336,evidence,0,0
148337,showing,0,0
148338,that,0,0
148339,physical,1,1
148340,activity,1,1
148341,and,1,1
148342,sun,1,0
148343,exposure,1,0
148344,are,0,0
148345,effective,0,1
148346,coadjuvant,0,0
148347,treatments,0,0
148348,for,0,0
148349,patients,0,0
148350,with,0,0
148351,mild,0,0
148352,to,0,0
148353,moderate,0,0
148354,depression,0,1
148355,.,0,0
148356,However,0,0
148357,",",0,0
148358,there,0,0
148359,is,0,0
148360,a,0,0
148361,lack,0,0
148362,of,0,0
148363,information,0,0
148364,regarding,0,0
148365,patient,0,1
148366,'s,0,0
148367,adherence,1,1
148368,to,0,0
148369,these,0,0
148370,recommendations,0,0
148371,in,0,0
148372,daily,0,0
148373,clinical,0,0
148374,practice,0,0
148375,.,0,0
148376,METHODS,0,0
148377,We,0,0
148378,conducted,0,0
148379,a,0,0
148380,study,0,0
148381,including,0,0
148382,15,0,0
148383,depressive,0,0
148384,patients,0,0
148385,who,0,0
148386,had,0,0
148387,been,0,0
148388,under,0,0
148389,antidepressant,0,0
148390,treatment,0,0
148391,for,0,0
148392,at,0,0
148393,least,0,0
148394,one,0,0
148395,month,0,0
148396,.,0,0
148397,They,0,0
148398,wore,0,0
148399,a,0,0
148400,wrist-watch-like,0,1
148401,actimetry,0,0
148402,sensor,0,0
148403,to,0,0
148404,measure,0,0
148405,physical,1,1
148406,activity,1,1
148407,and,1,1
148408,sun,1,0
148409,exposure,1,0
148410,24,0,0
148411,hours,0,0
148412,a,0,0
148413,day,0,0
148414,.,0,0
148415,After,0,0
148416,one,0,0
148417,week,0,0
148418,of,0,0
148419,baseline,0,0
148420,assessment,0,1
148421,",",0,0
148422,patients,0,0
148423,were,0,0
148424,randomised,0,0
148425,into,0,0
148426,one,0,0
148427,of,0,0
148428,the,0,0
148429,two,0,0
148430,arms,0,0
148431,of,0,0
148432,the,0,0
148433,study,0,0
148434,.,0,0
148435,Patients,0,0
148436,in,0,0
148437,the,0,0
148438,experimental,0,0
148439,group,0,0
148440,received,0,0
148441,a,0,0
148442,brief,0,0
148443,note,0,0
148444,in,0,0
148445,which,0,0
148446,they,0,0
148447,were,0,0
148448,explicitly,0,0
148449,asked,0,0
148450,to,0,0
148451,increase,0,0
148452,both,0,0
148453,their,0,0
148454,physical,1,0
148455,activity,1,1
148456,level,1,1
148457,and,1,1
148458,time,1,1
148459,of,1,1
148460,sun,1,0
148461,exposure,1,0
148462,",",0,0
148463,while,0,0
148464,control,0,0
148465,group,0,0
148466,patients,0,0
148467,did,0,0
148468,not,0,0
148469,receive,0,0
148470,these,0,0
148471,explicit,0,0
148472,recommendations,0,0
148473,.,0,0
148474,RESULTS,0,0
148475,One,0,0
148476,week,0,0
148477,after,0,0
148478,recommendations,0,0
148479,were,0,0
148480,delivered,0,0
148481,",",0,0
148482,only,0,0
148483,patients,0,0
148484,in,0,0
148485,the,0,0
148486,experimental,0,0
148487,group,0,0
148488,had,0,0
148489,increased,0,0
148490,time,1,1
148491,of,1,0
148492,sun,1,0
148493,exposure,1,1
148494,and,1,1
148495,physical,1,1
148496,activity,1,1
148497,(,0,0
148498,25.8,0,0
148499,%,0,0
148500,and,0,0
148501,14.3,0,0
148502,%,0,0
148503,",",0,0
148504,respectively,0,0
148505,),0,0
148506,.,0,0
148507,CONCLUSIONS,0,0
148508,Depressive,0,0
148509,patients,0,0
148510,are,0,0
148511,able,1,0
148512,to,1,0
148513,follow,1,0
148514,prescribed,1,0
148515,lifestyle,1,0
148516,recommendations,1,0
148517,in,1,0
148518,the,1,0
148519,short-term,1,0
148520,.,1,0
148521,Effects,0,0
148522,of,0,0
148523,a,0,0
148524,brief,0,0
148525,Early,0,0
148526,Start,0,0
148527,Denver,0,0
148528,model,0,0
148529,(,0,0
148530,ESDM,0,0
148531,),0,0
148532,-based,0,0
148533,parent,0,1
148534,intervention,0,0
148535,on,0,0
148536,toddlers,0,0
148537,at,0,0
148538,risk,0,1
148539,for,0,0
148540,autism,0,0
148541,spectrum,0,0
148542,disorders,0,0
148543,:,0,0
148544,a,0,0
148545,randomized,0,0
148546,controlled,0,0
148547,trial,0,0
148548,.,0,0
148549,OBJECTIVE,0,0
148550,This,0,0
148551,study,0,0
148552,was,0,0
148553,carried,0,0
148554,out,0,0
148555,to,0,0
148556,examine,0,0
148557,the,0,0
148558,efficacy,0,1
148559,of,0,0
148560,a,0,0
148561,12-week,0,0
148562,",",0,0
148563,low-intensity,0,0
148564,(,0,0
148565,1-hour/wk,0,0
148566,of,0,0
148567,therapist,0,0
148568,contact,0,1
148569,),0,0
148570,",",0,0
148571,parent-delivered,0,1
148572,intervention,0,0
148573,for,0,0
148574,toddlers,0,0
148575,at,0,0
148576,risk,0,1
148577,for,0,0
148578,autism,0,0
148579,spectrum,0,0
148580,disorders,0,0
148581,(,0,0
148582,ASD,0,0
148583,),0,0
148584,aged,0,0
148585,14,0,0
148586,to,0,0
148587,24,0,0
148588,months,0,0
148589,and,0,0
148590,their,0,0
148591,families,0,0
148592,.,0,0
148593,METHOD,0,0
148594,A,0,0
148595,randomized,0,0
148596,controlled,0,0
148597,trial,0,0
148598,involving,0,0
148599,98,0,0
148600,children,0,0
148601,and,0,0
148602,families,0,0
148603,was,0,0
148604,carried,0,0
148605,out,0,0
148606,in,0,0
148607,three,0,0
148608,different,0,0
148609,sites,0,0
148610,investigating,0,0
148611,the,0,0
148612,efficacy,1,1
148613,of,0,0
148614,a,0,0
148615,parent,0,0
148616,delivery,0,0
148617,of,0,0
148618,the,0,0
148619,Early,0,0
148620,Start,0,0
148621,Denver,0,0
148622,model,0,0
148623,(,0,0
148624,P-ESDM,0,1
148625,),0,0
148626,",",0,0
148627,which,0,0
148628,fosters,0,0
148629,parental,0,1
148630,use,0,0
148631,of,0,0
148632,a,0,0
148633,child-centered,0,0
148634,responsive,0,0
148635,interaction,0,1
148636,style,0,0
148637,that,0,0
148638,embeds,0,0
148639,many,0,0
148640,teaching,0,0
148641,opportunities,0,0
148642,into,0,0
148643,play,0,0
148644,",",0,0
148645,compared,0,0
148646,to,0,0
148647,community,0,0
148648,treatment,0,0
148649,as,0,0
148650,usual,0,0
148651,.,0,0
148652,Assessments,0,0
148653,were,0,0
148654,completed,0,0
148655,at,0,0
148656,baseline,0,0
148657,and,0,0
148658,12,0,0
148659,weeks,0,0
148660,later,0,0
148661,",",0,0
148662,immediately,0,0
148663,after,0,0
148664,the,0,0
148665,end,0,0
148666,of,0,0
148667,parent,0,1
148668,coaching,0,0
148669,sessions,0,0
148670,.,0,0
148671,RESULTS,0,0
148672,There,0,0
148673,was,0,0
148674,no,1,0
148675,effect,1,0
148676,of,0,0
148677,group,0,0
148678,assignment,0,0
148679,on,0,0
148680,parent-child,0,0
148681,interaction,0,1
148682,characteristics,0,1
148683,or,0,0
148684,on,0,0
148685,any,0,0
148686,child,0,0
148687,outcomes,0,0
148688,.,0,0
148689,Both,0,0
148690,groups,0,0
148691,of,0,0
148692,parents,0,0
148693,improved,0,1
148694,interaction,1,1
148695,skills,1,1
148696,",",0,0
148697,and,0,0
148698,both,0,0
148699,groups,0,0
148700,of,0,0
148701,children,0,0
148702,demonstrated,1,0
148703,progress,1,0
148704,.,1,0
148705,Parents,0,0
148706,receiving,0,0
148707,P-ESDM,0,1
148708,demonstrated,0,0
148709,significantly,0,0
148710,stronger,1,0
148711,working,1,1
148712,alliances,1,0
148713,with,0,0
148714,their,0,0
148715,therapists,1,0
148716,than,0,0
148717,did,0,0
148718,the,0,0
148719,community,0,0
148720,group,0,0
148721,.,0,0
148722,Children,0,0
148723,in,0,0
148724,the,0,0
148725,community,0,0
148726,group,0,0
148727,received,0,0
148728,significantly,0,0
148729,more,0,0
148730,intervention,1,0
148731,hours,1,0
148732,than,0,0
148733,those,0,0
148734,in,0,0
148735,the,0,0
148736,P-ESDM,0,0
148737,group,0,0
148738,.,0,0
148739,For,0,0
148740,the,0,0
148741,group,0,0
148742,as,0,0
148743,a,0,0
148744,whole,0,0
148745,",",0,0
148746,both,0,0
148747,younger,0,0
148748,child,0,1
148749,age,0,0
148750,at,0,0
148751,the,0,0
148752,start,0,0
148753,of,0,0
148754,intervention,0,0
148755,and,0,0
148756,a,0,0
148757,greater,0,0
148758,number,1,1
148759,of,1,1
148760,intervention,1,0
148761,hours,1,0
148762,were,0,0
148763,positively,0,0
148764,related,0,0
148765,to,0,0
148766,the,0,0
148767,degree,0,1
148768,of,0,0
148769,improvement,0,1
148770,in,0,0
148771,children,0,0
148772,'s,0,0
148773,behavior,0,1
148774,for,0,0
148775,most,0,0
148776,variables,0,0
148777,.,0,0
148778,CONCLUSIONS,0,0
148779,Parent-implemented,0,0
148780,intervention,0,0
148781,studies,0,0
148782,for,0,0
148783,early,0,0
148784,ASD,0,0
148785,thus,0,0
148786,far,0,0
148787,have,0,0
148788,not,0,0
148789,demonstrated,0,0
148790,the,0,0
148791,large,0,0
148792,effects,0,0
148793,seen,0,0
148794,in,0,0
148795,intensive-treatment,0,0
148796,studies,0,0
148797,.,0,0
148798,Evidence,0,0
148799,that,0,0
148800,both,0,0
148801,younger,0,0
148802,age,0,0
148803,and,0,1
148804,more,0,0
148805,intervention,0,0
148806,hours,0,0
148807,positively,0,0
148808,affect,0,0
148809,developmental,0,0
148810,rates,0,1
148811,has,0,0
148812,implications,0,0
148813,for,0,0
148814,clinical,0,0
148815,practice,0,0
148816,",",0,0
148817,service,0,1
148818,delivery,0,1
148819,",",0,0
148820,and,0,1
148821,public,0,0
148822,policy,0,0
148823,.,0,0
148824,Insular,0,1
148825,and,0,0
148826,anterior,0,1
148827,cingulate,0,1
148828,circuits,0,1
148829,in,0,0
148830,smokers,0,0
148831,with,0,0
148832,schizophrenia,0,0
148833,.,0,0
148834,Schizophrenia,0,1
148835,(,0,0
148836,SZ,0,0
148837,),0,0
148838,is,0,0
148839,associated,0,0
148840,with,0,0
148841,high,0,0
148842,rates,0,1
148843,of,0,0
148844,smoking,0,0
148845,.,0,0
148846,We,0,0
148847,previously,0,0
148848,found,0,0
148849,that,0,0
148850,resting,0,1
148851,state,0,0
148852,functional,0,1
148853,connectivity,0,1
148854,(,0,0
148855,rsFC,0,1
148856,),0,0
148857,between,0,0
148858,the,0,0
148859,dorsal,0,0
148860,anterior,0,1
148861,cingulate,0,1
148862,(,0,0
148863,dACC,0,0
148864,),0,1
148865,and,0,0
148866,striatum,0,1
148867,is,0,0
148868,independently,0,0
148869,associated,0,0
148870,with,0,0
148871,nicotine,0,0
148872,addiction,0,1
148873,and,0,0
148874,psychiatric,0,0
148875,illness,0,1
148876,.,0,0
148877,Since,0,0
148878,the,0,0
148879,insula,0,0
148880,is,0,0
148881,implicated,0,0
148882,in,0,0
148883,nicotine,0,0
148884,dependence,0,0
148885,",",0,0
148886,we,0,0
148887,hypothesized,0,0
148888,that,0,0
148889,SZ,0,0
148890,smokers,0,0
148891,will,0,0
148892,have,0,0
148893,greater,0,0
148894,dysfunction,0,1
148895,in,0,0
148896,smoking-related,0,0
148897,insular,0,1
148898,and,0,1
148899,dACC,0,0
148900,circuits,0,1
148901,than,0,0
148902,normal,0,0
148903,control,0,0
148904,smokers,0,0
148905,(,0,0
148906,NC,0,1
148907,),0,0
148908,independent,0,0
148909,of,0,0
148910,smoking,0,0
148911,severity,0,1
148912,",",0,0
148913,consistent,0,0
148914,with,0,0
148915,an,0,0
148916,inherent,0,0
148917,disease-related,0,1
148918,weakening,0,1
148919,of,0,0
148920,smoking-related,0,0
148921,circuits,0,0
148922,.,0,0
148923,Nicotine,0,0
148924,challenge,0,0
148925,was,0,0
148926,used,0,0
148927,to,0,0
148928,demonstrate,0,0
148929,that,0,0
148930,decreased,0,0
148931,rsFC,0,0
148932,in,0,0
148933,identified,0,0
148934,circuits,0,0
148935,reflects,0,0
148936,addiction,0,1
148937,trait,0,0
148938,and,0,0
148939,is,0,0
148940,not,0,0
148941,affected,0,0
148942,by,0,0
148943,pharmacological,0,0
148944,state,0,0
148945,.,0,0
148946,Twenty-four,0,0
148947,NC,0,1
148948,smokers,0,0
148949,and,0,0
148950,20,0,0
148951,smokers,0,0
148952,with,0,0
148953,SZ,0,0
148954,matched,0,0
148955,on,0,0
148956,nicotine,0,0
148957,addiction,0,1
148958,severity,0,1
148959,participated,0,0
148960,in,0,0
148961,a,0,0
148962,resting,0,1
148963,state,0,0
148964,fMRI,0,1
148965,study,0,0
148966,and,0,1
148967,were,0,0
148968,scanned,0,0
148969,during,0,0
148970,two,0,0
148971,separate,0,0
148972,sessions,0,0
148973,while,0,0
148974,receiving,0,0
148975,a,0,0
148976,placebo,0,0
148977,or,0,0
148978,nicotine,0,0
148979,patch,0,0
148980,",",0,0
148981,in,0,0
148982,a,0,0
148983,randomized,0,0
148984,",",0,0
148985,cross-over,0,0
148986,design,0,0
148987,.,0,0
148988,Using,0,0
148989,individualized,0,0
148990,",",0,0
148991,anatomically,0,0
148992,defined,0,0
148993,anterior,0,0
148994,and,0,0
148995,posterior,0,0
148996,insula,0,1
148997,and,0,1
148998,dACC,0,0
148999,as,0,0
149000,regions,0,0
149001,of,0,0
149002,interest,0,0
149003,(,0,0
149004,ROI,0,0
149005,),0,0
149006,",",0,0
149007,whole,0,1
149008,brain,0,1
149009,rsFC,0,1
149010,was,0,0
149011,performed,0,0
149012,using,0,0
149013,each,0,0
149014,ROI,0,0
149015,as,0,0
149016,a,0,0
149017,seed,0,0
149018,.,0,0
149019,Significant,0,0
149020,negative,0,1
149021,correlations,0,0
149022,between,0,0
149023,smoking,1,0
149024,severity,1,1
149025,and,1,1
149026,rsFC,1,1
149027,between,1,0
149028,insula,1,1
149029,",",0,0
149030,dACC,0,0
149031,and,0,1
149032,striatum,0,1
149033,were,0,0
149034,found,0,0
149035,for,0,0
149036,both,0,0
149037,groups,0,0
149038,.,0,0
149039,Furthermore,0,0
149040,",",0,0
149041,smokers,0,0
149042,with,0,0
149043,SZ,0,0
149044,demonstrated,0,0
149045,additive,0,0
149046,reductions,0,1
149047,in,0,0
149048,circuit,0,1
149049,strength,0,1
149050,between,0,0
149051,the,0,0
149052,dACC,0,0
149053,and,0,0
149054,insula,0,1
149055,compared,0,0
149056,to,0,0
149057,NC,0,1
149058,smokers,0,0
149059,independent,0,0
149060,of,0,0
149061,smoking,0,0
149062,severity,0,1
149063,.,0,0
149064,Nicotine,1,0
149065,challenge,1,0
149066,did,0,0
149067,not,0,0
149068,significantly,0,0
149069,alter,1,0
149070,rsFC,1,0
149071,in,1,0
149072,insula-dACC-striatal,1,0
149073,circuits,1,0
149074,.,1,0
149075,Reduced,0,0
149076,rsFC,1,0
149077,strength,1,1
149078,between,0,0
149079,the,0,0
149080,insula,0,1
149081,",",0,0
149082,dACC,0,0
149083,and,0,0
149084,striatum,0,1
149085,is,0,0
149086,associated,0,0
149087,with,0,0
149088,nicotine,0,0
149089,addiction,0,1
149090,severity,0,1
149091,in,0,0
149092,both,0,0
149093,non-psychiatrically,0,0
149094,ill,0,0
149095,and,0,0
149096,in,0,0
149097,SZ,0,0
149098,smokers,0,0
149099,.,0,0
149100,Decreased,0,0
149101,insula-dACC,0,0
149102,rsFC,0,0
149103,may,0,0
149104,index,0,1
149105,overlapping,0,0
149106,circuitry,0,1
149107,associated,0,0
149108,with,0,0
149109,smoking,0,0
149110,and,0,0
149111,SZ,0,0
149112,.,0,0
149113,The,0,0
149114,effects,0,0
149115,of,0,0
149116,moderate,0,0
149117,to,0,0
149118,vigorous,1,1
149119,aerobic,0,0
149120,exercise,0,0
149121,on,0,0
149122,the,0,0
149123,sleep,0,1
149124,need,0,0
149125,of,0,0
149126,sedentary,0,0
149127,young,0,0
149128,adults,0,0
149129,.,0,0
149130,Exercise,0,0
149131,has,0,0
149132,been,0,0
149133,recommended,0,0
149134,for,0,0
149135,enhancing,0,0
149136,sleep,0,1
149137,;,0,0
149138,a,0,0
149139,claim,0,0
149140,linked,0,0
149141,to,0,0
149142,the,0,0
149143,belief,0,0
149144,that,0,0
149145,sleep,0,0
149146,need,0,0
149147,-,0,0
149148,defined,0,0
149149,by,0,0
149150,sleep,0,1
149151,duration,0,1
149152,and,0,0
149153,depth,0,1
149154,-,0,0
149155,is,0,0
149156,increased,0,0
149157,post-exercise,0,0
149158,to,0,0
149159,allow,0,0
149160,tissue,0,0
149161,recovery,0,1
149162,.,0,0
149163,Objective,0,1
149164,studies,0,0
149165,investigating,0,0
149166,exercise-sleep,0,0
149167,responses,0,1
149168,have,0,0
149169,produced,0,0
149170,mixed,0,0
149171,outcomes,0,1
149172,",",0,0
149173,and,0,0
149174,the,0,0
149175,disparity,0,1
149176,in,0,0
149177,results,0,0
149178,between,0,0
149179,studies,0,0
149180,may,0,0
149181,be,0,0
149182,due,0,0
149183,to,0,0
149184,differences,0,0
149185,in,0,0
149186,individual,0,0
149187,characteristics,0,0
149188,and/or,0,0
149189,exercise,0,0
149190,protocol,0,0
149191,",",0,0
149192,emphasising,0,0
149193,the,0,0
149194,importance,0,0
149195,of,0,0
149196,carefully,0,0
149197,controlled,0,0
149198,trials,0,0
149199,.,0,0
149200,We,0,0
149201,investigated,0,0
149202,the,0,0
149203,role,0,0
149204,of,0,0
149205,exercise,0,0
149206,on,0,0
149207,the,0,0
149208,sleep,0,1
149209,need,0,0
149210,of,0,0
149211,sedentary,0,1
149212,adults,0,0
149213,",",0,0
149214,after,0,0
149215,controlling,0,0
149216,for,0,0
149217,exercise,0,0
149218,mode,0,0
149219,",",0,1
149220,timing,0,1
149221,and,0,1
149222,duration,0,1
149223,.,0,0
149224,Twelve,0,0
149225,healthy,0,0
149226,volunteers,0,0
149227,(,0,0
149228,25.2,0,0
149229,?,0,0
149230,4.0,0,0
149231,years,0,0
149232,",",0,0
149233,9,0,0
149234,females,0,0
149235,",",0,0
149236,[,0,0
149237,Vdot,0,1
149238,],0,0
149239,O,0,1
149240,(,0,0
149241,2,0,0
149242,),0,0
149243,max,0,0
149244,35.4,0,0
149245,?,0,0
149246,8.8,0,0
149247,ml?,0,0
149248,kg,0,0
149249,(,0,0
149250,-1,0,0
149251,),0,0
149252,?,0,0
149253,min,0,0
149254,(,0,0
149255,-1,0,0
149256,),0,0
149257,),0,0
149258,were,0,0
149259,randomised,0,0
149260,to,0,0
149261,no-exercise,0,0
149262,or,0,0
149263,to,0,0
149264,a,0,0
149265,bout,0,1
149266,of,0,0
149267,treadmill,0,0
149268,exercise,0,0
149269,at,0,0
149270,45,0,0
149271,%,0,0
149272,",",0,0
149273,55,0,0
149274,%,0,0
149275,",",0,0
149276,65,0,0
149277,%,0,0
149278,or,0,0
149279,75,0,0
149280,%,0,0
149281,[,0,0
149282,Vdot,0,1
149283,],0,0
149284,O,0,1
149285,(,0,0
149286,2,0,0
149287,),0,0
149288,max,0,0
149289,in,0,0
149290,a,0,0
149291,crossover,0,0
149292,design,0,0
149293,.,0,0
149294,Sleep,0,0
149295,on,0,0
149296,no-exercise,0,0
149297,and,0,1
149298,exercise,0,0
149299,nights,0,1
149300,were,0,0
149301,assessed,0,0
149302,by,0,0
149303,polysomnography,0,0
149304,.,0,0
149305,Participants,0,0
149306,spent,0,0
149307,a,0,0
149308,greater,0,0
149309,proportion,1,1
149310,of,1,1
149311,sleep,1,1
149312,in,1,0
149313,light,1,1
149314,sleep,1,1
149315,(,1,0
149316,stage,1,0
149317,1,0,0
149318,+,0,0
149319,stage,0,0
149320,2,0,0
149321,),0,0
149322,after,0,0
149323,exercise,0,0
149324,at,0,0
149325,both,0,0
149326,65,0,0
149327,%,0,0
149328,and,0,0
149329,75,0,0
149330,%,0,0
149331,[,0,0
149332,Vdot,0,1
149333,],0,0
149334,O,0,1
149335,(,0,0
149336,2,0,0
149337,),0,0
149338,max,0,0
149339,(,0,0
149340,P,0,0
149341,<,0,0
149342,0.05,0,0
149343,),0,0
149344,than,0,0
149345,the,0,0
149346,no-exercise,0,0
149347,condition,0,0
149348,.,0,0
149349,There,0,0
149350,was,0,0
149351,a,0,0
149352,trend,0,0
149353,of,0,0
149354,a,0,0
149355,reduced,0,0
149356,proportion,1,0
149357,of,1,0
149358,rapid,1,1
149359,eye,1,0
149360,movement,1,1
149361,sleep,1,1
149362,with,1,0
149363,increased,1,0
149364,exercise,1,0
149365,intensity,1,1
149366,(,1,0
149367,P,1,0
149368,=,0,0
149369,0.067,0,0
149370,),0,0
149371,.,0,0
149372,No,0,0
149373,other,0,0
149374,changes,0,1
149375,were,0,0
149376,observed,0,0
149377,in,0,0
149378,any,0,0
149379,other,0,0
149380,sleep,0,1
149381,variables,0,0
149382,.,0,0
149383,Two,0,0
149384,findings,0,0
149385,emerged,0,0
149386,:,0,0
149387,vigorous,0,1
149388,exercise,0,0
149389,did,0,0
149390,not,0,0
149391,increase,1,0
149392,sleep,1,1
149393,need,1,0
149394,;,1,0
149395,however,1,0
149396,",",0,0
149397,this,0,0
149398,level,0,1
149399,of,0,0
149400,exercise,0,0
149401,increased,1,0
149402,light,1,0
149403,sleep,1,1
149404,.,1,0
149405,Hemostasis,0,1
149406,by,0,0
149407,bipolar,0,0
149408,coagulation,0,1
149409,versus,0,0
149410,suture,0,0
149411,after,0,0
149412,surgical,0,0
149413,stripping,0,0
149414,of,0,0
149415,bilateral,0,0
149416,ovarian,0,0
149417,endometriomas,0,0
149418,:,0,0
149419,a,0,0
149420,randomized,0,0
149421,controlled,0,0
149422,trial,0,0
149423,.,0,0
149424,STUDY,0,0
149425,OBJECTIVE,0,0
149426,To,0,0
149427,estimate,0,0
149428,whether,0,0
149429,the,0,0
149430,suture,0,0
149431,of,0,0
149432,the,0,0
149433,ovary,0,0
149434,is,0,0
149435,superior,0,0
149436,to,0,0
149437,bipolar,0,0
149438,coagulation,0,0
149439,in,0,0
149440,preserving,0,1
149441,ovarian,0,0
149442,reserve,0,0
149443,in,0,0
149444,infertile,0,0
149445,women,0,0
149446,undergoing,0,0
149447,laparoscopic,0,0
149448,stripping,0,0
149449,of,0,0
149450,bilateral,0,0
149451,endometriomas,0,0
149452,.,0,0
149453,DESIGN,0,0
149454,Randomized,0,0
149455,controlled,0,0
149456,trial,0,0
149457,(,0,0
149458,Canadian,0,0
149459,Task,0,0
149460,Force,0,0
149461,classification,0,1
149462,I,0,0
149463,),0,0
149464,.,0,0
149465,SETTING,0,0
149466,University,0,0
149467,teaching,0,0
149468,hospital,0,1
149469,.,0,0
149470,PATIENTS,0,0
149471,100,0,0
149472,patients,0,0
149473,with,0,0
149474,bilateral,0,0
149475,endometriomas,0,0
149476,.,0,0
149477,INTERVENTIONS,0,1
149478,Patients,0,0
149479,underwent,0,0
149480,stripping,0,0
149481,of,0,0
149482,bilateral,0,0
149483,endometriomas,0,1
149484,and,0,0
149485,were,0,0
149486,randomized,0,0
149487,to,0,0
149488,undergo,0,0
149489,hemostasis,0,1
149490,by,0,0
149491,use,0,0
149492,of,0,0
149493,either,0,0
149494,laparoscopic,0,0
149495,suturing,0,0
149496,(,0,0
149497,LS,0,1
149498,group,0,0
149499,),0,0
149500,or,0,0
149501,bipolar,0,0
149502,coagulation,0,1
149503,(,0,0
149504,BC,0,1
149505,group,0,0
149506,),0,0
149507,.,0,0
149508,Changes,1,1
149509,in,1,0
149510,ovarian,1,0
149511,reserve,1,1
149512,were,0,0
149513,investigated,0,0
149514,by,0,0
149515,measuring,0,0
149516,the,0,0
149517,levels,0,1
149518,of,0,0
149519,anti-Mullerian,1,1
149520,hormone,1,1
149521,(,1,0
149522,AMH,1,0
149523,),1,0
149524,and,1,0
149525,basal,1,1
149526,follicle-stimulating,1,1
149527,hormone,1,1
149528,(,1,0
149529,FSH,1,1
149530,),1,0
149531,before,0,0
149532,surgery,0,0
149533,and,0,0
149534,at,0,0
149535,3,0,0
149536,",",0,0
149537,6,0,0
149538,and,0,0
149539,12,0,0
149540,months,0,0
149541,from,0,0
149542,surgery,0,0
149543,.,0,0
149544,MEASUREMENTS,0,0
149545,AND,0,0
149546,MAIN,0,0
149547,RESULTS,0,0
149548,At,0,0
149549,3-month,0,0
149550,",",0,0
149551,6-month,0,0
149552,",",0,0
149553,and,0,1
149554,12-month,0,1
149555,follow-up,0,0
149556,",",0,0
149557,in,0,0
149558,both,0,0
149559,study,0,0
149560,groups,0,0
149561,",",0,0
149562,postsurgical,1,0
149563,AMH,1,0
149564,levels,1,1
149565,were,0,0
149566,significantly,0,0
149567,lower,0,0
149568,and,0,0
149569,basal,1,1
149570,FSH,1,1
149571,levels,1,1
149572,were,0,0
149573,significantly,0,0
149574,higher,0,0
149575,than,0,0
149576,before,0,0
149577,surgery,0,0
149578,.,0,0
149579,There,0,0
149580,was,0,0
149581,no,0,0
149582,significant,0,0
149583,difference,0,0
149584,in,0,0
149585,the,0,0
149586,mean,0,1
149587,percentage,0,1
149588,decrease,0,0
149589,of,0,0
149590,AMH,1,0
149591,levels,1,1
149592,in,0,0
149593,the,0,0
149594,BC,0,1
149595,group,0,0
149596,and,0,1
149597,LS,0,1
149598,group,0,0
149599,at,0,0
149600,3-,0,0
149601,",",0,0
149602,6-,0,0
149603,",",0,0
149604,and,0,1
149605,12-month,0,0
149606,follow-up,0,0
149607,.,0,0
149608,The,0,0
149609,mean,0,1
149610,percentage,0,1
149611,increase,0,1
149612,in,0,0
149613,basal,1,1
149614,FSH,1,0
149615,was,0,0
149616,higher,0,0
149617,in,0,0
149618,the,0,0
149619,BC,0,1
149620,group,0,0
149621,than,0,0
149622,in,0,0
149623,the,0,0
149624,LS,0,0
149625,group,0,0
149626,at,0,0
149627,both,0,0
149628,3-month,0,0
149629,(,0,0
149630,p,0,0
149631,=,0,0
149632,.023,0,0
149633,),0,0
149634,and,0,0
149635,6-month,0,0
149636,follow-up,0,0
149637,(,0,0
149638,p,0,0
149639,=,0,0
149640,.029,0,0
149641,),0,0
149642,",",0,0
149643,but,0,0
149644,not,0,0
149645,at,0,0
149646,12-month,0,0
149647,follow-up,0,0
149648,.,0,0
149649,Pregnancy,1,1
149650,rate,1,1
149651,",",1,0
149652,time,1,1
149653,to,1,0
149654,conception,1,1
149655,",",1,0
149656,and,1,1
149657,rate,1,1
149658,of,1,1
149659,endometrioma,1,1
149660,recurrence,1,1
149661,was,0,0
149662,similar,0,0
149663,in,0,0
149664,the,0,0
149665,2,0,0
149666,study,0,0
149667,groups,0,0
149668,.,0,0
149669,CONCLUSION,0,0
149670,Laparoscopic,0,0
149671,stripping,0,0
149672,of,0,0
149673,ovarian,0,0
149674,endometriotic,0,1
149675,cyst,0,0
149676,significantly,0,0
149677,decreases,0,0
149678,serum,1,1
149679,AMH,1,0
149680,levels,1,1
149681,and,0,0
149682,increases,0,1
149683,basal,1,1
149684,FSH,1,0
149685,levels,1,1
149686,independent,0,0
149687,from,0,0
149688,the,0,0
149689,method,0,0
149690,used,0,0
149691,to,0,0
149692,obtain,0,0
149693,hemostasis,0,1
149694,on,0,0
149695,the,0,0
149696,ovarian,0,0
149697,tissue,0,0
149698,.,0,0
149699,ARIX,0,0
149700,:,0,0
149701,a,0,0
149702,randomised,0,0
149703,trial,0,0
149704,of,0,0
149705,acupuncture,0,0
149706,v,0,0
149707,oral,0,0
149708,care,0,0
149709,sessions,0,0
149710,in,0,0
149711,patients,0,0
149712,with,0,0
149713,chronic,0,0
149714,xerostomia,0,1
149715,following,0,0
149716,treatment,0,0
149717,of,0,0
149718,head,0,0
149719,and,0,1
149720,neck,0,1
149721,cancer,0,0
149722,.,0,0
149723,BACKGROUND,0,0
149724,Radiation,0,1
149725,treatment,0,0
149726,of,0,1
149727,head,0,0
149728,and,0,1
149729,neck,0,1
149730,cancer,0,0
149731,can,0,0
149732,cause,0,0
149733,chronic,0,0
149734,xerostomia,0,1
149735,which,0,0
149736,impairs,0,0
149737,patients,0,0
149738,',0,0
149739,quality,0,1
149740,of,0,0
149741,life,0,1
149742,.,0,0
149743,The,0,0
149744,study,0,0
149745,reported,0,0
149746,here,0,0
149747,examined,0,0
149748,the,0,0
149749,efficacy,1,1
149750,of,0,0
149751,acupuncture,0,0
149752,in,0,0
149753,alleviating,0,0
149754,xerostomia,0,1
149755,symptoms,0,1
149756,especially,0,0
149757,dry,0,0
149758,mouth,0,0
149759,.,0,0
149760,PATIENTS,0,0
149761,AND,0,0
149762,METHODS,0,0
149763,A,0,0
149764,total,0,1
149765,of,0,0
149766,145,0,0
149767,patients,0,0
149768,with,0,0
149769,chronic,0,0
149770,radiation-induced,0,0
149771,xerostomia,0,1
149772,>,0,0
149773,18,0,0
149774,months,0,0
149775,after,0,0
149776,treatments,0,0
149777,were,0,0
149778,recruited,0,0
149779,from,0,0
149780,seven,0,0
149781,UK,0,0
149782,cancer,0,0
149783,centres,0,0
149784,.,0,0
149785,The,0,0
149786,study,0,0
149787,employed,0,0
149788,a,0,0
149789,randomised,0,0
149790,crossover,0,0
149791,design,0,0
149792,with,0,0
149793,participants,0,0
149794,receiving,0,0
149795,two,0,0
149796,group,0,0
149797,sessions,0,0
149798,of,0,0
149799,oral,0,0
149800,care,0,0
149801,education,0,0
149802,and,0,0
149803,eight,0,0
149804,of,0,0
149805,acupuncture,0,0
149806,using,0,0
149807,standardised,0,0
149808,methods,0,0
149809,.,0,0
149810,Patient-reported,1,1
149811,outcome,1,1
149812,(,1,0
149813,PROs,1,1
149814,),1,0
149815,measures,1,1
149816,were,0,0
149817,completed,0,0
149818,at,0,0
149819,baseline,0,0
149820,and,0,0
149821,weeks,0,0
149822,5,0,0
149823,",",0,0
149824,9,0,0
149825,",",0,0
149826,13,0,0
149827,",",0,0
149828,17,0,0
149829,",",0,0
149830,and,0,0
149831,21,0,0
149832,.,0,0
149833,The,0,0
149834,primary,0,0
149835,outcome,0,1
149836,was,0,0
149837,improvement,1,1
149838,in,1,0
149839,dry,1,0
149840,mouth,1,0
149841,.,1,0
149842,OBJECTIVE,0,0
149843,saliva,1,1
149844,measurements,1,0
149845,were,0,0
149846,also,0,0
149847,carried,0,0
149848,out,0,0
149849,.,0,0
149850,RESULTS,0,0
149851,Acupuncture,0,0
149852,compared,0,0
149853,with,0,0
149854,oral,0,0
149855,care,0,0
149856,",",0,0
149857,produced,0,0
149858,significant,0,0
149859,reductions,0,1
149860,in,0,0
149861,patient,0,0
149862,reports,0,0
149863,of,0,0
149864,severe,1,1
149865,dry,1,0
149866,mouth,1,0
149867,(,0,0
149868,OR,0,0
149869,=,0,0
149870,2.01,0,0
149871,",",0,0
149872,P,0,0
149873,=,0,0
149874,0.031,0,0
149875,),0,0
149876,sticky,1,0
149877,saliva,1,1
149878,(,0,0
149879,OR,0,0
149880,=,0,0
149881,1.67,0,0
149882,",",0,0
149883,P,0,0
149884,=,0,0
149885,0.048,0,0
149886,),0,0
149887,",",0,0
149888,needing,1,0
149889,to,1,0
149890,sip,1,0
149891,fluids,1,0
149892,to,1,0
149893,swallow,1,0
149894,food,1,0
149895,(,0,0
149896,OR,0,0
149897,=,0,0
149898,2.08,0,0
149899,",",0,0
149900,P,0,0
149901,=,0,0
149902,0.011,0,0
149903,),0,0
149904,and,0,0
149905,in,0,0
149906,waking,1,1
149907,up,1,0
149908,at,1,0
149909,night,1,1
149910,to,1,0
149911,drink,1,0
149912,(,0,0
149913,OR,0,0
149914,=,0,0
149915,1.71,0,0
149916,",",0,0
149917,P,0,0
149918,=,0,0
149919,0.013,0,0
149920,),0,0
149921,.,0,0
149922,There,0,0
149923,were,0,0
149924,no,0,0
149925,significant,0,0
149926,changes,0,0
149927,in,0,0
149928,either,0,0
149929,stimulated,1,0
149930,or,1,0
149931,unstimulated,1,1
149932,saliva,1,1
149933,measurements,1,0
149934,over,0,0
149935,time,0,1
149936,.,0,0
149937,CONCLUSION,0,0
149938,Eight,0,1
149939,sessions,0,0
149940,of,0,0
149941,weekly,0,0
149942,group,0,0
149943,acupuncture,0,0
149944,compared,0,0
149945,with,0,0
149946,group,0,0
149947,oral,0,0
149948,care,0,0
149949,education,0,0
149950,provide,0,0
149951,significantly,0,0
149952,better,0,0
149953,relief,0,1
149954,of,0,1
149955,symptoms,0,1
149956,in,0,0
149957,patients,0,0
149958,suffering,0,0
149959,from,0,0
149960,chronic,0,0
149961,radiation-induced,0,0
149962,xerostomia,0,1
149963,.,0,0
149964,Acceleration,0,1
149965,of,0,0
149966,insulin,0,1
149967,pharmacodynamic,0,1
149968,profile,0,1
149969,by,0,0
149970,a,0,0
149971,novel,0,0
149972,insulin,0,1
149973,infusion,0,0
149974,site,0,1
149975,warming,0,0
149976,device,0,0
149977,.,0,0
149978,BACKGROUND,0,0
149979,AND,0,0
149980,OBJECTIVE,0,0
149981,Subcutaneously,0,0
149982,injected,0,0
149983,rapid-acting,0,0
149984,insulin,0,1
149985,analogs,0,0
149986,do,0,0
149987,not,0,0
149988,replicate,0,0
149989,physiologic,0,0
149990,insulin,0,1
149991,action,0,1
149992,due,0,0
149993,to,0,0
149994,delays,0,1
149995,in,0,0
149996,their,0,0
149997,onset,0,1
149998,and,0,0
149999,peak,0,1
150000,action,0,1
150001,resulting,0,0
150002,in,0,0
150003,postprandial,0,1
150004,glucose,0,1
150005,excursions,0,0
150006,.,0,0
150007,The,0,0
150008,InsuPatch,0,0
150009,(,0,0
150010,IP,0,0
150011,),0,0
150012,is,0,0
150013,a,0,0
150014,novel,0,0
150015,insulin,0,1
150016,infusion,0,0
150017,site,0,1
150018,warming,0,1
150019,device,0,0
150020,developed,0,0
150021,to,0,0
150022,accelerate,0,0
150023,insulin,0,1
150024,action,0,1
150025,by,0,0
150026,increasing,0,0
150027,blood,0,1
150028,flow,0,1
150029,to,0,0
150030,the,0,0
150031,area,0,1
150032,of,0,0
150033,insulin,0,1
150034,absorption,0,1
150035,.,0,0
150036,Thirteen,0,0
150037,adolescents,0,0
150038,with,0,0
150039,type,0,0
150040,1,0,0
150041,diabetes,0,0
150042,(,0,0
150043,T1D,0,0
150044,",",0,0
150045,mean,0,1
150046,age,0,0
150047,14,0,0
150048,?,0,0
150049,4,0,0
150050,yr,0,0
150051,),0,0
150052,were,0,0
150053,enrolled,0,0
150054,in,0,0
150055,this,0,0
150056,study,0,0
150057,to,0,0
150058,investigate,0,0
150059,the,0,0
150060,effect,0,0
150061,of,0,0
150062,the,0,0
150063,IP,0,0
150064,on,0,0
150065,the,0,0
150066,pharmacodynamics,0,0
150067,and,0,0
150068,pharmacokinetics,0,1
150069,of,0,0
150070,a,0,0
150071,0.2,0,0
150072,unit/kg,0,0
150073,bolus,0,0
150074,dose,0,0
150075,of,0,0
150076,aspart,0,0
150077,insulin,0,0
150078,using,0,0
150079,the,0,0
150080,euglycemic,0,0
150081,clamp,0,0
150082,technique,0,0
150083,.,0,0
150084,RESEARCH,0,0
150085,DESIGN,0,0
150086,AND,0,0
150087,METHODS,0,0
150088,Each,0,0
150089,subject,0,0
150090,underwent,0,0
150091,two,0,0
150092,euglycemic,0,0
150093,clamp,0,0
150094,procedures,0,0
150095,on,0,0
150096,separate,0,0
150097,occasions,0,0
150098,:,0,0
150099,one,0,0
150100,with,0,0
150101,IP,0,0
150102,and,0,0
150103,one,0,0
150104,without,0,0
150105,IP,0,0
150106,activation,0,1
150107,in,0,0
150108,random,0,0
150109,order,0,0
150110,.,0,0
150111,RESULTS,0,0
150112,When,0,0
150113,the,0,0
150114,insulin,0,1
150115,bolus,0,0
150116,was,0,0
150117,given,0,0
150118,with,0,0
150119,IP,0,0
150120,activation,0,1
150121,as,0,0
150122,compared,0,0
150123,to,0,0
150124,without,0,0
150125,IP,0,0
150126,activation,1,1
150127,",",1,0
150128,time,1,1
150129,to,1,0
150130,reach,1,0
150131,maximum,1,1
150132,insulin,1,1
150133,action,1,1
150134,(,1,0
150135,T,1,1
150136,(,1,0
150137,GIRmax,1,1
150138,),1,0
150139,),1,0
150140,and,1,0
150141,to,1,0
150142,reach,1,0
150143,50,0,0
150144,%,0,0
150145,maximum,1,0
150146,action,1,1
150147,(,1,0
150148,T,0,0
150149,(,0,0
150150,50,0,0
150151,%,0,0
150152,GIRmax,0,0
150153,),0,0
150154,),0,0
150155,were,0,0
150156,35,0,0
150157,and,0,0
150158,18,0,0
150159,min,0,0
150160,earlier,0,0
150161,(,0,0
150162,125,0,0
150163,?,0,0
150164,8,0,0
150165,min,0,0
150166,vs.,0,0
150167,90,0,0
150168,?,0,0
150169,6,0,0
150170,min,0,0
150171,",",0,0
150172,p,0,0
150173,=,0,0
150174,0.002,0,0
150175,and,0,0
150176,58,0,0
150177,?,0,0
150178,5,0,0
150179,min,0,0
150180,.,0,0
150181,vs.,0,0
150182,40,0,0
150183,?,0,0
150184,3,0,0
150185,min,0,0
150186,",",0,0
150187,p,0,0
150188,=,0,0
150189,0.01,0,0
150190,",",0,0
150191,respectively,0,0
150192,),0,0
150193,",",0,0
150194,and,1,0
150195,the,1,0
150196,area,1,1
150197,under,1,0
150198,curve,1,1
150199,",",1,0
150200,AUC,1,0
150201,(,1,0
150202,GIR,0,0
150203,0-90,0,1
150204,min,0,0
150205,),0,0
150206,",",0,0
150207,reflecting,0,0
150208,early,1,0
150209,glucodynamic,1,1
150210,action,1,1
150211,",",1,0
150212,was,1,0
150213,significantly,0,0
150214,greater,0,0
150215,(,0,0
150216,p,0,0
150217,=,0,0
150218,0.001,0,0
150219,),0,0
150220,.,0,0
150221,IP,0,0
150222,activation,0,1
150223,also,0,0
150224,accelerated,0,0
150225,the,0,0
150226,rise,1,0
150227,in,1,0
150228,plasma,1,1
150229,insulin,1,1
150230,levels,1,1
150231,after,0,0
150232,the,0,0
150233,bolus,0,0
150234,(,0,0
150235,p,0,0
150236,=,0,0
150237,0.03,0,0
150238,),0,0
150239,and,0,0
150240,resulted,0,0
150241,in,0,0
150242,a,0,0
150243,higher,0,0
150244,peak,1,1
150245,(,0,0
150246,p,0,0
150247,=,0,0
150248,0.04,0,0
150249,),0,0
150250,and,1,0
150251,greater,1,0
150252,overall,1,1
150253,increase,1,1
150254,(,0,0
150255,p,0,0
150256,=,0,0
150257,0.02,0,0
150258,),0,0
150259,in,1,0
150260,plasma,1,1
150261,insulin,1,1
150262,levels,1,1
150263,.,1,0
150264,CONCLUSIONS,1,0
150265,Our,0,0
150266,results,0,0
150267,show,0,0
150268,that,0,0
150269,insulin,0,1
150270,infusion,0,0
150271,site,0,1
150272,warming,0,0
150273,with,0,0
150274,IP,0,0
150275,activation,0,0
150276,accelerates,1,0
150277,the,1,0
150278,time,1,1
150279,action,1,1
150280,profile,1,1
150281,of,1,1
150282,aspart,1,0
150283,insulin,1,0
150284,which,1,0
150285,may,1,0
150286,be,0,0
150287,of,0,0
150288,benefit,0,0
150289,to,0,0
150290,current,0,0
150291,open-loop,0,0
150292,and,0,0
150293,future,0,0
150294,closed-loop,0,1
150295,insulin,0,1
150296,delivery,0,1
150297,in,0,0
150298,patients,0,0
150299,with,0,0
150300,T1D,0,0
150301,.,0,0
150302,Effects,0,0
150303,of,0,0
150304,strontium,0,0
150305,on,0,0
150306,the,0,0
150307,quality,1,1
150308,of,1,0
150309,bone,1,1
150310,apatite,1,0
150311,crystals,1,0
150312,:,1,0
150313,a,0,0
150314,paired,0,0
150315,biopsy,0,0
150316,study,0,0
150317,in,0,0
150318,postmenopausal,0,0
150319,osteoporotic,0,0
150320,women,0,0
150321,.,0,0
150322,UNLABELLED,0,0
150323,In,0,0
150324,paired,0,0
150325,biopsies,0,0
150326,of,0,0
150327,osteoporotic,0,0
150328,women,0,0
150329,treated,0,0
150330,with,0,0
150331,either,0,0
150332,strontium,0,0
150333,ranelate,0,0
150334,or,0,0
150335,a,0,0
150336,placebo,0,0
150337,for,0,0
150338,36,0,0
150339,months,0,0
150340,",",0,0
150341,characteristics,0,1
150342,of,0,1
150343,bone,0,1
150344,apatite,0,1
150345,crystals,0,0
150346,were,0,0
150347,not,0,0
150348,influenced,0,0
150349,by,0,0
150350,the,0,0
150351,presence,0,0
150352,of,0,0
150353,strontium,0,0
150354,.,0,0
150355,The,0,0
150356,mean,1,1
150357,rate,1,1
150358,of,1,0
150359,substitutions,1,0
150360,of,0,0
150361,calcium,0,0
150362,by,0,0
150363,strontium,0,0
150364,ions,0,0
150365,was,0,0
150366,4.5,0,0
150367,%,0,0
150368,.,0,0
150369,INTRODUCTION,0,0
150370,The,0,0
150371,potential,0,0
150372,effect,0,0
150373,of,0,0
150374,strontium,0,0
150375,(,0,0
150376,Sr,0,0
150377,),0,0
150378,on,0,0
150379,bone,0,1
150380,apatite,0,1
150381,crystals,0,0
150382,was,0,0
150383,investigated,0,0
150384,in,0,0
150385,paired,0,0
150386,biopsies,0,0
150387,of,0,0
150388,osteoporotic,0,0
150389,women,0,0
150390,treated,0,0
150391,with,0,0
150392,either,0,0
150393,strontium,0,0
150394,ranelate,0,0
150395,(,0,0
150396,SrRan,0,0
150397,),0,0
150398,or,0,0
150399,a,0,0
150400,placebo,0,0
150401,for,0,0
150402,36,0,0
150403,months,0,0
150404,.,0,0
150405,METHODS,0,0
150406,In,0,0
150407,ten,0,0
150408,paired,0,0
150409,biopsies,0,0
150410,",",0,0
150411,crystallinity,1,1
150412,",",1,1
150413,apparent,1,1
150414,length,1,1
150415,and,1,1
150416,width/thickness,1,1
150417,of,1,1
150418,crystals,1,0
150419,",",1,0
150420,interplanar,1,1
150421,distances,1,1
150422,",",1,0
150423,and,1,1
150424,lattice,1,1
150425,parameters,1,1
150426,of,1,0
150427,unit,1,0
150428,cells,1,1
150429,were,0,0
150430,assessed,0,0
150431,by,0,0
150432,X-ray,0,1
150433,diffraction,0,1
150434,and,0,0
150435,selected,0,0
150436,area,0,1
150437,electron,0,0
150438,diffraction,0,0
150439,.,0,0
150440,RESULTS,0,0
150441,All,0,0
150442,these,0,0
150443,parameters,0,1
150444,",",0,0
150445,reflecting,0,0
150446,crystal,0,1
150447,and,0,1
150448,unit,0,1
150449,cell,0,1
150450,characteristics,0,1
150451,",",0,0
150452,were,0,0
150453,not,1,0
150454,influenced,1,0
150455,by,0,0
150456,the,0,0
150457,presence,1,0
150458,of,1,0
150459,Sr,1,1
150460,and,0,0
150461,were,0,0
150462,similar,1,0
150463,in,0,0
150464,SrRan,0,0
150465,and,0,0
150466,placebo,0,0
150467,groups,0,0
150468,after,0,0
150469,36,0,0
150470,months,0,0
150471,of,0,0
150472,treatment,0,0
150473,.,0,0
150474,The,0,0
150475,mean,1,1
150476,rate,1,1
150477,of,1,0
150478,substitutions,1,0
150479,of,1,0
150480,calcium,1,0
150481,by,1,0
150482,Sr,1,0
150483,ions,1,0
150484,was,0,0
150485,4.5,0,0
150486,%,0,0
150487,.,0,0
150488,CONCLUSION,0,0
150489,Overall,0,0
150490,",",0,0
150491,the,0,0
150492,quality,1,1
150493,of,1,0
150494,bone,1,1
150495,apatite,1,1
150496,crystals,1,0
150497,was,0,0
150498,maintained,0,0
150499,after,0,0
150500,36,0,0
150501,months,0,0
150502,of,0,0
150503,treatment,0,0
150504,with,0,0
150505,SrRan,0,0
150506,.,0,0
150507,Custom-fit,0,0
150508,minimally,0,0
150509,invasive,0,0
150510,total,0,1
150511,knee,0,1
150512,arthroplasty,0,0
150513,:,0,0
150514,effect,0,0
150515,on,0,0
150516,blood,1,1
150517,loss,1,1
150518,and,0,1
150519,early,1,0
150520,clinical,1,0
150521,outcomes,1,0
150522,.,1,0
150523,PURPOSE,0,0
150524,Recently,0,0
150525,",",0,0
150526,new,0,0
150527,custom-fit,0,1
150528,pin,0,0
150529,guides,0,0
150530,in,0,0
150531,total,0,1
150532,knee,0,1
150533,arthroplasty,0,1
150534,(,0,0
150535,TKA,0,0
150536,),0,0
150537,have,0,0
150538,been,0,0
150539,introduced,0,0
150540,.,0,0
150541,Use,0,0
150542,of,0,0
150543,these,0,0
150544,guides,0,0
150545,may,0,0
150546,reduce,0,0
150547,operating,0,0
150548,time,0,1
150549,.,0,0
150550,Use,0,0
150551,of,0,0
150552,the,0,0
150553,guides,0,0
150554,combined,0,0
150555,with,0,0
150556,the,0,0
150557,absence,0,0
150558,of,0,0
150559,intramedullary,0,0
150560,alignment,0,0
150561,jigs,0,0
150562,may,0,0
150563,lead,0,0
150564,to,0,0
150565,reduced,0,0
150566,blood,1,1
150567,loss,1,1
150568,and,0,0
150569,improved,0,1
150570,early,1,0
150571,outcomes,1,0
150572,.,1,0
150573,Our,0,0
150574,aim,0,0
150575,was,0,0
150576,to,0,0
150577,evaluate,0,0
150578,blood,1,1
150579,loss,1,1
150580,and,0,1
150581,early,1,0
150582,clinical,1,0
150583,outcomes,1,0
150584,in,0,0
150585,patients,0,0
150586,undergoing,0,0
150587,minimally,0,0
150588,invasive,0,0
150589,TKA,0,0
150590,using,0,0
150591,custom-fit,0,1
150592,magnetic,0,0
150593,resonance,0,0
150594,imaging,0,1
150595,(,0,0
150596,MRI,0,1
150597,),0,0
150598,-based,0,0
150599,pin,0,0
150600,guides,0,0
150601,.,0,0
150602,METHODS,0,0
150603,A,0,0
150604,prospective,0,0
150605,study,0,0
150606,in,0,0
150607,80,0,0
150608,patients,0,0
150609,was,0,0
150610,carried,0,0
150611,out,0,0
150612,.,0,0
150613,Patients,0,0
150614,were,0,0
150615,divided,0,0
150616,randomly,0,0
150617,into,0,0
150618,2,0,0
150619,equal,0,0
150620,groups,0,0
150621,.,0,0
150622,In,0,0
150623,one,0,0
150624,group,0,0
150625,",",0,0
150626,intramedullary,0,0
150627,alignment,0,1
150628,jigs,0,0
150629,were,0,0
150630,used,0,0
150631,.,0,0
150632,In,0,0
150633,the,0,0
150634,second,0,0
150635,group,0,0
150636,",",0,0
150637,custom-fit,0,1
150638,MRI-based,0,0
150639,pin,0,0
150640,guides,0,0
150641,were,0,0
150642,used,0,0
150643,.,0,0
150644,All,0,0
150645,patients,0,0
150646,received,0,0
150647,the,0,0
150648,same,0,0
150649,cemented,0,0
150650,posterior-stabilized,0,0
150651,implant,0,0
150652,through,0,0
150653,a,0,0
150654,mini-midvastus,0,0
150655,approach,0,0
150656,.,0,0
150657,The,0,0
150658,volume,0,0
150659,in,0,0
150660,the,0,0
150661,drain,0,0
150662,bottles,0,0
150663,was,0,0
150664,recorded,0,0
150665,after,0,0
150666,48,0,0
150667,h.,0,0
150668,Hb,1,0
150669,loss,1,1
150670,was,0,0
150671,estimated,0,0
150672,by,0,0
150673,subtracting,0,0
150674,the,0,0
150675,postoperative,0,0
150676,from,0,0
150677,the,0,0
150678,preoperative,0,0
150679,Hb,0,1
150680,level,0,1
150681,.,0,0
150682,Transfusion,1,1
150683,requirements,1,1
150684,and,0,1
150685,surgical,1,1
150686,time,1,1
150687,were,0,0
150688,recorded,0,0
150689,.,0,0
150690,Outcome,0,1
150691,measures,0,1
150692,were,0,0
150693,Knee,1,1
150694,Society,1,1
150695,Scores,1,1
150696,(,1,0
150697,KSS,1,1
150698,),1,0
150699,",",1,0
150700,knee,1,1
150701,flexion,1,1
150702,",",1,0
150703,knee,1,1
150704,swelling,1,1
150705,and,1,0
150706,pain,1,1
150707,.,1,0
150708,RESULTS,0,0
150709,There,0,0
150710,was,0,0
150711,lower,0,0
150712,mean,1,1
150713,drainage,1,0
150714,of,1,0
150715,blood,1,1
150716,in,0,0
150717,the,0,0
150718,custom-fit,0,1
150719,group,0,0
150720,(,0,0
150721,391,0,0
150722,ml,0,0
150723,vs.,0,0
150724,603,0,0
150725,ml,0,0
150726,;,0,0
150727,p,0,0
150728,<,0,0
150729,0.0001,0,0
150730,),0,0
150731,.,0,0
150732,There,0,0
150733,was,0,0
150734,no,0,0
150735,difference,0,0
150736,in,0,0
150737,estimated,0,0
150738,loss,1,1
150739,of,1,0
150740,Hb,1,1
150741,(,0,0
150742,3.6,0,0
150743,g/dl,0,0
150744,vs.,0,0
150745,4.1,0,0
150746,g/dl,0,0
150747,;,0,0
150748,n.s,0,0
150749,.,0,0
150750,),0,0
150751,and,0,0
150752,in,0,0
150753,transfusion,1,1
150754,requirements,1,1
150755,(,0,0
150756,7.5,0,0
150757,%,0,0
150758,vs.,0,0
150759,10,0,0
150760,%,0,0
150761,;,0,0
150762,n.s.,0,0
150763,),0,0
150764,.,0,0
150765,Surgical,1,1
150766,time,1,1
150767,was,0,0
150768,reduced,0,0
150769,in,0,0
150770,the,0,0
150771,custom-fit,0,1
150772,group,0,0
150773,(,0,0
150774,12,0,0
150775,min,0,0
150776,less,0,0
150777,;,0,0
150778,p,0,0
150779,=,0,0
150780,0.001,0,0
150781,),0,0
150782,.,0,0
150783,KSS,1,1
150784,measured,0,0
150785,at,0,0
150786,week,0,0
150787,2,0,0
150788,",",0,0
150789,6,0,0
150790,and,0,0
150791,12,0,0
150792,showed,0,0
150793,no,0,0
150794,significant,0,0
150795,difference,0,0
150796,between,0,0
150797,groups,0,0
150798,.,0,0
150799,Knee,1,1
150800,flexion,1,1
150801,measured,0,0
150802,on,0,0
150803,days,0,0
150804,7,0,0
150805,",",0,0
150806,10,0,0
150807,and,0,0
150808,at,0,0
150809,week,0,0
150810,6,0,0
150811,",",0,0
150812,12,0,0
150813,and,0,0
150814,knee,1,0
150815,swelling,1,1
150816,and,1,0
150817,pain,1,1
150818,measured,0,1
150819,on,0,0
150820,days,0,0
150821,1,0,0
150822,",",0,0
150823,3,0,0
150824,",",0,0
150825,10,0,0
150826,and,0,0
150827,at,0,0
150828,week,0,0
150829,6,0,0
150830,",",0,0
150831,12,0,0
150832,showed,0,0
150833,no,0,0
150834,significant,0,0
150835,difference,0,0
150836,between,0,0
150837,groups,0,0
150838,.,0,0
150839,CONCLUSIONS,0,0
150840,Using,0,0
150841,custom-fit,0,1
150842,pin,0,0
150843,guides,0,0
150844,reduces,0,0
150845,blood,1,1
150846,drainage,1,0
150847,",",0,0
150848,but,0,0
150849,not,0,0
150850,the,0,0
150851,estimated,0,0
150852,Hb,1,1
150853,loss,1,1
150854,in,0,0
150855,minimally,0,0
150856,invasive,0,0
150857,TKA,0,0
150858,and,0,0
150859,does,0,0
150860,not,0,0
150861,affect,0,0
150862,transfusion,1,1
150863,rate,1,1
150864,.,1,0
150865,Surgical,1,0
150866,time,1,1
150867,is,0,0
150868,reduced,0,0
150869,.,0,0
150870,There,0,0
150871,is,0,0
150872,no,0,0
150873,effect,0,0
150874,on,0,0
150875,the,0,0
150876,early,1,0
150877,clinical,1,0
150878,outcomes,1,0
150879,.,1,0
150880,LEVEL,0,0
150881,OF,0,0
150882,EVIDENCE,0,0
150883,Therapeutic,0,0
150884,study,0,0
150885,",",0,0
150886,Level,0,0
150887,I,0,0
150888,.,0,0
150889,Clinical,0,0
150890,trial,0,0
150891,:,0,0
150892,marine,0,0
150893,lipid,0,1
150894,suppositories,0,0
150895,as,0,0
150896,laxatives,0,0
150897,.,0,0
150898,UNLABELLED,0,0
150899,Cod-liver,0,0
150900,oil,0,0
150901,and,0,0
150902,other,0,0
150903,marine,0,0
150904,products,0,1
150905,containing,0,0
150906,polyunsaturated,0,0
150907,fatty,0,1
150908,acids,0,0
150909,have,0,0
150910,anti-inflammatory,0,0
150911,",",0,0
150912,anti-bacterial,0,1
150913,and,0,1
150914,anti-viral,0,0
150915,effects,0,0
150916,and,0,0
150917,may,0,0
150918,be,0,0
150919,useful,0,0
150920,in,0,0
150921,the,0,0
150922,treatment,0,0
150923,of,0,0
150924,various,0,0
150925,inflammatory,0,1
150926,and,0,0
150927,infectious,0,1
150928,diseases,0,0
150929,.,0,0
150930,We,0,0
150931,developed,0,0
150932,suppositories,0,0
150933,and,0,1
150934,ointment,0,0
150935,with,0,0
150936,30,0,0
150937,%,0,0
150938,free,0,0
150939,fatty,0,1
150940,acid,0,0
150941,(,0,0
150942,FFA,0,0
150943,),0,0
150944,extract,0,0
150945,from,0,0
150946,omega-3,0,0
150947,fish,0,0
150948,oil,0,0
150949,.,0,0
150950,Our,0,0
150951,purpose,0,0
150952,was,0,0
150953,to,0,0
150954,evaluate,0,0
150955,the,0,0
150956,safety,1,1
150957,of,0,0
150958,marine,0,0
150959,lipid,0,1
150960,suppositories,0,0
150961,and,0,0
150962,ointment,0,0
150963,in,0,0
150964,healthy,0,0
150965,volunteers,0,0
150966,and,0,0
150967,to,0,0
150968,explore,0,0
150969,the,0,0
150970,laxative,1,0
150971,effect,1,0
150972,of,0,0
150973,the,0,0
150974,suppositories,0,0
150975,.,0,0
150976,Thirty,0,0
150977,healthy,0,0
150978,volunteers,0,0
150979,were,0,0
150980,randomized,0,0
150981,either,0,0
150982,to,0,0
150983,a,0,0
150984,study,0,0
150985,group,0,0
150986,administrating,0,0
150987,30,0,0
150988,%,0,0
150989,FFA,0,0
150990,suppositories,0,0
150991,and,0,0
150992,applying,0,0
150993,30,0,0
150994,%,0,0
150995,FFA,0,0
150996,ointment,0,0
150997,to,0,0
150998,the,0,0
150999,perianal,0,1
151000,region,0,0
151001,twice,0,0
151002,per,0,0
151003,day,0,0
151004,for,0,0
151005,two,0,0
151006,weeks,0,0
151007,",",0,0
151008,or,0,0
151009,to,0,0
151010,a,0,0
151011,control,0,0
151012,group,0,0
151013,using,0,0
151014,placebo,0,0
151015,suppositories,0,0
151016,and,0,1
151017,ointment,0,0
151018,in,0,0
151019,a,0,0
151020,double,0,0
151021,blinded,0,0
151022,manner,0,0
151023,.,0,0
151024,RESULTS,0,0
151025,No,0,0
151026,serious,1,1
151027,toxic,1,1
151028,effects,1,1
151029,or,1,1
151030,irritation,1,1
151031,were,0,0
151032,observed,0,0
151033,.,0,0
151034,In,0,0
151035,the,0,0
151036,study,0,0
151037,group,0,0
151038,93,0,0
151039,%,0,0
151040,felt,0,0
151041,the,0,0
151042,urge,1,1
151043,to,1,0
151044,defecate,1,1
151045,after,0,0
151046,administration,0,0
151047,of,0,0
151048,the,0,0
151049,suppositories,0,0
151050,as,0,0
151051,compared,0,0
151052,to,0,0
151053,37,0,0
151054,%,0,0
151055,in,0,0
151056,the,0,0
151057,control,0,0
151058,group,0,0
151059,(,0,0
151060,P,0,0
151061,=,0,0
151062,0.001,0,0
151063,),0,0
151064,.,0,0
151065,Subsequently,0,0
151066,90,0,0
151067,%,0,0
151068,in,0,0
151069,the,0,0
151070,study,0,0
151071,group,0,0
151072,defecated,1,1
151073,",",0,0
151074,compared,0,0
151075,to,0,0
151076,33,0,0
151077,%,0,0
151078,in,0,0
151079,the,0,0
151080,control,0,0
151081,group,0,0
151082,(,0,0
151083,P,0,0
151084,=,0,0
151085,0.001,0,0
151086,),0,0
151087,.,0,0
151088,CONCLUSION,0,0
151089,The,0,0
151090,marine,0,0
151091,lipid,0,1
151092,suppositories,0,0
151093,and,0,1
151094,ointment,0,0
151095,were,0,0
151096,well,0,0
151097,tolerated,0,1
151098,with,0,0
151099,no,0,0
151100,significant,0,0
151101,toxic,1,1
151102,side,1,1
151103,effects,1,1
151104,observed,0,0
151105,during,0,0
151106,the,0,0
151107,study,0,0
151108,period,0,0
151109,.,0,0
151110,The,0,0
151111,suppositories,0,0
151112,have,0,0
151113,a,0,0
151114,distinct,0,0
151115,laxative,1,1
151116,effect,1,0
151117,and,0,0
151118,we,0,0
151119,aim,0,0
151120,to,0,0
151121,explore,0,0
151122,this,0,0
151123,effect,0,0
151124,in,0,0
151125,further,0,0
151126,clinical,0,0
151127,trials,0,0
151128,.,0,0
151129,Prognostic,0,0
151130,interaction,0,1
151131,between,0,0
151132,expression,1,1
151133,of,1,0
151134,p53,1,1
151135,and,0,1
151136,estrogen,0,1
151137,receptor,0,1
151138,in,0,0
151139,patients,0,0
151140,with,0,0
151141,node-negative,0,0
151142,breast,0,0
151143,cancer,0,0
151144,:,0,0
151145,results,0,0
151146,from,0,0
151147,IBCSG,0,0
151148,Trials,0,1
151149,VIII,0,0
151150,and,0,0
151151,IX,0,0
151152,.,0,0
151153,INTRODUCTION,0,0
151154,The,0,0
151155,prognostic,0,1
151156,significance,0,1
151157,of,0,0
151158,p53,0,1
151159,protein,0,1
151160,expression,0,1
151161,in,0,0
151162,early,0,0
151163,breast,0,0
151164,cancer,0,0
151165,remains,0,0
151166,uncertain,0,0
151167,",",0,0
151168,with,0,0
151169,some,0,0
151170,but,0,0
151171,not,0,0
151172,all,0,0
151173,studies,0,0
151174,finding,0,0
151175,an,0,0
151176,association,0,0
151177,with,0,0
151178,poorer,1,0
151179,outcomes,1,1
151180,.,1,1
151181,Estrogen,1,0
151182,receptor,1,1
151183,(,1,0
151184,ER,1,0
151185,),1,0
151186,expression,1,1
151187,is,0,0
151188,both,0,0
151189,a,0,0
151190,positive,0,0
151191,prognostic,0,1
151192,marker,0,1
151193,and,0,1
151194,predictive,0,1
151195,of,0,0
151196,response,1,1
151197,to,1,0
151198,endocrine,1,0
151199,therapies,1,0
151200,.,1,0
151201,The,0,0
151202,relationship,0,0
151203,between,0,0
151204,these,0,0
151205,biomarkers,0,0
151206,is,0,0
151207,unknown,0,0
151208,.,0,0
151209,METHODS,0,0
151210,We,0,0
151211,constructed,0,0
151212,tissue,0,1
151213,microarrays,0,0
151214,(,0,0
151215,TMAs,0,0
151216,),0,0
151217,from,0,0
151218,available,0,0
151219,pathological,0,1
151220,material,0,0
151221,from,0,0
151222,1113,0,0
151223,patients,0,0
151224,participating,0,0
151225,in,0,0
151226,two,0,0
151227,randomized,0,0
151228,clinical,0,0
151229,trials,0,0
151230,comparing,0,0
151231,endocrine,0,0
151232,therapy,0,0
151233,alone,0,0
151234,versus,0,0
151235,chemo-endocrine,0,0
151236,therapy,0,0
151237,in,0,0
151238,node-negative,0,0
151239,breast,0,0
151240,cancer,0,0
151241,.,0,0
151242,Expression,1,1
151243,of,1,0
151244,p53,1,1
151245,defined,0,0
151246,as,0,0
151247,>,0,0
151248,10,0,0
151249,%,0,0
151250,positive,0,0
151251,nuclei,0,1
151252,was,0,0
151253,analyzed,0,0
151254,together,0,0
151255,with,0,0
151256,prior,0,0
151257,immunohistochemical,0,0
151258,assays,0,0
151259,of,0,0
151260,ER,0,0
151261,performed,0,0
151262,at,0,0
151263,central,0,1
151264,pathological,0,1
151265,review,0,0
151266,of,0,0
151267,whole,0,0
151268,tumor,0,0
151269,sections,0,0
151270,.,0,0
151271,RESULTS,0,0
151272,ER,1,0
151273,was,0,0
151274,present,0,0
151275,(,0,0
151276,i.e,0,0
151277,.,0,0
151278,>,0,0
151279,1,0,0
151280,%,0,0
151281,positive,0,0
151282,tumor,0,1
151283,cell,0,1
151284,nuclei,0,1
151285,),0,0
151286,in,0,0
151287,80.1,0,0
151288,%,0,0
151289,(,0,0
151290,880/1092,0,0
151291,),0,0
151292,.,0,0
151293,p53,1,1
151294,expression,1,1
151295,was,0,0
151296,significantly,0,0
151297,more,0,0
151298,frequent,0,0
151299,when,0,0
151300,ER,0,0
151301,was,0,0
151302,absent,0,0
151303,",",0,0
151304,125/212,0,0
151305,(,0,0
151306,59,0,0
151307,%,0,0
151308,),0,0
151309,than,0,0
151310,when,0,0
151311,ER,0,0
151312,was,0,0
151313,present,0,0
151314,",",0,0
151315,171/880,0,0
151316,(,0,0
151317,19,0,0
151318,%,0,0
151319,),0,0
151320,",",0,0
151321,p,0,0
151322,<,0,0
151323,0.0001,0,0
151324,.,0,0
151325,A,0,0
151326,significant,0,0
151327,qualitative,0,0
151328,interaction,0,1
151329,was,0,0
151330,observed,0,0
151331,such,0,0
151332,that,0,0
151333,p53,1,1
151334,expression,1,1
151335,was,0,0
151336,associated,0,0
151337,with,0,0
151338,better,0,0
151339,disease-free,1,1
151340,survival,1,1
151341,(,1,0
151342,DFS,1,1
151343,),1,0
151344,and,1,0
151345,overall,1,1
151346,survival,1,1
151347,(,1,0
151348,OS,1,1
151349,),1,0
151350,among,0,0
151351,patients,0,0
151352,whose,0,0
151353,tumors,0,0
151354,did,0,0
151355,not,0,0
151356,express,0,0
151357,ER,0,0
151358,",",0,0
151359,but,0,0
151360,worse,0,1
151361,DFS,1,1
151362,and,0,1
151363,OS,1,1
151364,among,0,0
151365,patients,0,0
151366,whose,0,0
151367,tumors,0,0
151368,expressed,0,0
151369,ER,0,0
151370,.,0,0
151371,The,0,0
151372,interaction,0,1
151373,remained,0,0
151374,significant,0,0
151375,after,0,0
151376,allowance,0,0
151377,for,0,0
151378,pathologic,0,1
151379,variables,0,1
151380,",",0,0
151381,and,0,0
151382,treatment,0,0
151383,.,0,1
151384,Similar,0,0
151385,effects,0,1
151386,were,0,0
151387,seen,0,0
151388,when,0,0
151389,luminal,0,1
151390,and,0,0
151391,non-luminal,0,1
151392,intrinsic,0,1
151393,subtypes,0,0
151394,were,0,0
151395,compared,0,0
151396,.,0,0
151397,CONCLUSIONS,0,0
151398,Interpretation,0,0
151399,of,0,0
151400,the,0,0
151401,prognostic,0,0
151402,significance,0,1
151403,of,0,0
151404,p53,1,0
151405,expression,1,1
151406,requires,0,0
151407,knowledge,0,1
151408,of,0,0
151409,concurrent,0,0
151410,expression,1,1
151411,of,1,0
151412,ER,1,0
151413,.,1,0
151414,The,0,0
151415,reason,0,0
151416,for,0,0
151417,the,0,0
151418,interaction,0,1
151419,between,0,0
151420,p53,0,1
151421,and,0,0
151422,ER,0,0
151423,is,0,0
151424,unknown,0,0
151425,but,0,0
151426,may,0,0
151427,reflect,0,0
151428,qualitatively,0,0
151429,different,0,0
151430,p53,1,1
151431,mutations,1,1
151432,underlying,0,0
151433,the,0,0
151434,p53,1,0
151435,expression,1,1
151436,in,0,0
151437,tumors,0,0
151438,with,0,0
151439,or,0,0
151440,without,0,0
151441,ER,0,0
151442,expression,0,1
151443,.,0,0
151444,TRIAL,0,0
151445,REGISTRATION,0,0
151446,Current,0,1
151447,Controlled,0,0
151448,Trials,0,1
151449,ACTRN12607000037404,0,0
151450,(,0,0
151451,Trial,0,0
151452,VIII,0,0
151453,),0,0
151454,and,0,0
151455,ACTRN12607000029493,0,0
151456,(,0,0
151457,Trial,0,0
151458,IX,0,0
151459,),0,0
151460,.,0,0
151461,The,0,0
151462,effect,0,0
151463,of,0,0
151464,values,0,1
151465,affirmation,0,0
151466,on,0,0
151467,race-discordant,0,0
151468,patient-provider,0,0
151469,communication,0,0
151470,.,0,0
151471,BACKGROUND,0,0
151472,Communication,0,1
151473,between,0,0
151474,African,0,0
151475,American,0,0
151476,patients,0,0
151477,and,0,0
151478,white,0,0
151479,health,0,1
151480,care,0,0
151481,providers,0,0
151482,has,0,0
151483,been,0,0
151484,shown,0,0
151485,to,0,0
151486,be,0,0
151487,of,0,0
151488,poorer,0,0
151489,quality,0,1
151490,when,0,0
151491,compared,0,0
151492,with,0,0
151493,race-concordant,0,0
151494,patient-provider,0,0
151495,communication,0,0
151496,.,0,0
151497,Fear,0,1
151498,on,0,0
151499,the,0,0
151500,part,0,0
151501,of,0,0
151502,patients,0,0
151503,that,0,0
151504,providers,0,0
151505,stereotype,0,0
151506,them,0,0
151507,negatively,0,0
151508,might,0,0
151509,be,0,0
151510,one,0,0
151511,cause,0,0
151512,of,0,0
151513,this,0,0
151514,poorer,0,0
151515,communication,0,0
151516,.,0,0
151517,This,0,0
151518,stereotype,0,0
151519,threat,0,0
151520,may,0,0
151521,be,0,0
151522,lessened,0,0
151523,by,0,0
151524,a,0,0
151525,values-affirmation,0,0
151526,intervention,0,0
151527,.,0,0
151528,METHODS,0,0
151529,In,0,0
151530,a,0,0
151531,blinded,0,0
151532,experiment,0,0
151533,",",0,0
151534,we,0,0
151535,randomized,0,0
151536,99,0,0
151537,African,0,0
151538,American,0,0
151539,patients,0,0
151540,with,0,0
151541,hypertension,0,0
151542,to,0,0
151543,perform,0,0
151544,a,0,0
151545,values-affirmation,0,1
151546,exercise,0,0
151547,or,0,0
151548,a,0,0
151549,control,0,0
151550,exercise,0,0
151551,before,0,0
151552,a,0,0
151553,visit,0,1
151554,with,0,0
151555,their,0,0
151556,primary,0,0
151557,care,0,0
151558,provider,0,0
151559,.,0,0
151560,We,0,0
151561,compared,0,0
151562,patient-provider,0,0
151563,communication,0,0
151564,for,0,0
151565,the,0,0
151566,2,0,0
151567,groups,0,0
151568,using,0,0
151569,audio,0,0
151570,recordings,0,0
151571,of,0,0
151572,the,0,0
151573,visit,0,1
151574,analyzed,0,0
151575,with,0,0
151576,the,0,0
151577,Roter,0,0
151578,Interaction,0,0
151579,Analysis,0,1
151580,System,0,0
151581,.,0,0
151582,We,0,0
151583,also,0,0
151584,evaluated,0,0
151585,visit,0,1
151586,satisfaction,0,1
151587,",",0,0
151588,trust,0,1
151589,",",0,1
151590,stress,0,1
151591,",",0,1
151592,and,0,1
151593,mood,0,1
151594,after,0,0
151595,the,0,0
151596,visit,0,1
151597,by,0,0
151598,means,0,0
151599,of,0,0
151600,a,0,0
151601,questionnaire,0,0
151602,.,0,0
151603,RESULTS,0,0
151604,Patients,0,0
151605,in,0,0
151606,the,0,0
151607,intervention,0,0
151608,group,0,0
151609,requested,0,0
151610,and,0,0
151611,provided,0,0
151612,more,0,0
151613,information,1,1
151614,about,0,0
151615,their,0,0
151616,medical,1,0
151617,condition,1,0
151618,(,0,0
151619,mean,0,1
151620,[,0,0
151621,SE,0,0
151622,],0,0
151623,number,0,1
151624,of,0,0
151625,utterances,0,0
151626,",",0,0
151627,66.3,0,0
151628,[,0,0
151629,6.8,0,0
151630,],0,0
151631,in,0,0
151632,the,0,0
151633,values-affirmation,0,1
151634,group,0,0
151635,vs,0,0
151636,48.1,0,0
151637,[,0,0
151638,5.9,0,0
151639,],0,0
151640,in,0,0
151641,the,0,0
151642,control,0,0
151643,group,0,0
151644,[,0,0
151645,P,0,0
151646,=,0,0
151647,.03,0,0
151648,],0,0
151649,),0,0
151650,.,0,0
151651,Patient-provider,0,1
151652,communication,0,0
151653,in,0,0
151654,the,0,0
151655,intervention,0,0
151656,group,0,0
151657,was,0,0
151658,characterized,0,0
151659,as,0,0
151660,being,0,0
151661,more,0,0
151662,interested,1,0
151663,",",1,0
151664,friendly,1,1
151665,",",1,0
151666,responsive,1,0
151667,",",1,0
151668,interactive,1,0
151669,",",1,0
151670,and,1,1
151671,respectful,1,1
151672,(,0,0
151673,P,0,0
151674,=,0,0
151675,.02,0,0
151676,),0,0
151677,and,0,0
151678,less,0,0
151679,depressed,1,1
151680,and,1,1
151681,distressed,1,0
151682,(,0,0
151683,P,0,0
151684,=,0,0
151685,.03,0,0
151686,),0,0
151687,.,0,0
151688,Patient,0,1
151689,questionnaires,0,0
151690,did,0,0
151691,not,0,0
151692,detect,0,0
151693,differences,0,0
151694,in,0,0
151695,visit,1,1
151696,satisfaction,1,1
151697,",",1,1
151698,trust,1,1
151699,",",1,1
151700,stress,1,1
151701,",",1,1
151702,or,1,0
151703,mood,1,1
151704,.,1,1
151705,Mean,1,0
151706,visit,1,1
151707,duration,1,1
151708,did,0,0
151709,not,0,0
151710,differ,0,0
151711,significantly,0,0
151712,between,0,0
151713,the,0,0
151714,groups,0,0
151715,(,0,0
151716,19.2,0,0
151717,minutes,0,0
151718,in,0,0
151719,the,0,0
151720,control,0,0
151721,group,0,0
151722,vs,0,0
151723,20.5,0,0
151724,minutes,0,0
151725,in,0,0
151726,the,0,0
151727,intervention,0,0
151728,group,0,0
151729,[,0,0
151730,P,0,0
151731,=,0,0
151732,.29,0,0
151733,],0,0
151734,),0,0
151735,.,0,0
151736,CONCLUSIONS,0,0
151737,A,0,0
151738,values-affirmation,0,0
151739,exercise,0,0
151740,improves,0,1
151741,aspects,0,0
151742,of,0,0
151743,patient-provider,0,0
151744,communication,0,0
151745,in,0,0
151746,race-discordant,0,0
151747,primary,0,0
151748,care,0,0
151749,visits,0,0
151750,.,0,0
151751,The,0,0
151752,clinical,0,0
151753,impact,0,0
151754,of,0,0
151755,the,0,0
151756,intervention,0,0
151757,must,0,0
151758,be,0,0
151759,defined,0,0
151760,before,0,0
151761,widespread,0,0
151762,implementation,0,0
151763,can,0,0
151764,be,0,0
151765,recommended,0,0
151766,.,0,0
151767,[,1,0
151768,Therapeutic,1,0
151769,efficacy,1,1
151770,of,0,0
151771,youdujing,0,0
151772,preparation,0,0
151773,in,0,0
151774,treating,0,0
151775,cervical,0,0
151776,high-risk,0,0
151777,human,0,0
151778,papilloma,0,0
151779,virus,0,0
151780,infection,0,1
151781,patients,0,0
151782,],0,0
151783,.,0,0
151784,OBJECTIVE,0,0
151785,To,0,0
151786,study,0,0
151787,the,0,0
151788,clinical,0,0
151789,efficacy,0,1
151790,and,0,1
151791,mechanisms,0,1
151792,of,0,1
151793,Youdujing,0,0
151794,(,0,0
151795,YDJ,0,0
151796,),0,0
151797,preparation,0,0
151798,in,0,0
151799,treating,0,0
151800,the,0,0
151801,cervical,0,0
151802,high-risk,0,0
151803,human,0,0
151804,papilloma,0,0
151805,virus,0,0
151806,(,0,0
151807,HR-HPV,0,0
151808,),0,0
151809,infection,0,1
151810,.,0,0
151811,METHODS,0,0
151812,Totally,0,0
151813,HR-HPV,0,0
151814,infection,0,0
151815,70,0,0
151816,patients,0,0
151817,were,0,0
151818,assigned,0,0
151819,to,0,0
151820,the,0,0
151821,treatment,0,0
151822,group,0,0
151823,and,0,0
151824,the,0,0
151825,control,0,0
151826,group,0,0
151827,using,0,0
151828,random,0,0
151829,single,0,0
151830,blind,0,0
151831,method,0,0
151832,",",0,0
151833,35,0,0
151834,cases,0,0
151835,in,0,0
151836,each,0,0
151837,group,0,0
151838,.,0,0
151839,YDJ,0,0
151840,external,0,0
151841,lotion,0,0
151842,and,0,1
151843,YDJ,0,1
151844,cream,0,0
151845,were,0,0
151846,applied,0,0
151847,to,0,0
151848,patients,0,0
151849,in,0,0
151850,the,0,0
151851,treatment,0,0
151852,group,0,0
151853,",",0,0
151854,while,0,0
151855,normal,0,0
151856,saline,0,0
151857,was,0,0
151858,applied,0,0
151859,for,0,0
151860,those,0,0
151861,in,0,0
151862,the,0,0
151863,control,0,0
151864,group,0,0
151865,.,0,0
151866,HR-HPV,1,0
151867,DNA,1,1
151868,detection,1,1
151869,was,0,0
151870,performed,0,0
151871,by,0,0
151872,the,0,0
151873,end,0,0
151874,of,0,0
151875,the,0,0
151876,1st,0,0
151877,menstruation,0,0
151878,after,0,0
151879,3,0,0
151880,menstrual,0,0
151881,cycles,0,0
151882,.,0,0
151883,The,0,0
151884,cervical,0,0
151885,biopsy,0,0
151886,and,0,0
151887,cervical,0,1
151888,smear,0,1
151889,were,0,0
151890,performed,0,0
151891,using,0,0
151892,vaginoscope,0,0
151893,before,0,0
151894,and,0,0
151895,after,0,0
151896,treatment,0,0
151897,.,0,0
151898,The,0,0
151899,mRNA,1,0
151900,expression,1,1
151901,of,1,0
151902,human,1,0
151903,telomerase,1,1
151904,reverse,1,1
151905,transcriptase,1,0
151906,(,1,0
151907,hTERT,1,1
151908,),1,0
151909,was,0,0
151910,detected,0,0
151911,from,0,0
151912,fresh,0,0
151913,tissues,0,1
151914,of,0,0
151915,the,0,0
151916,cervical,0,0
151917,lesion,0,0
151918,.,0,0
151919,RESULTS,0,0
151920,The,0,0
151921,total,1,1
151922,effective,1,1
151923,rate,1,1
151924,was,0,0
151925,96.6,0,0
151926,%,0,0
151927,in,0,0
151928,the,0,0
151929,treatment,0,0
151930,group,0,0
151931,",",0,0
151932,higher,0,0
151933,than,0,0
151934,that,0,0
151935,of,0,0
151936,the,0,0
151937,control,0,0
151938,group,0,0
151939,(,0,0
151940,70.00,0,0
151941,%,0,0
151942,",",0,0
151943,P,0,0
151944,<,0,0
151945,0.01,0,0
151946,),0,0
151947,.,0,0
151948,Before,0,0
151949,treatment,0,0
151950,there,0,0
151951,was,0,0
151952,no,0,0
151953,statistical,0,0
151954,difference,0,0
151955,in,0,0
151956,the,0,0
151957,pathological,1,0
151958,results,1,0
151959,of,1,0
151960,the,1,0
151961,cervix,1,0
151962,and,0,0
151963,the,0,0
151964,mRNA,1,0
151965,expression,1,1
151966,of,1,0
151967,hTERT,1,1
151968,between,0,0
151969,the,0,0
151970,two,0,0
151971,groups,0,0
151972,(,0,0
151973,P,0,0
151974,>,0,0
151975,0.05,0,0
151976,),0,0
151977,.,0,0
151978,The,0,0
151979,mRNA,1,0
151980,expression,1,1
151981,of,1,0
151982,hTERT,1,1
151983,decreased,0,0
151984,in,0,0
151985,the,0,0
151986,two,0,0
151987,groups,0,0
151988,after,0,0
151989,treatment,0,0
151990,",",0,0
151991,showing,0,0
151992,statistical,0,1
151993,difference,0,0
151994,(,0,0
151995,P,0,0
151996,<,0,0
151997,0.01,0,0
151998,),0,0
151999,.,0,0
152000,Better,0,0
152001,effects,0,0
152002,on,0,0
152003,the,0,0
152004,pathological,0,0
152005,results,0,0
152006,of,0,0
152007,the,0,0
152008,cervix,1,0
152009,and,0,0
152010,the,0,0
152011,mRNA,1,0
152012,expression,1,1
152013,of,1,0
152014,hTERT,1,1
152015,were,0,0
152016,obtained,0,0
152017,in,0,0
152018,the,0,0
152019,treatment,0,0
152020,group,0,0
152021,after,0,0
152022,treatment,0,0
152023,(,0,0
152024,P,0,0
152025,<,0,0
152026,0.05,0,0
152027,),0,0
152028,.,0,0
152029,CONCLUSION,0,0
152030,YDJ,0,0
152031,played,0,0
152032,a,0,0
152033,role,0,0
152034,in,0,0
152035,clearing,0,1
152036,HR-HPV,1,0
152037,infection,1,1
152038,and,0,0
152039,reversing,0,0
152040,the,0,0
152041,cervical,1,0
152042,precancerous,1,0
152043,changes,1,0
152044,possibly,0,0
152045,through,0,0
152046,down-regulating,0,1
152047,the,0,0
152048,mRNA,0,0
152049,expression,0,1
152050,of,0,0
152051,hTERT,0,1
152052,and,0,0
152053,lowering,0,0
152054,the,0,0
152055,telomerase,0,1
152056,activation,0,0
152057,.,0,0
152058,Parents,0,1
152059,',0,0
152060,state,0,0
152061,and,0,1
152062,trait,0,1
152063,anxiety,0,1
152064,:,0,0
152065,relationships,0,0
152066,with,0,0
152067,anxiety,1,1
152068,severity,1,1
152069,and,0,1
152070,treatment,0,0
152071,response,0,1
152072,in,0,0
152073,adolescents,0,0
152074,with,0,0
152075,autism,0,0
152076,spectrum,0,0
152077,disorders,0,0
152078,.,0,0
152079,Comorbid,0,0
152080,anxiety,0,1
152081,is,0,0
152082,common,0,0
152083,among,0,0
152084,children,0,0
152085,with,0,0
152086,Autism,0,1
152087,Spectrum,0,0
152088,Disorder,0,0
152089,(,0,0
152090,ASD,0,0
152091,),0,1
152092,",",0,0
152093,and,0,1
152094,parents,0,1
152095,of,0,0
152096,children,0,0
152097,with,0,0
152098,ASD,0,0
152099,are,0,0
152100,more,0,0
152101,likely,0,0
152102,to,0,0
152103,have,0,0
152104,anxiety,0,1
152105,disorders,0,0
152106,.,0,0
152107,This,0,0
152108,study,0,0
152109,investigated,0,0
152110,the,0,0
152111,relationship,0,0
152112,between,0,0
152113,parents,0,1
152114,',0,0
152115,state,1,0
152116,and,1,1
152117,trait,1,1
152118,anxiety,1,1
152119,and,0,1
152120,parent-reported,0,1
152121,internalizing,0,1
152122,and,0,0
152123,externalizing,0,1
152124,symptoms,0,1
152125,among,0,0
152126,adolescents,0,0
152127,(,0,0
152128,n,0,0
152129,=,0,0
152130,30,0,0
152131,),0,0
152132,with,0,0
152133,ASD,0,0
152134,",",0,0
152135,as,0,0
152136,well,0,0
152137,as,0,0
152138,the,0,0
152139,relationship,0,0
152140,of,0,0
152141,parents,1,1
152142,',1,0
152143,anxiety,1,1
152144,symptoms,1,1
152145,and,1,1
152146,adolescent,1,0
152147,treatment,1,0
152148,response,1,1
152149,in,1,0
152150,the,0,0
152151,context,0,0
152152,of,0,0
152153,a,0,0
152154,randomized,0,0
152155,controlled,0,0
152156,trial,1,0
152157,.,1,0
152158,Parental,1,1
152159,state,1,0
152160,anxiety,1,1
152161,correlated,1,0
152162,with,1,0
152163,severity,1,1
152164,of,1,0
152165,adolescent,1,0
152166,anxiety,1,1
152167,",",1,0
152168,and,1,1
152169,trait,1,1
152170,anxiety,1,1
152171,in,1,0
152172,parents,0,0
152173,correlated,0,0
152174,with,1,0
152175,parent-reported,1,0
152176,adolescent,1,0
152177,internalizing,1,1
152178,and,1,1
152179,externalizing,1,1
152180,symptoms,1,1
152181,.,1,0
152182,Also,0,0
152183,",",0,0
152184,parents,0,0
152185,of,0,1
152186,adolescent,0,0
152187,treatment,0,0
152188,responders,0,0
152189,experienced,0,0
152190,a,0,0
152191,decrease,1,0
152192,in,1,0
152193,their,1,0
152194,own,1,0
152195,trait,1,0
152196,anxiety,1,1
152197,.,1,0
152198,Findings,0,0
152199,highlight,0,0
152200,the,0,0
152201,importance,0,0
152202,of,0,0
152203,considering,1,0
152204,parental,1,1
152205,anxiety,1,1
152206,when,1,0
152207,targeting,1,0
152208,anxiety,1,1
152209,among,1,0
152210,youth,0,0
152211,with,0,0
152212,ASD,0,0
152213,.,0,0
152214,Simvastatin,0,0
152215,reduces,0,0
152216,sympathetic,0,1
152217,outflow,0,1
152218,and,0,0
152219,augments,0,1
152220,endothelium-independent,0,1
152221,dilation,0,1
152222,in,0,0
152223,non-hyperlipidaemic,0,0
152224,primary,0,0
152225,hypertension,0,0
152226,.,0,0
152227,OBJECTIVES,0,0
152228,Previous,0,0
152229,reports,0,0
152230,",",0,0
152231,involving,0,0
152232,hypercholesterolaemic,0,0
152233,hypertensive,0,0
152234,subjects,0,0
152235,",",0,0
152236,that,0,0
152237,statins,0,0
152238,reduce,0,0
152239,muscle,0,1
152240,sympathetic,0,1
152241,nerve,0,1
152242,activity,0,1
152243,(,0,0
152244,MSNA,0,1
152245,),0,0
152246,did,0,0
152247,not,0,0
152248,investigate,0,0
152249,potential,0,0
152250,neural,0,0
152251,sites,0,0
152252,of,0,0
152253,such,0,0
152254,sympathoinhibition,0,1
152255,or,0,0
152256,determine,0,0
152257,its,0,0
152258,consequences,0,0
152259,for,0,0
152260,endothelial,0,1
152261,function,0,1
152262,or,0,0
152263,insulin,0,1
152264,resistance,0,1
152265,.,0,0
152266,This,0,0
152267,study,0,0
152268,of,0,0
152269,hypertensive,0,0
152270,subjects,0,0
152271,with,0,0
152272,lower,0,0
152273,plasma,0,1
152274,cholesterol,0,1
152275,tested,0,0
152276,the,0,0
152277,hypotheses,0,0
152278,that,0,0
152279,lipophilic,0,0
152280,simvastatin,0,0
152281,would,0,0
152282,attenuate,0,0
152283,resting,0,1
152284,sympathoexcitation,0,1
152285,and,0,1
152286,augment,0,0
152287,baroreflex,0,1
152288,modulation,0,1
152289,of,0,0
152290,MSNA,0,1
152291,and,0,1
152292,heart,0,1
152293,rate,0,1
152294,(,0,0
152295,HR,0,1
152296,),0,0
152297,",",0,0
152298,flow-mediated,0,1
152299,vasodilation,0,1
152300,and,0,1
152301,insulin,0,1
152302,sensitivity,0,1
152303,.,0,0
152304,DESIGN,0,0
152305,Prospective,0,0
152306,",",0,0
152307,randomised,0,0
152308,",",0,0
152309,double-blind,0,0
152310,",",0,0
152311,placebo-controlled,0,0
152312,crossover,0,0
152313,study,0,0
152314,.,0,0
152315,SETTING,0,0
152316,Academic,0,1
152317,hospital-based,0,0
152318,study,0,0
152319,.,0,0
152320,PATIENTS,0,0
152321,Fourteen,0,0
152322,non-hyperlipidaemic,0,0
152323,primary,0,0
152324,hypertensive,0,0
152325,subjects,0,0
152326,(,0,0
152327,10,0,0
152328,men,0,0
152329,;,0,0
152330,overall,0,1
152331,mean?SD,0,1
152332,age,0,0
152333,58?12,0,0
152334,years,0,0
152335,),0,0
152336,.,0,0
152337,INTERVENTIONS,0,1
152338,Four,0,1
152339,weeks,0,0
152340,of,0,0
152341,simvastatin,0,0
152342,(,0,0
152343,80,0,0
152344,mg/day,0,0
152345,),0,0
152346,or,0,0
152347,placebo,0,0
152348,.,0,0
152349,MAIN,0,0
152350,OUTCOME,0,0
152351,MEASURES,1,0
152352,Resting,1,1
152353,blood,1,1
152354,pressure,1,1
152355,(,1,0
152356,BP,1,1
152357,),1,0
152358,",",1,0
152359,HR,1,1
152360,",",1,1
152361,MSNA,1,1
152362,",",1,0
152363,spontaneous,1,1
152364,arterial,1,1
152365,baroreflex,1,1
152366,MSNA,1,1
152367,and,1,1
152368,HR,1,1
152369,modulation,1,1
152370,",",1,0
152371,endothelium-dependent,1,1
152372,and,1,1
152373,endothelium-independent,1,1
152374,vasodilation,1,1
152375,",",1,0
152376,and,1,0
152377,the,1,0
152378,homoeostatic,1,1
152379,model,1,0
152380,assessment,1,0
152381,of,1,1
152382,insulin,1,1
152383,resistance,1,1
152384,(,1,0
152385,HOMA-IR,1,0
152386,),1,0
152387,.,1,0
152388,RESULTS,0,0
152389,Simvastatin,0,0
152390,lowered,1,0
152391,MSNA,1,0
152392,burst,1,1
152393,frequency,1,1
152394,(,1,0
152395,from,0,0
152396,32?12,0,0
152397,to,0,0
152398,25?9,0,0
152399,bursts/min,0,0
152400,),0,0
152401,and,0,0
152402,MSNA,1,1
152403,burst,1,1
152404,incidence,1,1
152405,(,1,0
152406,from,1,0
152407,55?23,0,0
152408,%,0,0
152409,to,0,0
152410,43?17,0,0
152411,%,0,0
152412,;,0,0
152413,all,0,0
152414,p,0,0
152415,<,0,0
152416,0.01,0,0
152417,),0,0
152418,without,0,0
152419,affecting,1,0
152420,BP,1,1
152421,",",1,0
152422,HR,1,1
152423,",",1,1
152424,baroreflex,1,1
152425,modulation,1,1
152426,of,1,0
152427,either,1,0
152428,MSNA,1,0
152429,or,1,0
152430,HR,1,1
152431,",",1,1
152432,or,1,0
152433,HR,1,1
152434,variability,1,1
152435,(,1,0
152436,all,1,0
152437,p,0,0
152438,>,0,0
152439,0.05,0,0
152440,),1,0
152441,.,1,0
152442,Plasma,1,1
152443,glucose,1,1
152444,",",1,1
152445,insulin,1,1
152446,",",1,1
152447,HOMA-IR,1,0
152448,and,1,1
152449,endothelium-dependent,1,1
152450,vasodilation,1,1
152451,(,1,0
152452,all,1,0
152453,p,0,0
152454,>,0,0
152455,0.05,0,0
152456,),0,0
152457,were,0,0
152458,unchanged,0,0
152459,",",0,0
152460,whereas,1,0
152461,endothelium-independent,1,1
152462,vasodilation,1,1
152463,increased,1,0
152464,(,0,0
152465,7.1?3.8,0,0
152466,%,0,0
152467,to,0,0
152468,9.7?3.9,0,0
152469,%,0,0
152470,",",0,0
152471,n=13,0,0
152472,;,0,0
152473,p,0,0
152474,<,0,0
152475,0.01,0,0
152476,),0,0
152477,.,0,0
152478,The,0,0
152479,fall,0,0
152480,in,0,0
152481,MSNA,1,0
152482,was,0,0
152483,unrelated,0,0
152484,to,0,0
152485,the,0,0
152486,decrease,0,0
152487,in,1,0
152488,low-density,1,1
152489,lipoprotein,1,1
152490,cholesterol,1,1
152491,(,1,0
152492,r=0.41,1,0
152493,",",0,1
152494,p=0.14,0,0
152495,),0,0
152496,.,0,0
152497,CONCLUSIONS,0,0
152498,These,0,0
152499,findings,0,0
152500,are,0,0
152501,consistent,0,0
152502,with,0,0
152503,the,0,0
152504,concept,0,0
152505,that,0,0
152506,",",0,0
152507,in,0,0
152508,non-hyperlipidaemic,0,0
152509,subjects,0,0
152510,with,0,0
152511,primary,0,0
152512,hypertension,0,1
152513,",",0,0
152514,simvastatin,0,0
152515,causes,0,0
152516,a,0,0
152517,cholesterol-independent,0,1
152518,reduction,0,0
152519,in,0,0
152520,an,0,0
152521,elevated,0,0
152522,central,0,0
152523,set-point,0,1
152524,for,0,0
152525,MSNA,0,0
152526,",",0,0
152527,without,0,0
152528,affecting,0,0
152529,arterial,0,1
152530,baroreflex,0,1
152531,modulation,0,0
152532,of,0,0
152533,either,0,0
152534,MSNA,0,0
152535,or,0,0
152536,HR,0,1
152537,.,0,0
152538,There,0,0
152539,may,0,0
152540,be,0,0
152541,less,0,0
152542,neurogenic,0,0
152543,constraint,0,1
152544,on,0,0
152545,endothelium-independent,0,1
152546,vasodilation,0,1
152547,as,0,0
152548,a,0,0
152549,consequence,0,0
152550,.,0,0
152551,Pseudoephedrine,0,0
152552,and,0,1
152553,preexercise,0,0
152554,feeding,0,1
152555,:,0,0
152556,influence,0,0
152557,on,0,0
152558,performance,1,1
152559,.,1,0
152560,PURPOSE,0,0
152561,This,0,0
152562,study,0,0
152563,examined,0,0
152564,the,0,0
152565,influence,0,0
152566,of,0,0
152567,preexercise,0,0
152568,food,0,0
152569,intake,0,1
152570,on,0,0
152571,plasma,1,1
152572,pseudoephedrine,1,0
152573,(,1,0
152574,PSE,1,0
152575,),1,0
152576,concentrations,1,1
152577,and,1,0
152578,subsequent,1,0
152579,high-intensity,1,0
152580,exercise,1,0
152581,.,1,0
152582,In,0,0
152583,addition,0,0
152584,",",0,0
152585,urinary,0,1
152586,PSE,0,1
152587,concentrations,0,1
152588,were,0,0
152589,measured,0,0
152590,under,0,0
152591,the,0,0
152592,same,0,0
152593,conditions,0,0
152594,and,0,0
152595,compared,0,0
152596,with,0,0
152597,the,0,0
152598,present,0,0
152599,threshold,0,1
152600,of,0,0
152601,the,0,0
152602,World,0,0
152603,Anti-Doping,0,0
152604,Agency,0,1
152605,(,0,0
152606,WADA,0,0
152607,),0,0
152608,.,0,0
152609,METHODS,0,0
152610,Ten,0,0
152611,highly,0,0
152612,trained,0,0
152613,male,0,0
152614,cyclists,0,0
152615,and,0,1
152616,triathletes,0,0
152617,(,0,0
152618,age,0,0
152619,=,0,0
152620,30.6,0,0
152621,?,0,0
152622,6.6,0,0
152623,yr,0,0
152624,",",0,0
152625,body,0,1
152626,mass,0,1
152627,[,0,0
152628,BM,0,1
152629,],0,0
152630,=,0,0
152631,72.9,0,0
152632,?,0,0
152633,5.1,0,0
152634,kg,0,0
152635,",",0,0
152636,and,0,1
152637,V?O2max,0,1
152638,=,0,0
152639,64.8,0,0
152640,?,0,0
152641,4.5,0,0
152642,mL?kg?min,0,0
152643,;,0,0
152644,mean,0,0
152645,?,0,0
152646,SD,0,0
152647,),0,0
152648,undertook,0,0
152649,four,0,0
152650,cycling,0,0
152651,time,0,1
152652,trials,0,0
152653,(,0,0
152654,TT,0,0
152655,),0,0
152656,",",0,0
152657,each,0,0
152658,requiring,0,0
152659,the,0,0
152660,completion,0,0
152661,of,0,0
152662,a,0,0
152663,set,0,0
152664,amount,0,1
152665,of,0,1
152666,work,0,0
152667,(,0,0
152668,7,0,0
152669,kJ?kg,0,0
152670,BM,0,0
152671,),0,0
152672,in,0,0
152673,the,0,0
152674,shortest,0,1
152675,possible,0,0
152676,time,0,1
152677,.,0,0
152678,Participants,0,0
152679,were,0,0
152680,randomized,0,0
152681,into,0,0
152682,a,0,0
152683,fed,0,0
152684,or,0,0
152685,nonfed,0,0
152686,condition,0,0
152687,and,0,0
152688,orally,0,0
152689,ingested,0,0
152690,2.8,0,0
152691,mg?kg,0,0
152692,BM,0,0
152693,of,0,0
152694,PSE,0,0
152695,or,0,0
152696,a,0,0
152697,placebo,0,0
152698,(,0,0
152699,PLA,0,0
152700,),0,0
152701,90,0,0
152702,min,0,0
152703,before,0,0
152704,exercise,0,0
152705,;,0,0
152706,in,0,0
152707,the,0,0
152708,fed,0,0
152709,trials,0,0
152710,",",0,0
152711,they,0,0
152712,consumed,0,0
152713,a,0,0
152714,meal,0,0
152715,providing,0,0
152716,1.5,0,0
152717,g?kg,0,0
152718,BM,0,0
152719,of,0,0
152720,CHO,0,0
152721,.,0,0
152722,Venous,0,1
152723,blood,0,1
152724,was,0,0
152725,sampled,0,0
152726,at,0,0
152727,30,0,0
152728,",",0,0
152729,50,0,0
152730,",",0,0
152731,and,0,0
152732,70,0,0
152733,min,0,0
152734,and,0,0
152735,pre-warm-up,0,0
152736,and,0,1
152737,postexercise,0,0
152738,for,0,0
152739,the,0,0
152740,analysis,0,0
152741,of,0,0
152742,plasma,0,1
152743,PSE,0,0
152744,and,0,1
152745,catecholamine,0,1
152746,concentrations,0,1
152747,",",0,0
152748,and,0,1
152749,urine,0,1
152750,was,0,0
152751,also,0,0
152752,collected,0,0
152753,for,0,0
152754,the,0,0
152755,analysis,0,0
152756,of,0,0
152757,PSE,0,0
152758,concentration,0,1
152759,.,0,0
152760,RESULTS,0,0
152761,Independent,0,0
152762,of,0,0
152763,the,0,0
152764,preexercise,0,0
152765,meal,0,0
152766,",",0,0
152767,2.8,0,0
152768,mg?kg,0,0
152769,BM,0,0
152770,of,0,0
152771,PSE,0,0
152772,did,0,0
152773,not,0,0
152774,significantly,1,0
152775,improve,1,0
152776,cycling,1,0
152777,TT,1,0
152778,performance,1,1
152779,.,1,0
152780,The,1,0
152781,fed,1,0
152782,trials,1,0
152783,resulted,0,0
152784,in,0,0
152785,lower,1,0
152786,plasma,1,1
152787,PSE,1,1
152788,concentrations,1,1
152789,at,1,0
152790,all,1,0
152791,time,1,1
152792,points,0,0
152793,compared,0,0
152794,with,0,0
152795,the,0,0
152796,nonfed,0,0
152797,trials,0,0
152798,.,0,0
152799,Both,1,0
152800,plasma,1,1
152801,epinephrine,1,0
152802,and,1,1
152803,blood,1,1
152804,lactate,1,1
152805,concentrations,1,1
152806,were,1,0
152807,higher,1,0
152808,in,0,0
152809,the,0,0
152810,PSE,0,0
152811,compared,0,0
152812,with,0,0
152813,the,0,0
152814,PLA,0,0
152815,trials,0,0
152816,",",0,0
152817,and,0,1
152818,preexercise,1,1
152819,and,1,1
152820,postexercise,1,1
152821,urinary,1,1
152822,PSE,1,0
152823,concentrations,1,1
152824,were,1,0
152825,significantly,1,0
152826,higher,0,0
152827,than,0,0
152828,the,0,0
152829,threshold,0,1
152830,(,0,0
152831,150,0,0
152832,?g?mL,0,0
152833,),0,0
152834,used,0,0
152835,by,0,0
152836,WADA,0,0
152837,to,0,0
152838,determine,0,0
152839,illicit,0,0
152840,PSE,0,0
152841,use,0,0
152842,.,0,0
152843,CONCLUSION,0,0
152844,Irrespective,0,0
152845,of,0,0
152846,the,0,0
152847,preexercise,0,0
152848,meal,1,1
152849,",",1,0
152850,cycling,1,1
152851,TT,1,0
152852,performance,1,1
152853,of,0,0
152854,approximately,0,0
152855,30,0,0
152856,min,0,0
152857,was,0,0
152858,not,0,0
152859,improved,0,0
152860,after,0,0
152861,PSE,0,0
152862,supplementation,0,0
152863,.,0,0
152864,Furthermore,0,0
152865,",",0,0
152866,2.8,0,0
152867,mg?kg,0,0
152868,BM,0,0
152869,of,0,0
152870,PSE,0,0
152871,taken,0,0
152872,90,0,0
152873,min,0,0
152874,before,0,0
152875,exercise,0,0
152876,",",0,0
152877,with,0,0
152878,or,0,0
152879,without,0,0
152880,food,0,0
152881,",",0,0
152882,resulted,0,0
152883,in,0,0
152884,urinary,0,1
152885,PSE,0,0
152886,concentrations,0,1
152887,exceeding,0,1
152888,the,0,0
152889,present,0,0
152890,WADA,0,0
152891,threshold,0,1
152892,.,0,0
152893,A,0,0
152894,phase,0,0
152895,III,0,0
152896,study,0,0
152897,of,0,0
152898,laparoscopy-assisted,0,0
152899,versus,0,0
152900,open,0,0
152901,distal,0,1
152902,gastrectomy,0,0
152903,with,0,0
152904,nodal,0,0
152905,dissection,0,0
152906,for,0,0
152907,clinical,0,0
152908,stage,0,0
152909,IA/IB,0,0
152910,gastric,0,1
152911,Cancer,0,0
152912,(,0,0
152913,JCOG0912,0,0
152914,),0,0
152915,.,0,0
152916,A,0,0
152917,Phase,0,0
152918,III,0,0
152919,study,0,0
152920,was,0,0
152921,started,0,0
152922,in,0,0
152923,Japan,0,0
152924,to,0,0
152925,evaluate,0,0
152926,the,0,0
152927,non-inferiority,0,0
152928,of,0,0
152929,overall,0,1
152930,survival,0,1
152931,of,0,0
152932,laparoscopy-assisted,0,0
152933,distal,0,0
152934,gastrectomy,0,0
152935,with,0,0
152936,open,0,0
152937,distal,0,0
152938,gastrectomy,0,0
152939,in,0,0
152940,patients,0,0
152941,with,0,0
152942,clinical,0,0
152943,IA,0,0
152944,(,0,0
152945,T1N0,0,1
152946,),0,0
152947,or,0,0
152948,IB,0,1
152949,[,0,1
152950,T1N1,0,1
152951,or,0,0
152952,T2,0,0
152953,(,0,0
152954,MP,0,0
152955,),0,0
152956,N0,0,1
152957,],0,0
152958,gastric,0,1
152959,cancer,0,0
152960,.,0,0
152961,This,0,0
152962,study,0,0
152963,followed,0,0
152964,the,0,0
152965,previous,0,0
152966,Phase,0,0
152967,II,0,0
152968,study,0,0
152969,to,0,0
152970,confirm,0,0
152971,the,0,0
152972,safety,0,1
152973,of,0,0
152974,laparoscopy-assisted,0,0
152975,distal,0,1
152976,gastrectomy,0,0
152977,(,0,0
152978,JCOG0703,0,1
152979,),0,1
152980,and,0,0
152981,began,0,0
152982,in,0,0
152983,March,0,0
152984,2010,0,0
152985,.,0,0
152986,A,0,0
152987,total,0,0
152988,of,0,0
152989,920,0,0
152990,patients,0,0
152991,will,0,0
152992,be,0,0
152993,accrued,0,0
152994,from,0,0
152995,33,0,0
152996,institutions,0,0
152997,within,0,0
152998,5,0,0
152999,years,0,0
153000,.,0,0
153001,The,0,0
153002,primary,0,0
153003,endpoint,0,0
153004,is,0,0
153005,overall,1,1
153006,survival,1,1
153007,.,1,0
153008,The,0,0
153009,secondary,0,0
153010,endpoints,0,1
153011,are,0,0
153012,relapse-free,1,1
153013,survival,1,1
153014,",",1,0
153015,proportion,1,1
153016,of,1,0
153017,laparoscopy-assisted,1,0
153018,distal,1,1
153019,gastrectomy,1,0
153020,completion,1,1
153021,",",1,0
153022,proportion,1,1
153023,of,1,0
153024,conversion,1,0
153025,to,1,0
153026,open,1,0
153027,surgery,1,0
153028,",",1,0
153029,adverse,1,1
153030,events,1,1
153031,",",1,0
153032,short-term,1,0
153033,clinical,1,0
153034,outcomes,1,1
153035,",",1,0
153036,postoperative,1,1
153037,quality,1,1
153038,of,1,0
153039,life,1,1
153040,.,1,0
153041,Only,0,0
153042,a,0,0
153043,credentialed,0,0
153044,surgeon,0,0
153045,can,0,0
153046,be,0,0
153047,responsible,0,0
153048,for,0,0
153049,both,0,0
153050,open,0,0
153051,distal,0,1
153052,gastrectomy,0,0
153053,and,0,1
153054,laparoscopy-assisted,0,0
153055,distal,0,1
153056,gastrectomy,0,0
153057,.,0,0
153058,A,0,0
153059,pilot,0,0
153060,randomised,0,0
153061,controlled,0,0
153062,trial,0,0
153063,of,0,0
153064,cognitive,0,1
153065,behavioural,0,0
153066,therapy,0,0
153067,for,0,0
153068,antenatal,0,0
153069,depression,0,1
153070,.,0,0
153071,BACKGROUND,0,0
153072,Few,0,0
153073,trials,0,0
153074,have,0,0
153075,evaluated,0,0
153076,the,0,0
153077,effectiveness,0,0
153078,of,0,0
153079,psychological,0,1
153080,treatment,0,0
153081,in,0,0
153082,improving,0,1
153083,depression,0,1
153084,by,0,0
153085,the,0,0
153086,end,0,0
153087,of,0,0
153088,pregnancy,0,0
153089,.,0,0
153090,This,0,0
153091,is,0,0
153092,the,0,0
153093,first,0,0
153094,pilot,0,0
153095,randomised,0,0
153096,controlled,0,0
153097,trial,0,0
153098,(,0,0
153099,RCT,0,0
153100,),0,0
153101,of,0,0
153102,individual,0,0
153103,cognitive,0,1
153104,behavioural,0,0
153105,therapy,0,0
153106,(,0,0
153107,CBT,0,0
153108,),0,0
153109,looking,0,0
153110,at,0,0
153111,treating,0,0
153112,depression,0,1
153113,by,0,0
153114,the,0,0
153115,end,0,0
153116,of,0,0
153117,pregnancy,0,1
153118,.,0,0
153119,Our,0,0
153120,aim,0,0
153121,was,0,0
153122,to,0,0
153123,assess,0,0
153124,the,0,0
153125,feasibility,0,0
153126,of,0,0
153127,delivering,0,0
153128,a,0,0
153129,CBT,0,0
153130,intervention,0,0
153131,modified,0,0
153132,for,0,0
153133,antenatal,0,0
153134,depression,0,1
153135,during,0,0
153136,pregnancy,0,1
153137,.,0,0
153138,METHODS,0,0
153139,Women,0,0
153140,in,0,0
153141,North,0,0
153142,Bristol,0,0
153143,",",0,0
153144,UK,0,1
153145,between,0,0
153146,8-18,0,0
153147,weeks,0,0
153148,pregnant,0,0
153149,were,0,0
153150,recruited,0,0
153151,through,0,0
153152,routine,0,0
153153,contact,0,1
153154,with,0,0
153155,midwives,0,0
153156,and,0,0
153157,randomised,0,0
153158,to,0,0
153159,receive,0,0
153160,up,0,0
153161,to,0,0
153162,12,0,0
153163,sessions,0,0
153164,of,0,0
153165,individual,0,0
153166,CBT,0,0
153167,in,0,0
153168,addition,0,0
153169,to,0,0
153170,usual,0,0
153171,care,0,0
153172,or,0,0
153173,to,0,0
153174,continue,0,0
153175,with,0,0
153176,usual,0,0
153177,care,0,0
153178,only,0,0
153179,.,0,0
153180,Women,0,0
153181,were,0,0
153182,eligible,0,0
153183,for,0,0
153184,randomisation,0,0
153185,if,0,0
153186,they,0,0
153187,screened,0,0
153188,positive,0,0
153189,on,0,0
153190,a,0,0
153191,3-question,0,0
153192,depression,0,1
153193,screen,0,0
153194,used,0,0
153195,routinely,0,0
153196,by,0,0
153197,midwives,0,0
153198,and,0,0
153199,met,0,0
153200,ICD-10,0,0
153201,criteria,0,0
153202,for,0,0
153203,depression,0,1
153204,assessed,0,0
153205,using,0,0
153206,the,0,0
153207,clinical,0,0
153208,interview,0,0
153209,schedule,0,0
153210,-,0,0
153211,revised,0,1
153212,version,0,0
153213,(,0,0
153214,CIS-R,0,0
153215,),0,0
153216,.,0,0
153217,Two,0,0
153218,CBT,0,0
153219,therapists,0,0
153220,delivered,0,0
153221,the,0,0
153222,intervention,0,0
153223,.,0,0
153224,Follow-up,0,0
153225,was,0,0
153226,at,0,0
153227,15,0,0
153228,and,0,0
153229,33,0,0
153230,weeks,0,0
153231,post-randomisation,0,0
153232,when,0,0
153233,assessments,0,0
153234,of,0,0
153235,mental,1,1
153236,health,1,1
153237,were,1,0
153238,made,0,0
153239,using,0,0
153240,measures,0,0
153241,which,0,0
153242,included,0,0
153243,the,0,0
153244,CIS-R,0,0
153245,.,0,0
153246,RESULTS,0,0
153247,Of,0,0
153248,the,0,0
153249,50,0,0
153250,women,0,0
153251,assessed,0,0
153252,for,0,0
153253,the,0,0
153254,trial,0,0
153255,",",0,0
153256,36,0,0
153257,met,0,0
153258,ICD-10,0,0
153259,depression,0,1
153260,criteria,0,0
153261,and,0,1
153262,were,0,0
153263,randomised,0,0
153264,:,0,0
153265,18,0,0
153266,to,0,0
153267,the,0,0
153268,intervention,0,0
153269,and,0,0
153270,18,0,0
153271,to,0,0
153272,usual,0,0
153273,care,0,0
153274,.,0,0
153275,Thirteen,0,0
153276,of,0,0
153277,the,0,0
153278,18,0,0
153279,(,0,0
153280,72,0,0
153281,%,0,0
153282,),0,0
153283,women,0,0
153284,who,0,0
153285,were,0,0
153286,allocated,0,0
153287,to,0,0
153288,receive,0,0
153289,the,0,0
153290,intervention,0,0
153291,completed,0,0
153292,9,0,0
153293,or,0,0
153294,more,0,0
153295,sessions,0,0
153296,of,0,1
153297,CBT,0,0
153298,before,0,0
153299,the,0,0
153300,end,0,0
153301,of,0,0
153302,pregnancy,0,1
153303,.,0,0
153304,Follow-up,0,0
153305,rates,0,1
153306,at,0,0
153307,15,0,0
153308,and,0,0
153309,33,0,0
153310,weeks,0,0
153311,post-randomisation,0,0
153312,were,0,0
153313,higher,0,0
153314,in,0,0
153315,the,0,0
153316,group,0,0
153317,who,0,0
153318,received,0,0
153319,the,0,0
153320,intervention,0,0
153321,(,0,0
153322,89,0,0
153323,%,0,0
153324,vs.,0,0
153325,72,0,0
153326,%,0,0
153327,at,0,0
153328,15,0,0
153329,weeks,0,0
153330,and,0,0
153331,89,0,0
153332,%,0,0
153333,vs.,0,0
153334,61,0,0
153335,%,0,0
153336,at,0,0
153337,33,0,0
153338,weeks,0,0
153339,post-randomisation,0,0
153340,),0,0
153341,.,0,0
153342,At,0,0
153343,15,0,0
153344,weeks,0,0
153345,post-randomisation,0,0
153346,(,0,0
153347,the,0,0
153348,end,0,0
153349,of,0,0
153350,pregnancy,0,1
153351,),0,0
153352,",",0,0
153353,there,0,0
153354,were,0,0
153355,more,0,0
153356,women,0,0
153357,in,0,0
153358,the,0,0
153359,intervention,0,0
153360,group,0,0
153361,(,0,0
153362,11/16,0,0
153363,;,0,0
153364,68.7,0,0
153365,%,0,0
153366,),0,0
153367,who,0,0
153368,recovered,0,0
153369,(,0,0
153370,i.e,0,0
153371,.,0,0
153372,no,0,0
153373,longer,0,0
153374,met,0,0
153375,ICD-10,0,0
153376,criteria,1,0
153377,for,1,0
153378,depression,1,1
153379,),1,0
153380,",",1,0
153381,than,1,0
153382,those,0,0
153383,receiving,0,0
153384,only,0,0
153385,usual,0,0
153386,care,0,0
153387,(,0,0
153388,5/13,0,0
153389,;,0,0
153390,38.5,0,0
153391,%,0,0
153392,),0,0
153393,.,0,0
153394,CONCLUSIONS,0,0
153395,This,0,0
153396,pilot,0,0
153397,trial,0,0
153398,shows,0,0
153399,the,0,0
153400,feasibility,0,0
153401,of,0,0
153402,conducting,0,0
153403,a,0,0
153404,large,0,0
153405,RCT,0,0
153406,to,0,0
153407,assess,0,0
153408,the,0,0
153409,effectiveness,0,0
153410,of,0,0
153411,CBT,0,0
153412,for,0,0
153413,treating,0,0
153414,antenatal,0,0
153415,depression,0,1
153416,before,0,0
153417,the,0,0
153418,end,0,0
153419,of,0,0
153420,pregnancy,0,0
153421,.,0,0
153422,The,0,0
153423,intervention,0,0
153424,could,0,0
153425,be,0,0
153426,delivered,0,0
153427,during,0,0
153428,the,0,0
153429,antenatal,0,0
153430,period,0,0
153431,and,0,0
153432,there,0,0
153433,was,0,0
153434,some,0,0
153435,evidence,0,0
153436,to,0,0
153437,suggest,0,0
153438,that,0,0
153439,it,0,0
153440,could,0,0
153441,be,0,0
153442,effective,0,0
153443,.,0,0
153444,TRIAL,0,0
153445,REGISTRATION,0,0
153446,ISRCTN44902048,0,0
153447,.,0,0
153448,Effects,0,0
153449,of,0,0
153450,coronary,0,0
153451,sinus,0,0
153452,occlusion,0,0
153453,on,0,0
153454,myocardial,0,1
153455,ischaemia,0,1
153456,in,0,0
153457,humans,0,0
153458,:,0,0
153459,role,0,0
153460,of,0,0
153461,coronary,0,0
153462,collateral,0,1
153463,function,0,1
153464,.,0,0
153465,OBJECTIVE,0,0
153466,This,0,0
153467,study,0,0
153468,tested,0,0
153469,the,0,0
153470,hypotheses,0,0
153471,that,0,0
153472,intermittent,0,0
153473,coronary,0,0
153474,sinus,0,0
153475,occlusion,0,1
153476,(,0,0
153477,iCSO,0,0
153478,),0,0
153479,reduces,0,0
153480,myocardial,1,1
153481,ischaemia,1,1
153482,",",0,0
153483,and,0,0
153484,that,0,0
153485,the,0,0
153486,amount,0,0
153487,of,0,0
153488,ischaemia,1,0
153489,reduction,0,0
153490,is,0,0
153491,related,0,0
153492,to,0,0
153493,coronary,0,0
153494,collateral,0,1
153495,function,0,1
153496,.,0,0
153497,DESIGN,0,0
153498,Prospective,0,0
153499,case-control,0,0
153500,study,0,0
153501,with,0,0
153502,intraindividual,0,0
153503,comparison,0,0
153504,of,0,0
153505,myocardial,0,1
153506,ischaemia,0,0
153507,during,0,0
153508,two,0,0
153509,2-min,0,0
153510,coronary,0,0
153511,artery,0,1
153512,balloon,0,0
153513,occlusions,0,1
153514,with,0,0
153515,and,0,0
153516,without,0,0
153517,simultaneous,0,0
153518,iCSO,0,0
153519,by,0,0
153520,a,0,0
153521,balloon-tipped,0,0
153522,catheter,0,0
153523,.,0,0
153524,SETTING,0,0
153525,University,0,0
153526,Hospital,0,0
153527,.,0,0
153528,PATIENTS,0,0
153529,35,0,0
153530,patients,0,0
153531,with,0,0
153532,chronic,0,0
153533,stable,0,0
153534,coronary,0,0
153535,artery,0,0
153536,disease,0,0
153537,.,0,0
153538,INTERVENTION,0,1
153539,2-min,0,0
153540,iCSO,0,0
153541,.,0,0
153542,MAIN,0,0
153543,OUTCOME,0,0
153544,MEASURES,0,0
153545,Myocardial,1,1
153546,ischaemia,1,1
153547,as,0,0
153548,assessed,0,0
153549,by,0,0
153550,intracoronary,1,0
153551,(,1,0
153552,i.c,1,0
153553,.,1,0
153554,),1,0
153555,ECG,1,1
153556,ST,1,1
153557,shift,1,0
153558,at,0,0
153559,2,0,0
153560,min,0,0
153561,of,0,0
153562,coronary,0,0
153563,artery,0,1
153564,balloon,0,0
153565,occlusion,0,0
153566,.,0,0
153567,Collateral,1,1
153568,flow,1,1
153569,index,1,1
153570,(,1,0
153571,CFI,1,1
153572,),1,0
153573,without,1,0
153574,iCSO,1,0
153575,",",1,0
153576,that,1,0
153577,is,0,0
153578,",",0,0
153579,the,0,0
153580,ratio,0,1
153581,between,0,0
153582,mean,0,1
153583,distal,0,0
153584,coronary,0,0
153585,occlusive,0,1
153586,(,0,0
153587,Poccl,0,1
153588,),0,0
153589,and,0,0
153590,mean,0,1
153591,aortic,0,1
153592,pressure,0,1
153593,(,0,0
153594,Pao,0,0
153595,),0,0
153596,both,0,0
153597,minus,0,0
153598,central,0,0
153599,venous,0,1
153600,pressure,0,1
153601,.,0,0
153602,RESULTS,0,0
153603,I.c,0,0
153604,.,0,0
153605,ECG,1,1
153606,ST,1,1
153607,segment,1,1
153608,shift,1,1
153609,(,0,0
153610,elevation,0,1
153611,in,0,0
153612,all,0,0
153613,),0,0
153614,at,0,0
153615,the,0,0
153616,end,0,0
153617,of,0,0
153618,the,0,0
153619,procedure,0,0
153620,with,0,0
153621,iCSO,0,0
153622,versus,0,0
153623,without,0,0
153624,iCSO,0,0
153625,was,0,0
153626,1.33?1.25,0,0
153627,mV,0,0
153628,versus,0,0
153629,1.85?1.45,0,0
153630,mV,0,0
153631,",",0,0
153632,p,0,0
153633,<,0,0
153634,0.0001,0,0
153635,.,0,0
153636,Regression,0,0
153637,analysis,0,0
153638,showed,0,0
153639,that,0,0
153640,the,0,0
153641,degree,0,1
153642,of,0,0
153643,i.c,1,0
153644,.,1,0
153645,ECG,1,1
153646,ST,1,1
153647,shift,1,0
153648,reduction,1,1
153649,during,1,0
153650,iCSO,0,0
153651,was,0,0
153652,related,0,0
153653,to,0,0
153654,CFI,0,1
153655,",",0,0
153656,best,0,0
153657,fitting,0,0
153658,a,0,0
153659,Lorentzian,0,0
153660,function,0,1
153661,(,0,0
153662,r,0,0
153663,(,1,0
153664,2,1,0
153665,),1,0
153666,=0.61,1,0
153667,),1,0
153668,.,1,0
153669,Ischaemia,1,1
153670,reduction,1,1
153671,with,1,0
153672,iCSO,1,0
153673,was,1,0
153674,greatest,1,0
153675,at,0,0
153676,a,0,0
153677,CFI,0,1
153678,of,0,0
153679,0.05-0.20,0,0
153680,",",0,0
153681,whereas,0,0
153682,in,0,0
153683,the,0,0
153684,low,0,0
153685,and,0,0
153686,high,0,0
153687,CFI,0,1
153688,range,0,0
153689,the,0,0
153690,effect,0,0
153691,of,0,0
153692,iCSO,0,0
153693,was,0,0
153694,absent,0,0
153695,.,0,0
153696,CONCLUSIONS,0,0
153697,ICSO,0,0
153698,reduces,0,0
153699,myocardial,0,1
153700,ischaemia,0,1
153701,in,0,0
153702,patients,0,0
153703,with,0,0
153704,chronic,0,0
153705,coronary,0,0
153706,artery,0,0
153707,disease,0,0
153708,.,0,0
153709,Ischaemia,0,1
153710,reduction,0,1
153711,by,0,0
153712,iCSO,0,0
153713,depends,0,0
153714,on,0,0
153715,coronary,0,0
153716,collateral,0,1
153717,function,0,1
153718,.,0,0
153719,A,0,0
153720,minimal,0,0
153721,degree,0,1
153722,of,0,0
153723,collateral,1,1
153724,function,1,1
153725,is,1,0
153726,necessary,0,0
153727,to,0,0
153728,render,0,0
153729,iCSO,0,0
153730,effective,0,0
153731,.,0,0
153732,ICSO,0,0
153733,can,0,0
153734,not,0,0
153735,manifest,0,0
153736,an,0,0
153737,effect,0,0
153738,when,0,0
153739,collateral,0,1
153740,function,0,1
153741,prevents,0,0
153742,ischaemia,0,1
153743,in,0,0
153744,the,0,0
153745,first,0,0
153746,place,0,0
153747,.,0,0
153748,Influence,0,1
153749,of,0,0
153750,Aloe,0,0
153751,arborescens,0,0
153752,Mill,0,0
153753,.,0,0
153754,extract,0,0
153755,on,0,0
153756,selected,0,0
153757,parameters,1,1
153758,of,0,0
153759,pro-oxidant-antioxidant,1,1
153760,equilibrium,1,1
153761,and,0,0
153762,cytokine,1,1
153763,synthesis,1,1
153764,in,0,0
153765,rowers,0,0
153766,.,0,0
153767,This,0,0
153768,investigation,0,0
153769,examined,0,0
153770,the,0,0
153771,effect,0,0
153772,of,0,0
153773,supplementation,0,0
153774,with,0,0
153775,Biostimine,0,0
153776,",",0,0
153777,extract,0,0
153778,from,0,0
153779,Aloe,0,0
153780,arborescens,0,0
153781,Mill,0,0
153782,.,0,0
153783,leaves,0,0
153784,",",0,0
153785,on,0,0
153786,the,0,0
153787,levels,0,1
153788,of,0,0
153789,pro-oxidant-antioxidant,1,1
153790,equilibrium,1,1
153791,markers,1,1
153792,and,0,1
153793,anti-,0,1
153794,and,0,1
153795,proinflammatory,1,1
153796,cytokines,1,1
153797,in,0,0
153798,rowers,0,0
153799,subjected,0,0
153800,to,0,0
153801,exhaustive,0,0
153802,exercise,0,0
153803,.,0,0
153804,This,0,0
153805,double-blind,0,0
153806,study,0,0
153807,included,0,0
153808,18,0,0
153809,members,0,0
153810,of,0,0
153811,the,0,0
153812,Polish,0,0
153813,Rowing,0,0
153814,Team,0,0
153815,.,0,0
153816,Subjects,0,0
153817,were,0,0
153818,randomly,0,0
153819,assigned,0,0
153820,to,0,0
153821,the,0,0
153822,supplemented,0,0
153823,group,0,0
153824,(,0,0
153825,n,0,0
153826,=,0,0
153827,9,0,0
153828,),0,0
153829,",",0,0
153830,which,0,0
153831,received,0,0
153832,one,0,0
153833,ampoule,0,0
153834,of,0,0
153835,Biostimine,0,0
153836,once,0,0
153837,daily,0,0
153838,for,0,0
153839,4,0,0
153840,weeks,0,0
153841,",",0,0
153842,or,0,0
153843,to,0,0
153844,the,0,0
153845,placebo,0,0
153846,group,0,0
153847,(,0,0
153848,n,0,0
153849,=,0,0
153850,9,0,0
153851,),0,0
153852,.,0,0
153853,Subjects,0,0
153854,performed,0,0
153855,a,0,0
153856,"2,000-meter-maximum",0,0
153857,test,0,0
153858,on,0,0
153859,a,0,0
153860,rowing,0,0
153861,ergometer,0,0
153862,at,0,0
153863,the,0,0
153864,beginning,0,0
153865,and,0,0
153866,end,0,0
153867,of,0,0
153868,the,0,0
153869,preparatory,0,0
153870,camp,0,1
153871,.,0,0
153872,Blood,0,1
153873,samples,0,0
153874,were,0,0
153875,obtained,0,0
153876,from,0,0
153877,the,0,0
153878,antecubital,0,1
153879,vein,0,0
153880,before,0,0
153881,each,0,0
153882,exercise,0,0
153883,test,0,0
153884,",",0,0
153885,1,0,0
153886,min,0,0
153887,after,0,0
153888,completing,0,0
153889,the,0,0
153890,test,0,0
153891,and,0,0
153892,after,0,0
153893,a,0,0
153894,24-hr,0,0
153895,recovery,0,1
153896,period,0,0
153897,.,0,0
153898,Superoxide,1,1
153899,dismutase,1,1
153900,and,1,1
153901,glutathione,1,1
153902,peroxidase,1,1
153903,activity,1,1
153904,as,0,0
153905,well,0,0
153906,as,0,0
153907,the,1,0
153908,concentration,1,1
153909,of,1,0
153910,thiobarbituric,1,1
153911,acid,1,0
153912,reactive,1,1
153913,substances,1,0
153914,(,1,0
153915,TBARS,1,1
153916,),1,0
153917,were,0,0
153918,assessed,0,0
153919,in,0,0
153920,erythrocytes,0,1
153921,.,0,0
153922,In,0,0
153923,addition,0,0
153924,",",0,0
153925,total,1,1
153926,antioxidant,1,1
153927,capacity,1,1
153928,(,1,0
153929,TAC,1,1
153930,),1,0
153931,and,1,0
153932,creatine,1,1
153933,kinase,1,0
153934,activity,1,1
153935,were,0,0
153936,measured,0,0
153937,in,0,0
153938,plasma,0,1
153939,samples,0,0
153940,",",0,0
153941,and,0,1
153942,cytokine,1,1
153943,(,1,1
153944,IL-6,1,1
153945,",",1,0
153946,IL-10,1,1
153947,),1,1
153948,concentrations,1,1
153949,were,0,0
153950,determined,0,0
153951,in,0,0
153952,the,0,0
153953,serum,0,1
153954,.,0,0
153955,Before,0,0
153956,and,0,0
153957,after,0,0
153958,Biostimine,0,1
153959,supplementation,0,0
153960,",",0,0
153961,exercise,0,0
153962,significantly,0,0
153963,increased,0,0
153964,the,0,0
153965,values,1,0
153966,of,1,0
153967,SOD,1,0
153968,",",1,0
153969,IL-6,1,1
153970,",",1,1
153971,IL-10,1,1
153972,",",1,1
153973,and,1,1
153974,TBARS,1,1
153975,in,0,0
153976,both,0,0
153977,groups,0,0
153978,.,0,0
153979,However,0,0
153980,",",0,0
153981,postexercise,0,1
153982,and,0,1
153983,recovery,0,1
153984,levels,0,1
153985,of,0,0
153986,TBARS,1,0
153987,were,0,0
153988,significantly,0,0
153989,lower,0,0
153990,in,0,0
153991,athletes,0,0
153992,receiving,0,0
153993,Biostimine,0,0
153994,than,0,0
153995,in,0,0
153996,controls,0,0
153997,.,0,0
153998,After,0,0
153999,supplementation,0,0
154000,",",0,0
154001,TAC,1,0
154002,was,0,0
154003,the,0,0
154004,only,0,0
154005,variable,0,0
154006,with,0,0
154007,the,0,0
154008,level,0,1
154009,being,0,0
154010,significantly,0,0
154011,higher,0,0
154012,in,0,0
154013,the,0,0
154014,supplemented,0,0
154015,group,0,0
154016,than,0,0
154017,in,0,0
154018,the,0,0
154019,placebo,0,0
154020,group,0,0
154021,.,0,0
154022,Consequently,0,0
154023,",",0,0
154024,we,0,0
154025,can,0,0
154026,conclude,0,0
154027,that,0,0
154028,Biostimine,0,0
154029,supplementation,0,0
154030,reduces,0,0
154031,the,0,0
154032,postexercise,0,0
154033,level,0,1
154034,of,0,0
154035,TBARS,1,0
154036,by,0,0
154037,increasing,0,0
154038,the,0,0
154039,antioxidant,1,0
154040,activity,1,1
154041,of,1,0
154042,plasma,1,1
154043,but,0,0
154044,has,0,0
154045,no,0,0
154046,effect,0,0
154047,on,0,0
154048,inflammatory,1,1
154049,markers,1,0
154050,.,1,0
154051,Supplementation,0,0
154052,with,0,0
154053,n3,0,0
154054,fatty,0,1
154055,acid,0,0
154056,ethyl,0,0
154057,esters,0,0
154058,increases,0,1
154059,large,0,0
154060,and,0,0
154061,small,0,1
154062,artery,0,1
154063,elasticity,1,1
154064,in,0,0
154065,obese,0,0
154066,adults,0,0
154067,on,0,0
154068,a,0,0
154069,weight,0,1
154070,loss,0,1
154071,diet,0,0
154072,.,0,0
154073,Increased,0,0
154074,arterial,0,0
154075,stiffness,0,1
154076,is,0,0
154077,associated,0,0
154078,with,0,0
154079,enhanced,0,0
154080,risk,0,1
154081,of,0,0
154082,cardiovascular,0,1
154083,disease,0,0
154084,in,0,0
154085,obese,0,0
154086,individuals,0,0
154087,.,0,0
154088,Whether,0,0
154089,n3,0,0
154090,fatty,0,1
154091,acid,0,0
154092,ethyl,0,0
154093,ester,0,1
154094,(,0,0
154095,FAEE,0,0
154096,),0,0
154097,supplementation,0,0
154098,improves,0,1
154099,arterial,0,1
154100,stiffness,0,1
154101,in,0,0
154102,obese,0,0
154103,participants,0,0
154104,on,0,0
154105,a,0,0
154106,weight,0,1
154107,loss,0,1
154108,diet,0,0
154109,has,0,0
154110,not,0,0
154111,yet,0,0
154112,been,0,0
154113,investigated,0,0
154114,.,0,0
154115,The,0,0
154116,objective,0,0
154117,of,0,0
154118,the,0,0
154119,study,0,0
154120,was,0,0
154121,to,0,0
154122,carry,0,0
154123,out,0,0
154124,a,0,0
154125,12-wk,0,0
154126,randomized,0,0
154127,",",0,0
154128,single-blind,0,0
154129,trial,0,0
154130,to,0,0
154131,test,0,0
154132,the,0,0
154133,effect,0,0
154134,of,0,0
154135,a,0,0
154136,25,0,0
154137,%,0,0
154138,energy,0,0
154139,deficit,0,1
154140,weight,0,1
154141,loss,0,1
154142,diet,0,0
154143,alone,0,0
154144,(,0,0
154145,WL,0,0
154146,),0,0
154147,(,0,0
154148,n,0,0
154149,=,0,0
154150,12,0,0
154151,),0,0
154152,or,0,0
154153,WL,0,0
154154,plus,0,0
154155,4,0,0
154156,g/d,0,0
154157,Omacor,0,0
154158,(,0,0
154159,46,0,0
154160,%,0,0
154161,EPA,0,0
154162,and,0,0
154163,38,0,0
154164,%,0,0
154165,DHA,0,0
154166,),0,1
154167,supplementation,0,0
154168,(,0,0
154169,WL+FAEE,0,0
154170,),0,0
154171,(,0,0
154172,n,0,0
154173,=,0,0
154174,13,0,0
154175,),0,0
154176,on,0,0
154177,arterial,0,1
154178,elasticity,0,1
154179,in,0,0
154180,obese,0,0
154181,adults,0,0
154182,.,0,0
154183,Large,1,0
154184,(,1,0
154185,C1,1,1
154186,),1,0
154187,and,1,0
154188,small,1,1
154189,artery,1,1
154190,elasticity,1,1
154191,(,1,0
154192,C2,1,0
154193,),1,0
154194,were,0,0
154195,measured,0,0
154196,by,0,0
154197,pulse,0,0
154198,contour,0,1
154199,analysis,0,0
154200,of,0,0
154201,the,0,0
154202,radial,0,0
154203,artery,0,0
154204,.,0,0
154205,WL,0,0
154206,alone,0,0
154207,reduced,1,0
154208,(,0,0
154209,P,0,0
154210,<,0,0
154211,0.05,0,0
154212,in,0,0
154213,all,0,0
154214,),0,0
154215,body,1,1
154216,weight,1,1
154217,(,0,0
154218,-3,0,0
154219,%,0,0
154220,),0,0
154221,",",0,0
154222,waist,1,1
154223,circumference,1,1
154224,(,0,0
154225,-4,0,0
154226,%,0,0
154227,),0,0
154228,",",0,0
154229,systolic,1,1
154230,(,0,0
154231,-3,0,0
154232,%,0,0
154233,),0,0
154234,and,0,0
154235,diastolic,1,1
154236,(,0,0
154237,-3,0,0
154238,%,0,0
154239,),0,0
154240,blood,1,1
154241,pressures,1,1
154242,",",1,0
154243,cardiac,1,1
154244,output,1,1
154245,(,1,0
154246,-4,1,0
154247,%,1,0
154248,),1,0
154249,",",1,0
154250,plasma,1,1
154251,TG,1,1
154252,concentration,1,1
154253,(,0,0
154254,-25,0,0
154255,%,0,0
154256,),0,0
154257,",",0,0
154258,and,0,0
154259,the,0,0
154260,homeostasis,1,1
154261,model,1,0
154262,assessment,1,1
154263,(,1,0
154264,HOMA,1,1
154265,),1,1
154266,score,1,1
154267,(,0,0
154268,-12,0,0
154269,%,0,0
154270,),0,0
154271,and,0,0
154272,increased,1,0
154273,plasma,1,1
154274,HDL,1,1
154275,cholesterol,1,1
154276,(,0,0
154277,+9,0,0
154278,%,0,0
154279,),0,0
154280,and,0,1
154281,adiponectin,1,1
154282,(,0,0
154283,+18,0,0
154284,%,0,0
154285,),0,0
154286,concentrations,1,1
154287,.,1,0
154288,However,0,0
154289,",",0,0
154290,WL,0,0
154291,alone,0,0
154292,did,0,0
154293,not,0,0
154294,alter,0,0
154295,C1,0,1
154296,and,0,0
154297,C2,0,0
154298,.,0,0
154299,The,0,0
154300,WL+FAEE,0,0
154301,intervention,0,0
154302,significantly,1,0
154303,reduced,1,0
154304,body,1,1
154305,weight,1,1
154306,(,0,0
154307,-4,0,0
154308,%,0,0
154309,),0,0
154310,",",0,0
154311,waist,1,1
154312,circumference,1,1
154313,(,0,0
154314,-4,0,0
154315,%,0,0
154316,),0,0
154317,",",0,0
154318,systolic,1,1
154319,(,0,0
154320,-8,0,0
154321,%,0,0
154322,),0,0
154323,and,0,0
154324,diastolic,1,1
154325,(,0,0
154326,-5,0,0
154327,%,0,0
154328,),0,0
154329,blood,1,1
154330,pressures,1,1
154331,",",1,0
154332,pulse,1,1
154333,pressure,1,1
154334,(,0,0
154335,-5,0,0
154336,%,0,0
154337,),0,0
154338,",",0,0
154339,heart,1,1
154340,rate,1,1
154341,(,0,0
154342,-8,0,0
154343,%,0,0
154344,),0,0
154345,",",0,0
154346,plasma,1,1
154347,TG,1,1
154348,concentration,1,1
154349,(,0,0
154350,-36,0,0
154351,%,0,0
154352,),0,0
154353,",",0,0
154354,and,0,1
154355,HOMA,1,1
154356,score,1,1
154357,(,0,0
154358,-12,0,0
154359,%,0,0
154360,),0,0
154361,and,0,0
154362,increased,1,1
154363,stroke,1,1
154364,volume,1,1
154365,(,0,0
154366,+3,0,0
154367,%,0,0
154368,),0,0
154369,",",0,0
154370,plasma,1,1
154371,HDL,1,1
154372,cholesterol,1,1
154373,(,0,0
154374,+6,0,0
154375,%,0,0
154376,),0,0
154377,and,0,0
154378,adiponectin,1,1
154379,concentrations,1,1
154380,(,0,0
154381,+28,0,0
154382,%,0,0
154383,),0,0
154384,",",0,0
154385,and,0,1
154386,C1,1,1
154387,(,0,0
154388,+20,0,0
154389,%,0,0
154390,),0,0
154391,and,0,1
154392,C2,1,1
154393,(,0,0
154394,+22,0,0
154395,%,0,0
154396,),0,0
154397,artery,1,0
154398,elasticity,1,1
154399,.,1,0
154400,The,0,0
154401,changes,0,0
154402,in,0,0
154403,systolic,1,1
154404,blood,1,1
154405,pressure,1,1
154406,",",1,1
154407,heart,1,1
154408,rate,1,1
154409,",",1,0
154410,plasma,1,1
154411,TGs,1,1
154412,",",1,0
154413,C1,1,1
154414,",",1,1
154415,and,1,1
154416,C2,1,1
154417,were,0,0
154418,significantly,1,0
154419,greater,1,0
154420,in,0,0
154421,the,0,0
154422,WL+FAEE,0,0
154423,group,0,0
154424,than,0,0
154425,in,0,0
154426,the,0,0
154427,WL,0,0
154428,group,0,0
154429,.,0,0
154430,Supplementation,0,0
154431,with,0,0
154432,n3,0,0
154433,FAEEs,0,0
154434,improves,0,1
154435,C1,1,1
154436,and,1,0
154437,C2,1,0
154438,independently,0,0
154439,of,0,0
154440,weight,1,1
154441,loss,1,1
154442,in,0,0
154443,obese,0,0
154444,adults,0,0
154445,.,0,0
154446,Drug-drug,0,0
154447,interaction,0,1
154448,study,0,0
154449,of,0,0
154450,ACT-178882,0,0
154451,",",0,0
154452,a,0,0
154453,new,0,0
154454,renin,0,1
154455,inhibitor,0,0
154456,",",0,1
154457,and,0,1
154458,diltiazem,0,0
154459,in,0,0
154460,healthy,0,0
154461,subjects,0,0
154462,.,0,0
154463,BACKGROUND,0,0
154464,AND,0,0
154465,OBJECTIVE,0,0
154466,The,0,0
154467,cytochrome,0,0
154468,P450,0,0
154469,(,0,0
154470,CYP,0,0
154471,),0,1
154472,enzyme,0,0
154473,",",0,0
154474,CYP3A4,0,0
154475,",",0,0
154476,metabolizes,0,0
154477,ACT-178882,0,0
154478,",",0,0
154479,a,0,0
154480,new,0,0
154481,direct,0,0
154482,renin,0,0
154483,inhibitor,0,0
154484,.,0,0
154485,This,0,0
154486,study,0,0
154487,investigated,0,0
154488,the,0,0
154489,effect,1,0
154490,of,0,0
154491,diltiazem,0,0
154492,",",0,0
154493,a,0,0
154494,moderate,0,0
154495,inhibitor,0,0
154496,of,0,0
154497,CYP3A4,0,0
154498,",",0,0
154499,on,0,0
154500,the,0,0
154501,single-dose,0,0
154502,pharmacokinetics,0,0
154503,of,0,0
154504,ACT-178882,0,0
154505,in,0,0
154506,healthy,0,0
154507,subjects,0,0
154508,.,0,0
154509,METHODS,0,0
154510,In,0,0
154511,this,0,0
154512,open-label,0,0
154513,",",0,0
154514,two-way,0,0
154515,crossover,0,0
154516,",",0,0
154517,drug-drug,0,0
154518,interaction,0,1
154519,study,0,0
154520,",",0,0
154521,healthy,0,0
154522,young,0,0
154523,male,0,0
154524,subjects,0,0
154525,received,0,0
154526,treatments,0,0
154527,A,0,0
154528,and,0,0
154529,B,0,0
154530,in,0,0
154531,a,0,0
154532,randomized,0,0
154533,fashion,0,0
154534,.,0,0
154535,Treatment,0,0
154536,A,0,0
154537,consisted,0,0
154538,of,0,0
154539,a,0,0
154540,single,0,0
154541,dose,0,0
154542,of,0,0
154543,100,0,0
154544,mg,0,0
154545,ACT-178882,0,0
154546,and,0,0
154547,treatment,0,0
154548,B,0,0
154549,of,0,0
154550,diltiazem,0,0
154551,300,0,0
154552,mg,0,0
154553,once,0,0
154554,a,0,0
154555,day,0,0
154556,for,0,0
154557,13,0,0
154558,days,0,0
154559,and,0,0
154560,a,0,0
154561,single,0,0
154562,dose,0,0
154563,of,0,0
154564,100,0,0
154565,mg,0,0
154566,ACT-178882,0,0
154567,on,0,0
154568,day,0,0
154569,4,0,0
154570,.,0,0
154571,Serial,0,0
154572,blood,0,1
154573,samples,0,0
154574,for,0,0
154575,the,0,0
154576,measurement,0,0
154577,of,0,0
154578,ACT-178882,0,0
154579,were,0,0
154580,drawn,0,0
154581,pre-dose,0,0
154582,and,0,0
154583,up,0,0
154584,to,0,0
154585,120,0,0
154586,h,0,0
154587,post-dose,0,0
154588,during,0,0
154589,treatment,0,0
154590,A,0,0
154591,and,0,0
154592,pre-dose,0,0
154593,ACT-178882,0,0
154594,and,0,0
154595,up,0,0
154596,to,0,0
154597,240,0,0
154598,h,0,0
154599,post-dose,0,0
154600,during,0,0
154601,treatment,0,0
154602,B.,0,1
154603,Trough,0,0
154604,blood,1,1
154605,samples,1,0
154606,for,1,0
154607,the,1,0
154608,measurement,0,0
154609,of,0,0
154610,diltiazem,0,0
154611,were,0,0
154612,taken,0,0
154613,on,0,0
154614,days,0,0
154615,1-5,0,0
154616,of,0,0
154617,dosing,0,0
154618,during,0,0
154619,treatment,1,0
154620,B,1,0
154621,.,1,0
154622,Safety,1,1
154623,was,1,0
154624,assessed,1,0
154625,by,1,0
154626,recording,1,0
154627,of,1,0
154628,vital,1,1
154629,signs,1,1
154630,and,1,1
154631,electrocardiogram,1,1
154632,",",1,1
154633,clinical,1,1
154634,laboratory,1,1
154635,tests,1,1
154636,and,1,1
154637,adverse,1,1
154638,event,1,1
154639,reporting,1,0
154640,.,1,0
154641,RESULTS,1,0
154642,Fourteen,0,0
154643,subjects,0,0
154644,were,0,0
154645,enrolled,0,0
154646,and,0,0
154647,completed,0,0
154648,the,0,0
154649,study,0,0
154650,.,0,0
154651,In,0,0
154652,the,0,0
154653,absence,0,0
154654,of,0,0
154655,diltiazem,0,0
154656,",",0,0
154657,the,0,0
154658,mean,0,1
154659,(,0,0
154660,95,0,0
154661,%,0,0
154662,confidence,0,0
154663,interval,0,0
154664,[,0,0
154665,CI,0,0
154666,],0,0
154667,),0,0
154668,maximum,0,1
154669,concentration,0,1
154670,(,0,0
154671,Cmax,0,1
154672,),0,1
154673,and,0,0
154674,area,0,1
154675,under,0,0
154676,the,0,0
154677,curve,0,1
154678,from,0,0
154679,time,0,0
154680,zero,0,0
154681,to,0,0
154682,infinity,0,0
154683,(,0,0
154684,AUC?,0,1
154685,),0,0
154686,were,0,0
154687,26.8,0,0
154688,(,0,0
154689,20.1-35.8,0,0
154690,),0,0
154691,ng/mL,0,0
154692,and,0,0
154693,454,0,0
154694,(,0,0
154695,351-587,0,0
154696,),0,0
154697,ng?h/mL,0,0
154698,",",0,0
154699,respectively,0,0
154700,.,0,0
154701,In,0,0
154702,the,0,0
154703,presence,0,0
154704,of,0,0
154705,diltiazem,0,0
154706,these,0,0
154707,values,0,1
154708,were,0,0
154709,43.5,0,0
154710,(,0,0
154711,36.8-51.4,0,0
154712,),0,0
154713,ng/mL,0,0
154714,and,0,0
154715,918,0,0
154716,(,0,0
154717,781-1078,0,0
154718,),0,0
154719,ng?h/mL,0,0
154720,",",0,0
154721,respectively,1,0
154722,.,1,0
154723,The,1,0
154724,median,1,0
154725,time,1,1
154726,to,1,0
154727,Cmax,1,1
154728,(,1,0
154729,tmax,1,0
154730,),1,0
154731,for,1,0
154732,ACT-178882,0,0
154733,was,0,0
154734,prolonged,0,0
154735,from,0,0
154736,3.5,0,0
154737,to,0,0
154738,5.0,0,0
154739,h,0,0
154740,by,0,0
154741,diltiazem,0,0
154742,whereas,0,0
154743,its,0,0
154744,apparent,1,0
154745,terminal,1,1
154746,half-life,1,1
154747,(,1,0
154748,t?,1,0
154749,),1,0
154750,was,1,0
154751,unaffected,1,0
154752,by,0,0
154753,diltiazem,0,0
154754,",",0,0
154755,22.9,0,0
154756,and,0,0
154757,24.2,0,0
154758,h,0,0
154759,for,0,0
154760,treatments,0,0
154761,A,0,0
154762,and,0,1
154763,B,0,0
154764,",",0,0
154765,respectively,0,0
154766,.,0,0
154767,Using,0,0
154768,treatment,0,0
154769,A,0,0
154770,as,0,0
154771,reference,0,0
154772,",",0,0
154773,the,1,0
154774,geometric,1,1
154775,mean,1,1
154776,ratio,1,1
154777,(,1,0
154778,90,0,0
154779,%,0,0
154780,CI,0,0
154781,),0,0
154782,was,0,0
154783,1.62,0,0
154784,(,0,0
154785,1.36-1.94,0,0
154786,),0,0
154787,for,1,0
154788,Cmax,1,1
154789,and,1,0
154790,2.02,0,0
154791,(,0,0
154792,1.75-2.34,0,0
154793,),0,0
154794,for,0,0
154795,AUC?,0,0
154796,",",0,0
154797,indicating,0,0
154798,a,0,0
154799,significant,0,0
154800,interaction,0,1
154801,between,0,0
154802,ACT-178882,0,0
154803,and,0,0
154804,diltiazem,0,0
154805,.,0,0
154806,One,0,0
154807,(,0,0
154808,7.1,0,0
154809,%,0,0
154810,),0,0
154811,and,0,0
154812,3,0,0
154813,(,0,0
154814,21.3,0,0
154815,%,0,0
154816,),0,0
154817,of,0,0
154818,14,0,0
154819,subjects,0,0
154820,reported,1,0
154821,an,1,0
154822,adverse,1,1
154823,event,1,0
154824,during,0,0
154825,treatment,0,0
154826,A,0,0
154827,and,0,1
154828,B,0,0
154829,",",0,0
154830,respectively,0,0
154831,",",0,0
154832,with,1,0
154833,headache,1,1
154834,being,0,0
154835,the,0,0
154836,most,0,0
154837,frequently,0,0
154838,reported,0,0
154839,",",0,0
154840,with,0,0
154841,three,0,0
154842,events,0,1
154843,.,0,0
154844,There,0,0
154845,were,0,0
154846,no,0,0
154847,clinically,0,0
154848,relevant,0,0
154849,effects,0,1
154850,of,0,0
154851,treatments,0,0
154852,on,0,0
154853,vital,0,1
154854,signs,0,1
154855,",",0,0
154856,electrocardiogram,0,1
154857,or,0,1
154858,clinical,0,1
154859,laboratory,0,0
154860,variables,0,0
154861,.,0,0
154862,CONCLUSION,0,0
154863,Concomitant,0,0
154864,administration,0,0
154865,of,0,0
154866,diltiazem,0,0
154867,doubled,0,0
154868,the,0,0
154869,exposure,0,0
154870,to,0,0
154871,ACT-178882,0,0
154872,without,0,0
154873,affecting,0,0
154874,t?,0,0
154875,.,0,0
154876,The,0,0
154877,clinical,0,0
154878,significance,0,0
154879,of,0,0
154880,this,0,0
154881,increase,0,0
154882,is,0,0
154883,at,0,0
154884,present,0,0
154885,unknown,0,0
154886,and,0,0
154887,will,0,0
154888,need,0,0
154889,to,0,0
154890,be,0,0
154891,investigated,0,0
154892,in,0,0
154893,future,0,0
154894,clinical,0,0
154895,studies,0,0
154896,.,0,0
154897,Treatment,0,0
154898,with,0,0
154899,ACT-178882,0,0
154900,alone,0,0
154901,or,0,0
154902,in,0,0
154903,combination,0,0
154904,with,0,0
154905,diltiazem,0,0
154906,was,0,0
154907,safe,0,1
154908,and,0,0
154909,well,0,0
154910,tolerated,0,1
154911,.,0,0
154912,Wheelchair,0,0
154913,skills,0,1
154914,training,0,0
154915,to,0,0
154916,improve,0,0
154917,confidence,1,0
154918,with,0,0
154919,using,0,0
154920,a,0,0
154921,manual,0,0
154922,wheelchair,0,0
154923,among,0,0
154924,older,0,0
154925,adults,0,0
154926,:,0,0
154927,a,0,0
154928,pilot,0,0
154929,study,0,0
154930,.,0,0
154931,OBJECTIVE,0,0
154932,To,0,0
154933,examine,0,0
154934,the,0,0
154935,effects,0,0
154936,of,0,0
154937,wheelchair,0,0
154938,skills,0,1
154939,training,0,0
154940,on,0,0
154941,confidence,1,0
154942,in,0,0
154943,older,0,0
154944,adults,0,0
154945,who,0,0
154946,are,0,0
154947,inexperienced,0,0
154948,wheelchair,0,0
154949,users,0,0
154950,.,0,0
154951,DESIGN,0,0
154952,Parallel,0,0
154953,group,0,0
154954,",",0,0
154955,single-blind,0,0
154956,randomized,0,0
154957,controlled,0,0
154958,trial,0,0
154959,.,0,0
154960,SETTING,0,0
154961,Research,0,0
154962,laboratory,0,0
154963,in,0,0
154964,a,0,0
154965,rehabilitation,0,0
154966,hospital,0,1
154967,.,0,0
154968,PARTICIPANTS,0,0
154969,Participants,0,0
154970,(,0,0
154971,N=20,0,0
154972,),0,0
154973,who,0,0
154974,were,0,0
154975,community-living,0,0
154976,older,0,0
154977,adults,0,0
154978,at,0,0
154979,least,0,0
154980,65,0,0
154981,years,0,0
154982,old,0,0
154983,(,0,0
154984,mean,0,1
154985,age,0,0
154986,",",0,0
154987,70y,0,0
154988,),0,0
154989,",",0,0
154990,50,0,0
154991,%,0,0
154992,women,0,0
154993,",",0,0
154994,and,0,1
154995,who,0,0
154996,had,0,0
154997,no,0,0
154998,experience,0,0
154999,of,0,0
155000,using,0,0
155001,a,0,0
155002,wheelchair,0,0
155003,were,0,0
155004,randomly,0,0
155005,allocated,0,0
155006,to,0,0
155007,an,0,0
155008,intervention,0,0
155009,(,0,0
155010,n=10,0,0
155011,),0,0
155012,or,0,0
155013,control,0,0
155014,(,0,1
155015,n=10,0,0
155016,),0,0
155017,group,0,0
155018,.,0,0
155019,INTERVENTIONS,0,0
155020,The,0,0
155021,intervention,0,0
155022,group,0,0
155023,received,0,0
155024,two,0,0
155025,1-hour,0,0
155026,training,0,0
155027,sessions,0,0
155028,that,0,0
155029,followed,0,0
155030,the,0,0
155031,Wheelchair,0,0
155032,Skills,0,1
155033,Training,0,1
155034,Program,0,0
155035,(,0,0
155036,WSTP,0,0
155037,),0,0
155038,protocol,0,0
155039,.,0,0
155040,The,0,0
155041,control,0,0
155042,group,0,0
155043,received,0,0
155044,a,0,0
155045,single,0,0
155046,socialization,0,0
155047,contact,0,1
155048,.,0,0
155049,MAIN,0,0
155050,OUTCOME,0,0
155051,MEASURE,0,0
155052,The,0,0
155053,Wheelchair,1,0
155054,Use,1,0
155055,Confidence,1,1
155056,Scale-Manual,1,1
155057,(,1,0
155058,WheelCon-M,1,1
155059,),1,0
155060,was,0,0
155061,used,0,0
155062,to,0,0
155063,evaluate,1,0
155064,confidence,1,0
155065,with,0,0
155066,using,0,0
155067,a,0,0
155068,manual,0,0
155069,wheelchair,0,0
155070,.,0,0
155071,The,0,0
155072,WheelCon-M,0,0
155073,is,0,0
155074,a,0,0
155075,self-report,0,0
155076,questionnaire,0,0
155077,that,0,0
155078,comprises,0,0
155079,65,0,0
155080,items,0,0
155081,in,0,0
155082,6,0,0
155083,conceptual,0,0
155084,areas,0,0
155085,.,0,0
155086,RESULTS,0,0
155087,A,0,0
155088,1-way,0,0
155089,between-groups,0,0
155090,analysis,0,0
155091,of,0,0
155092,covariance,0,1
155093,revealed,0,0
155094,a,0,0
155095,significant,1,0
155096,difference,1,0
155097,in,0,0
155098,postintervention,1,0
155099,WheelCon-M,1,0
155100,scores,1,1
155101,between,0,0
155102,the,0,0
155103,intervention,0,0
155104,and,0,0
155105,control,0,0
155106,groups,0,0
155107,(,0,0
155108,"F1,17=10.9",0,0
155109,",",0,0
155110,P=.004,0,0
155111,),0,0
155112,after,0,0
155113,controlling,0,0
155114,for,0,0
155115,baseline,0,0
155116,WheelCon-M,0,0
155117,scores,0,1
155118,.,0,0
155119,A,0,0
155120,large,0,0
155121,effect,1,0
155122,size,1,1
155123,was,0,0
155124,also,0,0
155125,observed,0,0
155126,(,0,0
155127,partial,0,0
155128,?,0,0
155129,(,0,0
155130,2,0,0
155131,),0,0
155132,=.39,0,0
155133,),0,0
155134,.,0,0
155135,Secondary,0,0
155136,analyses,0,0
155137,revealed,0,0
155138,that,0,0
155139,the,0,0
155140,WSTP,0,0
155141,had,0,0
155142,greater,1,0
155143,effects,1,1
155144,on,1,0
155145,confidence,1,0
155146,in,1,0
155147,areas,1,0
155148,related,1,0
155149,to,1,0
155150,maneuvering,1,0
155151,around,1,0
155152,the,1,0
155153,physical,1,1
155154,environment,1,0
155155,",",1,0
155156,knowledge,1,1
155157,and,1,1
155158,problem,1,1
155159,solving,1,1
155160,",",1,1
155161,advocacy,1,1
155162,",",1,1
155163,and,1,1
155164,managing,1,1
155165,emotions,1,1
155166,than,1,0
155167,in,1,0
155168,areas,1,0
155169,related,1,0
155170,to,1,0
155171,performing,1,0
155172,activities,1,1
155173,and,1,0
155174,behaving,1,0
155175,in,1,0
155176,social,1,1
155177,situations,1,0
155178,.,1,0
155179,CONCLUSION,0,0
155180,Two,0,0
155181,1-hour,0,0
155182,WSTP,0,0
155183,sessions,0,0
155184,improve,1,0
155185,confidence,1,0
155186,with,1,0
155187,using,1,0
155188,a,1,0
155189,manual,1,0
155190,wheelchair,1,0
155191,among,0,0
155192,older,0,0
155193,adults,0,0
155194,who,0,0
155195,are,0,0
155196,inexperienced,0,0
155197,wheelchair,0,0
155198,users,0,0
155199,.,0,0
155200,Plasma,0,1
155201,Epstein-Barr,0,1
155202,virus,0,0
155203,DNA,0,1
155204,predicts,0,0
155205,outcome,0,0
155206,in,0,0
155207,advanced,0,0
155208,Hodgkin,0,0
155209,lymphoma,0,0
155210,:,0,0
155211,correlative,0,0
155212,analysis,0,0
155213,from,0,0
155214,a,0,0
155215,large,0,0
155216,North,0,0
155217,American,0,0
155218,cooperative,0,0
155219,group,0,0
155220,trial,0,0
155221,.,0,0
155222,Epstein-Barr,0,1
155223,virus,0,0
155224,(,0,0
155225,EBV,0,0
155226,),0,0
155227,is,0,0
155228,associated,0,0
155229,with,0,0
155230,Hodgkin,0,1
155231,lymphoma,0,1
155232,(,0,0
155233,HL,0,1
155234,),0,0
155235,and,0,0
155236,can,0,0
155237,be,0,0
155238,detected,0,0
155239,by,0,0
155240,in,0,0
155241,situ,0,0
155242,hybridization,0,0
155243,(,0,0
155244,ISH,0,0
155245,),0,0
155246,of,0,0
155247,viral,0,0
155248,nucleic,0,0
155249,acid,0,0
155250,(,0,0
155251,EBER,0,0
155252,),0,0
155253,in,0,0
155254,tumor,0,0
155255,cells,0,1
155256,.,0,0
155257,We,0,0
155258,sought,0,0
155259,to,0,0
155260,determine,0,0
155261,whether,0,0
155262,plasma,0,1
155263,EBV-DNA,0,0
155264,could,0,0
155265,serve,0,0
155266,as,0,0
155267,a,0,0
155268,surrogate,0,0
155269,for,0,0
155270,EBER-ISH,1,0
155271,and,0,0
155272,to,0,0
155273,explore,0,0
155274,its,0,0
155275,prognostic,0,0
155276,utility,0,1
155277,in,0,0
155278,HL,0,1
155279,.,0,0
155280,Specimens,0,0
155281,from,0,0
155282,the,0,0
155283,Cancer,0,0
155284,Cooperative,0,0
155285,Intergroup,0,0
155286,Trial,0,0
155287,E2496,0,0
155288,were,0,0
155289,used,0,0
155290,to,0,0
155291,compare,0,0
155292,pretreatment,0,0
155293,plasma,0,1
155294,EBV-DNA,0,0
155295,quantification,0,0
155296,with,0,0
155297,EBV,0,0
155298,tumor,1,1
155299,status,1,1
155300,by,0,0
155301,EBER-ISH,1,0
155302,.,1,0
155303,A,0,0
155304,cutoff,0,1
155305,of,0,0
155306,>,0,0
155307,60,0,0
155308,viral,0,0
155309,copies/100,0,0
155310,?L,0,1
155311,plasma,0,1
155312,yielded,0,0
155313,96,0,0
155314,%,0,0
155315,concordance,0,0
155316,with,1,0
155317,EBER-ISH,1,0
155318,.,1,0
155319,Pretreatment,0,0
155320,and,0,0
155321,month,0,0
155322,6,0,0
155323,plasma,0,1
155324,specimens,0,0
155325,were,0,0
155326,designated,0,0
155327,EBV,0,0
155328,(,0,0
155329,-,0,0
155330,),0,0
155331,or,0,0
155332,EBV,0,0
155333,(,0,0
155334,+,0,0
155335,),0,0
155336,by,0,0
155337,this,0,0
155338,cutoff,0,0
155339,.,0,0
155340,Patients,0,0
155341,with,0,0
155342,pretreatment,0,0
155343,EBV,0,0
155344,(,0,0
155345,+,0,0
155346,),0,1
155347,plasma,0,1
155348,(,0,0
155349,n,0,0
155350,=,0,0
155351,54,0,0
155352,),0,0
155353,had,1,0
155354,inferior,1,0
155355,failure-free,1,1
155356,survival,1,1
155357,(,1,0
155358,FFS,1,0
155359,),1,0
155360,compared,0,0
155361,with,0,0
155362,those,0,0
155363,with,0,0
155364,pretreatment,0,0
155365,EBV,0,0
155366,(,0,0
155367,-,0,0
155368,),0,0
155369,plasma,0,1
155370,(,0,0
155371,n,0,0
155372,=,0,0
155373,274,0,0
155374,),0,0
155375,",",0,0
155376,log-rank,0,0
155377,P,0,0
155378,=,0,0
155379,.009,0,0
155380,.,0,0
155381,By,0,0
155382,contrast,0,0
155383,",",0,0
155384,no,0,0
155385,difference,0,0
155386,in,1,0
155387,FFS,1,0
155388,was,0,0
155389,observed,0,0
155390,when,0,0
155391,patients,0,0
155392,were,0,0
155393,stratified,0,0
155394,by,1,0
155395,EBER-ISH,1,0
155396,.,1,0
155397,Pretreatment,0,0
155398,plasma,0,1
155399,EBV,0,0
155400,positivity,0,1
155401,was,0,0
155402,an,0,0
155403,independent,0,0
155404,predictor,0,0
155405,of,0,0
155406,treatment,0,0
155407,failure,0,1
155408,on,0,0
155409,multivariate,0,0
155410,analyses,0,0
155411,.,0,0
155412,At,0,0
155413,month,0,0
155414,6,0,0
155415,",",0,0
155416,plasma,1,1
155417,EBV,1,0
155418,(,1,0
155419,+,1,0
155420,),1,0
155421,patients,0,0
155422,(,0,0
155423,n,0,0
155424,=,0,0
155425,7,0,0
155426,),0,0
155427,had,1,0
155428,inferior,1,0
155429,FFS,1,0
155430,compared,0,0
155431,with,1,0
155432,plasma,1,1
155433,EBV,1,0
155434,(,1,0
155435,-,1,0
155436,),1,0
155437,patients,0,0
155438,(,0,0
155439,n,0,0
155440,=,0,0
155441,125,0,0
155442,),0,0
155443,",",0,0
155444,log-rank,0,0
155445,P,0,0
155446,=,0,0
155447,.007,0,0
155448,.,0,0
155449,These,0,0
155450,results,0,0
155451,confirm,0,0
155452,that,0,0
155453,plasma,0,1
155454,EBV-DNA,0,0
155455,is,0,0
155456,highly,0,0
155457,concordant,0,0
155458,with,1,0
155459,EBER-ISH,1,0
155460,in,0,0
155461,HL,0,1
155462,and,0,0
155463,suggest,0,0
155464,that,0,0
155465,it,0,0
155466,may,0,0
155467,have,0,0
155468,prognostic,0,0
155469,utility,0,0
155470,both,0,0
155471,at,0,0
155472,baseline,0,0
155473,and,0,0
155474,after,0,0
155475,therapy,0,0
155476,.,0,0
155477,This,0,0
155478,trial,0,0
155479,was,0,0
155480,registered,0,0
155481,at,0,0
155482,www.clinicaltrials.gov,0,0
155483,as,0,0
155484,#,0,0
155485,NCT00003389,0,0
155486,.,0,0
155487,Antihistamines,0,0
155488,do,0,0
155489,not,0,0
155490,inhibit,0,0
155491,the,0,0
155492,wheal,0,1
155493,induced,0,0
155494,by,0,0
155495,the,0,0
155496,intradermal,0,0
155497,injection,0,0
155498,of,0,0
155499,autologous,0,0
155500,serum,0,1
155501,in,0,0
155502,resistant,0,0
155503,chronic,0,0
155504,idiopathic,0,0
155505,urticaria,0,1
155506,.,0,0
155507,Some,0,0
155508,patients,0,0
155509,with,0,0
155510,chronic,0,0
155511,idiopathic,0,0
155512,urticaria,0,1
155513,(,0,0
155514,CIU,0,0
155515,),0,0
155516,are,0,0
155517,resistant,0,0
155518,to,0,0
155519,conventional,0,0
155520,doses,0,0
155521,of,0,0
155522,antihistamines,0,0
155523,(,0,0
155524,AHs,0,0
155525,),0,0
155526,.,0,0
155527,This,0,0
155528,study,0,0
155529,was,0,0
155530,designed,0,0
155531,to,0,0
155532,check,0,0
155533,whether,0,0
155534,the,0,0
155535,skin,1,1
155536,wheal,1,1
155537,and,1,0
155538,flare,1,1
155539,reaction,1,1
155540,produced,0,0
155541,by,0,0
155542,the,0,0
155543,intradermal,0,0
155544,injection,0,0
155545,of,0,0
155546,autologous,0,0
155547,serum,0,1
155548,(,0,0
155549,AS,0,0
155550,),0,0
155551,and,0,0
155552,by,0,0
155553,histamine,0,1
155554,differs,0,0
155555,in,0,0
155556,AH-resistant,0,1
155557,and,0,0
155558,AH,0,0
155559,responder,0,1
155560,CIU,0,0
155561,patients,0,0
155562,.,0,0
155563,CIU,0,0
155564,patients,0,0
155565,with,0,0
155566,treatment,0,0
155567,failure,0,1
155568,under,0,0
155569,fexofenadine,0,0
155570,at,0,0
155571,180,0,0
155572,mg,0,0
155573,q.d,0,0
155574,.,0,0
155575,increased,0,0
155576,their,0,0
155577,daily,0,0
155578,dose,0,0
155579,of,0,0
155580,AH,0,0
155581,to,0,0
155582,4,0,0
155583,tablets,0,0
155584,daily,0,0
155585,.,0,0
155586,Those,0,0
155587,with,0,0
155588,significant,0,0
155589,improvement,0,1
155590,of,0,0
155591,urticaria,0,1
155592,activity,0,1
155593,score,0,1
155594,under,0,0
155595,fexofenadine,0,0
155596,at,0,0
155597,180,0,0
155598,mg,0,0
155599,were,0,0
155600,included,0,0
155601,in,0,0
155602,the,0,0
155603,CIU,0,0
155604,group,0,0
155605,.,0,0
155606,Subjects,0,0
155607,with,0,0
155608,treatment,0,0
155609,failure,0,0
155610,despite,0,0
155611,a,0,0
155612,full,0,0
155613,8-week,0,0
155614,fourfold,0,0
155615,fexofenadine,0,0
155616,treatment,0,0
155617,were,0,0
155618,included,0,0
155619,in,0,0
155620,the,0,0
155621,resistant,0,0
155622,CIU,0,0
155623,(,0,0
155624,R-CIU,0,1
155625,group,0,0
155626,),0,0
155627,.,0,0
155628,The,0,0
155629,control,0,0
155630,group,0,0
155631,consisted,0,0
155632,of,0,0
155633,sex-,0,0
155634,and,0,0
155635,age-matched,0,0
155636,patents,0,0
155637,with,0,0
155638,allergic,0,0
155639,rhinitis,0,0
155640,.,0,0
155641,The,0,0
155642,AS,0,0
155643,skin,0,1
155644,test,0,1
155645,and,0,0
155646,intradermal,0,1
155647,histamine-induced,0,1
155648,wheal,0,1
155649,and,0,0
155650,flare,0,1
155651,reaction,0,1
155652,were,0,0
155653,performed,0,0
155654,at,0,0
155655,baseline,0,0
155656,(,0,0
155657,without,0,0
155658,AH,0,1
155659,),0,0
155660,",",0,0
155661,after,0,0
155662,8,0,0
155663,and,0,0
155664,16,0,0
155665,weeks,0,0
155666,(,0,0
155667,under,0,0
155668,AH,0,1
155669,treatment,0,0
155670,),0,0
155671,.,0,0
155672,Forty-six,0,0
155673,subjects,0,0
155674,were,0,0
155675,included,0,0
155676,in,0,0
155677,the,0,0
155678,CIU,0,0
155679,group,0,0
155680,",",0,0
155681,21,0,0
155682,were,0,0
155683,in,0,0
155684,the,0,0
155685,R-CIU,0,0
155686,group,0,0
155687,",",0,0
155688,and,0,0
155689,44,0,0
155690,were,0,0
155691,in,0,0
155692,the,0,0
155693,control,0,0
155694,group,0,0
155695,.,0,0
155696,Under,0,0
155697,AH,0,1
155698,therapy,0,0
155699,",",0,0
155700,the,0,0
155701,skin,1,1
155702,reaction,1,0
155703,to,1,0
155704,intradermal,1,0
155705,histamine,1,1
155706,injection,1,0
155707,was,0,0
155708,significantly,0,0
155709,diminished,0,0
155710,in,0,0
155711,all,0,0
155712,study,0,0
155713,groups,0,0
155714,.,0,0
155715,In,0,0
155716,the,0,0
155717,R-CIU,0,0
155718,group,0,0
155719,",",0,0
155720,fexofenadine,0,0
155721,at,0,0
155722,180,0,0
155723,mg,0,0
155724,did,0,0
155725,not,0,0
155726,suppress,0,0
155727,AS-induced,1,0
155728,wheal,1,1
155729,reaction,1,1
155730,(,0,0
155731,5.96,0,0
155732,?,0,0
155733,2.25,0,0
155734,mm,0,0
155735,;,0,0
155736,p,0,0
155737,=,0,0
155738,0.85,0,0
155739,),0,0
155740,",",0,0
155741,and,0,0
155742,with,0,0
155743,a,0,0
155744,fourfold,0,0
155745,AH,0,0
155746,dose,0,0
155747,some,1,0
155748,reduction,1,0
155749,of,1,0
155750,AS-induced,1,0
155751,wheal,1,1
155752,(,0,0
155753,3.79,0,0
155754,?,0,0
155755,1.74,0,0
155756,mm,0,0
155757,;,0,0
155758,p,0,0
155759,=,0,0
155760,0.008,0,0
155761,),0,0
155762,was,0,0
155763,observed,0,0
155764,but,0,0
155765,remained,0,0
155766,larger,0,0
155767,than,0,0
155768,in,0,0
155769,the,0,0
155770,CIU,0,0
155771,(,0,0
155772,2.31,0,0
155773,?,0,0
155774,1.12,0,0
155775,;,0,0
155776,p,0,0
155777,=,0,0
155778,0.006,0,0
155779,),0,0
155780,and,0,0
155781,control,0,0
155782,groups,0,0
155783,(,0,0
155784,2.52,0,0
155785,?,0,0
155786,1.36,0,0
155787,;,0,0
155788,p,0,0
155789,=,0,0
155790,0.037,0,0
155791,),0,0
155792,.,0,0
155793,AHs,0,0
155794,do,0,0
155795,not,0,0
155796,inhibit,0,0
155797,the,0,0
155798,wheal,0,1
155799,induced,0,0
155800,by,0,0
155801,the,0,0
155802,intradermal,0,0
155803,injection,0,0
155804,of,0,0
155805,AS,0,0
155806,in,0,0
155807,R-CIU,0,0
155808,.,0,0
155809,Heat-exercise,0,0
155810,performance,0,1
155811,of,0,0
155812,pyridostigmine-treated,0,0
155813,subjects,0,0
155814,wearing,0,0
155815,chemical,0,1
155816,protective,0,0
155817,clothing,0,1
155818,.,0,0
155819,Pyridostigmine,0,0
155820,bromide,0,0
155821,is,0,0
155822,currently,0,0
155823,the,0,0
155824,pretreatment,0,0
155825,of,0,0
155826,choice,0,0
155827,for,0,0
155828,operation,0,0
155829,in,0,0
155830,a,0,0
155831,chemical,0,1
155832,warfare,0,0
155833,(,0,0
155834,CW,0,1
155835,),0,0
155836,environment,0,0
155837,.,0,0
155838,Under,0,0
155839,CW,0,0
155840,conditions,0,0
155841,",",0,0
155842,subjects,0,0
155843,are,0,0
155844,exposed,0,0
155845,to,0,0
155846,thermal,0,0
155847,stress,0,1
155848,caused,0,0
155849,by,0,0
155850,CW,0,0
155851,protective,0,0
155852,clothing,0,0
155853,.,0,0
155854,This,0,0
155855,investigation,0,0
155856,was,0,0
155857,conducted,0,0
155858,to,0,0
155859,determine,0,0
155860,if,0,0
155861,pyridostigmine,0,0
155862,affects,0,0
155863,various,0,0
155864,physiological,0,0
155865,and,0,0
155866,biophysical,0,1
155867,parameters,0,1
155868,of,0,0
155869,human,0,0
155870,temperature,0,1
155871,regulation,0,0
155872,in,0,0
155873,subjects,0,0
155874,wearing,0,0
155875,CW,0,0
155876,protective,0,0
155877,clothing,0,1
155878,.,0,0
155879,Pyridostigmine,0,0
155880,was,0,0
155881,administered,0,0
155882,orally,0,0
155883,in,0,0
155884,a,0,0
155885,randomized,0,0
155886,double-blind,0,0
155887,cross-over,0,0
155888,study,0,0
155889,in,0,0
155890,four,0,0
155891,doses,0,0
155892,of,0,0
155893,30,0,0
155894,mg,0,0
155895,every,0,0
155896,8,0,0
155897,h.,0,0
155898,An,0,0
155899,average,0,0
155900,of,0,0
155901,33,0,0
155902,%,0,0
155903,whole,0,0
155904,blood,0,1
155905,cholinesterase,0,1
155906,inhibition,0,1
155907,was,0,0
155908,induced,0,0
155909,in,0,0
155910,the,0,0
155911,pyridostigmine,0,0
155912,treated,0,0
155913,group,0,0
155914,4,0,0
155915,h,0,0
155916,after,0,0
155917,ingestion,0,0
155918,of,0,0
155919,last,0,0
155920,tablet,0,0
155921,.,0,0
155922,The,0,0
155923,subjects,0,0
155924,were,0,0
155925,exposed,0,0
155926,to,0,0
155927,170,0,0
155928,min,0,0
155929,exercise-heat,0,0
155930,stress,0,1
155931,(,0,0
155932,Tdb,0,0
155933,=,0,0
155934,33,0,0
155935,degrees,0,0
155936,C,0,0
155937,;,0,0
155938,rh,0,0
155939,=,0,0
155940,60,0,0
155941,%,0,0
155942,),0,0
155943,consisting,0,0
155944,of,0,0
155945,60,0,0
155946,min,0,0
155947,in,0,0
155948,a,0,0
155949,sitting,0,1
155950,position,0,0
155951,and,0,0
155952,two,0,0
155953,50-min,0,0
155954,walks,0,0
155955,(,0,0
155956,1.39,0,0
155957,m.s-1,0,0
155958,",",0,0
155959,5,0,0
155960,%,0,0
155961,grade,0,0
155962,),0,0
155963,separated,0,0
155964,by,0,0
155965,10,0,0
155966,min,0,0
155967,of,0,0
155968,rest,0,0
155969,.,0,0
155970,Non-evaporative,1,1
155971,heat,1,0
155972,exchange,1,1
155973,was,0,0
155974,significantly,0,0
155975,higher,0,0
155976,",",0,0
155977,-14.0,0,0
155978,and,0,0
155979,-10.6,0,0
155980,W.m-2,0,0
155981,(,0,0
155982,p,0,0
155983,less,0,0
155984,than,0,0
155985,0.03,0,0
155986,),0,0
155987,",",0,0
155988,for,0,0
155989,the,0,0
155990,pyridostigmine-treated,0,0
155991,subjects,0,0
155992,.,0,0
155993,No,0,0
155994,additional,0,0
155995,differences,0,0
155996,were,0,0
155997,found,0,0
155998,between,0,0
155999,treatments,0,0
156000,in,0,0
156001,the,0,0
156002,physiological,0,0
156003,responses,0,1
156004,and,0,1
156005,heat,0,0
156006,balance,0,1
156007,parameters,0,1
156008,at,0,0
156009,the,0,0
156010,end,0,0
156011,of,0,0
156012,exposure,0,0
156013,:,0,0
156014,heart,0,1
156015,rate,0,1
156016,(,0,0
156017,HR,0,1
156018,),0,1
156019,was,0,0
156020,(,0,0
156021,mean,0,1
156022,+/-,0,0
156023,S.D,0,0
156024,.,0,0
156025,),0,0
156026,154,0,0
156027,+/-,0,0
156028,16,0,0
156029,and,0,0
156030,151,0,0
156031,+/-,0,0
156032,24,0,0
156033,bpm,0,0
156034,",",0,0
156035,rectal,0,1
156036,temperature,0,1
156037,(,0,0
156038,Tre,0,0
156039,),0,0
156040,was,0,0
156041,39.0,0,0
156042,+/-,0,0
156043,0.4,0,0
156044,and,0,0
156045,38.9,0,0
156046,+/-,0,0
156047,0.2,0,0
156048,degrees,0,0
156049,C,0,0
156050,",",0,0
156051,heat,0,0
156052,storage,0,1
156053,over,0,0
156054,the,0,0
156055,2,0,0
156056,h,0,0
156057,of,0,0
156058,exercise,0,0
156059,was,0,0
156060,62,0,0
156061,+/-,0,0
156062,15,0,0
156063,and,0,0
156064,70,0,0
156065,+/-,0,0
156066,15,0,0
156067,W.m-2,0,0
156068,",",0,0
156069,and,0,1
156070,sweat,0,1
156071,rate,0,1
156072,was,0,0
156073,832,0,0
156074,+/-,0,0
156075,185,0,0
156076,and,0,0
156077,748,0,0
156078,+/-,0,0
156079,52,0,0
156080,g.h-1,0,0
156081,",",0,0
156082,in,0,0
156083,the,0,0
156084,pyridostigmine,0,0
156085,and,0,0
156086,placebo,0,0
156087,treatments,0,0
156088,",",0,0
156089,respectively,0,0
156090,.,0,0
156091,(,0,0
156092,ABSTRACT,0,1
156093,TRUNCATED,0,0
156094,AT,0,0
156095,250,0,0
156096,WORDS,0,0
156097,),0,0
156098,Effects,0,0
156099,of,0,0
156100,intranasal,0,0
156101,oxytocin,0,0
156102,on,0,0
156103,the,0,0
156104,neural,0,0
156105,basis,0,0
156106,of,0,0
156107,face,0,0
156108,processing,0,1
156109,in,0,0
156110,autism,0,0
156111,spectrum,0,0
156112,disorder,0,0
156113,.,0,0
156114,BACKGROUND,0,0
156115,Autism,0,1
156116,spectrum,0,0
156117,disorder,0,0
156118,(,0,0
156119,ASD,0,0
156120,),0,0
156121,is,0,0
156122,associated,0,0
156123,with,0,0
156124,altered,0,0
156125,face,0,0
156126,processing,0,1
156127,and,0,1
156128,decreased,0,1
156129,activity,0,1
156130,in,0,0
156131,brain,0,1
156132,regions,0,0
156133,involved,0,0
156134,in,0,0
156135,face,0,0
156136,processing,0,0
156137,.,0,0
156138,The,0,0
156139,neuropeptide,0,0
156140,oxytocin,0,0
156141,has,0,0
156142,been,0,0
156143,shown,0,0
156144,to,0,0
156145,promote,0,0
156146,face,0,0
156147,processing,0,1
156148,and,0,1
156149,modulate,0,0
156150,brain,0,1
156151,activity,0,1
156152,in,0,0
156153,healthy,0,0
156154,adults,0,0
156155,.,0,0
156156,The,0,0
156157,present,0,0
156158,study,0,0
156159,examined,0,0
156160,the,0,0
156161,effects,0,1
156162,of,0,0
156163,oxytocin,0,0
156164,on,0,0
156165,the,0,0
156166,neural,0,0
156167,basis,0,0
156168,of,0,0
156169,face,0,0
156170,processing,0,1
156171,in,0,0
156172,adults,0,0
156173,with,0,0
156174,Asperger,0,0
156175,syndrome,0,0
156176,(,0,0
156177,AS,0,0
156178,),0,0
156179,.,0,0
156180,METHODS,0,0
156181,A,0,0
156182,group,0,0
156183,of,0,0
156184,14,0,0
156185,individuals,0,0
156186,with,0,0
156187,AS,0,0
156188,and,0,0
156189,a,0,0
156190,group,0,0
156191,of,0,0
156192,14,0,0
156193,neurotypical,0,0
156194,control,0,0
156195,participants,0,0
156196,performed,0,0
156197,a,0,0
156198,face-matching,0,0
156199,and,0,0
156200,a,0,0
156201,house-matching,0,0
156202,task,0,0
156203,during,0,0
156204,functional,0,0
156205,magnetic,0,0
156206,resonance,0,0
156207,imaging,0,0
156208,.,0,0
156209,The,0,0
156210,effects,0,0
156211,of,0,0
156212,a,0,0
156213,single,0,0
156214,dose,0,0
156215,of,0,0
156216,24,0,0
156217,IU,0,0
156218,intranasally,0,0
156219,administered,0,0
156220,oxytocin,0,0
156221,were,0,0
156222,tested,0,0
156223,in,0,0
156224,a,0,0
156225,randomized,0,0
156226,",",0,0
156227,placebo-controlled,0,0
156228,",",0,0
156229,within-subject,0,0
156230,",",0,0
156231,cross-over,0,0
156232,design,0,0
156233,.,0,0
156234,RESULTS,0,0
156235,Under,0,0
156236,placebo,0,0
156237,",",0,0
156238,the,0,0
156239,AS,0,1
156240,group,0,0
156241,showed,0,0
156242,decreased,0,0
156243,activity,1,1
156244,in,1,0
156245,the,1,0
156246,right,1,0
156247,amygdala,1,1
156248,",",1,0
156249,fusiform,1,1
156250,gyrus,1,1
156251,",",1,0
156252,and,1,1
156253,inferior,1,1
156254,occipital,1,1
156255,gyrus,1,0
156256,compared,0,0
156257,with,0,0
156258,the,0,0
156259,control,0,0
156260,group,0,0
156261,during,0,0
156262,face,0,0
156263,processing,0,0
156264,.,0,0
156265,After,0,0
156266,oxytocin,0,1
156267,treatment,0,0
156268,",",0,0
156269,right,1,0
156270,amygdala,1,1
156271,activity,1,1
156272,to,1,0
156273,facial,1,0
156274,stimuli,1,1
156275,increased,0,0
156276,in,0,0
156277,the,0,0
156278,AS,0,0
156279,group,0,0
156280,.,0,0
156281,CONCLUSIONS,0,0
156282,These,0,0
156283,findings,0,0
156284,indicate,0,0
156285,that,0,0
156286,oxytocin,0,0
156287,increases,0,1
156288,the,0,0
156289,saliency,0,1
156290,of,0,0
156291,social,0,1
156292,stimuli,0,1
156293,and,0,0
156294,in,0,0
156295,ASD,0,0
156296,and,0,0
156297,suggest,0,0
156298,that,0,0
156299,oxytocin,0,0
156300,might,0,0
156301,promote,0,0
156302,face,0,0
156303,processing,0,1
156304,and,0,1
156305,eye,0,1
156306,contact,0,1
156307,in,0,0
156308,individuals,0,0
156309,with,0,0
156310,ASD,0,0
156311,as,0,0
156312,prerequisites,0,0
156313,for,0,0
156314,neurotypical,0,0
156315,social,0,1
156316,interaction,0,0
156317,.,0,0
156318,A,0,0
156319,randomized,0,0
156320,",",0,0
156321,placebo-controlled,0,0
156322,phase,0,0
156323,2,0,0
156324,study,0,0
156325,of,0,0
156326,ganitumab,0,0
156327,or,0,0
156328,conatumumab,0,0
156329,in,0,0
156330,combination,0,0
156331,with,0,0
156332,FOLFIRI,0,0
156333,for,0,0
156334,second-line,0,0
156335,treatment,0,0
156336,of,0,0
156337,mutant,0,0
156338,KRAS,0,0
156339,metastatic,0,0
156340,colorectal,0,0
156341,cancer,0,0
156342,.,0,0
156343,BACKGROUND,0,0
156344,Targeted,0,0
156345,agents,0,0
156346,presently,0,0
156347,available,0,0
156348,for,0,0
156349,mutant,0,0
156350,KRAS,0,0
156351,metastatic,0,0
156352,colorectal,0,0
156353,cancer,0,0
156354,(,0,0
156355,mCRC,0,0
156356,),0,0
156357,are,0,0
156358,bevacizumab,0,0
156359,and,0,0
156360,aflibercept,0,0
156361,.,0,0
156362,We,0,0
156363,evaluated,0,0
156364,the,0,0
156365,efficacy,1,1
156366,and,0,0
156367,safety,1,1
156368,of,0,1
156369,conatumumab,0,0
156370,(,0,0
156371,an,0,0
156372,agonistic,0,0
156373,monoclonal,0,0
156374,antibody,0,0
156375,against,0,1
156376,human,0,0
156377,death,0,1
156378,receptor,0,0
156379,5,0,0
156380,),0,0
156381,and,0,0
156382,ganitumab,0,0
156383,(,0,0
156384,a,0,0
156385,monoclonal,0,1
156386,antibody,0,0
156387,against,0,0
156388,the,0,0
156389,type,0,0
156390,1,0,0
156391,insulin-like,0,0
156392,growth,0,0
156393,factor,0,1
156394,receptor,0,1
156395,),0,0
156396,combined,0,0
156397,with,0,0
156398,standard,0,0
156399,FOLFIRI,0,0
156400,chemotherapy,0,0
156401,as,0,0
156402,a,0,0
156403,second-line,0,0
156404,treatment,0,0
156405,in,0,0
156406,patients,0,0
156407,with,0,0
156408,mutant,0,0
156409,KRAS,0,0
156410,mCRC,0,0
156411,.,0,0
156412,PATIENTS,0,0
156413,AND,0,0
156414,METHODS,0,0
156415,Patients,0,0
156416,with,0,0
156417,mutant,0,0
156418,KRAS,0,0
156419,metastatic,0,0
156420,adenocarcinoma,0,0
156421,of,0,0
156422,the,0,0
156423,colon,0,0
156424,or,0,0
156425,rectum,0,1
156426,refractory,0,0
156427,to,0,0
156428,fluoropyrimidine-,0,0
156429,and,0,0
156430,oxaliplatin-based,0,0
156431,chemotherapy,0,0
156432,were,0,0
156433,randomized,0,0
156434,1,0,0
156435,:,0,0
156436,1,0,0
156437,:,0,0
156438,1,0,0
156439,to,0,0
156440,receive,0,0
156441,intravenous,0,0
156442,FOLFIRI,0,0
156443,plus,0,0
156444,conatumumab,0,0
156445,10,0,0
156446,mg/kg,0,0
156447,(,0,0
156448,Arm,0,1
156449,A,0,0
156450,),0,0
156451,",",0,0
156452,ganitumab,0,0
156453,12,0,0
156454,mg/kg,0,0
156455,(,0,0
156456,Arm,0,1
156457,B,0,0
156458,),0,0
156459,",",0,0
156460,or,0,1
156461,placebo,0,0
156462,(,0,0
156463,Arm,0,1
156464,C,0,0
156465,),0,0
156466,Q2W,0,0
156467,.,0,0
156468,The,0,0
156469,primary,0,0
156470,end,0,0
156471,point,0,0
156472,was,0,0
156473,progression-free,1,1
156474,survival,1,1
156475,(,1,0
156476,PFS,1,0
156477,),1,0
156478,.,1,0
156479,RESULTS,0,0
156480,In,0,0
156481,total,0,1
156482,",",0,0
156483,155,0,0
156484,patients,0,0
156485,were,0,0
156486,randomized,0,0
156487,.,0,0
156488,Median,1,1
156489,PFS,1,0
156490,in,0,0
156491,Arms,0,1
156492,A,0,0
156493,",",0,0
156494,B,0,0
156495,",",0,1
156496,and,0,1
156497,C,0,0
156498,was,0,0
156499,6.5,0,0
156500,months,0,0
156501,(,0,0
156502,HR,0,1
156503,",",0,0
156504,0.69,0,0
156505,;,0,0
156506,P,0,0
156507,=,0,0
156508,0.147,0,0
156509,),0,0
156510,",",0,0
156511,4.5,0,0
156512,months,0,0
156513,(,0,0
156514,HR,0,1
156515,",",0,0
156516,1.01,0,0
156517,;,0,0
156518,P,0,0
156519,=,0,0
156520,0.998,0,0
156521,),0,0
156522,",",0,0
156523,and,0,0
156524,4.6,0,0
156525,months,0,0
156526,",",0,0
156527,respectively,0,0
156528,;,0,0
156529,median,1,1
156530,overall,1,1
156531,survival,1,1
156532,was,0,0
156533,12.3,0,0
156534,months,0,0
156535,(,0,0
156536,HR,0,1
156537,",",0,0
156538,0.89,0,0
156539,;,0,0
156540,P,0,0
156541,=,0,0
156542,0.650,0,0
156543,),0,0
156544,",",0,0
156545,12.4,0,0
156546,months,0,0
156547,(,0,0
156548,HR,0,1
156549,",",0,0
156550,1.27,0,0
156551,;,0,0
156552,P,0,0
156553,=,0,0
156554,0.357,0,0
156555,),0,0
156556,",",0,0
156557,and,0,0
156558,12.0,0,0
156559,months,0,0
156560,;,0,0
156561,and,0,0
156562,objective,1,0
156563,response,1,1
156564,rate,1,1
156565,was,0,0
156566,14,0,0
156567,%,0,0
156568,",",0,0
156569,8,0,0
156570,%,0,0
156571,",",0,0
156572,and,0,0
156573,2,0,0
156574,%,0,0
156575,.,0,0
156576,The,0,0
156577,most,0,0
156578,common,0,0
156579,grade,0,1
156580,?3,1,0
156581,adverse,1,1
156582,events,1,1
156583,in,1,0
156584,Arms,0,1
156585,A/B/C,0,1
156586,included,1,0
156587,neutropenia,1,1
156588,(,1,0
156589,30,0,0
156590,%,0,0
156591,/25,0,0
156592,%,0,0
156593,/18,0,0
156594,%,0,0
156595,),0,0
156596,and,1,1
156597,diarrhea,1,1
156598,(,1,0
156599,18,0,0
156600,%,0,0
156601,/2,0,0
156602,%,0,0
156603,/10,0,0
156604,%,0,0
156605,),0,0
156606,.,0,0
156607,CONCLUSIONS,0,0
156608,Conatumumab,0,0
156609,",",0,0
156610,but,0,0
156611,not,0,0
156612,ganitumab,0,0
156613,",",0,0
156614,plus,0,0
156615,FOLFIRI,0,0
156616,was,0,0
156617,associated,0,0
156618,with,0,0
156619,a,0,0
156620,trend,0,0
156621,toward,1,0
156622,improved,1,0
156623,PFS,1,0
156624,.,1,0
156625,Both,0,0
156626,combinations,0,0
156627,had,1,0
156628,acceptable,1,0
156629,toxicity,1,1
156630,.,1,0
156631,Lengthening,0,0
156632,the,0,0
156633,moment,0,1
156634,arm,0,0
156635,of,0,0
156636,the,0,0
156637,patella,0,0
156638,confers,0,0
156639,enhanced,0,0
156640,extensor,1,0
156641,mechanism,1,0
156642,power,1,1
156643,following,0,0
156644,total,0,1
156645,knee,0,1
156646,arthroplasty,0,0
156647,.,0,0
156648,We,0,0
156649,investigated,0,0
156650,whether,0,0
156651,a,0,0
156652,postulated,0,0
156653,biomechanical,0,0
156654,advantage,0,0
156655,conferred,0,0
156656,to,0,0
156657,the,0,0
156658,extensor,0,0
156659,mechanism,0,0
156660,by,0,0
156661,a,0,0
156662,change,0,0
156663,in,0,0
156664,knee,0,1
156665,implant,0,0
156666,design,0,0
156667,was,0,0
156668,detectable,0,1
156669,in,0,0
156670,patients,0,0
156671,by,0,0
156672,direct,0,0
156673,physical,0,0
156674,testing,0,0
156675,.,0,0
156676,212,0,0
156677,TKA,0,0
156678,patients,0,0
156679,were,0,0
156680,enrolled,0,0
156681,in,0,0
156682,a,0,0
156683,double,0,0
156684,blind,0,0
156685,randomized,0,0
156686,controlled,0,0
156687,trial,0,0
156688,to,0,0
156689,receive,0,0
156690,either,0,0
156691,a,0,0
156692,traditional,0,0
156693,implant,0,0
156694,or,0,0
156695,one,0,0
156696,which,0,0
156697,incorporated,0,0
156698,new,0,0
156699,design,0,0
156700,features,0,0
156701,.,0,0
156702,Extensor,1,1
156703,mechanism,1,0
156704,power,1,1
156705,output,1,1
156706,and,1,1
156707,physical,1,1
156708,performance,1,1
156709,on,1,0
156710,a,1,0
156711,battery,1,0
156712,of,1,0
156713,timed,1,1
156714,functional,1,0
156715,activities,1,1
156716,was,0,0
156717,assessed,0,0
156718,pre-operatively,0,0
156719,and,0,0
156720,then,0,0
156721,at,0,0
156722,6,0,0
156723,",",0,0
156724,26,0,0
156725,",",0,0
156726,and,0,0
156727,52,0,0
156728,weeks,0,0
156729,post-operatively,0,0
156730,.,0,0
156731,Significantly,0,0
156732,enhanced,0,0
156733,power,1,1
156734,output,1,1
156735,was,0,0
156736,observed,0,0
156737,in,0,0
156738,both,0,0
156739,groups,0,0
156740,post-arthroplasty,0,0
156741,;,0,0
156742,however,0,0
156743,",",0,0
156744,the,0,0
156745,new,0,0
156746,design,0,0
156747,implant,0,0
156748,group,0,0
156749,demonstrated,0,0
156750,a,0,0
156751,greater,0,0
156752,change,1,1
156753,in,1,0
156754,power,1,1
156755,output,1,1
156756,than,0,0
156757,the,0,0
156758,traditional,0,0
156759,implant,0,0
156760,group,0,0
156761,.,0,0
156762,Posthoc,1,0
156763,testing,1,0
156764,of,0,0
156765,between,0,0
156766,group,0,0
156767,differences,0,0
156768,highlighted,0,0
156769,greater,0,0
156770,improvement,0,1
156771,at,0,0
156772,all,1,0
156773,post-operative,1,0
156774,assessments,1,0
156775,.,1,0
156776,At,0,0
156777,52,0,0
156778,weeks,0,0
156779,",",0,0
156780,patients,0,0
156781,receiving,0,0
156782,the,0,0
156783,implant,0,0
156784,with,0,0
156785,the,0,0
156786,postulated,0,0
156787,biomechanical,0,0
156788,advantage,0,0
156789,achieved,0,0
156790,116,0,0
156791,%,0,0
156792,of,0,0
156793,the,0,0
156794,power,1,0
156795,output,1,1
156796,of,1,0
156797,their,1,0
156798,contralateral,1,0
156799,limb,1,1
156800,",",0,0
156801,whereas,0,0
156802,patients,0,0
156803,with,0,0
156804,the,0,0
156805,traditional,0,0
156806,design,0,0
156807,achieved,0,0
156808,90,0,0
156809,%,0,0
156810,.,0,0
156811,No,0,0
156812,between,0,0
156813,group,0,0
156814,difference,0,0
156815,was,0,0
156816,detected,0,0
156817,in,0,0
156818,the,0,0
156819,patient,0,1
156820,'s,0,0
156821,time,0,1
156822,to,0,0
156823,complete,0,1
156824,functional,0,0
156825,tasks,0,0
156826,.,0,0
156827,Thus,0,0
156828,",",0,0
156829,patients,0,0
156830,receiving,0,0
156831,a,0,0
156832,knee,0,1
156833,implant,0,0
156834,of,0,0
156835,a,0,0
156836,modern,0,0
156837,design,0,0
156838,(,0,0
156839,theoretically,0,0
156840,able,0,0
156841,to,0,0
156842,confer,0,0
156843,a,0,0
156844,mechanical,0,0
156845,advantage,0,0
156846,to,0,0
156847,the,0,0
156848,extensor,0,0
156849,mechanism,0,0
156850,),0,0
156851,were,0,0
156852,found,0,0
156853,to,0,0
156854,generate,0,0
156855,significantly,0,0
156856,greater,0,0
156857,extensor,1,1
156858,power,1,1
156859,than,0,0
156860,those,0,0
156861,receiving,0,0
156862,a,0,0
156863,traditional,0,0
156864,implant,0,0
156865,without,0,0
156866,the,0,0
156867,postulated,0,0
156868,mechanical,0,0
156869,advantage,0,0
156870,.,0,0
156871,Clinical,0,0
156872,benefits,0,0
156873,of,0,0
156874,concurrent,0,0
156875,capecitabine,0,0
156876,and,0,1
156877,cisplatin,0,0
156878,versus,0,0
156879,concurrent,0,0
156880,cisplatin,0,0
156881,and,0,1
156882,5-flurouracil,0,0
156883,in,0,0
156884,locally,0,0
156885,advanced,0,0
156886,squamous,0,0
156887,cell,0,1
156888,head,0,0
156889,and,0,1
156890,neck,0,1
156891,cancer,0,0
156892,.,0,0
156893,We,0,0
156894,aimed,0,0
156895,to,0,0
156896,assess,0,0
156897,the,0,0
156898,efficacy,0,1
156899,and,0,0
156900,safety,0,1
156901,of,0,1
156902,concurrent,0,0
156903,capecitabine,0,0
156904,and,0,1
156905,cisplatin,0,0
156906,over,0,0
156907,concurrent,0,0
156908,cisplatin,0,0
156909,and,0,1
156910,5-flurouracil,0,0
156911,(,0,0
156912,5-FU,0,0
156913,),0,0
156914,in,0,0
156915,locally,0,0
156916,advanced,0,0
156917,squamous,0,0
156918,cell,0,0
156919,carcinoma,0,0
156920,of,0,0
156921,the,0,0
156922,head,0,0
156923,and,0,0
156924,neck,0,0
156925,.,0,0
156926,One,0,0
156927,hundred,0,0
156928,and,0,0
156929,fifty-three,0,0
156930,patients,0,0
156931,(,0,0
156932,all,0,0
156933,of,0,0
156934,whom,0,0
156935,had,0,0
156936,stage,0,0
156937,III,0,1
156938,or,0,0
156939,IV,0,1
156940,unresectable,0,0
156941,disease,0,0
156942,with,0,0
156943,no,0,0
156944,distant,0,0
156945,metastases,0,0
156946,and,0,0
156947,who,0,0
156948,had,0,0
156949,received,0,0
156950,two,0,0
156951,cycles,0,0
156952,of,0,0
156953,taxol,0,0
156954,and,0,1
156955,cisplatin,0,0
156956,chemotherapy,0,0
156957,),0,0
156958,were,0,0
156959,randomly,0,0
156960,assigned,0,0
156961,to,0,0
156962,receive,0,0
156963,either,0,0
156964,concurrent,0,0
156965,cisplatin,0,0
156966,(,0,0
156967,75,0,0
156968,mg/m,0,0
156969,(,0,0
156970,2,0,0
156971,),0,0
156972,in,0,0
156973,day,0,0
156974,1,0,0
156975,and,0,0
156976,2,0,0
156977,),0,0
156978,and,0,0
156979,5-FU,0,0
156980,(,0,0
156981,750,0,0
156982,mg/m,0,0
156983,(,0,0
156984,2,0,0
156985,),0,0
156986,in,0,0
156987,day,0,0
156988,1,0,0
156989,",",0,0
156990,2,0,0
156991,",",0,0
156992,and,0,0
156993,3,0,0
156994,),0,0
156995,from,0,0
156996,the,0,0
156997,first,0,0
156998,day,0,0
156999,of,0,0
157000,radiotherapy,0,0
157001,at,0,0
157002,an,0,0
157003,interval,0,0
157004,of,0,0
157005,3,0,0
157006,weeks,0,0
157007,(,0,0
157008,Arm,0,0
157009,I,0,0
157010,),0,0
157011,or,0,0
157012,cisplatin,0,0
157013,(,0,0
157014,75,0,0
157015,mg/m,0,0
157016,(,0,0
157017,2,0,0
157018,),0,0
157019,in,0,0
157020,day,0,0
157021,1,0,0
157022,and,0,0
157023,2,0,0
157024,),0,0
157025,and,0,0
157026,capecitabine,0,0
157027,(,0,0
157028,750,0,0
157029,mg/m,0,0
157030,(,0,0
157031,2,0,0
157032,),0,0
157033,in,0,0
157034,two,0,0
157035,divided,0,0
157036,doses,0,0
157037,from,0,0
157038,day,0,0
157039,1-14,0,0
157040,),0,0
157041,from,0,0
157042,the,0,0
157043,first,0,0
157044,day,0,0
157045,of,0,0
157046,radiotherapy,0,0
157047,at,0,0
157048,a,0,0
157049,3-week,0,0
157050,interval,0,0
157051,(,0,0
157052,Arm,0,1
157053,II,0,0
157054,),0,0
157055,.,0,0
157056,Results,0,0
157057,showed,0,0
157058,that,0,0
157059,patients,0,0
157060,in,0,0
157061,Arm,0,0
157062,II,0,0
157063,had,0,0
157064,a,0,0
157065,significantly,0,0
157066,better,1,0
157067,rate,1,1
157068,of,1,0
157069,complete,1,1
157070,response,1,1
157071,",",1,0
157072,fewer,1,1
157073,nodes,1,1
157074,",",1,1
157075,and,1,0
157076,better,1,0
157077,overall,1,1
157078,response,1,1
157079,compared,0,0
157080,to,0,0
157081,those,0,0
157082,in,0,0
157083,Arm,0,0
157084,I,0,0
157085,.,0,0
157086,The,0,0
157087,two,0,0
157088,groups,0,0
157089,had,0,0
157090,a,0,0
157091,similar,0,0
157092,3-year,1,0
157093,disease-free,1,1
157094,survival,1,1
157095,",",1,0
157096,progression,1,1
157097,free,1,1
157098,survival,1,1
157099,",",1,0
157100,and,1,1
157101,overall,1,1
157102,survival,1,1
157103,",",0,0
157104,i.e,0,0
157105,.,0,0
157106,they,0,0
157107,did,0,0
157108,not,0,0
157109,differ,0,0
157110,significantly,0,0
157111,.,0,0
157112,Variables,0,0
157113,indicating,0,0
157114,the,0,0
157115,quality,1,1
157116,of,1,0
157117,life,1,1
157118,of,0,0
157119,the,0,0
157120,two,0,0
157121,groups,0,0
157122,were,0,0
157123,compared,0,0
157124,.,0,0
157125,Patients,0,0
157126,in,0,0
157127,Arm,0,0
157128,II,0,0
157129,had,0,0
157130,a,0,0
157131,significantly,0,0
157132,higher,0,0
157133,quality,1,1
157134,of,1,1
157135,life,1,1
157136,compared,0,0
157137,to,0,0
157138,those,0,0
157139,in,0,0
157140,Arm,0,0
157141,I,0,0
157142,.,0,0
157143,The,0,0
157144,two,0,0
157145,groups,0,0
157146,had,0,0
157147,similar,0,0
157148,treatment-related,0,1
157149,acute,1,0
157150,and,1,0
157151,late,1,1
157152,toxicity,1,1
157153,",",0,0
157154,i.e,0,0
157155,.,0,0
157156,they,0,0
157157,did,0,0
157158,not,0,0
157159,differ,0,0
157160,significantly,0,0
157161,.,0,0
157162,These,0,0
157163,results,0,0
157164,have,0,0
157165,thoroughly,0,0
157166,substantiated,0,0
157167,the,0,0
157168,contention,0,0
157169,that,0,0
157170,concurrent,0,0
157171,chemoradiation,0,0
157172,with,0,0
157173,capecitabine,0,0
157174,and,0,0
157175,cisplatin,0,0
157176,may,0,0
157177,be,0,0
157178,regarded,0,0
157179,as,0,0
157180,an,0,0
157181,effective,0,0
157182,and,0,0
157183,well-tolerated,0,0
157184,regimen,0,0
157185,in,0,0
157186,the,0,0
157187,treatment,0,0
157188,of,0,0
157189,the,0,0
157190,patients,0,0
157191,with,0,0
157192,locally,0,0
157193,advanced,0,0
157194,head,0,0
157195,and,0,0
157196,neck,0,1
157197,cancer,0,0
157198,.,0,0
157199,Randomized,0,0
157200,",",0,0
157201,controlled,0,0
157202,",",0,0
157203,parallel-group,0,0
157204,trial,0,0
157205,of,0,0
157206,routine,0,0
157207,prophylaxis,0,0
157208,vs.,0,0
157209,on-demand,0,0
157210,treatment,0,0
157211,with,0,0
157212,sucrose-formulated,0,0
157213,recombinant,0,0
157214,factor,0,0
157215,VIII,0,0
157216,in,0,0
157217,adults,0,0
157218,with,0,0
157219,severe,0,1
157220,hemophilia,0,0
157221,A,0,0
157222,(,0,0
157223,SPINART,0,0
157224,),0,0
157225,.,0,0
157226,BACKGROUND,0,0
157227,The,0,0
157228,benefits,0,0
157229,of,0,0
157230,routine,0,0
157231,prophylaxis,0,0
157232,vs.,0,0
157233,on-demand,0,0
157234,treatment,0,0
157235,with,0,0
157236,factor,0,0
157237,VIII,0,0
157238,products,0,0
157239,have,0,0
157240,not,0,0
157241,been,0,0
157242,evaluated,0,0
157243,in,0,0
157244,controlled,0,0
157245,clinical,0,0
157246,trials,0,0
157247,in,0,0
157248,older,0,0
157249,patients,0,0
157250,with,0,0
157251,hemophilia,0,0
157252,A,0,0
157253,.,0,0
157254,OBJECTIVES,0,0
157255,To,0,0
157256,report,0,0
157257,results,0,0
157258,from,0,0
157259,a,0,0
157260,preplanned,0,0
157261,analysis,0,0
157262,of,0,0
157263,data,0,0
157264,from,0,0
157265,the,0,0
157266,first,0,0
157267,year,0,0
157268,of,0,0
157269,the,0,0
157270,3-year,0,0
157271,SPINART,0,0
157272,study,0,0
157273,",",0,0
157274,which,0,0
157275,compares,0,0
157276,routine,0,0
157277,prophylaxis,0,0
157278,with,0,0
157279,on-demand,0,0
157280,treatment,0,0
157281,with,0,0
157282,sucrose-formulated,0,0
157283,recombinant,0,0
157284,FVIII,0,0
157285,(,0,0
157286,rFVIII-FS,0,0
157287,),0,0
157288,.,0,0
157289,PATIENTS/METHODS,0,0
157290,SPINART,0,0
157291,is,0,0
157292,an,0,0
157293,open-label,0,0
157294,",",0,0
157295,randomized,0,0
157296,",",0,0
157297,controlled,0,0
157298,",",0,0
157299,parallel-group,0,0
157300,",",0,1
157301,multinational,0,0
157302,trial,0,0
157303,.,0,0
157304,Males,0,0
157305,aged,0,0
157306,12-50,0,0
157307,years,0,0
157308,with,0,0
157309,severe,0,1
157310,hemophilia,0,0
157311,A,0,0
157312,",",0,0
157313,?,0,0
157314,150,0,0
157315,days,0,0
157316,of,0,0
157317,exposure,0,0
157318,to,0,0
157319,FVIII,0,0
157320,",",0,0
157321,no,0,0
157322,FVIII,0,0
157323,inhibitors,0,0
157324,",",0,0
157325,no,0,0
157326,prophylaxis,0,0
157327,for,0,0
157328,>,0,0
157329,12,0,0
157330,consecutive,0,0
157331,months,0,0
157332,in,0,0
157333,the,0,0
157334,past,0,0
157335,5,0,0
157336,years,0,0
157337,and,0,0
157338,6-24,0,0
157339,bleeding,0,1
157340,episodes,0,1
157341,in,0,0
157342,the,0,0
157343,preceding,0,0
157344,6,0,0
157345,months,0,0
157346,were,0,0
157347,randomized,0,0
157348,1,0,0
157349,:,0,0
157350,1,0,0
157351,to,0,0
157352,rFVIII-FS,0,0
157353,prophylaxis,0,0
157354,(,0,0
157355,25,0,0
157356,IU,0,0
157357,kg,0,0
157358,(,0,0
157359,-1,0,0
157360,),0,0
157361,",",0,0
157362,three,0,0
157363,times,0,1
157364,weekly,0,0
157365,),0,0
157366,or,0,0
157367,on-demand,0,0
157368,treatment,0,0
157369,.,0,0
157370,The,0,0
157371,primary,0,0
157372,efficacy,0,1
157373,endpoint,1,1
157374,",",1,0
157375,number,1,1
157376,of,1,0
157377,total,1,1
157378,bleeding,1,1
157379,episodes,1,1
157380,in,1,0
157381,the,0,0
157382,intent-to-treat,0,0
157383,population,0,0
157384,",",0,0
157385,was,0,0
157386,analyzed,0,0
157387,after,0,0
157388,the,0,0
157389,last,0,0
157390,patient,0,0
157391,had,0,0
157392,completed,0,0
157393,1,0,0
157394,year,0,0
157395,of,0,0
157396,follow-up,0,0
157397,.,0,0
157398,A,0,0
157399,negative,0,0
157400,binomial,0,1
157401,model,0,0
157402,was,0,0
157403,used,0,0
157404,for,0,0
157405,the,0,0
157406,primary,0,0
157407,endpoint,0,0
157408,analysis,0,0
157409,;,0,0
157410,analysis,0,0
157411,of,0,0
157412,variance,0,0
157413,was,0,0
157414,used,0,0
157415,for,0,0
157416,confirmatory,0,0
157417,analysis,0,0
157418,of,0,0
157419,annualized,0,0
157420,bleeding,0,1
157421,rates,0,1
157422,.,0,0
157423,RESULTS,0,0
157424,Eighty-four,0,0
157425,patients,0,0
157426,were,0,0
157427,enrolled,0,0
157428,and,0,0
157429,analyzed,0,0
157430,(,0,0
157431,n,0,0
157432,=,0,0
157433,42,0,0
157434,per,0,0
157435,group,0,0
157436,;,0,0
157437,mean,0,1
157438,age,0,0
157439,",",0,0
157440,30.6,0,0
157441,years,0,0
157442,;,0,0
157443,median,0,1
157444,treatment,0,0
157445,duration,0,1
157446,",",0,0
157447,1.7,0,0
157448,years,0,0
157449,),0,0
157450,.,0,0
157451,The,0,0
157452,median,0,0
157453,number,0,1
157454,of,0,0
157455,total,1,1
157456,bleeding,1,1
157457,episodes,1,1
157458,and,1,1
157459,total,1,1
157460,bleeding,1,1
157461,episodes,1,1
157462,per,0,0
157463,year,0,0
157464,were,0,0
157465,significantly,0,0
157466,lower,0,0
157467,with,0,0
157468,prophylaxis,0,0
157469,than,0,0
157470,with,0,0
157471,on-demand,0,0
157472,treatment,0,0
157473,(,0,0
157474,total,0,1
157475,",",0,0
157476,0,0,0
157477,vs.,0,0
157478,54.5,0,0
157479,;,0,0
157480,total,0,0
157481,per,0,0
157482,year,0,0
157483,",",0,0
157484,0,0,0
157485,vs.,0,0
157486,27.9,0,0
157487,;,0,0
157488,both,0,0
157489,P,0,0
157490,<,0,0
157491,0.0001,0,0
157492,),0,0
157493,.,0,0
157494,No,0,0
157495,treatment-related,0,1
157496,adverse,0,1
157497,events,0,1
157498,occurred,0,0
157499,",",0,0
157500,and,0,0
157501,no,0,0
157502,patients,0,0
157503,developed,0,0
157504,FVIII,0,0
157505,inhibitors,0,0
157506,.,0,0
157507,CONCLUSIONS,0,0
157508,Routine,0,1
157509,prophylaxis,0,0
157510,with,0,0
157511,rFVIII-FS,0,0
157512,leads,0,0
157513,to,0,0
157514,a,0,0
157515,significant,0,0
157516,reduction,0,1
157517,in,0,0
157518,bleeding,0,1
157519,as,0,0
157520,compared,0,0
157521,with,0,0
157522,on-demand,0,0
157523,treatment,0,0
157524,.,0,0
157525,Adverse,0,1
157526,events,0,1
157527,were,0,0
157528,consistent,0,0
157529,with,0,0
157530,the,0,0
157531,established,0,0
157532,rFVIII-FS,0,0
157533,safety,0,1
157534,profile,0,1
157535,.,0,0
157536,A,0,0
157537,randomized,0,0
157538,cross-over,0,0
157539,study,0,0
157540,of,0,0
157541,inhalation,0,0
157542,of,0,0
157543,diesel,0,0
157544,exhaust,0,0
157545,",",0,0
157546,hematological,0,1
157547,indices,0,1
157548,",",0,0
157549,and,0,1
157550,endothelial,0,1
157551,markers,0,1
157552,in,0,0
157553,humans,0,0
157554,.,0,0
157555,BACKGROUND,0,0
157556,Exposure,0,0
157557,to,0,0
157558,traffic-related,0,0
157559,air,0,1
157560,pollution,0,1
157561,(,0,0
157562,TRAP,0,0
157563,),0,0
157564,is,0,0
157565,considered,0,0
157566,a,0,0
157567,trigger,0,0
157568,for,0,0
157569,acute,0,0
157570,cardiovascular,0,1
157571,events,0,1
157572,.,0,0
157573,Diesel,0,0
157574,Exhaust,0,0
157575,(,0,0
157576,DE,0,1
157577,),0,0
157578,is,0,0
157579,a,0,0
157580,major,0,0
157581,contributor,0,0
157582,to,0,0
157583,TRAP,0,0
157584,in,0,0
157585,the,0,0
157586,world,0,0
157587,.,0,0
157588,We,0,0
157589,evaluated,0,0
157590,the,0,0
157591,effect,0,0
157592,of,0,0
157593,DE,0,1
157594,inhalation,0,0
157595,on,0,0
157596,circulating,0,1
157597,blood,0,1
157598,cell,0,1
157599,populations,0,0
157600,",",0,0
157601,hematological,0,1
157602,indices,0,1
157603,",",0,0
157604,and,0,1
157605,systemic,0,1
157606,inflammatory,0,1
157607,cytokines,0,1
157608,in,0,0
157609,humans,0,0
157610,using,0,0
157611,a,0,0
157612,specialized,0,0
157613,facility,0,0
157614,.,0,0
157615,METHODS,0,0
157616,In,0,0
157617,a,0,0
157618,randomized,0,0
157619,double-blind,0,0
157620,crossover,0,0
157621,study,0,0
157622,balanced,0,0
157623,to,0,0
157624,order,0,0
157625,",",0,0
157626,17,0,0
157627,metabolic,0,0
157628,syndrome,0,0
157629,(,0,0
157630,MetS,0,1
157631,),0,0
157632,and,0,0
157633,15,0,0
157634,healthy,0,0
157635,subjects,0,0
157636,inhaled,0,0
157637,filtered,0,0
157638,air,0,0
157639,(,0,0
157640,FA,0,0
157641,),0,0
157642,or,0,0
157643,DE,0,1
157644,exposure,0,1
157645,in,0,0
157646,two-hour,0,0
157647,sessions,0,0
157648,on,0,0
157649,different,0,0
157650,days,0,0
157651,with,0,0
157652,a,0,0
157653,minimum,0,1
157654,2-week,0,0
157655,washout,0,0
157656,period,0,0
157657,.,0,0
157658,We,0,0
157659,collected,0,0
157660,blood,0,1
157661,pre-exposure,0,0
157662,",",0,0
157663,7,0,0
157664,",",0,0
157665,and,0,0
157666,22,0,0
157667,hours,0,0
157668,after,0,0
157669,exposure,0,0
157670,initiation,0,1
157671,and,0,0
157672,measured,0,0
157673,the,0,0
157674,complete,0,1
157675,blood,1,1
157676,count,1,1
157677,and,1,0
157678,differential,1,0
157679,.,1,0
157680,We,0,0
157681,performed,0,0
157682,multiplex,0,0
157683,cytokine,0,1
157684,assay,0,0
157685,to,0,0
157686,measure,0,0
157687,the,0,0
157688,changes,0,0
157689,in,0,0
157690,the,0,0
157691,systemic,0,0
157692,inflammatory,0,1
157693,cytokines,0,1
157694,",",0,0
157695,and,0,1
157696,endothelial,0,1
157697,adhesion,0,1
157698,molecules,0,0
157699,(,0,0
157700,n=15,0,0
157701,),0,0
157702,.,0,0
157703,A,0,0
157704,paired,0,0
157705,analysis,0,0
157706,compared,0,0
157707,the,0,0
157708,effect,0,0
157709,of,0,0
157710,DE,0,1
157711,and,0,0
157712,FA,0,0
157713,exposures,0,0
157714,for,0,0
157715,the,0,0
157716,change,0,0
157717,from,0,0
157718,pre-exposure,0,0
157719,to,0,0
157720,the,0,0
157721,subsequent,0,0
157722,time,0,1
157723,points,0,0
157724,.,0,0
157725,RESULTS,0,0
157726,A,0,0
157727,significant,0,0
157728,increase,1,0
157729,in,1,0
157730,the,1,0
157731,hematocrit,1,1
157732,was,0,0
157733,noted,0,0
157734,7,0,0
157735,hrs,0,0
157736,after,0,0
157737,DE,0,1
157738,[,0,0
157739,1.4,0,0
157740,%,0,0
157741,(,0,0
157742,95,0,0
157743,%,0,0
157744,CI,0,0
157745,:,0,0
157746,0.9,0,0
157747,to,0,0
157748,1.9,0,0
157749,%,0,0
157750,),0,0
157751,],0,0
157752,compared,0,0
157753,to,0,0
157754,FA,0,0
157755,exposure,0,0
157756,[,0,0
157757,0.5,0,0
157758,%,0,0
157759,(,0,0
157760,95,0,0
157761,%,0,0
157762,CI,0,0
157763,:,0,0
157764,-0.09,0,0
157765,to,0,0
157766,1.0,0,0
157767,%,0,0
157768,),0,0
157769,;,0,0
157770,p=0.008,0,0
157771,.,0,0
157772,The,0,0
157773,hemoglobin,1,1
157774,levels,1,1
157775,increased,1,0
157776,non-significantly,0,0
157777,at,0,0
157778,7,0,0
157779,hrs,0,0
157780,post,0,0
157781,DE,0,1
157782,[,0,0
157783,0.3,0,0
157784,gm/dL,0,0
157785,(,0,0
157786,95,0,0
157787,%,0,0
157788,CI,0,0
157789,:,0,0
157790,0.2,0,0
157791,to,0,0
157792,0.5,0,0
157793,gm/dL,0,0
157794,),0,0
157795,],0,0
157796,versus,0,0
157797,FA,0,0
157798,exposure,0,0
157799,[,0,0
157800,0.2,0,0
157801,gm/dL,0,0
157802,(,0,0
157803,95,0,0
157804,%,0,0
157805,CI,0,0
157806,:,0,0
157807,0,0,0
157808,to,0,0
157809,0.3,0,0
157810,gm/dL,0,0
157811,),0,0
157812,],0,0
157813,;,0,0
157814,p=0.06,0,0
157815,.,0,0
157816,Furthermore,0,0
157817,",",0,0
157818,the,0,0
157819,platelet,1,1
157820,count,1,1
157821,increased,1,0
157822,22,0,0
157823,hrs,0,0
157824,after,0,0
157825,DE,0,1
157826,exposure,0,0
157827,in,0,0
157828,healthy,0,0
157829,",",0,0
157830,but,0,0
157831,not,0,0
157832,in,0,0
157833,MetS,0,0
157834,subjects,0,0
157835,[,0,0
157836,DE,0,1
157837,:,0,0
157838,16.6,0,0
157839,(,0,0
157840,95,0,0
157841,%,0,0
157842,CI,0,0
157843,:,0,0
157844,10.2,0,0
157845,to,0,0
157846,23,0,0
157847,),0,0
157848,thousand,0,0
157849,platelets/mL,0,0
157850,versus,0,0
157851,[,0,0
157852,FA,0,0
157853,:,0,0
157854,3.4,0,0
157855,(,0,0
157856,95,0,0
157857,%,0,0
157858,CI,0,0
157859,:,0,0
157860,-9.5,0,0
157861,to,0,0
157862,16.3,0,0
157863,),0,0
157864,thousand,0,0
157865,platelets/mL,0,0
157866,),0,0
157867,],0,0
157868,;,0,0
157869,p=0.04,0,0
157870,.,0,0
157871,No,0,0
157872,DE,1,1
157873,effect,1,0
157874,was,0,0
157875,observed,0,0
157876,for,0,0
157877,WBC,1,0
157878,",",1,0
157879,neutrophils,1,1
157880,",",1,0
157881,lymphocytes,1,1
157882,or,0,0
157883,erythrocytes,1,1
157884,.,1,0
157885,Using,0,0
157886,the,0,0
157887,multiplex,0,0
157888,assay,0,0
157889,",",0,0
157890,small,0,1
157891,borderline,0,1
157892,significant,0,0
157893,increases,1,1
157894,in,1,0
157895,matrix,1,0
157896,metalloproteinase-9,1,1
157897,",",1,0
157898,interleukins,1,1
157899,(,1,0
157900,IL,1,0
157901,),1,0
157902,-1,1,0
157903,beta,1,0
157904,",",1,0
157905,6,1,0
157906,and,1,0
157907,10,1,0
157908,occurred,0,0
157909,7,0,0
157910,hrs,0,0
157911,post,0,0
157912,exposure,0,1
157913,initiation,0,0
157914,",",0,0
157915,whereas,0,0
157916,E-selectin,1,1
157917,",",1,0
157918,intercellular,1,1
157919,adhesion,1,1
157920,molecule-1,1,1
157921,",",0,0
157922,and,0,1
157923,vascular,1,1
157924,cell,1,1
157925,adhesion,1,1
157926,molecule,1,0
157927,-1,1,0
157928,",",0,0
157929,and,0,0
157930,myeloperoxidase,1,1
157931,22,1,0
157932,hrs,0,0
157933,post,0,0
157934,exposure,0,0
157935,.,0,0
157936,CONCLUSIONS,0,0
157937,Our,0,0
157938,results,0,0
157939,suggest,0,0
157940,that,0,0
157941,short-term,0,0
157942,DE,0,1
157943,exposure,0,0
157944,results,0,0
157945,in,0,0
157946,hemoconcentration,1,1
157947,and,1,1
157948,thrombocytosis,1,1
157949,",",0,0
157950,which,0,0
157951,are,0,0
157952,important,0,0
157953,determinants,0,0
157954,of,0,0
157955,acute,0,0
157956,cardiovascular,0,1
157957,events,0,1
157958,.,0,0
157959,Multiplex,0,0
157960,assay,0,0
157961,showed,0,0
157962,a,0,0
157963,non-significant,0,0
157964,increase,0,0
157965,in,0,0
157966,IL-1?,0,0
157967,and,0,0
157968,IL-6,0,0
157969,immediately,0,0
157970,post,0,0
157971,exposure,0,0
157972,followed,0,0
157973,by,0,0
157974,myeloperoxidase,0,1
157975,and,0,0
157976,endothelial,0,1
157977,activation,0,1
157978,molecules,0,0
157979,.,0,0
157980,Further,0,0
157981,specific,0,0
157982,assays,0,0
157983,in,0,0
157984,a,0,0
157985,larger,0,0
157986,population,0,0
157987,will,0,0
157988,improve,0,0
157989,our,0,0
157990,understanding,0,0
157991,of,0,0
157992,the,0,0
157993,systemic,0,0
157994,inflammatory,0,1
157995,mechanisms,0,0
157996,following,0,0
157997,acute,0,0
157998,exposure,0,0
157999,to,0,0
158000,TRAP,0,0
158001,.,0,0
158002,Effect,0,0
158003,of,0,1
158004,beta-alanine,0,0
158005,",",0,0
158006,with,0,0
158007,and,0,0
158008,without,0,0
158009,sodium,0,1
158010,bicarbonate,0,0
158011,",",0,0
158012,on,0,0
158013,2000-m,1,1
158014,rowing,1,0
158015,performance,1,1
158016,.,1,0
158017,PURPOSE,0,0
158018,To,0,0
158019,examine,0,0
158020,the,0,0
158021,effect,0,0
158022,of,0,0
158023,beta-alanine,0,0
158024,only,0,0
158025,and,0,0
158026,beta-alanine,0,0
158027,with,0,0
158028,sodium,0,0
158029,bicarbonate,0,0
158030,supplementation,0,0
158031,on,0,0
158032,"2,000-m",1,0
158033,rowing,1,0
158034,performance,1,1
158035,.,1,0
158036,METHODS,0,0
158037,Twenty,0,0
158038,well-trained,0,0
158039,rowers,0,0
158040,(,0,0
158041,age,0,0
158042,23,0,0
158043,?,0,0
158044,4,0,0
158045,y,0,0
158046,;,0,0
158047,height,0,0
158048,1.85,0,0
158049,?,0,0
158050,0.08,0,0
158051,m,0,0
158052,;,0,0
158053,body,0,1
158054,mass,0,0
158055,82.5,0,0
158056,?,0,0
158057,8.9,0,0
158058,kg,0,0
158059,),0,0
158060,were,0,0
158061,assigned,0,0
158062,to,0,0
158063,either,0,0
158064,a,0,0
158065,placebo,0,0
158066,or,0,0
158067,beta-alanine,0,0
158068,(,0,0
158069,6.4,0,0
158070,g,0,0
158071,?,0,0
158072,d,0,0
158073,(,0,0
158074,-1,0,0
158075,),0,0
158076,for,0,0
158077,4,0,0
158078,weeks,0,0
158079,),0,0
158080,group,1,0
158081,.,1,0
158082,A,1,0
158083,"2,000-m",1,0
158084,rowing,1,0
158085,time,1,1
158086,trial,1,0
158087,(,1,0
158088,TT,1,0
158089,),1,0
158090,was,1,0
158091,performed,0,0
158092,before,0,0
158093,supplementation,0,0
158094,(,0,0
158095,Baseline,0,0
158096,),0,0
158097,and,0,0
158098,after,0,0
158099,28,0,0
158100,and,0,0
158101,30,0,0
158102,days,0,0
158103,of,0,0
158104,supplementation,0,0
158105,.,0,0
158106,The,0,0
158107,post,0,0
158108,supplementation,0,0
158109,trials,0,0
158110,involved,0,0
158111,supplementation,0,0
158112,with,0,0
158113,either,0,0
158114,maltodextrin,0,0
158115,or,0,0
158116,sodium,0,1
158117,bicarbonate,0,0
158118,in,0,0
158119,a,0,0
158120,double-blind,0,0
158121,",",0,0
158122,crossover,0,0
158123,design,0,0
158124,",",0,0
158125,creating,0,0
158126,four,0,0
158127,study,0,0
158128,conditions,0,0
158129,(,0,0
158130,placebo,0,0
158131,with,0,0
158132,maltodextrin,0,0
158133,;,0,0
158134,placebo,0,0
158135,with,0,0
158136,sodium,0,0
158137,bicarbonate,0,0
158138,;,0,0
158139,beta-alanine,0,0
158140,with,0,0
158141,maltodextrin,0,0
158142,;,0,0
158143,beta-alanine,0,0
158144,with,0,0
158145,sodium,0,0
158146,bicarbonate,1,0
158147,),1,0
158148,.,1,0
158149,Blood,1,1
158150,lactate,1,1
158151,",",1,1
158152,pH,1,1
158153,",",1,1
158154,bicarbonate,1,1
158155,",",1,1
158156,and,1,1
158157,base,1,1
158158,excess,1,1
158159,were,1,0
158160,measured,0,0
158161,pre-TT,0,0
158162,",",0,0
158163,immediately,0,0
158164,post-TT,0,0
158165,and,0,0
158166,at,0,0
158167,TT+5,0,0
158168,min,0,0
158169,.,0,0
158170,Performance,1,1
158171,data,1,0
158172,were,1,0
158173,analyzed,0,0
158174,using,1,0
158175,magnitude,1,1
158176,based,1,0
158177,inferences,1,0
158178,.,1,0
158179,RESULTS,1,0
158180,Beta-alanine,0,0
158181,supplementation,0,0
158182,was,0,0
158183,very,0,0
158184,likely,0,0
158185,to,0,0
158186,be,0,0
158187,beneficial,1,0
158188,to,1,0
158189,"2,000-m",1,0
158190,rowing,1,0
158191,performance,1,1
158192,(,1,0
158193,6.4,1,0
158194,?,0,0
158195,8.1,0,0
158196,s,0,0
158197,effect,0,0
158198,compared,0,0
158199,with,0,0
158200,placebo,0,0
158201,),0,0
158202,",",0,0
158203,with,0,0
158204,the,0,0
158205,effect,0,0
158206,of,0,0
158207,sodium,0,0
158208,bicarbonate,0,0
158209,having,0,0
158210,a,0,0
158211,likely,0,0
158212,benefit,0,0
158213,(,0,0
158214,3.2,0,0
158215,?,0,0
158216,8.8,0,0
158217,s,0,0
158218,),0,0
158219,.,0,0
158220,There,0,0
158221,was,0,0
158222,a,0,0
158223,small,0,0
158224,(,0,0
158225,1.1,0,0
158226,?,0,0
158227,5.6,0,0
158228,s,0,0
158229,),0,0
158230,but,0,0
158231,possibly,0,0
158232,beneficial,1,0
158233,additional,1,0
158234,effect,1,0
158235,when,0,0
158236,combining,0,0
158237,chronic,0,0
158238,beta-alanine,0,0
158239,supplementation,0,0
158240,with,0,0
158241,acute,0,0
158242,sodium,0,0
158243,bicarbonate,0,0
158244,supplementation,0,0
158245,compared,0,0
158246,with,0,0
158247,chronic,0,0
158248,beta-alanine,0,0
158249,supplementation,0,0
158250,alone,0,0
158251,.,0,0
158252,Sodium,0,0
158253,bicarbonate,0,0
158254,ingestion,0,0
158255,led,0,0
158256,to,0,0
158257,increases,1,1
158258,in,1,0
158259,plasma,1,1
158260,pH,1,1
158261,",",1,1
158262,base,1,1
158263,excess,1,1
158264,",",1,1
158265,bicarbonate,1,1
158266,",",1,1
158267,and,1,1
158268,lactate,1,1
158269,concentrations,1,1
158270,.,1,0
158271,CONCLUSIONS,1,0
158272,Both,0,0
158273,chronic,0,0
158274,beta-alanine,0,0
158275,and,0,0
158276,acute,0,1
158277,sodium,0,0
158278,bicarbonate,0,0
158279,supplementation,0,0
158280,alone,0,0
158281,had,0,0
158282,positive,0,0
158283,effects,0,1
158284,on,1,0
158285,"2,000-m",1,0
158286,rowing,1,0
158287,performance,1,1
158288,.,1,0
158289,The,1,0
158290,addition,1,0
158291,of,0,0
158292,acute,0,0
158293,sodium,0,0
158294,bicarbonate,0,0
158295,to,0,0
158296,chronic,0,0
158297,beta-alanine,0,0
158298,supplementation,0,0
158299,may,0,0
158300,further,0,0
158301,enhance,0,0
158302,rowing,1,0
158303,performance,1,1
158304,.,1,0
158305,Effect,0,0
158306,of,0,0
158307,duloxetine,0,0
158308,on,0,0
158309,pain,1,1
158310,",",1,0
158311,function,1,1
158312,",",1,1
158313,and,1,1
158314,quality,1,1
158315,of,1,1
158316,life,1,1
158317,among,0,0
158318,patients,0,0
158319,with,0,0
158320,chemotherapy-induced,0,0
158321,painful,0,0
158322,peripheral,0,1
158323,neuropathy,0,0
158324,:,0,0
158325,a,0,0
158326,randomized,0,0
158327,clinical,0,0
158328,trial,0,0
158329,.,0,0
158330,IMPORTANCE,0,0
158331,There,0,0
158332,are,0,0
158333,no,0,0
158334,known,0,0
158335,effective,0,0
158336,treatments,0,0
158337,for,0,0
158338,painful,0,0
158339,chemotherapy-induced,0,0
158340,peripheral,0,1
158341,neuropathy,0,0
158342,.,0,0
158343,OBJECTIVE,0,0
158344,To,0,0
158345,determine,0,0
158346,the,0,0
158347,effect,0,0
158348,of,0,0
158349,duloxetine,0,0
158350,",",0,0
158351,60,0,0
158352,mg,0,0
158353,daily,0,0
158354,",",0,0
158355,on,0,0
158356,average,1,1
158357,pain,1,1
158358,severity,1,1
158359,.,1,0
158360,DESIGN,0,0
158361,",",0,0
158362,SETTING,0,0
158363,",",0,0
158364,AND,0,0
158365,PATIENTS,0,1
158366,Randomized,0,0
158367,",",0,0
158368,double-blind,0,0
158369,",",0,1
158370,placebo-controlled,0,0
158371,crossover,0,0
158372,trial,0,0
158373,at,0,0
158374,8,0,0
158375,National,0,0
158376,Cancer,0,0
158377,Institute,0,0
158378,(,0,0
158379,NCI,0,1
158380,),0,0
158381,-funded,0,0
158382,cooperative,0,0
158383,research,0,0
158384,networks,0,0
158385,that,0,0
158386,enrolled,0,0
158387,231,0,0
158388,patients,0,0
158389,who,0,0
158390,were,0,0
158391,25,0,0
158392,years,0,0
158393,or,0,0
158394,older,0,0
158395,being,0,0
158396,treated,0,0
158397,at,0,0
158398,community,0,0
158399,and,0,0
158400,academic,0,1
158401,settings,0,0
158402,between,0,0
158403,April,0,0
158404,2008,0,0
158405,and,0,0
158406,March,0,0
158407,2011,0,0
158408,.,0,0
158409,Study,0,0
158410,follow-up,0,0
158411,was,0,0
158412,completed,0,0
158413,July,0,0
158414,2012,0,0
158415,.,0,0
158416,Stratified,0,0
158417,by,0,0
158418,chemotherapeutic,0,0
158419,drug,0,0
158420,and,0,1
158421,comorbid,0,0
158422,pain,0,1
158423,risk,0,1
158424,",",0,0
158425,patients,0,0
158426,were,0,0
158427,randomized,0,0
158428,to,0,0
158429,receive,0,0
158430,either,0,0
158431,duloxetine,0,0
158432,followed,0,0
158433,by,0,0
158434,placebo,0,0
158435,or,0,0
158436,placebo,0,0
158437,followed,0,0
158438,by,0,0
158439,duloxetine,0,0
158440,.,0,0
158441,Eligibility,0,1
158442,required,0,0
158443,that,0,0
158444,patients,0,0
158445,have,0,0
158446,grade,0,0
158447,1,0,0
158448,or,0,0
158449,higher,0,0
158450,sensory,0,1
158451,neuropathy,0,1
158452,according,0,0
158453,to,0,0
158454,the,0,0
158455,NCI,0,0
158456,Common,0,0
158457,Terminology,0,0
158458,Criteria,0,0
158459,for,0,0
158460,Adverse,0,1
158461,Events,0,0
158462,and,0,0
158463,at,0,0
158464,least,0,0
158465,4,0,0
158466,on,0,0
158467,a,0,0
158468,scale,0,1
158469,of,0,0
158470,0,0,0
158471,to,0,0
158472,10,0,0
158473,",",0,0
158474,representing,0,0
158475,average,0,1
158476,chemotherapy-induced,0,0
158477,pain,0,1
158478,",",0,0
158479,after,0,0
158480,paclitaxel,0,0
158481,",",0,0
158482,other,0,0
158483,taxane,0,0
158484,",",0,0
158485,or,0,1
158486,oxaliplatin,0,0
158487,treatment,0,0
158488,.,0,0
158489,INTERVENTIONS,0,0
158490,The,0,0
158491,initial,0,0
158492,treatment,0,0
158493,consisted,0,0
158494,of,0,0
158495,taking,0,0
158496,1,0,0
158497,capsule,0,0
158498,daily,0,0
158499,of,0,0
158500,either,0,0
158501,30,0,0
158502,mg,0,0
158503,of,0,0
158504,duloxetine,0,0
158505,or,0,0
158506,placebo,0,0
158507,for,0,0
158508,the,0,0
158509,first,0,0
158510,week,0,0
158511,and,0,0
158512,2,0,0
158513,capsules,0,0
158514,of,0,0
158515,either,0,0
158516,30,0,0
158517,mg,0,0
158518,of,0,0
158519,duloxetine,0,0
158520,or,0,0
158521,placebo,0,0
158522,daily,0,0
158523,for,0,0
158524,4,0,0
158525,additional,0,0
158526,weeks,0,0
158527,.,0,0
158528,MAIN,0,0
158529,OUTCOME,0,0
158530,MEASURES,0,0
158531,The,0,0
158532,primary,0,0
158533,hypothesis,0,0
158534,was,0,0
158535,that,0,0
158536,duloxetine,0,0
158537,would,0,0
158538,be,0,0
158539,more,0,0
158540,effective,0,1
158541,than,0,0
158542,placebo,0,0
158543,in,0,0
158544,decreasing,0,0
158545,chemotherapy-induced,1,0
158546,peripheral,1,1
158547,neuropathic,1,0
158548,pain,1,1
158549,.,1,0
158550,Pain,1,1
158551,severity,1,1
158552,was,0,0
158553,assessed,0,0
158554,using,0,0
158555,the,0,0
158556,Brief,1,0
158557,Pain,1,1
158558,Inventory-Short,1,1
158559,Form,1,0
158560,average,1,1
158561,pain,1,1
158562,item,1,1
158563,with,0,0
158564,0,0,0
158565,representing,0,0
158566,no,0,0
158567,pain,1,1
158568,and,0,0
158569,10,0,0
158570,representing,0,0
158571,as,0,0
158572,bad,0,0
158573,as,0,0
158574,can,0,0
158575,be,0,0
158576,imagined,0,0
158577,.,0,0
158578,RESULTS,0,0
158579,Individuals,0,0
158580,receiving,0,0
158581,duloxetine,0,0
158582,as,0,0
158583,their,0,0
158584,initial,0,0
158585,5-week,0,0
158586,treatment,0,0
158587,reported,0,0
158588,a,0,0
158589,mean,0,1
158590,decrease,0,0
158591,in,0,0
158592,average,1,1
158593,pain,1,1
158594,of,0,0
158595,1.06,0,0
158596,(,0,0
158597,95,0,0
158598,%,0,0
158599,CI,0,0
158600,",",0,0
158601,0.72-1.40,0,0
158602,),0,0
158603,vs,0,0
158604,0.34,0,0
158605,(,0,0
158606,95,0,0
158607,%,0,0
158608,CI,0,0
158609,",",0,0
158610,0.01-0.66,0,0
158611,),0,0
158612,among,0,0
158613,those,0,0
158614,who,0,0
158615,received,0,0
158616,placebo,0,0
158617,(,0,0
158618,P,0,0
158619,=,0,0
158620,.003,0,0
158621,;,0,0
158622,effect,0,1
158623,size,0,1
158624,",",0,0
158625,0.513,0,0
158626,),0,0
158627,.,0,0
158628,The,0,0
158629,observed,0,0
158630,mean,0,1
158631,difference,0,0
158632,in,0,0
158633,the,0,0
158634,average,1,0
158635,pain,1,1
158636,score,1,1
158637,between,0,0
158638,duloxetine,0,0
158639,and,0,1
158640,placebo,0,0
158641,was,0,0
158642,0.73,0,0
158643,(,0,0
158644,95,0,0
158645,%,0,0
158646,CI,0,0
158647,",",0,1
158648,0.26-1.20,0,0
158649,),0,0
158650,.,0,0
158651,Fifty-nine,0,0
158652,percent,0,0
158653,of,0,0
158654,those,0,0
158655,initially,0,0
158656,receiving,0,0
158657,duloxetine,0,0
158658,vs,0,0
158659,38,0,0
158660,%,0,0
158661,of,0,0
158662,those,0,0
158663,initially,0,0
158664,receiving,0,0
158665,placebo,0,0
158666,reported,0,0
158667,decreased,0,0
158668,pain,1,1
158669,of,0,0
158670,any,0,0
158671,amount,0,0
158672,.,0,0
158673,CONCLUSION,0,0
158674,AND,0,0
158675,RELEVANCE,0,1
158676,Among,0,0
158677,patients,0,0
158678,with,0,0
158679,painful,0,0
158680,chemotherapy-induced,0,0
158681,peripheral,0,1
158682,neuropathy,0,0
158683,",",0,0
158684,the,0,0
158685,use,0,0
158686,of,0,0
158687,duloxetine,0,0
158688,compared,0,0
158689,with,0,0
158690,placebo,0,0
158691,for,0,0
158692,5,0,0
158693,weeks,0,0
158694,resulted,0,0
158695,in,0,0
158696,a,0,0
158697,greater,0,0
158698,reduction,0,1
158699,in,0,0
158700,pain,1,1
158701,.,1,0
158702,TRIAL,0,0
158703,REGISTRATION,0,0
158704,clinicaltrials.gov,0,0
158705,Identifier,0,0
158706,:,0,0
158707,NCT00489411,0,0
158708,.,0,0
158709,Vilazodone,0,0
158710,lacks,0,0
158711,proarrhythmogenic,0,1
158712,potential,0,0
158713,in,0,0
158714,healthy,0,0
158715,participants,0,0
158716,:,0,0
158717,a,0,0
158718,thorough,0,0
158719,ECG,0,0
158720,study,0,0
158721,.,0,0
158722,OBJECTIVE,0,0
158723,Vilazodone,0,0
158724,is,0,0
158725,a,0,0
158726,potent,0,0
158727,serotonin,0,0
158728,reuptake,0,0
158729,inhibitor,0,0
158730,and,0,1
158731,5-HT1A,0,1
158732,receptor,0,1
158733,partial,0,1
158734,agonist,0,0
158735,approved,0,0
158736,for,0,0
158737,the,0,0
158738,treatment,0,0
158739,of,0,0
158740,major,0,0
158741,depressive,0,1
158742,disorder,0,0
158743,(,0,0
158744,MDD,0,0
158745,),0,0
158746,in,0,0
158747,adults,0,0
158748,.,0,0
158749,The,0,0
158750,effect,0,0
158751,of,0,0
158752,clinical,0,0
158753,and,0,0
158754,supratherapeutic,0,0
158755,doses,0,0
158756,of,0,0
158757,vilazodone,0,0
158758,on,0,0
158759,cardiac,0,1
158760,repolarization,0,1
158761,was,0,0
158762,determined,0,0
158763,in,0,0
158764,healthy,0,0
158765,volunteers,0,0
158766,.,0,0
158767,METHODS,0,0
158768,In,0,0
158769,this,0,0
158770,Phase,0,0
158771,1,0,0
158772,",",0,0
158773,randomized,0,0
158774,",",0,0
158775,doubleblind,0,0
158776,",",0,0
158777,placebo-,0,0
158778,and,0,1
158779,active-controlled,0,0
158780,",",0,0
158781,3-arm,0,0
158782,",",0,0
158783,parallel,0,0
158784,",",0,0
158785,single-center,0,0
158786,study,0,0
158787,",",0,0
158788,healthy,0,0
158789,subjects,0,0
158790,received,0,0
158791,placebo,0,0
158792,;,0,0
158793,moxifloxacin,0,0
158794,400,0,0
158795,mg,0,0
158796,;,0,0
158797,or,0,0
158798,vilazodone,0,0
158799,(,0,0
158800,sequentially,0,0
158801,escalated,0,0
158802,every,0,0
158803,3,0,0
158804,days,0,0
158805,),0,0
158806,10,0,0
158807,",",0,0
158808,20,0,0
158809,",",0,0
158810,40,0,0
158811,",",0,0
158812,60,0,0
158813,",",0,0
158814,and,0,0
158815,80,0,0
158816,mg/day,0,0
158817,.,0,0
158818,The,0,0
158819,primary,0,0
158820,endpoint,0,0
158821,was,0,0
158822,the,0,0
158823,time-matched,0,0
158824,change,0,0
158825,from,0,0
158826,baseline,0,0
158827,in,0,0
158828,the,0,0
158829,QT,1,1
158830,interval,1,0
158831,corrected,1,0
158832,for,1,0
158833,heart,1,1
158834,rate,1,1
158835,(,1,0
158836,QTc,1,1
158837,),1,0
158838,using,0,0
158839,an,0,0
158840,individual,0,0
158841,correction,0,0
158842,method,0,0
158843,(,0,0
158844,QTcI,0,0
158845,),0,0
158846,.,0,0
158847,RESULTS,0,0
158848,Placebo-corrected,0,0
158849,time-matched,0,0
158850,analysis,0,0
158851,of,0,0
158852,the,0,0
158853,QTcI,1,0
158854,duration,1,1
158855,for,0,0
158856,the,0,0
158857,vilazodone,0,0
158858,treatment,0,0
158859,effect,0,1
158860,indicated,0,0
158861,that,0,0
158862,no,0,0
158863,vilazodone,0,0
158864,dose,0,0
158865,had,0,0
158866,an,0,0
158867,upper,0,0
158868,bound,0,0
158869,that,0,0
158870,approached,0,0
158871,or,0,0
158872,exceeded,0,0
158873,10,0,0
158874,ms,0,0
158875,",",0,0
158876,demonstrating,0,0
158877,no,0,0
158878,signal,0,0
158879,for,0,0
158880,a,0,0
158881,significant,0,0
158882,vilazodone,0,0
158883,effect,0,0
158884,on,0,0
158885,cardiac,1,1
158886,repolarization,1,0
158887,.,1,0
158888,Vilazodone,0,0
158889,had,0,0
158890,no,0,0
158891,significant,0,0
158892,effect,0,0
158893,on,0,0
158894,heart,1,1
158895,rate,1,1
158896,",",1,1
158897,PR,1,1
158898,",",1,1
158899,or,1,0
158900,QRS,1,1
158901,interval,1,0
158902,duration,1,1
158903,.,1,0
158904,The,0,0
158905,pharmacokinetic/pharmacodynamic,0,0
158906,model,0,0
158907,showed,0,0
158908,that,0,0
158909,the,0,0
158910,QTcI,1,0
158911,slope,0,1
158912,for,0,0
158913,vilazodone,0,0
158914,was,0,0
158915,not,0,0
158916,different,0,0
158917,from,0,0
158918,0.0,0,0
158919,and,0,0
158920,that,0,0
158921,the,0,0
158922,predicted,0,0
158923,increase,0,0
158924,from,0,0
158925,baseline,0,0
158926,in,0,0
158927,the,0,0
158928,QTc,1,1
158929,at,1,0
158930,Cmax,1,1
158931,for,0,0
158932,the,0,0
158933,highest,0,0
158934,therapeutic,0,0
158935,dose,0,0
158936,(,0,0
158937,156,0,0
158938,ng/ml,0,0
158939,after,0,0
158940,40,0,0
158941,mg/day,0,0
158942,),0,0
158943,was,0,0
158944,<,0,0
158945,1,0,0
158946,ms,0,0
158947,.,0,0
158948,The,0,0
158949,incidence,0,1
158950,of,0,0
158951,adverse,1,1
158952,events,1,1
158953,(,1,0
158954,AEs,1,1
158955,),1,0
158956,was,0,0
158957,higher,0,0
158958,in,0,0
158959,the,0,0
158960,vilazodone,0,0
158961,group,0,0
158962,(,0,0
158963,57.6,0,0
158964,%,0,0
158965,),0,0
158966,than,0,0
158967,in,0,0
158968,the,0,0
158969,moxifloxacin,0,0
158970,(,0,0
158971,37.0,0,0
158972,%,0,0
158973,),0,0
158974,and,0,1
158975,placebo,0,0
158976,(,0,0
158977,35.6,0,0
158978,%,0,0
158979,),0,0
158980,groups,0,0
158981,",",0,0
158982,though,0,0
158983,AEs,1,1
158984,were,0,0
158985,generally,0,0
158986,mild,0,0
158987,to,0,0
158988,moderate,0,0
158989,in,0,0
158990,severity,0,1
158991,and,0,0
158992,resulted,0,0
158993,in,0,0
158994,few,0,0
158995,discontinuations,0,0
158996,.,0,0
158997,CONCLUSIONS,0,0
158998,Vilazodone,0,0
158999,had,0,0
159000,no,0,0
159001,significant,0,0
159002,effect,0,0
159003,on,0,0
159004,cardiac,1,1
159005,repolarization,1,1
159006,",",1,0
159007,heart,1,1
159008,rate,1,1
159009,",",1,1
159010,PR,1,1
159011,or,1,0
159012,QRS,1,1
159013,interval,1,0
159014,duration,1,1
159015,",",1,0
159016,or,1,1
159017,ECG,1,1
159018,morphology,1,1
159019,in,0,0
159020,healthy,0,0
159021,adult,0,0
159022,participants,0,0
159023,.,0,0
159024,Are,0,0
159025,postural,1,0
159026,responses,1,1
159027,to,0,0
159028,backward,0,0
159029,and,0,0
159030,forward,0,0
159031,perturbations,0,0
159032,processed,0,0
159033,by,0,0
159034,different,0,0
159035,neural,0,0
159036,circuits,0,0
159037,?,0,0
159038,Startle,0,0
159039,pathways,0,0
159040,may,0,0
159041,contribute,0,0
159042,to,0,0
159043,rapid,0,0
159044,accomplishment,0,0
159045,of,0,0
159046,postural,0,0
159047,stability,0,1
159048,.,0,0
159049,Here,0,0
159050,we,0,0
159051,investigate,0,0
159052,the,0,0
159053,possible,0,0
159054,influence,0,0
159055,of,0,0
159056,a,0,0
159057,startling,0,0
159058,auditory,0,1
159059,stimulus,0,1
159060,(,0,0
159061,SAS,0,0
159062,),0,0
159063,on,0,0
159064,postural,1,0
159065,responses,1,0
159066,.,1,0
159067,We,0,0
159068,formulated,0,0
159069,four,0,0
159070,specific,0,0
159071,questions,0,0
159072,:,0,0
159073,(,0,0
159074,1,0,0
159075,),0,0
159076,can,0,0
159077,a,0,0
159078,concurrent,0,0
159079,SAS,0,0
159080,shorten,0,0
159081,the,0,0
159082,onset,0,1
159083,of,0,0
159084,automatic,0,0
159085,postural,0,0
159086,responses,0,0
159087,?,0,0
159088,;,0,0
159089,and,0,0
159090,if,0,0
159091,so,0,0
159092,(,0,0
159093,2,0,0
159094,),0,0
159095,is,0,0
159096,this,0,0
159097,effect,0,0
159098,different,0,0
159099,for,0,0
159100,forward,0,0
159101,versus,0,0
159102,backward,0,1
159103,perturbations,0,0
159104,?,0,0
159105,;,0,0
159106,(,0,0
159107,3,0,0
159108,),0,0
159109,does,0,0
159110,this,0,0
159111,effect,0,0
159112,depend,0,0
159113,on,0,0
159114,prior,0,0
159115,knowledge,0,0
159116,of,0,0
159117,the,0,0
159118,perturbation,0,0
159119,direction,0,0
159120,?,0,0
159121,;,0,0
159122,and,0,0
159123,(,0,0
159124,4,0,0
159125,),0,0
159126,is,0,0
159127,this,0,0
159128,effect,0,0
159129,different,0,0
159130,for,0,0
159131,low-,0,0
159132,and,0,0
159133,high-magnitude,0,0
159134,perturbations,0,0
159135,?,0,0
159136,Balance,0,1
159137,was,0,0
159138,perturbed,0,0
159139,in,0,0
159140,11,0,0
159141,healthy,0,0
159142,participants,0,0
159143,by,0,0
159144,a,0,0
159145,movable,0,0
159146,platform,0,0
159147,that,0,0
159148,suddenly,0,0
159149,translated,0,0
159150,forward,0,0
159151,or,0,0
159152,backward,0,0
159153,.,0,0
159154,Each,0,0
159155,participant,0,0
159156,received,0,0
159157,160,0,0
159158,perturbations,0,0
159159,",",0,0
159160,25,0,0
159161,%,0,0
159162,of,0,0
159163,which,0,0
159164,were,0,0
159165,combined,0,0
159166,with,0,0
159167,a,0,0
159168,SAS,0,0
159169,.,0,0
159170,We,0,0
159171,varied,0,0
159172,the,0,0
159173,direction,0,1
159174,and,0,0
159175,magnitude,0,1
159176,of,0,0
159177,the,0,0
159178,perturbations,0,0
159179,",",0,0
159180,as,0,0
159181,well,0,0
159182,as,0,0
159183,the,0,0
159184,prior,0,0
159185,knowledge,0,0
159186,of,0,0
159187,perturbation,0,0
159188,direction,0,1
159189,.,0,0
159190,Perturbation,0,0
159191,trials,0,0
159192,were,0,0
159193,interspersed,0,0
159194,with,0,0
159195,SAS-only,0,0
159196,trials,0,0
159197,.,0,0
159198,The,0,0
159199,SAS,0,0
159200,accelerated,0,0
159201,and,0,0
159202,strengthened,0,0
159203,postural,1,1
159204,responses,1,1
159205,with,0,0
159206,clear,0,0
159207,functional,0,0
159208,benefits,0,0
159209,(,0,0
159210,better,0,0
159211,balance,0,1
159212,control,0,0
159213,),0,1
159214,",",0,0
159215,but,0,0
159216,this,0,0
159217,was,0,0
159218,only,0,0
159219,true,0,0
159220,for,0,0
159221,responses,0,1
159222,that,0,0
159223,protected,0,0
159224,against,0,0
159225,falling,0,1
159226,backwards,0,1
159227,(,0,0
159228,i.e,0,0
159229,.,0,0
159230,in,0,0
159231,tibialis,0,0
159232,anterior,0,1
159233,and,0,0
159234,rectus,0,1
159235,femoris,0,1
159236,),0,0
159237,.,0,0
159238,These,0,0
159239,muscles,0,0
159240,also,0,0
159241,demonstrated,0,0
159242,the,0,0
159243,most,0,0
159244,common,0,0
159245,SAS-triggered,1,0
159246,responses,1,1
159247,without,0,0
159248,perturbation,0,0
159249,.,0,0
159250,Increasing,0,0
159251,the,0,0
159252,perturbation,0,0
159253,magnitude,0,1
159254,accelerated,0,1
159255,postural,1,1
159256,responses,1,1
159257,",",0,0
159258,but,0,0
159259,again,0,0
159260,with,0,0
159261,a,0,0
159262,larger,0,0
159263,acceleration,0,1
159264,for,0,0
159265,backward,0,1
159266,perturbations,0,0
159267,.,0,0
159268,We,0,0
159269,conclude,0,0
159270,that,0,0
159271,postural,0,0
159272,responses,0,1
159273,to,0,0
159274,backward,0,0
159275,and,0,0
159276,forward,0,0
159277,perturbations,0,0
159278,may,0,0
159279,be,0,0
159280,processed,0,0
159281,by,0,0
159282,different,0,0
159283,neural,0,0
159284,circuits,0,1
159285,",",0,0
159286,with,0,0
159287,influence,0,0
159288,of,0,0
159289,startle,0,1
159290,pathways,0,0
159291,on,0,0
159292,postural,0,0
159293,responses,0,1
159294,to,0,0
159295,backward,0,0
159296,perturbations,0,0
159297,.,0,0
159298,These,0,0
159299,findings,0,0
159300,give,0,0
159301,directions,0,0
159302,for,0,0
159303,future,0,0
159304,studies,0,0
159305,investigating,0,0
159306,whether,0,0
159307,deficits,0,0
159308,in,0,0
159309,startle,0,0
159310,pathways,0,0
159311,may,0,0
159312,explain,0,0
159313,the,0,0
159314,prominent,0,0
159315,backward,0,1
159316,instability,0,1
159317,seen,0,0
159318,in,0,0
159319,patients,0,0
159320,with,0,0
159321,Parkinson,0,0
159322,'s,0,1
159323,disease,0,1
159324,and,0,0
159325,progressive,0,1
159326,supranuclear,0,0
159327,palsy,0,0
159328,.,0,0
159329,The,0,0
159330,use,0,0
159331,of,0,0
159332,transvaginal,0,0
159333,synthetic,0,0
159334,mesh,0,0
159335,for,0,0
159336,anterior,0,1
159337,vaginal,0,0
159338,wall,0,1
159339,prolapse,0,1
159340,repair,0,0
159341,:,0,0
159342,a,0,0
159343,randomized,0,0
159344,controlled,0,0
159345,trial,0,0
159346,.,0,0
159347,INTRODUCTION,0,1
159348,AND,0,0
159349,HYPOTHESIS,0,0
159350,The,0,0
159351,aim,0,0
159352,of,0,0
159353,the,0,0
159354,study,0,0
159355,was,0,0
159356,to,0,0
159357,compare,0,0
159358,the,0,0
159359,efficacy,1,1
159360,and,1,0
159361,safety,1,1
159362,of,0,1
159363,transvaginal,0,0
159364,trocar-guided,0,0
159365,polypropylene,0,0
159366,mesh,0,1
159367,insertion,0,0
159368,with,0,0
159369,traditional,0,0
159370,colporrhaphy,0,0
159371,for,0,0
159372,treatment,0,0
159373,of,0,0
159374,anterior,0,1
159375,vaginal,0,0
159376,wall,0,0
159377,prolapse,0,1
159378,.,0,0
159379,METHODS,0,0
159380,This,0,0
159381,is,0,0
159382,a,0,0
159383,randomized,0,0
159384,controlled,0,0
159385,trial,0,0
159386,in,0,0
159387,which,0,0
159388,women,0,0
159389,with,0,0
159390,advanced,0,0
159391,anterior,0,1
159392,vaginal,0,0
159393,wall,0,1
159394,prolapse,0,1
159395,",",0,0
159396,at,0,0
159397,least,0,0
159398,stage,0,0
159399,II,0,0
159400,with,0,0
159401,Ba,0,0
159402,?,0,0
159403,+1,0,0
159404,cm,0,0
159405,according,0,0
159406,to,0,0
159407,the,0,0
159408,Pelvic,0,0
159409,Organ,0,0
159410,Prolapse,0,1
159411,Quantification,0,1
159412,(,0,0
159413,POP-Q,0,0
159414,),0,1
159415,classification,0,1
159416,",",0,0
159417,were,0,0
159418,randomly,0,0
159419,assigned,0,0
159420,to,0,0
159421,have,0,0
159422,either,0,0
159423,anterior,0,0
159424,colporrhaphy,0,0
159425,(,0,0
159426,n,0,0
159427,=,0,0
159428,39,0,0
159429,),0,0
159430,or,0,0
159431,repair,0,0
159432,using,0,0
159433,trocar-guided,0,0
159434,transvaginal,0,0
159435,mesh,0,1
159436,(,0,0
159437,n,0,0
159438,=,0,0
159439,40,0,0
159440,),0,0
159441,.,0,0
159442,The,0,0
159443,primary,0,0
159444,outcome,0,1
159445,was,1,0
159446,objective,1,0
159447,cure,1,1
159448,rate,1,1
159449,of,1,0
159450,the,1,0
159451,anterior,1,0
159452,compartment,1,0
159453,(,1,0
159454,point,1,1
159455,Ba,1,0
159456,),1,0
159457,assessed,1,0
159458,at,0,0
159459,the,0,0
159460,12-month,0,0
159461,follow-up,0,0
159462,visit,0,1
159463,",",0,0
159464,with,0,0
159465,stages,0,0
159466,0,0,0
159467,and,0,0
159468,I,0,0
159469,defined,0,0
159470,as,0,0
159471,anatomical,0,0
159472,success,0,1
159473,.,0,0
159474,Secondary,0,0
159475,outcomes,0,1
159476,included,1,0
159477,quantification,1,0
159478,of,1,0
159479,other,1,0
159480,vaginal,1,0
159481,compartments,1,0
159482,(,1,0
159483,POP-Q,1,1
159484,points,1,0
159485,),1,0
159486,",",1,0
159487,comparison,1,0
159488,of,1,1
159489,quality,1,1
159490,of,1,0
159491,life,1,1
159492,by,1,0
159493,the,1,0
159494,prolapse,1,1
159495,quality,1,1
159496,of,1,1
159497,life,1,1
159498,(,1,0
159499,P-QOL,1,1
159500,),1,1
159501,questionnaire,1,1
159502,",",1,0
159503,and,1,1
159504,complication,1,1
159505,rate,1,1
159506,between,1,0
159507,the,0,0
159508,groups,0,0
159509,after,0,0
159510,1,0,0
159511,year,0,0
159512,.,0,0
159513,Study,0,0
159514,power,0,1
159515,was,0,0
159516,fixed,0,0
159517,as,0,0
159518,80,0,0
159519,%,0,0
159520,with,0,0
159521,5,0,0
159522,%,0,0
159523,cutoff,0,0
159524,point,0,1
159525,(,0,0
159526,p,0,0
159527,<,0,0
159528,0.05,0,0
159529,),0,0
159530,for,0,0
159531,statistical,0,0
159532,significance,0,0
159533,.,0,0
159534,RESULTS,0,0
159535,The,0,0
159536,groups,0,0
159537,were,0,0
159538,similar,0,0
159539,regarding,0,0
159540,demographic,0,1
159541,and,0,0
159542,clinical,0,0
159543,preoperative,0,0
159544,parameters,1,1
159545,.,1,0
159546,Anatomical,1,0
159547,success,1,1
159548,rates,1,1
159549,for,1,0
159550,colporrhaphy,1,0
159551,and,1,1
159552,repair,1,0
159553,with,1,0
159554,mesh,0,1
159555,placement,0,0
159556,groups,0,0
159557,were,0,0
159558,56.4,0,0
159559,vs,0,0
159560,82.5,0,0
159561,%,0,0
159562,(,0,0
159563,95,0,0
159564,%,0,0
159565,confidence,0,0
159566,interval,0,0
159567,0.068-0.54,0,0
159568,),0,0
159569,",",0,0
159570,respectively,0,0
159571,",",0,0
159572,and,0,0
159573,the,0,0
159574,difference,0,0
159575,between,0,0
159576,the,0,0
159577,groups,0,0
159578,was,0,0
159579,statistically,0,0
159580,significant,0,0
159581,(,0,0
159582,p,0,0
159583,=,0,0
159584,0.018,0,0
159585,),0,0
159586,.,0,0
159587,Similar,1,0
159588,total,1,1
159589,complication,1,1
159590,rates,1,1
159591,were,1,0
159592,observed,0,0
159593,in,0,0
159594,both,0,0
159595,groups,0,0
159596,",",0,0
159597,with,0,0
159598,tape,0,1
159599,exposure,0,0
159600,observed,0,0
159601,in,0,0
159602,5,0,0
159603,%,0,0
159604,of,0,0
159605,the,0,0
159606,patients,0,0
159607,.,0,0
159608,There,0,0
159609,was,0,0
159610,a,0,0
159611,significant,0,0
159612,improvement,0,0
159613,in,0,0
159614,all,1,0
159615,P-QOL,1,0
159616,domains,1,1
159617,as,1,0
159618,a,0,0
159619,result,0,0
159620,of,0,0
159621,both,0,0
159622,procedures,0,0
159623,(,0,0
159624,p,0,0
159625,<,0,0
159626,0.001,0,0
159627,),0,0
159628,",",0,0
159629,but,0,0
159630,they,0,0
159631,were,0,0
159632,not,0,0
159633,distinct,0,0
159634,between,0,0
159635,groups,0,0
159636,(,0,0
159637,p,0,0
159638,>,0,0
159639,0.05,0,0
159640,),0,0
159641,.,0,0
159642,CONCLUSIONS,0,0
159643,Trocar-guided,0,0
159644,transvaginal,0,0
159645,synthetic,0,0
159646,mesh,0,0
159647,for,0,0
159648,advanced,0,0
159649,anterior,0,1
159650,POP,0,0
159651,repair,0,0
159652,is,0,0
159653,associated,0,0
159654,with,0,0
159655,a,0,0
159656,higher,1,0
159657,anatomical,1,0
159658,success,1,1
159659,rate,1,1
159660,for,1,0
159661,the,0,0
159662,anterior,0,0
159663,compartment,0,0
159664,compared,0,0
159665,with,0,0
159666,traditional,0,0
159667,colporrhaphy,1,0
159668,.,1,0
159669,Quality,1,1
159670,of,1,0
159671,life,1,1
159672,equally,1,0
159673,improved,1,0
159674,after,0,0
159675,both,0,0
159676,techniques,0,0
159677,.,0,0
159678,However,0,0
159679,",",0,0
159680,the,0,0
159681,trial,0,0
159682,failed,0,0
159683,to,0,0
159684,detect,0,0
159685,differences,0,0
159686,in,0,0
159687,P-QOL,1,0
159688,scores,1,1
159689,and,1,1
159690,complication,1,1
159691,rates,1,1
159692,between,1,0
159693,the,0,0
159694,groups,0,0
159695,.,0,0
159696,Extra,0,0
159697,virgin,0,0
159698,olive,0,0
159699,oil,0,0
159700,(,0,0
159701,EVOO,0,0
159702,),0,1
159703,consumption,0,1
159704,and,0,0
159705,antioxidant,1,1
159706,status,1,1
159707,in,0,0
159708,healthy,0,0
159709,institutionalized,0,0
159710,elderly,0,0
159711,humans,0,0
159712,.,0,0
159713,Recent,0,0
159714,studies,0,0
159715,show,0,0
159716,that,0,0
159717,the,0,0
159718,elderly,0,0
159719,have,0,0
159720,increased,0,0
159721,oxidative,0,1
159722,stress,0,1
159723,and,0,0
159724,impaired,0,1
159725,antioxidant,0,1
159726,defense,0,1
159727,systems,0,0
159728,.,0,0
159729,Our,0,0
159730,study,0,0
159731,aims,0,0
159732,to,0,0
159733,evaluate,0,0
159734,the,0,0
159735,effects,0,0
159736,of,0,0
159737,daily,0,0
159738,consumption,0,1
159739,of,0,0
159740,EVOO,0,0
159741,in,0,0
159742,the,0,0
159743,healthy,0,0
159744,institutionalized,0,0
159745,elderly,0,0
159746,.,0,0
159747,We,0,0
159748,studied,0,0
159749,anthropometric,1,1
159750,",",1,0
159751,biochemical,1,1
159752,and,1,1
159753,antioxidant,1,1
159754,parameters,1,1
159755,in,0,0
159756,62,0,0
159757,subjects,0,0
159758,aged,0,0
159759,65-96,0,0
159760,years,0,0
159761,after,0,0
159762,a,0,0
159763,6-week,0,0
159764,daily,0,0
159765,intake,0,1
159766,of,0,0
159767,polyphenol-rich,0,0
159768,EVOO,0,0
159769,with,0,0
159770,high,0,0
159771,oleuropein,0,0
159772,derivative,0,0
159773,contents,0,0
159774,.,0,0
159775,Subjects,0,0
159776,were,0,0
159777,divided,0,0
159778,into,0,0
159779,a,0,0
159780,control,0,0
159781,group,0,0
159782,(,0,0
159783,CG,0,0
159784,),0,0
159785,who,0,0
159786,maintained,0,0
159787,their,0,0
159788,dietary,0,0
159789,habits,0,1
159790,(,0,0
159791,n=39,0,0
159792,),0,0
159793,and,0,0
159794,an,0,0
159795,olive,0,0
159796,group,0,0
159797,(,0,0
159798,OG,0,1
159799,),0,0
159800,who,0,0
159801,consumed,0,0
159802,EVOO,0,0
159803,as,0,0
159804,the,0,0
159805,only,0,0
159806,added,0,0
159807,fat,0,1
159808,",",0,0
159809,plus,0,0
159810,a,0,0
159811,daily,0,0
159812,dose,0,0
159813,of,0,0
159814,50ml,0,0
159815,(,0,0
159816,n=23,0,0
159817,),0,0
159818,.,0,0
159819,We,0,0
159820,found,0,0
159821,a,0,0
159822,significant,0,0
159823,reduction,0,1
159824,of,0,0
159825,total,1,1
159826,cholesterol,1,1
159827,(,1,0
159828,TC,1,1
159829,),1,0
159830,",",1,0
159831,HDL,1,1
159832,",",1,1
159833,LDL,1,1
159834,and,1,1
159835,TGs,1,0
159836,in,0,0
159837,OG,0,1
159838,subjects,0,0
159839,and,0,0
159840,a,0,0
159841,significant,0,0
159842,increase,0,0
159843,of,0,0
159844,HDL,0,1
159845,levels,0,1
159846,.,0,0
159847,There,0,0
159848,was,0,0
159849,no,0,0
159850,significant,0,0
159851,variation,0,0
159852,in,0,0
159853,the,0,0
159854,CG,0,0
159855,parameters,0,1
159856,.,0,0
159857,In,0,0
159858,OG,0,0
159859,the,0,0
159860,total,1,1
159861,antioxidant,1,0
159862,capacity,1,1
159863,(,1,0
159864,TAC,1,0
159865,),1,0
159866,in,1,0
159867,plasma,1,1
159868,increased,0,0
159869,with,0,0
159870,significant,0,0
159871,differences,0,0
159872,over,0,0
159873,CG,0,0
159874,.,0,0
159875,Plasma,1,1
159876,hydroxytyrosol,1,1
159877,(,1,0
159878,OH-Tyr,1,0
159879,),1,1
159880,concentration,1,1
159881,showed,0,0
159882,a,0,0
159883,significant,0,0
159884,increase,0,0
159885,after,0,0
159886,EVOO,0,0
159887,intervention,0,0
159888,.,0,0
159889,Daily,0,0
159890,consumption,0,1
159891,of,0,0
159892,EVOO,0,0
159893,was,0,0
159894,found,0,0
159895,to,0,0
159896,have,0,0
159897,positive,0,0
159898,effects,0,0
159899,on,0,0
159900,lipid,1,1
159901,profiles,1,0
159902,",",1,0
159903,OH-Tyr,1,1
159904,levels,1,1
159905,and,1,0
159906,TAC,1,0
159907,.,1,0
159908,The,0,0
159909,results,0,0
159910,also,0,0
159911,show,0,0
159912,a,0,0
159913,significant,0,0
159914,increase,0,0
159915,of,0,0
159916,catalase,1,1
159917,(,1,0
159918,CAT,1,0
159919,),1,0
159920,in,0,0
159921,erythrocytes,0,1
159922,and,0,0
159923,a,0,0
159924,decrease,0,1
159925,(,0,0
159926,p,0,0
159927,<,0,0
159928,0.05,0,0
159929,),0,0
159930,in,0,0
159931,superoxide,1,1
159932,dismutase,1,1
159933,(,1,0
159934,SOD,1,1
159935,),1,0
159936,and,1,0
159937,glutathione,1,1
159938,peroxidase,1,1
159939,(,1,0
159940,GH-PX,1,1
159941,),1,0
159942,activity,1,1
159943,after,0,0
159944,EVOO,0,0
159945,intake,0,1
159946,.,0,0
159947,To,0,0
159948,our,0,0
159949,knowledge,0,0
159950,",",0,0
159951,no,0,0
159952,other,0,0
159953,study,0,0
159954,has,0,0
159955,examined,0,0
159956,the,0,0
159957,effects,0,0
159958,of,0,0
159959,EVOO,0,0
159960,consumption,0,1
159961,on,0,0
159962,biochemical,1,1
159963,parameters,1,1
159964,",",1,0
159965,antioxidant,1,1
159966,capacity,1,1
159967,and,1,0
159968,antioxidant,1,1
159969,enzyme,1,1
159970,activity,1,1
159971,in,0,0
159972,healthy,0,0
159973,elderly,0,0
159974,subjects,0,0
159975,.,0,0
159976,In,0,0
159977,conclusion,0,0
159978,",",0,0
159979,our,0,0
159980,results,0,0
159981,show,0,0
159982,that,0,0
159983,nutritional,0,1
159984,intervention,0,0
159985,with,0,0
159986,EVOO,0,0
159987,improves,0,1
159988,antioxidant,0,0
159989,status,0,1
159990,in,0,0
159991,healthy,0,0
159992,elderly,0,0
159993,people,0,0
159994,.,0,0
159995,The,0,0
159996,efficacy,1,1
159997,",",1,0
159998,safety,1,1
159999,and,1,1
160000,cost-effectiveness,1,0
160001,of,0,1
160002,hydrotalcite,0,0
160003,versus,0,0
160004,esomeprazole,0,0
160005,in,0,0
160006,on-demand,0,0
160007,therapy,0,0
160008,of,0,0
160009,NERD,0,0
160010,:,0,0
160011,A,0,0
160012,multicenter,0,0
160013,",",0,0
160014,randomized,0,0
160015,",",0,0
160016,open-label,0,0
160017,study,0,0
160018,in,0,0
160019,China,0,0
160020,.,0,0
160021,OBJECTIVE,0,0
160022,The,0,0
160023,aim,0,0
160024,of,0,0
160025,the,0,0
160026,study,0,0
160027,was,0,0
160028,to,0,0
160029,investigate,0,0
160030,whether,0,0
160031,hydrotalcite,0,0
160032,was,0,0
160033,comparable,0,0
160034,to,0,0
160035,esomeprazole,0,0
160036,",",0,0
160037,a,0,0
160038,proton,0,0
160039,pump,0,0
160040,inhibitor,0,0
160041,",",0,0
160042,in,0,0
160043,on-demand,0,0
160044,therapy,0,0
160045,for,0,0
160046,non-erosive,0,1
160047,reflux,0,1
160048,disease,0,1
160049,(,0,0
160050,NERD,0,0
160051,),0,0
160052,.,0,0
160053,METHODS,0,0
160054,This,0,0
160055,was,0,0
160056,a,0,0
160057,multicenter,0,0
160058,",",0,0
160059,randomized,0,0
160060,",",0,0
160061,open-label,0,0
160062,clinical,0,0
160063,trial,0,0
160064,with,0,0
160065,initial,0,0
160066,and,0,0
160067,on-demand,0,0
160068,therapy,0,0
160069,.,0,0
160070,Patients,0,0
160071,who,0,0
160072,had,0,0
160073,complete,0,1
160074,symptom,0,1
160075,relief,0,1
160076,in,0,0
160077,the,0,0
160078,initial,0,0
160079,therapy,0,0
160080,were,0,0
160081,randomized,0,0
160082,to,0,0
160083,either,0,0
160084,hydrotalcite,0,0
160085,or,0,0
160086,esomeprazole,0,0
160087,in,0,0
160088,the,0,0
160089,on-demand,0,0
160090,therapy,0,0
160091,.,0,0
160092,The,0,0
160093,percentage,1,1
160094,of,0,0
160095,patients,1,0
160096,who,1,0
160097,quit,1,0
160098,on-demand,0,0
160099,therapy,0,0
160100,in,0,0
160101,the,0,0
160102,two,0,0
160103,groups,0,0
160104,and,0,0
160105,the,0,0
160106,cost-effectiveness,1,0
160107,of,0,0
160108,the,0,0
160109,treatment,0,0
160110,were,0,0
160111,evaluated,0,0
160112,as,0,0
160113,primary,0,0
160114,end,0,0
160115,points,0,0
160116,.,0,0
160117,The,0,0
160118,rate,1,1
160119,of,1,0
160120,symptom,1,1
160121,relief,1,1
160122,and,1,0
160123,the,1,0
160124,improvement,1,1
160125,of,1,0
160126,symptom,1,1
160127,score,1,1
160128,for,0,0
160129,initial,0,0
160130,therapy,0,0
160131,and,0,0
160132,the,0,0
160133,weekly,0,0
160134,average,0,1
160135,symptom,0,1
160136,score,0,1
160137,and,0,1
160138,weekly,1,0
160139,average,1,1
160140,number,1,1
160141,of,1,0
160142,days,1,0
160143,on,0,0
160144,treatment,0,0
160145,for,0,0
160146,on-demand,0,0
160147,therapy,0,0
160148,were,0,0
160149,evaluated,0,0
160150,as,0,0
160151,secondary,0,0
160152,end,0,0
160153,points,0,0
160154,.,0,0
160155,RESULTS,0,0
160156,In,0,0
160157,total,0,1
160158,",",0,0
160159,398,0,0
160160,patients,0,0
160161,were,0,0
160162,recruited,0,0
160163,in,0,0
160164,the,0,0
160165,initial,0,0
160166,therapy,0,0
160167,group,0,0
160168,",",0,0
160169,among,0,0
160170,whom,0,0
160171,253,0,0
160172,were,0,0
160173,included,0,0
160174,in,0,0
160175,on-demand,0,0
160176,therapy,0,0
160177,",",0,0
160178,with,0,0
160179,127,0,0
160180,patients,0,0
160181,in,0,0
160182,the,0,0
160183,hydrotalcite,0,0
160184,group,0,0
160185,and,0,0
160186,the,0,0
160187,remaining,0,0
160188,126,0,0
160189,in,0,0
160190,the,0,0
160191,esomeprazole,0,0
160192,group,0,0
160193,.,0,0
160194,14,0,0
160195,(,0,0
160196,11.0,0,0
160197,%,0,0
160198,),0,0
160199,patients,0,0
160200,in,0,0
160201,the,0,0
160202,hydrotalcite,0,0
160203,group,0,0
160204,and,0,0
160205,six,0,0
160206,(,0,0
160207,4.8,0,0
160208,%,0,0
160209,),0,0
160210,in,0,0
160211,the,0,0
160212,esomeprazole,0,0
160213,group,0,0
160214,quit,1,0
160215,the,0,0
160216,on-demand,0,0
160217,therapy,0,0
160218,due,0,0
160219,to,0,0
160220,unsatisfactory,0,0
160221,symptom,0,1
160222,control,0,0
160223,(,1,0
160224,P,1,0
160225,=,1,0
160226,0.065,1,0
160227,),1,0
160228,.,1,0
160229,Cost-effectiveness,1,0
160230,calculated,1,0
160231,as,0,0
160232,the,0,0
160233,ratio,0,0
160234,of,0,0
160235,the,0,0
160236,cost,0,1
160237,of,0,0
160238,hydrotalcite,0,0
160239,to,0,0
160240,that,0,0
160241,of,0,0
160242,esomeprazole,0,0
160243,(,0,0
160244,per,0,0
160245,person/day,0,1
160246,),0,0
160247,was,0,0
160248,35.3,0,0
160249,%,0,0
160250,in,0,0
160251,the,0,0
160252,on-demand,0,0
160253,therapy,0,0
160254,.,0,0
160255,Similar,0,0
160256,number,0,1
160257,of,0,0
160258,patients,0,0
160259,achieved,1,0
160260,symptom,1,1
160261,relief,1,1
160262,in,1,0
160263,both,0,0
160264,groups,0,0
160265,.,0,0
160266,CONCLUSION,0,0
160267,Hydrotalcite,0,0
160268,is,0,0
160269,a,0,0
160270,good,1,0
160271,option,1,0
160272,of,1,0
160273,on-demand,0,0
160274,therapy,0,0
160275,for,0,0
160276,NERD,0,0
160277,patients,0,0
160278,due,0,0
160279,to,0,0
160280,its,0,0
160281,cost-effectiveness,1,0
160282,and,1,1
160283,speed,1,1
160284,of,1,0
160285,action,1,0
160286,.,1,0
160287,Effects,0,0
160288,of,0,0
160289,exposure,0,0
160290,to,0,0
160291,thin-ideal,0,1
160292,media,0,0
160293,images,0,0
160294,on,0,0
160295,body,1,1
160296,dissatisfaction,1,1
160297,:,1,0
160298,testing,0,0
160299,the,0,0
160300,inclusion,0,0
160301,of,0,0
160302,a,0,0
160303,disclaimer,0,0
160304,versus,0,0
160305,warning,0,0
160306,label,0,0
160307,.,0,0
160308,The,0,0
160309,current,0,0
160310,study,0,0
160311,was,0,0
160312,designed,0,0
160313,to,0,0
160314,determine,0,0
160315,whether,0,0
160316,the,0,0
160317,inclusion,0,0
160318,of,0,0
160319,a,0,0
160320,disclaimer,0,0
160321,(,0,0
160322,i.e.,0,0
160323,",",0,0
160324,Retouched,0,1
160325,photograph,0,1
160326,aimed,0,0
160327,at,0,0
160328,changing,0,0
160329,a,0,0
160330,person,0,0
160331,'s,0,0
160332,physical,0,1
160333,appearance,0,0
160334,.,0,0
160335,),0,0
160336,or,0,0
160337,warning,0,0
160338,(,0,0
160339,i.e.,0,0
160340,",",0,0
160341,Warning,0,0
160342,:,0,0
160343,Trying,0,0
160344,to,0,0
160345,look,0,0
160346,as,0,0
160347,thin,0,0
160348,as,0,0
160349,this,0,0
160350,model,0,0
160351,may,0,0
160352,be,0,0
160353,dangerous,0,0
160354,to,0,0
160355,your,0,1
160356,health,0,0
160357,.,0,0
160358,),0,0
160359,added,0,0
160360,to,0,0
160361,images,0,0
160362,of,0,0
160363,thin/attractive,0,0
160364,models,0,0
160365,would,0,0
160366,affect,0,0
160367,body,1,1
160368,dissatisfaction,1,1
160369,and,0,0
160370,intent,0,0
160371,to,0,0
160372,diet,0,0
160373,in,0,0
160374,female,0,0
160375,undergraduate,0,0
160376,students,0,0
160377,(,0,0
160378,n=342,0,0
160379,),0,0
160380,.,0,0
160381,Participants,0,0
160382,were,0,0
160383,randomly,0,0
160384,assigned,0,0
160385,to,0,0
160386,one,0,0
160387,of,0,0
160388,four,0,0
160389,groups,0,0
160390,:,0,0
160391,(,0,0
160392,a,0,0
160393,),0,0
160394,disclaimer,0,0
160395,",",0,0
160396,(,0,1
160397,b,0,0
160398,),0,1
160399,warning,0,1
160400,",",0,0
160401,(,0,1
160402,c,0,0
160403,),0,1
160404,model,0,0
160405,control,0,0
160406,",",0,1
160407,or,0,1
160408,(,0,1
160409,d,0,0
160410,),0,1
160411,car,0,0
160412,control,0,0
160413,.,0,0
160414,Results,0,0
160415,revealed,0,0
160416,a,0,0
160417,significant,0,0
160418,interaction,0,1
160419,between,0,0
160420,group,0,0
160421,and,0,1
160422,time,0,1
160423,",",0,0
160424,whereby,0,0
160425,only,0,0
160426,the,0,0
160427,car,0,0
160428,control,0,0
160429,group,0,0
160430,reported,0,0
160431,a,0,0
160432,significant,0,0
160433,change,0,1
160434,(,0,0
160435,i.e.,0,0
160436,",",0,0
160437,decrease,0,1
160438,),0,0
160439,in,0,0
160440,body,1,1
160441,dissatisfaction,1,1
160442,over,0,0
160443,time,0,1
160444,.,0,0
160445,Groups,0,0
160446,did,0,0
160447,not,0,0
160448,differ,0,0
160449,on,0,0
160450,intent,0,0
160451,to,0,0
160452,diet,1,0
160453,measured,0,0
160454,at,0,0
160455,post-exposure,0,0
160456,.,0,0
160457,The,0,0
160458,results,0,0
160459,largely,0,0
160460,replicate,0,0
160461,other,0,0
160462,findings,0,0
160463,in,0,0
160464,this,0,0
160465,area,0,0
160466,and,0,0
160467,call,0,1
160468,into,0,0
160469,question,0,0
160470,advocacy,0,0
160471,efforts,0,0
160472,to,0,0
160473,label,0,0
160474,media,0,0
160475,images,0,0
160476,as,0,0
160477,a,0,0
160478,strategy,0,0
160479,to,0,0
160480,decrease,0,0
160481,women,0,0
160482,'s,0,0
160483,identification,0,0
160484,with,0,0
160485,the,0,0
160486,stimuli,0,0
160487,.,0,0
160488,The,0,0
160489,effectiveness,0,0
160490,of,0,0
160491,educational,0,0
160492,interventions,0,0
160493,to,0,0
160494,enhance,0,0
160495,the,0,0
160496,adoption,1,0
160497,of,1,0
160498,fee-based,1,0
160499,arsenic,1,0
160500,testing,1,0
160501,in,0,0
160502,Bangladesh,0,0
160503,:,0,0
160504,a,0,0
160505,cluster,0,0
160506,randomized,0,0
160507,controlled,0,0
160508,trial,0,0
160509,.,0,0
160510,Arsenic,0,0
160511,(,0,0
160512,As,0,0
160513,),0,0
160514,testing,0,0
160515,could,0,0
160516,help,0,0
160517,22,0,0
160518,million,0,0
160519,people,0,0
160520,",",0,0
160521,using,0,0
160522,drinking,0,1
160523,water,0,1
160524,sources,0,0
160525,that,0,0
160526,exceed,0,0
160527,the,0,0
160528,Bangladesh,0,0
160529,As,0,0
160530,standard,0,0
160531,",",0,0
160532,to,0,0
160533,identify,0,0
160534,safe,0,0
160535,sources,0,0
160536,.,0,0
160537,A,0,0
160538,cluster,0,0
160539,randomized,0,0
160540,controlled,0,0
160541,trial,0,0
160542,was,0,0
160543,conducted,0,0
160544,to,0,0
160545,evaluate,0,0
160546,the,0,0
160547,effectiveness,1,1
160548,of,1,0
160549,household,1,1
160550,education,1,0
160551,and,1,1
160552,local,1,1
160553,media,1,0
160554,in,0,0
160555,the,0,0
160556,increasing,0,0
160557,demand,0,1
160558,for,0,0
160559,fee-based,0,0
160560,As,0,0
160561,testing,0,0
160562,.,0,0
160563,Randomly,0,0
160564,selected,0,0
160565,households,0,0
160566,(,0,0
160567,N,0,0
160568,=,0,0
160569,452,0,0
160570,),0,0
160571,were,0,0
160572,divided,0,0
160573,into,0,0
160574,three,0,0
160575,interventions,0,0
160576,implemented,0,0
160577,by,0,0
160578,community,0,0
160579,workers,0,0
160580,:,0,0
160581,1,0,0
160582,),0,0
160583,fee-based,0,0
160584,As,0,0
160585,testing,0,0
160586,with,0,0
160587,household,0,1
160588,education,0,0
160589,(,0,0
160590,HE,0,0
160591,),0,0
160592,;,0,0
160593,2,0,0
160594,),0,0
160595,fee-based,0,0
160596,As,0,0
160597,testing,0,0
160598,with,0,0
160599,household,0,1
160600,education,0,0
160601,and,0,0
160602,a,0,0
160603,local,0,0
160604,media,0,0
160605,campaign,0,1
160606,(,0,0
160607,HELM,0,0
160608,),0,0
160609,;,0,0
160610,and,0,0
160611,3,0,0
160612,),0,0
160613,fee-based,0,0
160614,As,0,0
160615,testing,0,0
160616,alone,0,0
160617,(,0,0
160618,Control,0,0
160619,),0,0
160620,.,0,0
160621,The,0,0
160622,fee,0,0
160623,for,0,0
160624,the,0,0
160625,As,0,0
160626,test,0,0
160627,was,0,0
160628,US,0,0
160629,$,0,0
160630,0.28,0,0
160631,",",0,0
160632,higher,0,0
160633,than,0,0
160634,the,0,0
160635,cost,0,1
160636,of,0,0
160637,the,0,0
160638,test,0,0
160639,(,0,0
160640,US,0,1
160641,$,0,0
160642,0.16,0,0
160643,),0,0
160644,.,0,0
160645,Of,0,0
160646,households,0,0
160647,with,0,0
160648,untested,0,0
160649,wells,0,0
160650,",",0,0
160651,93,0,0
160652,%,0,0
160653,in,0,0
160654,both,0,0
160655,intervention,0,0
160656,groups,0,0
160657,HE,1,0
160658,and,1,0
160659,HELM,1,0
160660,purchased,1,0
160661,an,1,0
160662,As,1,0
160663,test,1,0
160664,",",0,0
160665,whereas,0,0
160666,only,0,0
160667,53,0,0
160668,%,0,0
160669,in,0,0
160670,the,0,0
160671,control,0,0
160672,group,0,0
160673,.,0,0
160674,In,0,0
160675,conclusion,0,0
160676,",",0,0
160677,fee-based,1,0
160678,As,1,0
160679,testing,1,0
160680,with,0,0
160681,household,1,1
160682,education,1,0
160683,is,1,0
160684,effective,1,0
160685,in,1,0
160686,the,1,0
160687,increasing,1,0
160688,demand,1,1
160689,for,1,0
160690,As,1,0
160691,testing,1,0
160692,in,0,0
160693,rural,0,0
160694,Bangladesh,0,0
160695,.,0,0
160696,A,0,0
160697,randomized,0,0
160698,",",0,0
160699,double-blind,0,0
160700,",",0,0
160701,placebo-controlled,0,0
160702,trial,0,0
160703,of,0,0
160704,the,0,0
160705,effect,0,0
160706,of,0,0
160707,dried,0,0
160708,purple,0,1
160709,carrot,0,0
160710,on,0,0
160711,body,0,1
160712,mass,0,1
160713,",",0,0
160714,lipids,0,1
160715,",",0,1
160716,blood,0,1
160717,pressure,0,1
160718,",",0,1
160719,body,0,1
160720,composition,0,1
160721,",",0,0
160722,and,0,1
160723,inflammatory,0,1
160724,markers,0,1
160725,in,0,0
160726,overweight,0,1
160727,and,0,0
160728,obese,0,0
160729,adults,0,0
160730,:,0,0
160731,the,0,0
160732,QUENCH,0,0
160733,trial,0,0
160734,.,0,0
160735,Obesity,0,0
160736,is,0,0
160737,a,0,0
160738,significant,0,0
160739,health,0,1
160740,issue,0,0
160741,worldwide,0,0
160742,and,0,0
160743,is,0,0
160744,associated,0,0
160745,with,0,0
160746,chronic,0,0
160747,",",0,0
160748,low-grade,0,0
160749,inflammation,0,1
160750,predisposing,0,0
160751,the,0,0
160752,individual,0,0
160753,to,0,0
160754,cardiovascular,0,1
160755,disease,0,1
160756,and,0,0
160757,impaired,0,1
160758,blood,0,1
160759,glucose,0,1
160760,homeostasis,0,1
160761,.,0,0
160762,Anthocyanins,0,1
160763,and,0,0
160764,phenolic,0,0
160765,acids,0,1
160766,from,0,0
160767,purple,0,0
160768,carrots,0,0
160769,are,0,0
160770,effective,0,0
160771,at,0,0
160772,reversing,0,0
160773,inflammation,0,1
160774,and,0,0
160775,metabolic,0,1
160776,alterations,0,1
160777,in,0,0
160778,animal,0,0
160779,models,0,0
160780,",",0,0
160781,potentially,0,0
160782,through,0,0
160783,inhibition,0,1
160784,of,0,0
160785,inflammatory,0,1
160786,pathways,0,0
160787,.,0,0
160788,The,0,0
160789,effects,0,0
160790,of,0,0
160791,dried,0,0
160792,purple,0,1
160793,carrot,0,0
160794,on,0,0
160795,body,1,1
160796,mass,1,1
160797,",",1,1
160798,body,1,1
160799,composition,1,1
160800,",",1,1
160801,blood,1,1
160802,pressure,1,1
160803,",",1,0
160804,lipids,1,1
160805,",",1,0
160806,inflammatory,1,1
160807,markers,1,1
160808,",",1,0
160809,liver,1,1
160810,function,1,1
160811,tests,1,1
160812,",",1,0
160813,and,1,0
160814,appetite,1,1
160815,were,0,0
160816,investigated,0,0
160817,in,0,0
160818,16,0,0
160819,males,0,0
160820,(,0,0
160821,aged,0,0
160822,53.1,0,0
160823,?,0,0
160824,7.6,0,0
160825,years,0,0
160826,and,0,0
160827,with,0,0
160828,a,0,0
160829,mean,0,1
160830,BMI,0,0
160831,of,0,0
160832,32.8,0,0
160833,?,0,0
160834,4.6,0,0
160835,kg/m,0,0
160836,(,0,0
160837,2,0,0
160838,),0,0
160839,),0,0
160840,with,0,0
160841,normal,0,0
160842,lipid,0,1
160843,and,0,0
160844,inflammatory,0,1
160845,markers,0,1
160846,.,0,0
160847,There,0,0
160848,was,0,0
160849,no,0,0
160850,evidence,0,0
160851,that,0,0
160852,118.5,0,0
160853,mg/day,0,0
160854,of,0,0
160855,anthocyanins,0,0
160856,and,0,0
160857,259.2,0,0
160858,mg/day,0,0
160859,of,0,0
160860,phenolic,0,0
160861,acids,0,0
160862,for,0,0
160863,4,0,0
160864,weeks,0,0
160865,resulted,0,0
160866,in,0,0
160867,statistically,0,0
160868,significant,0,0
160869,changes,0,1
160870,in,0,0
160871,body,1,1
160872,mass,1,1
160873,",",1,1
160874,body,1,1
160875,composition,1,1
160876,",",1,0
160877,appetite,1,1
160878,",",1,0
160879,dietary,1,1
160880,intake,1,1
160881,",",1,0
160882,low,1,0
160883,density,1,1
160884,lipoprotein,1,1
160885,",",1,0
160886,total,1,1
160887,cholesterol,1,1
160888,",",1,0
160889,blood,1,1
160890,pressure,1,1
160891,",",1,0
160892,or,1,1
160893,C-reactive,1,1
160894,protein,1,0
160895,in,1,0
160896,these,0,0
160897,obese,0,0
160898,participants,0,0
160899,at,0,0
160900,the,0,0
160901,dose,0,0
160902,and,0,0
160903,length,0,1
160904,of,0,1
160905,intervention,0,0
160906,used,0,0
160907,in,0,0
160908,this,0,0
160909,trial,1,0
160910,.,1,0
160911,High,1,0
160912,density,1,1
160913,lipoprotein,1,1
160914,cholesterol,1,1
160915,was,1,0
160916,lower,0,0
160917,in,0,0
160918,the,0,0
160919,intervention,0,0
160920,group,0,0
160921,(,0,0
160922,p,0,0
160923,<,0,0
160924,0.05,1,0
160925,),1,0
160926,.,1,0
160927,Aspartate,1,1
160928,amino,1,0
160929,transferase,1,1
160930,and,1,1
160931,alanine,1,1
160932,amino,1,1
160933,transferase,1,1
160934,did,1,0
160935,not,0,0
160936,change,0,0
160937,",",0,0
160938,indicating,0,0
160939,that,0,0
160940,the,0,0
160941,intervention,0,0
160942,was,0,0
160943,safe,0,0
160944,.,0,0
160945,More,0,0
160946,studies,0,0
160947,are,0,0
160948,required,0,0
160949,to,0,0
160950,establish,0,0
160951,the,1,0
160952,bioavailability,1,1
160953,and,1,0
160954,pharmacokinetic,1,1
160955,effects,1,1
160956,of,1,0
160957,purple,0,1
160958,carrot,0,0
160959,anthocyanins,0,1
160960,and,0,1
160961,phenolic,0,0
160962,acids,0,0
160963,prior,0,0
160964,to,0,0
160965,further,0,0
160966,trials,0,0
160967,of,0,0
160968,efficacy,0,1
160969,with,0,0
160970,respect,0,0
160971,to,0,0
160972,treating,1,0
160973,inflammation,1,1
160974,and,1,0
160975,metabolic,1,1
160976,alterations,1,0
160977,.,1,0
160978,Ultracision,0,0
160979,versus,0,0
160980,electrocautery,0,0
160981,in,0,0
160982,performing,0,0
160983,modified,0,0
160984,radical,0,0
160985,mastectomy,0,0
160986,and,0,0
160987,axillary,0,1
160988,lymph,0,1
160989,node,0,1
160990,dissection,0,0
160991,for,0,0
160992,breast,0,0
160993,cancer,0,0
160994,:,0,0
160995,a,0,0
160996,prospective,0,0
160997,randomized,0,0
160998,control,0,0
160999,trial,0,0
161000,.,0,0
161001,BACKGROUND,0,0
161002,Treatment,0,0
161003,for,0,0
161004,breast,0,0
161005,cancer,0,0
161006,has,0,0
161007,improved,0,0
161008,dramatically,0,0
161009,over,0,0
161010,the,0,0
161011,decades,0,0
161012,.,0,0
161013,Nevertheless,0,0
161014,",",0,0
161015,modified,0,0
161016,radical,0,0
161017,mastectomy,0,0
161018,with,0,0
161019,axillary,0,0
161020,dissection,0,0
161021,remains,0,0
161022,the,0,0
161023,standard,0,0
161024,treatment,0,0
161025,for,0,0
161026,most,0,0
161027,patients,0,0
161028,",",0,0
161029,especially,0,0
161030,those,0,0
161031,with,0,0
161032,big,0,0
161033,tumours,0,0
161034,.,0,0
161035,The,0,0
161036,conventional,0,0
161037,technology,0,0
161038,is,0,0
161039,to,0,0
161040,use,0,0
161041,diathermy,0,0
161042,to,0,0
161043,cut,0,0
161044,and,0,0
161045,coagulate,0,0
161046,blood,0,1
161047,vessels,0,0
161048,.,0,0
161049,The,0,0
161050,Ultracision,0,0
161051,dissector,0,0
161052,has,0,0
161053,been,0,0
161054,widely,0,0
161055,used,0,0
161056,in,0,0
161057,laparoscopic,0,0
161058,surgery,0,0
161059,and,0,0
161060,is,0,0
161061,documented,0,0
161062,to,0,0
161063,be,0,0
161064,safe,0,0
161065,and,0,0
161066,fast,0,0
161067,for,0,0
161068,cutting,0,0
161069,and,0,0
161070,coagulating,0,0
161071,tissue,0,0
161072,.,0,0
161073,The,0,0
161074,aim,0,0
161075,of,0,0
161076,this,0,0
161077,study,0,0
161078,is,0,0
161079,to,0,0
161080,compare,0,0
161081,ultracision,0,0
161082,to,0,0
161083,electrocautery,0,0
161084,",",0,0
161085,looking,0,0
161086,in,0,0
161087,terms,0,0
161088,of,0,0
161089,amount,0,1
161090,of,0,0
161091,post,0,0
161092,operative,0,1
161093,drainage,0,0
161094,",",0,0
161095,duration,0,1
161096,of,0,1
161097,drain,0,0
161098,days,0,0
161099,",",0,0
161100,seroma,0,1
161101,formation,0,1
161102,and,0,0
161103,other,0,0
161104,complications,0,1
161105,.,0,0
161106,METHODOLOGY,0,0
161107,This,0,0
161108,study,0,0
161109,was,0,0
161110,a,0,0
161111,prospective,0,0
161112,randomized,0,0
161113,control,0,0
161114,trial,0,0
161115,of,0,0
161116,modified,0,0
161117,radical,0,0
161118,mastectomy,0,0
161119,performed,0,0
161120,for,0,0
161121,breast,0,0
161122,cancer,0,0
161123,in,0,0
161124,Pusat,0,0
161125,Perubatan,0,0
161126,Universiti,0,0
161127,Kebangsaan,0,0
161128,Malaysia,0,0
161129,(,0,0
161130,PPUKM,0,0
161131,),0,0
161132,between,0,0
161133,1st,0,0
161134,June,0,0
161135,2007,0,0
161136,to,0,0
161137,31st,0,0
161138,December,0,0
161139,2008,0,0
161140,.,0,0
161141,Patients,0,0
161142,were,0,0
161143,randomized,0,0
161144,in,0,0
161145,two,0,0
161146,groups,0,0
161147,:,0,0
161148,group,0,0
161149,A,0,0
161150,(,0,0
161151,n,0,0
161152,=,0,0
161153,20,0,0
161154,),0,0
161155,underwent,0,0
161156,modified,0,0
161157,radical,0,0
161158,mastectomy,0,0
161159,using,0,0
161160,ultracision,0,0
161161,(,0,0
161162,UC,0,1
161163,),0,1
161164,and,0,0
161165,group,0,0
161166,B,0,0
161167,(,0,0
161168,n,0,0
161169,=,0,0
161170,20,0,0
161171,),0,0
161172,with,0,0
161173,the,0,0
161174,conventional,0,0
161175,electrocautery,0,0
161176,(,0,0
161177,EC,0,1
161178,),0,0
161179,method,0,0
161180,.,0,0
161181,Main,0,0
161182,outcome,0,1
161183,measures,0,1
161184,were,0,0
161185,amount,1,1
161186,of,1,1
161187,drainage,1,0
161188,and,1,1
161189,duration,1,1
161190,of,1,1
161191,drain,1,0
161192,days,1,0
161193,.,1,0
161194,An,0,0
161195,unpaired,0,0
161196,2-tailed,0,0
161197,Student,0,1
161198,'s,0,0
161199,t,0,0
161200,test,0,0
161201,and,0,0
161202,the,0,0
161203,?2,0,0
161204,test,0,0
161205,to,0,0
161206,compare,0,0
161207,the,0,0
161208,groups,0,0
161209,.,0,0
161210,RESULTS,0,0
161211,A,0,0
161212,total,0,0
161213,of,0,0
161214,40,0,0
161215,patients,0,0
161216,were,0,0
161217,involved,0,0
161218,in,0,0
161219,this,0,0
161220,study,0,0
161221,.,0,0
161222,The,0,0
161223,majority,0,0
161224,of,0,0
161225,patients,0,0
161226,were,0,0
161227,Malay,0,0
161228,(,0,0
161229,55,0,0
161230,%,0,0
161231,),0,0
161232,followed,0,0
161233,by,0,0
161234,Chinese,0,0
161235,(,0,0
161236,35,0,0
161237,%,0,0
161238,),0,0
161239,",",0,0
161240,Indian,0,0
161241,(,0,0
161242,5,0,0
161243,%,0,0
161244,),0,0
161245,and,0,0
161246,others,0,0
161247,(,0,0
161248,5,0,0
161249,%,0,0
161250,),0,0
161251,.,0,0
161252,The,1,0
161253,mean,1,1
161254,volume,1,1
161255,of,1,0
161256,drainage,1,0
161257,from,1,0
161258,the,1,0
161259,axilla,1,0
161260,in,0,0
161261,the,0,0
161262,EC,0,1
161263,group,0,0
161264,was,0,0
161265,significantly,0,0
161266,higher,0,0
161267,than,0,0
161268,UC,0,1
161269,group,0,0
161270,[,0,0
161271,489.5,0,0
161272,versus,0,0
161273,188.1,0,0
161274,mls,0,0
161275,(,0,0
161276,p,0,0
161277,<,0,0
161278,0.001,0,0
161279,),0,0
161280,],0,0
161281,.,0,0
161282,The,1,0
161283,mean,1,1
161284,volume,1,1
161285,of,1,0
161286,drainage,1,0
161287,from,1,0
161288,the,1,0
161289,breast,1,0
161290,and,1,0
161291,the,1,0
161292,total,1,1
161293,drainage,1,0
161294,from,1,0
161295,both,1,0
161296,the,1,0
161297,breast,1,0
161298,and,1,1
161299,axilla,1,1
161300,was,0,0
161301,also,0,0
161302,significantly,0,0
161303,higher,0,0
161304,in,0,0
161305,the,0,0
161306,EC,0,1
161307,group,0,0
161308,compared,0,0
161309,to,0,0
161310,UC,0,1
161311,[,0,0
161312,169.3,0,0
161313,versus,0,0
161314,58.8,0,0
161315,mls,0,0
161316,(,0,0
161317,p,0,0
161318,=,0,0
161319,0.004,0,0
161320,),0,0
161321,and,0,0
161322,663.7,0,0
161323,versus,0,0
161324,247.0,0,0
161325,mls,0,0
161326,(,0,0
161327,p,0,0
161328,<,0,0
161329,0.002,0,0
161330,),0,0
161331,respectively,0,0
161332,],0,0
161333,.,0,0
161334,The,0,0
161335,drainage,0,0
161336,consequently,0,0
161337,showed,0,0
161338,significant,1,0
161339,reduction,1,1
161340,in,1,0
161341,terms,1,0
161342,of,1,0
161343,drain,1,0
161344,days,1,0
161345,in,0,0
161346,the,0,0
161347,axilla,0,0
161348,[,0,0
161349,6,0,0
161350,days,0,0
161351,versus,0,0
161352,3,0,0
161353,days,0,0
161354,(,0,0
161355,p,0,0
161356,<,0,0
161357,0.002,0,0
161358,),0,0
161359,],0,0
161360,and,0,0
161361,the,0,0
161362,breast,0,0
161363,[,0,0
161364,3,0,0
161365,days,0,0
161366,versus,0,0
161367,2,0,0
161368,days,0,0
161369,(,0,0
161370,p,0,0
161371,<,0,0
161372,0.002,0,0
161373,),0,0
161374,],0,0
161375,in,0,0
161376,the,0,0
161377,UC,0,1
161378,compared,0,0
161379,to,0,0
161380,the,0,0
161381,EC,0,0
161382,.,0,0
161383,There,0,0
161384,was,0,0
161385,no,0,0
161386,significant,1,0
161387,complication,1,0
161388,in,0,0
161389,both,0,0
161390,arms,0,0
161391,.,0,0
161392,In,0,0
161393,conclusion,0,0
161394,",",0,0
161395,the,0,0
161396,use,0,0
161397,of,0,0
161398,ultracision,0,0
161399,able,0,0
161400,to,0,0
161401,reduce,0,0
161402,the,1,0
161403,amount,1,0
161404,of,1,0
161405,drainage,1,0
161406,and,1,0
161407,the,1,0
161408,number,1,1
161409,of,1,0
161410,drain,1,0
161411,days,1,0
161412,after,0,0
161413,performing,0,0
161414,modified,0,0
161415,radical,0,0
161416,mastectomy,0,0
161417,.,0,0
161418,In,0,0
161419,doing,0,0
161420,so,0,0
161421,",",0,0
161422,the,0,0
161423,use,0,0
161424,of,0,0
161425,this,0,0
161426,technology,0,0
161427,enable,0,0
161428,us,0,0
161429,to,0,0
161430,discharge,0,0
161431,patients,0,0
161432,earlier,0,0
161433,without,0,0
161434,significant,0,0
161435,morbidities,0,0
161436,.,0,0
161437,Markers,0,1
161438,of,0,0
161439,systemic,1,1
161440,inflammation,1,1
161441,predict,0,0
161442,survival,0,1
161443,in,0,0
161444,patients,0,0
161445,with,0,0
161446,advanced,0,0
161447,renal,0,1
161448,cell,0,0
161449,cancer,0,0
161450,.,0,0
161451,BACKGROUND,0,0
161452,The,0,0
161453,host,0,0
161454,inflammatory,0,1
161455,response,0,1
161456,has,0,0
161457,a,0,0
161458,vital,0,1
161459,role,0,0
161460,in,0,0
161461,carcinogenesis,0,0
161462,and,0,0
161463,tumour,0,1
161464,progression,0,1
161465,.,0,0
161466,We,0,0
161467,examined,0,0
161468,the,0,0
161469,prognostic,1,1
161470,value,1,0
161471,of,1,0
161472,inflammatory,1,1
161473,markers,1,1
161474,(,1,0
161475,albumin,1,1
161476,",",1,0
161477,white-cell,1,1
161478,count,1,1
161479,and,1,0
161480,its,1,0
161481,components,1,1
161482,",",1,0
161483,and,1,1
161484,platelets,1,1
161485,),1,0
161486,in,0,0
161487,pre-treated,0,0
161488,patients,0,0
161489,with,0,0
161490,advanced,0,0
161491,renal,0,1
161492,cell,0,1
161493,carcinoma,0,0
161494,(,0,0
161495,RCC,0,0
161496,),0,0
161497,.,0,0
161498,METHODS,0,0
161499,Using,0,0
161500,data,0,0
161501,from,0,0
161502,a,0,0
161503,randomised,0,0
161504,trial,0,0
161505,",",0,0
161506,multivariable,0,0
161507,proportional,0,1
161508,hazards,0,1
161509,models,0,0
161510,were,0,0
161511,generated,0,0
161512,to,0,0
161513,examine,0,0
161514,the,0,0
161515,impact,1,0
161516,of,1,0
161517,inflammatory,1,1
161518,markers,1,1
161519,and,0,0
161520,established,0,0
161521,prognostic,1,1
161522,factors,1,0
161523,(,0,0
161524,performance,0,1
161525,status,0,1
161526,",",0,1
161527,calcium,0,1
161528,",",0,1
161529,and,0,1
161530,haemoglobin,0,1
161531,),0,0
161532,on,0,0
161533,overall,1,1
161534,survival,1,1
161535,(,0,0
161536,OS,0,1
161537,),0,0
161538,.,0,0
161539,We,0,0
161540,evaluated,0,0
161541,a,0,0
161542,new,0,0
161543,prognostic,0,1
161544,classification,0,1
161545,incorporating,0,0
161546,additional,0,0
161547,information,0,0
161548,from,0,0
161549,inflammatory,0,1
161550,markers,0,1
161551,.,0,0
161552,RESULTS,0,0
161553,Of,0,0
161554,the,0,0
161555,416,0,0
161556,patients,0,0
161557,",",0,0
161558,362,0,0
161559,were,0,0
161560,included,0,0
161561,in,0,0
161562,the,0,0
161563,analysis,0,0
161564,.,0,0
161565,Elevated,1,1
161566,neutrophil,1,1
161567,counts,1,1
161568,",",1,0
161569,elevated,1,1
161570,platelet,1,1
161571,counts,1,1
161572,",",1,0
161573,and,1,0
161574,a,1,0
161575,high,1,0
161576,neutrophil-lymphocyte,1,1
161577,ratio,1,1
161578,were,0,0
161579,significant,0,0
161580,independent,0,0
161581,predictors,0,0
161582,for,0,0
161583,shorter,0,0
161584,OS,0,1
161585,in,0,0
161586,a,0,0
161587,model,0,0
161588,with,0,0
161589,established,0,0
161590,prognostic,0,0
161591,factors,0,0
161592,.,0,0
161593,The,0,0
161594,addition,0,0
161595,of,0,0
161596,inflammatory,0,0
161597,markers,0,0
161598,improves,0,0
161599,the,0,0
161600,discriminatory,0,0
161601,value,0,0
161602,of,0,0
161603,the,0,0
161604,prognostic,0,0
161605,classification,0,1
161606,as,0,0
161607,compared,0,0
161608,with,0,0
161609,established,0,0
161610,factors,0,0
161611,alone,0,0
161612,(,0,0
161613,C-statistic,0,0
161614,0.673,0,0
161615,vs,0,0
161616,0.654,0,0
161617,",",0,0
161618,P=0.002,0,0
161619,for,0,0
161620,the,0,0
161621,difference,0,0
161622,),0,0
161623,",",0,0
161624,with,0,0
161625,25.8,0,0
161626,%,0,0
161627,(,0,0
161628,P=0.004,0,0
161629,),0,0
161630,of,0,0
161631,patients,0,0
161632,more,0,0
161633,appropriately,0,0
161634,classified,0,0
161635,using,0,0
161636,the,0,0
161637,new,0,0
161638,classification,0,1
161639,.,0,0
161640,CONCLUSION,0,0
161641,Markers,0,1
161642,of,0,0
161643,systemic,0,1
161644,inflammation,0,1
161645,contribute,0,0
161646,significantly,0,0
161647,to,0,0
161648,prognostic,0,1
161649,classification,0,1
161650,in,0,0
161651,addition,0,0
161652,to,0,0
161653,established,0,0
161654,factors,0,0
161655,for,0,0
161656,pre-treated,0,0
161657,patients,0,0
161658,with,0,0
161659,advanced,0,0
161660,RCC,0,0
161661,.,0,0
161662,Upon,0,0
161663,validation,0,0
161664,of,0,0
161665,these,0,0
161666,data,0,0
161667,in,0,0
161668,independent,0,0
161669,studies,0,0
161670,",",0,0
161671,stratification,0,0
161672,of,0,0
161673,patients,0,0
161674,using,0,0
161675,these,0,0
161676,markers,0,0
161677,in,0,0
161678,future,0,0
161679,clinical,0,0
161680,trials,0,0
161681,is,0,0
161682,recommended,0,0
161683,.,0,0
161684,A,0,0
161685,head-to-head,0,0
161686,comparison,0,0
161687,of,0,0
161688,aripiprazole,0,0
161689,and,0,1
161690,risperidone,0,0
161691,for,0,0
161692,safety,0,1
161693,and,0,0
161694,treating,0,0
161695,autistic,0,1
161696,disorders,0,0
161697,",",0,0
161698,a,0,0
161699,randomized,0,0
161700,double,0,0
161701,blind,0,0
161702,clinical,0,0
161703,trial,0,0
161704,.,0,0
161705,Aripiprazole,0,0
161706,and,0,0
161707,risperidone,0,0
161708,are,0,0
161709,the,0,0
161710,only,0,0
161711,FDA,0,0
161712,approved,0,0
161713,medications,0,0
161714,for,0,0
161715,treating,0,0
161716,irritability,0,1
161717,in,0,0
161718,autistic,0,0
161719,disorder,0,0
161720,",",0,0
161721,however,0,0
161722,there,0,0
161723,are,0,0
161724,no,0,0
161725,head-to-head,0,0
161726,data,0,0
161727,comparing,0,0
161728,these,0,0
161729,agents,0,0
161730,.,0,0
161731,This,0,0
161732,is,0,0
161733,the,0,0
161734,first,0,0
161735,prospective,0,0
161736,randomized,0,0
161737,clinical,0,0
161738,trial,0,0
161739,comparing,0,0
161740,the,0,0
161741,safety,0,1
161742,and,0,0
161743,efficacy,0,1
161744,of,0,0
161745,these,0,0
161746,two,0,0
161747,medications,0,0
161748,in,0,0
161749,patients,0,0
161750,with,0,0
161751,autism,0,0
161752,spectrum,0,0
161753,disorders,0,0
161754,.,0,0
161755,Fifty,0,0
161756,nine,0,0
161757,children,0,0
161758,and,0,0
161759,adolescents,0,0
161760,with,0,0
161761,autism,0,0
161762,spectrum,0,0
161763,disorders,0,0
161764,were,0,0
161765,randomized,0,0
161766,to,0,0
161767,receive,0,0
161768,either,0,0
161769,aripiprazole,0,0
161770,or,0,0
161771,risperidone,0,0
161772,for,0,0
161773,2,0,0
161774,months,0,0
161775,.,0,0
161776,The,0,0
161777,primary,0,0
161778,outcome,0,1
161779,measure,0,1
161780,was,1,0
161781,change,1,1
161782,in,1,0
161783,Aberrant,1,1
161784,Behavior,1,1
161785,Checklist,1,1
161786,(,1,0
161787,ABC,1,1
161788,),1,0
161789,scores,1,1
161790,.,1,0
161791,Adverse,0,1
161792,events,0,1
161793,were,0,0
161794,assessed,0,0
161795,.,0,0
161796,Aripiprazole,0,0
161797,as,0,0
161798,well,0,0
161799,as,0,0
161800,risperidone,0,0
161801,lowered,1,0
161802,ABC,1,1
161803,scores,1,1
161804,during,0,0
161805,2,0,0
161806,months,0,0
161807,.,0,0
161808,The,1,0
161809,rates,1,1
161810,of,1,0
161811,adverse,1,1
161812,effects,1,1
161813,were,1,0
161814,not,0,0
161815,significantly,0,0
161816,different,0,0
161817,between,0,0
161818,the,0,0
161819,two,0,0
161820,groups,0,0
161821,.,0,0
161822,The,1,0
161823,safety,1,1
161824,and,1,0
161825,efficacy,1,1
161826,of,1,1
161827,aripiprazole,0,0
161828,(,0,0
161829,mean,0,0
161830,dose,0,0
161831,5.5,0,0
161832,mg/day,0,0
161833,),0,0
161834,and,0,1
161835,risperidone,0,0
161836,(,0,0
161837,mean,0,0
161838,dose,0,0
161839,1.12,0,0
161840,mg/day,0,0
161841,),0,0
161842,were,0,0
161843,comparable,0,0
161844,.,0,0
161845,The,0,0
161846,choice,0,0
161847,between,0,0
161848,these,0,0
161849,two,0,0
161850,medications,0,0
161851,should,0,0
161852,be,0,0
161853,on,0,0
161854,the,0,0
161855,basis,0,0
161856,of,0,0
161857,clinical,0,0
161858,equipoise,0,0
161859,considering,0,0
161860,the,0,0
161861,patient,0,1
161862,'s,0,0
161863,preference,0,1
161864,and,0,0
161865,clinical,0,0
161866,profile,0,1
161867,.,0,0
161868,Randomized,0,0
161869,trial,0,0
161870,of,0,0
161871,tailored,0,0
161872,skin,0,1
161873,cancer,0,0
161874,prevention,0,0
161875,for,0,0
161876,children,0,0
161877,:,0,0
161878,the,0,0
161879,Project,0,0
161880,SCAPE,0,1
161881,family,0,0
161882,study,0,0
161883,.,0,0
161884,This,0,0
161885,study,0,0
161886,evaluated,0,0
161887,a,0,0
161888,tailored,0,0
161889,intervention,0,0
161890,to,0,0
161891,promote,0,0
161892,sun,0,0
161893,protection,0,1
161894,in,0,0
161895,parents,0,0
161896,and,0,0
161897,their,0,0
161898,children,0,0
161899,",",0,0
161900,hypothesizing,0,0
161901,that,0,0
161902,the,0,0
161903,tailored,0,0
161904,intervention,0,0
161905,would,0,0
161906,lead,0,0
161907,to,0,0
161908,improved,1,1
161909,skin,1,1
161910,cancer,1,0
161911,prevention,1,0
161912,behaviors,1,1
161913,compared,0,0
161914,to,0,0
161915,generic,0,0
161916,materials,0,0
161917,.,0,0
161918,Families,0,0
161919,were,0,0
161920,recruited,0,0
161921,through,0,0
161922,schools,0,0
161923,and,0,1
161924,community,0,0
161925,centers,0,1
161926,and,0,1
161927,were,0,0
161928,included,0,0
161929,if,0,0
161930,there,0,0
161931,was,0,0
161932,1,0,0
161933,child,0,0
161934,in,0,0
161935,Grades,0,1
161936,1-3,0,0
161937,at,0,0
161938,moderate,0,0
161939,to,0,0
161940,high,0,0
161941,risk,0,1
161942,for,0,0
161943,skin,0,1
161944,cancer,0,0
161945,.,0,0
161946,Participants,0,0
161947,were,0,0
161948,randomized,0,0
161949,into,0,0
161950,one,0,0
161951,of,0,0
161952,two,0,0
161953,intervention,0,0
161954,groups,0,0
161955,:,0,0
161956,a,0,0
161957,tailored,0,0
161958,intervention,0,0
161959,",",0,0
161960,in,0,0
161961,which,0,0
161962,they,0,0
161963,received,0,0
161964,personalized,0,0
161965,skin,0,1
161966,cancer,0,0
161967,education,0,0
161968,through,0,0
161969,the,0,0
161970,mail,0,0
161971,;,0,0
161972,or,0,0
161973,a,0,0
161974,control,0,0
161975,group,0,0
161976,who,0,0
161977,received,0,0
161978,generic,0,0
161979,skin,0,1
161980,cancer,0,0
161981,information,0,0
161982,materials,0,0
161983,.,0,0
161984,Before,0,0
161985,and,0,0
161986,after,0,0
161987,intervention,0,0
161988,",",0,0
161989,parents,0,1
161990,completed,0,0
161991,questionnaires,0,0
161992,about,0,0
161993,their,0,0
161994,and,0,0
161995,their,0,0
161996,children,0,0
161997,'s,0,0
161998,skin,0,1
161999,cancer,0,0
162000,risk,0,1
162001,and,0,1
162002,prevention,0,1
162003,knowledge,0,1
162004,and,0,0
162005,behaviors,0,1
162006,.,0,0
162007,Parents,0,0
162008,also,0,0
162009,completed,0,0
162010,4-day,0,0
162011,sun,0,0
162012,exposure,0,1
162013,and,0,1
162014,protection,0,1
162015,diaries,0,1
162016,for,0,0
162017,their,0,0
162018,child,0,0
162019,and,0,0
162020,themselves,0,0
162021,.,0,0
162022,Tailored,0,0
162023,group,0,0
162024,participants,0,0
162025,demonstrated,0,0
162026,significantly,1,0
162027,greater,1,0
162028,positive,1,1
162029,changes,1,1
162030,in,1,0
162031,prevention,1,0
162032,behavior,1,1
162033,after,0,0
162034,the,0,0
162035,intervention,0,0
162036,",",0,0
162037,including,0,0
162038,children,1,0
162039,'s,1,0
162040,use,1,0
162041,of,1,0
162042,sunscreen,1,0
162043,",",1,0
162044,shirts,1,1
162045,",",1,1
162046,and,1,1
162047,hats,1,1
162048,",",1,1
162049,and,1,1
162050,parents,1,1
162051,',1,1
162052,use,1,0
162053,of,1,0
162054,shade,1,1
162055,",",1,0
162056,and,1,1
162057,skin,1,1
162058,examinations,1,0
162059,.,1,0
162060,Effect,1,0
162061,sizes,1,1
162062,were,0,0
162063,small,1,0
162064,and,1,0
162065,perceived,1,1
162066,benefits,1,1
162067,and,1,0
162068,social,1,1
162069,norms,1,1
162070,mediated,1,1
162071,intervention,1,0
162072,effects,1,0
162073,.,1,0
162074,Findings,0,0
162075,from,0,0
162076,this,0,0
162077,study,0,0
162078,support,0,0
162079,the,0,0
162080,efficacy,0,1
162081,of,0,0
162082,focusing,0,0
162083,tailored,0,0
162084,communications,0,0
162085,to,0,0
162086,families,0,0
162087,in,0,0
162088,order,0,0
162089,to,0,0
162090,change,0,0
162091,skin,0,1
162092,cancer,0,0
162093,prevention,0,0
162094,practices,0,0
162095,in,0,0
162096,young,0,0
162097,children,0,0
162098,.,0,0
162099,Perceptual,1,1
162100,learning,1,1
162101,of,1,0
162102,speech,1,1
162103,under,0,0
162104,optimal,0,0
162105,and,0,0
162106,adverse,0,1
162107,conditions,0,0
162108,.,0,0
162109,Humans,0,0
162110,have,0,0
162111,a,0,0
162112,remarkable,0,0
162113,ability,0,0
162114,to,0,0
162115,understand,0,0
162116,spoken,0,0
162117,language,0,0
162118,despite,0,0
162119,the,0,0
162120,large,0,0
162121,amount,0,1
162122,of,0,0
162123,variability,0,1
162124,in,0,0
162125,speech,0,1
162126,.,0,0
162127,Previous,0,0
162128,research,0,0
162129,has,0,0
162130,shown,0,0
162131,that,0,0
162132,listeners,0,0
162133,can,0,0
162134,use,0,0
162135,lexical,0,1
162136,information,0,0
162137,to,0,0
162138,guide,0,0
162139,their,0,0
162140,interpretation,0,0
162141,of,0,0
162142,atypical,0,0
162143,sounds,0,1
162144,in,0,0
162145,speech,0,1
162146,(,0,0
162147,Norris,0,1
162148,",",0,1
162149,McQueen,0,1
162150,",",0,1
162151,&,0,0
162152,Cutler,0,0
162153,",",0,0
162154,2003,0,0
162155,),0,0
162156,.,0,0
162157,This,0,0
162158,kind,0,0
162159,of,0,0
162160,lexically,0,0
162161,induced,0,0
162162,perceptual,1,1
162163,learning,1,0
162164,enables,0,0
162165,people,0,0
162166,to,0,0
162167,adjust,0,0
162168,to,0,0
162169,the,0,0
162170,variations,0,0
162171,in,0,0
162172,utterances,0,0
162173,due,0,0
162174,to,0,0
162175,talker-specific,0,0
162176,characteristics,0,0
162177,",",0,0
162178,such,0,0
162179,as,0,0
162180,individual,0,0
162181,identity,0,1
162182,and,0,0
162183,dialect,0,0
162184,.,0,0
162185,The,0,0
162186,current,0,0
162187,study,0,0
162188,investigated,0,0
162189,perceptual,1,1
162190,learning,1,0
162191,in,0,0
162192,two,0,0
162193,optimal,0,0
162194,conditions,0,0
162195,:,0,0
162196,conversational,0,1
162197,speech,0,1
162198,(,0,0
162199,Experiment,0,0
162200,1,0,0
162201,),0,0
162202,versus,0,0
162203,clear,0,0
162204,speech,0,1
162205,(,0,0
162206,Experiment,0,0
162207,2,0,0
162208,),0,0
162209,",",0,0
162210,and,0,0
162211,three,0,0
162212,adverse,0,1
162213,conditions,0,0
162214,:,0,0
162215,noise,0,0
162216,(,0,0
162217,Experiment,0,0
162218,3a,0,0
162219,),0,0
162220,versus,0,0
162221,two,0,0
162222,cognitive,0,0
162223,loads,0,0
162224,(,0,0
162225,Experiments,0,0
162226,4a,0,0
162227,and,0,0
162228,4b,0,0
162229,),0,0
162230,.,0,0
162231,Perceptual,1,0
162232,learning,1,1
162233,occurred,0,0
162234,in,0,0
162235,the,0,0
162236,two,0,0
162237,optimal,0,0
162238,conditions,0,0
162239,and,0,0
162240,in,0,0
162241,the,0,0
162242,two,0,0
162243,cognitive,0,0
162244,load,0,0
162245,conditions,0,0
162246,",",0,0
162247,but,0,0
162248,not,0,0
162249,in,0,0
162250,the,0,0
162251,noise,0,0
162252,condition,0,0
162253,.,0,0
162254,Furthermore,0,0
162255,",",0,0
162256,perceptual,1,1
162257,learning,1,1
162258,occurred,0,0
162259,only,0,0
162260,in,0,0
162261,the,0,0
162262,first,0,0
162263,of,0,0
162264,two,0,0
162265,sessions,0,0
162266,for,0,0
162267,each,0,0
162268,participant,0,0
162269,",",0,0
162270,and,0,0
162271,only,0,0
162272,for,0,0
162273,atypical,0,0
162274,/s/,0,1
162275,sounds,0,1
162276,and,0,0
162277,not,0,0
162278,for,0,0
162279,atypical,0,0
162280,/f/,0,0
162281,sounds,0,0
162282,.,0,0
162283,This,0,0
162284,pattern,0,0
162285,of,0,0
162286,learning,0,1
162287,and,0,0
162288,nonlearning,0,0
162289,reflects,0,0
162290,a,0,0
162291,balance,0,1
162292,between,0,0
162293,flexibility,0,1
162294,and,0,1
162295,stability,0,1
162296,that,0,0
162297,the,0,0
162298,speech,0,0
162299,system,0,0
162300,must,0,0
162301,have,0,0
162302,to,0,0
162303,deal,0,0
162304,with,0,0
162305,speech,0,1
162306,variability,0,1
162307,in,0,0
162308,the,0,0
162309,diverse,0,0
162310,conditions,0,0
162311,that,0,0
162312,speech,0,0
162313,is,0,0
162314,encountered,0,0
162315,.,0,0
162316,A,0,0
162317,randomized,0,0
162318,double,0,0
162319,blind,0,0
162320,placebo,0,0
162321,controlled,0,0
162322,clinical,0,0
162323,trial,0,0
162324,of,0,0
162325,N-Acetylcysteine,0,0
162326,added,0,0
162327,to,0,0
162328,risperidone,0,0
162329,for,0,0
162330,treating,0,0
162331,autistic,0,0
162332,disorders,0,0
162333,.,0,0
162334,BACKGROUND,0,0
162335,This,0,0
162336,study,0,0
162337,examined,0,0
162338,the,0,0
162339,efficacy,0,1
162340,and,0,0
162341,safety,0,1
162342,of,0,1
162343,N-acetylcysteine,0,0
162344,(,0,0
162345,NAC,0,1
162346,),0,0
162347,augmentation,0,0
162348,for,0,0
162349,treating,0,0
162350,irritability,0,1
162351,in,0,0
162352,children,0,0
162353,and,0,0
162354,adolescents,0,0
162355,with,0,0
162356,autism,0,0
162357,spectrum,0,0
162358,disorders,0,0
162359,(,0,0
162360,ASD,0,0
162361,),0,0
162362,.,0,0
162363,METHOD,0,0
162364,Forty,0,0
162365,children,0,0
162366,and,0,1
162367,adolescents,0,0
162368,met,0,0
162369,diagnostic,0,0
162370,criteria,0,0
162371,for,0,0
162372,ASD,0,0
162373,according,0,0
162374,to,0,0
162375,DSM-IV,0,0
162376,.,0,0
162377,They,0,0
162378,were,0,0
162379,randomly,0,0
162380,allocated,0,0
162381,into,0,0
162382,one,0,0
162383,of,0,0
162384,the,0,0
162385,two,0,0
162386,groups,0,0
162387,of,0,0
162388,NAC,0,1
162389,(,0,0
162390,1200,0,0
162391,mg/day,0,0
162392,),0,0
162393,+risperidone,0,0
162394,or,0,0
162395,placebo+risperidone,0,0
162396,.,0,1
162397,NAC,0,1
162398,and,0,1
162399,placebo,0,0
162400,were,0,0
162401,administered,0,0
162402,in,0,0
162403,the,0,0
162404,form,0,0
162405,of,0,0
162406,effervescent,0,0
162407,and,0,0
162408,in,0,0
162409,two,0,0
162410,divided,0,0
162411,doses,0,0
162412,for,0,0
162413,8,0,0
162414,weeks,1,0
162415,.,1,0
162416,Irritability,1,1
162417,subscale,1,1
162418,score,1,1
162419,of,1,0
162420,Aberrant,1,1
162421,Behavior,1,1
162422,Checklist,1,1
162423,(,1,0
162424,ABC,0,1
162425,),0,0
162426,was,0,0
162427,considered,0,0
162428,as,0,0
162429,the,0,0
162430,main,0,0
162431,outcome,0,0
162432,measure,1,0
162433,.,1,0
162434,Adverse,1,1
162435,effects,1,1
162436,were,1,0
162437,also,0,0
162438,checked,0,0
162439,.,0,0
162440,RESULTS,0,0
162441,The,1,0
162442,mean,1,1
162443,score,1,1
162444,of,1,0
162445,irritability,1,1
162446,in,1,0
162447,the,0,0
162448,NAC+risperidone,0,0
162449,and,0,0
162450,placebo+risperidone,0,0
162451,groups,0,0
162452,at,0,0
162453,baseline,0,0
162454,was,0,0
162455,13.2,0,0
162456,(,0,0
162457,5.3,0,0
162458,),0,0
162459,and,0,0
162460,16.7,0,0
162461,(,0,0
162462,7.8,0,0
162463,),0,0
162464,",",0,0
162465,respectively,0,0
162466,.,0,0
162467,The,0,0
162468,scores,0,1
162469,after,0,0
162470,8,0,0
162471,weeks,0,0
162472,were,0,0
162473,9.7,0,0
162474,(,0,0
162475,4.1,0,0
162476,),0,0
162477,and,0,0
162478,15.1,0,0
162479,(,0,0
162480,7.8,0,0
162481,),0,0
162482,",",0,0
162483,respectively,0,0
162484,.,0,0
162485,Repeated,0,0
162486,measures,0,0
162487,of,0,0
162488,ANOVA,0,0
162489,showed,0,0
162490,that,0,0
162491,there,0,0
162492,was,0,0
162493,a,0,0
162494,significant,0,0
162495,difference,0,0
162496,between,0,0
162497,the,0,0
162498,two,0,0
162499,groups,0,0
162500,after,0,0
162501,8,0,0
162502,weeks,0,0
162503,.,0,0
162504,The,0,0
162505,most,1,0
162506,common,1,0
162507,adverse,1,1
162508,effects,1,0
162509,in,1,0
162510,the,0,0
162511,NAC+risperidone,0,0
162512,group,0,0
162513,were,1,0
162514,constipation,1,1
162515,(,1,0
162516,16.1,1,0
162517,%,1,0
162518,),1,0
162519,",",1,0
162520,increased,1,1
162521,appetite,1,1
162522,(,1,0
162523,16.1,1,0
162524,%,1,0
162525,),1,0
162526,",",1,0
162527,fatigue,1,1
162528,(,1,0
162529,12.9,1,0
162530,%,1,0
162531,),1,0
162532,",",1,0
162533,nervousness,1,1
162534,(,1,0
162535,12.9,0,0
162536,%,0,0
162537,),0,0
162538,",",0,0
162539,and,1,1
162540,daytime,1,1
162541,drowsiness,1,1
162542,(,1,0
162543,12.9,0,0
162544,%,0,0
162545,),0,0
162546,.,0,0
162547,There,0,0
162548,was,0,0
162549,no,0,0
162550,fatal,1,1
162551,adverse,1,1
162552,effect,1,0
162553,.,1,0
162554,CONCLUSIONS,0,0
162555,Risperidone,0,0
162556,plus,0,0
162557,NAC,0,1
162558,more,0,0
162559,than,0,0
162560,risperidone,0,0
162561,plus,0,0
162562,placebo,0,0
162563,decreased,1,1
162564,irritability,1,1
162565,in,1,0
162566,children,0,0
162567,and,0,0
162568,adolescents,0,0
162569,with,0,0
162570,ASD,0,0
162571,.,0,0
162572,Meanwhile,0,0
162573,",",0,0
162574,it,0,0
162575,did,0,0
162576,not,0,0
162577,change,0,0
162578,the,1,0
162579,core,1,0
162580,symptoms,1,1
162581,of,1,0
162582,autism,1,0
162583,.,1,0
162584,Adverse,1,1
162585,effects,1,1
162586,were,1,0
162587,not,0,0
162588,common,0,0
162589,and,0,0
162590,NAC,0,1
162591,was,0,0
162592,generally,1,0
162593,tolerated,1,1
162594,well,1,0
162595,.,0,0
162596,TRIAL,0,0
162597,REGISTRATION,0,0
162598,This,0,0
162599,trial,0,0
162600,was,0,0
162601,registered,0,0
162602,at,0,0
162603,http,0,0
162604,:,0,0
162605,//www.irct.ir,0,0
162606,.,0,0
162607,The,0,0
162608,registration,0,0
162609,number,0,1
162610,of,0,0
162611,this,0,0
162612,trial,0,0
162613,was,0,0
162614,IRCT201106103930N6,0,0
162615,.,0,0
162616,EULAR,0,0
162617,Sjogren,0,0
162618,'s,0,0
162619,Syndrome,0,0
162620,Disease,0,1
162621,Activity,0,1
162622,Index,0,0
162623,(,0,0
162624,ESSDAI,0,0
162625,),0,0
162626,is,0,0
162627,sensitive,0,0
162628,to,0,0
162629,show,0,0
162630,efficacy,1,1
162631,of,0,0
162632,rituximab,0,0
162633,treatment,0,0
162634,in,0,0
162635,a,0,0
162636,randomised,0,0
162637,controlled,0,0
162638,trial,0,0
162639,.,0,0
162640,A,0,0
162641,study,0,0
162642,to,0,0
162643,evaluate,0,0
162644,safety,1,1
162645,and,0,1
162646,tolerability,1,1
162647,of,0,1
162648,repeated,0,0
162649,doses,0,0
162650,of,0,0
162651,tirasemtiv,0,0
162652,in,0,0
162653,patients,0,0
162654,with,0,0
162655,amyotrophic,0,0
162656,lateral,0,0
162657,sclerosis,0,0
162658,.,0,0
162659,Abstract,0,0
162660,Tirasemtiv,0,0
162661,is,0,0
162662,a,0,0
162663,fast,0,0
162664,skeletal,0,0
162665,muscle,0,1
162666,activator,0,0
162667,that,0,0
162668,increases,0,0
162669,the,0,0
162670,sensitivity,0,1
162671,of,0,0
162672,the,0,0
162673,sarcomere,0,1
162674,to,0,0
162675,calcium,0,0
162676,",",0,0
162677,increasing,0,0
162678,the,0,0
162679,efficiency,0,1
162680,of,0,0
162681,muscle,0,1
162682,contraction,0,1
162683,when,0,0
162684,the,0,0
162685,muscle,0,0
162686,is,0,0
162687,stimulated,0,0
162688,at,0,0
162689,submaximal,0,0
162690,contraction,0,0
162691,frequencies,0,1
162692,.,0,0
162693,A,0,0
162694,previous,0,0
162695,study,0,0
162696,showed,0,0
162697,single,0,0
162698,doses,0,0
162699,of,0,0
162700,tirasemtiv,0,0
162701,to,0,0
162702,be,0,0
162703,well,0,0
162704,tolerated,0,1
162705,and,0,0
162706,associated,0,0
162707,with,0,0
162708,potentially,0,0
162709,important,0,0
162710,improvements,0,0
162711,in,0,0
162712,a,0,0
162713,variety,0,0
162714,of,0,0
162715,functional,0,0
162716,outcomes,0,0
162717,.,0,0
162718,This,0,0
162719,study,0,0
162720,determined,0,0
162721,safety,1,1
162722,of,0,0
162723,tirasemtiv,0,0
162724,when,0,0
162725,given,0,0
162726,at,0,0
162727,doses,0,0
162728,up,0,0
162729,to,0,0
162730,500,0,0
162731,mg,0,0
162732,daily,0,0
162733,for,0,0
162734,three,0,0
162735,weeks,0,0
162736,.,0,0
162737,Tirasemtiv,0,0
162738,was,0,0
162739,given,0,0
162740,as,0,0
162741,a,0,0
162742,single,0,0
162743,daily,0,0
162744,dose,0,0
162745,up,0,0
162746,to,0,0
162747,375,0,0
162748,mg,0,0
162749,for,0,0
162750,two,0,0
162751,weeks,0,0
162752,",",0,0
162753,with,0,0
162754,and,0,0
162755,without,0,0
162756,concomitant,0,0
162757,riluzole,0,0
162758,.,0,0
162759,In,0,0
162760,a,0,0
162761,separate,0,0
162762,cohort,0,0
162763,",",0,0
162764,an,0,0
162765,ascending,0,0
162766,dose,0,0
162767,protocol,0,0
162768,evaluated,0,0
162769,a,0,0
162770,total,0,1
162771,dose,0,0
162772,of,0,0
162773,500,0,0
162774,mg,0,0
162775,daily,0,0
162776,given,0,0
162777,in,0,0
162778,two,0,0
162779,divided,0,0
162780,doses,0,0
162781,.,0,0
162782,Safety,1,1
162783,and,1,1
162784,tolerability,1,1
162785,were,0,0
162786,assessed,0,0
162787,",",0,0
162788,as,0,0
162789,well,0,0
162790,as,0,0
162791,measures,1,1
162792,of,1,0
162793,function,1,1
162794,",",1,0
162795,muscle,1,1
162796,strength,1,1
162797,and,1,0
162798,endurance,1,1
162799,.,1,1
162800,Results,0,0
162801,showed,0,0
162802,that,0,0
162803,tirasemtiv,0,0
162804,was,0,0
162805,well,0,0
162806,tolerated,1,1
162807,",",0,0
162808,with,0,0
162809,dizziness,1,0
162810,the,0,0
162811,most,0,0
162812,common,0,0
162813,adverse,0,1
162814,event,0,0
162815,.,0,0
162816,Tirasemtiv,0,0
162817,approximately,0,0
162818,doubled,0,0
162819,the,0,0
162820,serum,1,1
162821,concentration,1,1
162822,of,1,0
162823,riluzole,1,0
162824,.,1,0
162825,Trends,0,0
162826,were,0,0
162827,noted,0,0
162828,for,0,0
162829,improvement,0,0
162830,in,0,0
162831,ALSFRS-R,1,0
162832,",",1,0
162833,Maximum,1,1
162834,Minute,1,1
162835,Ventilation,1,1
162836,",",1,0
162837,and,1,1
162838,Nasal,1,1
162839,Inspiratory,1,1
162840,Pressure,1,1
162841,.,1,0
162842,In,0,0
162843,conclusion,0,0
162844,",",0,0
162845,tirasemtiv,0,0
162846,is,0,0
162847,well,0,0
162848,tolerated,0,1
162849,and,0,0
162850,can,0,0
162851,be,0,0
162852,given,0,0
162853,safely,1,0
162854,with,0,0
162855,a,0,0
162856,reduced,0,0
162857,dose,0,0
162858,of,0,0
162859,riluzole,0,0
162860,.,0,0
162861,Positive,0,1
162862,trends,0,0
162863,in,0,0
162864,multiple,1,0
162865,exploratory,1,0
162866,outcome,1,0
162867,measures,1,1
162868,support,0,0
162869,the,0,0
162870,further,0,0
162871,study,0,0
162872,of,0,0
162873,this,0,0
162874,agent,0,0
162875,in,0,0
162876,ALS,0,0
162877,.,0,0
162878,Infant,0,1
162879,distress,0,1
162880,and,0,1
162881,development,0,1
162882,of,0,1
162883,functional,0,0
162884,gastrointestinal,0,1
162885,disorders,0,0
162886,in,0,0
162887,childhood,0,0
162888,:,0,0
162889,is,0,0
162890,there,0,0
162891,a,0,0
162892,connection,0,0
162893,?,0,0
162894,Assessment,0,0
162895,of,0,0
162896,global,1,1
162897,functioning,1,1
162898,in,0,0
162899,adolescents,0,0
162900,with,0,0
162901,autism,0,0
162902,spectrum,0,0
162903,disorders,0,0
162904,:,0,0
162905,utility,0,0
162906,of,0,0
162907,the,0,0
162908,Developmental,1,0
162909,Disability-Child,1,0
162910,Global,1,1
162911,Assessment,1,0
162912,Scale,1,1
162913,.,1,0
162914,Assessment,0,0
162915,of,0,0
162916,global,1,0
162917,functioning,1,1
162918,is,0,0
162919,an,0,0
162920,important,0,0
162921,consideration,0,0
162922,in,0,0
162923,treatment,0,0
162924,outcome,0,1
162925,research,0,0
162926,;,0,0
162927,yet,0,0
162928,",",0,0
162929,there,0,0
162930,is,0,0
162931,little,0,0
162932,guidance,0,0
162933,on,0,0
162934,its,0,0
162935,evidence-based,0,0
162936,assessment,0,0
162937,for,0,0
162938,children,0,0
162939,with,0,0
162940,autism,0,0
162941,spectrum,0,0
162942,disorders,0,0
162943,.,0,0
162944,This,0,0
162945,study,0,0
162946,investigated,0,0
162947,the,0,0
162948,utility,0,1
162949,and,0,0
162950,validity,0,0
162951,of,0,1
162952,clinician-rated,0,1
162953,global,1,1
162954,functioning,1,1
162955,using,0,0
162956,the,0,0
162957,Developmental,1,0
162958,Disability-Child,1,0
162959,Global,1,1
162960,Assessment,1,0
162961,Scale,1,1
162962,in,0,0
162963,a,0,0
162964,sample,0,0
162965,of,0,0
162966,higher,0,0
162967,functioning,0,1
162968,adolescents,0,0
162969,with,0,0
162970,autism,0,0
162971,spectrum,0,0
162972,disorders,0,0
162973,and,0,1
162974,comorbid,0,0
162975,anxiety,0,1
162976,disorders,0,0
162977,enrolled,0,0
162978,in,0,0
162979,a,0,0
162980,randomized,0,0
162981,controlled,0,0
162982,trial,0,0
162983,(,0,0
162984,n,0,0
162985,=,0,0
162986,30,0,0
162987,),0,0
162988,.,0,0
162989,Pretreatment,0,0
162990,Developmental,1,0
162991,Disability-Child,1,0
162992,Global,1,1
162993,Assessment,1,0
162994,Scale,1,1
162995,scores,0,1
162996,correlated,0,0
162997,with,0,0
162998,severity,0,1
162999,of,0,0
163000,autism,0,0
163001,spectrum,0,0
163002,disorders,0,0
163003,core,0,0
163004,symptoms,0,1
163005,(,0,0
163006,r,0,0
163007,=,0,0
163008,-.388,0,0
163009,",",0,0
163010,p,0,0
163011,=,0,0
163012,.034,0,0
163013,),0,0
163014,",",0,0
163015,pragmatic,0,0
163016,communication,0,1
163017,(,0,0
163018,r,0,0
163019,=,0,0
163020,.407,0,0
163021,",",0,0
163022,p,0,0
163023,=,0,0
163024,.032,0,0
163025,),0,0
163026,",",0,0
163027,and,0,1
163028,verbal,0,1
163029,ability,0,1
163030,(,0,0
163031,r,0,0
163032,=,0,0
163033,.449,0,0
163034,",",0,0
163035,p,0,0
163036,=,0,0
163037,.013,0,1
163038,),0,0
163039,and,0,0
163040,did,0,0
163041,not,0,0
163042,correlate,0,0
163043,with,0,0
163044,severity,0,1
163045,of,0,0
163046,anxiety,1,1
163047,symptoms,1,1
163048,or,0,0
163049,with,0,0
163050,parent-reported,0,1
163051,adaptive,0,0
163052,behavior,0,1
163053,.,0,0
163054,Change,1,0
163055,in,1,0
163056,Developmental,1,0
163057,Disability-Child,1,1
163058,Global,1,1
163059,Assessment,1,0
163060,Scale,1,1
163061,scores,1,1
163062,during,0,0
163063,treatment,0,0
163064,was,0,0
163065,associated,0,0
163066,with,0,0
163067,autism,0,0
163068,spectrum,0,0
163069,disorders,0,0
163070,symptomatic,1,1
163071,improvement,1,1
163072,(,0,0
163073,r,0,0
163074,=,0,0
163075,.414,0,0
163076,",",0,0
163077,p,0,0
163078,=,0,0
163079,.040,0,0
163080,),0,0
163081,and,0,0
163082,with,0,0
163083,improved,0,1
163084,general,1,0
163085,communication,1,1
163086,(,0,0
163087,r,0,0
163088,=,0,0
163089,.499,0,0
163090,",",0,0
163091,p,0,0
163092,=,0,0
163093,.013,0,0
163094,),0,0
163095,.,0,0
163096,Results,0,0
163097,support,0,0
163098,the,0,0
163099,importance,0,0
163100,of,0,0
163101,assessing,0,0
163102,global,1,1
163103,functioning,1,1
163104,in,0,0
163105,addition,0,0
163106,to,0,0
163107,symptom,1,1
163108,change,1,1
163109,and,0,1
163110,treatment,1,0
163111,response,1,1
163112,in,0,0
163113,clinical,0,0
163114,trials,0,0
163115,.,0,0
163116,Incremental,0,1
163117,cost-effectiveness,1,0
163118,of,0,1
163119,pharmacotherapy,0,0
163120,and,0,0
163121,two,0,0
163122,brief,0,0
163123,cognitive-behavioral,0,0
163124,therapies,0,0
163125,compared,0,0
163126,with,0,0
163127,usual,0,0
163128,care,0,0
163129,for,0,0
163130,panic,1,1
163131,disorder,1,0
163132,and,0,0
163133,noncardiac,0,1
163134,chest,0,1
163135,pain,0,1
163136,.,0,0
163137,The,0,0
163138,aim,0,0
163139,of,0,0
163140,this,0,0
163141,study,0,0
163142,was,0,0
163143,to,0,0
163144,assess,0,0
163145,the,0,0
163146,incremental,0,0
163147,cost-effectiveness,1,0
163148,ratios,1,1
163149,(,0,0
163150,ICERs,0,0
163151,),0,0
163152,of,0,0
163153,two,0,0
163154,brief,0,0
163155,cognitive-behavioral,0,0
163156,therapy,0,0
163157,(,0,0
163158,CBT,0,0
163159,),0,0
163160,-based,0,0
163161,interventions,0,0
163162,and,0,0
163163,a,0,0
163164,pharmacological,0,0
163165,treatment,0,0
163166,",",0,0
163167,compared,0,0
163168,with,0,0
163169,usual,0,0
163170,care,0,0
163171,",",0,0
163172,initiated,0,0
163173,in,0,0
163174,the,0,0
163175,emergency,0,1
163176,department,0,0
163177,(,0,0
163178,ED,0,0
163179,),0,0
163180,for,0,0
163181,individuals,0,0
163182,with,0,0
163183,panic,1,1
163184,disorder,1,0
163185,(,0,0
163186,PD,0,1
163187,),0,0
163188,with,0,0
163189,a,0,0
163190,chief,0,0
163191,complaint,0,1
163192,of,0,0
163193,noncardiac,0,1
163194,chest,0,0
163195,pain,0,1
163196,.,0,0
163197,A,0,0
163198,total,0,0
163199,of,0,0
163200,69,0,0
163201,patients,0,0
163202,were,0,0
163203,followed,0,0
163204,up,0,0
163205,to,0,0
163206,6,0,0
163207,months,0,0
163208,.,0,0
163209,The,0,0
163210,primary,0,0
163211,outcome,0,1
163212,variables,0,1
163213,were,0,0
163214,direct,1,0
163215,and,1,0
163216,indirect,1,0
163217,costs,1,1
163218,of,1,0
163219,treatment,1,0
163220,and,1,1
163221,PD,1,1
163222,severity,1,1
163223,.,1,0
163224,Panic,0,1
163225,management,0,0
163226,(,0,0
163227,PM,0,0
163228,),0,0
163229,had,0,0
163230,an,0,0
163231,ICER,1,0
163232,of,0,0
163233,$,0,0
163234,124.05,0,0
163235,",",0,0
163236,per,0,0
163237,the,0,0
163238,Anxiety,0,0
163239,Disorders,0,0
163240,Interview,0,0
163241,Schedule,0,1
163242,for,0,0
163243,Diagnostic,0,0
163244,and,0,0
163245,Statistical,0,0
163246,Manual,0,1
163247,of,0,0
163248,Mental,0,0
163249,Disorders,0,0
163250,",",0,0
163251,Fourth,0,1
163252,Edition,0,1
163253,",",0,0
163254,severity,0,1
163255,score,0,1
163256,change,0,1
163257,(,0,0
163258,95,0,0
163259,%,0,0
163260,confidence,0,0
163261,interval,0,0
163262,[,0,0
163263,CI,0,0
163264,],0,0
163265,",",0,0
163266,$,0,0
163267,54.63-,0,0
163268,$,0,0
163269,314.57,0,0
163270,),0,0
163271,",",0,0
163272,compared,0,0
163273,with,0,0
163274,pharmacotherapy,0,0
163275,(,0,0
163276,paroxetine,0,0
163277,),0,0
163278,",",0,0
163279,with,0,0
163280,an,0,0
163281,ICER,1,0
163282,of,0,0
163283,$,0,0
163284,213.90,0,0
163285,(,0,0
163286,95,0,0
163287,%,0,0
163288,CI,0,0
163289,",",0,0
163290,$,0,0
163291,133.51-,0,0
163292,$,0,0
163293,394.94,0,0
163294,),0,0
163295,",",0,0
163296,and,0,1
163297,brief,0,1
163298,CBT,0,0
163299,",",0,0
163300,with,0,0
163301,an,0,0
163302,ICER,1,0
163303,of,0,0
163304,$,0,0
163305,309.31,0,0
163306,(,0,0
163307,95,0,0
163308,%,0,0
163309,CI,0,0
163310,",",0,0
163311,$,0,0
163312,151.27-,0,0
163313,$,0,0
163314,548.28,0,0
163315,),0,0
163316,.,0,0
163317,The,0,0
163318,pharmacological,0,0
163319,and,0,0
163320,CBT,0,0
163321,interventions,0,0
163322,were,0,0
163323,associated,0,0
163324,with,0,0
163325,a,0,0
163326,greater,0,0
163327,clinical,1,0
163328,improvement,1,1
163329,compared,0,0
163330,with,0,0
163331,usual,0,0
163332,care,0,0
163333,at,0,0
163334,posttest,0,0
163335,.,0,0
163336,PM,0,0
163337,presented,0,0
163338,a,0,0
163339,superior,0,0
163340,ICER,1,0
163341,",",0,0
163342,suggesting,0,0
163343,that,0,0
163344,it,0,0
163345,may,0,0
163346,be,0,0
163347,a,0,0
163348,promising,0,0
163349,treatment,0,0
163350,option,0,0
163351,to,0,0
163352,implement,0,0
163353,in,0,0
163354,EDs,0,0
163355,.,0,0
163356,Novel,0,1
163357,population,0,0
163358,pharmacokinetic,0,1
163359,method,0,0
163360,compared,0,0
163361,to,0,0
163362,the,0,0
163363,standard,0,0
163364,noncompartmental,0,0
163365,approach,0,0
163366,to,0,0
163367,assess,0,0
163368,bioequivalence,0,0
163369,of,0,0
163370,iron,0,0
163371,gluconate,0,0
163372,formulations,0,0
163373,.,0,0
163374,PURPOSE,0,0
163375,Iron-containing,0,0
163376,products,0,0
163377,are,0,0
163378,atypical,0,0
163379,in,0,0
163380,terms,0,0
163381,of,0,0
163382,their,0,0
163383,pharmacokinetic,0,0
163384,properties,0,1
163385,because,0,0
163386,iron,0,0
163387,is,0,0
163388,only,0,0
163389,removed,0,0
163390,by,0,0
163391,plasma,0,1
163392,sampling,0,0
163393,and,0,0
163394,is,0,0
163395,non-linear,0,0
163396,.,0,0
163397,This,0,0
163398,study,0,0
163399,aims,0,0
163400,to,0,0
163401,present,0,0
163402,a,0,0
163403,novel,0,0
163404,way,0,0
163405,of,0,0
163406,assessing,0,0
163407,the,0,0
163408,relative,0,0
163409,bioavailability,0,1
163410,of,0,0
163411,two,0,0
163412,sodium,0,0
163413,ferric,0,0
163414,gluconate,0,0
163415,complex,0,0
163416,(,0,0
163417,SFGC,0,1
163418,),0,0
163419,formulations,0,0
163420,and,0,0
163421,compare,0,0
163422,this,0,0
163423,approach,0,0
163424,to,0,0
163425,a,0,0
163426,standard,0,0
163427,previously,0,0
163428,published,0,0
163429,noncompartmental,0,0
163430,approach,0,0
163431,.,0,0
163432,METHODS,0,0
163433,Data,0,1
163434,were,0,0
163435,from,0,0
163436,open-label,0,0
163437,",",0,0
163438,randomized,0,0
163439,",",0,0
163440,single-dose,0,0
163441,studies,0,0
163442,(,0,0
163443,Study,0,0
163444,1,0,0
163445,was,0,0
163446,parallel,0,0
163447,whereas,0,0
163448,Study,0,0
163449,2,0,0
163450,was,0,0
163451,crossover,0,0
163452,),0,0
163453,.,0,0
163454,Subjects,0,0
163455,with,0,0
163456,low,0,0
163457,but,0,0
163458,normal,0,0
163459,iron,0,0
163460,levels,0,1
163461,were,0,0
163462,infused,0,0
163463,IV,0,1
163464,SFGC,0,1
163465,in,0,0
163466,sucrose,0,0
163467,by,0,0
163468,GeneraMedix,0,1
163469,Inc.,0,0
163470,and/or,0,0
163471,Ferrlecit,0,0
163472,?,0,0
163473,Injection,0,0
163474,(,0,0
163475,Watson,0,1
163476,Laboratories,0,0
163477,Inc.,0,0
163478,),0,0
163479,.,0,0
163480,In,0,0
163481,Study,0,0
163482,1,0,0
163483,(,0,0
163484,n=240,0,0
163485,),0,0
163486,",",0,0
163487,125,0,0
163488,mg,0,0
163489,was,0,0
163490,infused,0,0
163491,over,0,0
163492,10,0,0
163493,minutes,0,0
163494,.,0,0
163495,In,0,0
163496,Study,0,0
163497,2,0,0
163498,(,0,0
163499,n=29,0,0
163500,),0,0
163501,",",0,0
163502,62.5,0,0
163503,mg,0,0
163504,was,0,0
163505,infused,0,0
163506,over,0,0
163507,30,0,0
163508,minutes,0,0
163509,.,0,0
163510,Samples,0,0
163511,were,0,0
163512,assayed,0,0
163513,for,0,0
163514,total,0,1
163515,iron,0,0
163516,(,0,0
163517,TI,0,0
163518,),0,0
163519,and,0,0
163520,transferrin-bound,0,1
163521,iron,0,0
163522,(,0,0
163523,TBI,0,0
163524,),0,0
163525,over,0,0
163526,36,0,0
163527,hours,0,0
163528,(,0,0
163529,Study,0,0
163530,1,0,0
163531,),0,0
163532,or,0,0
163533,72,0,0
163534,hours,0,0
163535,(,0,0
163536,Study,0,0
163537,2,0,0
163538,),0,0
163539,post-dose,0,0
163540,.,0,0
163541,Studies,0,0
163542,1,0,0
163543,and,0,0
163544,2,0,0
163545,used,0,0
163546,standard,0,0
163547,noncompartmental,0,0
163548,analysis,0,0
163549,.,0,0
163550,Study,0,0
163551,2,0,0
163552,also,0,0
163553,used,0,0
163554,population,0,0
163555,PK,0,0
163556,(,0,0
163557,PPK,0,0
163558,),0,0
163559,analyses,0,0
163560,with,0,0
163561,ADAPT,0,0
163562,5?,0,0
163563,.,0,0
163564,The,0,0
163565,final,0,1
163566,model,0,0
163567,predicted,0,1
163568,SFGC,0,1
163569,area-under-the-curve,0,1
163570,(,0,0
163571,AUCpred,0,0
163572,),0,0
163573,and,0,0
163574,maximal,0,1
163575,concentration,0,1
163576,(,0,0
163577,Cmaxpred,0,0
163578,),0,0
163579,.,0,0
163580,Analyses,0,0
163581,of,0,0
163582,variance,0,0
163583,was,0,0
163584,conducted,0,0
163585,on,0,0
163586,ln-transformed,0,1
163587,PK,0,0
163588,parameters,0,1
163589,.,0,0
163590,Ratios,0,1
163591,of,0,0
163592,means,0,0
163593,and,0,0
163594,90,0,0
163595,%,0,0
163596,confidence,0,0
163597,intervals,0,0
163598,(,0,0
163599,CIs,0,1
163600,),0,0
163601,were,0,0
163602,estimated,0,0
163603,.,0,0
163604,Bioequivalence,0,0
163605,was,0,0
163606,demonstrated,0,0
163607,if,0,0
163608,values,0,1
163609,were,0,0
163610,within,0,0
163611,80-125,0,0
163612,%,0,0
163613,.,0,0
163614,RESULTS,0,0
163615,For,0,0
163616,Study,0,0
163617,1,0,0
163618,",",0,0
163619,ratios,0,0
163620,and,0,0
163621,90,0,0
163622,%,0,0
163623,CIs,0,0
163624,for,0,0
163625,TI,0,0
163626,baseline-corrected,0,0
163627,Cmax,0,1
163628,and,0,0
163629,AUC0-36,0,0
163630,were,0,0
163631,100.4,0,0
163632,(,0,0
163633,96.5,0,0
163634,-,0,0
163635,104.5,0,0
163636,),0,0
163637,and,0,0
163638,99.7,0,0
163639,(,0,0
163640,94.2,0,0
163641,-,0,0
163642,105.5,0,0
163643,),0,0
163644,.,0,0
163645,For,0,0
163646,TBI,0,0
163647,",",0,0
163648,results,0,0
163649,for,0,0
163650,TI,0,0
163651,baseline-corrected,0,0
163652,Cmax,0,1
163653,and,0,0
163654,AUC0-36,0,0
163655,were,0,0
163656,86.8,0,0
163657,(,0,0
163658,82.7,0,0
163659,-,0,0
163660,91.1,0,0
163661,),0,0
163662,and,0,0
163663,92.4,0,0
163664,(,0,0
163665,85.6,0,0
163666,-,0,0
163667,99.7,0,0
163668,),0,0
163669,.,0,0
163670,For,0,0
163671,Study,0,0
163672,2,0,0
163673,",",0,0
163674,a,0,0
163675,multi-compartmental,0,0
163676,model,0,0
163677,simultaneously,0,0
163678,described,0,0
163679,the,0,0
163680,PK,0,0
163681,of,0,0
163682,TI,0,0
163683,",",0,0
163684,TBI,0,0
163685,and,0,0
163686,SFGC,0,1
163687,.,0,1
163688,Ratios,0,1
163689,and,0,0
163690,90,0,0
163691,%,0,0
163692,CIs,0,0
163693,for,0,0
163694,SFGC,0,1
163695,Cmaxpred,0,0
163696,and,0,1
163697,AUCpred,0,0
163698,were,0,0
163699,89.9,0,0
163700,(,0,0
163701,85.9,0,0
163702,-,0,0
163703,94.0,0,0
163704,),0,0
163705,and,0,0
163706,89.7,0,0
163707,(,0,0
163708,85.7,0,0
163709,-,0,0
163710,93.9,0,0
163711,),0,0
163712,",",0,0
163713,while,0,0
163714,ratios,0,1
163715,and,0,0
163716,90,0,0
163717,%,0,0
163718,CI,0,0
163719,obtained,0,0
163720,from,0,0
163721,the,0,0
163722,noncompartmental,0,0
163723,analysis,0,0
163724,of,0,0
163725,Study,0,0
163726,2,0,0
163727,did,0,0
163728,not,0,0
163729,meet,0,0
163730,BE,0,0
163731,criteria,0,0
163732,because,0,0
163733,of,0,0
163734,low,0,0
163735,power,0,0
163736,.,0,0
163737,CONCLUSIONS,0,0
163738,Both,0,0
163739,the,0,0
163740,standard,0,0
163741,and,0,0
163742,PPK,0,0
163743,modeling,0,0
163744,approach,0,0
163745,suggested,0,0
163746,bioequivalence,0,0
163747,between,0,0
163748,the,0,0
163749,iron,0,0
163750,products,0,0
163751,.,0,0
163752,However,0,0
163753,",",0,0
163754,with,0,0
163755,the,0,0
163756,PPK,0,0
163757,method,0,0
163758,",",0,0
163759,less,0,0
163760,subjects,0,0
163761,were,0,0
163762,required,0,0
163763,to,0,0
163764,meet,0,0
163765,study,0,0
163766,objectives,0,0
163767,compared,0,0
163768,to,0,0
163769,the,0,0
163770,standard,0,0
163771,noncompartmental,0,0
163772,approach,0,0
163773,which,0,0
163774,required,0,0
163775,considerably,0,0
163776,more,0,0
163777,subjects,0,0
163778,(,0,0
163779,29,0,0
163780,vs,0,0
163781,240,0,0
163782,),0,0
163783,.,0,0
163784,Effectiveness,0,1
163785,of,0,0
163786,a,0,0
163787,theory-based,0,0
163788,intervention,0,0
163789,to,0,0
163790,increase,0,0
163791,colorectal,1,0
163792,cancer,1,0
163793,screening,1,0
163794,among,0,0
163795,Iranian,0,0
163796,health,0,1
163797,club,0,0
163798,members,0,0
163799,:,0,0
163800,a,0,0
163801,randomized,0,0
163802,trial,0,0
163803,.,0,0
163804,Colorectal,0,0
163805,cancer,0,0
163806,is,0,0
163807,the,0,0
163808,third,0,0
163809,most,0,0
163810,commonly,0,0
163811,diagnosed,0,0
163812,cancer,0,0
163813,and,0,0
163814,the,0,0
163815,fourth,0,0
163816,leading,0,0
163817,cause,0,0
163818,of,0,0
163819,death,0,1
163820,in,0,0
163821,the,0,0
163822,world,0,0
163823,.,0,0
163824,There,0,0
163825,are,0,0
163826,few,0,0
163827,published,0,0
163828,studies,0,0
163829,that,0,0
163830,have,0,0
163831,used,0,0
163832,theory-based,0,0
163833,interventions,0,0
163834,designed,0,0
163835,to,0,0
163836,increase,0,0
163837,colorectal,0,0
163838,cancer,0,0
163839,screening,0,0
163840,in,0,0
163841,community,0,0
163842,lay,0,0
163843,health,0,1
163844,organizations,0,0
163845,.,0,0
163846,The,0,0
163847,present,0,0
163848,study,0,0
163849,was,0,0
163850,guided,0,0
163851,by,0,0
163852,the,0,0
163853,theoretical,0,0
163854,concepts,0,0
163855,of,0,0
163856,the,0,0
163857,preventive,0,0
163858,health,0,0
163859,model,0,0
163860,.,0,0
163861,Twelve,0,0
163862,health,0,1
163863,clubs,0,0
163864,of,0,0
163865,a,0,0
163866,municipal,0,0
163867,district,0,0
163868,in,0,0
163869,Tehran,0,0
163870,were,0,0
163871,randomized,0,0
163872,to,0,0
163873,two,0,0
163874,study,0,0
163875,groups,0,0
163876,with,0,0
163877,equal,0,0
163878,ratio,0,1
163879,.,0,0
163880,The,0,0
163881,control,0,0
163882,group,0,0
163883,received,0,0
163884,usual,0,0
163885,services,0,0
163886,throughout,0,0
163887,the,0,0
163888,study,0,0
163889,while,0,0
163890,the,0,0
163891,intervention,0,0
163892,group,0,0
163893,also,0,0
163894,received,0,0
163895,a,0,0
163896,theory-based,0,0
163897,educational,0,0
163898,program,0,0
163899,on,0,0
163900,colorectal,0,0
163901,cancer,0,0
163902,screening,0,0
163903,plus,0,0
163904,a,0,0
163905,reminder,0,0
163906,call,0,1
163907,.,0,0
163908,Screening,1,0
163909,behavior,1,1
163910,",",0,0
163911,the,0,0
163912,main,0,0
163913,outcome,0,1
163914,",",0,0
163915,was,0,0
163916,assessed,0,0
163917,4,0,0
163918,months,0,0
163919,after,0,0
163920,randomization,0,0
163921,.,0,0
163922,A,0,0
163923,total,0,0
163924,of,0,0
163925,360,0,0
163926,members,0,0
163927,aged,0,0
163928,50,0,0
163929,and,0,0
163930,older,0,0
163931,from,0,0
163932,12,0,0
163933,health,0,0
163934,clubs,0,0
163935,completed,0,0
163936,a,0,0
163937,baseline,0,0
163938,survey,0,0
163939,.,0,0
163940,Participants,0,0
163941,in,0,0
163942,the,0,0
163943,intervention,0,0
163944,group,0,0
163945,reported,0,0
163946,increased,1,0
163947,knowledge,1,1
163948,of,1,0
163949,colorectal,1,0
163950,cancer,1,0
163951,and,1,1
163952,screening,1,0
163953,tests,1,1
163954,at,0,0
163955,4,0,0
163956,months,0,0
163957,follow-up,0,0
163958,(,0,0
163959,p,0,0
163960,'s,0,1
163961,<,0,0
163962,.001,0,0
163963,),0,0
163964,.,0,0
163965,Moreover,0,0
163966,",",0,0
163967,exposure,0,0
163968,to,0,0
163969,the,0,0
163970,theory-based,0,0
163971,intervention,0,0
163972,significantly,0,0
163973,improved,1,0
163974,self-efficacy,1,1
163975,",",1,0
163976,perceived,1,1
163977,susceptibility,1,1
163978,",",1,0
163979,efficacy,1,1
163980,of,1,1
163981,screening,1,0
163982,",",1,0
163983,social,1,1
163984,support,1,0
163985,",",1,0
163986,and,1,1
163987,intention,1,1
163988,to,1,0
163989,be,1,0
163990,screened,1,0
163991,for,1,0
163992,colorectal,1,0
163993,cancer,1,0
163994,",",0,0
163995,from,0,0
163996,baseline,0,0
163997,to,0,0
163998,4,0,0
163999,months,0,0
164000,follow-up,0,0
164001,(,0,0
164002,p,0,0
164003,'s,0,1
164004,<,0,0
164005,.001,0,0
164006,),0,0
164007,.,0,0
164008,The,0,0
164009,screening,1,0
164010,rate,1,1
164011,for,1,0
164012,colorectal,1,0
164013,cancer,1,0
164014,was,0,0
164015,significantly,0,0
164016,higher,0,0
164017,in,0,0
164018,the,0,0
164019,intervention,0,0
164020,group,0,0
164021,compared,0,0
164022,to,0,0
164023,the,0,0
164024,control,0,0
164025,group,0,0
164026,(,0,0
164027,odds,0,0
164028,ratio,0,1
164029,=,0,0
164030,15.93,0,0
164031,",",0,0
164032,95,0,0
164033,%,0,0
164034,CI,0,0
164035,=,0,0
164036,5.57,0,0
164037,",",0,0
164038,45.53,0,0
164039,),0,0
164040,.,0,0
164041,Our,0,0
164042,theory-based,0,0
164043,intervention,0,0
164044,was,0,0
164045,found,0,0
164046,to,0,0
164047,have,0,0
164048,a,0,0
164049,significant,0,0
164050,effect,0,0
164051,on,0,0
164052,colorectal,1,0
164053,cancer,1,0
164054,screening,1,0
164055,use,0,0
164056,as,0,0
164057,measured,0,0
164058,by,0,0
164059,self-report,0,0
164060,.,0,0
164061,The,0,0
164062,findings,0,0
164063,could,0,0
164064,have,0,0
164065,implications,0,0
164066,for,0,0
164067,colorectal,0,0
164068,cancer,0,0
164069,screening,0,0
164070,program,0,0
164071,development,0,1
164072,and,0,1
164073,implementation,0,0
164074,in,0,0
164075,primary,0,0
164076,health,0,1
164077,care,0,0
164078,settings,0,0
164079,and,0,0
164080,through,0,0
164081,other,0,0
164082,community,0,0
164083,organizations,0,0
164084,.,0,0
164085,Oxytocin,0,0
164086,promotes,0,0
164087,facial,1,1
164088,emotion,1,1
164089,recognition,1,1
164090,and,1,1
164091,amygdala,1,1
164092,reactivity,1,1
164093,in,0,0
164094,adults,0,0
164095,with,0,0
164096,asperger,0,0
164097,syndrome,0,0
164098,.,0,0
164099,The,0,0
164100,neuropeptide,0,0
164101,oxytocin,0,0
164102,has,0,0
164103,recently,0,0
164104,been,0,0
164105,shown,0,0
164106,to,0,0
164107,enhance,0,0
164108,eye,1,0
164109,gaze,1,1
164110,and,1,1
164111,emotion,1,1
164112,recognition,1,1
164113,in,0,0
164114,healthy,0,0
164115,men,0,0
164116,.,0,0
164117,Here,0,0
164118,",",0,0
164119,we,0,0
164120,report,0,0
164121,a,0,0
164122,randomized,0,0
164123,double-blind,0,0
164124,",",0,0
164125,placebo-controlled,0,0
164126,trial,0,0
164127,that,0,0
164128,examined,0,0
164129,the,0,0
164130,neural,0,0
164131,and,0,0
164132,behavioral,0,1
164133,effects,0,1
164134,of,0,0
164135,a,0,0
164136,single,0,0
164137,dose,0,0
164138,of,0,0
164139,intranasal,0,0
164140,oxytocin,0,0
164141,on,0,0
164142,emotion,0,1
164143,recognition,0,1
164144,in,0,0
164145,individuals,0,0
164146,with,0,0
164147,Asperger,0,0
164148,syndrome,0,0
164149,(,0,0
164150,AS,0,0
164151,),0,0
164152,",",0,0
164153,a,0,0
164154,clinical,0,0
164155,condition,0,0
164156,characterized,0,0
164157,by,0,0
164158,impaired,0,0
164159,eye,0,0
164160,gaze,0,1
164161,and,0,1
164162,facial,0,1
164163,emotion,0,1
164164,recognition,0,0
164165,.,0,0
164166,Using,0,0
164167,functional,0,0
164168,magnetic,0,0
164169,resonance,0,0
164170,imaging,0,0
164171,",",0,0
164172,we,0,0
164173,examined,0,0
164174,whether,0,0
164175,oxytocin,0,0
164176,would,0,0
164177,enhance,0,0
164178,emotion,1,1
164179,recognition,1,1
164180,from,0,0
164181,facial,0,0
164182,sections,0,0
164183,of,0,0
164184,the,0,0
164185,eye,0,0
164186,vs,0,0
164187,the,0,0
164188,mouth,0,0
164189,region,0,0
164190,and,0,0
164191,modulate,1,0
164192,regional,1,0
164193,activity,1,1
164194,in,1,0
164195,brain,1,1
164196,areas,1,0
164197,associated,1,0
164198,with,1,0
164199,face,1,0
164200,perception,1,1
164201,in,0,0
164202,both,0,0
164203,adults,0,0
164204,with,0,0
164205,AS,0,1
164206,",",0,0
164207,and,0,0
164208,a,0,0
164209,neurotypical,0,0
164210,control,0,0
164211,group,0,0
164212,.,0,0
164213,Intranasal,0,0
164214,administration,0,0
164215,of,0,0
164216,the,0,0
164217,neuropeptide,0,0
164218,oxytocin,0,0
164219,improved,0,1
164220,performance,1,1
164221,in,1,0
164222,a,1,0
164223,facial,1,0
164224,emotion,1,1
164225,recognition,1,1
164226,task,1,1
164227,in,0,0
164228,individuals,0,0
164229,with,0,0
164230,AS,0,0
164231,.,0,0
164232,This,0,0
164233,was,0,0
164234,linked,0,0
164235,to,0,0
164236,increased,1,0
164237,left,1,0
164238,amygdala,1,1
164239,reactivity,1,1
164240,in,0,0
164241,response,0,1
164242,to,0,0
164243,facial,0,1
164244,stimuli,0,1
164245,and,0,0
164246,increased,1,1
164247,activity,1,1
164248,in,0,0
164249,the,0,0
164250,neural,1,0
164251,network,1,0
164252,involved,0,0
164253,in,0,0
164254,social,0,1
164255,cognition,0,0
164256,.,0,0
164257,Our,0,0
164258,data,0,0
164259,suggest,0,0
164260,that,0,0
164261,the,0,0
164262,amygdala,0,1
164263,",",0,0
164264,together,0,0
164265,with,0,0
164266,functionally,0,0
164267,associated,0,0
164268,cortical,0,0
164269,areas,0,0
164270,mediate,0,0
164271,the,0,0
164272,positive,0,0
164273,effect,0,0
164274,of,0,0
164275,oxytocin,0,0
164276,on,0,0
164277,social,1,1
164278,cognitive,1,1
164279,functioning,1,1
164280,in,0,0
164281,AS,0,0
164282,.,0,0
164283,A,0,0
164284,shortened,0,0
164285,versus,0,0
164286,standard,0,0
164287,matched,0,0
164288,postpartum,0,1
164289,magnesium,0,0
164290,sulphate,0,0
164291,regimen,0,0
164292,in,0,0
164293,the,0,0
164294,treatment,0,0
164295,of,0,0
164296,eclampsia,0,0
164297,:,0,0
164298,a,0,0
164299,randomised,0,0
164300,controlled,0,0
164301,trial,0,0
164302,.,0,0
164303,Magnesium,0,0
164304,sulphate,0,0
164305,is,0,0
164306,currently,0,0
164307,the,0,0
164308,most,0,0
164309,ideal,0,0
164310,drug,0,0
164311,for,0,0
164312,the,0,0
164313,treatment,0,0
164314,of,0,0
164315,eclampsia,0,1
164316,but,0,0
164317,its,0,0
164318,use,0,0
164319,in,0,0
164320,Nigeria,0,0
164321,is,0,0
164322,still,0,0
164323,limited,0,0
164324,due,0,0
164325,its,0,0
164326,cost,0,1
164327,and,0,1
164328,clinicians,0,0
164329,inexperience,0,1
164330,with,0,0
164331,the,0,0
164332,drug,0,0
164333,.,0,0
164334,The,0,0
164335,purpose,0,0
164336,of,0,0
164337,this,0,0
164338,study,0,0
164339,was,0,0
164340,to,0,0
164341,determine,0,0
164342,whether,0,0
164343,a,0,0
164344,shortened,0,0
164345,postpartum,0,1
164346,course,0,1
164347,of,0,1
164348,magnesium,0,0
164349,sulphate,0,0
164350,is,0,0
164351,as,0,0
164352,effective,0,0
164353,as,0,0
164354,the,0,0
164355,standard,0,0
164356,Pritchard,0,0
164357,regimen,0,0
164358,in,0,0
164359,controlling,0,0
164360,fits,0,0
164361,in,0,0
164362,eclampsia,0,1
164363,Between,0,0
164364,January,0,0
164365,and,0,0
164366,June,0,0
164367,2011,0,0
164368,",",0,0
164369,98,0,0
164370,eclamptic,0,0
164371,mothers,0,0
164372,presenting,0,0
164373,at,0,0
164374,the,0,0
164375,labour,0,0
164376,ward,0,0
164377,of,0,0
164378,the,0,0
164379,University,0,0
164380,of,0,0
164381,Maiduguri,0,0
164382,Teaching,0,0
164383,Hospital,0,1
164384,were,0,0
164385,randomised,0,0
164386,to,0,0
164387,receive,0,0
164388,either,0,0
164389,the,0,0
164390,standard,0,0
164391,Pritchard,0,0
164392,regimen,0,0
164393,of,0,0
164394,magnesium,0,0
164395,sulphate,0,0
164396,or,0,0
164397,a,0,0
164398,shortened,0,1
164399,postpartum,0,1
164400,course,0,1
164401,in,0,0
164402,which,0,0
164403,only,0,0
164404,two,0,0
164405,doses,0,0
164406,of,0,0
164407,intramuscular,0,0
164408,magnesium,0,0
164409,sulphate,0,0
164410,is,0,0
164411,given,0,0
164412,four,0,0
164413,hours,0,0
164414,apart,0,0
164415,.,0,0
164416,The,0,0
164417,maternal,0,1
164418,and,0,0
164419,fetal,0,1
164420,outcomes,0,1
164421,were,0,0
164422,compared,0,0
164423,.,0,0
164424,The,0,0
164425,primary,0,0
164426,outcome,0,1
164427,measure,0,1
164428,was,0,0
164429,recurrence,1,1
164430,of,1,0
164431,fits,1,0
164432,.,1,0
164433,The,0,0
164434,recurrence,1,1
164435,of,1,0
164436,fits,1,0
164437,and,0,0
164438,other,1,0
164439,maternal,1,1
164440,complications,1,1
164441,were,0,0
164442,similar,1,0
164443,in,0,0
164444,the,0,0
164445,two,0,0
164446,groups,0,0
164447,.,0,0
164448,The,0,0
164449,total,1,1
164450,dosage,1,0
164451,of,1,0
164452,magnesium,1,0
164453,sulphate,1,0
164454,in,0,0
164455,the,0,0
164456,shortened,0,1
164457,group,0,0
164458,was,0,0
164459,reduced,1,0
164460,by,0,0
164461,40,0,0
164462,%,0,0
164463,in,0,0
164464,66,0,0
164465,%,0,0
164466,of,0,0
164467,patients,0,0
164468,.,0,0
164469,The,0,0
164470,shortened,0,0
164471,postpartum,0,1
164472,course,0,1
164473,of,0,1
164474,magnesium,0,0
164475,sulphate,1,0
164476,is,0,0
164477,as,0,0
164478,effective,1,0
164479,as,0,0
164480,the,0,0
164481,standard,0,0
164482,Pritchard,0,0
164483,regimen,0,0
164484,in,0,0
164485,the,0,0
164486,management,1,0
164487,of,1,0
164488,eclampsia,1,0
164489,.,1,0
164490,Pimecrolimus,0,0
164491,cream,0,0
164492,and,0,1
164493,Tacrolimus,0,0
164494,ointment,0,0
164495,in,0,0
164496,the,0,0
164497,treatment,0,0
164498,of,0,0
164499,atopic,1,0
164500,dermatitis,1,0
164501,:,1,0
164502,a,0,0
164503,pilot,0,0
164504,study,0,0
164505,on,0,0
164506,patient,0,0
164507,preference,0,0
164508,.,0,0
164509,BACKGROUND,0,0
164510,Pimecrolimus,0,0
164511,cream,0,0
164512,1,0,0
164513,%,0,0
164514,is,0,0
164515,approved,0,0
164516,for,0,0
164517,mild,0,0
164518,to,0,0
164519,moderate,0,0
164520,atopic,0,1
164521,dermatitis,0,1
164522,in,0,0
164523,children,0,0
164524,older,0,0
164525,than,0,0
164526,two,0,0
164527,years,0,0
164528,of,0,0
164529,age,0,0
164530,and,0,0
164531,adults,0,0
164532,.,0,0
164533,Tacrolimus,0,0
164534,ointment,0,0
164535,0.03,0,0
164536,%,0,0
164537,is,0,0
164538,approved,0,0
164539,for,0,0
164540,moderate,0,0
164541,to,0,0
164542,severe,0,1
164543,atopic,0,1
164544,dermatitis,0,1
164545,in,0,0
164546,the,0,0
164547,patient,0,0
164548,population,0,0
164549,between,0,0
164550,two,0,0
164551,to,0,0
164552,seventeen,0,0
164553,years,0,0
164554,of,0,0
164555,age,0,0
164556,and,0,0
164557,Tacrolimus,0,0
164558,0.1,0,0
164559,%,0,0
164560,ointment,0,0
164561,for,0,0
164562,moderate,0,0
164563,to,0,0
164564,severe,0,1
164565,atopic,0,1
164566,dermatitis,0,1
164567,in,0,0
164568,patients,0,0
164569,18,0,0
164570,years,0,0
164571,of,0,0
164572,age,0,0
164573,and,0,0
164574,older,0,0
164575,.,0,0
164576,However,0,0
164577,",",0,0
164578,beyond,0,0
164579,safety,1,1
164580,and,1,1
164581,efficacy,1,1
164582,",",0,0
164583,the,0,0
164584,delivery,0,1
164585,system,0,0
164586,or,0,0
164587,vehicle,0,0
164588,used,0,0
164589,in,0,0
164590,topical,0,0
164591,treatment,0,0
164592,formulations,0,0
164593,is,0,0
164594,equally,0,0
164595,important,0,0
164596,in,0,0
164597,affecting,0,0
164598,patient,1,1
164599,satisfaction,1,1
164600,",",1,0
164601,tolerability,1,1
164602,",",1,1
164603,and,1,1
164604,subsequent,1,0
164605,treatment,1,0
164606,compliance,1,1
164607,and,0,0
164608,hence,0,0
164609,clinical,1,0
164610,resolution,1,1
164611,of,0,0
164612,active,0,0
164613,disease,0,0
164614,.,0,0
164615,Use,0,0
164616,of,0,0
164617,ketorolac,0,0
164618,is,0,0
164619,associated,0,0
164620,with,0,0
164621,decreased,0,0
164622,pneumonia,0,0
164623,following,0,0
164624,rib,0,0
164625,fractures,0,0
164626,.,0,0
164627,BACKGROUND,0,0
164628,The,0,0
164629,effectiveness,0,0
164630,of,0,0
164631,the,0,0
164632,nonsteroidal,0,0
164633,anti-inflammatory,0,0
164634,drug,0,0
164635,ketorolac,0,0
164636,in,0,0
164637,reducing,0,0
164638,pulmonary,0,1
164639,morbidity,0,1
164640,after,0,0
164641,rib,0,0
164642,fractures,0,0
164643,remains,0,0
164644,largely,0,0
164645,unknown,0,0
164646,.,0,0
164647,METHODS,0,0
164648,A,0,0
164649,retrospective,0,0
164650,cohort,0,0
164651,study,0,0
164652,was,0,0
164653,conducted,0,0
164654,spanning,0,0
164655,January,0,0
164656,2003,0,0
164657,to,0,0
164658,June,0,0
164659,2011,0,0
164660,assessing,0,0
164661,pneumonia,0,0
164662,within,0,0
164663,30,0,0
164664,days,0,0
164665,and,0,0
164666,potential,0,1
164667,adverse,0,1
164668,effects,0,1
164669,of,0,0
164670,ketorolac,0,0
164671,among,0,0
164672,all,0,0
164673,patients,0,0
164674,with,0,0
164675,rib,0,0
164676,fractures,0,1
164677,who,0,0
164678,received,0,0
164679,ketorolac,0,0
164680,<,0,0
164681,4,0,0
164682,days,0,0
164683,after,0,0
164684,injury,0,0
164685,compared,0,0
164686,with,0,0
164687,a,0,0
164688,random,0,0
164689,sample,0,0
164690,of,0,0
164691,those,0,0
164692,who,0,0
164693,did,0,0
164694,not,0,0
164695,.,0,0
164696,RESULTS,0,0
164697,Among,0,0
164698,202,0,0
164699,patients,0,0
164700,who,0,0
164701,received,0,0
164702,ketorolac,0,0
164703,and,0,0
164704,417,0,0
164705,who,0,0
164706,did,0,0
164707,not,0,0
164708,",",0,0
164709,ketorolac,0,0
164710,use,0,1
164711,was,0,0
164712,associated,0,0
164713,with,0,0
164714,decreased,0,0
164715,pneumonia,1,0
164716,(,0,0
164717,odds,0,1
164718,ratio,0,1
164719,",",0,0
164720,.14,0,0
164721,;,0,0
164722,95,0,0
164723,%,0,0
164724,confidence,0,0
164725,interval,0,0
164726,",",0,0
164727,.04,0,0
164728,to,0,0
164729,.46,0,0
164730,),0,0
164731,and,0,0
164732,increased,0,0
164733,ventilator-free,1,0
164734,days,1,0
164735,(,0,0
164736,difference,0,0
164737,",",0,0
164738,1.8,0,0
164739,days,0,0
164740,;,0,0
164741,95,0,0
164742,%,0,0
164743,confidence,0,0
164744,interval,0,0
164745,",",0,0
164746,1.1,0,0
164747,to,0,0
164748,2.5,0,0
164749,),0,0
164750,and,0,0
164751,intensive,1,0
164752,care,1,0
164753,unit-free,1,1
164754,days,1,0
164755,(,0,0
164756,difference,0,0
164757,",",0,0
164758,2.1,0,0
164759,days,0,0
164760,;,0,0
164761,95,0,0
164762,%,0,0
164763,confidence,0,0
164764,interval,0,0
164765,",",0,0
164766,1.3,0,0
164767,to,0,0
164768,3.0,0,0
164769,),0,0
164770,within,0,0
164771,30,0,0
164772,days,0,0
164773,.,0,0
164774,The,0,0
164775,rates,1,1
164776,of,1,0
164777,acute,1,0
164778,kidney,1,1
164779,injury,1,1
164780,",",1,0
164781,gastrointestinal,1,1
164782,hemorrhage,1,1
164783,",",1,0
164784,and,1,1
164785,fracture,1,1
164786,nonunion,1,1
164787,were,0,0
164788,not,0,0
164789,different,0,0
164790,.,0,0
164791,CONCLUSIONS,0,0
164792,Early,0,0
164793,administration,0,0
164794,of,0,0
164795,ketorolac,0,0
164796,to,0,0
164797,patients,0,0
164798,with,0,0
164799,rib,0,0
164800,fractures,0,0
164801,is,0,0
164802,associated,0,0
164803,with,0,0
164804,a,0,0
164805,decreased,0,0
164806,likelihood,0,1
164807,of,0,0
164808,pneumonia,1,0
164809,",",0,0
164810,without,0,0
164811,apparent,0,0
164812,risks,0,0
164813,.,0,0
164814,Characterization,0,0
164815,of,0,0
164816,early,0,0
164817,thermal,0,0
164818,burns,0,0
164819,and,0,0
164820,the,0,0
164821,effects,0,1
164822,of,0,0
164823,hyperbaric,0,0
164824,oxygen,0,1
164825,treatment,0,0
164826,:,0,0
164827,a,0,0
164828,pilot,0,0
164829,study,0,0
164830,.,0,0
164831,BACKGROUND,0,0
164832,AND,0,0
164833,AIMS,0,1
164834,Studies,0,0
164835,investigating,0,0
164836,hyperbaric,0,0
164837,oxygen,0,1
164838,treatment,0,0
164839,(,0,0
164840,HBOT,0,0
164841,),0,0
164842,to,0,0
164843,improve,0,0
164844,outcome,0,1
164845,in,0,0
164846,burns,0,0
164847,have,0,0
164848,been,0,0
164849,inconclusive,0,0
164850,.,0,0
164851,In,0,0
164852,this,0,0
164853,study,0,0
164854,",",0,0
164855,we,0,0
164856,aimed,0,0
164857,to,0,0
164858,characterize,0,0
164859,early,0,0
164860,thermal,0,0
164861,burns,0,1
164862,injury,0,1
164863,in,0,0
164864,adult,0,0
164865,patients,0,0
164866,with,0,0
164867,<,0,0
164868,40,0,0
164869,%,0,0
164870,total,0,0
164871,body,0,1
164872,surface,0,1
164873,area,0,1
164874,(,0,0
164875,TBSA,0,0
164876,),0,0
164877,and,0,0
164878,to,0,0
164879,determine,0,0
164880,the,0,0
164881,effects,0,0
164882,of,0,0
164883,HBOT,0,1
164884,administered,0,0
164885,within,0,0
164886,24,0,0
164887,h,0,0
164888,to,0,0
164889,48,0,0
164890,h,0,0
164891,of,0,0
164892,a,0,0
164893,burn,0,0
164894,injury,0,0
164895,.,0,0
164896,METHODS,0,0
164897,Seventeen,0,0
164898,subjects,0,0
164899,were,0,0
164900,randomized,0,0
164901,into,0,0
164902,control,0,0
164903,(,0,0
164904,n,0,0
164905,=,0,0
164906,9,0,0
164907,),0,0
164908,and,0,0
164909,HBOT,0,1
164910,treatment,0,0
164911,(,0,0
164912,n,0,0
164913,=,0,0
164914,8,0,0
164915,),0,0
164916,arms,0,0
164917,.,0,0
164918,Burn,1,1
164919,depth,1,1
164920,",",0,0
164921,measured,0,1
164922,by,0,0
164923,laser,0,0
164924,Doppler,0,1
164925,imaging,0,1
164926,(,0,0
164927,LDI,0,0
164928,),0,0
164929,and,0,0
164930,histologically,0,0
164931,",",0,0
164932,white,1,0
164933,blood,1,1
164934,cell,1,1
164935,(,1,0
164936,WBC,1,1
164937,),1,1
164938,count,1,1
164939,and,0,0
164940,plasma,1,1
164941,cytokine,1,1
164942,inflammatory,1,1
164943,markers,1,1
164944,were,0,0
164945,assessed,0,0
164946,at,0,0
164947,24,0,0
164948,h,0,0
164949,(,0,0
164950,pre,0,1
164951,HBOT,0,1
164952,),0,0
164953,and,0,0
164954,48,0,0
164955,h,0,0
164956,(,0,0
164957,post,0,0
164958,HBOT,0,1
164959,),0,0
164960,post,0,0
164961,burn,0,0
164962,",",0,0
164963,as,0,0
164964,were,0,0
164965,immunohistochemistry,0,1
164966,and,0,1
164967,microbiology,0,1
164968,of,0,1
164969,burns,0,1
164970,tissue,0,1
164971,samples,0,0
164972,at,0,0
164973,48,0,0
164974,h,0,0
164975,post,0,0
164976,burn,0,0
164977,.,0,0
164978,RESULTS,0,0
164979,WBC,1,1
164980,count,1,1
164981,and,1,1
164982,serum,1,1
164983,interleukin,1,1
164984,(,1,0
164985,IL,1,0
164986,),1,1
164987,-1?,1,0
164988,",",1,0
164989,IL-4,1,1
164990,",",1,1
164991,IL-6,1,1
164992,",",1,1
164993,IL-10,1,1
164994,and,1,1
164995,interferon-?,1,1
164996,were,1,0
164997,significantly,0,0
164998,elevated,0,0
164999,24,0,0
165000,h,0,0
165001,after,0,0
165002,burn,0,0
165003,",",0,0
165004,but,0,0
165005,no,0,0
165006,significant,0,0
165007,changes,0,0
165008,in,0,0
165009,any,0,0
165010,of,0,0
165011,these,0,0
165012,parameters,0,1
165013,were,0,0
165014,found,0,0
165015,with,0,0
165016,HBOT,0,0
165017,.,0,0
165018,HBOT,0,0
165019,had,0,0
165020,no,0,0
165021,significant,0,0
165022,effect,0,0
165023,on,0,0
165024,burn,1,0
165025,depth,1,1
165026,.,1,0
165027,Two,0,0
165028,HBOT,0,0
165029,patients,0,0
165030,and,0,0
165031,four,0,0
165032,control,0,0
165033,patients,0,0
165034,developed,1,0
165035,positive,1,0
165036,bacterial,1,0
165037,cultures,1,0
165038,.,1,0
165039,CONCLUSIONS,0,0
165040,Slower,0,0
165041,than,0,0
165042,anticipated,0,0
165043,recruitment,0,0
165044,resulted,0,0
165045,in,0,0
165046,considerably,0,0
165047,fewer,0,0
165048,patients,0,0
165049,than,0,0
165050,planned,0,0
165051,being,0,0
165052,studied,1,0
165053,.,1,0
165054,Inflammatory,1,0
165055,markers,1,1
165056,were,1,0
165057,significantly,0,0
165058,increased,0,0
165059,at,0,0
165060,24,0,0
165061,h,0,0
165062,in,0,0
165063,patients,0,0
165064,with,0,0
165065,<,0,0
165066,40,0,0
165067,%,0,0
165068,TBSA,0,0
165069,burn,0,0
165070,.,0,0
165071,Early,0,0
165072,HBOT,0,0
165073,had,0,0
165074,no,0,0
165075,apparent,0,0
165076,effects,0,0
165077,on,0,0
165078,any,0,0
165079,of,0,0
165080,the,0,0
165081,parameters,0,1
165082,measured,0,0
165083,in,0,0
165084,this,0,0
165085,small,0,0
165086,pilot,0,0
165087,study,0,0
165088,.,0,0
165089,HBOT,0,0
165090,may,0,0
165091,possibly,0,0
165092,have,0,0
165093,a,0,0
165094,broad-spectrum,0,0
165095,antimicrobial,0,1
165096,effect,0,0
165097,worthy,0,0
165098,of,0,0
165099,further,0,0
165100,study,0,0
165101,.,0,0
165102,We,0,0
165103,report,0,0
165104,our,0,0
165105,methodology,0,0
165106,in,0,0
165107,detail,0,0
165108,as,0,0
165109,a,0,0
165110,possible,0,0
165111,model,0,0
165112,for,0,0
165113,future,0,0
165114,burns,0,0
165115,studies,0,0
165116,.,0,0
165117,Comparison,1,0
165118,of,0,0
165119,three,0,0
165120,software,0,0
165121,systems,0,0
165122,for,0,0
165123,semi-automatic,0,1
165124,volumetry,1,0
165125,of,1,0
165126,pulmonary,1,1
165127,nodules,1,0
165128,on,0,0
165129,baseline,0,0
165130,and,0,0
165131,follow-up,0,1
165132,CT,0,1
165133,examinations,0,0
165134,.,0,0
165135,BACKGROUND,0,0
165136,Early,0,0
165137,diagnosis,0,0
165138,of,0,0
165139,lung,0,0
165140,cancer,0,0
165141,in,0,0
165142,a,0,0
165143,treatable,0,0
165144,stage,0,0
165145,is,0,0
165146,the,0,0
165147,main,0,0
165148,purpose,0,0
165149,of,0,0
165150,lung,0,1
165151,cancer,0,0
165152,screening,0,0
165153,by,0,0
165154,computed,0,0
165155,tomography,0,0
165156,(,0,0
165157,CT,0,1
165158,),0,0
165159,.,0,0
165160,Accurate,0,1
165161,three-dimensional,0,0
165162,size,0,1
165163,and,0,1
165164,growth,0,1
165165,measurements,0,0
165166,are,0,0
165167,essential,0,0
165168,to,0,0
165169,assess,0,0
165170,the,0,0
165171,risk,0,0
165172,of,0,0
165173,malignancy,0,0
165174,.,0,0
165175,Nodule,0,0
165176,volumes,0,0
165177,can,0,0
165178,be,0,0
165179,calculated,0,0
165180,by,0,0
165181,using,0,0
165182,semi-automated,0,0
165183,volumetric,0,0
165184,software,0,0
165185,.,0,0
165186,Systematic,0,0
165187,differences,0,0
165188,in,0,0
165189,volume,0,1
165190,measurements,0,0
165191,between,0,0
165192,packages,0,0
165193,could,0,0
165194,influence,0,0
165195,nodule,0,1
165196,categorization,0,0
165197,and,0,1
165198,management,0,0
165199,decisions,0,0
165200,.,0,0
165201,PURPOSE,0,0
165202,To,0,0
165203,compare,0,0
165204,volumetric,1,1
165205,measurements,1,0
165206,of,0,0
165207,solid,0,0
165208,pulmonary,0,1
165209,nodules,0,0
165210,on,0,0
165211,baseline,0,0
165212,and,0,0
165213,follow-up,0,1
165214,CT,0,1
165215,scans,0,0
165216,as,0,0
165217,well,0,0
165218,as,0,0
165219,the,0,0
165220,volume,1,1
165221,doubling,1,1
165222,time,1,1
165223,(,1,0
165224,VDT,1,1
165225,),1,0
165226,for,0,0
165227,three,0,0
165228,software,0,0
165229,packages,0,0
165230,.,0,0
165231,MATERIAL,0,0
165232,AND,0,0
165233,METHODS,0,0
165234,From,0,0
165235,a,0,0
165236,Lung,0,0
165237,Cancer,0,0
165238,Screening,0,0
165239,study,0,0
165240,(,0,0
165241,NELSON,0,1
165242,),0,0
165243,",",0,0
165244,50,0,0
165245,participants,0,0
165246,were,0,0
165247,randomly,0,0
165248,selected,0,0
165249,from,0,0
165250,the,0,0
165251,baseline,0,0
165252,round,0,0
165253,.,0,0
165254,The,0,0
165255,study,0,0
165256,population,0,0
165257,comprised,0,0
165258,participants,0,0
165259,with,0,0
165260,at,0,0
165261,least,0,0
165262,one,0,0
165263,pulmonary,0,0
165264,nodule,0,0
165265,at,0,0
165266,the,0,0
165267,baseline,0,0
165268,and,0,0
165269,consecutive,0,0
165270,CT,0,1
165271,examination,0,0
165272,.,0,0
165273,The,0,0
165274,volume,1,0
165275,of,1,0
165276,each,1,0
165277,nodule,1,0
165278,was,0,0
165279,determined,0,0
165280,for,0,0
165281,both,0,0
165282,time,0,1
165283,points,0,0
165284,using,0,0
165285,three,0,0
165286,semi-automated,0,0
165287,software,0,0
165288,packages,0,0
165289,(,0,0
165290,P1,0,0
165291,",",0,1
165292,P2,0,0
165293,",",0,1
165294,and,0,1
165295,P3,0,0
165296,),0,0
165297,.,0,0
165298,Manual,0,0
165299,modification,0,0
165300,was,0,0
165301,performed,0,0
165302,when,0,0
165303,automated,0,0
165304,assessment,0,0
165305,was,0,0
165306,visually,0,0
165307,inaccurate,0,0
165308,.,0,0
165309,VDT,1,0
165310,was,0,0
165311,calculated,0,0
165312,to,0,0
165313,evaluate,1,0
165314,nodule,1,0
165315,growth,1,1
165316,.,1,0
165317,Volume,1,1
165318,",",1,0
165319,VDT,1,1
165320,",",1,1
165321,and,1,1
165322,nodule,1,1
165323,management,1,0
165324,were,0,0
165325,compared,0,0
165326,for,0,0
165327,the,0,0
165328,three,0,0
165329,software,0,0
165330,packages,0,0
165331,",",0,0
165332,using,0,0
165333,P1,0,0
165334,as,0,0
165335,the,0,0
165336,reference,0,0
165337,standard,0,0
165338,.,0,0
165339,RESULTS,0,0
165340,In,0,0
165341,25,0,0
165342,participants,0,0
165343,",",0,0
165344,147,0,0
165345,nodules,0,0
165346,were,0,0
165347,present,0,0
165348,on,0,0
165349,both,0,0
165350,examinations,0,0
165351,(,0,0
165352,volume,0,1
165353,:,0,0
165354,12.0-436.6,0,0
165355,mm,0,0
165356,(,0,0
165357,3,0,0
165358,),0,0
165359,),0,0
165360,.,0,0
165361,Initial,1,1
165362,segmentation,1,0
165363,at,0,0
165364,baseline,0,0
165365,was,0,0
165366,evaluated,0,0
165367,to,0,0
165368,be,0,0
165369,satisfactory,0,0
165370,in,0,0
165371,93.9,0,0
165372,%,0,0
165373,of,0,0
165374,nodules,0,0
165375,for,0,0
165376,P1,0,0
165377,",",0,0
165378,84.4,0,0
165379,%,0,0
165380,for,0,0
165381,P2,0,0
165382,",",0,0
165383,and,0,0
165384,88.4,0,0
165385,%,0,0
165386,for,0,0
165387,P3,0,0
165388,.,0,0
165389,Significant,0,0
165390,difference,0,0
165391,was,0,0
165392,found,0,0
165393,in,0,0
165394,measured,1,0
165395,volume,1,1
165396,between,0,0
165397,P1,0,0
165398,and,0,0
165399,the,0,0
165400,other,0,0
165401,two,0,0
165402,packages,0,0
165403,(,0,0
165404,P,0,0
165405,<,0,0
165406,0.001,0,0
165407,),0,0
165408,.,0,0
165409,P2,0,0
165410,overestimated,0,0
165411,the,0,0
165412,volume,1,1
165413,by,1,0
165414,38,0,0
165415,?,0,0
165416,24,0,0
165417,%,0,0
165418,",",0,0
165419,and,0,1
165420,P3,0,0
165421,by,0,0
165422,50,0,0
165423,?,0,0
165424,22,0,0
165425,%,0,0
165426,.,0,0
165427,At,0,0
165428,baseline,0,0
165429,",",0,0
165430,there,0,0
165431,was,0,0
165432,consensus,0,0
165433,on,1,0
165434,nodule,1,1
165435,size,1,1
165436,categorization,1,0
165437,in,1,0
165438,80,1,0
165439,%,1,0
165440,for,1,0
165441,P1,1,0
165442,&,0,0
165443,P2,0,0
165444,and,0,0
165445,74,0,0
165446,%,0,0
165447,for,0,0
165448,P1,0,0
165449,&,0,0
165450,P3,0,0
165451,.,0,0
165452,At,0,0
165453,follow-up,0,0
165454,",",0,0
165455,consensus,1,0
165456,on,1,0
165457,VDT,1,1
165458,categorization,1,0
165459,was,1,0
165460,present,1,0
165461,in,1,0
165462,47,0,0
165463,%,0,0
165464,for,0,0
165465,P1,0,0
165466,&,0,0
165467,P2,0,0
165468,and,0,0
165469,44,0,0
165470,%,0,0
165471,for,0,0
165472,P1,0,0
165473,&,0,0
165474,P3,0,0
165475,.,0,0
165476,CONCLUSION,0,0
165477,Software,0,0
165478,packages,0,0
165479,for,0,0
165480,lung,0,0
165481,nodule,0,1
165482,evaluation,0,0
165483,yield,0,1
165484,significant,0,0
165485,differences,0,0
165486,in,0,0
165487,volumetric,1,1
165488,measurements,1,0
165489,and,1,0
165490,VDT,1,0
165491,.,1,0
165492,This,1,0
165493,variation,0,0
165494,affects,1,0
165495,the,1,0
165496,classification,1,1
165497,of,1,0
165498,lung,1,0
165499,nodules,1,0
165500,",",1,0
165501,especially,0,0
165502,in,0,0
165503,follow-up,0,0
165504,examinations,0,0
165505,.,0,0
165506,Aripiprazole,0,0
165507,treatment,0,0
165508,of,0,0
165509,irritability,0,1
165510,associated,0,0
165511,with,0,0
165512,autistic,0,0
165513,disorder,0,0
165514,and,0,0
165515,the,0,0
165516,relationship,0,0
165517,between,0,0
165518,prior,0,0
165519,antipsychotic,0,0
165520,exposure,0,0
165521,",",0,0
165522,adverse,0,1
165523,events,0,1
165524,",",0,0
165525,and,0,1
165526,weight,0,1
165527,change,0,1
165528,.,0,0
165529,OBJECTIVE,0,0
165530,The,0,0
165531,purpose,0,0
165532,of,0,0
165533,this,0,0
165534,study,0,0
165535,was,0,0
165536,to,0,0
165537,evaluate,0,0
165538,the,0,0
165539,impact,0,0
165540,of,0,0
165541,prior,0,0
165542,antipsychotic,0,0
165543,exposure,0,0
165544,(,0,0
165545,PAE,0,1
165546,),0,0
165547,on,0,0
165548,safety,1,1
165549,and,1,1
165550,tolerability,1,1
165551,outcomes,1,1
165552,in,0,0
165553,pediatric,0,0
165554,subjects,0,0
165555,receiving,0,0
165556,aripiprazole,0,0
165557,treatment,0,0
165558,.,0,0
165559,METHODS,0,0
165560,This,0,0
165561,study,0,0
165562,was,0,0
165563,a,0,0
165564,post-hoc,0,0
165565,analysis,0,0
165566,of,0,0
165567,pooled,0,0
165568,data,0,0
165569,from,0,0
165570,two,0,0
165571,8-week,0,0
165572,",",0,0
165573,double-blind,0,0
165574,",",0,0
165575,randomized,0,0
165576,",",0,0
165577,placebo-controlled,0,0
165578,studies,0,0
165579,evaluating,0,0
165580,aripiprazole,0,0
165581,for,0,0
165582,the,0,0
165583,treatment,0,0
165584,of,0,0
165585,irritability,0,1
165586,in,0,0
165587,pediatric,0,0
165588,subjects,0,0
165589,with,0,0
165590,autistic,0,0
165591,disorder,0,0
165592,",",0,0
165593,aged,0,0
165594,6-17,0,0
165595,years,0,0
165596,.,0,0
165597,Subjects,0,0
165598,were,0,0
165599,stratified,0,0
165600,by,0,0
165601,PAE,0,0
165602,;,0,0
165603,adverse,0,1
165604,events,0,1
165605,(,0,0
165606,AEs,0,1
165607,),0,1
165608,",",0,0
165609,and,0,1
165610,changes,0,1
165611,in,0,0
165612,weight,0,1
165613,",",0,0
165614,and,0,1
165615,metabolic,0,1
165616,measures,0,1
165617,were,0,0
165618,evaluated,0,0
165619,.,0,0
165620,For,0,0
165621,subjects,0,0
165622,receiving,0,0
165623,aripiprazole,0,0
165624,",",0,0
165625,regardless,0,0
165626,of,0,0
165627,PAE,0,1
165628,",",0,0
165629,baseline,0,1
165630,weight,0,1
165631,",",0,1
165632,age,0,0
165633,",",0,1
165634,gender,0,1
165635,",",0,1
165636,and,0,1
165637,symptom,0,1
165638,severity,0,1
165639,were,0,0
165640,evaluated,0,0
165641,in,0,0
165642,a,0,0
165643,regression,0,0
165644,model,0,0
165645,predicting,0,1
165646,body,0,1
165647,weight,0,1
165648,change,0,0
165649,.,0,0
165650,RESULTS,0,0
165651,Of,0,0
165652,316,0,0
165653,randomized,0,0
165654,subjects,0,0
165655,",",0,0
165656,259,0,0
165657,(,0,0
165658,82.0,0,0
165659,%,0,0
165660,),0,0
165661,were,0,0
165662,antipsychotic,0,0
165663,na?ve,0,0
165664,(,0,0
165665,AN,0,0
165666,),0,0
165667,and,0,0
165668,57,0,0
165669,(,0,0
165670,18.0,0,0
165671,%,0,0
165672,),0,0
165673,had,0,0
165674,a,0,0
165675,PAE,0,0
165676,.,0,0
165677,Aripiprazole-treated,0,0
165678,AN,0,0
165679,subjects,0,0
165680,were,0,0
165681,more,0,0
165682,likely,0,0
165683,than,0,0
165684,PAE,0,0
165685,subjects,0,0
165686,to,0,0
165687,report,0,0
165688,somnolence,0,0
165689,(,0,0
165690,11.9,0,0
165691,%,0,0
165692,vs.,0,0
165693,2.8,0,0
165694,%,0,0
165695,),0,0
165696,",",0,0
165697,sedation,0,1
165698,(,0,0
165699,22.7,0,0
165700,%,0,0
165701,vs.,0,0
165702,11.1,0,0
165703,%,0,0
165704,),0,0
165705,",",0,0
165706,or,0,1
165707,fatigue,0,1
165708,(,0,0
165709,17.0,0,0
165710,%,0,0
165711,vs.,0,0
165712,13.9,0,0
165713,%,0,0
165714,),0,0
165715,.,0,0
165716,Rates,1,0
165717,of,1,0
165718,extrapyramidal,1,1
165719,disorder,1,0
165720,and,1,1
165721,drooling,1,1
165722,",",1,1
165723,but,1,0
165724,not,1,0
165725,akathisia,1,1
165726,or,1,0
165727,tremor,1,1
165728,",",1,0
165729,were,0,0
165730,marginally,0,0
165731,higher,0,0
165732,in,0,0
165733,AN,0,0
165734,subjects,0,0
165735,.,0,0
165736,Overall,0,0
165737,",",0,0
165738,10.8,0,0
165739,%,0,0
165740,of,0,0
165741,aripiprazole-treated,0,0
165742,AN,0,0
165743,subjects,0,0
165744,had,0,0
165745,at,0,0
165746,least,0,0
165747,one,0,0
165748,AE,0,0
165749,leading,0,0
165750,to,0,0
165751,discontinuation,0,0
165752,compared,0,0
165753,with,0,0
165754,8.3,0,0
165755,%,0,0
165756,of,0,0
165757,aripiprazole-treated,0,0
165758,PAE,0,0
165759,subjects,0,0
165760,.,0,0
165761,AN,0,0
165762,subjects,0,0
165763,receiving,0,0
165764,aripiprazole,0,0
165765,had,0,0
165766,a,0,0
165767,larger,0,0
165768,change,0,1
165769,in,0,0
165770,weight,0,1
165771,from,0,0
165772,baseline,0,0
165773,to,0,0
165774,endpoint,0,0
165775,compared,0,0
165776,with,0,0
165777,those,0,0
165778,receiving,0,0
165779,placebo,0,0
165780,(,0,0
165781,1.9,0,0
165782,vs.,0,0
165783,0.7,0,0
165784,kg,0,0
165785,;,0,0
165786,treatment,0,0
165787,difference,0,0
165788,1.2,0,0
165789,kg,0,0
165790,",",0,0
165791,95,0,0
165792,%,0,0
165793,CI,0,0
165794,:,0,0
165795,0.5,0,0
165796,",",0,0
165797,1.9,0,0
165798,),0,0
165799,than,0,0
165800,PAE,0,0
165801,subjects,0,0
165802,receiving,0,0
165803,aripiprazole,0,0
165804,compared,0,0
165805,with,0,0
165806,subjects,0,0
165807,receiving,0,0
165808,placebo,0,0
165809,(,0,0
165810,0.4,0,0
165811,vs.,0,0
165812,-0.4,0,0
165813,kg,0,0
165814,;,0,0
165815,treatment,0,0
165816,difference,0,0
165817,0.9,0,0
165818,kg,0,0
165819,",",0,0
165820,95,0,0
165821,%,0,0
165822,CI,0,0
165823,:,0,0
165824,-0.6,0,0
165825,",",0,0
165826,2.4,0,0
165827,),0,0
165828,.,0,0
165829,Regression,0,1
165830,analysis,0,0
165831,identified,0,0
165832,that,0,0
165833,younger,0,0
165834,subjects,0,0
165835,with,0,0
165836,higher,0,0
165837,baseline,0,0
165838,weight,0,1
165839,z-score,0,1
165840,were,0,0
165841,at,0,0
165842,highest,0,0
165843,risk,0,1
165844,for,0,0
165845,weight,0,1
165846,gain,0,1
165847,.,0,0
165848,There,0,0
165849,were,0,0
165850,no,0,0
165851,significant,0,0
165852,changes,0,0
165853,in,1,0
165854,metabolic,1,1
165855,measures,1,1
165856,compared,0,0
165857,with,0,0
165858,placebo,0,0
165859,in,0,0
165860,either,0,0
165861,group,0,0
165862,.,0,0
165863,CONCLUSIONS,1,0
165864,Weight,1,1
165865,gain,1,1
165866,was,0,0
165867,more,0,0
165868,pronounced,0,0
165869,in,0,0
165870,AN,0,0
165871,subjects,0,0
165872,and,0,0
165873,more,0,0
165874,likely,0,0
165875,to,0,0
165876,occur,0,0
165877,in,0,0
165878,younger,0,0
165879,subjects,0,0
165880,with,0,0
165881,a,0,0
165882,higher,0,0
165883,baseline,0,0
165884,weight,0,1
165885,z-score,0,0
165886,.,0,0
165887,AN,0,0
165888,subjects,0,0
165889,were,0,0
165890,more,0,0
165891,likely,0,0
165892,to,0,0
165893,experience,0,0
165894,AEs,0,0
165895,related,0,0
165896,to,0,0
165897,somnolence,0,0
165898,.,0,0
165899,However,0,0
165900,",",0,0
165901,based,0,0
165902,on,0,0
165903,discontinuations,0,0
165904,rates,0,1
165905,from,0,0
165906,AEs,0,1
165907,",",0,0
165908,overall,1,1
165909,tolerability,1,1
165910,was,0,0
165911,good,0,0
165912,for,0,0
165913,both,0,0
165914,AN,0,0
165915,and,0,0
165916,PAE,0,1
165917,groups,0,0
165918,.,0,0
165919,CLINICAL,0,0
165920,TRIAL,0,0
165921,REGISTRATION,0,0
165922,Study,0,0
165923,of,0,0
165924,aripiprazole,0,0
165925,in,0,0
165926,the,0,0
165927,treatment,0,0
165928,of,0,0
165929,children,0,0
165930,and,0,0
165931,adolescents,0,0
165932,with,0,0
165933,autistic,0,0
165934,disorder,0,0
165935,.,0,0
165936,Registry,0,0
165937,:,0,0
165938,www.clinicaltrials.gov,0,0
165939,.,0,0
165940,Identifiers,0,0
165941,:,0,0
165942,NCT00332241,0,0
165943,and,0,0
165944,NCT00337571,0,0
165945,.,0,0
165946,A,0,0
165947,randomized,0,0
165948,",",0,0
165949,double-blind,0,0
165950,",",0,0
165951,placebo-controlled,0,0
165952,crossover,0,0
165953,study,0,0
165954,of,0,0
165955,Cappra?,0,0
165956,for,0,0
165957,the,0,0
165958,treatment,0,0
165959,of,0,0
165960,mild,0,1
165961,or,0,0
165962,mild,0,1
165963,to,0,0
165964,moderate,0,0
165965,erectile,0,1
165966,dysfunction,0,1
165967,in,0,0
165968,Thai,0,0
165969,male,0,0
165970,.,0,0
165971,Erectile,0,0
165972,dysfunction,0,1
165973,(,0,0
165974,ED,0,0
165975,),0,0
165976,is,0,0
165977,one,0,0
165978,of,0,0
165979,the,0,0
165980,major,0,0
165981,health,0,0
165982,concerns,0,0
165983,affects,0,0
165984,the,0,0
165985,quality,0,1
165986,of,0,0
165987,life,0,1
165988,among,0,0
165989,Thai,0,0
165990,male,0,0
165991,.,0,0
165992,The,0,0
165993,treatment,0,0
165994,of,0,0
165995,ED,0,0
165996,by,0,0
165997,the,0,0
165998,first-line,0,0
165999,drugs,0,0
166000,is,0,0
166001,limited,0,0
166002,to,0,0
166003,a,0,0
166004,certain,0,0
166005,group,0,0
166006,of,0,0
166007,patients,0,0
166008,due,0,0
166009,to,0,0
166010,their,0,0
166011,side,0,1
166012,effects,0,1
166013,and,0,0
166014,costs,0,1
166015,.,0,0
166016,Alternative,0,0
166017,medicine,0,0
166018,can,0,0
166019,be,0,0
166020,beneficial,0,0
166021,for,0,0
166022,the,0,0
166023,treatment,0,0
166024,of,0,0
166025,ED,0,0
166026,.,0,0
166027,This,0,0
166028,is,0,0
166029,a,0,0
166030,randomized,0,0
166031,",",0,0
166032,double-blind,0,0
166033,",",0,0
166034,placebo-controlled,0,0
166035,",",0,0
166036,crossover,0,0
166037,study,0,0
166038,aimed,0,0
166039,to,0,0
166040,assess,0,0
166041,the,0,0
166042,efficacy,0,1
166043,and,0,0
166044,safety,0,1
166045,of,0,1
166046,Cappra,0,1
166047,(,0,0
166048,?,0,0
166049,),0,0
166050,",",0,0
166051,a,0,0
166052,traditional,0,0
166053,herbal,0,0
166054,medicine,0,0
166055,which,0,0
166056,was,0,0
166057,used,0,0
166058,in,0,0
166059,Thailand,0,0
166060,for,0,0
166061,decades,0,0
166062,",",0,0
166063,for,0,0
166064,the,0,0
166065,treatment,0,0
166066,of,0,0
166067,mild,0,1
166068,and,0,0
166069,mild,0,1
166070,to,0,0
166071,moderate,0,0
166072,ED,0,0
166073,in,0,0
166074,Thai,0,0
166075,patients,0,0
166076,.,0,0
166077,A,0,0
166078,total,0,0
166079,of,0,0
166080,63,0,0
166081,patients,0,0
166082,with,0,0
166083,mild,0,1
166084,or,0,0
166085,mild,0,0
166086,to,0,0
166087,moderate,0,0
166088,ED,0,0
166089,were,0,0
166090,randomized,0,0
166091,to,0,0
166092,receive,0,0
166093,Cappra,0,1
166094,(,0,0
166095,?,0,0
166096,),0,0
166097,or,0,0
166098,placebo,0,0
166099,for,0,0
166100,two,0,0
166101,weeks,0,0
166102,in,0,0
166103,the,0,0
166104,first,0,0
166105,period,0,0
166106,",",0,0
166107,followed,0,0
166108,by,0,0
166109,one,0,0
166110,week,0,0
166111,washout,0,0
166112,period,0,0
166113,.,0,0
166114,The,0,0
166115,patients,0,0
166116,were,0,0
166117,switched,0,0
166118,to,0,0
166119,the,0,0
166120,alternative,0,0
166121,treatment,0,0
166122,in,0,0
166123,the,0,0
166124,second,0,0
166125,period,0,0
166126,.,0,0
166127,The,0,0
166128,efficacy,1,1
166129,was,1,0
166130,assessed,0,0
166131,by,0,0
166132,the,0,0
166133,International,1,0
166134,Index,1,0
166135,of,1,0
166136,Erectile,1,0
166137,Function,1,1
166138,(,1,0
166139,IIEF,1,0
166140,),1,1
166141,questionnaire,1,1
166142,and,1,0
166143,adverse,1,1
166144,events,1,1
166145,.,1,0
166146,Sixty,1,0
166147,one,0,0
166148,patients,0,0
166149,completed,0,0
166150,the,0,0
166151,study,0,0
166152,.,0,0
166153,There,0,0
166154,was,0,0
166155,an,0,0
166156,improvement,0,1
166157,of,0,0
166158,IIEF,1,0
166159,score,1,1
166160,for,1,0
166161,all,0,0
166162,domains,0,1
166163,in,0,0
166164,Cappra,0,1
166165,(,0,0
166166,?,0,0
166167,),0,0
166168,group,0,0
166169,compared,0,0
166170,with,0,0
166171,placebo,0,0
166172,group,0,0
166173,.,0,0
166174,The,0,0
166175,mean,1,1
166176,change,1,0
166177,of,1,0
166178,IIEF,1,0
166179,score,1,1
166180,from,1,0
166181,baseline,0,0
166182,for,0,0
166183,erectile,0,1
166184,function,0,1
166185,domain,0,0
166186,of,0,1
166187,Cappra,0,1
166188,(,0,0
166189,?,0,0
166190,),0,0
166191,was,0,0
166192,significantly,0,0
166193,higher,0,0
166194,than,0,0
166195,placebo,0,0
166196,(,0,0
166197,4.87,0,0
166198,vs,0,0
166199,3.44,0,0
166200,",",0,0
166201,p,0,0
166202,=,0,0
166203,0.032,0,0
166204,),0,0
166205,.,0,0
166206,The,0,0
166207,most,0,0
166208,common,0,0
166209,adverse,0,1
166210,events,0,1
166211,were,0,0
166212,dizziness,1,0
166213,(,1,0
166214,13.3,1,0
166215,%,0,0
166216,Cappra,0,0
166217,(,0,0
166218,?,0,0
166219,),0,0
166220,",",0,0
166221,9.6,0,0
166222,%,0,0
166223,placebo,1,0
166224,),1,0
166225,",",1,0
166226,face,1,1
166227,numbness,1,1
166228,(,1,0
166229,1.6,1,0
166230,%,1,0
166231,Cappra,0,0
166232,(,0,0
166233,?,0,0
166234,),0,0
166235,",",0,0
166236,0,0,0
166237,%,0,0
166238,placebo,0,0
166239,),1,1
166240,",",1,0
166241,and,1,1
166242,tachycardia,1,1
166243,(,1,0
166244,1.6,1,0
166245,%,1,0
166246,Cappra,0,0
166247,(,0,0
166248,?,0,0
166249,),0,0
166250,",",0,0
166251,0,0,0
166252,%,0,0
166253,placebo,0,0
166254,),0,0
166255,.,0,0
166256,The,0,0
166257,results,0,0
166258,from,0,0
166259,this,0,0
166260,study,0,0
166261,demonstrated,0,0
166262,that,0,0
166263,Cappra,0,1
166264,(,0,0
166265,?,0,0
166266,),0,0
166267,is,0,0
166268,effective,0,1
166269,and,0,0
166270,well-tolerated,0,0
166271,and,0,0
166272,can,0,0
166273,be,0,0
166274,used,0,0
166275,as,0,0
166276,alternative,0,0
166277,therapy,0,0
166278,for,0,0
166279,mild,0,1
166280,and,0,0
166281,mild,0,1
166282,to,0,0
166283,moderate,0,0
166284,ED,0,0
166285,.,0,0
166286,Evaluating,0,0
166287,proton,0,0
166288,stereotactic,0,0
166289,body,0,1
166290,radiotherapy,0,0
166291,to,0,0
166292,reduce,0,0
166293,chest,0,0
166294,wall,0,1
166295,dose,0,0
166296,in,0,0
166297,the,0,0
166298,treatment,0,0
166299,of,0,0
166300,lung,0,0
166301,cancer,0,0
166302,.,0,0
166303,Stereotactic,0,0
166304,body,0,1
166305,radiotherapy,0,0
166306,(,0,0
166307,SBRT,0,0
166308,),0,0
166309,can,0,0
166310,produce,0,0
166311,excellent,0,0
166312,local,0,0
166313,control,0,0
166314,of,0,0
166315,several,0,0
166316,types,0,0
166317,of,0,0
166318,solid,0,0
166319,tumor,0,0
166320,;,0,0
166321,however,0,0
166322,",",0,0
166323,toxicity,0,1
166324,to,0,0
166325,nearby,0,0
166326,critical,0,0
166327,structures,0,0
166328,is,0,0
166329,a,0,0
166330,concern,0,0
166331,.,0,0
166332,We,0,0
166333,found,0,0
166334,previously,0,0
166335,that,0,0
166336,in,0,0
166337,SBRT,0,0
166338,for,0,0
166339,lung,0,1
166340,cancer,0,0
166341,",",0,0
166342,the,0,0
166343,chest,0,1
166344,wall,0,0
166345,(,0,0
166346,CW,0,1
166347,),0,0
166348,volume,0,1
166349,receiving,0,0
166350,20,0,0
166351,",",0,0
166352,30,0,0
166353,",",0,0
166354,or,0,0
166355,40Gy,0,0
166356,(,0,0
166357,V20,0,0
166358,",",0,1
166359,V30,0,0
166360,",",0,1
166361,or,0,1
166362,V40,0,0
166363,),0,1
166364,was,0,0
166365,linked,0,0
166366,with,0,0
166367,the,0,0
166368,development,0,0
166369,of,0,0
166370,neuropathy,0,0
166371,.,0,0
166372,Here,0,0
166373,we,0,0
166374,sought,0,0
166375,to,0,0
166376,determine,0,0
166377,whether,0,0
166378,the,0,0
166379,dosimetric,0,0
166380,advantages,0,0
166381,of,0,0
166382,protons,0,0
166383,could,0,0
166384,produce,0,0
166385,lower,0,0
166386,CW,0,1
166387,doses,0,0
166388,than,0,0
166389,traditional,0,0
166390,photon-based,0,0
166391,SBRT,0,0
166392,.,0,0
166393,We,0,0
166394,searched,0,0
166395,an,0,0
166396,institutional,0,0
166397,database,0,0
166398,to,0,0
166399,identify,0,0
166400,patients,0,0
166401,treated,0,0
166402,with,0,0
166403,photon,0,0
166404,SBRT,0,0
166405,for,0,0
166406,lung,0,0
166407,cancer,0,0
166408,with,0,0
166409,tumors,0,0
166410,within,0,0
166411,<,0,0
166412,2.5cm,0,0
166413,of,0,0
166414,the,0,0
166415,CW,0,0
166416,.,0,0
166417,We,0,0
166418,found,0,0
166419,260,0,0
166420,cases,0,0
166421,;,0,0
166422,of,0,0
166423,these,0,0
166424,",",0,0
166425,chronic,0,0
166426,grade,0,1
166427,?,0,0
166428,2,0,0
166429,CW,0,0
166430,pain,0,1
166431,was,0,0
166432,identified,0,0
166433,in,0,0
166434,23,0,0
166435,patients,0,0
166436,.,0,0
166437,We,0,0
166438,then,0,0
166439,selected,0,0
166440,10,0,0
166441,representative,0,0
166442,patients,0,0
166443,from,0,0
166444,this,0,0
166445,group,0,0
166446,and,0,0
166447,generated,0,0
166448,proton,0,0
166449,SBRT,0,0
166450,treatment,0,0
166451,plans,0,0
166452,",",0,0
166453,using,0,0
166454,the,0,0
166455,identical,0,0
166456,dose,0,0
166457,of,0,0
166458,50Gy,0,0
166459,in,0,0
166460,4,0,0
166461,fractions,0,0
166462,",",0,0
166463,and,0,1
166464,assessed,0,0
166465,potential,0,0
166466,differences,0,0
166467,in,0,0
166468,CW,0,0
166469,dose,0,0
166470,between,0,0
166471,the,0,0
166472,2,0,0
166473,plans,0,0
166474,.,0,0
166475,The,1,0
166476,proton,1,0
166477,SBRT,1,0
166478,plans,1,0
166479,reduced,1,0
166480,the,1,0
166481,CW,1,0
166482,doses,1,0
166483,at,1,0
166484,all,0,0
166485,dose,0,0
166486,levels,0,1
166487,measured,1,0
166488,.,1,0
166489,The,1,0
166490,median,1,0
166491,CW,1,0
166492,V20,1,0
166493,was,1,0
166494,364.0cm,0,0
166495,(,0,0
166496,3,0,0
166497,),0,0
166498,and,0,0
166499,160.0cm,0,0
166500,(,0,0
166501,3,0,0
166502,),0,0
166503,(,0,0
166504,p,0,0
166505,<,0,0
166506,0.0001,0,0
166507,),0,0
166508,",",0,0
166509,V30,0,0
166510,was,0,0
166511,144.6cm,0,0
166512,(,0,0
166513,3,0,0
166514,),0,0
166515,vs,0,0
166516,77.0cm,0,0
166517,(,0,0
166518,3,0,0
166519,),0,0
166520,(,0,0
166521,p,0,0
166522,=,0,0
166523,0.0012,0,0
166524,),0,0
166525,",",0,0
166526,V35,0,1
166527,was,0,0
166528,93.9cm,0,0
166529,(,0,0
166530,3,0,0
166531,),0,0
166532,vs,0,0
166533,57.9cm,0,0
166534,(,0,0
166535,3,0,0
166536,),0,0
166537,(,0,0
166538,p,0,0
166539,=,0,0
166540,0.005,0,0
166541,),0,0
166542,",",0,0
166543,V40,0,0
166544,was,0,0
166545,66.5cm,0,0
166546,(,0,0
166547,3,0,0
166548,),0,0
166549,vs,0,0
166550,45.4cm,0,0
166551,(,0,0
166552,3,0,0
166553,),0,0
166554,(,0,0
166555,p,0,0
166556,=,0,0
166557,0.0112,0,0
166558,),0,0
166559,",",0,0
166560,and,0,1
166561,mean,0,1
166562,lung,0,1
166563,dose,0,0
166564,was,0,0
166565,5.9Gy,0,0
166566,vs,0,0
166567,3.8Gy,0,0
166568,(,0,0
166569,p,0,0
166570,=,0,0
166571,0.0001,0,0
166572,),0,0
166573,for,0,0
166574,photons,0,0
166575,and,0,1
166576,protons,0,0
166577,",",0,0
166578,respectively,0,0
166579,.,0,0
166580,Coverage,0,0
166581,of,0,0
166582,the,1,0
166583,planning,1,0
166584,target,1,0
166585,volume,1,1
166586,(,1,0
166587,PTV,1,1
166588,),1,0
166589,was,1,0
166590,comparable,0,0
166591,between,0,0
166592,the,0,0
166593,2,0,0
166594,sets,0,0
166595,of,0,0
166596,plans,0,0
166597,(,0,0
166598,96.4,0,0
166599,%,0,0
166600,for,0,0
166601,photons,0,0
166602,and,0,0
166603,97,0,0
166604,%,0,0
166605,for,0,0
166606,protons,0,0
166607,),0,0
166608,.,0,0
166609,From,0,0
166610,a,0,0
166611,dosimetric,0,0
166612,standpoint,0,0
166613,",",0,0
166614,proton,0,0
166615,SBRT,0,0
166616,can,0,0
166617,achieve,0,0
166618,the,0,0
166619,same,0,0
166620,coverage,0,0
166621,of,0,0
166622,the,1,0
166623,PTV,1,1
166624,while,1,0
166625,significantly,1,0
166626,reducing,1,0
166627,the,1,0
166628,dose,1,0
166629,to,1,0
166630,the,1,0
166631,CW,1,0
166632,and,1,0
166633,lung,1,0
166634,relative,1,0
166635,to,1,0
166636,photon,1,0
166637,SBRT,1,0
166638,and,1,0
166639,therefore,0,0
166640,may,0,0
166641,be,0,0
166642,beneficial,0,0
166643,for,0,0
166644,the,0,0
166645,treatment,0,0
166646,of,0,0
166647,lesions,1,0
166648,closer,1,0
166649,to,0,0
166650,critical,0,0
166651,structures,0,0
166652,.,0,0
166653,Examination,1,0
166654,of,0,1
166655,aggression,1,1
166656,and,0,1
166657,self-injury,0,1
166658,in,0,0
166659,children,0,0
166660,with,0,0
166661,autism,0,0
166662,spectrum,0,0
166663,disorders,0,0
166664,and,0,0
166665,serious,0,1
166666,behavioral,0,1
166667,problems,0,0
166668,.,0,0
166669,This,0,0
166670,study,0,0
166671,identified,0,0
166672,subtypes,0,0
166673,of,0,0
166674,aggression,0,1
166675,in,0,0
166676,a,0,0
166677,sample,0,0
166678,of,0,0
166679,206,0,0
166680,children,0,0
166681,with,0,0
166682,autism,0,0
166683,spectrum,0,0
166684,disorder,0,0
166685,(,0,0
166686,ASD,0,0
166687,),0,0
166688,who,0,0
166689,participated,0,0
166690,in,0,0
166691,2,0,0
166692,risperidone,0,0
166693,trials,0,0
166694,.,0,0
166695,The,0,0
166696,narratives,0,0
166697,were,0,0
166698,derived,0,0
166699,from,0,0
166700,a,0,0
166701,parent,0,0
166702,interview,0,0
166703,about,0,0
166704,each,0,0
166705,child,0,0
166706,'s,0,0
166707,2,0,0
166708,most,0,0
166709,pressing,0,0
166710,problems,0,0
166711,.,0,0
166712,Five,0,0
166713,subtypes,0,0
166714,of,0,0
166715,aggression,0,1
166716,emerged,0,0
166717,:,0,0
166718,hot,1,1
166719,aggression,1,1
166720,only,1,0
166721,",",1,0
166722,cold,1,1
166723,aggression,1,1
166724,only,1,0
166725,",",1,0
166726,self-injurious,1,1
166727,behavior,1,1
166728,(,1,0
166729,SIB,1,0
166730,),1,0
166731,only,1,0
166732,",",1,0
166733,aggression,1,1
166734,and,1,1
166735,SIB,1,1
166736,",",0,1
166737,and,0,0
166738,nonaggressive,1,1
166739,.,1,0
166740,All,0,0
166741,groups,0,0
166742,showed,0,0
166743,a,0,0
166744,high,0,0
166745,rate,0,1
166746,of,0,0
166747,positive,1,0
166748,response,1,1
166749,to,0,0
166750,risperidone,0,0
166751,with,0,0
166752,no,0,0
166753,differences,0,0
166754,across,0,0
166755,subtypes,0,0
166756,.,0,0
166757,These,0,0
166758,study,0,0
166759,findings,0,0
166760,extend,0,0
166761,understanding,0,0
166762,of,0,0
166763,aggression,0,1
166764,in,0,0
166765,ASD,0,0
166766,and,0,0
166767,may,0,0
166768,be,0,0
166769,useful,0,0
166770,to,0,0
166771,guide,0,0
166772,further,0,0
166773,study,0,0
166774,on,0,0
166775,biological,0,0
166776,mechanisms,0,0
166777,and,0,0
166778,individualized,0,0
166779,treatment,0,0
166780,in,0,0
166781,ASD,0,0
166782,.,0,0
166783,Testing,0,0
166784,the,0,0
166785,efficacy,0,1
166786,of,0,0
166787,an,0,0
166788,HIV,1,1
166789,stigma,1,1
166790,reduction,1,1
166791,intervention,0,0
166792,with,0,0
166793,medical,0,0
166794,students,0,0
166795,in,0,0
166796,Puerto,0,0
166797,Rico,0,0
166798,:,0,0
166799,the,0,0
166800,SPACES,0,1
166801,project,0,0
166802,.,0,0
166803,INTRODUCTION,0,1
166804,Stigma,1,0
166805,associated,0,0
166806,with,0,0
166807,HIV,0,0
166808,has,0,0
166809,been,0,0
166810,documented,0,0
166811,as,0,0
166812,a,0,0
166813,barrier,0,0
166814,for,0,0
166815,accessing,0,0
166816,quality,0,1
166817,health-related,0,1
166818,services,0,0
166819,.,0,0
166820,When,0,0
166821,the,0,0
166822,stigma,0,1
166823,manifests,0,0
166824,in,0,0
166825,the,0,0
166826,health,0,1
166827,care,0,0
166828,setting,0,0
166829,",",0,0
166830,people,0,0
166831,living,0,0
166832,with,0,0
166833,HIV,0,0
166834,receive,0,0
166835,substandard,0,0
166836,services,0,1
166837,or,0,0
166838,even,0,0
166839,be,0,0
166840,denied,0,0
166841,care,0,0
166842,altogether,0,0
166843,.,0,0
166844,Although,0,0
166845,the,0,0
166846,consequences,0,0
166847,of,0,0
166848,HIV,1,0
166849,stigma,1,1
166850,have,0,0
166851,been,0,0
166852,documented,0,0
166853,extensively,0,0
166854,",",0,0
166855,efforts,0,0
166856,to,0,0
166857,reduce,0,0
166858,these,0,0
166859,negative,0,0
166860,attitudes,0,0
166861,have,0,0
166862,been,0,0
166863,scarce,0,0
166864,.,0,0
166865,Interventions,0,0
166866,to,0,0
166867,reduce,0,0
166868,HIV,1,0
166869,stigma,1,0
166870,should,0,0
166871,be,0,0
166872,implemented,0,0
166873,as,0,0
166874,part,0,0
166875,of,0,0
166876,the,0,0
166877,formal,0,0
166878,training,0,0
166879,of,0,0
166880,future,0,0
166881,health,0,1
166882,care,0,0
166883,professionals,0,0
166884,.,0,0
166885,The,0,0
166886,interventions,0,0
166887,that,0,0
166888,have,0,0
166889,been,0,0
166890,tested,0,0
166891,with,0,0
166892,health,0,1
166893,care,0,0
166894,professionals,0,0
166895,and,0,0
166896,published,0,0
166897,have,0,0
166898,several,0,0
166899,limitations,0,0
166900,that,0,0
166901,must,0,0
166902,be,0,0
166903,surpassed,0,0
166904,(,0,0
166905,i.e,0,0
166906,.,0,0
166907,lack,0,0
166908,of,0,0
166909,comparison,0,0
166910,groups,0,0
166911,in,0,0
166912,research,0,0
166913,designs,0,0
166914,and,0,0
166915,longitudinal,0,0
166916,follow-up,0,0
166917,data,0,0
166918,),0,0
166919,.,0,0
166920,Furthermore,0,0
166921,",",0,0
166922,Latino,0,0
166923,health,0,1
166924,care,0,0
166925,professionals,0,0
166926,have,0,0
166927,been,0,0
166928,absent,0,0
166929,from,0,0
166930,these,0,0
166931,intervention,0,0
166932,efforts,0,0
166933,even,0,0
166934,though,0,0
166935,the,0,0
166936,epidemic,0,0
166937,has,0,0
166938,affected,0,0
166939,this,0,0
166940,population,0,0
166941,disproportionately,0,0
166942,.,0,0
166943,METHODS,0,0
166944,In,0,0
166945,this,0,0
166946,article,0,0
166947,",",0,0
166948,we,0,0
166949,describe,0,0
166950,an,0,0
166951,intervention,0,0
166952,developed,0,0
166953,to,0,0
166954,reduce,0,0
166955,HIV,1,1
166956,stigma,1,1
166957,among,0,0
166958,medical,0,0
166959,students,0,0
166960,in,0,0
166961,Puerto,0,0
166962,Rico,0,0
166963,.,0,0
166964,A,0,0
166965,total,0,1
166966,of,0,0
166967,507,0,0
166968,medical,0,0
166969,students,0,0
166970,were,0,0
166971,randomly,0,0
166972,introduced,0,0
166973,into,0,0
166974,our,0,0
166975,intervention,0,0
166976,and,0,1
166977,control,0,0
166978,conditions,0,0
166979,.,0,0
166980,RESULTS,0,0
166981,The,0,0
166982,results,0,0
166983,show,0,0
166984,statistically,0,0
166985,significant,0,0
166986,differences,0,0
166987,between,0,0
166988,the,0,0
166989,intervention,0,0
166990,and,0,0
166991,control,0,0
166992,groups,0,0
166993,;,0,0
166994,intervention,0,0
166995,group,0,0
166996,participants,0,0
166997,had,0,0
166998,lower,1,0
166999,HIV,1,1
167000,stigma,1,1
167001,levels,1,1
167002,than,0,0
167003,control,0,0
167004,participants,0,0
167005,after,0,0
167006,the,0,0
167007,intervention,0,0
167008,.,0,0
167009,In,0,0
167010,addition,0,0
167011,",",0,0
167012,differences,0,0
167013,in,0,0
167014,HIV,1,1
167015,stigma,1,1
167016,levels,1,1
167017,between,0,0
167018,the,0,0
167019,groups,0,0
167020,were,0,0
167021,sustained,0,0
167022,for,0,0
167023,a,0,0
167024,12-month,0,0
167025,period,0,0
167026,.,0,0
167027,CONCLUSION,0,0
167028,The,0,0
167029,results,0,0
167030,of,0,0
167031,our,0,0
167032,study,0,0
167033,demonstrate,0,0
167034,the,0,0
167035,efficacy,0,1
167036,of,0,0
167037,the,0,0
167038,modes,0,0
167039,of,0,0
167040,intervention,0,0
167041,developed,0,0
167042,by,0,0
167043,us,0,0
167044,and,0,0
167045,serve,0,0
167046,as,0,0
167047,a,0,0
167048,new,0,0
167049,training,0,0
167050,tool,0,0
167051,for,0,0
167052,future,0,0
167053,health,0,1
167054,care,0,0
167055,professionals,0,0
167056,with,0,0
167057,regard,0,0
167058,to,0,0
167059,stigma,1,1
167060,reduction,1,0
167061,.,1,0
167062,Family-centred,0,0
167063,music,0,0
167064,therapy,0,0
167065,to,0,0
167066,promote,0,0
167067,social,1,1
167068,engagement,1,1
167069,in,0,0
167070,young,0,0
167071,children,0,0
167072,with,0,0
167073,severe,0,1
167074,autism,0,0
167075,spectrum,0,0
167076,disorder,0,0
167077,:,0,0
167078,a,0,0
167079,randomized,0,0
167080,controlled,0,0
167081,study,0,0
167082,.,0,0
167083,BACKGROUND,0,0
167084,Limited,0,0
167085,capacity,0,1
167086,for,0,0
167087,social,0,1
167088,engagement,0,0
167089,is,0,0
167090,a,0,0
167091,core,0,0
167092,feature,0,0
167093,of,0,1
167094,autism,0,0
167095,spectrum,0,0
167096,disorder,0,0
167097,(,0,0
167098,ASD,0,0
167099,),0,0
167100,",",0,0
167101,often,0,0
167102,evident,0,0
167103,early,0,0
167104,in,0,0
167105,the,0,0
167106,child,0,1
167107,'s,0,0
167108,development,0,0
167109,.,0,0
167110,While,0,0
167111,these,0,0
167112,skills,0,0
167113,are,0,0
167114,difficult,0,0
167115,to,0,0
167116,train,0,0
167117,",",0,0
167118,there,0,0
167119,is,0,0
167120,some,0,0
167121,evidence,0,0
167122,that,0,0
167123,active,0,0
167124,involvement,0,1
167125,in,0,0
167126,music-making,0,0
167127,provides,0,0
167128,unique,0,0
167129,opportunities,0,0
167130,for,0,0
167131,social,0,1
167132,interaction,0,1
167133,between,0,0
167134,participants,0,0
167135,.,0,0
167136,Family-centred,0,0
167137,music,0,0
167138,therapy,0,0
167139,(,0,0
167140,FCMT,0,1
167141,),0,0
167142,endeavours,0,0
167143,to,0,0
167144,support,0,0
167145,social,0,1
167146,engagement,0,1
167147,between,0,0
167148,child,0,1
167149,and,0,1
167150,parent,0,1
167151,within,0,0
167152,active,0,0
167153,music-making,0,1
167154,",",0,0
167155,yet,0,0
167156,the,0,0
167157,extent,0,0
167158,of,0,0
167159,benefits,0,0
167160,provided,0,0
167161,is,0,0
167162,unknown,0,0
167163,.,0,0
167164,AIM,0,0
167165,This,0,0
167166,study,0,0
167167,investigated,0,0
167168,the,0,0
167169,impacts,0,0
167170,of,0,0
167171,FCMT,0,1
167172,on,0,0
167173,social,0,1
167174,engagement,0,0
167175,abilities,0,1
167176,.,0,0
167177,METHODS,0,0
167178,Twenty-three,0,0
167179,children,0,0
167180,(,0,0
167181,36-60,0,0
167182,months,0,0
167183,),0,0
167184,with,0,0
167185,severe,0,1
167186,ASD,0,0
167187,received,0,0
167188,either,0,0
167189,16,0,0
167190,weeks,0,0
167191,of,0,0
167192,FCMT,0,1
167193,in,0,0
167194,addition,0,0
167195,to,0,0
167196,their,0,0
167197,early,0,0
167198,intervention,0,0
167199,programmes,0,0
167200,(,0,0
167201,n,0,0
167202,=,0,0
167203,12,0,0
167204,),0,0
167205,",",0,0
167206,or,0,0
167207,their,0,0
167208,early,0,0
167209,intervention,0,0
167210,programme,0,0
167211,only,0,0
167212,(,0,0
167213,n,0,0
167214,=,0,0
167215,11,0,0
167216,),0,0
167217,.,0,0
167218,Change,0,0
167219,in,0,0
167220,social,0,1
167221,engagement,0,1
167222,was,0,0
167223,measured,0,0
167224,with,0,0
167225,standardized,1,0
167226,parent-report,1,0
167227,assessments,1,0
167228,",",1,0
167229,parent,1,1
167230,interviews,1,0
167231,and,1,1
167232,clinician,1,0
167233,observation,1,0
167234,.,1,0
167235,RESULTS,0,0
167236,Intention-to-treat,0,0
167237,analysis,0,0
167238,for,0,0
167239,the,0,0
167240,Vineland,1,0
167241,Social,1,1
167242,Emotional,1,1
167243,Early,1,1
167244,Childhood,1,0
167245,Scale,1,1
167246,indicated,0,0
167247,a,0,0
167248,significant,0,0
167249,effect,0,0
167250,in,0,0
167251,favour,0,0
167252,of,0,0
167253,FCMT,0,1
167254,.,0,0
167255,Thematic,0,1
167256,qualitative,0,0
167257,analysis,0,0
167258,of,0,0
167259,the,0,0
167260,parent,0,0
167261,interviews,0,0
167262,showed,0,0
167263,that,0,0
167264,the,0,0
167265,parent-child,0,0
167266,relationship,0,0
167267,grew,0,0
167268,stronger,0,0
167269,.,0,0
167270,CONCLUSION,0,0
167271,FCMT,0,1
167272,improves,0,1
167273,social,0,1
167274,interactions,0,0
167275,in,0,0
167276,the,0,0
167277,home,0,0
167278,and,0,1
167279,community,0,0
167280,and,0,0
167281,the,0,0
167282,parent-child,0,0
167283,relationship,0,0
167284,",",0,0
167285,but,0,0
167286,not,0,0
167287,language,0,1
167288,skills,0,1
167289,or,0,0
167290,general,0,0
167291,social,0,1
167292,responsiveness,0,1
167293,.,0,0
167294,This,0,0
167295,study,0,0
167296,provides,0,0
167297,preliminary,0,0
167298,support,0,0
167299,for,0,0
167300,the,0,0
167301,use,0,0
167302,of,0,0
167303,FCMT,0,1
167304,to,0,0
167305,promote,0,0
167306,social,0,1
167307,engagement,0,1
167308,in,0,0
167309,children,0,0
167310,with,0,0
167311,severe,0,0
167312,ASD,0,0
167313,.,0,0
167314,A,0,0
167315,randomized,0,0
167316,trial,0,0
167317,comparison,0,0
167318,of,0,0
167319,the,0,0
167320,effects,0,0
167321,of,0,0
167322,verbal,0,1
167323,and,0,0
167324,pictorial,0,1
167325,naturalistic,0,0
167326,communication,0,1
167327,strategies,0,0
167328,on,0,0
167329,spoken,0,0
167330,language,0,0
167331,for,0,0
167332,young,0,0
167333,children,0,0
167334,with,0,0
167335,autism,0,0
167336,.,0,0
167337,Presently,0,0
167338,there,0,0
167339,is,0,0
167340,no,0,0
167341,consensus,0,0
167342,on,0,0
167343,the,0,0
167344,specific,0,0
167345,behavioral,0,1
167346,treatment,0,0
167347,of,0,0
167348,choice,0,0
167349,for,0,0
167350,targeting,0,0
167351,language,0,0
167352,in,0,0
167353,young,0,0
167354,nonverbal,0,1
167355,children,0,0
167356,with,0,0
167357,autism,0,0
167358,.,0,0
167359,This,0,0
167360,randomized,0,0
167361,clinical,0,0
167362,trial,0,0
167363,compared,0,0
167364,the,0,0
167365,effectiveness,0,0
167366,of,0,0
167367,a,0,0
167368,verbally-based,0,0
167369,intervention,0,0
167370,",",0,0
167371,Pivotal,0,1
167372,Response,0,1
167373,Training,0,0
167374,(,0,0
167375,PRT,0,0
167376,),0,0
167377,to,0,0
167378,a,0,0
167379,pictorially-based,0,0
167380,behavioral,0,1
167381,intervention,0,0
167382,",",0,0
167383,the,0,0
167384,Picture,0,1
167385,Exchange,0,0
167386,Communication,0,1
167387,System,0,0
167388,(,0,0
167389,PECS,0,0
167390,),0,0
167391,on,0,0
167392,the,0,0
167393,acquisition,0,0
167394,of,0,0
167395,spoken,0,1
167396,language,0,0
167397,by,0,0
167398,young,0,0
167399,(,0,0
167400,2-4,0,0
167401,years,0,0
167402,),0,0
167403,",",0,0
167404,nonverbal,0,1
167405,or,0,0
167406,minimally,0,0
167407,verbal,0,1
167408,(,0,0
167409,?9,0,1
167410,words,0,1
167411,),0,0
167412,children,0,0
167413,with,0,0
167414,autism,0,0
167415,.,0,0
167416,Thirty-nine,0,0
167417,children,0,0
167418,were,0,0
167419,randomly,0,0
167420,assigned,0,0
167421,to,0,0
167422,either,0,0
167423,the,0,0
167424,PRT,0,0
167425,or,0,0
167426,PECS,0,0
167427,condition,0,0
167428,.,0,0
167429,Participants,0,0
167430,received,0,0
167431,on,0,0
167432,average,0,0
167433,247,0,0
167434,h,0,0
167435,of,0,0
167436,intervention,0,0
167437,across,0,0
167438,23,0,0
167439,weeks,0,0
167440,.,0,0
167441,Dependent,0,0
167442,measures,0,1
167443,included,1,0
167444,overall,1,1
167445,communication,1,1
167446,",",1,0
167447,expressive,1,1
167448,vocabulary,1,1
167449,",",1,0
167450,pictorial,1,1
167451,communication,1,1
167452,and,1,1
167453,parent,1,1
167454,satisfaction,1,1
167455,.,1,0
167456,Children,1,0
167457,in,0,0
167458,both,0,0
167459,intervention,0,0
167460,groups,0,0
167461,demonstrated,0,0
167462,increases,1,1
167463,in,1,0
167464,spoken,1,0
167465,language,1,1
167466,skills,1,1
167467,",",1,0
167468,with,1,0
167469,no,0,0
167470,significant,0,0
167471,difference,0,0
167472,between,0,0
167473,the,0,0
167474,two,0,0
167475,conditions,0,0
167476,.,0,0
167477,Seventy-eight,0,0
167478,percent,0,0
167479,of,0,0
167480,all,0,0
167481,children,0,0
167482,exited,0,0
167483,the,0,0
167484,program,0,0
167485,with,0,0
167486,more,0,0
167487,than,0,0
167488,10,1,0
167489,functional,1,0
167490,words,1,0
167491,.,1,0
167492,Parents,1,0
167493,were,0,0
167494,very,0,0
167495,satisfied,0,0
167496,with,0,0
167497,both,0,0
167498,programs,0,0
167499,but,0,0
167500,indicated,0,0
167501,PECS,0,0
167502,was,0,0
167503,more,0,0
167504,difficult,0,0
167505,to,0,0
167506,implement,0,0
167507,.,0,0
167508,Neuropsychological,1,0
167509,outcomes,1,0
167510,after,0,0
167511,psychosocial,0,1
167512,intervention,0,0
167513,for,0,0
167514,depression,0,1
167515,in,0,0
167516,Parkinson,0,0
167517,'s,0,0
167518,disease,0,0
167519,.,0,0
167520,The,0,0
167521,authors,0,0
167522,describe,0,0
167523,neuropsychological,0,0
167524,outcomes,0,0
167525,in,0,0
167526,people,0,0
167527,with,0,0
167528,Parkinson,0,0
167529,'s,0,1
167530,disease,0,1
167531,(,0,0
167532,PD,0,1
167533,),0,0
167534,after,0,0
167535,their,0,0
167536,participation,0,0
167537,in,0,0
167538,an,0,0
167539,NIH-sponsored,0,0
167540,",",0,0
167541,randomized,0,0
167542,",",0,0
167543,controlled,0,0
167544,trial,0,0
167545,of,0,0
167546,cognitive-behavioral,0,0
167547,treatment,0,0
167548,for,0,0
167549,depression,0,1
167550,.,0,0
167551,Improvements,1,1
167552,in,1,0
167553,mood,1,1
167554,were,0,0
167555,associated,0,0
167556,with,0,0
167557,modest,1,0
167558,gains,1,1
167559,in,1,0
167560,verbal,1,1
167561,memory,1,1
167562,and,1,1
167563,executive,1,1
167564,functioning,1,1
167565,over,0,0
167566,the,0,0
167567,10-week,0,0
167568,treatment,0,0
167569,period,0,0
167570,and,0,1
167571,accounted,0,0
167572,for,0,0
167573,greater,0,0
167574,variance,0,0
167575,in,0,0
167576,neuropsychological,1,0
167577,outcomes,1,0
167578,at,0,0
167579,the,0,0
167580,end,0,0
167581,of,0,0
167582,treatment,0,0
167583,than,0,0
167584,other,0,0
167585,known,0,0
167586,correlates,0,0
167587,of,0,0
167588,cognitive,1,1
167589,functioning,1,1
167590,in,0,0
167591,PD,0,1
167592,",",0,0
167593,such,0,0
167594,as,0,0
167595,disease,0,1
167596,severity,0,1
167597,",",0,1
167598,age,0,0
167599,",",0,1
167600,and,0,1
167601,education,0,0
167602,.,0,0
167603,Baseline,1,0
167604,working,1,1
167605,memory,1,1
167606,and,1,1
167607,executive,1,1
167608,skills,1,1
167609,were,0,0
167610,also,0,0
167611,associated,0,0
167612,with,0,0
167613,depression,0,1
167614,improvement,0,1
167615,over,0,0
167616,time,0,1
167617,.,0,0
167618,Comparative,0,0
167619,evaluation,0,0
167620,of,0,0
167621,percutaneous,0,0
167622,laser,0,0
167623,and,0,1
167624,radiofrequency,0,0
167625,ablation,0,0
167626,in,0,0
167627,patients,0,0
167628,with,0,0
167629,HCC,0,0
167630,smaller,0,0
167631,than,0,0
167632,4,0,0
167633,cm,0,0
167634,.,0,0
167635,OBJECTIVE,0,0
167636,This,0,0
167637,study,0,0
167638,was,0,0
167639,done,0,0
167640,to,0,0
167641,compare,0,0
167642,percutaneous,0,0
167643,laser,0,0
167644,ablation,0,0
167645,(,0,0
167646,PLA,0,0
167647,),0,1
167648,and,0,0
167649,radiofrequency,0,0
167650,thermoablation,0,0
167651,(,0,0
167652,RFA,0,0
167653,),0,0
167654,for,0,0
167655,the,0,0
167656,treatment,0,0
167657,of,0,0
167658,hepatocellular,0,0
167659,carcinoma,0,0
167660,(,0,0
167661,HCC,0,0
167662,),0,0
167663,?,0,0
167664,4,0,0
167665,cm,0,0
167666,",",0,0
167667,in,0,0
167668,patients,0,0
167669,with,0,0
167670,liver,0,0
167671,cirrhosis,0,0
167672,.,0,0
167673,MATERIALS,0,0
167674,AND,0,0
167675,METHODS,0,0
167676,Thirty,0,0
167677,patients,0,0
167678,with,0,0
167679,single,0,0
167680,HCC,0,0
167681,?,0,0
167682,4,0,0
167683,cm,0,0
167684,in,0,0
167685,diameter,0,1
167686,were,0,0
167687,randomly,0,0
167688,assigned,0,0
167689,to,0,0
167690,one,0,0
167691,of,0,0
167692,two,0,0
167693,treatments,0,0
167694,:,0,0
167695,15,0,0
167696,patients,0,0
167697,were,0,0
167698,treated,0,0
167699,with,0,0
167700,PLA,0,0
167701,",",0,0
167702,using,0,0
167703,a,0,0
167704,multifibre,0,0
167705,system,0,0
167706,connected,0,0
167707,to,0,0
167708,a,0,0
167709,neodymium,0,0
167710,yttrium-aluminium-garnet,0,0
167711,laser,0,0
167712,source,0,0
167713,;,0,0
167714,15,0,0
167715,patients,0,0
167716,were,0,0
167717,treated,0,0
167718,with,0,0
167719,RFA,0,0
167720,",",0,0
167721,using,0,0
167722,an,0,0
167723,expandable,0,0
167724,needle,0,0
167725,electrode,0,0
167726,.,0,0
167727,Patients,0,0
167728,were,0,0
167729,followed,0,0
167730,up,0,0
167731,for,0,0
167732,up,0,0
167733,to,0,0
167734,12,0,0
167735,months,0,0
167736,.,0,0
167737,RESULTS,0,0
167738,A,0,0
167739,complete,0,1
167740,response,0,1
167741,was,0,0
167742,obtained,0,0
167743,in,0,0
167744,87,0,0
167745,%,0,0
167746,lesions,0,0
167747,treated,0,0
167748,with,0,0
167749,PLA,0,0
167750,and,0,0
167751,in,0,0
167752,93,0,0
167753,%,0,0
167754,lesions,0,0
167755,treated,0,0
167756,with,0,0
167757,RFA,0,0
167758,(,0,0
167759,p,0,0
167760,=,0,0
167761,ns,0,0
167762,),0,0
167763,.,0,0
167764,The,0,0
167765,overall,1,1
167766,local,1,0
167767,recurrence-free,1,1
167768,survival,1,1
167769,rates,1,1
167770,at,1,0
167771,3,0,0
167772,",",0,0
167773,6,0,0
167774,and,0,0
167775,12,0,0
167776,months,0,0
167777,were,0,0
167778,comparable,0,0
167779,.,0,0
167780,However,0,0
167781,",",0,0
167782,a,0,0
167783,higher,1,0
167784,rate,1,1
167785,of,1,1
167786,recurrence,1,1
167787,was,1,0
167788,observed,0,0
167789,in,0,0
167790,the,0,0
167791,PLA,0,0
167792,group,0,0
167793,for,0,0
167794,lesions,0,1
167795,?,0,0
167796,21,0,0
167797,mm,0,0
167798,(,0,0
167799,p,0,0
167800,=,0,0
167801,0.0081,0,0
167802,),1,0
167803,.,1,0
167804,A,1,0
167805,postablation,1,0
167806,syndrome,1,0
167807,was,1,0
167808,documented,1,0
167809,in,0,0
167810,13,0,0
167811,patients,0,0
167812,(,0,0
167813,1,0,0
167814,PLA,0,0
167815,;,0,0
167816,12,0,0
167817,RFA,0,0
167818,),0,0
167819,.,0,0
167820,Tumour,1,0
167821,necrosis,1,1
167822,factor-?,1,1
167823,was,1,0
167824,significantly,1,0
167825,higher,0,0
167826,in,0,0
167827,the,0,0
167828,RFA,0,0
167829,group,0,0
167830,(,0,0
167831,p,0,0
167832,<,0,0
167833,0.05,0,0
167834,),0,0
167835,.,0,0
167836,CONCLUSIONS,0,0
167837,RFA,0,0
167838,is,0,0
167839,more,0,0
167840,effective,0,0
167841,in,0,0
167842,the,0,0
167843,treatment,0,0
167844,of,0,0
167845,HCC,0,0
167846,compared,0,0
167847,to,0,0
167848,PLA,0,0
167849,for,0,0
167850,lesions,0,1
167851,?,0,0
167852,21,0,0
167853,mm,0,0
167854,.,0,0
167855,However,0,0
167856,",",0,0
167857,PLA,0,0
167858,should,0,0
167859,be,0,0
167860,considered,0,0
167861,a,0,0
167862,viable,0,0
167863,treatment,0,0
167864,option,0,0
167865,for,0,0
167866,HCC,0,0
167867,?,0,0
167868,20,0,0
167869,mm,0,0
167870,",",0,0
167871,in,0,0
167872,view,0,0
167873,of,0,0
167874,the,0,0
167875,lower,0,0
167876,incidence,0,1
167877,of,0,0
167878,complications,0,1
167879,.,0,0
167880,Influence,0,0
167881,of,0,0
167882,two,0,0
167883,different,0,0
167884,doses,0,0
167885,of,0,0
167886,antithymocyte,0,0
167887,globulin,0,1
167888,in,0,0
167889,patients,0,0
167890,with,0,0
167891,standard-risk,0,0
167892,disease,0,0
167893,following,0,0
167894,haploidentical,0,0
167895,transplantation,0,0
167896,:,0,0
167897,a,0,0
167898,randomized,0,0
167899,trial,0,0
167900,.,0,0
167901,To,0,0
167902,evaluate,0,0
167903,the,0,0
167904,effect,0,0
167905,of,0,0
167906,the,0,0
167907,different,0,0
167908,doses,0,0
167909,of,0,0
167910,antithymocyte,0,0
167911,globulin,0,1
167912,(,0,0
167913,ATG,0,1
167914,),0,0
167915,on,0,0
167916,the,0,0
167917,incidence,0,1
167918,of,0,0
167919,acute,0,0
167920,GVHD,0,1
167921,among,0,0
167922,patients,0,0
167923,receiving,0,0
167924,hematopoietic,0,0
167925,SCT,0,0
167926,without,0,0
167927,ex,0,0
167928,vivo,0,0
167929,T-cell-depletion,0,0
167930,from,0,0
167931,haploidentical,0,0
167932,donors,0,0
167933,",",0,0
167934,224,0,0
167935,patients,0,0
167936,with,0,0
167937,standard-risk,0,0
167938,hematological,0,1
167939,malignancy,0,0
167940,were,0,0
167941,randomized,0,0
167942,in,0,0
167943,this,0,0
167944,study,0,0
167945,.,0,0
167946,One,0,0
167947,hundred,0,0
167948,and,0,0
167949,twelve,0,0
167950,patients,0,0
167951,received,0,0
167952,6,0,0
167953,mg/kg,0,0
167954,ATG,0,0
167955,",",0,0
167956,whereas,0,0
167957,the,0,0
167958,remaining,0,0
167959,patients,0,0
167960,received,0,0
167961,10,0,0
167962,mg/kg,0,0
167963,ATG,0,0
167964,.,0,0
167965,This,0,0
167966,study,0,0
167967,was,0,0
167968,registered,0,0
167969,at,0,0
167970,http,0,0
167971,:,0,0
167972,//www.chictr.org,0,0
167973,as,0,0
167974,No,0,0
167975,.,0,0
167976,ChiCTR-TRC-11001761,0,0
167977,.,0,0
167978,The,0,0
167979,incidence,1,1
167980,of,1,0
167981,grade,1,1
167982,III-IV,1,0
167983,acute,1,0
167984,GVHD,1,1
167985,was,1,0
167986,higher,0,0
167987,in,0,0
167988,the,0,0
167989,ATG-6,0,0
167990,group,0,0
167991,(,0,0
167992,16.1,0,0
167993,%,0,0
167994,",",0,0
167995,95,0,0
167996,%,0,0
167997,confidence,0,0
167998,interval,0,0
167999,(,0,0
168000,CI,0,0
168001,),0,0
168002,",",0,0
168003,9.1-23.1,0,0
168004,%,0,0
168005,),0,0
168006,than,0,0
168007,in,0,0
168008,the,0,0
168009,ATG-10,0,0
168010,group,0,0
168011,(,0,0
168012,4.5,0,0
168013,%,0,0
168014,",",0,0
168015,CI,0,0
168016,",",0,0
168017,0.7-8.3,0,0
168018,%,0,0
168019,",",0,0
168020,P=0.005,0,0
168021,",",0,0
168022,95,0,0
168023,%,0,0
168024,CI,0,0
168025,for,0,0
168026,the,0,0
168027,difference,0,0
168028,",",0,0
168029,-19.4,0,0
168030,%,0,0
168031,to,0,0
168032,-3.8,0,0
168033,%,1,0
168034,),1,0
168035,.,1,0
168036,EBV,1,0
168037,reactivation,1,1
168038,occurred,1,0
168039,more,0,0
168040,frequently,0,0
168041,in,0,0
168042,the,0,0
168043,ATG-10,0,0
168044,group,0,0
168045,(,0,0
168046,25.3,0,0
168047,%,0,0
168048,",",0,0
168049,17.1-33.5,0,0
168050,%,0,0
168051,),0,0
168052,than,0,0
168053,in,0,0
168054,the,0,0
168055,ATG-6,0,0
168056,group,0,0
168057,(,0,0
168058,9.6,0,0
168059,%,0,0
168060,(,0,0
168061,4.0-15.2,0,0
168062,%,0,0
168063,),0,0
168064,",",0,0
168065,P=0.001,1,0
168066,),1,0
168067,.,1,0
168068,The,1,0
168069,1-year,1,0
168070,disease-free,1,1
168071,survival,1,1
168072,rates,1,1
168073,were,1,0
168074,84.3,0,0
168075,%,0,0
168076,(,0,0
168077,77.3-91.3,0,0
168078,%,0,0
168079,),0,0
168080,and,0,0
168081,86.0,0,0
168082,%,0,0
168083,(,0,0
168084,79.2-92.8,0,0
168085,%,0,0
168086,),0,0
168087,for,0,0
168088,the,0,0
168089,ATG-6,0,0
168090,group,0,0
168091,and,0,1
168092,ATG-10,0,0
168093,groups,0,0
168094,",",0,0
168095,respectively,0,0
168096,(,0,0
168097,P=0.88,0,0
168098,),0,0
168099,.,0,0
168100,In,0,0
168101,conclusion,0,0
168102,",",0,0
168103,although,0,0
168104,6,0,0
168105,mg/kg,0,0
168106,ATG,0,0
168107,applied,0,0
168108,in,0,0
168109,haploidentical,0,0
168110,transplantation,0,0
168111,decreased,1,0
168112,the,1,0
168113,risk,1,0
168114,of,1,0
168115,EBV,1,0
168116,reactivation,1,1
168117,compared,1,0
168118,with,0,0
168119,10,0,0
168120,mg/kg,0,0
168121,ATG,0,0
168122,",",0,0
168123,this,0,0
168124,treatment,0,0
168125,exposes,0,0
168126,patients,0,0
168127,to,0,0
168128,a,0,0
168129,higher,0,0
168130,risk,1,1
168131,for,1,0
168132,severe,1,1
168133,acute,1,0
168134,GVHD,1,1
168135,.,1,0
168136,Short-term,0,1
168137,amiodarone,0,0
168138,therapy,0,0
168139,after,0,0
168140,reversion,0,1
168141,of,0,0
168142,persistent,0,0
168143,atrial,0,1
168144,fibrillation,0,1
168145,reduces,0,0
168146,recurrences,1,1
168147,at,0,0
168148,18,0,0
168149,months,0,0
168150,.,0,0
168151,BACKGROUND,0,0
168152,The,0,0
168153,aim,0,0
168154,of,0,0
168155,this,0,0
168156,study,0,0
168157,was,0,0
168158,to,0,0
168159,compare,0,0
168160,the,0,0
168161,outcome,1,0
168162,of,0,0
168163,3,0,0
168164,months,0,0
168165,vs.,0,0
168166,18,0,0
168167,months,0,0
168168,of,0,0
168169,amiodarone,0,0
168170,treatment,0,0
168171,after,0,0
168172,atrial,0,1
168173,fibrillation,0,1
168174,(,0,0
168175,AF,0,1
168176,),0,0
168177,conversion,0,0
168178,in,0,0
168179,patients,0,0
168180,who,0,0
168181,experienced,0,0
168182,the,0,0
168183,first,0,0
168184,episode,0,0
168185,of,0,0
168186,persistent,0,0
168187,AF,0,0
168188,.,0,0
168189,METHODS,0,0
168190,We,0,0
168191,included,0,0
168192,51,0,0
168193,patients,0,0
168194,who,0,0
168195,experienced,0,0
168196,the,0,0
168197,first,0,0
168198,episode,0,0
168199,of,0,0
168200,persistent,0,0
168201,AF,0,0
168202,receiving,0,0
168203,amiodarone,0,0
168204,(,0,0
168205,600,0,0
168206,mg,0,0
168207,),0,0
168208,daily,0,0
168209,for,0,0
168210,4-6,0,0
168211,weeks,0,0
168212,.,0,0
168213,If,0,0
168214,AF,0,1
168215,persisted,0,0
168216,",",0,0
168217,electrical,0,1
168218,cardioversion,0,1
168219,(,0,0
168220,ECV,0,1
168221,),0,0
168222,was,0,0
168223,performed,0,0
168224,.,0,0
168225,All,0,0
168226,patients,0,0
168227,received,0,0
168228,amiodarone,0,0
168229,(,0,0
168230,200,0,0
168231,mg,0,0
168232,daily,0,0
168233,),0,0
168234,for,0,0
168235,3,0,0
168236,months,0,0
168237,and,0,0
168238,then,0,0
168239,were,0,0
168240,randomized,0,0
168241,to,0,0
168242,amiodarone,0,0
168243,(,0,0
168244,Group,0,0
168245,I,0,0
168246,),0,0
168247,or,0,0
168248,placebo,0,0
168249,(,0,0
168250,Group,0,0
168251,II,0,0
168252,),0,0
168253,and,0,0
168254,followed,0,0
168255,for,0,0
168256,15,0,0
168257,months,0,0
168258,.,0,0
168259,The,0,0
168260,control,0,0
168261,group,0,0
168262,comprised,0,0
168263,9,0,0
168264,untreated,0,0
168265,patients,0,0
168266,undergoing,0,0
168267,ECV,0,0
168268,.,0,0
168269,Treatment,0,0
168270,effectiveness,1,1
168271,was,0,0
168272,evaluated,0,0
168273,using,0,0
168274,a,0,0
168275,Bayesian,0,0
168276,model,0,0
168277,.,0,0
168278,RESULTS,0,0
168279,Eighteen,0,0
168280,months,0,0
168281,after,0,0
168282,AF,0,1
168283,reversion,0,1
168284,",",0,0
168285,22,0,0
168286,(,0,0
168287,81.5,0,0
168288,%,0,0
168289,),0,0
168290,patients,0,0
168291,in,0,0
168292,Group,0,0
168293,I,0,0
168294,",",0,0
168295,13,0,0
168296,(,0,0
168297,54.2,0,0
168298,%,0,0
168299,),0,0
168300,patients,0,0
168301,in,0,0
168302,Group,0,0
168303,II,0,0
168304,",",0,0
168305,and,0,0
168306,1,0,0
168307,(,0,0
168308,11.1,0,0
168309,%,0,0
168310,),0,0
168311,patient,0,0
168312,in,0,0
168313,the,0,0
168314,control,0,0
168315,group,0,0
168316,remained,1,0
168317,in,1,0
168318,sinus,1,0
168319,rhythm,1,0
168320,.,1,0
168321,No,0,0
168322,differences,0,0
168323,were,0,0
168324,found,0,0
168325,between,0,0
168326,Group,0,0
168327,I,0,0
168328,patients,0,0
168329,who,0,0
168330,required,0,0
168331,ECV,0,1
168332,and,0,1
168333,Group,0,0
168334,II,0,0
168335,patients,0,0
168336,.,0,0
168337,Sinus,1,0
168338,rhythm,1,1
168339,was,0,0
168340,preserved,0,0
168341,in,0,0
168342,all,0,0
168343,Group,0,0
168344,I,0,0
168345,patients,0,0
168346,when,0,0
168347,it,0,0
168348,was,0,0
168349,achieved,0,0
168350,during,0,0
168351,amiodarone,0,0
168352,administration,0,0
168353,.,0,0
168354,Limiting,1,0
168355,adverse,1,1
168356,effects,1,1
168357,occurred,0,0
168358,in,0,0
168359,3,0,0
168360,(,0,0
168361,11.1,0,0
168362,%,0,0
168363,),0,0
168364,patients,0,0
168365,in,0,0
168366,Group,0,0
168367,I,0,0
168368,.,0,0
168369,CONCLUSIONS,0,0
168370,In,0,0
168371,patients,0,0
168372,regaining,0,0
168373,sinus,0,0
168374,rhythm,0,1
168375,after,0,0
168376,the,0,0
168377,first,0,0
168378,episode,0,0
168379,of,0,0
168380,persistent,0,0
168381,AF,0,0
168382,",",0,0
168383,a,0,0
168384,3-month,0,0
168385,amiodarone,0,0
168386,treatment,0,0
168387,after,0,0
168388,reversion,0,0
168389,is,0,0
168390,a,0,0
168391,reasonable,0,0
168392,option,0,0
168393,for,0,0
168394,rhythm,0,1
168395,control,0,0
168396,.,0,0
168397,The,0,0
168398,effect,0,0
168399,of,0,0
168400,four,0,0
168401,different,0,0
168402,irrigation,0,0
168403,systems,0,0
168404,in,0,0
168405,the,0,0
168406,removal,0,0
168407,of,0,0
168408,a,0,0
168409,root,0,0
168410,canal,0,1
168411,sealer,0,0
168412,.,0,0
168413,OBJECTIVES,0,0
168414,The,0,0
168415,aim,0,0
168416,of,0,0
168417,this,0,0
168418,study,0,0
168419,was,0,0
168420,to,0,0
168421,compare,0,0
168422,the,0,0
168423,efficiency,1,1
168424,of,0,0
168425,sonic,0,0
168426,",",0,0
168427,ultrasonic,0,0
168428,",",0,0
168429,and,0,1
168430,hydrodynamic,0,1
168431,devices,0,0
168432,in,0,0
168433,the,0,0
168434,removal,0,0
168435,of,0,0
168436,a,0,0
168437,root,0,0
168438,canal,0,1
168439,sealer,0,0
168440,from,0,0
168441,the,0,0
168442,surface,0,0
168443,and,0,0
168444,from,0,0
168445,simulated,0,0
168446,irregularities,0,1
168447,of,0,0
168448,root,0,0
168449,canals,0,1
168450,.,0,0
168451,MATERIALS,0,0
168452,AND,0,0
168453,METHODS,0,0
168454,Fifty-three,0,0
168455,root,0,0
168456,canals,0,1
168457,with,0,0
168458,two,0,0
168459,standardized,0,0
168460,grooves,0,0
168461,in,0,0
168462,the,0,0
168463,apical,0,0
168464,and,0,0
168465,coronal,0,1
168466,parts,0,1
168467,of,0,0
168468,longitudinally,0,0
168469,split,0,0
168470,roots,0,0
168471,were,0,0
168472,covered,0,0
168473,with,0,0
168474,AH,0,0
168475,Plus,0,0
168476,root,0,0
168477,canal,0,1
168478,sealer,0,0
168479,.,0,0
168480,Compared,0,0
168481,were,0,0
168482,the,0,0
168483,effects,0,1
168484,of,0,0
168485,(,0,0
168486,control,0,0
168487,),0,1
168488,syringe,0,0
168489,irrigation,0,1
168490,",",0,0
168491,(,0,0
168492,1,0,0
168493,),0,0
168494,CanalBrush,0,0
168495,",",0,0
168496,(,0,0
168497,2,0,0
168498,),0,0
168499,passive,0,0
168500,ultrasonic,0,0
168501,irrigation,0,0
168502,",",0,0
168503,(,0,0
168504,3,0,0
168505,),0,0
168506,EndoActivator,0,0
168507,",",0,1
168508,and,0,0
168509,(,0,0
168510,4,0,0
168511,),0,0
168512,RinsEndo,0,0
168513,on,0,0
168514,the,0,0
168515,removal,1,0
168516,of,1,0
168517,the,1,0
168518,sealer,1,0
168519,.,1,0
168520,The,0,0
168521,specimens,0,0
168522,were,0,0
168523,divided,0,0
168524,into,0,0
168525,four,0,0
168526,groups,0,0
168527,(,0,0
168528,N,0,0
168529,=,0,0
168530,12,0,0
168531,),0,0
168532,and,0,0
168533,one,0,0
168534,control,0,0
168535,group,0,0
168536,(,0,0
168537,N,0,0
168538,=,0,0
168539,5,0,0
168540,),0,0
168541,via,0,0
168542,randomization,1,0
168543,.,1,0
168544,The,1,0
168545,amount,1,0
168546,of,1,0
168547,remaining,1,0
168548,sealer,1,0
168549,in,1,0
168550,the,1,0
168551,root,1,0
168552,canal,1,1
168553,irregularities,1,1
168554,was,1,0
168555,evaluated,1,0
168556,under,0,0
168557,a,0,0
168558,microscope,0,0
168559,using,0,0
168560,a,0,0
168561,4-grade,0,0
168562,scoring,0,1
168563,system,0,0
168564,",",0,0
168565,whereas,0,0
168566,the,1,0
168567,remaining,1,0
168568,sealer,1,0
168569,on,1,0
168570,the,1,0
168571,root,1,0
168572,canal,1,1
168573,surface,1,0
168574,was,0,0
168575,evaluated,1,0
168576,with,1,0
168577,a,1,0
168578,7-grade,1,0
168579,scoring,1,0
168580,system,1,0
168581,.,1,0
168582,RESULTS,0,0
168583,Passive,0,1
168584,ultrasonic,0,0
168585,irrigation,0,0
168586,is,0,0
168587,more,0,0
168588,effective,0,0
168589,than,0,0
168590,the,0,0
168591,other,0,0
168592,tested,0,0
168593,irrigation,0,0
168594,systems,0,0
168595,or,0,0
168596,syringe,0,0
168597,irrigation,1,0
168598,in,1,0
168599,removing,1,0
168600,sealer,1,0
168601,from,1,0
168602,root,1,0
168603,canal,1,1
168604,walls,1,1
168605,(,1,0
168606,p,0,0
168607,<,0,0
168608,0.01,0,0
168609,),0,0
168610,.,0,0
168611,None,0,0
168612,of,0,0
168613,the,0,0
168614,techniques,0,0
168615,had,0,0
168616,a,0,0
168617,significant,0,0
168618,effect,1,0
168619,on,1,0
168620,cleaning,1,0
168621,the,1,0
168622,lateral,1,0
168623,grooves,1,0
168624,.,1,0
168625,CONCLUSIONS,1,0
168626,Within,0,0
168627,the,0,0
168628,limitations,0,0
168629,of,0,0
168630,this,0,0
168631,study,0,0
168632,protocol,0,0
168633,ultrasonic,0,0
168634,irrigation,0,0
168635,shows,0,0
168636,a,0,0
168637,superior,0,0
168638,effect,1,0
168639,on,1,0
168640,sealer,1,0
168641,removal,1,0
168642,from,1,0
168643,the,1,0
168644,root,1,0
168645,canal,1,1
168646,surface,1,0
168647,during,1,0
168648,endodontic,0,0
168649,retreatment,0,0
168650,.,0,0
168651,Cleaning,1,0
168652,of,1,0
168653,lateral,1,0
168654,grooves,1,0
168655,seems,1,0
168656,not,0,0
168657,to,0,0
168658,be,0,0
168659,possible,0,0
168660,with,0,0
168661,one,0,0
168662,of,0,0
168663,the,0,0
168664,techniques,0,0
168665,investigated,0,0
168666,.,0,0
168667,CLINICAL,0,0
168668,RELEVANCE,0,0
168669,Incomplete,1,0
168670,removal,1,0
168671,of,1,0
168672,root,1,0
168673,canal,1,1
168674,sealer,1,0
168675,during,1,0
168676,re-treatment,0,0
168677,may,0,0
168678,cause,0,0
168679,treatment,0,0
168680,failure,0,1
168681,.,0,0
168682,Passive,0,1
168683,Ultrasonic,0,0
168684,irrigation,0,0
168685,seems,0,0
168686,to,0,0
168687,be,0,0
168688,the,0,0
168689,most,0,0
168690,effective,0,0
168691,system,1,0
168692,to,1,0
168693,remove,1,0
168694,sealer,1,0
168695,from,1,0
168696,a,1,0
168697,root,1,0
168698,canal,1,1
168699,.,1,0
168700,Intraluminal,0,1
168701,exfoliated,0,0
168702,cancer,0,0
168703,cells,0,1
168704,and,0,1
168705,effectiveness,0,1
168706,of,0,1
168707,bowel,0,1
168708,ligatures,0,0
168709,during,0,0
168710,sigmoidectomy,0,0
168711,for,0,0
168712,sigmoid,0,0
168713,colon,0,0
168714,cancer,0,0
168715,.,0,0
168716,PURPOSES,0,0
168717,To,0,0
168718,establish,0,0
168719,the,0,0
168720,efficiency,0,1
168721,of,0,0
168722,bowel,0,1
168723,ligatures,0,0
168724,in,0,0
168725,colon,0,0
168726,cancer,0,0
168727,surgery,0,0
168728,",",0,0
168729,focusing,0,0
168730,on,0,0
168731,the,0,0
168732,extent,0,0
168733,to,0,0
168734,which,0,0
168735,exfoliated,0,0
168736,cancer,0,0
168737,cells,0,1
168738,are,0,0
168739,shed,0,0
168740,in,0,0
168741,the,0,0
168742,colonic,0,0
168743,lumen,0,0
168744,during,0,0
168745,sigmoidectomy,0,0
168746,.,0,0
168747,METHODS,0,0
168748,Twenty,0,0
168749,consecutive,0,0
168750,patients,0,0
168751,who,0,0
168752,underwent,0,0
168753,sigmoidectomy,0,0
168754,for,0,0
168755,sigmoid,0,0
168756,colon,0,0
168757,cancer,0,0
168758,were,0,0
168759,prospectively,0,0
168760,randomized,0,0
168761,into,0,0
168762,two,0,0
168763,groups,0,0
168764,:,0,0
168765,the,0,0
168766,ligatures,0,0
168767,group,0,0
168768,",",0,0
168769,in,0,0
168770,which,0,0
168771,bowel,0,1
168772,ligatures,0,0
168773,were,0,0
168774,placed,0,0
168775,",",0,0
168776,3,0,0
168777,",",0,0
168778,5,0,0
168779,",",0,0
168780,10,0,0
168781,cm,0,0
168782,from,0,0
168783,the,0,0
168784,tumor,0,0
168785,proximally,0,0
168786,and,0,0
168787,distally,0,0
168788,before,0,0
168789,dissection,0,0
168790,;,0,0
168791,and,0,0
168792,the,0,0
168793,no,0,0
168794,ligatures,0,0
168795,group,0,0
168796,",",0,0
168797,in,0,0
168798,which,0,0
168799,the,0,0
168800,corresponding,0,0
168801,sites,0,0
168802,were,0,0
168803,ligated,0,0
168804,only,0,0
168805,immediately,0,0
168806,before,0,0
168807,taking,0,0
168808,the,0,0
168809,specimen,0,0
168810,out,0,0
168811,.,0,0
168812,Each,0,0
168813,colonic,0,0
168814,segment,0,0
168815,ligated,0,1
168816,was,0,0
168817,irrigated,0,0
168818,with,0,0
168819,saline,0,0
168820,and,0,1
168821,samples,0,0
168822,were,0,0
168823,sent,0,0
168824,for,0,0
168825,blind,0,0
168826,cytological,0,1
168827,examination,0,0
168828,.,0,0
168829,RESULTS,0,0
168830,Cancer,0,0
168831,cells,0,1
168832,were,0,0
168833,found,0,0
168834,in,0,0
168835,the,0,0
168836,colonic,0,0
168837,segment,0,0
168838,where,0,0
168839,the,0,0
168840,tumor,0,1
168841,was,0,0
168842,located,0,0
168843,",",0,0
168844,in,0,0
168845,18,0,0
168846,of,0,0
168847,20,0,0
168848,samples,0,0
168849,.,0,0
168850,The,0,0
168851,frequency,1,1
168852,of,1,0
168853,free,1,1
168854,cancer,1,0
168855,cells,1,1
168856,decreased,0,0
168857,from,0,0
168858,50,0,0
168859,to,0,0
168860,0,0,0
168861,%,0,0
168862,(,0,0
168863,p,0,0
168864,<,0,0
168865,0.04,0,0
168866,),0,0
168867,in,0,0
168868,the,0,0
168869,distal,0,0
168870,3-5,0,0
168871,cm,0,0
168872,colonic,0,1
168873,segment,0,0
168874,and,0,0
168875,from,0,0
168876,80,0,0
168877,to,0,0
168878,20,0,0
168879,%,0,0
168880,(,0,0
168881,p,0,0
168882,<,0,0
168883,0.03,0,0
168884,),0,0
168885,in,0,0
168886,the,0,0
168887,proximal,0,0
168888,colonic,0,0
168889,segment,0,0
168890,after,0,0
168891,performing,0,0
168892,bowel,0,0
168893,ligatures,0,0
168894,.,0,0
168895,Free,1,1
168896,cancer,1,0
168897,cells,1,1
168898,were,0,0
168899,confirmed,0,0
168900,in,0,0
168901,1,0,0
168902,of,0,0
168903,10,0,0
168904,samples,0,0
168905,at,0,0
168906,both,0,0
168907,colonic,0,0
168908,segments,0,0
168909,5-10,0,0
168910,cm,0,0
168911,from,0,0
168912,the,0,0
168913,tumor,0,1
168914,",",0,0
168915,even,0,0
168916,after,0,0
168917,bowel,0,0
168918,ligatures,0,0
168919,.,0,0
168920,CONCLUSIONS,0,0
168921,Intraluminal,0,1
168922,exfoliated,0,0
168923,cancer,0,0
168924,cells,0,1
168925,could,0,0
168926,be,0,0
168927,eliminated,0,0
168928,by,0,0
168929,placing,0,0
168930,bowel,0,1
168931,ligatures,0,0
168932,during,0,0
168933,sigmoidectomy,0,0
168934,.,0,0
168935,Measures,0,0
168936,should,0,0
168937,be,0,0
168938,considered,0,0
168939,to,0,0
168940,eliminate,0,0
168941,exfoliated,0,0
168942,cancer,0,0
168943,cells,0,1
168944,during,0,0
168945,colectomy,0,0
168946,",",0,0
168947,even,0,0
168948,after,0,0
168949,placing,0,0
168950,bowel,0,0
168951,ligatures,0,0
168952,.,0,0
168953,Learning,0,0
168954,the,0,0
168955,'traceback,0,0
168956,',0,0
168957,approach,0,0
168958,for,0,0
168959,interscalene,0,0
168960,block,0,0
168961,.,0,0
168962,Conduit,0,1
168963,artery,0,1
168964,structure,0,1
168965,and,0,1
168966,function,0,1
168967,in,0,0
168968,lowlanders,0,0
168969,and,0,0
168970,native,0,0
168971,highlanders,0,0
168972,:,0,0
168973,relationships,0,0
168974,with,0,0
168975,oxidative,0,1
168976,stress,0,1
168977,and,0,1
168978,role,0,0
168979,of,0,0
168980,sympathoexcitation,0,1
168981,.,0,0
168982,Research,0,0
168983,detailing,0,0
168984,the,0,0
168985,normal,0,0
168986,vascular,0,0
168987,adaptions,0,0
168988,to,0,0
168989,high,0,0
168990,altitude,0,0
168991,is,0,0
168992,minimal,0,1
168993,and,0,0
168994,often,0,0
168995,confounded,0,0
168996,by,0,0
168997,pathology,0,0
168998,(,0,0
168999,e.g.,0,0
169000,",",0,0
169001,chronic,0,0
169002,mountain,0,1
169003,sickness,0,1
169004,),0,0
169005,and,0,0
169006,methodological,0,1
169007,issues,0,0
169008,.,0,0
169009,We,0,0
169010,examined,0,0
169011,vascular,0,1
169012,function,0,1
169013,and,0,1
169014,structure,0,0
169015,in,0,0
169016,:,0,0
169017,(,0,0
169018,1,0,0
169019,),0,0
169020,healthy,0,0
169021,lowlanders,0,0
169022,during,0,0
169023,acute,0,0
169024,hypoxia,0,1
169025,and,0,1
169026,prolonged,0,1
169027,(,0,0
169028,?2,0,1
169029,weeks,0,0
169030,),0,0
169031,exposure,0,0
169032,to,0,0
169033,high,0,0
169034,altitude,0,0
169035,",",0,1
169036,and,0,0
169037,(,0,0
169038,2,0,0
169039,),0,0
169040,high-altitude,0,0
169041,natives,0,0
169042,at,0,0
169043,5050,0,0
169044,m,0,0
169045,(,0,0
169046,highlanders,0,0
169047,),0,0
169048,.,0,0
169049,In,0,0
169050,12,0,0
169051,healthy,0,0
169052,lowlanders,0,0
169053,(,0,0
169054,aged,0,0
169055,32,0,0
169056,?,0,0
169057,7,0,0
169058,years,0,0
169059,),0,0
169060,and,0,0
169061,12,0,0
169062,highlanders,0,0
169063,(,0,0
169064,Sherpa,0,0
169065,;,0,0
169066,33,0,0
169067,?,0,0
169068,14,0,0
169069,years,0,0
169070,),0,0
169071,we,0,0
169072,assessed,1,0
169073,brachial,1,0
169074,endothelium-dependent,1,1
169075,flow-mediated,1,1
169076,dilatation,1,1
169077,(,1,0
169078,FMD,1,1
169079,),1,0
169080,",",1,0
169081,endothelium-independent,1,1
169082,dilatation,1,1
169083,(,1,0
169084,via,1,0
169085,glyceryl,0,0
169086,trinitrate,0,0
169087,;,0,0
169088,GTN,0,0
169089,),0,0
169090,",",1,0
169091,common,1,0
169092,carotid,1,1
169093,intima-media,1,1
169094,thickness,1,1
169095,(,1,0
169096,CIMT,1,1
169097,),0,1
169098,and,0,1
169099,diameter,0,1
169100,(,0,1
169101,ultrasound,0,1
169102,),0,0
169103,",",0,0
169104,and,0,1
169105,arterial,1,1
169106,stiffness,1,1
169107,via,1,0
169108,pulse,1,0
169109,wave,1,1
169110,velocity,1,1
169111,(,1,0
169112,PWV,1,1
169113,;,0,0
169114,applanation,0,0
169115,tonometry,0,0
169116,),0,0
169117,.,0,0
169118,Cephalic,0,0
169119,venous,0,1
169120,biomarkers,0,0
169121,of,0,0
169122,free,0,1
169123,radical-mediated,0,1
169124,lipid,0,1
169125,peroxidation,0,1
169126,(,0,0
169127,lipid,0,1
169128,hydroperoxides,0,1
169129,",",0,0
169130,LOOH,0,1
169131,),0,0
169132,",",0,0
169133,nitrite,0,1
169134,(,0,0
169135,NO2-,0,1
169136,),0,0
169137,and,0,0
169138,lipid,0,1
169139,soluble,0,1
169140,antioxidants,0,0
169141,were,0,0
169142,also,0,0
169143,obtained,0,0
169144,at,0,0
169145,rest,0,0
169146,.,0,0
169147,In,0,0
169148,lowlanders,0,0
169149,",",0,0
169150,measurements,0,0
169151,were,0,0
169152,performed,0,0
169153,at,0,0
169154,sea,0,0
169155,level,0,1
169156,(,0,0
169157,334,0,0
169158,m,0,0
169159,),0,0
169160,and,0,0
169161,between,0,0
169162,days,0,0
169163,3-4,0,1
169164,(,0,0
169165,acute,0,0
169166,high,0,0
169167,altitude,0,0
169168,),0,0
169169,and,0,0
169170,12-14,0,0
169171,(,0,0
169172,chronic,0,0
169173,high,0,0
169174,altitude,0,0
169175,),0,0
169176,following,0,0
169177,arrival,0,0
169178,to,0,0
169179,5050,0,0
169180,m.,0,0
169181,Highlanders,0,0
169182,were,0,0
169183,assessed,0,0
169184,once,0,0
169185,at,0,0
169186,5050,0,0
169187,m.,0,0
169188,Compared,0,0
169189,with,0,0
169190,sea,0,0
169191,level,0,1
169192,",",0,0
169193,acute,0,1
169194,high,0,0
169195,altitude,0,0
169196,reduced,1,0
169197,lowlanders,1,1
169198,',1,1
169199,FMD,1,1
169200,(,0,0
169201,7.9,0,0
169202,?,0,0
169203,0.4,0,0
169204,vs.,0,0
169205,6.8,0,0
169206,?,0,0
169207,0.4,0,0
169208,%,0,0
169209,;,0,0
169210,P,0,0
169211,=,0,0
169212,0.004,0,0
169213,),0,0
169214,and,1,0
169215,GTN-induced,1,1
169216,dilatation,1,1
169217,(,1,0
169218,16.6,1,0
169219,?,0,0
169220,0.9,0,0
169221,vs.,0,0
169222,14.5,0,0
169223,?,0,0
169224,0.8,0,0
169225,%,0,0
169226,;,0,0
169227,P,0,0
169228,=,0,0
169229,0.006,0,0
169230,),0,0
169231,",",0,0
169232,and,0,1
169233,raised,1,1
169234,central,1,1
169235,PWV,1,1
169236,(,1,0
169237,6.0,1,0
169238,?,0,0
169239,0.2,0,0
169240,vs.,0,0
169241,6.6,0,0
169242,?,0,0
169243,0.3,0,0
169244,m,0,0
169245,s,0,0
169246,(,0,0
169247,-1,0,0
169248,),0,0
169249,;,0,0
169250,P,0,0
169251,=,0,0
169252,0.001,0,0
169253,),0,0
169254,.,0,0
169255,These,0,0
169256,changes,0,1
169257,persisted,0,0
169258,at,0,0
169259,days,0,0
169260,12-14,0,0
169261,",",0,0
169262,and,0,0
169263,after,0,0
169264,allometrically,0,0
169265,scaling,0,1
169266,FMD,0,1
169267,to,0,0
169268,adjust,0,0
169269,for,0,0
169270,altered,0,0
169271,baseline,0,0
169272,diameter,0,1
169273,.,0,0
169274,Compared,0,0
169275,to,0,0
169276,lowlanders,0,0
169277,at,0,0
169278,sea,0,0
169279,level,0,1
169280,and,0,1
169281,high,0,1
169282,altitude,0,0
169283,",",0,0
169284,highlanders,0,1
169285,had,0,0
169286,a,0,0
169287,lower,1,0
169288,carotid,1,0
169289,wall,1,1
169290,:,1,0
169291,lumen,1,0
169292,ratio,1,1
169293,(,1,0
169294,?19,1,0
169295,%,0,0
169296,",",0,0
169297,P,0,0
169298,?,0,0
169299,0.04,0,0
169300,),0,0
169301,",",0,0
169302,attributable,0,0
169303,to,0,0
169304,a,0,0
169305,narrower,0,0
169306,CIMT,0,1
169307,and,0,1
169308,wider,0,0
169309,lumen,0,0
169310,.,0,0
169311,Although,0,0
169312,both,0,0
169313,LOOH,1,1
169314,and,1,0
169315,NO2-,1,1
169316,increased,0,0
169317,with,0,0
169318,high,0,0
169319,altitude,0,0
169320,in,0,0
169321,lowlanders,0,0
169322,",",0,0
169323,only,1,0
169324,LOOH,1,1
169325,correlated,1,0
169326,with,0,0
169327,the,0,0
169328,reduction,0,0
169329,in,1,0
169330,GTN-induced,1,1
169331,dilatation,1,1
169332,evident,1,0
169333,during,0,0
169334,acute,0,0
169335,(,0,0
169336,n,0,0
169337,=,0,0
169338,11,0,0
169339,",",0,0
169340,r,0,0
169341,=,0,0
169342,-0.53,0,0
169343,),0,0
169344,and,0,0
169345,chronic,0,0
169346,(,0,0
169347,n,0,0
169348,=,0,0
169349,7,0,0
169350,",",0,0
169351,r,0,0
169352,=,0,0
169353,-0.69,0,0
169354,;,0,0
169355,P,0,0
169356,?,0,0
169357,0.01,0,0
169358,),0,0
169359,exposure,0,0
169360,to,0,0
169361,5050,0,0
169362,m.,0,0
169363,In,0,0
169364,a,0,0
169365,follow-up,0,0
169366,",",0,0
169367,placebo-controlled,0,0
169368,experiment,0,0
169369,(,0,0
169370,n,0,0
169371,=,0,0
169372,11,0,0
169373,healthy,0,0
169374,lowlanders,0,0
169375,),0,0
169376,conducted,0,0
169377,in,0,0
169378,a,0,0
169379,normobaric,0,0
169380,hypoxic,0,1
169381,chamber,0,0
169382,(,0,0
169383,inspired,0,1
169384,O2,0,0
169385,fraction,0,1
169386,(,0,0
169387,F,0,0
169388,IO,0,1
169389,2,0,0
169390,),0,0
169391,=,0,0
169392,0.11,0,0
169393,;,0,0
169394,6,0,0
169395,h,0,0
169396,),0,0
169397,",",0,0
169398,a,0,0
169399,sustained,0,1
169400,reduction,1,1
169401,in,1,0
169402,FMD,1,1
169403,was,1,0
169404,evident,1,0
169405,within,0,0
169406,1,0,0
169407,h,0,0
169408,of,0,0
169409,hypoxic,0,1
169410,exposure,0,0
169411,when,0,0
169412,compared,0,0
169413,to,0,0
169414,normoxic,0,0
169415,baseline,0,0
169416,(,0,0
169417,5.7,0,0
169418,?,0,0
169419,1.6,0,0
169420,vs.,0,0
169421,8.0,0,0
169422,?1.3,0,0
169423,%,0,0
169424,;,0,0
169425,P,0,0
169426,<,0,0
169427,0.01,0,0
169428,),0,0
169429,;,0,0
169430,this,0,0
169431,decline,1,0
169432,in,1,0
169433,FMD,1,1
169434,was,1,0
169435,largely,0,0
169436,reversed,0,0
169437,following,0,0
169438,?1-adrenoreceptor,0,0
169439,blockade,0,0
169440,.,0,0
169441,In,0,0
169442,conclusion,0,0
169443,",",0,0
169444,high-altitude,0,1
169445,exposure,0,0
169446,in,0,0
169447,lowlanders,0,0
169448,caused,1,0
169449,persistent,1,0
169450,impairment,1,1
169451,in,1,0
169452,vascular,1,1
169453,function,1,1
169454,",",1,0
169455,which,0,0
169456,was,0,0
169457,mediated,0,0
169458,partially,0,0
169459,via,0,0
169460,oxidative,0,1
169461,stress,0,1
169462,and,0,0
169463,sympathoexcitation,0,1
169464,.,0,0
169465,Although,0,0
169466,a,0,0
169467,lifetime,0,1
169468,of,0,0
169469,high-altitude,0,0
169470,exposure,0,0
169471,neither,0,0
169472,intensifies,0,0
169473,nor,0,0
169474,attenuates,0,0
169475,the,0,0
169476,impairments,0,0
169477,seen,0,0
169478,with,0,0
169479,short-term,0,0
169480,exposure,0,0
169481,",",0,0
169482,chronic,0,0
169483,high-altitude,0,0
169484,exposure,0,0
169485,appears,0,0
169486,to,0,0
169487,be,0,0
169488,associated,0,0
169489,with,0,0
169490,arterial,0,1
169491,remodelling,0,0
169492,.,0,0
169493,TGF-beta,0,1
169494,receptor,0,1
169495,type-2,0,0
169496,expression,0,1
169497,in,0,0
169498,cancer-associated,0,0
169499,fibroblasts,0,0
169500,regulates,0,1
169501,breast,0,0
169502,cancer,0,0
169503,cell,0,1
169504,growth,0,1
169505,and,0,1
169506,survival,0,1
169507,and,0,0
169508,is,0,0
169509,a,0,0
169510,prognostic,0,0
169511,marker,0,1
169512,in,0,0
169513,pre-menopausal,0,0
169514,breast,0,0
169515,cancer,0,0
169516,.,0,0
169517,Transforming,0,1
169518,growth,0,1
169519,factor-beta,0,1
169520,(,0,0
169521,TGF-?,0,0
169522,),0,0
169523,is,0,0
169524,a,0,0
169525,pleiotropic,0,0
169526,cytokine,0,1
169527,with,0,0
169528,the,0,0
169529,capability,0,0
169530,to,0,0
169531,act,0,0
169532,as,0,0
169533,tumour,0,1
169534,suppressor,0,1
169535,or,0,0
169536,tumour,0,1
169537,promoter,0,1
169538,depending,0,0
169539,on,0,0
169540,the,0,0
169541,cellular,0,0
169542,context,0,0
169543,.,0,0
169544,TGF-beta,0,1
169545,receptor,0,1
169546,type-2,0,0
169547,(,0,0
169548,TGFBR2,0,0
169549,),0,0
169550,is,0,0
169551,the,0,0
169552,ligand-binding,0,0
169553,receptor,0,0
169554,for,0,0
169555,all,0,0
169556,members,0,0
169557,of,0,0
169558,the,0,0
169559,TGF-?,0,0
169560,family,0,0
169561,.,0,0
169562,Data,0,0
169563,from,0,0
169564,mouse,0,0
169565,model,0,0
169566,experiments,0,0
169567,demonstrated,0,0
169568,that,0,0
169569,loss,0,1
169570,of,0,0
169571,Tgfbr2,0,0
169572,expression,0,1
169573,in,0,0
169574,mammary,0,1
169575,fibroblasts,0,1
169576,was,0,0
169577,linked,0,0
169578,to,0,0
169579,tumour,0,0
169580,initiation,0,0
169581,and,0,0
169582,metastasis,0,1
169583,.,0,0
169584,Using,0,0
169585,a,0,0
169586,randomised,0,0
169587,tamoxifen,0,0
169588,trial,0,0
169589,cohort,0,0
169590,including,0,0
169591,in,0,0
169592,total,0,0
169593,564,0,0
169594,invasive,0,0
169595,breast,0,0
169596,carcinomas,0,0
169597,",",0,0
169598,we,0,0
169599,examined,0,0
169600,TGFBR2,0,1
169601,expression,0,1
169602,(,0,0
169603,n=252,0,0
169604,),0,0
169605,and,0,0
169606,phosphorylation,0,1
169607,level,0,1
169608,of,0,0
169609,downstream,0,0
169610,target,0,1
169611,SMAD2,0,1
169612,(,0,0
169613,pSMAD2,0,0
169614,),0,1
169615,(,0,0
169616,n=319,0,0
169617,),0,0
169618,in,0,0
169619,cancer-associated,0,0
169620,fibroblasts,0,1
169621,(,0,0
169622,CAFs,0,1
169623,),0,0
169624,and,0,0
169625,assessed,0,0
169626,links,0,0
169627,to,0,0
169628,clinicopathological,0,0
169629,markers,0,1
169630,",",0,0
169631,prognostic,0,1
169632,and,0,1
169633,treatment-predictive,0,1
169634,values,0,1
169635,.,0,0
169636,The,0,0
169637,study,0,0
169638,revealed,0,0
169639,that,0,0
169640,CAF-specific,0,1
169641,TGFBR2,0,1
169642,expression,0,1
169643,correlated,0,0
169644,with,0,0
169645,improved,0,1
169646,recurrence-free,0,1
169647,survival,0,1
169648,.,0,0
169649,Multivariate,0,0
169650,analysis,0,0
169651,confirmed,0,0
169652,CAF-TGFBR2,0,0
169653,to,0,0
169654,be,0,0
169655,an,0,0
169656,independent,0,0
169657,prognostic,0,1
169658,marker,0,1
169659,(,0,0
169660,multivariate,0,0
169661,Cox,0,0
169662,regression,0,0
169663,",",0,0
169664,hazard,0,1
169665,ratio,0,1
169666,:,0,0
169667,0.534,0,0
169668,",",0,0
169669,95,0,0
169670,%,0,0
169671,(,0,0
169672,CI,0,0
169673,),0,0
169674,:,0,0
169675,0.360-0.793,0,0
169676,",",0,0
169677,P=0.002,1,0
169678,),1,0
169679,.,1,0
169680,CAF-specific,1,0
169681,pSMAD2,1,0
169682,levels,1,1
169683,",",1,0
169684,however,0,0
169685,",",0,0
169686,did,0,0
169687,not,0,0
169688,associate,0,0
169689,with,0,0
169690,survival,0,1
169691,outcome,0,0
169692,.,0,0
169693,Experimentally,1,0
169694,",",1,0
169695,TGF-?,1,0
169696,signalling,1,1
169697,in,1,0
169698,fibroblasts,1,1
169699,was,1,0
169700,modulated,0,0
169701,using,0,0
169702,a,0,0
169703,TGF-?,0,0
169704,ligand,0,0
169705,and,0,1
169706,inhibitor,0,0
169707,or,0,0
169708,through,0,0
169709,lentiviral,0,0
169710,short,0,1
169711,hairpin,0,0
169712,RNA-mediated,0,0
169713,TGFBR2-specific,0,0
169714,knockdown,0,1
169715,.,0,0
169716,To,0,0
169717,determine,0,0
169718,the,0,0
169719,role,0,0
169720,of,0,0
169721,fibroblastic,0,1
169722,TGF-?,0,0
169723,pathway,0,0
169724,on,0,0
169725,breast,0,0
169726,cancer,0,0
169727,cells,0,1
169728,",",0,0
169729,we,0,0
169730,used,0,0
169731,cell,0,1
169732,contact-dependent,0,1
169733,cell,0,1
169734,growth,0,1
169735,and,0,1
169736,clonogenicity,0,1
169737,assays,0,1
169738,",",0,0
169739,which,0,0
169740,showed,0,0
169741,that,0,0
169742,knockdown,0,1
169743,of,0,0
169744,TGFBR2,0,1
169745,in,0,0
169746,CAFs,0,1
169747,resulted,0,0
169748,in,0,0
169749,increased,1,0
169750,cell,1,0
169751,growth,1,1
169752,",",1,1
169753,proliferation,1,1
169754,and,1,1
169755,clonogenic,1,1
169756,survival,1,1
169757,.,1,0
169758,Further,1,1
169759,",",0,0
169760,in,0,0
169761,a,0,0
169762,mouse,0,0
169763,model,0,0
169764,transfected,0,1
169765,CAFs,0,1
169766,were,0,0
169767,co-injected,0,0
169768,with,0,0
169769,MCF7,0,0
169770,and,1,0
169771,tumour,1,1
169772,weight,1,1
169773,and,1,1
169774,proportion,1,1
169775,was,1,0
169776,monitored,0,0
169777,.,0,0
169778,We,0,0
169779,found,0,0
169780,that,0,0
169781,mouse,0,0
169782,xenograft,0,0
169783,tumours,0,0
169784,comprising,0,0
169785,TGFBR2,0,1
169786,knockdown,0,1
169787,fibroblasts,0,1
169788,were,0,0
169789,slightly,0,0
169790,bigger,0,0
169791,and,0,0
169792,displayed,0,1
169793,increased,0,0
169794,tumour,0,1
169795,cell,0,0
169796,capacity,0,1
169797,.,0,0
169798,Overall,0,0
169799,",",0,0
169800,our,0,0
169801,data,0,0
169802,demonstrate,0,0
169803,that,0,0
169804,fibroblast-related,0,0
169805,biomarkers,0,0
169806,possess,0,0
169807,clinically,0,0
169808,relevant,0,0
169809,information,0,0
169810,and,0,0
169811,that,0,0
169812,fibroblasts,0,1
169813,confer,0,0
169814,effects,0,1
169815,on,0,0
169816,breast,0,0
169817,cancer,0,0
169818,cell,0,1
169819,growth,0,1
169820,and,0,0
169821,survival,0,1
169822,.,0,1
169823,Regulation,0,1
169824,of,0,0
169825,tumour-stromal,0,1
169826,cross-talk,0,1
169827,through,0,0
169828,fibroblastic,0,1
169829,TGF-?,0,0
169830,pathway,0,0
169831,may,0,0
169832,depend,0,0
169833,on,0,0
169834,fibroblast,0,1
169835,phenotype,0,1
169836,",",0,0
169837,emphasising,0,0
169838,the,0,0
169839,importance,0,0
169840,to,0,0
169841,characterise,0,0
169842,tumour,0,1
169843,microenvironment,0,0
169844,subtypes,0,0
169845,.,0,0
169846,Mitigation,0,0
169847,of,0,0
169848,sociocommunicational,0,1
169849,deficits,0,0
169850,of,0,0
169851,autism,0,0
169852,through,0,0
169853,oxytocin-induced,0,1
169854,recovery,0,1
169855,of,0,0
169856,medial,0,1
169857,prefrontal,0,0
169858,activity,0,1
169859,:,0,0
169860,a,0,0
169861,randomized,0,0
169862,trial,0,0
169863,.,0,0
169864,IMPORTANCE,0,0
169865,Sociocommunicational,0,0
169866,deficits,0,0
169867,make,0,0
169868,it,0,0
169869,difficult,0,0
169870,for,0,0
169871,individuals,0,0
169872,with,0,0
169873,autism,0,0
169874,spectrum,0,0
169875,disorders,0,0
169876,(,0,0
169877,ASD,0,0
169878,),0,0
169879,to,0,0
169880,understand,0,0
169881,communication,0,1
169882,content,0,1
169883,with,0,0
169884,conflicting,0,0
169885,verbal,0,1
169886,and,0,0
169887,nonverbal,0,1
169888,information,0,0
169889,.,0,0
169890,Despite,0,0
169891,growing,0,0
169892,prospects,0,0
169893,for,0,0
169894,oxytocin,0,0
169895,as,0,0
169896,a,0,0
169897,therapeutic,0,0
169898,agent,0,0
169899,for,0,0
169900,ASD,0,0
169901,",",0,0
169902,no,0,0
169903,direct,0,0
169904,neurobiological,0,0
169905,evidence,0,0
169906,exists,0,0
169907,for,0,0
169908,oxytocin,0,1
169909,'s,0,0
169910,beneficial,0,0
169911,effects,0,0
169912,on,0,0
169913,this,0,0
169914,core,0,0
169915,symptom,0,1
169916,of,0,0
169917,ASD,0,0
169918,.,0,0
169919,This,0,0
169920,is,0,0
169921,slowing,0,1
169922,clinical,0,0
169923,application,0,0
169924,of,0,0
169925,the,0,0
169926,neuropeptide,0,0
169927,.,0,0
169928,OBJECTIVE,0,0
169929,To,0,0
169930,directly,0,0
169931,examine,0,0
169932,whether,0,0
169933,oxytocin,0,0
169934,has,0,0
169935,beneficial,0,0
169936,effects,0,0
169937,on,0,0
169938,the,0,0
169939,sociocommunicational,0,0
169940,deficits,0,0
169941,of,0,0
169942,ASD,0,0
169943,using,0,0
169944,both,0,0
169945,behavioral,0,1
169946,and,0,0
169947,neural,0,0
169948,measures,0,1
169949,.,0,0
169950,DESIGN,0,0
169951,",",0,0
169952,SETTING,0,0
169953,",",0,0
169954,AND,0,0
169955,PARTICIPANTS,0,0
169956,At,0,0
169957,the,0,0
169958,University,0,0
169959,of,0,0
169960,Tokyo,0,0
169961,Hospital,0,1
169962,",",0,0
169963,we,0,0
169964,conducted,0,0
169965,a,0,0
169966,randomized,0,0
169967,",",0,0
169968,double-blind,0,0
169969,",",0,0
169970,placebo-controlled,0,0
169971,",",0,0
169972,within-subject-crossover,0,0
169973,",",0,0
169974,single-site,0,0
169975,experimental,0,0
169976,trial,0,0
169977,in,0,0
169978,which,0,0
169979,intranasal,0,0
169980,oxytocin,0,1
169981,and,0,1
169982,placebo,0,0
169983,were,0,0
169984,administered,0,0
169985,.,0,0
169986,A,0,0
169987,total,0,0
169988,of,0,0
169989,40,0,0
169990,highly,0,0
169991,functioning,0,0
169992,men,0,0
169993,with,0,0
169994,ASD,0,0
169995,participated,0,0
169996,and,0,0
169997,were,0,0
169998,randomized,0,0
169999,in,0,0
170000,the,0,0
170001,trial,0,0
170002,.,0,0
170003,INTERVENTIONS,0,1
170004,Single-dose,0,0
170005,intranasal,0,0
170006,administration,0,0
170007,of,0,0
170008,oxytocin,0,0
170009,(,0,0
170010,24,0,0
170011,IU,0,0
170012,),0,0
170013,and,0,0
170014,placebo,0,0
170015,.,0,0
170016,MAIN,0,0
170017,OUTCOMES,0,0
170018,AND,0,0
170019,MEASURES,0,0
170020,Using,0,0
170021,functional,0,0
170022,magnetic,0,0
170023,resonance,0,0
170024,imaging,0,0
170025,",",0,0
170026,we,0,0
170027,examined,0,0
170028,effects,1,1
170029,of,1,0
170030,oxytocin,1,0
170031,on,0,0
170032,behavioral,1,1
170033,neural,1,0
170034,responses,1,1
170035,of,0,0
170036,the,0,0
170037,participants,0,0
170038,to,0,0
170039,a,0,0
170040,social,0,1
170041,psychological,0,1
170042,task,0,0
170043,.,0,0
170044,In,0,0
170045,our,0,0
170046,previous,0,0
170047,case-control,0,0
170048,study,0,0
170049,using,0,0
170050,the,0,0
170051,same,0,0
170052,psychological,0,1
170053,task,0,0
170054,",",0,0
170055,when,0,0
170056,making,0,0
170057,decisions,0,0
170058,about,0,0
170059,social,0,1
170060,information,0,0
170061,with,0,0
170062,conflicting,0,0
170063,verbal,0,1
170064,and,0,0
170065,nonverbal,0,1
170066,contents,0,1
170067,",",0,0
170068,participants,0,0
170069,with,0,0
170070,ASD,0,0
170071,made,0,0
170072,judgments,0,0
170073,based,0,0
170074,on,0,0
170075,nonverbal,0,0
170076,contents,0,1
170077,less,0,0
170078,frequently,0,0
170079,with,0,0
170080,longer,0,0
170081,time,0,1
170082,and,0,0
170083,could,0,0
170084,not,0,0
170085,induce,0,0
170086,enough,0,0
170087,activation,0,0
170088,in,0,0
170089,the,0,0
170090,medial,0,1
170091,prefrontal,0,0
170092,cortex,0,0
170093,.,0,0
170094,Therefore,0,0
170095,",",0,0
170096,our,0,0
170097,main,0,0
170098,outcomes,0,1
170099,and,0,0
170100,measures,0,1
170101,were,0,0
170102,the,0,0
170103,frequency,1,1
170104,of,1,0
170105,the,1,0
170106,nonverbal,1,1
170107,information-based,1,0
170108,judgments,1,0
170109,(,1,0
170110,NVJs,1,0
170111,),1,0
170112,",",1,0
170113,the,1,0
170114,response,1,1
170115,time,1,1
170116,for,1,0
170117,NVJs,1,0
170118,",",1,0
170119,and,1,1
170120,brain,1,1
170121,activity,1,1
170122,of,1,0
170123,the,1,0
170124,medial,1,1
170125,prefrontal,1,0
170126,cortex,1,0
170127,during,1,0
170128,NVJs,1,0
170129,.,1,0
170130,RESULTS,0,0
170131,Intranasal,0,0
170132,oxytocin,0,0
170133,enabled,0,0
170134,the,0,0
170135,participants,0,0
170136,to,0,0
170137,make,0,0
170138,NVJs,1,0
170139,more,0,0
170140,frequently,0,0
170141,(,0,0
170142,P,0,0
170143,=,0,0
170144,.03,0,0
170145,),0,0
170146,with,0,0
170147,shorter,1,0
170148,response,1,1
170149,time,1,1
170150,(,1,0
170151,P,0,0
170152,=,0,0
170153,.02,0,0
170154,),0,0
170155,.,0,0
170156,During,0,0
170157,the,0,0
170158,mitigated,0,0
170159,behavior,0,1
170160,",",0,0
170161,oxytocin,0,1
170162,increased,0,0
170163,the,0,0
170164,originally,1,0
170165,diminished,1,0
170166,brain,1,0
170167,activity,1,1
170168,in,1,0
170169,the,0,0
170170,medial,0,1
170171,prefrontal,0,1
170172,cortex,0,1
170173,(,0,0
170174,P,0,0
170175,<,0,0
170176,.001,0,0
170177,),0,0
170178,.,0,0
170179,Moreover,0,0
170180,",",0,0
170181,oxytocin,0,0
170182,enhanced,1,0
170183,functional,1,0
170184,coordination,1,1
170185,in,1,0
170186,the,1,0
170187,area,0,1
170188,(,0,0
170189,P,0,0
170190,<,0,0
170191,.001,0,0
170192,),0,0
170193,",",0,0
170194,and,0,0
170195,the,0,0
170196,magnitude,0,1
170197,of,0,0
170198,these,0,0
170199,neural,0,0
170200,effects,0,1
170201,was,0,0
170202,predictive,0,0
170203,of,0,0
170204,the,0,0
170205,behavioral,0,1
170206,effects,0,1
170207,(,0,0
170208,P,0,0
170209,?,0,0
170210,.01,0,0
170211,),0,0
170212,.,0,0
170213,CONCLUSIONS,0,0
170214,AND,0,0
170215,RELEVANCE,0,0
170216,These,0,0
170217,findings,0,0
170218,provide,0,0
170219,the,0,0
170220,first,0,0
170221,neurobiological,0,0
170222,evidence,0,0
170223,for,0,0
170224,oxytocin,0,1
170225,'s,0,0
170226,beneficial,0,0
170227,effects,0,0
170228,on,0,0
170229,sociocommunicational,0,0
170230,deficits,0,0
170231,of,0,0
170232,ASD,0,0
170233,and,0,0
170234,give,0,0
170235,us,0,0
170236,the,0,0
170237,initial,0,0
170238,account,0,0
170239,for,0,0
170240,neurobiological,0,0
170241,mechanisms,0,0
170242,underlying,0,0
170243,any,0,0
170244,beneficial,0,0
170245,effects,0,0
170246,of,0,0
170247,the,0,0
170248,neuropeptide,0,0
170249,.,0,0
170250,TRIAL,0,0
170251,REGISTRATION,0,0
170252,umin.ac.jp/ctr,0,0
170253,Identifier,0,0
170254,:,0,0
170255,UMIN000002241,0,0
170256,and,0,0
170257,UMIN000004393,0,0
170258,.,0,0
170259,Evaluating,0,0
170260,the,0,0
170261,acceptability,0,1
170262,and,0,0
170263,efficacy,0,1
170264,of,0,0
170265,a,0,0
170266,psycho-educational,0,0
170267,intervention,0,0
170268,for,0,0
170269,coping,0,1
170270,and,0,0
170271,symptom,0,1
170272,management,0,0
170273,by,0,0
170274,children,0,0
170275,with,0,0
170276,cancer,0,0
170277,:,0,0
170278,a,0,0
170279,randomized,0,0
170280,controlled,0,0
170281,study,0,0
170282,.,0,0
170283,AIMS,0,0
170284,To,0,0
170285,evaluate,0,0
170286,the,0,0
170287,acceptability,0,1
170288,and,0,0
170289,efficacy,0,1
170290,of,0,0
170291,a,0,0
170292,psycho-educational,0,0
170293,intervention,0,0
170294,designed,0,0
170295,to,0,0
170296,improve,0,0
170297,effective,0,1
170298,coping,0,1
170299,and,0,0
170300,reduce,0,0
170301,symptom,0,1
170302,severity,0,1
170303,in,0,0
170304,children,0,0
170305,with,0,0
170306,cancer,0,0
170307,.,0,0
170308,BACKGROUND,0,0
170309,Cancer,0,0
170310,treatments,0,0
170311,increase,0,0
170312,survival,0,1
170313,rates,0,1
170314,and,0,0
170315,also,0,0
170316,cause,0,0
170317,physical,0,1
170318,and,0,0
170319,psychological,0,1
170320,effects,0,1
170321,on,0,0
170322,children,0,0
170323,with,0,0
170324,cancer,0,0
170325,.,0,0
170326,A,0,0
170327,psycho-educational,0,0
170328,intervention,0,0
170329,is,0,0
170330,used,0,0
170331,to,0,0
170332,assist,0,0
170333,children,0,0
170334,and,0,0
170335,adolescents,0,0
170336,with,0,0
170337,these,0,0
170338,effects,0,0
170339,and,0,0
170340,its,0,0
170341,efficacy,0,1
170342,has,0,0
170343,been,0,0
170344,described,0,0
170345,in,0,0
170346,several,0,0
170347,studies,0,0
170348,.,0,0
170349,DESIGN,0,0
170350,A,0,0
170351,randomized,0,0
170352,controlled,0,0
170353,trial,0,0
170354,.,0,0
170355,METHODS,0,0
170356,Participants,0,0
170357,being,0,0
170358,treated,0,0
170359,were,0,0
170360,recruited,0,0
170361,and,0,0
170362,randomly,0,0
170363,assigned,0,0
170364,to,0,0
170365,two,0,0
170366,groups,0,0
170367,from,0,0
170368,September,0,0
170369,2011-February,0,0
170370,2013,0,0
170371,in,0,0
170372,Taiwan,0,0
170373,.,0,0
170374,The,0,0
170375,intervention,0,0
170376,group,0,0
170377,received,0,0
170378,a,0,0
170379,psycho-educational,0,0
170380,intervention,0,0
170381,in,0,0
170382,addition,0,0
170383,to,0,0
170384,standard,0,0
170385,care,0,0
170386,",",0,0
170387,while,0,0
170388,the,0,0
170389,control,0,0
170390,group,0,0
170391,received,0,0
170392,only,0,0
170393,standard,0,0
170394,care,0,0
170395,.,0,0
170396,Each,0,0
170397,participant,0,0
170398,was,0,0
170399,assessed,0,0
170400,using,0,0
170401,a,0,0
170402,paediatric,0,0
170403,cancer,0,0
170404,coping,0,1
170405,scale,0,1
170406,and,0,0
170407,perceived,0,1
170408,symptom,0,1
170409,severity,0,1
170410,was,0,0
170411,evaluated,0,0
170412,at,0,0
170413,three,0,0
170414,time,0,1
170415,points,0,0
170416,(,0,0
170417,baseline,0,0
170418,",",0,0
170419,1,0,0
170420,month,0,0
170421,and,0,0
170422,3,0,0
170423,months,0,0
170424,),0,0
170425,.,0,0
170426,A,0,0
170427,repeated-measures,0,0
170428,analysis,0,0
170429,of,0,0
170430,variance,0,0
170431,was,0,0
170432,used,0,0
170433,to,0,0
170434,estimate,0,0
170435,the,0,0
170436,effects,0,0
170437,of,0,0
170438,intervention,0,0
170439,.,0,0
170440,Qualitative,0,1
170441,findings,0,0
170442,were,0,0
170443,analysed,0,0
170444,using,0,0
170445,content,0,1
170446,analysis,0,0
170447,.,0,0
170448,RESULTS,0,0
170449,No,0,0
170450,significant,0,0
170451,difference,0,0
170452,in,0,0
170453,coping,0,1
170454,scores,0,1
170455,was,0,0
170456,found,0,0
170457,between,0,0
170458,groups,0,0
170459,",",0,0
170460,but,0,0
170461,the,0,0
170462,experimental,0,0
170463,group,0,0
170464,reported,0,0
170465,significantly,0,0
170466,lower,0,0
170467,scores,0,1
170468,in,0,0
170469,gastrointestinal,1,1
170470,problems,1,1
170471,and,1,0
170472,pain,1,1
170473,.,1,0
170474,Most,0,0
170475,symptoms,0,1
170476,decreased,0,0
170477,significantly,0,0
170478,over,0,0
170479,time,0,1
170480,in,0,0
170481,both,0,0
170482,groups,0,0
170483,",",0,0
170484,except,0,0
170485,for,0,0
170486,gastrointestinal,0,1
170487,problems,0,0
170488,.,0,0
170489,The,0,0
170490,scores,0,1
170491,in,0,0
170492,pain,1,1
170493,",",1,0
170494,bone,1,1
170495,marrow,1,1
170496,suppression,1,1
170497,and,1,1
170498,body,1,1
170499,image,1,1
170500,showed,0,0
170501,significant,0,0
170502,interaction,0,1
170503,effects,0,1
170504,between,0,0
170505,groups,0,0
170506,on,0,0
170507,changes,0,1
170508,over,0,0
170509,time,0,1
170510,.,0,0
170511,Qualitative,0,1
170512,results,0,0
170513,reported,0,0
170514,that,0,0
170515,participants,0,0
170516,evaluated,0,0
170517,the,0,0
170518,intervention,0,0
170519,positively,0,0
170520,",",0,0
170521,especially,0,0
170522,about,0,0
170523,receipt,0,0
170524,of,0,0
170525,psychological,0,1
170526,support,0,0
170527,and,0,1
170528,learnt,0,0
170529,coping,0,1
170530,skills,0,1
170531,.,0,0
170532,CONCLUSIONS,0,0
170533,The,0,0
170534,psycho-educational,0,0
170535,intervention,0,0
170536,administered,0,0
170537,was,0,0
170538,acceptable,0,0
170539,for,0,0
170540,children,0,0
170541,with,0,0
170542,cancer,0,0
170543,and,0,0
170544,was,0,0
170545,found,0,0
170546,to,0,0
170547,reduce,0,0
170548,gastrointestinal,0,1
170549,problems,0,1
170550,and,0,0
170551,pain,0,1
170552,.,0,0
170553,Addressing,0,0
170554,dental,0,0
170555,fear,0,1
170556,in,0,0
170557,children,0,0
170558,with,0,0
170559,autism,0,0
170560,spectrum,0,0
170561,disorders,0,0
170562,:,0,0
170563,a,0,0
170564,randomized,0,0
170565,controlled,0,0
170566,pilot,0,0
170567,study,0,0
170568,using,0,0
170569,electronic,0,0
170570,screen,0,0
170571,media,0,0
170572,.,0,0
170573,BACKGROUND,0,0
170574,Dental,0,0
170575,care,0,0
170576,is,0,0
170577,a,0,0
170578,significant,0,0
170579,unmet,0,0
170580,health,0,1
170581,care,0,0
170582,need,0,0
170583,for,0,0
170584,children,0,0
170585,with,0,0
170586,autism,0,0
170587,spectrum,0,0
170588,disorders,0,0
170589,(,0,0
170590,ASD,0,0
170591,),0,0
170592,.,0,0
170593,Many,0,0
170594,children,0,0
170595,with,0,0
170596,ASD,0,0
170597,do,0,0
170598,not,0,0
170599,receive,0,0
170600,dental,0,0
170601,care,0,0
170602,because,0,0
170603,of,0,0
170604,fear,0,1
170605,associated,0,0
170606,with,0,0
170607,dental,0,0
170608,procedures,0,0
170609,;,0,0
170610,oftentimes,0,0
170611,they,0,0
170612,require,0,0
170613,general,0,0
170614,anesthesia,0,0
170615,for,0,0
170616,regular,0,0
170617,dental,0,0
170618,procedures,0,0
170619,",",0,0
170620,placing,0,0
170621,them,0,0
170622,at,0,0
170623,risk,0,1
170624,of,0,0
170625,associated,0,0
170626,complications,0,1
170627,.,0,0
170628,Many,0,0
170629,children,0,0
170630,with,0,0
170631,ASD,0,0
170632,have,0,0
170633,a,0,0
170634,strong,0,0
170635,preference,0,0
170636,for,0,0
170637,visual,0,1
170638,stimuli,0,1
170639,",",0,0
170640,particularly,0,0
170641,electronic,0,0
170642,screen,0,0
170643,media,0,0
170644,.,0,0
170645,The,0,0
170646,use,0,0
170647,of,0,0
170648,visual,0,1
170649,teaching,0,0
170650,materials,0,0
170651,is,0,0
170652,a,0,0
170653,fundamental,0,0
170654,principle,0,0
170655,in,0,0
170656,designing,0,0
170657,educational,0,0
170658,programs,0,0
170659,for,0,0
170660,children,0,0
170661,with,0,0
170662,ASD,0,0
170663,.,0,0
170664,PURPOSE,0,0
170665,To,0,0
170666,determine,0,0
170667,if,0,0
170668,an,0,0
170669,innovative,0,0
170670,strategy,0,0
170671,using,0,0
170672,2,0,0
170673,types,0,0
170674,of,0,0
170675,electronic,0,0
170676,screen,0,0
170677,media,0,0
170678,was,0,0
170679,feasible,0,0
170680,and,0,0
170681,beneficial,0,0
170682,in,0,0
170683,reducing,0,0
170684,fear,0,1
170685,and,0,0
170686,uncooperative,0,0
170687,behaviors,0,1
170688,in,0,0
170689,children,0,0
170690,with,0,0
170691,ASD,0,0
170692,undergoing,0,0
170693,dental,0,0
170694,visits,0,0
170695,.,0,0
170696,METHODS,0,0
170697,We,0,0
170698,conducted,0,0
170699,a,0,0
170700,randomized,0,0
170701,controlled,0,0
170702,trial,0,0
170703,at,0,0
170704,Boston,0,0
170705,Children,0,0
170706,'s,0,0
170707,Hospital,0,1
170708,dental,0,0
170709,clinic,0,0
170710,.,0,0
170711,Eighty,0,0
170712,(,0,0
170713,80,0,0
170714,),0,0
170715,children,0,0
170716,aged,0,0
170717,7,0,0
170718,to,0,0
170719,17,0,0
170720,years,0,0
170721,with,0,0
170722,a,0,0
170723,known,0,0
170724,diagnosis,0,0
170725,of,0,0
170726,ASD,0,0
170727,and,0,0
170728,history,0,1
170729,of,0,1
170730,dental,0,0
170731,fear,0,1
170732,were,0,0
170733,enrolled,0,0
170734,in,0,0
170735,the,0,0
170736,study,0,0
170737,.,0,0
170738,Each,0,0
170739,child,0,0
170740,completed,0,0
170741,2,0,0
170742,preventive,0,0
170743,dental,0,0
170744,visits,0,0
170745,that,0,0
170746,were,0,0
170747,scheduled,0,0
170748,6,0,0
170749,months,0,0
170750,apart,0,0
170751,(,0,0
170752,visit,0,0
170753,1,0,0
170754,and,0,0
170755,visit,0,0
170756,2,0,0
170757,),0,0
170758,.,0,0
170759,After,0,0
170760,visit,0,0
170761,1,0,0
170762,",",0,0
170763,subjects,0,0
170764,were,0,0
170765,randomly,0,0
170766,assigned,0,0
170767,to,0,0
170768,1,0,0
170769,of,0,0
170770,4,0,0
170771,groups,0,0
170772,:,0,0
170773,(,0,0
170774,1,0,0
170775,),0,0
170776,group,0,0
170777,A,0,0
170778,",",0,1
170779,control,0,0
170780,(,0,0
170781,usual,0,0
170782,care,0,0
170783,),0,0
170784,;,0,0
170785,(,0,0
170786,2,0,0
170787,),0,0
170788,group,0,0
170789,B,0,0
170790,",",0,1
170791,treatment,0,0
170792,(,0,0
170793,video,0,0
170794,peer,0,0
170795,modeling,0,0
170796,that,0,0
170797,involved,0,0
170798,watching,0,1
170799,a,0,0
170800,DVD,0,1
170801,recording,0,0
170802,of,0,0
170803,a,0,0
170804,typically,0,0
170805,developing,0,0
170806,child,0,0
170807,undergoing,0,0
170808,a,0,0
170809,dental,0,0
170810,visit,0,0
170811,),0,0
170812,;,0,0
170813,(,0,0
170814,3,0,0
170815,),0,0
170816,group,0,0
170817,C,0,0
170818,",",0,1
170819,treatment,0,0
170820,(,0,0
170821,video,0,0
170822,goggles,0,0
170823,that,0,0
170824,involved,0,0
170825,watching,0,1
170826,a,0,0
170827,favorite,0,0
170828,movie,0,0
170829,during,0,0
170830,the,0,0
170831,dental,0,0
170832,visit,0,1
170833,using,0,0
170834,sunglass-style,0,0
170835,video,0,0
170836,eyewear,0,0
170837,),0,0
170838,;,0,0
170839,and,0,0
170840,(,0,0
170841,4,0,0
170842,),0,0
170843,group,0,0
170844,D,0,1
170845,",",0,1
170846,treatment,0,0
170847,(,0,0
170848,video,0,0
170849,peer,0,0
170850,modeling,0,0
170851,plus,0,0
170852,video,0,0
170853,goggles,0,0
170854,),0,0
170855,.,0,0
170856,Subjects,0,0
170857,who,0,0
170858,refused,0,0
170859,or,0,0
170860,were,0,0
170861,unable,0,0
170862,to,0,0
170863,wear,0,1
170864,the,0,0
170865,goggles,0,0
170866,watched,0,0
170867,the,0,0
170868,movie,0,0
170869,using,0,0
170870,a,0,0
170871,handheld,0,0
170872,portable,0,0
170873,DVD,0,1
170874,player,0,0
170875,.,0,0
170876,During,0,0
170877,both,0,0
170878,visits,0,0
170879,",",0,0
170880,the,0,0
170881,subject,0,0
170882,'s,0,0
170883,level,0,1
170884,of,0,0
170885,anxiety,0,1
170886,and,0,1
170887,behavior,0,1
170888,were,0,0
170889,measured,0,0
170890,using,0,0
170891,the,0,0
170892,Venham,0,0
170893,Anxiety,0,1
170894,and,0,0
170895,Behavior,0,1
170896,Scales,0,1
170897,.,0,0
170898,Analyses,0,0
170899,of,0,0
170900,variance,0,0
170901,and,0,0
170902,Fisher,0,1
170903,'s,0,1
170904,exact,0,0
170905,tests,0,1
170906,compared,0,0
170907,baseline,0,0
170908,characteristics,0,0
170909,across,0,0
170910,groups,0,0
170911,.,0,0
170912,Using,0,0
170913,intention,0,0
170914,to,0,0
170915,treat,0,0
170916,approach,0,0
170917,",",0,0
170918,repeated,0,0
170919,measures,0,1
170920,analyses,0,0
170921,were,0,0
170922,employed,0,0
170923,to,0,0
170924,test,0,0
170925,whether,0,0
170926,the,0,0
170927,outcomes,0,0
170928,differed,0,0
170929,significantly,0,0
170930,:,0,0
170931,(,0,0
170932,1,0,0
170933,),0,0
170934,between,0,0
170935,visits,0,0
170936,1,0,0
170937,and,0,0
170938,2,0,0
170939,within,0,0
170940,each,0,0
170941,group,0,0
170942,and,0,0
170943,(,0,0
170944,2,0,0
170945,),0,0
170946,between,0,0
170947,each,0,0
170948,intervention,0,0
170949,group,0,0
170950,and,0,0
170951,the,0,0
170952,control,0,0
170953,group,0,0
170954,over,0,0
170955,time,0,1
170956,(,0,0
170957,an,0,0
170958,interaction,0,0
170959,),0,0
170960,.,0,0
170961,RESULTS,0,0
170962,Between,0,0
170963,visits,0,0
170964,1,0,0
170965,and,0,0
170966,2,0,0
170967,",",0,0
170968,mean,1,1
170969,anxiety,1,1
170970,and,1,1
170971,behavior,1,1
170972,scores,1,1
170973,decreased,0,0
170974,significantly,0,0
170975,by,0,0
170976,0.8,0,0
170977,points,0,0
170978,(,0,0
170979,P,0,0
170980,=,0,0
170981,.03,0,0
170982,),0,0
170983,for,0,0
170984,subjects,0,0
170985,within,0,0
170986,groups,0,0
170987,C,0,0
170988,and,0,0
170989,D.,0,0
170990,Significant,0,1
170991,changes,0,1
170992,were,0,0
170993,not,0,0
170994,observed,0,0
170995,within,0,0
170996,groups,0,0
170997,A,0,0
170998,and,0,0
170999,B,0,0
171000,.,0,0
171001,Mean,1,1
171002,anxiety,1,1
171003,and,1,1
171004,behavior,1,1
171005,scores,1,1
171006,did,0,0
171007,not,0,0
171008,differ,0,0
171009,significantly,0,0
171010,between,0,0
171011,groups,0,0
171012,over,0,0
171013,time,0,1
171014,",",0,0
171015,although,0,0
171016,group,0,0
171017,A,0,0
171018,versus,0,0
171019,C,0,0
171020,pairwise,0,1
171021,comparisons,0,0
171022,showed,0,0
171023,a,0,0
171024,trend,0,0
171025,toward,0,0
171026,significance,0,1
171027,(,0,0
171028,P,0,0
171029,=,0,0
171030,.06,0,0
171031,),0,0
171032,.,0,0
171033,CONCLUSION,0,0
171034,These,0,0
171035,findings,0,0
171036,suggest,0,0
171037,that,0,0
171038,certain,0,0
171039,electronic,0,0
171040,screen,0,0
171041,media,0,0
171042,technologies,0,0
171043,may,0,0
171044,be,0,0
171045,useful,0,0
171046,tools,0,1
171047,for,0,0
171048,reducing,1,0
171049,fear,1,1
171050,and,1,0
171051,uncooperative,1,0
171052,behaviors,1,1
171053,among,0,0
171054,children,0,0
171055,with,0,0
171056,ASD,0,0
171057,undergoing,0,0
171058,dental,0,0
171059,visits,0,0
171060,.,0,0
171061,Further,0,0
171062,studies,0,0
171063,are,0,0
171064,needed,0,0
171065,to,0,0
171066,assess,0,0
171067,the,0,0
171068,efficacy,0,1
171069,of,0,0
171070,these,0,0
171071,strategies,0,0
171072,using,0,0
171073,larger,0,0
171074,sample,0,0
171075,sizes,0,1
171076,.,0,0
171077,Findings,0,0
171078,from,0,0
171079,future,0,0
171080,studies,0,0
171081,could,0,0
171082,be,0,0
171083,relevant,0,0
171084,for,0,0
171085,nondental,0,0
171086,providers,0,0
171087,who,0,0
171088,care,0,0
171089,for,0,0
171090,children,0,0
171091,with,0,0
171092,ASD,0,0
171093,in,0,0
171094,other,0,0
171095,medical,0,0
171096,settings,0,0
171097,.,0,0
171098,Preschool-based,0,0
171099,social,0,1
171100,communication,0,1
171101,treatment,0,0
171102,for,0,0
171103,children,0,0
171104,with,0,0
171105,autism,0,0
171106,:,0,0
171107,12-month,0,0
171108,follow-up,0,0
171109,of,0,0
171110,a,0,0
171111,randomized,0,0
171112,trial,0,0
171113,.,0,0
171114,OBJECTIVE,0,0
171115,This,0,0
171116,study,0,0
171117,reports,0,0
171118,12-month,0,0
171119,follow-up,0,0
171120,data,0,0
171121,from,0,0
171122,a,0,0
171123,randomized,0,0
171124,controlled,0,0
171125,trial,0,0
171126,of,0,0
171127,preschool-based,0,0
171128,social,0,1
171129,communication,0,1
171130,treatment,0,0
171131,for,0,0
171132,young,0,0
171133,children,0,0
171134,with,0,0
171135,autism,0,0
171136,.,0,0
171137,METHOD,0,0
171138,A,0,0
171139,total,0,1
171140,of,0,0
171141,61,0,0
171142,children,0,0
171143,(,0,0
171144,48,0,0
171145,males,0,0
171146,),0,0
171147,with,0,0
171148,autism,0,0
171149,",",0,0
171150,29,0,0
171151,to,0,0
171152,60,0,0
171153,months,0,0
171154,of,0,0
171155,age,0,0
171156,",",0,0
171157,had,0,0
171158,earlier,0,0
171159,been,0,0
171160,randomized,0,0
171161,either,0,0
171162,to,0,0
171163,8,0,0
171164,weeks,0,0
171165,of,0,0
171166,preschool-based,0,0
171167,social,0,1
171168,communication,0,1
171169,treatment,0,0
171170,in,0,0
171171,addition,0,0
171172,to,0,0
171173,standard,0,0
171174,preschool,0,0
171175,program,0,0
171176,(,0,0
171177,n,0,0
171178,=,0,0
171179,34,0,0
171180,),0,0
171181,or,0,0
171182,to,0,0
171183,standard,0,0
171184,preschool,0,0
171185,program,0,0
171186,only,0,0
171187,(,0,0
171188,n,0,0
171189,=,0,0
171190,27,0,0
171191,),0,0
171192,.,0,0
171193,Significant,0,0
171194,short-term,0,0
171195,effects,0,0
171196,on,0,0
171197,targeted,0,0
171198,social,0,1
171199,communication,0,0
171200,skills,0,1
171201,have,0,0
171202,previously,0,0
171203,been,0,0
171204,published,0,0
171205,.,0,0
171206,Long-term,0,0
171207,gains,0,1
171208,in,0,0
171209,social,1,1
171210,communication,1,1
171211,",",1,0
171212,language,1,1
171213,and,1,1
171214,global,1,1
171215,social,1,1
171216,functioning,1,1
171217,and,0,1
171218,communication,0,1
171219,were,0,0
171220,assessed,0,0
171221,from,0,0
171222,video-taped,0,0
171223,preschool,0,0
171224,teacher-child,0,0
171225,and,0,0
171226,mother-child,0,1
171227,interactions,0,0
171228,",",0,0
171229,Early,0,1
171230,Social,0,1
171231,Communication,0,1
171232,Scales,0,1
171233,",",0,0
171234,Reynell,0,0
171235,Developmental,0,1
171236,Language,0,1
171237,Scale,0,1
171238,",",0,0
171239,and,0,1
171240,Social,0,1
171241,Communication,0,1
171242,Questionnaire,0,1
171243,.,0,0
171244,RESULTS,0,0
171245,Compared,0,0
171246,with,0,0
171247,those,0,0
171248,in,0,0
171249,the,0,0
171250,control,0,0
171251,group,0,0
171252,",",0,0
171253,the,0,0
171254,treated,0,0
171255,children,0,0
171256,achieved,0,0
171257,significantly,0,0
171258,larger,0,0
171259,improvements,0,1
171260,in,0,0
171261,joint,1,1
171262,attention,1,0
171263,and,1,0
171264,joint,1,1
171265,engagement,1,1
171266,from,0,0
171267,baseline,0,0
171268,to,0,0
171269,12-month,0,0
171270,follow-up,0,0
171271,.,0,0
171272,However,0,0
171273,",",0,0
171274,no,0,0
171275,effects,0,1
171276,were,0,0
171277,detected,0,0
171278,on,0,0
171279,language,1,0
171280,and,1,0
171281,global,1,1
171282,ratings,1,1
171283,of,1,0
171284,social,1,1
171285,functioning,1,1
171286,and,1,0
171287,communication,1,1
171288,.,1,0
171289,The,0,0
171290,treatment,0,0
171291,effect,0,0
171292,on,0,0
171293,child,1,0
171294,initiation,1,0
171295,of,1,0
171296,joint,1,1
171297,attention,1,0
171298,increased,0,0
171299,with,0,0
171300,increasing,0,0
171301,level,1,1
171302,of,1,0
171303,sociability,1,1
171304,at,0,0
171305,baseline,0,0
171306,",",0,0
171307,whereas,0,0
171308,nonverbal,1,1
171309,IQ,1,1
171310,and,1,0
171311,expressive,1,1
171312,language,1,1
171313,had,0,0
171314,no,0,0
171315,moderating,0,0
171316,effect,0,0
171317,.,0,0
171318,CONCLUSIONS,0,0
171319,This,0,0
171320,study,0,0
171321,is,0,0
171322,the,0,0
171323,first,0,0
171324,to,0,0
171325,show,0,0
171326,that,0,0
171327,",",0,0
171328,similar,0,0
171329,to,0,0
171330,specialist-delivered,0,0
171331,treatment,0,0
171332,",",0,0
171333,preschool-based,0,0
171334,treatment,0,0
171335,may,0,0
171336,produce,0,0
171337,small,0,0
171338,but,0,0
171339,possibly,0,0
171340,clinically,0,0
171341,important,0,0
171342,long-term,0,0
171343,changes,0,1
171344,in,0,0
171345,social,1,1
171346,communication,1,0
171347,in,1,0
171348,young,0,0
171349,children,0,0
171350,with,0,0
171351,autism,0,0
171352,.,0,0
171353,The,0,0
171354,treatment,0,0
171355,did,0,0
171356,not,0,0
171357,affect,0,0
171358,language,1,1
171359,and,1,0
171360,global,1,1
171361,ratings,1,1
171362,of,1,0
171363,social,1,1
171364,functioning,1,1
171365,and,1,0
171366,communication,1,1
171367,.,1,0
171368,More,0,0
171369,studies,0,0
171370,are,0,0
171371,needed,0,0
171372,to,0,0
171373,better,0,0
171374,understand,0,0
171375,whether,0,0
171376,treatment,0,0
171377,effects,0,0
171378,may,0,0
171379,be,0,0
171380,improved,0,0
171381,by,0,0
171382,increasing,0,0
171383,the,0,0
171384,intensity,0,1
171385,and,0,0
171386,duration,0,1
171387,of,0,0
171388,the,0,0
171389,treatment,0,0
171390,.,0,0
171391,Clinical,0,1
171392,trial,0,0
171393,registration,0,0
171394,information,0,0
171395,--,0,0
171396,Joint,0,1
171397,Attention,0,1
171398,Intervention,0,0
171399,and,0,0
171400,Young,0,0
171401,Children,0,0
171402,With,0,0
171403,Autism,0,0
171404,;,0,0
171405,http,0,0
171406,:,0,0
171407,//clinicaltrials.gov/,0,0
171408,;,0,0
171409,NCT00378157,0,0
171410,.,0,0
171411,Economic,0,1
171412,burden,0,1
171413,of,0,0
171414,childhood,0,0
171415,autism,0,0
171416,spectrum,0,0
171417,disorders,0,0
171418,.,0,0
171419,OBJECTIVE,0,0
171420,To,0,0
171421,estimate,0,0
171422,the,0,0
171423,associations,0,0
171424,between,0,0
171425,autism,0,0
171426,spectrum,0,0
171427,disorder,0,0
171428,(,0,0
171429,ASD,0,0
171430,),0,0
171431,diagnoses,0,0
171432,and,0,1
171433,service,1,1
171434,use,1,1
171435,",",1,1
171436,caregiver,1,1
171437,time,1,1
171438,",",1,1
171439,and,1,1
171440,cost,1,1
171441,outcomes,1,1
171442,.,1,0
171443,METHODS,0,0
171444,We,0,0
171445,used,0,0
171446,national,0,0
171447,data,0,0
171448,from,0,0
171449,the,0,0
171450,Medical,0,0
171451,Expenditure,0,1
171452,Panel,0,1
171453,Survey,0,0
171454,linked,0,0
171455,to,0,0
171456,the,0,0
171457,National,0,0
171458,Health,0,1
171459,Interview,0,0
171460,Survey,0,0
171461,and,0,0
171462,a,0,0
171463,study-specific,0,0
171464,survey,0,0
171465,to,0,0
171466,estimate,0,0
171467,the,0,0
171468,annual,1,0
171469,utilization,1,1
171470,and,1,0
171471,costs,1,1
171472,for,0,0
171473,health,1,1
171474,care,1,0
171475,",",1,1
171476,school,1,0
171477,",",1,1
171478,ASD-related,1,1
171479,therapy,1,0
171480,",",1,0
171481,family-coordinated,1,1
171482,services,1,1
171483,",",0,0
171484,as,0,0
171485,well,0,0
171486,as,0,0
171487,caregiver,1,1
171488,time,1,1
171489,in,0,0
171490,children,0,0
171491,aged,0,0
171492,3,0,0
171493,to,0,0
171494,17,0,0
171495,years,0,0
171496,",",0,0
171497,with,0,0
171498,and,0,0
171499,without,0,0
171500,parent-reported,0,0
171501,ASD,0,0
171502,.,0,0
171503,Regression,0,0
171504,analyses,0,0
171505,estimated,0,0
171506,the,0,0
171507,association,0,0
171508,between,0,0
171509,ASD,0,0
171510,diagnosis,0,0
171511,and,0,1
171512,cost,1,1
171513,",",0,0
171514,controlling,0,0
171515,for,0,0
171516,child,0,1
171517,gender,0,0
171518,",",0,1
171519,age,0,0
171520,",",0,1
171521,race/ethnicity,0,0
171522,",",0,1
171523,insurance,0,1
171524,status,0,1
171525,",",0,0
171526,household,0,1
171527,income,0,1
171528,",",0,0
171529,country,0,1
171530,region,0,0
171531,and,0,1
171532,urban/rural,0,1
171533,classification,0,1
171534,",",0,0
171535,and,0,1
171536,non-ASD-related,0,1
171537,illnesses,0,1
171538,.,0,0
171539,RESULTS,0,0
171540,Children,0,0
171541,with,0,0
171542,parent-reported,0,1
171543,ASD,0,0
171544,had,0,0
171545,higher,1,0
171546,levels,1,1
171547,of,1,1
171548,health,1,1
171549,care,1,0
171550,office,1,1
171551,visits,1,1
171552,and,0,1
171553,prescription,1,0
171554,drug,1,1
171555,use,1,0
171556,compared,0,0
171557,with,0,0
171558,children,0,0
171559,without,0,0
171560,ASD,0,0
171561,(,0,0
171562,P,0,0
171563,<,0,0
171564,.05,0,0
171565,),0,0
171566,.,0,0
171567,A,0,0
171568,greater,0,0
171569,proportion,0,1
171570,of,0,1
171571,children,0,0
171572,in,0,0
171573,the,0,0
171574,ASD,0,0
171575,group,0,0
171576,used,0,0
171577,special,1,0
171578,educational,1,0
171579,services,1,0
171580,(,0,0
171581,76,0,0
171582,%,0,0
171583,vs.,0,0
171584,7,0,0
171585,%,0,0
171586,in,0,0
171587,the,0,0
171588,control,0,0
171589,group,0,0
171590,",",0,0
171591,P,0,0
171592,<,0,0
171593,.05,0,0
171594,),0,0
171595,.,0,0
171596,After,0,0
171597,adjusting,0,0
171598,for,0,0
171599,child,0,0
171600,demographic,0,1
171601,characteristics,0,1
171602,and,0,0
171603,non-ASD-associated,0,1
171604,illnesses,0,1
171605,",",0,0
171606,ASD,0,0
171607,was,0,0
171608,associated,0,0
171609,with,0,0
171610,$,0,0
171611,3020,0,0
171612,(,0,0
171613,95,0,0
171614,%,0,0
171615,confidence,0,0
171616,interval,0,0
171617,[,0,0
171618,CI,0,0
171619,],0,0
171620,:,0,0
171621,$,0,0
171622,1017-,0,0
171623,$,0,0
171624,4259,0,0
171625,),0,0
171626,higher,1,0
171627,health,1,1
171628,care,1,1
171629,costs,1,1
171630,and,0,0
171631,$,0,0
171632,"14,061",0,0
171633,(,0,0
171634,95,0,0
171635,%,0,0
171636,CI,0,0
171637,:,0,0
171638,$,0,0
171639,4390-,0,0
171640,$,0,0
171641,"24,302",0,0
171642,),0,0
171643,higher,1,0
171644,aggregate,1,1
171645,non-health,1,0
171646,care,1,0
171647,costs,1,1
171648,",",0,0
171649,including,0,0
171650,$,0,0
171651,8610,0,0
171652,(,0,0
171653,95,0,0
171654,%,0,0
171655,CI,0,0
171656,:,0,0
171657,$,0,0
171658,6595-,0,0
171659,$,0,0
171660,"10,421",0,0
171661,),0,0
171662,higher,1,0
171663,school,1,0
171664,costs,1,1
171665,.,1,0
171666,In,0,0
171667,adjusted,0,0
171668,analyses,0,0
171669,",",0,0
171670,parents,0,0
171671,who,0,0
171672,reported,0,0
171673,that,0,0
171674,their,0,0
171675,child,0,0
171676,had,0,0
171677,ASD,0,0
171678,did,0,0
171679,not,1,0
171680,have,1,0
171681,significantly,1,0
171682,higher,1,0
171683,out-of-pocket,1,1
171684,costs,1,1
171685,or,0,0
171686,spend,1,1
171687,more,1,0
171688,time,1,1
171689,on,1,0
171690,caregiving,1,1
171691,activities,1,1
171692,compared,0,0
171693,with,0,0
171694,control,0,0
171695,parents,0,0
171696,.,0,0
171697,CONCLUSIONS,0,0
171698,The,0,0
171699,economic,0,0
171700,burden,0,1
171701,associated,0,0
171702,with,0,0
171703,ASD,0,0
171704,is,0,0
171705,substantial,0,0
171706,and,0,0
171707,can,0,0
171708,be,0,0
171709,measured,0,0
171710,across,0,0
171711,multiple,0,0
171712,sectors,0,0
171713,of,0,0
171714,our,0,0
171715,society,0,0
171716,.,0,0
171717,Previous,0,0
171718,analyses,0,0
171719,that,0,0
171720,focused,0,0
171721,on,0,0
171722,health,0,1
171723,care,0,0
171724,underestimated,0,0
171725,this,0,0
171726,economic,0,0
171727,burden,0,1
171728,",",0,0
171729,particularly,0,0
171730,for,0,0
171731,school,0,0
171732,systems,0,0
171733,.,0,0
171734,The,0,0
171735,effect,0,0
171736,of,0,0
171737,deep,0,0
171738,brain,0,1
171739,stimulation,0,0
171740,randomized,0,0
171741,by,0,0
171742,site,0,0
171743,on,0,0
171744,balance,0,1
171745,in,0,0
171746,Parkinson,0,0
171747,'s,0,0
171748,disease,0,0
171749,.,0,0
171750,BACKGROUND,0,0
171751,The,0,0
171752,effect,0,0
171753,of,0,0
171754,the,0,0
171755,surgical,0,0
171756,site,0,0
171757,of,0,0
171758,DBS,0,1
171759,on,0,0
171760,balance,0,1
171761,and,0,1
171762,gait,0,1
171763,in,0,0
171764,Parkinson,0,0
171765,'s,0,0
171766,Disease,0,1
171767,(,0,0
171768,PD,0,0
171769,),0,0
171770,is,0,0
171771,uncertain,0,0
171772,.,0,0
171773,This,0,0
171774,is,0,0
171775,the,0,0
171776,first,0,0
171777,double-blind,0,0
171778,study,0,0
171779,of,0,0
171780,subjects,0,0
171781,randomized,0,0
171782,to,0,0
171783,either,0,0
171784,the,0,0
171785,STN,0,0
171786,(,0,0
171787,N,0,0
171788,=,0,0
171789,14,0,0
171790,),0,0
171791,or,0,0
171792,GPi,0,1
171793,(,0,0
171794,N,0,0
171795,=,0,0
171796,14,0,0
171797,),0,0
171798,who,0,0
171799,were,0,0
171800,assessed,0,0
171801,on,0,0
171802,a,0,0
171803,range,0,0
171804,of,0,0
171805,clinical,0,0
171806,balance,0,1
171807,measures,0,1
171808,.,0,0
171809,METHODS,0,0
171810,Balance,0,1
171811,testing,0,0
171812,occurred,0,0
171813,before,0,0
171814,and,0,0
171815,6,0,0
171816,months,0,0
171817,postsurgery,0,0
171818,.,0,0
171819,A,0,0
171820,control,0,0
171821,PD,0,1
171822,group,0,0
171823,was,0,0
171824,tested,0,0
171825,over,0,0
171826,the,0,0
171827,same,0,0
171828,period,0,0
171829,without,0,0
171830,surgery,0,0
171831,(,0,0
171832,N,0,0
171833,=,0,0
171834,9,0,0
171835,),0,0
171836,.,0,0
171837,All,0,0
171838,subjects,0,0
171839,were,0,0
171840,tested,0,0
171841,on,0,0
171842,and,0,0
171843,off,0,0
171844,medication,0,1
171845,and,0,0
171846,DBS,0,1
171847,subjects,0,0
171848,were,0,0
171849,also,0,0
171850,tested,0,0
171851,on,0,0
171852,and,0,0
171853,off,0,0
171854,DBS,0,0
171855,.,0,0
171856,The,1,0
171857,Postural,1,1
171858,Instability,1,1
171859,and,1,0
171860,Gait,1,1
171861,Disability,1,1
171862,items,1,0
171863,of,1,0
171864,the,1,0
171865,UPDRS,1,0
171866,and,1,0
171867,additional,1,0
171868,functional,1,1
171869,tests,1,1
171870,",",1,0
171871,which,1,0
171872,we,1,0
171873,call,1,0
171874,the,1,0
171875,Balance,1,1
171876,and,1,0
171877,Gait,1,1
171878,scale,1,1
171879,",",0,0
171880,were,0,0
171881,assessed,0,0
171882,.,0,0
171883,Activities,1,1
171884,of,1,0
171885,Balance,1,1
171886,Confidence,1,1
171887,and,1,0
171888,Activities,1,1
171889,of,1,0
171890,Daily,1,0
171891,Living,1,1
171892,questionnaires,1,1
171893,were,0,0
171894,also,0,0
171895,recorded,0,0
171896,.,0,0
171897,RESULTS,0,0
171898,Balance,0,1
171899,was,0,0
171900,not,0,0
171901,different,0,0
171902,between,0,0
171903,the,0,0
171904,best-treated,0,0
171905,states,0,0
171906,before,0,0
171907,and,0,0
171908,after,0,0
171909,DBS,0,1
171910,surgery,0,0
171911,for,0,0
171912,both,0,0
171913,sites,0,0
171914,.,0,0
171915,Switching,0,0
171916,DBS,0,1
171917,on,0,0
171918,improved,0,1
171919,balance,1,1
171920,scores,1,1
171921,",",0,0
171922,and,0,0
171923,scores,0,1
171924,further,0,0
171925,improved,0,1
171926,with,0,0
171927,medication,0,0
171928,",",0,0
171929,compared,0,0
171930,to,0,0
171931,the,0,0
171932,off,0,0
171933,state,0,0
171934,.,0,0
171935,The,0,0
171936,GPi,0,0
171937,group,0,0
171938,showed,0,0
171939,improved,0,1
171940,performance,0,1
171941,in,0,0
171942,the,0,0
171943,postsurgery,0,0
171944,off,0,0
171945,state,0,0
171946,and,0,0
171947,better,0,0
171948,ratings,0,1
171949,of,0,1
171950,balance,1,1
171951,confidence,1,0
171952,after,0,0
171953,surgery,0,0
171954,",",0,0
171955,compared,0,0
171956,to,0,0
171957,the,0,0
171958,STN,0,0
171959,group,0,0
171960,.,0,0
171961,CONCLUSIONS,0,0
171962,Clinical,0,1
171963,measures,0,1
171964,of,0,0
171965,balance,0,1
171966,function,0,1
171967,for,0,0
171968,both,0,0
171969,the,0,0
171970,STN,0,0
171971,and,0,0
171972,GPi,0,1
171973,sites,0,1
171974,showed,0,0
171975,that,0,0
171976,balance,0,1
171977,did,0,0
171978,not,0,0
171979,improve,0,0
171980,beyond,0,0
171981,the,0,0
171982,best,0,0
171983,medically,0,0
171984,treated,0,0
171985,state,0,0
171986,before,0,0
171987,surgery,0,0
171988,.,0,0
171989,Both,0,0
171990,clinical,0,0
171991,balance,0,1
171992,testing,0,0
171993,in,0,0
171994,the,0,0
171995,off/off,0,0
171996,state,0,0
171997,and,0,1
171998,self-reported,0,1
171999,balance,0,1
172000,confidence,0,0
172001,after,0,0
172002,surgery,0,0
172003,showed,0,0
172004,better,0,0
172005,performance,0,1
172006,in,0,0
172007,the,0,0
172008,GPi,0,0
172009,than,0,0
172010,the,0,0
172011,STN,0,0
172012,group,0,0
172013,.,0,0
172014,Evaluation,0,0
172015,of,0,0
172016,an,0,0
172017,interactive,0,0
172018,multi-media,0,0
172019,device,0,0
172020,for,0,0
172021,delivering,0,0
172022,information,0,0
172023,on,0,0
172024,Le,0,1
172025,Fort,0,0
172026,I,0,0
172027,osteotomy,0,0
172028,.,0,0
172029,This,0,0
172030,study,0,0
172031,was,0,0
172032,carried,0,0
172033,out,0,0
172034,on,0,0
172035,volunteers,0,0
172036,to,0,0
172037,evaluate,0,0
172038,a,0,0
172039,newly,0,0
172040,developed,0,0
172041,interactive,0,0
172042,software,0,0
172043,package,0,0
172044,aimed,0,0
172045,at,0,0
172046,informing,0,0
172047,prospective,0,0
172048,Le,0,1
172049,Fort,0,0
172050,I,0,0
172051,osteotomy,0,0
172052,patients,0,0
172053,regarding,0,0
172054,the,0,0
172055,surgical,0,0
172056,technique,0,0
172057,and,0,0
172058,possible,0,0
172059,complications,0,1
172060,.,0,0
172061,The,0,0
172062,aim,0,0
172063,of,0,0
172064,the,0,0
172065,study,0,0
172066,was,0,0
172067,to,0,0
172068,compare,0,0
172069,two,0,0
172070,methods,0,0
172071,of,0,0
172072,information,0,0
172073,delivery,0,0
172074,;,0,0
172075,a,0,0
172076,multi-media,0,0
172077,tablet,0,0
172078,device,0,0
172079,delivering,0,0
172080,both,0,0
172081,graphic,0,0
172082,and,0,0
172083,verbal,0,1
172084,information,0,1
172085,",",0,0
172086,and,0,0
172087,an,0,0
172088,audio,0,0
172089,device,0,0
172090,delivering,0,0
172091,essentially,0,0
172092,the,0,0
172093,same,0,0
172094,information,0,0
172095,in,0,0
172096,verbal,0,1
172097,form,0,0
172098,only,0,0
172099,.,0,0
172100,The,0,0
172101,null,0,0
172102,hypothesis,0,0
172103,was,0,0
172104,that,0,0
172105,there,0,0
172106,would,0,0
172107,be,0,0
172108,no,0,0
172109,difference,0,0
172110,between,0,0
172111,the,0,0
172112,efficiencies,1,1
172113,of,0,0
172114,the,0,0
172115,two,0,0
172116,methods,0,0
172117,.,0,0
172118,The,0,0
172119,subjects,0,0
172120,',0,0
172121,ability,1,0
172122,to,1,0
172123,recall,1,1
172124,the,1,0
172125,information,1,0
172126,delivered,0,0
172127,by,0,0
172128,both,0,0
172129,devices,0,0
172130,was,0,0
172131,assessed,0,0
172132,using,0,0
172133,a,0,0
172134,questionnaire,0,0
172135,.,0,0
172136,The,0,0
172137,tablet,0,0
172138,device,0,0
172139,participants,0,0
172140,scored,0,0
172141,an,0,0
172142,average,0,0
172143,of,0,0
172144,15.48,0,0
172145,points,0,0
172146,",",0,0
172147,while,0,0
172148,the,0,0
172149,audio,0,0
172150,device,0,0
172151,participants,0,0
172152,scored,0,0
172153,an,0,0
172154,average,0,0
172155,of,0,0
172156,268,0,0
172157,points,0,0
172158,.,0,0
172159,The,0,0
172160,difference,0,0
172161,was,0,0
172162,statistically,0,0
172163,significant,0,0
172164,(,0,0
172165,p,0,0
172166,<,0,0
172167,0.001,0,0
172168,),0,0
172169,",",0,0
172170,suggesting,0,0
172171,that,0,0
172172,the,0,0
172173,multi-media,0,0
172174,tablet,0,0
172175,device,0,0
172176,was,0,0
172177,more,0,0
172178,effective,0,1
172179,method,0,0
172180,.,0,0
172181,Effects,0,0
172182,of,0,0
172183,phosphorus-restricted,0,0
172184,diet,0,0
172185,and,0,0
172186,phosphate-binding,0,1
172187,therapy,0,0
172188,on,0,0
172189,outcomes,0,1
172190,in,0,0
172191,patients,0,0
172192,with,0,0
172193,chronic,0,0
172194,kidney,0,0
172195,disease,0,0
172196,.,0,0
172197,BACKGROUND,0,0
172198,Phosphorus,0,0
172199,is,0,0
172200,associated,0,0
172201,with,0,0
172202,mortality,0,1
172203,in,0,0
172204,patients,0,0
172205,with,0,0
172206,chronic,0,0
172207,kidney,0,1
172208,disease,0,1
172209,(,0,0
172210,CKD,0,0
172211,),0,0
172212,not,0,0
172213,on,0,0
172214,dialysis,0,0
172215,",",0,0
172216,possibly,0,0
172217,through,0,0
172218,phosphorus-dependent,0,0
172219,vascular,0,1
172220,calcification,0,1
172221,.,0,0
172222,Although,0,0
172223,a,0,0
172224,phosphorus-restricted,0,0
172225,diet,0,0
172226,reduces,0,0
172227,serum,0,1
172228,phosphorus,0,0
172229,",",0,0
172230,it,0,0
172231,is,0,0
172232,unlikely,0,0
172233,that,0,0
172234,it,0,0
172235,reduces,0,0
172236,vascular,0,1
172237,calcification,0,1
172238,progression,0,1
172239,in,0,0
172240,CKD,0,0
172241,.,0,0
172242,This,0,0
172243,study,0,0
172244,evaluated,0,0
172245,whether,0,0
172246,a,0,0
172247,combined,0,0
172248,strategy,0,0
172249,of,0,0
172250,phosphorus-restricted,0,0
172251,diet,0,0
172252,and,0,0
172253,phosphate-binding,0,0
172254,therapy,0,0
172255,can,0,0
172256,reduce,0,0
172257,the,0,0
172258,risk,1,0
172259,of,1,0
172260,all-cause,1,1
172261,mortality,1,1
172262,and/or,1,0
172263,dialysis,1,1
172264,initiation,1,0
172265,by,0,0
172266,attenuating,0,1
172267,coronary,1,0
172268,artery,1,1
172269,calcification,1,1
172270,(,1,0
172271,CAC,1,0
172272,),1,0
172273,progression,1,1
172274,in,0,0
172275,non-dialysis,0,0
172276,CKD,0,0
172277,patients,0,0
172278,.,0,0
172279,METHODS,0,0
172280,This,0,0
172281,was,0,0
172282,a,0,0
172283,post,0,0
172284,hoc,0,0
172285,analysis,0,0
172286,of,0,0
172287,a,0,0
172288,subgroup,0,0
172289,of,0,0
172290,patients,0,0
172291,from,0,0
172292,a,0,0
172293,study,0,0
172294,that,0,0
172295,evaluated,0,0
172296,the,0,0
172297,impact,0,0
172298,of,0,0
172299,two,0,0
172300,phosphorus,0,0
172301,binder,0,0
172302,regimens,0,0
172303,on,0,0
172304,hard,0,0
172305,outcomes,0,0
172306,in,0,0
172307,CKD,0,0
172308,.,0,0
172309,Patients,0,0
172310,(,0,0
172311,n,0,0
172312,=,0,0
172313,113,0,0
172314,),0,0
172315,with,0,0
172316,stage,0,0
172317,3-4,0,1
172318,CKD,0,0
172319,and,0,0
172320,evidence,0,0
172321,of,0,1
172322,CAC,0,0
172323,on,0,0
172324,a,0,0
172325,phosphorus-restricted,0,0
172326,diet,0,0
172327,were,0,0
172328,randomized,0,0
172329,to,0,0
172330,receive,0,0
172331,either,0,0
172332,calcium,0,0
172333,carbonate,0,0
172334,or,0,0
172335,sevelamer,0,1
172336,added,0,0
172337,to,0,0
172338,their,0,0
172339,phosphorus-restricted,0,0
172340,diet,0,0
172341,.,0,0
172342,End-points,0,1
172343,were,1,0
172344,death,1,1
172345,for,1,0
172346,any,1,0
172347,cause,1,0
172348,and,1,0
172349,initiation,1,0
172350,of,1,0
172351,dialysis,1,0
172352,.,1,0
172353,Patients,0,0
172354,were,0,0
172355,monitored,0,0
172356,to,0,0
172357,the,0,0
172358,first,0,0
172359,event,0,0
172360,or,0,0
172361,to,0,0
172362,conclusion,0,0
172363,of,0,0
172364,the,0,0
172365,36-month,0,0
172366,follow-up,0,0
172367,.,0,0
172368,RESULTS,0,0
172369,Overall,0,1
172370,",",0,0
172371,treatment,0,0
172372,with,0,0
172373,calcium,0,1
172374,carbonate,0,0
172375,was,0,0
172376,associated,0,0
172377,with,1,0
172378,increased,1,0
172379,CAC,1,0
172380,progression,1,1
172381,and,1,1
172382,occurrence,1,1
172383,of,1,1
172384,all-cause,1,1
172385,mortality,1,1
172386,",",1,0
172387,dialysis,1,1
172388,initiation,1,1
172389,",",1,0
172390,and,1,0
172391,the,1,0
172392,composite,1,1
172393,end-point,1,1
172394,.,1,0
172395,After,0,0
172396,adjustment,0,0
172397,for,0,0
172398,confounders,0,0
172399,",",0,0
172400,sevelamer,0,1
172401,use,0,0
172402,was,0,0
172403,the,0,0
172404,only,0,0
172405,independent,0,0
172406,predictive,0,1
172407,factor,0,0
172408,of,0,0
172409,reduced,1,0
172410,risk,1,0
172411,of,1,0
172412,each,1,0
172413,endpoint,1,1
172414,but,1,0
172415,only,0,0
172416,if,0,0
172417,CAC,1,0
172418,progression,1,1
172419,was,1,0
172420,either,0,0
172421,absent,0,1
172422,or,0,0
172423,moderate,1,0
172424,.,1,0
172425,Accelerated,1,0
172426,progression,1,1
172427,(,1,0
172428,annual,0,1
172429,CAC,0,1
172430,increase,0,0
172431,>,0,0
172432,75th,0,0
172433,percentile,0,0
172434,of,0,0
172435,the,0,0
172436,study,0,0
172437,cohort,0,0
172438,),0,0
172439,increased,0,0
172440,the,1,0
172441,risk,1,0
172442,of,1,0
172443,all-cause,1,1
172444,mortality,1,1
172445,and,1,0
172446,composite,1,1
172447,end-point,1,1
172448,(,1,0
172449,p,0,0
172450,=,0,0
172451,0.01,0,0
172452,),0,0
172453,independently,0,0
172454,of,0,0
172455,the,0,0
172456,use,0,0
172457,of,0,0
172458,sevelamer,0,0
172459,.,0,0
172460,CONCLUSIONS,0,0
172461,A,0,0
172462,significant,0,0
172463,reduction,1,1
172464,in,1,0
172465,all-cause,1,1
172466,mortality,1,1
172467,",",1,0
172468,dialysis,1,1
172469,initiation,1,1
172470,",",1,0
172471,and,1,1
172472,composite,1,1
172473,end-point,1,1
172474,risk,1,1
172475,was,1,0
172476,achieved,0,0
172477,by,0,0
172478,combining,0,0
172479,phosphorus-restricted,0,0
172480,diet,0,0
172481,and,0,0
172482,sevelamer,0,1
172483,in,0,0
172484,non-dialysis,0,0
172485,CKD,0,0
172486,patients,0,0
172487,with,0,0
172488,absent,0,0
172489,or,0,0
172490,moderate,0,0
172491,but,0,0
172492,not,0,0
172493,accelerated,1,0
172494,CAC,1,0
172495,progression,1,1
172496,.,1,0
172497,Future,1,0
172498,studies,0,0
172499,should,0,0
172500,investigate,0,0
172501,the,0,0
172502,role,0,0
172503,of,0,0
172504,serum,0,1
172505,phosphorus,0,1
172506,",",0,0
172507,the,0,0
172508,usefulness,0,0
172509,of,0,0
172510,a,0,0
172511,phosphorus-restricted,0,0
172512,diet,0,0
172513,",",0,0
172514,and,0,0
172515,the,0,0
172516,appropriateness,0,0
172517,of,0,0
172518,current,0,0
172519,normal,0,0
172520,ranges,0,1
172521,of,0,0
172522,serum,0,1
172523,phosphorus,0,1
172524,concentration,0,1
172525,in,0,0
172526,relation,0,0
172527,to,0,0
172528,events,0,1
172529,in,0,0
172530,non-dialyzed,0,0
172531,CKD,0,0
172532,patients,0,0
172533,.,0,0
172534,Safety,1,1
172535,and,0,0
172536,efficacy,1,1
172537,of,0,0
172538,a,0,0
172539,low,0,0
172540,molecular,0,0
172541,weight,0,1
172542,heparin,0,0
172543,(,0,0
172544,Logiparin,0,0
172545,),0,1
172546,versus,0,0
172547,dextran,0,0
172548,as,0,0
172549,prophylaxis,0,0
172550,against,0,1
172551,thrombosis,1,1
172552,after,0,0
172553,total,0,1
172554,hip,0,1
172555,replacement,0,0
172556,.,0,0
172557,In,0,0
172558,order,0,0
172559,to,0,0
172560,study,0,0
172561,the,0,0
172562,plasma,0,1
172563,levels,0,1
172564,of,0,0
172565,factor,0,0
172566,XaI,0,0
172567,and,0,1
172568,IIaI,0,0
172569,activity,0,1
172570,an,0,0
172571,enzymatically,0,0
172572,depolymerized,0,0
172573,low,0,0
172574,molecular,0,0
172575,weight,0,1
172576,heparin,0,0
172577,(,0,0
172578,LMW-heparin,0,0
172579,;,0,0
172580,Logiparin,0,0
172581,),0,0
172582,was,0,0
172583,given,0,0
172584,s.c.,0,0
172585,in,0,0
172586,a,0,0
172587,dose,0,0
172588,of,0,0
172589,35,0,0
172590,XaI,0,0
172591,mu/kg,0,0
172592,b.w,0,0
172593,.,0,0
172594,once,0,0
172595,daily,0,0
172596,for,0,0
172597,7,0,0
172598,days,0,0
172599,to,0,0
172600,10,0,0
172601,patients,0,0
172602,undergoing,0,0
172603,total,0,1
172604,hip,0,1
172605,replacement,0,0
172606,(,0,0
172607,THR,0,1
172608,),0,0
172609,in,0,0
172610,a,0,0
172611,pilot,0,0
172612,study,0,0
172613,.,0,0
172614,The,0,0
172615,XaI,0,0
172616,activity,0,1
172617,was,0,0
172618,less,0,0
172619,than,0,0
172620,or,0,0
172621,equal,0,0
172622,to,0,0
172623,0.24,0,0
172624,XaI,0,0
172625,units/ml,0,0
172626,and,0,0
172627,the,0,0
172628,IIaI,0,0
172629,activity,0,1
172630,less,0,0
172631,than,0,0
172632,or,0,0
172633,equal,0,0
172634,to,0,0
172635,0.043,0,0
172636,IIaI,0,0
172637,mu/ml,0,0
172638,.,0,0
172639,No,0,0
172640,accumulation,0,1
172641,of,0,0
172642,the,0,0
172643,activities,0,1
172644,were,0,0
172645,seen,0,0
172646,.,0,0
172647,No,0,0
172648,phlebographically,1,0
172649,verified,1,0
172650,thrombi,1,0
172651,or,0,0
172652,any,0,0
172653,bleeding,1,1
172654,complications,1,1
172655,were,0,0
172656,registered,0,0
172657,.,0,0
172658,From,0,0
172659,this,0,0
172660,study,0,0
172661,it,0,0
172662,was,0,0
172663,concluded,0,0
172664,that,0,0
172665,the,0,0
172666,given,0,0
172667,dose,0,0
172668,of,0,0
172669,Logiparin,0,0
172670,was,0,0
172671,safe,0,0
172672,with,0,0
172673,regard,0,0
172674,to,0,0
172675,bleeding,0,1
172676,complications,0,1
172677,.,0,0
172678,Based,0,0
172679,on,0,0
172680,these,0,0
172681,data,0,0
172682,",",0,0
172683,an,0,0
172684,open,0,0
172685,",",0,0
172686,randomized,0,0
172687,controlled,0,0
172688,trial,0,0
172689,was,0,0
172690,started,0,0
172691,.,0,0
172692,In,0,0
172693,this,0,0
172694,main,0,0
172695,study,0,0
172696,the,0,0
172697,thromboprophylactic,1,0
172698,effect,1,0
172699,of,0,0
172700,the,0,0
172701,LMW-heparin,0,0
172702,(,0,0
172703,Logiparin,0,0
172704,),0,0
172705,in,0,0
172706,a,0,0
172707,dose,0,0
172708,of,0,0
172709,35,0,0
172710,XaI,0,0
172711,mu/kg,0,0
172712,b.w,0,0
172713,.,0,0
172714,once,0,0
172715,daily,0,0
172716,was,0,0
172717,compared,0,0
172718,with,0,0
172719,that,0,0
172720,of,0,0
172721,dextran,0,0
172722,70,0,0
172723,in,0,0
172724,patients,0,0
172725,undergoing,0,0
172726,THR,0,0
172727,.,0,0
172728,100,0,0
172729,patients,0,0
172730,were,0,0
172731,randomized,0,0
172732,.,0,0
172733,The,0,0
172734,over-all,1,1
172735,thrombosis,1,1
172736,rate,1,1
172737,was,0,0
172738,28,0,0
172739,%,0,0
172740,in,0,0
172741,patients,0,0
172742,treated,0,0
172743,with,0,0
172744,LMW-heparin,0,0
172745,and,0,0
172746,39,0,0
172747,%,0,0
172748,in,0,0
172749,those,0,0
172750,given,0,0
172751,dextran,0,0
172752,",",0,0
172753,a,0,0
172754,non-significant,0,0
172755,difference,0,0
172756,.,0,0
172757,No,0,0
172758,bleeding,1,1
172759,complications,1,1
172760,",",1,0
172761,deaths,1,1
172762,or,1,1
172763,pulmonary,1,1
172764,embolism,1,1
172765,were,0,0
172766,recorded,0,0
172767,in,0,0
172768,either,0,0
172769,group,0,0
172770,.,0,0
172771,Peroperative,1,0
172772,blood,1,1
172773,loss,1,1
172774,and,1,1
172775,transfusion,1,1
172776,requirements,1,1
172777,were,0,0
172778,similar,0,0
172779,in,0,0
172780,the,0,0
172781,two,0,0
172782,groups,0,0
172783,.,0,0
172784,In,0,0
172785,conclusion,0,0
172786,",",0,0
172787,the,0,0
172788,investigated,0,0
172789,LMW-heparin,0,0
172790,(,0,0
172791,Logiparin,0,0
172792,),0,0
172793,is,0,0
172794,safe,0,0
172795,and,0,0
172796,effective,0,1
172797,in,0,0
172798,preventing,0,0
172799,postoperative,0,1
172800,thromboembolism,0,1
172801,in,0,0
172802,patients,0,0
172803,undergoing,0,0
172804,total,0,1
172805,hip,0,1
172806,replacement,0,0
172807,",",0,0
172808,but,0,0
172809,the,0,0
172810,dosage,0,0
172811,can,0,0
172812,probably,0,0
172813,be,0,0
172814,optimized,0,0
172815,.,0,0
172816,Prophylactic,0,0
172817,training,0,0
172818,for,0,0
172819,the,0,0
172820,prevention,0,0
172821,of,0,0
172822,radiotherapy-induced,0,0
172823,trismus,0,0
172824,-,0,0
172825,a,0,0
172826,randomised,0,0
172827,study,0,0
172828,.,0,0
172829,BACKGROUND,0,0
172830,Radiotherapy-induced,0,1
172831,trismus,0,1
172832,(,0,0
172833,RTIT,0,0
172834,),0,0
172835,is,0,0
172836,a,0,0
172837,debilitating,0,0
172838,condition,0,0
172839,without,0,0
172840,any,0,0
172841,proven,0,0
172842,effective,0,0
172843,treatment,0,0
172844,.,0,0
172845,This,0,0
172846,study,0,0
172847,investigates,0,0
172848,the,0,0
172849,effectiveness,1,0
172850,of,0,0
172851,prophylactic,0,0
172852,training,0,0
172853,to,0,0
172854,prevent,0,0
172855,RTIT,0,0
172856,during,0,0
172857,and,0,0
172858,up,0,0
172859,to,0,0
172860,12,0,0
172861,months,0,0
172862,after,0,0
172863,completed,0,0
172864,RT,0,0
172865,in,0,0
172866,patients,0,0
172867,with,0,0
172868,head,0,0
172869,and,0,1
172870,neck,0,1
172871,cancer,0,1
172872,(,0,0
172873,HNC,0,1
172874,),0,0
172875,",",0,0
172876,also,0,0
172877,investigating,0,0
172878,the,0,0
172879,incidence,0,1
172880,of,0,0
172881,RTIT,0,0
172882,.,0,0
172883,METHODS,0,0
172884,Sixty-six,0,0
172885,consecutive,0,0
172886,patients,0,0
172887,from,0,0
172888,two,0,0
172889,RT,0,0
172890,clinics,0,0
172891,in,0,0
172892,Sweden,0,0
172893,were,0,0
172894,randomised,0,0
172895,into,0,0
172896,one,0,0
172897,of,0,0
172898,two,0,0
172899,groups,0,0
172900,:,0,0
172901,training,0,0
172902,with,0,0
172903,TheraBite,0,0
172904,(,0,0
172905,?,0,0
172906,),0,0
172907,Jaw,0,0
172908,Motion,0,0
172909,Rehabilitation,0,1
172910,System,0,0
172911,(,0,0
172912,?,0,0
172913,),0,0
172914,or,0,0
172915,a,0,0
172916,control,0,0
172917,group,1,0
172918,.,1,0
172919,Maximum,1,1
172920,interincisal,1,1
172921,openings,1,1
172922,(,1,0
172923,MIO,1,0
172924,),1,0
172925,were,1,0
172926,recorded,1,0
172927,at,0,0
172928,baseline,0,0
172929,and,0,0
172930,once,0,0
172931,a,0,0
172932,week,0,0
172933,during,0,0
172934,treatment,0,0
172935,",",0,0
172936,three,0,0
172937,",",0,0
172938,six,0,0
172939,and,0,0
172940,12,0,0
172941,months,0,0
172942,after,0,0
172943,completed,0,0
172944,RT,0,0
172945,.,0,0
172946,Training,0,0
172947,frequency,0,1
172948,was,0,0
172949,recorded,0,0
172950,by,0,0
172951,patients,0,0
172952,in,0,0
172953,a,0,0
172954,log,0,1
172955,book,0,0
172956,.,0,0
172957,RESULTS,0,0
172958,There,0,0
172959,were,0,0
172960,no,0,0
172961,significant,0,0
172962,differences,0,0
172963,in,0,0
172964,MIO,1,0
172965,between,1,0
172966,the,0,0
172967,intervention,0,0
172968,and,0,0
172969,control,0,0
172970,groups,0,0
172971,at,0,0
172972,any,0,0
172973,of,0,0
172974,the,0,0
172975,measurement,0,0
172976,points,0,0
172977,.,0,0
172978,Patients,0,0
172979,in,0,0
172980,both,0,0
172981,groups,0,0
172982,maintained,0,0
172983,their,0,0
172984,normal,0,0
172985,variation,0,1
172986,in,0,0
172987,MIO,1,0
172988,at,1,0
172989,12,0,0
172990,months,0,0
172991,after,0,0
172992,completed,0,0
172993,RT,0,0
172994,.,0,0
172995,A,0,0
172996,small,0,0
172997,group,0,0
172998,of,0,0
172999,patients,0,0
173000,in,0,0
173001,the,0,0
173002,control,0,0
173003,group,0,0
173004,had,0,0
173005,a,0,0
173006,17,0,0
173007,%,0,0
173008,mean,0,0
173009,decrease,0,0
173010,in,0,0
173011,MIO,1,0
173012,by,1,0
173013,week,0,0
173014,6,0,0
173015,compared,0,0
173016,to,0,0
173017,baseline,0,0
173018,and,0,0
173019,improved,0,0
173020,their,1,0
173021,MIO,1,0
173022,by,1,0
173023,using,0,0
173024,the,0,0
173025,training,0,0
173026,programme,0,0
173027,.,0,0
173028,There,0,0
173029,was,0,0
173030,a,0,0
173031,significant,0,0
173032,mean,0,1
173033,difference,0,0
173034,in,0,0
173035,MIO,1,0
173036,from,1,0
173037,baseline,0,0
173038,to,0,0
173039,week,0,0
173040,6,0,0
173041,(,0,0
173042,3,0,0
173043,mm,0,0
173044,",",0,0
173045,p,0,0
173046,=,0,0
173047,0.018,0,0
173048,),0,0
173049,",",0,0
173050,and,0,0
173051,month,0,0
173052,6,0,0
173053,(,0,0
173054,2.7,0,0
173055,mm,0,0
173056,",",0,0
173057,p,0,0
173058,=,0,0
173059,0.040,0,0
173060,),0,0
173061,",",0,0
173062,for,0,0
173063,patients,0,0
173064,receiving,0,0
173065,3D,0,0
173066,conformal,0,0
173067,radiotherapy,0,0
173068,.,0,0
173069,There,0,0
173070,was,0,0
173071,a,0,0
173072,significant,0,0
173073,difference,0,0
173074,in,0,0
173075,MIO,1,0
173076,between,1,0
173077,patients,0,0
173078,treated,0,0
173079,with,0,0
173080,RT,0,0
173081,and,0,0
173082,concurrent,0,0
173083,chemotherapy,0,0
173084,compared,0,0
173085,to,0,0
173086,patients,0,0
173087,with,0,0
173088,RT,0,0
173089,only,0,0
173090,at,0,0
173091,12,0,0
173092,months,0,0
173093,(,0,0
173094,p,0,0
173095,=,0,0
173096,0.033,0,0
173097,),0,0
173098,.,0,0
173099,CONCLUSIONS,0,0
173100,Patients,0,0
173101,with,0,0
173102,HNC,0,0
173103,undergoing,0,0
173104,high,0,0
173105,dose,0,0
173106,RT,0,0
173107,do,0,0
173108,not,0,0
173109,need,0,0
173110,to,0,0
173111,be,0,0
173112,burdened,0,0
173113,with,0,0
173114,an,0,0
173115,intense,0,0
173116,prophylactic,0,0
173117,training,0,0
173118,programme,0,0
173119,during,0,0
173120,RT,0,0
173121,and,0,0
173122,up,0,0
173123,to,0,0
173124,12,0,0
173125,months,0,0
173126,after,0,0
173127,completed,0,0
173128,RT,0,0
173129,.,0,0
173130,MIO,1,0
173131,measurements,1,0
173132,during,0,0
173133,RT,0,0
173134,and,0,0
173135,up,0,0
173136,to,0,0
173137,12,0,0
173138,months,0,0
173139,after,0,0
173140,completed,0,0
173141,RT,0,0
173142,are,0,0
173143,recommended,0,0
173144,to,0,0
173145,identify,0,0
173146,a,0,0
173147,small,0,0
173148,risk,0,0
173149,group,0,0
173150,who,0,0
173151,are,0,0
173152,an,0,0
173153,exception,0,0
173154,and,0,0
173155,may,0,0
173156,need,0,0
173157,a,0,0
173158,training,0,0
173159,programme,0,0
173160,.,0,0
173161,Omitting,0,0
173162,radiotherapy,0,0
173163,in,0,0
173164,early,0,0
173165,positron,0,0
173166,emission,0,0
173167,tomography-negative,0,0
173168,stage,0,0
173169,I/II,0,0
173170,Hodgkin,0,1
173171,lymphoma,0,0
173172,is,0,0
173173,associated,0,0
173174,with,0,0
173175,an,0,0
173176,increased,0,0
173177,risk,0,0
173178,of,0,0
173179,early,0,0
173180,relapse,0,1
173181,:,0,0
173182,Clinical,0,1
173183,results,0,0
173184,of,0,0
173185,the,0,0
173186,preplanned,0,0
173187,interim,0,0
173188,analysis,0,0
173189,of,0,0
173190,the,0,0
173191,randomized,0,0
173192,EORTC/LYSA/FIL,0,0
173193,H10,0,0
173194,trial,0,0
173195,.,0,0
173196,PURPOSE,0,0
173197,Combined-modality,0,0
173198,treatment,0,0
173199,is,0,0
173200,standard,0,0
173201,treatment,0,0
173202,for,0,0
173203,patients,0,0
173204,with,0,0
173205,clinical,0,0
173206,stage,0,0
173207,I/II,0,0
173208,Hodgkin,0,1
173209,lymphoma,0,1
173210,(,0,0
173211,HL,0,1
173212,),0,0
173213,.,0,0
173214,We,0,0
173215,hypothesized,0,0
173216,that,0,0
173217,an,0,0
173218,early,0,0
173219,positron,0,0
173220,emission,0,1
173221,tomography,0,0
173222,(,0,0
173223,PET,0,1
173224,),0,0
173225,scan,0,0
173226,could,0,0
173227,be,0,0
173228,used,0,0
173229,to,0,0
173230,adapt,0,0
173231,treatment,0,0
173232,.,0,0
173233,Therefore,0,0
173234,",",0,0
173235,we,0,0
173236,started,0,0
173237,the,0,0
173238,randomized,0,0
173239,EORTC/LYSA/FIL,0,0
173240,Intergroup,0,0
173241,H10,0,1
173242,trial,0,0
173243,evaluating,0,0
173244,whether,0,0
173245,involved-node,0,0
173246,radiotherapy,0,0
173247,(,0,0
173248,IN-RT,0,1
173249,),0,0
173250,could,0,0
173251,be,0,0
173252,omitted,0,0
173253,without,0,0
173254,compromising,0,0
173255,progression-free,0,1
173256,survival,0,1
173257,in,0,0
173258,patients,0,0
173259,attaining,0,0
173260,a,0,0
173261,negative,0,0
173262,early,0,0
173263,PET,0,1
173264,scan,0,0
173265,after,0,0
173266,two,0,0
173267,cycles,0,0
173268,of,0,0
173269,ABVD,0,1
173270,(,0,0
173271,doxorubicin,0,0
173272,",",0,1
173273,bleomycin,0,0
173274,",",0,1
173275,vinblastine,0,0
173276,",",0,1
173277,and,0,1
173278,dacarbazine,0,0
173279,),0,0
173280,as,0,0
173281,compared,0,0
173282,with,0,0
173283,standard,0,0
173284,combined-modality,0,0
173285,treatment,0,0
173286,.,0,0
173287,PATIENTS,0,0
173288,AND,0,0
173289,METHODS,0,0
173290,Patients,0,0
173291,age,0,0
173292,15,0,0
173293,to,0,0
173294,70,0,0
173295,years,0,0
173296,with,0,0
173297,untreated,0,0
173298,clinical,0,0
173299,stage,0,0
173300,I/II,0,0
173301,HL,0,1
173302,were,0,0
173303,eligible,0,0
173304,.,0,0
173305,Here,0,0
173306,we,0,0
173307,report,0,0
173308,the,0,0
173309,clinical,0,0
173310,outcome,0,0
173311,of,0,0
173312,the,0,0
173313,preplanned,0,0
173314,interim,0,0
173315,futility,0,1
173316,analysis,0,0
173317,scheduled,0,0
173318,to,0,0
173319,occur,0,0
173320,after,0,0
173321,documentation,0,0
173322,of,0,0
173323,34,0,0
173324,events,0,1
173325,in,0,0
173326,the,0,0
173327,early,0,0
173328,PET-negative,0,0
173329,group,0,0
173330,.,0,0
173331,Because,0,0
173332,testing,0,0
173333,for,0,0
173334,futility,0,0
173335,in,0,0
173336,this,0,0
173337,noninferiority,0,0
173338,trial,0,0
173339,corresponds,0,0
173340,to,0,0
173341,testing,0,0
173342,the,0,0
173343,hypothesis,0,0
173344,of,0,0
173345,no,0,0
173346,difference,0,0
173347,",",0,0
173348,a,0,0
173349,one-sided,0,0
173350,superiority,0,0
173351,test,0,1
173352,was,0,0
173353,conducted,0,0
173354,.,0,0
173355,RESULTS,0,0
173356,The,0,0
173357,analysis,0,0
173358,included,0,0
173359,"1,137",0,0
173360,patients,0,0
173361,.,0,0
173362,In,0,0
173363,the,0,0
173364,favorable,0,0
173365,subgroup,0,0
173366,",",0,0
173367,85.8,0,0
173368,%,0,0
173369,had,0,0
173370,a,0,0
173371,negative,0,0
173372,early,0,0
173373,PET,0,0
173374,scan,0,0
173375,(,0,0
173376,standard,0,0
173377,arm,0,0
173378,",",0,0
173379,one,0,0
173380,event,0,0
173381,v,0,0
173382,experimental,0,0
173383,arm,0,0
173384,",",0,0
173385,nine,0,0
173386,events,0,1
173387,),0,0
173388,.,0,0
173389,In,0,0
173390,the,0,0
173391,unfavorable,0,0
173392,subgroup,0,0
173393,",",0,0
173394,74.8,0,0
173395,%,0,0
173396,had,0,0
173397,a,0,0
173398,negative,0,0
173399,early,0,0
173400,PET,0,0
173401,scan,0,0
173402,(,0,0
173403,standard,0,0
173404,arm,0,0
173405,",",0,0
173406,seven,0,0
173407,events,0,1
173408,v,0,0
173409,experimental,0,0
173410,arm,0,0
173411,",",0,0
173412,16,0,0
173413,events,0,1
173414,),0,0
173415,.,0,0
173416,The,0,0
173417,independent,0,0
173418,data,0,0
173419,monitoring,0,0
173420,committee,0,0
173421,concluded,0,0
173422,it,0,0
173423,was,0,0
173424,unlikely,0,0
173425,that,0,0
173426,we,0,0
173427,would,0,0
173428,show,0,0
173429,noninferiority,0,0
173430,in,0,0
173431,the,0,0
173432,final,0,0
173433,results,0,0
173434,for,0,0
173435,the,0,0
173436,experimental,0,0
173437,arm,0,0
173438,and,0,0
173439,advised,0,0
173440,stopping,0,1
173441,random,0,0
173442,assignment,0,0
173443,for,0,0
173444,early,0,0
173445,PET-negative,0,0
173446,patients,0,0
173447,.,0,0
173448,CONCLUSION,0,0
173449,On,0,0
173450,the,0,0
173451,basis,0,0
173452,of,0,0
173453,this,0,0
173454,analysis,0,0
173455,",",0,0
173456,combined-modality,0,0
173457,treatment,0,0
173458,resulted,0,0
173459,in,0,0
173460,fewer,0,0
173461,early,0,0
173462,progressions,0,1
173463,in,0,0
173464,clinical,1,0
173465,stage,1,0
173466,I/II,1,0
173467,HL,1,1
173468,",",0,0
173469,although,0,0
173470,early,0,0
173471,outcome,0,1
173472,was,0,0
173473,excellent,0,0
173474,in,0,0
173475,both,0,0
173476,arms,0,0
173477,.,0,0
173478,The,0,0
173479,final,0,0
173480,analysis,0,0
173481,will,0,0
173482,reveal,0,0
173483,whether,0,0
173484,this,0,0
173485,finding,0,0
173486,is,0,0
173487,maintained,0,0
173488,over,0,0
173489,time,0,0
173490,.,0,0
173491,Aerobic,0,0
173492,versus,0,0
173493,resistance,0,1
173494,training,0,0
173495,effects,0,1
173496,on,0,0
173497,health-related,1,1
173498,quality,1,1
173499,of,1,0
173500,life,1,1
173501,",",1,0
173502,body,1,1
173503,composition,1,1
173504,",",1,1
173505,and,1,1
173506,function,1,1
173507,of,1,0
173508,older,1,0
173509,adults,1,0
173510,.,1,0
173511,This,0,0
173512,study,0,0
173513,aimed,0,0
173514,to,0,0
173515,investigate,0,0
173516,the,0,0
173517,effects,0,0
173518,of,0,0
173519,training,0,0
173520,on,0,0
173521,health-related,1,1
173522,quality,1,1
173523,of,1,0
173524,life,1,1
173525,(,1,0
173526,HRQoL,1,1
173527,),1,0
173528,",",1,0
173529,body,1,1
173530,composition,1,1
173531,",",1,1
173532,and,1,1
173533,function,1,1
173534,in,0,0
173535,older,0,0
173536,adults,0,0
173537,.,0,1
173538,Fifty,0,0
173539,participants,0,0
173540,were,0,0
173541,randomized,0,0
173542,into,0,0
173543,aerobic,0,0
173544,training,0,0
173545,(,0,0
173546,AT,0,0
173547,--,0,0
173548,70,0,0
173549,%,0,0
173550,-80,0,0
173551,%,0,0
173552,HR,0,0
173553,reserve,0,1
173554,),0,0
173555,",",0,0
173556,resistance,0,1
173557,training,0,0
173558,(,0,0
173559,RT,0,0
173560,--,0,0
173561,80,0,0
173562,%,0,0
173563,1RM,0,0
173564,),0,0
173565,",",0,0
173566,or,0,0
173567,controls,0,0
173568,.,0,0
173569,They,0,0
173570,had,0,0
173571,HRQoL,1,1
173572,",",1,1
173573,body,1,1
173574,composition,1,1
173575,",",1,1
173576,and,1,1
173577,function,1,1
173578,assessed,0,0
173579,before,0,0
173580,and,0,0
173581,after,0,0
173582,8,0,0
173583,months,0,0
173584,.,0,0
173585,Training,0,0
173586,groups,0,0
173587,reduced,1,0
173588,body,1,1
173589,fat,1,1
173590,",",1,0
173591,increased,1,1
173592,performance,1,1
173593,in,1,0
173594,the,1,0
173595,stair,1,1
173596,ascent,1,0
173597,",",1,0
173598,8-ft,1,0
173599,up-and-go,1,0
173600,and,1,0
173601,sit-to-stand,1,1
173602,five-times,1,0
173603,tests,1,1
173604,",",0,0
173605,and,0,1
173606,improved,1,0
173607,their,1,0
173608,physical,1,1
173609,component,1,1
173610,score,1,1
173611,(,0,0
173612,PCS,0,0
173613,;,0,0
173614,p,0,0
173615,?,0,0
173616,.03,0,0
173617,),0,0
173618,.,0,0
173619,AT,0,0
173620,increased,1,0
173621,performance,1,1
173622,in,1,0
173623,the,0,0
173624,6MWT,0,0
173625,test,0,0
173626,",",0,0
173627,and,1,1
173628,improved,1,1
173629,general,1,0
173630,and,1,0
173631,mental,1,1
173632,health,1,1
173633,(,1,0
173634,MH,1,0
173635,),1,0
173636,domains,1,1
173637,when,0,0
173638,compared,0,0
173639,to,0,0
173640,controls,0,0
173641,(,0,0
173642,p,0,0
173643,<,0,0
173644,.01,0,0
173645,),0,0
173646,.,0,0
173647,Finally,0,0
173648,",",0,0
173649,changes,0,1
173650,in,0,0
173651,stair,0,1
173652,ascent,0,0
173653,were,0,0
173654,associated,0,0
173655,with,1,0
173656,changes,1,0
173657,in,1,0
173658,bodily,1,1
173659,pain,1,1
173660,",",1,0
173661,MH,1,0
173662,",",1,1
173663,and,1,1
173664,mental,1,1
173665,component,1,1
173666,score,1,1
173667,(,1,0
173668,p,0,0
173669,?,0,0
173670,.04,0,0
173671,),0,0
173672,",",0,0
173673,while,0,0
173674,changes,1,1
173675,in,1,0
173676,handgrip,1,1
173677,strength,1,1
173678,were,1,0
173679,associated,0,0
173680,with,0,0
173681,changes,1,0
173682,in,1,0
173683,physical,1,1
173684,role,1,0
173685,and,1,1
173686,MH,1,0
173687,(,0,0
173688,p,0,0
173689,=,0,0
173690,.03,0,0
173691,),0,0
173692,.,0,0
173693,AT,0,0
173694,and,0,0
173695,RT,0,0
173696,were,0,0
173697,effective,0,0
173698,interventions,0,0
173699,for,0,0
173700,decreasing,1,0
173701,body,1,1
173702,fat,1,1
173703,and,0,0
173704,improving,1,1
173705,functionality,1,1
173706,and,1,0
173707,the,0,0
173708,PCS,1,0
173709,in,1,0
173710,older,1,0
173711,adults,1,0
173712,.,1,0
173713,Multicenter,0,0
173714,randomized,0,0
173715,phase,0,0
173716,2,0,0
173717,clinical,0,0
173718,trial,0,0
173719,of,0,0
173720,a,0,0
173721,recombinant,0,0
173722,human,0,0
173723,endostatin,0,0
173724,adenovirus,0,1
173725,in,0,0
173726,patients,0,0
173727,with,0,0
173728,advanced,0,0
173729,head,0,0
173730,and,0,1
173731,neck,0,1
173732,carcinoma,0,0
173733,.,0,0
173734,A,0,0
173735,randomized,0,0
173736,",",0,0
173737,open-label,0,0
173738,",",0,0
173739,phase,0,0
173740,2,0,0
173741,",",0,0
173742,multicenter,0,0
173743,clinical,0,0
173744,trial,0,0
173745,was,0,0
173746,conducted,0,0
173747,to,0,0
173748,evaluate,0,0
173749,the,0,0
173750,efficacy,1,1
173751,and,1,0
173752,safety,1,1
173753,of,0,0
173754,the,0,0
173755,addition,0,0
173756,of,0,0
173757,a,0,0
173758,recombinant,0,0
173759,human,0,0
173760,endostatin,0,0
173761,adenovirus,0,1
173762,(,0,0
173763,E10A,0,0
173764,),0,0
173765,to,0,0
173766,cisplatin,0,0
173767,and,0,0
173768,paclitaxel,0,0
173769,in,0,0
173770,patients,0,0
173771,with,0,0
173772,advanced,0,0
173773,head,0,0
173774,and,0,1
173775,neck,0,1
173776,squamous,0,0
173777,cell,0,1
173778,carcinoma,0,0
173779,or,0,0
173780,nasopharyngeal,0,1
173781,carcinoma,0,0
173782,.,0,0
173783,Patients,0,0
173784,with,0,0
173785,locally,0,0
173786,advanced,0,0
173787,or,0,0
173788,metastatic,0,0
173789,head,0,1
173790,and,0,1
173791,neck,0,1
173792,squamous,0,0
173793,cell,0,1
173794,carcinoma,0,0
173795,or,0,0
173796,nasopharyngeal,0,1
173797,carcinoma,0,0
173798,not,0,0
173799,suitable,0,0
173800,for,0,0
173801,operation,0,0
173802,or,0,0
173803,radiotherapy,0,0
173804,were,0,0
173805,randomly,0,0
173806,assigned,0,0
173807,to,0,0
173808,receive,0,0
173809,E10A,0,0
173810,plus,0,0
173811,chemotherapy,0,0
173812,every,0,0
173813,3,0,0
173814,weeks,0,0
173815,for,0,0
173816,a,0,0
173817,maximum,0,0
173818,of,0,0
173819,six,0,0
173820,cycles,0,0
173821,or,0,0
173822,to,0,0
173823,receive,0,0
173824,chemotherapy,0,0
173825,only,0,0
173826,.,0,0
173827,One,0,0
173828,hundred,0,0
173829,and,0,0
173830,thirty-six,0,0
173831,eligible,0,0
173832,patients,0,0
173833,were,0,0
173834,randomly,0,0
173835,assigned,0,0
173836,.,0,0
173837,The,0,0
173838,addition,0,0
173839,of,0,0
173840,E10A,0,0
173841,did,0,0
173842,not,0,0
173843,significantly,0,0
173844,improve,0,0
173845,the,0,0
173846,objective,1,0
173847,response,1,1
173848,rate,1,1
173849,(,0,0
173850,29.9,0,0
173851,versus,0,0
173852,39.7,0,0
173853,%,0,0
173854,",",0,0
173855,P,0,0
173856,=,0,0
173857,0.154,0,0
173858,),0,0
173859,.,0,0
173860,However,0,0
173861,",",0,0
173862,patients,0,0
173863,who,0,0
173864,received,0,0
173865,endostatin,0,0
173866,had,0,0
173867,longer,0,0
173868,progression-free,1,1
173869,survival,1,1
173870,(,0,0
173871,7.03,0,0
173872,versus,0,0
173873,3.60,0,0
173874,months,0,0
173875,",",0,0
173876,P,0,0
173877,=,0,0
173878,0.006,0,0
173879,;,0,0
173880,hazard,0,0
173881,ratio,0,0
173882,:,0,0
173883,0.55,0,0
173884,),0,0
173885,.,0,0
173886,The,0,0
173887,combination,0,0
173888,of,0,0
173889,E10A,0,0
173890,with,0,0
173891,chemotherapy,0,0
173892,benefited,0,0
173893,prior,0,0
173894,chemotherapy-treated,0,0
173895,patients,0,0
173896,and,0,0
173897,those,0,0
173898,who,0,0
173899,received,0,0
173900,three,0,0
173901,to,0,0
173902,four,0,0
173903,treatment,0,0
173904,cycles,0,0
173905,(,0,0
173906,6.50,0,0
173907,versus,0,0
173908,3.43,0,0
173909,months,0,0
173910,",",0,0
173911,P,0,0
173912,=,0,0
173913,0.003,0,0
173914,;,0,0
173915,8.27,0,0
173916,versus,0,0
173917,4.27,0,0
173918,months,0,0
173919,",",0,0
173920,P,0,0
173921,=,0,0
173922,0.018,0,0
173923,;,0,0
173924,respectively,0,0
173925,),0,0
173926,.,0,0
173927,The,0,0
173928,overall,1,1
173929,disease,1,1
173930,control,1,0
173931,rate,1,1
173932,significantly,0,0
173933,increased,0,0
173934,from,0,0
173935,80.6,0,0
173936,%,0,0
173937,in,0,0
173938,the,0,0
173939,control,0,0
173940,group,0,0
173941,to,0,0
173942,92.6,0,0
173943,%,0,0
173944,in,0,0
173945,the,0,0
173946,test,0,0
173947,group,0,0
173948,(,0,0
173949,P,0,0
173950,=,0,0
173951,0.034,0,0
173952,),0,0
173953,.,0,0
173954,Except,0,0
173955,for,0,0
173956,fever,1,1
173957,",",1,0
173958,no,1,0
173959,adverse,1,1
173960,events,1,1
173961,were,0,0
173962,associated,0,0
173963,with,0,0
173964,the,0,0
173965,E10A,0,0
173966,treatment,0,0
173967,.,0,0
173968,In,0,0
173969,summary,0,0
173970,",",0,0
173971,E10A,0,0
173972,plus,0,0
173973,chemotherapy,0,0
173974,is,0,0
173975,a,0,0
173976,safe,1,0
173977,and,1,0
173978,effective,1,1
173979,therapeutic,1,0
173980,approach,1,0
173981,in,0,0
173982,patients,0,0
173983,with,0,0
173984,advanced,0,0
173985,head,0,0
173986,and,0,1
173987,neck,0,1
173988,squamous,0,0
173989,cell,0,1
173990,carcinoma,0,0
173991,or,0,0
173992,nasopharyngeal,0,1
173993,carcinoma,0,0
173994,.,0,0
173995,[,0,0
173996,Encephalopathy,0,1
173997,therapeutic,0,1
173998,tongue,0,1
173999,acupoint,0,0
174000,apparatus,0,0
174001,(,0,0
174002,ETTAA,0,0
174003,),0,0
174004,for,0,0
174005,42,0,0
174006,cases,0,0
174007,of,0,0
174008,autism,0,0
174009,],0,0
174010,.,0,0
174011,OBJECTIVE,0,0
174012,To,0,0
174013,observe,0,0
174014,the,0,0
174015,efficacy,1,1
174016,of,0,0
174017,encephalopathy,0,1
174018,therapeutic,0,0
174019,tongue,0,1
174020,acupoint,0,0
174021,apparatus,0,0
174022,(,0,0
174023,ETTAA,0,0
174024,),0,0
174025,in,0,0
174026,the,0,0
174027,treatment,0,0
174028,of,0,0
174029,autism,0,0
174030,.,0,0
174031,METHODS,0,0
174032,Eighty-four,0,0
174033,children,0,0
174034,of,0,0
174035,autism,0,0
174036,were,0,0
174037,randomly,0,0
174038,divided,0,0
174039,into,0,0
174040,a,0,0
174041,tongue,0,1
174042,acupuncture,0,0
174043,group,0,0
174044,(,0,0
174045,group,0,0
174046,A,0,0
174047,),0,0
174048,and,0,0
174049,a,0,0
174050,conventional,0,0
174051,training,0,0
174052,group,0,0
174053,(,0,0
174054,group,0,0
174055,B,0,0
174056,),0,0
174057,",",0,0
174058,42,0,0
174059,cases,0,0
174060,in,0,0
174061,each,0,0
174062,group,0,0
174063,.,0,0
174064,The,0,0
174065,behavior,0,1
174066,training,0,0
174067,and,0,0
174068,sensory,0,1
174069,integration,0,1
174070,training,0,0
174071,were,0,0
174072,carried,0,0
174073,out,0,0
174074,in,0,0
174075,group,0,0
174076,B,0,0
174077,and,0,0
174078,the,0,0
174079,ETTAA,0,0
174080,was,0,0
174081,added,0,0
174082,in,0,0
174083,group,0,0
174084,A,0,0
174085,.,0,0
174086,The,0,0
174087,apparatus,0,0
174088,was,0,0
174089,switched,0,0
174090,on,0,0
174091,for,0,0
174092,20,0,0
174093,min,0,0
174094,every,0,0
174095,time,0,1
174096,and,0,0
174097,3,0,0
174098,times,0,0
174099,a,0,0
174100,day,0,0
174101,.,0,0
174102,Treatment,0,0
174103,of,0,0
174104,two,0,0
174105,months,0,0
174106,were,0,0
174107,carried,0,0
174108,out,0,0
174109,in,0,0
174110,both,0,0
174111,groups,0,0
174112,.,0,0
174113,The,0,0
174114,score,1,1
174115,of,1,0
174116,childhood,1,0
174117,autism,1,0
174118,rating,1,1
174119,scale,1,1
174120,(,1,0
174121,CARS,1,0
174122,),1,0
174123,and,0,0
174124,clinical,1,0
174125,efficacy,1,1
174126,in,0,0
174127,both,0,0
174128,groups,0,0
174129,were,0,0
174130,observed,0,0
174131,before,0,0
174132,and,0,0
174133,after,0,0
174134,treatment,0,0
174135,.,0,0
174136,RESULTS,0,0
174137,After,0,0
174138,treatment,0,0
174139,",",0,0
174140,the,0,0
174141,CARS,1,0
174142,in,0,0
174143,both,0,0
174144,groups,0,0
174145,were,0,0
174146,significantly,0,0
174147,reduced,0,0
174148,(,0,0
174149,42.39,0,0
174150,+/-,0,0
174151,6.86,0,0
174152,vs,0,0
174153,32.15,0,0
174154,+/-,0,0
174155,5.12,0,0
174156,",",0,0
174157,P,0,0
174158,<,0,0
174159,0.001,0,0
174160,;,0,0
174161,44.58,0,0
174162,+/-,0,0
174163,6.76,0,0
174164,vs,0,0
174165,39.72,0,0
174166,+/-,0,0
174167,7.11,0,0
174168,",",0,0
174169,P,0,0
174170,<,0,0
174171,0.05,0,0
174172,),0,0
174173,",",0,0
174174,which,0,0
174175,was,0,0
174176,more,0,0
174177,significant,0,0
174178,in,0,0
174179,group,0,0
174180,A,0,0
174181,(,0,0
174182,P,0,0
174183,<,0,0
174184,0.01,0,0
174185,),0,0
174186,.,0,0
174187,The,0,0
174188,totally,1,0
174189,effective,1,0
174190,rate,1,1
174191,in,0,0
174192,group,0,0
174193,A,0,0
174194,[,0,0
174195,90.5,0,0
174196,%,0,0
174197,(,0,0
174198,38/42,0,0
174199,),0,0
174200,],0,0
174201,was,0,0
174202,superior,0,0
174203,to,0,0
174204,that,0,0
174205,in,0,0
174206,group,0,0
174207,B,0,0
174208,[,0,0
174209,66.7,0,0
174210,%,0,0
174211,(,0,0
174212,28/42,0,0
174213,),0,0
174214,",",0,0
174215,P,0,0
174216,<,0,0
174217,0.01,0,0
174218,],0,0
174219,.,0,0
174220,CONCLUSION,0,0
174221,The,0,0
174222,clinical,1,0
174223,efficacy,1,1
174224,in,0,0
174225,tongue,0,1
174226,acupuncture,0,0
174227,group,0,0
174228,is,0,0
174229,apparently,0,0
174230,superior,0,0
174231,to,0,0
174232,that,0,0
174233,in,0,0
174234,conventional,0,0
174235,training,0,0
174236,group,0,0
174237,",",0,0
174238,ETTAA,0,1
174239,combined,0,0
174240,with,0,0
174241,conventional,0,0
174242,training,0,0
174243,have,0,0
174244,a,0,0
174245,better,0,0
174246,curative,1,0
174247,effect,1,0
174248,in,0,0
174249,the,0,0
174250,treatment,0,0
174251,of,0,0
174252,autism,0,0
174253,.,0,0
174254,Decreased,0,0
174255,glutathione,0,1
174256,and,0,0
174257,elevated,0,1
174258,hair,0,1
174259,mercury,0,0
174260,levels,0,1
174261,are,0,0
174262,associated,0,0
174263,with,0,0
174264,nutritional,0,0
174265,deficiency-based,0,0
174266,autism,0,0
174267,in,0,0
174268,Oman,0,0
174269,.,0,0
174270,Genetic,0,0
174271,",",0,0
174272,nutrition,0,1
174273,",",0,1
174274,and,0,1
174275,environmental,0,0
174276,factors,0,0
174277,have,0,0
174278,each,0,0
174279,been,0,0
174280,implicated,0,0
174281,as,0,0
174282,sources,0,0
174283,of,0,0
174284,risk,0,1
174285,for,0,0
174286,autism,0,0
174287,.,0,0
174288,Oxidative,0,1
174289,stress,0,1
174290,",",0,0
174291,including,0,0
174292,low,0,0
174293,plasma,0,1
174294,levels,0,1
174295,of,0,0
174296,the,0,0
174297,antioxidant,0,0
174298,glutathione,0,0
174299,",",0,0
174300,has,0,0
174301,been,0,0
174302,reported,0,0
174303,by,0,0
174304,numerous,0,0
174305,autism,0,0
174306,studies,0,0
174307,",",0,0
174308,which,0,0
174309,can,0,0
174310,disrupt,0,0
174311,methylation-dependent,0,0
174312,epigenetic,0,0
174313,regulation,0,0
174314,of,0,0
174315,gene,0,1
174316,expression,0,1
174317,with,0,0
174318,neurodevelopmental,0,0
174319,consequences,0,0
174320,.,0,0
174321,We,0,0
174322,investigated,0,0
174323,the,0,0
174324,status,1,1
174325,of,0,0
174326,redox,0,1
174327,and,0,1
174328,methylation,0,1
174329,metabolites,0,1
174330,",",0,0
174331,as,0,0
174332,well,0,0
174333,as,0,0
174334,the,0,0
174335,level,0,1
174336,of,0,0
174337,protein,0,1
174338,homocysteinylation,0,1
174339,and,0,0
174340,hair,0,1
174341,mercury,0,0
174342,levels,0,1
174343,",",0,0
174344,in,0,0
174345,autistic,0,0
174346,and,0,0
174347,neurotypical,0,1
174348,control,0,0
174349,Omani,0,0
174350,children,0,0
174351,",",0,0
174352,who,0,0
174353,were,0,0
174354,previously,0,0
174355,shown,0,0
174356,to,0,0
174357,exhibit,0,0
174358,significant,0,0
174359,nutritional,0,1
174360,deficiencies,0,0
174361,in,0,0
174362,serum,0,1
174363,folate,0,1
174364,and,0,1
174365,vitamin,0,0
174366,B??,0,1
174367,.,0,0
174368,The,0,0
174369,serum,1,1
174370,level,1,1
174371,of,1,0
174372,glutathione,1,1
174373,in,1,0
174374,autistic,1,0
174375,subjects,1,0
174376,was,1,0
174377,significantly,0,0
174378,below,0,0
174379,control,0,0
174380,levels,0,1
174381,",",0,0
174382,while,1,0
174383,levels,1,1
174384,of,1,0
174385,homocysteine,1,1
174386,and,1,1
174387,S-adenosylhomocysteine,1,1
174388,were,1,0
174389,elevated,0,0
174390,",",0,0
174391,indicative,1,0
174392,of,1,0
174393,oxidative,1,1
174394,stress,1,1
174395,and,1,0
174396,decreased,1,1
174397,methionine,1,0
174398,synthase,1,0
174399,activity,1,1
174400,.,1,0
174401,Autistic,1,0
174402,males,0,0
174403,had,0,0
174404,lower,1,0
174405,glutathione,1,1
174406,and,1,1
174407,higher,1,1
174408,homocysteine,1,1
174409,levels,1,1
174410,than,1,0
174411,females,0,0
174412,",",0,0
174413,while,1,0
174414,homocysteinylation,1,1
174415,of,1,0
174416,serum,1,1
174417,proteins,1,0
174418,was,1,0
174419,increased,0,0
174420,in,0,0
174421,autistic,0,0
174422,males,0,0
174423,but,0,0
174424,not,0,0
174425,females,1,0
174426,.,1,0
174427,Mercury,1,0
174428,levels,1,1
174429,were,1,0
174430,markedly,0,0
174431,elevated,0,0
174432,in,0,0
174433,the,0,0
174434,hair,0,0
174435,of,0,0
174436,autistic,0,0
174437,subjects,0,0
174438,vs.,0,0
174439,control,0,0
174440,subjects,0,0
174441,",",0,0
174442,consistent,0,0
174443,with,0,0
174444,the,0,0
174445,importance,0,0
174446,of,0,0
174447,glutathione,0,1
174448,for,0,0
174449,its,0,0
174450,elimination,0,0
174451,.,0,0
174452,Thus,0,0
174453,",",0,0
174454,autism,0,0
174455,in,0,0
174456,Oman,0,0
174457,is,0,0
174458,associated,0,0
174459,with,0,0
174460,decreased,0,0
174461,antioxidant,0,0
174462,resources,0,0
174463,and,0,0
174464,decreased,0,1
174465,methylation,0,1
174466,capacity,0,1
174467,",",0,0
174468,in,0,0
174469,conjunction,0,0
174470,with,0,0
174471,elevated,0,1
174472,hair,0,1
174473,levels,0,1
174474,of,0,0
174475,mercury,0,0
174476,.,0,0
174477,Clonidine,0,0
174478,in,0,0
174479,patients,0,0
174480,undergoing,0,0
174481,noncardiac,0,0
174482,surgery,0,0
174483,.,0,0
174484,BACKGROUND,0,0
174485,Marked,0,0
174486,activation,0,1
174487,of,0,0
174488,the,0,0
174489,sympathetic,0,0
174490,nervous,0,0
174491,system,0,0
174492,occurs,0,0
174493,during,0,0
174494,and,0,0
174495,after,0,0
174496,noncardiac,0,1
174497,surgery,0,0
174498,.,0,0
174499,Low-dose,0,0
174500,clonidine,0,0
174501,",",0,0
174502,which,0,0
174503,blunts,0,0
174504,central,0,0
174505,sympathetic,0,1
174506,outflow,0,1
174507,",",0,0
174508,may,0,0
174509,prevent,0,0
174510,perioperative,1,0
174511,myocardial,1,1
174512,infarction,1,1
174513,and,1,1
174514,death,1,1
174515,without,0,0
174516,inducing,0,0
174517,hemodynamic,0,1
174518,instability,0,1
174519,.,0,0
174520,METHODS,0,0
174521,We,0,0
174522,performed,0,0
174523,a,0,0
174524,blinded,0,0
174525,",",0,0
174526,randomized,0,0
174527,trial,0,0
174528,with,0,0
174529,a,0,0
174530,2-by-2,0,0
174531,factorial,0,0
174532,design,0,0
174533,to,0,0
174534,allow,0,0
174535,separate,0,0
174536,evaluation,0,0
174537,of,0,0
174538,low-dose,0,0
174539,clonidine,0,0
174540,versus,0,0
174541,placebo,0,0
174542,and,0,1
174543,low-dose,0,0
174544,aspirin,0,0
174545,versus,0,0
174546,placebo,0,0
174547,in,0,0
174548,patients,0,0
174549,with,0,0
174550,",",0,0
174551,or,0,0
174552,at,0,0
174553,risk,0,1
174554,for,0,0
174555,",",0,0
174556,atherosclerotic,0,1
174557,disease,0,1
174558,who,0,0
174559,were,0,0
174560,undergoing,0,0
174561,noncardiac,0,0
174562,surgery,0,0
174563,.,0,0
174564,A,0,0
174565,total,0,0
174566,of,0,0
174567,"10,010",0,0
174568,patients,0,0
174569,at,0,0
174570,135,0,0
174571,centers,0,0
174572,in,0,0
174573,23,0,0
174574,countries,0,0
174575,were,0,0
174576,enrolled,0,0
174577,.,0,0
174578,For,0,0
174579,the,0,0
174580,comparison,0,0
174581,of,0,0
174582,clonidine,0,0
174583,with,0,0
174584,placebo,0,0
174585,",",0,0
174586,patients,0,0
174587,were,0,0
174588,randomly,0,0
174589,assigned,0,0
174590,to,0,0
174591,receive,0,0
174592,clonidine,0,0
174593,(,0,0
174594,0.2,0,0
174595,mg,0,0
174596,per,0,0
174597,day,0,0
174598,),0,0
174599,or,0,0
174600,placebo,0,0
174601,just,0,0
174602,before,0,0
174603,surgery,0,0
174604,",",0,0
174605,with,0,0
174606,the,0,0
174607,study,0,0
174608,drug,0,0
174609,continued,0,0
174610,until,0,0
174611,72,0,0
174612,hours,0,0
174613,after,0,0
174614,surgery,0,0
174615,.,0,0
174616,The,0,0
174617,primary,0,0
174618,outcome,0,0
174619,was,0,0
174620,a,0,0
174621,composite,0,1
174622,of,0,0
174623,death,1,1
174624,or,1,0
174625,nonfatal,1,1
174626,myocardial,1,1
174627,infarction,1,0
174628,at,0,0
174629,30,0,0
174630,days,0,0
174631,.,0,0
174632,RESULTS,0,0
174633,Clonidine,0,0
174634,",",0,0
174635,as,0,0
174636,compared,0,0
174637,with,0,0
174638,placebo,0,0
174639,",",0,0
174640,did,0,0
174641,not,0,0
174642,reduce,0,0
174643,the,0,0
174644,number,0,1
174645,of,0,0
174646,primary-outcome,1,0
174647,events,1,1
174648,(,0,0
174649,367,0,0
174650,and,0,0
174651,339,0,0
174652,",",0,0
174653,respectively,0,0
174654,;,0,0
174655,hazard,0,1
174656,ratio,0,1
174657,with,0,0
174658,clonidine,0,0
174659,",",0,0
174660,1.08,0,0
174661,;,0,0
174662,95,0,0
174663,%,0,0
174664,confidence,0,0
174665,interval,0,0
174666,[,0,0
174667,CI,0,0
174668,],0,0
174669,",",0,0
174670,0.93,0,0
174671,to,0,0
174672,1.26,0,0
174673,;,0,0
174674,P=0.29,0,0
174675,),0,0
174676,.,0,0
174677,Myocardial,1,1
174678,infarction,1,1
174679,occurred,0,0
174680,in,0,0
174681,329,0,0
174682,patients,0,0
174683,(,0,0
174684,6.6,0,0
174685,%,0,0
174686,),0,0
174687,assigned,0,0
174688,to,0,0
174689,clonidine,0,0
174690,and,0,0
174691,in,0,0
174692,295,0,0
174693,patients,0,0
174694,(,0,0
174695,5.9,0,0
174696,%,0,0
174697,),0,0
174698,assigned,0,0
174699,to,0,0
174700,placebo,0,0
174701,(,0,0
174702,hazard,0,1
174703,ratio,0,1
174704,",",0,0
174705,1.11,0,0
174706,;,0,0
174707,95,0,0
174708,%,0,0
174709,CI,0,0
174710,",",0,0
174711,0.95,0,0
174712,to,0,0
174713,1.30,0,0
174714,;,0,0
174715,P=0.18,0,0
174716,),0,0
174717,.,0,0
174718,Significantly,0,0
174719,more,0,0
174720,patients,0,0
174721,in,0,0
174722,the,0,0
174723,clonidine,0,0
174724,group,0,0
174725,than,0,0
174726,in,0,0
174727,the,0,0
174728,placebo,0,0
174729,group,0,0
174730,had,0,0
174731,clinically,0,0
174732,important,0,0
174733,hypotension,1,1
174734,(,0,0
174735,2385,0,0
174736,patients,0,0
174737,[,0,0
174738,47.6,0,0
174739,%,0,0
174740,],0,0
174741,vs.,0,0
174742,1854,0,0
174743,patients,0,0
174744,[,0,0
174745,37.1,0,0
174746,%,0,0
174747,],0,0
174748,;,0,0
174749,hazard,0,0
174750,ratio,0,0
174751,1.32,0,0
174752,;,0,0
174753,95,0,0
174754,%,0,0
174755,CI,0,0
174756,",",0,0
174757,1.24,0,0
174758,to,0,0
174759,1.40,0,0
174760,;,0,0
174761,P,0,0
174762,<,0,0
174763,0.001,0,0
174764,),0,0
174765,.,0,0
174766,Clonidine,0,0
174767,",",0,0
174768,as,0,0
174769,compared,0,0
174770,with,0,0
174771,placebo,0,0
174772,",",0,0
174773,was,0,0
174774,associated,0,0
174775,with,0,0
174776,an,0,0
174777,increased,0,0
174778,rate,0,1
174779,of,0,0
174780,nonfatal,1,1
174781,cardiac,1,1
174782,arrest,1,1
174783,(,0,0
174784,0.3,0,0
174785,%,0,0
174786,[,0,0
174787,16,0,0
174788,patients,0,0
174789,],0,0
174790,vs.,0,0
174791,0.1,0,0
174792,%,0,0
174793,[,0,0
174794,5,0,0
174795,patients,0,0
174796,],0,0
174797,;,0,0
174798,hazard,0,1
174799,ratio,0,1
174800,",",0,0
174801,3.20,0,0
174802,;,0,0
174803,95,0,0
174804,%,0,0
174805,CI,0,0
174806,",",0,0
174807,1.17,0,0
174808,to,0,0
174809,8.73,0,0
174810,;,0,0
174811,P=0.02,0,0
174812,),0,0
174813,.,0,0
174814,CONCLUSIONS,0,0
174815,Administration,0,0
174816,of,0,0
174817,low-dose,0,0
174818,clonidine,0,0
174819,in,0,0
174820,patients,0,0
174821,undergoing,0,0
174822,noncardiac,0,1
174823,surgery,0,0
174824,did,0,0
174825,not,0,0
174826,reduce,0,0
174827,the,0,0
174828,rate,0,1
174829,of,0,0
174830,the,0,0
174831,composite,0,1
174832,outcome,0,0
174833,of,0,0
174834,death,1,1
174835,or,0,0
174836,nonfatal,1,1
174837,myocardial,1,1
174838,infarction,1,0
174839,;,1,0
174840,it,0,0
174841,did,0,0
174842,",",0,0
174843,however,0,0
174844,",",0,0
174845,increase,0,0
174846,the,0,0
174847,risk,0,0
174848,of,0,0
174849,clinically,1,0
174850,important,1,0
174851,hypotension,1,1
174852,and,1,0
174853,nonfatal,1,1
174854,cardiac,1,1
174855,arrest,1,1
174856,.,1,0
174857,(,0,0
174858,Funded,0,0
174859,by,0,0
174860,the,0,0
174861,Canadian,0,0
174862,Institutes,0,0
174863,of,0,0
174864,Health,0,1
174865,Research,0,0
174866,and,0,0
174867,others,0,0
174868,;,0,0
174869,POISE-2,0,0
174870,ClinicalTrials.gov,0,0
174871,number,0,1
174872,",",0,0
174873,NCT01082874,0,0
174874,.,0,0
174875,),0,0
174876,.,0,0
174877,Interview,0,0
174878,skills,0,1
174879,for,0,0
174880,adults,0,0
174881,with,0,0
174882,autism,0,0
174883,spectrum,0,0
174884,disorder,0,0
174885,:,0,0
174886,a,0,0
174887,pilot,0,0
174888,randomized,0,0
174889,controlled,0,0
174890,trial,0,0
174891,.,0,0
174892,The,0,0
174893,purpose,0,0
174894,of,0,0
174895,this,0,0
174896,pilot,0,0
174897,study,0,0
174898,was,0,0
174899,to,0,0
174900,evaluate,0,0
174901,the,0,0
174902,efficacy,0,1
174903,of,0,0
174904,the,0,0
174905,interview,0,0
174906,skills,0,1
174907,curriculum,0,0
174908,(,0,0
174909,ISC,0,1
174910,),0,0
174911,",",0,0
174912,a,0,0
174913,manualized,0,0
174914,12-week,0,0
174915,group-delivered,0,0
174916,intervention,0,0
174917,for,0,0
174918,young,0,0
174919,adults,0,0
174920,with,0,0
174921,autism,0,0
174922,spectrum,0,0
174923,disorder,0,0
174924,(,0,0
174925,ASD,0,0
174926,),0,0
174927,.,0,0
174928,This,0,0
174929,intervention,0,0
174930,aims,0,0
174931,to,0,0
174932,increase,0,0
174933,social-pragmatic,0,0
174934,skills,0,1
174935,essential,0,0
174936,to,0,0
174937,a,0,0
174938,successful,0,0
174939,job,0,0
174940,interview,0,0
174941,.,0,0
174942,Twenty-eight,0,0
174943,adults,0,0
174944,(,0,0
174945,18-36,0,0
174946,years,0,0
174947,),0,0
174948,were,0,0
174949,randomly,0,0
174950,assigned,0,0
174951,to,0,0
174952,one,0,0
174953,of,0,0
174954,two,0,0
174955,groups,0,0
174956,:,0,0
174957,ISC,0,0
174958,or,0,0
174959,waitlist,0,0
174960,control,0,0
174961,.,0,0
174962,Results,0,0
174963,revealed,0,0
174964,that,0,0
174965,the,0,0
174966,experimental,0,0
174967,group,0,0
174968,showed,0,0
174969,larger,0,0
174970,gains,0,1
174971,in,0,0
174972,social-pragmatic,1,0
174973,skills,1,1
174974,observed,0,0
174975,during,0,0
174976,a,0,0
174977,mock,0,0
174978,job,0,1
174979,interview,0,0
174980,than,0,0
174981,the,0,0
174982,control,0,0
174983,group,0,0
174984,.,0,0
174985,Treatment,0,0
174986,effects,0,1
174987,on,0,0
174988,distal,0,1
174989,outcomes,0,1
174990,",",0,0
174991,including,0,0
174992,social,1,1
174993,adaptive,1,1
174994,behaviors,1,1
174995,and,1,0
174996,depressive,1,1
174997,symptoms,1,1
174998,were,0,0
174999,not,0,0
175000,significant,0,0
175001,",",0,0
175002,although,0,0
175003,the,0,0
175004,respective,0,0
175005,effect,0,0
175006,sizes,0,1
175007,were,0,0
175008,medium/large,0,0
175009,.,0,0
175010,Results,0,0
175011,indicate,0,0
175012,that,0,0
175013,a,0,0
175014,brief,0,0
175015,",",0,0
175016,low-intensity,0,0
175017,treatment,0,0
175018,can,0,0
175019,improve,0,0
175020,the,0,0
175021,job-interview,1,0
175022,performance,1,1
175023,of,0,0
175024,young,0,0
175025,adults,0,0
175026,with,0,0
175027,ASD,0,0
175028,.,0,0
175029,A,0,0
175030,prospective,0,0
175031,",",0,0
175032,randomized,0,0
175033,controlled,0,0
175034,trial,0,0
175035,of,0,0
175036,single-incision,0,0
175037,laparoscopic,0,0
175038,vs,0,0
175039,conventional,0,0
175040,3-port,0,0
175041,laparoscopic,0,0
175042,appendectomy,0,0
175043,for,0,0
175044,treatment,0,0
175045,of,0,0
175046,acute,0,0
175047,appendicitis,0,0
175048,.,0,0
175049,BACKGROUND,0,0
175050,Proponents,0,0
175051,of,0,0
175052,single-incision,0,0
175053,laparoscopic,0,0
175054,surgery,0,0
175055,(,0,0
175056,SILS,0,1
175057,),0,0
175058,claim,0,0
175059,patients,0,0
175060,have,0,0
175061,less,0,0
175062,pain,0,1
175063,",",0,1
175064,faster,0,1
175065,recovery,0,1
175066,",",0,1
175067,and,0,1
175068,better,0,0
175069,long-term,0,1
175070,cosmetic,0,0
175071,results,0,0
175072,than,0,0
175073,patients,0,0
175074,who,0,0
175075,undergo,0,0
175076,multiport,0,0
175077,laparoscopy,0,0
175078,.,0,0
175079,However,0,0
175080,",",0,0
175081,randomized,0,0
175082,comparisons,0,0
175083,are,0,0
175084,lacking,0,0
175085,.,0,0
175086,This,0,0
175087,study,0,0
175088,presents,0,0
175089,the,0,0
175090,results,0,0
175091,of,0,0
175092,a,0,0
175093,prospective,0,0
175094,randomized,0,0
175095,trial,0,0
175096,of,0,0
175097,SILS,0,1
175098,or,0,0
175099,3-port,0,0
175100,laparoscopic,0,0
175101,appendectomy,0,0
175102,.,0,0
175103,STUDY,0,1
175104,DESIGN,0,0
175105,Adults,0,0
175106,with,0,0
175107,uncomplicated,0,0
175108,acute,0,0
175109,appendicitis,0,1
175110,were,0,0
175111,randomized,0,0
175112,1:1,0,0
175113,to,0,0
175114,either,0,0
175115,SILS,0,1
175116,or,0,0
175117,3-port,0,0
175118,laparoscopic,0,0
175119,appendectomy,0,0
175120,.,0,0
175121,The,0,0
175122,primary,0,0
175123,end,0,0
175124,point,0,0
175125,was,0,0
175126,early,1,0
175127,postoperative,1,1
175128,pain,1,1
175129,(,0,0
175130,measured,0,0
175131,by,0,0
175132,opiate,0,0
175133,usage,0,0
175134,and,0,1
175135,pain,0,1
175136,score,0,1
175137,in,0,0
175138,the,0,0
175139,first,0,0
175140,12,0,0
175141,hours,0,0
175142,),0,0
175143,.,0,0
175144,Secondary,0,0
175145,end,0,0
175146,points,0,0
175147,were,0,0
175148,operative,1,1
175149,time,1,1
175150,",",1,0
175151,complication,1,1
175152,rate,1,1
175153,(,1,0
175154,including,1,0
175155,conversions,1,1
175156,),1,0
175157,",",1,0
175158,and,1,1
175159,recovery,1,1
175160,time,1,1
175161,(,1,0
175162,days,1,0
175163,of,1,0
175164,oral,1,0
175165,opiate,1,0
175166,usage,1,0
175167,and,1,0
175168,return,1,1
175169,to,1,0
175170,work,1,0
175171,),1,0
175172,.,0,0
175173,After,0,0
175174,6,0,0
175175,months,0,0
175176,",",0,0
175177,body,1,1
175178,image,1,1
175179,and,0,1
175180,cosmetic,1,1
175181,appearance,1,1
175182,were,0,0
175183,assessed,0,0
175184,using,0,0
175185,a,0,0
175186,validated,0,0
175187,survey,0,0
175188,.,0,0
175189,RESULTS,0,0
175190,The,0,0
175191,trial,0,0
175192,was,0,0
175193,planned,0,0
175194,for,0,0
175195,150,0,0
175196,patients,0,0
175197,",",0,0
175198,but,0,0
175199,was,0,0
175200,halted,0,0
175201,after,0,0
175202,75,0,0
175203,patients,0,0
175204,when,0,0
175205,planned,0,0
175206,interim,0,0
175207,analysis,0,0
175208,showed,0,0
175209,that,0,0
175210,SILS,0,1
175211,patients,0,0
175212,had,0,0
175213,more,0,0
175214,postoperative,1,1
175215,pain,1,1
175216,(,0,0
175217,pain,0,1
175218,score,0,1
175219,:,0,0
175220,4.4,0,0
175221,?,0,0
175222,1.6,0,0
175223,vs,0,0
175224,3.5,0,0
175225,?,0,0
175226,1.5,0,0
175227,;,0,0
175228,p,0,0
175229,=,0,0
175230,0.01,0,0
175231,),0,0
175232,and,0,0
175233,higher,1,1
175234,inpatient,1,1
175235,opiate,1,1
175236,usage,1,1
175237,(,1,0
175238,hydromorphone,0,0
175239,use,0,0
175240,:,0,0
175241,3.9,0,0
175242,?,0,0
175243,1.9,0,0
175244,mg,0,0
175245,vs,0,0
175246,2.8,0,0
175247,?,0,0
175248,1.7,0,0
175249,mg,0,0
175250,;,0,0
175251,p,0,0
175252,=,0,0
175253,0.01,0,0
175254,),0,0
175255,than,0,0
175256,3-port,0,0
175257,laparoscopy,1,0
175258,.,1,0
175259,Operative,1,0
175260,time,1,1
175261,for,1,0
175262,SILS,0,1
175263,averaged,0,0
175264,40,0,0
175265,%,0,0
175266,longer,0,0
175267,(,0,0
175268,54,0,0
175269,?,0,0
175270,17,0,0
175271,minutes,0,0
175272,vs,0,0
175273,38,0,0
175274,?,0,0
175275,11,0,0
175276,minutes,0,0
175277,;,0,0
175278,p,0,0
175279,<,0,0
175280,0.01,0,0
175281,),0,0
175282,.,0,0
175283,Only,0,0
175284,1,0,0
175285,SILS,1,0
175286,case,1,0
175287,was,0,0
175288,converted,0,0
175289,to,0,0
175290,3-port,0,0
175291,.,0,0
175292,There,0,0
175293,were,0,0
175294,no,0,0
175295,significant,0,0
175296,differences,1,0
175297,in,1,0
175298,length,1,1
175299,of,1,0
175300,stay,1,1
175301,",",1,0
175302,complications,1,1
175303,",",1,1
175304,oral,1,0
175305,pain,1,1
175306,medication,1,1
175307,usage,1,0
175308,after,1,0
175309,discharge,1,1
175310,",",1,0
175311,or,1,0
175312,return,1,1
175313,to,1,0
175314,work,1,0
175315,.,1,0
175316,After,0,0
175317,6,0,0
175318,months,0,0
175319,",",0,0
175320,body,0,1
175321,image,0,1
175322,and,0,1
175323,cosmetic,0,1
175324,appearance,0,1
175325,were,0,0
175326,excellent,0,0
175327,for,0,0
175328,both,0,0
175329,groups,0,0
175330,and,0,0
175331,indistinguishable,0,0
175332,by,0,0
175333,most,0,0
175334,measures,0,0
175335,.,0,0
175336,However,0,0
175337,",",0,0
175338,3-port,0,0
175339,patients,0,0
175340,reported,0,0
175341,better,0,0
175342,physical,1,1
175343,attractiveness,1,1
175344,(,1,0
175345,4.0,1,0
175346,?,0,0
175347,0.4,0,0
175348,vs,0,0
175349,3.8,0,0
175350,?,0,0
175351,0.4,0,0
175352,;,0,0
175353,p,0,0
175354,=,0,0
175355,0.04,0,0
175356,),0,0
175357,and,0,0
175358,SILS,0,1
175359,patients,0,0
175360,reported,0,0
175361,better,1,0
175362,scars,1,1
175363,(,1,0
175364,score,0,0
175365,18.4,0,0
175366,?,0,0
175367,2.7,0,0
175368,vs,0,0
175369,16.4,0,0
175370,?,0,0
175371,3.0,0,0
175372,;,0,0
175373,p,0,0
175374,<,0,0
175375,0.01,0,0
175376,),0,0
175377,.,0,0
175378,Results,0,0
175379,are,0,0
175380,reported,0,0
175381,as,0,0
175382,mean,0,0
175383,?,0,0
175384,SD,0,0
175385,.,0,0
175386,CONCLUSIONS,0,0
175387,Single-incision,0,0
175388,laparoscopic,0,0
175389,surgery,0,0
175390,appendectomy,0,0
175391,resulted,0,0
175392,in,0,0
175393,more,1,0
175394,pain,1,1
175395,and,0,0
175396,longer,0,0
175397,operative,1,1
175398,times,1,1
175399,without,1,0
175400,improving,0,1
175401,short-term,0,0
175402,recovery,0,1
175403,or,0,0
175404,complications,0,1
175405,.,0,0
175406,Long-term,0,1
175407,body,0,1
175408,image,0,1
175409,and,0,1
175410,cosmetic,0,1
175411,appearance,0,1
175412,were,0,0
175413,excellent,0,0
175414,in,0,0
175415,both,0,0
175416,groups,0,0
175417,.,0,0
175418,Effectiveness,1,1
175419,and,1,0
175420,Safety,1,1
175421,of,0,0
175422,Tapentadol,0,0
175423,Prolonged,0,0
175424,Release,0,1
175425,(,0,0
175426,PR,0,1
175427,),0,0
175428,Versus,0,0
175429,a,0,0
175430,Combination,0,0
175431,of,0,0
175432,Tapentadol,0,0
175433,PR,0,1
175434,and,0,0
175435,Pregabalin,0,0
175436,for,0,0
175437,the,0,0
175438,Management,0,0
175439,of,0,0
175440,Severe,0,0
175441,",",0,0
175442,Chronic,0,0
175443,Low,0,0
175444,Back,0,0
175445,Pain,0,1
175446,With,0,0
175447,a,0,0
175448,Neuropathic,0,0
175449,Component,0,0
175450,:,0,0
175451,A,0,0
175452,Randomized,0,0
175453,",",0,0
175454,Double-blind,0,0
175455,",",0,0
175456,Phase,0,0
175457,3b,0,0
175458,Study,0,0
175459,.,0,0
175460,OBJECTIVE,0,0
175461,To,0,0
175462,evaluate,0,0
175463,the,0,0
175464,effectiveness,1,1
175465,and,1,0
175466,tolerability,1,1
175467,of,0,1
175468,tapentadol,0,0
175469,PR,0,1
175470,monotherapy,0,0
175471,versus,0,0
175472,tapentadol,0,0
175473,PR/pregabalin,0,1
175474,combination,0,0
175475,therapy,0,0
175476,for,0,0
175477,severe,0,1
175478,",",0,0
175479,chronic,0,0
175480,low,0,0
175481,back,0,0
175482,pain,0,1
175483,with,0,0
175484,a,0,0
175485,neuropathic,0,0
175486,component,0,0
175487,.,0,0
175488,METHODS,0,0
175489,Eligible,0,0
175490,patients,0,0
175491,had,0,0
175492,painDETECT,0,0
175493,unclear,0,0
175494,or,0,0
175495,positive,0,1
175496,ratings,0,1
175497,and,0,0
175498,average,0,1
175499,pain,0,1
175500,intensity,0,0
175501,?,0,0
175502,6,0,0
175503,(,0,0
175504,11-point,0,1
175505,NRS-3,0,1
175506,[,0,0
175507,average,0,1
175508,3-day,0,0
175509,pain,0,1
175510,intensity,0,1
175511,],0,0
175512,),0,0
175513,at,0,0
175514,baseline,0,0
175515,.,0,0
175516,Patients,0,0
175517,were,0,0
175518,titrated,0,0
175519,to,0,0
175520,tapentadol,0,0
175521,PR,0,0
175522,300,0,0
175523,mg/day,0,0
175524,over,0,0
175525,3,0,0
175526,weeks,0,0
175527,.,0,0
175528,Patients,0,0
175529,with,0,0
175530,?,0,0
175531,1-point,0,1
175532,decrease,0,0
175533,in,1,0
175534,pain,1,1
175535,intensity,1,1
175536,and,1,1
175537,average,1,1
175538,pain,1,1
175539,intensity,1,0
175540,?,1,0
175541,4,1,0
175542,were,1,0
175543,randomized,0,0
175544,to,0,0
175545,tapentadol,0,0
175546,PR,0,1
175547,(,0,0
175548,500,0,0
175549,mg/day,0,0
175550,),0,0
175551,or,0,0
175552,tapentadol,0,0
175553,PR,0,1
175554,(,0,0
175555,300,0,0
175556,mg/day,0,0
175557,),0,0
175558,/pregabalin,0,0
175559,(,0,0
175560,300,0,0
175561,mg/day,0,0
175562,),0,0
175563,during,0,0
175564,an,0,0
175565,8-week,0,0
175566,comparative,0,0
175567,period,0,0
175568,.,0,0
175569,RESULTS,0,0
175570,In,0,0
175571,the,0,0
175572,per-protocol,0,0
175573,population,0,0
175574,(,0,0
175575,n,0,0
175576,=,0,0
175577,288,0,0
175578,),0,0
175579,",",0,0
175580,the,0,0
175581,effectiveness,1,1
175582,of,1,0
175583,tapentadol,0,0
175584,PR,0,1
175585,was,0,0
175586,clinically,0,0
175587,and,0,0
175588,statistically,0,0
175589,comparable,0,0
175590,to,0,0
175591,tapentadol,0,0
175592,PR/pregabalin,0,0
175593,based,0,0
175594,on,0,0
175595,the,0,0
175596,change,0,0
175597,in,0,0
175598,pain,1,1
175599,intensity,1,1
175600,from,0,0
175601,randomization,0,0
175602,to,0,0
175603,final,0,1
175604,evaluation,0,0
175605,(,0,0
175606,LOCF,0,0
175607,;,0,0
175608,LSMD,0,0
175609,[,0,0
175610,95,0,0
175611,%,0,0
175612,CI,0,0
175613,],0,0
175614,",",0,0
175615,-0.066,0,0
175616,[,0,1
175617,-0.57,0,0
175618,",",0,0
175619,0.43,0,0
175620,],0,0
175621,;,0,0
175622,P,0,0
175623,<,0,0
175624,0.0001,0,0
175625,for,0,0
175626,noninferiority,0,0
175627,),1,0
175628,.,1,0
175629,Neuropathic,1,0
175630,pain,1,1
175631,and,1,0
175632,quality-of-life,1,1
175633,measures,1,1
175634,improved,1,0
175635,significantly,0,0
175636,in,0,0
175637,both,1,0
175638,groups,1,0
175639,.,1,0
175640,Tolerability,1,1
175641,was,1,0
175642,good,0,0
175643,in,0,0
175644,both,0,0
175645,groups,0,0
175646,",",0,0
175647,in,0,0
175648,line,0,0
175649,with,0,0
175650,prior,0,0
175651,trials,0,0
175652,in,0,0
175653,the,0,0
175654,high,0,0
175655,dose,0,0
175656,range,0,0
175657,of,0,0
175658,500,0,0
175659,mg/day,0,0
175660,for,0,0
175661,tapentadol,0,0
175662,PR,0,1
175663,monotherapy,0,0
175664,",",0,0
175665,and,0,1
175666,favorable,0,0
175667,compared,0,0
175668,with,0,0
175669,historical,0,0
175670,combination,0,0
175671,trials,0,0
175672,of,0,0
175673,strong,0,0
175674,opioids,0,0
175675,and,0,0
175676,anticonvulsants,0,0
175677,for,0,0
175678,combination,0,0
175679,therapy,0,0
175680,.,0,0
175681,The,0,0
175682,incidence,0,1
175683,of,0,0
175684,the,0,0
175685,composite,0,1
175686,of,0,0
175687,dizziness,1,1
175688,and/or,1,0
175689,somnolence,1,1
175690,was,0,0
175691,significantly,0,0
175692,lower,0,0
175693,with,0,0
175694,tapentadol,0,0
175695,PR,0,1
175696,(,0,0
175697,16.9,0,0
175698,%,0,0
175699,),0,0
175700,than,0,0
175701,tapentadol,0,0
175702,PR/pregabalin,0,0
175703,(,0,0
175704,27.0,0,0
175705,%,0,0
175706,;,0,0
175707,P,0,0
175708,=,0,0
175709,0.0302,0,0
175710,),0,0
175711,.,0,0
175712,CONCLUSIONS,0,0
175713,Tapentadol,0,0
175714,PR,0,0
175715,500,0,0
175716,mg,0,0
175717,is,0,0
175718,associated,0,0
175719,with,0,0
175720,comparable,1,0
175721,improvements,1,1
175722,in,1,0
175723,pain,1,1
175724,intensity,1,1
175725,and,1,1
175726,quality-of-life,1,1
175727,measures,1,0
175728,to,1,0
175729,tapentadol,1,0
175730,PR,0,0
175731,300,0,0
175732,mg/pregabalin,0,0
175733,300,0,0
175734,mg,1,0
175735,",",1,0
175736,with,1,0
175737,improved,1,1
175738,central,1,0
175739,nervous,1,0
175740,system,1,0
175741,tolerability,1,1
175742,",",1,0
175743,suggesting,1,0
175744,that,0,0
175745,tapentadol,0,0
175746,PR,0,1
175747,monotherapy,0,0
175748,may,0,0
175749,offer,0,0
175750,a,0,0
175751,favorable,0,0
175752,treatment,0,0
175753,option,0,0
175754,for,0,0
175755,severe,0,1
175756,low,0,0
175757,back,0,0
175758,pain,0,1
175759,with,0,0
175760,a,0,0
175761,neuropathic,0,0
175762,component,0,0
175763,.,0,0
175764,Moderate,0,0
175765,sodium,0,0
175766,restriction,0,0
175767,",",0,0
175768,angiotensin,0,0
175769,converting,0,0
175770,enzyme,0,1
175771,inhibition,0,1
175772,",",0,0
175773,and,0,0
175774,thiazide,0,0
175775,diuretic,0,0
175776,in,0,0
175777,the,0,0
175778,management,0,0
175779,of,0,0
175780,essential,0,0
175781,hypertension,0,0
175782,.,0,0
175783,Dietary,0,0
175784,sodium,0,0
175785,restriction,0,0
175786,alone,0,0
175787,is,0,0
175788,effective,0,0
175789,in,0,0
175790,lowering,0,0
175791,blood,1,1
175792,pressure,1,1
175793,in,0,0
175794,some,0,0
175795,",",0,0
175796,but,0,0
175797,not,0,0
175798,all,0,0
175799,",",0,0
175800,patients,0,0
175801,with,0,0
175802,essential,0,0
175803,hypertension,0,0
175804,.,0,0
175805,Homeostatic,0,1
175806,mechanisms,0,0
175807,",",0,0
175808,including,0,0
175809,activation,0,1
175810,of,0,0
175811,the,0,0
175812,renin-aldosterone,0,1
175813,system,0,0
175814,",",0,0
175815,may,0,0
175816,counteract,0,0
175817,the,0,0
175818,effects,0,0
175819,of,0,0
175820,sodium,0,0
175821,restriction,0,0
175822,.,0,0
175823,Angiotensin,0,0
175824,converting,0,0
175825,enzyme,0,0
175826,(,0,0
175827,ACE,0,1
175828,),0,0
175829,inhibitors,0,0
175830,are,0,0
175831,also,0,0
175832,effective,1,0
175833,as,0,0
175834,sole,0,0
175835,therapy,0,0
175836,in,0,0
175837,many,0,0
175838,patients,0,0
175839,with,0,0
175840,essential,0,0
175841,hypertension,0,1
175842,",",0,0
175843,but,0,0
175844,may,0,0
175845,be,0,0
175846,less,0,0
175847,effective,0,0
175848,in,0,0
175849,those,0,0
175850,with,0,0
175851,low-renin,0,0
175852,hypertension,0,0
175853,.,0,0
175854,The,0,0
175855,combination,0,0
175856,of,0,0
175857,dietary,0,0
175858,sodium,0,0
175859,restriction,0,0
175860,with,0,0
175861,blockade,0,0
175862,of,0,0
175863,the,0,0
175864,renin,0,0
175865,system,0,0
175866,by,0,0
175867,an,0,0
175868,ACE,0,0
175869,inhibitor,0,0
175870,is,0,0
175871,a,0,0
175872,particularly,0,0
175873,effective,0,0
175874,way,0,0
175875,to,0,0
175876,improve,0,0
175877,blood,1,1
175878,pressure,1,1
175879,control,1,0
175880,.,1,0
175881,Addition,0,0
175882,of,0,0
175883,a,0,0
175884,thiazide,0,0
175885,diuretic,0,0
175886,will,0,0
175887,reduce,0,0
175888,pressure,1,1
175889,further,0,0
175890,.,0,0
175891,Cognitive,0,1
175892,control,0,0
175893,therapy,0,0
175894,and,0,1
175895,transcranial,0,0
175896,direct,0,0
175897,current,0,0
175898,stimulation,1,0
175899,for,1,0
175900,depression,1,0
175901,:,1,0
175902,a,0,0
175903,randomized,0,0
175904,",",0,0
175905,double-blinded,0,0
175906,",",0,0
175907,controlled,0,0
175908,trial,0,0
175909,.,0,0
175910,BACKGROUND,0,0
175911,Based,0,0
175912,on,0,0
175913,findings,0,0
175914,that,0,0
175915,major,0,0
175916,depressive,0,1
175917,disorder,0,0
175918,(,0,0
175919,MDD,0,0
175920,),0,0
175921,is,0,0
175922,associated,0,0
175923,to,0,0
175924,decreased,0,0
175925,dorsolateral,0,0
175926,prefrontal,0,0
175927,cortical,0,1
175928,(,0,0
175929,DLPFC,0,1
175930,),0,0
175931,activity,0,1
175932,;,0,0
175933,interventions,0,0
175934,that,0,0
175935,increase,0,1
175936,DLPFC,0,0
175937,activity,0,1
175938,might,0,0
175939,theoretically,0,0
175940,present,0,0
175941,antidepressant,0,0
175942,effects,0,0
175943,.,0,0
175944,Two,0,0
175945,of,0,0
175946,them,0,0
175947,are,0,0
175948,cognitive,0,1
175949,control,0,0
175950,therapy,0,0
175951,(,0,0
175952,CCT,0,0
175953,),0,0
175954,",",0,0
175955,a,0,0
175956,neurocognitive,0,1
175957,intervention,0,0
175958,that,0,0
175959,uses,0,0
175960,computer-based,0,0
175961,working,0,0
175962,memory,0,1
175963,exercises,0,0
175964,",",0,0
175965,and,0,1
175966,transcranial,0,0
175967,direct,0,0
175968,current,0,0
175969,stimulation,0,0
175970,(,0,0
175971,tDCS,0,0
175972,),0,0
175973,",",0,0
175974,which,0,0
175975,delivers,0,0
175976,weak,0,0
175977,",",0,0
175978,electric,0,0
175979,direct,0,0
175980,currents,0,0
175981,over,0,0
175982,the,0,0
175983,scalp,0,0
175984,.,0,0
175985,METHODS,0,0
175986,We,0,0
175987,investigated,0,0
175988,whether,0,0
175989,tDCS,0,0
175990,enhanced,0,0
175991,the,0,0
175992,effects,1,0
175993,of,1,0
175994,CCT,1,0
175995,in,0,0
175996,a,0,0
175997,double-blind,0,0
175998,trial,0,0
175999,",",0,0
176000,in,0,0
176001,which,0,0
176002,participants,0,0
176003,were,0,0
176004,randomized,0,0
176005,to,0,0
176006,sham,0,0
176007,tDCS,0,0
176008,and,0,1
176009,CCT,0,0
176010,(,0,1
176011,n=17,0,0
176012,),0,0
176013,vs.,0,0
176014,active,0,0
176015,tDCS,0,0
176016,and,0,1
176017,CCT,0,0
176018,(,0,1
176019,n=20,0,0
176020,),0,0
176021,.,0,0
176022,CCT,0,0
176023,and,0,0
176024,tDCS,0,0
176025,were,0,0
176026,applied,0,0
176027,for,0,0
176028,10,0,0
176029,consecutive,0,0
176030,workdays,0,0
176031,.,0,0
176032,Clinicaltrials.gov,0,0
176033,identifier,0,0
176034,:,0,0
176035,NCT01434836,0,0
176036,.,0,0
176037,RESULTS,0,0
176038,Both,0,0
176039,CCT,0,0
176040,alone,0,0
176041,and,0,0
176042,combined,0,0
176043,with,0,0
176044,tDCS,0,0
176045,ameliorated,1,1
176046,depressive,1,1
176047,symptoms,1,1
176048,after,0,0
176049,the,0,0
176050,acute,0,0
176051,treatment,0,0
176052,period,0,0
176053,and,0,0
176054,at,0,0
176055,follow-up,0,0
176056,",",0,0
176057,with,0,0
176058,a,0,0
176059,response,1,1
176060,rate,1,1
176061,of,0,0
176062,approximately,0,0
176063,25,0,0
176064,%,0,0
176065,.,0,0
176066,Older,0,0
176067,patients,0,0
176068,and,0,0
176069,those,0,0
176070,who,0,0
176071,presented,0,0
176072,better,0,0
176073,performance,0,1
176074,in,0,0
176075,the,0,0
176076,task,0,0
176077,throughout,0,0
176078,the,0,0
176079,trial,0,0
176080,(,0,0
176081,possibly,0,0
176082,indicating,0,0
176083,greater,0,0
176084,engagement,0,1
176085,and,0,1
176086,activation,0,1
176087,of,0,0
176088,the,0,0
176089,DLPFC,0,0
176090,),0,0
176091,had,0,0
176092,greater,0,0
176093,depression,1,1
176094,improvement,1,1
176095,in,0,0
176096,the,0,0
176097,combined,0,0
176098,treatment,0,0
176099,group,0,0
176100,.,0,0
176101,LIMITATIONS,0,0
176102,Our,0,0
176103,exploratory,0,0
176104,findings,0,0
176105,should,0,0
176106,be,0,0
176107,further,0,0
176108,confirmed,0,0
176109,in,0,0
176110,prospective,0,0
176111,controlled,0,0
176112,trials,0,0
176113,.,0,0
176114,DISCUSSION,0,1
176115,CCT,0,0
176116,and,0,0
176117,tDCS,0,0
176118,combined,0,0
176119,might,0,0
176120,be,0,0
176121,beneficial,0,0
176122,for,0,0
176123,older,0,0
176124,depressed,0,1
176125,patients,0,0
176126,",",0,0
176127,particularly,0,0
176128,for,0,0
176129,those,0,0
176130,who,0,0
176131,have,0,0
176132,cognitive,0,0
176133,resources,0,0
176134,to,0,0
176135,adequately,0,0
176136,learn,0,0
176137,and,0,0
176138,improve,0,0
176139,task,1,1
176140,performance,1,1
176141,over,0,0
176142,time,0,1
176143,.,0,0
176144,This,0,0
176145,combined,0,0
176146,therapy,0,0
176147,might,0,0
176148,be,0,0
176149,specifically,0,0
176150,relevant,0,0
176151,in,0,0
176152,this,0,0
176153,subgroup,0,0
176154,that,0,0
176155,is,0,0
176156,more,0,0
176157,prone,0,0
176158,to,0,0
176159,present,0,0
176160,cognitive,0,1
176161,decline,0,0
176162,and,0,0
176163,prefrontal,0,1
176164,cortical,0,1
176165,atrophy,0,0
176166,.,0,0
176167,[,0,0
176168,The,0,0
176169,effects,0,0
176170,of,0,0
176171,tirofiban,0,0
176172,on,0,0
176173,acute,0,0
176174,non-ST,0,0
176175,segment,0,0
176176,elevation,0,1
176177,myocardial,1,1
176178,infarction,1,1
176179,patients,0,0
176180,not,0,0
176181,receiving,0,0
176182,early,0,0
176183,reperfusion,0,1
176184,intervention,0,0
176185,],0,0
176186,.,0,0
176187,OBJECTIVE,0,0
176188,To,0,0
176189,study,0,0
176190,the,0,0
176191,efficacy,1,1
176192,and,1,0
176193,safety,1,1
176194,of,0,1
176195,tirofiban,0,0
176196,in,0,0
176197,patients,0,0
176198,with,0,0
176199,acute,0,0
176200,non-ST-,0,0
176201,segment,0,0
176202,elevation,0,1
176203,myocardial,0,1
176204,infarction,0,1
176205,(,0,0
176206,NSTEMI,0,0
176207,),0,0
176208,without,0,0
176209,early,0,0
176210,reperfusion,0,1
176211,intervention,0,0
176212,.,0,0
176213,METHODS,0,0
176214,A,0,0
176215,total,0,1
176216,of,0,0
176217,151,0,0
176218,NSTEMI,0,0
176219,patients,0,0
176220,without,0,0
176221,early,0,0
176222,reperfusion,0,1
176223,intervention,0,0
176224,were,0,0
176225,enrolled,0,0
176226,in,0,0
176227,the,0,0
176228,study,0,0
176229,and,0,0
176230,randomized,0,0
176231,to,0,0
176232,the,0,0
176233,tirofiban,0,0
176234,group,0,0
176235,(,0,0
176236,n,0,0
176237,=,0,0
176238,76,0,0
176239,),0,0
176240,and,0,0
176241,the,0,0
176242,control,0,0
176243,group,0,0
176244,(,0,0
176245,n,0,0
176246,=,0,0
176247,75,0,0
176248,),0,0
176249,.,0,0
176250,Coronary,0,0
176251,angiography,0,0
176252,was,0,0
176253,performed,0,0
176254,at,0,0
176255,day,0,0
176256,3,0,0
176257,and,0,0
176258,day,0,0
176259,7,0,0
176260,",",0,0
176261,while,0,0
176262,percutaneous,0,0
176263,coronary,0,0
176264,intervention,0,0
176265,(,0,0
176266,PCI,0,1
176267,),0,0
176268,was,0,0
176269,performed,0,0
176270,when,0,0
176271,necessary,0,0
176272,.,0,0
176273,Parameters,0,1
176274,including,0,0
176275,thrombolysis,1,0
176276,in,1,0
176277,myocardial,1,1
176278,infarction,1,1
176279,(,1,0
176280,TIMI,1,1
176281,),1,1
176282,flow,1,1
176283,",",1,0
176284,bleeding,1,1
176285,complications,1,1
176286,and,1,0
176287,clinic,1,0
176288,events,1,1
176289,within,0,0
176290,30,0,0
176291,days,0,0
176292,were,0,0
176293,compared,0,0
176294,between,0,0
176295,the,0,0
176296,two,0,0
176297,groups,0,0
176298,.,0,0
176299,RESULTS,0,0
176300,Before,0,0
176301,PCI,0,1
176302,",",0,0
176303,no,0,0
176304,increase,0,0
176305,in,0,0
176306,the,0,0
176307,percentage,1,1
176308,of,1,0
176309,patient,1,0
176310,with,1,0
176311,TIMI,1,0
176312,flow,1,1
176313,better,0,0
176314,than,0,0
176315,TIMI-2,0,1
176316,was,0,0
176317,observed,0,0
176318,by,0,0
176319,the,0,0
176320,treatment,0,0
176321,of,0,0
176322,tirofiban,0,0
176323,(,0,0
176324,69.3,0,0
176325,%,0,0
176326,vs,0,0
176327,78.9,0,0
176328,%,0,0
176329,",",0,0
176330,P,0,0
176331,=,0,0
176332,0.10,0,0
176333,),0,0
176334,.,0,0
176335,While,0,0
176336,after,0,0
176337,PCI,0,1
176338,",",0,0
176339,significant,0,0
176340,increase,0,0
176341,in,0,0
176342,the,0,0
176343,percentage,1,1
176344,of,1,0
176345,patient,1,0
176346,with,1,0
176347,TIMI,1,0
176348,flow,1,1
176349,better,0,0
176350,than,0,0
176351,TIMI-2,0,1
176352,was,0,0
176353,manifested,0,0
176354,in,0,0
176355,the,0,0
176356,tirofiban,0,0
176357,group,0,0
176358,(,0,0
176359,96.0,0,0
176360,%,0,0
176361,vs,0,0
176362,100.0,0,0
176363,%,0,0
176364,",",0,0
176365,P,0,0
176366,=,0,0
176367,0.04,0,0
176368,),0,0
176369,.,0,0
176370,Tirofiban,0,0
176371,treatment,0,0
176372,also,0,0
176373,significantly,0,0
176374,decreased,1,0
176375,the,1,0
176376,rate,1,1
176377,of,1,0
176378,poor,1,1
176379,myocardial,1,1
176380,perfusion,1,0
176381,after,0,0
176382,PCI,0,1
176383,(,0,0
176384,19.7,0,0
176385,%,0,0
176386,vs,0,0
176387,34.7,0,0
176388,%,0,0
176389,",",0,0
176390,P,0,0
176391,=,0,0
176392,0.04,0,0
176393,),0,0
176394,.,0,0
176395,There,0,0
176396,were,0,0
176397,0,0,0
176398,and,0,0
176399,4,0,0
176400,major,1,0
176401,adverse,1,1
176402,cardiovascular,1,1
176403,events,1,1
176404,(,1,0
176405,MACE,1,0
176406,),1,0
176407,within,0,0
176408,30,0,0
176409,days,0,0
176410,observed,0,0
176411,in,0,0
176412,the,0,0
176413,tirofiban,0,0
176414,group,0,0
176415,and,0,0
176416,the,0,0
176417,control,0,0
176418,group,0,0
176419,(,0,0
176420,0.0,0,0
176421,%,0,0
176422,vs,0,0
176423,5.3,0,0
176424,%,0,0
176425,",",0,0
176426,P,0,0
176427,=,0,0
176428,0.05,0,0
176429,),0,0
176430,.,0,0
176431,No,0,0
176432,difference,0,0
176433,between,0,0
176434,the,0,0
176435,two,0,0
176436,groups,0,0
176437,was,0,0
176438,found,0,0
176439,in,0,0
176440,the,0,0
176441,bleeding,1,1
176442,complications,1,1
176443,within,0,0
176444,30,0,0
176445,days,0,0
176446,including,0,0
176447,the,0,0
176448,mild,1,1
176449,hemorrhage,1,1
176450,(,0,0
176451,5,0,0
176452,vs,0,0
176453,4,0,0
176454,cases,0,0
176455,",",0,0
176456,P,0,0
176457,=,0,0
176458,0.75,0,0
176459,),0,0
176460,",",0,0
176461,severe,1,1
176462,hemorrhage,1,1
176463,(,0,0
176464,2,0,0
176465,vs,0,0
176466,1,0,0
176467,cases,0,0
176468,",",0,0
176469,P,0,0
176470,=,0,0
176471,0.56,0,0
176472,),0,0
176473,or,0,0
176474,severe,1,1
176475,thrombocytopenia,1,1
176476,(,0,0
176477,2,0,0
176478,vs,0,0
176479,0,0,0
176480,cases,0,0
176481,",",0,0
176482,P,0,0
176483,=,0,0
176484,0.49,0,0
176485,),0,0
176486,.,0,0
176487,CONCLUSIONS,0,0
176488,Tirofiban,0,0
176489,treatment,0,0
176490,does,0,0
176491,not,0,0
176492,increase,0,0
176493,the,0,0
176494,bleeding,1,1
176495,complications,1,1
176496,in,0,0
176497,NSTEMI,0,0
176498,patients,0,0
176499,without,0,0
176500,early,0,0
176501,PCI,0,1
176502,.,0,0
176503,Tirofiban,0,0
176504,can,0,0
176505,improve,0,0
176506,the,0,0
176507,TIMI,0,1
176508,flow,0,1
176509,and,0,0
176510,the,0,0
176511,myocardial,0,1
176512,perfusion,0,0
176513,after,0,0
176514,PCI,0,1
176515,with,0,0
176516,less,0,0
176517,MACE,0,0
176518,within,0,0
176519,30,0,0
176520,days,0,0
176521,.,0,0
176522,Evaluation,0,0
176523,of,0,0
176524,early,1,0
176525,weight,1,1
176526,loss,1,1
176527,thresholds,0,1
176528,for,0,0
176529,identifying,0,0
176530,nonresponders,0,0
176531,to,0,0
176532,an,0,0
176533,intensive,0,0
176534,lifestyle,0,0
176535,intervention,0,0
176536,.,0,0
176537,OBJECTIVE,0,0
176538,Weight,0,1
176539,losses,0,1
176540,in,0,0
176541,lifestyle,0,0
176542,interventions,0,0
176543,are,0,0
176544,variable,0,0
176545,",",0,0
176546,yet,0,0
176547,prediction,0,1
176548,of,0,1
176549,long-term,0,0
176550,success,0,1
176551,is,0,0
176552,difficult,0,0
176553,.,0,0
176554,The,0,0
176555,utility,0,0
176556,of,0,0
176557,using,0,0
176558,various,0,0
176559,weight,0,1
176560,loss,0,1
176561,thresholds,0,1
176562,in,0,0
176563,the,0,0
176564,first,0,0
176565,2,0,0
176566,months,0,0
176567,of,0,0
176568,treatment,0,0
176569,for,0,0
176570,predicting,0,1
176571,1-year,0,0
176572,outcomes,0,1
176573,was,0,0
176574,examined,0,0
176575,.,0,0
176576,METHODS,0,0
176577,Participants,0,0
176578,included,0,0
176579,2327,0,0
176580,adults,0,0
176581,with,0,0
176582,type,0,0
176583,2,0,0
176584,diabetes,0,0
176585,(,0,0
176586,BMI:35.8,0,0
176587,?,0,0
176588,6.0,0,0
176589,),0,0
176590,randomized,0,0
176591,to,0,0
176592,the,0,0
176593,intensive,0,0
176594,lifestyle,0,0
176595,intervention,0,0
176596,(,0,0
176597,ILI,0,1
176598,),0,0
176599,of,0,0
176600,the,0,0
176601,Look,0,0
176602,AHEAD,0,0
176603,trial,0,0
176604,.,0,0
176605,ILI,0,1
176606,included,0,0
176607,weekly,0,0
176608,behavioral,0,1
176609,sessions,0,0
176610,designed,0,0
176611,to,0,0
176612,increase,1,0
176613,physical,1,1
176614,activity,1,1
176615,and,1,0
176616,reduce,1,0
176617,caloric,1,0
176618,intake,1,1
176619,.,1,0
176620,1-month,1,0
176621,",",0,0
176622,2-month,0,0
176623,",",0,0
176624,and,0,1
176625,1-year,1,1
176626,weight,1,1
176627,changes,1,1
176628,were,1,0
176629,calculated,0,0
176630,.,0,0
176631,RESULTS,0,0
176632,Participants,0,0
176633,failing,0,0
176634,to,0,0
176635,achieve,1,0
176636,a,1,0
176637,?2,1,0
176638,%,1,0
176639,weight,1,0
176640,loss,1,1
176641,at,1,0
176642,Month,1,0
176643,1,1,0
176644,were,1,0
176645,5.6,0,0
176646,(,0,0
176647,95,0,0
176648,%,0,0
176649,CI:4.5,0,0
176650,",",0,0
176651,7.0,0,0
176652,),0,0
176653,times,0,0
176654,more,0,0
176655,likely,0,0
176656,to,0,0
176657,also,0,0
176658,not,0,0
176659,achieve,0,0
176660,a,0,0
176661,?10,0,0
176662,%,0,0
176663,weight,1,0
176664,loss,1,1
176665,at,1,0
176666,Year,1,0
176667,1,1,0
176668,",",1,0
176669,compared,0,0
176670,to,0,0
176671,those,0,0
176672,losing,0,0
176673,?2,0,0
176674,%,0,0
176675,initially,0,0
176676,.,0,0
176677,These,0,0
176678,odds,0,0
176679,were,0,0
176680,increased,0,0
176681,to,0,0
176682,11.6,0,0
176683,(,0,0
176684,95,0,0
176685,%,0,0
176686,CI:8.6,0,0
176687,",",0,0
176688,15.6,0,0
176689,),0,0
176690,when,0,0
176691,using,0,0
176692,a,0,0
176693,3,0,0
176694,%,0,0
176695,weight,1,1
176696,loss,1,1
176697,threshold,1,1
176698,at,0,0
176699,Month,0,0
176700,2,0,0
176701,.,0,0
176702,Only,0,0
176703,15.2,0,0
176704,%,0,0
176705,and,0,0
176706,8.2,0,0
176707,%,0,0
176708,of,0,0
176709,individuals,0,0
176710,failing,0,0
176711,to,0,0
176712,achieve,0,0
176713,the,0,0
176714,?2,0,1
176715,%,0,0
176716,and,0,0
176717,?3,0,0
176718,%,0,0
176719,thresholds,0,0
176720,at,0,0
176721,Months,0,0
176722,1,0,0
176723,and,0,0
176724,2,0,0
176725,",",0,0
176726,respectively,0,0
176727,",",0,0
176728,go,0,0
176729,on,0,0
176730,to,0,0
176731,achieve,0,0
176732,a,0,0
176733,?10,1,0
176734,%,1,0
176735,weight,1,0
176736,loss,1,1
176737,at,1,0
176738,Year,1,0
176739,1,1,0
176740,.,1,0
176741,CONCLUSIONS,0,0
176742,Given,0,0
176743,the,0,0
176744,association,0,0
176745,between,0,0
176746,initial,0,0
176747,and,0,0
176748,1-year,1,1
176749,weight,1,1
176750,loss,1,1
176751,",",1,0
176752,the,1,0
176753,first,0,0
176754,few,0,0
176755,months,0,0
176756,of,0,0
176757,treatment,0,0
176758,may,0,0
176759,be,0,0
176760,an,0,0
176761,opportune,0,0
176762,time,0,1
176763,to,0,0
176764,identify,0,0
176765,those,0,0
176766,who,0,0
176767,are,0,0
176768,unsuccessful,0,0
176769,and,0,0
176770,utilize,0,0
176771,rescue,0,0
176772,efforts,0,0
176773,.,0,0
176774,TRIAL,0,0
176775,REGISTRATION,0,0
176776,clinicaltrials.gov,0,0
176777,Identifier,0,0
176778,:,0,0
176779,NCT00017953,0,0
176780,.,0,0
176781,Virtual,0,0
176782,reality,0,0
176783,job,0,1
176784,interview,0,0
176785,training,0,0
176786,in,0,0
176787,adults,0,0
176788,with,0,0
176789,autism,0,0
176790,spectrum,0,0
176791,disorder,0,0
176792,.,0,0
176793,The,0,0
176794,feasibility,0,0
176795,and,0,0
176796,efficacy,0,1
176797,of,0,1
176798,virtual,0,0
176799,reality,0,0
176800,job,0,1
176801,interview,0,0
176802,training,0,0
176803,(,0,0
176804,VR-JIT,0,1
176805,),0,0
176806,was,0,0
176807,assessed,0,0
176808,in,0,0
176809,a,0,0
176810,single-blinded,0,0
176811,randomized,0,0
176812,controlled,0,0
176813,trial,0,0
176814,.,0,0
176815,Adults,0,0
176816,with,0,0
176817,autism,0,0
176818,spectrum,0,0
176819,disorder,0,0
176820,were,0,0
176821,randomized,0,0
176822,to,0,0
176823,VR-JIT,0,0
176824,(,0,0
176825,n,0,0
176826,=,0,0
176827,16,0,0
176828,),0,0
176829,or,0,0
176830,treatment-as-usual,0,0
176831,(,0,0
176832,TAU,0,1
176833,),0,0
176834,(,0,0
176835,n,0,0
176836,=,0,0
176837,10,0,0
176838,),0,0
176839,groups,0,0
176840,.,0,0
176841,VR-JIT,0,1
176842,consisted,0,0
176843,of,0,0
176844,simulated,0,0
176845,job,0,0
176846,interviews,0,0
176847,with,0,0
176848,a,0,0
176849,virtual,0,0
176850,character,0,0
176851,and,0,0
176852,didactic,0,0
176853,training,0,0
176854,.,0,0
176855,Participants,0,0
176856,attended,0,0
176857,90,0,0
176858,%,0,0
176859,of,0,0
176860,laboratory-based,0,0
176861,training,0,0
176862,sessions,0,0
176863,",",0,0
176864,found,0,0
176865,VR-JIT,0,1
176866,easy,1,0
176867,to,1,0
176868,use,1,0
176869,and,0,0
176870,enjoyable,1,1
176871,",",0,0
176872,and,0,0
176873,they,0,0
176874,felt,0,0
176875,prepared,1,0
176876,for,1,0
176877,future,1,0
176878,interviews,1,0
176879,.,1,0
176880,VR-JIT,0,0
176881,participants,0,0
176882,had,0,0
176883,greater,1,0
176884,improvement,1,1
176885,during,1,0
176886,live,1,0
176887,standardized,1,0
176888,job,1,1
176889,interview,1,0
176890,role-play,1,1
176891,performances,1,1
176892,than,0,0
176893,TAU,0,1
176894,participants,0,0
176895,(,0,0
176896,p,0,0
176897,=,0,0
176898,0.046,0,0
176899,),0,0
176900,.,0,0
176901,A,0,0
176902,similar,0,0
176903,pattern,0,0
176904,was,0,0
176905,observed,0,0
176906,for,0,0
176907,self-reported,1,1
176908,self-confidence,1,1
176909,at,0,0
176910,a,0,0
176911,trend,0,0
176912,level,0,1
176913,(,0,0
176914,p,0,0
176915,=,0,0
176916,0.060,0,0
176917,),0,0
176918,.,0,0
176919,VR-JIT,1,0
176920,simulation,1,0
176921,performance,1,1
176922,scores,1,1
176923,increased,0,0
176924,over,0,0
176925,time,0,1
176926,(,0,0
176927,R,0,0
176928,(,0,0
176929,2,0,0
176930,),0,0
176931,=,0,0
176932,0.83,0,0
176933,),0,0
176934,.,0,0
176935,Results,0,0
176936,indicate,0,0
176937,preliminary,0,0
176938,support,0,0
176939,for,0,0
176940,the,0,0
176941,feasibility,1,0
176942,and,0,0
176943,efficacy,1,1
176944,of,0,1
176945,VR-JIT,0,1
176946,",",0,0
176947,which,0,0
176948,can,0,0
176949,be,0,0
176950,administered,0,0
176951,using,0,0
176952,computer,0,0
176953,software,0,0
176954,or,0,0
176955,via,0,0
176956,the,0,0
176957,internet,0,0
176958,.,0,0
176959,Sociopsychological,0,0
176960,tailoring,0,0
176961,to,0,0
176962,address,0,0
176963,colorectal,0,0
176964,cancer,0,0
176965,screening,0,0
176966,disparities,0,0
176967,:,0,0
176968,a,0,0
176969,randomized,0,0
176970,controlled,0,0
176971,trial,0,0
176972,.,0,0
176973,PURPOSE,0,0
176974,Interventions,0,0
176975,tailored,0,0
176976,to,0,0
176977,sociopsychological,0,0
176978,factors,0,0
176979,associated,0,0
176980,with,0,0
176981,health,0,0
176982,behaviors,0,1
176983,have,0,0
176984,promise,0,0
176985,for,0,0
176986,reducing,0,0
176987,colorectal,0,0
176988,cancer,0,0
176989,screening,0,0
176990,disparities,0,0
176991,",",0,0
176992,but,0,0
176993,limited,0,0
176994,research,0,0
176995,has,0,0
176996,assessed,0,0
176997,their,0,0
176998,impact,0,0
176999,in,0,0
177000,multiethnic,0,0
177001,populations,0,0
177002,.,0,0
177003,We,0,0
177004,examined,0,0
177005,whether,0,0
177006,an,0,0
177007,interactive,0,0
177008,multimedia,0,0
177009,computer,0,0
177010,program,0,0
177011,(,0,0
177012,IMCP,0,0
177013,),0,0
177014,tailored,0,0
177015,to,0,0
177016,expanded,0,0
177017,health,0,1
177018,belief,0,0
177019,model,0,0
177020,sociopsychological,0,0
177021,factors,0,0
177022,could,0,0
177023,promote,0,0
177024,colorectal,0,0
177025,cancer,0,0
177026,screening,0,0
177027,in,0,0
177028,a,0,0
177029,multiethnic,0,0
177030,sample,0,0
177031,.,0,0
177032,METHODS,0,0
177033,We,0,0
177034,undertook,0,0
177035,a,0,0
177036,randomized,0,0
177037,controlled,0,0
177038,trial,0,0
177039,",",0,0
177040,comparing,0,0
177041,an,0,0
177042,IMCP,0,0
177043,tailored,0,0
177044,to,0,0
177045,colorectal,0,0
177046,cancer,0,0
177047,screening,0,0
177048,self-efficacy,0,1
177049,",",0,0
177050,knowledge,0,1
177051,",",0,1
177052,barriers,0,1
177053,",",0,1
177054,readiness,0,1
177055,",",0,1
177056,test,0,1
177057,preference,0,1
177058,",",0,1
177059,and,0,1
177060,experiences,0,1
177061,with,0,0
177062,a,0,0
177063,nontailored,0,0
177064,informational,0,0
177065,program,0,0
177066,",",0,0
177067,both,0,0
177068,delivered,0,0
177069,before,0,0
177070,office,0,0
177071,visits,0,0
177072,.,0,0
177073,The,0,0
177074,primary,0,0
177075,outcome,0,1
177076,was,0,0
177077,record-documented,1,0
177078,colorectal,1,0
177079,cancer,1,0
177080,screening,1,0
177081,during,1,0
177082,a,1,0
177083,12-month,1,0
177084,follow-up,1,0
177085,period,1,0
177086,.,1,0
177087,Secondary,0,0
177088,outcomes,0,1
177089,included,0,0
177090,postvisit,1,0
177091,sociopsychological,1,1
177092,factor,1,1
177093,status,1,1
177094,and,1,1
177095,discussion,1,0
177096,",",1,0
177097,as,1,0
177098,well,1,0
177099,as,1,0
177100,clinician,1,0
177101,recommendation,1,0
177102,of,1,0
177103,screening,1,0
177104,during,1,0
177105,office,1,0
177106,visits,1,0
177107,.,1,0
177108,We,0,0
177109,enrolled,0,0
177110,"1,164",0,0
177111,patients,0,0
177112,stratified,0,0
177113,by,0,0
177114,ethnicity,0,0
177115,and,0,1
177116,language,0,1
177117,(,0,0
177118,49.3,0,0
177119,%,0,0
177120,non-Hispanic,0,0
177121,",",0,0
177122,27.2,0,0
177123,%,0,0
177124,Hispanic/English,0,0
177125,",",0,0
177126,23.4,0,0
177127,%,0,0
177128,Hispanic/Spanish,0,0
177129,),0,0
177130,from,0,0
177131,26,0,0
177132,offices,0,0
177133,around,0,0
177134,5,0,0
177135,centers,0,0
177136,(,0,0
177137,Sacramento,0,0
177138,",",0,0
177139,California,0,0
177140,;,0,0
177141,Rochester,0,0
177142,and,0,0
177143,the,0,0
177144,Bronx,0,0
177145,",",0,0
177146,New,0,0
177147,York,0,0
177148,;,0,0
177149,Denver,0,0
177150,",",0,0
177151,Colorado,0,0
177152,;,0,0
177153,and,0,0
177154,San,0,0
177155,Antonio,0,0
177156,",",0,0
177157,Texas,0,0
177158,),0,0
177159,.,0,0
177160,RESULTS,0,0
177161,Adjusting,0,1
177162,for,0,0
177163,ethnicity/language,0,1
177164,",",0,0
177165,study,0,0
177166,center,0,0
177167,",",0,0
177168,and,0,0
177169,the,0,0
177170,previsit,0,0
177171,value,0,0
177172,of,0,0
177173,the,0,0
177174,dependent,0,0
177175,variable,0,0
177176,",",0,0
177177,compared,0,0
177178,with,0,0
177179,control,0,0
177180,patients,0,0
177181,",",0,0
177182,the,0,0
177183,IMCP,0,0
177184,led,0,0
177185,to,0,0
177186,significantly,0,0
177187,greater,0,0
177188,colorectal,1,0
177189,cancer,1,0
177190,screening,1,0
177191,knowledge,1,1
177192,",",1,0
177193,self-efficacy,1,1
177194,",",1,1
177195,readiness,1,1
177196,",",1,1
177197,test,1,1
177198,preference,1,1
177199,specificity,1,1
177200,",",1,1
177201,discussion,1,0
177202,",",1,1
177203,and,1,1
177204,recommendation,1,0
177205,.,1,0
177206,During,0,0
177207,the,0,0
177208,followup,0,0
177209,period,0,0
177210,",",0,0
177211,132,0,0
177212,(,0,0
177213,23,0,0
177214,%,0,0
177215,),0,0
177216,IMCP,0,0
177217,and,0,0
177218,123,0,0
177219,(,0,0
177220,22,0,0
177221,%,0,0
177222,),0,0
177223,control,0,0
177224,patients,0,0
177225,received,0,0
177226,screening,1,0
177227,(,0,0
177228,adjusted,0,0
177229,difference,0,0
177230,=,0,0
177231,0.5,0,0
177232,percentage,0,1
177233,points,0,0
177234,",",0,0
177235,95,0,0
177236,%,0,0
177237,CI,0,0
177238,-4.3,0,0
177239,to,0,0
177240,5.3,0,0
177241,),0,0
177242,.,0,0
177243,IMCP,1,0
177244,effects,0,1
177245,did,0,0
177246,not,0,0
177247,differ,0,0
177248,significantly,0,0
177249,by,0,0
177250,ethnicity/language,0,0
177251,.,0,0
177252,CONCLUSIONS,0,0
177253,Sociopsychological,0,1
177254,factor,0,1
177255,tailoring,0,0
177256,was,0,0
177257,no,0,0
177258,more,0,0
177259,effective,0,1
177260,than,0,0
177261,nontailored,0,0
177262,information,0,0
177263,in,0,0
177264,encouraging,0,0
177265,colorectal,0,0
177266,cancer,0,0
177267,screening,0,0
177268,in,0,0
177269,a,0,0
177270,multiethnic,0,0
177271,sample,0,0
177272,",",0,0
177273,despite,0,0
177274,enhancing,0,0
177275,sociopsychological,0,0
177276,factors,0,0
177277,and,0,1
177278,visit,0,1
177279,behaviors,0,1
177280,associated,0,0
177281,with,0,0
177282,screening,0,0
177283,.,0,0
177284,The,0,0
177285,utility,0,0
177286,of,0,0
177287,sociopsychological,0,0
177288,tailoring,0,0
177289,in,0,0
177290,addressing,0,0
177291,screening,0,0
177292,disparities,0,0
177293,remains,0,0
177294,uncertain,0,0
177295,.,0,0
177296,The,0,0
177297,effect,0,0
177298,of,0,0
177299,arm,0,0
177300,support,0,0
177301,combined,0,0
177302,with,0,0
177303,rehabilitation,0,0
177304,games,0,0
177305,on,0,0
177306,upper-extremity,1,0
177307,function,1,1
177308,in,0,0
177309,subacute,1,0
177310,stroke,1,0
177311,:,1,0
177312,a,0,0
177313,randomized,0,0
177314,controlled,0,0
177315,trial,0,0
177316,.,0,0
177317,BACKGROUND,0,0
177318,Use,0,0
177319,of,0,0
177320,rehabilitation,0,0
177321,technology,0,0
177322,",",0,0
177323,such,0,0
177324,as,0,0
177325,(,0,0
177326,electro,0,0
177327,),0,0
177328,mechanical,0,0
177329,devices,0,0
177330,or,0,0
177331,robotics,0,0
177332,",",0,0
177333,could,0,0
177334,partly,0,0
177335,relieve,0,0
177336,the,0,0
177337,increasing,0,0
177338,strain,0,0
177339,on,0,0
177340,stroke,0,1
177341,rehabilitation,0,0
177342,caused,0,0
177343,by,0,0
177344,an,0,0
177345,increasing,0,0
177346,prevalence,0,0
177347,of,0,0
177348,stroke,0,1
177349,.,0,0
177350,Arm,0,1
177351,support,0,0
177352,(,0,0
177353,AS,0,0
177354,),0,0
177355,training,0,0
177356,showed,0,0
177357,improvement,0,1
177358,of,0,0
177359,unsupported,0,0
177360,arm,1,0
177361,function,1,1
177362,in,0,0
177363,chronic,1,0
177364,stroke,1,0
177365,.,1,0
177366,OBJECTIVE,0,0
177367,To,0,0
177368,examine,0,0
177369,the,0,0
177370,effect,0,0
177371,of,0,0
177372,weight-supported,0,0
177373,arm,0,0
177374,training,0,0
177375,combined,0,0
177376,with,0,0
177377,computerized,0,0
177378,exercises,0,0
177379,on,0,0
177380,arm,1,0
177381,function,1,1
177382,and,0,1
177383,capacity,1,1
177384,",",0,0
177385,compared,0,0
177386,with,0,0
177387,dose-matched,0,0
177388,conventional,0,0
177389,reach,0,0
177390,training,0,0
177391,in,0,0
177392,subacute,0,0
177393,stroke,0,0
177394,patients,0,0
177395,.,0,0
177396,METHODS,0,0
177397,In,0,0
177398,a,0,0
177399,single-blind,0,0
177400,",",0,0
177401,multicenter,0,0
177402,",",0,0
177403,randomized,0,0
177404,controlled,0,0
177405,trial,0,0
177406,",",0,0
177407,70,0,0
177408,subacute,0,0
177409,stroke,0,0
177410,patients,0,0
177411,received,0,0
177412,6,0,0
177413,weeks,0,0
177414,of,0,0
177415,training,0,0
177416,with,0,0
177417,either,0,0
177418,an,0,0
177419,AS,0,0
177420,device,0,0
177421,combined,0,0
177422,with,0,0
177423,computerized,0,0
177424,exercises,0,0
177425,or,0,0
177426,dose-matched,0,0
177427,conventional,0,0
177428,training,0,0
177429,(,0,0
177430,CON,0,0
177431,),0,0
177432,.,0,0
177433,Arm,0,0
177434,function,0,1
177435,was,0,0
177436,evaluated,0,0
177437,pretraining,0,0
177438,and,0,0
177439,posttraining,0,1
177440,by,0,0
177441,Fugl-Meyer,1,1
177442,assessment,1,0
177443,(,1,0
177444,FM,1,1
177445,),1,0
177446,",",1,0
177447,maximal,1,1
177448,reach,1,0
177449,distance,1,1
177450,",",1,0
177451,Stroke,1,0
177452,Upper,1,0
177453,Limb,1,0
177454,Capacity,1,1
177455,Scale,1,1
177456,(,1,0
177457,SULCS,1,1
177458,),1,1
177459,",",1,0
177460,and,1,1
177461,arm,1,0
177462,pain,1,1
177463,via,1,0
177464,Visual,1,1
177465,Analogue,1,1
177466,Scale,1,1
177467,",",0,0
177468,in,0,0
177469,addition,0,0
177470,to,0,0
177471,perceived,0,0
177472,motivation,0,1
177473,by,0,0
177474,Intrinsic,0,0
177475,Motivation,0,1
177476,Inventory,0,1
177477,posttraining,0,0
177478,.,0,0
177479,RESULTS,0,0
177480,FM,1,1
177481,and,1,0
177482,SULCS,1,1
177483,scores,1,1
177484,and,1,0
177485,reach,1,0
177486,distance,1,1
177487,improved,0,0
177488,significantly,0,0
177489,within,0,0
177490,both,0,0
177491,groups,0,0
177492,.,0,0
177493,These,0,0
177494,improvements,0,1
177495,and,0,0
177496,experienced,0,0
177497,pain,1,1
177498,did,0,0
177499,not,0,0
177500,differ,0,0
177501,between,0,0
177502,groups,0,0
177503,.,0,0
177504,The,0,0
177505,AS,0,0
177506,group,0,0
177507,reported,0,0
177508,higher,1,0
177509,interest/enjoyment,1,1
177510,during,0,0
177511,training,0,0
177512,than,0,0
177513,the,0,0
177514,CON,0,0
177515,group,0,0
177516,.,0,0
177517,CONCLUSIONS,0,0
177518,AS,0,0
177519,training,0,0
177520,with,0,0
177521,computerized,0,0
177522,exercises,0,0
177523,is,0,0
177524,as,0,0
177525,effective,0,0
177526,as,0,0
177527,conventional,0,0
177528,therapy,0,0
177529,dedicated,0,0
177530,to,0,0
177531,the,0,0
177532,arm,0,0
177533,to,0,0
177534,improve,0,0
177535,arm,1,0
177536,function,1,1
177537,and,1,1
177538,activity,1,1
177539,in,0,0
177540,subacute,0,0
177541,stroke,0,1
177542,rehabilitation,0,0
177543,",",0,0
177544,when,0,0
177545,applied,0,0
177546,at,0,0
177547,the,0,0
177548,same,0,0
177549,dose,0,0
177550,.,0,0
177551,Quantitative,0,0
177552,measurements,0,0
177553,of,0,0
177554,HER2,0,0
177555,and,0,0
177556,phospho-HER2,0,0
177557,expression,0,1
177558,:,0,0
177559,correlation,0,0
177560,with,0,0
177561,pathologic,0,1
177562,response,0,1
177563,to,0,0
177564,neoadjuvant,0,0
177565,chemotherapy,0,0
177566,and,0,0
177567,trastuzumab,0,0
177568,.,0,0
177569,BACKGROUND,0,0
177570,Preoperative,0,1
177571,therapy,0,0
177572,with,0,0
177573,chemotherapy,0,0
177574,and,0,0
177575,the,0,0
177576,HER2-targeted,0,0
177577,monoclonal,0,0
177578,antibody,0,0
177579,trastuzumab,0,0
177580,is,0,0
177581,valuable,0,0
177582,for,0,0
177583,patients,0,0
177584,with,0,0
177585,large,0,0
177586,or,0,0
177587,locally,0,0
177588,advanced,0,0
177589,HER2-positive,0,0
177590,(,0,0
177591,HER2+,0,0
177592,),0,0
177593,breast,0,0
177594,cancers,0,1
177595,but,0,0
177596,traditional,0,0
177597,methods,0,0
177598,of,0,0
177599,measuring,0,0
177600,HER2,0,0
177601,expression,0,1
177602,do,0,0
177603,not,0,0
177604,accurately,0,0
177605,stratify,0,0
177606,patients,0,0
177607,for,0,0
177608,likelihood,0,1
177609,of,0,0
177610,response,0,1
177611,.,0,0
177612,Quantitative,0,0
177613,immunofluorescent,0,0
177614,approaches,0,0
177615,have,0,0
177616,the,0,0
177617,potential,0,0
177618,to,0,0
177619,provide,0,0
177620,a,0,0
177621,mathematically,0,0
177622,continuous,0,0
177623,measure,0,0
177624,of,0,0
177625,HER2,0,0
177626,.,0,0
177627,Here,0,0
177628,we,0,0
177629,seek,0,0
177630,to,0,0
177631,determine,0,0
177632,whether,0,0
177633,quantitative,0,0
177634,measurement,0,0
177635,of,0,0
177636,HER2,0,0
177637,or,0,0
177638,phospho-HER2,0,0
177639,correlates,0,0
177640,with,0,0
177641,likelihood,0,1
177642,of,0,0
177643,response,0,1
177644,to,0,0
177645,trastuzumab-,0,0
177646,containing,0,0
177647,neoadjuvant,0,0
177648,therapy,0,0
177649,.,0,0
177650,METHODS,0,0
177651,We,0,0
177652,evaluated,0,0
177653,core,0,0
177654,biopsy,0,0
177655,samples,0,0
177656,from,0,0
177657,27,0,0
177658,HER2+,0,0
177659,breast,0,0
177660,cancer,0,0
177661,patients,0,0
177662,enrolled,0,0
177663,in,0,0
177664,a,0,0
177665,preoperative,0,0
177666,clinical,0,0
177667,trial,0,0
177668,using,0,0
177669,trastuzumab,0,0
177670,",",0,0
177671,nab-paclitaxel,0,0
177672,and,0,1
177673,carboplatin,0,0
177674,combination,0,0
177675,therapy,0,0
177676,(,0,0
177677,BrUOG,0,0
177678,BR-211B,0,1
177679,(,0,0
177680,NCT00617942,0,0
177681,),0,0
177682,),0,0
177683,.,0,0
177684,Tumor,0,1
177685,core,0,1
177686,biopsies,0,0
177687,were,0,0
177688,taken,0,0
177689,before,0,0
177690,initiation,0,0
177691,of,0,0
177692,treatment,0,0
177693,and,0,0
177694,9-13,0,0
177695,days,0,0
177696,after,0,0
177697,patients,0,0
177698,received,0,0
177699,run-in,0,0
177700,doses,0,0
177701,of,0,0
177702,either,0,0
177703,single,0,0
177704,agent,0,0
177705,trastuzumab,0,0
177706,or,0,0
177707,nab-paclitaxel,0,0
177708,.,0,0
177709,The,0,0
177710,AQUA,0,1
177711,method,0,0
177712,of,0,0
177713,quantitative,0,0
177714,immunofluorescence,0,0
177715,was,0,0
177716,used,0,0
177717,for,0,0
177718,analysis,0,0
177719,of,0,0
177720,in,0,0
177721,situ,0,0
177722,protein,0,0
177723,expression,0,1
177724,.,0,0
177725,Patients,0,0
177726,then,0,0
177727,received,0,0
177728,18,0,0
177729,weeks,0,0
177730,of,0,0
177731,treatment,0,0
177732,",",0,0
177733,followed,0,0
177734,by,0,0
177735,surgery,0,0
177736,to,0,0
177737,assess,1,0
177738,pathologic,1,1
177739,response,1,1
177740,to,0,0
177741,the,0,0
177742,neoadjuvant,0,0
177743,regimen,0,0
177744,.,0,0
177745,RESULTS,0,0
177746,A,0,0
177747,HER2,0,0
177748,score,0,1
177749,of,0,0
177750,2111,0,0
177751,by,0,0
177752,AQUA,0,0
177753,analysis,0,0
177754,has,0,0
177755,been,0,0
177756,shown,0,0
177757,to,0,0
177758,be,0,0
177759,equivalent,0,0
177760,to,0,0
177761,HER2,0,0
177762,3+,0,0
177763,by,0,0
177764,immunohistochemical,0,0
177765,staining,0,1
177766,in,0,0
177767,previous,0,0
177768,studies,0,0
177769,.,0,0
177770,Of,0,0
177771,20,0,0
177772,evaluable,0,0
177773,patients,0,0
177774,",",0,0
177775,10,0,0
177776,cases,0,0
177777,who,0,0
177778,achieved,0,0
177779,a,0,0
177780,pathologic,1,1
177781,complete,1,1
177782,response,1,1
177783,(,1,0
177784,pathCR,1,0
177785,),1,0
177786,with,0,0
177787,neoadjuvant,0,0
177788,treatment,0,0
177789,had,0,0
177790,a,0,0
177791,mean,0,1
177792,HER2,0,0
177793,level,0,1
177794,of,0,0
177795,10251,0,0
177796,compared,0,0
177797,with,0,0
177798,4766,0,0
177799,in,0,0
177800,the,0,0
177801,patients,0,0
177802,without,0,0
177803,pathCR,0,0
177804,(,0,0
177805,p,0,0
177806,=,0,0
177807,0.0021,0,0
177808,),0,0
177809,.,0,0
177810,Measurement,1,1
177811,of,1,0
177812,phospho-HER2,1,0
177813,showed,1,0
177814,no,0,0
177815,difference,0,0
177816,in,0,0
177817,pathCR,0,0
177818,vs,0,0
177819,non-pathCR,0,0
177820,groups,0,0
177821,.,0,0
177822,In,0,0
177823,9,0,0
177824,patients,0,0
177825,who,0,0
177826,had,0,0
177827,HER2,0,0
177828,levels,0,1
177829,repeated,0,0
177830,after,0,0
177831,a,0,0
177832,single,0,0
177833,treatment,0,0
177834,with,0,0
177835,trastuzumab,0,0
177836,there,0,0
177837,was,0,0
177838,no,0,0
177839,evidence,0,0
177840,of,0,0
177841,a,0,0
177842,reduction,0,0
177843,in,0,0
177844,the,1,0
177845,HER2,1,0
177846,or,1,0
177847,phospho-HER2,1,0
177848,levels,1,1
177849,following,1,0
177850,that,0,0
177851,exposure,0,0
177852,.,0,0
177853,CONCLUSIONS,0,0
177854,High,0,0
177855,levels,1,1
177856,of,1,0
177857,HER2,1,0
177858,are,0,0
177859,associated,0,0
177860,with,0,0
177861,achievement,0,0
177862,of,0,0
177863,a,0,0
177864,pathCR,0,0
177865,in,0,0
177866,the,0,0
177867,preoperative,0,0
177868,setting,0,0
177869,",",0,0
177870,while,0,0
177871,levels,1,1
177872,of,1,0
177873,Phospho-HER2,1,1
177874,were,1,0
177875,not,0,0
177876,predictive,0,0
177877,of,0,0
177878,response,0,1
177879,.,0,0
177880,This,0,0
177881,data,0,0
177882,suggests,0,0
177883,that,0,0
177884,accurate,0,0
177885,measurement,0,0
177886,of,0,0
177887,HER2,0,0
177888,may,0,0
177889,help,0,0
177890,determine,0,0
177891,the,0,0
177892,likelihood,0,0
177893,of,0,0
177894,response,0,1
177895,in,0,0
177896,the,0,0
177897,pre-surgical,0,0
177898,setting,0,0
177899,.,0,0
177900,Further,0,0
177901,validation,0,0
177902,in,0,0
177903,larger,0,0
177904,cohorts,0,0
177905,is,0,0
177906,required,0,0
177907,",",0,0
177908,but,0,0
177909,this,0,0
177910,pilot,0,0
177911,data,0,0
177912,shows,0,0
177913,the,0,0
177914,feasibility,0,0
177915,of,0,0
177916,this,0,0
177917,approach,0,0
177918,.,0,0
177919,Failure,0,1
177920,of,0,0
177921,lithium,0,0
177922,to,0,0
177923,reduce,0,0
177924,period,0,0
177925,of,0,0
177926,neutropenia,0,1
177927,during,0,0
177928,induction,0,1
177929,therapy,0,0
177930,of,0,0
177931,acute,0,0
177932,myeloid,0,0
177933,leukemia,0,0
177934,.,0,0
177935,Fifty-four,0,0
177936,patients,0,0
177937,treated,0,0
177938,with,0,0
177939,daunorubicin,0,0
177940,",",0,0
177941,cytosine,0,0
177942,arabinoside,0,0
177943,and,0,1
177944,thioquanine,0,0
177945,for,0,0
177946,acute,0,0
177947,myeloid,0,0
177948,leukemia,0,0
177949,were,0,0
177950,randomly,0,0
177951,assigned,0,0
177952,to,0,0
177953,receive,0,0
177954,oral,0,0
177955,lithium,0,0
177956,carbonate,0,0
177957,1200,0,0
177958,mg,0,0
177959,daily,0,0
177960,or,0,0
177961,no,0,0
177962,lithium,0,0
177963,.,0,0
177964,The,0,0
177965,duration,1,1
177966,of,1,0
177967,neutropenia,1,1
177968,(,0,0
177969,less,0,0
177970,than,0,0
177971,0.5,0,0
177972,x,0,0
177973,10,0,0
177974,(,0,0
177975,9,0,0
177976,),0,0
177977,/L,0,0
177978,),0,0
177979,was,0,0
177980,similar,0,0
177981,between,0,0
177982,controls,0,0
177983,(,0,0
177984,median,0,0
177985,22.5,0,0
177986,days,0,0
177987,),0,0
177988,and,0,0
177989,patients,0,0
177990,treated,0,0
177991,with,0,0
177992,lithium,0,0
177993,(,0,0
177994,median,0,0
177995,24,0,0
177996,days,0,0
177997,),0,0
177998,.,0,0
177999,The,0,0
178000,number,1,1
178001,of,1,0
178002,remissions,1,1
178003,",",1,0
178004,relapse-free,1,1
178005,survival,1,1
178006,and,1,1
178007,survival,1,1
178008,were,0,0
178009,similar,1,0
178010,for,0,0
178011,the,0,0
178012,lithium,0,0
178013,treated,0,0
178014,and,0,0
178015,control,0,0
178016,groups,0,0
178017,of,0,0
178018,patients,0,0
178019,.,0,0
178020,There,0,0
178021,was,0,0
178022,no,0,0
178023,apparent,0,0
178024,clinical,1,0
178025,efficacy,1,1
178026,in,0,0
178027,the,0,0
178028,use,0,0
178029,of,0,0
178030,lithium,0,0
178031,to,0,0
178032,reduce,0,0
178033,the,0,0
178034,period,0,0
178035,of,0,0
178036,neutropenia,0,1
178037,in,0,0
178038,patients,0,0
178039,undergoing,0,0
178040,remission,0,1
178041,induction,0,1
178042,therapy,0,0
178043,for,0,0
178044,acute,0,0
178045,myeloid,0,0
178046,leukemia,0,0
178047,.,0,0
178048,COPD,0,0
178049,detected,0,0
178050,with,0,0
178051,screening,0,0
178052,:,0,0
178053,impact,0,0
178054,on,0,0
178055,patient,1,1
178056,management,1,0
178057,and,1,0
178058,prognosis,1,0
178059,.,1,0
178060,It,0,0
178061,is,0,0
178062,uncertain,0,0
178063,whether,0,0
178064,screening,0,0
178065,of,0,0
178066,older,0,0
178067,persons,0,0
178068,for,0,0
178069,chronic,0,0
178070,obstructive,0,0
178071,pulmonary,0,1
178072,disease,0,1
178073,(,0,0
178074,COPD,0,0
178075,),0,0
178076,is,0,0
178077,worthwhile,0,0
178078,because,0,0
178079,the,0,0
178080,effects,0,0
178081,on,0,0
178082,patient,1,1
178083,management,1,0
178084,and,1,0
178085,prognosis,1,1
178086,are,0,0
178087,unknown,0,0
178088,.,0,0
178089,We,0,0
178090,aimed,0,0
178091,to,0,0
178092,assess,0,0
178093,the,0,0
178094,short-term,1,0
178095,consequences,1,0
178096,of,0,0
178097,detecting,0,0
178098,COPD,0,0
178099,in,0,0
178100,frail,0,0
178101,elderly,0,0
178102,subjects,0,0
178103,with,0,0
178104,dyspnoea,0,1
178105,",",0,0
178106,considering,0,0
178107,pulmonary,1,1
178108,drug,1,0
178109,use,1,0
178110,",",1,0
178111,hospitalisations,1,1
178112,and,1,1
178113,all-cause,1,1
178114,mortality,1,1
178115,.,1,0
178116,Community-dwelling,0,0
178117,frail,0,0
178118,elderly,0,0
178119,subjects,0,0
178120,",",0,0
178121,aged,0,0
178122,65,0,0
178123,years,0,0
178124,and,0,0
178125,older,0,0
178126,",",0,1
178127,with,0,0
178128,dyspnoea,0,1
178129,",",0,0
178130,participating,0,0
178131,in,0,0
178132,a,0,0
178133,screening,0,0
178134,study,0,0
178135,on,0,0
178136,COPD,0,0
178137,and,0,1
178138,heart,0,1
178139,failure,0,1
178140,were,0,0
178141,included,0,0
178142,.,0,0
178143,Final,0,0
178144,diagnoses,0,0
178145,were,0,0
178146,assigned,0,0
178147,by,0,0
178148,an,0,0
178149,expert,0,0
178150,panel,0,0
178151,based,0,0
178152,on,0,0
178153,all,0,0
178154,data,0,0
178155,from,0,0
178156,the,0,0
178157,screening,0,0
178158,strategy,0,0
178159,",",0,0
178160,including,0,0
178161,spirometry,0,0
178162,.,0,0
178163,Follow-up,0,0
178164,data,0,0
178165,were,0,0
178166,collected,0,0
178167,from,0,0
178168,the,0,0
178169,general,0,0
178170,practitioners,0,0
178171,.,0,0
178172,Of,0,0
178173,the,0,0
178174,386,0,0
178175,patients,0,0
178176,",",0,0
178177,84,0,0
178178,(,0,0
178179,21.8,0,0
178180,%,0,0
178181,),0,0
178182,were,0,0
178183,received,0,0
178184,a,0,0
178185,new,0,0
178186,diagnosis,0,0
178187,of,0,0
178188,COPD,0,0
178189,.,0,0
178190,Overall,0,1
178191,",",0,0
178192,changes,1,1
178193,in,1,0
178194,pulmonary,1,1
178195,drug,1,0
178196,prescription,1,0
178197,during,0,0
178198,6,0,0
178199,months,0,0
178200,of,0,0
178201,follow-up,0,0
178202,were,0,0
178203,infrequent,0,0
178204,(,0,0
178205,n,0,0
178206,=,0,0
178207,53,0,0
178208,",",0,0
178209,13.7,0,0
178210,%,0,0
178211,;,0,0
178212,among,0,0
178213,new,0,0
178214,cases,0,0
178215,of,0,0
178216,COPD,0,0
178217,",",0,0
178218,15,0,0
178219,(,0,0
178220,17.9,0,0
178221,%,0,0
178222,),0,0
178223,out,0,0
178224,of,0,0
178225,84,0,0
178226,),0,0
178227,.,0,0
178228,Of,0,0
178229,all,0,0
178230,participants,0,0
178231,",",0,0
178232,25.9,0,0
178233,%,0,0
178234,were,0,0
178235,hospitalised,1,0
178236,in,0,0
178237,the,0,0
178238,first,0,0
178239,year,0,0
178240,of,0,0
178241,follow-up,0,0
178242,",",0,0
178243,with,0,0
178244,the,0,0
178245,highest,0,0
178246,rate,0,1
178247,in,0,0
178248,patients,0,0
178249,with,0,0
178250,newly,0,0
178251,detected,0,0
178252,COPD,0,0
178253,(,0,0
178254,32.1,0,0
178255,%,0,0
178256,),0,0
178257,.,0,0
178258,Many,0,0
178259,new,0,0
178260,cases,0,0
178261,of,0,0
178262,COPD,0,0
178263,could,0,0
178264,be,0,0
178265,detected,0,0
178266,by,0,0
178267,screening,0,0
178268,frail,0,0
178269,elderly,0,0
178270,subjects,0,0
178271,with,0,0
178272,dyspnoea,1,1
178273,",",0,0
178274,but,0,0
178275,the,0,0
178276,impact,0,0
178277,on,0,0
178278,patient,1,0
178279,management,1,0
178280,seems,0,0
178281,limited,0,0
178282,.,0,0
178283,Our,0,0
178284,study,0,0
178285,underlines,0,0
178286,the,0,0
178287,importance,0,0
178288,of,0,0
178289,obtaining,0,0
178290,follow-up,0,0
178291,data,0,0
178292,to,0,0
178293,assess,0,0
178294,the,0,0
178295,true,1,0
178296,impact,1,0
178297,of,0,0
178298,a,0,0
178299,(,0,0
178300,screen-detected,0,0
178301,),0,0
178302,diagnosis,0,0
178303,of,0,0
178304,COPD,0,0
178305,on,0,0
178306,patient,1,1
178307,management,1,0
178308,and,1,0
178309,outcome,1,1
178310,.,1,0
178311,A,0,0
178312,randomized,0,0
178313,",",0,0
178314,phase,0,0
178315,II,0,1
178316,study,0,0
178317,of,0,0
178318,afatinib,0,0
178319,versus,0,0
178320,cetuximab,0,0
178321,in,0,0
178322,metastatic,0,0
178323,or,0,0
178324,recurrent,0,1
178325,squamous,0,0
178326,cell,0,0
178327,carcinoma,0,0
178328,of,0,0
178329,the,0,0
178330,head,0,0
178331,and,0,0
178332,neck,0,1
178333,.,0,0
178334,BACKGROUND,0,0
178335,Afatinib,0,0
178336,is,0,0
178337,an,0,0
178338,oral,0,0
178339,",",0,0
178340,irreversible,0,1
178341,ErbB,0,0
178342,family,0,0
178343,blocker,0,0
178344,that,0,0
178345,has,0,0
178346,shown,0,0
178347,activity,0,1
178348,in,0,0
178349,epidermal,0,1
178350,growth,0,1
178351,factor,0,1
178352,receptor,0,1
178353,(,0,0
178354,EGFR,0,1
178355,),0,0
178356,-mutated,0,0
178357,lung,0,0
178358,cancer,0,0
178359,.,0,0
178360,We,0,0
178361,hypothesized,0,0
178362,that,0,0
178363,the,0,0
178364,agent,0,0
178365,would,0,0
178366,have,0,0
178367,greater,0,0
178368,antitumor,1,1
178369,activity,1,1
178370,compared,0,0
178371,with,0,0
178372,cetuximab,0,0
178373,in,0,0
178374,recurrent,0,1
178375,or,0,0
178376,metastatic,0,0
178377,(,0,0
178378,R/M,0,0
178379,),0,1
178380,head,0,0
178381,and,0,1
178382,neck,0,1
178383,squamous,0,0
178384,cell,0,1
178385,carcinoma,0,0
178386,(,0,0
178387,HNSCC,0,1
178388,),0,0
178389,patients,0,0
178390,",",0,0
178391,whose,0,0
178392,disease,0,0
178393,has,0,0
178394,progressed,0,0
178395,after,0,0
178396,platinum-containing,0,0
178397,therapy,0,0
178398,.,0,0
178399,PATIENTS,0,0
178400,AND,0,0
178401,METHODS,0,0
178402,An,0,0
178403,open-label,0,0
178404,",",0,0
178405,randomized,0,0
178406,",",0,0
178407,phase,0,0
178408,II,0,0
178409,trial,0,0
178410,was,0,0
178411,conducted,0,0
178412,in,0,0
178413,43,0,0
178414,centers,0,0
178415,;,0,0
178416,124,0,0
178417,patients,0,0
178418,were,0,0
178419,randomized,0,0
178420,(,0,0
178421,1,0,0
178422,:,0,0
178423,1,0,0
178424,),0,0
178425,to,0,0
178426,either,0,0
178427,afatinib,0,0
178428,(,0,0
178429,50,0,0
178430,mg/day,0,0
178431,),0,0
178432,or,0,0
178433,cetuximab,0,0
178434,(,0,0
178435,250,0,0
178436,mg/m,0,0
178437,(,0,0
178438,2,0,0
178439,),0,0
178440,/week,0,0
178441,),0,0
178442,until,0,0
178443,disease,0,1
178444,progression,0,1
178445,or,0,0
178446,intolerable,0,1
178447,adverse,0,1
178448,events,0,1
178449,(,0,0
178450,AEs,0,1
178451,),0,1
178452,(,0,0
178453,stage,0,0
178454,I,0,0
178455,),0,0
178456,",",0,0
178457,with,0,0
178458,optional,0,0
178459,crossover,0,0
178460,(,0,0
178461,stage,0,0
178462,II,0,0
178463,),0,0
178464,.,0,0
178465,The,0,0
178466,primary,0,0
178467,end,0,0
178468,point,0,0
178469,was,0,0
178470,tumor,1,1
178471,shrinkage,1,1
178472,before,1,0
178473,crossover,1,0
178474,assessed,1,0
178475,by,1,0
178476,investigator,1,0
178477,(,1,0
178478,IR,1,0
178479,),1,0
178480,and,1,0
178481,independent,1,0
178482,central,1,1
178483,review,1,0
178484,(,1,0
178485,ICR,1,1
178486,),1,0
178487,.,1,0
178488,RESULTS,0,0
178489,A,0,0
178490,total,0,0
178491,of,0,0
178492,121,0,0
178493,patients,0,0
178494,were,0,0
178495,treated,0,0
178496,(,0,0
178497,61,0,0
178498,afatinib,0,0
178499,",",0,0
178500,60,0,0
178501,cetuximab,0,0
178502,),0,0
178503,and,0,0
178504,68,0,0
178505,crossed,0,0
178506,over,0,0
178507,to,0,0
178508,stage,0,0
178509,II,0,0
178510,(,0,0
178511,32,0,0
178512,and,0,0
178513,36,0,0
178514,respectively,0,0
178515,),0,0
178516,.,0,0
178517,In,0,0
178518,stage,0,0
178519,I,0,0
178520,",",0,0
178521,mean,1,1
178522,tumor,1,1
178523,shrinkage,1,1
178524,by,1,0
178525,IR/ICR,1,0
178526,was,0,0
178527,10.4,0,0
178528,%,0,0
178529,/16.6,0,0
178530,%,0,0
178531,with,0,0
178532,afatinib,0,0
178533,and,0,0
178534,5.4,0,0
178535,%,0,0
178536,/10.1,0,0
178537,%,0,0
178538,with,0,0
178539,cetuximab,0,0
178540,(,0,0
178541,P,0,0
178542,=,0,0
178543,0.46/0.30,0,0
178544,),0,0
178545,.,0,0
178546,Objective,1,1
178547,response,1,1
178548,rate,1,1
178549,was,0,0
178550,16.1,0,0
178551,%,0,0
178552,/8.1,0,0
178553,%,0,0
178554,with,0,0
178555,afatinib,0,0
178556,and,0,0
178557,6.5,0,0
178558,%,0,0
178559,/9.7,0,0
178560,%,0,0
178561,with,0,0
178562,cetuximab,0,0
178563,(,0,0
178564,IR/ICR,0,0
178565,),0,0
178566,.,0,0
178567,Comparable,1,0
178568,disease,1,1
178569,control,1,0
178570,rates,1,1
178571,were,0,0
178572,observed,0,0
178573,with,0,0
178574,afatinib,0,0
178575,(,0,0
178576,50,0,0
178577,%,0,0
178578,),0,0
178579,and,0,1
178580,cetuximab,0,0
178581,(,0,0
178582,56.5,0,0
178583,%,0,0
178584,),0,0
178585,by,0,0
178586,IR,0,0
178587,;,0,0
178588,similar,0,0
178589,results,0,0
178590,were,0,0
178591,seen,0,0
178592,by,0,0
178593,ICR,0,0
178594,.,0,0
178595,Most,0,0
178596,common,0,0
178597,grade,0,1
178598,?3,1,0
178599,drug-related,1,1
178600,AEs,1,1
178601,(,1,0
178602,DRAEs,0,1
178603,),0,0
178604,were,1,0
178605,rash/acne,1,1
178606,(,1,0
178607,18,0,0
178608,%,0,0
178609,versus,0,0
178610,8.3,1,0
178611,%,1,0
178612,),1,0
178613,",",1,0
178614,diarrhea,1,1
178615,(,1,0
178616,14.8,0,0
178617,%,0,0
178618,versus,0,0
178619,0,0,0
178620,%,0,0
178621,),0,0
178622,",",0,0
178623,and,1,1
178624,stomatitis/mucositis,1,1
178625,(,1,0
178626,11.5,0,0
178627,%,0,0
178628,versus,0,0
178629,0,0,0
178630,%,0,0
178631,),0,0
178632,with,0,0
178633,afatinib,0,0
178634,and,0,1
178635,cetuximab,0,0
178636,",",0,0
178637,respectively,0,0
178638,.,0,0
178639,Patients,0,0
178640,with,1,0
178641,DRAEs,1,0
178642,leading,1,0
178643,to,1,0
178644,treatment,1,0
178645,discontinuation,1,0
178646,were,1,0
178647,23,0,0
178648,%,0,0
178649,with,0,0
178650,afatinib,0,0
178651,and,0,0
178652,5,0,0
178653,%,0,0
178654,with,0,0
178655,cetuximab,0,0
178656,.,0,0
178657,In,0,0
178658,stage,0,0
178659,II,0,0
178660,",",1,0
178661,disease,1,1
178662,control,1,0
178663,rate,1,1
178664,(,1,0
178665,IR/ICR,1,1
178666,),1,0
178667,was,1,0
178668,38.9,0,0
178669,%,0,0
178670,/33.3,0,0
178671,%,0,0
178672,with,0,0
178673,afatinib,0,0
178674,and,0,0
178675,18.8,0,0
178676,%,0,0
178677,/18.8,0,0
178678,%,0,0
178679,with,0,0
178680,cetuximab,0,0
178681,.,0,0
178682,CONCLUSION,0,0
178683,Afatinib,0,0
178684,showed,1,0
178685,antitumor,1,1
178686,activity,1,1
178687,comparable,1,0
178688,to,0,0
178689,cetuximab,0,0
178690,in,0,0
178691,R/M,0,0
178692,HNSCC,0,1
178693,in,0,0
178694,this,0,0
178695,exploratory,0,0
178696,phase,0,0
178697,II,0,0
178698,trial,0,0
178699,",",0,0
178700,although,0,0
178701,more,0,0
178702,patients,0,0
178703,on,0,0
178704,afatinib,0,0
178705,discontinued,0,0
178706,treatment,0,0
178707,due,0,0
178708,to,0,0
178709,AEs,0,0
178710,.,0,0
178711,Sequential,0,0
178712,EGFR/ErbB,0,0
178713,treatment,0,0
178714,with,0,0
178715,afatinib,0,0
178716,and,0,1
178717,cetuximab,0,0
178718,provided,0,0
178719,sustained,1,1
178720,clinical,1,0
178721,benefit,1,0
178722,in,1,0
178723,patients,0,0
178724,after,0,0
178725,crossover,0,0
178726,",",0,0
178727,suggesting,0,0
178728,a,0,0
178729,lack,0,0
178730,of,0,0
178731,cross-resistance,0,1
178732,.,0,0
178733,Standardized,0,0
178734,treatment,0,0
178735,of,0,0
178736,Chinese,0,0
178737,medicine,0,0
178738,decoction,0,0
178739,for,0,0
178740,cancer,0,0
178741,pain,0,1
178742,patients,0,0
178743,with,0,0
178744,opioid-induced,1,0
178745,constipation,1,1
178746,:,1,0
178747,a,0,0
178748,multi-center,0,0
178749,prospective,0,0
178750,randomized,0,0
178751,controlled,0,0
178752,study,0,0
178753,.,0,0
178754,OBJECTIVE,0,0
178755,To,0,0
178756,observe,0,0
178757,the,0,0
178758,efficacy,1,1
178759,and,0,0
178760,the,0,0
178761,influence,0,0
178762,on,0,0
178763,quality,1,1
178764,of,1,0
178765,life,1,1
178766,(,1,0
178767,QOL,1,1
178768,),1,0
178769,of,0,0
178770,syndrome,0,0
178771,differentiation,0,1
178772,treatment,0,0
178773,with,0,0
178774,Chinese,0,0
178775,medicine,0,0
178776,(,0,0
178777,CM,0,1
178778,),0,0
178779,for,0,0
178780,opioid-induced,1,0
178781,constipation,1,1
178782,as,0,0
178783,well,0,0
178784,as,0,0
178785,the,0,0
178786,safety,1,1
178787,and,1,0
178788,influence,1,0
178789,on,1,0
178790,analgesic,1,1
178791,effect,1,0
178792,of,1,0
178793,opioids,1,0
178794,.,1,0
178795,METHODS,0,0
178796,Totally,0,0
178797,406,0,0
178798,cases,0,0
178799,enrolled,0,0
178800,from,0,0
178801,53,0,0
178802,collaborating,0,0
178803,medical,0,0
178804,centers,0,0
178805,were,0,0
178806,randomly,0,0
178807,assigned,0,0
178808,to,0,0
178809,a,0,0
178810,CM,0,0
178811,group,0,0
178812,and,0,0
178813,a,0,0
178814,control,0,0
178815,group,0,0
178816,.,0,0
178817,The,0,0
178818,CM,0,0
178819,group,0,0
178820,were,0,0
178821,treated,0,0
178822,with,0,0
178823,CM,0,0
178824,decoction,0,0
178825,based,0,0
178826,on,0,0
178827,syndrome,0,0
178828,differentiation,0,1
178829,",",0,0
178830,and,0,0
178831,the,0,0
178832,control,0,0
178833,group,0,0
178834,were,0,0
178835,treated,0,0
178836,with,0,0
178837,Phenolphthalein,0,0
178838,Tablet,0,0
178839,.,0,0
178840,Both,0,0
178841,groups,0,0
178842,were,0,0
178843,treated,0,0
178844,for,0,0
178845,14,0,0
178846,days,0,0
178847,.,0,0
178848,Cleveland,1,0
178849,constipation,1,1
178850,score,1,1
178851,(,1,0
178852,CCS,1,0
178853,),1,0
178854,",",1,0
178855,numerical,1,1
178856,rating,1,1
178857,scale,1,1
178858,(,1,0
178859,NRS,1,1
178860,),1,0
178861,of,1,0
178862,pain,1,1
178863,and,1,0
178864,Chinese,1,0
178865,version,1,0
178866,of,1,0
178867,European,1,0
178868,Organisation,1,0
178869,for,1,0
178870,Research,1,0
178871,and,1,0
178872,Treatment,1,0
178873,of,1,1
178874,Cancer,1,0
178875,",",1,0
178876,Quality,1,1
178877,of,1,0
178878,Life,1,0
178879,Questionnaire-C30,1,1
178880,V3.0,1,1
178881,(,1,0
178882,EORTC,1,0
178883,QLQ-C30,1,0
178884,V3.0,1,1
178885,),1,0
178886,were,0,0
178887,used,0,0
178888,to,0,0
178889,evaluate,0,0
178890,the,0,0
178891,efficacy,1,1
178892,",",1,0
178893,pain,1,1
178894,controlled,1,0
178895,and,0,0
178896,QOL,1,1
178897,status,1,1
178898,.,1,0
178899,RESULTS,0,0
178900,The,0,0
178901,comparisons,0,0
178902,of,0,0
178903,CCS,1,0
178904,score,1,1
178905,reduction,1,1
178906,and,0,1
178907,QOL,1,1
178908,between,0,0
178909,the,0,0
178910,two,0,0
178911,groups,0,0
178912,after,0,0
178913,treatment,0,0
178914,suggested,0,0
178915,that,0,0
178916,the,0,0
178917,improvements,1,0
178918,of,1,0
178919,constipation,1,1
178920,and,1,0
178921,QOL,1,1
178922,in,0,0
178923,the,0,0
178924,CM,0,0
178925,group,0,0
178926,were,0,0
178927,better,0,0
178928,than,0,0
178929,that,0,0
178930,in,0,0
178931,the,0,0
178932,control,0,0
178933,group,0,0
178934,(,0,0
178935,P,0,0
178936,<,0,0
178937,0.05,0,0
178938,),0,0
178939,.,0,0
178940,The,0,0
178941,total,0,1
178942,efficiency,1,0
178943,of,0,0
178944,the,0,0
178945,CM,0,0
178946,group,0,0
178947,was,0,0
178948,better,0,0
178949,than,0,0
178950,the,0,0
178951,control,0,0
178952,group,0,0
178953,(,0,0
178954,93.5,0,0
178955,%,0,0
178956,vs.,0,0
178957,86.4,0,0
178958,%,0,0
178959,",",0,0
178960,P,0,0
178961,<,0,0
178962,0.05,0,0
178963,),0,0
178964,.,0,0
178965,There,0,0
178966,was,0,0
178967,no,0,0
178968,significant,0,0
178969,difference,0,0
178970,in,0,0
178971,NRS,1,1
178972,scores,1,1
178973,between,0,0
178974,before,0,0
178975,and,0,0
178976,after,0,0
178977,treatment,0,0
178978,in,0,0
178979,both,0,0
178980,groups,0,0
178981,.,0,0
178982,There,0,0
178983,was,0,0
178984,no,0,0
178985,serious,0,1
178986,drug-related,1,1
178987,adverse,1,1
178988,event,1,0
178989,during,0,0
178990,the,0,0
178991,course,0,0
178992,of,0,0
178993,study,0,0
178994,.,0,0
178995,CONCLUSION,0,0
178996,CM,0,0
178997,decoction,0,0
178998,could,0,0
178999,effectively,0,0
179000,treat,0,0
179001,opioid-induced,1,1
179002,constipation,1,1
179003,and,0,0
179004,improve,0,0
179005,patients,1,0
179006,',1,0
179007,QOL,1,1
179008,at,0,0
179009,the,0,0
179010,same,0,0
179011,time,0,0
179012,.,0,0
179013,It,0,0
179014,is,0,0
179015,safe,0,0
179016,and,0,0
179017,does,0,0
179018,n't,0,0
179019,affect,0,0
179020,the,0,0
179021,analgesic,1,1
179022,effect,1,0
179023,of,1,0
179024,opioids,1,0
179025,when,0,0
179026,treating,0,0
179027,constipation,1,1
179028,.,1,0
179029,High-dose,0,0
179030,vitamin,0,0
179031,D3,0,0
179032,supplementation,0,0
179033,in,0,0
179034,children,0,0
179035,and,0,0
179036,young,0,0
179037,adults,0,0
179038,with,0,0
179039,HIV,1,0
179040,:,1,0
179041,a,0,0
179042,randomized,0,0
179043,",",0,0
179044,placebo-controlled,0,0
179045,trial,0,0
179046,.,0,0
179047,BACKGROUND,0,0
179048,Suboptimal,0,0
179049,vitamin,0,0
179050,D,0,0
179051,status,0,1
179052,is,0,0
179053,prevalent,0,0
179054,in,0,0
179055,HIV-infected,0,0
179056,patients,0,0
179057,and,0,0
179058,associated,0,0
179059,with,0,0
179060,increased,0,0
179061,risk,1,1
179062,of,1,0
179063,disease,1,1
179064,severity,1,1
179065,and,1,0
179066,morbidity,1,1
179067,.,1,0
179068,We,0,0
179069,aimed,0,0
179070,to,0,0
179071,determine,0,0
179072,12-month,0,0
179073,safety,1,1
179074,and,1,1
179075,efficacy,1,1
179076,of,0,0
179077,daily,0,0
179078,7000,0,0
179079,IU,0,0
179080,vitamin,0,0
179081,D3,0,0
179082,(,0,0
179083,vitD3,0,0
179084,),0,1
179085,versus,0,0
179086,placebo,0,0
179087,to,0,0
179088,sustain,0,0
179089,increased,1,0
179090,serum,1,1
179091,25-hydroxyvitamin,1,1
179092,D,1,0
179093,(,1,0
179094,25,1,0
179095,(,1,0
179096,OH,1,0
179097,),1,0
179098,D,1,1
179099,),1,0
179100,and,1,0
179101,improve,1,0
179102,immune,1,1
179103,status,1,1
179104,in,0,0
179105,HIV-infected,0,0
179106,subjects,0,0
179107,.,0,0
179108,METHODS,0,0
179109,This,0,0
179110,was,0,0
179111,a,0,0
179112,double-blind,0,0
179113,trial,0,0
179114,of,0,0
179115,perinatally,0,0
179116,acquired,0,0
179117,HIV,0,0
179118,(,0,0
179119,PHIV,0,1
179120,),0,0
179121,-infected,0,0
179122,subjects,0,0
179123,or,0,0
179124,behaviorally,0,0
179125,acquired,0,0
179126,HIV,0,0
179127,(,0,0
179128,BHIV,0,1
179129,),0,0
179130,-infected,0,0
179131,subjects,0,0
179132,(,0,0
179133,5.0-24.9,0,0
179134,years,0,0
179135,),0,0
179136,.,0,0
179137,Safety,1,1
179138,",",1,0
179139,25,1,0
179140,(,1,0
179141,OH,1,0
179142,),1,0
179143,D-related,1,1
179144,parameters,1,1
179145,and,1,0
179146,immune,1,1
179147,status,1,1
179148,were,0,0
179149,assessed,0,0
179150,at,0,0
179151,baseline,0,0
179152,",",0,0
179153,3,0,0
179154,",",0,0
179155,6,0,0
179156,and,0,0
179157,12,0,0
179158,months,0,0
179159,.,0,0
179160,RESULTS,0,0
179161,Fifty-eight,0,0
179162,subjects,0,0
179163,enrolled,0,0
179164,(,0,0
179165,67,0,0
179166,%,0,0
179167,male,0,0
179168,",",0,0
179169,85,0,0
179170,%,0,0
179171,African,0,0
179172,American,0,0
179173,and,0,0
179174,64,0,0
179175,%,0,0
179176,BHIV,0,0
179177,),0,0
179178,and,0,0
179179,50,0,0
179180,completed,0,0
179181,with,0,0
179182,no,0,0
179183,safety,1,1
179184,concerns,1,0
179185,.,1,0
179186,In,0,0
179187,unadjusted,0,0
179188,analyses,0,0
179189,",",0,0
179190,there,0,0
179191,were,0,0
179192,no,0,0
179193,differences,0,0
179194,between,0,0
179195,randomization,0,0
179196,groups,0,0
179197,at,0,0
179198,baseline,0,0
179199,;,0,0
179200,at,0,0
179201,3,0,0
179202,",",0,0
179203,6,0,0
179204,and,0,0
179205,12,0,0
179206,months,0,0
179207,",",0,0
179208,25,0,0
179209,(,0,0
179210,OH,0,0
179211,),0,0
179212,D,0,1
179213,was,0,0
179214,higher,0,0
179215,with,0,0
179216,supplementation,0,0
179217,than,0,0
179218,baseline,0,0
179219,and,0,0
179220,higher,0,0
179221,than,0,0
179222,with,0,0
179223,placebo,0,0
179224,(,0,0
179225,P,0,0
179226,<,0,0
179227,0.05,0,0
179228,),0,0
179229,.,0,0
179230,In,0,0
179231,adjusted,0,0
179232,mixed,0,0
179233,models,0,0
179234,",",0,0
179235,in,0,0
179236,the,0,0
179237,supplementation,0,0
179238,group,0,0
179239,",",0,0
179240,the,0,0
179241,fixed,0,0
179242,effect,0,0
179243,of,0,0
179244,25,1,0
179245,(,1,0
179246,OH,1,0
179247,),1,0
179248,D,1,1
179249,was,0,0
179250,higher,0,0
179251,(,0,0
179252,P,0,0
179253,<,0,0
179254,0.001,0,0
179255,),0,0
179256,.,0,0
179257,Percentage,1,1
179258,of,1,0
179259,naive,1,0
179260,T-helper,1,0
179261,cells,1,1
179262,(,1,0
179263,Th,1,0
179264,naive,1,0
179265,%,1,0
179266,),1,0
179267,were,0,0
179268,significantly,0,0
179269,(,0,0
179270,P,0,0
179271,<,0,0
179272,0.01,0,0
179273,),0,0
179274,and,0,0
179275,T-helper,1,1
179276,cells,1,1
179277,(,1,0
179278,CD4,1,1
179279,%,1,0
179280,),1,0
179281,marginally,0,0
179282,(,0,0
179283,P,0,0
179284,<,0,0
179285,0.10,0,0
179286,),0,0
179287,increased,0,0
179288,with,0,0
179289,supplementation,0,0
179290,in,0,0
179291,those,0,0
179292,taking,0,0
179293,highly,0,0
179294,active,0,0
179295,antiretroviral,0,0
179296,therapy,0,0
179297,(,0,0
179298,HAART,0,0
179299,),0,1
179300,",",0,0
179301,and,0,1
179302,RNA,1,1
179303,viral,1,1
179304,load,1,1
179305,was,0,0
179306,reduced,0,0
179307,(,0,0
179308,P,0,0
179309,?,0,0
179310,0.05,0,0
179311,),0,0
179312,.,0,0
179313,In,0,0
179314,exploratory,0,0
179315,linear,0,0
179316,models,0,0
179317,",",0,0
179318,change,0,0
179319,in,0,0
179320,25,1,0
179321,(,1,0
179322,OH,1,0
179323,),1,0
179324,D,1,1
179325,predicted,1,0
179326,RNA,1,0
179327,viral,1,1
179328,load,1,1
179329,at,1,0
179330,3,0,0
179331,and,0,0
179332,12,0,0
179333,months,0,0
179334,and,1,0
179335,CD4,1,1
179336,%,1,0
179337,at,1,0
179338,3,0,0
179339,months,0,0
179340,(,0,0
179341,P,0,0
179342,<,0,0
179343,0.05,0,0
179344,),0,0
179345,.,0,0
179346,CONCLUSIONS,0,0
179347,Daily,0,0
179348,7000,0,0
179349,IU,0,0
179350,vitD3,0,0
179351,for,0,0
179352,12,0,0
179353,months,0,0
179354,was,0,0
179355,safe,0,0
179356,in,0,0
179357,HIV-infected,0,0
179358,subjects,0,0
179359,and,0,0
179360,effective,0,1
179361,in,0,0
179362,increasing,1,0
179363,25,1,0
179364,(,1,0
179365,OH,1,0
179366,),1,0
179367,D.,1,0
179368,Supplementation,0,0
179369,improved,0,0
179370,some,1,0
179371,clinically,1,0
179372,important,1,0
179373,HIV,1,1
179374,immune,1,1
179375,markers,1,1
179376,in,1,0
179377,subjects,0,0
179378,on,0,0
179379,HAART,0,0
179380,.,0,0
179381,Adjunct,0,0
179382,therapy,0,0
179383,with,0,0
179384,high-dose,0,0
179385,",",0,0
179386,daily,0,0
179387,vitD3,0,0
179388,for,0,0
179389,HIV-infected,0,0
179390,subjects,0,0
179391,and,0,0
179392,for,0,0
179393,those,0,0
179394,on/off,0,0
179395,HAART,0,0
179396,requires,0,0
179397,further,0,0
179398,investigation,0,0
179399,.,0,0
179400,Evidence,0,1
179401,for,0,0
179402,diminished,0,1
179403,multisensory,1,0
179404,integration,1,1
179405,in,0,0
179406,autism,0,0
179407,spectrum,0,0
179408,disorders,0,0
179409,.,0,0
179410,Individuals,0,0
179411,with,0,0
179412,autism,0,0
179413,spectrum,0,0
179414,disorders,0,0
179415,(,0,0
179416,ASD,0,0
179417,),0,0
179418,exhibit,0,0
179419,alterations,0,0
179420,in,0,0
179421,sensory,0,1
179422,processing,0,1
179423,",",0,0
179424,including,0,0
179425,changes,0,1
179426,in,0,0
179427,the,0,0
179428,integration,0,0
179429,of,0,0
179430,information,0,0
179431,across,0,0
179432,the,0,0
179433,different,0,0
179434,sensory,0,0
179435,modalities,0,0
179436,.,0,0
179437,In,0,0
179438,the,0,0
179439,current,0,0
179440,study,0,0
179441,",",0,0
179442,we,0,0
179443,used,0,0
179444,the,0,0
179445,sound-induced,0,1
179446,flash,0,0
179447,illusion,0,0
179448,to,0,0
179449,assess,0,0
179450,multisensory,1,0
179451,integration,1,1
179452,in,0,0
179453,children,0,0
179454,with,0,0
179455,ASD,0,0
179456,and,0,1
179457,typically-developing,0,0
179458,(,0,1
179459,TD,0,0
179460,),0,0
179461,controls,0,0
179462,.,0,0
179463,Thirty-one,0,0
179464,children,0,0
179465,with,0,0
179466,ASD,0,0
179467,and,0,0
179468,31,0,0
179469,age,0,0
179470,and,0,0
179471,IQ,0,1
179472,matched,0,0
179473,TD,0,1
179474,children,0,0
179475,(,0,0
179476,average,0,1
179477,age,0,0
179478,=,0,0
179479,12,0,0
179480,years,0,0
179481,),0,0
179482,were,0,0
179483,presented,0,0
179484,with,0,0
179485,simple,0,0
179486,visual,0,1
179487,(,0,0
179488,i.e.,0,0
179489,",",0,0
179490,flash,0,1
179491,),0,1
179492,and,0,1
179493,auditory,0,1
179494,(,0,0
179495,i.e.,0,0
179496,",",0,0
179497,beep,0,0
179498,),0,1
179499,stimuli,0,1
179500,of,0,0
179501,varying,0,0
179502,number,0,1
179503,.,0,0
179504,In,0,0
179505,illusory,0,0
179506,conditions,0,0
179507,",",0,0
179508,a,0,0
179509,single,0,0
179510,flash,0,0
179511,was,0,0
179512,presented,0,0
179513,with,0,0
179514,2-4,0,0
179515,beeps,0,0
179516,.,0,0
179517,In,0,0
179518,TD,0,1
179519,children,0,0
179520,",",0,0
179521,these,0,0
179522,conditions,0,0
179523,generally,0,0
179524,result,0,0
179525,in,0,0
179526,the,0,0
179527,perception,1,1
179528,of,1,0
179529,multiple,1,0
179530,flashes,1,1
179531,",",1,0
179532,implying,1,0
179533,a,1,0
179534,perceptual,1,1
179535,fusion,1,0
179536,across,1,0
179537,vision,1,1
179538,and,1,0
179539,audition,1,1
179540,.,1,0
179541,In,1,0
179542,the,0,0
179543,present,0,0
179544,study,0,0
179545,",",0,0
179546,children,0,0
179547,with,0,0
179548,ASD,0,0
179549,were,0,0
179550,significantly,0,0
179551,less,0,0
179552,likely,0,0
179553,to,0,0
179554,perceive,1,0
179555,the,1,0
179556,illusion,1,0
179557,relative,1,0
179558,to,0,0
179559,TD,0,1
179560,controls,0,0
179561,",",0,0
179562,suggesting,0,0
179563,that,1,0
179564,multisensory,1,0
179565,integration,1,1
179566,and,1,0
179567,cross-modal,1,0
179568,binding,1,0
179569,may,1,0
179570,be,0,0
179571,weaker,0,0
179572,in,0,0
179573,some,0,0
179574,children,0,0
179575,with,0,0
179576,ASD,0,0
179577,.,0,0
179578,These,0,0
179579,results,0,0
179580,are,0,0
179581,discussed,0,0
179582,in,0,0
179583,the,0,0
179584,context,0,0
179585,of,0,0
179586,previous,0,0
179587,findings,0,0
179588,for,0,0
179589,multisensory,1,0
179590,integration,1,0
179591,in,1,0
179592,ASD,0,0
179593,and,0,0
179594,future,0,0
179595,directions,0,0
179596,for,0,0
179597,research,0,0
179598,.,0,0
179599,Examining,0,0
179600,the,0,0
179601,temperature,0,1
179602,of,0,0
179603,embryo,0,0
179604,culture,0,1
179605,in,0,0
179606,in,0,0
179607,vitro,0,0
179608,fertilization,0,0
179609,:,0,0
179610,a,0,0
179611,randomized,0,0
179612,controlled,0,0
179613,trial,0,0
179614,comparing,0,0
179615,traditional,0,0
179616,core,0,1
179617,temperature,0,1
179618,(,0,0
179619,37?C,0,0
179620,),0,0
179621,to,0,0
179622,a,0,0
179623,more,0,0
179624,physiologic,0,0
179625,",",0,0
179626,cooler,0,0
179627,temperature,0,1
179628,(,0,0
179629,36?C,0,0
179630,),0,0
179631,.,0,0
179632,OBJECTIVE,0,0
179633,To,0,0
179634,determine,0,0
179635,whether,0,0
179636,culture,0,0
179637,at,0,0
179638,a,0,0
179639,more,0,0
179640,physiologically,0,0
179641,cooler,0,0
179642,temperature,0,1
179643,",",0,0
179644,as,0,0
179645,suggested,0,0
179646,by,0,0
179647,limited,0,0
179648,human,0,0
179649,and,0,1
179650,animal,0,0
179651,data,0,0
179652,",",0,0
179653,would,0,0
179654,improve,0,0
179655,blastulation,0,0
179656,and,0,1
179657,pregnancy,0,1
179658,rates,0,1
179659,in,0,0
179660,human,0,0
179661,clinical,0,0
179662,IVF,0,0
179663,.,0,0
179664,DESIGN,0,0
179665,Paired,0,0
179666,randomized,0,0
179667,controlled,0,0
179668,trial,0,0
179669,.,0,0
179670,SETTING,0,0
179671,Academic,0,0
179672,.,0,0
179673,PATIENT,0,1
179674,(,0,0
179675,S,0,0
179676,),0,0
179677,Infertile,0,0
179678,couples,0,0
179679,(,0,0
179680,n=52,0,0
179681,),0,0
179682,with,0,0
179683,a,0,0
179684,female,0,0
179685,partner,0,0
179686,less,0,0
179687,than,0,0
179688,42,0,0
179689,years,0,0
179690,old,0,0
179691,with,0,0
179692,eight,0,0
179693,or,0,0
179694,more,0,0
179695,mature,0,0
179696,oocytes,0,0
179697,retrieved,0,0
179698,.,0,0
179699,INTERVENTION,0,0
179700,(,0,0
179701,S,0,0
179702,),0,0
179703,Mature,0,0
179704,oocytes,0,0
179705,obtained,0,0
179706,from,0,0
179707,a,0,0
179708,single,0,0
179709,cohort,0,0
179710,of,0,0
179711,oocytes,0,0
179712,were,0,0
179713,randomly,0,0
179714,divided,0,0
179715,into,0,0
179716,two,0,0
179717,groups,0,0
179718,;,0,0
179719,one,0,0
179720,was,0,0
179721,cultured,0,0
179722,at,0,0
179723,37?C,0,0
179724,and,0,0
179725,the,0,0
179726,other,0,0
179727,at,0,0
179728,36?C,0,0
179729,from,0,0
179730,the,0,0
179731,time,0,1
179732,of,0,0
179733,ICSI,0,0
179734,to,0,0
179735,the,0,0
179736,time,0,1
179737,of,0,0
179738,embryo,0,0
179739,transfer,0,1
179740,or,0,0
179741,vitrification,0,0
179742,.,0,0
179743,Paired,0,0
179744,embryo,0,0
179745,transfers,0,1
179746,were,0,0
179747,accomplished,0,0
179748,by,0,0
179749,transferring,0,0
179750,one,0,0
179751,euploid,0,0
179752,embryo,0,0
179753,from,0,0
179754,each,0,0
179755,group,0,0
179756,.,0,0
179757,DNA,0,1
179758,fingerprinting,0,0
179759,was,0,0
179760,used,0,0
179761,as,0,0
179762,needed,0,0
179763,to,0,0
179764,determine,0,0
179765,the,0,0
179766,outcome,0,0
179767,for,0,0
179768,each,0,0
179769,embryo,0,0
179770,.,0,0
179771,MAIN,0,0
179772,OUTCOME,0,0
179773,MEASURE,1,0
179774,(,1,0
179775,S,1,0
179776,),1,0
179777,Rate,1,0
179778,of,1,0
179779,development,1,1
179780,of,1,0
179781,expanded,1,0
179782,blastocysts,1,1
179783,suitable,1,0
179784,for,1,0
179785,transfer,1,1
179786,or,1,0
179787,vitrification,1,1
179788,(,1,0
179789,primary,1,0
179790,outcome,1,1
179791,),1,0
179792,",",1,0
179793,fertilization,1,1
179794,",",1,1
179795,aneuploidy,1,1
179796,",",1,1
179797,and,1,1
179798,sustained,1,1
179799,implantation,1,0
179800,.,1,1
179801,RESULT,1,0
179802,(,0,0
179803,S,0,0
179804,),0,0
179805,A,0,0
179806,total,0,1
179807,of,0,0
179808,805,0,0
179809,mature,1,0
179810,oocytes,1,0
179811,were,1,0
179812,cultured,0,0
179813,;,0,0
179814,399,0,0
179815,at,0,0
179816,36?C,0,0
179817,and,0,0
179818,406,0,0
179819,at,0,0
179820,37?C,0,0
179821,.,0,0
179822,Paired,0,0
179823,analysis,0,0
179824,demonstrated,0,0
179825,a,0,0
179826,higher,0,0
179827,rate,1,1
179828,of,1,1
179829,usable,1,0
179830,blastocyst,1,1
179831,formation,1,1
179832,per,1,0
179833,zygote,1,0
179834,at,1,0
179835,37?C,1,0
179836,(,0,0
179837,48.4,0,0
179838,%,0,0
179839,),0,0
179840,vs.,0,0
179841,at,0,0
179842,36?C,0,0
179843,(,0,0
179844,41.2,0,0
179845,%,0,0
179846,),0,0
179847,.,0,0
179848,Rates,1,0
179849,of,1,0
179850,fertilization,1,0
179851,",",1,0
179852,aneuploidy,1,1
179853,",",1,1
179854,and,1,1
179855,sustained,1,1
179856,implantation,1,0
179857,were,1,0
179858,equivalent,1,0
179859,.,0,0
179860,CONCLUSION,0,0
179861,(,0,0
179862,S,0,0
179863,),0,0
179864,IVF,0,1
179865,culture,0,0
179866,at,0,0
179867,36?C,0,0
179868,does,0,0
179869,not,0,0
179870,improve,0,0
179871,clinically,0,0
179872,relevant,0,0
179873,parameters,0,1
179874,of,0,0
179875,embryo,0,0
179876,development,0,1
179877,or,0,0
179878,sustained,0,1
179879,implantation,0,0
179880,rates,0,1
179881,.,0,0
179882,CLINICAL,0,0
179883,TRIAL,0,0
179884,REGISTRATION,0,0
179885,NUMBER,0,0
179886,NCT01506089,0,0
179887,.,0,0
179888,Effects,0,0
179889,of,0,0
179890,a,0,0
179891,music,0,0
179892,therapy,0,0
179893,group,0,0
179894,intervention,0,0
179895,on,0,0
179896,enhancing,0,0
179897,social,1,1
179898,skills,1,1
179899,in,0,0
179900,children,0,0
179901,with,0,0
179902,autism,0,0
179903,.,0,0
179904,BACKGROUND,0,0
179905,Research,0,0
179906,indicates,0,0
179907,that,0,0
179908,music,0,0
179909,therapy,0,0
179910,can,0,0
179911,improve,0,0
179912,social,0,1
179913,behaviors,0,1
179914,and,0,0
179915,joint,0,1
179916,attention,0,1
179917,in,0,0
179918,children,0,0
179919,with,0,0
179920,Autism,0,1
179921,Spectrum,0,0
179922,Disorder,0,0
179923,(,0,0
179924,ASD,0,0
179925,),0,0
179926,;,0,0
179927,however,0,0
179928,",",0,0
179929,more,0,0
179930,research,0,0
179931,on,0,0
179932,the,0,0
179933,use,0,0
179934,of,0,0
179935,music,0,0
179936,therapy,0,0
179937,interventions,0,0
179938,for,0,0
179939,social,1,0
179940,skills,1,1
179941,is,0,0
179942,needed,0,0
179943,to,0,0
179944,determine,0,0
179945,the,0,0
179946,impact,0,0
179947,of,0,0
179948,group,0,0
179949,music,0,0
179950,therapy,0,0
179951,.,0,0
179952,OBJECTIVE,0,0
179953,To,0,0
179954,examine,0,0
179955,the,0,0
179956,effects,0,0
179957,of,0,0
179958,a,0,0
179959,music,0,0
179960,therapy,0,0
179961,group,0,0
179962,intervention,0,0
179963,on,0,0
179964,eye,1,1
179965,gaze,1,0
179966,",",1,0
179967,joint,1,1
179968,attention,1,1
179969,",",1,0
179970,and,1,1
179971,communication,1,1
179972,in,0,0
179973,children,0,0
179974,with,0,0
179975,ASD,0,0
179976,.,0,0
179977,METHOD,0,0
179978,Seventeen,0,1
179979,children,0,0
179980,",",0,0
179981,ages,0,0
179982,6,0,0
179983,to,0,0
179984,9,0,0
179985,",",0,0
179986,with,0,0
179987,a,0,0
179988,diagnosis,0,0
179989,of,0,0
179990,ASD,0,0
179991,were,0,0
179992,randomly,0,0
179993,assigned,0,0
179994,to,0,0
179995,the,0,0
179996,music,0,0
179997,therapy,0,0
179998,group,0,0
179999,(,0,0
180000,MTG,0,1
180001,),0,0
180002,or,0,0
180003,the,0,0
180004,no-music,0,0
180005,social,0,1
180006,skills,0,1
180007,group,0,0
180008,(,0,0
180009,SSG,0,1
180010,),0,0
180011,.,0,0
180012,Children,0,0
180013,participated,0,0
180014,in,0,0
180015,ten,0,0
180016,50-minute,0,0
180017,group,0,0
180018,sessions,0,0
180019,over,0,0
180020,a,0,0
180021,period,0,0
180022,of,0,0
180023,5,0,0
180024,weeks,0,0
180025,.,0,0
180026,All,0,0
180027,group,0,0
180028,sessions,0,0
180029,were,0,0
180030,designed,0,0
180031,to,0,0
180032,target,0,0
180033,social,0,1
180034,skills,0,1
180035,.,0,0
180036,The,0,0
180037,Social,1,1
180038,Responsiveness,1,1
180039,Scale,1,1
180040,(,1,0
180041,SRS,1,0
180042,),1,0
180043,",",1,0
180044,the,1,0
180045,Autism,1,1
180046,Treatment,1,0
180047,Evaluation,1,0
180048,Checklist,1,1
180049,(,1,0
180050,ATEC,1,0
180051,),1,1
180052,",",1,0
180053,and,1,1
180054,video,1,0
180055,analysis,1,0
180056,of,1,0
180057,sessions,1,0
180058,were,0,0
180059,used,0,0
180060,to,0,0
180061,evaluate,0,0
180062,changes,0,1
180063,in,0,0
180064,social,0,1
180065,behavior,0,1
180066,.,0,0
180067,RESULTS,0,0
180068,There,0,0
180069,were,0,0
180070,significant,0,0
180071,between-group,0,0
180072,differences,0,0
180073,for,0,0
180074,joint,1,1
180075,attention,1,0
180076,with,1,0
180077,peers,1,0
180078,and,1,1
180079,eye,1,1
180080,gaze,1,1
180081,towards,1,0
180082,persons,1,0
180083,",",0,0
180084,with,0,0
180085,participants,0,0
180086,in,0,0
180087,the,0,0
180088,MTG,0,0
180089,demonstrating,0,0
180090,greater,0,0
180091,gains,0,1
180092,.,0,1
180093,There,0,0
180094,were,0,0
180095,no,0,0
180096,significant,0,0
180097,between-group,0,0
180098,differences,0,0
180099,for,0,0
180100,initiation,1,0
180101,of,1,0
180102,communication,1,1
180103,",",1,0
180104,response,1,1
180105,to,1,0
180106,communication,1,1
180107,",",1,0
180108,or,1,0
180109,social,1,1
180110,withdraw/behaviors,1,1
180111,.,1,0
180112,There,0,0
180113,was,0,0
180114,a,0,0
180115,significant,0,0
180116,interaction,0,1
180117,between,0,0
180118,time,0,1
180119,and,0,1
180120,group,0,0
180121,for,0,0
180122,SRS,1,0
180123,scores,1,1
180124,",",0,0
180125,with,0,0
180126,improvements,0,1
180127,for,0,0
180128,the,0,0
180129,MTG,0,0
180130,but,0,0
180131,not,0,0
180132,the,0,0
180133,SSG,0,0
180134,.,0,0
180135,Scores,1,0
180136,on,1,0
180137,the,1,0
180138,ATEC,1,0
180139,did,0,0
180140,not,0,0
180141,differ,0,0
180142,over,0,0
180143,time,0,1
180144,between,0,0
180145,the,0,0
180146,MTG,0,0
180147,and,0,0
180148,SSG,0,1
180149,.,0,0
180150,CONCLUSIONS,0,0
180151,The,0,0
180152,results,0,0
180153,of,0,0
180154,this,0,0
180155,study,0,0
180156,support,0,0
180157,further,0,0
180158,research,0,0
180159,on,0,0
180160,the,0,0
180161,use,0,0
180162,of,0,0
180163,music,0,0
180164,therapy,0,0
180165,group,0,0
180166,interventions,0,0
180167,for,0,0
180168,social,1,1
180169,skills,1,1
180170,in,0,0
180171,children,0,0
180172,with,0,0
180173,ASD,0,0
180174,.,0,0
180175,Statistical,0,0
180176,results,0,0
180177,demonstrate,0,0
180178,initial,0,0
180179,support,0,0
180180,for,0,0
180181,the,0,0
180182,use,0,0
180183,of,0,0
180184,music,0,0
180185,therapy,0,0
180186,social,0,1
180187,groups,0,0
180188,to,0,0
180189,develop,0,0
180190,joint,1,1
180191,attention,1,0
180192,.,1,0
180193,Prior,0,1
180194,experience,0,0
180195,with,0,0
180196,a,0,0
180197,pain,0,1
180198,stimulus,0,1
180199,as,0,0
180200,a,0,0
180201,predictor,0,0
180202,of,0,0
180203,placebo,0,0
180204,analgesia,1,1
180205,.,1,0
180206,Placebo,0,0
180207,effects,0,0
180208,are,0,0
180209,important,0,0
180210,in,0,0
180211,pain,1,1
180212,reduction,1,1
180213,",",0,0
180214,but,0,0
180215,the,0,0
180216,effects,0,0
180217,are,0,0
180218,inconsistent,0,0
180219,.,0,0
180220,Prior,0,1
180221,experience,0,0
180222,with,0,0
180223,a,0,0
180224,pain,0,1
180225,stimulus,0,0
180226,may,0,0
180227,moderate,0,0
180228,placebo,0,0
180229,analgesia,1,0
180230,.,1,0
180231,The,0,0
180232,current,0,0
180233,study,0,0
180234,tests,0,0
180235,the,0,0
180236,effect,0,0
180237,of,0,0
180238,prior,0,0
180239,experience,0,0
180240,with,0,0
180241,a,0,0
180242,pain,0,1
180243,stimulus,0,1
180244,on,0,0
180245,placebo,1,0
180246,analgesia,1,1
180247,during,0,0
180248,a,0,0
180249,laboratory,0,0
180250,pain,0,1
180251,task,0,0
180252,.,0,0
180253,Healthy,0,0
180254,normotensive,0,0
180255,undergraduates,0,0
180256,(,0,0
180257,66,0,0
180258,women,0,0
180259,",",0,0
180260,68,0,0
180261,men,0,0
180262,),0,0
180263,who,0,0
180264,either,0,0
180265,did,0,0
180266,or,0,0
180267,did,0,0
180268,not,0,0
180269,report,0,0
180270,prior,0,0
180271,experience,0,0
180272,with,0,0
180273,pain,1,1
180274,from,0,0
180275,submerging,0,0
180276,a,0,0
180277,limb,0,1
180278,in,0,0
180279,cold,0,1
180280,water,0,1
180281,were,0,0
180282,enrolled,0,0
180283,.,0,0
180284,In,0,0
180285,the,0,0
180286,laboratory,0,0
180287,",",0,0
180288,an,0,0
180289,experimenter,0,0
180290,applied,0,0
180291,an,0,0
180292,inert,0,0
180293,",",0,0
180294,medicinal-smelling,0,1
180295,cream,0,0
180296,to,0,0
180297,participants,0,0
180298,',0,0
180299,non-dominant,0,0
180300,hand,0,0
180301,.,0,0
180302,Participants,0,0
180303,randomized,0,0
180304,to,0,0
180305,the,0,0
180306,no-expectation,0,0
180307,group,0,0
180308,were,0,0
180309,told,0,0
180310,that,0,0
180311,the,0,0
180312,cream,0,0
180313,was,0,0
180314,a,0,0
180315,hand,0,0
180316,cleanser,0,0
180317,.,0,0
180318,Participants,0,0
180319,randomized,0,0
180320,to,0,0
180321,the,0,0
180322,placebo,0,0
180323,expectation,0,1
180324,group,0,0
180325,were,0,0
180326,told,0,0
180327,that,0,0
180328,the,0,0
180329,cream,0,0
180330,would,0,0
180331,reduce,0,0
180332,the,0,0
180333,pain,1,1
180334,associated,0,0
180335,with,0,0
180336,the,0,0
180337,cold,0,0
180338,pressor,0,1
180339,task,0,0
180340,.,0,0
180341,Participants,0,0
180342,then,0,0
180343,completed,0,0
180344,the,0,0
180345,cold,0,0
180346,pressor,0,1
180347,task,0,1
180348,and,0,1
180349,reported,0,0
180350,their,0,0
180351,pain,1,1
180352,on,0,0
180353,the,0,0
180354,short,0,0
180355,form,0,0
180356,of,0,0
180357,the,0,0
180358,McGill,1,0
180359,Pain,1,1
180360,Questionnaire,1,1
180361,.,1,0
180362,Analysis,0,0
180363,of,0,0
180364,variance,0,0
180365,revealed,0,0
180366,a,0,0
180367,main,0,0
180368,effect,0,0
180369,of,0,0
180370,expectation,0,0
180371,(,0,0
180372,p,0,0
180373,<,0,0
180374,.05,0,0
180375,),0,0
180376,",",0,0
180377,such,0,0
180378,that,0,0
180379,participants,0,0
180380,in,0,0
180381,the,0,0
180382,placebo,0,0
180383,expectation,0,1
180384,group,0,0
180385,reported,0,0
180386,less,1,0
180387,pain,1,1
180388,.,1,0
180389,An,0,0
180390,interaction,0,1
180391,was,0,0
180392,also,0,0
180393,found,0,0
180394,between,0,0
180395,expectation,0,0
180396,and,0,0
180397,prior,0,1
180398,experience,0,0
180399,(,0,0
180400,p,0,0
180401,<,0,0
180402,.05,0,0
180403,),0,0
180404,",",0,0
180405,such,0,0
180406,that,0,0
180407,participants,0,0
180408,with,0,0
180409,prior,0,0
180410,experience,0,0
180411,with,0,0
180412,pain,1,1
180413,from,1,0
180414,cold,0,1
180415,water,0,1
180416,immersion,0,0
180417,showed,0,0
180418,no,0,0
180419,difference,1,0
180420,in,1,0
180421,pain,1,1
180422,reports,1,0
180423,between,1,0
180424,expectation,0,0
180425,groups,0,0
180426,.,0,0
180427,In,0,0
180428,a,0,0
180429,pain,0,1
180430,context,0,0
180431,",",0,0
180432,prior,0,0
180433,experience,0,0
180434,with,0,0
180435,the,0,0
180436,pain,0,1
180437,stimulus,0,0
180438,may,0,0
180439,prevent,0,0
180440,a,0,0
180441,placebo,0,0
180442,expectation,0,0
180443,from,0,0
180444,reducing,0,0
180445,the,0,0
180446,experience,1,0
180447,of,1,0
180448,pain,1,1
180449,.,1,0
180450,[,0,0
180451,Effect,0,0
180452,of,0,0
180453,zero-balanced,0,0
180454,ultrafiltration,0,0
180455,and,0,0
180456,modified,0,0
180457,ultrafiltration,0,0
180458,on,0,0
180459,pulmonary,0,1
180460,function,0,1
180461,after,0,0
180462,cardiac,0,1
180463,surgery,0,0
180464,in,0,0
180465,infants,0,0
180466,],0,0
180467,.,0,0
180468,OBJECTIVE,0,0
180469,To,0,0
180470,determine,0,0
180471,the,0,0
180472,protective,0,0
180473,effect,0,0
180474,of,0,0
180475,zero-balanced,0,0
180476,ultrafiltration,0,0
180477,and,0,0
180478,modified,0,0
180479,ultrafiltration,0,0
180480,on,0,0
180481,infants,0,0
180482,',0,0
180483,pulmonary,0,1
180484,function,0,1
180485,after,0,0
180486,cardiac,0,1
180487,surgery,0,0
180488,.,0,0
180489,METHODS,0,0
180490,Sixty,0,0
180491,infants,0,0
180492,with,0,0
180493,congenital,0,0
180494,heart,0,1
180495,diseases,0,0
180496,were,0,0
180497,randomly,0,0
180498,divided,0,0
180499,into,0,0
180500,3,0,0
180501,groups,0,0
180502,:,0,0
180503,a,0,0
180504,zero-balanced,0,0
180505,ultrafiltration,0,1
180506,group,0,0
180507,(,0,0
180508,Z,0,1
180509,group,0,0
180510,),0,0
180511,",",0,0
180512,a,0,0
180513,modified,0,0
180514,ultrafiltration,0,1
180515,group,0,0
180516,(,0,0
180517,M,0,1
180518,group,0,0
180519,),0,0
180520,and,0,0
180521,a,0,0
180522,zero-balanced,0,0
180523,ultrafiltration,0,0
180524,with,0,0
180525,modified,0,0
180526,ultrafiltration,0,1
180527,group,0,0
180528,(,0,0
180529,Z+M,0,1
180530,group,0,0
180531,),0,0
180532,.,0,0
180533,Oxygenation,1,1
180534,index,1,1
180535,(,1,0
180536,OI,1,1
180537,),1,0
180538,",",1,0
180539,difference,1,0
180540,of,1,1
180541,alveoli-arterial,1,1
180542,oxygen,1,1
180543,pressure,1,1
180544,(,1,0
180545,P,1,0
180546,(,1,0
180547,A-?,1,0
180548,),1,0
180549,O2,1,0
180550,),1,0
180551,",",1,0
180552,static,1,1
180553,lung,1,1
180554,compliance,1,1
180555,(,1,0
180556,Cstat,1,0
180557,),1,1
180558,",",1,0
180559,and,1,0
180560,airway,1,1
180561,resistance,1,1
180562,(,1,0
180563,Raw,1,0
180564,),1,0
180565,were,1,0
180566,measured,1,0
180567,before,0,0
180568,caridopulmonary,0,0
180569,bypass,0,0
180570,(,0,0
180571,CPB,0,1
180572,",",0,0
180573,T1,0,1
180574,),0,0
180575,",",0,0
180576,20,0,0
180577,minutes,0,0
180578,after,0,0
180579,the,0,0
180580,CPB,0,0
180581,(,0,0
180582,T2,0,0
180583,),0,0
180584,",",0,0
180585,2,0,0
180586,h,0,0
180587,after,0,0
180588,the,0,0
180589,operation,0,0
180590,(,0,0
180591,T3,0,0
180592,),0,0
180593,",",0,0
180594,6,0,0
180595,h,0,0
180596,after,0,0
180597,the,0,0
180598,operation,0,0
180599,(,0,0
180600,T4,0,0
180601,),0,0
180602,and,0,0
180603,12,0,0
180604,h,0,0
180605,after,0,0
180606,the,0,0
180607,operation,0,0
180608,(,0,0
180609,T5,0,0
180610,),0,0
180611,.,0,0
180612,The,1,0
180613,time,1,1
180614,of,1,0
180615,mechanical,1,0
180616,ventilation,1,0
180617,was,0,0
180618,also,0,0
180619,monitored,0,0
180620,.,0,0
180621,RESULTS,0,0
180622,After,0,0
180623,the,1,0
180624,CPB,1,0
180625,",",1,0
180626,OI,1,1
180627,and,1,1
180628,Cstat,1,0
180629,in,0,0
180630,all,0,0
180631,groups,0,0
180632,decreased,0,0
180633,significantly,0,0
180634,",",0,0
180635,while,1,0
180636,Raw,1,0
180637,and,1,1
180638,P,1,0
180639,(,1,0
180640,A-?,1,0
180641,),1,0
180642,O2,1,0
180643,increased,1,0
180644,significantly,0,0
180645,.,0,0
180646,At,0,0
180647,T3,1,0
180648,",",1,0
180649,T4,1,0
180650,and,1,1
180651,T5,1,0
180652,",",1,1
180653,OI,1,1
180654,and,1,1
180655,Cstat,1,0
180656,in,1,0
180657,the,0,0
180658,Z+M,0,1
180659,group,0,0
180660,were,0,0
180661,significantly,0,0
180662,higher,0,0
180663,than,0,0
180664,those,0,0
180665,in,0,0
180666,the,0,0
180667,Z,0,0
180668,group,0,0
180669,and,0,0
180670,the,0,0
180671,M,0,0
180672,group,0,0
180673,(,0,0
180674,P,0,0
180675,<,1,0
180676,0.05,1,0
180677,),1,0
180678,",",1,0
180679,Raw,1,1
180680,and,1,1
180681,P,1,0
180682,(,1,0
180683,A-?,1,0
180684,),1,0
180685,O2,1,0
180686,in,1,0
180687,the,0,0
180688,Z+M,0,1
180689,group,0,0
180690,were,0,0
180691,significantly,0,0
180692,lower,0,0
180693,than,0,0
180694,those,0,0
180695,in,0,0
180696,the,0,0
180697,Z,0,0
180698,group,0,0
180699,and,0,0
180700,the,0,0
180701,M,0,0
180702,group,0,0
180703,(,0,0
180704,P,0,0
180705,<,0,0
180706,0.05,0,0
180707,),0,0
180708,.,0,0
180709,The,0,0
180710,ventilation,1,0
180711,time,1,1
180712,in,1,0
180713,the,0,0
180714,Z+M,0,1
180715,group,0,0
180716,was,0,0
180717,significantly,0,0
180718,shorter,0,0
180719,than,0,0
180720,that,0,0
180721,in,0,0
180722,the,0,0
180723,Z,0,0
180724,group,0,0
180725,and,0,0
180726,the,0,0
180727,M,0,0
180728,group,0,0
180729,(,0,0
180730,P,0,0
180731,<,0,0
180732,0.05,0,0
180733,),0,0
180734,.,0,0
180735,CONCLUSION,0,0
180736,Zero-balanced,0,0
180737,ultrafiltration,0,1
180738,and,0,0
180739,modified,0,0
180740,ultrafiltration,0,0
180741,can,0,0
180742,effectively,0,0
180743,promote,0,0
180744,the,0,0
180745,pulmonary,0,0
180746,function,0,1
180747,after,0,0
180748,cardiac,0,1
180749,surgery,0,0
180750,in,0,0
180751,infants,0,0
180752,.,0,0
180753,Safety,1,1
180754,and,1,0
180755,effectiveness,1,1
180756,of,0,1
180757,bevacizumab-containing,0,0
180758,treatment,0,0
180759,for,0,0
180760,non-small-cell,0,0
180761,lung,0,0
180762,cancer,0,0
180763,:,0,0
180764,final,0,1
180765,results,0,0
180766,of,0,0
180767,the,0,0
180768,ARIES,0,0
180769,observational,0,0
180770,cohort,0,0
180771,study,0,0
180772,.,0,0
180773,INTRODUCTION,0,1
180774,Bevacizumab,0,0
180775,",",0,0
180776,a,0,0
180777,recombinant,0,0
180778,humanized,0,0
180779,monoclonal,0,0
180780,antibody,0,0
180781,against,0,0
180782,vascular,0,1
180783,endothelial,0,1
180784,growth,0,1
180785,factor,0,1
180786,",",0,0
180787,was,0,0
180788,approved,0,0
180789,by,0,0
180790,the,0,0
180791,US,0,1
180792,Food,0,1
180793,and,0,0
180794,Drug,0,0
180795,Administration,0,0
180796,for,0,0
180797,the,0,0
180798,treatment,0,0
180799,of,0,0
180800,advanced,0,0
180801,non-small-cell,0,0
180802,lung,0,1
180803,cancer,0,0
180804,(,0,0
180805,NSCLC,0,1
180806,),0,0
180807,in,0,0
180808,combination,0,0
180809,with,0,0
180810,carboplatin,0,0
180811,and,0,0
180812,paclitaxel,0,0
180813,.,0,1
180814,ARIES,0,1
180815,(,0,0
180816,Avastin,0,0
180817,Regimens,0,0
180818,:,0,0
180819,Investigation,0,0
180820,of,0,0
180821,Effectiveness,0,1
180822,and,0,1
180823,Safety,0,1
180824,),0,0
180825,",",0,0
180826,a,0,0
180827,prospective,0,0
180828,observational,0,0
180829,cohort,0,0
180830,study,0,0
180831,",",0,0
180832,evaluated,0,0
180833,outcomes,0,0
180834,in,0,0
180835,a,0,0
180836,large,0,0
180837,",",0,0
180838,community-based,0,0
180839,population,0,0
180840,of,0,0
180841,patients,0,0
180842,with,0,0
180843,first-line,0,0
180844,NSCLC,0,1
180845,.,0,0
180846,METHODS,0,0
180847,From,0,0
180848,2006,0,0
180849,to,0,0
180850,2009,0,0
180851,",",0,0
180852,ARIES,0,0
180853,enrolled,0,0
180854,patients,0,0
180855,with,0,0
180856,locally,0,0
180857,advanced,0,0
180858,or,0,0
180859,metastatic,0,0
180860,NSCLC,0,1
180861,who,0,0
180862,were,0,0
180863,eligible,0,0
180864,for,0,0
180865,bevacizumab,0,0
180866,",",0,0
180867,excluding,0,0
180868,those,0,0
180869,with,0,0
180870,predominantly,0,0
180871,squamous,0,0
180872,histology,0,1
180873,.,0,0
180874,Patients,0,0
180875,were,0,0
180876,required,0,0
180877,to,0,0
180878,provide,0,0
180879,informed,0,0
180880,consent,0,0
180881,and,0,0
180882,to,0,0
180883,have,0,0
180884,initiated,0,0
180885,bevacizumab,0,0
180886,with,0,0
180887,chemotherapy,0,0
180888,within,0,0
180889,4,0,0
180890,months,0,0
180891,before,0,0
180892,enrollment,0,0
180893,.,0,0
180894,There,0,0
180895,were,0,0
180896,no,0,0
180897,protocol-defined,0,0
180898,treatments,0,0
180899,or,0,0
180900,assessments,0,0
180901,.,0,0
180902,The,0,0
180903,dosing,0,0
180904,of,0,0
180905,bevacizumab,0,0
180906,and,0,1
180907,chemotherapy,0,0
180908,",",0,0
180909,and,0,0
180910,the,0,0
180911,choice,0,0
180912,of,0,0
180913,chemotherapy,0,0
180914,regimen,0,0
180915,",",0,0
180916,was,0,0
180917,at,0,0
180918,the,0,0
180919,discretion,0,0
180920,of,0,0
180921,the,0,0
180922,treating,0,0
180923,physician,0,0
180924,.,0,0
180925,RESULTS,0,0
180926,ARIES,0,0
180927,enrolled,0,0
180928,1967,0,0
180929,patients,0,0
180930,with,0,0
180931,first-line,0,0
180932,NSCLC,0,1
180933,.,0,0
180934,At,0,0
180935,study,0,0
180936,closure,0,0
180937,",",0,0
180938,median,1,1
180939,follow-up,1,0
180940,was,0,0
180941,12.5,0,0
180942,months,0,0
180943,(,0,0
180944,range,0,0
180945,",",0,1
180946,0.2-65.5,0,0
180947,),0,0
180948,.,0,0
180949,Median,0,1
180950,age,0,0
180951,was,0,0
180952,65,0,0
180953,years,0,0
180954,(,0,0
180955,range,0,0
180956,",",0,1
180957,31-93,0,0
180958,),0,0
180959,",",0,0
180960,and,0,0
180961,252,0,0
180962,patients,0,0
180963,(,0,0
180964,12.8,0,0
180965,%,0,0
180966,),0,0
180967,identified,0,0
180968,as,0,0
180969,never,0,0
180970,smokers,0,0
180971,.,0,0
180972,Median,1,1
180973,progression-free,1,1
180974,survival,1,1
180975,was,0,0
180976,6.6,0,0
180977,months,0,0
180978,(,0,0
180979,95,0,0
180980,%,0,0
180981,confidence,0,0
180982,interval,0,0
180983,",",0,0
180984,6.3-6.9,0,0
180985,),0,0
180986,",",0,0
180987,and,0,1
180988,median,1,1
180989,overall,1,1
180990,survival,1,1
180991,was,0,0
180992,13.0,0,0
180993,months,0,0
180994,(,0,0
180995,95,0,0
180996,%,0,0
180997,confidence,0,0
180998,interval,0,0
180999,",",0,0
181000,12.2-13.8,0,0
181001,),0,0
181002,with,0,0
181003,first-line,0,0
181004,bevacizumab,0,0
181005,plus,0,0
181006,chemotherapy,0,0
181007,.,0,0
181008,Incidences,1,1
181009,of,1,0
181010,bevacizumab-associated,1,0
181011,adverse,1,1
181012,events,1,1
181013,(,0,0
181014,19.7,0,0
181015,%,0,0
181016,overall,0,1
181017,),0,0
181018,were,0,0
181019,consistent,0,0
181020,with,0,0
181021,those,0,0
181022,in,0,0
181023,randomized,0,0
181024,controlled,0,0
181025,trials,0,0
181026,of,0,0
181027,bevacizumab,0,0
181028,in,0,0
181029,NSCLC,0,1
181030,.,0,0
181031,CONCLUSION,0,0
181032,Results,0,0
181033,from,0,0
181034,ARIES,0,0
181035,demonstrate,0,0
181036,similar,0,0
181037,outcomes,0,0
181038,to,0,0
181039,randomized,0,0
181040,controlled,0,0
181041,trials,0,0
181042,of,0,0
181043,bevacizumab,0,0
181044,when,0,0
181045,added,0,0
181046,to,0,0
181047,standard,0,0
181048,chemotherapy,0,0
181049,in,0,0
181050,a,0,0
181051,real-world,0,0
181052,patient,0,0
181053,population,0,0
181054,with,0,0
181055,advanced,0,0
181056,NSCLC,0,0
181057,.,0,0
181058,A,0,0
181059,randomized,0,0
181060,trial,0,0
181061,of,0,0
181062,prophylactic,0,0
181063,palifermin,0,0
181064,on,0,0
181065,gastrointestinal,0,1
181066,toxicity,0,1
181067,after,0,0
181068,intensive,0,0
181069,induction,0,1
181070,therapy,0,0
181071,for,0,0
181072,acute,0,0
181073,myeloid,0,0
181074,leukaemia,0,0
181075,.,0,0
181076,Gastrointestinal,0,1
181077,toxicity,0,1
181078,",",0,0
181079,including,0,0
181080,oral,0,0
181081,mucositis,0,1
181082,",",0,0
181083,is,0,0
181084,a,0,0
181085,frequent,0,0
181086,complication,0,1
181087,of,0,0
181088,intensive,0,0
181089,combination,0,0
181090,chemotherapy,0,0
181091,for,0,0
181092,acute,0,0
181093,myeloid,0,0
181094,leukaemia,0,1
181095,(,0,0
181096,AML,0,0
181097,),0,0
181098,and,0,0
181099,contributes,0,0
181100,substantially,0,0
181101,to,0,0
181102,treatment-related,0,1
181103,mortality,0,1
181104,.,0,0
181105,We,0,0
181106,conducted,0,0
181107,a,0,0
181108,placebo-controlled,0,0
181109,randomized,0,0
181110,trial,0,0
181111,to,0,0
181112,evaluate,0,0
181113,the,0,0
181114,efficacy,0,1
181115,of,0,0
181116,palifermin,0,0
181117,(,0,0
181118,keratinocyte,0,1
181119,growth,0,1
181120,factor,0,1
181121,),0,0
181122,",",0,0
181123,given,0,0
181124,at,0,0
181125,60,0,0
181126,?g/kg,0,0
181127,per,0,0
181128,daily,0,0
181129,IV,0,0
181130,for,0,0
181131,3,0,0
181132,d,0,0
181133,before,0,0
181134,and,0,0
181135,after,0,0
181136,chemotherapy,0,0
181137,",",0,0
181138,for,0,0
181139,mucosal,0,1
181140,protection,0,1
181141,in,0,0
181142,adult,0,0
181143,patients,0,0
181144,with,0,0
181145,previously,0,0
181146,untreated,0,0
181147,AML,0,0
181148,receiving,0,0
181149,induction,0,1
181150,therapy,0,0
181151,with,0,0
181152,idarubicin,0,0
181153,",",0,0
181154,high-dose,0,0
181155,cytarabine,0,0
181156,and,0,0
181157,etoposide,0,0
181158,.,0,0
181159,Among,0,0
181160,155,0,0
181161,randomized,0,0
181162,patients,0,0
181163,",",0,0
181164,there,0,0
181165,was,0,0
181166,no,0,0
181167,statistically,0,0
181168,significant,0,0
181169,difference,0,0
181170,in,0,0
181171,the,0,0
181172,rate,1,1
181173,of,1,0
181174,grade,1,0
181175,3,1,0
181176,and,1,0
181177,4,1,0
181178,oral,1,0
181179,mucositis,1,1
181180,(,1,0
181181,primary,1,0
181182,study,0,0
181183,endpoint,0,1
181184,),0,0
181185,between,0,0
181186,the,0,0
181187,two,0,0
181188,treatment,0,0
181189,arms,0,0
181190,(,0,0
181191,three,0,0
181192,in,0,0
181193,palifermin,0,0
181194,arm,0,0
181195,(,0,0
181196,4,0,0
181197,%,0,0
181198,),0,0
181199,",",0,0
181200,8,0,0
181201,in,0,0
181202,placebo,0,0
181203,arm,0,0
181204,(,0,0
181205,10,0,0
181206,%,0,0
181207,;,0,0
181208,P,0,0
181209,=,0,0
181210,0?21,0,0
181211,),0,0
181212,;,0,0
181213,however,0,0
181214,",",0,0
181215,when,0,0
181216,considering,1,0
181217,the,1,0
181218,severity,1,1
181219,of,1,0
181220,oral,1,0
181221,mucositis,1,1
181222,(,1,0
181223,World,1,0
181224,Health,0,1
181225,Organization,0,1
181226,grade,0,1
181227,0-4,0,0
181228,),0,0
181229,",",0,0
181230,there,0,0
181231,was,0,0
181232,evidence,0,0
181233,of,0,0
181234,reduced,1,0
181235,rates,1,1
181236,of,1,0
181237,higher,1,0
181238,grades,1,1
181239,of,1,1
181240,oral,1,0
181241,mucositis,1,1
181242,in,1,0
181243,the,1,0
181244,palifermin,0,0
181245,arm,0,0
181246,(,0,0
181247,P,0,0
181248,=,0,0
181249,0?0007,0,0
181250,",",0,0
181251,test,0,0
181252,for,0,0
181253,trend,0,0
181254,),0,0
181255,.,0,0
181256,There,0,0
181257,was,0,0
181258,a,0,0
181259,statistically,0,0
181260,significantly,0,0
181261,lower,0,0
181262,rate,1,1
181263,of,1,0
181264,grades,1,0
181265,3,1,0
181266,and,1,0
181267,4,1,0
181268,gastrointestinal,1,0
181269,adverse,1,1
181270,events,1,1
181271,in,1,0
181272,the,0,0
181273,palifermin,0,0
181274,arm,0,0
181275,(,0,0
181276,21,0,0
181277,%,0,0
181278,vs.,0,0
181279,44,0,0
181280,%,0,0
181281,in,0,0
181282,placebo,0,0
181283,arm,0,0
181284,;,0,0
181285,P,0,0
181286,=,0,0
181287,0?003,0,0
181288,),0,0
181289,",",0,0
181290,mainly,0,0
181291,due,0,0
181292,to,0,0
181293,a,0,0
181294,reduction,0,0
181295,in,0,0
181296,severe,1,1
181297,diarrhoea,1,1
181298,(,1,0
181299,8,0,0
181300,%,0,0
181301,palifermin,0,0
181302,",",0,0
181303,26,0,0
181304,%,0,0
181305,placebo,0,0
181306,;,0,0
181307,P,0,0
181308,=,0,0
181309,0?01,0,0
181310,),0,0
181311,.,0,0
181312,Palifermin,0,0
181313,has,0,0
181314,activity,0,1
181315,as,0,0
181316,a,0,0
181317,mucosal,0,1
181318,protectant,0,0
181319,in,0,0
181320,AML,0,0
181321,patients,0,0
181322,receiving,0,0
181323,intensive,0,0
181324,chemotherapy,0,0
181325,.,0,0
181326,This,0,0
181327,trial,0,0
181328,is,0,0
181329,registered,0,0
181330,at,0,0
181331,ACTRN012605000095662,0,0
181332,.,0,0
181333,Tofacitinib,0,0
181334,with,0,0
181335,methotrexate,0,0
181336,in,0,0
181337,third-line,0,0
181338,treatment,0,0
181339,of,0,0
181340,patients,0,0
181341,with,0,0
181342,active,0,0
181343,rheumatoid,0,0
181344,arthritis,0,0
181345,:,0,0
181346,patient-reported,0,1
181347,outcomes,0,0
181348,from,0,0
181349,a,0,0
181350,phase,0,0
181351,III,0,0
181352,trial,0,0
181353,.,0,0
181354,OBJECTIVE,0,0
181355,To,0,0
181356,assess,0,0
181357,patient-reported,0,1
181358,outcomes,0,1
181359,(,0,0
181360,PROs,0,1
181361,),0,0
181362,for,0,0
181363,tofacitinib,0,0
181364,",",0,0
181365,an,0,0
181366,oral,0,0
181367,JAK,0,1
181368,inhibitor,0,0
181369,for,0,0
181370,the,0,0
181371,treatment,0,0
181372,of,0,0
181373,rheumatoid,0,1
181374,arthritis,0,0
181375,(,0,0
181376,RA,0,1
181377,),0,0
181378,",",0,0
181379,in,0,0
181380,a,0,0
181381,6-month,0,0
181382,",",0,0
181383,phase,0,0
181384,III,0,1
181385,",",0,0
181386,randomized,0,0
181387,controlled,0,0
181388,trial,0,0
181389,.,0,0
181390,METHODS,0,0
181391,Patients,0,0
181392,ages,0,0
181393,?18,0,0
181394,years,0,0
181395,with,0,0
181396,active,0,0
181397,RA,0,0
181398,with,0,0
181399,an,0,0
181400,inadequate,0,0
181401,response,0,0
181402,to,0,0
181403,?1,0,0
181404,tumor,0,1
181405,necrosis,0,1
181406,factor,0,1
181407,inhibitor,0,0
181408,(,0,0
181409,TNFi,0,1
181410,),0,0
181411,and,0,0
181412,receiving,0,0
181413,stable,0,1
181414,background,0,0
181415,methotrexate,0,0
181416,were,0,0
181417,randomized,0,0
181418,2:2:1:1,0,0
181419,to,0,0
181420,tofacitinib,0,0
181421,5,0,0
181422,mg,0,0
181423,or,0,0
181424,10,0,0
181425,mg,0,0
181426,twice,0,0
181427,daily,0,0
181428,",",0,0
181429,or,0,1
181430,placebo,0,0
181431,advanced,0,0
181432,to,0,0
181433,tofacitinib,0,0
181434,5,0,0
181435,mg,0,0
181436,or,0,0
181437,10,0,0
181438,mg,0,0
181439,twice,0,0
181440,daily,0,0
181441,at,0,0
181442,month,0,0
181443,3,0,0
181444,.,0,0
181445,PROs,0,0
181446,measured,0,0
181447,at,0,0
181448,month,0,0
181449,3,0,0
181450,included,1,0
181451,patient,1,0
181452,global,1,1
181453,assessment,1,0
181454,of,1,0
181455,disease,1,1
181456,activity,1,1
181457,(,1,0
181458,PtGA,1,1
181459,),1,0
181460,",",1,0
181461,pain,1,1
181462,",",1,0
181463,Health,1,1
181464,Assessment,1,1
181465,Questionnaire,1,1
181466,(,1,0
181467,HAQ,1,1
181468,),1,1
181469,disability,1,1
181470,index,1,1
181471,(,1,0
181472,DI,1,1
181473,),1,0
181474,",",1,0
181475,Medical,1,0
181476,Outcomes,1,1
181477,Study,1,0
181478,(,1,0
181479,MOS,1,0
181480,),1,0
181481,Short,1,0
181482,Form,1,0
181483,36,1,0
181484,Health,1,0
181485,Survey,1,0
181486,version,1,0
181487,2,1,0
181488,(,1,0
181489,SF-36v2,1,0
181490,;,1,0
181491,acute,1,0
181492,),1,0
181493,",",1,0
181494,Functional,1,0
181495,Assessment,1,0
181496,of,1,0
181497,Chronic,1,0
181498,Illness,1,1
181499,Therapy-Fatigue,1,1
181500,(,1,0
181501,FACIT-F,1,0
181502,),1,1
181503,",",1,0
181504,and,1,1
181505,MOS,1,1
181506,Sleep,1,1
181507,Scale,1,1
181508,.,1,0
181509,RESULTS,1,0
181510,Patients,0,0
181511,received,0,0
181512,tofacitinib,0,0
181513,5,0,0
181514,mg,0,0
181515,(,0,0
181516,n,0,0
181517,=,0,0
181518,133,0,0
181519,),0,0
181520,or,0,0
181521,10,0,0
181522,mg,0,0
181523,(,0,0
181524,n,0,0
181525,=,0,0
181526,134,0,0
181527,),0,0
181528,or,0,0
181529,placebo,0,0
181530,advanced,0,0
181531,to,0,0
181532,tofacitinib,0,0
181533,5,0,0
181534,mg,0,0
181535,(,0,0
181536,n,0,0
181537,=,0,0
181538,66,0,0
181539,),0,0
181540,or,0,0
181541,10,0,0
181542,mg,0,0
181543,(,0,0
181544,n,0,0
181545,=,0,0
181546,66,0,0
181547,),0,0
181548,.,0,0
181549,HAQ,1,1
181550,DI,1,1
181551,(,1,0
181552,reported,1,0
181553,previously,1,0
181554,),1,0
181555,",",1,0
181556,PtGA,1,1
181557,(,1,0
181558,P,1,0
181559,<,1,0
181560,0.0001,1,0
181561,),1,0
181562,",",1,0
181563,and,1,1
181564,SF-36v2,1,1
181565,physical,1,1
181566,and,1,0
181567,mental,1,1
181568,component,1,1
181569,summary,1,0
181570,(,1,0
181571,P,1,0
181572,<,1,0
181573,0.05,1,0
181574,),1,0
181575,scores,1,1
181576,were,1,0
181577,improved,1,0
181578,for,1,0
181579,both,0,0
181580,tofacitinib,0,0
181581,doses,0,0
181582,versus,0,0
181583,placebo,0,0
181584,.,0,0
181585,Furthermore,0,0
181586,",",0,0
181587,improvements,0,1
181588,greater,0,0
181589,than,0,0
181590,or,0,0
181591,equal,0,0
181592,to,0,0
181593,the,0,0
181594,minimum,0,0
181595,clinically,0,0
181596,important,0,0
181597,difference,0,0
181598,were,0,0
181599,more,0,0
181600,frequently,0,0
181601,reported,0,0
181602,by,0,0
181603,tofacitinib-treated,0,0
181604,patients,0,0
181605,versus,0,0
181606,placebo,0,0
181607,for,0,0
181608,PtGA,1,1
181609,(,1,0
181610,P,1,0
181611,<,0,0
181612,0.05,0,0
181613,),1,0
181614,",",1,0
181615,pain,1,1
181616,(,1,0
181617,P,1,0
181618,<,0,0
181619,0.0001,1,0
181620,),1,0
181621,",",1,0
181622,HAQ,1,1
181623,DI,1,1
181624,(,0,0
181625,P,0,0
181626,<,0,0
181627,0.05,0,0
181628,),1,0
181629,",",1,0
181630,SF-36v2,1,0
181631,physical,1,1
181632,and,1,0
181633,mental,1,1
181634,component,1,1
181635,summary,1,0
181636,scores,1,1
181637,(,1,0
181638,P,1,0
181639,<,0,0
181640,0.05,0,0
181641,),0,0
181642,",",0,0
181643,and,0,1
181644,FACIT-F,1,1
181645,(,1,0
181646,P,1,0
181647,<,0,0
181648,0.001,0,0
181649,for,0,0
181650,5,0,0
181651,mg,0,0
181652,twice,0,0
181653,daily,1,0
181654,),1,0
181655,.,1,0
181656,No,1,0
181657,statistical,1,0
181658,differences,1,0
181659,were,1,0
181660,observed,0,0
181661,in,0,0
181662,the,0,0
181663,MOS,1,0
181664,Sleep,1,0
181665,Scale,1,1
181666,.,1,0
181667,CONCLUSION,1,0
181668,Tofacitinib,0,0
181669,treatment,0,0
181670,resulted,0,0
181671,in,0,0
181672,significant,0,0
181673,",",0,0
181674,clinically,0,1
181675,meaningful,0,0
181676,improvements,0,1
181677,in,0,0
181678,multiple,0,0
181679,PROs,0,1
181680,versus,0,0
181681,placebo,0,0
181682,over,0,0
181683,3,0,0
181684,months,0,0
181685,of,0,0
181686,treatment,0,0
181687,in,0,0
181688,patients,0,0
181689,with,0,0
181690,active,0,0
181691,RA,0,0
181692,and,0,0
181693,a,0,0
181694,previous,0,0
181695,inadequate,0,0
181696,response,0,1
181697,to,0,0
181698,TNFi,0,0
181699,.,0,0
181700,Acute,0,0
181701,effects,0,1
181702,of,0,0
181703,static,0,1
181704,active,0,0
181705,or,0,0
181706,dynamic,0,0
181707,active,0,0
181708,stretching,0,0
181709,on,0,0
181710,eccentric-exercise-induced,1,0
181711,hamstring,1,1
181712,muscle,1,1
181713,damage,1,1
181714,.,1,0
181715,OBJECTIVES,0,0
181716,To,0,0
181717,examine,0,0
181718,whether,0,0
181719,an,0,0
181720,acute,0,0
181721,bout,0,1
181722,of,0,0
181723,active,0,0
181724,or,0,0
181725,dynamic,0,0
181726,hamstring-stretching,0,0
181727,exercises,0,0
181728,would,0,0
181729,reduce,0,0
181730,the,0,0
181731,amount,0,0
181732,of,0,0
181733,muscle,0,1
181734,damage,0,1
181735,observed,0,0
181736,after,0,0
181737,a,0,0
181738,strenuous,0,0
181739,eccentric,0,0
181740,task,0,0
181741,and,0,0
181742,to,0,0
181743,determine,0,0
181744,whether,0,0
181745,the,0,0
181746,stretching,0,0
181747,protocols,0,0
181748,elicit,0,0
181749,similar,0,0
181750,responses,0,0
181751,.,0,0
181752,DESIGN,0,0
181753,A,0,0
181754,randomized,0,0
181755,controlled,0,0
181756,clinical,0,0
181757,trial,0,0
181758,.,0,0
181759,METHODS,0,0
181760,Thirty-six,0,0
181761,young,0,0
181762,male,0,0
181763,students,0,0
181764,performed,0,0
181765,5,0,0
181766,min,0,0
181767,of,0,0
181768,jogging,0,0
181769,as,0,0
181770,a,0,0
181771,warm-up,0,0
181772,and,0,0
181773,were,0,0
181774,allocated,0,0
181775,to,0,0
181776,1,0,0
181777,of,0,0
181778,3,0,0
181779,groups,0,0
181780,:,0,0
181781,3,0,0
181782,min,0,0
181783,of,0,0
181784,static,0,1
181785,active,0,0
181786,stretching,0,0
181787,(,0,0
181788,SAS,0,0
181789,),0,0
181790,",",0,0
181791,3,0,0
181792,min,0,0
181793,of,0,0
181794,dynamic,0,0
181795,active,0,0
181796,stretching,0,0
181797,(,0,0
181798,DAS,0,1
181799,),0,1
181800,",",0,0
181801,or,0,1
181802,control,0,0
181803,(,0,1
181804,CON,0,0
181805,),0,0
181806,.,0,0
181807,All,0,0
181808,subjects,0,0
181809,performed,0,0
181810,eccentric,0,0
181811,exercise,0,0
181812,immediately,0,0
181813,after,0,0
181814,stretching,0,0
181815,.,0,0
181816,Heart,0,0
181817,rate,0,1
181818,",",0,0
181819,core,0,1
181820,temperature,0,1
181821,",",0,0
181822,maximal,0,1
181823,voluntary,0,0
181824,isometric,0,1
181825,contraction,0,1
181826,",",0,0
181827,passive,0,1
181828,hip,0,1
181829,flexion,0,1
181830,",",0,0
181831,passive,0,1
181832,hamstring,0,1
181833,stiffness,0,1
181834,(,0,0
181835,PHS,0,0
181836,),0,0
181837,",",0,0
181838,plasma,0,1
181839,creatine,0,1
181840,kinase,0,0
181841,activity,0,1
181842,",",0,1
181843,and,0,1
181844,myoglobin,0,1
181845,were,0,0
181846,recorded,0,0
181847,at,0,0
181848,prestretching,0,0
181849,",",0,0
181850,at,0,0
181851,poststretching,0,1
181852,",",0,0
181853,and,0,0
181854,every,0,0
181855,day,0,0
181856,after,0,0
181857,the,0,0
181858,eccentric,0,0
181859,exercises,0,0
181860,for,0,0
181861,5,0,0
181862,d.,0,0
181863,RESULTS,0,0
181864,After,0,0
181865,stretching,0,0
181866,",",0,0
181867,the,0,0
181868,change,1,1
181869,in,1,0
181870,hip,1,1
181871,flexion,1,1
181872,was,0,0
181873,significantly,0,0
181874,higher,0,0
181875,in,0,0
181876,the,0,0
181877,SAS,0,0
181878,(,0,0
181879,5?,0,0
181880,),0,0
181881,and,0,0
181882,DAS,0,1
181883,(,0,0
181884,10.8?,0,0
181885,),0,0
181886,groups,0,0
181887,than,0,0
181888,in,0,0
181889,the,0,0
181890,CON,0,0
181891,(,0,0
181892,-4.1?,0,0
181893,),0,0
181894,group,0,0
181895,.,0,0
181896,The,0,0
181897,change,0,0
181898,in,0,0
181899,PHS,1,0
181900,was,1,0
181901,significantly,0,0
181902,higher,0,0
181903,in,0,0
181904,the,0,0
181905,DAS,0,0
181906,(,0,0
181907,5.6,0,0
181908,%,0,0
181909,),0,0
181910,group,0,0
181911,than,0,0
181912,in,0,0
181913,the,0,0
181914,CON,0,0
181915,(,0,0
181916,-5.7,0,0
181917,%,0,0
181918,),0,0
181919,and,0,1
181920,SAS,0,0
181921,(,0,0
181922,-6.7,0,0
181923,%,0,0
181924,),0,0
181925,groups,0,0
181926,.,0,0
181927,Furthermore,1,0
181928,",",1,0
181929,changes,1,1
181930,in,1,0
181931,muscle-damage,1,1
181932,markers,1,1
181933,were,1,0
181934,smaller,0,0
181935,in,0,0
181936,the,0,0
181937,SAS,0,0
181938,group,0,0
181939,than,0,0
181940,in,0,0
181941,the,0,0
181942,DAS,0,0
181943,and,0,0
181944,CON,0,0
181945,groups,0,0
181946,.,0,0
181947,CONCLUSIONS,0,0
181948,Prior,0,1
181949,active,0,0
181950,stretching,0,0
181951,could,0,0
181952,be,0,0
181953,useful,0,0
181954,for,0,0
181955,attenuating,0,0
181956,the,0,0
181957,symptoms,0,1
181958,of,0,0
181959,muscle,0,1
181960,damage,0,1
181961,after,0,0
181962,eccentric,0,0
181963,exercise,0,0
181964,.,0,0
181965,SAS,0,0
181966,is,0,0
181967,recommended,0,0
181968,over,0,0
181969,DAS,0,0
181970,as,0,0
181971,a,0,0
181972,stretching,0,0
181973,protocol,0,0
181974,in,0,0
181975,terms,0,0
181976,of,0,0
181977,strength,0,1
181978,",",0,0
181979,hamstring,0,1
181980,range,0,0
181981,of,0,0
181982,motion,0,1
181983,",",0,0
181984,and,0,1
181985,damage,0,1
181986,markers,0,1
181987,.,0,0
181988,Efficacy,0,1
181989,of,0,0
181990,artemisinin-based,0,0
181991,combination,0,0
181992,treatments,0,0
181993,of,0,0
181994,uncomplicated,0,0
181995,falciparum,0,0
181996,malaria,0,0
181997,in,0,0
181998,under-five-year-old,0,0
181999,Nigerian,0,0
182000,children,0,0
182001,.,0,0
182002,The,0,0
182003,efficacy,0,1
182004,of,0,0
182005,3-day,0,0
182006,regimens,0,0
182007,of,0,0
182008,artemether-lumefantrine,0,0
182009,and,0,0
182010,artesunate-amodiaquine,0,0
182011,were,0,0
182012,evaluated,0,0
182013,in,0,0
182014,747,0,0
182015,children,0,0
182016,<,0,0
182017,5,0,0
182018,years,0,0
182019,of,0,0
182020,age,0,0
182021,with,0,0
182022,uncomplicated,0,0
182023,malaria,0,0
182024,from,0,0
182025,six,0,0
182026,geographical,0,0
182027,areas,0,0
182028,of,0,0
182029,Nigeria,0,0
182030,.,0,0
182031,Fever,0,0
182032,clearance,1,1
182033,was,0,0
182034,significantly,0,0
182035,faster,0,0
182036,(,0,0
182037,P,0,0
182038,=,0,0
182039,0.006,0,0
182040,),0,0
182041,and,0,0
182042,the,0,0
182043,proportion,0,1
182044,of,0,0
182045,children,0,0
182046,with,0,0
182047,parasitemia,0,1
182048,1,0,0
182049,day,0,0
182050,after,0,0
182051,treatment,0,0
182052,began,0,0
182053,was,0,0
182054,significantly,0,0
182055,lower,0,0
182056,(,0,0
182057,P,0,0
182058,=,0,0
182059,0.016,0,0
182060,),0,0
182061,in,0,0
182062,artesunate-amodiaquine-compared,0,0
182063,with,0,0
182064,artemether-lumefantrine-treated,0,0
182065,children,0,0
182066,.,0,0
182067,Parasite,1,1
182068,clearance,1,1
182069,times,0,1
182070,were,0,0
182071,similar,0,0
182072,with,0,0
182073,both,0,0
182074,treatments,0,0
182075,.,0,0
182076,Overall,0,1
182077,efficacy,0,1
182078,was,0,0
182079,96.3,0,0
182080,%,0,0
182081,(,0,0
182082,95,0,0
182083,%,0,0
182084,confidence,0,0
182085,interval,0,0
182086,[,0,0
182087,CI,0,0
182088,],0,0
182089,94.5-97.6,0,0
182090,%,0,0
182091,),0,0
182092,",",0,0
182093,and,0,1
182094,was,0,0
182095,similar,0,0
182096,for,0,0
182097,both,0,0
182098,regimens,0,0
182099,.,0,0
182100,Polymerase,1,1
182101,chain,1,1
182102,reaction-corrected,1,0
182103,parasitologic,1,0
182104,cure,1,1
182105,rates,1,1
182106,on,0,0
182107,Day,0,0
182108,28,0,0
182109,were,0,0
182110,96.9,0,0
182111,%,0,0
182112,(,0,0
182113,95,0,0
182114,%,0,0
182115,CI,0,0
182116,93.9-98.2,0,0
182117,%,0,0
182118,),0,0
182119,and,0,0
182120,98.3,0,0
182121,%,0,0
182122,(,0,0
182123,95,0,0
182124,%,0,0
182125,CI,0,0
182126,96.1-99.3,0,0
182127,%,0,0
182128,),0,0
182129,for,0,0
182130,artemether-lumefantrine,0,0
182131,and,0,0
182132,artesunate-amodiaquine,0,0
182133,",",0,0
182134,respectively,0,0
182135,.,0,0
182136,Gametocyte,1,1
182137,carriage,1,1
182138,post,1,1
182139,treatment,1,0
182140,was,0,0
182141,significantly,0,0
182142,lower,0,0
182143,than,0,0
182144,pretreatment,0,0
182145,(,0,0
182146,P,0,0
182147,<,0,0
182148,0.0001,0,0
182149,),0,0
182150,.,0,0
182151,In,0,0
182152,anemic,0,0
182153,children,0,0
182154,",",0,0
182155,mean,1,1
182156,time,1,1
182157,to,1,0
182158,recovery,1,1
182159,from,1,0
182160,anemia,1,0
182161,was,0,0
182162,10,0,0
182163,days,0,0
182164,(,0,0
182165,95,0,0
182166,%,0,0
182167,CI,0,0
182168,9.04-10.9,0,0
182169,),0,0
182170,and,0,0
182171,was,0,0
182172,similar,0,0
182173,for,0,0
182174,both,0,0
182175,regimens,0,0
182176,.,0,0
182177,Both,0,0
182178,treatments,0,0
182179,were,0,0
182180,well,1,0
182181,tolerated,1,1
182182,and,1,0
182183,are,1,0
182184,safe,1,1
182185,and,1,0
182186,efficacious,1,1
182187,treatments,1,0
182188,of,0,0
182189,uncomplicated,0,0
182190,falciparum,0,0
182191,malaria,0,1
182192,in,0,0
182193,young,0,0
182194,Nigerian,0,0
182195,children,0,0
182196,.,0,0
182197,Selenium,0,0
182198,Treatment,0,0
182199,and,0,0
182200,Chagasic,0,1
182201,Cardiopathy,0,1
182202,(,0,0
182203,STCC,0,0
182204,),0,0
182205,:,0,0
182206,study,0,0
182207,protocol,0,0
182208,for,0,0
182209,a,0,0
182210,double-blind,0,0
182211,randomized,0,0
182212,controlled,0,0
182213,trial,0,0
182214,.,0,0
182215,BACKGROUND,0,0
182216,Heart,0,0
182217,disease,0,0
182218,progression,0,1
182219,occurs,0,0
182220,in,0,0
182221,30,0,0
182222,%,0,0
182223,of,0,0
182224,patients,0,0
182225,with,0,0
182226,chronic,0,0
182227,Trypanosoma,0,0
182228,cruzi,0,0
182229,infection,0,1
182230,.,0,0
182231,Supplementation,0,0
182232,with,0,0
182233,selenium,0,0
182234,(,0,0
182235,Se,0,1
182236,),0,0
182237,in,0,0
182238,animal,0,0
182239,model,0,0
182240,of,0,0
182241,T.,0,1
182242,cruzi,0,0
182243,infection,0,1
182244,produced,0,0
182245,promising,0,0
182246,results,0,0
182247,.,0,0
182248,There,0,0
182249,is,0,0
182250,evidence,0,0
182251,that,0,0
182252,patients,0,0
182253,with,0,0
182254,Chagas,0,1
182255,heart,0,0
182256,disease,0,0
182257,have,0,0
182258,lower,0,0
182259,Se,0,1
182260,levels,0,1
182261,than,0,0
182262,healthy,0,0
182263,individuals,0,0
182264,and,0,0
182265,patients,0,0
182266,with,0,0
182267,T.,0,0
182268,cruzi,0,0
182269,infection,0,1
182270,without,0,0
182271,of,0,0
182272,cardiac,0,0
182273,disease,0,0
182274,.,0,0
182275,The,0,0
182276,aim,0,0
182277,of,0,0
182278,this,0,0
182279,investigation,0,0
182280,is,0,0
182281,to,0,0
182282,estimate,0,0
182283,the,0,0
182284,effect,0,0
182285,of,0,0
182286,Se,0,1
182287,treatment,0,0
182288,on,0,0
182289,prevention,0,0
182290,of,0,0
182291,heart,0,1
182292,disease,0,1
182293,progression,0,1
182294,in,0,0
182295,patients,0,0
182296,with,0,0
182297,chagasic,0,0
182298,cardiopathy,0,0
182299,.,0,0
182300,METHODS,0,0
182301,The,0,0
182302,Selenium,0,0
182303,Treatment,0,0
182304,and,0,0
182305,Chagasic,0,1
182306,Cardiopathy,0,0
182307,trial,0,0
182308,is,0,0
182309,a,0,0
182310,superiority,0,0
182311,",",0,0
182312,double-blind,0,0
182313,",",0,0
182314,placebo-controlled,0,0
182315,",",0,0
182316,randomized,0,0
182317,clinical,0,0
182318,trial,0,0
182319,.,0,0
182320,The,0,0
182321,eligibility,0,0
182322,criteria,0,0
182323,are,0,0
182324,as,0,0
182325,follows,0,0
182326,:,0,0
182327,(,0,0
182328,1,0,0
182329,),0,0
182330,a,0,0
182331,Chagas,0,0
182332,disease,0,1
182333,diagnosis,0,0
182334,confirmed,0,0
182335,by,0,0
182336,serology,0,0
182337,;,0,0
182338,(,0,0
182339,2,0,0
182340,),0,0
182341,segmental,0,0
182342,",",0,0
182343,mild,0,1
182344,or,0,0
182345,moderate,0,0
182346,global,0,1
182347,left,0,0
182348,ventricular,0,1
182349,systolic,0,1
182350,dysfunction,0,0
182351,;,0,0
182352,and,0,0
182353,(,0,0
182354,3,0,0
182355,),0,0
182356,age,0,0
182357,between,0,0
182358,18,0,0
182359,and,0,0
182360,65,0,0
182361,years,0,0
182362,.,0,0
182363,The,0,0
182364,exclusion,0,0
182365,criteria,0,0
182366,are,0,0
182367,as,0,0
182368,follows,0,0
182369,:,0,0
182370,(,0,0
182371,1,0,0
182372,),0,0
182373,pregnancy,0,0
182374,",",0,0
182375,(,0,0
182376,2,0,0
182377,),0,0
182378,diabetes,0,0
182379,mellitus,0,0
182380,",",0,0
182381,(,0,0
182382,3,0,0
182383,),0,0
182384,tobacco,0,0
182385,use,0,1
182386,",",0,0
182387,(,0,0
182388,4,0,0
182389,),0,0
182390,alcohol,0,0
182391,abuse,0,1
182392,",",0,0
182393,(,0,0
182394,5,0,0
182395,),0,0
182396,evidence,0,0
182397,of,0,0
182398,nonchagasic,0,0
182399,heart,0,1
182400,disease,0,1
182401,",",0,0
182402,(,0,0
182403,6,0,0
182404,),0,0
182405,depression,0,0
182406,",",0,0
182407,(,0,0
182408,7,0,0
182409,),0,0
182410,dysphagia,0,0
182411,with,0,0
182412,evidence,0,0
182413,of,0,0
182414,food,0,0
182415,residues,0,0
182416,in,0,0
182417,the,0,0
182418,esophagus,0,0
182419,",",0,0
182420,(,0,0
182421,8,0,0
182422,),0,0
182423,dysphagia,0,0
182424,with,0,0
182425,weight,0,1
182426,loss,0,1
182427,higher,0,0
182428,than,0,0
182429,15,0,0
182430,%,0,0
182431,of,0,0
182432,usual,0,0
182433,weight,0,1
182434,in,0,0
182435,the,0,0
182436,last,0,0
182437,four,0,0
182438,months,0,0
182439,and/or,0,0
182440,(,0,0
182441,9,0,0
182442,),0,0
182443,conditions,0,0
182444,that,0,0
182445,may,0,0
182446,result,0,0
182447,in,0,0
182448,low,0,0
182449,protocol,0,0
182450,adherence,0,0
182451,.,0,0
182452,The,0,0
182453,intervention,0,0
182454,will,0,0
182455,be,0,0
182456,100,0,0
182457,?g,0,0
182458,of,0,0
182459,sodium,0,0
182460,selenite,0,0
182461,once,0,0
182462,daily,0,0
182463,for,0,0
182464,365,0,0
182465,consecutive,0,0
182466,days,0,0
182467,compared,0,0
182468,to,0,0
182469,placebo,0,0
182470,.,0,0
182471,The,0,0
182472,following,0,0
182473,are,0,0
182474,the,0,0
182475,primary,0,0
182476,outcomes,0,0
182477,to,0,0
182478,be,0,0
182479,measured,1,0
182480,:,1,0
182481,(,1,0
182482,1,1,0
182483,),1,0
182484,the,1,0
182485,trajectories,1,0
182486,of,1,0
182487,the,1,0
182488,left,1,0
182489,ventricular,1,1
182490,ejection,1,1
182491,fraction,1,1
182492,in,1,0
182493,the,1,0
182494,follow-up,1,0
182495,period,1,0
182496,;,1,0
182497,(,1,0
182498,2,1,0
182499,),1,0
182500,reduction,1,0
182501,of,1,0
182502,heart,1,1
182503,disease,1,1
182504,progression,1,1
182505,rates,1,1
182506,",",1,0
182507,with,1,0
182508,progression,1,1
182509,defined,1,0
182510,as,1,0
182511,a,1,0
182512,10,1,0
182513,%,1,0
182514,decrease,1,0
182515,in,1,0
182516,left,1,1
182517,ventricular,1,1
182518,ejection,1,0
182519,fraction,1,1
182520,;,1,0
182521,and,1,0
182522,(,1,0
182523,3,1,0
182524,),1,0
182525,rate,1,1
182526,of,1,0
182527,hospital,1,1
182528,admissions,1,1
182529,attributable,1,0
182530,to,1,0
182531,dysrhythmia,1,1
182532,",",1,0
182533,heart,1,1
182534,failure,1,1
182535,or,1,0
182536,stroke,1,1
182537,due,1,0
182538,to,1,0
182539,Chagas,1,0
182540,disease,1,0
182541,.,1,0
182542,One,0,0
182543,hundred,0,0
182544,thirty,0,0
182545,patients,0,0
182546,will,0,0
182547,be,0,0
182548,randomly,0,0
182549,allocated,0,0
182550,into,0,0
182551,either,0,0
182552,the,0,0
182553,intervention,0,0
182554,or,0,0
182555,placebo,0,0
182556,group,0,0
182557,at,0,0
182558,a,0,0
182559,ratio,0,0
182560,of,0,0
182561,1:1,0,0
182562,.,0,0
182563,The,0,0
182564,sequence,0,0
182565,allocation,0,1
182566,concealment,0,1
182567,and,0,1
182568,blinding,0,0
182569,were,0,0
182570,planned,0,0
182571,to,0,0
182572,be,0,0
182573,conducted,0,0
182574,with,0,0
182575,the,0,0
182576,strategy,0,0
182577,of,0,0
182578,numbered,0,0
182579,boxes,0,0
182580,.,0,0
182581,Both,0,0
182582,patients,0,0
182583,and,0,0
182584,health-care,0,0
182585,providers,0,0
182586,will,0,0
182587,remain,0,0
182588,blinded,0,0
182589,to,0,0
182590,the,0,0
182591,intervention,0,0
182592,groups,0,0
182593,during,0,0
182594,the,0,0
182595,5,0,0
182596,years,0,0
182597,of,0,0
182598,follow-up,0,0
182599,.,0,0
182600,DISCUSSION,0,1
182601,If,0,0
182602,Se,0,1
182603,treatment,0,0
182604,reduces,0,0
182605,the,1,0
182606,progression,1,1
182607,of,1,0
182608,Chagas,1,1
182609,cardiopathy,1,0
182610,",",1,0
182611,the,0,0
182612,inclusion,0,0
182613,of,0,0
182614,this,0,0
182615,micronutrient,0,0
182616,in,0,0
182617,the,0,0
182618,daily,0,0
182619,diet,0,0
182620,can,0,0
182621,improve,0,0
182622,the,0,0
182623,therapeutic,0,0
182624,regimen,0,0
182625,for,0,0
182626,this,0,0
182627,neglected,0,0
182628,tropical,0,0
182629,disease,0,0
182630,at,0,0
182631,low,0,0
182632,cost,0,1
182633,.,0,0
182634,TRIAL,0,0
182635,REGISTRATION,0,0
182636,Clinical,0,1
182637,Trials.gov,0,0
182638,ID,0,0
182639,:,0,0
182640,NCT00875173,0,0
182641,(,0,0
182642,registered,0,0
182643,20,0,0
182644,October,0,0
182645,20,0,0
182646,2008,0,0
182647,),0,0
182648,.,0,0
182649,Disorder-dissociated,0,0
182650,effects,0,1
182651,of,0,0
182652,fluoxetine,0,0
182653,on,0,0
182654,brain,0,1
182655,function,0,1
182656,of,0,0
182657,working,0,1
182658,memory,0,1
182659,in,0,0
182660,attention,0,1
182661,deficit,0,1
182662,hyperactivity,0,1
182663,disorder,0,0
182664,and,0,1
182665,autism,0,0
182666,spectrum,0,0
182667,disorder,0,0
182668,.,0,0
182669,BACKGROUND,0,0
182670,Attention,0,1
182671,deficit,0,1
182672,hyperactivity,0,1
182673,disorder,0,0
182674,(,0,0
182675,ADHD,0,0
182676,),0,1
182677,and,0,0
182678,autism,0,0
182679,spectrum,0,0
182680,disorder,0,0
182681,(,0,0
182682,ASD,0,0
182683,),0,0
182684,are,0,0
182685,often,0,0
182686,co-morbid,0,0
182687,and,0,0
182688,share,0,0
182689,performance,0,1
182690,and,0,1
182691,brain,0,1
182692,dysfunctions,0,1
182693,during,0,0
182694,working,0,1
182695,memory,0,1
182696,(,0,0
182697,WM,0,1
182698,),0,0
182699,.,0,0
182700,Serotonin,0,0
182701,agonists,0,0
182702,modulate,0,0
182703,WM,0,1
182704,and,0,0
182705,there,0,0
182706,is,0,0
182707,evidence,0,0
182708,of,0,0
182709,positive,0,1
182710,behavioural,0,0
182711,effects,0,0
182712,in,0,0
182713,both,0,0
182714,disorders,0,0
182715,.,0,0
182716,We,0,0
182717,therefore,0,0
182718,used,0,0
182719,functional,0,0
182720,magnetic,0,0
182721,resonance,0,0
182722,imaging,0,1
182723,(,0,0
182724,fMRI,0,0
182725,),0,0
182726,to,0,0
182727,investigate,0,0
182728,shared,0,0
182729,and,0,0
182730,disorder-specific,0,1
182731,brain,0,1
182732,dysfunctions,0,1
182733,of,0,0
182734,WM,0,1
182735,in,0,0
182736,these,0,0
182737,disorders,0,0
182738,",",0,0
182739,and,0,0
182740,the,0,0
182741,effects,0,0
182742,of,0,0
182743,a,0,0
182744,single,0,0
182745,dose,0,0
182746,of,0,0
182747,the,0,0
182748,selective,0,0
182749,serotonin,0,0
182750,reuptake,0,0
182751,inhibitor,0,0
182752,(,0,0
182753,SSRI,0,1
182754,),0,0
182755,fluoxetine,0,0
182756,.,0,0
182757,METHOD,0,0
182758,Age-matched,0,0
182759,boys,0,0
182760,with,0,0
182761,ADHD,0,0
182762,(,0,0
182763,n,0,0
182764,=,0,0
182765,17,0,0
182766,),0,0
182767,",",0,0
182768,ASD,0,0
182769,(,0,0
182770,n,0,0
182771,=,0,0
182772,17,0,0
182773,),0,0
182774,and,0,0
182775,controls,0,0
182776,(,0,0
182777,n,0,0
182778,=,0,0
182779,22,0,0
182780,),0,0
182781,were,0,0
182782,compared,0,0
182783,using,0,0
182784,fMRI,0,0
182785,during,0,0
182786,an,0,0
182787,N-back,0,0
182788,WM,0,1
182789,task,0,0
182790,.,0,0
182791,Patients,0,0
182792,were,0,0
182793,scanned,0,0
182794,twice,0,0
182795,",",0,0
182796,under,0,0
182797,either,0,0
182798,an,0,0
182799,acute,0,0
182800,dose,0,0
182801,of,0,1
182802,fluoxetine,0,0
182803,or,0,0
182804,placebo,0,0
182805,in,0,0
182806,a,0,0
182807,double-blind,0,0
182808,",",0,0
182809,placebo-controlled,0,0
182810,randomized,0,0
182811,design,0,0
182812,.,0,0
182813,Repeated-measures,0,0
182814,analyses,0,0
182815,within,0,0
182816,patients,0,0
182817,assessed,0,0
182818,drug,0,0
182819,effects,0,1
182820,on,0,0
182821,performance,0,1
182822,and,0,1
182823,brain,0,1
182824,function,0,1
182825,.,0,0
182826,To,0,0
182827,test,0,0
182828,for,0,0
182829,normalization,0,0
182830,effects,0,1
182831,of,0,0
182832,brain,0,1
182833,dysfunctions,0,1
182834,",",0,0
182835,patients,0,0
182836,under,0,0
182837,each,0,0
182838,drug,0,0
182839,condition,0,0
182840,were,0,0
182841,compared,0,0
182842,to,0,0
182843,controls,0,0
182844,.,0,0
182845,RESULTS,0,0
182846,Under,0,0
182847,placebo,0,0
182848,",",0,0
182849,relative,0,1
182850,to,0,0
182851,controls,0,0
182852,",",0,0
182853,both,0,0
182854,ADHD,0,0
182855,and,0,0
182856,ASD,0,0
182857,boys,0,0
182858,shared,0,0
182859,underactivation,1,0
182860,in,1,0
182861,the,1,0
182862,right,1,0
182863,dorsolateral,1,0
182864,prefrontal,1,1
182865,cortex,1,1
182866,(,1,0
182867,DLPFC,1,0
182868,),1,0
182869,.,1,0
182870,Fluoxetine,1,0
182871,significantly,0,0
182872,normalized,1,0
182873,the,1,0
182874,DLPFC,1,1
182875,underactivation,1,0
182876,in,1,0
182877,ASD,1,0
182878,relative,0,0
182879,to,0,0
182880,controls,0,0
182881,whereas,0,0
182882,it,0,0
182883,increased,1,0
182884,posterior,1,0
182885,cingulate,1,1
182886,cortex,1,1
182887,(,1,0
182888,PCC,1,1
182889,),1,0
182890,deactivation,1,1
182891,in,1,0
182892,ADHD,1,0
182893,relative,0,0
182894,to,0,0
182895,control,0,0
182896,boys,0,0
182897,.,0,0
182898,Within-patient,0,1
182899,analyses,0,0
182900,showed,0,0
182901,inverse,0,0
182902,effects,0,1
182903,of,0,0
182904,fluoxetine,0,0
182905,on,0,0
182906,PCC,0,1
182907,deactivation,0,1
182908,",",0,0
182909,which,0,0
182910,it,0,0
182911,enhanced,0,0
182912,in,0,0
182913,ADHD,0,0
182914,and,0,0
182915,decreased,0,0
182916,in,0,0
182917,ASD,0,0
182918,.,0,0
182919,CONCLUSIONS,0,0
182920,The,0,0
182921,findings,0,0
182922,show,0,0
182923,that,0,0
182924,fluoxetine,0,0
182925,modulates,0,1
182926,brain,0,1
182927,activation,0,1
182928,during,0,0
182929,WM,0,1
182930,in,0,0
182931,a,0,0
182932,disorder-specific,0,0
182933,manner,0,0
182934,by,0,0
182935,normalizing,0,0
182936,task-positive,0,0
182937,DLPFC,0,1
182938,dysfunction,0,1
182939,in,0,0
182940,ASD,0,0
182941,boys,0,0
182942,and,0,0
182943,enhancing,0,0
182944,task-negative,0,1
182945,default,0,0
182946,mode,0,1
182947,network,0,0
182948,(,0,0
182949,DMN,0,0
182950,),0,0
182951,deactivation,0,1
182952,in,0,0
182953,ADHD,0,0
182954,.,0,0
182955,Benefits,0,1
182956,of,0,0
182957,an,0,0
182958,oxygen,0,1
182959,reservoir,0,1
182960,cannula,0,1
182961,versus,0,0
182962,a,0,0
182963,conventional,0,0
182964,nasal,0,1
182965,cannula,0,1
182966,during,0,0
182967,exercise,0,0
182968,in,0,0
182969,hypoxemic,0,1
182970,COPD,0,0
182971,patients,0,0
182972,:,0,0
182973,a,0,0
182974,crossover,0,0
182975,trial,0,0
182976,.,0,0
182977,BACKGROUND,0,0
182978,The,0,0
182979,Oxymizer?,0,0
182980,is,0,0
182981,a,0,0
182982,special,0,0
182983,nasal,0,1
182984,cannula,0,1
182985,that,0,0
182986,provides,0,0
182987,a,0,0
182988,higher,0,0
182989,luminal,0,1
182990,diameter,0,1
182991,in,0,0
182992,combination,0,0
182993,with,0,0
182994,an,0,0
182995,incorporated,0,0
182996,oxygen,0,1
182997,(,0,0
182998,O2,0,0
182999,),0,0
183000,reservoir,0,0
183001,.,0,0
183002,It,0,0
183003,is,0,0
183004,assumed,0,0
183005,that,0,0
183006,a,0,0
183007,higher,0,0
183008,O2,0,0
183009,concentration,0,1
183010,can,0,0
183011,be,0,0
183012,delivered,0,0
183013,breath,0,1
183014,by,0,0
183015,breath,0,1
183016,in,0,0
183017,order,0,0
183018,to,0,0
183019,increase,0,0
183020,oxygenation,0,1
183021,.,0,0
183022,OBJECTIVE,0,0
183023,We,0,0
183024,aimed,0,0
183025,to,0,0
183026,investigate,0,0
183027,the,0,0
183028,effects,0,0
183029,of,0,0
183030,the,0,0
183031,Oxymizer,0,0
183032,on,1,0
183033,endurance,1,1
183034,time,1,1
183035,in,0,0
183036,comparison,0,0
183037,to,0,0
183038,a,0,0
183039,conventional,0,0
183040,nasal,0,1
183041,cannula,0,1
183042,(,0,0
183043,CNC,0,0
183044,),0,0
183045,.,0,0
183046,METHODS,0,0
183047,Forty-three,0,0
183048,patients,0,0
183049,with,0,0
183050,severe,0,1
183051,chronic,0,0
183052,obstructive,0,0
183053,pulmonary,0,1
183054,disease,0,1
183055,(,0,0
183056,COPD,0,0
183057,",",0,0
183058,age,0,0
183059,60,0,0
183060,?,0,0
183061,9,0,0
183062,years,0,0
183063,",",0,0
183064,FEV1,0,0
183065,37,0,0
183066,?,0,0
183067,16,0,0
183068,%,0,0
183069,pred,0,0
183070,.,0,0
183071,),0,0
183072,and,0,0
183073,indications,0,0
183074,for,0,0
183075,LTOT,0,0
183076,were,0,0
183077,recruited,0,0
183078,during,0,0
183079,pulmonary,0,0
183080,rehabilitation,0,0
183081,for,0,0
183082,this,0,0
183083,cross-over,0,0
183084,study,0,0
183085,.,0,0
183086,After,0,0
183087,an,0,0
183088,initial,0,0
183089,maximal,0,1
183090,incremental,0,0
183091,cycle,0,1
183092,test,0,0
183093,",",0,0
183094,all,0,0
183095,patients,0,0
183096,performed,0,0
183097,4,0,0
183098,cycling,0,0
183099,endurance,0,0
183100,time,0,1
183101,tests,0,0
183102,at,0,0
183103,70,0,0
183104,%,0,0
183105,of,0,0
183106,their,0,0
183107,peak,0,1
183108,work,0,0
183109,rate,0,1
183110,(,0,0
183111,twice,0,0
183112,with,0,0
183113,the,0,0
183114,Oxymizer,0,0
183115,and,0,0
183116,twice,0,0
183117,with,0,0
183118,a,0,0
183119,CNC,0,0
183120,",",0,0
183121,in,0,0
183122,reverse,0,1
183123,order,0,0
183124,),0,0
183125,.,0,0
183126,RESULTS,0,0
183127,The,0,0
183128,endurance,1,1
183129,time,1,1
183130,was,1,0
183131,significantly,0,0
183132,higher,0,0
183133,when,0,0
183134,patients,0,0
183135,cycled,0,0
183136,while,0,0
183137,using,0,0
183138,the,0,0
183139,Oxymizer,0,0
183140,in,0,0
183141,comparison,0,0
183142,to,0,0
183143,while,0,0
183144,using,0,0
183145,the,0,0
183146,CNC,0,0
183147,[,0,0
183148,858,0,0
183149,?,0,0
183150,754,0,0
183151,vs.,0,0
183152,766,0,0
183153,?,0,0
183154,652,0,0
183155,s,0,0
183156,;,0,0
183157,between-group,0,0
183158,difference,0,0
183159,92,0,0
183160,s,0,0
183161,(,0,0
183162,95,0,0
183163,%,0,0
183164,confidence,0,0
183165,interval,0,0
183166,32-152,0,0
183167,),0,0
183168,",",0,0
183169,p,0,0
183170,<,0,0
183171,0.001,0,0
183172,],0,0
183173,.,0,0
183174,In,0,0
183175,addition,0,0
183176,to,0,0
183177,a,0,0
183178,longer,1,0
183179,cycling,1,1
183180,duration,1,1
183181,",",1,0
183182,O2,1,0
183183,saturation,1,1
183184,at,1,0
183185,isotime,1,1
183186,was,1,0
183187,significantly,0,0
183188,higher,0,0
183189,with,0,0
183190,the,0,0
183191,Oxymizer,0,0
183192,(,0,0
183193,93.5,0,0
183194,?,0,0
183195,5.4,0,0
183196,vs.,0,0
183197,90.4,0,0
183198,?,0,0
183199,5.3,0,0
183200,%,0,0
183201,;,0,0
183202,p,0,0
183203,=,0,0
183204,0.027,0,0
183205,),0,0
183206,.,0,0
183207,Furthermore,0,0
183208,",",0,0
183209,there,0,0
183210,was,0,0
183211,a,0,0
183212,positive,0,1
183213,correlation,0,0
183214,(,0,0
183215,r,0,0
183216,=,0,0
183217,0.427,0,0
183218,",",0,0
183219,p,0,0
183220,=,0,0
183221,0.002,0,0
183222,),0,0
183223,between,0,0
183224,the,1,0
183225,O2,1,0
183226,flow,1,1
183227,rate,1,1
183228,and,1,1
183229,improvements,1,1
183230,in,1,0
183231,the,1,0
183232,constant,1,0
183233,work,1,0
183234,rate,1,1
183235,test,1,1
183236,",",1,0
183237,showing,0,0
183238,greater,0,0
183239,improvements,0,1
183240,in,0,0
183241,favor,0,0
183242,of,0,0
183243,the,0,0
183244,Oxymizer,0,0
183245,in,0,0
183246,patients,0,0
183247,with,0,0
183248,a,0,0
183249,higher,0,0
183250,demand,0,1
183251,for,0,0
183252,O2,0,0
183253,(,0,0
183254,?,0,0
183255,4,0,0
183256,liters/min,0,0
183257,),0,0
183258,.,0,0
183259,CONCLUSION,0,0
183260,We,0,0
183261,show,0,0
183262,that,0,0
183263,O2,0,0
183264,delivery,0,0
183265,via,0,0
183266,the,0,0
183267,Oxymizer,0,0
183268,is,0,0
183269,superior,0,0
183270,to,0,0
183271,a,0,0
183272,CNC,0,0
183273,with,0,0
183274,regard,0,0
183275,to,0,0
183276,endurance,1,1
183277,capacity,1,1
183278,and,1,1
183279,oxygenation,1,1
183280,during,1,0
183281,exercise,1,0
183282,in,0,0
183283,patients,0,0
183284,with,0,0
183285,severe,0,0
183286,COPD,0,0
183287,.,0,0
183288,It,0,0
183289,seems,0,0
183290,that,0,0
183291,patients,0,0
183292,with,0,0
183293,a,0,0
183294,higher,0,0
183295,demand,0,1
183296,for,0,0
183297,O2,0,0
183298,(,0,0
183299,?,0,0
183300,4,0,0
183301,liters/min,0,0
183302,),0,0
183303,",",0,0
183304,in,0,0
183305,particular,0,0
183306,",",0,0
183307,may,0,0
183308,benefit,0,0
183309,more,0,0
183310,from,0,0
183311,the,0,0
183312,use,0,0
183313,of,0,0
183314,the,0,0
183315,Oxymizer,0,0
183316,.,0,0
183317,Safety,0,1
183318,and,0,0
183319,possible,0,0
183320,effects,0,1
183321,of,0,0
183322,low-intensity,0,0
183323,resistance,0,1
183324,training,0,0
183325,associated,0,0
183326,with,0,0
183327,partial,0,0
183328,blood,0,1
183329,flow,0,1
183330,restriction,0,0
183331,in,0,0
183332,polymyositis,0,1
183333,and,0,0
183334,dermatomyositis,0,1
183335,.,0,0
183336,INTRODUCTION,0,0
183337,Our,0,0
183338,aim,0,0
183339,was,0,0
183340,to,0,0
183341,evaluate,0,0
183342,the,0,0
183343,safety,0,1
183344,and,0,0
183345,efficacy,0,1
183346,of,0,0
183347,a,0,0
183348,low-intensity,0,0
183349,resistance,0,1
183350,training,0,0
183351,program,0,0
183352,combined,0,0
183353,with,0,0
183354,partial,0,0
183355,blow,0,1
183356,flow,0,1
183357,restriction,0,0
183358,(,0,0
183359,BFR,0,1
183360,training,0,0
183361,),0,0
183362,in,0,0
183363,a,0,0
183364,cohort,0,0
183365,of,0,0
183366,patients,0,0
183367,with,0,0
183368,polymyositis,0,1
183369,(,0,0
183370,PM,0,0
183371,),0,1
183372,and,0,1
183373,dermatomyositis,0,1
183374,(,0,1
183375,DM,0,0
183376,),0,0
183377,.,0,0
183378,METHODS,0,0
183379,In,0,0
183380,total,0,1
183381,",",0,0
183382,13,0,0
183383,patients,0,0
183384,with,0,0
183385,PM,0,0
183386,and,0,0
183387,DM,0,0
183388,completed,0,0
183389,a,0,0
183390,12-week,0,0
183391,twice,0,0
183392,a,0,0
183393,week,0,0
183394,low-intensity,0,0
183395,(,0,0
183396,that,0,0
183397,is,0,0
183398,",",0,0
183399,30,0,0
183400,%,0,0
183401,one-repetition-maximum,0,0
183402,(,0,0
183403,1RM,0,0
183404,),0,0
183405,),0,0
183406,resistance,0,1
183407,exercise,0,0
183408,training,0,0
183409,program,0,0
183410,combined,0,0
183411,with,0,0
183412,partial,0,0
183413,blood,0,1
183414,flow,0,1
183415,restriction,0,0
183416,(,0,0
183417,BFR,0,0
183418,),0,0
183419,.,0,0
183420,Assessments,0,0
183421,of,0,0
183422,muscle,0,1
183423,strength,0,1
183424,",",0,0
183425,physical,0,1
183426,function,0,1
183427,",",0,0
183428,quadriceps,0,0
183429,cross,0,0
183430,sectional,0,0
183431,(,0,0
183432,CSA,0,0
183433,),0,1
183434,area,0,1
183435,",",0,0
183436,health-related,0,1
183437,quality,0,1
183438,of,0,0
183439,life,0,1
183440,",",0,0
183441,and,0,1
183442,clinical,0,1
183443,and,0,1
183444,laboratory,0,0
183445,parameters,0,1
183446,were,0,0
183447,assessed,0,0
183448,at,0,0
183449,baseline,0,0
183450,and,0,0
183451,after,0,0
183452,the,0,0
183453,intervention,0,0
183454,.,0,0
183455,RESULTS,0,0
183456,The,0,0
183457,BFR,0,0
183458,training,0,0
183459,program,0,0
183460,was,0,0
183461,effective,0,0
183462,in,0,0
183463,increasing,0,0
183464,the,0,0
183465,maximal,1,1
183466,dynamic,1,0
183467,strength,1,1
183468,in,0,0
183469,both,0,0
183470,the,0,0
183471,leg-press,0,0
183472,(,0,0
183473,19.6,0,0
183474,%,0,0
183475,",",0,0
183476,P,0,0
183477,<,0,0
183478,0.001,0,0
183479,),0,0
183480,and,0,0
183481,knee-extension,1,1
183482,exercises,1,0
183483,(,0,0
183484,25.2,0,0
183485,%,0,0
183486,P,0,0
183487,<,0,0
183488,0.001,0,0
183489,),0,0
183490,",",0,0
183491,as,0,0
183492,well,0,0
183493,as,0,0
183494,in,0,0
183495,the,0,0
183496,timed-stands,1,0
183497,(,0,0
183498,15.1,0,0
183499,%,0,0
183500,",",0,0
183501,P,0,0
183502,<,0,0
183503,0.001,0,0
183504,),0,0
183505,and,0,0
183506,timed-up-and-go,1,1
183507,test,1,1
183508,(,0,0
183509,-4.5,0,0
183510,%,0,0
183511,",",0,0
183512,P,0,0
183513,=0.002,0,0
183514,),0,0
183515,.,0,0
183516,Quadriceps,1,1
183517,CSA,1,0
183518,was,0,0
183519,also,0,0
183520,significantly,0,0
183521,increased,0,0
183522,after,0,0
183523,the,0,0
183524,intervention,0,0
183525,(,0,0
183526,4.57,0,0
183527,%,0,0
183528,",",0,0
183529,P,0,0
183530,=0.01,0,1
183531,),0,0
183532,.,0,0
183533,Similarly,0,0
183534,",",0,0
183535,all,0,0
183536,of,0,0
183537,the,0,0
183538,components,0,0
183539,of,0,0
183540,the,0,0
183541,Short,1,0
183542,Form-36,1,1
183543,Health,1,1
183544,Survey,1,0
183545,",",1,0
183546,the,1,0
183547,Health,1,1
183548,Assessment,1,0
183549,Questionnaire,1,1
183550,scores,1,1
183551,",",1,0
183552,and,1,0
183553,the,1,0
183554,patient-,1,1
183555,and,1,0
183556,physician,1,0
183557,reported,1,0
183558,Visual,1,1
183559,Analogue,1,1
183560,Scale,1,1
183561,were,0,0
183562,significantly,0,0
183563,improved,0,0
183564,after,0,0
183565,training,0,0
183566,(,0,0
183567,P,0,0
183568,<,0,0
183569,0.05,0,0
183570,),0,0
183571,.,0,0
183572,Importantly,0,0
183573,",",0,0
183574,no,0,0
183575,clinical,0,0
183576,evidence,0,0
183577,or,0,0
183578,any,0,0
183579,other,0,0
183580,self-reported,1,1
183581,adverse,1,1
183582,event,0,1
183583,were,0,0
183584,found,0,0
183585,.,0,0
183586,Laboratory,1,0
183587,parameters,1,1
183588,(,1,0
183589,creatine,1,1
183590,kinase,1,0
183591,and,1,1
183592,aldolase,1,1
183593,),1,1
183594,were,0,0
183595,also,0,0
183596,unchanged,0,0
183597,(,0,0
183598,P,0,0
183599,>,0,0
183600,0.05,0,0
183601,),0,0
183602,after,0,0
183603,the,0,0
183604,intervention,0,0
183605,.,0,0
183606,CONCLUSIONS,0,0
183607,We,0,0
183608,demonstrated,0,0
183609,that,0,0
183610,a,0,0
183611,12-week,0,0
183612,supervised,0,0
183613,low-intensity,0,0
183614,resistance,0,1
183615,training,0,0
183616,program,0,0
183617,associated,0,0
183618,with,0,0
183619,partial,0,0
183620,blood,0,1
183621,flow,0,1
183622,restriction,0,0
183623,may,0,0
183624,be,0,0
183625,safe,0,0
183626,and,0,0
183627,effective,0,1
183628,in,0,0
183629,improving,0,1
183630,muscle,0,1
183631,strength,0,1
183632,and,0,1
183633,function,0,1
183634,as,0,0
183635,well,0,0
183636,as,0,0
183637,muscle,0,1
183638,mass,0,1
183639,and,0,1
183640,health-related,0,1
183641,quality,0,1
183642,of,0,0
183643,life,0,1
183644,in,0,0
183645,patients,0,0
183646,with,0,0
183647,PM,0,0
183648,and,0,0
183649,DM,0,0
183650,.,0,0
183651,TRIAL,0,0
183652,REGISTRATION,0,0
183653,Clinicaltrials.gov,0,0
183654,NCT01501019,0,0
183655,.,0,0
183656,Registered,0,0
183657,November,0,0
183658,29,0,0
183659,",",0,0
183660,2011,0,0
183661,.,0,0
183662,Atomoxetine,0,0
183663,in,0,0
183664,autism,0,0
183665,spectrum,0,0
183666,disorder,0,0
183667,:,0,0
183668,no,0,0
183669,effects,0,0
183670,on,0,0
183671,social,1,1
183672,functioning,1,1
183673,;,1,0
183674,some,0,0
183675,beneficial,0,0
183676,effects,0,0
183677,on,0,0
183678,stereotyped,1,1
183679,behaviors,1,1
183680,",",1,0
183681,inappropriate,1,1
183682,speech,1,1
183683,",",0,0
183684,and,0,1
183685,fear,1,1
183686,of,1,0
183687,change,1,0
183688,.,1,0
183689,UNLABELLED,0,0
183690,Abstract,0,0
183691,Objective,0,1
183692,:,0,0
183693,The,0,0
183694,objective,0,0
183695,of,0,0
183696,this,0,0
183697,study,0,0
183698,was,0,0
183699,to,0,0
183700,investigate,0,0
183701,the,0,0
183702,short-term,0,0
183703,treatment,0,0
183704,effects,0,1
183705,of,0,0
183706,atomoxetine,0,0
183707,on,0,0
183708,autism,0,0
183709,spectrum,0,0
183710,disorder,0,0
183711,(,0,0
183712,ASD,0,0
183713,),0,0
183714,symptoms,0,1
183715,in,0,0
183716,children,0,0
183717,and,0,0
183718,adolescents,0,0
183719,with,0,0
183720,both,0,0
183721,ASD,0,0
183722,and,0,0
183723,attention-deficit/hyperactivity,0,0
183724,disorder,0,0
183725,(,0,0
183726,ADHD,0,0
183727,),0,0
183728,.,0,0
183729,METHODS,0,0
183730,A,0,0
183731,total,0,1
183732,of,0,0
183733,97,0,0
183734,patients,0,0
183735,6-17,0,0
183736,years,0,0
183737,of,0,0
183738,age,0,0
183739,",",0,0
183740,with,0,0
183741,ASD,0,0
183742,and,0,1
183743,ADHD,0,1
183744,",",0,1
183745,were,0,0
183746,treated,0,0
183747,with,0,0
183748,1.2,0,0
183749,mg/kg/day,0,0
183750,of,0,0
183751,atomoxetine,0,0
183752,during,0,0
183753,an,0,0
183754,8,0,0
183755,week,0,0
183756,double-blind,0,0
183757,placebo-controlled,0,0
183758,period,0,0
183759,.,0,0
183760,Here,0,0
183761,",",0,0
183762,we,0,0
183763,investigated,0,0
183764,effects,0,0
183765,on,0,0
183766,two,0,0
183767,parent-based,0,0
183768,secondary,0,0
183769,outcome,0,1
183770,measures,0,1
183771,",",0,0
183772,the,1,0
183773,Aberrant,1,1
183774,Behavior,1,1
183775,Checklist,1,1
183776,(,1,0
183777,ABC,1,1
183778,),1,0
183779,and,1,0
183780,the,1,0
183781,Children,1,0
183782,'s,1,0
183783,Social,1,1
183784,Behavior,1,1
183785,Questionnaire,1,1
183786,(,1,0
183787,CSBQ,1,0
183788,),1,0
183789,.,1,0
183790,RESULTS,0,0
183791,After,0,0
183792,8,0,0
183793,weeks,0,0
183794,of,0,0
183795,double-blind,0,0
183796,treatment,0,0
183797,",",0,0
183798,atomoxetine,0,0
183799,administration,0,0
183800,was,0,0
183801,associated,0,0
183802,with,0,0
183803,significant,0,0
183804,treatment,0,0
183805,effects,0,0
183806,on,0,0
183807,the,1,0
183808,ABC,1,0
183809,subscales,1,1
183810,Hyperactivity,1,1
183811,",",1,0
183812,Inappropriate,1,1
183813,Speech,1,1
183814,",",1,0
183815,and,1,1
183816,Stereotypic,1,1
183817,Behavior,1,1
183818,",",1,0
183819,and,1,0
183820,on,1,0
183821,the,1,0
183822,CSBQ,1,0
183823,subscale,1,1
183824,Fear,1,1
183825,for,1,0
183826,Changes,1,1
183827,.,1,0
183828,CONCLUSIONS,0,0
183829,Our,0,0
183830,study,0,0
183831,results,0,0
183832,indicate,0,0
183833,no,0,0
183834,beneficial,0,0
183835,effects,0,0
183836,of,0,0
183837,atomoxetine,0,0
183838,on,0,0
183839,social,1,1
183840,functioning,1,1
183841,.,1,0
183842,However,0,0
183843,",",0,0
183844,atomoxetine,0,0
183845,may,0,0
183846,ameliorate,0,0
183847,restricted,0,0
183848,and,1,0
183849,stereotyped,1,1
183850,behaviors,1,1
183851,and,1,0
183852,communication,1,0
183853,.,1,0
183854,This,0,0
183855,study,0,0
183856,has,0,0
183857,been,0,0
183858,registered,0,0
183859,in,0,0
183860,ClinicalTrials.gov,0,0
183861,(,0,0
183862,www.clinicaltrials.gov,0,0
183863,),0,0
183864,under,0,0
183865,registration,0,0
183866,number,0,1
183867,NCT00380692,0,0
183868,.,0,0
183869,Evaluating,0,0
183870,the,0,0
183871,efficacy,1,1
183872,of,0,0
183873,thoracoscopy,0,0
183874,and,0,0
183875,talc,0,0
183876,poudrage,0,0
183877,versus,0,0
183878,pleurodesis,0,0
183879,using,0,0
183880,talc,0,0
183881,slurry,0,0
183882,(,0,0
183883,TAPPS,0,0
183884,trial,0,0
183885,),0,0
183886,:,0,0
183887,protocol,0,0
183888,of,0,0
183889,an,0,0
183890,open-label,0,0
183891,randomised,0,0
183892,controlled,0,0
183893,trial,0,0
183894,.,0,0
183895,INTRODUCTION,0,0
183896,The,0,0
183897,management,0,0
183898,of,0,0
183899,recurrent,0,1
183900,malignant,0,0
183901,pleural,0,1
183902,effusions,0,0
183903,(,0,0
183904,MPE,0,0
183905,),0,0
183906,can,0,0
183907,be,0,0
183908,challenging,0,0
183909,.,0,0
183910,Various,0,0
183911,options,0,0
183912,are,0,0
183913,available,0,0
183914,",",0,0
183915,with,0,0
183916,the,0,0
183917,most,0,0
183918,efficacious,0,0
183919,and,0,0
183920,widely,0,0
183921,used,0,0
183922,being,0,0
183923,talc,0,0
183924,pleurodesis,0,0
183925,.,0,0
183926,Talc,0,0
183927,can,0,0
183928,either,0,0
183929,be,0,0
183930,applied,0,0
183931,via,0,0
183932,a,0,0
183933,chest,0,0
183934,drain,0,0
183935,in,0,0
183936,the,0,0
183937,form,0,0
183938,of,0,0
183939,slurry,0,0
183940,",",0,0
183941,or,0,0
183942,at,0,0
183943,medical,0,0
183944,thoracoscopy,0,0
183945,using,0,0
183946,poudrage,0,0
183947,.,0,0
183948,Current,0,0
183949,evidence,0,0
183950,regarding,0,0
183951,which,0,0
183952,method,0,0
183953,is,0,0
183954,most,0,0
183955,effective,0,0
183956,is,0,0
183957,conflicting,0,0
183958,and,0,0
183959,often,0,0
183960,methodologically,0,0
183961,flawed,0,0
183962,.,0,0
183963,The,0,0
183964,TAPPS,0,0
183965,trial,0,0
183966,is,0,0
183967,a,0,0
183968,suitably,0,0
183969,powered,0,0
183970,",",0,0
183971,multicentre,0,0
183972,",",0,0
183973,open-label,0,0
183974,",",0,0
183975,randomised,0,0
183976,controlled,0,0
183977,trial,0,0
183978,designed,0,0
183979,to,0,0
183980,compare,0,0
183981,the,0,0
183982,pleurodesis,0,0
183983,success,0,1
183984,rate,0,1
183985,of,0,0
183986,medical,0,0
183987,thoracoscopy,0,0
183988,and,0,0
183989,talc,0,0
183990,poudrage,0,0
183991,with,0,0
183992,chest,0,1
183993,drain,0,1
183994,insertion,0,1
183995,and,0,1
183996,talc,0,0
183997,slurry,0,0
183998,.,0,0
183999,METHODS,0,0
184000,AND,0,0
184001,ANALYSIS,0,0
184002,330,0,0
184003,patients,0,0
184004,with,0,0
184005,a,0,0
184006,confirmed,0,0
184007,MPE,0,0
184008,requiring,0,0
184009,intervention,0,0
184010,will,0,0
184011,be,0,0
184012,recruited,0,0
184013,from,0,0
184014,UK,0,0
184015,hospitals,0,0
184016,.,0,0
184017,Patients,0,0
184018,will,0,0
184019,be,0,0
184020,randomised,0,0
184021,(,0,0
184022,1:1,0,0
184023,),0,0
184024,to,0,0
184025,undergo,0,0
184026,either,0,0
184027,small,0,0
184028,bore,0,1
184029,(,0,0
184030,<,0,0
184031,14,0,0
184032,Fr,0,0
184033,),0,0
184034,Seldinger,0,0
184035,chest,0,1
184036,drain,0,0
184037,insertion,0,0
184038,followed,0,0
184039,by,0,0
184040,instillation,0,0
184041,of,0,0
184042,sterile,0,0
184043,talc,0,0
184044,(,0,0
184045,4,0,0
184046,g,0,0
184047,),0,0
184048,",",0,0
184049,or,0,0
184050,to,0,0
184051,undergo,0,0
184052,medical,0,0
184053,thoracoscopy,0,0
184054,and,0,0
184055,simultaneous,0,0
184056,poudrage,0,0
184057,(,0,0
184058,4,0,0
184059,g,0,0
184060,),0,0
184061,.,0,0
184062,The,0,0
184063,allocated,0,0
184064,procedure,0,0
184065,will,0,0
184066,be,0,0
184067,performed,0,0
184068,as,0,0
184069,an,0,0
184070,inpatient,0,0
184071,within,0,0
184072,3,0,0
184073,days,0,0
184074,of,0,0
184075,randomisation,0,0
184076,taking,0,0
184077,place,0,0
184078,.,0,0
184079,Following,0,0
184080,discharge,0,1
184081,",",0,0
184082,patients,0,0
184083,will,0,0
184084,be,0,0
184085,followed,0,0
184086,up,0,0
184087,at,0,0
184088,regular,0,0
184089,intervals,0,0
184090,for,0,0
184091,6,0,0
184092,months,0,0
184093,.,0,0
184094,The,0,0
184095,primary,0,0
184096,outcome,0,0
184097,measure,0,0
184098,is,0,0
184099,pleurodesis,1,0
184100,failure,1,1
184101,rates,1,1
184102,at,1,0
184103,3,0,0
184104,months,0,0
184105,.,0,0
184106,Pleurodesis,1,0
184107,failure,1,0
184108,is,1,0
184109,defined,0,0
184110,as,0,0
184111,the,0,0
184112,need,0,0
184113,for,0,0
184114,further,0,0
184115,pleural,0,1
184116,intervention,0,0
184117,for,0,0
184118,fluid,0,1
184119,management,0,0
184120,on,0,0
184121,the,0,0
184122,side,0,0
184123,of,0,0
184124,the,0,0
184125,trial,0,0
184126,intervention,0,0
184127,.,0,0
184128,ETHICS,0,0
184129,AND,0,0
184130,DISSEMINATION,0,1
184131,The,0,0
184132,trial,0,0
184133,has,0,0
184134,received,0,0
184135,ethical,0,0
184136,approval,0,0
184137,from,0,0
184138,the,0,0
184139,National,0,0
184140,Research,0,0
184141,Ethics,0,1
184142,Service,0,0
184143,Committee,0,0
184144,North,0,0
184145,West-Preston,0,0
184146,(,0,0
184147,12/NW/0467,0,0
184148,),0,0
184149,.,0,0
184150,There,0,0
184151,is,0,0
184152,a,0,0
184153,trial,0,0
184154,steering,0,0
184155,committee,0,0
184156,which,0,0
184157,includes,0,0
184158,independent,0,0
184159,members,0,0
184160,and,0,0
184161,a,0,0
184162,patient,0,1
184163,and,0,0
184164,public,0,0
184165,representative,0,0
184166,.,0,0
184167,The,0,0
184168,trial,0,0
184169,results,0,0
184170,will,0,0
184171,be,0,0
184172,published,0,0
184173,in,0,0
184174,a,0,0
184175,peer-reviewed,0,0
184176,journal,0,0
184177,and,0,0
184178,presented,0,0
184179,at,0,0
184180,international,0,0
184181,conferences,0,0
184182,",",0,0
184183,as,0,0
184184,well,0,0
184185,as,0,0
184186,being,0,0
184187,disseminated,0,0
184188,via,0,0
184189,local,0,0
184190,and,0,0
184191,national,0,1
184192,charities,0,0
184193,and,0,0
184194,patient,0,0
184195,groups,0,0
184196,.,0,0
184197,All,0,0
184198,participants,0,0
184199,who,0,0
184200,wish,0,0
184201,to,0,0
184202,know,0,0
184203,the,0,0
184204,study,0,0
184205,results,0,0
184206,will,0,0
184207,also,0,0
184208,be,0,0
184209,contacted,0,0
184210,directly,0,0
184211,on,0,0
184212,their,0,0
184213,publication,0,0
184214,.,0,0
184215,TRIAL,0,0
184216,REGISTRATION,0,0
184217,NUMBER,0,0
184218,ISRCTN47845793,0,0
184219,.,0,0
184220,Absence,0,1
184221,of,0,0
184222,analgesic,0,1
184223,effect,0,0
184224,of,0,0
184225,intravenous,0,0
184226,melatonin,0,0
184227,administration,0,0
184228,during,0,0
184229,daytime,0,1
184230,after,0,0
184231,laparoscopic,0,0
184232,cholecystectomy,0,0
184233,:,0,0
184234,a,0,0
184235,randomized,0,0
184236,trial,0,0
184237,.,0,0
184238,STUDY,0,0
184239,OBJECTIVE,0,0
184240,To,0,0
184241,investigate,0,0
184242,whether,0,0
184243,melatonin,0,0
184244,administered,0,0
184245,intraoperatively,0,0
184246,reduced,0,0
184247,pain,1,1
184248,following,0,0
184249,laparoscopic,0,0
184250,cholecystectomy,0,0
184251,.,0,0
184252,DESIGN,0,0
184253,Randomized,0,0
184254,",",0,0
184255,placebo-controlled,0,0
184256,",",0,0
184257,double-blinded,0,0
184258,study,0,0
184259,.,0,0
184260,SETTING,0,0
184261,Two,0,0
184262,surgical,0,0
184263,departments,0,0
184264,in,0,0
184265,Copenhagen,0,0
184266,.,0,0
184267,PATIENTS,0,0
184268,44,0,0
184269,women,0,0
184270,between,0,0
184271,18,0,0
184272,and,0,0
184273,70,0,0
184274,years,0,0
184275,of,0,0
184276,age,0,0
184277,",",0,0
184278,who,0,0
184279,were,0,0
184280,surgical,0,0
184281,candidates,0,0
184282,for,0,0
184283,laparoscopic,0,0
184284,cholecystectomy,0,0
184285,.,0,0
184286,INTERVENTIONS,0,0
184287,Patients,0,0
184288,were,0,0
184289,anesthetized,0,0
184290,by,0,0
184291,a,0,0
184292,standard,0,0
184293,protocol,0,0
184294,and,0,0
184295,received,0,0
184296,a,0,0
184297,standard,0,0
184298,multimodal,0,0
184299,postoperative,0,1
184300,analgesic,0,1
184301,regimen,0,0
184302,.,0,0
184303,Patients,0,0
184304,undergoing,0,0
184305,surgery,0,0
184306,were,0,0
184307,admitted,0,0
184308,on,0,0
184309,the,0,0
184310,day,0,0
184311,of,0,0
184312,surgery,0,0
184313,and,0,0
184314,were,0,0
184315,discharged,0,0
184316,the,0,0
184317,day,0,0
184318,after,0,0
184319,surgery,0,0
184320,.,0,0
184321,Ten,0,0
184322,mg,0,0
184323,of,0,0
184324,intravenous,0,0
184325,(,0,0
184326,IV,0,1
184327,),0,1
184328,melatonin,0,0
184329,or,0,0
184330,placebo,0,0
184331,were,0,0
184332,administered,0,0
184333,at,0,0
184334,the,0,0
184335,time,0,1
184336,of,0,0
184337,surgical,0,0
184338,incision,0,0
184339,.,0,0
184340,MEASUREMENTS,0,0
184341,Pain,1,1
184342,was,0,0
184343,assessed,0,0
184344,by,0,0
184345,a,0,0
184346,set,0,0
184347,of,0,0
184348,questionnaires,0,0
184349,documenting,0,0
184350,pain,0,1
184351,at,0,0
184352,rest,0,0
184353,using,0,0
184354,a,0,0
184355,visual,1,1
184356,analog,1,1
184357,scale,1,1
184358,(,1,0
184359,VAS,1,0
184360,),1,0
184361,.,0,0
184362,The,0,0
184363,use,0,0
184364,of,0,0
184365,rescue,0,1
184366,medication,0,1
184367,was,0,0
184368,recorded,0,0
184369,.,0,0
184370,Sleep,1,0
184371,quality,1,1
184372,and,1,0
184373,general,1,1
184374,well-being,1,1
184375,were,0,0
184376,measured,0,0
184377,on,0,0
184378,separate,0,0
184379,VAS,1,0
184380,scales,1,1
184381,.,1,0
184382,Sleepiness,1,1
184383,was,0,0
184384,assessed,0,0
184385,by,0,0
184386,the,0,0
184387,Karolinska,0,0
184388,Sleepiness,0,1
184389,Scale,0,1
184390,.,0,0
184391,MAIN,0,0
184392,RESULTS,0,0
184393,Forty-four,0,0
184394,patients,0,0
184395,were,0,0
184396,included,0,0
184397,and,0,0
184398,randomized,0,0
184399,to,0,0
184400,the,0,0
184401,study,0,0
184402,.,0,0
184403,Three,0,0
184404,patients,0,0
184405,did,0,0
184406,not,0,0
184407,complete,0,0
184408,the,0,0
184409,study,0,0
184410,.,0,0
184411,No,0,0
184412,differences,0,0
184413,in,0,0
184414,VAS,1,1
184415,pain,1,1
184416,scores,1,1
184417,",",1,0
184418,sleep,1,1
184419,quality,1,1
184420,",",1,0
184421,general,1,1
184422,well-being,1,1
184423,",",1,0
184424,or,1,1
184425,sleepiness,1,1
184426,were,0,0
184427,found,0,0
184428,between,0,0
184429,the,0,0
184430,two,0,0
184431,groups,0,0
184432,in,0,0
184433,the,0,0
184434,postoperative,0,0
184435,period,0,0
184436,.,0,0
184437,The,0,0
184438,use,0,0
184439,of,0,0
184440,postoperative,0,1
184441,rescue,0,1
184442,medication,0,1
184443,did,0,0
184444,not,0,0
184445,differ,0,0
184446,between,0,0
184447,the,0,0
184448,groups,0,0
184449,.,0,0
184450,CONCLUSIONS,0,0
184451,The,0,0
184452,use,0,0
184453,of,0,0
184454,10mg,0,0
184455,of,0,0
184456,IV,0,0
184457,melatonin,0,0
184458,administered,0,0
184459,during,0,0
184460,laparoscopic,0,0
184461,cholecystectomy,0,0
184462,did,0,0
184463,not,0,0
184464,affect,0,0
184465,postoperative,1,1
184466,pain,1,1
184467,or,1,0
184468,use,1,1
184469,of,1,1
184470,analgesic,1,1
184471,medication,1,0
184472,.,1,0
184473,Does,0,0
184474,cognition,0,1
184475,predict,0,0
184476,treatment,0,0
184477,response,0,1
184478,and,0,1
184479,remission,0,1
184480,in,0,0
184481,psychotherapy,0,0
184482,for,0,0
184483,late-life,0,0
184484,depression,0,1
184485,?,0,0
184486,OBJECTIVES,0,0
184487,To,0,0
184488,identify,0,0
184489,cognitive,0,1
184490,predictors,0,0
184491,of,0,0
184492,geriatric,0,0
184493,depression,0,1
184494,treatment,0,0
184495,outcome,0,1
184496,.,0,0
184497,METHOD,0,0
184498,Older,0,0
184499,participants,0,0
184500,completed,0,0
184501,baseline,0,0
184502,measures,0,1
184503,of,0,0
184504,memory,0,1
184505,and,0,1
184506,executive,0,1
184507,function,0,1
184508,",",0,1
184509,health,0,1
184510,",",0,1
184511,and,0,1
184512,baseline,0,1
184513,and,0,1
184514,post-treatment,0,1
184515,Hamilton,0,1
184516,Depression,0,1
184517,Scales,0,1
184518,(,0,0
184519,HAM-D,0,0
184520,),0,0
184521,in,0,0
184522,a,0,0
184523,12-week,0,0
184524,trial,0,0
184525,comparing,0,0
184526,psychotherapies,0,0
184527,(,0,0
184528,problem-solving,0,1
184529,vs.,0,0
184530,supportive,0,0
184531,;,0,0
184532,N,0,0
184533,=,0,0
184534,46,0,0
184535,),0,0
184536,.,0,0
184537,We,0,0
184538,examined,0,0
184539,cognitive,0,0
184540,predictors,0,0
184541,to,0,0
184542,identify,0,0
184543,treatment,0,0
184544,responders,0,0
184545,(,0,0
184546,i.e.,0,0
184547,",",0,0
184548,HAM-D,1,0
184549,scores,1,1
184550,reduced,0,0
184551,by,0,0
184552,?50,0,0
184553,%,0,0
184554,),0,0
184555,and,0,0
184556,remitters,0,0
184557,(,0,0
184558,i.e.,0,0
184559,",",0,0
184560,post-treatment,0,0
184561,HAM-D,0,1
184562,score,0,1
184563,?10,0,0
184564,),0,0
184565,.,0,0
184566,RESULTS,0,0
184567,Empirically,0,0
184568,derived,0,0
184569,decision,0,0
184570,trees,0,1
184571,identified,0,0
184572,poorer,0,0
184573,performance,1,1
184574,on,1,0
184575,switching,1,0
184576,(,0,0
184577,i.e.,0,0
184578,",",0,0
184579,Trails,0,1
184580,B,0,0
184581,),0,0
184582,",",0,0
184583,with,0,0
184584,a,0,0
184585,cut-score,0,1
184586,of,0,0
184587,?82,0,0
184588,predicting,0,1
184589,psychotherapy,0,0
184590,responders,0,0
184591,.,0,0
184592,No,0,0
184593,other,0,0
184594,cognitive,0,1
184595,or,0,0
184596,health,0,1
184597,variables,0,1
184598,predicted,0,1
184599,psychotherapy,1,0
184600,outcomes,1,1
184601,in,0,0
184602,the,0,0
184603,decision,0,0
184604,trees,0,0
184605,.,0,0
184606,CONCLUSIONS,0,0
184607,Psychotherapies,0,0
184608,that,0,0
184609,support,0,0
184610,or,0,0
184611,improve,1,0
184612,the,1,0
184613,executive,1,1
184614,skill,1,1
184615,of,1,0
184616,switching,0,0
184617,may,0,0
184618,augment,0,0
184619,treatment,0,0
184620,response,0,1
184621,for,0,0
184622,older,0,0
184623,patients,0,0
184624,exhibiting,0,1
184625,executive,1,1
184626,dysfunction,1,1
184627,in,1,0
184628,depression,1,1
184629,.,1,0
184630,If,1,0
184631,replicated,1,0
184632,",",0,0
184633,Trails,0,0
184634,B,0,0
184635,has,0,0
184636,potential,0,0
184637,as,0,0
184638,a,0,0
184639,brief,0,0
184640,cognitive,0,1
184641,tool,0,0
184642,for,0,0
184643,clinical,0,0
184644,decision-making,0,1
184645,in,0,0
184646,geriatric,0,0
184647,depression,0,0
184648,.,0,0
184649,Exercise,0,0
184650,echocardiography,0,0
184651,demonstrates,0,0
184652,biventricular,0,0
184653,systolic,0,1
184654,dysfunction,0,1
184655,and,0,1
184656,reveals,0,0
184657,decreased,0,1
184658,left,0,0
184659,ventricular,0,1
184660,contractile,0,1
184661,reserve,0,1
184662,in,0,0
184663,children,0,0
184664,after,0,0
184665,tetralogy,0,0
184666,of,0,0
184667,Fallot,0,0
184668,repair,0,0
184669,.,0,0
184670,BACKGROUND,0,0
184671,Long-term,0,1
184672,biventricular,0,0
184673,systolic,0,1
184674,performance,0,0
184675,is,0,0
184676,a,0,0
184677,key,0,0
184678,determinant,0,0
184679,of,0,0
184680,clinical,0,0
184681,outcomes,0,0
184682,late,0,0
184683,after,0,0
184684,tetralogy,0,0
184685,of,0,0
184686,Fallot,0,0
184687,(,0,0
184688,TOF,0,0
184689,),0,0
184690,repair,0,0
184691,.,0,0
184692,A,0,0
184693,need,0,0
184694,exists,0,0
184695,for,0,0
184696,early,0,0
184697,indices,0,1
184698,of,0,0
184699,both,0,0
184700,left,0,0
184701,ventricular,0,1
184702,(,0,0
184703,LV,0,1
184704,),0,0
184705,and,0,0
184706,right,0,0
184707,ventricular,0,1
184708,(,0,0
184709,RV,0,1
184710,),0,0
184711,compromise,0,0
184712,in,0,0
184713,this,0,0
184714,population,0,0
184715,.,0,0
184716,METHODS,0,0
184717,Twenty-nine,0,0
184718,children,0,0
184719,(,0,0
184720,age,0,0
184721,range,0,0
184722,",",0,0
184723,5-18,0,0
184724,years,0,0
184725,),0,0
184726,with,0,0
184727,repaired,0,0
184728,TOF,0,0
184729,and,0,0
184730,44,0,0
184731,healthy,0,0
184732,controls,0,0
184733,were,0,0
184734,prospectively,0,0
184735,evaluated,0,0
184736,.,0,0
184737,M-mode,0,0
184738,and,0,0
184739,tissue,0,1
184740,Doppler,0,1
184741,data,0,0
184742,were,0,0
184743,obtained,0,0
184744,for,0,0
184745,each,0,0
184746,ventricle,0,0
184747,and,0,0
184748,the,0,0
184749,RV,0,1
184750,outflow,0,1
184751,tract,0,0
184752,at,0,0
184753,rest,0,0
184754,and,0,0
184755,during,0,0
184756,semisupine,0,1
184757,bicycle,0,0
184758,exercise,0,0
184759,.,0,0
184760,By,0,0
184761,making,0,0
184762,measurements,0,0
184763,of,0,0
184764,myocardial,0,1
184765,acceleration,0,1
184766,during,0,0
184767,isovolumic,0,0
184768,contraction,0,1
184769,during,0,0
184770,exercise,0,0
184771,",",0,0
184772,at,0,0
184773,increasing,0,0
184774,heart,0,1
184775,rates,0,1
184776,",",0,0
184777,LV,0,1
184778,force-frequency,0,1
184779,curves,0,1
184780,were,0,0
184781,constructed,0,0
184782,.,0,0
184783,Patients,0,0
184784,also,0,0
184785,underwent,0,0
184786,cardiac,0,1
184787,magnetic,0,0
184788,resonance,0,0
184789,imaging,0,1
184790,",",0,0
184791,cardiopulmonary,0,1
184792,exercise,0,0
184793,testing,0,0
184794,",",0,1
184795,and,0,1
184796,measurement,0,1
184797,of,0,1
184798,serum,0,1
184799,neurohormonal,0,0
184800,markers,0,0
184801,.,0,0
184802,RESULTS,0,0
184803,Children,0,0
184804,with,0,0
184805,repaired,0,0
184806,TOF,0,0
184807,had,0,0
184808,dilated,0,1
184809,right,0,0
184810,ventricles,0,0
184811,(,0,0
184812,RV,0,1
184813,end-diastolic,0,1
184814,volume,0,1
184815,index,0,1
184816,=,0,0
184817,153,0,0
184818,?,0,0
184819,37.3,0,0
184820,mL/m,0,0
184821,(,0,0
184822,2,0,0
184823,),0,0
184824,),0,0
184825,but,0,0
184826,normal,0,0
184827,ejection,0,1
184828,fractions,0,1
184829,as,0,0
184830,measured,0,0
184831,on,0,0
184832,magnetic,0,0
184833,resonance,0,0
184834,imaging,0,1
184835,(,0,0
184836,LV,0,1
184837,ejection,0,1
184838,fraction,0,1
184839,=,0,0
184840,59.3,0,0
184841,?,0,0
184842,6.2,0,0
184843,%,0,0
184844,",",0,0
184845,RV,0,1
184846,ejection,0,1
184847,fraction,0,1
184848,=,0,0
184849,50.2,0,0
184850,?,0,0
184851,8.5,0,0
184852,%,0,0
184853,),0,0
184854,and,0,0
184855,normal,1,0
184856,serum,1,1
184857,neurohormonal,1,0
184858,markers,1,0
184859,.,1,0
184860,Detailed,1,0
184861,resting,0,0
184862,echocardiography,0,0
184863,detected,1,0
184864,abnormal,1,1
184865,ventricular,1,1
184866,function,1,1
184867,",",1,0
184868,worst,1,1
184869,in,0,0
184870,the,0,0
184871,right,0,0
184872,ventricle,0,0
184873,and,0,0
184874,RV,0,1
184875,outflow,0,1
184876,tract,0,0
184877,.,0,0
184878,Exercise,0,0
184879,exacerbated,0,0
184880,these,0,0
184881,findings,0,0
184882,and,0,0
184883,provoked,0,0
184884,significant,0,0
184885,decline,0,0
184886,in,0,0
184887,LV,1,0
184888,indices,1,1
184889,.,1,0
184890,The,1,0
184891,LV,1,0
184892,force-frequency,1,1
184893,curves,1,1
184894,of,1,0
184895,patients,0,0
184896,were,0,0
184897,attenuated,0,0
184898,",",0,0
184899,with,0,0
184900,an,0,0
184901,early,0,0
184902,plateau,0,1
184903,and,0,0
184904,inadequate,0,1
184905,increase,0,1
184906,of,0,0
184907,isovolumic,0,0
184908,contraction,0,0
184909,.,0,0
184910,Correlations,0,0
184911,were,0,0
184912,seen,0,0
184913,between,0,0
184914,peak,0,1
184915,exercise,0,0
184916,LV,0,1
184917,isovolumic,0,1
184918,contraction,0,1
184919,and,0,1
184920,percentage,0,1
184921,predicted,1,1
184922,peak,1,1
184923,oxygen,1,1
184924,uptake,1,1
184925,(,1,0
184926,r,1,0
184927,=,0,0
184928,0.51,0,0
184929,",",0,0
184930,P,0,0
184931,=,0,0
184932,.02,0,0
184933,),1,0
184934,",",1,0
184935,LV,1,1
184936,and,1,1
184937,RV,1,1
184938,ejection,1,1
184939,fractions,1,1
184940,(,1,0
184941,r,1,0
184942,=,0,0
184943,0.41,0,0
184944,",",0,0
184945,P,0,0
184946,=,0,0
184947,.03,0,0
184948,),0,0
184949,",",0,0
184950,and,0,1
184951,RV,1,1
184952,and,1,1
184953,LV,1,1
184954,long-axis,1,1
184955,fractional,1,1
184956,shortening,1,1
184957,(,1,0
184958,r,1,0
184959,=,0,0
184960,0.44,0,0
184961,",",0,0
184962,P,0,0
184963,=,0,0
184964,.02,0,0
184965,),0,0
184966,.,0,0
184967,CONCLUSIONS,0,0
184968,The,0,0
184969,postsurgical,0,0
184970,pathophysiology,0,0
184971,of,0,0
184972,TOF,0,0
184973,begins,0,0
184974,early,0,0
184975,after,0,0
184976,repair,0,0
184977,.,0,0
184978,At,0,0
184979,a,0,0
184980,time,0,1
184981,when,0,0
184982,clinically,0,0
184983,well,0,0
184984,and,0,0
184985,while,0,0
184986,routine,0,0
184987,indices,0,1
184988,of,0,0
184989,heart,0,0
184990,function,0,1
184991,remain,0,0
184992,normal,0,0
184993,",",0,0
184994,children,0,0
184995,with,0,0
184996,repaired,0,0
184997,TOF,0,0
184998,exhibit,0,0
184999,RV,0,1
185000,dilatation,0,1
185001,and,0,1
185002,subtle,0,1
185003,",",0,1
185004,interlinked,0,0
185005,biventricular,0,0
185006,abnormalities,0,0
185007,on,0,0
185008,resting,0,0
185009,echocardiography,0,0
185010,.,0,0
185011,Exercise,0,0
185012,echocardiography,0,0
185013,provides,0,0
185014,additional,0,0
185015,information,0,1
185016,and,0,0
185017,reveals,0,0
185018,abnormal,0,1
185019,LV,0,0
185020,excitation-contractile,0,0
185021,coupling,0,0
185022,that,0,0
185023,may,0,0
185024,be,0,0
185025,linked,0,0
185026,to,0,0
185027,impaired,0,0
185028,exercise,0,0
185029,capacity,0,1
185030,.,0,0
185031,Randomised,0,0
185032,trial,0,0
185033,of,0,0
185034,text,0,0
185035,messaging,0,0
185036,on,0,0
185037,adherence,1,0
185038,to,0,0
185039,cardiovascular,0,1
185040,preventive,0,1
185041,treatment,0,0
185042,(,0,0
185043,INTERACT,0,0
185044,trial,0,0
185045,),0,0
185046,.,0,0
185047,BACKGROUND,0,0
185048,About,0,0
185049,one,0,0
185050,third,0,0
185051,of,0,0
185052,patients,0,0
185053,prescribed,0,0
185054,blood,0,1
185055,pressure,0,1
185056,or,0,0
185057,lipid-lowering,0,0
185058,drugs,0,0
185059,for,0,0
185060,the,0,0
185061,prevention,0,0
185062,of,0,0
185063,coronary,0,0
185064,heart,0,1
185065,disease,0,1
185066,and,0,0
185067,stroke,0,1
185068,do,0,0
185069,not,0,0
185070,take,0,0
185071,their,0,0
185072,medication,0,0
185073,as,0,0
185074,prescribed,0,0
185075,.,0,0
185076,We,0,0
185077,conducted,0,0
185078,a,0,0
185079,randomized,0,0
185080,trial,0,0
185081,to,0,0
185082,evaluate,0,0
185083,text,0,0
185084,messaging,0,0
185085,as,0,0
185086,a,0,0
185087,means,0,0
185088,of,0,0
185089,improving,0,1
185090,adherence,1,0
185091,to,0,0
185092,cardiovascular,0,1
185093,disease,0,1
185094,preventive,0,0
185095,treatment,0,0
185096,.,0,0
185097,METHODS,0,0
185098,303,0,0
185099,patients,0,0
185100,taking,0,0
185101,blood,0,1
185102,pressure,0,1
185103,and/or,0,0
185104,lipid-lowering,0,0
185105,medications,0,0
185106,were,0,0
185107,randomly,0,0
185108,assigned,0,0
185109,to,0,0
185110,being,0,0
185111,sent,0,0
185112,text,0,0
185113,messages,0,0
185114,(,0,0
185115,Text,0,1
185116,group,0,0
185117,",",0,0
185118,151,0,0
185119,),0,0
185120,or,0,0
185121,not,0,0
185122,being,0,0
185123,sent,0,0
185124,them,0,0
185125,(,0,0
185126,No,0,0
185127,text,0,1
185128,group,0,0
185129,",",0,0
185130,152,0,0
185131,),0,0
185132,.,0,0
185133,Texts,0,1
185134,were,0,0
185135,sent,0,0
185136,daily,0,0
185137,for,0,0
185138,2,0,0
185139,weeks,0,0
185140,",",0,0
185141,alternate,0,0
185142,days,0,0
185143,for,0,0
185144,2,0,0
185145,weeks,0,0
185146,and,0,0
185147,weekly,0,0
185148,thereafter,0,0
185149,for,0,0
185150,22,0,0
185151,weeks,0,0
185152,(,0,0
185153,6,0,0
185154,months,0,0
185155,overall,0,1
185156,),0,0
185157,",",0,0
185158,using,0,0
185159,an,0,0
185160,automated,0,0
185161,computer,0,0
185162,programme,0,0
185163,.,0,0
185164,Patients,0,0
185165,were,0,0
185166,asked,0,0
185167,to,0,0
185168,respond,0,0
185169,on,0,0
185170,whether,0,0
185171,they,0,0
185172,had,0,0
185173,taken,0,0
185174,their,0,0
185175,medication,0,0
185176,",",0,0
185177,whether,0,0
185178,the,0,0
185179,text,0,0
185180,reminded,0,0
185181,them,0,0
185182,to,0,0
185183,do,0,0
185184,so,0,0
185185,if,0,0
185186,they,0,0
185187,had,0,0
185188,forgotten,0,0
185189,",",0,0
185190,and,0,0
185191,if,0,0
185192,they,0,0
185193,had,0,0
185194,not,0,0
185195,taken,0,0
185196,their,0,0
185197,medication,0,0
185198,to,0,0
185199,determine,0,0
185200,if,0,0
185201,there,0,0
185202,was,0,0
185203,a,0,0
185204,reason,0,0
185205,for,0,0
185206,not,0,0
185207,doing,0,0
185208,so,0,0
185209,.,0,0
185210,At,0,0
185211,6,0,0
185212,months,0,0
185213,",",0,0
185214,use,0,0
185215,of,0,1
185216,medication,0,1
185217,was,0,0
185218,assessed,0,0
185219,.,0,0
185220,RESULTS,0,0
185221,Two,0,0
185222,patients,0,0
185223,were,0,0
185224,lost,0,1
185225,to,0,0
185226,follow-up,0,0
185227,",",0,0
185228,providing,0,0
185229,data,0,0
185230,on,0,0
185231,301,0,0
185232,for,0,0
185233,analysis,0,0
185234,.,0,0
185235,In,0,0
185236,the,0,0
185237,No,0,0
185238,text,0,0
185239,group,0,0
185240,38/151,0,0
185241,(,0,0
185242,25,0,0
185243,%,0,0
185244,),0,0
185245,took,0,0
185246,less,0,0
185247,than,0,0
185248,80,0,0
185249,%,0,0
185250,of,0,0
185251,the,0,0
185252,prescribed,0,0
185253,regimen,0,0
185254,(,0,0
185255,ie,0,0
185256,.,0,0
185257,stopped,0,0
185258,medication,0,1
185259,completely,0,0
185260,or,0,0
185261,took,0,0
185262,it,0,0
185263,on,0,0
185264,fewer,0,0
185265,than,0,0
185266,22,0,0
185267,of,0,0
185268,the,0,0
185269,last,0,0
185270,28,0,0
185271,days,0,0
185272,of,0,0
185273,follow-up,0,0
185274,),0,0
185275,compared,0,0
185276,to,0,0
185277,14/150,0,0
185278,patients,0,0
185279,(,0,0
185280,9,0,0
185281,%,0,0
185282,),0,0
185283,in,0,0
185284,the,0,0
185285,Text,0,0
185286,group,0,0
185287,-,0,0
185288,an,0,0
185289,improvement,0,1
185290,in,0,0
185291,adherence,1,0
185292,affecting,0,0
185293,16,0,0
185294,per,0,0
185295,100,0,0
185296,patients,0,0
185297,(,0,0
185298,95,0,0
185299,%,0,0
185300,CI,0,0
185301,7,0,0
185302,to,0,0
185303,24,0,0
185304,),0,0
185305,",",0,0
185306,p,0,0
185307,<,0,0
185308,0.001,0,0
185309,.,0,0
185310,The,0,0
185311,texts,0,0
185312,reminded,0,0
185313,98/151,0,0
185314,patients,0,0
185315,(,0,0
185316,65,0,0
185317,%,0,0
185318,),0,0
185319,to,0,0
185320,take,1,0
185321,medication,1,0
185322,on,0,0
185323,at,0,0
185324,least,0,0
185325,one,0,0
185326,occasion,0,0
185327,and,0,0
185328,lead,0,0
185329,to,0,0
185330,20/151,0,0
185331,(,0,0
185332,13,0,0
185333,%,0,0
185334,),0,0
185335,who,0,0
185336,stopped,0,0
185337,taking,0,0
185338,medication,0,1
185339,because,0,0
185340,of,0,0
185341,concern,0,0
185342,over,0,0
185343,efficacy,1,1
185344,or,1,0
185345,side-effects,1,1
185346,",",1,0
185347,resuming,1,0
185348,treatment,1,0
185349,.,1,0
185350,CONCLUSIONS,0,0
185351,In,0,0
185352,patients,0,0
185353,taking,0,0
185354,blood,0,1
185355,pressure,0,1
185356,or,0,0
185357,lipid-lowering,0,0
185358,treatment,0,0
185359,for,0,0
185360,the,0,0
185361,prevention,0,0
185362,of,0,0
185363,cardiovascular,0,1
185364,disease,0,1
185365,",",0,0
185366,text,0,1
185367,messaging,0,0
185368,improved,0,1
185369,medication,1,1
185370,adherence,1,1
185371,compared,0,0
185372,with,0,0
185373,no,0,0
185374,text,0,0
185375,messaging,0,0
185376,.,0,0
185377,TRIAL,0,0
185378,REGISTRATION,0,0
185379,Controlled-Trials.com,0,0
185380,ISRCTN74757601,0,0
185381,.,0,0
185382,Effect,0,0
185383,of,0,0
185384,L-type,0,0
185385,calcium,0,1
185386,channel,0,0
185387,blocker,0,0
185388,(,0,0
185389,amlodipine,0,0
185390,),0,0
185391,on,0,0
185392,myocardial,1,1
185393,iron,1,0
185394,deposition,1,1
185395,in,0,0
185396,patients,0,0
185397,with,0,0
185398,thalassaemia,0,0
185399,with,0,0
185400,moderate-to-severe,0,0
185401,myocardial,1,1
185402,iron,1,0
185403,deposition,1,1
185404,:,1,0
185405,protocol,0,0
185406,for,0,0
185407,a,0,0
185408,randomised,0,0
185409,",",0,0
185410,controlled,0,0
185411,trial,0,0
185412,.,0,0
185413,INTRODUCTION,0,1
185414,Sideroblastic,0,0
185415,cardiomyopathy,0,1
185416,secondary,0,0
185417,to,0,0
185418,repeated,1,0
185419,blood,1,1
185420,transfusions,1,1
185421,is,0,0
185422,a,0,0
185423,feared,0,1
185424,complication,0,1
185425,in,0,0
185426,thalassaemia,0,0
185427,.,0,0
185428,Control,0,0
185429,of,0,0
185430,myocardial,1,0
185431,iron,1,0
185432,is,0,0
185433,thus,0,0
185434,becoming,0,0
185435,the,0,0
185436,cornerstone,0,0
185437,of,0,0
185438,thalassaemia,0,0
185439,management,0,0
185440,.,0,0
185441,Recent,0,0
185442,evidence,0,0
185443,suggests,0,0
185444,a,0,0
185445,role,0,0
185446,for,0,0
185447,L-type,0,0
185448,Ca,0,1
185449,(,0,0
185450,2+,0,0
185451,),0,0
185452,channels,0,0
185453,in,0,0
185454,mediating,0,1
185455,iron,0,0
185456,uptake,0,1
185457,by,0,0
185458,the,0,0
185459,heart,0,0
185460,.,0,0
185461,Blocking,0,0
185462,the,0,0
185463,cellular,0,0
185464,iron,0,0
185465,uptake,0,1
185466,through,0,0
185467,these,0,0
185468,channels,0,0
185469,may,0,0
185470,add,0,0
185471,to,0,0
185472,the,0,0
185473,benefit,0,0
185474,of,0,0
185475,therapy,0,0
185476,to,0,0
185477,standard,0,0
185478,chelation,0,0
185479,in,0,0
185480,reducing,0,0
185481,myocardial,1,1
185482,iron,1,0
185483,.,1,0
185484,We,0,0
185485,aim,0,0
185486,to,0,0
185487,determine,0,0
185488,the,0,0
185489,efficacy,0,1
185490,of,0,0
185491,amlodipine,0,0
185492,(,0,0
185493,a,0,0
185494,calcium,0,0
185495,channel,0,0
185496,blocker,0,0
185497,),0,0
185498,as,0,0
185499,an,0,0
185500,adjunct,0,0
185501,to,0,0
185502,standard,0,0
185503,aggressive,0,1
185504,chelation,0,0
185505,in,0,0
185506,retarding,0,0
185507,myocardial,1,1
185508,iron,1,0
185509,deposition,1,1
185510,in,0,0
185511,thalassaemics,0,0
185512,with,0,0
185513,or,0,0
185514,without,0,0
185515,cardiomyopathy,0,1
185516,.,0,0
185517,OUTCOMES,0,0
185518,The,0,0
185519,primary,0,0
185520,outcome,0,0
185521,is,0,0
185522,to,0,0
185523,compare,1,0
185524,the,1,0
185525,efficacy,1,1
185526,of,1,0
185527,amlodipine+chelation,1,0
185528,(,1,0
185529,intervention,1,0
185530,),1,0
185531,versus,1,0
185532,standard,1,0
185533,chelation,1,1
185534,(,1,0
185535,control,1,0
185536,),1,0
185537,in,1,0
185538,retarding,1,0
185539,myocardial,1,1
185540,iron,1,0
185541,deposition,1,1
185542,.,1,0
185543,Secondary,0,0
185544,outcomes,0,0
185545,include,0,0
185546,the,0,0
185547,effect,1,0
185548,of,1,0
185549,amlodipine,1,0
185550,therapy,1,0
185551,on,1,0
185552,systolic,1,1
185553,and,1,0
185554,diastolic,1,1
185555,function,1,1
185556,",",1,0
185557,strain,1,1
185558,and,1,1
185559,strain,1,1
185560,rate,1,1
185561,and,1,1
185562,liver,1,1
185563,iron,1,0
185564,content,1,1
185565,.,1,0
185566,METHODS,0,0
185567,AND,0,0
185568,ANALYSIS,0,0
185569,This,0,0
185570,is,0,0
185571,a,0,0
185572,single-centre,0,0
185573,",",0,0
185574,parallel-group,0,0
185575,",",0,0
185576,prospective,0,0
185577,randomised,0,0
185578,control,0,0
185579,trial,0,0
185580,.,0,0
185581,Twenty,0,0
185582,patients,0,0
185583,will,0,0
185584,be,0,0
185585,randomised,0,0
185586,in,0,0
185587,a,0,0
185588,1:1,0,0
185589,allocation,0,0
185590,ratio,0,0
185591,into,0,0
185592,the,0,0
185593,intervention,0,0
185594,and,0,0
185595,control,0,0
185596,arms,0,0
185597,.,0,0
185598,In,0,0
185599,addition,0,0
185600,to,0,0
185601,conventional,0,0
185602,echocardiography,0,1
185603,",",0,0
185604,MRI,0,1
185605,T2*,0,1
185606,values,0,1
185607,for,0,0
185608,assessment,0,0
185609,of,0,0
185610,cardiac,1,1
185611,and,1,1
185612,liver,1,1
185613,iron,1,0
185614,load,1,1
185615,will,0,0
185616,be,0,0
185617,obtained,0,0
185618,at,0,0
185619,baseline,0,0
185620,and,0,0
185621,at,0,0
185622,6,0,0
185623,and,0,0
185624,12,0,0
185625,months,0,0
185626,.,0,0
185627,Cardiac,0,1
185628,T2*,0,1
185629,will,0,0
185630,be,0,0
185631,reported,0,0
185632,as,0,0
185633,the,0,0
185634,geometric,0,0
185635,mean,0,1
185636,and,0,0
185637,per,0,1
185638,cent,0,0
185639,coefficient,0,1
185640,of,0,1
185641,variation,0,1
185642,",",0,0
185643,and,0,0
185644,an,0,0
185645,increase,0,0
185646,in,0,0
185647,cardiac,0,1
185648,T2*,0,1
185649,values,0,1
185650,from,0,0
185651,baseline,0,0
185652,will,0,0
185653,be,0,0
185654,used,0,0
185655,as,0,0
185656,an,0,0
185657,end,0,0
185658,point,0,0
185659,to,0,0
185660,compare,0,0
185661,the,0,0
185662,efficacy,0,1
185663,of,0,0
185664,therapy,0,0
185665,.,0,0
185666,A,0,0
185667,p,0,0
185668,Value,0,0
185669,of,0,0
185670,<,0,0
185671,0.05,0,0
185672,will,0,0
185673,be,0,0
185674,considered,0,0
185675,significant,0,0
185676,.,0,0
185677,STUDY,0,1
185678,SETTING,0,0
185679,Department,0,0
185680,of,0,0
185681,Pediatric,0,0
185682,and,0,0
185683,Child,0,1
185684,Health,0,1
185685,",",0,0
185686,Aga,0,0
185687,Khan,0,0
185688,University,0,0
185689,Hospital,0,1
185690,",",0,0
185691,Karachi,0,1
185692,",",0,0
185693,Pakistan,0,0
185694,.,0,1
185695,ETHICS,0,0
185696,AND,0,0
185697,DISSEMINATION,0,1
185698,This,0,0
185699,study,0,0
185700,has,0,0
185701,been,0,0
185702,approved,0,0
185703,by,0,0
185704,the,0,0
185705,Ethics,0,0
185706,Review,0,0
185707,Committee,0,0
185708,and,0,0
185709,Clinical,0,1
185710,Trials,0,1
185711,Unit,0,0
185712,at,0,0
185713,The,0,0
185714,Aga,0,0
185715,Khan,0,0
185716,University,0,0
185717,with,0,0
185718,respect,0,0
185719,to,0,0
185720,scientific,0,1
185721,content,0,1
185722,and,0,1
185723,compliance,0,1
185724,with,0,0
185725,applicable,0,0
185726,research,0,0
185727,and,0,0
185728,human,0,0
185729,subjects,0,0
185730,regulations,0,0
185731,.,0,0
185732,Findings,0,0
185733,will,0,0
185734,be,0,0
185735,reported,0,0
185736,through,0,0
185737,scientific,0,0
185738,publications,0,0
185739,and,0,1
185740,research,0,0
185741,conferences,0,0
185742,and,0,1
185743,project,0,0
185744,summary,0,1
185745,papers,0,0
185746,for,0,0
185747,participants,0,0
185748,.,0,0
185749,TRIAL,0,0
185750,REGISTRATION,0,0
185751,NUMBER,0,0
185752,ClinicalTrials.Gov,0,0
185753,.,0,0
185754,Registration,0,0
185755,no,0,0
185756,:,0,0
185757,NCT02065492,0,0
185758,.,0,0
185759,Most,0,0
185760,functional,0,0
185761,outcomes,0,0
185762,are,0,0
185763,similar,0,0
185764,for,0,0
185765,men,0,0
185766,and,0,0
185767,women,0,0
185768,after,0,0
185769,hip,0,0
185770,fracture,0,0
185771,:,0,0
185772,a,0,0
185773,secondary,0,0
185774,analysis,0,0
185775,of,0,0
185776,the,0,0
185777,enhancing,0,0
185778,mobility,0,1
185779,after,0,0
185780,hip,0,1
185781,fracture,0,1
185782,trial,0,0
185783,.,0,0
185784,BACKGROUND,0,0
185785,The,0,0
185786,impact,0,0
185787,of,0,0
185788,gender,0,0
185789,on,0,0
185790,functional,0,0
185791,outcomes,0,1
185792,after,0,0
185793,hip,0,0
185794,fracture,0,0
185795,is,0,0
185796,not,0,0
185797,known,0,0
185798,.,0,0
185799,We,0,0
185800,aimed,0,0
185801,to,0,0
185802,determine,0,0
185803,the,0,0
185804,extent,0,0
185805,to,0,0
185806,which,0,0
185807,gender,0,0
185808,influenced,0,0
185809,functional,1,0
185810,outcome,1,1
185811,and,1,0
185812,response,1,1
185813,to,1,0
185814,exercise,1,0
185815,in,0,0
185816,older,0,0
185817,people,0,0
185818,after,0,0
185819,hip,0,1
185820,fracture,0,1
185821,",",0,0
185822,and,0,0
185823,to,0,0
185824,determine,0,0
185825,if,0,0
185826,any,0,0
185827,differences,0,0
185828,persisted,0,0
185829,after,0,0
185830,adjusting,0,0
185831,for,0,0
185832,cognition,0,1
185833,",",0,0
185834,weight,0,1
185835,and,0,1
185836,age,0,0
185837,.,0,0
185838,METHOD,0,0
185839,Secondary,0,0
185840,analysis,0,0
185841,of,0,0
185842,data,0,0
185843,from,0,0
185844,the,0,0
185845,Enhancing,0,0
185846,Mobility,0,1
185847,After,0,0
185848,Hip,0,0
185849,Fracture,0,1
185850,trial,0,0
185851,in,0,0
185852,which,0,0
185853,older,0,0
185854,people,0,0
185855,after,0,0
185856,hip,0,1
185857,fracture,0,1
185858,received,0,0
185859,either,0,0
185860,a,0,0
185861,lower,0,0
185862,or,0,0
185863,higher,0,1
185864,intensity,0,1
185865,exercise,0,0
185866,program,0,0
185867,.,0,0
185868,Functional,1,0
185869,outcomes,1,1
185870,included,0,0
185871,physical,1,1
185872,performance,1,1
185873,and,1,0
185874,self-reported,1,1
185875,measures,1,1
185876,.,1,0
185877,Regression,0,1
185878,models,0,0
185879,were,0,0
185880,used,0,0
185881,to,0,0
185882,compare,0,0
185883,genders,0,0
185884,at,0,0
185885,baseline,0,0
185886,",",0,0
185887,week,0,0
185888,4,0,0
185889,and,0,0
185890,week,0,0
185891,16,0,0
185892,",",0,0
185893,with,0,0
185894,adjustment,0,0
185895,for,0,0
185896,baseline,0,0
185897,values,0,1
185898,",",0,1
185899,cognition,0,1
185900,",",0,1
185901,weight,0,1
185902,and,0,1
185903,age,0,0
185904,.,0,1
185905,Interaction,0,0
185906,terms,0,0
185907,were,0,0
185908,used,0,0
185909,to,0,0
185910,assess,0,0
185911,a,0,0
185912,differential,0,0
185913,impact,0,0
185914,of,0,0
185915,the,0,0
185916,intervention,0,0
185917,by,0,0
185918,gender,0,0
185919,.,0,0
185920,RESULTS,0,0
185921,Outcome,0,1
185922,data,0,0
185923,were,0,0
185924,available,0,0
185925,for,0,0
185926,160,0,0
185927,participants,0,0
185928,",",0,0
185929,30,0,0
185930,men,0,0
185931,(,0,0
185932,19,0,0
185933,%,0,0
185934,),0,0
185935,and,0,0
185936,130,0,0
185937,women,0,0
185938,(,0,0
185939,81,0,0
185940,%,0,0
185941,),0,0
185942,at,0,0
185943,baseline,0,0
185944,",",0,0
185945,with,0,0
185946,the,0,0
185947,withdrawal,0,0
185948,of,0,0
185949,4,0,0
185950,men,0,0
185951,(,0,0
185952,13,0,0
185953,%,0,0
185954,),0,0
185955,and,0,0
185956,6,0,0
185957,women,0,0
185958,(,0,0
185959,5,0,0
185960,%,0,0
185961,),0,0
185962,at,0,0
185963,week,0,0
185964,16,0,0
185965,.,0,0
185966,There,0,0
185967,were,0,0
185968,no,1,0
185969,gender,1,0
185970,differences,1,0
185971,for,0,0
185972,any,0,0
185973,baseline,1,0
185974,measures,1,1
185975,or,0,0
185976,for,0,0
185977,most,0,0
185978,of,0,0
185979,the,0,0
185980,19,0,0
185981,functional,1,0
185982,outcome,1,0
185983,measures,1,1
185984,at,0,0
185985,weeks,0,0
185986,4,0,0
185987,and,0,0
185988,16,0,0
185989,.,0,0
185990,At,0,0
185991,week,0,0
185992,4,0,0
185993,men,0,0
185994,performed,0,0
185995,better,0,0
185996,in,0,0
185997,knee,1,1
185998,extensor,1,1
185999,strength,1,1
186000,(,0,0
186001,2.1,0,0
186002,kg,0,0
186003,",",0,0
186004,95,0,0
186005,%,0,0
186006,CI,0,0
186007,0.6,0,0
186008,to,0,0
186009,3.7,0,0
186010,",",0,0
186011,p,0,0
186012,<,0,0
186013,0.01,0,0
186014,),0,0
186015,.,0,0
186016,This,0,0
186017,difference,1,0
186018,did,1,0
186019,not,1,0
186020,persist,1,0
186021,after,0,0
186022,adjustment,0,0
186023,for,0,0
186024,body,1,1
186025,weight,1,1
186026,",",0,0
186027,however,0,0
186028,persisted,0,0
186029,after,0,0
186030,adjusting,0,0
186031,for,0,0
186032,baseline,1,0
186033,",",1,0
186034,cognition,1,1
186035,",",1,1
186036,and,1,1
186037,age,1,0
186038,(,0,0
186039,p,0,0
186040,=,0,0
186041,0.038,0,0
186042,),0,0
186043,.,0,0
186044,At,0,0
186045,week,0,0
186046,4,0,0
186047,",",0,0
186048,men,0,0
186049,performed,0,0
186050,better,0,0
186051,in,0,0
186052,coordinated,1,0
186053,stability,1,1
186054,(,0,0
186055,-10.0,0,0
186056,error,0,1
186057,score,0,1
186058,",",0,0
186059,95,0,0
186060,%,0,0
186061,CI,0,0
186062,-17.6,0,0
186063,to,0,0
186064,-2.4,0,0
186065,",",0,0
186066,p=0.010,0,0
186067,),0,0
186068,and,0,0
186069,this,0,0
186070,persisted,1,0
186071,after,0,0
186072,adjusting,0,0
186073,for,0,0
186074,baseline,1,0
186075,values,1,1
186076,only,0,0
186077,but,0,0
186078,not,0,0
186079,for,0,0
186080,cognition,1,1
186081,and,1,1
186082,age,1,0
186083,(,0,0
186084,p,0,0
186085,=,0,0
186086,0.073,0,0
186087,),0,0
186088,.,0,0
186089,At,0,0
186090,week,0,0
186091,16,0,0
186092,",",0,0
186093,men,0,0
186094,performed,0,0
186095,better,0,0
186096,in,0,0
186097,coordinated,1,0
186098,stability,1,1
186099,(,0,0
186100,-10.2,0,0
186101,error,0,1
186102,score,0,1
186103,",",0,0
186104,95,0,0
186105,%,0,0
186106,CI,0,0
186107,-18.4,0,0
186108,to,0,0
186109,-1.9,0,0
186110,",",0,0
186111,p=0.016,0,0
186112,),0,0
186113,and,0,0
186114,this,0,0
186115,persisted,1,0
186116,after,0,0
186117,adjusting,0,0
186118,only,0,0
186119,for,0,0
186120,cognitive,1,1
186121,impairment,1,1
186122,(,0,0
186123,p,0,0
186124,=,0,0
186125,0.029,0,0
186126,),0,0
186127,but,0,0
186128,not,0,0
186129,for,0,0
186130,age,1,0
186131,and,1,1
186132,baseline,1,1
186133,(,0,0
186134,p,0,0
186135,=,0,0
186136,0.135,0,0
186137,),0,0
186138,.,0,0
186139,There,0,0
186140,was,0,0
186141,no,0,0
186142,indication,0,0
186143,of,0,0
186144,a,0,0
186145,differential,1,0
186146,impact,1,0
186147,of,1,0
186148,intervention,1,0
186149,type,1,0
186150,on,0,0
186151,the,0,0
186152,basis,0,0
186153,of,0,0
186154,gender,0,0
186155,.,0,0
186156,CONCLUSIONS,0,0
186157,A,0,0
186158,few,0,0
186159,between,0,0
186160,gender,0,0
186161,differences,0,0
186162,were,0,0
186163,observed,0,0
186164,in,0,0
186165,strength,1,1
186166,and,1,1
186167,balance,1,1
186168,",",0,0
186169,however,0,0
186170,these,0,0
186171,appeared,0,0
186172,to,0,0
186173,be,0,0
186174,confounded,0,0
186175,by,0,0
186176,body,1,1
186177,weight,1,1
186178,",",1,0
186179,age,1,0
186180,and/or,1,0
186181,cognition,1,0
186182,.,1,0
186183,Cognitive,0,1
186184,behavioral,0,1
186185,therapy,0,0
186186,for,0,0
186187,early,0,0
186188,adolescents,0,0
186189,with,0,0
186190,autism,0,0
186191,spectrum,0,0
186192,disorders,0,0
186193,and,0,1
186194,clinical,0,0
186195,anxiety,0,1
186196,:,0,0
186197,a,0,0
186198,randomized,0,0
186199,",",0,0
186200,controlled,0,0
186201,trial,0,0
186202,.,0,0
186203,Clinically,0,0
186204,elevated,0,0
186205,anxiety,0,0
186206,is,0,0
186207,a,0,0
186208,common,0,0
186209,",",0,0
186210,impairing,0,1
186211,feature,0,0
186212,of,0,0
186213,autism,0,0
186214,spectrum,0,0
186215,disorders,0,0
186216,(,0,0
186217,ASD,0,0
186218,),0,0
186219,.,0,0
186220,A,0,0
186221,modular,0,0
186222,CBT,0,0
186223,program,0,0
186224,designed,0,0
186225,for,0,0
186226,preteens,0,0
186227,with,0,0
186228,ASD,0,0
186229,",",0,0
186230,Behavioral,0,1
186231,Interventions,0,0
186232,for,0,0
186233,Anxiety,0,0
186234,in,0,0
186235,Children,0,0
186236,with,0,0
186237,Autism,0,1
186238,(,0,0
186239,BIACA,0,1
186240,;,0,0
186241,Wood,0,1
186242,et,0,0
186243,al.,0,0
186244,",",0,0
186245,2009,0,0
186246,),0,0
186247,was,0,0
186248,enhanced,0,0
186249,and,0,0
186250,modified,0,0
186251,to,0,0
186252,address,0,0
186253,the,0,0
186254,developmental,0,0
186255,needs,0,0
186256,of,0,0
186257,early,0,0
186258,adolescents,0,0
186259,with,0,0
186260,ASD,0,0
186261,and,0,0
186262,clinical,0,0
186263,anxiety,0,1
186264,.,0,0
186265,Thirty-three,0,0
186266,adolescents,0,0
186267,(,0,0
186268,11-15,0,0
186269,years,0,0
186270,old,0,0
186271,),0,0
186272,were,0,0
186273,randomly,0,0
186274,assigned,0,0
186275,to,0,0
186276,16,0,0
186277,sessions,0,0
186278,of,0,0
186279,CBT,0,0
186280,or,0,0
186281,an,0,0
186282,equivalent,0,0
186283,waitlist,0,0
186284,period,0,0
186285,.,0,0
186286,The,0,0
186287,CBT,0,0
186288,model,0,0
186289,emphasized,0,0
186290,exposure,0,0
186291,",",0,0
186292,challenging,0,0
186293,irrational,0,1
186294,beliefs,0,1
186295,",",0,0
186296,and,0,1
186297,behavioral,0,1
186298,supports,0,0
186299,provided,0,0
186300,by,0,0
186301,caregivers,0,0
186302,",",0,0
186303,as,0,0
186304,well,0,0
186305,as,0,0
186306,numerous,0,0
186307,ASD-specific,0,0
186308,treatment,0,0
186309,elements,0,0
186310,.,0,0
186311,Independent,0,0
186312,evaluators,0,0
186313,",",0,0
186314,parents,0,1
186315,",",0,1
186316,and,0,1
186317,adolescents,0,0
186318,rated,0,1
186319,symptom,1,1
186320,severity,1,1
186321,at,0,0
186322,baseline,0,0
186323,and,0,0
186324,posttreatment/postwaitlist,0,0
186325,.,0,0
186326,In,0,0
186327,intent-to-treat,0,0
186328,analyses,0,0
186329,",",0,0
186330,the,0,0
186331,CBT,0,0
186332,group,0,0
186333,outperformed,0,0
186334,the,0,0
186335,waitlist,0,0
186336,group,0,0
186337,on,0,0
186338,independent,0,0
186339,evaluators,0,0
186340,',0,0
186341,ratings,1,1
186342,of,1,0
186343,anxiety,1,1
186344,severity,1,1
186345,on,1,0
186346,the,1,0
186347,Pediatric,1,0
186348,Anxiety,1,1
186349,Rating,1,1
186350,Scale,1,1
186351,(,1,0
186352,PARS,1,1
186353,),1,0
186354,and,0,0
186355,79,0,0
186356,%,0,0
186357,of,0,0
186358,the,0,0
186359,CBT,0,0
186360,group,0,0
186361,met,0,0
186362,Clinical,1,1
186363,Global,1,1
186364,Impressions-Improvement,1,1
186365,scale,1,1
186366,criteria,0,0
186367,for,0,0
186368,positive,0,1
186369,treatment,0,0
186370,response,0,1
186371,at,0,0
186372,posttreatment,0,0
186373,",",0,0
186374,as,0,0
186375,compared,0,0
186376,to,0,0
186377,only,0,0
186378,28.6,0,0
186379,%,0,0
186380,of,0,0
186381,the,0,0
186382,waitlist,0,0
186383,group,0,0
186384,.,0,0
186385,Group,0,0
186386,differences,0,0
186387,were,0,0
186388,not,0,0
186389,found,0,0
186390,for,0,0
186391,diagnostic,1,0
186392,remission,1,1
186393,or,1,0
186394,questionnaire,1,1
186395,measures,1,1
186396,of,1,0
186397,anxiety,1,1
186398,.,1,0
186399,However,0,0
186400,",",0,0
186401,parent-report,1,1
186402,data,1,0
186403,indicated,0,0
186404,that,0,0
186405,there,0,0
186406,was,0,0
186407,a,0,0
186408,positive,1,1
186409,treatment,1,0
186410,effect,1,0
186411,of,1,0
186412,CBT,1,0
186413,on,1,0
186414,autism,1,0
186415,symptom,1,1
186416,severity,1,1
186417,.,1,0
186418,The,0,0
186419,CBT,0,0
186420,manual,0,0
186421,under,0,0
186422,investigation,0,0
186423,",",0,0
186424,enhanced,0,0
186425,for,0,0
186426,early,0,0
186427,adolescents,0,0
186428,with,0,0
186429,ASD,0,0
186430,",",0,0
186431,yielded,0,0
186432,meaningful,0,1
186433,treatment,0,0
186434,effects,0,0
186435,on,0,0
186436,the,0,0
186437,primary,0,0
186438,outcome,0,1
186439,measure,0,1
186440,(,0,0
186441,PARS,0,1
186442,),0,0
186443,",",0,0
186444,although,0,0
186445,additional,0,0
186446,developmental,0,0
186447,modifications,0,0
186448,to,0,0
186449,the,0,0
186450,manual,0,0
186451,are,0,0
186452,likely,0,0
186453,warranted,0,0
186454,.,0,0
186455,Future,0,0
186456,studies,0,0
186457,examining,0,0
186458,this,0,0
186459,protocol,0,0
186460,relative,0,0
186461,to,0,0
186462,an,0,0
186463,active,0,0
186464,control,0,0
186465,are,0,0
186466,needed,0,0
186467,.,0,0
186468,Improving,0,1
186469,peer,1,0
186470,engagement,1,1
186471,of,0,0
186472,children,0,0
186473,with,0,0
186474,autism,0,0
186475,on,0,0
186476,the,0,0
186477,school,0,0
186478,playground,0,0
186479,:,0,0
186480,a,0,0
186481,randomized,0,0
186482,controlled,0,0
186483,trial,0,0
186484,.,0,0
186485,This,0,0
186486,study,0,0
186487,aimed,0,0
186488,to,0,0
186489,test,0,0
186490,the,0,0
186491,effects,0,0
186492,of,0,0
186493,a,0,0
186494,psychosocial,0,0
186495,intervention,0,0
186496,",",0,0
186497,Remaking,0,1
186498,Recess,0,0
186499,",",0,0
186500,on,0,0
186501,peer,0,0
186502,engagement,0,1
186503,for,0,0
186504,children,0,0
186505,with,0,0
186506,autism,0,0
186507,spectrum,0,0
186508,disorder,0,0
186509,(,0,0
186510,ASD,0,0
186511,),0,0
186512,.,0,0
186513,Using,0,0
186514,a,0,0
186515,randomized,0,0
186516,",",0,0
186517,wait-list-controlled,0,0
186518,design,0,0
186519,",",0,0
186520,the,0,0
186521,intervention,0,0
186522,was,0,0
186523,implemented,0,0
186524,during,0,0
186525,recess,0,0
186526,at,0,0
186527,four,0,0
186528,elementary,0,0
186529,schools,0,0
186530,.,0,0
186531,The,0,0
186532,immediate,0,0
186533,treatment,0,0
186534,(,0,0
186535,IT,0,1
186536,),0,1
186537,group,0,0
186538,consisted,0,0
186539,of,0,0
186540,13,0,0
186541,(,0,0
186542,2,0,0
186543,female,0,0
186544,),0,0
186545,elementary,0,0
186546,school,0,0
186547,students,0,0
186548,with,0,0
186549,ASD,0,0
186550,and,0,0
186551,the,0,0
186552,wait-list,0,0
186553,(,0,0
186554,WL,0,0
186555,),0,1
186556,group,0,0
186557,contained,0,0
186558,11,0,0
186559,(,0,0
186560,4,0,0
186561,female,0,0
186562,),0,0
186563,students,0,0
186564,with,0,0
186565,ASD,0,0
186566,.,0,0
186567,All,0,0
186568,of,0,0
186569,the,0,0
186570,children,0,0
186571,with,0,0
186572,ASD,0,0
186573,were,0,0
186574,fully,0,0
186575,included,0,0
186576,in,0,0
186577,the,0,0
186578,general,0,0
186579,education,0,0
186580,program,0,0
186581,.,0,0
186582,Analyses,0,0
186583,revealed,0,0
186584,that,0,0
186585,time,1,1
186586,spent,1,0
186587,engaged,1,0
186588,with,1,0
186589,peers,1,0
186590,was,1,0
186591,significantly,1,0
186592,increased,1,0
186593,for,0,0
186594,the,0,0
186595,IT,0,1
186596,group,0,0
186597,and,0,1
186598,maintained,0,0
186599,over,0,0
186600,the,0,0
186601,follow-up,0,0
186602,.,0,0
186603,School,0,0
186604,playground,0,0
186605,staff,0,0
186606,in,0,0
186607,the,0,0
186608,IT,0,1
186609,group,0,0
186610,showed,1,0
186611,increased,1,0
186612,behaviors,1,1
186613,aimed,1,0
186614,at,1,0
186615,improving,1,1
186616,peer,1,0
186617,engagement,1,1
186618,for,1,0
186619,children,1,0
186620,with,0,0
186621,ASD,0,0
186622,compared,0,0
186623,to,0,0
186624,playground,0,0
186625,staff,0,0
186626,at,0,0
186627,the,0,0
186628,WL,0,0
186629,sites,0,0
186630,.,0,0
186631,These,0,0
186632,improvements,1,1
186633,did,1,0
186634,not,1,0
186635,maintain,1,0
186636,to,0,0
186637,follow-up,0,0
186638,.,0,0
186639,These,0,0
186640,results,0,0
186641,suggest,0,0
186642,that,0,0
186643,a,0,0
186644,low,0,0
186645,dose,0,0
186646,",",0,0
186647,brief,0,0
186648,intervention,0,0
186649,can,0,0
186650,be,0,0
186651,beneficial,0,0
186652,in,0,0
186653,increasing,0,0
186654,peer,1,0
186655,engagement,1,1
186656,for,1,0
186657,children,1,0
186658,with,1,0
186659,autism,1,0
186660,in,0,0
186661,inclusive,0,0
186662,settings,0,0
186663,",",0,0
186664,but,0,0
186665,continued,0,0
186666,support,0,0
186667,of,0,0
186668,playground,0,0
186669,staff,0,0
186670,is,0,0
186671,likely,0,0
186672,needed,0,0
186673,.,0,0
186674,Crohn,0,1
186675,'s,0,1
186676,disease,0,1
186677,management,0,0
186678,after,0,0
186679,intestinal,0,1
186680,resection,0,0
186681,:,0,0
186682,a,0,0
186683,randomised,0,0
186684,trial,0,0
186685,.,0,0
186686,BACKGROUND,0,0
186687,Most,0,0
186688,patients,0,0
186689,with,0,0
186690,Crohn,0,0
186691,'s,0,0
186692,disease,0,0
186693,need,0,0
186694,an,0,0
186695,intestinal,0,1
186696,resection,0,0
186697,",",0,0
186698,but,0,0
186699,a,0,0
186700,majority,0,0
186701,will,0,0
186702,subsequently,0,0
186703,experience,0,0
186704,disease,0,1
186705,recurrence,1,1
186706,and,0,0
186707,require,0,0
186708,further,0,0
186709,surgery,0,0
186710,.,0,0
186711,This,0,0
186712,study,0,0
186713,aimed,0,0
186714,to,0,0
186715,identify,0,0
186716,the,0,0
186717,optimal,0,0
186718,strategy,0,0
186719,to,0,0
186720,prevent,0,0
186721,postoperative,0,1
186722,disease,0,0
186723,recurrence,0,1
186724,.,0,0
186725,METHODS,0,0
186726,In,0,0
186727,this,0,0
186728,randomised,0,0
186729,trial,0,0
186730,",",0,0
186731,consecutive,0,0
186732,patients,0,0
186733,from,0,0
186734,17,0,0
186735,centres,0,0
186736,in,0,0
186737,Australia,0,0
186738,and,0,0
186739,New,0,1
186740,Zealand,0,0
186741,undergoing,0,0
186742,intestinal,0,1
186743,resection,0,0
186744,of,0,0
186745,all,0,0
186746,macroscopic,0,1
186747,Crohn,0,1
186748,'s,0,1
186749,disease,0,1
186750,",",0,0
186751,with,0,0
186752,an,0,0
186753,endoscopically,0,0
186754,accessible,0,0
186755,anastomosis,0,0
186756,",",0,0
186757,received,0,0
186758,3,0,0
186759,months,0,0
186760,of,0,0
186761,metronidazole,0,0
186762,therapy,0,0
186763,.,0,0
186764,Patients,0,0
186765,at,0,0
186766,high,0,0
186767,risk,0,1
186768,of,0,0
186769,recurrence,0,1
186770,also,0,0
186771,received,0,0
186772,a,0,0
186773,thiopurine,0,1
186774,",",0,0
186775,or,0,0
186776,adalimumab,0,0
186777,if,0,0
186778,they,0,0
186779,were,0,0
186780,intolerant,0,0
186781,to,0,0
186782,thiopurines,0,0
186783,.,0,0
186784,Patients,0,0
186785,were,0,0
186786,randomly,0,0
186787,assigned,0,0
186788,to,0,0
186789,parallel,0,0
186790,groups,0,0
186791,:,0,0
186792,colonoscopy,0,0
186793,at,0,0
186794,6,0,0
186795,months,0,0
186796,(,0,0
186797,active,0,0
186798,care,0,0
186799,),0,0
186800,or,0,0
186801,no,0,0
186802,colonoscopy,0,1
186803,(,0,0
186804,standard,0,0
186805,care,0,0
186806,),0,0
186807,.,0,0
186808,We,0,0
186809,used,0,0
186810,computer-generated,0,0
186811,block,0,0
186812,randomisation,0,0
186813,to,0,0
186814,allocate,0,0
186815,patients,0,0
186816,in,0,0
186817,each,0,0
186818,centre,0,0
186819,to,0,0
186820,active,0,0
186821,or,0,0
186822,standard,0,0
186823,care,0,0
186824,in,0,0
186825,a,0,0
186826,2:1,0,0
186827,ratio,0,0
186828,.,0,0
186829,For,0,0
186830,endoscopic,1,1
186831,recurrence,1,1
186832,(,0,0
186833,Rutgeerts,0,0
186834,score,0,1
186835,?i2,0,0
186836,),0,0
186837,at,0,0
186838,6,0,0
186839,months,0,0
186840,",",0,0
186841,patients,0,0
186842,stepped-up,0,0
186843,to,0,0
186844,thiopurine,0,0
186845,",",0,0
186846,fortnightly,0,0
186847,adalimumab,0,0
186848,with,0,0
186849,thiopurine,0,1
186850,",",0,0
186851,or,0,1
186852,weekly,0,0
186853,adalimumab,0,0
186854,.,0,0
186855,The,1,0
186856,primary,1,0
186857,endpoint,1,1
186858,was,1,0
186859,endoscopic,1,1
186860,recurrence,1,1
186861,at,1,0
186862,18,0,0
186863,months,0,0
186864,.,0,0
186865,Patients,0,0
186866,and,0,0
186867,treating,0,0
186868,physicians,0,0
186869,were,0,0
186870,aware,0,0
186871,of,0,0
186872,the,0,0
186873,patient,0,1
186874,'s,0,0
186875,study,0,0
186876,group,0,0
186877,and,0,1
186878,treatment,0,0
186879,",",0,1
186880,but,0,0
186881,central,0,1
186882,reading,0,0
186883,of,0,0
186884,the,0,0
186885,endoscopic,0,0
186886,findings,0,0
186887,was,0,0
186888,undertaken,0,0
186889,blind,0,0
186890,to,0,0
186891,the,0,0
186892,study,0,0
186893,group,0,0
186894,and,0,0
186895,treatment,0,0
186896,.,0,1
186897,Analysis,0,0
186898,included,0,0
186899,all,0,0
186900,patients,0,0
186901,who,0,0
186902,received,0,0
186903,at,0,0
186904,least,0,0
186905,one,0,0
186906,dose,0,0
186907,of,0,0
186908,study,0,0
186909,drug,0,0
186910,.,0,0
186911,This,0,0
186912,trial,0,0
186913,is,0,0
186914,registered,0,0
186915,with,0,0
186916,ClinicalTrials.gov,0,0
186917,",",0,0
186918,number,0,1
186919,NCT00989560,0,1
186920,.,0,0
186921,FINDINGS,0,0
186922,Between,0,0
186923,Oct,0,0
186924,13,0,0
186925,",",0,0
186926,2009,0,0
186927,",",0,0
186928,and,0,0
186929,Sept,0,0
186930,28,0,0
186931,",",0,0
186932,2011,0,0
186933,",",0,0
186934,174,0,0
186935,(,0,0
186936,83,0,0
186937,%,0,0
186938,high,0,0
186939,risk,0,0
186940,across,0,0
186941,both,0,0
186942,active,0,0
186943,and,0,0
186944,standard,0,0
186945,care,0,0
186946,groups,0,0
186947,),0,0
186948,patients,0,0
186949,were,0,0
186950,enrolled,0,0
186951,and,0,0
186952,received,0,0
186953,at,0,0
186954,least,0,0
186955,one,0,0
186956,dose,0,0
186957,of,0,0
186958,study,0,0
186959,drug,0,0
186960,.,0,0
186961,Of,0,0
186962,122,0,0
186963,patients,0,0
186964,in,0,0
186965,the,0,0
186966,active,0,0
186967,care,0,0
186968,group,0,0
186969,",",0,0
186970,47,0,0
186971,(,0,0
186972,39,0,0
186973,%,0,0
186974,),0,0
186975,stepped-up,0,0
186976,treatment,0,0
186977,.,0,0
186978,At,0,0
186979,18,0,0
186980,months,1,0
186981,",",1,0
186982,endoscopic,1,1
186983,recurrence,1,1
186984,occurred,1,0
186985,in,0,0
186986,60,0,0
186987,(,0,0
186988,49,0,0
186989,%,0,0
186990,),0,0
186991,patients,0,0
186992,in,0,0
186993,the,0,0
186994,active,0,0
186995,care,0,0
186996,group,0,0
186997,and,0,0
186998,35,0,0
186999,(,0,0
187000,67,0,0
187001,%,0,0
187002,),0,0
187003,patients,0,0
187004,in,0,0
187005,the,0,0
187006,standard,0,0
187007,care,0,0
187008,group,0,0
187009,(,0,0
187010,p=0.03,1,0
187011,),1,0
187012,.,1,0
187013,Complete,1,0
187014,mucosal,1,1
187015,normality,1,1
187016,was,1,0
187017,maintained,0,0
187018,in,0,0
187019,27,0,0
187020,(,0,0
187021,22,0,0
187022,%,0,0
187023,),0,0
187024,of,0,0
187025,122,0,0
187026,patients,0,0
187027,in,0,0
187028,the,0,0
187029,active,0,0
187030,care,0,0
187031,group,0,0
187032,versus,0,0
187033,four,0,0
187034,(,0,0
187035,8,0,0
187036,%,0,0
187037,),0,0
187038,in,0,0
187039,the,0,0
187040,standard,0,0
187041,care,0,0
187042,group,0,0
187043,(,0,0
187044,p=0.03,0,0
187045,),0,0
187046,.,0,0
187047,In,0,0
187048,the,0,0
187049,active,0,0
187050,care,0,0
187051,arm,0,0
187052,",",0,0
187053,of,0,0
187054,those,0,0
187055,with,0,0
187056,6,0,0
187057,months,1,0
187058,recurrence,1,1
187059,who,1,0
187060,stepped,0,0
187061,up,0,0
187062,treatment,0,0
187063,",",0,0
187064,18,0,0
187065,(,0,0
187066,38,0,0
187067,%,0,0
187068,),0,0
187069,of,0,0
187070,47,0,0
187071,patients,0,0
187072,were,0,0
187073,in,0,0
187074,remission,1,1
187075,12,1,0
187076,months,0,0
187077,later,0,0
187078,;,0,0
187079,conversely,0,0
187080,",",0,0
187081,of,0,0
187082,those,0,0
187083,in,0,0
187084,remission,0,1
187085,at,0,0
187086,6,0,0
187087,months,0,0
187088,who,0,0
187089,did,0,0
187090,not,0,0
187091,change,0,0
187092,therapy,1,0
187093,recurrence,1,1
187094,occurred,1,0
187095,in,0,0
187096,31,0,0
187097,(,0,0
187098,41,0,0
187099,%,0,0
187100,),0,0
187101,of,0,0
187102,75,0,0
187103,patients,0,0
187104,12,0,0
187105,months,0,0
187106,later,0,0
187107,.,0,0
187108,Smoking,0,1
187109,(,0,0
187110,odds,0,0
187111,ratio,0,0
187112,[,0,0
187113,OR,0,0
187114,],0,0
187115,2.4,0,0
187116,",",0,0
187117,95,0,0
187118,%,0,0
187119,CI,0,0
187120,1.2-4.8,0,0
187121,",",0,0
187122,p=0.02,0,0
187123,),0,0
187124,and,0,0
187125,the,0,0
187126,presence,0,0
187127,of,0,0
187128,two,0,0
187129,or,0,0
187130,more,0,0
187131,clinical,0,1
187132,risk,0,1
187133,factors,0,0
187134,including,0,0
187135,smoking,0,1
187136,(,0,0
187137,OR,0,0
187138,2.8,0,0
187139,",",0,0
187140,95,0,0
187141,%,0,0
187142,CI,0,0
187143,1.01-7.7,0,0
187144,",",0,0
187145,p=0.05,0,0
187146,),0,0
187147,increased,0,0
187148,the,1,0
187149,risk,1,0
187150,of,1,0
187151,endoscopic,1,0
187152,recurrence,1,1
187153,.,1,0
187154,The,1,0
187155,incidence,1,1
187156,and,1,0
187157,type,1,0
187158,of,1,1
187159,adverse,1,1
187160,and,1,0
187161,severe,1,1
187162,adverse,1,1
187163,events,1,1
187164,did,1,0
187165,not,0,0
187166,differ,0,0
187167,significantly,0,0
187168,between,0,0
187169,patients,0,0
187170,in,0,0
187171,the,0,0
187172,active,0,0
187173,care,0,0
187174,and,0,1
187175,standard,0,0
187176,care,0,1
187177,groups,0,0
187178,(,0,0
187179,100,0,0
187180,[,0,0
187181,82,0,0
187182,%,0,0
187183,],0,0
187184,of,0,0
187185,122,0,0
187186,vs,0,0
187187,45,0,0
187188,[,0,0
187189,87,0,0
187190,%,0,0
187191,],0,0
187192,of,0,0
187193,52,0,0
187194,;,0,0
187195,p=0.51,0,0
187196,),0,1
187197,and,0,0
187198,(,0,0
187199,33,0,0
187200,[,0,0
187201,27,0,0
187202,%,0,0
187203,],0,0
187204,of,0,0
187205,122,0,0
187206,vs,0,0
187207,18,0,0
187208,[,0,0
187209,35,0,0
187210,%,0,0
187211,],0,0
187212,of,0,0
187213,52,0,0
187214,;,0,0
187215,p=0.36,0,0
187216,),0,0
187217,",",0,0
187218,respectively,0,0
187219,.,0,0
187220,INTERPRETATION,0,0
187221,Treatment,0,0
187222,according,0,0
187223,to,0,0
187224,clinical,1,0
187225,risk,1,1
187226,of,1,0
187227,recurrence,1,1
187228,",",1,0
187229,with,0,0
187230,early,0,0
187231,colonoscopy,0,1
187232,and,0,1
187233,treatment,0,0
187234,step-up,0,0
187235,for,0,0
187236,recurrence,0,1
187237,",",0,0
187238,is,0,0
187239,better,0,0
187240,than,0,0
187241,conventional,0,0
187242,drug,0,0
187243,therapy,0,0
187244,alone,0,0
187245,for,0,0
187246,prevention,0,0
187247,of,0,0
187248,postoperative,1,1
187249,Crohn,1,0
187250,'s,1,0
187251,disease,1,0
187252,recurrence,1,1
187253,.,1,0
187254,Selective,0,0
187255,immune,0,1
187256,suppression,0,1
187257,",",0,0
187258,adjusted,0,0
187259,for,0,0
187260,early,0,0
187261,recurrence,0,1
187262,",",0,0
187263,rather,0,0
187264,than,0,0
187265,routine,0,0
187266,use,0,0
187267,",",0,0
187268,leads,0,0
187269,to,0,0
187270,disease,1,0
187271,control,1,0
187272,in,1,0
187273,most,0,0
187274,patients,0,0
187275,.,0,0
187276,Clinical,0,1
187277,risk,0,0
187278,factors,0,0
187279,predict,1,0
187280,recurrence,1,1
187281,",",1,0
187282,but,0,0
187283,patients,0,0
187284,at,0,0
187285,low,0,0
187286,risk,0,0
187287,also,0,0
187288,need,1,0
187289,monitoring,1,0
187290,.,1,0
187291,Early,1,0
187292,remission,1,1
187293,does,1,0
187294,not,0,0
187295,preclude,0,0
187296,the,0,0
187297,need,0,0
187298,for,0,0
187299,ongoing,0,0
187300,monitoring,0,0
187301,.,0,0
187302,FUNDING,0,1
187303,AbbVie,0,0
187304,",",0,0
187305,Gutsy,0,1
187306,Group,0,0
187307,",",0,0
187308,Gandel,0,1
187309,Philanthropy,0,1
187310,",",0,0
187311,Angior,0,1
187312,Foundation,0,1
187313,",",0,0
187314,Crohn,0,1
187315,'s,0,1
187316,Colitis,0,1
187317,Australia,0,0
187318,",",0,0
187319,and,0,0
187320,the,0,0
187321,National,0,1
187322,Health,0,1
187323,and,0,0
187324,Medical,0,0
187325,Research,0,0
187326,Council,0,0
187327,.,0,0
187328,Exploring,0,0
187329,the,0,0
187330,role,0,0
187331,of,0,0
187332,tanezumab,0,0
187333,as,0,0
187334,a,0,0
187335,novel,0,0
187336,treatment,0,0
187337,for,0,0
187338,the,0,0
187339,relief,0,1
187340,of,0,0
187341,neuropathic,0,0
187342,pain,0,1
187343,.,0,0
187344,OBJECTIVE,0,0
187345,Evaluate,0,0
187346,efficacy,0,1
187347,and,0,1
187348,safety,0,1
187349,of,0,1
187350,tanezumab,0,0
187351,",",0,0
187352,a,0,0
187353,humanized,0,0
187354,monoclonal,0,0
187355,antibody,0,0
187356,against,0,1
187357,nerve,0,1
187358,growth,0,1
187359,factor,0,1
187360,",",0,0
187361,in,0,0
187362,neuropathic,0,0
187363,pain,0,1
187364,.,0,0
187365,DESIGN,0,0
187366,Two,0,0
187367,randomized,0,0
187368,controlled,0,0
187369,trials,0,0
187370,.,0,0
187371,SUBJECTS,0,0
187372,Patients,0,0
187373,with,0,0
187374,pain,0,1
187375,due,0,0
187376,to,0,0
187377,diabetic,0,0
187378,peripheral,0,1
187379,neuropathy,0,1
187380,(,0,0
187381,DPN,0,0
187382,),0,0
187383,or,0,0
187384,postherpetic,0,0
187385,neuralgia,0,1
187386,(,0,0
187387,PHN,0,0
187388,),0,0
187389,.,0,0
187390,METHODS,0,0
187391,In,0,0
187392,the,0,0
187393,DPN,0,0
187394,study,0,0
187395,",",0,0
187396,patients,0,0
187397,received,0,0
187398,subcutaneous,0,0
187399,tanezumab,0,0
187400,20,0,0
187401,mg,0,0
187402,or,0,0
187403,placebo,0,0
187404,on,0,0
187405,Day,0,0
187406,1,0,0
187407,and,0,0
187408,Week,0,0
187409,8,0,0
187410,.,0,0
187411,Evaluations,0,0
187412,included,0,0
187413,change,0,0
187414,from,0,0
187415,baseline,0,0
187416,in,0,0
187417,average,0,1
187418,DPN,0,0
187419,pain,0,1
187420,(,0,0
187421,primary,0,0
187422,endpoint,0,1
187423,),0,0
187424,",",0,0
187425,Patient,0,1
187426,'s,0,1
187427,Global,0,1
187428,Assessment,0,0
187429,of,0,0
187430,DPN,0,0
187431,",",0,0
187432,and,0,1
187433,safety,0,1
187434,(,0,0
187435,including,0,0
187436,neuropathy,0,1
187437,assessments,0,0
187438,),0,0
187439,.,0,0
187440,Due,0,0
187441,to,0,0
187442,a,0,0
187443,partial,0,0
187444,clinical,0,0
187445,hold,0,0
187446,limiting,0,1
187447,enrollment,0,0
187448,and,0,1
187449,treatment,0,0
187450,duration,0,1
187451,",",0,0
187452,the,0,0
187453,prespecified,0,0
187454,landmark,0,0
187455,analysis,0,0
187456,was,0,0
187457,modified,0,0
187458,post,0,0
187459,hoc,0,0
187460,from,0,0
187461,Week,0,0
187462,16,0,0
187463,to,0,0
187464,Week,0,0
187465,8,0,0
187466,.,0,0
187467,In,0,0
187468,the,0,0
187469,PHN,0,0
187470,study,0,0
187471,",",0,0
187472,patients,0,0
187473,received,0,0
187474,intravenous,0,0
187475,tanezumab,0,0
187476,50,0,0
187477,?g/kg,0,0
187478,",",0,0
187479,tanezumab,0,0
187480,200,0,0
187481,?g/kg,0,0
187482,",",0,0
187483,or,0,1
187484,placebo,0,0
187485,on,0,0
187486,Day,0,0
187487,1,0,0
187488,.,0,0
187489,Evaluations,0,0
187490,included,0,0
187491,change,0,0
187492,from,0,0
187493,baseline,0,0
187494,in,0,0
187495,average,1,1
187496,daily,1,0
187497,pain,1,1
187498,(,1,0
187499,primary,1,0
187500,endpoint,1,1
187501,),1,0
187502,",",1,0
187503,Brief,1,0
187504,Pain,1,1
187505,Inventory-short,1,1
187506,form,1,0
187507,",",1,0
187508,Patient,1,1
187509,'s,1,1
187510,Global,1,1
187511,Assessment,1,0
187512,of,1,0
187513,pain,1,1
187514,from,1,0
187515,PHN,1,0
187516,",",1,0
187517,and,1,0
187518,safety,1,1
187519,.,1,0
187520,RESULTS,1,0
187521,Mean,1,0
187522,DPN,1,0
187523,pain,1,1
187524,reduction,1,1
187525,from,1,0
187526,baseline,0,0
187527,to,0,0
187528,Week,0,0
187529,8,0,0
187530,was,0,0
187531,greater,0,0
187532,with,0,0
187533,tanezumab,0,1
187534,vs,0,0
187535,placebo,0,0
187536,(,0,0
187537,P,0,0
187538,=,0,0
187539,0.009,0,0
187540,),0,0
187541,;,0,0
187542,differences,0,0
187543,in,0,0
187544,Patient,1,1
187545,'s,1,0
187546,Global,1,1
187547,Assessment,1,0
187548,of,1,0
187549,DPN,1,0
187550,were,1,0
187551,not,0,0
187552,significant,0,0
187553,(,0,0
187554,P,0,0
187555,>,0,0
187556,0.05,0,0
187557,),0,0
187558,.,0,0
187559,Neither,0,0
187560,tanezumab,0,1
187561,dose,0,0
187562,resulted,0,0
187563,in,0,0
187564,significant,0,0
187565,differences,0,0
187566,vs,0,0
187567,placebo,0,0
187568,in,0,0
187569,efficacy,1,1
187570,in,1,0
187571,PHN,0,0
187572,(,0,0
187573,P,0,0
187574,>,0,0
187575,0.05,0,0
187576,),0,0
187577,",",0,0
187578,although,0,0
187579,tanezumab,0,0
187580,200,0,0
187581,?g/kg,0,0
187582,provided,0,0
187583,some,0,0
187584,benefit,1,0
187585,.,1,0
187586,Neuropathy,1,0
187587,assessments,1,0
187588,showed,1,0
187589,no,0,0
187590,meaningful,0,0
187591,changes,0,0
187592,.,0,0
187593,CONCLUSIONS,0,0
187594,Tanezumab,0,1
187595,provided,0,0
187596,effective,1,1
187597,pain,1,1
187598,reduction,1,1
187599,in,1,0
187600,DPN,0,0
187601,.,0,0
187602,In,0,0
187603,PHN,0,0
187604,",",0,0
187605,only,0,0
187606,the,0,0
187607,highest,0,0
187608,tanezumab,0,0
187609,dose,0,0
187610,reduced,1,0
187611,pain,1,1
187612,;,1,0
187613,treatment,1,0
187614,differences,0,0
187615,were,0,0
187616,not,0,0
187617,significant,0,0
187618,.,0,0
187619,No,0,0
187620,new,0,0
187621,safety,0,1
187622,concerns,0,1
187623,were,0,0
187624,observed,0,0
187625,despite,0,0
187626,preexisting,0,0
187627,neuropathy,0,0
187628,.,0,0
187629,Randomized,0,0
187630,Controlled,0,0
187631,Trial,0,0
187632,of,0,0
187633,Mind,0,1
187634,Reading,0,1
187635,and,0,0
187636,In,0,0
187637,Vivo,0,0
187638,Rehearsal,0,1
187639,for,0,0
187640,High-Functioning,0,0
187641,Children,0,0
187642,with,0,0
187643,ASD,0,0
187644,.,0,0
187645,This,0,0
187646,randomized,0,0
187647,controlled,0,0
187648,trial,0,0
187649,evaluated,0,0
187650,the,0,0
187651,efficacy,0,1
187652,of,0,0
187653,a,0,0
187654,computer,0,0
187655,software,0,0
187656,(,0,0
187657,i.e.,0,0
187658,",",0,0
187659,Mind,0,1
187660,Reading,0,1
187661,),0,0
187662,and,0,0
187663,in,0,0
187664,vivo,0,0
187665,rehearsal,0,1
187666,treatment,0,0
187667,on,0,0
187668,the,0,0
187669,emotion,1,1
187670,decoding,1,0
187671,and,1,0
187672,encoding,1,1
187673,skills,1,1
187674,",",1,0
187675,autism,1,0
187676,symptoms,1,1
187677,",",1,0
187678,and,1,1
187679,social,1,1
187680,skills,1,1
187681,of,0,0
187682,43,0,0
187683,children,0,0
187684,",",0,0
187685,ages,0,0
187686,7-12,0,0
187687,years,0,0
187688,with,0,0
187689,high-functioning,0,0
187690,autism,0,0
187691,spectrum,0,0
187692,disorder,0,0
187693,(,0,0
187694,HFASD,0,0
187695,),0,0
187696,.,0,0
187697,Children,0,0
187698,in,0,0
187699,treatment,0,0
187700,(,0,0
187701,n,0,0
187702,=,0,0
187703,22,0,0
187704,),0,0
187705,received,0,0
187706,the,0,0
187707,manualized,0,0
187708,protocol,0,0
187709,over,0,0
187710,12,0,0
187711,weeks,0,0
187712,.,0,0
187713,Primary,0,0
187714,analyses,0,0
187715,indicated,1,0
187716,significantly,1,0
187717,better,1,0
187718,posttest,1,0
187719,performance,1,1
187720,for,1,0
187721,the,0,0
187722,treatment,0,0
187723,group,0,0
187724,(,0,0
187725,compared,0,0
187726,to,0,0
187727,controls,1,0
187728,),1,0
187729,on,1,0
187730,3,1,0
187731,of,1,0
187732,the,1,0
187733,4,1,0
187734,measures,1,0
187735,of,1,0
187736,emotion,1,1
187737,decoding,1,0
187738,and,1,1
187739,encoding,1,1
187740,and,1,0
187741,these,0,0
187742,were,0,0
187743,maintained,0,0
187744,at,0,0
187745,5-week,0,0
187746,follow-up,0,0
187747,.,0,0
187748,Analyses,0,0
187749,of,0,0
187750,secondary,0,0
187751,measures,0,0
187752,favored,0,0
187753,the,0,0
187754,treatment,0,0
187755,group,0,0
187756,for,0,0
187757,1,0,0
187758,of,0,0
187759,the,0,0
187760,2,0,0
187761,measures,0,0
187762,;,0,0
187763,specifically,1,0
187764,",",1,0
187765,ASD,1,0
187766,symptoms,1,1
187767,were,1,0
187768,significantly,1,0
187769,lower,1,0
187770,at,1,0
187771,posttest,0,0
187772,and,0,0
187773,follow-up,0,0
187774,.,0,0
187775,A,0,0
187776,feasibility,0,0
187777,study,0,0
187778,for,0,0
187779,a,0,0
187780,randomised,0,0
187781,controlled,0,0
187782,trial,0,0
187783,of,0,0
187784,treatment,0,0
187785,withdrawal,0,1
187786,in,0,0
187787,psoriatic,0,1
187788,arthritis,0,0
187789,(,0,0
187790,REmoval,0,1
187791,of,0,0
187792,treatment,0,0
187793,for,0,0
187794,patients,0,0
187795,in,0,0
187796,REmission,0,1
187797,in,0,0
187798,psoriatic,0,1
187799,ArThritis,0,0
187800,(,0,0
187801,RETREAT,0,0
187802,(,0,0
187803,F,0,0
187804,),0,0
187805,),0,0
187806,.,0,0
187807,TNF,0,0
187808,therapy,0,0
187809,is,0,0
187810,effective,0,0
187811,for,0,0
187812,all,0,0
187813,aspects,0,0
187814,of,0,0
187815,psoriatic,0,1
187816,disease,0,1
187817,",",0,0
187818,but,0,0
187819,these,0,0
187820,drugs,0,0
187821,are,0,0
187822,costly,0,0
187823,and,0,0
187824,the,0,0
187825,long-term,0,0
187826,effects,0,0
187827,are,0,0
187828,unknown,0,0
187829,.,0,0
187830,Further,0,0
187831,",",0,0
187832,methotrexate,0,0
187833,causes,0,0
187834,concern,0,0
187835,with,0,0
187836,long-term,0,0
187837,adverse,0,1
187838,events,0,1
187839,.,0,0
187840,The,0,0
187841,purpose,0,0
187842,of,0,0
187843,this,0,0
187844,pilot,0,0
187845,study,0,0
187846,was,0,0
187847,to,0,0
187848,test,1,0
187849,the,1,0
187850,feasibility,1,0
187851,of,0,0
187852,drug,0,0
187853,withdrawal,0,1
187854,from,0,0
187855,patients,0,0
187856,with,0,0
187857,psoriatic,0,1
187858,arthritis,0,0
187859,",",0,0
187860,in,0,0
187861,stable,0,1
187862,low,0,0
187863,disease,0,0
187864,state,0,0
187865,.,0,0
187866,We,0,0
187867,examined,0,0
187868,the,0,0
187869,availability,1,0
187870,of,1,0
187871,patients,1,0
187872,",",1,0
187873,their,1,0
187874,willingness,1,0
187875,to,1,0
187876,participate,1,0
187877,",",1,0
187878,study,1,0
187879,procedures,1,0
187880,",",1,0
187881,and,1,0
187882,the,1,0
187883,proportion,1,1
187884,of,1,0
187885,patients,1,0
187886,in,1,0
187887,the,1,0
187888,withdrawal,1,0
187889,arm,1,0
187890,who,1,0
187891,relapsed,1,0
187892,during,0,0
187893,the,0,0
187894,study,0,0
187895,.,0,0
187896,Low,0,0
187897,disease,0,1
187898,state,0,0
187899,was,0,0
187900,defined,0,0
187901,by,0,0
187902,minimal,0,0
187903,disease,0,1
187904,activity,0,1
187905,criteria,0,0
187906,(,0,0
187907,MDA,0,1
187908,),0,1
187909,",",0,0
187910,and,0,1
187911,relapse,0,1
187912,by,0,0
187913,failure,0,0
187914,to,0,0
187915,achieve,0,0
187916,these,0,0
187917,criteria,0,0
187918,.,0,0
187919,Patients,0,0
187920,in,0,0
187921,the,0,0
187922,withdrawal,0,0
187923,group,0,0
187924,underwent,0,0
187925,a,0,0
187926,phased,0,0
187927,withdrawal,0,0
187928,of,0,0
187929,medication,0,0
187930,where,0,0
187931,the,0,0
187932,last,0,0
187933,treatment,0,0
187934,added,0,0
187935,was,0,0
187936,the,0,0
187937,first,0,0
187938,withdrawn,0,0
187939,.,0,0
187940,Assessments,1,1
187941,were,0,0
187942,monthly,0,0
187943,for,0,0
187944,3,0,0
187945,months,0,0
187946,before,0,0
187947,study,0,0
187948,exit,0,0
187949,.,0,0
187950,Seventy-two,0,0
187951,patients,0,0
187952,were,0,0
187953,invited,0,0
187954,to,0,0
187955,participate,0,0
187956,",",0,0
187957,of,0,0
187958,which,0,0
187959,57,0,0
187960,were,0,0
187961,found,0,0
187962,to,0,0
187963,be,0,0
187964,eligible,0,0
187965,.,0,0
187966,Twenty-six,0,0
187967,(,0,0
187968,36.1,0,0
187969,%,0,0
187970,),0,0
187971,subsequently,0,0
187972,attended,0,0
187973,the,0,0
187974,screening,0,0
187975,visit,0,1
187976,but,0,0
187977,9,0,0
187978,failed,0,0
187979,eligibility,0,0
187980,criteria,0,0
187981,so,0,0
187982,that,0,0
187983,17,0,0
187984,patients,0,0
187985,(,0,0
187986,29.8,0,0
187987,%,0,0
187988,of,0,0
187989,the,0,0
187990,57,0,0
187991,eligible,0,0
187992,patients,0,0
187993,",",0,0
187994,95,0,0
187995,%,0,0
187996,confidence,0,0
187997,interval,0,0
187998,(,0,0
187999,CI,0,0
188000,),0,0
188001,18.4,0,0
188002,",",0,0
188003,43.4,0,0
188004,%,0,0
188005,),0,0
188006,were,0,0
188007,randomised,0,0
188008,at,0,0
188009,a,0,0
188010,ratio,0,0
188011,of,0,0
188012,2:1,0,0
188013,in,0,0
188014,favour,0,0
188015,of,0,0
188016,the,0,0
188017,withdrawal,0,0
188018,arm,0,0
188019,(,0,0
188020,11,0,0
188021,withdrawals,0,0
188022,",",0,0
188023,6,0,0
188024,standard,0,0
188025,care,0,0
188026,),0,0
188027,.,0,0
188028,Six,0,0
188029,patients,0,0
188030,experienced,0,0
188031,a,0,0
188032,flare,1,1
188033,",",0,0
188034,all,0,0
188035,of,0,0
188036,whom,0,0
188037,were,0,0
188038,in,0,0
188039,the,0,0
188040,withdrawal,0,0
188041,arm,0,0
188042,(,0,0
188043,relapse,0,1
188044,rate,0,1
188045,54.6,0,0
188046,%,0,0
188047,",",0,0
188048,95,0,0
188049,%,0,0
188050,CI,0,0
188051,23.4,0,0
188052,",",0,0
188053,83.3,0,0
188054,%,0,0
188055,),0,0
188056,.,0,0
188057,Four,0,0
188058,of,0,0
188059,the,0,0
188060,flares,0,1
188061,were,0,0
188062,apparent,0,0
188063,from,0,0
188064,visit,0,0
188065,3,0,0
188066,(,0,0
188067,8,0,0
188068,weeks,0,0
188069,after,0,0
188070,starting,0,0
188071,withdrawal,0,0
188072,),0,0
188073,.,0,0
188074,Given,0,0
188075,the,0,0
188076,high,0,0
188077,relapse,1,1
188078,rate,1,1
188079,",",0,0
188080,an,0,0
188081,alternative,0,0
188082,trial,0,0
188083,design,0,0
188084,of,0,0
188085,partial,0,0
188086,treatment,0,0
188087,withdrawal,0,1
188088,",",0,0
188089,possibly,0,0
188090,including,0,0
188091,a,0,0
188092,patient,0,0
188093,preference,0,0
188094,arm,0,0
188095,",",0,0
188096,is,0,0
188097,recommended,0,0
188098,.,0,0
188099,Baseline,0,0
188100,distribution,0,0
188101,of,0,0
188102,participants,0,0
188103,with,0,0
188104,depression,0,1
188105,and,0,0
188106,impaired,0,1
188107,quality,0,1
188108,of,0,0
188109,life,0,1
188110,in,0,0
188111,the,0,0
188112,Treatment,0,0
188113,of,0,0
188114,Preserved,0,0
188115,Cardiac,0,1
188116,Function,0,1
188117,Heart,0,0
188118,Failure,0,1
188119,with,0,0
188120,an,0,0
188121,Aldosterone,0,1
188122,Antagonist,0,0
188123,Trial,0,0
188124,.,0,0
188125,BACKGROUND,0,0
188126,Previous,0,0
188127,studies,0,0
188128,have,0,0
188129,demonstrated,0,0
188130,the,0,0
188131,psychosocial,0,0
188132,effect,0,0
188133,of,0,0
188134,heart,0,1
188135,failure,0,1
188136,in,0,0
188137,patients,0,0
188138,with,0,0
188139,reduced,0,0
188140,ejection,0,0
188141,fraction,0,1
188142,.,0,0
188143,However,0,0
188144,",",0,0
188145,the,0,0
188146,effects,0,1
188147,on,0,0
188148,patients,0,0
188149,with,0,0
188150,preserved,0,0
188151,ejection,0,0
188152,fraction,0,1
188153,have,0,0
188154,not,0,0
188155,yet,0,0
188156,been,0,0
188157,elucidated,0,0
188158,.,0,0
188159,This,0,0
188160,study,0,0
188161,aimed,0,0
188162,to,0,0
188163,determine,0,0
188164,the,0,0
188165,baseline,0,0
188166,characteristics,0,0
188167,of,0,0
188168,participants,0,0
188169,with,0,0
188170,heart,0,1
188171,failure,0,1
188172,with,0,0
188173,preserved,0,0
188174,ejection,0,1
188175,fraction,0,1
188176,as,0,0
188177,it,0,0
188178,relates,0,0
188179,to,0,0
188180,impaired,0,0
188181,quality,0,1
188182,of,0,0
188183,life,0,1
188184,(,0,0
188185,QOL,0,1
188186,),0,1
188187,and,0,1
188188,depression,0,1
188189,",",0,1
188190,identify,0,0
188191,predictors,0,0
188192,of,0,0
188193,poor,0,1
188194,QOL,0,1
188195,and,0,1
188196,depression,0,1
188197,",",0,0
188198,and,0,0
188199,determine,0,0
188200,the,0,0
188201,correlation,0,0
188202,between,0,0
188203,QOL,0,1
188204,and,0,0
188205,depression,0,1
188206,.,0,1
188207,METHODS,0,0
188208,AND,0,0
188209,RESULTS,0,0
188210,Among,0,0
188211,patients,0,0
188212,enrolled,0,0
188213,in,0,0
188214,the,0,0
188215,Treatment,0,0
188216,of,0,0
188217,Preserved,0,0
188218,Cardiac,0,1
188219,Function,0,1
188220,Heart,0,0
188221,Failure,0,1
188222,With,0,0
188223,an,0,0
188224,Aldosterone,0,1
188225,Antagonist,0,0
188226,Trial,0,0
188227,(,0,0
188228,TOPCAT,0,0
188229,),0,0
188230,",",0,0
188231,3400,0,0
188232,patients,0,0
188233,completed,0,0
188234,the,0,0
188235,Kansas,1,0
188236,City,1,1
188237,Cardiomyopathy,1,1
188238,Questionnaire,1,1
188239,",",0,0
188240,3395,0,0
188241,patients,0,0
188242,completed,0,0
188243,European,1,0
188244,QOL,1,0
188245,5D,1,0
188246,Visual,1,0
188247,Analog,1,0
188248,Scale,1,1
188249,",",0,0
188250,and,0,0
188251,1431,0,0
188252,patients,0,0
188253,in,0,0
188254,United,0,0
188255,States,0,1
188256,and,0,0
188257,Canada,0,0
188258,completed,0,0
188259,the,0,0
188260,Patient,1,1
188261,Health,1,0
188262,Questionnaire-9,1,0
188263,.,1,0
188264,The,0,0
188265,mean,0,1
188266,summary,0,0
188267,score,0,1
188268,on,0,0
188269,the,0,0
188270,Kansas,1,0
188271,City,1,1
188272,Cardiomyopathy,1,1
188273,Questionnaire,1,1
188274,was,0,0
188275,54.8,0,0
188276,",",0,0
188277,and,0,0
188278,on,0,0
188279,European,1,0
188280,QOL,1,0
188281,5D,1,0
188282,Visual,1,0
188283,Analog,1,0
188284,Scale,1,1
188285,",",0,0
188286,it,0,0
188287,was,0,0
188288,60.3,0,0
188289,;,0,0
188290,27,0,0
188291,%,0,0
188292,of,0,0
188293,patients,0,0
188294,had,0,0
188295,moderate,0,0
188296,to,0,0
188297,severe,0,1
188298,depression,0,1
188299,.,0,0
188300,Factors,0,0
188301,associated,0,0
188302,with,0,0
188303,better,0,0
188304,Kansas,1,0
188305,City,1,1
188306,Cardiomyopathy,1,1
188307,Questionnaire,1,1
188308,and,1,0
188309,European,1,0
188310,QOL,1,1
188311,5D,1,0
188312,Visual,1,0
188313,Analog,1,0
188314,Scale,1,1
188315,via,0,0
188316,multiple,0,0
188317,logistic,0,0
188318,regression,0,0
188319,analysis,0,0
188320,were,0,0
188321,American,0,0
188322,region,0,0
188323,",",0,0
188324,older,0,0
188325,age,0,0
188326,",",0,0
188327,no,0,0
188328,history,0,0
188329,of,0,0
188330,angina,0,1
188331,pectoris,0,0
188332,or,0,0
188333,asthma,0,0
188334,",",0,0
188335,no,0,0
188336,use,0,0
188337,of,0,0
188338,hypoglycemic,0,1
188339,agent,0,0
188340,",",0,0
188341,more,0,0
188342,activity,0,1
188343,level,0,1
188344,",",0,0
188345,and,0,1
188346,lower,0,1
188347,New,0,1
188348,York,0,0
188349,Heart,0,0
188350,Association,0,0
188351,class,0,0
188352,.,0,0
188353,Factors,0,0
188354,associated,0,0
188355,with,0,0
188356,depression,0,1
188357,via,0,0
188358,multiple,0,0
188359,logistic,0,0
188360,regression,0,0
188361,analysis,0,0
188362,included,0,0
188363,younger,0,0
188364,age,0,0
188365,",",0,1
188366,female,0,0
188367,sex,0,0
188368,",",0,0
188369,comorbid,0,1
188370,angina,0,1
188371,",",0,0
188372,chronic,0,0
188373,obstructive,0,0
188374,pulmonary,0,1
188375,disease,0,1
188376,",",0,0
188377,use,0,0
188378,of,0,0
188379,a,0,0
188380,hypoglycemic,0,1
188381,agent,0,0
188382,",",0,0
188383,lower,0,1
188384,activity,0,1
188385,level,0,1
188386,",",0,0
188387,higher,0,0
188388,New,0,1
188389,York,0,0
188390,Heart,0,0
188391,Association,0,0
188392,class,0,0
188393,",",0,0
188394,and,0,1
188395,selective,0,1
188396,serotonin,0,1
188397,reuptake,0,0
188398,inhibitor,0,0
188399,use,0,0
188400,.,0,0
188401,There,0,0
188402,were,0,0
188403,significant,0,0
188404,correlations,0,0
188405,between,0,0
188406,each,0,0
188407,of,0,0
188408,the,0,0
188409,QOL,1,1
188410,scores,1,1
188411,and,1,0
188412,depression,1,1
188413,.,1,1
188414,CONCLUSIONS,0,0
188415,Patients,0,0
188416,with,0,0
188417,heart,0,1
188418,failure,0,1
188419,with,0,0
188420,preserved,0,0
188421,ejection,0,1
188422,fraction,0,1
188423,",",0,0
188424,who,0,0
188425,were,0,0
188426,younger,0,0
188427,had,0,0
188428,higher,0,0
188429,New,0,1
188430,York,0,0
188431,Heart,0,0
188432,Association,0,0
188433,class,0,1
188434,or,0,0
188435,comorbid,0,0
188436,angina,0,1
188437,pectoris,0,0
188438,",",0,0
188439,had,0,0
188440,lower,0,0
188441,activity,0,1
188442,levels,0,1
188443,",",0,0
188444,lived,0,0
188445,in,0,0
188446,Eastern,0,0
188447,Europe,0,0
188448,or,0,0
188449,were,0,0
188450,taking,0,0
188451,hypoglycemic,0,1
188452,agents,0,0
188453,",",0,0
188454,were,0,0
188455,more,0,0
188456,likely,0,0
188457,to,0,0
188458,have,0,0
188459,impaired,0,0
188460,QOL,0,1
188461,and,0,0
188462,depression,0,1
188463,.,0,0
188464,CLINICAL,0,1
188465,TRIAL,0,0
188466,REGISTRATION,0,0
188467,URL,0,0
188468,:,0,0
188469,http,0,0
188470,:,0,0
188471,//www.clinicaltrials.gov,0,0
188472,.,0,0
188473,Unique,0,0
188474,identifier,0,0
188475,:,0,0
188476,NCT00094302,0,0
188477,.,0,0
188478,Effects,0,0
188479,of,0,0
188480,sodium,0,0
188481,and,0,1
188482,potassium,0,1
188483,supplementation,0,0
188484,on,0,0
188485,blood,1,1
188486,pressure,1,1
188487,and,1,1
188488,arterial,1,1
188489,stiffness,1,1
188490,:,1,0
188491,a,0,0
188492,fully,0,0
188493,controlled,0,0
188494,dietary,0,0
188495,intervention,0,0
188496,study,0,0
188497,.,0,0
188498,We,0,0
188499,performed,0,0
188500,a,0,0
188501,randomised,0,0
188502,",",0,0
188503,placebo-controlled,0,0
188504,",",0,0
188505,crossover,0,0
188506,study,0,0
188507,to,0,0
188508,examine,0,0
188509,the,0,0
188510,effects,0,0
188511,of,0,0
188512,sodium,0,0
188513,and,0,1
188514,potassium,0,1
188515,supplementation,0,0
188516,on,0,0
188517,blood,1,1
188518,pressure,1,1
188519,(,1,0
188520,BP,1,1
188521,),1,0
188522,and,1,0
188523,arterial,1,1
188524,stiffness,1,1
188525,in,0,0
188526,untreated,0,0
188527,(,0,0
188528,pre,0,0
188529,),0,0
188530,hypertensive,0,0
188531,individuals,0,0
188532,.,0,0
188533,During,0,0
188534,the,0,0
188535,study,0,0
188536,",",0,0
188537,subjects,0,0
188538,were,0,0
188539,on,0,0
188540,a,0,0
188541,fully,0,0
188542,controlled,0,0
188543,diet,0,0
188544,that,0,0
188545,was,0,0
188546,relatively,0,0
188547,low,0,0
188548,in,0,0
188549,sodium,0,0
188550,and,0,0
188551,potassium,0,1
188552,.,0,0
188553,After,0,0
188554,a,0,0
188555,1-week,0,0
188556,run-in,0,0
188557,period,0,0
188558,",",0,0
188559,subjects,0,0
188560,received,0,0
188561,capsules,0,0
188562,with,0,0
188563,supplemental,0,0
188564,sodium,0,0
188565,(,0,0
188566,3,0,0
188567,g,0,0
188568,d,0,0
188569,(,0,0
188570,-1,0,0
188571,),0,0
188572,",",0,0
188573,equals,0,0
188574,7.6,0,0
188575,g,0,0
188576,d,0,0
188577,(,0,0
188578,-1,0,0
188579,),0,0
188580,of,0,0
188581,salt,0,0
188582,),0,0
188583,",",0,0
188584,supplemental,0,0
188585,potassium,0,1
188586,(,0,0
188587,3,0,0
188588,g,0,0
188589,d,0,0
188590,(,0,0
188591,-1,0,0
188592,),0,0
188593,),0,0
188594,or,0,0
188595,placebo,0,0
188596,",",0,0
188597,for,0,0
188598,4,0,0
188599,weeks,0,0
188600,each,0,0
188601,",",0,0
188602,in,0,0
188603,random,0,0
188604,order,0,0
188605,.,1,0
188606,Fasting,1,1
188607,office,1,0
188608,BP,1,1
188609,",",1,0
188610,24-h,1,1
188611,ambulatory,1,0
188612,BP,1,1
188613,and,1,0
188614,measures,1,1
188615,of,0,1
188616,arterial,1,1
188617,stiffness,1,1
188618,were,1,0
188619,assessed,0,0
188620,at,0,0
188621,baseline,0,0
188622,and,0,0
188623,every,0,0
188624,4,0,0
188625,weeks,0,0
188626,.,0,0
188627,Of,0,0
188628,37,0,0
188629,randomized,0,0
188630,subjects,0,0
188631,",",0,0
188632,36,0,0
188633,completed,0,0
188634,the,0,0
188635,study,0,0
188636,.,0,0
188637,They,0,0
188638,had,0,0
188639,a,0,0
188640,mean,0,1
188641,pre-treatment,1,0
188642,BP,1,1
188643,of,1,0
188644,145/81,1,0
188645,mm,0,0
188646,Hg,0,0
188647,and,1,0
188648,69,1,0
188649,%,1,0
188650,had,1,0
188651,systolic,1,1
188652,BP,1,1
188653,?140,0,0
188654,mm,1,0
188655,Hg,1,0
188656,.,1,0
188657,Sodium,1,0
188658,excretion,1,1
188659,was,1,0
188660,increased,0,0
188661,by,0,0
188662,98,0,0
188663,mmol,0,0
188664,per,0,0
188665,24,0,0
188666,h,0,0
188667,and,1,0
188668,potassium,1,1
188669,excretion,1,1
188670,by,0,0
188671,63,0,0
188672,mmol,0,0
188673,per,0,0
188674,24,0,0
188675,h,0,0
188676,during,0,0
188677,active,0,0
188678,interventions,0,0
188679,",",0,0
188680,compared,0,0
188681,with,0,0
188682,placebo,0,0
188683,.,0,0
188684,During,0,0
188685,sodium,0,0
188686,supplementation,1,0
188687,",",1,0
188688,office,1,1
188689,BP,1,1
188690,was,1,0
188691,significantly,1,0
188692,increased,0,0
188693,by,0,0
188694,7.5/3.3,0,0
188695,mm,0,0
188696,Hg,0,0
188697,",",1,0
188698,24-h,1,1
188699,BP,1,1
188700,by,0,0
188701,7.5/2.7,0,0
188702,mm,0,0
188703,Hg,0,0
188704,and,0,0
188705,central,1,1
188706,BP,1,1
188707,by,0,0
188708,8.5/3.6,0,0
188709,mm,0,0
188710,Hg,0,0
188711,.,0,0
188712,During,0,0
188713,potassium,0,1
188714,supplementation,1,0
188715,",",1,0
188716,24-h,1,1
188717,BP,1,1
188718,was,1,0
188719,significantly,0,0
188720,reduced,0,0
188721,by,0,0
188722,3.9/1.6,0,0
188723,mm,0,0
188724,Hg,0,0
188725,and,1,0
188726,central,1,1
188727,pulse,1,1
188728,pressure,1,1
188729,by,1,0
188730,2.9,1,0
188731,mm,1,0
188732,Hg,1,0
188733,.,1,0
188734,Pulse,1,0
188735,wave,1,1
188736,velocity,1,1
188737,and,1,1
188738,augmentation,1,1
188739,index,1,1
188740,were,1,0
188741,not,0,0
188742,significantly,0,0
188743,affected,0,0
188744,by,0,0
188745,sodium,0,0
188746,or,0,0
188747,potassium,0,1
188748,supplementation,0,0
188749,.,0,0
188750,In,0,0
188751,conclusion,0,0
188752,",",0,0
188753,increasing,0,0
188754,the,0,0
188755,intake,0,1
188756,of,0,0
188757,sodium,0,0
188758,caused,0,0
188759,a,0,0
188760,substantial,0,0
188761,increase,0,0
188762,in,1,0
188763,BP,1,1
188764,in,0,0
188765,subjects,0,0
188766,with,0,0
188767,untreated,0,0
188768,elevated,1,0
188769,BP,1,1
188770,.,1,0
188771,Increased,0,0
188772,potassium,0,1
188773,intake,0,1
188774,",",0,0
188775,on,0,0
188776,top,0,0
188777,of,0,0
188778,a,0,0
188779,relatively,0,0
188780,low-sodium,0,0
188781,diet,0,0
188782,",",0,0
188783,had,0,0
188784,a,0,0
188785,beneficial,0,0
188786,effect,1,0
188787,on,1,0
188788,BP,1,1
188789,.,1,0
188790,Arterial,1,0
188791,stiffness,1,1
188792,did,0,0
188793,not,0,0
188794,materially,0,0
188795,change,0,0
188796,during,0,0
188797,4-week,0,0
188798,interventions,0,0
188799,with,0,0
188800,sodium,0,0
188801,or,0,0
188802,potassium,0,1
188803,.,0,0
188804,Computer-Assisted,0,0
188805,Face,0,0
188806,Processing,0,0
188807,Instruction,0,0
188808,Improves,0,0
188809,Emotion,1,1
188810,Recognition,1,0
188811,",",1,0
188812,Mentalizing,1,0
188813,",",1,1
188814,and,1,1
188815,Social,1,1
188816,Skills,1,1
188817,in,0,0
188818,Students,0,0
188819,with,0,0
188820,ASD,0,0
188821,.,0,0
188822,This,0,0
188823,study,0,0
188824,examined,0,0
188825,the,0,0
188826,extent,0,0
188827,to,0,0
188828,which,0,0
188829,a,0,0
188830,computer-based,0,0
188831,social,0,1
188832,skills,0,1
188833,intervention,0,0
188834,called,0,0
188835,FaceSay,0,0
188836,was,0,0
188837,associated,0,0
188838,with,0,0
188839,improvements,0,0
188840,in,0,0
188841,affect,1,0
188842,recognition,1,1
188843,",",1,0
188844,mentalizing,1,1
188845,",",1,1
188846,and,1,1
188847,social,1,1
188848,skills,1,1
188849,of,0,0
188850,school-aged,0,0
188851,children,0,0
188852,with,0,0
188853,Autism,0,1
188854,Spectrum,0,0
188855,Disorder,0,0
188856,(,0,0
188857,ASD,0,0
188858,),0,0
188859,.,0,0
188860,FaceSay,0,0
188861,offers,0,0
188862,students,0,0
188863,simulated,0,0
188864,practice,0,0
188865,with,0,0
188866,eye,1,1
188867,gaze,1,0
188868,",",1,0
188869,joint,1,1
188870,attention,1,1
188871,",",1,0
188872,and,1,1
188873,facial,1,1
188874,recognition,1,0
188875,skills,1,1
188876,.,1,0
188877,This,0,0
188878,randomized,0,0
188879,control,0,0
188880,trial,0,0
188881,included,0,0
188882,school-aged,0,0
188883,children,0,0
188884,meeting,0,0
188885,educational,0,0
188886,criteria,0,0
188887,for,0,0
188888,autism,0,0
188889,(,0,0
188890,N,0,0
188891,=,0,0
188892,31,0,0
188893,),0,0
188894,.,0,0
188895,Results,0,0
188896,demonstrated,0,0
188897,that,0,0
188898,participants,0,0
188899,who,0,0
188900,received,0,0
188901,the,0,0
188902,intervention,0,0
188903,improved,0,0
188904,their,0,0
188905,affect,1,0
188906,recognition,1,1
188907,and,1,1
188908,mentalizing,1,1
188909,skills,1,1
188910,",",1,0
188911,as,1,0
188912,well,1,0
188913,as,1,0
188914,their,1,0
188915,social,1,0
188916,skills,1,1
188917,.,1,0
188918,These,0,0
188919,findings,0,0
188920,suggest,0,0
188921,that,0,0
188922,",",0,0
188923,by,0,0
188924,targeting,0,0
188925,face-processing,0,1
188926,skills,0,1
188927,",",0,0
188928,computer-based,0,0
188929,interventions,0,0
188930,may,0,0
188931,produce,0,0
188932,changes,0,1
188933,in,0,0
188934,broader,1,0
188935,cognitive,1,1
188936,and,1,1
188937,social-skills,1,1
188938,domains,1,1
188939,in,0,0
188940,a,0,0
188941,cost-,1,0
188942,and,1,0
188943,time-efficient,1,0
188944,manner,1,0
188945,.,1,0
188946,Long-term,1,0
188947,functional,1,0
188948,outcomes,1,1
188949,and,1,0
188950,predictors,1,0
188951,of,1,1
188952,shunt-dependent,1,0
188953,hydrocephalus,1,1
188954,after,0,0
188955,treatment,0,0
188956,of,0,0
188957,ruptured,0,0
188958,intracranial,0,1
188959,aneurysms,0,1
188960,in,0,0
188961,the,0,0
188962,BRAT,0,0
188963,trial,0,0
188964,:,0,0
188965,revisiting,0,0
188966,the,0,0
188967,clip,0,0
188968,vs,0,0
188969,coil,0,0
188970,debate,0,0
188971,.,0,0
188972,BACKGROUND,0,0
188973,Acute,0,0
188974,hydrocephalus,0,0
188975,is,0,0
188976,a,0,0
188977,well-known,0,0
188978,sequela,0,0
188979,of,0,0
188980,aneurysmal,0,1
188981,subarachnoid,0,0
188982,hemorrhage,0,1
188983,(,0,0
188984,SAH,0,0
188985,),0,0
188986,.,0,0
188987,Controversy,0,0
188988,exists,0,0
188989,about,0,0
188990,whether,0,0
188991,open,0,0
188992,microsurgical,0,0
188993,methods,0,0
188994,serve,0,0
188995,to,0,0
188996,reduce,0,0
188997,shunt,1,0
188998,dependency,1,1
188999,compared,0,0
189000,with,0,0
189001,endovascular,0,0
189002,techniques,0,0
189003,.,0,0
189004,OBJECTIVE,0,0
189005,To,0,0
189006,determine,0,0
189007,predictors,0,0
189008,of,0,0
189009,shunt-dependent,1,1
189010,hydrocephalus,1,1
189011,and,1,0
189012,functional,1,0
189013,outcomes,1,1
189014,after,0,0
189015,aneurysmal,0,1
189016,SAH,0,0
189017,.,0,0
189018,METHODS,0,0
189019,A,0,0
189020,total,0,1
189021,of,0,0
189022,471,0,0
189023,patients,0,0
189024,who,0,0
189025,were,0,0
189026,part,0,0
189027,of,0,0
189028,a,0,0
189029,prospective,0,0
189030,",",0,0
189031,randomized,0,0
189032,",",0,0
189033,controlled,0,0
189034,trial,0,0
189035,from,0,0
189036,2003,0,0
189037,to,0,0
189038,2007,0,0
189039,were,0,0
189040,retrospectively,0,0
189041,reviewed,0,0
189042,.,0,0
189043,All,0,0
189044,variables,0,0
189045,including,0,0
189046,demographic,1,1
189047,data,1,0
189048,",",1,0
189049,medical,1,0
189050,history,1,1
189051,",",1,0
189052,treatment,1,0
189053,",",1,1
189054,imaging,1,1
189055,",",1,1
189056,and,1,1
189057,functional,1,1
189058,outcomes,1,1
189059,were,0,0
189060,included,0,0
189061,as,0,0
189062,part,0,0
189063,of,0,0
189064,the,0,0
189065,trial,0,0
189066,.,0,0
189067,No,0,0
189068,additional,0,0
189069,variables,0,0
189070,were,0,0
189071,retrospectively,0,0
189072,collected,0,0
189073,.,0,0
189074,RESULTS,0,0
189075,Ultimately,0,0
189076,",",0,0
189077,147,0,0
189078,patients,0,0
189079,(,0,0
189080,31.2,0,0
189081,%,0,0
189082,),0,0
189083,required,0,0
189084,a,0,0
189085,ventriculoperitoneal,0,0
189086,shunt,0,0
189087,(,0,0
189088,VPS,0,0
189089,),0,0
189090,in,0,0
189091,our,0,0
189092,series,0,0
189093,.,0,0
189094,Age,0,1
189095,",",0,0
189096,dissecting,0,0
189097,aneurysm,0,1
189098,type,0,0
189099,",",0,0
189100,ruptured,0,0
189101,vertebrobasilar,0,1
189102,aneurysm,0,1
189103,",",0,0
189104,Fisher,0,1
189105,grade,0,1
189106,",",0,0
189107,Hunt,0,1
189108,and,0,1
189109,Hess,0,1
189110,grade,0,1
189111,",",0,0
189112,admission,0,1
189113,intraventricular,0,1
189114,hemorrhage,0,1
189115,",",0,0
189116,admission,0,1
189117,intraparenchymal,0,1
189118,hemorrhage,0,1
189119,",",0,0
189120,blood,0,1
189121,in,0,0
189122,the,0,0
189123,fourth,0,0
189124,ventricle,0,0
189125,on,0,0
189126,admission,0,1
189127,",",0,0
189128,perioperative,0,1
189129,ventriculostomy,0,1
189130,",",0,0
189131,and,0,1
189132,hemicraniectomy,0,0
189133,were,0,0
189134,significant,0,0
189135,risk,0,1
189136,factors,0,0
189137,(,0,0
189138,P,0,0
189139,<,0,0
189140,.05,0,0
189141,),0,0
189142,associated,0,0
189143,with,0,0
189144,shunt-dependent,1,0
189145,hydrocephalus,1,1
189146,on,0,0
189147,univariate,0,0
189148,analysis,0,0
189149,.,0,0
189150,On,0,0
189151,multivariate,0,0
189152,analysis,0,0
189153,",",0,0
189154,intraventricular,1,1
189155,hemorrhage,1,1
189156,and,1,0
189157,intraparenchymal,1,1
189158,hemorrhage,1,1
189159,were,0,0
189160,independent,0,0
189161,risk,0,1
189162,factors,0,0
189163,for,0,0
189164,shunt,1,0
189165,dependency,1,1
189166,(,0,0
189167,P,0,0
189168,<,0,0
189169,.05,0,0
189170,),0,0
189171,.,0,0
189172,Clipping,0,0
189173,vs,0,0
189174,coiling,0,0
189175,treatment,0,0
189176,was,0,0
189177,not,0,0
189178,statistically,0,0
189179,associated,0,0
189180,with,0,0
189181,VPS,0,0
189182,after,0,0
189183,SAH,0,0
189184,on,0,0
189185,both,0,0
189186,univariate,0,0
189187,and,0,0
189188,multivariate,0,0
189189,analyses,0,0
189190,.,0,0
189191,Patients,0,0
189192,who,0,0
189193,did,0,0
189194,not,0,0
189195,receive,0,0
189196,a,0,0
189197,VPS,0,0
189198,at,0,0
189199,discharge,0,1
189200,had,0,0
189201,higher,0,0
189202,Glasgow,1,0
189203,Outcome,1,1
189204,Scale,1,1
189205,and,1,0
189206,Barthel,1,1
189207,Index,1,1
189208,scores,1,1
189209,and,0,0
189210,were,0,0
189211,more,0,0
189212,likely,0,0
189213,to,0,0
189214,be,0,0
189215,functionally,0,0
189216,independent,0,0
189217,and,0,0
189218,to,0,0
189219,return,0,0
189220,to,0,0
189221,work,0,0
189222,72,0,0
189223,months,0,0
189224,after,0,0
189225,surgery,0,0
189226,(,0,0
189227,P,0,0
189228,<,0,0
189229,.05,0,0
189230,),0,0
189231,.,0,0
189232,CONCLUSION,0,0
189233,There,0,0
189234,is,0,0
189235,no,0,0
189236,difference,0,0
189237,in,0,0
189238,shunt,1,0
189239,dependency,1,1
189240,after,0,0
189241,SAH,0,0
189242,among,0,0
189243,patients,0,0
189244,treated,0,0
189245,by,0,0
189246,endovascular,0,0
189247,or,0,0
189248,microsurgical,0,0
189249,means,0,0
189250,.,0,0
189251,Patients,0,0
189252,in,0,0
189253,whom,0,0
189254,shunt-dependent,1,0
189255,hydrocephalus,1,0
189256,does,0,0
189257,not,0,0
189258,develop,0,0
189259,after,0,0
189260,SAH,0,0
189261,tend,0,0
189262,to,0,0
189263,have,0,0
189264,improved,0,0
189265,long-term,0,0
189266,functional,0,0
189267,outcomes,0,0
189268,.,0,0
189269,Mask,0,0
189270,ventilation,0,0
189271,with,0,0
189272,two,0,0
189273,different,0,0
189274,face,0,0
189275,masks,0,0
189276,in,0,0
189277,the,0,0
189278,delivery,0,0
189279,room,0,0
189280,for,0,0
189281,preterm,0,0
189282,infants,0,0
189283,:,0,0
189284,a,0,0
189285,randomized,0,0
189286,controlled,0,0
189287,trial,0,0
189288,.,0,0
189289,BACKGROUND,0,0
189290,If,0,0
189291,an,0,0
189292,infant,0,0
189293,fails,0,0
189294,to,0,0
189295,initiate,0,0
189296,spontaneous,0,1
189297,breathing,0,0
189298,after,0,0
189299,birth,0,1
189300,",",0,0
189301,international,0,0
189302,guidelines,0,0
189303,recommend,0,0
189304,a,0,0
189305,positive,0,0
189306,pressure,0,1
189307,ventilation,0,0
189308,(,0,0
189309,PPV,0,0
189310,),0,0
189311,.,0,0
189312,However,0,0
189313,",",0,0
189314,PPV,0,1
189315,by,0,0
189316,face,0,0
189317,mask,0,0
189318,is,0,0
189319,frequently,0,0
189320,inadequate,0,0
189321,because,0,0
189322,of,0,0
189323,leak,0,1
189324,between,0,0
189325,the,0,0
189326,face,0,0
189327,and,0,0
189328,mask,0,0
189329,.,0,0
189330,Despite,0,0
189331,a,0,0
189332,variety,0,0
189333,of,0,0
189334,available,0,0
189335,face,0,0
189336,masks,0,0
189337,",",0,0
189338,none,0,0
189339,have,0,0
189340,been,0,0
189341,prospectively,0,0
189342,compared,0,0
189343,in,0,0
189344,a,0,0
189345,randomized,0,0
189346,fashion,0,0
189347,.,0,0
189348,We,0,0
189349,aimed,0,0
189350,to,0,0
189351,evaluate,0,0
189352,and,0,0
189353,compare,0,0
189354,leak,1,1
189355,between,1,0
189356,two,1,0
189357,commercially,1,0
189358,available,1,0
189359,round,1,0
189360,face,1,1
189361,masks,1,0
189362,(,0,0
189363,Fisher,0,1
189364,&,0,0
189365,Paykel,0,1
189366,(,0,0
189367,F,0,0
189368,&,0,0
189369,P,0,0
189370,),0,1
189371,and,0,0
189372,Laerdal,0,0
189373,),0,0
189374,in,0,0
189375,preterm,0,0
189376,infants,0,0
189377,<,0,0
189378,33,0,0
189379,weeks,0,0
189380,gestational,0,0
189381,age,0,0
189382,in,0,0
189383,the,0,0
189384,delivery,0,0
189385,room,0,0
189386,.,0,0
189387,METHODS,0,0
189388,Infants,0,0
189389,born,0,0
189390,at,0,0
189391,the,0,0
189392,Royal,0,0
189393,Alexandra,0,0
189394,Hospital,0,1
189395,from,0,0
189396,April,0,0
189397,to,0,0
189398,September,0,0
189399,2013,0,0
189400,at,0,0
189401,<,0,0
189402,33,0,0
189403,weeks,0,0
189404,gestational,0,0
189405,age,0,0
189406,who,0,0
189407,received,0,0
189408,mask,0,0
189409,PPV,0,0
189410,in,0,0
189411,the,0,0
189412,delivery,0,0
189413,room,0,0
189414,routinely,0,0
189415,had,0,0
189416,a,0,0
189417,flow,0,1
189418,sensor,0,0
189419,placed,0,0
189420,between,0,0
189421,the,0,0
189422,mask,0,0
189423,and,0,0
189424,T-piece,0,0
189425,resuscitator,0,0
189426,.,0,0
189427,Infants,0,0
189428,were,0,0
189429,randomly,0,0
189430,assigned,0,0
189431,to,0,0
189432,receive,0,0
189433,PPV,0,0
189434,with,0,0
189435,either,0,0
189436,a,0,0
189437,F,0,0
189438,&,0,0
189439,P,0,0
189440,or,0,1
189441,Laerdal,0,1
189442,face,0,0
189443,mask,0,0
189444,.,0,0
189445,All,0,0
189446,resuscitators,0,0
189447,were,0,0
189448,trained,0,0
189449,in,0,0
189450,the,0,0
189451,use,0,0
189452,of,0,0
189453,both,0,0
189454,face,0,0
189455,masks,0,0
189456,.,0,0
189457,We,0,0
189458,compared,0,0
189459,mask,1,0
189460,leak,1,1
189461,",",1,0
189462,airway,1,1
189463,pressures,1,1
189464,",",1,0
189465,tidal,1,1
189466,volume,1,1
189467,and,1,1
189468,ventilation,1,1
189469,rate,1,1
189470,between,0,0
189471,the,0,0
189472,two,0,0
189473,groups,0,0
189474,.,0,0
189475,RESULTS,0,0
189476,Fifty-six,0,0
189477,preterm,0,0
189478,infants,0,0
189479,(,0,0
189480,n=28,0,0
189481,in,0,0
189482,each,0,0
189483,group,0,0
189484,),0,0
189485,were,0,0
189486,enrolled,0,0
189487,;,0,0
189488,mean?s.d,0,0
189489,.,0,0
189490,gestational,0,1
189491,age,0,0
189492,28?3,0,0
189493,weeks,0,0
189494,;,0,0
189495,birth,0,0
189496,weight,0,0
189497,1210?448,0,0
189498,g,0,0
189499,;,0,0
189500,and,0,0
189501,30,0,0
189502,(,0,0
189503,52,0,0
189504,%,0,0
189505,),0,0
189506,were,0,0
189507,male,0,0
189508,.,0,0
189509,Apgar,0,1
189510,scores,0,1
189511,at,0,0
189512,1,0,0
189513,and,0,0
189514,5,0,0
189515,min,0,0
189516,were,0,0
189517,5?3,0,0
189518,and,0,0
189519,7?2,0,0
189520,",",0,0
189521,respectively,0,0
189522,.,0,0
189523,Infants,0,0
189524,randomized,0,0
189525,to,0,0
189526,the,0,0
189527,F,0,0
189528,&,0,0
189529,P,0,0
189530,face,0,1
189531,mask,0,0
189532,and,0,1
189533,Laerdal,0,1
189534,face,0,1
189535,mask,0,0
189536,had,0,0
189537,similar,1,0
189538,mask,1,0
189539,leak,1,1
189540,(,1,0
189541,30,1,0
189542,(,0,0
189543,25-38,0,0
189544,),0,0
189545,versus,0,0
189546,35,0,0
189547,(,0,0
189548,24-46,0,0
189549,),0,0
189550,%,0,0
189551,",",0,0
189552,median,0,1
189553,(,0,0
189554,interquartile,0,1
189555,range,0,0
189556,),0,0
189557,",",0,0
189558,respectively,0,0
189559,",",0,0
189560,P=0.40,0,0
189561,),0,1
189562,and,1,0
189563,tidal,1,1
189564,volume,1,1
189565,(,1,0
189566,7.1,0,0
189567,(,0,0
189568,4.9-8.9,0,0
189569,),0,0
189570,versus,0,0
189571,6.6,0,0
189572,(,0,0
189573,5.2-8.9,0,0
189574,),0,0
189575,ml,0,0
189576,kg,0,0
189577,(,0,0
189578,-1,0,0
189579,),0,0
189580,",",0,0
189581,P=0.69,0,0
189582,),0,0
189583,during,0,0
189584,PPV,0,0
189585,.,0,0
189586,There,0,0
189587,were,0,0
189588,no,0,0
189589,significant,0,0
189590,differences,0,0
189591,in,1,0
189592,ventilation,1,0
189593,rate,1,1
189594,",",1,1
189595,inflation,1,1
189596,time,1,1
189597,or,1,0
189598,airway,1,1
189599,pressures,1,1
189600,between,1,0
189601,groups,0,0
189602,.,0,0
189603,CONCLUSION,0,0
189604,The,0,0
189605,use,0,0
189606,of,0,0
189607,either,0,0
189608,face,0,0
189609,mask,0,0
189610,during,0,0
189611,PPV,0,0
189612,in,0,0
189613,the,0,0
189614,delivery,0,0
189615,room,0,0
189616,yields,0,1
189617,similar,1,0
189618,mask,1,0
189619,leak,1,1
189620,in,1,0
189621,preterm,0,0
189622,infants,0,0
189623,<,0,0
189624,33,0,0
189625,weeks,0,0
189626,gestational,0,0
189627,age,0,0
189628,.,0,0
189629,A,0,0
189630,possible,0,0
189631,link,0,0
189632,between,0,0
189633,early,0,0
189634,probiotic,0,0
189635,intervention,0,0
189636,and,0,0
189637,the,0,0
189638,risk,1,1
189639,of,1,0
189640,neuropsychiatric,1,1
189641,disorders,1,0
189642,later,0,0
189643,in,0,0
189644,childhood,0,0
189645,:,0,0
189646,a,0,0
189647,randomized,0,0
189648,trial,0,0
189649,.,0,0
189650,BACKGROUND,0,0
189651,Recent,0,0
189652,experimental,0,0
189653,evidence,0,0
189654,suggests,0,0
189655,that,0,0
189656,gut,0,0
189657,microbiota,0,0
189658,may,0,0
189659,alter,0,0
189660,function,0,1
189661,within,0,0
189662,the,0,0
189663,nervous,0,0
189664,system,0,0
189665,providing,0,0
189666,new,0,0
189667,insight,0,0
189668,on,0,0
189669,the,0,0
189670,mechanism,0,0
189671,of,0,0
189672,neuropsychiatric,0,0
189673,disorders,0,0
189674,.,0,0
189675,METHODS,0,0
189676,Seventy-five,0,0
189677,infants,0,0
189678,who,0,0
189679,were,0,0
189680,randomized,0,0
189681,to,0,0
189682,receive,0,0
189683,Lactobacillus,0,0
189684,rhamnosus,0,0
189685,GG,0,0
189686,(,0,0
189687,ATCC,0,0
189688,53103,0,0
189689,),0,0
189690,or,0,0
189691,placebo,0,0
189692,during,0,0
189693,the,0,0
189694,first,0,0
189695,6,0,0
189696,mo,0,0
189697,of,0,0
189698,life,0,1
189699,were,0,0
189700,followed-up,0,0
189701,for,0,0
189702,13,0,0
189703,y,0,0
189704,.,0,0
189705,Gut,1,0
189706,microbiota,1,1
189707,was,0,0
189708,assessed,0,0
189709,at,0,0
189710,the,0,0
189711,age,0,0
189712,of,0,0
189713,3,0,0
189714,wk,0,0
189715,",",0,0
189716,3,0,0
189717,",",0,0
189718,6,0,0
189719,",",0,0
189720,12,0,0
189721,",",0,0
189722,18,0,0
189723,",",0,0
189724,24,0,0
189725,mo,0,0
189726,",",0,0
189727,and,0,0
189728,13,0,0
189729,y,0,0
189730,using,0,0
189731,fluorescein,0,0
189732,in,0,0
189733,situ,0,0
189734,hybridization,0,0
189735,(,0,0
189736,FISH,0,0
189737,),0,0
189738,and,0,0
189739,qPCR,0,0
189740,",",0,0
189741,and,0,0
189742,indirectly,0,1
189743,by,0,0
189744,determining,0,0
189745,the,1,0
189746,blood,1,1
189747,group,1,0
189748,secretor,1,1
189749,type,1,0
189750,at,1,0
189751,the,0,0
189752,age,0,0
189753,of,0,0
189754,13,0,0
189755,y,0,0
189756,.,0,0
189757,The,0,0
189758,diagnoses,0,0
189759,of,0,0
189760,attention,1,0
189761,deficit,1,1
189762,hyperactivity,1,1
189763,disorder,1,0
189764,(,1,0
189765,ADHD,1,0
189766,),1,0
189767,and,1,0
189768,Asperger,1,0
189769,syndrome,1,0
189770,(,1,0
189771,AS,1,0
189772,),1,0
189773,by,1,0
189774,a,0,0
189775,child,0,0
189776,neurologist,0,0
189777,or,0,0
189778,psychiatrist,0,0
189779,were,0,0
189780,based,0,0
189781,on,0,0
189782,ICD-10,0,0
189783,diagnostic,0,0
189784,criteria,0,0
189785,.,0,0
189786,RESULTS,0,0
189787,At,0,0
189788,the,0,0
189789,age,0,0
189790,of,0,0
189791,13,0,0
189792,y,0,0
189793,",",0,0
189794,ADHD,1,0
189795,or,1,1
189796,AS,1,1
189797,was,1,0
189798,diagnosed,0,0
189799,in,0,0
189800,6/35,0,0
189801,(,0,0
189802,17.1,0,0
189803,%,0,0
189804,),0,0
189805,children,0,0
189806,in,0,0
189807,the,0,0
189808,placebo,0,0
189809,and,0,0
189810,none,0,0
189811,in,0,0
189812,the,0,0
189813,probiotic,0,0
189814,group,0,0
189815,(,0,0
189816,P,0,0
189817,=,0,0
189818,0.008,0,0
189819,),0,0
189820,.,0,0
189821,The,1,0
189822,mean,1,1
189823,(,1,0
189824,SD,1,0
189825,),1,0
189826,numbers,1,1
189827,of,1,0
189828,Bifidobacterium,1,0
189829,species,1,0
189830,bacteria,1,1
189831,in,1,0
189832,feces,1,1
189833,during,1,0
189834,the,1,0
189835,first,1,0
189836,6,1,0
189837,mo,1,0
189838,of,1,0
189839,life,1,1
189840,was,1,0
189841,lower,0,0
189842,in,0,0
189843,affected,0,0
189844,children,0,0
189845,8.26,0,0
189846,(,0,0
189847,1.24,0,0
189848,),0,0
189849,log,0,0
189850,cells/g,0,1
189851,than,0,0
189852,in,0,0
189853,healthy,0,0
189854,children,0,0
189855,9.12,0,0
189856,(,0,0
189857,0.64,0,0
189858,),0,0
189859,log,0,0
189860,cells/g,0,0
189861,;,0,0
189862,P,0,0
189863,=,0,0
189864,0.03,0,0
189865,.,0,0
189866,CONCLUSION,0,0
189867,Probiotic,0,1
189868,supplementation,0,0
189869,early,0,0
189870,in,0,0
189871,life,0,1
189872,may,0,0
189873,reduce,0,0
189874,the,1,0
189875,risk,1,0
189876,of,1,0
189877,neuropsychiatric,1,1
189878,disorder,1,0
189879,development,1,1
189880,later,1,0
189881,in,0,0
189882,childhood,0,0
189883,possible,0,0
189884,by,0,0
189885,mechanisms,0,0
189886,not,0,0
189887,limited,0,0
189888,to,0,0
189889,gut,0,0
189890,microbiota,0,0
189891,composition,0,0
189892,.,0,0
189893,Safety,0,1
189894,and,0,0
189895,benefit,0,1
189896,of,0,0
189897,discontinuing,0,0
189898,statin,0,0
189899,therapy,0,0
189900,in,0,0
189901,the,0,0
189902,setting,0,0
189903,of,0,0
189904,advanced,0,0
189905,",",0,0
189906,life-limiting,0,0
189907,illness,0,1
189908,:,0,0
189909,a,0,0
189910,randomized,0,0
189911,clinical,0,0
189912,trial,0,0
189913,.,0,0
189914,IMPORTANCE,0,0
189915,For,0,0
189916,patients,0,0
189917,with,0,0
189918,limited,0,0
189919,prognosis,0,0
189920,",",0,0
189921,some,0,0
189922,medication,0,0
189923,risks,0,0
189924,may,0,0
189925,outweigh,0,0
189926,the,0,0
189927,benefits,0,0
189928,",",0,0
189929,particularly,0,0
189930,when,0,0
189931,benefits,0,0
189932,take,0,0
189933,years,0,0
189934,to,0,0
189935,accrue,0,0
189936,;,0,0
189937,statins,0,0
189938,are,0,0
189939,one,0,0
189940,example,0,0
189941,.,0,0
189942,Data,0,0
189943,are,0,0
189944,lacking,0,0
189945,regarding,0,0
189946,the,0,0
189947,risks,0,1
189948,and,0,0
189949,benefits,0,0
189950,of,0,0
189951,discontinuing,0,0
189952,statin,0,0
189953,therapy,0,0
189954,for,0,0
189955,patients,0,0
189956,with,0,0
189957,limited,0,0
189958,life,0,1
189959,expectancy,0,1
189960,.,0,0
189961,OBJECTIVE,0,0
189962,To,0,0
189963,evaluate,0,0
189964,the,0,0
189965,safety,0,1
189966,",",0,0
189967,clinical,0,1
189968,",",0,0
189969,and,0,1
189970,cost,0,1
189971,impact,0,0
189972,of,0,0
189973,discontinuing,0,0
189974,statin,0,0
189975,medications,0,0
189976,for,0,0
189977,patients,0,0
189978,in,0,0
189979,the,0,0
189980,palliative,0,0
189981,care,0,0
189982,setting,0,0
189983,.,0,0
189984,DESIGN,0,0
189985,",",0,0
189986,SETTING,0,0
189987,",",0,0
189988,AND,0,0
189989,PARTICIPANTS,0,0
189990,This,0,0
189991,was,0,0
189992,a,0,0
189993,multicenter,0,0
189994,",",0,0
189995,parallel-group,0,0
189996,",",0,1
189997,unblinded,0,0
189998,",",0,0
189999,pragmatic,0,0
190000,clinical,0,0
190001,trial,0,0
190002,.,0,0
190003,Eligibility,0,1
190004,included,0,0
190005,adults,0,0
190006,with,0,0
190007,an,0,0
190008,estimated,0,0
190009,life,0,1
190010,expectancy,0,1
190011,of,0,0
190012,between,0,0
190013,1,0,0
190014,month,0,0
190015,and,0,0
190016,1,0,0
190017,year,0,0
190018,",",0,0
190019,statin,0,0
190020,therapy,0,0
190021,for,0,0
190022,3,0,0
190023,months,0,0
190024,or,0,0
190025,more,0,0
190026,for,0,0
190027,primary,0,0
190028,or,0,0
190029,secondary,0,0
190030,prevention,0,0
190031,of,0,0
190032,cardiovascular,0,1
190033,disease,0,0
190034,",",0,0
190035,recent,0,0
190036,deterioration,0,1
190037,in,0,0
190038,functional,0,0
190039,status,0,1
190040,",",0,0
190041,and,0,0
190042,no,0,0
190043,recent,0,0
190044,active,0,0
190045,cardiovascular,0,1
190046,disease,0,0
190047,.,0,0
190048,Participants,0,0
190049,were,0,0
190050,randomized,0,0
190051,to,0,0
190052,either,0,0
190053,discontinue,0,0
190054,or,0,0
190055,continue,0,0
190056,statin,0,0
190057,therapy,0,0
190058,and,0,0
190059,were,0,0
190060,monitored,0,0
190061,monthly,0,0
190062,for,0,0
190063,up,0,0
190064,to,0,0
190065,1,0,0
190066,year,0,0
190067,.,0,0
190068,The,0,0
190069,study,0,0
190070,was,0,0
190071,conducted,0,0
190072,from,0,0
190073,June,0,0
190074,3,0,0
190075,",",0,0
190076,2011,0,0
190077,",",0,0
190078,to,0,0
190079,May,0,0
190080,2,0,0
190081,",",0,0
190082,2013,0,0
190083,.,0,0
190084,All,0,0
190085,analyses,0,0
190086,were,0,0
190087,performed,0,0
190088,using,0,0
190089,an,0,0
190090,intent-to-treat,0,0
190091,approach,0,0
190092,.,0,0
190093,INTERVENTIONS,0,1
190094,Statin,0,1
190095,therapy,0,0
190096,was,0,0
190097,withdrawn,0,0
190098,from,0,0
190099,eligible,0,0
190100,patients,0,0
190101,who,0,0
190102,were,0,0
190103,randomized,0,0
190104,to,0,0
190105,the,0,0
190106,discontinuation,0,0
190107,group,0,0
190108,.,0,0
190109,Patients,0,0
190110,in,0,0
190111,the,0,0
190112,continuation,0,0
190113,group,0,0
190114,continued,0,0
190115,to,0,0
190116,receive,0,0
190117,statins,0,0
190118,.,0,0
190119,MAIN,0,0
190120,OUTCOMES,0,0
190121,AND,0,0
190122,MEASURES,0,0
190123,Outcomes,0,1
190124,included,0,0
190125,death,1,1
190126,within,1,0
190127,60,1,0
190128,days,1,0
190129,(,1,0
190130,primary,1,0
190131,outcome,1,1
190132,),1,0
190133,",",1,0
190134,survival,1,1
190135,",",1,0
190136,cardiovascular,1,1
190137,events,1,1
190138,",",1,0
190139,performance,1,1
190140,status,1,1
190141,",",1,0
190142,quality,1,1
190143,of,1,1
190144,life,1,1
190145,(,1,0
190146,QOL,1,1
190147,),1,0
190148,",",1,0
190149,symptoms,1,1
190150,",",1,1
190151,number,1,1
190152,of,1,1
190153,nonstatin,1,0
190154,medications,1,0
190155,",",1,0
190156,and,1,1
190157,cost,1,1
190158,savings,1,0
190159,.,1,0
190160,RESULTS,0,0
190161,A,0,0
190162,total,0,0
190163,of,0,0
190164,381,0,0
190165,patients,0,0
190166,were,0,0
190167,enrolled,0,0
190168,;,0,0
190169,189,0,0
190170,of,0,0
190171,these,0,0
190172,were,0,0
190173,randomized,0,0
190174,to,0,0
190175,discontinue,0,0
190176,statins,0,0
190177,",",0,0
190178,and,0,0
190179,192,0,0
190180,were,0,0
190181,randomized,0,0
190182,to,0,0
190183,continue,0,0
190184,therapy,0,0
190185,.,0,0
190186,Mean,1,0
190187,(,1,0
190188,SD,1,0
190189,),1,1
190190,age,1,0
190191,was,0,0
190192,74.1,0,0
190193,(,0,0
190194,11.6,0,0
190195,),0,0
190196,years,0,0
190197,",",0,0
190198,22.0,0,0
190199,%,0,0
190200,of,0,0
190201,the,0,0
190202,participants,0,0
190203,were,0,0
190204,cognitively,0,0
190205,impaired,0,0
190206,",",0,0
190207,and,0,0
190208,48.8,0,0
190209,%,0,0
190210,had,0,0
190211,cancer,0,0
190212,.,0,0
190213,The,0,0
190214,proportion,0,0
190215,of,0,0
190216,participants,0,0
190217,in,0,0
190218,the,0,0
190219,discontinuation,0,0
190220,vs,0,0
190221,continuation,0,0
190222,groups,0,0
190223,who,0,0
190224,died,0,0
190225,within,0,0
190226,60,0,0
190227,days,0,0
190228,was,0,0
190229,not,0,0
190230,significantly,0,0
190231,different,0,0
190232,(,0,0
190233,23.8,0,0
190234,%,0,0
190235,vs,0,0
190236,20.3,0,0
190237,%,0,0
190238,;,0,0
190239,90,0,0
190240,%,0,0
190241,CI,0,0
190242,",",0,0
190243,-3.5,0,0
190244,%,0,0
190245,to,0,0
190246,10.5,0,0
190247,%,0,0
190248,;,0,0
190249,P=.36,0,0
190250,),0,0
190251,and,0,0
190252,did,0,0
190253,not,0,0
190254,meet,0,0
190255,the,0,0
190256,noninferiority,0,0
190257,end,0,0
190258,point,0,0
190259,.,0,0
190260,Total,1,0
190261,QOL,1,1
190262,was,0,0
190263,better,0,0
190264,for,0,0
190265,the,0,0
190266,group,0,0
190267,discontinuing,0,0
190268,statin,0,0
190269,therapy,0,0
190270,(,0,0
190271,mean,0,1
190272,McGill,0,1
190273,QOL,0,1
190274,score,0,1
190275,",",0,0
190276,7.11,0,0
190277,vs,0,0
190278,6.85,0,0
190279,;,0,0
190280,P=.04,0,0
190281,),0,0
190282,.,0,0
190283,Few,0,1
190284,participants,0,0
190285,experienced,0,0
190286,cardiovascular,1,1
190287,events,1,1
190288,(,0,0
190289,13,0,0
190290,in,0,0
190291,the,0,0
190292,discontinuation,0,0
190293,group,0,0
190294,vs,0,0
190295,11,0,0
190296,in,0,0
190297,the,0,0
190298,continuation,0,0
190299,group,0,0
190300,),0,0
190301,.,0,0
190302,Mean,1,0
190303,cost,1,1
190304,savings,1,1
190305,were,0,0
190306,$,0,0
190307,3.37,0,0
190308,per,0,0
190309,day,0,0
190310,and,0,0
190311,$,0,0
190312,716,0,0
190313,per,0,0
190314,patient,0,0
190315,.,0,0
190316,CONCLUSIONS,0,0
190317,AND,0,0
190318,RELEVANCE,0,0
190319,This,0,0
190320,pragmatic,0,0
190321,trial,0,0
190322,suggests,0,0
190323,that,0,0
190324,stopping,0,0
190325,statin,0,0
190326,medication,0,0
190327,therapy,0,0
190328,is,0,0
190329,safe,0,0
190330,and,0,0
190331,may,0,0
190332,be,0,0
190333,associated,0,0
190334,with,0,0
190335,benefits,0,0
190336,including,0,0
190337,improved,1,1
190338,QOL,1,1
190339,",",1,0
190340,use,1,0
190341,of,1,0
190342,fewer,1,0
190343,nonstatin,1,0
190344,medications,1,1
190345,",",1,0
190346,and,1,0
190347,a,1,0
190348,corresponding,1,1
190349,reduction,1,1
190350,in,1,0
190351,medication,1,0
190352,costs,1,1
190353,.,1,0
190354,Thoughtful,0,0
190355,patient-provider,0,0
190356,discussions,0,0
190357,regarding,0,0
190358,the,0,0
190359,uncertain,0,0
190360,benefit,0,0
190361,and,0,0
190362,potential,0,1
190363,decrement,0,1
190364,in,0,0
190365,QOL,0,1
190366,associated,0,0
190367,with,0,0
190368,statin,0,0
190369,continuation,0,0
190370,in,0,0
190371,this,0,0
190372,setting,0,0
190373,are,0,0
190374,warranted,0,0
190375,.,0,0
190376,TRIAL,0,0
190377,REGISTRATION,0,0
190378,clinicaltrials.gov,0,0
190379,Identifier,0,0
190380,:,0,0
190381,NCT01415934,0,0
190382,.,0,0
190383,Role,0,1
190384,of,0,0
190385,warm,0,0
190386,saline,0,0
190387,mouth,0,1
190388,rinse,0,0
190389,in,0,0
190390,prevention,0,0
190391,of,0,0
190392,alveolar,1,1
190393,osteitis,1,0
190394,:,1,0
190395,a,0,0
190396,randomized,0,0
190397,controlled,0,0
190398,trial,0,0
190399,.,0,0
190400,BACKGROUND,0,0
190401,The,0,0
190402,present,0,0
190403,study,0,0
190404,was,0,0
190405,aimed,0,0
190406,at,0,0
190407,determining,0,0
190408,the,0,0
190409,role,0,0
190410,warm,0,0
190411,saline,0,0
190412,rinse,0,0
190413,in,0,0
190414,the,0,0
190415,prevention,1,0
190416,of,1,0
190417,alveolar,1,1
190418,osteitis,1,1
190419,following,0,0
190420,dental,0,0
190421,extractions,0,0
190422,.,0,0
190423,MATERIALS,0,0
190424,AND,0,0
190425,METHODS,0,0
190426,Apparently,0,0
190427,patients,0,0
190428,aged,0,0
190429,16,0,0
190430,and,0,0
190431,above,0,0
190432,who,0,0
190433,were,0,0
190434,referred,0,0
190435,to,0,0
190436,the,0,0
190437,Oral,0,1
190438,Surgery,0,1
190439,Clinic,0,0
190440,of,0,0
190441,our,0,0
190442,institution,0,0
190443,",",0,0
190444,with,0,0
190445,an,0,0
190446,indication,0,0
190447,for,0,0
190448,non-surgical,0,0
190449,extraction,0,0
190450,of,0,0
190451,pathologic,0,1
190452,teeth,0,0
190453,were,0,0
190454,prospectively,0,0
190455,and,0,0
190456,uniformly,0,0
190457,randomized,0,0
190458,into,0,0
190459,warm,0,0
190460,saline,0,0
190461,group,0,0
190462,and,0,0
190463,control,0,0
190464,.,0,0
190465,The,0,0
190466,experimental,0,0
190467,group,0,0
190468,(,0,0
190469,n,0,0
190470,=,0,0
190471,80,0,0
190472,),0,0
190473,were,0,0
190474,instructed,0,0
190475,to,0,0
190476,gargle,0,0
190477,6,0,0
190478,times,0,0
190479,daily,0,0
190480,with,0,0
190481,warm,0,0
190482,saline,0,0
190483,and,0,0
190484,no,0,0
190485,such,0,0
190486,instructions,0,0
190487,were,0,0
190488,given,0,0
190489,to,0,0
190490,the,0,0
190491,second,0,0
190492,group,0,0
190493,(,0,0
190494,n,0,0
190495,=,0,0
190496,80,0,0
190497,),0,0
190498,to,0,0
190499,serve,0,0
190500,as,0,0
190501,controls,0,0
190502,.,0,0
190503,Information,0,0
190504,on,0,0
190505,demographic,1,1
190506,",",1,0
190507,indications,1,0
190508,for,1,0
190509,extraction,1,0
190510,",",1,0
190511,and,1,1
190512,development,1,1
190513,of,1,1
190514,alveolar,1,1
190515,osteitis,1,1
190516,were,0,0
190517,obtained,0,0
190518,and,0,0
190519,analyzed,0,0
190520,.,0,0
190521,Comparative,0,0
190522,statistics,0,0
190523,were,0,0
190524,done,0,0
190525,using,0,0
190526,Pearson,0,1
190527,'s,0,0
190528,chi,0,0
190529,square,0,0
190530,or,0,0
190531,Fisher,0,1
190532,'s,0,1
190533,exact,0,0
190534,test,0,0
190535,as,0,0
190536,appropriate,0,0
190537,.,0,0
190538,A,0,0
190539,p,0,0
190540,value,0,0
190541,of,0,0
190542,less,0,0
190543,than,0,0
190544,0.05,0,0
190545,was,0,0
190546,considered,0,0
190547,significant,0,0
190548,.,0,0
190549,RESULTS,0,0
190550,The,0,0
190551,demographic,1,0
190552,and,1,0
190553,other,1,0
190554,baseline,1,0
190555,parameters,1,1
190556,such,1,0
190557,as,1,0
190558,indications,1,0
190559,for,1,0
190560,extractions,1,0
190561,were,0,0
190562,comparable,0,0
190563,among,0,0
190564,the,0,0
190565,study,0,0
190566,groups,0,0
190567,(,0,0
190568,p,0,0
190569,>,0,0
190570,0.05,0,0
190571,),0,0
190572,.,0,0
190573,The,0,0
190574,overall,1,1
190575,prevalence,1,0
190576,of,1,0
190577,alveolar,1,1
190578,osteitis,1,1
190579,was,0,0
190580,13.7,0,0
190581,%,0,0
190582,.,0,0
190583,There,0,0
190584,was,0,0
190585,a,0,0
190586,statistical,0,0
190587,significant,0,0
190588,difference,0,0
190589,between,0,0
190590,the,0,0
190591,study,0,0
190592,groups,0,0
190593,with,0,0
190594,respect,0,0
190595,to,0,0
190596,development,0,1
190597,of,0,0
190598,alveolar,1,1
190599,osteitis,1,1
190600,(,0,0
190601,X2,0,0
190602,=,0,0
190603,15.00,0,0
190604,",",0,0
190605,df,0,0
190606,=,0,0
190607,1,0,0
190608,",",0,0
190609,p,0,0
190610,=,0,0
190611,0.001,0,0
190612,),0,0
190613,.The,0,0
190614,risk,1,1
190615,of,1,0
190616,development,1,1
190617,of,1,0
190618,alveolar,1,1
190619,osteitis,1,1
190620,was,0,0
190621,4,0,0
190622,times,0,0
190623,higher,0,0
190624,in,0,0
190625,the,0,0
190626,control,0,0
190627,group,0,0
190628,(,0,0
190629,OR,0,0
190630,=,0,0
190631,4.33,0,0
190632,",",0,0
190633,P,0,0
190634,=,0,0
190635,0.001,0,0
190636,),0,0
190637,.,0,0
190638,CONCLUSION,0,0
190639,Warm,0,0
190640,saline,0,0
190641,mouth,0,1
190642,rinse,0,0
190643,instruction,0,0
190644,is,0,0
190645,beneficial,0,0
190646,in,0,0
190647,the,0,0
190648,prevention,0,0
190649,of,0,0
190650,development,0,1
190651,of,0,0
190652,alveolar,1,1
190653,osteitis,1,1
190654,after,0,0
190655,dental,0,0
190656,extractions,0,0
190657,.,0,0
190658,Subcutaneous,1,0
190659,versus,1,0
190660,intravenous,1,0
190661,bortezomib,1,0
190662,in,0,0
190663,two,0,0
190664,different,0,0
190665,induction,0,0
190666,therapies,0,0
190667,for,0,0
190668,newly,0,0
190669,diagnosed,0,0
190670,multiple,0,0
190671,myeloma,0,0
190672,:,0,0
190673,an,0,0
190674,interim,0,0
190675,analysis,0,0
190676,from,0,0
190677,the,0,0
190678,prospective,0,0
190679,GMMG-MM5,0,0
190680,trial,0,0
190681,.,0,0
190682,We,0,0
190683,investigated,0,0
190684,the,0,0
190685,impact,0,0
190686,of,0,0
190687,subcutaneous,1,0
190688,versus,0,0
190689,intravenous,1,0
190690,bortezomib,1,0
190691,in,0,0
190692,the,0,0
190693,MM5,0,0
190694,trial,0,0
190695,of,0,0
190696,the,0,0
190697,German-Speaking,0,0
190698,Myeloma,0,0
190699,Multicenter,0,0
190700,Group,0,0
190701,which,0,0
190702,compared,0,0
190703,bortezomib,0,0
190704,",",0,0
190705,doxorubicin,0,0
190706,",",0,1
190707,and,0,1
190708,dexamethasone,0,0
190709,with,0,0
190710,bortezomib,0,0
190711,",",0,0
190712,cyclophosphamide,0,0
190713,",",0,1
190714,and,0,1
190715,dexamethasone,0,0
190716,induction,0,1
190717,therapy,0,0
190718,in,0,0
190719,newly,0,0
190720,diagnosed,0,0
190721,multiple,0,0
190722,myeloma,0,0
190723,.,0,0
190724,Based,0,0
190725,on,0,0
190726,data,0,0
190727,from,0,0
190728,relapsed,0,0
190729,myeloma,0,0
190730,",",0,0
190731,the,0,0
190732,route,0,0
190733,of,0,0
190734,administration,0,0
190735,for,0,0
190736,bortezomib,0,0
190737,was,0,0
190738,changed,0,0
190739,from,0,0
190740,intravenous,0,0
190741,to,0,0
190742,subcutaneous,0,0
190743,after,0,0
190744,314,0,0
190745,of,0,0
190746,604,0,0
190747,patients,0,0
190748,had,0,0
190749,been,0,0
190750,enrolled,0,0
190751,.,0,0
190752,We,0,0
190753,analyzed,0,0
190754,598,0,0
190755,patients,0,0
190756,who,0,0
190757,received,0,0
190758,at,0,0
190759,least,0,0
190760,one,0,0
190761,dose,0,0
190762,of,0,0
190763,trial,0,0
190764,medication,0,1
190765,.,0,0
190766,Adverse,1,1
190767,events,1,1
190768,were,0,0
190769,reported,0,0
190770,more,0,0
190771,frequently,0,0
190772,in,0,0
190773,patients,0,0
190774,treated,0,0
190775,with,0,0
190776,intravenous,0,0
190777,bortezomib,0,0
190778,(,0,0
190779,intravenous=65,0,0
190780,%,0,0
190781,;,0,0
190782,subcutaneous=56,0,0
190783,%,0,0
190784,",",0,1
190785,P=0.02,0,0
190786,),0,0
190787,.,0,0
190788,Rates,1,0
190789,of,1,0
190790,grade,1,0
190791,2,1,0
190792,or,1,0
190793,more,1,0
190794,peripheral,1,1
190795,neuropathy,1,1
190796,were,0,0
190797,higher,0,0
190798,in,0,0
190799,patients,0,0
190800,treated,0,0
190801,with,0,0
190802,intravenous,0,0
190803,bortezomib,0,0
190804,during,0,0
190805,the,0,0
190806,third,0,0
190807,cycle,0,1
190808,(,0,0
190809,intravenous=8,0,0
190810,%,0,0
190811,;,0,0
190812,subcutaneous=2,0,0
190813,%,0,0
190814,",",0,1
190815,P=0.001,0,0
190816,),0,0
190817,.,0,0
190818,Overall,1,0
190819,response,1,1
190820,rates,1,1
190821,were,0,0
190822,similar,0,0
190823,in,0,0
190824,patients,0,0
190825,treated,0,0
190826,intravenously,0,0
190827,or,0,0
190828,subcutaneously,0,0
190829,.,0,0
190830,The,0,0
190831,presence,0,0
190832,of,0,0
190833,International,1,0
190834,Staging,1,0
190835,System,1,0
190836,stage,1,0
190837,III,1,1
190838,disease,1,1
190839,",",1,0
190840,renal,1,1
190841,impairment,1,1
190842,or,1,0
190843,adverse,1,1
190844,cytogenetic,1,1
190845,abnormalities,1,0
190846,did,0,0
190847,not,0,0
190848,have,0,0
190849,a,0,0
190850,negative,0,0
190851,impact,0,0
190852,on,0,0
190853,overall,0,1
190854,response,0,1
190855,rates,0,1
190856,in,0,0
190857,either,0,0
190858,group,0,0
190859,.,0,0
190860,To,0,0
190861,our,0,0
190862,knowledge,0,0
190863,this,0,0
190864,is,0,0
190865,the,0,0
190866,largest,0,0
190867,study,0,0
190868,to,0,0
190869,present,0,0
190870,data,0,0
190871,comparing,0,0
190872,subcutaneous,0,0
190873,with,0,0
190874,intravenous,0,0
190875,bortezomib,0,0
190876,in,0,0
190877,newly,0,0
190878,diagnosed,0,0
190879,myeloma,1,0
190880,.,1,0
190881,We,0,0
190882,show,0,0
190883,better,0,0
190884,tolerance,1,1
190885,and,0,1
190886,similar,0,0
190887,overall,0,1
190888,response,1,1
190889,rates,0,1
190890,for,0,0
190891,subcutaneous,0,0
190892,compared,0,0
190893,to,0,0
190894,intravenous,0,0
190895,bortezomib,0,0
190896,.,0,0
190897,The,0,0
190898,clinical,0,0
190899,trial,0,0
190900,is,0,0
190901,registered,0,0
190902,at,0,0
190903,eudract.ema.europa.eu,0,0
190904,as,0,0
190905,n.,0,0
190906,2010-019173-16,0,0
190907,.,0,0
190908,Visual,0,1
190909,Assessment,0,0
190910,of,0,0
190911,Relative,0,0
190912,Apical,0,0
190913,Sparing,0,0
190914,Pattern,0,0
190915,Is,0,0
190916,More,0,0
190917,Useful,0,1
190918,Than,0,0
190919,Quantitative,0,0
190920,Assessment,0,0
190921,for,0,0
190922,Diagnosing,0,1
190923,Cardiac,0,1
190924,Amyloidosis,0,1
190925,in,0,0
190926,Borderline,0,1
190927,or,0,0
190928,Mildly,0,0
190929,Increased,0,0
190930,Left,0,0
190931,Ventricular,0,1
190932,Wall,0,1
190933,Thickness,0,1
190934,.,0,0
190935,BACKGROUND,0,0
190936,Relative,0,0
190937,apical,0,1
190938,sparing,0,0
190939,pattern,0,0
190940,of,0,0
190941,longitudinal,0,0
190942,strain,0,1
190943,(,0,0
190944,RapSP-LS,0,0
190945,),0,0
190946,was,0,0
190947,suggested,0,0
190948,in,0,0
190949,advanced,0,0
190950,cardiac,0,1
190951,amyloidosis,0,1
190952,(,0,0
190953,CA,0,0
190954,),0,0
190955,.,0,0
190956,It,0,0
190957,is,0,0
190958,unclear,0,0
190959,whether,0,0
190960,it,0,0
190961,is,0,0
190962,present,0,0
190963,in,0,0
190964,less,0,0
190965,advanced,0,0
190966,CA,0,0
190967,.,0,0
190968,METHODS,0,0
190969,AND,0,0
190970,RESULTS,0,0
190971,Patients,0,0
190972,with,0,0
190973,presumptive,0,1
190974,diagnosis,0,0
190975,of,0,0
190976,CA,0,0
190977,and,0,0
190978,mean,0,1
190979,left,0,1
190980,ventricular,0,1
190981,wall,0,1
190982,thickness,0,1
190983,(,0,0
190984,LVWT,0,0
190985,),0,0
190986,?14,0,0
190987,mm,0,0
190988,were,0,0
190989,recruited,0,0
190990,.,0,0
190991,Apart,0,0
190992,from,0,0
190993,RapSP-LS,0,0
190994,visually,0,0
190995,identified,0,0
190996,",",0,0
190997,relative,0,1
190998,apical,0,1
190999,longitudinal,0,0
191000,strain,0,1
191001,index,0,1
191002,(,0,0
191003,RapLSI,0,0
191004,),0,0
191005,was,0,0
191006,defined,0,0
191007,as,0,0
191008,[,0,0
191009,average,0,0
191010,apical,0,1
191011,LS/,0,0
191012,(,0,0
191013,average,0,1
191014,basal,0,1
191015,LS+average,0,1
191016,mid-ventricle,0,1
191017,LS,0,0
191018,),0,0
191019,],0,0
191020,.,0,0
191021,Among,0,0
191022,119,0,0
191023,patients,0,0
191024,included,0,0
191025,",",0,0
191026,47,0,0
191027,were,0,0
191028,finally,0,0
191029,diagnosed,0,0
191030,with,0,0
191031,CA,0,0
191032,.,1,0
191033,RapLSI,1,0
191034,was,1,0
191035,higher,0,0
191036,in,0,0
191037,the,0,0
191038,CA,0,0
191039,group,0,0
191040,compared,0,0
191041,to,0,0
191042,other,0,0
191043,causes,0,0
191044,of,0,0
191045,increased,1,0
191046,mean,1,1
191047,LVWT,1,0
191048,(,1,0
191049,P,0,0
191050,<,0,0
191051,0.001,0,0
191052,),0,0
191053,",",0,0
191054,but,0,0
191055,with,0,0
191056,a,0,0
191057,significant,0,0
191058,range,0,0
191059,of,0,0
191060,overlap,0,0
191061,noted,0,0
191062,.,0,0
191063,In,0,0
191064,contrast,0,0
191065,",",0,0
191066,RapSP-LS,0,0
191067,visually,0,1
191068,assessed,0,0
191069,was,0,0
191070,noted,0,0
191071,in,0,0
191072,most,0,0
191073,CA,0,0
191074,patients,0,0
191075,(,0,0
191076,31/47,0,0
191077,",",0,0
191078,66.0,0,0
191079,%,0,0
191080,),0,0
191081,except,0,0
191082,in,0,0
191083,those,0,0
191084,with,0,0
191085,preserved,0,0
191086,LV,0,0
191087,ejection,0,1
191088,fraction,0,1
191089,",",0,0
191090,normal,0,0
191091,LVWT,0,0
191092,",",0,0
191093,and,0,0
191094,mildly,0,0
191095,decreased,0,0
191096,global,0,1
191097,LS,0,0
191098,",",0,0
191099,suggesting,0,0
191100,least,0,0
191101,advanced,0,0
191102,CA,0,0
191103,.,0,0
191104,On,0,0
191105,multivariate,0,0
191106,analysis,0,0
191107,of,0,0
191108,the,0,0
191109,added,0,0
191110,diagnostic,0,0
191111,role,0,0
191112,of,0,0
191113,RapSP-LS,0,0
191114,or,0,0
191115,RapLSI,0,0
191116,on,0,0
191117,top,0,0
191118,of,0,0
191119,clinical,0,0
191120,",",0,0
191121,electrocardiographic,0,1
191122,",",0,0
191123,and,0,1
191124,conventional,0,0
191125,echocardiographic,0,1
191126,parameters,0,1
191127,",",0,0
191128,addition,0,0
191129,of,0,1
191130,RapLSI,0,0
191131,produced,0,0
191132,only,0,0
191133,borderline,0,0
191134,increase,0,0
191135,in,0,0
191136,area,0,0
191137,under,0,0
191138,the,0,0
191139,curve,0,1
191140,of,0,0
191141,the,0,0
191142,multivariate,0,0
191143,model,0,0
191144,(,0,0
191145,P=0.05,0,0
191146,),0,0
191147,",",0,0
191148,whereas,0,0
191149,addition,0,0
191150,of,0,0
191151,RapSP-LS,0,0
191152,significantly,0,0
191153,increased,0,0
191154,it,0,0
191155,(,0,0
191156,P,0,0
191157,<,0,0
191158,0.001,0,0
191159,),0,0
191160,.,0,0
191161,CONCLUSIONS,0,0
191162,Visual,0,1
191163,identification,0,1
191164,of,0,0
191165,RapSP-LS,0,0
191166,is,0,0
191167,useful,0,0
191168,in,0,0
191169,terms,0,0
191170,of,0,0
191171,added,1,0
191172,diagnostic,1,0
191173,value,1,0
191174,compared,1,0
191175,with,0,0
191176,quantitative,0,0
191177,calculation,0,0
191178,of,0,0
191179,RapLSI,0,0
191180,.,0,0
191181,Its,0,0
191182,clinical,0,0
191183,application,0,0
191184,",",0,0
191185,however,0,0
191186,",",0,0
191187,should,0,0
191188,be,0,0
191189,used,0,0
191190,with,0,0
191191,caution,0,0
191192,in,0,0
191193,patients,0,0
191194,with,0,0
191195,less,0,0
191196,advanced,0,0
191197,CA,0,0
191198,.,0,0
191199,Peritoneovenous,0,0
191200,shunting,0,0
191201,as,0,0
191202,compared,0,0
191203,with,0,0
191204,medical,0,0
191205,treatment,0,0
191206,in,0,0
191207,patients,0,0
191208,with,0,0
191209,alcoholic,0,0
191210,cirrhosis,0,0
191211,and,0,0
191212,massive,0,0
191213,ascites,0,1
191214,.,0,0
191215,Veterans,0,0
191216,Administration,0,0
191217,Cooperative,0,0
191218,Study,0,0
191219,on,0,0
191220,Treatment,0,0
191221,of,0,0
191222,Alcoholic,0,0
191223,Cirrhosis,0,0
191224,with,0,0
191225,Ascites,0,0
191226,.,0,0
191227,The,0,0
191228,optimal,0,0
191229,management,0,0
191230,of,0,0
191231,severe,0,1
191232,ascites,0,1
191233,in,0,0
191234,patients,0,0
191235,with,0,0
191236,alcoholic,0,0
191237,cirrhosis,0,0
191238,has,0,0
191239,not,0,0
191240,been,0,0
191241,defined,0,0
191242,.,0,0
191243,in,0,0
191244,a,0,0
191245,5,0,0
191246,1/2-year,0,0
191247,study,0,0
191248,",",0,0
191249,we,0,0
191250,randomly,0,0
191251,assigned,0,0
191252,299,0,0
191253,men,0,0
191254,with,0,0
191255,alcoholic,0,0
191256,cirrhosis,0,0
191257,",",0,0
191258,who,0,0
191259,had,0,0
191260,persistent,0,0
191261,or,0,0
191262,recurrent,0,1
191263,severe,0,1
191264,ascites,0,0
191265,despite,0,0
191266,a,0,0
191267,standard,0,0
191268,medical,0,0
191269,regimen,0,0
191270,",",0,0
191271,to,0,0
191272,receive,0,0
191273,either,0,0
191274,intensive,0,0
191275,medical,0,0
191276,treatment,0,0
191277,or,0,0
191278,peritoneovenous,0,0
191279,(,0,0
191280,LeVeen,0,0
191281,),0,0
191282,shunting,0,0
191283,.,0,0
191284,We,0,0
191285,identified,0,0
191286,three,0,0
191287,risk,0,0
191288,groups,0,0
191289,:,0,0
191290,Group,0,0
191291,1,0,0
191292,had,0,0
191293,normal,0,0
191294,or,0,0
191295,mildly,0,0
191296,abnormal,0,1
191297,results,0,0
191298,on,0,0
191299,liver-function,0,1
191300,tests,0,1
191301,",",0,0
191302,Group,0,0
191303,2,0,0
191304,had,0,0
191305,more,0,0
191306,severe,0,1
191307,liver,0,0
191308,dysfunction,0,1
191309,or,0,0
191310,previous,0,0
191311,complications,0,1
191312,",",0,0
191313,and,0,0
191314,Group,0,0
191315,3,0,0
191316,had,0,0
191317,severe,0,0
191318,prerenal,0,0
191319,azotemia,0,0
191320,without,0,0
191321,kidney,0,0
191322,disease,0,0
191323,.,0,0
191324,For,0,0
191325,the,0,0
191326,patients,0,0
191327,who,0,0
191328,received,0,0
191329,the,0,0
191330,medical,0,0
191331,treatment,0,0
191332,and,0,0
191333,those,0,0
191334,who,0,0
191335,received,0,0
191336,the,0,0
191337,surgical,0,0
191338,treatment,0,0
191339,combined,0,0
191340,",",0,0
191341,the,0,0
191342,median,0,1
191343,survival,0,1
191344,times,0,1
191345,were,0,0
191346,1093,0,0
191347,days,0,0
191348,in,0,0
191349,Group,0,0
191350,1,0,0
191351,",",0,0
191352,222,0,0
191353,days,0,0
191354,in,0,0
191355,Group,0,0
191356,2,0,0
191357,",",0,0
191358,and,0,0
191359,37,0,0
191360,days,0,0
191361,in,0,0
191362,Group,0,0
191363,3,0,0
191364,(,0,0
191365,P,0,0
191366,less,0,0
191367,than,0,0
191368,or,0,0
191369,equal,0,0
191370,to,0,0
191371,0.01,0,0
191372,),0,0
191373,for,0,0
191374,all,0,0
191375,comparisons,0,0
191376,),0,0
191377,.,0,0
191378,For,0,0
191379,all,0,0
191380,the,0,0
191381,groups,0,0
191382,combined,0,0
191383,",",0,0
191384,the,0,0
191385,median,0,0
191386,time,0,1
191387,to,0,0
191388,the,0,0
191389,resolution,0,1
191390,of,0,0
191391,ascites,0,1
191392,was,0,0
191393,5.4,0,0
191394,weeks,0,0
191395,for,0,0
191396,medical,0,0
191397,patients,0,0
191398,and,0,0
191399,3.0,0,0
191400,weeks,0,0
191401,for,0,0
191402,surgical,0,0
191403,patients,0,0
191404,(,0,0
191405,P,0,0
191406,less,0,0
191407,than,0,0
191408,0.01,0,0
191409,),0,0
191410,.,0,0
191411,Within,0,0
191412,each,0,0
191413,risk,0,1
191414,group,0,0
191415,",",0,0
191416,mortality,1,1
191417,during,0,0
191418,the,0,0
191419,initial,0,0
191420,hospitalization,0,1
191421,and,0,0
191422,median,1,1
191423,long-term,1,1
191424,survival,1,1
191425,were,0,0
191426,similar,0,0
191427,among,0,0
191428,patients,0,0
191429,receiving,0,0
191430,either,0,0
191431,treatment,0,0
191432,.,0,0
191433,However,0,0
191434,",",0,0
191435,the,0,0
191436,median,0,0
191437,time,0,1
191438,to,0,0
191439,the,0,0
191440,recurrence,1,1
191441,of,1,0
191442,ascites,1,1
191443,in,0,0
191444,Group,0,0
191445,1,0,0
191446,was,0,0
191447,4,0,0
191448,months,0,0
191449,in,0,0
191450,medical,0,0
191451,patients,0,0
191452,",",0,0
191453,as,0,0
191454,compared,0,0
191455,with,0,0
191456,18,0,0
191457,months,0,0
191458,in,0,0
191459,surgical,0,0
191460,patients,0,0
191461,(,0,0
191462,P,0,0
191463,=,0,0
191464,0.01,0,0
191465,),0,0
191466,;,0,0
191467,in,0,0
191468,Group,0,0
191469,2,0,0
191470,it,0,0
191471,was,0,0
191472,3,0,0
191473,months,0,0
191474,in,0,0
191475,medical,0,0
191476,patients,0,0
191477,as,0,0
191478,compared,0,0
191479,with,0,0
191480,12,0,0
191481,months,0,0
191482,in,0,0
191483,surgical,0,0
191484,patients,0,0
191485,(,0,0
191486,P,0,0
191487,=,0,0
191488,0.04,0,0
191489,),0,0
191490,.,0,0
191491,The,0,0
191492,median,1,0
191493,duration,1,1
191494,of,1,0
191495,hospitalization,1,1
191496,was,0,0
191497,longer,0,0
191498,in,0,0
191499,medical,0,0
191500,patients,0,0
191501,than,0,0
191502,in,0,0
191503,surgical,0,0
191504,patients,0,0
191505,(,0,0
191506,6.1,0,0
191507,vs.,0,0
191508,2.4,0,0
191509,weeks,0,0
191510,in,0,0
191511,Group,0,0
191512,1,0,0
191513,[,0,0
191514,P,0,0
191515,less,0,0
191516,than,0,0
191517,0.001,0,0
191518,],0,0
191519,and,0,0
191520,5.0,0,0
191521,vs.,0,0
191522,3.1,0,0
191523,weeks,0,0
191524,in,0,0
191525,Group,0,0
191526,2,0,0
191527,[,0,0
191528,P,0,0
191529,less,0,0
191530,than,0,0
191531,0.01,0,0
191532,],0,0
191533,),0,0
191534,.,0,0
191535,Group,0,0
191536,3,0,0
191537,was,0,0
191538,too,0,0
191539,small,0,0
191540,to,0,0
191541,permit,0,0
191542,a,0,0
191543,meaningful,0,0
191544,comparison,0,0
191545,.,0,0
191546,During,0,0
191547,the,0,0
191548,initial,0,0
191549,hospitalization,0,1
191550,",",0,0
191551,the,0,0
191552,incidence,1,1
191553,of,1,0
191554,infections,1,1
191555,",",1,0
191556,gastrointestinal,1,1
191557,bleeding,1,1
191558,",",1,0
191559,and,1,1
191560,encephalopathy,1,1
191561,was,0,0
191562,similar,0,0
191563,among,0,0
191564,the,0,0
191565,medical,0,0
191566,and,0,0
191567,surgical,0,0
191568,patients,0,0
191569,.,0,0
191570,We,0,0
191571,conclude,0,0
191572,that,0,0
191573,peritoneovenous,0,0
191574,shunting,0,0
191575,alleviated,0,0
191576,disabling,1,0
191577,ascites,1,1
191578,more,0,0
191579,rapidly,0,0
191580,than,0,0
191581,medical,0,0
191582,management,0,0
191583,.,0,0
191584,However,0,0
191585,",",0,0
191586,survival,1,1
191587,was,0,0
191588,closely,0,0
191589,related,0,0
191590,to,0,0
191591,the,0,0
191592,severity,0,1
191593,of,0,0
191594,the,0,0
191595,illness,0,0
191596,at,0,0
191597,the,0,0
191598,time,0,1
191599,of,0,0
191600,randomization,0,0
191601,and,0,0
191602,was,0,0
191603,not,0,0
191604,altered,0,0
191605,by,0,0
191606,shunting,0,0
191607,.,0,0
191608,Afatinib,0,0
191609,versus,0,0
191610,methotrexate,0,0
191611,as,0,0
191612,second-line,0,0
191613,treatment,0,0
191614,in,0,0
191615,patients,0,0
191616,with,0,0
191617,recurrent,0,1
191618,or,0,0
191619,metastatic,0,0
191620,squamous-cell,0,0
191621,carcinoma,0,0
191622,of,0,0
191623,the,0,0
191624,head,0,0
191625,and,0,0
191626,neck,0,1
191627,progressing,0,1
191628,on,0,0
191629,or,0,0
191630,after,0,0
191631,platinum-based,0,0
191632,therapy,0,0
191633,(,0,0
191634,LUX-Head,0,1
191635,&,0,0
191636,Neck,0,0
191637,1,0,0
191638,),0,0
191639,:,0,0
191640,an,0,0
191641,open-label,0,0
191642,",",0,0
191643,randomised,0,0
191644,phase,0,0
191645,3,0,0
191646,trial,0,0
191647,.,0,0
191648,BACKGROUND,0,0
191649,Patients,0,0
191650,with,0,0
191651,recurrent,0,1
191652,or,0,0
191653,metastatic,0,0
191654,squamous-cell,0,0
191655,carcinoma,0,0
191656,of,0,0
191657,the,0,0
191658,head,0,0
191659,and,0,1
191660,neck,0,1
191661,(,0,1
191662,HNSCC,0,1
191663,),0,0
191664,progressing,0,0
191665,after,0,0
191666,first-line,0,0
191667,platinum,0,0
191668,regimens,0,0
191669,have,0,0
191670,a,0,0
191671,poor,0,1
191672,prognosis,0,1
191673,and,0,0
191674,few,0,0
191675,treatment,0,0
191676,options,0,0
191677,.,0,0
191678,Afatinib,0,0
191679,",",0,0
191680,an,0,0
191681,irreversible,0,0
191682,ERBB,0,0
191683,family,0,1
191684,blocker,0,0
191685,",",0,0
191686,has,0,0
191687,shown,0,0
191688,efficacy,0,0
191689,in,0,0
191690,a,0,0
191691,phase,0,0
191692,2,0,0
191693,study,0,0
191694,in,0,0
191695,this,0,0
191696,setting,0,0
191697,.,0,0
191698,We,0,0
191699,aimed,0,0
191700,to,0,0
191701,assess,0,0
191702,the,0,0
191703,efficacy,0,1
191704,and,0,0
191705,safety,0,1
191706,of,0,1
191707,afatinib,0,0
191708,compared,0,0
191709,with,0,0
191710,methotrexate,0,0
191711,as,0,0
191712,second-line,0,0
191713,treatment,0,0
191714,in,0,0
191715,patients,0,0
191716,with,0,0
191717,recurrent,0,1
191718,or,0,0
191719,metastatic,0,0
191720,HNSCC,0,1
191721,progressing,0,1
191722,on,0,0
191723,or,0,0
191724,after,0,0
191725,platinum-based,0,0
191726,therapy,0,0
191727,.,0,0
191728,METHODS,0,0
191729,In,0,0
191730,this,0,0
191731,open-label,0,0
191732,",",0,0
191733,phase,0,0
191734,3,0,0
191735,",",0,0
191736,randomised,0,0
191737,controlled,0,0
191738,trial,0,0
191739,conducted,0,0
191740,in,0,0
191741,101,0,0
191742,centres,0,0
191743,in,0,0
191744,19,0,0
191745,countries,0,0
191746,",",0,0
191747,we,0,0
191748,enrolled,0,0
191749,patients,0,0
191750,aged,0,0
191751,18,0,0
191752,years,0,0
191753,or,0,0
191754,older,0,0
191755,with,0,0
191756,histologically,0,0
191757,or,0,0
191758,cytologically,0,0
191759,confirmed,0,0
191760,HNSCC,0,1
191761,that,0,0
191762,was,0,0
191763,recurrent,0,1
191764,",",0,1
191765,metastatic,0,0
191766,",",0,0
191767,or,0,0
191768,both,0,0
191769,who,0,0
191770,had,0,0
191771,progressed,0,0
191772,on,0,0
191773,or,0,0
191774,after,0,0
191775,first-line,0,0
191776,platinum-based,0,0
191777,therapy,0,0
191778,",",0,0
191779,were,0,0
191780,not,0,0
191781,amenable,0,0
191782,for,0,0
191783,salvage,0,1
191784,surgery,0,0
191785,or,0,1
191786,radiotherapy,0,0
191787,",",0,0
191788,and,0,1
191789,who,0,0
191790,had,0,0
191791,an,0,0
191792,Eastern,0,0
191793,Cooperative,0,0
191794,Oncology,0,0
191795,Group,0,0
191796,(,0,0
191797,ECOG,0,0
191798,),0,1
191799,performance,0,1
191800,status,0,1
191801,of,0,0
191802,0,0,0
191803,or,0,0
191804,1,0,0
191805,.,0,0
191806,Previous,0,0
191807,treatment,0,0
191808,with,0,0
191809,more,0,0
191810,than,0,0
191811,one,0,0
191812,systemic,0,0
191813,regimen,0,0
191814,in,0,0
191815,this,0,0
191816,setting,0,0
191817,was,0,0
191818,not,0,0
191819,allowed,0,0
191820,;,0,0
191821,previous,0,0
191822,treatment,0,0
191823,with,0,0
191824,EGFR-targeted,0,0
191825,antibody,0,1
191826,therapy,0,0
191827,(,0,0
191828,but,0,0
191829,not,0,0
191830,EGFR-targeted,0,0
191831,tyrosine-kinase,0,0
191832,inhibitors,0,0
191833,),0,0
191834,was,0,0
191835,allowed,0,0
191836,.,0,0
191837,We,0,0
191838,randomly,0,0
191839,assigned,0,0
191840,eligible,0,0
191841,patients,0,0
191842,in,0,0
191843,a,0,0
191844,2:1,0,0
191845,ratio,0,0
191846,to,0,0
191847,receive,0,0
191848,oral,0,0
191849,afatinib,0,0
191850,(,0,0
191851,40,0,0
191852,mg/day,0,0
191853,),0,0
191854,or,0,0
191855,intravenous,0,0
191856,methotrexate,0,0
191857,(,0,0
191858,40,0,0
191859,mg/m,0,0
191860,(,0,0
191861,2,0,0
191862,),0,0
191863,per,0,0
191864,week,0,0
191865,),0,0
191866,",",0,0
191867,stratified,0,0
191868,by,0,0
191869,ECOG,0,0
191870,performance,0,1
191871,status,0,1
191872,and,0,1
191873,previous,0,0
191874,EGFR-targeted,0,0
191875,antibody,0,0
191876,therapy,0,0
191877,for,0,0
191878,recurrent,0,1
191879,or,0,0
191880,metastatic,0,0
191881,disease,0,1
191882,.,0,0
191883,Randomisation,0,0
191884,was,0,0
191885,done,0,0
191886,centrally,0,0
191887,with,0,0
191888,an,0,0
191889,interactive,0,0
191890,voice,0,1
191891,or,0,0
191892,web-based,0,0
191893,response,0,1
191894,system,0,0
191895,.,0,0
191896,Clinicians,0,0
191897,and,0,0
191898,patients,0,0
191899,were,0,0
191900,not,0,0
191901,masked,0,0
191902,to,0,0
191903,treatment,0,0
191904,allocation,0,0
191905,;,0,0
191906,independent,0,0
191907,review,0,0
191908,of,0,0
191909,tumour,0,1
191910,response,0,1
191911,was,0,0
191912,done,0,0
191913,in,0,0
191914,a,0,0
191915,blinded,0,0
191916,manner,0,0
191917,.,0,0
191918,The,0,0
191919,primary,0,0
191920,endpoint,0,1
191921,was,0,0
191922,progression-free,1,1
191923,survival,1,1
191924,as,0,0
191925,assessed,0,0
191926,by,0,0
191927,an,0,0
191928,independent,0,0
191929,",",0,0
191930,central,0,1
191931,imaging,0,1
191932,review,0,0
191933,committee,0,0
191934,.,0,0
191935,Efficacy,1,1
191936,analyses,1,0
191937,were,0,0
191938,done,0,0
191939,in,0,0
191940,the,0,0
191941,intention-to-treat,0,0
191942,population,0,0
191943,and,0,1
191944,safety,1,1
191945,analyses,1,0
191946,were,0,0
191947,done,0,0
191948,in,0,0
191949,patients,0,0
191950,who,0,0
191951,received,0,0
191952,at,0,0
191953,least,0,0
191954,one,0,0
191955,dose,0,0
191956,of,0,0
191957,study,0,0
191958,drug,0,0
191959,.,0,0
191960,This,0,0
191961,ongoing,0,0
191962,study,0,0
191963,is,0,0
191964,registered,0,0
191965,with,0,0
191966,ClinicalTrials.gov,0,0
191967,",",0,0
191968,number,0,1
191969,NCT01345682,0,0
191970,.,0,0
191971,FINDINGS,0,0
191972,Between,0,0
191973,Jan,0,0
191974,10,0,0
191975,",",0,0
191976,2012,0,0
191977,",",0,0
191978,and,0,0
191979,Dec,0,0
191980,12,0,0
191981,",",0,0
191982,2013,0,0
191983,",",0,0
191984,we,0,0
191985,enrolled,0,0
191986,483,0,0
191987,patients,0,0
191988,and,0,0
191989,randomly,0,0
191990,assigned,0,0
191991,322,0,0
191992,to,0,0
191993,afatinib,0,0
191994,and,0,0
191995,161,0,0
191996,to,0,0
191997,methotrexate,0,0
191998,.,0,0
191999,After,0,0
192000,a,0,0
192001,median,0,0
192002,follow-up,0,0
192003,of,0,0
192004,6?7,0,0
192005,months,0,0
192006,(,0,0
192007,IQR,0,0
192008,3?1-9?0,1,0
192009,),1,0
192010,",",1,0
192011,progression-free,1,1
192012,survival,1,1
192013,was,1,0
192014,longer,0,0
192015,in,0,0
192016,the,0,0
192017,afatinib,0,0
192018,group,0,0
192019,than,0,0
192020,in,0,0
192021,the,0,0
192022,methotrexate,0,0
192023,group,0,0
192024,(,0,0
192025,median,0,0
192026,2?6,0,0
192027,months,0,0
192028,[,0,0
192029,95,0,0
192030,%,0,0
192031,CI,0,0
192032,2?0-2?7,0,0
192033,],0,0
192034,for,0,0
192035,the,0,0
192036,afatinib,0,0
192037,group,0,0
192038,vs,0,0
192039,1?7,0,0
192040,months,0,0
192041,[,0,0
192042,1?5-2?4,0,0
192043,],0,0
192044,for,0,0
192045,the,0,0
192046,methotrexate,0,0
192047,group,0,0
192048,;,0,0
192049,hazard,0,1
192050,ratio,0,1
192051,[,0,0
192052,HR,0,0
192053,],0,0
192054,0?80,0,0
192055,[,0,0
192056,95,0,0
192057,%,0,0
192058,CI,0,0
192059,0?65-0?98,0,0
192060,],0,0
192061,",",0,0
192062,p=0?030,0,0
192063,),0,0
192064,.,0,0
192065,The,0,0
192066,most,0,0
192067,frequent,0,0
192068,grade,0,0
192069,3,0,0
192070,or,0,0
192071,4,0,0
192072,drug-related,1,1
192073,adverse,1,1
192074,events,1,1
192075,were,1,0
192076,rash,1,1
192077,or,1,0
192078,acne,1,1
192079,(,0,0
192080,31,0,0
192081,[,0,0
192082,10,0,0
192083,%,0,0
192084,],0,0
192085,of,0,0
192086,320,0,0
192087,patients,0,0
192088,in,0,0
192089,the,0,0
192090,afatinib,0,0
192091,group,0,0
192092,vs,0,0
192093,none,0,0
192094,of,0,0
192095,160,0,0
192096,patients,0,0
192097,in,0,0
192098,the,0,0
192099,methotrexate,0,0
192100,group,1,0
192101,),1,0
192102,",",1,0
192103,diarrhoea,1,1
192104,(,1,0
192105,30,0,0
192106,[,0,0
192107,9,0,0
192108,%,0,0
192109,],0,0
192110,vs,0,0
192111,three,0,0
192112,[,0,0
192113,2,0,0
192114,%,0,0
192115,],0,0
192116,),0,0
192117,",",0,0
192118,stomatitis,1,0
192119,(,0,0
192120,20,0,0
192121,[,0,0
192122,6,0,0
192123,%,0,0
192124,],0,0
192125,vs,0,0
192126,13,0,0
192127,[,0,0
192128,8,0,0
192129,%,0,0
192130,],0,0
192131,),0,0
192132,",",0,0
192133,fatigue,1,1
192134,(,1,0
192135,18,1,0
192136,[,0,0
192137,6,0,0
192138,%,0,0
192139,],0,0
192140,vs,0,0
192141,five,0,0
192142,[,0,0
192143,3,0,0
192144,%,0,0
192145,],0,0
192146,),0,1
192147,",",0,0
192148,and,1,1
192149,neutropenia,1,1
192150,(,0,0
192151,1,0,0
192152,[,0,0
192153,<,0,0
192154,1,0,0
192155,%,0,0
192156,],0,0
192157,vs,0,0
192158,11,0,0
192159,[,0,0
192160,7,0,0
192161,%,0,0
192162,],0,0
192163,),0,0
192164,;,0,0
192165,serious,1,1
192166,adverse,1,1
192167,events,1,1
192168,occurred,1,0
192169,in,0,0
192170,44,0,0
192171,(,0,0
192172,14,0,0
192173,%,0,0
192174,),0,0
192175,of,0,0
192176,afatinib-treated,0,0
192177,patients,0,0
192178,and,0,0
192179,18,0,0
192180,(,0,0
192181,11,0,0
192182,%,0,0
192183,),0,0
192184,of,0,0
192185,methotrexate-treated,0,0
192186,patients,0,0
192187,.,0,0
192188,INTERPRETATION,0,0
192189,Afatinib,0,0
192190,was,0,0
192191,associated,0,0
192192,with,0,0
192193,significant,0,0
192194,improvements,0,1
192195,in,1,0
192196,progression-free,1,1
192197,survival,1,1
192198,and,1,0
192199,had,0,0
192200,a,0,0
192201,manageable,0,0
192202,safety,0,1
192203,profile,0,0
192204,.,0,0
192205,These,0,0
192206,findings,0,0
192207,provide,0,0
192208,important,0,0
192209,new,0,0
192210,insights,0,0
192211,into,0,0
192212,the,0,0
192213,treatment,0,0
192214,of,0,0
192215,this,0,0
192216,patient,0,0
192217,population,0,0
192218,and,0,1
192219,support,0,0
192220,further,0,0
192221,investigations,0,0
192222,with,0,0
192223,irreversible,0,0
192224,ERBB,0,0
192225,family,0,0
192226,blockers,0,0
192227,in,0,0
192228,HNSCC,0,1
192229,.,0,0
192230,FUNDING,0,0
192231,Boehringer,0,0
192232,Ingelheim,0,0
192233,.,0,0
192234,Icosapent,0,1
192235,Ethyl,0,0
192236,(,0,0
192237,Eicosapentaenoic,0,0
192238,Acid,0,1
192239,Ethyl,0,0
192240,Ester,0,0
192241,),0,0
192242,:,0,0
192243,Effects,0,0
192244,Upon,0,0
192245,High-Sensitivity,0,1
192246,C-Reactive,0,0
192247,Protein,0,0
192248,and,0,0
192249,Lipid,0,0
192250,Parameters,0,1
192251,in,0,0
192252,Patients,0,0
192253,With,0,0
192254,Metabolic,0,0
192255,Syndrome,0,0
192256,.,0,0
192257,BACKGROUND,0,0
192258,The,0,0
192259,aim,0,0
192260,of,0,0
192261,this,0,0
192262,analysis,0,0
192263,was,0,0
192264,to,0,0
192265,examine,0,0
192266,the,0,0
192267,effects,0,0
192268,of,0,0
192269,icosapent,0,0
192270,ethyl,0,0
192271,(,0,0
192272,eicosapentaenoic,0,0
192273,acid,0,1
192274,ethyl,0,0
192275,ester,0,1
192276,",",0,1
192277,IPE,0,1
192278,),0,0
192279,on,0,0
192280,high-sensitivity,0,1
192281,C-reactive,0,1
192282,protein,0,1
192283,(,0,0
192284,hsCRP,0,1
192285,),0,1
192286,and,0,0
192287,lipid,0,1
192288,parameters,0,1
192289,in,0,0
192290,patients,0,0
192291,with,0,0
192292,metabolic,0,1
192293,syndrome,0,0
192294,",",0,0
192295,with,0,0
192296,and,0,0
192297,without,0,0
192298,stable,0,1
192299,statin,0,0
192300,therapy,0,0
192301,.,0,0
192302,METHODS,0,0
192303,This,0,0
192304,post,0,0
192305,hoc,0,0
192306,exploratory,0,0
192307,analysis,0,0
192308,evaluated,0,0
192309,patients,0,0
192310,with,0,0
192311,metabolic,0,1
192312,syndrome,0,0
192313,treated,0,0
192314,with,0,0
192315,IPE,0,1
192316,4,0,0
192317,grams/day,0,0
192318,",",0,0
192319,IPE,0,1
192320,2,0,0
192321,grams/day,0,0
192322,",",0,0
192323,or,0,1
192324,placebo,0,0
192325,in,0,0
192326,phase,0,0
192327,3,0,0
192328,",",0,0
192329,randomized,0,0
192330,",",0,0
192331,placebo-controlled,0,0
192332,studies,0,0
192333,entitled,0,0
192334,:,0,0
192335,MARINE,0,0
192336,[,0,0
192337,triglyceride,0,1
192338,(,0,0
192339,TG,0,1
192340,),0,0
192341,levels,0,1
192342,?500,0,0
192343,and,0,0
192344,?2000,0,0
192345,mg/dL,0,0
192346,],0,0
192347,and,0,1
192348,ANCHOR,0,0
192349,[,0,0
192350,TG,0,1
192351,levels,0,1
192352,?200,0,0
192353,and,0,0
192354,<,0,0
192355,500,0,0
192356,mg/dL,0,0
192357,",",0,0
192358,despite,0,0
192359,low-density,0,1
192360,lipoprotein,0,1
192361,cholesterol,0,1
192362,(,0,0
192363,LDL-C,0,1
192364,),0,0
192365,control,0,0
192366,with,0,0
192367,stable,0,1
192368,statin,0,0
192369,therapy,0,0
192370,],0,0
192371,.,0,0
192372,RESULTS,0,0
192373,Compared,0,0
192374,with,0,0
192375,placebo,0,0
192376,in,0,0
192377,patients,0,0
192378,with,0,0
192379,metabolic,0,1
192380,syndrome,0,0
192381,in,0,0
192382,MARINE,0,1
192383,(,0,0
192384,n=204,0,0
192385,),0,1
192386,and,0,1
192387,ANCHOR,0,1
192388,(,0,1
192389,n=645,0,0
192390,),0,0
192391,",",0,0
192392,at,0,0
192393,the,0,0
192394,approved,0,0
192395,dose,0,0
192396,of,0,0
192397,4,0,0
192398,grams/day,0,0
192399,",",0,0
192400,IPE,0,1
192401,significantly,1,0
192402,lowered,1,0
192403,hsCRP,1,0
192404,levels,1,1
192405,40.0,1,0
192406,%,0,0
192407,(,0,0
192408,P=0.0007,0,0
192409,),0,0
192410,in,0,0
192411,MARINE,0,0
192412,and,0,0
192413,23.0,0,0
192414,%,0,0
192415,(,0,0
192416,P=0.0003,0,0
192417,),0,0
192418,in,0,0
192419,ANCHOR,0,0
192420,.,0,0
192421,Compared,0,0
192422,with,0,0
192423,placebo,0,0
192424,in,0,0
192425,MARINE,0,1
192426,",",0,0
192427,which,0,0
192428,included,0,0
192429,patients,0,0
192430,with,0,0
192431,and,0,0
192432,without,0,0
192433,statin,0,0
192434,therapy,0,0
192435,",",0,0
192436,IPE,0,1
192437,4,0,0
192438,grams/day,0,0
192439,significantly,1,0
192440,reduced,1,0
192441,hsCRP,1,0
192442,levels,1,1
192443,78.0,1,0
192444,%,0,0
192445,in,0,0
192446,statin-treated,0,0
192447,patients,0,0
192448,(,0,0
192449,P=0.0035,0,0
192450,",",0,1
192451,n=16,0,0
192452,),0,0
192453,.,0,0
192454,Compared,0,0
192455,with,0,0
192456,placebo,0,0
192457,in,0,0
192458,MARINE,0,1
192459,",",0,0
192460,IPE,0,1
192461,4,0,0
192462,grams/day,0,0
192463,significantly,1,0
192464,reduced,1,0
192465,TG,1,0
192466,levels,1,1
192467,(,0,0
192468,35.0,0,0
192469,%,0,0
192470,;,0,0
192471,P,0,0
192472,<,0,0
192473,0.0001,0,0
192474,),0,0
192475,",",0,0
192476,non-high-density,1,0
192477,lipoprotein,1,1
192478,cholesterol,1,1
192479,(,1,0
192480,non-HDL-C,1,0
192481,;,1,0
192482,19.9,1,0
192483,%,1,0
192484,;,1,0
192485,P,1,0
192486,<,1,0
192487,0.0001,0,0
192488,),0,0
192489,",",0,0
192490,and,1,0
192491,apolipoprotein,1,1
192492,B,1,0
192493,levels,1,1
192494,(,0,0
192495,ApoB,0,1
192496,),0,0
192497,(,0,0
192498,9.1,0,0
192499,%,0,0
192500,;,0,0
192501,P=0.0015,0,0
192502,),0,0
192503,without,0,0
192504,raising,1,0
192505,LDL-C,1,0
192506,levels,1,1
192507,.,1,0
192508,Compared,1,0
192509,with,0,0
192510,placebo,0,0
192511,in,0,0
192512,ANCHOR,0,0
192513,",",0,0
192514,IPE,0,1
192515,4,0,0
192516,grams/day,0,0
192517,significantly,1,0
192518,reduced,1,0
192519,TG,1,0
192520,(,1,0
192521,21.7,1,0
192522,%,1,0
192523,;,0,0
192524,P,0,0
192525,<,0,0
192526,0.0001,0,0
192527,),0,0
192528,",",0,0
192529,non-HDL-C,1,0
192530,(,0,0
192531,13.5,0,0
192532,%,0,0
192533,;,0,0
192534,P,0,0
192535,<,0,0
192536,0.0001,0,0
192537,),0,0
192538,",",0,0
192539,ApoB,1,1
192540,(,1,0
192541,8.8,1,0
192542,%,0,0
192543,;,0,0
192544,P,0,0
192545,<,0,0
192546,0.0001,0,0
192547,),0,0
192548,",",0,0
192549,LDL-C,1,1
192550,(,1,0
192551,5.2,1,0
192552,%,0,0
192553,;,0,0
192554,P=0.0236,0,0
192555,),0,0
192556,",",0,0
192557,and,1,1
192558,HDL-C,1,1
192559,levels,1,1
192560,(,1,0
192561,4.0,1,0
192562,%,0,0
192563,;,0,0
192564,P=0.0053,0,0
192565,),0,0
192566,.,0,0
192567,CONCLUSIONS,0,0
192568,Compared,0,0
192569,with,0,0
192570,placebo,0,0
192571,",",0,0
192572,IPE,0,1
192573,4,0,0
192574,grams/day,0,0
192575,significantly,0,0
192576,lowered,0,0
192577,hsCRP,0,0
192578,levels,0,1
192579,and,0,0
192580,improved,0,1
192581,lipids,0,0
192582,without,0,0
192583,raising,0,0
192584,LDL-C,0,0
192585,levels,0,1
192586,in,0,0
192587,patients,0,0
192588,with,0,0
192589,metabolic,0,1
192590,syndrome,0,0
192591,and,0,1
192592,high,0,1
192593,(,0,0
192594,?200,0,0
192595,and,0,0
192596,<,0,0
192597,500,0,0
192598,mg/dL,0,0
192599,),0,0
192600,or,0,0
192601,very,0,0
192602,high,0,0
192603,(,0,0
192604,?500,0,0
192605,and,0,0
192606,?2000,0,0
192607,mg/dL,0,0
192608,),0,0
192609,TG,0,1
192610,levels,0,1
192611,",",0,0
192612,with,0,0
192613,or,0,0
192614,without,0,0
192615,stable,0,1
192616,statin,0,0
192617,therapy,0,0
192618,.,0,0
192619,The,0,0
192620,impact,0,0
192621,of,0,0
192622,amalgam,0,0
192623,dental,0,0
192624,fillings,0,0
192625,on,0,0
192626,the,0,0
192627,frequency,1,1
192628,of,1,0
192629,Helicobacter,1,1
192630,pylori,1,0
192631,infection,1,1
192632,and,1,0
192633,H.,1,1
192634,pylori,1,1
192635,eradication,1,1
192636,rates,1,1
192637,in,0,0
192638,patients,0,0
192639,treated,0,0
192640,with,0,0
192641,concomitant,0,0
192642,",",0,0
192643,quadruple,0,0
192644,",",0,1
192645,and,0,1
192646,levofloxacin-based,0,0
192647,therapies,0,0
192648,.,0,0
192649,BACKGROUND,0,0
192650,AND,0,0
192651,AIM,0,1
192652,Mercury,0,0
192653,exposure,0,0
192654,is,0,0
192655,encountered,0,0
192656,most,0,0
192657,commonly,0,0
192658,in,0,0
192659,individuals,0,0
192660,with,0,0
192661,amalgam,0,0
192662,fillings,0,0
192663,.,0,0
192664,The,0,0
192665,toxic,0,1
192666,",",0,0
192667,bactericidal,0,1
192668,",",0,1
192669,and,0,1
192670,immunosuppressive,0,1
192671,effects,0,1
192672,of,0,0
192673,mercury,0,0
192674,are,0,0
192675,well,0,0
192676,known,0,0
192677,.,0,0
192678,Furthermore,0,0
192679,",",0,0
192680,multiple,0,1
192681,antibiotic,0,0
192682,resistance,0,0
192683,can,0,0
192684,be,0,0
192685,transferred,0,0
192686,",",0,0
192687,together,0,0
192688,with,0,0
192689,mercury,0,0
192690,resistance,0,1
192691,.,0,0
192692,The,0,0
192693,aim,0,0
192694,of,0,0
192695,this,0,0
192696,study,0,0
192697,was,0,0
192698,to,0,0
192699,investigate,0,0
192700,the,0,0
192701,frequency,1,1
192702,of,1,0
192703,Helicobacter,1,0
192704,pylori,1,0
192705,infection,1,1
192706,in,0,0
192707,dyspeptic,0,1
192708,patients,0,0
192709,with,0,0
192710,amalgam,0,0
192711,fillings,0,0
192712,and,0,0
192713,the,0,0
192714,effect,0,0
192715,of,0,0
192716,the,0,0
192717,amalgam,0,0
192718,fillings,0,0
192719,on,0,0
192720,H.,1,0
192721,pylori,1,0
192722,eradication,1,1
192723,rates,1,1
192724,in,0,0
192725,these,0,0
192726,patients,0,0
192727,.,0,0
192728,PATIENTS,0,0
192729,AND,0,0
192730,METHODS,0,0
192731,Four,0,1
192732,hundred,0,0
192733,and,0,0
192734,seventy-five,0,0
192735,patients,0,0
192736,who,0,0
192737,presented,0,0
192738,with,0,0
192739,dyspeptic,0,1
192740,complaints,0,1
192741,and,0,0
192742,underwent,0,0
192743,upper,0,0
192744,gastrointestinal,0,1
192745,endoscopy,0,0
192746,and,0,0
192747,gastric,0,1
192748,biopsy,0,0
192749,were,0,0
192750,included,0,0
192751,in,0,0
192752,this,0,0
192753,study,0,0
192754,.,0,0
192755,One,0,0
192756,hundred,0,0
192757,and,0,0
192758,sixty-nine,0,0
192759,(,0,0
192760,35.6,0,0
192761,%,0,0
192762,),0,0
192763,patients,0,0
192764,were,0,0
192765,negative,0,0
192766,and,0,0
192767,306,0,0
192768,(,0,0
192769,64.4,0,0
192770,%,0,0
192771,),0,0
192772,patients,0,0
192773,were,0,0
192774,positive,0,0
192775,for,0,0
192776,H.,0,0
192777,pylori,0,0
192778,.,0,0
192779,All,0,0
192780,of,0,0
192781,the,0,0
192782,participants,0,0
192783,underwent,0,0
192784,dental,0,0
192785,examinations,0,0
192786,in,0,0
192787,a,0,0
192788,blinded,0,0
192789,manner,0,0
192790,.,0,0
192791,The,0,0
192792,participants,0,0
192793,were,0,0
192794,divided,0,0
192795,into,0,0
192796,two,0,0
192797,groups,0,0
192798,on,0,0
192799,the,0,0
192800,basis,0,0
192801,of,0,0
192802,the,0,0
192803,presence,0,0
192804,of,0,0
192805,amalgam,0,0
192806,fillings,0,0
192807,.,0,0
192808,The,0,0
192809,H.,0,0
192810,pylori-positive,0,0
192811,patients,0,0
192812,were,0,0
192813,divided,0,0
192814,randomly,0,0
192815,into,0,0
192816,three,0,0
192817,subgroups,0,0
192818,:,0,0
192819,patients,0,0
192820,who,0,0
192821,received,0,0
192822,concomitant,0,0
192823,therapy,0,0
192824,(,0,0
192825,CT,0,1
192826,),0,0
192827,(,0,0
192828,rabeprazole-amoxicillin-clarithromycin-metronidazole,0,0
192829,for,0,0
192830,14,0,0
192831,days,0,0
192832,;,0,0
192833,n=122,0,0
192834,),0,0
192835,;,0,0
192836,patients,0,0
192837,who,0,0
192838,received,0,0
192839,quadruple,0,0
192840,therapy,0,0
192841,(,0,0
192842,QT,0,1
192843,),0,0
192844,(,0,0
192845,rabeprazole-tetracycline-metronidazole-colloidal,0,0
192846,bismuth,0,0
192847,subcitrate,0,0
192848,for,0,0
192849,10,0,0
192850,days,0,0
192851,;,0,0
192852,n=97,0,0
192853,),0,0
192854,;,0,0
192855,and,0,0
192856,patients,0,0
192857,who,0,0
192858,received,0,0
192859,levofloxacin-based,0,0
192860,therapy,0,0
192861,(,0,0
192862,LT,0,1
192863,),0,0
192864,(,0,0
192865,rabeprazole-amoxicillin-levofloxacin,0,0
192866,for,0,0
192867,10,0,0
192868,days,0,0
192869,;,0,0
192870,n=87,0,0
192871,),0,0
192872,.,0,0
192873,Eradication,1,1
192874,success,1,1
192875,was,0,0
192876,detected,0,0
192877,by,0,0
192878,a,0,0
192879,urea,0,1
192880,breath,0,1
192881,test,0,0
192882,6,0,0
192883,weeks,0,0
192884,after,0,0
192885,the,0,0
192886,end,0,0
192887,of,0,0
192888,treatment,0,0
192889,.,0,0
192890,RESULTS,0,0
192891,The,0,0
192892,frequency,1,1
192893,of,0,0
192894,H.,1,0
192895,pylori,1,0
192896,infection,1,1
192897,was,0,0
192898,significantly,0,0
192899,lower,0,0
192900,in,0,0
192901,the,0,0
192902,filling,0,0
192903,group,0,0
192904,compared,0,0
192905,with,0,0
192906,the,0,0
192907,nonfilling,0,0
192908,group,0,0
192909,(,0,0
192910,53.7,0,0
192911,and,0,0
192912,78.8,0,0
192913,%,0,0
192914,",",0,0
192915,respectively,0,0
192916,;,0,0
192917,P,0,0
192918,<,0,0
192919,0.001,0,0
192920,),0,0
192921,.,0,0
192922,The,0,0
192923,eradication,1,1
192924,rates,1,1
192925,in,0,0
192926,the,0,0
192927,CT,0,1
192928,",",0,0
192929,QT,0,1
192930,",",0,1
192931,and,0,1
192932,LT,0,1
192933,groups,0,0
192934,were,0,0
192935,65.5,0,0
192936,",",0,0
192937,67.0,0,0
192938,",",0,0
192939,and,0,0
192940,58.6,0,0
192941,%,0,0
192942,",",0,0
192943,respectively,0,0
192944,",",0,0
192945,in,0,0
192946,the,0,0
192947,intention-to-treat,0,0
192948,(,0,0
192949,ITT,0,0
192950,),0,1
192951,analysis,0,0
192952,and,0,0
192953,69.6,0,0
192954,",",0,0
192955,70.7,0,0
192956,",",0,0
192957,and,0,0
192958,62.2,0,0
192959,%,0,0
192960,",",0,0
192961,respectively,0,0
192962,",",0,0
192963,in,0,0
192964,the,0,0
192965,per-protocol,0,0
192966,(,0,0
192967,PP,0,0
192968,),0,0
192969,analysis,0,0
192970,.,0,0
192971,In,0,0
192972,all,0,0
192973,of,0,0
192974,the,0,0
192975,H.,0,0
192976,pylori-positive,0,0
192977,patients,0,0
192978,and,0,0
192979,separately,0,0
192980,in,0,0
192981,the,0,0
192982,CT,0,1
192983,and,0,0
192984,LT,0,1
192985,groups,0,0
192986,",",0,0
192987,the,0,0
192988,eradication,1,1
192989,rates,1,1
192990,were,0,0
192991,significantly,0,0
192992,lower,0,0
192993,in,0,0
192994,the,0,0
192995,filling,0,0
192996,group,0,0
192997,compared,0,0
192998,with,0,0
192999,the,0,0
193000,nonfilling,0,0
193001,group,0,0
193002,.,0,0
193003,However,0,0
193004,",",0,0
193005,in,0,0
193006,the,0,0
193007,QT,0,1
193008,group,0,0
193009,",",0,0
193010,there,0,0
193011,was,0,0
193012,no,0,0
193013,significant,0,0
193014,difference,0,0
193015,between,0,0
193016,the,0,0
193017,patients,0,0
193018,with,0,0
193019,and,0,0
193020,without,0,0
193021,fillings,0,1
193022,(,0,0
193023,P=0.001,0,0
193024,",",0,0
193025,0.003,0,0
193026,",",0,0
193027,0.012,0,0
193028,",",0,0
193029,0.14,0,0
193030,",",0,0
193031,respectively,0,0
193032,),0,0
193033,.,0,0
193034,Logistic,0,0
193035,regression,0,0
193036,analysis,0,0
193037,showed,0,0
193038,that,0,0
193039,the,0,0
193040,absence,0,0
193041,of,0,0
193042,amalgam,0,0
193043,filling,0,0
193044,exerts,0,0
193045,independent,0,0
193046,effects,0,0
193047,on,0,0
193048,the,0,0
193049,increased,0,0
193050,frequency,1,1
193051,of,1,0
193052,H.,1,0
193053,pylori,1,0
193054,infection,1,1
193055,and,0,0
193056,increased,1,1
193057,rate,1,1
193058,of,1,0
193059,H.,1,0
193060,pylori,1,0
193061,eradication,1,1
193062,.,1,0
193063,CONCLUSION,0,0
193064,This,0,0
193065,is,0,0
193066,the,0,0
193067,first,0,0
193068,study,0,0
193069,to,0,0
193070,show,0,0
193071,a,0,0
193072,lower,0,0
193073,frequency,1,1
193074,of,1,1
193075,H.,1,0
193076,pylori,1,0
193077,colonization,1,1
193078,in,0,0
193079,patients,0,0
193080,with,0,0
193081,amalgam,0,0
193082,fillings,0,0
193083,than,0,0
193084,without,0,0
193085,and,0,0
193086,that,0,0
193087,H.,1,1
193088,pylori,1,0
193089,eradication,1,1
193090,rates,1,1
193091,are,0,0
193092,lower,0,0
193093,in,0,0
193094,patients,0,0
193095,with,0,0
193096,amalgam,0,0
193097,fillings,0,0
193098,compared,0,0
193099,to,0,0
193100,those,0,0
193101,without,0,0
193102,.,0,0
193103,A,0,0
193104,trial,0,0
193105,of,0,0
193106,d-cycloserine,0,0
193107,to,0,0
193108,treat,0,0
193109,the,0,0
193110,social,0,1
193111,deficit,0,0
193112,in,0,0
193113,older,0,0
193114,adolescents,0,0
193115,and,0,1
193116,young,0,0
193117,adults,0,0
193118,with,0,0
193119,autism,0,0
193120,spectrum,0,0
193121,disorders,0,0
193122,.,0,0
193123,Autism,0,1
193124,spectrum,0,0
193125,disorders,0,0
193126,are,0,0
193127,difficult,0,0
193128,for,0,0
193129,older,0,0
193130,adolescents,0,0
193131,and,0,1
193132,young,0,0
193133,adults,0,0
193134,as,0,0
193135,impaired,0,0
193136,social,0,1
193137,communication,0,0
193138,affects,0,0
193139,the,0,0
193140,transition,0,0
193141,to,0,0
193142,adult,0,0
193143,life,0,1
193144,.,0,0
193145,d-Cycloserine,0,0
193146,",",0,0
193147,a,0,0
193148,partial,0,0
193149,glycine,0,0
193150,agonist,0,0
193151,at,0,0
193152,the,0,0
193153,N-methyl-d-aspartic,0,0
193154,acid,0,0
193155,receptor,0,1
193156,",",0,0
193157,was,0,0
193158,tested,0,0
193159,in,0,0
193160,a,0,0
193161,double-blind,0,0
193162,randomized,0,0
193163,trial,0,0
193164,in,0,0
193165,20,0,0
193166,older,0,0
193167,adolescents,0,0
193168,and,0,1
193169,young,0,0
193170,adults,0,0
193171,with,0,0
193172,autism,0,0
193173,spectrum,0,0
193174,disorders,0,0
193175,using,0,0
193176,two,0,0
193177,dosing,0,0
193178,strategies,0,0
193179,(,0,0
193180,50,0,0
193181,mg,0,0
193182,daily,0,0
193183,versus,0,0
193184,50,0,0
193185,mg,0,0
193186,weekly,0,0
193187,),0,0
193188,for,0,0
193189,8,0,0
193190,weeks,0,0
193191,with,0,0
193192,a,0,0
193193,2-week,0,0
193194,follow-up,0,0
193195,after,0,0
193196,discontinuation,0,0
193197,.,0,0
193198,d-Cycloserine,0,0
193199,caused,0,0
193200,statistically,0,0
193201,and,0,0
193202,clinically,0,1
193203,significant,0,0
193204,improvement,0,0
193205,with,0,0
193206,no,0,0
193207,differentiation,0,0
193208,between,0,0
193209,dosing,1,0
193210,strategies,1,0
193211,on,1,0
193212,the,1,0
193213,Social,1,1
193214,Responsiveness,1,1
193215,Scale,1,1
193216,and,1,0
193217,the,1,0
193218,Aberrant,1,1
193219,Behavior,1,1
193220,Checklist,1,1
193221,before,0,0
193222,and,0,0
193223,after,0,0
193224,d-cycloserine,0,0
193225,administration,0,0
193226,.,0,0
193227,Environmental,0,0
193228,enrichment,0,0
193229,as,0,0
193230,a,0,0
193231,therapy,0,0
193232,for,0,0
193233,autism,0,0
193234,:,0,0
193235,A,0,0
193236,clinical,0,0
193237,trial,0,0
193238,replication,0,0
193239,and,0,0
193240,extension,0,1
193241,.,0,0
193242,Based,0,0
193243,on,0,0
193244,work,0,0
193245,done,0,0
193246,in,0,0
193247,animal,0,0
193248,models,0,0
193249,showing,0,0
193250,that,0,0
193251,autism-like,0,0
193252,symptoms,0,1
193253,are,0,0
193254,ameliorated,0,0
193255,following,0,0
193256,exposure,0,0
193257,to,0,0
193258,an,0,0
193259,enriched,0,0
193260,sensorimotor,0,1
193261,environment,0,0
193262,",",0,0
193263,we,0,0
193264,attempted,0,0
193265,to,0,0
193266,develop,0,0
193267,a,0,0
193268,comparable,0,0
193269,therapy,0,0
193270,for,0,0
193271,children,0,0
193272,with,0,0
193273,autism,0,0
193274,.,0,0
193275,In,0,0
193276,an,0,0
193277,initial,0,0
193278,randomized,0,0
193279,controlled,0,0
193280,trial,0,0
193281,",",0,0
193282,children,0,0
193283,with,0,0
193284,autism,0,0
193285,who,0,0
193286,received,0,0
193287,sensorimotor,0,1
193288,enrichment,0,1
193289,at,0,0
193290,home,0,0
193291,for,0,0
193292,6,0,0
193293,months,0,0
193294,had,0,0
193295,significant,0,0
193296,improvements,0,1
193297,in,0,0
193298,both,0,0
193299,their,0,0
193300,cognitive,0,1
193301,ability,0,1
193302,and,0,0
193303,the,0,0
193304,severity,0,1
193305,of,0,0
193306,their,0,0
193307,autism,0,0
193308,symptoms,0,1
193309,(,0,0
193310,Woo,0,0
193311,&,0,0
193312,Leon,0,1
193313,",",0,0
193314,2013,0,0
193315,),0,0
193316,.,0,0
193317,We,0,0
193318,now,0,0
193319,report,0,0
193320,the,0,0
193321,outcomes,0,0
193322,of,0,0
193323,a,0,0
193324,similar,0,0
193325,randomized,0,0
193326,controlled,0,0
193327,trial,0,0
193328,in,0,0
193329,which,0,0
193330,children,0,0
193331,with,0,0
193332,autism,0,0
193333,",",0,0
193334,3,0,0
193335,to,0,0
193336,6,0,0
193337,years,0,0
193338,old,0,0
193339,",",0,0
193340,were,0,0
193341,randomly,0,0
193342,assigned,0,0
193343,to,0,0
193344,groups,0,0
193345,that,0,0
193346,received,0,0
193347,either,0,0
193348,daily,0,0
193349,sensorimotor,0,1
193350,enrichment,0,1
193351,",",0,0
193352,administered,0,0
193353,by,0,0
193354,their,0,0
193355,parents,0,0
193356,",",0,0
193357,along,0,0
193358,with,0,0
193359,standard,0,0
193360,care,0,0
193361,",",0,0
193362,or,0,0
193363,they,0,0
193364,received,0,0
193365,standard,0,0
193366,care,0,0
193367,alone,0,0
193368,.,0,0
193369,After,0,0
193370,6,0,0
193371,months,0,0
193372,",",0,0
193373,enriched,0,0
193374,children,0,0
193375,showed,0,0
193376,statistically,0,0
193377,significant,0,0
193378,gains,0,1
193379,in,0,0
193380,their,0,0
193381,IQ,1,0
193382,scores,1,1
193383,",",0,0
193384,a,0,0
193385,decline,0,0
193386,in,0,0
193387,their,0,0
193388,atypical,1,0
193389,sensory,1,1
193390,responses,1,1
193391,",",0,0
193392,and,0,0
193393,an,0,0
193394,improvement,0,1
193395,in,0,0
193396,their,0,0
193397,receptive,1,1
193398,language,1,1
193399,performance,1,1
193400,",",0,0
193401,compared,0,0
193402,to,0,0
193403,controls,0,0
193404,.,0,0
193405,Furthermore,0,0
193406,",",0,0
193407,after,0,0
193408,6,0,0
193409,months,0,0
193410,of,0,0
193411,enrichment,0,1
193412,therapy,0,0
193413,",",0,0
193414,21,0,0
193415,%,0,0
193416,of,0,0
193417,the,0,0
193418,children,0,0
193419,who,0,0
193420,initially,0,0
193421,had,0,0
193422,been,0,0
193423,given,0,0
193424,an,0,0
193425,autism,0,0
193426,classification,0,1
193427,",",0,0
193428,using,0,0
193429,the,0,0
193430,Autism,0,1
193431,Diagnostic,0,0
193432,Observation,0,0
193433,Schedule,0,1
193434,",",0,0
193435,improved,0,0
193436,to,0,0
193437,the,0,0
193438,point,0,0
193439,that,0,0
193440,",",0,0
193441,although,0,0
193442,they,0,0
193443,remained,0,0
193444,on,0,0
193445,the,0,0
193446,autism,0,0
193447,spectrum,0,0
193448,",",0,0
193449,they,0,0
193450,no,0,0
193451,longer,0,0
193452,met,0,0
193453,the,0,0
193454,criteria,0,0
193455,for,0,0
193456,classic,0,0
193457,autism,0,0
193458,.,0,0
193459,None,0,0
193460,of,0,0
193461,the,0,0
193462,standard,0,0
193463,care,0,0
193464,controls,0,0
193465,reached,0,0
193466,an,0,0
193467,equivalent,0,0
193468,level,0,1
193469,of,0,0
193470,improvement,0,1
193471,.,0,0
193472,Finally,0,0
193473,",",0,0
193474,the,0,0
193475,outcome,1,1
193476,measures,1,1
193477,for,0,0
193478,children,0,0
193479,who,0,0
193480,received,0,0
193481,only,0,0
193482,a,0,0
193483,subset,0,0
193484,of,0,0
193485,sensory,0,1
193486,stimuli,0,1
193487,were,0,0
193488,similar,0,0
193489,to,0,0
193490,those,0,0
193491,receiving,0,0
193492,the,0,0
193493,full,0,0
193494,complement,0,0
193495,of,0,0
193496,enrichment,0,0
193497,exercises,0,0
193498,.,0,0
193499,Sensorimotor,0,1
193500,enrichment,0,1
193501,therapy,0,0
193502,therefore,0,0
193503,appears,0,0
193504,to,0,0
193505,be,0,0
193506,a,0,0
193507,cost-effective,1,0
193508,means,0,0
193509,of,0,0
193510,treating,0,0
193511,a,0,0
193512,range,0,0
193513,of,0,0
193514,symptoms,0,1
193515,for,0,0
193516,children,0,0
193517,with,0,0
193518,autism,0,0
193519,.,0,0
193520,A,0,0
193521,Randomized,0,0
193522,",",0,0
193523,Placebo-Controlled,0,0
193524,Trial,0,0
193525,Evaluating,0,0
193526,Safety,0,1
193527,and,0,0
193528,Immunogenicity,0,1
193529,of,0,0
193530,the,0,0
193531,Killed,0,0
193532,",",0,0
193533,Bivalent,0,0
193534,",",0,0
193535,Whole-Cell,0,1
193536,Oral,0,1
193537,Cholera,0,0
193538,Vaccine,0,0
193539,in,0,0
193540,Ethiopia,0,0
193541,.,0,0
193542,Killed,0,0
193543,whole-cell,0,0
193544,oral,0,0
193545,cholera,0,0
193546,vaccine,0,0
193547,(,0,0
193548,OCV,0,0
193549,),0,0
193550,has,0,0
193551,been,0,0
193552,a,0,0
193553,key,0,0
193554,component,0,0
193555,of,0,0
193556,a,0,0
193557,comprehensive,0,0
193558,package,0,0
193559,including,0,0
193560,water,0,1
193561,and,0,1
193562,sanitation,0,1
193563,measures,0,1
193564,for,0,0
193565,recent,0,0
193566,cholera,0,0
193567,epidemics,0,0
193568,.,0,0
193569,The,0,0
193570,vaccine,0,0
193571,",",0,0
193572,given,0,0
193573,in,0,0
193574,a,0,0
193575,two-dose,0,0
193576,regimen,0,0
193577,",",0,0
193578,has,0,0
193579,been,0,0
193580,evaluated,0,0
193581,in,0,0
193582,a,0,0
193583,large,0,0
193584,number,0,1
193585,of,0,0
193586,human,0,0
193587,volunteers,0,0
193588,in,0,0
193589,India,0,0
193590,",",0,0
193591,Vietnam,0,1
193592,",",0,1
193593,and,0,1
193594,Bangladesh,0,1
193595,",",0,0
193596,where,0,0
193597,it,0,0
193598,has,0,0
193599,demonstrated,0,0
193600,safety,0,1
193601,",",0,0
193602,immunogenicity,0,1
193603,",",0,1
193604,and,0,1
193605,clinical,0,0
193606,efficacy,0,1
193607,.,0,0
193608,We,0,0
193609,conducted,0,0
193610,a,0,0
193611,double-blind,0,0
193612,randomized,0,0
193613,placebo-controlled,0,0
193614,trial,0,0
193615,in,0,0
193616,Ethiopia,0,0
193617,",",0,0
193618,where,0,0
193619,we,0,0
193620,evaluated,0,0
193621,the,0,0
193622,safety,1,1
193623,and,1,0
193624,immunogenicity,1,1
193625,of,0,0
193626,the,0,0
193627,vaccine,0,0
193628,in,0,0
193629,216,0,0
193630,healthy,0,0
193631,adults,0,0
193632,and,0,0
193633,children,0,0
193634,.,0,1
193635,OCV,0,0
193636,was,0,0
193637,found,0,0
193638,to,0,0
193639,be,0,0
193640,safe,1,1
193641,and,1,0
193642,elicited,1,0
193643,a,1,0
193644,robust,1,1
193645,immunological,1,0
193646,response,1,1
193647,against,1,1
193648,Vibrio,1,0
193649,cholerae,1,0
193650,O1,1,0
193651,",",0,0
193652,with,0,0
193653,81,0,0
193654,%,0,0
193655,adults,0,0
193656,and,0,0
193657,77,0,0
193658,%,0,0
193659,children,0,0
193660,demonstrating,0,0
193661,seroconversion,1,0
193662,14,0,0
193663,days,0,0
193664,after,0,0
193665,the,0,0
193666,second,0,0
193667,dose,0,0
193668,of,0,0
193669,vaccine,0,0
193670,.,0,0
193671,This,0,0
193672,is,0,0
193673,the,0,0
193674,first,0,0
193675,study,0,0
193676,to,0,0
193677,evaluate,0,0
193678,safety,0,1
193679,and,0,1
193680,immunogenicity,0,1
193681,of,0,0
193682,the,0,0
193683,vaccine,0,0
193684,in,0,0
193685,a,0,0
193686,population,0,0
193687,outside,0,0
193688,Asia,0,0
193689,using,0,0
193690,a,0,0
193691,placebo-controlled,0,0
193692,",",0,0
193693,double-blind,0,0
193694,",",0,0
193695,randomized,0,0
193696,study,0,0
193697,design,0,0
193698,.,0,0
193699,[,0,0
193700,Effect,0,0
193701,of,0,0
193702,Preoperative,0,1
193703,Oral,0,1
193704,Rehydration,1,1
193705,on,0,0
193706,Onset,0,0
193707,Time,0,0
193708,and,0,0
193709,Recovery,0,1
193710,Time,0,0
193711,of,0,0
193712,Rocuronium,0,0
193713,],0,0
193714,.,0,0
193715,BACKGROUND,0,0
193716,Preoperative,0,1
193717,oral,0,0
193718,rehydration,1,1
193719,solution,0,0
193720,(,0,0
193721,ORS,0,0
193722,),0,0
193723,prevents,0,0
193724,hypovolemia,1,0
193725,.,1,0
193726,The,0,0
193727,aim,0,0
193728,of,0,0
193729,this,0,0
193730,study,0,0
193731,was,0,0
193732,to,0,0
193733,compare,0,0
193734,the,0,0
193735,effect,0,0
193736,of,0,0
193737,intubating,0,0
193738,dose,0,0
193739,of,0,0
193740,rocuronium,0,0
193741,in,0,0
193742,patients,0,0
193743,taking,0,0
193744,and,0,0
193745,those,0,0
193746,not,0,0
193747,taking,0,0
193748,preoperative,1,0
193749,ORS,1,0
193750,.,1,0
193751,METHODS,0,0
193752,Twenty,0,0
193753,patients,0,0
193754,",",0,0
193755,ASA,0,0
193756,I,0,0
193757,aged,0,0
193758,20-50,0,0
193759,years,0,0
193760,scheduled,0,0
193761,for,0,0
193762,elective,0,0
193763,surgery,0,0
193764,",",0,0
193765,were,0,0
193766,investigated,0,0
193767,and,0,0
193768,randomly,0,0
193769,assigned,0,0
193770,to,0,0
193771,two,0,0
193772,groups,0,0
193773,:,0,0
193774,drinking,0,0
193775,"1,500",0,0
193776,ml,0,0
193777,ORS,0,0
193778,6,0,0
193779,to,0,0
193780,2,0,0
193781,hours,0,0
193782,before,0,0
193783,anesthesia,0,0
193784,(,0,0
193785,ORS,0,1
193786,group,0,0
193787,),0,0
193788,and,0,0
193789,nothing,0,1
193790,by,0,0
193791,mouth,0,0
193792,from,0,0
193793,6,0,0
193794,hours,0,0
193795,before,0,0
193796,anesthesia,0,0
193797,(,0,0
193798,control,0,0
193799,group,0,0
193800,),0,0
193801,.,0,0
193802,Anesthesia,0,1
193803,was,0,0
193804,maintained,0,0
193805,with,0,0
193806,propofol,0,0
193807,and,0,1
193808,remifentanil,1,0
193809,",",0,1
193810,and,0,0
193811,rocuronium,0,0
193812,0.6,0,0
193813,mg,0,0
193814,x,0,0
193815,kg,0,0
193816,(,0,0
193817,-1,0,0
193818,),0,0
193819,was,0,0
193820,administrated,0,0
193821,.,0,0
193822,To,0,0
193823,evaluate,0,0
193824,the,0,0
193825,effect,0,0
193826,of,0,0
193827,rocuronium,0,0
193828,",",0,0
193829,acceleromyography,1,0
193830,at,0,0
193831,the,0,0
193832,adductor,0,0
193833,pollicis,0,0
193834,was,0,0
193835,performed,0,0
193836,using,0,0
193837,0.1,0,0
193838,Hz,0,0
193839,stimulation,0,0
193840,.,0,0
193841,Cardiac,1,1
193842,index,1,1
193843,(,1,0
193844,CI,1,0
193845,),1,1
193846,and,1,0
193847,stroke,1,1
193848,volume,1,1
193849,variation,1,1
193850,(,1,0
193851,SVV,1,0
193852,),1,0
193853,from,0,0
193854,FloTra/Vigileo,0,0
193855,",",0,0
193856,times,0,1
193857,to,0,0
193858,95,0,0
193859,%,0,0
193860,twitch,0,0
193861,depression,1,1
193862,as,0,0
193863,onset,1,1
193864,time,1,1
193865,(,1,0
193866,OT,1,1
193867,),1,1
193868,",",0,0
193869,and,0,0
193870,times,0,1
193871,to,0,0
193872,first,0,0
193873,twitch,1,1
193874,re-detection,1,0
193875,(,1,0
193876,TR,1,1
193877,),1,0
193878,were,0,0
193879,recorded,0,0
193880,.,0,0
193881,RESULTS,0,0
193882,SVV,0,0
193883,was,0,0
193884,significantly,0,0
193885,lower,0,0
193886,in,0,0
193887,ORS,1,1
193888,group,0,0
193889,(,0,0
193890,P,0,0
193891,=,0,0
193892,0.03,0,0
193893,),0,0
193894,",",0,0
193895,and,0,1
193896,CI,0,0
193897,showed,0,0
193898,no,0,0
193899,difference,0,0
193900,.,0,0
193901,In,0,0
193902,ORS,0,1
193903,group,0,0
193904,",",0,0
193905,TR,0,1
193906,was,0,0
193907,significantly,0,0
193908,shorter,0,0
193909,than,0,0
193910,that,0,0
193911,of,0,0
193912,control,0,0
193913,group,0,0
193914,(,0,0
193915,P=0.002,0,0
193916,),0,1
193917,",",0,0
193918,and,0,1
193919,OT,0,1
193920,tended,0,0
193921,to,0,0
193922,be,0,0
193923,prolonged,0,0
193924,(,0,0
193925,99.0,0,0
193926,?,0,0
193927,36.3,0,0
193928,s,0,0
193929,vs.,0,0
193930,84.0,0,0
193931,?,0,0
193932,37.5,0,0
193933,s,0,0
193934,),0,0
193935,",",0,0
193936,but,0,0
193937,not,0,0
193938,significantly,0,0
193939,.,0,0
193940,CONCLUSIONS,0,0
193941,Preoperative,0,1
193942,oral,0,0
193943,rehydration,0,0
193944,possibly,0,0
193945,increases,0,1
193946,circulating,0,1
193947,blood,0,1
193948,volume,0,1
193949,",",0,0
193950,and,0,0
193951,shortens,0,0
193952,the,0,0
193953,duration,0,1
193954,of,0,0
193955,rocuronium,1,0
193956,effect,1,0
193957,.,1,0
193958,Effects,1,0
193959,of,0,0
193960,Combined,0,0
193961,Resistive,0,0
193962,Underwater,0,0
193963,Exercises,0,0
193964,and,0,0
193965,Interferential,0,1
193966,Current,0,1
193967,Therapy,0,0
193968,in,0,0
193969,Patients,0,0
193970,with,0,0
193971,Juvenile,0,0
193972,Idiopathic,0,0
193973,Arthritis,0,1
193974,:,0,0
193975,A,0,0
193976,Randomized,0,0
193977,Controlled,0,0
193978,Trial,0,0
193979,.,0,0
193980,OBJECTIVE,0,0
193981,The,0,0
193982,objective,0,0
193983,of,0,0
193984,this,0,0
193985,study,0,0
193986,was,0,0
193987,to,0,0
193988,verify,0,0
193989,the,0,0
193990,effects,1,0
193991,of,0,0
193992,combined,0,0
193993,resistive,0,1
193994,underwater,0,0
193995,exercises,0,0
193996,and,0,0
193997,interferential,0,0
193998,current,0,0
193999,on,0,0
194000,the,0,0
194001,peak,0,1
194002,torque,0,1
194003,of,0,0
194004,the,0,0
194005,quadriceps,0,0
194006,and,0,0
194007,hamstrings,0,1
194008,and,0,1
194009,pain,0,1
194010,levels,0,1
194011,in,0,0
194012,patients,0,0
194013,with,0,0
194014,juvenile,0,0
194015,idiopathic,0,0
194016,arthritis,0,0
194017,.,0,0
194018,DESIGN,0,0
194019,This,0,0
194020,is,0,0
194021,a,0,0
194022,randomized,0,0
194023,controlled,0,0
194024,study,0,0
194025,;,0,0
194026,30,0,0
194027,children,0,0
194028,with,0,0
194029,polyarticular,0,0
194030,juvenile,0,0
194031,idiopathic,0,0
194032,arthritis,0,0
194033,were,0,0
194034,randomly,0,0
194035,distributed,0,0
194036,into,0,0
194037,two,0,0
194038,groups,0,0
194039,:,0,0
194040,the,0,0
194041,control,0,0
194042,group,0,0
194043,(,0,0
194044,n,0,0
194045,=,0,0
194046,15,0,0
194047,),0,0
194048,received,0,0
194049,the,0,0
194050,traditional,0,0
194051,physical,0,1
194052,therapy,0,0
194053,program,0,0
194054,and,0,0
194055,the,0,0
194056,study,0,0
194057,group,0,0
194058,(,0,0
194059,n,0,0
194060,=,0,0
194061,15,0,0
194062,),0,0
194063,received,0,0
194064,resistive,0,1
194065,underwater,0,0
194066,exercises,0,0
194067,and,0,0
194068,interferential,0,0
194069,current,0,0
194070,therapy,0,0
194071,.,0,0
194072,Peak,1,1
194073,torque,1,1
194074,of,1,0
194075,the,1,0
194076,quadriceps,1,0
194077,and,1,0
194078,hamstrings,1,1
194079,and,1,1
194080,pain,1,1
194081,levels,1,1
194082,were,0,0
194083,evaluated,0,0
194084,before,0,0
194085,treatment,0,0
194086,",",0,0
194087,1,0,0
194088,mo,0,0
194089,later,0,0
194090,",",0,0
194091,and,0,0
194092,after,0,0
194093,3,0,0
194094,mos,0,0
194095,using,0,0
194096,the,0,0
194097,HUMAC,0,1
194098,NORM,0,0
194099,",",0,0
194100,CSMI,0,1
194101,Testing,0,1
194102,and,0,0
194103,Rehabilitation,0,1
194104,Isokinetic,0,1
194105,System,0,0
194106,and,0,0
194107,visual,0,1
194108,analog,0,1
194109,scale,0,1
194110,",",0,0
194111,respectively,0,0
194112,.,0,0
194113,RESULTS,0,0
194114,In,0,0
194115,the,0,0
194116,control,0,0
194117,group,0,0
194118,",",0,0
194119,all,0,0
194120,measures,1,1
194121,showed,0,0
194122,significant,0,0
194123,differences,0,0
194124,(,0,0
194125,P,0,0
194126,<,0,0
194127,0.05,0,0
194128,),0,0
194129,after,0,0
194130,1,0,0
194131,mo,0,0
194132,except,0,0
194133,peak,1,1
194134,torque,1,1
194135,of,1,0
194136,left,1,1
194137,quadriceps,1,0
194138,and,1,1
194139,pain,1,1
194140,levels,1,1
194141,",",0,0
194142,and,0,1
194143,significant,0,0
194144,differences,0,0
194145,were,0,0
194146,found,0,0
194147,after,0,0
194148,3,0,0
194149,mos,0,0
194150,(,0,0
194151,P,0,0
194152,<,0,0
194153,0.05,0,0
194154,),0,0
194155,in,0,0
194156,all,0,0
194157,.,0,0
194158,In,0,0
194159,the,0,0
194160,study,0,0
194161,group,0,0
194162,",",0,0
194163,all,0,0
194164,measures,0,1
194165,showed,0,0
194166,significant,0,0
194167,differences,0,0
194168,after,0,0
194169,1,0,0
194170,and,0,0
194171,3,0,0
194172,mos,0,0
194173,(,0,0
194174,P,0,0
194175,<,0,0
194176,0.05,0,0
194177,),0,0
194178,and,0,0
194179,there,0,0
194180,were,0,0
194181,significant,0,0
194182,differences,0,0
194183,between,0,0
194184,groups,0,0
194185,after,0,0
194186,1,0,0
194187,and,0,0
194188,3,0,0
194189,mos,0,0
194190,in,0,0
194191,favor,0,0
194192,of,0,0
194193,the,0,0
194194,study,0,0
194195,group,0,0
194196,(,0,0
194197,P,0,0
194198,<,0,0
194199,0.05,0,0
194200,),0,0
194201,.,0,0
194202,CONCLUSION,0,0
194203,The,0,0
194204,combination,0,0
194205,of,0,0
194206,resistive,0,1
194207,underwater,0,0
194208,exercises,0,0
194209,and,0,0
194210,interferential,0,0
194211,current,0,0
194212,therapy,0,0
194213,is,0,0
194214,a,0,0
194215,potentially,0,0
194216,valuable,0,0
194217,treatment,0,0
194218,for,0,0
194219,patients,0,0
194220,with,0,0
194221,juvenile,0,0
194222,idiopathic,0,0
194223,arthritis,0,0
194224,.,0,0
194225,Disclosure,0,0
194226,of,0,0
194227,HSV-2,0,0
194228,serological,0,0
194229,test,0,0
194230,results,0,0
194231,in,0,0
194232,the,0,0
194233,context,0,0
194234,of,0,0
194235,an,0,0
194236,adolescent,0,0
194237,HIV,0,1
194238,prevention,0,0
194239,trial,0,0
194240,in,0,0
194241,Kenya,0,0
194242,.,0,0
194243,OBJECTIVES,0,0
194244,Herpes,0,0
194245,simplex,0,0
194246,virus,0,0
194247,type,0,0
194248,2,0,0
194249,(,0,0
194250,HSV-2,0,0
194251,),0,0
194252,biomarkers,0,0
194253,are,0,0
194254,often,0,0
194255,used,0,0
194256,in,0,0
194257,adolescent,0,0
194258,sub-Saharan,0,0
194259,HIV,0,1
194260,prevention,0,0
194261,studies,0,0
194262,",",0,0
194263,but,0,0
194264,evaluations,0,0
194265,of,0,1
194266,test,0,1
194267,performance,0,1
194268,and,0,1
194269,disclosure,0,1
194270,outcomes,0,1
194271,are,0,0
194272,rare,0,0
194273,in,0,0
194274,the,0,0
194275,published,0,0
194276,literature,0,0
194277,.,0,0
194278,Therefore,0,0
194279,",",0,0
194280,we,0,0
194281,investigated,0,0
194282,the,0,0
194283,proportion,0,0
194284,of,0,0
194285,ELISA-positive,0,0
194286,and,0,0
194287,indeterminate,0,0
194288,samples,0,0
194289,confirmed,0,0
194290,by,0,0
194291,western,0,0
194292,blot,0,0
194293,(,0,0
194294,WB,0,0
194295,),0,0
194296,",",0,0
194297,the,0,0
194298,psychosocial,0,0
194299,response,0,1
194300,to,0,0
194301,disclosure,0,1
194302,and,0,0
194303,whether,0,0
194304,reports,0,0
194305,of,0,0
194306,sexual,0,1
194307,behaviour,0,1
194308,and,0,0
194309,HSV-2,0,0
194310,symptoms,0,1
194311,are,0,0
194312,consistent,0,0
194313,with,0,0
194314,WB,0,0
194315,confirmatory,0,0
194316,results,0,0
194317,among,0,0
194318,adolescent,0,0
194319,orphans,0,0
194320,in,0,0
194321,Kenya,0,0
194322,.,0,0
194323,METHODS,0,0
194324,In,0,0
194325,2011,0,0
194326,",",0,0
194327,837,0,0
194328,Kenyan,0,0
194329,orphan,0,0
194330,youth,0,0
194331,in,0,0
194332,grades,0,0
194333,7,0,0
194334,and,0,0
194335,8,0,0
194336,enrolled,0,0
194337,in,0,0
194338,an,0,0
194339,HIV,0,0
194340,prevention,0,0
194341,clinical,0,0
194342,trial,0,0
194343,with,0,0
194344,HSV-2,0,0
194345,biomarker,0,0
194346,outcomes,0,0
194347,.,0,0
194348,We,0,0
194349,used,0,0
194350,a,0,0
194351,modified,0,0
194352,algorithm,0,0
194353,for,0,0
194354,the,0,0
194355,Kalon,0,1
194356,HSV-2,0,0
194357,ELISA,0,0
194358,to,0,0
194359,improve,0,0
194360,specificity,0,0
194361,;,0,0
194362,positive,0,1
194363,and,0,0
194364,indeterminate,0,0
194365,results,0,0
194366,were,0,0
194367,WB,0,0
194368,tested,0,0
194369,.,0,0
194370,We,0,0
194371,developed,0,0
194372,culturally,0,0
194373,sensitive,0,0
194374,protocols,0,0
194375,for,0,0
194376,disclosing,0,0
194377,positive,0,1
194378,results,0,0
194379,",",0,0
194380,and,0,1
194381,documented,0,0
194382,psychosocial,0,1
194383,responses,0,1
194384,",",0,0
194385,reports,0,0
194386,of,0,1
194387,sexual,0,1
194388,contact,0,1
194389,and,0,0
194390,HSV-2,0,0
194391,symptoms,0,1
194392,.,0,0
194393,RESULTS,0,0
194394,28,0,0
194395,adolescents,0,0
194396,(,0,0
194397,3.3,0,0
194398,%,0,0
194399,),0,0
194400,were,0,0
194401,identified,0,0
194402,as,0,0
194403,HSV-2,0,0
194404,seropositive,0,0
194405,",",0,0
194406,six,0,0
194407,as,0,0
194408,indeterminate,0,0
194409,.,0,0
194410,Of,0,0
194411,these,0,0
194412,",",0,0
194413,22,0,0
194414,positive,0,0
194415,and,0,0
194416,all,0,0
194417,indeterminates,0,0
194418,were,0,0
194419,WB,0,0
194420,tested,0,0
194421,;,0,0
194422,20,0,0
194423,and,0,0
194424,5,0,0
194425,",",0,0
194426,respectively,0,0
194427,",",0,0
194428,were,0,0
194429,confirmed,0,0
194430,positive,0,0
194431,.,0,0
194432,Most,0,0
194433,youth,0,0
194434,reported,0,0
194435,moderate,1,0
194436,brief,1,0
194437,stress,1,1
194438,after,1,0
194439,disclosure,1,0
194440,;,1,0
194441,22,0,0
194442,%,0,0
194443,reported,0,0
194444,longer,1,0
194445,and,1,0
194446,more,1,0
194447,severe,1,1
194448,distress,1,1
194449,.,1,0
194450,Boys,0,0
194451,were,0,0
194452,more,0,0
194453,likely,0,0
194454,to,0,0
194455,be,0,0
194456,in,0,0
194457,the,0,0
194458,latter,0,0
194459,category,0,0
194460,.,0,0
194461,Self-reported,1,1
194462,virginity,1,1
194463,was,0,0
194464,highly,0,0
194465,inconsistent,0,0
194466,with,0,0
194467,WB-confirmed,1,0
194468,positives,1,0
194469,.,1,0
194470,CONCLUSIONS,0,0
194471,The,0,0
194472,higher,0,0
194473,than,0,0
194474,manufacturer,0,0
194475,'s,0,0
194476,cut-off,0,1
194477,for,0,0
194478,Kalon,0,1
194479,ELISA,0,0
194480,modestly,0,0
194481,reduced,0,0
194482,the,0,0
194483,rate,0,1
194484,of,0,0
194485,false-positive,1,1
194486,test,1,1
194487,results,1,0
194488,",",0,0
194489,but,0,0
194490,also,0,0
194491,increased,0,0
194492,false,1,1
194493,negatives,1,1
194494,.,1,0
194495,Investigators,0,0
194496,should,0,0
194497,consider,0,0
194498,the,0,0
194499,risk,0,0
194500,:,0,0
194501,benefit,0,0
194502,ratio,0,1
194503,in,0,0
194504,deciding,0,0
194505,whether,0,0
194506,or,0,0
194507,not,0,0
194508,to,0,0
194509,disclose,0,0
194510,HSV-2,0,0
194511,results,0,0
194512,to,0,0
194513,adolescent,0,0
194514,participants,0,0
194515,under,0,0
194516,specific,0,0
194517,field,0,0
194518,conditions,0,0
194519,.,0,0
194520,TRIAL,0,0
194521,REGISTRATION,0,0
194522,NUMBER,0,0
194523,NCT01501864,0,0
194524,.,0,0
194525,Optimal,1,0
194526,vaccination,1,0
194527,program,0,0
194528,for,0,0
194529,healthy,0,0
194530,adults,0,0
194531,in,0,0
194532,China,0,0
194533,.,0,0
194534,There,0,0
194535,is,0,0
194536,still,0,0
194537,no,0,0
194538,suitable,0,0
194539,routine,0,0
194540,hepatitis,0,0
194541,B,0,0
194542,immunization,0,1
194543,strategy,0,0
194544,for,0,0
194545,adults,0,0
194546,in,0,0
194547,China,0,0
194548,.,0,0
194549,To,0,0
194550,establish,0,0
194551,an,0,0
194552,optimal,1,0
194553,vaccination,1,0
194554,schedule,1,0
194555,for,0,0
194556,healthy,0,0
194557,adults,0,0
194558,",",0,0
194559,we,0,0
194560,investigated,0,0
194561,various,0,0
194562,schedules,0,0
194563,in,0,0
194564,healthy,0,0
194565,adults,0,0
194566,.,0,0
194567,In,0,0
194568,this,0,0
194569,randomized,0,0
194570,5143,0,0
194571,healthy,0,0
194572,adults,0,0
194573,received,0,0
194574,10,0,0
194575,?g,0,0
194576,hepatitis,0,0
194577,B,0,0
194578,vaccine,0,0
194579,at,0,0
194580,0,0,0
194581,",",0,0
194582,1,0,0
194583,and,0,0
194584,3,0,0
194585,months,0,0
194586,(,0,0
194587,group,0,0
194588,A,0,0
194589,),0,0
194590,",",0,0
194591,0,0,0
194592,",",0,0
194593,1,0,0
194594,and,0,0
194595,6,0,0
194596,months,0,0
194597,(,0,0
194598,group,0,0
194599,B,0,0
194600,),0,0
194601,",",0,0
194602,or,0,0
194603,0,0,0
194604,",",0,0
194605,1,0,0
194606,and,0,0
194607,12,0,0
194608,months,0,0
194609,(,0,0
194610,group,0,0
194611,C,0,0
194612,),0,0
194613,.,0,0
194614,Blood,1,1
194615,samples,1,0
194616,were,0,0
194617,collected,0,0
194618,after,0,0
194619,1,0,0
194620,month,0,0
194621,and,0,0
194622,12,0,0
194623,months,0,0
194624,after,0,0
194625,the,0,0
194626,third,0,0
194627,dose,0,0
194628,.,0,0
194629,The,1,0
194630,geometric,1,0
194631,mean,1,1
194632,titer,1,1
194633,(,1,0
194634,GMT,1,1
194635,),1,0
194636,",",1,0
194637,seroconversion,1,1
194638,rate,1,1
194639,(,1,0
194640,levels,1,1
194641,of,1,0
194642,anti-HBs,1,0
194643,?,1,0
194644,10,1,0
194645,mIU/mL,1,0
194646,),1,0
194647,and,1,0
194648,high,1,0
194649,response,1,1
194650,rate,1,1
194651,(,1,0
194652,levels,1,1
194653,of,1,0
194654,anti-HBs,1,0
194655,?,1,0
194656,100,1,0
194657,mIU/mL,1,0
194658,),1,0
194659,were,1,0
194660,assayed,0,0
194661,.,0,0
194662,In,0,0
194663,our,0,0
194664,study,0,0
194665,",",0,0
194666,2438,0,0
194667,healthy,0,0
194668,adults,0,0
194669,finished,0,0
194670,the,0,0
194671,full,0,0
194672,vaccination,0,0
194673,program,0,0
194674,and,0,0
194675,follow-up,0,0
194676,.,0,0
194677,The,0,0
194678,seroconversion/sero-protective,1,0
194679,rate,1,1
194680,of,0,0
194681,groups,0,0
194682,A-C,0,0
194683,at,0,0
194684,one,0,0
194685,and,0,0
194686,12,0,0
194687,month,0,0
194688,after,0,0
194689,administration,0,0
194690,of,0,0
194691,the,0,0
194692,third,0,0
194693,vaccine,0,0
194694,dose,0,0
194695,was,0,0
194696,100,0,0
194697,%,0,0
194698,",",0,0
194699,99.9,0,0
194700,%,0,0
194701,and,0,0
194702,97.9,0,0
194703,%,0,0
194704,verse,0,0
194705,64.9,0,0
194706,%,0,0
194707,",",0,0
194708,75.7,0,0
194709,%,0,0
194710,and,0,0
194711,79.0,0,0
194712,%,0,0
194713,",",0,0
194714,respectively,1,0
194715,.,1,0
194716,GMT,1,1
194717,for,1,0
194718,anti-HBs,1,0
194719,tested,1,0
194720,in,0,0
194721,group,0,0
194722,A,0,0
194723,to,0,0
194724,C,0,0
194725,within,0,0
194726,1,0,0
194727,or,0,0
194728,12,0,0
194729,month,0,0
194730,after,0,0
194731,the,0,0
194732,third,0,0
194733,vaccination,0,0
194734,was,0,0
194735,213.16,0,0
194736,",",0,0
194737,432.58,0,0
194738,and,0,0
194739,451.47,0,0
194740,mIU/ml,0,0
194741,verse,0,0
194742,22.07,0,0
194743,",",0,0
194744,46.70,0,0
194745,and,0,0
194746,56.18,0,0
194747,mIU/ml,0,0
194748,",",0,0
194749,respectively,0,0
194750,.,0,0
194751,There,0,0
194752,were,0,0
194753,significant,0,0
194754,differences,1,0
194755,of,1,0
194756,seroconversion/sero-protective,1,1
194757,rate,1,1
194758,and,1,0
194759,GMT,1,1
194760,among,0,0
194761,the,0,0
194762,3,0,0
194763,groups,0,0
194764,(,0,0
194765,p,0,0
194766,<,0,0
194767,0.01,0,0
194768,),0,0
194769,.,0,0
194770,Given,0,0
194771,the,0,0
194772,high,0,0
194773,anti-HBs,1,0
194774,seroconversion,1,1
194775,rate,1,1
194776,and,1,1
194777,GMT,1,1
194778,in,0,0
194779,all,0,0
194780,3,0,0
194781,groups,0,0
194782,",",0,0
194783,a,0,0
194784,flexible,0,0
194785,schedule,0,0
194786,for,0,0
194787,Hepatitis,0,0
194788,B,0,0
194789,vaccine,0,0
194790,should,0,0
194791,be,0,0
194792,recommended,0,0
194793,to,0,0
194794,adults,0,0
194795,",",0,0
194796,but,0,0
194797,0-1-12,0,0
194798,schedule,0,0
194799,is,0,0
194800,a,0,0
194801,better,0,0
194802,choice,0,0
194803,.,0,0
194804,Cost,1,0
194805,effectiveness,1,1
194806,of,1,0
194807,treatment,1,0
194808,with,1,0
194809,percutaneous,1,0
194810,Kirschner,1,0
194811,wires,1,0
194812,versus,0,0
194813,volar,0,0
194814,locking,0,0
194815,plate,0,0
194816,for,0,0
194817,adult,0,0
194818,patients,0,0
194819,with,0,0
194820,a,0,0
194821,dorsally,0,0
194822,displaced,0,0
194823,fracture,0,0
194824,of,0,0
194825,the,0,0
194826,distal,0,0
194827,radius,0,0
194828,:,0,0
194829,analysis,0,0
194830,from,0,0
194831,the,0,0
194832,DRAFFT,0,0
194833,trial,0,0
194834,.,0,0
194835,We,0,0
194836,present,0,0
194837,an,0,0
194838,economic,0,0
194839,evaluation,0,0
194840,using,0,0
194841,data,0,0
194842,from,0,0
194843,the,0,0
194844,Distal,0,0
194845,Radius,0,0
194846,Acute,0,0
194847,Fracture,0,1
194848,Fixation,0,0
194849,Trial,0,0
194850,(,0,0
194851,DRAFFT,0,0
194852,),0,0
194853,to,0,0
194854,compare,0,0
194855,the,0,0
194856,relative,0,0
194857,cost,0,1
194858,effectiveness,0,1
194859,of,0,0
194860,percutaneous,0,0
194861,Kirschner,0,0
194862,wire,0,0
194863,(,0,0
194864,K-wire,0,0
194865,),0,1
194866,fixation,0,0
194867,and,0,0
194868,volar,0,0
194869,locking-plate,0,0
194870,fixation,0,0
194871,for,0,0
194872,patients,0,0
194873,with,0,0
194874,dorsally-displaced,0,0
194875,fractures,0,0
194876,of,0,0
194877,the,0,0
194878,distal,0,0
194879,radius,0,0
194880,.,0,0
194881,The,0,0
194882,cost,0,1
194883,effectiveness,0,1
194884,analysis,0,0
194885,(,1,0
194886,cost,1,1
194887,per,1,0
194888,quality-adjusted,1,0
194889,life,1,1
194890,year,1,0
194891,;,1,0
194892,QALY,1,0
194893,),1,0
194894,was,0,0
194895,derived,0,0
194896,from,0,0
194897,a,0,0
194898,multi-centre,0,0
194899,",",0,0
194900,two-arm,0,0
194901,",",0,0
194902,parallel,0,0
194903,group,0,0
194904,",",0,0
194905,assessor-blind,0,0
194906,",",0,1
194907,randomised,0,0
194908,controlled,0,0
194909,trial,0,0
194910,which,0,0
194911,took,0,0
194912,place,0,0
194913,in,0,0
194914,18,0,0
194915,trauma,0,0
194916,centres,0,0
194917,in,0,0
194918,the,0,0
194919,United,0,0
194920,Kingdom,0,0
194921,.,0,0
194922,Data,0,0
194923,from,0,0
194924,460,0,0
194925,patients,0,0
194926,were,0,0
194927,available,0,0
194928,for,0,0
194929,analysis,0,0
194930,",",0,0
194931,which,0,0
194932,includes,0,0
194933,both,0,0
194934,a,0,0
194935,National,0,0
194936,Health,0,1
194937,Service,0,0
194938,cost,0,1
194939,perspective,0,0
194940,including,0,0
194941,costs,1,1
194942,of,1,0
194943,surgery,1,0
194944,",",1,0
194945,implants,1,0
194946,and,0,1
194947,healthcare,1,1
194948,resource,1,0
194949,use,1,0
194950,over,0,0
194951,a,0,0
194952,12-month,0,0
194953,period,0,0
194954,after,0,0
194955,surgery,0,0
194956,",",0,0
194957,and,0,0
194958,a,0,0
194959,societal,0,1
194960,perspective,0,0
194961,",",0,0
194962,which,0,0
194963,includes,0,0
194964,the,0,0
194965,cost,1,1
194966,of,1,0
194967,time,1,1
194968,off,1,0
194969,work,1,0
194970,and,0,0
194971,the,0,0
194972,need,0,0
194973,for,0,0
194974,additional,1,0
194975,private,1,0
194976,care,1,0
194977,.,1,0
194978,There,0,0
194979,was,0,0
194980,only,0,0
194981,a,0,0
194982,small,0,0
194983,difference,0,0
194984,in,0,0
194985,QALYs,1,0
194986,gained,0,0
194987,for,0,0
194988,patients,0,0
194989,treated,0,0
194990,with,0,0
194991,locking-plate,0,0
194992,fixation,0,0
194993,over,0,0
194994,those,0,0
194995,treated,0,0
194996,with,0,0
194997,K-wires,0,0
194998,.,0,0
194999,At,0,0
195000,a,0,0
195001,mean,0,1
195002,additional,0,0
195003,cost,0,1
195004,of,0,0
195005,?714,0,0
195006,(,0,0
195007,95,0,0
195008,%,0,0
195009,confidence,0,0
195010,interval,0,0
195011,588,0,0
195012,to,0,0
195013,865,0,0
195014,),0,0
195015,per,0,0
195016,patient,0,0
195017,",",0,0
195018,locking-plate,0,0
195019,fixation,0,0
195020,presented,0,0
195021,an,1,0
195022,incremental,1,0
195023,cost,1,1
195024,effectiveness,1,1
195025,ratio,1,1
195026,(,1,0
195027,ICER,1,1
195028,),1,0
195029,of,0,0
195030,"?89,322",0,0
195031,per,0,0
195032,QALY,0,0
195033,within,0,0
195034,the,0,0
195035,first,0,0
195036,12,0,0
195037,months,0,0
195038,of,0,0
195039,treatment,0,0
195040,.,0,0
195041,Sensitivity,0,1
195042,analyses,0,0
195043,were,0,0
195044,undertaken,0,0
195045,to,0,0
195046,assess,0,0
195047,the,1,0
195048,ICER,1,0
195049,of,1,0
195050,locking-plate,0,0
195051,fixation,0,0
195052,compared,0,0
195053,with,0,0
195054,K-wires,0,0
195055,.,0,0
195056,These,0,0
195057,were,0,0
195058,greater,0,0
195059,than,0,0
195060,"?30,000",0,0
195061,.,0,0
195062,Compared,0,0
195063,with,0,0
195064,locking-plate,0,0
195065,fixation,0,0
195066,",",0,0
195067,K-wire,0,0
195068,fixation,0,0
195069,is,0,0
195070,a,0,0
195071,'cost,0,1
195072,saving,0,0
195073,',0,0
195074,intervention,0,0
195075,",",0,0
195076,with,0,0
195077,similar,0,0
195078,health,0,0
195079,benefits,0,0
195080,.,0,0
195081,Inference-Based,0,0
195082,Approach,0,0
195083,versus,0,0
195084,Cognitive,0,1
195085,Behavioral,0,0
195086,Therapy,0,0
195087,in,0,0
195088,the,0,0
195089,Treatment,0,0
195090,of,0,0
195091,Obsessive-Compulsive,0,1
195092,Disorder,0,0
195093,with,0,0
195094,Poor,0,0
195095,Insight,0,0
195096,:,0,0
195097,A,0,0
195098,24-Session,0,0
195099,Randomized,0,0
195100,Controlled,0,0
195101,Trial,0,0
195102,.,0,0
195103,OBJECTIVE,0,0
195104,Obsessive-compulsive,0,1
195105,disorder,0,0
195106,(,0,0
195107,OCD,0,0
195108,),0,0
195109,with,0,0
195110,poor,0,0
195111,insight,0,0
195112,has,0,0
195113,severe,0,1
195114,consequences,0,0
195115,for,0,0
195116,patients,0,0
195117,;,0,0
195118,nonetheless,0,0
195119,",",0,0
195120,no,0,0
195121,randomized,0,0
195122,controlled,0,0
195123,trial,0,0
195124,has,0,0
195125,ever,0,0
195126,been,0,0
195127,performed,0,0
195128,to,0,0
195129,evaluate,0,0
195130,the,0,0
195131,effectiveness,0,0
195132,of,0,0
195133,any,0,0
195134,treatment,0,0
195135,specifically,0,0
195136,for,0,0
195137,poor-insight,0,0
195138,OCD,0,0
195139,.,0,0
195140,A,0,0
195141,new,0,0
195142,psychotherapy,0,0
195143,for,0,0
195144,OCD,0,0
195145,",",0,0
195146,the,0,0
195147,inference-based,0,0
195148,approach,0,0
195149,(,0,0
195150,IBA,0,0
195151,),0,0
195152,",",0,0
195153,targets,0,0
195154,insight,0,0
195155,in,0,0
195156,OCD,0,0
195157,by,0,0
195158,strengthening,0,0
195159,normal,0,0
195160,sensory-driven,0,0
195161,reality,0,0
195162,testing,0,0
195163,.,0,0
195164,The,0,0
195165,goal,0,0
195166,of,0,0
195167,the,0,0
195168,present,0,0
195169,study,0,0
195170,is,0,0
195171,to,0,0
195172,compare,0,0
195173,the,0,0
195174,effectiveness,0,0
195175,of,0,0
195176,this,0,0
195177,new,0,0
195178,treatment,0,0
195179,to,0,0
195180,the,0,0
195181,effectiveness,0,0
195182,of,0,0
195183,cognitive,0,1
195184,behavior,0,1
195185,therapy,0,0
195186,(,0,0
195187,CBT,0,0
195188,),0,0
195189,for,0,0
195190,patients,0,0
195191,with,0,0
195192,OCD,0,0
195193,with,0,0
195194,poor,0,1
195195,insight,0,0
195196,.,0,0
195197,METHOD,0,0
195198,A,0,0
195199,randomized,0,0
195200,controlled,0,0
195201,trial,0,0
195202,was,0,0
195203,conducted,0,0
195204,",",0,0
195205,in,0,0
195206,which,0,0
195207,90,0,0
195208,patients,0,0
195209,with,0,0
195210,OCD,0,0
195211,with,0,0
195212,poor,0,1
195213,insight,0,0
195214,received,0,0
195215,either,0,0
195216,24,0,0
195217,CBT,0,0
195218,sessions,0,0
195219,or,0,0
195220,24,0,0
195221,IBA,0,0
195222,sessions,0,0
195223,.,0,0
195224,The,0,0
195225,primary,0,0
195226,outcome,0,1
195227,measure,0,0
195228,was,0,0
195229,the,0,0
195230,Yale-Brown,1,0
195231,Obsessive,1,0
195232,Compulsive,1,1
195233,Scale,1,1
195234,(,1,0
195235,YBOCS,1,0
195236,),1,0
195237,.,1,0
195238,Secondary,0,0
195239,outcome,0,1
195240,measures,0,1
195241,were,0,0
195242,level,1,1
195243,of,1,1
195244,insight,1,0
195245,",",1,0
195246,anxiety,1,1
195247,and,1,1
195248,depressive,1,1
195249,symptoms,1,1
195250,",",1,0
195251,and,1,1
195252,quality,1,1
195253,of,1,0
195254,life,1,1
195255,.,1,0
195256,Mixed-effects,0,0
195257,models,0,0
195258,were,0,0
195259,used,0,0
195260,to,0,0
195261,determine,0,0
195262,the,0,0
195263,treatment,0,0
195264,effect,0,0
195265,.,0,0
195266,RESULTS,0,0
195267,In,0,0
195268,both,0,0
195269,conditions,0,0
195270,",",0,0
195271,a,0,0
195272,significant,1,0
195273,OCD,1,0
195274,symptom,1,1
195275,reduction,1,1
195276,was,0,0
195277,reached,0,0
195278,",",0,0
195279,but,0,0
195280,no,0,0
195281,condition,0,0
195282,effects,0,1
195283,were,0,0
195284,established,0,0
195285,.,0,0
195286,Post,0,0
195287,hoc,0,0
195288,",",0,0
195289,in,0,0
195290,a,0,0
195291,small,0,0
195292,subgroup,0,0
195293,of,0,0
195294,patients,0,0
195295,with,0,0
195296,the,0,0
195297,worst,0,1
195298,insight,1,0
195299,(,0,0
195300,n,0,0
195301,=,0,0
195302,23,0,0
195303,),0,0
195304,",",0,0
195305,it,0,0
195306,was,0,0
195307,found,0,0
195308,that,0,0
195309,the,0,0
195310,patients,0,0
195311,treated,0,0
195312,with,0,0
195313,the,0,0
195314,IBA,0,0
195315,reached,0,0
195316,a,0,0
195317,significantly,0,0
195318,higher,0,0
195319,OCD,1,0
195320,symptom,1,1
195321,reduction,1,0
195322,than,0,0
195323,the,0,0
195324,patients,0,0
195325,treated,0,0
195326,with,0,0
195327,CBT,0,0
195328,[,0,0
195329,estimated,0,0
195330,marginal,0,1
195331,mean,0,1
195332,=,0,0
195333,-7.77,0,0
195334,",",0,0
195335,t,0,0
195336,(,0,0
195337,219.45,0,0
195338,),0,0
195339,=,0,0
195340,-2.4,0,0
195341,",",0,1
195342,p,0,0
195343,=,0,0
195344,0.017,0,0
195345,],0,0
195346,.,0,0
195347,CONCLUSION,0,0
195348,Patients,0,0
195349,with,0,0
195350,OCD,0,0
195351,with,0,0
195352,poor,0,0
195353,insight,0,0
195354,improve,0,0
195355,significantly,0,0
195356,after,0,0
195357,psychological,0,1
195358,treatment,0,0
195359,.,0,0
195360,The,0,0
195361,results,0,0
195362,of,0,0
195363,this,0,0
195364,study,0,0
195365,suggest,0,0
195366,that,0,0
195367,both,0,0
195368,CBT,0,0
195369,and,0,0
195370,the,0,0
195371,IBA,0,0
195372,are,0,0
195373,effective,0,0
195374,treatments,0,0
195375,for,0,0
195376,OCD,0,0
195377,with,0,0
195378,poor,0,1
195379,insight,0,0
195380,.,0,0
195381,The,0,0
195382,IBA,0,0
195383,might,0,0
195384,be,0,0
195385,more,0,0
195386,promising,0,0
195387,than,0,0
195388,CBT,0,0
195389,for,0,0
195390,patients,0,0
195391,with,0,0
195392,more,0,0
195393,extreme,0,0
195394,poor,0,1
195395,insight,0,0
195396,.,0,0
195397,Recruitment,1,1
195398,and,1,1
195399,Reasons,1,1
195400,for,1,0
195401,Non-Participation,1,1
195402,in,0,0
195403,a,0,0
195404,Family-Coping-Orientated,0,0
195405,Palliative,0,0
195406,Home,0,0
195407,Care,0,0
195408,Trial,0,0
195409,(,0,0
195410,FamCope,0,0
195411,),0,0
195412,.,0,0
195413,Cancer,0,0
195414,patients,0,0
195415,and,0,0
195416,their,0,0
195417,family,0,0
195418,caregivers,0,0
195419,need,0,0
195420,support,0,0
195421,to,0,0
195422,cope,0,1
195423,with,0,0
195424,physical,0,1
195425,",",0,0
195426,psychosocial,0,1
195427,",",0,0
195428,and,0,1
195429,existential,0,1
195430,problems,0,1
195431,early,0,0
195432,in,0,0
195433,the,0,0
195434,palliative,0,0
195435,care,0,0
195436,trajectory,0,1
195437,.,0,0
195438,Many,0,0
195439,interventions,0,0
195440,target,0,0
195441,patient,0,1
195442,symptomatology,0,1
195443,",",0,0
195444,with,0,0
195445,health,0,1
195446,care,0,0
195447,professionals,0,0
195448,acting,0,0
195449,as,0,0
195450,problem-solvers,0,0
195451,.,0,0
195452,Family,0,0
195453,coping,0,1
195454,",",0,0
195455,however,0,0
195456,",",0,0
195457,is,0,0
195458,a,0,0
195459,new,0,0
195460,research,0,0
195461,area,0,1
195462,within,0,0
195463,palliative,0,0
195464,care,0,0
195465,.,0,0
195466,The,0,0
195467,FamCope,0,0
195468,intervention,0,0
195469,was,0,0
195470,developed,0,0
195471,to,0,0
195472,test,0,0
195473,if,0,0
195474,a,0,0
195475,nurse-led,0,0
195476,family-coping-orientated,0,1
195477,palliative,0,0
195478,home,0,0
195479,care,0,0
195480,intervention,0,0
195481,would,0,0
195482,help,0,0
195483,families,0,0
195484,cope,0,1
195485,with,0,0
195486,physical,0,1
195487,and,0,0
195488,psychosocial,0,1
195489,problems,0,1
195490,at,0,0
195491,home,0,0
195492,--,0,0
195493,together,0,0
195494,as,0,0
195495,a,0,0
195496,family,0,0
195497,and,0,0
195498,in,0,0
195499,interaction,0,1
195500,with,0,0
195501,health,0,1
195502,care,0,0
195503,professionals,0,0
195504,.,0,0
195505,However,0,0
195506,",",0,0
195507,an,0,0
195508,unexpectedly,0,0
195509,high,0,0
195510,number,0,1
195511,of,0,0
195512,families,0,0
195513,declined,0,0
195514,participation,1,0
195515,in,0,0
195516,the,0,0
195517,trial,0,0
195518,.,0,0
195519,We,0,0
195520,describe,0,0
195521,and,0,0
195522,discuss,0,0
195523,the,0,0
195524,recruitment,1,0
195525,strategy,1,0
195526,and,0,1
195527,patient,1,1
195528,reported,1,0
195529,reasons,1,0
195530,for,0,0
195531,non-participation,1,0
195532,to,0,0
195533,add,0,0
195534,to,0,0
195535,the,0,0
195536,knowledge,0,0
195537,about,0,0
195538,what,0,0
195539,impedes,0,0
195540,recruitment,0,0
195541,and,0,0
195542,to,0,0
195543,identify,0,0
195544,the,0,0
195545,factors,0,0
195546,that,0,0
195547,influence,0,0
195548,willingness,0,0
195549,to,0,0
195550,participate,0,0
195551,in,0,0
195552,research,0,0
195553,aimed,0,0
195554,at,0,0
195555,family,0,0
195556,coping,0,1
195557,early,0,0
195558,in,0,0
195559,the,0,0
195560,palliative,0,0
195561,care,0,0
195562,trajectory,0,1
195563,.,0,0
195564,Patients,0,0
195565,with,0,0
195566,advanced,0,0
195567,cancer,0,0
195568,and,0,0
195569,their,0,0
195570,closest,0,1
195571,relative,0,0
195572,were,0,0
195573,recruited,0,0
195574,from,0,0
195575,medical,0,0
195576,",",0,0
195577,surgical,0,1
195578,",",0,0
195579,and,0,1
195580,oncological,0,1
195581,departments,0,0
195582,.,0,0
195583,Reasons,0,0
195584,for,0,0
195585,non-participation,1,0
195586,were,0,0
195587,registered,0,0
195588,and,0,0
195589,characteristics,0,1
195590,of,0,1
195591,participants,0,0
195592,and,0,0
195593,non-participants,0,0
195594,were,0,0
195595,compared,0,0
195596,to,0,0
195597,evaluate,0,0
195598,differences,0,0
195599,between,0,0
195600,subgroups,0,0
195601,of,0,0
195602,non-participants,0,0
195603,based,0,0
195604,on,0,0
195605,reasons,0,0
195606,not,0,0
195607,to,0,0
195608,participate,0,0
195609,and,0,0
195610,reasons,0,0
195611,to,0,0
195612,participate,0,0
195613,in,0,0
195614,the,0,0
195615,trial,0,0
195616,.,0,0
195617,A,0,0
195618,total,0,0
195619,of,0,0
195620,65.9,0,0
195621,%,0,0
195622,of,0,0
195623,the,0,0
195624,families,0,0
195625,declined,0,0
195626,participation,1,0
195627,.,1,0
195628,Two,0,0
195629,main,0,0
195630,categories,0,0
195631,for,0,0
195632,declining,0,0
195633,participation,1,0
195634,emerged,0,0
195635,:,0,0
195636,first,0,0
195637,",",0,0
195638,that,0,0
195639,the,0,0
195640,burden,0,1
195641,of,0,0
195642,illness,0,1
195643,is,0,0
195644,too,0,0
195645,great,0,0
195646,and,0,0
195647,",",0,1
195648,second,0,0
195649,",",0,0
195650,that,0,0
195651,it,0,0
195652,was,0,0
195653,too,0,0
195654,soon,0,0
195655,to,0,0
195656,receive,0,0
195657,this,0,0
195658,kind,0,0
195659,of,0,0
195660,support,0,0
195661,.,0,0
195662,Men,0,0
195663,were,0,0
195664,more,0,0
195665,likely,0,0
195666,to,0,0
195667,participate,1,0
195668,than,0,0
195669,women,0,0
195670,.,0,0
195671,Patients,0,0
195672,in,0,0
195673,the,0,0
195674,too,0,0
195675,soon,0,0
195676,group,0,0
195677,had,0,0
195678,similar,0,0
195679,characteristics,0,1
195680,to,0,0
195681,participants,0,0
195682,in,0,0
195683,the,0,0
195684,trial,0,0
195685,.,0,0
195686,Timing,0,0
195687,of,0,0
195688,interventions,0,0
195689,and,0,0
195690,readiness,0,1
195691,of,0,1
195692,patients,0,0
195693,and,0,0
195694,their,0,0
195695,relatives,0,0
195696,seems,0,0
195697,to,0,0
195698,affect,0,0
195699,willingness,1,0
195700,to,1,0
195701,receive,1,0
195702,a,1,0
195703,family-coping-orientated,1,1
195704,care,1,0
195705,approach,1,0
195706,and,0,1
195707,impeded,0,0
195708,recruitment,0,0
195709,to,0,0
195710,this,0,0
195711,trial,0,0
195712,.,0,0
195713,Our,0,0
195714,findings,0,0
195715,can,0,0
195716,be,0,0
195717,used,0,0
195718,in,0,0
195719,further,0,0
195720,research,0,0
195721,and,0,0
195722,in,0,0
195723,clinical,0,0
195724,practice,0,0
195725,in,0,0
195726,order,0,0
195727,to,0,0
195728,construct,0,0
195729,interventions,0,0
195730,and,0,0
195731,target,0,0
195732,relevant,0,0
195733,populations,0,0
195734,for,0,0
195735,early,0,0
195736,family-coping-orientated,0,1
195737,palliative,0,0
195738,care,0,0
195739,.,0,0
195740,An,0,0
195741,endovascular,0,0
195742,simulation,0,0
195743,exercise,0,0
195744,among,0,0
195745,radiology,0,0
195746,residents,0,0
195747,:,0,0
195748,comparison,1,0
195749,of,0,0
195750,simulation,1,0
195751,performance,1,1
195752,with,0,0
195753,and,0,0
195754,without,0,0
195755,practice,0,0
195756,.,0,0
195757,PURPOSE,0,0
195758,The,0,0
195759,purpose,0,0
195760,was,0,0
195761,to,0,0
195762,compare,1,0
195763,resident,0,0
195764,endovascular,1,0
195765,simulator,1,0
195766,performance,1,1
195767,with,0,0
195768,and,0,0
195769,without,0,0
195770,prior,0,0
195771,simulation,0,0
195772,.,0,0
195773,METHODS,0,0
195774,Radiology,0,1
195775,residents,0,0
195776,were,0,0
195777,guided,0,0
195778,through,0,0
195779,a,0,0
195780,practice,0,0
195781,simulation,0,0
195782,and,0,0
195783,lectured,0,0
195784,on,0,0
195785,endovascular,0,0
195786,therapy,0,0
195787,",",0,0
195788,then,0,0
195789,randomized,0,0
195790,to,0,0
195791,simulate,0,0
195792,femoral,0,1
195793,arterial,0,1
195794,intervention,0,0
195795,with,0,0
195796,or,0,0
195797,without,0,0
195798,prior,0,0
195799,iliac,0,0
195800,simulation,0,0
195801,.,0,0
195802,Simulator,1,0
195803,measurements,1,0
195804,",",1,0
195805,performance,1,1
195806,grading,1,1
195807,and,1,1
195808,resident,1,1
195809,surveys,1,0
195810,were,0,0
195811,recorded,0,0
195812,.,0,0
195813,RESULTS,0,0
195814,Prior,0,1
195815,simulation,0,0
195816,of,0,0
195817,iliac,0,0
195818,intervention,0,0
195819,significantly,0,0
195820,improved,0,0
195821,resident,1,0
195822,performance,1,1
195823,.,1,0
195824,In,0,0
195825,particular,0,0
195826,",",0,0
195827,it,0,0
195828,resulted,0,0
195829,in,0,0
195830,less,1,0
195831,catheter,1,0
195832,placement,1,0
195833,without,1,0
195834,a,1,0
195835,wire,1,0
195836,(,0,0
195837,P=.01,0,0
195838,),0,0
195839,",",0,0
195840,shorter,1,1
195841,time,1,1
195842,to,1,0
195843,proper,1,0
195844,catheter,1,0
195845,positioning,1,0
195846,(,0,0
195847,P=.045,0,1
195848,),0,1
195849,and,0,0
195850,use,1,0
195851,of,1,1
195852,oblique,1,0
195853,digital,1,0
195854,subtraction,1,0
195855,angiography,1,0
195856,(,0,0
195857,P=.035,0,0
195858,),0,0
195859,.,0,0
195860,Survey,0,0
195861,respondents,0,0
195862,valued,0,0
195863,the,0,0
195864,experience,0,0
195865,.,0,0
195866,CONCLUSION,0,0
195867,Endovascular,0,0
195868,simulator,0,0
195869,training,0,0
195870,improves,0,1
195871,simulation,1,0
195872,skills,1,1
195873,.,1,0
195874,Improvement,0,1
195875,of,0,0
195876,real-world,0,0
195877,performance,1,1
195878,and,0,0
195879,generalizability,0,0
195880,remain,0,0
195881,to,0,0
195882,be,0,0
195883,shown,0,0
195884,.,0,0
195885,A,0,0
195886,controlled,0,0
195887,trial,0,0
195888,of,0,0
195889,extended,0,0
195890,radical,0,0
195891,versus,0,0
195892,radical,0,0
195893,mastectomy,0,0
195894,.,0,0
195895,Ten-year,0,0
195896,results,0,0
195897,.,0,0
195898,In,0,0
195899,view,0,0
195900,of,0,0
195901,increasing,0,0
195902,debate,0,0
195903,over,0,0
195904,possible,0,0
195905,benefit,0,0
195906,of,0,0
195907,more,0,0
195908,complete,0,1
195909,surgery,0,0
195910,compared,0,0
195911,to,0,0
195912,conservative,0,0
195913,procedures,0,0
195914,",",0,0
195915,a,0,0
195916,randomized,0,0
195917,controlled,0,0
195918,trial,0,0
195919,contrasting,0,0
195920,the,0,0
195921,then,0,0
195922,standard,0,0
195923,Halsted,0,0
195924,radical,0,0
195925,(,0,0
195926,RDL,0,1
195927,),0,0
195928,operation,0,0
195929,with,0,0
195930,the,0,0
195931,more,0,0
195932,complete,0,1
195933,extended,0,0
195934,radical,0,0
195935,(,0,0
195936,EXT,0,1
195937,),0,1
195938,mastectomy,0,0
195939,was,0,0
195940,initiated,0,0
195941,in,0,0
195942,1973,0,0
195943,.,0,0
195944,Between,0,0
195945,November,0,0
195946,1973,0,0
195947,and,0,0
195948,July,0,0
195949,1982,0,0
195950,",",0,0
195951,123,0,0
195952,women,0,0
195953,younger,0,0
195954,than,0,0
195955,70,0,0
195956,years,0,0
195957,of,0,0
195958,age,0,0
195959,and,0,0
195960,at,0,0
195961,clinical,0,0
195962,Stages,0,0
195963,I,0,0
195964,and,0,0
195965,II,0,0
195966,were,0,0
195967,enrolled,0,0
195968,.,0,0
195969,Of,0,0
195970,the,0,0
195971,total,0,1
195972,series,0,0
195973,",",0,0
195974,112,0,0
195975,were,0,0
195976,treated,0,0
195977,by,0,0
195978,the,0,0
195979,same,0,0
195980,surgeon,0,0
195981,and,0,0
195982,confirmed,0,0
195983,pathologically,0,0
195984,as,0,0
195985,having,0,0
195986,invasive,0,0
195987,mammary,0,0
195988,carcinoma,0,0
195989,.,0,0
195990,In,0,0
195991,this,0,0
195992,more,0,0
195993,homogeneous,0,0
195994,subgroup,0,0
195995,",",0,0
195996,the,0,0
195997,10-year,1,1
195998,survival,1,1
195999,rates,1,1
196000,(,0,0
196001,and,0,0
196002,standard,0,0
196003,errors,0,1
196004,),0,0
196005,were,0,0
196006,for,0,0
196007,RDL,0,1
196008,",",0,0
196009,60,0,0
196010,%,0,0
196011,(,0,0
196012,+/-,0,0
196013,7,0,0
196014,%,0,0
196015,),0,0
196016,and,0,0
196017,for,0,0
196018,EXT,0,1
196019,",",0,0
196020,74,0,0
196021,%,0,0
196022,(,0,0
196023,+/-,0,0
196024,6,0,0
196025,%,0,0
196026,),0,0
196027,(,0,0
196028,P,0,0
196029,value,0,1
196030,for,0,0
196031,comparison,0,0
196032,of,0,0
196033,survival,0,1
196034,curves,0,0
196035,=,0,0
196036,0.13,0,0
196037,),0,0
196038,.,0,0
196039,In,0,0
196040,patients,0,0
196041,from,0,0
196042,this,0,0
196043,subgroup,0,0
196044,with,0,0
196045,central-medial,0,0
196046,tumors,0,0
196047,",",0,0
196048,comprising,0,0
196049,62,0,0
196050,%,0,0
196051,of,0,0
196052,the,0,0
196053,total,0,1
196054,",",0,0
196055,survival,1,1
196056,after,0,0
196057,RDL,0,1
196058,at,0,0
196059,10,0,0
196060,years,0,0
196061,was,0,0
196062,60,0,0
196063,%,0,0
196064,(,0,0
196065,+/-,0,0
196066,8,0,0
196067,%,0,0
196068,),0,0
196069,",",0,0
196070,and,0,0
196071,after,0,0
196072,EXT,0,0
196073,86,0,0
196074,%,0,0
196075,(,0,0
196076,+/-,0,0
196077,6,0,0
196078,%,0,0
196079,),0,0
196080,(,0,0
196081,P,0,0
196082,=,0,0
196083,0.025,0,0
196084,),0,0
196085,.,0,0
196086,In,0,0
196087,the,0,0
196088,remaining,0,0
196089,patients,0,0
196090,with,0,0
196091,lateral,0,0
196092,tumors,0,0
196093,",",0,0
196094,survival,1,1
196095,rates,1,1
196096,were,0,0
196097,unaffected,0,0
196098,by,0,0
196099,treatment,0,0
196100,:,0,0
196101,58,0,0
196102,%,0,0
196103,(,0,0
196104,+/-,0,0
196105,13,0,0
196106,%,0,0
196107,),0,0
196108,and,0,0
196109,56,0,0
196110,%,0,0
196111,(,0,0
196112,+/-,0,0
196113,11,0,0
196114,%,0,0
196115,),0,0
196116,",",0,0
196117,respectively,0,0
196118,(,0,0
196119,P,0,0
196120,=,0,0
196121,0.62,0,0
196122,),0,0
196123,.,0,0
196124,Comparison,0,0
196125,of,0,0
196126,a,0,0
196127,nonrandomized,0,0
196128,series,0,0
196129,of,0,0
196130,266,0,0
196131,RDL,0,0
196132,and,0,0
196133,124,0,0
196134,EXT,0,0
196135,patients,0,0
196136,treated,0,0
196137,between,0,0
196138,1960,0,0
196139,and,0,0
196140,1978,0,0
196141,found,0,0
196142,differences,0,0
196143,consistent,0,0
196144,with,0,0
196145,those,0,0
196146,of,0,0
196147,the,0,0
196148,randomized,0,0
196149,study,0,0
196150,",",0,0
196151,although,0,0
196152,not,0,0
196153,statistically,0,0
196154,significant,0,0
196155,.,0,0
196156,DESFLURANE,0,0
196157,COMPARED,0,1
196158,TO,0,1
196159,SEVOFLURANE,0,0
196160,FOR,0,0
196161,CIRRHOTIC,0,0
196162,PATIENTS,0,0
196163,UNDERGOING,0,0
196164,MAJOR,0,0
196165,LIVER,0,0
196166,RESECTION,0,0
196167,.,0,0
196168,A,0,0
196169,RANDOMIZED,0,1
196170,CONTROL,0,0
196171,STUDY,0,0
196172,.,0,0
196173,BACKGROUND,0,0
196174,Major,0,1
196175,liver,0,0
196176,resection,0,0
196177,is,0,0
196178,associated,0,0
196179,with,0,0
196180,haemodynamic,0,1
196181,",",0,0
196182,hepatic,0,1
196183,and,0,1
196184,renal,0,1
196185,changes,0,1
196186,as,0,0
196187,a,0,0
196188,result,0,0
196189,of,0,0
196190,the,0,0
196191,procedure,0,0
196192,.,0,0
196193,AIM,0,0
196194,To,0,0
196195,compare,0,0
196196,Desflurane,0,0
196197,(,0,0
196198,D,0,1
196199,),0,0
196200,versus,0,0
196201,Sevoflurane,0,0
196202,(,0,0
196203,S,0,0
196204,),0,0
196205,on,0,0
196206,hepatic,1,0
196207,",",1,0
196208,renal,1,1
196209,functions,1,1
196210,",",1,0
196211,haemodynamics,1,1
196212,and,1,1
196213,perioperative,1,1
196214,course,1,1
196215,for,0,0
196216,cirrhotic,0,0
196217,patients,0,0
196218,undergoing,0,0
196219,major,0,0
196220,liver,0,0
196221,resection,0,0
196222,.,0,0
196223,PATIENTS,0,0
196224,AND,0,0
196225,METHODS,0,0
196226,A,0,0
196227,prospective,0,0
196228,randomized,0,0
196229,control,0,0
196230,study,0,0
196231,with,0,0
196232,50,0,0
196233,patients,0,0
196234,(,0,0
196235,Child,0,1
196236,A,0,0
196237,),0,0
196238,(,0,0
196239,D,0,1
196240,",",0,0
196241,n,0,0
196242,=,0,0
196243,25,0,0
196244,and,0,0
196245,S,0,0
196246,",",0,0
196247,n,0,0
196248,=,0,0
196249,25,0,0
196250,),0,0
196251,.,0,0
196252,End,1,0
196253,tidal,1,1
196254,D,1,1
196255,or,1,0
196256,S,1,0
196257,adjusted,1,0
196258,with,1,0
196259,Entropy,1,1
196260,(,0,0
196261,40-60,0,0
196262,),0,0
196263,.,0,0
196264,Haemodynamics,1,1
196265,monitored,1,0
196266,with,1,0
196267,invasive,1,0
196268,blood,1,1
196269,pressure,1,1
196270,and,1,1
196271,trans-oesophageal,1,1
196272,Doppler,1,1
196273,(,1,0
196274,TED,1,0
196275,),1,0
196276,.,1,0
196277,Liver,1,0
196278,and,1,0
196279,kidney,1,1
196280,function,1,1
196281,tests,1,1
196282,",",1,0
196283,blood,1,1
196284,Glutathione-S-transferase,1,1
196285,(,1,0
196286,GST,1,1
196287,),1,0
196288,",",1,0
196289,urinary,1,1
196290,microalbuminuria,1,1
196291,(,1,0
196292,Microalb,1,1
196293,),1,0
196294,were,1,0
196295,assayed,1,0
196296,.,1,0
196297,Extubation,1,0
196298,time,1,1
196299,and,1,1
196300,anaesthetic,1,1
196301,consumption,1,1
196302,were,1,0
196303,recorded,1,0
196304,.,1,0
196305,RESULTS,0,0
196306,Systemic,1,0
196307,vascular,1,1
196308,resistance,1,1
196309,(,1,0
196310,SVR,1,1
196311,),1,1
196312,post-resection,1,0
196313,and,1,1
196314,stroke,1,1
196315,volume,1,1
196316,of,0,0
196317,D,0,0
196318,vs,0,0
196319,S,0,0
196320,were,0,0
196321,835.04,0,0
196322,?,0,0
196323,12.02,0,0
196324,vs,0,0
196325,778.16,0,0
196326,?,0,0
196327,11.97,0,0
196328,dyn.sec.cm,0,0
196329,(,0,0
196330,-5,0,0
196331,),0,0
196332,",",0,0
196333,P,0,0
196334,<,0,0
196335,0.01,0,0
196336,",",0,0
196337,and,0,0
196338,85.72,0,0
196339,?,0,0
196340,2.95,0,0
196341,vs,0,0
196342,76.16,0,0
196343,?,0,0
196344,6.52,0,0
196345,ml,0,0
196346,",",0,0
196347,P,0,0
196348,<,0,0
196349,0.01,0,0
196350,respectively,1,0
196351,.,1,0
196352,Doppler,1,1
196353,corrected,1,0
196354,flow,1,1
196355,time,1,1
196356,(,1,0
196357,FTc,1,1
196358,),1,0
196359,between,1,0
196360,groups,0,0
196361,were,0,0
196362,comparable,0,0
196363,(,0,0
196364,P,0,0
196365,>,0,0
196366,0.05,0,0
196367,),0,0
196368,.,0,0
196369,No,0,0
196370,difference,0,0
196371,post-operatively,0,1
196372,regarding,1,0
196373,hepatic,1,0
196374,and,1,0
196375,renal,1,1
196376,functions,1,1
196377,",",1,0
196378,and,1,1
196379,urine,1,1
196380,Microalb,1,0
196381,(,1,0
196382,14.76,1,0
196383,?,0,0
196384,3.95,0,0
196385,vs,0,0
196386,l4.24,0,0
196387,?,0,0
196388,8.65,0,0
196389,?g/ml,0,1
196390,",",0,0
196391,P,0,0
196392,=,0,0
196393,0.78,0,0
196394,),0,0
196395,",",0,0
196396,but,0,0
196397,a,0,0
196398,statistically,0,0
196399,difference,0,0
196400,was,0,0
196401,found,0,0
196402,with,1,0
196403,GST,1,0
196404,(,1,0
196405,0.046,1,0
196406,?,0,0
196407,[,0,0
196408,symbols,0,0
196409,:,0,0
196410,see,0,0
196411,text,0,0
196412,],0,0
196413,",",0,0
196414,vs,0,0
196415,0.043,0,0
196416,?,0,0
196417,[,0,0
196418,symbols,0,0
196419,:,0,0
196420,see,0,0
196421,text,0,0
196422,],0,0
196423,IU/ml,0,1
196424,",",0,0
196425,P,0,0
196426,<,0,0
196427,0.01,0,0
196428,),0,0
196429,.,0,0
196430,Despite,0,0
196431,a,0,0
196432,higher,0,0
196433,D,1,1
196434,consumption,1,1
196435,(,1,0
196436,73,1,0
196437,?,1,0
196438,17,1,0
196439,vs,0,0
196440,64,0,0
196441,?,0,0
196442,22,0,0
196443,ml,0,0
196444,",",0,0
196445,P,0,0
196446,=,0,0
196447,0.102,0,0
196448,),0,0
196449,",",0,0
196450,cost,1,1
196451,in,1,0
196452,Egyptian,1,0
196453,pounds,1,1
196454,(,1,0
196455,LE,1,0
196456,),0,0
196457,was,0,0
196458,lower,0,0
196459,with,0,0
196460,D,0,1
196461,(,0,0
196462,141.14,0,0
196463,?,0,0
196464,32.90,0,0
196465,vs,0,0
196466,320.60,0,0
196467,?,0,0
196468,114.01,0,0
196469,",",0,0
196470,LE,0,0
196471,",",0,0
196472,P,0,0
196473,<,0,0
196474,0.01,0,0
196475,),0,0
196476,.,1,0
196477,Extubation,1,0
196478,time,1,1
196479,and,1,0
196480,ICU,1,0
196481,stay,1,1
196482,with,0,0
196483,D,0,1
196484,vS,0,0
196485,(,0,0
196486,4.52,0,0
196487,?,0,0
196488,2,0,0
196489,vs,0,0
196490,7.72,0,0
196491,?,0,0
196492,2,0,0
196493,min,0,0
196494,",",0,0
196495,P,0,0
196496,<,0,0
196497,0.01,0,0
196498,),0,0
196499,and,0,0
196500,(,0,0
196501,1.40,0,0
196502,0.50,0,0
196503,vs,0,0
196504,1.64,0,0
196505,?,0,0
196506,0.48,0,0
196507,",",0,0
196508,days,0,0
196509,P,0,0
196510,=,0,0
196511,0.09,0,0
196512,),0,0
196513,respectively,0,0
196514,.,0,0
196515,CONCLUSION,0,0
196516,Neither,0,0
196517,D,0,1
196518,nor,0,0
196519,S,0,0
196520,were,0,0
196521,clinically,0,0
196522,superior,0,0
196523,to,0,0
196524,the,0,0
196525,other,0,0
196526,with,0,0
196527,respect,0,0
196528,to,0,0
196529,liver,1,0
196530,and,1,0
196531,kidneys,1,1
196532,functions,1,1
196533,",",1,0
196534,but,1,0
196535,D,0,1
196536,was,0,0
196537,found,0,0
196538,to,0,0
196539,preserve,0,0
196540,better,0,0
196541,the,1,0
196542,haemodynamic,1,1
196543,parameters,1,1
196544,and,1,0
196545,enhance,1,0
196546,recovery,1,1
196547,at,1,0
196548,a,1,0
196549,lower,1,0
196550,cost,0,1
196551,.,0,0
196552,The,0,0
196553,effectiveness,0,0
196554,of,0,0
196555,single-dose,0,0
196556,metronidazole,0,0
196557,therapy,0,0
196558,for,0,0
196559,patients,0,0
196560,and,0,0
196561,their,0,0
196562,partners,0,0
196563,with,0,0
196564,bacterial,0,0
196565,vaginosis,0,0
196566,.,0,0
196567,A,0,0
196568,randomized,0,0
196569,",",0,0
196570,placebo-controlled,0,0
196571,",",0,0
196572,double-blind,0,0
196573,clinical,0,0
196574,trial,0,0
196575,was,0,0
196576,performed,0,0
196577,to,0,0
196578,test,0,0
196579,the,0,0
196580,hypothesis,0,0
196581,that,0,0
196582,a,0,0
196583,2-g,0,0
196584,single,0,0
196585,dose,0,0
196586,of,0,0
196587,metronidazole,0,0
196588,for,0,0
196589,male,0,0
196590,partners,0,0
196591,of,0,0
196592,women,0,0
196593,with,0,0
196594,bacterial,0,1
196595,vaginosis,0,1
196596,was,0,0
196597,more,0,0
196598,effective,0,1
196599,than,0,0
196600,placebo,0,0
196601,in,0,0
196602,improving,0,1
196603,cure,0,1
196604,rate,0,1
196605,and,0,1
196606,decreasing,0,1
196607,recurrence,0,1
196608,rate,0,1
196609,.,0,0
196610,In,0,0
196611,addition,0,0
196612,",",0,0
196613,the,0,0
196614,effectiveness,0,1
196615,of,0,0
196616,a,0,0
196617,2-g,0,0
196618,single,0,0
196619,dose,0,0
196620,of,0,0
196621,metronidazole,0,0
196622,was,0,0
196623,compared,0,0
196624,with,0,0
196625,a,0,0
196626,seven-day,0,0
196627,course,0,0
196628,of,0,0
196629,500,0,0
196630,mg,0,0
196631,of,0,0
196632,metronidazole,0,0
196633,twice,0,0
196634,a,0,0
196635,day,0,0
196636,in,0,0
196637,patients,0,0
196638,with,0,0
196639,bacterial,0,0
196640,vaginosis,0,0
196641,.,0,0
196642,Statistically,0,0
196643,significant,0,0
196644,benefits,0,0
196645,of,0,0
196646,partner,0,0
196647,treatment,0,0
196648,were,0,0
196649,noted,0,0
196650,in,0,0
196651,the,0,0
196652,initial,0,0
196653,cure,0,1
196654,rate,0,1
196655,by,0,0
196656,Gram-stained,0,1
196657,smear,0,0
196658,criteria,0,0
196659,(,0,0
196660,P,0,0
196661,less,0,0
196662,than,0,0
196663,.01,0,0
196664,),0,0
196665,and,0,0
196666,in,0,0
196667,percentage,0,1
196668,of,0,0
196669,women,0,0
196670,with,0,0
196671,symptoms,0,0
196672,eight,0,0
196673,weeks,0,0
196674,after,0,0
196675,initiating,0,0
196676,therapy,0,0
196677,(,0,0
196678,P,0,0
196679,less,0,0
196680,than,0,0
196681,.05,0,0
196682,),0,0
196683,.,0,0
196684,The,0,0
196685,seven-day,0,0
196686,course,0,0
196687,of,0,0
196688,metronidazole,0,0
196689,was,0,0
196690,superior,0,0
196691,to,0,0
196692,the,0,0
196693,single-dose,0,0
196694,regimen,0,0
196695,in,0,0
196696,the,0,0
196697,percentage,0,1
196698,of,0,0
196699,patients,0,0
196700,with,0,0
196701,clue,0,0
196702,cells,0,1
196703,and,0,0
196704,the,0,0
196705,percentage,0,1
196706,of,0,0
196707,patients,0,0
196708,with,0,0
196709,a,0,0
196710,positive,0,0
196711,sniff,0,1
196712,test,0,0
196713,at,0,0
196714,the,0,0
196715,first,0,0
196716,follow-up,0,0
196717,visit,0,1
196718,;,0,0
196719,however,0,0
196720,",",0,0
196721,differences,0,0
196722,in,0,0
196723,the,0,0
196724,initial,1,0
196725,cure,1,1
196726,rate,1,1
196727,assessed,1,0
196728,by,1,0
196729,clinical,1,0
196730,criteria,1,0
196731,and,1,0
196732,Gram-stained,1,1
196733,smear,1,1
196734,criteria,1,0
196735,were,0,0
196736,not,0,0
196737,statistically,0,0
196738,significant,0,0
196739,between,0,0
196740,the,0,0
196741,two,0,0
196742,patient,0,0
196743,treatment,0,0
196744,regimens,0,0
196745,.,0,0
196746,Recurrence,1,1
196747,rates,1,1
196748,by,1,0
196749,Gram-stained,1,1
196750,smear,1,0
196751,criteria,1,0
196752,between,0,0
196753,patient,0,1
196754,and,0,1
196755,partner,0,1
196756,treatment,0,0
196757,groups,0,0
196758,at,0,0
196759,five,0,0
196760,and,0,0
196761,eight,0,0
196762,weeks,0,0
196763,after,0,0
196764,initiation,0,0
196765,of,0,0
196766,treatment,0,0
196767,were,0,0
196768,also,0,0
196769,not,0,0
196770,significantly,0,0
196771,different,0,0
196772,between,0,0
196773,the,0,0
196774,two,0,0
196775,patient,0,0
196776,regimens,0,0
196777,.,0,0
196778,Single-dose,0,0
196779,metronidazole,0,0
196780,treatment,0,0
196781,of,0,0
196782,the,0,0
196783,sexual,0,1
196784,partner,0,0
196785,of,0,0
196786,women,0,0
196787,with,0,0
196788,bacterial,0,0
196789,vaginosis,0,0
196790,improves,0,1
196791,initial,0,0
196792,bacterial,1,1
196793,vaginosis,1,1
196794,cure,1,1
196795,rates,1,1
196796,.,1,0
196797,The,0,0
196798,seven-day,0,0
196799,course,0,0
196800,of,0,0
196801,metronidazole,0,0
196802,was,0,0
196803,not,0,0
196804,found,0,0
196805,by,0,0
196806,statistical,0,0
196807,analysis,0,0
196808,to,0,0
196809,be,0,0
196810,significantly,0,0
196811,superior,0,0
196812,to,0,0
196813,single-dose,0,0
196814,therapy,0,0
196815,when,0,0
196816,considering,0,0
196817,initial,0,0
196818,cure,0,1
196819,rates,0,1
196820,by,0,0
196821,clinical,0,0
196822,or,0,0
196823,Gram-stained,0,1
196824,smear,0,1
196825,criteria,0,0
196826,or,0,0
196827,recurrence,0,1
196828,rates,0,1
196829,.,0,0
196830,(,0,0
196831,ABSTRACT,0,1
196832,TRUNCATED,0,0
196833,AT,0,0
196834,250,0,0
196835,WORDS,0,0
196836,),0,0
196837,Randomized,0,0
196838,trial,0,0
196839,of,0,0
196840,recombinant,0,0
196841,alpha,0,0
196842,2b-interferon,0,0
196843,with,0,0
196844,or,0,0
196845,without,0,0
196846,indomethacin,0,0
196847,in,0,0
196848,patients,0,0
196849,with,0,0
196850,metastatic,0,0
196851,malignant,0,0
196852,melanoma,0,0
196853,.,0,0
196854,alpha-Interferon,0,0
196855,has,0,0
196856,antitumor,0,1
196857,activity,0,1
196858,in,0,0
196859,a,0,0
196860,variety,0,0
196861,of,0,0
196862,malignancies,0,0
196863,but,0,0
196864,is,0,0
196865,frequently,0,0
196866,associated,0,0
196867,with,0,0
196868,unacceptable,0,0
196869,toxic,1,1
196870,side-effects,1,0
196871,.,1,0
196872,The,0,0
196873,routine,0,0
196874,use,0,0
196875,of,0,0
196876,agents,0,0
196877,potentially,0,0
196878,capable,0,0
196879,of,0,0
196880,reducing,0,0
196881,these,0,0
196882,side-effects,0,0
196883,has,0,0
196884,not,0,0
196885,been,0,0
196886,recommended,0,0
196887,out,0,0
196888,of,0,0
196889,concern,0,0
196890,for,0,0
196891,possible,0,0
196892,reductions,0,0
196893,in,0,0
196894,the,0,0
196895,therapeutic,0,0
196896,activity,0,1
196897,of,0,0
196898,interferon,0,0
196899,.,0,0
196900,We,0,0
196901,conducted,0,0
196902,a,0,0
196903,prospective,0,0
196904,randomized,0,0
196905,trial,0,0
196906,of,0,0
196907,alpha-interferon,0,0
196908,given,0,0
196909,with,0,0
196910,or,0,0
196911,without,0,0
196912,indomethacin,0,0
196913,to,0,0
196914,patients,0,0
196915,with,0,0
196916,malignant,0,0
196917,melanoma,0,0
196918,to,0,0
196919,determine,0,0
196920,what,0,0
196921,effect,0,0
196922,",",0,0
196923,if,0,0
196924,any,0,0
196925,",",0,0
196926,indomethacin,0,0
196927,might,0,0
196928,have,0,0
196929,on,0,0
196930,the,0,0
196931,toxic,1,1
196932,",",1,0
196933,immunomodulatory,1,1
196934,",",1,1
196935,and,1,1
196936,therapeutic,1,1
196937,properties,1,1
196938,of,0,0
196939,interferon,0,0
196940,in,0,0
196941,this,0,0
196942,disease,0,0
196943,.,0,0
196944,53,0,0
196945,patients,0,0
196946,were,0,0
196947,stratified,0,0
196948,according,0,0
196949,to,0,0
196950,performance,0,1
196951,status,0,1
196952,and,0,0
196953,randomized,0,0
196954,to,0,0
196955,receive,0,0
196956,alpha,0,0
196957,2b-interferon,0,0
196958,",",0,0
196959,20,0,0
196960,million,0,0
196961,units,0,0
196962,per,0,0
196963,m2,0,0
196964,i.v.,0,0
196965,",",0,0
196966,5,0,0
196967,days,0,0
196968,per,0,0
196969,week,0,0
196970,for,0,0
196971,4,0,0
196972,weeks,0,0
196973,followed,0,0
196974,by,0,0
196975,10,0,0
196976,million,0,0
196977,units,0,0
196978,per,0,0
196979,m2,0,0
196980,s.c.,0,0
196981,three,0,0
196982,times,0,0
196983,per,0,0
196984,week,0,0
196985,",",0,0
196986,either,0,0
196987,with,0,0
196988,or,0,0
196989,without,0,0
196990,indomethacin,0,0
196991,",",0,0
196992,25,0,0
196993,mg,0,0
196994,orally,0,0
196995,three,0,0
196996,times,0,0
196997,a,0,0
196998,day,0,0
196999,.,0,0
197000,The,0,0
197001,overall,1,1
197002,major,1,0
197003,response,1,1
197004,rate,1,1
197005,was,0,0
197006,13,0,0
197007,%,0,0
197008,(,0,0
197009,three,0,0
197010,complete,0,0
197011,responders,0,0
197012,and,0,0
197013,three,0,0
197014,partial,0,0
197015,responders,0,0
197016,among,0,0
197017,47,0,0
197018,evaluable,0,0
197019,patients,0,0
197020,),0,0
197021,and,0,0
197022,was,0,0
197023,the,0,0
197024,same,0,0
197025,on,0,0
197026,both,0,0
197027,arms,0,0
197028,.,0,0
197029,The,0,0
197030,mean,1,1
197031,maximal,1,1
197032,temperature,1,1
197033,elevation,1,1
197034,induced,0,0
197035,by,0,0
197036,interferon,0,0
197037,was,0,0
197038,significantly,0,0
197039,reduced,0,0
197040,(,0,0
197041,from,0,0
197042,102.1,0,0
197043,to,0,0
197044,100.7,0,0
197045,",",0,0
197046,P,0,0
197047,=,0,0
197048,0.0002,0,0
197049,),0,0
197050,by,0,0
197051,indomethacin,0,0
197052,",",0,0
197053,but,0,0
197054,the,0,0
197055,incidence,1,1
197056,and,1,0
197057,severity,1,1
197058,of,1,1
197059,interferon-related,1,1
197060,fatigue,1,1
197061,",",1,0
197062,reduction,1,1
197063,in,1,0
197064,performance,1,1
197065,status,1,1
197066,",",1,1
197067,headache,1,1
197068,",",1,1
197069,depression,1,1
197070,",",1,1
197071,confusion,1,1
197072,",",1,1
197073,elevations,1,1
197074,in,1,0
197075,liver,1,0
197076,function,1,1
197077,tests,1,1
197078,",",1,0
197079,and,1,1
197080,myelosuppression,1,1
197081,were,0,0
197082,no,0,0
197083,different,0,0
197084,in,0,0
197085,either,0,0
197086,arm,0,0
197087,of,0,0
197088,the,0,0
197089,study,0,0
197090,.,0,0
197091,Indomethacin,0,0
197092,did,0,0
197093,not,0,0
197094,reduce,0,0
197095,the,0,0
197096,frequency,1,1
197097,of,1,0
197098,dose,1,0
197099,reductions,1,1
197100,for,1,0
197101,toxic,1,1
197102,side-effects,1,1
197103,and,0,0
197104,did,0,0
197105,not,0,0
197106,permit,0,0
197107,the,0,0
197108,administration,1,0
197109,of,1,0
197110,higher,1,0
197111,interferon,1,0
197112,doses,1,0
197113,.,1,0
197114,Peripheral,1,0
197115,blood,1,1
197116,natural,1,0
197117,killer,1,1
197118,activity,1,1
197119,was,0,0
197120,significantly,0,0
197121,enhanced,0,0
197122,in,0,0
197123,patients,0,0
197124,during,0,0
197125,maintenance,0,0
197126,therapy,0,0
197127,whether,0,0
197128,or,0,0
197129,not,0,0
197130,they,0,0
197131,received,0,0
197132,indomethacin,0,0
197133,.,0,0
197134,Indomethacin,0,0
197135,appeared,0,0
197136,to,0,0
197137,inhibit,0,0
197138,augmentation,1,0
197139,of,1,0
197140,natural,1,0
197141,killer,1,1
197142,activity,1,1
197143,during,0,0
197144,high,0,0
197145,dose,0,0
197146,induction,0,0
197147,therapy,0,0
197148,.,0,0
197149,Immunological,1,1
197150,changes,1,1
197151,did,0,0
197152,not,0,0
197153,correlate,0,0
197154,with,0,0
197155,response,0,1
197156,status,0,0
197157,.,0,0
197158,We,0,0
197159,conclude,0,0
197160,that,0,0
197161,indomethacin,0,0
197162,can,0,0
197163,reduce,0,0
197164,the,0,0
197165,fever,1,1
197166,associated,0,0
197167,with,0,0
197168,interferon,0,0
197169,therapy,0,0
197170,in,0,0
197171,patients,0,0
197172,with,0,0
197173,malignant,0,0
197174,melanoma,0,0
197175,without,0,0
197176,interfering,0,0
197177,with,0,0
197178,its,0,0
197179,therapeutic,1,0
197180,or,1,0
197181,chronic,1,0
197182,immunomodulatory,1,0
197183,activities,1,1
197184,.,1,0
197185,Since,0,0
197186,fever,1,0
197187,is,0,0
197188,rarely,0,0
197189,the,0,0
197190,dose-limiting,0,0
197191,toxicity,0,1
197192,of,0,0
197193,interferon,0,1
197194,",",0,0
197195,indomethacin,0,0
197196,is,0,0
197197,of,0,0
197198,marginal,0,1
197199,benefit,0,0
197200,to,0,0
197201,patients,0,0
197202,with,0,0
197203,malignant,0,0
197204,melanoma,0,0
197205,receiving,0,0
197206,interferon,0,0
197207,at,0,0
197208,the,0,0
197209,doses,0,0
197210,outlined,0,0
197211,in,0,0
197212,this,0,0
197213,study,0,0
197214,.,0,0
197215,Treatments,0,0
197216,of,0,0
197217,preterm,0,0
197218,premature,0,0
197219,rupture,0,1
197220,of,0,0
197221,the,0,0
197222,membranes,0,0
197223,:,0,0
197224,a,0,0
197225,meta-analysis,0,0
197226,.,0,0
197227,The,0,0
197228,objective,0,0
197229,of,0,0
197230,this,0,0
197231,overview,0,0
197232,was,0,0
197233,to,0,0
197234,critically,0,0
197235,evaluate,0,0
197236,published,0,0
197237,randomized,0,0
197238,controlled,0,0
197239,trials,0,0
197240,on,0,0
197241,treatments,0,0
197242,in,0,0
197243,preterm,0,0
197244,premature,0,0
197245,rupture,0,1
197246,of,0,0
197247,the,0,0
197248,membranes,0,0
197249,.,0,0
197250,The,0,0
197251,Oxford,0,0
197252,data,0,0
197253,base,0,1
197254,on,0,0
197255,perinatal,0,1
197256,trials,0,0
197257,",",0,0
197258,MEDLINE,0,1
197259,",",0,0
197260,Excerpta,0,0
197261,Medica,0,0
197262,",",0,0
197263,and,0,1
197264,Index,0,1
197265,Medicus,0,0
197266,were,0,0
197267,searched,0,0
197268,.,0,0
197269,Through,0,0
197270,primary,0,0
197271,and,0,0
197272,secondary,0,0
197273,review,0,0
197274,with,0,0
197275,preset,0,0
197276,inclusion,0,0
197277,criteria,0,0
197278,",",0,0
197279,two,0,0
197280,independent,0,0
197281,judges,0,0
197282,identified,0,0
197283,27,0,0
197284,randomized,0,0
197285,controlled,0,0
197286,trials,0,0
197287,",",0,0
197288,of,0,0
197289,which,0,0
197290,13,0,0
197291,met,0,0
197292,inclusion,0,0
197293,criteria,0,0
197294,.,0,0
197295,The,0,0
197296,quality,0,1
197297,of,0,0
197298,these,0,0
197299,randomized,0,0
197300,controlled,0,0
197301,trials,0,0
197302,was,0,0
197303,scored,0,0
197304,.,0,0
197305,Five,0,0
197306,randomized,0,0
197307,controlled,0,0
197308,trials,0,0
197309,regarding,0,0
197310,antenatal,0,0
197311,use,0,0
197312,of,0,0
197313,corticosteroids,0,0
197314,to,0,0
197315,prevent,0,0
197316,respiratory,1,1
197317,distress,1,1
197318,syndrome,1,0
197319,could,0,0
197320,be,0,0
197321,combined,0,0
197322,meta-analytically,0,0
197323,and,0,0
197324,showed,0,0
197325,a,0,0
197326,reduction,0,1
197327,in,0,0
197328,respiratory,1,1
197329,distress,1,1
197330,syndrome,1,0
197331,in,0,0
197332,the,0,0
197333,treatment,0,0
197334,group,0,0
197335,(,0,0
197336,p,0,0
197337,=,0,0
197338,0.001,0,0
197339,),0,0
197340,.,0,0
197341,However,0,0
197342,",",0,0
197343,no,0,0
197344,significant,0,0
197345,reduction,0,1
197346,in,0,0
197347,respiratory,1,1
197348,distress,1,1
197349,syndrome,1,0
197350,(,0,0
197351,p,0,0
197352,=,0,0
197353,0.286,0,0
197354,),0,0
197355,was,0,0
197356,found,0,0
197357,after,0,0
197358,one,0,0
197359,study,0,0
197360,",",0,0
197361,with,0,0
197362,the,0,0
197363,lowest,0,0
197364,quality,0,1
197365,score,0,1
197366,",",0,0
197367,was,0,0
197368,excluded,0,0
197369,.,0,0
197370,A,0,0
197371,significant,0,0
197372,increase,0,0
197373,in,0,0
197374,endometritis,1,1
197375,and,0,0
197376,a,0,0
197377,trend,0,0
197378,toward,0,0
197379,an,0,0
197380,increase,0,0
197381,in,0,0
197382,neonatal,1,1
197383,infections,1,1
197384,and,1,0
197385,cesarean,1,1
197386,section,1,0
197387,rates,1,1
197388,were,0,0
197389,noted,0,0
197390,with,0,0
197391,treatment,0,0
197392,.,0,0
197393,Tocolysis,0,0
197394,",",0,0
197395,prophylactic,0,0
197396,antibiotics,0,1
197397,",",0,0
197398,and,0,1
197399,other,0,0
197400,interventions,0,0
197401,studied,0,0
197402,were,0,0
197403,not,0,0
197404,found,0,0
197405,to,0,0
197406,be,0,0
197407,of,0,0
197408,proved,0,0
197409,benefit,0,0
197410,and,0,0
197411,therefore,0,0
197412,should,0,0
197413,not,0,0
197414,be,0,0
197415,used,0,0
197416,outside,0,0
197417,of,0,0
197418,a,0,0
197419,randomized,0,0
197420,controlled,0,0
197421,trial,0,0
197422,.,0,0
197423,The,0,0
197424,role,0,0
197425,of,0,0
197426,routinely,0,0
197427,given,0,0
197428,hyoscine-N-butylbromide,0,0
197429,in,0,0
197430,colonoscopy,0,0
197431,:,0,0
197432,a,0,0
197433,double-blind,0,0
197434,",",0,0
197435,randomized,0,0
197436,",",0,0
197437,placebo-controlled,0,0
197438,",",0,0
197439,clinical,0,0
197440,trial,0,0
197441,.,0,0
197442,OBJECTIVE,0,0
197443,Hyoscine-N-butylbromide,0,0
197444,(,0,0
197445,HBB,0,1
197446,),0,0
197447,has,0,0
197448,been,0,0
197449,proposed,0,0
197450,to,0,0
197451,ease,0,0
197452,colonoscopy,0,0
197453,and,0,0
197454,improve,0,0
197455,mucosal,0,1
197456,visualization,0,0
197457,",",0,0
197458,yet,0,0
197459,the,0,0
197460,results,0,0
197461,from,0,0
197462,previous,0,0
197463,studies,0,0
197464,are,0,0
197465,conflicting,0,0
197466,.,0,0
197467,In,0,0
197468,our,0,0
197469,prospective,0,0
197470,",",0,0
197471,double-blind,0,0
197472,",",0,0
197473,placebo-controlled,0,0
197474,",",0,0
197475,randomized,0,0
197476,study,0,0
197477,we,0,0
197478,aimed,0,0
197479,at,0,0
197480,evaluating,0,0
197481,whether,0,0
197482,routine,0,0
197483,administration,0,0
197484,of,0,0
197485,HBB,0,1
197486,",",0,0
197487,before,0,0
197488,and,0,0
197489,during,0,0
197490,colonoscopy,0,0
197491,",",0,0
197492,ease,1,0
197493,the,1,0
197494,procedure,1,0
197495,or,1,0
197496,increase,1,0
197497,the,1,0
197498,detection,1,1
197499,rate,1,1
197500,for,1,0
197501,polyps,1,0
197502,.,1,0
197503,MATERIAL,0,0
197504,AND,0,0
197505,METHODS,0,0
197506,One,0,0
197507,hundred,0,0
197508,fifty,0,0
197509,outpatients,0,0
197510,scheduled,0,0
197511,for,0,0
197512,an,0,0
197513,elective,0,0
197514,colonoscopy,0,0
197515,were,0,0
197516,randomized,0,0
197517,to,0,0
197518,receive,0,0
197519,intravenous,0,0
197520,injections,0,0
197521,of,0,0
197522,either,0,0
197523,10,0,0
197524,mg,0,0
197525,hyoscine-N-butylbromide,0,0
197526,or,0,0
197527,saline,0,0
197528,before,0,0
197529,insertion,0,1
197530,and,0,0
197531,at,0,0
197532,cecum,0,1
197533,.,0,0
197534,Patient,1,1
197535,tolerance,1,1
197536,and,1,0
197537,technical,1,1
197538,ease,1,1
197539,of,1,0
197540,colonoscopy,1,1
197541,were,0,0
197542,evaluated,0,0
197543,by,0,0
197544,visual,0,1
197545,analogue,0,1
197546,scale,0,1
197547,(,0,0
197548,VAS,0,0
197549,),0,0
197550,.,0,0
197551,Procedure,1,0
197552,times,1,1
197553,were,0,0
197554,recorded,0,0
197555,.,0,0
197556,Number,1,0
197557,of,1,0
197558,detected,1,0
197559,polyps,1,0
197560,per,1,0
197561,patient,1,0
197562,was,0,0
197563,evaluated,0,0
197564,as,0,0
197565,well,0,0
197566,.,0,0
197567,Heart,1,0
197568,rate,1,1
197569,was,0,0
197570,monitored,0,0
197571,with,0,0
197572,a,0,0
197573,pulse,0,0
197574,oximetry,0,0
197575,.,0,0
197576,RESULTS,0,0
197577,HBB,0,1
197578,did,0,0
197579,not,0,0
197580,improve,0,0
197581,patient,1,1
197582,tolerance,1,1
197583,or,1,0
197584,technically,1,0
197585,ease,1,0
197586,the,1,0
197587,procedure,1,0
197588,as,0,0
197589,evaluated,0,0
197590,by,0,0
197591,VAS,0,0
197592,.,0,0
197593,However,0,0
197594,",",0,0
197595,HBB,0,1
197596,led,0,0
197597,to,0,0
197598,faster,0,0
197599,ileal,1,1
197600,intubation,1,0
197601,(,0,0
197602,1.5,0,0
197603,vs,0,0
197604,2.0,0,0
197605,min,0,0
197606,",",0,0
197607,p,0,0
197608,<,0,0
197609,0.001,0,0
197610,),0,0
197611,and,0,0
197612,shorter,0,1
197613,total,1,1
197614,procedure,1,0
197615,time,1,1
197616,(,0,0
197617,22.0,0,0
197618,vs,0,0
197619,24.0,0,0
197620,min,0,0
197621,",",0,0
197622,p,0,0
197623,=,0,0
197624,0.03,0,0
197625,),0,0
197626,.,0,0
197627,Patients,0,0
197628,who,0,0
197629,received,0,0
197630,HBB,0,1
197631,also,0,0
197632,needed,0,0
197633,less,0,0
197634,often,0,0
197635,external,1,0
197636,abdominal,1,1
197637,pressure,1,1
197638,(,0,0
197639,48.6,0,0
197640,vs,0,0
197641,66.7,0,0
197642,%,0,0
197643,",",0,0
197644,p,0,0
197645,=,0,0
197646,0.03,0,0
197647,),0,0
197648,.,0,0
197649,HBB,0,1
197650,did,0,0
197651,not,0,0
197652,improve,0,0
197653,polyp,1,1
197654,detection,1,1
197655,rate,1,1
197656,(,0,0
197657,0.89,0,0
197658,vs,0,0
197659,0.91,0,0
197660,",",0,0
197661,p,0,0
197662,=,0,0
197663,0.90,0,0
197664,),0,0
197665,.,0,0
197666,HBB,0,1
197667,induced,0,0
197668,a,0,0
197669,significant,0,0
197670,rise,0,0
197671,in,0,0
197672,heart,1,1
197673,rate,1,1
197674,(,0,0
197675,p,0,0
197676,<,0,0
197677,0.001,0,0
197678,),0,0
197679,and,0,0
197680,more,0,0
197681,often,0,0
197682,tachycardia,1,0
197683,(,0,0
197684,17.6,0,0
197685,vs,0,0
197686,0,0,0
197687,%,0,0
197688,",",0,0
197689,p,0,0
197690,<,0,0
197691,0.001,0,0
197692,),0,0
197693,.,0,0
197694,CONCLUSIONS,0,0
197695,Routine,0,1
197696,administration,0,0
197697,of,0,0
197698,HBB,0,1
197699,before,0,0
197700,and,0,0
197701,during,0,0
197702,colonoscopy,0,1
197703,yields,0,1
197704,only,0,0
197705,limited,0,0
197706,improvement,0,0
197707,in,0,0
197708,the,0,0
197709,technical,1,0
197710,performance,1,1
197711,of,1,0
197712,the,1,0
197713,examination,1,0
197714,compromised,0,0
197715,by,0,0
197716,high,0,0
197717,incidence,0,1
197718,of,0,0
197719,tachycardia,1,0
197720,.,1,0
197721,[,0,0
197722,EMLA,0,1
197723,cream,0,0
197724,(,0,0
197725,lidocaine/prilocaine,0,0
197726,),0,1
197727,versus,0,0
197728,infiltration,0,1
197729,analgesia,0,1
197730,with,0,0
197731,carbocaine,0,0
197732,(,0,0
197733,mepivacaine,0,0
197734,),0,0
197735,in,0,0
197736,vasectomy,0,0
197737,],0,0
197738,.,0,0
197739,The,0,0
197740,analgesic,1,1
197741,efficacy,1,1
197742,of,0,0
197743,EMLA,0,0
197744,cream,0,0
197745,was,0,0
197746,compared,0,0
197747,with,0,0
197748,infiltration,0,0
197749,with,0,0
197750,1,0,0
197751,%,0,0
197752,carbocaine,0,0
197753,in,0,0
197754,13,0,0
197755,bilateral,0,0
197756,vasectomies,0,0
197757,.,0,0
197758,Twelve,0,0
197759,patients,0,0
197760,preferred,0,0
197761,infiltration,0,1
197762,analgesia,0,1
197763,.,0,0
197764,EMLA,0,0
197765,analgesia,0,1
197766,was,0,0
197767,only,1,0
197768,effective,1,0
197769,in,1,0
197770,the,1,0
197771,skin,1,1
197772,",",0,0
197773,and,0,0
197774,had,1,0
197775,to,1,0
197776,be,1,0
197777,supplemented,1,0
197778,as,0,0
197779,the,0,0
197780,incision,0,0
197781,reached,0,0
197782,subcutaneous,0,0
197783,tissue,0,0
197784,.,0,0
197785,Oxidized,0,0
197786,Regenerated,0,0
197787,Cellulose,0,0
197788,Reduces,0,0
197789,the,0,0
197790,Amount,0,0
197791,of,0,0
197792,Fluid,0,1
197793,Drainage,0,0
197794,after,0,0
197795,Liver,0,0
197796,Resection,0,0
197797,:,0,0
197798,A,0,0
197799,Randomized,0,0
197800,Prospective,0,0
197801,Clinical,0,1
197802,Trial,0,0
197803,.,0,0
197804,BACKGROUND/AIMS,0,0
197805,Oxidized,0,0
197806,regenerated,0,0
197807,cellulose,0,0
197808,(,0,0
197809,ORC,0,1
197810,),0,0
197811,has,0,0
197812,been,0,0
197813,registered,0,0
197814,as,0,0
197815,adjuncts,0,0
197816,to,0,0
197817,stimulate,0,0
197818,hemostasis,0,1
197819,in,0,0
197820,liver,0,0
197821,surgery,0,0
197822,.,0,0
197823,However,0,0
197824,",",0,0
197825,most,0,0
197826,previous,0,0
197827,studies,0,0
197828,were,0,0
197829,primarily,0,0
197830,designed,0,0
197831,to,0,0
197832,study,0,0
197833,the,0,0
197834,intra-operative,0,0
197835,hemostatic,0,0
197836,efficacy,0,1
197837,",",0,0
197838,and,0,0
197839,the,0,0
197840,effect,0,0
197841,on,0,0
197842,prophylactic,0,0
197843,application,0,0
197844,was,0,0
197845,never,0,0
197846,studied,0,0
197847,as,0,0
197848,a,0,0
197849,primary,0,0
197850,endpoint,0,0
197851,.,0,0
197852,This,0,0
197853,randomized,0,0
197854,prospective,0,0
197855,clinical,0,0
197856,trial,0,0
197857,was,0,0
197858,undertaken,0,0
197859,to,0,0
197860,evaluate,0,0
197861,whether,0,0
197862,ORC,0,0
197863,is,0,0
197864,safe,0,0
197865,and,0,0
197866,effective,0,1
197867,when,0,0
197868,used,0,0
197869,as,0,0
197870,a,0,0
197871,prophylactic,0,0
197872,agent,0,0
197873,covering,0,0
197874,the,0,0
197875,raw,0,0
197876,cut,0,0
197877,surface,0,0
197878,during,0,0
197879,the,0,0
197880,hepatectomy,0,0
197881,to,0,0
197882,reduce,0,0
197883,the,0,0
197884,volume,0,1
197885,and,0,0
197886,duration,0,1
197887,of,0,0
197888,drainage,0,0
197889,.,0,0
197890,METHODOLOGY,0,0
197891,Between,0,0
197892,June,0,0
197893,2011,0,0
197894,and,0,0
197895,August,0,0
197896,2012,0,0
197897,",",0,0
197898,a,0,0
197899,total,0,1
197900,of,0,0
197901,40,0,0
197902,patients,0,0
197903,undergoing,0,0
197904,major,0,0
197905,hepatectomy,0,0
197906,were,0,0
197907,randomly,0,0
197908,assigned,0,0
197909,to,0,0
197910,ORC,0,1
197911,or,0,0
197912,control,0,0
197913,groups,0,0
197914,(,0,0
197915,20,0,0
197916,in,0,0
197917,each,0,0
197918,group,0,0
197919,),0,0
197920,.,0,0
197921,Patient,1,1
197922,characteristics,1,0
197923,",",1,0
197924,resection-related,1,1
197925,factors,1,0
197926,",",1,0
197927,debit,1,1
197928,of,1,1
197929,drainage,1,0
197930,and,1,0
197931,postoperative,1,1
197932,complications,1,1
197933,were,0,0
197934,compared,0,0
197935,between,0,0
197936,the,0,0
197937,two,0,0
197938,groups,0,0
197939,.,0,0
197940,RESULTS,0,0
197941,The,0,0
197942,two,0,0
197943,groups,0,0
197944,were,0,0
197945,comparable,0,0
197946,in,0,0
197947,terms,0,0
197948,of,0,0
197949,demographics,1,1
197950,",",1,0
197951,indications,1,0
197952,for,1,0
197953,surgery,1,0
197954,",",1,0
197955,extent,1,0
197956,of,1,1
197957,hepatectomy,1,0
197958,",",1,0
197959,and,1,1
197960,intraoperative,1,1
197961,blood,1,1
197962,loss,1,1
197963,.,1,0
197964,The,0,0
197965,amount,1,0
197966,of,1,0
197967,drainage,1,0
197968,after,1,0
197969,operation,1,0
197970,was,0,0
197971,significantly,0,0
197972,less,0,0
197973,in,0,0
197974,the,0,0
197975,ORC,0,1
197976,group,0,0
197977,compared,0,0
197978,with,0,0
197979,the,0,0
197980,control,0,0
197981,group,0,0
197982,(,0,0
197983,406.9,0,0
197984,?,0,0
197985,308.1,0,0
197986,vs.,0,0
197987,627.0,0,0
197988,?,0,0
197989,301.6,0,0
197990,ml,0,0
197991,",",0,0
197992,P,0,0
197993,=,0,0
197994,0.028,0,0
197995,),0,0
197996,.,0,0
197997,CONCLUSIONS,0,0
197998,Application,0,1
197999,of,0,0
198000,ORC,0,1
198001,covering,0,0
198002,the,0,0
198003,raw,0,0
198004,cut,0,0
198005,surface,0,0
198006,during,0,0
198007,the,0,0
198008,hepatectomy,0,0
198009,can,0,0
198010,significantly,0,0
198011,decrease,0,0
198012,the,0,0
198013,amount,0,0
198014,of,0,0
198015,drainage,0,0
198016,.,0,0
198017,Effects,0,0
198018,of,0,0
198019,heat,0,0
198020,and,0,1
198021,cold,0,1
198022,on,0,0
198023,the,0,0
198024,perineum,0,1
198025,after,0,0
198026,episiotomy/laceration,0,0
198027,.,0,0
198028,The,0,0
198029,Redness,1,1
198030,Edema,1,1
198031,Ecchymosis,1,1
198032,Discharge,1,1
198033,Approximation,1,0
198034,(,1,0
198035,REEDA,1,0
198036,),1,1
198037,tool,1,0
198038,",",0,0
198039,devised,0,0
198040,to,0,0
198041,evaluate,0,0
198042,postpartum,0,1
198043,healing,0,1
198044,of,0,0
198045,the,0,0
198046,perineum,0,1
198047,following,0,0
198048,an,0,0
198049,episiotomy/laceration,0,0
198050,",",0,0
198051,was,0,0
198052,used,0,0
198053,to,0,0
198054,evaluate,0,0
198055,the,0,0
198056,effects,0,0
198057,of,0,0
198058,heat,0,0
198059,and,0,1
198060,cold,0,1
198061,on,0,0
198062,the,0,0
198063,perineum,0,1
198064,during,0,0
198065,the,0,0
198066,first,0,0
198067,24,0,0
198068,hours,0,0
198069,after,0,0
198070,delivery,0,0
198071,.,0,0
198072,Ninety,0,0
198073,patients,0,0
198074,were,0,0
198075,randomly,0,0
198076,assigned,0,0
198077,to,0,0
198078,one,0,0
198079,of,0,0
198080,three,0,0
198081,treatment,0,0
198082,groups,0,0
198083,.,0,0
198084,Treatment,0,0
198085,consisted,0,0
198086,of,0,0
198087,30,0,0
198088,subjects,0,0
198089,applying,0,0
198090,a,0,0
198091,warm,0,0
198092,perineal,0,1
198093,pack,0,0
198094,",",0,0
198095,30,0,0
198096,applying,0,0
198097,a,0,0
198098,cold,0,0
198099,perineal,0,1
198100,pack,0,0
198101,",",0,0
198102,and,0,0
198103,30,0,0
198104,taking,0,0
198105,a,0,0
198106,warm,0,0
198107,sitz,0,0
198108,bath,0,0
198109,.,0,0
198110,Analysis,0,1
198111,of,0,0
198112,variance,0,0
198113,indicated,0,0
198114,no,0,0
198115,difference,0,0
198116,in,0,0
198117,the,0,0
198118,REEDA,1,0
198119,score,1,1
198120,before,0,0
198121,or,0,0
198122,two,0,0
198123,hours,0,0
198124,after,0,0
198125,treatment,0,0
198126,.,0,0
198127,A,0,0
198128,Pearson,0,0
198129,r,0,1
198130,correlation,0,0
198131,indicated,0,0
198132,the,0,0
198133,REEDA,0,0
198134,score,0,1
198135,was,0,0
198136,associated,0,0
198137,with,0,0
198138,a,0,0
198139,laceration,1,1
198140,and,1,0
198141,not,1,0
198142,with,1,0
198143,infant,1,0
198144,weight,1,1
198145,.,1,0
198146,Although,0,0
198147,these,0,0
198148,findings,0,0
198149,do,0,0
198150,not,0,0
198151,support,0,0
198152,assumptions,0,0
198153,from,0,0
198154,the,0,0
198155,literature,0,0
198156,",",0,0
198157,this,0,0
198158,study,0,0
198159,provides,0,0
198160,baseline,0,0
198161,data,0,0
198162,and,0,0
198163,trends,0,0
198164,for,0,0
198165,future,0,0
198166,study,0,0
198167,.,0,0
198168,Randomized,0,0
198169,clinical,0,0
198170,trial,0,0
198171,comparing,0,0
198172,systemic,0,1
198173,interferon,0,0
198174,with,0,0
198175,diathermocoagulation,0,0
198176,in,0,0
198177,primary,0,0
198178,multiple,0,0
198179,and,0,0
198180,widespread,0,0
198181,anogenital,0,1
198182,condyloma,0,0
198183,.,0,0
198184,Two,0,0
198185,hundred,0,0
198186,three,0,0
198187,patients,0,0
198188,(,0,0
198189,median,0,0
198190,age,0,0
198191,26,0,0
198192,years,0,0
198193,;,0,0
198194,range,0,0
198195,18-45,0,0
198196,),0,0
198197,with,0,0
198198,untreated,0,0
198199,multiple,0,0
198200,and,0,0
198201,widespread,0,0
198202,anogenital,0,1
198203,condyloma,0,0
198204,were,0,0
198205,randomly,0,0
198206,assigned,0,0
198207,to,0,0
198208,one,0,0
198209,of,0,0
198210,four,0,0
198211,study,0,0
198212,arms,0,0
198213,in,0,0
198214,order,0,0
198215,to,0,0
198216,compare,0,0
198217,the,0,0
198218,efficacy,1,1
198219,",",1,0
198220,toxicity,1,1
198221,",",1,1
198222,and,1,1
198223,tolerability,1,1
198224,of,0,1
198225,recombinant,0,0
198226,interferon,0,0
198227,alpha-2b,0,0
198228,with,0,0
198229,those,0,0
198230,of,0,0
198231,diathermocoagulation,0,0
198232,.,0,0
198233,Of,0,0
198234,200,0,0
198235,evaluable,0,0
198236,patients,0,0
198237,",",0,0
198238,51,0,0
198239,were,0,0
198240,treated,0,0
198241,intramuscularly,0,0
198242,(,0,0
198243,IM,0,1
198244,),0,0
198245,with,0,0
198246,3,0,0
198247,x,0,0
198248,10,0,0
198249,(,0,0
198250,6,0,0
198251,),0,0
198252,U,0,0
198253,(,0,0
198254,3,0,0
198255,MU,0,0
198256,),0,0
198257,/m2,0,0
198258,daily,0,0
198259,for,0,0
198260,3,0,0
198261,weeks,0,0
198262,(,0,0
198263,total,0,0
198264,dose,0,0
198265,63,0,0
198266,MU/m2,0,0
198267,),0,0
198268,",",0,0
198269,50,0,0
198270,received,0,0
198271,subcutaneous,0,0
198272,thrice-weekly,0,0
198273,injections,0,0
198274,of,0,0
198275,3,0,0
198276,MU/m2,0,0
198277,for,0,0
198278,4,0,0
198279,weeks,0,0
198280,(,0,0
198281,total,0,0
198282,dose,0,0
198283,36,0,0
198284,MU/m2,0,0
198285,),0,0
198286,",",0,0
198287,51,0,0
198288,underwent,0,0
198289,diathermocoagulation,0,0
198290,",",0,0
198291,and,0,0
198292,48,0,0
198293,were,0,0
198294,not,0,0
198295,treated,0,0
198296,and,0,0
198297,were,0,0
198298,used,0,0
198299,as,0,0
198300,a,0,0
198301,control,0,0
198302,group,0,0
198303,.,0,0
198304,Six,0,0
198305,months,0,0
198306,after,0,0
198307,the,0,0
198308,end,0,0
198309,of,0,0
198310,treatment,0,0
198311,",",0,0
198312,the,0,0
198313,overall,1,1
198314,response,1,1
198315,rate,1,1
198316,(,1,0
198317,complete,1,1
198318,and,1,0
198319,partial,1,1
198320,responses,1,1
198321,),1,0
198322,was,0,0
198323,70,0,0
198324,%,0,0
198325,:,0,0
198326,57,0,0
198327,and,0,0
198328,82,0,0
198329,%,0,0
198330,for,0,0
198331,patients,0,0
198332,receiving,0,0
198333,interferon,0,1
198334,alpha-2b,0,0
198335,(,0,0
198336,IM,0,1
198337,and,0,0
198338,subcutaneously,0,0
198339,),0,0
198340,and,0,0
198341,diathermocoagulation,0,0
198342,",",0,0
198343,respectively,0,0
198344,",",0,0
198345,and,0,0
198346,8,0,0
198347,%,0,0
198348,for,0,0
198349,the,0,0
198350,control,0,0
198351,group,0,0
198352,.,0,0
198353,After,0,0
198354,6,0,0
198355,months,0,0
198356,from,0,0
198357,therapy,0,0
198358,",",0,0
198359,no,0,0
198360,significant,0,0
198361,differences,0,0
198362,in,0,0
198363,complete,1,1
198364,response,1,1
198365,were,0,0
198366,found,0,0
198367,among,0,0
198368,the,0,0
198369,different,0,0
198370,types,0,0
198371,of,0,0
198372,treatment,0,0
198373,:,0,0
198374,20,0,0
198375,",",0,0
198376,20,0,0
198377,",",0,0
198378,and,0,0
198379,35,0,0
198380,%,0,0
198381,for,0,0
198382,the,0,0
198383,two,0,0
198384,interferon,0,0
198385,groups,0,0
198386,and,0,0
198387,the,0,0
198388,diathermocoagulation,0,0
198389,group,0,0
198390,",",0,0
198391,respectively,0,0
198392,.,0,0
198393,Fifteen,0,0
198394,and,0,0
198395,two,0,0
198396,complete,0,0
198397,responders,0,0
198398,in,0,0
198399,the,0,0
198400,cauterization,0,1
198401,and,0,0
198402,interferon,0,1
198403,groups,0,0
198404,",",0,0
198405,respectively,0,0
198406,",",0,0
198407,experienced,0,0
198408,disease,1,1
198409,recurrence,1,1
198410,(,0,0
198411,P,0,0
198412,less,0,0
198413,than,0,0
198414,.01,0,0
198415,),0,0
198416,.,0,0
198417,All,0,0
198418,patients,0,0
198419,given,0,0
198420,interferon,0,0
198421,therapy,0,0
198422,complained,0,0
198423,of,0,0
198424,flu-like,1,1
198425,symptoms,1,1
198426,",",0,0
198427,which,0,0
198428,declined,0,0
198429,progressively,0,0
198430,after,0,0
198431,the,0,0
198432,first,0,0
198433,week,0,0
198434,of,0,0
198435,treatment,0,0
198436,.,0,0
198437,Fatigue,1,1
198438,",",0,0
198439,lasting,0,1
198440,as,0,0
198441,long,0,0
198442,as,0,0
198443,patients,0,0
198444,received,0,0
198445,interferon,0,1
198446,",",0,0
198447,was,0,0
198448,the,0,0
198449,most,0,0
198450,prevalent,0,0
198451,chronic,0,0
198452,side,1,1
198453,effect,1,0
198454,.,1,0
198455,We,0,0
198456,conclude,0,0
198457,that,0,0
198458,systemic,0,0
198459,recombinant,0,0
198460,interferon,0,0
198461,alpha-2b,0,0
198462,is,0,0
198463,active,0,0
198464,in,0,0
198465,treating,0,0
198466,patients,0,0
198467,with,0,0
198468,primary,0,0
198469,condyloma,0,0
198470,lesions,0,1
198471,and,0,0
198472,does,0,0
198473,so,0,0
198474,as,0,0
198475,well,0,0
198476,as,0,0
198477,cauterization,0,0
198478,.,0,0
198479,(,0,0
198480,ABSTRACT,0,1
198481,TRUNCATED,0,0
198482,AT,0,0
198483,250,0,0
198484,WORDS,0,0
198485,),0,0
198486,A,0,0
198487,comparison,0,0
198488,of,0,0
198489,sclerotherapy,0,0
198490,with,0,0
198491,staple,0,0
198492,transection,0,0
198493,of,0,0
198494,the,0,0
198495,esophagus,0,0
198496,for,0,0
198497,the,0,0
198498,emergency,0,0
198499,control,1,0
198500,of,1,0
198501,bleeding,1,1
198502,from,0,0
198503,esophageal,0,0
198504,varices,0,0
198505,.,0,0
198506,We,0,0
198507,compared,0,0
198508,two,0,0
198509,procedures,0,0
198510,for,0,0
198511,the,0,0
198512,emergency,0,0
198513,treatment,0,0
198514,of,0,0
198515,bleeding,1,1
198516,esophageal,0,0
198517,varices,0,1
198518,in,0,0
198519,patients,0,0
198520,who,0,0
198521,did,0,0
198522,not,0,0
198523,respond,0,0
198524,to,0,0
198525,blood,0,1
198526,transfusion,0,1
198527,and,0,0
198528,vasoactive,0,1
198529,drugs,0,0
198530,.,0,0
198531,We,0,0
198532,randomly,0,0
198533,assigned,0,0
198534,101,0,0
198535,patients,0,0
198536,with,0,0
198537,cirrhosis,0,0
198538,of,0,0
198539,the,0,0
198540,liver,0,0
198541,and,0,0
198542,bleeding,0,1
198543,esophageal,0,0
198544,varices,0,1
198545,to,0,0
198546,undergo,0,0
198547,either,0,0
198548,emergency,0,1
198549,sclerotherapy,0,0
198550,(,0,0
198551,n,0,0
198552,=,0,0
198553,50,0,0
198554,),0,0
198555,or,0,0
198556,staple,0,0
198557,transection,0,0
198558,of,0,0
198559,the,0,0
198560,esophagus,0,0
198561,(,0,0
198562,n,0,0
198563,=,0,0
198564,51,0,0
198565,),0,0
198566,.,0,0
198567,Four,0,0
198568,patients,0,0
198569,assigned,0,0
198570,to,0,0
198571,sclerotherapy,0,0
198572,and,0,0
198573,12,0,0
198574,assigned,0,0
198575,to,0,0
198576,staple,0,0
198577,transection,0,0
198578,did,0,0
198579,not,0,0
198580,actually,0,0
198581,undergo,0,0
198582,those,0,0
198583,procedures,0,0
198584,",",0,0
198585,but,0,0
198586,all,0,0
198587,analyses,0,0
198588,were,0,0
198589,made,0,0
198590,on,0,0
198591,an,0,0
198592,intention-to-treat,0,0
198593,basis,0,0
198594,.,0,0
198595,Total,1,0
198596,mortality,1,1
198597,did,0,0
198598,not,0,0
198599,differ,0,0
198600,significantly,0,0
198601,between,0,0
198602,the,0,0
198603,two,0,0
198604,groups,0,0
198605,;,0,0
198606,the,0,0
198607,relative,1,0
198608,risk,1,1
198609,of,1,0
198610,death,1,1
198611,for,0,0
198612,staple,0,0
198613,transection,0,0
198614,as,0,0
198615,compared,0,0
198616,with,0,0
198617,sclerotherapy,0,0
198618,was,0,0
198619,0.88,0,0
198620,(,0,0
198621,95,0,0
198622,percent,0,0
198623,confidence,0,0
198624,interval,0,0
198625,",",0,0
198626,0.51,0,0
198627,to,0,0
198628,1.54,0,0
198629,),0,0
198630,.,0,0
198631,Mortality,1,1
198632,at,0,0
198633,six,0,0
198634,weeks,0,0
198635,was,0,0
198636,44,0,0
198637,percent,0,0
198638,among,0,0
198639,those,0,0
198640,assigned,0,0
198641,to,0,0
198642,sclerotherapy,0,0
198643,and,0,0
198644,35,0,0
198645,percent,0,0
198646,among,0,0
198647,those,0,0
198648,assigned,0,0
198649,to,0,0
198650,staple,0,0
198651,transection,0,0
198652,.,0,0
198653,Complication,1,1
198654,rates,1,1
198655,were,0,0
198656,similar,0,0
198657,for,0,0
198658,the,0,0
198659,two,0,0
198660,groups,0,0
198661,.,0,0
198662,An,0,0
198663,interval,1,0
198664,of,1,0
198665,five,1,0
198666,days,1,0
198667,without,1,0
198668,bleeding,1,1
198669,was,0,0
198670,achieved,0,0
198671,in,0,0
198672,88,0,0
198673,percent,0,0
198674,of,0,0
198675,those,0,0
198676,assigned,0,0
198677,to,0,0
198678,staple,0,0
198679,transection,0,0
198680,and,0,0
198681,in,0,0
198682,62,0,0
198683,percent,0,0
198684,of,0,0
198685,those,0,0
198686,assigned,0,0
198687,to,0,0
198688,sclerotherapy,0,0
198689,after,0,0
198690,a,0,0
198691,single,0,0
198692,injection,0,0
198693,(,0,0
198694,P,0,0
198695,less,0,0
198696,than,0,0
198697,0.01,0,0
198698,),0,0
198699,and,0,0
198700,82,0,0
198701,percent,0,0
198702,after,0,0
198703,three,0,0
198704,injections,0,0
198705,.,0,0
198706,In,0,0
198707,only,0,0
198708,2,0,0
198709,of,0,0
198710,the,0,0
198711,11,0,0
198712,patients,0,0
198713,who,0,0
198714,received,0,0
198715,a,0,0
198716,third,0,0
198717,sclerotherapy,0,0
198718,injection,0,0
198719,was,0,0
198720,bleeding,1,1
198721,controlled,1,0
198722,for,0,0
198723,more,0,0
198724,than,0,0
198725,five,0,0
198726,days,0,0
198727,",",0,0
198728,and,0,0
198729,9,0,0
198730,died,0,0
198731,.,0,0
198732,We,0,0
198733,conclude,0,0
198734,that,0,0
198735,staple,0,0
198736,transection,0,0
198737,of,0,0
198738,the,0,0
198739,esophagus,0,0
198740,is,0,0
198741,as,1,0
198742,safe,1,0
198743,as,1,0
198744,sclerotherapy,1,0
198745,for,0,0
198746,the,0,0
198747,emergency,1,0
198748,treatment,1,0
198749,of,1,0
198750,bleeding,1,1
198751,esophageal,0,0
198752,varices,0,1
198753,and,0,0
198754,that,0,0
198755,it,0,0
198756,is,0,0
198757,more,0,0
198758,effective,0,0
198759,than,0,0
198760,a,0,0
198761,single,0,0
198762,sclerotherapy,0,0
198763,procedure,0,0
198764,.,0,0
198765,We,0,0
198766,currently,0,0
198767,recommend,0,0
198768,surgery,0,0
198769,after,0,0
198770,two,0,0
198771,injection,0,0
198772,treatments,0,0
198773,have,0,0
198774,failed,0,0
198775,.,0,0
198776,Combined,0,0
198777,action,0,1
198778,of,0,1
198779,enalapril,0,0
198780,or,0,0
198781,timolol,0,0
198782,with,0,0
198783,hydrochlorothiazide,0,0
198784,plus,0,0
198785,amiloride,0,0
198786,in,0,0
198787,hypertension,0,0
198788,.,0,0
198789,59,0,0
198790,mild,0,0
198791,to,0,0
198792,moderate,0,0
198793,hypertensives,0,0
198794,were,0,0
198795,treated,0,0
198796,for,0,0
198797,four,0,0
198798,weeks,0,0
198799,with,0,0
198800,50,0,0
198801,mg,0,0
198802,hydrochlorothiazide,0,0
198803,plus,0,0
198804,5,0,0
198805,mg,0,0
198806,of,0,0
198807,amiloride,0,0
198808,",",0,0
198809,then,0,0
198810,concomitantly,0,0
198811,with,0,0
198812,these,0,0
198813,diuretics,0,0
198814,with,0,0
198815,either,0,0
198816,enalapril,0,0
198817,(,0,0
198818,10-20,0,0
198819,mg,0,0
198820,),0,0
198821,or,0,0
198822,timolol,0,0
198823,(,0,0
198824,10-20,0,0
198825,mg,0,0
198826,),0,0
198827,in,0,0
198828,two,0,0
198829,parallel,0,0
198830,treatment,0,0
198831,groups,0,0
198832,for,0,0
198833,an,0,0
198834,additional,0,0
198835,12,0,0
198836,weeks,0,0
198837,in,0,0
198838,an,0,0
198839,open,0,0
198840,study,0,0
198841,.,0,0
198842,Addition,0,0
198843,of,0,0
198844,these,0,0
198845,drugs,0,0
198846,lowered,0,0
198847,the,0,0
198848,blood,1,1
198849,pressure,1,1
198850,by,0,0
198851,25,0,0
198852,+/-,0,0
198853,3/16,0,0
198854,+/-,0,0
198855,2,0,0
198856,mm,0,0
198857,Hg,0,0
198858,and,0,0
198859,15,0,0
198860,+/-,0,0
198861,3/14,0,0
198862,+/-,0,0
198863,1,0,0
198864,mm,0,0
198865,Hg,0,0
198866,",",0,0
198867,respectively,0,0
198868,.,0,0
198869,The,0,0
198870,difference,0,0
198871,of,0,0
198872,the,0,0
198873,reduction,0,0
198874,of,0,0
198875,the,0,0
198876,systolic,1,1
198877,blood,1,1
198878,pressure,1,1
198879,between,0,0
198880,enalapril,0,0
198881,and,0,1
198882,timolol,0,0
198883,group,0,0
198884,at,0,0
198885,the,0,0
198886,end,0,0
198887,of,0,0
198888,the,0,0
198889,combined,0,0
198890,treatment,0,0
198891,was,0,0
198892,statistically,0,0
198893,significant,0,0
198894,(,0,0
198895,p,0,0
198896,less,0,0
198897,than,0,0
198898,0.01,0,0
198899,),0,0
198900,.,0,0
198901,The,0,0
198902,mean,1,1
198903,serum,1,1
198904,potassium,1,1
198905,was,0,0
198906,elevated,0,0
198907,by,0,0
198908,0.3,0,0
198909,mmol/l,0,0
198910,after,0,0
198911,addition,0,0
198912,of,0,0
198913,enalapril,0,0
198914,to,0,0
198915,the,0,0
198916,diuretic,0,0
198917,treatment,0,0
198918,",",0,0
198919,but,0,0
198920,none,0,0
198921,of,0,0
198922,the,0,0
198923,patients,0,0
198924,developed,0,0
198925,hyperkalaemia,1,0
198926,.,1,0
198927,No,0,0
198928,adverse,1,1
198929,effects,1,0
198930,on,0,0
198931,other,0,0
198932,routine,0,0
198933,laboratory,0,0
198934,values,0,1
198935,were,0,0
198936,observed,0,0
198937,.,0,0
198938,Both,0,0
198939,drug,0,0
198940,combinations,0,0
198941,can,0,0
198942,be,0,0
198943,considered,0,0
198944,efficient,0,0
198945,",",0,0
198946,well,0,0
198947,tolerated,1,1
198948,and,1,0
198949,safe,1,0
198950,in,0,0
198951,the,0,0
198952,treatment,0,0
198953,of,0,0
198954,mild,0,0
198955,to,0,0
198956,moderate,0,0
198957,hypertension,0,0
198958,.,0,0
198959,Comparison,0,0
198960,of,0,0
198961,the,0,0
198962,efficacy,1,1
198963,and,1,0
198964,safety,1,1
198965,of,0,1
198966,esmolol,0,0
198967,",",0,0
198968,a,0,0
198969,short-acting,0,0
198970,beta,0,1
198971,blocker,0,0
198972,",",0,0
198973,with,0,0
198974,placebo,0,0
198975,in,0,0
198976,the,0,0
198977,treatment,0,0
198978,of,0,0
198979,supraventricular,0,1
198980,tachyarrhythmias,0,1
198981,.,0,0
198982,The,0,0
198983,Esmolol,0,0
198984,vs,0,0
198985,Placebo,0,0
198986,Multicenter,0,0
198987,Study,0,0
198988,Group,0,0
198989,.,0,0
198990,The,0,0
198991,efficacy,1,1
198992,and,1,0
198993,safety,1,1
198994,of,0,1
198995,esmolol,0,0
198996,",",0,0
198997,a,0,0
198998,short-acting,0,0
198999,intravenous,0,0
199000,beta-adrenergic-blocking,0,0
199001,agent,0,0
199002,",",0,0
199003,and,0,1
199004,placebo,0,0
199005,were,0,0
199006,compared,0,0
199007,in,0,0
199008,patients,0,0
199009,with,0,0
199010,supraventricular,0,1
199011,tachyarrhythmias,0,1
199012,(,0,0
199013,heart,0,1
199014,rate,0,1
199015,greater,0,0
199016,than,0,0
199017,120,0,0
199018,bpm,0,0
199019,),0,0
199020,in,0,0
199021,a,0,0
199022,multicenter,0,0
199023,",",0,0
199024,double-blind,0,0
199025,",",0,0
199026,partial-crossover,0,0
199027,study,0,0
199028,.,0,0
199029,Seventy-one,0,0
199030,patients,0,0
199031,were,0,0
199032,randomized,0,0
199033,to,0,0
199034,receive,0,0
199035,either,0,0
199036,esmolol,0,0
199037,(,0,0
199038,n,0,0
199039,=,0,0
199040,36,0,0
199041,),0,0
199042,or,0,0
199043,placebo,0,0
199044,(,0,0
199045,n,0,0
199046,=,0,0
199047,35,0,0
199048,),0,0
199049,as,0,0
199050,initial,0,0
199051,treatment,0,0
199052,.,0,0
199053,Therapeutic,0,0
199054,failures,0,1
199055,were,0,0
199056,crossed,0,0
199057,over,0,0
199058,to,0,0
199059,the,0,0
199060,other,0,0
199061,study,0,0
199062,medication,0,1
199063,.,0,0
199064,Therapeutic,1,0
199065,response,1,1
199066,was,0,0
199067,defined,0,0
199068,as,0,0
199069,greater,0,0
199070,than,0,0
199071,or,0,0
199072,equal,0,0
199073,to,0,0
199074,20,0,0
199075,%,0,0
199076,reduction,0,0
199077,in,0,0
199078,heart,1,1
199079,rate,1,1
199080,",",1,1
199081,heart,1,1
199082,rate,1,1
199083,less,1,0
199084,than,1,0
199085,100,1,0
199086,bpm,1,0
199087,",",1,0
199088,or,1,0
199089,conversion,1,1
199090,to,1,0
199091,normal,1,0
199092,sinus,1,0
199093,rhythm,1,0
199094,.,1,0
199095,The,1,0
199096,therapeutic,1,0
199097,response,1,0
199098,to,0,0
199099,esmolol,0,0
199100,during,0,0
199101,the,0,0
199102,initial,0,0
199103,treatment,0,0
199104,period,0,0
199105,(,0,0
199106,72,0,0
199107,%,0,0
199108,),0,0
199109,was,0,0
199110,similar,0,0
199111,to,0,0
199112,that,0,0
199113,obtained,0,0
199114,when,0,0
199115,esmolol,0,0
199116,was,0,0
199117,given,0,0
199118,as,0,0
199119,a,0,0
199120,second,0,0
199121,agent,0,0
199122,.,0,0
199123,The,0,0
199124,average,0,0
199125,esmolol,0,0
199126,dosage,0,0
199127,producing,0,0
199128,a,0,0
199129,therapeutic,0,0
199130,response,0,1
199131,was,0,0
199132,97.5,0,0
199133,micrograms/kg/min,0,0
199134,.,0,0
199135,Four,0,0
199136,patients,0,0
199137,(,0,0
199138,6,0,0
199139,%,0,0
199140,),0,0
199141,converted,0,0
199142,to,0,0
199143,normal,1,0
199144,sinus,1,0
199145,rhythm,1,1
199146,during,0,0
199147,esmolol,0,0
199148,infusion,0,0
199149,.,0,0
199150,In,0,0
199151,the,0,0
199152,majority,0,0
199153,of,0,0
199154,patients,0,0
199155,(,0,0
199156,80,0,0
199157,%,0,0
199158,),0,0
199159,",",0,0
199160,therapeutic,1,1
199161,response,1,1
199162,was,0,0
199163,lost,0,0
199164,within,0,0
199165,30,0,0
199166,minutes,0,0
199167,following,0,0
199168,discontinuation,0,0
199169,of,0,0
199170,esmolol,0,0
199171,infusion,0,0
199172,",",0,0
199173,a,0,0
199174,finding,0,0
199175,indicative,0,0
199176,of,0,0
199177,rapid,0,0
199178,reversal,0,0
199179,of,0,0
199180,beta-adrenoceptor,0,0
199181,blockade,0,0
199182,.,0,0
199183,The,0,0
199184,most,0,0
199185,prevalent,0,0
199186,adverse,1,1
199187,effect,1,0
199188,during,0,0
199189,esmolol,0,0
199190,infusion,0,0
199191,was,0,0
199192,hypotension,1,1
199193,which,0,0
199194,occurred,0,0
199195,in,0,0
199196,eight,0,0
199197,patients,0,0
199198,(,0,0
199199,12,0,0
199200,%,0,0
199201,),0,0
199202,.,0,0
199203,Hypotension,1,1
199204,and,1,0
199205,associated,1,0
199206,symptoms,1,1
199207,resolved,0,0
199208,within,0,0
199209,30,0,0
199210,minutes,0,0
199211,after,0,0
199212,discontinuation,0,0
199213,of,0,0
199214,esmolol,0,0
199215,infusion,0,0
199216,",",0,0
199217,which,0,0
199218,is,0,0
199219,consistent,0,0
199220,with,0,0
199221,the,0,0
199222,short,0,0
199223,duration,0,1
199224,of,0,0
199225,action,0,1
199226,of,0,0
199227,esmolol,0,0
199228,(,0,0
199229,elimination,0,1
199230,half-life,0,1
199231,of,0,0
199232,9.2,0,0
199233,minutes,0,0
199234,),0,0
199235,.,0,0
199236,Multicenter,0,0
199237,trial,0,0
199238,of,0,0
199239,cryotherapy,0,0
199240,for,0,0
199241,retinopathy,0,1
199242,of,0,0
199243,prematurity,0,1
199244,:,0,0
199245,preliminary,0,0
199246,results,0,0
199247,.,0,0
199248,Cryotherapy,0,0
199249,for,0,0
199250,Retinopathy,0,0
199251,of,0,0
199252,Prematurity,0,1
199253,Cooperative,0,0
199254,Group,0,0
199255,.,0,0
199256,We,0,0
199257,report,0,0
199258,the,0,0
199259,preliminary,0,0
199260,3-month,0,0
199261,outcome,0,0
199262,of,0,0
199263,a,0,0
199264,multicenter,0,0
199265,randomized,0,0
199266,trial,0,0
199267,of,0,0
199268,cryotherapy,0,0
199269,for,0,0
199270,treatment,0,0
199271,of,0,0
199272,retinopathy,0,1
199273,of,0,0
199274,prematurity,0,1
199275,(,0,0
199276,ROP,0,0
199277,),0,0
199278,.,0,0
199279,Transscleral,0,0
199280,cryotherapy,0,0
199281,to,0,0
199282,the,0,0
199283,avascular,0,0
199284,retina,0,0
199285,was,0,0
199286,applied,0,0
199287,to,0,0
199288,one,0,0
199289,randomly,0,0
199290,selected,0,0
199291,eye,0,0
199292,when,0,0
199293,there,0,0
199294,was,0,0
199295,threshold,0,1
199296,disease,0,1
199297,(,0,0
199298,defined,0,0
199299,as,0,0
199300,five,0,0
199301,or,0,0
199302,more,0,0
199303,contiguous,0,0
199304,or,0,0
199305,eight,0,0
199306,cumulative,0,0
199307,30,0,0
199308,degree,0,0
199309,sectors,0,0
199310,[,0,0
199311,clock,0,0
199312,hours,0,0
199313,],0,0
199314,of,0,0
199315,stage,0,0
199316,3,0,0
199317,ROP,0,0
199318,in,0,0
199319,zone,0,0
199320,1,0,0
199321,or,0,0
199322,2,0,0
199323,in,0,0
199324,the,0,0
199325,presence,0,0
199326,of,0,0
199327,plus,0,0
199328,disease,0,0
199329,),0,0
199330,.,0,0
199331,An,0,0
199332,unfavorable,0,0
199333,outcome,0,1
199334,was,0,0
199335,defined,0,0
199336,as,0,0
199337,posterior,1,0
199338,retinal,1,1
199339,detachment,1,1
199340,",",1,0
199341,retinal,1,1
199342,fold,1,1
199343,involving,1,0
199344,the,1,0
199345,macula,1,1
199346,",",1,0
199347,or,1,1
199348,retrolental,1,1
199349,tissue,1,1
199350,.,1,0
199351,At,0,0
199352,this,0,0
199353,writing,0,0
199354,",",0,0
199355,172,0,0
199356,infants,0,0
199357,had,0,0
199358,been,0,0
199359,examined,0,0
199360,3,0,0
199361,months,0,0
199362,after,0,0
199363,randomization,0,0
199364,.,0,0
199365,An,0,0
199366,unfavorable,1,0
199367,outcome,1,1
199368,was,0,0
199369,significantly,0,0
199370,less,0,0
199371,frequent,0,0
199372,in,0,0
199373,the,0,0
199374,eyes,0,0
199375,undergoing,0,0
199376,cryotherapy,0,0
199377,(,0,0
199378,21.8,0,0
199379,%,0,0
199380,),0,0
199381,compared,0,0
199382,with,0,0
199383,the,0,0
199384,untreated,0,0
199385,eyes,0,0
199386,(,0,0
199387,43,0,0
199388,%,0,0
199389,),0,0
199390,.,0,0
199391,While,0,0
199392,the,0,0
199393,surgery,0,0
199394,was,0,0
199395,stressful,0,0
199396,",",0,0
199397,no,0,0
199398,unexpected,1,0
199399,complications,1,1
199400,occurred,0,0
199401,during,0,0
199402,or,0,0
199403,following,0,0
199404,treatment,0,0
199405,.,0,0
199406,These,0,0
199407,data,0,0
199408,support,0,0
199409,the,0,0
199410,efficacy,1,1
199411,of,0,0
199412,cryotherapy,0,0
199413,in,0,0
199414,reducing,0,0
199415,by,0,0
199416,approximately,0,0
199417,one,0,0
199418,half,0,0
199419,the,0,0
199420,risk,0,0
199421,of,0,0
199422,unfavorable,0,0
199423,retinal,0,0
199424,outcome,0,0
199425,from,0,0
199426,threshold,0,1
199427,ROP,0,0
199428,.,0,0
199429,[,0,0
199430,Therapeutic,0,0
199431,value,0,0
199432,of,0,0
199433,a,0,0
199434,combination,0,0
199435,of,0,0
199436,trimetazidine,0,0
199437,with,0,0
199438,a,0,0
199439,calcium,0,0
199440,inhibitor,0,0
199441,in,0,0
199442,the,0,0
199443,treatment,0,0
199444,of,0,0
199445,chronic,0,0
199446,coronary,0,0
199447,insufficiency,0,1
199448,],0,0
199449,.,0,0
199450,This,0,0
199451,double-blind,0,0
199452,",",0,0
199453,placebo-controlled,0,0
199454,study,0,0
199455,sought,0,0
199456,to,0,0
199457,examine,0,0
199458,the,0,0
199459,short-term,0,0
199460,benefit,0,0
199461,of,0,0
199462,adding,0,0
199463,60,0,0
199464,mg,0,0
199465,of,0,0
199466,trimetazidine,0,0
199467,to,0,0
199468,the,0,0
199469,daily,0,0
199470,therapeutic,0,0
199471,regimen,0,0
199472,of,0,0
199473,29,0,0
199474,male,0,0
199475,patients,0,0
199476,with,0,0
199477,coronary,0,0
199478,insufficiency,0,1
199479,who,0,0
199480,had,0,0
199481,persistent,0,0
199482,ST,0,1
199483,depression,0,1
199484,on,0,0
199485,exercise,0,0
199486,tolerance,0,1
199487,test,0,1
199488,(,0,0
199489,greater,0,0
199490,than,0,0
199491,or,0,0
199492,equal,0,0
199493,to,0,0
199494,1,0,0
199495,mm,0,0
199496,),0,0
199497,",",0,0
199498,despite,0,0
199499,treatment,0,0
199500,with,0,0
199501,nifedipine,0,0
199502,40,0,0
199503,mg,0,0
199504,per,0,0
199505,day,0,0
199506,.,0,0
199507,As,1,0
199508,compared,1,0
199509,with,1,0
199510,the,1,0
199511,placebo,1,0
199512,group,1,0
199513,",",1,0
199514,after,1,0
199515,only,1,0
199516,14,1,0
199517,days,1,0
199518,",",1,0
199519,the,1,0
199520,patients,1,0
199521,treated,1,0
199522,with,1,0
199523,trimetazidine,1,0
199524,showed,1,0
199525,statistically,1,0
199526,significant,1,0
199527,increases,1,0
199528,in,1,0
199529,the,1,0
199530,maximum,1,1
199531,workload,1,1
199532,level,1,1
199533,attained,1,0
199534,before,1,0
199535,ST,1,1
199536,depression,1,1
199537,occurred,1,0
199538,(,1,0
199539,31,1,0
199540,%,1,0
199541,versus,1,0
199542,-,1,0
199543,6,1,0
199544,%,1,0
199545,;,1,0
199546,P,1,0
199547,=,1,0
199548,0.009,1,0
199549,),1,0
199550,",",1,0
199551,the,1,0
199552,total,1,1
199553,work,1,0
199554,performed,1,0
199555,(,1,0
199556,31,1,0
199557,%,1,0
199558,versus,1,0
199559,2,1,0
199560,%,1,0
199561,;,1,0
199562,P,1,0
199563,=,1,0
199564,0.024,1,0
199565,),1,0
199566,and,1,0
199567,a,1,0
199568,significant,1,0
199569,decrease,1,0
199570,in,1,0
199571,the,1,0
199572,systolic,1,1
199573,tension,1,1
199574,time,1,1
199575,(,1,0
199576,double,1,0
199577,product,1,1
199578,),1,0
199579,/workload,1,1
199580,ratio,1,1
199581,(,1,0
199582,-5,1,0
199583,%,1,0
199584,versus,1,0
199585,+11,1,0
199586,%,1,0
199587,;,1,0
199588,P,1,0
199589,=,1,0
199590,0.005,1,0
199591,),1,0
199592,.,1,0
199593,Throughout,0,0
199594,the,0,0
199595,study,0,0
199596,the,0,0
199597,clinical,0,0
199598,acceptability,0,1
199599,was,0,0
199600,excellent,0,0
199601,",",0,0
199602,with,0,0
199603,no,0,0
199604,side,0,1
199605,effects,0,0
199606,attributable,0,0
199607,to,0,0
199608,trimetazidine,0,0
199609,being,0,0
199610,recorded,0,0
199611,.,0,0
199612,This,0,0
199613,study,0,0
199614,shows,0,0
199615,that,0,0
199616,the,0,0
199617,addition,0,0
199618,of,0,0
199619,trimetazidine,0,0
199620,to,0,0
199621,a,0,0
199622,calcium,0,0
199623,antagonist,0,0
199624,brings,0,0
199625,a,0,0
199626,valuable,0,0
199627,improvement,0,1
199628,in,0,0
199629,therapeutic,0,0
199630,results,0,0
199631,.,0,0
199632,Flow-cytometric,0,0
199633,studies,0,0
199634,with,0,0
199635,eleutherococcus,0,0
199636,senticosus,0,0
199637,extract,0,0
199638,as,0,0
199639,an,0,0
199640,immunomodulatory,0,0
199641,agent,0,0
199642,.,0,0
199643,A,0,0
199644,placebo-controlled,0,0
199645,study,0,0
199646,of,0,0
199647,the,0,0
199648,effect,0,0
199649,of,0,0
199650,an,0,0
199651,Eleutherococcus,0,0
199652,senticosus,0,0
199653,extract,0,0
199654,(,0,0
199655,Eleukokk,0,0
199656,),0,0
199657,on,0,0
199658,the,0,0
199659,immune,0,1
199660,system,0,0
199661,was,0,0
199662,performed,0,0
199663,with,0,0
199664,36,0,0
199665,healthy,0,0
199666,volunteers,0,0
199667,utilising,0,0
199668,quantitative,0,0
199669,multi-parameter,0,0
199670,flow,0,1
199671,cytometry,0,0
199672,with,0,0
199673,monoclonal,0,0
199674,antibodies,0,0
199675,directed,0,0
199676,against,0,0
199677,specific,0,0
199678,surface,0,0
199679,markers,0,1
199680,of,0,0
199681,human,0,0
199682,lymphocyte,0,1
199683,subsets,0,0
199684,.,0,0
199685,Volunteers,0,0
199686,in,0,0
199687,the,0,0
199688,verum,0,0
199689,group,0,0
199690,received,0,0
199691,10,0,0
199692,ml,0,0
199693,of,0,0
199694,an,0,0
199695,ethanolic,0,0
199696,(,0,0
199697,vincamine,0,0
199698,free,0,1
199699,),0,0
199700,eleutherococcus,0,0
199701,senticosus,0,0
199702,preparation,0,0
199703,",",0,0
199704,3,0,0
199705,times,0,0
199706,daily,0,0
199707,for,0,0
199708,4,0,0
199709,weeks,0,0
199710,.,0,0
199711,In,0,0
199712,the,0,0
199713,placebo,0,0
199714,",",0,0
199715,the,0,0
199716,eleutherococcus,0,0
199717,extract,0,0
199718,was,0,0
199719,substituted,0,0
199720,by,0,0
199721,additional,0,0
199722,wine,0,0
199723,",",0,0
199724,resulting,0,0
199725,in,0,0
199726,identical,0,0
199727,final,0,1
199728,concentrations,0,1
199729,of,0,0
199730,ethanol,0,0
199731,in,0,0
199732,both,0,0
199733,preparations,0,0
199734,.,0,0
199735,The,0,0
199736,purpose,0,0
199737,of,0,0
199738,the,0,0
199739,double-blind,0,0
199740,study,0,0
199741,was,0,0
199742,the,0,0
199743,demonstration,0,0
199744,of,0,0
199745,possible,0,0
199746,effects,0,0
199747,on,0,0
199748,the,0,0
199749,cellular,1,1
199750,immune,1,1
199751,status,1,1
199752,",",0,0
199753,as,0,0
199754,determined,0,0
199755,by,0,0
199756,quantitative,1,0
199757,flow,1,1
199758,cytometry,1,0
199759,.,1,0
199760,The,0,0
199761,most,0,0
199762,salient,0,1
199763,feature,0,0
199764,in,0,0
199765,the,0,0
199766,verum,0,0
199767,group,0,0
199768,was,0,0
199769,a,0,0
199770,drastic,0,0
199771,increase,0,0
199772,in,0,0
199773,the,0,0
199774,absolute,1,1
199775,number,1,1
199776,of,1,0
199777,immunocompetent,1,0
199778,cells,1,1
199779,",",0,0
199780,with,0,0
199781,an,0,0
199782,especially,0,0
199783,pronounced,0,0
199784,effect,0,0
199785,on,0,0
199786,T,1,0
199787,lymphocytes,1,1
199788,",",0,0
199789,predominantly,0,0
199790,of,0,0
199791,the,0,0
199792,helper/inducer,1,1
199793,type,1,0
199794,",",0,0
199795,but,0,0
199796,also,0,0
199797,on,0,0
199798,cytotoxic,1,1
199799,and,1,0
199800,natural,1,1
199801,killer,1,1
199802,cells,1,1
199803,.,1,0
199804,In,0,0
199805,addition,0,0
199806,",",0,0
199807,a,0,0
199808,general,0,0
199809,enhancement,0,0
199810,of,0,0
199811,the,0,0
199812,activation,1,1
199813,state,1,0
199814,of,1,0
199815,T,1,0
199816,lymphocytes,1,1
199817,was,0,0
199818,observed,0,0
199819,.,0,0
199820,No,0,0
199821,side,1,1
199822,effects,1,1
199823,were,0,0
199824,observed,0,0
199825,during,0,0
199826,the,0,0
199827,trial,0,0
199828,or,0,0
199829,afterwards,0,0
199830,(,0,1
199831,observation,0,0
199832,period,0,0
199833,6,0,0
199834,months,0,0
199835,),0,0
199836,.,0,0
199837,Plasma,0,1
199838,"3,4-dihydroxyphenylethyleneglycol",0,0
199839,and,0,0
199840,3-methoxy-4-hydroxyphenylethyleneglycol,0,0
199841,as,0,0
199842,indicators,0,1
199843,of,0,0
199844,central,0,0
199845,noradrenergic,0,0
199846,activity,0,1
199847,.,0,0
199848,A,0,0
199849,comparative,0,0
199850,study,0,0
199851,on,0,0
199852,control,0,0
199853,subjects,0,0
199854,and,0,1
199855,depressed,0,1
199856,patients,0,0
199857,.,0,0
199858,Animal,0,0
199859,studies,0,0
199860,have,0,0
199861,suggested,0,0
199862,interspecies,0,0
199863,differences,0,0
199864,in,0,0
199865,brain,0,1
199866,norepinephrine,0,1
199867,(,0,0
199868,NE,0,1
199869,),0,1
199870,metabolism,0,1
199871,",",0,0
199872,especially,0,0
199873,with,0,0
199874,regard,0,0
199875,to,0,0
199876,the,0,0
199877,relative,0,0
199878,proportions,0,1
199879,of,0,0
199880,"3,4-dihydroxyphenylethyleneglycol",0,0
199881,(,0,0
199882,DOPEG,0,0
199883,),0,0
199884,compared,0,0
199885,to,0,0
199886,3-methoxy-4-hydroxyphenylethyleneglycol,0,0
199887,(,0,0
199888,MOPEG,0,0
199889,),0,0
199890,.,0,0
199891,In,0,0
199892,order,0,0
199893,to,0,0
199894,question,0,0
199895,the,0,0
199896,value,0,0
199897,of,0,0
199898,both,0,0
199899,glycol,0,0
199900,metabolites,0,0
199901,as,0,0
199902,peripheral,0,1
199903,indices,0,1
199904,of,0,0
199905,central,1,0
199906,noradrenergic,1,1
199907,activity,1,1
199908,",",0,0
199909,a,0,0
199910,comparative,0,0
199911,study,0,0
199912,of,0,0
199913,plasma,0,1
199914,DOPEG,0,0
199915,and,0,1
199916,MOPEG,0,1
199917,(,0,0
199918,measured,0,0
199919,by,0,0
199920,HPLC,0,1
199921,),0,0
199922,related,0,0
199923,to,0,0
199924,depression,0,1
199925,",",0,0
199926,sex,0,0
199927,",",0,1
199928,age,0,0
199929,and,0,1
199930,diagnostic,0,1
199931,categories,0,1
199932,(,0,0
199933,DSM-III,0,0
199934,),0,0
199935,was,0,0
199936,carried,0,0
199937,out,0,0
199938,on,0,0
199939,depressed,0,1
199940,and,0,0
199941,control,0,0
199942,subjects,0,0
199943,.,0,0
199944,In,0,0
199945,addition,0,0
199946,",",0,0
199947,two,0,0
199948,groups,0,0
199949,of,0,0
199950,8,0,0
199951,patients,0,0
199952,were,0,0
199953,randomly,0,0
199954,submitted,0,0
199955,to,0,0
199956,a,0,0
199957,desipramine,0,0
199958,150,0,0
199959,mg/day,0,0
199960,",",0,0
199961,or,0,0
199962,a,0,0
199963,metapramine,0,0
199964,450,0,0
199965,mg/day,0,0
199966,antidepressant,0,0
199967,treatment,0,0
199968,influencing,0,0
199969,the,0,0
199970,formation,0,1
199971,of,0,0
199972,DOPEG,0,0
199973,and,0,0
199974,MOPEG,0,1
199975,in,0,0
199976,a,0,0
199977,different,0,0
199978,way,0,0
199979,.,0,0
199980,The,0,0
199981,study,0,0
199982,did,0,0
199983,not,0,0
199984,demonstrate,0,0
199985,any,0,0
199986,difference,0,0
199987,between,0,0
199988,DOPEG,0,0
199989,and,0,0
199990,MOPEG,0,1
199991,for,0,0
199992,most,0,0
199993,of,0,0
199994,the,0,0
199995,experimental,0,0
199996,factors,0,0
199997,.,0,0
199998,We,0,0
199999,found,0,0
200000,also,0,0
200001,a,0,0
200002,significant,0,0
200003,positive,1,0
200004,correlation,1,0
200005,between,1,0
200006,plasma,1,1
200007,levels,1,1
200008,of,1,0
200009,DOPEG,1,0
200010,and,1,0
200011,MOPEG,1,1
200012,.,1,0
200013,Our,0,0
200014,results,0,0
200015,support,0,0
200016,the,0,0
200017,idea,0,0
200018,that,0,0
200019,each,0,0
200020,of,0,0
200021,these,0,0
200022,two,0,0
200023,biological,0,0
200024,indices,0,0
200025,can,0,0
200026,be,0,0
200027,used,0,0
200028,in,0,0
200029,the,0,0
200030,assessment,0,0
200031,of,0,0
200032,central,1,0
200033,noradrenergic,1,0
200034,activity,1,1
200035,.,1,0
200036,Effects,0,0
200037,of,0,0
200038,mecamylamine,0,0
200039,on,0,0
200040,human,0,0
200041,cigarette,0,0
200042,smoking,0,1
200043,and,0,1
200044,subjective,0,1
200045,ratings,0,1
200046,.,0,0
200047,Multiple,0,0
200048,measures,0,1
200049,of,0,0
200050,cigarette,0,0
200051,smoking,0,1
200052,",",0,0
200053,subjective,0,1
200054,effect,0,1
200055,and,0,0
200056,physiological,0,1
200057,effect,0,1
200058,were,0,0
200059,collected,0,0
200060,during,0,0
200061,90-min,0,0
200062,test,0,0
200063,sessions,0,0
200064,in,0,0
200065,normal,0,0
200066,volunteers,0,0
200067,.,0,0
200068,Before,0,0
200069,sessions,0,0
200070,subjects,0,0
200071,received,0,0
200072,oral,0,0
200073,doses,0,0
200074,of,0,0
200075,mecamylamine,0,0
200076,(,0,0
200077,2.5,0,0
200078,",",0,0
200079,5.0,0,0
200080,",",0,0
200081,10,0,0
200082,",",0,0
200083,20,0,0
200084,mg,0,0
200085,),0,0
200086,or,0,0
200087,placebo,0,0
200088,.,0,0
200089,Each,0,0
200090,dose,0,0
200091,and,0,1
200092,placebo,0,0
200093,was,0,0
200094,given,0,0
200095,three,0,0
200096,times,0,0
200097,in,0,0
200098,a,0,0
200099,randomized,0,0
200100,block,0,0
200101,sequence,0,0
200102,.,0,0
200103,Mecamylamine,0,0
200104,increased,0,0
200105,several,0,0
200106,measures,0,1
200107,of,0,0
200108,cigarette,0,0
200109,smoking,0,1
200110,",",0,0
200111,including,0,0
200112,number,1,1
200113,of,1,0
200114,cigarettes,1,1
200115,",",1,0
200116,number,1,1
200117,of,1,0
200118,puffs,1,0
200119,per,1,0
200120,cigarette,1,0
200121,",",1,0
200122,and,1,1
200123,expired,1,1
200124,air,1,1
200125,carbon,1,1
200126,monoxide,1,0
200127,level,1,1
200128,.,1,0
200129,Mecamylamine,0,0
200130,also,0,0
200131,produced,0,0
200132,modest,0,0
200133,",",0,0
200134,dose-related,0,1
200135,decreases,0,1
200136,in,0,0
200137,standing,0,0
200138,blood,1,1
200139,pressure,1,1
200140,and,0,1
200141,increases,0,1
200142,in,0,0
200143,standing,1,0
200144,heart,1,0
200145,rate,1,1
200146,.,1,0
200147,The,0,0
200148,subjective,0,1
200149,effects,0,0
200150,produced,0,0
200151,by,0,0
200152,mecamylamine,0,0
200153,were,0,0
200154,not,0,0
200155,characteristic,0,0
200156,of,0,0
200157,those,0,0
200158,of,0,0
200159,psychoactive,0,0
200160,drugs,0,0
200161,.,0,0
200162,Mecamylamine,0,0
200163,appears,0,0
200164,to,0,0
200165,have,0,0
200166,increased,0,0
200167,cigarette,0,0
200168,smoking,0,0
200169,by,0,0
200170,decreasing,0,0
200171,the,0,0
200172,effective,0,0
200173,dose,0,0
200174,level,0,1
200175,of,0,0
200176,nicotine,0,0
200177,available,0,0
200178,from,0,0
200179,cigarette,0,0
200180,smoking,0,0
200181,.,0,0
200182,Antibiotic,0,0
200183,prophylaxis,0,0
200184,in,0,0
200185,high-risk,0,0
200186,head,0,0
200187,and,0,1
200188,neck,0,1
200189,surgery,0,0
200190,:,0,0
200191,one-day,0,0
200192,vs.,0,0
200193,five-day,0,0
200194,therapy,0,0
200195,.,0,0
200196,Patients,0,0
200197,who,0,0
200198,undergo,0,0
200199,major,0,0
200200,contaminated,0,0
200201,surgery,0,0
200202,of,0,0
200203,the,0,0
200204,head,0,0
200205,and,0,1
200206,neck,0,1
200207,benefit,0,1
200208,from,0,0
200209,perioperative,0,0
200210,antibiotic,0,0
200211,prophylaxis,0,0
200212,.,0,0
200213,This,0,0
200214,study,0,0
200215,was,0,0
200216,developed,0,0
200217,to,0,0
200218,determine,0,0
200219,if,0,0
200220,5,0,0
200221,days,0,0
200222,of,0,0
200223,antibiotic,1,0
200224,administration,1,0
200225,would,0,0
200226,be,0,0
200227,more,0,0
200228,effective,0,0
200229,than,0,0
200230,1,0,0
200231,day,0,0
200232,.,0,0
200233,A,0,0
200234,multi-institutional,0,0
200235,prospective,0,0
200236,randomized,0,0
200237,double-blind,0,0
200238,study,0,0
200239,was,0,0
200240,designed,0,0
200241,.,0,0
200242,Patients,0,0
200243,who,0,0
200244,were,0,0
200245,identified,0,0
200246,as,0,0
200247,requiring,0,0
200248,pedicled,0,0
200249,flap,0,1
200250,reconstruction,0,0
200251,were,0,0
200252,potential,0,0
200253,candidates,0,0
200254,for,0,0
200255,the,0,0
200256,study,0,0
200257,.,0,0
200258,Later,0,1
200259,",",0,0
200260,patients,0,0
200261,were,0,0
200262,randomly,0,0
200263,assigned,0,0
200264,to,0,0
200265,receive,0,0
200266,cefoperazone,0,0
200267,sodium,0,0
200268,for,0,0
200269,either,0,0
200270,24,0,0
200271,hours,0,0
200272,or,0,0
200273,120,0,0
200274,hours,0,0
200275,.,0,0
200276,In,0,0
200277,each,0,0
200278,case,0,0
200279,",",0,0
200280,the,0,0
200281,drug,0,0
200282,was,0,0
200283,administered,0,0
200284,intravenously,0,0
200285,",",0,0
200286,beginning,0,0
200287,1,0,0
200288,to,0,0
200289,2,0,0
200290,hours,0,0
200291,preoperatively,0,0
200292,and,0,0
200293,continued,0,0
200294,for,0,0
200295,the,0,0
200296,prescribed,0,0
200297,period,0,0
200298,.,0,0
200299,One,0,0
200300,hundred,0,0
200301,nine,0,0
200302,patients,0,0
200303,were,0,0
200304,evaluable,0,0
200305,.,0,0
200306,Fifty-three,0,0
200307,patients,0,0
200308,were,0,0
200309,assigned,0,0
200310,to,0,0
200311,1,0,0
200312,day,0,0
200313,of,0,0
200314,perioperative,0,0
200315,prophylaxis,0,0
200316,.,0,0
200317,Wound,1,0
200318,infection,1,1
200319,developed,0,0
200320,in,0,0
200321,ten,0,0
200322,patients,0,0
200323,(,0,0
200324,18.9,0,0
200325,%,0,0
200326,),0,0
200327,.,0,0
200328,Fifty-six,0,0
200329,patients,0,0
200330,were,0,0
200331,assigned,0,0
200332,to,0,0
200333,5,0,0
200334,days,0,0
200335,of,0,0
200336,perioperative,0,0
200337,antibiotic,0,0
200338,prophylaxis,0,0
200339,.,0,0
200340,Wound,1,0
200341,infection,1,1
200342,developed,0,0
200343,in,0,0
200344,14,0,0
200345,(,0,0
200346,25,0,0
200347,%,0,0
200348,),0,0
200349,of,0,0
200350,these,0,0
200351,patients,0,0
200352,(,0,0
200353,P,0,0
200354,greater,0,0
200355,than,0,0
200356,.05,0,0
200357,),0,0
200358,.,0,0
200359,These,0,0
200360,data,0,0
200361,suggest,0,0
200362,that,0,0
200363,no,0,0
200364,beneficial,0,0
200365,effect,0,0
200366,from,0,0
200367,administration,0,0
200368,of,0,0
200369,antibiotics,0,0
200370,for,0,0
200371,longer,0,0
200372,than,0,0
200373,24,0,0
200374,hours,0,0
200375,postoperatively,0,0
200376,can,0,0
200377,be,0,0
200378,achieved,0,0
200379,in,0,0
200380,patients,0,0
200381,who,0,0
200382,undergo,0,0
200383,myocutaneous,0,0
200384,flap,0,0
200385,reconstruction,0,0
200386,.,0,0
200387,Effect,0,0
200388,of,0,0
200389,fenfluramine,0,0
200390,on,0,0
200391,autistic,0,0
200392,symptoms,0,1
200393,.,0,0
200394,Serum,1,1
200395,C-peptide,1,0
200396,after,0,0
200397,6,0,0
200398,months,0,0
200399,on,0,0
200400,glibenclamide,0,0
200401,remains,0,0
200402,higher,0,0
200403,than,0,0
200404,during,0,0
200405,insulin,0,1
200406,treatment,0,0
200407,.,0,0
200408,Serum,1,1
200409,C-peptide,1,1
200410,was,0,0
200411,measured,0,0
200412,fasting,0,1
200413,and,0,0
200414,6,0,0
200415,minutes,0,0
200416,after,0,0
200417,glucagon,0,1
200418,(,0,0
200419,1,0,0
200420,mg,0,0
200421,given,0,0
200422,intravenously,0,0
200423,),0,0
200424,in,0,0
200425,49,0,0
200426,patients,0,0
200427,with,0,0
200428,non-insulin-dependent,0,0
200429,diabetes,0,0
200430,mellitus,0,0
200431,",",0,0
200432,after,0,0
200433,4,0,0
200434,and,0,0
200435,6,0,0
200436,months,0,0
200437,of,0,0
200438,successive,0,0
200439,periods,0,0
200440,of,0,0
200441,treatment,0,0
200442,with,0,0
200443,insulin,0,1
200444,and,0,0
200445,oral,0,0
200446,hypoglycaemics,0,1
200447,(,0,0
200448,glibenclamide,0,0
200449,and,0,1
200450,metformin,0,0
200451,),0,1
200452,",",0,0
200453,given,0,0
200454,in,0,0
200455,random,0,0
200456,order,0,0
200457,.,0,0
200458,Glycaemic,1,1
200459,control,1,0
200460,was,0,0
200461,not,0,0
200462,significantly,0,0
200463,different,0,0
200464,on,0,0
200465,the,0,0
200466,two,0,0
200467,treatments,0,0
200468,",",0,0
200469,but,0,0
200470,C-peptide,1,1
200471,was,0,0
200472,much,0,0
200473,higher,0,0
200474,while,0,0
200475,the,0,0
200476,patients,0,0
200477,were,0,0
200478,on,0,0
200479,glibenclamide,0,0
200480,.,0,0
200481,We,0,0
200482,conclude,0,0
200483,that,0,0
200484,glibenclamide,0,0
200485,stimulates,0,0
200486,pancreatic,0,1
200487,insulin,0,1
200488,production,0,1
200489,even,0,0
200490,after,0,0
200491,6,0,0
200492,months,0,0
200493,treatment,0,0
200494,.,0,0
200495,Prospective,0,0
200496,controlled,0,0
200497,study,0,0
200498,of,0,1
200499,androgen,0,1
200500,therapy,0,0
200501,in,0,0
200502,the,0,0
200503,anemia,1,0
200504,of,0,0
200505,chronic,0,0
200506,renal,0,0
200507,disease,0,0
200508,:,0,0
200509,effects,0,1
200510,on,0,0
200511,iron,0,0
200512,kinetics,0,1
200513,.,0,0
200514,Ferrokinetic,1,0
200515,and,1,0
200516,RBC,1,1
200517,mass,1,1
200518,determinations,1,0
200519,were,0,0
200520,made,0,0
200521,at,0,0
200522,3-month,0,0
200523,intervals,0,0
200524,in,0,0
200525,iron-replete,0,0
200526,hemodialysis,0,0
200527,patients,0,0
200528,randomized,0,0
200529,to,0,0
200530,a,0,0
200531,control,0,0
200532,group,0,0
200533,or,0,0
200534,to,0,0
200535,nandrolone,0,0
200536,decanoate,0,0
200537,therapy,0,0
200538,.,0,0
200539,After,0,0
200540,3,0,0
200541,months,0,0
200542,",",0,0
200543,RBC,1,1
200544,mass,1,1
200545,increased,0,0
200546,in,0,0
200547,two,0,0
200548,of,0,0
200549,4,0,0
200550,androgen-treated,0,0
200551,patients,0,0
200552,.,0,0
200553,Erythron,1,1
200554,iron,1,0
200555,turnover,1,1
200556,",",0,0
200557,an,0,0
200558,index,0,1
200559,of,0,0
200560,RBC,0,1
200561,production,0,1
200562,",",0,0
200563,increased,0,0
200564,in,0,0
200565,the,0,0
200566,one,0,0
200567,responder,0,0
200568,studied,0,0
200569,but,0,0
200570,not,0,0
200571,in,0,0
200572,the,0,0
200573,two,0,0
200574,nonresponders,0,0
200575,.,0,0
200576,Similarly,0,0
200577,",",0,0
200578,in,0,0
200579,a,0,0
200580,fifth,0,0
200581,subject,0,0
200582,",",0,0
200583,who,0,0
200584,was,0,0
200585,not,0,0
200586,restudied,0,0
200587,until,0,0
200588,6,0,0
200589,months,0,0
200590,of,0,0
200591,androgen,0,1
200592,therapy,0,0
200593,were,0,0
200594,completed,0,0
200595,",",0,0
200596,an,0,0
200597,increase,0,0
200598,in,0,0
200599,RBC,1,1
200600,mass,1,1
200601,was,0,0
200602,associated,0,0
200603,with,0,0
200604,an,0,0
200605,increase,0,0
200606,in,0,0
200607,erythron,0,1
200608,iron,0,0
200609,turnover,0,1
200610,.,0,0
200611,However,0,0
200612,",",0,0
200613,between,0,0
200614,3,0,0
200615,and,0,0
200616,6,0,0
200617,months,0,0
200618,",",0,0
200619,RBC,1,1
200620,mass,1,1
200621,increased,0,0
200622,in,0,0
200623,all,0,0
200624,4,0,0
200625,androgen-treated,0,0
200626,patients,0,0
200627,studied,0,0
200628,even,0,0
200629,though,0,0
200630,erythron,0,1
200631,iron,0,0
200632,turnovers,0,1
200633,remained,0,0
200634,unchanged,0,0
200635,and,0,0
200636,dialysis-associated,1,1
200637,blood,1,1
200638,losses,1,1
200639,did,0,0
200640,not,0,0
200641,decrease,0,0
200642,.,0,0
200643,Thus,0,0
200644,",",0,0
200645,at,0,0
200646,least,0,0
200647,two,0,0
200648,androgen-treated,0,0
200649,patients,0,0
200650,had,0,0
200651,increases,0,1
200652,in,0,0
200653,RBC,1,1
200654,mass,1,1
200655,without,0,0
200656,ever,0,0
200657,increasing,0,0
200658,their,0,0
200659,erythron,1,1
200660,iron,1,0
200661,turnover,1,1
200662,.,1,0
200663,Two,0,0
200664,of,0,0
200665,three,0,0
200666,control,0,0
200667,subjects,0,0
200668,also,0,0
200669,had,0,0
200670,increased,0,0
200671,erythron,1,1
200672,iron,1,0
200673,turnovers,1,1
200674,",",0,0
200675,which,0,0
200676,in,0,0
200677,one,0,0
200678,case,0,0
200679,was,0,0
200680,related,0,0
200681,to,0,0
200682,increased,0,0
200683,dialysis-associated,1,0
200684,blood,1,1
200685,losses,1,1
200686,.,1,0
200687,Changes,0,1
200688,in,0,0
200689,RBC,1,1
200690,mass,1,1
200691,were,0,0
200692,not,0,0
200693,consistently,0,0
200694,paralleled,0,0
200695,by,0,0
200696,changes,0,0
200697,in,0,0
200698,Hb,0,0
200699,.,0,0
200700,These,0,0
200701,findings,0,0
200702,suggest,0,0
200703,that,0,0
200704,increases,0,1
200705,in,0,0
200706,RBC,1,1
200707,mass,1,1
200708,during,0,0
200709,nandrolone,0,0
200710,decanoate,0,0
200711,therapy,0,0
200712,result,0,0
200713,from,0,0
200714,two,0,0
200715,mechanisms,0,0
200716,:,0,0
200717,increased,0,0
200718,erythropoiesis,0,1
200719,(,0,0
200720,shown,0,0
200721,by,0,0
200722,simultaneous,0,0
200723,increases,0,1
200724,in,0,0
200725,RBC,1,1
200726,mass,1,1
200727,and,0,1
200728,erythron,1,1
200729,iron,1,0
200730,turnover,1,1
200731,),1,0
200732,and,0,0
200733,increased,0,1
200734,RBC,1,1
200735,survival,1,1
200736,(,0,0
200737,indirectly,0,0
200738,shown,0,0
200739,by,0,0
200740,increases,0,0
200741,in,0,0
200742,RBC,1,1
200743,mass,1,1
200744,without,0,0
200745,increases,0,1
200746,in,0,0
200747,erythron,1,1
200748,iron,1,0
200749,turnover,1,1
200750,),1,0
200751,.,0,0
200752,The,0,0
200753,importance,0,0
200754,of,0,0
200755,control,0,0
200756,groups,0,0
200757,",",0,0
200758,RBC,1,1
200759,mass,1,1
200760,determinations,0,0
200761,and,0,0
200762,the,0,0
200763,monitoring,0,0
200764,of,0,0
200765,dialysis-associated,1,0
200766,blood,1,1
200767,losses,1,1
200768,in,0,0
200769,studying,0,0
200770,the,0,0
200771,effects,0,0
200772,of,0,0
200773,androgens,0,1
200774,on,0,0
200775,erythropoiesis,0,1
200776,in,0,0
200777,chronic,0,0
200778,hemodialysis,0,0
200779,patients,0,0
200780,is,0,0
200781,also,0,0
200782,demonstrated,0,0
200783,.,0,0
200784,[,0,0
200785,Supplementary,0,0
200786,treatment,0,0
200787,with,0,0
200788,Esberitox,0,0
200789,of,0,0
200790,female,0,0
200791,patients,0,0
200792,undergoing,0,0
200793,curative,0,0
200794,adjuvant,0,0
200795,irradiation,0,0
200796,following,0,0
200797,breast,0,0
200798,cancer,0,0
200799,],0,0
200800,.,0,0
200801,1,0,0
200802,.,0,0
200803,The,0,0
200804,study,0,0
200805,was,0,0
200806,supposed,0,0
200807,to,0,0
200808,investigate,0,0
200809,a,0,0
200810,possible,0,0
200811,prevention,1,0
200812,or,1,0
200813,reduction,1,1
200814,of,1,0
200815,the,1,0
200816,toxicity,1,1
200817,of,0,0
200818,radiotherapy,0,0
200819,by,0,0
200820,an,0,0
200821,additional,0,0
200822,treatment,0,0
200823,with,0,0
200824,Esberitox,0,0
200825,.,0,0
200826,This,0,0
200827,question,0,0
200828,arose,0,0
200829,when,0,0
200830,performing,0,0
200831,an,0,0
200832,investigation,0,0
200833,about,0,0
200834,the,0,0
200835,effect,0,0
200836,of,0,0
200837,Esberitox,0,0
200838,in,0,0
200839,a,0,0
200840,combined,0,0
200841,chemo-radiotherapy,0,0
200842,.,0,0
200843,Whereas,0,0
200844,the,0,0
200845,latter,0,0
200846,induces,0,0
200847,above,0,0
200848,all,0,0
200849,a,0,0
200850,systemic,0,0
200851,damage,0,1
200852,to,0,0
200853,the,0,0
200854,hemopoietic,0,0
200855,system,0,0
200856,",",0,0
200857,radiotherapy,0,0
200858,is,0,0
200859,a,0,0
200860,regional,0,0
200861,noxa,0,0
200862,.,0,0
200863,2,0,0
200864,.,0,0
200865,The,0,0
200866,present,0,0
200867,prospective,0,0
200868,",",0,0
200869,randomized,0,0
200870,study,0,0
200871,was,0,0
200872,conducted,0,0
200873,with,0,0
200874,50,0,0
200875,patients,0,0
200876,submitted,0,0
200877,to,0,0
200878,curative,0,0
200879,adjuvant,0,0
200880,irradiation,0,0
200881,following,0,0
200882,surgery,0,0
200883,for,0,0
200884,mammary,0,0
200885,carcinoma,0,0
200886,.,0,0
200887,The,0,0
200888,radiotherapy,0,0
200889,was,0,0
200890,performed,0,0
200891,in,0,0
200892,the,0,0
200893,same,0,0
200894,way,0,0
200895,in,0,0
200896,all,0,0
200897,patients,0,0
200898,with,0,0
200899,irradiations,0,0
200900,of,0,0
200901,the,0,0
200902,thoracic,0,0
200903,wall,0,0
200904,and,0,0
200905,the,0,0
200906,regional,0,0
200907,lymph,0,0
200908,nodes,0,0
200909,.,0,0
200910,Two,0,0
200911,groups,0,0
200912,were,0,0
200913,built,0,0
200914,by,0,0
200915,randomization,0,0
200916,.,0,0
200917,The,0,0
200918,study,0,0
200919,group,0,0
200920,received,0,0
200921,an,0,0
200922,additional,0,0
200923,treatment,0,0
200924,with,0,0
200925,Esberitox,0,0
200926,",",0,0
200927,the,0,0
200928,control,0,0
200929,group,0,0
200930,did,0,0
200931,not,0,0
200932,receive,0,0
200933,an,0,0
200934,additional,0,0
200935,treatment,0,0
200936,.,0,0
200937,3,0,0
200938,.,0,0
200939,As,0,0
200940,a,0,0
200941,result,0,0
200942,",",0,0
200943,no,0,0
200944,protective,0,1
200945,influence,0,0
200946,of,0,0
200947,Esberitox,0,0
200948,could,0,0
200949,be,0,0
200950,demonstrated,0,0
200951,.,0,0
200952,The,0,0
200953,parameters,0,1
200954,investigated,0,0
200955,were,0,0
200956,the,0,0
200957,peripheral,1,1
200958,blood,1,1
200959,count,1,1
200960,(,1,0
200961,leucocytes,1,1
200962,",",1,0
200963,granulocytes,1,1
200964,",",1,1
200965,lymphocytes,1,1
200966,",",1,1
200967,monocytes,1,1
200968,",",1,1
200969,thrombocytes,1,1
200970,",",1,1
200971,hemoglobin,1,1
200972,",",1,1
200973,hematocrit,1,1
200974,),1,0
200975,and,1,0
200976,the,1,0
200977,incidence,1,1
200978,of,1,0
200979,infections,1,0
200980,.,1,0
200981,4,0,0
200982,.,0,0
200983,This,0,0
200984,result,0,0
200985,diverging,0,0
200986,from,0,0
200987,literature,0,0
200988,is,0,0
200989,discussed,0,0
200990,.,0,0
200991,It,0,0
200992,is,0,0
200993,probably,0,0
200994,affected,0,0
200995,by,0,0
200996,volume,0,1
200997,and,0,1
200998,extension,0,1
200999,of,0,0
201000,the,0,0
201001,injury,0,0
201002,induced,0,0
201003,by,0,0
201004,a,0,0
201005,hematotoxic,0,1
201006,noxa,0,1
201007,and,0,1
201008,furthermore,0,0
201009,by,0,0
201010,the,0,0
201011,ability,0,1
201012,of,0,0
201013,regeneration,0,0
201014,.,0,0
201015,If,0,0
201016,this,0,0
201017,ability,0,0
201018,is,0,0
201019,exhausted,0,0
201020,",",0,0
201021,the,0,0
201022,protective,0,1
201023,effect,0,0
201024,of,0,0
201025,Esberitox,0,0
201026,can,0,0
201027,act,0,0
201028,no,0,0
201029,longer,0,0
201030,.,0,0
201031,Therefore,0,0
201032,the,0,0
201033,essential,0,0
201034,factor,0,0
201035,seems,0,0
201036,to,0,0
201037,be,0,0
201038,the,0,0
201039,duration,0,1
201040,of,0,0
201041,exposure,0,0
201042,to,0,0
201043,the,0,0
201044,noxa,0,0
201045,.,0,0
201046,Esberitox,0,0
201047,was,0,0
201048,effective,0,0
201049,in,0,0
201050,case,0,0
201051,of,0,0
201052,a,0,0
201053,short,0,1
201054,toxicity,0,1
201055,",",0,0
201056,it,0,0
201057,was,0,0
201058,ineffective,0,0
201059,in,0,0
201060,case,0,0
201061,of,0,0
201062,prolonged,0,1
201063,toxicity,0,1
201064,",",0,0
201065,if,0,0
201066,the,0,0
201067,treatment,0,0
201068,continuity,0,1
201069,(,0,0
201070,noxa,0,1
201071,),0,0
201072,was,0,0
201073,not,0,0
201074,broken,0,0
201075,up,0,0
201076,by,0,0
201077,some,0,0
201078,regeneration,0,0
201079,intervals,0,0
201080,.,0,0
201081,The,0,0
201082,radiotherapy,0,0
201083,studied,0,0
201084,in,0,0
201085,this,0,0
201086,trial,0,0
201087,had,0,0
201088,a,0,0
201089,duration,0,1
201090,of,0,0
201091,50,0,0
201092,days,0,0
201093,",",0,0
201094,and,0,0
201095,its,0,0
201096,effect,0,0
201097,was,0,0
201098,that,0,0
201099,of,0,0
201100,a,0,0
201101,longterm,0,0
201102,injury,0,0
201103,.,0,0
201104,[,0,0
201105,Complaints,0,1
201106,in,0,0
201107,the,0,0
201108,postoperative,0,1
201109,phase,0,0
201110,related,0,0
201111,to,0,0
201112,anesthetics,0,0
201113,],0,0
201114,.,0,0
201115,In,0,0
201116,two,0,0
201117,prospective,0,0
201118,",",0,0
201119,randomized,0,0
201120,studies,0,0
201121,the,0,0
201122,frequency,1,1
201123,of,1,0
201124,headache,1,1
201125,",",1,0
201126,nausea,1,1
201127,",",1,1
201128,vomiting,1,1
201129,",",1,1
201130,and,1,1
201131,analgesic,1,1
201132,requirement,1,1
201133,during,0,0
201134,the,0,0
201135,first,0,0
201136,postoperative,0,0
201137,24,0,0
201138,h,0,0
201139,was,0,0
201140,observed,0,0
201141,in,0,0
201142,order,0,0
201143,to,0,0
201144,study,0,0
201145,differences,0,0
201146,between,0,0
201147,the,0,0
201148,sexes,0,0
201149,and,0,0
201150,the,0,0
201151,inhalation,0,0
201152,anesthetics,0,0
201153,halothane,0,1
201154,",",0,0
201155,enflurane,0,0
201156,",",0,1
201157,isoflurane,0,0
201158,",",0,1
201159,or,0,1
201160,balanced,0,0
201161,anesthesia,0,0
201162,with,0,0
201163,enflurane/alfentanil,0,0
201164,.,0,0
201165,Nausea,1,1
201166,and,1,1
201167,vomiting,1,1
201168,were,0,0
201169,more,0,0
201170,frequent,0,1
201171,after,0,0
201172,enflurane,0,0
201173,than,0,0
201174,after,0,0
201175,halothane,0,0
201176,or,0,0
201177,isoflurane,0,0
201178,.,0,0
201179,There,0,0
201180,was,0,0
201181,no,0,0
201182,significant,0,0
201183,difference,0,0
201184,between,0,0
201185,anesthetics,0,0
201186,and,0,0
201187,frequency,1,1
201188,of,1,1
201189,headache,1,1
201190,",",0,0
201191,but,0,0
201192,there,0,0
201193,were,0,0
201194,significant,0,0
201195,differences,0,0
201196,in,0,0
201197,postoperative,1,1
201198,analgesic,1,1
201199,requirements,1,1
201200,which,0,0
201201,were,0,0
201202,highest,0,0
201203,after,0,0
201204,halothane,0,0
201205,and,0,0
201206,lowest,0,0
201207,after,0,0
201208,isoflurane,0,0
201209,.,0,0
201210,Postoperative,1,0
201211,complaints,1,1
201212,were,0,0
201213,always,0,0
201214,significantly,0,0
201215,greater,0,0
201216,among,0,0
201217,women,0,0
201218,than,0,0
201219,among,0,0
201220,men,0,0
201221,.,0,0
201222,The,0,0
201223,second,0,0
201224,study,0,0
201225,indicated,0,0
201226,that,0,0
201227,balanced,0,0
201228,anesthesia,0,0
201229,did,0,0
201230,not,0,0
201231,reduce,0,0
201232,the,0,0
201233,analgesic,1,1
201234,requirement,1,1
201235,compared,0,0
201236,to,0,0
201237,enflurane,0,0
201238,without,0,0
201239,alfentanil,0,0
201240,",",0,0
201241,but,0,0
201242,lead,0,0
201243,to,0,0
201244,a,0,0
201245,higher,0,0
201246,incidence,0,1
201247,of,0,0
201248,vomiting,1,1
201249,.,1,0
201250,After,0,0
201251,premedication,0,0
201252,with,0,0
201253,flunitrazepam,0,0
201254,and,0,1
201255,atropine,0,0
201256,and,0,1
201257,combined,0,0
201258,with,0,0
201259,70,0,0
201260,%,0,0
201261,N2O/30,0,0
201262,%,0,0
201263,O2,0,0
201264,",",0,1
201265,isoflurane,0,0
201266,was,0,0
201267,the,0,0
201268,most,0,0
201269,favorable,0,0
201270,anesthetic,0,0
201271,agent,0,0
201272,with,0,0
201273,regard,0,0
201274,to,0,0
201275,the,0,0
201276,parameters,0,0
201277,studied,0,0
201278,.,0,0
201279,Balanced,0,0
201280,anesthesia,0,0
201281,with,0,0
201282,enflurane/alfentanil,0,0
201283,did,0,0
201284,not,0,0
201285,show,0,0
201286,any,0,0
201287,advantages,0,0
201288,for,0,0
201289,patients,0,0
201290,in,0,0
201291,the,0,0
201292,postoperative,0,1
201293,phase,0,0
201294,under,0,0
201295,the,0,0
201296,given,0,0
201297,conditions,0,0
201298,.,0,0
201299,[,0,0
201300,Trial,0,0
201301,of,0,0
201302,a,0,0
201303,calcium,0,0
201304,antagonist,0,0
201305,in,0,0
201306,dysmenorrhea,1,1
201307,],1,0
201308,.,0,0
201309,Randomized,0,0
201310,study,0,0
201311,of,0,0
201312,13-cis,0,0
201313,retinoic,0,0
201314,acid,0,1
201315,v,0,0
201316,placebo,0,0
201317,in,0,0
201318,the,0,0
201319,myelodysplastic,0,0
201320,disorders,0,0
201321,.,0,0
201322,A,0,0
201323,double-blind,0,0
201324,",",0,0
201325,placebo-controlled,0,0
201326,randomized,0,0
201327,trial,0,0
201328,of,0,0
201329,13-cis,0,0
201330,retinoic,0,0
201331,acid,0,1
201332,was,0,0
201333,performed,0,0
201334,to,0,0
201335,determine,0,0
201336,if,0,0
201337,the,0,0
201338,drug,0,0
201339,has,0,0
201340,a,0,0
201341,therapeutic,1,0
201342,effect,1,0
201343,in,0,0
201344,patients,0,0
201345,with,0,0
201346,myelodysplastic,0,0
201347,syndromes,0,0
201348,(,0,0
201349,MDS,0,0
201350,),0,0
201351,.,0,0
201352,Sixty-eight,0,0
201353,evaluable,0,0
201354,patients,0,0
201355,with,0,0
201356,MDS,0,0
201357,were,0,0
201358,randomized,0,0
201359,to,0,0
201360,receive,0,0
201361,a,0,0
201362,single,0,0
201363,",",0,0
201364,daily,0,0
201365,oral,0,0
201366,dose,0,0
201367,of,0,0
201368,either,0,0
201369,13-cis,0,0
201370,retinoic,0,0
201371,acid,0,1
201372,(,0,0
201373,13-CRA,0,0
201374,",",0,0
201375,100,0,0
201376,mg/m2,0,0
201377,),0,0
201378,or,0,0
201379,matching,0,0
201380,placebo,0,0
201381,.,0,0
201382,Treatment,0,0
201383,was,0,0
201384,continued,0,0
201385,",",0,0
201386,when,0,0
201387,possible,0,0
201388,",",0,0
201389,for,0,0
201390,a,0,0
201391,period,0,0
201392,of,0,0
201393,6,0,0
201394,months,0,0
201395,.,0,0
201396,Determination,0,0
201397,of,0,0
201398,response,0,1
201399,to,0,0
201400,treatment,0,0
201401,was,0,0
201402,based,0,0
201403,on,0,0
201404,clinical,1,0
201405,course,1,1
201406,",",1,0
201407,repeat,1,1
201408,bone,1,1
201409,marrow,1,1
201410,biopsies,1,1
201411,",",0,0
201412,and,0,1
201413,aspirates,1,1
201414,and,1,1
201415,blood,1,1
201416,counts,1,1
201417,(,1,0
201418,CBC,1,1
201419,),1,0
201420,with,1,0
201421,WBC,1,1
201422,differential,1,0
201423,",",1,1
201424,platelet,1,1
201425,",",1,1
201426,and,1,1
201427,reticulocyte,1,1
201428,numbers,1,1
201429,at,1,0
201430,specified,1,0
201431,intervals,1,0
201432,.,1,0
201433,No,0,0
201434,significant,0,0
201435,difference,0,0
201436,was,0,0
201437,noted,0,0
201438,between,0,0
201439,the,0,0
201440,two,0,0
201441,treatment,0,0
201442,groups,0,0
201443,in,0,0
201444,response,0,1
201445,to,0,0
201446,test,0,0
201447,drug,0,0
201448,(,0,0
201449,P,0,0
201450,=,0,0
201451,.66,0,0
201452,),0,0
201453,.,0,0
201454,One,0,0
201455,patient,0,0
201456,(,0,0
201457,3,0,0
201458,%,0,0
201459,),0,0
201460,in,0,0
201461,the,0,0
201462,13-CRA,0,0
201463,group,0,0
201464,and,0,0
201465,two,0,0
201466,patients,0,0
201467,(,0,0
201468,6,0,0
201469,%,0,0
201470,),0,0
201471,in,0,0
201472,the,0,0
201473,placebo,0,0
201474,group,0,0
201475,had,0,0
201476,a,0,0
201477,minor,0,0
201478,response,1,1
201479,.,1,0
201480,Approximately,0,0
201481,30,0,0
201482,%,0,0
201483,of,0,0
201484,patients,0,0
201485,in,0,0
201486,both,0,0
201487,groups,0,0
201488,had,0,0
201489,progression,1,1
201490,of,1,0
201491,their,1,0
201492,disease,1,0
201493,",",0,0
201494,and,0,1
201495,progression-free,1,1
201496,survival,1,1
201497,was,0,0
201498,nearly,0,0
201499,identical,0,0
201500,.,0,0
201501,Greater,0,0
201502,than,0,0
201503,90,0,0
201504,%,0,0
201505,of,0,0
201506,the,0,0
201507,patients,0,0
201508,receiving,0,0
201509,13-CRA,0,0
201510,developed,0,1
201511,mild,1,1
201512,or,1,0
201513,moderate,1,0
201514,skin,1,1
201515,toxicity,1,1
201516,that,0,0
201517,was,0,0
201518,reversible,0,0
201519,with,0,0
201520,decreasing,0,0
201521,or,0,0
201522,discontinuing,0,0
201523,the,0,0
201524,drug,0,0
201525,.,0,0
201526,Our,0,0
201527,study,0,0
201528,did,0,0
201529,not,0,0
201530,find,0,0
201531,that,0,0
201532,13-CRA,0,0
201533,exerts,0,0
201534,a,0,0
201535,beneficial,0,0
201536,therapeutic,1,0
201537,effect,1,0
201538,in,0,0
201539,patients,0,0
201540,with,0,0
201541,MDS,0,0
201542,.,0,0
201543,BCG,0,0
201544,(,0,0
201545,RIVM,0,1
201546,),0,0
201547,versus,0,0
201548,mitomycin,0,0
201549,intravesical,0,0
201550,therapy,0,0
201551,in,0,0
201552,superficial,0,1
201553,bladder,0,0
201554,cancer,0,0
201555,.,0,0
201556,First,0,1
201557,results,0,0
201558,of,0,0
201559,randomized,0,0
201560,prospective,0,0
201561,trial,0,0
201562,.,0,0
201563,This,0,0
201564,study,0,0
201565,presents,0,0
201566,the,0,0
201567,preliminary,0,0
201568,results,0,0
201569,of,0,0
201570,a,0,0
201571,randomized,0,0
201572,prospective,0,0
201573,two-arm,0,0
201574,study,0,0
201575,in,0,0
201576,which,0,0
201577,bacillus,0,0
201578,Calmette-Gu?rin,0,0
201579,(,0,0
201580,BCG,0,0
201581,),0,0
201582,RIVM,0,1
201583,",",0,0
201584,a,0,0
201585,Dutch,0,0
201586,BCG,0,0
201587,preparation,0,0
201588,",",0,0
201589,is,0,0
201590,compared,0,0
201591,with,0,0
201592,mitomycin,0,0
201593,C,0,0
201594,(,0,0
201595,MMC,0,0
201596,),0,0
201597,in,0,0
201598,patients,0,0
201599,with,0,0
201600,primary,0,0
201601,or,0,0
201602,recurrent,0,1
201603,superficial,0,1
201604,bladder,0,0
201605,tumors,0,1
201606,",",0,0
201607,including,0,0
201608,carcinoma,0,0
201609,in,0,0
201610,situ,0,0
201611,(,0,0
201612,CIS,0,0
201613,),0,0
201614,.,0,0
201615,Therapeutic,0,0
201616,regimens,0,0
201617,were,0,0
201618,as,0,0
201619,follows,0,0
201620,:,0,0
201621,after,0,0
201622,complete,0,1
201623,transurethral,0,0
201624,resection,0,0
201625,of,0,0
201626,all,0,0
201627,visible,0,1
201628,tumors,0,0
201629,",",0,0
201630,BCG,0,0
201631,RIVM,0,1
201632,(,0,0
201633,1,0,0
201634,x,0,0
201635,10,0,0
201636,(,0,0
201637,9,0,0
201638,),0,0
201639,bacilli,0,0
201640,in,0,0
201641,50,0,0
201642,mL,0,0
201643,saline,0,0
201644,),0,0
201645,was,0,0
201646,instilled,0,0
201647,once,0,0
201648,a,0,0
201649,week,0,0
201650,for,0,0
201651,six,0,0
201652,consecutive,0,0
201653,weeks,0,0
201654,",",0,0
201655,and,0,0
201656,mitomycin,0,0
201657,C,0,0
201658,(,0,0
201659,30,0,0
201660,mg,0,0
201661,in,0,0
201662,50,0,0
201663,mL,0,0
201664,saline,0,0
201665,),0,0
201666,was,0,0
201667,administered,0,0
201668,once,0,0
201669,a,0,0
201670,week,0,0
201671,for,0,0
201672,one,0,0
201673,month,0,0
201674,(,0,0
201675,weeks,0,0
201676,1,0,0
201677,to,0,0
201678,4,0,0
201679,),0,0
201680,and,0,0
201681,thereafter,0,0
201682,once,0,0
201683,a,0,0
201684,month,0,0
201685,for,0,0
201686,a,0,0
201687,total,0,0
201688,of,0,0
201689,six,0,0
201690,months,0,0
201691,.,0,0
201692,Reported,1,0
201693,are,1,0
201694,the,1,0
201695,incidence,1,1
201696,of,1,0
201697,side,1,1
201698,effects,1,0
201699,in,0,0
201700,165,0,0
201701,patients,0,0
201702,and,0,0
201703,the,1,0
201704,recurrence,1,1
201705,rate,1,1
201706,of,1,0
201707,tumors,1,0
201708,in,0,0
201709,308,0,0
201710,patients,0,0
201711,after,0,0
201712,a,0,0
201713,follow-up,0,0
201714,period,0,0
201715,of,0,0
201716,twelve,0,0
201717,months,0,0
201718,.,0,0
201719,Drug-induced,1,0
201720,",",1,0
201721,or,1,1
201722,chemical,1,1
201723,cystitis,1,1
201724,was,0,0
201725,observed,0,0
201726,in,0,0
201727,13,0,0
201728,(,0,0
201729,16.7,0,0
201730,%,0,0
201731,),0,0
201732,of,0,0
201733,78,0,0
201734,BCG-treated,0,0
201735,patients,0,0
201736,and,0,0
201737,in,0,0
201738,12,0,0
201739,(,0,0
201740,13.8,0,0
201741,%,0,0
201742,),0,0
201743,of,0,0
201744,87,0,0
201745,MMC-treated,0,0
201746,patients,0,0
201747,.,0,0
201748,In,0,0
201749,the,0,0
201750,same,0,0
201751,groups,1,0
201752,bacterial,1,1
201753,cystitis,1,1
201754,occurred,0,0
201755,in,0,0
201756,17,0,0
201757,(,0,0
201758,21.8,0,0
201759,%,0,0
201760,),0,0
201761,patients,0,0
201762,and,0,0
201763,in,0,0
201764,16,0,0
201765,(,0,0
201766,18.4,0,0
201767,%,0,0
201768,),0,0
201769,patients,0,0
201770,",",0,0
201771,respectively,0,0
201772,.,0,0
201773,In,0,0
201774,the,0,0
201775,BCG-treated,0,0
201776,group,0,0
201777,(,0,0
201778,N,0,0
201779,=,0,0
201780,148,0,0
201781,),0,0
201782,",",0,0
201783,44,0,0
201784,(,0,0
201785,29.8,0,0
201786,%,0,0
201787,),0,0
201788,had,1,0
201789,recurrent,1,1
201790,tumors,1,1
201791,",",1,0
201792,while,0,0
201793,in,0,0
201794,the,0,0
201795,MMC-treated,0,0
201796,group,0,0
201797,(,0,0
201798,N,0,0
201799,=,0,0
201800,160,0,0
201801,),0,0
201802,",",0,0
201803,40,0,0
201804,(,0,0
201805,25.0,0,0
201806,%,0,0
201807,),0,0
201808,had,0,0
201809,a,0,0
201810,recurrence,1,1
201811,.,1,0
201812,The,1,0
201813,recurrence,1,1
201814,rate,1,1
201815,for,0,0
201816,BCG-treated,0,0
201817,patients,0,0
201818,was,0,0
201819,0.33,0,0
201820,;,0,0
201821,the,0,0
201822,recurrence,0,1
201823,rate,0,1
201824,for,0,0
201825,MMC-treated,0,0
201826,patients,0,0
201827,was,0,0
201828,0.29,0,0
201829,(,0,0
201830,P,0,0
201831,=,0,0
201832,0.560,0,0
201833,",",0,0
201834,not,0,0
201835,significant,0,0
201836,),0,0
201837,.,0,0
201838,These,0,0
201839,preliminary,0,0
201840,data,0,0
201841,demonstrated,0,0
201842,no,0,0
201843,statistically,0,0
201844,significant,0,0
201845,difference,0,0
201846,between,0,0
201847,the,0,0
201848,two,0,0
201849,arms,0,0
201850,with,0,0
201851,regard,0,0
201852,to,1,0
201853,toxicity,1,1
201854,and,1,1
201855,recurrence,1,1
201856,of,1,0
201857,tumors,1,0
201858,.,1,0
201859,Dysthymia,0,0
201860,:,0,0
201861,a,0,0
201862,randomized,0,0
201863,study,0,0
201864,of,0,0
201865,cognitive,0,1
201866,marital,0,1
201867,therapy,0,0
201868,and,0,0
201869,antidepressants,0,0
201870,.,0,0
201871,Preliminary,0,0
201872,data,0,0
201873,from,0,0
201874,a,0,0
201875,randomized,0,0
201876,study,0,0
201877,of,0,0
201878,the,0,0
201879,effectiveness,0,0
201880,of,0,0
201881,combined,0,0
201882,marital,0,1
201883,therapy,0,0
201884,and,0,0
201885,antidepressant,0,0
201886,medication,0,1
201887,in,0,0
201888,the,0,0
201889,treatment,0,0
201890,of,0,0
201891,dysthymic,0,0
201892,married,0,0
201893,women,0,0
201894,is,0,0
201895,presented,0,0
201896,.,0,0
201897,The,0,0
201898,study,0,0
201899,compares,0,0
201900,doxepin,0,0
201901,with,0,0
201902,placebo,0,0
201903,",",0,0
201904,and,0,0
201905,a,0,0
201906,marital,0,0
201907,therapy,0,0
201908,designed,0,0
201909,to,0,0
201910,enhance,0,0
201911,intimacy,0,1
201912,through,0,0
201913,facilitating,0,0
201914,self-disclosure,0,1
201915,between,0,0
201916,spouses,0,0
201917,with,0,0
201918,a,0,0
201919,more,0,0
201920,supportive,0,0
201921,and,0,0
201922,educational,0,1
201923,therapeutic,0,0
201924,approach,0,0
201925,.,0,0
201926,After,0,0
201927,ten,0,0
201928,weeks,0,0
201929,of,0,0
201930,combined,0,0
201931,treatment,0,0
201932,",",0,0
201933,the,0,0
201934,dysthymic,0,0
201935,women,0,0
201936,show,0,0
201937,statistically,0,0
201938,significant,0,0
201939,improvement,0,1
201940,on,0,0
201941,all,0,0
201942,the,0,0
201943,depression,1,0
201944,measures,1,0
201945,as,0,0
201946,well,0,0
201947,as,0,0
201948,on,0,0
201949,the,0,0
201950,intimacy,1,1
201951,scale,1,1
201952,.,1,0
201953,A,0,0
201954,trend,0,0
201955,is,0,0
201956,developing,0,0
201957,for,0,0
201958,greater,0,0
201959,reduction,0,1
201960,of,0,1
201961,depressive,1,1
201962,symptomatology,1,1
201963,in,0,0
201964,the,0,0
201965,group,0,0
201966,treated,0,0
201967,with,0,0
201968,self-disclosure,0,1
201969,.,0,0
201970,The,0,0
201971,evidence,0,0
201972,appears,0,0
201973,to,0,0
201974,suggest,0,0
201975,the,0,0
201976,possibility,0,0
201977,that,0,0
201978,the,0,0
201979,presence,0,0
201980,of,0,0
201981,a,0,0
201982,patient,0,1
201983,'s,0,0
201984,husband,0,1
201985,as,0,0
201986,a,0,0
201987,supportive,0,0
201988,figure,0,0
201989,may,0,0
201990,of,0,0
201991,itself,0,0
201992,be,0,0
201993,a,0,0
201994,potent,0,0
201995,therapeutic,0,0
201996,manoeuvre,0,0
201997,in,0,0
201998,the,0,0
201999,treatment,0,0
202000,of,0,0
202001,dysthymic,0,0
202002,women,0,0
202003,.,0,0
202004,Pulsatile,1,1
202005,insulin,1,1
202006,delivery,1,0
202007,is,0,0
202008,more,0,0
202009,efficient,0,0
202010,than,0,0
202011,continuous,0,0
202012,infusion,0,0
202013,in,0,0
202014,modulating,0,0
202015,islet,0,1
202016,cell,0,1
202017,function,0,1
202018,in,0,0
202019,normal,0,0
202020,subjects,0,0
202021,and,0,0
202022,patients,0,0
202023,with,0,0
202024,type,0,0
202025,1,0,0
202026,diabetes,0,0
202027,.,0,0
202028,The,0,0
202029,respective,0,0
202030,modulating,0,0
202031,effects,0,1
202032,of,0,0
202033,continuous,0,0
202034,and,0,0
202035,intermittent,0,0
202036,insulin,0,1
202037,delivery,0,0
202038,on,0,0
202039,pancreatic,0,1
202040,islet,0,1
202041,cell,0,1
202042,function,0,1
202043,were,0,0
202044,studied,0,0
202045,in,0,0
202046,seven,0,0
202047,normal,0,0
202048,men,0,0
202049,and,0,0
202050,nine,0,0
202051,insulin-dependent,0,0
202052,(,0,0
202053,type,0,0
202054,1,0,0
202055,),0,0
202056,diabetic,0,0
202057,patients,0,0
202058,.,0,0
202059,In,0,0
202060,the,0,0
202061,normal,0,0
202062,men,0,0
202063,",",0,0
202064,saline,0,0
202065,or,0,1
202066,continuous,0,0
202067,(,0,0
202068,0.8,0,0
202069,mU,0,1
202070,kg-1,0,0
202071,min-1,0,0
202072,),0,0
202073,or,0,0
202074,pulsatile,0,1
202075,(,0,0
202076,5.2,0,0
202077,mU,0,1
202078,kg-1,0,0
202079,min-1,0,0
202080,",",0,0
202081,with,0,0
202082,a,0,0
202083,switching,0,0
202084,on/off,0,0
202085,length,0,1
202086,of,0,0
202087,2/11,0,0
202088,min,0,0
202089,),0,0
202090,human,0,0
202091,insulin,0,1
202092,were,0,0
202093,delivered,0,0
202094,on,0,0
202095,different,0,0
202096,days,0,0
202097,and,0,0
202098,in,0,0
202099,random,0,0
202100,order,0,0
202101,.,0,0
202102,Despite,0,0
202103,hyperinsulinemia,0,1
202104,",",0,0
202105,blood,0,1
202106,glucose,0,1
202107,was,0,0
202108,kept,0,0
202109,close,0,0
202110,to,0,0
202111,its,0,0
202112,basal,0,0
202113,value,0,0
202114,by,0,0
202115,the,0,0
202116,glucose,0,1
202117,clamp,0,0
202118,technique,0,0
202119,.,0,0
202120,The,0,0
202121,diabetic,0,0
202122,patients,0,0
202123,also,0,0
202124,were,0,0
202125,infused,0,0
202126,in,0,0
202127,random,0,0
202128,order,0,0
202129,and,0,0
202130,on,0,0
202131,different,0,0
202132,days,0,0
202133,with,0,0
202134,either,0,0
202135,saline,0,0
202136,or,0,0
202137,a,0,0
202138,smaller,0,0
202139,amount,0,1
202140,of,0,1
202141,insulin,0,1
202142,delivered,0,0
202143,continuously,0,0
202144,(,0,0
202145,0.15,0,0
202146,mU,0,1
202147,kg-1,0,0
202148,min-1,0,0
202149,),0,0
202150,or,0,0
202151,in,0,0
202152,a,0,0
202153,pulsatile,0,1
202154,manner,0,0
202155,(,0,0
202156,0.97,0,0
202157,mU,0,1
202158,kg-1,0,0
202159,min-1,0,0
202160,for,0,0
202161,2,0,0
202162,min,0,0
202163,",",0,0
202164,followed,0,0
202165,by,0,0
202166,11,0,0
202167,min,0,0
202168,during,0,0
202169,which,0,0
202170,no,0,0
202171,insulin,0,1
202172,was,0,0
202173,infused,0,0
202174,),0,0
202175,.,0,0
202176,In,0,0
202177,all,0,0
202178,experiments,0,0
202179,",",0,0
202180,5,0,0
202181,g,0,0
202182,arginine,0,0
202183,were,0,0
202184,given,0,0
202185,iv,0,0
202186,as,0,0
202187,a,0,0
202188,bolus,0,0
202189,dose,0,0
202190,30,0,0
202191,min,0,0
202192,before,0,0
202193,the,0,0
202194,end,0,0
202195,of,0,0
202196,the,0,0
202197,study,0,0
202198,",",0,0
202199,and,0,1
202200,plasma,1,1
202201,C-peptide,1,1
202202,and,1,0
202203,glucagon,1,1
202204,levels,1,1
202205,were,0,0
202206,determined,0,0
202207,to,0,0
202208,assess,0,0
202209,islet,0,1
202210,cell,0,0
202211,function,0,1
202212,.,0,0
202213,In,0,0
202214,the,0,0
202215,normal,0,0
202216,men,0,0
202217,",",0,0
202218,insulin,0,1
202219,administration,0,0
202220,resulted,0,0
202221,in,0,0
202222,a,0,0
202223,significant,0,0
202224,decline,0,0
202225,of,0,0
202226,basal,1,1
202227,plasma,1,1
202228,glucagon,1,1
202229,and,1,1
202230,C-peptide,1,1
202231,levels,1,1
202232,and,0,0
202233,in,0,0
202234,a,0,0
202235,clear-cut,0,0
202236,decrease,0,0
202237,in,0,0
202238,the,0,0
202239,arginine-induced,1,0
202240,glucagon,1,0
202241,response,1,1
202242,.,1,0
202243,These,0,0
202244,effects,0,0
202245,of,0,0
202246,insulin,0,1
202247,were,0,0
202248,significantly,0,0
202249,more,0,0
202250,marked,0,0
202251,when,0,0
202252,insulin,0,1
202253,was,0,0
202254,delivered,0,0
202255,in,0,0
202256,a,0,0
202257,pulsatile,0,0
202258,rather,0,0
202259,than,0,0
202260,a,0,0
202261,continuous,0,0
202262,manner,0,0
202263,.,0,0
202264,In,0,0
202265,the,0,0
202266,insulin-dependent,0,0
202267,diabetic,0,0
202268,patients,0,0
202269,",",0,0
202270,the,0,0
202271,lower,0,0
202272,dose,0,0
202273,of,0,1
202274,insulin,0,1
202275,infused,0,0
202276,continuously,0,0
202277,did,0,0
202278,not,0,0
202279,alter,0,0
202280,the,0,0
202281,basal,1,0
202282,or,1,0
202283,arginine-stimulated,1,1
202284,glucagon,1,1
202285,response,1,1
202286,.,1,0
202287,In,0,0
202288,contrast,0,0
202289,",",0,0
202290,when,0,0
202291,the,0,0
202292,same,0,0
202293,amount,0,1
202294,of,0,0
202295,insulin,0,1
202296,was,0,0
202297,delivered,0,0
202298,intermittently,0,0
202299,",",0,0
202300,arginine-induced,1,1
202301,glucagon,1,1
202302,release,1,1
202303,was,0,0
202304,greatly,0,0
202305,reduced,0,0
202306,.,0,0
202307,Thus,0,0
202308,",",0,0
202309,these,0,0
202310,data,0,0
202311,support,0,0
202312,the,0,0
202313,concept,0,0
202314,that,0,0
202315,insulin,0,1
202316,per,0,0
202317,se,0,0
202318,is,0,0
202319,a,0,0
202320,potent,0,0
202321,physiological,1,0
202322,modulator,1,0
202323,of,1,0
202324,islet,1,1
202325,A-,1,1
202326,and,1,1
202327,B-cell,1,1
202328,function,1,1
202329,.,1,0
202330,Furthermore,0,0
202331,",",0,0
202332,they,0,0
202333,suggest,0,0
202334,that,0,0
202335,these,0,0
202336,effects,0,0
202337,of,0,0
202338,insulin,0,0
202339,are,0,0
202340,reinforced,0,0
202341,when,0,0
202342,the,0,0
202343,hormone,0,0
202344,is,0,0
202345,administered,0,0
202346,in,0,0
202347,an,0,0
202348,intermittent,0,0
202349,manner,0,0
202350,in,0,0
202351,an,0,0
202352,attempt,0,0
202353,to,0,0
202354,reproduce,0,0
202355,the,0,0
202356,pulsatile,1,1
202357,physiological,1,0
202358,release,1,1
202359,of,1,0
202360,insulin,1,0
202361,.,1,0
202362,Dexamethasone,0,0
202363,therapy,0,0
202364,and,0,1
202365,cortisol,0,1
202366,excretion,0,1
202367,in,0,0
202368,severe,0,1
202369,pediatric,0,0
202370,head,0,0
202371,injury,0,0
202372,.,0,0
202373,Glucocorticoids,0,0
202374,are,0,0
202375,used,0,0
202376,in,0,0
202377,an,0,0
202378,attempt,0,0
202379,to,0,0
202380,reduce,0,0
202381,brain,0,1
202382,edema,0,1
202383,secondary,0,0
202384,to,0,0
202385,head,0,0
202386,injury,0,0
202387,.,0,0
202388,Nevertheless,0,0
202389,",",0,0
202390,their,0,0
202391,usefulness,0,0
202392,remains,0,0
202393,uncertain,0,0
202394,and,0,0
202395,contradictory,0,0
202396,.,0,0
202397,In,0,0
202398,a,0,0
202399,randomized,0,0
202400,study,0,0
202401,of,0,0
202402,24,0,0
202403,children,0,0
202404,with,0,0
202405,severe,0,1
202406,head,0,0
202407,injury,0,1
202408,",",0,0
202409,urinary,0,1
202410,free,0,1
202411,cortisol,0,1
202412,was,0,0
202413,measured,0,0
202414,by,0,0
202415,radioimmunoassay,0,0
202416,.,0,0
202417,Twelve,0,0
202418,patients,0,0
202419,(,0,0
202420,group,0,0
202421,1,0,0
202422,),0,0
202423,received,0,0
202424,dexamethasone,0,0
202425,and,0,0
202426,12,0,0
202427,(,0,0
202428,group,0,0
202429,2,0,0
202430,),0,0
202431,did,0,0
202432,not,0,0
202433,.,0,0
202434,All,0,0
202435,patients,0,0
202436,were,0,0
202437,treated,0,0
202438,with,0,0
202439,a,0,0
202440,standardized,0,0
202441,regimen,0,0
202442,.,0,0
202443,In,0,0
202444,group,0,0
202445,1,0,0
202446,there,0,0
202447,was,0,0
202448,complete,0,1
202449,suppression,1,1
202450,of,1,0
202451,endogenous,1,1
202452,cortisol,1,1
202453,production,1,1
202454,.,1,0
202455,In,0,0
202456,group,0,0
202457,2,0,0
202458,free,0,1
202459,cortisol,0,0
202460,was,0,0
202461,up,0,0
202462,to,0,0
202463,20-fold,0,0
202464,higher,0,0
202465,than,0,0
202466,under,0,0
202467,basal,0,1
202468,conditions,0,0
202469,and,0,0
202470,reached,0,0
202471,maximum,0,1
202472,values,0,1
202473,on,0,0
202474,days,0,0
202475,1-3,0,0
202476,.,0,0
202477,Since,0,0
202478,the,0,0
202479,excretion,1,1
202480,of,1,0
202481,cortisol,1,1
202482,in,1,0
202483,urine,1,0
202484,reflects,0,0
202485,the,0,0
202486,production,0,1
202487,rate,0,1
202488,closely,0,0
202489,and,0,0
202490,is,0,0
202491,not,0,0
202492,influenced,0,0
202493,by,0,0
202494,liver,0,0
202495,function,0,1
202496,and,0,1
202497,barbiturates,0,0
202498,",",0,0
202499,the,0,0
202500,results,0,0
202501,in,0,0
202502,group,0,0
202503,2,0,0
202504,show,0,0
202505,that,0,0
202506,the,0,0
202507,endogenous,0,0
202508,production,0,1
202509,of,0,0
202510,steroids,0,0
202511,is,0,0
202512,an,0,0
202513,adequate,0,0
202514,reaction,0,0
202515,to,0,0
202516,severe,0,1
202517,head,0,0
202518,injury,0,0
202519,.,0,0
202520,Exogenous,0,0
202521,glucocorticoids,0,0
202522,are,0,0
202523,thus,0,0
202524,unlikely,0,0
202525,to,0,0
202526,have,0,0
202527,any,0,0
202528,more,0,0
202529,beneficial,0,0
202530,effects,0,1
202531,than,0,0
202532,endogenous,0,0
202533,cortisol,0,1
202534,.,0,0
202535,Intravenous,0,0
202536,lignocaine,0,0
202537,&,0,0
202538,haemodynamic,1,1
202539,responses,1,1
202540,to,0,0
202541,cystoscopy,0,0
202542,.,0,0
202543,Topical,0,1
202544,fibronectin,0,1
202545,therapy,0,0
202546,for,0,0
202547,treatment,0,0
202548,of,0,0
202549,a,0,0
202550,patient,0,0
202551,with,0,0
202552,chronic,1,0
202553,stasis,1,1
202554,ulcers,1,0
202555,.,1,0
202556,The,0,0
202557,effects,0,0
202558,of,0,0
202559,hypoxemia,0,1
202560,on,0,0
202561,cardiac,0,1
202562,output,0,1
202563,.,0,0
202564,A,0,0
202565,dose-response,0,0
202566,curve,0,1
202567,.,0,0
202568,To,0,0
202569,establish,0,0
202570,a,0,0
202571,dose-response,0,0
202572,curve,0,1
202573,for,0,0
202574,the,0,0
202575,effects,0,0
202576,of,0,0
202577,isocapnic,0,1
202578,hypoxemia,0,1
202579,on,0,0
202580,cardiac,1,1
202581,output,1,1
202582,(,1,0
202583,CO,1,1
202584,),1,0
202585,",",0,0
202586,we,0,0
202587,studied,0,0
202588,20,0,0
202589,healthy,0,0
202590,men,0,0
202591,",",0,0
202592,aged,0,0
202593,20,0,0
202594,to,0,0
202595,34,0,0
202596,years,0,0
202597,",",0,0
202598,using,0,0
202599,a,0,0
202600,tight-fitting,0,0
202601,face,0,0
202602,mask,0,0
202603,and,0,0
202604,an,0,0
202605,isocapnic,0,1
202606,partial,0,0
202607,rebreathing,0,1
202608,system,0,0
202609,(,0,0
202610,a,0,0
202611,modified,0,0
202612,anesthesia,0,0
202613,machine,0,0
202614,),0,0
202615,.,0,0
202616,We,0,0
202617,blended,0,0
202618,oxygen,0,1
202619,and,0,1
202620,hypoxic,0,1
202621,gas,0,1
202622,to,0,0
202623,achieve,0,0
202624,arterial,0,1
202625,oxygen,0,1
202626,saturations,0,1
202627,(,0,0
202628,SaO2,0,0
202629,),0,0
202630,of,0,0
202631,80,0,0
202632,",",0,0
202633,85,0,0
202634,",",0,0
202635,and,0,0
202636,90,0,0
202637,percent,0,0
202638,;,0,0
202639,subjects,0,0
202640,also,0,0
202641,breathed,0,0
202642,100,0,0
202643,percent,0,0
202644,oxygen,0,0
202645,and,0,1
202646,room,0,1
202647,air,0,1
202648,(,0,0
202649,RA,0,0
202650,),0,0
202651,.,0,0
202652,Target,0,1
202653,SaO2,0,0
202654,and,0,0
202655,end-tidal,0,1
202656,carbon,0,1
202657,dioxide,0,0
202658,were,0,0
202659,continuously,0,0
202660,monitored,0,0
202661,using,0,0
202662,an,0,0
202663,ear,0,0
202664,oximeter,0,0
202665,and,0,1
202666,CO2,0,0
202667,gas,0,1
202668,analyzer,0,0
202669,.,0,0
202670,Subjects,0,0
202671,experienced,0,0
202672,the,0,0
202673,five,0,0
202674,SaO2,0,0
202675,measurements,0,0
202676,in,0,0
202677,random,0,0
202678,order,0,0
202679,.,0,0
202680,CO,1,1
202681,was,0,0
202682,measured,0,0
202683,noninvasively,0,0
202684,at,0,0
202685,approximately,0,0
202686,two-minute,0,0
202687,intervals,0,0
202688,",",0,0
202689,using,0,0
202690,continuous-wave,0,1
202691,Doppler,0,0
202692,echocardiography,0,0
202693,.,0,0
202694,Mean,1,0
202695,cardiac,1,1
202696,output,1,1
202697,increased,0,0
202698,with,0,0
202699,increasing,0,0
202700,hypoxemia,1,1
202701,from,0,0
202702,6.84,0,0
202703,L/min,0,0
202704,at,0,0
202705,FIo2,0,0
202706,1.0,0,0
202707,to,0,0
202708,8.44,0,0
202709,L/min,0,0
202710,at,0,0
202711,SaO2,0,0
202712,80,0,0
202713,percent,0,0
202714,(,0,0
202715,p,0,0
202716,less,0,0
202717,than,0,0
202718,0.0005,0,0
202719,),0,0
202720,;,0,0
202721,the,0,0
202722,increase,0,0
202723,was,0,0
202724,entirely,0,0
202725,due,0,0
202726,to,0,0
202727,increased,0,0
202728,heart,1,0
202729,rate,1,1
202730,.,1,0
202731,We,0,0
202732,concluded,0,0
202733,that,0,0
202734,cardiac,1,1
202735,output,1,1
202736,increases,0,1
202737,significantly,0,0
202738,in,0,0
202739,a,0,0
202740,dose-response,0,0
202741,manner,0,0
202742,in,0,0
202743,response,0,1
202744,to,0,0
202745,acute,0,0
202746,isocapnic,0,1
202747,hypoxemia,0,1
202748,in,0,0
202749,normal,0,0
202750,persons,0,0
202751,.,0,0
202752,Moisture-vapour-permeable,0,0
202753,film,0,0
202754,as,0,0
202755,an,0,0
202756,outpatient,0,0
202757,burn,0,0
202758,dressing,0,0
202759,.,0,0
202760,This,0,0
202761,study,0,0
202762,compares,0,0
202763,a,0,0
202764,moisture-vapour-permeable,0,0
202765,film,0,0
202766,(,0,0
202767,MVPF,0,0
202768,),0,0
202769,with,0,0
202770,silver,0,0
202771,sulphadiazine,0,0
202772,in,0,0
202773,a,0,0
202774,randomized,0,0
202775,prospective,0,0
202776,manner,0,0
202777,for,0,0
202778,the,0,0
202779,treatment,0,0
202780,of,0,0
202781,outpatient,0,0
202782,burns,0,0
202783,.,0,0
202784,The,0,0
202785,two,0,0
202786,treatment,0,0
202787,groups,0,0
202788,were,0,0
202789,closely,0,0
202790,matched,0,0
202791,in,0,0
202792,age,0,0
202793,",",0,0
202794,sex,0,0
202795,",",0,0
202796,per,0,0
202797,cent,0,0
202798,of,0,0
202799,BSA,0,1
202800,burned,0,0
202801,",",0,0
202802,and,0,1
202803,in,0,0
202804,burn,0,0
202805,severity,0,1
202806,and,0,0
202807,locations,0,0
202808,.,0,0
202809,The,0,0
202810,MVPF,0,0
202811,group,0,0
202812,demonstrated,0,0
202813,a,0,0
202814,39.0,0,0
202815,per,0,0
202816,cent,0,0
202817,greater,0,0
202818,reduction,0,1
202819,in,0,0
202820,pain,1,1
202821,after,0,0
202822,application,0,0
202823,of,0,0
202824,the,0,0
202825,dressing,0,0
202826,over,0,0
202827,the,0,0
202828,silver,0,0
202829,sulphadiazine,0,0
202830,group,0,0
202831,.,0,0
202832,Patients,0,0
202833,in,0,0
202834,the,0,0
202835,MVPF,0,0
202836,film,0,0
202837,group,0,0
202838,also,0,0
202839,reported,0,0
202840,significantly,0,0
202841,less,0,0
202842,difficulty,1,1
202843,in,1,0
202844,wound,1,1
202845,care,1,0
202846,and,0,0
202847,in,0,0
202848,dressing,1,0
202849,interference,1,0
202850,with,1,0
202851,their,1,0
202852,daily,1,0
202853,functions,1,0
202854,.,1,0
202855,The,0,0
202856,clinical,1,0
202857,infection,1,1
202858,rate,1,1
202859,and,1,0
202860,time,1,1
202861,to,1,0
202862,healing,1,1
202863,were,0,0
202864,similar,0,0
202865,in,0,0
202866,both,0,0
202867,groups,0,0
202868,.,0,0
202869,In,0,0
202870,the,0,0
202871,management,1,0
202872,of,0,0
202873,outpatient,0,0
202874,burns,0,1
202875,",",0,0
202876,MVPF,0,0
202877,was,0,0
202878,found,0,0
202879,to,0,0
202880,be,0,0
202881,superior,0,0
202882,to,0,0
202883,silver,0,0
202884,sulphadiazine,0,0
202885,.,0,0
202886,Placebo-controlled,0,0
202887,double-blind,0,0
202888,trial,0,0
202889,of,0,0
202890,mianserin,0,0
202891,hydrochloride,0,0
202892,.,0,0
202893,Effect,0,0
202894,of,0,0
202895,negative,0,1
202896,air,0,0
202897,ionization,0,0
202898,on,0,0
202899,hyperactive,0,0
202900,and,0,0
202901,autistic,0,0
202902,children,0,0
202903,.,0,0
202904,Twenty-one,0,0
202905,attention,0,0
202906,deficit,0,0
202907,disorder,0,0
202908,with,0,0
202909,hyperactivity,0,0
202910,and,0,0
202911,seven,0,0
202912,autistic,0,0
202913,children,0,0
202914,were,0,0
202915,randomly,0,0
202916,exposed,0,0
202917,to,0,0
202918,negatively,0,0
202919,ionized,0,1
202920,and,0,0
202921,ambient,0,0
202922,atmospheres,0,0
202923,under,0,0
202924,rigorously,0,0
202925,controlled,0,0
202926,experimental,0,0
202927,conditions,0,0
202928,.,0,0
202929,The,0,0
202930,negatively,0,0
202931,ionized,0,1
202932,condition,0,0
202933,did,0,0
202934,not,0,0
202935,significantly,0,0
202936,affect,0,0
202937,measurements,0,0
202938,of,0,0
202939,activity,1,1
202940,level,1,1
202941,",",1,1
202942,impulsivity,1,1
202943,",",1,1
202944,reality,1,0
202945,orientation,1,1
202946,",",1,1
202947,destructive/constructiveness,1,1
202948,",",1,1
202949,attention,1,1
202950,",",1,1
202951,or,1,1
202952,task,1,1
202953,performance,1,1
202954,.,1,0
202955,Significant,0,0
202956,results,0,0
202957,might,0,0
202958,be,0,0
202959,obtained,0,0
202960,if,0,0
202961,subgroups,0,0
202962,of,0,0
202963,known,0,0
202964,hyperserotoninemic,0,0
202965,autistic,0,0
202966,and,0,1
202967,attention,0,1
202968,deficit,0,1
202969,disorder,0,0
202970,children,0,0
202971,were,0,0
202972,exposed,0,0
202973,to,0,0
202974,negatively,0,0
202975,ionized,0,1
202976,conditions,0,0
202977,.,0,0
202978,Effects,0,0
202979,of,0,0
202980,platelet,0,1
202981,suppressant,0,0
202982,",",0,0
202983,anticoagulant,0,1
202984,and,0,1
202985,fibrinolytic,0,0
202986,therapy,0,0
202987,in,0,0
202988,patients,0,0
202989,with,0,0
202990,recurrent,0,0
202991,venous,0,1
202992,thrombosis,0,0
202993,.,0,0
202994,Review,0,0
202995,of,0,0
202996,the,0,0
202997,Multicenter,0,0
202998,Trial,0,0
202999,Committee,0,0
203000,report,0,0
203001,:,0,0
203002,a,0,0
203003,prospective,0,0
203004,",",0,0
203005,randomized,0,0
203006,study,0,0
203007,on,0,0
203008,the,0,0
203009,prophylaxis,0,0
203010,of,0,0
203011,postoperative,0,1
203012,deep,0,0
203013,venous,0,1
203014,thrombosis,0,0
203015,.,0,0
203016,The,0,0
203017,etiology,0,0
203018,of,0,0
203019,postoperative,0,1
203020,deep,0,0
203021,venous,0,1
203022,thrombosis,0,1
203023,(,0,0
203024,DVT,0,0
203025,),0,0
203026,is,0,0
203027,thought,0,0
203028,to,0,0
203029,be,0,0
203030,due,0,0
203031,to,0,0
203032,a,0,0
203033,combination,0,0
203034,of,0,0
203035,factors,0,0
203036,including,0,0
203037,stasis,0,1
203038,",",0,0
203039,a,0,0
203040,hypercoagulable,0,1
203041,state,0,0
203042,and,0,0
203043,venous,0,1
203044,endothelial,0,1
203045,damage,0,1
203046,.,0,0
203047,Methods,0,0
203048,of,0,0
203049,prophylaxis,0,0
203050,are,0,0
203051,directed,0,0
203052,toward,0,0
203053,correcting,0,0
203054,one,0,0
203055,or,0,0
203056,more,0,0
203057,of,0,0
203058,these,0,0
203059,pathologic,0,1
203060,events,0,1
203061,.,0,0
203062,Methods,0,0
203063,counteracting,0,0
203064,more,0,0
203065,than,0,0
203066,one,0,0
203067,of,0,0
203068,these,0,0
203069,factors,0,0
203070,can,0,0
203071,be,0,0
203072,expected,0,0
203073,to,0,0
203074,be,0,0
203075,even,0,0
203076,more,0,0
203077,effective,0,0
203078,.,0,0
203079,The,0,0
203080,combination,0,0
203081,of,0,0
203082,dihydroergotamine,0,0
203083,(,0,0
203084,DHE,0,0
203085,),0,1
203086,and,0,0
203087,heparin,0,0
203088,was,0,0
203089,anticipated,0,0
203090,to,0,0
203091,minimize,0,0
203092,stasis,0,1
203093,and,0,0
203094,the,0,0
203095,hypercoagulable,0,1
203096,state,0,0
203097,respectively,0,0
203098,.,0,0
203099,Based,0,0
203100,upon,0,0
203101,current,0,0
203102,experimental,0,0
203103,evidence,0,0
203104,and,0,0
203105,current,0,0
203106,theory,0,0
203107,",",0,0
203108,an,0,0
203109,additional,0,0
203110,benefit,0,0
203111,might,0,0
203112,include,0,0
203113,minimizing,0,0
203114,venous,0,1
203115,endothelial,0,1
203116,injury,0,0
203117,by,0,0
203118,controlling,0,0
203119,venomotor,0,0
203120,tone,0,1
203121,.,0,0
203122,A,0,0
203123,prospective,0,0
203124,",",0,0
203125,randomized,0,0
203126,",",0,0
203127,double-blind,0,0
203128,",",0,0
203129,multicenter,0,0
203130,trial,0,0
203131,was,0,0
203132,designed,0,0
203133,and,0,0
203134,performed,0,0
203135,in,0,0
203136,the,0,0
203137,United,0,0
203138,States,0,0
203139,evaluating,0,0
203140,the,0,0
203141,prophylactic,0,0
203142,efficacy,0,1
203143,of,0,0
203144,DHE,0,0
203145,0.5,0,0
203146,mg,0,0
203147,plus,0,0
203148,heparin,0,0
203149,5000,0,0
203150,U,0,0
203151,",",0,0
203152,DHE,0,0
203153,0.5,0,0
203154,mg,0,0
203155,plus,0,0
203156,heparin,0,0
203157,2500,0,0
203158,U,0,0
203159,",",0,0
203160,heparin,0,0
203161,5000,0,0
203162,U,0,0
203163,",",0,0
203164,and,0,0
203165,DHE,0,0
203166,0.5,0,0
203167,mg,0,0
203168,versus,0,0
203169,placebo,0,0
203170,.,0,0
203171,General,0,1
203172,surgical,0,0
203173,patients,0,0
203174,including,0,0
203175,those,0,0
203176,undergoing,0,0
203177,noncardiac,0,1
203178,thoracic,0,0
203179,and,0,0
203180,pelvic,0,0
203181,operations,0,0
203182,who,0,0
203183,were,0,0
203184,identified,0,0
203185,at,0,0
203186,moderate,0,0
203187,to,0,0
203188,high,0,0
203189,risk,0,1
203190,for,0,0
203191,postop,0,0
203192,DVT,0,0
203193,were,0,0
203194,included,0,0
203195,.,0,0
203196,Study,0,0
203197,medications,0,0
203198,were,0,0
203199,injected,0,0
203200,subcutaneously,0,0
203201,two,0,0
203202,hours,0,0
203203,preoperatively,0,0
203204,and,0,0
203205,every,0,0
203206,12,0,0
203207,hours,0,0
203208,postoperatively,0,0
203209,for,0,0
203210,5-7,0,0
203211,days,0,0
203212,or,0,0
203213,until,0,0
203214,the,0,0
203215,125I-fibrinogen-uptake,0,1
203216,test,0,0
203217,(,0,0
203218,RFUT,0,1
203219,),0,0
203220,became,0,0
203221,positive,0,0
203222,.,0,0
203223,Eight,0,1
203224,hundred,0,0
203225,and,0,0
203226,eighty,0,0
203227,eight,0,0
203228,patients,0,0
203229,were,0,0
203230,entered,0,0
203231,into,0,0
203232,this,0,0
203233,trial,0,0
203234,and,0,0
203235,744,0,0
203236,(,0,0
203237,85,0,0
203238,%,0,0
203239,),0,0
203240,completed,0,0
203241,the,0,0
203242,study,0,0
203243,.,0,0
203244,Results,1,0
203245,showed,1,0
203246,a,1,0
203247,statistically,1,0
203248,significant,1,0
203249,benefit,1,0
203250,from,1,0
203251,DHE/Hep,1,0
203252,5000,1,0
203253,compared,1,0
203254,to,1,0
203255,placebo,1,0
203256,(,1,0
203257,p,1,0
203258,less,1,0
203259,than,1,0
203260,0.01,1,0
203261,),1,0
203262,and,1,0
203263,compared,1,0
203264,to,1,0
203265,other,1,0
203266,active,1,0
203267,agents,1,0
203268,(,1,0
203269,p,1,0
203270,less,1,0
203271,than,1,0
203272,0.05,1,0
203273,),1,0
203274,.,1,0
203275,None,0,0
203276,of,0,0
203277,the,0,0
203278,other,0,0
203279,active,0,0
203280,agents,0,0
203281,showed,0,0
203282,a,0,0
203283,statistically,0,0
203284,significant,0,0
203285,prophylactic,0,0
203286,benefit,0,0
203287,.,0,0
203288,(,0,0
203289,ABSTRACT,0,1
203290,TRUNCATED,0,0
203291,AT,0,0
203292,250,0,0
203293,WORDS,0,0
203294,),0,0
203295,An,0,0
203296,analysis,0,0
203297,of,0,0
203298,the,0,0
203299,radiation,0,0
203300,related,0,0
203301,morbidity,1,1
203302,observed,0,0
203303,in,0,0
203304,a,0,0
203305,randomized,0,0
203306,trial,0,0
203307,of,0,0
203308,neutron,0,0
203309,therapy,0,0
203310,for,0,0
203311,bladder,0,0
203312,cancer,0,0
203313,.,0,0
203314,This,0,0
203315,report,0,0
203316,is,0,0
203317,an,0,0
203318,analysis,0,0
203319,of,0,0
203320,the,0,0
203321,morbidity,1,1
203322,in,0,0
203323,the,0,0
203324,bladder,0,0
203325,and,0,0
203326,bowel,0,1
203327,observed,0,0
203328,in,0,0
203329,a,0,0
203330,randomized,0,0
203331,trial,0,0
203332,of,0,0
203333,d,0,0
203334,(,0,0
203335,15,0,0
203336,),0,0
203337,+Be,0,0
203338,neutrons,0,0
203339,versus,0,0
203340,megavoltage,0,0
203341,photons,0,0
203342,in,0,0
203343,the,0,0
203344,treatment,0,0
203345,of,0,0
203346,bladder,0,0
203347,cancer,0,0
203348,.,0,0
203349,Acute,1,0
203350,reactions,1,1
203351,in,0,0
203352,the,0,0
203353,bladder,0,0
203354,and,0,1
203355,bowel,0,1
203356,were,0,0
203357,significantly,0,0
203358,worse,0,0
203359,after,0,0
203360,photon,0,0
203361,therapy,0,0
203362,.,0,0
203363,Of,0,0
203364,the,0,0
203365,patients,0,0
203366,treated,0,0
203367,with,0,0
203368,photons,0,0
203369,45.7,0,0
203370,%,0,0
203371,had,0,0
203372,severe,0,1
203373,reactions,1,1
203374,in,1,0
203375,the,1,0
203376,bladder,1,0
203377,compared,0,0
203378,with,0,0
203379,10.6,0,0
203380,%,0,0
203381,after,0,0
203382,neutron,0,0
203383,therapy,0,0
203384,(,0,0
203385,p,0,0
203386,less,0,0
203387,than,0,0
203388,0.001,0,0
203389,),0,0
203390,.,0,0
203391,Severe,1,0
203392,acute,1,0
203393,bowel,1,1
203394,reactions,1,1
203395,were,0,0
203396,observed,0,0
203397,in,0,0
203398,8.5,0,0
203399,%,0,0
203400,of,0,0
203401,the,0,0
203402,patients,0,0
203403,after,0,0
203404,photon,0,0
203405,therapy,0,0
203406,compared,0,0
203407,with,0,0
203408,3.8,0,0
203409,%,0,0
203410,after,0,0
203411,neutron,0,0
203412,therapy,0,0
203413,(,0,0
203414,p,0,0
203415,less,0,0
203416,than,0,0
203417,0.05,0,0
203418,),0,0
203419,.,0,0
203420,Late,1,0
203421,reactions,1,1
203422,were,0,0
203423,significantly,0,0
203424,worse,0,0
203425,after,0,0
203426,neutrons,0,0
203427,.,0,0
203428,Severe,1,0
203429,late,1,0
203430,reactions,1,1
203431,in,1,0
203432,the,1,0
203433,bladder,1,0
203434,were,0,0
203435,seen,0,0
203436,in,0,0
203437,58.5,0,0
203438,%,0,0
203439,of,0,0
203440,patients,0,0
203441,after,0,0
203442,neutron,0,0
203443,therapy,0,0
203444,and,0,0
203445,in,0,0
203446,40.5,0,0
203447,%,0,0
203448,after,0,0
203449,photon,0,1
203450,therapy,0,0
203451,(,0,0
203452,p,0,0
203453,less,0,0
203454,than,0,0
203455,0.05,0,0
203456,),0,0
203457,.,0,0
203458,In,0,0
203459,the,0,0
203460,bowel,0,0
203461,they,0,0
203462,were,0,0
203463,observed,0,0
203464,in,0,0
203465,53.3,0,0
203466,%,0,0
203467,of,0,0
203468,patients,0,0
203469,after,0,0
203470,neutron,0,0
203471,therapy,0,0
203472,compared,0,0
203473,with,0,0
203474,8,0,0
203475,%,0,0
203476,after,0,0
203477,photon,0,1
203478,therapy,0,0
203479,(,0,0
203480,p,0,0
203481,less,0,0
203482,than,0,0
203483,0.0001,0,0
203484,),0,0
203485,.,0,0
203486,The,0,0
203487,disparity,1,0
203488,in,1,0
203489,the,1,0
203490,degree,1,1
203491,of,1,0
203492,early,1,0
203493,and,1,0
203494,late,1,0
203495,complications,1,1
203496,makes,0,0
203497,assessment,0,0
203498,of,0,0
203499,RBE,1,0
203500,values,1,1
203501,difficult,0,0
203502,.,0,0
203503,It,0,0
203504,is,0,0
203505,estimated,0,0
203506,that,0,0
203507,for,0,0
203508,bladder,1,0
203509,morbidity,1,1
203510,the,0,0
203511,RBE,1,0
203512,value,1,0
203513,",",0,0
203514,for,0,0
203515,photon,0,1
203516,dose,0,0
203517,fractions,0,0
203518,of,0,0
203519,2.75,0,0
203520,Gy,0,0
203521,",",0,0
203522,is,0,0
203523,less,0,0
203524,than,0,0
203525,3.3,0,0
203526,for,0,0
203527,early,0,0
203528,reactions,0,1
203529,and,0,0
203530,equal,0,0
203531,to,0,0
203532,3.4,0,0
203533,for,0,0
203534,late,0,0
203535,effects,0,0
203536,.,0,0
203537,The,0,0
203538,respective,0,0
203539,RBE,1,0
203540,values,1,1
203541,for,0,0
203542,early,0,0
203543,and,0,0
203544,late,0,1
203545,effects,0,1
203546,in,0,0
203547,the,0,0
203548,bowel,0,0
203549,are,0,0
203550,less,0,0
203551,than,0,0
203552,3.4,0,0
203553,and,0,0
203554,3.8,0,0
203555,.,0,0
203556,Untoward,0,1
203557,effects,0,1
203558,of,0,0
203559,fenfluramine,0,0
203560,in,0,0
203561,autistic,0,0
203562,children,0,0
203563,.,0,0
203564,Several,0,0
203565,recent,0,0
203566,studies,0,0
203567,have,0,0
203568,described,0,0
203569,the,0,0
203570,benefits,0,0
203571,of,0,0
203572,fenfluramine,0,0
203573,for,0,0
203574,the,0,0
203575,symptomatic,0,0
203576,treatment,0,0
203577,of,0,0
203578,infantile,0,0
203579,autism,0,0
203580,.,0,0
203581,No,0,0
203582,large,0,0
203583,surveys,0,0
203584,of,0,0
203585,side,0,1
203586,effects,0,0
203587,of,0,0
203588,this,0,0
203589,drug,0,0
203590,have,0,0
203591,been,0,0
203592,reported,0,0
203593,in,0,0
203594,autistic,0,0
203595,children,0,0
203596,.,0,0
203597,To,0,0
203598,evaluate,0,0
203599,the,0,0
203600,untoward,0,0
203601,effects,0,0
203602,of,0,0
203603,fenfluramine,0,0
203604,in,0,0
203605,children,0,0
203606,with,0,0
203607,autism,0,0
203608,",",0,0
203609,12,0,0
203610,subjects,0,0
203611,were,0,0
203612,systematically,0,0
203613,studied,0,0
203614,.,0,0
203615,Medication,0,0
203616,was,0,0
203617,administered,0,0
203618,in,0,0
203619,a,0,0
203620,double-blind,0,0
203621,",",0,0
203622,placebo-controlled,0,0
203623,cross-over,0,0
203624,study,0,0
203625,.,0,0
203626,Parents,0,0
203627,were,0,0
203628,trained,0,0
203629,in,0,0
203630,monitoring,0,0
203631,untoward,0,0
203632,effects,0,0
203633,.,0,0
203634,These,0,0
203635,observations,0,0
203636,were,0,0
203637,compiled,0,0
203638,in,0,0
203639,detailed,0,0
203640,daily,0,0
203641,notes,0,0
203642,.,0,0
203643,In,0,0
203644,addition,0,0
203645,",",0,0
203646,four,0,0
203647,cases,0,0
203648,describing,0,0
203649,unusual,0,0
203650,effects,0,0
203651,found,0,0
203652,in,0,0
203653,a,0,0
203654,sample,0,0
203655,of,0,0
203656,170,0,0
203657,patients,0,0
203658,treated,0,0
203659,with,0,0
203660,fenfluramine,0,0
203661,are,0,0
203662,also,0,0
203663,reported,0,0
203664,.,0,0
203665,In,0,0
203666,the,0,0
203667,initial,0,0
203668,2,0,0
203669,weeks,0,0
203670,of,0,0
203671,active,0,0
203672,drug,0,0
203673,listlessness,0,1
203674,",",0,1
203675,food,1,1
203676,refusal,1,1
203677,",",1,1
203678,and,1,1
203679,stomach,1,1
203680,upset,1,1
203681,were,0,0
203682,frequently,0,0
203683,seen,0,0
203684,.,0,0
203685,A,0,0
203686,different,0,0
203687,pattern,0,0
203688,of,0,0
203689,untoward,1,1
203690,effects,1,1
203691,was,0,0
203692,seen,0,0
203693,in,0,0
203694,the,0,0
203695,final,0,0
203696,14,0,0
203697,weeks,0,0
203698,of,0,0
203699,treatment,0,0
203700,.,0,0
203701,Irritability,1,1
203702,",",1,0
203703,agitation,1,1
203704,",",1,1
203705,and,1,1
203706,crying,1,1
203707,along,1,0
203708,with,1,0
203709,continued,1,0
203710,food,1,0
203711,refusal,1,1
203712,were,0,0
203713,noted,0,0
203714,.,0,0
203715,The,0,0
203716,subjects,0,0
203717,lost,0,0
203718,2.1,0,0
203719,%,0,0
203720,of,0,0
203721,body,1,1
203722,weight,1,1
203723,during,0,0
203724,active,0,0
203725,drug,0,0
203726,phase,0,0
203727,",",0,0
203728,but,0,0
203729,there,0,0
203730,was,0,0
203731,a,0,0
203732,rebound,1,1
203733,weight,1,1
203734,gain,1,1
203735,during,0,0
203736,the,0,0
203737,subsequent,0,0
203738,placebo,0,0
203739,phase,0,0
203740,.,0,0
203741,A,0,0
203742,thorough,0,0
203743,understanding,0,0
203744,of,0,0
203745,fenfluramine,0,0
203746,'s,0,0
203747,side,0,1
203748,effects,0,1
203749,and,0,1
203750,adverse,0,1
203751,reactions,0,1
203752,is,0,0
203753,necessary,0,0
203754,so,0,0
203755,as,0,0
203756,to,0,0
203757,differentiate,0,0
203758,them,0,0
203759,from,0,0
203760,the,0,0
203761,multiple,0,0
203762,symptoms,0,1
203763,inherent,0,0
203764,in,0,0
203765,the,0,0
203766,syndrome,0,0
203767,of,0,0
203768,autism,0,0
203769,.,0,0
203770,Comparison,0,0
203771,of,0,0
203772,inhaled,0,0
203773,albuterol,0,0
203774,powder,0,0
203775,and,0,1
203776,aerosol,0,0
203777,in,0,0
203778,asthma,0,0
203779,.,0,0
203780,In,0,0
203781,this,0,0
203782,multicenter,0,0
203783,",",0,0
203784,randomized,0,0
203785,",",0,0
203786,double-blind,0,0
203787,study,0,0
203788,comparing,0,0
203789,the,0,0
203790,efficacy,0,1
203791,and,0,0
203792,safety,0,1
203793,of,0,1
203794,aerosolized,0,0
203795,albuterol,0,0
203796,with,0,0
203797,the,0,0
203798,dry,0,0
203799,powder,0,0
203800,formulation,0,0
203801,",",0,0
203802,231,0,0
203803,patients,0,0
203804,with,0,0
203805,chronic,0,0
203806,reversible,0,0
203807,obstructive,0,0
203808,airway,0,1
203809,disease,0,1
203810,were,0,0
203811,randomly,0,0
203812,allocated,0,0
203813,to,0,0
203814,receive,0,0
203815,either,0,0
203816,placebo,0,0
203817,albuterol,0,0
203818,aerosol,0,0
203819,followed,0,0
203820,immediately,0,0
203821,by,0,0
203822,active,0,0
203823,albuterol,0,0
203824,powder,0,0
203825,(,0,0
203826,200,0,0
203827,micrograms,0,0
203828,),0,0
203829,or,0,0
203830,active,0,0
203831,albuterol,0,0
203832,aerosol,0,0
203833,(,0,0
203834,two,0,0
203835,puffs,0,0
203836,",",0,0
203837,180,0,0
203838,micrograms,0,0
203839,),0,0
203840,followed,0,0
203841,immediately,0,0
203842,by,0,0
203843,placebo,0,0
203844,lactose,0,0
203845,powder,0,0
203846,four,0,0
203847,times,0,0
203848,a,0,0
203849,day,0,0
203850,for,0,0
203851,a,0,0
203852,period,0,0
203853,of,0,0
203854,12,0,0
203855,weeks,0,0
203856,.,0,0
203857,No,0,0
203858,statistically,0,0
203859,significant,0,0
203860,differences,0,0
203861,were,0,0
203862,found,0,0
203863,between,0,0
203864,the,0,0
203865,powder,0,0
203866,and,0,0
203867,aerosol,0,0
203868,formulations,0,0
203869,with,0,0
203870,respect,0,0
203871,to,0,0
203872,pulmonary,1,1
203873,function,1,1
203874,",",1,0
203875,length,1,1
203876,of,1,1
203877,time,1,1
203878,mean,1,1
203879,FEV1,1,1
203880,remained,0,0
203881,greater,0,0
203882,than,0,0
203883,or,0,0
203884,equal,0,0
203885,to,0,0
203886,15,0,0
203887,%,0,0
203888,above,0,0
203889,baseline,0,0
203890,",",0,0
203891,physicians,1,1
203892,',1,0
203893,assessments,1,0
203894,of,1,0
203895,patients,1,0
203896,',1,0
203897,clinical,1,0
203898,response,1,1
203899,",",0,0
203900,or,0,0
203901,patients,1,0
203902,',1,1
203903,subjective,1,1
203904,symptom,1,1
203905,scores,1,1
203906,.,1,0
203907,There,0,0
203908,were,0,0
203909,also,0,0
203910,no,0,0
203911,significant,0,0
203912,differences,0,0
203913,between,0,0
203914,treatment,0,0
203915,groups,0,0
203916,in,0,0
203917,cardiovascular,1,1
203918,effects,1,1
203919,",",1,0
203920,laboratory,1,1
203921,values,1,1
203922,",",1,0
203923,or,1,0
203924,adverse,1,1
203925,events,1,1
203926,.,1,0
203927,Among,0,0
203928,patients,0,0
203929,who,0,0
203930,expressed,0,0
203931,a,0,0
203932,preference,1,0
203933,for,1,0
203934,one,1,0
203935,of,1,0
203936,the,1,0
203937,delivery,1,0
203938,systems,1,0
203939,",",0,1
203940,half,0,0
203941,preferred,0,0
203942,using,0,0
203943,the,0,0
203944,powder,0,0
203945,.,0,0
203946,Results,0,0
203947,of,0,0
203948,this,0,0
203949,study,0,0
203950,demonstrate,0,0
203951,that,0,0
203952,200,0,0
203953,micrograms,0,0
203954,of,0,0
203955,albuterol,0,0
203956,powder,0,0
203957,is,0,0
203958,as,0,0
203959,safe,0,0
203960,and,0,0
203961,effective,0,0
203962,as,0,0
203963,180,0,0
203964,micrograms,0,0
203965,of,0,0
203966,albuterol,0,0
203967,aerosol,0,0
203968,.,0,0
203969,Gastric,1,1
203970,contents,1,1
203971,and,0,1
203972,pH,0,1
203973,after,0,0
203974,oral,0,0
203975,premedication,0,0
203976,.,0,0
203977,Forty,0,0
203978,women,0,0
203979,",",0,0
203980,aged,0,0
203981,26-40,0,0
203982,years,0,0
203983,",",0,0
203984,were,0,0
203985,investigated,0,0
203986,with,0,0
203987,regard,0,0
203988,to,0,0
203989,gastric,0,1
203990,contents,0,1
203991,and,0,0
203992,pH,0,1
203993,before,0,0
203994,general,0,0
203995,anaesthesia,0,0
203996,.,0,0
203997,The,0,0
203998,patients,0,0
203999,were,0,0
204000,divided,0,0
204001,into,0,0
204002,two,0,0
204003,groups,0,0
204004,(,0,0
204005,20,0,0
204006,in,0,0
204007,each,0,0
204008,),0,0
204009,.,0,0
204010,Group,0,0
204011,100,0,0
204012,received,0,0
204013,0.3,0,0
204014,mg,0,0
204015,kg-1,0,0
204016,diazepam,0,0
204017,orally,0,0
204018,with,0,0
204019,100,0,0
204020,ml,0,0
204021,of,0,0
204022,water,0,0
204023,2,0,0
204024,h,0,0
204025,before,0,0
204026,surgery,0,0
204027,.,0,0
204028,Group,0,0
204029,50,0,0
204030,received,0,0
204031,0.3,0,0
204032,mg,0,0
204033,kg-1,0,0
204034,diazepam,0,0
204035,with,0,0
204036,50,0,0
204037,ml,0,0
204038,of,0,0
204039,water,0,0
204040,2,0,0
204041,h,0,0
204042,before,0,0
204043,surgery,0,0
204044,.,0,0
204045,The,0,0
204046,amount,1,0
204047,of,1,0
204048,gastric,1,1
204049,content,1,1
204050,was,0,0
204051,significantly,0,0
204052,greater,0,0
204053,in,0,0
204054,Group,0,0
204055,100,0,0
204056,than,0,0
204057,in,0,0
204058,Group,0,0
204059,50,0,0
204060,(,0,0
204061,P,0,0
204062,less,0,0
204063,than,0,0
204064,0.05,0,0
204065,),0,0
204066,.,0,0
204067,There,0,0
204068,was,0,0
204069,no,0,0
204070,statistical,0,0
204071,difference,0,0
204072,in,0,0
204073,pH,1,0
204074,values,1,1
204075,between,0,0
204076,the,0,0
204077,groups,0,0
204078,.,0,0
204079,The,0,0
204080,number,0,1
204081,of,0,0
204082,patients,0,0
204083,with,0,0
204084,both,0,0
204085,gastric,1,1
204086,pH,1,0
204087,less,0,0
204088,than,0,0
204089,2.5,0,0
204090,and,0,0
204091,gastric,1,0
204092,volume,1,1
204093,greater,0,0
204094,than,0,0
204095,25,0,0
204096,ml,0,0
204097,was,0,0
204098,significantly,0,0
204099,higher,0,0
204100,in,0,0
204101,Group,0,0
204102,100,0,0
204103,compared,0,0
204104,to,0,0
204105,Group,0,0
204106,50,0,0
204107,(,0,0
204108,P,0,0
204109,less,0,0
204110,than,0,0
204111,0.05,0,0
204112,),0,0
204113,.,0,0
204114,We,0,0
204115,can,0,0
204116,not,0,0
204117,recommend,0,0
204118,the,0,0
204119,use,0,0
204120,of,0,0
204121,oral,0,0
204122,premedication,0,0
204123,using,0,0
204124,these,0,0
204125,amounts,0,0
204126,of,0,0
204127,water,0,1
204128,",",0,0
204129,considering,0,0
204130,the,0,0
204131,increased,0,0
204132,risk,0,0
204133,of,0,0
204134,aspiration,0,0
204135,of,0,0
204136,gastric,0,1
204137,contents,0,0
204138,.,0,0
204139,Pre-exposure,0,0
204140,studies,0,0
204141,with,0,0
204142,purified,0,0
204143,chick,0,0
204144,embryo,0,0
204145,cell,0,0
204146,culture,0,0
204147,rabies,0,0
204148,vaccine,0,0
204149,and,0,0
204150,human,0,0
204151,diploid,0,1
204152,cell,0,0
204153,vaccine,0,0
204154,:,0,0
204155,serological,0,0
204156,and,0,0
204157,clinical,0,0
204158,responses,0,1
204159,in,0,0
204160,man,0,0
204161,.,0,0
204162,Clinical,0,1
204163,reactions,0,1
204164,and,0,0
204165,neutralizing,0,1
204166,antibody,0,0
204167,responses,0,1
204168,to,0,0
204169,six,0,0
204170,pre-exposure,0,0
204171,regimens,0,0
204172,of,0,0
204173,purified,0,0
204174,chick,0,0
204175,embryo,0,0
204176,cell,0,0
204177,culture,0,0
204178,rabies,0,0
204179,vaccine,0,0
204180,(,0,0
204181,PCECV,0,0
204182,),0,0
204183,and,0,0
204184,human,0,0
204185,diploid,0,1
204186,cell,0,1
204187,strain,0,0
204188,rabies,0,0
204189,vaccine,0,0
204190,(,0,0
204191,HDCSV,0,1
204192,),0,0
204193,were,0,0
204194,studied,0,0
204195,in,0,0
204196,177,0,0
204197,volunteers,0,0
204198,.,0,0
204199,Antibody,1,0
204200,kinetics,1,1
204201,",",1,0
204202,height,1,1
204203,of,1,0
204204,the,1,0
204205,response,1,1
204206,and,1,0
204207,persistence,1,1
204208,of,1,1
204209,antibody,1,0
204210,over,1,0
204211,two,1,0
204212,years,1,0
204213,were,0,0
204214,virtually,0,0
204215,identical,0,0
204216,after,0,0
204217,PCECV,0,0
204218,and,0,0
204219,HDCSV,0,0
204220,.,0,0
204221,An,0,0
204222,antibody,1,0
204223,response,1,1
204224,was,0,0
204225,detected,0,0
204226,in,0,0
204227,all,0,0
204228,subjects,0,0
204229,on,0,0
204230,day,0,0
204231,14,0,0
204232,when,0,0
204233,the,0,0
204234,highest,0,0
204235,titres,0,1
204236,were,0,0
204237,found,0,0
204238,after,0,0
204239,two,0,0
204240,intramuscular,0,0
204241,(,0,0
204242,i.m,0,0
204243,.,0,0
204244,),0,0
204245,1.0,0,0
204246,ml,0,0
204247,doses,0,0
204248,of,0,0
204249,a,0,0
204250,schedule,0,0
204251,of,0,0
204252,immunization,0,0
204253,on,0,0
204254,days,0,0
204255,0,0,0
204256,",",0,0
204257,7,0,0
204258,and,0,0
204259,21,0,0
204260,.,0,0
204261,In,0,0
204262,comparison,0,0
204263,",",0,0
204264,a,0,0
204265,schedule,0,0
204266,of,0,0
204267,immunization,0,0
204268,on,0,0
204269,days,0,0
204270,0,0,0
204271,",",0,0
204272,28,0,0
204273,and,0,0
204274,56,0,0
204275,ultimately,0,0
204276,evoked,0,0
204277,the,0,0
204278,highest,0,0
204279,titres,1,0
204280,21,1,0
204281,days,1,0
204282,after,1,0
204283,the,1,0
204284,final,1,1
204285,injection,1,0
204286,",",0,0
204287,but,0,0
204288,antibody,0,1
204289,persisted,0,0
204290,equally,0,0
204291,well,0,0
204292,over,0,0
204293,two,0,0
204294,years,0,0
204295,with,0,0
204296,either,0,0
204297,schedule,0,0
204298,.,0,0
204299,Neutralizing,1,0
204300,antibody,1,0
204301,titres,1,1
204302,were,0,0
204303,lower,0,0
204304,after,0,0
204305,intradermal,0,1
204306,(,0,0
204307,i.d,0,0
204308,.,0,0
204309,),0,0
204310,vaccination,0,0
204311,with,0,0
204312,0.1,0,0
204313,ml,0,0
204314,compared,0,0
204315,to,0,0
204316,1.0,0,0
204317,ml,0,0
204318,i.m,0,0
204319,.,0,0
204320,on,0,0
204321,days,0,0
204322,0,0,0
204323,",",0,0
204324,7,0,0
204325,and,0,0
204326,21,0,0
204327,",",0,0
204328,but,0,0
204329,when,0,0
204330,given,0,0
204331,on,0,0
204332,days,0,0
204333,0,0,0
204334,",",0,0
204335,28,0,0
204336,and,0,0
204337,56,0,0
204338,the,0,0
204339,responses,0,0
204340,were,0,0
204341,comparable,0,0
204342,.,0,0
204343,Three,0,0
204344,subjects,0,0
204345,with,0,0
204346,a,0,0
204347,personal,0,1
204348,or,0,0
204349,family,0,1
204350,history,0,1
204351,of,0,0
204352,atopy,0,1
204353,developed,0,0
204354,urticarial,1,1
204355,lesions,1,1
204356,after,0,0
204357,PCECV,0,0
204358,.,0,0
204359,Both,0,0
204360,vaccines,0,0
204361,were,0,0
204362,otherwise,0,0
204363,well,0,0
204364,tolerated,0,1
204365,.,0,0
204366,[,0,0
204367,Randomized,0,0
204368,cooperative,0,0
204369,studies,0,0
204370,of,0,0
204371,the,0,0
204372,surgical,0,0
204373,treatment,0,0
204374,of,0,0
204375,cancer,0,0
204376,of,0,0
204377,the,0,0
204378,thyroid,0,0
204379,gland,0,0
204380,],0,0
204381,.,0,0
204382,Management,0,1
204383,of,0,0
204384,unstable,0,0
204385,angina,0,1
204386,at,0,0
204387,rest,0,0
204388,by,0,0
204389,verapamil,0,0
204390,.,0,0
204391,A,0,0
204392,double-blind,0,0
204393,cross-over,0,0
204394,study,0,0
204395,in,0,0
204396,coronary,0,0
204397,care,0,0
204398,unit,0,0
204399,.,0,0
204400,A,0,0
204401,therapeutic,0,0
204402,trial,0,0
204403,with,0,0
204404,verapamil,0,0
204405,",",0,0
204406,a,0,0
204407,calcium-antagonist,0,0
204408,drug,0,0
204409,",",0,0
204410,was,0,0
204411,performed,0,0
204412,in,0,0
204413,12,0,0
204414,patients,0,0
204415,admitted,0,0
204416,to,0,0
204417,our,0,0
204418,coronary,0,0
204419,care,0,0
204420,unit,0,0
204421,because,0,0
204422,of,0,0
204423,frequent,0,0
204424,daily,0,0
204425,attacks,0,1
204426,of,0,0
204427,angina,0,1
204428,at,0,0
204429,rest,0,0
204430,attributed,0,0
204431,to,0,0
204432,coronary,0,0
204433,vasospasm,0,1
204434,.,0,0
204435,After,0,0
204436,a,0,0
204437,48-hour,0,1
204438,run-in,0,0
204439,period,0,0
204440,",",0,0
204441,oral,0,0
204442,verapamil,0,0
204443,480,0,0
204444,mg/day,0,0
204445,and,0,0
204446,placebo,0,0
204447,were,0,0
204448,administered,0,0
204449,alternately,0,0
204450,during,0,0
204451,4,0,0
204452,randomised,0,0
204453,48-hour,0,0
204454,periods,0,0
204455,.,0,0
204456,Transient,1,0
204457,ischaemic,1,0
204458,attacks,1,1
204459,with,1,0
204460,ST,1,1
204461,segment,1,1
204462,elevation,1,1
204463,or,1,1
204464,depression,1,1
204465,",",1,1
204466,with,1,0
204467,or,1,0
204468,without,1,0
204469,pain,1,1
204470,",",0,0
204471,were,0,0
204472,documented,0,0
204473,by,0,0
204474,continuous,1,0
204475,electrocardiographic,1,1
204476,monitoring,1,0
204477,.,1,0
204478,The,0,0
204479,number,1,1
204480,of,1,0
204481,attacks,1,0
204482,during,0,0
204483,the,0,0
204484,run-in,0,0
204485,and,0,0
204486,2,0,0
204487,placebo,0,0
204488,periods,0,0
204489,were,0,0
204490,128,0,0
204491,",",0,0
204492,123,0,0
204493,",",0,0
204494,and,0,0
204495,130,0,0
204496,",",0,0
204497,respectively,0,0
204498,",",0,0
204499,and,0,0
204500,31,0,0
204501,and,0,0
204502,23,0,0
204503,during,0,0
204504,the,0,0
204505,2,0,0
204506,treatment,0,0
204507,periods,0,0
204508,(,0,0
204509,P,0,0
204510,less,0,0
204511,than,0,0
204512,0.006,0,0
204513,and,0,0
204514,P,0,0
204515,less,0,0
204516,than,0,0
204517,0.003,0,0
204518,),0,0
204519,.,0,0
204520,This,0,0
204521,drug,0,0
204522,therefore,0,0
204523,appears,0,0
204524,to,0,0
204525,be,0,0
204526,effective,0,0
204527,in,0,0
204528,the,0,0
204529,management,0,0
204530,of,0,0
204531,patients,0,0
204532,with,0,0
204533,frequent,0,0
204534,attacks,1,1
204535,of,1,0
204536,angina,1,1
204537,at,1,0
204538,rest,1,0
204539,.,1,0
204540,[,0,0
204541,Results,0,0
204542,of,0,0
204543,a,0,0
204544,cooperative,0,0
204545,prospective,0,0
204546,study,0,0
204547,of,0,0
204548,treatment,0,0
204549,of,0,0
204550,primary,0,0
204551,digestive,0,0
204552,localizations,0,1
204553,of,0,0
204554,non-Hodgkin,0,0
204555,'s,0,1
204556,lymphoma,0,1
204557,],0,0
204558,.,0,0
204559,We,0,0
204560,report,0,0
204561,the,0,0
204562,results,0,0
204563,of,0,0
204564,chemotherapy,0,0
204565,treatment,0,0
204566,in,0,0
204567,82,0,0
204568,patients,0,0
204569,presenting,0,0
204570,with,0,0
204571,primary,0,0
204572,digestive,0,0
204573,lymphoma,0,1
204574,and,0,0
204575,included,0,0
204576,in,0,0
204577,a,0,0
204578,study,0,0
204579,conducted,0,0
204580,between,0,0
204581,October,0,0
204582,1977,0,0
204583,and,0,0
204584,October,0,0
204585,1985,0,0
204586,.,0,0
204587,There,0,0
204588,were,0,0
204589,31,0,0
204590,gastric,0,0
204591,lymphoma,0,0
204592,",",0,0
204593,18,0,0
204594,small,0,0
204595,intestinal,0,0
204596,lymphomas,0,1
204597,",",0,0
204598,and,0,0
204599,19,0,0
204600,with,0,0
204601,multiple,0,0
204602,involvement,0,0
204603,:,0,0
204604,63,0,0
204605,patients,0,0
204606,had,0,0
204607,had,0,0
204608,a,0,0
204609,surgical,0,0
204610,staging,0,0
204611,with,0,0
204612,total,0,1
204613,tumor,0,1
204614,resection,0,0
204615,in,0,0
204616,15,0,0
204617,cases,0,0
204618,.,0,0
204619,Nineteen,0,0
204620,patients,0,0
204621,with,0,0
204622,limited,0,0
204623,disease,0,1
204624,(,0,0
204625,ID,0,0
204626,and,0,1
204627,IID,0,0
204628,),0,1
204629,were,0,0
204630,randomly,0,0
204631,assigned,0,0
204632,to,0,0
204633,either,0,0
204634,a,0,0
204635,3-week,0,0
204636,chemotherapy,0,0
204637,regimen,0,0
204638,associated,0,0
204639,with,0,0
204640,whole,0,0
204641,abdominal,0,1
204642,radiotherapy,0,0
204643,or,0,0
204644,chemotherapy,0,0
204645,for,0,0
204646,3,0,0
204647,years,0,0
204648,.,0,0
204649,Twenty-seven,0,0
204650,stage,0,0
204651,IIID,0,0
204652,and,0,1
204653,thirty-six,0,0
204654,stage,0,1
204655,IV,0,1
204656,were,0,0
204657,treated,0,0
204658,with,0,0
204659,chemotherapy,0,0
204660,alone,0,0
204661,for,0,0
204662,3,0,0
204663,years,0,0
204664,.,0,0
204665,Low,0,0
204666,grade,0,1
204667,lymphomas,0,1
204668,(,0,0
204669,16,0,0
204670,patients,0,0
204671,),0,0
204672,received,0,0
204673,a,0,0
204674,cyclophosphamide,0,0
204675,",",0,0
204676,vincristine,0,0
204677,",",0,1
204678,prednisone,0,0
204679,association,0,0
204680,.,0,0
204681,Intermediate,0,0
204682,(,0,0
204683,56,0,0
204684,patients,0,0
204685,),0,0
204686,and,0,0
204687,high,0,1
204688,grade,0,1
204689,(,0,0
204690,10,0,0
204691,patients,0,0
204692,),0,0
204693,lymphomas,0,0
204694,received,0,0
204695,cyclophosphamide,0,0
204696,",",0,0
204697,vincristine,0,0
204698,",",0,1
204699,adriamycin,0,0
204700,",",0,0
204701,prednisone,0,0
204702,.,0,0
204703,The,0,0
204704,overall,1,1
204705,complete,1,1
204706,remission,1,1
204707,obtained,0,0
204708,was,0,0
204709,63,0,0
204710,p.,0,0
204711,100,0,0
204712,(,0,0
204713,51,0,0
204714,patients,0,0
204715,),0,0
204716,with,0,0
204717,17,0,0
204718,patients,0,0
204719,in,0,0
204720,relapse,1,1
204721,within,0,0
204722,6,0,0
204723,to,0,0
204724,40,0,0
204725,months,0,0
204726,.,0,0
204727,Overall,1,1
204728,survival,1,1
204729,was,0,0
204730,46,0,0
204731,p.,0,0
204732,100,0,0
204733,at,0,0
204734,5,0,0
204735,years,0,0
204736,.,0,0
204737,Survival,1,1
204738,was,0,0
204739,dependent,0,0
204740,on,0,0
204741,abdominal,1,1
204742,extension,1,1
204743,",",1,0
204744,histologic,1,1
204745,grade,1,1
204746,according,1,0
204747,to,1,0
204748,the,1,0
204749,new,1,0
204750,working,1,0
204751,formulation,1,0
204752,used,1,0
204753,for,1,0
204754,lymph-node,1,1
204755,lymphomas,1,1
204756,",",1,0
204757,initial,1,1
204758,localization,1,1
204759,(,0,0
204760,gastric,0,1
204761,lymphomas,0,0
204762,have,0,0
204763,the,0,0
204764,best,0,0
204765,survival,0,1
204766,),0,0
204767,and,0,0
204768,achievement,0,1
204769,of,0,1
204770,complete,1,1
204771,remission,1,1
204772,.,1,0
204773,Chemotherapy,0,0
204774,is,0,0
204775,an,0,0
204776,effective,0,0
204777,treatment,1,0
204778,for,0,0
204779,primary,0,0
204780,digestive,0,0
204781,lymphomas,0,0
204782,.,0,0
204783,The,0,0
204784,role,0,0
204785,of,0,0
204786,surgery,0,0
204787,in,0,0
204788,the,0,0
204789,management,0,0
204790,of,0,0
204791,lymphomas,0,0
204792,has,0,0
204793,to,0,0
204794,be,0,0
204795,defined,0,0
204796,by,0,0
204797,further,0,0
204798,studies,0,0
204799,.,0,0
204800,5,0,0
204801,FU,0,0
204802,infusion,0,0
204803,with,0,0
204804,mitomycin-C,0,0
204805,vs.,0,0
204806,5,0,0
204807,FU,0,0
204808,infusion,0,0
204809,with,0,0
204810,methyl-CCNU,0,0
204811,in,0,0
204812,the,0,0
204813,treatment,0,0
204814,of,0,0
204815,advanced,0,0
204816,upper,0,0
204817,gastrointestinal,0,1
204818,cancer,0,0
204819,:,0,0
204820,a,0,0
204821,Southwest,0,0
204822,Oncology,0,0
204823,Group,0,0
204824,Study,0,0
204825,.,0,0
204826,A,0,0
204827,randomized,0,0
204828,trial,0,0
204829,was,0,0
204830,conducted,0,0
204831,by,0,0
204832,the,0,0
204833,Southwest,0,0
204834,Oncology,0,0
204835,Group,0,0
204836,(,0,0
204837,SWOG,0,0
204838,),0,0
204839,in,0,0
204840,advanced,0,0
204841,carcinoma,0,0
204842,of,0,0
204843,the,0,0
204844,stomach,0,1
204845,and,0,0
204846,pancreas,0,0
204847,.,0,1
204848,Patients,0,0
204849,were,0,0
204850,assigned,0,0
204851,to,0,0
204852,receive,0,0
204853,monthly,0,0
204854,5-fluorouracil,0,0
204855,96-hour,0,0
204856,continuous,0,0
204857,infusions,0,0
204858,with,0,0
204859,either,0,0
204860,bolus,0,0
204861,mitomycin-C,0,0
204862,or,0,0
204863,oral,0,0
204864,methyl-CCNU,0,0
204865,.,0,0
204866,Mitomycin-C,0,0
204867,and,0,0
204868,methyl-CCNU,0,0
204869,were,0,0
204870,administered,0,0
204871,every,0,0
204872,eight,0,0
204873,weeks,0,0
204874,.,0,0
204875,The,0,0
204876,5,0,0
204877,FU-mitomycin,0,0
204878,combination,0,0
204879,produced,0,0
204880,a,0,0
204881,14,0,0
204882,%,0,0
204883,and,0,0
204884,22,0,0
204885,%,0,0
204886,response,1,1
204887,rate,1,1
204888,in,0,0
204889,disseminated,0,0
204890,stomach,0,1
204891,and,0,0
204892,pancreatic,0,1
204893,carcinoma,0,0
204894,",",0,0
204895,respectively,0,0
204896,.,0,0
204897,The,0,0
204898,combination,0,0
204899,of,0,0
204900,infusion,0,0
204901,5,0,0
204902,FU,0,0
204903,and,0,0
204904,methyl-CCNU,0,0
204905,achieved,0,0
204906,responses,1,1
204907,in,0,0
204908,9,0,0
204909,%,0,0
204910,and,0,0
204911,5,0,0
204912,%,0,0
204913,of,0,0
204914,stomach,0,1
204915,and,0,0
204916,pancreatic,0,1
204917,tumors,0,1
204918,",",0,0
204919,respectively,0,0
204920,.,0,0
204921,There,0,0
204922,was,0,0
204923,no,0,0
204924,significant,0,0
204925,difference,1,0
204926,in,1,0
204927,survival,1,1
204928,between,0,0
204929,limbs,0,0
204930,for,0,0
204931,either,0,0
204932,tumor,0,0
204933,.,0,0
204934,Median,1,1
204935,survival,1,1
204936,in,0,0
204937,gastric,0,1
204938,carcinoma,0,0
204939,on,0,0
204940,the,0,0
204941,5,0,0
204942,FU-mitomycin,0,0
204943,regimen,0,0
204944,was,0,0
204945,25,0,0
204946,weeks,0,0
204947,vs.,0,0
204948,18,0,0
204949,weeks,0,0
204950,on,0,0
204951,the,0,0
204952,5,0,0
204953,FU-METHYL-CCNU,0,0
204954,arm,0,0
204955,.,0,0
204956,In,0,0
204957,pancreatic,1,1
204958,carcinoma,1,0
204959,median,1,1
204960,survival,1,1
204961,on,0,0
204962,the,0,0
204963,mitomycin,0,0
204964,limb,0,1
204965,was,0,0
204966,19,0,0
204967,weeks,0,0
204968,as,0,0
204969,compared,0,0
204970,to,0,0
204971,17,0,0
204972,weeks,0,0
204973,on,0,0
204974,the,0,0
204975,methyl-CCNU,0,0
204976,program,0,0
204977,.,0,0
204978,Leukopenia,1,1
204979,was,0,0
204980,greater,0,0
204981,for,0,0
204982,the,0,0
204983,first,0,0
204984,course,0,0
204985,on,0,0
204986,the,0,0
204987,mitomycin,0,0
204988,limb,0,1
204989,.,0,0
204990,Regression,0,1
204991,analysis,0,0
204992,demonstrated,0,0
204993,that,0,0
204994,performance,1,1
204995,status,1,1
204996,was,0,0
204997,the,0,0
204998,most,0,0
204999,important,0,0
205000,pretreatment,0,0
205001,characteristic,0,1
205002,for,0,0
205003,predicting,0,1
205004,survival,1,1
205005,in,0,0
205006,both,0,0
205007,tumors,0,0
205008,.,0,0
205009,Neither,0,0
205010,5,0,0
205011,FU,0,1
205012,infusion,0,0
205013,combination,0,0
205014,appears,0,0
205015,to,0,0
205016,significantly,0,0
205017,alter,1,0
205018,the,1,0
205019,dismal,1,0
205020,prognosis,1,0
205021,of,0,0
205022,advanced,0,0
205023,upper,0,0
205024,gastrointestinal,0,1
205025,neoplasms,0,0
205026,.,0,0
205027,Randomized,0,0
205028,trial,0,0
205029,of,0,0
205030,combination,0,0
205031,chemotherapy,0,0
205032,in,0,0
205033,hormone-resistant,0,0
205034,metastatic,0,0
205035,prostate,0,0
205036,carcinoma,0,0
205037,.,0,0
205038,A,0,0
205039,prospective,0,0
205040,randomized,0,0
205041,study,0,0
205042,was,0,0
205043,conducted,0,0
205044,in,0,0
205045,51,0,0
205046,patients,0,0
205047,with,0,0
205048,stage,0,0
205049,D,0,0
205050,hormone-resistant,0,0
205051,prostatic,0,0
205052,carcinoma,0,0
205053,",",0,0
205054,comparing,0,0
205055,a,0,0
205056,combination,0,0
205057,of,0,0
205058,doxorubicin,0,0
205059,and,0,1
205060,lomustine,0,0
205061,(,0,1
205062,DC,0,0
205063,),0,0
205064,with,0,0
205065,cyclophosphamide,0,0
205066,and,0,1
205067,5-FU,0,1
205068,(,0,0
205069,CF,0,0
205070,),0,0
205071,.,0,0
205072,Patients,0,0
205073,were,0,0
205074,assessed,0,0
205075,objectively,0,0
205076,(,0,0
205077,employing,0,0
205078,National,0,1
205079,Prostate,0,0
205080,Cancer,0,0
205081,Project,0,1
205082,criteria,0,0
205083,),0,0
205084,and,0,0
205085,subjectively,0,1
205086,(,0,0
205087,using,0,0
205088,a,0,0
205089,numerical,0,1
205090,scoring,0,1
205091,scheme,0,0
205092,),0,0
205093,.,0,0
205094,Each,0,0
205095,regimen,0,0
205096,was,0,0
205097,well,0,0
205098,tolerated,1,1
205099,with,0,0
205100,acceptable,0,0
205101,levels,1,1
205102,of,1,0
205103,myelosuppression,1,1
205104,.,1,0
205105,The,0,0
205106,objective,1,0
205107,partial,1,0
205108,response,1,1
205109,rate,1,1
205110,was,0,0
205111,57,0,0
205112,%,0,0
205113,for,0,0
205114,DC,0,0
205115,and,0,0
205116,8,0,0
205117,%,0,0
205118,for,0,0
205119,CF,0,0
205120,.,0,0
205121,Objective,1,1
205122,stabilization,1,1
205123,occurred,0,0
205124,",",0,0
205125,respectively,0,0
205126,",",0,0
205127,in,0,0
205128,14,0,0
205129,%,0,0
205130,and,0,0
205131,44,0,0
205132,%,0,0
205133,of,0,0
205134,the,0,0
205135,patients,0,0
205136,.,0,0
205137,Similarly,0,0
205138,",",0,0
205139,DC,0,0
205140,demonstrated,0,0
205141,a,0,0
205142,significantly,0,0
205143,superior,0,0
205144,subjective,1,1
205145,response,1,1
205146,rate,1,1
205147,(,1,0
205148,partial,1,1
205149,plus,1,0
205150,complete,1,1
205151,),1,0
205152,of,0,0
205153,82,0,0
205154,%,0,0
205155,",",0,0
205156,compared,0,0
205157,to,0,0
205158,48,0,0
205159,%,0,0
205160,for,0,0
205161,CF,0,0
205162,.,0,0
205163,Patients,0,0
205164,with,0,0
205165,poor,0,1
205166,initial,0,0
205167,performance,0,1
205168,status,0,1
205169,or,0,0
205170,liver,0,1
205171,involvement,0,1
205172,had,0,0
205173,significantly,0,0
205174,lower,0,0
205175,response,1,1
205176,rates,1,1
205177,and,0,1
205178,reduced,0,0
205179,survival,1,1
205180,.,1,0
205181,Overall,0,0
205182,",",0,0
205183,there,1,0
205184,was,1,0
205185,no,1,0
205186,significant,1,0
205187,difference,1,0
205188,in,1,0
205189,survival,1,1
205190,between,1,0
205191,the,1,0
205192,two,1,0
205193,arms,1,0
205194,",",1,0
205195,reflecting,1,0
205196,the,1,0
205197,similarity,1,0
205198,between,1,0
205199,DC,1,0
205200,and,1,0
205201,CF,1,1
205202,in,1,0
205203,total,1,1
205204,objective,1,0
205205,response,1,1
205206,rate,1,1
205207,(,1,0
205208,partial,1,1
205209,response,1,1
205210,plus,1,0
205211,stable,1,1
205212,disease,1,0
205213,),1,0
205214,.,1,0
205215,DC,0,0
205216,provided,0,0
205217,superior,0,0
205218,palliation,1,0
205219,and,0,0
205220,was,0,0
205221,well,0,0
205222,tolerated,1,1
205223,by,0,0
205224,an,0,0
205225,essentially,0,0
205226,geriatric,0,0
205227,population,0,0
205228,.,0,0
205229,The,0,0
205230,treatment,0,0
205231,of,0,0
205232,senile,1,0
205233,dementia,1,1
205234,associated,0,0
205235,with,0,0
205236,cerebrovascular,0,1
205237,insufficiency,0,0
205238,:,0,0
205239,a,0,0
205240,comparative,0,0
205241,study,0,0
205242,of,0,0
205243,buflomedil,0,0
205244,and,0,0
205245,dihydrogenated,0,1
205246,ergot,0,0
205247,alkaloids,0,1
205248,.,0,0
205249,Seventy-six,0,0
205250,patients,0,0
205251,took,0,0
205252,part,0,0
205253,in,0,0
205254,a,0,0
205255,randomized,0,0
205256,",",0,0
205257,comparative,0,0
205258,study,0,0
205259,of,0,0
205260,the,0,0
205261,efficacy,0,1
205262,of,0,0
205263,buflomedil,0,0
205264,hydrochloride,0,0
205265,and,0,1
205266,dihydrogenated,0,1
205267,ergot,0,0
205268,alkaloids,0,1
205269,in,0,0
205270,the,0,0
205271,treatment,0,0
205272,of,0,0
205273,senile,1,0
205274,dementia,1,1
205275,associated,0,0
205276,with,0,0
205277,cerebrovascular,0,1
205278,insufficiency,0,1
205279,.,0,0
205280,Efficacy,1,1
205281,was,0,0
205282,assessed,0,0
205283,by,0,0
205284,the,0,0
205285,patients,0,0
205286,',0,0
205287,performance,0,1
205288,in,0,0
205289,four,0,0
205290,psychometric,1,0
205291,tests,1,0
205292,.,1,0
205293,The,0,0
205294,results,0,0
205295,showed,0,0
205296,that,0,0
205297,a,0,0
205298,trend,0,0
205299,in,0,0
205300,favour,0,0
205301,of,0,0
205302,the,0,0
205303,buflomedil,0,0
205304,group,0,0
205305,in,0,0
205306,three,0,0
205307,of,0,0
205308,the,0,0
205309,tests,0,0
205310,became,0,0
205311,statistically,0,0
205312,significant,0,0
205313,in,0,0
205314,the,0,0
205315,fourth,0,0
205316,.,0,0
205317,Both,0,0
205318,drugs,0,0
205319,appeared,0,0
205320,to,0,0
205321,be,0,0
205322,safe,1,0
205323,",",0,0
205324,causing,0,0
205325,no,0,0
205326,marked,0,0
205327,adverse,1,1
205328,reactions,1,1
205329,.,1,0
205330,In,0,0
205331,conclusion,0,0
205332,",",0,0
205333,buflomedil,0,0
205334,is,0,0
205335,as,0,0
205336,effective,0,1
205337,or,0,0
205338,more,0,0
205339,effective,0,1
205340,than,0,0
205341,dihydrogenated,0,0
205342,ergot,0,0
205343,alkaloids,0,0
205344,in,0,0
205345,the,0,0
205346,treatment,0,0
205347,of,0,0
205348,senile,1,0
205349,dementia,1,1
205350,associated,0,0
205351,with,0,0
205352,cerebrovascular,0,1
205353,insufficiency,0,1
205354,and,0,0
205355,could,0,0
205356,prove,0,0
205357,a,0,0
205358,valuable,0,0
205359,addition,0,0
205360,to,0,0
205361,long-term,0,0
205362,therapy,0,0
205363,if,0,0
205364,further,0,0
205365,studies,0,0
205366,support,0,0
205367,the,0,0
205368,trend,0,0
205369,shown,0,0
205370,in,0,0
205371,this,0,0
205372,study,0,0
205373,.,0,0
205374,[,0,0
205375,Randomized,0,0
205376,control,0,0
205377,study,0,0
205378,of,0,0
205379,high-dose,0,0
205380,metoclopramide,0,0
205381,in,0,0
205382,the,0,0
205383,prevention,0,0
205384,of,0,0
205385,CDDP-induced,1,0
205386,emesis,1,1
205387,],1,0
205388,.,0,0
205389,The,0,0
205390,effect,0,0
205391,of,0,0
205392,high-dose,0,0
205393,metoclopramide,0,0
205394,(,0,0
205395,2,0,0
205396,mg/kg,0,0
205397,",",0,0
205398,4,0,0
205399,times,0,0
205400,every,0,0
205401,2,0,0
205402,hours,0,0
205403,),0,0
205404,on,0,0
205405,the,0,0
205406,emesis,1,1
205407,of,0,0
205408,patients,0,0
205409,treated,0,0
205410,with,0,0
205411,CDDP,0,0
205412,(,0,0
205413,80,0,0
205414,mg/m2,0,0
205415,),0,0
205416,was,0,0
205417,examined,0,0
205418,by,0,0
205419,randomized,0,0
205420,control,0,0
205421,trial,0,0
205422,.,0,0
205423,The,0,0
205424,above,0,0
205425,metoclopramide,0,0
205426,regimen,0,0
205427,significantly,0,0
205428,suppressed,1,0
205429,the,1,0
205430,frequency,1,1
205431,of,1,0
205432,vomiting,1,1
205433,on,0,0
205434,the,0,0
205435,day,0,0
205436,of,0,0
205437,CDDP,0,0
205438,administration,0,0
205439,.,0,0
205440,The,0,0
205441,duration,0,1
205442,of,0,0
205443,nausea,1,1
205444,and,1,1
205445,anorexia,1,1
205446,after,0,0
205447,CDDP,0,1
205448,treatment,0,0
205449,was,0,0
205450,also,0,0
205451,shortened,0,0
205452,by,0,0
205453,high-dose,0,0
205454,metoclopramide,0,0
205455,administration,0,0
205456,.,0,0
205457,Interference,0,1
205458,on,0,0
205459,metabolism,0,1
205460,induced,0,0
205461,by,0,0
205462,muzolimine,0,0
205463,and,0,1
205464,chlorthalidone,0,0
205465,in,0,0
205466,type,0,0
205467,II,0,0
205468,hypertensive,0,0
205469,diabetics,0,0
205470,.,0,0
205471,There,0,0
205472,is,0,0
205473,a,0,0
205474,very,0,0
205475,high,0,0
205476,prevalence,0,0
205477,of,0,0
205478,hypertension,0,1
205479,in,0,0
205480,diabetic,0,0
205481,subjects,0,0
205482,",",0,0
205483,which,0,0
205484,makes,0,0
205485,it,0,0
205486,necessary,0,0
205487,to,0,0
205488,use,0,0
205489,an,0,0
205490,antihypertensive,0,0
205491,drug,0,0
205492,with,0,0
205493,the,0,0
205494,least,0,0
205495,possible,0,0
205496,metabolic,0,0
205497,interference,0,0
205498,.,0,0
205499,For,0,0
205500,example,0,0
205501,",",0,0
205502,in,0,0
205503,the,0,0
205504,early,0,0
205505,phase,0,0
205506,of,0,0
205507,hypertension,0,1
205508,",",0,0
205509,diuretics,0,0
205510,usually,0,0
205511,worsen,0,0
205512,the,0,0
205513,metabolic,1,0
205514,equilibrium,1,0
205515,.,1,0
205516,According,0,0
205517,to,0,0
205518,recent,0,0
205519,reports,0,0
205520,",",0,0
205521,a,0,0
205522,new,0,0
205523,diuretic,0,0
205524,",",0,0
205525,muzolimine,0,0
205526,(,0,1
205527,MZ,0,1
205528,),0,0
205529,",",0,0
205530,which,0,0
205531,acts,0,0
205532,on,0,0
205533,the,0,0
205534,loop,0,0
205535,of,0,0
205536,Henle,0,0
205537,",",0,0
205538,seems,0,0
205539,to,0,0
205540,present,0,0
205541,a,0,0
205542,minor,0,0
205543,effect,0,0
205544,on,0,0
205545,carbohydrate,0,0
205546,metabolic,0,1
205547,balance,0,1
205548,.,0,0
205549,In,0,0
205550,order,0,0
205551,to,0,0
205552,determine,0,0
205553,whether,0,0
205554,this,0,0
205555,assumption,0,0
205556,was,0,0
205557,correct,0,0
205558,or,0,0
205559,not,0,0
205560,",",0,0
205561,we,0,0
205562,carried,0,0
205563,out,0,0
205564,a,0,0
205565,clinical,0,0
205566,trial,0,0
205567,on,0,0
205568,26,0,0
205569,type,0,0
205570,II,0,0
205571,(,0,0
205572,non-insulin-dependent,0,0
205573,),0,0
205574,diabetics,0,0
205575,",",0,0
205576,in,0,0
205577,fairly,0,0
205578,good,0,0
205579,metabolic,0,1
205580,control,0,0
205581,and,0,0
205582,with,0,0
205583,moderate,0,0
205584,hypertension,0,1
205585,(,0,0
205586,orthostatic,0,1
205587,diastolic,0,1
205588,pressure,0,1
205589,from,0,0
205590,100,0,0
205591,to,0,0
205592,115,0,0
205593,mmHg,0,0
205594,),0,0
205595,",",0,0
205596,comparing,0,0
205597,the,0,0
205598,effect,0,0
205599,of,0,0
205600,MZ,0,0
205601,with,0,0
205602,those,0,0
205603,of,0,0
205604,chlorthalidone,0,0
205605,(,0,0
205606,CL,0,0
205607,),0,0
205608,.,0,0
205609,According,0,0
205610,to,0,0
205611,a,0,0
205612,randomized,0,0
205613,",",0,0
205614,single-blind,0,0
205615,cross-over,0,0
205616,design,0,0
205617,",",0,0
205618,the,0,0
205619,patients,0,0
205620,were,0,0
205621,treated,0,0
205622,with,0,0
205623,MZ,0,0
205624,(,0,0
205625,20,0,0
205626,mg/day,0,0
205627,),0,0
205628,or,0,0
205629,CL,0,0
205630,(,0,0
205631,50,0,0
205632,mg/day,0,0
205633,),0,0
205634,for,0,0
205635,the,0,0
205636,duration,0,0
205637,of,0,0
205638,4,0,0
205639,weeks,0,0
205640,.,0,0
205641,After,0,0
205642,the,0,0
205643,treatment,0,0
205644,period,0,0
205645,with,0,0
205646,the,0,0
205647,first,0,0
205648,drug,0,0
205649,",",0,0
205650,there,0,0
205651,was,0,0
205652,a,0,0
205653,2,0,0
205654,week,0,0
205655,wash-out,0,0
205656,period,0,0
205657,on,0,0
205658,placebo,0,0
205659,(,0,0
205660,PL,0,0
205661,),0,0
205662,before,0,0
205663,the,0,0
205664,second,0,0
205665,drug,0,0
205666,was,0,0
205667,given,0,0
205668,.,0,0
205669,During,0,0
205670,the,0,0
205671,study,0,0
205672,",",0,0
205673,a,0,0
205674,set,0,0
205675,of,0,0
205676,metabolic,1,1
205677,and,1,0
205678,non-metabolic,1,0
205679,parameters,1,1
205680,was,0,0
205681,monitored,0,0
205682,",",0,0
205683,as,0,0
205684,were,0,0
205685,the,0,0
205686,clinostatic,1,0
205687,and,1,0
205688,orthostatic,1,1
205689,blood,1,1
205690,pressure,1,1
205691,values,1,1
205692,.,1,0
205693,The,0,0
205694,results,0,0
205695,show,0,0
205696,that,0,0
205697,the,0,0
205698,antihypertensive,1,0
205699,effect,1,0
205700,of,0,0
205701,the,0,0
205702,two,0,0
205703,drugs,0,0
205704,was,0,0
205705,the,0,0
205706,same,0,0
205707,(,0,0
205708,both,0,0
205709,caused,0,0
205710,a,0,0
205711,more,0,0
205712,than,0,0
205713,10,0,0
205714,%,0,0
205715,decrease,0,0
205716,in,0,0
205717,systolic,1,1
205718,and,1,0
205719,diastolic,1,1
205720,blood,1,1
205721,pressure,1,1
205722,),1,0
205723,.,0,0
205724,No,0,0
205725,significant,0,0
205726,changes,0,1
205727,in,0,0
205728,plasma,1,1
205729,electrolyte,1,1
205730,levels,1,1
205731,occurred,0,0
205732,.,0,0
205733,There,0,0
205734,was,0,0
205735,a,0,0
205736,significant,0,0
205737,(,0,0
205738,p,0,0
205739,less,0,0
205740,than,0,0
205741,0.05,0,0
205742,),0,0
205743,increase,0,0
205744,in,0,0
205745,urinary,1,1
205746,aldosterone,1,1
205747,excretion,1,1
205748,after,0,0
205749,CL,0,0
205750,(,0,0
205751,20.7,0,0
205752,+/-,0,0
205753,11,0,0
205754,micrograms/24,0,0
205755,hours,0,0
205756,vs.,0,0
205757,13.3,0,0
205758,+/-,0,0
205759,8.5,0,0
205760,after,0,0
205761,PL,0,0
205762,",",0,0
205763,and,0,0
205764,14.5,0,0
205765,+/-,0,0
205766,7.2,0,0
205767,after,0,0
205768,MZ,0,0
205769,),0,0
205770,(,0,0
205771,mean,0,1
205772,values,0,1
205773,+/-,0,0
205774,standard,0,0
205775,deviations,0,0
205776,),0,0
205777,.,0,0
205778,(,0,0
205779,ABSTRACT,0,1
205780,TRUNCATED,0,0
205781,AT,0,0
205782,250,0,0
205783,WORDS,0,0
205784,),0,0
205785,A,0,0
205786,randomized,0,0
205787,comparative,0,0
205788,trial,0,0
205789,of,0,0
205790,combined,0,0
205791,versus,0,0
205792,alternating,0,0
205793,therapy,0,0
205794,with,0,0
205795,cytostatic,0,0
205796,drugs,0,0
205797,and,0,0
205798,high-dose,0,0
205799,medroxyprogesteron,0,0
205800,acetate,0,0
205801,in,0,0
205802,advanced,0,0
205803,breast,0,0
205804,cancer,0,0
205805,.,0,0
205806,A,0,0
205807,prospective,0,0
205808,multicenter,0,0
205809,trial,0,0
205810,was,0,0
205811,conducted,0,0
205812,in,0,0
205813,155,0,0
205814,consecutive,0,0
205815,patients,0,0
205816,with,0,0
205817,Stage,0,0
205818,IV,0,1
205819,breast,0,0
205820,cancer,0,0
205821,randomly,0,0
205822,allocated,0,0
205823,to,0,0
205824,receive,0,0
205825,either,0,0
205826,(,0,0
205827,1,0,0
205828,),0,0
205829,vincristin,0,0
205830,(,0,0
205831,V,0,0
205832,),0,0
205833,1.2,0,0
205834,mg/m2,0,0
205835,(,0,0
205836,maximum,0,1
205837,dose,0,0
205838,",",0,0
205839,2,0,0
205840,mg,0,0
205841,),0,0
205842,",",0,0
205843,Adriamycin,0,0
205844,(,0,0
205845,A,0,0
205846,),0,1
205847,(,0,0
205848,doxorubicin,0,0
205849,),0,0
205850,40,0,0
205851,mg/m2,0,0
205852,",",0,0
205853,and,0,1
205854,cyclophosphamide,0,0
205855,(,0,1
205856,C,0,0
205857,),0,0
205858,500,0,0
205859,mg/m2,0,0
205860,",",0,0
205861,all,0,0
205862,intravenously,0,0
205863,on,0,0
205864,day,0,0
205865,1,0,0
205866,",",0,0
205867,every,0,0
205868,4,0,0
205869,weeks,0,0
205870,",",0,0
205871,in,0,0
205872,combination,0,0
205873,with,0,0
205874,medroxyprogesteron,0,0
205875,acetate,0,0
205876,(,0,0
205877,MPA,0,0
205878,),0,0
205879,600,0,0
205880,mg,0,0
205881,orally,0,0
205882,on,0,0
205883,days,0,0
205884,1,0,0
205885,through,0,0
205886,14,0,0
205887,",",0,0
205888,500,0,0
205889,mg,0,0
205890,intramuscularly,0,0
205891,on,0,0
205892,days,0,0
205893,1,0,0
205894,through,0,0
205895,28,0,0
205896,",",0,0
205897,and,0,0
205898,twice,0,0
205899,weekly,0,0
205900,afterwards,0,0
205901,(,0,0
205902,combined,0,0
205903,chemoendocrine,0,0
205904,approach,0,0
205905,),0,1
205906,or,0,0
205907,(,0,0
205908,2,0,0
205909,),0,0
205910,the,0,0
205911,same,0,0
205912,combination,0,0
205913,chemotherapy,0,0
205914,(,0,0
205915,VAC,0,0
205916,),0,0
205917,for,0,0
205918,three,0,0
205919,cycles,0,0
205920,alternating,0,0
205921,with,0,0
205922,MPA,0,0
205923,in,0,0
205924,the,0,0
205925,above-mentioned,0,0
205926,dosage,0,0
205927,during,0,0
205928,8,0,0
205929,weeks,0,0
205930,(,0,0
205931,alternating,0,0
205932,chemoendocrine,0,0
205933,approach,0,0
205934,),0,0
205935,.,0,0
205936,Results,0,0
205937,show,0,0
205938,an,0,0
205939,overall,1,1
205940,response,1,1
205941,rate,1,1
205942,of,0,0
205943,73,0,0
205944,%,0,0
205945,with,0,0
205946,26,0,0
205947,%,0,0
205948,complete,0,0
205949,responses,0,1
205950,in,0,0
205951,the,0,0
205952,combined,0,0
205953,treatment,0,0
205954,arm,0,0
205955,",",0,0
205956,whereas,0,0
205957,in,0,0
205958,the,0,0
205959,alternating,0,0
205960,arm,0,0
205961,",",0,0
205962,an,0,0
205963,overall,1,1
205964,response,1,1
205965,rate,1,1
205966,of,0,0
205967,76,0,0
205968,%,0,0
205969,with,0,0
205970,20,0,0
205971,%,0,0
205972,complete,0,0
205973,responses,0,1
205974,was,0,0
205975,observed,0,0
205976,.,0,0
205977,In,0,0
205978,patients,0,0
205979,with,0,0
205980,more,0,0
205981,than,0,0
205982,one,0,0
205983,metastatic,0,0
205984,site,0,0
205985,",",0,0
205986,response,1,1
205987,rate,1,1
205988,was,0,0
205989,higher,0,0
205990,in,0,0
205991,the,0,0
205992,combination,0,0
205993,treatment,0,0
205994,",",0,0
205995,and,0,0
205996,only,0,0
205997,in,0,0
205998,this,0,0
205999,arm,0,0
206000,were,0,0
206001,complete,0,1
206002,responses,0,1
206003,observed,0,0
206004,in,0,0
206005,these,0,0
206006,patients,0,0
206007,.,0,0
206008,Although,0,0
206009,the,0,0
206010,median,1,0
206011,duration,1,1
206012,of,1,0
206013,response,1,1
206014,was,1,0
206015,long,1,0
206016,in,0,0
206017,both,0,0
206018,treatment,0,0
206019,arms,0,0
206020,(,0,0
206021,combination,0,0
206022,",",0,0
206023,19,0,0
206024,months,0,0
206025,versus,0,0
206026,alternating,0,0
206027,",",0,0
206028,21,0,0
206029,months,0,0
206030,),0,0
206031,",",0,0
206032,the,0,0
206033,median,0,1
206034,overall,1,1
206035,survival,1,1
206036,in,0,0
206037,both,0,0
206038,groups,0,0
206039,was,0,0
206040,not,0,0
206041,definitely,0,0
206042,prolonged,0,0
206043,(,0,0
206044,22,0,0
206045,versus,0,0
206046,24,0,0
206047,months,0,0
206048,",",0,0
206049,respectively,0,0
206050,),0,0
206051,.,0,0
206052,However,0,0
206053,",",0,0
206054,results,0,0
206055,in,0,0
206056,subsets,0,0
206057,of,0,0
206058,patients,0,0
206059,suggest,0,0
206060,that,0,0
206061,the,0,0
206062,alternating,0,0
206063,chemoendocrine,0,0
206064,approach,0,0
206065,may,0,0
206066,be,0,0
206067,better,0,0
206068,for,0,0
206069,estrogen,0,1
206070,receptor,0,1
206071,(,0,0
206072,ER,0,0
206073,),0,0
206074,-negative,0,1
206075,patients,0,0
206076,",",0,0
206077,for,0,0
206078,patients,0,0
206079,younger,0,0
206080,than,0,0
206081,51,0,0
206082,years,0,0
206083,of,0,0
206084,age,0,0
206085,",",0,0
206086,and,0,1
206087,for,0,0
206088,patients,0,0
206089,with,0,0
206090,a,0,0
206091,disease-free,0,1
206092,interval,0,0
206093,of,0,0
206094,1,0,0
206095,year,0,0
206096,or,0,0
206097,less,0,0
206098,.,0,0
206099,Patients,0,0
206100,with,0,0
206101,these,0,0
206102,parameters,0,0
206103,probably,0,0
206104,belong,0,0
206105,to,0,0
206106,the,0,0
206107,same,0,0
206108,population,0,0
206109,.,0,0
206110,It,0,0
206111,is,0,0
206112,concluded,0,0
206113,that,0,0
206114,combination,1,0
206115,of,1,0
206116,chemotherapy,1,0
206117,and,1,0
206118,high-dose,1,0
206119,MPA,1,0
206120,may,1,0
206121,be,1,0
206122,indicated,1,0
206123,in,1,0
206124,ER-positive,1,0
206125,patients,1,0
206126,when,0,0
206127,a,0,0
206128,clinical,0,0
206129,response,0,0
206130,is,0,0
206131,urgently,0,0
206132,needed,0,0
206133,.,0,0
206134,In,0,0
206135,ER-negative,0,0
206136,patients,0,0
206137,",",0,0
206138,the,0,0
206139,alternating,0,0
206140,use,0,0
206141,of,0,0
206142,both,0,0
206143,treatment,0,0
206144,modalities,0,0
206145,deserves,0,0
206146,further,0,0
206147,investigation,0,0
206148,.,0,0
206149,Double-blind,0,0
206150,trial,0,0
206151,comparing,0,0
206152,the,0,0
206153,effectiveness,0,0
206154,of,0,0
206155,the,0,0
206156,homeopathic,0,0
206157,preparation,0,0
206158,Galphimia,0,0
206159,potentiation,0,1
206160,D6,0,1
206161,",",0,0
206162,Galphimia,0,0
206163,dilution,0,0
206164,10,0,0
206165,(,0,0
206166,-6,0,0
206167,),0,1
206168,and,0,0
206169,placebo,0,0
206170,on,0,0
206171,pollinosis,1,0
206172,.,1,0
206173,The,0,0
206174,preparation,0,0
206175,of,0,0
206176,homeopathic,0,0
206177,drugs,0,0
206178,is,0,0
206179,based,0,0
206180,on,0,0
206181,potentiation,0,0
206182,.,0,0
206183,In,0,0
206184,this,0,0
206185,potentiation,0,0
206186,the,0,0
206187,primary,0,0
206188,substance,0,0
206189,is,0,0
206190,specially,0,0
206191,mixed,0,0
206192,with,0,0
206193,a,0,0
206194,carrier,0,0
206195,(,0,0
206196,typically,0,0
206197,90,0,0
206198,%,0,0
206199,ethanol,0,0
206200,),0,0
206201,in,0,0
206202,the,0,0
206203,ratio,0,0
206204,1:10,0,0
206205,.,0,0
206206,Usually,0,0
206207,this,0,0
206208,potentiation,0,0
206209,is,0,0
206210,done,0,0
206211,repeatedly,0,0
206212,and,0,0
206213,the,0,0
206214,final,0,0
206215,drug,0,0
206216,is,0,0
206217,labeled,0,0
206218,",",0,0
206219,e.g.,0,0
206220,",",0,1
206221,D6,0,0
206222,which,0,0
206223,means,0,0
206224,a,0,0
206225,6,0,0
206226,times,0,0
206227,decimal,0,1
206228,potentiation,0,1
206229,.,0,0
206230,In,0,0
206231,a,0,0
206232,controlled,0,0
206233,randomized,0,0
206234,strictly,0,0
206235,double-blind,0,0
206236,trial,0,0
206237,with,0,0
206238,164,0,0
206239,patients,0,0
206240,the,0,0
206241,effectiveness,0,0
206242,of,0,0
206243,homeopathically,0,0
206244,prepared,0,0
206245,Galphimia,0,0
206246,D6,0,0
206247,",",0,0
206248,a,0,0
206249,conventional,0,0
206250,Galphimia,0,0
206251,dilution,0,0
206252,10,0,0
206253,(,0,0
206254,-6,0,0
206255,),0,0
206256,and,0,0
206257,a,0,0
206258,placebo,0,0
206259,was,0,0
206260,investigated,0,0
206261,for,0,0
206262,the,0,0
206263,therapy,0,0
206264,of,0,0
206265,pollinosis,1,0
206266,.,1,0
206267,The,0,0
206268,average,1,0
206269,duration,1,1
206270,of,1,0
206271,treatment,1,0
206272,was,0,0
206273,about,0,0
206274,5,0,0
206275,weeks,0,0
206276,.,0,0
206277,Although,0,0
206278,no,0,0
206279,statistical,0,0
206280,significance,0,1
206281,was,0,0
206282,achieved,0,0
206283,",",0,0
206284,it,0,0
206285,is,0,0
206286,remarkable,0,0
206287,that,0,0
206288,there,0,0
206289,was,0,0
206290,a,0,0
206291,clear,0,0
206292,trend,0,0
206293,for,0,0
206294,the,0,0
206295,superiority,1,0
206296,of,0,0
206297,Galphimia,1,0
206298,D6,1,0
206299,while,0,0
206300,the,0,0
206301,Galphimia,1,0
206302,dilution,1,0
206303,10,1,0
206304,(,1,0
206305,-6,1,0
206306,),1,0
206307,was,0,0
206308,about,0,0
206309,equally,0,0
206310,effective,0,0
206311,compared,0,0
206312,with,0,0
206313,placebo,0,0
206314,.,0,0
206315,The,0,0
206316,study,0,0
206317,itself,0,0
206318,demonstrates,0,0
206319,that,0,0
206320,it,0,0
206321,is,0,0
206322,possible,0,0
206323,to,0,0
206324,do,0,0
206325,strictly,0,0
206326,controlled,0,0
206327,trials,0,0
206328,for,0,0
206329,homeopathic,0,0
206330,drugs,0,0
206331,and,0,0
206332,with,0,0
206333,medical,0,0
206334,practitioners,0,0
206335,.,0,0
206336,Drug,0,0
206337,preference,0,0
206338,in,0,0
206339,normal,0,0
206340,volunteers,0,0
206341,:,0,0
206342,effects,0,1
206343,of,0,0
206344,age,0,0
206345,and,0,1
206346,time,0,1
206347,of,0,0
206348,day,0,0
206349,.,0,0
206350,These,0,0
206351,experiments,0,0
206352,assessed,0,0
206353,the,0,0
206354,influence,0,0
206355,of,0,0
206356,two,0,0
206357,variables,0,0
206358,",",0,0
206359,age,0,0
206360,of,0,1
206361,subjects,0,0
206362,and,0,0
206363,time,0,1
206364,of,0,1
206365,drug,0,0
206366,administration,0,0
206367,",",0,0
206368,on,0,0
206369,the,0,0
206370,reinforcing,0,0
206371,properties,0,1
206372,of,0,0
206373,amphetamine,0,0
206374,and,0,0
206375,of,0,1
206376,diazepam,0,0
206377,in,0,0
206378,normal,0,0
206379,volunteers,0,0
206380,.,0,0
206381,Three,0,0
206382,groups,0,0
206383,of,0,0
206384,subjects,0,0
206385,were,0,0
206386,tested,0,0
206387,:,0,0
206388,i,0,0
206389,),0,0
206390,a,0,0
206391,group,0,0
206392,of,0,0
206393,40-55-year-old,0,0
206394,subjects,0,0
206395,(,0,0
206396,AGE,0,0
206397,group,0,0
206398,;,0,0
206399,N,0,0
206400,=,0,0
206401,11,0,0
206402,),0,0
206403,who,0,0
206404,were,0,0
206405,tested,0,0
206406,in,0,0
206407,the,0,0
206408,morning,0,0
206409,",",0,0
206410,ii,0,0
206411,),0,0
206412,a,0,0
206413,group,0,0
206414,of,0,0
206415,21-35-year-old,0,0
206416,subjects,0,0
206417,(,0,0
206418,CTL,0,0
206419,group,0,0
206420,;,0,0
206421,N,0,0
206422,=,0,0
206423,12,0,0
206424,),0,0
206425,who,0,0
206426,were,0,0
206427,also,0,0
206428,tested,0,0
206429,in,0,0
206430,the,0,0
206431,morning,0,0
206432,",",0,0
206433,and,0,1
206434,iii,0,0
206435,),0,0
206436,a,0,0
206437,group,0,0
206438,of,0,0
206439,21-35-year-olds,0,0
206440,who,0,0
206441,were,0,0
206442,tested,0,0
206443,in,0,0
206444,the,0,0
206445,late,0,0
206446,afternoon,0,1
206447,(,0,0
206448,AFT,0,0
206449,group,0,0
206450,;,0,0
206451,N,0,0
206452,=,0,0
206453,13,0,0
206454,),0,0
206455,.,0,0
206456,All,0,0
206457,subjects,0,0
206458,participated,0,0
206459,in,0,0
206460,three,0,0
206461,separate,0,0
206462,experiments,0,0
206463,comparing,0,0
206464,one,0,0
206465,drug,0,0
206466,(,0,0
206467,5,0,0
206468,mg,0,0
206469,d,0,0
206470,",",0,0
206471,l-amphetamine,0,0
206472,",",0,0
206473,5,0,0
206474,mg,0,0
206475,diazepam,0,0
206476,or,0,0
206477,10,0,0
206478,mg,0,0
206479,diazepam,0,0
206480,),0,0
206481,to,0,0
206482,placebo,0,0
206483,.,0,0
206484,Each,0,0
206485,experiment,0,0
206486,consisted,0,0
206487,of,0,0
206488,nine,0,0
206489,sessions,0,0
206490,:,0,0
206491,On,0,0
206492,the,0,0
206493,first,0,0
206494,four,0,0
206495,sessions,0,0
206496,subjects,0,0
206497,sampled,0,0
206498,two,0,0
206499,color-coded,0,0
206500,capsules,0,0
206501,on,0,0
206502,alternate,0,0
206503,sessions,0,0
206504,and,0,0
206505,on,0,0
206506,the,0,0
206507,following,0,0
206508,five,0,0
206509,sessions,0,0
206510,they,0,0
206511,chose,0,0
206512,and,0,0
206513,ingested,0,0
206514,the,0,0
206515,capsule,0,0
206516,they,0,0
206517,preferred,0,0
206518,.,0,0
206519,Subjective,0,1
206520,effects,0,0
206521,of,0,0
206522,the,0,0
206523,drugs,0,0
206524,were,0,0
206525,monitored,0,0
206526,using,0,0
206527,the,0,0
206528,Profile,1,1
206529,of,1,0
206530,Mood,1,1
206531,States,1,1
206532,(,1,0
206533,POMS,1,1
206534,),1,0
206535,and,1,0
206536,a,1,0
206537,shortened,1,1
206538,version,1,0
206539,of,1,0
206540,the,1,0
206541,Addiction,1,0
206542,Research,1,0
206543,Center,1,0
206544,Inventory,1,1
206545,(,1,0
206546,ARCI,1,1
206547,),1,0
206548,.,1,0
206549,Subjects,0,0
206550,in,0,0
206551,all,0,0
206552,three,0,0
206553,groups,0,0
206554,chose,0,0
206555,5,0,0
206556,mg,0,0
206557,diazepam,0,0
206558,as,0,0
206559,often,0,0
206560,as,0,0
206561,placebo,0,0
206562,but,0,0
206563,preferred,0,0
206564,placebo,0,0
206565,to,0,0
206566,10,0,0
206567,mg,0,0
206568,diazepam,0,0
206569,.,0,0
206570,In,0,0
206571,contrast,0,0
206572,",",0,0
206573,they,0,0
206574,chose,0,0
206575,amphetamine,0,0
206576,either,0,0
206577,as,0,0
206578,often,0,0
206579,as,0,0
206580,or,0,0
206581,more,0,0
206582,often,0,0
206583,than,0,0
206584,placebo,0,0
206585,.,0,0
206586,The,0,0
206587,subjective,0,1
206588,effects,0,0
206589,of,0,0
206590,diazepam,0,0
206591,(,0,0
206592,i.e,0,0
206593,.,0,0
206594,sedation,0,1
206595,),0,0
206596,were,0,0
206597,similar,0,0
206598,across,0,0
206599,all,0,0
206600,three,0,0
206601,groups,0,0
206602,",",0,0
206603,but,0,0
206604,after,0,0
206605,amphetamine,0,0
206606,the,0,0
206607,AGE,0,0
206608,group,0,0
206609,showed,0,0
206610,greater,0,0
206611,stimulant,0,0
206612,effects,0,1
206613,.,0,0
206614,In,0,0
206615,addition,0,0
206616,",",0,0
206617,the,0,0
206618,AFT,0,0
206619,group,0,0
206620,showed,0,0
206621,fewer,0,0
206622,positive,0,1
206623,mood,0,1
206624,effects,0,1
206625,after,0,0
206626,amphetamine,0,0
206627,than,0,0
206628,the,0,0
206629,CTL,0,0
206630,group,0,0
206631,.,0,0
206632,(,0,0
206633,ABSTRACT,0,1
206634,TRUNCATED,0,0
206635,AT,0,0
206636,250,0,0
206637,WORDS,0,0
206638,),0,0
206639,Haemodynamic,0,1
206640,profile,0,1
206641,of,0,0
206642,angiotensin,0,0
206643,II,0,0
206644,antagonism,0,1
206645,in,0,0
206646,essential,0,0
206647,hypertensive,0,0
206648,patients,0,0
206649,.,0,0
206650,1,0,0
206651,.,0,0
206652,The,0,0
206653,haemodynamic,0,1
206654,response,0,1
206655,to,0,0
206656,antagonistic,0,0
206657,(,0,0
206658,10,0,0
206659,microgram,0,0
206660,min-1,0,0
206661,kg-1,0,0
206662,),0,0
206663,and,0,0
206664,agonistic,0,0
206665,(,0,0
206666,40,0,0
206667,microgram,0,0
206668,min-1,0,0
206669,kg-1,0,0
206670,),0,0
206671,doses,0,0
206672,of,0,0
206673,saralasin,0,0
206674,was,0,0
206675,studied,0,0
206676,in,0,0
206677,young,0,0
206678,essential,0,0
206679,hypertensive,0,0
206680,patients,0,0
206681,.,0,0
206682,Blood,1,1
206683,pressure,1,1
206684,behaviour,1,1
206685,alone,0,0
206686,was,0,0
206687,thought,0,0
206688,to,0,0
206689,be,0,0
206690,inadequate,0,0
206691,to,0,0
206692,describe,0,0
206693,the,0,0
206694,response,0,1
206695,pattern,0,0
206696,.,0,0
206697,2,0,0
206698,.,0,0
206699,Pre-saralasin,0,0
206700,setting,0,0
206701,of,0,0
206702,the,0,0
206703,renin-angiotensin,0,0
206704,axis,0,0
206705,was,0,0
206706,varied,0,0
206707,with,0,0
206708,salt,0,0
206709,intake,0,1
206710,(,0,0
206711,15,0,0
206712,and,0,0
206713,290,0,0
206714,mmol,0,0
206715,of,0,0
206716,Na+/day,0,0
206717,),0,0
206718,each,0,0
206719,for,0,0
206720,10,0,0
206721,days,0,0
206722,.,0,0
206723,This,0,0
206724,failed,0,0
206725,to,0,0
206726,influence,0,0
206727,blood,1,1
206728,pressure,1,1
206729,or,1,1
206730,plasma,1,1
206731,volume,1,1
206732,.,1,0
206733,3,0,0
206734,.,0,0
206735,Antagonist,0,0
206736,blockade,0,0
206737,after,0,0
206738,low,0,0
206739,salt,0,0
206740,lowered,0,0
206741,blood,1,1
206742,pressure,1,1
206743,in,0,0
206744,three,0,0
206745,patients,0,0
206746,with,0,0
206747,the,0,0
206748,highest,0,0
206749,plasma,0,1
206750,renin,0,1
206751,values,0,1
206752,.,0,0
206753,Cardiac,1,1
206754,output,1,1
206755,rose,0,0
206756,in,0,0
206757,two,0,0
206758,of,0,0
206759,these,0,0
206760,",",0,0
206761,but,0,0
206762,it,0,0
206763,dropped,0,0
206764,in,0,0
206765,all,0,0
206766,others,0,0
206767,.,0,0
206768,4,0,0
206769,.,0,0
206770,Decreases,0,0
206771,in,0,0
206772,cardiac,1,1
206773,output,1,1
206774,occurred,0,0
206775,with,0,0
206776,both,0,0
206777,doses,0,0
206778,of,0,0
206779,saralasin,0,0
206780,and,0,0
206781,even,0,0
206782,with,0,0
206783,suppression,0,1
206784,of,0,0
206785,the,0,0
206786,renin-angiotensin,0,0
206787,axis,0,0
206788,.,0,0
206789,This,0,0
206790,response,0,0
206791,is,0,0
206792,therefore,0,0
206793,unlikely,0,0
206794,to,0,0
206795,be,0,0
206796,due,0,0
206797,to,0,0
206798,removal,0,0
206799,of,0,0
206800,myocardial,1,1
206801,or,1,0
206802,venous,1,1
206803,angiotensin,1,0
206804,effects,1,0
206805,.,1,0
206806,5,0,0
206807,.,0,0
206808,The,0,0
206809,renin-angiotensin,0,0
206810,system,0,0
206811,played,0,0
206812,a,0,0
206813,part,0,0
206814,in,0,0
206815,maintenance,0,0
206816,of,0,0
206817,blood,1,1
206818,pressure,1,1
206819,only,0,0
206820,with,0,0
206821,severe,0,1
206822,salt,0,0
206823,restriction,0,0
206824,and,0,0
206825,in,0,0
206826,a,0,0
206827,small,0,0
206828,proportion,0,0
206829,of,0,0
206830,cases,0,0
206831,.,0,0
206832,6,0,0
206833,.,0,0
206834,No,0,0
206835,heart,1,1
206836,rate,1,1
206837,effect,1,1
206838,was,0,0
206839,seen,0,0
206840,with,0,0
206841,sarcalasin,0,0
206842,.,0,0
206843,7,0,0
206844,.,0,0
206845,Blood,1,0
206846,pressure,1,1
206847,and,1,1
206848,total,1,1
206849,peripheral,1,1
206850,resistance,1,1
206851,responses,1,1
206852,were,0,0
206853,dependent,0,0
206854,on,0,0
206855,pre-,0,0
206856,(,0,0
206857,antagonist/agonist,0,0
206858,),0,1
206859,setting,0,0
206860,",",0,0
206861,but,0,0
206862,heart,1,1
206863,rate,1,1
206864,and,0,1
206865,cardiac,1,1
206866,output,1,1
206867,were,0,0
206868,not,0,0
206869,influenced,0,0
206870,by,0,0
206871,this,0,0
206872,factor,0,0
206873,.,0,0
206874,The,0,0
206875,effect,0,0
206876,of,0,0
206877,polyvinylpyrrolidone-iodine,0,0
206878,as,0,0
206879,an,0,0
206880,disinfectant,1,0
206881,in,0,0
206882,eye,0,0
206883,surgery,0,0
206884,.,0,0
206885,105,0,0
206886,patients,0,0
206887,admitted,0,0
206888,for,0,0
206889,cataract,0,0
206890,surgery,0,0
206891,were,0,0
206892,treated,0,0
206893,pre-operatively,0,0
206894,with,0,0
206895,polyvinylpyrrolidone-iodine,0,0
206896,(,0,0
206897,PVP-I,0,0
206898,),0,0
206899,as,0,0
206900,a,0,0
206901,disinfectant,0,0
206902,",",0,0
206903,and,0,1
206904,consecutive,0,0
206905,bacterial,0,1
206906,cultures,0,0
206907,were,0,0
206908,obtained,0,0
206909,before,0,0
206910,initiating,0,0
206911,surgery,0,0
206912,and,0,0
206913,at,0,0
206914,the,0,0
206915,end,0,0
206916,of,0,0
206917,the,0,0
206918,operation,0,0
206919,.,0,0
206920,A,0,0
206921,control,0,0
206922,group,0,0
206923,(,0,0
206924,n,0,0
206925,=,0,0
206926,99,0,0
206927,),0,0
206928,only,0,0
206929,had,0,0
206930,a,0,0
206931,standard,1,0
206932,disinfection,1,1
206933,procedure,0,0
206934,of,0,0
206935,the,0,0
206936,eye,0,0
206937,(,0,0
206938,including,0,0
206939,instillation,0,0
206940,of,0,0
206941,Terramycin,0,0
206942,cum,0,0
206943,polymyxin,0,0
206944,B,0,0
206945,cream,0,0
206946,in,0,0
206947,the,0,0
206948,conjunctival,0,0
206949,sac,0,0
206950,the,0,0
206951,evening,0,0
206952,before,0,0
206953,surgery,0,0
206954,),0,0
206955,.,0,0
206956,The,0,0
206957,cultures,0,0
206958,obtained,0,0
206959,from,0,0
206960,the,0,0
206961,conjunctival,0,0
206962,sac,0,1
206963,of,0,0
206964,the,0,0
206965,control,0,0
206966,group,0,0
206967,principally,0,0
206968,showed,0,0
206969,growth,0,1
206970,of,0,0
206971,Staph,0,0
206972,.,0,0
206973,albus,0,0
206974,and,0,0
206975,Staph,0,0
206976,.,0,1
206977,aureus,0,0
206978,",",0,0
206979,and,0,0
206980,to,0,0
206981,a,0,0
206982,minor,0,0
206983,degree,0,1
206984,diphtheroids,0,0
206985,(,0,0
206986,Corynebacterium,0,0
206987,species,0,0
206988,),0,0
206989,.,0,0
206990,Proteus,0,1
206991,mirabilis,0,1
206992,",",0,0
206993,Escherichia,0,1
206994,coli,0,1
206995,and,0,0
206996,micrococci,0,1
206997,.,0,0
206998,There,0,0
206999,was,0,0
207000,a,0,0
207001,significant,1,0
207002,quantitative,1,0
207003,diminished,1,1
207004,growth,1,1
207005,(,0,0
207006,P,0,0
207007,less,0,0
207008,than,0,0
207009,0.05,0,0
207010,),0,0
207011,of,0,0
207012,bacteria,0,1
207013,in,0,0
207014,the,0,0
207015,group,0,0
207016,of,0,0
207017,patients,0,0
207018,treated,0,0
207019,with,0,0
207020,PVP-I,0,0
207021,compared,0,0
207022,to,0,0
207023,the,0,0
207024,control,0,0
207025,group,0,0
207026,.,0,0
207027,Concerning,0,0
207028,the,0,0
207029,growth,0,0
207030,of,0,0
207031,Staph,0,0
207032,.,0,0
207033,albus,0,0
207034,",",0,0
207035,this,0,0
207036,was,0,0
207037,reduced,0,0
207038,to,0,0
207039,almost,0,0
207040,one,0,0
207041,third,0,0
207042,and,0,0
207043,other,0,0
207044,bacteria,0,1
207045,were,0,0
207046,almost,0,0
207047,eliminated,0,0
207048,in,0,0
207049,the,0,0
207050,group,0,0
207051,receiving,0,0
207052,PVP-I,0,0
207053,.,0,0
207054,As,0,0
207055,we,0,0
207056,disclosed,0,0
207057,no,0,0
207058,toxic,1,1
207059,or,1,0
207060,allergic,1,1
207061,reaction,1,1
207062,post-operatively,1,0
207063,which,0,0
207064,could,0,0
207065,be,0,0
207066,related,0,0
207067,to,0,0
207068,the,0,0
207069,use,0,0
207070,of,0,0
207071,PVP-I,0,0
207072,as,0,0
207073,a,0,0
207074,disinfectant,0,0
207075,",",0,0
207076,this,0,0
207077,agent,0,0
207078,seems,0,0
207079,to,0,0
207080,constitute,0,0
207081,an,0,0
207082,effective,1,0
207083,pre-operative,1,0
207084,antimicrobial,1,1
207085,treatment,1,0
207086,",",0,0
207087,taking,0,0
207088,into,0,0
207089,consideration,0,0
207090,the,0,0
207091,broad,0,0
207092,antimicrobial,0,1
207093,spectrum,0,0
207094,of,0,0
207095,PVP-I,0,0
207096,shown,0,0
207097,by,0,0
207098,other,0,0
207099,authors,0,0
207100,.,0,0
207101,Differential,1,0
207102,inhibition,1,1
207103,of,1,0
207104,bronchoconstriction,1,1
207105,by,0,0
207106,the,0,0
207107,calcium,0,0
207108,channel,0,0
207109,blockers,0,0
207110,",",0,1
207111,verapamil,0,0
207112,and,0,1
207113,nifedipine,0,0
207114,.,0,1
207115,Recent,0,0
207116,studies,0,0
207117,have,0,0
207118,demonstrated,0,0
207119,that,0,0
207120,the,0,0
207121,calcium,0,0
207122,channel,0,0
207123,blocking,0,0
207124,agents,0,0
207125,can,0,0
207126,inhibit,0,0
207127,experimentally,1,0
207128,induced,1,0
207129,bronchoconstriction,1,1
207130,in,0,0
207131,asthmatics,0,0
207132,",",0,0
207133,but,0,0
207134,their,0,0
207135,protective,0,0
207136,action,0,0
207137,has,0,0
207138,been,0,0
207139,variable,0,0
207140,.,0,0
207141,To,0,0
207142,clarify,0,0
207143,the,0,0
207144,influence,0,0
207145,of,0,0
207146,stimulus,0,1
207147,intensity,0,1
207148,and,0,1
207149,choice,0,0
207150,of,0,1
207151,calcium,0,0
207152,blocker,0,0
207153,on,0,0
207154,these,0,0
207155,reported,0,0
207156,differences,0,0
207157,in,0,0
207158,outcome,0,0
207159,",",0,0
207160,we,0,0
207161,performed,0,0
207162,noncumulative,0,1
207163,thermal,0,0
207164,stimulus-response,0,1
207165,curves,0,1
207166,using,0,0
207167,isocapnic,0,1
207168,hyperventilation,0,1
207169,of,0,0
207170,cold,0,1
207171,air,0,0
207172,in,0,0
207173,8,0,0
207174,asthmatics,0,0
207175,.,0,0
207176,Subjects,0,0
207177,received,0,0
207178,pretreatment,0,0
207179,with,0,0
207180,orally,0,0
207181,administered,0,0
207182,nifedipine,0,0
207183,(,0,0
207184,20,0,0
207185,mg,0,0
207186,),0,0
207187,",",0,0
207188,intravenously,0,0
207189,administered,0,0
207190,verapamil,0,0
207191,(,0,0
207192,10,0,0
207193,mg,0,0
207194,bolus,0,0
207195,followed,0,0
207196,by,0,0
207197,a,0,0
207198,continuous,0,0
207199,infusion,0,0
207200,),0,0
207201,",",0,0
207202,or,0,0
207203,appropriate,0,0
207204,placebos,0,0
207205,in,0,0
207206,a,0,0
207207,randomized,0,0
207208,",",0,0
207209,double-blind,0,0
207210,fashion,0,0
207211,.,0,0
207212,Verapamil,0,0
207213,afforded,0,0
207214,no,0,0
207215,consistent,0,0
207216,protection,0,0
207217,against,0,0
207218,the,0,0
207219,thermal,0,0
207220,challenges,0,0
207221,",",0,0
207222,whereas,0,0
207223,nifedipine,0,0
207224,significantly,0,0
207225,blunted,0,0
207226,the,0,0
207227,bronchoconstrictor,1,0
207228,response,1,1
207229,to,1,0
207230,stimuli,1,1
207231,of,1,0
207232,low,1,0
207233,(,0,0
207234,p,0,0
207235,less,0,0
207236,than,0,0
207237,0.02,0,0
207238,),0,0
207239,and,0,0
207240,middle,1,0
207241,(,0,0
207242,p,0,0
207243,less,0,0
207244,than,0,0
207245,0.03,0,0
207246,),0,0
207247,intensity,0,0
207248,.,0,0
207249,At,0,0
207250,the,0,0
207251,highest,0,0
207252,thermal,0,0
207253,burden,0,1
207254,",",0,0
207255,the,0,0
207256,effect,1,0
207257,of,1,0
207258,nifedipine,1,0
207259,was,0,0
207260,inconsistent,0,0
207261,and,0,0
207262,not,0,0
207263,significantly,0,0
207264,different,0,0
207265,from,0,0
207266,that,0,0
207267,of,0,0
207268,placebo,0,0
207269,.,0,0
207270,These,0,0
207271,results,0,0
207272,indicate,0,0
207273,that,0,0
207274,the,0,0
207275,protection,1,0
207276,from,1,0
207277,bronchoconstriction,1,1
207278,afforded,0,0
207279,by,0,0
207280,the,0,0
207281,calcium,0,0
207282,channel,0,0
207283,blockers,0,0
207284,depends,0,0
207285,on,0,0
207286,the,0,0
207287,choice,0,0
207288,of,0,0
207289,agent,0,0
207290,and,0,0
207291,the,0,0
207292,intensity,0,0
207293,of,0,0
207294,the,0,0
207295,bronchoconstricting,0,1
207296,stimulus,0,1
207297,",",0,0
207298,and,0,0
207299,they,0,0
207300,raise,0,0
207301,the,0,0
207302,possibility,0,0
207303,that,0,0
207304,the,0,0
207305,contribution,0,0
207306,of,0,0
207307,transmembrane,0,1
207308,calcium,0,1
207309,ion,0,1
207310,influx,0,1
207311,to,0,0
207312,the,0,0
207313,pathogenesis,0,0
207314,of,0,0
207315,bronchoconstriction,0,0
207316,may,0,0
207317,vary,0,0
207318,according,0,0
207319,to,0,0
207320,stimulus,0,1
207321,intensity,0,0
207322,.,0,0
207323,Comparative,0,0
207324,trial,0,0
207325,of,0,0
207326,carbenicillin,0,0
207327,and,0,1
207328,ampicillin,0,1
207329,therapy,0,0
207330,for,0,0
207331,purulent,0,1
207332,meningitis,0,0
207333,.,0,0
207334,A,0,0
207335,randomized,0,0
207336,therapeutic,0,0
207337,trial,0,0
207338,of,0,0
207339,carbenicillin,0,0
207340,(,0,0
207341,CB,0,1
207342,),0,1
207343,or,0,0
207344,ampicillin,0,1
207345,(,0,1
207346,AMP,0,0
207347,),0,0
207348,in,0,0
207349,purulent,0,1
207350,meningitis,0,0
207351,was,0,0
207352,performed,0,0
207353,in,0,0
207354,86,0,0
207355,pediatric,0,0
207356,and,0,0
207357,adult,0,0
207358,patients,0,0
207359,(,0,0
207360,41,0,0
207361,Haemophilus,0,0
207362,influenzae,0,0
207363,",",0,0
207364,22,0,0
207365,Streptococcus,0,0
207366,pneumoniae,0,0
207367,",",0,0
207368,13,0,0
207369,Neisseria,0,0
207370,meningitidis,0,0
207371,",",0,0
207372,and,0,0
207373,10,0,0
207374,of,0,0
207375,unknown,0,0
207376,etiology,0,0
207377,),0,0
207378,.,0,0
207379,All,0,0
207380,isolates,0,0
207381,",",0,0
207382,incuding,0,0
207383,H.,0,1
207384,influenzae,0,0
207385,",",0,0
207386,were,0,0
207387,susceptible,0,0
207388,to,0,0
207389,CB,0,1
207390,and,0,0
207391,AMP,0,0
207392,.,0,0
207393,Median,0,1
207394,cerebrospinal,1,1
207395,fluid,1,1
207396,(,1,0
207397,CSF,1,0
207398,),1,0
207399,antibiotic,1,0
207400,concentrations,1,1
207401,were,0,0
207402,0.85,0,0
207403,and,0,0
207404,1.60,0,0
207405,mug/ml,0,0
207406,for,0,0
207407,CB,0,1
207408,and,0,1
207409,AMP,0,1
207410,",",0,0
207411,respectively,0,0
207412,",",0,0
207413,during,0,0
207414,administration,0,0
207415,of,0,0
207416,daily,0,0
207417,doses,0,0
207418,of,0,0
207419,400,0,0
207420,mg/kg,0,0
207421,and,0,0
207422,0.65,0,0
207423,and,0,0
207424,0.45,0,0
207425,mug/ml,0,0
207426,",",0,0
207427,respectively,0,0
207428,",",0,0
207429,on,0,0
207430,daily,0,0
207431,doses,0,0
207432,of,0,0
207433,200,0,0
207434,mg/kg,0,0
207435,.,0,0
207436,Higher,1,0
207437,CSF,1,0
207438,concentrations,1,1
207439,",",0,0
207440,up,0,0
207441,to,0,0
207442,a,0,0
207443,median,0,0
207444,concentration,0,1
207445,of,0,0
207446,4.5,0,0
207447,mug/ml,0,0
207448,",",0,0
207449,were,0,0
207450,observed,0,0
207451,in,0,0
207452,patients,0,0
207453,with,0,0
207454,CSF,0,0
207455,protein,0,0
207456,concentrations,0,1
207457,>,0,0
207458,/=75,0,0
207459,mg/100,0,0
207460,ml,0,0
207461,.,0,0
207462,Clinical,1,1
207463,responses,1,1
207464,were,0,0
207465,equivalent,0,0
207466,on,0,0
207467,either,0,0
207468,antibiotic,0,0
207469,regimen,0,0
207470,.,0,0
207471,Among,0,0
207472,AMP,0,0
207473,patients,0,0
207474,(,0,0
207475,45,0,0
207476,),0,0
207477,",",0,0
207478,8,0,0
207479,had,1,0
207480,significant,1,0
207481,residua,1,0
207482,and,0,0
207483,3,0,0
207484,died,1,0
207485,;,1,0
207486,among,0,0
207487,CB,0,1
207488,patients,0,0
207489,(,0,0
207490,41,0,0
207491,),0,0
207492,",",0,0
207493,5,0,0
207494,had,1,0
207495,residua,1,0
207496,and,0,1
207497,none,1,0
207498,died,1,0
207499,.,1,0
207500,However,0,0
207501,",",0,0
207502,38,0,0
207503,%,0,0
207504,of,0,0
207505,H.,0,1
207506,influenzae,0,0
207507,patients,0,0
207508,treated,0,0
207509,with,0,0
207510,CB,0,1
207511,had,0,0
207512,positive,1,1
207513,CSF,1,0
207514,cultures,1,0
207515,on,0,0
207516,day,0,0
207517,1,0,0
207518,follow-up,0,0
207519,lumbar,0,0
207520,punctures,0,0
207521,",",0,0
207522,compared,0,0
207523,with,0,0
207524,only,0,0
207525,5.8,0,0
207526,%,0,0
207527,of,0,0
207528,AMP,0,0
207529,patients,0,0
207530,with,0,0
207531,H.,0,0
207532,influenzae,0,0
207533,.,0,0
207534,The,0,0
207535,significance,0,0
207536,of,0,0
207537,a,0,0
207538,delay,1,1
207539,of,1,0
207540,CSF,1,0
207541,sterilization,1,0
207542,among,0,0
207543,CB-treated,0,0
207544,patients,0,0
207545,is,0,0
207546,unknown,0,0
207547,",",0,0
207548,since,0,0
207549,there,0,0
207550,was,0,0
207551,no,0,0
207552,correlation,0,0
207553,between,0,0
207554,persistence,0,1
207555,of,0,0
207556,hemophilus,0,0
207557,organisms,0,0
207558,and,0,0
207559,the,0,0
207560,frequency,0,1
207561,of,0,0
207562,adverse,0,1
207563,outcome,0,0
207564,.,0,0
207565,AMP,0,0
207566,and,0,0
207567,CB,0,1
207568,are,0,0
207569,equivalent,0,0
207570,for,0,0
207571,the,0,0
207572,treatment,0,0
207573,of,0,0
207574,bacterial,0,1
207575,meningitis,0,0
207576,due,0,0
207577,to,0,0
207578,susceptible,0,0
207579,organisms,0,0
207580,.,0,0
207581,Comparison,0,0
207582,of,0,0
207583,the,0,0
207584,potassium-,1,0
207585,retaining,1,0
207586,effects,1,1
207587,of,0,1
207588,amiloride,0,0
207589,and,0,1
207590,spironolactone,0,0
207591,in,0,0
207592,hypertensive,0,0
207593,patients,0,0
207594,with,0,0
207595,thiazide-induced,0,0
207596,hypokalaemia,0,1
207597,.,0,0
207598,[,0,0
207599,Prognostic,0,1
207600,experiences,0,0
207601,in,0,0
207602,the,0,0
207603,long-term,0,0
207604,differential,0,0
207605,therapy,0,0
207606,of,0,0
207607,chronic,0,0
207608,aggressive,0,0
207609,hepatitides,0,0
207610,],0,0
207611,.,0,0
207612,A,0,0
207613,double-blind,0,0
207614,crossover,0,0
207615,comparison,0,0
207616,of,0,1
207617,pindolol,0,0
207618,",",0,0
207619,metoprolol,0,0
207620,",",0,1
207621,atenolol,0,0
207622,and,0,1
207623,labetalol,0,1
207624,in,0,0
207625,mild,0,0
207626,to,0,0
207627,moderate,0,0
207628,hypertension,0,0
207629,.,0,0
207630,1,0,0
207631,This,0,0
207632,study,0,0
207633,was,0,0
207634,designed,0,0
207635,to,0,0
207636,compare,0,0
207637,in,0,0
207638,a,0,0
207639,double-blind,0,0
207640,randomized,0,0
207641,crossover,0,0
207642,trial,0,0
207643,",",0,1
207644,atenolol,0,0
207645,",",0,1
207646,labetalol,0,1
207647,",",0,1
207648,metoprolol,0,0
207649,and,0,1
207650,pindolol,0,0
207651,.,0,1
207652,Considerable,0,0
207653,differences,0,0
207654,in,0,0
207655,dose,1,0
207656,(,0,0
207657,atenolol,0,0
207658,138,0,0
207659,+/-,0,0
207660,13,0,0
207661,mg,0,0
207662,daily,0,0
207663,;,0,0
207664,labetalol,0,0
207665,308,0,0
207666,+/-,0,0
207667,34,0,0
207668,mg,0,0
207669,daily,0,0
207670,;,0,0
207671,metoprolol,0,0
207672,234,0,0
207673,+/-,0,0
207674,22,0,0
207675,mg,0,0
207676,daily,0,0
207677,;,0,0
207678,and,0,0
207679,pindolol,0,0
207680,24,0,0
207681,+/-2,0,0
207682,mg,0,0
207683,daily,0,0
207684,were,0,0
207685,required,0,0
207686,to,0,0
207687,produce,0,0
207688,similar,0,0
207689,antihypertensive,1,0
207690,effects,1,0
207691,.,1,0
207692,3,0,0
207693,The,1,0
207694,overall,1,0
207695,incidence,1,1
207696,of,1,0
207697,side-effects,1,1
207698,was,1,0
207699,similar,1,0
207700,with,1,0
207701,atenolol,1,0
207702,",",1,0
207703,metoprolol,1,0
207704,and,1,1
207705,pindolol,1,0
207706,but,1,0
207707,was,1,0
207708,slightly,1,0
207709,less,1,0
207710,with,1,0
207711,labetalol,1,0
207712,.,0,0
207713,Sleep,1,0
207714,disturbances,1,1
207715,and,1,0
207716,abnormal,1,1
207717,dreaming,1,1
207718,patterns,1,1
207719,were,1,0
207720,most,1,0
207721,frequent,1,0
207722,with,1,0
207723,pindolol,1,0
207724,.,0,0
207725,4,0,0
207726,There,1,0
207727,was,1,0
207728,a,1,0
207729,significantly,1,0
207730,greater,1,0
207731,fall,1,1
207732,in,1,0
207733,pulse,1,1
207734,rate,1,1
207735,during,1,0
207736,atenolol,1,0
207737,and,1,1
207738,metoprolol,1,0
207739,treatment,1,0
207740,periods,1,0
207741,.,0,0
207742,[,0,0
207743,Carticaine,0,0
207744,in,0,0
207745,the,0,0
207746,therapie,0,0
207747,of,0,0
207748,pain,1,1
207749,(,0,0
207750,author,0,0
207751,'s,0,1
207752,transl,0,0
207753,),0,0
207754,],0,0
207755,.,0,0
207756,The,0,0
207757,gastric,1,1
207758,emptying,1,1
207759,and,1,0
207760,small,1,1
207761,intestinal,1,1
207762,transit,1,1
207763,after,0,0
207764,highly,0,0
207765,selective,0,0
207766,vagotomy,0,0
207767,without,0,0
207768,drainage,0,0
207769,and,0,0
207770,selective,0,1
207771,vagotomy,0,0
207772,with,0,0
207773,pyloroplasty,0,0
207774,.,0,0
207775,[,1,0
207776,Folic,1,0
207777,acid,1,1
207778,deficiency,1,0
207779,in,0,0
207780,pregnant,0,0
207781,women,0,0
207782,in,0,0
207783,Switzerland,0,0
207784,],0,0
207785,.,0,0
207786,A,0,0
207787,controlled,0,0
207788,study,0,0
207789,of,0,0
207790,early,0,0
207791,discharge,0,1
207792,after,0,0
207793,uncomplicated,0,0
207794,myocardial,0,1
207795,infarction,0,0
207796,.,0,0
207797,Out,0,0
207798,of,0,0
207799,383,0,0
207800,myocardial,0,0
207801,infarction,0,0
207802,(,0,0
207803,MI,0,0
207804,),0,0
207805,patients,0,0
207806,aged,0,0
207807,below,0,0
207808,70,0,0
207809,years,0,0
207810,",",0,0
207811,252,0,0
207812,(,0,0
207813,66,0,0
207814,%,0,0
207815,),0,0
207816,were,0,0
207817,judged,0,0
207818,after,0,0
207819,the,0,0
207820,third,0,0
207821,day,0,0
207822,in,0,0
207823,hospital,0,0
207824,to,0,0
207825,have,0,0
207826,had,0,0
207827,uncomplicated,0,0
207828,infarctions,0,0
207829,.,0,0
207830,These,0,0
207831,patients,0,0
207832,were,0,0
207833,allocated,0,0
207834,at,0,0
207835,random,0,0
207836,to,0,0
207837,two,0,0
207838,groups,0,0
207839,",",0,0
207840,one,0,0
207841,of,0,0
207842,which,0,0
207843,was,0,0
207844,given,0,0
207845,treatment,0,0
207846,for,0,0
207847,8,0,0
207848,days,0,0
207849,and,0,0
207850,the,0,0
207851,other,0,0
207852,for,0,0
207853,15,0,0
207854,days,0,0
207855,.,0,0
207856,No,0,0
207857,significant,0,0
207858,differences,1,0
207859,in,1,0
207860,mortality,1,1
207861,",",1,0
207862,morbidity,1,1
207863,or,1,1
207864,incapacity,1,1
207865,for,1,0
207866,work,1,0
207867,could,0,0
207868,be,0,0
207869,detected,0,0
207870,during,0,0
207871,the,0,0
207872,three-month,0,0
207873,period,0,0
207874,of,0,0
207875,follow-up,0,0
207876,.,0,0
207877,The,0,0
207878,findings,0,0
207879,thus,0,0
207880,support,0,0
207881,previous,0,0
207882,conclusions,0,0
207883,that,0,0
207884,early,0,0
207885,discharge,0,0
207886,from,0,0
207887,hospital,0,1
207888,after,0,0
207889,uncomplicated,0,0
207890,MI,0,0
207891,is,0,0
207892,not,0,0
207893,associated,0,0
207894,with,0,0
207895,greater,0,0
207896,risk,0,1
207897,for,0,0
207898,the,0,0
207899,patient,0,0
207900,than,0,0
207901,later,0,0
207902,discharge,0,0
207903,.,0,0
207904,A,0,0
207905,randomized,0,0
207906,controlled,0,0
207907,trial,0,0
207908,of,0,0
207909,ergotamine,0,0
207910,tartrate,0,0
207911,.,0,0
207912,Persistent,0,1
207913,phenothiazine,0,0
207914,dyskinesia,0,0
207915,treated,0,0
207916,with,0,0
207917,tetrabenazine,0,0
207918,.,0,0
207919,Six,0,0
207920,patients,0,0
207921,with,0,0
207922,persistent,0,0
207923,phenothiazine,0,1
207924,dyskinesia,0,1
207925,were,0,0
207926,treated,0,0
207927,in,0,0
207928,a,0,0
207929,double-blind,0,0
207930,controlled,0,0
207931,trial,0,0
207932,with,0,0
207933,tetrabenazine,0,0
207934,100,0,0
207935,mg,0,0
207936,in,0,0
207937,divided,0,0
207938,dosage,0,0
207939,.,0,0
207940,In,0,0
207941,three,0,0
207942,patients,0,0
207943,the,0,0
207944,abnormal,0,1
207945,movements,0,0
207946,were,0,0
207947,abolished,0,0
207948,and,0,0
207949,in,0,0
207950,two,0,0
207951,others,0,0
207952,there,0,0
207953,was,0,0
207954,some,0,0
207955,improvement,0,1
207956,",",0,0
207957,but,0,0
207958,this,0,0
207959,was,0,0
207960,no,0,0
207961,greater,0,0
207962,than,0,0
207963,that,0,0
207964,achieved,0,0
207965,with,0,0
207966,the,0,0
207967,diazepam,0,0
207968,control,0,0
207969,.,0,0
207970,Tetrabenazine,0,0
207971,may,0,0
207972,be,0,0
207973,useful,0,0
207974,in,0,0
207975,the,0,0
207976,treatment,0,0
207977,of,0,0
207978,some,0,0
207979,patients,0,0
207980,with,0,0
207981,persistent,0,0
207982,phenothiazine,0,0
207983,dyskinesia,0,0
207984,.,0,0
207985,Miotics,0,0
207986,in,0,0
207987,cataract,0,0
207988,surgery,0,0
207989,.,0,0
207990,Anaerobic,0,1
207991,infection,0,1
207992,in,0,0
207993,cancer,0,0
207994,patients,0,0
207995,:,0,0
207996,comparative,0,0
207997,evaluation,0,0
207998,of,0,0
207999,clindamycin,0,0
208000,and,0,0
208001,cefoxitin,0,0
208002,.,0,1
208003,Clindamycin,0,0
208004,and,0,0
208005,cefoxitin,0,0
208006,with,0,0
208007,or,0,0
208008,without,0,0
208009,gentamicin,0,0
208010,were,0,0
208011,administered,0,0
208012,to,0,0
208013,cancer,0,0
208014,patients,0,0
208015,having,0,0
208016,localized,0,0
208017,infections,0,0
208018,presumably,0,0
208019,caused,0,0
208020,by,0,0
208021,anaerobic,0,0
208022,pathogens,0,0
208023,.,0,0
208024,The,0,0
208025,rates,0,1
208026,of,0,0
208027,favorable,1,0
208028,response,1,1
208029,were,0,0
208030,89,0,0
208031,%,0,0
208032,in,0,0
208033,patients,0,0
208034,receiving,0,0
208035,clindamycine,0,0
208036,alone,0,0
208037,and,0,0
208038,78,0,0
208039,%,0,0
208040,in,0,0
208041,patients,0,0
208042,receiving,0,0
208043,cefoxitin,0,0
208044,alone,0,0
208045,.,0,0
208046,When,0,0
208047,the,0,0
208048,total,0,0
208049,experience,0,0
208050,is,0,0
208051,considered,0,0
208052,(,0,0
208053,clindamycin,0,0
208054,or,0,0
208055,cefoxitin,0,0
208056,with,0,0
208057,and,0,0
208058,without,0,0
208059,gentamicin,0,0
208060,),0,0
208061,",",0,0
208062,20,0,0
208063,of,0,0
208064,24,0,0
208065,patients,0,0
208066,(,0,0
208067,83,0,0
208068,%,0,0
208069,),0,0
208070,responded,1,0
208071,to,0,0
208072,clindamycin,0,0
208073,and,0,0
208074,18,0,0
208075,of,0,0
208076,22,0,0
208077,(,0,0
208078,82,0,0
208079,%,0,0
208080,),0,0
208081,responded,1,0
208082,to,0,0
208083,cefoxitin,0,0
208084,.,0,0
208085,Both,0,0
208086,therapies,0,0
208087,were,0,0
208088,well,1,0
208089,tolerated,1,1
208090,.,1,0
208091,Clindamycin,0,0
208092,was,0,0
208093,found,0,0
208094,to,0,0
208095,be,0,0
208096,more,0,0
208097,effective,1,1
208098,than,0,0
208099,cefoxitin,0,0
208100,in,0,0
208101,eradicating,1,0
208102,the,1,0
208103,offending,1,0
208104,anaerobic,1,0
208105,pathogens,1,1
208106,from,1,0
208107,the,1,0
208108,site,1,0
208109,of,1,0
208110,infection,1,1
208111,.,1,0
208112,Aerobic,0,0
208113,pathogens,0,1
208114,were,0,0
208115,frequently,0,0
208116,isolated,0,0
208117,along,0,0
208118,with,0,0
208119,anaerobes,0,0
208120,from,0,0
208121,the,0,0
208122,infectious,0,0
208123,sites,0,0
208124,in,0,0
208125,this,0,0
208126,series,0,0
208127,;,0,0
208128,their,0,0
208129,susceptibility,0,1
208130,or,0,0
208131,resistance,0,1
208132,to,0,0
208133,clindamycin,0,0
208134,or,0,0
208135,cefoxitin,0,0
208136,did,0,0
208137,not,0,0
208138,influence,0,0
208139,the,0,0
208140,therapeutic,0,0
208141,response,0,0
208142,.,0,0
208143,Psychiatric,0,1
208144,treatment,0,0
208145,of,0,0
208146,eczema,0,0
208147,:,0,0
208148,a,0,0
208149,controlled,0,0
208150,trial,0,0
208151,.,0,0
208152,Seventy-two,0,0
208153,patients,0,0
208154,with,0,0
208155,eczema,0,1
208156,were,0,0
208157,randomly,0,0
208158,allotted,0,0
208159,to,0,0
208160,one,0,0
208161,of,0,0
208162,two,0,0
208163,treatment,0,0
208164,groups,0,0
208165,:,0,0
208166,A,0,0
208167,",",0,0
208168,those,0,0
208169,receiving,0,0
208170,dermatological,0,0
208171,treatment,0,0
208172,only,0,0
208173,",",0,0
208174,and,0,1
208175,B,0,0
208176,",",0,0
208177,those,0,0
208178,receiving,0,0
208179,the,0,0
208180,same,0,0
208181,dermatological,0,0
208182,treatment,0,0
208183,plus,0,0
208184,psychiatric,0,1
208185,treatment,0,0
208186,",",0,0
208187,limited,0,0
208188,where,0,0
208189,possible,0,0
208190,to,0,0
208191,four,0,0
208192,months,0,0
208193,.,0,0
208194,Cases,0,0
208195,were,0,0
208196,followed,0,0
208197,up,0,0
208198,at,0,0
208199,six-monthly,0,0
208200,dermatological,0,0
208201,assessments,0,0
208202,",",0,0
208203,57,0,0
208204,(,0,0
208205,79,0,0
208206,%,0,0
208207,),0,0
208208,for,0,0
208209,18,0,0
208210,months,0,0
208211,.,0,0
208212,The,0,0
208213,findings,0,0
208214,suggest,0,0
208215,that,0,0
208216,in,0,0
208217,the,0,0
208218,presence,1,0
208219,of,1,0
208220,overt,1,1
208221,emotional,1,1
208222,disturbance,1,1
208223,",",0,0
208224,of,0,0
208225,new,1,0
208226,psychological,1,1
208227,or,1,0
208228,psychophysiological,1,1
208229,symptoms,1,1
208230,preceding,1,0
208231,the,1,0
208232,rash,1,1
208233,by,0,0
208234,up,0,0
208235,to,0,0
208236,a,0,0
208237,year,0,0
208238,",",0,0
208239,and,0,1
208240,of,0,1
208241,high,1,0
208242,motivation,1,1
208243,for,0,0
208244,it,0,0
208245,",",0,0
208246,brief,0,0
208247,psychiatric,0,0
208248,treatment,0,0
208249,improves,1,0
208250,the,0,0
208251,outcome,0,0
208252,in,0,0
208253,eczema,1,1
208254,(,0,0
208255,the,0,0
208256,proportion,0,0
208257,clear,0,0
208258,at,0,0
208259,18,0,0
208260,months,0,0
208261,was,0,0
208262,about,0,0
208263,doubled,0,0
208264,),0,0
208265,",",0,0
208266,whereas,0,0
208267,in,0,0
208268,their,0,0
208269,absence,0,0
208270,such,0,0
208271,treatment,0,0
208272,may,0,0
208273,worsen,1,0
208274,it,1,0
208275,",",0,0
208276,especially,0,0
208277,in,0,0
208278,the,0,0
208279,short,0,0
208280,term,0,0
208281,.,0,0
208282,Incidence,1,1
208283,of,1,0
208284,candida,1,0
208285,in,0,0
208286,hospital,0,1
208287,in-patients,0,0
208288,and,0,0
208289,the,0,0
208290,effects,0,1
208291,of,0,0
208292,antibiotic,0,0
208293,therapy,0,0
208294,.,0,0
208295,One-trial,1,0
208296,learning,1,0
208297,with,0,0
208298,control,0,0
208299,of,0,0
208300,item-difficulty,0,1
208301,.,0,0
208302,Alcoholism,0,1
208303,",",0,0
208304,avoidance,1,1
208305,learning,1,1
208306,and,0,1
208307,emotional,1,1
208308,responsiveness,1,1
208309,.,1,0
208310,Effect,0,0
208311,of,0,0
208312,carbon,0,0
208313,monoxide,0,0
208314,on,0,0
208315,exercise,1,0
208316,performance,1,1
208317,in,0,0
208318,chronic,0,0
208319,obstructive,0,0
208320,pulmonary,0,0
208321,disease,0,0
208322,.,0,0
208323,We,0,0
208324,evaluated,0,0
208325,the,0,0
208326,effect,0,0
208327,of,0,0
208328,breathing,0,0
208329,100,0,0
208330,ppm,0,0
208331,of,0,0
208332,carbon,0,0
208333,monoxide,0,1
208334,versus,0,0
208335,compressed,0,0
208336,",",0,0
208337,purified,0,0
208338,air,0,0
208339,for,0,0
208340,1,0,0
208341,hour,0,0
208342,on,0,0
208343,exercise,1,0
208344,performance,1,1
208345,in,0,0
208346,10,0,0
208347,patients,0,0
208348,with,0,0
208349,chronic,0,0
208350,obstructive,0,0
208351,pulmonary,0,1
208352,disease,0,0
208353,in,0,0
208354,a,0,0
208355,double-blind,0,0
208356,",",0,0
208357,randomized,0,0
208358,",",0,0
208359,crossover,0,0
208360,study,0,0
208361,.,0,0
208362,The,0,0
208363,mean,1,1
208364,arterial,1,1
208365,carboxyhemoglobin,1,0
208366,was,0,0
208367,1.48,0,0
208368,per,0,0
208369,cent,0,0
208370,in,0,0
208371,the,0,0
208372,carbon,0,0
208373,monoxide,0,1
208374,control,0,0
208375,period,0,0
208376,and,0,1
208377,increased,0,0
208378,from,0,0
208379,1.43,0,0
208380,to,0,0
208381,4.08,0,0
208382,per,0,0
208383,cent,0,0
208384,after,0,0
208385,breathing,0,0
208386,carbon,0,0
208387,monoxide,0,1
208388,(,0,0
208389,P,0,0
208390,less,0,0
208391,than,0,0
208392,0.001,0,0
208393,),0,0
208394,.,0,0
208395,The,0,0
208396,mean,1,1
208397,arterial,1,1
208398,carboxyhemoglobin,1,1
208399,level,1,1
208400,was,0,0
208401,1.52,0,0
208402,percent,0,0
208403,in,0,0
208404,the,0,0
208405,air,0,0
208406,control,0,0
208407,period,0,0
208408,and,0,0
208409,decreased,0,0
208410,from,0,0
208411,1.47,0,0
208412,to,0,0
208413,1.34,0,0
208414,per,0,0
208415,cent,0,0
208416,after,0,0
208417,purified,0,0
208418,air,0,0
208419,(,0,0
208420,P,0,0
208421,less,0,0
208422,than,0,0
208423,0.001,0,0
208424,),0,0
208425,.,0,0
208426,The,0,0
208427,mean,1,1
208428,exercise,1,0
208429,time,1,1
208430,until,1,0
208431,marked,1,0
208432,dyspnea,1,1
208433,decreased,0,0
208434,from,0,0
208435,218.5,0,0
208436,seconds,0,0
208437,in,0,0
208438,the,0,0
208439,carbon,0,0
208440,monoxide,0,1
208441,control,0,0
208442,period,0,0
208443,to,0,0
208444,146.6,0,0
208445,seconds,0,0
208446,after,0,0
208447,breathing,0,0
208448,carbon,0,0
208449,monoxide,0,1
208450,(,0,0
208451,P,0,0
208452,less,0,0
208453,than,0,0
208454,0.001,0,0
208455,),0,0
208456,.,0,0
208457,The,0,0
208458,mean,1,1
208459,exercise,1,0
208460,time,1,1
208461,was,0,0
208462,219.9,0,0
208463,seconds,0,0
208464,in,0,0
208465,the,0,0
208466,air,0,0
208467,control,0,0
208468,period,0,0
208469,and,0,0
208470,221.3,0,0
208471,seconds,0,0
208472,after,0,0
208473,purified,0,0
208474,air,0,0
208475,(,0,0
208476,P,0,0
208477,not,0,0
208478,significant,0,0
208479,),0,0
208480,.,0,0
208481,Breathing,0,0
208482,100,0,0
208483,ppm,0,0
208484,of,0,0
208485,carbon,0,0
208486,monoxide,0,0
208487,for,0,0
208488,1,0,0
208489,hour,0,0
208490,caused,0,0
208491,a,0,0
208492,significant,0,0
208493,reduction,0,1
208494,in,0,0
208495,exercise,1,0
208496,performance,1,1
208497,in,0,0
208498,patients,0,0
208499,with,0,0
208500,chronic,0,0
208501,obstructive,0,0
208502,pulmonary,0,0
208503,disease,0,0
208504,.,0,0
208505,An,0,0
208506,assessment,0,0
208507,of,0,0
208508,beta-adrenoceptor,0,0
208509,blockade,0,0
208510,in,0,0
208511,man,0,0
208512,by,0,0
208513,prizidilol,0,0
208514,hydrochloride,0,0
208515,.,0,0
208516,1,0,0
208517,Prizidilol,0,0
208518,hydrochloride,0,0
208519,(,0,0
208520,SK,0,1
208521,&,0,0
208522,F,0,0
208523,92657,0,0
208524,),0,0
208525,is,0,0
208526,a,0,0
208527,new,0,0
208528,compound,0,0
208529,which,0,0
208530,causes,0,0
208531,both,0,0
208532,arteriolar,0,1
208533,dilatation,0,1
208534,and,0,1
208535,beta-adrenoceptor,1,0
208536,blockade,1,0
208537,.,1,0
208538,The,0,0
208539,effect,0,0
208540,of,0,0
208541,a,0,0
208542,single,0,0
208543,oral,0,0
208544,dose,0,0
208545,on,0,0
208546,the,0,0
208547,responses,0,1
208548,of,0,0
208549,heart,0,1
208550,rate,0,1
208551,and,0,1
208552,blood,0,1
208553,pressure,0,1
208554,to,0,0
208555,isoprenaline,0,0
208556,infusion,0,0
208557,has,0,0
208558,been,0,0
208559,studied,0,0
208560,in,0,0
208561,healthy,0,0
208562,volunteers,0,0
208563,.,0,0
208564,2,0,0
208565,Isoprenaline,0,0
208566,heart,1,0
208567,rate,1,1
208568,dose-response,1,0
208569,curves,1,1
208570,showed,0,0
208571,parallel,0,0
208572,shifts,0,0
208573,to,0,0
208574,the,0,0
208575,right,0,0
208576,after,0,0
208577,oral,0,0
208578,prizidilol,0,0
208579,",",0,0
208580,indicating,0,0
208581,antagonism,0,0
208582,by,0,0
208583,this,0,0
208584,compound,0,0
208585,at,0,0
208586,beta-adrenoceptors,0,0
208587,in,0,0
208588,the,0,0
208589,heart,0,0
208590,.,0,0
208591,3,0,0
208592,Isoprenaline,0,0
208593,dose-response,0,0
208594,curves,0,1
208595,for,0,0
208596,decreases,0,0
208597,in,0,0
208598,diastolic,1,1
208599,blood,1,1
208600,pressure,1,1
208601,also,0,0
208602,showed,0,0
208603,shifts,0,0
208604,to,0,0
208605,the,0,0
208606,right,0,0
208607,after,0,0
208608,oral,0,0
208609,prizidilol,0,0
208610,",",0,0
208611,providing,0,0
208612,evidence,0,0
208613,of,0,0
208614,beta-adrenoceptor,0,0
208615,antagonism,0,0
208616,by,0,0
208617,this,0,0
208618,drug,0,0
208619,in,0,0
208620,peripheral,0,1
208621,resistance,0,1
208622,vessels,0,0
208623,.,0,0
208624,4,0,0
208625,The,0,0
208626,peak,0,0
208627,effect,0,0
208628,of,0,0
208629,a,0,0
208630,40,0,0
208631,mg,0,0
208632,dose,0,0
208633,of,0,1
208634,propranolol,0,0
208635,was,0,0
208636,greater,0,0
208637,than,0,0
208638,that,0,0
208639,of,0,0
208640,a,0,0
208641,200,0,0
208642,mg,0,0
208643,dose,0,0
208644,of,0,1
208645,prizidilol,0,0
208646,but,0,0
208647,both,0,0
208648,drugs,0,0
208649,caused,0,0
208650,persistent,0,0
208651,beta-adrenoceptor,1,0
208652,blockade,1,0
208653,for,0,0
208654,at,0,0
208655,least,0,0
208656,7,0,0
208657,h,0,0
208658,after,0,0
208659,ingestion,0,0
208660,.,0,0
208661,Effects,1,0
208662,of,0,0
208663,nutritional,0,1
208664,supplementation,0,0
208665,on,0,0
208666,IQ,1,1
208667,and,0,0
208668,certain,0,0
208669,other,0,0
208670,variables,0,0
208671,associated,0,0
208672,with,0,0
208673,Down,0,0
208674,syndrome,0,0
208675,.,0,0
208676,In,0,0
208677,a,0,0
208678,double-blind,0,0
208679,study,0,0
208680,",",0,0
208681,24,0,0
208682,Down,0,0
208683,syndrome,0,0
208684,children,0,0
208685,",",0,0
208686,ages,0,0
208687,6,0,0
208688,to,0,0
208689,17,0,0
208690,years,0,0
208691,living,0,0
208692,at,0,0
208693,home,0,0
208694,",",0,0
208695,were,0,0
208696,given,0,0
208697,a,0,0
208698,megadose,0,0
208699,multi-vitamin/mineral,0,0
208700,supplement,0,0
208701,for,0,0
208702,4,0,0
208703,months,0,0
208704,.,0,0
208705,A,0,0
208706,matched,0,0
208707,group,0,0
208708,of,0,0
208709,23,0,0
208710,children,0,0
208711,received,0,0
208712,a,0,0
208713,placebo,0,0
208714,in,0,0
208715,identical,0,0
208716,form,0,0
208717,.,0,0
208718,The,1,0
208719,children,1,0
208720,'s,1,0
208721,IQ,1,1
208722,",",1,0
208723,vision,1,1
208724,",",1,1
208725,and,1,1
208726,visual-motor,1,1
208727,integration,1,1
208728,were,0,0
208729,tested,0,0
208730,before,0,0
208731,and,0,0
208732,after,0,0
208733,supplementation,0,0
208734,",",0,0
208735,and,0,1
208736,weekly,0,1
208737,checks,0,1
208738,were,0,0
208739,made,0,0
208740,to,0,0
208741,monitor,0,0
208742,behavioral,0,1
208743,changes,0,0
208744,.,0,0
208745,No,0,0
208746,differences,0,0
208747,were,0,0
208748,found,0,0
208749,on,0,0
208750,any,0,0
208751,measures,0,0
208752,as,0,0
208753,a,0,0
208754,result,0,0
208755,of,0,0
208756,supplementation,0,0
208757,.,0,0
208758,Comparison,0,0
208759,of,0,0
208760,hypnotherapy,0,0
208761,with,0,0
208762,systematic,0,0
208763,relaxation,0,1
208764,in,0,0
208765,the,0,0
208766,treatment,0,0
208767,of,0,0
208768,cigarette,0,0
208769,habituation,0,1
208770,.,0,0
208771,Because,0,0
208772,of,0,0
208773,the,0,0
208774,methodological,0,0
208775,deficiencies,0,0
208776,in,0,0
208777,this,0,0
208778,area,0,1
208779,of,0,0
208780,research,0,0
208781,",",0,0
208782,it,0,0
208783,is,0,0
208784,impossible,0,0
208785,to,0,0
208786,make,0,0
208787,any,0,0
208788,valid,0,0
208789,conclusions,0,0
208790,about,0,0
208791,whether,0,0
208792,hypnosis,0,0
208793,itself,0,0
208794,is,0,0
208795,effective,0,0
208796,in,0,0
208797,the,0,0
208798,treatment,0,0
208799,of,0,0
208800,cigarette,0,0
208801,habituation,0,1
208802,.,0,0
208803,In,0,0
208804,this,0,0
208805,study,0,0
208806,",",0,0
208807,87,0,0
208808,volunteers,0,0
208809,who,0,0
208810,wanted,0,0
208811,to,0,0
208812,quit,0,1
208813,cigarette,0,0
208814,smoking,0,1
208815,were,0,0
208816,assigned,0,0
208817,randomly,0,0
208818,to,0,0
208819,the,0,0
208820,experimental,0,0
208821,hypnosis,0,0
208822,group,0,0
208823,",",0,0
208824,the,0,0
208825,comparison,0,0
208826,relaxation,0,1
208827,group,0,0
208828,",",0,0
208829,and,0,0
208830,the,0,0
208831,waiting,0,1
208832,list,0,0
208833,control,0,0
208834,group,0,0
208835,.,0,0
208836,Ss,0,0
208837,in,0,0
208838,the,0,0
208839,treatment,0,0
208840,groups,0,0
208841,had,0,0
208842,four,0,0
208843,weekly,0,0
208844,50-minute,0,0
208845,",",0,0
208846,individual,0,0
208847,sessions,0,0
208848,.,0,0
208849,Four,0,0
208850,months,0,0
208851,after,0,0
208852,the,0,0
208853,completion,0,0
208854,of,0,0
208855,treatment,0,0
208856,",",0,0
208857,Ss,0,0
208858,were,0,0
208859,administered,0,0
208860,a,0,0
208861,questionnaire,1,0
208862,and,1,0
208863,a,1,0
208864,hypnotic,1,1
208865,susceptibility,1,1
208866,scale,1,1
208867,.,1,0
208868,Ss,0,0
208869,in,0,0
208870,the,0,0
208871,hypnosis,0,0
208872,group,0,0
208873,who,0,0
208874,were,0,0
208875,in,0,0
208876,the,0,0
208877,upper,0,0
208878,two-thirds,0,0
208879,of,0,0
208880,the,0,0
208881,group,0,0
208882,in,0,0
208883,terms,0,0
208884,of,0,0
208885,hypnotic,0,0
208886,susceptibility,0,1
208887,reduced,0,0
208888,their,0,0
208889,cigarette,1,0
208890,consumption,1,1
208891,substantially,0,0
208892,more,0,0
208893,than,0,0
208894,Ss,0,0
208895,in,0,0
208896,the,0,0
208897,relaxation,0,1
208898,group,0,0
208899,who,0,0
208900,were,0,0
208901,in,0,0
208902,the,0,0
208903,upper,0,0
208904,two-thirds,0,0
208905,of,0,0
208906,the,0,0
208907,group,0,0
208908,in,0,0
208909,terms,0,0
208910,of,0,0
208911,hypnotic,1,0
208912,susceptibility,1,1
208913,.,1,0
208914,Therefore,0,0
208915,",",0,0
208916,the,0,0
208917,hypnotic,0,0
208918,state,0,0
208919,appears,0,0
208920,to,0,0
208921,be,0,0
208922,therapeutic,0,0
208923,for,0,0
208924,individuals,0,0
208925,who,0,0
208926,can,0,0
208927,enter,0,0
208928,medium,0,0
208929,or,0,0
208930,deep,0,1
208931,states,0,0
208932,of,0,0
208933,hypnosis,0,0
208934,.,0,0
208935,A,0,0
208936,comparative,0,0
208937,study,0,0
208938,of,0,0
208939,netilmicin-cefoxitin,0,0
208940,and,0,0
208941,gentamicin-cefoxitin,0,0
208942,in,0,0
208943,surgical,0,0
208944,patients,0,0
208945,with,0,0
208946,serious,0,1
208947,systemic,0,0
208948,infection,0,1
208949,.,0,0
208950,A,0,0
208951,double-blind,0,0
208952,",",0,0
208953,randomized,0,0
208954,study,0,0
208955,of,0,0
208956,gentamicin,0,0
208957,and,0,1
208958,netilmicin,0,0
208959,",",0,0
208960,each,0,0
208961,in,0,0
208962,combination,0,0
208963,with,0,0
208964,cefoxitin,0,0
208965,",",0,0
208966,was,0,0
208967,done,0,0
208968,to,0,0
208969,compare,0,0
208970,their,0,0
208971,respective,0,0
208972,efficacy,1,1
208973,and,1,1
208974,toxicity,1,1
208975,in,0,0
208976,patients,0,0
208977,with,0,0
208978,serious,0,1
208979,systemic,0,0
208980,infection,0,1
208981,.,0,0
208982,Thirty-seven,0,0
208983,surgical,0,0
208984,patients,0,0
208985,were,0,0
208986,evaluated,0,0
208987,for,0,0
208988,efficacy,1,1
208989,and,0,0
208990,46,0,0
208991,patients,0,0
208992,were,0,0
208993,evaluated,0,0
208994,for,0,0
208995,toxicity,0,1
208996,.,0,0
208997,The,0,0
208998,most,0,0
208999,frequently,0,0
209000,cultured,0,0
209001,organisms,0,0
209002,were,0,0
209003,Escherichia,0,1
209004,coli,0,0
209005,(,0,0
209006,15,0,0
209007,),0,0
209008,",",0,0
209009,Klebsiella,0,1
209010,sp,0,0
209011,(,0,0
209012,9,0,0
209013,),0,0
209014,",",0,0
209015,Proteus,0,1
209016,sp,0,0
209017,(,0,0
209018,6,0,0
209019,),0,0
209020,",",0,0
209021,and,0,1
209022,Bacteroides,0,1
209023,sp,0,0
209024,(,0,0
209025,4,0,0
209026,),0,0
209027,.,0,0
209028,For,0,0
209029,23,0,0
209030,patients,0,0
209031,treated,0,0
209032,with,0,0
209033,gentamicin-cefoxitin,0,0
209034,(,0,0
209035,G-C,0,1
209036,),0,0
209037,",",0,0
209038,the,0,0
209039,clinical,1,0
209040,response,1,1
209041,was,0,0
209042,favorable,0,0
209043,in,0,0
209044,20/21,0,0
209045,(,0,0
209046,95.2,0,0
209047,%,0,0
209048,),0,0
209049,evaluable,0,0
209050,cases,0,0
209051,",",0,0
209052,and,0,1
209053,elimination,0,1
209054,or,0,1
209055,marked,0,0
209056,reduction,0,0
209057,of,0,0
209058,33/34,0,0
209059,(,0,0
209060,97.1,0,0
209061,%,0,0
209062,),0,0
209063,organisms,0,0
209064,was,0,0
209065,achieved,0,0
209066,.,0,0
209067,For,0,0
209068,14,0,0
209069,patients,0,0
209070,treated,0,0
209071,with,0,0
209072,netilmicin-cefoxitin,0,0
209073,(,0,0
209074,N-C,0,1
209075,),0,0
209076,",",0,0
209077,the,0,0
209078,clinical,1,0
209079,response,1,1
209080,was,0,0
209081,favorable,0,0
209082,in,0,0
209083,13/13,0,0
209084,(,0,0
209085,100,0,0
209086,%,0,0
209087,),0,0
209088,evaluable,0,0
209089,cases,0,0
209090,",",0,0
209091,and,0,0
209092,19/20,0,0
209093,(,0,0
209094,95,0,0
209095,%,0,0
209096,),0,0
209097,organisms,0,0
209098,were,0,0
209099,eliminated,0,0
209100,or,0,0
209101,markedly,0,0
209102,reduced,0,0
209103,.,0,0
209104,Nephrotoxicity,1,1
209105,was,0,0
209106,defined,0,0
209107,as,0,0
209108,an,0,0
209109,increase,0,0
209110,in,0,0
209111,serum,1,1
209112,creatinine,1,1
209113,to,0,0
209114,greater,0,0
209115,than,0,0
209116,25,0,0
209117,%,0,0
209118,over,0,0
209119,baseline,0,0
209120,with,0,0
209121,an,0,0
209122,absolute,0,1
209123,rise,0,0
209124,of,0,0
209125,at,0,0
209126,least,0,0
209127,0.5,0,0
209128,mg/100,0,0
209129,ml,0,0
209130,to,0,0
209131,a,0,0
209132,value,0,0
209133,greater,0,0
209134,than,0,0
209135,or,0,0
209136,equal,0,0
209137,to,0,0
209138,1.3,0,0
209139,mg/100,0,0
209140,ml,0,0
209141,.,0,0
209142,Based,0,0
209143,on,0,0
209144,these,0,0
209145,criteria,0,0
209146,",",0,0
209147,nephrotoxicity,1,1
209148,was,0,0
209149,seen,0,0
209150,in,0,0
209151,2/27,0,0
209152,(,0,0
209153,7.4,0,0
209154,%,0,0
209155,),0,0
209156,patients,0,0
209157,treated,0,0
209158,with,0,0
209159,G-C,0,0
209160,and,0,0
209161,in,0,0
209162,3/19,0,0
209163,(,0,0
209164,15.8,0,0
209165,%,0,0
209166,),0,0
209167,patients,0,0
209168,treated,0,0
209169,with,0,0
209170,N-C.,0,0
209171,Ototoxicity,1,1
209172,was,0,0
209173,defined,0,0
209174,as,0,0
209175,a,0,0
209176,greater,0,0
209177,than,0,0
209178,20,0,0
209179,dB,0,0
209180,loss,0,0
209181,at,0,0
209182,any,0,0
209183,frequency,0,1
209184,.,0,0
209185,Based,0,0
209186,on,0,0
209187,these,0,0
209188,criteria,0,0
209189,",",0,0
209190,ototoxicity,1,1
209191,was,0,0
209192,seen,0,0
209193,in,0,0
209194,5/27,0,0
209195,(,0,0
209196,18.5,0,0
209197,%,0,0
209198,),0,0
209199,patients,0,0
209200,treated,0,0
209201,with,0,0
209202,G-C,0,0
209203,and,0,0
209204,2/19,0,0
209205,(,0,0
209206,10.5,0,0
209207,%,0,0
209208,),0,0
209209,patients,0,0
209210,treated,0,0
209211,with,0,0
209212,N-C,0,0
209213,.,0,0
209214,The,0,0
209215,data,0,0
209216,show,0,0
209217,no,0,0
209218,significant,0,0
209219,difference,0,0
209220,in,0,0
209221,toxicity,1,1
209222,and,0,0
209223,suggest,0,0
209224,that,0,0
209225,netilmicin,0,0
209226,and,0,0
209227,gentamicin,0,0
209228,are,0,0
209229,both,0,0
209230,highly,0,0
209231,effective,0,0
209232,in,0,0
209233,combination,0,0
209234,with,0,0
209235,cefoxitin,0,0
209236,in,0,0
209237,patients,0,0
209238,who,0,0
209239,have,0,0
209240,serious,0,1
209241,infections,0,1
209242,after,0,0
209243,surgery,0,0
209244,.,0,0
209245,Netilmicin,0,0
209246,versus,0,0
209247,tobramycin,0,0
209248,in,0,0
209249,multi-centre,0,0
209250,studies,0,0
209251,.,0,0
209252,In,0,0
209253,two,0,0
209254,prospective,0,0
209255,",",0,0
209256,randomized,0,0
209257,studies,0,0
209258,conducted,0,0
209259,in,0,0
209260,West,0,1
209261,Germany,0,0
209262,and,0,0
209263,involving,0,0
209264,80,0,0
209265,patients,0,0
209266,",",0,0
209267,netilmicin-ticarcillin,0,1
209268,was,0,0
209269,compared,0,0
209270,to,0,0
209271,tobramycin-ticarcillin,0,0
209272,in,0,0
209273,the,0,0
209274,treatment,0,0
209275,of,0,0
209276,serious,0,1
209277,systemic,0,0
209278,infections,0,0
209279,.,0,0
209280,Both,0,0
209281,regimens,0,0
209282,were,0,0
209283,essentially,0,0
209284,identical,0,0
209285,with,0,0
209286,respect,0,0
209287,to,0,0
209288,the,0,0
209289,clinical,0,0
209290,and,0,0
209291,bacteriological,0,1
209292,results,0,0
209293,they,0,0
209294,produced,0,0
209295,.,0,0
209296,The,0,0
209297,netilmicin,0,0
209298,group,0,0
209299,developed,0,0
209300,significantly,0,0
209301,less,0,0
209302,nephrotoxicity,1,1
209303,than,0,0
209304,the,0,0
209305,tobramycin,0,0
209306,group,0,0
209307,(,0,0
209308,0,0,0
209309,%,0,0
209310,versus,0,0
209311,15,0,0
209312,%,0,0
209313,",",0,0
209314,P,0,0
209315,=,0,0
209316,0.03,0,0
209317,),0,0
209318,.,0,0
209319,Ototoxicity,1,1
209320,also,0,0
209321,occurred,0,0
209322,less,0,0
209323,frequently,0,0
209324,in,0,0
209325,the,0,0
209326,netilmicin-treated,0,0
209327,patients,0,0
209328,(,0,0
209329,3,0,0
209330,%,0,0
209331,versus,0,0
209332,10,0,0
209333,%,0,0
209334,",",0,0
209335,P,0,0
209336,=,0,0
209337,0.4,0,0
209338,),0,0
209339,.,0,0
209340,In,0,0
209341,a,0,0
209342,large,0,0
209343,collaborative,0,0
209344,study,0,0
209345,involving,0,0
209346,15,0,0
209347,centres,0,0
209348,",",0,0
209349,254,0,0
209350,patients,0,0
209351,were,0,0
209352,enrolled,0,0
209353,.,0,0
209354,Clinical,1,0
209355,and,1,0
209356,bacteriological,1,1
209357,responses,1,1
209358,were,0,0
209359,excellent,0,0
209360,",",0,0
209361,with,0,0
209362,netilmicin,0,0
209363,and,0,0
209364,tobramycin,0,0
209365,equally,0,0
209366,effective,1,0
209367,",",0,0
209368,but,0,0
209369,the,0,0
209370,incidences,0,1
209371,of,0,0
209372,nephrotoxicity,1,1
209373,and,1,1
209374,ototoxicity,1,1
209375,were,0,0
209376,lower,0,0
209377,in,0,0
209378,patients,0,0
209379,treated,0,0
209380,with,0,0
209381,netilmicin,0,0
209382,than,0,0
209383,those,0,0
209384,receiving,0,0
209385,tobramycin,0,0
209386,.,0,0
209387,Effect,0,0
209388,of,0,0
209389,oral,0,0
209390,diuretics,0,0
209391,on,0,0
209392,pulmonary,0,1
209393,mechanics,0,0
209394,in,0,0
209395,infants,0,0
209396,with,0,0
209397,chronic,0,0
209398,bronchopulmonary,0,1
209399,dysplasia,0,0
209400,:,0,0
209401,results,0,0
209402,of,0,0
209403,a,0,0
209404,double-blind,0,0
209405,crossover,0,0
209406,sequential,0,0
209407,trial,0,0
209408,.,0,0
209409,In,0,0
209410,a,0,0
209411,randomized,0,0
209412,double-blind,0,0
209413,crossover,0,0
209414,trial,0,0
209415,with,0,0
209416,sequential,0,0
209417,analysis,0,0
209418,",",0,0
209419,the,0,0
209420,effects,0,1
209421,of,0,0
209422,oral,0,0
209423,diuretics,0,0
209424,were,0,0
209425,compared,0,0
209426,with,0,0
209427,the,0,0
209428,effects,0,0
209429,of,0,0
209430,placebo,0,0
209431,on,0,0
209432,pulmonary,0,1
209433,mechanics,0,0
209434,in,0,0
209435,ten,0,0
209436,infants,0,0
209437,with,0,0
209438,bronchopulmonary,0,1
209439,dysplasia,0,0
209440,(,0,0
209441,BPD,0,0
209442,),0,0
209443,.,0,0
209444,Pulmonary,0,1
209445,mechanics,0,0
209446,were,0,0
209447,measured,0,0
209448,before,0,0
209449,and,0,0
209450,at,0,0
209451,the,0,0
209452,end,0,0
209453,of,0,0
209454,a,0,0
209455,week,0,0
209456,of,0,0
209457,treatment,0,0
209458,with,0,0
209459,oral,0,0
209460,diuretics,0,0
209461,(,0,0
209462,chlorothiazide,0,0
209463,",",0,0
209464,20,0,0
209465,mg/kg/dose,0,0
209466,and,0,0
209467,spironolactone,0,0
209468,",",0,0
209469,1.5,0,0
209470,mg/kg/dose,0,0
209471,),0,0
209472,given,0,0
209473,twice,0,0
209474,daily,0,0
209475,",",0,0
209476,or,0,0
209477,placebo,0,0
209478,.,0,0
209479,Mean,1,0
209480,airway,1,1
209481,resistance,1,1
209482,decreased,0,0
209483,35.3,0,0
209484,cm,0,0
209485,H2O/L/s,0,0
209486,",",0,0
209487,mean,0,1
209488,specific,1,0
209489,airway,1,1
209490,conductance,1,1
209491,increased,0,0
209492,0.095,0,0
209493,1/L/s/cm,0,0
209494,H2O,0,0
209495,",",0,0
209496,and,0,1
209497,mean,1,1
209498,dynamic,1,0
209499,pulmonary,1,1
209500,compliance,1,1
209501,increased,0,0
209502,1.74,0,0
209503,mL/cm,0,0
209504,H2O,0,0
209505,during,0,0
209506,treatment,0,0
209507,with,0,0
209508,diuretics,0,0
209509,(,0,0
209510,all,0,0
209511,P,0,0
209512,less,0,0
209513,than,0,0
209514,.001,0,0
209515,),0,0
209516,",",0,0
209517,but,0,0
209518,not,0,0
209519,during,0,0
209520,treatment,0,0
209521,with,0,0
209522,placebo,0,0
209523,.,0,0
209524,The,0,0
209525,infants,0,0
209526,',0,0
209527,rate,0,1
209528,of,0,0
209529,weight,1,1
209530,gain,1,1
209531,decreased,0,0
209532,on,0,0
209533,the,0,0
209534,first,0,0
209535,three,0,0
209536,days,0,0
209537,of,0,0
209538,diuretic,0,1
209539,treatment,0,0
209540,",",0,0
209541,but,0,0
209542,was,0,0
209543,thereafter,0,0
209544,comparable,0,0
209545,with,0,0
209546,weight,1,1
209547,gain,1,1
209548,during,0,0
209549,treatment,0,0
209550,with,0,0
209551,placebo,0,0
209552,.,0,0
209553,Fluid,1,1
209554,intake,1,1
209555,was,0,0
209556,similar,0,0
209557,in,0,0
209558,infants,0,0
209559,receiving,0,0
209560,diuretics,0,0
209561,and,0,0
209562,placebo,0,0
209563,.,0,1
209564,But,0,0
209565,",",0,0
209566,infants,0,0
209567,receiving,0,0
209568,diuretics,0,0
209569,not,0,0
209570,only,0,0
209571,had,0,0
209572,significantly,0,0
209573,increased,0,0
209574,urine,1,1
209575,output,1,1
209576,",",1,0
209577,osmolal,1,1
209578,clearance,1,1
209579,",",1,0
209580,and,1,1
209581,potassium,1,1
209582,and,1,1
209583,phosphorus,1,1
209584,excretion,1,1
209585,",",0,0
209586,but,0,0
209587,these,0,0
209588,infants,0,0
209589,also,0,0
209590,retained,1,0
209591,less,1,0
209592,fluid,1,1
209593,",",0,1
209594,and,0,1
209595,",",0,1
209596,in,0,0
209597,addition,0,0
209598,",",0,0
209599,excreted,1,1
209600,less,1,0
209601,calcium,1,1
209602,than,0,0
209603,infants,0,0
209604,receiving,0,0
209605,placebo,0,0
209606,.,0,0
209607,It,0,0
209608,is,0,0
209609,concluded,0,0
209610,that,0,0
209611,oral,0,0
209612,diuretics,0,0
209613,improve,0,0
209614,lung,1,0
209615,function,1,1
209616,in,0,0
209617,infants,0,0
209618,with,0,0
209619,chronic,0,0
209620,bronchopulmonary,0,1
209621,dysplasia,0,0
209622,;,0,0
209623,however,0,0
209624,",",0,0
209625,potassium,0,1
209626,and,0,1
209627,phosphorus,0,1
209628,depletion,0,0
209629,are,0,0
209630,potential,0,0
209631,complications,0,1
209632,of,0,0
209633,treatment,0,0
209634,.,0,0
209635,Comparison,0,0
209636,of,0,0
209637,tocainide,0,0
209638,and,0,1
209639,prajmalium,0,1
209640,bitartrate,0,0
209641,for,0,0
209642,the,0,0
209643,treatment,0,0
209644,of,0,0
209645,ventricular,0,1
209646,arrhythmias,0,1
209647,.,0,0
209648,The,0,0
209649,antiarrhythmic,0,1
209650,efficacy,1,1
209651,of,0,0
209652,tocainide,0,0
209653,",",0,0
209654,a,0,0
209655,new,0,0
209656,antiarrhythmic,0,1
209657,substance,0,0
209658,",",0,0
209659,has,0,0
209660,been,0,0
209661,compared,0,0
209662,with,0,0
209663,that,0,0
209664,of,0,0
209665,prajmalium,0,0
209666,bitartrate,0,0
209667,",",0,0
209668,a,0,0
209669,drug,0,0
209670,in,0,0
209671,clinical,0,0
209672,use,0,0
209673,for,0,0
209674,many,0,0
209675,years,0,0
209676,in,0,0
209677,the,0,0
209678,German,0,0
209679,speaking,0,0
209680,countries,0,0
209681,.,0,0
209682,The,0,0
209683,investigation,0,0
209684,was,0,0
209685,performed,0,0
209686,as,0,0
209687,a,0,0
209688,double-blind,0,0
209689,cross-over,0,0
209690,study,0,0
209691,in,0,0
209692,20,0,0
209693,patients,0,0
209694,with,0,0
209695,ventricular,0,1
209696,arrhythmias,0,1
209697,(,0,0
209698,VA,0,0
209699,),0,0
209700,of,0,0
209701,various,0,0
209702,origin,0,0
209703,.,0,0
209704,The,0,0
209705,efficacy,0,1
209706,was,0,0
209707,assessed,0,0
209708,by,0,0
209709,serial,0,0
209710,Holter,1,0
209711,monitoring,1,0
209712,.,1,0
209713,Plasma,1,1
209714,levels,1,1
209715,were,0,0
209716,measured,0,0
209717,to,0,0
209718,study,0,0
209719,the,0,0
209720,dose-effect,0,0
209721,relationship,0,0
209722,.,0,0
209723,Applying,0,0
209724,to,0,0
209725,the,0,0
209726,criterion,0,0
209727,of,0,0
209728,a,0,0
209729,reduction,1,0
209730,of,1,0
209731,VA,1,0
209732,of,0,0
209733,more,0,0
209734,than,0,0
209735,75,0,0
209736,%,0,0
209737,or,0,0
209738,an,0,0
209739,improvement,0,1
209740,according,0,0
209741,to,0,0
209742,the,0,0
209743,Lown,1,0
209744,grading,1,0
209745,8,0,0
209746,pts,0,0
209747,.,0,0
209748,under,0,0
209749,tocainide,0,0
209750,and,0,0
209751,7,0,0
209752,under,0,0
209753,prajmalium,0,0
209754,bitartrate,0,0
209755,were,0,0
209756,responders,0,0
209757,.,0,0
209758,Side,1,0
209759,effects,1,1
209760,were,0,0
209761,few,0,0
209762,and,0,0
209763,under,0,0
209764,tocainide,0,0
209765,only,0,0
209766,2,0,0
209767,pts,0,0
209768,.,0,0
209769,had,0,0
209770,to,0,0
209771,discontinue,0,0
209772,the,0,0
209773,therapy,0,0
209774,.,0,0
209775,From,0,0
209776,the,0,0
209777,present,0,0
209778,findings,0,0
209779,tocainide,0,0
209780,and,0,1
209781,prajmalium,0,0
209782,bitartrate,0,0
209783,have,0,0
209784,the,0,0
209785,same,0,0
209786,efficient,0,0
209787,antiarrhythmic,1,1
209788,effects,1,0
209789,in,0,0
209790,the,0,0
209791,majority,0,0
209792,of,0,0
209793,patients,0,0
209794,.,0,0
209795,[,0,0
209796,Randomized,0,0
209797,controlled,0,0
209798,study,0,0
209799,of,0,0
209800,OK-432,0,0
209801,in,0,0
209802,the,0,0
209803,treatment,0,0
209804,of,0,0
209805,cancerous,1,0
209806,pleurisy,1,0
209807,],1,0
209808,.,0,0
209809,A,0,0
209810,randomized,0,0
209811,controlled,0,0
209812,study,0,0
209813,was,0,0
209814,performed,0,0
209815,to,0,0
209816,evaluate,0,0
209817,the,0,0
209818,efficacy,0,1
209819,of,0,0
209820,intrapleural,0,0
209821,and,0,0
209822,systemic,0,1
209823,administration,0,0
209824,of,0,0
209825,OK-432,0,0
209826,",",0,0
209827,streptococcus,0,0
209828,preparation,0,0
209829,",",0,0
209830,in,0,0
209831,patients,0,0
209832,with,0,0
209833,cancerous,0,0
209834,pleurisy,0,0
209835,.,0,0
209836,A,0,0
209837,total,0,0
209838,of,0,0
209839,53,0,0
209840,patients,0,0
209841,were,0,0
209842,accessed,0,0
209843,to,0,0
209844,the,0,0
209845,study,0,0
209846,:,0,0
209847,29,0,0
209848,patients,0,0
209849,for,0,0
209850,the,0,0
209851,OK-432,0,0
209852,group,0,0
209853,and,0,0
209854,24,0,0
209855,patients,0,0
209856,for,0,0
209857,the,0,0
209858,control,0,0
209859,group,0,0
209860,.,0,0
209861,Intrapleural,0,0
209862,instillation,0,0
209863,of,0,0
209864,50,0,0
209865,mg,0,0
209866,of,0,0
209867,adriamycin,0,0
209868,and,0,0
209869,a,0,0
209870,combination,0,0
209871,chemotherapy,0,0
209872,of,0,1
209873,MFC,0,1
209874,(,0,0
209875,mitomycin,0,0
209876,C,0,0
209877,0.08,0,0
209878,mg/kg,0,0
209879,",",0,0
209880,5-FU,0,0
209881,10,0,0
209882,mg/kg,0,0
209883,",",0,0
209884,ara-C,0,0
209885,0.8,0,0
209886,mg/kg,0,0
209887,iv,0,0
209888,",",0,0
209889,weekly,0,0
209890,),0,0
209891,were,0,0
209892,administered,0,0
209893,in,0,0
209894,both,0,0
209895,groups,0,0
209896,.,0,0
209897,In,0,0
209898,the,0,0
209899,OK-432,0,0
209900,group,0,0
209901,intrapleural,0,0
209902,instillation,0,0
209903,of,0,0
209904,2,0,0
209905,units,0,0
209906,of,0,0
209907,OK-432,0,0
209908,was,0,0
209909,administered,0,0
209910,daily,0,0
209911,until,0,0
209912,disappearance,0,1
209913,of,0,0
209914,pleural,0,1
209915,effusion,0,0
209916,;,0,0
209917,thereafter,0,0
209918,",",0,0
209919,2,0,0
209920,to,0,0
209921,5,0,0
209922,units,0,0
209923,of,0,0
209924,OK-432,0,0
209925,were,0,0
209926,administered,0,0
209927,intradermally,0,0
209928,every,0,0
209929,other,0,0
209930,day,0,0
209931,.,0,0
209932,Patients,0,0
209933,with,0,0
209934,stage,0,0
209935,III,0,0
209936,in,0,0
209937,the,0,0
209938,OK-432,0,0
209939,group,0,0
209940,survived,1,0
209941,significantly,1,0
209942,longer,1,0
209943,than,0,0
209944,those,0,0
209945,in,0,0
209946,the,0,0
209947,control,0,0
209948,group,0,0
209949,(,0,0
209950,P,0,0
209951,less,0,0
209952,than,0,0
209953,0.05,0,0
209954,),0,0
209955,",",0,0
209956,but,0,0
209957,there,0,0
209958,was,0,0
209959,no,0,0
209960,significance,0,1
209961,between,0,0
209962,in,0,0
209963,patients,0,0
209964,with,0,0
209965,stage,0,0
209966,IV,0,0
209967,of,0,0
209968,both,0,0
209969,treatment,0,0
209970,groups,0,0
209971,.,0,0
209972,Also,0,0
209973,patients,0,0
209974,with,0,0
209975,PPD,0,0
209976,negative,0,1
209977,skin,0,1
209978,reaction,0,1
209979,at,0,0
209980,the,0,0
209981,time,0,1
209982,of,0,0
209983,beginning,0,0
209984,of,0,0
209985,treatment,0,0
209986,in,0,0
209987,the,0,0
209988,OK-432,0,0
209989,group,0,0
209990,survived,0,0
209991,significantly,0,0
209992,longer,0,0
209993,than,0,0
209994,those,0,0
209995,in,0,0
209996,the,0,0
209997,control,0,0
209998,group,0,0
209999,(,0,0
210000,P,0,0
210001,less,0,0
210002,than,0,0
210003,0.001,0,0
210004,),0,0
210005,",",0,0
210006,but,0,0
210007,there,0,0
210008,was,0,0
210009,no,0,0
210010,significance,0,0
210011,between,0,0
210012,both,0,0
210013,treatment,0,0
210014,groups,0,0
210015,in,0,0
210016,patients,0,0
210017,with,0,0
210018,PPD,0,0
210019,positive,0,1
210020,skin,1,1
210021,reaction,1,1
210022,at,0,0
210023,the,0,0
210024,time,0,1
210025,of,0,0
210026,beginning,0,0
210027,of,0,0
210028,treatment,0,0
210029,.,0,0
210030,Eighteen,0,0
210031,(,0,0
210032,62,0,0
210033,%,0,0
210034,),0,0
210035,of,0,0
210036,29,0,0
210037,patients,0,0
210038,treated,0,0
210039,with,0,0
210040,OK-432,0,0
210041,had,0,0
210042,a,0,0
210043,fever,0,1
210044,",",0,0
210045,but,0,0
210046,well,0,0
210047,tolerated,0,1
210048,.,0,0
210049,Blood,0,1
210050,pressure,0,1
210051,control,0,0
210052,during,0,0
210053,weight,0,1
210054,reduction,0,1
210055,in,0,0
210056,obese,0,0
210057,hypertensive,0,0
210058,men,0,0
210059,:,0,0
210060,separate,0,0
210061,effects,0,1
210062,of,0,0
210063,sodium,0,0
210064,and,0,1
210065,energy,0,1
210066,restriction,0,0
210067,.,0,0
210068,The,0,0
210069,separate,0,0
210070,and,0,0
210071,combined,0,0
210072,effects,0,1
210073,of,0,0
210074,dietary,0,0
210075,energy,0,1
210076,and,0,0
210077,sodium,0,0
210078,restriction,0,0
210079,on,0,0
210080,regulation,0,0
210081,of,0,0
210082,blood,1,1
210083,pressure,1,1
210084,were,0,0
210085,investigated,0,0
210086,in,0,0
210087,30,0,0
210088,middle,0,0
210089,aged,0,0
210090,obese,0,0
210091,men,0,0
210092,with,0,0
210093,essential,0,0
210094,hypertension,0,0
210095,attending,0,0
210096,the,0,0
210097,outpatient,0,0
210098,department,0,0
210099,.,0,0
210100,In,0,0
210101,group,0,0
210102,1,0,0
210103,(,0,0
210104,n,0,0
210105,=,0,0
210106,15,0,0
210107,),0,0
210108,a,0,0
210109,basal,0,0
210110,period,0,0
210111,with,0,0
210112,no,0,0
210113,dietary,0,0
210114,restriction,0,0
210115,was,0,0
210116,followed,0,0
210117,by,0,0
210118,a,0,0
210119,period,0,0
210120,taking,0,0
210121,an,0,0
210122,energy,0,1
210123,reduced,0,0
210124,diet,0,0
210125,(,0,0
210126,5.1,0,0
210127,MJ,0,0
210128,;,0,0
210129,1230,0,0
210130,kcal,0,0
210131,),0,0
210132,",",0,0
210133,the,0,0
210134,sodium,0,0
210135,intake,0,1
210136,being,0,0
210137,supplemented,0,0
210138,and,0,0
210139,hence,0,0
210140,unchanged,0,0
210141,(,0,0
210142,1,0,0
210143,:,0,0
210144,ErSn,0,0
210145,),0,0
210146,.,0,0
210147,In,0,0
210148,group,0,0
210149,2,0,0
210150,(,0,0
210151,n,0,0
210152,=,0,0
210153,15,0,0
210154,),0,0
210155,the,0,0
210156,basal,0,0
210157,period,0,0
210158,preceded,0,0
210159,a,0,0
210160,control,0,0
210161,period,0,0
210162,with,0,0
210163,no,0,0
210164,intervention,0,0
210165,",",0,0
210166,which,0,0
210167,was,0,0
210168,followed,0,0
210169,by,0,0
210170,taking,0,0
210171,a,0,0
210172,diet,0,0
210173,restricted,0,0
210174,in,0,0
210175,energy,0,0
210176,(,0,0
210177,5.1,0,0
210178,MJ,0,0
210179,;,0,0
210180,1220,0,0
210181,kcal,0,0
210182,),0,0
210183,and,0,1
210184,sodium,0,0
210185,(,0,0
210186,2,0,0
210187,:,0,0
210188,ErSr,0,0
210189,),0,0
210190,.,0,0
210191,During,0,0
210192,period,0,0
210193,1,0,0
210194,:,0,0
210195,ErSn,0,0
210196,there,0,0
210197,were,0,0
210198,reductions,0,1
210199,in,0,0
210200,heart,1,1
210201,rate,1,1
210202,and,1,1
210203,urinary,1,1
210204,noradrenaline,1,1
210205,output,1,1
210206,but,0,0
210207,not,0,0
210208,in,0,0
210209,systolic,1,1
210210,or,1,0
210211,diastolic,1,1
210212,blood,1,1
210213,pressure,1,1
210214,.,1,0
210215,Body,1,0
210216,weight,1,1
210217,decreased,0,0
210218,by,0,0
210219,4.9-11.7,0,0
210220,kg,0,0
210221,and,0,0
210222,urinary,1,1
210223,sodium,1,0
210224,excretion,1,1
210225,did,0,0
210226,not,0,0
210227,change,0,0
210228,.,0,0
210229,In,0,0
210230,period,0,0
210231,2,0,0
210232,:,0,0
210233,ErSr,0,0
210234,urinary,1,1
210235,sodium,1,0
210236,output,1,1
210237,was,0,0
210238,reduced,0,0
210239,by,0,0
210240,81.4,0,0
210241,(,0,0
210242,SEM,0,0
210243,17.8,0,0
210244,),0,0
210245,mmol,0,0
210246,(,0,0
210247,mEq,0,0
210248,),0,1
210249,/24,0,1
210250,h,0,0
210251,and,0,1
210252,there,0,0
210253,was,0,0
210254,a,0,0
210255,weight,1,1
210256,loss,1,1
210257,of,0,0
210258,8.2,0,0
210259,(,0,0
210260,SEM,0,0
210261,0.7,0,0
210262,),0,0
210263,kg,0,0
210264,.,0,0
210265,Systolic,1,1
210266,and,1,0
210267,diastolic,1,1
210268,blood,1,1
210269,pressures,1,1
210270,fell,0,1
210271,significantly,0,0
210272,",",0,0
210273,as,0,0
210274,did,0,0
210275,the,0,0
210276,heart,1,1
210277,rate,1,1
210278,and,0,1
210279,urinary,1,1
210280,noradrenaline,1,1
210281,excretion,1,1
210282,.,1,0
210283,These,0,0
210284,results,0,0
210285,show,0,0
210286,that,0,0
210287,in,0,0
210288,hypertensive,0,0
210289,obese,0,0
210290,men,0,0
210291,a,0,0
210292,moderate,0,0
210293,weight,0,1
210294,reducing,0,0
210295,diet,0,0
210296,decreases,0,0
210297,indices,0,1
210298,of,0,0
210299,sympathetic,1,1
210300,nervous,1,0
210301,system,1,0
210302,activity,1,1
210303,.,1,0
210304,Reduction,0,0
210305,of,0,0
210306,blood,1,1
210307,pressure,1,1
210308,to,0,0
210309,the,0,0
210310,normotensive,0,0
210311,range,0,0
210312,was,0,0
210313,observed,0,0
210314,only,0,0
210315,when,0,0
210316,there,0,0
210317,was,0,0
210318,a,0,0
210319,concomitant,0,0
210320,restriction,0,0
210321,of,0,0
210322,sodium,0,0
210323,intake,0,1
210324,.,0,0
210325,Short-term,0,0
210326,pulmonary,0,1
210327,effects,0,0
210328,of,0,0
210329,total,0,1
210330,parenteral,0,0
210331,nutrition,0,0
210332,in,0,0
210333,children,0,0
210334,with,0,0
210335,cystic,0,0
210336,fibrosis,0,1
210337,.,0,0
210338,Indices,0,1
210339,of,0,0
210340,respiratory,0,1
210341,muscle,0,1
210342,strength,0,1
210343,",",0,0
210344,pulmonary,0,1
210345,function,0,1
210346,",",0,0
210347,and,0,1
210348,pulmonary,0,1
210349,diffusing,0,1
210350,capacity,0,1
210351,were,0,0
210352,measured,0,0
210353,in,0,0
210354,11,0,0
210355,malnourished,0,0
210356,children,0,0
210357,(,0,0
210358,age,0,0
210359,10,0,0
210360,to,0,0
210361,17,0,0
210362,years,0,0
210363,),0,0
210364,with,0,0
210365,cystic,0,0
210366,fibrosis,0,1
210367,",",0,0
210368,before,0,0
210369,and,0,0
210370,after,0,0
210371,improvement,0,1
210372,of,0,0
210373,nutritional,0,1
210374,status,0,1
210375,with,0,0
210376,supplemental,0,0
210377,parenteral,0,0
210378,nutrients,0,0
210379,for,0,0
210380,1,0,0
210381,month,0,0
210382,.,0,0
210383,During,0,0
210384,this,0,0
210385,time,0,1
210386,",",0,0
210387,the,0,0
210388,children,0,0
210389,received,0,0
210390,120,0,0
210391,%,0,0
210392,of,0,0
210393,estimated,0,0
210394,energy,0,1
210395,requirements,0,1
210396,(,0,0
210397,either,0,0
210398,3.75,0,0
210399,%,0,0
210400,or,0,0
210401,22.5,0,0
210402,%,0,0
210403,as,0,0
210404,lipid,0,1
210405,),0,0
210406,and,0,0
210407,amino,0,0
210408,acids,0,0
210409,2.5,0,0
210410,gm/120,0,0
210411,kcal,0,0
210412,by,0,0
210413,central,0,0
210414,venous,0,1
210415,catheter,0,0
210416,",",0,0
210417,plus,0,0
210418,as,0,0
210419,much,0,0
210420,of,0,0
210421,their,0,0
210422,usual,0,0
210423,diet,0,0
210424,as,0,0
210425,desired,0,0
210426,.,0,0
210427,With,0,0
210428,nutritional,1,1
210429,supplementation,1,0
210430,",",1,0
210431,body,1,1
210432,weight,1,1
210433,",",1,0
210434,triceps,1,1
210435,skinfold,1,1
210436,thickness,1,1
210437,",",1,1
210438,and,1,1
210439,mid-arm,1,1
210440,muscle,1,1
210441,circumference,1,1
210442,increased,0,0
210443,(,0,0
210444,mean,0,0
210445,15,0,0
210446,%,0,0
210447,",",0,0
210448,62,0,0
210449,%,0,0
210450,",",0,0
210451,and,0,0
210452,95,0,0
210453,%,0,0
210454,",",0,0
210455,respectively,0,0
210456,),0,0
210457,.,0,0
210458,Maximum,1,1
210459,inspiratory,1,1
210460,airway,1,1
210461,pressure,1,1
210462,also,0,0
210463,increased,0,0
210464,(,0,0
210465,mean,0,0
210466,29,0,0
210467,%,0,0
210468,;,0,0
210469,P,0,0
210470,less,0,0
210471,than,0,0
210472,0.01,0,0
210473,),0,0
210474,",",0,0
210475,suggesting,0,0
210476,improvement,0,1
210477,in,0,0
210478,respiratory,1,1
210479,muscle,1,0
210480,strength,1,1
210481,.,1,0
210482,However,0,0
210483,",",0,0
210484,none,0,0
210485,of,0,0
210486,the,0,0
210487,indices,1,1
210488,of,1,0
210489,pulmonary,1,1
210490,function,1,1
210491,improved,0,0
210492,.,0,0
210493,Pulmonary,1,0
210494,diffusing,1,1
210495,capacity,1,1
210496,did,0,0
210497,not,0,0
210498,change,0,0
210499,during,0,0
210500,parenteral,0,0
210501,nutrition,0,1
210502,regardless,0,0
210503,of,0,0
210504,the,0,0
210505,amount,0,0
210506,of,0,0
210507,parenteral,1,0
210508,energy,1,1
210509,intake,1,1
210510,supplied,0,0
210511,by,0,0
210512,lipid,0,1
210513,",",0,0
210514,but,0,0
210515,arterial,1,1
210516,oxygen,1,1
210517,saturation,1,1
210518,decreased,0,1
210519,(,0,0
210520,mean,0,0
210521,of,0,0
210522,93.5,0,0
210523,%,0,0
210524,to,0,0
210525,91.5,0,0
210526,%,0,0
210527,;,0,0
210528,P,0,0
210529,less,0,0
210530,than,0,0
210531,0.005,0,0
210532,),0,0
210533,.,0,0
210534,During,0,0
210535,the,0,0
210536,month,0,0
210537,following,0,0
210538,parenteral,0,0
210539,nutrition,0,1
210540,",",0,0
210541,weight,0,1
210542,",",0,1
210543,skinfold,0,1
210544,thickness,0,1
210545,",",0,0
210546,and,0,1
210547,mid-arm,0,1
210548,muscle,0,1
210549,circumference,0,1
210550,",",0,0
210551,but,0,0
210552,not,0,0
210553,MIP,0,0
210554,",",0,0
210555,decreased,0,0
210556,and,0,1
210557,arterial,0,1
210558,oxygen,0,1
210559,saturation,0,1
210560,returned,0,0
210561,to,0,0
210562,the,0,0
210563,initial,0,0
210564,value,0,0
210565,(,0,0
210566,P,0,0
210567,less,0,0
210568,than,0,0
210569,0.01,0,0
210570,),0,0
210571,.,0,0
210572,Ascorbic,0,0
210573,acid,0,1
210574,and,0,1
210575,performance,1,1
210576,in,0,0
210577,man,0,0
210578,.,0,0
210579,Effects,0,0
210580,on,0,0
210581,performance,1,1
210582,of,0,0
210583,1,0,0
210584,",",0,0
210585,2,0,0
210586,and,0,0
210587,4,0,0
210588,g,0,0
210589,ascorbic,0,0
210590,acid,0,0
210591,were,0,0
210592,studied,0,0
210593,from,0,0
210594,0.5-5.5,0,0
210595,h,0,0
210596,after,0,0
210597,ingestion,0,0
210598,in,0,0
210599,six,0,0
210600,healthy,0,0
210601,females,0,0
210602,.,0,0
210603,Diazepam,0,0
210604,(,0,0
210605,5,0,0
210606,mg,0,0
210607,),0,0
210608,was,0,0
210609,included,0,0
210610,as,0,0
210611,an,0,0
210612,active,0,0
210613,control,0,0
210614,",",0,0
210615,and,0,0
210616,it,0,0
210617,impaired,0,1
210618,digit,1,1
210619,symbol,1,0
210620,substitution,1,1
210621,",",1,1
210622,visuomotor,1,1
210623,coordination,1,1
210624,and,1,1
210625,complex,1,0
210626,reaction,1,1
210627,time,1,1
210628,.,1,0
210629,There,0,0
210630,were,0,0
210631,no,0,0
210632,effects,0,0
210633,of,0,0
210634,any,0,0
210635,dose,0,0
210636,of,0,0
210637,ascorbic,0,0
210638,acid,0,0
210639,on,0,0
210640,performance,1,1
210641,.,1,0
210642,The,0,0
210643,treatment,0,0
210644,of,0,0
210645,acne,0,1
210646,vulgaris,0,0
210647,in,0,0
210648,general,0,0
210649,practice,0,0
210650,.,0,0
210651,A,0,0
210652,double-blind,0,0
210653,assessment,0,0
210654,of,0,0
210655,co-trimoxazole,0,0
210656,and,0,0
210657,tetracycline,0,0
210658,.,0,0
210659,Comparison,0,0
210660,of,0,0
210661,the,0,0
210662,hypotensive,0,1
210663,effects,0,0
210664,of,0,0
210665,bendrofluazide,0,0
210666,",",0,0
210667,bumetanide,0,0
210668,and,0,0
210669,xipamide,0,0
210670,.,0,0
210671,A,0,0
210672,randomized,0,0
210673,",",0,0
210674,triple,0,0
210675,crossover,0,0
210676,study,0,0
210677,was,0,0
210678,carried,0,0
210679,out,0,0
210680,in,0,0
210681,24,0,0
210682,elderly,0,0
210683,patients,0,0
210684,requiring,0,0
210685,chronic,0,0
210686,diuretic,0,0
210687,therapy,0,0
210688,to,0,0
210689,assess,0,0
210690,the,0,0
210691,different,0,0
210692,hypotensive,0,1
210693,effects,0,0
210694,of,0,0
210695,a,0,0
210696,fixed,0,0
210697,daily,0,0
210698,dose,0,0
210699,of,0,0
210700,5,0,0
210701,mg,0,0
210702,bendrofluazide,0,0
210703,",",0,0
210704,1,0,0
210705,mg,0,0
210706,bumetanide,0,0
210707,and,0,0
210708,40,0,0
210709,mg,0,0
210710,xipamide,0,0
210711,.,0,0
210712,Each,0,0
210713,treatment,0,0
210714,was,0,0
210715,given,0,0
210716,for,0,0
210717,3,0,0
210718,months,0,0
210719,.,0,0
210720,The,0,0
210721,results,0,0
210722,showed,0,0
210723,that,0,0
210724,no,0,0
210725,significant,0,0
210726,weight,1,1
210727,change,1,1
210728,took,0,0
210729,place,0,0
210730,during,0,0
210731,the,0,0
210732,study,0,0
210733,period,0,0
210734,.,0,0
210735,There,0,0
210736,was,0,0
210737,",",0,0
210738,however,0,0
210739,",",0,0
210740,a,0,0
210741,significant,0,0
210742,(,0,0
210743,p,0,0
210744,less,0,0
210745,than,0,0
210746,0.001,0,0
210747,),0,0
210748,decrease,0,0
210749,compared,0,0
210750,to,0,0
210751,baseline,1,0
210752,values,1,0
210753,both,1,0
210754,in,1,0
210755,systolic,1,1
210756,and,1,0
210757,diastolic,1,1
210758,blood,1,1
210759,pressure,1,1
210760,during,0,0
210761,the,0,0
210762,xipamide,0,0
210763,period,0,0
210764,and,0,0
210765,a,0,0
210766,decrease,0,0
210767,in,0,0
210768,diastolic,1,1
210769,blood,1,1
210770,pressure,1,1
210771,(,0,0
210772,p,0,0
210773,less,0,0
210774,than,0,0
210775,0.05,0,0
210776,),0,0
210777,when,0,0
210778,taking,0,0
210779,bumetanide,0,0
210780,.,0,0
210781,Only,0,0
210782,minor,1,0
210783,side-effects,1,1
210784,were,0,0
210785,reported,0,0
210786,.,0,0
210787,Comparative,1,0
210788,efficacy,1,1
210789,and,1,1
210790,safety,1,1
210791,of,0,1
210792,lofexidine,0,0
210793,and,0,0
210794,clonidine,0,0
210795,given,0,0
210796,alone,0,0
210797,or,0,0
210798,concomitantly,0,0
210799,with,0,0
210800,hydrochlorothiazide,0,0
210801,in,0,0
210802,hypertensive,0,0
210803,outpatients,0,0
210804,.,0,0
210805,Modifying,1,0
210806,the,1,0
210807,Type,1,0
210808,A,1,0
210809,coronary-prone,1,0
210810,behavior,1,1
210811,pattern,1,0
210812,.,1,0
210813,Breathlessness,0,1
210814,and,0,0
210815,psychiatric,0,0
210816,morbidity,0,1
210817,in,0,0
210818,chronic,0,0
210819,bronchitis,0,1
210820,and,0,0
210821,emphysema,0,0
210822,:,0,0
210823,a,0,0
210824,study,0,0
210825,of,0,0
210826,psychotherapeutic,0,0
210827,management,0,0
210828,.,0,0
210829,This,0,0
210830,paper,0,0
210831,describes,0,0
210832,a,0,0
210833,study,0,0
210834,of,0,0
210835,the,0,0
210836,outcome,0,0
210837,of,0,0
210838,psychotherapy,0,0
210839,with,0,0
210840,patients,0,0
210841,disabled,0,0
210842,by,0,0
210843,chronic,0,0
210844,obstructive,0,0
210845,airways,0,1
210846,disease,0,1
210847,giving,0,0
210848,rise,0,0
210849,to,0,0
210850,dyspnoea,0,1
210851,.,0,0
210852,Forty-three,0,0
210853,men,0,0
210854,and,0,0
210855,22,0,0
210856,women,0,0
210857,with,0,0
210858,severe,0,1
210859,COAD,0,0
210860,were,0,0
210861,randomly,0,0
210862,allocated,0,0
210863,for,0,0
210864,8,0,0
210865,weeks,0,0
210866,to,0,0
210867,one,0,0
210868,of,0,0
210869,three,0,0
210870,types,0,0
210871,of,0,0
210872,psychotherapy,0,0
210873,or,0,0
210874,to,0,0
210875,an,0,0
210876,untreated,0,0
210877,control,0,0
210878,group,0,0
210879,",",0,1
210880,and,0,1
210881,were,0,0
210882,followed,0,0
210883,up,0,0
210884,six,0,0
210885,months,0,0
210886,later,0,0
210887,.,0,0
210888,The,0,0
210889,group,0,0
210890,treated,0,0
210891,by,0,0
210892,a,0,0
210893,medical,0,0
210894,nurse,0,0
210895,without,0,0
210896,training,0,0
210897,in,0,0
210898,psychotherapy,0,0
210899,experienced,0,0
210900,sustained,0,1
210901,relief,0,1
210902,of,0,0
210903,dyspnoea,1,1
210904,but,0,0
210905,tended,0,0
210906,to,0,0
210907,undergo,0,0
210908,less,0,0
210909,psychodynamic,1,0
210910,change,1,1
210911,;,1,0
210912,psychiatric,1,0
210913,symptoms,1,1
210914,were,0,0
210915,reduced,0,0
210916,in,0,0
210917,those,0,0
210918,receiving,0,0
210919,supportive,0,0
210920,",",0,0
210921,but,0,0
210922,not,0,0
210923,analytical,0,0
210924,",",0,0
210925,psychotherapy,0,0
210926,.,0,0
210927,The,0,0
210928,psychosomatic,0,0
210929,mechanisms,0,0
210930,involved,0,0
210931,and,0,0
210932,the,0,0
210933,implications,0,0
210934,for,0,0
210935,medical,0,0
210936,and,0,0
210937,nursing,0,0
210938,practice,0,0
210939,and,0,0
210940,for,0,0
210941,liaison,0,0
210942,psychotherapy,0,0
210943,are,0,0
210944,discussed,0,0
210945,.,0,0
210946,Nonspecific,0,0
210947,and,0,0
210948,selective,0,1
210949,stimulation,0,0
210950,of,0,0
210951,the,0,0
210952,immune,0,1
210953,system,0,0
210954,in,0,0
210955,the,0,0
210956,treatment,0,0
210957,of,0,0
210958,carcinoma,0,0
210959,in,0,0
210960,humans,0,0
210961,.,0,0
210962,The,0,0
210963,experience,0,0
210964,of,0,0
210965,the,0,0
210966,Toronto,0,0
210967,General,0,1
210968,Hospital,0,1
210969,in,0,0
210970,the,0,0
210971,use,0,0
210972,of,0,0
210973,nonspecific,0,0
210974,stimulation,0,0
210975,of,0,0
210976,the,0,0
210977,immune,0,1
210978,system,0,0
210979,with,0,0
210980,bacille,0,0
210981,Calmette-Gu?rin,0,0
210982,(,0,0
210983,BCG,0,0
210984,),0,0
210985,for,0,0
210986,the,0,0
210987,treatment,0,0
210988,of,0,0
210989,cancer,0,0
210990,of,0,0
210991,the,0,0
210992,gastrointestinal,0,1
210993,tract,0,0
210994,",",0,0
210995,malignant,0,0
210996,melanoma,0,0
210997,and,0,1
210998,breast,0,0
210999,cancer,0,0
211000,is,0,0
211001,described,0,0
211002,.,0,0
211003,The,0,0
211004,results,0,0
211005,are,0,0
211006,presented,0,0
211007,in,0,0
211008,terms,0,0
211009,of,1,0
211010,survival,1,1
211011,curves,1,1
211012,.,1,0
211013,The,0,0
211014,use,0,0
211015,of,0,0
211016,BCG,0,0
211017,administered,0,0
211018,intraperitoneally,0,0
211019,in,0,0
211020,a,0,0
211021,randomized,0,0
211022,study,0,0
211023,of,0,0
211024,patients,0,0
211025,with,0,0
211026,gastric,0,1
211027,",",0,0
211028,pancreatic,0,1
211029,and,0,1
211030,colorectal,0,0
211031,cancer,0,0
211032,proved,0,0
211033,of,0,0
211034,no,1,0
211035,benefit,1,0
211036,.,1,0
211037,On,0,0
211038,the,0,0
211039,other,0,0
211040,hand,0,0
211041,",",0,0
211042,when,0,0
211043,BCG,0,0
211044,was,0,0
211045,given,0,0
211046,orally,0,0
211047,in,0,0
211048,a,0,0
211049,randomized,0,0
211050,study,0,0
211051,of,0,0
211052,patients,0,0
211053,with,0,0
211054,resectable,0,0
211055,cancer,0,0
211056,of,0,0
211057,the,0,0
211058,colon,0,0
211059,and,0,0
211060,in,0,0
211061,nonrandomized,0,0
211062,consecutive,0,0
211063,studies,0,0
211064,of,0,0
211065,patients,0,0
211066,with,0,0
211067,malignant,0,0
211068,melanoma,0,0
211069,and,0,1
211070,stage,0,1
211071,IV,0,1
211072,carcinoma,0,0
211073,of,0,0
211074,the,0,0
211075,breast,1,0
211076,survival,1,1
211077,was,0,0
211078,increased,0,0
211079,.,0,0
211080,In,0,0
211081,a,0,0
211082,group,0,0
211083,of,0,0
211084,patients,0,0
211085,with,0,0
211086,advanced,0,0
211087,gastrointestinal,0,1
211088,cancer,0,0
211089,selective,0,0
211090,stimulation,0,0
211091,of,0,0
211092,the,0,0
211093,immune,0,1
211094,system,0,0
211095,with,0,0
211096,NED,0,0
211097,137,0,0
211098,produced,0,0
211099,a,0,0
211100,significant,0,0
211101,increase,0,0
211102,in,1,0
211103,survival,1,1
211104,when,0,0
211105,compared,0,0
211106,with,0,0
211107,the,0,0
211108,survival,0,1
211109,of,0,0
211110,historical,0,0
211111,controls,0,0
211112,(,0,0
211113,the,0,0
211114,patients,0,0
211115,given,0,0
211116,BCG,0,0
211117,intraperitoneally,0,0
211118,along,0,0
211119,with,0,0
211120,5-fluorouracil,0,0
211121,for,0,0
211122,gastrointestinal,0,1
211123,cancer,0,0
211124,),0,0
211125,.,0,0
211126,The,0,0
211127,results,0,0
211128,of,0,0
211129,these,0,0
211130,studies,0,0
211131,suggest,0,0
211132,the,0,0
211133,need,0,0
211134,for,0,0
211135,a,0,0
211136,more,0,0
211137,rational,0,0
211138,approach,0,0
211139,in,0,0
211140,manipulating,0,0
211141,the,0,0
211142,immune,0,0
211143,response,0,0
211144,that,0,0
211145,would,0,0
211146,combine,0,0
211147,chemotherapy,0,0
211148,with,0,0
211149,selective,0,0
211150,stimulation,0,0
211151,of,0,0
211152,the,0,0
211153,immune,0,0
211154,system,0,0
211155,.,0,0
211156,Cardiovascular,0,0
211157,complications,0,1
211158,to,0,0
211159,treatment,0,0
211160,of,0,0
211161,prostate,0,0
211162,cancer,0,0
211163,with,0,0
211164,estramustine,0,0
211165,phosphate,0,0
211166,(,0,0
211167,Estracyt,0,0
211168,),0,0
211169,or,0,0
211170,conventional,0,0
211171,estrogen,0,0
211172,.,0,0
211173,A,0,0
211174,follow-up,0,0
211175,of,0,0
211176,212,0,0
211177,randomized,0,0
211178,patients,0,0
211179,.,0,0
211180,Two,0,0
211181,hundred,0,0
211182,and,0,0
211183,twelve,0,0
211184,patients,0,0
211185,treated,0,0
211186,for,0,0
211187,prostatic,0,0
211188,cancer,0,0
211189,grade,0,1
211190,I,0,0
211191,or,0,0
211192,II,0,0
211193,were,0,0
211194,investigated,0,0
211195,for,0,0
211196,cardiovascular,0,0
211197,complications,0,1
211198,.,0,0
211199,The,0,0
211200,patients,0,0
211201,were,0,0
211202,part,0,0
211203,of,0,0
211204,a,0,0
211205,multicentre,0,0
211206,study,0,0
211207,in,0,0
211208,the,0,0
211209,Stockholm,0,0
211210,area,0,1
211211,and,0,1
211212,had,0,0
211213,been,0,0
211214,randomized,0,0
211215,to,0,0
211216,treatment,0,0
211217,with,0,0
211218,either,0,0
211219,estramustine,0,0
211220,phosphate,0,0
211221,(,0,0
211222,Estracyt,0,0
211223,),0,0
211224,or,0,0
211225,polyestradiol,0,0
211226,phosphate,0,0
211227,and,0,0
211228,ethinyl,0,0
211229,estradiol,0,0
211230,.,0,0
211231,Cardiovascular,0,1
211232,complications,0,1
211233,categorized,0,0
211234,as,0,0
211235,impaired,0,0
211236,arterial,0,1
211237,circulation,0,1
211238,including,0,0
211239,ischemic,1,1
211240,heart,1,1
211241,disease,1,1
211242,",",1,0
211243,venous,1,1
211244,thromboembolism,1,1
211245,",",1,0
211246,cardiac,1,1
211247,incompensation,1,1
211248,and,1,0
211249,cerebral,1,1
211250,depression,1,1
211251,were,0,0
211252,found,0,0
211253,to,0,0
211254,be,0,0
211255,equally,0,0
211256,frequent,0,0
211257,following,0,0
211258,the,0,0
211259,two,0,0
211260,different,0,0
211261,forms,0,0
211262,of,0,0
211263,treatment,0,0
211264,.,0,0
211265,Among,0,0
211266,the,0,0
211267,patients,0,0
211268,getting,0,0
211269,cardiovascular,0,1
211270,complications,0,1
211271,",",0,0
211272,these,0,0
211273,occurred,0,0
211274,within,0,0
211275,two,0,0
211276,months,0,0
211277,after,0,0
211278,the,0,0
211279,start,0,0
211280,of,0,0
211281,treatment,0,0
211282,in,0,0
211283,50,0,0
211284,%,0,0
211285,and,0,0
211286,within,0,0
211287,one,0,0
211288,year,0,0
211289,in,0,0
211290,85,0,0
211291,%,0,0
211292,of,0,0
211293,them,0,0
211294,.,0,0
211295,There,0,0
211296,was,0,0
211297,a,0,0
211298,statistically,0,0
211299,significant,0,0
211300,correlation,0,0
211301,between,0,0
211302,the,0,0
211303,incidence,1,1
211304,of,1,0
211305,cardiovascular,1,1
211306,complications,1,1
211307,and,1,0
211308,a,1,0
211309,history,1,0
211310,of,1,0
211311,previous,1,0
211312,cardiovascular,1,1
211313,disease,1,0
211314,.,1,0
211315,This,0,0
211316,criterion,0,0
211317,was,0,0
211318,however,0,0
211319,in,0,0
211320,retrospect,0,0
211321,found,0,0
211322,to,0,0
211323,predict,0,0
211324,cardiovascular,1,1
211325,complications,1,1
211326,in,0,0
211327,only,0,0
211328,67,0,0
211329,of,0,0
211330,the,0,0
211331,126,0,0
211332,patients,0,0
211333,getting,0,0
211334,one,0,0
211335,or,0,0
211336,several,0,0
211337,of,0,0
211338,these,0,0
211339,complications,0,0
211340,.,0,0
211341,Ambulation,0,1
211342,in,0,0
211343,labour,0,0
211344,.,0,0
211345,In,0,0
211346,a,0,0
211347,randomised,0,0
211348,prospective,0,0
211349,study,0,0
211350,of,0,0
211351,68,0,0
211352,women,0,0
211353,in,0,0
211354,spontaneous,0,1
211355,labour,0,1
211356,half,0,0
211357,were,0,0
211358,allocated,0,0
211359,to,0,0
211360,an,0,0
211361,ambulant,0,0
211362,group,0,0
211363,and,0,0
211364,half,0,0
211365,to,0,0
211366,a,0,0
211367,recumbent,0,1
211368,group,0,0
211369,.,0,0
211370,The,0,0
211371,duration,1,1
211372,of,1,0
211373,labour,1,1
211374,was,0,0
211375,significantly,0,0
211376,shorter,0,0
211377,",",0,0
211378,the,0,0
211379,need,1,0
211380,for,1,0
211381,analgesia,1,1
211382,significantly,0,0
211383,less,0,0
211384,",",0,0
211385,and,0,0
211386,the,0,0
211387,incidence,1,1
211388,of,1,0
211389,fetal,1,1
211390,heart,1,1
211391,abnormalities,1,0
211392,significantly,0,0
211393,smaller,0,0
211394,in,0,0
211395,the,0,0
211396,ambulant,0,0
211397,group,0,0
211398,than,0,0
211399,in,0,0
211400,the,0,0
211401,recumbent,0,1
211402,group,0,0
211403,.,0,0
211404,Apgar,1,1
211405,scores,1,1
211406,at,0,0
211407,one,0,0
211408,and,0,0
211409,five,0,0
211410,minutes,0,0
211411,were,0,0
211412,also,0,0
211413,significantly,0,0
211414,greater,0,0
211415,in,0,0
211416,the,0,0
211417,ambulant,0,0
211418,group,0,0
211419,.,0,0
211420,More,0,0
211421,patients,0,0
211422,in,0,0
211423,the,0,0
211424,recumbent,0,1
211425,group,0,0
211426,required,0,0
211427,augmentations,1,0
211428,with,1,0
211429,oxytocic,1,1
211430,drugs,1,0
211431,.,1,0
211432,There,0,0
211433,was,0,0
211434,no,0,0
211435,statistically,0,0
211436,significant,0,0
211437,difference,0,0
211438,in,0,0
211439,the,0,0
211440,third,1,0
211441,stage,1,0
211442,loss,1,1
211443,in,0,0
211444,the,0,0
211445,two,0,0
211446,groups,0,0
211447,.,0,0
211448,Ambulation,0,1
211449,in,0,0
211450,labour,0,0
211451,should,0,0
211452,be,0,0
211453,encouraged,0,0
211454,:,0,0
211455,it,0,0
211456,may,0,0
211457,bring,0,0
211458,human,0,0
211459,benefits,0,0
211460,while,0,0
211461,allowing,0,0
211462,the,0,0
211463,advantages,0,0
211464,of,0,0
211465,hospital,0,0
211466,supervision,0,0
211467,.,0,0
211468,Carbenicillin-trimethoprim/sulfamethoxazole,0,0
211469,versus,0,0
211470,carbenicillin-gentamicin,0,0
211471,as,0,0
211472,empiric,0,0
211473,therapy,0,0
211474,of,0,0
211475,infection,0,1
211476,in,0,0
211477,granulocytopenic,0,0
211478,patients,0,0
211479,.,0,0
211480,A,0,0
211481,prospective,0,0
211482,",",0,0
211483,randomized,0,0
211484,",",0,0
211485,double-blind,0,0
211486,study,0,0
211487,.,0,0
211488,The,0,0
211489,results,0,0
211490,of,0,0
211491,therapy,0,0
211492,with,0,0
211493,carbenicillin,0,0
211494,plus,0,0
211495,trimethoprim-sulfamethoxazole,0,0
211496,(,0,0
211497,C-T/S,0,0
211498,),0,0
211499,were,0,0
211500,compared,0,0
211501,to,0,0
211502,those,0,0
211503,obtained,0,0
211504,with,0,0
211505,carbenicillin,0,0
211506,plus,0,0
211507,gentamicin,0,0
211508,(,0,0
211509,C-G,0,0
211510,),0,0
211511,in,0,0
211512,a,0,0
211513,prospective,0,0
211514,double-blind,0,0
211515,study,0,0
211516,of,0,0
211517,empiric,0,0
211518,antibiotic,0,0
211519,therapy,0,0
211520,in,0,0
211521,granulocytopenic,0,0
211522,patients,0,0
211523,.,0,0
211524,Patients,0,0
211525,were,0,0
211526,stratified,0,0
211527,into,0,0
211528,two,0,0
211529,groups,0,0
211530,:,0,0
211531,favorable-prognosis,0,0
211532,",",0,0
211533,group,0,0
211534,1,0,0
211535,(,0,0
211536,carcinoma,0,0
211537,",",0,1
211538,lymphoma,0,1
211539,",",0,1
211540,multiple,0,1
211541,myeloma,0,1
211542,),0,0
211543,",",0,0
211544,or,0,1
211545,unfavorable-prognosis,0,0
211546,",",0,0
211547,group,0,0
211548,2,0,0
211549,(,0,0
211550,acute,0,0
211551,leukemia,0,0
211552,",",0,0
211553,bone,0,1
211554,marrow,0,1
211555,transplantation,0,0
211556,),0,0
211557,",",0,0
211558,based,0,0
211559,on,0,0
211560,anticipated,0,0
211561,duration,0,1
211562,of,0,0
211563,granulocytopenia,0,1
211564,.,0,0
211565,Over-all,0,1
211566,",",0,0
211567,empiric,0,0
211568,antibiotic,0,0
211569,trials,0,0
211570,were,0,0
211571,more,0,0
211572,often,0,0
211573,successful,1,0
211574,(,0,0
211575,P,0,0
211576,=,0,0
211577,0.004,0,0
211578,),0,0
211579,in,0,0
211580,group,0,0
211581,1,0,0
211582,(,0,0
211583,55,0,0
211584,of,0,0
211585,62,0,0
211586,patients,0,0
211587,or,0,0
211588,89,0,0
211589,per,0,0
211590,cent,0,0
211591,),0,0
211592,than,0,0
211593,in,0,0
211594,group,0,0
211595,2,0,0
211596,(,0,0
211597,42,0,0
211598,of,0,0
211599,64,0,0
211600,patients,0,0
211601,",",0,0
211602,66,0,0
211603,per,0,0
211604,cent,0,0
211605,),0,0
211606,mwithin,0,0
211607,group,0,0
211608,1,0,0
211609,",",0,0
211610,there,0,0
211611,was,0,0
211612,a,0,0
211613,favorable,1,0
211614,outcome,1,0
211615,in,0,0
211616,30,0,0
211617,of,0,0
211618,32,0,0
211619,(,0,0
211620,94,0,0
211621,per,0,0
211622,cent,0,0
211623,),0,0
211624,C-T/S,0,1
211625,trials,0,0
211626,and,0,0
211627,in,0,0
211628,25,0,0
211629,of,0,0
211630,30,0,0
211631,(,0,0
211632,83,0,0
211633,per,0,0
211634,cent,0,0
211635,),0,0
211636,C-G,0,0
211637,trials,0,0
211638,(,0,0
211639,P,0,0
211640,=,0,0
211641,0.25,0,0
211642,),0,0
211643,;,0,0
211644,within,0,0
211645,group,0,0
211646,2,0,0
211647,",",0,0
211648,there,0,0
211649,was,0,0
211650,a,0,0
211651,favorable,0,0
211652,outcome,0,0
211653,in,0,0
211654,23,0,0
211655,of,0,0
211656,30,0,0
211657,(,0,0
211658,77,0,0
211659,per,0,0
211660,cent,0,0
211661,),0,0
211662,C-T/S,0,1
211663,trials,0,0
211664,and,0,0
211665,in,0,0
211666,19,0,0
211667,of,0,0
211668,34,0,0
211669,(,0,0
211670,56,0,0
211671,per,0,0
211672,cent,0,0
211673,),0,0
211674,C-G,0,0
211675,trials,0,0
211676,(,0,0
211677,P,0,0
211678,=,0,0
211679,0.14,0,0
211680,),0,0
211681,",",0,0
211682,Combined,0,0
211683,results,0,0
211684,in,0,0
211685,both,0,0
211686,groups,0,0
211687,indicated,0,0
211688,a,0,0
211689,higher,0,0
211690,proportion,0,0
211691,of,0,1
211692,favorable,1,0
211693,outcome,1,0
211694,in,0,0
211695,C-T/S,0,1
211696,trials,0,0
211697,(,0,0
211698,53,0,0
211699,of,0,0
211700,62,0,0
211701,",",0,0
211702,85,0,0
211703,per,0,0
211704,cent,0,0
211705,),0,0
211706,than,0,0
211707,in,0,0
211708,C-G,0,0
211709,trials,0,0
211710,(,0,0
211711,44,0,0
211712,of,0,0
211713,64,0,0
211714,",",0,0
211715,69,0,0
211716,per,0,0
211717,cent,0,0
211718,),0,0
211719,.,0,0
211720,Further,0,0
211721,analysis,1,0
211722,(,1,0
211723,Manetl-Naenszel,1,0
211724,test,1,1
211725,),1,0
211726,showed,0,0
211727,the,0,0
211728,over-all,0,1
211729,difference,0,0
211730,in,0,0
211731,outcome,0,0
211732,to,0,0
211733,be,0,0
211734,significant,0,0
211735,(,0,0
211736,P,0,0
211737,=,0,0
211738,0.049,0,0
211739,),0,0
211740,",",0,0
211741,but,0,0
211742,the,0,0
211743,general,0,0
211744,applicability,0,0
211745,of,0,0
211746,this,0,0
211747,result,0,0
211748,may,0,0
211749,be,0,0
211750,limited,0,0
211751,by,0,0
211752,the,0,0
211753,rather,0,0
211754,low,0,0
211755,incidence,0,1
211756,of,0,0
211757,gram-negative,0,1
211758,bacterial,0,1
211759,infections,0,0
211760,in,0,0
211761,this,0,0
211762,study,0,0
211763,.,0,0
211764,There,0,0
211765,was,0,0
211766,no,1,0
211767,difference,1,0
211768,between,0,0
211769,the,0,0
211770,treatment,0,0
211771,regimens,0,0
211772,in,0,0
211773,antibiotic,1,0
211774,toxicity,1,1
211775,",",0,0
211776,and,0,1
211777,serious,1,1
211778,superinfection,1,1
211779,occurred,0,0
211780,only,0,0
211781,in,0,0
211782,group,0,0
211783,2,0,0
211784,patients,0,0
211785,(,0,0
211786,21,0,0
211787,per,0,0
211788,cent,0,0
211789,of,0,0
211790,trials,0,0
211791,),0,0
211792,",",0,0
211793,equally,0,0
211794,divided,0,0
211795,between,0,0
211796,treatment,0,0
211797,arms,0,0
211798,.,0,0
211799,Initial,0,1
211800,protocol,0,0
211801,dosing,0,0
211802,achieved,0,0
211803,target,0,0
211804,plasma,0,1
211805,levels,0,1
211806,of,0,1
211807,trimethoprim,0,0
211808,(,0,0
211809,3,0,0
211810,to,0,0
211811,8,0,0
211812,micrograms/ml,0,0
211813,),0,0
211814,or,0,0
211815,gentamicin,0,0
211816,(,0,0
211817,4,0,0
211818,to,0,0
211819,10,0,0
211820,micrograms/ml,0,0
211821,),0,0
211822,in,0,0
211823,57,0,0
211824,of,0,0
211825,68,0,0
211826,(,0,0
211827,84,0,0
211828,per,0,0
211829,cent,0,0
211830,),0,0
211831,C-T/S,0,0
211832,trials,0,0
211833,compared,0,0
211834,to,0,0
211835,21,0,0
211836,of,0,0
211837,60,0,0
211838,(,0,0
211839,35,0,0
211840,per,0,0
211841,cent,0,0
211842,),0,0
211843,C-G,0,0
211844,trials,0,0
211845,.,0,0
211846,Comparison,0,0
211847,of,0,0
211848,antihypertensive,1,0
211849,effects,1,1
211850,of,0,0
211851,captopril,0,0
211852,and,0,1
211853,propranolol,0,0
211854,in,0,0
211855,essential,0,0
211856,hypertension,0,0
211857,.,0,0
211858,The,0,0
211859,antihypertensive,0,0
211860,effects,0,0
211861,of,0,0
211862,the,0,0
211863,oral,0,0
211864,converting,0,0
211865,enzyme,0,1
211866,inhibitor,0,0
211867,captopril,0,0
211868,and,0,0
211869,of,0,1
211870,propranolol,0,0
211871,were,0,0
211872,evaluated,0,0
211873,in,0,0
211874,a,0,0
211875,single-blind,0,0
211876,trial,0,0
211877,of,0,0
211878,12,0,0
211879,weeks,0,0
211880,in,0,0
211881,19,0,0
211882,ambulatory,0,0
211883,men,0,0
211884,with,0,0
211885,moderated,0,0
211886,essential,0,0
211887,hypertension,0,1
211888,(,1,0
211889,supine,1,1
211890,diastolic,1,1
211891,blood,1,1
211892,pressure,1,1
211893,[,1,0
211894,DPB,1,0
211895,],1,0
211896,",",0,0
211897,100,0,0
211898,to,0,0
211899,120,0,0
211900,mm,0,0
211901,Hg,0,0
211902,after,0,0
211903,receiving,0,0
211904,placebo,0,0
211905,for,0,0
211906,two,0,0
211907,weeks,0,0
211908,),0,0
211909,whose,0,0
211910,sodium,0,0
211911,intake,0,1
211912,was,0,0
211913,unrestricted,0,0
211914,.,0,0
211915,The,0,0
211916,captopril,0,0
211917,group,0,0
211918,included,0,0
211919,12,0,0
211920,patients,0,0
211921,and,0,0
211922,the,0,0
211923,propranolol,0,0
211924,group,0,0
211925,seven,0,0
211926,.,0,0
211927,After,0,0
211928,the,0,0
211929,initial,0,0
211930,dose-finding,0,0
211931,period,0,0
211932,of,0,0
211933,four,0,0
211934,weeks,0,0
211935,",",0,0
211936,supine,1,1
211937,DBP,1,1
211938,was,0,0
211939,significantly,1,0
211940,reduced,1,0
211941,in,0,0
211942,eight,0,0
211943,patients,0,0
211944,receiving,0,0
211945,captopril,0,0
211946,and,0,0
211947,in,0,0
211948,four,0,0
211949,of,0,0
211950,the,0,0
211951,patients,0,0
211952,receiving,0,0
211953,propranolol,0,0
211954,.,0,0
211955,In,0,0
211956,these,0,0
211957,patients,0,0
211958,DBP,1,0
211959,decreased,0,0
211960,throughout,0,0
211961,the,0,0
211962,following,0,0
211963,eight,0,0
211964,weeks,0,0
211965,.,0,0
211966,In,0,0
211967,the,0,0
211968,remaining,0,0
211969,patients,0,0
211970,from,0,0
211971,each,0,0
211972,group,0,0
211973,",",0,0
211974,DBP,1,1
211975,was,0,0
211976,not,0,0
211977,reduced,0,0
211978,by,0,0
211979,either,0,0
211980,drug,0,0
211981,given,0,0
211982,alone,0,0
211983,at,0,0
211984,maximum,0,1
211985,allowable,0,0
211986,dosages,0,0
211987,during,0,0
211988,dose-finding,0,0
211989,periods,0,0
211990,",",0,0
211991,nor,0,0
211992,by,0,0
211993,combined,0,0
211994,administration,0,0
211995,in,0,0
211996,following,0,0
211997,weeks,0,0
211998,.,0,0
211999,No,1,0
212000,adverse,1,1
212001,side,1,1
212002,effects,1,1
212003,attributable,0,0
212004,to,0,0
212005,captopril,0,0
212006,were,0,0
212007,noted,0,0
212008,",",0,0
212009,except,0,0
212010,in,0,0
212011,one,0,0
212012,patient,0,0
212013,in,0,0
212014,whom,0,0
212015,proteinuria,1,1
212016,developed,0,0
212017,after,0,0
212018,seven,0,0
212019,weeks,0,0
212020,.,0,0
212021,Captopril,0,0
212022,has,0,0
212023,potential,0,0
212024,value,0,0
212025,in,0,0
212026,the,0,0
212027,treatment,0,0
212028,of,0,0
212029,moderate,0,0
212030,essential,0,0
212031,hypertension,0,0
212032,.,0,0
212033,Report,0,0
212034,on,0,0
212035,the,0,0
212036,second,0,0
212037,myelomatosis,0,1
212038,trial,0,0
212039,after,0,0
212040,five,0,0
212041,years,0,0
212042,of,0,0
212043,follow-up,0,0
212044,.,0,0
212045,Medical,0,0
212046,Research,0,0
212047,Council,0,1
212048,'s,0,0
212049,Working,0,0
212050,Party,0,0
212051,on,0,0
212052,Leukaemia,0,0
212053,in,0,0
212054,Adults,0,0
212055,.,0,0
212056,Three,0,0
212057,hundred,0,0
212058,and,0,0
212059,seventy-two,0,0
212060,patients,0,0
212061,were,0,0
212062,randomized,0,0
212063,between,0,0
212064,3,0,0
212065,regimens,0,0
212066,of,0,0
212067,chemotherapy,0,0
212068,:,0,0
212069,cyclophosphamide,0,0
212070,",",0,0
212071,intermittent,0,1
212072,melphalan,0,0
212073,",",0,1
212074,and,0,1
212075,melphalan,0,0
212076,with,0,0
212077,prednisone,0,0
212078,",",0,0
212079,and,0,1
212080,were,0,0
212081,followed,0,0
212082,up,0,0
212083,to,0,0
212084,death,0,1
212085,or,0,0
212086,for,0,0
212087,at,0,0
212088,least,0,0
212089,5,0,0
212090,years,0,0
212091,.,0,0
212092,There,0,0
212093,was,0,0
212094,no,0,0
212095,difference,0,0
212096,in,0,0
212097,survival,1,1
212098,between,0,0
212099,the,0,0
212100,treatments,0,0
212101,",",0,0
212102,either,0,0
212103,overall,0,1
212104,or,0,0
212105,in,0,0
212106,any,0,0
212107,subgroup,0,0
212108,of,0,0
212109,patients,0,0
212110,.,0,0
212111,Therefore,0,0
212112,",",0,0
212113,the,0,0
212114,choice,0,0
212115,among,0,0
212116,these,0,0
212117,3,0,0
212118,treatments,0,0
212119,should,0,0
212120,be,0,0
212121,guided,0,0
212122,by,0,0
212123,the,0,0
212124,patient,0,1
212125,'s,0,0
212126,comfort,0,1
212127,and,0,0
212128,convenience,0,0
212129,.,0,0
212130,The,0,0
212131,most,0,0
212132,important,0,0
212133,prognostic,0,1
212134,feature,0,0
212135,at,0,0
212136,presentation,0,1
212137,was,0,0
212138,the,0,0
212139,quality,0,1
212140,of,0,0
212141,renal,1,1
212142,function,1,1
212143,.,1,0
212144,It,0,0
212145,was,0,0
212146,possible,0,0
212147,to,0,0
212148,define,0,0
212149,good,0,0
212150,",",0,0
212151,intermediate,0,0
212152,and,0,1
212153,poor,0,1
212154,renal-function,0,0
212155,groups,0,0
212156,which,0,0
212157,were,0,0
212158,highly,0,0
212159,correlated,0,0
212160,with,0,0
212161,prognosis,0,0
212162,(,0,0
212163,X2,0,0
212164,for,0,0
212165,trend,0,0
212166,=,0,0
212167,62.6,0,0
212168,),0,0
212169,.,0,0
212170,The,0,0
212171,haemoglobin,1,1
212172,level,1,1
212173,at,0,0
212174,presentation,0,1
212175,was,0,0
212176,strongly,0,0
212177,correlated,0,0
212178,with,0,0
212179,prognosis,0,0
212180,among,0,0
212181,patients,0,0
212182,in,0,0
212183,the,0,0
212184,good,0,0
212185,renal-function,0,0
212186,group,0,0
212187,.,0,0
212188,Among,0,0
212189,107,0,0
212190,patients,0,0
212191,who,0,0
212192,presented,0,0
212193,with,0,0
212194,good,0,0
212195,renal,0,1
212196,function,0,1
212197,and,0,0
212198,with,0,0
212199,haemoglobin,0,1
212200,above,0,0
212201,100,0,0
212202,g/l,0,0
212203,",",0,0
212204,the,0,0
212205,5-year,0,0
212206,survival,1,1
212207,was,0,0
212208,43,0,0
212209,%,0,0
212210,.,0,0
212211,Other,0,0
212212,prognostic,0,1
212213,features,0,0
212214,were,0,0
212215,much,0,0
212216,less,0,0
212217,important,0,0
212218,when,0,0
212219,account,0,0
212220,was,0,0
212221,taken,0,0
212222,of,0,0
212223,renal,0,1
212224,function,0,1
212225,and,0,0
212226,haemoglobin,0,1
212227,level,0,1
212228,.,0,0
212229,The,0,0
212230,influence,0,0
212231,of,0,0
212232,amiloride,0,0
212233,on,0,0
212234,the,0,0
212235,therapeutic,0,0
212236,and,0,0
212237,metabolic,0,1
212238,effects,0,1
212239,of,0,0
212240,carbenoxolone,0,0
212241,in,0,0
212242,patients,0,0
212243,with,0,0
212244,gastric,0,1
212245,ulcer,0,0
212246,.,0,0
212247,A,0,0
212248,double-blind,0,0
212249,controlled,0,0
212250,trial,0,0
212251,.,0,0
212252,Patients,0,0
212253,with,0,0
212254,benign,0,0
212255,gastric,0,1
212256,ulcer,0,1
212257,were,0,0
212258,treated,0,0
212259,for,0,0
212260,four,0,0
212261,weeks,0,0
212262,with,0,0
212263,carbenoxolone,0,0
212264,sodium,0,0
212265,as,0,0
212266,Biogastrone,0,0
212267,tablets,0,0
212268,100,0,0
212269,mg,0,0
212270,three,0,0
212271,times,0,0
212272,a,0,0
212273,day,0,0
212274,",",0,0
212275,and,0,0
212276,if,0,0
212277,the,0,0
212278,ulcers,0,1
212279,were,0,0
212280,not,0,0
212281,healed,0,0
212282,at,0,0
212283,4,0,0
212284,weeks,0,0
212285,treatment,0,0
212286,was,0,0
212287,continued,0,0
212288,for,0,0
212289,a,0,0
212290,further,0,0
212291,4,0,0
212292,weeks,0,0
212293,.,0,0
212294,Fifty,0,0
212295,two,0,0
212296,patients,0,0
212297,entered,0,0
212298,the,0,0
212299,trial,0,0
212300,",",0,0
212301,and,0,0
212302,12,0,0
212303,were,0,0
212304,withdrawn,0,0
212305,.,0,0
212306,In,0,0
212307,17,0,0
212308,patients,0,0
212309,who,0,0
212310,were,0,0
212311,randomly,0,0
212312,allotted,0,0
212313,double-blind,0,0
212314,additional,0,0
212315,dummy,0,0
212316,tablets,0,0
212317,16,0,0
212318,of,0,0
212319,their,0,0
212320,ulcer,0,0
212321,healed,0,0
212322,completely,0,0
212323,endoscopically,0,0
212324,",",0,0
212325,whereas,0,0
212326,of,0,0
212327,the,0,0
212328,23,0,0
212329,patients,0,0
212330,given,0,0
212331,additional,0,0
212332,amiloride,0,0
212333,5,0,0
212334,mg,0,0
212335,three,0,0
212336,times,0,0
212337,a,0,0
212338,day,0,0
212339,only,0,0
212340,14,0,0
212341,ulcers,0,0
212342,healed,0,0
212343,",",0,0
212344,a,0,0
212345,significant,0,0
212346,reduction,0,1
212347,in,0,0
212348,ulcer,0,1
212349,healing,0,1
212350,.,0,0
212351,The,0,0
212352,clinical,0,0
212353,(,1,0
212354,weight,1,1
212355,gain,1,1
212356,and,1,1
212357,oedema,1,1
212358,),1,1
212359,and,0,0
212360,metabolic,0,1
212361,(,1,0
212362,hypertension,1,1
212363,",",1,1
212364,hypokalaemia,1,1
212365,and,1,1
212366,hypernatraemia,1,1
212367,),1,1
212368,side-effects,0,1
212369,were,0,0
212370,reduced,0,0
212371,by,0,0
212372,the,0,0
212373,active,0,0
212374,amiloride,0,0
212375,therapy,0,0
212376,",",0,0
212377,but,0,0
212378,serum,1,1
212379,carbenoxolone,1,0
212380,levels,1,1
212381,were,0,0
212382,not,0,0
212383,affected,0,0
212384,.,0,0
212385,Thus,0,0
212386,the,0,0
212387,potassium-retaining,0,0
212388,diuretic,0,0
212389,amiloride,0,0
212390,",",0,0
212391,like,0,0
212392,the,0,0
212393,aldosterone,0,1
212394,antagonist,0,0
212395,spironolactone,0,0
212396,",",0,0
212397,markedly,0,0
212398,reduces,0,0
212399,both,0,0
212400,the,0,0
212401,ulcer-healing,1,1
212402,and,0,0
212403,the,0,0
212404,metabolic,1,1
212405,side-effects,1,1
212406,of,0,0
212407,carbenoxolone,0,0
212408,sodium,0,0
212409,",",0,0
212410,and,0,0
212411,should,0,0
212412,not,0,0
212413,be,0,0
212414,used,0,0
212415,together,0,0
212416,with,0,0
212417,it,0,0
212418,in,0,0
212419,the,0,0
212420,treatment,0,0
212421,of,0,0
212422,peptic,0,0
212423,ulcer,0,0
212424,.,0,0
212425,Corticosteroid-induced,0,0
212426,osteopenia,1,1
212427,and,1,1
212428,vitamin,1,0
212429,D,1,1
212430,metabolism,1,1
212431,.,1,0
212432,Effect,0,0
212433,of,0,0
212434,vitamin,0,0
212435,D2,0,0
212436,",",0,0
212437,calcium,0,1
212438,phosphate,0,1
212439,and,0,1
212440,sodium,0,1
212441,fluoride,0,0
212442,administration,0,0
212443,.,0,0
212444,Thirty-one,0,0
212445,patients,0,0
212446,scheduled,0,0
212447,for,0,0
212448,long-term,0,0
212449,(,0,0
212450,24,0,0
212451,weeks,0,0
212452,),0,0
212453,treatment,0,0
212454,with,0,0
212455,prednisone,0,0
212456,in,0,0
212457,comparatively,0,0
212458,high,0,0
212459,doses,0,0
212460,were,0,0
212461,randomly,0,0
212462,allocated,0,0
212463,to,0,0
212464,two,0,0
212465,further,0,0
212466,treatment,0,0
212467,groups,0,0
212468,.,0,0
212469,Group,0,0
212470,A,0,0
212471,received,0,0
212472,prednisone,0,0
212473,plus,0,0
212474,'triple-treatment,0,0
212475,',0,0
212476,(,0,0
212477,vitamin,0,0
212478,D2,0,0
212479,45000,0,0
212480,iu,0,0
212481,twice,0,0
212482,weekly,0,0
212483,",",0,0
212484,sodium,0,0
212485,fluoride,0,0
212486,50,0,0
212487,mg,0,0
212488,and,0,0
212489,calcium,0,0
212490,phosphate,0,0
212491,4.5,0,0
212492,g,0,0
212493,daily,0,0
212494,),0,0
212495,",",0,0
212496,group,0,0
212497,B,0,0
212498,received,0,0
212499,only,0,0
212500,prednisone,0,0
212501,.,0,0
212502,The,0,0
212503,study,0,0
212504,was,0,0
212505,undertaken,0,0
212506,in,0,0
212507,order,0,0
212508,to,0,0
212509,evaluate,0,0
212510,the,0,0
212511,effect,0,0
212512,of,0,0
212513,prednisone-,0,0
212514,and,0,0
212515,triple-treatment,0,0
212516,upon,0,0
212517,bone,1,1
212518,mineral,1,1
212519,content,1,1
212520,(,1,0
212521,BMC,1,1
212522,),1,0
212523,and,1,0
212524,vitamin,1,0
212525,D,1,1
212526,metabolism,1,0
212527,.,1,0
212528,The,0,0
212529,groups,0,0
212530,were,0,0
212531,comparable,0,0
212532,with,0,0
212533,regard,0,0
212534,to,0,0
212535,age,0,0
212536,",",0,0
212537,sex,0,0
212538,and,0,1
212539,prednisone,0,0
212540,dose,0,0
212541,.,0,0
212542,BMC,1,1
212543,fell,0,1
212544,rapidly,0,0
212545,and,0,0
212546,similarly,0,0
212547,in,0,0
212548,both,0,0
212549,groups,0,0
212550,",",0,0
212551,demonstrating,0,0
212552,that,0,0
212553,the,0,0
212554,triple-treatment,0,0
212555,has,0,0
212556,no,0,0
212557,preventive,0,0
212558,effect,0,0
212559,on,0,0
212560,corticosteroid,0,0
212561,induced,0,0
212562,osteopenia,0,0
212563,.,0,0
212564,Serum,1,1
212565,concentrations,1,1
212566,of,1,0
212567,25OHD2,1,0
212568,",",1,0
212569,25OHD3,1,0
212570,and,1,0
212571,"1,25",1,0
212572,(,1,0
212573,OH,1,0
212574,),1,0
212575,2D,1,1
212576,were,0,0
212577,unchanged,0,0
212578,in,0,0
212579,group,0,0
212580,B,0,0
212581,(,0,0
212582,without,0,0
212583,triple-treatment,0,0
212584,),0,0
212585,",",0,0
212586,whereas,0,0
212587,in,0,0
212588,group,0,0
212589,A,0,0
212590,25OHD2,1,0
212591,increased,0,0
212592,enormously,0,0
212593,",",0,0
212594,25OHD3,1,0
212595,was,0,0
212596,suppressed,0,0
212597,possibly,0,0
212598,by,0,0
212599,substrate,0,1
212600,competition,0,0
212601,for,0,0
212602,hydroxylation,0,0
212603,in,0,0
212604,the,0,0
212605,liver,0,0
212606,and,0,0
212607,"1,25",1,0
212608,(,1,0
212609,OH,1,0
212610,),1,0
212611,2D,1,1
212612,was,0,0
212613,halved,0,0
212614,.,0,0
212615,The,0,0
212616,suppression,0,1
212617,of,0,0
212618,"1,25",1,0
212619,(,1,0
212620,OH,1,0
212621,),1,0
212622,2D,1,0
212623,may,0,0
212624,be,0,0
212625,an,0,0
212626,effect,0,0
212627,of,0,0
212628,raised,0,0
212629,25OHD2,0,0
212630,alone,0,0
212631,",",0,0
212632,or,0,0
212633,in,0,0
212634,combination,0,0
212635,with,0,0
212636,corticosteroid,0,0
212637,excess,0,0
212638,.,0,0
212639,Non-Hodgkin,0,0
212640,'s,0,0
212641,malignant,0,0
212642,lymphomas,0,0
212643,:,0,0
212644,treatment,0,0
212645,of,0,0
212646,localized,0,0
212647,relapses,0,1
212648,with,0,0
212649,chemo,0,0
212650,+,0,0
212651,radio,0,1
212652,+,0,0
212653,BCG-therapy,0,0
212654,.,0,0
212655,16,0,0
212656,patients,0,0
212657,with,0,0
212658,relapsing,0,0
212659,non-Hodgkin,0,0
212660,'s,0,0
212661,malignant,0,0
212662,lymphomas,0,1
212663,considered,0,0
212664,as,0,0
212665,clinical,0,0
212666,stage,0,0
212667,I,0,0
212668,or,0,0
212669,II,0,0
212670,were,0,0
212671,treated,0,0
212672,by,0,0
212673,an,0,0
212674,association,0,0
212675,of,0,0
212676,chemo,0,0
212677,+,0,0
212678,radiotherapy,0,0
212679,and,0,0
212680,thereafter,0,0
212681,by,0,0
212682,maintenance,0,0
212683,BCG,0,0
212684,therapy,0,0
212685,.,0,0
212686,5,0,0
212687,of,0,0
212688,them,0,0
212689,were,0,0
212690,included,0,0
212691,in,0,0
212692,a,0,0
212693,randomized,0,0
212694,trial,0,0
212695,and,0,0
212696,have,0,0
212697,a,0,0
212698,significantly,0,0
212699,different,0,0
212700,disease-free,1,1
212701,survival,1,1
212702,from,0,0
212703,patients,0,0
212704,receiving,0,0
212705,the,0,0
212706,same,0,0
212707,treatment,0,0
212708,but,0,0
212709,without,0,0
212710,BCG,0,0
212711,.,0,0
212712,11,0,0
212713,were,0,0
212714,systematically,0,0
212715,treated,0,0
212716,by,0,0
212717,BCG,0,0
212718,and,0,0
212719,they,0,0
212720,also,0,0
212721,have,0,0
212722,a,0,0
212723,fairly,0,0
212724,good,0,0
212725,disease-free,1,1
212726,survival,1,1
212727,.,1,0
212728,Such,0,0
212729,a,0,0
212730,treatment,0,0
212731,appears,0,0
212732,to,0,0
212733,be,0,0
212734,of,0,0
212735,value,0,0
212736,in,0,0
212737,treating,0,0
212738,these,0,0
212739,patients,0,0
212740,and,0,0
212741,even,0,0
212742,probably,0,0
212743,of,0,0
212744,curing,0,0
212745,some,0,0
212746,of,0,0
212747,them,0,0
212748,.,0,0
212749,Perception,0,1
212750,of,0,0
212751,social,1,1
212752,interactions,1,0
212753,in,0,0
212754,depressed,0,1
212755,psychiatric,0,0
212756,patients,0,0
212757,.,0,0
212758,Intraoperative,0,0
212759,microscopy,0,0
212760,of,0,0
212761,bile,0,0
212762,--,0,0
212763,is,0,0
212764,it,0,0
212765,useful,0,0
212766,?,0,0
212767,Direct,0,1
212768,microscopy,0,0
212769,of,0,0
212770,the,0,0
212771,bile,0,1
212772,was,0,0
212773,performed,0,0
212774,during,0,0
212775,cholecystectomy,0,0
212776,in,0,0
212777,111,0,0
212778,patients,0,0
212779,in,0,0
212780,an,0,0
212781,attempt,0,0
212782,to,0,0
212783,identify,0,0
212784,those,0,0
212785,with,0,0
212786,a,0,0
212787,high,0,0
212788,risk,0,0
212789,of,0,0
212790,wound,0,0
212791,infection,0,1
212792,.,0,0
212793,Bacteria,0,1
212794,were,0,0
212795,identified,0,0
212796,in,0,0
212797,23,0,0
212798,patients,0,0
212799,",",0,0
212800,11,0,0
212801,of,0,0
212802,83,0,0
212803,undergoing,0,0
212804,cholecystectomy,0,0
212805,alone,0,0
212806,and,0,0
212807,12,0,0
212808,of,0,0
212809,28,0,0
212810,undergoing,0,0
212811,exploration,0,0
212812,of,0,0
212813,the,0,0
212814,common,0,0
212815,bile,0,1
212816,duct,0,1
212817,(,0,0
212818,P,0,0
212819,less,0,0
212820,than,0,0
212821,0.01,0,0
212822,),0,0
212823,.,0,0
212824,These,0,0
212825,23,0,0
212826,patients,0,0
212827,were,0,0
212828,randomly,0,0
212829,allocated,0,0
212830,to,0,0
212831,an,0,0
212832,antibiotic,0,0
212833,group,0,0
212834,or,0,0
212835,a,0,0
212836,control,0,0
212837,group,0,0
212838,;,0,0
212839,there,0,0
212840,was,0,0
212841,one,0,0
212842,wound,0,0
212843,infection,0,0
212844,in,0,0
212845,the,0,0
212846,antibiotic,0,0
212847,group,0,0
212848,and,0,0
212849,two,0,0
212850,in,0,0
212851,the,0,0
212852,control,0,0
212853,group,0,0
212854,.,0,0
212855,A,0,0
212856,total,0,0
212857,of,0,0
212858,14,0,0
212859,patients,0,0
212860,developed,0,0
212861,wound,1,0
212862,sepsis,1,1
212863,.,1,0
212864,Infection,1,0
212865,was,0,0
212866,more,0,0
212867,likely,0,0
212868,if,0,0
212869,the,0,0
212870,common,0,0
212871,bile,0,1
212872,duct,0,1
212873,was,0,0
212874,explored,0,0
212875,(,0,0
212876,6,0,0
212877,of,0,0
212878,28,0,0
212879,),0,0
212880,rather,0,0
212881,than,0,0
212882,cholecystectomy,0,0
212883,alone,0,0
212884,(,0,0
212885,8,0,0
212886,of,0,0
212887,83,0,0
212888,),0,0
212889,.,0,0
212890,There,0,0
212891,was,0,0
212892,a,0,0
212893,poor,0,1
212894,correlation,0,0
212895,between,0,0
212896,microscopy,0,1
212897,and,0,1
212898,culture,0,1
212899,of,0,0
212900,the,0,0
212901,bile,0,1
212902,for,0,0
212903,bacteria,1,1
212904,and,0,0
212905,there,0,0
212906,was,0,0
212907,no,0,0
212908,increase,0,0
212909,in,0,0
212910,sepsis,1,1
212911,when,0,0
212912,bacteria,0,1
212913,were,0,0
212914,observed,0,0
212915,on,0,0
212916,microscopy,0,0
212917,.,0,0
212918,We,0,0
212919,were,0,0
212920,not,0,0
212921,able,0,0
212922,to,0,0
212923,identify,0,0
212924,a,0,0
212925,high,0,0
212926,risk,0,1
212927,group,0,0
212928,of,0,0
212929,patients,0,0
212930,by,0,0
212931,intraoperative,0,0
212932,microscopy,0,0
212933,of,0,0
212934,bile,0,1
212935,.,0,0
212936,Menstrual,1,1
212937,cycle,1,1
212938,symptoms,1,1
212939,in,0,0
212940,infertile,0,0
212941,and,0,0
212942,control,0,0
212943,subjects,0,0
212944,:,0,0
212945,a,0,0
212946,re-evaluation,0,0
212947,of,0,0
212948,the,0,0
212949,evidence,0,0
212950,for,0,0
212951,psychological,1,1
212952,changes,1,0
212953,.,1,0
212954,Theophylline,1,0
212955,concentrations,1,1
212956,in,0,0
212957,serum,0,1
212958,and,0,1
212959,saliva,0,1
212960,after,0,0
212961,oral,0,0
212962,microcrystalline,0,0
212963,and,0,0
212964,sustained-release,0,0
212965,preparations,0,0
212966,in,0,0
212967,asthmatics,0,0
212968,.,0,0
212969,Theophylline,1,0
212970,concentrations,1,1
212971,in,0,0
212972,saliva,0,0
212973,have,0,0
212974,been,0,0
212975,compared,0,0
212976,with,0,0
212977,those,0,0
212978,in,0,0
212979,serum,0,1
212980,in,0,0
212981,13,0,0
212982,asthmatic,0,0
212983,patients,0,0
212984,after,0,0
212985,single,0,0
212986,and,0,0
212987,multiple,0,1
212988,oral,0,0
212989,dosage,0,0
212990,of,0,0
212991,a,0,0
212992,microcrystalline,0,0
212993,theophylline,0,0
212994,tablet,0,0
212995,(,0,0
212996,Nuelin,0,0
212997,),0,0
212998,and,0,0
212999,a,0,0
213000,sustained-release,0,0
213001,preparation,0,0
213002,(,0,0
213003,Nuelin,0,0
213004,Retard,0,0
213005,),0,0
213006,.,0,0
213007,There,0,0
213008,was,0,0
213009,wide,0,0
213010,individual,0,0
213011,variation,0,0
213012,in,0,0
213013,the,0,0
213014,ratio,1,1
213015,of,1,0
213016,serum,1,1
213017,to,1,0
213018,saliva,1,0
213019,concentrations,1,1
213020,indicating,0,0
213021,that,0,0
213022,",",0,0
213023,even,0,0
213024,when,0,0
213025,individual,0,0
213026,serum,0,1
213027,to,0,0
213028,saliva,0,0
213029,ratios,0,0
213030,have,0,0
213031,been,0,0
213032,established,0,0
213033,",",0,0
213034,the,0,0
213035,use,0,0
213036,of,0,0
213037,saliva,0,1
213038,theophylline,0,0
213039,measurements,0,0
213040,alone,0,0
213041,is,0,0
213042,unreliable,0,0
213043,for,0,0
213044,the,0,0
213045,routine,0,0
213046,monitoring,0,0
213047,of,0,0
213048,theophylline,0,0
213049,therapy,0,0
213050,.,0,0
213051,Both,0,0
213052,preparations,0,0
213053,produced,0,0
213054,mean,1,1
213055,serum,1,1
213056,theophylline,1,0
213057,concentrations,1,1
213058,within,0,0
213059,the,0,0
213060,10,0,0
213061,--,0,0
213062,20,0,0
213063,mcg/ml,0,0
213064,range,0,0
213065,",",0,0
213066,the,0,0
213067,sustained-release,0,0
213068,tablet,0,0
213069,giving,0,0
213070,higher,0,0
213071,monitoring,0,0
213072,through,0,0
213073,values,0,1
213074,and,0,0
213075,smaller,0,0
213076,through,0,0
213077,to,0,0
213078,peak,1,1
213079,variation,1,0
213080,.,1,0
213081,The,0,0
213082,preparations,0,0
213083,were,0,0
213084,equally,0,0
213085,and,0,0
213086,highly,0,0
213087,bioavailable,0,0
213088,.,0,0
213089,Side,1,0
213090,effects,1,1
213091,were,0,0
213092,reported,0,0
213093,by,0,0
213094,three,0,0
213095,patients,0,0
213096,",",0,0
213097,which,0,0
213098,were,0,0
213099,the,0,0
213100,patients,0,0
213101,with,0,0
213102,the,0,0
213103,highest,0,0
213104,AUC,0,0
213105,.,0,0
213106,The,0,0
213107,Nuelin,0,0
213108,Retard,0,0
213109,preparation,0,0
213110,appears,0,0
213111,to,0,0
213112,provide,0,0
213113,smooth,0,1
213114,",",0,0
213115,sustained,0,1
213116,serum,1,1
213117,theophylline,1,0
213118,concentrations,1,1
213119,within,0,0
213120,the,0,0
213121,therapeutic,0,0
213122,range,0,0
213123,and,0,0
213124,the,0,0
213125,simple,0,0
213126,",",0,0
213127,twice-daily,0,0
213128,dosage,0,0
213129,should,0,0
213130,result,0,0
213131,in,0,0
213132,improved,0,1
213133,patient,0,0
213134,compliance,0,1
213135,.,0,0
213136,[,1,0
213137,Changes,1,1
213138,in,0,0
213139,renal,1,1
213140,arterial,1,1
213141,flow,1,1
213142,during,0,0
213143,the,0,0
213144,treatment,0,0
213145,of,0,0
213146,essential,0,0
213147,arterial,0,1
213148,hypertension,0,0
213149,;,0,0
213150,prazosin,0,0
213151,in,0,0
213152,comparison,0,0
213153,with,0,0
213154,propranolol,0,0
213155,],0,0
213156,.,0,0
213157,Changing,0,0
213158,sodium,0,0
213159,intake,0,1
213160,in,0,0
213161,children,0,0
213162,.,0,0
213163,The,0,0
213164,Minneapolis,0,0
213165,Children,0,0
213166,'s,0,0
213167,Blood,0,1
213168,Pressure,0,1
213169,Study,0,0
213170,.,0,0
213171,To,0,0
213172,assess,0,0
213173,the,0,0
213174,effects,0,0
213175,of,0,0
213176,modifying,0,0
213177,dietary,0,0
213178,sodium,0,0
213179,intake,0,1
213180,",",0,0
213181,80,0,0
213182,school,0,0
213183,children,0,0
213184,with,0,0
213185,blood,0,1
213186,pressures,0,1
213187,above,0,0
213188,the,0,0
213189,95th,0,1
213190,percentile,0,0
213191,for,0,0
213192,age,0,0
213193,and,0,1
213194,sex,0,0
213195,but,0,0
213196,below,0,0
213197,130/90,0,0
213198,mm,0,0
213199,Hg,0,0
213200,at,0,0
213201,school,0,0
213202,screening,0,0
213203,were,0,0
213204,randomized,0,0
213205,to,0,0
213206,a,0,0
213207,family,0,0
213208,intervention,0,0
213209,program,0,0
213210,or,0,0
213211,a,0,0
213212,control,0,0
213213,group,0,0
213214,.,0,0
213215,Twenty,0,0
213216,children,0,0
213217,aged,0,0
213218,6,0,0
213219,to,0,0
213220,9,0,0
213221,years,0,0
213222,and,0,0
213223,their,0,0
213224,families,0,0
213225,began,0,0
213226,a,0,0
213227,program,0,0
213228,to,0,0
213229,modify,0,0
213230,the,0,0
213231,family,0,0
213232,diet,0,0
213233,toward,0,0
213234,a,0,0
213235,goal,0,0
213236,of,0,0
213237,70,0,0
213238,mEq,0,0
213239,sodium,0,0
213240,per,0,0
213241,person,0,0
213242,per,0,0
213243,day,0,0
213244,.,0,0
213245,Adherence,1,1
213246,was,0,0
213247,assessed,0,0
213248,by,0,0
213249,3-day,1,0
213250,food,1,0
213251,records,1,0
213252,and,1,1
213253,urine,1,1
213254,collections,1,0
213255,in,1,0
213256,children,1,0
213257,and,1,0
213258,adults,1,0
213259,.,1,0
213260,The,0,0
213261,sodium,1,0
213262,intakes,1,1
213263,and,1,1
213264,blood,1,1
213265,pressures,1,1
213266,of,0,0
213267,the,0,0
213268,intervention,0,0
213269,and,0,1
213270,control,0,0
213271,group,0,0
213272,were,0,0
213273,compared,0,0
213274,1,0,0
213275,year,0,0
213276,after,0,0
213277,randomization,0,0
213278,.,0,0
213279,Sodium,1,0
213280,intake,1,1
213281,was,0,0
213282,significantly,0,0
213283,lower,0,0
213284,in,0,0
213285,the,0,0
213286,intervention,0,0
213287,group,0,0
213288,only,0,0
213289,in,0,0
213290,the,0,0
213291,active,0,0
213292,participants,0,0
213293,as,0,0
213294,compared,0,0
213295,to,0,0
213296,dropouts,0,0
213297,and,0,1
213298,controls,0,0
213299,(,0,0
213300,87,0,0
213301,vs,0,0
213302,130,0,0
213303,and,0,0
213304,133,0,0
213305,mmoles/24,0,0
213306,hr,0,0
213307,),0,0
213308,.,0,0
213309,There,0,0
213310,were,0,0
213311,no,0,0
213312,significant,0,0
213313,differences,0,0
213314,between,0,0
213315,the,0,0
213316,groups,0,0
213317,in,0,0
213318,height,1,1
213319,",",1,0
213320,weight,1,1
213321,",",1,1
213322,or,1,1
213323,blood,1,1
213324,pressure,1,1
213325,.,1,0
213326,Is,0,0
213327,anti-Pseudomonas,0,1
213328,therapy,0,0
213329,warranted,0,0
213330,in,0,0
213331,acute,0,0
213332,respiratory,1,1
213333,exacerbations,1,1
213334,in,0,0
213335,children,0,0
213336,with,0,0
213337,cystic,0,0
213338,fibrosis,0,0
213339,?,0,0
213340,A,0,0
213341,controlled,0,0
213342,study,0,0
213343,was,0,0
213344,designed,0,0
213345,to,0,0
213346,clarify,0,0
213347,the,0,0
213348,indications,0,0
213349,for,0,0
213350,antibiotic,0,0
213351,therapy,0,0
213352,in,0,0
213353,children,0,0
213354,with,0,0
213355,advanced,0,0
213356,cystic,0,0
213357,fibrosis,0,1
213358,hospitalized,0,0
213359,with,0,0
213360,respiratory,0,1
213361,exacerbations,0,1
213362,.,0,0
213363,Twenty-two,0,0
213364,children,0,0
213365,with,0,0
213366,severe,0,1
213367,CF,0,1
213368,and,0,0
213369,signs,0,1
213370,of,0,1
213371,acute,0,0
213372,lower,0,0
213373,respiratory,0,1
213374,infection,0,1
213375,were,0,0
213376,randomly,0,0
213377,assigned,0,0
213378,to,0,0
213379,receive,0,0
213380,either,0,0
213381,cloxacillin,0,0
213382,or,0,0
213383,carbenicillin,0,0
213384,plus,0,0
213385,gentamicin,0,0
213386,administered,0,0
213387,intravenously,0,0
213388,for,0,0
213389,ten,0,0
213390,days,0,0
213391,.,0,0
213392,Other,0,0
213393,aspects,0,0
213394,of,0,0
213395,therapy,0,0
213396,were,0,0
213397,constant,0,0
213398,.,0,0
213399,The,0,0
213400,groups,0,0
213401,were,0,0
213402,comparable,0,0
213403,in,0,0
213404,all,0,0
213405,respects,0,0
213406,and,0,0
213407,Pseudomonas,0,1
213408,aeruginosa,0,1
213409,was,0,0
213410,the,0,0
213411,predominant,0,0
213412,sputum,0,0
213413,pathogen,0,1
213414,in,0,0
213415,most,0,0
213416,patients,0,0
213417,.,0,0
213418,Clinical,1,1
213419,improvement,1,0
213420,",",1,0
213421,chest,1,1
213422,radiograph,1,0
213423,changes,1,1
213424,",",1,0
213425,evidence,1,0
213426,of,1,1
213427,airway,1,1
213428,obstruction,1,1
213429,",",1,0
213430,and,1,1
213431,bacteriologic,1,1
213432,flora,1,1
213433,of,1,0
213434,sputum,1,0
213435,were,0,0
213436,no,0,0
213437,different,0,0
213438,regardless,0,0
213439,of,0,0
213440,the,0,0
213441,regimen,0,0
213442,used,0,0
213443,.,0,0
213444,These,0,0
213445,results,0,0
213446,suggest,0,0
213447,that,0,0
213448,the,0,0
213449,use,0,0
213450,of,0,0
213451,anti-Pseudomonas,0,1
213452,medication,0,0
213453,in,0,0
213454,these,0,0
213455,children,0,0
213456,may,0,0
213457,not,0,0
213458,always,0,0
213459,be,0,0
213460,necessary,0,0
213461,.,0,0
213462,These,0,0
213463,observations,0,0
213464,need,0,0
213465,to,0,0
213466,be,0,0
213467,confirmed,0,0
213468,by,0,0
213469,blind-controlled,0,0
213470,studies,0,0
213471,in,0,0
213472,larger,0,0
213473,numbers,0,1
213474,of,0,1
213475,patients,0,0
213476,with,0,0
213477,mild,0,0
213478,as,0,0
213479,well,0,0
213480,as,0,0
213481,severe,0,1
213482,respiratory,0,1
213483,involvement,0,0
213484,.,0,0
213485,Vaginal,1,1
213486,pH,1,1
213487,and,1,1
213488,microflora,1,1
213489,related,0,0
213490,to,0,0
213491,yeast,0,0
213492,infections,0,1
213493,and,0,0
213494,treatment,0,0
213495,.,0,0
213496,The,0,0
213497,relationship,0,0
213498,between,0,0
213499,vaginal,1,1
213500,pH,1,0
213501,",",1,0
213502,microflora,1,1
213503,",",0,1
213504,and,0,1
213505,yeast,0,0
213506,infection,0,1
213507,was,0,0
213508,investigated,0,0
213509,in,0,0
213510,93,0,0
213511,women,0,0
213512,randomly,0,0
213513,treated,0,0
213514,with,0,0
213515,either,0,0
213516,nystatin,0,0
213517,or,0,0
213518,miconazole,0,0
213519,pessaries,0,0
213520,and,0,0
213521,cream,0,0
213522,for,0,0
213523,two,0,0
213524,weeks,0,0
213525,.,0,0
213526,The,0,0
213527,vaginal,1,0
213528,pH,1,0
213529,was,0,0
213530,measured,0,0
213531,in,0,0
213532,a,0,0
213533,control,0,0
213534,group,0,0
213535,of,0,0
213536,48,0,0
213537,women,0,0
213538,.,0,0
213539,In,0,0
213540,the,0,0
213541,study,0,0
213542,group,0,0
213543,",",0,0
213544,37,0,0
213545,patients,0,0
213546,defaulted,0,0
213547,",",0,0
213548,39,0,0
213549,were,0,0
213550,cured,0,0
213551,",",0,0
213552,and,0,0
213553,17,0,0
213554,required,0,0
213555,treatment,0,0
213556,during,0,0
213557,the,0,0
213558,six-month,0,0
213559,follow-up,0,0
213560,period,0,0
213561,.,0,0
213562,In,0,0
213563,both,0,0
213564,study,0,0
213565,and,0,0
213566,control,0,0
213567,groups,0,0
213568,before,0,0
213569,and,0,0
213570,after,0,0
213571,treatment,0,0
213572,the,0,0
213573,mean,1,1
213574,vaginal,1,0
213575,pH,1,0
213576,was,0,0
213577,in,0,0
213578,the,0,0
213579,range,0,0
213580,of,0,0
213581,4.3-4.6,0,0
213582,.,0,0
213583,Lactobacilli,1,1
213584,were,0,0
213585,plentiful,0,0
213586,in,0,0
213587,78,0,0
213588,(,0,0
213589,91,0,0
213590,%,0,0
213591,),0,0
213592,out,0,0
213593,of,0,0
213594,86,0,0
213595,patients,0,0
213596,and,0,0
213597,shows,0,0
213598,that,0,0
213599,lactobacilli,0,1
213600,and,0,0
213601,yeasts,0,0
213602,commonly,0,0
213603,coexist,0,0
213604,.,0,0
213605,The,0,0
213606,influence,0,0
213607,of,0,0
213608,other,0,0
213609,organisms,0,0
213610,appeared,0,0
213611,to,0,0
213612,be,0,0
213613,negligible,0,0
213614,.,0,0
213615,The,0,0
213616,trial,0,0
213617,showed,0,0
213618,that,0,0
213619,nystatin,0,0
213620,and,0,1
213621,micromazole,0,0
213622,were,0,0
213623,equallly,0,0
213624,effective,1,0
213625,in,0,0
213626,the,0,0
213627,treatment,0,0
213628,of,0,0
213629,vaginal,0,0
213630,yeast,0,0
213631,infection,0,1
213632,and,0,0
213633,that,0,0
213634,the,0,0
213635,broad-spectrum,0,0
213636,activity,0,1
213637,of,0,0
213638,micronazole,0,0
213639,offered,0,0
213640,no,0,0
213641,advantage,0,0
213642,in,0,0
213643,this,0,0
213644,condition,0,0
213645,.,0,0
213646,Corticosteroids,0,0
213647,plus,0,0
213648,pulse,0,1
213649,cyclophosphamide,0,0
213650,and,0,1
213651,plasma,0,1
213652,exchanges,0,0
213653,versus,0,0
213654,corticosteroids,0,0
213655,plus,0,0
213656,pulse,0,1
213657,cyclophosphamide,0,0
213658,alone,0,0
213659,in,0,0
213660,the,0,0
213661,treatment,0,0
213662,of,0,0
213663,polyarteritis,0,0
213664,nodosa,0,0
213665,and,0,1
213666,Churg-Strauss,0,1
213667,syndrome,0,0
213668,patients,0,0
213669,with,0,0
213670,factors,0,0
213671,predicting,0,1
213672,poor,0,1
213673,prognosis,0,0
213674,.,0,0
213675,A,0,0
213676,prospective,0,0
213677,",",0,0
213678,randomized,0,0
213679,trial,0,0
213680,in,0,0
213681,sixty-two,0,0
213682,patients,0,0
213683,.,0,0
213684,OBJECTIVE,0,0
213685,To,0,0
213686,define,0,0
213687,the,0,0
213688,most,0,0
213689,effective,0,0
213690,treatment,0,0
213691,for,0,0
213692,severe,0,1
213693,polyarteritis,0,0
213694,nodosa,0,0
213695,(,0,0
213696,PAN,0,1
213697,),0,0
213698,and,0,0
213699,Churg-Strauss,0,0
213700,syndrome,0,0
213701,(,0,0
213702,CSS,0,0
213703,),0,0
213704,and,0,0
213705,to,0,0
213706,investigate,0,0
213707,the,0,0
213708,indication,0,0
213709,for,0,0
213710,plasma,0,1
213711,exchange,0,1
213712,treatment,0,0
213713,.,0,0
213714,METHODS,0,0
213715,We,0,0
213716,conducted,0,0
213717,a,0,0
213718,prospective,0,0
213719,",",0,0
213720,randomized,0,0
213721,",",0,0
213722,multicenter,0,0
213723,trial,0,0
213724,in,0,0
213725,which,0,0
213726,62,0,0
213727,patients,0,0
213728,were,0,0
213729,randomly,0,0
213730,assigned,0,0
213731,to,0,0
213732,receive,0,0
213733,either,0,0
213734,prednisone,0,0
213735,plus,0,0
213736,cyclophosphamide,0,0
213737,(,0,0
213738,intravenous,0,0
213739,bolus,0,0
213740,),0,0
213741,(,0,0
213742,group,0,0
213743,A,0,0
213744,;,0,0
213745,n,0,0
213746,=,0,0
213747,28,0,0
213748,),0,0
213749,or,0,0
213750,prednisone,0,0
213751,plus,0,0
213752,cyclophosphamide,0,0
213753,(,0,0
213754,intravenous,0,0
213755,bolus,0,0
213756,),0,0
213757,plus,0,0
213758,plasma,0,1
213759,exchanges,0,1
213760,(,0,0
213761,group,0,0
213762,B,0,0
213763,;,0,0
213764,n,0,0
213765,=,0,0
213766,34,0,0
213767,),0,0
213768,as,0,0
213769,first-line,0,0
213770,treatment,0,0
213771,for,0,0
213772,severe,0,1
213773,PAN,0,1
213774,or,0,0
213775,CSS,0,0
213776,.,0,0
213777,Factors,0,0
213778,predicting,0,1
213779,poor,0,1
213780,prognosis,0,1
213781,were,0,0
213782,renal,0,1
213783,symptoms,0,1
213784,",",0,0
213785,gastrointestinal,0,1
213786,tract,0,1
213787,involvement,0,1
213788,",",0,1
213789,cardiomyopathy,0,1
213790,",",0,0
213791,central,0,1
213792,nervous,0,1
213793,system,0,0
213794,involvement,0,1
213795,",",0,0
213796,weight,0,1
213797,loss,0,1
213798,>,0,0
213799,10,0,0
213800,%,0,0
213801,of,0,0
213802,body,0,1
213803,weight,0,1
213804,",",0,1
213805,and,0,0
213806,age,0,0
213807,>,0,0
213808,50,0,0
213809,years,0,0
213810,old,0,0
213811,.,0,0
213812,Patients,0,0
213813,with,0,0
213814,hepatitis,0,0
213815,B,0,0
213816,virus-related,0,0
213817,PAN,0,1
213818,were,0,0
213819,not,0,0
213820,included,0,0
213821,in,0,0
213822,this,0,0
213823,study,0,0
213824,.,0,0
213825,The,0,0
213826,end,0,0
213827,point,0,0
213828,of,0,0
213829,the,0,0
213830,study,0,0
213831,was,0,0
213832,control,0,0
213833,of,0,0
213834,the,0,0
213835,disease,0,0
213836,(,0,0
213837,recovery,0,1
213838,or,0,1
213839,remission,0,1
213840,),0,1
213841,or,0,0
213842,death,0,1
213843,.,0,0
213844,RESULTS,0,0
213845,Clinical,0,1
213846,symptoms,0,1
213847,and,0,0
213848,laboratory,0,0
213849,findings,0,0
213850,did,0,0
213851,not,0,0
213852,differ,0,0
213853,significantly,0,0
213854,in,0,0
213855,the,0,0
213856,2,0,0
213857,groups,0,0
213858,.,0,0
213859,Initial,0,1
213860,control,0,0
213861,of,0,0
213862,the,0,0
213863,disease,0,0
213864,was,0,0
213865,similar,0,0
213866,in,0,0
213867,both,0,0
213868,groups,0,0
213869,.,0,0
213870,Relapse,1,1
213871,after,0,0
213872,initial,0,0
213873,control,0,0
213874,of,0,0
213875,the,0,0
213876,disease,0,0
213877,was,0,0
213878,observed,0,0
213879,in,0,0
213880,7,0,0
213881,patients,0,0
213882,(,0,0
213883,4,0,0
213884,in,0,0
213885,group,0,0
213886,A,0,0
213887,and,0,0
213888,3,0,0
213889,in,0,0
213890,group,0,0
213891,B,0,0
213892,),0,0
213893,.,0,0
213894,The,0,0
213895,mean,1,1
213896,+/-,1,0
213897,SD,1,0
213898,followup,1,1
213899,period,0,0
213900,was,0,0
213901,31.1,0,0
213902,+/-,0,0
213903,20,0,0
213904,months,0,0
213905,for,0,0
213906,group,0,0
213907,A,0,0
213908,and,0,0
213909,35.9,0,0
213910,+/-,0,0
213911,16.8,0,0
213912,months,0,0
213913,for,0,0
213914,group,0,0
213915,B,0,0
213916,.,0,0
213917,At,0,0
213918,5,0,0
213919,years,0,0
213920,of,0,0
213921,followup,0,0
213922,",",0,0
213923,38,0,0
213924,patients,0,0
213925,(,0,0
213926,61.3,0,0
213927,%,0,0
213928,),0,0
213929,were,0,0
213930,cured,1,0
213931,(,0,0
213932,16,0,0
213933,in,0,0
213934,group,0,0
213935,A,0,0
213936,and,0,0
213937,22,0,0
213938,in,0,0
213939,group,0,0
213940,B,0,0
213941,),0,0
213942,",",0,0
213943,and,0,0
213944,5,0,0
213945,(,0,0
213946,8.1,0,0
213947,%,0,0
213948,),0,0
213949,were,0,0
213950,in,0,0
213951,remission,0,1
213952,without,0,0
213953,treatment,0,0
213954,but,0,0
213955,had,0,0
213956,not,0,0
213957,yet,0,0
213958,completed,0,0
213959,the,0,0
213960,cure-defining,0,0
213961,period,0,0
213962,of,0,0
213963,18,0,0
213964,months,0,0
213965,(,0,0
213966,3,0,0
213967,in,0,0
213968,group,0,0
213969,A,0,0
213970,and,0,0
213971,2,0,0
213972,in,0,0
213973,group,0,0
213974,B,0,0
213975,),0,0
213976,.,0,0
213977,Eight,0,0
213978,(,0,0
213979,12.9,0,0
213980,%,0,0
213981,),0,0
213982,(,0,0
213983,2,0,0
213984,in,0,0
213985,group,0,0
213986,A,0,0
213987,and,0,0
213988,2,0,0
213989,in,0,0
213990,group,0,0
213991,B,0,0
213992,),0,0
213993,were,0,0
213994,considered,0,0
213995,to,0,0
213996,be,0,0
213997,in,0,0
213998,clinical,1,0
213999,remission,1,1
214000,and,0,0
214001,required,0,0
214002,a,0,0
214003,maintenance,1,0
214004,regimen,1,0
214005,of,1,0
214006,low-dose,1,0
214007,corticosteroids,1,0
214008,.,1,0
214009,Eleven,0,0
214010,patients,0,0
214011,died,1,0
214012,during,0,0
214013,the,0,0
214014,study,0,0
214015,period,0,0
214016,(,0,0
214017,7,0,0
214018,in,0,0
214019,group,0,0
214020,A,0,0
214021,[,0,0
214022,25,0,0
214023,%,0,0
214024,],0,0
214025,",",0,0
214026,4,0,0
214027,in,0,0
214028,group,0,0
214029,B,0,0
214030,[,0,0
214031,11.8,0,0
214032,%,0,0
214033,],0,0
214034,),0,0
214035,.,0,0
214036,Uncontrolled,0,0
214037,vasculitis,0,0
214038,was,0,0
214039,responsible,0,0
214040,for,0,0
214041,4,0,0
214042,deaths,1,0
214043,(,0,0
214044,2,0,0
214045,in,0,0
214046,each,0,0
214047,group,0,0
214048,),0,0
214049,",",0,0
214050,and,0,1
214051,treatment,1,0
214052,side,1,1
214053,effects,1,1
214054,caused,0,0
214055,the,0,0
214056,death,1,1
214057,of,0,0
214058,1,0,0
214059,patient,0,0
214060,in,0,0
214061,group,0,0
214062,A,0,0
214063,.,0,0
214064,There,0,0
214065,was,0,0
214066,no,0,0
214067,significant,0,0
214068,difference,0,0
214069,between,0,0
214070,the,0,0
214071,5-year,1,0
214072,cumulative,1,1
214073,survival,1,1
214074,rates,1,1
214075,of,0,0
214076,the,0,0
214077,2,0,0
214078,groups,0,0
214079,(,0,0
214080,75,0,0
214081,%,0,0
214082,and,0,0
214083,88,0,0
214084,%,0,0
214085,",",0,0
214086,respectively,0,0
214087,),0,0
214088,.,0,0
214089,CONCLUSION,0,0
214090,Based,0,0
214091,on,0,0
214092,our,0,0
214093,data,0,0
214094,",",0,0
214095,combined,0,0
214096,treatment,0,0
214097,with,0,0
214098,prednisone,0,0
214099,",",0,0
214100,cyclophosphamide,0,0
214101,",",0,1
214102,and,0,1
214103,plasma,0,1
214104,exchanges,0,0
214105,is,0,0
214106,not,0,0
214107,superior,0,0
214108,to,0,0
214109,treatment,0,0
214110,with,0,0
214111,prednisone,0,0
214112,and,0,0
214113,cyclophosphamide,0,0
214114,alone,0,0
214115,",",0,0
214116,and,0,1
214117,plasma,0,1
214118,exchanges,0,0
214119,should,0,0
214120,not,0,0
214121,be,0,0
214122,systematically,0,0
214123,proposed,0,0
214124,for,0,0
214125,initial,0,0
214126,treatment,0,0
214127,of,0,0
214128,severe,0,1
214129,PAN,0,1
214130,or,0,0
214131,CSS,0,0
214132,.,0,0
214133,Optimized,0,0
214134,strategy,0,0
214135,for,0,0
214136,detection,0,1
214137,of,0,0
214138,early,0,0
214139,stage,0,0
214140,",",0,0
214141,curable,0,0
214142,prostate,0,0
214143,cancer,0,0
214144,:,0,0
214145,role,0,0
214146,of,0,0
214147,prescreening,0,0
214148,with,0,0
214149,prostate-specific,0,1
214150,antigen,0,1
214151,.,0,0
214152,In,0,0
214153,"1,002",0,0
214154,men,0,0
214155,aged,0,0
214156,45-80,0,0
214157,y,0,0
214158,",",0,0
214159,81,0,0
214160,%,0,0
214161,of,0,0
214162,the,0,0
214163,cancers,0,0
214164,detectable,0,1
214165,by,0,0
214166,serum,1,1
214167,prostate-specific,1,1
214168,antigen,1,1
214169,(,1,0
214170,PSA,1,1
214171,),1,0
214172,",",1,0
214173,digital,1,0
214174,rectal,1,1
214175,examination,1,0
214176,(,1,0
214177,DRE,1,1
214178,),1,1
214179,",",1,0
214180,and,1,1
214181,transrectal,1,1
214182,ultrasonography,1,1
214183,(,1,0
214184,TRUS,1,1
214185,),1,0
214186,were,0,0
214187,present,0,0
214188,in,0,0
214189,a,0,0
214190,subpopulation,0,0
214191,(,0,0
214192,19,0,0
214193,%,0,0
214194,of,0,0
214195,total,0,1
214196,),0,0
214197,identified,0,0
214198,by,0,0
214199,serum,0,1
214200,PSA,0,0
214201,above,0,0
214202,the,0,0
214203,threshold,0,1
214204,value,0,0
214205,of,0,0
214206,3.0,0,0
214207,micrograms/L,0,0
214208,.,0,0
214209,This,0,0
214210,study,0,0
214211,was,0,0
214212,extended,0,0
214213,to,0,0
214214,"7,350",0,0
214215,men,0,0
214216,using,0,0
214217,serum,0,1
214218,PSA,0,1
214219,and,0,0
214220,DRE,0,1
214221,as,0,0
214222,first,0,0
214223,approach,0,0
214224,",",0,0
214225,followed,0,0
214226,by,0,0
214227,TRUS,0,0
214228,only,0,0
214229,when,0,0
214230,1,0,0
214231,of,0,0
214232,these,0,0
214233,2,0,0
214234,tests,0,0
214235,was,0,0
214236,abnormal,0,1
214237,.,0,0
214238,Because,0,0
214239,the,0,0
214240,aim,0,0
214241,of,0,0
214242,prostate,0,0
214243,cancer,0,0
214244,detection,0,0
214245,is,0,0
214246,to,0,0
214247,find,0,0
214248,cancers,0,0
214249,at,0,0
214250,an,0,0
214251,early,0,0
214252,",",0,0
214253,potentially,0,0
214254,curable,0,0
214255,stage,0,0
214256,",",0,0
214257,it,0,0
214258,is,0,0
214259,of,0,0
214260,major,0,0
214261,interest,0,0
214262,that,0,0
214263,71.8,0,0
214264,%,0,0
214265,of,0,0
214266,evaluable,0,0
214267,cancers,0,0
214268,were,0,0
214269,clinical,0,0
214270,stage,0,0
214271,B,0,0
214272,;,0,0
214273,8.4,0,0
214274,%,0,0
214275,and,0,0
214276,10.7,0,0
214277,%,0,0
214278,were,0,0
214279,stages,0,1
214280,C1,0,1
214281,and,0,1
214282,C2,0,1
214283,",",0,0
214284,respectively,0,0
214285,;,0,0
214286,only,0,0
214287,9.2,0,0
214288,%,0,0
214289,were,0,0
214290,stage,0,0
214291,D,0,1
214292,(,0,0
214293,metastatic,0,0
214294,),0,0
214295,at,0,0
214296,first,0,0
214297,visit,0,1
214298,while,0,0
214299,none,0,0
214300,was,0,0
214301,at,0,0
214302,stage,0,0
214303,D,0,1
214304,at,0,0
214305,follow-up,0,0
214306,visits,0,0
214307,.,0,0
214308,This,0,0
214309,study,0,0
214310,",",0,0
214311,the,0,0
214312,first,0,0
214313,performed,0,0
214314,in,0,0
214315,an,0,0
214316,unselected,0,0
214317,",",0,0
214318,unscreened,0,0
214319,population,0,0
214320,",",0,0
214321,shows,0,0
214322,that,0,0
214323,serum,1,1
214324,PSA,1,0
214325,is,0,0
214326,the,0,0
214327,most,0,0
214328,sensitive,1,0
214329,technique,1,0
214330,to,0,0
214331,identify,0,0
214332,men,0,0
214333,at,0,0
214334,high,0,0
214335,risk,1,1
214336,of,1,0
214337,having,1,0
214338,prostate,1,0
214339,cancer,1,0
214340,and,0,0
214341,that,0,0
214342,12,0,0
214343,%,0,0
214344,more,0,0
214345,cancers,0,0
214346,can,0,0
214347,be,0,0
214348,found,0,0
214349,at,0,0
214350,first,0,0
214351,visit,0,1
214352,by,0,0
214353,doing,0,0
214354,DRE,0,0
214355,in,0,0
214356,addition,0,0
214357,to,0,0
214358,PSA,0,0
214359,.,0,0
214360,Follow-ups,0,0
214361,can,0,0
214362,be,0,0
214363,done,0,0
214364,every,0,0
214365,second,0,0
214366,year,0,0
214367,using,0,0
214368,serum,1,1
214369,PSA,1,0
214370,alone,1,0
214371,",",0,0
214372,as,0,0
214373,97,0,0
214374,%,0,0
214375,of,0,0
214376,the,0,0
214377,cancers,0,0
214378,detected,0,0
214379,at,0,0
214380,annual,0,1
214381,follow-up,0,0
214382,by,0,0
214383,DRE,0,1
214384,+,0,0
214385,PSA,0,1
214386,were,0,0
214387,PSA+,0,0
214388,.,0,0
214389,Cancers,0,0
214390,are,0,0
214391,discovered,0,0
214392,by,0,0
214393,the,0,0
214394,present,0,0
214395,approach,0,0
214396,at,0,0
214397,an,0,0
214398,estimated,1,0
214399,cost,1,1
214400,of,0,0
214401,$,0,0
214402,"2,665",0,0
214403,per,0,0
214404,cancer,0,0
214405,.,0,0
214406,Such,0,0
214407,cancers,0,0
214408,are,0,0
214409,potentially,0,0
214410,curable,1,0
214411,in,0,0
214412,at,0,0
214413,least,0,0
214414,80,0,0
214415,%,0,0
214416,of,0,0
214417,cases,0,0
214418,detected,0,0
214419,at,0,0
214420,first,0,0
214421,visit,0,1
214422,and,0,0
214423,in,0,0
214424,97,0,0
214425,%,0,0
214426,of,0,0
214427,cases,0,0
214428,at,0,0
214429,follow-up,0,0
214430,.,0,0
214431,This,0,0
214432,strategy,0,0
214433,offers,0,0
214434,the,0,0
214435,possibility,0,0
214436,to,0,0
214437,improve,0,0
214438,markedly,0,0
214439,morbidity,1,1
214440,and,1,1
214441,mortality,1,1
214442,from,1,0
214443,prostate,1,0
214444,cancer,1,0
214445,",",0,0
214446,presently,0,0
214447,the,0,0
214448,second,0,0
214449,leading,0,0
214450,cause,0,0
214451,of,0,0
214452,cancer,0,0
214453,death,0,1
214454,in,0,0
214455,North,0,0
214456,American,0,0
214457,men,0,0
214458,.,0,0
214459,Using,0,0
214460,repeated,0,0
214461,measures,0,1
214462,of,0,0
214463,symptom,0,1
214464,score,0,1
214465,",",0,1
214466,uroflowmetry,0,1
214467,and,0,1
214468,prostate,0,0
214469,specific,0,1
214470,antigen,0,1
214471,in,0,0
214472,the,0,0
214473,clinical,0,0
214474,management,0,0
214475,of,0,0
214476,prostate,0,0
214477,disease,0,0
214478,.,0,0
214479,Benign,0,0
214480,Prostatic,0,0
214481,Hyperplasia,0,1
214482,Treatment,0,0
214483,Outcomes,0,1
214484,Study,0,0
214485,Group,0,0
214486,.,0,0
214487,Measurements,0,0
214488,of,0,0
214489,American,1,0
214490,Urological,1,1
214491,Association,1,0
214492,symptom,1,1
214493,score,1,1
214494,",",1,0
214495,peak,1,1
214496,urine,1,1
214497,flow,1,1
214498,rate,1,1
214499,and,0,1
214500,prostate,1,0
214501,specific,1,1
214502,antigen,1,1
214503,(,1,0
214504,PSA,1,0
214505,),1,0
214506,are,0,0
214507,often,0,0
214508,followed,0,0
214509,over,0,0
214510,time,0,1
214511,in,0,0
214512,urological,0,0
214513,management,0,0
214514,.,0,0
214515,However,0,0
214516,",",0,0
214517,their,0,0
214518,interpretation,0,0
214519,is,0,0
214520,confounded,0,0
214521,by,0,0
214522,within-patient,0,0
214523,variability,0,1
214524,due,0,0
214525,to,0,0
214526,chance,0,1
214527,.,0,0
214528,Data,0,0
214529,from,0,0
214530,2,0,0
214531,clinical,0,0
214532,trials,0,0
214533,are,0,0
214534,used,0,0
214535,to,0,0
214536,examine,0,0
214537,the,0,0
214538,magnitude,0,1
214539,of,0,0
214540,this,0,0
214541,variation,0,0
214542,.,0,0
214543,When,0,0
214544,these,0,0
214545,measures,0,0
214546,are,0,0
214547,repeated,0,0
214548,at,0,0
214549,a,0,0
214550,short,0,0
214551,interval,0,0
214552,variation,0,0
214553,is,0,0
214554,modest,0,0
214555,and,0,0
214556,might,0,0
214557,easily,0,0
214558,be,0,0
214559,misinterpreted,0,0
214560,as,0,0
214561,a,0,0
214562,true,0,0
214563,change,0,0
214564,in,0,0
214565,patient,0,0
214566,condition,0,0
214567,.,0,0
214568,For,0,0
214569,example,0,0
214570,",",0,0
214571,approximately,0,0
214572,20,0,0
214573,%,0,0
214574,of,0,0
214575,patients,0,0
214576,might,0,0
214577,be,0,0
214578,expected,0,0
214579,to,0,0
214580,have,0,0
214581,a,0,0
214582,chance,0,1
214583,increase,0,1
214584,or,0,0
214585,decrease,0,1
214586,in,0,0
214587,symptom,0,1
214588,score,0,1
214589,by,0,0
214590,at,0,0
214591,least,0,0
214592,4.9,0,0
214593,points,0,0
214594,",",0,0
214595,in,0,0
214596,peak,0,1
214597,urine,0,1
214598,flow,0,1
214599,rate,0,1
214600,by,0,0
214601,at,0,0
214602,least,0,0
214603,4.1,0,0
214604,ml,0,0
214605,.,0,0
214606,per,0,0
214607,second,0,0
214608,or,0,0
214609,in,0,0
214610,PSA,0,1
214611,by,0,0
214612,at,0,0
214613,least,0,0
214614,1.6,0,0
214615,ng./ml,0,0
214616,.,0,0
214617,Clinicians,0,0
214618,can,0,0
214619,use,0,0
214620,these,0,0
214621,data,0,0
214622,to,0,0
214623,help,0,0
214624,interpret,0,0
214625,repeated,0,0
214626,measures,0,0
214627,of,0,0
214628,these,0,0
214629,variables,0,0
214630,in,0,0
214631,patients,0,0
214632,",",0,0
214633,and,0,0
214634,can,0,0
214635,consider,0,0
214636,obtaining,0,0
214637,paired,0,0
214638,measurements,0,0
214639,to,0,0
214640,decrease,0,0
214641,the,0,0
214642,effect,0,0
214643,of,0,0
214644,chance,0,1
214645,variation,0,0
214646,when,0,0
214647,they,0,0
214648,plan,0,0
214649,on,0,0
214650,following,0,0
214651,them,0,0
214652,over,0,0
214653,time,0,1
214654,.,0,0
214655,Double-blind,0,0
214656,comparison,0,0
214657,of,0,0
214658,the,0,0
214659,efficacy,1,1
214660,and,1,0
214661,safety,1,1
214662,of,0,0
214663,trandolapril,0,0
214664,2,0,0
214665,mg,0,0
214666,and,0,0
214667,hydrochlorothiazide,0,0
214668,25,0,0
214669,mg,0,0
214670,in,0,0
214671,patients,0,0
214672,with,0,0
214673,mild-to-moderate,0,0
214674,essential,0,0
214675,hypertension,0,0
214676,.,0,0
214677,Investigator,0,0
214678,Study,0,0
214679,Group,0,0
214680,.,0,0
214681,This,0,0
214682,multicenter,0,0
214683,international,0,0
214684,trial,0,0
214685,recruited,0,0
214686,205,0,0
214687,patients,0,0
214688,from,0,0
214689,16,0,0
214690,investigators,0,0
214691,.,0,0
214692,After,0,0
214693,a,0,0
214694,4-week,0,0
214695,",",0,0
214696,single-blind,0,0
214697,placebo,0,0
214698,run-in,0,0
214699,",",0,0
214700,patients,0,0
214701,were,0,0
214702,randomized,0,0
214703,to,0,0
214704,receive,0,0
214705,16,0,0
214706,weeks,0,0
214707,of,0,0
214708,trandolapril,0,0
214709,2,0,0
214710,mg/day,0,0
214711,(,0,0
214712,68,0,0
214713,patients,0,0
214714,),0,0
214715,",",0,0
214716,hydrochlorothiazide,0,0
214717,(,0,0
214718,HCTZ,0,0
214719,),0,0
214720,25,0,0
214721,mg/day,0,0
214722,(,0,0
214723,68,0,0
214724,patients,0,0
214725,),0,0
214726,",",0,0
214727,or,0,0
214728,the,0,0
214729,combination,0,0
214730,(,0,0
214731,69,0,0
214732,patients,0,0
214733,),0,0
214734,.,0,0
214735,Morning,1,0
214736,predosing,1,0
214737,supine,1,0
214738,diastolic,1,1
214739,blood,1,1
214740,pressure,1,1
214741,(,1,0
214742,DBP,1,1
214743,),1,0
214744,was,0,0
214745,the,0,0
214746,primary,0,0
214747,efficacy,0,1
214748,measurement,0,0
214749,.,0,0
214750,Intention-to-treat,0,0
214751,analysis,0,0
214752,showed,0,0
214753,significant,0,0
214754,decreases,0,0
214755,in,0,0
214756,all,0,0
214757,three,0,0
214758,groups,0,0
214759,in,0,0
214760,mean,0,1
214761,(,0,0
214762,+/-,0,0
214763,SEM,0,0
214764,),0,0
214765,supine,1,0
214766,DBP,1,0
214767,throughout,0,0
214768,the,0,0
214769,study,0,0
214770,",",0,0
214771,with,0,0
214772,no,0,0
214773,significant,0,0
214774,differences,0,0
214775,at,0,0
214776,week,0,0
214777,16,0,0
214778,between,0,0
214779,trandolapril,0,0
214780,(,0,0
214781,-10.6,0,0
214782,+/-,0,0
214783,1.3,0,0
214784,mm,0,0
214785,Hg,0,0
214786,),0,0
214787,and,0,0
214788,HCTZ,0,1
214789,(,0,0
214790,-10.9,0,0
214791,+/-,0,0
214792,1.3,0,0
214793,mm,0,0
214794,Hg,0,0
214795,),0,0
214796,.,0,0
214797,The,0,0
214798,combination,0,0
214799,gave,0,0
214800,a,0,0
214801,significantly,0,0
214802,greater,0,0
214803,reduction,0,1
214804,than,0,0
214805,either,0,0
214806,drug,0,0
214807,alone,0,0
214808,(,0,0
214809,-15.1,0,0
214810,+/-,0,0
214811,1.13,0,0
214812,mm,0,0
214813,Hg,0,0
214814,),0,0
214815,.,0,0
214816,Blood,1,1
214817,pressure,1,1
214818,was,0,0
214819,normalized,0,0
214820,in,0,0
214821,the,0,0
214822,combination,0,0
214823,group,0,0
214824,in,0,0
214825,67,0,0
214826,%,0,0
214827,of,0,0
214828,patients,0,0
214829,",",0,0
214830,a,0,0
214831,significantly,0,0
214832,higher,0,0
214833,proportion,0,0
214834,than,0,0
214835,either,0,0
214836,trandolapril,0,0
214837,(,0,0
214838,63,0,0
214839,%,0,0
214840,),0,0
214841,or,0,0
214842,HCTZ,0,1
214843,(,0,0
214844,60,0,0
214845,%,0,0
214846,;,0,0
214847,p,0,0
214848,=,0,0
214849,0.04,0,0
214850,),0,0
214851,.,0,0
214852,Each,0,0
214853,treatment,0,0
214854,was,0,0
214855,well,0,0
214856,tolerated,0,1
214857,.,0,0
214858,The,0,0
214859,incidence,0,1
214860,of,0,0
214861,adverse,1,1
214862,events,1,1
214863,was,0,0
214864,similar,0,0
214865,in,0,0
214866,all,0,0
214867,three,0,0
214868,groups,0,0
214869,.,0,0
214870,Trandolapril,0,0
214871,2,0,0
214872,mg,0,0
214873,once,0,0
214874,daily,0,0
214875,is,0,0
214876,an,0,0
214877,effective,0,0
214878,antihypertensive,0,0
214879,agent,0,0
214880,",",0,0
214881,comparable,0,0
214882,to,0,0
214883,HCTZ,0,0
214884,.,0,0
214885,Furthermore,0,0
214886,",",0,0
214887,the,0,0
214888,combination,0,0
214889,of,0,0
214890,the,0,0
214891,two,0,0
214892,drugs,0,0
214893,was,0,0
214894,shown,0,0
214895,to,0,0
214896,enhance,0,0
214897,the,0,0
214898,antihypertensive,1,0
214899,effect,1,0
214900,of,0,0
214901,the,0,0
214902,two,0,0
214903,compounds,0,0
214904,alone,0,0
214905,.,0,0
214906,Hemostatic,1,0
214907,function,1,1
214908,of,0,0
214909,aspirin-treated,0,1
214910,platelets,0,1
214911,vulnerable,0,0
214912,to,0,0
214913,cardiopulmonary,0,0
214914,bypass,0,0
214915,.,0,0
214916,Altered,0,0
214917,shear-induced,0,1
214918,pathway,0,0
214919,.,0,0
214920,The,0,0
214921,impaired,0,0
214922,hemostasis,0,1
214923,of,0,0
214924,aspirin-treated,0,0
214925,patients,0,0
214926,is,0,0
214927,an,0,0
214928,annoying,0,1
214929,problem,0,0
214930,during,0,0
214931,and,0,0
214932,after,0,0
214933,cardiopulmonary,0,1
214934,bypass,0,0
214935,.,0,0
214936,The,0,0
214937,hemostatic,1,0
214938,function,1,1
214939,of,0,0
214940,platelets,0,1
214941,comprises,0,0
214942,two,0,0
214943,mechanisms,0,0
214944,:,0,0
214945,the,0,0
214946,shear-induced,0,0
214947,and,0,0
214948,the,0,0
214949,cyclooxygenase,0,0
214950,pathways,0,0
214951,.,0,0
214952,Because,0,0
214953,the,0,0
214954,latter,0,0
214955,is,0,0
214956,inhibited,0,0
214957,in,0,0
214958,aspirin-treated,0,0
214959,patients,0,0
214960,",",0,0
214961,the,0,0
214962,hemostatic,0,0
214963,function,0,1
214964,depends,0,0
214965,mainly,0,0
214966,on,0,0
214967,the,0,0
214968,former,0,0
214969,pathway,0,0
214970,.,0,0
214971,To,0,0
214972,investigate,0,0
214973,the,0,0
214974,effect,0,0
214975,of,0,0
214976,cardiopulmonary,0,1
214977,bypass,0,0
214978,on,0,0
214979,the,0,0
214980,shear-induced,0,1
214981,pathway,0,0
214982,",",0,0
214983,a,0,0
214984,double-blind,0,0
214985,study,0,0
214986,of,0,0
214987,preoperative,0,0
214988,aspirin,0,0
214989,treatment,0,0
214990,(,0,0
214991,325,0,0
214992,mg,0,0
214993,),0,0
214994,and,0,1
214995,placebo,0,0
214996,was,0,0
214997,conducted,0,0
214998,in,0,0
214999,40,0,0
215000,patients,0,0
215001,undergoing,0,0
215002,coronary,0,0
215003,artery,0,1
215004,bypass,0,0
215005,grafting,0,0
215006,.,0,0
215007,Postoperative,1,1
215008,blood,1,1
215009,loss,1,1
215010,was,0,0
215011,higher,0,0
215012,in,0,0
215013,the,0,0
215014,aspirin-treated,0,0
215015,patients,0,0
215016,than,0,0
215017,in,0,0
215018,the,0,0
215019,placebo-treated,0,0
215020,patients,0,0
215021,(,0,0
215022,p,0,0
215023,<,0,0
215024,0.05,0,0
215025,),0,0
215026,.,0,0
215027,The,0,0
215028,shear-induced,1,1
215029,hemostasis,1,1
215030,was,0,0
215031,monitored,0,0
215032,by,0,0
215033,the,0,0
215034,in,0,0
215035,vitro,0,0
215036,bleeding,0,1
215037,test,0,1
215038,(,0,0
215039,Thrombostat,0,0
215040,),0,0
215041,",",0,0
215042,which,0,0
215043,mimics,0,0
215044,bleeding,0,1
215045,through,0,0
215046,an,0,0
215047,injured,0,0
215048,arteriole,0,1
215049,.,0,0
215050,The,0,0
215051,shear-induced,1,1
215052,pathway,1,0
215053,of,1,0
215054,aspirin-treated,1,1
215055,platelets,1,1
215056,was,0,0
215057,not,0,0
215058,affected,0,0
215059,before,0,0
215060,cardiopulmonary,0,0
215061,bypass,0,0
215062,",",0,0
215063,but,0,0
215064,it,0,0
215065,was,0,0
215066,impaired,0,0
215067,more,0,0
215068,during,0,0
215069,the,0,0
215070,operation,0,0
215071,(,0,0
215072,p,0,0
215073,<,0,0
215074,0.01,0,0
215075,),0,0
215076,and,0,0
215077,remained,0,0
215078,worse,0,1
215079,afterward,0,0
215080,(,0,0
215081,p,0,0
215082,<,0,0
215083,0.05,0,0
215084,),0,0
215085,",",0,0
215086,compared,0,0
215087,with,0,0
215088,that,0,0
215089,of,0,0
215090,placebo-treated,0,0
215091,platelets,0,1
215092,.,0,0
215093,The,0,0
215094,inhibitory,0,1
215095,effects,0,0
215096,of,0,0
215097,aspirin,0,0
215098,on,0,0
215099,thromboxane,1,1
215100,production,1,1
215101,and,1,0
215102,on,1,0
215103,collagen-induced,1,1
215104,platelet,1,1
215105,aggregation,1,1
215106,remained,0,0
215107,throughout,0,0
215108,the,0,0
215109,operation,0,0
215110,.,0,0
215111,In,0,0
215112,aspirin-treated,0,1
215113,platelets,0,1
215114,",",0,0
215115,the,0,0
215116,aggregation,1,1
215117,capacity,1,1
215118,induced,0,0
215119,by,0,0
215120,adenosine,0,0
215121,diphosphate,0,0
215122,was,0,0
215123,inhibited,0,0
215124,before,0,0
215125,the,0,0
215126,operation,0,0
215127,(,0,0
215128,p,0,0
215129,<,0,0
215130,0.05,0,0
215131,),0,0
215132,and,0,0
215133,showed,0,0
215134,substantial,0,0
215135,recovery,0,1
215136,during,0,0
215137,the,0,0
215138,operation,0,0
215139,(,0,0
215140,p,0,0
215141,<,0,0
215142,0.05,0,0
215143,),0,0
215144,.,0,0
215145,These,0,0
215146,results,0,0
215147,suggest,0,0
215148,that,0,0
215149,the,0,0
215150,shear-induced,0,1
215151,pathway,0,0
215152,of,0,0
215153,aspirin-treated,0,0
215154,platelets,0,1
215155,is,0,0
215156,more,0,0
215157,vulnerable,0,0
215158,to,0,0
215159,cardiopulmonary,0,1
215160,bypass,0,0
215161,than,0,0
215162,the,0,0
215163,pathway,0,0
215164,in,0,0
215165,normal,0,0
215166,platelets,0,1
215167,and,0,0
215168,causes,0,0
215169,severe,0,1
215170,impairment,0,1
215171,of,0,0
215172,hemostasis,0,1
215173,afterward,0,0
215174,.,0,0
215175,Why,0,0
215176,are,0,0
215177,there,0,0
215178,sometimes,0,0
215179,concreteness,1,1
215180,effects,1,1
215181,in,1,0
215182,memory,1,1
215183,for,0,0
215184,prose,0,0
215185,?,0,0
215186,Four,0,0
215187,experiments,0,0
215188,explored,0,0
215189,on-line,0,0
215190,encoding,0,1
215191,strategies,0,0
215192,and,0,1
215193,memory,0,1
215194,for,0,0
215195,high,0,0
215196,imagery,0,0
215197,and,0,0
215198,low,0,0
215199,imagery,0,0
215200,texts,0,0
215201,.,0,0
215202,Results,0,0
215203,consistently,0,0
215204,indicated,0,0
215205,that,0,0
215206,concreteness,1,1
215207,effects,1,1
215208,in,1,0
215209,memory,1,1
215210,for,1,0
215211,text,1,0
215212,depend,0,0
215213,on,0,0
215214,how,0,0
215215,materials,0,0
215216,are,0,0
215217,presented,0,0
215218,in,0,0
215219,several,0,0
215220,different,0,0
215221,respects,0,0
215222,.,0,0
215223,Most,0,0
215224,importantly,0,0
215225,",",0,0
215226,the,0,0
215227,experiments,0,0
215228,clarified,0,0
215229,apparently,0,0
215230,contradictory,0,0
215231,results,0,0
215232,of,0,0
215233,previous,0,0
215234,studies,0,0
215235,by,0,0
215236,indicating,0,0
215237,that,0,0
215238,concreteness,1,1
215239,effects,1,0
215240,generally,0,0
215241,do,0,0
215242,not,0,0
215243,occur,0,0
215244,in,0,0
215245,memory,0,1
215246,for,0,0
215247,prose,0,0
215248,when,0,0
215249,imageability,0,0
215250,is,0,0
215251,manipulated,0,0
215252,between-subjects,0,0
215253,",",0,0
215254,and,0,0
215255,that,0,0
215256,their,0,0
215257,occurrence,0,0
215258,when,0,0
215259,imageability,0,0
215260,is,0,0
215261,manipulated,0,0
215262,within-subjects,0,0
215263,depends,0,0
215264,on,0,0
215265,the,0,0
215266,order,0,0
215267,occurrence,0,1
215268,when,0,0
215269,imageability,0,0
215270,is,0,0
215271,manipulated,0,0
215272,within-subjects,0,0
215273,depends,0,0
215274,on,0,0
215275,the,0,0
215276,order,0,0
215277,of,0,0
215278,presentation,0,0
215279,.,0,0
215280,In,0,0
215281,addition,0,0
215282,",",0,0
215283,moving,0,0
215284,window,0,0
215285,analyses,0,0
215286,of,0,0
215287,text,0,0
215288,processing,0,1
215289,strategies,0,0
215290,indicated,0,0
215291,that,0,0
215292,differential,0,0
215293,strategies,0,0
215294,observed,0,0
215295,in,0,0
215296,previous,0,0
215297,studies,0,0
215298,when,0,0
215299,subjects,0,0
215300,listened,0,0
215301,to,0,0
215302,high,0,0
215303,vs,0,0
215304,low,0,0
215305,imagery,0,0
215306,text,0,0
215307,do,0,0
215308,not,0,0
215309,generalize,0,0
215310,to,0,0
215311,reading,0,0
215312,of,0,0
215313,the,0,0
215314,same,0,0
215315,materials,0,0
215316,.,0,0
215317,Potential,0,0
215318,explanations,0,0
215319,for,0,0
215320,the,0,0
215321,pattern,0,0
215322,of,0,0
215323,results,0,0
215324,are,0,0
215325,evaluated,0,0
215326,",",0,0
215327,and,0,0
215328,implications,0,0
215329,for,0,0
215330,theories,0,0
215331,of,0,0
215332,mental,0,1
215333,imagery,0,0
215334,and,0,0
215335,memory,0,1
215336,are,0,0
215337,considered,0,0
215338,.,0,0
215339,Does,0,0
215340,tetanus,0,0
215341,immune,0,1
215342,globulin,0,0
215343,interfere,0,0
215344,with,0,0
215345,the,0,0
215346,immune,1,0
215347,response,1,1
215348,to,0,0
215349,simultaneous,0,0
215350,administration,0,0
215351,of,0,0
215352,tetanus-diphtheria,0,0
215353,vaccine,0,0
215354,?,0,0
215355,A,0,0
215356,comparative,0,0
215357,clinical,0,0
215358,trial,0,0
215359,in,0,0
215360,adults,0,0
215361,.,0,0
215362,In,0,0
215363,the,0,0
215364,management,0,0
215365,of,0,0
215366,wounds,0,1
215367,",",0,0
215368,sometimes,0,0
215369,it,0,0
215370,is,0,0
215371,recommended,0,0
215372,to,0,0
215373,give,0,0
215374,an,0,0
215375,adult-type,0,0
215376,tetanus-diphtheria,0,0
215377,(,0,0
215378,Td,0,1
215379,),0,0
215380,vaccine,0,0
215381,dose,0,0
215382,plus,0,0
215383,tetanus,0,0
215384,immune,0,1
215385,globulin,0,1
215386,(,0,0
215387,TIG,0,1
215388,),0,0
215389,.,0,0
215390,Sixty,0,0
215391,and,0,0
215392,59,0,0
215393,healthy,0,0
215394,young,0,0
215395,adults,0,0
215396,previously,0,0
215397,immunized,0,0
215398,against,0,0
215399,tetanus,0,0
215400,(,0,0
215401,T,0,1
215402,),0,1
215403,and,0,1
215404,diphtheria,0,0
215405,(,0,1
215406,D,0,1
215407,),0,0
215408,were,0,0
215409,randomized,0,0
215410,to,0,0
215411,receive,0,0
215412,intramuscularly,0,0
215413,either,0,0
215414,Td,0,1
215415,vaccine,0,0
215416,alone,0,0
215417,(,0,0
215418,group,0,0
215419,1,0,0
215420,),0,0
215421,or,0,0
215422,Td,0,1
215423,vaccine,0,0
215424,plus,0,0
215425,500,0,0
215426,IU,0,0
215427,of,0,0
215428,TIG,0,1
215429,(,0,0
215430,group,0,0
215431,2,0,0
215432,),0,0
215433,simultaneously,0,0
215434,.,0,0
215435,Antitoxin,1,0
215436,response,1,1
215437,was,0,0
215438,assessed,0,0
215439,after,0,0
215440,4,0,0
215441,weeks,0,0
215442,and,0,0
215443,4,0,0
215444,months,0,0
215445,.,0,0
215446,Circulating,1,0
215447,antibodies,1,0
215448,were,1,0
215449,measured,1,0
215450,by,1,0
215451,enzyme-linked,1,0
215452,immunosorbent,1,0
215453,assay,1,0
215454,(,1,0
215455,ELISA,1,0
215456,),1,0
215457,.,1,0
215458,The,0,0
215459,cutoff,0,0
215460,of,0,0
215461,these,0,0
215462,tests,0,0
215463,was,0,0
215464,0.1,0,0
215465,IU/mL,0,0
215466,.,0,0
215467,Titers,0,0
215468,of,0,0
215469,0.1,0,0
215470,IU/mL,0,0
215471,or,0,0
215472,greater,0,0
215473,were,0,0
215474,considered,0,0
215475,protective,0,0
215476,.,0,0
215477,For,0,0
215478,geometric,0,0
215479,mean,0,1
215480,titers,0,1
215481,(,0,0
215482,GMT,0,1
215483,),0,0
215484,",",0,0
215485,antibody,1,1
215486,titers,1,1
215487,below,0,0
215488,the,0,0
215489,cutoff,0,0
215490,of,0,0
215491,the,0,0
215492,assay,0,0
215493,were,0,0
215494,given,0,0
215495,",",0,0
215496,arbitrarily,0,0
215497,",",0,0
215498,0.05,0,0
215499,IU/mL,0,0
215500,.,0,0
215501,At,0,0
215502,4,0,0
215503,weeks,0,0
215504,",",0,0
215505,98,0,0
215506,%,0,0
215507,or,0,0
215508,more,0,0
215509,of,0,0
215510,the,0,0
215511,subjects,0,0
215512,in,0,0
215513,group,0,0
215514,1,0,0
215515,had,0,0
215516,circulating,1,0
215517,T,1,1
215518,and,1,1
215519,D,1,1
215520,antitoxin,1,1
215521,levels,1,1
215522,of,0,0
215523,0.1,0,0
215524,IU/mL,0,0
215525,or,0,0
215526,higher,0,0
215527,;,0,0
215528,in,0,0
215529,group,0,0
215530,2,0,0
215531,",",0,0
215532,95,0,0
215533,%,0,0
215534,and,0,0
215535,90,0,0
215536,%,0,0
215537,of,0,0
215538,the,0,0
215539,subjects,0,0
215540,had,0,0
215541,titers,0,1
215542,above,0,0
215543,this,0,0
215544,limit,0,0
215545,for,0,0
215546,T,0,0
215547,and,0,1
215548,D,0,1
215549,",",0,0
215550,respectively,0,0
215551,.,0,0
215552,At,0,0
215553,4,0,0
215554,months,0,0
215555,",",0,0
215556,these,0,0
215557,percentages,0,0
215558,were,0,0
215559,98,0,0
215560,%,0,0
215561,and,0,0
215562,95,0,0
215563,%,0,0
215564,for,0,0
215565,T,1,0
215566,antitoxin,1,1
215567,levels,1,1
215568,in,0,0
215569,groups,0,0
215570,1,0,0
215571,and,0,0
215572,2,0,0
215573,",",0,0
215574,respectively,0,0
215575,;,0,0
215576,whereas,0,0
215577,96,0,0
215578,%,0,0
215579,and,0,0
215580,88,0,0
215581,%,0,0
215582,of,0,0
215583,the,0,0
215584,subjects,0,0
215585,in,0,0
215586,groups,0,0
215587,1,0,0
215588,and,0,0
215589,2,0,0
215590,had,0,0
215591,D,1,0
215592,antitoxin,1,1
215593,levels,1,1
215594,of,0,0
215595,0.1,0,0
215596,IU/mL,0,0
215597,or,0,0
215598,higher,0,0
215599,",",0,0
215600,respectively,0,0
215601,.,0,0
215602,Significantly,0,0
215603,(,0,0
215604,P,0,0
215605,<,0,0
215606,.05,0,0
215607,),0,0
215608,higher,0,0
215609,GMTs,0,1
215610,were,0,0
215611,seen,0,0
215612,at,0,0
215613,the,0,0
215614,4-week,0,0
215615,assessment,0,0
215616,(,0,0
215617,but,0,0
215618,not,0,0
215619,at,0,0
215620,4,0,0
215621,months,0,0
215622,),0,0
215623,in,0,0
215624,group,0,0
215625,1,0,0
215626,",",0,0
215627,as,0,0
215628,compared,0,0
215629,with,0,0
215630,group,0,0
215631,2,0,0
215632,",",0,0
215633,in,0,0
215634,both,0,0
215635,T,0,0
215636,and,0,0
215637,D,0,1
215638,antitoxin,0,1
215639,levels,0,1
215640,(,0,0
215641,9.91,0,0
215642,IU/mL,0,0
215643,versus,0,0
215644,5.60,0,0
215645,IU/mL,0,0
215646,for,0,0
215647,T,0,1
215648,antitoxin,0,1
215649,",",0,0
215650,and,0,0
215651,2.86,0,0
215652,IU/mL,0,0
215653,versus,0,0
215654,1.45,0,0
215655,IU/mL,0,0
215656,for,0,0
215657,D,0,1
215658,antitoxin,0,1
215659,),0,0
215660,.,0,0
215661,This,0,0
215662,finding,0,0
215663,resulted,0,0
215664,from,0,0
215665,those,0,0
215666,participants,0,0
215667,with,0,0
215668,low,0,0
215669,(,0,0
215670,<,0,0
215671,0.1,0,0
215672,IU/mL,0,0
215673,),0,0
215674,prevaccination,0,0
215675,antibody,0,0
215676,titers,0,1
215677,.,0,0
215678,(,0,0
215679,ABSTRACT,0,1
215680,TRUNCATED,0,0
215681,AT,0,0
215682,250,0,0
215683,WORDS,0,0
215684,),0,0
215685,[,0,0
215686,Late,0,0
215687,cardiac,1,1
215688,toxicity,1,1
215689,in,0,0
215690,Hodgkin,0,1
215691,'s,0,0
215692,disease,0,0
215693,.,0,0
215694,A,0,0
215695,study,0,0
215696,with,0,0
215697,pulsed,0,0
215698,Doppler,0,1
215699,echocardiography,0,1
215700,],0,0
215701,.,0,0
215702,49,0,0
215703,patients,0,0
215704,(,0,0
215705,22,0,0
215706,women,0,0
215707,",",0,0
215708,27,0,0
215709,men,0,0
215710,",",0,0
215711,mean,0,1
215712,age,0,0
215713,43.7,0,0
215714,[,0,0
215715,21-65,0,0
215716,],0,0
215717,years,0,0
215718,),0,0
215719,with,0,0
215720,Hodgkin,0,1
215721,'s,0,0
215722,disease,0,1
215723,were,0,0
215724,examined,0,0
215725,by,0,0
215726,Doppler,0,0
215727,echocardiography,0,0
215728,a,0,0
215729,median,0,0
215730,of,0,0
215731,5.37,0,0
215732,(,0,0
215733,2-10,0,0
215734,),0,0
215735,years,0,0
215736,after,0,0
215737,the,0,0
215738,end,0,0
215739,of,0,0
215740,chemotherapy,0,0
215741,(,0,0
215742,given,0,0
215743,according,0,0
215744,to,0,0
215745,the,0,0
215746,COPP/ABVD,0,1
215747,scheme,0,0
215748,",",0,0
215749,with,0,0
215750,or,0,0
215751,without,0,0
215752,mediastinal,0,1
215753,irradiation,0,0
215754,),0,0
215755,for,0,0
215756,possible,0,0
215757,chronic,1,0
215758,changes,1,1
215759,in,1,0
215760,myocardium,1,1
215761,",",1,0
215762,pericardium,1,1
215763,or,1,1
215764,cardiac,1,1
215765,valves,1,0
215766,",",0,0
215767,as,0,0
215768,well,0,0
215769,as,0,0
215770,for,0,0
215771,any,0,0
215772,haemodynamic,1,1
215773,sequelae,1,1
215774,.,1,0
215775,Maximal,1,1
215776,and,1,0
215777,integrated,1,0
215778,early,1,0
215779,(,1,0
215780,E,1,0
215781,",",1,0
215782,Ei,1,1
215783,),1,1
215784,and,0,0
215785,late,1,1
215786,(,1,0
215787,A,1,0
215788,",",1,0
215789,Ai,1,1
215790,),1,1
215791,diastolic,1,1
215792,flow,1,1
215793,velocities,1,1
215794,and,1,0
215795,their,1,0
215796,ratio,1,1
215797,(,1,0
215798,E/A,1,1
215799,",",1,0
215800,Ei/Ai,1,1
215801,),1,0
215802,were,0,0
215803,measured,0,0
215804,by,0,0
215805,pulsed,0,0
215806,Doppler,0,0
215807,over,0,0
215808,the,0,0
215809,mitral,0,1
215810,and,0,0
215811,tricuspid,0,1
215812,valves,0,0
215813,.,0,0
215814,Although,0,0
215815,on,0,0
215816,two-dimensional,0,0
215817,echo,0,0
215818,21,0,0
215819,patients,0,0
215820,(,0,0
215821,42.9,0,0
215822,%,0,0
215823,),0,0
215824,were,0,0
215825,found,0,0
215826,to,0,0
215827,have,0,0
215828,valvar,1,1
215829,thickening,1,1
215830,",",0,0
215831,19,0,0
215832,(,0,0
215833,38.8,0,0
215834,%,0,0
215835,),0,0
215836,pericardial,1,1
215837,thickening,1,1
215838,and,0,0
215839,9,0,0
215840,(,0,0
215841,18.4,0,0
215842,%,0,0
215843,),0,0
215844,a,0,0
215845,reduced,1,0
215846,fibre,1,0
215847,shortening,1,1
215848,fraction,1,1
215849,",",1,0
215850,the,1,0
215851,Doppler,1,1
215852,indices,1,1
215853,were,0,0
215854,statistically,0,0
215855,not,0,0
215856,significantly,0,0
215857,different,0,0
215858,from,0,0
215859,those,0,0
215860,in,0,0
215861,25,0,0
215862,controls,0,0
215863,with,0,0
215864,normal,0,0
215865,hearts,0,0
215866,.,0,0
215867,These,0,0
215868,echocardiographic,0,0
215869,data,0,0
215870,of,0,0
215871,functional,1,0
215872,and,1,0
215873,morphological,1,0
215874,parameters,1,1
215875,indicate,0,0
215876,that,0,0
215877,there,0,0
215878,was,0,0
215879,no,0,0
215880,effect,0,0
215881,on,0,0
215882,various,0,0
215883,measurements,1,0
215884,of,1,0
215885,diastolic,1,1
215886,function,1,1
215887,after,0,0
215888,chemotherapy,0,0
215889,with,0,0
215890,or,0,0
215891,without,0,0
215892,mediastinal,0,1
215893,radiation,0,0
215894,.,0,0
215895,In,0,0
215896,successfully,0,0
215897,treated,0,0
215898,patients,0,0
215899,with,0,0
215900,Hodgkin,0,1
215901,'s,0,0
215902,disease,0,0
215903,the,0,0
215904,described,0,0
215905,changes,0,0
215906,are,0,0
215907,of,0,0
215908,minor,0,0
215909,significance,0,0
215910,.,0,0
215911,Prophylactic,0,0
215912,cranial,0,0
215913,irradiation,0,0
215914,for,0,0
215915,patients,0,0
215916,with,0,0
215917,small-cell,0,0
215918,lung,0,0
215919,cancer,0,0
215920,in,0,0
215921,complete,0,1
215922,remission,0,1
215923,.,0,0
215924,BACKGROUND,0,0
215925,Prophylactic,0,0
215926,cranial,0,0
215927,irradiation,0,0
215928,in,0,0
215929,patients,0,0
215930,with,0,0
215931,small-cell,0,0
215932,lung,0,0
215933,cancer,0,0
215934,decreases,0,0
215935,the,0,0
215936,overall,0,1
215937,rate,1,1
215938,of,1,0
215939,brain,1,1
215940,metastases,1,0
215941,without,0,0
215942,an,0,0
215943,effect,0,0
215944,on,0,0
215945,overall,1,1
215946,survival,1,1
215947,.,1,0
215948,It,0,0
215949,has,0,0
215950,been,0,0
215951,suggested,0,0
215952,that,0,0
215953,this,0,0
215954,treatment,0,0
215955,may,0,0
215956,increase,0,0
215957,neuropsychological,1,0
215958,syndromes,1,0
215959,and,1,1
215960,brain,1,1
215961,abnormalities,1,1
215962,indicated,0,0
215963,by,0,0
215964,computed,0,0
215965,tomography,0,0
215966,scans,0,0
215967,.,0,0
215968,However,0,0
215969,",",0,0
215970,other,0,0
215971,retrospective,0,0
215972,data,0,0
215973,suggested,0,0
215974,a,0,0
215975,beneficial,0,0
215976,effect,0,0
215977,on,0,0
215978,overall,0,1
215979,survival,0,1
215980,for,0,0
215981,patients,0,0
215982,in,0,0
215983,complete,0,0
215984,remission,0,1
215985,.,0,0
215986,PURPOSE,0,0
215987,Our,0,0
215988,purpose,0,0
215989,was,0,0
215990,to,0,0
215991,evaluate,0,0
215992,the,0,0
215993,effects,0,0
215994,of,0,0
215995,prophylactic,0,0
215996,cranial,0,0
215997,irradiation,0,0
215998,on,0,0
215999,brain,1,1
216000,metastasis,1,1
216001,",",1,0
216002,overall,1,1
216003,survival,1,1
216004,",",0,0
216005,and,0,1
216006,late-occurring,1,1
216007,toxic,1,1
216008,effects,1,1
216009,in,0,0
216010,patients,0,0
216011,with,0,0
216012,small-cell,0,0
216013,lung,0,0
216014,cancer,0,0
216015,in,0,0
216016,complete,0,1
216017,remission,0,1
216018,.,0,0
216019,METHODS,0,0
216020,We,0,0
216021,conducted,0,0
216022,a,0,0
216023,prospective,0,0
216024,study,0,0
216025,of,0,0
216026,300,0,0
216027,patients,0,0
216028,who,0,0
216029,had,0,0
216030,small-cell,0,0
216031,lung,0,1
216032,cancer,0,0
216033,that,0,0
216034,was,0,0
216035,in,0,0
216036,complete,0,1
216037,remission,0,1
216038,.,0,0
216039,The,0,0
216040,patients,0,0
216041,were,0,0
216042,randomly,0,0
216043,assigned,0,0
216044,to,0,0
216045,receive,0,0
216046,either,0,0
216047,prophylactic,0,0
216048,cranial,0,0
216049,irradiation,0,0
216050,delivering,0,0
216051,24,0,0
216052,Gy,0,0
216053,in,0,0
216054,eight,0,0
216055,fractions,0,0
216056,during,0,0
216057,12,0,0
216058,days,0,0
216059,(,0,0
216060,treatment,0,0
216061,group,0,0
216062,),0,0
216063,or,0,0
216064,no,0,0
216065,prophylactic,0,0
216066,cranial,0,0
216067,irradiation,0,0
216068,(,0,0
216069,control,0,0
216070,group,0,0
216071,),0,0
216072,.,0,0
216073,A,0,0
216074,neuropsychological,0,0
216075,examination,0,0
216076,and,0,0
216077,a,0,0
216078,computed,0,0
216079,tomography,0,0
216080,scan,0,0
216081,of,0,0
216082,the,0,0
216083,brain,0,0
216084,were,0,0
216085,performed,0,0
216086,at,0,0
216087,the,0,0
216088,time,0,1
216089,of,0,0
216090,random,0,0
216091,assignment,0,0
216092,and,0,0
216093,repeatedly,0,0
216094,assessed,0,0
216095,at,0,0
216096,6,0,0
216097,",",0,0
216098,18,0,0
216099,",",0,0
216100,30,0,0
216101,",",0,0
216102,and,0,0
216103,48,0,0
216104,months,0,0
216105,.,0,0
216106,Patterns,0,0
216107,of,0,0
216108,failure,0,1
216109,were,0,0
216110,analyzed,0,0
216111,according,0,0
216112,to,0,0
216113,total,0,1
216114,event,0,1
216115,rates,0,1
216116,and,0,0
216117,also,0,0
216118,according,0,0
216119,to,0,0
216120,an,0,0
216121,isolated,0,0
216122,first,0,0
216123,site,0,0
216124,of,0,0
216125,relapse,0,1
216126,",",0,0
216127,using,0,0
216128,a,0,0
216129,competing-risk,0,0
216130,approach,0,0
216131,.,0,0
216132,RESULTS,0,0
216133,Two,0,0
216134,hundred,0,0
216135,ninety-four,0,0
216136,patients,0,0
216137,who,0,0
216138,did,0,0
216139,not,0,0
216140,have,0,0
216141,brain,0,1
216142,metastases,0,0
216143,at,0,0
216144,the,0,0
216145,time,0,1
216146,of,0,0
216147,random,0,0
216148,assignment,0,0
216149,were,0,0
216150,analyzed,0,0
216151,.,0,0
216152,The,0,0
216153,2-year,1,0
216154,cumulative,1,1
216155,rate,1,1
216156,of,1,0
216157,brain,1,1
216158,metastasis,1,1
216159,as,0,0
216160,an,0,0
216161,isolated,0,0
216162,first,0,0
216163,site,0,0
216164,of,0,0
216165,relapse,1,1
216166,was,0,0
216167,45,0,0
216168,%,0,0
216169,in,0,0
216170,the,0,0
216171,control,0,0
216172,group,0,0
216173,and,0,0
216174,19,0,0
216175,%,0,0
216176,in,0,0
216177,the,0,0
216178,treatment,0,0
216179,group,0,0
216180,(,0,0
216181,P,0,0
216182,<,0,0
216183,10,0,0
216184,(,0,0
216185,-6,0,0
216186,),0,0
216187,),0,0
216188,.,0,0
216189,The,0,0
216190,total,1,1
216191,2-year,1,0
216192,rate,1,1
216193,of,1,0
216194,brain,1,1
216195,metastasis,1,1
216196,was,0,0
216197,67,0,0
216198,%,0,0
216199,and,0,0
216200,40,0,0
216201,%,0,0
216202,",",0,0
216203,respectively,0,0
216204,(,0,0
216205,relative,0,1
216206,risk,0,1
216207,=,0,0
216208,0.35,0,0
216209,;,0,0
216210,P,0,0
216211,<,0,0
216212,10,0,0
216213,(,0,0
216214,-13,0,0
216215,),0,0
216216,),0,0
216217,.,0,0
216218,The,0,0
216219,2-year,1,0
216220,overall,1,1
216221,survival,1,1
216222,rate,1,1
216223,was,0,0
216224,21.5,0,0
216225,%,0,0
216226,in,0,0
216227,the,0,0
216228,control,0,0
216229,group,0,0
216230,and,0,0
216231,29,0,0
216232,%,0,0
216233,in,0,0
216234,the,0,0
216235,treatment,0,0
216236,group,0,0
216237,(,0,0
216238,relative,0,1
216239,risk,0,1
216240,=,0,0
216241,0.83,0,0
216242,;,0,0
216243,P,0,0
216244,=,0,0
216245,.14,0,0
216246,),0,0
216247,.,0,0
216248,There,0,0
216249,were,0,0
216250,no,0,0
216251,significant,0,0
216252,differences,0,0
216253,between,0,0
216254,the,0,0
216255,two,0,0
216256,groups,0,0
216257,in,0,0
216258,terms,0,0
216259,of,0,0
216260,neuropsychological,1,0
216261,function,1,1
216262,or,1,0
216263,abnormalities,1,1
216264,indicated,0,0
216265,by,0,0
216266,computed,0,0
216267,tomography,0,0
216268,brain,0,1
216269,scans,0,0
216270,.,0,0
216271,CONCLUSIONS,0,0
216272,Prophylactic,0,0
216273,cranial,0,0
216274,irradiation,0,0
216275,given,0,0
216276,to,0,0
216277,patients,0,0
216278,with,0,0
216279,small-cell,0,0
216280,lung,0,0
216281,cancer,0,0
216282,in,0,0
216283,complete,0,0
216284,remission,0,0
216285,decreases,0,0
216286,the,0,0
216287,risk,0,0
216288,of,0,0
216289,brain,0,1
216290,metastasis,0,1
216291,threefold,0,0
216292,without,0,0
216293,a,0,0
216294,significant,0,0
216295,increase,0,0
216296,in,0,0
216297,complications,0,1
216298,.,0,0
216299,A,0,0
216300,possible,0,0
216301,beneficial,0,0
216302,effect,0,0
216303,on,0,0
216304,overall,0,1
216305,survival,0,1
216306,should,0,0
216307,be,0,0
216308,tested,0,0
216309,with,0,0
216310,a,0,0
216311,higher,0,0
216312,statistical,0,0
216313,power,0,0
216314,.,0,0
216315,IMPLICATIONS,0,0
216316,The,0,0
216317,results,0,0
216318,of,0,0
216319,the,0,0
216320,trial,0,0
216321,favor,0,0
216322,",",0,0
216323,at,0,0
216324,present,0,0
216325,",",0,0
216326,the,0,0
216327,indication,0,0
216328,of,0,0
216329,prophylactic,0,0
216330,cranial,0,0
216331,irradiation,0,0
216332,for,0,0
216333,patients,0,0
216334,who,0,0
216335,are,0,0
216336,in,0,0
216337,complete,0,0
216338,remission,0,1
216339,.,0,0
216340,A,0,0
216341,longer,0,0
216342,follow-up,0,1
216343,and,0,1
216344,confirmatory,0,0
216345,trials,0,0
216346,are,0,0
216347,needed,0,0
216348,to,0,0
216349,fully,0,0
216350,assess,0,0
216351,late-occurring,0,0
216352,toxic,0,1
216353,effects,0,0
216354,.,0,0
216355,The,0,0
216356,possible,0,0
216357,effect,0,0
216358,on,0,0
216359,overall,1,1
216360,survival,1,1
216361,needs,0,0
216362,to,0,0
216363,be,0,0
216364,evaluated,0,0
216365,with,0,0
216366,a,0,0
216367,larger,0,0
216368,number,0,1
216369,of,0,1
216370,patients,0,0
216371,in,0,0
216372,complete,0,1
216373,remission,0,1
216374,",",0,0
216375,and,0,0
216376,a,0,0
216377,meta-analysis,0,0
216378,of,0,0
216379,similar,0,0
216380,trials,0,0
216381,is,0,0
216382,recommended,0,0
216383,.,0,0
216384,Effects,0,0
216385,of,0,0
216386,the,0,0
216387,cholinomimetic,0,0
216388,SDZ,0,0
216389,ENS-163,0,0
216390,on,0,0
216391,scopolamine-induced,0,0
216392,cognitive,1,1
216393,impairment,1,1
216394,in,0,0
216395,humans,0,0
216396,.,0,0
216397,Scopolamine-induced,0,0
216398,cognitive,0,1
216399,impairment,0,1
216400,was,0,0
216401,used,0,0
216402,in,0,0
216403,healthy,0,0
216404,men,0,0
216405,to,0,0
216406,evaluate,0,0
216407,the,0,0
216408,central,0,0
216409,nervous,0,0
216410,system,0,0
216411,activity,0,1
216412,of,0,0
216413,the,0,0
216414,new,0,0
216415,cholinomimetic,0,1
216416,SDZ,0,0
216417,ENS-163,0,0
216418,.,0,0
216419,Eighteen,0,0
216420,subjects,0,0
216421,were,0,0
216422,treated,0,0
216423,in,0,0
216424,a,0,0
216425,crossover,0,0
216426,design,0,0
216427,with,0,0
216428,oral,0,0
216429,placebo/intravenous,0,0
216430,saline,0,0
216431,",",0,0
216432,50,0,0
216433,mg,0,0
216434,of,0,0
216435,oral,0,0
216436,SDZ,0,0
216437,ENS-163/intravenous,0,0
216438,saline,0,0
216439,",",0,0
216440,oral,0,0
216441,placebo/0.4,0,0
216442,mg,0,0
216443,of,0,0
216444,intravenous,0,0
216445,scopolamine,0,0
216446,",",0,0
216447,and,0,0
216448,50,0,0
216449,mg,0,0
216450,of,0,0
216451,oral,0,0
216452,SDZ,0,0
216453,ENS-163/0.4,0,0
216454,mg,0,0
216455,of,0,0
216456,intravenous,0,0
216457,scopolamine,0,0
216458,.,0,0
216459,The,0,0
216460,administration,0,0
216461,of,0,0
216462,placebo,0,0
216463,with,0,0
216464,scopolamine,0,0
216465,caused,0,0
216466,significant,1,0
216467,cognitive,1,1
216468,impairment,1,1
216469,",",0,0
216470,as,0,0
216471,assessed,0,0
216472,by,0,0
216473,the,0,0
216474,Computerized,1,0
216475,Neuropsychological,1,0
216476,Test,1,1
216477,Battery,1,1
216478,(,1,0
216479,CNTB,1,0
216480,),1,1
216481,",",0,0
216482,and,0,0
216483,also,0,0
216484,decreased,1,0
216485,salivation,1,1
216486,and,1,0
216487,heart,1,1
216488,rate,1,1
216489,.,1,0
216490,In,0,0
216491,contrast,0,0
216492,",",0,0
216493,SDZ,0,1
216494,ENS-163,0,0
216495,with,0,0
216496,saline,0,0
216497,had,0,0
216498,no,0,0
216499,effect,1,0
216500,on,1,0
216501,CNTB,1,0
216502,scores,1,1
216503,",",1,0
216504,increased,1,1
216505,salivation,1,1
216506,",",1,0
216507,and,1,1
216508,increased,1,1
216509,heart,1,1
216510,rate,1,1
216511,.,1,0
216512,Despite,0,0
216513,the,0,0
216514,observed,0,0
216515,cholinomimetic,1,1
216516,effects,1,0
216517,of,0,0
216518,SDZ,0,0
216519,ENS-163,0,0
216520,when,0,0
216521,administered,0,0
216522,with,0,0
216523,saline,0,0
216524,",",0,0
216525,the,0,0
216526,changes,1,1
216527,in,1,0
216528,CNTB,1,0
216529,scores,1,1
216530,",",1,0
216531,heart,1,1
216532,rate,1,1
216533,",",1,1
216534,and,1,1
216535,salivation,1,1
216536,were,0,0
216537,indistinguishable,0,0
216538,between,0,0
216539,placebo/scopolamine,0,0
216540,and,0,0
216541,SDZ,0,1
216542,ENS-163/scopolamine,0,0
216543,.,0,0
216544,Thus,0,0
216545,",",0,0
216546,50,0,0
216547,mg,0,0
216548,of,0,0
216549,oral,0,0
216550,SDZ,0,0
216551,ENS-163,0,0
216552,has,0,0
216553,cholinomimetic,1,1
216554,activity,1,1
216555,in,0,0
216556,normal,0,0
216557,men,0,0
216558,",",0,0
216559,but,0,0
216560,this,0,0
216561,dose,0,0
216562,is,0,0
216563,insufficient,0,0
216564,to,0,0
216565,reverse,0,0
216566,the,0,0
216567,muscarinic,1,0
216568,effects,1,0
216569,of,0,0
216570,0.4,0,0
216571,mg,0,0
216572,of,0,0
216573,intravenous,0,0
216574,scopolamine,0,0
216575,.,0,0
216576,Dose-related,0,1
216577,difference,0,0
216578,in,0,0
216579,progression,0,1
216580,rates,0,1
216581,of,0,0
216582,cytomegalovirus,0,1
216583,retinopathy,0,1
216584,during,0,0
216585,foscarnet,0,0
216586,maintenance,0,0
216587,therapy,0,0
216588,.,0,0
216589,AIDS,0,0
216590,Clinical,0,1
216591,Trials,0,1
216592,Group,0,0
216593,Protocol,0,0
216594,915,0,0
216595,Team,0,0
216596,.,0,0
216597,PURPOSE,0,0
216598,A,0,0
216599,previous,0,0
216600,dose-ranging,0,0
216601,study,0,0
216602,of,0,0
216603,foscarnet,0,0
216604,maintenance,0,0
216605,therapy,0,0
216606,for,0,0
216607,cytomegalovirus,0,1
216608,retinopathy,0,1
216609,showed,0,0
216610,a,0,0
216611,positive,0,0
216612,relationship,0,0
216613,between,0,0
216614,dose,0,0
216615,and,0,1
216616,survival,0,1
216617,but,0,0
216618,could,0,0
216619,not,0,0
216620,confirm,0,0
216621,a,0,0
216622,relationship,0,0
216623,between,0,0
216624,dose,0,0
216625,and,0,0
216626,time,0,1
216627,to,0,0
216628,first,0,0
216629,progression,0,1
216630,.,0,0
216631,This,0,0
216632,retrospective,0,0
216633,analysis,0,0
216634,of,0,0
216635,data,0,0
216636,from,0,0
216637,that,0,0
216638,study,0,0
216639,was,0,0
216640,undertaken,0,0
216641,to,0,0
216642,determine,0,0
216643,whether,0,0
216644,there,0,0
216645,was,0,0
216646,a,0,0
216647,relationship,0,0
216648,between,0,0
216649,dose,0,0
216650,and,0,1
216651,progression,0,1
216652,rates,0,1
216653,",",0,0
216654,which,0,0
216655,reflects,0,0
216656,the,0,0
216657,amount,0,0
216658,of,0,0
216659,retina,0,0
216660,destroyed,0,0
216661,when,0,0
216662,progression,0,0
216663,occurs,0,0
216664,.,0,0
216665,METHODS,0,0
216666,Patients,0,0
216667,were,0,0
216668,randomly,0,0
216669,given,0,0
216670,one,0,0
216671,of,0,0
216672,two,0,0
216673,foscarnet,0,0
216674,maintenance,0,0
216675,therapy,0,0
216676,doses,0,0
216677,(,0,0
216678,90,0,0
216679,mg/kg,0,0
216680,of,0,0
216681,body,0,1
216682,weight/day,0,0
216683,[,0,0
216684,FOS-90,0,1
216685,group,0,0
216686,],0,0
216687,or,0,0
216688,120,0,0
216689,mg/kg,0,0
216690,of,0,0
216691,body,0,1
216692,weight/day,0,0
216693,[,0,0
216694,FOS-120,0,0
216695,group,0,0
216696,],0,0
216697,after,0,0
216698,induction,0,0
216699,therapy,0,0
216700,.,0,0
216701,Using,0,0
216702,baseline,0,0
216703,and,0,0
216704,follow-up,0,1
216705,photographs,0,1
216706,and,0,0
216707,pre-established,0,1
216708,definitions,0,1
216709,and,0,0
216710,methodology,0,0
216711,in,0,0
216712,a,0,0
216713,masked,0,0
216714,analysis,0,0
216715,",",0,0
216716,posterior,0,0
216717,progression,0,1
216718,rates,0,1
216719,and,0,1
216720,foveal,0,1
216721,proximity,0,1
216722,rates,0,1
216723,for,0,0
216724,individual,0,0
216725,lesions,0,1
216726,",",0,0
216727,selected,0,0
216728,by,0,0
216729,prospectively,0,0
216730,defined,0,0
216731,criteria,0,0
216732,",",0,0
216733,were,0,0
216734,calculated,0,0
216735,in,0,0
216736,each,0,0
216737,patient,0,0
216738,.,0,0
216739,Rates,0,0
216740,were,0,0
216741,compared,0,0
216742,between,0,0
216743,groups,0,0
216744,.,0,0
216745,RESULTS,0,0
216746,The,0,0
216747,following,0,0
216748,median,1,0
216749,rates,1,1
216750,were,0,0
216751,greater,0,0
216752,for,0,0
216753,the,0,0
216754,FOS-90,0,0
216755,group,0,0
216756,(,0,0
216757,N,0,0
216758,=,0,0
216759,8,0,0
216760,),0,0
216761,than,0,0
216762,for,0,0
216763,the,0,0
216764,FOS-120,0,0
216765,group,0,0
216766,(,0,0
216767,N,0,0
216768,=,0,0
216769,10,0,0
216770,),0,0
216771,:,0,0
216772,greatest,1,0
216773,maximum,1,1
216774,rate,1,1
216775,at,1,0
216776,which,1,0
216777,lesions,1,1
216778,enlarged,0,0
216779,in,0,0
216780,a,0,0
216781,posterior,0,0
216782,direction,0,0
216783,(,0,0
216784,43.5,0,0
216785,vs,0,0
216786,12.5,0,0
216787,microns/day,0,0
216788,;,0,0
216789,P,0,0
216790,=,0,0
216791,.002,0,0
216792,),0,0
216793,;,0,0
216794,posterior,1,0
216795,progression,1,1
216796,rate,1,1
216797,for,1,0
216798,lesions,1,0
216799,closest,1,0
216800,to,1,0
216801,the,1,0
216802,fovea,1,1
216803,(,0,0
216804,42.8,0,0
216805,vs,0,0
216806,5.5,0,0
216807,microns/day,0,0
216808,;,0,0
216809,P,0,0
216810,=,0,0
216811,.010,0,0
216812,),0,0
216813,;,0,0
216814,and,0,0
216815,maximum,1,1
216816,foveal,1,1
216817,proximity,1,1
216818,rate,1,1
216819,for,1,0
216820,either,1,0
216821,eye,1,0
216822,(,0,0
216823,32.3,0,0
216824,vs,0,0
216825,3.4,0,0
216826,microns/day,0,0
216827,;,0,0
216828,P,0,0
216829,=,0,0
216830,.031,0,0
216831,),0,0
216832,.,0,0
216833,CONCLUSION,0,0
216834,Patients,0,0
216835,receiving,0,0
216836,higher,0,0
216837,doses,0,0
216838,of,0,0
216839,foscarnet,0,0
216840,have,0,0
216841,slower,0,0
216842,rates,0,1
216843,of,0,0
216844,progression,0,1
216845,and,0,0
216846,therefore,0,0
216847,less,0,0
216848,retinal,0,1
216849,tissue,0,1
216850,damage,0,1
216851,during,0,0
216852,maintenance,0,0
216853,therapy,0,0
216854,.,0,0
216855,A,0,0
216856,foscarnet,0,0
216857,maintenance,0,0
216858,therapy,0,0
216859,dose,0,0
216860,of,0,0
216861,120,0,0
216862,mg/kg,0,0
216863,of,0,0
216864,body,0,1
216865,weight/day,0,0
216866,instead,0,0
216867,of,0,0
216868,90,0,0
216869,mg/kg,0,0
216870,of,0,0
216871,body,0,1
216872,weight/day,0,0
216873,may,0,0
216874,help,0,0
216875,to,0,0
216876,preserve,0,0
216877,vision,0,1
216878,in,0,0
216879,patients,0,0
216880,with,0,0
216881,cytomegalovirus,0,1
216882,retinopathy,0,1
216883,.,0,0
216884,The,0,0
216885,effect,0,0
216886,of,0,0
216887,fasting,0,0
216888,on,0,0
216889,total,1,1
216890,serum,1,1
216891,bilirubin,1,1
216892,concentrations,1,1
216893,.,1,0
216894,Thirty-seven,0,0
216895,healthy,0,0
216896,volunteers,0,0
216897,",",0,0
216898,19,0,0
216899,of,0,0
216900,whom,0,0
216901,had,0,0
216902,consistently,0,0
216903,elevated,0,0
216904,total,1,1
216905,serum,1,1
216906,bilirubin,1,1
216907,(,1,0
216908,TSB,1,1
216909,),1,0
216910,concentrations,1,1
216911,",",0,0
216912,took,0,0
216913,part,0,0
216914,in,0,0
216915,an,0,0
216916,open,0,0
216917,",",0,0
216918,randomised,0,0
216919,cross-over,0,0
216920,study,0,0
216921,to,0,0
216922,determine,0,0
216923,the,0,0
216924,effect,0,0
216925,of,0,0
216926,fasting,0,0
216927,on,0,0
216928,TSB,0,0
216929,concentrations,0,1
216930,.,0,0
216931,The,0,0
216932,study,0,0
216933,comprised,0,0
216934,of,0,0
216935,two,0,0
216936,treatments,0,0
216937,.,0,0
216938,During,0,0
216939,one,0,0
216940,treatment,0,0
216941,period,0,0
216942,volunteers,0,0
216943,ate,0,0
216944,a,0,0
216945,standard,0,0
216946,supper,0,0
216947,but,0,0
216948,fasted,0,0
216949,for,0,0
216950,24,0,0
216951,h,0,0
216952,thereafter,0,0
216953,.,0,0
216954,During,0,0
216955,the,0,0
216956,other,0,0
216957,treatment,0,0
216958,period,0,0
216959,volunteers,0,0
216960,ate,0,0
216961,a,0,0
216962,standard,0,0
216963,supper,0,0
216964,",",0,0
216965,snacks,0,0
216966,",",0,1
216967,breakfast,0,1
216968,and,0,1
216969,lunch,0,0
216970,.,0,1
216971,TSB,1,1
216972,concentrations,1,1
216973,were,0,0
216974,measured,0,0
216975,at,0,0
216976,regular,0,0
216977,intervals,0,0
216978,.,0,0
216979,In,0,0
216980,both,0,0
216981,the,0,0
216982,normal,0,0
216983,and,0,0
216984,high,0,0
216985,bilirubin,0,1
216986,groups,0,0
216987,",",0,0
216988,minimum,1,1
216989,TSB,1,1
216990,values,1,1
216991,were,0,0
216992,recorded,0,0
216993,4,0,0
216994,h,0,0
216995,after,0,0
216996,the,0,0
216997,supper,0,0
216998,.,0,0
216999,A,0,0
217000,24,0,0
217001,h,0,0
217002,fast,0,0
217003,more,1,0
217004,than,1,0
217005,doubled,1,0
217006,TSB,1,1
217007,concentration,1,1
217008,from,0,0
217009,baseline,0,0
217010,values,0,1
217011,in,0,0
217012,both,0,0
217013,the,0,0
217014,normal,0,0
217015,and,0,0
217016,high,0,0
217017,bilirubin,0,1
217018,groups,0,0
217019,.,0,0
217020,A,0,0
217021,clinically,0,0
217022,relevant,0,0
217023,rise,1,0
217024,in,1,0
217025,TSB,1,1
217026,took,0,0
217027,place,0,0
217028,after,0,0
217029,12,0,0
217030,h,0,0
217031,into,0,0
217032,the,0,0
217033,fasting,0,1
217034,period,0,0
217035,(,0,0
217036,TSB,0,0
217037,of,0,0
217038,17.3,0,0
217039,mumol,0,0
217040,l-1,0,0
217041,in,0,0
217042,the,0,0
217043,fasted,0,0
217044,group,0,0
217045,vs,0,0
217046,14.0,0,0
217047,mumol,0,0
217048,l-1,0,0
217049,in,0,0
217050,the,0,0
217051,non-fasted,0,0
217052,group,0,0
217053,),0,0
217054,.,0,0
217055,When,0,0
217056,designing,0,0
217057,a,0,0
217058,clinical,0,0
217059,trial,0,0
217060,",",0,0
217061,selecting,0,0
217062,volunteers,0,0
217063,",",0,0
217064,or,0,0
217065,judging,0,0
217066,the,0,0
217067,tolerance,0,1
217068,of,0,0
217069,a,0,0
217070,new,0,0
217071,drug,0,0
217072,",",0,0
217073,the,0,0
217074,rise,0,0
217075,in,0,0
217076,TSB,1,0
217077,caused,0,0
217078,by,0,0
217079,fasting,0,0
217080,must,0,0
217081,therefore,0,0
217082,be,0,0
217083,taken,0,0
217084,into,0,0
217085,account,0,0
217086,",",0,0
217087,particularly,0,0
217088,in,0,0
217089,trials,0,0
217090,where,0,0
217091,volunteers,0,0
217092,or,0,0
217093,patients,0,0
217094,fast,0,0
217095,before,0,0
217096,entering,0,0
217097,the,0,0
217098,study,0,0
217099,.,0,0
217100,[,0,0
217101,Postoperative,0,0
217102,analgesia,0,0
217103,:,0,0
217104,peridural,0,0
217105,morphine,0,0
217106,versus,0,0
217107,sublingual,0,0
217108,buprenorphine,0,0
217109,.,0,0
217110,Comparative,0,0
217111,clinical,0,0
217112,study,0,0
217113,],0,0
217114,.,0,0
217115,The,0,0
217116,authors,0,0
217117,herein,0,0
217118,present,0,0
217119,their,0,0
217120,personal,0,0
217121,series,0,0
217122,on,0,0
217123,the,0,0
217124,clinical,0,0
217125,evaluation,0,0
217126,of,0,0
217127,the,0,0
217128,analgesic,0,1
217129,efficacy,0,1
217130,of,0,0
217131,2,0,0
217132,opiodes,0,0
217133,",",0,0
217134,peridural,0,0
217135,morphine,0,1
217136,hydrochloride,0,0
217137,(,0,0
217138,0.5,0,0
217139,mg/kg,0,0
217140,),0,0
217141,administered,0,0
217142,to,0,0
217143,group,0,0
217144,A,0,0
217145,patients,0,0
217146,",",0,0
217147,and,0,1
217148,sublingual,0,1
217149,buprenorphine,0,0
217150,(,0,0
217151,0.4,0,0
217152,mg,0,0
217153,),0,0
217154,administered,0,0
217155,to,0,0
217156,group,0,0
217157,B,0,0
217158,patients,0,0
217159,in,0,0
217160,the,0,0
217161,management,0,0
217162,of,0,0
217163,post-operative,0,1
217164,pain,0,1
217165,in,0,0
217166,major,0,0
217167,abdominal,0,0
217168,surgery,0,0
217169,.,0,0
217170,The,0,0
217171,study,0,0
217172,was,0,0
217173,conducted,0,0
217174,on,0,0
217175,44,0,0
217176,patients,0,0
217177,",",0,0
217178,both,0,0
217179,male,0,0
217180,and,0,1
217181,female,0,0
217182,",",0,1
217183,classified,0,0
217184,as,0,0
217185,ASA,0,0
217186,II,0,0
217187,and,0,0
217188,III,0,0
217189,.,0,0
217190,Statistical,0,0
217191,analysis,0,0
217192,of,0,0
217193,cardiovascular,1,1
217194,parameters,1,1
217195,(,1,0
217196,BP,1,1
217197,and,1,1
217198,cardiac,1,1
217199,frequency,1,1
217200,),1,0
217201,",",1,0
217202,respiratory,1,1
217203,frequency,1,1
217204,and,1,1
217205,pain,1,1
217206,score,1,1
217207,showed,0,0
217208,an,0,0
217209,overlapping,0,0
217210,progression,0,1
217211,among,0,0
217212,the,0,0
217213,two,0,0
217214,groups,0,0
217215,.,0,0
217216,Spontaneous,1,1
217217,pain,1,1
217218,decreased,0,0
217219,significantly,0,0
217220,to,0,0
217221,zero,0,0
217222,at,0,0
217223,T6,0,0
217224,(,0,0
217225,p,0,0
217226,<,0,0
217227,0.001,0,0
217228,),0,0
217229,.,0,0
217230,However,0,0
217231,",",0,0
217232,the,0,0
217233,necessity,0,0
217234,to,0,0
217235,administer,0,0
217236,buprenorphine,0,0
217237,more,0,0
217238,frequently,0,0
217239,after,0,0
217240,the,0,0
217241,sixth,0,0
217242,hour,0,0
217243,and,0,0
217244,the,0,0
217245,consequent,0,0
217246,increase,0,0
217247,in,0,0
217248,side,1,1
217249,effects,1,0
217250,",",0,0
217251,lead,0,0
217252,us,0,0
217253,to,0,0
217254,believe,0,0
217255,that,0,0
217256,the,0,0
217257,method,0,0
217258,used,0,0
217259,for,0,0
217260,group,0,0
217261,A,0,0
217262,patients,0,0
217263,is,0,0
217264,more,0,0
217265,advantageous,0,0
217266,.,0,0
217267,[,0,0
217268,Double-blind,0,0
217269,placebo-controlled,0,0
217270,study,0,0
217271,of,0,0
217272,the,0,0
217273,effectiveness,1,1
217274,and,1,0
217275,tolerability,1,1
217276,of,0,0
217277,10,0,0
217278,and,0,0
217279,30,0,0
217280,mg,0,0
217281,ketorolac,0,0
217282,tromethamine,0,0
217283,suppositories,0,0
217284,in,0,0
217285,post-cholecystectomy,0,0
217286,pain,0,1
217287,],0,0
217288,.,0,0
217289,OBJECTIVE,0,0
217290,To,0,0
217291,evaluate,0,0
217292,the,0,0
217293,efficacy,1,1
217294,and,0,0
217295,tolerability,1,1
217296,of,0,1
217297,ketorolac,0,0
217298,tromethamine,0,0
217299,10,0,0
217300,mg,0,0
217301,and,0,0
217302,30,0,0
217303,mg,0,0
217304,suppositories,0,0
217305,in,0,0
217306,comparison,0,0
217307,to,0,0
217308,placebo,0,0
217309,",",0,0
217310,after,0,0
217311,single,0,0
217312,dose,0,0
217313,administration,0,0
217314,in,0,0
217315,patients,0,0
217316,suffering,0,0
217317,from,0,0
217318,post-operative,0,1
217319,pain,0,1
217320,after,0,0
217321,cholecystectomy,0,0
217322,.,0,0
217323,DESIGN,0,0
217324,Double-blind,0,0
217325,",",0,0
217326,randomized,0,0
217327,",",0,0
217328,controlled,0,0
217329,study,0,0
217330,.,0,0
217331,SETTING,0,0
217332,Anaesthesia,0,0
217333,Service,0,0
217334,.,0,0
217335,PATIENTS,0,0
217336,99,0,0
217337,patients,0,0
217338,with,0,0
217339,severe,0,1
217340,pain,0,1
217341,following,0,0
217342,surgery,0,0
217343,.,0,0
217344,INTERVENTIONS,0,0
217345,Cholecystectomy,0,0
217346,.,0,0
217347,MEASUREMENTS,0,0
217348,AND,0,0
217349,MAIN,0,0
217350,RESULTS,0,0
217351,The,0,0
217352,analgesia,0,1
217353,activity,0,1
217354,of,0,0
217355,ketorolac,0,0
217356,tromethamine,0,0
217357,10,0,0
217358,mg,0,0
217359,and,0,0
217360,30,0,0
217361,mg,0,0
217362,suppositories,0,0
217363,were,0,0
217364,evaluated,0,0
217365,after,0,0
217366,single,0,0
217367,dose,0,0
217368,administration,0,0
217369,by,0,0
217370,assessing,0,0
217371,pain,1,1
217372,intensity,1,1
217373,and,1,1
217374,pain,1,1
217375,relief,1,1
217376,using,1,0
217377,a,1,0
217378,4,1,0
217379,point,1,0
217380,scale,1,1
217381,(,1,0
217382,VRS,1,0
217383,),1,0
217384,.,1,0
217385,At,0,0
217386,the,0,0
217387,end,0,0
217388,of,0,0
217389,the,0,0
217390,treatment,0,0
217391,period,0,0
217392,overall,0,1
217393,assessment,0,0
217394,of,0,0
217395,safety,1,1
217396,and,1,1
217397,efficacy,1,1
217398,were,0,0
217399,recorded,0,0
217400,by,0,0
217401,physician,0,0
217402,and,0,0
217403,patient,0,0
217404,.,0,0
217405,The,0,0
217406,results,0,0
217407,show,0,0
217408,that,0,0
217409,in,0,0
217410,both,0,0
217411,active,0,0
217412,groups,0,0
217413,after,0,0
217414,30,0,0
217415,',0,0
217416,and,0,0
217417,until,0,0
217418,4,0,0
217419,hours,0,0
217420,",",0,0
217421,pain,1,1
217422,intensity,1,1
217423,decreased,0,0
217424,significantly,0,0
217425,with,0,0
217426,respect,0,0
217427,to,0,0
217428,the,0,0
217429,baseline,0,0
217430,.,0,0
217431,However,0,0
217432,a,0,0
217433,statistically,0,0
217434,significant,0,0
217435,difference,0,0
217436,between,0,0
217437,groups,0,0
217438,of,0,0
217439,p,0,0
217440,<,0,0
217441,0.02,0,0
217442,",",0,0
217443,p,0,0
217444,<,0,0
217445,0.01,0,0
217446,and,0,0
217447,p,0,0
217448,<,0,0
217449,0.05,0,0
217450,was,0,0
217451,found,0,0
217452,in,0,0
217453,favour,0,0
217454,of,0,0
217455,the,0,0
217456,30,0,0
217457,mg,0,0
217458,dose,0,0
217459,respectively,0,0
217460,at,0,0
217461,30,0,0
217462,',0,0
217463,",",0,0
217464,6,0,0
217465,and,0,0
217466,8,0,0
217467,hours,0,0
217468,after,0,0
217469,administration,0,0
217470,.,0,0
217471,All,0,0
217472,the,0,0
217473,patients,0,0
217474,treated,0,0
217475,with,0,0
217476,placebo,0,0
217477,suppositories,0,0
217478,required,0,0
217479,another,0,0
217480,rescue,1,0
217481,analgesic,1,1
217482,drug,1,0
217483,and,0,1
217484,withdrew,0,0
217485,from,0,0
217486,the,0,0
217487,trial,0,0
217488,.,0,0
217489,Three,0,0
217490,patients,0,0
217491,complained,0,0
217492,adverse,1,1
217493,events,1,1
217494,not,0,0
217495,related,0,0
217496,to,0,0
217497,treatment,0,0
217498,:,0,0
217499,two,0,0
217500,on,0,0
217501,placebo,0,0
217502,and,0,0
217503,one,0,0
217504,on,0,0
217505,ketorolac,0,0
217506,10,0,0
217507,mg,0,0
217508,.,0,0
217509,The,0,0
217510,systemic,1,0
217511,and,1,0
217512,local,1,1
217513,tolerability,1,1
217514,of,0,0
217515,the,0,0
217516,drug,0,0
217517,was,0,0
217518,good,0,0
217519,.,0,0
217520,CONCLUSIONS,0,0
217521,This,0,0
217522,study,0,0
217523,shows,0,0
217524,that,0,0
217525,ketorolac,0,0
217526,30,0,0
217527,mg,0,0
217528,suppositories,0,0
217529,are,0,0
217530,effective,0,0
217531,in,0,0
217532,clinical,0,0
217533,conditions,0,0
217534,",",0,0
217535,such,0,0
217536,as,0,0
217537,after,0,0
217538,surgery,0,0
217539,",",0,0
217540,in,0,0
217541,which,0,0
217542,pain,0,1
217543,control,0,0
217544,must,0,0
217545,be,0,0
217546,achieved,0,0
217547,within,0,0
217548,the,0,0
217549,shortest,0,1
217550,time,0,1
217551,interval,0,0
217552,and,0,1
217553,maintained,0,0
217554,or,0,0
217555,improved,0,1
217556,by,0,0
217557,means,0,0
217558,of,0,0
217559,a,0,0
217560,single,0,0
217561,route,0,0
217562,of,0,0
217563,administration,0,0
217564,.,0,0
217565,[,0,0
217566,A,0,0
217567,comparison,0,0
217568,of,0,0
217569,2,0,0
217570,methods,0,0
217571,of,0,0
217572,plastic,0,0
217573,cast,0,0
217574,fixation,0,1
217575,in,0,0
217576,treatment,0,0
217577,of,0,0
217578,loco,0,1
217579,classico,0,0
217580,radius,0,0
217581,fracture,0,1
217582,.,0,0
217583,A,0,0
217584,prospective,0,0
217585,",",0,0
217586,randomized,0,0
217587,study,0,0
217588,],0,0
217589,.,0,0
217590,The,0,0
217591,purpose,0,0
217592,of,0,0
217593,this,0,0
217594,study,0,0
217595,was,0,0
217596,to,0,0
217597,compare,0,0
217598,the,0,0
217599,functional,0,0
217600,and,0,0
217601,radiological,0,1
217602,result,0,0
217603,of,0,0
217604,two,0,0
217605,different,0,0
217606,positions,0,0
217607,of,0,0
217608,the,0,0
217609,wrist,0,0
217610,in,0,0
217611,a,0,0
217612,plaster,0,0
217613,cast,0,0
217614,following,0,0
217615,Colles,0,1
217616,',0,0
217617,fracture,0,0
217618,.,0,0
217619,For,0,0
217620,this,0,0
217621,prospective,0,0
217622,study,0,0
217623,",",0,0
217624,each,0,0
217625,of,0,0
217626,50,0,0
217627,patients,0,0
217628,with,0,0
217629,type,0,0
217630,A,0,0
217631,2.2,0,0
217632,",",0,0
217633,A,0,0
217634,3.3,0,0
217635,",",0,0
217636,C,0,0
217637,1.2,0,0
217638,or,0,0
217639,C,0,0
217640,2.2,0,0
217641,(,0,0
217642,AO,0,1
217643,classification,0,1
217644,),0,0
217645,fractures,0,0
217646,of,0,0
217647,the,0,0
217648,radius,0,0
217649,was,0,0
217650,randomly,0,0
217651,assigned,0,0
217652,to,0,0
217653,one,0,0
217654,of,0,0
217655,two,0,0
217656,groups,0,0
217657,.,0,0
217658,Both,0,0
217659,groups,0,0
217660,were,0,0
217661,treated,0,0
217662,in,0,0
217663,the,0,0
217664,same,0,0
217665,way,0,0
217666,as,0,0
217667,far,0,0
217668,as,0,0
217669,anaesthesia,0,0
217670,and,0,1
217671,reduction,0,1
217672,were,0,0
217673,concerned,0,0
217674,.,0,0
217675,The,0,0
217676,only,0,0
217677,difference,0,0
217678,in,0,0
217679,treatment,0,0
217680,lay,0,0
217681,in,0,0
217682,the,0,0
217683,position,0,0
217684,of,0,0
217685,fixation,0,0
217686,in,0,0
217687,plaster,0,0
217688,.,0,0
217689,In,0,0
217690,group,0,0
217691,1,0,0
217692,the,0,0
217693,wrist,0,0
217694,was,0,0
217695,immobilized,0,0
217696,in,0,0
217697,neutral,0,0
217698,flexion-extension,0,0
217699,.,0,0
217700,In,0,0
217701,group,0,0
217702,2,0,0
217703,the,0,0
217704,wrist,0,0
217705,was,0,0
217706,dorsiflexed,0,0
217707,20,0,0
217708,degrees,0,0
217709,",",0,0
217710,while,0,0
217711,the,0,0
217712,carpus,0,0
217713,was,0,0
217714,pushed,0,0
217715,in,0,0
217716,a,0,0
217717,volar,0,0
217718,direction,0,0
217719,by,0,0
217720,an,0,0
217721,impression,0,0
217722,in,0,0
217723,the,0,0
217724,plaster,0,0
217725,cast,0,0
217726,.,0,0
217727,At,0,0
217728,review,0,0
217729,2-7,0,0
217730,years,0,0
217731,after,0,0
217732,the,0,0
217733,accidents,0,0
217734,",",0,0
217735,the,0,0
217736,two,0,0
217737,groups,0,0
217738,were,0,0
217739,compared,0,0
217740,with,0,0
217741,reference,0,0
217742,to,0,0
217743,symptoms,1,1
217744,",",1,0
217745,range,1,0
217746,of,1,1
217747,motion,1,1
217748,at,1,0
217749,the,1,0
217750,wrist,1,0
217751,",",1,0
217752,power,1,1
217753,of,1,1
217754,first,1,0
217755,closure,1,0
217756,and,1,0
217757,radiographic,1,1
217758,appearance,1,1
217759,.,1,0
217760,In,0,0
217761,group,0,0
217762,1,0,0
217763,there,0,0
217764,were,0,0
217765,5,0,0
217766,patients,0,0
217767,with,0,0
217768,significant,0,0
217769,disability,0,1
217770,",",0,0
217771,compared,0,0
217772,with,0,0
217773,only,0,0
217774,1,0,0
217775,in,0,0
217776,group,0,0
217777,2,0,0
217778,.,0,0
217779,A,0,0
217780,significant,0,0
217781,difference,0,0
217782,was,0,0
217783,found,0,0
217784,in,0,0
217785,the,0,0
217786,range,1,0
217787,of,1,0
217788,movement,1,1
217789,between,0,0
217790,the,0,0
217791,two,0,0
217792,groups,0,0
217793,for,0,0
217794,flexion,0,1
217795,and,0,0
217796,ulnar,0,1
217797,abduction,0,1
217798,(,0,0
217799,p,0,0
217800,<,0,0
217801,0.01,0,0
217802,),0,0
217803,.,0,0
217804,The,0,0
217805,loss,1,1
217806,of,1,0
217807,power,1,1
217808,of,1,0
217809,first,1,0
217810,clenching,1,1
217811,(,0,0
217812,difference,0,0
217813,between,0,0
217814,injured,0,0
217815,and,0,0
217816,healthy,0,0
217817,hand,0,1
217818,),0,0
217819,was,0,0
217820,6.2,0,0
217821,mmHg,0,0
217822,for,0,0
217823,group,0,0
217824,1,0,0
217825,and,0,0
217826,3.8,0,0
217827,mmHg,0,0
217828,for,0,0
217829,group,0,0
217830,2,0,0
217831,(,0,0
217832,not,0,0
217833,significant,0,0
217834,),0,0
217835,.,0,0
217836,The,0,0
217837,radiographic,0,1
217838,examination,0,0
217839,showed,0,0
217840,significant,0,0
217841,differences,0,0
217842,both,0,0
217843,in,0,0
217844,sagittal,0,1
217845,inclination,0,1
217846,(,0,0
217847,p,0,0
217848,<,0,0
217849,0.001,0,0
217850,),0,0
217851,and,0,0
217852,in,0,0
217853,radial,0,1
217854,shortening,0,1
217855,(,0,0
217856,p,0,0
217857,<,0,0
217858,0.05,0,0
217859,),0,0
217860,.,0,0
217861,(,0,0
217862,ABSTRACT,0,1
217863,TRUNCATED,0,0
217864,AT,0,0
217865,250,0,0
217866,WORDS,0,0
217867,),0,0
217868,The,0,0
217869,effect,0,0
217870,of,0,0
217871,cisapride,0,0
217872,on,0,0
217873,delayed,0,0
217874,colonic,1,1
217875,transit,1,1
217876,time,1,1
217877,in,0,0
217878,patients,0,0
217879,with,0,0
217880,idiopathic,0,0
217881,Parkinson,0,0
217882,'s,0,0
217883,disease,0,0
217884,.,0,0
217885,Disorders,0,0
217886,of,0,0
217887,autonomic,0,0
217888,regulation,0,0
217889,are,0,0
217890,common,0,0
217891,in,0,0
217892,patients,0,0
217893,with,0,0
217894,Parkinson,0,0
217895,'s,0,1
217896,disease,0,1
217897,(,0,0
217898,PD,0,0
217899,),0,0
217900,.,0,0
217901,Patients,0,0
217902,most,0,0
217903,frequently,0,0
217904,complain,0,0
217905,of,0,0
217906,dysphagia,0,1
217907,and,0,1
217908,therapy,0,0
217909,resistant,0,1
217910,constipation,0,1
217911,",",0,0
217912,as,0,0
217913,far,0,0
217914,as,0,0
217915,the,0,0
217916,gastrointestinal,0,0
217917,tract,0,0
217918,is,0,0
217919,concerned,0,0
217920,.,0,0
217921,These,0,0
217922,symptoms,0,0
217923,have,0,0
217924,to,0,0
217925,be,0,0
217926,attributed,0,0
217927,to,0,0
217928,a,0,0
217929,neuronal,0,1
217930,degeneration,0,0
217931,.,0,0
217932,In,0,0
217933,a,0,0
217934,pilot,0,0
217935,study,0,0
217936,we,0,0
217937,therefore,0,0
217938,investigated,0,0
217939,the,0,0
217940,effect,0,0
217941,of,0,0
217942,stimulation,0,0
217943,of,0,0
217944,the,0,0
217945,myenteric,0,1
217946,plexus,0,0
217947,by,0,0
217948,cisapride,0,0
217949,.,0,0
217950,11,0,0
217951,women,0,0
217952,and,0,0
217953,13,0,0
217954,men,0,0
217955,were,0,0
217956,examined,0,0
217957,",",0,0
217958,the,0,0
217959,average,0,1
217960,age,0,0
217961,was,0,0
217962,67.3,0,0
217963,years,0,0
217964,",",0,0
217965,the,0,0
217966,Webster,0,0
217967,rating,0,1
217968,17,0,0
217969,points,0,0
217970,.,0,0
217971,In,0,0
217972,2,0,0
217973,out,0,0
217974,of,0,0
217975,24,0,0
217976,patients,0,0
217977,",",0,0
217978,colonic,1,1
217979,transit,1,1
217980,was,0,0
217981,prolonged,0,0
217982,up,0,0
217983,to,0,0
217984,the,0,0
217985,limit,0,0
217986,",",0,0
217987,both,0,0
217988,with,0,0
217989,and,0,0
217990,without,0,0
217991,therapy,0,0
217992,.,0,0
217993,The,0,0
217994,other,0,0
217995,22,0,0
217996,patients,0,0
217997,showed,0,0
217998,an,0,0
217999,acceleration,1,1
218000,in,1,0
218001,transit,1,1
218002,on,0,0
218003,response,0,1
218004,to,0,0
218005,cisapride,0,0
218006,.,0,0
218007,On,0,0
218008,average,0,0
218009,the,0,0
218010,colonic,1,0
218011,transit,1,0
218012,of,0,0
218013,130,0,0
218014,hours,0,0
218015,was,0,0
218016,reduced,0,0
218017,to,0,0
218018,79,0,0
218019,hours,0,0
218020,.,0,0
218021,This,0,0
218022,objective,0,0
218023,improvement,0,1
218024,was,0,0
218025,associated,0,0
218026,with,0,0
218027,a,0,0
218028,subjective,0,1
218029,improvement,0,0
218030,.,0,0
218031,Central,0,1
218032,side,0,1
218033,effects,0,1
218034,or,0,0
218035,a,0,0
218036,worsening,1,1
218037,of,1,0
218038,Parkinsonian,1,0
218039,symptoms,1,1
218040,were,0,0
218041,not,0,0
218042,found,0,0
218043,.,0,0
218044,We,0,0
218045,conclude,0,0
218046,that,0,0
218047,cisapride,0,0
218048,is,0,0
218049,effective,0,0
218050,in,0,0
218051,the,0,0
218052,treatment,0,0
218053,of,0,0
218054,constipation,0,1
218055,in,0,0
218056,idiopathic,0,0
218057,PD,0,0
218058,.,0,0
218059,Efficacy,0,1
218060,and,0,1
218061,safety,0,1
218062,of,0,1
218063,timolol/pilocarpine,0,0
218064,combination,0,0
218065,drops,0,0
218066,in,0,0
218067,glaucoma,0,0
218068,patients,0,0
218069,.,0,0
218070,The,0,0
218071,aim,0,0
218072,of,0,0
218073,this,0,0
218074,randomized,0,0
218075,",",0,0
218076,double-blind,0,0
218077,study,0,0
218078,with,0,0
218079,two,0,0
218080,parallel,0,0
218081,groups,0,0
218082,was,0,0
218083,to,0,0
218084,examine,0,0
218085,the,0,0
218086,safety,0,1
218087,",",0,0
218088,efficacy,0,1
218089,and,0,1
218090,tolerability,0,1
218091,of,0,0
218092,two,0,0
218093,combination,0,0
218094,eye,0,0
218095,drops,0,0
218096,containing,0,0
218097,0.5,0,0
218098,%,0,0
218099,timolol,0,0
218100,and,0,0
218101,2,0,0
218102,%,0,0
218103,pilocarpine,0,0
218104,(,0,0
218105,Fotil,0,0
218106,",",0,1
218107,Leiras,0,0
218108,",",0,1
218109,Finland,0,0
218110,",",0,1
218111,and,0,1
218112,Timpilo,0,0
218113,",",0,1
218114,MSD,0,0
218115,",",0,1
218116,USA,0,0
218117,),0,0
218118,in,0,0
218119,patients,0,0
218120,with,0,0
218121,glaucoma,0,0
218122,or,0,0
218123,ocular,0,1
218124,hypertension,0,1
218125,.,0,0
218126,Efficacy,0,1
218127,was,0,0
218128,determined,0,0
218129,based,0,0
218130,on,0,0
218131,daytime,0,1
218132,intraocular,0,1
218133,pressure,0,1
218134,curve,0,1
218135,and,0,1
218136,safety,0,1
218137,by,0,0
218138,examining,0,0
218139,visual,0,1
218140,fields,0,0
218141,",",0,0
218142,visual,0,1
218143,acuity,0,1
218144,",",0,0
218145,optic,0,0
218146,discs,0,0
218147,",",0,0
218148,by,0,0
218149,determining,0,0
218150,blood,0,1
218151,pressure,0,1
218152,and,0,1
218153,pulse,0,1
218154,rate,0,1
218155,",",0,0
218156,and,0,1
218157,by,0,0
218158,performing,0,0
218159,Schirmer,0,1
218160,and,0,0
218161,fluorescein,0,0
218162,tests,0,0
218163,.,0,0
218164,A,0,0
218165,total,0,0
218166,of,0,0
218167,89,0,0
218168,patients,0,0
218169,were,0,0
218170,enrolled,0,0
218171,",",0,0
218172,and,0,0
218173,71,0,0
218174,completed,0,0
218175,the,0,0
218176,10-week,0,0
218177,treatment,0,0
218178,period,0,0
218179,.,0,0
218180,This,0,0
218181,study,0,0
218182,showed,0,0
218183,that,0,0
218184,the,0,0
218185,two,0,0
218186,combinations,0,0
218187,of,0,0
218188,0.5,0,0
218189,%,0,0
218190,timolol,0,0
218191,maleate,0,0
218192,and,0,0
218193,2,0,0
218194,%,0,0
218195,pilocarpine,0,0
218196,HCl,0,1
218197,compared,0,0
218198,in,0,0
218199,this,0,0
218200,study,0,0
218201,were,0,0
218202,equally,0,0
218203,effective,0,0
218204,in,0,0
218205,reducing,0,0
218206,intraocular,1,1
218207,pressure,1,1
218208,.,1,0
218209,The,0,0
218210,decrease,0,0
218211,in,0,0
218212,mean,1,1
218213,daily,1,0
218214,intraocular,1,1
218215,pressure,1,1
218216,from,0,0
218217,0,0,0
218218,to,0,0
218219,10,0,0
218220,weeks,0,0
218221,was,0,0
218222,7.48,0,0
218223,mmHg,0,0
218224,for,0,0
218225,Fotil,0,0
218226,",",0,0
218227,and,0,0
218228,6.31,0,0
218229,for,0,0
218230,Timpilo,0,0
218231,.,0,0
218232,The,0,0
218233,mean,0,1
218234,decrease,0,0
218235,in,0,0
218236,mean,1,1
218237,daily,1,0
218238,intraocular,1,1
218239,pressure,1,1
218240,was,0,0
218241,29.3,0,0
218242,%,0,0
218243,for,0,0
218244,Fotil,0,0
218245,",",0,0
218246,and,0,0
218247,26.0,0,0
218248,%,0,0
218249,for,0,0
218250,Timpilo,0,0
218251,.,0,0
218252,No,0,0
218253,significant,0,0
218254,differences,0,0
218255,were,0,0
218256,found,0,0
218257,between,0,0
218258,the,0,0
218259,groups,0,0
218260,.,0,0
218261,Adverse,1,1
218262,event,1,1
218263,were,0,0
218264,reported,0,0
218265,by,0,0
218266,70,0,0
218267,out,0,0
218268,of,0,0
218269,89,0,0
218270,patients,0,0
218271,by,0,0
218272,the,0,0
218273,end,0,0
218274,of,0,0
218275,2,0,0
218276,weeks,0,0
218277,",",0,0
218278,but,0,0
218279,were,0,0
218280,severe,0,1
218281,enough,0,0
218282,only,0,0
218283,in,0,0
218284,11,0,0
218285,for,0,0
218286,the,0,0
218287,treatment,0,0
218288,to,0,0
218289,be,0,0
218290,discontinued,0,0
218291,.,0,0
218292,In,0,0
218293,all,0,0
218294,others,0,0
218295,",",0,0
218296,adverse,1,1
218297,events,1,1
218298,were,0,0
218299,of,0,0
218300,transient,0,1
218301,nature,0,0
218302,and,0,0
218303,considered,0,0
218304,mild,0,0
218305,.,0,0
218306,In,0,0
218307,general,0,0
218308,",",0,0
218309,adverse,1,1
218310,events,1,1
218311,were,0,0
218312,similar,0,0
218313,in,0,0
218314,both,0,0
218315,study,0,0
218316,groups,0,0
218317,.,0,0
218318,However,0,0
218319,",",0,0
218320,burning,1,0
218321,was,0,0
218322,more,0,0
218323,common,0,0
218324,in,0,0
218325,patients,0,0
218326,on,0,0
218327,Fotil,0,0
218328,",",0,0
218329,and,0,1
218330,blurring,1,1
218331,of,1,1
218332,vision,1,1
218333,and,1,0
218334,light,1,1
218335,sensitivity,1,1
218336,were,0,0
218337,more,0,0
218338,common,0,0
218339,in,0,0
218340,patients,0,0
218341,on,0,0
218342,Timpilo,0,0
218343,.,0,0
218344,In,0,0
218345,patients,0,0
218346,with,0,0
218347,no,0,0
218348,contraindication,0,0
218349,to,0,0
218350,beta-blockers,0,0
218351,",",0,0
218352,these,0,0
218353,drugs,0,0
218354,appeared,0,0
218355,to,0,0
218356,be,0,0
218357,safe,0,0
218358,.,0,0
218359,(,0,0
218360,ABSTRACT,0,1
218361,TRUNCATED,0,0
218362,AT,0,0
218363,250,0,0
218364,WORDS,0,0
218365,),0,0
218366,Scales,0,1
218367,for,0,0
218368,the,0,0
218369,assessment,0,0
218370,of,0,0
218371,neuroleptic,1,1
218372,response,1,1
218373,in,0,0
218374,schizophrenic,0,0
218375,children,0,0
218376,:,0,0
218377,specific,0,0
218378,measures,0,1
218379,derived,0,0
218380,from,0,0
218381,the,0,0
218382,CPRS,0,0
218383,.,0,0
218384,This,0,0
218385,article,0,0
218386,reports,0,0
218387,the,0,0
218388,psychometric,0,0
218389,properties,0,0
218390,of,0,0
218391,two,0,0
218392,scales,0,1
218393,for,0,0
218394,rating,0,1
218395,positive,0,1
218396,and,0,0
218397,negative,0,1
218398,schizophrenic,0,0
218399,signs,0,1
218400,and,0,0
218401,symptoms,0,1
218402,.,0,0
218403,These,0,0
218404,Positive,1,1
218405,and,1,0
218406,Negative,1,0
218407,Syndrome,1,1
218408,Scales,1,1
218409,consist,0,0
218410,of,0,0
218411,items,0,0
218412,selected,0,0
218413,from,0,0
218414,the,0,0
218415,Children,0,0
218416,'s,0,0
218417,Psychiatric,0,0
218418,Rating,0,1
218419,Scale,0,1
218420,(,0,0
218421,CPRS,0,0
218422,),0,0
218423,",",0,0
218424,which,0,0
218425,contains,0,0
218426,items,0,0
218427,covering,0,0
218428,a,0,0
218429,wide,0,0
218430,range,0,0
218431,of,0,0
218432,childhood,0,0
218433,psychopathology,0,1
218434,.,0,0
218435,CPRS,0,0
218436,rating,0,1
218437,data,0,0
218438,were,0,0
218439,analyzed,0,0
218440,for,0,0
218441,19,0,0
218442,schizophrenic,0,0
218443,children,0,0
218444,",",0,0
218445,16,0,0
218446,males,0,0
218447,and,0,0
218448,3,0,0
218449,females,0,0
218450,",",0,0
218451,mean,0,1
218452,age,0,0
218453,8.9,0,0
218454,years,0,0
218455,(,0,0
218456,range,0,0
218457,5.5-11.7,0,0
218458,),0,0
218459,",",0,0
218460,evaluated,0,0
218461,in,0,0
218462,a,0,0
218463,double-blind,0,0
218464,",",0,0
218465,placebo-controlled,0,0
218466,crossover,0,0
218467,study,0,0
218468,of,0,0
218469,haloperidol,0,0
218470,.,0,0
218471,We,0,0
218472,describe,0,0
218473,the,0,0
218474,item,0,1
218475,composition,0,0
218476,and,0,1
218477,coherence,0,0
218478,of,0,0
218479,each,0,0
218480,scale,0,1
218481,",",0,0
218482,the,0,0
218483,interrater,0,1
218484,reliabilities,0,1
218485,of,0,0
218486,clinicians,0,0
218487,using,0,0
218488,the,0,0
218489,scales,0,1
218490,",",0,0
218491,and,0,0
218492,the,0,0
218493,sensitivity,0,1
218494,of,0,0
218495,the,0,0
218496,scales,0,1
218497,for,0,0
218498,resolving,0,1
218499,treatment,0,0
218500,response,0,1
218501,.,0,0
218502,Schizophrenic,0,0
218503,children,0,0
218504,showed,0,0
218505,both,0,0
218506,positive,1,1
218507,and,1,0
218508,negative,1,1
218509,signs,1,1
218510,and,1,1
218511,symptoms,1,1
218512,",",0,0
218513,and,0,0
218514,both,0,0
218515,improved,0,0
218516,with,0,0
218517,neuroleptic,1,0
218518,treatment,1,0
218519,.,1,0
218520,The,0,0
218521,effect,0,0
218522,of,0,0
218523,eradication,0,1
218524,of,0,0
218525,Helicobacter,0,0
218526,pylori,0,0
218527,upon,0,0
218528,the,0,0
218529,duodenal,1,0
218530,ulcer,1,0
218531,recurrence,1,1
218532,--,1,0
218533,a,1,0
218534,24,0,0
218535,month,0,0
218536,follow-up,0,0
218537,study,0,0
218538,.,0,0
218539,OBJECTIVES,0,0
218540,To,0,0
218541,evaluate,0,0
218542,the,0,0
218543,effect,0,0
218544,of,0,0
218545,eradication,1,1
218546,of,0,0
218547,Helicobacter,0,0
218548,pylori,0,0
218549,(,0,0
218550,H.pylori,0,1
218551,),0,0
218552,in,0,0
218553,the,0,0
218554,patients,0,0
218555,with,0,0
218556,duodenal,0,0
218557,ulcer,0,1
218558,(,0,0
218559,Du,0,1
218560,),0,0
218561,upon,0,0
218562,the,0,0
218563,DU,1,1
218564,recurrence,1,1
218565,.,1,0
218566,METHODS,0,0
218567,This,0,0
218568,study,0,0
218569,was,0,0
218570,performed,0,0
218571,for,0,0
218572,190,0,0
218573,patients,0,0
218574,with,0,0
218575,DU,0,0
218576,.,0,0
218577,Four,0,0
218578,different,0,0
218579,methods-microscopy,0,0
218580,of,0,0
218581,Gram,1,0
218582,stained,1,1
218583,mucosal,1,1
218584,smear,1,1
218585,",",1,0
218586,specific,1,1
218587,culture,1,1
218588,",",1,0
218589,biopsy,1,0
218590,urease,1,1
218591,test,1,1
218592,",",1,0
218593,histology,1,1
218594,of,1,1
218595,H,1,0
218596,&,1,0
218597,E,1,1
218598,staining-were,1,1
218599,taken,0,0
218600,for,0,0
218601,identifying,0,0
218602,colonization,0,1
218603,of,0,0
218604,H.,0,0
218605,pylori,0,0
218606,before,0,0
218607,treatment,0,0
218608,",",0,0
218609,and,0,1
218610,for,0,0
218611,finding,0,0
218612,the,0,0
218613,eradication,0,1
218614,of,0,0
218615,H.,0,0
218616,pylori,0,0
218617,4,0,0
218618,weeks,0,0
218619,after,0,0
218620,completion,0,0
218621,of,0,0
218622,therapy,0,0
218623,in,0,0
218624,each,0,0
218625,treatment,0,0
218626,group,0,0
218627,(,0,0
218628,cometidine,0,0
218629,",",0,1
218630,omeprazole,0,0
218631,",",0,1
218632,colloidal,0,0
218633,bismuth,0,0
218634,subcitrate,0,0
218635,(,0,0
218636,CBS,0,1
218637,),0,0
218638,",",0,0
218639,CBS,0,1
218640,and,0,1
218641,metronidazole,0,0
218642,double,0,0
218643,therapy,0,0
218644,",",0,0
218645,CBS,0,1
218646,",",0,1
218647,metronidazole,0,0
218648,and,0,1
218649,amoxicillin,0,0
218650,triple,0,0
218651,therapy,0,0
218652,),0,0
218653,.,0,0
218654,To,0,0
218655,detect,0,0
218656,DU,1,1
218657,recurrence,1,1
218658,",",0,0
218659,the,0,0
218660,gastroscopy,1,0
218661,was,0,0
218662,performed,0,0
218663,at,0,0
218664,6,0,0
218665,",",0,0
218666,12,0,0
218667,",",0,0
218668,18,0,0
218669,",",0,0
218670,and,0,0
218671,24,0,0
218672,months,0,0
218673,after,0,0
218674,therapy,0,0
218675,.,0,0
218676,RESULTS,0,0
218677,The,0,0
218678,eradication,1,1
218679,rate,1,1
218680,of,0,0
218681,the,0,0
218682,cimetidine,0,0
218683,group,0,0
218684,the,0,0
218685,omeprazole,0,0
218686,group,0,0
218687,",",0,0
218688,and,0,0
218689,the,0,0
218690,CBS,0,1
218691,group,0,0
218692,were,0,0
218693,0,0,0
218694,%,0,0
218695,",",0,0
218696,7.7,0,0
218697,%,0,0
218698,",",0,0
218699,0,0,0
218700,%,0,0
218701,",",0,0
218702,respectively,0,0
218703,",",0,0
218704,and,0,0
218705,that,0,0
218706,of,0,0
218707,the,0,0
218708,double,0,0
218709,therapy,0,0
218710,group,0,0
218711,and,0,0
218712,the,0,0
218713,triple,0,0
218714,therapy,0,0
218715,group,0,0
218716,were,0,0
218717,44.4,0,0
218718,%,0,0
218719,and,0,0
218720,89.3,0,0
218721,%,0,0
218722,",",0,0
218723,respectively,0,0
218724,.,0,0
218725,Seventy,0,0
218726,three,0,0
218727,patients,0,0
218728,who,0,0
218729,were,0,0
218730,followed,0,0
218731,up,0,0
218732,for,0,0
218733,2,0,0
218734,years,0,0
218735,were,0,0
218736,categorized,0,0
218737,into,0,0
218738,two,0,0
218739,groups,0,0
218740,according,0,0
218741,to,0,0
218742,the,0,0
218743,eradication,1,1
218744,of,1,0
218745,H.,1,0
218746,pylori,1,0
218747,.,1,0
218748,The,0,0
218749,recurrence,1,1
218750,rate,1,1
218751,was,0,0
218752,3.2,0,0
218753,%,0,0
218754,both,0,0
218755,in,0,0
218756,1,0,0
218757,year,0,0
218758,and,0,0
218759,2,0,0
218760,years,0,0
218761,later,0,0
218762,in,0,0
218763,the,0,0
218764,former,0,0
218765,group-one,0,0
218766,consisting,0,0
218767,of,0,0
218768,31,0,0
218769,patients,0,0
218770,with,0,0
218771,H.,0,1
218772,pylori,0,1
218773,eradicated,0,0
218774,",",0,0
218775,while,0,0
218776,the,0,0
218777,recurrence,1,1
218778,rate,1,1
218779,was,0,0
218780,57.1,0,0
218781,%,0,0
218782,in,0,0
218783,1,0,0
218784,year,0,0
218785,and,0,0
218786,78.6,0,0
218787,%,0,0
218788,in,0,0
218789,2,0,0
218790,years,0,0
218791,later,0,0
218792,",",0,0
218793,in,0,0
218794,the,0,0
218795,latter,0,0
218796,group-the,0,0
218797,other,0,0
218798,of,0,0
218799,42,0,0
218800,patients,0,0
218801,with,0,0
218802,H.,0,0
218803,pylori,0,0
218804,not,0,0
218805,eradicated,0,0
218806,.,0,0
218807,CONCLUSION,0,0
218808,The,0,0
218809,eradication,0,1
218810,of,0,0
218811,H.,0,0
218812,pylori,0,0
218813,in,0,0
218814,patients,0,0
218815,with,0,0
218816,DU,0,0
218817,reduces,0,0
218818,the,0,0
218819,recurrence,1,1
218820,of,1,0
218821,DU,1,1
218822,.,1,0
218823,Changes,0,1
218824,in,0,0
218825,beta-carotene,0,0
218826,levels,0,1
218827,by,0,0
218828,long-term,0,0
218829,administration,0,0
218830,of,0,0
218831,natural,0,0
218832,beta-carotene,0,0
218833,derived,0,0
218834,from,0,0
218835,Dunaliella,0,0
218836,bardawil,0,0
218837,in,0,0
218838,humans,0,0
218839,.,0,0
218840,Long-term,0,0
218841,administration,0,0
218842,of,0,0
218843,a,0,0
218844,beta-carotene,0,0
218845,preparation,0,0
218846,derived,0,0
218847,from,0,0
218848,Dunaliella,0,0
218849,bardawil,0,0
218850,",",0,0
218851,a,0,0
218852,beta-carotene-rich,0,0
218853,algae,0,0
218854,",",0,0
218855,was,0,0
218856,studied,0,0
218857,in,0,0
218858,healthy,0,0
218859,young,0,0
218860,male,0,0
218861,volunteers,0,0
218862,.,0,0
218863,The,0,0
218864,daily,0,0
218865,administration,0,0
218866,of,0,0
218867,60,0,0
218868,mg,0,0
218869,of,0,0
218870,the,0,0
218871,beta-carotene,0,0
218872,preparation,0,0
218873,(,0,0
218874,30,0,0
218875,mg,0,0
218876,of,0,0
218877,all-trans,0,0
218878,beta-carotene,0,0
218879,and,0,0
218880,30,0,0
218881,mg,0,0
218882,of,0,0
218883,9-cis,0,0
218884,beta-carotene,0,0
218885,),0,0
218886,was,0,0
218887,performed,0,0
218888,and,0,0
218889,beta-carotene,0,0
218890,concentrations,0,1
218891,were,0,0
218892,determined,0,0
218893,in,0,0
218894,the,0,0
218895,plasma,1,1
218896,",",1,0
218897,red,1,1
218898,blood,1,1
218899,cells,1,1
218900,(,1,0
218901,RBC,1,1
218902,),1,0
218903,",",1,0
218904,platelets,1,1
218905,(,1,0
218906,PLT,1,1
218907,),1,1
218908,",",1,0
218909,and,1,1
218910,mononuclear,1,1
218911,cells,1,1
218912,(,1,0
218913,MN,1,0
218914,),1,0
218915,.,1,0
218916,The,0,0
218917,all-trans,1,0
218918,beta-carotene,1,0
218919,level,1,1
218920,increased,0,0
218921,four-,0,0
218922,",",0,0
218923,two-,0,0
218924,",",0,1
218925,and,0,0
218926,threefold,0,0
218927,the,0,0
218928,baseline,0,0
218929,in,0,0
218930,plasma,1,1
218931,",",1,0
218932,PLT,1,1
218933,",",1,1
218934,and,1,1
218935,MN,1,1
218936,",",0,0
218937,respectively,0,0
218938,.,0,0
218939,Basal,1,0
218940,levels,1,1
218941,of,1,0
218942,9-cis,1,0
218943,beta-carotene,1,0
218944,in,1,0
218945,plasma,1,1
218946,",",1,0
218947,PLT,1,1
218948,",",1,1
218949,and,1,1
218950,MN,1,1
218951,were,0,0
218952,low,0,0
218953,and,0,0
218954,found,0,0
218955,as,0,0
218956,one-tenth,0,0
218957,",",0,0
218958,one-fifth,0,0
218959,",",0,0
218960,and,0,1
218961,one-fifth,0,0
218962,of,0,0
218963,all-trans,0,0
218964,beta-carotene,0,0
218965,",",0,0
218966,which,0,0
218967,increased,0,0
218968,three-,0,0
218969,",",0,1
218970,two-,0,0
218971,",",0,0
218972,and,0,0
218973,1.5-fold,0,0
218974,the,0,0
218975,baseline,0,0
218976,",",0,0
218977,respectively,0,0
218978,.,0,0
218979,Plasma,1,1
218980,and,1,0
218981,RBC,1,1
218982,alpha-tocopherol,1,1
218983,levels,1,1
218984,were,0,0
218985,not,0,0
218986,changed,0,0
218987,by,0,0
218988,the,0,0
218989,intake,0,1
218990,of,0,0
218991,beta-carotene,0,0
218992,.,0,0
218993,No,1,0
218994,side,1,1
218995,effects,1,1
218996,or,1,0
218997,toxicities,1,1
218998,were,0,0
218999,documented,0,0
219000,in,0,0
219001,any,0,0
219002,of,0,0
219003,the,0,0
219004,subjects,0,0
219005,during,0,0
219006,the,0,0
219007,administration,0,0
219008,period,0,0
219009,.,0,0
219010,In,0,0
219011,conclusion,0,0
219012,",",0,0
219013,the,0,0
219014,bioavailability,0,1
219015,of,0,0
219016,beta-carotene,0,0
219017,derived,0,0
219018,from,0,0
219019,Dunaliella,0,0
219020,bardawil,0,0
219021,was,0,0
219022,preferential,0,0
219023,for,0,0
219024,all-trans,0,0
219025,beta-carotene,0,0
219026,",",0,0
219027,although,0,0
219028,a,0,0
219029,small,0,0
219030,amount,0,0
219031,of,0,0
219032,the,0,0
219033,9-cis,0,0
219034,form,0,0
219035,was,0,0
219036,detected,0,0
219037,in,0,0
219038,the,0,0
219039,plasma,0,1
219040,and,0,0
219041,blood,0,1
219042,cells,0,1
219043,.,0,0
219044,Angiotensin,0,0
219045,converting,0,0
219046,enzyme,0,0
219047,inhibition,0,0
219048,does,0,0
219049,not,0,0
219050,affect,0,0
219051,the,0,0
219052,response,0,1
219053,to,0,0
219054,exogenous,0,0
219055,angiotensin,0,0
219056,II,0,0
219057,in,0,0
219058,the,0,0
219059,human,0,0
219060,forearm,0,0
219061,.,0,0
219062,Suppression,0,1
219063,of,0,0
219064,endogenous,0,1
219065,levels,0,1
219066,of,0,0
219067,angiotensin,0,0
219068,II,0,0
219069,by,0,0
219070,angiotensin,0,0
219071,converting,0,0
219072,enzyme,0,1
219073,inhibition,0,1
219074,",",0,0
219075,may,0,0
219076,result,0,0
219077,in,0,0
219078,up-regulation,0,1
219079,of,0,0
219080,vascular,0,1
219081,AT1,0,0
219082,receptors,0,0
219083,.,0,0
219084,We,0,0
219085,have,0,0
219086,evaluated,0,0
219087,the,0,0
219088,effects,0,0
219089,of,0,0
219090,orally,0,0
219091,administered,0,0
219092,enalapril,0,0
219093,on,0,0
219094,angiotensin,0,0
219095,II,0,0
219096,induced,0,0
219097,vasoconstriction,0,0
219098,in,0,0
219099,the,0,0
219100,human,0,0
219101,forearm,0,0
219102,.,0,0
219103,Subjects,0,0
219104,received,0,0
219105,in,0,0
219106,random,0,0
219107,order,0,0
219108,",",0,1
219109,enalapril,0,0
219110,(,0,0
219111,20,0,0
219112,mg,0,0
219113,),0,0
219114,or,0,0
219115,matched,0,0
219116,placebo,0,0
219117,daily,0,0
219118,for,0,0
219119,2,0,0
219120,weeks,0,0
219121,.,0,0
219122,Forearm,1,1
219123,blood,1,1
219124,flow,1,1
219125,response,0,1
219126,to,0,0
219127,increasing,0,0
219128,doses,0,0
219129,of,0,0
219130,angiotensin,0,0
219131,II,0,0
219132,was,0,0
219133,measured,0,0
219134,using,0,0
219135,venous,0,1
219136,occlusion,0,0
219137,plethysmography,0,0
219138,at,0,0
219139,the,0,0
219140,beginning,0,0
219141,of,0,0
219142,the,0,0
219143,study,0,0
219144,and,0,0
219145,at,0,0
219146,the,0,0
219147,end,0,0
219148,of,0,0
219149,each,0,0
219150,2,0,0
219151,week,0,0
219152,treatment,0,0
219153,period,0,0
219154,.,0,0
219155,Treatment,0,0
219156,with,0,0
219157,enalapril,0,0
219158,significantly,0,0
219159,reduced,0,0
219160,plasma,1,1
219161,angiotensin,1,0
219162,II,1,0
219163,levels,1,1
219164,and,1,0
219165,supine,1,0
219166,blood,1,1
219167,pressure,1,1
219168,compared,0,0
219169,with,0,0
219170,placebo,0,0
219171,.,0,0
219172,The,0,0
219173,percentage,0,1
219174,reductions,1,1
219175,in,1,0
219176,forearm,1,1
219177,blood,1,1
219178,flow,1,1
219179,in,0,0
219180,the,0,0
219181,infused,0,0
219182,arm,0,0
219183,",",0,0
219184,in,0,0
219185,response,0,1
219186,to,0,0
219187,the,0,0
219188,maximum,0,1
219189,dose,0,0
219190,of,0,0
219191,angiotensin,0,0
219192,II,0,0
219193,(,0,0
219194,"50,000",0,0
219195,fmol,0,0
219196,min-1,0,0
219197,),0,0
219198,were,0,0
219199,48.1,0,0
219200,+/-,0,0
219201,3.6,0,0
219202,%,0,0
219203,at,0,0
219204,baseline,0,0
219205,",",0,0
219206,57.5,0,0
219207,+/-,0,0
219208,3.6,0,0
219209,%,0,0
219210,on,0,0
219211,placebo,0,0
219212,and,0,0
219213,54.5,0,0
219214,+/-,0,0
219215,4.2,0,0
219216,%,0,0
219217,on,0,0
219218,enalapril,0,0
219219,.,0,0
219220,The,0,0
219221,differences,0,0
219222,were,0,0
219223,not,0,0
219224,significantly,0,0
219225,different,0,0
219226,.,0,0
219227,This,0,0
219228,demonstrates,0,0
219229,that,0,0
219230,suppression,0,1
219231,of,0,0
219232,plasma,0,1
219233,angiotensin,0,0
219234,II,0,0
219235,for,0,0
219236,a,0,0
219237,14,0,0
219238,day,0,0
219239,period,0,0
219240,does,0,0
219241,not,0,0
219242,enhance,0,0
219243,the,0,0
219244,response,0,1
219245,to,0,0
219246,exogenous,0,0
219247,intra-arterial,0,0
219248,angiotensin,0,0
219249,II,0,0
219250,in,0,0
219251,the,0,0
219252,human,0,0
219253,forearm,0,0
219254,of,0,0
219255,healthy,0,0
219256,salt,0,0
219257,replete,0,0
219258,subjects,0,0
219259,.,0,0
219260,Warfarin,0,0
219261,versus,0,0
219262,aspirin,0,0
219263,for,0,0
219264,prevention,0,0
219265,of,0,0
219266,thromboembolism,1,1
219267,in,0,0
219268,atrial,0,0
219269,fibrillation,0,0
219270,:,0,0
219271,Stroke,0,0
219272,Prevention,0,0
219273,in,0,0
219274,Atrial,0,0
219275,Fibrillation,0,1
219276,II,0,0
219277,Study,0,0
219278,.,0,0
219279,Warfarin,0,0
219280,is,0,0
219281,an,0,0
219282,established,0,0
219283,treatment,0,0
219284,for,0,0
219285,prevention,0,0
219286,of,0,0
219287,ischaemic,0,0
219288,stroke,0,1
219289,in,0,0
219290,patients,0,0
219291,with,0,0
219292,atrial,0,1
219293,fibrillation,0,1
219294,",",0,0
219295,but,0,0
219296,the,0,0
219297,value,0,0
219298,of,0,0
219299,this,0,0
219300,agent,0,0
219301,relative,0,0
219302,to,0,0
219303,aspirin,0,0
219304,in,0,0
219305,unclear,0,0
219306,.,0,0
219307,In,0,0
219308,the,0,0
219309,first,0,0
219310,Stroke,0,0
219311,Prevention,0,0
219312,in,0,0
219313,Atrial,0,0
219314,Fibrillation,0,1
219315,(,0,0
219316,SPAF-I,0,0
219317,),0,1
219318,study,0,0
219319,",",0,0
219320,direct,0,1
219321,comparison,0,0
219322,of,0,0
219323,warfarin,0,0
219324,with,0,0
219325,aspirin,0,0
219326,was,0,0
219327,limited,0,0
219328,by,0,0
219329,the,0,0
219330,small,0,0
219331,number,0,1
219332,of,0,0
219333,thromboembolic,0,1
219334,events,0,1
219335,.,0,0
219336,SPAF-II,0,0
219337,aims,0,0
219338,to,0,0
219339,address,0,0
219340,this,0,0
219341,issue,0,0
219342,and,0,0
219343,also,0,0
219344,to,0,0
219345,assess,0,0
219346,the,0,0
219347,differential,0,0
219348,effects,0,0
219349,of,0,0
219350,the,0,0
219351,two,0,0
219352,treatments,0,0
219353,according,0,0
219354,to,0,0
219355,age,0,0
219356,.,0,0
219357,We,0,0
219358,compared,0,0
219359,warfarin,0,0
219360,(,0,0
219361,prothrombin,0,1
219362,time,0,1
219363,ratio,0,1
219364,1.3-1.8,0,0
219365,",",0,0
219366,international,0,0
219367,normalised,0,1
219368,ratio,0,1
219369,2.0-4.5,0,0
219370,),0,0
219371,with,0,0
219372,aspirin,0,0
219373,325,0,0
219374,mg,0,0
219375,daily,0,0
219376,for,0,0
219377,prevention,0,0
219378,of,0,0
219379,ischaemic,1,1
219380,stroke,1,1
219381,and,0,0
219382,systemic,1,1
219383,embolism,1,1
219384,(,0,0
219385,primary,0,0
219386,events,0,1
219387,),0,0
219388,in,0,0
219389,two,0,0
219390,parallel,0,0
219391,randomised,0,0
219392,trials,0,0
219393,involving,0,0
219394,715,0,0
219395,patients,0,0
219396,aged,0,0
219397,75,0,0
219398,years,0,0
219399,or,0,0
219400,less,0,0
219401,and,0,0
219402,385,0,0
219403,patients,0,0
219404,older,0,0
219405,than,0,0
219406,75,0,0
219407,;,0,0
219408,we,0,0
219409,sought,0,0
219410,reductions,0,0
219411,in,0,0
219412,the,0,0
219413,absolute,0,1
219414,rate,0,1
219415,of,0,0
219416,primary,0,0
219417,events,0,1
219418,by,0,0
219419,warfarin,0,0
219420,compared,0,0
219421,with,0,0
219422,aspirin,0,0
219423,of,0,0
219424,2,0,0
219425,%,0,0
219426,per,0,0
219427,year,0,0
219428,and,0,0
219429,4,0,0
219430,%,0,0
219431,per,0,0
219432,year,0,0
219433,",",0,0
219434,respectively,0,0
219435,.,0,0
219436,In,0,0
219437,the,0,0
219438,younger,0,0
219439,patients,0,0
219440,",",0,1
219441,warfarin,0,0
219442,decreased,0,0
219443,the,0,0
219444,absolute,1,1
219445,rate,1,1
219446,of,1,0
219447,primary,1,0
219448,events,1,1
219449,by,0,0
219450,0.7,0,0
219451,%,0,0
219452,per,0,0
219453,year,0,0
219454,(,0,0
219455,95,0,0
219456,%,0,0
219457,CI-0.4,0,0
219458,to,0,0
219459,1.7,0,0
219460,),0,0
219461,.,0,0
219462,The,0,0
219463,primary,1,0
219464,event,1,0
219465,rate,1,1
219466,per,1,0
219467,year,1,0
219468,was,0,0
219469,1.3,0,0
219470,%,0,0
219471,with,0,0
219472,warfarin,0,0
219473,and,0,0
219474,1.9,0,0
219475,%,0,0
219476,with,0,0
219477,aspirin,0,0
219478,(,0,0
219479,relative,0,1
219480,risk,0,1
219481,[,0,0
219482,RR,0,0
219483,],0,0
219484,0.67,0,0
219485,",",0,0
219486,p,0,0
219487,=,0,0
219488,0.24,0,0
219489,),0,0
219490,.,0,0
219491,The,0,0
219492,absolute,1,1
219493,rate,1,1
219494,of,1,0
219495,primary,1,0
219496,events,1,1
219497,in,0,0
219498,low-risk,0,0
219499,younger,0,0
219500,patients,0,0
219501,(,0,0
219502,without,0,0
219503,hypertension,0,1
219504,",",0,0
219505,recent,0,0
219506,heart,0,1
219507,failure,0,1
219508,",",0,0
219509,or,0,1
219510,previous,0,0
219511,thromboembolism,0,1
219512,),0,0
219513,on,0,0
219514,aspirin,0,0
219515,was,0,0
219516,0.5,0,0
219517,%,0,0
219518,per,0,0
219519,year,0,0
219520,(,0,0
219521,95,0,0
219522,%,0,0
219523,CI,0,0
219524,0.1,0,0
219525,to,0,0
219526,1.9,0,0
219527,),0,0
219528,.,0,0
219529,Among,0,0
219530,older,0,0
219531,patients,0,0
219532,",",0,1
219533,warfarin,0,0
219534,decreased,0,0
219535,the,0,0
219536,absolute,1,1
219537,rate,1,1
219538,of,1,0
219539,primary,1,0
219540,events,1,1
219541,by,0,0
219542,1.2,0,0
219543,%,0,0
219544,per,0,0
219545,year,0,0
219546,(,0,0
219547,95,0,0
219548,%,0,0
219549,CI-1.7,0,0
219550,to,0,0
219551,4.1,0,0
219552,),0,0
219553,.,0,0
219554,The,0,0
219555,primary,1,0
219556,event,1,0
219557,rate,1,1
219558,per,1,0
219559,year,1,0
219560,was,0,0
219561,3.6,0,0
219562,%,0,0
219563,with,0,0
219564,warfarin,0,0
219565,and,0,0
219566,4.8,0,0
219567,%,0,0
219568,with,0,0
219569,aspirin,0,0
219570,(,0,0
219571,RR,0,0
219572,0.73,0,0
219573,",",0,0
219574,p,0,0
219575,=,0,0
219576,0.39,0,0
219577,),0,0
219578,.,0,0
219579,In,0,0
219580,this,0,0
219581,older,0,0
219582,group,0,0
219583,",",0,0
219584,the,0,0
219585,rate,1,1
219586,of,1,0
219587,all,1,0
219588,stroke,1,0
219589,with,1,0
219590,residual,1,1
219591,deficit,1,1
219592,(,0,0
219593,ischaemic,0,1
219594,or,0,0
219595,haemorrhagic,0,1
219596,),0,0
219597,was,0,0
219598,4.3,0,0
219599,%,0,0
219600,per,0,0
219601,year,0,0
219602,with,0,0
219603,aspirin,0,0
219604,and,0,0
219605,4.6,0,0
219606,%,0,0
219607,per,0,0
219608,year,0,0
219609,with,0,0
219610,warfarin,0,0
219611,(,0,0
219612,RR,0,0
219613,1.1,0,0
219614,),0,0
219615,.,0,0
219616,Warfarin,0,0
219617,may,0,0
219618,be,0,0
219619,more,0,0
219620,effective,0,1
219621,than,0,0
219622,aspirin,0,0
219623,for,0,0
219624,prevention,0,0
219625,of,0,0
219626,ischaemic,1,0
219627,stroke,1,1
219628,in,0,0
219629,patients,0,0
219630,with,0,0
219631,atrial,0,1
219632,fibrillation,0,1
219633,",",0,0
219634,but,0,0
219635,the,0,0
219636,absolute,1,1
219637,reduction,1,1
219638,in,0,0
219639,stroke,1,1
219640,rate,1,1
219641,by,0,0
219642,warfarin,0,0
219643,is,0,0
219644,small,0,0
219645,.,0,0
219646,Younger,0,0
219647,patients,0,0
219648,without,0,0
219649,risk,0,1
219650,factors,0,0
219651,had,0,0
219652,a,0,0
219653,low,0,0
219654,rate,1,1
219655,of,1,0
219656,stroke,1,1
219657,when,0,0
219658,treated,0,0
219659,with,0,0
219660,aspirin,0,0
219661,.,0,0
219662,In,0,0
219663,older,0,0
219664,patients,0,0
219665,the,0,0
219666,rate,1,1
219667,of,1,0
219668,stroke,1,1
219669,(,0,0
219670,ischaemic,0,1
219671,and,0,1
219672,haemorrhagic,0,1
219673,),0,1
219674,was,0,0
219675,substantial,0,0
219676,",",0,0
219677,irrespective,0,0
219678,of,0,0
219679,which,0,0
219680,agent,0,0
219681,was,0,0
219682,given,0,0
219683,.,0,0
219684,Patient,0,1
219685,age,0,0
219686,and,0,0
219687,the,0,0
219688,inherent,0,0
219689,risk,0,1
219690,of,0,0
219691,thromboembolism,0,1
219692,should,0,0
219693,be,0,0
219694,considered,0,0
219695,in,0,0
219696,the,0,0
219697,choice,0,0
219698,of,0,0
219699,antithrombotic,0,0
219700,prophylaxis,0,0
219701,for,0,0
219702,patients,0,0
219703,with,0,0
219704,atrial,0,0
219705,fibrillation,0,0
219706,.,0,0
219707,[,0,0
219708,Postlaparoscopic,0,0
219709,pain,0,1
219710,syndrome,0,0
219711,.,0,0
219712,Results,0,0
219713,of,0,0
219714,a,0,0
219715,prospective,0,0
219716,",",0,0
219717,randomized,0,0
219718,study,0,0
219719,],0,0
219720,.,0,0
219721,The,0,0
219722,so-called,0,0
219723,post-laparoscopic,0,0
219724,algesia,0,0
219725,is,0,0
219726,a,0,0
219727,specific,0,0
219728,impairment,0,1
219729,of,0,0
219730,about,0,0
219731,63,0,0
219732,%,0,0
219733,of,0,0
219734,the,0,0
219735,patients,0,0
219736,who,0,0
219737,undergo,0,0
219738,laparoscopic,0,0
219739,surgical,0,0
219740,operations,0,0
219741,.,0,0
219742,This,0,0
219743,impairment,0,0
219744,takes,0,0
219745,the,0,0
219746,form,0,0
219747,of,0,0
219748,mild,0,0
219749,to,0,0
219750,moderate,0,0
219751,shoulder,0,0
219752,pain,0,1
219753,.,0,0
219754,Eliminating,0,0
219755,the,0,0
219756,causes,0,0
219757,of,0,0
219758,pain,0,0
219759,has,0,0
219760,a,0,0
219761,clear,0,0
219762,advantage,0,0
219763,over,0,0
219764,symptomatic,0,1
219765,treatment,0,0
219766,using,0,0
219767,analgetics,0,1
219768,",",0,0
219769,a,0,0
219770,fact,0,0
219771,worth,0,0
219772,a,0,0
219773,good,0,0
219774,consideration,0,0
219775,especially,0,0
219776,with,0,0
219777,the,0,0
219778,post-operative,0,0
219779,sojourn,0,0
219780,at,0,0
219781,the,0,0
219782,hospital,0,0
219783,becoming,0,0
219784,shorter,0,1
219785,and,0,0
219786,shorter,0,1
219787,.,0,0
219788,In,0,0
219789,a,0,0
219790,prospective,0,0
219791,controlled,0,0
219792,study,0,0
219793,",",0,0
219794,involving,0,0
219795,42,0,0
219796,patients,0,0
219797,subdivided,0,0
219798,into,0,0
219799,four,0,0
219800,groups,0,0
219801,namely,0,0
219802,",",0,0
219803,higher,0,0
219804,or,0,1
219805,lower,0,1
219806,insufflation,0,1
219807,pressures,0,1
219808,",",0,0
219809,chemically,0,0
219810,inert,0,0
219811,insufflation,0,0
219812,gas,0,1
219813,and,0,1
219814,control,0,0
219815,groups,0,0
219816,;,0,0
219817,the,0,0
219818,use,0,0
219819,of,0,0
219820,analgetics,1,1
219821,",",1,0
219822,lung,1,1
219823,function,1,1
219824,",",1,1
219825,operation,1,1
219826,duration,1,1
219827,",",1,0
219828,amount,1,1
219829,of,1,1
219830,insufflated,1,0
219831,gas,1,1
219832,",",1,0
219833,intraperitoneal,1,0
219834,pH-values,1,1
219835,and,1,0
219836,post-operative,1,1
219837,complications,1,1
219838,in,0,0
219839,the,0,0
219840,various,0,0
219841,subgroups,0,0
219842,were,0,0
219843,compared,0,0
219844,to,0,0
219845,each,0,0
219846,other,0,0
219847,with,0,0
219848,regard,0,0
219849,to,0,0
219850,post-operative,0,1
219851,pain,0,1
219852,perception,0,1
219853,.,0,0
219854,The,0,0
219855,results,0,0
219856,did,0,0
219857,not,0,0
219858,show,0,0
219859,any,0,0
219860,significant,0,0
219861,differences,0,0
219862,among,0,0
219863,the,0,0
219864,groups,0,0
219865,regarding,0,0
219866,the,0,0
219867,main,0,0
219868,parameters,0,1
219869,like,0,0
219870,pH-value,1,1
219871,or,1,0
219872,different,1,0
219873,insufflation,1,0
219874,pressures,1,1
219875,etc,0,0
219876,.,0,0
219877,These,0,0
219878,results,0,0
219879,led,0,0
219880,to,0,0
219881,the,0,0
219882,termination,0,0
219883,of,0,0
219884,the,0,0
219885,study,0,0
219886,based,0,0
219887,on,0,0
219888,the,0,0
219889,raised,0,0
219890,criteria,0,0
219891,since,0,0
219892,we,0,0
219893,anticipated,0,0
219894,the,0,0
219895,actual,0,1
219896,cause,0,0
219897,of,0,0
219898,the,0,0
219899,shoulder,0,0
219900,pain,0,1
219901,to,0,0
219902,be,0,0
219903,due,0,0
219904,to,0,0
219905,an,0,0
219906,unknown,0,0
219907,factor,0,0
219908,.,0,0
219909,By,0,0
219910,the,0,0
219911,evaluation,0,0
219912,of,0,0
219913,the,0,0
219914,individual,0,0
219915,data,0,0
219916,",",0,0
219917,it,0,0
219918,became,0,0
219919,apparent,0,0
219920,that,0,0
219921,",",0,0
219922,the,0,0
219923,pains,1,1
219924,increase,1,0
219925,with,0,0
219926,increasing,0,0
219927,gas,0,1
219928,consumption,0,1
219929,",",0,0
219930,a,0,0
219931,fact,0,0
219932,which,0,0
219933,led,0,0
219934,to,0,0
219935,assumption,0,0
219936,that,0,0
219937,the,0,0
219938,pains,1,1
219939,are,0,0
219940,caused,0,0
219941,by,0,0
219942,a,0,0
219943,physical,0,0
219944,effect,0,0
219945,such,0,0
219946,as,0,0
219947,the,0,0
219948,cooling,0,0
219949,of,0,0
219950,the,0,0
219951,peritoneum,0,0
219952,.,0,0
219953,[,0,0
219954,Effect,0,0
219955,of,0,0
219956,dopexamine,0,0
219957,in,0,0
219958,splanchnic,0,1
219959,perfusion,0,0
219960,during,0,0
219961,surgery,0,0
219962,of,0,0
219963,the,0,0
219964,abdominal,0,1
219965,aorta,0,0
219966,],0,0
219967,.,0,0
219968,Abdominal,0,1
219969,aortic,0,0
219970,surgery,0,0
219971,has,0,0
219972,significant,0,0
219973,effects,0,1
219974,on,0,0
219975,cardiac,0,1
219976,and,0,0
219977,splanchnic,0,1
219978,perfusion,0,0
219979,.,0,0
219980,The,0,0
219981,purpose,0,0
219982,of,0,0
219983,this,0,0
219984,study,0,0
219985,was,0,0
219986,to,0,0
219987,examine,0,0
219988,the,0,0
219989,effects,0,0
219990,of,0,0
219991,dopexamine,0,0
219992,",",0,0
219993,an,0,0
219994,inodilator,0,1
219995,drug,0,0
219996,",",0,0
219997,on,0,0
219998,hemodynamic,0,1
219999,and,0,0
220000,splanchnic,0,1
220001,perfusion,0,1
220002,with,0,0
220003,measurement,0,0
220004,of,0,0
220005,gastric,0,1
220006,intramucosal,0,1
220007,pH,0,1
220008,",",0,0
220009,by,0,0
220010,the,0,0
220011,method,0,0
220012,of,0,0
220013,gastric,0,1
220014,tonometry,0,1
220015,",",0,0
220016,during,0,0
220017,abdominal,0,1
220018,aneurysm,0,0
220019,resection,0,0
220020,.,0,0
220021,Twenty-five,0,0
220022,patients,0,0
220023,undergoing,0,0
220024,excision,0,0
220025,of,0,0
220026,an,0,0
220027,aortic,0,1
220028,abdominal,0,1
220029,aneurysm,0,1
220030,were,0,0
220031,randomly,0,0
220032,divided,0,0
220033,into,0,0
220034,two,0,0
220035,groups,0,0
220036,.,0,0
220037,During,0,0
220038,aortic,0,1
220039,cross-clamping,0,0
220040,Group,0,0
220041,II,0,0
220042,patients,0,0
220043,received,0,0
220044,dopexamine,0,0
220045,infusion,0,0
220046,",",0,0
220047,at,0,0
220048,a,0,0
220049,dose,0,0
220050,of,0,0
220051,1,0,0
220052,microgram/kg/m,0,0
220053,",",0,0
220054,and,0,0
220055,at,0,0
220056,a,0,0
220057,dose,0,0
220058,of,0,0
220059,0.5,0,0
220060,micrograms/kg/m,0,0
220061,from,0,0
220062,declamping,0,0
220063,to,0,0
220064,the,0,0
220065,end,0,0
220066,of,0,0
220067,the,0,0
220068,surgery,0,0
220069,.,0,0
220070,Whereas,0,0
220071,Group,0,0
220072,I,0,0
220073,patients,0,0
220074,did,0,0
220075,not,0,0
220076,receive,0,0
220077,a,0,0
220078,dopexamine,0,0
220079,infusion,0,0
220080,.,0,0
220081,During,0,0
220082,aortic,0,0
220083,cross-clamping,0,0
220084,the,0,0
220085,intramucosal,1,1
220086,pH,1,0
220087,value,1,0
220088,decreased,0,0
220089,in,0,0
220090,Group,0,0
220091,I,0,0
220092,patients,0,0
220093,",",0,0
220094,but,0,0
220095,did,0,0
220096,not,0,0
220097,change,0,0
220098,in,0,0
220099,Group,0,0
220100,II,0,0
220101,patients,0,0
220102,.,0,0
220103,Heart,1,0
220104,rate,1,1
220105,",",1,0
220106,cardiac,1,1
220107,index,1,1
220108,",",1,0
220109,and,1,1
220110,mixed,1,0
220111,venous,1,1
220112,oxygen,1,1
220113,saturation,1,1
220114,increased,0,0
220115,significantly,0,0
220116,during,0,0
220117,dopexamine,0,0
220118,infusion,0,0
220119,",",0,0
220120,whereas,0,0
220121,systemic,1,1
220122,vascular,1,1
220123,resistance,1,1
220124,was,0,0
220125,reduced,0,0
220126,.,0,0
220127,During,0,0
220128,aortic,0,1
220129,cross-clamping,0,0
220130,dopexamine,0,0
220131,was,0,0
220132,a,0,0
220133,useful,0,0
220134,agent,0,0
220135,in,0,0
220136,improving,0,1
220137,splanchnic,1,1
220138,blood,1,1
220139,flow,1,1
220140,",",1,0
220141,cardiac,1,1
220142,index,1,1
220143,venous,1,1
220144,saturation,1,1
220145,.,1,0
220146,Also,0,0
220147,",",0,0
220148,since,0,0
220149,the,0,0
220150,drug,0,0
220151,produces,0,0
220152,dose,0,0
220153,related,0,0
220154,hemodynamic,0,1
220155,changes,0,1
220156,of,0,0
220157,rapid,0,1
220158,onset,0,1
220159,and,0,1
220160,reversibility,0,1
220161,",",0,0
220162,it,0,0
220163,is,0,0
220164,possible,0,0
220165,to,0,0
220166,interrupt,0,0
220167,the,0,0
220168,infusion,0,0
220169,before,0,0
220170,aortic,0,1
220171,declamping,0,0
220172,to,0,0
220173,avoid,0,0
220174,the,0,0
220175,decrease,0,0
220176,in,0,0
220177,the,0,0
220178,intramucosal,0,1
220179,pH,0,0
220180,value,0,0
220181,.,0,0
220182,Promoting,0,0
220183,health,0,1
220184,in,0,0
220185,schools,0,0
220186,through,0,0
220187,a,0,0
220188,board,0,0
220189,game,0,0
220190,.,0,0
220191,Primary,0,1
220192,prevention,0,0
220193,and,0,1
220194,health,0,1
220195,promotion,0,0
220196,have,0,0
220197,become,0,0
220198,salient,0,0
220199,topics,0,0
220200,in,0,0
220201,Canadian,0,0
220202,society,0,0
220203,and,0,0
220204,in,0,0
220205,nursing,0,0
220206,during,0,0
220207,the,0,0
220208,past,0,0
220209,two,0,0
220210,decades,0,0
220211,.,0,0
220212,The,0,0
220213,noncommunicable,0,0
220214,chronic,0,0
220215,diseases,0,0
220216,",",0,0
220217,such,0,0
220218,as,0,0
220219,heart,0,1
220220,disease,0,1
220221,and,0,1
220222,cancer,0,0
220223,",",0,0
220224,have,0,0
220225,been,0,0
220226,linked,0,0
220227,to,0,0
220228,specific,0,0
220229,lifestyle,1,0
220230,behaviors,1,1
220231,or,0,0
220232,habits,0,1
220233,",",0,0
220234,which,0,0
220235,often,0,0
220236,develop,0,0
220237,early,0,0
220238,in,0,0
220239,life,0,1
220240,.,0,0
220241,The,0,0
220242,success,0,1
220243,of,0,0
220244,public,0,0
220245,health,0,0
220246,efforts,0,0
220247,to,0,0
220248,improve,0,0
220249,the,0,0
220250,health,0,1
220251,status,0,1
220252,of,0,0
220253,all,0,0
220254,Canadians,0,0
220255,depends,0,0
220256,substantially,0,0
220257,on,0,0
220258,the,0,0
220259,success,0,1
220260,of,0,0
220261,educational,0,0
220262,programs,0,0
220263,directed,0,0
220264,toward,0,0
220265,children,0,0
220266,.,0,0
220267,Effective,0,0
220268,teaching,0,0
220269,strategies,0,0
220270,that,0,0
220271,seek,0,0
220272,to,0,0
220273,promote,0,0
220274,health,0,1
220275,and,0,1
220276,wellness,0,1
220277,in,0,0
220278,children,0,0
220279,need,0,0
220280,to,0,0
220281,be,0,0
220282,developed,0,0
220283,and,0,0
220284,empirically,0,0
220285,evaluated,0,0
220286,.,0,0
220287,Educational,0,0
220288,games,0,0
220289,may,0,0
220290,provide,0,0
220291,an,0,0
220292,efficient,0,0
220293,vehicle,0,0
220294,for,0,0
220295,carrying,0,0
220296,out,0,0
220297,developmentally,0,0
220298,specific,0,0
220299,nursing,0,0
220300,interventions,0,0
220301,in,0,0
220302,school,0,0
220303,settings,0,0
220304,.,0,0
220305,This,0,0
220306,article,0,0
220307,begins,0,0
220308,with,0,0
220309,a,0,0
220310,brief,0,0
220311,overview,0,0
220312,of,0,0
220313,the,0,0
220314,historical,0,0
220315,origins,0,0
220316,of,0,0
220317,games,0,0
220318,",",0,0
220319,along,0,0
220320,with,0,0
220321,their,0,0
220322,advantages,0,0
220323,and,0,0
220324,disadvantages,0,0
220325,as,0,0
220326,educational,0,0
220327,strategies,0,0
220328,.,0,0
220329,The,0,0
220330,results,0,0
220331,of,0,0
220332,a,0,0
220333,pretest-posttest,0,0
220334,control,0,0
220335,group,0,0
220336,design,0,0
220337,study,0,0
220338,that,0,0
220339,evaluated,0,0
220340,the,0,0
220341,effectiveness,0,0
220342,of,0,0
220343,a,0,0
220344,board,0,0
220345,game,0,0
220346,as,0,0
220347,a,0,0
220348,primary,0,0
220349,prevention,0,0
220350,teaching,0,0
220351,strategy,0,0
220352,with,0,0
220353,23,0,0
220354,sixth,0,0
220355,grade,0,0
220356,children,0,0
220357,in,0,0
220358,Winnipeg,0,0
220359,",",0,0
220360,Manitoba,0,0
220361,are,0,0
220362,presented,0,0
220363,.,0,0
220364,The,0,0
220365,experimental,0,0
220366,group,0,0
220367,had,0,0
220368,significant,0,0
220369,gains,0,1
220370,in,0,0
220371,knowledge,1,0
220372,related,1,0
220373,to,1,0
220374,anatomy,1,0
220375,and,1,0
220376,physiology,1,1
220377,",",1,0
220378,diet,1,0
220379,",",1,0
220380,and,1,1
220381,lifestyle,1,1
220382,risk,1,1
220383,factors,1,0
220384,associated,1,0
220385,with,1,0
220386,the,1,0
220387,development,1,0
220388,of,1,0
220389,heart,1,1
220390,disease,1,1
220391,and,1,0
220392,cancer,1,0
220393,.,1,0
220394,Late,0,0
220395,hemodynamic,0,1
220396,effects,0,0
220397,of,0,0
220398,the,0,0
220399,preserved,0,0
220400,papillary,0,0
220401,muscles,0,0
220402,during,0,0
220403,mitral,0,1
220404,valve,0,0
220405,replacement,0,0
220406,.,0,0
220407,BACKGROUND,0,0
220408,The,0,0
220409,late,0,0
220410,hemodynamic,0,1
220411,effects,0,0
220412,of,0,0
220413,preserving,0,0
220414,the,0,0
220415,papillary,0,0
220416,muscles,0,0
220417,during,0,0
220418,mitral,0,1
220419,valve,0,0
220420,replacement,0,0
220421,have,0,0
220422,not,0,0
220423,been,0,0
220424,evaluated,0,0
220425,.,0,0
220426,METHODS,0,0
220427,AND,0,0
220428,RESULTS,0,0
220429,Sixteen,0,0
220430,patients,0,0
220431,who,0,0
220432,had,0,0
220433,chronic,0,0
220434,mitral,0,1
220435,regurgitation,0,1
220436,due,0,0
220437,to,0,0
220438,myxomatous,0,0
220439,degeneration,0,0
220440,were,0,0
220441,randomized,0,0
220442,to,0,0
220443,preservation,0,0
220444,(,0,0
220445,Pres,0,1
220446,group,0,0
220447,",",0,0
220448,n,0,0
220449,=,0,0
220450,8,0,0
220451,),0,0
220452,or,0,0
220453,no,0,0
220454,preservation,0,0
220455,(,0,0
220456,No,0,1
220457,Pres,0,1
220458,group,0,0
220459,",",0,0
220460,n,0,0
220461,=,0,0
220462,8,0,0
220463,),0,0
220464,of,0,0
220465,the,0,0
220466,chordae,0,1
220467,tendineae,0,1
220468,and,0,1
220469,papillary,0,1
220470,muscles,0,0
220471,during,0,0
220472,mitral,0,1
220473,valve,0,0
220474,replacement,0,0
220475,.,0,0
220476,Rest,0,0
220477,and,0,0
220478,exercise,0,0
220479,nuclear,0,1
220480,ventriculograms,0,0
220481,were,0,0
220482,performed,0,0
220483,early,0,0
220484,(,0,0
220485,3,0,0
220486,months,0,0
220487,),0,0
220488,and,0,0
220489,late,0,0
220490,(,0,0
220491,5,0,0
220492,years,0,0
220493,),0,0
220494,after,0,0
220495,surgery,0,0
220496,.,0,0
220497,Early,0,0
220498,after,0,0
220499,surgery,0,0
220500,",",0,0
220501,the,0,0
220502,No,0,0
220503,Pres,0,1
220504,group,0,0
220505,had,0,0
220506,lower,1,0
220507,ejection,1,1
220508,fractions,1,1
220509,and,1,1
220510,stroke,1,1
220511,work,1,0
220512,indexes,1,1
220513,(,0,0
220514,P,0,0
220515,<,0,0
220516,.05,0,0
220517,by,0,0
220518,repeated-measures,0,0
220519,[,0,0
220520,rm,0,0
220521,],0,0
220522,ANOVA,0,0
220523,),0,0
220524,than,0,0
220525,the,0,0
220526,Pres,0,0
220527,group,0,0
220528,did,0,0
220529,at,0,0
220530,similar,0,0
220531,end-diastolic,0,1
220532,volume,0,1
220533,indexes,0,1
220534,.,0,0
220535,The,0,0
220536,No,0,0
220537,Pres,0,1
220538,group,0,0
220539,had,0,0
220540,similar,0,0
220541,cardiac,1,1
220542,indexes,1,1
220543,after,0,0
220544,exercise,0,0
220545,because,0,0
220546,heart,1,1
220547,rate,1,1
220548,increased,1,0
220549,(,0,0
220550,P,0,0
220551,<,0,0
220552,.005,0,0
220553,by,0,0
220554,rm,0,0
220555,ANOVA,0,0
220556,),0,0
220557,.,0,0
220558,Late,0,0
220559,after,0,0
220560,surgery,0,0
220561,",",0,0
220562,ejection,1,1
220563,fraction,1,1
220564,was,0,0
220565,greater,0,0
220566,at,0,0
220567,similar,0,0
220568,end-diastolic,1,1
220569,volume,1,1
220570,indexes,1,1
220571,(,0,0
220572,P,0,0
220573,<,0,0
220574,.005,0,0
220575,by,0,0
220576,rm,0,0
220577,ANCOVA,0,1
220578,),0,0
220579,",",0,0
220580,and,0,1
220581,preload,1,1
220582,recruitable,1,1
220583,stroke,1,1
220584,work,1,0
220585,indexes,1,1
220586,(,0,0
220587,P,0,0
220588,<,0,0
220589,.001,0,0
220590,by,0,0
220591,rm,0,0
220592,ANCOVA,0,1
220593,),0,0
220594,were,0,0
220595,better,0,0
220596,in,0,0
220597,the,0,0
220598,Pres,0,0
220599,group,0,0
220600,.,0,0
220601,CONCLUSIONS,0,0
220602,Preserving,0,0
220603,chordal,0,0
220604,attachments,0,0
220605,enhanced,0,0
220606,the,0,0
220607,late,0,0
220608,hemodynamic,0,1
220609,recovery,0,1
220610,after,0,0
220611,mitral,0,1
220612,valve,0,0
220613,replacement,0,0
220614,for,0,0
220615,mitral,0,1
220616,regurgitation,0,1
220617,.,0,0
220618,Preventing,0,0
220619,disability,1,0
220620,and,1,0
220621,falls,1,1
220622,in,1,0
220623,older,1,0
220624,adults,1,0
220625,:,1,0
220626,a,0,0
220627,population-based,0,0
220628,randomized,0,0
220629,trial,0,0
220630,.,0,0
220631,OBJECTIVES,0,0
220632,Because,0,0
220633,preventing,0,0
220634,disability,1,0
220635,and,1,0
220636,falls,1,1
220637,in,1,0
220638,older,1,0
220639,adults,1,0
220640,is,0,0
220641,a,0,0
220642,national,0,0
220643,priority,0,0
220644,",",0,0
220645,a,0,0
220646,randomized,0,0
220647,controlled,0,0
220648,trial,0,0
220649,was,0,0
220650,conducted,0,0
220651,to,0,0
220652,test,0,0
220653,a,0,0
220654,multicomponent,0,0
220655,intervention,0,0
220656,program,0,0
220657,.,0,0
220658,METHODS,0,0
220659,From,0,0
220660,a,0,0
220661,random,0,0
220662,sample,0,0
220663,of,0,0
220664,health,0,1
220665,maintenance,0,0
220666,organization,0,1
220667,(,0,0
220668,HMO,0,0
220669,),0,0
220670,enrollees,0,0
220671,65,0,0
220672,years,0,0
220673,and,0,0
220674,older,0,0
220675,",",0,0
220676,1559,0,0
220677,ambulatory,0,0
220678,seniors,0,0
220679,were,0,0
220680,randomized,0,0
220681,to,0,0
220682,one,0,0
220683,of,0,0
220684,three,0,0
220685,groups,0,0
220686,:,0,0
220687,a,0,0
220688,nurse,0,0
220689,assessment,0,0
220690,visit,0,1
220691,and,0,1
220692,follow-up,0,0
220693,interventions,0,0
220694,targeting,0,0
220695,risk,0,1
220696,factors,0,0
220697,for,0,0
220698,disability,0,1
220699,and,0,1
220700,falls,0,1
220701,(,0,0
220702,group,0,0
220703,1,0,0
220704,",",0,0
220705,n,0,0
220706,=,0,0
220707,635,0,0
220708,),0,0
220709,;,0,0
220710,a,0,0
220711,general,0,0
220712,health,0,1
220713,promotion,0,0
220714,nurse,0,1
220715,visit,0,1
220716,(,0,0
220717,group,0,0
220718,2,0,0
220719,",",0,0
220720,n,0,0
220721,=,0,0
220722,317,0,0
220723,),0,0
220724,;,0,0
220725,and,0,0
220726,usual,0,0
220727,care,0,0
220728,(,0,0
220729,group,0,0
220730,3,0,0
220731,",",0,0
220732,n,0,0
220733,=,0,0
220734,607,0,0
220735,),0,0
220736,.,0,0
220737,Data,0,1
220738,collection,0,0
220739,consisted,0,0
220740,of,0,0
220741,a,0,0
220742,baseline,0,0
220743,and,0,0
220744,two,0,0
220745,annual,0,0
220746,follow-up,0,0
220747,surveys,0,0
220748,.,0,0
220749,RESULTS,0,0
220750,After,0,0
220751,1,0,0
220752,year,0,0
220753,",",0,0
220754,group,0,0
220755,1,0,0
220756,subjects,0,0
220757,reported,0,0
220758,a,0,0
220759,significantly,0,0
220760,lower,0,0
220761,incidence,1,1
220762,of,1,0
220763,declining,1,0
220764,functional,1,0
220765,status,1,1
220766,and,0,0
220767,a,0,0
220768,significantly,0,0
220769,lower,0,0
220770,incidence,1,1
220771,of,1,1
220772,falls,1,1
220773,than,0,0
220774,group,0,0
220775,3,0,0
220776,subjects,0,0
220777,.,0,0
220778,Group,0,0
220779,2,0,0
220780,subjects,0,0
220781,had,0,0
220782,intermediate,0,0
220783,levels,0,1
220784,of,0,0
220785,most,0,0
220786,outcomes,0,0
220787,.,0,0
220788,After,0,0
220789,2,0,0
220790,years,0,0
220791,of,0,0
220792,follow-up,0,0
220793,",",0,0
220794,the,0,0
220795,differences,0,0
220796,narrowed,0,0
220797,.,0,0
220798,CONCLUSIONS,0,0
220799,The,0,0
220800,results,0,0
220801,suggest,0,0
220802,that,0,0
220803,a,0,0
220804,modest,0,0
220805,",",0,0
220806,one-time,0,0
220807,prevention,0,0
220808,program,0,0
220809,appeared,0,0
220810,to,0,0
220811,confer,0,0
220812,short-term,1,0
220813,health,1,1
220814,benefits,1,0
220815,on,0,0
220816,ambulatory,0,0
220817,HMO,0,0
220818,enrollees,0,0
220819,",",0,0
220820,although,0,0
220821,benefits,1,0
220822,diminished,1,0
220823,by,0,0
220824,the,0,0
220825,second,0,0
220826,year,0,0
220827,of,0,0
220828,follow-up,0,0
220829,.,0,0
220830,The,0,0
220831,mechanisms,0,0
220832,by,0,0
220833,which,0,0
220834,the,0,0
220835,intervention,0,0
220836,may,0,0
220837,have,0,0
220838,improved,0,0
220839,outcomes,0,0
220840,require,0,0
220841,further,0,0
220842,investigation,0,0
220843,.,0,0
220844,Anaphylactoid,1,1
220845,reactions,1,1
220846,and,1,1
220847,histamine,1,1
220848,release,1,1
220849,by,0,0
220850,plasma,0,1
220851,substitutes,0,0
220852,:,0,0
220853,a,0,0
220854,randomized,0,0
220855,controlled,0,0
220856,trial,0,0
220857,in,0,0
220858,human,0,0
220859,subjects,0,0
220860,and,0,0
220861,in,0,0
220862,dogs,0,0
220863,[,0,0
220864,proceedings,0,0
220865,],0,0
220866,.,0,0
220867,Endurance,0,1
220868,physical,0,1
220869,activity,0,1
220870,",",0,0
220871,diet,0,0
220872,and,0,0
220873,fibrinolysis,0,1
220874,.,0,0
220875,The,0,0
220876,impact,0,0
220877,of,0,0
220878,long-term,0,0
220879,",",0,0
220880,heavy,0,0
220881,exercise,0,0
220882,on,0,0
220883,recently,0,0
220884,established,0,0
220885,cardiovascular/thromboembolic,0,1
220886,risk,0,0
220887,factors,0,0
220888,of,0,0
220889,the,0,0
220890,fibrinolytic,0,0
220891,system,0,0
220892,",",0,0
220893,tissue,0,1
220894,plasminogen,0,1
220895,activator,0,0
220896,(,0,0
220897,tPA,0,1
220898,),0,1
220899,and,0,0
220900,plasminogen,0,1
220901,activator,0,1
220902,inhibitor,0,0
220903,(,0,0
220904,PAI-1,0,0
220905,),0,0
220906,in,0,0
220907,relation,0,0
220908,to,0,0
220909,food,0,0
220910,composition,0,0
220911,was,0,0
220912,studied,0,0
220913,.,0,0
220914,Twenty,0,0
220915,healthy,0,0
220916,men,0,0
220917,",",0,0
220918,aged,0,0
220919,18-55,0,0
220920,years,0,0
220921,participated,0,0
220922,in,0,0
220923,a,0,0
220924,14-day,0,0
220925,skiing,0,0
220926,tour,0,0
220927,through,0,0
220928,the,0,0
220929,Swedish,0,0
220930,mountains,0,0
220931,",",0,0
220932,carrying,0,0
220933,a,0,0
220934,pack,0,0
220935,load,0,1
220936,of,0,0
220937,30,0,0
220938,kg,0,0
220939,",",0,0
220940,and,0,0
220941,spending,0,1
220942,each,0,0
220943,night,0,1
220944,in,0,0
220945,self-dug,0,1
220946,igloos,0,0
220947,(,0,0
220948,ambient,0,1
220949,temp,0,1
220950,-10,0,0
220951,degrees,0,0
220952,to,0,0
220953,-25,0,0
220954,degrees,0,0
220955,C,0,0
220956,),0,0
220957,",",0,0
220958,and,0,1
220959,were,0,0
220960,randomized,0,0
220961,to,0,0
220962,2,0,0
220963,food,0,0
220964,regimens,0,0
220965,having,0,0
220966,30,0,0
220967,or,0,0
220968,40,0,0
220969,energy,0,1
220970,percent,0,0
220971,of,0,0
220972,fat,0,1
220973,.,0,0
220974,Individual,0,0
220975,records,0,0
220976,were,0,0
220977,kept,0,0
220978,of,0,0
220979,all,0,0
220980,consumed,0,0
220981,food,0,0
220982,.,0,0
220983,Citrated,1,0
220984,plasma,1,1
220985,was,0,0
220986,obtained,0,0
220987,before,0,0
220988,and,0,0
220989,after,0,0
220990,1,0,0
220991,and,0,0
220992,2,0,0
220993,weeks,0,0
220994,of,0,0
220995,exercise,0,0
220996,:,0,0
220997,tPA,1,1
220998,release,1,1
220999,was,0,0
221000,assessed,0,0
221001,by,0,0
221002,a,0,0
221003,10,0,0
221004,min,0,0
221005,venous,0,1
221006,occlusion,0,1
221007,(,0,0
221008,VO,0,1
221009,),0,0
221010,test,0,0
221011,.,0,0
221012,At,0,0
221013,baseline,0,0
221014,",",0,0
221015,daily,1,0
221016,dietary,1,0
221017,fiber,1,0
221018,intake,1,1
221019,correlated,0,0
221020,negatively,0,0
221021,with,0,0
221022,PAI-1,0,0
221023,activity,0,1
221024,.,0,0
221025,Already,0,0
221026,after,0,0
221027,the,0,0
221028,first,0,0
221029,week,0,0
221030,of,0,0
221031,the,0,0
221032,skiing,0,0
221033,tour,0,0
221034,there,0,0
221035,were,0,0
221036,significant,0,0
221037,drops,0,0
221038,in,0,0
221039,PAI-1,1,0
221040,activities,1,1
221041,",",1,0
221042,cholesterol,1,1
221043,and,1,0
221044,triglycerides,1,1
221045,.,1,0
221046,The,0,0
221047,tPA,1,1
221048,mass,1,1
221049,concentrations,1,1
221050,also,0,0
221051,dropped,0,0
221052,",",0,0
221053,both,0,0
221054,before,0,0
221055,and,0,0
221056,after,0,0
221057,VO,0,1
221058,",",0,0
221059,but,0,0
221060,tPA,1,1
221061,activities,1,1
221062,were,0,0
221063,unchanged,0,0
221064,",",0,0
221065,as,0,0
221066,were,0,0
221067,von,1,0
221068,Willebrand,1,1
221069,factor,1,1
221070,(,1,0
221071,vWF,1,1
221072,),1,0
221073,levels,1,1
221074,.,1,0
221075,These,0,0
221076,changes,0,1
221077,were,0,0
221078,related,0,0
221079,mainly,0,0
221080,to,0,0
221081,the,0,0
221082,expenditure,0,1
221083,of,0,0
221084,energy,0,1
221085,",",0,0
221086,calculated,0,0
221087,from,0,0
221088,the,0,0
221089,food,0,0
221090,consumption,0,1
221091,",",0,1
221092,and,0,0
221093,appeared,0,0
221094,to,0,0
221095,be,0,0
221096,mediated,0,0
221097,through,0,0
221098,changed,0,0
221099,insulin,0,1
221100,sensitivity,0,1
221101,and,0,1
221102,decreased,0,1
221103,body,0,1
221104,fat,0,1
221105,mass,0,1
221106,.,0,0
221107,The,0,0
221108,energy,0,1
221109,percent,0,1
221110,of,0,0
221111,fat,0,1
221112,in,0,0
221113,the,0,0
221114,food,0,0
221115,had,0,0
221116,no,0,0
221117,differential,0,0
221118,impact,0,0
221119,.,0,0
221120,The,0,0
221121,effects,0,0
221122,receded,0,0
221123,a,0,0
221124,few,0,0
221125,weeks,0,0
221126,after,0,0
221127,cessation,0,0
221128,of,0,0
221129,the,0,0
221130,endurance,0,0
221131,exercise,0,0
221132,.,0,0
221133,Thus,0,0
221134,",",0,0
221135,endurance,0,1
221136,physical,0,0
221137,activity,0,1
221138,improves,0,0
221139,the,0,0
221140,fibrinolytic,0,0
221141,risk,0,1
221142,factor,0,1
221143,profile,0,1
221144,by,0,0
221145,reducing,0,0
221146,PAI-1,0,0
221147,while,0,0
221148,leaving,0,0
221149,tPA,1,1
221150,activity,0,1
221151,unaffected,0,0
221152,",",0,0
221153,independently,0,0
221154,of,0,0
221155,food,0,0
221156,composition,0,0
221157,.,0,0
221158,A,0,0
221159,low,0,0
221160,dietary,0,0
221161,fiber,0,0
221162,intake,0,0
221163,appears,0,0
221164,to,0,0
221165,be,0,0
221166,associated,0,0
221167,with,0,0
221168,higher,0,0
221169,PAI-1,1,0
221170,activities,1,1
221171,at,0,0
221172,baseline,0,0
221173,.,0,0
221174,Interactive,0,0
221175,effects,0,1
221176,of,0,0
221177,indomethacin,0,0
221178,",",0,0
221179,angiotensin,0,1
221180,II,0,0
221181,and,0,0
221182,frusemide,0,0
221183,on,0,0
221184,renal,0,1
221185,haemodynamics,0,1
221186,and,0,0
221187,natriuresis,0,1
221188,in,0,0
221189,man,0,0
221190,.,0,0
221191,The,0,0
221192,responses,0,1
221193,of,0,0
221194,renal,0,1
221195,haemodynamic,0,1
221196,and,0,0
221197,natriuretic,0,1
221198,indices,0,1
221199,to,0,0
221200,the,0,0
221201,oral,0,0
221202,prostaglandin,0,0
221203,synthetase,0,0
221204,inhibitor,0,0
221205,indomethacin,0,0
221206,(,0,0
221207,200,0,0
221208,mg,0,0
221209,),0,0
221210,",",0,0
221211,to,0,0
221212,infused,0,0
221213,angiotensin,0,0
221214,II,0,0
221215,(,0,0
221216,1,0,0
221217,ng,0,0
221218,min-1,0,0
221219,kg-1,0,0
221220,),0,0
221221,and,0,0
221222,to,0,0
221223,the,0,0
221224,combination,0,0
221225,of,0,0
221226,the,0,0
221227,two,0,0
221228,were,0,0
221229,studies,0,0
221230,in,0,0
221231,placebo-controlled,0,0
221232,fashion,0,0
221233,in,0,0
221234,eight,0,0
221235,normal,0,0
221236,male,0,0
221237,subjects,0,0
221238,both,0,0
221239,prior,0,0
221240,to,0,0
221241,and,0,0
221242,following,0,0
221243,administration,0,0
221244,of,0,0
221245,intravenous,0,0
221246,frusemide,0,0
221247,(,0,0
221248,20,0,0
221249,mg,0,0
221250,),0,0
221251,.,0,0
221252,As,0,0
221253,compared,0,0
221254,with,0,0
221255,placebo,0,0
221256,",",0,0
221257,angiotensin,0,1
221258,II,0,1
221259,infusion,0,0
221260,alone,0,0
221261,caused,0,0
221262,significant,0,0
221263,reductions,0,1
221264,in,0,0
221265,absolute,1,1
221266,rate,1,1
221267,of,1,0
221268,sodium,1,0
221269,excretion,1,1
221270,",",1,0
221271,fractional,1,1
221272,sodium,1,0
221273,excretion,1,1
221274,",",1,0
221275,urine,1,1
221276,flow,1,1
221277,rate,1,1
221278,and,1,1
221279,effective,1,1
221280,renal,1,1
221281,plasma,1,1
221282,flow,1,1
221283,(,0,0
221284,all,0,0
221285,P,0,0
221286,<,0,0
221287,0.001,0,0
221288,vs,0,0
221289,placebo,0,0
221290,),0,1
221291,but,0,0
221292,had,0,0
221293,no,0,0
221294,effect,0,0
221295,on,0,0
221296,glomerular,1,1
221297,filtration,1,1
221298,rate,1,1
221299,.,1,0
221300,The,0,0
221301,only,0,0
221302,change,0,0
221303,observed,0,0
221304,in,0,0
221305,these,0,0
221306,parameters,0,1
221307,with,0,0
221308,indomethacin,0,0
221309,alone,0,0
221310,was,0,0
221311,a,0,0
221312,small,0,0
221313,but,0,0
221314,significant,0,0
221315,reduction,0,1
221316,in,0,0
221317,urine,1,1
221318,flow,1,1
221319,rate,1,1
221320,(,0,0
221321,P,0,0
221322,<,0,0
221323,0.005,0,0
221324,vs,0,0
221325,placebo,0,0
221326,),0,0
221327,.,0,0
221328,As,0,0
221329,compared,0,0
221330,with,0,0
221331,the,0,0
221332,effects,0,0
221333,of,0,0
221334,angiotensin,0,0
221335,II,0,0
221336,alone,0,0
221337,",",0,0
221338,indomethacin,0,0
221339,pre-treatment,0,0
221340,followed,0,0
221341,by,0,0
221342,angiotensin,0,0
221343,II,0,0
221344,infusion,0,0
221345,led,0,0
221346,to,0,0
221347,much,0,0
221348,greater,0,0
221349,falls,1,1
221350,in,0,0
221351,absolute,1,1
221352,rate,1,1
221353,of,1,0
221354,sodium,1,0
221355,excretion,1,1
221356,",",1,0
221357,fractional,1,1
221358,sodium,1,0
221359,excretion,1,1
221360,",",1,0
221361,urine,1,1
221362,flow,1,1
221363,rate,1,1
221364,and,1,1
221365,effective,1,1
221366,renal,1,1
221367,plasma,1,1
221368,flow,1,1
221369,(,0,0
221370,all,0,0
221371,P,0,0
221372,<,0,0
221373,0.0001,0,0
221374,vs,0,0
221375,placebo,0,0
221376,),0,0
221377,associated,0,0
221378,with,0,0
221379,a,0,0
221380,significant,0,0
221381,reduction,0,1
221382,in,0,0
221383,glomerular,1,1
221384,filtration,1,1
221385,rate,1,1
221386,(,0,0
221387,P,0,0
221388,<,0,0
221389,0.0001,0,0
221390,),0,0
221391,not,0,0
221392,observed,0,0
221393,with,0,0
221394,angiotensin,0,0
221395,II,0,0
221396,alone,0,0
221397,.,0,0
221398,Frusemide,0,0
221399,administration,0,0
221400,at,0,0
221401,the,0,0
221402,midpoint,0,0
221403,of,0,0
221404,each,0,0
221405,study,0,0
221406,limb,0,1
221407,resulted,0,0
221408,in,0,0
221409,each,0,0
221410,case,0,0
221411,in,0,0
221412,a,0,0
221413,prompt,0,0
221414,15,0,0
221415,to,0,0
221416,20,0,0
221417,fold,0,0
221418,increase,0,0
221419,in,0,0
221420,natriuresis,1,1
221421,.,1,0
221422,The,0,0
221423,renal,1,1
221424,haemodynamic,1,1
221425,and,1,0
221426,natriuretic,1,1
221427,effects,1,1
221428,of,0,0
221429,angiotensin,0,0
221430,II,0,0
221431,",",0,1
221432,indomethacin,0,0
221433,and,0,0
221434,their,0,0
221435,combination,0,0
221436,were,0,0
221437,not,0,0
221438,qualitatively,0,0
221439,different,0,0
221440,from,0,0
221441,those,0,0
221442,observed,0,0
221443,in,0,0
221444,the,0,0
221445,pre-frusemide,0,0
221446,phase,0,0
221447,.,0,0
221448,Our,0,0
221449,findings,0,0
221450,provide,0,0
221451,a,0,0
221452,clear,0,0
221453,demonstration,0,0
221454,in,0,0
221455,man,0,0
221456,of,0,0
221457,the,0,0
221458,important,0,0
221459,homeostatic,1,1
221460,role,1,0
221461,of,0,0
221462,renal,0,1
221463,prostaglandins,0,1
221464,in,0,0
221465,preserving,0,0
221466,renal,1,1
221467,function,1,1
221468,",",1,0
221469,particularly,1,0
221470,glomerular,1,1
221471,filtration,1,1
221472,",",0,0
221473,under,0,0
221474,conditions,0,0
221475,of,0,0
221476,elevated,0,0
221477,circulating,0,1
221478,angiotensin,0,0
221479,II,0,0
221480,.,0,0
221481,Relationship,0,0
221482,between,0,0
221483,subjective,0,1
221484,effects,0,1
221485,and,0,1
221486,drug,0,0
221487,preferences,0,0
221488,:,0,0
221489,ethanol,0,0
221490,and,0,0
221491,diazepam,0,0
221492,.,0,0
221493,The,0,0
221494,relationship,0,0
221495,between,0,0
221496,subjective,0,1
221497,effects,0,1
221498,and,0,1
221499,drug,0,0
221500,preferences,0,1
221501,in,0,0
221502,normal,0,0
221503,volunteers,0,0
221504,was,0,0
221505,explored,0,0
221506,in,0,0
221507,a,0,0
221508,meta-analysis,0,0
221509,of,0,0
221510,several,0,0
221511,previously,0,0
221512,published,0,0
221513,studies,0,0
221514,.,0,0
221515,Subjective,0,1
221516,effects,0,1
221517,of,0,0
221518,",",0,0
221519,and,0,1
221520,preference,0,1
221521,for,0,0
221522,",",0,0
221523,ethanol,0,0
221524,and,0,1
221525,diazepam,0,0
221526,vs.,0,0
221527,placebo,0,0
221528,were,0,0
221529,measured,0,0
221530,using,0,0
221531,a,0,0
221532,choice,0,0
221533,procedure,0,0
221534,.,0,0
221535,Subjects,0,0
221536,were,0,0
221537,grouped,0,0
221538,according,0,0
221539,to,0,0
221540,their,0,0
221541,drug,0,0
221542,choices,0,0
221543,:,0,0
221544,'non-choosers,0,0
221545,',0,0
221546,never,0,0
221547,chose,0,0
221548,drug,0,0
221549,",",0,0
221550,whereas,0,0
221551,'choosers,0,0
221552,',0,0
221553,always,0,0
221554,chose,0,0
221555,drug,0,0
221556,.,0,0
221557,The,0,0
221558,two,0,0
221559,groups,0,0
221560,were,0,0
221561,compared,0,0
221562,on,0,0
221563,their,0,0
221564,subjective,0,1
221565,responses,0,1
221566,to,0,0
221567,drug,0,0
221568,and,0,0
221569,on,0,0
221570,demographic,0,0
221571,variables,0,0
221572,.,0,0
221573,Ethanol,0,0
221574,decreased,1,0
221575,Arousal,1,1
221576,",",1,0
221577,Elation,1,1
221578,",",1,0
221579,Positive,1,1
221580,Mood,1,1
221581,and,1,1
221582,Vigor,1,1
221583,",",0,1
221584,and,0,1
221585,increased,1,1
221586,Anxiety,1,1
221587,",",1,0
221588,Depression,1,1
221589,and,1,1
221590,Fatigue,1,1
221591,in,0,0
221592,the,0,0
221593,non-choosers,0,0
221594,",",0,0
221595,whereas,0,0
221596,it,0,0
221597,increased,1,0
221598,Arousal,1,1
221599,and,1,1
221600,Vigor,1,1
221601,in,0,0
221602,the,0,0
221603,choosers,0,0
221604,.,0,0
221605,Ethanol,0,0
221606,choosers,0,0
221607,were,0,0
221608,also,0,0
221609,more,0,0
221610,likely,1,0
221611,to,1,0
221612,be,1,0
221613,males,1,0
221614,and/or,1,0
221615,full-time,1,0
221616,students,1,0
221617,than,0,0
221618,non-choosers,0,0
221619,.,0,0
221620,Diazepam,0,0
221621,produced,0,0
221622,sedative-like,1,1
221623,effects,1,0
221624,in,0,0
221625,both,0,0
221626,choosers,0,0
221627,and,0,0
221628,non-choosers,0,0
221629,",",0,1
221630,but,0,0
221631,markedly,0,0
221632,decreased,1,0
221633,Anxiety,1,1
221634,and,1,1
221635,increased,1,0
221636,Friendliness,1,1
221637,in,0,0
221638,choosers,0,0
221639,only,0,0
221640,.,0,0
221641,Diazepam,0,0
221642,choice,0,0
221643,was,0,0
221644,also,0,0
221645,associated,0,0
221646,with,0,0
221647,more,1,0
221648,frequent,1,1
221649,recreational,1,0
221650,use,1,0
221651,of,1,0
221652,marijuana,1,1
221653,and,1,0
221654,stimulants,1,0
221655,.,1,0
221656,Thus,0,0
221657,",",0,0
221658,both,0,0
221659,demographic,1,1
221660,variables,1,0
221661,and,1,0
221662,subjective,1,1
221663,drug,1,0
221664,effects,1,1
221665,were,0,0
221666,related,0,0
221667,to,0,0
221668,drug,0,0
221669,preference,0,0
221670,.,0,0
221671,Surrogate,0,0
221672,and,0,0
221673,auxiliary,0,1
221674,endpoints,0,1
221675,in,0,0
221676,clinical,0,0
221677,trials,0,0
221678,",",0,0
221679,with,0,0
221680,potential,0,0
221681,applications,0,0
221682,in,0,0
221683,cancer,0,0
221684,and,0,1
221685,AIDS,0,0
221686,research,0,0
221687,.,0,0
221688,Surrogate,0,0
221689,endpoints,0,1
221690,have,0,0
221691,been,0,0
221692,defined,0,0
221693,by,0,0
221694,Prentice,0,0
221695,as,0,0
221696,response,0,1
221697,variables,0,0
221698,that,0,0
221699,can,0,0
221700,substitute,0,0
221701,for,0,0
221702,a,0,0
221703,'true,0,1
221704,',0,0
221705,endpoint,0,0
221706,for,0,0
221707,the,0,0
221708,purpose,0,0
221709,of,0,0
221710,comparing,0,0
221711,specific,0,0
221712,interventions,0,0
221713,or,0,0
221714,treatments,0,0
221715,in,0,0
221716,a,0,0
221717,clinical,0,0
221718,trial,0,0
221719,.,0,0
221720,The,0,0
221721,applicability,0,0
221722,of,0,0
221723,this,0,0
221724,definition,0,0
221725,",",0,0
221726,and,0,1
221727,of,0,1
221728,related,0,1
221729,surrogate,0,0
221730,endpoint,0,1
221731,criteria,0,0
221732,",",0,0
221733,is,0,0
221734,discussed,0,0
221735,",",0,0
221736,with,0,0
221737,emphasis,0,0
221738,on,0,0
221739,cancer,0,0
221740,and,0,1
221741,AIDS,0,0
221742,research,0,0
221743,settings,0,0
221744,.,0,0
221745,Auxiliary,0,0
221746,endpoints,0,1
221747,are,0,0
221748,defined,0,0
221749,as,0,0
221750,response,0,1
221751,variables,0,1
221752,",",0,0
221753,or,0,0
221754,covariates,0,1
221755,",",0,0
221756,that,0,0
221757,can,0,0
221758,strengthen,0,0
221759,true,0,0
221760,endpoint,0,0
221761,analyses,0,0
221762,.,0,0
221763,Specifically,0,0
221764,",",0,0
221765,such,0,0
221766,response,0,1
221767,variables,0,0
221768,provide,0,0
221769,some,0,0
221770,additional,0,0
221771,information,0,0
221772,on,0,0
221773,true,0,0
221774,endpoint,0,1
221775,occurrence,0,1
221776,times,0,1
221777,for,0,0
221778,study,0,0
221779,subjects,0,0
221780,having,0,0
221781,censored,0,0
221782,values,0,1
221783,for,0,0
221784,such,0,0
221785,times,0,0
221786,.,0,0
221787,Auxiliary,0,0
221788,variables,0,0
221789,will,0,0
221790,very,0,0
221791,frequently,0,0
221792,be,0,0
221793,available,0,0
221794,",",0,0
221795,and,0,0
221796,they,0,0
221797,may,0,0
221798,be,0,0
221799,able,0,0
221800,to,0,0
221801,be,0,0
221802,used,0,0
221803,without,0,0
221804,making,0,0
221805,additional,0,0
221806,strong,0,0
221807,assumptions,0,0
221808,.,0,0
221809,Approaches,0,0
221810,to,0,0
221811,the,0,0
221812,use,0,0
221813,of,0,0
221814,auxiliary,0,0
221815,variables,0,0
221816,using,0,0
221817,ideas,0,0
221818,based,0,0
221819,on,0,0
221820,augmented,0,0
221821,score,0,1
221822,and,0,0
221823,augmented,0,1
221824,likelihood,0,1
221825,methods,0,0
221826,are,0,0
221827,described,0,0
221828,.,0,0
221829,Short-term,0,0
221830,effects,0,1
221831,of,0,0
221832,denopamine,0,0
221833,on,0,0
221834,anaerobic,1,0
221835,threshold,1,1
221836,and,1,0
221837,related,1,1
221838,parameters,1,1
221839,in,0,0
221840,patients,0,0
221841,with,0,0
221842,chronic,0,0
221843,heart,0,0
221844,failure,0,0
221845,:,0,0
221846,a,0,0
221847,double-blind,0,0
221848,crossover,0,0
221849,study,0,0
221850,.,0,0
221851,BACKGROUND,0,0
221852,The,0,0
221853,short-term,0,0
221854,effects,0,0
221855,of,0,0
221856,denopamine,0,0
221857,",",0,0
221858,an,0,0
221859,orally,0,0
221860,available,0,0
221861,beta-stimulant,0,0
221862,",",0,0
221863,on,0,0
221864,exercise,0,0
221865,capacity,0,1
221866,were,0,0
221867,studied,0,0
221868,in,0,0
221869,patients,0,0
221870,with,0,0
221871,chronic,0,0
221872,heart,0,0
221873,failure,0,1
221874,.,0,0
221875,METHODS,0,0
221876,AND,0,0
221877,RESULTS,0,0
221878,Nineteen,0,0
221879,patients,0,0
221880,entered,0,0
221881,the,0,0
221882,study,0,0
221883,.,0,0
221884,Three,0,0
221885,patients,0,0
221886,had,0,0
221887,ischemic,0,0
221888,heart,0,1
221889,disease,0,0
221890,",",0,0
221891,13,0,0
221892,had,0,0
221893,dilated,0,0
221894,cardiomyopathy,0,1
221895,",",0,0
221896,and,0,0
221897,three,0,0
221898,had,0,0
221899,valvular,0,0
221900,disease,0,0
221901,;,0,0
221902,16,0,0
221903,patients,0,0
221904,were,0,0
221905,in,0,0
221906,New,0,1
221907,York,0,0
221908,Heart,0,0
221909,Association,0,0
221910,class,0,0
221911,II,0,0
221912,",",0,0
221913,and,0,0
221914,three,0,0
221915,patients,0,0
221916,were,0,0
221917,in,0,0
221918,New,0,1
221919,York,0,0
221920,Heart,0,0
221921,Association,0,0
221922,class,0,0
221923,III,0,0
221924,.,0,0
221925,Symptom-limited,0,0
221926,exercise,0,0
221927,testing,0,0
221928,(,0,0
221929,ramp,0,1
221930,protocol,0,0
221931,),0,0
221932,on,0,0
221933,a,0,0
221934,bicycle,0,0
221935,ergometer,0,0
221936,with,0,0
221937,gas,0,1
221938,exchange,0,1
221939,analysis,0,0
221940,was,0,0
221941,conducted,0,0
221942,1,0,0
221943,hour,0,0
221944,after,0,0
221945,oral,0,0
221946,administration,0,0
221947,of,0,0
221948,either,0,0
221949,20,0,0
221950,mg,0,0
221951,denopamine,0,0
221952,or,0,0
221953,placebo,0,0
221954,.,0,1
221955,Drug,0,0
221956,administration,0,0
221957,sequence,0,1
221958,was,0,0
221959,randomly,0,0
221960,assigned,0,0
221961,in,0,0
221962,a,0,0
221963,double-blind,0,0
221964,crossover,0,0
221965,method,0,0
221966,",",0,0
221967,with,0,0
221968,1,0,0
221969,week,0,0
221970,between,0,0
221971,drugs,0,0
221972,.,0,0
221973,Peak,1,1
221974,VO2,1,0
221975,was,0,0
221976,20.4,0,0
221977,+/-,0,0
221978,3.2,0,0
221979,and,0,0
221980,21.2,0,0
221981,+/-,0,0
221982,3.1,0,0
221983,ml/min/kg,0,0
221984,",",0,0
221985,respectively,0,0
221986,",",0,0
221987,for,0,0
221988,those,0,0
221989,administered,0,0
221990,the,0,0
221991,placebo,0,0
221992,and,0,0
221993,the,0,0
221994,drug,0,0
221995,",",0,0
221996,and,0,1
221997,anaerobic,1,1
221998,threshold,1,1
221999,was,0,0
222000,13.1,0,0
222001,+/-,0,0
222002,2.1,0,0
222003,and,0,0
222004,14.0,0,0
222005,+/-,0,0
222006,2.0,0,0
222007,ml/min/kg,0,0
222008,.,0,0
222009,There,0,0
222010,was,0,0
222011,a,0,0
222012,significant,0,0
222013,increase,0,0
222014,in,0,0
222015,peak,1,1
222016,VO2,1,0
222017,(,0,0
222018,p,0,0
222019,<,0,0
222020,0.05,0,0
222021,),0,0
222022,and,0,0
222023,anaerobic,1,1
222024,threshold,1,1
222025,(,0,0
222026,p,0,0
222027,<,0,0
222028,0.01,0,0
222029,),0,0
222030,with,0,0
222031,denopamine,0,0
222032,",",0,0
222033,whereas,0,0
222034,no,0,0
222035,significant,0,0
222036,change,0,0
222037,was,0,0
222038,observed,0,0
222039,in,0,0
222040,peak,1,1
222041,work,1,0
222042,rate,1,1
222043,or,1,1
222044,exercise,1,0
222045,time,1,1
222046,.,1,0
222047,Denopamine,0,0
222048,increased,0,0
222049,heart,1,1
222050,rate,1,1
222051,in,0,0
222052,patients,0,0
222053,with,0,0
222054,atrial,0,1
222055,fibrillation,0,1
222056,but,0,0
222057,had,0,0
222058,little,0,0
222059,effect,0,0
222060,on,0,0
222061,heart,1,1
222062,rate,1,1
222063,in,0,0
222064,patients,0,0
222065,with,0,0
222066,sinus,0,0
222067,rhythm,0,0
222068,.,0,0
222069,CONCLUSION,0,0
222070,Data,0,1
222071,obtained,0,0
222072,from,0,0
222073,gas,0,1
222074,exchange,0,1
222075,analysis,0,0
222076,are,0,0
222077,more,0,0
222078,sensitive,0,0
222079,and,0,0
222080,potentially,0,0
222081,more,0,0
222082,useful,0,0
222083,in,0,0
222084,the,0,0
222085,detection,0,0
222086,of,0,0
222087,short-term,0,0
222088,changes,0,1
222089,in,0,0
222090,exercise,1,0
222091,capacity,1,1
222092,than,0,0
222093,data,0,0
222094,obtained,0,0
222095,from,0,0
222096,either,0,0
222097,exercise,0,0
222098,time,0,1
222099,or,0,0
222100,peak,0,1
222101,work,0,1
222102,rate,0,1
222103,",",0,0
222104,indexes,0,1
222105,that,0,0
222106,are,0,0
222107,commonly,0,0
222108,used,0,0
222109,to,0,0
222110,assess,0,0
222111,drug,0,0
222112,therapy,0,0
222113,.,0,0
222114,Patients,0,0
222115,with,0,0
222116,mild-to-moderate,0,0
222117,heart,0,1
222118,failure,0,1
222119,with,0,0
222120,sinus,0,0
222121,rhythm,0,1
222122,",",0,0
222123,but,0,0
222124,not,0,0
222125,those,0,0
222126,with,0,0
222127,atrial,0,1
222128,fibrillation,0,1
222129,because,0,0
222130,of,0,0
222131,its,0,0
222132,frequent,0,0
222133,induction,0,0
222134,of,0,0
222135,tachycardia,0,0
222136,",",0,0
222137,may,0,0
222138,be,0,0
222139,good,0,0
222140,candidates,0,0
222141,for,0,0
222142,denopamine,0,0
222143,therapy,0,0
222144,.,0,0
222145,Intraperitoneal,1,0
222146,distribution,1,0
222147,imaging,0,0
222148,prior,0,0
222149,to,0,0
222150,chromic,0,0
222151,phosphate,0,0
222152,(,0,0
222153,P-32,0,0
222154,),0,0
222155,therapy,0,0
222156,in,0,0
222157,ovarian,0,1
222158,cancer,0,0
222159,patients,0,0
222160,.,0,0
222161,This,0,0
222162,study,0,0
222163,addressed,0,0
222164,the,0,0
222165,technique,0,0
222166,of,0,0
222167,intraperitoneal,0,0
222168,distribution,0,1
222169,imaging,0,1
222170,(,0,0
222171,IDI,0,0
222172,),0,0
222173,.,0,0
222174,A,0,0
222175,literature,0,0
222176,search,0,0
222177,(,0,0
222178,MEDLINE,0,1
222179,database,0,0
222180,),0,0
222181,revealed,0,0
222182,wide,0,0
222183,variations,0,0
222184,in,0,0
222185,IDI,0,0
222186,techniques,0,0
222187,without,0,0
222188,a,0,0
222189,basis,0,0
222190,for,0,0
222191,comparison,0,0
222192,.,0,0
222193,From,0,0
222194,April,0,0
222195,1990,0,0
222196,to,0,0
222197,September,0,0
222198,1992,0,0
222199,",",0,0
222200,the,0,0
222201,authors,0,0
222202,studied,0,0
222203,8,0,0
222204,patients,0,0
222205,(,0,0
222206,age,0,0
222207,43-65,0,0
222208,years,0,0
222209,),0,0
222210,with,0,0
222211,ovarian,0,0
222212,cancer,0,0
222213,.,0,0
222214,A,0,0
222215,total,0,0
222216,of,0,0
222217,1000,0,0
222218,ml,0,0
222219,of,0,0
222220,normal,0,0
222221,saline,0,0
222222,and,0,0
222223,1,0,0
222224,mCi,0,0
222225,of,0,0
222226,Tc-99m,0,0
222227,SC,0,0
222228,was,0,0
222229,infused,0,0
222230,intraperitoneally,0,0
222231,for,0,0
222232,IDI,0,0
222233,.,0,0
222234,In,0,0
222235,one,0,0
222236,patient,0,0
222237,loculation,1,0
222238,was,0,0
222239,observed,0,0
222240,",",0,0
222241,but,0,0
222242,only,0,0
222243,250,0,0
222244,ml,0,0
222245,of,0,0
222246,normal,0,0
222247,saline,0,0
222248,was,0,0
222249,infused,0,0
222250,with,0,0
222251,Tc-99m,0,0
222252,SC,0,0
222253,.,0,0
222254,A,0,0
222255,repeat,0,1
222256,study,0,0
222257,using,0,0
222258,our,0,0
222259,standard,0,0
222260,technique,0,0
222261,rendered,0,0
222262,free,1,1
222263,intraperitoneal,1,0
222264,distribution,1,0
222265,in,0,0
222266,this,0,0
222267,patient,0,0
222268,",",0,0
222269,as,0,0
222270,well,0,0
222271,as,0,0
222272,in,0,0
222273,the,0,0
222274,other,0,0
222275,seven,0,0
222276,cases,0,0
222277,.,0,0
222278,Some,0,0
222279,investigators,0,0
222280,recommend,0,0
222281,low,0,0
222282,volumes,0,1
222283,",",0,0
222284,but,0,0
222285,in,0,0
222286,our,0,0
222287,experience,0,0
222288,this,0,0
222289,produced,0,0
222290,the,0,0
222291,finding,0,0
222292,of,0,0
222293,pseudoloculation,1,0
222294,",",0,0
222295,which,0,0
222296,could,0,0
222297,change,0,0
222298,treatment,0,0
222299,inappropriately,0,0
222300,.,0,0
222301,Although,0,0
222302,the,0,0
222303,number,0,1
222304,of,0,0
222305,patients,0,0
222306,studied,0,0
222307,at,0,0
222308,our,0,0
222309,institution,0,0
222310,was,0,0
222311,small,0,0
222312,",",0,0
222313,administration,0,0
222314,of,0,0
222315,1,0,0
222316,liter,0,0
222317,intraperitoneally,0,0
222318,provided,0,0
222319,consistent,0,0
222320,IDI,1,0
222321,results,0,0
222322,.,0,0
222323,Maternal,1,1
222324,erythropoietin,1,1
222325,in,0,0
222326,singleton,0,0
222327,pregnancies,0,0
222328,:,0,0
222329,a,0,0
222330,randomized,0,0
222331,trial,0,0
222332,on,0,0
222333,the,0,0
222334,effect,0,0
222335,of,0,0
222336,oral,0,0
222337,hematinic,0,0
222338,supplementation,0,0
222339,.,0,0
222340,OBJECTIVE,0,0
222341,Our,0,0
222342,purpose,0,0
222343,was,0,0
222344,to,0,0
222345,study,0,0
222346,the,0,0
222347,effect,0,0
222348,of,0,0
222349,hematinic,0,1
222350,supplementation,0,0
222351,on,0,0
222352,the,0,0
222353,maternal,1,1
222354,erythropoietin,1,0
222355,response,1,1
222356,during,0,0
222357,singleton,0,0
222358,pregnancy,0,0
222359,.,0,0
222360,STUDY,0,1
222361,DESIGN,0,0
222362,In,0,0
222363,a,0,0
222364,randomized,0,0
222365,",",0,0
222366,double-blind,0,0
222367,trial,0,0
222368,97,0,0
222369,patients,0,0
222370,with,0,0
222371,a,0,0
222372,first-trimester,0,0
222373,hemoglobin,0,1
222374,level,0,1
222375,>,0,0
222376,or,0,0
222377,=,0,0
222378,14.0,0,0
222379,gm/dl,0,0
222380,received,0,0
222381,either,0,0
222382,iron,0,0
222383,and,0,1
222384,folic,0,0
222385,acid,0,1
222386,(,0,0
222387,hematinic,0,1
222388,group,0,0
222389,",",0,0
222390,n,0,0
222391,=,0,0
222392,53,0,0
222393,),0,0
222394,or,0,0
222395,a,0,0
222396,placebo,0,0
222397,(,0,0
222398,n,0,0
222399,=,0,0
222400,44,0,0
222401,),0,0
222402,.,0,0
222403,Serial,1,0
222404,hemoglobin,1,1
222405,",",1,0
222406,hematocrit,1,1
222407,",",1,1
222408,and,1,1
222409,serum,1,1
222410,erythropoietin,1,1
222411,were,0,0
222412,recorded,0,0
222413,from,0,0
222414,maternal,0,1
222415,blood,0,1
222416,and,0,0
222417,from,0,0
222418,cord,0,1
222419,blood,0,1
222420,on,0,0
222421,delivery,0,0
222422,.,0,0
222423,Serum,1,1
222424,ferritin,1,0
222425,was,0,0
222426,measured,0,0
222427,in,0,0
222428,the,0,0
222429,first,0,0
222430,trimester,0,0
222431,",",0,0
222432,at,0,0
222433,36,0,0
222434,weeks,0,0
222435,',0,0
222436,gestation,0,0
222437,",",0,0
222438,and,0,1
222439,in,0,0
222440,cord,0,1
222441,blood,0,1
222442,.,0,0
222443,RESULTS,0,0
222444,In,0,0
222445,both,0,0
222446,groups,0,0
222447,(,0,0
222448,1,0,0
222449,),0,0
222450,the,0,0
222451,mean,1,1
222452,hemoglobin,1,1
222453,was,0,0
222454,lower,0,0
222455,(,0,0
222456,p,0,0
222457,<,0,0
222458,0.01,0,0
222459,),0,0
222460,at,0,0
222461,40,0,0
222462,weeks,0,0
222463,',0,0
222464,gestation,0,0
222465,than,0,0
222466,when,0,0
222467,first,0,0
222468,examined,0,0
222469,and,0,0
222470,(,0,0
222471,2,0,0
222472,),0,0
222473,the,0,0
222474,mean,0,1
222475,serum,0,1
222476,erythropoietin,0,1
222477,was,0,0
222478,higher,0,0
222479,(,0,0
222480,p,0,0
222481,<,0,0
222482,0.01,0,0
222483,),0,0
222484,.,0,0
222485,The,0,0
222486,mean,1,1
222487,serum,1,1
222488,ferritin,1,1
222489,was,0,0
222490,lower,0,0
222491,(,0,0
222492,p,0,0
222493,<,0,0
222494,0.001,0,0
222495,),0,0
222496,in,0,0
222497,both,0,0
222498,groups,0,0
222499,at,0,0
222500,36,0,0
222501,weeks,0,0
222502,',0,0
222503,gestation,0,0
222504,than,0,0
222505,at,0,0
222506,presentation,0,1
222507,but,0,0
222508,higher,0,1
222509,(,0,0
222510,p,0,0
222511,=,0,0
222512,0.04,0,0
222513,),0,0
222514,in,0,0
222515,the,0,0
222516,hematinic,0,1
222517,group,0,0
222518,than,0,0
222519,in,0,0
222520,the,0,0
222521,placebo,0,0
222522,group,0,0
222523,.,0,0
222524,The,0,0
222525,mean,1,1
222526,hemoglobin,1,1
222527,and,1,1
222528,hematocrit,1,1
222529,were,0,0
222530,similar,0,0
222531,in,0,0
222532,the,0,0
222533,two,0,0
222534,groups,0,0
222535,until,0,0
222536,the,0,0
222537,third,0,0
222538,trimester,0,0
222539,but,0,0
222540,thereafter,0,0
222541,were,0,0
222542,higher,0,0
222543,(,0,0
222544,p,0,0
222545,<,0,0
222546,0.05,0,0
222547,),0,0
222548,in,0,0
222549,the,0,0
222550,hematinic,0,0
222551,group,0,0
222552,.,0,0
222553,The,0,0
222554,mean,1,1
222555,maternal,1,1
222556,serum,1,1
222557,erythropoietin,1,1
222558,was,0,0
222559,higher,0,0
222560,(,0,0
222561,p,0,0
222562,<,0,0
222563,0.05,0,0
222564,),0,0
222565,in,0,0
222566,the,0,0
222567,placebo,0,0
222568,group,0,0
222569,than,0,0
222570,in,0,0
222571,the,0,0
222572,hematinic,0,0
222573,group,0,0
222574,after,0,0
222575,24,0,0
222576,weeks,0,0
222577,',0,0
222578,gestation,0,0
222579,.,0,0
222580,The,0,0
222581,mean,1,1
222582,cord,1,1
222583,blood,1,1
222584,hematologic,1,1
222585,values,1,1
222586,were,0,0
222587,similar,0,0
222588,in,0,0
222589,the,0,0
222590,two,0,0
222591,groups,0,0
222592,.,0,0
222593,CONCLUSION,0,0
222594,Maternal,1,1
222595,serum,1,1
222596,erythropoietin,1,1
222597,increased,0,0
222598,during,0,0
222599,pregnancy,0,1
222600,",",0,0
222601,but,0,0
222602,this,0,0
222603,response,0,1
222604,was,0,0
222605,reduced,0,0
222606,in,0,0
222607,the,0,0
222608,third,0,0
222609,trimester,0,0
222610,in,0,0
222611,the,0,0
222612,hematinic-supplemented,0,0
222613,group,0,0
222614,.,0,0
222615,Risk,0,0
222616,of,0,0
222617,aspiration,0,0
222618,with,0,0
222619,the,0,0
222620,laryngeal,0,0
222621,mask,0,0
222622,.,0,0
222623,In,0,0
222624,order,0,0
222625,to,0,0
222626,assess,0,0
222627,if,0,0
222628,the,0,0
222629,use,0,0
222630,of,0,0
222631,the,0,0
222632,laryngeal,0,0
222633,mask,0,0
222634,airway,0,1
222635,is,0,0
222636,associated,0,0
222637,with,0,0
222638,an,0,0
222639,increased,0,0
222640,risk,0,0
222641,of,0,0
222642,gastric,0,1
222643,regurgitation,0,1
222644,during,0,0
222645,mechanical,0,0
222646,ventilation,0,0
222647,",",0,0
222648,we,0,0
222649,studied,0,0
222650,50,0,0
222651,patients,0,0
222652,allocated,0,0
222653,randomly,0,0
222654,to,0,0
222655,undergo,0,0
222656,anaesthesia,0,0
222657,with,0,0
222658,either,0,0
222659,artificial,0,0
222660,ventilation,0,0
222661,with,0,0
222662,isoflurane,0,0
222663,and,0,0
222664,nitrous,0,0
222665,oxide,0,0
222666,in,0,0
222667,oxygen,0,1
222668,and,0,1
222669,atracurium,0,1
222670,(,0,0
222671,group,0,0
222672,A,0,0
222673,),0,0
222674,or,0,0
222675,spontaneous,0,1
222676,ventilation,0,0
222677,with,0,0
222678,isoflurane,0,0
222679,and,0,0
222680,nitrous,0,0
222681,oxide,0,0
222682,in,0,0
222683,oxygen,0,1
222684,(,0,0
222685,group,0,0
222686,B,0,0
222687,),0,0
222688,.,0,0
222689,In,0,0
222690,both,0,0
222691,groups,0,0
222692,a,0,0
222693,laryngeal,0,0
222694,mask,0,0
222695,airway,0,1
222696,was,0,0
222697,used,0,0
222698,.,0,0
222699,Regurgitation,0,1
222700,was,0,0
222701,assessed,0,0
222702,by,0,0
222703,the,0,0
222704,patient,0,0
222705,ingesting,0,0
222706,a,0,0
222707,methylene,0,0
222708,blue,0,0
222709,capsule,0,0
222710,10,0,0
222711,min,0,0
222712,before,0,0
222713,induction,0,1
222714,of,0,0
222715,anaesthesia,0,0
222716,and,0,0
222717,examining,0,0
222718,the,0,0
222719,oropharynx,0,0
222720,by,0,0
222721,direct,0,0
222722,laryngoscopy,0,0
222723,at,0,0
222724,the,0,0
222725,end,0,0
222726,of,0,0
222727,surgery,0,0
222728,.,0,0
222729,In,0,0
222730,one,0,0
222731,patient,0,0
222732,in,0,0
222733,each,0,0
222734,group,0,0
222735,",",0,0
222736,there,0,0
222737,was,0,0
222738,staining,1,0
222739,of,1,0
222740,the,1,0
222741,oropharynx,1,0
222742,with,0,0
222743,blue,0,0
222744,dye,0,0
222745,at,0,0
222746,the,0,0
222747,end,0,0
222748,of,0,0
222749,surgery,0,0
222750,.,0,0
222751,In,0,0
222752,the,0,0
222753,patient,0,0
222754,in,0,0
222755,group,0,0
222756,A,0,0
222757,",",0,1
222758,dye,1,1
222759,was,1,0
222760,present,1,0
222761,in,1,0
222762,the,1,0
222763,trachea,1,0
222764,and,1,0
222765,bronchi,1,0
222766,.,0,0
222767,Antifungal,0,0
222768,prophylaxis,0,0
222769,during,0,0
222770,remission,0,1
222771,induction,0,1
222772,therapy,0,0
222773,for,0,0
222774,acute,0,0
222775,leukemia,0,0
222776,fluconazole,0,0
222777,versus,0,0
222778,intravenous,0,0
222779,amphotericin,0,0
222780,B,0,0
222781,.,0,0
222782,BACKGROUND,0,0
222783,Fungal,0,0
222784,infection,0,0
222785,is,0,0
222786,a,0,0
222787,frequent,0,0
222788,and,0,0
222789,often,0,0
222790,fatal,0,1
222791,complication,0,1
222792,in,0,0
222793,patients,0,0
222794,undergoing,0,0
222795,remission,0,1
222796,induction,0,1
222797,therapy,0,0
222798,for,0,0
222799,acute,0,0
222800,leukemia,0,0
222801,.,0,0
222802,Although,0,0
222803,candidiasis,0,0
222804,is,0,0
222805,the,0,0
222806,most,0,0
222807,common,0,0
222808,infection,0,1
222809,",",0,0
222810,mold,0,1
222811,infections,0,0
222812,are,0,0
222813,increasing,0,0
222814,in,0,0
222815,frequency,0,1
222816,.,0,0
222817,Fluconazole,0,0
222818,(,0,0
222819,FLU,0,1
222820,),0,0
222821,is,0,0
222822,a,0,0
222823,new,0,0
222824,antifungal,0,0
222825,agent,0,0
222826,that,0,0
222827,has,0,0
222828,been,0,0
222829,used,0,0
222830,successfully,0,0
222831,to,0,0
222832,treat,0,0
222833,Candida,0,0
222834,infections,0,0
222835,and,0,0
222836,has,0,0
222837,modest,0,0
222838,activity,0,1
222839,against,0,1
222840,aspergillosis,0,0
222841,in,0,0
222842,animal,0,0
222843,models,0,0
222844,.,0,0
222845,Subtherapeutic,0,0
222846,doses,0,0
222847,of,0,0
222848,amphotericin,0,0
222849,B,0,0
222850,(,0,0
222851,AMB,0,0
222852,),0,0
222853,have,0,0
222854,been,0,0
222855,considered,0,0
222856,effective,0,0
222857,as,0,0
222858,prophylaxis,0,0
222859,in,0,0
222860,these,0,0
222861,patients,0,0
222862,.,0,0
222863,This,0,0
222864,study,0,0
222865,was,0,0
222866,designed,0,0
222867,to,0,0
222868,compare,0,0
222869,the,0,0
222870,efficacy,1,1
222871,and,1,0
222872,toxicity,1,1
222873,of,0,0
222874,these,0,0
222875,agents,0,0
222876,as,0,0
222877,antifungal,0,0
222878,prophylaxis,0,0
222879,.,0,0
222880,METHODS,0,0
222881,Adults,0,0
222882,with,0,0
222883,acute,0,0
222884,leukemia,0,0
222885,undergoing,0,0
222886,remission,0,1
222887,induction,0,1
222888,chemotherapy,0,0
222889,randomly,0,0
222890,were,0,0
222891,assigned,0,0
222892,to,0,0
222893,receive,0,0
222894,antifungal,0,0
222895,prophylaxis,0,0
222896,with,0,0
222897,AMB,0,0
222898,(,0,0
222899,0.5,0,0
222900,mg/kg,0,0
222901,three,0,0
222902,times,0,0
222903,weekly,0,0
222904,),0,0
222905,or,0,0
222906,FLU,0,1
222907,(,0,0
222908,400,0,0
222909,mg,0,0
222910,daily,0,0
222911,),0,0
222912,.,0,0
222913,Trimethoprim-sulfamethoxazole,0,0
222914,was,0,0
222915,administered,0,0
222916,as,0,0
222917,an,0,0
222918,antibacterial,0,0
222919,prophylaxis,0,0
222920,.,0,0
222921,Prophylaxis,0,0
222922,was,0,0
222923,continued,0,0
222924,until,0,0
222925,the,0,0
222926,patient,0,0
222927,achieved,0,0
222928,complete,0,1
222929,remission,0,1
222930,or,0,0
222931,was,0,0
222932,treated,0,0
222933,for,0,0
222934,8,0,0
222935,weeks,0,0
222936,without,0,0
222937,antileukemic,0,1
222938,response,0,1
222939,.,0,0
222940,Prophylaxis,0,0
222941,was,0,0
222942,discontinued,0,0
222943,if,0,0
222944,the,0,0
222945,patient,0,0
222946,experienced,0,0
222947,a,0,0
222948,possible,0,0
222949,or,0,0
222950,proven,0,0
222951,fungal,0,0
222952,infection,0,1
222953,or,0,0
222954,a,0,0
222955,serious,0,1
222956,toxicity,0,1
222957,.,0,0
222958,RESULTS,0,0
222959,Overall,0,0
222960,",",0,0
222961,58,0,0
222962,%,0,0
222963,of,0,0
222964,the,0,0
222965,36,0,0
222966,patients,0,0
222967,assigned,0,0
222968,to,0,0
222969,AMB,0,0
222970,successfully,0,0
222971,completed,0,0
222972,prophylaxis,0,0
222973,compared,0,0
222974,with,0,0
222975,80,0,0
222976,%,0,0
222977,of,0,0
222978,the,0,0
222979,41,0,0
222980,patients,0,0
222981,assigned,0,0
222982,to,0,0
222983,FLU,0,1
222984,(,0,0
222985,<,0,0
222986,0.05,0,0
222987,),0,0
222988,.,0,0
222989,Proven,1,0
222990,",",1,0
222991,probable,1,1
222992,",",1,0
222993,or,1,0
222994,possible,1,0
222995,fungal,1,0
222996,infections,1,1
222997,occurred,0,0
222998,in,0,0
222999,31,0,0
223000,%,0,0
223001,and,0,0
223002,17,0,0
223003,%,0,0
223004,of,0,0
223005,the,0,0
223006,patients,0,0
223007,",",0,0
223008,respectively,0,0
223009,.,0,0
223010,The,0,0
223011,risk,0,0
223012,of,0,0
223013,discontinuing,0,0
223014,prophylaxis,0,0
223015,due,0,0
223016,to,0,0
223017,fungal,1,0
223018,infection,1,1
223019,or,0,0
223020,toxicity,1,1
223021,increased,0,0
223022,with,0,0
223023,time,0,1
223024,in,0,0
223025,the,0,0
223026,study,0,0
223027,and,0,0
223028,was,0,0
223029,significantly,0,0
223030,greater,0,0
223031,for,0,0
223032,AMB,0,0
223033,(,0,0
223034,P,0,0
223035,=,0,0
223036,0.02,0,0
223037,),0,0
223038,.,0,0
223039,CONCLUSIONS,0,0
223040,At,0,0
223041,the,0,0
223042,dose,0,0
223043,used,0,0
223044,in,0,0
223045,this,0,0
223046,study,0,0
223047,",",0,0
223048,AMB,0,0
223049,was,0,0
223050,no,0,0
223051,more,0,0
223052,effective,1,1
223053,and,0,0
223054,was,0,0
223055,more,0,0
223056,toxic,1,1
223057,than,0,0
223058,FLU,0,1
223059,for,0,0
223060,prophylaxis,0,0
223061,of,0,0
223062,fungal,1,0
223063,infections,1,1
223064,in,0,0
223065,patients,0,0
223066,undergoing,0,0
223067,remission,0,1
223068,induction,0,1
223069,chemotherapy,0,0
223070,for,0,0
223071,acute,0,0
223072,leukemia,0,0
223073,.,0,0
223074,Ketorolac,0,0
223075,versus,0,0
223076,fentanyl,0,0
223077,for,0,0
223078,gynaecological,0,0
223079,day-case,0,0
223080,surgery,0,0
223081,.,0,0
223082,The,0,0
223083,effectiveness,0,1
223084,of,0,0
223085,fentanyl,0,0
223086,and,0,1
223087,ketorolac,0,0
223088,in,0,0
223089,providing,0,0
223090,analgesia,0,1
223091,for,0,0
223092,day-case,0,0
223093,gynaecological,0,0
223094,procedures,0,0
223095,was,0,0
223096,evaluated,0,0
223097,in,0,0
223098,55,0,0
223099,healthy,0,0
223100,volunteers,0,0
223101,in,0,0
223102,a,0,0
223103,single,0,0
223104,blinded,0,0
223105,fashion,0,0
223106,.,0,0
223107,Fentanyl,0,0
223108,(,0,0
223109,1,0,0
223110,mcg/kg,0,0
223111,iv,0,0
223112,),0,0
223113,and,0,1
223114,ketorolac,0,0
223115,(,0,0
223116,30,0,0
223117,mg,0,0
223118,im,0,0
223119,),0,0
223120,were,0,0
223121,administered,0,0
223122,immediately,0,0
223123,following,0,0
223124,induction,0,0
223125,of,0,0
223126,anaesthesia,0,0
223127,.,0,0
223128,Anaesthesia,0,1
223129,was,0,0
223130,standardized,0,0
223131,with,0,0
223132,propofol,0,0
223133,",",0,0
223134,nitrous,0,0
223135,oxide,0,1
223136,and,0,0
223137,enflurane,0,0
223138,.,0,1
223139,Outcome,0,1
223140,variables,0,1
223141,assessed,0,0
223142,were,0,0
223143,pain,1,1
223144,",",1,0
223145,additional,1,0
223146,analgesic,1,1
223147,requirements,1,1
223148,",",1,0
223149,and,1,1
223150,incidence,1,1
223151,of,1,1
223152,postoperative,1,1
223153,nausea,1,1
223154,and,1,0
223155,vomiting,1,1
223156,.,1,0
223157,All,0,0
223158,variables,0,0
223159,were,0,0
223160,recorded,0,0
223161,at,0,0
223162,15,0,0
223163,minutes,0,0
223164,",",0,0
223165,2,0,0
223166,hours,0,0
223167,and,0,0
223168,24,0,0
223169,hours,0,0
223170,postoperatively,0,0
223171,.,0,0
223172,There,0,0
223173,was,0,0
223174,no,0,0
223175,significant,0,0
223176,difference,0,0
223177,between,0,0
223178,the,0,0
223179,2,0,0
223180,groups,0,0
223181,with,0,0
223182,respect,0,0
223183,to,0,0
223184,any,0,0
223185,of,0,0
223186,the,0,0
223187,measured,0,0
223188,variables,0,0
223189,.,0,0
223190,Both,0,0
223191,drugs,0,0
223192,were,0,0
223193,ineffective,1,0
223194,as,0,0
223195,sole,1,0
223196,analgesic,1,1
223197,agents,1,0
223198,in,0,0
223199,half,0,0
223200,of,0,0
223201,their,0,0
223202,respective,0,0
223203,groups,0,0
223204,.,0,0
223205,It,0,0
223206,may,0,0
223207,be,0,0
223208,that,0,0
223209,a,0,0
223210,combination,0,0
223211,of,0,0
223212,these,0,0
223213,drugs,0,0
223214,",",0,0
223215,providing,0,0
223216,a,0,0
223217,multireceptor,0,0
223218,approach,0,0
223219,to,0,0
223220,analgesia,0,0
223221,",",0,0
223222,will,0,0
223223,prove,0,0
223224,to,0,0
223225,be,0,0
223226,more,0,0
223227,effective,0,0
223228,.,0,0
223229,Trimetazidine,0,0
223230,:,0,0
223231,a,0,0
223232,new,0,0
223233,concept,0,0
223234,in,0,0
223235,the,0,0
223236,treatment,0,0
223237,of,0,0
223238,angina,0,0
223239,.,0,0
223240,Comparison,0,0
223241,with,0,0
223242,propranolol,0,0
223243,in,0,0
223244,patients,0,0
223245,with,0,0
223246,stable,0,0
223247,angina,0,0
223248,.,0,0
223249,Trimetazidine,0,0
223250,European,0,0
223251,Multicenter,0,0
223252,Study,0,0
223253,Group,0,0
223254,.,0,0
223255,1,0,0
223256,.,0,0
223257,Trimetazidine,0,0
223258,has,0,0
223259,a,0,0
223260,direct,0,0
223261,anti-ischaemic,1,0
223262,effect,1,0
223263,on,0,0
223264,the,0,0
223265,myocardium,0,0
223266,without,0,0
223267,altering,0,0
223268,the,0,0
223269,rate,1,1
223270,x,1,0
223271,pressure,1,1
223272,product,1,1
223273,or,0,0
223274,coronary,1,1
223275,blood,1,1
223276,flow,1,1
223277,.,1,0
223278,2,0,0
223279,.,0,0
223280,The,0,0
223281,effects,0,0
223282,of,0,0
223283,trimetazidine,0,0
223284,(,0,0
223285,20,0,0
223286,mg,0,0
223287,three,0,0
223288,times,0,0
223289,daily,0,0
223290,),0,0
223291,were,0,0
223292,compared,0,0
223293,with,0,0
223294,those,0,0
223295,of,0,0
223296,propranolol,0,0
223297,(,0,0
223298,40,0,0
223299,mg,0,0
223300,three,0,0
223301,times,0,0
223302,daily,0,0
223303,),0,0
223304,in,0,0
223305,a,0,0
223306,double-blind,0,0
223307,parallel,0,0
223308,group,0,0
223309,multicentre,0,0
223310,study,0,0
223311,in,0,0
223312,149,0,0
223313,men,0,0
223314,with,0,0
223315,stable,0,0
223316,angina,0,0
223317,.,0,0
223318,3,0,0
223319,.,0,0
223320,Reproducibility,0,1
223321,of,0,0
223322,exercise,0,0
223323,performance,0,1
223324,was,0,0
223325,verified,0,0
223326,during,0,0
223327,a,0,0
223328,3,0,0
223329,week,0,0
223330,run-in,0,0
223331,placebo,0,0
223332,washout,0,0
223333,period,0,0
223334,.,0,0
223335,All,0,0
223336,patients,0,0
223337,had,0,0
223338,>,0,0
223339,1,0,0
223340,mm,0,0
223341,ST-depression,0,0
223342,on,0,0
223343,exercise,0,0
223344,test,0,0
223345,.,0,0
223346,4,0,0
223347,.,0,0
223348,After,0,0
223349,3,0,0
223350,months,0,0
223351,",",0,0
223352,similar,0,0
223353,anti-anginal,1,0
223354,efficacy,1,1
223355,was,0,0
223356,observed,0,0
223357,between,0,0
223358,the,0,0
223359,trimetazidine,0,0
223360,(,0,0
223361,n,0,0
223362,=,0,0
223363,71,0,0
223364,),0,0
223365,and,0,0
223366,propranolol,0,0
223367,(,0,0
223368,n,0,0
223369,=,0,0
223370,78,0,0
223371,),0,0
223372,groups,0,0
223373,.,0,0
223374,No,0,0
223375,significant,0,0
223376,differences,0,0
223377,were,0,0
223378,observed,0,0
223379,between,0,0
223380,trimetazidine,0,0
223381,and,0,1
223382,propranolol,0,0
223383,as,0,0
223384,regards,0,0
223385,anginal,1,1
223386,attack,1,1
223387,rate,1,1
223388,per,1,0
223389,week,1,0
223390,(,0,0
223391,mean,0,1
223392,difference,0,0
223393,P-TMZ,0,0
223394,:,0,0
223395,2,0,0
223396,;,0,0
223397,95,0,0
223398,%,0,0
223399,CI,0,0
223400,:,0,0
223401,-4.4,0,0
223402,",",0,0
223403,0.5,0,0
223404,),0,0
223405,and,0,0
223406,exercise,1,0
223407,duration,1,1
223408,(,0,0
223409,mean,0,1
223410,difference,0,0
223411,P-TMZ,0,0
223412,:,0,0
223413,0,0,0
223414,s,0,0
223415,;,0,0
223416,95,0,0
223417,%,0,0
223418,CI,0,0
223419,:,0,0
223420,-33,0,0
223421,",",0,0
223422,34,0,0
223423,),0,0
223424,or,0,0
223425,time,0,1
223426,to,0,0
223427,1,0,0
223428,mm,0,0
223429,ST,1,0
223430,segment,1,1
223431,depression,1,1
223432,(,0,0
223433,mean,0,1
223434,difference,0,0
223435,P-TMZ,0,0
223436,:,0,0
223437,13,0,0
223438,s,0,0
223439,;,0,0
223440,95,0,0
223441,%,0,0
223442,CI,0,0
223443,:,0,0
223444,-24,0,0
223445,",",0,0
223446,51,0,0
223447,),0,0
223448,.,0,0
223449,Heart,1,0
223450,rate,1,1
223451,and,1,1
223452,rate,1,1
223453,x,1,0
223454,pressure,1,1
223455,product,1,1
223456,at,1,0
223457,rest,1,0
223458,and,0,0
223459,at,0,0
223460,peak,0,1
223461,exercise,0,0
223462,remained,0,0
223463,unchanged,0,0
223464,in,0,0
223465,the,0,0
223466,trimetazidine,0,0
223467,group,0,0
223468,but,0,0
223469,significantly,0,0
223470,decreased,0,0
223471,with,0,0
223472,propranolol,0,0
223473,(,0,0
223474,P,0,0
223475,<,0,0
223476,0.001,0,0
223477,in,0,0
223478,all,0,0
223479,cases,0,0
223480,),0,0
223481,.,0,0
223482,With,0,0
223483,both,0,0
223484,drugs,0,0
223485,there,0,0
223486,was,0,0
223487,a,0,0
223488,trend,0,0
223489,to,0,0
223490,decreased,0,0
223491,ischaemic,1,0
223492,episodes,1,0
223493,in,0,0
223494,the,0,0
223495,46,0,0
223496,%,0,0
223497,patients,0,0
223498,who,0,0
223499,experienced,0,0
223500,ambulatory,0,0
223501,ischaemia,0,1
223502,on,0,0
223503,Holter,0,0
223504,monitoring,0,0
223505,.,0,0
223506,Six,0,0
223507,patients,0,0
223508,stopped,0,0
223509,trimetazidine,0,0
223510,and,0,0
223511,12,0,0
223512,propranolol,0,0
223513,.,0,0
223514,Of,0,0
223515,these,0,0
223516,",",0,0
223517,five,0,0
223518,in,0,0
223519,each,0,0
223520,group,0,0
223521,were,0,0
223522,withdrawn,1,0
223523,because,0,0
223524,of,0,0
223525,deterioration,0,1
223526,in,0,0
223527,cardiovascular,0,1
223528,status,0,0
223529,.,0,0
223530,5,0,0
223531,.,0,0
223532,The,0,0
223533,results,0,0
223534,suggest,0,0
223535,that,0,0
223536,trimetazidine,0,0
223537,and,0,1
223538,propranolol,0,0
223539,at,0,0
223540,the,0,0
223541,doses,0,0
223542,studied,0,0
223543,have,0,0
223544,similar,0,0
223545,efficacy,0,1
223546,in,0,0
223547,patients,0,0
223548,with,0,0
223549,stable,0,0
223550,angina,0,0
223551,pectoris,0,0
223552,.,0,0
223553,(,0,0
223554,ABSTRACT,0,1
223555,TRUNCATED,0,0
223556,AT,0,0
223557,250,0,0
223558,WORDS,0,0
223559,),0,0
223560,[,0,0
223561,Perioperative,0,0
223562,teicoplanin,0,0
223563,prophylaxis,0,0
223564,in,0,0
223565,patients,0,0
223566,undergoing,0,0
223567,breast,0,0
223568,reconstruction,0,0
223569,with,0,0
223570,the,0,0
223571,abdominal,0,0
223572,wall,0,0
223573,.,0,0
223574,A,0,0
223575,case-control,0,0
223576,study,0,0
223577,],0,0
223578,.,0,0
223579,The,0,0
223580,authors,0,0
223581,report,0,0
223582,the,0,0
223583,results,0,0
223584,of,0,0
223585,a,0,0
223586,randomized,0,0
223587,clinical,0,0
223588,trial,0,0
223589,of,0,0
223590,antibiotic,0,0
223591,prophylaxis,0,0
223592,of,0,0
223593,postoperative,0,1
223594,infection,0,1
223595,following,0,0
223596,breast,0,0
223597,reconstruction,0,0
223598,by,0,0
223599,transposition,0,1
223600,of,0,0
223601,rectus,0,1
223602,abdominis,0,0
223603,myocutaneous,0,1
223604,flap,0,1
223605,(,0,0
223606,TRAMF,0,0
223607,),0,0
223608,.,0,0
223609,The,0,0
223610,aim,0,0
223611,was,0,0
223612,to,0,0
223613,evaluate,0,0
223614,the,0,0
223615,efficacy,0,1
223616,and,0,0
223617,tolerability,0,1
223618,of,0,0
223619,a,0,0
223620,short-term,0,0
223621,parenteral,0,0
223622,prophylaxis,0,0
223623,with,0,0
223624,Teicoplanin,0,0
223625,and,0,0
223626,the,0,0
223627,end-point,0,1
223628,of,0,0
223629,the,0,0
223630,study,0,0
223631,was,0,0
223632,the,0,0
223633,evaluation,0,0
223634,of,0,0
223635,wound,0,1
223636,contamination,0,1
223637,assessed,0,0
223638,by,0,0
223639,means,0,0
223640,of,0,0
223641,microbiologic,0,1
223642,culture,0,1
223643,of,0,0
223644,drainage,0,0
223645,fluid,0,1
223646,.,0,0
223647,From,0,0
223648,October,0,0
223649,1990,0,0
223650,to,0,0
223651,March,0,0
223652,1992,0,0
223653,38,0,0
223654,patients,0,0
223655,were,0,0
223656,recruited,0,0
223657,:,0,0
223658,20,0,0
223659,patients,0,0
223660,in,0,0
223661,the,0,0
223662,antibiotic,0,0
223663,prophylaxis,0,0
223664,arm,0,0
223665,and,0,0
223666,18,0,0
223667,patients,0,0
223668,in,0,0
223669,the,0,0
223670,control,0,0
223671,group,0,0
223672,.,0,0
223673,Analysis,0,1
223674,of,0,0
223675,drainage,0,0
223676,fluids,0,0
223677,showed,0,0
223678,a,0,0
223679,higher,1,0
223680,contamination,1,1
223681,rate,1,1
223682,(,0,0
223683,15/18,0,0
223684,=,0,0
223685,83,0,0
223686,%,0,0
223687,),0,0
223688,in,0,0
223689,the,0,0
223690,control,0,0
223691,group,0,0
223692,as,0,0
223693,compared,0,0
223694,to,0,0
223695,the,0,0
223696,prophylaxis,0,0
223697,arm,0,0
223698,(,0,0
223699,2/20,0,0
223700,=,0,0
223701,10,0,0
223702,%,0,0
223703,),0,0
223704,(,0,0
223705,p,0,0
223706,<,0,0
223707,0.0001,0,0
223708,),0,0
223709,.,0,0
223710,Moreover,0,0
223711,",",0,0
223712,11,0,0
223713,patients,0,0
223714,in,0,0
223715,the,0,0
223716,control,0,0
223717,arm,0,0
223718,suffered,0,0
223719,from,0,0
223720,fever,1,1
223721,>,1,0
223722,37.5,1,0
223723,degrees,1,0
223724,C,1,0
223725,for,0,0
223726,at,0,0
223727,least,0,0
223728,3,0,0
223729,days,0,0
223730,as,0,0
223731,compared,0,0
223732,to,0,0
223733,1,0,0
223734,patient,0,0
223735,in,0,0
223736,the,0,0
223737,antibiotic,0,0
223738,prophylaxis,0,0
223739,group,0,0
223740,;,0,0
223741,the,0,0
223742,postoperative,1,1
223743,stay,1,1
223744,was,0,0
223745,13.3,0,0
223746,+/-,0,0
223747,4.3,0,0
223748,and,0,0
223749,9.0,0,0
223750,+/-,0,0
223751,1.6,0,0
223752,in,0,0
223753,the,0,0
223754,control,0,0
223755,and,0,0
223756,antibiotic,0,0
223757,arm,0,0
223758,respectively,0,0
223759,.,0,0
223760,No,0,0
223761,antibiotic,1,0
223762,related,1,0
223763,side,1,1
223764,effects,1,1
223765,were,0,0
223766,evidenced,0,0
223767,through,0,0
223768,the,0,0
223769,study,0,0
223770,.,0,0
223771,These,0,0
223772,results,0,0
223773,seem,0,0
223774,to,0,0
223775,confirm,0,0
223776,the,0,0
223777,value,0,0
223778,of,0,0
223779,parenteral,0,0
223780,short-term,0,0
223781,antibiotic,0,0
223782,prophylaxis,0,0
223783,of,0,0
223784,postoperative,0,1
223785,infection,0,1
223786,in,0,0
223787,such,0,0
223788,kind,0,0
223789,of,0,0
223790,clean,0,0
223791,operative,0,0
223792,procedure,0,0
223793,.,0,0
223794,A,0,0
223795,double-blind,0,0
223796,comparison,0,0
223797,of,0,0
223798,oral,0,0
223799,ketoprofen,0,0
223800,'controlled,0,0
223801,release,0,1
223802,',0,1
223803,and,0,0
223804,indomethacin,0,0
223805,suppository,0,0
223806,in,0,0
223807,the,0,0
223808,treatment,0,0
223809,of,0,0
223810,rheumatoid,0,0
223811,arthritis,0,0
223812,with,0,0
223813,special,0,0
223814,regard,0,0
223815,to,0,0
223816,morning,0,0
223817,stiffness,0,1
223818,and,0,1
223819,pain,0,1
223820,on,0,0
223821,awakening,0,1
223822,.,0,0
223823,A,0,0
223824,double-blind,0,0
223825,",",0,0
223826,double-dummy,0,0
223827,",",0,0
223828,crossover,0,0
223829,study,0,0
223830,was,0,0
223831,carried,0,0
223832,out,0,0
223833,in,0,0
223834,8,0,0
223835,centres,0,0
223836,to,0,0
223837,compare,0,0
223838,the,0,0
223839,efficacy,0,1
223840,and,0,0
223841,tolerability,0,1
223842,of,0,1
223843,'controlled-release,0,0
223844,',0,0
223845,ketoprofen,0,0
223846,tablets,0,0
223847,(,0,0
223848,200,0,0
223849,mg,0,0
223850,),0,0
223851,with,0,0
223852,that,0,0
223853,of,0,0
223854,indomethacin,0,0
223855,suppositories,0,0
223856,(,0,0
223857,100,0,0
223858,mg,0,0
223859,),0,0
223860,in,0,0
223861,out-patients,0,0
223862,with,0,0
223863,definite,0,0
223864,or,0,0
223865,classical,0,1
223866,rheumatoid,0,1
223867,arthritis,0,0
223868,.,0,0
223869,Patients,0,0
223870,were,0,0
223871,allocated,0,0
223872,at,0,0
223873,random,0,0
223874,to,0,0
223875,receive,0,0
223876,a,0,0
223877,daily,0,0
223878,bedtime,0,0
223879,dose,0,0
223880,of,0,0
223881,either,0,0
223882,1,0,0
223883,ketoprofen,0,0
223884,tablet,0,0
223885,or,0,0
223886,1,0,0
223887,indomethacin,0,0
223888,suppository,0,0
223889,plus,0,0
223890,the,0,0
223891,dummy,0,0
223892,of,0,0
223893,the,0,0
223894,other,0,0
223895,formulation,0,0
223896,for,0,0
223897,a,0,0
223898,period,0,0
223899,of,0,0
223900,3,0,0
223901,weeks,0,0
223902,.,0,0
223903,They,0,0
223904,were,0,0
223905,then,0,0
223906,crossed,0,0
223907,over,0,0
223908,to,0,0
223909,the,0,0
223910,alternative,0,0
223911,treatment,0,0
223912,for,0,0
223913,a,0,0
223914,further,0,0
223915,3,0,0
223916,weeks,0,0
223917,.,0,0
223918,Daily,0,0
223919,diary,0,0
223920,records,0,0
223921,were,0,0
223922,kept,0,0
223923,by,0,0
223924,patients,0,0
223925,of,0,0
223926,the,0,0
223927,number,0,1
223928,of,0,0
223929,night-time,0,1
223930,awakenings,0,1
223931,due,0,0
223932,to,0,0
223933,pain,0,1
223934,",",0,0
223935,pain,0,1
223936,severity,0,1
223937,at,0,0
223938,awakening,0,1
223939,in,0,0
223940,the,0,0
223941,morning,0,0
223942,and,0,0
223943,the,0,0
223944,duration,0,1
223945,of,0,0
223946,early,0,0
223947,morning,0,0
223948,stiffness,0,1
223949,.,0,0
223950,Treatment,0,0
223951,efficacy,0,1
223952,was,0,0
223953,also,0,0
223954,assessed,0,0
223955,at,0,0
223956,the,0,0
223957,end,0,0
223958,of,0,0
223959,each,0,0
223960,trial,0,0
223961,period,0,0
223962,by,0,0
223963,means,0,0
223964,of,0,0
223965,an,0,0
223966,articular,0,1
223967,index,0,1
223968,and,0,0
223969,by,0,0
223970,physician,0,1
223971,'s,0,1
223972,and,0,0
223973,patient,0,1
223974,'s,0,1
223975,overall,0,1
223976,evaluation,0,0
223977,of,0,0
223978,response,0,1
223979,.,0,0
223980,Adverse,0,1
223981,effects,0,0
223982,spontaneously,0,0
223983,mentioned,0,0
223984,by,0,0
223985,the,0,0
223986,patients,0,0
223987,or,0,0
223988,elicited,0,0
223989,by,0,0
223990,direct,0,0
223991,questioning,0,0
223992,using,0,0
223993,a,0,0
223994,symptom,0,1
223995,check-list,0,1
223996,were,0,0
223997,recorded,0,0
223998,.,0,0
223999,Statistical,0,0
224000,analysis,0,0
224001,of,0,0
224002,the,0,0
224003,results,0,0
224004,from,0,0
224005,83,0,0
224006,evaluable,0,0
224007,patients,0,0
224008,showed,0,0
224009,that,0,0
224010,the,0,0
224011,'controlled-release,1,0
224012,',1,0
224013,tablet,1,0
224014,formulation,1,0
224015,of,1,0
224016,200,1,0
224017,mg,1,0
224018,ketoprofen,0,0
224019,was,0,0
224020,equally,0,0
224021,as,0,0
224022,effective,0,0
224023,as,0,0
224024,the,0,0
224025,100,1,0
224026,mg,1,0
224027,indomethacin,1,0
224028,suppository,1,0
224029,in,0,0
224030,the,0,0
224031,treatment,0,0
224032,of,0,0
224033,rheumatoid,0,1
224034,arthritis,0,0
224035,",",0,0
224036,especially,0,0
224037,with,0,0
224038,regard,0,0
224039,to,0,0
224040,pain,1,1
224041,at,1,0
224042,awakening,1,1
224043,and,1,1
224044,morning,1,0
224045,stiffness,1,1
224046,.,1,0
224047,Side-effects,0,0
224048,in,0,0
224049,both,0,0
224050,groups,0,0
224051,were,0,0
224052,those,0,0
224053,commonly,0,0
224054,seen,0,0
224055,with,0,0
224056,non-steroidal,0,0
224057,anti-inflammatory,0,0
224058,drugs,0,0
224059,and,0,0
224060,",",0,0
224061,as,0,0
224062,expected,0,0
224063,",",0,0
224064,gastro-intestinal,1,1
224065,and,1,1
224066,CNS,1,1
224067,disturbances,1,1
224068,predominated,0,0
224069,.,0,0
224070,Overall,0,1
224071,",",0,0
224072,side-effects,1,1
224073,were,0,0
224074,fewer,0,0
224075,with,0,0
224076,ketoprofen,1,0
224077,than,1,0
224078,with,1,0
224079,indomethacin,1,0
224080,.,1,0
224081,Ovulation,0,1
224082,and,0,0
224083,follicular,0,1
224084,development,0,1
224085,associated,0,0
224086,with,0,0
224087,three,0,0
224088,low-dose,0,0
224089,oral,0,0
224090,contraceptives,0,0
224091,:,0,0
224092,a,0,0
224093,randomized,0,0
224094,controlled,0,0
224095,trial,0,0
224096,.,0,0
224097,OBJECTIVE,0,0
224098,To,0,0
224099,address,0,0
224100,the,0,0
224101,hypothesis,0,0
224102,that,0,0
224103,multiphasic,0,0
224104,oral,0,0
224105,contraceptives,0,0
224106,(,0,0
224107,OCs,0,0
224108,),0,0
224109,increase,0,0
224110,rather,0,0
224111,than,0,0
224112,decrease,0,0
224113,the,0,0
224114,risk,1,0
224115,of,1,0
224116,functional,1,0
224117,ovarian,1,0
224118,cysts,1,0
224119,.,1,0
224120,METHODS,0,0
224121,In,0,0
224122,this,0,0
224123,single-center,0,0
224124,",",0,0
224125,randomized,0,0
224126,controlled,0,0
224127,study,0,0
224128,",",0,1
224129,women,0,0
224130,were,0,0
224131,assigned,0,0
224132,to,0,0
224133,a,0,0
224134,multiphasic,0,0
224135,pill,0,0
224136,",",0,0
224137,a,0,0
224138,lower-dose,0,0
224139,monophasic,0,0
224140,pill,0,0
224141,",",0,0
224142,a,0,0
224143,higher-dose,0,0
224144,monophasic,0,0
224145,pill,0,0
224146,",",0,0
224147,or,0,1
224148,nonsteroidal,0,0
224149,contraception,0,0
224150,.,0,0
224151,Forty,0,0
224152,volunteers,0,0
224153,were,0,0
224154,randomized,0,0
224155,(,0,0
224156,ten,0,0
224157,each,0,0
224158,),0,0
224159,to,0,0
224160,three,0,0
224161,different,0,0
224162,pill,0,0
224163,regimens,0,0
224164,or,0,0
224165,to,0,0
224166,nonsteroidal,0,0
224167,contraception,0,0
224168,.,0,0
224169,During,0,0
224170,6,0,0
224171,months,0,0
224172,of,0,0
224173,treatment,0,0
224174,",",0,0
224175,follicular,1,1
224176,development,1,1
224177,was,0,0
224178,measured,0,0
224179,by,0,0
224180,vaginal,0,0
224181,ultrasonography,0,1
224182,and,0,1
224183,ovulation,1,1
224184,was,0,0
224185,indicated,0,0
224186,by,0,0
224187,serum,0,1
224188,progesterone,0,1
224189,levels,0,1
224190,.,0,0
224191,RESULTS,0,0
224192,The,0,0
224193,relative,1,0
224194,risk,1,1
224195,(,1,0
224196,RR,1,0
224197,),1,0
224198,of,1,0
224199,developing,1,0
224200,a,1,0
224201,follicular,1,0
224202,structure,1,0
224203,greater,1,0
224204,than,1,0
224205,30,1,0
224206,mm,1,0
224207,in,1,0
224208,diameter,1,1
224209,during,0,0
224210,a,0,0
224211,cycle,0,0
224212,with,0,0
224213,the,0,0
224214,higher-dose,0,0
224215,monophasic,0,0
224216,pill,0,0
224217,was,0,0
224218,0.5,0,0
224219,(,0,0
224220,95,0,0
224221,%,0,0
224222,confidence,0,0
224223,interval,0,0
224224,[,0,0
224225,CI,0,0
224226,],0,0
224227,0.1-1.9,0,0
224228,;,0,0
224229,P,0,0
224230,=,0,0
224231,.49,0,0
224232,),0,0
224233,compared,0,0
224234,with,0,0
224235,the,0,0
224236,multiphasic,0,0
224237,pill,0,0
224238,.,0,0
224239,The,0,0
224240,risk,1,0
224241,with,1,0
224242,the,1,0
224243,lower-dose,1,0
224244,monophasic,1,0
224245,pill,1,0
224246,was,0,0
224247,comparable,0,0
224248,to,0,0
224249,that,0,0
224250,with,0,0
224251,the,0,0
224252,multiphasic,0,0
224253,pill,0,0
224254,(,0,0
224255,RR,0,0
224256,1.3,0,0
224257,",",0,0
224258,95,0,0
224259,%,0,0
224260,CI,0,0
224261,0.5-3.6,0,0
224262,;,0,0
224263,P,0,0
224264,=,0,0
224265,.56,0,0
224266,),0,0
224267,.,0,0
224268,With,0,0
224269,the,0,0
224270,multiphasic,0,0
224271,pill,0,0
224272,",",0,0
224273,the,0,0
224274,maximum,1,1
224275,ovulation,1,1
224276,rate,1,1
224277,over,0,0
224278,60,0,0
224279,cycles,0,0
224280,was,0,0
224281,1.7,0,0
224282,per,0,0
224283,100,0,0
224284,cycles,0,0
224285,(,0,0
224286,95,0,0
224287,%,0,0
224288,CI,0,0
224289,0.0-8.9,0,0
224290,),0,0
224291,.,0,0
224292,CONCLUSION,0,0
224293,This,0,0
224294,multiphasic,0,0
224295,pill,0,0
224296,more,0,0
224297,closely,0,0
224298,resembled,0,0
224299,the,0,0
224300,lower-dose,0,0
224301,monophasic,0,0
224302,pill,0,0
224303,than,0,0
224304,the,0,0
224305,higher-dose,0,0
224306,monophasic,0,0
224307,pill,0,0
224308,in,0,0
224309,its,0,0
224310,suppression,1,1
224311,of,1,0
224312,follicular,1,0
224313,development,1,0
224314,.,1,0
224315,A,0,0
224316,workplace,0,0
224317,intervention,0,0
224318,for,0,0
224319,increasing,0,0
224320,outdoor,0,1
224321,workers,0,0
224322,',0,0
224323,use,0,0
224324,of,0,0
224325,solar,0,0
224326,protection,0,0
224327,.,0,0
224328,OBJECTIVES,0,0
224329,Outdoor,0,0
224330,workers,0,0
224331,are,0,0
224332,at,0,0
224333,high,0,0
224334,risk,0,1
224335,of,0,0
224336,developing,0,0
224337,skin,0,1
224338,cancer,0,0
224339,.,0,0
224340,Primary,0,0
224341,prevention,0,0
224342,in,0,0
224343,this,0,0
224344,group,0,0
224345,can,0,0
224346,potentially,0,0
224347,reduce,0,0
224348,the,0,0
224349,incidence,0,1
224350,of,0,0
224351,skin,0,1
224352,cancer,0,0
224353,",",0,0
224354,and,0,0
224355,also,0,0
224356,potentiates,0,0
224357,the,0,0
224358,spontaneous,0,1
224359,remission,0,1
224360,of,0,0
224361,existing,0,0
224362,solar,0,0
224363,keratoses,0,0
224364,.,0,0
224365,A,0,0
224366,randomized,0,0
224367,controlled,0,0
224368,trial,0,0
224369,was,0,0
224370,conducted,0,0
224371,to,0,0
224372,evaluate,0,0
224373,a,0,0
224374,solar,0,0
224375,protection,0,1
224376,intervention,0,0
224377,targeting,0,0
224378,outdoor,0,1
224379,workers,0,0
224380,.,0,0
224381,METHODS,0,0
224382,Outdoor,0,0
224383,workers,0,0
224384,were,0,0
224385,randomly,0,0
224386,allocated,0,0
224387,to,0,0
224388,an,0,0
224389,intervention,0,0
224390,(,0,0
224391,n,0,0
224392,=,0,0
224393,65,0,0
224394,),0,0
224395,or,0,0
224396,control,0,0
224397,group,0,0
224398,(,0,0
224399,n,0,0
224400,=,0,0
224401,77,0,0
224402,),0,0
224403,.,0,0
224404,The,0,0
224405,intervention,0,0
224406,group,0,0
224407,received,0,0
224408,individual,0,0
224409,skin,0,1
224410,screening,0,0
224411,by,0,0
224412,a,0,0
224413,dermatologist,0,1
224414,and,0,0
224415,participated,0,0
224416,in,0,0
224417,an,0,0
224418,education,0,0
224419,session,0,0
224420,.,0,0
224421,Pre-,0,0
224422,and,0,0
224423,posttest,0,0
224424,outcome,0,1
224425,measures,0,1
224426,included,0,0
224427,solar,1,0
224428,protection,1,1
224429,behavior,1,1
224430,(,0,0
224431,assessed,0,0
224432,using,0,0
224433,a,0,0
224434,validated,0,0
224435,diary,0,0
224436,),0,0
224437,",",0,0
224438,knowledge,1,1
224439,",",0,1
224440,and,0,0
224441,attitudes,1,1
224442,.,1,0
224443,RESULTS,0,0
224444,There,0,0
224445,was,0,0
224446,a,0,0
224447,significant,1,0
224448,increase,1,0
224449,(,0,0
224450,16,0,0
224451,%,0,0
224452,),0,0
224453,in,0,0
224454,the,0,0
224455,percentage,0,1
224456,of,0,0
224457,outdoor,0,0
224458,workers,0,0
224459,who,0,0
224460,were,0,0
224461,using,0,0
224462,a,0,0
224463,high,1,0
224464,level,1,1
224465,of,1,0
224466,solar,1,0
224467,protection,1,1
224468,at,0,0
224469,posttest,0,0
224470,compared,0,0
224471,to,0,0
224472,pretest,0,0
224473,in,0,0
224474,the,0,0
224475,intervention,0,0
224476,group,0,0
224477,",",0,0
224478,but,0,0
224479,there,0,0
224480,was,0,0
224481,no,1,0
224482,change,1,0
224483,in,0,0
224484,the,0,0
224485,control,0,0
224486,group,0,0
224487,.,0,0
224488,Although,0,0
224489,both,0,0
224490,groups,0,0
224491,improved,1,0
224492,in,0,0
224493,their,0,0
224494,knowledge,1,1
224495,score,1,1
224496,",",0,0
224497,the,0,0
224498,intervention,1,0
224499,group,1,0
224500,showed,1,0
224501,a,1,0
224502,significantly,1,0
224503,greater,1,0
224504,improvement,1,1
224505,at,0,0
224506,posttest,0,0
224507,.,0,0
224508,No,1,0
224509,changes,1,0
224510,in,1,0
224511,attitudes,1,1
224512,were,0,0
224513,detected,0,0
224514,.,0,0
224515,CONCLUSIONS,0,0
224516,The,0,0
224517,findings,0,0
224518,suggest,0,0
224519,that,0,0
224520,changes,0,1
224521,in,0,0
224522,solar,1,0
224523,protection,1,0
224524,are,0,0
224525,achievable,0,0
224526,with,0,0
224527,outdoor,0,0
224528,workers,0,0
224529,.,0,0
224530,[,0,0
224531,Hemostatic,0,0
224532,balance,0,1
224533,during,0,0
224534,treatment,0,0
224535,with,0,0
224536,the,0,0
224537,newest,0,0
224538,contraceptives,0,0
224539,],0,0
224540,.,0,0
224541,Thirty-four,0,0
224542,healthy,0,0
224543,young,0,0
224544,women,0,0
224545,were,0,0
224546,allocated,0,0
224547,to,0,0
224548,12,0,0
224549,consecutive,0,0
224550,cycles,0,0
224551,of,0,0
224552,treatment,0,0
224553,with,0,0
224554,monophasic,0,0
224555,combinations,0,0
224556,of,0,0
224557,:,0,0
224558,20,0,0
224559,micrograms,0,0
224560,ethinyl,0,0
224561,estradiol,0,0
224562,and,0,0
224563,150,0,0
224564,micrograms,0,0
224565,desogestrel,0,0
224566,(,0,0
224567,n,0,0
224568,=,0,0
224569,15,0,0
224570,),0,0
224571,or,0,0
224572,30,0,0
224573,micrograms,0,0
224574,ethinyl,0,0
224575,estradiol,0,0
224576,and,0,0
224577,75,0,0
224578,micrograms,0,0
224579,gestodene,0,0
224580,(,0,0
224581,n,0,0
224582,=,0,0
224583,19,0,0
224584,),0,0
224585,.,0,0
224586,In,0,0
224587,both,0,0
224588,groups,0,0
224589,plasma,1,1
224590,levels,1,1
224591,of,1,0
224592,fibrinogen,1,1
224593,and,1,1
224594,factor,1,1
224595,VII,1,1
224596,increased,0,0
224597,while,0,0
224598,the,0,0
224599,capacity,0,1
224600,of,0,0
224601,coagulation,0,1
224602,inhibition,0,1
224603,was,0,0
224604,affected,0,0
224605,by,0,0
224606,increased,1,0
224607,protein,1,1
224608,C,1,0
224609,and,1,0
224610,decreased,1,0
224611,protein,1,1
224612,S,1,0
224613,levels,1,1
224614,.,1,0
224615,Increased,0,0
224616,fibrinolytic,1,0
224617,capacity,1,1
224618,was,0,0
224619,indicated,0,0
224620,by,0,0
224621,elevated,0,0
224622,activity,0,1
224623,and,0,0
224624,reduced,0,1
224625,antigen,1,1
224626,levels,1,1
224627,of,1,0
224628,tissue,1,1
224629,plasminogen,1,1
224630,activator,1,0
224631,and,0,1
224632,reduced,0,1
224633,activity,0,1
224634,and,0,1
224635,concentration,1,1
224636,of,1,1
224637,tissue,1,1
224638,plasminogen,1,1
224639,activator,1,0
224640,inhibitor,1,0
224641,.,1,0
224642,The,0,0
224643,ratio,1,1
224644,between,1,0
224645,thrombin-antithrombin-III-complexes,1,1
224646,and,1,0
224647,fibrin,1,1
224648,degradation,1,1
224649,products,1,1
224650,were,1,0
224651,unchanged,1,0
224652,signifying,0,0
224653,no,0,0
224654,effect,0,0
224655,of,0,0
224656,hormonal,0,1
224657,intake,0,1
224658,on,0,0
224659,the,0,0
224660,balance,0,1
224661,between,0,0
224662,thrombin,0,1
224663,formation,0,1
224664,and,0,0
224665,fibrin,0,1
224666,resolution,0,1
224667,.,0,0
224668,In,0,0
224669,conclusion,0,0
224670,",",0,0
224671,the,0,0
224672,dynamic,0,0
224673,balance,0,1
224674,between,0,0
224675,generation,0,1
224676,and,0,1
224677,resolution,0,1
224678,of,0,1
224679,fibrin,0,1
224680,was,0,0
224681,undisturbed,0,0
224682,during,0,0
224683,treatment,0,0
224684,with,0,0
224685,both,0,0
224686,hormonal,0,0
224687,compounds,0,0
224688,and,0,0
224689,our,0,0
224690,findings,0,0
224691,do,0,0
224692,not,0,0
224693,provide,0,0
224694,evidence,0,0
224695,for,0,0
224696,increased,0,0
224697,risk,0,0
224698,of,0,0
224699,thrombosis,0,1
224700,in,0,0
224701,normal,0,0
224702,women,0,0
224703,.,0,0
224704,A,0,0
224705,comparison,0,0
224706,of,0,0
224707,seven,0,0
224708,antiarrhythmic,0,0
224709,drugs,0,0
224710,in,0,0
224711,patients,0,0
224712,with,0,0
224713,ventricular,0,1
224714,tachyarrhythmias,0,1
224715,.,0,0
224716,Electrophysiologic,0,0
224717,Study,0,0
224718,versus,0,0
224719,Electrocardiographic,0,0
224720,Monitoring,0,0
224721,Investigators,0,0
224722,.,0,0
224723,BACKGROUND,0,0
224724,The,0,0
224725,relative,0,0
224726,efficacies,0,1
224727,of,0,0
224728,various,0,0
224729,antiarrhythmic,0,1
224730,drugs,0,0
224731,in,0,0
224732,the,0,0
224733,treatment,0,0
224734,of,0,0
224735,ventricular,0,1
224736,tachyarrhythmias,0,1
224737,are,0,0
224738,not,0,0
224739,well,0,0
224740,known,0,0
224741,.,0,0
224742,This,0,0
224743,study,0,0
224744,examined,0,0
224745,the,0,0
224746,effectiveness,0,1
224747,of,0,0
224748,imipramine,0,0
224749,",",0,0
224750,mexiletine,0,0
224751,",",0,1
224752,pirmenol,0,1
224753,",",0,1
224754,procainamide,0,0
224755,",",0,1
224756,propafenone,0,0
224757,",",0,1
224758,quinidine,0,1
224759,",",0,1
224760,and,0,1
224761,sotalol,0,0
224762,in,0,0
224763,patients,0,0
224764,with,0,0
224765,ventricular,0,0
224766,tachyarrhythmias,0,1
224767,who,0,0
224768,were,0,0
224769,enrolled,0,0
224770,in,0,0
224771,the,0,0
224772,Electrophysiologic,0,0
224773,Study,0,0
224774,versus,0,0
224775,Electrocardiographic,0,1
224776,Monitoring,0,0
224777,trial,0,0
224778,.,0,0
224779,METHODS,0,0
224780,Patients,0,0
224781,were,0,0
224782,randomly,0,0
224783,assigned,0,0
224784,to,0,0
224785,undergo,0,0
224786,serial,0,0
224787,testing,0,0
224788,of,0,0
224789,the,0,0
224790,efficacy,0,1
224791,of,0,0
224792,the,0,0
224793,seven,0,0
224794,antiarrhythmic,0,0
224795,drugs,0,0
224796,by,0,0
224797,one,0,0
224798,of,0,0
224799,two,0,0
224800,strategies,0,0
224801,:,0,0
224802,electrophysiologic,0,1
224803,study,0,0
224804,or,0,0
224805,Holter,0,0
224806,monitoring,0,0
224807,together,0,0
224808,with,0,0
224809,exercise,0,0
224810,testing,0,0
224811,.,0,0
224812,The,0,0
224813,seven,0,0
224814,drugs,0,0
224815,were,0,0
224816,then,0,0
224817,tested,0,0
224818,for,0,0
224819,efficacy,0,1
224820,in,0,0
224821,random,0,0
224822,order,0,0
224823,in,0,0
224824,patients,0,0
224825,who,0,0
224826,were,0,0
224827,eligible,0,0
224828,to,0,0
224829,receive,0,0
224830,them,0,0
224831,.,0,0
224832,The,0,0
224833,frequencies,0,1
224834,of,0,0
224835,predictions,0,0
224836,of,0,0
224837,drug,0,0
224838,efficacy,0,1
224839,and,0,0
224840,of,0,1
224841,adverse,0,1
224842,drug,0,0
224843,effects,0,0
224844,during,0,0
224845,the,0,0
224846,initial,0,0
224847,drug,0,0
224848,titration,0,0
224849,were,0,0
224850,tabulated,0,0
224851,for,0,0
224852,all,0,0
224853,486,0,0
224854,randomized,0,0
224855,subjects,0,0
224856,.,0,0
224857,Patients,0,0
224858,received,0,0
224859,long-term,0,0
224860,treatment,0,0
224861,with,0,0
224862,the,0,0
224863,first,0,0
224864,antiarrhythmic,0,1
224865,drug,0,0
224866,that,0,0
224867,was,0,0
224868,predicted,0,0
224869,to,0,0
224870,be,0,0
224871,effective,0,0
224872,on,0,0
224873,the,0,0
224874,basis,0,0
224875,of,0,0
224876,drug,0,0
224877,testing,0,0
224878,.,0,0
224879,Recurrences,0,1
224880,of,0,0
224881,arrhythmia,0,1
224882,",",0,0
224883,deaths,0,1
224884,",",0,1
224885,and,0,1
224886,adverse,0,1
224887,drug,0,0
224888,effects,0,1
224889,during,0,0
224890,long-term,0,0
224891,follow-up,0,0
224892,were,0,0
224893,recorded,0,0
224894,for,0,0
224895,the,0,0
224896,296,0,0
224897,patients,0,0
224898,in,0,0
224899,whom,0,0
224900,an,0,0
224901,antiarrhythmic,0,1
224902,drug,0,0
224903,was,0,0
224904,predicted,0,0
224905,to,0,0
224906,be,0,0
224907,effective,0,0
224908,.,0,0
224909,RESULTS,0,0
224910,In,0,0
224911,the,0,0
224912,electrophysiologic-study,0,0
224913,group,0,0
224914,",",0,0
224915,the,0,0
224916,percentage,0,1
224917,of,0,0
224918,patients,0,0
224919,who,0,0
224920,had,0,0
224921,predictions,0,0
224922,of,0,0
224923,drug,1,0
224924,efficacy,1,1
224925,was,0,0
224926,higher,1,0
224927,with,0,0
224928,sotalol,0,0
224929,(,0,0
224930,35,0,0
224931,percent,0,0
224932,),0,0
224933,than,0,0
224934,with,0,0
224935,the,0,0
224936,other,0,0
224937,drugs,0,0
224938,(,0,0
224939,16,0,0
224940,percent,0,0
224941,",",0,0
224942,P,0,0
224943,<,0,0
224944,0.001,0,0
224945,),0,0
224946,.,0,0
224947,There,0,0
224948,was,0,0
224949,no,1,0
224950,significant,1,0
224951,difference,1,0
224952,among,0,0
224953,the,0,0
224954,drugs,0,0
224955,in,0,0
224956,the,0,0
224957,Holter-monitoring,0,0
224958,group,0,0
224959,.,0,0
224960,The,0,0
224961,percentage,0,1
224962,of,0,0
224963,patients,1,0
224964,with,1,0
224965,adverse,1,1
224966,drug,1,0
224967,effects,1,1
224968,was,0,0
224969,lowest,1,0
224970,among,0,0
224971,those,0,0
224972,receiving,0,0
224973,sotalol,0,0
224974,.,0,0
224975,The,0,0
224976,actuarial,1,1
224977,probability,1,0
224978,of,1,0
224979,a,1,0
224980,recurrence,1,1
224981,of,1,0
224982,arrhythmia,1,1
224983,after,0,0
224984,a,0,0
224985,prediction,0,0
224986,of,0,0
224987,drug,0,0
224988,efficacy,0,1
224989,by,0,0
224990,either,0,0
224991,strategy,0,0
224992,was,0,0
224993,significantly,1,0
224994,lower,1,0
224995,for,0,0
224996,patients,0,0
224997,treated,0,0
224998,with,0,0
224999,sotalol,0,0
225000,than,0,0
225001,for,0,0
225002,patients,0,0
225003,treated,0,0
225004,with,0,0
225005,the,0,0
225006,other,0,0
225007,drugs,0,0
225008,(,0,0
225009,risk,0,1
225010,ratio,0,1
225011,",",0,0
225012,0.43,0,0
225013,;,0,0
225014,95,0,0
225015,percent,0,0
225016,confidence,0,0
225017,interval,0,0
225018,",",0,0
225019,0.29,0,0
225020,to,0,0
225021,0.62,0,0
225022,;,0,0
225023,P,0,0
225024,<,0,0
225025,0.001,0,0
225026,),0,0
225027,.,0,0
225028,With,0,0
225029,sotalol,0,0
225030,",",0,0
225031,as,0,0
225032,compared,0,0
225033,with,0,0
225034,the,0,0
225035,other,0,0
225036,drugs,0,0
225037,combined,0,0
225038,",",0,0
225039,there,0,0
225040,were,0,0
225041,lower,1,0
225042,risks,1,1
225043,of,1,1
225044,death,1,1
225045,from,0,0
225046,any,0,0
225047,cause,0,0
225048,(,0,0
225049,risk,0,1
225050,ratio,0,1
225051,",",0,0
225052,0.50,0,0
225053,;,0,0
225054,95,0,0
225055,percent,0,0
225056,confidence,0,0
225057,interval,0,0
225058,",",0,0
225059,0.30,0,0
225060,to,0,0
225061,0.80,0,0
225062,;,0,0
225063,P,0,0
225064,=,0,0
225065,0.004,0,0
225066,),0,0
225067,",",0,0
225068,death,0,1
225069,from,0,0
225070,cardiac,0,1
225071,causes,0,0
225072,",",0,0
225073,(,0,0
225074,0.50,0,0
225075,;,0,0
225076,P,0,0
225077,=,0,0
225078,0.02,0,0
225079,),0,0
225080,",",0,0
225081,and,0,1
225082,death,1,1
225083,from,1,0
225084,arrhythmia,1,1
225085,(,0,0
225086,0.50,0,0
225087,;,0,0
225088,P,0,0
225089,=,0,0
225090,0.04,0,0
225091,),0,0
225092,.,0,0
225093,The,0,0
225094,cumulative,0,1
225095,percentage,0,1
225096,of,0,0
225097,patients,0,0
225098,in,0,0
225099,whom,0,0
225100,a,0,0
225101,drug,0,0
225102,was,0,0
225103,predicted,0,0
225104,to,0,0
225105,be,0,0
225106,effective,1,1
225107,and,0,0
225108,in,0,0
225109,whom,0,0
225110,it,0,0
225111,remained,0,0
225112,effective,1,1
225113,and,1,1
225114,tolerated,1,1
225115,was,0,0
225116,higher,1,0
225117,for,0,0
225118,sotalol,0,0
225119,than,0,0
225120,for,0,0
225121,the,0,0
225122,other,0,0
225123,drugs,0,0
225124,(,0,0
225125,P,0,0
225126,<,0,0
225127,0.001,0,0
225128,),0,0
225129,.,0,0
225130,CONCLUSIONS,0,0
225131,Sotalol,0,0
225132,was,0,0
225133,more,0,0
225134,effective,1,1
225135,than,0,0
225136,the,0,0
225137,other,0,0
225138,six,0,0
225139,antiarrhythmic,0,0
225140,drugs,0,0
225141,in,0,0
225142,preventing,1,0
225143,death,1,1
225144,and,1,0
225145,recurrences,1,1
225146,of,1,0
225147,arrhythmia,1,1
225148,.,1,0
225149,In,0,0
225150,patients,0,0
225151,similar,0,0
225152,to,0,0
225153,those,0,0
225154,in,0,0
225155,this,0,0
225156,study,0,0
225157,",",0,0
225158,if,0,0
225159,antiarrhythmic-drug,0,0
225160,therapy,0,0
225161,is,0,0
225162,to,0,0
225163,be,0,0
225164,used,0,0
225165,to,0,0
225166,prevent,0,0
225167,recurrences,0,1
225168,of,0,0
225169,ventricular,0,1
225170,tachyarrhythmias,0,1
225171,",",0,0
225172,treatment,0,0
225173,with,0,0
225174,sotalol,0,0
225175,and,0,1
225176,assessment,0,1
225177,of,0,0
225178,its,0,0
225179,potential,0,0
225180,efficacy,0,1
225181,by,0,0
225182,Holter,0,0
225183,monitoring,0,0
225184,are,0,0
225185,a,0,0
225186,reasonable,0,0
225187,initial,0,0
225188,strategy,0,0
225189,.,0,0
225190,Use,0,0
225191,of,0,0
225192,activated,0,1
225193,charcoal,0,0
225194,in,0,0
225195,a,0,0
225196,simulated,0,0
225197,poisoning,0,0
225198,with,0,0
225199,acetaminophen,0,0
225200,:,0,0
225201,a,0,0
225202,new,0,0
225203,loading,0,0
225204,dose,0,0
225205,for,0,0
225206,N-acetylcysteine,0,0
225207,?,0,0
225208,STUDY,0,0
225209,OBJECTIVES,0,0
225210,To,0,0
225211,investigate,0,0
225212,the,0,0
225213,ability,0,0
225214,of,0,0
225215,a,0,0
225216,supranormal,0,0
225217,dose,0,0
225218,of,0,0
225219,N-acetylcysteine,0,0
225220,to,0,0
225221,overcome,0,0
225222,the,0,0
225223,effects,0,0
225224,of,0,0
225225,activated,0,0
225226,charcoal,0,0
225227,on,0,0
225228,N-acetylcysteine,0,0
225229,bioavailability,0,1
225230,and,0,0
225231,to,0,0
225232,determine,0,0
225233,the,0,0
225234,effects,0,0
225235,of,0,0
225236,activated,0,0
225237,charcoal,0,0
225238,on,0,0
225239,serum,0,1
225240,acetaminophen,0,0
225241,levels,0,1
225242,.,0,0
225243,DESIGN,0,0
225244,",",0,0
225245,SETTING,0,0
225246,",",0,0
225247,AND,0,0
225248,PARTICIPANTS,0,1
225249,Ten,0,0
225250,healthy,0,0
225251,adult,0,0
225252,volunteers,0,0
225253,participated,0,0
225254,in,0,0
225255,a,0,0
225256,controlled,0,0
225257,cross-over,0,0
225258,experiment,0,0
225259,.,0,0
225260,During,0,0
225261,phase,0,0
225262,I,0,0
225263,(,0,0
225264,control,0,0
225265,),0,0
225266,",",0,0
225267,subjects,0,0
225268,ingested,0,0
225269,3,0,0
225270,g,0,0
225271,acetaminophen,0,0
225272,",",0,0
225273,followed,0,0
225274,one,0,0
225275,hour,0,0
225276,later,0,0
225277,by,0,0
225278,the,0,0
225279,normal,0,0
225280,loading,0,0
225281,dose,0,0
225282,of,0,0
225283,N-acetylcysteine,0,0
225284,(,0,0
225285,140,0,0
225286,mg/kg,0,0
225287,),0,0
225288,.,0,0
225289,During,0,0
225290,phase,0,0
225291,II,0,0
225292,(,0,0
225293,charcoal,0,0
225294,),0,0
225295,",",0,0
225296,subjects,0,0
225297,ingested,0,0
225298,3,0,0
225299,g,0,0
225300,acetaminophen,0,0
225301,",",0,0
225302,followed,0,0
225303,one,0,0
225304,hour,0,0
225305,later,0,0
225306,by,0,0
225307,60,0,0
225308,g,0,0
225309,activated,0,0
225310,charcoal,0,0
225311,and,0,0
225312,a,0,0
225313,supranormal,0,1
225314,loading,0,0
225315,dose,0,0
225316,of,0,1
225317,N-acetylcysteine,0,0
225318,(,0,0
225319,235,0,0
225320,mg/kg,0,0
225321,),0,0
225322,.,0,0
225323,MAIN,0,0
225324,OUTCOME,0,0
225325,MEASURES,0,0
225326,Serum,1,1
225327,levels,1,1
225328,of,1,0
225329,N-acetylcysteine,1,0
225330,were,0,0
225331,measured,0,0
225332,every,0,0
225333,30,0,0
225334,minutes,0,0
225335,for,0,0
225336,six,0,0
225337,hours,0,0
225338,.,0,0
225339,A,0,0
225340,serum,1,1
225341,acetaminophen,1,0
225342,level,1,1
225343,was,0,0
225344,measured,0,0
225345,at,0,0
225346,four,0,0
225347,hours,0,0
225348,.,0,0
225349,RESULTS,0,0
225350,The,0,0
225351,area,1,0
225352,under,1,0
225353,the,1,0
225354,curve,1,1
225355,for,1,0
225356,N-acetylcysteine,1,0
225357,was,0,0
225358,significantly,0,0
225359,higher,0,0
225360,for,0,0
225361,phase,0,0
225362,II,0,0
225363,than,0,0
225364,phase,0,0
225365,I,0,0
225366,(,0,0
225367,P,0,0
225368,<,0,0
225369,.05,0,0
225370,",",0,0
225371,two-tailed,0,0
225372,paired,0,0
225373,t-test,0,0
225374,),0,0
225375,.,0,0
225376,Peak,1,1
225377,N-acetylcysteine,1,0
225378,and,1,0
225379,time,1,1
225380,to,1,0
225381,peak,1,1
225382,were,0,0
225383,not,0,0
225384,significantly,0,0
225385,different,0,0
225386,.,0,0
225387,The,0,0
225388,four-hour,1,0
225389,serum,1,1
225390,acetaminophen,1,0
225391,level,1,1
225392,was,0,0
225393,significantly,0,0
225394,lower,0,0
225395,for,0,0
225396,phase,0,0
225397,II,0,0
225398,than,0,0
225399,phase,0,0
225400,I,0,0
225401,(,0,0
225402,P,0,0
225403,<,0,0
225404,.05,0,0
225405,",",0,0
225406,two-tailed,0,0
225407,paired,0,0
225408,t-test,0,0
225409,),0,0
225410,.,0,0
225411,Diarrhea,1,1
225412,occurred,0,0
225413,during,0,0
225414,both,0,0
225415,phases,0,0
225416,",",0,0
225417,but,0,0
225418,N-acetylcysteine,0,0
225419,was,0,0
225420,otherwise,0,0
225421,well,0,0
225422,tolerated,1,1
225423,.,1,0
225424,CONCLUSION,0,0
225425,These,0,0
225426,results,0,0
225427,suggest,0,0
225428,that,0,0
225429,activated,0,0
225430,charcoal,0,0
225431,can,0,0
225432,be,0,0
225433,used,0,0
225434,safely,0,0
225435,for,0,0
225436,victims,0,0
225437,of,0,0
225438,acetaminophen,0,0
225439,overdose,0,0
225440,.,0,0
225441,A,0,0
225442,beneficial,0,0
225443,effect,0,0
225444,in,0,0
225445,preventing,0,0
225446,acetaminophen,0,0
225447,absorption,0,0
225448,can,0,0
225449,be,0,0
225450,expected,0,0
225451,if,0,0
225452,it,0,0
225453,is,0,0
225454,given,0,0
225455,within,0,0
225456,one,0,0
225457,hour,0,0
225458,after,0,0
225459,ingestion,0,0
225460,.,0,0
225461,If,0,0
225462,N-acetylcysteine,0,0
225463,is,0,0
225464,needed,0,0
225465,because,0,0
225466,of,0,0
225467,a,0,0
225468,toxic,0,1
225469,serum,0,1
225470,acetaminophen,0,0
225471,level,0,1
225472,",",0,0
225473,bioavailability,0,1
225474,can,0,0
225475,be,0,0
225476,ensured,0,0
225477,by,0,0
225478,increasing,0,0
225479,the,0,0
225480,N-acetylcysteine,0,0
225481,loading,0,0
225482,dose,0,0
225483,from,0,0
225484,140,0,0
225485,mg/kg,0,0
225486,to,0,0
225487,235,0,0
225488,mg/kg,0,0
225489,.,0,0
225490,Early,0,0
225491,versus,0,0
225492,late,0,1
225493,replacement,0,0
225494,of,0,0
225495,autotransfused,0,0
225496,blood,0,1
225497,in,0,0
225498,elective,0,0
225499,spinal,0,0
225500,surgery,0,0
225501,.,0,0
225502,A,0,0
225503,prospective,0,0
225504,randomized,0,0
225505,study,0,0
225506,.,0,0
225507,The,0,0
225508,use,0,0
225509,of,0,0
225510,autologous,0,0
225511,blood,0,1
225512,is,0,0
225513,a,0,0
225514,well,0,0
225515,established,0,0
225516,and,0,0
225517,extremely,0,0
225518,popular,0,0
225519,technique,0,0
225520,to,0,0
225521,decrease,0,0
225522,the,0,0
225523,necessity,0,0
225524,for,0,0
225525,homologous,0,1
225526,transfusions,0,1
225527,and,0,0
225528,the,0,0
225529,attendant,0,0
225530,risks,0,1
225531,of,0,0
225532,hepatitis,0,0
225533,",",0,0
225534,HIV,0,1
225535,",",0,1
225536,and,0,0
225537,HTLV,0,0
225538,--,0,0
225539,I/II,0,0
225540,infections,0,0
225541,.,0,0
225542,The,0,0
225543,most,0,0
225544,beneficial,0,0
225545,timing,0,1
225546,for,0,0
225547,autologous,0,0
225548,reinfusion,0,0
225549,of,0,0
225550,predonated,0,0
225551,blood,0,1
225552,remains,0,0
225553,unknown,0,0
225554,.,0,0
225555,The,0,0
225556,present,0,0
225557,study,0,0
225558,was,0,0
225559,undertaken,0,0
225560,to,0,0
225561,determine,0,0
225562,the,0,0
225563,optimal,0,0
225564,timing,0,1
225565,of,0,0
225566,autologous,0,0
225567,blood,0,1
225568,reinfusion,0,0
225569,in,0,0
225570,elective,0,0
225571,spinal,0,0
225572,surgery,0,0
225573,.,0,0
225574,Fifty-seven,0,0
225575,patients,0,0
225576,were,0,0
225577,prospectively,0,0
225578,individually,0,0
225579,randomly,0,0
225580,allocated,0,0
225581,into,0,0
225582,early,0,0
225583,versus,0,0
225584,delayed,0,0
225585,reinfusion,0,0
225586,groups,0,0
225587,prior,0,0
225588,to,0,0
225589,undergoing,0,0
225590,elective,0,0
225591,spinal,0,0
225592,surgery,0,0
225593,by,0,0
225594,a,0,0
225595,single,0,0
225596,surgeon,0,0
225597,.,0,0
225598,Three,0,0
225599,surgical,0,0
225600,subgroups,0,0
225601,were,0,0
225602,entered,0,0
225603,into,0,0
225604,the,0,0
225605,study,0,0
225606,:,0,0
225607,anterior/posterior,0,1
225608,(,0,0
225609,A/P,0,1
225610,),0,0
225611,spinal,0,0
225612,fusion,0,1
225613,patients,0,0
225614,",",0,0
225615,posterior,0,0
225616,thoracolumbar,0,1
225617,scoliosis,0,1
225618,fusion,0,1
225619,patients,0,0
225620,(,0,0
225621,PSF,0,0
225622,),0,1
225623,",",0,0
225624,and,0,1
225625,degenerative,0,0
225626,posterior,0,0
225627,lumbar,0,0
225628,fusion,0,1
225629,patients,0,0
225630,(,0,0
225631,LF,0,0
225632,),0,0
225633,.,0,0
225634,Randomization,0,0
225635,was,0,0
225636,successful,0,0
225637,in,0,0
225638,that,0,0
225639,three,0,0
225640,was,0,0
225641,no,0,0
225642,significant,0,0
225643,difference,0,0
225644,in,0,0
225645,male,0,0
225646,to,0,0
225647,female,0,0
225648,ratio,0,1
225649,",",0,0
225650,age,0,0
225651,",",0,1
225652,preoperative,0,1
225653,hemoglobin,0,1
225654,",",0,0
225655,or,0,1
225656,number,0,1
225657,of,0,1
225658,units,0,0
225659,predonated,0,0
225660,between,0,0
225661,the,0,0
225662,early,0,0
225663,and,0,0
225664,delayed,0,1
225665,reinfusion,0,0
225666,groups,0,0
225667,.,0,0
225668,Likewise,0,0
225669,",",0,0
225670,there,0,0
225671,was,0,0
225672,no,0,0
225673,significant,0,0
225674,difference,0,0
225675,in,0,0
225676,the,0,0
225677,details,0,0
225678,of,0,0
225679,the,0,0
225680,operative,0,0
225681,procedure,0,0
225682,when,0,0
225683,compared,0,0
225684,as,0,0
225685,a,0,0
225686,group,0,0
225687,for,0,0
225688,the,0,0
225689,early,0,0
225690,versus,0,0
225691,delayed,0,0
225692,reinfusion,0,0
225693,groups,0,0
225694,.,0,0
225695,A,0,0
225696,significant,0,0
225697,increase,0,0
225698,in,0,0
225699,the,0,0
225700,postoperative,0,1
225701,day,1,0
225702,#,1,0
225703,1,1,0
225704,",",1,0
225705,2,1,0
225706,and,1,0
225707,3,1,0
225708,hemoglobin,1,1
225709,was,0,0
225710,seen,0,0
225711,in,0,0
225712,the,0,0
225713,early,0,0
225714,reinfusion,0,0
225715,group,0,0
225716,",",0,0
225717,while,0,0
225718,there,0,0
225719,was,0,0
225720,no,0,0
225721,significant,0,0
225722,difference,0,0
225723,seen,0,0
225724,in,0,0
225725,the,0,0
225726,postoperative,0,1
225727,day,0,0
225728,#,0,0
225729,7,0,0
225730,hemoglobin,0,0
225731,between,0,0
225732,the,0,0
225733,early,0,0
225734,versus,0,0
225735,delayed,0,0
225736,reinfusion,0,0
225737,group,0,0
225738,.,0,0
225739,There,0,0
225740,was,0,0
225741,no,0,0
225742,effect,0,0
225743,of,0,0
225744,surgical,0,0
225745,grouping,0,0
225746,on,0,0
225747,these,0,0
225748,significant,0,0
225749,comparisons,0,0
225750,.,0,0
225751,Earlier,0,0
225752,patient,1,1
225753,mobilization,1,0
225754,was,0,0
225755,also,0,0
225756,seen,0,0
225757,in,0,0
225758,the,0,0
225759,early,0,0
225760,reinfusion,0,0
225761,groups,0,0
225762,for,0,0
225763,the,0,0
225764,A/P,0,0
225765,and,0,0
225766,PSF,0,0
225767,groups,0,0
225768,.,0,0
225769,There,0,0
225770,was,0,0
225771,no,0,0
225772,difference,0,0
225773,in,0,0
225774,patients,0,0
225775,',0,0
225776,subjective,0,1
225777,evaluation,0,0
225778,of,0,0
225779,satisfaction,0,1
225780,and,0,1
225781,discomfort,0,1
225782,between,0,0
225783,the,0,0
225784,early,0,0
225785,or,0,0
225786,delayed,0,0
225787,reinfusion,0,0
225788,groups,0,0
225789,as,0,0
225790,determined,0,0
225791,by,0,0
225792,blinded,0,0
225793,interview,0,0
225794,on,0,0
225795,days,0,0
225796,1,0,0
225797,",",0,0
225798,3,0,0
225799,",",0,0
225800,5,0,0
225801,",",0,0
225802,and,0,0
225803,7,0,0
225804,postoperatively,0,0
225805,.,0,0
225806,(,0,0
225807,ABSTRACT,0,1
225808,TRUNCATED,0,0
225809,AT,0,0
225810,250,0,0
225811,WORDS,0,0
225812,),0,0
225813,Radiation-induced,0,0
225814,brachial,0,0
225815,plexopathy,0,0
225816,:,0,0
225817,neurological,0,1
225818,follow-up,0,0
225819,in,0,0
225820,161,0,0
225821,recurrence-free,0,1
225822,breast,0,0
225823,cancer,0,0
225824,patients,0,0
225825,.,0,0
225826,PURPOSE,0,0
225827,The,0,0
225828,purpose,0,0
225829,was,0,0
225830,to,0,0
225831,assess,1,0
225832,the,1,0
225833,incidence,1,1
225834,and,1,0
225835,clinical,1,0
225836,manifestations,1,1
225837,of,0,0
225838,radiation-induced,0,0
225839,brachial,0,0
225840,plexopathy,0,0
225841,in,0,0
225842,breast,0,0
225843,cancer,0,0
225844,patients,0,0
225845,",",0,0
225846,treated,0,0
225847,according,0,0
225848,to,0,0
225849,the,0,0
225850,Danish,0,0
225851,Breast,0,0
225852,Cancer,0,0
225853,Cooperative,0,0
225854,Group,0,0
225855,protocols,0,0
225856,.,0,0
225857,METHODS,0,0
225858,AND,0,0
225859,MATERIALS,0,0
225860,One,0,0
225861,hundred,0,0
225862,and,0,0
225863,sixty-one,0,0
225864,recurrence-free,0,1
225865,breast,0,0
225866,cancer,0,0
225867,patients,0,0
225868,were,0,0
225869,examined,0,0
225870,for,0,0
225871,radiation-induced,0,0
225872,brachial,0,0
225873,plexopathy,0,0
225874,after,0,0
225875,a,0,0
225876,median,0,0
225877,follow-up,0,0
225878,period,0,0
225879,of,0,0
225880,50,0,0
225881,months,0,0
225882,(,0,0
225883,13-99,0,0
225884,months,0,0
225885,),0,0
225886,.,0,0
225887,After,0,0
225888,total,0,1
225889,mastectomy,0,0
225890,and,0,0
225891,axillary,0,1
225892,node,0,1
225893,sampling,0,0
225894,",",0,0
225895,high-risk,0,0
225896,patients,0,0
225897,were,0,0
225898,randomized,0,0
225899,to,0,0
225900,adjuvant,0,0
225901,therapy,0,0
225902,.,0,0
225903,One,0,0
225904,hundred,0,0
225905,twenty-eight,0,0
225906,patients,0,0
225907,were,0,0
225908,treated,0,0
225909,with,0,0
225910,postoperative,0,1
225911,radiotherapy,0,0
225912,with,0,0
225913,50,0,0
225914,Gy,0,0
225915,in,0,0
225916,25,0,0
225917,daily,0,0
225918,fractions,0,0
225919,over,0,0
225920,5,0,0
225921,weeks,0,0
225922,.,0,0
225923,In,0,0
225924,addition,0,0
225925,",",0,0
225926,82,0,0
225927,of,0,0
225928,these,0,0
225929,patients,0,0
225930,received,0,0
225931,cytotoxic,0,1
225932,therapy,0,0
225933,(,0,0
225934,cyclophosphamide,0,0
225935,",",0,1
225936,methotrexate,0,0
225937,",",0,1
225938,and,0,1
225939,5-fluorouracil,0,0
225940,),0,0
225941,and,0,0
225942,46,0,0
225943,received,0,0
225944,tamoxifen,0,0
225945,.,0,0
225946,RESULTS,0,0
225947,Five,0,0
225948,percent,0,0
225949,and,0,0
225950,9,0,0
225951,%,0,0
225952,of,0,0
225953,the,0,0
225954,patients,0,0
225955,receiving,0,0
225956,radiotherapy,0,0
225957,had,0,0
225958,disabling,1,1
225959,and,1,1
225960,mild,1,1
225961,radiation-induced,1,1
225962,brachial,1,1
225963,plexopathy,1,1
225964,",",0,0
225965,respectively,0,0
225966,.,0,0
225967,Radiation-induced,1,0
225968,brachial,1,1
225969,plexopathy,1,1
225970,was,0,0
225971,more,0,0
225972,frequent,0,1
225973,in,0,0
225974,patients,0,0
225975,receiving,0,0
225976,cytotoxic,0,1
225977,therapy,0,0
225978,(,0,0
225979,p,0,0
225980,=,0,0
225981,0.04,0,0
225982,),0,0
225983,and,0,0
225984,in,0,0
225985,younger,0,0
225986,patients,0,0
225987,(,0,0
225988,p,0,0
225989,=,0,0
225990,0.04,0,0
225991,),0,0
225992,.,0,0
225993,The,0,0
225994,clinical,0,0
225995,manifestations,0,1
225996,were,0,0
225997,paraesthesia,1,1
225998,(,0,0
225999,100,0,0
226000,%,0,0
226001,),0,0
226002,",",0,0
226003,hypaesthesia,1,1
226004,(,0,0
226005,74,0,0
226006,%,0,0
226007,),0,0
226008,",",0,0
226009,weakness,1,1
226010,(,0,0
226011,58,0,0
226012,%,0,0
226013,),0,0
226014,",",0,0
226015,decreased,1,1
226016,muscle,1,1
226017,stretch,1,0
226018,reflexes,1,1
226019,(,0,0
226020,47,0,0
226021,%,0,0
226022,),0,0
226023,",",0,0
226024,and,0,1
226025,pain,1,1
226026,(,0,0
226027,47,0,0
226028,%,0,0
226029,),0,0
226030,.,0,0
226031,CONCLUSION,0,0
226032,The,0,0
226033,brachial,0,0
226034,plexus,0,0
226035,is,0,0
226036,more,0,0
226037,vulnerable,0,0
226038,to,0,0
226039,large,0,0
226040,fraction,0,1
226041,size,0,1
226042,.,0,0
226043,Fractions,0,0
226044,of,0,0
226045,2,0,0
226046,Gy,0,0
226047,or,0,0
226048,less,0,0
226049,are,0,0
226050,advisable,0,0
226051,.,0,0
226052,Cytotoxic,0,1
226053,therapy,0,0
226054,adds,0,0
226055,to,0,0
226056,the,0,0
226057,damaging,0,0
226058,effect,0,0
226059,of,0,0
226060,radiotherapy,0,0
226061,.,0,0
226062,Peripheral,0,0
226063,nerves,0,0
226064,in,0,0
226065,younger,0,0
226066,patients,0,0
226067,seems,0,0
226068,more,0,0
226069,vulnerable,0,0
226070,.,0,0
226071,Radiation-induced,0,0
226072,brachial,0,0
226073,plexopathy,0,0
226074,occurs,0,0
226075,mainly,0,0
226076,as,0,0
226077,diffuse,0,0
226078,damage,0,1
226079,to,0,0
226080,the,0,0
226081,brachial,0,0
226082,plexus,0,0
226083,.,0,0
226084,Milk,0,1
226085,protein,0,1
226086,quantity,0,1
226087,and,0,1
226088,quality,0,1
226089,in,0,0
226090,low-birth-weight,0,0
226091,infants,0,0
226092,.,0,0
226093,IV,0,0
226094,.,0,0
226095,Effects,0,0
226096,on,0,0
226097,tyrosine,1,0
226098,and,0,1
226099,phenylalanine,1,1
226100,in,1,0
226101,plasma,1,1
226102,and,1,0
226103,urine,1,1
226104,.,1,1
226105,Well,0,0
226106,",",0,0
226107,appropriate-for-gestational,0,0
226108,age,0,0
226109,",",0,0
226110,low-birth-weight,0,0
226111,infants,0,0
226112,were,0,0
226113,divided,0,0
226114,into,0,0
226115,three,0,0
226116,gestational,0,0
226117,age,0,0
226118,groups,0,0
226119,and,0,1
226120,assigned,0,0
226121,randomly,0,0
226122,within,0,0
226123,each,0,0
226124,age,0,0
226125,group,0,0
226126,to,0,0
226127,one,0,0
226128,of,0,0
226129,five,0,0
226130,feeding,0,0
226131,regimens,0,0
226132,:,0,0
226133,pooled,0,0
226134,human,0,0
226135,milk,0,0
226136,(,0,0
226137,BM,0,0
226138,),0,0
226139,;,0,0
226140,formula,0,0
226141,1,0,0
226142,(,0,0
226143,F1,0,0
226144,),0,0
226145,=,0,0
226146,1.5,0,0
226147,gm/dl,0,0
226148,protein,0,0
226149,",",0,0
226150,60,0,0
226151,parts,0,0
226152,bovine,0,0
226153,whey,0,0
226154,proteins,0,0
226155,:,0,0
226156,40,0,0
226157,parts,0,0
226158,bovine,0,0
226159,caseins,0,1
226160,;,0,0
226161,F2,0,0
226162,=,0,0
226163,3.0,0,0
226164,gm/dl,0,0
226165,",",0,0
226166,60:40,0,0
226167,;,0,0
226168,F3,0,0
226169,=,0,0
226170,1.5,0,0
226171,gm/dl,0,0
226172,",",0,0
226173,18:82,0,0
226174,;,0,0
226175,F4,0,0
226176,=,0,0
226177,3.0,0,0
226178,gm/dl,0,0
226179,",",0,0
226180,18:82,0,0
226181,.,0,0
226182,Plasma,1,0
226183,and,1,0
226184,urine,1,1
226185,concentrations,1,1
226186,of,1,0
226187,tyrosine,1,0
226188,and,1,1
226189,phenylalanine,1,1
226190,were,0,0
226191,far,0,0
226192,higher,1,0
226193,in,0,0
226194,the,0,0
226195,infants,0,0
226196,fed,0,0
226197,F1,0,0
226198,to,0,0
226199,F4,0,0
226200,",",0,0
226201,especially,0,0
226202,F2,0,0
226203,and,0,1
226204,F4,0,0
226205,",",0,0
226206,than,0,0
226207,in,0,0
226208,the,0,0
226209,infants,0,0
226210,fed,0,0
226211,BM,0,0
226212,.,0,0
226213,These,0,0
226214,findings,0,0
226215,offer,0,0
226216,further,0,0
226217,evidence,0,0
226218,for,0,0
226219,the,0,0
226220,limited,0,0
226221,capacity,0,0
226222,of,0,0
226223,the,0,0
226224,low-birth-weight,0,0
226225,infant,0,0
226226,to,0,0
226227,catabolize,1,0
226228,tyrosine,1,0
226229,.,1,0
226230,Infants,0,0
226231,fed,0,0
226232,F3,0,0
226233,had,0,0
226234,significantly,1,0
226235,higher,1,0
226236,plasma,1,1
226237,tyrosine,1,1
226238,concentrations,1,1
226239,than,0,0
226240,infants,0,0
226241,fed,0,0
226242,F1,0,0
226243,",",0,0
226244,and,0,0
226245,those,0,0
226246,fed,0,0
226247,F4,0,0
226248,had,0,0
226249,higher,0,0
226250,concentrations,0,1
226251,than,0,0
226252,those,0,0
226253,fed,0,0
226254,F2,0,0
226255,.,0,0
226256,Thus,0,1
226257,",",0,0
226258,increased,1,0
226259,plasma,1,1
226260,tyrosine,1,0
226261,concentrations,1,1
226262,in,0,0
226263,low-birth-weight,0,0
226264,infants,0,0
226265,are,0,0
226266,related,0,0
226267,directly,0,0
226268,both,0,0
226269,to,0,0
226270,the,0,0
226271,quantity,0,0
226272,and,0,0
226273,to,0,0
226274,the,0,0
226275,quality,0,1
226276,of,0,0
226277,the,0,0
226278,protein,0,0
226279,in,0,0
226280,their,0,0
226281,diets,0,0
226282,.,0,0
226283,The,0,0
226284,relative,0,0
226285,contributions,0,0
226286,of,0,0
226287,medication,0,1
226288,adherence,0,1
226289,and,0,1
226290,AA,0,1
226291,meeting,0,0
226292,attendance,0,1
226293,to,0,0
226294,abstinent,0,0
226295,outcome,0,0
226296,for,0,0
226297,chronic,0,0
226298,alcoholics,0,0
226299,.,0,0
226300,Our,0,0
226301,preliminary,0,0
226302,studies,0,0
226303,of,0,0
226304,the,0,0
226305,efficacy,0,1
226306,of,0,0
226307,lithium,0,0
226308,carbonate,0,0
226309,therapy,0,0
226310,for,0,0
226311,alcoholism,0,0
226312,under,0,0
226313,double-blind,0,0
226314,",",0,0
226315,placebo-controlled,0,0
226316,conditions,0,0
226317,demonstrated,0,0
226318,that,0,0
226319,alcoholics,0,0
226320,who,0,0
226321,took,0,0
226322,their,0,0
226323,assigned,0,0
226324,medication,0,1
226325,(,0,0
226326,lithium,0,0
226327,or,0,1
226328,placebo,0,0
226329,),0,0
226330,for,0,0
226331,the,0,0
226332,first,0,0
226333,6,0,0
226334,months,0,0
226335,after,0,0
226336,discharge,0,0
226337,from,0,0
226338,an,0,0
226339,inpatient,0,0
226340,rehabilitation,0,0
226341,program,0,0
226342,were,0,0
226343,more,0,0
226344,likely,0,0
226345,to,0,0
226346,abstain,0,0
226347,from,0,0
226348,any,0,0
226349,alcohol,0,0
226350,use,0,0
226351,for,0,0
226352,18,0,0
226353,months,0,0
226354,following,0,0
226355,discharge,0,1
226356,than,0,0
226357,were,0,0
226358,alcoholics,0,0
226359,who,0,0
226360,took,0,0
226361,their,0,0
226362,medication,0,0
226363,erratically,0,1
226364,or,0,0
226365,not,0,0
226366,at,0,0
226367,all,0,0
226368,.,0,0
226369,Attendance,0,1
226370,at,0,0
226371,Alcoholics,0,0
226372,Anonymous,0,0
226373,(,0,0
226374,AA,0,0
226375,),0,0
226376,meetings,0,0
226377,was,0,0
226378,also,0,0
226379,associated,0,0
226380,with,0,0
226381,medication,0,0
226382,adherence,0,0
226383,.,0,0
226384,We,0,0
226385,applied,0,0
226386,a,0,0
226387,structural,0,0
226388,equation,0,0
226389,model,0,0
226390,to,0,0
226391,data,0,0
226392,on,0,0
226393,the,0,0
226394,relationships,0,0
226395,between,0,0
226396,medication,0,1
226397,adherence,0,1
226398,",",0,0
226399,AA,0,1
226400,meeting,0,1
226401,attendance,0,1
226402,and,0,1
226403,abstinent,1,0
226404,outcome,1,0
226405,to,0,0
226406,clarify,0,0
226407,whether,0,0
226408,medication,0,1
226409,adherence,0,1
226410,or,0,0
226411,AA,0,1
226412,meeting,0,0
226413,attendance,0,1
226414,better,0,0
226415,explains,0,0
226416,the,0,0
226417,positive-outcome,0,0
226418,adherence,1,0
226419,effect,0,0
226420,we,0,0
226421,observed,0,0
226422,.,0,0
226423,Both,0,0
226424,medication,0,1
226425,adherence,0,1
226426,and,0,1
226427,AA,0,1
226428,meeting,0,1
226429,attendance,0,1
226430,evidenced,0,0
226431,direct,0,0
226432,and,0,0
226433,independent,0,0
226434,influences,0,0
226435,on,0,0
226436,abstinent,0,0
226437,outcome,0,0
226438,:,0,0
226439,medication,0,1
226440,adherence,0,1
226441,showed,0,0
226442,a,0,0
226443,small,0,0
226444,direct,0,0
226445,influence,0,0
226446,",",0,0
226447,and,0,1
226448,AA,0,1
226449,meeting,0,1
226450,attendance,0,1
226451,showed,0,0
226452,a,0,0
226453,much,0,0
226454,larger,0,0
226455,",",0,0
226456,independent,0,0
226457,influence,0,0
226458,.,0,0
226459,Cimetidine,0,0
226460,is,0,0
226461,not,0,0
226462,more,0,0
226463,effective,1,1
226464,than,0,0
226465,placebo,0,0
226466,in,0,0
226467,acute,0,0
226468,infectious,0,0
226469,mononucleosis,0,0
226470,.,0,0
226471,Timing,0,0
226472,of,0,0
226473,antibiotic,0,0
226474,administration,0,0
226475,in,0,0
226476,knee,0,1
226477,replacement,0,0
226478,under,0,0
226479,tourniquet,0,0
226480,.,0,0
226481,Cephamandole,1,0
226482,levels,1,1
226483,in,1,0
226484,serum,1,1
226485,and,1,1
226486,drain,1,1
226487,fluid,1,1
226488,were,0,0
226489,measured,0,0
226490,in,0,0
226491,32,0,0
226492,knee,0,0
226493,replacement,0,0
226494,operations,0,0
226495,to,0,0
226496,determine,0,0
226497,the,0,0
226498,benefit,0,0
226499,of,0,0
226500,an,0,0
226501,intravenous,0,0
226502,dose,0,0
226503,of,0,0
226504,antibiotic,0,0
226505,at,0,0
226506,the,0,0
226507,time,0,1
226508,of,0,0
226509,tourniquet,0,0
226510,deflation,0,0
226511,.,0,0
226512,Concentrations,0,1
226513,of,0,0
226514,cephamandole,1,0
226515,in,1,0
226516,drain,1,1
226517,fluid,1,1
226518,were,0,0
226519,directly,0,0
226520,proportional,0,0
226521,to,0,0
226522,the,0,0
226523,serum,0,1
226524,concentration,0,1
226525,at,0,0
226526,the,0,0
226527,time,0,1
226528,of,0,0
226529,tourniquet,0,0
226530,release,0,0
226531,.,0,0
226532,A,0,0
226533,'tourniquet-release,0,0
226534,',0,0
226535,dose,0,0
226536,of,0,0
226537,antibiotic,0,0
226538,increased,0,0
226539,drain,1,0
226540,fluid,1,1
226541,concentration,1,1
226542,threefold,0,0
226543,.,0,0
226544,Effects,0,0
226545,of,0,0
226546,reducing,0,0
226547,dietary,0,0
226548,[,0,0
226549,(,0,0
226550,Na+,0,1
226551,+,0,0
226552,K+,0,0
226553,),0,0
226554,-,0,0
226555,(,0,0
226556,Cl-,0,1
226557,+,0,0
226558,SO4=,0,0
226559,),0,0
226560,],0,0
226561,on,0,0
226562,the,0,0
226563,rate,0,1
226564,of,0,0
226565,calcium,0,0
226566,mobilisation,0,1
226567,by,0,0
226568,dairy,0,0
226569,cows,0,0
226570,at,0,0
226571,parturition,0,1
226572,.,0,0
226573,The,0,0
226574,effects,0,0
226575,of,0,0
226576,feeding,0,0
226577,diets,0,0
226578,with,0,0
226579,different,0,0
226580,milliequivalents,0,0
226581,(,0,0
226582,meq,0,0
226583,),0,0
226584,of,0,0
226585,dietary,0,0
226586,[,0,0
226587,(,0,0
226588,Na+,0,1
226589,+,0,0
226590,K+,0,0
226591,),0,0
226592,-,0,0
226593,(,0,0
226594,Cl-,0,1
226595,+,0,0
226596,SO4=,0,0
226597,),0,0
226598,],0,0
226599,to,0,0
226600,dairy,0,0
226601,cows,0,0
226602,during,0,0
226603,the,0,0
226604,last,0,0
226605,seven,0,0
226606,weeks,0,0
226607,of,0,0
226608,pregnancy,0,1
226609,on,0,0
226610,their,0,0
226611,acid-base,0,1
226612,status,0,1
226613,and,0,1
226614,calcium,0,1
226615,mobilisation,0,1
226616,rate,0,1
226617,around,0,0
226618,parturition,0,1
226619,were,0,0
226620,studied,0,0
226621,.,0,0
226622,Ten,0,0
226623,monozygotic,0,0
226624,twin,0,0
226625,pairs,0,0
226626,of,0,0
226627,pregnant,0,0
226628,cows,0,0
226629,(,0,0
226630,five,0,0
226631,pairs,0,0
226632,of,0,0
226633,parity,0,0
226634,1,0,0
226635,or,0,0
226636,2,0,0
226637,",",0,0
226638,and,0,0
226639,five,0,0
226640,pairs,0,0
226641,of,0,0
226642,parity,0,0
226643,3,0,0
226644,or,0,0
226645,more,0,0
226646,),0,1
226647,were,0,0
226648,allocated,0,0
226649,to,0,0
226650,two,0,0
226651,diets,0,0
226652,which,0,0
226653,were,0,0
226654,formulated,0,0
226655,to,0,0
226656,provide,0,0
226657,either,0,0
226658,-4,0,0
226659,meq,0,0
226660,(,0,0
226661,anion,0,1
226662,diet,0,0
226663,),0,0
226664,or,0,0
226665,+572.5,0,0
226666,meq,0,0
226667,(,0,0
226668,cation,0,1
226669,diet,0,0
226670,),0,0
226671,of,0,0
226672,[,0,0
226673,(,0,0
226674,Na+,0,1
226675,+,0,0
226676,K+,0,0
226677,),0,0
226678,-,0,0
226679,(,0,0
226680,Cl-,0,1
226681,+,0,0
226682,SO4=,0,0
226683,),0,0
226684,],0,0
226685,kg-1,0,0
226686,dietary,0,0
226687,dry,0,0
226688,matter,0,0
226689,(,0,0
226690,DM,0,0
226691,),0,0
226692,.,0,0
226693,The,0,0
226694,daily,0,0
226695,rations,0,0
226696,consisted,0,0
226697,of,0,0
226698,4,0,0
226699,kg,0,0
226700,grass,0,0
226701,hay,0,0
226702,and,0,0
226703,7,0,0
226704,kg,0,0
226705,concentrates,0,0
226706,.,0,0
226707,Changes,0,1
226708,in,0,0
226709,meq,0,0
226710,of,0,0
226711,dietary,1,0
226712,[,1,0
226713,(,1,0
226714,Na+,1,1
226715,+,1,0
226716,K+,1,0
226717,),1,0
226718,-,1,0
226719,(,1,0
226720,Cl-,1,1
226721,+,1,0
226722,SO4=,1,0
226723,),1,0
226724,],1,0
226725,were,0,0
226726,achieved,0,0
226727,by,0,0
226728,adding,0,0
226729,KCl,0,1
226730,",",0,0
226731,K2SO4,0,1
226732,and,0,1
226733,(,0,0
226734,NH4,0,0
226735,),0,0
226736,2SO4,0,0
226737,(,0,0
226738,anion,0,0
226739,diet,0,0
226740,),0,0
226741,or,0,0
226742,K2CO3,0,1
226743,(,0,0
226744,cation,0,1
226745,diet,0,0
226746,),0,0
226747,to,0,0
226748,basal,0,0
226749,concentrates,0,0
226750,.,0,0
226751,Plasma,1,1
226752,calcium,1,1
226753,concentration,1,1
226754,and,1,1
226755,blood,1,1
226756,acid-base,1,1
226757,parameters,1,1
226758,were,0,0
226759,not,0,0
226760,affected,0,0
226761,by,0,0
226762,dietary,0,0
226763,treatment,0,0
226764,.,0,0
226765,However,0,0
226766,",",0,0
226767,urinary,1,1
226768,calcium,1,1
226769,excretion,1,1
226770,was,0,0
226771,markedly,0,0
226772,higher,0,0
226773,and,0,1
226774,urinary,1,1
226775,pH,1,1
226776,and,1,1
226777,bicarbonate,1,1
226778,excretion,1,1
226779,significantly,0,0
226780,lower,0,0
226781,in,0,0
226782,cows,0,0
226783,fed,0,0
226784,the,0,0
226785,anion,0,1
226786,diet,0,0
226787,than,0,0
226788,in,0,0
226789,cows,0,0
226790,fed,0,0
226791,the,0,0
226792,cation,0,0
226793,diet,0,0
226794,.,0,0
226795,The,0,0
226796,responses,0,0
226797,to,0,0
226798,hypocalcaemia,0,1
226799,induced,0,0
226800,by,0,0
226801,an,0,0
226802,intravenous,0,0
226803,infusion,0,0
226804,of,0,0
226805,EDTA,0,1
226806,solution,0,0
226807,were,0,0
226808,similar,0,0
226809,in,0,0
226810,the,0,0
226811,cows,0,0
226812,fed,0,0
226813,either,0,0
226814,diet,0,0
226815,.,0,0
226816,[,0,0
226817,Prevention,0,0
226818,of,0,0
226819,pneumonia,1,0
226820,by,0,0
226821,endotracheal,0,0
226822,micronebulization,0,0
226823,of,0,0
226824,tobramycin,0,0
226825,],0,0
226826,.,0,0
226827,In,0,0
226828,69,0,0
226829,artificially,0,0
226830,ventilated,0,0
226831,patients,0,0
226832,the,0,0
226833,clinical,1,0
226834,",",1,0
226835,bacteriological,1,1
226836,and,0,1
226837,pharmacological,1,0
226838,effects,1,1
226839,of,0,0
226840,endotracheally,0,0
226841,administered,0,0
226842,tobramycin,0,0
226843,were,0,0
226844,studied,0,0
226845,in,0,0
226846,comparison,0,0
226847,to,0,0
226848,a,0,0
226849,control,0,0
226850,group,0,0
226851,.,0,0
226852,In,0,0
226853,the,0,0
226854,therapy,0,0
226855,group,0,0
226856,",",0,0
226857,52,0,0
226858,%,0,0
226859,of,0,0
226860,all,0,0
226861,specimens,0,0
226862,were,0,0
226863,sterile,0,0
226864,",",0,0
226865,in,0,0
226866,the,0,0
226867,control,0,0
226868,group,0,0
226869,only,0,0
226870,25,0,0
226871,%,0,0
226872,.,0,0
226873,During,0,0
226874,the,0,0
226875,first,0,0
226876,4,0,0
226877,days,0,0
226878,these,0,0
226879,changes,0,1
226880,were,0,0
226881,significant,0,0
226882,(,0,0
226883,p,0,0
226884,<,0,0
226885,0.05,0,0
226886,),0,0
226887,.,0,0
226888,In,0,0
226889,the,0,0
226890,therapy,0,0
226891,group,0,0
226892,the,0,0
226893,endotracheal,1,0
226894,colonisation,1,1
226895,with,1,0
226896,ps,1,0
226897,.,1,0
226898,aeruginosa,1,1
226899,was,0,0
226900,significantly,0,0
226901,lower,0,0
226902,between,0,0
226903,the,0,0
226904,4th,0,0
226905,and,0,0
226906,14th,0,0
226907,day,0,0
226908,(,0,0
226909,p,0,0
226910,<,0,0
226911,0.05,0,0
226912,),0,0
226913,.,0,0
226914,The,0,0
226915,incidence,1,1
226916,of,1,0
226917,secondary,1,0
226918,pneumonia,1,0
226919,was,0,0
226920,reduced,0,0
226921,from,0,0
226922,42,0,0
226923,%,0,0
226924,to,0,0
226925,17.5,0,0
226926,%,0,0
226927,(,0,0
226928,not,0,0
226929,significant,0,0
226930,),0,0
226931,.,0,0
226932,Systemic,1,0
226933,administration,1,0
226934,of,1,0
226935,antibiotics,1,0
226936,",",0,0
226937,e.g,0,0
226938,.,0,0
226939,of,0,0
226940,aminoglycosides,0,0
226941,",",0,0
226942,was,0,0
226943,significantly,0,0
226944,more,0,0
226945,often,0,0
226946,necessary,0,0
226947,in,0,0
226948,the,0,0
226949,control,0,0
226950,group,0,0
226951,.,0,0
226952,No,0,0
226953,increasing,0,0
226954,of,0,0
226955,growth,1,1
226956,of,1,0
226957,fungi,1,1
226958,in,1,0
226959,the,1,0
226960,upper,1,0
226961,respiratory,1,1
226962,tract,1,0
226963,was,0,0
226964,observed,0,0
226965,",",0,0
226966,but,0,0
226967,these,0,0
226968,was,0,0
226969,a,0,0
226970,non-significantly,0,0
226971,higher,0,0
226972,incidence,1,1
226973,mainly,1,0
226974,of,1,0
226975,staph,1,0
226976,.,1,0
226977,epidermidis,1,0
226978,.,1,0
226979,The,0,0
226980,application,0,0
226981,of,0,0
226982,80,0,0
226983,mg,0,0
226984,tobramycin,0,0
226985,four,0,0
226986,times,0,0
226987,a,0,0
226988,day,0,0
226989,as,0,0
226990,an,0,0
226991,aerosol,0,0
226992,was,0,0
226993,well,0,0
226994,tolerated,1,1
226995,by,0,0
226996,the,0,0
226997,patients,0,0
226998,.,0,0
226999,Under,0,0
227000,there,0,0
227001,conditions,0,0
227002,",",0,0
227003,tobramycin,0,0
227004,could,0,0
227005,not,0,0
227006,be,0,0
227007,measured,0,0
227008,in,0,0
227009,the,0,0
227010,serum,0,1
227011,.,0,0
227012,No,0,0
227013,allergic,1,0
227014,reactions,1,1
227015,",",0,0
227016,increased,0,0
227017,respiratory,1,1
227018,pressures,1,1
227019,or,0,0
227020,bronchoconstrictions,1,1
227021,were,0,0
227022,observed,0,0
227023,.,0,0
227024,Comparison,0,0
227025,of,0,0
227026,rectal,0,1
227027,midazolam,0,0
227028,and,0,1
227029,diazepam,0,0
227030,for,0,0
227031,premedication,0,0
227032,in,0,0
227033,pediatric,0,0
227034,dental,0,0
227035,patients,0,0
227036,.,0,0
227037,Rectally,0,0
227038,administered,0,0
227039,midazolam,0,0
227040,(,0,0
227041,0.35,0,0
227042,mg/kg,0,0
227043,),0,0
227044,and,0,1
227045,diazepam,0,0
227046,(,0,0
227047,0.70,0,0
227048,mg/kg,0,0
227049,),0,0
227050,were,0,0
227051,compared,0,0
227052,with,0,0
227053,each,0,0
227054,other,0,0
227055,and,0,0
227056,with,0,0
227057,placebo,0,0
227058,for,0,0
227059,preanesthetic,0,0
227060,medication,0,1
227061,in,0,0
227062,children,0,0
227063,undergoing,0,0
227064,dental,0,0
227065,extractions,0,0
227066,.,0,0
227067,All,0,0
227068,rectal,0,1
227069,medications,0,0
227070,were,0,0
227071,very,0,0
227072,well,0,0
227073,accepted,0,0
227074,",",0,0
227075,but,0,0
227076,mask,1,1
227077,acceptance,1,1
227078,",",0,0
227079,improvement,0,1
227080,in,0,0
227081,anxiety,1,1
227082,",",0,0
227083,and,0,1
227084,sedation,1,1
227085,were,0,0
227086,best,0,0
227087,in,0,0
227088,the,0,0
227089,midazolam,0,0
227090,group,0,0
227091,.,0,0
227092,Improvement,0,1
227093,in,0,0
227094,anxiety,1,1
227095,and,1,1
227096,sedation,1,1
227097,were,0,0
227098,significantly,0,0
227099,better,0,0
227100,in,0,0
227101,the,0,0
227102,two,0,0
227103,drug,0,0
227104,groups,0,0
227105,than,0,0
227106,in,0,0
227107,those,0,0
227108,patients,0,0
227109,who,0,0
227110,had,0,0
227111,received,0,0
227112,placebo,0,0
227113,.,0,0
227114,Thirty,0,0
227115,minutes,0,0
227116,after,0,0
227117,rectal,0,1
227118,administration,0,0
227119,of,0,0
227120,midazolam,0,0
227121,",",0,0
227122,patients,0,0
227123,showed,0,0
227124,a,0,0
227125,decrease,0,0
227126,in,0,0
227127,both,0,0
227128,systolic,1,1
227129,and,1,0
227130,diastolic,1,1
227131,blood,1,1
227132,pressure,1,1
227133,and,1,1
227134,heart,1,1
227135,rate,1,1
227136,.,1,0
227137,Although,0,0
227138,these,0,0
227139,decreases,0,0
227140,differed,0,0
227141,significantly,0,0
227142,from,0,0
227143,the,0,0
227144,premedication,0,0
227145,values,0,1
227146,",",0,0
227147,they,0,0
227148,were,0,0
227149,probably,0,0
227150,of,0,0
227151,little,0,0
227152,clinical,0,0
227153,importance,0,0
227154,.,0,0
227155,Only,0,0
227156,minor,1,0
227157,adverse,1,1
227158,effects,1,1
227159,were,0,0
227160,observed,0,0
227161,in,0,0
227162,this,0,0
227163,study,0,0
227164,.,0,0
227165,Overall,0,0
227166,rectally,0,0
227167,administered,0,0
227168,midazolam,0,0
227169,appeared,0,0
227170,to,0,0
227171,be,0,0
227172,somewhat,0,0
227173,more,0,0
227174,efficacious,0,1
227175,than,0,0
227176,diazepam,0,0
227177,.,0,0
227178,A,0,0
227179,community-based,0,0
227180,randomized,0,0
227181,trial,0,0
227182,of,0,0
227183,praziquantel,0,0
227184,to,0,0
227185,control,0,0
227186,schistosomiasis,0,0
227187,morbidity,0,1
227188,in,0,0
227189,schoolchildren,0,0
227190,in,0,0
227191,Zambia,0,0
227192,.,0,0
227193,A,0,0
227194,community-based,0,0
227195,",",0,0
227196,double-blind,0,0
227197,",",0,0
227198,randomized,0,0
227199,trial,0,0
227200,of,0,0
227201,praziquantel,0,0
227202,was,0,0
227203,carried,0,0
227204,out,0,0
227205,in,0,0
227206,an,0,0
227207,area,0,0
227208,of,0,0
227209,Zambia,0,0
227210,endemic,0,0
227211,for,0,0
227212,schistosomiasis,0,0
227213,.,0,0
227214,The,0,0
227215,aim,0,0
227216,of,0,0
227217,the,0,0
227218,study,0,0
227219,was,0,0
227220,to,0,0
227221,assess,0,0
227222,the,0,0
227223,impact,0,0
227224,of,0,0
227225,the,0,0
227226,treatment,0,0
227227,on,0,0
227228,Schistosoma,0,0
227229,mansoni,0,0
227230,morbidity,0,1
227231,.,0,0
227232,A,0,0
227233,total,0,0
227234,of,0,0
227235,377,0,0
227236,infected,0,0
227237,children,0,0
227238,",",0,0
227239,aged,0,0
227240,seven,0,0
227241,to,0,0
227242,19,0,0
227243,years,0,0
227244,",",0,0
227245,was,0,0
227246,randomized,0,0
227247,into,0,0
227248,two,0,0
227249,groups,0,0
227250,:,0,0
227251,one,0,0
227252,of,0,0
227253,190,0,0
227254,(,0,0
227255,group,0,0
227256,A,0,0
227257,),0,0
227258,and,0,0
227259,one,0,0
227260,of,0,0
227261,187,0,0
227262,(,0,0
227263,group,0,0
227264,B,0,0
227265,),0,0
227266,.,0,0
227267,All,0,0
227268,children,0,0
227269,were,0,0
227270,treated,0,0
227271,with,0,0
227272,40,0,0
227273,mg,0,0
227274,praziquantel/kg,0,0
227275,at,0,0
227276,the,0,0
227277,start,0,0
227278,of,0,0
227279,the,0,0
227280,study,0,0
227281,.,0,0
227282,Six,0,0
227283,months,0,0
227284,later,0,0
227285,",",0,0
227286,the,0,0
227287,children,0,0
227288,in,0,0
227289,group,0,0
227290,A,0,0
227291,were,0,0
227292,re-treated,0,0
227293,with,0,0
227294,the,0,0
227295,same,0,0
227296,dose,0,0
227297,of,0,0
227298,praziquantel,0,0
227299,",",0,0
227300,while,0,0
227301,the,0,0
227302,children,0,0
227303,in,0,0
227304,group,0,0
227305,B,0,0
227306,were,0,0
227307,given,0,0
227308,placebos,0,0
227309,.,0,0
227310,All,0,0
227311,children,0,0
227312,were,0,0
227313,followed,0,0
227314,up,0,0
227315,three,0,0
227316,",",0,0
227317,six,0,0
227318,and,0,0
227319,12,0,0
227320,months,0,0
227321,after,0,0
227322,the,0,0
227323,initial,0,0
227324,treatment,0,0
227325,",",0,0
227326,morbidity,1,1
227327,being,0,0
227328,clinically,0,0
227329,evaluated,0,0
227330,at,0,0
227331,the,0,0
227332,six-,0,1
227333,and,0,0
227334,12-month,0,0
227335,follow-ups,0,0
227336,.,0,0
227337,The,0,0
227338,results,0,0
227339,show,0,0
227340,that,0,0
227341,",",0,0
227342,in,0,0
227343,both,0,0
227344,groups,0,0
227345,of,0,0
227346,children,0,0
227347,",",0,0
227348,there,0,0
227349,were,0,0
227350,significant,0,0
227351,reductions,0,1
227352,in,0,0
227353,splenomegaly,1,1
227354,",",1,0
227355,hepatomegaly,1,1
227356,",",1,1
227357,and,1,1
227358,subjective,1,1
227359,symptoms,1,1
227360,of,1,0
227361,morbidity,1,1
227362,six,0,0
227363,and,0,0
227364,12,0,0
227365,months,0,0
227366,after,0,0
227367,initial,0,0
227368,treatment,0,0
227369,.,0,0
227370,However,0,0
227371,",",0,0
227372,there,0,0
227373,were,0,0
227374,no,0,0
227375,significant,0,0
227376,differences,0,0
227377,",",0,0
227378,between,0,0
227379,the,0,0
227380,two,0,0
227381,groups,0,0
227382,",",0,0
227383,in,0,0
227384,the,0,0
227385,prevalences,0,0
227386,of,0,0
227387,these,0,0
227388,symptoms,0,1
227389,of,0,0
227390,morbidity,1,1
227391,.,1,0
227392,It,0,0
227393,therefore,0,0
227394,appears,0,0
227395,that,0,0
227396,once-yearly,0,0
227397,treatment,0,0
227398,of,0,0
227399,children,0,0
227400,",",0,0
227401,in,0,0
227402,this,0,0
227403,and,0,0
227404,similar,0,0
227405,endemic,0,0
227406,areas,0,0
227407,",",0,0
227408,is,0,0
227409,sufficient,0,0
227410,to,0,0
227411,reduce,0,0
227412,schistosomiasis,0,0
227413,morbidity,0,1
227414,to,0,0
227415,",",0,0
227416,and,0,0
227417,maintain,0,0
227418,it,0,0
227419,at,0,0
227420,",",0,0
227421,a,0,0
227422,tolerable,0,1
227423,level,0,0
227424,.,0,0
227425,No,0,0
227426,effect,0,0
227427,of,0,0
227428,beta-carotene,0,0
227429,supplementation,0,0
227430,on,0,0
227431,the,0,0
227432,susceptibility,0,1
227433,of,0,0
227434,low,0,0
227435,density,0,1
227436,lipoprotein,0,1
227437,to,0,0
227438,in,1,0
227439,vitro,1,0
227440,oxidation,1,1
227441,among,0,0
227442,hypercholesterolaemic,0,0
227443,",",0,0
227444,postmenopausal,0,0
227445,women,0,0
227446,.,0,0
227447,The,0,0
227448,effect,0,0
227449,of,0,0
227450,beta-carotene,0,0
227451,on,0,0
227452,the,0,0
227453,susceptibility,0,1
227454,of,0,0
227455,low,0,0
227456,density,0,1
227457,lipoprotein,0,1
227458,(,0,0
227459,LDL,0,1
227460,),0,0
227461,to,0,0
227462,oxidative,0,1
227463,modification,0,0
227464,was,0,0
227465,investigated,0,0
227466,in,0,0
227467,a,0,0
227468,double-blind,0,0
227469,",",0,0
227470,randomized,0,0
227471,placebo-controlled,0,0
227472,study,0,0
227473,.,0,0
227474,Hypercholesterolaemic,0,0
227475,",",0,0
227476,postmenopausal,0,0
227477,women,0,0
227478,were,0,0
227479,given,0,0
227480,30,0,0
227481,mg,0,0
227482,beta-carotene,0,0
227483,per,0,0
227484,day,0,0
227485,(,0,0
227486,n,0,0
227487,=,0,0
227488,15,0,0
227489,subjects,0,0
227490,),0,0
227491,or,0,0
227492,placebo,0,0
227493,capsules,0,0
227494,(,0,0
227495,n,0,0
227496,=,0,0
227497,15,0,0
227498,subjects,0,0
227499,),0,0
227500,for,0,0
227501,10,0,0
227502,weeks,0,0
227503,.,0,0
227504,They,0,0
227505,were,0,0
227506,instructed,0,0
227507,to,0,0
227508,follow,0,0
227509,the,0,0
227510,American,0,0
227511,Heart,0,0
227512,Association,0,0
227513,Step,0,0
227514,One,0,0
227515,diet,0,0
227516,.,0,0
227517,LDL,0,1
227518,",",0,0
227519,isolated,0,0
227520,before,0,0
227521,and,0,0
227522,after,0,0
227523,treatment,0,0
227524,was,0,0
227525,subjected,0,0
227526,to,0,0
227527,copper-catalysed,0,0
227528,lipid,0,0
227529,peroxidation,0,1
227530,.,0,0
227531,There,0,0
227532,were,0,0
227533,no,0,0
227534,significant,0,0
227535,differences,0,0
227536,between,0,0
227537,LDL,1,0
227538,from,1,0
227539,the,1,0
227540,beta-carotene,1,0
227541,and,0,0
227542,placebo,0,0
227543,groups,0,0
227544,",",0,0
227545,as,0,0
227546,assessed,0,0
227547,by,0,0
227548,measuring,0,0
227549,the,0,0
227550,lag,1,1
227551,time,1,1
227552,for,1,0
227553,formation,1,1
227554,of,1,0
227555,conjugated,1,0
227556,dienes,1,0
227557,;,1,0
227558,the,0,0
227559,rate,1,1
227560,of,1,0
227561,formation,1,1
227562,and,1,0
227563,the,1,0
227564,amount,1,1
227565,of,1,0
227566,conjugated,1,0
227567,dienes,1,0
227568,formed,1,0
227569,;,1,0
227570,the,0,0
227571,amount,1,0
227572,of,1,0
227573,lipid,1,1
227574,peroxides,1,1
227575,generated,1,0
227576,;,1,0
227577,and,0,0
227578,the,0,0
227579,relative,0,0
227580,electrophoretic,1,0
227581,mobility,1,1
227582,",",0,0
227583,at,0,0
227584,baseline,0,0
227585,and,0,0
227586,after,0,0
227587,treatment,0,0
227588,.,0,0
227589,Dietary,0,0
227590,records,0,0
227591,showed,0,0
227592,that,0,0
227593,the,0,0
227594,subjects,0,0
227595,were,0,0
227596,consuming,0,0
227597,similar,0,0
227598,amounts,0,1
227599,and,0,0
227600,types,0,0
227601,of,0,0
227602,fat,0,0
227603,.,0,0
227604,No,0,0
227605,significant,0,0
227606,differences,0,0
227607,were,0,0
227608,found,0,0
227609,in,0,0
227610,the,0,0
227611,lipid,1,1
227612,composition,1,0
227613,and,1,0
227614,fatty,1,1
227615,acid,1,1
227616,pattern,1,0
227617,of,1,0
227618,LDL,1,0
227619,from,0,0
227620,the,0,0
227621,two,0,0
227622,groups,0,0
227623,.,0,0
227624,In,0,0
227625,conclusion,0,0
227626,",",0,0
227627,the,0,0
227628,results,0,0
227629,indicated,0,0
227630,that,0,0
227631,supplementation,0,0
227632,with,0,0
227633,beta-carotene,0,0
227634,in,0,0
227635,non-smoking,0,0
227636,",",0,0
227637,hypercholesterolaemic,0,0
227638,",",0,0
227639,postmenopausal,0,0
227640,women,0,0
227641,had,0,0
227642,no,0,0
227643,protective,1,0
227644,effect,1,0
227645,on,0,0
227646,the,0,0
227647,susceptibility,0,1
227648,of,0,0
227649,LDL,0,1
227650,to,0,0
227651,copper-catalysed,0,0
227652,modification,0,0
227653,in,0,0
227654,vitro,0,0
227655,.,0,0
227656,[,0,0
227657,Evaluating,0,0
227658,an,0,0
227659,interactive,0,0
227660,",",0,0
227661,multi-media,0,0
227662,learning,0,1
227663,system,0,0
227664,for,0,0
227665,the,0,0
227666,study,0,0
227667,of,0,0
227668,primary,0,0
227669,open,0,0
227670,angle,0,1
227671,glaucoma,0,0
227672,],0,0
227673,.,0,0
227674,Using,0,0
227675,the,0,0
227676,interactive,0,0
227677,multimedia,0,0
227678,learning,0,1
227679,system,0,0
227680,for,0,0
227681,studying,0,0
227682,open-angle,0,0
227683,glaucoma,0,0
227684,[,0,0
227685,3,0,0
227686,],0,0
227687,a,0,0
227688,prospective,0,0
227689,",",0,0
227690,randomized,0,0
227691,",",0,0
227692,case-controlled,0,0
227693,study,0,0
227694,was,0,0
227695,carried,0,0
227696,out,0,0
227697,to,0,0
227698,determine,0,0
227699,the,0,0
227700,value,0,0
227701,of,0,0
227702,this,0,0
227703,new,0,0
227704,form,0,0
227705,of,0,0
227706,learning,0,0
227707,in,0,0
227708,terms,0,0
227709,of,0,0
227710,acceptance,1,1
227711,and,1,0
227712,the,1,0
227713,imparting,1,0
227714,of,1,0
227715,knowledge,1,0
227716,.,1,0
227717,This,0,0
227718,article,0,0
227719,describes,0,0
227720,details,0,0
227721,of,0,0
227722,the,0,0
227723,study,0,0
227724,and,0,0
227725,presents,0,0
227726,their,0,0
227727,results,0,0
227728,.,0,0
227729,Results,0,0
227730,were,0,0
227731,established,0,0
227732,on,0,0
227733,the,0,0
227734,basis,0,0
227735,of,0,0
227736,targeted,0,0
227737,questions,0,1
227738,asked,0,0
227739,prior,0,0
227740,to,0,0
227741,and,0,0
227742,after,0,0
227743,the,0,0
227744,learning,0,1
227745,phase,0,0
227746,",",0,0
227747,followed,0,0
227748,by,0,0
227749,an,0,0
227750,analysis,0,0
227751,of,0,0
227752,frequencies,0,1
227753,and,0,1
227754,significance,0,1
227755,testing,0,0
227756,by,0,0
227757,the,0,0
227758,Chi,0,0
227759,squared,0,1
227760,method,0,0
227761,.,0,0
227762,It,0,0
227763,was,0,0
227764,shown,0,0
227765,that,0,0
227766,the,0,0
227767,imparting,1,0
227768,of,1,0
227769,knowledge,1,0
227770,is,0,0
227771,significantly,0,0
227772,improved,0,0
227773,when,0,0
227774,this,0,0
227775,learning,0,0
227776,system,0,0
227777,is,0,0
227778,employed,0,0
227779,.,0,0
227780,In,0,0
227781,addition,0,0
227782,",",0,0
227783,after,0,0
227784,its,0,0
227785,first,0,0
227786,use,0,0
227787,",",0,0
227788,acceptance,1,1
227789,of,1,0
227790,this,1,0
227791,new,1,0
227792,medium,1,0
227793,rose,0,0
227794,dramatically,0,0
227795,.,0,0
227796,Iobitridol,0,0
227797,300,0,0
227798,compared,0,0
227799,to,0,0
227800,iopromide,0,0
227801,300,0,0
227802,--,0,0
227803,a,0,0
227804,double-blind,0,0
227805,randomized,0,0
227806,phase-III,0,0
227807,study,0,0
227808,of,0,0
227809,clinical,0,0
227810,tolerance,0,1
227811,in,0,0
227812,total,0,1
227813,body,0,1
227814,CT.,0,0
227815,UNLABELLED,0,1
227816,PURPOSE,0,0
227817,",",0,0
227818,MATERIAL,0,0
227819,AND,0,0
227820,METHODS,0,0
227821,:,0,0
227822,The,0,0
227823,clinical,0,0
227824,safety,0,1
227825,of,0,0
227826,iobitriodol,0,0
227827,300,0,0
227828,mg,0,0
227829,I/ml,0,0
227830,and,0,0
227831,iopromide,0,0
227832,300,0,0
227833,mg,0,0
227834,I/ml,0,0
227835,were,0,0
227836,compared,0,0
227837,in,0,0
227838,a,0,0
227839,randomized,0,0
227840,double,0,0
227841,blind,0,0
227842,phase-III,0,0
227843,study,0,0
227844,conducted,0,0
227845,on,0,0
227846,60,0,0
227847,patients,0,0
227848,undergoing,0,0
227849,abdominal,0,1
227850,CT,0,1
227851,for,0,0
227852,a,0,0
227853,variety,0,0
227854,of,0,0
227855,indications,0,0
227856,.,0,0
227857,Each,0,0
227858,examination,0,0
227859,was,0,0
227860,rated,0,1
227861,as,0,0
227862,diagnostic,0,0
227863,or,0,0
227864,nondiagnostic,0,1
227865,and,0,0
227866,the,0,0
227867,image,0,1
227868,quality,0,1
227869,was,0,0
227870,noted,0,0
227871,.,0,0
227872,Nature,0,0
227873,",",0,0
227874,onset,1,1
227875,",",0,1
227876,intensity,0,1
227877,as,0,0
227878,well,0,0
227879,as,0,0
227880,outcome,0,0
227881,of,0,0
227882,each,0,0
227883,adverse,1,1
227884,reaction,1,1
227885,were,0,0
227886,recorded,0,0
227887,.,0,0
227888,RESULTS,0,0
227889,There,0,0
227890,was,0,0
227891,no,0,0
227892,significant,0,0
227893,difference,0,0
227894,in,0,0
227895,imaging,1,0
227896,quality,1,1
227897,and,1,1
227898,side,1,1
227899,effects,1,1
227900,between,0,0
227901,the,0,0
227902,contrast,0,0
227903,media,0,0
227904,.,0,0
227905,In,0,0
227906,this,0,0
227907,study,0,0
227908,",",0,0
227909,both,0,0
227910,iobitridol,0,0
227911,and,0,0
227912,iopromide,0,0
227913,provided,0,0
227914,excellent,1,0
227915,image,1,1
227916,quality,1,1
227917,and,0,0
227918,a,0,0
227919,low,1,0
227920,rate,1,1
227921,of,1,0
227922,side,1,1
227923,effects,1,0
227924,.,1,0
227925,CONCLUSION,0,0
227926,Iobitridol,0,0
227927,is,0,0
227928,a,0,0
227929,safe,1,0
227930,and,1,0
227931,effective,1,1
227932,nonionic,1,0
227933,contrast,1,0
227934,agent,1,0
227935,for,0,0
227936,contrast-enhanced,0,0
227937,body,0,1
227938,CT,0,1
227939,.,0,0
227940,[,0,0
227941,Clinical,0,1
227942,early,0,0
227943,phase,0,0
227944,II,0,0
227945,study,0,0
227946,of,0,1
227947,bicalutamide,0,0
227948,(,0,0
227949,Casodex,0,0
227950,),0,0
227951,in,0,0
227952,patients,0,0
227953,with,0,0
227954,prostatic,0,0
227955,cancer,0,0
227956,],0,0
227957,.,0,0
227958,To,0,0
227959,investigate,0,0
227960,the,0,0
227961,efficacy,1,1
227962,and,1,0
227963,safety,1,1
227964,of,0,1
227965,bicalutamide,0,0
227966,(,0,0
227967,Casodex,0,0
227968,),0,0
227969,with,0,0
227970,its,0,0
227971,clinically,0,0
227972,recommended,0,0
227973,dose,0,0
227974,",",0,0
227975,the,0,0
227976,randomized,0,0
227977,early,0,0
227978,phase,0,0
227979,II,0,0
227980,study,0,0
227981,was,0,0
227982,performed,0,0
227983,in,0,0
227984,124,0,0
227985,patients,0,0
227986,with,0,0
227987,prostatic,0,0
227988,cancer,0,0
227989,(,0,0
227990,stage,0,1
227991,C,0,0
227992,",",0,0
227993,D,0,1
227994,),0,0
227995,.,0,0
227996,The,0,0
227997,patients,0,0
227998,were,0,0
227999,given,0,0
228000,50,0,0
228001,",",0,0
228002,80,0,0
228003,or,0,0
228004,100,0,0
228005,mg,0,0
228006,of,0,0
228007,bicalutamide,0,0
228008,orally,0,0
228009,once,0,0
228010,a,0,0
228011,day,0,0
228012,in,0,0
228013,fixed,0,0
228014,doses,0,0
228015,for,0,0
228016,12,0,0
228017,weeks,0,0
228018,;,0,0
228019,122,0,0
228020,patients,0,0
228021,were,0,0
228022,eligible,0,0
228023,for,0,0
228024,evaluation,0,0
228025,.,0,0
228026,The,0,0
228027,overall,1,1
228028,response,1,1
228029,rate,1,1
228030,was,0,0
228031,50.0,0,0
228032,%,0,0
228033,(,0,0
228034,20/40,0,0
228035,),0,0
228036,",",0,0
228037,61.0,0,0
228038,%,0,0
228039,(,0,0
228040,25/41,0,0
228041,),0,0
228042,and,0,0
228043,53.7,0,0
228044,%,0,0
228045,(,0,0
228046,22/41,0,0
228047,),0,0
228048,in,0,0
228049,the,0,0
228050,50,0,0
228051,mg,0,0
228052,",",0,0
228053,80,0,0
228054,mg,0,0
228055,and,0,0
228056,100,0,0
228057,mg,0,0
228058,groups,0,0
228059,",",0,0
228060,respectively,0,0
228061,.,0,0
228062,The,0,0
228063,response,1,1
228064,rate,1,1
228065,in,1,0
228066,prostate,1,0
228067,lesion,1,1
228068,",",1,1
228069,bone,1,1
228070,and,1,1
228071,lymph,1,1
228072,node,1,1
228073,metastases,1,0
228074,was,0,0
228075,slightly,0,0
228076,higher,0,0
228077,in,0,0
228078,the,0,0
228079,80,0,0
228080,mg,0,0
228081,group,0,0
228082,than,0,0
228083,in,0,0
228084,the,0,0
228085,50,0,0
228086,mg,0,0
228087,and,0,0
228088,100,0,0
228089,mg,0,0
228090,groups,0,0
228091,.,0,0
228092,The,0,0
228093,proportion,1,0
228094,of,1,0
228095,patients,1,0
228096,showing,1,0
228097,a,1,0
228098,response,1,1
228099,with,1,0
228100,regard,1,0
228101,to,1,0
228102,serum,1,1
228103,PSA,1,0
228104,(,1,0
228105,CR,1,1
228106,and,1,1
228107,PR,1,1
228108,),1,0
228109,was,0,0
228110,84.2,0,0
228111,",",0,0
228112,92.7,0,0
228113,and,0,0
228114,97.6,0,0
228115,%,0,0
228116,in,0,0
228117,the,0,0
228118,50,0,0
228119,",",0,0
228120,80,0,0
228121,and,0,0
228122,100,0,0
228123,mg,0,0
228124,groups,0,0
228125,",",0,0
228126,respectively,0,0
228127,.,0,0
228128,The,0,0
228129,incidence,1,1
228130,of,1,0
228131,adverse,1,1
228132,reactions,1,1
228133,was,0,0
228134,65.0,0,0
228135,",",0,0
228136,61.0,0,0
228137,and,0,0
228138,61.0,0,0
228139,%,0,0
228140,in,0,0
228141,the,0,0
228142,50,0,0
228143,",",0,0
228144,80,0,0
228145,and,0,0
228146,100,0,0
228147,mg,0,0
228148,groups,0,0
228149,",",0,0
228150,respectively,0,0
228151,",",0,0
228152,and,0,1
228153,there,0,0
228154,was,0,0
228155,no,1,0
228156,significant,1,0
228157,difference,1,0
228158,in,0,0
228159,overall,1,1
228160,safety,1,1
228161,rating,1,1
228162,in,0,0
228163,the,0,0
228164,three,0,0
228165,groups,0,0
228166,.,0,0
228167,Frequent,1,0
228168,adverse,1,1
228169,reactions,1,1
228170,were,0,0
228171,gynecomastia,1,1
228172,and,1,1
228173,breast,1,0
228174,pain,1,1
228175,.,1,0
228176,Only,0,0
228177,one,0,0
228178,patient,0,0
228179,in,0,0
228180,the,0,0
228181,80,0,0
228182,mg,0,0
228183,group,0,0
228184,was,0,0
228185,withdrawn,1,0
228186,due,1,0
228187,to,1,0
228188,shortness,1,1
228189,of,1,0
228190,breath,1,1
228191,.,1,0
228192,Serum,1,1
228193,concentrations,1,1
228194,of,1,0
228195,LH,1,1
228196,",",1,0
228197,testosterone,1,1
228198,and,1,1
228199,estradiol,1,1
228200,increased,1,0
228201,significantly,1,0
228202,after,0,0
228203,treatment,0,0
228204,.,0,0
228205,Bicalutamide,0,0
228206,was,0,0
228207,concluded,0,0
228208,to,0,0
228209,be,0,0
228210,effective,0,1
228211,and,0,0
228212,well,0,0
228213,tolerated,0,1
228214,in,0,0
228215,patients,0,0
228216,with,0,0
228217,prostatic,0,0
228218,cancer,0,0
228219,",",0,0
228220,and,0,0
228221,its,0,0
228222,recommended,0,0
228223,dose,0,0
228224,was,0,0
228225,80,0,0
228226,mg,0,0
228227,once,0,0
228228,daily,0,0
228229,.,0,0
228230,Effect,0,0
228231,of,0,0
228232,chronic,0,0
228233,aerobic,0,0
228234,exercise,0,0
228235,and,0,0
228236,progressive,0,1
228237,relaxation,0,1
228238,on,0,0
228239,motor,0,1
228240,performance,0,1
228241,and,0,1
228242,affect,0,0
228243,following,0,0
228244,acute,0,0
228245,stress,0,1
228246,.,0,0
228247,The,0,0
228248,effects,0,0
228249,of,0,0
228250,a,0,0
228251,10-week,0,0
228252,aerobic,0,0
228253,exercise,0,0
228254,and,0,0
228255,progressive,0,1
228256,relaxation,0,1
228257,training,0,0
228258,program,0,0
228259,on,0,0
228260,somatic,0,1
228261,",",0,0
228262,emotional,0,1
228263,",",0,0
228264,and,0,1
228265,behavioral,0,1
228266,responses,0,1
228267,to,0,0
228268,acute,0,0
228269,stress,0,1
228270,",",0,0
228271,as,0,0
228272,determined,0,0
228273,by,0,0
228274,quality,0,1
228275,of,0,0
228276,motor,0,1
228277,performance,0,1
228278,and,0,1
228279,affect,0,1
228280,",",0,1
228281,were,0,0
228282,examined,0,0
228283,.,0,0
228284,The,0,0
228285,participants,0,0
228286,consisted,0,0
228287,of,0,0
228288,60,0,0
228289,unfit,0,0
228290,male,0,0
228291,university,0,0
228292,undergraduate,0,0
228293,students,0,0
228294,with,0,0
228295,no,0,0
228296,previous,0,0
228297,training,0,0
228298,in,0,0
228299,stress,0,1
228300,management,0,0
228301,who,0,0
228302,were,0,0
228303,randomly,0,0
228304,and,0,0
228305,evenly,0,0
228306,assigned,0,0
228307,to,0,0
228308,engage,0,0
228309,in,0,0
228310,one,0,0
228311,of,0,0
228312,four,0,0
228313,treatments,0,0
228314,over,0,0
228315,10,0,0
228316,weeks,0,0
228317,:,0,0
228318,(,0,0
228319,a,0,0
228320,),0,0
228321,moderate,0,0
228322,aerobic,0,1
228323,exercise,0,0
228324,",",0,0
228325,(,0,1
228326,b,0,0
228327,),0,1
228328,progressive,0,1
228329,relaxation,0,1
228330,",",0,1
228331,(,0,1
228332,c,0,0
228333,),0,0
228334,a,0,0
228335,placebo,0,0
228336,group,0,0
228337,that,0,0
228338,engaged,0,0
228339,in,0,0
228340,group,0,0
228341,discussion,0,0
228342,but,0,0
228343,did,0,0
228344,experience,0,0
228345,acute,0,1
228346,stress,0,1
228347,",",0,1
228348,and,0,1
228349,(,0,1
228350,d,0,0
228351,),0,0
228352,a,0,0
228353,nonintervention,0,0
228354,control,0,0
228355,group,0,0
228356,that,0,0
228357,did,0,0
228358,not,0,0
228359,experience,0,0
228360,stress,0,1
228361,while,0,0
228362,performing,0,0
228363,the,0,0
228364,motor,0,1
228365,task,0,0
228366,.,0,0
228367,Acute,0,0
228368,stress,0,1
228369,consisted,0,0
228370,of,0,0
228371,losing,0,0
228372,against,0,0
228373,a,0,0
228374,competitor,0,0
228375,of,0,0
228376,the,0,0
228377,opposite,0,0
228378,sex,0,0
228379,on,0,0
228380,the,0,0
228381,criterion,0,0
228382,motor,0,1
228383,task,0,1
228384,while,0,0
228385,receiving,0,0
228386,unpleasant,0,1
228387,information,0,0
228388,about,0,0
228389,their,0,0
228390,performance,0,0
228391,over,0,0
228392,30,0,0
228393,preintervention,0,0
228394,and,0,0
228395,30,0,0
228396,postintervention,0,0
228397,trials,0,0
228398,.,0,0
228399,Analyses,0,0
228400,indicated,0,0
228401,that,0,0
228402,aerobic,0,0
228403,exercisers,0,0
228404,",",0,0
228405,in,0,0
228406,comparisons,0,0
228407,with,0,0
228408,the,0,0
228409,other,0,0
228410,groups,0,0
228411,",",0,0
228412,responded,0,0
228413,to,0,0
228414,acute,1,0
228415,stress,1,1
228416,with,0,0
228417,more,0,0
228418,positive,0,1
228419,affect,0,0
228420,",",0,0
228421,lower,1,0
228422,stressor,1,1
228423,task,1,1
228424,heart,1,1
228425,rate,1,1
228426,",",1,0
228427,reduced,1,1
228428,systolic,1,1
228429,(,1,0
228430,but,1,0
228431,not,1,0
228432,diastolic,1,1
228433,),1,0
228434,blood,1,1
228435,pressure,1,1
228436,",",0,0
228437,and,0,1
228438,superior,0,1
228439,motor,1,1
228440,performance,1,1
228441,.,1,0
228442,Progressive,0,0
228443,relaxation,0,1
228444,markedly,0,0
228445,reduced,0,0
228446,systolic,1,1
228447,blood,1,1
228448,pressure,1,1
228449,but,0,0
228450,did,0,0
228451,not,0,0
228452,favorably,0,0
228453,influence,0,0
228454,performance,0,1
228455,or,0,0
228456,affect,0,0
228457,in,0,0
228458,response,0,1
228459,to,0,0
228460,acute,1,0
228461,stress,1,1
228462,.,1,0
228463,Placebo,0,0
228464,and,0,0
228465,control,0,0
228466,groups,0,0
228467,were,0,0
228468,statistically,0,0
228469,similar,0,0
228470,on,0,0
228471,all,0,0
228472,measures,0,0
228473,.,0,0
228474,The,0,0
228475,findings,0,0
228476,indicated,0,0
228477,support,0,0
228478,for,0,0
228479,the,0,0
228480,use,0,0
228481,of,0,0
228482,chronic,0,0
228483,aerobic,0,0
228484,exercise,0,0
228485,as,0,0
228486,a,0,0
228487,strategy,0,0
228488,for,0,0
228489,improved,0,1
228490,coping,0,1
228491,with,0,0
228492,acute,0,0
228493,stress,0,1
228494,.,0,0
228495,Measuring,0,0
228496,the,0,0
228497,impact,0,0
228498,of,0,0
228499,patient,0,1
228500,counseling,0,0
228501,in,0,0
228502,the,0,0
228503,outpatient,0,0
228504,pharmacy,0,0
228505,setting,0,0
228506,:,0,0
228507,the,0,0
228508,research,0,0
228509,design,0,0
228510,of,0,0
228511,the,0,0
228512,Kaiser,0,0
228513,Permanente/USC,0,0
228514,patient,0,1
228515,consultation,0,0
228516,study,0,0
228517,.,0,0
228518,This,0,0
228519,article,0,0
228520,describes,0,0
228521,the,0,0
228522,research,0,0
228523,method,0,0
228524,used,0,0
228525,to,0,0
228526,measure,0,0
228527,the,0,0
228528,impact,0,0
228529,of,0,0
228530,three,0,0
228531,alternative,0,0
228532,models,0,0
228533,of,0,0
228534,patient,0,0
228535,counseling,0,0
228536,in,0,0
228537,the,0,0
228538,outpatient,0,0
228539,pharmacy,0,0
228540,setting,0,0
228541,.,0,0
228542,The,0,0
228543,study,0,0
228544,was,0,0
228545,conducted,0,0
228546,in,0,0
228547,pharmacies,0,0
228548,operated,0,0
228549,by,0,0
228550,the,0,0
228551,Southern,0,0
228552,California,0,0
228553,region,0,0
228554,Kaiser,0,0
228555,Permanente,0,0
228556,Medical,0,0
228557,Care,0,0
228558,Program,0,0
228559,.,0,0
228560,Both,0,0
228561,random,0,0
228562,assignment,0,0
228563,and,0,0
228564,large-scale,0,0
228565,geographic,0,1
228566,area,0,1
228567,research,0,0
228568,designs,0,0
228569,were,0,0
228570,used,0,0
228571,.,0,0
228572,The,0,0
228573,presentation,0,0
228574,of,0,0
228575,the,0,0
228576,research,0,0
228577,design,0,0
228578,includes,0,0
228579,discussions,0,0
228580,of,0,0
228581,data,0,0
228582,collection,0,0
228583,and,0,0
228584,patient,0,1
228585,sampling,0,0
228586,methods,0,0
228587,;,0,0
228588,the,0,0
228589,measurement,0,0
228590,of,0,0
228591,patient,1,1
228592,outcomes,1,1
228593,",",0,0
228594,including,0,0
228595,measures,1,1
228596,of,1,0
228597,health,1,1
228598,care,1,0
228599,costs,1,1
228600,and,1,1
228601,utilization,1,1
228602,",",1,1
228603,patient,1,1
228604,functional,1,1
228605,status,1,1
228606,",",1,0
228607,and,1,1
228608,quality,1,1
228609,of,1,0
228610,life,1,1
228611,.,1,0
228612,Demographic,0,0
228613,data,0,0
228614,are,0,0
228615,presented,0,0
228616,for,0,0
228617,the,0,0
228618,study,0,0
228619,population,0,0
228620,",",0,0
228621,including,0,0
228622,an,0,0
228623,analysis,0,0
228624,of,0,0
228625,potential,0,0
228626,biased,0,0
228627,selection,0,0
228628,of,0,0
228629,patients,0,0
228630,electing,0,0
228631,to,0,0
228632,participate,0,0
228633,in,0,0
228634,random,0,0
228635,assignment,0,0
228636,.,0,0
228637,Data,0,0
228638,are,0,0
228639,also,0,0
228640,presented,0,0
228641,documenting,0,0
228642,potential,0,0
228643,selection,0,0
228644,bias,0,0
228645,across,0,0
228646,geographically,0,0
228647,determined,0,0
228648,treatment,0,0
228649,groups,0,0
228650,in,0,0
228651,the,0,0
228652,geographic,0,0
228653,area,0,1
228654,design,0,0
228655,arm,0,0
228656,.,0,0
228657,Finally,0,0
228658,",",0,0
228659,the,0,0
228660,article,0,0
228661,presents,0,0
228662,the,0,0
228663,analysis,0,0
228664,plan,0,0
228665,for,0,0
228666,the,0,0
228667,study,0,0
228668,and,0,0
228669,discusses,0,0
228670,study,0,0
228671,limitations,0,0
228672,.,0,0
228673,The,0,0
228674,effect,0,0
228675,of,0,0
228676,tunnelling,0,1
228677,on,0,0
228678,epidural,1,0
228679,catheter,1,0
228680,migration,1,0
228681,.,1,0
228682,A,0,0
228683,prospective,0,0
228684,",",0,0
228685,randomised,0,0
228686,study,0,0
228687,of,0,0
228688,82,0,0
228689,patients,0,0
228690,having,0,0
228691,postoperative,0,1
228692,epidural,0,0
228693,analgesia,0,1
228694,was,0,0
228695,performed,0,0
228696,to,0,0
228697,determine,0,0
228698,whether,0,0
228699,the,0,0
228700,tunnelling,0,0
228701,of,0,0
228702,an,0,0
228703,epidural,0,0
228704,catheter,0,0
228705,influences,1,0
228706,its,1,0
228707,migration,1,0
228708,.,1,0
228709,Tunnelling,0,0
228710,of,0,0
228711,the,0,0
228712,catheter,0,0
228713,subcutaneously,0,0
228714,for,0,0
228715,a,0,0
228716,distance,0,0
228717,of,0,0
228718,5,0,0
228719,cm,0,0
228720,reduced,0,0
228721,the,0,0
228722,incidence,1,1
228723,of,1,0
228724,inward,1,0
228725,migration,1,0
228726,of,0,0
228727,1,1,0
228728,cm,1,0
228729,or,1,0
228730,more,1,0
228731,(,0,0
228732,p,0,0
228733,<,0,0
228734,0.01,0,0
228735,),0,0
228736,compared,0,0
228737,to,0,0
228738,a,0,0
228739,standard,0,0
228740,method,1,0
228741,of,1,0
228742,fixation,1,0
228743,with,0,0
228744,a,0,0
228745,transparent,1,0
228746,adhesive,1,0
228747,dressing,1,0
228748,.,1,0
228749,This,0,0
228750,effect,0,0
228751,was,0,0
228752,more,0,0
228753,marked,0,0
228754,if,0,0
228755,the,0,0
228756,epidural,0,0
228757,catheter,0,0
228758,was,0,0
228759,sited,0,0
228760,in,0,0
228761,the,0,0
228762,thoracic,0,0
228763,rather,0,0
228764,than,0,0
228765,the,0,0
228766,lumbar,0,0
228767,area,0,0
228768,.,0,0
228769,Sixty,0,0
228770,two,0,0
228771,percent,0,0
228772,(,0,0
228773,n,0,0
228774,=,0,0
228775,26,0,0
228776,),0,0
228777,of,0,0
228778,tunnelled,0,0
228779,catheters,0,0
228780,remained,1,0
228781,within,1,0
228782,0.5,1,0
228783,cm,1,0
228784,of,1,0
228785,their,1,0
228786,original,1,0
228787,position,1,0
228788,compared,0,0
228789,to,0,0
228790,38,0,0
228791,%,0,0
228792,(,0,0
228793,n,0,0
228794,=,0,0
228795,16,0,0
228796,),0,0
228797,of,0,0
228798,non-tunnelled,0,0
228799,catheters,0,0
228800,",",0,0
228801,although,0,0
228802,this,0,0
228803,difference,0,0
228804,was,0,0
228805,not,0,0
228806,statistically,0,0
228807,significant,0,0
228808,.,0,0
228809,Outward,1,0
228810,catheter,1,0
228811,migration,1,1
228812,was,0,0
228813,not,0,0
228814,reduced,0,0
228815,by,0,0
228816,subcutaneous,0,0
228817,tunnelling,0,0
228818,.,0,0
228819,Metabolic,0,1
228820,and,0,0
228821,hormonal,0,1
228822,responses,0,1
228823,to,0,0
228824,induced,0,0
228825,hypotension,0,1
228826,for,0,0
228827,middle,0,0
228828,ear,0,0
228829,surgery,0,0
228830,.,0,0
228831,We,0,0
228832,have,0,0
228833,investigated,0,0
228834,in,0,0
228835,30,0,0
228836,patients,0,0
228837,the,0,0
228838,metabolic,0,0
228839,and,0,0
228840,hormonal,0,1
228841,responses,0,1
228842,to,0,0
228843,middle,0,0
228844,ear,0,0
228845,surgery,0,0
228846,using,0,0
228847,induced,0,0
228848,hypotension,0,0
228849,to,0,0
228850,a,0,0
228851,mean,0,1
228852,arterial,0,1
228853,pressure,0,1
228854,of,0,0
228855,55,0,0
228856,mm,0,0
228857,Hg,0,0
228858,.,0,0
228859,A,0,0
228860,standardized,0,0
228861,anaesthetic,0,0
228862,technique,0,0
228863,of,0,0
228864,propranolol,0,0
228865,",",0,0
228866,thiopentone-vecuronium-isoflurane,0,0
228867,was,0,0
228868,used,0,0
228869,in,0,0
228870,all,0,0
228871,patients,0,0
228872,and,0,0
228873,hypotension,0,1
228874,induced,0,0
228875,with,0,0
228876,sodium,0,0
228877,nitroprusside,0,0
228878,",",0,0
228879,trimetaphan,0,0
228880,camsylate,0,0
228881,or,0,0
228882,additional,0,0
228883,isoflurane,0,0
228884,.,0,0
228885,All,0,0
228886,patients,0,0
228887,showed,0,0
228888,a,0,0
228889,classic,1,0
228890,stress,1,1
228891,response,1,1
228892,with,1,0
228893,an,1,0
228894,increase,1,0
228895,in,1,0
228896,circulating,1,1
228897,blood,1,1
228898,glucose,1,1
228899,",",1,1
228900,cortisol,1,1
228901,and,1,1
228902,growth,1,1
228903,hormone,1,1
228904,concentrations,1,1
228905,.,1,0
228906,Blood,1,1
228907,lactate,1,1
228908,and,1,1
228909,plasma,1,1
228910,uric,1,1
228911,acid,1,1
228912,concentrations,1,1
228913,changed,0,0
228914,little,0,0
228915,during,0,0
228916,operation,0,0
228917,",",0,0
228918,suggesting,0,0
228919,that,0,0
228920,tissue,0,1
228921,oxygenation,0,1
228922,was,0,0
228923,adequate,0,0
228924,.,0,0
228925,However,0,0
228926,",",0,0
228927,the,0,0
228928,former,0,0
228929,declined,0,0
228930,after,0,0
228931,operation,0,0
228932,",",0,0
228933,possibly,0,0
228934,as,0,0
228935,a,0,0
228936,result,0,0
228937,of,0,0
228938,the,0,0
228939,concomitant,0,0
228940,use,0,0
228941,of,0,0
228942,propranolol,0,0
228943,.,0,0
228944,There,0,0
228945,were,0,0
228946,no,0,0
228947,significant,0,0
228948,differences,0,0
228949,between,0,0
228950,the,0,0
228951,three,0,0
228952,hypotensive,0,0
228953,techniques,0,0
228954,in,0,0
228955,their,0,0
228956,effects,0,0
228957,on,0,0
228958,the,0,0
228959,hormonal,0,0
228960,and,0,0
228961,metabolic,0,1
228962,response,0,1
228963,",",0,0
228964,although,0,0
228965,the,0,0
228966,increase,0,0
228967,in,0,0
228968,blood,1,1
228969,glucose,1,1
228970,concentration,1,1
228971,in,0,0
228972,the,0,0
228973,trimetaphan,0,0
228974,group,0,0
228975,was,0,0
228976,obtunded,0,0
228977,.,0,0
228978,We,0,0
228979,conclude,0,0
228980,that,0,0
228981,induced,0,0
228982,hypotension,0,1
228983,for,0,0
228984,middle,0,0
228985,ear,0,0
228986,surgery,0,0
228987,induced,0,0
228988,an,0,0
228989,endocrine,0,1
228990,and,0,0
228991,metabolic,0,1
228992,response,0,1
228993,of,0,0
228994,small,0,0
228995,magnitude,0,1
228996,and,0,0
228997,short,0,1
228998,duration,0,1
228999,.,0,0
229000,Randomized,0,0
229001,controlled,0,0
229002,trial,0,0
229003,of,0,0
229004,acellular,0,0
229005,diphtheria,0,0
229006,",",0,0
229007,pertussis,0,0
229008,and,0,1
229009,tetanus,0,0
229010,vaccines,1,0
229011,in,0,0
229012,southern,0,0
229013,Ghana,0,0
229014,.,0,0
229015,A,0,0
229016,randomized,0,0
229017,controlled,0,0
229018,trial,0,0
229019,of,0,0
229020,acellular,0,0
229021,diphtheria/pertussis/tetanus,0,0
229022,(,0,0
229023,ADPT,0,0
229024,),0,0
229025,freeze-dried,0,0
229026,and,0,0
229027,liquid,0,0
229028,vaccines,0,0
229029,in,0,0
229030,infants,0,0
229031,was,0,0
229032,conducted,0,0
229033,in,0,0
229034,a,0,0
229035,peri-urban,0,0
229036,community,0,0
229037,(,0,0
229038,Ashaiman,0,0
229039,),0,0
229040,in,0,0
229041,southern,0,0
229042,Ghana,0,0
229043,.,0,0
229044,Immunogenicity,1,1
229045,of,0,0
229046,the,0,0
229047,acellular,0,0
229048,vaccines,0,0
229049,",",0,0
229050,persistence,0,1
229051,of,0,1
229052,antibodies,0,1
229053,and,0,0
229054,adverse,0,1
229055,reactions,0,1
229056,were,0,0
229057,compared,0,0
229058,with,0,0
229059,those,0,0
229060,achieved,0,0
229061,with,0,0
229062,a,0,0
229063,whole-cell,0,0
229064,diphtheria-pertussis-tetanus,0,0
229065,(,0,0
229066,DPT,0,0
229067,),0,0
229068,vaccine,0,0
229069,.,0,0
229070,The,0,0
229071,incidence,0,1
229072,of,0,0
229073,pertussis,0,0
229074,in,0,0
229075,the,0,0
229076,vaccine,0,0
229077,groups,0,0
229078,and,0,1
229079,prevalence,0,1
229080,of,0,1
229081,pertussis,0,0
229082,in,0,0
229083,children,0,0
229084,under,0,0
229085,5,0,0
229086,years,0,0
229087,of,0,0
229088,age,0,0
229089,in,0,0
229090,the,0,0
229091,study,0,0
229092,area,0,1
229093,were,0,0
229094,also,0,0
229095,determined,0,0
229096,.,0,0
229097,The,0,0
229098,acellular,0,0
229099,vaccines,0,0
229100,produced,0,0
229101,significantly,0,0
229102,fewer,0,0
229103,local,1,1
229104,and,1,1
229105,systemic,1,0
229106,reactions,1,1
229107,.,1,0
229108,Local,1,0
229109,reactions,1,1
229110,such,0,0
229111,as,0,0
229112,swelling,1,1
229113,and,1,0
229114,redness,1,1
229115,were,0,0
229116,observed,0,0
229117,in,0,0
229118,2,0,0
229119,%,0,0
229120,(,0,0
229121,8/399,0,0
229122,),0,0
229123,to,0,0
229124,2.3,0,0
229125,%,0,0
229126,(,0,0
229127,9/385,0,0
229128,),0,0
229129,of,0,0
229130,the,0,0
229131,acellular,0,0
229132,vaccine,0,0
229133,recipients,0,0
229134,as,0,0
229135,against,0,0
229136,31,0,0
229137,%,0,0
229138,(,0,0
229139,122/394,0,0
229140,),0,0
229141,in,0,0
229142,the,0,0
229143,whole-cell,0,0
229144,vaccine,0,0
229145,group,0,0
229146,.,0,0
229147,Fever,1,0
229148,(,0,0
229149,>,0,0
229150,or,0,0
229151,=,0,0
229152,37.5,0,0
229153,degrees,0,0
229154,C,0,0
229155,),0,0
229156,occurred,0,0
229157,in,0,0
229158,7.27,0,0
229159,%,0,0
229160,(,0,0
229161,29/399,0,0
229162,),0,0
229163,to,0,0
229164,9.8,0,0
229165,%,0,0
229166,(,0,0
229167,38/385,0,0
229168,),0,0
229169,in,0,0
229170,the,0,0
229171,acellular,0,0
229172,vaccine,0,0
229173,groups,0,0
229174,compared,0,0
229175,with,0,0
229176,36.6,0,0
229177,%,0,0
229178,(,0,0
229179,145/394,0,0
229180,),0,0
229181,in,0,0
229182,the,0,0
229183,whole-cell,0,0
229184,vaccine,0,0
229185,group,0,0
229186,.,0,0
229187,Geometric,1,1
229188,mean,1,1
229189,titres,1,1
229190,(,1,0
229191,GMTs,1,1
229192,),1,0
229193,",",0,0
229194,measured,0,0
229195,by,0,0
229196,ELISA,1,0
229197,",",0,0
229198,to,0,0
229199,pertussis,1,0
229200,toxin,1,0
229201,(,1,0
229202,PT,1,1
229203,),1,0
229204,and,1,0
229205,filamentous,1,1
229206,haemagglutinin,1,1
229207,(,1,0
229208,FHA,1,0
229209,),1,0
229210,were,0,0
229211,significantly,0,0
229212,higher,0,0
229213,in,0,0
229214,the,0,0
229215,acellular,0,0
229216,vaccine,0,0
229217,groups,0,0
229218,than,0,0
229219,in,0,0
229220,the,0,0
229221,whole-cell,0,0
229222,DPT,0,0
229223,(,0,0
229224,WCDPT,0,0
229225,),0,0
229226,group,0,0
229227,.,0,0
229228,There,0,0
229229,were,0,0
229230,no,0,0
229231,significant,0,0
229232,differences,0,0
229233,in,0,0
229234,the,0,0
229235,GMTs,1,1
229236,of,1,0
229237,tetanus,1,0
229238,and,1,1
229239,diphtheria,1,0
229240,antitoxins,1,1
229241,between,0,0
229242,the,0,0
229243,two,0,0
229244,groups,0,0
229245,after,0,0
229246,each,0,0
229247,vaccination,0,0
229248,.,0,0
229249,Twelve,0,0
229250,months,0,0
229251,after,0,0
229252,primary,0,0
229253,vaccination,0,0
229254,",",0,0
229255,GMTs,1,1
229256,to,1,0
229257,PT,1,1
229258,in,0,0
229259,the,0,0
229260,freeze-dried,0,0
229261,",",0,0
229262,liquid,0,0
229263,ADPT,0,0
229264,groups,0,0
229265,and,0,0
229266,the,0,0
229267,WCDPT,0,0
229268,group,0,0
229269,have,0,0
229270,fallen,0,0
229271,from,0,0
229272,56.23,0,0
229273,",",0,0
229274,62.63,0,0
229275,and,0,0
229276,44.97,0,0
229277,ELISA,0,0
229278,U/ml,0,0
229279,to,0,0
229280,6.08,0,0
229281,",",0,0
229282,6.18,0,0
229283,and,0,0
229284,11.30,0,0
229285,ELISA,0,0
229286,U/ml,0,1
229287,",",0,0
229288,respectively,0,0
229289,.,0,0
229290,GMTs,1,1
229291,to,1,0
229292,FHA,1,0
229293,in,0,0
229294,all,0,0
229295,the,0,0
229296,vaccine,0,0
229297,groups,0,0
229298,also,0,0
229299,dropped,0,0
229300,during,0,0
229301,the,0,0
229302,same,0,0
229303,period,0,0
229304,from,0,0
229305,49.94,0,0
229306,",",0,0
229307,41.73,0,0
229308,and,0,0
229309,20.74,0,0
229310,ELISA,0,0
229311,U/ml,0,0
229312,to,0,0
229313,7.26,0,0
229314,",",0,0
229315,7.72,0,0
229316,and,0,0
229317,5.91,0,0
229318,ELISA,0,0
229319,U/ml,0,1
229320,",",0,0
229321,respectively,0,0
229322,.,0,0
229323,In,0,0
229324,this,0,0
229325,comparative,0,0
229326,controlled,0,0
229327,trial,0,0
229328,",",0,0
229329,the,0,0
229330,ADPT,0,0
229331,vaccines,0,0
229332,were,0,0
229333,more,0,0
229334,immunogenic,1,1
229335,",",0,0
229336,with,0,0
229337,less,1,0
229338,local,1,1
229339,and,1,1
229340,systemic,1,1
229341,reactions,1,1
229342,",",0,0
229343,than,0,0
229344,the,0,0
229345,WCDPT,0,0
229346,vaccine,0,0
229347,but,0,0
229348,there,0,0
229349,was,0,0
229350,a,0,0
229351,considerable,0,0
229352,drop,0,0
229353,in,0,0
229354,antibody,1,0
229355,titres,1,1
229356,in,0,0
229357,all,0,0
229358,the,0,0
229359,vaccine,0,0
229360,groups,0,0
229361,12,0,0
229362,months,0,0
229363,after,0,0
229364,primary,0,0
229365,vaccination,0,0
229366,.,0,0
229367,However,0,0
229368,",",0,0
229369,the,0,0
229370,levels,0,1
229371,of,0,0
229372,titres,0,1
229373,of,0,0
229374,anti-PT,1,1
229375,and,1,0
229376,anti-FHA,1,0
229377,antibodies,1,1
229378,in,0,0
229379,all,0,0
229380,the,0,0
229381,three,0,0
229382,vaccines,0,0
229383,that,0,0
229384,confer,0,0
229385,protection,0,0
229386,are,0,0
229387,not,0,0
229388,known,0,0
229389,.,0,0
229390,Further,0,0
229391,studies,0,0
229392,are,0,0
229393,necessary,0,0
229394,to,0,0
229395,provide,0,0
229396,this,0,0
229397,information,0,0
229398,in,0,0
229399,order,0,0
229400,to,0,0
229401,assess,0,0
229402,the,0,0
229403,need,0,0
229404,for,0,0
229405,subsequent,0,0
229406,booster,0,0
229407,doses,0,0
229408,after,0,0
229409,primary,0,0
229410,immunization,0,0
229411,with,0,0
229412,both,0,0
229413,ADPT,0,0
229414,and,0,0
229415,WCDPT,0,0
229416,vaccines,0,0
229417,.,0,0
229418,Warfarin,0,0
229419,for,0,0
229420,atrial,0,1
229421,fibrillation,0,0
229422,.,0,0
229423,The,0,0
229424,patient,0,1
229425,'s,0,0
229426,perspective,0,0
229427,.,0,0
229428,OBJECTIVE,0,0
229429,To,0,0
229430,determine,0,0
229431,the,0,0
229432,minimal,1,0
229433,clinically,1,0
229434,important,1,0
229435,difference,1,0
229436,(,1,0
229437,MCID,1,0
229438,),1,0
229439,of,0,0
229440,warfarin,0,0
229441,therapy,0,0
229442,for,0,0
229443,the,0,0
229444,treatment,0,0
229445,of,0,0
229446,nonvalvular,0,0
229447,atrial,0,1
229448,fibrillation,0,0
229449,from,0,0
229450,the,0,0
229451,perspective,0,0
229452,of,0,0
229453,patients,0,0
229454,using,0,0
229455,2,0,0
229456,different,0,0
229457,elicitation,0,0
229458,methods,0,0
229459,.,0,0
229460,DESIGN,0,0
229461,All,0,0
229462,patients,0,0
229463,completed,0,0
229464,2,0,0
229465,face-to-face,0,0
229466,interviews,0,0
229467,",",0,0
229468,which,0,0
229469,were,0,0
229470,2,0,0
229471,weeks,0,0
229472,apart,0,0
229473,.,0,0
229474,For,0,0
229475,each,0,0
229476,interview,0,0
229477,",",0,0
229478,they,0,0
229479,were,0,0
229480,randomized,0,0
229481,to,0,0
229482,receive,0,0
229483,1,0,0
229484,of,0,0
229485,2,0,0
229486,elicitation,0,0
229487,methods,0,0
229488,:,0,0
229489,ping-ponging,0,0
229490,or,0,0
229491,starting,0,0
229492,at,0,0
229493,the,0,0
229494,known,0,0
229495,efficacy,0,1
229496,.,0,0
229497,SETTING,0,0
229498,The,0,0
229499,practices,0,0
229500,of,0,0
229501,2,0,0
229502,university-affiliated,0,0
229503,family,0,0
229504,medicine,0,0
229505,centers,0,0
229506,(,0,0
229507,8,0,0
229508,physicians,0,0
229509,each,0,0
229510,),0,0
229511,",",0,0
229512,14,0,0
229513,community-based,0,0
229514,family,0,0
229515,physicians,0,0
229516,",",0,0
229517,and,0,0
229518,2,0,0
229519,cardiologists,0,0
229520,.,0,0
229521,PATIENTS,0,0
229522,Sixty-four,0,0
229523,patients,0,0
229524,with,0,0
229525,nonvalvular,0,0
229526,atrial,0,0
229527,fibrillation,0,1
229528,who,0,0
229529,were,0,0
229530,initiated,0,0
229531,with,0,0
229532,warfarin,0,0
229533,therapy,0,0
229534,at,0,0
229535,least,0,0
229536,3,0,0
229537,months,0,0
229538,before,0,0
229539,the,0,0
229540,study,0,0
229541,.,0,0
229542,INTERVENTION,0,0
229543,During,0,0
229544,each,0,0
229545,interview,0,0
229546,",",0,0
229547,the,0,0
229548,patients,0,0
229549,',0,0
229550,MCIDs,0,0
229551,were,0,0
229552,determined,0,0
229553,by,0,0
229554,using,0,0
229555,(,0,0
229556,1,0,0
229557,),0,0
229558,a,1,0
229559,pictorial,1,0
229560,flip,1,0
229561,chart,1,0
229562,to,1,0
229563,describe,1,0
229564,atrial,1,0
229565,fibrillation,1,0
229566,;,1,0
229567,the,1,0
229568,consequences,1,0
229569,of,1,0
229570,a,1,0
229571,minor,1,0
229572,stroke,1,0
229573,",",1,0
229574,a,1,0
229575,major,1,1
229576,stroke,1,1
229577,",",1,0
229578,and,1,0
229579,a,1,0
229580,major,1,1
229581,bleeding,1,1
229582,episode,1,0
229583,;,1,0
229584,the,0,0
229585,chance,1,1
229586,of,1,0
229587,stroke,1,1
229588,if,1,0
229589,not,1,0
229590,taking,1,0
229591,warfarin,1,0
229592,;,1,0
229593,the,0,0
229594,chance,1,0
229595,of,1,0
229596,a,1,0
229597,major,1,0
229598,bleeding,1,1
229599,episode,1,1
229600,if,1,0
229601,taking,1,0
229602,warfarin,1,0
229603,;,1,0
229604,examples,0,0
229605,of,0,0
229606,the,0,0
229607,inconvenience,1,1
229608,",",1,0
229609,minor,1,0
229610,side,1,1
229611,effects,1,1
229612,",",1,0
229613,and,1,1
229614,costs,1,1
229615,of,1,1
229616,warfarin,1,0
229617,therapy,1,0
229618,;,1,0
229619,and,0,0
229620,then,0,0
229621,(,0,0
229622,2,0,0
229623,),0,0
229624,1,0,0
229625,of,0,0
229626,the,0,0
229627,2,0,0
229628,elicitation,1,0
229629,methods,1,0
229630,to,1,0
229631,determine,1,0
229632,their,1,0
229633,MCIDs,1,0
229634,(,1,0
229635,the,1,0
229636,smallest,1,1
229637,reduction,1,1
229638,in,1,0
229639,stroke,1,1
229640,risk,1,1
229641,at,1,0
229642,which,1,0
229643,the,1,0
229644,patients,1,0
229645,were,1,0
229646,willing,1,0
229647,to,1,0
229648,take,1,0
229649,warfarin,1,0
229650,),1,0
229651,.,1,0
229652,Patients,1,0
229653,',1,0
229654,knowledge,1,0
229655,of,1,0
229656,their,1,0
229657,stroke,1,1
229658,risk,1,1
229659,",",1,0
229660,acceptability,1,1
229661,of,1,0
229662,the,1,0
229663,interview,1,0
229664,process,1,0
229665,",",1,1
229666,and,1,1
229667,factors,1,1
229668,determining,1,0
229669,their,1,0
229670,preferences,1,0
229671,were,0,0
229672,also,0,0
229673,assessed,0,0
229674,.,0,0
229675,MAIN,0,0
229676,RESULTS,0,0
229677,Given,0,1
229678,a,0,0
229679,baseline,0,0
229680,risk,0,1
229681,of,0,0
229682,having,0,0
229683,a,0,0
229684,stroke,0,0
229685,in,0,0
229686,the,0,0
229687,next,0,0
229688,2,0,0
229689,years,0,0
229690,",",0,0
229691,if,0,0
229692,not,0,0
229693,taking,0,0
229694,warfarin,0,0
229695,",",0,0
229696,of,0,0
229697,10,0,0
229698,of,0,0
229699,100,0,0
229700,",",0,0
229701,the,0,0
229702,mean,1,1
229703,MCID,1,0
229704,was,0,0
229705,2.01,0,0
229706,of,0,0
229707,100,0,0
229708,(,0,0
229709,95,0,0
229710,%,0,0
229711,confidence,0,0
229712,interval,0,0
229713,",",0,0
229714,1.60-2.42,0,0
229715,),0,0
229716,.,0,0
229717,Fifty-two,0,0
229718,percent,0,0
229719,of,0,0
229720,the,0,0
229721,patients,0,0
229722,would,0,0
229723,take,0,0
229724,warfarin,0,0
229725,for,0,0
229726,an,0,0
229727,absolute,0,1
229728,decrease,0,0
229729,in,0,0
229730,stroke,1,1
229731,risk,1,0
229732,of,0,0
229733,1,0,0
229734,%,0,0
229735,over,0,0
229736,2,0,0
229737,years,0,0
229738,.,0,0
229739,Before,0,0
229740,eliciting,0,0
229741,their,0,0
229742,MCIDs,0,0
229743,",",0,0
229744,patients,0,0
229745,showed,0,0
229746,poor,0,1
229747,knowledge,1,1
229748,of,1,0
229749,their,1,0
229750,stroke,1,1
229751,risk,1,1
229752,",",0,0
229753,which,0,0
229754,improved,0,0
229755,afterward,0,0
229756,.,0,0
229757,The,0,0
229758,interview,0,0
229759,process,0,0
229760,was,0,0
229761,well,0,0
229762,accepted,0,0
229763,by,0,0
229764,the,0,0
229765,patients,0,0
229766,.,0,0
229767,The,0,0
229768,MCID,1,0
229769,using,0,0
229770,the,0,0
229771,ping-ponging,0,0
229772,elicitation,0,0
229773,method,0,0
229774,was,0,0
229775,1.015,0,0
229776,of,0,0
229777,100,0,0
229778,smaller,0,0
229779,compared,0,0
229780,with,0,0
229781,use,0,0
229782,of,0,0
229783,the,0,0
229784,starting,0,0
229785,at,0,0
229786,the,0,0
229787,known,0,0
229788,efficacy,0,1
229789,method,0,0
229790,(,0,0
229791,P,0,0
229792,=,0,0
229793,.01,0,0
229794,),0,0
229795,.,0,0
229796,CONCLUSIONS,0,0
229797,We,0,0
229798,were,0,0
229799,able,0,0
229800,to,0,0
229801,determine,0,0
229802,the,0,0
229803,MCID,1,0
229804,of,0,0
229805,warfarin,0,0
229806,therapy,0,0
229807,for,0,0
229808,the,0,0
229809,prevention,0,0
229810,of,0,0
229811,stroke,0,0
229812,from,0,0
229813,the,0,0
229814,perspective,0,0
229815,of,0,0
229816,patients,0,0
229817,with,0,0
229818,nonvalvular,0,0
229819,atrial,0,0
229820,fibrillation,0,0
229821,.,0,0
229822,Their,0,0
229823,MCIDs,0,0
229824,were,0,0
229825,much,0,0
229826,smaller,0,0
229827,than,0,0
229828,those,0,0
229829,that,0,0
229830,have,0,0
229831,been,0,0
229832,implied,0,0
229833,by,0,0
229834,some,0,0
229835,experts,0,0
229836,and,0,0
229837,clinicians,0,0
229838,.,0,0
229839,The,0,0
229840,interview,0,0
229841,process,0,0
229842,",",0,0
229843,using,0,0
229844,the,0,0
229845,flip,0,0
229846,chart,0,0
229847,approach,0,0
229848,",",0,0
229849,appeared,0,0
229850,to,0,0
229851,improve,0,0
229852,the,0,0
229853,patients,1,0
229854,',1,0
229855,knowledge,1,0
229856,of,1,0
229857,their,1,0
229858,disease,1,0
229859,and,1,0
229860,its,1,0
229861,consequences,1,0
229862,and,1,0
229863,treatment,1,0
229864,.,1,0
229865,The,0,0
229866,method,0,0
229867,used,0,0
229868,to,0,0
229869,elicit,0,0
229870,the,0,0
229871,patients,0,0
229872,',0,0
229873,MCIDs,1,0
229874,can,0,0
229875,have,0,0
229876,a,0,0
229877,clinically,0,0
229878,important,0,0
229879,effect,0,0
229880,on,0,0
229881,patient,0,0
229882,responses,0,1
229883,.,0,0
229884,The,0,0
229885,method,0,0
229886,used,0,0
229887,in,0,0
229888,our,0,0
229889,study,0,0
229890,can,0,0
229891,be,0,0
229892,generalized,0,0
229893,to,0,0
229894,other,0,0
229895,conditions,0,0
229896,and,0,0
229897,",",0,0
229898,thus,0,0
229899,",",0,0
229900,could,0,0
229901,be,0,0
229902,helpful,0,0
229903,in,0,0
229904,3,0,0
229905,ways,0,0
229906,:,0,0
229907,(,0,0
229908,1,0,0
229909,),0,0
229910,from,0,0
229911,a,0,0
229912,clinical,0,0
229913,decision-making,0,1
229914,perspective,0,0
229915,",",0,0
229916,it,0,0
229917,could,0,0
229918,facilitate,0,0
229919,patient-physician,0,0
229920,communication,0,0
229921,;,0,0
229922,(,0,0
229923,2,0,0
229924,),0,0
229925,it,0,0
229926,could,0,0
229927,clarify,0,0
229928,the,0,0
229929,patient,0,0
229930,perspective,0,0
229931,when,0,0
229932,interpreting,0,0
229933,the,0,0
229934,results,0,0
229935,of,0,0
229936,previously,0,0
229937,completed,0,0
229938,trials,0,0
229939,;,0,0
229940,and,0,0
229941,(,0,0
229942,3,0,0
229943,),0,0
229944,it,0,0
229945,could,0,0
229946,be,0,0
229947,used,0,0
229948,to,0,0
229949,derive,0,0
229950,more,0,0
229951,clinically,0,1
229952,relevant,0,0
229953,sample,0,0
229954,sizes,0,1
229955,for,0,0
229956,randomized,0,0
229957,treatment,0,0
229958,trials,0,0
229959,.,0,0
229960,The,0,0
229961,long-term,0,0
229962,effects,0,0
229963,of,0,0
229964,auditory,0,1
229965,training,0,0
229966,on,0,0
229967,children,0,0
229968,with,0,0
229969,autism,0,0
229970,.,0,0
229971,Eighty,0,1
229972,children,0,0
229973,",",0,0
229974,3-17,0,0
229975,years,0,0
229976,of,0,0
229977,age,0,0
229978,",",0,0
229979,with,0,0
229980,autism,0,0
229981,or,0,0
229982,Asperger,0,1
229983,syndrome,0,1
229984,and,0,0
229985,mild,0,1
229986,to,0,0
229987,severe,0,1
229988,distress,0,1
229989,in,0,0
229990,the,0,0
229991,presence,0,0
229992,of,0,0
229993,some,0,0
229994,sounds,0,1
229995,",",0,0
229996,were,0,0
229997,randomly,0,0
229998,allocated,0,0
229999,to,0,0
230000,two,0,0
230001,groups,0,0
230002,.,0,0
230003,The,0,0
230004,experimental,0,0
230005,group,0,0
230006,received,0,0
230007,auditory,0,1
230008,training,0,0
230009,and,0,0
230010,the,0,0
230011,control,0,0
230012,group,0,0
230013,listened,0,0
230014,to,0,0
230015,the,0,0
230016,same,0,0
230017,unmodified,0,0
230018,music,0,0
230019,under,0,0
230020,the,0,0
230021,same,0,0
230022,conditions,0,0
230023,.,0,0
230024,Significant,0,0
230025,improvements,0,1
230026,in,0,0
230027,behavior,1,1
230028,and,1,1
230029,severity,1,1
230030,of,1,1
230031,autism,1,0
230032,were,0,0
230033,maintained,0,0
230034,for,0,0
230035,12,0,0
230036,months,0,0
230037,by,0,0
230038,both,0,0
230039,groups,0,0
230040,.,0,0
230041,Informal,0,0
230042,data,0,0
230043,suggested,0,0
230044,that,0,0
230045,a,0,0
230046,range,1,0
230047,of,1,0
230048,abnormal,1,1
230049,responses,1,1
230050,to,0,0
230051,sound,1,0
230052,and,1,0
230053,other,1,0
230054,sensory,1,1
230055,abnormalities,1,0
230056,may,0,0
230057,also,0,0
230058,have,0,0
230059,improved,0,0
230060,.,0,0
230061,Verbal,1,0
230062,and,1,0
230063,performance,1,1
230064,IQ,1,1
230065,increased,0,0
230066,significantly,0,0
230067,3,0,0
230068,to,0,0
230069,12,0,0
230070,months,0,0
230071,after,0,0
230072,interventions,0,0
230073,.,0,0
230074,Findings,0,0
230075,suggest,0,0
230076,that,0,0
230077,some,0,0
230078,aspect,0,0
230079,of,0,0
230080,both,0,0
230081,auditory,0,1
230082,training,0,0
230083,and,0,0
230084,listening,0,0
230085,to,0,0
230086,selected,0,0
230087,unmodified,0,0
230088,music,0,0
230089,may,0,0
230090,have,0,0
230091,a,0,0
230092,beneficial,1,0
230093,effect,1,0
230094,on,0,0
230095,children,0,0
230096,with,0,0
230097,autism,0,0
230098,and,0,0
230099,sound,0,1
230100,sensitivity,0,1
230101,",",0,0
230102,and,0,0
230103,indicate,0,0
230104,a,0,0
230105,need,0,0
230106,for,0,0
230107,further,0,0
230108,research,0,0
230109,into,0,0
230110,the,0,0
230111,effects,0,0
230112,that,0,0
230113,led,0,0
230114,to,0,0
230115,these,0,0
230116,changes,0,0
230117,and,0,0
230118,the,0,0
230119,mechanisms,0,0
230120,involved,0,0
230121,in,0,0
230122,the,0,0
230123,sensory,0,1
230124,abnormalities,0,0
230125,commonly,0,0
230126,associated,0,0
230127,with,0,0
230128,autism,0,0
230129,.,0,0
230130,Long-term,0,0
230131,results,0,0
230132,regarding,0,0
230133,the,0,0
230134,use,0,0
230135,of,0,0
230136,recombinant,0,0
230137,interferon,0,0
230138,alpha-2b,0,0
230139,in,0,0
230140,the,0,0
230141,treatment,0,0
230142,of,0,0
230143,II,0,0
230144,type,0,0
230145,mixed,0,0
230146,essential,0,0
230147,cryoglobulinemia,0,1
230148,.,0,0
230149,Thirty-three,0,0
230150,patients,0,0
230151,with,0,0
230152,II,0,0
230153,type,0,0
230154,mixed,0,0
230155,essential,0,0
230156,cryoglobulinemia,0,1
230157,(,0,0
230158,MEC,0,0
230159,),0,0
230160,were,0,0
230161,randomized,0,0
230162,into,0,0
230163,two,0,0
230164,groups,0,0
230165,:,0,0
230166,one,0,0
230167,to,0,0
230168,receive,0,0
230169,combined,0,0
230170,therapy,0,0
230171,including,0,0
230172,prednisone,0,0
230173,plus,0,0
230174,interferon,0,1
230175,",",0,0
230176,the,0,0
230177,other,0,0
230178,to,0,0
230179,receive,0,0
230180,prednisone,0,0
230181,therapy,0,0
230182,.,0,0
230183,Interferon,0,0
230184,was,0,0
230185,administered,0,0
230186,as,0,0
230187,induction,0,1
230188,treatment,0,0
230189,(,0,0
230190,3,0,0
230191,Mu/day,0,0
230192,),0,0
230193,and,0,0
230194,then,0,0
230195,as,0,0
230196,maintenance,0,0
230197,therapy,0,0
230198,(,0,0
230199,3,0,0
230200,Mu,0,0
230201,three,0,0
230202,times,0,0
230203,a,0,0
230204,week,0,0
230205,),0,0
230206,.,0,0
230207,83,0,0
230208,%,0,0
230209,of,0,0
230210,the,0,0
230211,combined,0,0
230212,therapy,0,0
230213,patients,0,0
230214,responded,0,0
230215,as,0,0
230216,opposed,0,0
230217,to,0,0
230218,27,0,0
230219,%,0,0
230220,of,0,0
230221,the,0,0
230222,prednisone,0,0
230223,treated,0,0
230224,patients,0,0
230225,.,0,0
230226,Among,0,0
230227,the,0,0
230228,patients,0,0
230229,that,0,0
230230,responded,0,0
230231,to,0,0
230232,combined,0,0
230233,therapy,0,0
230234,",",0,0
230235,nine,0,0
230236,of,0,0
230237,them,0,0
230238,had,0,0
230239,a,0,0
230240,complete,0,1
230241,response,0,1
230242,",",0,0
230243,four,0,0
230244,a,0,0
230245,partial,0,0
230246,response,0,1
230247,",",0,0
230248,and,0,0
230249,two,0,0
230250,a,0,0
230251,minor,0,0
230252,response,0,1
230253,.,0,0
230254,None,0,0
230255,of,0,0
230256,the,0,0
230257,patients,0,0
230258,treated,0,0
230259,with,0,0
230260,prednisone,0,0
230261,therapy,0,0
230262,responded,0,0
230263,completely,0,0
230264,but,0,0
230265,only,0,0
230266,two,0,0
230267,had,0,0
230268,a,0,0
230269,partial,0,0
230270,and,0,0
230271,two,0,0
230272,a,0,0
230273,minor,0,0
230274,response,0,0
230275,.,0,0
230276,Four,0,0
230277,patients,0,0
230278,(,0,0
230279,three,0,0
230280,of,0,0
230281,combined,0,0
230282,therapy,0,0
230283,and,0,0
230284,one,0,0
230285,of,0,0
230286,prednisone,0,0
230287,therapy,0,0
230288,),0,0
230289,showed,0,0
230290,proteinuria,1,1
230291,before,0,0
230292,the,0,0
230293,treatment,0,0
230294,which,0,0
230295,improved,0,0
230296,at,0,0
230297,the,0,0
230298,end,0,0
230299,of,0,0
230300,the,0,0
230301,induction,0,0
230302,therapy,0,0
230303,.,0,0
230304,Ten,0,0
230305,patients,0,0
230306,showed,0,0
230307,anti-HCV,1,1
230308,positivity,1,1
230309,which,0,0
230310,remained,0,0
230311,unchanged,0,0
230312,after,0,0
230313,the,0,0
230314,treatment,0,0
230315,.,0,0
230316,Three,0,0
230317,patients,0,0
230318,showed,0,0
230319,liver,1,0
230320,involvement,1,1
230321,secondary,0,0
230322,to,0,0
230323,cryoglobulinemia,1,1
230324,and,0,0
230325,an,0,0
230326,improvement,0,1
230327,of,0,0
230328,histological,1,1
230329,pattern,1,0
230330,after,0,0
230331,the,0,0
230332,induction,0,0
230333,with,0,0
230334,combined,0,0
230335,therapy,0,0
230336,.,0,0
230337,One,0,0
230338,patient,0,0
230339,showed,0,0
230340,an,0,0
230341,improvement,0,1
230342,of,0,0
230343,peripheral,1,1
230344,neuropathy,1,0
230345,after,0,0
230346,induction,0,0
230347,with,0,0
230348,the,0,0
230349,combined,0,0
230350,therapy,0,0
230351,.,0,0
230352,These,0,0
230353,data,0,0
230354,suggest,0,0
230355,the,0,0
230356,effectiveness,0,1
230357,of,0,0
230358,interferon,0,0
230359,given,0,0
230360,as,0,0
230361,induction,0,0
230362,and,0,0
230363,as,0,0
230364,maintenance,0,0
230365,treatment,0,0
230366,in,0,0
230367,the,0,0
230368,therapy,0,0
230369,of,0,0
230370,II,0,0
230371,type,0,0
230372,mixed,0,0
230373,essential,0,0
230374,cryoglobulinemia,0,1
230375,.,0,0
230376,The,0,0
230377,comparative,0,0
230378,safety,1,1
230379,and,1,0
230380,diagnostic,1,1
230381,accuracy,1,1
230382,of,0,0
230383,adenosine,0,0
230384,myocardial,0,1
230385,perfusion,0,0
230386,imaging,0,0
230387,in,0,0
230388,women,0,0
230389,versus,0,0
230390,men,0,0
230391,.,0,0
230392,STUDY,0,0
230393,OBJECTIVE,0,0
230394,To,0,0
230395,determine,0,0
230396,if,0,0
230397,the,0,0
230398,diagnostic,0,0
230399,accuracy,0,1
230400,and,0,1
230401,safety,0,1
230402,of,0,1
230403,intravenous,0,0
230404,adenosine,0,0
230405,myocardial,0,1
230406,perfusion,0,0
230407,imaging,0,0
230408,is,0,0
230409,significantly,0,0
230410,different,0,0
230411,in,0,0
230412,men,0,0
230413,compared,0,0
230414,with,0,0
230415,women,0,0
230416,.,0,0
230417,DESIGN,0,0
230418,Prospective,0,0
230419,",",0,0
230420,comparative,0,0
230421,",",0,0
230422,open-label,0,0
230423,clinical,0,0
230424,trial,0,0
230425,.,0,0
230426,SETTING,0,0
230427,Nuclear,0,0
230428,medicine,0,0
230429,laboratory,0,0
230430,in,0,0
230431,a,0,0
230432,university-affiliated,0,0
230433,hospital,0,0
230434,.,0,0
230435,PATIENTS,0,0
230436,Consecutive,0,0
230437,patients,0,0
230438,who,0,0
230439,were,0,0
230440,referred,0,0
230441,for,0,0
230442,evaluation,0,0
230443,of,0,0
230444,known,0,0
230445,or,0,0
230446,suspected,0,0
230447,coronary,0,0
230448,artery,0,0
230449,disease,0,0
230450,.,0,0
230451,Patients,0,0
230452,were,0,0
230453,judged,0,0
230454,not,0,0
230455,to,0,0
230456,be,0,0
230457,able,0,0
230458,to,0,0
230459,exercise,0,0
230460,adequately,0,0
230461,.,0,0
230462,INTERVENTIONS,0,1
230463,Coronary,0,0
230464,angiography,0,0
230465,was,0,0
230466,conducted,0,0
230467,within,0,0
230468,6,0,0
230469,weeks,0,0
230470,of,0,0
230471,an,0,0
230472,adenosine,0,0
230473,thallium-201,0,0
230474,myocardial,0,1
230475,perfusion,0,0
230476,imaging,0,0
230477,study,0,0
230478,.,0,0
230479,MEASUREMENTS,0,0
230480,AND,0,0
230481,MAIN,0,0
230482,RESULTS,0,0
230483,Diagnostic,1,0
230484,accuracy,1,0
230485,is,0,0
230486,shown,0,0
230487,in,0,0
230488,the,0,0
230489,table,0,0
230490,.,0,0
230491,[,0,0
230492,table,0,0
230493,:,0,0
230494,see,0,0
230495,text,0,0
230496,],0,0
230497,Overall,0,1
230498,",",0,0
230499,side,1,1
230500,effects,1,1
230501,from,0,0
230502,adenosine,0,0
230503,were,0,0
230504,not,0,0
230505,different,0,0
230506,between,0,0
230507,men,0,0
230508,and,0,0
230509,women,0,0
230510,.,0,0
230511,The,0,0
230512,frequencies,1,1
230513,of,1,0
230514,ST,1,1
230515,depression,1,1
230516,and,1,1
230517,chest,1,1
230518,pain,1,1
230519,were,0,0
230520,significantly,0,0
230521,greater,0,0
230522,in,0,0
230523,women,0,0
230524,than,0,0
230525,men,0,0
230526,",",0,0
230527,although,0,0
230528,their,0,0
230529,etiologies,0,0
230530,are,0,0
230531,unknown,0,0
230532,.,0,0
230533,The,0,0
230534,frequency,1,1
230535,of,1,0
230536,severe,1,1
230537,side,1,1
230538,effects,1,1
230539,such,1,0
230540,as,1,0
230541,heart,1,1
230542,block,1,0
230543,and,1,1
230544,hypotension,1,1
230545,was,0,0
230546,not,0,0
230547,different,0,0
230548,between,0,0
230549,men,0,0
230550,and,0,0
230551,women,0,0
230552,.,0,0
230553,CONCLUSIONS,0,0
230554,The,0,0
230555,diagnostic,0,0
230556,accuracy,0,1
230557,and,0,1
230558,safety,0,1
230559,of,0,1
230560,adenosine,0,0
230561,thallium-201,0,0
230562,myocardial,0,1
230563,perfusion,0,0
230564,imaging,0,0
230565,are,0,0
230566,generally,0,0
230567,similar,0,0
230568,in,0,0
230569,women,0,0
230570,and,0,0
230571,men,0,0
230572,.,0,0
230573,Final,0,1
230574,report,0,0
230575,of,0,0
230576,a,0,0
230577,randomized,0,0
230578,controlled,0,0
230579,study,0,0
230580,with,0,0
230581,streptococcal,0,0
230582,preparation,0,0
230583,OK-432,0,0
230584,as,0,0
230585,a,0,0
230586,supplementary,0,0
230587,immunopotentiator,0,0
230588,for,0,0
230589,laryngeal,0,0
230590,cancer,0,0
230591,.,0,0
230592,We,0,0
230593,conducted,0,0
230594,a,0,0
230595,randomized,0,0
230596,controlled,0,0
230597,study,0,0
230598,of,0,0
230599,streptococcal,0,0
230600,preparation,0,0
230601,OK-432,0,0
230602,on,0,0
230603,120,0,0
230604,newly,0,0
230605,identified,0,0
230606,cases,0,0
230607,of,0,0
230608,laryngeal,0,0
230609,squamous,0,0
230610,cell,0,0
230611,carcinoma,0,0
230612,who,0,0
230613,were,0,0
230614,registered,0,0
230615,at,0,0
230616,10,0,0
230617,participating,0,0
230618,institutions,0,0
230619,between,0,0
230620,November,0,0
230621,1984,0,0
230622,and,0,0
230623,October,0,0
230624,1989,0,0
230625,.,0,0
230626,The,0,0
230627,patients,0,0
230628,were,0,0
230629,divided,0,0
230630,into,0,0
230631,two,0,0
230632,groups,0,0
230633,:,0,0
230634,those,0,0
230635,in,0,0
230636,early,0,0
230637,stages,0,0
230638,(,0,0
230639,stage,0,0
230640,I,0,0
230641,or,0,0
230642,II,0,0
230643,),0,0
230644,and,0,0
230645,those,0,0
230646,in,0,0
230647,advanced,0,0
230648,stages,0,0
230649,(,0,0
230650,stage,0,0
230651,III,0,1
230652,or,0,0
230653,IV,0,1
230654,),0,0
230655,;,0,0
230656,these,0,0
230657,groups,0,0
230658,were,0,0
230659,further,0,0
230660,subdivided,0,0
230661,into,0,0
230662,an,0,0
230663,immunotherapy,0,0
230664,group,0,0
230665,(,0,0
230666,receiving,0,0
230667,OK-432,0,0
230668,),0,0
230669,and,0,0
230670,a,0,0
230671,control,0,0
230672,group,0,0
230673,(,0,0
230674,who,0,0
230675,did,0,0
230676,not,0,0
230677,receive,0,0
230678,OK-432,0,0
230679,),0,0
230680,.,0,0
230681,The,0,0
230682,usefulness,0,0
230683,of,0,0
230684,OK-432,0,0
230685,was,0,0
230686,studied,0,0
230687,using,0,0
230688,the,0,0
230689,sealed,0,0
230690,envelope,0,0
230691,method,0,0
230692,.,0,0
230693,The,0,0
230694,basic,0,0
230695,therapy,0,0
230696,for,0,0
230697,all,0,0
230698,cases,0,0
230699,was,0,0
230700,radiotherapy,0,0
230701,and,0,1
230702,",",0,0
230703,when,0,0
230704,required,0,0
230705,",",0,0
230706,surgery,0,0
230707,.,0,0
230708,As,0,0
230709,adjuvant,0,0
230710,therapy,0,0
230711,",",0,0
230712,5Fu,0,0
230713,or,0,0
230714,derivatives,0,0
230715,were,0,0
230716,administered,0,0
230717,to,0,0
230718,all,0,0
230719,cases,0,0
230720,from,0,0
230721,the,0,0
230722,beginning,0,0
230723,of,0,0
230724,the,0,0
230725,treatment,0,0
230726,period,0,0
230727,to,0,0
230728,one,0,0
230729,year,0,0
230730,after,0,0
230731,the,0,0
230732,basic,0,0
230733,therapy,0,0
230734,",",0,0
230735,with,0,0
230736,the,0,0
230737,exception,0,0
230738,of,0,0
230739,cases,0,0
230740,in,0,0
230741,whom,0,0
230742,side,0,1
230743,effects,0,1
230744,were,0,0
230745,serious,0,0
230746,enough,0,0
230747,to,0,0
230748,contraindicate,0,0
230749,use,0,0
230750,of,0,0
230751,the,0,0
230752,drug,0,0
230753,.,0,0
230754,The,0,0
230755,target,0,0
230756,administration,0,0
230757,period,0,0
230758,was,0,0
230759,5,0,0
230760,years,0,0
230761,.,0,0
230762,Of,0,0
230763,the,0,0
230764,initial,0,0
230765,120,0,0
230766,cases,0,0
230767,",",0,0
230768,11,0,0
230769,cases,0,0
230770,were,0,0
230771,disqualified,0,0
230772,(,0,0
230773,3,0,0
230774,cases,0,0
230775,of,0,0
230776,double,0,0
230777,cancer,0,0
230778,and,0,0
230779,8,0,0
230780,of,0,0
230781,incomplete,0,0
230782,primary,0,0
230783,therapy,0,0
230784,),0,0
230785,and,0,0
230786,the,0,0
230787,remaining,0,0
230788,109,0,0
230789,were,0,0
230790,used,0,0
230791,for,0,0
230792,evaluation,0,0
230793,.,0,0
230794,The,0,0
230795,5-year,1,0
230796,survival,1,1
230797,rate,1,1
230798,and,1,0
230799,the,1,0
230800,5-year,1,0
230801,recurrence-free,1,1
230802,rate,1,1
230803,were,0,0
230804,76,0,0
230805,%,0,0
230806,and,0,0
230807,84,0,0
230808,%,0,0
230809,",",0,0
230810,respectively,0,0
230811,",",0,0
230812,in,0,0
230813,the,0,0
230814,immunized,0,0
230815,groups,0,0
230816,(,0,0
230817,both,0,0
230818,the,0,0
230819,early,0,0
230820,and,0,0
230821,advanced,0,0
230822,groups,0,0
230823,),0,0
230824,",",0,0
230825,whereas,0,0
230826,the,0,0
230827,same,0,0
230828,rates,0,1
230829,for,0,0
230830,the,0,0
230831,control,0,0
230832,groups,0,0
230833,were,0,0
230834,78,0,0
230835,%,0,0
230836,and,0,0
230837,75,0,0
230838,%,0,0
230839,.,0,0
230840,There,0,0
230841,was,0,0
230842,a,0,0
230843,tendency,0,0
230844,for,0,0
230845,the,0,0
230846,immunized,0,0
230847,groups,0,0
230848,to,0,0
230849,enjoy,0,0
230850,a,0,0
230851,slightly,1,0
230852,longer,1,0
230853,recurrence-free,1,1
230854,period,1,0
230855,.,1,0
230856,Over,0,0
230857,a,0,0
230858,24-month,0,0
230859,observation,0,0
230860,period,0,0
230861,the,0,0
230862,immunized,0,0
230863,group,0,0
230864,always,0,0
230865,had,0,0
230866,higher,0,0
230867,levels,1,1
230868,of,1,1
230869,peripheral,1,1
230870,leukocytes,1,1
230871,and,1,0
230872,peripheral,1,1
230873,lymphocytes,1,1
230874,;,1,0
230875,this,0,0
230876,difference,0,0
230877,was,0,0
230878,significant,0,0
230879,for,0,0
230880,the,0,0
230881,first,0,0
230882,21,0,0
230883,months,0,0
230884,.,0,0
230885,Inhibition,1,0
230886,of,1,0
230887,bone,1,1
230888,marrow,1,0
230889,function,1,1
230890,is,0,0
230891,sometimes,0,0
230892,observed,0,0
230893,with,0,0
230894,radiotherapy,0,0
230895,.,0,0
230896,It,0,0
230897,is,0,0
230898,hoped,0,0
230899,that,0,0
230900,",",0,0
230901,if,0,0
230902,this,0,0
230903,inhibition,0,0
230904,can,0,0
230905,be,0,0
230906,mitigated,0,0
230907,",",0,0
230908,it,0,0
230909,will,0,0
230910,be,0,0
230911,possible,0,0
230912,to,0,0
230913,assist,0,0
230914,the,0,0
230915,compromised,0,0
230916,immune,0,1
230917,system,0,0
230918,and,0,0
230919,maintain,0,0
230920,a,0,0
230921,certain,1,0
230922,level,1,1
230923,of,1,0
230924,immune,1,1
230925,performance,1,1
230926,which,0,0
230927,will,0,0
230928,prevent,0,0
230929,recurrence,0,1
230930,and,0,0
230931,improve,1,0
230932,survival,1,1
230933,rate,1,1
230934,.,1,0
230935,In,0,0
230936,the,0,0
230937,present,0,0
230938,study,0,0
230939,we,0,0
230940,observed,0,0
230941,a,0,0
230942,tendency,0,0
230943,of,0,0
230944,the,0,0
230945,lower,0,0
230946,recurrence,0,1
230947,rate,0,1
230948,in,0,0
230949,the,0,0
230950,immunized,0,0
230951,group,0,0
230952,",",0,0
230953,and,0,0
230954,we,0,0
230955,hypothesize,0,0
230956,that,0,0
230957,OK-432,0,0
230958,is,0,0
230959,effective,0,0
230960,in,0,0
230961,extending,0,0
230962,the,0,0
230963,recurrence-free,0,1
230964,period,0,0
230965,.,0,0
230966,Effects,0,0
230967,of,0,0
230968,tryptophan,0,0
230969,depletion,0,0
230970,in,0,0
230971,drug-free,0,0
230972,adults,0,0
230973,with,0,0
230974,autistic,0,0
230975,disorder,0,0
230976,.,0,0
230977,BACKGROUND,0,0
230978,The,0,0
230979,primary,0,0
230980,objective,0,0
230981,of,0,0
230982,this,0,0
230983,study,0,0
230984,was,0,0
230985,to,0,0
230986,investigate,0,0
230987,the,0,0
230988,behavioral,0,1
230989,and,0,0
230990,biochemical,0,1
230991,responses,0,1
230992,to,0,0
230993,acute,0,0
230994,tryptophan,0,0
230995,depletion,0,0
230996,in,0,0
230997,drug-free,0,0
230998,adult,0,0
230999,patients,0,0
231000,with,0,0
231001,autistic,0,0
231002,disorder,0,0
231003,.,0,0
231004,METHODS,0,0
231005,Twenty,0,0
231006,drug-free,0,0
231007,adults,0,0
231008,with,0,0
231009,autistic,0,0
231010,disorder,0,0
231011,(,0,0
231012,16,0,0
231013,men,0,0
231014,and,0,0
231015,4,0,0
231016,women,0,0
231017,),0,0
231018,(,0,0
231019,mean,0,1
231020,[,0,0
231021,+/-,0,0
231022,SD,0,0
231023,],0,0
231024,age,0,0
231025,",",0,0
231026,30.5,0,0
231027,+/-,0,0
231028,8.5,0,0
231029,years,0,0
231030,),0,0
231031,underwent,0,0
231032,short-term,0,0
231033,tryptophan,0,0
231034,depletion,0,0
231035,in,0,0
231036,a,0,0
231037,double-blind,0,0
231038,",",0,0
231039,placebo-controlled,0,0
231040,",",0,0
231041,randomized,0,0
231042,crossover,0,0
231043,design,0,0
231044,.,0,0
231045,Patients,0,0
231046,received,0,0
231047,a,0,0
231048,24-hour,0,1
231049,",",0,0
231050,low-tryptophan,0,0
231051,diet,0,0
231052,followed,0,0
231053,the,0,0
231054,next,0,0
231055,morning,0,0
231056,by,0,0
231057,an,0,0
231058,amino,0,0
231059,acid,0,0
231060,drink,0,0
231061,.,0,0
231062,Behavioral,0,0
231063,ratings,0,1
231064,were,0,0
231065,obtained,0,0
231066,on,0,0
231067,the,0,0
231068,morning,0,0
231069,of,0,0
231070,the,0,0
231071,amino,0,0
231072,acid,0,1
231073,drink,0,0
231074,(,0,0
231075,baseline,0,0
231076,),0,0
231077,and,0,0
231078,180,0,0
231079,",",0,0
231080,300,0,0
231081,",",0,0
231082,and,0,0
231083,420,0,0
231084,minutes,0,0
231085,after,0,0
231086,the,0,0
231087,drink,0,0
231088,.,0,0
231089,Plasma,1,1
231090,free,1,1
231091,and,1,0
231092,total,1,1
231093,tryptophan,1,0
231094,levels,1,1
231095,were,0,0
231096,obtained,0,0
231097,at,0,0
231098,baseline,0,0
231099,and,0,0
231100,5,0,0
231101,hours,0,0
231102,after,0,0
231103,the,0,0
231104,drink,0,0
231105,.,0,0
231106,The,0,0
231107,active,0,0
231108,and,0,0
231109,sham,0,0
231110,testing,0,0
231111,sessions,0,0
231112,were,0,0
231113,separated,0,0
231114,by,0,0
231115,7,0,0
231116,days,0,0
231117,.,0,0
231118,RESULTS,0,0
231119,Eleven,0,0
231120,(,0,0
231121,65,0,0
231122,%,0,0
231123,),0,0
231124,of,0,0
231125,the,0,0
231126,17,0,0
231127,patients,0,0
231128,who,0,0
231129,completed,0,0
231130,both,0,0
231131,test,0,0
231132,days,0,0
231133,showed,0,0
231134,a,0,0
231135,significant,0,0
231136,global,0,1
231137,worsening,0,1
231138,of,0,0
231139,behavioral,0,1
231140,symptoms,0,1
231141,with,0,0
231142,short-term,0,0
231143,tryptophan,0,0
231144,depletion,0,1
231145,",",0,1
231146,but,0,0
231147,none,0,0
231148,of,0,0
231149,the,0,0
231150,17,0,0
231151,patients,0,0
231152,showed,0,0
231153,any,0,0
231154,significant,0,0
231155,change,0,0
231156,in,0,0
231157,clinical,0,0
231158,status,0,1
231159,from,0,0
231160,baseline,0,0
231161,after,0,0
231162,sham,0,0
231163,depletion,0,0
231164,(,0,0
231165,P,0,0
231166,=,0,0
231167,.001,0,0
231168,),0,0
231169,.,0,0
231170,Tryptophan,0,0
231171,depletion,0,0
231172,led,0,0
231173,to,0,0
231174,a,0,0
231175,significant,0,0
231176,increase,0,0
231177,in,0,0
231178,behaviors,0,1
231179,such,0,0
231180,as,0,0
231181,whirling,1,1
231182,",",1,0
231183,flapping,1,1
231184,",",1,1
231185,pacing,1,0
231186,",",1,1
231187,banging,1,1
231188,and,1,1
231189,hitting,1,1
231190,self,1,1
231191,",",1,0
231192,rocking,1,1
231193,",",1,1
231194,and,1,1
231195,toe,1,1
231196,walking,1,1
231197,(,0,0
231198,P,0,0
231199,<,0,0
231200,.05,0,0
231201,),0,0
231202,.,0,0
231203,In,0,0
231204,addition,0,0
231205,",",0,0
231206,patients,0,0
231207,were,0,0
231208,significantly,0,0
231209,less,0,0
231210,calm,1,1
231211,and,1,1
231212,happy,1,1
231213,and,1,0
231214,more,1,0
231215,anxious,1,1
231216,.,1,0
231217,No,0,0
231218,significant,0,0
231219,change,0,0
231220,was,0,0
231221,observed,0,0
231222,in,0,0
231223,social,1,1
231224,relatedness,1,1
231225,or,1,0
231226,repetitive,1,1
231227,thoughts,1,1
231228,and,1,0
231229,behavior,1,1
231230,.,1,0
231231,Plasma,1,1
231232,total,1,1
231233,and,1,0
231234,free,1,1
231235,tryptophan,1,0
231236,levels,1,1
231237,were,0,0
231238,reduced,0,0
231239,86,0,0
231240,%,0,0
231241,and,0,0
231242,69,0,0
231243,%,0,0
231244,",",0,0
231245,respectively,0,0
231246,",",0,0
231247,5,0,0
231248,hours,0,0
231249,after,0,0
231250,the,0,0
231251,tryptophan-deficient,0,0
231252,amino,0,0
231253,acid,0,0
231254,drink,0,0
231255,.,0,0
231256,Patients,0,0
231257,who,0,0
231258,had,0,0
231259,a,0,0
231260,significant,0,0
231261,global,0,1
231262,exacerbation,0,1
231263,of,0,0
231264,symptoms,0,1
231265,had,0,0
231266,significantly,0,0
231267,higher,0,0
231268,baseline,1,0
231269,plasma,1,1
231270,total,1,1
231271,tryptophan,1,0
231272,levels,1,1
231273,(,0,0
231274,P,0,0
231275,<,0,0
231276,.001,0,0
231277,),0,0
231278,and,0,0
231279,Autism,1,1
231280,Behavior,1,1
231281,Checklist,1,1
231282,scores,1,1
231283,(,0,0
231284,P,0,0
231285,=,0,0
231286,.005,0,0
231287,),0,0
231288,than,0,0
231289,did,0,0
231290,patients,0,0
231291,who,0,0
231292,showed,0,0
231293,no,0,0
231294,significant,0,0
231295,change,0,0
231296,in,0,0
231297,symptoms,0,1
231298,after,0,0
231299,tryptophan,0,0
231300,depletion,0,0
231301,.,0,0
231302,CONCLUSIONS,0,0
231303,The,0,0
231304,results,0,0
231305,of,0,0
231306,this,0,0
231307,study,0,0
231308,are,0,0
231309,consistent,0,0
231310,with,0,0
231311,previous,0,0
231312,research,0,0
231313,that,0,0
231314,has,0,0
231315,implicated,0,0
231316,a,0,0
231317,dysregulation,0,0
231318,in,0,0
231319,serotonin,0,0
231320,function,0,1
231321,in,0,0
231322,some,0,0
231323,patients,0,0
231324,with,0,0
231325,autism,0,0
231326,.,0,0
231327,These,0,0
231328,data,0,0
231329,suggest,0,0
231330,that,0,0
231331,the,0,0
231332,short-term,0,0
231333,reduction,0,1
231334,of,0,0
231335,serotonin,0,0
231336,precursor,0,0
231337,availability,0,0
231338,may,0,0
231339,exacerbate,0,0
231340,some,0,0
231341,symptoms,1,1
231342,characteristic,1,0
231343,of,1,0
231344,autism,1,0
231345,in,0,0
231346,some,0,0
231347,patients,0,0
231348,.,0,0
231349,Continued,0,0
231350,investigation,0,0
231351,into,0,0
231352,the,0,0
231353,role,0,0
231354,of,0,0
231355,serotonin,0,0
231356,in,0,0
231357,the,0,0
231358,pathogenesis,0,0
231359,and,0,0
231360,treatment,0,0
231361,of,0,1
231362,autistic,0,0
231363,disorder,0,0
231364,is,0,0
231365,warranted,0,0
231366,.,0,0
231367,A,0,0
231368,double-blind,0,0
231369,",",0,0
231370,placebo-controlled,0,0
231371,study,0,0
231372,of,0,0
231373,fluvoxamine,0,0
231374,in,0,0
231375,adults,0,0
231376,with,0,0
231377,autistic,0,0
231378,disorder,0,0
231379,.,0,0
231380,BACKGROUND,0,0
231381,Autistic,0,0
231382,disorder,0,0
231383,is,0,0
231384,characterized,0,0
231385,by,0,0
231386,a,0,0
231387,fundamental,0,0
231388,disturbance,0,1
231389,in,0,0
231390,social,0,1
231391,interaction,0,1
231392,",",0,0
231393,impairments,0,1
231394,in,0,0
231395,communication,0,1
231396,",",0,0
231397,and,0,0
231398,a,0,0
231399,markedly,0,0
231400,restricted,0,0
231401,repertoire,0,1
231402,of,0,0
231403,activities,0,1
231404,and,0,0
231405,interests,0,0
231406,.,0,0
231407,Abnormalities,0,0
231408,in,0,0
231409,the,0,0
231410,serotonin,0,0
231411,neurotransmitter,0,1
231412,system,0,0
231413,have,0,0
231414,been,0,0
231415,identified,0,0
231416,in,0,0
231417,some,0,0
231418,persons,0,0
231419,with,0,0
231420,autism,0,0
231421,.,0,0
231422,No,0,0
231423,consistently,0,0
231424,effective,0,0
231425,and,0,0
231426,safe,0,0
231427,drugs,0,0
231428,have,0,0
231429,been,0,0
231430,developed,0,0
231431,for,0,0
231432,treating,0,0
231433,the,0,0
231434,symptoms,0,1
231435,of,0,0
231436,autism,0,0
231437,.,0,0
231438,METHODS,0,0
231439,Thirty,0,0
231440,adults,0,0
231441,with,0,0
231442,autistic,0,0
231443,disorder,0,0
231444,completed,0,0
231445,a,0,0
231446,12-week,0,0
231447,double-blind,0,0
231448,",",0,0
231449,placebo-controlled,0,0
231450,trial,0,0
231451,of,0,0
231452,the,0,0
231453,potent,0,0
231454,and,0,0
231455,selective,0,1
231456,serotonin,0,1
231457,uptake,0,1
231458,inhibitor,0,0
231459,fluvoxamine,0,0
231460,maleate,0,0
231461,.,0,0
231462,Behavioral,1,0
231463,ratings,1,1
231464,were,0,0
231465,obtained,0,0
231466,at,0,0
231467,baseline,0,0
231468,and,0,0
231469,after,0,0
231470,4,0,0
231471,",",0,0
231472,8,0,0
231473,",",0,0
231474,and,0,0
231475,12,0,0
231476,weeks,0,0
231477,of,0,0
231478,treatment,0,0
231479,.,0,0
231480,RESULTS,0,0
231481,Eight,0,0
231482,(,0,0
231483,53,0,0
231484,%,0,0
231485,),0,0
231486,of,0,0
231487,15,0,0
231488,patients,0,0
231489,in,0,0
231490,the,0,0
231491,fluvoxamine-treated,0,0
231492,group,0,0
231493,were,0,0
231494,categorized,0,0
231495,as,0,0
231496,responders,0,0
231497,compared,0,0
231498,with,0,0
231499,none,0,0
231500,of,0,0
231501,15,0,0
231502,in,0,0
231503,the,0,0
231504,placebo,0,0
231505,group,0,0
231506,(,0,0
231507,P,0,0
231508,=,0,0
231509,.001,0,0
231510,),0,0
231511,.,0,0
231512,Fluvoxamine,0,0
231513,was,0,0
231514,superior,0,0
231515,to,0,0
231516,placebo,0,0
231517,in,0,0
231518,reducing,0,0
231519,repetitive,1,1
231520,thoughts,1,1
231521,and,1,1
231522,behavior,1,1
231523,(,0,0
231524,P,0,0
231525,<,0,0
231526,.001,0,0
231527,),0,0
231528,",",0,0
231529,maladaptive,1,1
231530,behavior,1,1
231531,(,0,0
231532,P,0,0
231533,<,0,0
231534,.001,0,0
231535,),0,0
231536,",",0,0
231537,and,0,1
231538,aggression,1,1
231539,(,0,0
231540,P,0,0
231541,<,0,0
231542,.03,0,0
231543,),0,0
231544,",",0,0
231545,and,0,0
231546,in,0,0
231547,improving,0,1
231548,some,0,0
231549,aspects,0,0
231550,of,0,0
231551,social,1,1
231552,relatedness,1,1
231553,(,0,0
231554,P,0,0
231555,<,0,0
231556,.04,0,0
231557,),0,0
231558,",",0,0
231559,especially,0,0
231560,language,1,1
231561,usage,1,0
231562,(,0,0
231563,P,0,0
231564,<,0,0
231565,.008,0,0
231566,),0,0
231567,.,0,0
231568,Treatment,0,0
231569,response,0,1
231570,was,0,0
231571,not,0,0
231572,correlated,0,0
231573,with,0,0
231574,age,0,0
231575,level,0,1
231576,of,0,0
231577,autistic,0,0
231578,behavior,0,1
231579,",",0,0
231580,or,0,0
231581,full-scale,0,0
231582,IQ,0,1
231583,.,0,0
231584,Other,0,0
231585,than,0,0
231586,mild,1,1
231587,sedation,1,1
231588,and,1,1
231589,nausea,1,1
231590,in,0,0
231591,a,0,0
231592,few,0,0
231593,patients,0,0
231594,",",0,0
231595,fluvoxamine,0,0
231596,was,0,0
231597,well,0,0
231598,tolerated,0,1
231599,.,0,0
231600,No,0,0
231601,dyskinesias,1,1
231602,",",1,0
231603,adverse,1,1
231604,cardiovascular,1,1
231605,events,1,1
231606,",",1,0
231607,or,1,0
231608,seizures,1,1
231609,occurred,0,0
231610,.,0,0
231611,CONCLUSIONS,0,0
231612,Fluvoxamine,0,0
231613,is,0,0
231614,more,0,0
231615,effective,0,1
231616,than,0,0
231617,placebo,0,0
231618,in,0,0
231619,the,0,0
231620,short-term,0,0
231621,treatment,0,0
231622,of,0,0
231623,the,0,0
231624,symptoms,0,1
231625,of,0,0
231626,autistic,0,0
231627,disorder,0,0
231628,in,0,0
231629,adults,0,0
231630,.,0,0
231631,Controlled,0,0
231632,studies,0,0
231633,of,0,0
231634,fluvoxamine,0,0
231635,and,0,0
231636,other,0,1
231637,potent,0,0
231638,and,0,0
231639,selective,0,1
231640,serotonin,0,0
231641,uptake,0,1
231642,inhibitors,0,0
231643,seem,0,0
231644,warranted,0,0
231645,in,0,0
231646,children,0,0
231647,and,0,0
231648,adolescents,0,0
231649,with,0,0
231650,autism,0,0
231651,.,0,0
231652,The,0,0
231653,immunogenicity,1,1
231654,of,0,0
231655,three,0,0
231656,Haemophilus,0,0
231657,influenzae,0,0
231658,type,0,0
231659,B,0,0
231660,conjugate,0,0
231661,vaccines,0,0
231662,after,0,0
231663,a,0,0
231664,primary,0,0
231665,vaccination,0,0
231666,series,0,0
231667,in,0,0
231668,Philippine,0,0
231669,infants,0,0
231670,.,0,0
231671,Serum,1,1
231672,antibody,1,0
231673,responses,1,1
231674,to,0,0
231675,three,0,0
231676,Haemophilus,0,0
231677,influenzae,0,0
231678,type,0,0
231679,b,0,0
231680,(,0,0
231681,Hib,0,1
231682,),0,0
231683,capsular,0,0
231684,polysaccharide-protein,0,0
231685,conjugate,0,0
231686,vaccine,0,0
231687,(,0,0
231688,PRP-OMP,0,1
231689,",",0,1
231690,PRP-T,0,1
231691,",",0,1
231692,and,0,1
231693,HbOC,0,1
231694,),0,1
231695,were,0,0
231696,evaluated,0,0
231697,in,0,0
231698,174,0,0
231699,Philippine,0,0
231700,infants,0,0
231701,after,0,0
231702,a,0,0
231703,primary,0,0
231704,vaccination,0,0
231705,series,0,0
231706,.,0,0
231707,Children,0,0
231708,were,0,0
231709,randomized,0,0
231710,to,0,0
231711,receive,0,0
231712,one,0,0
231713,of,0,0
231714,the,0,0
231715,Hib,0,0
231716,vaccines,0,0
231717,(,0,0
231718,Hib,0,1
231719,groups,0,0
231720,),0,0
231721,or,0,0
231722,into,0,0
231723,a,0,0
231724,control,0,0
231725,group,0,0
231726,.,0,0
231727,Vaccination,0,0
231728,was,0,0
231729,carried,0,0
231730,out,0,0
231731,at,0,0
231732,six,0,0
231733,",",0,0
231734,10,0,0
231735,and,0,0
231736,14,0,0
231737,weeks,0,0
231738,of,0,0
231739,age,0,0
231740,based,0,0
231741,on,0,0
231742,the,0,0
231743,local,0,0
231744,Expanded,0,0
231745,Program,0,0
231746,of,0,0
231747,Immunization,0,0
231748,schedule,0,0
231749,.,0,0
231750,Sera,0,0
231751,were,0,0
231752,collected,0,0
231753,at,0,0
231754,six,0,0
231755,weeks,0,0
231756,of,0,0
231757,age,0,0
231758,for,0,0
231759,the,0,0
231760,Hib,0,0
231761,groups,0,0
231762,and,0,0
231763,one,0,0
231764,month,0,0
231765,after,0,0
231766,the,0,0
231767,third,0,0
231768,dose,0,0
231769,for,0,0
231770,all,0,0
231771,subjects,0,0
231772,.,0,0
231773,Anti-Hib,1,0
231774,concentrations,1,1
231775,were,1,0
231776,determined,1,0
231777,by,1,0
231778,the,1,0
231779,Farr-type,1,0
231780,radioimmunoassay,1,0
231781,.,1,0
231782,There,0,0
231783,were,0,0
231784,no,0,0
231785,significant,0,0
231786,differences,0,0
231787,(,0,0
231788,P,0,0
231789,=,0,0
231790,0.3626,0,0
231791,),0,0
231792,in,0,0
231793,the,0,0
231794,prevaccination,1,0
231795,anti-Hib,1,0
231796,geometric,1,1
231797,mean,1,1
231798,concentration,1,1
231799,(,1,0
231800,GMC,1,1
231801,),1,0
231802,among,0,0
231803,the,0,0
231804,three,0,0
231805,Hib,0,0
231806,groups,0,0
231807,.,0,0
231808,Differences,0,0
231809,in,0,0
231810,the,0,0
231811,GMC,1,0
231812,after,0,0
231813,the,0,0
231814,primary,0,0
231815,series,0,0
231816,of,0,0
231817,three,0,0
231818,doses,0,0
231819,were,0,0
231820,significant,0,0
231821,(,0,0
231822,P,0,0
231823,<,0,0
231824,0.0001,0,0
231825,),0,0
231826,;,0,0
231827,GMC,1,0
231828,was,0,0
231829,highest,0,0
231830,for,0,0
231831,PRP-T,0,0
231832,(,0,0
231833,6.62,0,0
231834,micrograms/ml,0,0
231835,),0,0
231836,",",0,0
231837,followed,0,0
231838,by,0,0
231839,HbOC,0,0
231840,(,0,0
231841,1.9,0,0
231842,micrograms/ml,0,0
231843,),0,0
231844,",",0,0
231845,then,0,0
231846,PRP-OMP,0,0
231847,(,0,0
231848,1.06,0,0
231849,micrograms/ml,0,0
231850,),0,0
231851,",",0,0
231852,and,0,0
231853,lowest,0,0
231854,for,0,0
231855,the,0,0
231856,control,0,0
231857,group,0,0
231858,(,0,0
231859,0.11,0,0
231860,microgram/ml,0,0
231861,),0,0
231862,.,0,0
231863,We,0,0
231864,conclude,0,0
231865,that,0,0
231866,all,0,0
231867,three,0,0
231868,Hib,0,0
231869,conjugate,0,0
231870,vaccines,0,0
231871,(,0,0
231872,PRP-T,0,0
231873,",",0,1
231874,HbOC,0,1
231875,",",0,1
231876,and,0,1
231877,PRP-OMP,0,1
231878,),0,1
231879,were,0,0
231880,immunogenic,1,0
231881,after,0,0
231882,three,0,0
231883,primary,0,0
231884,doses,0,0
231885,among,0,0
231886,Philippine,0,0
231887,infants,0,0
231888,.,0,0
231889,Thoracoscopic,0,0
231890,talc,0,0
231891,insufflation,0,0
231892,versus,0,0
231893,talc,0,0
231894,slurry,0,0
231895,for,0,0
231896,symptomatic,0,0
231897,malignant,0,0
231898,pleural,0,1
231899,effusion,0,1
231900,.,0,0
231901,BACKGROUND,0,0
231902,Talc,0,0
231903,has,0,0
231904,been,0,0
231905,generally,0,0
231906,accepted,0,0
231907,to,0,0
231908,be,0,0
231909,the,0,0
231910,most,0,0
231911,effective,0,0
231912,sclerosant,0,0
231913,for,0,0
231914,chemical,0,1
231915,pleurodesis,0,0
231916,",",0,0
231917,although,0,0
231918,the,0,0
231919,optimal,0,0
231920,route,0,0
231921,of,0,0
231922,administration,0,0
231923,remains,0,0
231924,unclear,0,0
231925,.,0,0
231926,METHODS,0,0
231927,We,0,0
231928,designed,0,0
231929,a,0,0
231930,prospective,0,0
231931,",",0,0
231932,randomized,0,0
231933,study,0,0
231934,to,0,0
231935,compare,0,0
231936,video-assisted,0,0
231937,thoracoscopic,0,0
231938,talc,0,0
231939,insufflation,0,0
231940,with,0,0
231941,bedside,0,0
231942,talc,0,0
231943,slurry,0,0
231944,in,0,0
231945,the,0,0
231946,treatment,0,0
231947,of,0,0
231948,malignant,0,0
231949,pleural,0,1
231950,effusion,0,1
231951,.,0,0
231952,From,0,0
231953,September,0,0
231954,1993,0,0
231955,to,0,0
231956,November,0,0
231957,1995,0,0
231958,",",0,0
231959,57,0,0
231960,patients,0,0
231961,were,0,0
231962,recruited,0,0
231963,and,0,0
231964,randomized,0,0
231965,to,0,0
231966,either,0,0
231967,video-assisted,0,0
231968,thoracoscopic,0,0
231969,talc,0,0
231970,insufflation,0,0
231971,under,0,0
231972,general,0,0
231973,anesthesia,0,0
231974,(,0,0
231975,n,0,0
231976,=,0,0
231977,28,0,0
231978,),0,0
231979,or,0,0
231980,talc,0,0
231981,slurry,0,0
231982,by,0,0
231983,the,0,0
231984,bedside,0,0
231985,(,0,0
231986,n,0,0
231987,=,0,0
231988,29,0,0
231989,),0,0
231990,.,0,0
231991,Patients,0,0
231992,with,0,0
231993,poor,0,1
231994,general,0,0
231995,condition,0,0
231996,(,0,0
231997,Karnofsky,0,0
231998,score,0,1
231999,less,0,0
232000,than,0,0
232001,30,0,0
232002,%,0,0
232003,),0,0
232004,",",0,0
232005,poor,0,1
232006,pulmonary,0,1
232007,function,0,1
232008,(,0,0
232009,forced,0,1
232010,expiratory,0,1
232011,volume,0,1
232012,in,0,0
232013,1,0,0
232014,second,0,0
232015,less,0,0
232016,than,0,0
232017,0.5,0,0
232018,L,0,0
232019,),0,0
232020,",",0,0
232021,or,0,0
232022,trapped,0,1
232023,lungs,0,1
232024,were,0,0
232025,excluded,0,0
232026,from,0,0
232027,this,0,0
232028,study,0,0
232029,.,0,0
232030,Five,0,0
232031,grams,0,0
232032,of,0,0
232033,purified,0,0
232034,talc,0,0
232035,was,0,0
232036,used,0,0
232037,for,0,0
232038,either,0,0
232039,video-assisted,0,0
232040,thoracoscopic,0,0
232041,talc,0,0
232042,insufflation,0,0
232043,or,0,1
232044,talc,0,0
232045,slurry,0,0
232046,.,0,0
232047,RESULTS,0,0
232048,There,0,0
232049,was,0,0
232050,no,0,0
232051,statistically,0,0
232052,significant,1,0
232053,difference,1,0
232054,between,1,0
232055,the,1,0
232056,two,1,0
232057,groups,1,0
232058,of,1,0
232059,patients,1,0
232060,with,1,0
232061,respect,1,0
232062,to,1,0
232063,age,1,0
232064,",",1,0
232065,sex,1,1
232066,ratio,1,1
232067,",",1,0
232068,chest,1,1
232069,drainage,1,1
232070,duration,1,1
232071,",",1,0
232072,postprocedural,1,1
232073,hospital,1,1
232074,stay,1,1
232075,",",1,0
232076,parenteral,1,0
232077,narcotics,1,1
232078,requirement,1,1
232079,",",1,0
232080,complications,1,1
232081,",",1,1
232082,or,1,1
232083,procedure,1,0
232084,failure,1,1
232085,(,1,0
232086,ie,1,0
232087,",",1,1
232088,recurrence,1,1
232089,),1,0
232090,.,1,0
232091,CONCLUSIONS,0,0
232092,Video-assisted,0,0
232093,thoracoscopic,0,0
232094,talc,0,0
232095,insufflation,0,0
232096,has,0,0
232097,not,0,0
232098,been,0,0
232099,shown,0,0
232100,to,0,0
232101,be,0,0
232102,a,0,0
232103,superior,0,0
232104,approach,0,0
232105,compared,0,0
232106,with,0,0
232107,talc,0,0
232108,slurry,0,0
232109,in,0,0
232110,our,0,0
232111,study,0,0
232112,.,0,0
232113,Because,0,0
232114,the,0,0
232115,former,0,0
232116,demands,0,0
232117,more,0,0
232118,resources,0,0
232119,",",0,0
232120,we,0,0
232121,advocate,0,0
232122,that,0,0
232123,talc,0,0
232124,slurry,0,0
232125,should,0,0
232126,be,0,0
232127,considered,0,0
232128,as,0,0
232129,the,0,0
232130,procedure,0,0
232131,of,0,0
232132,choice,0,0
232133,in,0,0
232134,the,0,0
232135,treatment,0,0
232136,of,0,0
232137,symptomatic,0,0
232138,malignant,0,0
232139,pleural,0,1
232140,effusion,0,1
232141,in,0,0
232142,patients,0,0
232143,who,0,0
232144,do,0,0
232145,not,0,0
232146,have,0,0
232147,trapped,0,0
232148,lungs,0,0
232149,.,0,0
232150,A,0,0
232151,randomised,0,0
232152,open,0,0
232153,multicentre,0,0
232154,comparative,0,0
232155,trial,0,0
232156,of,0,0
232157,lamotrigine,0,0
232158,and,0,1
232159,carbamazepine,0,0
232160,as,0,0
232161,monotherapy,0,0
232162,in,0,0
232163,patients,0,0
232164,with,0,0
232165,newly,0,0
232166,diagnosed,0,0
232167,or,0,0
232168,recurrent,0,0
232169,epilepsy,0,0
232170,.,0,0
232171,The,0,0
232172,efficacy,1,1
232173,and,1,0
232174,safety,1,1
232175,of,0,1
232176,lamotrigine,0,0
232177,and,0,1
232178,carbamazepine,0,0
232179,as,0,0
232180,monotherapy,0,0
232181,in,0,0
232182,patients,0,0
232183,with,0,0
232184,untreated,0,0
232185,",",0,0
232186,newly,0,0
232187,diagnosed,0,0
232188,or,0,0
232189,recurrent,0,1
232190,partial,0,1
232191,and/or,0,0
232192,generalised,0,1
232193,tonic-clonic,0,1
232194,seizures,0,1
232195,",",0,0
232196,were,0,0
232197,compared,0,0
232198,in,0,0
232199,a,0,0
232200,randomised,0,0
232201,",",0,0
232202,open,0,0
232203,",",0,0
232204,multicentre,0,0
232205,study,0,0
232206,.,0,0
232207,Patients,0,0
232208,received,0,0
232209,24,0,0
232210,weeks,0,0
232211,',0,0
232212,treatment,0,0
232213,with,0,0
232214,oral,0,0
232215,lamotrigine,0,0
232216,100,0,0
232217,mg,0,0
232218,(,0,0
232219,LTG,0,1
232220,100,0,0
232221,",",0,0
232222,n,0,0
232223,=,0,0
232224,115,0,0
232225,),0,0
232226,or,0,0
232227,200,0,0
232228,mg,0,0
232229,(,0,0
232230,LTG,0,1
232231,200,0,0
232232,",",0,0
232233,n,0,0
232234,=,0,0
232235,111,0,0
232236,),0,0
232237,or,0,0
232238,carbamazepine,0,0
232239,600,0,0
232240,mg,0,0
232241,(,0,0
232242,CBZ,0,0
232243,600,0,0
232244,",",0,0
232245,n,0,0
232246,=,0,0
232247,117,0,0
232248,),0,0
232249,.,0,0
232250,Efficacy,1,1
232251,measurements,1,0
232252,were,0,0
232253,comparable,0,0
232254,between,0,0
232255,the,0,0
232256,three,0,0
232257,treatment,0,0
232258,groups,0,0
232259,",",0,0
232260,although,0,0
232261,the,0,0
232262,higher,0,0
232263,lamotrigine,0,0
232264,dose,0,0
232265,was,0,0
232266,possibly,0,0
232267,most,0,0
232268,effective,0,0
232269,",",0,0
232270,with,0,0
232271,60.4,0,0
232272,%,0,0
232273,completing,0,0
232274,seizure,0,1
232275,free,0,1
232276,compared,0,0
232277,with,0,0
232278,51.3,0,0
232279,%,0,0
232280,(,0,0
232281,LTG,0,1
232282,100,0,0
232283,),0,0
232284,and,0,0
232285,54.7,0,0
232286,%,0,0
232287,(,0,0
232288,CBZ,0,0
232289,600,0,0
232290,),0,0
232291,.,0,0
232292,Both,0,0
232293,dosage,0,0
232294,regimens,0,0
232295,of,0,0
232296,lamotrigine,0,0
232297,were,0,0
232298,well,0,0
232299,tolerated,1,1
232300,.,1,0
232301,More,0,0
232302,patients,0,0
232303,on,0,0
232304,CBZ,0,0
232305,600,0,0
232306,reported,0,0
232307,adverse,1,1
232308,experiences,1,0
232309,",",0,0
232310,66,0,0
232311,%,0,0
232312,versus,0,0
232313,53,0,0
232314,%,0,0
232315,(,0,0
232316,LTG,0,1
232317,100,0,0
232318,),0,0
232319,and,0,0
232320,58,0,0
232321,%,0,0
232322,(,0,0
232323,LTG,0,1
232324,200,0,0
232325,),0,0
232326,",",0,0
232327,and,0,0
232328,of,0,0
232329,these,0,0
232330,a,0,0
232331,greater,0,0
232332,proportion,0,1
232333,were,0,0
232334,attributed,0,0
232335,to,0,0
232336,CBZ,0,0
232337,600,0,0
232338,treatment,0,0
232339,",",0,0
232340,53,0,0
232341,%,0,0
232342,versus,0,0
232343,23,0,0
232344,%,0,0
232345,(,0,0
232346,LTG,0,1
232347,100,0,0
232348,),0,0
232349,and,0,0
232350,28,0,0
232351,%,0,0
232352,(,0,0
232353,LTG,0,1
232354,200,0,0
232355,),0,0
232356,.,0,0
232357,Similarly,0,0
232358,",",0,0
232359,a,0,0
232360,greater,0,0
232361,proportion,0,0
232362,of,0,0
232363,the,0,0
232364,CBZ,0,0
232365,600,0,0
232366,group,0,0
232367,required,0,0
232368,a,0,0
232369,change,0,0
232370,in,0,0
232371,dose,0,0
232372,",",0,0
232373,47,0,0
232374,%,0,0
232375,versus,0,0
232376,20,0,0
232377,%,0,0
232378,(,0,0
232379,LTG,0,1
232380,100,0,0
232381,),0,0
232382,and,0,0
232383,17,0,0
232384,%,0,0
232385,(,0,0
232386,LTG,0,1
232387,200,0,0
232388,),0,0
232389,or,0,0
232390,withdrew,0,0
232391,completely,0,0
232392,due,0,0
232393,to,0,0
232394,adverse,1,1
232395,experiences,1,0
232396,",",0,0
232397,10.3,0,0
232398,%,0,0
232399,versus,0,0
232400,4.3,0,0
232401,%,0,0
232402,(,0,0
232403,LTG,0,1
232404,100,0,0
232405,),0,0
232406,and,0,0
232407,4.5,0,0
232408,%,0,0
232409,(,0,0
232410,LTG,0,1
232411,200,0,0
232412,),0,0
232413,.,0,0
232414,The,0,0
232415,most,0,0
232416,common,0,0
232417,adverse,1,1
232418,experience,1,0
232419,leading,0,0
232420,to,0,0
232421,withdrawal,0,0
232422,was,0,0
232423,rash,1,1
232424,",",0,0
232425,with,0,0
232426,approximately,0,0
232427,double,0,0
232428,the,0,0
232429,proportion,0,0
232430,of,0,0
232431,reports,0,0
232432,occurring,0,0
232433,in,0,0
232434,patients,0,0
232435,on,0,0
232436,CBZ,0,0
232437,600,0,0
232438,(,0,0
232439,5.1,0,0
232440,%,0,0
232441,),0,0
232442,compared,0,0
232443,with,0,0
232444,lamotrigine,0,0
232445,(,0,0
232446,1.7,0,0
232447,%,0,0
232448,on,0,0
232449,LTG,0,1
232450,100,0,0
232451,and,0,0
232452,2.7,0,0
232453,%,0,0
232454,on,0,0
232455,LTG,0,1
232456,200,0,0
232457,),0,0
232458,.,0,0
232459,Overall,0,1
232460,lamotrigine,0,0
232461,appeared,0,0
232462,equally,0,0
232463,effective,0,0
232464,but,0,0
232465,better,0,0
232466,tolerated,0,1
232467,compared,0,0
232468,with,0,0
232469,carbamazepine,0,0
232470,.,0,0
232471,Effects,0,0
232472,of,0,0
232473,fenoterol,0,0
232474,on,0,0
232475,inspiratory,0,1
232476,effort,0,1
232477,sensation,0,1
232478,and,0,1
232479,fatigue,0,1
232480,during,0,0
232481,inspiratory,0,1
232482,threshold,0,1
232483,loading,0,0
232484,.,0,0
232485,We,0,0
232486,studied,0,0
232487,the,0,0
232488,effects,0,0
232489,of,0,0
232490,a,0,0
232491,single,0,0
232492,dose,0,0
232493,of,0,0
232494,fenoterol,0,0
232495,on,0,0
232496,the,0,0
232497,relationship,0,0
232498,between,0,0
232499,inspiratory,0,1
232500,effort,0,1
232501,sensation,0,1
232502,(,0,0
232503,IES,0,0
232504,),0,0
232505,and,0,0
232506,inspiratory,0,1
232507,muscle,0,1
232508,fatigue,0,1
232509,induced,0,0
232510,by,0,0
232511,inspiratory,0,1
232512,threshold,0,1
232513,loading,0,1
232514,in,0,0
232515,healthy,0,0
232516,subjects,0,0
232517,.,0,0
232518,The,0,0
232519,magnitude,0,1
232520,of,0,0
232521,the,0,0
232522,threshold,0,1
232523,was,0,0
232524,60,0,0
232525,%,0,0
232526,of,0,0
232527,maximal,0,1
232528,static,0,1
232529,inspiratory,0,1
232530,mouth,0,1
232531,pressure,0,1
232532,(,0,0
232533,PI,0,0
232534,",",0,1
232535,mmax,0,1
232536,),0,0
232537,at,0,0
232538,functional,0,0
232539,residual,0,1
232540,capacity,0,1
232541,",",0,0
232542,and,0,0
232543,the,0,0
232544,duty,0,0
232545,cycle,0,1
232546,was,0,0
232547,0.5,0,0
232548,.,0,0
232549,Subjects,0,0
232550,continued,0,0
232551,the,0,0
232552,threshold,0,1
232553,loaded,0,0
232554,breathing,0,0
232555,until,0,0
232556,the,0,0
232557,target,0,0
232558,mouth,0,0
232559,pressure,0,1
232560,could,0,0
232561,no,0,0
232562,longer,0,0
232563,be,0,0
232564,maintained,0,0
232565,(,0,0
232566,endurance,0,1
232567,time,0,1
232568,),0,0
232569,.,0,0
232570,The,0,0
232571,intensity,0,0
232572,of,0,0
232573,the,0,0
232574,IES,0,0
232575,was,0,0
232576,scored,0,0
232577,with,0,0
232578,a,0,0
232579,modified,0,0
232580,Borg,0,0
232581,scale,0,1
232582,.,0,0
232583,Either,0,0
232584,fenoterol,0,0
232585,(,0,0
232586,5,0,0
232587,mg,0,0
232588,),0,0
232589,or,0,0
232590,a,0,0
232591,placebo,0,0
232592,was,0,0
232593,given,0,0
232594,orally,0,0
232595,2,0,0
232596,h,0,0
232597,before,0,0
232598,loading,0,0
232599,in,0,0
232600,a,0,0
232601,randomized,0,0
232602,double-blind,0,0
232603,crossover,0,0
232604,protocol,0,0
232605,.,0,0
232606,The,0,0
232607,endurance,1,1
232608,time,1,1
232609,with,0,0
232610,fenoterol,0,0
232611,(,0,0
232612,34.4,0,0
232613,+/-,0,0
232614,8.6,0,0
232615,min,0,0
232616,),0,0
232617,was,0,0
232618,longer,0,0
232619,than,0,0
232620,that,0,0
232621,with,0,0
232622,the,0,0
232623,placebo,0,0
232624,(,0,0
232625,22.2,0,0
232626,+/-,0,0
232627,7.1,0,0
232628,min,0,0
232629,;,0,0
232630,P,0,0
232631,<,0,0
232632,0.05,0,0
232633,),0,0
232634,.,0,0
232635,The,0,0
232636,ratio,1,1
232637,of,1,0
232638,high-,1,0
232639,to,1,0
232640,low-frequency,1,0
232641,power,1,0
232642,of,1,0
232643,the,1,0
232644,diaphragmatic,1,0
232645,electromyogram,1,0
232646,(,1,0
232647,EMGdi,1,1
232648,),1,0
232649,decreased,0,0
232650,during,0,0
232651,loading,0,0
232652,;,0,0
232653,the,0,0
232654,decrease,0,0
232655,was,0,0
232656,less,0,0
232657,with,0,0
232658,fenoterol,0,0
232659,(,0,0
232660,P,0,0
232661,<,0,0
232662,0.05,0,0
232663,),0,0
232664,.,0,0
232665,The,0,0
232666,EMGdi,1,0
232667,also,0,0
232668,decreased,0,0
232669,with,0,0
232670,loading,0,0
232671,;,0,0
232672,the,0,0
232673,decrease,0,0
232674,was,0,0
232675,greater,0,0
232676,on,0,0
232677,fenoterol,0,1
232678,treatment,0,0
232679,(,0,0
232680,P,0,0
232681,<,0,0
232682,0.01,0,0
232683,),0,0
232684,.,0,0
232685,The,0,0
232686,PI,1,0
232687,",",1,0
232688,mmax,1,1
232689,and,1,1
232690,maximal,1,1
232691,transdiaphragmatic,1,1
232692,pressure,1,1
232693,(,1,0
232694,Pdi,1,1
232695,),1,0
232696,were,0,0
232697,similarly,0,0
232698,decreased,0,0
232699,after,0,0
232700,loading,0,0
232701,on,0,0
232702,either,0,0
232703,treatment,0,0
232704,.,0,0
232705,The,0,0
232706,intensity,1,0
232707,of,1,0
232708,the,1,0
232709,IES,1,0
232710,rose,1,0
232711,with,1,0
232712,time,1,1
232713,during,0,0
232714,loading,0,0
232715,in,0,0
232716,both,0,0
232717,groups,0,0
232718,but,0,0
232719,was,0,0
232720,lower,0,0
232721,with,0,0
232722,fenoterol,0,0
232723,than,0,0
232724,with,0,0
232725,the,0,0
232726,placebo,0,0
232727,(,0,0
232728,P,0,0
232729,<,0,0
232730,0.05,0,0
232731,),0,0
232732,.,0,0
232733,The,0,0
232734,ratio,1,1
232735,of,1,0
232736,Pdi,1,1
232737,to,0,0
232738,integrated,0,0
232739,activity,0,1
232740,of,0,0
232741,the,0,0
232742,EMGdi,0,0
232743,increased,0,0
232744,with,0,0
232745,fenoterol,0,0
232746,(,0,0
232747,P,0,0
232748,<,0,0
232749,0.05,0,0
232750,),0,0
232751,.,0,0
232752,Fenoterol,0,0
232753,treatment,0,0
232754,increased,0,0
232755,both,0,0
232756,superimposed,1,0
232757,Pdi,1,1
232758,twitch,1,1
232759,and,1,1
232760,Pdi,1,1
232761,twitch,1,1
232762,of,1,0
232763,relaxed,1,0
232764,diaphragm,1,0
232765,and,0,0
232766,decreased,0,0
232767,the,0,0
232768,value,1,0
232769,of,1,0
232770,(,1,0
232771,1-superimposed,1,0
232772,Pdi,1,1
232773,twitch/Pdi,1,0
232774,twitch,1,1
232775,of,1,0
232776,relaxed,1,0
232777,diaphragm,1,0
232778,),1,0
232779,.,1,0
232780,Thus,0,0
232781,we,0,0
232782,conclude,0,0
232783,that,0,0
232784,in,0,0
232785,normal,0,0
232786,subjects,0,0
232787,fenoterol,0,0
232788,reduces,0,0
232789,diaphragmatic,0,0
232790,fatigue,0,1
232791,and,0,0
232792,decreases,0,0
232793,the,0,0
232794,motor,0,1
232795,command,0,0
232796,to,0,0
232797,the,0,0
232798,diaphragm,0,0
232799,",",0,0
232800,resulting,0,0
232801,in,0,0
232802,a,0,0
232803,decrease,0,0
232804,in,0,0
232805,IES,0,0
232806,during,0,0
232807,inspiratory,0,1
232808,threshold,0,1
232809,loading,0,0
232810,and,0,0
232811,a,0,0
232812,prolongation,0,1
232813,of,0,0
232814,endurance,0,0
232815,.,0,0
232816,Improving,0,1
232817,care,0,0
232818,givers,0,1
232819,',0,0
232820,satisfaction,0,1
232821,with,0,0
232822,information,0,0
232823,received,0,0
232824,during,0,0
232825,hospitalization,0,1
232826,.,0,0
232827,As,0,0
232828,competition,0,0
232829,for,0,0
232830,patient,0,0
232831,volume,0,1
232832,escalates,0,0
232833,among,0,0
232834,hospital,0,1
232835,providers,0,0
232836,",",0,0
232837,administrators,0,0
232838,must,0,0
232839,identify,0,0
232840,ways,0,0
232841,to,0,0
232842,attract,0,0
232843,new,0,0
232844,patients,0,0
232845,and,0,1
232846,maintain,0,0
232847,or,0,0
232848,increase,0,1
232849,patient,0,1
232850,volume,0,1
232851,.,0,0
232852,Family,0,0
232853,care,0,0
232854,givers,0,0
232855,are,0,0
232856,known,0,0
232857,to,0,0
232858,greatly,0,0
232859,influence,0,0
232860,individuals,0,0
232861,',0,0
232862,choices,0,0
232863,in,0,0
232864,these,0,0
232865,matters,0,0
232866,of,0,0
232867,selection,0,0
232868,of,0,0
232869,healthcare,0,1
232870,services,0,1
232871,and,0,0
232872,providers,0,0
232873,.,0,0
232874,The,0,0
232875,results,0,0
232876,of,0,0
232877,a,0,0
232878,successful,0,0
232879,nurse-initiated,0,0
232880,daily,0,0
232881,phone,0,0
232882,calls,0,1
232883,program,0,0
232884,",",0,0
232885,designed,0,0
232886,to,0,0
232887,improve,0,0
232888,family,0,0
232889,care,0,0
232890,giver,0,1
232891,satisfaction,0,1
232892,by,0,0
232893,enhancing,0,0
232894,the,0,0
232895,provision,0,0
232896,of,0,0
232897,patient-specific,0,1
232898,information,0,0
232899,",",0,0
232900,are,0,0
232901,presented,0,0
232902,.,0,0
232903,The,0,0
232904,components,1,0
232905,of,1,0
232906,the,1,0
232907,program,1,0
232908,",",1,0
232909,associated,1,0
232910,costs,1,1
232911,",",1,0
232912,and,1,1
232913,implications,1,0
232914,on,1,0
232915,delivery,1,0
232916,of,1,0
232917,care,1,0
232918,are,0,0
232919,discussed,0,0
232920,.,0,0
232921,Outcome,1,1
232922,assessment,1,0
232923,for,0,0
232924,clinical,0,0
232925,trials,0,0
232926,:,0,0
232927,how,0,0
232928,many,0,0
232929,adjudicators,0,0
232930,do,0,0
232931,we,0,0
232932,need,0,0
232933,?,0,0
232934,Canadian,0,0
232935,Lung,0,0
232936,Oncology,0,0
232937,Group,0,0
232938,.,0,0
232939,Considerable,0,0
232940,effort,0,0
232941,is,0,0
232942,often,0,0
232943,expended,0,0
232944,to,0,0
232945,adjudicate,0,0
232946,outcomes,0,0
232947,in,0,0
232948,clinical,0,0
232949,trials,0,0
232950,",",0,0
232951,but,0,0
232952,little,0,0
232953,has,0,0
232954,been,0,0
232955,written,0,0
232956,on,0,0
232957,the,0,0
232958,administration,0,0
232959,of,0,0
232960,the,0,0
232961,adjudication,0,1
232962,process,0,0
232963,and,0,0
232964,its,0,0
232965,possible,0,0
232966,impact,0,0
232967,on,0,0
232968,study,0,0
232969,results,0,0
232970,.,0,0
232971,As,0,0
232972,a,0,0
232973,case,0,0
232974,study,0,0
232975,",",0,0
232976,we,0,0
232977,describe,0,0
232978,the,0,0
232979,function,1,1
232980,and,1,0
232981,performance,1,1
232982,of,1,0
232983,an,1,0
232984,adjudication,1,1
232985,committee,1,0
232986,in,0,0
232987,a,0,0
232988,large,0,0
232989,randomized,0,0
232990,trial,0,0
232991,of,0,0
232992,two,0,0
232993,diagnostic,0,0
232994,approaches,0,0
232995,to,0,0
232996,potentially,0,0
232997,operable,0,0
232998,lung,0,0
232999,cancer,0,0
233000,.,0,0
233001,Up,0,0
233002,to,0,0
233003,five,0,0
233004,independent,0,0
233005,adjudicators,0,0
233006,independently,0,0
233007,determined,0,0
233008,two,0,0
233009,primary,0,0
233010,outcomes,0,0
233011,:,0,0
233012,tumor,1,1
233013,status,1,1
233014,at,1,0
233015,death,1,1
233016,or,1,0
233017,at,1,0
233018,final,1,1
233019,follow-up,1,0
233020,and,1,0
233021,the,1,0
233022,cause,1,0
233023,of,1,0
233024,death,1,1
233025,.,1,0
233026,Patients,0,0
233027,for,0,0
233028,whom,0,0
233029,there,0,0
233030,was,0,0
233031,any,0,0
233032,disagreement,0,0
233033,were,0,0
233034,discussed,0,0
233035,in,0,0
233036,committee,0,0
233037,until,0,0
233038,a,0,0
233039,consensus,0,0
233040,was,0,0
233041,achieved,0,0
233042,.,0,0
233043,We,0,0
233044,describe,0,0
233045,the,0,0
233046,pattern,0,0
233047,of,0,0
233048,agreement,0,0
233049,among,0,0
233050,the,0,0
233051,adjudicators,0,1
233052,and,0,0
233053,with,0,0
233054,the,0,0
233055,final,0,1
233056,consensus,0,0
233057,result,0,0
233058,.,0,0
233059,Additionally,0,0
233060,",",0,0
233061,we,0,0
233062,model,0,0
233063,the,0,0
233064,adjudication,0,1
233065,process,0,0
233066,and,0,0
233067,predict,0,0
233068,the,0,0
233069,results,0,0
233070,if,0,0
233071,a,0,0
233072,smaller,0,0
233073,committee,0,0
233074,had,0,0
233075,been,0,0
233076,used,0,0
233077,.,0,0
233078,We,0,0
233079,found,0,0
233080,that,0,0
233081,reducing,0,0
233082,the,0,0
233083,number,1,1
233084,of,1,0
233085,adjudicators,1,1
233086,from,0,0
233087,five,0,0
233088,to,0,0
233089,two,0,0
233090,or,0,0
233091,three,0,0
233092,would,0,0
233093,probably,0,0
233094,have,0,0
233095,changed,0,0
233096,the,0,0
233097,consensus,0,0
233098,outcome,0,1
233099,in,0,0
233100,less,0,0
233101,than,0,0
233102,10,0,0
233103,%,0,0
233104,of,0,0
233105,cases,0,0
233106,.,0,0
233107,Correspondingly,0,0
233108,",",0,0
233109,the,0,0
233110,effect,0,0
233111,on,0,0
233112,the,0,0
233113,final,0,1
233114,study,0,0
233115,results,0,0
233116,(,0,0
233117,comparing,0,0
233118,primary,0,0
233119,outcomes,0,0
233120,in,0,0
233121,both,0,0
233122,randomized,0,0
233123,arms,0,0
233124,),0,0
233125,would,0,0
233126,have,0,0
233127,been,0,0
233128,altered,0,0
233129,very,0,0
233130,little,0,0
233131,.,0,0
233132,Even,0,0
233133,using,0,0
233134,a,0,0
233135,single,0,0
233136,adjudicator,0,1
233137,would,0,0
233138,not,0,0
233139,have,0,0
233140,affected,0,0
233141,the,0,0
233142,results,0,0
233143,substantially,0,0
233144,.,0,0
233145,About,0,0
233146,90,0,0
233147,minutes,0,0
233148,of,0,0
233149,person-time,0,0
233150,per,0,0
233151,patient,0,0
233152,was,0,0
233153,required,0,0
233154,for,0,0
233155,activities,0,1
233156,directly,0,0
233157,related,0,0
233158,to,0,0
233159,the,0,0
233160,adjudication,0,1
233161,process,0,0
233162,",",0,0
233163,or,0,0
233164,approximately,0,0
233165,6,0,0
233166,months,0,0
233167,of,0,0
233168,full,0,0
233169,time,0,1
233170,work,0,0
233171,for,0,0
233172,the,0,0
233173,entire,0,0
233174,study,0,0
233175,.,0,0
233176,This,0,0
233177,level,0,1
233178,of,0,0
233179,effort,0,0
233180,could,0,0
233181,be,0,0
233182,substantially,0,0
233183,reduced,0,0
233184,by,0,0
233185,using,0,0
233186,fewer,0,0
233187,adjudicators,0,1
233188,with,0,0
233189,little,0,0
233190,impact,0,0
233191,on,0,0
233192,the,0,0
233193,results,0,0
233194,.,0,0
233195,Thus,0,0
233196,",",0,0
233197,we,0,0
233198,suggest,0,0
233199,that,0,0
233200,when,0,0
233201,high,0,0
233202,observer,0,0
233203,agreement,0,0
233204,is,0,0
233205,demonstrated,0,0
233206,or,0,0
233207,anticipated,0,0
233208,",",0,0
233209,adjudication,0,1
233210,committees,0,0
233211,should,0,0
233212,consist,0,0
233213,of,0,0
233214,no,0,0
233215,more,0,0
233216,than,0,0
233217,three,0,0
233218,members,0,0
233219,.,0,0
233220,Further,0,0
233221,work,0,0
233222,is,0,0
233223,needed,0,0
233224,to,0,0
233225,evaluate,0,0
233226,if,0,0
233227,smaller,0,0
233228,committees,0,0
233229,are,0,0
233230,adequate,0,0
233231,to,0,0
233232,detect,0,0
233233,small,0,0
233234,but,0,0
233235,important,0,0
233236,treatment,0,0
233237,effects,0,1
233238,or,0,0
233239,if,0,0
233240,they,0,0
233241,compromise,0,0
233242,validity,0,0
233243,when,0,0
233244,the,0,0
233245,level,0,1
233246,of,0,0
233247,adjudicator,0,1
233248,agreement,0,0
233249,is,0,0
233250,lower,0,0
233251,.,0,0
233252,Randomised,0,0
233253,trial,0,0
233254,of,0,0
233255,effect,0,0
233256,of,0,0
233257,amiodarone,0,0
233258,on,0,0
233259,mortality,1,1
233260,in,0,0
233261,patients,0,0
233262,with,0,0
233263,left-ventricular,0,1
233264,dysfunction,0,1
233265,after,0,0
233266,recent,0,0
233267,myocardial,0,1
233268,infarction,0,0
233269,:,0,0
233270,EMIAT,0,0
233271,.,0,0
233272,European,0,0
233273,Myocardial,0,1
233274,Infarct,0,1
233275,Amiodarone,0,0
233276,Trial,0,0
233277,Investigators,0,0
233278,.,0,0
233279,BACKGROUND,0,0
233280,Ventricular,0,0
233281,arrhythmias,0,1
233282,are,0,0
233283,a,0,0
233284,major,0,0
233285,cause,0,0
233286,of,0,0
233287,death,0,1
233288,after,0,0
233289,myocardial,0,1
233290,infarction,0,1
233291,",",0,0
233292,especially,0,0
233293,in,0,0
233294,patients,0,0
233295,with,0,0
233296,poor,0,1
233297,left-ventricular,0,1
233298,function,0,1
233299,.,0,0
233300,Previous,0,0
233301,attempts,0,0
233302,to,0,0
233303,identify,0,0
233304,and,0,0
233305,suppress,0,1
233306,arrhythmias,0,1
233307,with,0,0
233308,various,0,0
233309,antiarrhythmic,0,1
233310,drugs,0,0
233311,failed,0,0
233312,to,0,0
233313,reduce,0,0
233314,or,0,0
233315,actually,0,0
233316,increase,0,0
233317,mortality,0,1
233318,.,0,0
233319,Amiodarone,0,0
233320,is,0,0
233321,a,0,0
233322,powerful,0,0
233323,antiarrhythmic,0,1
233324,drug,0,0
233325,with,0,0
233326,several,0,0
233327,potentially,0,0
233328,beneficial,0,0
233329,actions,0,1
233330,",",0,0
233331,and,0,0
233332,has,0,0
233333,shown,0,0
233334,benefit,0,0
233335,in,0,0
233336,several,0,0
233337,small-scale,0,0
233338,studies,0,0
233339,.,0,0
233340,We,0,0
233341,postulated,0,0
233342,that,0,0
233343,this,0,0
233344,drug,0,0
233345,might,0,0
233346,reduce,0,0
233347,mortality,0,1
233348,in,0,0
233349,patients,0,0
233350,at,0,0
233351,high,0,0
233352,risk,0,1
233353,of,0,0
233354,death,0,1
233355,after,0,0
233356,myocardial,0,1
233357,infarction,0,1
233358,because,0,0
233359,of,0,0
233360,impaired,0,0
233361,ventricular,0,1
233362,function,0,1
233363,",",0,0
233364,irrespective,0,0
233365,of,0,0
233366,whether,0,0
233367,they,0,0
233368,had,0,0
233369,ventricular,0,1
233370,arrhythmias,0,1
233371,.,0,0
233372,METHODS,0,0
233373,The,0,0
233374,European,0,0
233375,Myocardial,0,1
233376,Infarct,0,1
233377,Amiodarone,0,0
233378,Trial,0,0
233379,(,0,0
233380,EMIAT,0,0
233381,),0,0
233382,was,0,0
233383,a,0,0
233384,randomised,0,0
233385,double-blind,0,0
233386,placebo-controlled,0,0
233387,trial,0,0
233388,to,0,0
233389,assess,0,0
233390,whether,0,0
233391,amiodarone,0,0
233392,reduced,0,0
233393,all-cause,1,1
233394,mortality,1,1
233395,(,0,0
233396,primary,0,0
233397,endpoint,0,1
233398,),0,0
233399,and,0,0
233400,cardiac,1,1
233401,mortality,1,1
233402,and,1,0
233403,arrhythmic,1,1
233404,death,1,1
233405,(,0,0
233406,secondary,0,0
233407,endpoints,0,1
233408,),0,0
233409,in,0,0
233410,survivors,0,0
233411,of,0,0
233412,myocardial,0,1
233413,infarction,0,0
233414,with,0,0
233415,a,0,0
233416,left-ventricular,0,1
233417,ejection,0,1
233418,fraction,0,1
233419,(,0,0
233420,LVEF,0,1
233421,),0,0
233422,of,0,0
233423,40,0,0
233424,%,0,0
233425,or,0,0
233426,less,0,0
233427,.,0,1
233428,Intention-to-treat,0,0
233429,and,0,0
233430,on-treatment,0,1
233431,analyses,0,0
233432,were,0,0
233433,done,0,0
233434,.,0,0
233435,FINDINGS,0,0
233436,EMIAT,0,0
233437,enrolled,0,0
233438,1486,0,0
233439,patients,0,0
233440,(,0,0
233441,743,0,0
233442,in,0,0
233443,the,0,0
233444,amiodarone,0,0
233445,group,0,0
233446,",",0,0
233447,743,0,0
233448,in,0,0
233449,the,0,0
233450,placebo,0,0
233451,group,0,0
233452,),0,0
233453,.,0,0
233454,Median,0,1
233455,follow-up,0,0
233456,was,0,0
233457,21,0,0
233458,months,0,0
233459,.,0,0
233460,All-cause,1,1
233461,mortality,1,1
233462,(,0,0
233463,103,0,0
233464,deaths,0,0
233465,in,0,0
233466,the,0,0
233467,amiodarone,0,0
233468,group,0,0
233469,",",0,0
233470,102,0,0
233471,in,0,0
233472,the,0,0
233473,placebo,0,0
233474,group,0,0
233475,),0,0
233476,and,0,0
233477,cardiac,1,1
233478,mortality,1,1
233479,did,0,0
233480,not,0,0
233481,differ,0,0
233482,between,0,0
233483,the,0,0
233484,two,0,0
233485,groups,0,0
233486,.,0,0
233487,However,0,0
233488,",",0,0
233489,in,0,0
233490,the,0,0
233491,amiodarone,0,0
233492,group,0,0
233493,",",0,0
233494,there,0,0
233495,was,0,0
233496,a,0,0
233497,35,0,0
233498,%,0,0
233499,risk,1,0
233500,reduction,1,1
233501,(,0,0
233502,95,0,0
233503,%,0,0
233504,CI,0,0
233505,0-58,0,0
233506,",",0,0
233507,p,0,0
233508,=,0,0
233509,0.05,0,0
233510,),0,0
233511,in,0,0
233512,arrhythmic,1,1
233513,deaths,1,1
233514,.,1,0
233515,INTERPRETATION,0,0
233516,Our,0,0
233517,findings,0,0
233518,do,0,0
233519,not,0,0
233520,support,0,0
233521,the,0,0
233522,systematic,0,0
233523,prophylactic,0,0
233524,use,0,0
233525,of,0,0
233526,amiodarone,0,0
233527,in,0,0
233528,all,0,0
233529,patients,0,0
233530,with,0,0
233531,depressed,0,1
233532,left-ventricular,0,1
233533,function,0,1
233534,after,0,0
233535,myocardial,0,1
233536,infarction,0,0
233537,.,0,0
233538,However,0,0
233539,",",0,0
233540,the,0,0
233541,lack,0,0
233542,of,0,0
233543,proarrhythmia,0,1
233544,and,0,0
233545,the,0,0
233546,reduction,0,1
233547,in,0,0
233548,arrhythmic,1,1
233549,death,1,1
233550,support,0,0
233551,the,0,0
233552,use,0,0
233553,of,0,0
233554,amiodarone,0,0
233555,in,0,0
233556,patients,0,0
233557,for,0,0
233558,whom,0,0
233559,antiarrhythmic,0,0
233560,therapy,0,0
233561,is,0,0
233562,indicated,0,0
233563,.,0,0
233564,Effects,0,0
233565,of,0,0
233566,age,0,0
233567,at,0,0
233568,introduction,0,0
233569,of,0,0
233570,complementary,0,0
233571,foods,0,0
233572,to,0,0
233573,breast-fed,0,0
233574,infants,0,0
233575,on,0,0
233576,duration,0,1
233577,of,0,0
233578,lactational,0,0
233579,amenorrhea,0,1
233580,in,0,0
233581,Honduran,0,0
233582,women,0,0
233583,.,0,0
233584,Lactational,1,0
233585,amenorrhea,1,1
233586,(,0,0
233587,LA,0,0
233588,),0,0
233589,is,0,0
233590,associated,0,0
233591,with,0,0
233592,postpartum,0,1
233593,infertility,0,0
233594,and,0,0
233595,is,0,0
233596,known,0,0
233597,to,0,0
233598,be,0,0
233599,related,0,0
233600,to,0,0
233601,breast-feeding,0,0
233602,frequency,0,1
233603,and,0,1
233604,duration,0,1
233605,",",0,0
233606,but,0,0
233607,the,0,0
233608,exact,0,0
233609,role,0,0
233610,of,0,0
233611,complementary,0,0
233612,feeding,0,0
233613,of,0,0
233614,the,0,0
233615,infant,0,0
233616,has,0,0
233617,not,0,0
233618,been,0,0
233619,clearly,0,0
233620,defined,0,0
233621,.,0,0
233622,Data,0,0
233623,on,0,0
233624,LA,0,1
233625,were,0,0
233626,collected,0,0
233627,during,0,0
233628,and,0,0
233629,after,0,0
233630,a,0,0
233631,2-mo,0,0
233632,intervention,0,0
233633,trial,0,0
233634,in,0,0
233635,which,0,0
233636,low-income,0,0
233637,Honduran,0,0
233638,women,0,0
233639,who,0,0
233640,had,0,0
233641,breast-fed,0,0
233642,fully,0,0
233643,for,0,0
233644,4,0,0
233645,mo,0,0
233646,were,0,0
233647,randomly,0,0
233648,assigned,0,0
233649,to,0,0
233650,one,0,0
233651,of,0,0
233652,three,0,0
233653,groups,0,0
233654,:,0,0
233655,continued,0,0
233656,full,0,0
233657,breast-feeding,0,0
233658,until,0,0
233659,6,0,0
233660,mo,0,0
233661,(,0,0
233662,FBF,0,0
233663,",",0,0
233664,n,0,0
233665,=,0,0
233666,50,0,0
233667,),0,0
233668,",",0,0
233669,introduction,0,0
233670,of,0,1
233671,complementary,0,0
233672,foods,0,0
233673,at,0,0
233674,4,0,0
233675,mo,0,0
233676,with,0,0
233677,ad,0,0
233678,libitum,0,0
233679,breast-feeding,0,0
233680,from,0,0
233681,4,0,0
233682,to,0,0
233683,6,0,0
233684,mo,0,0
233685,(,0,0
233686,SF,0,0
233687,",",0,0
233688,n,0,0
233689,=,0,0
233690,47,0,0
233691,),0,0
233692,",",0,0
233693,or,0,0
233694,introduction,0,0
233695,of,0,1
233696,complementary,0,0
233697,foods,0,0
233698,at,0,0
233699,4,0,0
233700,mo,0,0
233701,with,0,0
233702,maintenance,0,0
233703,of,0,0
233704,baseline,0,0
233705,breast-feeding,0,0
233706,frequency,0,1
233707,from,0,0
233708,4,0,0
233709,to,0,0
233710,6,0,0
233711,mo,0,0
233712,(,0,0
233713,SF-M,0,0
233714,",",0,0
233715,n,0,0
233716,=,0,0
233717,44,0,0
233718,),0,0
233719,.,0,0
233720,Women,0,0
233721,were,0,0
233722,followed,0,0
233723,up,0,0
233724,until,0,0
233725,the,0,0
233726,infant,0,0
233727,was,0,0
233728,12,0,0
233729,mo,0,0
233730,of,0,0
233731,age,0,0
233732,",",0,0
233733,or,0,0
233734,later,0,1
233735,if,0,0
233736,menses,0,1
233737,had,0,0
233738,not,0,0
233739,occurred,0,0
233740,by,0,0
233741,then,0,0
233742,.,0,0
233743,All,0,0
233744,but,0,0
233745,six,0,0
233746,of,0,0
233747,the,0,0
233748,women,0,0
233749,continued,0,0
233750,to,0,0
233751,breast-feed,0,0
233752,for,0,0
233753,>,0,0
233754,or,0,0
233755,=,0,0
233756,12,0,0
233757,mo,0,0
233758,.,0,0
233759,With,0,0
233760,the,0,0
233761,exclusion,0,0
233762,of,0,0
233763,those,0,0
233764,whose,0,0
233765,menses,0,1
233766,returned,0,0
233767,before,0,0
233768,18,0,0
233769,wk,0,0
233770,postpartum,0,0
233771,(,0,0
233772,which,0,0
233773,could,0,0
233774,not,0,0
233775,have,0,0
233776,been,0,0
233777,due,0,0
233778,to,0,0
233779,the,0,0
233780,intervention,0,0
233781,),0,0
233782,",",0,0
233783,the,0,0
233784,proportion,1,0
233785,of,1,0
233786,women,1,0
233787,who,1,0
233788,were,1,0
233789,amenorrheic,1,0
233790,at,0,0
233791,6,0,0
233792,mo,0,0
233793,was,0,0
233794,64.5,0,0
233795,%,0,0
233796,in,0,0
233797,the,0,0
233798,SF,0,0
233799,group,0,0
233800,",",0,0
233801,80.0,0,0
233802,%,0,0
233803,in,0,0
233804,the,0,0
233805,FBF,0,0
233806,group,0,0
233807,",",0,0
233808,and,0,0
233809,85.7,0,0
233810,%,0,0
233811,in,0,0
233812,the,0,0
233813,SF-M,0,0
233814,group,0,0
233815,(,0,0
233816,chi-square,0,0
233817,test,0,0
233818,=,0,0
233819,4.13,0,0
233820,",",0,0
233821,P,0,0
233822,=,0,0
233823,0.02,0,0
233824,;,0,0
233825,one-tailed,0,0
233826,test,0,0
233827,with,0,0
233828,the,0,0
233829,latter,0,0
233830,two,0,0
233831,groups,0,0
233832,combined,0,0
233833,),0,0
233834,.,0,0
233835,The,0,0
233836,total,1,1
233837,duration,1,1
233838,of,1,0
233839,LA,1,1
233840,did,0,0
233841,not,0,0
233842,differ,0,0
233843,significantly,0,0
233844,among,0,0
233845,groups,0,0
233846,.,0,0
233847,The,0,0
233848,most,0,0
233849,significant,0,0
233850,determinant,0,1
233851,of,0,0
233852,LA,1,1
233853,was,0,0
233854,time,1,1
233855,spent,1,1
233856,breast-feeding,1,0
233857,(,1,0
233858,min/d,1,0
233859,),1,0
233860,",",0,0
233861,which,0,0
233862,was,0,0
233863,in,0,0
233864,turn,0,0
233865,negatively,0,0
233866,associated,0,0
233867,(,0,0
233868,P,0,0
233869,=,0,0
233870,0.06,0,0
233871,),0,0
233872,with,0,0
233873,the,0,0
233874,infant,1,1
233875,'s,1,0
233876,energy,1,1
233877,intake,1,1
233878,from,0,0
233879,complementary,0,0
233880,foods,0,0
233881,in,0,0
233882,regression,0,0
233883,analyses,0,0
233884,.,0,0
233885,These,0,0
233886,results,0,0
233887,indicate,0,0
233888,that,0,0
233889,there,0,0
233890,is,0,0
233891,a,0,0
233892,significant,0,0
233893,effect,0,0
233894,of,0,0
233895,introducing,0,0
233896,foods,0,0
233897,at,0,0
233898,4,0,0
233899,mo,0,0
233900,on,0,0
233901,the,0,0
233902,likelihood,0,0
233903,of,0,0
233904,amenorrhea,0,1
233905,at,0,0
233906,6,0,0
233907,mo,0,0
233908,postpartum,0,0
233909,",",0,0
233910,but,0,0
233911,not,0,0
233912,thereafter,0,0
233913,",",0,0
233914,and,0,0
233915,that,0,0
233916,this,0,0
233917,effect,0,0
233918,is,0,0
233919,not,0,0
233920,seen,0,0
233921,in,0,0
233922,mothers,0,0
233923,who,0,0
233924,maintain,0,0
233925,breast-feeding,0,0
233926,frequency,0,1
233927,.,0,0
233928,Clinical,0,1
233929,evaluation,0,0
233930,of,0,0
233931,the,0,0
233932,speed,1,1
233933,and,1,0
233934,effectiveness,1,1
233935,of,1,1
233936,subgingival,1,0
233937,calculus,1,1
233938,removal,1,0
233939,on,0,0
233940,single-rooted,0,0
233941,teeth,0,0
233942,with,0,0
233943,diamond-coated,0,0
233944,ultrasonic,0,0
233945,tips,0,0
233946,.,0,0
233947,Several,0,0
233948,studies,0,0
233949,have,0,0
233950,found,0,0
233951,incomplete,0,0
233952,calculus,1,0
233953,removal,1,0
233954,during,0,0
233955,periodontal,0,0
233956,treatment,0,0
233957,with,0,0
233958,traditional,0,0
233959,hand,0,0
233960,curets,0,1
233961,",",0,0
233962,sonic,0,1
233963,",",0,0
233964,and,0,1
233965,ultrasonic,0,0
233966,instruments,0,0
233967,.,0,0
233968,This,0,0
233969,study,0,0
233970,evaluated,0,0
233971,the,0,0
233972,speed,1,1
233973,and,1,0
233974,effectiveness,1,1
233975,of,1,1
233976,subgingival,1,0
233977,calculus,1,1
233978,removal,1,0
233979,with,0,0
233980,new,0,0
233981,diamond-coated,0,0
233982,ultrasonic,0,0
233983,tips,0,0
233984,on,0,0
233985,single-rooted,0,0
233986,teeth,0,0
233987,.,0,0
233988,Single,0,0
233989,session,0,0
233990,subgingival,0,1
233991,scaling,0,1
233992,and,0,1
233993,root,0,1
233994,planing,0,0
233995,was,0,0
233996,performed,0,0
233997,on,0,0
233998,80,0,0
233999,teeth,0,0
234000,with,0,0
234001,5,0,0
234002,to,0,0
234003,12,0,0
234004,mm,0,0
234005,probing,0,0
234006,depths,0,0
234007,in,0,0
234008,15,0,0
234009,patients,0,0
234010,.,0,0
234011,Each,0,0
234012,patient,0,0
234013,provided,0,0
234014,groups,0,0
234015,of,0,0
234016,4,0,0
234017,teeth,0,0
234018,that,0,0
234019,were,0,0
234020,randomly,0,0
234021,treated,0,0
234022,with,0,0
234023,either,0,0
234024,hand,0,0
234025,curets,0,0
234026,(,0,0
234027,HAND,0,0
234028,),0,0
234029,;,0,0
234030,standard,0,0
234031,smooth,0,1
234032,ultrasonic,0,0
234033,tip,0,0
234034,(,0,0
234035,US,0,0
234036,),0,0
234037,;,0,0
234038,or,0,0
234039,fine,0,1
234040,grit,0,1
234041,(,0,0
234042,FINDIAM,0,1
234043,),0,1
234044,or,0,0
234045,medium,0,1
234046,grit,0,1
234047,(,0,0
234048,MEDDIAM,0,0
234049,),0,0
234050,diamond-coated,0,0
234051,ultrasonic,0,0
234052,tips,0,0
234053,.,0,0
234054,The,0,0
234055,time,1,1
234056,taken,1,0
234057,to,1,0
234058,reach,1,0
234059,the,1,0
234060,therapeutic,1,0
234061,endpoint,1,0
234062,of,1,0
234063,a,1,0
234064,clean,1,0
234065,",",1,0
234066,smooth,1,1
234067,root,1,0
234068,surface,1,0
234069,in,1,0
234070,a,1,0
234071,defined,1,0
234072,region,1,0
234073,on,1,0
234074,each,1,0
234075,tooth,1,0
234076,with,0,0
234077,each,0,0
234078,instrument,0,0
234079,by,0,0
234080,the,0,0
234081,3,0,0
234082,therapists,0,0
234083,with,0,0
234084,differing,0,0
234085,experience,0,0
234086,levels,0,1
234087,was,0,0
234088,recorded,0,0
234089,.,0,0
234090,The,0,0
234091,teeth,0,0
234092,were,0,0
234093,then,0,0
234094,atraumatically,0,0
234095,extracted,0,0
234096,",",0,0
234097,stored,0,0
234098,in,0,0
234099,a,0,0
234100,surfactant,0,0
234101,",",0,0
234102,photographed,0,0
234103,at,0,0
234104,10X,0,0
234105,",",0,0
234106,and,0,0
234107,the,0,0
234108,percent,0,0
234109,of,0,0
234110,calculus,0,1
234111,present,0,0
234112,in,0,0
234113,the,0,0
234114,area,0,0
234115,of,0,0
234116,the,0,0
234117,pocket,0,1
234118,or,0,0
234119,on,0,0
234120,a,0,0
234121,comparable,0,0
234122,control,0,0
234123,surface,0,0
234124,calculated,0,0
234125,by,0,0
234126,histometric,0,0
234127,point,0,0
234128,counting,0,1
234129,.,0,0
234130,ANOVA,0,0
234131,and,0,0
234132,paired,0,0
234133,t,0,1
234134,tests,0,1
234135,showed,0,0
234136,that,0,0
234137,mean,1,1
234138,percent,1,0
234139,remaining,1,0
234140,calculus,1,1
234141,on,0,0
234142,treated,0,0
234143,versus,0,0
234144,control,0,0
234145,surfaces,0,0
234146,was,0,0
234147,HAND,0,0
234148,4.6,0,0
234149,+/-,0,0
234150,5.3,0,0
234151,versus,0,0
234152,57.5,0,0
234153,+/-,0,0
234154,28.2,0,0
234155,",",0,0
234156,US,0,0
234157,4.7,0,0
234158,+/-,0,0
234159,6.4,0,0
234160,versus,0,0
234161,54.4,0,0
234162,+/-,0,0
234163,25.9,0,0
234164,",",0,0
234165,FINDIAM,0,0
234166,4.3,0,0
234167,+/-,0,0
234168,5.2,0,0
234169,versus,0,0
234170,37.5,0,0
234171,+/-,0,0
234172,22.1,0,0
234173,",",0,0
234174,and,0,0
234175,MEDDIAM,0,0
234176,3.4,0,0
234177,+/-,0,0
234178,4.2,0,0
234179,versus,0,0
234180,50.7,0,0
234181,+/-,0,0
234182,20.1,0,0
234183,",",0,0
234184,respectively,0,0
234185,(,0,0
234186,all,0,0
234187,P,0,0
234188,<,0,0
234189,0.01,0,0
234190,),0,0
234191,.,0,0
234192,The,0,0
234193,mean,1,1
234194,time,1,1
234195,in,1,0
234196,seconds,1,0
234197,to,1,0
234198,reach,1,0
234199,the,1,0
234200,clinical,1,0
234201,endpoint,1,1
234202,ranged,0,0
234203,from,0,0
234204,HAND,0,0
234205,289,0,0
234206,+/-,0,0
234207,193,0,0
234208,",",0,0
234209,US,0,0
234210,194,0,0
234211,+/-,0,0
234212,67,0,0
234213,",",0,0
234214,FINDIAM,0,0
234215,167,0,0
234216,+/-,0,0
234217,71,0,0
234218,",",0,0
234219,to,0,0
234220,MEDDIAM,0,0
234221,147,0,0
234222,+/-,0,0
234223,92,0,0
234224,.,0,0
234225,All,0,0
234226,powered,0,0
234227,instruments,0,0
234228,were,0,0
234229,significantly,0,0
234230,faster,0,0
234231,than,0,0
234232,HAND,0,1
234233,(,0,0
234234,P,0,0
234235,<,0,0
234236,0.05,0,0
234237,),0,0
234238,",",0,0
234239,but,0,0
234240,did,0,0
234241,not,0,0
234242,differ,0,0
234243,from,0,0
234244,each,0,0
234245,other,0,0
234246,.,0,0
234247,On,0,0
234248,a,0,0
234249,0,0,0
234250,=,0,0
234251,smooth,0,0
234252,to,0,0
234253,3,0,0
234254,=,0,0
234255,rough,0,0
234256,scale,0,1
234257,",",0,0
234258,most,0,0
234259,often,0,0
234260,HAND,0,0
234261,resulted,0,0
234262,in,0,0
234263,smooth,1,1
234264,surfaces,1,0
234265,(,0,0
234266,10/20,0,0
234267,),0,0
234268,",",0,0
234269,the,0,0
234270,powered,0,0
234271,tips,0,0
234272,of,0,0
234273,all,0,0
234274,types,0,0
234275,slight,1,1
234276,surface,1,0
234277,roughness,1,1
234278,(,0,0
234279,10/20,0,0
234280,each,0,0
234281,),0,0
234282,",",0,0
234283,and,0,0
234284,US,0,0
234285,the,0,0
234286,most,0,0
234287,moderate,1,0
234288,roughness,1,1
234289,(,0,0
234290,7/20,0,0
234291,),0,0
234292,.,0,0
234293,There,0,0
234294,were,0,0
234295,no,0,0
234296,differences,0,0
234297,in,0,0
234298,percent,1,0
234299,calculus,1,1
234300,remaining,1,0
234301,",",1,0
234302,surface,1,1
234303,roughness,1,1
234304,",",1,1
234305,or,1,1
234306,time,1,1
234307,spent,1,0
234308,among,1,0
234309,the,1,0
234310,3,1,0
234311,treating,1,0
234312,clinicians,1,0
234313,despite,0,0
234314,their,0,0
234315,varying,0,0
234316,experience,0,0
234317,levels,0,1
234318,.,0,0
234319,The,0,0
234320,results,0,0
234321,of,0,0
234322,this,0,0
234323,study,0,0
234324,showed,0,0
234325,that,0,0
234326,percent,1,1
234327,calculus,1,1
234328,remaining,1,0
234329,was,0,0
234330,<,0,0
234331,5,0,0
234332,%,0,0
234333,with,0,0
234334,all,0,0
234335,the,0,0
234336,instruments,0,0
234337,given,0,0
234338,time,0,1
234339,ad,0,0
234340,libitum,0,0
234341,on,0,0
234342,a,0,0
234343,given,0,0
234344,root,0,0
234345,surface,0,0
234346,.,0,0
234347,Root,1,0
234348,roughness,1,1
234349,was,0,0
234350,generally,0,0
234351,slightly,0,0
234352,greater,0,0
234353,with,0,0
234354,all,0,0
234355,3,0,0
234356,powered,0,0
234357,tips,0,0
234358,.,0,0
234359,All,0,0
234360,of,0,0
234361,the,0,0
234362,powered,0,0
234363,instruments,0,0
234364,took,0,0
234365,significantly,0,0
234366,less,0,0
234367,time,1,1
234368,than,0,0
234369,the,0,0
234370,HAND,0,0
234371,.,0,0
234372,Both,0,0
234373,DIAM,0,0
234374,tips,0,0
234375,took,0,0
234376,less,0,0
234377,time,1,1
234378,than,0,0
234379,US,0,0
234380,.,0,0
234381,Diamond-coated,0,0
234382,ultrasonic,0,0
234383,tips,0,0
234384,appeared,0,0
234385,to,0,0
234386,be,0,0
234387,much,0,0
234388,more,0,0
234389,efficient,0,0
234390,than,0,0
234391,HAND,0,0
234392,or,0,0
234393,US,0,1
234394,in,0,0
234395,removing,0,0
234396,calculus,0,1
234397,in,0,0
234398,moderate-deep,0,0
234399,probing,0,0
234400,depths,0,1
234401,on,0,0
234402,single-rooted,0,0
234403,teeth,0,0
234404,in,0,0
234405,vivo,0,0
234406,.,0,0
234407,Low,0,0
234408,intensity,0,1
234409,physical,0,1
234410,training,0,0
234411,in,0,0
234412,older,0,0
234413,subjects,0,0
234414,.,0,0
234415,BACKGROUND,0,0
234416,This,0,0
234417,study,0,0
234418,was,0,0
234419,designed,0,0
234420,to,0,0
234421,evaluate,0,0
234422,the,0,0
234423,effects,0,0
234424,of,0,0
234425,a,0,0
234426,low,0,0
234427,intensity,0,1
234428,general,0,0
234429,training,0,0
234430,program,0,0
234431,(,0,0
234432,<,0,0
234433,50,0,0
234434,%,0,0
234435,of,0,0
234436,heart,0,1
234437,rate,0,1
234438,reserve,0,1
234439,),0,0
234440,on,0,0
234441,physical,0,1
234442,fitness,0,1
234443,of,0,0
234444,healthy,0,0
234445,older,0,0
234446,subjects,0,0
234447,",",0,0
234448,by,0,0
234449,comparing,0,0
234450,maximal,0,1
234451,and,0,0
234452,submaximal,0,1
234453,indices,0,1
234454,of,0,0
234455,training,0,0
234456,response,0,1
234457,.,0,0
234458,METHODS,0,0
234459,Twenty-two,0,0
234460,volunteers,0,0
234461,over,0,0
234462,60,0,0
234463,years,0,0
234464,of,0,0
234465,age,0,0
234466,participated,0,0
234467,in,0,0
234468,the,0,0
234469,present,0,0
234470,study,0,0
234471,.,0,0
234472,The,0,0
234473,sample,0,0
234474,was,0,0
234475,randomly,0,0
234476,divided,0,0
234477,in,0,0
234478,an,0,0
234479,experimental,0,0
234480,group,0,0
234481,of,0,0
234482,13,0,0
234483,older,0,0
234484,subjects,0,0
234485,(,0,0
234486,3,0,0
234487,men,0,0
234488,and,0,0
234489,10,0,0
234490,women,0,0
234491,",",0,0
234492,mean,0,1
234493,age,0,0
234494,63.5,0,0
234495,+/-,0,0
234496,3,0,0
234497,years,0,0
234498,),0,0
234499,while,0,0
234500,the,0,0
234501,remaining,0,0
234502,9,0,0
234503,subjects,0,0
234504,(,0,0
234505,3,0,0
234506,men,0,0
234507,and,0,0
234508,6,0,0
234509,women,0,0
234510,",",0,0
234511,mean,0,1
234512,age,0,0
234513,64.2,0,0
234514,+/-,0,0
234515,4,0,0
234516,years,0,0
234517,),0,0
234518,served,0,0
234519,as,0,0
234520,inactive,0,0
234521,control,0,0
234522,group,0,0
234523,.,0,0
234524,After,0,0
234525,medical,0,0
234526,screening,0,0
234527,all,0,0
234528,participants,0,0
234529,were,0,0
234530,evaluated,0,0
234531,before,0,0
234532,and,0,0
234533,after,0,0
234534,12,0,0
234535,weeks,0,0
234536,in,0,0
234537,which,0,0
234538,the,0,0
234539,experimental,0,0
234540,subjects,0,0
234541,underwent,0,0
234542,a,0,0
234543,low,0,0
234544,intensity,0,0
234545,training,0,0
234546,.,0,0
234547,Each,0,0
234548,subjects-either,0,0
234549,inactive,0,0
234550,or,0,0
234551,active-performed,0,0
234552,two,0,0
234553,treadmill,0,0
234554,tests,0,0
234555,at,0,0
234556,two-days,0,0
234557,interval,0,0
234558,",",0,0
234559,to,0,0
234560,measure,0,0
234561,maximal,0,1
234562,and,0,0
234563,submaximal,0,1
234564,responses,0,1
234565,to,0,0
234566,exercise,0,0
234567,",",0,0
234568,respectively,0,0
234569,.,0,0
234570,Heart,0,0
234571,rate,0,1
234572,(,0,0
234573,HR,0,1
234574,),0,0
234575,",",0,0
234576,oxygen,1,1
234577,uptake,1,1
234578,(,1,0
234579,VO2,1,1
234580,),1,0
234581,and,0,0
234582,pulmonary,1,1
234583,ventilation,1,1
234584,(,1,0
234585,VE,1,1
234586,),1,0
234587,were,0,0
234588,measured,0,0
234589,using,0,0
234590,a,0,0
234591,telemetric,0,0
234592,apparatus,0,0
234593,.,0,0
234594,RESULTS,0,0
234595,The,0,0
234596,major,0,0
234597,finding,0,0
234598,of,0,0
234599,the,0,0
234600,study,0,0
234601,was,0,0
234602,the,0,0
234603,significant,0,0
234604,improvement,0,1
234605,in,0,0
234606,submaximal,1,0
234607,response,1,1
234608,to,1,0
234609,exercise,1,0
234610,of,1,0
234611,experimental,1,0
234612,subjects,1,0
234613,",",0,0
234614,expressed,0,0
234615,by,0,0
234616,the,0,0
234617,reduction,0,0
234618,in,0,0
234619,HR,1,1
234620,",",1,0
234621,VO2,1,1
234622,VE,1,1
234623,while,1,0
234624,VO2,1,1
234625,max,1,1
234626,did,0,0
234627,not,0,0
234628,change,0,0
234629,.,0,0
234630,CONCLUSIONS,0,0
234631,Thus,0,0
234632,",",0,0
234633,it,0,0
234634,appears,0,0
234635,that,0,0
234636,a,0,0
234637,low,0,0
234638,intensity,0,1
234639,general,0,0
234640,training,0,0
234641,similar,0,0
234642,to,0,0
234643,that,0,0
234644,followed,0,0
234645,in,0,0
234646,the,0,0
234647,present,0,0
234648,study,0,0
234649,may,0,0
234650,represent,0,0
234651,a,0,0
234652,good,0,0
234653,means,0,0
234654,to,0,0
234655,improve,0,0
234656,physical,1,1
234657,fitness,1,1
234658,in,0,0
234659,healthy,0,0
234660,elderly,0,0
234661,people,0,0
234662,.,0,0
234663,Similarly,0,0
234664,",",0,0
234665,this,0,0
234666,study,0,0
234667,supports,0,0
234668,the,0,0
234669,effectiveness,0,1
234670,of,0,0
234671,evaluation,0,0
234672,tests,0,1
234673,based,0,0
234674,on,0,0
234675,submaximal,1,0
234676,responses,1,1
234677,to,0,0
234678,exercise,0,0
234679,in,0,0
234680,this,0,0
234681,population,0,0
234682,.,0,0
234683,Safety,1,1
234684,of,0,0
234685,nifedipine,0,0
234686,in,0,0
234687,patients,0,0
234688,with,0,0
234689,hypertension,0,0
234690,:,0,0
234691,a,0,0
234692,meta-analysis,0,0
234693,.,0,0
234694,Our,0,0
234695,objective,0,0
234696,was,0,0
234697,to,0,0
234698,compare,0,0
234699,cardiovascular,1,1
234700,event,1,0
234701,rates,1,1
234702,in,0,0
234703,patients,0,0
234704,with,0,0
234705,mild,0,1
234706,or,0,0
234707,moderate,0,0
234708,hypertension,0,1
234709,who,0,0
234710,received,0,0
234711,nifedipine,0,0
234712,with,0,0
234713,active,0,0
234714,drug,0,0
234715,controls,0,0
234716,.,0,0
234717,We,0,0
234718,performed,0,0
234719,a,0,0
234720,MEDLARS,0,0
234721,search,0,0
234722,using,0,0
234723,the,0,0
234724,MeSH,0,0
234725,heading,0,1
234726,hypertension,0,1
234727,and,0,0
234728,the,0,0
234729,text,0,0
234730,word,0,1
234731,nifedipine,0,0
234732,to,0,0
234733,identify,0,0
234734,all,0,0
234735,articles,0,0
234736,that,0,0
234737,were,0,0
234738,published,0,0
234739,between,0,0
234740,1966,0,0
234741,and,0,0
234742,August,0,0
234743,1995,0,0
234744,in,0,0
234745,English,0,0
234746,",",0,0
234747,French,0,0
234748,",",0,1
234749,German,0,0
234750,",",0,1
234751,Italian,0,0
234752,",",0,1
234753,and,0,1
234754,Spanish,0,1
234755,languages,0,1
234756,and,0,0
234757,that,0,0
234758,involved,0,0
234759,human,0,0
234760,subjects,0,0
234761,.,0,0
234762,The,0,0
234763,computerized,0,0
234764,search,0,0
234765,was,0,0
234766,supplemented,0,0
234767,by,0,0
234768,a,0,0
234769,manual,0,0
234770,search,0,0
234771,of,0,0
234772,article,0,0
234773,bibliographies,0,0
234774,.,0,0
234775,Review,0,0
234776,of,0,0
234777,1880,0,0
234778,citations,0,0
234779,revealed,0,0
234780,98,0,0
234781,randomized,0,0
234782,controlled,0,0
234783,clinical,0,0
234784,trials,0,0
234785,that,0,0
234786,met,0,0
234787,protocol,0,0
234788,criteria,0,0
234789,.,0,0
234790,Articles,0,0
234791,were,0,0
234792,extracted,0,0
234793,independently,0,0
234794,by,0,0
234795,two,0,0
234796,doctors,0,0
234797,who,0,0
234798,were,0,0
234799,blinded,0,0
234800,for,0,0
234801,author,0,0
234802,",",0,0
234803,institution,0,0
234804,",",0,1
234805,and,0,1
234806,treatment,0,0
234807,regimen,0,0
234808,",",0,0
234809,using,0,0
234810,a,0,0
234811,structured,0,0
234812,",",0,0
234813,pretested,0,0
234814,extraction,0,0
234815,form,0,0
234816,.,0,0
234817,Differences,0,0
234818,of,0,0
234819,opinion,0,0
234820,were,0,0
234821,resolved,0,0
234822,by,0,0
234823,consensus,0,0
234824,.,0,0
234825,Fourteen,0,0
234826,events,0,1
234827,occurred,0,0
234828,in,0,0
234829,5198,0,0
234830,exposures,0,0
234831,(,0,0
234832,0.27,0,0
234833,%,0,0
234834,),0,0
234835,to,0,0
234836,nifedipine,0,0
234837,and,0,0
234838,24,0,0
234839,events,0,1
234840,in,0,0
234841,5402,0,0
234842,exposures,0,0
234843,(,0,0
234844,0.44,0,0
234845,%,0,0
234846,),0,0
234847,to,0,0
234848,other,0,0
234849,active,0,0
234850,drug,0,0
234851,controls,0,0
234852,.,0,0
234853,Unadjusted,1,0
234854,odds,1,0
234855,ratios,1,0
234856,for,0,0
234857,nifedipine,0,0
234858,versus,0,0
234859,controls,0,0
234860,were,0,0
234861,0.49,0,0
234862,(,0,0
234863,95,0,0
234864,%,0,0
234865,confidence,0,0
234866,interval,0,0
234867,[,0,0
234868,CI,0,0
234869,],0,0
234870,",",0,0
234871,0.22-1.09,0,0
234872,),0,0
234873,for,0,0
234874,definitive,1,0
234875,events,1,1
234876,(,1,0
234877,death,1,1
234878,",",1,0
234879,nonfatal,1,1
234880,myocardial,1,1
234881,infarction,1,1
234882,or,1,0
234883,stroke,1,1
234884,",",1,1
234885,revascularization,1,1
234886,procedure,1,0
234887,),1,0
234888,and,0,0
234889,0.61,0,0
234890,(,0,0
234891,95,0,0
234892,%,0,0
234893,CI,0,0
234894,",",0,0
234895,0.31-1.17,0,0
234896,),0,0
234897,for,0,0
234898,all,1,0
234899,events,1,1
234900,(,1,0
234901,definitive,1,0
234902,plus,1,0
234903,increased,1,0
234904,angina,1,0
234905,),1,0
234906,.,1,0
234907,The,0,0
234908,odds,1,0
234909,ratio,1,1
234910,for,1,0
234911,nifedipine,1,0
234912,monotherapy,1,0
234913,(,0,0
234914,sustained-,0,0
234915,or,0,0
234916,extended-release,0,0
234917,in,0,0
234918,91,0,0
234919,%,0,0
234920,of,0,0
234921,exposures,0,0
234922,),0,0
234923,was,0,0
234924,nonsignificantly,0,0
234925,higher,0,0
234926,for,0,0
234927,definitive,0,0
234928,and,0,0
234929,all,0,0
234930,events,0,1
234931,(,0,0
234932,odds,0,1
234933,ratio,0,1
234934,",",0,0
234935,1.40,0,0
234936,;,0,0
234937,95,0,0
234938,%,0,0
234939,CI,0,0
234940,",",0,0
234941,0.49-4.03,0,0
234942,and,0,1
234943,odds,0,1
234944,ratio,0,1
234945,",",0,0
234946,1.39,0,0
234947,;,0,0
234948,95,0,0
234949,%,0,0
234950,CI,0,0
234951,",",0,0
234952,0.59-3.32,0,0
234953,",",0,0
234954,respectively,0,0
234955,),0,0
234956,.,0,0
234957,The,0,0
234958,odds,1,0
234959,ratio,1,1
234960,for,1,0
234961,nifedipine,1,0
234962,in,1,0
234963,combination,1,0
234964,with,1,0
234965,another,1,0
234966,drug,1,0
234967,was,0,0
234968,significantly,0,0
234969,lower,0,0
234970,for,0,0
234971,definitive,0,0
234972,and,0,0
234973,all,0,0
234974,events,0,1
234975,(,0,0
234976,odds,0,1
234977,ratio,0,1
234978,",",0,0
234979,0.09,0,0
234980,;,0,0
234981,95,0,0
234982,%,0,0
234983,CI,0,0
234984,",",0,0
234985,0.01-0.66,0,0
234986,and,0,1
234987,odds,0,1
234988,ratio,0,1
234989,",",0,0
234990,0.15,0,0
234991,;,0,0
234992,95,0,0
234993,%,0,0
234994,CI,0,0
234995,",",0,0
234996,0.03-0.65,0,0
234997,",",0,0
234998,respectively,0,0
234999,),0,0
235000,.,0,0
235001,Differences,1,0
235002,in,1,0
235003,odds,1,0
235004,ratio,1,1
235005,for,1,0
235006,nifedipine,1,0
235007,monotherapy,1,0
235008,and,1,0
235009,combined,1,0
235010,therapy,1,0
235011,were,0,0
235012,statistically,0,0
235013,significant,0,0
235014,(,0,0
235015,P=.02,0,1
235016,for,0,0
235017,definitive,0,0
235018,events,0,1
235019,and,0,0
235020,P=.001,0,0
235021,for,0,0
235022,all,0,0
235023,events,0,1
235024,),0,0
235025,.,0,0
235026,Results,0,0
235027,support,0,0
235028,the,0,0
235029,safety,1,1
235030,of,1,0
235031,sustained-,1,0
235032,and,1,0
235033,extended-release,1,0
235034,nifedipine,1,0
235035,in,0,0
235036,the,0,0
235037,treatment,0,0
235038,of,0,0
235039,mild,0,1
235040,or,0,0
235041,moderate,0,0
235042,hypertension,0,0
235043,when,0,0
235044,it,0,0
235045,is,0,0
235046,used,0,0
235047,in,0,0
235048,combination,0,0
235049,with,0,0
235050,other,0,0
235051,drugs,0,0
235052,.,0,0
235053,Cranberry,0,0
235054,concentrate,0,0
235055,:,0,0
235056,UTI,0,1
235057,prophylaxis,0,0
235058,.,0,0
235059,The,0,0
235060,nature,0,0
235061,and,0,0
235062,importance,0,1
235063,of,0,1
235064,changes,0,1
235065,in,0,0
235066,toe-brachial,0,1
235067,pressure,0,1
235068,indices,0,1
235069,following,0,0
235070,percutaneous,0,0
235071,transluminal,0,0
235072,angioplasty,0,0
235073,for,0,0
235074,leg,0,1
235075,ischaemia,0,1
235076,.,0,0
235077,OBJECTIVES,0,0
235078,To,0,0
235079,document,0,0
235080,changes,0,1
235081,in,0,0
235082,toe-brachial,1,1
235083,pressure,1,1
235084,indices,1,1
235085,(,1,0
235086,TBPI,1,0
235087,),1,0
235088,during,0,0
235089,the,0,0
235090,6,0,0
235091,months,0,0
235092,following,0,0
235093,percutaneous,0,0
235094,transluminal,0,0
235095,angioplasty,0,0
235096,(,0,0
235097,PTA,0,1
235098,),0,0
235099,and,0,0
235100,relate,0,0
235101,these,0,0
235102,changes,0,0
235103,to,0,0
235104,restenosis,0,1
235105,.,0,0
235106,Furthermore,0,0
235107,",",0,0
235108,to,0,0
235109,ascertain,0,0
235110,the,0,0
235111,effect,1,0
235112,of,0,0
235113,administering,0,0
235114,a,0,0
235115,vasodilator,0,0
235116,",",0,0
235117,glyceryl,0,0
235118,trinitrate,0,0
235119,(,0,0
235120,GTN,0,0
235121,),0,0
235122,",",0,0
235123,immediately,0,0
235124,following,0,0
235125,PTA,0,0
235126,.,0,0
235127,DESIGN,0,0
235128,Eighty-three,0,0
235129,technically,0,0
235130,successful,0,0
235131,PTA,0,0
235132,procedures,0,0
235133,were,0,0
235134,studied,0,0
235135,.,0,0
235136,Fifty-six,0,0
235137,were,0,0
235138,for,0,0
235139,intermittent,0,0
235140,claudication,0,1
235141,",",0,0
235142,14,0,0
235143,for,0,0
235144,ischaemic,0,0
235145,rest,0,0
235146,pain,0,1
235147,",",0,0
235148,and,0,0
235149,13,0,0
235150,for,0,0
235151,non-healing,0,0
235152,ulcers,0,0
235153,.,0,0
235154,Immediately,0,0
235155,following,0,0
235156,balloon,0,0
235157,dilatation,0,0
235158,an,0,0
235159,intra-arterial,0,0
235160,bolus,0,0
235161,of,0,0
235162,either,0,0
235163,150,0,0
235164,micrograms,0,0
235165,GTN,0,0
235166,",",0,0
235167,with,0,0
235168,or,0,0
235169,without,0,0
235170,a,0,0
235171,10,0,0
235172,mg,0,0
235173,GTN,0,0
235174,patch,0,0
235175,for,0,0
235176,24,0,0
235177,h,0,0
235178,",",0,0
235179,or,0,0
235180,a,0,0
235181,saline,0,0
235182,placebo,0,0
235183,was,0,0
235184,administered,0,0
235185,.,0,0
235186,TBPI,1,0
235187,were,0,0
235188,measured,0,0
235189,before,0,0
235190,and,0,0
235191,for,0,0
235192,6,0,0
235193,h,0,0
235194,after,0,0
235195,PTA,0,0
235196,and,0,0
235197,then,0,0
235198,at,0,0
235199,24,0,0
235200,h,0,0
235201,",",0,0
235202,1,0,0
235203,week,0,0
235204,",",0,0
235205,1,0,0
235206,month,0,0
235207,and,0,0
235208,6,0,0
235209,months,0,0
235210,.,0,0
235211,At,0,0
235212,this,0,0
235213,time,0,1
235214,",",0,0
235215,patency,0,1
235216,at,0,0
235217,the,0,0
235218,PTA,0,0
235219,site,0,0
235220,was,0,0
235221,determined,0,0
235222,by,0,0
235223,arteriography,0,0
235224,.,0,0
235225,RESULTS,0,0
235226,There,0,0
235227,was,0,0
235228,continuing,0,0
235229,TBPI,1,0
235230,improvement,0,1
235231,over,0,0
235232,1,0,0
235233,month,0,0
235234,in,0,0
235235,patients,0,0
235236,given,0,0
235237,saline,0,0
235238,following,0,0
235239,PTA,0,0
235240,.,0,0
235241,In,0,0
235242,patients,0,0
235243,given,0,0
235244,GTN,0,0
235245,",",0,0
235246,peak,1,1
235247,TBPI,1,0
235248,was,0,0
235249,achieved,0,0
235250,by,0,0
235251,1,0,0
235252,week,0,0
235253,",",0,0
235254,and,0,1
235255,corresponded,0,0
235256,with,0,0
235257,the,0,0
235258,TBPI,1,0
235259,observed,0,0
235260,immediately,0,0
235261,following,0,0
235262,GTN,0,0
235263,administration,0,0
235264,.,0,0
235265,Restenosis,1,1
235266,occurred,0,0
235267,in,0,0
235268,27,0,0
235269,(,0,0
235270,33,0,0
235271,%,0,0
235272,),0,0
235273,patients,0,0
235274,",",0,0
235275,and,0,1
235276,was,0,0
235277,significantly,0,0
235278,more,0,0
235279,frequent,0,0
235280,following,0,0
235281,the,0,0
235282,procedures,0,0
235283,for,0,0
235284,rest,0,0
235285,pain,0,1
235286,or,0,1
235287,ulceration,0,1
235288,",",0,1
235289,or,0,0
235290,where,0,0
235291,a,0,0
235292,TBPI,1,0
235293,increase,0,0
235294,of,0,0
235295,more,0,0
235296,than,0,0
235297,0.15,0,0
235298,by,0,0
235299,1,0,0
235300,week,0,0
235301,was,0,0
235302,observed,0,0
235303,.,0,0
235304,CONCLUSIONS,0,0
235305,Haemodynamic,0,1
235306,changes,0,1
235307,following,0,0
235308,PTA,0,0
235309,continue,0,0
235310,for,0,0
235311,at,0,0
235312,least,0,0
235313,1,0,0
235314,month,0,0
235315,",",0,0
235316,can,0,0
235317,be,0,0
235318,modified,0,0
235319,by,0,0
235320,GTN,0,0
235321,administration,0,0
235322,",",0,0
235323,and,0,0
235324,are,0,0
235325,predictive,0,1
235326,of,0,0
235327,subsequent,0,0
235328,restenosis,0,1
235329,.,0,0
235330,Measuring,0,0
235331,the,0,0
235332,TBPI,1,0
235333,increase,0,0
235334,during,0,0
235335,the,0,0
235336,first,0,0
235337,week,0,0
235338,following,0,0
235339,PTA,0,0
235340,underestimates,0,0
235341,total,0,1
235342,improvement,0,1
235343,",",0,0
235344,and,0,0
235345,may,0,0
235346,give,0,1
235347,false,0,1
235348,reassurance,0,1
235349,with,0,0
235350,respect,0,0
235351,to,0,0
235352,recurrent,0,0
235353,disease,0,0
235354,.,0,0
235355,Evaluation,0,0
235356,of,0,0
235357,hypertensive,0,0
235358,patients,0,0
235359,after,0,0
235360,care,0,0
235361,provided,0,0
235362,by,0,0
235363,community,0,0
235364,pharmacists,0,0
235365,in,0,0
235366,a,0,0
235367,rural,0,0
235368,setting,0,0
235369,.,0,0
235370,We,0,0
235371,evaluated,0,0
235372,blood,1,1
235373,pressure,1,1
235374,control,1,0
235375,",",1,0
235376,quality,1,1
235377,of,1,1
235378,life,1,1
235379,",",1,0
235380,quality,1,1
235381,of,1,1
235382,care,1,0
235383,",",1,0
235384,and,1,1
235385,satisfaction,1,1
235386,of,1,0
235387,patients,1,0
235388,who,0,0
235389,were,0,0
235390,monitored,0,0
235391,by,0,0
235392,specially,0,0
235393,trained,0,0
235394,community,0,0
235395,pharmacists,0,0
235396,in,0,0
235397,a,0,0
235398,group,0,0
235399,medical,0,0
235400,practice,0,0
235401,.,0,0
235402,After,0,0
235403,participating,0,0
235404,in,0,0
235405,an,0,0
235406,intensive,0,0
235407,skill,0,1
235408,development,0,1
235409,program,0,0
235410,",",0,0
235411,pharmacists,0,0
235412,performed,0,0
235413,in,0,0
235414,an,0,0
235415,interdisciplinary,0,0
235416,team,0,0
235417,in,0,0
235418,a,0,0
235419,rural,0,0
235420,clinic,0,0
235421,.,0,0
235422,The,0,0
235423,primary,0,0
235424,objective,0,0
235425,was,0,0
235426,assessed,0,0
235427,by,0,0
235428,evaluating,0,0
235429,outcome,0,1
235430,variables,0,0
235431,at,0,0
235432,6,0,0
235433,months,0,0
235434,compared,0,0
235435,with,0,0
235436,baseline,0,0
235437,in,0,0
235438,25,0,0
235439,patients,0,0
235440,randomly,0,0
235441,assigned,0,0
235442,to,0,0
235443,a,0,0
235444,study,0,0
235445,group,0,0
235446,.,0,0
235447,A,0,0
235448,control,0,0
235449,group,0,0
235450,of,0,0
235451,26,0,0
235452,patients,0,0
235453,was,0,0
235454,also,0,0
235455,evaluated,0,0
235456,to,0,0
235457,determine,0,0
235458,if,0,0
235459,outcome,0,1
235460,variables,0,0
235461,remained,0,0
235462,constant,0,0
235463,from,0,0
235464,baseline,0,0
235465,to,0,0
235466,6,0,0
235467,months,0,0
235468,.,0,0
235469,Systolic,1,1
235470,blood,1,1
235471,pressure,1,1
235472,was,0,0
235473,reduced,0,0
235474,in,0,0
235475,the,0,0
235476,study,0,0
235477,group,0,0
235478,(,0,0
235479,151,0,0
235480,mm,0,0
235481,Hg,0,0
235482,baseline,0,0
235483,",",0,0
235484,140,0,0
235485,mm,0,0
235486,Hg,0,0
235487,at,0,0
235488,6,0,0
235489,mo,0,0
235490,",",0,0
235491,p,0,0
235492,<,0,0
235493,0.001,0,0
235494,),0,0
235495,and,0,0
235496,diastolic,1,1
235497,blood,1,1
235498,pressure,1,1
235499,was,0,0
235500,significantly,0,0
235501,lower,0,0
235502,at,0,0
235503,2,0,0
235504,",",0,0
235505,4,0,0
235506,",",0,0
235507,and,0,0
235508,5,0,0
235509,months,0,0
235510,compared,0,0
235511,with,0,0
235512,baseline,0,0
235513,.,0,0
235514,Ratings,0,0
235515,from,0,0
235516,a,0,0
235517,blinded,0,0
235518,peer,0,0
235519,review,0,0
235520,panel,0,0
235521,indicated,0,0
235522,significant,0,0
235523,improvement,0,1
235524,in,0,0
235525,the,0,0
235526,appropriateness,0,0
235527,of,0,0
235528,the,0,0
235529,blood,0,1
235530,pressure,0,1
235531,regimen,0,0
235532,",",0,0
235533,going,0,0
235534,from,0,0
235535,8.7,0,0
235536,+/-,0,0
235537,4.7,0,0
235538,to,0,0
235539,10.9,0,0
235540,+/-,0,0
235541,4.5,0,0
235542,in,0,0
235543,the,0,0
235544,study,0,0
235545,group,0,0
235546,(,0,0
235547,p,0,0
235548,<,0,0
235549,0.01,0,0
235550,),0,0
235551,",",0,0
235552,but,0,0
235553,they,0,0
235554,did,0,0
235555,not,0,0
235556,change,0,0
235557,in,0,0
235558,the,0,0
235559,control,0,0
235560,group,0,0
235561,.,0,0
235562,Several,0,0
235563,quality,1,1
235564,of,1,0
235565,life,1,1
235566,scores,1,1
235567,improved,0,0
235568,significantly,0,0
235569,in,0,0
235570,the,0,0
235571,study,0,0
235572,group,0,0
235573,after,0,0
235574,6,0,0
235575,months,0,0
235576,(,0,0
235577,p,0,0
235578,<,0,0
235579,0.05,0,0
235580,),0,0
235581,.,0,0
235582,These,0,0
235583,included,0,0
235584,physical,1,1
235585,functioning,1,1
235586,(,0,0
235587,61.6,0,0
235588,vs,0,0
235589,70.7,0,0
235590,),0,0
235591,",",0,0
235592,physical,1,1
235593,role,1,0
235594,limitations,1,0
235595,(,0,0
235596,56.8,0,0
235597,vs,0,0
235598,72.8,0,0
235599,),0,0
235600,",",0,0
235601,and,0,0
235602,bodily,1,1
235603,pain,1,1
235604,(,0,0
235605,60.0,0,0
235606,vs,0,0
235607,71.7,0,0
235608,),0,0
235609,at,0,0
235610,baseline,0,0
235611,and,0,0
235612,6,0,0
235613,months,0,0
235614,",",0,0
235615,respectively,0,0
235616,.,0,0
235617,There,0,0
235618,were,0,0
235619,no,0,0
235620,significant,0,0
235621,changes,0,0
235622,in,0,0
235623,the,0,0
235624,control,0,0
235625,group,0,0
235626,.,0,0
235627,Patient,1,1
235628,satisfaction,1,1
235629,scores,1,1
235630,were,0,0
235631,consistently,0,0
235632,higher,0,0
235633,in,0,0
235634,the,0,0
235635,study,0,0
235636,group,0,0
235637,at,0,0
235638,the,0,0
235639,end,0,0
235640,of,0,0
235641,the,0,0
235642,study,0,0
235643,.,0,0
235644,Our,0,0
235645,results,0,0
235646,indicate,0,0
235647,that,0,0
235648,when,0,0
235649,community,0,0
235650,pharmacists,0,0
235651,in,0,0
235652,a,0,0
235653,clinic,0,0
235654,setting,0,0
235655,are,0,0
235656,trained,0,0
235657,and,0,0
235658,included,0,0
235659,as,0,0
235660,members,0,0
235661,of,0,0
235662,the,0,0
235663,primary,0,0
235664,care,0,0
235665,team,0,0
235666,",",0,0
235667,significant,0,0
235668,improvements,0,1
235669,in,0,0
235670,blood,1,1
235671,pressure,1,1
235672,control,1,0
235673,",",1,0
235674,quality,1,1
235675,of,1,1
235676,life,1,1
235677,",",1,0
235678,and,1,1
235679,patient,1,1
235680,satisfaction,1,1
235681,can,0,0
235682,be,0,0
235683,achieved,0,0
235684,.,0,0
235685,MSL-109,0,0
235686,adjuvant,0,0
235687,therapy,0,0
235688,for,0,0
235689,cytomegalovirus,0,1
235690,retinitis,0,0
235691,in,0,0
235692,patients,0,0
235693,with,0,0
235694,acquired,0,0
235695,immunodeficiency,0,0
235696,syndrome,0,0
235697,:,0,0
235698,the,0,0
235699,Monoclonal,0,1
235700,Antibody,0,0
235701,Cytomegalovirus,0,0
235702,Retinitis,0,1
235703,Trial,0,0
235704,.,0,0
235705,The,0,0
235706,Studies,0,0
235707,of,0,0
235708,Ocular,0,0
235709,Complications,0,1
235710,of,0,0
235711,AIDS,0,0
235712,Research,0,0
235713,Group,0,0
235714,.,0,0
235715,AIDS,0,0
235716,Clinical,0,1
235717,Trials,0,0
235718,Group,0,0
235719,.,0,0
235720,OBJECTIVE,0,0
235721,To,0,0
235722,evaluate,0,0
235723,the,0,0
235724,efficacy,1,1
235725,and,1,0
235726,safety,1,1
235727,of,0,0
235728,an,0,0
235729,intravenous,0,0
235730,human,0,0
235731,monoclonal,0,0
235732,antibody,0,0
235733,to,0,0
235734,cytomegalovirus,0,1
235735,(,0,0
235736,CMV,0,0
235737,),0,0
235738,",",0,0
235739,MSL-109,0,0
235740,",",0,0
235741,as,0,0
235742,adjuvant,0,0
235743,treatment,0,0
235744,for,0,0
235745,CMV,0,0
235746,retinitis,0,0
235747,.,0,0
235748,METHODS,0,0
235749,Two,0,0
235750,hundred,0,0
235751,nine,0,0
235752,patients,0,0
235753,with,0,0
235754,acquired,0,0
235755,immunodeficiency,0,0
235756,syndrome,0,0
235757,and,0,1
235758,active,0,0
235759,CMV,0,0
235760,retinitis,0,0
235761,were,0,0
235762,enrolled,0,0
235763,in,0,0
235764,a,0,0
235765,multicenter,0,0
235766,",",0,0
235767,phase,0,0
235768,2/3,0,0
235769,",",0,0
235770,randomized,0,0
235771,",",0,0
235772,placebo-controlled,0,0
235773,clinical,0,0
235774,trial,0,0
235775,.,0,0
235776,Patients,0,0
235777,received,0,0
235778,adjuvant,0,0
235779,treatment,0,0
235780,with,0,0
235781,MSL-109,0,0
235782,",",0,0
235783,60,0,0
235784,mg,0,0
235785,intravenously,0,0
235786,every,0,0
235787,2,0,0
235788,weeks,0,0
235789,",",0,0
235790,or,0,0
235791,placebo,0,0
235792,.,0,1
235793,Randomization,0,0
235794,was,0,0
235795,stratified,0,0
235796,on,0,0
235797,the,0,0
235798,basis,0,0
235799,of,0,0
235800,whether,0,0
235801,patients,0,0
235802,had,0,0
235803,untreated,0,0
235804,or,0,0
235805,relapsed,0,0
235806,retinitis,0,0
235807,.,0,0
235808,Primary,0,0
235809,drug,0,0
235810,therapy,0,0
235811,for,0,0
235812,CMV,0,0
235813,retinitis,0,0
235814,was,0,0
235815,determined,0,0
235816,by,0,0
235817,the,0,0
235818,treating,0,0
235819,physician,0,0
235820,.,0,0
235821,RESULTS,0,0
235822,The,0,0
235823,rates,1,1
235824,of,1,0
235825,retinitis,1,0
235826,progression,1,1
235827,",",0,0
235828,as,0,0
235829,evaluated,0,0
235830,in,0,0
235831,a,0,0
235832,masked,0,0
235833,fashion,0,0
235834,",",0,0
235835,were,0,0
235836,3.04/person-year,0,0
235837,in,0,0
235838,the,0,0
235839,MSL-109-treated,0,0
235840,group,0,0
235841,and,0,0
235842,3.05/person-year,0,0
235843,in,0,0
235844,the,0,0
235845,placebo-treated,0,0
235846,group,0,0
235847,(,0,0
235848,P=.98,0,0
235849,;,0,0
235850,Wald,0,1
235851,test,0,0
235852,),0,0
235853,;,0,0
235854,the,0,0
235855,median,0,0
235856,times,0,1
235857,to,0,0
235858,progression,0,1
235859,were,0,0
235860,67,0,0
235861,days,0,0
235862,in,0,0
235863,the,0,0
235864,MSL-109-treated,0,0
235865,group,0,0
235866,and,0,0
235867,65,0,0
235868,days,0,0
235869,in,0,0
235870,the,0,0
235871,placebo-treated,0,0
235872,group,0,0
235873,.,0,0
235874,No,0,0
235875,differences,0,0
235876,between,0,0
235877,the,0,0
235878,2,0,0
235879,groups,0,0
235880,were,0,0
235881,noted,0,0
235882,in,0,0
235883,the,0,0
235884,rates,1,1
235885,of,1,0
235886,increase,1,0
235887,in,1,0
235888,retinal,1,1
235889,area,1,1
235890,involved,1,0
235891,by,1,0
235892,CMV,1,0
235893,",",1,0
235894,visual,1,1
235895,field,1,0
235896,loss,1,1
235897,",",1,0
235898,or,1,1
235899,visual,1,1
235900,acuity,1,1
235901,outcomes,1,0
235902,.,1,0
235903,The,0,0
235904,mortality,1,1
235905,rate,1,1
235906,in,0,0
235907,the,0,0
235908,MSL-109-treated,0,0
235909,group,0,0
235910,was,0,0
235911,0.68/person-year,0,0
235912,",",0,0
235913,and,0,0
235914,in,0,0
235915,the,0,0
235916,placebo-treated,0,0
235917,group,0,0
235918,",",0,0
235919,0.31/person-year,0,0
235920,(,0,0
235921,P=.01,0,0
235922,),0,0
235923,.,0,0
235924,The,0,0
235925,mortality,1,1
235926,difference,0,0
235927,was,0,0
235928,not,0,0
235929,explained,0,0
235930,by,0,0
235931,differences,0,0
235932,in,0,0
235933,baseline,0,0
235934,variables,0,1
235935,or,0,0
235936,in,0,0
235937,concurrent,0,0
235938,antiretroviral,0,0
235939,therapy,0,0
235940,.,0,0
235941,Among,0,0
235942,patients,0,0
235943,with,0,0
235944,newly,0,0
235945,diagnosed,0,0
235946,retinitis,0,0
235947,",",0,0
235948,mortality,1,1
235949,rates,1,1
235950,were,0,0
235951,similar,0,0
235952,(,0,0
235953,MSL-109,0,0
235954,",",0,0
235955,0.41/person-year,0,0
235956,;,0,0
235957,placebo,0,0
235958,",",0,0
235959,0.42/person-year,0,0
235960,;,0,0
235961,P=.95,0,0
235962,),0,0
235963,",",0,0
235964,whereas,0,0
235965,among,0,0
235966,patients,0,0
235967,with,0,0
235968,relapsed,0,0
235969,retinitis,0,0
235970,the,0,0
235971,MSL-109-treated,0,0
235972,group,0,0
235973,had,0,0
235974,a,0,0
235975,greater,0,0
235976,mortality,1,1
235977,rate,1,1
235978,(,0,0
235979,MSL-109,0,0
235980,",",0,0
235981,0.83/person-year,0,0
235982,;,0,0
235983,placebo,0,0
235984,",",0,0
235985,0.24/person-year,0,0
235986,;,0,0
235987,P=.003,0,0
235988,),0,0
235989,.,0,0
235990,However,0,0
235991,",",0,0
235992,the,0,0
235993,mortality,1,1
235994,rate,1,1
235995,in,0,0
235996,the,0,0
235997,placebo-treated,0,0
235998,patients,0,0
235999,with,0,0
236000,relapsed,0,0
236001,CMV,0,0
236002,retinitis,0,0
236003,was,0,0
236004,lower,0,0
236005,than,0,0
236006,that,0,0
236007,in,0,0
236008,the,0,0
236009,placebo-treated,0,0
236010,patients,0,0
236011,with,0,0
236012,newly,0,0
236013,diagnosed,0,0
236014,CMV,0,0
236015,retinitis,0,0
236016,and,0,0
236017,lower,0,0
236018,than,0,0
236019,that,0,0
236020,in,0,0
236021,other,0,0
236022,trials,0,0
236023,of,0,0
236024,patients,0,0
236025,with,0,0
236026,relapsed,0,0
236027,CMV,0,0
236028,retinitis,0,0
236029,.,0,0
236030,CONCLUSIONS,0,0
236031,Intravenous,0,0
236032,MSL-109,0,0
236033,",",0,0
236034,60,0,0
236035,mg,0,0
236036,every,0,0
236037,2,0,0
236038,weeks,0,0
236039,",",0,0
236040,appeared,0,0
236041,to,0,0
236042,be,0,0
236043,ineffective,1,1
236044,adjuvant,0,0
236045,therapy,0,0
236046,for,0,0
236047,CMV,0,0
236048,retinitis,0,0
236049,.,0,0
236050,The,0,0
236051,mortality,1,1
236052,rate,1,1
236053,was,0,0
236054,higher,0,0
236055,in,0,0
236056,the,0,0
236057,MSL-109-treated,0,0
236058,group,0,0
236059,",",0,0
236060,but,0,0
236061,the,0,0
236062,reasons,0,0
236063,for,0,0
236064,this,0,0
236065,difference,0,0
236066,remain,0,0
236067,uncertain,0,0
236068,.,0,0
236069,Randomised,0,0
236070,community-based,0,0
236071,trial,0,0
236072,of,0,0
236073,annual,0,0
236074,single-dose,0,0
236075,diethylcarbamazine,0,0
236076,with,0,0
236077,or,0,0
236078,without,0,0
236079,ivermectin,0,0
236080,against,0,1
236081,Wuchereria,0,0
236082,bancrofti,0,0
236083,infection,0,1
236084,in,0,0
236085,human,0,0
236086,beings,0,0
236087,and,0,0
236088,mosquitoes,0,0
236089,.,0,0
236090,BACKGROUND,0,0
236091,WHO,0,0
236092,has,0,0
236093,targeted,0,0
236094,lymphatic,0,0
236095,filariasis,0,0
236096,for,0,0
236097,elimination,0,0
236098,.,0,0
236099,Studies,0,0
236100,of,0,0
236101,vector-parasite,0,0
236102,relations,0,0
236103,of,0,0
236104,Wuchereria,0,0
236105,bancrofti,0,0
236106,suggest,0,0
236107,that,0,0
236108,a,0,0
236109,reduction,0,0
236110,in,0,0
236111,the,0,0
236112,microfilarial,0,0
236113,reservoir,0,1
236114,by,0,0
236115,mass,0,1
236116,chemotherapy,0,0
236117,may,0,0
236118,interrupt,0,0
236119,transmission,0,1
236120,and,0,0
236121,thereby,0,0
236122,eliminate,0,0
236123,infection,0,1
236124,.,0,0
236125,However,0,0
236126,",",0,0
236127,no,0,0
236128,field,0,0
236129,data,0,0
236130,exist,0,0
236131,on,0,0
236132,the,0,0
236133,impact,0,0
236134,of,0,0
236135,chemotherapy,0,0
236136,alone,0,0
236137,on,0,0
236138,vector,0,0
236139,efficiency,0,1
236140,and,0,1
236141,transmission,0,1
236142,intensity,0,1
236143,of,0,0
236144,W,0,1
236145,bancrofti,0,0
236146,.,0,0
236147,We,0,0
236148,compared,0,0
236149,the,0,0
236150,impact,0,0
236151,of,0,0
236152,an,0,0
236153,annual,0,0
236154,community-wide,0,0
236155,single-dose,0,0
236156,treatment,0,0
236157,with,0,0
236158,diethylcarbamazine,0,0
236159,alone,0,0
236160,or,0,0
236161,with,0,0
236162,ivermectin,0,0
236163,on,0,0
236164,rate,0,1
236165,and,0,1
236166,intensity,0,1
236167,of,0,1
236168,microfilaraemia,0,1
236169,",",0,0
236170,and,0,1
236171,transmission,0,1
236172,intensity,0,1
236173,in,0,0
236174,an,0,0
236175,area,0,0
236176,of,0,0
236177,Papua,0,0
236178,New,0,0
236179,Guinea,0,0
236180,endemic,0,0
236181,for,0,0
236182,intense,0,0
236183,W,0,1
236184,bancrofti,0,0
236185,transmission,0,1
236186,.,0,0
236187,METHODS,0,0
236188,We,0,0
236189,carried,0,0
236190,out,0,0
236191,clinical,0,0
236192,and,0,0
236193,parasitological,0,1
236194,surveys,0,0
236195,in,0,0
236196,14,0,0
236197,communities,0,0
236198,in,0,0
236199,matched,0,0
236200,pairs,0,0
236201,.,0,0
236202,People,0,0
236203,aged,0,0
236204,5,0,0
236205,years,0,0
236206,or,0,0
236207,older,0,0
236208,in,0,0
236209,seven,0,0
236210,communities,0,0
236211,received,0,0
236212,randomly,0,0
236213,assigned,0,0
236214,diethylcarbamazine,0,0
236215,6,0,0
236216,mg/kg,0,0
236217,and,0,0
236218,people,0,0
236219,in,0,0
236220,the,0,0
236221,other,0,0
236222,seven,0,0
236223,communities,0,0
236224,received,0,0
236225,diethylcarbamazine,0,0
236226,6,0,0
236227,mg/kg,0,0
236228,plus,0,0
236229,ivermectin,0,0
236230,400,0,0
236231,micrograms/kg,0,0
236232,.,0,0
236233,We,0,0
236234,made,0,0
236235,physical,0,1
236236,examinations,0,0
236237,for,0,0
236238,hydroceles,0,0
236239,and,0,1
236240,leg,0,1
236241,oedema,0,1
236242,and,0,1
236243,investigated,0,0
236244,microfilarial,0,1
236245,densities,0,1
236246,by,0,0
236247,membrane,0,0
236248,filtration,0,1
236249,before,0,0
236250,and,0,0
236251,after,0,0
236252,treatment,0,0
236253,.,0,0
236254,We,0,0
236255,selected,0,0
236256,five,0,0
236257,communities,0,0
236258,for,0,0
236259,monthly,0,0
236260,entomological,0,1
236261,surveys,0,0
236262,between,0,0
236263,September,0,0
236264,",",0,0
236265,1993,0,0
236266,",",0,0
236267,and,0,0
236268,September,0,0
236269,",",0,0
236270,1995,0,0
236271,.,0,0
236272,Mosquitoes,0,0
236273,were,0,0
236274,collected,0,0
236275,in,0,0
236276,these,0,0
236277,communities,0,0
236278,by,0,0
236279,the,0,0
236280,all-night,0,0
236281,landing,0,0
236282,catch,0,1
236283,method,0,0
236284,and,0,1
236285,were,0,0
236286,individually,0,0
236287,dissected,0,0
236288,to,0,0
236289,identify,0,0
236290,rates,0,1
236291,of,0,0
236292,infection,0,1
236293,and,0,0
236294,infectiveness,0,1
236295,.,0,0
236296,FINDINGS,0,0
236297,2219,0,0
236298,(,0,0
236299,87.6,0,0
236300,%,0,0
236301,),0,0
236302,of,0,0
236303,2534,0,0
236304,eligible,0,0
236305,people,0,0
236306,received,0,0
236307,treatment,0,0
236308,.,0,0
236309,Microfilarial,1,1
236310,rate,1,1
236311,and,1,1
236312,density,1,1
236313,had,0,0
236314,decreased,0,0
236315,1,0,0
236316,year,0,0
236317,after,0,0
236318,treatment,0,0
236319,in,0,0
236320,all,0,0
236321,14,0,0
236322,communities,0,0
236323,;,0,0
236324,this,0,0
236325,decrease,0,0
236326,was,0,0
236327,significantly,0,0
236328,higher,0,0
236329,in,0,0
236330,communities,0,0
236331,given,0,0
236332,combined,0,0
236333,therapy,0,0
236334,than,0,0
236335,in,0,0
236336,those,0,0
236337,given,0,0
236338,diethylcarbamazine,0,0
236339,alone,0,0
236340,(,0,0
236341,mean,0,0
236342,decreases,0,0
236343,57.5,0,0
236344,%,0,0
236345,and,0,0
236346,30.6,0,0
236347,%,0,0
236348,",",0,0
236349,respectively,0,0
236350,;,0,0
236351,p,0,0
236352,=,0,0
236353,0.0013,0,0
236354,),0,0
236355,.,0,0
236356,Greater,0,0
236357,decreases,0,1
236358,were,0,0
236359,also,0,0
236360,seen,0,0
236361,in,0,0
236362,community-specific,1,0
236363,microfilarial,1,0
236364,intensity,1,1
236365,with,0,0
236366,combined,0,0
236367,therapy,0,0
236368,(,0,0
236369,mean,0,1
236370,reductions,0,0
236371,91.1,0,0
236372,%,0,0
236373,and,0,0
236374,69.8,0,0
236375,%,0,0
236376,",",0,0
236377,respectively,0,0
236378,;,0,0
236379,p,0,0
236380,=,0,0
236381,0.0047,0,0
236382,),0,0
236383,.,0,0
236384,The,0,0
236385,rate,1,1
236386,of,1,0
236387,leg,1,1
236388,oedema,1,1
236389,was,0,0
236390,not,0,0
236391,altered,0,0
236392,",",0,0
236393,but,0,0
236394,the,0,0
236395,frequency,1,1
236396,of,1,0
236397,advanced,1,0
236398,hydroceles,1,0
236399,decreased,0,0
236400,by,0,0
236401,47,0,0
236402,%,0,0
236403,with,0,0
236404,combined,0,0
236405,therapy,0,0
236406,and,0,0
236407,56,0,0
236408,%,0,0
236409,with,0,0
236410,diethylcarbamazine,0,0
236411,alone,0,0
236412,.,0,0
236413,"26,641",0,0
236414,Anopheles,0,0
236415,punctulatus,0,0
236416,mosquitoes,0,0
236417,were,0,0
236418,caught,0,0
236419,during,0,0
236420,499,0,0
236421,person-nights,0,0
236422,of,0,0
236423,landing,0,0
236424,catches,0,0
236425,.,0,0
236426,Exposure,1,0
236427,to,1,0
236428,infective,1,1
236429,third-stage,1,0
236430,larvae,1,0
236431,decreased,0,0
236432,in,0,0
236433,all,0,0
236434,monitored,0,0
236435,five,0,0
236436,communities,0,0
236437,.,0,0
236438,Annual,1,1
236439,transmission,1,1
236440,potential,1,0
236441,decreased,0,0
236442,by,0,0
236443,between,0,0
236444,75.7,0,0
236445,%,0,0
236446,and,0,0
236447,98.8,0,0
236448,%,0,0
236449,in,0,0
236450,combined-therapy,0,0
236451,communities,0,0
236452,and,0,0
236453,between,0,0
236454,75.6,0,0
236455,%,0,0
236456,and,0,0
236457,79.4,0,0
236458,%,0,0
236459,in,0,0
236460,communities,0,0
236461,given,0,0
236462,diethylcarbamazine,0,0
236463,alone,0,0
236464,.,0,0
236465,Transmission,0,1
236466,was,0,0
236467,almost,0,0
236468,interrupted,0,0
236469,in,0,0
236470,two,0,0
236471,communities,0,0
236472,treated,0,0
236473,with,0,0
236474,combined,0,0
236475,therapy,0,0
236476,.,0,0
236477,INTERPRETATION,0,0
236478,Annual,0,1
236479,single-dose,0,0
236480,community-wide,0,0
236481,treatment,0,0
236482,with,0,0
236483,diethylcarbamazine,0,0
236484,alone,0,0
236485,or,0,0
236486,with,0,0
236487,ivermectin,0,0
236488,is,0,0
236489,effective,1,0
236490,for,0,0
236491,the,0,0
236492,control,0,0
236493,of,0,0
236494,lymphatic,0,0
236495,filariasis,0,0
236496,in,0,0
236497,highly,0,0
236498,endemic,0,0
236499,areas,0,1
236500,",",0,0
236501,but,0,0
236502,combination,0,0
236503,therapy,0,0
236504,brings,0,0
236505,about,0,0
236506,greater,0,0
236507,decreases,0,1
236508,in,0,0
236509,rates,1,1
236510,and,1,0
236511,intensity,1,1
236512,of,1,0
236513,microfilaraemia,1,0
236514,.,1,0
236515,Effect,0,0
236516,of,0,0
236517,indomethacin,0,0
236518,phonophoresis,0,0
236519,on,0,0
236520,the,0,0
236521,relief,0,1
236522,of,0,0
236523,temporomandibular,0,0
236524,joint,0,1
236525,pain,0,1
236526,.,0,0
236527,The,0,0
236528,pain-relieving,1,0
236529,effect,1,0
236530,of,0,0
236531,indomethacin,0,0
236532,phonophoresis,0,0
236533,on,0,0
236534,temporomandibular,1,1
236535,(,1,0
236536,TMJ,1,1
236537,),1,1
236538,joint,1,1
236539,pain,1,1
236540,was,0,0
236541,evaluated,0,0
236542,in,0,0
236543,a,0,0
236544,double-blind,0,0
236545,",",0,0
236546,placebo-controlled,0,0
236547,clinical,0,0
236548,trial,0,0
236549,.,0,0
236550,Twenty,0,0
236551,subjects,0,0
236552,",",0,0
236553,who,0,0
236554,have,0,0
236555,TMJ,0,1
236556,pain,0,1
236557,",",0,0
236558,were,0,0
236559,included,0,0
236560,for,0,0
236561,this,0,0
236562,study,0,0
236563,and,0,0
236564,randomly,0,0
236565,assigned,0,0
236566,to,0,0
236567,either,0,0
236568,the,0,0
236569,experimental,0,0
236570,group,0,0
236571,(,0,0
236572,n,0,0
236573,=,0,0
236574,10,0,0
236575,),0,0
236576,or,0,0
236577,the,0,0
236578,control,0,0
236579,group,0,0
236580,(,0,0
236581,n,0,0
236582,=,0,0
236583,10,0,0
236584,),0,0
236585,.,0,0
236586,Each,0,0
236587,treatment,0,0
236588,consisted,0,0
236589,of,0,0
236590,the,0,0
236591,application,0,0
236592,of,0,0
236593,ultrasound,0,1
236594,massage,0,0
236595,(,0,0
236596,1.0,0,0
236597,MHz,0,0
236598,",",0,0
236599,0.8,0,0
236600,to,0,0
236601,1.5,0,0
236602,W/cm2,0,0
236603,continuous,0,0
236604,output,0,1
236605,),0,0
236606,for,0,0
236607,15,0,0
236608,minutes,0,0
236609,to,0,0
236610,the,0,0
236611,painful,0,0
236612,temporomandibular,0,0
236613,joint,0,1
236614,.,0,0
236615,As,0,0
236616,a,0,0
236617,conducting,0,0
236618,medium,0,0
236619,",",0,0
236620,1,0,0
236621,%,0,0
236622,indomethacin,0,0
236623,cream,0,0
236624,was,0,0
236625,used,0,0
236626,for,0,0
236627,the,0,0
236628,experimental,0,0
236629,group,0,0
236630,and,0,1
236631,placebo,0,0
236632,cream,0,0
236633,for,0,0
236634,the,0,0
236635,control,0,0
236636,group,0,0
236637,respectively,0,0
236638,.,0,0
236639,Pre-,0,0
236640,and,0,0
236641,post-treatment,0,1
236642,pain,1,1
236643,levels,1,1
236644,and,1,1
236645,pain,1,1
236646,sensitivity,1,1
236647,were,0,0
236648,assessed,0,0
236649,with,0,0
236650,visual,1,1
236651,analogue,1,1
236652,scales,1,1
236653,(,1,0
236654,VAS,1,1
236655,),1,1
236656,and,0,0
236657,pressure,1,1
236658,pain,1,1
236659,threshold,1,1
236660,(,1,0
236661,PPT,1,0
236662,),1,0
236663,.,1,0
236664,Mean,0,0
236665,data,0,0
236666,indicated,0,0
236667,that,0,0
236668,post-treatment,1,0
236669,VAS,1,1
236670,was,0,0
236671,significantly,0,0
236672,decreased,0,0
236673,and,0,0
236674,post-treatment,1,0
236675,PPT,1,1
236676,was,0,0
236677,significantly,0,0
236678,increased,0,0
236679,in,0,0
236680,the,0,0
236681,experimental,0,0
236682,group,0,0
236683,",",0,0
236684,not,0,0
236685,in,0,0
236686,the,0,0
236687,control,0,0
236688,group,0,0
236689,.,0,0
236690,The,0,0
236691,results,0,0
236692,of,0,0
236693,this,0,0
236694,study,0,0
236695,suggest,0,0
236696,that,0,0
236697,indomethacin,0,0
236698,phonophoresis,0,0
236699,provides,0,0
236700,significant,0,0
236701,pain,1,1
236702,relieving,0,1
236703,effect,0,0
236704,over,0,0
236705,the,0,0
236706,TMJ,0,0
236707,pain,0,1
236708,.,0,0
236709,[,0,0
236710,Value,0,0
236711,of,0,0
236712,absorbable,0,0
236713,clips,0,0
236714,in,0,0
236715,laparoscopic,0,0
236716,cholecystectomy,0,0
236717,.,0,0
236718,A,0,0
236719,randomized,0,0
236720,prospective,0,0
236721,study,0,0
236722,],0,0
236723,.,0,0
236724,Most,0,0
236725,surgeons,0,0
236726,use,0,0
236727,metal,0,0
236728,clips,0,0
236729,in,0,0
236730,laparoscopic,0,0
236731,cholecystectomy,0,0
236732,.,0,0
236733,The,0,0
236734,aim,0,0
236735,of,0,0
236736,this,0,0
236737,prospective,0,0
236738,randomized,0,0
236739,controlled,0,0
236740,study,0,0
236741,was,0,0
236742,to,0,0
236743,evaluate,0,0
236744,the,0,0
236745,efficacy,1,1
236746,of,1,0
236747,absorbable,1,0
236748,clips,1,0
236749,in,0,0
236750,elective,1,0
236751,laparoscopic,1,0
236752,cholecystectomy,1,0
236753,.,1,0
236754,One,0,0
236755,hundred,0,0
236756,consecutive,0,0
236757,patients,0,0
236758,with,0,0
236759,symptomatic,0,0
236760,gallstones,0,1
236761,without,0,0
236762,complications,0,1
236763,were,0,0
236764,randomized,0,0
236765,into,0,0
236766,groups,0,0
236767,;,0,0
236768,group,0,0
236769,T,0,0
236770,had,0,0
236771,two,0,0
236772,metal,0,0
236773,clips,0,0
236774,(,0,0
236775,titan,0,0
236776,clip,0,0
236777,ETHICONR,0,0
236778,),0,0
236779,",",0,0
236780,group,0,0
236781,R,0,1
236782,(,0,0
236783,laproclipR,0,0
236784,Davis,0,0
236785,and,0,1
236786,Geck,0,1
236787,),0,0
236788,had,0,0
236789,one,0,0
236790,absorbable,0,0
236791,clip,0,0
236792,applied,0,0
236793,on,0,0
236794,the,0,0
236795,cystic,0,0
236796,duct,0,1
236797,and,0,0
236798,cystic,0,0
236799,artery,0,0
236800,.,0,0
236801,The,0,0
236802,patients,0,0
236803,were,0,0
236804,followed,0,0
236805,for,0,0
236806,one,0,0
236807,year,0,0
236808,.,0,0
236809,There,0,0
236810,was,0,0
236811,no,0,0
236812,difference,0,0
236813,between,0,0
236814,the,0,0
236815,two,0,0
236816,groups,0,0
236817,concerning,0,0
236818,operative,1,1
236819,time,1,1
236820,",",1,0
236821,hospital,1,1
236822,stay,1,1
236823,and,1,1
236824,postoperative,1,1
236825,complications,1,1
236826,.,1,0
236827,The,0,0
236828,absorbable,1,0
236829,clips,1,0
236830,seem,1,0
236831,to,1,0
236832,be,1,0
236833,as,1,0
236834,effective,1,0
236835,as,1,0
236836,metal,1,0
236837,clips,1,0
236838,in,0,0
236839,providing,0,0
236840,hemostasis,1,1
236841,in,0,0
236842,cystic,0,0
236843,artery,0,1
236844,and,0,0
236845,in,0,0
236846,cystic,0,0
236847,duct,0,1
236848,ligation,0,0
236849,.,0,0
236850,Efficacy,0,1
236851,of,0,0
236852,intravenous,0,0
236853,granisetron,0,0
236854,to,0,0
236855,control,0,0
236856,nausea,0,1
236857,and,0,0
236858,vomiting,0,1
236859,during,0,0
236860,multiple,0,0
236861,cycles,0,0
236862,of,0,0
236863,cisplatin-based,0,0
236864,chemotherapy,0,0
236865,.,0,0
236866,The,0,0
236867,safety,0,1
236868,and,0,0
236869,efficacy,0,1
236870,of,0,1
236871,granisetron,0,0
236872,(,0,0
236873,10,0,0
236874,micrograms/kg,0,0
236875,and,0,0
236876,40,0,0
236877,micrograms/kg,0,0
236878,),0,0
236879,were,0,0
236880,evaluated,0,0
236881,during,0,0
236882,a,0,0
236883,second,0,0
236884,(,0,0
236885,n,0,0
236886,=,0,0
236887,393,0,0
236888,),0,0
236889,and,0,0
236890,third,0,1
236891,(,0,0
236892,n,0,0
236893,=,0,0
236894,200,0,0
236895,),0,0
236896,cycle,0,0
236897,of,0,0
236898,chemotherapy,0,0
236899,in,0,0
236900,this,0,0
236901,multicenter,0,0
236902,",",0,0
236903,double-blind,0,0
236904,",",0,1
236905,randomized,0,0
236906,",",0,0
236907,parallel-group,0,0
236908,study,0,0
236909,.,0,0
236910,Granisetron,0,0
236911,was,0,0
236912,administered,0,0
236913,as,0,0
236914,a,0,0
236915,single,0,0
236916,intravenous,0,0
236917,dose,0,0
236918,before,0,0
236919,the,0,0
236920,start,0,0
236921,of,0,0
236922,cisplatin,0,0
236923,chemotherapy,0,0
236924,(,0,0
236925,>,0,0
236926,or,0,0
236927,=,0,0
236928,60,0,0
236929,mg/m2,0,0
236930,),0,0
236931,.,0,0
236932,Total,1,0
236933,control,1,0
236934,(,1,0
236935,no,1,0
236936,vomiting,1,1
236937,",",1,0
236938,no,1,0
236939,retching,1,1
236940,",",1,0
236941,no,1,0
236942,nausea,1,1
236943,",",1,0
236944,and,1,0
236945,no,1,0
236946,use,1,0
236947,of,1,0
236948,antiemetic,1,0
236949,rescue,1,1
236950,medication,1,1
236951,),1,0
236952,after,1,0
236953,the,1,0
236954,first,1,0
236955,24,1,0
236956,hr,1,0
236957,following,0,0
236958,chemotherapy,0,0
236959,was,0,0
236960,achieved,0,0
236961,in,0,0
236962,40,0,0
236963,%,0,0
236964,and,0,0
236965,49,0,0
236966,%,0,0
236967,of,0,0
236968,patients,0,0
236969,in,0,0
236970,Cycles,0,0
236971,2,0,0
236972,and,0,0
236973,3,0,0
236974,",",0,0
236975,respectively,0,0
236976,",",0,0
236977,for,0,0
236978,the,0,0
236979,10,0,0
236980,micrograms/kg,0,0
236981,group,0,0
236982,",",0,0
236983,and,0,0
236984,in,0,0
236985,42,0,0
236986,%,0,0
236987,and,0,0
236988,38,0,0
236989,%,0,0
236990,of,0,0
236991,patients,0,0
236992,in,0,0
236993,Cycles,0,0
236994,2,0,0
236995,and,0,0
236996,3,0,0
236997,",",0,0
236998,respectively,0,0
236999,",",0,0
237000,for,0,0
237001,the,0,0
237002,40,0,0
237003,micrograms/kg,0,0
237004,group,0,0
237005,.,0,0
237006,Both,0,0
237007,dose,1,0
237008,levels,1,1
237009,of,1,0
237010,granisetron,1,0
237011,were,0,0
237012,well,0,0
237013,tolerated,1,1
237014,.,1,0
237015,The,0,0
237016,results,0,0
237017,demonstrate,0,0
237018,comparable,0,0
237019,efficacy,0,1
237020,between,0,0
237021,the,0,0
237022,10,0,0
237023,micrograms/kg,0,0
237024,and,0,0
237025,40,0,0
237026,micrograms/kg,0,0
237027,doses,0,0
237028,of,0,0
237029,granisetron,0,0
237030,in,0,0
237031,preventing,0,0
237032,nausea,1,1
237033,and,1,0
237034,vomiting,1,1
237035,during,0,0
237036,repeat,0,1
237037,cycles,0,0
237038,of,0,0
237039,high-dose,0,0
237040,cisplatin-based,0,0
237041,chemotherapy,0,0
237042,.,0,0
237043,The,0,0
237044,results,0,0
237045,of,0,0
237046,this,0,0
237047,study,0,0
237048,show,0,0
237049,that,0,0
237050,granisetron,0,0
237051,10,0,0
237052,micrograms/kg,0,0
237053,is,0,0
237054,safe,0,1
237055,and,0,0
237056,well,0,0
237057,tolerated,0,1
237058,",",0,0
237059,and,0,0
237060,remains,0,0
237061,effective,0,1
237062,with,0,0
237063,repeat,0,1
237064,cycle,0,1
237065,use,0,0
237066,.,0,0
237067,Histopathologic,1,1
237068,changes,1,1
237069,of,1,0
237070,the,1,0
237071,eyelid,1,0
237072,skin,1,1
237073,following,0,0
237074,trichloroacetic,0,0
237075,acid,0,0
237076,chemical,0,0
237077,peel,0,0
237078,.,0,0
237079,The,0,0
237080,use,0,0
237081,of,0,0
237082,trichloroacetic,0,0
237083,acid,0,0
237084,(,0,0
237085,TCA,0,1
237086,),0,0
237087,as,0,0
237088,a,0,0
237089,periorbital,0,1
237090,and,0,0
237091,eyelid,0,1
237092,peel,0,0
237093,for,0,0
237094,skin,0,1
237095,rejuvenation,0,0
237096,is,0,0
237097,gaining,0,0
237098,significant,0,0
237099,acceptance,0,1
237100,among,0,0
237101,oculoplastic,0,0
237102,surgeons,0,0
237103,",",0,0
237104,dermatologists,0,0
237105,",",0,1
237106,and,0,1
237107,other,0,1
237108,surgery,0,0
237109,groups,0,0
237110,.,0,0
237111,In,0,0
237112,spite,0,0
237113,of,0,0
237114,the,0,0
237115,current,0,0
237116,enthusiasm,0,0
237117,",",0,0
237118,there,0,0
237119,remain,0,0
237120,potentially,0,0
237121,serious,0,0
237122,complications,0,1
237123,resulting,0,0
237124,from,0,0
237125,any,0,0
237126,periorbital,0,1
237127,peel,0,0
237128,.,0,0
237129,Cases,0,0
237130,of,0,0
237131,cicatricial,0,1
237132,ectropion,0,0
237133,have,0,0
237134,been,0,0
237135,reported,0,0
237136,in,0,0
237137,phenol-peeled,0,0
237138,patients,0,0
237139,",",0,0
237140,and,0,0
237141,lower,0,1
237142,eyelid,0,1
237143,ectropion,0,0
237144,has,0,0
237145,reportedly,0,0
237146,occurred,0,0
237147,in,0,0
237148,patients,0,0
237149,undergoing,0,0
237150,deep,0,0
237151,eyelid,0,1
237152,peel,0,0
237153,in,0,0
237154,conjunction,0,0
237155,with,0,0
237156,a,0,0
237157,blepharoplasty,0,0
237158,(,0,0
237159,"1,2",0,0
237160,),0,0
237161,.,0,0
237162,To,0,0
237163,avoid,0,0
237164,this,0,0
237165,complication,0,0
237166,",",0,0
237167,it,0,0
237168,is,0,0
237169,necessary,0,0
237170,to,0,0
237171,better,0,0
237172,understand,0,0
237173,the,0,0
237174,depth,0,1
237175,of,0,0
237176,the,0,0
237177,wound,0,0
237178,produced,0,0
237179,by,0,0
237180,different,0,0
237181,strengths,0,0
237182,and,0,0
237183,combinations,0,0
237184,of,0,0
237185,peeling,0,0
237186,agents,0,0
237187,applied,0,0
237188,to,0,0
237189,living,0,0
237190,eyelid,0,1
237191,tissue,0,1
237192,and,0,0
237193,",",0,0
237194,more,0,0
237195,important,0,0
237196,",",0,0
237197,to,0,0
237198,determine,0,0
237199,the,0,0
237200,concentrations,0,1
237201,of,0,0
237202,TCA,0,0
237203,that,0,0
237204,are,0,0
237205,likely,0,0
237206,to,0,0
237207,lead,0,0
237208,to,0,0
237209,cicatricial,0,1
237210,ectropion,0,0
237211,when,0,0
237212,applied,0,0
237213,in,0,0
237214,a,0,0
237215,consistent,0,0
237216,fashion,0,0
237217,.,0,0
237218,We,0,0
237219,chose,0,0
237220,upper-eyelid,0,1
237221,skin,0,1
237222,because,0,0
237223,it,0,0
237224,is,0,0
237225,easier,0,0
237226,to,0,0
237227,obtain,0,0
237228,for,0,0
237229,histopathologic,0,1
237230,study,0,0
237231,than,0,0
237232,lower-eyelid,0,1
237233,skin,0,1
237234,and,0,0
237235,",",0,0
237236,in,0,0
237237,our,0,0
237238,experience,0,0
237239,",",0,0
237240,is,0,0
237241,more,0,0
237242,sensitive,0,0
237243,to,0,0
237244,hypertrophic,0,0
237245,changes,0,1
237246,after,0,0
237247,chemical,0,1
237248,peeling,0,1
237249,or,0,0
237250,carbon,0,0
237251,dioxide,0,0
237252,laser,0,0
237253,resurfacing,0,0
237254,.,0,0
237255,We,0,0
237256,applied,0,0
237257,TCA,0,0
237258,to,0,0
237259,the,0,0
237260,preseptal,0,0
237261,skin,0,0
237262,of,0,0
237263,10,0,0
237264,patients,0,0
237265,48,0,0
237266,h,0,0
237267,before,0,0
237268,standard,0,0
237269,upper-eyelid,0,0
237270,blepharoplasty,0,0
237271,.,0,0
237272,The,0,0
237273,acid,0,0
237274,was,0,0
237275,applied,0,0
237276,to,0,0
237277,produce,0,0
237278,a,0,0
237279,frost,0,0
237280,",",0,0
237281,using,0,0
237282,varying,0,0
237283,concentrations,0,1
237284,of,0,0
237285,acid,0,0
237286,",",0,0
237287,ranging,0,0
237288,from,0,0
237289,20,0,0
237290,to,0,0
237291,50,0,0
237292,%,0,0
237293,.,0,0
237294,The,0,0
237295,treated,0,0
237296,skin,0,1
237297,removed,0,0
237298,at,0,0
237299,the,0,0
237300,time,0,1
237301,of,0,0
237302,blepharoplasty,0,0
237303,was,0,0
237304,reviewed,0,0
237305,in,0,0
237306,a,0,0
237307,masked,0,0
237308,fashion,0,0
237309,by,0,0
237310,a,0,0
237311,dermatopathologist,0,0
237312,to,0,0
237313,determine,0,0
237314,the,0,0
237315,depth,0,1
237316,of,0,0
237317,necrosis,0,0
237318,.,0,0
237319,We,0,0
237320,found,0,0
237321,that,0,0
237322,superficial,1,1
237323,peels,1,0
237324,with,1,0
237325,necrosis,1,0
237326,involving,0,0
237327,30,0,0
237328,%,0,0
237329,of,0,0
237330,the,0,0
237331,epidermis,0,1
237332,were,0,0
237333,produced,0,0
237334,by,0,0
237335,the,0,0
237336,lowest-concentration,0,1
237337,combination,0,0
237338,of,0,0
237339,TCA,0,1
237340,applied,1,0
237341,(,0,0
237342,20,0,0
237343,%,0,0
237344,followed,0,0
237345,by,0,0
237346,0,0,0
237347,%,0,0
237348,),0,0
237349,.,0,0
237350,As,0,0
237351,the,0,0
237352,strength,1,1
237353,increased,1,0
237354,",",0,0
237355,so,0,0
237356,did,0,0
237357,the,0,0
237358,depth,0,1
237359,of,0,0
237360,peel,0,0
237361,.,0,0
237362,The,0,0
237363,combination,0,0
237364,of,0,0
237365,50,0,0
237366,%,0,0
237367,followed,0,0
237368,by,0,0
237369,a,0,0
237370,second,0,0
237371,application,0,0
237372,of,0,0
237373,50,0,0
237374,%,0,0
237375,produced,0,0
237376,the,0,0
237377,deepest,1,1
237378,peel,1,0
237379,",",0,0
237380,with,0,0
237381,necrosis,0,1
237382,into,0,0
237383,the,0,0
237384,papillary,0,0
237385,dermis,0,0
237386,.,0,0
237387,This,0,0
237388,finding,0,0
237389,would,0,0
237390,indicate,0,0
237391,that,0,0
237392,the,0,0
237393,chance,0,0
237394,of,0,0
237395,developing,0,0
237396,cicatricial,0,1
237397,ectropion,0,0
237398,with,0,0
237399,any,0,0
237400,of,0,0
237401,the,0,0
237402,tested,0,0
237403,combinations,0,0
237404,of,0,0
237405,TCA,0,0
237406,should,0,0
237407,be,0,0
237408,very,0,0
237409,remote,0,0
237410,.,0,0
237411,Effect,0,0
237412,of,0,0
237413,L-carnitine,0,0
237414,on,0,0
237415,myocardial,0,1
237416,metabolism,0,0
237417,:,0,0
237418,results,0,0
237419,of,0,0
237420,a,0,0
237421,balanced,0,0
237422,",",0,0
237423,placebo-controlled,0,0
237424,",",0,0
237425,double-blind,0,0
237426,study,0,0
237427,in,0,0
237428,patients,0,0
237429,undergoing,0,0
237430,open,0,0
237431,heart,0,0
237432,surgery,0,0
237433,.,0,0
237434,The,0,0
237435,effects,0,0
237436,of,0,0
237437,L-carnitine,0,0
237438,on,0,0
237439,cardiac,0,1
237440,performance,0,1
237441,after,0,0
237442,open,0,0
237443,heart,0,1
237444,surgery,0,0
237445,were,0,0
237446,evaluated,0,0
237447,in,0,0
237448,a,0,0
237449,balanced,0,0
237450,",",0,0
237451,placebo-controlled,0,0
237452,",",0,0
237453,double-blind,0,0
237454,study,0,0
237455,in,0,0
237456,38,0,0
237457,patients,0,0
237458,.,0,0
237459,Preoperative,0,1
237460,haemodynamic,0,1
237461,status,0,1
237462,was,0,0
237463,good,0,0
237464,in,0,0
237465,all,0,0
237466,of,0,0
237467,them,0,0
237468,.,0,0
237469,Seventeen,0,0
237470,subjects,0,0
237471,underwent,0,0
237472,mitral,0,1
237473,valve,0,1
237474,replacement,0,0
237475,and,0,0
237476,19,0,0
237477,patients,0,0
237478,coronary,0,0
237479,artery,0,0
237480,bypass,0,0
237481,grafting,0,0
237482,.,0,0
237483,Five,0,0
237484,grams,0,0
237485,L-carnitine,0,0
237486,were,0,0
237487,given,0,0
237488,intravenously,0,0
237489,over,0,0
237490,2,0,0
237491,h,0,0
237492,",",0,0
237493,twice,0,0
237494,daily,0,0
237495,for,0,0
237496,5,0,0
237497,consecutive,0,0
237498,days,0,0
237499,;,0,0
237500,moreover,0,0
237501,",",0,0
237502,10,0,0
237503,g,0,0
237504,L-carnitine,0,0
237505,in,0,0
237506,1500,0,0
237507,ml,0,0
237508,cardioplegia,0,0
237509,were,0,0
237510,administered,0,0
237511,through,0,0
237512,the,0,0
237513,aortic,0,1
237514,root,0,0
237515,after,0,0
237516,aortic,0,1
237517,cross-clamping,0,0
237518,.,0,0
237519,Surgery,0,1
237520,was,0,0
237521,always,0,0
237522,planned,0,0
237523,on,0,0
237524,treatment,0,0
237525,day,0,0
237526,3,0,0
237527,.,0,0
237528,The,0,0
237529,post-ischaemic,0,0
237530,functional,0,0
237531,recovery,0,1
237532,of,0,0
237533,the,0,0
237534,heart,0,0
237535,was,0,0
237536,assessed,0,0
237537,by,0,0
237538,clinical,0,0
237539,parameters,0,1
237540,",",0,0
237541,as,0,0
237542,well,0,0
237543,as,0,0
237544,by,0,0
237545,biochemical,0,1
237546,and,0,0
237547,ultrastructure,0,0
237548,evaluations,0,0
237549,on,0,0
237550,biopsy,0,0
237551,specimens,0,0
237552,.,0,0
237553,No,0,0
237554,differences,0,0
237555,were,0,0
237556,found,0,0
237557,between,0,0
237558,the,0,0
237559,control,0,0
237560,and,0,0
237561,the,0,0
237562,treatment,0,0
237563,group,0,0
237564,with,0,0
237565,respect,0,0
237566,to,0,0
237567,all,0,0
237568,clinical,0,0
237569,parameters,0,1
237570,of,0,0
237571,cardiac,0,1
237572,performance,0,1
237573,after,0,0
237574,cardiopulmonary,0,0
237575,bypass,0,0
237576,.,0,0
237577,At,0,0
237578,anaesthesia,0,0
237579,induction,0,1
237580,",",0,0
237581,serum,1,1
237582,carnitine,1,1
237583,was,0,0
237584,significantly,0,0
237585,increased,0,0
237586,in,0,0
237587,treated,0,0
237588,patients,0,0
237589,",",0,0
237590,but,0,0
237591,carnitine,1,1
237592,concentrations,1,1
237593,in,0,0
237594,the,0,0
237595,right,0,0
237596,atrial,0,1
237597,biopsy,0,0
237598,obtained,0,0
237599,just,0,0
237600,before,0,0
237601,aortic,0,1
237602,declamping,0,0
237603,were,0,0
237604,similar,0,0
237605,in,0,0
237606,the,0,0
237607,two,0,0
237608,groups,0,0
237609,.,0,0
237610,In,0,0
237611,patients,0,0
237612,with,0,0
237613,mitral,0,1
237614,valve,0,0
237615,replacement,0,0
237616,",",0,0
237617,L-carnitine,0,1
237618,therapy,0,0
237619,was,0,0
237620,associated,0,0
237621,with,0,0
237622,significantly,0,0
237623,higher,0,0
237624,concentrations,0,1
237625,of,0,1
237626,pyruvate,1,0
237627,",",1,0
237628,ATP,1,0
237629,and,1,1
237630,creatine,1,1
237631,phosphate,1,0
237632,in,0,0
237633,papillary,0,0
237634,muscle,0,0
237635,.,0,0
237636,Glycogen,1,1
237637,levels,1,1
237638,were,0,0
237639,also,0,0
237640,higher,0,0
237641,in,0,0
237642,the,0,0
237643,treated,0,0
237644,group,0,0
237645,",",0,0
237646,but,0,0
237647,the,0,0
237648,difference,0,0
237649,was,0,0
237650,not,0,0
237651,statistically,0,0
237652,significant,0,0
237653,.,0,0
237654,Myocardial,0,1
237655,ultrastructure,0,0
237656,on,0,0
237657,septal,0,0
237658,biopsies,0,0
237659,",",0,0
237660,obtained,0,0
237661,within,0,0
237662,5,0,0
237663,min,0,0
237664,from,0,0
237665,weaning,0,0
237666,from,0,0
237667,extracorporeal,0,0
237668,circulation,0,1
237669,",",0,0
237670,showed,0,0
237671,better,0,0
237672,preservation,0,0
237673,scores,0,1
237674,for,0,0
237675,all,0,0
237676,considered,0,0
237677,parameters,0,1
237678,(,1,0
237679,nucleus,1,0
237680,",",1,0
237681,sarcoplasmic,1,1
237682,reticulum,1,1
237683,",",1,0
237684,mitochondria,1,1
237685,and,1,1
237686,cellular,1,1
237687,oedema,1,1
237688,),1,0
237689,in,0,0
237690,the,0,0
237691,treated,0,0
237692,subjects,0,0
237693,",",0,0
237694,although,0,0
237695,the,0,0
237696,difference,0,0
237697,reached,0,0
237698,statistical,0,0
237699,significance,0,1
237700,only,0,0
237701,for,0,0
237702,nuclei,0,0
237703,.,0,0
237704,When,0,0
237705,biochemical,0,1
237706,and,0,0
237707,ultrastructural,0,0
237708,data,0,0
237709,are,0,0
237710,considered,0,0
237711,",",0,0
237712,these,0,0
237713,findings,0,0
237714,suggest,0,0
237715,that,0,0
237716,L-carnitine,0,0
237717,improves,0,1
237718,myocardial,1,1
237719,metabolism,1,0
237720,.,1,0
237721,However,0,0
237722,",",0,0
237723,it,0,0
237724,can,0,0
237725,not,0,0
237726,be,0,0
237727,concluded,0,0
237728,that,0,0
237729,L-carnitine,0,0
237730,provides,0,0
237731,an,0,0
237732,advantageous,1,0
237733,support,1,0
237734,therapy,1,0
237735,for,0,0
237736,well-compensated,0,0
237737,patients,0,0
237738,requiring,0,0
237739,cardiac,0,0
237740,surgery,0,0
237741,.,0,0
237742,In,0,0
237743,contrast,0,0
237744,",",0,0
237745,the,0,0
237746,positive,0,0
237747,effects,0,0
237748,of,0,0
237749,L-carnitine,0,0
237750,on,0,0
237751,cardiac,1,1
237752,recovery,1,1
237753,after,0,0
237754,bypass,0,0
237755,might,0,0
237756,become,0,0
237757,clinically,0,0
237758,relevant,0,0
237759,in,0,0
237760,the,0,0
237761,surgical,0,0
237762,setting,0,0
237763,for,0,0
237764,haemodynamically,0,0
237765,compromised,0,0
237766,patients,0,0
237767,",",0,0
237768,in,0,0
237769,which,0,0
237770,further,0,0
237771,investigations,0,0
237772,are,0,0
237773,required,0,0
237774,.,0,0
237775,Bronchodilator,0,0
237776,response,0,1
237777,to,0,0
237778,salbutamol,0,0
237779,after,0,0
237780,spontaneous,0,1
237781,recovery,0,1
237782,from,0,0
237783,nonspecific,0,0
237784,bronchial,0,0
237785,provocation,0,0
237786,tests,0,1
237787,in,0,0
237788,asthma,0,0
237789,.,0,0
237790,Assessment,0,0
237791,of,0,0
237792,airway,0,1
237793,responsiveness,0,1
237794,by,0,0
237795,bronchoprovocation,0,1
237796,and,0,1
237797,bronchodilatation,0,1
237798,tests,0,0
237799,is,0,0
237800,important,0,0
237801,in,0,0
237802,the,0,0
237803,diagnostic,0,0
237804,work-up,0,0
237805,protocol,0,0
237806,of,0,0
237807,bronchial,0,1
237808,asthma,0,0
237809,and,0,0
237810,it,0,0
237811,would,0,0
237812,be,0,0
237813,convenient,0,0
237814,to,0,0
237815,undertake,0,0
237816,both,0,0
237817,tests,0,0
237818,on,0,0
237819,the,0,0
237820,same,0,0
237821,occasion,0,0
237822,.,0,0
237823,However,0,0
237824,",",0,0
237825,it,0,0
237826,is,0,0
237827,not,0,0
237828,known,0,0
237829,whether,0,0
237830,this,0,0
237831,can,0,0
237832,be,0,0
237833,done,0,0
237834,accurately,0,0
237835,.,0,0
237836,Therefore,0,0
237837,",",0,0
237838,this,0,0
237839,study,0,0
237840,evaluated,0,0
237841,the,0,0
237842,effect,0,0
237843,of,0,0
237844,a,0,0
237845,prior,0,0
237846,bronchial,0,0
237847,provocation,0,0
237848,test,0,0
237849,on,0,0
237850,the,0,0
237851,bronchodilator,0,0
237852,response,0,1
237853,to,0,0
237854,salbutamol,0,0
237855,after,0,0
237856,spontaneous,0,1
237857,recovery,0,1
237858,of,0,0
237859,the,0,0
237860,forced,0,0
237861,expiratory,0,1
237862,volume,0,1
237863,in,0,0
237864,one,0,0
237865,second,0,0
237866,(,1,0
237867,FEV1,1,1
237868,),1,0
237869,in,0,0
237870,a,0,0
237871,group,0,0
237872,of,0,0
237873,asthmatic,0,0
237874,subjects,0,0
237875,.,0,0
237876,On,0,0
237877,two,0,0
237878,separate,0,0
237879,occasions,0,0
237880,at,0,0
237881,the,0,0
237882,same,0,0
237883,time,0,1
237884,of,0,0
237885,day,0,0
237886,",",0,0
237887,concentration-response,0,1
237888,studies,0,0
237889,with,0,0
237890,inhaled,0,0
237891,histamine,0,1
237892,or,0,0
237893,methacholine,0,1
237894,",",0,0
237895,or,0,0
237896,a,0,0
237897,sham,0,0
237898,challenge,0,0
237899,with,0,0
237900,normal,0,0
237901,saline,0,0
237902,were,0,0
237903,carried,0,0
237904,out,0,0
237905,in,0,0
237906,a,0,0
237907,blinded,0,0
237908,",",0,0
237909,randomized,0,0
237910,manner,0,0
237911,.,0,0
237912,Changes,0,1
237913,in,0,0
237914,airway,0,1
237915,calibre,0,1
237916,were,0,0
237917,followed,0,0
237918,as,0,0
237919,FEV1,1,1
237920,and,0,0
237921,agonist,0,0
237922,responsiveness,0,1
237923,expressed,0,0
237924,as,0,0
237925,the,0,0
237926,provocative,0,0
237927,concentration,0,1
237928,causing,0,0
237929,a,0,0
237930,20,0,0
237931,%,0,0
237932,fall,0,0
237933,in,0,0
237934,FEV1,1,1
237935,(,0,0
237936,PC20,0,0
237937,),0,0
237938,.,0,0
237939,After,0,0
237940,either,0,0
237941,spontaneous,0,1
237942,recovery,0,1
237943,or,0,0
237944,a,0,0
237945,fixed-duration,0,0
237946,wait,0,0
237947,of,0,0
237948,45,0,0
237949,min,0,0
237950,(,0,0
237951,when,0,0
237952,appropriate,0,0
237953,),0,0
237954,",",0,0
237955,the,0,0
237956,subjects,0,0
237957,received,0,0
237958,2x100,0,0
237959,microg,0,0
237960,of,0,0
237961,salbutamol,0,0
237962,from,0,0
237963,a,0,0
237964,metered,0,0
237965,dose,0,0
237966,inhaler,0,0
237967,with,0,0
237968,a,0,0
237969,spacer,0,0
237970,.,0,0
237971,The,0,0
237972,bronchodilator,0,0
237973,response,0,1
237974,to,0,0
237975,salbutamol,0,0
237976,was,0,0
237977,expressed,0,0
237978,as,0,0
237979,a,0,0
237980,percentage,0,1
237981,of,0,0
237982,initial,1,0
237983,FEV1,1,1
237984,(,0,0
237985,deltaFEV1,0,0
237986,%,0,0
237987,init,0,0
237988,),0,0
237989,.,0,0
237990,Bronchial,0,0
237991,challenge,0,0
237992,with,0,0
237993,both,0,0
237994,agonists,0,0
237995,failed,0,0
237996,to,0,0
237997,alter,0,0
237998,significantly,0,0
237999,the,0,0
238000,airway,1,1
238001,response,1,1
238002,to,0,0
238003,salbutamol,0,0
238004,",",0,0
238005,with,0,0
238006,the,0,0
238007,deltaFEV1,1,1
238008,%,1,0
238009,init,1,1
238010,mean,1,1
238011,value,1,1
238012,(,0,0
238013,range,0,0
238014,),0,0
238015,being,0,0
238016,16.9,0,0
238017,%,0,0
238018,(,0,0
238019,9.0-31.9,0,0
238020,),0,0
238021,and,0,0
238022,17.5,0,0
238023,%,0,0
238024,(,0,0
238025,11.6-31.2,0,0
238026,),0,0
238027,on,0,0
238028,the,0,0
238029,sham,0,0
238030,and,0,0
238031,histamine/methacholine,0,1
238032,challenge,0,0
238033,day,0,0
238034,respectively,0,0
238035,.,0,0
238036,It,0,0
238037,was,0,0
238038,shown,0,0
238039,that,0,0
238040,the,0,0
238041,degree,0,1
238042,of,0,0
238043,bronchodilatation,0,1
238044,achieved,0,0
238045,after,0,0
238046,salbutamol,0,0
238047,200,0,0
238048,microg,0,0
238049,is,0,0
238050,not,0,0
238051,affected,0,0
238052,by,0,0
238053,prior,0,0
238054,bronchoprovocation,0,0
238055,testing,0,0
238056,when,0,0
238057,enough,0,0
238058,time,0,1
238059,is,0,0
238060,allowed,0,0
238061,for,0,0
238062,the,0,0
238063,airways,0,0
238064,to,0,0
238065,recover,0,0
238066,spontaneously,0,0
238067,to,0,0
238068,baseline,0,0
238069,forced,0,0
238070,expiratory,0,1
238071,volume,0,1
238072,in,0,0
238073,one,0,0
238074,second,0,0
238075,.,0,0
238076,Thus,0,1
238077,evaluation,0,0
238078,of,0,0
238079,airway,0,1
238080,responsiveness,0,1
238081,by,0,0
238082,both,0,0
238083,bronchial,0,0
238084,provocation,0,0
238085,tests,0,1
238086,and,0,1
238087,bronchodilator,0,1
238088,testing,0,0
238089,can,0,0
238090,be,0,0
238091,assessed,0,0
238092,reliably,0,0
238093,within,0,0
238094,a,0,0
238095,few,0,0
238096,hours,0,0
238097,in,0,0
238098,asthmatic,0,0
238099,patients,0,0
238100,.,0,0
238101,The,0,0
238102,Treatment,0,0
238103,of,0,0
238104,Lead-exposed,0,0
238105,Children,0,0
238106,(,0,0
238107,TLC,0,1
238108,),0,0
238109,trial,0,0
238110,:,0,0
238111,design,0,0
238112,and,0,1
238113,recruitment,0,0
238114,for,0,0
238115,a,0,0
238116,study,0,0
238117,of,0,0
238118,the,0,0
238119,effect,0,0
238120,of,0,0
238121,oral,0,0
238122,chelation,0,0
238123,on,0,0
238124,growth,0,1
238125,and,0,1
238126,development,0,1
238127,in,0,0
238128,toddlers,0,0
238129,.,0,0
238130,Exposure,0,0
238131,to,0,0
238132,lead,0,0
238133,impairs,0,0
238134,cognitive,0,1
238135,development,0,0
238136,in,0,0
238137,young,0,0
238138,children,0,0
238139,",",0,0
238140,but,0,0
238141,the,0,0
238142,benefits,0,0
238143,of,0,0
238144,lowering,0,0
238145,blood,0,1
238146,lead,0,0
238147,pharmacologically,0,0
238148,are,0,0
238149,not,0,0
238150,clear,0,0
238151,.,0,0
238152,This,0,0
238153,report,0,0
238154,describes,0,0
238155,the,0,0
238156,design,0,0
238157,",",0,0
238158,recruitment,0,1
238159,",",0,1
238160,enrolment,0,0
238161,and,0,1
238162,baseline,0,0
238163,results,0,0
238164,of,0,0
238165,the,0,0
238166,Treatment,0,0
238167,of,0,0
238168,Lead-Exposed,0,0
238169,Children,0,0
238170,(,0,0
238171,TLC,0,1
238172,),0,1
238173,trial,0,0
238174,",",0,0
238175,a,0,0
238176,randomised,0,0
238177,",",0,0
238178,multicentre,0,0
238179,",",0,0
238180,placebo-controlled,0,0
238181,",",0,0
238182,double-blind,0,0
238183,clinical,0,0
238184,trial,0,0
238185,of,0,0
238186,the,0,0
238187,effects,0,0
238188,of,0,0
238189,treating,0,0
238190,lead-exposed,0,0
238191,children,0,0
238192,with,0,0
238193,succimer,0,0
238194,",",0,0
238195,a,0,0
238196,drug,0,0
238197,that,0,0
238198,enhances,0,0
238199,urinary,0,1
238200,excretion,0,1
238201,of,0,0
238202,lead,0,0
238203,",",0,0
238204,on,0,0
238205,cognitive,0,1
238206,",",0,0
238207,behavioural,0,1
238208,and,0,1
238209,physical,0,1
238210,development,0,1
238211,.,0,0
238212,TLC,0,1
238213,clinical,0,0
238214,sites,0,0
238215,were,0,0
238216,in,0,0
238217,Baltimore,0,0
238218,",",0,0
238219,Cincinnati,0,0
238220,and,0,1
238221,Columbus,0,0
238222,",",0,1
238223,Newark,0,0
238224,and,0,0
238225,Philadelphia,0,0
238226,.,0,1
238227,Children,0,0
238228,were,0,0
238229,eligible,0,0
238230,for,0,0
238231,TLC,0,0
238232,if,0,0
238233,they,0,0
238234,were,0,0
238235,between,0,0
238236,12,0,0
238237,and,0,0
238238,33,0,0
238239,months,0,0
238240,of,0,0
238241,age,0,0
238242,",",0,0
238243,had,0,0
238244,a,0,0
238245,confirmed,0,0
238246,blood,0,1
238247,lead,0,0
238248,concentration,0,1
238249,between,0,0
238250,20,0,0
238251,and,0,0
238252,44,0,0
238253,micrograms/dL,0,0
238254,and,0,0
238255,lived,0,0
238256,in,0,0
238257,a,0,0
238258,residence,0,0
238259,suitable,0,0
238260,for,0,0
238261,lead,0,0
238262,dust,0,0
238263,reduction,0,1
238264,.,0,0
238265,Randomised,0,0
238266,children,0,0
238267,received,0,0
238268,up,0,0
238269,to,0,0
238270,three,0,0
238271,26-day,0,0
238272,courses,0,0
238273,of,0,0
238274,succimer,0,0
238275,or,0,0
238276,placebo,0,0
238277,",",0,1
238278,and,0,1
238279,were,0,0
238280,then,0,0
238281,followed,0,0
238282,for,0,0
238283,3,0,0
238284,years,0,0
238285,.,0,0
238286,The,0,0
238287,study,0,0
238288,can,0,0
238289,detect,0,0
238290,a,0,0
238291,three-point,0,0
238292,difference,0,0
238293,in,0,0
238294,full-scale,1,0
238295,IQ,1,0
238296,at,0,0
238297,3-year,0,0
238298,follow-up,0,0
238299,.,0,0
238300,Statistical,0,0
238301,power,0,0
238302,for,0,0
238303,the,0,0
238304,other,0,0
238305,end,0,0
238306,points,0,0
238307,is,0,0
238308,more,0,0
238309,difficult,0,0
238310,to,0,0
238311,estimate,0,0
238312,.,0,0
238313,A,0,0
238314,total,0,0
238315,of,0,0
238316,1854,0,0
238317,children,0,0
238318,were,0,0
238319,evaluated,0,0
238320,and,0,0
238321,780,0,0
238322,children,0,0
238323,were,0,0
238324,randomised,0,0
238325,between,0,0
238326,August,0,0
238327,1994,0,0
238328,and,0,0
238329,January,0,0
238330,1997,0,0
238331,.,0,0
238332,The,0,0
238333,mean,0,1
238334,age,0,0
238335,of,0,0
238336,randomised,0,0
238337,children,0,0
238338,was,0,0
238339,24,0,0
238340,months,0,0
238341,and,0,0
238342,mean,0,1
238343,blood,0,1
238344,lead,0,0
238345,level,0,0
238346,26,0,0
238347,micrograms/dL,0,0
238348,.,0,0
238349,Three-quarters,0,0
238350,were,0,0
238351,African-American,0,0
238352,.,0,0
238353,Most,0,0
238354,children,0,0
238355,had,0,0
238356,poor,0,1
238357,",",0,0
238358,single,0,0
238359,mothers,0,0
238360,who,0,0
238361,had,0,0
238362,completed,0,0
238363,12,0,0
238364,or,0,0
238365,fewer,0,0
238366,years,0,0
238367,of,0,1
238368,school,0,0
238369,and,0,0
238370,who,0,0
238371,lived,0,0
238372,in,0,0
238373,older,0,0
238374,",",0,0
238375,poorly,0,0
238376,maintained,0,0
238377,residences,0,0
238378,.,0,0
238379,A,0,0
238380,double,0,0
238381,blind,0,0
238382,randomized,0,0
238383,study,0,0
238384,of,0,0
238385,oral,0,0
238386,clodronate,0,0
238387,in,0,0
238388,the,0,0
238389,treatment,0,0
238390,of,0,0
238391,bone,0,1
238392,metastases,0,0
238393,from,0,0
238394,tumors,0,0
238395,poorly,0,0
238396,responsive,0,0
238397,to,0,0
238398,chemotherapy,0,0
238399,.,0,0
238400,Bisphosphonates,0,0
238401,are,0,0
238402,used,0,0
238403,in,0,0
238404,oncology,0,0
238405,as,0,0
238406,a,0,0
238407,means,0,0
238408,of,0,0
238409,decreasing,0,0
238410,complications,0,1
238411,due,0,0
238412,to,0,0
238413,bone,0,1
238414,metastases,0,0
238415,",",0,0
238416,in,0,0
238417,association,0,0
238418,with,0,0
238419,anticancer,0,0
238420,treatment,0,0
238421,",",0,0
238422,especially,0,0
238423,in,0,0
238424,patients,0,0
238425,with,0,0
238426,breast,0,0
238427,cancer,0,0
238428,",",0,1
238429,prostate,0,0
238430,cancer,0,1
238431,and,0,0
238432,myeloma,0,0
238433,.,0,0
238434,Little,0,0
238435,is,0,0
238436,known,0,0
238437,about,0,0
238438,the,0,0
238439,effects,0,0
238440,of,0,0
238441,bisphosphonates,0,0
238442,on,0,0
238443,bone,0,1
238444,metastases,0,0
238445,from,0,0
238446,other,0,0
238447,tumors,0,0
238448,and,0,0
238449,in,0,0
238450,particular,0,0
238451,from,0,0
238452,tumors,0,0
238453,for,0,0
238454,which,0,0
238455,no,0,0
238456,effective,0,0
238457,treatment,0,0
238458,is,0,0
238459,available,0,0
238460,.,0,0
238461,We,0,0
238462,conducted,0,0
238463,a,0,0
238464,randomized,0,0
238465,",",0,0
238466,double-blind,0,0
238467,placebo-controlled,0,0
238468,trial,0,0
238469,of,0,0
238470,oral,0,0
238471,clodronate,0,0
238472,in,0,0
238473,patients,0,0
238474,with,0,0
238475,bone,0,1
238476,metastases,0,0
238477,from,0,0
238478,tumors,0,0
238479,poorly,0,0
238480,responsive,0,0
238481,to,0,0
238482,chemotherapy,0,0
238483,",",0,0
238484,with,0,0
238485,the,0,0
238486,aims,0,0
238487,of,0,0
238488,evaluating,0,0
238489,the,0,0
238490,effects,1,0
238491,of,1,0
238492,this,1,0
238493,drug,1,0
238494,on,1,0
238495,symptoms,1,1
238496,control,1,0
238497,and,1,1
238498,bone,1,1
238499,metastases,1,0
238500,evolution,1,1
238501,.,1,0
238502,Sixty-six,0,0
238503,patients,0,0
238504,with,0,0
238505,poorly,0,0
238506,responsive,0,0
238507,tumors,0,0
238508,such,0,0
238509,as,0,0
238510,non-small,0,0
238511,cell,0,1
238512,lung,0,1
238513,cancer,0,0
238514,(,0,0
238515,NSCLC,0,1
238516,),0,0
238517,",",0,0
238518,bladder,0,1
238519,cancer,0,0
238520,",",0,0
238521,gastrointestinal,0,1
238522,cancers,0,1
238523,",",0,0
238524,kidney,0,1
238525,cancer,0,1
238526,",",0,1
238527,melanoma,0,0
238528,and,0,1
238529,metastatic,0,0
238530,carcinoma,0,0
238531,of,0,0
238532,unknown,0,0
238533,origin,0,0
238534,entered,0,0
238535,the,0,0
238536,study,0,0
238537,.,0,0
238538,Patients,0,0
238539,were,0,0
238540,randomized,0,0
238541,to,0,0
238542,receive,0,0
238543,either,0,0
238544,clodronate,0,0
238545,"1,600",0,0
238546,mg/day,0,0
238547,for,0,0
238548,one,0,0
238549,year,0,0
238550,or,0,0
238551,identical,0,0
238552,placebo-containing,0,0
238553,tablets,0,0
238554,.,0,0
238555,Various,0,0
238556,parameters,0,1
238557,such,0,0
238558,as,0,0
238559,Karnofsky,1,0
238560,performance,1,1
238561,status,1,1
238562,",",1,1
238563,pain,1,1
238564,score,1,1
238565,(,1,0
238566,measured,1,0
238567,by,1,0
238568,a,1,0
238569,visual-analogue,1,1
238570,scale,1,1
238571,),1,0
238572,and,1,0
238573,analgesic,1,1
238574,requirement,1,1
238575,were,0,0
238576,recorded,0,0
238577,at,0,0
238578,monthly,0,0
238579,intervals,0,0
238580,.,0,0
238581,Of,0,0
238582,the,0,0
238583,66,0,0
238584,patients,0,0
238585,enrolled,0,0
238586,",",0,0
238587,9,0,0
238588,were,0,0
238589,observed,0,0
238590,for,0,0
238591,one,0,0
238592,month,0,0
238593,or,0,0
238594,less,0,0
238595,;,0,0
238596,7,0,0
238597,were,0,0
238598,followed,0,0
238599,for,0,0
238600,two,0,0
238601,months,0,0
238602,;,0,0
238603,only,0,0
238604,50,0,0
238605,patients,0,0
238606,were,0,0
238607,followed,0,0
238608,for,0,0
238609,more,0,0
238610,than,0,0
238611,2,0,0
238612,months,0,0
238613,and,0,0
238614,could,0,0
238615,be,0,0
238616,adequately,0,0
238617,evaluated,0,0
238618,.,0,0
238619,At,0,0
238620,3,0,0
238621,months,0,0
238622,both,0,0
238623,clodronate,0,0
238624,and,0,0
238625,placebo-treated,0,0
238626,patients,0,0
238627,had,0,0
238628,a,0,0
238629,decrease,1,0
238630,in,1,0
238631,Karnofsky,1,1
238632,performance,1,1
238633,status,1,1
238634,",",0,0
238635,with,0,0
238636,the,0,0
238637,decrease,0,0
238638,being,0,0
238639,more,0,0
238640,evident,0,0
238641,in,0,0
238642,the,0,0
238643,placebo,0,0
238644,group,0,0
238645,.,0,0
238646,Mean,1,0
238647,pain,1,1
238648,scores,1,1
238649,showed,0,0
238650,an,0,0
238651,increase,1,0
238652,of,1,0
238653,pain,1,1
238654,in,0,0
238655,patients,0,0
238656,receiving,0,0
238657,placebo,0,0
238658,and,0,0
238659,a,0,0
238660,decrease,0,0
238661,of,0,0
238662,pain,0,1
238663,in,0,0
238664,patients,0,0
238665,receiving,0,0
238666,clodronate,0,0
238667,",",0,0
238668,although,0,0
238669,the,0,0
238670,difference,0,0
238671,failed,0,0
238672,to,0,0
238673,be,0,0
238674,statistically,0,0
238675,significant,0,0
238676,.,0,0
238677,Analgesics,1,0
238678,requirement,1,1
238679,increased,0,0
238680,in,0,0
238681,both,0,0
238682,groups,0,0
238683,",",0,0
238684,but,0,0
238685,significantly,0,0
238686,more,0,0
238687,in,0,0
238688,patients,0,0
238689,receiving,0,0
238690,placebo,0,0
238691,(,0,0
238692,p,0,0
238693,=,0,0
238694,0.042,0,0
238695,),0,0
238696,",",0,0
238697,in,0,0
238698,whom,0,0
238699,increase,0,0
238700,in,0,0
238701,opioid,0,1
238702,requirements,0,1
238703,was,0,0
238704,particularly,0,0
238705,evident,0,0
238706,.,0,0
238707,Toxicity,1,1
238708,was,1,0
238709,low,1,0
238710,",",0,0
238711,with,0,0
238712,occasional,1,1
238713,gastroenteric,1,0
238714,discomfort,1,1
238715,in,0,0
238716,both,0,0
238717,groups,0,0
238718,.,0,0
238719,The,0,0
238720,main,0,0
238721,problem,0,0
238722,of,0,0
238723,this,0,0
238724,study,0,0
238725,was,0,0
238726,the,0,0
238727,difficulty,0,1
238728,in,0,0
238729,recruiting,0,0
238730,an,0,0
238731,adequate,0,0
238732,number,0,1
238733,of,0,0
238734,patients,0,0
238735,and,0,0
238736,following,0,0
238737,them,0,0
238738,for,0,0
238739,a,0,0
238740,sufficient,0,0
238741,period,0,0
238742,of,0,0
238743,time,0,1
238744,:,0,0
238745,general,0,0
238746,conditions,0,0
238747,rapidly,0,0
238748,deteriorated,0,0
238749,in,0,0
238750,many,0,0
238751,patients,0,0
238752,",",0,0
238753,and,0,0
238754,approximately,0,0
238755,25,0,0
238756,%,0,0
238757,of,0,0
238758,the,0,0
238759,66,0,0
238760,enrolled,0,0
238761,were,0,0
238762,not,0,0
238763,considered,0,0
238764,evaluable,0,0
238765,;,0,0
238766,few,0,0
238767,patients,0,0
238768,survived,0,0
238769,for,0,0
238770,the,0,0
238771,length,0,1
238772,of,0,0
238773,the,0,0
238774,study,0,0
238775,",",0,0
238776,one,0,0
238777,year,0,0
238778,.,0,0
238779,This,0,0
238780,might,0,0
238781,partly,0,0
238782,account,0,0
238783,for,0,0
238784,the,0,0
238785,lack,0,0
238786,of,0,0
238787,significance,0,1
238788,of,0,0
238789,some,0,0
238790,of,0,0
238791,the,0,0
238792,parameters,0,1
238793,under,0,0
238794,study,0,0
238795,.,0,0
238796,With,0,0
238797,these,0,0
238798,limits,0,0
238799,",",0,0
238800,oral,0,0
238801,clodronate,0,0
238802,demonstrated,0,0
238803,some,0,0
238804,efficacy,0,1
238805,in,0,0
238806,symptom,0,1
238807,control,0,0
238808,and,0,0
238809,in,0,0
238810,reducing,0,0
238811,the,0,0
238812,need,0,0
238813,for,0,0
238814,analgesics,0,0
238815,.,0,0
238816,The,0,0
238817,influence,0,0
238818,of,0,0
238819,sequential,0,0
238820,annual,0,1
238821,vaccination,0,0
238822,and,0,0
238823,of,0,1
238824,DHEA,0,0
238825,administration,0,0
238826,on,0,0
238827,the,0,0
238828,efficacy,0,1
238829,of,0,0
238830,the,0,0
238831,immune,0,0
238832,response,0,0
238833,to,0,0
238834,influenza,0,0
238835,vaccine,0,0
238836,in,0,0
238837,the,0,0
238838,elderly,0,0
238839,.,0,0
238840,The,0,0
238841,present,0,0
238842,study,0,0
238843,examined,0,0
238844,the,0,0
238845,effect,0,0
238846,of,0,0
238847,repeated,0,0
238848,vaccination,0,0
238849,and,0,0
238850,of,0,1
238851,dehydroepiandrosterone,0,1
238852,(,0,0
238853,DHEA,0,0
238854,),0,0
238855,treatment,0,0
238856,on,0,0
238857,the,0,0
238858,immune,0,0
238859,response,0,0
238860,to,0,0
238861,influenza,0,0
238862,vaccine,0,0
238863,in,0,0
238864,elderly,0,0
238865,subjects,0,0
238866,.,0,0
238867,Seventy-one,0,0
238868,elderly,0,0
238869,volunteers,0,0
238870,",",0,0
238871,aged,0,0
238872,61-89,0,0
238873,years,0,0
238874,",",0,0
238875,enrolled,0,0
238876,in,0,0
238877,a,0,0
238878,prospective,0,0
238879,randomized,0,0
238880,",",0,0
238881,double-blind,0,0
238882,study,0,0
238883,to,0,0
238884,receive,0,0
238885,either,0,0
238886,DHEA,0,0
238887,(,0,0
238888,50,0,0
238889,mg,0,0
238890,qd,0,0
238891,p.o,0,0
238892,.,0,0
238893,for,0,0
238894,4,0,0
238895,consecutive,0,0
238896,days,0,0
238897,starting,0,0
238898,2,0,0
238899,days,0,0
238900,before,0,0
238901,immunization,0,0
238902,),0,0
238903,or,0,0
238904,placebo,0,0
238905,.,0,1
238906,Antibody,0,0
238907,response,0,1
238908,against,0,0
238909,the,0,0
238910,three,0,0
238911,strains,0,0
238912,of,0,0
238913,vaccine,0,0
238914,was,0,0
238915,measured,0,0
238916,before,0,0
238917,and,0,0
238918,28,0,0
238919,days,0,0
238920,after,0,0
238921,vaccination,0,0
238922,",",0,0
238923,and,0,1
238924,compared,0,0
238925,between,0,0
238926,previously,0,0
238927,vaccinated,0,0
238928,and,0,0
238929,non-vaccinated,0,0
238930,subjects,0,0
238931,.,0,0
238932,DHEA,0,0
238933,treatment,0,0
238934,did,0,0
238935,not,0,0
238936,enhance,0,0
238937,established,1,0
238938,immunity,1,1
238939,.,1,0
238940,A,0,0
238941,significant,0,0
238942,decrease,0,0
238943,in,0,0
238944,attainment,0,1
238945,of,0,0
238946,protective,1,1
238947,antibody,1,1
238948,titer,1,1
238949,(,0,0
238950,titer,0,1
238951,of,0,0
238952,1:40,0,0
238953,or,0,0
238954,greater,0,0
238955,),0,0
238956,against,0,1
238957,A/Texas,0,0
238958,in,0,0
238959,subjects,0,0
238960,with,0,0
238961,non-protective,0,0
238962,baseline,0,0
238963,antibody,0,1
238964,titer,0,1
238965,was,0,0
238966,recorded,0,0
238967,following,0,0
238968,DHEA,0,0
238969,treatment,0,0
238970,compared,0,0
238971,to,0,0
238972,placebo,0,0
238973,(,0,0
238974,52,0,0
238975,vs.,0,0
238976,84,0,0
238977,%,0,0
238978,",",0,0
238979,P,0,0
238980,<,0,0
238981,0.05,0,0
238982,),0,0
238983,.,0,0
238984,Post-immunization,1,0
238985,titers,1,1
238986,against,0,0
238987,influenza,0,0
238988,A,0,0
238989,strains,0,0
238990,were,0,0
238991,significantly,0,0
238992,higher,0,0
238993,in,0,0
238994,those,0,0
238995,subjects,0,0
238996,who,0,0
238997,were,0,0
238998,never,0,0
238999,immunized,0,0
239000,before,0,0
239001,.,0,0
239002,Additionally,0,0
239003,",",0,0
239004,post-vaccination,1,1
239005,protective,1,1
239006,titers,1,1
239007,against,0,0
239008,the,0,0
239009,A/Johannesburg,0,0
239010,strain,0,1
239011,were,0,0
239012,more,0,0
239013,prevalent,0,0
239014,in,0,0
239015,those,0,0
239016,subjects,0,0
239017,who,0,0
239018,were,0,0
239019,never,0,0
239020,vaccinated,0,0
239021,before,0,0
239022,.,0,0
239023,The,0,0
239024,results,0,0
239025,were,0,0
239026,not,0,0
239027,the,0,0
239028,same,0,0
239029,for,0,0
239030,anti-B/Harbin,0,0
239031,antibodies-repeated,0,0
239032,vaccination,0,0
239033,caused,0,0
239034,a,0,0
239035,non-significant,0,0
239036,increase,0,0
239037,in,0,0
239038,HI,0,0
239039,titer,0,1
239040,in,0,0
239041,previously,0,0
239042,vaccinated,0,0
239043,subjects,0,0
239044,.,0,0
239045,Inhaled,0,0
239046,fluticasone,0,0
239047,reduces,0,0
239048,sputum,1,0
239049,inflammatory,1,1
239050,indices,1,1
239051,in,0,0
239052,severe,0,1
239053,bronchiectasis,0,0
239054,.,0,0
239055,Although,0,0
239056,corticosteroid,0,0
239057,therapy,0,0
239058,might,0,0
239059,be,0,0
239060,clinically,0,0
239061,beneficial,0,0
239062,for,0,0
239063,bronchiectasis,0,0
239064,",",0,0
239065,very,0,0
239066,little,0,0
239067,is,0,0
239068,known,0,0
239069,of,0,0
239070,its,0,0
239071,effects,0,0
239072,on,0,0
239073,the,0,0
239074,inflammatory,1,1
239075,and,1,0
239076,infective,1,1
239077,markers,1,1
239078,in,0,0
239079,bronchiectasis,0,0
239080,.,0,0
239081,We,0,0
239082,have,0,0
239083,therefore,0,0
239084,performed,0,0
239085,a,0,0
239086,double-blind,0,0
239087,",",0,0
239088,placebo-controlled,0,0
239089,study,0,0
239090,to,0,0
239091,evaluate,0,0
239092,the,0,0
239093,effects,0,0
239094,of,0,0
239095,a,0,0
239096,4-wk,0,0
239097,administration,0,0
239098,of,0,0
239099,inhaled,0,0
239100,fluticasone,0,0
239101,in,0,0
239102,bronchiectasis,0,0
239103,.,0,0
239104,Twenty-four,0,0
239105,patients,0,0
239106,(,0,0
239107,12,0,0
239108,female,0,0
239109,;,0,0
239110,mean,0,1
239111,age,0,0
239112,51,0,0
239113,yr,0,0
239114,),0,0
239115,were,0,0
239116,randomized,0,0
239117,into,0,0
239118,receiving,0,0
239119,either,0,0
239120,inhaled,0,0
239121,fluticasone,0,0
239122,(,0,0
239123,500,0,0
239124,microgram,0,0
239125,twice,0,0
239126,daily,0,0
239127,),0,0
239128,via,0,0
239129,the,0,0
239130,Accuhaler,0,0
239131,device,0,0
239132,(,0,0
239133,n,0,0
239134,=,0,0
239135,12,0,0
239136,),0,0
239137,or,0,0
239138,placebo,0,0
239139,.,0,0
239140,At,0,0
239141,each,0,0
239142,visit,0,1
239143,",",0,0
239144,spirometry,1,1
239145,",",1,1
239146,24-h,1,1
239147,sputum,1,1
239148,volume,1,1
239149,",",1,1
239150,sputum,1,1
239151,leukocyte,1,1
239152,density,1,1
239153,",",1,0
239154,bacterial,1,1
239155,densities,1,1
239156,",",0,0
239157,and,0,1
239158,concentrations,1,1
239159,of,1,1
239160,interleukin,1,1
239161,(,1,0
239162,IL,1,0
239163,),1,1
239164,-1beta,1,0
239165,",",1,0
239166,IL-8,1,1
239167,",",1,1
239168,tumor,1,1
239169,necrosis,1,1
239170,factor-alpha,1,1
239171,(,1,0
239172,TNF-alpha,1,1
239173,),1,1
239174,",",0,0
239175,and,0,1
239176,leukotriene,1,1
239177,B4,1,1
239178,(,1,0
239179,LTB4,1,0
239180,),1,0
239181,were,0,0
239182,determined,0,0
239183,.,0,0
239184,There,0,0
239185,was,0,0
239186,a,0,0
239187,significant,0,0
239188,(,0,0
239189,p,0,0
239190,<,0,0
239191,0.05,0,0
239192,),0,0
239193,decrease,0,0
239194,in,0,0
239195,sputum,1,0
239196,leukocyte,1,1
239197,density,1,1
239198,and,0,1
239199,IL-1beta,1,1
239200,",",1,1
239201,IL-8,1,1
239202,",",0,1
239203,and,0,1
239204,LTB4,1,0
239205,after,0,0
239206,fluticasone,0,0
239207,treatment,0,0
239208,.,0,0
239209,The,0,0
239210,fluticasone,0,0
239211,group,0,0
239212,had,0,0
239213,one,0,0
239214,and,0,0
239215,the,0,0
239216,placebo,0,0
239217,group,0,0
239218,three,0,0
239219,episodes,0,0
239220,of,0,0
239221,exacerbation,1,0
239222,.,1,0
239223,There,0,0
239224,were,0,0
239225,no,0,0
239226,significant,0,0
239227,changes,0,1
239228,in,0,0
239229,spirometry,1,1
239230,(,0,0
239231,p,0,0
239232,>,0,0
239233,0.05,0,0
239234,),0,0
239235,or,0,0
239236,any,0,0
239237,reported,0,0
239238,adverse,1,1
239239,reactions,1,1
239240,in,0,0
239241,either,0,0
239242,group,0,0
239243,.,0,0
239244,The,0,0
239245,results,0,0
239246,of,0,0
239247,this,0,0
239248,study,0,0
239249,show,0,0
239250,that,0,0
239251,high-dose,0,0
239252,fluticasone,0,0
239253,is,0,0
239254,effective,0,0
239255,in,0,0
239256,reducing,0,0
239257,the,0,0
239258,sputum,1,0
239259,inflammatory,1,1
239260,indices,1,1
239261,in,0,0
239262,bronchiectasis,0,0
239263,.,0,0
239264,Large-scale,0,0
239265,and,0,0
239266,long-term,0,0
239267,studies,0,0
239268,are,0,0
239269,indicated,0,0
239270,to,0,0
239271,evaluate,0,0
239272,the,0,0
239273,effects,0,0
239274,of,0,0
239275,inhaled,0,0
239276,steroid,0,0
239277,therapy,0,0
239278,on,0,0
239279,the,0,0
239280,inflammatory,0,1
239281,components,0,0
239282,in,0,0
239283,bronchiectasis,0,0
239284,.,0,0
239285,Leptin,0,1
239286,levels,0,1
239287,in,0,0
239288,protracted,0,0
239289,critical,0,0
239290,illness,0,1
239291,:,0,0
239292,effects,0,1
239293,of,0,0
239294,growth,0,1
239295,hormone-secretagogues,0,1
239296,and,0,1
239297,thyrotropin-releasing,0,1
239298,hormone,0,1
239299,.,0,0
239300,Prolonged,0,0
239301,critical,0,0
239302,illness,0,1
239303,is,0,0
239304,characterized,0,0
239305,by,0,0
239306,feeding-resistant,0,1
239307,wasting,0,1
239308,of,0,0
239309,protein,0,1
239310,",",0,0
239311,whereas,0,0
239312,reesterification,0,1
239313,",",0,0
239314,instead,0,0
239315,of,0,0
239316,oxidation,0,1
239317,of,0,0
239318,fatty,0,1
239319,acids,0,0
239320,",",0,0
239321,allows,0,0
239322,fat,0,1
239323,stores,0,0
239324,to,0,0
239325,accrue,0,0
239326,and,0,0
239327,associate,0,0
239328,with,0,0
239329,a,0,0
239330,low-activity,0,0
239331,status,0,0
239332,of,0,0
239333,the,0,0
239334,somatotropic,0,1
239335,and,0,1
239336,thyrotropic,0,1
239337,axis,0,1
239338,",",0,0
239339,which,0,0
239340,seems,0,0
239341,to,0,0
239342,be,0,0
239343,partly,0,0
239344,of,0,0
239345,hypothalamic,0,1
239346,origin,0,0
239347,.,0,0
239348,To,0,0
239349,further,0,0
239350,unravel,0,0
239351,this,0,0
239352,paradoxical,0,0
239353,metabolic,0,1
239354,condition,0,0
239355,",",0,0
239356,and,0,1
239357,in,0,0
239358,search,0,0
239359,of,0,0
239360,potential,0,0
239361,therapeutic,0,0
239362,strategies,0,0
239363,",",0,0
239364,we,0,0
239365,measured,0,0
239366,serum,0,1
239367,concentrations,0,1
239368,of,0,0
239369,leptin,0,1
239370,;,0,0
239371,studied,0,0
239372,the,0,0
239373,relationship,0,0
239374,with,0,0
239375,body,0,1
239376,mass,0,1
239377,index,0,1
239378,",",0,1
239379,insulin,0,1
239380,",",0,1
239381,cortisol,0,1
239382,",",0,1
239383,thyroid,0,1
239384,hormones,0,1
239385,",",0,0
239386,and,0,0
239387,somatomedins,0,1
239388,;,0,0
239389,and,0,0
239390,documented,0,0
239391,the,0,0
239392,effects,0,0
239393,of,0,0
239394,hypothalamic,0,1
239395,releasing,0,0
239396,factors,0,0
239397,",",0,0
239398,in,0,0
239399,particular,0,0
239400,",",0,0
239401,GH-secretagogues,0,1
239402,and,0,0
239403,TRH,0,0
239404,.,0,0
239405,Twenty,0,0
239406,adults,0,0
239407,",",0,0
239408,critically,0,0
239409,ill,0,0
239410,for,0,0
239411,several,0,0
239412,weeks,0,0
239413,and,0,0
239414,supported,0,0
239415,with,0,0
239416,normocaloric,0,0
239417,",",0,0
239418,continuously,0,0
239419,administered,0,0
239420,parenteral,0,0
239421,and/or,0,0
239422,enteral,0,0
239423,feeding,0,1
239424,",",0,0
239425,were,0,0
239426,studied,0,0
239427,for,0,0
239428,45,0,0
239429,h.,0,0
239430,They,0,0
239431,had,0,0
239432,been,0,0
239433,randomized,0,0
239434,to,0,0
239435,receive,0,0
239436,one,0,0
239437,of,0,0
239438,three,0,0
239439,combinations,0,0
239440,of,0,0
239441,peptide,0,1
239442,infusions,0,0
239443,",",0,0
239444,in,0,0
239445,random,0,0
239446,order,0,0
239447,:,0,0
239448,TRH,0,0
239449,(,0,0
239450,one,0,0
239451,day,0,0
239452,),0,0
239453,and,0,1
239454,placebo,0,0
239455,(,0,0
239456,other,0,0
239457,day,0,0
239458,),0,0
239459,;,0,0
239460,TRH,0,0
239461,+,0,0
239462,GH-releasing,0,0
239463,peptide,0,1
239464,(,0,0
239465,GHRP,0,0
239466,),0,1
239467,-2,0,0
239468,and,0,0
239469,GHRP-2,0,1
239470,;,0,0
239471,TRH,0,0
239472,+,0,0
239473,GHRH,0,0
239474,+,0,0
239475,GHRP-2,0,1
239476,and,0,0
239477,GHRH,0,1
239478,+,0,0
239479,GHRP-2,0,0
239480,.,0,0
239481,Peptide,0,1
239482,infusions,0,0
239483,were,0,0
239484,started,0,0
239485,after,0,0
239486,a,0,0
239487,1-microgram/kg,0,0
239488,bolus,0,0
239489,at,0,0
239490,0900,0,0
239491,h,0,0
239492,and,0,0
239493,infused,0,0
239494,(,0,0
239495,1,0,0
239496,microgram/kg.h,0,0
239497,),0,0
239498,until,0,0
239499,0600,0,0
239500,h,0,0
239501,the,0,0
239502,next,0,0
239503,morning,0,0
239504,.,0,0
239505,Serum,1,1
239506,concentrations,1,1
239507,of,1,0
239508,leptin,1,1
239509,",",1,0
239510,insulin,1,1
239511,",",1,1
239512,cortisol,1,1
239513,",",1,1
239514,T4,1,0
239515,",",1,1
239516,T3,1,0
239517,",",1,1
239518,insulin-like,1,1
239519,growth,1,1
239520,factor,1,1
239521,(,1,0
239522,IGF,1,0
239523,),1,1
239524,-I,1,0
239525,",",1,0
239526,IGF-binding,1,1
239527,protein-3,1,0
239528,and,1,0
239529,the,1,0
239530,acid-labile,1,1
239531,subunit,1,0
239532,(,1,0
239533,ALS,1,0
239534,),1,0
239535,were,0,0
239536,measured,0,0
239537,at,0,0
239538,0900,0,0
239539,h,0,0
239540,",",0,0
239541,2100,0,0
239542,h,0,0
239543,",",0,0
239544,and,0,0
239545,0600,0,0
239546,h,0,0
239547,on,0,0
239548,each,0,0
239549,of,0,0
239550,the,0,0
239551,2,0,0
239552,study,0,0
239553,days,0,0
239554,.,0,0
239555,Baseline,1,0
239556,leptin,1,1
239557,levels,1,1
239558,(,0,0
239559,mean,0,1
239560,+/-,0,0
239561,SEM,0,0
239562,:,0,0
239563,12.4,0,0
239564,+/-,0,0
239565,2.1,0,0
239566,micrograms/L,0,0
239567,),0,0
239568,were,0,0
239569,independent,0,0
239570,of,0,0
239571,body,0,1
239572,mass,0,1
239573,index,0,1
239574,(,0,0
239575,25,0,0
239576,+/-,0,0
239577,1,0,0
239578,kg/m2,0,0
239579,),0,0
239580,",",0,0
239581,insulin,0,1
239582,(,0,0
239583,18.6,0,0
239584,+/-,0,0
239585,2.9,0,0
239586,microIU/mL,0,0
239587,),0,0
239588,",",0,0
239589,cortisol,0,1
239590,(,0,0
239591,504,0,0
239592,+/-,0,0
239593,43,0,0
239594,mmol/L,0,0
239595,),0,0
239596,",",0,0
239597,and,0,1
239598,thyroid,0,1
239599,hormones,0,1
239600,(,0,0
239601,T4,0,0
239602,:,0,0
239603,63,0,0
239604,+/-,0,0
239605,5,0,0
239606,nmol/L,0,0
239607,",",0,0
239608,T3,0,0
239609,:,0,0
239610,0.72,0,0
239611,+/-,0,0
239612,0.08,0,0
239613,nmol/L,0,0
239614,),0,0
239615,but,0,0
239616,correlated,0,0
239617,positively,0,0
239618,with,0,0
239619,circulating,0,1
239620,levels,0,1
239621,of,0,0
239622,IGF-I,0,0
239623,[,0,0
239624,86,0,0
239625,+/-,0,0
239626,6,0,0
239627,micrograms/L,0,0
239628,",",0,0
239629,determination,0,0
239630,coefficient,0,1
239631,(,0,0
239632,R2,0,1
239633,),0,0
239634,=,0,0
239635,0.25,0,0
239636,],0,0
239637,and,0,0
239638,ALS,0,0
239639,(,0,0
239640,7.2,0,0
239641,+/-,0,0
239642,0.6,0,0
239643,mg/L,0,0
239644,",",0,0
239645,R2,0,1
239646,=,0,0
239647,0.32,0,0
239648,),0,0
239649,.,0,0
239650,Infusion,0,1
239651,of,0,0
239652,placebo,0,0
239653,or,0,0
239654,TRH,0,0
239655,had,0,0
239656,no,0,0
239657,effect,0,0
239658,on,0,0
239659,leptin,1,1
239660,.,1,0
239661,In,0,0
239662,contrast,0,0
239663,",",0,0
239664,GH-secretagogues,0,1
239665,elevated,0,1
239666,leptin,1,1
239667,levels,1,1
239668,within,0,0
239669,12,0,0
239670,h.,0,0
239671,Infusion,0,0
239672,of,0,0
239673,GHRP-2,0,0
239674,alone,0,0
239675,induced,0,0
239676,a,0,0
239677,maximal,1,1
239678,leptin,1,1
239679,increase,1,0
239680,of,0,0
239681,+87,0,0
239682,%,0,0
239683,after,0,0
239684,24,0,0
239685,h,0,0
239686,",",0,0
239687,whereas,0,0
239688,GHRH,0,0
239689,+,0,0
239690,GHRP-2,0,1
239691,elevated,0,1
239692,leptin,1,1
239693,by,0,0
239694,up,0,0
239695,to,0,0
239696,+157,0,0
239697,%,0,0
239698,after,0,0
239699,24,0,0
239700,h.,0,0
239701,The,0,0
239702,increase,0,0
239703,in,0,0
239704,leptin,1,1
239705,within,1,0
239706,12,1,0
239707,h,1,0
239708,was,0,0
239709,related,0,0
239710,(,0,0
239711,R2,0,1
239712,=,0,0
239713,0.58,0,0
239714,),0,0
239715,to,0,0
239716,the,0,0
239717,substantial,0,0
239718,rise,0,0
239719,in,0,0
239720,insulin,0,1
239721,.,0,0
239722,After,0,0
239723,45,0,0
239724,h,0,0
239725,",",0,0
239726,and,0,1
239727,having,0,0
239728,reached,0,0
239729,a,0,0
239730,plateau,0,0
239731,",",0,0
239732,leptin,1,1
239733,was,0,0
239734,related,0,0
239735,to,0,0
239736,the,0,0
239737,increased,1,0
239738,IGF-I,1,0
239739,(,0,0
239740,R2,0,1
239741,=,0,0
239742,0.37,0,0
239743,),0,0
239744,.,0,0
239745,In,0,0
239746,conclusion,0,0
239747,",",0,0
239748,circulating,1,1
239749,leptin,1,1
239750,levels,1,1
239751,during,0,0
239752,protracted,0,0
239753,critical,0,0
239754,illness,0,1
239755,were,0,0
239756,linked,0,0
239757,to,0,0
239758,the,0,0
239759,activity,0,1
239760,state,0,0
239761,of,0,0
239762,the,0,0
239763,GH/IGF-I,0,0
239764,axis,0,0
239765,.,0,0
239766,Stimulating,0,0
239767,the,0,0
239768,GH/IGF-I,0,0
239769,axis,0,0
239770,with,0,0
239771,GH-secretagogues,0,1
239772,increased,0,0
239773,leptin,1,1
239774,levels,1,1
239775,within,0,0
239776,12,0,0
239777,h.,0,0
239778,Because,0,0
239779,leptin,0,0
239780,may,0,0
239781,stimulate,0,0
239782,oxidation,0,1
239783,of,0,0
239784,fatty,0,1
239785,acids,0,1
239786,",",0,0
239787,and,0,0
239788,because,0,0
239789,GH,0,1
239790,",",0,0
239791,IGF-I,0,1
239792,",",0,1
239793,and,0,0
239794,insulin,0,1
239795,have,0,0
239796,a,0,0
239797,protein-sparing,0,0
239798,effect,0,0
239799,",",0,0
239800,GH-secretagogue,0,0
239801,administration,0,0
239802,may,0,0
239803,be,0,0
239804,expected,0,0
239805,to,0,0
239806,result,0,0
239807,in,0,0
239808,increased,0,0
239809,utilization,0,0
239810,of,0,0
239811,fat,0,1
239812,as,0,0
239813,preferential,0,0
239814,substrate,0,0
239815,and,0,0
239816,to,0,0
239817,restore,0,0
239818,protein,0,0
239819,content,0,1
239820,in,0,0
239821,vital,0,1
239822,tissues,0,1
239823,and,0,0
239824,",",0,0
239825,consequently,0,0
239826,",",0,0
239827,has,0,0
239828,potential,0,0
239829,as,0,0
239830,a,0,0
239831,strategy,0,0
239832,to,0,0
239833,reverse,0,0
239834,the,0,0
239835,paradoxical,0,0
239836,metabolic,0,1
239837,condition,0,0
239838,of,0,0
239839,protracted,0,0
239840,critical,0,0
239841,illness,0,0
239842,.,0,0
239843,Evaluation,0,0
239844,of,0,0
239845,the,0,0
239846,safety,1,1
239847,",",1,0
239848,immunogenicity,1,1
239849,",",1,1
239850,and,1,1
239851,pharmacokinetic,1,1
239852,profile,1,1
239853,of,0,0
239854,a,0,0
239855,new,0,0
239856,",",0,0
239857,highly,0,0
239858,purified,0,0
239859,",",0,0
239860,heat-treated,0,0
239861,equine,0,0
239862,rabies,0,0
239863,immunoglobulin,0,0
239864,",",0,0
239865,administered,0,0
239866,either,0,0
239867,alone,0,0
239868,or,0,0
239869,in,0,0
239870,association,0,0
239871,with,0,0
239872,a,0,0
239873,purified,0,0
239874,",",0,0
239875,Vero-cell,0,0
239876,rabies,0,0
239877,vaccine,0,0
239878,.,0,0
239879,A,0,0
239880,clinical,0,0
239881,evaluation,0,0
239882,of,0,0
239883,a,0,0
239884,new,0,0
239885,",",0,0
239886,purified,0,0
239887,",",0,0
239888,heat-treated,0,0
239889,equine,0,0
239890,rabies,0,0
239891,immunoglobulin,0,0
239892,(,0,0
239893,PHT-Erig,0,1
239894,),0,0
239895,",",0,0
239896,F,0,0
239897,(,0,0
239898,ab,0,1
239899,',0,0
239900,),0,0
239901,2,0,0
239902,preparation,0,0
239903,",",0,0
239904,was,0,0
239905,carried,0,0
239906,out,0,0
239907,in,0,0
239908,Thailand,0,0
239909,and,0,0
239910,in,0,0
239911,the,0,0
239912,Philippines-two,0,0
239913,countries,0,0
239914,where,0,0
239915,rabies,0,0
239916,is,0,0
239917,endemic,0,0
239918,.,0,0
239919,An,0,0
239920,initial,0,0
239921,prospective,0,0
239922,",",0,0
239923,randomised,0,0
239924,",",0,0
239925,controlled,0,0
239926,trial,0,0
239927,(,0,0
239928,Study,0,0
239929,1,0,0
239930,),0,0
239931,",",0,0
239932,compared,0,0
239933,the,0,0
239934,safety,1,1
239935,and,1,0
239936,pharmacokinetics,1,1
239937,(,1,0
239938,serum,1,1
239939,concentrations,1,1
239940,of,1,0
239941,rabies,1,0
239942,antibodies,1,0
239943,),1,0
239944,after,0,0
239945,administration,0,0
239946,either,0,0
239947,of,0,0
239948,PHT-Erig,0,0
239949,or,0,0
239950,of,0,0
239951,a,0,0
239952,commercially-available,0,0
239953,",",0,0
239954,equine,0,0
239955,rabies,0,0
239956,immune,0,1
239957,globulin,0,1
239958,(,0,0
239959,Erig,0,0
239960,PMC,0,0
239961,),0,0
239962,.,0,0
239963,A,0,0
239964,second,0,0
239965,trial,0,0
239966,(,0,0
239967,Study,0,0
239968,2,0,0
239969,),0,0
239970,simulated,0,0
239971,post-exposure,0,0
239972,rabies,0,0
239973,prophylaxis,0,0
239974,by,0,0
239975,using,0,0
239976,a,0,0
239977,reference,0,0
239978,cell,0,1
239979,culture,0,1
239980,vaccine,0,0
239981,",",0,0
239982,the,0,0
239983,purified,0,0
239984,Vero-cell,0,0
239985,rabies,0,0
239986,vaccine,0,0
239987,(,0,0
239988,PVRV,0,1
239989,),0,0
239990,",",0,0
239991,administered,0,0
239992,in,0,0
239993,association,0,0
239994,with,0,0
239995,either,0,0
239996,Erig,0,0
239997,PMC,0,0
239998,or,0,0
239999,PHT-Erig,0,0
240000,.,0,0
240001,In,0,0
240002,Study,0,0
240003,1,0,0
240004,",",0,0
240005,27,0,0
240006,healthy,0,0
240007,",",0,0
240008,Thai,0,0
240009,adults,0,0
240010,received,0,0
240011,a,0,0
240012,40,0,0
240013,IU,0,0
240014,kg,0,0
240015,(,0,0
240016,-1,0,0
240017,),0,0
240018,dose,0,0
240019,of,0,0
240020,either,0,0
240021,Erig,0,0
240022,PMC,0,0
240023,(,0,0
240024,n,0,0
240025,=,0,0
240026,12,0,0
240027,),0,0
240028,or,0,0
240029,PHT-Erig,0,1
240030,(,0,0
240031,n,0,0
240032,=,0,0
240033,15,0,0
240034,),0,0
240035,via,0,0
240036,the,0,0
240037,intramuscular,0,0
240038,(,0,0
240039,i.m,0,0
240040,.,0,0
240041,),0,0
240042,route,0,0
240043,;,0,0
240044,half,0,0
240045,of,0,0
240046,the,0,0
240047,dose,0,0
240048,was,0,0
240049,injected,0,0
240050,into,0,0
240051,the,0,0
240052,deltoid,0,0
240053,area,0,1
240054,and,0,0
240055,the,0,0
240056,other,0,0
240057,half,0,0
240058,into,0,0
240059,the,0,0
240060,buttocks,0,0
240061,.,0,0
240062,Serum,0,0
240063,for,0,0
240064,rabies,0,0
240065,antibody,0,1
240066,determination,0,0
240067,and,0,1
240068,F,0,0
240069,(,0,0
240070,ab,0,1
240071,',0,0
240072,),0,0
240073,2,0,0
240074,concentration,0,1
240075,was,0,0
240076,collected,0,0
240077,at,0,0
240078,hours,0,0
240079,(,0,0
240080,H,0,0
240081,),0,0
240082,0,0,0
240083,",",0,0
240084,6,0,0
240085,and,0,0
240086,12,0,0
240087,",",0,0
240088,and,0,0
240089,on,0,0
240090,day,0,0
240091,(,0,0
240092,D,0,0
240093,),0,0
240094,2,0,0
240095,",",0,0
240096,3,0,0
240097,",",0,0
240098,4,0,0
240099,",",0,0
240100,6,0,0
240101,",",0,0
240102,8,0,0
240103,",",0,0
240104,10,0,0
240105,",",0,0
240106,12,0,0
240107,and,0,0
240108,15,0,0
240109,.,0,0
240110,Both,0,0
240111,products,0,0
240112,were,0,0
240113,safe,0,0
240114,",",0,0
240115,with,0,0
240116,no,0,0
240117,serious,0,1
240118,adverse,0,1
240119,events,0,1
240120,",",0,0
240121,and,0,0
240122,in,0,0
240123,particular,0,0
240124,",",0,0
240125,no,0,0
240126,anaphylactic,0,1
240127,reactions,0,1
240128,or,0,0
240129,serum,0,1
240130,sickness,0,1
240131,was,0,0
240132,reported,0,0
240133,.,0,0
240134,A,0,0
240135,statistical,0,0
240136,comparison,0,0
240137,of,0,0
240138,the,0,0
240139,pharmacokinetic,1,0
240140,parameters,1,1
240141,did,0,0
240142,not,0,0
240143,demonstrate,0,0
240144,bioequivalence,0,0
240145,of,0,0
240146,the,0,0
240147,two,0,0
240148,products,0,0
240149,.,0,0
240150,Nonetheless,0,0
240151,",",0,0
240152,the,0,0
240153,relative,1,0
240154,bioavailability,1,1
240155,of,0,0
240156,93,0,0
240157,%,0,0
240158,and,0,0
240159,the,0,0
240160,similar,0,0
240161,absorption,1,0
240162,rates,1,1
240163,suggest,0,0
240164,the,0,0
240165,pharmacokinetic,0,0
240166,profiles,0,0
240167,of,0,0
240168,Erig,0,0
240169,and,0,0
240170,PHT-Erig,0,0
240171,are,0,0
240172,similar,0,0
240173,.,0,0
240174,The,0,0
240175,antibody,1,0
240176,level,1,1
240177,in,0,0
240178,either,0,0
240179,group,0,0
240180,were,0,0
240181,low,0,0
240182,throughout,0,0
240183,the,0,0
240184,15-day,0,0
240185,study,0,0
240186,period,0,0
240187,.,0,0
240188,The,0,0
240189,geometric,1,0
240190,mean,1,1
240191,titer,1,1
240192,(,1,0
240193,GMT,1,1
240194,),1,0
240195,values,1,1
240196,ranged,0,0
240197,from,0,0
240198,group,0,0
240199,0.027-0.117,0,0
240200,IU,0,0
240201,ml,0,0
240202,(,0,0
240203,-1,0,0
240204,),0,0
240205,in,0,0
240206,the,0,0
240207,Erig,0,0
240208,group,0,0
240209,and,0,0
240210,from,0,0
240211,0.029,0,0
240212,to,0,0
240213,0.072,0,0
240214,IU,0,0
240215,ml,0,0
240216,(,0,0
240217,-1,0,0
240218,),0,0
240219,in,0,0
240220,the,0,0
240221,PHT-Erig,0,0
240222,.,0,0
240223,There,0,0
240224,was,0,0
240225,no,0,0
240226,significant,0,0
240227,difference,0,0
240228,between,0,0
240229,the,0,0
240230,evolution,1,1
240231,of,1,0
240232,GMT,1,1
240233,values,1,1
240234,for,0,0
240235,the,0,0
240236,two,0,0
240237,groups,0,0
240238,.,0,0
240239,In,0,0
240240,Study,0,0
240241,2,0,0
240242,",",0,0
240243,71,0,0
240244,healthy,0,0
240245,volunteers,0,0
240246,received,0,0
240247,40,0,0
240248,IU,0,0
240249,kg,0,0
240250,(,0,0
240251,-1,0,0
240252,),0,0
240253,via,0,0
240254,the,0,0
240255,intramuscular,0,0
240256,route,0,0
240257,of,0,0
240258,either,0,0
240259,Erig,0,0
240260,PMC,0,0
240261,(,0,0
240262,n,0,0
240263,=,0,0
240264,36,0,0
240265,),0,0
240266,or,0,0
240267,PHT-Erig,0,1
240268,(,0,0
240269,n,0,0
240270,=,0,0
240271,35,0,0
240272,),0,0
240273,on,0,0
240274,D0,0,1
240275,",",0,0
240276,in,0,0
240277,association,0,0
240278,with,0,0
240279,five,0,0
240280,doses,0,0
240281,of,0,0
240282,PVRV,0,0
240283,on,0,0
240284,D0,0,1
240285,",",0,0
240286,D3,0,0
240287,",",0,1
240288,D7,0,0
240289,",",0,1
240290,D14,0,1
240291,and,0,0
240292,D28,0,0
240293,.,0,0
240294,The,0,0
240295,safety,1,1
240296,evaluation,1,0
240297,was,0,0
240298,performed,0,0
240299,during,0,0
240300,the,0,0
240301,28-day,0,1
240302,follow-up,0,0
240303,and,0,1
240304,serum,1,1
240305,samples,1,0
240306,for,1,0
240307,anti-rabies,1,0
240308,antibody,1,1
240309,titration,1,0
240310,were,0,0
240311,collected,0,0
240312,on,0,0
240313,D0,0,1
240314,(,0,0
240315,before,0,0
240316,injection,0,0
240317,),0,0
240318,D3,0,0
240319,",",0,0
240320,D7,0,0
240321,",",0,1
240322,D14,0,1
240323,and,0,0
240324,D28,0,0
240325,.,0,0
240326,No,0,0
240327,serious,1,1
240328,reactions,1,1
240329,were,0,0
240330,reported,0,0
240331,in,0,0
240332,either,0,0
240333,group,0,0
240334,.,0,0
240335,In,0,0
240336,particular,0,0
240337,",",0,0
240338,no,0,0
240339,immediate,1,1
240340,(,1,0
240341,anaphylactic,1,1
240342,type,1,0
240343,),1,0
240344,or,1,0
240345,delayed,1,0
240346,(,1,0
240347,serum,1,1
240348,sickness,1,1
240349,),1,0
240350,allergic,1,0
240351,reactions,1,1
240352,were,0,0
240353,observed,0,0
240354,.,0,0
240355,Over,0,0
240356,the,0,0
240357,28-day,0,1
240358,follow-up,0,0
240359,period,0,0
240360,",",0,0
240361,GMT,1,1
240362,profiles,1,0
240363,of,0,0
240364,the,0,0
240365,two,0,0
240366,groups,0,0
240367,were,0,0
240368,statistically,0,0
240369,equivalent,0,0
240370,.,0,0
240371,On,0,0
240372,D14,0,0
240373,",",0,0
240374,100,0,0
240375,%,0,0
240376,of,0,0
240377,the,0,0
240378,subjects,0,0
240379,had,0,0
240380,protective,1,1
240381,antibody,1,1
240382,titers,1,1
240383,(,0,0
240384,anti-rabies,0,0
240385,antibodies,0,0
240386,>,0,0
240387,or,0,0
240388,=,0,0
240389,0.5,0,0
240390,IU,0,0
240391,ml,0,0
240392,(,0,0
240393,-1,0,0
240394,),0,0
240395,",",0,0
240396,which,0,0
240397,is,0,0
240398,the,0,0
240399,WHO-recommended,0,0
240400,level,0,1
240401,of,0,0
240402,seroconversion,0,1
240403,),0,0
240404,",",0,0
240405,and,0,1
240406,Erig,0,0
240407,PMC,0,1
240408,and,0,1
240409,PHT-Erig,0,1
240410,were,0,0
240411,indistinguishable,0,0
240412,according,0,0
240413,to,0,0
240414,the,0,0
240415,clinical,0,0
240416,definition,0,0
240417,chosen,0,0
240418,.,0,0
240419,On,0,0
240420,D28,0,0
240421,",",0,0
240422,the,0,0
240423,GMT,1,1
240424,values,1,1
240425,were,0,0
240426,33.2,0,0
240427,IU,0,0
240428,ml,0,0
240429,(,0,0
240430,-1,0,0
240431,),0,0
240432,(,0,0
240433,95,0,0
240434,%,0,0
240435,CI,0,0
240436,",",0,0
240437,23.8-46.1,0,0
240438,IU,0,0
240439,ml,0,0
240440,(,0,0
240441,-1,0,0
240442,),0,0
240443,),0,0
240444,in,0,0
240445,the,0,0
240446,Erig,0,0
240447,PMC/PVRV,0,0
240448,group,0,0
240449,and,0,0
240450,31.4,0,0
240451,IU,0,0
240452,ml,0,0
240453,(,0,0
240454,-1,0,0
240455,),0,0
240456,(,0,0
240457,95,0,0
240458,%,0,0
240459,confidence,0,0
240460,interval,0,0
240461,",",0,1
240462,CI,0,1
240463,",",0,0
240464,23.4-42.2,0,0
240465,IU,0,0
240466,ml,0,0
240467,(,0,0
240468,-1,0,0
240469,),0,0
240470,),0,0
240471,in,0,0
240472,the,0,0
240473,PHT-Erig/PVRV,0,0
240474,group,0,0
240475,",",0,0
240476,showing,0,0
240477,evidence,0,0
240478,of,0,0
240479,adequate,0,0
240480,vaccine-induced,0,1
240481,antibody,1,0
240482,responses,1,1
240483,in,0,0
240484,both,0,0
240485,groups,0,0
240486,.,0,0
240487,The,0,0
240488,increased,0,0
240489,purity,0,1
240490,",",0,0
240491,the,0,0
240492,heat-treatment,0,1
240493,step,0,0
240494,introduced,0,0
240495,in,0,0
240496,the,0,0
240497,manufacturing,0,0
240498,process,0,0
240499,of,0,0
240500,PHT-Erig,0,1
240501,",",0,0
240502,and,0,0
240503,the,0,0
240504,good,0,0
240505,clinical,0,0
240506,results,0,0
240507,substantiate,0,0
240508,the,0,0
240509,use,0,0
240510,of,0,0
240511,this,0,0
240512,new,0,0
240513,generation,0,1
240514,",",0,0
240515,purified,0,0
240516,equine,0,0
240517,F,0,0
240518,(,0,0
240519,ab,0,1
240520,',0,0
240521,),0,0
240522,2,0,0
240523,preparation,0,0
240524,in,0,0
240525,the,0,0
240526,post-exposure,0,0
240527,prophylaxis,0,0
240528,of,0,0
240529,rabies,0,0
240530,.,0,0
240531,Acute,0,0
240532,effects,0,1
240533,of,0,0
240534,caffeine,0,0
240535,ingestion,0,0
240536,on,0,0
240537,signal-averaged,1,0
240538,electrocardiograms,1,0
240539,.,1,0
240540,BACKGROUND,0,0
240541,Although,0,0
240542,moderate,0,0
240543,caffeine,0,0
240544,ingestion,0,0
240545,has,0,0
240546,not,0,0
240547,been,0,0
240548,shown,0,0
240549,to,0,0
240550,be,0,0
240551,arrhythmogenic,0,0
240552,",",0,0
240553,caffeine,0,0
240554,toxicity,0,1
240555,can,0,0
240556,cause,0,0
240557,severe,0,1
240558,cardiac,0,1
240559,arrhythmias,0,1
240560,",",0,0
240561,including,0,0
240562,atrial,0,1
240563,fibrillation,0,1
240564,and,0,0
240565,ventricular,0,1
240566,tachycardia,0,1
240567,.,0,0
240568,Atrial,0,0
240569,fibrillation,0,1
240570,and,0,0
240571,ventricular,0,1
240572,tachycardia,0,1
240573,have,0,0
240574,been,0,0
240575,associated,0,0
240576,with,0,0
240577,prolongation,1,1
240578,of,1,0
240579,P-wave,1,1
240580,and,1,0
240581,QRS,1,1
240582,complex,1,0
240583,durations,1,0
240584,on,1,0
240585,signal-averaged,1,0
240586,electrocardiograms,1,0
240587,.,1,0
240588,This,0,0
240589,study,0,0
240590,investigated,0,0
240591,acute,0,0
240592,effects,0,1
240593,of,0,0
240594,caffeine,0,0
240595,ingestion,0,0
240596,on,0,0
240597,signal-averaged,1,1
240598,P-wave,1,0
240599,and,1,0
240600,QRS,1,1
240601,complexes,1,0
240602,.,1,0
240603,METHODS,0,0
240604,AND,0,0
240605,RESULTS,0,0
240606,Signal-averaged,1,1
240607,electrocardiograms,1,0
240608,were,0,0
240609,obtained,0,0
240610,from,0,0
240611,12,0,0
240612,normal,0,0
240613,subjects,0,0
240614,(,0,0
240615,6,0,0
240616,men,0,0
240617,",",0,0
240618,6,0,0
240619,women,0,0
240620,;,0,0
240621,ages,0,0
240622,21,0,0
240623,to,0,0
240624,26,0,0
240625,years,0,0
240626,),0,0
240627,before,0,0
240628,and,0,0
240629,after,0,0
240630,ingestion,0,1
240631,of,0,0
240632,caffeine,0,0
240633,(,0,0
240634,5,0,0
240635,mg/kg,0,0
240636,body,0,0
240637,weight,0,1
240638,),0,1
240639,or,0,0
240640,placebo,0,0
240641,in,0,0
240642,a,0,0
240643,randomized,0,0
240644,",",0,0
240645,double-blind,0,0
240646,",",0,0
240647,crossover,0,0
240648,fashion,0,0
240649,.,0,0
240650,Electrocardiograms,0,1
240651,for,0,0
240652,signal,0,1
240653,averaging,0,0
240654,were,0,0
240655,recorded,0,0
240656,from,0,0
240657,electrodes,0,0
240658,left,0,0
240659,in,0,0
240660,a,0,0
240661,constant,0,0
240662,location,0,0
240663,.,0,0
240664,After,0,0
240665,bandpass,0,0
240666,filtering,0,0
240667,(,0,0
240668,30,0,0
240669,to,0,0
240670,300,0,0
240671,Hz,0,0
240672,),0,0
240673,and,0,1
240674,amplification,0,1
240675,",",0,1
240676,signals,0,1
240677,were,0,0
240678,sampled,0,0
240679,over,0,0
240680,7.2,0,0
240681,minutes,0,0
240682,at,0,0
240683,2000,0,0
240684,Hz,0,0
240685,.,0,0
240686,Signal-averaged,1,1
240687,P-wave,1,0
240688,and,1,0
240689,QRS,1,1
240690,complex,1,0
240691,durations,1,1
240692,did,0,0
240693,not,0,0
240694,significantly,0,0
240695,change,0,0
240696,after,0,0
240697,placebo,0,0
240698,ingestion,0,0
240699,.,0,0
240700,After,0,0
240701,caffeine,0,0
240702,ingestion,0,0
240703,QRS,1,1
240704,duration,1,1
240705,prolonged,0,0
240706,in,0,0
240707,9,0,0
240708,of,0,0
240709,11,0,0
240710,subjects,0,0
240711,at,0,0
240712,90,0,0
240713,minutes,0,0
240714,(,0,0
240715,mean,0,1
240716,+/-,0,0
240717,SEM,0,0
240718,=,0,0
240719,0.8+/-0.3,0,0
240720,ms,0,0
240721,",",0,0
240722,P,0,0
240723,<,0,0
240724,.02,0,0
240725,),0,0
240726,and,0,0
240727,in,0,0
240728,8,0,0
240729,of,0,0
240730,9,0,0
240731,after,0,0
240732,3,0,0
240733,hours,0,0
240734,(,0,0
240735,1.1+/-0.2,0,0
240736,ms,0,0
240737,",",0,0
240738,P,0,0
240739,<,0,0
240740,.001,0,0
240741,),0,0
240742,.,0,0
240743,No,0,0
240744,significant,0,0
240745,change,0,0
240746,in,0,0
240747,P-wave,1,1
240748,duration,1,1
240749,or,1,0
240750,heart,1,1
240751,rate,1,1
240752,was,0,0
240753,found,0,0
240754,after,0,0
240755,caffeine,0,0
240756,ingestion,0,0
240757,at,0,0
240758,any,0,0
240759,test,0,0
240760,interval,0,0
240761,.,0,0
240762,Average,1,1
240763,caffeine,1,0
240764,level,1,1
240765,in,1,0
240766,saliva,1,0
240767,90,0,0
240768,minutes,0,0
240769,after,0,0
240770,ingestion,0,0
240771,was,0,0
240772,6.6+/-1.6,0,0
240773,(,0,0
240774,SD,0,0
240775,),0,0
240776,microg/dL,0,0
240777,.,0,0
240778,CONCLUSIONS,0,0
240779,Although,0,0
240780,probably,0,0
240781,not,0,0
240782,arrhythmogenic,0,0
240783,in,0,0
240784,normal,0,0
240785,subjects,0,0
240786,",",0,0
240787,moderate,0,0
240788,caffeine,0,0
240789,ingestion,0,0
240790,does,0,0
240791,produce,0,0
240792,a,0,0
240793,small,0,0
240794,but,0,0
240795,statistically,0,0
240796,significant,0,0
240797,prolongation,0,1
240798,of,0,0
240799,signal-averaged,1,0
240800,QRS,1,1
240801,complexes,1,0
240802,.,1,0
240803,Further,0,0
240804,prolongation,0,1
240805,caused,0,0
240806,by,0,0
240807,excessive,0,0
240808,caffeine,0,0
240809,intake,0,0
240810,may,0,0
240811,be,0,0
240812,a,0,0
240813,factor,0,0
240814,in,0,0
240815,the,0,0
240816,genesis,0,0
240817,of,0,0
240818,arrhythmias,0,1
240819,associated,0,0
240820,with,0,0
240821,caffeine,0,0
240822,toxicity,0,1
240823,.,0,0
240824,Treatment,0,0
240825,of,0,0
240826,children,0,0
240827,with,0,0
240828,autism,0,0
240829,:,0,0
240830,a,0,0
240831,randomized,0,0
240832,controlled,0,0
240833,trial,0,0
240834,to,0,0
240835,evaluate,0,0
240836,a,0,0
240837,caregiver-based,0,0
240838,intervention,0,0
240839,program,0,0
240840,in,0,0
240841,community,0,0
240842,day-care,0,0
240843,centers,0,0
240844,.,0,0
240845,This,0,0
240846,study,0,0
240847,reports,0,0
240848,on,0,0
240849,the,0,0
240850,results,0,0
240851,of,0,0
240852,a,0,0
240853,randomized,0,0
240854,controlled,0,0
240855,trial,0,0
240856,that,0,0
240857,evaluated,0,0
240858,a,0,0
240859,caregiver-based,0,1
240860,intervention,0,0
240861,program,0,0
240862,for,0,0
240863,children,0,0
240864,with,0,0
240865,autism,0,0
240866,in,0,0
240867,community,0,0
240868,day-care,0,0
240869,centers,0,0
240870,.,0,0
240871,Thirty-five,0,0
240872,preschool,0,0
240873,children,0,0
240874,with,0,0
240875,a,0,0
240876,DSM,0,0
240877,III-R,0,0
240878,diagnosis,0,0
240879,of,0,1
240880,autism,0,0
240881,or,0,0
240882,pervasive,0,0
240883,developmental,0,0
240884,disorder,0,0
240885,were,0,0
240886,randomized,0,0
240887,to,0,0
240888,an,0,0
240889,experimental,0,0
240890,or,0,0
240891,control,0,0
240892,group,0,0
240893,.,0,0
240894,Children,0,0
240895,in,0,0
240896,the,0,0
240897,experimental,0,0
240898,group,0,0
240899,were,0,0
240900,enrolled,0,0
240901,in,0,0
240902,day,0,0
240903,care,0,0
240904,and,0,0
240905,their,0,0
240906,parents,0,0
240907,and,0,1
240908,child,0,1
240909,care,0,1
240910,workers,0,0
240911,received,0,0
240912,a,0,0
240913,12-week,0,0
240914,intervention,0,0
240915,consisting,0,0
240916,of,0,0
240917,lectures,0,0
240918,and,0,0
240919,on-site,0,0
240920,consultations,0,0
240921,to,0,0
240922,day-care,0,0
240923,centers,0,0
240924,.,0,0
240925,In,0,0
240926,addition,0,0
240927,",",0,0
240928,supportive,0,0
240929,work,0,0
240930,was,0,0
240931,undertaken,0,0
240932,with,0,0
240933,families,0,0
240934,.,0,0
240935,Control,0,0
240936,subjects,0,0
240937,received,0,0
240938,day,0,0
240939,care,0,0
240940,alone,0,0
240941,.,0,0
240942,In,0,0
240943,the,0,0
240944,experimental,0,0
240945,group,0,0
240946,",",0,0
240947,there,0,0
240948,were,0,0
240949,greater,0,0
240950,gains,0,1
240951,in,0,0
240952,language,1,1
240953,abilities,1,1
240954,",",0,0
240955,significant,0,0
240956,increases,0,1
240957,in,0,0
240958,caregivers,1,1
240959,',1,0
240960,knowledge,1,1
240961,about,1,0
240962,autism,1,0
240963,",",0,0
240964,greater,0,0
240965,perception,1,1
240966,of,1,1
240967,control,1,0
240968,on,1,0
240969,the,1,0
240970,part,1,0
240971,of,1,0
240972,mothers,1,0
240973,",",0,0
240974,and,0,1
240975,greater,0,1
240976,parent,1,1
240977,satisfaction,1,1
240978,.,1,0
240979,We,0,0
240980,conclude,0,0
240981,that,0,0
240982,this,0,0
240983,research,0,0
240984,design,0,0
240985,demonstrated,0,0
240986,that,0,0
240987,the,0,0
240988,intervention,0,0
240989,was,0,0
240990,significantly,0,0
240991,superior,0,0
240992,to,0,0
240993,day,0,0
240994,care,0,0
240995,alone,0,0
240996,.,0,0
240997,Amonafide,0,0
240998,:,0,0
240999,An,0,0
241000,active,0,0
241001,agent,0,0
241002,in,0,0
241003,the,0,0
241004,treatment,0,0
241005,of,0,0
241006,previously,0,0
241007,untreated,0,0
241008,advanced,0,0
241009,breast,0,0
241010,cancer,0,0
241011,--,0,0
241012,a,0,0
241013,cancer,0,0
241014,and,0,1
241015,leukemia,0,0
241016,group,0,0
241017,B,0,0
241018,study,0,0
241019,(,0,0
241020,CALGB,0,0
241021,8642,0,0
241022,),0,0
241023,.,0,0
241024,Amonafide,0,0
241025,is,0,0
241026,a,0,0
241027,new,0,0
241028,imide,0,0
241029,derivative,0,0
241030,of,0,0
241031,naphthalic,0,0
241032,acid,0,0
241033,.,0,0
241034,The,0,0
241035,drug,0,0
241036,had,0,0
241037,demonstrated,0,0
241038,significant,0,0
241039,activity,0,1
241040,in,0,0
241041,preclinical,0,0
241042,studies,0,0
241043,and,0,0
241044,some,0,0
241045,activity,0,1
241046,in,0,0
241047,Phase,0,0
241048,I,0,0
241049,trials,0,0
241050,.,0,0
241051,The,0,0
241052,drug,0,0
241053,is,0,0
241054,extensively,0,0
241055,metabolized,0,0
241056,and,0,0
241057,detected,0,0
241058,in,0,0
241059,plasma,0,1
241060,and,0,0
241061,urine,0,1
241062,.,0,0
241063,Its,0,0
241064,toxicity,0,1
241065,has,0,0
241066,previously,0,0
241067,been,0,0
241068,correlated,0,0
241069,to,0,0
241070,the,0,0
241071,formation,0,1
241072,of,0,0
241073,an,0,0
241074,active,0,0
241075,metabolite,0,0
241076,",",0,0
241077,N-acetyl-amonafide,0,0
241078,.,0,1
241079,Amonafide,0,0
241080,was,0,0
241081,chosen,0,0
241082,for,0,0
241083,inclusion,0,0
241084,in,0,0
241085,the,0,0
241086,Cancer,0,0
241087,and,0,0
241088,Leukemia,0,1
241089,Group,0,0
241090,B,0,0
241091,(,0,0
241092,CALGB,0,0
241093,),0,0
241094,master,0,0
241095,metastatic,0,0
241096,breast,0,0
241097,cancer,0,0
241098,protocol,0,0
241099,.,0,0
241100,CALGB,0,0
241101,8642,0,0
241102,randomizes,0,0
241103,previously,0,0
241104,untreated,0,0
241105,metastatic,0,0
241106,breast,0,0
241107,cancer,0,0
241108,patients,0,0
241109,either,0,0
241110,to,0,0
241111,one,0,0
241112,of,0,0
241113,several,0,0
241114,Phase,0,0
241115,II,0,0
241116,agents,0,0
241117,given,0,0
241118,for,0,0
241119,up,0,0
241120,to,0,0
241121,four,0,0
241122,cycles,0,0
241123,and,0,0
241124,then,0,0
241125,followed,0,0
241126,by,0,0
241127,standard,0,0
241128,cyclophosphamide-doxorubicin-5-fluorouracil,0,0
241129,",",0,0
241130,or,0,0
241131,to,0,0
241132,immediate,0,1
241133,treatment,0,0
241134,with,0,0
241135,standard,0,0
241136,cyclophosphamide-doxorubicin-5-fluorouracil,0,0
241137,.,0,0
241138,The,0,0
241139,end,0,0
241140,point,0,0
241141,of,0,0
241142,CALGB,0,0
241143,8642,0,0
241144,is,0,0
241145,to,0,0
241146,assess,0,0
241147,the,0,0
241148,difference,0,0
241149,in,0,0
241150,survival,1,1
241151,",",1,0
241152,toxicity,1,1
241153,",",1,1
241154,and,1,1
241155,overall,1,1
241156,response,1,1
241157,when,0,0
241158,limited,0,0
241159,exposure,0,0
241160,to,0,0
241161,Phase,0,0
241162,II,0,0
241163,agents,0,0
241164,precedes,0,0
241165,standard,0,0
241166,chemotherapy,0,0
241167,.,0,0
241168,This,0,0
241169,report,0,0
241170,deals,0,0
241171,only,0,0
241172,with,0,0
241173,amonafide,0,0
241174,as,0,0
241175,a,0,0
241176,Phase,0,0
241177,II,0,0
241178,agent,0,0
241179,.,0,0
241180,Comparisons,0,0
241181,with,0,0
241182,the,0,0
241183,cyclophosphamide-doxorubicin-5-fluorouracil,0,0
241184,arm,0,0
241185,will,0,0
241186,not,0,0
241187,be,0,0
241188,addressed,0,0
241189,.,0,0
241190,Patients,0,0
241191,had,0,0
241192,to,0,0
241193,have,0,0
241194,histologically,0,0
241195,documented,0,0
241196,measurable,0,0
241197,breast,0,0
241198,cancer,0,0
241199,and,0,0
241200,a,0,0
241201,performance,0,1
241202,status,0,1
241203,of,0,0
241204,0-1,0,0
241205,.,0,0
241206,Patients,0,0
241207,could,0,0
241208,not,0,0
241209,have,0,0
241210,had,0,0
241211,prior,0,0
241212,chemotherapy,0,0
241213,for,0,0
241214,metastatic,0,0
241215,disease,0,0
241216,.,0,0
241217,Prior,0,1
241218,adjuvant,0,0
241219,chemotherapy,0,0
241220,was,0,0
241221,permitted,0,0
241222,.,0,0
241223,Patients,0,0
241224,could,0,0
241225,not,0,0
241226,have,0,0
241227,visceral,0,1
241228,crisis,0,1
241229,.,0,0
241230,Amonafide,0,0
241231,was,0,0
241232,given,0,0
241233,at,0,0
241234,300,0,0
241235,mg/m2/day,0,0
241236,i.v,0,0
241237,.,0,0
241238,for,0,0
241239,5,0,0
241240,days,0,0
241241,",",0,0
241242,and,0,1
241243,repeated,0,0
241244,at,0,0
241245,21-day,0,0
241246,intervals,0,0
241247,for,0,0
241248,a,0,0
241249,maximum,0,0
241250,of,0,0
241251,four,0,0
241252,cycles,0,0
241253,.,0,0
241254,Escalation,0,0
241255,and,0,1
241256,reduction,0,1
241257,in,0,0
241258,dose,0,0
241259,was,0,0
241260,mandated,0,0
241261,dependent,0,0
241262,on,0,0
241263,hematotoxicity,1,1
241264,or,0,0
241265,lack,0,0
241266,thereof,0,1
241267,.,0,0
241268,Toxicity,1,1
241269,was,0,0
241270,primarily,0,0
241271,hematological,0,1
241272,and,0,0
241273,bimodal,0,0
241274,:,0,0
241275,32,0,0
241276,%,0,0
241277,had,0,0
241278,grade,1,0
241279,3,1,0
241280,or,1,0
241281,4,1,0
241282,leukopenia,1,1
241283,and,0,0
241284,24,0,0
241285,%,0,0
241286,had,0,0
241287,grade,1,0
241288,3,1,0
241289,or,1,0
241290,4,1,0
241291,thrombocytopenia,1,0
241292,;,1,0
241293,22,0,0
241294,%,0,0
241295,had,0,0
241296,no,0,0
241297,leukopenia,1,1
241298,and,0,0
241299,44,0,0
241300,%,0,0
241301,had,0,0
241302,no,0,0
241303,thrombocytopenia,1,0
241304,.,1,0
241305,The,0,0
241306,response,1,1
241307,rate,1,1
241308,was,0,0
241309,18,0,0
241310,%,0,0
241311,",",0,0
241312,including,0,0
241313,one,0,0
241314,complete,0,0
241315,response,0,0
241316,.,0,0
241317,When,0,0
241318,response,0,1
241319,was,0,0
241320,analyzed,0,0
241321,by,0,0
241322,hematological,1,1
241323,toxicity,1,1
241324,",",0,0
241325,there,0,0
241326,was,0,0
241327,a,0,0
241328,35.7,0,0
241329,%,0,0
241330,response,0,0
241331,if,0,0
241332,patients,0,0
241333,had,0,0
241334,leukopenia,1,1
241335,grade,0,0
241336,3/4,0,0
241337,(,0,0
241338,versus,0,0
241339,8.3,0,0
241340,%,0,0
241341,",",0,0
241342,P,0,0
241343,=,0,0
241344,0.08,0,0
241345,),0,0
241346,.,0,0
241347,There,0,0
241348,was,0,0
241349,a,0,0
241350,50,0,0
241351,%,0,0
241352,response,1,0
241353,if,0,0
241354,patients,0,0
241355,had,0,0
241356,thrombocytopenia,1,0
241357,grade,0,0
241358,3/4,0,0
241359,(,0,0
241360,versus,0,0
241361,7.1,0,0
241362,%,0,0
241363,",",0,0
241364,P,0,0
241365,=,0,0
241366,<,0,0
241367,0.01,0,0
241368,),0,0
241369,.,0,0
241370,We,0,0
241371,conclude,0,0
241372,that,0,0
241373,amonafide,0,0
241374,is,0,0
241375,somewhat,0,0
241376,active,0,0
241377,in,0,0
241378,previously,0,0
241379,untreated,0,0
241380,breast,0,0
241381,cancer,0,0
241382,patients,0,0
241383,.,0,0
241384,There,0,0
241385,may,0,0
241386,be,0,0
241387,a,0,0
241388,steep,1,0
241389,dose-response,1,0
241390,curve,1,1
241391,",",0,0
241392,based,0,0
241393,on,0,0
241394,the,0,0
241395,significant,0,0
241396,correlation,0,0
241397,between,0,0
241398,myelosuppression,1,1
241399,and,0,0
241400,response,0,1
241401,.,0,0
241402,Rates,1,0
241403,of,1,0
241404,responses,1,1
241405,in,0,0
241406,patients,0,0
241407,adequately,0,0
241408,dosed,0,0
241409,(,0,0
241410,i.e.,0,0
241411,",",0,0
241412,with,0,0
241413,significant,0,0
241414,hematotoxicity,0,1
241415,),0,0
241416,with,0,0
241417,amonafide,0,0
241418,ranged,0,0
241419,from,0,0
241420,35,0,0
241421,to,0,0
241422,50,0,0
241423,%,0,0
241424,.,0,0
241425,Further,0,0
241426,studies,0,0
241427,will,0,0
241428,incorporate,0,0
241429,individualized,0,0
241430,dosing,0,0
241431,based,0,0
241432,on,0,0
241433,pretreatment,0,0
241434,acetylator,0,0
241435,phenotyping,0,0
241436,.,0,0
241437,Long-term,1,0
241438,outcome,1,0
241439,of,0,0
241440,migraine,0,0
241441,therapy,0,0
241442,:,0,0
241443,predictive,0,1
241444,value,0,0
241445,of,0,0
241446,the,0,0
241447,frontotemporal,0,0
241448,nitroglycerin,0,0
241449,test,0,0
241450,.,0,0
241451,We,0,0
241452,evaluated,0,0
241453,whether,0,0
241454,type,0,0
241455,of,0,0
241456,response,0,1
241457,to,0,0
241458,the,0,0
241459,migraine-induction,0,0
241460,test,0,0
241461,with,0,0
241462,a,0,0
241463,nitroglycerin,0,0
241464,ointment,0,0
241465,applied,0,0
241466,to,0,0
241467,the,0,0
241468,frontotemporal,0,0
241469,head,0,0
241470,region,0,0
241471,could,0,0
241472,predict,1,0
241473,the,1,0
241474,efficacy,1,1
241475,of,1,0
241476,antimigraine,1,0
241477,therapy,1,0
241478,.,1,0
241479,Forty-two,0,0
241480,patients,0,0
241481,with,0,0
241482,migraine,0,0
241483,without,0,0
241484,aura,0,0
241485,underwent,0,0
241486,the,0,0
241487,test,0,0
241488,before,0,0
241489,and,0,0
241490,2,0,0
241491,months,0,0
241492,after,0,0
241493,antimigraine,0,0
241494,therapy,0,0
241495,.,0,0
241496,Two,0,0
241497,and,0,0
241498,4,0,0
241499,months,0,0
241500,after,0,0
241501,treatment,0,0
241502,withdrawal,0,1
241503,",",0,0
241504,most,0,0
241505,subjects,0,0
241506,with,0,0
241507,a,0,0
241508,negative,0,0
241509,response,0,1
241510,to,0,0
241511,the,0,0
241512,post-treatment,0,0
241513,test,0,0
241514,maintained,1,0
241515,treatment,1,0
241516,benefit,1,1
241517,",",0,0
241518,whereas,0,0
241519,benefit,1,1
241520,was,0,0
241521,lost,0,1
241522,in,0,0
241523,patients,0,0
241524,with,0,0
241525,an,0,0
241526,early,1,0
241527,onset,1,1
241528,migraine,1,0
241529,response,1,1
241530,.,1,0
241531,Yohimbine,0,0
241532,in,0,0
241533,neurally,0,0
241534,mediated,0,0
241535,syncope,0,0
241536,.,0,0
241537,Pathophysiological,0,1
241538,implications,0,0
241539,.,0,0
241540,In,0,0
241541,this,0,0
241542,study,0,0
241543,",",0,0
241544,we,0,0
241545,evaluated,0,0
241546,if,0,0
241547,increased,0,0
241548,sympathetic,0,0
241549,stimulation,0,0
241550,is,0,0
241551,an,0,0
241552,essential,0,0
241553,requirement,0,1
241554,for,0,0
241555,the,0,0
241556,development,0,0
241557,of,0,0
241558,neurally,0,0
241559,mediated,0,0
241560,syncope,0,0
241561,(,0,0
241562,NMS,0,0
241563,),0,0
241564,by,0,0
241565,manipulating,0,0
241566,overall,0,1
241567,sympathetic,0,1
241568,outflow,0,1
241569,in,0,0
241570,subjects,0,0
241571,susceptible,0,0
241572,to,0,0
241573,tilt-induced,0,0
241574,syncope,0,0
241575,.,0,0
241576,Eight,0,0
241577,previously,0,0
241578,characterized,0,0
241579,patients,0,0
241580,with,0,0
241581,recurrent,0,1
241582,NMS,0,0
241583,(,0,0
241584,five,0,0
241585,females,0,0
241586,and,0,0
241587,three,0,0
241588,males,0,0
241589,;,0,0
241590,34+/-2,0,0
241591,yr,0,0
241592,),0,0
241593,were,0,0
241594,recruited,0,0
241595,from,0,0
241596,the,0,0
241597,Vanderbilt,0,0
241598,Syncope,0,1
241599,Unit,0,0
241600,and,0,0
241601,eight,0,0
241602,age-matched,0,0
241603,controls,0,0
241604,underwent,0,0
241605,initial,0,0
241606,administration,0,0
241607,of,0,0
241608,clonidine,0,0
241609,(,0,0
241610,CLO,0,0
241611,),0,1
241612,or,0,0
241613,yohimbine,0,0
241614,(,0,1
241615,YHO,0,1
241616,),0,0
241617,.,0,0
241618,This,0,0
241619,was,0,0
241620,done,0,0
241621,",",0,0
241622,prospectively,0,0
241623,",",0,0
241624,to,0,0
241625,determine,0,0
241626,doses,0,0
241627,of,0,0
241628,these,0,0
241629,agents,0,0
241630,that,0,0
241631,would,0,0
241632,increase,0,0
241633,or,0,0
241634,decrease,0,1
241635,plasma,1,1
241636,norepinephrine,1,1
241637,levels,1,1
241638,by,0,0
241639,>,0,0
241640,/=,0,0
241641,30,0,0
241642,%,0,0
241643,.,0,0
241644,On,0,0
241645,a,0,0
241646,different,0,0
241647,day,0,0
241648,",",0,0
241649,in,0,0
241650,all,0,0
241651,subjects,0,0
241652,we,0,0
241653,determined,0,0
241654,intraarterial,1,0
241655,blood,1,1
241656,pressure,1,1
241657,",",1,1
241658,EKG,1,0
241659,and,1,1
241660,muscle,1,1
241661,sympathetic,1,1
241662,nerve,1,1
241663,activity,1,1
241664,(,1,0
241665,MSNA,1,0
241666,),1,0
241667,both,0,0
241668,supine,0,0
241669,and,0,0
241670,during,0,0
241671,upright,0,0
241672,tilt,0,1
241673,.,0,0
241674,After,0,0
241675,this,0,0
241676,",",0,0
241677,subjects,0,0
241678,randomly,0,0
241679,received,0,0
241680,either,0,0
241681,CLO,0,0
241682,or,0,1
241683,YHO,0,1
241684,",",0,0
241685,and,0,0
241686,3,0,0
241687,h,0,0
241688,later,0,0
241689,another,0,0
241690,tilt,0,1
241691,was,0,0
241692,performed,0,0
241693,.,0,0
241694,After,0,0
241695,1,0,0
241696,wk,0,0
241697,",",0,0
241698,a,0,0
241699,similar,0,0
241700,procedure,0,0
241701,with,0,0
241702,the,0,0
241703,other,0,0
241704,drug,0,0
241705,was,0,0
241706,performed,0,0
241707,.,0,0
241708,During,0,0
241709,the,0,0
241710,two,0,0
241711,basal,0,0
241712,tilts,0,0
241713,",",0,0
241714,all,0,0
241715,the,0,0
241716,control,0,0
241717,subjects,0,0
241718,completed,0,0
241719,the,0,0
241720,study,0,0
241721,",",0,0
241722,whereas,0,0
241723,all,0,0
241724,the,0,0
241725,NMS,0,0
241726,patients,0,0
241727,developed,0,0
241728,syncope,0,0
241729,.,0,0
241730,Reduction,1,0
241731,in,1,0
241732,sympathetic,1,1
241733,tone,1,1
241734,by,0,0
241735,CLO,0,0
241736,resulted,0,0
241737,in,0,0
241738,a,0,0
241739,decreased,0,0
241740,tolerance,1,1
241741,to,1,0
241742,tilt,1,0
241743,in,0,0
241744,three,0,0
241745,out,0,0
241746,of,0,0
241747,eight,0,0
241748,controls,0,0
241749,and,0,0
241750,in,0,0
241751,all,0,0
241752,the,0,0
241753,NMS,0,0
241754,patients,0,0
241755,.,0,0
241756,In,0,0
241757,contrast,0,0
241758,",",0,0
241759,YHO,0,1
241760,not,0,0
241761,only,0,0
241762,increased,0,0
241763,basal,1,1
241764,plasma,1,1
241765,NorEpi,1,1
241766,levels,1,1
241767,and,1,1
241768,MSNA,1,1
241769,",",0,1
241770,but,0,0
241771,also,0,0
241772,prevented,0,0
241773,syncope,1,0
241774,in,0,0
241775,seven,0,0
241776,out,0,0
241777,of,0,0
241778,eight,0,0
241779,patients,0,0
241780,.,0,0
241781,In,0,0
241782,a,0,0
241783,selected,0,0
241784,population,0,0
241785,of,0,0
241786,patients,0,0
241787,",",0,0
241788,increased,0,0
241789,sympathetic,1,0
241790,activity,1,1
241791,is,0,0
241792,not,0,0
241793,a,0,0
241794,prerequisite,0,0
241795,for,0,0
241796,the,0,0
241797,development,0,0
241798,of,0,0
241799,syncope,0,0
241800,.,0,0
241801,Yohimbine-induced,0,0
241802,enhancement,0,0
241803,of,0,0
241804,sympathetic,0,1
241805,tone,0,1
241806,in,0,0
241807,patients,0,0
241808,with,0,0
241809,NMS,0,0
241810,improves,0,1
241811,orthostatic,0,1
241812,tolerance,0,1
241813,and,0,0
241814,raises,0,0
241815,the,0,0
241816,possibility,0,0
241817,that,0,0
241818,this,0,0
241819,drug,0,0
241820,may,0,0
241821,be,0,0
241822,a,0,0
241823,useful,0,0
241824,agent,0,0
241825,in,0,0
241826,the,0,0
241827,treatment,0,0
241828,of,0,0
241829,NMS,0,0
241830,.,0,0
241831,BEACOPP,0,0
241832,",",0,0
241833,a,0,0
241834,new,0,0
241835,dose-escalated,0,0
241836,and,0,0
241837,accelerated,0,1
241838,regimen,0,0
241839,",",0,0
241840,is,0,0
241841,at,0,0
241842,least,0,0
241843,as,0,0
241844,effective,0,0
241845,as,0,0
241846,COPP/ABVD,0,1
241847,in,0,0
241848,patients,0,0
241849,with,0,0
241850,advanced-stage,0,0
241851,Hodgkin,0,1
241852,'s,0,0
241853,lymphoma,0,0
241854,:,0,0
241855,interim,0,0
241856,report,0,0
241857,from,0,0
241858,a,0,0
241859,trial,0,0
241860,of,0,0
241861,the,0,0
241862,German,0,0
241863,Hodgkin,0,1
241864,'s,0,0
241865,Lymphoma,0,0
241866,Study,0,0
241867,Group,0,0
241868,.,0,0
241869,PURPOSE,0,0
241870,The,0,0
241871,HD9,0,1
241872,trial,0,0
241873,aims,0,0
241874,to,0,0
241875,evaluate,0,0
241876,whether,0,0
241877,moderate,0,0
241878,dose,0,0
241879,escalation,0,0
241880,and/or,0,0
241881,acceleration,0,1
241882,of,0,0
241883,standard,0,0
241884,polychemotherapy,0,0
241885,is,0,0
241886,beneficial,0,0
241887,for,0,0
241888,advanced-stage,0,0
241889,Hodgkin,0,1
241890,'s,0,1
241891,disease,0,1
241892,(,0,0
241893,HD,0,0
241894,),0,0
241895,.,0,0
241896,Two,0,0
241897,variants,0,0
241898,of,0,0
241899,a,0,0
241900,novel,0,0
241901,bleomycin,0,0
241902,",",0,0
241903,etoposide,0,0
241904,",",0,0
241905,doxorubicin,0,0
241906,",",0,1
241907,cyclophosphamide,0,0
241908,",",0,1
241909,vincristine,0,0
241910,",",0,1
241911,procarbazine,0,0
241912,",",0,1
241913,and,0,1
241914,prednisone,0,0
241915,(,0,1
241916,BEACOPP,0,0
241917,),0,1
241918,scheme,0,0
241919,(,0,0
241920,standard,0,0
241921,and,0,1
241922,escalated,0,0
241923,dose,0,0
241924,),0,0
241925,are,0,0
241926,compared,0,0
241927,with,0,0
241928,cyclophosphamide,0,0
241929,",",0,0
241930,vincristine,0,0
241931,",",0,1
241932,procarbazine,0,0
241933,",",0,1
241934,and,0,1
241935,prednisone,0,0
241936,(,0,1
241937,COPP,0,1
241938,),0,1
241939,/doxorubicin,0,0
241940,",",0,0
241941,bleomycin,0,0
241942,",",0,1
241943,vinblastine,0,0
241944,",",0,1
241945,and,0,1
241946,dacarbazine,0,0
241947,(,0,1
241948,ABVD,0,1
241949,),0,0
241950,.,0,0
241951,PATIENTS,0,0
241952,AND,0,0
241953,METHODS,0,0
241954,The,0,0
241955,randomized,0,0
241956,",",0,0
241957,three-arm,0,0
241958,trial,0,0
241959,recruited,0,0
241960,patients,0,0
241961,in,0,0
241962,stages,0,0
241963,IIB,0,1
241964,and,0,0
241965,IIIA,0,1
241966,with,0,0
241967,risk,0,1
241968,factors,0,0
241969,and,0,0
241970,stages,0,1
241971,IIIB,0,1
241972,and,0,0
241973,IV,0,1
241974,.,0,0
241975,BEACOPP,0,0
241976,in,0,0
241977,baseline,0,0
241978,dose,0,0
241979,contains,0,0
241980,all,0,0
241981,drug,0,0
241982,dosages,0,0
241983,of,0,0
241984,COPP/ABVD,0,1
241985,(,0,0
241986,except,0,0
241987,vincristine,0,0
241988,and,0,1
241989,procarbazine,0,0
241990,),0,1
241991,rearranged,0,0
241992,in,0,0
241993,a,0,0
241994,shorter,0,0
241995,",",0,0
241996,3-week,0,0
241997,cycle,0,1
241998,.,0,0
241999,Escalated,0,0
242000,BEACOPP,0,0
242001,uses,0,0
242002,higher,0,0
242003,doses,0,0
242004,of,0,1
242005,cyclophosphamide,0,0
242006,",",0,0
242007,doxorubicin,0,0
242008,",",0,1
242009,and,0,0
242010,etoposide,0,0
242011,with,0,0
242012,granulocyte,0,1
242013,colony-stimulating,0,1
242014,factor,0,0
242015,(,0,0
242016,G-CSF,0,0
242017,),0,0
242018,support,0,0
242019,.,0,0
242020,After,0,0
242021,eight,0,0
242022,chemotherapy,0,0
242023,cycles,0,0
242024,",",0,0
242025,initial,0,1
242026,bulky,0,0
242027,and,0,0
242028,residual,0,1
242029,disease,0,0
242030,is,0,0
242031,irradiated,0,0
242032,.,0,0
242033,The,0,0
242034,trial,0,0
242035,is,0,0
242036,monitored,0,0
242037,and,0,0
242038,analyzed,0,0
242039,by,0,0
242040,means,0,0
242041,of,0,0
242042,a,0,0
242043,sequential,0,0
242044,strategy,0,0
242045,.,0,0
242046,RESULTS,0,0
242047,An,0,0
242048,interim,0,0
242049,analysis,0,0
242050,with,0,0
242051,505,0,0
242052,assessable,0,0
242053,patients,0,0
242054,and,0,0
242055,a,0,0
242056,median,0,1
242057,follow-up,0,0
242058,of,0,0
242059,23,0,0
242060,months,0,0
242061,showed,0,0
242062,a,0,0
242063,significant,0,0
242064,inferiority,0,0
242065,(,0,0
242066,according,0,0
242067,to,0,0
242068,sequential,0,0
242069,monitoring,0,0
242070,strategy,0,0
242071,),0,0
242072,of,0,0
242073,the,0,0
242074,COPP/ABVD,0,1
242075,regimen,0,0
242076,in,0,0
242077,progression,1,1
242078,rate,1,1
242079,and,1,1
242080,freedom,1,1
242081,from,1,0
242082,treatment,1,0
242083,failure,1,1
242084,(,1,0
242085,FFTF,1,0
242086,),1,0
242087,compared,0,0
242088,with,0,0
242089,the,0,0
242090,pooled,0,0
242091,results,0,0
242092,of,0,0
242093,both,0,0
242094,BEACOPP,0,0
242095,variants,0,0
242096,.,0,0
242097,The,0,0
242098,24-month,1,0
242099,FFTF,1,0
242100,rate,1,1
242101,was,0,0
242102,75,0,0
242103,%,0,0
242104,for,0,0
242105,COPP/ABVD,0,1
242106,and,0,0
242107,84,0,0
242108,%,0,0
242109,for,0,0
242110,BEACOPP,0,1
242111,pooled,0,0
242112,(,0,0
242113,P,0,0
242114,=,0,0
242115,.034,0,0
242116,),0,0
242117,.,0,0
242118,There,0,0
242119,was,0,0
242120,12,0,0
242121,%,0,0
242122,progressive,1,0
242123,disease,1,0
242124,with,0,0
242125,COPP/ABVD,0,1
242126,and,0,0
242127,6,0,0
242128,%,0,0
242129,with,0,0
242130,BEACOPP,0,0
242131,pooled,0,0
242132,.,0,0
242133,Differences,1,0
242134,in,1,0
242135,survival,1,1
242136,were,0,0
242137,not,0,0
242138,significant,0,0
242139,in,0,0
242140,sequential,0,0
242141,analysis,0,0
242142,.,0,0
242143,The,0,0
242144,acute,1,0
242145,toxicity,1,1
242146,of,1,0
242147,baseline,1,0
242148,BEACOPP,1,0
242149,resembled,0,0
242150,that,0,0
242151,of,0,0
242152,COPP/ABVD,0,1
242153,;,0,0
242154,escalated,0,0
242155,BEACOPP,0,0
242156,showed,0,0
242157,increased,0,0
242158,but,0,0
242159,manageable,0,0
242160,hematologic,0,1
242161,toxicity,0,1
242162,.,0,0
242163,CONCLUSION,0,0
242164,Combined,0,0
242165,with,0,0
242166,local,0,1
242167,irradiation,0,0
242168,",",0,0
242169,BEACOPP,0,0
242170,in,0,0
242171,one,0,0
242172,or,0,0
242173,both,0,0
242174,variants,0,0
242175,shows,0,0
242176,superior,0,0
242177,disease,0,1
242178,control,0,0
242179,compared,0,0
242180,with,0,0
242181,COPP/ABVD,0,1
242182,",",0,0
242183,with,0,0
242184,acceptable,0,1
242185,acute,0,0
242186,toxicity,0,1
242187,.,0,0
242188,Further,0,0
242189,follow-up,0,0
242190,is,0,0
242191,required,0,0
242192,to,0,0
242193,assess,0,0
242194,the,0,0
242195,effect,0,0
242196,of,0,0
242197,dosage,0,0
242198,and,0,0
242199,the,0,0
242200,effect,0,0
242201,on,0,0
242202,survival,0,1
242203,and,0,0
242204,late,0,0
242205,toxicities,0,1
242206,.,0,0
242207,Study,0,0
242208,of,0,0
242209,cytosine,0,0
242210,arabinoside,0,0
242211,(,0,0
242212,NSC-63878,0,0
242213,),0,1
242214,synchronization,0,1
242215,plus,0,0
242216,vincristine,0,0
242217,(,0,1
242218,NSC-67574,0,0
242219,),0,0
242220,",",0,0
242221,prednisone,0,0
242222,(,0,1
242223,NSC-10023,0,0
242224,),0,1
242225,",",0,0
242226,and,0,1
242227,L-asparaginase,0,0
242228,(,0,0
242229,NSC-109229,0,0
242230,),0,0
242231,for,0,0
242232,remission,0,1
242233,induction,0,1
242234,in,0,0
242235,advanced,0,0
242236,acute,0,0
242237,leukemia,0,0
242238,in,0,0
242239,children,0,0
242240,.,0,0
242241,Cytosine,0,0
242242,arabinoside,0,0
242243,(,0,0
242244,CA,0,0
242245,),0,0
242246,was,0,0
242247,utilized,0,0
242248,in,0,0
242249,efforts,0,0
242250,to,0,0
242251,synchronize,0,0
242252,leukemic,0,1
242253,cells,0,1
242254,in,0,0
242255,DNA,0,1
242256,synthesis,0,1
242257,for,0,0
242258,treatment,0,0
242259,with,0,0
242260,vincristine,0,0
242261,",",0,0
242262,prednisone,0,0
242263,",",0,1
242264,and,0,1
242265,L-asparaginase,0,0
242266,in,0,0
242267,children,0,0
242268,with,0,0
242269,acute,0,0
242270,leukemia,0,0
242271,in,0,0
242272,relapse,0,1
242273,.,0,0
242274,The,0,0
242275,results,0,0
242276,did,0,0
242277,not,0,0
242278,indicate,0,0
242279,any,0,0
242280,therapeutic,1,0
242281,advantage,1,0
242282,for,0,0
242283,patients,0,0
242284,treated,0,0
242285,with,0,0
242286,this,0,0
242287,combination,0,0
242288,compared,0,0
242289,to,0,0
242290,those,0,0
242291,treated,0,0
242292,without,0,0
242293,any,0,0
242294,attempt,0,0
242295,at,0,0
242296,CA,0,0
242297,synchronization,0,0
242298,.,0,0
242299,Videotaped,0,0
242300,training,0,0
242301,in,0,0
242302,alcohol,0,0
242303,counseling,0,0
242304,for,0,0
242305,obstetric,0,1
242306,care,0,0
242307,practitioners,0,0
242308,:,0,0
242309,a,0,0
242310,randomized,0,0
242311,controlled,0,0
242312,trial,0,0
242313,.,0,0
242314,OBJECTIVE,0,0
242315,To,0,0
242316,determine,0,0
242317,the,0,0
242318,feasibility,0,0
242319,of,0,0
242320,videotaped,0,0
242321,training,0,0
242322,for,0,0
242323,obstetric,0,1
242324,care,0,0
242325,practitioners,0,0
242326,in,0,0
242327,motivational,0,0
242328,interviewing,0,0
242329,skills,0,1
242330,that,0,0
242331,could,0,0
242332,be,0,0
242333,used,0,0
242334,in,0,0
242335,brief,0,0
242336,patient,0,0
242337,consultations,0,0
242338,on,0,0
242339,problem,0,0
242340,drinking,0,1
242341,.,0,0
242342,METHODS,0,0
242343,Thirty,0,0
242344,health,0,1
242345,care,0,0
242346,practitioners,0,0
242347,participated,0,0
242348,in,0,0
242349,a,0,0
242350,clinical,0,0
242351,trial,0,0
242352,using,0,0
242353,a,0,0
242354,20-minute,0,0
242355,videotape,0,0
242356,to,0,0
242357,instruct,0,0
242358,them,0,0
242359,in,0,0
242360,motivational,0,0
242361,interviewing,0,0
242362,.,0,0
242363,Participants,0,0
242364,engaged,0,0
242365,in,0,0
242366,a,0,0
242367,pretest,0,0
242368,roleplay,0,0
242369,with,0,0
242370,an,0,0
242371,actress,0,0
242372,playing,0,0
242373,a,0,0
242374,drinking,0,1
242375,pregnant,0,0
242376,woman,0,0
242377,.,0,0
242378,Those,0,0
242379,randomly,0,0
242380,assigned,0,0
242381,to,0,0
242382,the,0,0
242383,experimental,0,0
242384,condition,0,0
242385,watched,0,0
242386,the,0,0
242387,motivational,0,0
242388,interviewing,0,0
242389,videotape,0,0
242390,.,0,0
242391,Control,0,0
242392,condition,0,0
242393,participants,0,0
242394,watched,0,0
242395,a,0,0
242396,20-minute,0,0
242397,docudrama,0,0
242398,of,0,0
242399,a,0,0
242400,pregnant,0,0
242401,problem,0,0
242402,drinker,0,0
242403,.,0,0
242404,Both,0,0
242405,groups,0,0
242406,then,0,0
242407,engaged,0,0
242408,in,0,0
242409,a,0,0
242410,post-test,0,0
242411,roleplay,0,0
242412,similar,0,0
242413,to,0,0
242414,the,0,0
242415,pretest,0,0
242416,.,0,0
242417,Behavioral,1,0
242418,ratings,1,1
242419,of,1,0
242420,the,1,0
242421,roleplays,1,0
242422,and,1,0
242423,participant,1,0
242424,evaluations,1,0
242425,of,1,0
242426,the,1,0
242427,motivational,1,0
242428,interviewing,1,0
242429,video,1,0
242430,constituted,1,0
242431,the,1,0
242432,outcome,1,0
242433,measures,1,0
242434,.,1,0
242435,RESULTS,0,0
242436,Participant,0,0
242437,evaluations,0,0
242438,indicated,0,0
242439,that,0,0
242440,the,0,0
242441,training,0,0
242442,video,0,0
242443,was,0,0
242444,clear,0,0
242445,in,0,0
242446,explaining,0,0
242447,and,0,0
242448,demonstrating,0,0
242449,the,0,0
242450,principles,0,0
242451,and,0,0
242452,skills,0,1
242453,of,0,1
242454,motivational,0,0
242455,interviewing,0,0
242456,.,0,0
242457,Change,0,0
242458,in,0,0
242459,behavioral,0,1
242460,ratings,0,1
242461,from,0,0
242462,pretest,0,0
242463,to,0,0
242464,post-test,0,0
242465,showed,0,0
242466,significant,0,0
242467,differences,0,0
242468,in,0,0
242469,motivational,0,0
242470,interviewing,0,0
242471,skills,0,1
242472,between,0,0
242473,the,0,0
242474,experimental,0,0
242475,and,0,0
242476,control,0,0
242477,groups,0,0
242478,.,0,0
242479,Obstetric,0,1
242480,care,0,0
242481,practitioners,0,0
242482,who,0,0
242483,viewed,0,0
242484,the,0,0
242485,training,0,0
242486,video,0,0
242487,were,0,0
242488,rated,0,1
242489,as,0,0
242490,showing,0,0
242491,greater,0,0
242492,empathy,1,1
242493,",",0,1
242494,minimizing,0,1
242495,patient,1,1
242496,defensiveness,1,1
242497,",",0,0
242498,and,0,1
242499,supporting,1,0
242500,women,1,0
242501,'s,1,0
242502,beliefs,1,0
242503,in,1,0
242504,their,1,0
242505,ability,1,0
242506,to,1,0
242507,change,1,0
242508,.,1,0
242509,CONCLUSION,0,0
242510,Obstetric,0,1
242511,care,0,0
242512,practitioners,0,0
242513,can,0,0
242514,improve,0,0
242515,their,0,0
242516,alcohol,0,0
242517,intervention,0,0
242518,skills,0,1
242519,through,0,0
242520,the,0,0
242521,use,0,0
242522,of,0,0
242523,a,0,0
242524,20-minute,0,0
242525,videotaped,0,0
242526,instruction,0,0
242527,in,0,0
242528,motivational,0,0
242529,interviewing,0,0
242530,.,0,0
242531,Clinicians,0,0
242532,who,0,0
242533,improve,0,0
242534,their,0,0
242535,skills,0,1
242536,in,0,0
242537,motivational,0,0
242538,interviewing,0,0
242539,can,0,0
242540,intervene,0,0
242541,more,0,0
242542,effectively,0,0
242543,with,0,0
242544,their,0,0
242545,drinking,0,0
242546,pregnant,0,0
242547,patients,0,0
242548,.,0,0
242549,Using,0,0
242550,motivational,0,0
242551,interviewing,0,0
242552,with,0,0
242553,this,0,0
242554,population,0,0
242555,holds,0,0
242556,promise,0,0
242557,for,0,0
242558,helping,0,0
242559,prevent,0,0
242560,alcohol-related,0,0
242561,health,0,0
242562,problems,0,0
242563,.,0,0
